Skeletal B-Gene +
muscle I-Gene +
type I-Gene +
ryanodine I-Gene +
receptor I-Gene +
is O +
involved O +
in O +
calcium O +
signaling O +
in O +
human O +
B O +
lymphocytes O +
. O +

The O +
regulation O +
of O +
intracellular O +
free O +
Ca2 O -
+ O +
concentration O +
( O +
[ O +
Ca2 O -
+ O +
] O +
i O +
) O +
in O +
B O +
cells O +
remains O +
poorly O +
understood O +
and O +
is O +
presently O +
explained O +
almost O +
solely O +
by O +
inositol O +
1,4,5-triphosphate O +
( O +
IP3 O +
) O +
- O +
mediated O +
Ca2 O -
+ O +
release O +
, O +
followed O +
by O +
activation O +
of O +
a O +
store O +
- O +
operated O +
channel O +
mechanism O +
. O +

In O +
fact O +
, O +
there O +
are O +
reports O +
indicating O +
that O +
IP3 O +
production O +
does O +
not O +
always O +
correlate O +
with O +
the O +
magnitude O +
of O +
Ca2 O -
+ O +
release O +
. O +

We O +
demonstrate O +
here O +
that O +
human O +
B O +
cells O +
express O +
a O +
ryanodine B-Gene +
receptor I-Gene +
( O +
RYR B-Gene +
) O +
that O +
functions O +
as O +
a O +
Ca2 O -
+ O +
release O +
channel O +
during O +
the O +
B B-Gene +
cell I-Gene +
antigen I-Gene +
receptor I-Gene +
( O +
BCR B-Gene +
) O +
- O +
stimulated O +
Ca2 O -
+ O +
signaling O +
process O +
. O +

Immunoblotting O +
studies O +
showed O +
that O +
both O +
human O +
primary O +
CD19 B-Gene +
( O +
+ O +
) O +
B O +
and O +
DAKIKI O +
cells O +
express O +
a O +
565 O +
- O +
kDa O +
immunoreactive O +
protein O +
that O +
is O +
indistinguishable O +
in O +
molecular O +
size O +
and O +
immunoreactivity O +
from O +
the O +
RYR B-Gene +
. O +

Selective O +
reverse O +
transcription O +
- O +
polymerase O +
chain O +
reaction O +
, O +
restriction O +
fragment O +
length O +
polymorphism O +
, O +
and O +
sequencing O +
of O +
cloned O +
cDNA O +
indicated O +
that O +
the O +
major O +
isoform O +
of O +
the O +
RYR B-Gene +
expressed O +
in O +
primary O +
CD19 B-Gene +
( O +
+ O +
) O +
B O +
and O +
DAKIKI O +
cells O +
is O +
identical O +
to O +
the O +
skeletal B-Gene +
muscle I-Gene +
type I-Gene +
( O +
RYR1 B-Gene +
) O +
. O +

Saturation O +
analysis O +
of O +
[ O -
3H O -
] O -
ryanodine O +
binding O +
yielded O +
Bmax O +
= O +
150 O +
fmol O +
/ O +
mg O +
of O +
protein O +
and O +
Kd O +
= O +
110 O +
nM O +
in O +
DAKIKI O +
cells O +
. O +

In O +
fluo-3-loaded O +
CD19 B-Gene +
( O +
+ O +
) O +
B O +
and O +
DAKIKI O +
cells O +
, O +
4-chloro O -
- O -
m O -
- O -
cresol O +
, O +
a O +
potent O +
activator O +
of O +
Ca2 O -
+ O +
release O +
mediated O +
by O +
the O +
ryanodine O +
- O +
sensitive O +
Ca2 O -
+ O +
release O +
channel O +
, O +
induced O +
Ca2 O -
+ O +
release O +
in O +
a O +
dose O +
- O +
dependent O +
and O +
ryanodine O +
- O +
sensitive O +
fashion O +
. O +

Furthermore O +
, O +
BCR B-Gene +
- O +
mediated O +
Ca2 O -
+ O +
release O +
in O +
CD19 B-Gene +
( O +
+ O +
) O +
B O +
cells O +
was O +
significantly O +
altered O +
by O +
4-chloro O -
- O -
m O -
- O -
cresol O +
and O +
ryanodine O +
. O +

These O +
results O +
indicate O +
that O +
RYR1 B-Gene +
functions O +
as O +
a O +
Ca2 O -
+ O +
release O +
channel O +
during O +
BCR B-Gene +
- O +
stimulated O +
Ca2 O -
+ O +
signaling O +
and O +
suggest O +
that O +
complex O +
Ca2 O -
+ O +
signals O +
that O +
control O +
the O +
cellular O +
activities O +
of O +
B O +
cells O +
may O +
be O +
generated O +
by O +
cooperation O +
of O +
the O +
IP3 B-Gene +
receptor I-Gene +
and O +
RYR1 B-Gene +
. O +

An O +
interluekin B-Gene +
1B I-Gene +
allele O +
, O +
which O +
correlates O +
with O +
a O +
high O +
secretor O +
phenotype O +
, O +
is O +
associated O +
with O +
diabetic O +
nephropathy O +
. O +

Induction O +
of O +
interleukin B-Gene +
1 I-Gene +
activates O +
vascular O +
endothelial O +
and O +
kidney O +
mesangial O +
cells O +
, O +
and O +
increases O +
production O +
of O +
type O +
IV O +
( O +
basement O +
membrane O +
) O +
collagen B-Gene +
. O +

Hence O +
, O +
genes O +
within O +
the O +
interleukin B-Gene +
1 I-Gene +
gene O +
cluster O +
are O +
potential O +
candidates O +
in O +
the O +
pathogenesis O +
of O +
diabetic O +
nephropathy O +
. O +

In O +
a O +
previously O +
validated O +
case O +
- O +
control O +
study O +
from O +
Northern O +
Ireland O +
, O +
consisting O +
of O +
95 O +
patients O +
with O +
insulin B-Gene +
- O +
dependent O +
( O +
type O +
1 O +
) O +
diabetes O +
and O +
nephropathy O +
( O +
cases O +
) O +
and O +
96 O +
patients O +
with O +
insulin B-Gene +
- O +
dependent O +
( O +
type O +
1 O +
) O +
diabetes O +
without O +
nephropathy O +
( O +
controls O +
) O +
, O +
the O +
authors O +
performed O +
PCR O +
- O +
based O +
genotyping O +
of O +
specific O +
DNA O +
polymorphisms O +
within O +
the O +
interleukin B-Gene +
1A I-Gene +
, O +
interleukin B-Gene +
1B I-Gene +
, O +
interleukin B-Gene +
1 I-Gene +
( I-Gene +
type I-Gene +
1 I-Gene +
) I-Gene +
receptor I-Gene +
and O +
interleukin B-Gene +
1 I-Gene +
receptor I-Gene +
antagonist I-Gene +
genes O +
. O +

The O +
groups O +
were O +
matched O +
for O +
age O +
at O +
onset O +
and O +
duration O +
of O +
diabetes O +
. O +

A O +
statistically O +
significant O +
increase O +
was O +
found O +
in O +
the O +
allele O +
frequency O +
of O +
the O +
interleukin B-Gene +
1B*2 I-Gene +
allele O +
in O +
cases O +
compared O +
to O +
controls O +
( O +
chi2 O +
= O +
7 O -
. O +
19 O +
, O +
df O -
. O +
= O +
1 O +
; O +
P O +
= O +
0.007 O +
, O +
Pcorr O +
= O +
0.028 O +
) O +
. O +

The O +
results O +
of O +
this O +
study O +
suggest O +
that O +
the O +
interleukin B-Gene +
1B*2 I-Gene +
allele O +
, O +
or O +
a O +
susceptibility O +
factor O +
in O +
linkage O +
disequilibrium O +
with O +
this O +
allele O +
, O +
is O +
associated O +
with O +
diabetic O +
nephropathy O +
in O +
the O +
Northern O +
Ireland O +
population O +
. O +

Massive O +
presence O +
of O +
the O +
Escherichia O +
coli O +
' O +
major O +
cold B-Gene +
- I-Gene +
shock I-Gene +
protein I-Gene +
' O +
CspA B-Gene +
under O +
non O +
- O +
stress O +
conditions O +
. O +

The O +
most O +
characteristic O +
event O +
of O +
cold O +
- O +
shock O +
activation O +
in O +
Escherichia O +
coli O +
is O +
believed O +
to O +
be O +
the O +
de O +
novo O +
synthesis O +
of O +
CspA B-Gene +
. O +

We O +
demonstrate O +
, O +
however O +
, O +
that O +
the O +
cellular O +
concentration O +
of O +
this O +
protein O +
is O +
> O +
or O +
= O +
50 O +
microM O +
during O +
early O +
exponential O +
growth O +
at O +
37 O +
degrees O +
C O +
; O +
therefore O +
, O +
its O +
designation O +
as O +
a O +
major O +
cold B-Gene +
- I-Gene +
shock I-Gene +
protein I-Gene +
is O +
a O +
misnomer O +
. O +

The O +
cspA B-Gene +
mRNA O +
level O +
decreases O +
rapidly O +
with O +
increasing O +
cell O +
density O +
, O +
becoming O +
virtually O +
undetectable O +
by O +
mid O +
- O +
to O +
- O +
late O +
exponential O +
growth O +
phase O +
while O +
the O +
CspA B-Gene +
level O +
declines O +
, O +
although O +
always O +
remaining O +
clearly O +
detectable O +
. O +

A O +
burst O +
of O +
cspA B-Gene +
expression O +
followed O +
by O +
a O +
renewed O +
decline O +
ensues O +
upon O +
dilution O +
of O +
stationary O +
phase O +
cultures O +
with O +
fresh O +
medium O +
. O +

The O +
extent O +
of O +
cold O +
- O +
shock O +
induction O +
of O +
cspA B-Gene +
varies O +
as O +
a O +
function O +
of O +
the O +
growth O +
phase O +
, O +
being O +
inversely O +
proportional O +
to O +
the O +
pre O +
- O +
existing O +
level O +
of O +
CspA B-Gene +
which O +
suggests O +
feedback O +
autorepression O +
by O +
this O +
protein O +
. O +

Both O +
transcriptional O +
and O +
post O +
- O +
transcriptional O +
controls O +
regulate O +
cspA B-Gene +
expression O +
under O +
non O +
- O +
stress O +
conditions O +
; O +
transcription O +
of O +
cspA B-Gene +
mRNA O +
is O +
under O +
the O +
antagonistic O +
control O +
of O +
DNA O +
- O +
binding O +
proteins O +
Fis B-Gene +
and O +
H B-Gene -
- I-Gene -
NS I-Gene +
both O +
in O +
vivo O +
and O +
in O +
vitro O +
, O +
while O +
its O +
decreased O +
half O +
- O +
life O +
with O +
increasing O +
cell O +
density O +
contributes O +
to O +
its O +
rapid O +
disappearance O +
. O +

The O +
cspA B-Gene +
mRNA O +
instability O +
is O +
due O +
to O +
its O +
5 O -
' O +
untranslated O +
leader O +
and O +
is O +
counteracted O +
in O +
vivo O +
by O +
the O +
cold B-Gene +
- I-Gene +
shock I-Gene +
DeaD I-Gene +
box I-Gene +
RNA I-Gene +
helicase I-Gene +
( O +
CsdA B-Gene +
) O +
. O +

Gene O +
expression O +
during O +
differentiation O +
of O +
human O +
dendritic O +
cells O +
from O +
cord O +
blood O +
cd34 B-Gene +
stem O +
cells O +
. O +

Human O +
cord O +
blood O +
CD34 B-Gene +
( O +
+ O +
) O +
stem O +
cells O +
were O +
allowed O +
to O +
differentiate O +
in O +
the O +
presence O +
of O +
cytokines B-Gene +
stem B-Gene +
cell I-Gene +
factor I-Gene +
( O +
SCF B-Gene +
) O +
, O +
granulocyte B-Gene +
- I-Gene +
macrophage I-Gene +
colony I-Gene +
- I-Gene +
stimulating I-Gene +
factor I-Gene +
( O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
) O +
and O +
tumour B-Gene +
necrosis I-Gene +
factor I-Gene +
alpha I-Gene +
( O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
) O +
into O +
functional O +
CD1a B-Gene +
+ O +
dendritic O +
cells O +
( O +
DC O +
) O +
. O +

A O +
maximum O +
of O +
1.9 O +
x O +
10 O -
( O -
6 O -
) O +
CD1a B-Gene +
+ O +
cells O +
were O +
separated O +
from O +
the O +
cells O +
generated O +
from O +
1.2 O +
x O +
10 O -
( O -
6 O -
) O +
CD34 B-Gene +
( O +
+ O +
) O +
stem O +
cells O +
from O +
an O +
individual O +
donor O +
. O +

The O +
percentage O +
of O +
CD1a B-Gene +
+ O +
cells O +
separated O +
rose O +
to O +
a O +
maximum O +
of O +
27 O +
% O +
at O +
day O +
11 O +
and O +
fell O +
to O +
8 O +
% O +
at O +
21 O +
days O +
. O +

Reverse O +
transcription O +
- O +
polymerase O +
chain O +
reaction O +
analysis O +
showed O +
that O +
interleukin B-Gene +
2 I-Gene +
receptor I-Gene +
, O +
interleukin B-Gene +
3 I-Gene +
receptor I-Gene +
, O +
interleukin B-Gene +
6 I-Gene +
receptor I-Gene +
, O +
interleukin B-Gene +
12 I-Gene +
receptor I-Gene +
( O +
IL-12R B-Gene +
) O +
and O +
signal B-Gene +
transducer I-Gene +
and I-Gene +
activator I-Gene +
of I-Gene +
transcription I-Gene +
( I-Gene +
STAT I-Gene +
) I-Gene +
3 I-Gene +
, O +
STAT B-Gene +
4 I-Gene +
mRNA O +
was O +
expressed O +
in O +
all O +
CD1a B-Gene +
+ O +
cell O +
populations O +
throughout O +
and O +
appears O +
to O +
be O +
constitutive O +
. O +

Expression O +
of O +
IL-12RmRNA B-Gene +
was O +
unexpected O +
in O +
CD1a B-Gene +
+ O +
DC O +
normally O +
considered O +
to O +
be O +
of O +
myeloid O +
lineage O +
. O +

Expression O +
of O +
interleukin B-Gene +
12 I-Gene +
( I-Gene +
IL-12 I-Gene +
) I-Gene +
p40 I-Gene +
subunit O +
mRNA O +
was O +
not O +
detected O +
. O +

Intermittent O +
expression O +
of O +
the O +
IL-12p35 B-Gene +
subunit O +
and O +
IL-4R B-Gene +
mRNA O +
suggested O +
that O +
gene O +
expression O +
is O +
inducible O +
, O +
but O +
not O +
obviously O +
correlated O +
with O +
progressive O +
DC O +
development O +
. O +

Expression O +
of O +
mRNA O +
for O +
a O +
spectrum O +
of O +
cytokine B-Gene +
receptors O +
indicates O +
that O +
CD1a B-Gene +
+ O +
DC O +
have O +
the O +
potential O +
to O +
respond O +
to O +
a O +
variety O +
of O +
maturational O +
signals O +
. O +

Involvement O +
of O +
receptor O +
- O +
bound O +
protein O +
methyltransferase B-Gene +
PRMT1 B-Gene +
in O +
antiviral O +
and O +
antiproliferative O +
effects O +
of O +
type B-Gene +
I I-Gene +
interferons I-Gene +
. O +

Protein B-Gene +
arginine I-Gene +
N I-Gene -
- I-Gene -
methyltransferase I-Gene +
( O +
PRMT1 B-Gene +
) O +
is O +
one O +
of O +
the O +
proteins O +
that O +
bind O +
to O +
the O +
intracytoplasmatic O +
domain O +
of O +
the O +
IFNAR-1 B-Gene +
chain O +
of O +
the O +
type B-Gene +
I I-Gene +
interferon I-Gene +
( I-Gene +
IFN I-Gene +
) I-Gene +
receptor I-Gene +
system O +
. O +

The O +
attachment O +
is O +
specific O +
and O +
is O +
not O +
seen O +
with O +
PRMT2 B-Gene +
, O +
another O +
member O +
of O +
this O +
protein O +
family O +
. O +

Antisense O +
PRMT1 B-Gene +
cDNA O +
constructs O +
expressed O +
under O +
the O +
early O +
cytomegalovirus O +
( O +
CMV O +
) O +
promoter O +
were O +
transfected O +
into O +
HeLa O +
cells O +
, O +
and O +
stable O +
transformants O +
were O +
selected O +
. O +

Antibodies O +
to O +
PRMT1 B-Gene +
were O +
used O +
to O +
identify O +
clones O +
with O +
reduced O +
PRMT1 B-Gene +
expression O +
. O +

In O +
such O +
clones O +
, O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
inhibited O +
three O +
to O +
five O +
times O +
less O +
the O +
replication O +
of O +
vesicular O +
stomatitis O +
virus O +
( O +
VSV O +
) O +
than O +
in O +
the O +
original O +
HeLa O +
cells O +
. O +

The O +
antiproliferative O +
effect O +
of O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
was O +
also O +
reduced O +
up O +
to O +
fivefold O +
in O +
the O +
clones O +
with O +
low O +
PRMT1 B-Gene +
expression O +
. O +

No O +
difference O +
was O +
seen O +
when O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
was O +
used O +
alone O +
to O +
inhibit O +
cell O +
growth O +
. O +

The O +
protein O +
methylating O +
enzyme O +
, O +
bound O +
to O +
IFNAR-1 B-Gene +
, O +
appears O +
to O +
regulate O +
positively O +
the O +
biologic O +
activity O +
of O +
type B-Gene +
I I-Gene +
IFN I-Gene +
. O +

Crystal O +
structure O +
of O +
the O +
HLA B-Gene -
- I-Gene -
Cw3 I-Gene +
allotype O +
- O +
specific O +
killer O +
cell O +
inhibitory O +
receptor O +
KIR2DL2 B-Gene +
. O +

Killer O +
cell O +
inhibitory O +
receptors O +
( O +
KIR B-Gene +
) O +
protect O +
class B-Gene +
I I-Gene +
HLAs I-Gene +
expressing O +
target O +
cells O +
from O +
natural O +
killer O +
( O +
NK O +
) O +
cell O +
- O +
mediated O +
lysis O +
. O +

To O +
understand O +
the O +
molecular O +
basis O +
of O +
this O +
receptor O +
- O +
ligand O +
recognition O +
, O +
we O +
have O +
crystallized O +
the O +
extracellular O +
ligand O +
- O +
binding O +
domains O +
of O +
KIR2DL2 B-Gene +
, O +
a O +
member O +
of O +
the O +
Ig B-Gene +
superfamily I-Gene +
receptors O +
that O +
recognize O +
HLA B-Gene -
- I-Gene -
Cw1 I-Gene +
, I-Gene +
3 I-Gene +
, I-Gene +
7 I-Gene +
, I-Gene +
and I-Gene +
8 I-Gene +
allotypes O +
. O +

The O +
structure O +
was O +
determined O +
in O +
two O +
different O +
crystal O +
forms O +
, O +
an O +
orthorhombic O +
P212121 O +
and O +
a O +
trigonal O +
P3221 O +
space O +
group O +
, O +
to O +
resolutions O +
of O +
3.0 O +
and O +
2.9 O +
A O +
, O +
respectively O +
. O +

The O +
overall O +
fold O +
of O +
this O +
structure O +
, O +
like O +
KIR2DL1 B-Gene +
, O +
exhibits O +
K O -
- O -
type O +
Ig B-Gene +
topology O +
with O +
cis O -
- O -
proline O +
residues O +
in O +
both O +
domains O +
that O +
define O +
beta O -
- O -
strand O +
switching O +
, O +
which O +
sets O +
KIR B-Gene +
apart O +
from O +
the O +
C2 O +
- O +
type O +
hematopoietic O +
growth B-Gene +
hormone I-Gene +
receptor I-Gene +
fold O +
. O +

The O +
hinge O +
angle O +
of O +
KIR2DL2 B-Gene +
is O +
approximately O +
80 O +
degrees O +
, O +
14 O +
degrees O +
larger O +
than O +
that O +
observed O +
in O +
KIR2DL1 B-Gene +
despite O +
the O +
existence O +
of O +
conserved O +
hydrophobic O +
residues O +
near O +
the O +
hinge O +
region O +
. O +

There O +
is O +
also O +
a O +
5 O +
degrees O +
difference O +
in O +
the O +
observed O +
hinge O +
angles O +
in O +
two O +
crystal O +
forms O +
of O +
2DL2 B-Gene +
, O +
suggesting O +
that O +
the O +
interdomain O +
hinge O +
angle O +
is O +
not O +
fixed O +
. O +

The O +
putative O +
ligand O +
- O +
binding O +
site O +
is O +
formed O +
by O +
residues O +
from O +
several O +
variable O +
loops O +
with O +
charge O +
distribution O +
apparently O +
complementary O +
to O +
that O +
of O +
HLA B-Gene -
- I-Gene -
C I-Gene +
. O +

The O +
packing O +
of O +
the O +
receptors O +
in O +
the O +
orthorhombic O +
crystal O +
form O +
offers O +
an O +
intriguing O +
model O +
for O +
receptor O +
aggregation O +
on O +
the O +
cell O +
surface O +
. O +

Identification O +
of O +
the O +
enzyme O +
required O +
for O +
activation O +
of O +
the O +
small O +
ubiquitin B-Gene +
- O +
like O +
protein O +
SUMO-1 B-Gene +
. O +

The O +
ubiquitin B-Gene +
- O +
like O +
protein O +
SUMO-1 B-Gene +
is O +
conjugated O +
to O +
a O +
variety O +
of O +
proteins O +
including O +
Ran B-Gene +
GTPase I-Gene +
- I-Gene +
activating I-Gene +
protein I-Gene +
1 I-Gene +
( O +
RanGAP1 B-Gene +
) O +
, O +
IkappaBalpha B-Gene +
, O +
and O +
PML B-Gene +
. O +

SUMO-1 B-Gene +
- O +
modified O +
proteins O +
display O +
altered O +
subcellular O +
targeting O +
and/or O +
stability O +
. O +

We O +
have O +
purified O +
the O +
SUMO-1 B-Gene +
- O +
activating O +
enzyme O +
from O +
human O +
cells O +
and O +
shown O +
that O +
it O +
contains O +
two O +
subunits O +
of O +
38 O +
and O +
72 O +
kDa O +
. O +

Isolation O +
of O +
cDNAs O +
for O +
each O +
subunit O +
indicates O +
that O +
they O +
are O +
homologous O +
to O +
ubiquitin B-Gene +
- O +
activating O +
enzymes O +
and O +
to O +
the O +
Saccharomyces O +
cerevisiae O +
enzymes O +
responsible O +
for O +
conjugation O +
of O +
Smt3p B-Gene +
and O +
Rub-1p B-Gene +
. O +

In O +
vitro O +
, O +
recombinant O +
SAE1 B-Gene +
/ O +
SAE2 B-Gene +
( O +
SUMO-1 B-Gene +
- I-Gene +
activating I-Gene +
enzyme I-Gene +
) O +
was O +
capable O +
of O +
catalyzing O +
the O +
ATP O +
- O +
dependent O +
formation O +
of O +
a O +
thioester O +
linkage O +
between O +
SUMO-1 B-Gene +
and O +
SAE2 B-Gene +
. O +

The O +
addition O +
of O +
the O +
SUMO-1 B-Gene +
- O +
conjugating O +
enzyme O +
Ubch9 B-Gene +
resulted O +
in O +
efficient O +
transfer O +
of O +
the O +
thioester O +
- O +
linked O +
SUMO-1 B-Gene +
from O +
SAE2 B-Gene +
to O +
Ubch9 B-Gene +
. O +

In O +
the O +
presence O +
of O +
SAE1 B-Gene +
/ O +
SAE2 B-Gene +
, O +
Ubch9 B-Gene +
, O +
and O +
ATP O +
, O +
SUMO-1 B-Gene +
was O +
efficiently O +
conjugated O +
to O +
the O +
protein O +
substrate O +
IkappaBalpha B-Gene +
. O +

As O +
SAE1 B-Gene +
/ O +
SAE2 B-Gene +
, O +
Ubch9 B-Gene +
, O +
SUMO-1 B-Gene +
, O +
and O +
IkappaBalpha B-Gene +
are O +
all O +
homogeneous O +
, O +
recombinant O +
proteins O +
, O +
it O +
appears O +
that O +
SUMO-1 B-Gene +
conjugation O +
of O +
IkappaBalpha B-Gene +
in O +
vitro O +
does O +
not O +
require O +
the O +
equivalent O +
of O +
an O +
E3 B-Gene +
ubiquitin I-Gene +
protein I-Gene +
ligase I-Gene +
activity O +
. O +

Comparison O +
of O +
clinical O +
staging O +
algorithms O +
and O +
111indium O -
- O -
capromab O +
pendetide O +
immunoscintigraphy O +
in O +
the O +
prediction O +
of O +
lymph O +
node O +
involvement O +
in O +
high O +
risk O +
prostate O +
carcinoma O +
patients O +
. O +

BACKGROUND O +
: O +

The O +
pretherapy O +
prediction O +
of O +
occult O +
lymph O +
node O +
involvement O +
and O +
the O +
avoidance O +
of O +
otherwise O +
futile O +
and O +
potentially O +
morbid O +
definitive O +
local O +
therapy O +
is O +
paramount O +
in O +
men O +
with O +
newly O +
diagnosed O +
prostate O +
carcinoma O +
. O +

To O +
identify O +
patients O +
with O +
prostate O +
carcinoma O +
who O +
likely O +
have O +
lymph O +
node O +
involvement O +
and O +
would O +
benefit O +
from O +
staging O +
lymphadenectomy O +
prior O +
to O +
definitive O +
local O +
therapy O +
, O +
the O +
authors O +
compared O +
the O +
ability O +
of O +
several O +
predictive O +
staging O +
algorithms O +
and O +
a O +
radiolabeled O +
monoclonal O +
antibody O +
scan O +
to O +
predict O +
lymphatic O +
metastases O +
prior O +
to O +
treatment O +
. O +

METHODS O +
: O +

Between O +
August O +
1991 O +
and O +
June O +
1994 O +
, O +
198 O +
men O +
with O +
clinical O +
T2 O +
or O +
T3 O +
classified O +
( O +
TNM O +
) O +
prostate O +
carcinoma O +
( O +
bone O +
scan O +
negative O +
) O +
who O +
were O +
at O +
high O +
risk O +
of O +
lymph O +
node O +
involvement O +
underwent O +
a O +
111In O +
- O +
capromab O +
pendetide O +
scan O +
prior O +
to O +
staging O +
lymphadenectomy O +
. O +

Several O +
predictive O +
models O +
based O +
on O +
preoperative O +
prostate O +
specific O +
antigen O +
level O +
, O +
biopsy O +
Gleason O +
score O +
, O +
and O +
clinical O +
stage O +
were O +
selected O +
to O +
predict O +
those O +
men O +
having O +
a O +
> O +
or O +
= O +
20 O +
% O +
probability O +
of O +
lymph O +
node O +
involvement O +
. O +

The O +
ability O +
to O +
predict O +
pathologic O +
stage O +
using O +
several O +
clinical O +
algorithms O +
and O +
the O +
monoclonal O +
antibody O +
scan O +
was O +
compared O +
with O +
pathologic O +
examination O +
of O +
the O +
lymph O +
nodes O +
. O +

RESULTS O +
: O +

Overall O +
, O +
39 O +
% O +
of O +
the O +
pelvic O +
lymph O +
node O +
specimens O +
were O +
positive O +
for O +
metastatic O +
disease O +
by O +
pathologic O +
analysis O +
. O +

Published O +
algorithms O +
predicting O +
lymph O +
node O +
metastases O +
had O +
a O +
positive O +
predictive O +
value O +
( O +
PPV O +
) O +
ranging O +
from O +
40.5 O +
% O +
to O +
46.6 O +
% O +
and O +
an O +
area O +
under O +
the O +
receiver O +
operating O +
characteristic O +
curve O +
( O +
AUC O +
) O +
ranging O +
from O +
0.52 O +
to O +
0.61 O +
. O +

The O +
monoclonal O +
antibody O +
scan O +
had O +
a O +
PPV O +
of O +
66.7 O +
% O +
and O +
an O +
AUC O +
of O +
0.71 O +
. O +

The O +
differences O +
between O +
the O +
PPV O +
and O +
the O +
AUC O +
for O +
the O +
individual O +
clinical O +
algorithms O +
when O +
compared O +
with O +
immunoscintigraphy O +
were O +
statistically O +
significant O +
. O +

Combining O +
the O +
radiolabeled O +
monoclonal O +
antibody O +
scan O +
with O +
clinical O +
predictive O +
models O +
, O +
a O +
PPV O +
of O +
up O +
to O +
72.1 O +
% O +
could O +
be O +
obtained O +
. O +

CONCLUSIONS O +
: O +

These O +
data O +
suggest O +
that O +
the O +
PPVs O +
for O +
the O +
clinical O +
predictive O +
algorithms O +
are O +
similar O +
and O +
that O +
the O +
PPV O +
of O +
the O +
radiolabeled O +
monoclonal O +
antibody O +
scan O +
alone O +
or O +
in O +
combination O +
with O +
the O +
algorithms O +
has O +
additional O +
value O +
in O +
predicting O +
lymph O +
node O +
involvement O +
in O +
prostate O +
carcinoma O +
patients O +
at O +
high O +
risk O +
of O +
regional O +
disease O +
spread O +
. O +

These O +
algorithms O +
and O +
the O +
111In O +
- O +
capromab O +
pendetide O +
scan O +
may O +
be O +
used O +
for O +
the O +
appropriate O +
selection O +
of O +
candidates O +
for O +
definitive O +
local O +
therapy O +
in O +
men O +
with O +
clinically O +
localized O +
prostate O +
carcinoma O +
and O +
significant O +
risk O +
of O +
lymph O +
node O +
involvement O +
. O +

Crystal O +
structure O +
of O +
the O +
human O +
p58 B-Gene +
killer I-Gene +
cell I-Gene +
inhibitory I-Gene +
receptor I-Gene +
( O +
KIR2DL3 B-Gene +
) O +
specific O +
for O +
HLA B-Gene -
- I-Gene -
Cw3 I-Gene +
- O +
related O +
MHC B-Gene +
class I-Gene +
I I-Gene +
. O +

BACKGROUND O +
: O +

T O +
cells O +
and O +
natural O +
killer O +
( O +
NK O +
) O +
cells O +
perform O +
complementary O +
roles O +
in O +
the O +
cellular O +
immune O +
system O +
. O +

T O +
cells O +
identify O +
infected O +
cells O +
directly O +
through O +
recognition O +
of O +
antigenic O +
peptides O +
that O +
are O +
displayed O +
at O +
the O +
target O +
cell O +
surface O +
by O +
the O +
classical B-Gene +
major I-Gene +
histocompatibility I-Gene +
complex I-Gene +
( B-Gene +
MHC I-Gene +
) I-Gene +
class I-Gene +
I I-Gene +
molecules O +
. O +

NK O +
cells O +
monitor O +
the O +
target O +
cell O +
surface O +
for O +
malfunction O +
of O +
this O +
display O +
system O +
, O +
lysing O +
potentially O +
infected O +
cells O +
that O +
might O +
otherwise O +
evade O +
recognition O +
by O +
the O +
T O +
cells O +
. O +

Human O +
killer B-Gene +
cell I-Gene +
inhibitory I-Gene +
receptors I-Gene +
( O +
KIRs B-Gene +
) O +
control O +
this O +
process O +
by O +
either O +
inhibiting O +
or O +
activating O +
the O +
cytotoxic O +
activity O +
of O +
NK O +
cells O +
via O +
specific O +
binding O +
to O +
MHC B-Gene +
class I-Gene +
I I-Gene +
molecules O +
on O +
the O +
target O +
cell O +
. O +

RESULTS O +
: O +

We O +
report O +
the O +
crystal O +
structure O +
of O +
the O +
extracellular O +
region O +
of O +
the O +
human O +
p58 B-Gene +
KIR I-Gene +
( O +
KIR2DL3 B-Gene +
) O +
, O +
which O +
is O +
specific O +
for O +
the O +
human O +
MHC B-Gene +
class I-Gene +
I I-Gene +
molecule O +
HLA B-Gene -
- I-Gene -
Cw3 I-Gene +
and O +
related O +
alleles O +
. O +

The O +
structure O +
shows O +
the O +
predicted O +
topology O +
of O +
two O +
tandem O +
immunoglobulin B-Gene +
- O +
like O +
domains O +
, O +
but O +
comparison O +
with O +
the O +
previously O +
reported O +
structure O +
of O +
the O +
related O +
receptor O +
KIR2DL1 B-Gene +
reveals O +
an O +
unexpected O +
change O +
of O +
23 O +
degrees O +
in O +
the O +
relative O +
orientation O +
of O +
these O +
domains O +
. O +

CONCLUSIONS O +
: O +

The O +
altered O +
orientation O +
of O +
the O +
immunoglobulin B-Gene +
- O +
like O +
domains O +
maintains O +
an O +
unusually O +
acute O +
interdomain O +
elbow O +
angle O +
, O +
which O +
therefore O +
appears O +
to O +
be O +
a O +
distinctive O +
feature O +
of O +
the O +
KIRs B-Gene +
. O +

The O +
putative O +
MHC B-Gene +
class I-Gene +
I I-Gene +
binding O +
site O +
is O +
located O +
on O +
the O +
outer O +
surface O +
of O +
the O +
elbow O +
, O +
spanning O +
both O +
domains O +
. O +

The O +
unexpected O +
observation O +
that O +
this O +
binding O +
site O +
can O +
be O +
modulated O +
by O +
differences O +
in O +
the O +
relative O +
domain O +
orientations O +
has O +
implications O +
for O +
the O +
general O +
mechanism O +
of O +
KIR B-Gene +
- O +
MHC B-Gene +
class I-Gene +
I I-Gene +
complex O +
formation O +
. O +

The O +
SpoIIE B-Gene +
phosphatase B-Gene +
, O +
the O +
sporulation O +
septum O +
and O +
the O +
establishment O +
of O +
forespore O +
- O +
specific O +
transcription O +
in O +
Bacillus O +
subtilis O +
: O +
a O +
reassessment O +
. O +

Making O +
a O +
spore O +
in O +
Bacillus O +
subtilis O +
requires O +
the O +
formation O +
of O +
two O +
cells O +
, O +
the O +
forespore O +
and O +
the O +
mother O +
cell O +
, O +
which O +
follow O +
dissimilar O +
patterns O +
of O +
gene O +
expression O +
. O +

Cell O +
specificity O +
is O +
first O +
established O +
in O +
the O +
forespore O +
under O +
the O +
control O +
of O +
the O +
sigma B-Gene +
F I-Gene +
factor I-Gene +
, O +
which O +
is O +
itself O +
activated O +
through O +
the O +
action O +
of O +
the O +
SpoIIE B-Gene +
serine B-Gene +
phosphatase I-Gene +
, O +
an O +
enzyme O +
targeted O +
to O +
the O +
septum O +
between O +
the O +
two O +
cells O +
. O +

Deletion O +
of O +
the O +
10 O +
transmembrane O +
segments O +
of O +
the O +
SpoIIE B-Gene +
protein O +
leads O +
to O +
random O +
distribution O +
of O +
SpoIIE B-Gene +
in O +
the O +
cytoplasm O +
. O +

Activation O +
of O +
sigma B-Gene +
F I-Gene +
is O +
slightly O +
delayed O +
and O +
less O +
efficient O +
than O +
in O +
wild O +
type O +
, O +
but O +
it O +
remains O +
restricted O +
to O +
the O +
forespore O +
in O +
a O +
large O +
proportion O +
of O +
cells O +
and O +
the O +
bacteria O +
sporulate O +
with O +
30 O +
% O +
efficiency O +
. O +

Overexpression O +
of O +
the O +
complete O +
SpoIIE B-Gene +
protein O +
in O +
a O +
divIC B-Gene +
mutant O +
leads O +
to O +
significant O +
sigma B-Gene +
F I-Gene +
activity O +
, O +
indicating O +
that O +
the O +
septum O +
requirement O +
for O +
activating O +
sigma B-Gene +
F I-Gene +
can O +
be O +
bypassed O +
. O +

In O +
contradiction O +
to O +
current O +
models O +
, O +
we O +
propose O +
that O +
genetic O +
asymmetry O +
is O +
not O +
created O +
by O +
unequal O +
distribution O +
of O +
SpoIIE B-Gene +
within O +
the O +
sporangium O +
, O +
but O +
by O +
exclusion O +
of O +
an O +
inhibitor O +
of O +
SpoIIE B-Gene +
from O +
the O +
forespore O +
. O +

This O +
putative O +
inhibitor O +
would O +
be O +
a O +
cytoplasmic O +
molecule O +
that O +
interacts O +
with O +
SpoIIE B-Gene +
and O +
shuts O +
off O +
its O +
phosphatase B-Gene +
activity O +
until O +
it O +
disappears O +
specifically O +
from O +
the O +
forespore O +
. O +

Post O +
- O +
streptococcal O +
reactive O +
arthritis O +
: O +
a O +
clinical O +
and O +
serological O +
description O +
, O +
revealing O +
its O +
distinction O +
from O +
acute O +
rheumatic O +
fever O +
. O +

OBJECTIVE O +
: O +

To O +
follow O +
- O +
up O +
prospectively O +
patients O +
with O +
arthritis O +
after O +
infection O +
with O +
beta O -
- O -
haemolytic O +
streptococci O +
of O +
Lancefield O +
group O +
A O +
( O +
beta O +
HSA O +
) O +
, O +
with O +
emphasis O +
on O +
clinical O +
characteristics O +
and O +
serological O +
features O +
. O +

We O +
additionally O +
investigated O +
whether O +
these O +
patients O +
, O +
though O +
often O +
fulfilling O +
the O +
Jones O +
' O +
criteria O +
for O +
acute O +
rheumatic O +
fever O +
( O +
ARF O +
) O +
, O +
had O +
a O +
disease O +
with O +
clinical O +
characteristics O +
different O +
from O +
ARF O +
. O +

DESIGN O +
: O +

We O +
performed O +
a O +
systematic O +
prospective O +
observational O +
study O +
of O +
consecutive O +
patients O +
at O +
a O +
Dutch O +
Outpatient O +
Clinic O +
and O +
Department O +
of O +
Rheumatology O +
, O +
with O +
arthritis O +
after O +
throat O +
infection O +
with O +
beta O +
HSA O +
presenting O +
to O +
rheumatologist O +
or O +
internist O +
from O +
September O +
1992 O +
until O +
September O +
1996 O +
. O +

Main O +
outcome O +
measures O +
were O +
clinical O +
and O +
biochemical O +
characteristics O +
with O +
special O +
reference O +
to O +
carditis O +
. O +

RESULTS O +
: O +

A O +
total O +
of O +
23 O +
patients O +
( O +
21 O +
Dutch O +
, O +
two O +
Turkish O +
; O +
female O +
/ O +
male O +
ratio O +
15 O +
/ O +
8 O +
; O +
mean O +
( O +
SD O +
) O +
age O +
42 O +
( O +
14 O +
) O +
years O +
) O +
with O +
predominantly O +
non O +
- O +
migratory O +
arthritis O +
were O +
included O +
. O +

A O +
positive O +
throat O +
swab O +
culture O +
was O +
obtained O +
in O +
17 O +
% O +
. O +

All O +
patients O +
showed O +
a O +
significant O +
rise O +
of O +
antistreptolysine O -
- O -
O O +
( O +
ASO O +
; O +
normal O +
< O +
200 O +
i.u O -
. O +
mL-1 O +
) O +
and O +
antideoxyribonuclease O -
- O -
B O +
( O +
anti O +
- O +
DNase B-Gene +
- I-Gene +
B I-Gene +
; O +
normal O +
< O +
200 O +
i.u O -
. O +
mL-1 O +
) O +
titre O +
. O +

The O +
mean O +
( O +
SEM O +
) O +
maximal O +
ASO O +
was O +
1305 O +
( O +
195 O +
) O +
i.u O -
. O +
mL-1 O +
, O +
and O +
anti O +
- O +
DNase B-Gene +
- I-Gene +
B I-Gene +
titre O +
980 O +
( O +
115 O +
) O +
i.u O -
. O +
mL-1 O +
. O +

Arthritis O +
was O +
present O +
in O +
mean O +
( O +
SEM O +
) O +
5.4 O +
( O +
0.9 O +
) O +
joints O +
: O +
2.2 O +
( O +
0.7 O +
) O +
small O +
, O +
3.2 O +
( O +
0.4 O +
) O +
larger O +
joints O +
. O +

The O +
arthritis O +
was O +
monarticular O +
in O +
23 O +
% O +
of O +
the O +
patients O +
, O +
oligoarticular O +
in O +
35 O +
% O +
, O +
and O +
polyarticular O +
in O +
43 O +
% O +
. O +

Skin O +
abnormalities O +
were O +
present O +
in O +
12 O +
patients O +
: O +
erythema O +
nodosum O +
in O +
seven O +
patients O +
( O +
30 O +
% O +
) O +
, O +
and O +
erythema O +
multiforme O +
in O +
five O +
patients O +
( O +
22 O +
% O +
) O +
. O +

A O +
transient O +
cholestatic O +
hepatitis O +
was O +
found O +
in O +
four O +
patients O +
( O +
17 O +
% O +
) O +
. O +

In O +
two O +
patients O +
a O +
transient O +
first O +
- O +
degree O +
conduction O +
block O +
was O +
found O +
; O +
however O +
, O +
neither O +
echocardiography O +
nor O +
clinical O +
course O +
supported O +
carditis O +
. O +

All O +
patients O +
were O +
advised O +
to O +
receive O +
monthly O +
penicillin O +
prophylaxis O +
during O +
a O +
period O +
of O +
2 O +
years O +
. O +

Two O +
patients O +
refused O +
to O +
follow O +
medical O +
advice O +
: O +
in O +
one O +
a O +
non O +
- O +
migratory O +
arthritis O +
recurred O +
15 O +
months O +
after O +
the O +
first O +
episode O +
of O +
arthritis O +
. O +

CONCLUSION O +
: O +

Commonly O +
, O +
arthritis O +
secondary O +
to O +
beta O +
HSA O +
infection O +
in O +
the O +
Netherlands O +
, O +
a O +
prosperous O +
West O +
- O +
European O +
country O +
with O +
State O +
Welfare O +
, O +
is O +
not O +
accompanied O +
by O +
carditis O +
, O +
contrary O +
to O +
literature O +
on O +
classical O +
ARF O +
. O +

Other O +
factors O +
discriminating O +
it O +
from O +
ARF O +
are O +
the O +
age O +
of O +
onset O +
, O +
the O +
non O +
- O +
migratory O +
character O +
of O +
the O +
arthritis O +
, O +
the O +
high O +
frequency O +
of O +
erythema O +
nodosum O +
and O +
multiforme O +
, O +
as O +
well O +
as O +
the O +
presence O +
of O +
transient O +
hepatitis O +
. O +

As O +
arthritis O +
is O +
the O +
hallmark O +
of O +
this O +
syndrome O +
, O +
post O +
- O +
streptococcal O +
reactive O +
arthritis O +
( O +
PSRA O +
) O +
is O +
the O +
most O +
proper O +
name O +
for O +
this O +
disease O +
entity O +
. O +

Whether O +
penicillin O +
profylaxis O +
is O +
needed O +
in O +
PSRA O +
, O +
as O +
it O +
is O +
in O +
ARF O +
, O +
warrants O +
further O +
prospective O +
investigation O +
. O +

Transcriptional O +
regulation O +
of O +
molybdoenzyme O +
synthesis O +
in O +
Escherichia O +
coli O +
in O +
response O +
to O +
molybdenum O +
: O +
ModE B-Gene +
- O +
molybdate O +
, O +
a O +
repressor O +
of O +
the O +
modABCD B-Gene +
( I-Gene +
molybdate I-Gene +
transport I-Gene +
) I-Gene +
operon I-Gene +
is O +
a O +
secondary O +
transcriptional O +
activator O +
for O +
the O +
hyc B-Gene +
and I-Gene +
nar I-Gene +
operons I-Gene +
. O +

Escherichia O +
coli O +
growing O +
under O +
anaerobic O +
conditions O +
produces O +
several O +
molybdoenzymes O +
, O +
such O +
as O +
formate B-Gene +
hydrogenlyase I-Gene +
( O +
formate O +
to O +
H2 O +
and O +
CO2 O +
; O +
hyc B-Gene +
and O +
fdhF B-Gene +
genes O +
) O +
and O +
nitrate B-Gene +
reductase I-Gene +
( O +
narGHJI B-Gene +
genes O +
) O +
. O +

Synthesis O +
of O +
these O +
molybdoenzymes O +
, O +
even O +
in O +
the O +
presence O +
of O +
the O +
cognate O +
transcriptional O +
activators O +
and O +
effectors O +
, O +
requires O +
molybdate O +
in O +
the O +
medium O +
. O +

Besides O +
the O +
need O +
for O +
molybdopterin O +
cofactor O +
synthesis O +
, O +
molybdate O +
is O +
also O +
required O +
for O +
transcription O +
of O +
the O +
genes O +
encoding O +
these O +
molybdoenzymes O +
. O +

In O +
E. O +
coli O +
, O +
ModE B-Gene +
was O +
previously O +
identified O +
as O +
a O +
repressor O +
controlling O +
transcription O +
of O +
the O +
operon O +
encoding O +
molybdate O +
transport O +
components O +
( O +
modABCD B-Gene +
) O +
. O +

In O +
this O +
work O +
, O +
the O +
ModE B-Gene +
protein O +
was O +
also O +
found O +
to O +
be O +
a O +
required O +
component O +
in O +
the O +
activation O +
of O +
hyc B-Gene +
- O +
lacZ B-Gene +
to O +
an O +
optimum O +
level O +
, O +
but O +
only O +
in O +
the O +
presence O +
of O +
molybdate O +
. O +

Mutant O +
ModE B-Gene +
proteins O +
which O +
are O +
molybdate O +
- O +
independent O +
for O +
repression O +
of O +
modA B-Gene +
- O +
lacZ B-Gene +
also O +
restored O +
hyc B-Gene +
- O +
lacZ B-Gene +
expression O +
to O +
the O +
wild O +
- O +
type O +
level O +
even O +
in O +
the O +
absence O +
of O +
molybdate O +
. O +

Nitrate O +
- O +
dependent O +
enhancement O +
of O +
transcription O +
of O +
narX B-Gene +
- O +
lacZ B-Gene +
was O +
completely O +
abolished O +
in O +
a O +
modE B-Gene +
mutant O +
. O +

Nitrate O +
- O +
response O +
by O +
narG B-Gene +
- O +
lacZ B-Gene +
and O +
narK B-Gene +
- O +
lacZ B-Gene +
was O +
reduced O +
by O +
about O +
50 O +
% O +
in O +
a O +
modE B-Gene +
mutant O +
. O +

DNase B-Gene +
I I-Gene +
footprinting O +
experiments O +
revealed O +
that O +
the O +
ModE B-Gene +
protein O +
binds O +
the O +
hyc B-Gene +
promoter O +
DNA O +
in O +
the O +
presence O +
of O +
molybdate O +
. O +

ModE B-Gene +
- O +
molybdate O +
also O +
protected O +
DNA O +
in O +
the O +
intergenic O +
region O +
between O +
narXL B-Gene +
and O +
narK B-Gene +
from O +
DNase B-Gene +
I I-Gene +
hydrolysis O +
. O +

DNA O +
sequences O +
( O +
5 O -
' O +
TAYAT O +
3 O +
' O +
and O +
5 O -
' O +
GTTA O +
3 O -
' O +
) O +
found O +
in O +
ModE B-Gene +
- O +
molybdate O +
- O +
protected O +
modABCD B-Gene +
operator O +
DNA O +
were O +
also O +
found O +
in O +
the O +
ModE B-Gene +
- O +
molybdate O +
- O +
protected O +
region O +
of O +
hyc B-Gene +
promoter O +
DNA O +
( O +
5 O -
' O +
GTTA O +
- O +
7 O +
bp O +
- O +
CATAT O +
3 O -
' O +
) O +
and O +
narX B-Gene +
- O +
narK B-Gene +
intergenic O +
region O +
( O +
5 O -
' O +
GTTA O +
- O +
7 O +
bp O +
- O +
TACAT O +
3 O -
' O +
) O +
. O +

Based O +
on O +
these O +
results O +
, O +
a O +
working O +
model O +
is O +
proposed O +
in O +
which O +
ModE B-Gene +
- O +
molybdate O +
serves O +
as O +
a O +
secondary O +
transcriptional O +
activator O +
of O +
both O +
the O +
hyc B-Gene +
and I-Gene +
narXL I-Gene +
operons I-Gene +
which O +
are O +
activated O +
primarily O +
by O +
the O +
transcriptional O +
activators O +
, O +
FhlA B-Gene +
and O +
NarL B-Gene +
, O +
respectively O +
. O +

Indian B-Gene +
hedgehog I-Gene +
in O +
the O +
late O +
- O +
phase O +
differentiation O +
in O +
mouse O +
chondrogenic O +
EC O +
cells O +
, O +
ATDC5 O +
: O +
upregulation O +
of O +
type B-Gene +
X I-Gene +
collagen I-Gene +
and O +
osteoprotegerin B-Gene +
ligand I-Gene +
mRNAs O +
. O +

Endochondral O +
bone O +
formation O +
includes O +
a O +
cascade O +
of O +
cellular O +
events O +
such O +
as O +
proliferation O +
, O +
maturation O +
, O +
hypertrophic O +
conversion O +
and O +
calcification O +
of O +
chondrocytes O +
and O +
the O +
cartilage O +
replacement O +
by O +
bone O +
. O +

During O +
these O +
processes O +
, O +
hypertrophic O +
conversion O +
and O +
calcification O +
of O +
chondrocytes O +
( O +
the O +
late O +
- O +
phase O +
differentiation O +
) O +
is O +
a O +
crucial O +
process O +
of O +
chondrogenic O +
differentiation O +
. O +

Indian B-Gene +
hedgehog I-Gene +
( O +
Ihh B-Gene +
) O +
, O +
a O +
secreted O +
protein O +
expressed O +
in O +
early O +
hypertrophic O +
chondrocytes O +
, O +
is O +
thought O +
to O +
be O +
involved O +
in O +
regulation O +
of O +
hypertrophic O +
conversion O +
via O +
a O +
feedback O +
loop O +
through O +
the O +
perichondrium O +
. O +

In O +
the O +
present O +
study O +
, O +
we O +
showed O +
by O +
Northern O +
analysis O +
and O +
in O +
situ O +
hybridization O +
that O +
Smoothened B-Gene +
( O +
Smo B-Gene +
) O +
, O +
a O +
key O +
component O +
in O +
hedgehog B-Gene +
signal O +
transduction O +
, O +
was O +
expressed O +
in O +
chondrocytes O +
in O +
both O +
adult O +
mice O +
and O +
mouse O +
embryos O +
at O +
16 O +
days O +
post O +
- O +
coitum O +
in O +
vivo O +
, O +
suggesting O +
that O +
Ihh B-Gene +
directly O +
acts O +
on O +
chondrocytes O +
. O +

We O +
previously O +
reported O +
that O +
Ihh B-Gene +
, O +
Patched B-Gene +
and O +
Smo B-Gene +
were O +
all O +
expressed O +
in O +
differentiated O +
ATDC5 O +
cells O +
. O +

Exogenously O +
administered O +
mouse O +
recombinant O +
N O +
- O +
terminal O +
protein O +
of O +
Ihh B-Gene +
( O +
mrIhh B-Gene +
- O +
N O +
) O +
upregulated O +
the O +
gene O +
expression O +
of O +
type B-Gene +
X I-Gene +
collagen I-Gene +
, O +
a O +
phenotypic O +
marker O +
of O +
hypertrophic O +
chondrocytes O +
, O +
as O +
well O +
as O +
osteoprotegerin B-Gene +
ligand I-Gene +
( O +
OPGL B-Gene +
) O +
, O +
a O +
potent O +
stimulator O +
of O +
osteoclastogenesis O +
and O +
osteoclast O +
activity O +
, O +
while O +
it O +
did O +
not O +
modulate O +
the O +
expression O +
of O +
Ihh O +
itself O +
, O +
bone B-Gene +
morphogenetic I-Gene +
protein I-Gene +
( I-Gene +
BMP I-Gene +
) I-Gene +
- I-Gene +
4 I-Gene +
, O +
BMP-6 B-Gene +
, O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
( I-Gene +
TGF I-Gene +
) I-Gene +
- I-Gene +
beta1 I-Gene +
and O +
TGF B-Gene -
- I-Gene -
beta2 I-Gene +
in O +
differentiated O +
ATDC5 O +
cells O +
. O +

Moreover O +
, O +
when O +
added O +
to O +
the O +
osteoclast O +
cultures O +
, O +
mrIhh O -
- O -
N O +
N O +
markedly O +
stimulated O +
the O +
formation O +
of O +
resorption O +
pits O +
on O +
dentine O +
slices O +
. O +

Our O +
data O +
support O +
the O +
hypothesis O +
that O +
Ihh O +
stimulated O +
the O +
late O +
- O +
phase O +
chondrogenic O +
differentiation O +
in O +
differentiated O +
ATDC5 O +
cells O +
and O +
upregulated O +
the O +
gene O +
expression O +
of O +
OPGL B-Gene +
in O +
these O +
cells O +
. O +

Regulation O +
of O +
the O +
enteric O +
nervous O +
system O +
in O +
the O +
internal O +
anal O +
sphincter O +
in O +
Hirschsprung O +
's O +
disease O +
. O +

BACKGROUND O +
/ O +
AIMS O +
: O +

The O +
cause O +
of O +
impaired O +
motility O +
of O +
the O +
aganglionic O +
internal O +
anal O +
sphincter O +
( O +
IAS O +
) O +
in O +
Hirschsprung O +
's O +
disease O +
( O +
HD O +
) O +
is O +
unknown O +
. O +

To O +
clarify O +
the O +
physiological O +
significance O +
of O +
non O +
- O +
adrenergic O +
non O +
- O +
cholinergic O +
( O +
NANC O +
) O +
excitatory O +
and O +
inhibitory O +
nerves O +
in O +
the O +
IAS O +
of O +
HD O +
, O +
we O +
investigated O +
the O +
enteric O +
nerve O +
responses O +
on O +
lesional O +
and O +
normal O +
IAS O +
in O +
patients O +
with O +
HD O +
and O +
in O +
patients O +
who O +
had O +
undergone O +
rectal O +
amputation O +
for O +
low O +
rectal O +
cancer O +
. O +

METHODOLOGY O +
: O +

Twelve O +
preparations O +
were O +
taken O +
from O +
the O +
lesional O +
IAS O +
of O +
7 O +
patients O +
with O +
HD O +
( O +
5 O +
boys O +
and O +
2 O +
girls O +
aged O +
between O +
6 O +
months O +
and O +
1.5 O +
years O +
with O +
a O +
mean O +
age O +
of O +
8 O +
months O +
) O +
. O +

Twenty O +
preparations O +
were O +
taken O +
from O +
the O +
normal O +
IAS O +
of O +
10 O +
patients O +
with O +
low O +
rectal O +
cancer O +
( O +
6 O +
men O +
and O +
2 O +
women O +
, O +
aged O +
between O +
48 O +
and O +
72 O +
years O +
with O +
a O +
mean O +
age O +
of O +
54.6 O +
years O +
) O +
. O +

A O +
mechanographic O +
technique O +
was O +
used O +
to O +
evaluate O +
in O +
vitro O +
muscle O +
responses O +
to O +
the O +
electrical O +
field O +
stimulation O +
( O +
EFS O +
) O +
of O +
adrenergic O +
and O +
cholinergic O +
nerves O +
before O +
and O +
after O +
treatment O +
with O +
various O +
autonomic O +
nerve O +
blockers O +
. O +

RESULTS O +
: O +

Cholinergic O +
nerves O +
are O +
mainly O +
involved O +
in O +
the O +
regulation O +
of O +
enteric O +
nerve O +
responses O +
to O +
EFS O +
in O +
the O +
normal O +
IAS O +
. O +

The O +
aganglionic O +
IAS O +
of O +
patients O +
with O +
HD O +
was O +
more O +
strongly O +
innervated O +
by O +
cholinergic O +
nerves O +
than O +
the O +
normal O +
IAS O +
( O +
p O +
< O +
0.05 O +
) O +
. O +

NANC O +
excitatory O +
and O +
inhibitory O +
nerves O +
were O +
found O +
to O +
act O +
on O +
the O +
normal O +
IAS O +
, O +
but O +
had O +
no O +
effect O +
on O +
it O +
in O +
aganglionosis O +
. O +

CONCLUSIONS O +
: O +

These O +
findings O +
suggest O +
that O +
NANC O +
excitatory O +
and O +
inhibitory O +
nerves O +
play O +
an O +
important O +
role O +
in O +
the O +
impaired O +
motility O +
observed O +
in O +
the O +
IAS O +
in O +
HD O +
. O +

A O +
newly O +
identified O +
member O +
of O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
receptor I-Gene +
superfamily I-Gene +
( O +
TR6 B-Gene +
) O +
suppresses O +
LIGHT B-Gene +
- O +
mediated O +
apoptosis O +
. O +

TR6 B-Gene +
( O +
decoy B-Gene +
receptor I-Gene +
3 I-Gene +
( O +
DcR3 B-Gene +
) O +
) O +
is O +
a O +
new O +
member O +
of O +
the O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
receptor I-Gene +
( I-Gene +
TNFR I-Gene +
) I-Gene +
family I-Gene +
. O +

TR6 B-Gene +
mRNA O +
is O +
expressed O +
in O +
lung O +
tissues O +
and O +
colon O +
adenocarcinoma O +
, O +
SW480 O +
. O +

In O +
addition O +
, O +
the O +
expression O +
of O +
TR6 B-Gene +
mRNA O +
was O +
shown O +
in O +
the O +
endothelial O +
cell O +
line O +
and O +
induced O +
by O +
phorbol O +
12-myristate O +
13-acetate O +
/ O +
ionomycin O +
in O +
Jurkat O +
T O +
leukemia O +
cells O +
. O +

The O +
open O +
reading O +
frame O +
of O +
TR6 B-Gene +
encodes O +
300 O +
amino O +
acids O +
with O +
a O +
29 O +
- O +
residue O +
signal O +
sequence O +
but O +
no O +
transmembrane O +
region O +
. O +

Using O +
histidine O +
- O +
tagged O +
recombinant O +
TR6 B-Gene +
, O +
we O +
screened O +
soluble O +
forms O +
of O +
TNF B-Gene +
- O +
ligand O +
proteins O +
with O +
immunoprecipitation O +
. O +

Here O +
, O +
we O +
demonstrate O +
that O +
TR6 B-Gene +
specifically O +
binds O +
two O +
cellular O +
ligands O +
, O +
LIGHT B-Gene +
( O +
herpes B-Gene +
virus I-Gene +
entry I-Gene +
mediator I-Gene +
( I-Gene +
HVEM I-Gene +
) I-Gene +
- I-Gene +
L I-Gene +
) O +
and O +
Fas B-Gene +
ligand I-Gene +
( O +
FasL B-Gene +
/ O +
CD95L B-Gene +
) O +
. O +

These O +
bindings O +
were O +
confirmed O +
with O +
HEK O +
293 O +
EBNA O +
cells O +
transfected O +
with O +
LIGHT B-Gene +
cDNA O +
by O +
flow O +
cytometry O +
. O +

TR6 B-Gene +
inhibited O +
LIGHT B-Gene +
- O +
induced O +
cytotoxicity O +
in O +
HT29 O +
cells O +
. O +

It O +
has O +
been O +
shown O +
that O +
LIGHT B-Gene +
triggers O +
apoptosis O +
of O +
various O +
tumor O +
cells O +
including O +
HT29 O +
cells O +
that O +
express O +
both O +
lymphotoxin B-Gene +
beta I-Gene +
receptor I-Gene +
( O +
LTbetaR B-Gene +
) O +
and O +
HVEM B-Gene +
/ O +
TR2 B-Gene +
receptors O +
. O +

Our O +
data O +
suggest O +
that O +
TR6 B-Gene +
inhibits O +
the O +
interactions O +
of O +
LIGHT B-Gene +
with O +
HVEM B-Gene +
/ O +
TR2 B-Gene +
and O +
LTbetaR B-Gene +
, O +
thereby O +
suppressing O +
LIGHT B-Gene +
- O +
mediated O +
HT29 O +
cell O +
death O +
. O +

Thus O +
, O +
TR6 B-Gene +
may O +
play O +
a O +
regulatory O +
role O +
for O +
suppressing O +
in O +
FasL B-Gene +
- O +
and O +
LIGHT B-Gene +
- O +
mediated O +
cell O +
death O +
. O +

Shared O +
and O +
unique O +
determinants O +
of O +
the O +
erythropoietin B-Gene +
( I-Gene +
EPO I-Gene +
) I-Gene +
receptor I-Gene +
are O +
important O +
for O +
binding O +
EPO B-Gene +
and O +
EPO B-Gene +
mimetic O +
peptide O +
. O +

We O +
have O +
shown O +
previously O +
that O +
Phe93 O +
in O +
the O +
extracellular O +
domain O +
of O +
the O +
erythropoietin B-Gene +
( I-Gene +
EPO I-Gene +
) I-Gene +
receptor I-Gene +
( O +
EPOR B-Gene +
) O +
is O +
crucial O +
for O +
binding O +
EPO B-Gene +
. O +

Substitution O +
of O +
Phe93 O +
with O +
alanine O +
resulted O +
in O +
a O +
dramatic O +
decrease O +
in O +
EPO B-Gene +
binding O +
to O +
the O +
Escherichia O +
coli O +
- O +
expressed O +
extracellular O +
domain O +
of O +
the O +
EPOR B-Gene +
( O +
EPO B-Gene +
- O +
binding O +
protein O +
or O +
EBP O +
) O +
and O +
no O +
detectable O +
binding O +
to O +
full O +
- O +
length O +
mutant O +
receptor O +
expressed O +
in O +
COS O +
cells O +
. O +

Remarkably O +
, O +
Phe93 O +
forms O +
extensive O +
contacts O +
with O +
a O +
peptide O +
ligand O +
in O +
the O +
crystal O +
structure O +
of O +
the O +
EBP O +
bound O +
to O +
an O +
EPO B-Gene +
- O +
mimetic O +
peptide O +
( O +
EMP1 O +
) O +
, O +
suggesting O +
that O +
Phe93 O +
is O +
also O +
important O +
for O +
EMP1 O +
binding O +
. O +

We O +
used O +
alanine O +
substitution O +
of O +
EBP O +
residues O +
that O +
contact O +
EMP1 O +
in O +
the O +
crystal O +
structure O +
to O +
investigate O +
the O +
function O +
of O +
these O +
residues O +
in O +
both O +
EMP1 O +
and O +
EPO B-Gene +
binding O +
. O +

The O +
three O +
largest O +
hydrophobic O +
contacts O +
at O +
Phe93 O +
, O +
Met150 O +
, O +
and O +
Phe205 O +
and O +
a O +
hydrogen O +
bonding O +
interaction O +
at O +
Thr151 O +
were O +
examined O +
. O +

Our O +
results O +
indicate O +
that O +
Phe93 O +
and O +
Phe205 O +
are O +
important O +
for O +
both O +
EPO B-Gene +
and O +
EMP1 O +
binding O +
, O +
Met150 O +
is O +
not O +
important O +
for O +
EPO B-Gene +
binding O +
but O +
is O +
critical O +
for O +
EMP1 O +
binding O +
, O +
and O +
Thr151 O +
is O +
not O +
important O +
for O +
binding O +
either O +
ligand O +
. O +

Thus O +
, O +
Phe93 O +
and O +
Phe205 O +
are O +
important O +
binding O +
determinants O +
for O +
both O +
EPO B-Gene +
and O +
EMP1 O +
, O +
even O +
though O +
these O +
ligands O +
share O +
no O +
sequence O +
or O +
structural O +
homology O +
, O +
suggesting O +
that O +
these O +
residues O +
may O +
represent O +
a O +
minimum O +
epitope O +
on O +
the O +
EPOR B-Gene +
for O +
productive O +
ligand O +
binding O +
. O +

Interplay O +
of O +
global O +
regulators O +
and O +
cell O +
physiology O +
in O +
the O +
general O +
stress O +
response O +
of O +
Escherichia O +
coli O +
. O +

Under O +
various O +
stress O +
conditions O +
, O +
two O +
sigma O +
subunits O +
of O +
RNA B-Gene +
polymerase I-Gene +
, O +
sigmaS B-Gene +
and O +
sigma70 B-Gene +
, O +
coexist O +
in O +
Escherichia O +
coli O +
cells O +
. O +

In O +
contrast O +
to O +
sigma70 B-Gene +
, O +
sigmaS B-Gene +
is O +
subject O +
to O +
intricate O +
regulation O +
and O +
coordinates O +
an O +
emergency O +
reaction O +
to O +
stress O +
as O +
well O +
as O +
long O +
term O +
stress O +
adaptation O +
. O +

In O +
vivo O +
, O +
the O +
two O +
sigma B-Gene +
factors I-Gene +
clearly O +
control O +
different O +
genes O +
. O +

Yet O +
, O +
they O +
are O +
structurally O +
and O +
functionally O +
very O +
similar O +
and O +
basically O +
recognize O +
the O +
same O +
promoter O +
sequences O +
. O +

Recent O +
data O +
suggest O +
that O +
sigma B-Gene +
factor I-Gene +
specificity O +
at O +
stress O +
- O +
activated O +
promoters O +
is O +
affected O +
by O +
the O +
interplay O +
of O +
the O +
two O +
RNA O +
polymeraseholoenzymes O +
with O +
additional O +
regulatory O +
factors O +
, O +
such O +
as O +
H B-Gene -
- I-Gene -
NS I-Gene +
, O +
Lrp B-Gene +
, O +
CRP B-Gene +
, O +
IHF B-Gene +
or O +
Fis B-Gene +
, O +
that O +
differentially O +
affect O +
transcription O +
initiation O +
by O +
sigmaS B-Gene +
or O +
sigma70 B-Gene +
in O +
a O +
promoter O +
- O +
specific O +
manner O +
. O +

Epidemiology O +
of O +
tuberculosis O +
in O +
Sardinia O +
: O +
a O +
comparison O +
of O +
two O +
data O +
- O +
gathering O +
methods O +
. O +

SETTING O +
: O +

A O +
complete O +
surveillance O +
system O +
for O +
tuberculosis O +
should O +
be O +
able O +
to O +
guarantee O +
constant O +
updating O +
of O +
incidence O +
and O +
provide O +
useful O +
data O +
on O +
a O +
variety O +
of O +
problems O +
related O +
to O +
tuberculosis O +
such O +
as O +
drug O +
resistance O +
, O +
co O +
- O +
infection O +
with O +
the O +
human O +
immunodeficiency O +
virus O +
( O +
HIV O +
) O +
, O +
the O +
geographic O +
origin O +
of O +
patients O +
, O +
and O +
mycobacterial O +
species O +
. O +

OBJECTIVE O +
AND O +
DESIGN O +
: O +

To O +
assess O +
the O +
completeness O +
of O +
the O +
surveillance O +
system O +
currently O +
operating O +
in O +
Sardinia O +
, O +
cases O +
seen O +
by O +
all O +
medical O +
centres O +
between O +
1987 O +
and O +
1995 O +
were O +
compared O +
with O +
those O +
notified O +
to O +
Sardinian O +
Public O +
Health O +
Services O +
for O +
the O +
same O +
period O +
. O +

RESULTS O +
: O +

Each O +
year O +
, O +
on O +
average O +
39 O +
% O +
of O +
cases O +
seen O +
in O +
Sardinia O +
are O +
notified O +
; O +
646 O +
( O +
40 O +
% O +
) O +
of O +
the O +
1591 O +
patients O +
notified O +
during O +
the O +
study O +
period O +
were O +
never O +
seen O +
by O +
regional O +
medical O +
centres O +
. O +

An O +
analysis O +
of O +
the O +
results O +
shows O +
that O +
from O +
1992 O +
the O +
decline O +
recorded O +
in O +
incidence O +
rates O +
in O +
previous O +
years O +
ceased O +
: O +
1992 O +
( O +
26 O +
/ O +
100,000 O +
) O +
, O +
1993 O +
( O +
25 O +
/ O +
100,000 O +
) O +
, O +
1994 O +
( O +
28 O +
/ O +
100,000 O +
) O +
, O +
and O +
1995 O +
( O +
24 O +
/ O +
100 O +
, O +
000 O +
) O +
. O +

CONCLUSIONS O +
: O +

The O +
current O +
surveillance O +
system O +
in O +
Sardinia O +
is O +
inadequate O +
for O +
performing O +
an O +
accurate O +
epidemiological O +
survey O +
of O +
the O +
disease O +
. O +

Epidemiological O +
analysis O +
based O +
solely O +
on O +
notification O +
can O +
provide O +
neither O +
reliable O +
incidence O +
rates O +
nor O +
useful O +
information O +
concerning O +
many O +
aspects O +
of O +
tuberculosis O +
. O +

Association O +
of O +
terminal O +
complement B-Gene +
proteins I-Gene +
in O +
solution O +
and O +
modulation O +
by O +
suramin O +
. O +

The O +
association O +
of O +
terminal O +
complement B-Gene +
proteins I-Gene +
was O +
investigated O +
by O +
analytical O +
ultracentrifugation O +
and O +
multi O +
- O +
angle O +
laser O +
light O +
scattering O +
. O +

Native O +
C8 B-Gene +
and O +
C9 B-Gene +
formed O +
a O +
heterodimer O +
in O +
solution O +
of O +
physiological O +
ionic O +
strength O +
with O +
a O +
free O +
- O +
energy O +
change O +
DeltaG O +
degrees O +
of O +
- O +
8.3 O +
kcal O +
/ O +
mol O +
and O +
a O +
dissociation O +
constant O +
Kd O +
of O +
0.6 O +
microM O +
( O +
at O +
20 O +
degrees O +
C O +
) O +
that O +
was O +
ionic O +
strength O +
- O +
and O +
temperature O +
- O +
dependent O +
. O +

A O +
van O +
' O +
t O +
Hoff O +
plot O +
of O +
the O +
change O +
in O +
Kd O +
was O +
linear O +
between O +
10 O +
and O +
37 O +
degrees O +
C O +
and O +
yielded O +
values O +
of O +
DeltaH O +
degrees O +
= O +
- O +
12.9 O +
kcal O +
/ O +
mol O +
and O +
DeltaS O +
degrees O +
= O +
- O +
15.9 O +
cal O +
mol O +
- O +
1 O +
deg-1 O +
, O +
suggesting O +
that O +
electrostatic O +
forces O +
play O +
a O +
prominent O +
role O +
in O +
the O +
interaction O +
of O +
C8 B-Gene +
with O +
C9 B-Gene +
. O +

Native O +
C8 B-Gene +
also O +
formed O +
a O +
heterodimer O +
with O +
C5 B-Gene +
, O +
and O +
low O +
concentrations O +
of O +
polyionic O +
ligands O +
such O +
as O +
protamine O +
and O +
suramin O +
inhibited O +
the O +
interaction O +
. O +

Suramin O +
induced O +
high O +
- O +
affinity O +
trimerization O +
of O +
C8 O +
( O +
Kd O +
= O +
0.10 O +
microM O +
at O +
20 O +
degrees O +
C O +
) O +
and O +
dimerization O +
of O +
C9 B-Gene +
( O +
Kd O +
= O +
0.86 O +
microM O +
at O +
20 O +
degrees O +
C O +
) O +
. O +

Suramin O +
- O +
induced O +
C8 B-Gene +
oligomerization O +
may O +
be O +
the O +
primary O +
reason O +
for O +
the O +
drug O +
's O +
ability O +
to O +
prevent O +
complement O +
- O +
mediated O +
hemolysis O +
. O +

Analysis O +
of O +
sedimentation O +
equilibria O +
and O +
also O +
of O +
the O +
fluorescence O +
enhancement O +
of O +
suramin O +
when O +
bound O +
to O +
protein O +
provided O +
evidence O +
for O +
two O +
suramin O +
- O +
binding O +
sites O +
on O +
each O +
C9 B-Gene +
and O +
three O +
on O +
each O +
C8 B-Gene +
in O +
the O +
oligomers O +
. O +

Oligomerization O +
could O +
be O +
reversed O +
by O +
high O +
suramin O +
concentrations O +
, O +
but O +
8-aminonaphthalene-1,3,6- O +
trisulfonate O +
( O +
ANTS2- O +
) O +
, O +
which O +
mimics O +
half O +
a O +
suramin O +
molecule O +
, O +
could O +
not O +
compete O +
with O +
suramin O +
binding O +
and O +
oligomerization O +
suggesting O +
that O +
the O +
drug O +
also O +
binds O +
nonionically O +
to O +
the O +
proteins O +
. O +

Contrast O +
enhanced O +
pulsed O +
Doppler O +
and O +
colour O +
- O +
coded O +
duplex O +
studies O +
of O +
the O +
cranial O +
vasculature O +
. O +

INTRODUCTION O +
: O +

The O +
aim O +
of O +
this O +
study O +
was O +
to O +
assess O +
the O +
effect O +
of O +
Albunex O +
, O +
a O +
vascular O +
contrast O +
agent O +
based O +
on O +
albumin B-Gene +
- O +
coated O +
air O +
microbubbles O +
, O +
on O +
pulsed O +
Doppler O +
and O +
colour O +
- O +
coded O +
duplex O +
sonography O +
of O +
the O +
cranial O +
vasculature O +
. O +

METHODS O +
: O +

Twenty O +
healthy O +
male O +
volunteers O +
received O +
intravenous O +
injections O +
of O +
contrast O +
in O +
single O +
doses O +
ranging O +
from O +
0.08 O +
to O +
0.30 O +
ml O +
/ O +
kg O +
. O +

Pulsed O +
wave O +
Doppler O +
sonography O +
examination O +
and O +
colour O +
- O +
coded O +
duplex O +
sonography O +
were O +
carried O +
out O +
in O +
the O +
right O +
internal O +
carotid O +
artery O +
( O +
ICA O +
) O +
and O +
middle O +
cerebral O +
artery O +
( O +
MCA O +
) O +
before O +
and O +
after O +
i.v O -
. O +
contrast O +
. O +

The O +
relative O +
intensity O +
increase O +
of O +
the O +
Doppler O +
signal O +
was O +
measured O +
in O +
decibels O +
. O +

RESULTS O +
: O +

Transpulmonary O +
passage O +
of O +
contrast O +
occurred O +
in O +
sufficient O +
amounts O +
to O +
enhance O +
the O +
intensity O +
of O +
the O +
Doppler O +
signal O +
significantly O +
, O +
but O +
the O +
duration O +
of O +
this O +
effect O +
was O +
short O +
. O +

Contrast O +
enhancement O +
also O +
improved O +
visualization O +
of O +
both O +
the O +
ICA O +
and O +
MCA O +
in O +
all O +
subjects O +
. O +

For O +
the O +
transcranial O +
examinations O +
, O +
this O +
resulted O +
in O +
visualization O +
of O +
a O +
greater O +
length O +
of O +
the O +
middle O +
cerebral O +
arteries O +
and O +
additional O +
vessels O +
in O +
the O +
Circle O +
of O +
Willis O +
. O +

CONCLUSIONS O +
: O +

These O +
results O +
confirm O +
that O +
contrast O +
enhancement O +
can O +
significantly O +
improve O +
the O +
quality O +
of O +
Doppler O +
examination O +
and O +
colour O +
- O +
coded O +
duplex O +
sonography O +
of O +
both O +
the O +
intracranial O +
and O +
extracranial O +
vessels O +
. O +

However O +
, O +
the O +
use O +
of O +
Albunex O +
in O +
neurosonology O +
will O +
be O +
of O +
limited O +
value O +
due O +
to O +
its O +
relatively O +
short O +
duration O +
. O +

Presenilins B-Gene +
interact O +
with O +
Rab11 B-Gene +
, O +
a O +
small B-Gene +
GTPase I-Gene +
involved O +
in O +
the O +
regulation O +
of O +
vesicular O +
transport O +
. O +

Presenilin B-Gene +
1 I-Gene +
( O +
PS1 B-Gene +
) O +
mutations O +
account O +
for O +
the O +
majority O +
of O +
early O -
- O -
onset O +
dominant O +
cases O +
of O +
familial O +
Alzheimer O +
's O +
disease O +
. O +

Presenilins B-Gene +
( O +
PSs B-Gene +
) O +
are O +
located O +
in O +
many O +
intra O +
- O +
cellular O +
compartments O +
such O +
as O +
the O +
endoplasmic O +
reticulum O +
, O +
Golgi O +
apparatus O +
, O +
nuclear O +
region O +
and O +
vesicular O +
structures O +
. O +

These O +
proteins O +
include O +
from O +
seven O +
to O +
nine O +
putative O +
transmembrane O +
domains O +
, O +
with O +
the O +
N O +
- O +
and O +
C O +
- O +
terminal O +
ends O +
and O +
a O +
large O +
hydrophilic O +
loop O +
orientated O +
towards O +
the O +
cytoplasm O +
. O +

We O +
report O +
an O +
interaction O +
between O +
the O +
human O +
PS1 B-Gene +
or O +
PS2 B-Gene +
hydrophilic O +
loop O +
and O +
Rab11 B-Gene +
, O +
a O +
small B-Gene +
GTPase I-Gene +
belonging O +
to O +
the O +
Ras B-Gene +
- I-Gene +
related I-Gene +
superfamily I-Gene +
. O +

Interaction O +
domains O +
were O +
mapped O +
to O +
codons O +
374 O +
- O +
400 O +
for O +
PS1 B-Gene +
and O +
to O +
codons O +
106 O +
- O +
179 O +
for O +
Rab11 B-Gene +
, O +
a O +
region O +
including O +
the O +
fourth O +
GTP O +
- O +
binding O +
domain O +
. O +

Considering O +
the O +
implication O +
of O +
Rab B-Gene +
proteins O +
in O +
vesicular O +
transport O +
pathways O +
, O +
the O +
PS B-Gene +
- O +
Rab11 B-Gene +
inter O +
- O +
action O +
suggests O +
that O +
PSs B-Gene +
might O +
be O +
involved O +
in O +
amyloid O +
precursor O +
protein O +
vesicular O +
routing O +
. O +

Computer O +
analysis O +
of O +
transcription O +
regulatory O +
patterns O +
in O +
completely O +
sequenced O +
bacterial O +
genomes O +
. O +

Recognition O +
of O +
transcription O +
regulation O +
sites O +
( O +
operators O +
) O +
is O +
a O +
hard O +
problem O +
in O +
computational O +
molecular O +
biology O +
. O +

In O +
most O +
cases O +
, O +
small O +
sample O +
size O +
and O +
low O +
degree O +
of O +
sequence O +
conservation O +
preclude O +
the O +
construction O +
of O +
reliable O +
recognition O +
rules O +
. O +

We O +
suggest O +
an O +
approach O +
to O +
this O +
problem O +
based O +
on O +
simultaneous O +
analysis O +
of O +
several O +
related O +
genomes O +
. O +

It O +
appears O +
that O +
as O +
long O +
as O +
a O +
gene O +
coding O +
for O +
a O +
transcription O +
regulator O +
is O +
conserved O +
in O +
the O +
compared O +
bacterial O +
genomes O +
, O +
the O +
regulation O +
of O +
the O +
respective O +
group O +
of O +
genes O +
( O +
regulons O +
) O +
also O +
tends O +
to O +
be O +
maintained O +
. O +

Thus O +
a O +
gene O +
can O +
be O +
confidently O +
predicted O +
to O +
belong O +
to O +
a O +
particular O +
regulon O +
in O +
case O +
not O +
only O +
itself O +
, O +
but O +
also O +
its O +
orthologs O +
in O +
other O +
genomes O +
have O +
candidate O +
operators O +
in O +
the O +
regulatory O +
regions O +
. O +

This O +
provides O +
for O +
a O +
greater O +
sensitivity O +
of O +
operator O +
identification O +
as O +
even O +
relatively O +
weak O +
signals O +
are O +
likely O +
to O +
be O +
functionally O +
relevant O +
when O +
conserved O +
. O +

We O +
use O +
this O +
approach O +
to O +
analyze O +
the O +
purine O +
( O +
PurR B-Gene +
) O +
, O +
arginine O +
( O +
ArgR B-Gene +
) O +
and O +
aromatic O +
amino O +
acid O +
( O +
TrpR B-Gene +
and O +
TyrR B-Gene +
) O +
regulons O +
of O +
Escherichia O +
coli O +
and O +
Haemophilus O +
influenzae O +
. O +

Candidate O +
binding O +
sites O +
in O +
regulatory O +
regions O +
of O +
the O +
respective O +
H.influenzae O +
genes O +
are O +
identified O +
, O +
a O +
new O +
family B-Gene +
of I-Gene +
purine I-Gene +
transport I-Gene +
proteins I-Gene +
predicted O +
to O +
belong O +
to O +
the O +
PurR B-Gene +
regulon O +
is O +
described O +
, O +
and O +
probable O +
regulation O +
of O +
arginine O +
transport O +
by O +
ArgR B-Gene +
is O +
demonstrated O +
. O +

Differences O +
in O +
the O +
regulation O +
of O +
some O +
orthologous O +
genes O +
in O +
E.coli O +
and O +
H.influenzae O +
, O +
in O +
particular O +
the O +
apparent O +
lack O +
of O +
the O +
autoregulation O +
of O +
the O +
purine B-Gene +
repressor I-Gene +
gene O +
in O +
H.influenzae O +
, O +
are O +
demonstrated O +
. O +

Assaying O +
RNA O +
chaperone B-Gene +
activity O +
in O +
vivo O +
using O +
a O +
novel O +
RNA O +
folding O +
trap O +
. O +

In O +
the O +
absence O +
of O +
proteins O +
, O +
RNAs O +
often O +
misfold O +
in O +
vitro O +
due O +
to O +
alternative O +
base O +
pairings O +
which O +
result O +
from O +
the O +
molecule O +
being O +
trapped O +
in O +
inactive O +
conformations O +
. O +

We O +
identify O +
an O +
in O +
vivo O +
folding O +
trap O +
in O +
the O +
T4 O +
phage O +
td B-Gene +
gene O +
, O +
caused O +
by O +
nine O +
base O +
pairs O +
between O +
a O +
sequence O +
element O +
in O +
the O +
upstream O +
exon O +
of O +
the O +
td B-Gene +
gene O +
and O +
another O +
at O +
the O +
3 O -
' O +
end O +
of O +
the O +
intron O +
. O +

During O +
translation O +
, O +
the O +
ribosome O +
resolves O +
this O +
interaction O +
; O +
consequently O +
the O +
intron O +
folds O +
correctly O +
and O +
splicing O +
occurs O +
. O +

The O +
introduction O +
of O +
a O +
stop O +
codon O +
upstream O +
of O +
this O +
base O +
pairing O +
prevents O +
resolution O +
of O +
the O +
inactive O +
structure O +
so O +
that O +
splicing O +
can O -
not O +
proceed O +
. O +

We O +
have O +
used O +
this O +
folding O +
trap O +
to O +
probe O +
for O +
RNA O +
binding O +
proteins O +
which O +
, O +
when O +
overexpressed O +
, O +
either O +
resolve O +
the O +
misfolded O +
structure O +
or O +
impede O +
its O +
formation O +
in O +
vivo O +
. O +

We O +
distinguish O +
between O +
proteins O +
which O +
recognize O +
the O +
intron O +
structure O +
and O +
those O +
which O +
bind O +
non O +
- O +
specifically O +
and O +
apparently O +
ignore O +
the O +
intron O +
. O +

The O +
first O +
class O +
, O +
e.g. O +
Neurospora O +
crassa O +
CYT-18 B-Gene +
, O +
can O +
rescue O +
the O +
exonic O +
trap O +
and O +
intron O +
mutants O +
which O +
cause O +
a O +
structural O +
defect O +
. O +

However O +
, O +
known O +
RNA O +
chaperones B-Gene +
such O +
as O +
Escherichia O +
coli O +
StpA B-Gene +
and O +
S12 B-Gene +
and O +
the O +
HIV O +
protein O +
NCp7 B-Gene +
, O +
only O +
resolve O +
the O +
exonic O +
trap O +
without O +
suppressing O +
intron O +
mutations O +
. O +

Thus O +
, O +
this O +
structural O +
trap O +
enables O +
detection O +
of O +
RNA O +
chaperone B-Gene +
activity O +
in O +
vivo O +
. O +

Endogenous O +
presenilin B-Gene +
1 I-Gene +
redistributes O +
to O +
the O +
surface O +
of O +
lamellipodia O +
upon O +
adhesion O +
of O +
Jurkat O +
cells O +
to O +
a O +
collagen B-Gene +
matrix O +
. O +

Most O +
familial O +
early O +
- O +
onset O +
Alzheimer O +
's O +
disease O +
cases O +
are O +
caused O +
by O +
mutations O +
in O +
the O +
presenilin B-Gene +
1 I-Gene +
( O +
PS1 B-Gene +
) O +
gene O +
. O +

Subcellular O +
localization O +
of O +
the O +
endogenous O +
PS1 B-Gene +
is O +
essential O +
for O +
understanding O +
its O +
function O +
, O +
interactions O +
with O +
proteins O +
, O +
and O +
role O +
in O +
Alzheimer O +
's O +
disease O +
. O +

Although O +
numerous O +
studies O +
revealed O +
predominant O +
localization O +
of O +
PS1 B-Gene +
to O +
endoplasmic O +
reticulum O +
and O +
Golgi O +
, O +
there O +
are O +
conflicting O +
reports O +
on O +
the O +
localization O +
of O +
PS1 B-Gene +
to O +
the O +
cell O +
surface O +
. O +

We O +
found O +
that O +
endogenous O +
PS1 B-Gene +
is O +
highly O +
expressed O +
in O +
T O +
lymphocytes O +
( O +
Jurkat O +
cells O +
) O +
. O +

Using O +
a O +
variety O +
of O +
methods O +
, O +
we O +
present O +
evidence O +
that O +
endogenous O +
PS1 B-Gene +
is O +
localized O +
to O +
the O +
cell O +
surface O +
in O +
addition O +
to O +
intracellular O +
membrane O +
compartments O +
. O +

Moreover O +
, O +
PS1 B-Gene +
appeared O +
in O +
high O +
levels O +
on O +
the O +
surface O +
of O +
lamellipodia O +
upon O +
adhesion O +
of O +
the O +
cells O +
to O +
a O +
collagen B-Gene +
matrix O +
. O +

The O +
redistribution O +
of O +
PS1 B-Gene +
in O +
adhered O +
cells O +
was O +
strikingly O +
similar O +
to O +
that O +
of O +
the O +
well O +
characterized O +
adhesion B-Gene +
protein I-Gene +
CD44 B-Gene +
. O +

Cell O +
surface O +
PS1 B-Gene +
formed O +
complexes O +
in O +
vivo O +
with O +
actin B-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
filamin B-Gene +
( O +
ABP-280 B-Gene +
) O +
, O +
which O +
is O +
known O +
to O +
form O +
bridges O +
between O +
cell O +
surface O +
receptors O +
and O +
cytoskeleton O +
and O +
mediate O +
cell O +
adhesion O +
and O +
cell O +
motility O +
. O +

Taken O +
together O +
, O +
our O +
results O +
suggest O +
a O +
role O +
of O +
PS1 B-Gene +
in O +
cell O +
adhesion O +
and/or O +
cell O +
- O +
matrix O +
interaction O +
. O +

A O +
single O +
amino O +
acid O +
substitution O +
in O +
the O +
cyclin B-Gene +
D I-Gene +
binding O +
domain O +
of O +
the O +
infected O +
cell O +
protein O +
no O +
. O +

0 O +
abrogates O +
the O +
neuroinvasiveness O +
of O +
herpes O +
simplex O +
virus O +
without O +
affecting O +
its O +
ability O +
to O +
replicate O +
. O +

The O +
infected O +
cell O +
protein O +
no O +
. O +

0 O +
( O +
ICP0 B-Gene +
) O +
of O +
herpes O +
simplex O +
virus O +
1 O +
is O +
a O +
promiscuous O +
transactivator O +
shown O +
to O +
enhance O +
the O +
expression O +
of O +
genes O +
introduced O +
into O +
cells O +
by O +
infection O +
or O +
transfection O +
. O +

The O +
protein O +
interacts O +
with O +
several O +
viral O +
and O +
cellular O +
proteins O +
. O +

Earlier O +
studies O +
have O +
shown O +
that O +
ICP0 B-Gene +
binds O +
and O +
stabilizes O +
cyclin B-Gene +
D3 I-Gene +
but O +
does O +
interfere O +
with O +
the O +
phosphorylation O +
of O +
retinoblastoma B-Gene +
protein I-Gene +
, O +
its O +
major O +
function O +
. O +

Cyclin B-Gene +
D3 I-Gene +
plays O +
a O +
key O +
role O +
in O +
the O +
transition O +
from O +
G1 O +
to O +
S O +
phase O +
. O +

To O +
define O +
the O +
role O +
of O +
cyclin B-Gene +
D3 I-Gene +
in O +
productive O +
infection O +
, O +
the O +
ICP0 B-Gene +
binding O +
site O +
for O +
cyclin B-Gene +
D3 I-Gene +
was O +
mapped O +
and O +
mutagenized O +
by O +
substitution O +
of O +
aspartic O +
acid O +
codon O +
199 O +
with O +
the O +
alanine O +
codon O +
. O +

We O +
report O +
that O +
the O +
substitution O +
precluded O +
the O +
interaction O +
of O +
this O +
protein O +
with O +
cyclin B-Gene +
D3 I-Gene +
in O +
the O +
yeast O +
two O +
- O +
hybrid O +
system O +
and O +
the O +
stabilization O +
of O +
cyclin B-Gene +
D3 I-Gene +
in O +
infected O +
cells O +
. O +

A O +
recombinant O +
virus O +
carrying O +
this O +
mutation O +
could O +
not O +
be O +
differentiated O +
from O +
wild O +
- O +
type O +
parent O +
with O +
respect O +
to O +
replication O +
in O +
dividing O +
cells O +
but O +
yielded O +
10 O +
- O +
fold O +
less O +
progeny O +
from O +
infected O +
resting O +
cells O +
and O +
serum O +
- O +
deprived O +
or O +
contact O +
- O +
inhibited O +
human O +
fibroblasts O +
. O +

In O +
mice O +
, O +
the O +
mutant O +
was O +
only O +
slightly O +
less O +
pathogenic O +
than O +
the O +
wild O +
- O +
type O +
parent O +
by O +
intracerebral O +
route O +
but O +
was O +
significantly O +
less O +
neuroinvasive O +
after O +
peripheral O +
inoculation O +
. O +

Replacement O +
of O +
the O +
mutated O +
amino O +
acid O +
with O +
aspartic O +
acid O +
restored O +
wild O +
- O +
type O +
phenotype O +
. O +

Stabilization O +
of O +
cyclin B-Gene +
D3 I-Gene +
therefore O +
is O +
linked O +
to O +
higher O +
virus O +
yields O +
in O +
nondividing O +
cells O +
and O +
potentially O +
higher O +
virulence O +
in O +
experimental O +
and O +
natural O +
hosts O +
. O +

One O +
function O +
of O +
ICP0 B-Gene +
is O +
to O +
scavenge O +
the O +
cell O +
for O +
proteins O +
that O +
could O +
bolster O +
viral O +
replication O +
. O +

Intracellular O +
expression O +
and O +
functional O +
properties O +
of O +
an O +
anti O +
- O +
p21Ras B-Gene +
scFv O +
derived O +
from O +
a O +
rat O +
hybridoma O +
containing O +
specific O +
lambda O +
and O +
irrelevant O +
kappa B-Gene +
light I-Gene +
chains I-Gene +
. O +

A O +
rat O +
single O +
- O +
chain O +
Fv O +
( O +
Y238 O +
scFv O +
) O +
was O +
derived O +
from O +
the O +
Y13 O -
- O -
238 O +
monoclonal O +
antibody B-Gene +
, O +
a O +
non O +
- O +
neutralizing O +
anti O +
- O +
Ras B-Gene +
antibody B-Gene +
. O +

The O +
Y13 O -
- O -
238 O +
hybridoma O +
expresses O +
two O +
functional O +
light O +
chains O +
. O +

N O -
- O -
terminus O +
microsequencing O +
of O +
these O +
chains O +
showed O +
the O +
presence O +
of O +
the O +
Y3 O +
Ag1.2.3 O +
Vkappa B-Gene +
chain I-Gene +
derived O +
from O +
the O +
rat O +
fusion O +
partner O +
and O +
of O +
a O +
rat O +
Vlambda B-Gene +
chain I-Gene +
. O +

Primers O +
designed O +
for O +
rat O +
Vlambda B-Gene +
amplification O +
allowed O +
the O +
cloning O +
of O +
a O +
functional O +
scFv O +
that O +
could O +
bind O +
p21Ras B-Gene +
. O +

The O +
kinetics O +
of O +
interaction O +
of O +
purified O +
Y238 O +
scFv O +
with O +
the O +
p21Ras B-Gene +
protein O +
was O +
evaluated O +
by O +
BIAcore O +
with O +
a O +
NTA O +
sensor O +
chip O +
and O +
gave O +
an O +
apparent O +
affinity O +
constant O +
in O +
the O +
nanomolar O +
range O +
( O +
K O -
( O -
D O -
) O +
= O +
4.58 O +
+ O -
/- O +
0.63 O +
nM O +
) O +
. O +

Immunoprecipitation O +
experiments O +
of O +
Y238 O +
scFv O +
expressed O +
in O +
Xenopus O +
laevis O +
oocytes O +
confirmed O +
the O +
specificity O +
of O +
the O +
scFv O +
for O +
the O +
Ras B-Gene +
protein O +
. O +

Y238 O +
scFv O +
could O +
be O +
intracellularly O +
expressed O +
in O +
oocytes O +
and O +
in O +
mammaliam O +
cells O +
without O +
adverse O +
effect O +
on O +
the O +
Ras B-Gene +
signalling O +
cascade O +
. O +

This O +
scFv O +
was O +
therefore O +
used O +
as O +
control O +
in O +
experiments O +
where O +
another O +
anti O +
- O +
Ras B-Gene +
scFv O +
( O +
Y259 O +
scFv O +
, O +
derived O +
from O +
the O +
neutralizing O +
anti O +
- O +
Ras B-Gene +
mAb O +
Y13 O -
- O -
259 O +
) O +
blocked O +
the O +
Ras B-Gene +
pathway O +
in O +
vitro O +
and O +
led O +
to O +
tumor O +
regression O +
in O +
a O +
nude O +
mouse O +
model O +
[ O +
Cochet O +
, O +
O. O +
, O +
Kenigsberg O +
, O +
M. O +
, O +
Delumeau O +
, O +
I. O +
, O +
Virone O +
- O +
Oddos O +
, O +
A. O +
, O +
Multon O +
, O +
M.C. O +
, O +
Fridman O +
, O +
W.H. O +
, O +
Schweighoffer O +
, O +
F. O +
, O +
Teillaud O +
, O +
J.L. O +
, O +
TocquÃ?Â O -
© O +
, O +
B. O +
, O +
1998 O -
. O +
Intracellular O +
expression O +
of O +
an O +
antibody O +
fragment O +
- O +
neutralizing O +
p21 B-Gene +
ras I-Gene +
promotes O +
tumor O +
regression O -
. O +
Cancer O +
Res O -
. O +
58 O +
, O +
1170 O +
- O +
1176 O -
. O +
] O +
. O +

Finally O +
, O +
BIAcore O +
analyses O +
indicated O +
that O +
the O +
epitopes O +
recognized O +
by O +
Y238 O +
and O +
Y259 O +
scFvs O +
are O +
not O +
overlapping O +
and O +
allowed O +
a O +
more O +
precise O +
definition O +
of O +
the O +
Y13 O -
- O -
238 O +
epitope O +
. O +

A O +
region O +
of O +
sigmaK B-Gene +
involved O +
in O +
promoter O +
activation O +
by O +
GerE B-Gene +
in O +
Bacillus O +
subtilis O +
. O +

During O +
endospore O +
formation O +
in O +
Bacillus O +
subtilis O +
, O +
the O +
DNA O +
binding O +
protein O +
GerE B-Gene +
stimulates O +
transcription O +
from O +
several O +
promoters O +
that O +
are O +
used O +
by O +
RNA B-Gene +
polymerase I-Gene +
containing O +
sigmaK B-Gene +
. O +

GerE B-Gene +
binds O +
to O +
a O +
site O +
on O +
one O +
of O +
these O +
promoters O +
, O +
cotX B-Gene +
, O +
that O +
overlaps O +
its O +
- O +
35 O +
region O +
. O +

We O +
tested O +
the O +
model O +
that O +
GerE B-Gene +
interacts O +
with O +
sigmaK B-Gene +
at O +
the O +
cotX B-Gene +
promoter O +
by O +
seeking O +
amino O +
acid O +
substitutions O +
in O +
sigmaK B-Gene +
that O +
interfered O +
with O +
GerE B-Gene +
- O +
dependent O +
activation O +
of O +
the O +
cotX B-Gene +
promoter O +
but O +
which O +
did O +
not O +
affect O +
utilization O +
of O +
the O +
sigmaK B-Gene +
- O +
dependent O +
, O +
GerE B-Gene +
- O +
independent O +
promoter O +
gerE B-Gene +
. O +

We O +
identified O +
two O +
amino O +
acid O +
substitutions O +
in O +
sigmaK B-Gene +
, O +
E216 O -
K O +
and O +
H225Y O +
, O +
that O +
decrease O +
cotX B-Gene +
promoter O +
utilization O +
but O +
do O +
not O +
affect O +
gerE B-Gene +
promoter O +
activity O +
. O +

Alanine O +
substitutions O +
at O +
these O +
positions O +
had O +
similar O +
effects O +
. O +

We O +
also O +
examined O +
the O +
effects O +
of O +
the O +
E216A O +
and O +
H225Y O +
substitutions O +
in O +
sigmaK B-Gene +
on O +
transcription O +
in O +
vitro O +
. O +

We O +
found O +
that O +
these O +
substitutions O +
specifically O +
reduced O +
utilization O +
of O +
the O +
cotX B-Gene +
promoter O +
. O +

These O +
and O +
other O +
results O +
suggest O +
that O +
the O +
amino O +
acid O +
residues O +
at O +
positions O +
216 O +
and O +
225 O +
are O +
required O +
for O +
GerE B-Gene +
- O +
dependent O +
cotX B-Gene +
promoter O +
activity O +
, O +
that O +
the O +
histidine O +
at O +
position O +
225 O +
of O +
sigmaK B-Gene +
may O +
interact O +
with O +
GerE B-Gene +
at O +
the O +
cotX B-Gene +
promoter O +
, O +
and O +
that O +
this O +
interaction O +
may O +
facilitate O +
the O +
initial O +
binding O +
of O +
sigmaK B-Gene +
RNA B-Gene +
polymerase I-Gene +
to O +
the O +
cotX B-Gene +
promoter O +
. O +

We O +
also O +
found O +
that O +
the O +
alanine O +
substitutions O +
at O +
positions O +
216 O +
and O +
225 O +
of O +
sigmaK B-Gene +
had O +
no O +
effect O +
on O +
utilization O +
of O +
the O +
GerE B-Gene +
- O +
dependent O +
promoter O +
cotD B-Gene +
, O +
which O +
contains O +
GerE B-Gene +
binding O +
sites O +
that O +
do O +
not O +
overlap O +
with O +
its O +
- O +
35 O +
region O +
. O +

The O +
nuclear O +
receptor O +
corepressor O +
N B-Gene -
- I-Gene -
CoR I-Gene +
regulates O +
differentiation O +
: O +
N B-Gene -
- I-Gene -
CoR I-Gene +
directly O +
interacts O +
with O +
MyoD B-Gene +
. O +

Classical O +
ligand O +
- O +
activated O +
nuclear O +
receptors O +
( O +
e.g. O +
thyroid B-Gene +
hormone I-Gene +
receptor I-Gene +
, O +
retinoic B-Gene +
acid I-Gene +
receptor I-Gene +
) O +
, O +
orphan O +
nuclear O +
receptors O +
( O +
e.g. O +
Rev B-Gene -
- I-Gene -
erbAalpha I-Gene +
/ I-Gene +
beta I-Gene +
) O +
, O +
Mad B-Gene +
/ O +
Max B-Gene +
bHLH O +
( O +
basic O +
helix O +
loop O +
helix O +
) O +
- O +
LZ O +
proteins O +
, O +
and O +
oncoproteins O +
, O +
PLZF B-Gene +
and O +
LAZ3 B-Gene +
/ O +
BCL6 B-Gene +
, O +
bind O +
DNA O +
and O +
silence O +
transcription O +
by O +
recruiting O +
a O +
repressor O +
complex O +
that O +
contains O +
N B-Gene -
- I-Gene -
CoR I-Gene +
( O +
nuclear B-Gene +
receptor I-Gene +
corepressor I-Gene +
) O +
/ O +
SMRT B-Gene +
( O +
silencing B-Gene +
mediator I-Gene +
of I-Gene +
retinoic I-Gene +
acid I-Gene +
and I-Gene +
thyroid I-Gene +
hormone I-Gene +
receptor I-Gene +
) O +
, O +
Sin3A B-Gene +
/ I-Gene +
B I-Gene +
, O +
and O +
HDAc-1 B-Gene +
/ I-Gene +
- I-Gene +
2 I-Gene +
proteins O +
. O +

The O +
function O +
of O +
the O +
corepressor O +
, O +
N B-Gene -
- I-Gene -
CoR I-Gene +
, O +
in O +
the O +
process O +
of O +
cellular O +
differentiation O +
and O +
coupled O +
phenotypic O +
acquisition O +
, O +
has O +
not O +
been O +
investigated O +
. O +

We O +
examined O +
the O +
functional O +
role O +
of O +
N B-Gene -
- I-Gene -
CoR I-Gene +
in O +
myogenesis O +
( O +
muscle O +
differentiation O +
) O +
, O +
an O +
ideal O +
paradigm O +
for O +
the O +
analysis O +
of O +
the O +
determinative O +
events O +
that O +
govern O +
the O +
cell O +
's O +
decision O +
to O +
divide O +
or O +
differentiate O +
. O +

We O +
observed O +
that O +
the O +
mRNA O +
encoding O +
N B-Gene -
- I-Gene -
CoR I-Gene +
was O +
suppressed O +
as O +
proliferating O +
myoblasts O +
exited O +
the O +
cell O +
cycle O +
, O +
and O +
formed O +
morphologically O +
and O +
biochemically O +
differentiated O +
myotubes O +
. O +

Exogenous O +
expression O +
of O +
N B-Gene -
- I-Gene -
CoR I-Gene +
( O +
but O +
not O +
RIP13 B-Gene +
) O +
in O +
myogenic O +
cells O +
ablated O +
1 O +
) O +
myogenic O +
differentiation O +
, O +
2 O -
) O +
the O +
expression O +
of O +
the O +
myoD B-Gene +
gene I-Gene +
family I-Gene +
that O +
encode O +
the O +
myogenic O +
specific O +
bHLH O +
proteins O +
, O +
and O +
3 O +
) O +
the O +
crucial O +
cell O +
cycle O +
regulator O +
, O +
p21Waf-1 B-Gene +
/ O +
Cip-1 B-Gene +
mRNA O +
. O +

Furthermore O +
, O +
N B-Gene -
- I-Gene -
CoR I-Gene +
expression O +
efficiently O +
inhibits O +
the O +
myoD B-Gene +
- O +
mediated O +
myogenic O +
conversion O +
of O +
pluripotential O +
C3H10T1 O +
/ O +
2 O +
cells O +
. O +

We O +
demonstrate O +
that O +
MyoD B-Gene +
- O +
mediated O +
transactivation O +
and O +
activity O +
are O +
repressed O +
by O +
N B-Gene -
- I-Gene -
CoR I-Gene +
. O +

The O +
mechanism O +
involves O +
direct O +
interactions O +
between O +
MyoD B-Gene +
and O +
N B-Gene -
- I-Gene -
CoR I-Gene +
; O +
moreover O +
, O +
the O +
interaction O +
was O +
dependent O +
on O +
the O +
amino O +
- O +
terminal O +
repression O +
domain O +
( O +
RD1 O +
) O +
of O +
N B-Gene -
- I-Gene -
CoR I-Gene +
and O +
the O +
bHLH O +
region O +
of O +
MyoD B-Gene +
. O +

Trichostatin O +
A O +
treatment O +
significantly O +
stimulated O +
the O +
activity O +
of O +
MyoD B-Gene +
by O +
approximately O +
10 O +
- O +
fold O +
and O +
inhibited O +
the O +
ability O +
of O +
N B-Gene -
- I-Gene -
CoR I-Gene +
to O +
repress O +
MyoD B-Gene +
- O +
mediated O +
transactivation O +
, O +
consistent O +
with O +
the O +
involvement O +
of O +
the O +
corepressor O +
and O +
the O +
recruitment O +
of O +
a O +
histone B-Gene +
deacteylase I-Gene +
activity O +
in O +
the O +
process O +
. O +

This O +
work O +
demonstrates O +
that O +
the O +
corepressor O +
N B-Gene -
- I-Gene -
CoR I-Gene +
is O +
a O +
key O +
regulator O +
of O +
MyoD B-Gene +
activity O +
and O +
mammalian O +
differentiation O +
, O +
and O +
that O +
N B-Gene -
- I-Gene -
CoR I-Gene +
has O +
a O +
multifaceted O +
role O +
in O +
myogenesis O +
. O +

Role O +
of O +
lon B-Gene +
and O +
ClpX B-Gene +
in O +
the O +
post O +
- O +
translational O +
regulation O +
of O +
a O +
sigma B-Gene +
subunit I-Gene +
of I-Gene +
RNA I-Gene +
polymerase I-Gene +
required O +
for O +
cellular O +
differentiation O +
in O +
Bacillus O +
subtilis O +
. O +

The O +
RNA B-Gene +
polymerase I-Gene +
sigma I-Gene +
subunit I-Gene +
, O +
sigmaH B-Gene +
( O +
Spo0H B-Gene +
) O +
of O +
Bacillus O +
subtilis O +
, O +
is O +
essential O +
for O +
the O +
transcription O +
of O +
genes O +
that O +
function O +
in O +
sporulation O +
and O +
genetic O +
competence O +
. O +

Although O +
spo0H B-Gene +
is O +
transcriptionally O +
regulated O +
by O +
the O +
key O +
regulatory O +
device O +
that O +
controls O +
sporulation O +
initiation O +
, O +
the O +
Spo0 B-Gene +
phosphorelay O +
, O +
there O +
is O +
considerable O +
evidence O +
implicating O +
a O +
mechanism O +
of O +
post O +
- O +
translational O +
control O +
that O +
governs O +
the O +
activity O +
and O +
concentration O +
of O +
sigmaH B-Gene +
. O +

Post O +
- O +
translational O +
control O +
of O +
spo0H B-Gene +
is O +
responsible O +
for O +
the O +
reduced O +
expression O +
of O +
genes O +
requiring O +
sigmaH B-Gene +
under O +
conditions O +
of O +
low O +
environmental O +
pH O +
. O +

It O +
is O +
also O +
responsible O +
for O +
heightened O +
sigmaH B-Gene +
activity O +
upon O +
relief O +
of O +
acid O +
stress O +
and O +
during O +
nutritional O +
depletion O +
. O +

In O +
this O +
study O +
, O +
the O +
ATP O +
- O +
dependent O +
proteases O +
LonA B-Gene +
and I-Gene +
B I-Gene +
and O +
the O +
regulatory O +
ATPase B-Gene +
ClpX B-Gene +
were O +
found O +
to O +
function O +
in O +
the O +
post O +
- O +
translational O +
control O +
of O +
sigmaH B-Gene +
. O +

Mutations O +
in O +
lonA B-Gene +
and O +
lonB B-Gene +
result O +
in O +
elevated O +
sigmaH B-Gene +
protein O +
concentrations O +
in O +
low O +
- O +
pH O +
cultures O +
. O +

However O +
, O +
this O +
is O +
not O +
sufficient O +
to O +
increase O +
sigmaH B-Gene +
- O +
dependent O +
transcription O +
. O +

Activation O +
of O +
sigmaH B-Gene +
- O +
dependent O +
transcription O +
upon O +
raising O +
medium O +
pH O +
and O +
in O +
cells O +
undergoing O +
sporulation O +
requires O +
clpX B-Gene +
, O +
as O +
shown O +
by O +
measuring O +
the O +
expression O +
of O +
lacZ B-Gene +
fusions O +
that O +
require O +
sigmaH B-Gene +
for O +
transcription O +
and O +
by O +
complementation O +
of O +
a O +
clpX B-Gene +
null O +
mutation O +
. O +

A O +
hypothesis O +
is O +
presented O +
that O +
low O +
environmental O +
pH O +
results O +
in O +
the O +
Lon B-Gene +
- O +
dependent O +
degradation O +
of O +
sigmaH B-Gene +
, O +
but O +
the O +
activity O +
of O +
sigmaH B-Gene +
in O +
sporulating O +
cells O +
and O +
in O +
cultures O +
at O +
neutral O +
pH O +
is O +
stimulated O +
by O +
a O +
ClpX B-Gene +
- O +
dependent O +
mechanism O +
in O +
response O +
to O +
nutritional O +
stress O +
. O +

Cardiopulmonary O +
and O +
CD4 B-Gene +
cell O +
changes O +
in O +
response O +
to O +
exercise O +
training O +
in O +
early O +
symptomatic O +
HIV O +
infection O +
. O +

PURPOSE O +
: O +

The O +
purposes O +
of O +
the O +
present O +
study O +
were O +
to O +
assess O +
the O +
effects O +
of O +
a O +
12 O +
- O +
wk O +
laboratory O +
based O +
aerobic O +
exercise O +
program O +
on O +
cardiopulmonary O +
function O +
, O +
CD4 B-Gene +
cell O +
count O +
, O +
and O +
physician O +
- O +
assessed O +
health O +
status O +
among O +
symptomatic O +
pre O +
- O +
AIDS O +
HIV O +
- O +
infected O +
individuals O +
( O +
N O +
= O +
28 O +
) O +
and O +
to O +
assess O +
the O +
degree O +
to O +
which O +
ill O +
health O +
was O +
associated O +
with O +
exercise O +
relapse O +
. O +

METHODS O +
: O +

Responses O +
to O +
graded O +
exercise O +
test O +
, O +
physician O +
- O +
assessed O +
health O +
status O +
, O +
and O +
CD4 B-Gene +
cell O +
counts O +
were O +
determined O +
at O +
baseline O +
and O +
12 O +
- O +
wk O +
follow O +
- O +
up O +
for O +
participants O +
randomly O +
assigned O +
to O +
exercise O +
or O +
control O +
conditions O +
, O +
and O +
reasons O +
for O +
exercise O +
noncompliance O +
were O +
recorded O +
. O +

RESULTS O +
: O +

Approximately O +
61 O +
% O +
of O +
exercise O +
- O +
assigned O +
participants O +
complied O +
( O +
> O +
50 O +
% O +
attendance O +
) O +
with O +
the O +
exercise O +
program O +
, O +
and O +
analyses O +
of O +
exercise O +
relapse O +
data O +
indicated O +
that O +
obesity O +
and O +
smoking O +
status O +
, O +
but O +
not O +
exercise O +
- O +
associated O +
illness O +
, O +
differentiated O +
compliant O +
from O +
noncompliant O +
exercisers O +
. O +

Compliant O +
exercisers O +
significantly O +
improved O +
peak O +
oxygen O +
consumption O +
( O +
VO2peak O +
; O +
12 O +
% O +
) O +
, O +
oxygen O +
pulse O +
( O +
O2pulse O +
; O +
13 O +
% O +
) O +
, O +
tidal O +
volume O +
( O +
TV O +
; O +
8 O +
% O +
) O +
, O +
ventilation O +
( O +
VE O +
; O +
17 O +
% O +
) O +
, O +
and O +
leg O +
power O +
( O +
25 O +
% O +
) O +
to O +
a O +
greater O +
degree O +
than O +
control O +
participants O +
and O +
noncompliant O +
exercisers O +
( O +
all O +
P O +
< O +
0.05 O +
) O +
. O +

Although O +
no O +
group O +
differences O +
in O +
health O +
status O +
were O +
found O +
, O +
a O +
significant O +
interaction O +
effect O +
indicated O +
that O +
noncompliant O +
exercisers O +
' O +
CD4 B-Gene +
cells O +
declined O +
( O +
18 O +
% O +
) O +
significantly O +
, O +
whereas O +
compliant O +
exercisers O +
' O +
cell O +
counts O +
significantly O +
increased O +
( O +
13 O +
% O +
; O +
P O +
< O +
0.05 O +
) O +
. O +

CONCLUSION O +
: O +

We O +
conclude O +
that O +
although O +
aerobic O +
exercise O +
can O +
improve O +
cardiopulmonary O +
functioning O +
in O +
symptomatic O +
HIV O +
- O +
infected O +
individuals O +
with O +
minimal O +
health O +
risks O +
, O +
attention O +
to O +
factors O +
associated O +
with O +
exercise O +
adherence O +
is O +
warranted O +
. O +

Multifocal O +
neural O +
conduction O +
impairment O +
in O +
forestry O +
workers O +
exposed O +
and O +
not O +
exposed O +
to O +
vibration O +
. O +

OBJECTIVE O +
: O +

The O +
aim O +
of O +
the O +
study O +
was O +
to O +
assess O +
peripheral O +
neural O +
involvement O +
induced O +
by O +
exposure O +
to O +
hand O +
- O +
arm O +
vibration O +
. O +

METHODS O +
: O +

Twenty O +
lumberjacks O +
, O +
working O +
regularly O +
with O +
chain O +
- O +
saws O +
and O +
exposed O +
to O +
hand O +
- O +
arm O +
vibration O +
( O +
group O +
E O +
) O +
and O +
20 O +
forestry O +
workers O +
performing O +
heavy O +
manual O +
work O +
and O +
not O +
exposed O +
to O +
vibration O +
( O +
group O +
NE O +
) O +
were O +
matched O +
with O +
a O +
control O +
group O +
of O +
20 O +
healthy O +
non O +
- O +
manual O +
workers O +
( O +
group O +
C O +
) O +
. O +

The O +
subjects O +
of O +
groups O +
E O +
and O +
NE O +
, O +
all O +
symptomatic O +
, O +
and O +
of O +
group O +
C O +
underwent O +
extensive O +
bilateral O +
neurophysiological O +
examination O +
consisting O +
of O +
: O +
sensory O +
conduction O +
( O +
velocity O +
and O +
amplitude O +
) O +
of O +
radial O +
, O +
median O +
and O +
ulnar O +
nerves O +
in O +
digit O +
- O +
wrist O +
segments O +
; O +
sensory O +
conduction O +
( O +
velocity O +
) O +
of O +
median O +
nerve O +
in O +
wrist O +
- O +
elbow O +
segment O +
; O +
mixed O +
conduction O +
( O +
velocity O +
and O +
amplitude O +
) O +
of O +
median O +
and O +
ulnar O +
nerves O +
in O +
palm O +
- O +
wrist O +
segments O +
; O +
motor O +
conduction O +
velocity O +
, O +
including O +
distal O +
motor O +
latencies O +
, O +
and O +
amplitude O +
of O +
median O +
( O +
elbow O +
- O +
wrist O +
) O +
and O +
ulnar O +
( O +
elbow O +
- O +
wrist O +
and O +
across O +
the O +
elbow O +
) O +
nerves O +
. O +

RESULTS O +
: O +

Electrophysiological O +
abnormalities O +
were O +
found O +
in O +
85 O +
% O +
of O +
group O +
E O -
's O +
limbs O +
, O +
versus O +
62.5 O +
% O +
of O +
group O +
NE O +
's O +
limbs O +
. O +

The O +
most O +
frequent O +
pathological O +
pattern O +
in O +
group O +
E O +
was O +
a O +
' O +
multifocal O +
' O +
impairment O +
( O +
multiple O +
sites O +
of O +
several O +
nerve O +
segments O +
) O +
, O +
with O +
a O +
prevalent O +
involvement O +
of O +
sensory O +
rather O +
than O +
motor O +
fibres O +
in O +
the O +
hand O +
, O +
seldom O +
extending O +
to O +
the O +
forearm O +
. O +

Multivariate O +
analysis O +
showed O +
that O +
the O +
neurographic O +
parameters O +
which O +
better O +
characterized O +
workers O +
exposed O +
to O +
hand O +
- O +
arm O +
vibration O +
had O +
a O +
pattern O +
different O +
from O +
that O +
usually O +
found O +
in O +
idiopathic O +
carpal O +
tunnel O +
syndrome O +
( O +
CTS O +
) O +
. O +

CONCLUSION O +
: O +

These O +
results O +
suggest O +
that O +
vibration O +
- O +
induced O +
neural O +
involvement O +
can O +
be O +
considered O +
neither O +
pure O +
digital O +
neuropathy O +
, O +
nor O +
definite O +
CTS O +
, O +
as O +
previously O +
described O +
. O +

Diversity O +
of O +
the O +
repertoire O +
of O +
p58 B-Gene +
killer I-Gene +
cell I-Gene +
inhibitory I-Gene +
receptors I-Gene +
in O +
a O +
single O +
individual O +
. O +

p58 B-Gene +
Killer I-Gene +
cell I-Gene +
inhibitory I-Gene +
receptors I-Gene +
( O +
KIRs B-Gene +
) O +
recognize O +
HLA B-Gene -
- I-Gene -
C I-Gene +
molecules O +
on O +
target O +
cell O +
surface O +
and O +
transmit O +
an O +
inhibitory O +
signal O +
to O +
prevent O +
cell O +
- O +
mediated O +
cytotoxicity O +
. O +

p58 B-Gene +
KIR I-Gene +
family I-Gene +
is O +
composed O +
of O +
multiple O +
receptors O +
whose O +
amino O +
acid O +
sequences O +
are O +
similar O +
but O +
their O +
ligand O +
specificity O +
is O +
different O +
. O +

However O +
, O +
it O +
is O +
not O +
clear O +
how O +
diverse O +
the O +
repertoire O +
of O +
p58 B-Gene +
KIR I-Gene +
is O +
, O +
particularly O +
in O +
a O +
single O +
individual O +
. O +

To O +
address O +
this O +
question O +
, O +
cDNAs O +
were O +
cloned O +
encoding O +
the O +
extracellular O +
domain O +
of O +
p58 B-Gene +
KIR I-Gene +
from O +
a O +
single O +
individual O +
. O +

Twelve O +
different O +
p58 B-Gene +
KIRs I-Gene +
were O +
identified O +
suggesting O +
that O +
the O +
repertoire O +
in O +
a O +
single O +
individual O +
is O +
highly O +
diverse O +
. O +

Interestingly O +
, O +
seven O +
of O +
them O +
have O +
hybrid O +
sequences O +
of O +
three O +
previously O +
reported O +
p58 B-Gene +
KIRs I-Gene +
. O +

Using O +
an O +
RNase B-Gene +
protection O +
assay O +
, O +
it O +
was O +
demonstrated O +
that O +
the O +
mRNA O +
transcripts O +
of O +
the O +
hybrid O +
KIRs B-Gene +
are O +
present O +
in O +
peripheral O +
blood O +
mononuclear O +
cells O +
( O +
PBMCs O +
) O +
. O +

Four O +
differently O +
spliced O +
forms O +
of O +
p58 B-Gene +
KIR I-Gene +
were O +
also O +
identified O +
indicating O +
that O +
the O +
repertoire O +
is O +
diverse O +
in O +
size O +
as O +
well O +
as O +
in O +
sequence O +
. O +

Putative O +
splicing O +
sites O +
found O +
in O +
p58 B-Gene +
KIR I-Gene +
cDNAs O +
suggest O +
that O +
the O +
differently O +
spliced O +
forms O +
are O +
produced O +
by O +
alternative O +
splicing O +
mechanism O +
, O +
and O +
that O +
the O +
hybrid O +
KIRs B-Gene +
may O +
also O +
be O +
generated O +
by O +
alternative O +
splicing O +
of O +
two O +
consecutive O +
genes O +
and/or O +
by O +
trans O +
- O +
splicing O +
mechanism O +
found O +
in O +
Ig B-Gene +
genes O +
in O +
B O +
cells O +
. O +

[ O +
Biopsy O +
of O +
labial O +
salivary O +
glands O +
and O +
lacrimal O +
glands O +
in O +
the O +
diagnosis O +
of O +
SjÃ?Â¶gren O +
's O +
syndrome O +
] O +

OBJECTIVES O +
: O +

To O +
determine O +
the O +
diagnostic O +
value O +
for O +
SjÃ?Â¶gren O +
's O +
syndrome O +
( O +
SS O +
) O +
by O +
evaluating O +
the O +
presence O +
of O +
focal O +
adenitis O +
in O +
labial O +
salivary O +
gland O +
( O +
LSG O +
) O +
and O +
lacrimal O +
gland O +
( O +
LG O +
) O +
biopsy O +
specimens O +
. O +

METHODS O +
: O +

109 O +
suspected O +
cases O +
with O +
SS O +
underwent O +
the O +
biopsies O +
. O +

The O +
diagnostic O +
criteria O +
of O +
Fox O +
et O +
al. O +
were O +
followed O +
. O +

Both O +
Chisholm O +
- O +
Manson O +
's O +
grading O +
standard O +
and O +
Greenspan O +
's O +
focus O +
score O +
were O +
used O +
for O +
the O +
evaluation O +
. O +

RESULTS O +
: O +

Myoepithelial O +
islands O +
and O +
severe O +
lymphocyte O +
infiltration O +
with O +
germinal O +
centers O +
were O +
observed O +
only O +
in O +
LG O +
biopsy O +
specimens O +
. O +

The O +
lymphocytic O +
foci O +
scored O +
of O +
LG O +
were O +
significantly O +
higher O +
than O +
that O +
of O +
LSG O +
in O +
23 O +
cases O +
having O +
both O +
biopsy O +
results O +
. O +

The O +
evaluation O +
of O +
both O +
kinds O +
of O +
specimen O +
for O +
such O +
a O +
patient O +
was O +
significantly O +
more O +
effective O +
in O +
diagnosing O +
SS O +
than O +
using O +
either O +
one O +
of O +
them O +
alone O +
. O +

CONCLUSION O +
: O +

We O +
recommend O +
that O +
both O +
LSG O +
and O +
LG O +
biopsies O +
be O +
performed O +
in O +
patients O +
suspected O +
of O +
having O +
SS O +
to O +
reduce O +
false O +
negative O +
results O +
and O +
improve O +
diagnostic O +
accuracy O +
. O +

Localization O +
of O +
a O +
new O +
prostate B-Gene +
- I-Gene +
specific I-Gene +
antigen I-Gene +
- O +
related O +
serine B-Gene +
protease I-Gene +
gene O +
, O +
KLK4 B-Gene +
, O +
is O +
evidence O +
for O +
an O +
expanded O +
human O +
kallikrein B-Gene +
gene I-Gene +
family I-Gene +
cluster O +
on O +
chromosome O +
19q13.3 O +
- O +
13.4 O +
. O +

The O +
human O +
tissue B-Gene +
kallikrein I-Gene +
( I-Gene +
KLK I-Gene +
) I-Gene +
family I-Gene +
of I-Gene +
serine I-Gene +
proteases I-Gene +
, O +
which O +
is O +
important O +
in O +
post O +
- O +
translational O +
processing O +
events O +
, O +
currently O +
consists O +
of O +
just O +
three O +
genes O +
- O +
tissue B-Gene +
kallikrein I-Gene +
( O +
KLK1 B-Gene +
) O +
, O +
KLK2 B-Gene +
, O +
and O +
prostate B-Gene +
- I-Gene +
specific I-Gene +
antigen I-Gene +
( O +
PSA B-Gene +
) O +
( O +
KLK3 B-Gene +
) O +
- O +
clustered O +
at O +
chromosome O +
19q13 O -
. O +
3 O +
- O +
13.4 O +
. O +

We O +
identified O +
an O +
expressed O +
sequence O +
tag O +
from O +
an O +
endometrial O +
carcinoma O +
cDNA O +
library O +
with O +
50 O +
% O +
identity O +
to O +
the O +
three O +
known O +
KLK B-Gene +
genes O +
. O +

Primers O +
designed O +
to O +
putative O +
exon O +
2 O +
and O +
exon O +
3 O +
regions O +
from O +
this O +
novel O +
kallikrein B-Gene +
- O +
related O +
sequence O +
were O +
used O +
to O +
polymerase O +
chain O +
reaction O +
- O +
screen O +
five O +
cosmids O +
spanning O +
130 O +
kb O +
around O +
the O +
KLK B-Gene +
locus O +
on O +
chromosome O +
19 O +
. O +

This O +
new O +
gene O +
, O +
which O +
we O +
have O +
named O +
KLK4 B-Gene +
, O +
is O +
25 O +
kb O +
downstream O +
of O +
the O +
KLK2 B-Gene +
gene O +
and O +
follows O +
a O +
region O +
that O +
includes O +
two O +
other O +
putative O +
KLK B-Gene +
- O +
like O +
gene O +
fragments O +
. O +

KLK4 B-Gene +
spans O +
5.2 O +
kb O +
, O +
has O +
an O +
identical O +
genomic O +
structure O +
- O +
five O +
exons O +
and O +
four O +
introns O +
- O +
to O +
the O +
other O +
KLK B-Gene +
genes O +
and O +
is O +
transcribed O +
on O +
the O +
reverse O +
strand O +
, O +
in O +
the O +
same O +
direction O +
as O +
KLK1 B-Gene +
but O +
opposite O +
to O +
that O +
of O +
KLK2 B-Gene +
and O +
KLK3 B-Gene +
. O +

It O +
encodes O +
a O +
254 O +
- O +
amino O +
acid O +
prepro O +
- O +
serine B-Gene +
protease I-Gene +
that O +
is O +
most O +
similar O +
( O +
78 O +
% O +
identical O +
) O +
to O +
pig O +
enamel B-Gene +
matrix I-Gene +
serine I-Gene +
protease I-Gene +
but O +
is O +
also O +
37 O +
% O +
identical O +
to O +
PSA B-Gene +
. O +

These O +
data O +
suggest O +
that O +
the O +
human O +
kallikrein B-Gene +
gene I-Gene +
family I-Gene +
locus O +
on O +
chromosome O +
19 O +
is O +
larger O +
than O +
previously O +
thought O +
and O +
also O +
indicate O +
a O +
greater O +
sequence O +
divergence O +
within O +
this O +
family O +
compared O +
with O +
the O +
highly O +
conserved O +
rodent O +
kallikrein B-Gene +
genes O +
. O +

Functional O +
analysis O +
of O +
DNA O +
sequences O +
required O +
for O +
conidium O +
- O +
specific O +
expression O +
of O +
the O +
SpoC1-C1C B-Gene +
gene O +
of O +
Aspergillus O +
nidulans O +
. O +

The O +
SpoC1-C1C B-Gene +
gene O +
is O +
centrally O +
located O +
within O +
the O +
A. O +
nidulans O +
conidium O +
- O +
specific O +
SpoC1 B-Gene +
gene O +
cluster O +
. O +

With O +
one O +
exception O +
, O +
the O +
14 O +
genes O +
within O +
the O +
cluster O +
are O +
coordinately O +
regulated O +
. O +

C1C B-Gene +
transcript O +
is O +
first O +
detected O +
late O +
in O +
conidiation O +
, O +
coincidental O +
with O +
the O +
appearance O +
of O +
mature O +
conidia O +
, O +
and O +
accumulates O +
approximately O +
1000 O +
- O +
fold O +
in O +
conidia O +
. O +

We O +
show O +
that O +
C1C B-Gene +
expression O +
is O +
restricted O +
to O +
conidia O +
, O +
with O +
mRNA O +
abundance O +
decreasing O +
immediately O +
after O +
induction O +
of O +
germination O +
. O +

C1C B-Gene +
transcription O +
and O +
translation O +
are O +
not O +
temporally O +
separated O +
and O +
, O +
similar O +
to O +
C1C B-Gene +
RNA O +
abundance O +
, O +
a O +
C1C B-Gene +
: O +
: O +
beta B-Gene -
- I-Gene -
galactosidase I-Gene +
fusion O +
protein O +
is O +
first O +
detected O +
with O +
the O +
appearance O +
of O +
mature O +
conidia O +
and O +
decreases O +
after O +
induction O +
of O +
germination O +
. O +

Cell O +
- O +
specific O +
C1C B-Gene +
expression O +
requires O +
both O +
a O +
position O +
- O +
dependent O +
mechanism O +
of O +
regulation O +
, O +
responsible O +
for O +
repression O +
in O +
hyphae O +
, O +
and O +
a O +
position O +
- O +
independent O +
mechanism O +
of O +
regulation O +
, O +
responsible O +
for O +
developmental O +
expression O +
. O +

We O +
show O +
by O +
functional O +
analysis O +
of O +
upstream O +
DNA O +
sequences O +
that O +
a O +
10 O +
- O +
bp O +
sequence O +
and O +
two O +
adjacent O +
6 O +
- O +
bp O +
direct O +
repeats O +
are O +
necessary O +
for O +
position O +
- O +
independent O +
, O +
condium O +
- O +
specific O +
expression O +
of O +
both O +
the O +
intact O +
C1C B-Gene +
gene O +
and O +
the O +
reporter O +
gene O +
. O +

At O +
least O +
one O +
repeat O +
( O +
CAACAT O +
) O +
is O +
required O +
for O +
normal O +
levels O +
of O +
expression O +
. O +

We O +
find O +
that O +
the O +
C1C B-Gene +
gene O +
is O +
not O +
a O +
direct O +
target O +
of O +
the O +
BrlAp B-Gene +
and O +
AbaAp B-Gene +
developmental O +
regulators O +
, O +
but O +
of O +
a O +
yet O +
unidentified O +
conidium O +
- O +
specific O +
transcriptional O +
activator O +
. O +

Binge O +
drinking O +
and O +
bone O +
metabolism O +
in O +
a O +
young O +
actively O +
growing O +
rat O +
model O +
. O +

BACKGROUND O +
: O +

Chronic O +
alcohol O +
consumption O +
has O +
been O +
demonstrated O +
to O +
be O +
deleterious O +
to O +
bone O +
health O +
. O +

However O +
, O +
binge O +
drinking O +
is O +
the O +
prevalent O +
form O +
of O +
drinking O +
in O +
young O +
people O +
, O +
which O +
was O +
the O +
impetus O +
for O +
the O +
present O +
study O +
to O +
determine O +
the O +
effect O +
of O +
week O +
- O +
end O +
and O +
week O +
- O +
long O +
binge O +
drinking O +
on O +
bone O +
health O +
in O +
a O +
young O +
actively O +
growing O +
animal O +
model O +
. O +

METHODS O +
: O +

Four O +
- O +
week O +
- O +
old O +
, O +
female O +
, O +
Sprague O +
- O +
Dawley O +
rats O +
were O +
given O +
the O +
amount O +
of O +
5 O +
% O +
alcohol O +
by O +
gavage O +
to O +
be O +
equivalent O +
to O +
a O +
63 O +
kg O +
woman O +
drinking O +
six O +
beers O +
a O +
day O +
for O +
either O +
2 O +
or O +
5 O +
consecutive O +
days O +
per O +
week O +
. O +

RESULTS O +
: O +

There O +
were O +
no O +
changes O +
in O +
the O +
5 O +
- O +
day O +
binge O +
animals O +
, O +
but O +
the O +
2 O +
- O +
day O +
binge O +
animals O +
were O +
hypocalcemic O +
. O +

Similarly O +
, O +
2 O +
- O +
day O +
binge O +
animals O +
had O +
slightly O +
increased O +
bone O +
chemistry O +
and O +
histomorphometric O +
values O +
for O +
both O +
tibia O +
and O +
femur O +
, O +
but O +
only O +
femur O +
length O +
, O +
dry O +
weight O +
, O +
and O +
ash O +
weight O +
as O +
well O +
as O +
femur O +
density O +
, O +
presented O +
either O +
as O +
g O +
/ O +
ml O +
or O +
ash O +
weight O +
per O +
unit O +
volume O +
, O +
were O +
increased O +
by O +
a O +
statistically O +
significant O +
level O +
. O +

Cross O +
- O +
section O +
periosteal O +
Mineral O +
Apposition O +
Rate O +
( O +
MAR O +
) O +
was O +
significantly O +
decreased O +
in O +
the O +
2 O +
- O +
day O +
alcohol O +
fed O +
animals O +
. O +

CONCLUSIONS O +
: O +

Actively O +
growing O +
rats O +
given O +
5 O +
% O +
alcohol O +
by O +
gavage O +
for O +
2 O +
days O +
per O +
week O +
have O +
an O +
increased O +
bone O +
length O +
, O +
bone O +
weight O +
, O +
and O +
bone O +
density O +
. O +

The O +
interpretation O +
of O +
these O +
results O +
must O +
be O +
viewed O +
with O +
great O +
caution O +
because O +
studies O +
of O +
chronic O +
alcohol O +
consumption O +
, O +
and O +
many O +
studies O +
of O +
acute O +
drinking O +
, O +
clearly O +
indicate O +
deleterious O +
effects O +
of O +
alcohol O +
on O +
bone O +
health O +
. O +

Those O +
fed O +
alcohol O +
for O +
5 O +
days O +
per O +
week O +
showed O +
no O +
change O +
. O +

Efficacy O +
of O +
misoprostol O +
in O +
prevention O +
of O +
gastric O +
hemorrhage O +
in O +
dogs O +
treated O +
with O +
high O +
doses O +
of O +
methylprednisolone O +
sodium O +
succinate O +
. O +

OBJECTIVE O +
: O +

To O +
determine O +
whether O +
administration O +
of O +
misoprostol O +
prevents O +
gastric O +
hemorrhage O +
in O +
healthy O +
dogs O +
treated O +
with O +
high O +
doses O +
of O +
methylprednisolone O +
sodium O +
succinate O +
( O +
MPSS O +
) O +
. O +

ANIMALS O +
: O +

18 O +
healthy O +
hound O +
- O +
type O +
dogs O +
of O +
both O +
sexes O +
. O +

PROCEDURE O +
: O +

All O +
dogs O +
were O +
given O +
high O +
doses O +
of O +
MPSS O +
( O +
30 O +
mg O +
/ O +
kg O +
of O +
body O +
weight O +
, O +
initially O +
, O +
then O +
15 O +
mg O +
/ O +
kg O +
2 O +
and O +
6 O +
hours O +
later O +
, O +
and O +
, O +
subsequently O +
, O +
q O +
6 O +
h O +
for O +
a O +
total O +
of O +
48 O +
hours O +
) O +
IV O +
. O +

Dogs O +
were O +
assigned O +
randomly O +
to O +
receive O +
concurrent O +
treatment O +
with O +
misoprostol O +
( O +
4 O +
to O +
6 O +
microg O +
/ O +
kg O +
, O +
PO O +
, O +
q O +
8 O +
h O +
; O +
n O +
= O +
9 O +
) O +
or O +
an O +
empty O +
gelatin O +
capsule O +
( O +
9 O +
) O +
. O +

Gastroduodenoscopy O +
was O +
performed O +
before O +
and O +
after O +
treatment O +
. O +

Hemorrhage O +
was O +
graded O +
from O +
none O +
( O +
0 O +
) O +
to O +
severe O +
( O +
3 O +
) O +
for O +
each O +
cardia O +
, O +
fundus O +
, O +
antrum O +
, O +
and O +
duodenum O +
. O +

A O +
total O +
stomach O +
score O +
was O +
calculated O +
as O +
the O +
sum O +
of O +
the O +
regional O +
stomach O +
scores O +
. O +

Food O +
retention O +
was O +
recorded O +
, O +
and O +
pH O +
of O +
gastric O +
fluid O +
was O +
determined O +
. O +

Gastric O +
and O +
fecal O +
occult O +
blood O +
was O +
measured O +
. O +

RESULTS O +
: O +

Gastric O +
hemorrhage O +
was O +
evident O +
in O +
all O +
dogs O +
after O +
MPSS O +
administration O +
, O +
and O +
its O +
severity O +
was O +
similar O +
in O +
both O +
groups O +
. O +

Median O +
total O +
stomach O +
score O +
was O +
6 O +
for O +
misoprostol O +
- O +
treated O +
dogs O +
and O +
5.5 O +
for O +
dogs O +
given O +
the O +
gelatin O +
capsule O +
. O +

Difference O +
in O +
gastric O +
acidity O +
, O +
frequency O +
of O +
food O +
retention O +
, O +
and O +
incidence O +
of O +
occult O +
blood O +
in O +
gastric O +
fluid O +
and O +
feces O +
was O +
not O +
apparent O +
between O +
the O +
2 O +
groups O +
. O +

CONCLUSIONS O +
AND O +
CLINICAL O +
RELEVANCE O +
: O +

Administration O +
of O +
misoprostol O +
( O +
4 O +
to O +
6 O +
microg O +
/ O +
kg O +
, O +
PO O +
, O +
q O +
8 O +
h O +
) O +
does O +
not O +
prevent O +
gastric O +
hemorrhage O +
caused O +
by O +
high O +
doses O +
of O +
MPSS O +
. O +

Alternative O +
prophylactic O +
treatment O +
should O +
be O +
considered O +
. O +

Grb10 B-Gene +
, O +
a O +
positive O +
, O +
stimulatory O +
signaling O +
adapter O +
in O +
platelet B-Gene +
- I-Gene +
derived I-Gene +
growth I-Gene +
factor I-Gene +
BB I-Gene +
- O +
, O +
insulin B-Gene +
- I-Gene +
like I-Gene +
growth I-Gene +
factor I-Gene +
I I-Gene +
- O +
, O +
and O +
insulin B-Gene +
- O +
mediated O +
mitogenesis O +
. O +

Grb10 B-Gene +
has O +
been O +
described O +
as O +
a O +
cellular O +
partner O +
of O +
several O +
receptor B-Gene +
tyrosine I-Gene +
kinases I-Gene +
, O +
including O +
the O +
insulin B-Gene +
receptor I-Gene +
( O +
IR B-Gene +
) O +
and O +
the O +
insulin B-Gene +
- I-Gene +
like I-Gene +
growth I-Gene +
factor I-Gene +
I I-Gene +
( I-Gene +
IGF I-Gene -
- I-Gene -
I I-Gene +
) I-Gene +
receptor I-Gene +
( O +
IGF B-Gene -
- I-Gene -
IR I-Gene +
) O +
. O +

Its O +
cellular O +
role O +
is O +
still O +
unclear O +
and O +
a O +
positive O +
as O +
well O +
as O +
an O +
inhibitory O +
role O +
in O +
mitogenesis O +
depending O +
on O +
the O +
cell O +
context O +
has O +
been O +
implicated O +
. O +

We O +
have O +
tested O +
other O +
mitogenic O +
receptor B-Gene +
tyrosine I-Gene +
kinases I-Gene +
as O +
putative O +
Grb10 B-Gene +
partners O +
and O +
have O +
identified O +
the O +
activated O +
forms O +
of O +
platelet B-Gene +
- I-Gene +
derived I-Gene +
growth I-Gene +
factor I-Gene +
( I-Gene +
PDGF I-Gene +
) I-Gene +
receptor I-Gene +
beta I-Gene +
( O +
PDGFRbeta B-Gene +
) O +
, O +
hepatocyte B-Gene +
growth I-Gene +
factor I-Gene +
receptor I-Gene +
( O +
Met B-Gene +
) O +
, O +
and O +
fibroblast B-Gene +
growth I-Gene +
factor I-Gene +
receptor I-Gene +
as O +
candidates O +
. O +

We O +
have O +
mapped O +
Y771 O +
as O +
a O +
PDFGRbeta B-Gene +
site O +
that O +
is O +
involved O +
in O +
the O +
association O +
with O +
Grb10 B-Gene +
via O +
its O +
SH2 O +
domain O +
. O +

We O +
have O +
further O +
investigated O +
the O +
putative O +
role O +
of O +
Grb10 B-Gene +
in O +
mitogenesis O +
with O +
four O +
independent O +
experimental O +
strategies O +
and O +
found O +
that O +
all O +
consistently O +
suggested O +
a O +
role O +
as O +
a O +
positive O +
, O +
stimulatory O +
signaling O +
adaptor O +
in O +
normal O +
fibroblasts O +
. O +

( O -
i O +
) O +

Complete O +
Grb10 B-Gene +
expression O +
from O +
cDNA O +
with O +
an O +
ecdysone O +
- O +
regulated O +
transient O +
expression O +
system O +
stimulated O +
PDGF B-Gene -
- I-Gene -
BB I-Gene +
- O +
, O +
IGF B-Gene -
- I-Gene -
I I-Gene +
, O +
and O +
insulin B-Gene +
- O +
but O +
not O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
( O +
EGF B-Gene +
) O +
- O +
induced O +
DNA O +
synthesis O +
in O +
an O +
ecdysone O +
dose O +
- O +
responsive O +
fashion O +
. O +

( O -
ii O -
) O +
Microinjection O +
of O +
the O +
( O +
dominant O +
- O +
negative O +
) O +
Grb10 B-Gene +
SH2 O +
domain O +
interfered O +
with O +
PDGF B-Gene -
- I-Gene -
BB I-Gene +
- O +
and O +
insulin B-Gene +
- O +
induced O +
DNA O +
synthesis O +
. O +

( O -
iii O -
) O +
Alternative O +
experiments O +
were O +
based O +
on O +
cell O +
- O +
permeable O +
fusion O +
peptides O +
with O +
the O +
Drosophila O +
antennapedia O +
homeodomain O +
which O +
effectively O +
traverse O +
the O +
plasma O +
membrane O +
of O +
cultured O +
cells O +
. O +

A O +
cell O +
- O +
permeable O +
Grb10 B-Gene +
SH2 O +
domain O +
similarly O +
interfered O +
with O +
PDGF B-Gene -
- I-Gene -
BB I-Gene +
- O +
, O +
IGF B-Gene -
- I-Gene -
I I-Gene +
- O +
, O +
and O +
insulin B-Gene +
- O +
induced O +
DNA O +
synthesis O +
. O +

In O +
contrast O +
, O +
a O +
cell O +
- O +
permeable O +
Grb10 B-Gene +
Pro O +
- O +
rich O +
putative O +
SH3 O +
domain O +
binding O +
region O +
interfered O +
with O +
IGF B-Gene -
- I-Gene -
I I-Gene +
- O +
and O +
insulin B-Gene +
- O +
but O +
not O +
with O +
PDGF B-Gene -
- I-Gene -
BB I-Gene +
- O +
or O +
EGF B-Gene +
- O +
induced O +
DNA O +
synthesis O +
. O +

( O -
iv O -
) O +
Transient O +
overexpression O +
of O +
complete O +
Grb10 B-Gene +
increased O +
whereas O +
cell O +
- O +
permeable O +
Grb10 B-Gene +
SH2 O +
domain O +
fusion O +
peptides O +
substantially O +
decreased O +
the O +
cell O +
proliferation O +
rate O +
( O +
as O +
measured O +
by O +
cell O +
numbers O +
) O +
in O +
normal O +
fibroblasts O +
. O +

These O +
experimental O +
strategies O +
independently O +
suggest O +
that O +
Grb10 B-Gene +
functions O +
as O +
a O +
positive O +
, O +
stimulatory O +
, O +
mitogenic O +
signaling O +
adapter O +
in O +
PDGF B-Gene -
- I-Gene -
BB I-Gene +
, O +
IGF B-Gene -
- I-Gene -
I I-Gene +
, O +
and O +
insulin B-Gene +
action O +
. O +

This O +
function O +
appears O +
to O +
involve O +
the O +
Grb10 B-Gene +
SH2 O +
domain O +
, O +
a O +
novel O +
sequence O +
termed O +
BPS O +
, O +
and O +
the O +
Pro O +
- O +
rich O +
putative O +
SH3 O +
domain O +
binding O +
region O +
in O +
IGF B-Gene -
- I-Gene -
I I-Gene +
- O +
and O +
insulin B-Gene +
- O +
mediated O +
mitogenesis O +
. O +

In O +
contrast O +
, O +
PDGF B-Gene -
- I-Gene -
BB I-Gene +
- O +
mediated O +
mitogenesis O +
appears O +
to O +
depend O +
on O +
the O +
SH2 O +
but O +
not O +
on O +
the O +
Pro O +
- O +
rich O +
region O +
and O +
may O +
involve O +
other O +
, O +
unidentified O +
Grb10 B-Gene +
domains O +
. O +

Distinct O +
protein O +
domains O +
may O +
help O +
to O +
define O +
specific O +
Grb10 B-Gene +
functions O +
in O +
different O +
signaling O +
pathways O +
. O +

An O +
autoregulatory O +
circuit O +
affecting O +
peptide O +
signaling O +
in O +
Bacillus O +
subtilis O +
. O +

The O +
competence B-Gene +
and I-Gene +
sporulation I-Gene +
factor I-Gene +
( O +
CSF B-Gene +
) O +
of O +
Bacillus O +
subtilis O +
is O +
an O +
extracellular O +
pentapeptide O +
produced O +
from O +
the O +
product O +
of O +
phrC B-Gene +
. O +

CSF B-Gene +
has O +
at O +
least O +
three O +
activities O +
: O +
( O -
i O -
) O +
at O +
low O +
concentrations O +
, O +
it O +
stimulates O +
expression O +
of O +
genes O +
activated O +
by O +
the O +
transcription B-Gene +
factor I-Gene +
ComA B-Gene +
; O +
at O +
higher O +
concentrations O +
, O +
it O +
( O -
ii O -
) O +
inhibits O +
expression O +
of O +
those O +
same O +
genes O +
and O +
( O -
iii O -
) O +
stimulates O +
sporulation O +
. O +

Because O +
the O +
activities O +
of O +
CSF B-Gene +
are O +
concentration O +
dependent O +
, O +
we O +
measured O +
the O +
amount O +
of O +
extracellular O +
CSF B-Gene +
produced O +
by O +
cells O +
. O +

We O +
found O +
that O +
by O +
mid O +
- O +
exponential O +
phase O +
, O +
CSF B-Gene +
accumulated O +
to O +
concentrations O +
( O +
1 O +
to O +
5 O +
nM O +
) O +
that O +
stimulate O +
ComA B-Gene +
- O +
dependent O +
gene O +
expression O +
. O +

Upon O +
entry O +
into O +
stationary O +
phase O +
, O +
CSF B-Gene +
reached O +
50 O +
to O +
100 O +
nM O +
, O +
concentrations O +
that O +
stimulate O +
sporulation O +
and O +
inhibit O +
ComA B-Gene +
- O +
dependent O +
gene O +
expression O +
. O +

Transcription O +
of O +
phrC B-Gene +
was O +
found O +
to O +
be O +
controlled O +
by O +
two O +
promoters O +
: O +
P1 O +
, O +
which O +
precedes O +
rapC B-Gene +
, O +
the O +
gene O +
upstream O +
of O +
phrC B-Gene +
; O +
and O +
P2 O +
, O +
which O +
directs O +
transcription O +
of O +
phrC B-Gene +
only O +
. O +

Both O +
RapC B-Gene +
and O +
CSF B-Gene +
were O +
found O +
to O +
be O +
part O +
of O +
autoregulatory O +
loops O +
that O +
affect O +
transcription O +
from O +
P1 O +
, O +
which O +
we O +
show O +
is O +
activated O +
by O +
ComA B-Gene +
approximately O +
P. O +
RapC B-Gene +
negatively O +
regulates O +
its O +
own O +
expression O +
, O +
presumably O +
due O +
to O +
its O +
ability O +
to O +
inhibit O +
accumulation O +
of O +
ComA B-Gene +
approximately O +
P. O +
CSF B-Gene +
positively O +
regulates O +
its O +
own O +
expression O +
, O +
presumably O +
due O +
to O +
its O +
ability O +
to O +
inhibit O +
RapC B-Gene +
activity O +
. O +

Transcription O +
from O +
P2 O +
, O +
which O +
is O +
controlled O +
by O +
the O +
alternate O +
sigma B-Gene +
factor I-Gene +
sigma B-Gene +
( I-Gene +
H I-Gene +
) I-Gene +
, O +
increased O +
as O +
cells O +
entered O +
stationary O +
phase O +
, O +
contributing O +
to O +
the O +
increase O +
in O +
extracellular O +
CSF B-Gene +
at O +
this O +
time O +
. O +

In O +
addition O +
to O +
controlling O +
transcription O +
of O +
phrC B-Gene +
, O +
sigmaH B-Gene +
appears O +
to O +
control O +
expression O +
of O +
at O +
least O +
one O +
other O +
gene O +
required O +
for O +
production O +
of O +
CSF B-Gene +
. O +

The O +
Escherichia O +
coli O +
NadR B-Gene +
regulator O +
is O +
endowed O +
with O +
nicotinamide B-Gene +
mononucleotide I-Gene +
adenylyltransferase I-Gene +
activity O +
. O +

The O +
first O +
identification O +
and O +
characterization O +
of O +
a O +
catalytic O +
activity O +
associated O +
with O +
NadR B-Gene +
protein O +
is O +
reported O +
. O +

A O +
computer O +
- O +
aided O +
search O +
for O +
sequence O +
similarity O +
revealed O +
the O +
presence O +
in O +
NadR B-Gene +
of O +
a O +
29 O +
- O +
residue O +
region O +
highly O +
conserved O +
among O +
known O +
nicotinamide B-Gene +
mononucleotide I-Gene +
adenylyltransferases I-Gene +
. O +

The O +
Escherichia O +
coli O +
nadR B-Gene +
gene O +
was O +
cloned O +
into O +
a O +
T7 O +
- O +
based O +
vector O +
and O +
overexpressed O +
. O +

In O +
addition O +
to O +
functionally O +
specific O +
DNA O +
binding O +
properties O +
, O +
the O +
homogeneous O +
recombinant O +
protein O +
catalyzes O +
NAD O +
synthesis O +
from O +
nicotinamide O +
mononucleotide O +
and O +
ATP O +
. O +

An O +
enhancer O +
element O +
located O +
downstream O +
of O +
the O +
major O +
glutamate B-Gene +
dehydrogenase I-Gene +
gene O +
of O +
Bacillus O +
subtilis O +
. O +

The O +
rocG B-Gene +
gene O +
of O +
Bacillus O +
subtilis O +
, O +
encoding O +
a O +
catabolic O +
glutamate B-Gene +
dehydrogenase I-Gene +
, O +
is O +
transcribed O +
by O +
SigL B-Gene +
( O +
sigma B-Gene -
( I-Gene -
54 I-Gene -
) I-Gene +
) O +
- O +
containing O +
RNA B-Gene +
polymerase I-Gene +
and O +
requires O +
for O +
its O +
expression O +
RocR B-Gene +
, O +
a O +
member O +
of O +
the O +
NtrC B-Gene +
/ I-Gene +
NifA I-Gene +
family I-Gene +
of O +
proteins O +
that O +
bind O +
to O +
enhancer O +
- O +
like O +
elements O +
, O +
called O +
upstream O +
activating O +
sequences O +
( O +
UAS O +
) O +
. O +

Unlike O +
the O +
case O +
for O +
other O +
sigma B-Gene -
( I-Gene -
54 I-Gene -
) I-Gene +
- O +
dependent O +
genes O +
, O +
rocG B-Gene +
has O +
no O +
UAS O +
; O +
instead O +
, O +
its O +
expression O +
depends O +
on O +
a O +
sequence O +
located O +
1.5 O +
kilobases O +
downstream O +
of O +
the O +
rocG B-Gene +
promoter O +
, O +
beyond O +
the O +
end O +
of O +
the O +
rocG B-Gene +
coding O +
region O +
. O +

The O +
same O +
sequence O +
also O +
serves O +
as O +
the O +
UAS O +
for O +
the O +
downstream O +
rocABC B-Gene +
operon I-Gene +
and O +
can O +
activate O +
rocG B-Gene +
if O +
moved O +
upstream O +
of O +
its O +
promoter O +
. O +

Furthermore O +
, O +
the O +
activating O +
sequence O +
can O +
be O +
moved O +
as O +
far O +
as O +
15 O +
kilobases O +
downstream O +
of O +
the O +
rocG B-Gene +
promoter O +
and O +
still O +
retain O +
partial O +
activity O +
. O +

Signal O +
joint O +
formation O +
is O +
inhibited O +
in O +
murine O +
scid O +
preB O +
cells O +
and O +
fibroblasts O +
in O +
substrates O +
with O +
homopolymeric O +
coding O +
ends O +
. O +

During O +
B O +
and O +
T O +
lymphocyte O +
development O +
, O +
immunoglobulin B-Gene +
and O +
T B-Gene +
cell I-Gene +
receptor I-Gene +
genes O +
are O +
assembled O +
from O +
the O +
germline O +
V O +
, O +
( O +
D O +
) O +
and O +
J O +
gene O +
segments O +
( O +
Lewis O +
, O +
S.M. O +
, O +
1994 O -
. O +
The O +
mechanism O +
of O +
V O -
( O -
D O -
) O +
J O +
joining O +
: O +
lessons O +
from O +
molecular O +
, O +
immunological O +
and O +
comparative O +
analyses O -
. O +
Adv O -
. O +
Immunol O -
. O +
56 O +
, O +
27 O +
- O +
150 O +
) O +
. O +

These O +
DNA O +
rearrangements O +
, O +
responsible O +
for O +
immune O +
system O +
diversity O +
, O +
are O +
mediated O +
by O +
a O +
site O +
specific O +
recombination O +
machinery O +
via O +
recognition O +
signal O +
sequences O +
( O +
RSSs O +
) O +
composed O +
of O +
conserved O +
heptamers O +
and O +
nonamers O +
separated O +
by O +
spacers O +
of O +
12 O +
or O +
23 O +
nucleotides O +
( O +
Lewis O +
, O +
S.M. O +
, O +
1994 O -
. O +
The O +
mechanism O +
of O +
V O -
( O -
D O -
) O +
J O +
joining O +
: O +
lessons O +
from O +
molecular O +
, O +
immunological O +
and O +
comparative O +
analyses O -
. O +
Adv O -
. O +
Immunol O -
. O +
56 O +
, O +
27 O +
- O +
150 O +
) O +
. O +

Recombination O +
occurs O +
only O +
between O +
a O +
RSS O +
with O +
a O +
12mer O +
spacer O +
and O +
a O +
RSS O +
with O +
a O +
23mer O +
spacer O +
( O +
Lewis O +
, O +
S.M. O +
, O +
1994 O -
. O +
The O +
mechanism O +
of O +
V O -
( O -
D O -
) O -
J O +
joining O +
: O +
lessons O +
from O +
molecular O +
, O +
immunological O +
and O +
comparative O +
analyses O +
. O +

Adv O +
. O +

Immunol O -
. O +
56 O +
, O +
27 O +
- O +
150 O +
) O +
. O +

RAG1 B-Gene +
and O +
RAG2 B-Gene +
proteins O +
cleave O +
precisely O +
at O +
the O +
RSS O +
- O +
coding O +
sequence O +
border O +
leading O +
to O +
flush O +
signal O +
ends O +
and O +
coding O +
ends O +
with O +
a O +
hairpin O +
structure O +
( O +
Eastman O +
, O +
M. O +
, O +
Leu O +
, O +
T. O +
, O +
Schatz O +
, O +
D. O +
, O +
1996 O +
. O +

Initiation O +
of O +
V O -
( O -
D O -
) O -
J O +
recombination O +
in O +
vitro O +
obeying O +
the O +
12 O +
/ O +
23 O +
rule O +
. O +

Nature O +
380 O +
, O +
85 O +
- O +
88 O +
; O +
Roth O +
, O +
D.B. O +
, O +
Menetski O +
, O +
J.P. O +
, O +
Nakajima O +
, O +
P.B. O +
, O +
Bosma O +
, O +
M.J. O +
, O +
Gellert O +
, O +
M. O +
, O +
1992 O -
. O +
V O -
( O -
D O -
) O -
J O +
recombination O +
: O +
broken O +
DNA O +
molecules O +
with O +
covalently O +
sealed O +
( O +
hairpin O +
) O +
coding O +
ends O +
in O +
scid O +
mouse O +
thymocytes O +
. O +

Cell O +
983 O +
- O +
991 O +
: O +
Roth O +
, O +
D.B. O +
, O +
Zhu O +
, O +
C. O +
, O +
Gellert O -
. O +
M. O +
, O +
1993 O +
. O +

Characterization O +
of O +
broken O +
DNA O +
molecules O +
associated O +
with O +
V O -
( O -
D O -
) O -
J O +
recombination O +
. O +

Proc O -
. O +
Natl O -
. O +
Acad O -
. O +
Sci O -
. O +
USA O +
90 O +
, O +
10 O +
, O +
788 O +
- O +
10 O +
, O +
792 O +
; O +
van O +
Gent O +
, O +
D. O +
, O +
McBlane O +
, O +
J. O +
. O +

Sadofsky O +
, O +
M. O +
, O +
Hesse O +
, O +
J. O +
, O +
Gellert O +
, O +
M. O +
, O +
1995 O +
. O +

Initiation O +
of O +
V O -
( O -
D O -
) O -
J O +
recombination O +
in O +
a O +
cell O +
- O +
free O +
system O +
. O +

Cell O +
81 O +
, O +
925 O +
- O +
934 O +
) O +
. O +

Signal O +
ends O +
join O +
, O +
forming O +
a O +
signal O +
joint O +
. O +

The O +
hairpin O +
coding O +
ends O +
are O +
opened O +
by O +
a O +
yet O +
unknown O +
endonuclease B-Gene +
, O +
and O +
are O +
further O +
processed O +
to O +
form O +
the O +
coding O +
joint O +
( O +
Lewis O +
, O +
S.M. O +
, O +
1994 O +
. O +

The O +
mechanism O +
of O +
V O -
( O -
D O -
) O -
J O +
joining O +
: O +
lessons O +
from O +
molecular O +
, O +
immunological O +
and O +
comparative O +
analyses O +
. O +

Ad O +
. O +

Immunol O -
. O +
56 O +
, O +
27 O +
- O +
150 O -
. O +
) O +
The O +
murine O +
scid O +
mutation O +
has O +
been O +
shown O +
to O +
affect O +
coding O +
joints O +
, O +
but O +
much O +
less O +
signal O +
joint O +
formation O +
. O +

In O +
this O +
study O +
we O +
demonstrate O +
that O +
the O +
murine O +
scid O +
mutation O +
inhibits O +
correct O +
signal O +
joint O +
formation O +
when O +
both O +
coding O +
ends O +
contain O +
homopolymeric O +
sequences O +
. O +

We O +
suggest O +
that O +
this O +
finding O +
may O +
be O +
due O +
to O +
the O +
function O +
of O +
the O +
SCID O +
protein O +
as O +
an O +
assembly O +
component O +
in O +
V O -
( O -
D O -
) O -
J O +
recombination O +
. O +

Modulation O +
of O +
haematopoietic O +
progenitor O +
development O +
by O +
FLT-3 B-Gene +
ligand I-Gene +
. O +

The O +
Flt-3 B-Gene +
receptor O +
is O +
expressed O +
in O +
primitive O +
haematopoietic O +
cells O +
and O +
its O +
ligand O +
exerts O +
proliferative O +
effects O +
on O +
these O +
cells O +
in O +
vitro O +
in O +
synergy O +
with O +
other O +
cytokines B-Gene +
. O +

To O +
increase O +
our O +
knowledge O +
of O +
the O +
functional O +
properties O +
of O +
the O +
human O +
Flt-3 B-Gene +
ligand I-Gene +
( O +
FL B-Gene +
) O +
as O +
relating O +
to O +
in O +
vitro O +
expansion O +
of O +
haematopoietic O +
stem O +
cells O +
, O +
the O +
effects O +
on O +
murine O +
haematopoiesis O +
of O +
FL B-Gene +
alone O +
or O +
in O +
combination O +
with O +
other O +
growth B-Gene +
factors I-Gene +
were O +
studied O +
. O +

Analysis O +
of O +
Flk-2 B-Gene +
/ O +
Flt-3 B-Gene +
mRNA O +
expression O +
indicated O +
that O +
Flk-2 B-Gene +
/ O +
Flt-3 B-Gene +
was O +
preferentially O +
expressed O +
in O +
primitive O +
haematopoietic O +
cell O +
populations O +
. O +

To O +
examine O +
the O +
expression O +
of O +
the O +
Flk-2 B-Gene +
/ O +
Flt-3 B-Gene +
receptor O +
on O +
megakaryocyte O +
progenitors O +
( O +
CFU O -
- O -
Meg O +
) O +
, O +
Flk-2 B-Gene +
/ O +
Flt-3 B-Gene +
positive O +
and O +
negative O +
CD34 B-Gene +
( O +
+ O +
) O +
populations O +
were O +
separated O +
from O +
human O +
bone O +
marrow O +
and O +
cultured O +
in O +
a O +
plasma O +
clot O +
culture O +
system O +
. O +

CFU O +
- O +
Meg O +
colonies O +
were O +
found O +
in O +
the O +
Flk-2 B-Gene +
/ O +
Flt-3 B-Gene +
negative O +
fraction O +
. O +

Myeloid O +
( O +
CFU O -
- O -
GM O +
) O +
derived O +
colonies O +
appeared O +
in O +
the O +
presence O +
of O +
FL B-Gene +
alone O +
. O +

Neither O +
FL B-Gene +
+ O +
IL-3 B-Gene +
nor O +
FL B-Gene +
+ O +
IL-3 B-Gene +
+ O +
IL-6 B-Gene +
had O +
any O +
effect O +
on O +
the O +
generation O +
of O +
megakaryocyte O +
colonies O +
( O +
CFU O -
- O -
MK O +
) O +
, O +
due O +
to O +
the O +
lack O +
of O +
FL B-Gene +
receptor I-Gene +
expression O +
on O +
megakaryocyte O +
progenitors O +
. O +

Bone O +
marrow O +
cells O +
remaining O +
after O +
5-fluorouracil O +
( O +
5-FU O +
) O +
treatment O +
of O +
mice O +
represent O +
a O +
very O +
primitive O +
population O +
of O +
progenitors O +
enriched O +
for O +
reconstituting O +
stem O +
cells O +
. O +

This O +
cell O +
population O +
expressed O +
FL B-Gene +
receptors I-Gene +
, O +
as O +
revealed O +
by O +
RT O +
- O +
PCR O +
analysis O +
. O +

Addition O +
of O +
FL B-Gene +
alone O +
did O +
not O +
enhance O +
the O +
replication O +
of O +
such O +
cells O +
in O +
liquid O +
cultures O +
as O +
compared O +
to O +
controls O +
. O +

However O +
, O +
a O +
significantly O +
greater O +
generation O +
of O +
myeloid O +
progenitors O +
( O +
CFU O -
- O -
GM O +
) O +
in O +
clonogenic O +
assays O +
was O +
observed O +
in O +
the O +
presence O +
of O +
FL B-Gene +
+ O +
IL-3 B-Gene +
, O +
FL B-Gene +
+ O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
or O +
FL B-Gene +
+ O +
CSF-1 B-Gene +
. O +

In O +
addition O +
, O +
the O +
effects O +
of O +
FL B-Gene +
on O +
in O +
vitro O +
expansion O +
of O +
murine O +
haematopoietic O +
stem O +
cells O +
were O +
studied O +
using O +
lineage O +
- O +
negative O +
( O +
lin O +
( O +
- O +
) O +
) O +
Sca-1 B-Gene +
positive O +
( O +
Sca-1 B-Gene +
( O +
+ O +
) O +
) O +
c B-Gene -
- I-Gene -
kit I-Gene +
positive O +
( O +
c B-Gene -
- I-Gene -
kit I-Gene +
( O +
+ O +
) O +
) O +
marrow O +
cells O +
from O +
5-FU O +
treated O +
mice O +
. O +

FL B-Gene +
enhanced O +
the O +
survival O +
of O +
primitive O +
murine O +
lin O -
( O -
- O -
) O +
Sca-1 B-Gene +
( O -
+ O -
) O +
c B-Gene -
- I-Gene -
kit I-Gene +
( O +
+ O +
) O +
cells O +
. O +

FL B-Gene +
and O +
IL-6 B-Gene +
were O +
able O +
to O +
significantly O +
expand O +
murine O +
progenitor O +
stem O +
cells O +
in O +
vitro O +
and O +
promote O +
their O +
survival O +
. O +

These O +
studies O +
strongly O +
suggest O +
that O +
FL B-Gene +
significantly O +
and O +
selectively O +
enhanced O +
the O +
generation O +
of O +
myeloid O +
progenitors O +
in O +
vitro O +
and O +
increased O +
myeloid O +
progenitor O +
responsiveness O +
to O +
later O +
acting O +
growth B-Gene +
factors I-Gene +
. O +

In O +
addition O +
, O +
FL B-Gene +
synergized O +
with O +
IL-6 B-Gene +
to O +
support O +
in O +
vitro O +
expansion O +
of O +
haematopoietic O +
progenitors O +
and O +
promoted O +
the O +
survival O +
of O +
lin O -
( O -
- O -
) O +
Sca-1 B-Gene +
( O -
+ O -
) O +
c B-Gene -
- I-Gene -
kit I-Gene +
( O +
+ O +
) O +
cells O +
. O +

Cxc B-Gene +
chemokine I-Gene +
receptor I-Gene +
expression O +
on O +
human O +
endothelial O +
cells O +
. O +

CXC B-Gene +
chemokines I-Gene +
play O +
a O +
important O +
role O +
in O +
the O +
process O +
of O +
leukocyte O +
recruitment O +
and O +
activation O +
at O +
sites O +
of O +
inflammation O +
. O +

However O +
, O +
recent O +
evidence O +
suggests O +
that O +
these O +
molecules O +
can O +
also O +
regulate O +
endothelial O +
cell O +
functions O +
such O +
as O +
migration O +
, O +
angiogenesis O +
and O +
proliferation O +
. O +

In O +
this O +
study O +
we O +
have O +
investigated O +
CXC B-Gene +
chemokine I-Gene +
receptor I-Gene +
expression O +
in O +
both O +
primary O +
cultures O +
of O +
human O +
umbilical O +
vein O +
endothelial O +
cells O +
( O +
HUVEC O +
) O +
and O +
the O +
spontaneously O +
transformed O +
HUVEC O +
cell O +
line O +
, O +
ECV304 O +
. O +

We O +
found O +
that O +
both O +
cell O +
types O +
express O +
mRNA O +
for O +
chemokine O +
receptors O +
CXCR1 B-Gene +
, O +
CXCR2 B-Gene +
and O +
CXCR4 B-Gene +
, O +
but O +
not O +
CXCR3 B-Gene +
. O +

Flow O +
cytometric O +
analysis O +
revealed O +
low O +
levels O +
of O +
CXCR1 B-Gene +
but O +
higher O +
levels O +
of O +
CXCR4 B-Gene +
cell O +
surface O +
expression O +
. O +

HUVECs O +
responded O +
to O +
SDF-1alpha B-Gene +
with O +
a O +
rapid O +
and O +
robust O +
calcium O +
flux O +
, O +
however O +
no O +
calcium O +
flux O +
was O +
seen O +
with O +
either O +
IL-8 B-Gene +
or O +
Gro B-Gene -
- I-Gene -
alpha I-Gene +
. O +

HUVECs O +
and O +
ECV304 O +
cells O +
did O +
not O +
proliferate O +
in O +
response O +
to O +
CXC B-Gene +
chemokines I-Gene +
, O +
although O +
ECV304 O +
cells O +
did O +
migrate O +
towards O +
SDF-1alpha B-Gene +
and O +
IL-8 B-Gene +
. O +

These O +
data O +
demonstrate O +
that O +
HUVECs O +
and O +
the O +
endothelial O +
cell O +
line O +
, O +
ECV304 O +
express O +
functional O +
CXC B-Gene +
chemokine I-Gene +
receptors I-Gene +
. O +

Characterization O +
of O +
the O +
targeting O +
, O +
binding O +
, O +
and O +
phosphorylation O +
site O +
domains O +
of O +
an O +
A B-Gene +
kinase I-Gene +
anchor I-Gene +
protein I-Gene +
and O +
a O +
myristoylated B-Gene +
alanine I-Gene +
- I-Gene +
rich I-Gene +
C I-Gene +
kinase I-Gene +
substrate I-Gene +
- O +
like O +
analog O +
that O +
are O +
encoded O +
by O +
a O +
single O +
gene O +
. O +

A O +
novel O +
Drosophila O +
A B-Gene +
kinase I-Gene +
anchor I-Gene +
protein I-Gene +
, O +
Drosophila O +
A B-Gene +
kinase I-Gene +
anchor I-Gene +
protein I-Gene +
200 I-Gene +
( O +
DAKAP200 B-Gene +
) O +
, O +
is O +
predicted O +
to O +
be O +
involved O +
in O +
routing O +
, O +
mediating O +
, O +
and O +
integrating O +
signals O +
carried O +
by O +
cAMP O +
, O +
Ca O -
( O -
2 O -
+ O -
) O +
, O +
and O +
diacylglycerol O +
( O +
Li O +
, O +
Z. O +
, O +
Rossi O +
, O +
E. O +
A. O +
, O +
Hoheisel O +
, O +
J. O +
D. O +
, O +
Kalderon O +
, O +
D. O +
, O +
and O +
Rubin O +
, O +
C. O +
S. O +
( O +
1999 O +
) O +
J. O +
Biol O -
. O +
Chem O -
. O +
274 O +
, O +
27191 O +
- O +
27200 O +
) O +
. O +

Experiments O +
designed O +
to O +
assess O +
this O +
hypothesis O +
now O +
( O -
a O -
) O +
establish O +
the O +
function O +
, O +
boundaries O +
and O +
identity O +
of O +
critical O +
amino O +
acids O +
of O +
the O +
protein B-Gene +
kinase I-Gene +
AII I-Gene +
( O +
PKAII B-Gene +
) O +
tethering O +
site O +
of O +
DAKAP200 B-Gene +
; O +
( O -
b O -
) O +
demonstrate O +
that O +
residues O +
119 O +
- O +
148 O +
mediate O +
binding O +
with O +
Ca O -
( O -
2 O -
+ O -
) O +
- O +
calmodulin B-Gene +
and O +
F B-Gene -
- I-Gene -
actin I-Gene +
; O +
( O -
c O -
) O +
show O +
that O +
a O +
polybasic O +
region O +
of O +
DAKAP200 B-Gene +
is O +
a O +
substrate O +
for O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
; O +
( O -
d O -
) O +
reveal O +
that O +
phosphorylation O +
of O +
the O +
polybasic O +
domain O +
regulates O +
affinity O +
for O +
F B-Gene -
- I-Gene -
actin I-Gene +
and O +
Ca O -
( O -
2 O -
+ O -
) O +
- O +
calmodulin B-Gene +
; O +
and O +
( O -
e O -
) O +
indicate O +
that O +
DAKAP200 B-Gene +
is O +
myristoylated O +
and O +
that O +
this O +
modification O +
promotes O +
targeting O +
of O +
DAKAP200 B-Gene +
to O +
plasma O +
membrane O +
. O +

DeltaDAKAP200 B-Gene +
, O +
a O +
second O +
product O +
of O +
the O +
DAKAP200 B-Gene +
gene O +
, O +
can O -
not O +
tether O +
PKAII B-Gene +
. O +

However O +
, O +
DeltaDAKAP200 B-Gene +
is O +
myristoylated O +
and O +
contains O +
a O +
phosphorylation O +
site O +
domain O +
that O +
binds O +
Ca O -
( O -
2 O -
+ O -
) O +
- O +
calmodulin B-Gene +
and O +
F B-Gene -
- I-Gene -
actin I-Gene +
. O +

An O +
atypical O +
amino O +
acid O +
composition O +
, O +
a O +
high O +
level O +
of O +
negative O +
charge O +
, O +
exceptional O +
thermostability O +
, O +
unusual O +
hydrodynamic O +
properties O +
, O +
properties O +
of O +
the O +
phosphorylation O +
site O +
domain O +
, O +
and O +
a O +
calculated O +
M O -
( O -
r O -
) O +
of O +
38,000 O +
suggest O +
that O +
DeltaDAKAP200 B-Gene +
is O +
a O +
new O +
member O +
of O +
the O +
myristoylated B-Gene +
alanine I-Gene +
- I-Gene +
rich I-Gene +
C I-Gene +
kinase I-Gene +
substrate I-Gene +
protein I-Gene +
family I-Gene +
. O +

DAKAP200 B-Gene +
is O +
a O +
potentially O +
mobile O +
, O +
chimeric O +
A B-Gene +
kinase I-Gene +
anchor I-Gene +
protein I-Gene +
- O +
myristoylated B-Gene +
alanine I-Gene +
- I-Gene +
rich I-Gene +
C I-Gene +
kinase I-Gene +
substrate I-Gene +
protein O +
that O +
may O +
facilitate O +
localized O +
reception O +
and O +
targeted O +
transmission O +
of O +
signals O +
carried O +
by O +
cAMP O +
, O +
Ca O -
( O -
2 O -
+ O -
) O +
, O +
and O +
diacylglycerol O +
. O +

Biochemistry O +
of O +
the O +
infarcted O +
heart O +
. O +

I O +
am O +
honored O +
by O +
the O +
invitation O +
to O +
contribute O +
to O +
a O +
volume O +
in O +
Neuroscience O +
, O +
dedicated O +
to O +
Professor O +
Galoyan O +
, O +
whose O +
accomplishments O +
in O +
the O +
field O +
of O +
neuroscience O +
and O +
circulation O +
have O +
been O +
unique O +
. O +

In O +
his O +
book O +
, O +
Dr. O +
Galoyan O +
has O +
summarized O +
the O +
results O +
of O +
his O +
discovery O +
of O +
cardioactive O +
neurohormones O +
. O +

His O +
discovery O +
of O +
biosynthesis O +
of O +
cytokines B-Gene +
in O +
the O +
neurosecretory O +
cells O +
of O +
the O +
hypothalamus O +
have O +
opened O +
a O +
new O +
page O +
in O +
immunology O +
. O +

Solution O +
conformation O +
of O +
the O +
( O -
+ O -
) O -
-trans O -
- O -
anti O -
- O -
benzo O -
[ O -
g O -
] O -
chrysene O -
- O -
dA O +
adduct O +
opposite O +
dT O +
in O +
a O +
DNA O +
duplex O +
. O +

The O +
solution O +
structure O +
of O +
the O +
adduct O +
derived O +
from O +
the O +
covalent O +
bonding O +
of O +
the O +
fjord O +
region O +
( O -
+ O -
) O -
- O -
( O -
11S O -
, O +
12R O +
, O +
13R O +
, O +
14S O +
) O +
stereoisomer O +
of O +
anti O +
- O +
11 O +
, O +
12 O +
- O +
dihydroxy O +
- O +
13 O +
, O +
14 O +
- O +
epoxy O +
- O +
11 O +
, O +
12 O +
, O +
13 O +
, O +
14 O +
- O +
tetrahydrobenzo O +
[ O +
g O +
] O +
chrysene O +
, O +
( O -
+ O -
) O +
- O +
anti O +
- O +
B O -
[ O -
g O -
] O -
CDE O +
, O +
to O +
the O +
exocyclic O +
N O -
( O -
6 O -
) O +
amino O +
group O +
of O +
the O +
adenine O +
residue O +
dA6 O +
, O +
( O +
designated O +
( O -
+ O -
) O +
- O +
trans O -
- O -
anti O +
- O -
( O -
B O -
[ O -
g O -
] O -
C O -
) O -
dA6 O -
) O +
, O +
positioned O +
opposite O +
a O +
thymine O +
residue O +
dT17 O +
in O +
the O +
DNA O +
sequence O +
context O +
d O -
( O -
C1-T2 O +
- O +
C3 O +
- O +
T4 O +
- O +
C5 O +
- O +
( O +
B O +
[ O +
g O +
] O +
C O +
) O +
A6 O +
- O +
C7 O +
- O +
T8 O +
- O +
T9 O +
- O +
C10 O +
- O +
C11 O +
) O +
. O +

d O -
( O -
G12-G13-A14-A15-G16-T17-G18-A19-G20 O +
+ O -
+ O +
+ O -
-A21-G22 O +
) O +
( O +
designated O +
( O +
B O -
[ O -
g O -
] O -
C O +
) O +
dA. O +
dT O +
11-mer O +
duplex O +
) O +
, O +
has O +
been O +
studied O +
using O +
structural O +
information O +
derived O +
from O +
NMR O +
data O +
in O +
combination O +
with O +
molecular O +
dynamics O +
( O +
MD O +
) O +
calculations O +
. O +

The O +
solution O +
structure O +
of O +
the O +
( O +
+ O +
) O +
- O +
trans O +
- O +
anti O +
- O +
( O +
B O -
[ O -
g O -
] O -
C O +
) O +
dA.dT O +
11-mer O +
duplex O +
has O +
been O +
determined O +
using O +
an O +
MD O +
protocol O +
where O +
both O +
interproton O +
distance O +
and O +
dihedral O +
angle O +
restraints O +
deduced O +
from O +
NOESY O +
and O +
COSY O +
spectra O +
are O +
used O +
during O +
the O +
refinement O +
process O +
, O +
followed O +
by O +
additional O +
relaxation O +
matrix O +
refinement O +
to O +
the O +
observed O +
NOESY O +
intensities O +
to O +
account O +
for O +
spin O +
diffusion O +
effects O +
. O +

The O +
results O +
established O +
that O +
the O +
covalently O +
attached O +
benzo O -
[ O -
g O -
] O -
chrysene O +
ring O +
intercalates O +
into O +
the O +
DNA O +
helix O +
directed O +
towards O +
the O +
5 O -
' O +
- O +
side O +
of O +
the O +
modified O +
strand O +
and O +
stacks O +
predominantly O +
with O +
dT17 O +
when O +
intercalated O +
between O +
dC5.dG18 O +
and O +
( O +
B O -
[ O -
g O -
] O -
C O +
) O +
dA6.dT17 O +
base O +
- O +
pairs O +
. O +

All O +
base O +
- O +
pairs O +
, O +
including O +
the O +
modified O +
( O +
B O -
[ O -
g O -
] O -
C O +
) O +
dA6.dT17 O +
base O -
- O -
pair O +
, O +
are O +
aligned O +
through O +
Watson O +
- O +
Crick O +
pairing O +
as O +
in O +
normal O +
B O +
- O +
DNA O +
. O +

In O +
addition O +
, O +
the O +
potential O +
strain O +
associated O +
with O +
the O +
highly O +
sterically O +
hindered O +
fjord O +
region O +
of O +
the O +
aromatic O +
portion O +
of O +
the O +
benzo O -
[ O -
g O -
] O -
chrysenyl O +
ring O +
is O +
relieved O +
through O +
the O +
adoption O +
of O +
a O +
non O +
- O +
planar O +
, O +
propeller O +
- O +
like O +
geometry O +
within O +
the O +
chrysenyl O +
ring O +
system O +
. O +

This O +
conformation O +
shares O +
common O +
structural O +
features O +
with O +
the O +
related O +
( O +
+ O +
) O +
- O +
trans O +
- O +
anti O +
- O +
( O +
B O -
[ O -
c O -
] O -
Ph O +
) O +
dA O +
adduct O +
in O +
the O +
identical O +
base O +
sequence O +
context O +
, O +
derived O +
from O +
the O +
fjord O +
region O +
( O -
+ O -
) O -
- O -
( O -
1S,2R,3R,4S O -
) O -
-3 O +
, O +
4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenzo O -
[ O -
c O -
] O -
phenanthrene O +
stereoisomer O +
, O +
in O +
which O +
intercalation O +
is O +
also O +
observed O +
towards O +
the O +
5 O -
' O +
- O +
side O +
of O +
the O +
modified O +
dA6.dT17 O +
base O +
- O +
pair O +
. O +

A O +
phylogenetic O +
approach O +
to O +
target O +
selection O +
for O +
structural O +
genomics O +
: O +
solution O +
structure O +
of O +
YciH B-Gene +
. O +

Structural O +
genomics O +
presents O +
an O +
enormous O +
challenge O +
with O +
up O +
to O +
100 O +
000 O +
protein O +
targets O +
in O +
the O +
human O +
genome O +
alone O +
. O +

At O +
current O +
rates O +
of O +
structure O +
deter O +
- O +
mination O +
, O +
judicious O +
selection O +
of O +
targets O +
is O +
necessary O +
. O +

Here O +
, O +
a O +
phylogenetic O +
approach O +
to O +
target O +
selection O +
is O +
described O +
which O +
makes O +
use O +
of O +
the O +
National O +
Center O +
for O +
Biotechnology O +
Information O +
database O +
of O +
Clusters O +
of O +
Orthologous O +
Groups O +
( O +
COGS O +
) O +
. O +

The O +
strategy O +
is O +
designed O +
so O +
that O +
each O +
new O +
protein O +
structure O +
is O +
likely O +
to O +
provide O +
novel O +
sequence O +
- O +
fold O +
information O +
. O +

To O +
demonstrate O +
this O +
approach O +
, O +
the O +
NMR O +
solution O +
structure O +
of O +
YciH B-Gene +
( O +
COG0023 O +
) O +
, O +
a O +
putative O +
translation O +
initiation O +
factor O +
from O +
Escherichia O +
coli O +
, O +
has O +
been O +
determined O +
and O +
its O +
fold O +
classified O +
. O +

YciH B-Gene +
is O +
an O +
ortholog O +
of O +
eIF-1 B-Gene +
/ O +
SUI1 B-Gene +
, O +
an O +
integral O +
component O +
of O +
the O +
translation O +
initiation O +
complex O +
in O +
eukaryotes O +
. O +

The O +
structure O +
consists O +
of O +
two O +
antiparallel O +
alpha O +
- O +
helices O +
packed O +
against O +
the O +
same O +
side O +
of O +
a O +
five O +
- O +
stranded O +
beta O -
- O -
sheet O +
. O +

The O +
first O +
31 O +
residues O +
of O +
the O +
11.5 O +
kDa O +
protein O +
are O +
unstructured O +
in O +
solution O +
. O +

Comparative O +
analysis O +
indicates O +
that O +
the O +
folded O +
portion O +
of O +
YciH B-Gene +
resembles O +
a O +
number O +
of O +
structures O +
with O +
the O +
alpha O -
- O -
beta O +
plait O +
topology O +
, O +
though O +
its O +
sequence O +
is O +
not O +
homologous O +
to O +
any O +
of O +
them O +
. O +

Thus O +
, O +
the O +
phylogenetic O +
approach O +
to O +
target O +
selection O +
described O +
here O +
was O +
used O +
successfully O +
to O +
identify O +
a O +
new O +
homologous O +
superfamily O +
within O +
this O +
topology O +
. O +

The O +
c B-Gene -
- I-Gene -
kit I-Gene +
receptor I-Gene +
and O +
its O +
ligand O +
stem B-Gene +
cell I-Gene +
factor I-Gene +
in O +
childhood O +
malignant O +
lymphoid O +
precursors O +
. O +

The O +
c B-Gene -
- I-Gene -
kit I-Gene +
receptor I-Gene +
( O +
CD117 B-Gene +
) O +
and O +
its O +
ligand O +
stem B-Gene +
cell I-Gene +
factor I-Gene +
( O +
SCF B-Gene +
) O +
play O +
an O +
important O +
role O +
in O +
the O +
development O +
, O +
differentiation O +
, O +
and O +
survival O +
of O +
normal O +
and O +
malignant O +
hematopoietic O +
cells O +
. O +

The O +
aim O +
of O +
this O +
work O +
is O +
to O +
review O +
the O +
cellular O +
distribution O +
of O +
this O +
receptor O +
and O +
the O +
effect O +
of O +
SCF B-Gene +
on O +
the O +
hematopoietic O +
system O +
, O +
particularly O +
among O +
lymphoid O +
lineage O +
, O +
either O +
in O +
normal O +
or O +
malignant O +
cell O +
progenitors O +
. O +

We O +
examined O +
reports O +
and O +
results O +
in O +
the O +
field O +
and O +
articles O +
or O +
abstracts O +
published O +
in O +
journals O +
covered O +
by O +
MEDLINE O +
. O +

Additionally O +
, O +
we O +
evaluated O +
CD117 B-Gene +
expression O +
on O +
fresh O +
blast O +
cells O +
of O +
376 O +
newly O +
diagnosed O +
cases O +
of O +
childhood O +
acute O +
lymphoblastic O +
leukemia O +
( O +
ALL O +
) O +
that O +
were O +
referred O +
to O +
centers O +
affiliated O +
with O +
the O +
Italian O +
Association O +
for O +
Pediatric O +
Hematology O +
and O +
Oncology O +
( O +
AIEOP O +
) O +
. O +

In O +
view O +
of O +
our O +
data O +
, O +
approximately O +
11 O +
% O +
of O +
ALL O +
are O +
CD117 B-Gene +
positive O +
. O +

In O +
particular O +
, O +
this O +
receptor O +
can O +
be O +
expressed O +
in O +
10 O +
% O +
and O +
11.5 O +
% O +
of O +
T O -
- O -
lineage O +
and O +
B O -
- O -
lineage O +
ALL O +
, O +
respectively O +
. O +

Its O +
expression O +
is O +
associated O +
with O +
an O +
intermediate O +
/ O +
mature O +
phenotype O +
in O +
T O -
- O -
lineage O +
ALL O +
, O +
whereas O +
in O +
B O -
- O -
lineage O +
ALL O +
, O +
the O +
majority O +
of O +
the O +
positive O +
cases O +
are O +
classified O +
as O +
early O +
B O +
ALL O +
. O +

The O +
effect O +
of O +
SCF B-Gene +
on O +
malignant O +
hematopoiesis O +
and O +
its O +
potential O +
clinical O +
uses O +
are O +
reviewed O +
. O +

Zinc O +
finger O +
of O +
replication B-Gene +
protein I-Gene +
A I-Gene +
, O +
a O +
non O +
- O +
DNA O +
binding O +
element O +
, O +
regulates O +
its O +
DNA O +
binding O +
activity O +
through O +
redox O +
. O +

Eukaryotic O +
replication B-Gene +
protein I-Gene +
A I-Gene +
( O +
RPA B-Gene +
) O +
is O +
a O +
single O +
- O +
stranded O +
DNA O +
- O +
binding O +
protein O +
with O +
multiple O +
functions O +
in O +
DNA O +
replication O +
, O +
repair O +
, O +
and O +
genetic O +
recombination O +
. O +

RPA B-Gene +
contains O +
an O +
evolutionarily O +
conserved O +
4 O +
- O +
cysteine O +
- O +
type O +
zinc O +
finger O +
motif O +
( O +
X O -
( O -
3 O -
) O -
CX O -
( O -
2 O -
- O -
4 O -
) O -
CX O -
( O -
12 O -
- O -
15 O -
) O -
CX O -
( O -
2 O -
) O +
C O +
) O +
that O +
has O +
a O +
potential O +
role O +
in O +
regulation O +
of O +
DNA O +
replication O +
and O +
repair O +
( O +
Dong O +
, O +
J. O +
, O +
Park O +
, O +
J O -
- O -
S. O +
, O +
and O +
Lee O +
, O +
S O -
- O -
H. O +
( O +
1999 O +
) O +
Biochem O -
. O +
J. O +
337 O +
, O +
311 O +
- O +
317 O +
and O +
Lin O +
, O +
Y. O +
- O +
L. O +
, O +
Shivji O +
, O +
M. O +
K. O +
K. O +
, O +
Chen O +
, O +
C. O +
, O +
Kolodner O +
, O +
R. O +
, O +
Wood O +
, O +
R. O +
D. O +
, O +
and O +
Dutta O +
, O +
A. O +
( O +
1998 O +
) O +
J. O +
Biol O -
. O +
Chem O -
. O +
273 O +
, O +
1453 O +
- O +
1461 O +
) O +
, O +
even O +
though O +
the O +
zinc O +
finger O +
itself O +
is O +
not O +
essential O +
for O +
its O +
DNA O +
binding O +
activity O +
( O +
Kim O +
, O +
D. O +
K. O +
, O +
Stigger O +
, O +
E. O +
, O +
and O +
Lee O +
, O +
S. O +
- O +
H. O +
( O +
1996 O +
) O +
J. O +
Biol O -
. O +
Chem O -
. O +
271 O +
, O +
15124 O +
- O +
15129 O +
) O +
. O +

Here O +
, O +
we O +
show O +
that O +
RPA B-Gene +
single O +
- O +
stranded O +
DNA O +
( O +
ssDNA O +
) O +
binding O +
activity O +
is O +
regulated O +
by O +
reduction O +
- O +
oxidation O +
( O +
redox O +
) O +
through O +
its O +
zinc O +
finger O +
domain O +
. O +

RPA B-Gene +
- O +
ssDNA O +
interaction O +
was O +
stimulated O +
10 O +
- O +
fold O +
by O +
the O +
reducing O +
agent O +
, O +
dithiothreitol O +
( O +
DTT O +
) O +
, O +
whereas O +
treatment O +
of O +
RPA B-Gene +
with O +
oxidizing O +
agent O +
, O +
diazene O +
dicarboxylic O +
acid O +
bis O -
[ O -
N O -
, O -
N O -
- O -
dimethylamide O +
] O +
( O +
diamide O +
) O +
, O +
significantly O +
reduced O +
this O +
interaction O +
. O +

The O +
effect O +
of O +
diamide O +
was O +
reversed O +
by O +
the O +
addition O +
of O +
excess O +
DTT O +
, O +
suggesting O +
that O +
RPA B-Gene +
ssDNA O +
binding O +
activity O +
is O +
regulated O +
by O +
redox O +
. O +

Redox O +
regulation O +
of O +
RPA B-Gene +
- O +
ssDNA O +
interaction O +
was O +
more O +
effective O +
in O +
the O +
presence O +
of O +
0.2 O +
M O +
NaCl O +
or O +
higher O +
. O +

Cellular O +
redox O +
factor O +
, O +
thioredoxin O +
, O +
was O +
able O +
to O +
replace O +
DTT O +
in O +
stimulation O +
of O +
RPA B-Gene +
DNA O +
binding O +
activity O +
, O +
suggesting O +
that O +
redox O +
protein O +
may O +
be O +
involved O +
in O +
RPA B-Gene +
modulation O +
in O +
vivo O +
. O +

In O +
contrast O +
to O +
wild O +
- O +
type O +
RPA B-Gene +
, O +
zinc O +
finger O +
mutant O +
( O +
cysteine O +
to O +
alanine O +
mutation O +
at O +
amino O +
acid O +
486 O +
) O +
did O +
not O +
require O +
DTT O +
for O +
its O +
ssDNA O +
binding O +
activity O +
and O +
is O +
not O +
affected O +
by O +
redox O +
. O +

Together O +
, O +
these O +
results O +
suggest O +
a O +
novel O +
function O +
for O +
a O +
putative O +
zinc O +
finger O +
in O +
the O +
regulation O +
of O +
RPA B-Gene +
DNA O +
binding O +
activity O +
through O +
cellular O +
redox O +
. O +

Congenital O +
horizontal O +
tarsal O +
kink O +
: O +
clinical O +
characteristics O +
from O +
a O +
large O +
series O +
. O +

PURPOSE O +
: O +

To O +
describe O +
the O +
clinical O +
characteristics O +
of O +
congenital O +
horizontal O +
tarsal O +
kink O +
. O +

METHODS O +
: O +

Retrospective O +
clinical O +
series O +
derived O +
from O +
a O +
literature O +
review O +
and O +
mail O +
survey O +
. O +

Characteristics O +
included O +
sex O +
, O +
race O +
, O +
association O +
with O +
systemic O +
diseases O +
, O +
interval O +
between O +
birth O +
and O +
diagnosis O +
, O +
laterality O +
, O +
presence O +
of O +
corneal O +
ulcer O +
and O +
causative O +
infectious O +
agent O +
, O +
treatment O +
, O +
and O +
visual O +
outcome O +
. O +

RESULTS O +
: O +

Twenty O -
- O -
five O +
cases O +
were O +
reviewed O +
. O +

The O +
typical O +
patient O +
is O +
a O +
white O +
male O +
diagnosed O +
at O +
7.2 O +
weeks O +
of O +
age O +
. O +

Right O +
- O +
sided O +
and O +
bilateral O +
cases O +
were O +
most O +
common O +
. O +

Ulcers O +
were O +
present O +
in O +
12 O +
/ O +
24 O +
patients O +
; O +
most O +
were O +
culture O +
negative O +
. O +

Various O +
methods O +
of O +
surgical O +
repair O +
were O +
successful O +
. O +

Visual O +
outcomes O +
, O +
in O +
general O +
, O +
were O +
favorable O +
although O +
amblyopia O +
developed O +
in O +
4 O +
/ O +
15 O +
patients O +
. O +

CONCLUSIONS O +
: O +

Congenital O +
horizontal O +
tarsal O +
kink O +
is O +
rare O +
and O +
its O +
cause O +
is O +
unknown O +
. O +

A O +
poor O +
visual O +
outcome O +
usually O +
results O +
from O +
a O +
corneal O +
ulcer O +
scar O +
and O +
a O +
delay O +
in O +
diagnosis O +
. O +

Amblyopia O +
not O +
related O +
to O +
corneal O +
opacification O +
can O +
also O +
occur O +
. O +

Characterization O +
of O +
a O +
new O +
sigma B-Gene +
- I-Gene +
K I-Gene +
- O +
dependent O +
peptidoglycan B-Gene +
hydrolase I-Gene +
gene O +
that O +
plays O +
a O +
role O +
in O +
Bacillus O +
subtilis O +
mother O +
cell O +
lysis O +
. O +

Bacillus O +
subtilis O +
produces O +
a O +
30 O +
- O +
kDa O +
peptidoglycan B-Gene +
hydrolase I-Gene +
, O +
CwlH B-Gene +
, O +
during O +
the O +
late O +
sporulation O +
phase O +
. O +

Disruption O +
of O +
yqeE B-Gene +
led O +
to O +
a O +
complete O +
loss O +
of O +
CwlH B-Gene +
formation O +
, O +
indicating O +
the O +
identity O +
of O +
yqeE B-Gene +
with O +
cwlH B-Gene +
. O +

Northern O +
blot O +
analysis O +
of O +
cwlH B-Gene +
revealed O +
a O +
0.8 O +
- O +
kb O +
transcript O +
after O +
6 O +
to O +
7.5 O +
h O +
for O +
the O +
wild O +
- O +
type O +
strain O +
but O +
not O +
for O +
the O +
sigma B-Gene +
( I-Gene +
F I-Gene +
) I-Gene +
, O +
sigma B-Gene +
( I-Gene +
E I-Gene +
) I-Gene +
, O +
sigma B-Gene +
( I-Gene +
G I-Gene +
) I-Gene +
, O +
and O +
sigma B-Gene +
( I-Gene +
K I-Gene +
) I-Gene +
mutants O +
. O +

Expression O +
of O +
the O +
sigma B-Gene -
( I-Gene -
K I-Gene -
) I-Gene +
- O +
dependent O +
cwlH B-Gene +
gene O +
depended O +
on O +
gerE B-Gene +
. O +

Primer O +
extension O +
analysis O +
also O +
suggested O +
that O +
cwlH B-Gene +
is O +
transcribed O +
by O +
Esigma B-Gene -
( I-Gene -
K I-Gene -
) I-Gene +
RNA B-Gene +
polymerase I-Gene +
. O +

CwlH B-Gene +
produced O +
in O +
Escherichia O +
coli O +
harboring O +
a O +
cwlH B-Gene +
plasmid O +
is O +
an O +
N B-Gene -
- I-Gene -
acetylmuramoyl I-Gene -
- I-Gene -
L I-Gene -
- I-Gene -
alanine I-Gene +
amidase I-Gene +
( O +
EC B-Gene +
3.5.1.28 I-Gene +
) O +
and O +
exhibited O +
an O +
optimum O +
pH O +
of O +
7.0 O +
and O +
high O +
- O +
level O +
binding O +
to O +
the O +
B. O +
subtilis O +
cell O +
wall O +
. O +

A O +
cwlC B-Gene +
cwlH B-Gene +
double O +
mutation O +
led O +
to O +
a O +
lack O +
of O +
mother O +
cell O +
lysis O +
even O +
after O +
7 O +
days O +
of O +
incubation O +
in O +
DSM O +
medium O +
, O +
but O +
the O +
single O +
mutations O +
led O +
to O +
mother O +
cell O +
lysis O +
after O +
24 O +
h O +
. O +

rpoS B-Gene +
function O +
is O +
essential O +
for O +
bgl B-Gene +
silencing O +
caused O +
by O +
C O +
- O +
terminally O +
truncated O +
H B-Gene -
- I-Gene -
NS I-Gene +
in O +
Escherichia O +
coli O +
. O +

From O +
evolutionary O +
and O +
physiological O +
viewpoints O +
, O +
the O +
Escherichia O +
coli O +
bgl B-Gene +
operon I-Gene +
is O +
intriguing O +
because O +
its O +
expression O +
is O +
silent O +
( O +
Bgl B-Gene +
( O -
- O -
) O +
phenotype O +
) O +
, O +
at O +
least O +
under O +
several O +
laboratory O +
conditions O +
. O +

H B-Gene -
- I-Gene -
NS I-Gene +
, O +
a O +
nucleoid O +
protein O +
, O +
is O +
known O +
as O +
a O +
DNA O +
- O +
binding O +
protein O +
involved O +
in O +
bgl B-Gene +
silencing O +
. O +

However O +
, O +
we O +
previously O +
found O +
that O +
bgl B-Gene +
expression O +
is O +
still O +
silent O +
in O +
a O +
certain O +
subset O +
of O +
hns B-Gene +
mutations O +
, O +
each O +
of O +
which O +
results O +
in O +
a O +
defect O +
in O +
its O +
DNA O +
- O +
binding O +
ability O +
. O +

Based O +
on O +
this O +
fact O +
, O +
we O +
proposed O +
a O +
model O +
in O +
which O +
a O +
postulated O +
DNA O +
- O +
binding O +
protein O +
( O -
s O -
) O +
has O +
an O +
adapter O +
function O +
by O +
interacting O +
with O +
both O +
the O +
cis O +
- O +
acting O +
element O +
of O +
the O +
bgl B-Gene +
promoter O +
and O +
the O +
mutated O +
H B-Gene -
- I-Gene -
NS I-Gene +
. O +

To O +
identify O +
such O +
a O +
presumed O +
adapter O +
molecule O +
, O +
we O +
attempted O +
to O +
isolate O +
mutants O +
exhibiting O +
the O +
Bgl B-Gene +
( O +
+ O +
) O +
phenotype O +
in O +
the O +
background O +
of O +
hns60 B-Gene +
, O +
encoding O +
the O +
mutant O +
H B-Gene -
- I-Gene -
NS I-Gene +
protein O +
lacking O +
the O +
DNA O +
- O +
binding O +
domain O +
by O +
random O +
insertion O +
mutagenesis O +
with O +
the O +
mini O +
- O +
Tn10cam O +
transposon O +
. O +

These O +
isolated O +
mutations O +
were O +
mapped O +
to O +
five O +
loci O +
on O +
the O +
chromosome O +
. O +

Among O +
these O +
loci O +
, O +
three O +
appeared O +
to O +
be O +
leuO B-Gene +
, O +
hns B-Gene +
, O +
and O +
bglJ B-Gene +
, O +
which O +
were O +
previously O +
characterized O +
, O +
while O +
the O +
other O +
two O +
were O +
novel O +
. O +

Genetic O +
analysis O +
revealed O +
that O +
the O +
two O +
insertions O +
are O +
within O +
the O +
rpoS B-Gene +
gene O +
and O +
in O +
front O +
of O +
the O +
lrhA B-Gene +
gene O +
, O +
respectively O +
. O +

The O +
former O +
encodes O +
the O +
stationary O +
- O +
phase O +
- O +
specific O +
sigma B-Gene +
factor I-Gene +
, O +
sigma B-Gene -
( I-Gene -
S I-Gene -
) I-Gene +
, O +
and O +
the O +
latter O +
encodes O +
a O +
LysR B-Gene +
- O +
like O +
DNA O +
- O +
binding O +
protein O +
. O +

It O +
was O +
found O +
that O +
sigma B-Gene -
( I-Gene -
S I-Gene -
) I-Gene +
is O +
defective O +
in O +
both O +
types O +
of O +
mutant O +
cells O +
. O +

These O +
results O +
showed O +
that O +
the O +
rpoS B-Gene +
function O +
is O +
involved O +
in O +
the O +
mechanism O +
underlying O +
bgl B-Gene +
silencing O +
, O +
at O +
least O +
in O +
the O +
hns60 B-Gene +
background O +
used O +
in O +
this O +
study O +
. O +

We O +
also O +
examined O +
whether O +
the O +
H B-Gene -
- I-Gene -
NS I-Gene +
homolog O +
StpA B-Gene +
has O +
such O +
an O +
adapter O +
function O +
, O +
as O +
was O +
previously O +
proposed O +
. O +

Our O +
results O +
did O +
not O +
support O +
the O +
idea O +
that O +
StpA B-Gene +
has O +
an O +
adapter O +
function O +
in O +
the O +
genetic O +
background O +
used O +
. O +

The O +
kissing O +
- O +
loop O +
motif O +
is O +
a O +
preferred O +
site O +
of O +
5 O -
' O +
leader O +
recombination O +
during O +
replication O +
of O +
SL3 O -
- O -
3 O +
murine O +
leukemia O +
viruses O +
in O +
mice O +
. O +

A O +
panel O +
of O +
mouse O +
T O -
- O -
cell O +
lymphomas O +
induced O +
by O +
SL3 O -
- O -
3 O +
murine O +
leukemia O +
virus O +
( O +
MLV O +
) O +
and O +
three O +
primer O +
binding O +
site O +
mutants O +
thereof O +
( O +
A. O +
H. O +
Lund O +
, O +
J. O +
Schmidt O +
, O +
A. O +
Luz O +
, O +
A. O +
B. O +
Sorensen O +
, O +
M. O +
Duch O +
, O +
and O +
F. O +
S. O +
Pedersen O +
, O +
J. O +
Virol O -
. O +
73 O +
: O +
6117 O +
- O +
6122 O +
, O +
1999 O +
) O +
were O +
analyzed O +
for O +
the O +
occurrence O +
of O +
recombination O +
between O +
the O +
exogenous O +
input O +
virus O +
and O +
endogenous O +
MLV O +
- O +
like O +
sequences O +
within O +
the O +
5 O -
' O +
leader O +
region O +
. O +

Evidence O +
of O +
recombination O +
within O +
the O +
region O +
studied O +
was O +
found O +
in O +
14 O +
of O +
52 O +
tumors O +
analyzed O +
. O +

Sequence O +
analysis O +
of O +
a O +
approximately O +
330 O +
- O +
bp O +
fragment O +
of O +
44 O +
chimeric O +
proviruses O +
, O +
encompassing O +
the O +
U5 O +
, O +
the O +
primer O +
binding O +
site O +
, O +
and O +
the O +
upstream O +
part O +
of O +
the O +
5 O -
' O +
untranslated O +
region O +
, O +
enabled O +
us O +
to O +
map O +
recombination O +
sites O +
, O +
guided O +
by O +
distinct O +
scattered O +
nucleotide O +
differences O +
. O +

In O +
30 O +
of O +
44 O +
analyzed O +
sequences O +
, O +
recombination O +
was O +
mapped O +
to O +
a O +
33 O +
- O +
nucleotide O +
similarity O +
window O +
coinciding O +
with O +
the O +
kissing O +
- O +
loop O +
stem O +
- O +
loop O +
motif O +
implicated O +
in O +
dimerization O +
of O +
the O +
diploid O +
genome O +
. O +

Interestingly O +
, O +
the O +
recombination O +
pattern O +
preference O +
found O +
in O +
replication O +
- O +
competent O +
viruses O +
from O +
T O -
- O -
cell O +
tumors O +
is O +
very O +
similar O +
to O +
the O +
pattern O +
previously O +
reported O +
for O +
retroviral O +
vectors O +
in O +
cell O +
culture O +
experiments O +
. O +

The O +
data O +
therefore O +
sustain O +
the O +
hypothesis O +
that O +
the O +
kissing O +
loop O +
, O +
presumably O +
via O +
a O +
role O +
in O +
RNA O +
dimer O +
formation O +
, O +
constitutes O +
a O +
hot O +
spot O +
for O +
reverse B-Gene +
transcriptase I-Gene +
- O +
mediated O +
recombination O +
in O +
MLV O +
. O +

Elevated O +
plasma O +
eotaxin B-Gene +
levels O +
in O +
patients O +
with O +
acute O +
asthma O +
. O +

BACKGROUND O +
: O +

The O +
eosinophil O +
chemotactic O +
and O +
activating O +
effects O +
of O +
eotaxin B-Gene +
and O +
the O +
known O +
association O +
of O +
eosinophils O +
with O +
asthma O +
suggest O +
that O +
eotaxin B-Gene +
expression O +
is O +
increased O +
during O +
asthma O +
exacerbations O +
. O +

OBJECTIVE O +
: O +

We O +
sought O +
to O +
determine O +
whether O +
plasma O +
eotaxin B-Gene +
levels O +
are O +
elevated O +
in O +
patients O +
presenting O +
for O +
emergency O +
treatment O +
of O +
acute O +
asthma O +
and O +
to O +
correlate O +
eotaxin B-Gene +
levels O +
with O +
disease O +
activity O +
and O +
responses O +
to O +
treatment O +
. O +

METHODS O +
: O +

A O +
case O +
- O +
control O +
study O +
of O +
plasma O +
eotaxin B-Gene +
levels O +
was O +
performed O +
in O +
the O +
46 O +
patients O +
who O +
presented O +
for O +
emergency O +
asthma O +
treatment O +
and O +
133 O +
age O +
- O +
, O +
sex O +
- O +
, O +
and O +
ethnicity O +
- O +
matched O +
subjects O +
with O +
stable O +
asthma O +
. O +

RESULTS O +
: O +

Plasma O +
eotaxin B-Gene +
levels O +
were O +
significantly O +
higher O +
in O +
46 O +
patients O +
with O +
acute O +
asthma O +
symptoms O +
and O +
airflow O +
obstruction O +
( O +
520 O +
pg O +
/ O +
mL O +
[ O +
250 O +
, O +
1100 O +
pg O +
/ O +
mL O +
] O +
; O +
geometric O +
mean O +
[ O -
-1 O +
SD O +
, O +
+ O -
1 O +
SD O +
] O +
) O +
than O +
in O +
133 O +
subjects O +
with O +
stable O +
asthma O +
( O +
350 O +
pg O +
/ O +
mL O +
[ O +
190 O +
, O +
620 O +
pg O +
/ O +
mL O +
] O +
; O +
P O +
= O +
.0008 O +
) O +
. O +

Among O +
the O +
patients O +
with O +
emergency O +
asthma O +
flares O +
, O +
those O +
who O +
responded O +
to O +
asthma O +
treatment O +
with O +
an O +
increase O +
in O +
peak O +
expiratory O +
flow O +
rate O +
by O +
an O +
amount O +
equal O +
to O +
at O +
least O +
20 O +
% O +
of O +
their O +
predicted O +
normal O +
value O +
had O +
lower O +
eotaxin B-Gene +
levels O +
than O +
those O +
who O +
did O +
not O +
( O +
410 O +
pg O +
/ O +
mL O +
[ O +
210 O +
, O +
800 O +
pg O +
/ O +
mL O +
] O +
and O +
660 O +
pg O +
/ O +
mL O +
[ O +
300 O +
, O +
1480 O +
pg O +
/ O +
mL O +
] O +
, O +
respectively O +
; O +
P O +
= O +
.04 O +
) O +
. O +

CONCLUSION O +
: O +

These O +
findings O +
imply O +
that O +
eotaxin B-Gene +
either O +
is O +
mechanistically O +
involved O +
in O +
acute O +
asthma O +
or O +
serves O +
as O +
a O +
biomarker O +
for O +
activity O +
of O +
the O +
CCR3 B-Gene +
receptor O +
ligand O +
system O +
, O +
which O +
is O +
functionally O +
linked O +
to O +
asthma O +
. O +

FGF-19 B-Gene +
, O +
a O +
novel O +
fibroblast B-Gene +
growth I-Gene +
factor I-Gene +
with O +
unique O +
specificity O +
for O +
FGFR4 B-Gene +
. O +

We O +
have O +
identified O +
a O +
novel O +
fibroblast B-Gene +
growth I-Gene +
factor I-Gene +
, O +
FGF-19 B-Gene +
, O +
the O +
most O +
distant O +
member O +
of O +
the O +
FGF B-Gene +
family I-Gene +
described O +
to O +
date O +
. O +

FGF-19 B-Gene +
is O +
a O +
high O +
affinity O +
, O +
heparin O +
dependent O +
ligand O +
for O +
FGFR4 B-Gene +
and O +
is O +
the O +
first O +
member O +
of O +
the O +
FGF B-Gene +
family I-Gene +
to O +
show O +
exclusive O +
binding O +
to O +
FGFR4 B-Gene +
. O +

Human O +
FGF-19 B-Gene +
maps O +
to O +
chromosome O +
11 O +
q13.1 O +
, O +
a O +
region O +
associated O +
with O +
an O +
osteoporosis O +
- O +
pseudoglioma O +
syndrome O +
of O +
skeletal O +
and O +
retinal O +
defects O +
. O +

FGF-19 B-Gene +
message O +
is O +
expressed O +
in O +
several O +
tissues O +
including O +
fetal O +
cartilage O +
, O +
skin O +
, O +
and O +
retina O +
, O +
as O +
well O +
as O +
adult O +
gall O +
bladder O +
and O +
is O +
overexpressed O +
in O +
a O +
colon O +
adenocarcinoma O +
cell O +
line O +
. O +

Smooth O +
pursuit O +
tracking O +
deficits O +
of O +
patients O +
with O +
schizophrenia O +
at O +
specific O +
within O +
- O +
sine O +
wave O +
bins O +
. O +

BACKGROUND O +
: O +

Early O +
information O +
processing O +
deficits O +
are O +
consistently O +
reported O +
for O +
patients O +
with O +
schizophrenia O +
on O +
smooth O +
pursuit O +
tracking O +
tasks O +
. O +

A O +
growing O +
number O +
of O +
studies O +
have O +
applied O +
a O +
transient O +
( O +
magnocellular O +
) O +
or O +
sustained O +
( O +
parvocellular O +
) O +
explanation O +
to O +
account O +
for O +
deficient O +
processing O +
of O +
briefly O +
presented O +
visual O +
stimuli O +
, O +
moving O +
stimuli O +
, O +
and O +
particularly O +
, O +
stimuli O +
requiring O +
smooth O +
tracking O +
eye O +
movements O +
in O +
patients O +
with O +
schizophrenia O +
. O +

OBJECTIVE O +
: O +

Although O +
the O +
preponderance O +
of O +
findings O +
offer O +
support O +
for O +
transient O +
( O +
where O +
is O +
it O +
? O +
) O +
as O +
opposed O +
to O +
sustained O +
( O +
what O +
is O +
it O +
? O +
) O +
deficit O +
, O +
a O +
need O +
remains O +
for O +
specific O +
depiction O +
of O +
the O +
deficit O +
. O +

This O +
was O +
accomplished O +
by O +
applying O +
a O +
unique O +
analytic O +
method O +
to O +
a O +
smooth O +
pursuit O +
tracking O +
task O +
. O +

METHODS O +
: O +

Fourteen O +
patients O +
with O +
schizophrenia O +
and O +
fifteen O +
normal O +
control O +
subjects O +
were O +
tested O +
on O +
smooth O +
pursuit O +
tracking O +
performance O +
at O +
five O +
different O +
" O +
within O +
- O +
wave O +
" O +
dot O +
velocity O +
frequencies O +
that O +
ranged O +
from O +
.3 O +
to O +
1.1 O +
hz O +
. O +

Performance O +
data O +
was O +
extracted O +
from O +
each O +
of O +
the O +
five O +
frequencies O +
and O +
then O +
separated O +
into O +
12 O +
discrete O +
components O +
that O +
corresponded O +
to O +
light O +
velocity O +
( O +
i.e. O +
, O +
12 O +
bins O +
) O +
. O +

RESULTS O +
: O +

A O +
repeated O +
measures O +
multivariate O +
analysis O +
of O +
covariance O +
indicated O +
that O +
the O +
performance O +
of O +
patients O +
with O +
schizophrenia O +
was O +
significantly O +
poorer O +
than O +
that O +
of O +
their O +
normal O +
counterparts O +
for O +
three O +
separate O +
analyses O +
of O +
the O +
time O +
in O +
smooth O +
pursuit O +
, O +
F O -
( O -
11,594 O +
) O +
= O +
8.99 O +
; O +
p O +
< O +
0.00001 O +
, O +
percentage O +
of O +
time O +
in O +
smooth O +
pursuit O +
, O +
F O -
( O -
11,594 O +
) O +
= O +
3.06 O +
; O +
p O +
< O +
0.0005 O +
, O +
and O +
time O +
in O +
saccade O +
eye O +
movement O +
, O +
F O -
( O -
11,594 O +
) O +
= O +
3.11 O +
; O +
p O +
< O +
0.0004 O +
. O +

A O +
regression O +
analysis O +
revealed O +
that O +
the O +
medication O +
dosage O +
was O +
not O +
significantly O +
associated O +
with O +
performance O +
on O +
any O +
of O +
the O +
critical O +
measures O +
, O +
although O +
trends O +
were O +
observed O +
. O +

CONCLUSIONS O +
: O +

The O +
findings O +
provide O +
support O +
for O +
an O +
early O +
information O +
processing O +
deficit O +
in O +
patients O +
with O +
schizophrenia O +
. O +

In O +
addition O +
, O +
the O +
results O +
support O +
the O +
current O +
neurophysiologic O +
model O +
for O +
abnormal O +
smooth O +
pursuit O +
tracking O +
in O +
patients O +
with O +
schizophrenia O +
, O +
specifically O +
implicating O +
a O +
transient O +
channel O +
deficiency O +
. O +

Lamivudine O +
as O +
initial O +
treatment O +
for O +
chronic O +
hepatitis O +
B O +
in O +
the O +
United O +
States O +
. O +

BACKGROUND O +
AND O +
METHODS O +
: O +

Although O +
the O +
nucleoside O +
analogue O +
lamivudine O +
has O +
shown O +
promise O +
in O +
patients O +
with O +
chronic O +
hepatitis O +
B O +
, O +
long O +
- O +
term O +
data O +
on O +
patients O +
from O +
the O +
United O +
States O +
are O +
lacking O +
. O +

We O +
randomly O +
assigned O +
previously O +
untreated O +
patients O +
with O +
chronic O +
hepatitis O +
B O +
to O +
receive O +
either O +
100 O +
mg O +
of O +
oral O +
lamivudine O +
or O +
placebo O +
daily O +
for O +
52 O +
weeks O +
. O +

We O +
then O +
followed O +
them O +
for O +
an O +
additional O +
16 O +
weeks O +
to O +
evaluate O +
post O +
- O +
treatment O +
safety O +
and O +
the O +
durability O +
of O +
responses O +
. O +

The O +
primary O +
end O +
point O +
with O +
respect O +
to O +
efficacy O +
was O +
a O +
reduction O +
of O +
at O +
least O +
2 O +
points O +
in O +
the O +
score O +
on O +
the O +
Histologic O +
Activity O +
Index O +
. O +

On O +
this O +
scale O +
, O +
scores O +
can O +
range O +
from O +
0 O +
( O +
normal O +
) O +
to O +
22 O +
( O +
most O +
severe O +
abnormalities O +
) O +
. O +

RESULTS O +
: O +

Of O +
the O +
143 O +
randomized O +
patients O +
, O +
137 O +
were O +
included O +
in O +
the O +
efficacy O +
analysis O +
: O +
66 O +
in O +
the O +
lamivudine O +
group O +
and O +
71 O +
in O +
the O +
placebo O +
group O +
. O +

The O +
other O +
six O +
patients O +
were O +
excluded O +
at O +
the O +
base O +
- O +
line O +
visit O +
because O +
of O +
the O +
absence O +
of O +
a O +
documented O +
history O +
of O +
hepatitis O +
B O +
surface O +
antigen O +
for O +
at O +
least O +
six O +
months O +
. O +

After O +
52 O +
weeks O +
of O +
treatment O +
, O +
lamivudine O +
recipients O +
were O +
more O +
likely O +
than O +
placebo O +
recipients O +
to O +
have O +
a O +
histologic O +
response O +
( O +
52 O +
percent O +
vs. O +
23 O +
percent O +
, O +
P O +
< O +
0.001 O +
) O +
, O +
loss O +
of O +
hepatitis O +
B O +
e B-Gene +
antigen I-Gene +
( O +
HBeAg B-Gene +
) O +
in O +
serum O +
( O +
32 O +
percent O +
vs. O +
11 O +
percent O +
, O +
P O +
= O +
0.003 O +
) O +
, O +
sustained O +
suppression O +
of O +
serum O +
hepatitis O +
B O +
virus O +
( O +
HBV O +
) O +
DNA O +
to O +
undetectable O +
levels O +
( O +
44 O +
percent O +
vs. O +
16 O +
percent O +
, O +
P O +
< O +
0.001 O +
) O +
, O +
and O +
sustained O +
normalization O +
of O +
serum O +
alanine B-Gene +
aminotransferase I-Gene +
levels O +
( O +
41 O +
percent O +
vs. O +
7 O +
percent O +
, O +
P O +
< O +
0.001 O +
) O +
, O +
and O +
they O +
were O +
less O +
likely O +
to O +
have O +
increased O +
hepatic O +
fibrosis O +
( O +
5 O +
percent O +
vs. O +
20 O +
percent O +
, O +
P O +
= O +
0.01 O +
) O +
. O +

Lamivudine O +
recipients O +
were O +
also O +
more O +
likely O +
to O +
undergo O +
HBeAg B-Gene +
seroconversion O +
, O +
defined O +
as O +
the O +
loss O +
of O +
HBeAg B-Gene +
, O +
undetectable O +
levels O +
of O +
serum O +
HBV O +
DNA O +
, O +
and O +
the O +
appearance O +
of O +
antibodies O +
against O +
HBeAg B-Gene +
( O +
17 O +
percent O +
vs. O +
6 O +
percent O +
, O +
P O +
= O +
0.04 O +
) O +
. O +

HBeAg B-Gene +
responses O +
persisted O +
in O +
most O +
patients O +
for O +
16 O +
weeks O +
after O +
the O +
discontinuation O +
of O +
treatment O +
. O +

Lamivudine O +
was O +
well O +
tolerated O +
. O +

Self O +
- O +
limited O +
post O +
- O +
treatment O +
elevations O +
in O +
serum O +
alanine B-Gene +
aminotransferase I-Gene +
were O +
more O +
common O +
in O +
lamivudine O +
recipients O +
: O +
25 O +
percent O +
had O +
serum O +
alanine B-Gene +
aminotransferase I-Gene +
levels O +
that O +
were O +
at O +
least O +
three O +
times O +
base O +
- O +
line O +
levels O +
, O +
as O +
compared O +
with O +
8 O +
percent O +
of O +
placebo O +
recipients O +
( O +
P O +
= O +
0.01 O +
) O +
. O +

The O +
clinical O +
condition O +
of O +
all O +
patients O +
remained O +
stable O +
during O +
the O +
study O +
. O +

CONCLUSIONS O +
: O +

In O +
U.S. O +
patients O +
with O +
previously O +
untreated O +
chronic O +
hepatitis O +
B O +
, O +
one O +
year O +
of O +
lamivudine O +
therapy O +
had O +
favorable O +
effects O +
on O +
histologic O +
, O +
virologic O +
, O +
and O +
biochemical O +
features O +
of O +
the O +
disease O +
and O +
was O +
well O +
tolerated O +
. O +

HBeAg B-Gene +
responses O +
were O +
generally O +
sustained O +
after O +
treatment O +
. O +

Recombinant O +
human O +
liver O +
betaine B-Gene +
- I-Gene +
homocysteine I-Gene +
S I-Gene -
- I-Gene -
methyltransferase I-Gene +
: O +
identification O +
of O +
three O +
cysteine O +
residues O +
critical O +
for O +
zinc O +
binding O +
. O +

Betaine B-Gene +
- I-Gene +
homocysteine I-Gene +
S I-Gene -
- I-Gene -
methyltransferase I-Gene +
( O +
BHMT B-Gene +
; O +
EC B-Gene +
2.1.1.5 I-Gene +
) O +
catalyzes O +
the O +
transfer O +
of O +
an O +
N O -
- O -
methyl O +
group O +
from O +
betaine O +
to O +
homocysteine O +
to O +
produce O +
dimethylglycine O +
and O +
methionine O +
, O +
respectively O +
. O +

The O +
enzyme O +
is O +
found O +
in O +
the O +
pathway O +
of O +
choline O +
oxidation O +
and O +
is O +
abundantly O +
expressed O +
in O +
liver O +
and O +
kidney O +
. O +

We O +
have O +
recently O +
shown O +
that O +
human O +
BHMT B-Gene +
is O +
a O +
zinc O +
metalloenzyme O +
[ O +
Millian O +
, O +
N. O +
S. O +
, O +
and O +
Garrow O +
, O +
T. O +
A. O +
( O +
1998 O +
) O +
Arch O -
. O +
Biochem O -
. O +
Biophys O -
. O +
356 O +
, O +
93 O +
- O +
98 O +
] O +
. O +

To O +
facilitate O +
the O +
rapid O +
purification O +
of O +
human O +
BHMT B-Gene +
for O +
further O +
physical O +
and O +
mechanistic O +
studies O +
, O +
including O +
characterizing O +
its O +
metal O +
binding O +
properties O +
, O +
we O +
have O +
overexpressed O +
the O +
enzyme O +
in O +
E. O +
coli O +
as O +
a O +
fusion O +
construct O +
which O +
facilitated O +
its O +
subsequent O +
purification O +
by O +
a O +
self O +
- O +
cleavable O +
affinity O +
tag O +
system O +
( O +
IMPACT O +
T7 O +
) O +
. O +

Using O +
this O +
expression O +
and O +
purification O +
system O +
in O +
conjunction O +
with O +
site O +
- O +
directed O +
mutagenesis O +
, O +
we O +
have O +
identified O +
Cys217 O +
, O +
Cys299 O +
, O +
and O +
Cys300 O +
as O +
zinc O +
ligands O +
. O +

Mutating O +
any O +
of O +
these O +
Cys O +
residues O +
to O +
Ala O +
results O +
in O +
the O +
complete O +
loss O +
of O +
activity O +
and O +
a O +
significant O +
reduction O +
in O +
the O +
ability O +
of O +
the O +
protein O +
to O +
bind O +
zinc O +
. O +

Comparing O +
the O +
regions O +
of O +
BHMT B-Gene +
amino O +
acid O +
sequence O +
surrounding O +
these O +
Cys O +
residues O +
with O +
similar O +
amino O +
acid O +
sequences O +
retrievable O +
from O +
protein O +
databases O +
, O +
we O +
have O +
identified O +
the O +
following O +
motif O +
: O +
G O -
[ O -
ILV O -
] O -
NCX O +
( O +
20 O +
, O +
100 O +
) O +
[ O +
ALV O +
] O +
X O -
( O -
2 O -
) O +
[ O +
ILV O +
] O +
GGCCX O +
( O +
3 O +
) O +
PX O +
( O +
2 O +
) O +
I O +
, O +
which O +
we O +
propose O +
to O +
be O +
a O +
signature O +
for O +
a O +
family O +
of O +
zinc O +
- O +
dependent O +
methyltransferases B-Gene +
that O +
utilize O +
thiols O +
or O +
selenols O +
as O +
methyl O +
acceptors O +
. O +

Some O +
of O +
the O +
members O +
of O +
this O +
family O +
include O +
the O +
vitamin B-Gene +
B I-Gene +
( I-Gene +
12 I-Gene +
) I-Gene +
- I-Gene +
dependent I-Gene +
methionine I-Gene +
synthases I-Gene +
, O +
E. O +
coli O +
S B-Gene -
- I-Gene -
methylmethionine I-Gene -
- I-Gene -
S I-Gene -
- I-Gene -
homocysteine I-Gene +
methyltransferase I-Gene +
, O +
and O +
A. O +
bisulcatus O +
S B-Gene +
- I-Gene +
methylmethionine I-Gene +
- I-Gene +
selenocysteine I-Gene +
methyltransferase I-Gene +
. O +

Interaction O +
of O +
the O +
metalloprotease B-Gene +
disintegrins I-Gene +
MDC9 B-Gene +
and O +
MDC15 B-Gene +
with O +
two O +
SH3 O +
domain O +
- O +
containing O +
proteins O +
, O +
endophilin B-Gene +
I I-Gene +
and O +
SH3PX1 B-Gene +
. O +

Metalloprotease B-Gene +
disintegrins I-Gene +
( O +
a B-Gene +
disintegrin I-Gene +
and I-Gene +
metalloprotease I-Gene +
( O +
ADAM B-Gene +
) O +
and O +
metalloprotease B-Gene +
, I-Gene +
disintegrin I-Gene +
, I-Gene +
cysteine I-Gene +
- I-Gene +
rich I-Gene +
proteins I-Gene +
( O +
MDC B-Gene +
) O +
) O +
are O +
a O +
family O +
of O +
membrane O +
- O +
anchored O +
glycoproteins O +
that O +
function O +
in O +
diverse O +
biological O +
processes O +
, O +
including O +
fertilization O +
, O +
neurogenesis O +
, O +
myogenesis O +
, O +
and O +
ectodomain O +
processing O +
of O +
cytokines B-Gene +
and O +
other O +
proteins O +
. O +

The O +
cytoplasmic O +
domains O +
of O +
ADAMs B-Gene +
often O +
include O +
putative O +
signaling O +
motifs O +
, O +
such O +
as O +
proline O +
- O +
rich O +
SH3 O +
ligand O +
domains O +
, O +
suggesting O +
that O +
interactions O +
with O +
cytoplasmic O +
proteins O +
may O +
affect O +
metalloprotease B-Gene +
disintegrin I-Gene +
function O +
. O +

Here O +
we O +
report O +
that O +
two O +
SH3 O +
domain O +
- O +
containing O +
proteins O +
, O +
endophilin B-Gene +
I I-Gene +
( O +
SH3GL2 B-Gene +
, O +
SH3p4 B-Gene +
) O +
and O +
a O +
novel O +
SH3 O +
domain O +
- O +
and O +
phox O +
homology O +
( O +
PX O +
) O +
domain O +
- O +
containing O +
protein O +
, O +
termed O +
SH3PX1 B-Gene +
, O +
can O +
interact O +
with O +
the O +
cytoplasmic O +
domains O +
of O +
the O +
metalloprotease B-Gene +
disintegrins I-Gene +
MDC9 B-Gene +
and O +
MDC15 B-Gene +
. O +

These O +
interactions O +
were O +
initially O +
identified O +
in O +
a O +
yeast O +
two O +
- O +
hybrid O +
screen O +
and O +
then O +
confirmed O +
using O +
bacterial O +
fusion O +
proteins O +
and O +
co O +
- O +
immunoprecipitations O +
from O +
eukaryotic O +
cells O +
expressing O +
both O +
binding O +
partners O +
. O +

SH3PX1 B-Gene +
and O +
endophilin B-Gene +
I I-Gene +
both O +
preferentially O +
bind O +
the O +
precursor O +
but O +
not O +
the O +
processed O +
form O +
of O +
MDC9 B-Gene +
and O +
MDC15 B-Gene +
in O +
COS-7 O +
cells O +
. O +

Since O +
rat O +
endophilin B-Gene +
I I-Gene +
is O +
thought O +
to O +
play O +
a O +
role O +
in O +
synaptic O +
vesicle O +
endocytosis O +
and O +
SH3PX1 B-Gene +
has O +
sequence O +
similarity O +
to O +
sorting B-Gene +
nexins I-Gene +
in O +
yeast O +
, O +
we O +
propose O +
that O +
endophilin B-Gene +
I I-Gene +
and O +
SH3PX1 B-Gene +
may O +
have O +
a O +
role O +
in O +
regulating O +
the O +
function O +
of O +
MDC9 B-Gene +
and O +
MDC15 B-Gene +
by O +
influencing O +
their O +
intracellular O +
processing O +
, O +
transport O +
, O +
or O +
final O +
subcellular O +
localization O +
. O +

Micrometastases O +
of O +
bone O +
marrow O +
in O +
localized O +
prostate O +
cancer O +
: O +
correlation O +
with O +
established O +
risk O +
factors O +
. O +

PURPOSE O +
: O +

The O +
presence O +
of O +
cytokeratin O +
18 O +
- O +
positive O +
cells O +
in O +
bone O +
marrow O +
correlates O +
with O +
conventional O +
risk O +
factors O +
in O +
many O +
tumors O +
. O +

We O +
examined O +
whether O +
this O +
was O +
also O +
valid O +
for O +
localized O +
or O +
lymphatically O +
spread O +
prostate O +
cancer O +
. O +

PATIENTS O +
AND O +
METHODS O +
: O +

Immediately O +
before O +
radical O +
prostatectomy O +
, O +
bone O +
marrow O +
aspirates O +
from O +
both O +
sides O +
of O +
the O +
iliac O +
crest O +
were O +
taken O +
from O +
287 O +
patients O +
. O +

The O +
presence O +
of O +
cells O +
containing O +
cytokeratin O +
18 O +
was O +
interpreted O +
as O +
micrometastasis O +
. O +

RESULTS O +
: O +

In O +
patients O +
with O +
negative O +
lymph O +
nodes O +
( O +
n O +
= O +
219 O +
) O +
, O +
conventional O +
risk O +
factors O +
( O +
Gleason O +
score O +
, O +
pathologic O +
stage O +
, O +
ploidy O +
, O +
and O +
preoperative O +
prostate O +
- O +
specific O +
antigen O +
) O +
did O +
not O +
correlate O +
with O +
the O +
preoperative O +
detection O +
of O +
cells O +
containing O +
cytokeratin O +
18 O +
. O +

There O +
was O +
also O +
no O +
correlation O +
with O +
lymph O +
node O +
metastases O +
. O +

Furthermore O +
, O +
there O +
was O +
no O +
interdependency O +
between O +
the O +
preoperatively O +
detected O +
number O +
of O +
cells O +
and O +
the O +
established O +
risk O +
factors O +
. O +

CONCLUSION O +
: O +

We O +
assume O +
the O +
presence O +
of O +
epithelial O +
cells O +
in O +
bone O +
marrow O +
to O +
be O +
an O +
independent O +
parameter O +
, O +
the O +
clinical O +
importance O +
of O +
which O +
must O +
be O +
substantiated O +
by O +
further O +
studies O +
. O +

Identification O +
of O +
a O +
novel O +
PSD-95 B-Gene +
/ O +
Dlg B-Gene +
/ O +
ZO-1 B-Gene +
( O +
PDZ O +
) O +
- O +
like O +
protein O +
interacting O +
with O +
the O +
C O +
terminus O +
of O +
presenilin-1 B-Gene +
. O +

Presenilin-1 B-Gene +
( O +
PS-1 B-Gene +
) O +
is O +
the O +
most O +
causative O +
Alzheimer O +
gene O +
product O +
, O +
and O +
its O +
function O +
is O +
not O +
well O +
understood O +
. O +

In O +
an O +
attempt O +
to O +
elucidate O +
the O +
function O +
of O +
PS-1 B-Gene +
, O +
we O +
screened O +
a O +
human O +
brain O +
cDNA O +
library O +
for O +
PS-1 B-Gene +
- O +
interacting O +
proteins O +
using O +
the O +
yeast O +
two O +
- O +
hybrid O +
system O +
and O +
isolated O +
a O +
novel O +
protein O +
containing O +
a O +
PSD B-Gene +
- I-Gene +
95 I-Gene +
/ O +
Dlg B-Gene +
/ O +
ZO-1 B-Gene +
( O +
PDZ O +
) O +
- O +
like O +
domain O +
. O +

This O +
novel O +
PS-1 B-Gene +
- I-Gene +
associated I-Gene +
protein I-Gene +
( O +
PSAP B-Gene +
) O +
shares O +
a O +
significant O +
similarity O +
with O +
a O +
Caenorhabditis O +
elegans O +
protein O +
of O +
unknown O +
function O +
. O +

Northern O +
blot O +
analysis O +
revealed O +
that O +
PSAP B-Gene +
is O +
predominantly O +
expressed O +
in O +
the O +
brain O +
. O +

Deletion O +
of O +
the O +
first O +
four O +
C O +
- O +
terminal O +
amino O +
acid O +
residues O +
of O +
PS-1 B-Gene +
, O +
which O +
contain O +
the O +
PDZ O +
domain O +
- O +
binding O +
motif O +
( O +
Gln O -
- O -
Phe O -
- O -
Tyr O -
- O -
Ile O +
) O +
, O +
reduced O +
the O +
binding O +
activity O +
of O +
PS-1 B-Gene +
toward O +
PSAP B-Gene +
4 O +
- O +
fold O +
. O +

These O +
data O +
suggest O +
that O +
PS-1 B-Gene +
may O +
associate O +
with O +
a O +
PDZ O +
- O +
like O +
domain O +
- O +
containing O +
protein O +
in O +
vivo O +
and O +
thus O +
may O +
participate O +
in O +
receptor O +
or O +
channel O +
clustering O +
and O +
intracellular O +
signaling O +
events O +
in O +
the O +
brain O +
. O +

Transmembrane O +
helix O +
M6 O +
in O +
sarco B-Gene +
( I-Gene +
endo I-Gene +
) I-Gene +
plasmic I-Gene +
reticulum I-Gene +
Ca I-Gene -
( I-Gene -
2+ I-Gene -
) I-Gene -
-ATPase I-Gene +
forms O +
a O +
functional O +
interaction O +
site O +
with O +
phospholamban B-Gene +
. O +

Evidence O +
for O +
physical O +
interactions O +
at O +
other O +
sites O +
. O +

In O +
an O +
earlier O +
study O +
( O +
Kimura O +
, O +
Y. O +
, O +
Kurzydlowski O +
, O +
K. O +
, O +
Tada O +
, O +
M. O +
, O +
and O +
MacLennan O +
, O +
D. O +
H. O +
( O +
1997 O +
) O +
J. O +
Biol O -
. O +
Chem O -
. O +
272 O +
, O +
15061 O +
- O +
15064 O +
) O +
, O +
mutation O +
of O +
amino O +
acids O +
on O +
one O +
face O +
of O +
the O +
phospholamban B-Gene +
( O +
PLN B-Gene +
) O +
transmembrane O +
helix O +
led O +
to O +
loss O +
of O +
PLN B-Gene +
inhibition O +
of O +
sarco B-Gene +
( I-Gene +
endo I-Gene +
) I-Gene +
plasmic I-Gene +
reticulum I-Gene +
Ca I-Gene -
( I-Gene -
2+ I-Gene -
) I-Gene -
-ATPase I-Gene +
( O +
SERCA B-Gene +
) O +
molecules O +
. O +

This O +
helical O +
face O +
was O +
proposed O +
to O +
form O +
a O +
site O +
of O +
PLN B-Gene +
interaction O +
with O +
a O +
transmembrane O +
helix O +
in O +
SERCA B-Gene +
molecules O +
. O +

To O +
determine O +
whether O +
predicted O +
transmembrane O +
helices O +
M4 O +
, O +
M5 O +
, O +
M6 O +
, O +
or O +
M8 O +
in O +
SERCA1a B-Gene +
interact O +
with O +
PLN B-Gene +
, O +
SERCA1a B-Gene +
mutants O +
were O +
co O +
- O +
expressed O +
with O +
wild O +
- O +
type O +
PLN B-Gene +
and O +
effects O +
on O +
Ca O -
( O -
2 O -
+ O -
) O +
dependence O +
of O +
Ca O -
( O -
2 O -
+ O -
) O +
transport O +
were O +
measured O +
. O +

Wild O +
- O +
type O +
inhibitory O +
interactions O +
shifted O +
apparent O +
Ca O -
( O -
2 O -
+ O -
) O +
affinity O +
of O +
SERCA1a B-Gene +
by O +
an O +
average O +
of O +
- O +
0.34 O +
pCa O +
units O +
, O +
but O +
four O +
of O +
the O +
seven O +
mutations O +
in O +
M4 O +
led O +
to O +
a O +
more O +
inhibitory O +
shift O +
in O +
apparent O +
Ca O -
( O -
2 O -
+ O -
) O +
affinity O +
, O +
averaging O +
- O +
0.53 O +
pCa O +
units O +
. O +

Seven O +
mutations O +
in O +
M5 O +
led O +
to O +
an O +
average O +
shift O +
of O +
- O +
0.32 O +
pCa O +
units O +
and O +
seven O +
mutations O +
in O +
M8 O +
led O +
to O +
an O +
average O +
shift O +
of O +
- O +
0.30 O +
pCa O +
units O +
. O +

Among O +
11 O +
mutations O +
in O +
M6 O +
, O +
1 O +
, O +
Q791A O +
, O +
increased O +
the O +
inhibitory O +
shift O +
( O +
- O +
0.59 O +
pCa O +
units O +
) O +
and O +
5 O +
, O +
V795A O +
( O -
-0.11 O +
) O +
, O +
L802A O +
( O +
- O +
0.07 O +
) O +
, O +
L802V O +
( O +
- O +
0.04 O +
) O +
, O +
T805A O +
( O +
- O +
0.11 O +
) O +
, O +
and O +
F809A O +
( O -
-0.12 O +
) O +
, O +
reduced O +
the O +
inhibitory O +
shift O +
, O +
consistent O +
with O +
the O +
view O +
that O +
Val O -
( O -
795 O -
) O +
, O +
Leu O -
( O -
802 O -
) O +
, O +
Thr O -
( O -
805 O -
) O +
, O +
and O +
Phe O -
( O -
809 O -
) O +
, O +
located O +
on O +
one O +
face O +
of O +
a O +
predicted O +
M6 O +
helix O +
, O +
form O +
a O +
site O +
in O +
SERCA1a B-Gene +
for O +
interaction O +
with O +
PLN B-Gene +
. O +

Those O +
mutations O +
in O +
M4 O +
, O +
M6 O +
, O +
or O +
M8 O +
of O +
SERCA1a B-Gene +
that O +
enhanced O +
PLN B-Gene +
inhibitory O +
function O +
did O +
not O +
enhance O +
PLN B-Gene +
physical O +
association O +
with O +
SERCA1a B-Gene +
, O +
but O +
mutants O +
V795A O +
and O +
L802A O +
in O +
M6 O +
, O +
which O +
decreased O +
PLN B-Gene +
inhibitory O +
function O +
, O +
decreased O +
physical O +
association O +
, O +
as O +
measured O +
by O +
co O +
- O +
immunoprecipitation O +
. O +

In O +
related O +
studies O +
, O +
those O +
PLN B-Gene +
mutants O +
that O +
gained O +
inhibitory O +
function O +
also O +
increased O +
levels O +
of O +
co O +
- O +
immunoprecipitation O +
of O +
wild O +
- O +
type O +
SERCA1a B-Gene +
and O +
those O +
that O +
lost O +
inhibitory O +
function O +
also O +
reduced O +
association O +
, O +
correlating O +
functional O +
interaction O +
sites O +
with O +
physical O +
interaction O +
sites O +
. O +

Thus O +
, O +
both O +
functional O +
and O +
physical O +
data O +
confirm O +
that O +
PLN B-Gene +
interacts O +
with O +
M6 O +
SERCA1a B-Gene +
. O +

Twelve O +
species O +
of O +
the O +
nucleoid O +
- O +
associated O +
protein O +
from O +
Escherichia O +
coli O +
. O +

Sequence O +
recognition O +
specificity O +
and O +
DNA O +
binding O +
affinity O +
. O +

The O +
genome O +
of O +
Escherichia O +
coli O +
is O +
composed O +
of O +
a O +
single O +
molecule O +
of O +
circular O +
DNA O +
with O +
the O +
length O +
of O +
about O +
47,000 O +
kilobase O +
pairs O +
, O +
which O +
is O +
associated O +
with O +
about O +
10 O +
major O +
DNA O +
- O +
binding O +
proteins O +
, O +
altogether O +
forming O +
the O +
nucleoid O +
. O +

We O +
expressed O +
and O +
purified O +
12 O +
species O +
of O +
the O +
DNA O +
- O +
binding O +
protein O +
, O +
i.e. O +
CbpA B-Gene +
( O +
curved B-Gene +
DNA I-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
A I-Gene +
) O +
, O +
CbpB B-Gene +
or O +
Rob B-Gene +
( O +
curved O +
DNA O +
- O +
binding O +
protein O +
B O +
or O +
right O +
arm O +
of O +
the O +
replication O +
origin O +
binding O +
protein O +
) O +
, O +
DnaA B-Gene +
( O +
DNA O +
- O +
binding O +
protein O +
A O +
) O +
, O +
Dps B-Gene +
( O +
DNA O +
- O +
binding O +
protein O +
from O +
starved O +
cells O +
) O +
, O +
Fis B-Gene +
( O +
factor B-Gene +
for I-Gene +
inversion I-Gene +
stimulation I-Gene +
) O +
, O +
Hfq B-Gene +
( O +
host O +
factor O +
for O +
phage O +
Q O -
( O -
beta O -
) O -
) O +
, O +
H B-Gene -
- I-Gene -
NS I-Gene +
( O +
histone O +
- O +
like O +
nucleoid O +
structuring O +
protein O +
) O +
, O +
HU B-Gene +
( O +
heat O +
- O +
unstable O +
nucleoid O +
protein O +
) O +
, O +
IciA B-Gene +
( O +
inhibitor B-Gene +
of I-Gene +
chromosome I-Gene +
initiation I-Gene +
A I-Gene +
) O +
, O +
IHF B-Gene +
( O +
integration B-Gene +
host I-Gene +
factor I-Gene +
) O +
, O +
Lrp B-Gene +
( O +
leucine B-Gene +
- I-Gene +
responsive I-Gene +
regulatory I-Gene +
protein I-Gene +
) O +
, O +
and O +
StpA B-Gene +
( O +
suppressor O +
of O +
td O +
( O +
- O +
) O +
phenotype O +
A O +
) O +
. O +

The O +
sequence O +
specificity O +
of O +
DNA O +
binding O +
was O +
determined O +
for O +
all O +
the O +
purified O +
nucleoid O +
proteins O +
using O +
gel O +
- O +
mobility O +
shift O +
assays O +
. O +

Five O +
proteins O +
( O +
CbpB B-Gene +
, O +
DnaA B-Gene +
, O +
Fis B-Gene +
, O +
IHF B-Gene +
, O +
and O +
Lrp B-Gene +
) O +
were O +
found O +
to O +
bind O +
to O +
specific O +
DNA O +
sequences O +
, O +
while O +
the O +
remaining O +
seven O +
proteins O +
( O +
CbpA B-Gene +
, O +
Dps B-Gene +
, O +
Hfq B-Gene +
, O +
H B-Gene -
- I-Gene -
NS I-Gene +
, O +
HU B-Gene +
, O +
IciA B-Gene +
, O +
and O +
StpA B-Gene +
) O +
showed O +
apparently O +
sequence O +
- O +
nonspecific O +
DNA O +
binding O +
activities O +
. O +

Four O +
proteins O +
, O +
CbpA B-Gene +
, O +
Hfq B-Gene +
, O +
H B-Gene -
- I-Gene -
NS I-Gene +
, O +
and O +
IciA B-Gene +
, O +
showed O +
the O +
binding O +
preference O +
for O +
the O +
curved O +
DNA O +
. O +

From O +
the O +
apparent O +
dissociation O +
constant O +
( O +
K O -
( O -
d O -
) O +
) O +
determined O +
using O +
the O +
sequence O +
- O +
specific O +
or O +
nonspecific O +
DNA O +
probes O +
, O +
the O +
order O +
of O +
DNA O +
binding O +
affinity O +
were O +
determined O +
to O +
be O +
: O +
HU B-Gene +
> O +
IHF B-Gene +
> O +
Lrp B-Gene +
> O +
CbpB B-Gene +
( O +
Rob B-Gene +
) O +
> O +
Fis B-Gene +
> O +
H B-Gene -
- I-Gene -
NS I-Gene +
> O +
StpA B-Gene +
> O +
CbpA B-Gene +
> O +
IciA B-Gene +
> O +
Hfq B-Gene +
/ O +
Dps B-Gene +
, O +
ranging O +
from O +
25 O +
nM O +
( O +
HU B-Gene +
binding O +
to O +
the O +
non O +
- O +
curved O +
DNA O +
) O +
to O +
250 O +
nM O +
( O +
Hfq B-Gene +
binding O +
to O +
the O +
non O +
- O +
curved O +
DNA O +
) O +
, O +
under O +
the O +
assay O +
conditions O +
employed O +
. O +

Differing O +
susceptibility O +
of O +
echocardiographic O +
contrast O +
agents O +
to O +
adverse O +
effects O +
of O +
biologic O +
factors O +
: O +
multicenter O +
, O +
videodensitometric O +
comparison O +
of O +
octafluoropropane O +
- O +
filled O +
microspheres O +
with O +
air O +
- O +
filled O +
microspheres O +
for O +
left O +
ventricular O +
opacification O +
. O +

BACKGROUND O +
: O +

Echocardiographic O +
contrast O +
enhancement O +
of O +
the O +
left O +
ventricle O +
has O +
diagnostic O +
value O +
in O +
the O +
assessment O +
of O +
regional O +
and O +
global O +
left O +
ventricular O +
( O +
LV O +
) O +
function O +
. O +

The O +
efficacy O +
of O +
both O +
octafluoropropane O +
- O +
filled O +
human O +
albumin B-Gene +
microbubbles O +
( O +
OCTA O +
) O +
and O +
of O +
air O +
- O +
filled O +
human O +
albumin B-Gene +
microbubbles O +
( O +
AIR O +
) O +
for O +
LV O +
endocardial O +
delineation O +
and O +
qualitative O +
LV O +
opacification O +
has O +
previously O +
been O +
reported O +
. O +

However O +
, O +
pulmonary O +
disease O +
, O +
obesity O +
, O +
impaired O +
LV O +
function O +
, O +
and O +
decreased O +
echogenicity O +
may O +
diminish O +
the O +
efficacy O +
of O +
contrast O +
agents O +
for O +
LV O +
opacification O +
. O +

The O +
purpose O +
of O +
this O +
study O +
was O +
to O +
compare O +
the O +
susceptibility O +
of O +
2 O +
contrast O +
agents O +
currently O +
approved O +
by O +
the O +
Food O +
and O +
Drug O +
Administration O +
to O +
these O +
biologic O +
factors O +
. O +

METHODS O +
: O +

To O +
compare O +
quantitative O +
LV O +
opacification O +
with O +
OCTA O +
( O +
0.2 O +
, O +
0 O -
. O +
5 O +
, O +
3.0 O +
, O +
5.0 O +
mL O +
) O +
versus O +
AIR O +
( O +
0.08 O +
mL O +
/ O +
kg O +
, O +
0.22 O +
mL O +
/ O +
kg O +
) O +
, O +
we O +
performed O +
videodensitometry O +
in O +
199 O +
patients O +
( O +
average O +
age O +
59.2 O +
+ O -
/- O +
13.3 O +
years O +
, O +
79 O +
% O +
men O +
) O +
studied O +
in O +
2 O +
identical O +
, O +
prospective O +
, O +
multicenter O +
, O +
blinded O +
trials O +
, O +
of O +
whom O +
74 O +
had O +
impaired O +
LV O +
function O +
, O +
pulmonary O +
disease O +
, O +
or O +
both O +
, O +
70 O +
were O +
obese O +
( O +
body O +
mass O +
index O +
> O +
30 O +
kg O +
/ O +
m O -
( O -
2 O -
) O +
) O +
, O +
and O +
45 O +
were O +
nonechogenic O +
( O +
> O +
/ O +
= O +
4 O +
of O +
6 O +
endocardial O +
segments O +
were O +
not O +
seen O +
in O +
the O +
apical O +
4-chamber O +
view O +
) O +
. O +

Changes O +
in O +
videodensity O +
from O +
noncontrast O +
to O +
contrast O +
agent O +
with O +
the O +
same O +
gain O +
settings O +
were O +
determined O +
at O +
end O +
diastole O +
and O +
end O +
systole O +
( O +
gray O +
scale O +
0 O +
to O +
255 O +
U O +
) O +
for O +
2 O +
regions O +
of O +
interest O +
: O +
left O +
ventricle O +
apex O +
- O +
to O +
- O +
mid O +
- O +
cavity O +
and O +
mid O +
- O +
cavity O +
- O +
to O +
- O +
base O +
. O +

The O +
relative O +
influence O +
of O +
clinically O +
evident O +
pulmonary O +
disease O +
, O +
impaired O +
LV O +
function O +
on O +
echocardiography O +
, O +
and O +
echogenicity O +
on O +
LV O +
opacification O +
produced O +
by O +
both O +
contrast O +
agents O +
was O +
determined O +
by O +
multivariate O +
analysis O +
. O +

RESULTS O +
: O +

Significant O +
videodensity O +
increases O +
ranging O +
from O +
67 O +
% O +
to O +
143 O +
% O +
were O +
observed O +
with O +
both O +
agents O +
. O +

At O +
the O +
recommended O +
initial O +
doses O +
( O +
0.5 O +
mL O +
for O +
OCTA O +
, O +
0.22 O +
mL O +
/ O +
kg O +
for O +
AIR O +
) O +
, O +
OCTA O +
produced O +
greater O +
opacification O +
than O +
AIR O +
in O +
both O +
regions O +
of O +
interest O +
and O +
at O +
both O +
phases O +
of O +
the O +
cardiac O +
cycle O +
. O +

Poor O +
LV O +
function O +
was O +
associated O +
with O +
decreased O +
LV O +
opacification O +
for O +
AIR O +
but O +
not O +
for O +
OCTA O +
. O +

Diminished O +
echogenicity O +
was O +
more O +
strongly O +
associated O +
with O +
impaired O +
opacification O +
for O +
AIR O +
than O +
for O +
OCTA O +
. O +

Obesity O +
and O +
clinically O +
evident O +
pulmonary O +
disease O +
were O +
associated O +
with O +
diminished O +
chamber O +
opacification O +
with O +
both O +
OCTA O +
and O +
AIR O +
. O +

CONCLUSIONS O +
: O +

In O +
addition O +
to O +
the O +
superiority O +
of O +
octafluoropropane O +
- O +
filled O +
microspheres O +
to O +
air O +
- O +
filled O +
microspheres O +
for O +
LV O +
opacification O +
, O +
the O +
efficacy O +
of O +
OCTA O +
is O +
relatively O +
unaffected O +
by O +
impaired O +
LV O +
function O +
and O +
is O +
less O +
susceptible O +
to O +
the O +
effects O +
of O +
poor O +
echogenicity O +
than O +
AIR O +
. O +

Radiographic O +
joint O +
space O +
in O +
rheumatoid O +
acromioclavicular O +
joints O +
: O +
a O +
15 O +
year O +
prospective O +
follow O +
- O +
up O +
study O +
in O +
74 O +
patients O +
. O +

OBJECTIVE O +
: O +

To O +
evaluate O +
radiographically O +
the O +
acromioclavicular O +
joint O +
space O +
in O +
patients O +
with O +
long O +
- O +
term O +
rheumatoid O +
arthritis O +
( O +
RA O +
) O +
. O +

METHODS O +
: O +

A O +
cohort O +
of O +
74 O +
patients O +
with O +
RA O +
was O +
followed O +
prospectively O +
for O +
15 O +
yr O +
. O +

At O +
the O +
end O +
point O +
, O +
148 O +
shoulders O +
were O +
radiographed O +
with O +
a O +
standard O +
method O +
. O +

The O +
acromioclavicular O +
( O +
AC O +
) O +
joint O +
space O +
was O +
examined O +
from O +
the O +
radiographs O +
with O +
a O +
method O +
developed O +
previously O +
for O +
population O +
studies O +
; O +
the O +
joint O +
space O +
was O +
measured O +
at O +
its O +
superior O +
and O +
inferior O +
border O +
, O +
and O +
the O +
average O +
of O +
the O +
two O +
measurements O +
, O +
the O +
integral O +
space O +
, O +
calculated O +
. O +

RESULTS O +
: O +

Mean O +
AC O +
joint O +
space O +
in O +
RA O +
patients O +
was O +
4.9 O +
( O +
S.D. O +
3.7 O +
) O +
, O +
range O +
0 O +
- O +
20.5 O +
mm O +
; O +
6.2 O +
mm O +
( O +
S.D. O +
5.1 O +
) O +
in O +
men O +
and O +
4.5 O +
mm O +
( O +
S.D. O +
3 O -
. O +
0 O +
) O +
in O +
women O +
. O +

An O +
AC O +
joint O +
space O +
wider O +
than O +
7 O +
mm O +
in O +
men O +
was O +
found O +
in O +
11 O +
( O +
31 O +
% O +
) O +
out O +
of O +
36 O +
joints O +
and O +
wider O +
than O +
6 O +
mm O +
in O +
women O +
in O +
17 O +
( O +
15 O +
% O +
) O +
out O +
of O +
112 O +
joints O +
. O +

Joint O +
space O +
widening O +
was O +
associated O +
( O +
r O +
= O +
0.87 O +
, O +
95 O +
% O +
CI O +
0.82 O +
- O +
0.90 O +
) O +
with O +
increasing O +
destruction O +
( O +
Larsen O +
grading O +
) O +
of O +
the O +
joint O +
and O +
it O +
seems O +
to O +
be O +
an O +
inevitable O +
consequence O +
of O +
AC O +
joint O +
affection O +
in O +
RA O +
. O +

Joint O +
space O +
widening O +
is O +
more O +
progressive O +
on O +
the O +
caudal O +
side O +
because O +
of O +
the O +
nature O +
of O +
the O +
erosive O +
destruction O +
. O +

Degeneration O +
with O +
joint O +
space O +
narrowing O +
was O +
observed O +
in O +
8 O +
( O +
11 O +
% O +
) O +
patients O +
( O +
11 O +
joints O +
, O +
7 O +
% O +
; O +
three O +
bilateral O +
) O +
. O +

CONCLUSIONS O +
: O +

The O +
largest O +
value O +
of O +
the O +
joint O +
space O +
may O +
be O +
used O +
when O +
evaluating O +
rheumatoid O +
AC O +
joint O +
space O +
. O +

In O +
RA O +
patients O +
, O +
a O +
joint O +
space O +
of O +
> O +
7 O +
mm O +
in O +
men O +
and O +
> O +
5 O +
mm O +
in O +
women O +
is O +
a O +
sign O +
of O +
destructive O +
AC O +
joint O +
affection O +
. O +

Structure O +
and O +
transcriptional O +
control O +
of O +
the O +
flagellar O +
master O +
operon O +
of O +
Salmonella O +
typhimurium O +
. O +

The O +
flhD B-Gene +
and O +
flhC B-Gene +
genes O +
constitute O +
the O +
flagellar O +
master O +
operon O +
whose O +
products O +
are O +
required O +
for O +
expression O +
of O +
all O +
the O +
remaining O +
flagellar O +
operons O +
in O +
Salmonella O +
typhimurium O +
. O +

Here O +
we O +
report O +
the O +
molecular O +
structure O +
and O +
in O +
vivo O +
and O +
in O +
vitro O +
expression O +
of O +
the O +
flhD B-Gene +
operon I-Gene +
. O +

Nucleotide O +
sequence O +
analysis O +
revealed O +
that O +
the O +
upstream O +
region O +
of O +
this O +
operon O +
contains O +
the O +
consensus O +
sequence O +
for O +
the O +
cAMP O +
- O +
CRP B-Gene +
binding O +
site O +
. O +

Primer O +
extension O +
analysis O +
demonstrated O +
six O +
possible O +
transcription O +
start O +
sites O +
for O +
this O +
operon O +
. O +

They O +
include O +
CRP B-Gene +
- O +
dependent O +
and O +
CRP B-Gene +
- O +
repressible O +
transcription O +
start O +
sites O +
. O +

The O +
CRP B-Gene +
- O +
dependent O +
transcription O +
start O +
site O +
is O +
located O +
203 O +
bp O +
upstream O +
of O +
the O +
initiation O +
codon O +
of O +
the O +
flhD B-Gene +
gene O +
and O +
preceded O +
by O +
the O +
consensus O +
sequences O +
of O +
the O +
- O +
10 O +
and O +
- O +
35 O +
regions O +
of O +
the O +
sigma B-Gene +
70 I-Gene +
- O +
dependent O +
promoter O +
. O +

The O +
putative O +
cAMP O +
- O +
CRP B-Gene +
binding O +
site O +
is O +
located O +
centered O +
70 O +
bp O +
upstream O +
of O +
this O +
start O +
site O +
. O +

The O +
CRP B-Gene +
- O +
repressible O +
transcription O +
start O +
site O +
is O +
located O +
within O +
this O +
putative O +
cAMP O +
- O +
CRP B-Gene +
binding O +
site O +
. O +

These O +
two O +
start O +
sites O +
were O +
confirmed O +
by O +
in O +
vitro O +
transcription O +
experiments O +
using O +
sigma B-Gene +
70 I-Gene +
- O +
RNA B-Gene +
polymerase I-Gene +
with O +
or O +
without O +
cAMP O +
- O +
CRP B-Gene +
. O +

Reaction O +
mechanism O +
of O +
recombinant O +
3-oxoacyl- B-Gene -
( I-Gene -
acyl I-Gene -
- I-Gene -
carrier I-Gene -
- I-Gene -
protein I-Gene +
) I-Gene +
synthase I-Gene +
III I-Gene +
from O +
Cuphea O +
wrightii O +
embryo O +
, O +
a O +
fatty B-Gene +
acid I-Gene +
synthase I-Gene +
type I-Gene +
II I-Gene +
condensing O +
enzyme O +
. O +

A O +
unique O +
feature O +
of O +
fatty B-Gene +
acid I-Gene +
synthase I-Gene +
( I-Gene +
FAS I-Gene +
) I-Gene +
type I-Gene +
II I-Gene +
of O +
higher O +
plants O +
and O +
bacteria O +
is O +
3-oxoacyl- B-Gene -
[ I-Gene -
acyl I-Gene -
- I-Gene -
carrier I-Gene -
- I-Gene -
protein I-Gene +
( I-Gene +
ACP I-Gene +
) I-Gene +
] I-Gene +
synthase I-Gene +
III I-Gene +
( O +
KAS B-Gene +
III I-Gene +
) O +
, O +
which O +
catalyses O +
the O +
committing O +
condensing O +
reaction O +
. O +

Working O +
with O +
KAS B-Gene +
IIIs I-Gene +
from O +
Cuphea O +
seeds O +
we O +
obtained O +
kinetic O +
evidence O +
that O +
KAS B-Gene +
III I-Gene +
catalysis O +
follows O +
a O +
Ping O +
- O +
Pong O +
mechanism O +
and O +
that O +
these O +
enzymes O +
have O +
substrate O +
- O +
binding O +
sites O +
for O +
acetyl O -
- O -
CoA O +
and O +
malonyl O +
- O +
ACP O +
. O +

It O +
was O +
the O +
aim O +
of O +
the O +
present O +
study O +
to O +
identify O +
these O +
binding O +
sites O +
and O +
to O +
elucidate O +
the O +
catalytic O +
mechanism O +
of O +
recombinant O +
Cuphea O +
wrightii O +
KAS B-Gene +
III I-Gene +
, O +
which O +
we O +
expressed O +
in O +
Escherichia O +
coli O +
. O +

We O +
engineered O +
mutants O +
, O +
which O +
allowed O +
us O +
to O +
dissect O +
the O +
condensing O +
reaction O +
into O +
three O +
stages O +
, O +
i.e. O +
formation O +
of O +
acyl O -
- O -
enzyme O +
, O +
decarboxylation O +
of O +
malonyl O -
- O -
ACP O +
, O +
and O +
final O +
Claisen O +
condensation O +
. O +

Incubation O +
of O +
recombinant O +
enzyme O +
with O +
[ O -
1- O -
( O -
14 O -
) O -
C O -
] O -
acetyl O -
- O -
CoA O -
- O -
labelled O +
Cys O -
( O -
111 O -
) O +
, O +
and O +
the O +
replacement O +
of O +
this O +
residue O +
by O +
Ala O +
and O +
Ser O +
resulted O +
in O +
loss O +
of O +
overall O +
condensing O +
activity O +
. O +

The O +
Cys O +
( O +
111 O +
) O +
Ser O +
mutant O +
, O +
however O +
, O +
still O +
was O +
able O +
to O +
bind O +
acetyl O -
- O -
CoA O +
and O +
to O +
catalyse O +
subsequent O +
binding O +
and O +
decarboxylation O +
of O +
malonyl O +
- O +
ACP O +
to O +
acetyl O +
- O +
ACP O +
. O +

We O +
replaced O +
His O -
( O -
261 O -
) O +
with O +
Ala O +
and O +
Arg O +
and O +
found O +
that O +
the O +
former O +
lost O +
activity O +
, O +
whereas O +
the O +
latter O +
retained O +
overall O +
condensing O +
activity O +
, O +
which O +
indicated O +
a O +
general O +
- O +
base O +
action O +
of O +
His O +
( O +
261 O +
) O +
. O +

Double O +
mutants O +
Cys O -
( O -
111 O -
) O +
Ser O +
/ O +
His O -
( O -
261 O -
) O +
Ala O +
and O +
Cys O -
( O -
111 O -
) O +
Ser O +
/ O +
His O -
( O -
261 O -
) O +
Arg O +
were O +
not O +
able O +
to O +
catalyse O +
overall O +
condensation O +
, O +
but O +
the O +
double O +
mutant O +
containing O +
Arg O +
induced O +
decarboxylation O +
of O +
[ O -
2- O -
( O -
14 O -
) O -
C O -
] O -
malonyl O -
- O -
ACP O +
, O +
a O +
reaction O +
indicating O +
the O +
role O +
of O +
His O -
( O -
261 O -
) O +
in O +
general O +
- O +
acid O +
catalysis O +
. O +

Finally O +
, O +
alanine O +
scanning O +
revealed O +
the O +
involvement O +
of O +
Arg O +
( O +
150 O +
) O +
and O +
Arg O -
( O -
306 O -
) O +
in O +
KAS B-Gene +
III I-Gene +
catalysis O +
. O +

The O +
results O +
offer O +
for O +
the O +
first O +
time O +
a O +
detailed O +
mechanism O +
for O +
a O +
condensing O +
reaction O +
catalysed O +
by O +
a O +
FAS B-Gene +
type I-Gene +
II I-Gene +
condensing O +
enzyme O +
. O +

Genetic O +
analysis O +
of O +
a O +
chromosomal O +
region O +
containing O +
genes O +
required O +
for O +
assimilation O +
of O +
allantoin O +
nitrogen O +
and O +
linked O +
glyoxylate O +
metabolism O +
in O +
Escherichia O +
coli O +
. O +

Growth O +
experiments O +
with O +
Escherichia O +
coli O +
have O +
shown O +
that O +
this O +
organism O +
is O +
able O +
to O +
use O +
allantoin O +
as O +
a O +
sole O +
nitrogen O +
source O +
but O +
not O +
as O +
a O +
sole O +
carbon O +
source O +
. O +

Nitrogen O +
assimilation O +
from O +
this O +
compound O +
was O +
possible O +
only O +
under O +
anaerobic O +
conditions O +
, O +
in O +
which O +
all O +
the O +
enzyme O +
activities O +
involved O +
in O +
allantoin O +
metabolism O +
were O +
detected O +
. O +

Of O +
the O +
nine O +
genes O +
encoding O +
proteins O +
required O +
for O +
allantoin O +
degradation O +
, O +
only O +
the O +
one O +
encoding O +
glyoxylate B-Gene +
carboligase I-Gene +
( O +
gcl B-Gene +
) O +
, O +
the O +
first O +
enzyme O +
of O +
the O +
pathway O +
leading O +
to O +
glycerate O +
, O +
had O +
been O +
identified O +
and O +
mapped O +
at O +
centisome O +
12 O +
on O +
the O +
chromosome O +
map O +
. O +

Phenotypic O +
complementation O +
of O +
mutations O +
in O +
the O +
other O +
two O +
genes O +
of O +
the O +
glycerate O +
pathway O +
, O +
encoding O +
tartronic B-Gene +
semialdehyde I-Gene +
reductase I-Gene +
( O +
glxR B-Gene +
) O +
and O +
glycerate B-Gene +
kinase I-Gene +
( O +
glxK B-Gene +
) O +
, O +
allowed O +
us O +
to O +
clone O +
and O +
map O +
them O +
closely O +
linked O +
to O +
gcl B-Gene +
. O +

Complete O +
sequencing O +
of O +
a O +
15.8 O +
- O +
kb O +
fragment O +
encompassing O +
these O +
genes O +
defined O +
a O +
regulon O +
with O +
12 O +
open O +
reading O +
frames O +
( O +
ORFs O +
) O +
. O +

Due O +
to O +
the O +
high O +
similarity O +
of O +
the O +
products O +
of O +
two O +
of O +
these O +
ORFs O +
with O +
yeast O +
allantoinase B-Gene +
and O +
yeast O +
allantoate B-Gene +
amidohydrolase I-Gene +
, O +
a O +
systematic O +
analysis O +
of O +
the O +
gene O +
cluster O +
was O +
undertaken O +
to O +
identify O +
genes O +
involved O +
in O +
allantoin O +
utilization O +
. O +

A O +
BLASTP O +
search O +
predicted O +
four O +
of O +
the O +
genes O +
that O +
we O +
sequenced O +
to O +
encode O +
allantoinase B-Gene +
( O +
allB B-Gene +
) O +
, O +
allantoate B-Gene +
amidohydrolase I-Gene +
( O +
allC B-Gene +
) O +
, O +
ureidoglycolate B-Gene +
hydrolase I-Gene +
( O +
allA B-Gene +
) O +
, O +
and O +
ureidoglycolate B-Gene +
dehydrogenase I-Gene +
( O +
allD B-Gene +
) O +
. O +

The O +
products O +
of O +
these O +
genes O +
were O +
overexpressed O +
and O +
shown O +
to O +
have O +
the O +
predicted O +
corresponding O +
enzyme O +
activities O +
. O +

Transcriptional O +
fusions O +
to O +
lacZ B-Gene +
permitted O +
the O +
identification O +
of O +
three O +
functional O +
promoters O +
corresponding O +
to O +
three O +
transcriptional O +
units O +
for O +
the O +
structural O +
genes O +
and O +
another O +
promoter O +
for O +
the O +
regulatory O +
gene O +
allR B-Gene +
. O +

Deletion O +
of O +
this O +
regulatory O +
gene O +
led O +
to O +
constitutive O +
expression O +
of O +
the O +
regulon O +
, O +
indicating O +
a O +
negatively O +
acting O +
function O +
. O +

Cloning O +
, O +
expression O +
, O +
and O +
fatty O +
acid O +
regulation O +
of O +
the O +
human O +
delta-5 B-Gene +
desaturase I-Gene +
. O +

Arachidonic O +
( O +
20:4 O -
( O -
n-6 O +
) O +
) O +
, O +
eicosapentaenoic O +
( O +
20 O +
: O +
5 O -
( O -
n-3 O +
) O +
) O +
, O +
and O +
docosahexaenoic O +
( O +
22 O +
: O +
6 O -
( O -
n-3 O +
) O +
) O +
acids O +
are O +
major O +
components O +
of O +
brain O +
and O +
retina O +
phospholipids O +
, O +
substrates O +
for O +
eicosanoid O +
production O +
, O +
and O +
regulators O +
of O +
nuclear O +
transcription B-Gene +
factors I-Gene +
. O +

One O +
of O +
the O +
two O +
rate O +
- O +
limiting O +
steps O +
in O +
the O +
production O +
of O +
these O +
polyenoic O +
fatty O +
acids O +
is O +
the O +
desaturation O +
of O +
20:3 O -
( O -
n-6 O +
) O +
and O +
20 O +
: O +
4 O -
( O -
n-3 O +
) O +
by O +
Delta-5 B-Gene +
desaturase I-Gene +
. O +

This O +
report O +
describes O +
the O +
cloning O +
and O +
expression O +
of O +
the O +
human O +
Delta-5 B-Gene +
desaturase I-Gene +
, O +
and O +
it O +
compares O +
the O +
structural O +
characteristics O +
and O +
nutritional O +
regulation O +
of O +
the O +
Delta-5 B-Gene +
and I-Gene +
Delta-6 I-Gene +
desaturases I-Gene +
. O +

The O +
open O +
reading O +
frame O +
of O +
the O +
human O +
Delta-5 B-Gene +
desaturase I-Gene +
encodes O +
a O +
444 O +
- O +
amino O +
acid O +
peptide O +
which O +
is O +
identical O +
in O +
size O +
to O +
the O +
Delta-6 B-Gene +
desaturase I-Gene +
and O +
which O +
shares O +
61 O +
% O +
identity O +
with O +
the O +
human O +
Delta-6 B-Gene +
desaturase I-Gene +
. O +

The O +
Delta-5 B-Gene +
desaturase I-Gene +
contains O +
two O +
membrane O +
- O +
spanning O +
domains O +
, O +
three O +
histidine O +
- O +
rich O +
regions O +
, O +
and O +
a O +
cytochrome O +
b O -
( O -
5 O -
) O +
domain O +
that O +
all O +
align O +
perfectly O +
with O +
the O +
same O +
domains O +
located O +
in O +
the O +
Delta B-Gene +
- I-Gene +
6 I-Gene +
desaturase I-Gene +
. O +

Expression O +
of O +
the O +
open O +
reading O +
frame O +
in O +
Chinese O +
hamster O +
ovary O +
cells O +
instilled O +
the O +
ability O +
to O +
convert O +
20 O +
: O +
3 O -
( O -
n-6 O +
) O +
to O +
20 O +
: O +
4 O -
( O -
n-6 O +
) O +
. O +

Northern O +
analysis O +
revealed O +
that O +
many O +
human O +
tissues O +
including O +
skeletal O +
muscle O +
, O +
lung O +
, O +
placenta O +
, O +
kidney O +
, O +
and O +
pancreas O +
expressed O +
Delta-5 B-Gene +
desaturase I-Gene +
mRNA O +
, O +
but O +
Delta B-Gene +
- I-Gene +
5 I-Gene +
desaturase I-Gene +
was O +
most O +
abundant O +
in O +
the O +
liver O +
, O +
brain O +
, O +
and O +
heart O +
. O +

However O +
, O +
in O +
all O +
tissues O +
, O +
the O +
abundance O +
of O +
Delta-5 B-Gene +
desaturase I-Gene +
mRNA O +
was O +
much O +
lower O +
than O +
that O +
observed O +
for O +
the O +
Delta B-Gene +
- I-Gene +
6 I-Gene +
desaturase I-Gene +
. O +

When O +
rats O +
were O +
fed O +
a O +
diet O +
containing O +
10 O +
% O +
safflower O +
oil O +
or O +
menhaden O +
fish O +
oil O +
, O +
the O +
level O +
of O +
hepatic O +
mRNA O +
for O +
Delta-5 B-Gene +
and I-Gene +
Delta-6 I-Gene +
desaturase I-Gene +
was O +
only O +
25 O +
% O +
of O +
that O +
found O +
in O +
the O +
liver O +
of O +
rats O +
fed O +
a O +
fat O +
- O +
free O +
diet O +
or O +
a O +
diet O +
containing O +
triolein O +
. O +

Finally O +
, O +
a O +
BLAST O +
and O +
Genemap O +
search O +
of O +
the O +
human O +
genome O +
revealed O +
that O +
the O +
Delta-5 B-Gene +
and I-Gene +
Delta-6 I-Gene +
desaturase I-Gene +
genes O +
reside O +
in O +
reverse O +
orientation O +
on O +
chromosome O +
11 O +
and O +
that O +
they O +
are O +
separated O +
by O +
< O +
11,000 O +
base O +
pairs O +
. O +

Identification O +
and O +
characterization O +
of O +
an O +
active O +
plasmid O +
partition O +
mechanism O +
for O +
the O +
novel O +
Lactococcus O +
lactis O +
plasmid O +
pCI2000 O +
. O +

The O +
replication O +
region O +
of O +
the O +
lactococcal O +
plasmid O +
pCI2000 O +
was O +
subcloned O +
and O +
analyzed O +
. O +

The O +
nucleotide O +
sequence O +
of O +
one O +
5.6 O +
- O +
kb O +
EcoRI B-Gene +
fragment O +
which O +
was O +
capable O +
of O +
supporting O +
replication O +
when O +
cloned O +
on O +
a O +
replication O +
probe O +
vector O +
revealed O +
the O +
presence O +
of O +
seven O +
putative O +
open O +
reading O +
frames O +
( O +
ORFs O +
) O +
. O +

One O +
ORF O +
exhibited O +
significant O +
homology O +
to O +
several O +
replication O +
proteins O +
from O +
plasmids O +
considered O +
to O +
replicate O +
via O +
a O +
theta O +
mode O +
. O +

Deletion O +
analysis O +
showed O +
that O +
this O +
ORF O +
, O +
designated O +
repA B-Gene +
, O +
is O +
indeed O +
required O +
for O +
replication O +
. O +

The O +
results O +
also O +
suggest O +
that O +
the O +
origin O +
of O +
replication O +
is O +
located O +
outside O +
repA B-Gene +
. O +

Upstream O +
and O +
divergently O +
transcribed O +
from O +
repA B-Gene +
, O +
an O +
ORF O +
that O +
showed O +
significant O +
( O +
48 O +
to O +
64 O +
% O +
) O +
homology O +
to O +
a O +
number O +
of O +
proteins O +
that O +
are O +
required O +
for O +
faithful O +
segregation O +
of O +
chromosomal O +
or O +
plasmid O +
DNA O +
of O +
gram O +
- O +
negative O +
bacteria O +
was O +
identified O +
. O +

Gene O +
interruption O +
and O +
transcomplementation O +
experiments O +
showed O +
that O +
this O +
ORF O +
, O +
designated O +
parA B-Gene +
, O +
is O +
required O +
for O +
stable O +
inheritance O +
of O +
pCI2000 O +
and O +
is O +
active O +
in O +
trans O +
. O +

This O +
is O +
the O +
first O +
example O +
of O +
such O +
a O +
partitioning O +
mechanism O +
for O +
plasmids O +
in O +
gram O +
- O +
positive O +
bacteria O +
. O +

Structural O +
interactions O +
of O +
fibroblast B-Gene +
growth I-Gene +
factor I-Gene +
receptor I-Gene +
with O +
its O +
ligands O +
. O +

Fibroblast B-Gene +
growth I-Gene +
factors I-Gene +
( O +
FGFs B-Gene +
) O +
effect O +
cellular O +
responses O +
by O +
binding O +
to O +
FGF B-Gene +
receptors I-Gene +
( O +
FGFRs B-Gene +
) O +
. O +

FGF B-Gene +
bound O +
to O +
extracellular O +
domains O +
on O +
the O +
FGFR B-Gene +
in O +
the O +
presence O +
of O +
heparin O +
activates O +
the O +
cytoplasmic O +
receptor B-Gene +
tyrosine I-Gene +
kinase I-Gene +
through O +
autophosphorylation O +
. O +

We O +
have O +
crystallized O +
a O +
complex O +
between O +
human O +
FGF1 B-Gene +
and O +
a O +
two O +
- O +
domain O +
extracellular O +
fragment O +
of O +
human O +
FGFR2 B-Gene +
. O +

The O +
crystal O +
structure O +
, O +
determined O +
by O +
multiwavelength O +
anomalous O +
diffraction O +
analysis O +
of O +
the O +
selenomethionyl O +
protein O +
, O +
is O +
a O +
dimeric O +
assemblage O +
of O +
1 O +
: O +
1 O +
ligand O +
: O +
receptor O +
complexes O +
. O +

FGF B-Gene +
is O +
bound O +
at O +
the O +
junction O +
between O +
the O +
two O +
domains O +
of O +
one O +
FGFR B-Gene +
, O +
and O +
two O +
such O +
units O +
are O +
associated O +
through O +
receptor O +
: O +
receptor O +
and O +
secondary O +
ligand O +
: O +
receptor O +
interfaces O +
. O +

Sulfate O +
ion O +
positions O +
appear O +
to O +
mark O +
the O +
course O +
of O +
heparin O +
binding O +
between O +
FGF B-Gene +
molecules O +
through O +
a O +
basic O +
region O +
on O +
receptor O +
D2 O +
domains O +
. O +

This O +
dimeric O +
assemblage O +
provides O +
a O +
structural O +
mechanism O +
for O +
FGF B-Gene +
signal O +
transduction O +
. O +

Regulation O +
of O +
HMG B-Gene -
- I-Gene -
CoA I-Gene +
synthase I-Gene +
and O +
HMG B-Gene -
- I-Gene -
CoA I-Gene +
reductase I-Gene +
by O +
insulin B-Gene +
and O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
in O +
HaCaT O +
keratinocytes O +
. O +

Synthesis O +
of O +
cholesterol O +
, O +
via O +
the O +
isoprenoid O +
/ O +
mevalonate O +
pathway O +
, O +
is O +
required O +
for O +
keratinocyte O +
growth O +
and O +
differentiation O +
, O +
and O +
maintenance O +
of O +
the O +
stratum O +
corneum O +
lipid O +
lamellae O +
. O +

3-hydroxy-3-methylglutaryl B-Gene +
coenzyme I-Gene +
A I-Gene +
synthase I-Gene +
catalyzes O +
the O +
first O +
step O +
in O +
isoprenoid O +
/ O +
mevalonate O +
synthesis O +
and O +
under O +
some O +
conditions O +
controls O +
the O +
flux O +
into O +
the O +
pathway O +
. O +

We O +
have O +
investigated O +
whether O +
selected O +
growth B-Gene +
factors I-Gene +
and O +
hormones O +
could O +
increase O +
3-hydroxy-3-methylglutaryl B-Gene +
coenzyme I-Gene +
A I-Gene +
synthase I-Gene +
mRNA O +
in O +
keratinocytes O +
. O +

Northern O +
blotting O +
was O +
used O +
to O +
demonstrate O +
that O +
10 O +
microg O +
per O +
ml O +
insulin B-Gene +
and O +
0.1 O +
microg O +
per O +
ml O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
both O +
increased O +
steady O +
- O +
state O +
levels O +
of O +
3-hydroxy-3-methylglutaryl B-Gene +
coenzyme I-Gene +
A I-Gene +
synthase I-Gene +
mRNA O +
by O +
2.5 O +
and O +
6 O +
- O +
fold O +
, O +
respectively O +
. O +

Epidermal B-Gene +
growth I-Gene +
factor I-Gene +
and O +
insulin B-Gene +
also O +
increased O +
3-hydroxy-3-methylglutaryl B-Gene +
coenzyme I-Gene +
A I-Gene +
reductase I-Gene +
enzyme O +
activity O +
. O +

3-hydroxy-3-methylglutaryl B-Gene +
coenzyme I-Gene +
A I-Gene +
synthase I-Gene +
promoter O +
activity O +
in O +
a O +
luciferase B-Gene +
reporter O +
construct O +
was O +
increased O +
2 O +
- O +
fold O +
by O +
insulin B-Gene +
and O +
2.9 O +
- O +
fold O +
by O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
. O +

When O +
a O +
mutation O +
in O +
the O +
sterol O +
regulatory O +
element O +
was O +
introduced O +
into O +
the O +
3-hydroxy-3-methylglutaryl B-Gene +
coenzyme I-Gene +
A I-Gene +
synthase I-Gene +
promoter O +
, O +
activity O +
was O +
not O +
increased O +
by O +
insulin B-Gene +
, O +
but O +
was O +
increased O +
by O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
. O +

Mutation O +
of O +
an O +
AP-1 B-Gene +
site O +
in O +
the O +
3-hydroxy-3-methylglutaryl B-Gene +
coenzyme I-Gene +
A I-Gene +
synthase I-Gene +
promoter O +
did O +
not O +
affect O +
the O +
increase O +
in O +
activity O +
following O +
treatment O +
with O +
insulin B-Gene +
or O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
. O +

Therefore O +
, O +
3-hydroxy-3-methylglutaryl B-Gene +
coenzyme I-Gene +
A I-Gene +
synthase I-Gene +
expression O +
in O +
keratinocytes O +
is O +
regulated O +
by O +
insulin B-Gene +
and O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
by O +
different O +
mechanisms O +
. O +

These O +
results O +
suggest O +
a O +
role O +
for O +
hormones O +
and O +
growth B-Gene +
factors I-Gene +
in O +
the O +
control O +
of O +
epidermal O +
cholesterol O +
synthesis O +
. O +

Use O +
of O +
an O +
antibody O +
against O +
the O +
soluble O +
interleukin B-Gene +
2 I-Gene +
receptor I-Gene +
alpha I-Gene +
subunit O +
can O +
modulate O +
the O +
stability O +
and O +
biodistribution O +
of O +
interleukin-2 B-Gene +
. O +

The O +
authors O +
have O +
previously O +
reported O +
that O +
the O +
soluble O +
serum O +
form O +
of O +
the O +
alpha B-Gene +
subunit I-Gene +
of I-Gene +
the I-Gene +
IL-2 I-Gene +
receptor I-Gene +
( O +
sIL-2Ralpha B-Gene +
) O +
, O +
whose O +
natural O +
half O +
- O +
life O +
is O +
approximately O +
40 O +
min O +
, O +
survived O +
much O +
longer O +
in O +
the O +
circulation O +
when O +
bound O +
by O +
a O +
specific O +
antibody O +
. O +

In O +
the O +
present O +
study O +
, O +
the O +
authors O +
evaluated O +
the O +
extent O +
to O +
which O +
sIL-2Ralpha B-Gene +
protected O +
IL-2 B-Gene +
in O +
freshly O +
collected O +
serum O +
using O +
biochemical O +
analyses O +
, O +
and O +
a O +
functional O +
CTLL-2 O +
assay O +
. O +

In O +
particular O +
, O +
sIL-2Ralpha B-Gene +
protected O +
IL-2 B-Gene +
from O +
forming O +
complexes O +
with O +
alpha B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene -
-macroglobulin I-Gene +
and O +
from O +
inactivation O +
in O +
vitro O +
. O +

In O +
addition O +
, O +
the O +
authors O +
demonstrated O +
that O +
the O +
anti O +
- O +
IL-2Ralpha B-Gene +
monoclonal O +
antibody O +
7G7 O +
/ O +
B6 O +
, O +
which O +
does O +
not O +
inhibit O +
the O +
binding O +
of O +
IL-2 B-Gene +
to O +
its O +
binding O +
site O +
on O +
sIL-2Ralpha B-Gene +
, O +
protected O +
IL-2 B-Gene +
from O +
degradation O +
and O +
inactivation O +
in O +
vivo O +
in O +
the O +
presence O +
of O +
sIL-2Ralpha B-Gene +
. O +

Both O -
( O -
125 O -
) O -
I O -
- O -
labelled O +
and O +
unlabelled O +
IL-2 B-Gene +
were O +
injected O +
into O +
mice O +
preinjected O +
with O +
humanized O +
anti O +
- O +
Tac B-Gene +
( O +
hTac B-Gene +
) O +
or O +
7G7 O +
/ O +
B6 O +
and O +
sIL-2Ralpha B-Gene +
, O +
or O +
sIL-2Ralpha B-Gene +
alone O +
. O +

Using O +
size O +
- O +
exclusion O +
HPLC O +
, O +
ELISA O +
, O +
and O +
CTLL-2 O +
cell O +
proliferation O +
assays O +
, O +
we O +
observed O +
that O +
the O +
presence O +
of O +
7G7 O +
/ O +
B6 O +
led O +
to O +
formation O +
of O +
complexes O +
with O +
sIL-2Ralpha B-Gene +
and O +
increased O +
the O +
serum O +
levels O +
of O +
IL-2 B-Gene +
more O +
than O +
3 O +
- O +
to O +
40 O +
- O +
fold O +
those O +
of O +
groups O +
receiving O +
IL-2 B-Gene +
alone O +
, O +
sIL-2Ralpha B-Gene +
, O +
or O +
hTac B-Gene +
. O +

Taken O +
as O +
a O +
whole O +
, O +
these O +
results O +
suggest O +
that O +
the O +
complex O +
of O +
7G7 O +
/ O +
B6 O +
and O +
sIL-2Ralpha B-Gene +
not O +
only O +
prolongs O +
the O +
survival O +
of O +
IL-2 B-Gene +
in O +
vivo O +
, O +
but O +
also O +
maintains O +
the O +
bioactivity O +
of O +
IL-2 B-Gene +
. O +

The O +
use O +
of O +
antibodies O +
against O +
endogenous O +
soluble O +
receptors O +
could O +
increase O +
the O +
in O +
vivo O +
survival O +
of O +
cytokines B-Gene +
, O +
protect O +
their O +
bioactivity O +
and O +
thereby O +
facilitate O +
their O +
clinical O +
use O +
in O +
the O +
treatment O +
of O +
various O +
malignancies O +
and O +
AIDS O +
. O +

Human O +
CD8 B-Gene +
beta I-Gene +
, O +
but O +
not O +
mouse O +
CD8 B-Gene +
beta I-Gene +
, O +
can O +
be O +
expressed O +
in O +
the O +
absence O +
of O +
CD8 B-Gene +
alpha I-Gene +
as O +
a O +
beta O +
beta O +
homodimer O +
. O +

The O +
T O +
cell O +
coreceptor O +
CD8 B-Gene +
exists O +
on O +
mature O +
T O +
cells O +
as O +
disulfide O +
- O +
linked O +
homodimers O +
of O +
CD8 B-Gene +
alpha I-Gene +
polypeptide O +
chains O +
and O +
heterodimers O +
of O +
CD8 B-Gene +
alpha I-Gene +
- O +
and O +
CD8 B-Gene +
beta I-Gene +
- O +
chains O +
. O +

The O +
function O +
of O +
the O +
CD8 B-Gene +
alpha I-Gene +
- O +
chain O +
for O +
binding O +
to O +
MHC B-Gene +
class I-Gene +
I I-Gene +
and O +
associating O +
with O +
the O +
tyrosine B-Gene +
kinase I-Gene +
p56lck B-Gene +
was O +
demonstrated O +
with O +
CD8 B-Gene +
alpha I-Gene +
alpha O +
homodimers O +
. O +

CD8 B-Gene +
alpha I-Gene +
beta I-Gene +
functions O +
as O +
a O +
better O +
coreceptor O +
, O +
but O +
the O +
actual O +
function O +
of O +
CD8 B-Gene +
beta I-Gene +
is O +
less O +
clear O +
. O +

Addressing O +
this O +
issue O +
has O +
been O +
hampered O +
by O +
the O +
apparent O +
inability O +
of O +
CD8 B-Gene +
beta I-Gene +
to O +
be O +
expressed O +
without O +
CD8 B-Gene +
alpha I-Gene +
. O +

This O +
study O +
demonstrates O +
that O +
human O +
, O +
but O +
not O +
mouse O +
, O +
CD8 B-Gene +
beta I-Gene +
can O +
be O +
expressed O +
on O +
the O +
cell O +
surface O +
without O +
CD8 B-Gene +
alpha I-Gene +
in O +
both O +
transfected O +
COS-7 O +
cells O +
and O +
murine O +
lymphocytes O +
. O +

By O +
creating O +
chimeric O +
proteins O +
, O +
we O +
show O +
that O +
the O +
murine O +
Ig B-Gene +
domain O +
of O +
CD8 B-Gene +
beta I-Gene +
is O +
responsible O +
for O +
the O +
lack O +
of O +
expression O +
of O +
murine O +
CD8 B-Gene +
beta I-Gene +
beta O +
dimers O +
. O +

In O +
contrast O +
to O +
CD8 B-Gene +
alpha I-Gene +
alpha O +
, O +
CD8 B-Gene +
beta I-Gene +
beta O +
is O +
unable O +
to O +
bind O +
MHC B-Gene +
class I-Gene +
I I-Gene +
in O +
a O +
cell O +
- O +
cell O +
adhesion O +
assay O +
. O +

Detection O +
of O +
this O +
form O +
of O +
CD8 B-Gene +
should O +
facilitate O +
studies O +
on O +
the O +
function O +
of O +
the O +
CD8 B-Gene +
beta I-Gene +
- O +
chain O +
and O +
indicates O +
that O +
caution O +
should O +
be O +
used O +
when O +
interpreting O +
studies O +
on O +
CD8 B-Gene +
function O +
using O +
chimeric O +
protein O +
with O +
the O +
murine O +
CD8 B-Gene +
beta I-Gene +
beta O +
Ig B-Gene +
domain O +
. O +

In O +
addition O +
, O +
we O +
demonstrate O +
that O +
the O +
Ig B-Gene +
domains O +
of O +
CD8 B-Gene +
alpha I-Gene +
are O +
also O +
involved O +
in O +
controlling O +
the O +
ability O +
of O +
CD8 B-Gene +
to O +
be O +
expressed O +
. O +

Mutation O +
of O +
B O +
- O +
and O +
F O +
- O +
strand O +
cysteine O +
residues O +
in O +
CD8 B-Gene +
alpha I-Gene +
reduced O +
the O +
ability O +
of O +
the O +
protein O +
to O +
fold O +
properly O +
and O +
, O +
therefore O +
, O +
to O +
be O +
expressed O +
. O +

Substrate O +
specificities O +
of O +
peroxisomal O +
members O +
of O +
short B-Gene +
- I-Gene +
chain I-Gene +
alcohol I-Gene +
dehydrogenase I-Gene +
superfamily I-Gene +
: O +
expression O +
and O +
characterization O +
of O +
dehydrogenase B-Gene +
part O +
of O +
Candida O +
tropicalis O +
multifunctional O +
enzyme O +
. O +

In O +
addition O +
to O +
several O +
other O +
enzymes O +
, O +
the O +
short B-Gene +
- I-Gene +
chain I-Gene +
alcohol I-Gene +
dehydrogenase I-Gene +
superfamily I-Gene +
includes O +
a O +
group O +
of O +
peroxisomal O +
multifunctional O +
enzymes O +
involved O +
in O +
fatty O +
acid O +
and O +
cholesterol O +
side O +
- O +
chain O +
beta O -
- O -
oxidation O +
. O +

Mammalian O +
peroxisomal B-Gene +
multifunctional I-Gene +
enzyme I-Gene +
type I-Gene +
2 I-Gene +
( O +
perMFE-2 B-Gene +
) O +
is O +
a O +
2-enoyl B-Gene -
- I-Gene -
CoA I-Gene +
hydratase-2 I-Gene -
/ I-Gene -
( I-Gene -
R I-Gene -
) I-Gene -
-3-hydroxyacyl I-Gene -
- I-Gene -
CoA I-Gene +
dehydrogenase I-Gene +
. O +

As O +
has O +
been O +
shown O +
previously O +
, O +
perMFE-2 B-Gene +
hydrates O +
( O -
24E O -
) O -
-3alpha,7alpha O +
, O +
12alpha O -
- O -
trihydroxy-5beta O -
- O -
cholest-24-enoyl O -
- O -
CoA O +
to O +
( O +
24R O +
, O +
25R O -
) O -
-3alpha O +
, O +
7alpha,12alpha,24xi O -
- O -
tetrahydroxy-5beta O -
- O -
choles O +
tanoyl O -
- O -
CoA O +
, O +
which O +
has O +
been O +
characterized O +
as O +
a O +
physiological O +
intermediate O +
in O +
cholic O +
acid O +
synthesis O +
. O +

Out O +
of O +
four O +
possible O +
stereoisomers O +
of O +
3alpha,7alpha O +
, O +
12alpha,24xi O -
- O -
tetrahydroxy-5beta O -
- O -
cholestanoyl O -
- O -
CoA O +
, O +
the O +
mammalian O +
perMFE-2 B-Gene +
dehydrogenates O +
only O +
the O +
( O +
24R,25R O -
) O -
-isomer O +
. O +

The O +
yeast O +
peroxisomal B-Gene +
multifunctional I-Gene +
enzyme I-Gene +
( O +
MFE B-Gene +
) O +
was O +
first O +
described O +
as O +
2-enoyl B-Gene -
- I-Gene -
CoA I-Gene +
hydratase-2 I-Gene -
/ I-Gene -
( I-Gene -
R I-Gene -
) I-Gene -
-3-hydroxyacyl I-Gene -
- I-Gene -
CoA I-Gene +
dehydrogenase I-Gene +
. O +

To O +
investigate O +
the O +
stereospecificity O +
of O +
yeast O +
peroxisomal B-Gene +
MFE I-Gene +
, O +
the O +
two O +
dehydrogenase B-Gene +
domains O +
of O +
C. O +
tropicalis O +
MFE B-Gene +
were O +
expressed O +
in O +
E. O +
coli O +
as O +
a O +
65 O +
kDa O +
recombinant O +
protein O +
. O +

This O +
protein O +
catalyzes O +
the O +
dehydrogenation O +
of O +
straight O +
- O +
chain O +
( O -
R O -
) O -
-3-hydroxyacyl O -
- O -
CoAs O +
, O +
but O +
it O +
is O +
devoid O +
of O +
( B-Gene -
S I-Gene -
) I-Gene -
-3-hydroxyacyl I-Gene -
- I-Gene -
CoA I-Gene +
dehydrogenase I-Gene +
and O +
2-enoyl B-Gene -
- I-Gene -
CoA I-Gene +
hydratase I-Gene +
activities O +
. O +

The O +
protein O +
dehydrogenates O +
( O +
24R,25R O -
) O +
- O +
and O +
( O +
24R O +
, O +
25S O +
) O +
- O +
isomers O +
of O +
3alpha,7alpha O +
, O +
12alpha O +
, O +
24xi O -
- O -
tetrahydroxy-5beta O +
- O +
cholestanoyl O +
- O +
CoA O +
. O +

Interestingly O +
, O +
the O +
protein O +
also O +
shows O +
17beta B-Gene -
- I-Gene -
estradiol I-Gene +
dehydrogenase I-Gene +
activity O -
. O -
As O +
a O +
monofunctional O +
( O +
R O +
) O +
- O +
specific O +
3-hydroxyacyl B-Gene -
- I-Gene -
CoA I-Gene +
dehydrogenase I-Gene +
is O +
currently O +
unavailable O +
, O +
this O +
recombinant O +
enzyme O +
can O +
be O +
used O +
to O +
study O +
the O +
stereochemistry O +
of O +
bile O +
acid O +
synthesis O +
. O +

FRS2 B-Gene +
proteins O +
recruit O +
intracellular O +
signaling O +
pathways O +
by O +
binding O +
to O +
diverse O +
targets O +
on O +
fibroblast B-Gene +
growth I-Gene +
factor I-Gene +
and I-Gene +
nerve I-Gene +
growth I-Gene +
factor I-Gene +
receptors I-Gene +
. O +

The O +
docking O +
protein O +
FRS2 B-Gene +
was O +
implicated O +
in O +
the O +
transmission O +
of O +
extracellular O +
signals O +
from O +
the O +
fibroblast B-Gene +
growth I-Gene +
factor I-Gene +
( I-Gene +
FGF I-Gene +
) I-Gene +
or I-Gene +
nerve I-Gene +
growth I-Gene +
factor I-Gene +
( I-Gene +
NGF I-Gene +
) I-Gene +
receptors I-Gene +
to O +
the O +
Ras B-Gene +
/ O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
signaling O +
cascade O +
. O +

The O +
two O +
members O +
of O +
the O +
FRS2 B-Gene +
family I-Gene +
, O +
FRS2alpha B-Gene +
and O +
FRS2beta B-Gene +
, O +
are O +
structurally O +
very O +
similar O +
. O +

Each O +
is O +
composed O +
of O +
an O +
N O +
- O +
terminal O +
myristylation O +
signal O +
, O +
a O +
phosphotyrosine O +
- O +
binding O +
( O +
PTB O +
) O +
domain O +
, O +
and O +
a O +
C O -
- O -
terminal O +
tail O +
containing O +
multiple O +
binding O +
sites O +
for O +
the O +
SH2 O +
domains O +
of O +
the O +
adapter B-Gene +
protein I-Gene +
Grb2 B-Gene +
and O +
the O +
protein B-Gene +
tyrosine I-Gene +
phosphatase I-Gene +
Shp2 B-Gene +
. O +

Here O +
we O +
show O +
that O +
the O +
PTB O +
domains O +
of O +
both O +
the O +
alpha B-Gene +
and I-Gene +
beta I-Gene +
isoforms I-Gene +
of I-Gene +
FRS2 I-Gene +
bind O +
directly O +
to O +
the O +
FGF B-Gene +
or I-Gene +
NGF I-Gene +
receptors I-Gene +
. O +

The O +
PTB O +
domains O +
of O +
the O +
FRS2 B-Gene +
proteins O +
bind O +
to O +
a O +
highly O +
conserved O +
sequence O +
in O +
the O +
juxtamembrane O +
region O +
of O +
FGFR1 B-Gene +
. O +

While O +
FGFR1 B-Gene +
interacts O +
with O +
FRS2 B-Gene +
constitutively O +
, O +
independent O +
of O +
ligand O +
stimulation O +
and O +
tyrosine O +
phosphorylation O +
, O +
NGF B-Gene +
receptor I-Gene +
( O +
TrkA B-Gene +
) O +
binding O +
to O +
FRS2 B-Gene +
is O +
strongly O +
dependent O +
on O +
receptor O +
activation O +
. O +

Complex O +
formation O +
with O +
TrkA B-Gene +
is O +
dependent O +
on O +
phosphorylation O +
of O +
Y490 O +
, O +
a O +
canonical O +
PTB O +
domain O +
binding O +
site O +
that O +
also O +
functions O +
as O +
a O +
binding O +
site O +
for O +
Shc B-Gene +
( O +
NPXpY O +
) O +
. O +

Using O +
deletion O +
and O +
alanine O +
scanning O +
mutagenesis O +
as O +
well O +
as O +
peptide O +
competition O +
assays O +
, O +
we O +
demonstrate O +
that O +
the O +
PTB O +
domains O +
of O +
the O +
FRS2 B-Gene +
proteins O +
specifically O +
recognize O +
two O +
different O +
primary O +
structures O +
in O +
two O +
different O +
receptors O +
in O +
a O +
phosphorylation O +
- O +
dependent O +
or O +
- O +
independent O +
manner O +
. O +

In O +
addition O +
, O +
NGF B-Gene +
- O +
induced O +
tyrosine O +
phosphorylation O +
of O +
FRS2alpha B-Gene +
is O +
diminished O +
in O +
cells O +
that O +
overexpress O +
a O +
kinase B-Gene +
- O +
inactive O +
mutant O +
of O +
FGFR1 B-Gene +
. O +

This O +
experiment O +
suggests O +
that O +
FGFR1 B-Gene +
may O +
regulate O +
signaling O +
via O +
NGF B-Gene +
receptors I-Gene +
by O +
sequestering O +
a O +
common O +
key O +
element O +
which O +
both O +
receptors O +
utilize O +
for O +
transmitting O +
their O +
signals O +
. O +

The O +
multiple O +
interactions O +
mediated O +
by O +
FRS2 B-Gene +
appear O +
to O +
play O +
an O +
important O +
role O +
in O +
target O +
selection O +
and O +
in O +
defining O +
the O +
specificity O +
of O +
several O +
families O +
of O +
receptor B-Gene +
tyrosine I-Gene +
kinases I-Gene +
. O +

Identification O +
and O +
characterization O +
of O +
a O +
new O +
prespore O +
- O +
specific O +
regulatory O +
gene O +
, O +
rsfA B-Gene +
, O +
of O +
Bacillus O +
subtilis O +
. O +

Differential O +
gene O +
expression O +
during O +
Bacillus O +
subtilis O +
sporulation O +
is O +
controlled O +
by O +
sigma B-Gene +
factors I-Gene +
and O +
other O +
regulatory O +
effectors O +
. O +

The O +
first O +
compartmentalized O +
sigma B-Gene +
factor I-Gene +
, O +
sigma B-Gene +
( I-Gene +
F I-Gene +
) I-Gene +
, O +
is O +
active O +
specifically O +
in O +
the O +
prespore O +
compartment O +
. O +

During O +
our O +
screening O +
for O +
new O +
chromosome O +
segregation O +
mutants O +
using O +
a O +
sigma B-Gene +
( I-Gene +
F I-Gene +
) I-Gene +
- O +
dependent O +
gpr B-Gene +
- O +
lacZ B-Gene +
reporter O +
as O +
a O +
probe O +
, O +
we O +
identified O +
a O +
new O +
gene O +
( O +
ywfN B-Gene +
) O +
required O +
for O +
maximal O +
expression O +
of O +
the O +
reporter O +
and O +
named O +
it O +
rsfA B-Gene +
. O +

The O +
product O +
of O +
rsfA B-Gene +
has O +
features O +
of O +
gene O +
regulatory O +
proteins O +
, O +
and O +
the O +
protein O +
colocalizes O +
with O +
DNA O +
. O +

The O +
expression O +
of O +
rsfA B-Gene +
is O +
under O +
the O +
control O +
of O +
both O +
sigma B-Gene +
( I-Gene +
F I-Gene +
) I-Gene +
and O +
sigma B-Gene +
( I-Gene +
G I-Gene +
) I-Gene +
. O +

Null O +
mutations O +
in O +
rsfA B-Gene +
have O +
different O +
effects O +
on O +
the O +
expression O +
of O +
sigma B-Gene -
( I-Gene -
F I-Gene -
) I-Gene +
- O +
dependent O +
genes O +
, O +
suggesting O +
that O +
the O +
RsfA B-Gene +
protein O +
is O +
a O +
regulator O +
of O +
transcription O +
that O +
fine O +
- O +
tunes O +
gene O +
expression O +
in O +
the O +
prespore O +
. O +

Flt-3 B-Gene +
ligand I-Gene +
, O +
in O +
combination O +
with O +
bovine O +
granulocyte B-Gene +
- I-Gene +
macrophage I-Gene +
colony I-Gene +
- I-Gene +
stimulating I-Gene +
factor I-Gene +
and O +
interleukin B-Gene +
- I-Gene +
4 I-Gene +
, O +
promotes O +
the O +
growth O +
of O +
bovine O +
bone O +
marrow O +
derived O +
dendritic O +
cells O +
. O +

Culture O +
of O +
bone O +
marrow O +
precursor O +
cells O +
with O +
cytokines B-Gene +
, O +
including O +
granulocyte B-Gene +
- I-Gene +
macrophage I-Gene +
colony I-Gene +
- I-Gene +
stimulating I-Gene +
factor I-Gene +
( O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
) O +
, O +
interleukin B-Gene +
- I-Gene +
4 I-Gene +
( O +
IL-4 B-Gene +
) O +
and O +
the O +
tyrosine B-Gene +
kinase I-Gene +
receptor I-Gene +
binding O +
proteins O +
Flt B-Gene +
- I-Gene +
3 I-Gene +
ligand I-Gene +
( B-Gene +
Flt I-Gene +
- I-Gene +
3L I-Gene +
) O +
and O +
stem B-Gene -
- I-Gene -
cell I-Gene +
factor I-Gene +
( O +
SCF B-Gene +
) O +
, O +
has O +
previously O +
been O +
shown O +
, O +
in O +
both O +
mouse O +
and O +
human O +
, O +
to O +
result O +
in O +
the O +
generation O +
of O +
large O +
numbers O +
of O +
dendritic O +
cells O +
. O +

We O +
extend O +
these O +
findings O +
to O +
bovine O +
dendritic O +
cells O +
. O +

Culture O +
of O +
bovine O +
bone O +
marrow O +
cells O +
with O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
, O +
IL-4 B-Gene +
and O +
either O +
Flt-3L B-Gene +
or O +
SCF B-Gene +
enhanced O +
the O +
generation O +
of O +
low O +
buoyant O +
- O +
density O +
dendritic O +
cells O +
. O +

However O +
, O +
only O +
the O +
addition O +
of O +
Flt B-Gene +
- I-Gene +
3L I-Gene +
to O +
cells O +
cultured O +
with O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
and O +
IL-4 B-Gene +
was O +
shown O +
to O +
increase O +
the O +
number O +
of O +
dendritic O +
cells O +
and O +
induce O +
the O +
differentiation O +
of O +
dendritic O +
cells O +
with O +
potent O +
capacity O +
to O +
stimulate O +
allogeneic O +
T O +
cells O +
and O +
resting O +
CD4 B-Gene +
+ O +
memory O +
T O +
cells O +
. O +

The O +
effective O +
ability O +
to O +
stimulate O +
T O +
cells O +
was O +
associated O +
with O +
the O +
expression O +
of O +
major B-Gene +
histocompatibility I-Gene +
complex I-Gene +
( I-Gene +
MHC I-Gene +
) I-Gene +
class I-Gene +
II I-Gene +
molecules O +
and O +
CD80 B-Gene +
/ I-Gene +
86 I-Gene +
by O +
dendritic O +
cells O +
. O +

Bovine O +
bone O +
marrow O +
derived O +
dendritic O +
cells O +
appeared O +
to O +
be O +
exclusively O +
of O +
myeloid O +
origin O +
because O +
they O +
expressed O +
the O +
myeloid O +
- O +
related O +
antigens O +
CD14 B-Gene +
, O +
MyD-1 B-Gene +
and O +
CD11b B-Gene +
. O +

Vps52p B-Gene +
, O +
Vps53p B-Gene +
, O +
and O +
Vps54p B-Gene +
form O +
a O +
novel O +
multisubunit O +
complex O +
required O +
for O +
protein O +
sorting O +
at O +
the O +
yeast O +
late O +
Golgi O +
. O +

The O +
late O +
Golgi O +
of O +
the O +
yeast O +
Saccharomyces O +
cerevisiae O +
receives O +
membrane O +
traffic O +
from O +
the O +
secretory O +
pathway O +
as O +
well O +
as O +
retrograde O +
traffic O +
from O +
post O +
- O +
Golgi O +
compartments O +
, O +
but O +
the O +
machinery O +
that O +
regulates O +
these O +
vesicle O +
- O +
docking O +
and O +
fusion O +
events O +
has O +
not O +
been O +
characterized O +
. O +

We O +
have O +
identified O +
three O +
components O +
of O +
a O +
novel O +
protein O +
complex O +
that O +
is O +
required O +
for O +
protein O +
sorting O +
at O +
the O +
yeast O +
late O +
Golgi O +
compartment O +
. O +

Mutation O +
of O +
VPS52 B-Gene +
, O +
VPS53 B-Gene +
, O +
or O +
VPS54 B-Gene +
results O +
in O +
the O +
missorting O +
of O +
70 O +
% O +
of O +
the O +
vacuolar O +
hydrolase B-Gene +
carboxypeptidase B-Gene +
Y I-Gene +
as O +
well O +
as O +
the O +
mislocalization O +
of O +
late O +
Golgi O +
membrane O +
proteins O +
to O +
the O +
vacuole O +
, O +
whereas O +
protein O +
traffic O +
through O +
the O +
early O +
part O +
of O +
the O +
Golgi O +
complex O +
is O +
unaffected O +
. O +

A O +
vps52 B-Gene +
/ I-Gene +
53 I-Gene +
/ I-Gene +
54 I-Gene +
triple O +
mutant O +
strain O +
is O +
phenotypically O +
indistinguishable O +
from O +
each O +
of O +
the O +
single O +
mutants O +
, O +
consistent O +
with O +
the O +
model O +
that O +
all O +
three O +
are O +
required O +
for O +
a O +
common O +
step O +
in O +
membrane O +
transport O +
. O +

Native O +
coimmunoprecipitation O +
experiments O +
indicate O +
that O +
Vps52p B-Gene +
, O +
Vps53p B-Gene +
, O +
and O +
Vps54p B-Gene +
are O +
associated O +
in O +
a O +
1 O +
: O +
1 O +
: O +
1 O +
complex O +
that O +
sediments O +
as O +
a O +
single O +
peak O +
on O +
sucrose O +
velocity O +
gradients O +
. O +

This O +
complex O +
, O +
which O +
exists O +
both O +
in O +
a O +
soluble O +
pool O +
and O +
as O +
a O +
peripheral O +
component O +
of O +
a O +
membrane O +
fraction O +
, O +
colocalizes O +
with O +
markers O +
of O +
the O +
yeast O +
late O +
Golgi O +
by O +
immunofluorescence O +
microscopy O +
. O +

Together O +
, O +
the O +
phenotypic O +
and O +
biochemical O +
data O +
suggest O +
that O +
VPS52 B-Gene +
, O +
VPS53 B-Gene +
, O +
and O +
VPS54 B-Gene +
are O +
required O +
for O +
the O +
retrograde O +
transport O +
of O +
Golgi O +
membrane O +
proteins O +
from O +
an O +
endosomal O +
/ O +
prevacuolar O +
compartment O +
. O +

The O +
Vps52 B-Gene +
/ I-Gene +
53 I-Gene +
/ I-Gene +
54 I-Gene +
complex I-Gene +
joins O +
a O +
growing O +
list O +
of O +
distinct O +
multisubunit O +
complexes O +
that O +
regulate O +
membrane O +
- O +
trafficking O +
events O +
. O +

Cytokine B-Gene +
production O +
from O +
murine O +
CD4 B-Gene +
and O +
CD8 B-Gene +
cells O +
after O +
mannan O +
- O +
MUC1 B-Gene +
immunization O +
. O +

Immunotherapy O +
with O +
oxidized O +
mannan O +
- O +
MUC1 B-Gene +
fusion O +
protein O +
( O +
M O -
- O -
FP O +
) O +
leads O +
to O +
a O +
T1 O +
immune O +
response O +
characterized O +
by O +
the O +
generation O +
of O +
cytotoxic O +
T O +
lymphocytes O +
( O +
CTL O +
) O +
, O +
few O +
antibodies O +
, O +
secretion O +
of O +
interleukin-2 B-Gene +
( O +
IL-2 B-Gene +
) O +
, O +
IL-12 B-Gene +
, O +
and O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
and O +
tumor O +
protection O +
. O +

Immunotherapy O +
with O +
reduced O +
M O -
- O -
FP O +
or O +
fusion O +
protein O +
( O +
FP O +
) O +
alone O +
leads O +
to O +
a O +
T2 O +
immune O +
response O +
characterized O +
by O +
the O +
generation O +
of O +
MUC1 B-Gene +
antibodies O +
, O +
few O +
CTL O +
, O +
IL-4 B-Gene +
secretion O +
, O +
and O +
no O +
tumor O +
protection O +
. O +

In O +
these O +
studies O +
, O +
cytokine B-Gene +
production O +
from O +
T O +
cells O +
was O +
measured O +
from O +
cultures O +
containing O +
whole O +
spleens O +
. O +

We O +
now O +
report O +
the O +
cytokine B-Gene +
secretion O +
patterns O +
from O +
spleen O +
cells O +
separated O +
into O +
CD4 B-Gene +
+ O +
and O +
CD8 B-Gene +
+ O +
T O +
cells O +
obtained O +
from O +
mice O +
immunized O +
with O +
either O +
oxidized O +
M O -
- O -
FP O +
, O +
reduced O +
M O -
- O -
FP O +
or O +
FP O +
, O +
or O +
the O +
simultaneous O +
administration O +
of O +
oxidized O +
M O -
- O -
FP O +
and O +
FP O +
. O +

Immunization O +
with O +
oxidized O +
M O -
- O -
FP O +
led O +
to O +
the O +
secretion O +
of O +
T1 O +
cytokines B-Gene +
from O +
CD8 B-Gene +
+ O +
T O +
cells O +
( O +
IL-2 B-Gene +
, O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
, O +
and O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
[ O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
] O +
) O +
and O +
from O +
CD4 B-Gene +
+ O +
T O +
cells O +
( O +
IL-2 B-Gene +
and O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
. O +

IL-12 B-Gene +
production O +
, O +
presumably O +
from O +
activated O +
macrophages O +
, O +
was O +
observed O +
in O +
CD8 B-Gene +
+ O +
but O +
not O +
CD4 B-Gene +
+ O +
cultures O +
. O +

Immunization O +
with O +
either O +
reduced O +
M O +
- O +
FP O +
or O +
FP O +
led O +
to O +
the O +
secretion O +
of O +
predominantly O +
T2 O +
cytokines B-Gene +
from O +
CD4 B-Gene +
+ O +
T O +
cells O +
( O +
IL-4 B-Gene +
and O +
IL-10 B-Gene +
) O +
and O +
IL-2 B-Gene +
production O +
in O +
both O +
CD4 B-Gene +
+ O +
and O +
CD8 B-Gene +
+ O +
T O +
cell O +
cultures O +
. O +

The O +
simultaneous O +
immunization O +
of O +
both O +
oxidized O +
M O -
- O -
FP O +
and O +
FP O +
led O +
to O +
the O +
production O +
of O +
both O +
T1 O +
and O +
T2 O +
cytokines B-Gene +
from O +
CD8 B-Gene +
+ O +
T O +
cells O +
( O +
IL-2 B-Gene +
, O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
, O +
and O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
) O +
and O +
CD4 B-Gene +
+ O +
cells O +
( O +
IL-2 B-Gene +
, O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
, O +
IL-4 B-Gene +
, O +
and O +
IL-10 B-Gene +
) O +
and O +
IL-12 B-Gene +
production O +
in O +
CD8 B-Gene +
+ O +
cultures O +
that O +
is O +
, O +
both O +
types O +
of O +
immune O +
responses O +
could O +
occur O +
together O +
. O +

The O +
results O +
demonstrate O +
that O +
the O +
cellular O +
immune O +
response O +
observed O +
in O +
oxidized O +
M O -
- O -
FP O +
- O +
immunized O +
mice O +
is O +
indeed O +
dependent O +
on O +
the O +
T1 O +
cytokine B-Gene +
profile O +
secreted O +
by O +
CD8 B-Gene +
+ O +
T O +
cells O +
, O +
and O +
the O +
simultaneous O +
production O +
of O +
both O +
T1 O +
and O +
T2 O +
cytokines B-Gene +
is O +
not O +
cross O +
- O +
inhibitory O +
. O +

Crystal O +
structure O +
of O +
the O +
hereditary B-Gene +
haemochromatosis I-Gene +
protein I-Gene +
HFE B-Gene +
complexed O +
with O +
transferrin B-Gene +
receptor I-Gene +
. O +

HFE B-Gene +
is O +
related O +
to O +
major B-Gene +
histocompatibility I-Gene +
complex I-Gene +
( I-Gene +
MHC I-Gene +
) I-Gene +
class I-Gene +
I I-Gene +
proteins O +
and O +
is O +
mutated O +
in O +
the O +
iron O +
- O +
overload O +
disease O +
hereditary O +
haemochromatosis O +
. O +

HFE B-Gene +
binds O +
to O +
the O +
transferrin B-Gene +
receptor I-Gene +
( O +
TfR B-Gene +
) O +
, O +
a O +
receptor O +
by O +
which O +
cells O +
acquire O +
iron O +
- O +
loaded O +
transferrin B-Gene +
. O +

The O +
2.8 O +
A O +
crystal O +
structure O +
of O +
a O +
complex O +
between O +
the O +
extracellular O +
portions O +
of O +
HFE B-Gene +
and O +
TfR B-Gene +
shows O +
two O +
HFE B-Gene +
molecules O +
which O +
grasp O +
each O +
side O +
of O +
a O +
twofold O +
symmetric O +
TfR B-Gene +
dimer O +
. O +

On O +
a O +
cell O +
membrane O +
containing O +
both O +
proteins O +
, O +
HFE B-Gene +
would O +
' O +
lie O +
down O +
' O +
parallel O +
to O +
the O +
membrane O +
, O +
such O +
that O +
the O +
HFE B-Gene +
helices O +
that O +
delineate O +
the O +
counterpart O +
of O +
the O +
MHC B-Gene +
peptide O +
- O +
binding O +
groove O +
make O +
extensive O +
contacts O +
with O +
helices O +
in O +
the O +
TfR B-Gene +
dimerization O +
domain O +
. O +

The O +
structures O +
of O +
TfR B-Gene +
alone O +
and O +
complexed O +
with O +
HFE B-Gene +
differ O +
in O +
their O +
domain O +
arrangement O +
and O +
dimer O +
interfaces O +
, O +
providing O +
a O +
mechanism O +
for O +
communicating O +
binding O +
events O +
between O +
TfR B-Gene +
chains O +
. O +

The O +
HFE B-Gene +
- O +
TfR B-Gene +
complex O +
suggests O +
a O +
binding O +
site O +
for O +
transferrin O +
on O +
TfR B-Gene +
and O +
sheds O +
light O +
upon O +
the O +
function O +
of O +
HFE B-Gene +
in O +
regulating O +
iron O +
homeostasis O +
. O +

Characterization O +
of O +
a O +
second O +
member O +
of O +
the O +
subfamily O +
of O +
calcium O +
- O +
binding O +
mitochondrial O +
carriers O +
expressed O +
in O +
human O +
non O +
- O +
excitable O +
tissues O +
. O +

We O +
have O +
recently O +
identified O +
a O +
subfamily O +
of O +
mitochondrial O +
carriers O +
that O +
bind O +
calcium O +
, O +
and O +
cloned O +
ARALAR1 B-Gene +
, O +
a O +
member O +
of O +
this O +
subfamily O +
expressed O +
in O +
human O +
muscle O +
and O +
brain O +
. O +

We O +
have O +
now O +
cloned O +
a O +
second O +
human O +
ARALAR B-Gene +
gene O +
( O +
ARALAR2 B-Gene +
) O +
coding O +
for O +
a O +
protein O +
78.3 O +
% O +
identical O +
to O +
Aralar1 B-Gene +
, O +
but O +
expressed O +
in O +
liver O +
and O +
non O +
- O +
excitable O +
tissues O +
. O +

Aralar2 B-Gene +
is O +
identical O +
to O +
citrin B-Gene +
, O +
the O +
product O +
of O +
the O +
gene O +
mutated O +
in O +
type O -
- O -
II O +
citrullinaemia O +
[ O +
Kobayashi O +
, O +
Sinasac O +
, O +
Iijima O +
, O +
Boright O +
, O +
Begum O +
, O +
Lee O +
, O +
Yasuda O +
, O +
Ikeda O +
, O +
Hirano O +
, O +
Terazono O +
et O +
al. O +
( O +
1999 O +
) O +
Nat O -
. O +
Genet O -
. O +
22 O +
, O +
159 O +
- O +
163 O +
] O +
. O +

A O +
related O +
protein O +
, O +
DmAralar B-Gene +
, O +
69 O +
% O +
identical O +
to O +
Aralar1 B-Gene +
, O +
was O +
found O +
in O +
Drosophila O +
melanogaster O +
, O +
the O +
DMARALAR B-Gene +
locus O +
lying O +
on O +
the O +
right O +
arm O +
of O +
the O +
third O +
chromosome O +
, O +
band O +
99F O +
. O +

The O +
N O +
- O +
terminal O +
half O +
of O +
Aralar2 B-Gene +
/ O +
citrin B-Gene +
is O +
able O +
to O +
bind O +
calcium O +
and O +
this O +
requires O +
the O +
presence O +
of O +
the O +
two O +
most O +
distal O +
EF O -
- O -
hands O +
. O +

The O +
localization O +
of O +
Aralar2 B-Gene +
/ O +
citrin B-Gene +
expressed O +
in O +
human O +
cell O +
lines O +
is O +
mitochondrial O +
, O +
the O +
C O +
- O +
terminal O +
half O +
containing O +
sufficient O +
information O +
for O +
import O +
and O +
assembly O +
into O +
mitochondria O +
. O +

The O +
C O +
- O +
terminal O +
half O +
of O +
Aralar B-Gene +
proteins O +
is O +
related O +
to O +
the O +
yeast O +
YPR020c B-Gene +
gene O +
, O +
with O +
a O +
very O +
high O +
sequence O +
conservation O +
( O +
54.3 O +
% O +
identity O +
) O +
, O +
suggesting O +
that O +
these O +
proteins O +
play O +
an O +
important O +
role O +
. O +

Thus O +
Aralar B-Gene +
proteins O +
are O +
probably O +
expressed O +
in O +
all O +
tissues O +
in O +
an O +
isoform O +
- O +
specific O +
fashion O +
, O +
where O +
they O +
function O +
as O +
calcium O +
- O +
regulated O +
metabolite O +
( O +
possibly O +
anionic O +
) O +
carriers O +
. O +

Cloning O +
, O +
expression O +
, O +
and O +
functional O +
characterization O +
of O +
the O +
beta B-Gene +
regulatory I-Gene +
subunit I-Gene +
of I-Gene +
human I-Gene +
methionine I-Gene +
adenosyltransferase I-Gene +
( O +
MAT B-Gene +
II I-Gene +
) O +
. O +

MAT B-Gene +
II I-Gene +
, O +
the O +
extrahepatic O +
form O +
of O +
methionine B-Gene +
adenosyltransferase I-Gene +
( O +
MAT B-Gene +
) O +
, O +
consists O +
of O +
catalytic O +
alpha O -
( O -
2 O -
) O -
/ O -
alpha O -
( O -
2 O -
' O -
) O +
subunits O +
and O +
a O +
noncatalytic O +
beta O +
subunit O +
, O +
believed O +
to O +
have O +
a O +
regulatory O +
function O +
. O +

The O +
full O +
- O +
length O +
cDNA O +
that O +
encodes O +
the O +
beta O +
subunit O +
of O +
human O +
MAT B-Gene +
II I-Gene +
was O +
cloned O +
and O +
found O +
to O +
encode O +
for O +
a O +
334 O +
- O +
amino O +
acid O +
protein O +
with O +
a O +
calculated O +
molecular O +
weight O +
of O +
37 O +
, O +
552 O +
. O +

Analysis O +
of O +
sequence O +
homology O +
showed O +
similarity O +
with O +
bacterial O +
enzymes O +
that O +
catalyze O +
the O +
reduction O +
of O +
TDP O +
- O +
linked O +
sugars O +
. O +

The O +
beta O +
subunit O +
cDNA O +
was O +
cloned O +
into O +
the O +
pQE-30 O +
expression O +
vector O +
, O +
and O +
the O +
recombinant O +
His O +
tagged O +
protein O +
, O +
which O +
was O +
expressed O +
in O +
Escherichia O +
coli O +
, O +
was O +
recognized O +
by O +
antibodies O +
to O +
the O +
human O +
MAT B-Gene +
II I-Gene +
, O +
to O +
synthetic O +
peptides O +
copying O +
the O +
sequence O +
of O +
native O +
beta O +
subunit O +
protein O +
, O +
and O +
to O +
the O +
rbeta O +
protein O +
. O +

There O +
is O +
no O +
cross O +
- O +
reactivity O +
between O +
the O +
MAT B-Gene +
II I-Gene +
alpha I-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
or I-Gene +
beta I-Gene +
subunits O +
. O +

None O +
of O +
the O +
anti O +
- O +
beta O +
subunit O +
antibodies O +
reacted O +
with O +
protein O +
extracts O +
of O +
E. O +
coli O +
host O +
cells O +
, O +
suggesting O +
that O +
these O +
bacteria O +
have O +
no O +
beta O +
subunit O +
protein O +
. O +

Interestingly O +
, O +
the O +
rbeta O +
subunit O +
associated O +
with O +
E. O +
coli O +
as O +
well O +
as O +
human O +
MAT B-Gene +
alpha I-Gene +
subunits O +
. O +

This O +
association O +
changed O +
the O +
kinetic O +
properties O +
of O +
both O +
enzymes O +
and O +
lowered O +
the O +
K O -
( O -
m O -
) O +
of O +
MAT B-Gene +
for O +
L O -
- O -
methionine O +
. O +

Together O +
, O +
the O +
data O +
show O +
that O +
we O +
have O +
cloned O +
and O +
expressed O +
the O +
human O +
MAT B-Gene +
II I-Gene +
beta I-Gene +
subunit O +
and O +
confirmed O +
its O +
long O +
suspected O +
regulatory O +
function O +
. O +

This O +
knowledge O +
affords O +
a O +
molecular O +
means O +
by O +
which O +
MAT B-Gene +
activity O +
and O +
consequently O +
the O +
levels O +
of O +
AdoMet O +
may O +
be O +
modulated O +
in O +
mammalian O +
cells O +
. O +

ESE-3 B-Gene +
, O +
a O +
novel O +
member O +
of O +
an O +
epithelium B-Gene +
- I-Gene +
specific I-Gene +
ets I-Gene +
transcription I-Gene +
factor I-Gene +
subfamily I-Gene +
, O +
demonstrates O +
different O +
target O +
gene O +
specificity O +
from O +
ESE-1 B-Gene +
. O +

Most O +
cancers O +
originate O +
as O +
a O +
result O +
of O +
aberrant O +
gene O +
expression O +
in O +
mainly O +
glandular O +
epithelial O +
tissues O +
leading O +
to O +
defects O +
in O +
epithelial O +
cell O +
differentiation O +
. O +

The O +
latter O +
is O +
governed O +
by O +
distinct O +
sets O +
of O +
transcriptional O +
regulators O +
. O +

Here O +
we O +
report O +
the O +
characterization O +
of O +
epithelium B-Gene +
- I-Gene +
specific I-Gene +
Ets I-Gene +
factor I-Gene +
, I-Gene +
family I-Gene +
member I-Gene +
3 I-Gene +
( O +
ESE-3 B-Gene +
) O +
, O +
a O +
novel O +
member O +
of O +
the O +
ESE B-Gene +
subfamily I-Gene +
of I-Gene +
Ets I-Gene +
transcription I-Gene +
factors I-Gene +
. O +

ESE-3 B-Gene +
shows O +
highest O +
homology O +
to O +
two O +
other O +
epithelium O +
restricted O +
Ets B-Gene +
factors O +
, O +
ESE-1 B-Gene +
and O +
ESE-2 B-Gene +
. O +

ESE-3 B-Gene +
, O +
like O +
ESE-1 B-Gene +
and O +
ESE-2 B-Gene +
, O +
is O +
exclusively O +
expressed O +
in O +
a O +
subset O +
of O +
epithelial O +
cells O +
with O +
highest O +
expression O +
in O +
glandular O +
epithelium O +
such O +
as O +
prostate O +
, O +
pancreas O +
, O +
salivary O +
gland O +
, O +
and O +
trachea O +
. O +

A O +
potential O +
role O +
in O +
branching O +
morphogenesis O +
is O +
suggested O +
, O +
since O +
ESE-3 B-Gene +
transactivates O +
the O +
c B-Gene -
- I-Gene -
MET I-Gene +
promoter O +
via O +
three O +
high O +
affinity O +
binding O +
sites O +
. O +

Additionally O +
, O +
ESE-3 B-Gene +
binding O +
to O +
DNA O +
sequences O +
in O +
the O +
promoters O +
of O +
several O +
glandular O +
epithelium O +
- O +
specific O +
genes O +
suggests O +
a O +
role O +
for O +
ESE-3 B-Gene +
in O +
later O +
stages O +
of O +
glandular O +
epithelium O +
differentiation O +
. O +

Although O +
ESE-3 B-Gene +
and O +
ESE-1 B-Gene +
bind O +
with O +
similar O +
affinity O +
to O +
various O +
Ets B-Gene +
binding O +
sites O +
, O +
ESE-3 B-Gene +
and O +
ESE-1 B-Gene +
differ O +
significantly O +
in O +
their O +
ability O +
to O +
transactivate O +
the O +
promoters O +
containing O +
these O +
sites O +
. O +

Our O +
results O +
support O +
the O +
notion O +
that O +
ESE-1 B-Gene +
, O +
ESE-2 B-Gene +
, O +
and O +
ESE-3 B-Gene +
represent O +
a O +
unique O +
epithelium B-Gene +
- I-Gene +
specific I-Gene +
subfamily I-Gene +
of I-Gene +
Ets I-Gene +
factors I-Gene +
that O +
have O +
critical O +
but O +
distinct O +
functions O +
in O +
epithelial O +
cell O +
differentiation O +
and O +
proliferation O +
. O +

Sustained O +
expression O +
of O +
human O +
apolipoprotein B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
after O +
adenoviral O +
gene O +
transfer O +
in O +
C57BL O -
/ O -
6 O +
mice O +
: O +
role O +
of O +
apolipoprotein B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
promoter O +
, O +
apolipoprotein B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
introns O +
, O +
and O +
human O +
apolipoprotein B-Gene +
E I-Gene +
enhancer O +
. O +

Elevation O +
of O +
HDL B-Gene +
cholesterol O +
, O +
after O +
adenoviral O +
apolipoprotein B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
( O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
) O +
gene O +
transfer O +
, O +
may O +
delay O +
or O +
revert O +
ischemic O +
cardiovascular O +
disease O +
, O +
provided O +
transgene O +
expression O +
is O +
persistent O +
. O +

Previously O +
, O +
we O +
observed O +
transient O +
human O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
expression O +
after O +
adenoviral O +
gene O +
transfer O +
with O +
a O +
cytomegalovirus O +
( O +
CMV O +
) O +
- O +
driven O +
construct O +
containing O +
the O +
human O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
cDNA O +
. O +

Therefore O +
, O +
the O +
effects O +
of O +
promoters O +
( O +
CMV O +
or O +
256 O +
base O +
pairs O +
of O +
the O +
human O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
promoter O +
) O +
, O +
introns O +
of O +
the O +
human O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
gene O +
, O +
and O +
the O +
liver O +
- O +
specific O +
human O +
apolipoprotein B-Gene +
E I-Gene +
( O +
apo B-Gene +
E I-Gene +
) O +
enhancer O +
on O +
adenovirus O +
- O +
mediated O +
human O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
expression O +
were O +
evaluated O +
in O +
C57BL O -
/ O -
6 O +
mice O +
. O +

In O +
the O +
presence O +
of O +
the O +
CMV O +
promoter O +
, O +
human O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
introns O +
prolonged O +
expression O +
above O +
20 O +
mg O +
/ O +
dl O +
from O +
14 O +
to O +
35 O +
days O +
. O +

Addition O +
of O +
one O +
, O +
two O +
, O +
or O +
four O +
copies O +
of O +
the O +
human O +
apo B-Gene +
E I-Gene +
enhancer O +
in O +
these O +
constructs O +
resulted O +
in O +
a O +
copy O +
- O +
dependent O +
but O +
transient O +
increase O +
in O +
expression O +
for O +
14 O +
days O +
. O +

The O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
promoter O +
induced O +
3.2 O +
- O +
fold O +
lower O +
peak O +
levels O +
of O +
human O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
than O +
did O +
the O +
CMV O +
promoter O +
, O +
but O +
insertion O +
of O +
four O +
apo B-Gene +
E I-Gene +
enhancers O +
in O +
the O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
promoter O +
- O +
driven O +
construct O +
resulted O +
in O +
human O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
levels O +
above O +
20 O +
mg O +
/ O +
dl O +
for O +
6 O +
months O +
. O +

The O +
decline O +
between O +
day O +
6 O +
and O +
day O +
35 O +
of O +
human O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
expression O +
driven O +
by O +
the O +
CMV O +
promoter O +
was O +
due O +
to O +
( O -
1 O -
) O +
a O +
2.5 O +
- O +
fold O +
decline O +
in O +
transgene O +
DNA O +
levels O +
that O +
is O +
not O +
observed O +
with O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
promoter O +
- O +
driven O +
constructs O +
, O +
and O +
( O -
2 O -
) O +
CMV O +
promoter O +
attenuation O +
as O +
evidenced O +
by O +
a O +
7.6 O +
- O +
fold O +
decline O +
in O +
the O +
human O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
mRNA O +
/ O +
human O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
DNA O +
copy O +
number O +
ratio O +
between O +
day O +
6 O +
and O +
day O +
35 O +
. O +

Hepatotoxicity O +
, O +
as O +
evidenced O +
by O +
up O +
to O +
10 O +
- O +
fold O +
higher O +
serum O +
levels O +
of O +
transaminases B-Gene +
on O +
day O +
6 O +
after O +
gene O +
transfer O +
with O +
CMV O +
promoter O +
- O +
driven O +
constructs O +
than O +
with O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
promoter O +
- O +
driven O +
constructs O +
, O +
probably O +
caused O +
the O +
accelerated O +
decline O +
of O +
transgene O +
DNA O +
. O +

In O +
conclusion O +
, O +
gene O +
transfer O +
with O +
an O +
adenovirus O +
comprising O +
the O +
256 O +
- O +
bp O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
promoter O +
, O +
the O +
genomic O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
DNA O +
, O +
and O +
four O +
apo B-Gene +
E I-Gene +
enhancers O +
, O +
all O +
of O +
human O +
origin O +
, O +
is O +
associated O +
with O +
low O +
hepatotoxicity O +
and O +
with O +
the O +
absence O +
of O +
promoter O +
shutoff O +
resulting O +
in O +
human O +
apo B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
expression O +
above O +
20 O +
mg O +
/ O +
dl O +
for O +
up O +
to O +
6 O +
months O +
. O +

Impact O +
of O +
restriction O +
of O +
placental O +
and O +
fetal O +
growth O +
on O +
expression O +
of O +
11beta B-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
type I-Gene +
1 I-Gene +
and I-Gene +
type I-Gene +
2 I-Gene +
messenger O +
ribonucleic O +
acid O +
in O +
the O +
liver O +
, O +
kidney O +
, O +
and O +
adrenal O +
of O +
the O +
sheep O +
fetus O +
. O +

We O +
have O +
investigated O +
the O +
effects O +
of O +
fetal O +
growth O +
restriction O +
, O +
induced O +
by O +
restriction O +
of O +
placental O +
growth O +
and O +
function O +
( O +
PR O +
) O +
, O +
on O +
11beta B-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
type I-Gene +
1 I-Gene +
( O +
11betaHSD-1 B-Gene +
) O +
and O +
11betaHSD-2 B-Gene +
messenger O +
RNA O +
( O +
mRNA O +
) O +
expression O +
in O +
fetal O +
tissues O +
in O +
the O +
sheep O +
, O +
using O +
Northern O +
blot O +
analysis O +
. O +

Fetal O +
liver O +
, O +
kidney O +
, O +
and O +
adrenals O +
were O +
collected O +
from O +
normally O +
grown O +
fetuses O +
at O +
90 O +
days O +
( O +
n O +
= O +
6 O +
) O +
, O +
125 O +
days O +
( O +
n O +
= O +
6 O +
) O +
, O +
and O +
141 O +
- O +
145 O +
days O +
( O +
n O +
= O +
7 O +
) O +
and O +
from O +
PR O +
fetuses O +
at O +
141 O +
- O +
145 O +
days O +
( O +
n O +
= O +
6 O +
) O +
. O +

Expression O +
of O +
11betaHSD-1 B-Gene +
mRNA O +
in O +
the O +
fetal O +
liver O +
increased O +
significantly O +
between O +
125 O +
days O +
( O +
7.4 O +
+ O -
/- O +
0.8 O +
) O +
and O +
141 O -
- O -
145 O +
days O +
gestation O +
( O +
27 O +
+ O +
/ O +
- O +
5.3 O +
) O +
. O +

There O +
was O +
also O +
an O +
approximately O +
2 O +
- O +
fold O +
increase O +
in O +
the O +
ratio O +
of O +
11betaHSD-1 B-Gene +
mRNA O +
/ O +
18S O +
rRNA O +
expression O +
in O +
the O +
PR O +
group O +
( O +
53.8 O +
+ O -
/- O +
7.9 O +
) O +
compared O +
with O +
that O +
in O +
control O +
animals O +
at O +
141 O +
- O +
145 O +
days O +
gestation O +
. O +

There O +
was O +
a O +
significant O +
decrease O +
in O +
11betaHSD-2 B-Gene +
mRNA O +
in O +
fetal O +
adrenals O +
between O +
125 O +
days O +
( O +
41.6 O +
+ O -
/- O +
2.4 O +
) O +
and O +
141 O -
- O -
145 O +
days O +
( O +
26.7 O +
+ O -
/- O +
1.1 O +
) O +
gestation O +
, O +
but O +
there O +
was O +
no O +
effect O +
of O +
PR O +
on O +
the O +
expression O +
of O +
adrenal O +
11betaHSD-2 B-Gene +
mRNA O +
. O +

11betaHSD-2 B-Gene +
mRNA O +
expression O +
in O +
the O +
fetal O +
kidney O +
increased O +
between O +
90 O +
days O +
( O +
16.8 O +
+ O -
/- O +
1.7 O +
) O +
and O +
141 O -
- O -
145 O +
days O +
gestation O +
( O +
31.7 O +
+ O -
/- O +
4.3 O +
) O +
, O +
but O +
there O +
was O +
no O +
effect O +
of O +
PR O +
on O +
the O +
levels O +
of O +
11betaHSD-2 B-Gene +
mRNA O +
in O +
the O +
fetal O +
kidney O +
. O +

In O +
summary O +
, O +
11betaHSD-2 B-Gene +
mRNA O +
is O +
differentially O +
regulated O +
in O +
the O +
fetal O +
adrenal O +
and O +
kidney O +
in O +
the O +
sheep O +
fetus O +
during O +
late O +
gestation O +
. O +

There O +
is O +
also O +
a O +
specific O +
increase O +
in O +
the O +
expression O +
of O +
11betaHSD-1 B-Gene +
mRNA O +
in O +
the O +
liver O +
of O +
growth O +
- O +
restricted O +
fetuses O +
in O +
late O +
gestation O +
. O +

This O +
suggests O +
that O +
there O +
is O +
increased O +
hepatic O +
exposure O +
to O +
cortisol O +
in O +
the O +
growth O +
- O +
restricted O +
fetus O +
, O +
which O +
may O +
be O +
important O +
in O +
the O +
reprogramming O +
of O +
hepatic O +
physiology O +
that O +
occurs O +
after O +
growth O +
restriction O +
in O +
utero O +
. O +

Enhancement O +
of O +
secretion O +
and O +
extracellular O +
stability O +
of O +
staphylokinase B-Gene +
in O +
Bacillus O +
subtilis O +
by O +
wprA B-Gene +
gene O +
disruption O +
. O +

Staphylokinase B-Gene +
( O +
SAK B-Gene +
) O +
, O +
a O +
polypeptide O +
secreted O +
by O +
Staphylococcus O +
aureus O +
, O +
is O +
a O +
plasminogen B-Gene +
activator O +
with O +
a O +
therapeutic O +
potential O +
in O +
thrombosis O +
diseases O +
. O +

A O +
Bacillus O +
subtilis O +
strain O +
which O +
is O +
multiply O +
deficient O +
in O +
exoproteases B-Gene +
was O +
transformed O +
by O +
an O +
expression O +
plasmid O +
carrying O +
a O +
promoter O +
and O +
a O +
signal O +
sequence O +
of O +
subtilisin B-Gene +
fused O +
in O +
frame O +
with O +
the O +
sak B-Gene +
open O +
reading O +
frame O +
. O +

However O +
, O +
the O +
amount O +
of O +
SAK B-Gene +
secretion O +
was O +
marginal O +
( O +
45 O +
mg O +
/ O +
liter O +
) O +
. O +

In O +
contrast O +
, O +
disruption O +
of O +
the O +
wprA B-Gene +
gene O +
, O +
which O +
encodes O +
a O +
subtilisin B-Gene +
- O +
type O +
protease B-Gene +
, O +
strongly O +
promoted O +
the O +
production O +
of O +
SAK B-Gene +
in O +
the O +
stationary O +
phase O +
( O +
181 O +
mg O +
/ O +
liter O +
) O +
. O +

In O +
addition O +
, O +
the O +
extracellular O +
stability O +
of O +
mature O +
SAK B-Gene +
was O +
dramatically O +
enhanced O +
. O +

These O +
data O +
indicate O +
a O +
significant O +
role O +
of O +
the O +
wprA B-Gene +
gene O +
product O +
in O +
degrading O +
foreign O +
proteins O +
, O +
both O +
during O +
secretion O +
and O +
in O +
the O +
extracellular O +
milieu O +
. O +

Targeted O +
disruption O +
of O +
the O +
murine O +
junD B-Gene +
gene O +
results O +
in O +
multiple O +
defects O +
in O +
male O +
reproductive O +
function O +
. O +

JunD B-Gene +
is O +
one O +
of O +
three O +
mammalian O +
Jun B-Gene +
proteins O +
that O +
contribute O +
to O +
the O +
AP-1 B-Gene +
transcription B-Gene +
factor I-Gene +
complex O +
. O +

Distinct O +
regulation O +
and O +
functions O +
have O +
been O +
proposed O +
for O +
each O +
Jun B-Gene +
member O +
, O +
but O +
less O +
is O +
known O +
about O +
the O +
biological O +
functions O +
of O +
each O +
of O +
these O +
proteins O +
in O +
vivo O +
. O +

To O +
investigate O +
the O +
role O +
of O +
JunD B-Gene +
, O +
we O +
have O +
inactivated O +
the O +
murine O +
gene O +
by O +
replacement O +
with O +
a O +
bacterial O +
lacZ B-Gene +
reporter O +
gene O +
. O +

Embryonic O +
JunD B-Gene +
expression O +
was O +
initially O +
detected O +
in O +
the O +
developing O +
heart O +
and O +
cardiovascular O +
system O +
. O +

Subsequent O +
broadening O +
phases O +
of O +
JunD B-Gene +
expression O +
were O +
observed O +
during O +
embryonic O +
development O +
and O +
expression O +
in O +
the O +
adult O +
was O +
widespread O +
in O +
many O +
tissues O +
and O +
cell O +
lineages O +
. O +

Mutant O +
animals O +
lack O +
JunD B-Gene +
mRNA O +
and O +
protein O +
and O +
showed O +
no O +
evidence O +
of O +
upregulation O +
of O +
c B-Gene -
- I-Gene -
Jun I-Gene +
and O +
JunB B-Gene +
mRNA O +
levels O +
. O +

In O +
contrast O +
to O +
the O +
other O +
two O +
Jun B-Gene +
members O +
, O +
homozygous O +
JunD B-Gene +
- O +
/ O +
- O +
mutant O +
animals O +
were O +
viable O +
and O +
appeared O +
healthy O +
. O +

However O +
, O +
homozygous O +
JunD B-Gene +
- O +
/ O +
- O +
animals O +
showed O +
a O +
reduced O +
postnatal O +
growth O +
. O +

Furthermore O +
, O +
JunD B-Gene +
- O +
/ O +
- O +
males O +
exhibited O +
multiple O +
age O +
- O +
dependent O +
defects O +
in O +
reproduction O +
, O +
hormone O +
imbalance O +
and O +
impaired O +
spermatogenesis O +
with O +
abnormalities O +
in O +
head O +
and O +
flagellum O +
sperm O +
structures O +
. O +

No O +
defects O +
in O +
fertility O +
were O +
observed O +
in O +
JunD B-Gene +
- O +
/ O +
- O +
female O +
animals O +
. O +

These O +
results O +
provide O +
evidence O +
for O +
redundant O +
functions O +
for O +
members O +
of O +
the O +
Jun B-Gene +
family I-Gene +
during O +
development O +
and O +
specific O +
functions O +
for O +
JunD B-Gene +
in O +
male O +
reproductive O +
function O +
. O +

Palindromes O +
as O +
substrates O +
for O +
multiple O +
pathways O +
of O +
recombination O +
in O +
Escherichia O +
coli O +
. O +

A O +
246 O +
- O +
bp O +
imperfect O +
palindrome O +
has O +
the O +
potential O +
to O +
form O +
hairpin O +
structures O +
in O +
single O +
- O +
stranded O +
DNA O +
during O +
replication O +
. O +

Genetic O +
evidence O +
suggests O +
that O +
these O +
structures O +
are O +
converted O +
to O +
double O +
- O +
strand O +
breaks O +
by O +
the O +
SbcCD B-Gene +
nuclease I-Gene +
and O +
that O +
the O +
double O +
- O +
strand O +
breaks O +
are O +
repaired O +
by O +
recombination O +
. O +

We O +
investigated O +
the O +
role O +
of O +
a O +
range O +
of O +
recombination O +
mutations O +
on O +
the O +
viability O +
of O +
cells O +
containing O +
this O +
palindrome O +
. O +

The O +
palindrome O +
was O +
introduced O +
into O +
the O +
Escherichia O +
coli O +
chromosome O +
by O +
phage O +
lambda O +
lysogenization O +
. O +

This O +
was O +
done O +
in O +
both O +
wt O +
and O +
sbcC B-Gene +
backgrounds O +
. O +

Repair O +
of O +
the O +
SbcCD B-Gene +
- O +
induced O +
double O +
- O +
strand O +
breaks O +
requires O +
a O +
large O +
number O +
of O +
proteins O +
, O +
including O +
the O +
components O +
of O +
both O +
the O +
RecB B-Gene +
and O +
RecF B-Gene +
pathways O +
. O +

Repair O +
does O +
not O +
involve O +
PriA B-Gene +
- O +
dependent O +
replication O +
fork O +
restart O +
, O +
which O +
suggests O +
that O +
the O +
double O +
- O +
strand O +
break O +
occurs O +
after O +
the O +
replication O +
fork O +
has O +
passed O +
the O +
palindrome O +
. O +

In O +
the O +
absence O +
of O +
SbcCD B-Gene +
, O +
recombination O +
still O +
occurs O +
, O +
probably O +
using O +
a O +
gap O +
substrate O +
. O +

This O +
process O +
is O +
also O +
PriA B-Gene +
independent O +
, O +
suggesting O +
that O +
there O +
is O +
no O +
collapse O +
of O +
the O +
replication O +
fork O +
. O +

In O +
the O +
absence O +
of O +
RecA B-Gene +
, O +
the O +
RecQ B-Gene +
helicase B-Gene +
is O +
required O +
for O +
palindrome O +
viability O +
in O +
a O +
sbcC B-Gene +
mutant O +
, O +
suggesting O +
that O +
a O +
helicase B-Gene +
- O +
dependent O +
pathway O +
exists O +
to O +
allow O +
replicative O +
bypass O +
of O +
secondary O +
structures O +
. O +

alpha5beta1 B-Gene +
integrin I-Gene +
expression O +
and O +
luminal O +
edge O +
fibronectin B-Gene +
matrix O +
assembly O +
by O +
smooth O +
muscle O +
cells O +
after O +
arterial O +
injury O +
. O +

Fibronectin B-Gene +
is O +
secreted O +
from O +
the O +
cell O +
as O +
a O +
soluble O +
protein O +
that O +
must O +
then O +
polymerize O +
to O +
regulate O +
cell O +
function O +
. O +

To O +
elucidate O +
the O +
process O +
of O +
fibronectin B-Gene +
matrix O +
assembly O +
in O +
vascular O +
disease O +
, O +
we O +
immunostained O +
sections O +
of O +
balloon O +
- O +
injured O +
rat O +
carotid O +
artery O +
for O +
the O +
fibronectin B-Gene +
- O +
binding O +
alpha5beta1 B-Gene +
integrin I-Gene +
. O +

Whereas O +
alpha5beta1 B-Gene +
integrin I-Gene +
was O +
not O +
evident O +
in O +
the O +
normal O +
carotid O +
artery O +
, O +
its O +
expression O +
was O +
induced O +
after O +
a O +
vascular O +
injury O +
. O +

By O +
14 O +
days O +
, O +
the O +
alpha5beta1 B-Gene +
integrin I-Gene +
was O +
localized O +
exclusively O +
to O +
the O +
less O +
differentiated O +
smooth O +
muscle O +
cells O +
( O +
SMCs O +
) O +
at O +
the O +
luminal O +
surface O +
of O +
the O +
neointima O +
. O +

Platelet B-Gene +
- I-Gene +
derived I-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
BB I-Gene +
, O +
dominant O +
in O +
neointimal O +
formation O +
, O +
selectively O +
increased O +
the O +
expression O +
of O +
the O +
alpha5beta1 B-Gene +
integrin I-Gene +
by O +
human O +
SMCs O +
in O +
culture O +
. O +

To O +
track O +
the O +
assembly O +
of O +
fibronectin B-Gene +
fibers O +
, O +
fluorescence O +
- O +
labeled O +
soluble O +
fibronectin B-Gene +
protomers O +
were O +
added O +
to O +
cultured O +
SMCs O +
and O +
to O +
fresh O +
segments O +
of O +
normal O +
and O +
balloon O +
- O +
injured O +
rat O +
carotid O +
arteries O +
. O +

Fibronectin B-Gene +
fiber O +
formation O +
in O +
cultured O +
SMCs O +
could O +
be O +
detected O +
within O +
10 O +
minutes O +
, O +
and O +
was O +
blocked O +
by O +
an O +
RGD O +
peptide O +
, O +
an O +
anti O +
- O +
beta1 B-Gene +
integrin I-Gene +
antibody O +
, O +
and O +
an O +
anti O +
- O +
alpha5beta1 B-Gene +
integrin I-Gene +
antibody O +
, O +
but O +
not O +
by O +
an O +
anti O +
- O +
beta3 B-Gene +
integrin I-Gene +
antibody O +
. O +

En O +
face O +
confocal O +
microscopy O +
of O +
arterial O +
segments O +
revealed O +
that O +
soluble O +
fibronectin B-Gene +
had O +
polymerized O +
on O +
the O +
alpha5beta1 B-Gene +
integrin I-Gene +
- O +
expressing O +
SMCs O +
of O +
the O +
luminal O +
surface O +
of O +
the O +
injured O +
arterial O +
neointima O +
, O +
but O +
not O +
on O +
the O +
alpha5beta1 B-Gene +
integrin I-Gene +
- O +
negative O +
neointimal O +
SMCs O +
below O +
this O +
or O +
on O +
the O +
endothelial O +
cells O +
of O +
uninjured O +
arteries O +
. O +

Furthermore O +
, O +
in O +
situ O +
fibronectin B-Gene +
assembly O +
by O +
the O +
neointimal O +
SMCs O +
was O +
inhibited O +
by O +
an O +
RGD O +
peptide O +
and O +
by O +
an O +
anti O +
- O +
beta1 B-Gene +
integrin I-Gene +
antibody O +
. O +

These O +
studies O +
indicate O +
that O +
a O +
subpopulation O +
of O +
SMCs O +
in O +
the O +
repairing O +
artery O +
wall O +
orchestrates O +
integrin B-Gene +
- O +
mediated O +
fibronectin B-Gene +
assembly O +
. O +

Pattern O +
of O +
morphological O +
diversification O +
in O +
the O +
Leptocarabus O +
ground O +
beetles O +
( O +
Coleoptera O +
: O +
Carabidae O +
) O +
as O +
deduced O +
from O +
mitochondrial O +
ND5 B-Gene +
gene O +
and O +
nuclear O +
28S O +
rDNA O +
sequences O +
. O +

Most O +
of O +
the O +
mitochondrial O +
NADH B-Gene +
dehydrogenase I-Gene +
subunit I-Gene +
5 I-Gene +
( O +
ND5 B-Gene +
) O +
gene O +
and O +
a O +
part O +
of O +
nuclear O +
28S O +
ribosomal O +
RNA O +
gene O +
were O +
sequenced O +
for O +
14 O +
species O +
of O +
ground O +
beetles O +
belonging O +
to O +
the O +
genus O +
Leptocarabus O +
. O +

In O +
both O +
the O +
ND5 B-Gene +
and O +
the O +
28S O +
rDNA O +
phylogenetic O +
trees O +
of O +
Leptocarabus O +
, O +
three O +
major O +
lineages O +
were O +
recognized O +
: O +
( O -
1 O -
) O +
L. O +
marcilhaci O +
/ O +
L. O +
yokoael O +
/ O +
Leptocarabus O +
sp. O +
from O +
China O +
, O +
( O +
2 O +
) O +
L. O +
koreanus O +
/ O +
L. O +
truncaticollis O +
/ O +
L. O +
seishinensis O +
/ O +
L. O +
semiopacus O +
/ O +
L. O +
canaliculatus O +
/ O +
L. O +
kurilensis O +
from O +
the O +
northern O +
Eurasian O +
continent O +
including O +
Korea O +
and O +
Hokkaido O +
, O +
Japan O +
, O +
and O +
( O -
3 O -
) O +
all O +
of O +
the O +
Japanese O +
species O +
except O +
L. O +
kurilensis O +
. O +

Clustering O +
of O +
the O +
species O +
in O +
the O +
trees O +
is O +
largely O +
linked O +
to O +
their O +
geographic O +
distribution O +
and O +
does O +
not O +
correlate O +
with O +
morphological O +
characters O +
. O +

The O +
species O +
belonging O +
to O +
different O +
species O +
groups O +
are O +
clustered O +
in O +
the O +
same O +
lineages O +
, O +
and O +
those O +
in O +
the O +
same O +
species O +
group O +
are O +
scattered O +
among O +
the O +
different O +
lineages O +
. O +

One O +
of O +
the O +
possible O +
interpretations O +
of O +
the O +
present O +
results O +
would O +
be O +
that O +
morphological O +
transformations O +
independently O +
took O +
place O +
in O +
the O +
different O +
lineages O +
, O +
sometimes O +
with O +
accompanying O +
parallel O +
morphological O +
evolution O +
, O +
resulting O +
in O +
the O +
occurrence O +
of O +
the O +
morphological O +
species O +
belonging O +
to O +
the O +
same O +
species O +
group O +
( O +
= O +
type O +
) O +
in O +
the O +
different O +
lineages O +
. O +

Identification O +
of O +
the O +
Nogo B-Gene +
inhibitor O +
of O +
axon O +
regeneration O +
as O +
a O +
Reticulon B-Gene +
protein O +
. O +

Adult O +
mammalian O +
axon O +
regeneration O +
is O +
generally O +
successful O +
in O +
the O +
peripheral O +
nervous O +
system O +
( O +
PNS O +
) O +
but O +
is O +
dismally O +
poor O +
in O +
the O +
central O +
nervous O +
system O +
( O +
CNS O +
) O +
. O +

However O +
, O +
many O +
classes O +
of O +
CNS O +
axons O +
can O +
extend O +
for O +
long O +
distances O +
in O +
peripheral O +
nerve O +
grafts O +
. O +

A O +
comparison O +
of O +
myelin O +
from O +
the O +
CNS O +
and O +
the O +
PNS O +
has O +
revealed O +
that O +
CNS O +
white O +
matter O +
is O +
selectively O +
inhibitory O +
for O +
axonal O +
outgrowth O +
. O +

Several O +
components O +
of O +
CNS O +
white O +
matter O +
, O +
NI35 O +
, O +
NI250 O +
( O +
Nogo B-Gene +
) O +
and O +
MAG B-Gene +
, O +
that O +
have O +
inhibitory O +
activity O +
for O +
axon O +
extension O +
have O +
been O +
described O +
. O +

The O +
IN-1 O +
antibody O +
, O +
which O +
recognizes O +
NI35 O +
and O +
NI250 O +
( O +
Nogo B-Gene +
) O +
, O +
allows O +
moderate O +
degrees O +
of O +
axonal O +
regeneration O +
and O +
functional O +
recovery O +
after O +
spinal O +
cord O +
injury O +
. O +

Here O +
we O +
identify O +
Nogo B-Gene +
as O +
a O +
member O +
of O +
the O +
Reticulon B-Gene +
family I-Gene +
, O +
Reticulon B-Gene +
4-A I-Gene +
. O +

Nogo B-Gene +
is O +
expressed O +
by O +
oligodendrocytes O +
but O +
not O +
by O +
Schwann O +
cells O +
, O +
and O +
associates O +
primarily O +
with O +
the O +
endoplasmic O +
reticulum O +
. O +

A O +
66 O +
- O +
residue O +
lumenal O +
/ O +
extracellular O +
domain O +
inhibits O +
axonal O +
extension O +
and O +
collapses O +
dorsal O +
root O +
ganglion O +
growth O +
cones O +
. O +

In O +
contrast O +
to O +
Nogo B-Gene +
, O +
Reticulon B-Gene +
1 I-Gene +
and I-Gene +
3 I-Gene +
are O +
not O +
expressed O +
by O +
oligodendrocytes O +
, O +
and O +
the O +
66 O +
- O +
residue O +
lumenal O +
/ O +
extracellular O +
domains O +
from O +
Reticulon B-Gene +
1 I-Gene +
, I-Gene +
2 I-Gene +
and I-Gene +
3 I-Gene +
do O +
not O +
inhibit O +
axonal O +
regeneration O +
. O +

These O +
data O +
provide O +
a O +
molecular O +
basis O +
to O +
assess O +
the O +
contribution O +
of O +
Nogo B-Gene +
to O +
the O +
failure O +
of O +
axonal O +
regeneration O +
in O +
the O +
adult O +
CNS O +
. O +

Restoration O +
of O +
cytotoxic O +
T O +
lymphocyte O +
function O +
in O +
malignant O +
pleural O +
effusion O +
: O +
interleukin-15 B-Gene +
vs. O +
interleukin-2 B-Gene +
. O +

The O +
present O +
study O +
attempts O +
to O +
define O +
the O +
role O +
of O +
interleukin-15 B-Gene +
( O +
IL-15 B-Gene +
) O +
, O +
as O +
compared O +
with O +
IL-2 B-Gene +
, O +
in O +
generating O +
cytotoxic O +
T O +
lymphocytes O +
( O +
CTL O +
) O +
from O +
the O +
malignant O +
effusions O +
of O +
cancer O +
patients O +
. O +

Effusion O +
- O +
associated O +
lymphocytes O +
( O +
EAL O +
) O +
from O +
malignant O +
effusion O +
were O +
incubated O +
with O +
IL-15 B-Gene +
or O +
IL-2 B-Gene +
with O +
or O +
without O +
alphaCD3 B-Gene +
. O +

Proliferation O +
and O +
cytotoxicity O +
assays O +
were O +
performed O +
. O +

IL-15 B-Gene +
was O +
found O +
to O +
have O +
at O +
least O +
an O +
equivalent O +
, O +
if O +
not O +
higher O +
, O +
activity O +
to O +
IL-2 B-Gene +
in O +
terms O +
of O +
lymphocyte O +
proliferation O +
and O +
generation O +
of O +
CTL O +
from O +
EAL O +
. O +

The O +
proliferative O +
response O +
of O +
EAL O +
, O +
cocultured O +
with O +
IL-15 B-Gene +
, O +
with O +
or O +
without O +
alphaCD3 B-Gene +
, O +
was O +
partly O +
inhibited O +
by O +
pretreatment O +
with O +
an O +
anti O +
- O +
IL2 B-Gene +
receptor I-Gene +
beta I-Gene +
chain O +
monoclonal O +
antibody O +
( O +
mAb O +
) O +
. O +

The O +
proliferative O +
response O +
of O +
EAL O +
, O +
cocultured O +
with O +
alphaCD3 B-Gene +
, O +
IL-2 B-Gene +
, O +
or O +
both O +
, O +
was O +
partly O +
inhibited O +
by O +
pretreatment O +
with O +
an O +
anti O +
- O +
IL-2 B-Gene +
receptor I-Gene +
alpha I-Gene +
chain O +
mAb O +
. O +

Overnight O +
[ O +
5lCr O +
] O +
release O +
assays O +
against O +
K562 O +
, O +
Daudi O +
, O +
and O +
the O +
patients O +
' O +
autologous O +
tumor O +
cells O +
were O +
done O +
to O +
evaluate O +
EAL O +
's O +
cytolytic O +
activity O +
. O +

MHC B-Gene +
class I-Gene +
I I-Gene +
Ab O +
blocked O +
the O +
stimulated O +
cytolytic O +
activity O +
of O +
EAL O +
against O +
autologous O +
tumors O +
. O +

An O +
mAb O +
depletion O +
assay O +
showed O +
that O +
the O +
phenotype O +
of O +
the O +
restored O +
EAL O +
was O +
CD16 B-Gene +
- O +
CD4 B-Gene +
- O +
CD8 B-Gene +
+ O +
; O +
thus O +
, O +
the O +
restored O +
activity O +
of O +
EAL O +
was O +
CTL O +
activity O +
. O +

The O +
results O +
suggest O +
that O +
both O +
IL-15 B-Gene +
and O +
IL-2 B-Gene +
can O +
restore O +
CTL O +
activity O +
from O +
EAL O +
in O +
the O +
presence O +
of O +
T B-Gene +
cell I-Gene +
receptor I-Gene +
( O +
TCR B-Gene +
) O +
- O +
CD3 B-Gene +
engagement O +
, O +
but O +
the O +
effect O +
of O +
IL-15 B-Gene +
was O +
superior O +
. O +

Tyrosine O +
462 O +
of O +
the O +
membrane O +
- O +
proximal O +
F'-G O -
' O +
loop O +
of O +
murine O +
Mpl B-Gene +
is O +
not O +
essential O +
for O +
high O +
- O +
affinity O +
binding O +
of O +
thrombopoietin B-Gene +
. O +

The O +
ligand O +
binding O +
site O +
of O +
Mpl B-Gene +
, O +
the O +
thrombopoietin B-Gene +
( I-Gene +
Tpo I-Gene +
) I-Gene +
receptor I-Gene +
, O +
has O +
not O +
been O +
determined O +
. O +

Tyr O -
( O -
462 O -
) O +
of O +
murine O +
Mpl B-Gene +
corresponds O +
to O +
Tyr O -
( O -
421 O -
) O +
of O +
the O +
common B-Gene +
beta I-Gene +
chain I-Gene +
of I-Gene +
the I-Gene +
human I-Gene +
IL-3 I-Gene +
, I-Gene +
IL-5 I-Gene +
and I-Gene +
GM I-Gene -
- I-Gene -
CSF I-Gene +
receptors I-Gene +
. O +

Tyr O -
( O -
421 O -
) O +
has O +
been O +
identified O +
as O +
essential O +
for O +
high O +
- O +
affinity O +
ligand O +
binding O +
. O +

To O +
determine O +
whether O +
Tyr O -
( O -
462 O -
) O +
is O +
similarly O +
required O +
for O +
Tpo B-Gene +
binding O +
, O +
wild O +
- O +
type O +
murine O +
Mpl B-Gene +
( O +
Mpl B-Gene +
- O +
WT O +
) O +
or O +
mutant O +
receptors O +
containing O +
an O +
alanine O +
( O +
Y462A O +
) O +
or O +
lysine O +
( O +
Y462 O -
K O +
) O +
in O +
place O +
of O +
Tyr O -
( O -
462 O -
) O +
were O +
expressed O +
in O +
BaF3 O +
cells O +
. O +

In O +
proliferation O +
studies O +
, O +
the O +
Y462A O +
mutation O +
had O +
no O +
effect O +
on O +
Tpo B-Gene +
- O +
induced O +
growth O +
. O +

In O +
contrast O +
, O +
the O +
Y462 O -
K O +
mutation O +
led O +
to O +
an O +
attenuated O +
proliferative O +
response O +
to O +
Tpo B-Gene +
. O +

In O +
single O +
- O +
point O +
binding O +
studies O +
, O +
both O +
Mpl B-Gene +
- O +
WT O +
and O +
Y462A O +
cells O +
were O +
able O +
to O +
bind O +
[ O -
( O -
125 O -
) O -
I O -
] O +
Tpo B-Gene +
in O +
a O +
specific O +
manner O +
. O +

In O +
contrast O +
, O +
there O +
was O +
a O +
marked O +
reduction O +
in O +
binding O +
of O +
[ O -
( O -
125 O -
) O -
I O -
] O +
Tpo B-Gene +
by O +
Y462 O -
K O +
cells O +
. O +

Mpl B-Gene +
- O +
WT O +
cells O +
bound O +
Tpo B-Gene +
with O +
a O +
K O -
( O -
d O -
) O +
of O +
approximately O +
330 O +
pM O +
, O +
while O +
Y462A O +
cells O +
bound O +
Tpo B-Gene +
with O +
a O +
K O -
( O -
d O -
) O +
of O +
approximately O +
268 O +
pM O +
. O +

The O +
binding O +
affinity O +
of O +
Y462 O -
K O +
cells O +
was O +
below O +
that O +
quantifiable O +
by O +
Scatchard O +
analysis O +
. O +

This O +
study O +
suggests O +
that O +
unlike O +
the O +
corresponding O +
Tyr O -
( O -
421 O -
) O +
of O +
the O +
common O +
human O +
beta O +
chain O +
, O +
Tyr O -
( O -
462 O -
) O +
of O +
murine O +
Mpl B-Gene +
is O +
not O +
required O +
for O +
high O +
- O +
affinity O +
ligand O +
binding O +
, O +
although O +
it O +
may O +
be O +
located O +
in O +
proximity O +
to O +
the O +
ligand O +
binding O +
site O +
. O +

Introduction O +
of O +
polyphosphate O +
as O +
a O +
novel O +
phosphate O +
pool O +
in O +
the O +
chloroplast O +
of O +
transgenic O +
potato O +
plants O +
modifies O +
carbohydrate O +
partitioning O +
. O +

Potato O +
plants O +
( O +
Solanum O +
tuberosum O +
L. O +
, O +
cv O -
. O +
DÃ?Â O -
© O -
sirÃ?Â O -
© O -
e O +
) O +
were O +
transformed O +
with O +
the O +
polyphosphate B-Gene +
kinase I-Gene +
gene O +
from O +
Escherichia O +
coli O +
fused O +
to O +
the O +
leader O +
sequence O +
of O +
the O +
ferredoxin B-Gene +
oxidoreductase I-Gene +
gene O +
( O +
FNR B-Gene +
) O +
from O +
Spinacea O +
oleracea O +
under O +
the O +
control O +
of O +
the O +
leaf O +
specific O +
St O +
- O +
LS1 B-Gene +
promoter O +
to O +
introduce O +
a O +
novel O +
phosphate O +
pool O +
in O +
the O +
chloroplasts O +
of O +
green O +
tissues O +
. O +

Transgenic O +
plants O +
( O +
cpPPK O +
) O +
in O +
tissue O +
culture O +
developed O +
necrotic O +
lesions O +
in O +
older O +
leaves O +
and O +
showed O +
earlier O +
leaf O +
senescence O +
while O +
greenhouse O +
plants O +
showed O +
no O +
noticeable O +
phenotype O +
. O +

Leaves O +
of O +
cpPPK O +
plants O +
contained O +
less O +
starch O +
but O +
higher O +
concentrations O +
of O +
soluble O +
sugars O +
. O +

The O +
presence O +
of O +
polyphosphate O +
in O +
cpPPK O +
leaves O +
was O +
demonstrated O +
by O +
toluidine O +
blue O +
staining O +
and O +
unambiguously O +
verified O +
and O +
quantified O +
by O +
in O +
vitro O +
31P O -
- O -
NMR O +
of O +
extracts O +
. O +

Polyphosphate O +
accumulated O +
during O +
leaf O +
development O +
from O +
0.06 O +
in O +
juvenile O +
leaves O +
to O +
0.83 O +
mg O +
P O +
g-1 O +
DW O +
in O +
old O +
leaves O +
and O +
had O +
an O +
average O +
chain O +
length O +
of O +
18 O +
residues O +
in O +
mature O +
leaves O +
. O +

In O +
situ O +
31P O -
- O -
NMR O +
on O +
small O +
leaf O +
pieces O +
perfused O +
with O +
well O +
- O +
oxygenated O +
medium O +
showed O +
only O +
0.036 O +
mg O +
P O +
g-1 O +
DW O +
polyphosphate O +
that O +
was O +
, O +
however O +
, O +
greatly O +
increased O +
upon O +
treatment O +
with O +
50 O +
mM O +
ammonium O +
sulfate O +
at O +
pH O +
7.3 O +
. O +

This O +
phenomenon O +
along O +
with O +
a O +
yield O +
of O +
0.47 O +
mg O +
P O +
g-1 O +
DW O +
polyphosphate O +
from O +
an O +
extract O +
of O +
the O +
same O +
leaf O +
material O +
suggests O +
that O +
93 O +
% O +
of O +
the O +
polyphosphate O +
pool O +
is O +
immobile O +
. O +

This O +
conclusion O +
is O +
substantiated O +
by O +
the O +
observation O +
that O +
no O +
differences O +
in O +
polyphosphate O +
pool O +
sizes O +
could O +
be O +
discerned O +
between O +
darkened O +
and O +
illuminated O +
leaves O +
, O +
leaves O +
treated O +
with O +
methylviologen O +
or O +
anaerobis O +
and O +
control O +
leaves O +
, O +
treatments O +
causing O +
a O +
change O +
in O +
the O +
pool O +
of O +
ATP O +
available O +
for O +
polyPi O +
synthesis O +
. O +

Results O +
are O +
discussed O +
in O +
the O +
context O +
of O +
the O +
chelating O +
properties O +
of O +
polyphosphates O +
for O +
cations O +
and O +
its O +
consequences O +
for O +
the O +
partitioning O +
of O +
photoassimilate O +
between O +
starch O +
and O +
soluble O +
sugars O +
. O +

Distribution O +
of O +
PDE4A B-Gene +
and O +
G B-Gene -
( I-Gene -
o I-Gene -
) I-Gene +
alpha I-Gene +
immunoreactivity O +
in O +
the O +
accessory O +
olfactory O +
system O +
of O +
the O +
mouse O +
. O +

Distribution O +
of O +
the O +
cAMP O +
- O +
specific O +
phosphodiesterase B-Gene +
PDE4A B-Gene +
was O +
examined O +
in O +
the O +
accessory O +
olfactory O +
system O +
by O +
immunohistochemistry O +
. O +

Adjacent O +
sections O +
through O +
the O +
vomeronasal O +
organ O +
( O +
VNO O +
) O +
and O +
accessory O +
olfactory O +
bulb O +
( O +
AOB O +
) O +
were O +
alternately O +
immunostained O +
with O +
antibodies O +
against O +
PDE4A B-Gene +
or O +
the O +
G B-Gene +
- I-Gene +
protein I-Gene +
alpha I-Gene +
subunit O +
G B-Gene +
( I-Gene +
o I-Gene +
) I-Gene +
alpha I-Gene +
, O +
which O +
labels O +
basal O +
VNO O +
neurons O +
, O +
in O +
order O +
to O +
determine O +
whether O +
PDE4A B-Gene +
occurs O +
preferentially O +
in O +
one O +
of O +
two O +
segregated O +
VNO O +
pathways O +
. O +

We O +
found O +
that O +
PDE4A B-Gene +
strongly O +
labeled O +
apical O +
VNO O +
neurons O +
and O +
rostral O +
AOB O +
glomeruli O +
. O +

There O +
was O +
virtually O +
no O +
overlap O +
in O +
G B-Gene -
( I-Gene -
o I-Gene -
) I-Gene +
alpha I-Gene +
and O +
PDE4A B-Gene +
staining O +
, O +
and O +
there O +
were O +
no O +
regions O +
of O +
the O +
VNO O +
neuroepithelium O +
or O +
AOB O +
glomeruli O +
not O +
labeled O +
by O +
either O +
antibody O +
. O +

These O +
results O +
identify O +
a O +
potential O +
member O +
of O +
the O +
pheromone O +
transduction O +
cascade O +
in O +
apical O +
neurons O +
, O +
and O +
provide O +
further O +
evidence O +
that O +
the O +
VNO O +
consists O +
of O +
functionally O +
distinct O +
pathways O +
. O +

Cloning O +
and O +
characterization O +
of O +
additional O +
members O +
of O +
the O +
G B-Gene +
protein I-Gene +
- I-Gene +
coupled I-Gene +
receptor I-Gene +
family I-Gene +
. O +

A O +
search O +
of O +
the O +
expressed O +
sequence O +
tag O +
( O +
EST O +
) O +
database O +
retrieved O +
a O +
human O +
cDNA O +
sequence O +
which O +
partially O +
encoded O +
a O +
novel O +
G B-Gene +
protein I-Gene +
- I-Gene +
coupled I-Gene +
receptor I-Gene +
( O +
GPCR B-Gene +
) O +
GPR26 B-Gene +
. O +

A O +
human O +
genomic O +
DNA O +
fragment O +
encoding O +
a O +
partial O +
open O +
reading O +
frame O +
( O +
ORF O +
) O +
and O +
a O +
rat O +
cDNA O +
encoding O +
the O +
full O +
length O +
ORF O +
of O +
GPR26 B-Gene +
were O +
obtained O +
by O +
library O +
screening O +
. O +

The O +
rat O +
GPR26 B-Gene +
cDNA O +
encoded O +
a O +
protein O +
of O +
317 O +
amino O +
acids O +
, O +
most O +
similar O +
( O +
albeit O +
distantly O +
related O +
) O +
to O +
the O +
serotonin B-Gene +
5-HT I-Gene -
( I-Gene -
5A I-Gene -
) I-Gene +
and O +
gastrin B-Gene +
releasing I-Gene +
hormone I-Gene +
BB2 I-Gene +
receptors I-Gene +
. O +

GPR26 B-Gene +
mRNA O +
expression O +
analysis O +
revealed O +
signals O +
in O +
the O +
striatum O +
, O +
pons O +
, O +
cerebellum O +
and O +
cortex O +
. O +

HEK293 O +
and O +
Rh7777 O +
cells O +
transfected O +
with O +
GPR26 B-Gene +
cDNA O +
displayed O +
high O +
basal O +
cAMP O +
levels O +
, O +
slow O +
growth O +
rate O +
of O +
clonal O +
populations O +
and O +
derangements O +
of O +
normal O +
cell O +
shape O +
. O +

We O +
also O +
used O +
a O +
sequence O +
reported O +
only O +
in O +
the O +
patent O +
literature O +
encoding O +
GPR57 B-Gene +
( O +
a.k.a O -
. O +
HNHCI32 O +
) O +
to O +
PCR O +
amplify O +
a O +
DNA O +
fragment O +
which O +
was O +
used O +
to O +
screen O +
a O +
human O +
genomic O +
library O +
. O +

This O +
resulted O +
in O +
the O +
cloning O +
of O +
a O +
genomic O +
fragment O +
containing O +
a O +
pseudogene O +
, O +
psiGPR57 B-Gene +
, O +
with O +
a O +
99.6 O +
% O +
nucleotide O +
identity O +
to O +
GPR57 B-Gene +
. O +

Based O +
on O +
shared O +
sequence O +
identities O +
, O +
the O +
receptor O +
encoded O +
by O +
GPR57 B-Gene +
was O +
predicted O +
to O +
belong O +
to O +
a O +
novel O +
subfamily O +
of O +
GPCRs B-Gene +
together O +
with O +
GPR58 B-Gene +
( O +
a.k.a O -
. O +
phBL5 O +
, O +
reported O +
only O +
in O +
the O +
patent O +
literature O +
) O +
, O +
putative B-Gene +
neurotransmitter I-Gene +
receptor I-Gene +
( O +
PNR B-Gene +
) O +
and O +
a O +
5-HT B-Gene -
( I-Gene -
4 I-Gene -
) I-Gene +
pseudogene I-Gene +
. O +

Analysis O +
of O +
this O +
subfamily O +
revealed O +
greatest O +
identities O +
( O +
approximately O +
56 O +
% O +
) O +
between O +
the O +
receptors O +
encoded O +
by O +
GPR57 B-Gene +
and O +
GPR58 B-Gene +
, O +
each O +
with O +
shared O +
identities O +
of O +
approximately O +
40 O +
% O +
with O +
PNR B-Gene +
. O +

Furthermore O +
, O +
psiGPR57 B-Gene +
, O +
GPR58 B-Gene +
, O +
PNR B-Gene +
and O +
the O +
5-HT B-Gene -
( I-Gene -
4 I-Gene -
) I-Gene +
pseudogene I-Gene +
were O +
mapped O +
in O +
a O +
cluster O +
localized O +
to O +
chromosome O +
6q22 O +
- O +
24 O +
. O +

PNR B-Gene +
and O +
GPR58 B-Gene +
were O +
expressed O +
in O +
COS O +
cells O +
, O +
however O +
no O +
specific O +
binding O +
was O +
observed O +
for O +
various O +
serotonin B-Gene +
receptor I-Gene +
- O +
specific O +
ligands O +
. O +

Antirestriction B-Gene +
protein I-Gene +
Ard I-Gene +
( I-Gene +
Type I-Gene +
C I-Gene +
) I-Gene +
encoded O +
by O +
IncW O +
plasmid O +
pSa O +
has O +
a O +
high O +
similarity O +
to O +
the O +
" O +
protein O +
transport O +
" O +
domain O +
of O +
TraC1 B-Gene +
primase I-Gene +
of O +
promiscuous O +
plasmid O +
RP4 O +
. O +

The O +
IncW O +
plasmid O +
pSa O +
contains O +
the O +
gene O +
ard B-Gene +
encoding O +
an O +
antirestriction O +
function O +
that O +
is O +
specific O +
for O +
type O +
I O +
restriction O +
and O +
modification O +
systems O +
. O +

The O +
nucleotide O +
sequence O +
of O +
ard B-Gene +
was O +
determined O +
and O +
an O +
appropriate O +
polypeptide O +
of O +
about O +
33 O +
kDa O +
was O +
identified O +
in O +
Escherichia O +
coli O +
T7 O +
expression O +
system O +
. O +

Analysis O +
of O +
deduced O +
amino O +
acid O +
sequence O +
of O +
Ard B-Gene +
encoded O +
by O +
pSa O +
revealed O +
that O +
this O +
protein O +
has O +
no O +
significant O +
similarities O +
with O +
the O +
known O +
Ard B-Gene +
proteins O +
( O +
ArdA B-Gene +
and O +
ArdB B-Gene +
types O +
) O +
except O +
the O +
" O +
antirestriction O +
" O +
motif O +
( O +
14 O +
amino O +
acid O +
residues O +
in O +
length O +
) O +
conserved O +
for O +
all O +
known O +
Ard B-Gene +
proteins O +
. O +

This O +
finding O +
suggests O +
that O +
pSa O +
Ard B-Gene +
may O +
be O +
classified O +
as O +
a O +
new O +
type O +
of O +
Ard B-Gene +
proteins O +
which O +
we O +
designated O +
ArdC B-Gene +
. O +

The O +
remarkable O +
feature O +
of O +
ArdC B-Gene +
is O +
that O +
it O +
has O +
a O +
high O +
degree O +
of O +
similarity O +
( O +
about O +
38 O +
% O +
identity O +
) O +
to O +
the O +
N O -
- O -
terminal O +
region O +
of O +
RP4 O +
TraC1 B-Gene +
primase I-Gene +
which O +
includes O +
about O +
300 O +
amino O +
acid O +
residues O +
and O +
seems O +
to O +
be O +
essential O +
for O +
binding O +
to O +
the O +
single O +
- O +
stranded O +
DNA O +
and O +
TraC1 B-Gene +
protein O +
transport O +
to O +
the O +
recipient O +
cells O +
during O +
the O +
conjugal O +
transfer O +
of O +
plasmid O +
DNA O +
. O +

ArdC B-Gene +
also O +
binds O +
to O +
single O +
- O +
stranded O +
DNA O +
. O +

In O +
addition O +
, O +
this O +
protein O +
is O +
able O +
in O +
vitro O +
to O +
protect O +
the O +
single O +
- O +
stranded O +
but O +
not O +
double O +
- O +
stranded O +
plasmid O +
DNA O +
against O +
the O +
activity O +
of O +
type B-Gene +
II I-Gene +
restriction I-Gene +
endonuclease I-Gene +
HhaI B-Gene +
that O +
cleaves O +
both O +
single O +
and O +
double O +
- O +
stranded O +
DNA O +
. O +

We O +
suggest O +
that O +
like O +
TraC1 B-Gene +
, O +
ArdC B-Gene +
would O +
be O +
transported O +
as O +
a O +
result O +
of O +
their O +
interaction O +
with O +
the O +
single O +
- O +
stranded O +
DNA O +
of O +
transferred O +
plasmid O +
strand O +
during O +
conjugative O +
passage O +
through O +
the O +
cell O +
envelope O +
to O +
the O +
recipient O +
bacterium O +
. O +

Such O +
properties O +
of O +
ArdC B-Gene +
protein O +
might O +
be O +
useful O +
to O +
protect O +
immediately O +
the O +
incoming O +
single O +
- O +
stranded O +
DNA O +
from O +
the O +
host O +
endonucleases B-Gene +
. O +

Plasma O +
fibrinogen B-Gene +
, O +
haemostatic O +
factors O +
and O +
prediction O +
of O +
peripheral O +
arterial O +
disease O +
in O +
the O +
Edinburgh O +
Artery O +
Study O +
. O +

The O +
role O +
of O +
fibrinogen B-Gene +
and O +
other O +
haemostatic O +
factors O +
in O +
prediction O +
of O +
peripheral O +
arterial O +
disease O +
( O +
PAD O +
) O +
has O +
not O +
been O +
established O +
. O +

We O +
examined O +
the O +
associations O +
of O +
plasma O +
fibrinogen B-Gene +
, O +
von B-Gene +
Willebrand I-Gene +
Factor I-Gene +
( O +
vWF B-Gene +
) O +
, O +
tissue B-Gene +
plasminogen I-Gene +
activator I-Gene +
( O +
t B-Gene -
- I-Gene -
PA I-Gene +
) O +
antigen O +
, O +
fibrin B-Gene +
D O -
- O -
dimer O +
, O +
and O +
factor B-Gene +
VII I-Gene +
with O +
the O +
development O +
and O +
clinical O +
progression O +
of O +
PAD O +
. O +

In O +
the O +
Edinburgh O +
Artery O +
Study O +
, O +
1592 O +
men O +
and O +
women O +
, O +
aged O +
between O +
55 O +
and O +
74 O +
years O +
, O +
were O +
followed O +
prospectively O +
over O +
5 O +
years O +
to O +
detect O +
the O +
onset O +
of O +
PAD O +
, O +
and O +
the O +
deterioration O +
of O +
established O +
PAD O +
. O +

At O +
baseline O +
, O +
418 O +
individuals O +
had O +
evidence O +
of O +
PAD O +
and O +
60 O +
( O +
14.4 O +
% O +
) O +
subsequently O +
deteriorated O +
. O +

1080 O +
subjects O +
had O +
no O +
baseline O +
disease O +
, O +
but O +
59 O +
( O +
5.5 O +
% O +
) O +
developed O +
PAD O +
during O +
follow O +
- O +
up O +
. O +

Median O +
levels O +
of O +
fibrinogen B-Gene +
and O +
vWF B-Gene +
were O +
higher O +
in O +
the O +
group O +
developing O +
disease O +
compared O +
with O +
the O +
group O +
which O +
did O +
not O +
( O +
2.78 O +
g O +
/ O +
l O +
versus O +
2.57 O +
g O +
/ O +
l O +
, O +
P O +
< O +
or O +
= O +
0.01 O +
; O +
116 O +
IU O +
/ O +
dl O +
versus O +
104 O +
IU O +
/ O +
dl O +
, O +
P O +
< O +
or O +
= O +
0.05 O +
; O +
respectively O +
) O +
. O +

After O +
adjusting O +
for O +
age O +
and O +
sex O +
, O +
fibrinogen B-Gene +
( O +
P O +
< O +
or O +
= O +
0.01 O +
) O +
and O +
vWF B-Gene +
( O +
P O +
< O +
or O +
= O +
0.05 O +
) O +
were O +
significantly O +
associated O +
with O +
the O +
risk O +
of O +
developing O +
PAD O +
. O +

The O +
association O +
between O +
fibrinogen B-Gene +
and O +
development O +
of O +
disease O +
remained O +
after O +
adjusting O +
for O +
cardiovascular O +
risk O +
factors O +
and O +
baseline O +
ischaemic O +
heart O +
disease O +
( O +
relative O +
risk O +
, O +
1.35 O +
, O +
95 O +
% O +
confidence O +
interval O +
, O +
1.05 O +
, O +
1.73 O +
; O +
P O +
< O +
or O +
= O +
0.05 O +
) O +
. O +

None O +
of O +
the O +
haemostatic O +
factors O +
were O +
significantly O +
associated O +
with O +
progression O +
of O +
PAD O +
. O +

In O +
conclusion O +
, O +
plasma O +
fibrinogen B-Gene +
levels O +
are O +
related O +
to O +
the O +
future O +
onset O +
of O +
PAD O +
, O +
providing O +
further O +
evidence O +
of O +
a O +
possible O +
role O +
of O +
elevated O +
fibrinogen B-Gene +
in O +
the O +
development O +
of O +
atherosclerotic O +
disease O +
. O +

High O +
altitude O +
increases O +
circulating O +
interleukin-6 B-Gene +
, O +
interleukin-1 B-Gene +
receptor I-Gene +
antagonist I-Gene +
and O +
C B-Gene +
- I-Gene +
reactive I-Gene +
protein I-Gene +
. O +

Hypoxic O +
pulmonary O +
vasoconstriction O +
is O +
associated O +
with O +
but O +
may O +
not O +
be O +
sufficient O +
for O +
the O +
development O +
of O +
high O +
- O +
altitude O +
pulmonary O +
oedema O +
( O +
HAPO O +
) O +
. O +

Hypoxia O +
is O +
known O +
to O +
induce O +
an O +
inflammatory O +
response O +
in O +
immune O +
cells O +
and O +
endothelial O +
cells O +
. O +

It O +
has O +
been O +
speculated O +
that O +
hypoxia O +
- O +
induced O +
inflammatory O +
cytokines B-Gene +
at O +
high O +
altitude O +
may O +
contribute O +
to O +
the O +
development O +
of O +
HAPO O +
by O +
causing O +
capillary O +
leakage O +
in O +
the O +
lung O +
. O +

We O +
were O +
interested O +
if O +
such O +
an O +
inflammatory O +
response O +
, O +
possibly O +
involved O +
in O +
a O +
later O +
development O +
of O +
HAPO O +
, O +
is O +
detectable O +
at O +
high O +
altitude O +
in O +
individuals O +
without O +
HAPO O +
. O +

We O +
examined O +
the O +
plasma O +
levels O +
of O +
interleukin B-Gene +
6 I-Gene +
( O +
IL-6 B-Gene +
) O +
, O +
interleukin B-Gene +
1 I-Gene +
receptor I-Gene +
antagonist I-Gene +
( O +
IL-1ra B-Gene +
) O +
and O +
C B-Gene +
- I-Gene +
reactive I-Gene +
protein I-Gene +
( O +
CRP B-Gene +
) O +
in O +
two O +
independent O +
studies O +
: O +
study O +
A O +
, O +
Jungfraujoch O +
, O +
Switzerland O +
, O +
three O +
overnight O +
stays O +
at O +
3458 O +
m O +
, O +
n O +
= O +
12 O +
; O +
study O +
B O +
: O +
Capanna O +
Regina O +
Margherita O +
, O +
Italy O +
, O +
3 O +
overnight O +
stays O +
at O +
3647 O +
m O +
and O +
one O +
overnight O +
stay O +
at O +
4559 O +
m O +
, O +
n O +
= O +
10 O +
. O +

In O +
both O +
studies O +
, O +
probands O +
showed O +
symptoms O +
of O +
acute O +
mountain O +
sickness O +
but O +
no O +
signs O +
of O +
HAPO O +
. O +

At O +
the O +
Jungfraujoch O +
, O +
IL-6 B-Gene +
increased O +
from O +
0.1 O +
+ O -
/- O +
0.03 O +
pg O +
/ O +
ml O +
to O +
2 O +
. O +

0 O +
+ O -
/- O +
0.5 O +
pg O +
/ O +
ml O +
( O +
day O +
2 O +
, O +
P O +
= O +
0.03 O +
) O +
, O +
IL-1ra B-Gene +
from O +
101 O +
+ O -
/- O +
21 O +
to O +
284 O +
+ O -
/- O +
73 O +
pg O +
/ O +
ml O +
( O +
day O +
2 O +
, O +
P O +
= O +
0.01 O +
) O +
, O +
and O +
CRP B-Gene +
from O +
1.0 O +
+ O -
/- O +
0.4 O +
to O +
5.8 O +
+ O -
/- O +
1.5 O +
micrograms O +
/ O +
ml O +
( O +
day O +
4 O +
, O +
P O +
= O +
0.01 O +
) O +
. O +

At O +
the O +
Capanna O +
Margherita O +
, O +
IL-6 B-Gene +
increased O +
from O +
0 O -
. O +
5 O +
+ O -
/- O +
0.2 O +
pg O +
/ O +
ml O +
to O +
2.0 O +
+ O -
/- O +
0.8 O +
pg O +
/ O +
ml O +
( O +
P O +
= O +
0.02 O +
) O +
, O +
IL-1ra B-Gene +
from O +
118 O +
+ O -
/- O +
25 O +
to O +
213 O +
+ O -
/- O +
28 O +
pg O +
/ O +
ml O +
( O +
P O +
= O +
0.02 O +
) O +
, O +
and O +
CRP B-Gene +
from O +
0.4 O +
+ O -
/- O +
0.03 O +
to O +
3.5 O +
+ O -
/- O +
1.1 O +
micrograms O +
/ O +
ml O +
( O +
P O +
= O +
0.03 O +
) O +
. O +

IL-8 B-Gene +
was O +
below O +
the O +
detection O +
limit O +
of O +
the O +
ELISA O +
( O +
< O +
25 O +
pg O +
/ O +
ml O +
) O +
in O +
both O +
studies O +
. O +

The O +
increase O +
of O +
IL-6 B-Gene +
and O +
IL-1ra B-Gene +
in O +
response O +
to O +
high O +
altitude O +
was O +
delayed O +
and O +
preceded O +
the O +
increase O +
of O +
CRP B-Gene +
. O +

We O +
conclude O +
that O +
: O +
( O -
1 O -
) O +
circulating O +
IL-6 B-Gene +
, O +
IL-1ra B-Gene +
and O +
CRP B-Gene +
are O +
upregulated O +
in O +
response O +
to O +
hypobaric O +
hypoxic O +
conditions O +
at O +
high O +
altitude O +
, O +
and O +
( O -
2 O -
) O +
the O +
moderate O +
systemic O +
increase O +
of O +
these O +
inflammatory O +
markers O +
may O +
reflect O +
considerable O +
local O +
inflammation O +
. O +

The O +
existence O +
and O +
the O +
kinetics O +
of O +
high O +
altitude O +
- O +
induced O +
cytokines B-Gene +
found O +
in O +
this O +
study O +
support O +
the O +
hypothesis O +
that O +
inflammation O +
is O +
involved O +
in O +
the O +
development O +
of O +
HAPO O +
. O +

Stem B-Gene +
cell I-Gene +
factor I-Gene +
( O +
SCF B-Gene +
) O +
can O +
regulate O +
the O +
activation O +
and O +
expansion O +
of O +
murine O +
intraepithelial O +
lymphocytes O +
. O +

Murine O +
intraepithelial O +
lymphocytes O +
( O +
IEL O +
) O +
express O +
c B-Gene -
- I-Gene -
kit I-Gene +
, O +
the O +
receptor B-Gene +
for I-Gene +
stem I-Gene +
cell I-Gene +
factor I-Gene +
( O +
SCF B-Gene +
) O +
. O +

SCF B-Gene +
induced O +
a O +
low O +
but O +
significant O +
proliferative O +
response O +
in O +
IEL O +
, O +
but O +
not O +
in O +
splenic O +
T O +
cells O +
. O +

SCF B-Gene +
stimulation O +
of O +
IEL O +
resulted O +
in O +
an O +
expansion O +
of O +
the O +
c B-Gene -
- I-Gene -
kit I-Gene +
( O +
+ O +
) O +
, O +
TCRgammadelta B-Gene +
( O +
+ O +
) O +
cell O +
population O +
. O +

SCF B-Gene +
- O +
induced O +
proliferation O +
was O +
dependent O +
upon O +
SCF B-Gene +
- O +
c B-Gene -
- I-Gene -
kit I-Gene +
interactions O +
, O +
since O +
antibody O +
to O +
c B-Gene -
- I-Gene -
kit I-Gene +
blocked O +
this O +
response O +
, O +
and O +
IEL O +
obtained O +
from O +
c B-Gene -
- I-Gene -
kit I-Gene +
mutant O +
( O +
W O +
/ O +
W O +
( O +
v O +
) O +
) O +
mice O +
failed O +
to O +
respond O +
to O +
SCF B-Gene +
. O +

SCF B-Gene +
acted O +
synergistically O +
with O +
anti O +
- O +
TCRgammadelta B-Gene +
and O +
with O +
concavalin O +
A O +
( O +
Con O +
A O +
) O +
to O +
induce O +
proliferation O +
and O +
interferon B-Gene +
gamma I-Gene +
( O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
production O +
in O +
IEL O +
. O +

Finally O +
, O +
mice O +
injected O +
with O +
SCF B-Gene +
had O +
a O +
significant O +
increase O +
in O +
the O +
number O +
of O +
IEL O +
in O +
the O +
small O +
intestine O +
. O +

SCF B-Gene +
- O +
treated O +
mice O +
had O +
increased O +
numbers O +
of O +
TCRalphabeta B-Gene +
( O +
+ O +
) O +
and O +
TCRgammadelta B-Gene +
( O +
+ O +
) O +
cell O +
populations O +
, O +
as O +
well O +
as O +
increased O +
numbers O +
of O +
c B-Gene -
- I-Gene -
kit I-Gene +
( O +
+ O +
) O +
and O +
c B-Gene -
- I-Gene -
kit I-Gene +
( O -
- O -
) O +
IEL O +
. O +

These O +
data O +
suggest O +
that O +
SCF B-Gene +
- O +
c B-Gene -
- I-Gene -
kit I-Gene +
interactions O +
play O +
an O +
important O +
role O +
in O +
regulating O +
IEL O +
expansion O +
and O +
activation O +
. O +

A O +
new O +
single O +
- O +
copy O +
mycobacterial O +
plasmid O +
, O +
pMF1 O +
, O +
from O +
Mycobacterium O +
fortuitum O +
which O +
is O +
compatible O +
with O +
the O +
pAL5000 O +
replicon O +
. O +

A O +
9.2 O +
kb O +
cryptic O +
Mycobacterium O +
fortuitum O +
plasmid O +
, O +
pMF1 O +
, O +
was O +
isolated O +
from O +
strain O +
110 O +
and O +
its O +
restriction O +
map O +
constructed O +
. O +

A O +
4.2 O +
kb O +
HindIII B-Gene +
fragment O +
of O +
pMF1 O +
was O +
found O +
to O +
support O +
replication O +
in O +
mycobacteria O +
and O +
this O +
fragment O +
was O +
cloned O +
and O +
sequenced O +
to O +
characterize O +
the O +
replication O +
elements O +
of O +
the O +
plasmid O +
. O +

Computer O +
analysis O +
identified O +
a O +
putative O +
Rep B-Gene +
protein O +
( O +
362 O +
amino O +
acids O +
) O +
with O +
high O +
homology O +
to O +
the O +
putative O +
Rep B-Gene +
protein O +
of O +
the O +
Mycobacterium O +
celatum O +
plasmid O +
pCLP O +
and O +
limited O +
homology O +
, O +
mostly O +
in O +
the O +
N O +
- O +
terminal O +
region O +
, O +
to O +
the O +
Rep B-Gene +
proteins O +
of O +
Mycobacterium O +
avium O +
pLR7 O +
, O +
M. O +
fortuitum O +
pJAZ38 O +
and O +
Mycobacterium O +
scrofulaceum O +
pMSC262 O +
. O +

A O +
region O +
containing O +
a O +
putative O +
ori O +
site O +
was O +
located O +
upstream O +
of O +
the O +
rep B-Gene +
gene O +
; O +
this O +
region O +
displayed O +
high O +
homology O +
at O +
the O +
nucleotide O +
level O +
with O +
the O +
predicted O +
ori O +
of O +
pCLP O +
and O +
pJAZ38 O +
. O +

A O +
plasmid O +
carrying O +
the O +
4.2 O +
kb O +
HindIII B-Gene +
fragment O +
and O +
a O +
kanamycin O +
resistance O +
marker O +
, O +
designated O +
pBP4 O +
, O +
was O +
maintained O +
as O +
a O +
single O +
- O +
copy O +
plasmid O +
in O +
Mycobacterium O +
smegmatis O +
and O +
was O +
stably O +
inherited O +
in O +
the O +
absence O +
of O +
antibiotic O +
selection O +
. O +

Plasmid O +
pBP4 O +
was O +
incompatible O +
with O +
the O +
pJAZ38 O +
replicon O +
but O +
was O +
compatible O +
with O +
the O +
widely O +
used O +
pAL5000 O +
replicon O +
, O +
indicating O +
that O +
among O +
the O +
mycobacterial O +
vectors O +
now O +
available O +
there O +
are O +
two O +
incompatibility O +
groups O +
. O +

Significantly O +
, O +
the O +
plasmid O +
was O +
able O +
to O +
replicate O +
in O +
the O +
pathogen O +
Mycobacterium O +
tuberculosis O +
, O +
making O +
it O +
a O +
useful O +
tool O +
for O +
gene O +
expression O +
studies O +
. O +

To O +
provide O +
a O +
choice O +
of O +
restriction O +
sites O +
and O +
easy O +
manipulation O +
, O +
a O +
2.1 O +
kb O +
fragment O +
containing O +
the O +
minimal O +
replication O +
region O +
was O +
cloned O +
to O +
make O +
the O +
mycobacterial O +
shuttle O +
vector O +
pBP10 O +
, O +
which O +
showed O +
similar O +
stability O +
to O +
pBP4 O +
. O +

Agonist O +
peptide O +
from O +
a O +
cytotoxic O +
t O +
- O +
lymphocyte O +
epitope O +
of O +
human O +
carcinoembryonic B-Gene +
antigen I-Gene +
stimulates O +
production O +
of O +
tc1 O +
- O +
type O +
cytokines B-Gene +
and O +
increases O +
tyrosine O +
phosphorylation O +
more O +
efficiently O +
than O +
cognate O +
peptide O +
. O +

The O +
identification O +
of O +
an O +
agonist O +
peptide O +
( O +
YLSGADLNL O +
, O +
designated O +
CAP1 O +
- O +
6D O +
) O +
to O +
an O +
immunodominant O +
cytotoxic O +
T O +
- O +
lymphocyte O +
( O +
CTL O +
) O +
epitope O +
( O +
designated O +
CAP1 O +
) O +
of O +
human O +
carcinoembryonic B-Gene +
antigen I-Gene +
( O +
CEA B-Gene +
) O +
has O +
previously O +
been O +
reported O +
. O +

The O +
agonist O +
peptide O +
harbors O +
a O +
single O +
amino O +
acid O +
substitution O +
at O +
a O +
non O +
- O +
MHC B-Gene +
anchor O +
residue O +
and O +
is O +
proposed O +
to O +
exert O +
its O +
effects O +
at O +
the O +
level O +
of O +
the O +
T B-Gene -
- I-Gene -
cell I-Gene +
receptor I-Gene +
( O +
TCR B-Gene +
) O +
. O +

The O +
type O +
and O +
magnitude O +
of O +
cytokines B-Gene +
produced O +
by O +
CAP1 O +
- O +
reactive O +
CTL O +
upon O +
stimulation O +
with O +
the O +
agonist O +
peptide O +
, O +
CAP1 O +
- O +
6D O +
, O +
were O +
compared O +
to O +
those O +
obtained O +
upon O +
stimulation O +
with O +
the O +
cognate O +
CAP1 O +
peptide O +
. O +

In O +
addition O +
, O +
early O +
events O +
in O +
the O +
TCR B-Gene +
signaling O +
pathway O +
were O +
examined O +
for O +
differences O +
in O +
tyrosine O +
phosphorylation O +
. O +

Upon O +
stimulation O +
with O +
the O +
agonist O +
peptide O +
CAP1 O +
- O +
6D O +
, O +
several O +
different O +
CEA B-Gene +
- O +
specific O +
CTL O +
lines O +
exhibited O +
a O +
marked O +
shift O +
in O +
the O +
peptide O +
dose O +
response O +
, O +
which O +
resulted O +
in O +
as O +
much O +
as O +
a O +
1,000 O +
- O +
fold O +
increase O +
in O +
the O +
levels O +
of O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
and O +
gamma B-Gene -
- I-Gene -
IFN I-Gene +
produced O +
as O +
compared O +
with O +
the O +
use O +
of O +
the O +
CAP1 O +
peptide O +
. O +

However O +
, O +
levels O +
of O +
IL-4 B-Gene +
and O +
IL B-Gene +
- I-Gene +
10 I-Gene +
, O +
which O +
are O +
associated O +
with O +
anti O +
- O +
inflammatory O +
effects O +
, O +
were O +
very O +
low O +
or O +
non O +
- O +
existent O +
. O +

The O +
cytokine B-Gene +
profile O +
of O +
CAP1 O +
- O +
and O +
CAP1 O +
- O +
6D O +
- O +
specific O +
CTL O +
is O +
consistent O +
with O +
a O +
Tc1 O +
- O +
type O +
CTL O +
. O +

Consistent O +
with O +
these O +
findings O +
, O +
CEA B-Gene +
- O +
specific O +
CTL O +
showed O +
increased O +
tyrosine O +
phosphorylation O +
of O +
TCR B-Gene +
signaling O +
proteins O +
ZAP B-Gene +
- I-Gene +
70 I-Gene +
and O +
TCR B-Gene +
zeta I-Gene +
chains O +
in O +
response O +
to O +
both O +
peptides O +
. O +

However O +
, O +
when O +
CAP1 O +
- O +
6D O +
was O +
compared O +
with O +
the O +
wild O +
- O +
type O +
peptide O +
, O +
the O +
increase O +
in O +
ZAP B-Gene +
- I-Gene +
70 I-Gene +
phosphorylation O +
was O +
greater O +
than O +
the O +
increase O +
in O +
zeta O +
phosphorylation O +
. O +

CTL O +
generated O +
with O +
the O +
CAP1 O -
- O -
6D O +
agonist O +
were O +
shown O +
capable O +
of O +
lysis O +
of O +
human O +
carcinoma O +
cells O +
expressing O +
native O +
CEA B-Gene +
. O +

The O +
ability O +
to O +
upregulate O +
the O +
production O +
of O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
, O +
gamma B-Gene -
- I-Gene -
IFN I-Gene +
, O +
TNFalpha B-Gene +
and O +
IL-2 B-Gene +
with O +
the O +
agonist O +
peptide O +
, O +
as O +
compared O +
with O +
CAP1 O +
, O +
may O +
help O +
in O +
initiating O +
or O +
sustaining O +
anti O +
- O +
tumor O +
immune O +
responses O +
and O +
thus O +
potentially O +
prove O +
to O +
be O +
useful O +
in O +
the O +
treatment O +
of O +
CEA B-Gene +
- O +
positive O +
tumors O +
. O +

Bone B-Gene +
morphogenetic I-Gene +
protein I-Gene +
receptor I-Gene +
complexes O +
on O +
the O +
surface O +
of O +
live O +
cells O +
: O +
a O +
new O +
oligomerization O +
mode O +
for O +
serine B-Gene +
/ I-Gene +
threonine I-Gene +
kinase I-Gene +
receptors I-Gene +
. O +

The O +
bone B-Gene +
morphogenetic I-Gene +
proteins I-Gene +
( O +
BMPs B-Gene +
) O +
play O +
important O +
roles O +
in O +
embryogenesis O +
and O +
normal O +
cell O +
growth O +
. O +

The O +
BMP B-Gene +
receptors I-Gene +
belong O +
to O +
the O +
family B-Gene +
of I-Gene +
serine I-Gene +
/ I-Gene +
threonine I-Gene +
kinase I-Gene +
receptors I-Gene +
, O +
whose O +
activation O +
has O +
been O +
investigated O +
intensively O +
for O +
the O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
beta I-Gene +
( I-Gene +
TGF I-Gene -
- I-Gene -
beta I-Gene +
) I-Gene +
receptor I-Gene +
subfamily I-Gene +
. O +

However O +
, O +
the O +
interactions O +
between O +
the O +
BMP B-Gene +
receptors I-Gene +
, O +
the O +
composition O +
of O +
the O +
active O +
receptor O +
complex O +
, O +
and O +
the O +
role O +
of O +
the O +
ligand O +
in O +
its O +
formation O +
have O +
not O +
yet O +
been O +
investigated O +
and O +
were O +
usually O +
assumed O +
to O +
follow O +
the O +
same O +
pattern O +
as O +
the O +
TGF B-Gene +
- I-Gene +
beta I-Gene +
receptors I-Gene +
. O +

Here O +
we O +
demonstrate O +
that O +
the O +
oligomerization O +
pattern O +
of O +
the O +
BMP B-Gene +
receptors I-Gene +
is O +
different O +
and O +
is O +
more O +
flexible O +
and O +
susceptible O +
to O +
modulation O +
by O +
ligand O +
. O +

Using O +
several O +
complementary O +
approaches O +
, O +
we O +
investigated O +
the O +
formation O +
of O +
homomeric O +
and O +
heteromeric O +
complexes O +
between O +
the O +
two O +
known O +
BMP B-Gene +
type I-Gene +
I I-Gene +
receptors I-Gene +
( O +
BR B-Gene +
- I-Gene +
Ia I-Gene +
and O +
BR B-Gene +
- I-Gene +
Ib I-Gene +
) O +
and O +
the O +
BMP B-Gene +
type I-Gene +
II I-Gene +
receptor I-Gene +
( O +
BR B-Gene -
- I-Gene -
II I-Gene +
) O +
. O +

Coimmunoprecipitation O +
studies O +
detected O +
the O +
formation O +
of O +
heteromeric O +
and O +
homomeric O +
complexes O +
among O +
all O +
the O +
BMP B-Gene +
receptor I-Gene +
types O +
even O +
in O +
the O +
absence O +
of O +
ligand O +
. O +

These O +
complexes O +
were O +
also O +
detected O +
at O +
the O +
cell O +
surface O +
after O +
BMP-2 B-Gene +
binding O +
and O +
cross O +
- O +
linking O +
. O +

Using O +
antibody O +
- O +
mediated O +
immunofluorescence O +
copatching O +
of O +
epitope O +
- O +
tagged O +
receptors O +
, O +
we O +
provide O +
evidence O +
in O +
live O +
cells O +
for O +
preexisting O +
heteromeric O +
( O +
BR B-Gene +
- I-Gene +
II I-Gene +
/ O +
BR B-Gene +
- I-Gene +
Ia I-Gene +
and O +
BR B-Gene +
- I-Gene +
II I-Gene +
/ O +
BR B-Gene +
- I-Gene +
Ib I-Gene +
) O +
and O +
homomeric O +
( O +
BR B-Gene +
- I-Gene +
II I-Gene +
/ O +
BR B-Gene +
- I-Gene +
II I-Gene +
, O +
BR B-Gene +
- I-Gene +
Ia I-Gene +
/ O +
BR B-Gene +
- I-Gene +
Ia I-Gene +
, O +
BR B-Gene +
- I-Gene +
Ib I-Gene +
/ O +
BR B-Gene +
- I-Gene +
Ib I-Gene +
, O +
and O +
also O +
BR B-Gene -
- I-Gene -
Ia I-Gene +
/ O +
BR B-Gene -
- I-Gene -
Ib I-Gene +
) O +
oligomers O +
in O +
the O +
absence O +
of O +
ligand O +
. O +

BMP-2 B-Gene +
binding O +
significantly O +
increased O +
hetero O +
- O +
and O +
homo O +
- O +
oligomerization O +
( O +
except O +
for O +
the O +
BR B-Gene +
- I-Gene +
II I-Gene +
homo O +
- O +
oligomer O +
, O +
which O +
binds O +
ligand O +
poorly O +
in O +
the O +
absence O +
of O +
BR B-Gene -
- I-Gene -
I I-Gene +
) O +
. O +

In O +
contrast O +
to O +
previous O +
observations O +
on O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
receptors I-Gene +
, O +
which O +
were O +
found O +
to O +
be O +
fully O +
homodimeric O +
in O +
the O +
absence O +
of O +
ligand O +
, O +
the O +
BMP O +
receptors O +
show O +
a O +
much O +
more O +
flexible O +
oligomerization O +
pattern O +
. O +

This O +
novel O +
feature O +
in O +
the O +
oligomerization O +
mode O +
of O +
the O +
BMP B-Gene +
receptors I-Gene +
allows O +
higher O +
variety O +
and O +
flexibility O +
in O +
their O +
responses O +
to O +
various O +
ligands O +
as O +
compared O +
with O +
the O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
receptors I-Gene +
. O +

Modulation O +
of O +
humoral O +
and O +
cell O +
- O +
mediated O +
immune O +
responses O +
by O +
dietary O +
lutein O +
in O +
cats O +
. O +

The O +
immuno O +
- O +
modulatory O +
role O +
of O +
dietary O +
lutein O +
in O +
domestic O +
cats O +
is O +
unknown O +
. O +

Female O +
Tabby O +
cats O +
( O +
10 O +
- O +
month O +
old O +
; O +
n O +
= O +
56 O +
) O +
were O +
supplemented O +
daily O +
for O +
12 O +
weeks O +
with O +
0 O +
, O +
1 O +
, O +
5 O +
or O +
10 O -
mg O +
lutein O +
. O +

Blood O +
was O +
collected O +
on O +
Weeks O +
0 O +
, O +
2 O +
, O +
4 O +
, O +
8 O +
and O +
12 O +
to O +
assess O +
the O +
following O +
: O +
( O -
1 O -
) O +
mitogen O +
- O +
induced O +
peripheral O +
blood O +
mononuclear O +
cells O +
( O +
PBMCs O +
) O +
proliferation O +
, O +
( O +
2 O +
) O +
changes O +
in O +
PBMC O +
subpopulations O +
, O +
( O +
3 O +
) O +
interleukin-2 B-Gene +
( O +
IL-2 B-Gene +
) O +
production O +
and O +
( O +
4 O +
) O +
plasma O +
immunoglobulin B-Gene +
( I-Gene +
Ig I-Gene +
) I-Gene +
G I-Gene +
production O +
. O +

In O +
addition O +
, O +
delayed O +
- O +
type O +
hypersensitivity O +
( O +
DTH O +
) O +
response O +
to O +
concanavalin O +
A O +
( O +
Con O +
A O +
) O +
or O +
a O +
polyvalent O +
vaccine O +
was O +
performed O +
on O +
Weeks O +
0 O +
, O +
6 O +
and O +
12 O +
. O +

Dietary O +
lutein O +
increased O +
plasma O +
lutein O +
concentrations O +
in O +
a O +
dose O +
- O +
dependent O +
manner O +
( O +
p O +
< O +
0.001 O +
) O +
and O +
concentrations O +
had O +
not O +
reached O +
steady O +
state O +
after O +
12 O +
weeks O +
of O +
feeding O +
in O +
cats O +
given O +
5 O +
or O +
10 O -
mg O +
lutein O +
. O +

Concentrations O +
of O +
plasma O +
retinol O +
and O +
alpha O -
- O -
tocopherol O +
were O +
not O +
influenced O +
by O +
diet O +
. O +

The O +
DTH O +
response O +
to O +
vaccine O +
but O +
not O +
to O +
Con O +
A O +
increased O +
( O +
p O +
< O +
0.05 O +
) O +
in O +
a O +
dose O +
- O +
dependent O +
manner O +
on O +
Week O +
6 O +
. O +

Compared O +
to O +
control O +
, O +
cats O +
fed O +
lutein O +
also O +
showed O +
enhanced O +
Con O +
A O +
- O +
and O +
pokeweed O +
mitogen O +
- O +
stimulated O +
PBMCs O +
proliferation O +
. O +

Dietary O +
lutein O +
also O +
increased O +
the O +
percentages O +
of O +
CD4 B-Gene +
+ O +
and O +
CD21 B-Gene +
+ O +
lymphocytes O +
on O +
Week O +
12 O +
but O +
had O +
no O +
significant O +
effect O +
on O +
pan O +
T O +
, O +
CD8 B-Gene +
and O +
MHC B-Gene +
class I-Gene +
II I-Gene +
markers O +
. O +

Plasma O +
IgG B-Gene +
was O +
higher O +
( O +
p O +
< O +
0.05 O +
) O +
in O +
cats O +
fed O +
10 O -
mg O +
lutein O +
on O +
Weeks O +
8 O +
and O +
12 O +
. O +

These O +
results O +
support O +
the O +
immuno O +
- O +
modulatory O +
action O +
of O +
lutein O +
in O +
domestic O +
cats O +
. O +

Nucleotide O +
sequence O +
and O +
differential O +
expression O +
of O +
the O +
human O +
3-phosphoglycerate B-Gene +
dehydrogenase I-Gene +
gene O +
. O +

The O +
nucleotide O +
sequence O +
of O +
Hs O +
3-PGDH B-Gene +
gene O +
, O +
encoding O +
human O +
3-phosphoglycerate B-Gene +
dehydrogenase I-Gene +
that O +
catalyzes O +
the O +
initiating O +
step O +
in O +
the O +
phosphorylated O +
pathway O +
of O +
serine O +
biosynthesis O +
, O +
has O +
been O +
determined O +
. O +

The O +
3-PGDH B-Gene +
gene O +
has O +
a O +
predicted O +
533 O +
amino O +
acid O +
open O +
reading O +
frame O +
, O +
encoding O +
a O +
56.8kDa O +
protein O +
that O +
shares O +
94.0 O +
% O +
similarity O +
with O +
rat O +
- O +
liver O +
3-PGDH B-Gene +
. O +

Two O +
different O +
transcripts O +
corresponding O +
to O +
3-PGDH B-Gene +
mRNA O +
were O +
detected O +
in O +
human O +
normal O +
tissues O +
. O +

A O +
dominant O +
2.1 O -
kb O +
transcript O +
was O +
expressed O +
at O +
high O +
levels O +
in O +
prostate O +
, O +
testis O +
, O +
ovary O +
, O +
brain O +
, O +
liver O +
, O +
kidney O +
, O +
and O +
pancreas O +
, O +
and O +
weakly O +
expressed O +
in O +
thymus O +
, O +
colon O +
, O +
and O +
heart O +
. O +

A O +
710bp O +
transcript O +
also O +
appeared O +
as O +
a O +
weaker O +
band O +
where O +
the O +
2.1 O -
kb O +
mRNA O +
was O +
expressed O +
, O +
and O +
it O +
was O +
more O +
significant O +
than O +
the O +
2.1 O -
kb O +
mRNA O +
in O +
heart O +
and O +
skeletal O +
muscle O +
. O +

The O +
TPA O +
- O +
induced O +
monocytic O +
differentiation O +
of O +
U937 O +
, O +
which O +
also O +
resulted O +
in O +
growth O +
arrest O +
, O +
abruptly O +
downregulated O +
the O +
expression O +
of O +
3-PGDH B-Gene +
. O +

Removal O +
of O +
TPA O +
restored O +
cell O +
growth O +
through O +
the O +
retrodifferentiation O +
process O +
and O +
subsequent O +
expression O +
of O +
3-PGDH B-Gene +
. O +

The O +
3-PGDH B-Gene +
mRNA O +
was O +
markedly O +
expressed O +
in O +
human O +
leukemias O +
, O +
lymphoma O +
Sup O -
- O -
T1 O +
, O +
colon O +
adenocarcinoma O +
COLO O +
320DM O +
, O +
epitheloid O +
carcinoma O +
HeLa O +
S3 O +
, O +
and O +
murine O +
lymphoma O +
BW5147.G.1.4 O +
, O +
but O +
not O +
in O +
human O +
leukemia O +
K562 O +
. O +

This O +
report O +
demonstrates O +
that O +
the O +
human O +
3-PGDH B-Gene +
gene O +
is O +
regulated O +
at O +
the O +
transcriptional O +
level O +
depending O +
on O +
tissue O +
specificty O +
and O +
cellular O +
proliferative O +
status O +
, O +
and O +
its O +
transcriptional O +
regulation O +
mechanism O +
may O +
be O +
a O +
useful O +
target O +
for O +
diagnosis O +
and O +
therapy O +
of O +
cancer O +
. O +

Partial O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
/ I-Gene +
beta I-Gene +
and I-Gene +
IFN I-Gene -
- I-Gene -
gamma I-Gene +
receptor I-Gene +
knockout O +
trisomy O +
16 O +
mouse O +
fetuses O +
show O +
improved O +
growth O +
and O +
cultured O +
neuron O +
viability O +
. O +

The O +
trisomy O +
16 O +
mouse O +
fetus O +
is O +
a O +
well O +
- O +
studied O +
model O +
for O +
Down O +
syndrome O +
( O +
trisomy O +
21 O +
) O +
, O +
the O +
leading O +
genetic O +
cause O +
of O +
mental O +
retardation O +
in O +
the O +
newborn O +
population O +
. O +

Human O +
chromosome O +
21 O +
and O +
mouse O +
chromosome O +
16 O +
each O +
carry O +
a O +
large O +
cluster O +
of O +
genes O +
that O +
code O +
for O +
components O +
of O +
the O +
interferon B-Gene +
( I-Gene +
IFN I-Gene -
) I-Gene -
-alpha I-Gene +
/ I-Gene +
beta I-Gene +
and I-Gene +
IFN I-Gene -
- I-Gene -
gamma I-Gene +
receptors I-Gene +
, O +
and O +
Down O +
syndrome O +
cells O +
display O +
significantly O +
increased O +
sensitivity O +
to O +
IFN B-Gene +
action O +
. O +

We O +
have O +
previously O +
reported O +
that O +
in O +
utero O +
anti O +
- O +
IFN B-Gene +
IgG B-Gene +
treatment O +
of O +
mice O +
pregnant O +
with O +
trisomy O +
16 O +
fetuses O +
results O +
in O +
a O +
significant O +
improvement O +
in O +
trisomy O +
16 O +
fetus O +
growth O +
and O +
morphology O +
and O +
that O +
anti O +
- O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
IgG B-Gene +
treatment O +
can O +
prevent O +
the O +
premature O +
death O +
of O +
trisomy O +
16 O +
fetal O +
mouse O +
cortical O +
neurons O +
in O +
culture O +
. O +

We O +
have O +
now O +
used O +
IFN B-Gene +
receptor I-Gene +
subunit O +
knockout O +
mice O +
to O +
produce O +
mouse O +
fetuses O +
that O +
carry O +
three O +
No. O +
16 O +
chromosomes O +
and O +
one O +
copy O +
each O +
of O +
disabled O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
receptor I-Gene +
( O +
IFNGR B-Gene +
) O +
and O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
/ I-Gene +
beta I-Gene +
receptor I-Gene +
( O +
IFNAR-2 B-Gene +
) O +
component O +
genes O +
. O +

We O +
report O +
here O +
that O +
this O +
partial O +
IFN B-Gene +
receptor I-Gene +
knockout O +
trisomy O +
( O +
PIRKOT O +
) O +
mouse O +
fetus O +
has O +
significantly O +
improved O +
growth O +
and O +
yields O +
cortical O +
neurons O +
whose O +
viability O +
is O +
the O +
equivalent O +
of O +
that O +
seen O +
in O +
their O +
euploid O +
counterparts O +
. O +

Corrective O +
effects O +
of O +
interleukin-12 B-Gene +
on O +
age O +
- O +
related O +
deficiencies O +
in O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
production O +
and O +
IL-12Rbeta2 B-Gene +
expression O +
in O +
virus O +
- O +
specific O +
CD8 B-Gene +
+ O +
T O +
cells O +
. O +

Interleukin-12 B-Gene +
receptor I-Gene +
beta2 I-Gene +
( O +
IL-12Rbeta2 B-Gene +
) O +
has O +
been O +
shown O +
to O +
be O +
selectively O +
expressed O +
on O +
Th1 O +
T O +
cell O +
subsets O +
, O +
and O +
we O +
have O +
previously O +
shown O +
that O +
influenza O +
- O +
specific O +
CD8 B-Gene +
+ O +
cytotoxic O +
T O +
lymphocyte O +
( O +
CTL O +
) O +
deficiency O +
in O +
old O +
mice O +
was O +
associated O +
with O +
deficient O +
Th1 O +
( O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
[ O +
IFN B-Gene -
- I-Gene -
gamma I-Gene -
] I-Gene -
) I-Gene +
cytokine B-Gene +
production O +
. O +

This O +
study O +
tested O +
whether O +
IL-12Rbeta2 B-Gene +
expression O +
was O +
also O +
deficient O +
in O +
CD8 B-Gene +
+ O +
CTL O +
from O +
old O +
mice O +
and O +
the O +
effect O +
of O +
IL-12 B-Gene +
treatment O +
on O +
these O +
responses O +
. O +

Splenic O +
lymphocytes O +
from O +
influenza O +
- O +
primed O +
old O +
and O +
young O +
BALB O -
/ O -
c O +
mice O +
were O +
stimulated O +
with O +
influenza O +
virus O +
in O +
vitro O +
with O +
and O +
without O +
IL-12 B-Gene +
and O +
then O +
enriched O +
for O +
CD8 B-Gene +
+ O +
T O +
cells O +
. O +

IFN B-Gene -
- I-Gene -
gamma I-Gene +
was O +
significantly O +
reduced O +
, O +
whereas O +
IL-4 B-Gene +
and O +
IL-12p40 B-Gene +
( O +
an O +
antagonist O +
of O +
IL-12 B-Gene +
function O +
) O +
were O +
evaluated O +
in O +
old O +
when O +
compared O +
with O +
young O +
mice O +
. O +

This O +
was O +
true O +
for O +
secreted O +
protein O +
measured O +
by O +
ELISA O +
and O +
for O +
mRNA O +
levels O +
quantitated O +
by O +
RT O +
- O +
PCR O +
. O +

IL-12Rbeta2 B-Gene +
mRNA O +
expression O +
in O +
CD8 B-Gene +
+ O +
CTL O +
was O +
also O +
significantly O +
reduced O +
in O +
old O +
mice O +
. O +

IL-12 B-Gene +
treatment O +
in O +
vitro O +
caused O +
significant O +
upregulation O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
IL-12Rbeta2 B-Gene +
and O +
downregulation O +
of O +
IL-4 B-Gene +
in O +
CD8 B-Gene +
+ O +
T O +
cells O +
from O +
old O +
mice O +
and O +
young O +
mice O +
. O +

The O +
present O +
demonstration O +
of O +
an O +
age O +
- O +
related O +
downregulation O +
in O +
IL-12Rbeta2 B-Gene +
expression O +
and O +
our O +
previous O +
data O +
showing O +
reduced O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
elevated O +
IL-4 B-Gene +
production O +
provide O +
strong O +
evidence O +
that O +
CD8 B-Gene +
+ O +
CTL O +
deficiency O +
in O +
aging O +
results O +
from O +
a O +
Th1 O +
/ O +
Th2 O +
cytokine B-Gene +
production O +
switch O +
. O +

Agents O +
that O +
increase O +
IL-12Rbeta2 B-Gene +
expression O +
and O +
redirect O +
Th2 O +
to O +
Thl O +
immune O +
responses O +
are O +
likely O +
to O +
enhance O +
CD8 B-Gene +
+ O +
CTL O +
- O +
mediated O +
control O +
of O +
viral O +
infections O +
in O +
aging O +
. O +

Recombinant O +
expression O +
and O +
neutralizing O +
activity O +
of O +
an O +
MHC B-Gene +
class I-Gene +
II I-Gene +
binding O +
epitope O +
of O +
toxic B-Gene +
shock I-Gene +
syndrome I-Gene +
toxin-1 I-Gene +
. O +

Toxic O +
shock O +
syndrome O +
( O +
TSS O +
) O +
is O +
caused O +
by O +
the O +
staphylococcal O +
superantigen B-Gene +
, O +
TSST-1 B-Gene +
. O +

The O +
MHC B-Gene +
class I-Gene +
II I-Gene +
binding O +
domain O +
of O +
TSST-1 B-Gene +
containing O +
a O +
conserved O +
sequence O +
with O +
other O +
related O +
staphylococcal O +
enterotoxins O +
, O +
comprising O +
TSST B-Gene +
- I-Gene +
1 I-Gene +
residues O +
47 O +
- O +
64 O +
[ O +
( O +
T O -
( O -
47 O -
- O -
64 O +
) O +
] O +
, O +
was O +
expressed O +
as O +
a O +
fusion O +
protein O +
with O +
either O +
glutathione B-Gene +
- I-Gene +
S I-Gene +
- I-Gene +
transferase I-Gene +
( O +
GST B-Gene +
( O +
47 O +
- O +
64 O +
) O +
) O +
, O +
filamentous O +
phage O +
coat B-Gene +
protein I-Gene +
( O +
pIII O +
( O +
47 O +
- O +
64 O +
) O +
) O +
, O +
or O +
E. O +
coli O +
outer O +
membrane O +
porin B-Gene +
protein O +
( O +
OprF B-Gene +
( O +
47 O +
- O +
64 O +
) O +
) O +
, O +
or O +
synthesized O +
as O +
a O +
peptide O +
conjugated O +
to O +
bovine O +
serum B-Gene +
albumin I-Gene +
, O +
BSA B-Gene +
( O +
47 O +
- O +
64 O +
) O +
. O +
GST B-Gene +
( O +
47 O +
- O +
64 O +
) O +
, O +
OprF B-Gene +
( O +
47 O +
- O +
64 O +
) O +
and O +
BSA B-Gene +
( O +
47 O +
- O +
64 O +
) O +
, O +
but O +
not O +
pIII O +
( O +
47 O +
- O +
64 O +
) O +
, O +
all O +
induced O +
high O +
- O +
titer O +
T O -
( O -
47 O -
- O -
64 O +
) O +
- O +
specific O +
antibodies O +
in O +
Balb O +
/ O +
c O +
mice O -
. O +
However O +
, O +
only O +
anti O +
- O +
GST B-Gene +
( O +
47 O -
- O -
64 O +
) O +
antibodies O +
inhibited O +
( O +
125 O +
) O +
I O +
- O +
TSST B-Gene +
- I-Gene +
1 I-Gene +
binding O +
to O +
MHC B-Gene +
class I-Gene +
II I-Gene +
and O +
abrogated O +
TSST B-Gene +
- I-Gene +
1 I-Gene +
- O +
induced O +
T O +
cell O +
mitogenesis O +
and O +
TNFalpha B-Gene +
secretion O +
in O +
human O +
peripheral O +
blood O +
mononuclear O +
cells O +
. O +

Purified O +
GST B-Gene +
( O +
47 O -
- O -
64 O +
) O +
also O +
inhibited O +
( O +
125 O +
) O +
I O +
- O +
TSST B-Gene +
- I-Gene +
1 I-Gene +
binding O +
in O +
a O +
dose O +
- O +
dependent O +
manner O +
. O +

These O +
findings O +
suggest O +
that O +
GST B-Gene +
( O +
47 O -
- O -
64 O +
) O +
may O +
have O +
potential O +
as O +
a O +
recombinant O +
peptide O +
vaccine O +
or O +
TSST B-Gene +
- I-Gene +
1 I-Gene +
receptor O +
inhibitor O +
against O +
TSS O +
. O +

Glycochelates O +
and O +
the O +
etiology O +
of O +
diabetic O +
peripheral O +
neuropathy O +
. O +

People O +
with O +
diabetes O +
are O +
prone O +
to O +
develop O +
peripheral O +
vascular O +
and O +
nerve O +
abnormalities O +
which O +
, O +
in O +
extreme O +
cases O +
, O +
can O +
lead O +
to O +
limb O +
amputations O +
. O +

Although O +
numerous O +
theories O +
have O +
been O +
advanced O +
for O +
these O +
complications O +
, O +
no O +
firm O +
explanation O +
is O +
yet O +
available O +
. O +

Recently O +
, O +
evidence O +
has O +
appeared O +
suggesting O +
that O +
these O +
vascular O +
and O +
nerve O +
abnormalities O +
may O +
involve O +
transition O +
metals O +
; O +
administration O +
of O +
chelators O +
such O +
as O +
desferrioxamine O +
has O +
been O +
shown O +
to O +
prevent O +
or O +
actually O +
reverse O +
slowed O +
peripheral O +
nerve O +
conduction O +
and O +
neuronal O +
blood O +
flow O +
, O +
as O +
well O +
as O +
impaired O +
endothelium O +
- O +
dependent O +
arterial O +
relaxation O +
. O +

Here O +
, O +
we O +
argue O +
that O +
( O -
i O -
) O +
the O +
heavily O +
glycated O +
proteins O +
known O +
to O +
accumulate O +
in O +
people O +
with O +
diabetes O +
gain O +
an O +
increased O +
affinity O +
for O +
transition O +
metals O +
such O +
as O +
iron O +
and O +
copper O +
, O +
( O +
ii O +
) O +
as O +
a O +
result O +
, O +
proteins O +
such O +
as O +
elastin B-Gene +
and O +
collagen B-Gene +
within O +
the O +
arterial O +
wall O +
- O +
which O +
are O +
known O +
to O +
be O +
particularly O +
heavily O +
glycosylated O +
in O +
diabetes O +
- O +
may O +
accumulate O +
bound O +
metal O +
, O +
especially O +
copper O +
, O +
( O -
iii O -
) O +
the O +
bound O +
metal O +
causes O +
the O +
catalytic O +
destruction O +
of O +
endothelium O +
derived O +
relaxing O +
factor O +
( O +
nitric O +
oxide O +
or O +
a O +
derivative O +
thereof O +
) O +
, O +
thereby O +
engendering O +
a O +
state O +
of O +
chronic O +
vasoconstriction O +
. O +

The O +
resulting O +
impairment O +
of O +
blood O +
flow O +
to O +
peripheral O +
nerves O +
restricts O +
the O +
delivery O +
of O +
oxygen O +
and O +
nutrients O +
and O +
, O +
in O +
extremis O +
, O +
nerve O +
death O +
eventuates O +
. O +

If O +
this O +
hypothesis O +
is O +
proved O +
correct O +
, O +
there O +
are O +
important O +
implications O +
for O +
the O +
development O +
of O +
novel O +
pharmaceuticals O +
for O +
the O +
treatment O +
of O +
diabetic O +
peripheral O +
neuropathy O +
. O +

Single O +
effects O +
of O +
apolipoprotein B-Gene +
B I-Gene +
, I-Gene +
( I-Gene +
a I-Gene +
) I-Gene +
, I-Gene +
and I-Gene +
E I-Gene +
polymorphisms O +
and O +
interaction O +
between O +
plasminogen B-Gene +
activator I-Gene +
inhibitor-1 I-Gene +
and O +
apolipoprotein B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
genotypes O +
and O +
the O +
risk O +
of O +
coronary O +
artery O +
disease O +
in O +
Czech O +
male O +
caucasians O +
. O +

To O +
evaluate O +
whether O +
polymorphisms O +
in O +
genes O +
whose O +
products O +
are O +
involved O +
in O +
lipid O +
metabolism O +
and O +
fibrinolysis O +
alter O +
the O +
risk O +
of O +
coronary O +
artery O +
disease O +
( O +
CAD O +
) O +
, O +
allele O +
frequencies O +
of O +
four O +
genetic O +
polymorphisms O +
were O +
ascertained O +
by O +
PCR O +
- O +
based O +
methods O +
in O +
175 O +
Czech O +
male O +
patients O +
with O +
coronary O +
artery O +
disease O +
and O +
in O +
222 O +
Czech O +
men O +
with O +
no O +
symptoms O +
of O +
CAD O +
. O +

The O +
following O +
polymorphisms O +
were O +
studied O +
: O +
apolipoprotein B-Gene +
B I-Gene +
( O +
apo B-Gene +
B I-Gene +
) O +
signal O +
peptide O +
insertion O +
/ O +
deletion O +
polymorphism O +
, O +
5 O -
' O +
apolipoprotein B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
[ O +
apo B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
] O +

TTTTA O +
repeat O +
polymorphism O +
, O +
apolipoprotein B-Gene +
E I-Gene +
( O +
apo B-Gene +
E I-Gene +
) O +
varepsilon2 O +
, O +
varepsilon3 O +
, O +
varepsilon4 O +
polymorphism O +
, O +
and O +
plasminogen B-Gene +
activator I-Gene +
inhibitor-1 I-Gene +
( O +
PAI-1 B-Gene +
) O +
4 O -
G O +
/ O +
5 O -
G O +
promoter O +
polymorphism O +
. O +

Apo B-Gene +
B I-Gene +
and O +
apo B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
allele O +
frequencies O +
differed O +
significantly O +
between O +
the O +
CAD O +
and O +
the O +
control O +
groups O +
( O +
P O +
< O +
0.01 O +
each O +
) O +
, O +
with O +
higher O +
frequencies O +
of O +
apo B-Gene +
B I-Gene +
deletion O +
and O +
apo B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
shorter O +
repeat O +
alleles O +
in O +
the O +
CAD O +
group O +
. O +

We O +
did O +
not O +
observe O +
any O +
differences O +
in O +
allele O +
frequencies O +
of O +
either O +
PAI-1 B-Gene +
or O +
apo B-Gene +
E I-Gene +
polymorphisms O +
but O +
the O +
genotype O +
frequencies O +
of O +
apo B-Gene +
E I-Gene +
were O +
slightly O +
different O +
between O +
the O +
two O +
groups O +
( O +
P O +
< O +
0.05 O +
) O +
. O +

In O +
addition O +
, O +
we O +
observed O +
a O +
gene O +
- O +
gene O +
interaction O +
between O +
the O +
PAI-1 B-Gene +
and O +
apo B-Gene +
( I-Gene +
a I-Gene +
) I-Gene +
polymorphisms O +
with O +
respect O +
to O +
the O +
risk O +
of O +
CAD O +
. O +

None O +
of O +
the O +
polymorphisms O +
studied O +
were O +
associated O +
with O +
the O +
severity O +
of O +
CAD O +
or O +
a O +
history O +
of O +
myocardial O +
infarction O +
. O +

Our O +
findings O +
support O +
the O +
idea O +
that O +
several O +
polymorphisms O +
in O +
apolipoprotein B-Gene +
genes O +
may O +
by O +
themselves O +
and/or O +
in O +
interaction O +
with O +
other O +
polymorphisms O +
contribute O +
to O +
risk O +
factors O +
for O +
CAD O +
in O +
men O +
. O +

Cloning O +
and O +
characterization O +
of O +
a O +
novel O +
histone B-Gene +
acetyltransferase I-Gene +
homologue O +
from O +
the O +
protozoan O +
parasite O +
Toxoplasma O +
gondii O +
reveals O +
a O +
distinct O +
GCN5 B-Gene +
family I-Gene +
member O +
. O +

In O +
an O +
effort O +
to O +
identify O +
gene O +
products O +
involved O +
in O +
transcriptional O +
regulation O +
in O +
apicomplexan O +
parasites O +
, O +
the O +
Toxoplasma O +
gondii O +
expressed O +
sequence O +
tag O +
( O +
EST O +
) O +
database O +
was O +
examined O +
for O +
sequences O +
containing O +
similarity O +
to O +
known O +
transcriptional O +
components O +
. O +

One O +
EST O +
( O +
dbEST O +
ID O +
# O -
466792 O +
) O +
exhibited O +
strong O +
similarity O +
to O +
yeast O +
GCN5 B-Gene +
and O +
other O +
histone B-Gene +
acetyltransferases I-Gene +
( O +
HATs B-Gene +
) O +
. O +

Primers O +
were O +
designed O +
based O +
on O +
the O +
EST O +
sequence O +
and O +
used O +
to O +
amplify O +
an O +
850 O +
bp O +
fragment O +
( O +
containing O +
an O +
intron O +
) O +
from O +
T. O +
gondii O +
genomic O +
DNA O +
which O +
was O +
used O +
to O +
identify O +
four O +
cDNA O +
clones O +
from O +
a O +
tachyzoite O +
cDNA O +
library O +
. O +

The O +
complete O +
open O +
reading O +
frame O +
( O +
ORF O +
) O +
of O +
3.5 O +
kb O +
was O +
elucidated O +
using O +
5 O -
' O +
RACE O +
and O +
genomic O +
sequence O +
. O +

The O +
deduced O +
amino O +
acid O +
sequence O +
of O +
the O +
coding O +
region O +
shows O +
that O +
the O +
C O +
- O +
terminal O +
domain O +
possesses O +
unequivocal O +
similarity O +
to O +
GCN5 B-Gene +
family I-Gene +
members O +
. O +

However O +
, O +
unlike O +
other O +
lower O +
eukaryotes O +
, O +
T. O +
gondii O +
GCN5 B-Gene +
has O +
an O +
extended O +
N O -
- O -
terminal O +
domain O +
similar O +
in O +
length O +
, O +
but O +
not O +
in O +
composition O +
, O +
to O +
metazoan O +
HAT B-Gene +
proteins O +
. O +

These O +
features O +
distinguish O +
T. O +
gondii O +
GCN5 B-Gene +
as O +
a O +
novel O +
member O +
of O +
the O +
GCN5 B-Gene +
family I-Gene +
. O +

A O +
portion O +
of O +
the O +
cDNA O +
sequence O +
was O +
used O +
as O +
a O +
probe O +
to O +
isolate O +
three O +
overlapping O +
clones O +
from O +
a O +
T. O +
gondii O +
genomic O +
library O +
, O +
generating O +
a O +
approximately O +
7.5 O +
kb O +
map O +
of O +
the O +
GCN5 B-Gene +
locus O +
which O +
contains O +
seven O +
exons O +
separated O +
by O +
six O +
introns O +
. O +

Southern O +
analysis O +
verifies O +
the O +
predicted O +
map O +
and O +
suggests O +
that O +
a O +
similar O +
locus O +
may O +
be O +
present O +
elsewhere O +
in O +
the O +
genome O +
. O +

Relationship O +
between O +
ataxin-1 B-Gene +
nuclear O +
inclusions O +
and O +
Purkinje O +
cell O +
specific O +
proteins O +
in O +
SCA-1 O +
transgenic O +
mice O +
. O +

Spinocerebellar O +
ataxia-1 O +
( O +
SCA-1 O +
) O +
, O +
like O +
other O +
polyglutamine O +
diseases O +
, O +
is O +
associated O +
with O +
aggregation O +
of O +
mutant O +
protein O +
ataxin B-Gene +
- I-Gene +
1 I-Gene +
in O +
the O +
nuclei O +
of O +
susceptible O +
neurons O +
. O +

The O +
role O +
of O +
ataxin-1 B-Gene +
aggregates O +
in O +
the O +
pathogenesis O +
of O +
susceptible O +
neurons O +
, O +
especially O +
cerebellar O +
Purkinje O +
cells O +
, O +
is O +
unknown O +
. O +

The O +
present O +
study O +
was O +
initiated O +
to O +
determine O +
the O +
temporal O +
relationship O +
between O +
ataxin-1 B-Gene +
aggregation O +
and O +
the O +
sequence O +
of O +
specific O +
biochemical O +
changes O +
in O +
Purkinje O +
cells O +
in O +
SCA-1 O +
transgenic O +
mice O +
( O +
TM O +
) O +
. O +

Earlier O +
, O +
we O +
demonstrated O +
that O +
SCA-1 O +
TM O +
with O +
no O +
Purkinje O +
cell O +
loss O +
and O +
no O +
alterations O +
in O +
home O +
cage O +
behavior O +
show O +
decreased O +
expression O +
of O +
calcium O +
- O +
binding O +
proteins O +
calbindin B-Gene +
- I-Gene +
D28k I-Gene +
( O +
CaB B-Gene +
) O +
and O +
parvalbumin B-Gene +
( O +
PV B-Gene +
) O +
in O +
Purkinje O +
cells O +
. O +

To O +
determine O +
if O +
increased O +
expression O +
of O +
mutant O +
ataxin-1 B-Gene +
in O +
TM O +
is O +
also O +
associated O +
with O +
earlier O +
biochemical O +
changes O +
in O +
Purkinje O +
cells O +
, O +
both O +
heterozygous O +
and O +
homozygous O +
( O +
B05 O +
line O +
of O +
SCA-1 O +
) O +
TM O +
were O +
used O +
. O +

The O +
age O +
of O +
onset O +
of O +
ataxia O +
in O +
SCA-1 O +
TM O +
was O +
at O +
12 O +
weeks O +
in O +
heterozygotes O +
and O +
6 O +
weeks O +
in O +
homozygotes O +
. O +

In O +
6 O +
week O +
old O +
heterozygous O +
TM O +
, O +
Western O +
blot O +
analysis O +
of O +
growth B-Gene +
associated I-Gene +
protein I-Gene +
43 I-Gene +
( O +
GAP-43 B-Gene +
) O +
and O +
synaptophysin B-Gene +
revealed O +
no O +
significant O +
alterations O +
as O +
compared O +
with O +
the O +
age O +
- O +
matched O +
nontransgenic O +
mice O +
( O +
nTM O +
) O +
, O +
whereas O +
CaB B-Gene +
was O +
significantly O +
reduced O +
. O +

beta B-Gene -
- I-Gene -
III I-Gene +
- I-Gene +
Tubulin I-Gene +
was O +
used O +
as O +
a O +
specific O +
Purkinje O +
cell O +
marker O +
protein O +
, O +
immunohistochemical O +
localization O +
showed O +
strong O +
beta B-Gene +
- I-Gene +
III I-Gene +
- I-Gene +
tubulin I-Gene +
immunoreactivity O +
( O +
IR O +
) O +
in O +
Purkinje O +
cells O +
in O +
6 O +
week O +
old O +
heterozygous O +
TM O +
, O +
whereas O +
CaB B-Gene +
and O +
PV B-Gene +
IR O +
were O +
markedly O +
reduced O +
in O +
the O +
same O +
neurons O +
( O +
double O +
immunofluorescence O +
staining O +
) O +
. O +

Most O +
Purkinje O +
cells O +
from O +
heterozygous O +
( O +
12 O +
weeks O +
old O +
) O +
and O +
homozygous O +
( O +
6 O +
weeks O +
old O +
) O +
TM O +
contained O +
ataxin B-Gene +
- I-Gene +
1 I-Gene +
nuclear O +
inclusions O +
( O +
NIs O +
) O +
. O +

Cells O +
with O +
and O +
without O +
visible O +
NIs O +
revealed O +
reduced O +
PV B-Gene +
and O +
CaB B-Gene +
IR O +
; O +
however O +
, O +
the O +
changes O +
were O +
overtly O +
more O +
severe O +
in O +
cells O +
with O +
visible O +
NIs O +
. O +

In O +
contrast O +
, O +
the O +
same O +
cells O +
were O +
strongly O +
immunoreactive O +
to O +
beta B-Gene +
- I-Gene +
III I-Gene +
- I-Gene +
tubulin I-Gene +
. O +

CaB B-Gene +
, O +
which O +
is O +
also O +
present O +
in O +
the O +
nucleus O +
, O +
colocalized O +
with O +
ataxin B-Gene +
- I-Gene +
1 I-Gene +
and O +
ubiquitin O +
positive O +
NIs O +
. O +

Further O +
, O +
RT O +
- O +
PCR O +
analysis O +
of O +
CaB B-Gene +
mRNA O +
in O +
the O +
cerebellum O +
in O +
6 O +
week O +
old O +
heterozygous O +
TM O +
demonstrated O +
a O +
significant O +
decrease O +
in O +
mRNA O +
in O +
comparison O +
with O +
the O +
aged O +
- O +
matched O +
nTM O +
. O +

These O +
data O +
suggest O +
that O +
there O +
are O +
selective O +
alterations O +
in O +
the O +
expression O +
of O +
CaB B-Gene +
and O +
PV B-Gene +
in O +
Purkinje O +
cells O +
which O +
possibly O +
occur O +
earlier O +
than O +
ataxin-1 B-Gene +
aggregation O +
. O +

Further O +
, O +
we O +
speculate O +
that O +
ataxin-1 B-Gene +
aggregates O +
may O +
not O +
be O +
toxic O +
in O +
general O +
; O +
however O +
, O +
they O +
may O +
deplete O +
specific O +
proteins O +
essential O +
for O +
Purkinje O +
cell O +
viability O +
in O +
SCA-1 O +
TM O +
. O +

Efficient O +
incorporation O +
of O +
HLA B-Gene +
class I-Gene +
II I-Gene +
onto O +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
requires O +
envelope O +
glycoprotein O +
packaging O +
. O +

HLA B-Gene +
class I-Gene +
II I-Gene +
DR B-Gene +
is O +
one O +
of O +
the O +
most O +
abundant O +
cell O +
surface O +
proteins O +
incorporated O +
onto O +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
( O +
HIV-1 O +
) O +
during O +
budding O +
. O +

The O +
mechanism O +
for O +
HLA B-Gene +
class I-Gene +
II I-Gene +
protein O +
incorporation O +
is O +
not O +
known O +
and O +
may O +
involve O +
a O +
viral O +
protein O +
. O +

To O +
determine O +
whether O +
Env B-Gene +
affects O +
HLA B-Gene +
class I-Gene +
II I-Gene +
protein O +
incorporation O +
, O +
HIV-1 O +
virions O +
, O +
either O +
with O +
or O +
without O +
Env B-Gene +
on O +
their O +
surface O +
, O +
were O +
produced O +
from O +
HLA B-Gene +
class I-Gene +
II I-Gene +
- O +
expressing O +
cells O +
and O +
analyzed O +
by O +
whole O +
- O +
virus O +
immunoprecipitation O +
with O +
antisera O +
against O +
HLA B-Gene +
class I-Gene +
II I-Gene +
proteins O +
. O +

HLA B-Gene +
class I-Gene +
II I-Gene +
proteins O +
were O +
detected O +
on O +
virions O +
only O +
when O +
wild O +
- O +
type O +
Env B-Gene +
was O +
incorporated O +
, O +
while O +
similar O +
experiments O +
showed O +
that O +
HLA B-Gene +
class I-Gene +
I I-Gene +
proteins O +
were O +
incorporated O +
independent O +
of O +
Env B-Gene +
packaging O +
. O +

Therefore O +
, O +
the O +
packaging O +
of O +
HIV-1 O +
Env B-Gene +
protein O +
is O +
required O +
for O +
the O +
efficient O +
incorporation O +
of O +
HLA B-Gene +
class I-Gene +
II I-Gene +
but O +
not O +
class O +
I O +
proteins O +
into O +
the O +
virion O +
. O +

Analysis O +
of O +
two O +
Env B-Gene +
mutants O +
revealed O +
that O +
the O +
presence O +
of O +
a O +
43 O +
- O +
amino O +
- O +
acid O +
sequence O +
between O +
amino O +
acids O +
708 O +
and O +
750 O +
in O +
the O +
gp41 B-Gene +
( O +
TM O +
) O +
cytoplasmic O +
tail O +
was O +
required O +
for O +
efficient O +
incorporation O +
of O +
HLA B-Gene +
class I-Gene +
II I-Gene +
proteins O +
. O +

These O +
data O +
show O +
that O +
HIV-1 O +
actively O +
incorporates O +
HLA B-Gene +
class I-Gene +
II I-Gene +
proteins O +
in O +
a O +
process O +
that O +
, O +
either O +
directly O +
or O +
indirectly O +
, O +
requires O +
Env B-Gene +
. O +

Choline O +
plus O +
cytidine O +
stimulate O +
phospholipid O +
production O +
, O +
and O +
the O +
expression O +
and O +
secretion O +
of O +
amyloid B-Gene +
precursor I-Gene +
protein I-Gene +
in O +
rat O +
PC12 O +
cells O +
. O +

The O +
amyloid B-Gene +
precursor I-Gene +
protein I-Gene +
( O +
APP B-Gene +
) O +
is O +
a O +
transmembrane O +
protein O +
anchored O +
in O +
the O +
membrane O +
lipid O +
bilayer O +
. O +

Choline O +
and O +
cytidine O +
are O +
major O +
precursors O +
of O +
cell O +
membranes O +
, O +
and O +
are O +
regulatory O +
elements O +
in O +
membrane O +
biosynthesis O +
. O +

We O +
examined O +
the O +
levels O +
of O +
cellular O +
APP B-Gene +
holoprotein O +
and O +
secreted O +
APPs B-Gene +
when O +
rat O +
PC12 O +
cells O +
are O +
stimulated O +
to O +
undergo O +
increase O +
in O +
membrane O +
phospholipids O +
by O +
choline O +
+ O +
cytidine O +
( O +
2 O -
+ O -
2,5 O -
+ O -
5,10 O -
+ O -
10 O +
or O +
50 O +
+ O +
50 O +
microM O +
) O +
treatment O +
. O +

We O +
now O +
show O +
that O +
as O +
phospholipids O +
levels O +
are O +
increased O +
by O +
supplemental O +
choline O +
and O +
cytidine O +
treatment O +
, O +
the O +
levels O +
of O +
cell O +
- O +
associated O +
APP B-Gene +
also O +
rise O +
stoichiometrically O +
; O +
these O +
treatments O +
also O +
caused O +
major O +
( O +
up O +
to O +
6 O -
. O +
8 O +
- O +
fold O +
) O +
increases O +
in O +
the O +
amounts O +
of O +
secreted O +
APP B-Gene +
released O +
into O +
the O +
cell O +
medium O +
, O +
and O +
also O +
stimulated O +
increased O +
process O +
formation O +
. O +

These O +
results O +
show O +
that O +
choline O +
plus O +
cytidine O +
increase O +
both O +
phospholipid O +
levels O +
, O +
and O +
the O +
expression O +
and O +
secretion O +
in O +
PC12 O +
cells O +
. O +

It O +
appears O +
that O +
agents O +
that O +
stimulate O +
cellular O +
membrane O +
biosynthesis O +
may O +
be O +
used O +
to O +
stimulate O +
the O +
secretion O +
of O +
neurotrophic O +
APPs B-Gene +
and O +
neurite O +
formation O +
in O +
neurodegenerative O +
disorders O +
such O +
as O +
Alzheimer O +
's O +
disease O +
. O +

Serum O +
antibody O +
responses O +
of O +
cats O +
to O +
soluble O +
whole O +
cell O +
antigens O +
of O +
feline O +
Porphyromonas O +
gingivalis O +
. O +

The O +
whole O +
cell O +
soluble O +
antigens O +
of O +
two O +
strains O +
( O +
VPB O +
3457 O +
and O +
VPB O +
3492 O +
) O +
of O +
feline O +
Porphyromonas O +
gingivalis O +
were O +
analysed O +
by O +
Western O +
blotting O +
using O +
serum O +
taken O +
from O +
40 O +
domestic O +
cats O +
with O +
various O +
grades O +
of O +
periodontal O +
disease O +
. O +

Five O +
strongly O +
immunogenic O +
protein O +
bands O +
( O +
70 O +
, O +
34 O +
, O +
27 O +
, O +
24 O +
and O +
19kDa O +
) O +
from O +
VPB O +
3457 O +
and O +
seven O +
from O +
VPB O +
3492 O +
( O +
58 O +
, O +
44 O +
, O +
34 O +
, O +
27 O +
, O +
25 O +
, O +
24 O +
and O +
21kDa O +
) O +
were O +
selected O +
for O +
further O +
study O +
. O +

A O +
significant O +
positive O +
correlation O +
was O +
found O +
between O +
the O +
serum O +
antibody O +
response O +
to O +
the O +
70 O +
, O +
34 O +
, O +
27 O +
, O +
24 O +
and O +
19kDa O +
bands O +
of O +
VPB O +
3457 O +
and O +
the O +
58 O +
, O +
44 O +
, O +
25 O +
, O +
24 O +
and O +
21kDa O +
bands O +
of O +
VPB O +
3492 O +
and O +
the O +
overall O +
periodontal O +
grade O +
. O +

A O +
significant O +
positive O +
correlation O +
was O +
also O +
found O +
between O +
the O +
serum O +
antibody O +
response O +
to O +
the O +
24kDa O +
band O +
of O +
VPB O +
3457 O +
and O +
the O +
total O +
colony O +
forming O +
units O +
of O +
P. O +
gingivalis O +
. O +

N O +
- O +
terminal O +
sequencing O +
of O +
the O +
44kDa O +
band O +
of O +
VPB O +
3492 O +
showed O +
75 O +
% O +
identity O +
with O +
the O +
translated O +
amino O +
acids O +
from O +
the O +
hag B-Gene +
A I-Gene +
( O +
haemagglutinin B-Gene +
) O +
gene O +
of O +
a O +
human O +
strain O +
of O +
P. O +
gingivalis O +
and O +
N O +
- O +
terminal O +
amino O +
acid O +
sequence O +
of O +
the O +
27kDa O +
band O +
of O +
VPB O +
3457 O +
showed O +
88 O +
% O +
identity O +
with O +
the O +
amino O +
acid O +
sequences O +
translated O +
from O +
DNA O +
of O +
purported O +
genes O +
coding O +
for O +
variously O +
named O +
proteinases B-Gene +
of O +
human O +
strains O +
of O +
P. O +
gingivalis O +
. O +

Proline B-Gene +
- I-Gene +
and I-Gene +
alanine I-Gene +
- I-Gene +
rich I-Gene +
Ste20 I-Gene +
- I-Gene +
related I-Gene +
kinase I-Gene +
associates O +
with O +
F O +
- O +
actin B-Gene +
and O +
translocates O +
from O +
the O +
cytosol O +
to O +
cytoskeleton O +
upon O +
cellular O +
stresses O +
. O +

Proline B-Gene +
- I-Gene +
and I-Gene +
alanine I-Gene +
- I-Gene +
rich I-Gene +
Ste20 I-Gene +
- I-Gene +
related I-Gene +
kinase I-Gene +
( O +
PASK B-Gene +
) O +
is O +
a O +
Ste20 B-Gene +
- O +
related O +
protein B-Gene +
kinase I-Gene +
isolated O +
from O +
rat O +
brain O +
. O +

Cell O +
fractionation O +
studies O +
showed O +
that O +
PASK B-Gene +
was O +
present O +
both O +
in O +
the O +
cytosol O +
and O +
in O +
Triton O +
X-100 O +
- O +
insoluble O +
cytoskeletal O +
fraction O +
in O +
rat O +
tissues O +
. O +

In O +
brain O +
, O +
PASK B-Gene +
associated O +
with O +
protein O +
complexes O +
that O +
contained O +
actin B-Gene +
and O +
tubulin B-Gene +
, O +
confirming O +
the O +
association O +
of O +
PASK B-Gene +
with O +
the O +
cytoskeleton O +
in O +
vivo O +
. O +

Glutathione B-Gene +
S I-Gene -
- I-Gene -
transferase I-Gene +
- O +
PASK B-Gene +
fusion O +
protein O +
cosedimented O +
with O +
F B-Gene -
- I-Gene -
actin I-Gene +
, O +
indicating O +
that O +
PASK B-Gene +
binds O +
to O +
F O +
- O +
actin B-Gene +
. O +

In O +
contrast O +
to O +
rat O +
tissues O +
, O +
PASK B-Gene +
was O +
detected O +
only O +
in O +
the O +
Triton O +
X O +
- O +
100 O +
- O +
soluble O +
cytosolic O +
fraction O +
in O +
cultured O +
PC12 O +
and O +
NIH O +
3T3 O +
cells O +
. O +

Cytosolic O +
PASK B-Gene +
translocated O +
to O +
the O +
cytoskeleton O +
when O +
these O +
cells O +
were O +
stimulated O +
with O +
severe O +
cellular O +
stresses O +
such O +
as O +
hypertonic O +
sodium O +
chloride O +
, O +
hydrogen O +
peroxide O +
, O +
and O +
heat O +
shock O +
at O +
45 O +
degrees O +
C O +
. O +

Our O +
results O +
suggest O +
that O +
PASK B-Gene +
may O +
be O +
involved O +
in O +
the O +
regulation O +
of O +
the O +
cytoskeleton O +
in O +
response O +
to O +
cellular O +
stresses O +
such O +
as O +
hyperosmotic O +
shock O +
. O +

Expression O +
of O +
15 O +
glutamate B-Gene +
receptor I-Gene +
subunits O +
and O +
various O +
splice O +
variants O +
in O +
tissue O +
slices O +
and O +
single O +
neurons O +
of O +
brainstem O +
nuclei O +
and O +
potential O +
functional O +
implications O +
. O +

Brainstem O +
nuclei O +
serve O +
a O +
diverse O +
array O +
of O +
functions O +
in O +
many O +
of O +
which O +
ionotropic O +
glutamate B-Gene +
receptors I-Gene +
are O +
known O +
to O +
be O +
involved O +
. O +

However O +
, O +
little O +
detailed O +
information O +
is O +
available O +
on O +
the O +
expression O +
of O +
different O +
glutamate B-Gene +
receptor I-Gene +
subunits O +
in O +
specific O +
nuclei O +
. O +

We O +
used O +
RT O +
- O +
PCR O +
in O +
mice O +
to O +
analyze O +
the O +
glutamate B-Gene +
receptor I-Gene +
subunit O +
composition O +
of O +
the O +
pre O +
- O +
BÃ?Â¶tzinger O +
complex O +
, O +
the O +
hypoglossal O +
nucleus O +
, O +
the O +
nucleus O +
of O +
the O +
solitary O +
tract O +
, O +
and O +
the O +
inferior O +
olive O +
. O +

Analyzing O +
15 O +
receptor O +
subunits O +
and O +
five O +
variants O +
, O +
we O +
found O +
all O +
four O +
alpha O +
- O +
amino O +
- O +
3 O +
- O +
hydroxy O +
- O +
5 O +
- O +
methyl O +
- O +
4 O +
- O +
propionic O +
acid O +
( O +
AMPA O +
) O +
and O +
six O +
NMDA B-Gene +
receptor I-Gene +
( O +
NR B-Gene +
) O +
subunits O +
as O +
well O +
as O +
three O +
of O +
five O +
kainate B-Gene +
( I-Gene +
KA I-Gene +
) I-Gene +
receptors I-Gene +
( O +
GluR5 B-Gene +
, O +
GluR6 B-Gene +
, O +
and O +
KA1 B-Gene +
) O +
to O +
be O +
expressed O +
in O +
all O +
nuclei O +
. O +

However O +
, O +
some O +
distinct O +
differences O +
were O +
observed O +
: O +

The O +
inferior O +
olive O +
preferentially O +
expresses O +
flop O +
variants O +
of O +
AMPA B-Gene +
receptors I-Gene +
, O +
GluR7 B-Gene +
is O +
more O +
abundant O +
in O +
the O +
pre O +
- O +
BÃ?Â¶tzinger O +
complex O +
than O +
in O +
the O +
other O +
nuclei O +
, O +
and O +
NR2C B-Gene +
is O +
most O +
prominent O +
in O +
the O +
nucleus O +
of O +
the O +
solitary O +
tract O +
. O +

In O +
single O +
hypoglossal O +
motoneurons O +
and O +
interneurons O +
of O +
the O +
pre O +
- O +
BÃ?Â¶tzinger O +
complex O +
investigation O +
of O +
GluR2 B-Gene +
editing O +
revealed O +
strong O +
expression O +
of O +
the O +
GluR2 B-Gene +
- O +
R O +
editing O +
variant O +
, O +
suggesting O +
low O +
Ca2 O +
+ O +
permeability O +
of O +
AMPA B-Gene +
receptors I-Gene +
. O +

Thus O +
, O +
Ca2 O -
+ O +
- O +
permeable O +
AMPA B-Gene +
receptors I-Gene +
are O +
unlikely O +
to O +
be O +
the O +
cause O +
for O +
the O +
reported O +
selective O +
vulnerability O +
of O +
hypoglossal O +
motoneurons O +
during O +
excitotoxic O +
events O +
. O +

Allene B-Gene +
oxide I-Gene +
synthases I-Gene +
of O +
barley O +
( O +
Hordeum O +
vulgare O +
cv O -
. O +
Salome O +
) O +
: O +
tissue O +
specific O +
regulation O +
in O +
seedling O +
development O +
. O +

Allene B-Gene +
oxide I-Gene +
synthase I-Gene +
( O +
AOS B-Gene +
) O +
is O +
the O +
first O +
enzyme O +
in O +
the O +
lipoxygenase B-Gene +
( O +
LOX B-Gene +
) O +
pathway O +
which O +
leads O +
to O +
formation O +
of O +
jasmonic O +
acid O +
( O +
JA O +
) O +
. O +

Two O +
full O +
- O +
length O +
cDNAs O +
of O +
AOS B-Gene +
designated O +
as O +
AOS1 B-Gene +
and O +
AOS2 B-Gene +
, O +
respectively O +
, O +
were O +
isolated O +
from O +
barley O +
( O +
H. O +
vulgare O +
cv O -
. O +
Salome O +
) O +
leaves O +
, O +
which O +
represent O +
the O +
first O +
AOS B-Gene +
clones O +
from O +
a O +
monocotyledonous O +
species O +
. O +

For O +
AOS1 B-Gene +
, O +
the O +
open O +
reading O +
frame O +
encompasses O +
1461 O +
bp O +
encoding O +
a O +
polypeptide O +
of O +
487 O +
amino O +
acids O +
with O +
calculated O +
molecular O +
mass O +
of O +
53.4 O +
kDa O +
and O +
an O +
isoelectric O +
point O +
of O +
9.3 O +
, O +
whereas O +
the O +
corresponding O +
data O +
of O +
AOS2 B-Gene +
are O +
1443 O +
bp O +
, O +
480 O +
amino O +
acids O +
, O +
52.7 O +
kDa O +
and O +
7.9 O +
. O +

Southern O +
blot O +
analysis O +
revealed O +
at O +
least O +
two O +
genes O +
. O +

Despite O +
the O +
lack O +
of O +
a O +
putative O +
chloroplast O +
signal O +
peptide O +
in O +
both O +
sequences O +
, O +
the O +
protein O +
co O +
- O +
purified O +
with O +
chloroplasts O +
and O +
was O +
localized O +
within O +
chloroplasts O +
by O +
immunocytochemical O +
analysis O +
. O +

The O +
barley O +
AOSs B-Gene +
, O +
expressed O +
in O +
bacteria O +
as O +
active O +
enzymes O +
, O +
catalyze O +
the O +
dehydration O +
of O +
LOX B-Gene +
- O +
derived O +
9 O +
- O +
as O +
well O +
as O +
13-hydroperoxides O +
of O +
polyenoic O +
fatty O +
acids O +
to O +
the O +
unstable O +
allene O +
oxides O +
. O +

In O +
leaves O +
, O +
AOS B-Gene +
mRNA O +
accumulated O +
upon O +
treatment O +
with O +
jasmonates O +
, O +
octadecanoids O +
and O +
metabolizable O +
carbohydrates O +
, O +
but O +
not O +
upon O +
floating O +
on O +
abscisic O +
acid O +
, O +
NaCl O +
, O +
Na O -
- O -
salicylate O +
or O +
infection O +
with O +
powdery O +
mildew O +
. O +

In O +
developing O +
seedlings O +
, O +
AOS B-Gene +
mRNA O +
strongly O +
accumulated O +
in O +
the O +
scutellar O +
nodule O +
, O +
but O +
less O +
in O +
the O +
leaf O +
base O +
. O +

Both O +
tissues O +
exhibited O +
elevated O +
JA O +
levels O +
. O +

In O +
situ O +
hybridizations O +
revealed O +
the O +
preferential O +
occurrence O +
of O +
AOS B-Gene +
mRNA O +
in O +
parenchymatic O +
cells O +
surrounding O +
the O +
vascular O +
bundles O +
of O +
the O +
scutellar O +
nodule O +
and O +
in O +
the O +
young O +
convoluted O +
leaves O +
as O +
well O +
as O +
within O +
the O +
first O +
internode O +
. O +

The O +
properties O +
of O +
both O +
barley O +
AOSs B-Gene +
, O +
their O +
up O +
- O +
regulation O +
of O +
their O +
mRNAs O +
and O +
their O +
tissue O +
specific O +
expression O +
suggest O +
a O +
role O +
during O +
seedling O +
development O +
and O +
jasmonate O +
biosynthesis O +
. O +

Molecular O +
cloning O +
and O +
characterization O +
of O +
mouse O +
CD97 B-Gene +
. O +

The O +
EGF B-Gene -
- I-Gene -
TM7 I-Gene +
family I-Gene +
( O +
CD97 B-Gene +
and O +
EMR1 B-Gene +
) O +
is O +
a O +
group O +
of O +
class O +
II O +
seven B-Gene +
- I-Gene +
span I-Gene +
transmembrane I-Gene +
receptors I-Gene +
predominantly O +
expressed O +
by O +
cells O +
of O +
the O +
immune O +
system O +
. O +

Recently O +
, O +
we O +
have O +
identified O +
CD55 B-Gene +
, O +
a O +
regulatory O +
molecule O +
of O +
the O +
complement O +
cascade O +
, O +
as O +
a O +
cellular O +
ligand O +
of O +
human O +
CD97 B-Gene +
( O +
hCD97 B-Gene +
) O +
. O +

In O +
this O +
study O +
, O +
the O +
molecular O +
properties O +
of O +
mouse O +
CD97 B-Gene +
( O +
mCD97 B-Gene +
) O +
are O +
described O +
. O +

Like O +
hCD97 B-Gene +
, O +
mCD97 B-Gene +
has O +
an O +
extended O +
extracellular O +
region O +
with O +
several O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
- O +
like O +
( O +
EGF B-Gene +
) O +
domains O +
. O +

Due O +
to O +
alternative O +
RNA O +
splicing O +
, O +
isoforms O +
with O +
three O +
and O +
four O +
EGF B-Gene +
domains O +
exist O +
, O +
designated O +
mCD97 B-Gene +
( O +
EGF1 O +
, O +
2,4 O +
) O +
and O +
mCD97 O +
( O +
EGF1 O +
, O +
2 O +
, O +
3,4 O +
) O +
respectively O +
. O +

All O +
EGF B-Gene +
domains O +
, O +
except O +
for O +
the O +
N O +
- O +
terminal O +
one O +
, O +
possess O +
a O +
calcium O +
- O +
binding O +
site O +
. O +

In O +
a O +
third O +
isoform O +
mCD97 B-Gene +
( O +
EGF1,2,X,3,4 O +
) O +
, O +
a O +
sequence O +
of O +
45 O +
amino O +
acids O +
was O +
found O +
between O +
the O +
second O +
and O +
third O +
EGF B-Gene +
domain O +
that O +
does O +
not O +
correspond O +
to O +
any O +
known O +
protein O +
module O +
. O +

Using O +
newly O +
generated O +
mCD97 B-Gene +
mAb O +
, O +
we O +
show O +
that O +
analogous O +
to O +
the O +
blood O +
expression O +
pattern O +
of O +
hCD97 B-Gene +
, O +
mCD97 B-Gene +
can O +
be O +
found O +
on O +
lymphoid O +
and O +
myeloid O +
cells O +
. O +

Adhesion O +
of O +
mouse O +
erythrocytes O +
and O +
splenocytes O +
to O +
COS O +
cells O +
expressing O +
mCD97 B-Gene +
( O +
EGF1,2,4 O +
) O +
or O +
mCD97 B-Gene +
( O +
EGF1 O +
, O +
2 O +
, O +
3 O +
, O +
4 O +
) O +
could O +
be O +
blocked O +
by O +
mouse O +
CD55 B-Gene +
( O +
mCD55 B-Gene +
) O +
antibody O +
, O +
identifying O +
mCD55 B-Gene +
as O +
a O +
cellular O +
ligand O +
for O +
mCD97 B-Gene +
. O +

Consistent O +
with O +
the O +
necessity O +
of O +
directly O +
linked O +
EGF B-Gene +
domains O +
for O +
the O +
integrity O +
of O +
the O +
CD55 B-Gene +
- O +
binding O +
site O +
on O +
hCD97 B-Gene +
, O +
no O +
adhesion O +
was O +
detected O +
to O +
the O +
largest O +
mouse O +
isoform O +
mCD97 B-Gene +
( O +
EGF1 O +
, O +
2 O +
, O +
X,3,4 O +
) O +
. O +

Remarkably O +
, O +
we O +
found O +
that O +
the O +
interaction O +
between O +
CD97 B-Gene +
and O +
CD55 B-Gene +
is O +
phylogenetically O +
restricted O +
, O +
as O +
indicated O +
by O +
the O +
selective O +
adhesion O +
of O +
primate O +
erythrocytes O +
to O +
hCD97 B-Gene +
transfectants O +
, O +
and O +
of O +
mouse O +
and O +
rat O +
erythrocytes O +
to O +
mCD97 B-Gene +
transfectants O +
respectively O +
. O +

Direct O +
interaction O +
between O +
the O +
cell O +
division O +
protein O +
FtsZ B-Gene +
and O +
the O +
cell O +
differentiation O +
protein O +
SpoIIE B-Gene +
. O +

SpoIIE B-Gene +
is O +
a O +
bifunctional O +
protein O +
with O +
two O +
critical O +
roles O +
in O +
the O +
establishment O +
of O +
cell O +
fate O +
in O +
Bacillus O +
subtilis O +
. O +

First O +
, O +
SpoIIE B-Gene +
is O +
needed O +
for O +
the O +
normal O +
formation O +
of O +
the O +
asymmetrically O +
positioned O +
septum O +
that O +
forms O +
early O +
in O +
sporulation O +
and O +
separates O +
the O +
mother O +
cell O +
from O +
the O +
prespore O +
compartment O +
. O +

Secondly O +
, O +
SpoIIE B-Gene +
is O +
essential O +
for O +
the O +
activation O +
of O +
the O +
first O +
compartment O +
- O +
specific O +
transcription B-Gene +
factor I-Gene +
sigma B-Gene +
( I-Gene +
F I-Gene +
) I-Gene +
in O +
the O +
prespore O +
. O +

After O +
initiation O +
of O +
sporulation O +
, O +
SpoIIE B-Gene +
localizes O +
to O +
the O +
potential O +
asymmetric O +
cell O +
division O +
sites O +
near O +
one O +
or O +
both O +
cell O +
poles O +
. O +

Localization O +
of O +
SpoIIE B-Gene +
was O +
shown O +
to O +
be O +
dependent O +
on O +
the O +
essential O +
cell O +
division O +
protein O +
FtsZ B-Gene +
. O +

To O +
understand O +
how O +
SpoIIE B-Gene +
is O +
targeted O +
to O +
the O +
asymmetric O +
septum O +
we O +
have O +
now O +
analysed O +
its O +
interaction O +
with O +
FtsZ B-Gene +
in O +
vitro O +
. O +

Using O +
the O +
yeast O +
two O +
- O +
hybrid O +
system O +
and O +
purified O +
FtsZ B-Gene +
, O +
and O +
full O +
- O +
length O +
and O +
truncated O +
SpoIIE B-Gene +
proteins O +
, O +
we O +
demonstrate O +
that O +
the O +
two O +
proteins O +
interact O +
directly O +
and O +
that O +
domain O +
II O +
and O +
possibly O +
domain O +
I O +
of O +
SpoIIE B-Gene +
are O +
required O +
for O +
the O +
interaction O +
. O +

Moreover O +
, O +
we O +
show O +
that O +
SpoIIE B-Gene +
interacts O +
with O +
itself O +
and O +
suggest O +
that O +
this O +
self O +
- O +
interaction O +
plays O +
a O +
role O +
in O +
assembly O +
of O +
SpoIIE B-Gene +
into O +
the O +
division O +
machinery O +
. O +

Probing O +
contacts O +
between O +
the O +
ribonuclease B-Gene +
H I-Gene +
domain O +
of O +
HIV-1 O +
reverse B-Gene +
transcriptase I-Gene +
and O +
nucleic O +
acid O +
by O +
site O +
- O +
specific O +
photocross O +
- O +
linking O +
. O +

Cys O -
( O -
38 O -
) O +
and O +
Cys O +
( O +
280 O +
) O +
of O +
p66 B-Gene +
/ O +
p51 B-Gene +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
reverse B-Gene +
transcriptase I-Gene +
( O +
HIV-1 O +
RT B-Gene +
) O +
can O +
be O +
converted O +
to O +
Ser O +
without O +
affecting O +
enzyme O +
function O +
. O +

We O +
have O +
exploited O +
this O +
feature O +
to O +
construct O +
and O +
purify O +
" O +
monocysteine O +
" O +
RT B-Gene +
derivatives O +
for O +
site O +
- O +
specific O +
modification O +
with O +
the O +
photoactivable O +
cross O +
- O +
linking O +
agent O +
, O +
p O -
- O -
azidophenacyl O +
bromide O +
. O +

Acylation O +
of O +
a O +
unique O +
cysteine O +
residue O +
introduced O +
at O +
the O +
extreme O +
C O +
terminus O +
of O +
the O +
p66 B-Gene +
subunit O +
( O +
C O -
( O -
561 O -
) O +
) O +
with O +
an O +
azidophenacyl O +
group O +
allowed O +
us O +
to O +
probe O +
contacts O +
between O +
residues O +
C O +
- O +
terminal O +
to O +
alpha O +
- O +
helix O +
E O -
' O +
of O +
the O +
RNase B-Gene +
H I-Gene +
domain O +
and O +
structurally O +
divergent O +
nucleic O +
acid O +
duplexes O +
. O +

In O +
a O +
binary O +
complex O +
of O +
RT B-Gene +
and O +
template O +
- O +
primer O +
, O +
we O +
demonstrate O +
efficient O +
cross O +
- O +
linking O +
to O +
primer O +
nucleotides O +
- O +
21 O +
to O +
- O +
24 O +
/ O +
- O +
25 O +
, O +
and O +
template O +
nucleotides O +
- O +
18 O +
to O +
- O +
21 O +
. O +

Cross O +
- O +
linking O +
specificity O +
was O +
confirmed O +
by O +
an O +
analogous O +
evaluation O +
following O +
limited O +
primer O +
extension O +
, O +
where O +
the O +
profile O +
is O +
displaced O +
by O +
the O +
register O +
of O +
DNA O +
synthesis O +
. O +

Finally O +
, O +
contact O +
with O +
a O +
DNA O +
primer O +
hybridized O +
to O +
an O +
isogenic O +
RNA O +
or O +
DNA O +
template O +
indicates O +
subtle O +
alterations O +
in O +
cross O +
- O +
linking O +
specificity O +
, O +
suggesting O +
differences O +
in O +
nucleic O +
acid O +
geometry O +
between O +
duplex O +
DNA O +
and O +
RNA O +
/ O +
DNA O +
hybrids O +
at O +
the O +
RNase B-Gene +
H I-Gene +
domain O +
. O +

These O +
data O +
exemplify O +
how O +
site O +
- O +
specific O +
acylation O +
of O +
HIV-1 O +
RT B-Gene +
can O +
be O +
used O +
to O +
provide O +
high O +
resolution O +
structural O +
data O +
to O +
complement O +
crystallographic O +
studies O +
. O +

Reverse O +
transcriptase O +
( O +
RT O +
) O +
- O +
independent O +
as O +
well O +
as O +
RT O +
- O +
dependent O +
HIV-1 O +
replication O +
exists O +
in O +
syncytia O +
following O +
cell O +
fusion O +
. O +

We O +
studied O +
the O +
role O +
of O +
reverse O +
transcriptase O +
( O +
RT O +
) O +
in O +
human O +
immunodeficiency O +
virus O +
( O +
HIV O +
) O +
- O +
1 O +
replication O +
in O +
syncytia O +
following O +
cell O +
fusion O +
. O +

A O +
chronically O +
HIV-1 O +
- O +
infected O +
MOLT-4 O +
( O +
MOLT O +
- O +
4 O +
/ O +
IIIB O +
) O +
cells O +
allow O +
HIV-1 O +
replication O +
and O +
induce O +
syncytium O +
formation O +
between O +
uninfected O +
MOLT-4 O +
cells O +
. O +

AZT O +
( O +
3'-azido-3'-deoxythymidine O +
, O +
1 O +
microM O +
) O +
inhibited O +
neither O +
HIV-1 O +
replication O +
in O +
MOLT-4 O +
/ O +
IIIB O +
cells O +
nor O +
the O +
syncytium O +
formation O +
induced O +
by O +
concultivation O +
of O +
MOLT-4 O +
/ O +
IIIB O +
cells O +
with O +
uninfected O +
MOLT-4 O +
cells O +
. O +

In O +
the O +
supernatant O +
of O +
the O +
syncytium O +
containing O +
culture O +
a O +
remarkably O +
higher O +
titer O +
of O +
p24 B-Gene +
antigen O +
was O +
produced O +
than O +
in O +
that O +
of O +
MOLT O +
/ O +
IIIB O +
cell O +
culture O +
. O +

AZT O +
inhibited O +
p24 B-Gene +
antigen O +
production O +
by O +
HIV-1 O +
in O +
the O +
syncytia O +
to O +
levels O +
to O +
comparable O +
to O +
that O +
in O +
MOLT-4 O +
/ O +
IIIB O +
cells O +
which O +
were O +
treated O +
with O +
AZT O +
. O +

In O +
addition O +
, O +
p24 B-Gene +
production O +
by O +
HIV-1 O +
in O +
the O +
syncytia O +
formed O +
by O +
cocultivation O +
of O +
CL-2 O +
cells O +
, O +
which O +
are O +
chronically O +
infected O +
with O +
HIV-1 O +
but O +
lack O +
functional O +
RT B-Gene +
, O +
with O +
uninfected O +
MOLT-4 O +
cells O +
was O +
not O +
different O +
from O +
that O +
in O +
CL-2 O +
cells O +
alone O +
. O +

The O +
results O +
suggest O +
that O +
HIV-1 O +
RT B-Gene +
plays O +
an O +
important O +
role O +
in O +
HIV-1 O +
replication O +
within O +
the O +
syncytia O +
but O +
an O +
RT B-Gene +
- O +
independent O +
replication O +
process O +
which O +
is O +
essential O +
for O +
syncytium O +
formation O +
also O +
exists O +
in O +
the O +
syncytia O +
. O +

These O +
results O +
indicate O +
that O +
not O +
only O +
RT B-Gene +
inhibitors O +
but O +
also O +
inhibitors O +
of O +
syncytium O +
formation O +
are O +
essential O +
for O +
anti O +
- O +
HIV O +
therapy O +
. O +

Regulation O +
of O +
expression O +
of O +
the O +
human O +
beta-1,2-N B-Gene -
- I-Gene -
acetylglucosaminyltransferase I-Gene +
II I-Gene +
gene O +
( O +
MGAT2 B-Gene +
) O +
by O +
Ets B-Gene +
transcription B-Gene +
factors I-Gene +
. O +

Oncogenic O +
transformation O +
of O +
fibroblasts O +
by O +
the O +
src B-Gene +
oncogene O +
has O +
long O +
been O +
known O +
to O +
cause O +
an O +
increase O +
in O +
the O +
size O +
of O +
cell O +
- O +
surface O +
protein O +
- O +
bound O +
oligosaccharides O +
, O +
owing O +
primarily O +
to O +
increased O +
N O +
- O +
glycan O +
branching O +
mediated O +
by O +
increased O +
beta-1,6-N B-Gene -
- I-Gene -
acetylglucosaminyltransferase I-Gene +
V I-Gene +
( O +
GnT B-Gene +
V I-Gene +
) O +
activity O +
. O +

The O +
src B-Gene +
- O +
responsive O +
element O +
of O +
the O +
GnT B-Gene +
V I-Gene +
promoter O +
was O +
localized O +
to O +
Ets B-Gene +
- O +
binding O +
sites O +
and O +
the O +
promoter O +
was O +
transcriptionally O +
stimulated O +
by O +
both O +
ets-1 B-Gene +
and O +
ets-2 B-Gene +
expression O +
[ O +
Buckhaults O +
, O +
Chen O +
, O +
Fregien O +
and O +
Pierce O +
( O +
1997 O +
) O +
J. O +
Biol O -
. O +
Chem O -
. O +
272 O +
, O +
19575 O +
- O +
19581 O +
; O +
Kang O +
, O +
Saito O +
, O +
Ihara O +
, O +
Miyoshi O +
, O +
Koyama O +
, O +
Sheng O +
and O +
Taniguchi O +
( O +
1996 O +
) O +
J. O +
Biol O -
. O +
Chem O -
. O +
271 O +
, O +
26706 O +
- O +
26712 O +
] O +
. O +

Because O +
GnT B-Gene +
V I-Gene +
action O +
requires O +
the O +
prior O +
action O +
of O +
beta-1,2-N B-Gene -
- I-Gene -
acetylglucosaminyltransferase I-Gene +
II I-Gene +
( O +
GnT B-Gene +
II I-Gene +
) O +
and O +
the O +
human O +
GnT B-Gene +
II I-Gene +
promoter O +
contains O +
four O +
putative O +
Ets B-Gene +
- O +
binding O +
sites O +
[ O +
Chen O +
, O +
Zhou O +
, O +
Tan O +
and O +
Schachter O +
( O +
1998 O +
) O +
Glycoconj O -
. O +
J. O +
15 O +
, O +
301 O +
- O +
308 O +
] O +
, O +
GnT B-Gene +
II I-Gene +
might O +
also O +
be O +
under O +
oncogenic O +
control O +
via O +
Ets B-Gene +
transcription B-Gene +
factors I-Gene +
. O +

We O +
now O +
report O +
that O +
co O +
- O +
transfection O +
into O +
HepG2 O +
or O +
COS-1 O +
cells O +
of O +
either O +
ets-1 B-Gene +
or O +
ets-2 B-Gene +
expression O +
plasmids O +
together O +
with O +
chimaeric O +
GnT B-Gene +
II I-Gene +
promoter O +
- O +
chloramphenicol B-Gene +
acetyltransferase I-Gene +
plasmids O +
results O +
in O +
a O +
2 O +
- O +
4 O +
- O +
fold O +
stimulation O +
of O +
promoter O +
activity O +
. O +

Mobility O +
- O +
shift O +
assays O +
and O +
South O +
- O +
Western O +
blots O +
localized O +
the O +
functional O +
Ets B-Gene +
- O +
binding O +
site O +
to O +
one O +
of O +
the O +
four O +
putative O +
sites O +
on O +
the O +
GnT B-Gene +
II I-Gene +
promoter O +
. O +

The O +
GnT B-Gene +
II I-Gene +
promoter O +
, O +
unlike O +
the O +
GnT B-Gene +
V I-Gene +
promoter O +
, O +
is O +
not O +
activated O +
by O +
either O +
src B-Gene +
or O +
neu B-Gene +
. O +

Therefore O +
although O +
both O +
promoters O +
are O +
stimulated O +
by O +
a O +
member O +
of O +
the O +
Ets B-Gene +
family I-Gene +
of O +
transcription B-Gene +
factors I-Gene +
, O +
the O +
functional O +
role O +
of O +
this O +
Ets B-Gene +
transcriptional O +
control O +
seems O +
to O +
be O +
different O +
for O +
the O +
two O +
genes O +
. O +

Fine O +
characterization O +
of O +
the O +
antigenic O +
site O +
within O +
the O +
flap O +
region O +
in O +
the O +
protease B-Gene +
protein O +
of O +
HIV-1 O +
. O +

The O +
aspartate B-Gene +
protease I-Gene +
encoded O +
by O +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
is O +
essential O +
for O +
cleavage O +
of O +
the O +
gag B-Gene +
and O +
gag B-Gene +
- I-Gene +
pol I-Gene +
precursor O +
proteins O +
. O +

The O +
majority O +
of O +
HIV-1 O +
- O +
antibody O +
- O +
positive O +
sera O +
react O +
with O +
the O +
protease B-Gene +
. O +

In O +
this O +
study O +
we O +
used O +
a O +
substitution O +
set O +
of O +
peptides O +
for O +
detailed O +
characterization O +
of O +
the O +
earlier O +
defined O +
antigenic O +
site O +
( O +
aa O +
44 O +
- O +
58 O +
) O +
within O +
the O +
central O +
" O +
flap O +
" O +
region O +
, O +
also O +
important O +
in O +
the O +
context O +
of O +
conformational O +
flexibility O +
during O +
protease B-Gene +
inhibitor O +
binding O +
. O +

We O +
found O +
that O +
isoleucine O +
at O +
position O +
54 O +
was O +
important O +
for O +
creating O +
an O +
antigenic O +
site O +
required O +
for O +
binding O +
of O +
anti O +
- O +
HIV-1 O +
sera O +
. O +

The O +
identification O +
of O +
structurally O +
essential O +
amino O +
acids O +
in O +
the O +
flap O +
region O +
of O +
HIV-1 O +
PR O +
may O +
have O +
important O +
implications O +
in O +
future O +
development O +
of O +
antiviral O +
drugs O +
. O +

Epitope O +
spreading O +
and O +
a O +
varying O +
but O +
not O +
disease O +
- O +
specific O +
GAD65 B-Gene +
antibody O +
response O +
in O +
Type O +
I O +
diabetes O +
. O +

The O +
Childhood O +
Diabetes O +
in O +
Finland O +
Study O +
Group O +
. O +

AIMS O +
/ O +
HYPOTHESIS O +
: O +

The O +
aim O +
of O +
this O +
study O +
was O +
to O +
analyse O +
the O +
conformational O +
and O +
linear O +
epitope O +
profiles O +
of O +
glutamic B-Gene +
acid I-Gene +
decarboxylase I-Gene +
antibody O +
( O +
GAD65 B-Gene +
- O +
ab O +
) O +
- O +
positive O +
sera O +
to O +
find O +
disease O +
- O +
specific O +
epitope O +
profiles O +
and O +
to O +
study O +
, O +
whether O +
GAD65 B-Gene +
- O +
ab O +
epitope O +
recognition O +
changes O +
or O +
spreads O +
during O +
the O +
prediabetic O +
period O +
and O +
, O +
thus O +
, O +
can O +
provide O +
markers O +
to O +
differentiate O +
early O +
from O +
later O +
stages O +
of O +
progression O +
to O +
diabetes O +
. O +

METHODS O +
: O +

Sera O +
from O +
subjects O +
before O +
( O +
n O +
= O +
21 O +
) O +
, O +
at O +
onset O +
( O +
n O +
= O +
44 O +
) O +
, O +
or O +
at O +
increased O +
risk O +
of O +
Type O +
I O +
( O +
insulin B-Gene +
- O +
dependent O +
) O +
diabetes O +
mellitus O +
( O +
n O +
= O +
20 O +
) O +
and O +
from O +
patients O +
with O +
stiff O +
- O +
man O +
syndrome O +
( O +
SMS O +
, O +
n O +
= O +
18 O +
) O +
or O +
polyendocrine O +
autoimmune O +
syndrome O +
( O +
PAS O +
, O +
n O +
= O +
21 O +
) O +
were O +
analysed O +
for O +
conformational O +
and O +
linear O +
GAD65 B-Gene +
epitope O +
recognition O +
by O +
an O +
immunohistochemical O +
blocking O +
test O +
based O +
on O +
human O +
monoclonal O +
GAD65 B-Gene +
- O +
ab O +
( O +
MICA O +
1 O +
- O +
10 O +
) O +
and O +
western O +
blotting O +
of O +
a O +
GAD65 B-Gene +
epitope O +
- O +
cDNA O +
- O +
library O +
. O +

RESULTS O +
: O +

A O +
redundant O +
reactivity O +
of O +
many O +
GAD65 B-Gene +
- O +
ab O +
positive O +
sera O +
to O +
three O +
major O +
conformational O +
( O +
EP-1 O +
, O +
EP-2 O +
, O +
EP-3 O +
) O +
and O +
two O +
dominant O +
linear O +
epitope O +
clusters O +
( O +
amino O +
acid O +
1 O +
- O +
124 O +
and O +
535 O +
- O +
585 O +
) O +
was O +
observed O +
in O +
diabetes O +
, O +
polyendocrine O +
autoimmune O +
syndrome O +
and O +
stiff O +
- O +
man O +
syndrome O +
and O +
no O +
disease O +
- O +
specific O +
epitopes O +
or O +
epitope O +
- O +
profiles O +
were O +
detected O +
. O +

Epitope O +
recognition O +
broadened O +
with O +
higher O +
titres O +
and O +
with O +
the O +
vulnerability O +
of O +
patients O +
to O +
acquire O +
additional O +
autoimmune O +
diseases O +
apart O +
from O +
diabetes O +
. O +

Low O +
GAD65 B-Gene +
- O +
ab O +
serum O +
titres O +
( O +
< O +
1200 O +
arbitrary O +
units O +
) O +
and O +
EP-1 O +
recognition O +
in O +
the O +
absence O +
of O +
EP O +
- O +
2 O +
binding O +
characterised O +
the O +
early O +
immune O +
response O +
. O +

Changing O +
epitope O +
profiles O +
combined O +
stable O +
recognition O +
of O +
EP-1 O +
with O +
gain O +
or O +
loss O +
of O +
reactivity O +
to O +
C O +
- O +
terminal O +
epitopes O +
during O +
follow O +
- O +
up O +
. O +

CONCLUSION O +
/ O +
INTERPRETATION O +
: O +

A O +
maturing O +
autoantibody O +
response O +
, O +
which O +
could O +
spread O +
from O +
EP O +
- O +
1 O +
- O +
recognition O +
to O +
other O +
regions O +
of O +
GAD65 B-Gene +
, O +
resulted O +
in O +
titre O +
- O +
related O +
rather O +
than O +
disease O +
- O +
specific O +
epitope O +
profiles O +
which O +
were O +
not O +
sufficient O +
to O +
predict O +
whether O +
GAD65 B-Gene +
- O +
ab O +
positive O +
subjects O +
will O +
progress O +
to O +
Type O +
I O +
diabetes O +
, O +
autoimmune O +
polyendocrine O +
syndrome O +
or O +
stiff O +
- O +
man O +
syndrome O +
. O +

delta B-Gene -
- I-Gene -
catenin I-Gene +
is O +
a O +
nervous O +
system O +
- O +
specific O +
adherens O +
junction O +
protein O +
which O +
undergoes O +
dynamic O +
relocalization O +
during O +
development O +
. O +

delta B-Gene -
- I-Gene -
catenin I-Gene +
is O +
a O +
member O +
of O +
the O +
Armadillo B-Gene +
repeat I-Gene +
family I-Gene +
and O +
component O +
of O +
the O +
adherens O +
junction O +
discovered O +
in O +
a O +
two O +
- O +
hybrid O +
assay O +
as O +
a O +
bona O +
fide O +
interactor O +
with O +
presenilin-1 B-Gene +
( O +
Zhou O +
et O +
al. O +
, O +
[ O +
1997 O +
] O +
, O +
NeuroReport O +
8 O +
: O +
2085 O -
- O -
2090 O +
) O +
, O +
a O +
protein O +
which O +
carries O +
mutations O +
that O +
cause O +
familial O +
Alzheimer O +
' O +
s O +
disease O +
. O +

The O +
expression O +
pattern O +
of O +
delta B-Gene -
- I-Gene -
catenin I-Gene +
was O +
mapped O +
between O +
embryonic O +
day O +
10 O +
( O +
E10 O +
) O +
and O +
adulthood O +
by O +
Northern O +
blots O +
, O +
in O +
situ O +
hybridization O +
and O +
immunohistochemistry O +
in O +
the O +
mouse O +
. O +

In O +
development O +
, O +
delta B-Gene -
- I-Gene -
catenin I-Gene +
is O +
dynamically O +
regulated O +
with O +
respect O +
to O +
its O +
site O +
of O +
expression O +
. O +

It O +
is O +
first O +
expressed O +
within O +
proliferating O +
neuronal O +
progenitor O +
cells O +
of O +
the O +
neuroepithelium O +
, O +
becomes O +
down O +
- O +
regulated O +
during O +
neuronal O +
migration O +
, O +
and O +
is O +
later O +
reexpressed O +
in O +
the O +
dendritic O +
compartment O +
of O +
postmitotic O +
neurons O +
. O +

In O +
the O +
mouse O +
, O +
delta B-Gene -
- I-Gene -
catenin I-Gene +
mRNA O +
is O +
expressed O +
by O +
E10 O +
, O +
increases O +
and O +
peaks O +
at O +
postnatal O +
day O +
( O +
P O +
) O +
7 O +
, O +
with O +
lower O +
levels O +
in O +
adulthood O +
. O +

In O +
the O +
developing O +
neocortex O +
, O +
delta B-Gene -
- I-Gene -
catenin I-Gene +
mRNA O +
is O +
strongly O +
expressed O +
in O +
the O +
proliferative O +
ventricular O +
zone O +
and O +
the O +
developing O +
cortical O +
plate O +
, O +
yet O +
is O +
conspicuously O +
less O +
prominent O +
in O +
the O +
intermediate O +
zone O +
, O +
which O +
contains O +
migrating O +
cortical O +
neurons O +
, O +
delta B-Gene +
- I-Gene +
catenin I-Gene +
protein O +
forms O +
a O +
honeycomb O +
pattern O +
in O +
the O +
neuroepithelium O +
by O +
labeling O +
the O +
cell O +
periphery O +
in O +
a O +
typical O +
adherens O +
junction O +
pattern O +
. O +

By O +
E18 O +
, O +
delta B-Gene -
- I-Gene -
catenin I-Gene +
expression O +
shifts O +
primarily O +
to O +
nascent O +
apical O +
dendrites O +
, O +
a O +
pattern O +
that O +
continues O +
through O +
adulthood O +
. O +

The O +
dynamic O +
relocalization O +
of O +
delta B-Gene -
- I-Gene -
catenin I-Gene +
expression O +
during O +
development O +
, O +
taken O +
together O +
with O +
previously O +
published O +
data O +
which O +
described O +
a O +
role O +
for O +
delta B-Gene -
- I-Gene -
catenin I-Gene +
in O +
cell O +
motility O +
( O +
Lu O +
et O +
al. O +
, O +
[ O +
1999 O +
] O +
J. O +
Cell O -
. O +
Biol O -
. O +
144 O +
: O +
519 O +
- O +
532 O +
) O +
, O +
suggests O +
the O +
hypothesis O +
that O +
delta B-Gene +
- I-Gene +
catenin I-Gene +
regulation O +
is O +
closely O +
linked O +
to O +
neuronal O +
migration O +
and O +
may O +
play O +
a O +
role O +
in O +
the O +
establishment O +
of O +
mature O +
dendritic O +
relationships O +
in O +
the O +
neuropil O +
. O +

Haemophilus O +
influenzae O +
stimulates O +
ICAM-1 B-Gene +
expression O +
on O +
respiratory O +
epithelial O +
cells O +
. O +

Epithelial O +
cells O +
interact O +
directly O +
with O +
bacteria O +
in O +
the O +
environment O +
and O +
play O +
a O +
critical O +
role O +
in O +
airway O +
defense O +
against O +
microbial O +
pathogens O +
. O +

In O +
this O +
study O +
, O +
we O +
examined O +
the O +
response O +
of O +
respiratory O +
epithelial O +
cells O +
to O +
infection O +
with O +
nontypable O +
Haemophilus O +
influenzae O +
. O +

Using O +
an O +
in O +
vitro O +
cell O +
culture O +
model O +
, O +
we O +
found O +
that O +
epithelial O +
cell O +
monolayers O +
released O +
significant O +
quantities O +
of O +
IL-8 B-Gene +
and O +
expressed O +
increased O +
levels O +
of O +
ICAM-1 B-Gene +
mRNA O +
and O +
surface O +
protein O +
in O +
response O +
to O +
H. O +
influenzae O +
. O +

In O +
contrast O +
, O +
levels O +
of O +
IL-1beta B-Gene +
, O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
, O +
and O +
MHC B-Gene +
class I-Gene +
I I-Gene +
were O +
not O +
significantly O +
affected O +
, O +
suggesting O +
preferential O +
activation O +
of O +
a O +
specific O +
subset O +
of O +
epithelial O +
genes O +
directed O +
toward O +
defense O +
against O +
bacteria O +
. O +

Induction O +
of O +
ICAM-1 B-Gene +
required O +
direct O +
bacterial O +
interaction O +
with O +
the O +
epithelial O +
cell O +
surface O +
and O +
was O +
not O +
reproduced O +
by O +
purified O +
H. O +
influenzae O +
lipooligosaccharide O +
. O +

Consistent O +
with O +
a O +
functional O +
role O +
for O +
this O +
response O +
, O +
induction O +
of O +
ICAM-1 B-Gene +
by O +
H. O +
influenzae O +
mediated O +
increased O +
neutrophil O +
adherence O +
to O +
the O +
epithelial O +
cell O +
surface O +
. O +

Furthermore O +
, O +
in O +
an O +
in O +
vivo O +
murine O +
model O +
of O +
airway O +
infection O +
with O +
H. O +
influenzae O +
, O +
increased O +
epithelial O +
cell O +
ICAM-1 B-Gene +
expression O +
coincided O +
with O +
increased O +
chemokine B-Gene +
levels O +
and O +
neutrophil O +
recruitment O +
in O +
the O +
airway O +
. O +

These O +
results O +
indicate O +
that O +
ICAM-1 B-Gene +
expression O +
on O +
human O +
respiratory O +
epithelial O +
cells O +
is O +
induced O +
by O +
epithelial O +
cell O +
interaction O +
with O +
H. O +
influenzae O +
and O +
suggest O +
that O +
an O +
ICAM-1 B-Gene +
- O +
dependent O +
mechanism O +
can O +
mediate O +
neutrophil O +
adherence O +
to O +
these O +
cells O +
independent O +
of O +
inflammatory O +
mediator O +
release O +
by O +
other O +
cell O +
types O +
. O +

Direct O +
induction O +
of O +
specific O +
epithelial O +
cell O +
genes O +
( O +
such O +
as O +
ICAM-1 B-Gene +
and O +
IL-8 B-Gene +
) O +
by O +
bacterial O +
infection O +
may O +
allow O +
for O +
rapid O +
and O +
efficient O +
innate O +
defense O +
in O +
the O +
airway O +
. O +

Alterations O +
in O +
cathepsin B-Gene +
H I-Gene +
activity O +
and O +
protein O +
patterns O +
in O +
human O +
colorectal O +
carcinomas O +
. O +

Our O +
analyses O +
of O +
cathepsin B-Gene +
H I-Gene +
activity O +
levels O +
and O +
protein O +
forms O +
in O +
human O +
colorectal O +
cancers O +
compared O +
to O +
matched O +
control O +
mucosa O +
support O +
the O +
concept O +
that O +
altered O +
proteinase B-Gene +
expression O +
patterns O +
may O +
reflect O +
both O +
cancer O +
stage O +
and O +
site O +
. O +

Cathepsin B-Gene +
H I-Gene +
- O +
specific O +
activity O +
was O +
significantly O +
increased O +
in O +
colorectal O +
cancers O +
compared O +
to O +
control O +
mucosa O +
( O +
P O +
= O +
0.003 O +
; O +
n O +
= O +
77 O +
) O +
. O +

Highest O +
specific O +
activities O +
and O +
cancer O +
/ O +
normal O +
ratios O +
( O +
C O +
/ O +
N O +
) O +
for O +
activity O +
were O +
measured O +
in O +
Dukes O +
' O +
B O +
and O +
C O +
stage O +
carcinomas O +
, O +
cancers O +
involved O +
in O +
local O +
spread O +
and O +
invasion O +
to O +
lymph O +
nodes O +
. O +

In O +
contrast O +
, O +
cathepsin B-Gene +
B I-Gene +
and I-Gene +
L I-Gene +
activities O +
analysed O +
in O +
the O +
same O +
paired O +
extracts O +
had O +
been O +
shown O +
to O +
be O +
most O +
frequently O +
elevated O +
in O +
earlier O +
stage O +
carcinomas O +
( O +
Dukes O +
' O +
A O +
and O +
B O +
) O +
, O +
confirming O +
that O +
cathepsin B-Gene +
H I-Gene +
demonstrates O +
a O +
distinct O +
pattern O +
of O +
expression O +
during O +
colorectal O +
cancer O +
progression O +
. O +

Although O +
cathepsin B-Gene +
H I-Gene +
activities O +
were O +
most O +
commonly O +
elevated O +
in O +
Dukes O +
' O +
C O +
cancers O +
at O +
all O +
colon O +
sites O +
, O +
both O +
specific O +
activity O +
and O +
C O +
/ O +
N O +
ratios O +
were O +
significantly O +
higher O +
for O +
cancers O +
of O +
the O +
left O +
colon O +
compared O +
to O +
other O +
colon O +
locations O +
. O +

A O +
subset O +
of O +
43 O +
paired O +
extracts O +
analysed O +
on O +
Western O +
blots O +
also O +
revealed O +
consistent O +
changes O +
in O +
cathepsin B-Gene +
H I-Gene +
protein O +
forms O +
in O +
cancers O +
. O +

Normal O +
mucosa O +
typically O +
showed O +
a O +
strong O +
protein O +
doublet O +
at O +
31 O +
and O +
29 O +
kDa O +
while O +
cancers O +
demonstrated O +
decreased O +
expression O +
or O +
total O +
loss O +
of O +
the O +
31 O +
kDa O +
protein O +
( O +
90 O +
% O +
of O +
cases O +
) O +
, O +
equal O +
or O +
increased O +
expression O +
of O +
the O +
29 O +
- O +
kDa O +
protein O +
( O +
67 O +
% O +
of O +
cases O +
) O +
and O +
the O +
new O +
appearance O +
or O +
up O +
- O +
regulation O +
of O +
a O +
cathepsin B-Gene +
H I-Gene +
band O +
at O +
22 O +
kDa O +
( O +
78 O +
% O +
of O +
cases O +
) O +
. O +

C O +
/ O +
N O +
ratios O +
for O +
cathepsin B-Gene +
H I-Gene +
enzyme O +
activity O +
correlated O +
significantly O +
with O +
C O +
/ O +
N O +
ratios O +
for O +
the O +
29 O +
kDa O +
mature O +
single O +
- O +
chain O +
protein O +
form O +
( O +
P O +
< O +
0.001 O +
) O +
, O +
with O +
increased O +
activity O +
most O +
commonly O +
associated O +
with O +
elevated O +
expression O +
of O +
29 O +
- O +
kDa O +
cathepsin B-Gene +
H I-Gene +
but O +
also O +
with O +
up O +
- O +
regulation O +
of O +
the O +
22 O +
- O +
kDa O +
band O +
, O +
suggesting O +
a O +
shift O +
to O +
more O +
fully O +
processed O +
, O +
mature O +
active O +
cathepsin B-Gene +
H I-Gene +
protein O +
forms O +
in O +
cancers O +
. O +

Changes O +
in O +
cathepsin B-Gene +
H I-Gene +
expression O +
were O +
also O +
detected O +
by O +
immunohistochemistry O +
as O +
elevated O +
cathepsin B-Gene +
H I-Gene +
staining O +
in O +
tumour O +
epithelial O +
cells O +
. O +

Dual O +
control O +
of O +
muscle O +
cell O +
survival O +
by O +
distinct O +
growth B-Gene +
factor I-Gene +
- O +
regulated O +
signaling O +
pathways O +
. O +

In O +
addition O +
to O +
their O +
ability O +
to O +
stimulate O +
cell O +
proliferation O +
, O +
polypeptide O +
growth B-Gene +
factors I-Gene +
are O +
able O +
to O +
maintain O +
cell O +
survival O +
under O +
conditions O +
that O +
otherwise O +
lead O +
to O +
apoptotic O +
death O +
. O +

Growth B-Gene +
factors I-Gene +
control O +
cell O +
viability O +
through O +
regulation O +
of O +
critical O +
intracellular O +
signal O +
transduction O +
pathways O +
. O +

We O +
previously O +
characterized O +
C2 O +
muscle O +
cell O +
lines O +
that O +
lacked O +
endogenous O +
expression O +
of O +
insulin B-Gene +
- I-Gene +
like I-Gene +
growth I-Gene +
factor I-Gene +
II I-Gene +
( O +
IGF B-Gene -
- I-Gene -
II I-Gene +
) O +
. O +

These O +
cells O +
did O +
not O +
differentiate O +
but O +
underwent O +
apoptotic O +
death O +
in O +
low O +
- O +
serum O +
differentiation O +
medium O +
. O +

Death O +
could O +
be O +
prevented O +
by O +
IGF B-Gene +
analogues O +
that O +
activated O +
the O +
IGF B-Gene -
- I-Gene -
I I-Gene +
receptor I-Gene +
or O +
by O +
unrelated O +
growth B-Gene +
factors I-Gene +
such O +
as O +
platelet B-Gene +
- I-Gene +
derived I-Gene +
growth I-Gene +
factor I-Gene +
BB I-Gene +
( O +
PDGF B-Gene -
- I-Gene -
BB I-Gene +
) O +
. O +

Here O +
we O +
analyze O +
the O +
signaling O +
pathways O +
involved O +
in O +
growth B-Gene +
factor I-Gene +
- O +
mediated O +
myoblast O +
survival O +
. O +

PDGF B-Gene +
treatment O +
caused O +
sustained O +
activation O +
of O +
extracellular B-Gene +
- I-Gene +
regulated I-Gene +
kinases I-Gene +
1 I-Gene +
and I-Gene +
2 I-Gene +
( O +
ERK1 B-Gene +
and I-Gene +
- I-Gene +
2 I-Gene +
) O +
, O +
while O +
IGF B-Gene -
- I-Gene -
I I-Gene +
only O +
transiently O +
induced O +
these O +
enzymes O +
. O +

Transient O +
transfection O +
of O +
a O +
constitutively O +
active O +
Mek1 B-Gene +
, O +
a O +
specific O +
upstream O +
activator O +
of O +
ERKs B-Gene +
, O +
maintained O +
myoblast O +
viability O +
in O +
the O +
absence O +
of O +
growth B-Gene +
factors I-Gene +
, O +
while O +
inhibition O +
of O +
Mek1 B-Gene +
by O +
the O +
drug O +
UO126 O +
blocked O +
PDGF B-Gene +
- O +
mediated O +
but O +
not O +
IGF B-Gene +
- O +
stimulated O +
survival O +
. O +

Although O +
both O +
growth B-Gene +
factors I-Gene +
activated O +
phosphatidylinositol B-Gene +
3-kinase I-Gene +
( O +
PI3-kinase B-Gene +
) O +
to O +
similar O +
extents O +
, O +
only O +
IGF B-Gene -
- I-Gene -
I I-Gene +
treatment O +
led O +
to O +
sustained O +
stimulation O +
of O +
its O +
downstream O +
kinase B-Gene +
, O +
Akt B-Gene +
. O +

Transient O +
transfection O +
of O +
a O +
constitutively O +
active O +
PI3 B-Gene +
- I-Gene +
kinase I-Gene +
or O +
an O +
inducible O +
Akt B-Gene +
promoted O +
myoblast O +
viability O +
in O +
the O +
absence O +
of O +
growth B-Gene +
factors I-Gene +
, O +
while O +
inhibition O +
of O +
PI3 B-Gene +
- I-Gene +
kinase I-Gene +
activity O +
by O +
the O +
drug O +
LY294002 O +
selectively O +
blocked O +
IGF B-Gene +
- O +
but O +
not O +
PDGF B-Gene +
- O +
mediated O +
muscle O +
cell O +
survival O +
. O +

In O +
aggregate O +
, O +
these O +
observations O +
demonstrate O +
that O +
distinct O +
growth B-Gene +
factor I-Gene +
- O +
regulated O +
signaling O +
pathways O +
independently O +
control O +
myoblast O +
survival O +
. O +

Since O +
IGF B-Gene +
action O +
also O +
stimulates O +
muscle O +
differentiation O +
, O +
these O +
results O +
suggest O +
a O +
means O +
to O +
regulate O +
myogenesis O +
through O +
selective O +
manipulation O +
of O +
different O +
signal O +
transduction O +
pathways O +
. O +

DNA B-Gene +
methyltransferase I-Gene +
levels O +
and O +
altered O +
CpG O +
methylation O +
in O +
the O +
total O +
genome O +
and O +
in O +
the O +
GSTP1 B-Gene +
gene O +
in O +
human O +
glioma O +
cells O +
transfected O +
with O +
sense O +
and O +
antisense O +
DNA O +
methyltransferase B-Gene +
cDNA O +
. O +

This O +
study O +
examines O +
the O +
efficacy O +
of O +
using O +
plasmid O +
expression O +
vectors O +
containing O +
sense O +
and O +
antisense O +
DNA B-Gene +
MTase I-Gene +
cDNA O +
to O +
both O +
up O +
- O +
and O +
downregulate O +
intracellular O +
DNA B-Gene +
MTase I-Gene +
levels O +
in O +
human O +
glioma O +
cells O +
. O +

The O +
effects O +
of O +
the O +
changes O +
in O +
MTase B-Gene +
levels O +
on O +
global O +
genomic O +
DNA O +
methylation O +
and O +
on O +
the O +
methylation O +
status O +
of O +
CpG O +
dinucleotides O +
in O +
the O +
GSTP1 B-Gene +
gene O +
were O +
determined O +
in O +
a O +
glioma O +
cell O +
line O +
that O +
overexpresses O +
the O +
GSTP1 B-Gene +
gene O +
. O +

In O +
cells O +
transfected O +
with O +
sense O +
DNA B-Gene +
MTase I-Gene +
cDNA O +
, O +
MTase B-Gene +
gene O +
transcripts O +
increased O +
to O +
a O +
maximum O +
of O +
2 O +
. O +

5 O +
- O +
fold O +
at O +
24 O +
h O +
, O +
while O +
MTase B-Gene +
activity O +
increased O +
to O +
a O +
maximum O +
of O +
3 O +
. O +

6 O +
- O +
fold O +
at O +
48 O +
h O +
. O +

The O +
effects O +
of O +
antisense O +
MTase B-Gene +
cDNA O +
transfections O +
were O +
less O +
pronounced O +
, O +
and O +
levels O +
of O +
MTase B-Gene +
gene O +
transcripts O +
and O +
enzyme O +
activity O +
in O +
transfectants O +
were O +
decreased O +
to O +
only O +
, O +
approximately O +
, O +
one O -
- O -
half O +
the O +
levels O +
of O +
controls O +
. O +

The O +
alterations O +
in O +
DNA B-Gene +
MTase I-Gene +
expression O +
were O +
associated O +
with O +
corresponding O +
changes O +
in O +
the O +
level O +
of O +
global O +
DNA O +
methylation O +
and O +
in O +
the O +
methylation O +
of O +
the O +
GSTP1 B-Gene +
gene O +
in O +
the O +
cells O +
, O +
however O +
, O +
with O +
no O +
detectable O +
morphological O +
or O +
cytotoxic O +
effects O +
on O +
the O +
cells O +
. O +

No O +
significant O +
changes O +
in O +
GSTP1 B-Gene +
gene O +
expression O +
were O +
detected O +
after O +
the O +
transfections O +
, O +
presumably O +
because O +
of O +
the O +
high O +
levels O +
of O +
basal O +
GSTP1 B-Gene +
expression O +
in O +
the O +
cells O +
. O +

Consequently O +
, O +
the O +
p16 B-Gene +
gene O +
, O +
known O +
to O +
be O +
repressed O +
transcriptionally O +
by O +
DNA O +
methylation O +
, O +
was O +
examined O +
for O +
the O +
functional O +
effects O +
of O +
the O +
altered O +
MTase B-Gene +
levels O +
. O +

The O +
results O +
showed O +
a O +
2 O +
- O +
fold O +
decrease O +
in O +
p16 B-Gene +
gene O +
transcripts O +
with O +
the O +
sense O +
MTase B-Gene +
transfectants O +
, O +
while O +
in O +
the O +
MTase B-Gene +
antisense O +
- O +
transfected O +
cells O +
p16 B-Gene +
transcript O +
levels O +
increased O +
by O +
30 O +
% O +
. O +

Together O +
, O +
these O +
results O +
demonstrate O +
the O +
feasibility O +
of O +
using O +
both O +
sense O +
and O +
antisense O +
DNA B-Gene +
MTase I-Gene +
expression O +
vectors O +
to O +
regulate O +
DNA B-Gene +
MTase I-Gene +
levels O +
in O +
glioma O +
cells O +
and O +
that O +
, O +
over O +
relatively O +
short O +
periods O +
of O +
time O +
, O +
the O +
alterations O +
in O +
MTase B-Gene +
activities O +
are O +
not O +
deleterious O +
to O +
the O +
cells O +
. O +

The O +
system O +
provides O +
a O +
model O +
with O +
which O +
the O +
role O +
of O +
DNA O +
methylation O +
in O +
critical O +
genes O +
and O +
DNA O +
sequences O +
can O +
be O +
investigated O +
in O +
glioma O +
cells O +
. O +

p53 B-Gene +
- O +
independent O +
induction O +
of O +
p21 B-Gene +
( O +
WAF1 B-Gene +
/ O +
CIP1 B-Gene +
) O +
, O +
reduction O +
of O +
cyclin B-Gene +
B1 I-Gene +
and O +
G2 O +
/ O +
M O +
arrest O +
by O +
the O +
isoflavone O +
genistein O +
in O +
human O +
prostate O +
carcinoma O +
cells O +
. O +

Genistein O +
, O +
a O +
natural O +
isoflavonoid O +
phytoestrogen O +
, O +
is O +
a O +
strong O +
inhibitor O +
of O +
protein B-Gene +
tyrosine I-Gene +
kinase I-Gene +
and O +
DNA B-Gene +
topoisomerase I-Gene +
II I-Gene +
activities O +
. O +

Genistein O +
has O +
been O +
shown O +
to O +
have O +
anticancer O +
proliferation O +
, O +
differentiation O +
and O +
chemopreventive O +
effects O +
. O +

In O +
the O +
present O +
study O +
, O +
we O +
have O +
addressed O +
the O +
mechanism O +
of O +
action O +
by O +
which O +
genistein O +
suppressed O +
the O +
proliferation O +
of O +
p53 B-Gene +
- O +
null O +
human O +
prostate O +
carcinoma O +
cells O +
. O +

Genistein O +
significantly O +
inhibited O +
the O +
cell O +
growth O +
, O +
which O +
effect O +
was O +
reversible O +
, O +
and O +
induced O +
dendrite O +
- O +
like O +
structure O +
. O +

The O +
inhibitory O +
effects O +
of O +
genistein O +
on O +
cell O +
growth O +
proliferation O +
were O +
associated O +
with O +
a O +
G2 O +
/ O +
M O +
arrest O +
in O +
cell O +
cycle O +
progression O +
concomitant O +
with O +
a O +
marked O +
inhibition O +
of O +
cyclin B-Gene +
B1 I-Gene +
and O +
an O +
induction O +
of O +
Cdk B-Gene +
inhibitor I-Gene +
p21 B-Gene +
( O +
WAF1 B-Gene +
/ O +
CIP1 B-Gene +
) O +
in O +
a O +
p53 B-Gene +
- O +
independent O +
manner O +
. O +

Following O +
genistein O +
treatment O +
of O +
cells O +
, O +
an O +
increased O +
binding O +
of O +
p21 B-Gene +
with O +
Cdk2 B-Gene +
and O +
Cdc2 B-Gene +
paralleled O +
a O +
significant O +
decrease O +
in O +
Cdc2 B-Gene +
and O +
Cdk2 B-Gene +
kinase B-Gene +
activity O +
with O +
no O +
change O +
in O +
Cdk2 B-Gene +
and O +
Cdc2 B-Gene +
expression O +
. O +

Genistein O +
also O +
induced O +
the O +
activation O +
of O +
a O +
p21 B-Gene +
promoter O +
reporter O +
construct O +
, O +
utilizing O +
a O +
sequence O +
distinct O +
from O +
the O +
p53 B-Gene +
- O +
binding O +
site O +
. O +

Analysis O +
of O +
deletion O +
constructs O +
of O +
the O +
p21 B-Gene +
promoter O +
indicated O +
that O +
the O +
response O +
to O +
genistein O +
could O +
be O +
localized O +
to O +
the O +
300 O +
base O +
pairs O +
proximal O +
to O +
the O +
transcription O +
start O +
site O +
. O +

These O +
data O +
suggest O +
that O +
genistein O +
may O +
exert O +
a O +
strong O +
anticarcinogenic O +
effect O +
, O +
and O +
that O +
this O +
effect O +
possibly O +
involves O +
an O +
induction O +
of O +
p21 B-Gene +
, O +
which O +
inhibits O +
the O +
threshold O +
kinase B-Gene +
activities O +
of O +
Cdks B-Gene +
and O +
associated O +
cyclins B-Gene +
, O +
leading O +
to O +
a O +
G2 O +
/ O +
M O +
arrest O +
in O +
the O +
cell O +
cycle O +
progression O +
. O +

Tunicamycin O +
enhances O +
the O +
anticellular O +
activity O +
of O +
interferon B-Gene +
by O +
inhibiting O +
G1 O +
/ O +
S O +
phase O +
progression O +
in O +
3T3 O +
cells O +
. O +

We O +
have O +
shown O +
earlier O +
that O +
the O +
cell O +
growth O +
inhibitory O +
activity O +
of O +
interferon B-Gene +
( O +
IFN B-Gene +
) O +
is O +
significantly O +
enhanced O +
by O +
tunicamycin O +
( O +
TM O +
) O +
( O +
Maheshwari O +
et O +
al. O +
, O +
Science O +
219 O +
, O +
1339 O +
- O +
1341 O +
, O +
1983 O +
) O +
. O +

In O +
this O +
report O +
, O +
we O +
investigated O +
various O +
regulatory O +
points O +
of O +
synergistic O +
action O +
between O +
TM O +
and O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
/ I-Gene +
beta I-Gene +
that O +
inhibit O +
cell O +
growth O +
in O +
NIH O +
3T3 O +
cells O +
. O +

The O +
MTT O +
( O +
3- O -
[ O -
4,5-dimethylthiazol-2-yl O -
] O -
-2,5-diphenyl O +
tetrazolium O +
bromide O +
) O +
viability O +
assays O +
showed O +
a O +
dose O +
- O +
dependent O +
increase O +
in O +
percentage O +
inhibition O +
of O +
the O +
cells O +
when O +
treated O +
with O +
either O +
TM O +
or O +
IFN B-Gene +
. O +

When O +
doses O +
of O +
TM O +
and O +
IFN B-Gene +
that O +
had O +
no O +
significant O +
inhibition O +
on O +
cell O +
viability O +
were O +
used O +
in O +
combination O +
, O +
there O +
was O +
a O +
pronounced O +
suppression O +
of O +
DNA O +
synthesis O +
( O +
tritiated O +
thymidine O +
incorporation O +
) O +
. O +

Flow O +
cytometry O +
studies O +
revealed O +
that O +
individual O +
treatments O +
with O +
either O +
IFN B-Gene +
or O +
TM O +
that O +
did O +
not O +
alter O +
the O +
cell O +
cycle O +
profile O +
, O +
when O +
combined O +
, O +
resulted O +
in O +
an O +
impaired O +
cell O +
cycle O +
by O +
inhibiting O +
G1 O +
/ O +
S O +
progression O +
. O +

The O +
blockage O +
of O +
G1 O +
/ O +
S O +
transition O +
was O +
associated O +
with O +
reduction O +
of O +
cyclin B-Gene +
- I-Gene +
dependent I-Gene +
kinase I-Gene +
( O +
CDK4 B-Gene +
) O +
activity O +
. O +

The O +
mRNA O +
( O +
analyzed O +
by O +
ribonuclease B-Gene +
protection O +
assay O +
) O +
and O +
protein O +
levels O +
( O +
assayed O +
by O +
Western O +
blotting O +
) O +
of O +
cyclins B-Gene +
D1 I-Gene +
, I-Gene +
D3 I-Gene +
, O +
and O +
CDK4 B-Gene +
were O +
downregulated O +
by O +
combined O +
treatment O +
with O +
IFN B-Gene +
and O +
TM O +
. O +

An O +
increase O +
in O +
the O +
expression O +
of O +
p27 B-Gene +
/ I-Gene +
kipl I-Gene +
, O +
an O +
inhibitor O +
of O +
CDK4 B-Gene +
, O +
was O +
observed O +
in O +
cells O +
that O +
were O +
treated O +
with O +
both O +
IFN B-Gene +
and O +
TM O +
. O +

These O +
studies O +
suggest O +
that O +
insufficient O +
formation O +
of O +
the O +
active O +
cyclin B-Gene +
/ O +
CDK B-Gene +
complex O +
could O +
possibly O +
be O +
deferring O +
the O +
cells O +
from O +
normal O +
cycling O +
and O +
may O +
be O +
responsible O +
for O +
the O +
ability O +
of O +
TM O +
to O +
enhance O +
cell O +
growth O +
inhibition O +
induced O +
by O +
IFN B-Gene +
. O +

Identification O +
of O +
two O +
polyketide B-Gene +
synthase I-Gene +
gene O +
clusters O +
on O +
the O +
linear O +
plasmid O +
pSLA2-L O +
in O +
Streptomyces O +
rochei O +
. O +

The O +
200 O -
kb O +
linear O +
plasmid O +
pSLA2-L O +
was O +
suggested O +
to O +
be O +
involved O +
in O +
the O +
production O +
of O +
two O +
macrolide O +
antibiotics O +
, O +
lankamycin O +
( O +
Lm O +
) O +
and O +
lankacidin O +
( O +
Lc O +
) O +
, O +
in O +
Streptomyces O +
rochei O +
7434AN4 O +
. O +

Hybridization O +
experiments O +
with O +
the O +
polyketide B-Gene +
synthase I-Gene +
( O +
PKS B-Gene +
) O +
genes O +
for O +
erythromycin O +
and O +
actinorhodin O +
identified O +
two O +
eryAI B-Gene +
- O +
homologous O +
regions O +
and O +
an O +
actI B-Gene +
- O +
homologous O +
region O +
on O +
pSLA2-L O +
. O +

The O +
nucleotide O +
sequence O +
of O +
a O +
3.6 O -
kb O +
SacI B-Gene +
fragment O +
carrying O +
one O +
of O +
the O +
eryAI B-Gene +
- O +
homologs O +
revealed O +
that O +
it O +
codes O +
for O +
part O +
of O +
a O +
large O +
protein O +
with O +
four O +
domains O +
for O +
ketoreductase B-Gene +
, O +
acyl B-Gene +
carrier I-Gene +
protein I-Gene +
, O +
ketosynthase B-Gene +
, O +
and O +
acyltransferase B-Gene +
. O +

Gene O +
disruption O +
confirmed O +
that O +
the O +
two O +
eryAI B-Gene +
- O +
homologs O +
are O +
parts O +
of O +
a O +
large O +
type O -
- O -
I O +
PKS B-Gene +
gene O +
cluster O +
for O +
Lm O +
. O +

A O +
4.8 O -
kb O +
DNA O +
carrying O +
the O +
actI B-Gene +
- O +
homologous O +
region O +
contains O +
four O +
open O +
reading O +
frames O +
( O +
ORF1 O +
- O +
ORF4 O +
) O +
as O +
well O +
as O +
an O +
additional O +
ORF O +
, O +
i.e. O +
ORF5 O +
, O +
which O +
might O +
code O +
for O +
a O +
thioesterase B-Gene +
. O +

Deletion O +
of O +
the O +
ORF2 O +
- O +
ORF4 O +
region O +
showed O +
that O +
it O +
is O +
not O +
involved O +
in O +
the O +
synthesis O +
of O +
Lm O +
or O +
Lc O +
. O +

Thus O +
, O +
it O +
was O +
confirmed O +
that O +
pSLA2-L O +
contains O +
two O +
PKS B-Gene +
gene O +
clusters O +
for O +
Lm O +
and O +
an O +
unknown O +
type O +
- O +
II O +
polyketide O +
. O +

Characterization O +
of O +
ywhE B-Gene +
, O +
which O +
encodes O +
a O +
putative O +
high O +
- O +
molecular O +
- O +
weight O +
class O +
A O +
penicillin O +
- O +
binding O +
protein O +
in O +
Bacillus O +
subtilis O +
. O +

The O +
Bacillus O +
subtilis O +
genome O +
sequencing O +
project O +
[ O +
Kunst O +
et O +
al. O +
, O +
Nature O +
390 O +
( O +
1997 O +
) O +
249 O +
- O +
256 O +
] O +
identified O +
ywhE B-Gene +
as O +
a O +
gene O +
that O +
potentially O +
encodes O +
a O +
high O +
- O +
molecular O +
- O +
weight O +
class O +
A O +
penicillin O +
- O +
binding O +
protein O +
. O +

Analysis O +
of O +
the O +
expression O +
of O +
a O +
translational O +
ywhE B-Gene +
- O +
lacZ B-Gene +
fusion O +
showed O +
that O +
ywhE B-Gene +
expression O +
is O +
sporulation O +
- O +
specific O +
, O +
and O +
is O +
controlled O +
predominantly O +
by O +
the O +
forespore O +
- O +
specific O +
sigma B-Gene +
factor I-Gene +
sigma B-Gene +
( I-Gene +
F I-Gene +
) I-Gene +
, O +
and O +
to O +
a O +
lesser O +
extent O +
by O +
sigma B-Gene +
( I-Gene +
G I-Gene +
) I-Gene +
. O +

Primer O +
extension O +
analysis O +
identified O +
two O +
transcription O +
start O +
sites O +
located O +
26 O +
and O +
27 O +
nucleotides O +
upstream O +
of O +
the O +
ywhE B-Gene +
translational O +
initiation O +
codon O +
. O +

Sequences O +
located O +
in O +
the O +
- O +
10 O +
and O +
- O +
35 O +
regions O +
relative O +
to O +
the O +
transcription O +
start O +
sites O +
showed O +
good O +
homology O +
to O +
the O +
consensus O +
sequences O +
for O +
promoter O +
elements O +
of O +
sigma B-Gene -
( I-Gene -
F I-Gene -
) I-Gene +
- O +
dependent O +
genes O +
. O +

An O +
insertional O +
mutation O +
in O +
ywhE B-Gene +
had O +
no O +
significant O +
effect O +
on O +
growth O +
, O +
morphology O +
, O +
and O +
sporulation O +
, O +
and O +
ywhE B-Gene +
spores O +
had O +
normal O +
heat O +
- O +
resistance O +
, O +
cortex O +
structure O +
, O +
and O +
germination O +
and O +
outgrowth O +
properties O +
. O +

However O +
, O +
overexpression O +
of O +
ywhE B-Gene +
in O +
Escherichia O +
coli O +
resulted O +
in O +
cell O +
lysis O +
. O +

Mechanism O +
of O +
atherosclerotic O +
calcification O +
. O +

Calcification O +
is O +
almost O +
invariably O +
associated O +
with O +
atherosclerotic O +
plaque O +
lesions O +
. O +

Recent O +
data O +
suggest O +
that O +
plaque O +
calcification O +
is O +
an O +
active O +
, O +
regulated O +
process O +
similar O +
to O +
osteogenesis O +
. O +

In O +
order O +
to O +
clarify O +
the O +
mechanism O +
of O +
plaque O +
calcification O +
, O +
we O +
developed O +
an O +
in O +
vitro O +
model O +
of O +
vascular O +
calcification O +
by O +
utilizing O +
bovine O +
vascular O +
smooth O +
muscle O +
cells O +
( O +
BVSMCs O +
) O +
. O +

This O +
model O +
is O +
useful O +
in O +
that O +
diffuse O +
and O +
massive O +
calcification O +
can O +
be O +
induced O +
within O +
2 O +
weeks O +
and O +
thereby O +
biochemical O +
analyses O +
of O +
vascular O +
calcification O +
can O +
be O +
performed O +
. O +

We O +
have O +
analyzed O +
several O +
aspects O +
of O +
vascular O +
calcification O +
by O +
using O +
this O +
model O +
and O +
demonstrated O +
as O +
follows O +
: O +
1 O +
) O +
in O +
vitro O +
calcification O +
of O +
BVSMCs O +
is O +
regulated O +
by O +
calciotropic O +
hormones O +
and O +
BVSMCs O +
are O +
equipped O +
with O +
a O +
unique O +
autocrine O +
and/or O +
paracrine O +
system O +
regulating O +
calcium O +
metabolism O +
. O +

2 O -
) O +
Sodium O +
- O +
dependent O +
phosphate O +
cotransport O +
plays O +
a O +
crucial O +
role O +
in O +
BVSMC O +
calcification O +
as O +
well O +
as O +
in O +
mineralization O +
of O +
skeletal O +
tissues O +
. O +

3 O -
) O +
BVSMCs O +
acquire O +
osteoblastic O +
phenotype O +
under O +
certain O +
conditions O +
. O +

Finally O +
, O +
we O +
discuss O +
the O +
roles O +
of O +
macrophages O +
in O +
the O +
development O +
of O +
atherosclerotic O +
calcification O +
. O +

Interferon B-Gene +
- I-Gene +
gamma I-Gene +
( O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
induces O +
gene O +
expression O +
of O +
25-hydrovitamin B-Gene +
D-1 I-Gene +
alpha I-Gene -
- I-Gene -
hydroxylase I-Gene +
( O +
1 B-Gene +
alpha I-Gene +
OHase I-Gene +
) O +
and O +
its O +
activity O +
in O +
macrophages O +
. O +

Since O +
1 B-Gene +
alpha I-Gene +
OHase I-Gene +
can O +
locally O +
convert O +
25-hydroxyvitamin O +
D O +
into O +
1 O +
alpha O +
, O +
25-dihydroxyvitamin O +
D O +
( O +
1,25 O -
( O -
OH O -
) O -
2D O +
) O +
, O +
an O +
active O +
metabolite O +
of O +
vitamin O +
D O +
, O +
it O +
is O +
suggested O +
that O +
local O +
production O +
of O +
1,25 O -
( O -
OH O -
) O -
2D O +
by O +
macrophages O +
may O +
promote O +
atherosclerotic O +
calcification O +
. O +

Moreover O +
, O +
macrophages O +
may O +
be O +
involved O +
in O +
the O +
phenotypic O +
changes O +
of O +
vascular O +
smooth O +
muscle O +
cells O +
( O +
VSMCs O +
) O +
to O +
acquire O +
calcifying O +
capacity O +
. O +

Therefore O +
, O +
the O +
phenotypic O +
changes O +
of O +
VSMCs O +
in O +
atherosclerotic O +
plaque O +
may O +
contribute O +
to O +
the O +
development O +
of O +
atherosclerotic O +
calcification O +
. O +

Novel O +
beta B-Gene -
- I-Gene -
lactamase I-Gene +
genes O +
from O +
two O +
environmental O +
isolates O +
of O +
Vibrio O +
harveyi O +
. O +

Two O +
ampicillin O +
- O +
resistant O +
( O +
Amp O -
( O -
r O -
) O +
) O +
isolates O +
of O +
Vibrio O +
harveyi O +
, O +
W3B O +
and O +
HB3 O +
, O +
were O +
obtained O +
from O +
the O +
coastal O +
waters O +
of O +
the O +
Indonesian O +
island O +
of O +
Java O +
. O +

Strain O +
W3B O +
was O +
isolated O +
from O +
marine O +
water O +
near O +
a O +
shrimp O +
farm O +
in O +
North O +
Java O +
while O +
HB3 O +
was O +
from O +
pristine O +
seawater O +
in O +
South O +
Java O +
. O +

In O +
this O +
study O +
, O +
novel O +
beta B-Gene -
- I-Gene -
lactamase I-Gene +
genes O +
from O +
W3B O +
( O +
bla B-Gene +
( O +
VHW-1 O +
) O +
) O +
and O +
HB3 O +
( O +
bla B-Gene +
( O +
VHH-1 O +
) O +
) O +
were O +
cloned O +
and O +
their O +
nucleotide O +
sequences O +
were O +
determined O +
. O +

An O +
open O +
reading O +
frame O +
( O +
ORF O +
) O +
of O +
870 O +
bp O +
encoding O +
a O +
deduced O +
protein O +
of O +
290 O +
amino O +
acids O +
( O +
VHW-1 O +
) O +
was O +
revealed O +
for O +
the O +
bla B-Gene +
gene O +
of O +
strain O +
W3B O +
while O +
an O +
ORF O +
of O +
849 O +
bp O +
encoding O +
a O +
283-amino O -
- O -
acid O +
protein O +
( O +
VHH-1 O +
) O +
was O +
deduced O +
for O +
bla B-Gene +
( O +
VHH-1 O +
) O +
. O +

At O +
the O +
DNA O +
level O +
, O +
genes O +
for O +
VHW-1 O +
and O +
VHH-1 O +
have O +
a O +
97 O +
% O +
homology O +
, O +
while O +
at O +
the O +
protein O +
level O +
they O +
have O +
a O +
91 O +
% O +
homology O +
of O +
amino O +
acid O +
sequences O +
. O +

Neither O +
gene O +
sequence O +
showed O +
homology O +
to O +
any O +
other O +
beta B-Gene -
- I-Gene -
lactamases I-Gene +
in O +
the O +
databases O +
. O +

The O +
deduced O +
proteins O +
were O +
found O +
to O +
be O +
class O +
A O +
beta B-Gene -
- I-Gene -
lactamases I-Gene +
bearing O +
low O +
levels O +
of O +
homology O +
( O +
< O +
50 O +
% O +
) O +
to O +
other O +
beta B-Gene -
- I-Gene -
lactamases I-Gene +
of O +
the O +
same O +
class O +
. O +

The O +
highest O +
level O +
of O +
identity O +
was O +
obtained O +
with O +
beta B-Gene -
- I-Gene -
lactamases I-Gene +
from O +
Pseudomonas O +
aeruginosa O +
, O +
i.e. O +
, O +
PSE-1 B-Gene +
, O +
PSE-4 B-Gene +
, O +
and O +
CARB B-Gene +
- I-Gene +
3 I-Gene +
, O +
and O +
Vibrio O +
cholerae O +
CARB-6 B-Gene +
. O +

Our O +
study O +
showed O +
that O +
both O +
strains O +
W3B O +
and O +
HB3 O +
possess O +
an O +
endogenous O +
plasmid O +
of O +
approximately O +
60 O +
kb O +
in O +
size O +
. O +

However O +
, O +
Southern O +
hybridization O +
analysis O +
employing O +
bla B-Gene +
( O +
VHW-1 O +
) O +
as O +
a O +
gene O +
probe O +
demonstrated O +
that O +
the O +
bla B-Gene +
gene O +
was O +
not O +
located O +
in O +
the O +
plasmid O +
. O +

A O +
total O +
of O +
nine O +
ampicillin O +
- O +
resistant O +
V. O +
harveyi O +
strains O +
, O +
including O +
W3B O +
and O +
HB3 O +
, O +
were O +
examined O +
by O +
pulsed O +
- O +
field O +
gel O +
electrophoresis O +
of O +
NotI B-Gene +
- O +
digested O +
genomic O +
DNA O +
. O +

Despite O +
a O +
high O +
level O +
of O +
intrastrain O +
genetic O +
diversity O +
, O +
the O +
bla B-Gene +
( O +
VHW-1 O +
) O +
probe O +
hybridized O +
only O +
to O +
an O +
80 O +
- O +
or O +
160 O +
- O +
kb O +
NotI B-Gene +
genomic O +
fragment O +
in O +
different O +
isolates O +
. O +

The O +
bHLH O +
gene O +
Hes1 B-Gene +
regulates O +
differentiation O +
of O +
multiple O +
cell O +
types O +
. O +

For O +
embryos O +
that O +
have O +
small O +
pancreas O +
and O +
lack O +
brain O +
, O +
eyes O +
and O +
thymus O +
, O +
the O +
defects O +
are O +
caused O +
by O +
mutation O +
of O +
a O +
single O +
gene O +
, O +
Hes1 B-Gene +
. O +

Hes1 B-Gene +
encodes O +
a O +
basic O +
helix O +
- O +
loop O +
- O +
helix O +
( O +
bHLH O +
) O +
transcriptional O +
repressor O +
and O +
functionally O +
antagonizes O +
positive O +
bHLH O +
genes O +
such O +
as O +
the O +
neuronal O +
determination O +
gene O +
, O +
Mash1 B-Gene +
. O +

Misexpression O +
of O +
Hes1 B-Gene +
inhibits O +
cell O +
differentiation O +
and O +
keeps O +
cells O +
at O +
the O +
precursor O +
stage O +
or O +
proliferative O +
stage O +
. O +

Conversely O +
, O +
in O +
the O +
absence O +
of O +
Hes1 B-Gene +
, O +
the O +
expression O +
of O +
positive O +
bHLH O +
genes O +
is O +
upregulated O +
and O +
cells O +
differentiate O +
prematurely O +
without O +
sufficient O +
cell O +
growth O +
. O +

As O +
a O +
result O +
, O +
the O +
development O +
of O +
many O +
tissues O +
such O +
as O +
the O +
brain O +
, O +
eye O +
and O +
pancreas O +
is O +
severely O +
affected O +
. O +

Thus O +
, O +
Hes1 B-Gene +
regulates O +
tissue O +
morphogenesis O +
by O +
maintaining O +
undifferentiated O +
cells O +
. O +

In O +
the O +
case O +
of O +
T O +
cell O +
development O +
, O +
Hes1 B-Gene +
mutation O +
leads O +
to O +
defects O +
of O +
expansion O +
of O +
early O +
T O +
cell O +
precursors O +
and O +
thereby O +
suppresses O +
T O +
cell O +
fate O +
specification O +
. O +

Thus O +
, O +
Hes1 B-Gene +
promotes O +
differentiation O +
of O +
some O +
cell O +
types O +
in O +
addition O +
to O +
maintenance O +
of O +
the O +
undifferentiated O +
state O +
. O +

Interestingly O +
, O +
Hes1 B-Gene +
expression O +
is O +
controlled O +
by O +
the O +
transmembrane O +
protein O +
Notch B-Gene +
, O +
which O +
is O +
activated O +
by O +
the O +
ligands O +
expressed O +
on O +
the O +
surface O +
of O +
neighboring O +
cells O +
. O +

Taken O +
together O +
, O +
these O +
results O +
indicate O +
that O +
the O +
Notch B-Gene +
- O +
Hes1 B-Gene +
pathway O +
, O +
which O +
is O +
controlled O +
by O +
cell O +
- O +
cell O +
interaction O +
, O +
plays O +
an O +
essential O +
role O +
in O +
differentiation O +
of O +
many O +
cell O +
types O +
. O +

Diversity O +
of O +
the O +
p70 B-Gene +
killer I-Gene +
cell I-Gene +
inhibitory I-Gene +
receptor I-Gene +
( I-Gene +
KIR3DL I-Gene +
) I-Gene +
family I-Gene +
members O +
in O +
a O +
single O +
individual O +
. O +

NK O +
cells O +
and O +
some O +
T O +
cells O +
express O +
members O +
of O +
a O +
multigenic O +
family O +
of O +
killer O +
cell O +
inhibitory O +
receptors O +
( O +
KIRs B-Gene +
) O +
including O +
p70 B-Gene +
KIR I-Gene +
( O +
KIR3DL B-Gene +
) O +
and O +
p58 B-Gene +
KIR I-Gene +
( I-Gene +
KIR2DL I-Gene +
) I-Gene +
family I-Gene +
that O +
recognize O +
polymorphic O +
class B-Gene +
I I-Gene +
MHC I-Gene +
molecules O +
on O +
target O +
cells O +
and O +
transmit O +
an O +
inhibitory O +
signal O +
to O +
prevent O +
killer O +
cell O +
- O +
mediated O +
cytoxicity O +
. O +

The O +
cDNA O +
sequences O +
of O +
p70 B-Gene +
KIR I-Gene +
family I-Gene +
members O +
reported O +
so O +
far O +
suggest O +
that O +
the O +
p70 B-Gene +
KIR I-Gene +
gene O +
consists O +
of O +
a O +
multigene O +
complex O +
and O +
that O +
each O +
gene O +
may O +
exhibit O +
certain O +
degrees O +
of O +
polymorphism O +
. O +

However O +
, O +
it O +
is O +
not O +
clear O +
how O +
diverse O +
the O +
repertoire O +
of O +
the O +
p70 B-Gene +
KIR I-Gene +
family I-Gene +
is O +
, O +
particularly O +
in O +
a O +
single O +
individual O +
. O +

To O +
address O +
this O +
question O +
in O +
more O +
detail O +
and O +
to O +
determine O +
some O +
indication O +
as O +
to O +
the O +
origin O +
of O +
the O +
diversity O +
, O +
we O +
cloned O +
p70 B-Gene +
KIR I-Gene +
cDNAs O +
from O +
a O +
single O +
individual O +
. O +

We O +
identified O +
nine O +
new O +
KIRs B-Gene +
that O +
are O +
different O +
from O +
the O +
previously O +
reported O +
ones O +
. O +

A O +
comparison O +
of O +
the O +
amino O +
acid O +
sequences O +
with O +
published O +
sequences O +
of O +
p70 B-Gene +
KIRs I-Gene +
showed O +
that O +
two O +
clones O +
belonged O +
to O +
the O +
KIR3DL1 B-Gene +
family I-Gene +
, O +
five O +
clones O +
belonged O +
to O +
the O +
KIR3DL2 B-Gene +
family I-Gene +
, O +
one O +
clone O +
belonged O +
to O +
the O +
KIR2DL4 B-Gene +
family I-Gene +
, O +
and O +
one O +
clone O +
appeared O +
to O +
be O +
an O +
alternatively O +
spliced O +
form O +
of O +
p70 B-Gene +
KIR I-Gene +
. O +

These O +
results O +
suggested O +
that O +
the O +
repertoire O +
of O +
p70 B-Gene +
KIR I-Gene +
family I-Gene +
members O +
in O +
a O +
single O +
individual O +
is O +
highly O +
diverse O +
. O +

It O +
is O +
not O +
clear O +
how O +
the O +
diverse O +
receptors O +
are O +
generated O +
in O +
a O +
single O +
individual O +
, O +
but O +
a O +
comparison O +
of O +
amino O +
acid O +
sequences O +
of O +
p70 B-Gene +
KIR I-Gene +
family I-Gene +
members O +
suggested O +
that O +
some O +
of O +
them O +
may O +
be O +
encoded O +
by O +
distinct O +
genes O +
or O +
their O +
alleles O +
, O +
while O +
others O +
may O +
be O +
generated O +
by O +
a O +
recombination O +
mechanism O +
and/or O +
an O +
alternative O +
splicing O +
mechanism O +
at O +
the O +
maturation O +
of O +
the O +
mRNA O +
transcripts O +
. O +

Functional O +
differences O +
between O +
human O +
and O +
bovine O +
immunodeficiency O +
virus O +
Tat B-Gene +
transcription B-Gene +
factors I-Gene +
. O +

Transcriptional O +
transactivation O +
of O +
the O +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
( O +
HIV-1 O +
) O +
long O +
terminal O +
repeat O +
( O +
LTR O +
) O +
promoter O +
element O +
by O +
the O +
essential O +
viral O +
Tat B-Gene +
protein O +
requires O +
recruitment O +
of O +
positive B-Gene +
transcription I-Gene +
elongation I-Gene +
factor I-Gene +
b I-Gene +
( O +
P B-Gene +
- I-Gene +
TEFb I-Gene +
) O +
to O +
the O +
viral O +
TAR O +
RNA O +
target O +
. O +

The O +
recruitment O +
of O +
P B-Gene -
- I-Gene -
TEFb I-Gene +
, O +
which O +
has O +
been O +
proposed O +
to O +
be O +
necessary O +
and O +
sufficient O +
for O +
activation O +
of O +
viral O +
gene O +
expression O +
, O +
is O +
mediated O +
by O +
the O +
highly O +
cooperative O +
interaction O +
of O +
Tat B-Gene +
and O +
cyclin B-Gene +
T1 I-Gene +
, O +
an O +
essential O +
component O +
of O +
P B-Gene +
- I-Gene +
TEFb I-Gene +
, O +
with O +
the O +
HIV-1 O +
TAR O +
element O +
. O +

Species O +
, O +
such O +
as O +
rodents O +
, O +
that O +
encode O +
cyclin B-Gene +
T1 I-Gene +
variants O +
that O +
are O +
unable O +
to O +
support O +
TAR O +
binding O +
by O +
the O +
Tat B-Gene +
- O +
cyclin B-Gene +
T1 I-Gene +
heterodimer O +
are O +
also O +
unable O +
to O +
support O +
HIV-1 O +
Tat B-Gene +
function O +
. O +

In O +
contrast O +
, O +
we O +
here O +
demonstrate O +
that O +
the O +
bovine O +
immunodeficiency O +
virus O +
( O +
BIV O +
) O +
Tat B-Gene +
protein O +
is O +
fully O +
able O +
to O +
bind O +
to O +
BIV O +
TAR O +
both O +
in O +
vivo O +
and O +
in O +
vitro O +
in O +
the O +
absence O +
of O +
any O +
cellular O +
cofactor O +
. O +

Nevertheless O +
, O +
BIV O +
Tat B-Gene +
can O +
specifically O +
recruit O +
cyclin B-Gene +
T1 I-Gene +
to O +
the O +
BIV O +
TAR O +
element O +
, O +
and O +
this O +
recruitment O +
is O +
as O +
essential O +
for O +
BIV O +
Tat B-Gene +
function O +
as O +
it O +
is O +
for O +
HIV-1 O +
Tat B-Gene +
activity O +
. O +

However O +
, O +
because O +
the O +
cyclin B-Gene +
T1 I-Gene +
protein O +
does O +
not O +
contribute O +
to O +
TAR O +
binding O +
, O +
BIV O +
Tat B-Gene +
is O +
able O +
to O +
function O +
effectively O +
in O +
cells O +
from O +
several O +
species O +
that O +
do O +
not O +
support O +
HIV-1 O +
Tat B-Gene +
function O +
. O +

Thus O +
, O +
BIV O +
Tat B-Gene +
, O +
while O +
apparently O +
dependent O +
on O +
the O +
same O +
cellular O +
cofactor O +
as O +
the O +
Tat B-Gene +
proteins O +
encoded O +
by O +
other O +
lentiviruses O +
, O +
is O +
nevertheless O +
unique O +
in O +
terms O +
of O +
the O +
mechanism O +
used O +
to O +
recruit O +
the O +
BIV O +
Tat B-Gene +
- O +
cyclin B-Gene +
T1 I-Gene +
complex O +
to O +
the O +
viral O +
LTR O +
promoter O +
. O +

A O +
novel O +
3-methyladenine B-Gene +
DNA I-Gene +
glycosylase I-Gene +
from O +
helicobacter O +
pylori O +
defines O +
a O +
new O +
class O +
within O +
the O +
endonuclease B-Gene +
III I-Gene +
family I-Gene +
of I-Gene +
base I-Gene +
excision I-Gene +
repair I-Gene +
glycosylases I-Gene +
. O +

The O +
cloning O +
, O +
purification O +
, O +
and O +
characterization O +
of O +
MagIII B-Gene +
, O +
a O +
3 B-Gene +
- I-Gene +
methyladenine I-Gene +
DNA I-Gene +
glycosylase I-Gene +
from O +
Helicobacter O +
pylori O +
, O +
is O +
presented O +
in O +
this O +
paper O +
. O +

Sequence O +
analysis O +
of O +
the O +
genome O +
of O +
this O +
pathogen O +
failed O +
to O +
identify O +
open O +
reading O +
frames O +
potentially O +
coding O +
for O +
proteins O +
with O +
a O +
3-methyladenine B-Gene +
DNA I-Gene +
glycosylase I-Gene +
activity O +
. O +

The O +
putative O +
product O +
of O +
the O +
HP602 O +
open O +
reading O +
frame O +
, O +
reported O +
as O +
an O +
endonuclease B-Gene +
III I-Gene +
, O +
shares O +
extensive O +
amino O +
acid O +
sequence O +
homology O +
with O +
some O +
bacterial O +
members O +
of O +
this O +
family O +
and O +
has O +
the O +
canonic O +
active O +
site O +
helix O -
- O -
hairpin O -
- O -
helix O -
- O -
GPD O +
motif O +
. O +

Surprisingly O +
, O +
this O +
predicted O +
H. O +
pylori O +
endonuclease B-Gene +
III I-Gene +
encodes O +
a O +
25,220-Da O +
protein O +
able O +
to O +
release O +
3-methyladenine O +
, O +
but O +
not O +
oxidized O +
bases O +
, O +
from O +
modified O +
DNA O +
. O +

MagIII B-Gene +
has O +
no O +
abasic B-Gene +
site I-Gene +
lyase I-Gene +
activity O +
and O +
displays O +
the O +
substrate O +
specificity O +
of O +
the O +
3-methyladenine B-Gene -
- I-Gene -
DNA I-Gene +
glycosylase I-Gene +
type I-Gene +
I I-Gene +
of O +
Escherichia O +
coli O +
( O +
Tag O +
) O +
because O +
it O +
is O +
not O +
able O +
to O +
recognize O +
7-methylguanine O +
or O +
hypoxanthine O +
as O +
substrates O +
. O +

The O +
expression O +
of O +
the O +
magIII B-Gene +
open O +
reading O +
frame O +
in O +
null O +
3-methyladenine B-Gene +
glycosylase I-Gene +
E. O +
coli O +
( O +
tag O +
alkA B-Gene +
) O +
restores O +
to O +
this O +
mutant O +
partial O +
resistance O +
to O +
alkylating O +
agents O +
. O +

MagIII B-Gene +
- O +
deficient O +
H. O +
pylori O +
cells O +
show O +
an O +
alkylation O +
- O +
sensitive O +
phenotype O +
. O +

H. O +
pylori O +
wild O +
type O +
cells O +
exposed O +
to O +
alkylating O +
agents O +
present O +
an O +
adaptive O +
response O +
by O +
inducing O +
the O +
expression O +
of O +
magIII B-Gene +
. O +

MagIII B-Gene +
is O +
thus O +
a O +
novel O +
bacterial O +
member O +
of O +
the O +
endonuclease B-Gene +
III I-Gene +
family I-Gene +
, O +
which O +
displays O +
biochemical O +
properties O +
not O +
described O +
for O +
any O +
of O +
the O +
members O +
of O +
this O +
group O +
until O +
now O +
. O +

Aquaporin B-Gene +
adipose I-Gene +
, O +
a O +
putative O +
glycerol B-Gene +
channel I-Gene +
in O +
adipocytes O +
. O +

Adipose O +
tissue O +
is O +
a O +
major O +
site O +
of O +
glycerol O +
production O +
in O +
response O +
to O +
energy O +
balance O +
. O +

However O +
, O +
molecular O +
basis O +
of O +
glycerol O +
release O +
from O +
adipocytes O +
has O +
not O +
yet O +
been O +
elucidated O +
. O +

We O +
recently O +
cloned O +
a O +
novel O +
member O +
of O +
the O +
aquaporin B-Gene +
family I-Gene +
, O +
aquaporin B-Gene +
adipose I-Gene +
( O +
AQPap B-Gene +
) O +
, O +
which O +
has O +
glycerol O +
permeability O +
. O +

The O +
current O +
study O +
was O +
designed O +
to O +
examine O +
the O +
hypothesis O +
that O +
AQPap B-Gene +
serves O +
as O +
a O +
glycerol B-Gene +
channel I-Gene +
in O +
adipocytes O +
. O +

Adipose O +
tissue O +
expressed O +
AQPap B-Gene +
mRNA O +
in O +
high O +
abundance O +
, O +
but O +
not O +
the O +
mRNAs O +
for O +
the O +
other O +
aquaglyceroporins B-Gene +
, O +
AQP3 B-Gene +
and O +
AQP9 B-Gene +
, O +
indicating O +
that O +
AQPap B-Gene +
is O +
the O +
only O +
known O +
aquaglyceroporin B-Gene +
expressed O +
in O +
adipose O +
tissue O +
. O +

Glycerol O +
release O +
from O +
3T3-L1 O +
cells O +
was O +
increased O +
during O +
differentiation O +
in O +
parallel O +
with O +
AQPap B-Gene +
mRNA O +
levels O +
and O +
suppressed O +
by O +
mercury O +
ion O +
, O +
which O +
inhibits O +
the O +
function O +
of O +
AQPs B-Gene +
, O +
supporting O +
AQPap B-Gene +
functions O +
as O +
a O +
glycerol B-Gene +
channel I-Gene +
in O +
adipocytes O +
. O +

Fasting O +
increased O +
and O +
refeeding O +
suppressed O +
adipose O +
AQPap B-Gene +
mRNA O +
levels O +
in O +
accordance O +
with O +
plasma O +
glycerol O +
levels O +
and O +
oppositely O +
to O +
plasma O +
insulin B-Gene +
levels O +
in O +
mice O +
. O +

Insulin B-Gene +
dose O +
- O +
dependently O +
suppressed O +
AQPap B-Gene +
mRNA O +
expression O +
in O +
3T3-L1 O +
cells O +
. O +

AQPap B-Gene +
mRNA O +
levels O +
and O +
adipose O +
glycerol O +
concentrations O +
measured O +
by O +
the O +
microdialysis O +
technique O +
were O +
increased O +
in O +
obese O +
mice O +
with O +
insulin B-Gene +
resistance O +
. O +

Accordingly O +
, O +
negative O +
regulation O +
of O +
AQPap B-Gene +
expression O +
by O +
insulin B-Gene +
was O +
impaired O +
in O +
the O +
insulin B-Gene +
- O +
resistant O +
state O +
. O +

Exposure O +
of O +
epinephrine O +
translocated O +
AQPap B-Gene +
protein O +
from O +
perinuclear O +
cytoplasm O +
to O +
the O +
plasma O +
membrane O +
in O +
3T3-L1 O +
adipocytes O +
. O +

These O +
results O +
strongly O +
suggest O +
that O +
AQPap B-Gene +
plays O +
an O +
important O +
role O +
in O +
glycerol O +
release O +
from O +
adipocytes O +
. O +

Transcriptional O +
regulation O +
of O +
the O +
ATP B-Gene +
citrate I-Gene +
- I-Gene +
lyase I-Gene +
gene O +
by O +
sterol B-Gene +
regulatory I-Gene +
element I-Gene +
- I-Gene +
binding I-Gene +
proteins I-Gene +
. O +

In O +
an O +
attempt O +
to O +
identify O +
unknown O +
target O +
genes O +
for O +
SREBP-1 B-Gene +
, O +
total O +
RNA O +
from O +
a O +
stable O +
Chinese O +
hamster O +
ovary O +
cell O +
line O +
( O +
CHO-487 O +
) O +
expressing O +
a O +
mature O +
form O +
of O +
human O +
SREBP-1a B-Gene +
( O +
amino O +
acids O +
1 O +
- O +
487 O +
) O +
with O +
a O +
LacSwitch O +
Inducible O +
Mammalian O +
Expression O +
System O +
was O +
subjected O +
to O +
a O +
polymerase O +
chain O +
reaction O +
subtraction O +
method O +
. O +

One O +
of O +
the O +
fragments O +
was O +
found O +
to O +
have O +
90 O +
and O +
86 O +
% O +
homology O +
with O +
rat O +
and O +
human O +
ATP B-Gene +
citrate I-Gene +
- I-Gene +
lyase I-Gene +
( O +
ACL B-Gene +
) O +
cDNA O +
, O +
respectively O +
. O +

When O +
Hep O +
G2 O +
cells O +
are O +
cultured O +
under O +
either O +
sterol O +
- O +
loaded O +
or O +
- O +
depleted O +
conditions O +
, O +
expression O +
of O +
the O +
gene O +
is O +
induced O +
approximately O +
2 O -
- O -
3-fold O +
by O +
sterol O +
depletion O +
. O +

To O +
investigate O +
the O +
direct O +
effect O +
of O +
SREBP-1a B-Gene +
on O +
transcription O +
, O +
luciferase B-Gene +
assays O +
using O +
the O +
promoter O +
of O +
the O +
human O +
ACL B-Gene +
gene O +
were O +
performed O +
. O +

These O +
deletion O +
studies O +
indicated O +
that O +
a O +
minimum O +
160 O +
- O +
base O +
pair O +
segment O +
contains O +
the O +
information O +
required O +
for O +
the O +
transcriptional O +
regulation O +
brought O +
about O +
by O +
enforced O +
expression O +
of O +
SREBP-1a B-Gene +
. O +

Luciferase B-Gene +
assays O +
using O +
mutant O +
reporter O +
genes O +
revealed O +
that O +
SREBP B-Gene +
- O +
dependent O +
transcriptional O +
regulation O +
is O +
mediated O +
by O +
two O +
nearby O +
motifs O +
, O +
the O +
SREBP B-Gene +
- O +
binding O +
site O +
( O +
a O +
TCAGGCTAG O +
sequence O +
) O +
and O +
the O +
NF B-Gene -
- I-Gene -
Y I-Gene +
- O +
binding O +
site O +
( O +
a O +
CCAAT O +
box O +
) O +
. O +

It O +
was O +
confirmed O +
by O +
gel O +
mobility O +
shift O +
assays O +
that O +
recombinant O +
SREBP-1a B-Gene +
binds O +
to O +
the O +
sequence O +
. O +

Data O +
from O +
studies O +
with O +
transgenic O +
mice O +
and O +
reporter O +
assays O +
show O +
that O +
the O +
ACL B-Gene +
gene O +
promoter O +
is O +
activated O +
by O +
SREBP-1a B-Gene +
more O +
strongly O +
than O +
SREBP-2 B-Gene +
in O +
contrast O +
to O +
the O +
HMG B-Gene +
CoA I-Gene +
synthase I-Gene +
and O +
LDL B-Gene +
receptor I-Gene +
gene O +
promoters O +
, O +
which O +
exhibit O +
the O +
same O +
preference O +
for O +
the O +
two O +
factors O +
. O +

Therefore O +
, O +
SREBPs B-Gene +
transcriptionally O +
regulates O +
ACL B-Gene +
enzyme O +
activity O +
, O +
which O +
generates O +
the O +
cytosolic O +
acetyl O +
CoA O +
required O +
for O +
both O +
cholesterol O +
and O +
fatty O +
acid O +
synthesis O +
. O +

Selective O +
regulation O +
of O +
endogenous O +
G B-Gene +
protein I-Gene +
- I-Gene +
coupled I-Gene +
receptors I-Gene +
by O +
arrestins B-Gene +
in O +
HEK293 O +
cells O +
. O +

Arrestins B-Gene +
play O +
an O +
important O +
role O +
in O +
regulating O +
desensitization O +
and O +
trafficking O +
of O +
G B-Gene +
protein I-Gene +
- I-Gene +
coupled I-Gene +
receptors I-Gene +
( O +
GPCRs B-Gene +
) O +
. O +

However O +
, O +
limited O +
insight O +
into O +
the O +
specificity O +
of O +
arrestin B-Gene +
- O +
mediated O +
regulation O +
of O +
GPCRs B-Gene +
is O +
currently O +
available O +
. O +

Recently O +
, O +
we O +
used O +
an O +
antisense O +
strategy O +
to O +
reduce O +
arrestin B-Gene +
levels O +
in O +
HEK293 O +
cells O +
and O +
characterize O +
the O +
role O +
of O +
arrestins B-Gene +
on O +
endogenous O +
G B-Gene -
( I-Gene -
s I-Gene -
) I-Gene -
-coupled I-Gene +
receptors I-Gene +
( O +
Mundell O +
, O +
S. O +
J. O +
, O +
Loudon O +
, O +
R. O +
B. O +
, O +
and O +
Benovic O +
, O +
J. O +
L. O +
( O +
1999 O +
) O +
Biochemistry O +
38 O +
, O +
8723 O +
- O +
8732 O +
) O +
. O +

Here O +
, O +
we O +
characterized O +
GPCRs B-Gene +
coupled O +
to O +
either O +
G B-Gene -
( I-Gene -
q I-Gene -
) I-Gene +
( O +
M B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
muscarinic I-Gene +
acetylcholine I-Gene +
receptor I-Gene +
( O +
M B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
AchR I-Gene +
) O +
and O +
P2y B-Gene +
( I-Gene +
1 I-Gene +
) I-Gene +
and O +
P2y B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
purinergic I-Gene +
receptors I-Gene +
) O +
or O +
G B-Gene -
( I-Gene -
i I-Gene -
) I-Gene +
( O +
somatostatin B-Gene +
and I-Gene +
AT1 I-Gene +
angiotensin I-Gene +
receptors I-Gene +
) O +
in O +
wild O +
type O +
and O +
arrestin B-Gene +
antisense O +
HEK293 O +
cells O +
. O +

The O +
agonist O +
- O +
specific O +
desensitization O +
of O +
the O +
M B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
Ach I-Gene +
and I-Gene +
somatostatin I-Gene +
receptors I-Gene +
was O +
significantly O +
attenuated O +
in O +
antisense O +
- O +
expressing O +
cells O +
, O +
whereas O +
desensitization O +
of O +
P2y B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
and O +
P2y B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
purinergic O +
and O +
AT1 B-Gene +
angiotensin I-Gene +
receptors I-Gene +
was O +
unaffected O +
by O +
reduced O +
arrestin B-Gene +
levels O +
. O +

To O +
further O +
examine O +
arrestin B-Gene +
/ O +
GPCR B-Gene +
specificity O +
, O +
we O +
studied O +
the O +
effects O +
of O +
endogenous O +
GPCR B-Gene +
activation O +
on O +
the O +
redistribution O +
of O +
arrestin-2 B-Gene +
epitope O +
tagged O +
with O +
the O +
green B-Gene +
fluorescent I-Gene +
protein I-Gene +
( O +
arrestin-2 B-Gene +
- O +
GFP B-Gene +
) O +
. O +

These O +
studies O +
revealed O +
a O +
receptor O +
- O +
specific O +
movement O +
of O +
arrestin-2 B-Gene +
- O +
GFP B-Gene +
that O +
mirrored O +
the O +
arrestin B-Gene +
- O +
receptor O +
specificity O +
observed O +
in O +
the O +
antisense O +
cells O +
. O +

Thus O +
, O +
agonist O +
- O +
induced O +
activation O +
of O +
endogenous O +
beta B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene -
-adrenergic I-Gene +
, I-Gene +
prostaglandin I-Gene +
E I-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
, I-Gene +
M I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
Ach I-Gene +
, I-Gene +
and I-Gene +
somatostatin I-Gene +
receptors I-Gene +
induced O +
arrestin-2 B-Gene +
- O +
GFP B-Gene +
redistribution O +
to O +
early O +
endosomes O +
, O +
whereas O +
P2y B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
and O +
P2y B-Gene +
( I-Gene +
2 I-Gene +
) I-Gene +
purinergic O +
and O +
AT1 B-Gene +
angiotensin I-Gene +
receptor I-Gene +
activation O +
did O +
not O +
. O +

Thus O +
, O +
endogenous O +
arrestins B-Gene +
mediate O +
the O +
regulation O +
of O +
selective O +
G B-Gene -
( I-Gene -
q I-Gene -
) I-Gene +
- O +
and O +
G B-Gene -
( I-Gene -
i I-Gene -
) I-Gene +
- O +
coupled O +
receptors O +
in O +
HEK293 O +
cells O +
. O +

PDZ O +
domain O +
- O +
dependent O +
suppression O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
/ O +
p65 B-Gene +
- O +
induced O +
Abeta42 B-Gene +
production O +
by O +
a O +
neuron O +
- O +
specific B-Gene +
X11 I-Gene +
- I-Gene +
like I-Gene +
protein I-Gene +
. O +

It O +
is O +
widely O +
believed O +
that O +
one O +
of O +
the O +
causes O +
of O +
Alzheimer O +
's O +
disease O +
( O +
AD O +
) O +
is O +
the O +
generation O +
and O +
secretion O +
of O +
beta B-Gene +
- I-Gene +
amyloid I-Gene +
( O +
Abeta B-Gene +
) O +
from O +
amyloid B-Gene +
precursor I-Gene +
protein I-Gene +
in O +
the O +
brain O +
. O +

Here O +
we O +
report O +
that O +
a O +
transcription B-Gene +
factor I-Gene +
, O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
/ O +
p65 B-Gene +
, O +
induces O +
increased O +
secretion O +
of O +
amyloidogenic O +
Abeta42 B-Gene +
but O +
not O +
Abeta40 B-Gene +
. O +

The O +
kappaB O +
motif O +
- O +
dependent O +
production O +
of O +
Abeta42 B-Gene +
was O +
suppressed O +
by O +
binding O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
/ O +
p65 B-Gene +
to O +
the O +
PDZ O +
domain O +
of O +
the B-Gene +
X11 I-Gene +
- I-Gene +
like I-Gene +
protein I-Gene +
( O +
X11L B-Gene +
) O +
, O +
which O +
a O +
human O +
homologue O +
protein O +
of O +
LIN B-Gene +
- I-Gene +
10 I-Gene +
. O +

The O +
results O +
suggest O +
that O +
the O +
PDZ O +
domain O +
of O +
X11L B-Gene +
can O +
control O +
the O +
ability O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
/ O +
p65 B-Gene +
to O +
induce O +
expression O +
of O +
protein O -
( O -
s O -
) O +
involved O +
in O +
Abeta42 B-Gene +
production O +
. O +

The O +
amino O +
acids O +
161 O +
- O +
163 O +
in O +
Rel B-Gene +
homology O +
domain O +
( O +
RHD O +
) O +
of O +
NF B-Gene +
- I-Gene +
kappaB I-Gene +
/ O +
p65 B-Gene +
is O +
important O +
in O +
interaction O +
of O +
NF B-Gene +
- I-Gene +
kappaB I-Gene +
/ O +
p65 B-Gene +
with O +
X11L B-Gene +
. O +

Another O +
subunit O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
/ O +
p50 B-Gene +
and O +
heterodimers O +
of O +
p65 B-Gene +
and O +
p50 B-Gene +
do O +
not O +
bind O +
to O +
X11L B-Gene +
. O +

Our O +
finding O +
indicates O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
and O +
X11L B-Gene +
may O +
, O +
in O +
novel O +
way O +
, O +
regulate O +
Abeta B-Gene +
production O +
in O +
neuronal O +
cells O +
. O +

Targeting O +
X11L B-Gene +
by O +
specific O +
therapy O +
may O +
provide O +
the O +
possibility O +
to O +
control O +
the O +
progression O +
of O +
AD O +
. O +

The O +
differential O +
expression O +
of O +
apoptosis O +
factors O +
in O +
the O +
alveolar O +
epithelium O +
is O +
redox O +
sensitive O +
and O +
requires O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
( O +
RelA B-Gene +
) O +
- O +
selective O +
targeting O +
. O +

Fetal O +
alveolar O +
type O +
II O +
( O +
fATII O +
) O +
epithelial O +
cells O +
were O +
used O +
to O +
evaluate O +
the O +
role O +
of O +
signaling O +
factors O +
involved O +
in O +
oxidative O +
stress O +
- O +
induced O +
programmed O +
cell O +
death O +
( O +
PCD O +
; O +
apoptosis O +
) O +
. O +

Bcl-2 B-Gene +
, O +
an O +
antiapoptotic O +
proto O +
- O +
oncogene O +
, O +
showed O +
maximum O +
abundance O +
in O +
hypoxia O +
and O +
mild O +
reoxygenation O +
, O +
but O +
declined O +
thereafter O +
. O +

The O +
Bcl-2 B-Gene +
counterpart O +
, O +
Bax B-Gene +
, O +
which O +
promotes O +
PCD O +
, O +
displayed O +
an O +
increasing O +
logarithmic O +
profile O +
with O +
ascending O +
DeltapO O +
( O +
2 O +
) O +
regimen O +
, O +
such O +
that O +
the O +
ratio O +
of O +
Bcl B-Gene +
- I-Gene +
2 I-Gene +
/ O +
Bax B-Gene +
decreased O +
as O +
pO O +
( O +
2 O +
) O +
increased O +
. O +

The O +
expression O +
of O +
p53 B-Gene +
, O +
a O +
cell O +
cycle O +
regulator O +
, O +
paralleled O +
Bax B-Gene +
abundance O +
. O +

Pretreatment O +
of O +
fATII O +
cells O +
with O +
l O -
- O -
buthionine- O -
( O -
S O -
, O -
R O -
) O -
-sulfoximine O +
, O +
an O +
irreversible O +
inhibitor O +
of O +
gamma B-Gene +
- I-Gene +
glutamylcysteine I-Gene +
synthetase I-Gene +
, O +
the O +
rate O +
- O +
limiting O +
enzyme O +
in O +
the O +
biosynthesis O +
of O +
glutathione O +
( O +
GSH O +
) O +
, O +
enhanced O +
Bax B-Gene +
and O +
p53 B-Gene +
expression O +
over O +
Bcl-2 B-Gene +
. O +

The O +
GSH O +
analogue O +
, O +
gamma O -
- O -
glutamylcysteinyl O +
- O +
ethyl O +
ester O +
, O +
down O +
- O +
regulated O +
Bax B-Gene +
/ O +
p53 B-Gene +
abundance O +
but O +
restored O +
that O +
of O +
Bcl-2 B-Gene +
, O +
thereby O +
increasing O +
Bcl-2 B-Gene +
/ O +
Bax B-Gene +
. O +

The O +
antioxidant O +
and O +
GSH O +
precursor O +
N O -
- O -
acetyl O -
- O -
l O -
- O -
cysteine O +
favored O +
Bcl-2 B-Gene +
at O +
the O +
expense O +
of O +
Bax B-Gene +
/ O +
p53 B-Gene +
, O +
whereas O +
pyrrolidine O +
dithiocarbamate O +
induced O +
Bax B-Gene +
against O +
Bcl B-Gene +
- I-Gene +
2 I-Gene +
, O +
with O +
mild O +
effect O +
on O +
p53 B-Gene +
. O +

Sulfasalazine O +
, O +
a O +
potent O +
and O +
specific O +
inhibitor O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
, O +
induced O +
Bax B-Gene +
at O +
the O +
expense O +
of O +
Bcl B-Gene +
- I-Gene +
2 I-Gene +
, O +
in O +
a O +
p53 B-Gene +
- O +
dependent O +
manner O +
. O +

We O +
conclude O +
that O +
the O +
differential O +
expression O +
of O +
signaling O +
factors O +
involved O +
in O +
PCD O +
in O +
the O +
alveolar O +
epithelium O +
is O +
redox O +
- O +
sensitive O +
and O +
mediated O +
, O +
at O +
least O +
in O +
part O +
, O +
by O +
a O +
negative O +
feedback O +
mechanism O +
transduced O +
by O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
. O +

Molecular O +
cloning O +
and O +
expression O +
of O +
two O +
distinct O +
human O +
chondroitin B-Gene +
4-O I-Gene -
- I-Gene -
sulfotransferases I-Gene +
that O +
belong O +
to O +
the O +
HNK-1 B-Gene +
sulfotransferase I-Gene +
gene I-Gene +
family I-Gene +
. O +

Using O +
an O +
expression O +
cloning O +
strategy O +
, O +
the O +
cDNA O +
encoding O +
the O +
human O +
HNK-1 B-Gene +
sulfotransferase I-Gene +
( O +
HNK-1ST B-Gene +
) O +
has O +
been O +
cloned O +
. O +

During O +
this O +
cloning O +
we O +
found O +
that O +
HNK-1ST B-Gene +
and O +
other O +
Golgi O +
- O +
associated O +
sulfotransferases B-Gene +
cloned O +
before O +
share O +
homologous O +
sequences O +
including O +
the O +
RDP O +
motif O +
( O +
Ong O +
, O +
E. O +
, O +
Yeh O +
, O +
J. O +
- O +
C. O +
, O +
Ding O +
, O +
Y. O +
, O +
Hindsgaul O +
, O +
O. O +
, O +
and O +
Fukuda O +
, O +
M. O +
( O +
1998 O +
) O +
J. O +
Biol O -
. O +
Chem O -
. O +
223 O +
, O +
5190 O +
- O +
5195 O +
) O +
. O +

Using O +
this O +
conserved O +
sequence O +
in O +
HNK-1ST B-Gene +
as O +
a O +
probe O +
, O +
we O +
identified O +
two O +
expressed O +
sequence O +
tags O +
in O +
EST O +
data O +
base O +
which O +
have O +
31.6 O +
and O +
30.7 O +
% O +
identity O +
with O +
HNK-1ST B-Gene +
at O +
the O +
amino O +
acid O +
levels O +
. O +

Expression O +
of O +
these O +
two O +
full O +
- O +
length O +
cDNAs O +
failed O +
to O +
form O +
HNK-1 B-Gene +
glycan O +
nor O +
to O +
add O +
sulfate O +
to O +
CD34 B-Gene +
or O +
NCAM B-Gene +
. O +

Surprisingly O +
, O +
proteins O +
expressed O +
by O +
these O +
cDNAs O +
transferred O +
sulfate O +
to O +
the O +
C-4 O +
position O +
of O +
N O -
- O -
acetylgalactosamine O +
in O +
chondroitin O +
and O +
desulfated O +
dermatan O +
sulfate O +
, O +
thus O +
we O +
named O +
these O +
two O +
enzymes O +
, O +
chondroitin B-Gene +
4-O I-Gene -
- I-Gene -
sulfotransferase I-Gene +
1 I-Gene +
and I-Gene +
- I-Gene +
2 I-Gene +
( O +
C4ST-1 B-Gene +
and O +
C4ST-2 B-Gene +
) O +
. O +

Both O +
C4ST-1 B-Gene +
and O +
C4ST-2 B-Gene +
, O +
however O +
, O +
did O +
not O +
form O +
4 O +
, O +
6-di O -
- O -
O O -
- O -
sulfated O +
N O -
- O -
acetylgalactosamine O +
when O +
chondroitin O +
sulfate O +
C O +
was O +
used O +
as O +
an O +
acceptor O +
. O +

Moreover O +
, O +
analysis O +
of O +
( O +
35 O +
) O +
S O +
- O +
labeled O +
dermatan O +
sulfate O +
formed O +
by O +
C4ST-1 B-Gene +
indicate O +
that O +
sulfation O +
preferentially O +
took O +
place O +
in O +
GlcA O +
-- O -
> O +
GalNAc O +
unit O +
than O +
in O +
IdoA O +
-- O -
> O +
GalNAc O +
unit O +
, O +
suggesting O +
that O +
4-O O -
- O -
sulfation O +
at O +
N O -
- O -
acetylgalactosamine O +
may O +
precede O +
epimerization O +
of O +
glucuronic O +
acid O +
to O +
iduronic O +
acid O +
during O +
dermatan O +
sulfate O +
biosynthesis O +
. O +

Northern O +
analysis O +
demonstrated O +
that O +
the O +
transcript O +
for O +
C4ST-1 B-Gene +
is O +
predominantly O +
expressed O +
in O +
peripheral O +
leukocytes O +
and O +
hematopoietic O +
tissues O +
while O +
the O +
C4ST-2 B-Gene +
transcript O +
is O +
more O +
widely O +
expressed O +
in O +
various O +
tissues O +
. O +

These O +
results O +
indicate O +
C4ST-1 B-Gene +
and O +
C4ST-2 B-Gene +
play O +
complementary O +
roles O +
in O +
chondroitin O +
and O +
dermatan O +
sulfate O +
synthesis O +
in O +
different O +
tissues O +
. O +

Postprandial O +
metabolism O +
of O +
apolipoprotein B-Gene +
B-48 I-Gene +
- I-Gene +
and I-Gene +
B-100 I-Gene +
- O +
containing O +
particles O +
in O +
type O +
2 O +
diabetes O +
mellitus O +
: O +
relations O +
to O +
angiographically O +
verified O +
severity O +
of O +
coronary O +
artery O +
disease O +
. O +

The O +
aim O +
of O +
the O +
present O +
cross O +
- O +
sectional O +
angiographic O +
study O +
was O +
to O +
examine O +
if O +
there O +
is O +
a O +
relationship O +
between O +
the O +
severity O +
of O +
CAD O +
and O +
postprandial O +
lipemia O +
in O +
patients O +
with O +
type O +
2 O +
diabetes O +
mellitus O +
. O +

Special O +
emphasis O +
was O +
directed O +
to O +
determining O +
the O +
contribution O +
of O +
apolipoprotein B-Gene +
B-48 I-Gene +
( O +
apoB B-Gene +
- I-Gene +
48 I-Gene +
) O +
- O +
containing O +
and O +
B-100 B-Gene +
( O +
apoB B-Gene +
- I-Gene +
100 I-Gene +
) O +
- O +
containing O +
triglyceride O +
- O +
rich O +
particles O +
to O +
the O +
magnitude O +
of O +
postprandial O +
lipemia O +
and O +
degree O +
of O +
CAD O +
. O +

The O +
role O +
of O +
apolipoprotein B-Gene +
E I-Gene +
( O +
apoE B-Gene +
) O +
phenotype O +
as O +
a O +
modulator O +
of O +
postprandial O +
lipemia O +
was O +
also O +
evaluated O +
. O +

The O +
severity O +
of O +
CAD O +
was O +
determined O +
by O +
a O +
quantitative O +
coronary O +
angiography O +
and O +
the O +
subjects O +
were O +
classified O +
into O +
two O +
groups O +
based O +
on O +
the O +
presence O +
( O +
severe O +
CAD O +
) O +
or O +
absence O +
( O +
mild O +
CAD O +
) O +
of O +
at O +
least O +
50 O +
% O +
stenosis O +
in O +
a O +
major O +
coronary O +
vessel O +
. O +

The O +
study O +
population O +
consisted O +
of O +
43 O +
subjects O +
( O +
31 O +
men O +
and O +
12 O +
women O +
) O +
with O +
fair O +
glycemic O +
control O +
and O +
comparable O +
fasting O +
lipids O +
and O +
body O +
mass O +
index O +
. O +

Postprandial O +
responses O +
of O +
TG O +
, O +
apoB B-Gene +
- I-Gene +
48 I-Gene +
and O +
apoB B-Gene +
- I-Gene +
100 I-Gene +
in O +
lipoprotein B-Gene +
subfractions O +
( O +
chylomicrons B-Gene +
, O +
VLDL1 B-Gene +
, O +
VLDL2 B-Gene +
and O +
IDL B-Gene +
) O +
were O +
determined O +
after O +
a O +
fat O +
load O +
. O +

Type O +
2 O +
diabetic O +
patients O +
exhibited O +
the O +
classical O +
dyslipidemia O +
of O +
the O +
insulin B-Gene +
resistance O +
syndrome O +
and O +
delayed O +
clearance O +
of O +
both O +
hepatic O +
and O +
intestinal O +
particles O +
. O +

Fasting O +
or O +
postprandial O +
lipid O +
or O +
lipoprotein B-Gene +
measurements O +
, O +
including O +
apoB B-Gene +
- I-Gene +
48 I-Gene +
and O +
apoB B-Gene +
- I-Gene +
100 I-Gene +
concentrations O +
, O +
did O +
not O +
differ O +
between O +
the O +
groups O +
. O +

The O +
presence O +
or O +
absence O +
of O +
apoE-4 B-Gene +
allele O +
did O +
not O +
significantly O +
influence O +
postprandial O +
lipemia O +
. O +

The O +
severity O +
of O +
the O +
most O +
significant O +
coronary O +
stenosis O +
in O +
angiography O +
correlated O +
with O +
plasma O +
and O +
with O +
chylomicron B-Gene +
area O +
under O +
curve O +
( O +
AUC O +
) O +
for O +
TG O +
( O +
n O +
= O +
27 O +
) O +
and O +
chylomicron B-Gene +
AUC O +
for O +
apoB-48 B-Gene +
( O +
n O +
= O +
20 O +
) O +
. O +

The O +
strongest O +
correlate O +
of O +
maximal O +
stenosis O +
was O +
area O +
under O +
incremental O +
curve O +
( O +
AUIC O +
) O +
for O +
apoB-100 B-Gene +
in O +
IDL B-Gene +
fraction O +
( O +
r O +
= O +
0.548 O +
, O +
P O +
= O +
0 O -
. O +
012 O +
, O +
n O +
= O +
20 O +
) O +
. O +

In O +
conclusion O +
, O +
postprandial O +
apoB B-Gene +
- I-Gene +
48 I-Gene +
and O +
apoB B-Gene +
- I-Gene +
100 I-Gene +
metabolism O +
in O +
triglyceride O +
rich O +
lipoproteins B-Gene +
is O +
distorted O +
in O +
type O +
2 O +
diabetic O +
patients O +
, O +
even O +
in O +
those O +
with O +
only O +
mild O +
CAD O +
. O +

The O +
data O +
suggest O +
that O +
postprandial O +
change O +
in O +
small O +
remnant O +
particle O +
numbers O +
may O +
contribute O +
to O +
the O +
severity O +
of O +
CAD O +
in O +
type O +
2 O +
diabetes O +
. O +

Combined O +
action O +
of O +
two O +
transcription B-Gene +
factors I-Gene +
regulates O +
genes O +
encoding O +
spore O +
coat O +
proteins O +
of O +
Bacillus O +
subtilis O +
. O +

During O +
sporulation O +
of O +
Bacillus O +
subtilis O +
, O +
spore O +
coat O +
proteins O +
encoded O +
by O +
cot B-Gene +
genes O +
are O +
expressed O +
in O +
the O +
mother O +
cell O +
and O +
deposited O +
on O +
the O +
forespore O +
. O +

Transcription O +
of O +
the O +
cotB B-Gene +
, O +
cotC B-Gene +
, O +
and O +
cotX B-Gene +
genes O +
by O +
final O +
sigma B-Gene +
( I-Gene +
K I-Gene +
) I-Gene +
RNA B-Gene +
polymerase I-Gene +
is O +
activated O +
by O +
a O +
small O +
, O +
DNA O +
- O +
binding O +
protein O +
called O +
GerE B-Gene +
. O +

The O +
promoter O +
region O +
of O +
each O +
of O +
these O +
genes O +
has O +
two O +
GerE B-Gene +
binding O +
sites O +
. O +

5 O -
' O +
deletions O +
that O +
eliminated O +
the O +
more O +
upstream O +
GerE B-Gene +
site O +
decreased O +
expression O +
of O +
lacZ B-Gene +
fused O +
to O +
cotB B-Gene +
and O +
cotX B-Gene +
by O +
approximately O +
80 O +
% O +
and O +
60 O +
% O +
, O +
respectively O +
but O +
had O +
no O +
effect O +
on O +
cotC B-Gene +
- O +
lacZ B-Gene +
expression O +
. O +

The O +
cotC B-Gene +
- O +
lacZ B-Gene +
fusion O +
was O +
expressed O +
later O +
during O +
sporulation O +
than O +
the O +
other O +
two O +
fusions O +
. O +

Primer O +
extension O +
analysis O +
confirmed O +
that O +
cotB B-Gene +
mRNA O +
increases O +
first O +
during O +
sporulation O +
, O +
followed O +
by O +
cotX B-Gene +
and O +
cotC B-Gene +
mRNAs O +
over O +
a O +
2 O +
- O +
h O +
period O +
. O +

In O +
vitro O +
transcription O +
experiments O +
suggest O +
that O +
the O +
differential O +
pattern O +
of O +
cot B-Gene +
gene O +
expression O +
results O +
from O +
the O +
combined O +
action O +
of O +
GerE B-Gene +
and O +
another O +
transcription B-Gene +
factor I-Gene +
, O +
SpoIIID B-Gene +
. O +

A O +
low O +
concentration O +
of O +
GerE B-Gene +
activated O +
cotB B-Gene +
transcription O +
by O +
final O +
sigma B-Gene +
( I-Gene +
K I-Gene +
) I-Gene +
RNA B-Gene +
polymerase I-Gene +
, O +
whereas O +
a O +
higher O +
concentration O +
was O +
needed O +
to O +
activate O +
transcription O +
of O +
cotX B-Gene +
or O +
cotC B-Gene +
. O +

SpoIIID B-Gene +
at O +
low O +
concentration O +
repressed O +
cotC B-Gene +
transcription O +
, O +
whereas O +
a O +
higher O +
concentration O +
only O +
partially O +
repressed O +
cotX B-Gene +
transcription O +
and O +
had O +
little O +
effect O +
on O +
cotB B-Gene +
transcription O +
. O +

DNase B-Gene +
I I-Gene +
footprinting O +
showed O +
that O +
SpoIIID B-Gene +
binds O +
strongly O +
to O +
two O +
sites O +
in O +
the O +
cotC B-Gene +
promoter O +
region O +
, O +
binds O +
weakly O +
to O +
one O +
site O +
in O +
the O +
cotX B-Gene +
promoter O +
, O +
and O +
does O +
not O +
bind O +
specifically O +
to O +
cotB B-Gene +
. O +

We O +
propose O +
that O +
late O +
in O +
sporulation O +
the O +
rising O +
level O +
of O +
GerE B-Gene +
and O +
the O +
falling O +
level O +
of O +
SpoIIID B-Gene +
, O +
together O +
with O +
the O +
position O +
and O +
affinity O +
of O +
binding O +
sites O +
for O +
these O +
transcription B-Gene +
factors I-Gene +
in O +
cot B-Gene +
gene O +
promoters O +
, O +
dictates O +
the O +
timing O +
and O +
level O +
of O +
spore O +
coat O +
protein O +
synthesis O +
, O +
ensuring O +
optimal O +
assembly O +
of O +
the O +
protein O +
shell O +
on O +
the O +
forespore O +
surface O +
. O +

Identification O +
of O +
a O +
novel O +
four O +
- O +
domain O +
member O +
of O +
the O +
proteinase B-Gene +
inhibitor I-Gene +
II I-Gene +
family I-Gene +
from O +
the O +
stigmas O +
of O +
Nicotiana O +
alata O +
. O +

Proteinase B-Gene +
inhibitors I-Gene +
( I-Gene +
PIs I-Gene +
) I-Gene +
of I-Gene +
the I-Gene +
potato I-Gene +
type I-Gene +
II I-Gene +
family I-Gene +
have O +
been O +
identified O +
in O +
a O +
number O +
of O +
solanaceous O +
species O +
. O +

Most O +
family O +
members O +
have O +
two O +
PI O +
domains O +
which O +
are O +
specific O +
for O +
either O +
chymotrypsin B-Gene +
or O +
trypsin B-Gene +
. O +

More O +
recently O +
family O +
members O +
have O +
been O +
described O +
with O +
three O +
or O +
six O +
repeated O +
PI O +
domains O +
. O +

Here O +
we O +
describe O +
a O +
novel O +
four O +
- O +
domain O +
family O +
member O +
produced O +
in O +
the O +
stigmas O +
and O +
leaves O +
of O +
the O +
ornamental O +
tobacco O +
, O +
Nicotiana O +
alata O +
, O +
which O +
has O +
high O +
sequence O +
identity O +
with O +
a O +
six O +
- O +
domain O +
member O +
from O +
the O +
same O +
species O +
. O +

Both O +
proteins O +
are O +
produced O +
as O +
precursors O +
that O +
enter O +
the O +
secretory O +
pathway O +
and O +
are O +
subsequently O +
processed O +
into O +
a O +
series O +
of O +
6 O +
kDa O +
Pis O +
. O +

The O +
four O +
- O +
and O +
six O +
- O +
domain O +
precursor O +
proteins O +
were O +
isolated O +
from O +
immature O +
stigmas O +
and O +
characterised O +
by O +
mass O +
spectrometry O +
which O +
revealed O +
that O +
both O +
proteins O +
had O +
been O +
trimmed O +
at O +
the O +
N O +
- O +
terminus O +
, O +
at O +
a O +
position O +
corresponding O +
to O +
the O +
predicted O +
signal O +
peptide O +
cleavage O +
site O +
. O +

Furthermore O +
, O +
no O +
post O +
- O +
translational O +
modifications O +
were O +
apparent O +
. O +

Cloning O +
and O +
functional O +
characterization O +
of O +
a O +
putative O +
sodium B-Gene +
channel I-Gene +
auxiliary O +
subunit O +
gene O +
from O +
the O +
house O +
fly O +
( O +
Musca O +
domestica O +
) O +
. O +

The O +
functional O +
expression O +
of O +
cloned O +
Drosophila O +
melanogaster O +
and O +
house O +
fly O +
( O +
Musca O +
domestica O +
) O +
voltage B-Gene +
- I-Gene +
sensitive I-Gene +
sodium I-Gene +
channels O +
in O +
Xenopus O +
oocytes O +
is O +
enhanced O +
, O +
and O +
the O +
inactivation O +
kinetics O +
of O +
the O +
expressed O +
channels O +
are O +
accelerated O +
, O +
by O +
coexpression O +
with O +
the O +
tipE B-Gene +
protein O +
, O +
a O +
putative O +
sodium B-Gene +
channel I-Gene +
auxiliary O +
subunit O +
encoded O +
by O +
the O +
tipE B-Gene +
gene O +
of O +
D. O +
melanogaster O +
. O +

These O +
results O +
predict O +
the O +
existence O +
of O +
a O +
tipE B-Gene +
ortholog O +
in O +
the O +
house O +
fly O +
. O +

Using O +
a O +
PCR O +
- O +
based O +
homology O +
probing O +
approach O +
, O +
we O +
isolated O +
cDNA O +
clones O +
encoding O +
an O +
ortholog O +
of O +
tipE B-Gene +
( O +
designated O +
Vssc B-Gene +
beta O +
) O +
from O +
adult O +
house O +
fly O +
heads O +
. O +

Clones O +
comprising O +
3444 O +
bp O +
of O +
cDNA O +
sequence O +
contained O +
a O +
1317 O +
bp O +
open O +
- O +
reading O +
frame O +
encoding O +
a O +
438 O +
amino O +
acid O +
protein O +
. O +

The O +
predicted O +
Vssc B-Gene +
beta O +
protein O +
exhibited O +
72 O +
% O +
amino O +
acid O +
sequence O +
identity O +
to O +
the O +
entire O +
D. O +
melanogaster O +
tipE B-Gene +
protein O +
sequence O +
and O +
97 O +
% O +
identity O +
within O +
the O +
two O +
hydrophobic O +
segments O +
identified O +
as O +
probable O +
transmembrane O +
domains O +
. O +

Coexpression O +
of O +
Vssc B-Gene +
beta O +
with O +
the O +
house O +
fly O +
sodium B-Gene +
channel I-Gene +
alpha O +
subunit O +
( O +
Vssc1 B-Gene +
) O +
in O +
oocytes O +
enhanced O +
the O +
level O +
of O +
sodium O +
current O +
expression O +
five O +
- O +
fold O +
and O +
accelerated O +
the O +
rate O +
of O +
sodium O +
current O +
inactivation O +
2.2 O +
- O +
fold O +
. O +

Both O +
of O +
these O +
effects O +
were O +
significantly O +
larger O +
in O +
magnitude O +
than O +
the O +
corresponding O +
effects O +
of O +
the O +
D. O +
melanogaster O +
tipE B-Gene +
protein O +
on O +
the O +
expression O +
and O +
kinetics O +
of O +
Vssc1 B-Gene +
sodium B-Gene +
channels I-Gene +
. O +

These O +
results O +
identify O +
a O +
second O +
example O +
of O +
a O +
putative O +
sodium B-Gene +
channel I-Gene +
auxiliary O +
subunit O +
from O +
an O +
insect O +
having O +
functional O +
but O +
not O +
structural O +
homology O +
to O +
vertebrate O +
sodium B-Gene +
channel I-Gene +
beta O +
subunits O +
. O +

Crystal O +
structure O +
of O +
the O +
Escherichia O +
coli O +
Rob B-Gene +
transcription B-Gene +
factor I-Gene +
in O +
complex O +
with O +
DNA O +
. O +

The O +
Escherichia O +
coli O +
Rob B-Gene +
protein O +
is O +
a O +
transcription B-Gene +
factor I-Gene +
belonging O +
to O +
the O +
AraC B-Gene +
/ I-Gene +
XylS I-Gene +
protein I-Gene +
family I-Gene +
that O +
regulates O +
genes O +
involved O +
in O +
resistance O +
to O +
antibiotics O +
, O +
organic O +
solvents O +
and O +
heavy O +
metals O +
. O +

The O +
genes O +
encoding O +
these O +
proteins O +
are O +
activated O +
by O +
the O +
homologous O +
proteins O +
MarA B-Gene +
and O +
SoxS B-Gene +
, O +
although O +
the O +
level O +
of O +
activation O +
can O +
vary O +
for O +
the O +
different O +
transcription B-Gene +
factors I-Gene +
. O +

Here O +
we O +
report O +
a O +
2.7 O +
A O +
crystal O +
structure O +
of O +
Rob B-Gene +
in O +
complex O +
with O +
the O +
micF B-Gene +
promoter O +
that O +
reveals O +
an O +
unusual O +
mode O +
of O +
binding O +
to O +
DNA O +
. O +

The O +
Rob B-Gene +
- O +
DNA O +
complex O +
differs O +
from O +
the O +
previously O +
reported O +
structure O +
of O +
MarA B-Gene +
bound O +
to O +
the O +
mar O +
promoter O +
, O +
in O +
that O +
only O +
one O +
of O +
Rob B-Gene +
' O +
s O +
dual O +
helix O +
- O +
turn O +
- O +
helix O +
( O +
HTH O +
) O +
motifs O +
engages O +
the O +
major O +
groove O +
of O +
the O +
binding O +
site O +
. O +

Biochemical O +
studies O +
show O +
that O +
sequence O +
specific O +
interactions O +
involving O +
only O +
one O +
of O +
Rob B-Gene +
's O +
HTH O +
motifs O +
are O +
sufficient O +
for O +
high O +
affinity O +
binding O +
to O +
DNA O +
. O +

The O +
two O +
different O +
modes O +
of O +
DNA O +
binding O +
seen O +
in O +
crystal O +
structures O +
of O +
Rob B-Gene +
and O +
MarA B-Gene +
also O +
match O +
the O +
distinctive O +
patterns O +
of O +
DNA O +
protection O +
by O +
AraC B-Gene +
at O +
several O +
sites O +
within O +
the O +
pBAD O +
promoter O +
. O +

These O +
and O +
other O +
findings O +
suggest O +
that O +
gene O +
activation O +
by O +
AraC B-Gene +
/ O +
XylS B-Gene +
transcription B-Gene +
factors I-Gene +
might O +
involve O +
two O +
alternative O +
modes O +
of O +
binding O +
to O +
DNA O +
in O +
different O +
promoter O +
contexts O +
. O +

Dual O +
effect O +
of O +
IL-4 B-Gene +
on O +
resistance O +
to O +
systemic O +
gram O +
- O +
negative O +
infection O +
and O +
production O +
of O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
. O +

To O +
determine O +
the O +
effect O +
of O +
interleukin B-Gene +
4 I-Gene +
( O +
IL-4 B-Gene +
) O +
administration O +
in O +
a O +
live O +
sepsis O +
model O +
characterised O +
by O +
high O +
- O +
level O +
production O +
of O +
tumour B-Gene +
necrosis I-Gene +
factor I-Gene +
a I-Gene +
( O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
) O +
, O +
mice O +
infected O +
systemically O +
with O +
lethal O +
or O +
sublethal O +
inocula O +
of O +
Pseudomonas O +
aeruginosa O +
were O +
given O +
the O +
recombinant O +
cytokine B-Gene +
at O +
different O +
times O +
before O +
infection O +
. O +

Improved O +
survival O +
and O +
decreased O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
production O +
were O +
observed O +
in O +
lethally O +
infected O +
mice O +
treated O +
with O +
the O +
cytokine B-Gene +
1 O +
day O +
before O +
challenge O +
. O +

In O +
contrast O +
, O +
increased O +
mortality O +
and O +
overproduction O +
of O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
were O +
observed O +
in O +
sublethally O +
infected O +
mice O +
given O +
IL-4 B-Gene +
at O +
the O +
time O +
of O +
infection O +
. O +

ARP3beta B-Gene +
, O +
the O +
gene O +
encoding O +
a O +
new O +
human O +
actin B-Gene +
- I-Gene +
related I-Gene +
protein I-Gene +
, O +
is O +
alternatively O +
spliced O +
and O +
predominantly O +
expressed O +
in O +
brain O +
neuronal O +
cells O +
. O +

A O +
cDNA O +
encoding O +
a O +
new O +
human O +
actin B-Gene +
- I-Gene +
related I-Gene +
protein I-Gene +
( O +
ARP B-Gene +
) O +
was O +
cloned O +
. O +

The O +
corresponding O +
protein O +
is O +
highly O +
conserved O +
with O +
the O +
previously O +
described O +
ARP3 B-Gene +
protein O +
, O +
suggesting O +
that O +
it O +
represents O +
a O +
second O +
isoform O +
of O +
the O +
human O +
ARP3 B-Gene +
subfamily O +
. O +

This O +
new O +
actin B-Gene +
- I-Gene +
related I-Gene +
protein I-Gene +
was O +
subsequently O +
named O +
ARP3beta B-Gene +
and O +
represents O +
the O +
second O +
example O +
of O +
multiple O +
isoforms O +
of O +
an O +
actin B-Gene +
- I-Gene +
related I-Gene +
protein I-Gene +
in O +
a O +
single O +
organism O +
. O +

The O +
ARP3beta B-Gene +
gene O +
was O +
mapped O +
to O +
chromosome O +
band O +
7q34 O +
, O +
centromeric O +
to O +
Sonic B-Gene +
Hedgehog I-Gene +
. O +

Gene O +
structure O +
analysis O +
revealed O +
that O +
at O +
least O +
part O +
of O +
the O +
observed O +
ARP3beta B-Gene +
mRNA O +
heterogeneity O +
is O +
caused O +
by O +
alternative O +
splicing O +
resulting O +
in O +
exon O +
skipping O +
. O +

Transcripts O +
produced O +
after O +
exon O +
2 O +
skipping O +
are O +
predicted O +
to O +
encode O +
truncated O +
products O +
, O +
whose O +
functionality O +
is O +
still O +
unclear O +
. O +

An O +
ARP3beta B-Gene +
pseudogene O +
was O +
detected O +
on O +
chromosome O +
2p11 O +
by O +
database O +
searching O +
. O +

Several O +
ARP3beta B-Gene +
mRNA O +
species O +
were O +
detected O +
by O +
Northern O +
blotting O +
and O +
their O +
abundance O +
varied O +
importantly O +
among O +
tissues O +
: O +
the O +
highest O +
expression O +
levels O +
were O +
detected O +
in O +
fetal O +
and O +
adult O +
brain O +
, O +
whereas O +
lower O +
levels O +
were O +
observed O +
in O +
liver O +
, O +
muscle O +
and O +
pancreas O +
. O +

In O +
contrast O +
, O +
ARP3 B-Gene +
mRNAs O +
were O +
detected O +
in O +
all O +
tissues O +
tested O +
. O +

Using O +
in O +
situ O +
hybridization O +
, O +
the O +
expression O +
of O +
ARP3beta B-Gene +
in O +
brain O +
was O +
shown O +
to O +
be O +
restricted O +
to O +
neurons O +
and O +
epithelial O +
cells O +
from O +
choroid O +
plexus O +
. O +

This O +
suggests O +
a O +
specific O +
function O +
for O +
ARP3beta B-Gene +
in O +
the O +
physiology O +
of O +
the O +
development O +
and/or O +
maintenance O +
of O +
distinct O +
subsets O +
of O +
nerve O +
cells O +
. O +

Expression O +
and O +
localization O +
of O +
enzymes O +
of O +
arginine O +
metabolism O +
in O +
the O +
rat O +
eye O +
. O +

PURPOSE O +
: O +

Production O +
of O +
NO O +
may O +
be O +
regulated O +
by O +
argininosuccinate B-Gene +
synthetase I-Gene +
and O +
argininosuccinate B-Gene +
lyase I-Gene +
which O +
recycle O +
citrulline O +
to O +
arginine O +
, O +
and O +
by O +
arginase O +
which O +
hydrolyzes O +
arginine O +
to O +
urea O +
and O +
ornithine O +
. O +

Expression O +
of O +
these O +
and O +
related O +
enzymes O +
in O +
rat O +
eye O +
was O +
studied O +
. O +

METHODS O +
: O +

mRNAs O +
for O +
the O +
enzymes O +
were O +
analyzed O +
by O +
reverse O +
transcription O +
- O +
polymerase B-Gene +
chain O +
reaction O +
( O +
RT O +
- O +
PCR O +
) O +
. O +

Localization O +
of O +
the O +
enzyme O +
proteins O +
and O +
mRNAs O +
was O +
analyzed O +
by O +
immunohistochemistry O +
and O +
in O +
situ O +
hybridization O +
, O +
respectively O +
. O +

RESULTS O +
: O +

In O +
RT O +
- O +
PCR O +
analysis O +
, O +
arginase B-Gene +
II I-Gene +
( O +
nonhepatic O +
type O +
) O +
mRNA O +
was O +
detected O +
in O +
retina O +
and O +
weakly O +
in O +
cornea O +
, O +
whereas O +
arginase B-Gene +
I I-Gene +
( O +
hepatic O +
type O +
) O +
mRNA O +
was O +
not O +
detected O +
in O +
any O +
area O +
. O +

mRNAs O +
for O +
argininosuccinate B-Gene +
synthetase I-Gene +
, O +
argininosuccinate B-Gene +
lyase I-Gene +
, O +
ornithine B-Gene +
aminotransferase I-Gene +
and O +
ornithine B-Gene +
decarboxylase I-Gene +
were O +
present O +
in O +
all O +
areas O +
. O +

In O +
immunohistochemical O +
analysis O +
, O +
arginase B-Gene +
II I-Gene +
was O +
stained O +
in O +
cornea O +
, O +
epithelium O +
of O +
iris O +
and O +
ciliary O +
process O +
, O +
inner O +
part O +
of O +
neural O +
retina O +
and O +
retinal O +
pigment O +
epithelium O +
. O +

Immunostaining O +
of O +
ornithine B-Gene +
aminotransferase I-Gene +
resembled O +
that O +
of O +
arginase B-Gene +
II I-Gene +
. O +

In O +
in O +
situ O +
hybridization O +
, O +
arginase B-Gene +
II I-Gene +
and O +
ornithine B-Gene +
aminotransferase I-Gene +
mRNAs O +
were O +
located O +
much O +
as O +
seen O +
with O +
the O +
enzyme O +
proteins O +
. O +

CONCLUSIONS O +
: O +

These O +
results O +
indicate O +
that O +
arginine O +
recycling O +
activity O +
from O +
citrulline O +
is O +
present O +
widely O +
in O +
ocular O +
tissues O +
, O +
whereas O +
expression O +
of O +
arginase B-Gene +
II I-Gene +
differs O +
among O +
the O +
tissues O +
. O +

We O +
suggest O +
that O +
NO O +
production O +
may O +
be O +
regulated O +
by O +
these O +
enzymes O +
in O +
the O +
cells O +
where O +
NO B-Gene +
synthase I-Gene +
is O +
colocalized O +
. O +

Colocalization O +
of O +
arginase B-Gene +
II I-Gene +
and O +
ornithine B-Gene +
aminotransferase I-Gene +
suggests O +
a O +
role O +
for O +
arginase B-Gene +
II I-Gene +
in O +
collagen B-Gene +
synthesis O +
in O +
the O +
eye O +
. O +

Bradykinin B-Gene +
B2 I-Gene +
- I-Gene +
receptor I-Gene +
antagonism O +
attenuates O +
fatal O +
cardiocirculatory O +
breakdown O +
induced O +
by O +
severe O +
experimental O +
pancreatitis O +
. O +

OBJECTIVES O +
: O +

To O +
investigate O +
the O +
impact O +
of O +
the O +
long O +
- O +
acting O +
bradykinin B-Gene +
B2 I-Gene +
receptor I-Gene +
antagonist O +
HOE O +
140 O +
( O +
Icatibant O +
) O +
on O +
survival O +
time O +
in O +
a O +
model O +
of O +
severe O +
porcine O +
pancreatitis O +
. O +

DESIGN O +
: O +

Randomized O +
, O +
controlled O +
intervention O +
trial O +
. O +

SUBJECTS O +
: O +

Thirty O +
domestic O +
pigs O +
of O +
either O +
gender O +
anesthetized O +
by O +
intravenous O +
application O +
of O +
piritramide O +
, O +
midazolam O +
, O +
and O +
pancuronium O +
and O +
mechanically O +
ventilated O +
. O +

INTERVENTIONS O +
: O +

Pancreatitis O +
was O +
induced O +
by O +
an O +
injection O +
of O +
sodium O +
taurocholate O +
( O +
5 O +
% O +
, O +
1 O +
mL O +
/ O +
kg O +
body O +
weight O +
[ O +
BW O +
] O +
) O +
and O +
enterokinase B-Gene +
( O +
10 O +
U O +
/ O +
kg O +
BW O +
) O +
. O +

Control O +
animals O +
( O +
group O +
1 O +
, O +
n O +
= O +
10 O +
) O +
underwent O +
the O +
spontaneous O +
course O +
of O +
the O +
disease O +
. O +

In O +
two O +
treatment O +
groups O +
, O +
Icatibant O +
was O +
administered O +
either O +
in O +
a O +
low O +
( O +
100 O +
nmol O +
/ O +
kg O +
BW O +
; O +
group O +
2 O +
, O +
n O +
= O +
10 O +
) O +
or O +
in O +
a O +
high O +
dosage O +
( O +
5000 O +
nmol O +
/ O +
kg O +
BW O +
; O +
group O +
3 O +
, O +
n O +
= O +
10 O +
) O +
. O +

MEASUREMENTS O +
AND O +
MAIN O +
RESULTS O +
: O +

Mean O +
survival O +
time O +
was O +
significantly O +
prolonged O +
by O +
Icatibant O +
( O +
controls O +
, O +
6.6 O +
hrs O +
; O +
group O +
2 O +
, O +
9.8 O +
hrs O +
; O +
p O +
= O +
.022 O +
; O +
group O +
3 O +
, O +
10.9 O +
hrs O +
; O +
p O +
= O +
.007 O +
) O +
. O +

Six O +
hours O +
postinduction O +
, O +
the O +
decline O +
of O +
total O +
peripheral O +
resistance O +
( O +
52 O +
% O +
of O +
baseline O +
) O +
and O +
cardiac O +
index O +
( O +
92 O +
% O +
of O +
baseline O +
) O +
in O +
controls O +
was O +
significantly O +
improved O +
by O +
Icatibant O +
, O +
both O +
in O +
the O +
low O +
( O +
16 O +
% O +
and O +
44 O +
% O +
; O +
p O +
< O +
.05 O +
) O +
and O +
high O +
( O +
6 O +
% O +
and O +
45 O +
% O +
; O +
p O +
< O +
.05 O +
) O +
dosage O +
. O +

The O +
concentrations O +
of O +
free O +
, O +
nonreceptor O +
- O +
bound O +
kinin B-Gene +
in O +
plasma O +
6 O +
hrs O +
postinduction O +
were O +
significantly O +
lower O +
in O +
controls O +
than O +
in O +
groups O +
2 O +
and O +
3 O +
animals O +
( O +
111 O +
+ O +
/ O +
- O +
50 O +
vs. O +
208 O +
+ O -
/- O +
40 O +
and O +
237 O +
+ O +
/ O +
- O +
52 O +
fmol O +
/ O +
mL O +
, O +
respectively O +
) O +
. O +

Six O +
hours O +
postinduction O +
, O +
the O +
pretreatment O +
with O +
Icatibant O +
was O +
associated O +
with O +
significantly O +
higher O +
plasma O +
concentrations O +
of O +
phospholipase B-Gene +
A2 I-Gene +
( O +
controls O +
, O +
+ O +
1194 O +
% O +
; O +
group O +
2 O +
, O +
+ O +
2000 O +
% O +
; O +
group O +
3 O +
, O +
+ O +
2285 O +
% O +
of O +
baseline O +
values O +
) O +
and O +
interleukin-1 B-Gene +
receptor I-Gene +
antagonist I-Gene +
( O +
controls O +
, O +
1900 O +
+ O +
/ O +
- O +
800 O +
; O +
group O +
2 O +
, O +
3100 O +
+ O +
/ O +
- O +
800 O +
; O +
group O +
3 O +
, O +
3600 O +
+ O +
/ O +
- O +
800 O +
pg O +
/ O +
mL O +
) O +
. O +

In O +
contrast O +
, O +
the O +
increase O +
of O +
urinary O +
trypsinogen B-Gene +
activation O +
peptides O +
indicating O +
local O +
pancreatic O +
damage O +
( O +
589 O +
+ O +
/ O +
- O +
114 O +
nmol O +
/ O +
L O +
in O +
controls O +
) O +
was O +
substantially O +
attenuated O +
by O +
pretreatment O +
with O +
Icatibant O +
( O +
group O +
2 O +
, O +
467 O +
+ O +
/ O +
- O +
102 O +
, O +
NS O +
; O +
352 O -
+ O +
/ O +
- O +
91 O +
nmol O +
/ O +
L O +
in O +
group O +
3 O +
; O +
p O +
= O +
.022 O +
vs. O +
controls O +
) O +
. O +

Systemic O +
inflammatory O +
reactions O +
, O +
however O +
, O +
as O +
quantified O +
by O +
C B-Gene +
- I-Gene +
reactive I-Gene +
protein I-Gene +
and O +
the O +
extracellularly O +
discharged O +
neutrophil O +
cytosolic O +
inhibitor O +
leukocyte O +
neutral B-Gene +
proteinase I-Gene +
inhibitor O +
were O +
not O +
influenced O +
by O +
the O +
bradykinin B-Gene +
B2 I-Gene +
- I-Gene +
receptor I-Gene +
antagonist O +
. O +

CONCLUSIONS O +
: O +

Pretreatment O +
with O +
the O +
bradykinin B-Gene +
B2 I-Gene +
receptor I-Gene +
antagonist O +
Icatibant O +
resulted O +
in O +
prolonged O +
survival O +
time O +
and O +
in O +
delayed O +
impairment O +
of O +
major O +
macrocirculatory O +
and O +
pulmonary O +
variables O +
. O +

Icatibant O +
resulted O +
in O +
elevated O +
concentrations O +
of O +
free O +
, O +
circulating O +
kinin B-Gene +
. O +

This O +
was O +
associated O +
with O +
increased O +
concentrations O +
of O +
phospholipase B-Gene +
A2 I-Gene +
and O +
interleukin-1 B-Gene +
receptor I-Gene +
antagonist I-Gene +
, O +
suggesting O +
that O +
circulating O +
kinins B-Gene +
strengthen O +
the O +
activation O +
of O +
some O +
mediator O +
cascades O +
, O +
the O +
association O +
of O +
which O +
with O +
the O +
kinin B-Gene +
metabolism O +
requires O +
further O +
experimental O +
clarification O +
. O +

Other O +
variables O +
indicating O +
a O +
systemic O +
inflammatory O +
response O +
( O +
C B-Gene +
- I-Gene +
reactive I-Gene +
protein I-Gene +
, O +
leukocyte O +
neutral B-Gene +
proteinase I-Gene +
inhibitor O +
) O +
remained O +
unaffected O +
by O +
Icatibant O +
. O +

Bradykinin B-Gene +
antagonism O +
distinctly O +
ameliorated O +
the O +
local O +
pancreatic O +
damage O +
, O +
indicated O +
by O +
increased O +
urinary O +
concentrations O +
of O +
trypsinogen B-Gene +
activation O +
peptides O +
. O +

It O +
is O +
concluded O +
that O +
the O +
kinin B-Gene +
metabolism O +
plays O +
an O +
important O +
role O +
in O +
the O +
pathophysiology O +
of O +
systemic O +
complications O +
after O +
severe O +
experimental O +
pancreatitis O +
. O +

Regulation O +
of O +
human O +
GH B-Gene +
receptor I-Gene +
gene O +
transcription O +
by O +
20 O +
and O +
22 O +
kDa O +
GH B-Gene +
in O +
a O +
human O +
hepatoma O +
cell O +
line O +
. O +

The O +
human O +
GH B-Gene +
gene O +
is O +
1.7 O +
kilobase O +
pairs O +
( O +
kb O +
) O +
in O +
length O +
and O +
is O +
composed O +
of O +
five O +
exons O +
and O +
four O +
introns O +
. O +

This O +
gene O +
is O +
expressed O +
in O +
the O +
pituitary O +
gland O +
and O +
encodes O +
a O +
22 O +
kDa O +
protein O +
. O +

In O +
addition O +
to O +
this O +
predominant O +
( O +
75 O +
% O +
) O +
form O +
, O +
5 O +
- O +
10 O +
% O +
of O +
pituitary O +
GH B-Gene +
is O +
present O +
as O +
a O +
20 O +
kDa O +
protein O +
that O +
has O +
an O +
amino O +
acid O +
( O +
aa O +
) O +
sequence O +
identical O +
to O +
the O +
22 O +
kDa O +
form O +
except O +
for O +
a O +
15 O +
aa O +
internal O +
deletion O +
of O +
residues O +
32 O -
- O -
46 O +
as O +
a O +
result O +
of O +
an O +
alternative O +
splicing O +
event O +
. O +

Because O +
it O +
has O +
been O +
reported O +
that O +
non O +
- O +
22 O +
- O +
kDa O +
GH B-Gene +
isoforms O +
might O +
be O +
partly O +
responsible O +
for O +
short O +
stature O +
and O +
growth O +
retardation O +
in O +
children O +
, O +
the O +
aim O +
of O +
this O +
study O +
was O +
to O +
compare O +
the O +
impact O +
of O +
both O +
22 O +
kDa O +
and O +
20 O +
kDa O +
GH B-Gene +
on O +
GH B-Gene +
receptor I-Gene +
gene O +
( O +
GH B-Gene +
receptor I-Gene +
/ O +
GH B-Gene +
binding I-Gene +
protein I-Gene +
( O +
GHR B-Gene +
/ O +
GHBP B-Gene +
) O +
) O +
expression O +
. O +

Various O +
concentrations O +
of O +
20 O +
kDa O +
and O +
22 O +
kDa O +
GH B-Gene +
( O +
0 O +
, O +
2 O +
, O +
5 O +
, O +
12.5 O +
, O +
25 O +
, O +
50 O +
and O +
150 O +
ng O +
/ O +
ml O +
) O +
were O +
added O +
to O +
human O +
hepatoma O +
( O +
HuH7 O +
) O +
cells O +
cultured O +
in O +
serum O +
- O +
free O +
hormonally O +
defined O +
medium O +
for O +
0 O +
, O +
1 O +
and O +
2 O +
h O +
. O +

Thereafter O +
GHR B-Gene +
/ O +
GHBP B-Gene +
mRNA O +
expression O +
was O +
measured O +
by O +
quantitative O +
PCR O +
. O +

Addition O +
of O +
either O +
20 O +
kDa O +
or O +
22 O +
kDa O +
GH B-Gene +
, O +
at O +
low O +
or O +
normal O +
physiological O +
concentrations O +
( O +
0 O +
, O +
2 O +
, O +
5 O +
, O +
12.5 O +
, O +
25 O +
or O +
50 O +
ng O +
/ O +
ml O +
) O +
induced O +
a O +
dose O +
- O +
dependent O +
increase O +
in O +
GHR B-Gene +
/ O +
GHBP B-Gene +
expression O +
. O +

However O +
, O +
a O +
supraphysiological O +
concentration O +
of O +
20 O +
kDa O +
GH B-Gene +
( O +
150 O +
ng O +
/ O +
ml O +
) O +
resulted O +
in O +
a O +
significantly O +
lower O +
( O +
P O +
< O +
0.05 O +
) O +
downregulation O +
of O +
GHR B-Gene +
/ O +
GHBP B-Gene +
gene O +
transcription O +
compared O +
with O +
the O +
downregulation O +
achieved O +
by O +
this O +
concentration O +
of O +
22 O +
kDa O +
GH B-Gene +
. O +

This O +
difference O +
might O +
be O +
explained O +
by O +
a O +
decreased O +
ability O +
to O +
form O +
a O +
1 O +
: O +
1 O +
complex O +
with O +
GHR B-Gene +
and/or O +
GHBP B-Gene +
, O +
which O +
normally O +
occurs O +
at O +
high O +
concentrations O +
of O +
GH B-Gene +
. O +

Nuclear O +
run O +
- O +
on O +
experiments O +
and O +
GHBP B-Gene +
determinations O +
confirmed O +
the O +
changes O +
in O +
GHR B-Gene +
/ O +
GHBP B-Gene +
mRNA O +
levels O +
. O +

In O +
conclusion O +
, O +
we O +
report O +
that O +
both O +
20 O +
kDa O +
and O +
22 O +
kDa O +
GH B-Gene +
, O +
in O +
low O +
and O +
normal O +
physiological O +
concentrations O +
, O +
have O +
the O +
same O +
effect O +
on O +
regulation O +
of O +
GHR B-Gene +
/ O +
GHBP B-Gene +
gene O +
transcription O +
in O +
a O +
human O +
hepatoma O +
cell O +
line O +
. O +

At O +
a O +
supraphysiological O +
concentration O +
of O +
150 O +
ng O +
/ O +
ml O +
, O +
however O +
, O +
20 O +
kDa O +
GH B-Gene +
has O +
a O +
less O +
self O +
- O +
inhibitory O +
effect O +
than O +
the O +
22 O +
kDa O +
form O +
. O +

Effective O +
fragment O +
potentials O +
and O +
the O +
enzyme O +
active O +
site O +
. O +

Optimization O +
of O +
the O +
binding O +
conformation O +
of O +
a O +
substrate O +
in O +
an O +
enzyme O +
active O +
site O +
using O +
ab O +
initio O +
quantum O +
chemistry O +
methods O +
are O +
intractable O +
since O +
the O +
active O +
site O +
comprises O +
several O +
hundred O +
atoms O +
. O +

However O +
, O +
the O +
active O +
site O +
can O +
be O +
decomposed O +
into O +
an O +
active O +
and O +
spectator O +
region O +
where O +
the O +
spectator O +
residues O +
are O +
represented O +
by O +
effective O +
fragment O +
potentials O +
and O +
reducing O +
the O +
number O +
of O +
all O +
- O +
electron O +
atoms O +
involved O +
in O +
the O +
chemistry O +
to O +
a O +
reasonable O +
level O +
. O +

The O +
effective O +
fragment O +
potentials O +
for O +
electrostatics O +
and O +
polarization O +
are O +
implemented O +
in O +
GAMESS O +
but O +
the O +
repulsive O +
and O +
charge O +
transfer O +
potentials O +
are O +
fit O +
to O +
interaction O +
energies O +
of O +
water O +
with O +
models O +
of O +
the O +
residues O +
. O +

These O +
repulsive O +
/ O +
charge O +
transfer O +
potentials O +
are O +
generated O +
for O +
the O +
protein O +
residues O +
and O +
the O +
EFP O +
are O +
then O +
used O +
to O +
optimize O +
binding O +
of O +
a O +
transition O +
state O +
analogue O +
to O +
chorismate B-Gene +
mutase I-Gene +
( O +
B. O +
subtilis O +
) O +
and O +
small O +
dianions O +
to O +
ribonuclease B-Gene +
A I-Gene +
. O +

For O +
chorismate B-Gene +
mutase I-Gene +
the O +
calculated O +
binding O +
conformation O +
compares O +
well O +
to O +
the O +
comparable O +
X O +
- O +
ray O +
structure O +
. O +

The O +
binding O +
of O +
the O +
inhibitor O +
to O +
the O +
glutamate O +
/ O +
glutamine O +
mutant O +
active O +
site O +
is O +
then O +
predicted O +
with O +
the O +
optimization O +
including O +
the O +
glutamine O +
residue O +
constrained O +
only O +
at O +
the O +
C O +
alpha O +
atom O +
. O +

The O +
binding O +
conformations O +
suggest O +
important O +
roles O +
for O +
tyr108 O +
and O +
arg63 O +
, O +
which O +
have O +
not O +
been O +
noted O +
earlier O +
. O +

The O +
electrostatic O +
stabilization O +
of O +
the O +
transition O +
state O +
by O +
the O +
active O +
site O +
charge O +
distribution O +
has O +
to O +
be O +
augmented O +
by O +
a O +
specific O +
electronic O +
activation O +
by O +
glu78 O +
. O +

In O +
ribonuclease B-Gene +
A I-Gene +
, O +
the O +
protons O +
are O +
found O +
to O +
move O +
to O +
provide O +
a O +
clustering O +
of O +
the O +
charges O +
to O +
bind O +
the O +
small O +
dianions O +
, O +
phosphate O +
, O +
thiophosphate O +
, O +
and O +
sulfate O +
. O +

Identification O +
and O +
localization O +
of O +
the O +
carboxysome O +
peptide O +
Csos3 B-Gene +
and O +
its O +
corresponding O +
gene O +
in O +
Thiobacillus O +
neapolitanus O +
. O +

Four O +
genes O +
encoding O +
carboxysome B-Gene +
shell I-Gene +
peptides I-Gene +
( O +
csoS1A B-Gene +
, O +
csoS1B B-Gene +
, O +
csoS1C B-Gene +
, O +
csoS2 B-Gene +
) O +
, O +
the O +
genes O +
encoding O +
the O +
large O +
and O +
small O +
subunits O +
of O +
RuBisCO B-Gene +
( O +
cbbL B-Gene +
, O +
cbbS B-Gene +
) O +
, O +
and O +
three O +
unidentified O +
ORFs O +
constitute O +
an O +
operon O +
in O +
Thiobacillus O +
neapolitanus O +
. O +

An O +
unidentified O +
ORF O +
1.54 O +
kb O +
in O +
size O +
is O +
predicted O +
from O +
sequence O +
analysis O +
to O +
encode O +
a O +
protein O +
with O +
a O +
molecular O +
mass O +
of O +
approximately O +
57 O +
kDa O +
. O +

When O +
this O +
ORF O +
was O +
expressed O +
in O +
Escherichia O +
coli O +
under O +
the O +
control O +
of O +
its O +
endogenous O +
ribosome O +
- O +
binding O +
site O +
, O +
no O +
peptide O +
product O +
was O +
observed O +
. O +

In O +
order O +
to O +
correlate O +
this O +
ORF O +
with O +
a O +
carboxysome O +
peptide O +
, O +
the O +
ORF O +
was O +
overexpressed O +
in O +
E. O +
coli O +
by O +
cloning O +
it O +
into O +
pProExHTb O +
, O +
a O +
prokaryotic O +
expression O +
vector O +
containing O +
an O +
E. O +
coli O +
ribosome O +
binding O +
site O +
. O +

When O +
antibodies O +
raised O +
against O +
the O +
recombinant O +
protein O +
were O +
used O +
to O +
probe O +
an O +
immunoblot O +
containing O +
carboxysome O +
peptides O +
, O +
a O +
60 O +
- O +
kDa O +
peptide O +
was O +
recognized O +
. O +

The O +
peptide O +
was O +
subsequently O +
named O +
CsoS3 B-Gene +
. O +

CsoS3 B-Gene +
is O +
a O +
minor O +
component O +
of O +
the O +
carboxysome O +
; O +
a O +
peptide O +
of O +
this O +
size O +
is O +
commonly O +
not O +
observed O +
or O +
is O +
very O +
faint O +
on O +
Coomassie O +
blue O +
- O +
stained O +
SDS O +
- O +
polyacrylamide O +
gels O +
of O +
purified O +
carboxysomes O +
. O +

Immunogold O +
labeling O +
established O +
CsoS3 B-Gene +
to O +
be O +
a O +
component O +
of O +
the O +
carboxysome O +
shell O +
. O +

The O +
zinc O +
- O +
responsive O +
regulator O +
Zur B-Gene +
and O +
its O +
control O +
of O +
the O +
znu B-Gene +
gene O +
cluster O +
encoding O +
the O +
ZnuABC B-Gene +
zinc O +
uptake O +
system O +
in O +
Escherichia O +
coli O +
. O +

The O +
synthesis O +
of O +
the O +
Escherichia O +
coli O +
zinc O +
transporter O +
, O +
encoded O +
by O +
the O +
znuACB B-Gene +
gene O +
cluster O +
, O +
is O +
regulated O +
in O +
response O +
to O +
the O +
intracellular O +
zinc O +
concentration O +
by O +
the O +
zur B-Gene +
gene O +
product O +
. O +

Inactivation O +
of O +
the O +
zur B-Gene +
gene O +
demonstrated O +
that O +
Zur B-Gene +
acts O +
as O +
a O +
repressor O +
when O +
binding O +
Zn O -
( O -
2 O -
+ O -
) O +
. O +

Eight O +
chromosomal O +
mutant O +
zur B-Gene +
alleles O +
were O +
sequenced O +
to O +
correlate O +
the O +
loss O +
of O +
Zur B-Gene +
function O +
with O +
individual O +
mutations O +
. O +

Wild O +
- O +
type O +
Zur B-Gene +
and O +
ZurDelta46 B-Gene +
- O +
91 O +
formed O +
homo O +
- O +
and O +
heterodimers O +
. O +

Dimerization O +
was O +
independent O +
of O +
metal O +
ions O +
since O +
it O +
also O +
occurred O +
in O +
the O +
presence O +
of O +
metal O +
chelators O +
. O +

Using O +
an O +
in O +
vivo O +
titration O +
assay O +
, O +
the O +
znu B-Gene +
operator O +
was O +
narrowed O +
down O +
to O +
a O +
31 O +
- O +
base O +
pair O +
region O +
overlapping O +
the O +
translational O +
start O +
site O +
of O +
znuA B-Gene +
. O +

This O +
location O +
was O +
confirmed O +
by O +
footprinting O +
assays O +
. O +

Zur B-Gene +
directly O +
binds O +
to O +
a O +
single O +
region O +
comprising O +
a O +
nearly O +
perfect O +
palindrome O +
. O +

Zinc O +
chelators O +
completely O +
inhibited O +
and O +
Zn O -
( O -
2 O -
+ O -
) O +
in O +
low O +
concentrations O +
enhanced O +
DNA O +
binding O +
of O +
Zur B-Gene +
. O +

No O +
evidence O +
for O +
autoregulation O +
of O +
Zur B-Gene +
was O +
found O +
. O +

Zur B-Gene +
binds O +
at O +
least O +
2 O +
zinc O +
ions O +
/ O +
dimer O +
specifically O +
. O +

Although O +
most O +
of O +
the O +
mutant O +
Zur B-Gene +
proteins O +
bound O +
to O +
the O +
znu B-Gene +
operator O +
in O +
vitro O +
, O +
no O +
protection O +
was O +
observed O +
in O +
in O +
vivo O +
footprinting O +
experiments O +
. O +

Analysis O +
of O +
the O +
mutant O +
Zur B-Gene +
proteins O +
suggested O +
an O +
amino O +
- O +
terminal O +
DNA O +
contact O +
domain O +
around O +
residue O +
65 O +
and O +
a O +
dimerization O +
and O +
Zn O -
( O -
2 O -
+ O -
) O +
- O +
binding O +
domain O +
toward O +
the O +
carboxyl O +
- O +
terminal O +
end O +
. O +

Modular O +
organization O +
and O +
identification O +
of O +
a O +
mononuclear O +
iron O +
- O +
binding O +
site O +
within O +
the O +
NifU B-Gene +
protein O +
. O +

The O +
NifS B-Gene +
and O +
NifU B-Gene +
nitrogen O +
fixation O +
- O +
specific O +
gene O +
products O +
are O +
required O +
for O +
the O +
full O +
activation O +
of O +
both O +
the O +
Fe B-Gene +
- I-Gene +
protein I-Gene +
and I-Gene +
MoFe I-Gene +
- I-Gene +
protein I-Gene +
of I-Gene +
nitrogenase I-Gene +
from O +
Azotobacter O +
vinelandii O +
. O +

Because O +
the O +
two O +
nitrogenase B-Gene +
component O +
proteins O +
both O +
require O +
the O +
assembly O +
of O +
[ O -
Fe O -
- O -
S O -
] O -
-containing O +
clusters O +
for O +
their O +
activation O +
, O +
it O +
has O +
been O +
suggested O +
that O +
NifS B-Gene +
and O +
NifU B-Gene +
could O +
have O +
complementary O +
functions O +
in O +
the O +
mobilization O +
of O +
sulfur O +
and O +
iron O +
necessary O +
for O +
nitrogenase B-Gene +
- O +
specific O +
[ O +
Fe O -
- O -
S O -
] O +
cluster O +
assembly O +
. O +

The O +
NifS B-Gene +
protein O +
has O +
been O +
shown O +
to O +
have O +
cysteine B-Gene +
desulfurase I-Gene +
activity O +
and O +
can O +
be O +
used O +
to O +
supply O +
sulfide O +
for O +
the O +
in O +
vitro O +
catalytic O +
formation O +
of O +
[ O +
Fe O -
- O -
S O -
] O +
clusters O +
. O +

The O +
NifU B-Gene +
protein O +
was O +
previously O +
purified O +
and O +
shown O +
to O +
be O +
a O +
homodimer O +
with O +
a O +
[ O -
2Fe-2S O -
] O +
cluster O +
in O +
each O +
subunit O +
. O +

In O +
the O +
present O +
work O +
, O +
primary O +
sequence O +
comparisons O +
, O +
amino O +
acid O +
substitution O +
experiments O +
, O +
and O +
optical O +
and O +
resonance O +
Raman O +
spectroscopic O +
characterization O +
of O +
recombinantly O +
produced O +
NifU B-Gene +
and O +
NifU B-Gene +
fragments O +
are O +
used O +
to O +
show O +
that O +
NifU B-Gene +
has O +
a O +
modular O +
structure O +
. O +

One O +
module O +
is O +
contained O +
in O +
approximately O +
the O +
N O +
- O +
terminal O +
third O +
of O +
NifU B-Gene +
and O +
is O +
shown O +
to O +
provide O +
a O +
labile O +
rubredoxin O +
- O +
like O +
ferric O +
- O +
binding O +
site O +
. O +

Cysteine O +
residues O +
Cys35 O +
, O +
Cys62 O +
, O +
and O +
Cys106 O +
are O +
necessary O +
for O +
binding O +
iron O +
in O +
the O +
rubredoxin O +
- O +
like O +
mode O +
and O +
visible O +
extinction O +
coefficients O +
indicate O +
that O +
up O +
to O +
one O +
ferric O +
ion O +
can O +
be O +
bound O +
per O +
NifU B-Gene +
monomer O +
. O +

The O +
second O +
module O +
is O +
contained O +
in O +
approximately O +
the O +
C O +
- O +
terminal O +
half O +
of O +
NifU B-Gene +
and O +
provides O +
the O +
[ O +
2Fe-2S O +
] O +
cluster O +
- O +
binding O +
site O +
. O +

Cysteine O +
residues O +
Cys137 O +
, O +
Cys139 O +
, O +
Cys172 O +
, O +
and O +
Cys175 O +
provide O +
ligands O +
to O +
the O +
[ O +
2Fe O +
- O +
2S O +
] O +
cluster O +
. O +

The O +
cysteines O +
involved O +
in O +
ligating O +
the O +
mononuclear O +
Fe O +
in O +
the O +
rubredoxin O +
- O +
like O +
site O +
and O +
those O +
that O +
provide O +
the O +
[ O +
2Fe-2S O +
] O +
cluster O +
ligands O +
are O +
all O +
required O +
for O +
the O +
full O +
physiological O +
function O +
of O +
NifU B-Gene +
. O +

The O +
only O +
two O +
other O +
cysteines O +
contained O +
within O +
NifU B-Gene +
, O +
Cys272 O +
and O +
Cys275 O +
, O +
are O +
not O +
necessary O +
for O +
iron O +
binding O +
at O +
either O +
site O +
, O +
nor O +
are O +
they O +
required O +
for O +
the O +
full O +
physiological O +
function O +
of O +
NifU B-Gene +
. O +

The O +
results O +
provide O +
the O +
basis O +
for O +
a O +
model O +
where O +
iron O +
bound O +
in O +
labile O +
rubredoxin O +
- O +
like O +
sites O +
within O +
NifU B-Gene +
is O +
used O +
for O +
[ O +
Fe O -
- O -
S O -
] O +
cluster O +
formation O +
. O +

The O +
[ O +
2Fe-2S O -
] O +
clusters O +
contained O +
within O +
NifU B-Gene +
are O +
proposed O +
to O +
have O +
a O +
redox O +
function O +
involving O +
the O +
release O +
of O +
Fe O +
from O +
bacterioferritin B-Gene +
and O +
/ O +
or O +
the O +
release O +
of O +
Fe O +
or O +
an O +
[ O +
Fe O +
- O +
S O +
] O +
cluster O +
precursor O +
from O +
the O +
rubredoxin O +
- O +
like O +
binding O +
site O +
. O +

ATPase B-Gene +
kinetic O +
characterization O +
and O +
single O +
molecule O +
behavior O +
of O +
mutant O +
human O +
kinesin B-Gene +
motors O +
defective O +
in O +
microtubule O +
- O +
based O +
motility O +
. O +

Conventional B-Gene +
kinesin I-Gene +
is O +
a O +
microtubule O +
- O +
based O +
motor B-Gene +
protein I-Gene +
that O +
is O +
an O +
important O +
model O +
system O +
for O +
understanding O +
mechanochemical O +
transduction O +
. O +

To O +
identify O +
regions O +
of O +
the O +
kinesin B-Gene +
protein O +
that O +
participate O +
in O +
microtubule O +
binding O +
and O +
force O +
production O +
, O +
Woehlke O +
et O +
al. O +
[ O +
( O +
1997 O +
) O +
Cell O +
90 O +
, O +
207 O -
- O -
216 O +
] O +
generated O +
35 O +
alanine O +
mutations O +
in O +
solvent O +
- O +
exposed O +
residues O +
. O +

Here O +
, O +
we O +
have O +
performed O +
presteady O +
- O +
state O +
kinetic O +
and O +
single O +
molecule O +
motility O +
analyses O +
on O +
three O +
of O +
these O +
mutants O +
[ O +
Y138A O +
, O +
loop O +
11 O +
triple O +
( O +
L248A O +
/ O +
D249A O +
/ O +
E250A O +
) O +
, O +
and O +
E311A O +
] O +
that O +
exhibited O +
a O +
similar O +
approximately O +
3 O +
- O +
fold O +
reduction O +
in O +
both O +
microtubule O +
gliding O +
velocity O +
and O +
microtubule O +
- O +
stimulated O +
ATPase B-Gene +
activity O +
. O +

All O +
mutants O +
showed O +
normal O +
second O +
- O +
order O +
ATP O +
binding O +
kinetics O +
, O +
indicating O +
correct O +
folding O +
of O +
the O +
active O +
site O +
. O +

The O +
Y138A O +
and O +
loop O +
11 O +
triple O +
mutants O +
were O +
defective O +
both O +
in O +
nucleotide O +
hydrolysis O +
and O +
in O +
microtubule O +
- O +
stimulated O +
ADP O +
release O +
rates O +
, O +
the O +
latter O +
suggesting O +
a O +
defect O +
in O +
allosteric O +
communication O +
between O +
the O +
microtubule O +
and O +
the O +
active O +
site O +
. O +

A O +
single O +
molecule O +
fluorescence O +
assay O +
further O +
revealed O +
that O +
the O +
loop O +
11 O +
mutant O +
is O +
defective O +
in O +
initiating O +
processive O +
motion O +
, O +
suggesting O +
that O +
this O +
loop O +
is O +
important O +
for O +
the O +
initial O +
contact O +
between O +
kinesin B-Gene +
and O +
the O +
microtubule O +
. O +

Y138A O +
, O +
on O +
the O +
other O +
hand O +
, O +
can O +
bind O +
to O +
the O +
microtubule O +
normally O +
but O +
can O -
not O +
move O +
processively O +
. O +

For O +
E311A O +
, O +
neither O +
the O +
rate O +
of O +
nucleotide O +
hydrolysis O +
nor O +
ADP O +
release O +
could O +
account O +
for O +
its O +
slower O +
ATPase B-Gene +
and O +
gliding O +
velocity O +
, O +
which O +
suggests O +
that O +
either O +
phosphate O +
release O +
or O +
a O +
conformational O +
transition O +
is O +
rate O +
- O +
limiting O +
in O +
this O +
mutant O +
. O +

The O +
single O +
molecule O +
assay O +
showed O +
that O +
E311A O +
has O +
a O +
reduced O +
velocity O +
of O +
movement O +
, O +
but O +
is O +
not O +
defective O +
in O +
processivity O +
. O +

Thus O +
, O +
while O +
these O +
mutants O +
behave O +
similarly O +
in O +
solution O +
ATPase B-Gene +
and O +
multiple O +
motor O +
gliding O +
assays O +
, O +
kinetic O +
and O +
single O +
molecule O +
analyses O +
reveal O +
defects O +
in O +
distinct O +
processes O +
in O +
kinesin B-Gene +
' O +
s O +
mechanochemical O +
cycle O +
. O +

Interactions O +
between O +
the O +
soluble O +
domain O +
I O +
of O +
nicotinamide B-Gene +
nucleotide I-Gene +
transhydrogenase I-Gene +
from O +
Rhodospirillum O +
rubrum O +
and O +
transhydrogenase B-Gene +
from O +
Escherichia O +
coli O +
. O +

Effects O +
on O +
catalytic O +
and O +
H O +
+ O +
- O +
pumping O +
activities O +
. O +

Nicotinamide B-Gene +
nucleotide I-Gene +
transhydrogenase I-Gene +
from O +
Escherichia O +
coli O +
is O +
composed O +
of O +
two O +
subunits O +
, O +
the O +
alpha O +
and O +
the O +
beta O +
subunits O +
, O +
each O +
of O +
which O +
contains O +
a O +
hydrophilic O +
domain O +
, O +
domain O +
I O +
and O +
III O +
, O +
respectively O +
, O +
as O +
well O +
as O +
several O +
transmembrane O +
helices O +
, O +
collectively O +
denoted O +
domain O +
II O +
. O +

The O +
interactions O +
between O +
domain O +
I O +
from O +
Rhodospirillum O +
rubrum O +
( O +
rrI O +
) O +
and O +
the O +
intact O +
or O +
the O +
protease B-Gene +
- O +
treated O +
enzyme O +
from O +
E. O +
coli O +
was O +
investigated O +
using O +
the O +
separately O +
expressed O +
and O +
purified O +
domain O +
I O +
from O +
R. O +
rubrum O +
, O +
and O +
His O +
- O +
tagged O +
intact O +
and O +
trypsin B-Gene +
- O +
treated O +
E. O +
coli O +
transhydrogenase B-Gene +
. O +

Despite O +
harsh O +
treatments O +
with O +
, O +
e.g. O +
detergents O +
and O +
denaturing O +
agents O +
, O +
the O +
alpha O +
and O +
beta O +
subunits O +
remained O +
tightly O +
associated O +
. O +

A O +
monoclonal O +
antibody O +
directed O +
towards O +
the O +
alpha O +
subunit O +
was O +
strongly O +
inhibitory O +
, O +
an O +
effect O +
that O +
was O +
relieved O +
by O +
added O +
rrI O +
. O +

In O +
addition O +
, O +
rrI O +
also O +
reactivated O +
the O +
trypsin B-Gene +
- O +
digested O +
E. O +
coli O +
enzyme O +
in O +
which O +
domain O +
I O +
had O +
been O +
partly O +
removed O +
. O +

This O +
suggests O +
that O +
the O +
hydrophilic O +
domains O +
I O +
and O +
III O +
are O +
not O +
in O +
permanent O +
contact O +
but O +
are O +
mobile O +
during O +
catalysis O +
while O +
being O +
anchored O +
to O +
domain O +
II O +
. O +

Replacement O +
of O +
domain O +
I O +
of O +
intact O +
, O +
as O +
well O +
as O +
trypsin B-Gene +
- O +
digested O +
, O +
E. O +
coli O +
transhydrogenase B-Gene +
with O +
rrI O +
resulted O +
in O +
a O +
markedly O +
different O +
pH O +
dependence O +
of O +
the O +
cyclic O +
reduction O +
of O +
3 O +
- O +
acetyl O +
- O +
pyridine O +
- O +
NAD O +
+ O +
by O +
NADH O +
in O +
the O +
presence O +
of O +
NADP O +
( O +
H O +
) O +
, O +
suggesting O +
that O +
the O +
protonation O +
of O +
one O +
or O +
more O +
protonable O +
groups O +
in O +
domain O +
I O +
is O +
controlling O +
this O +
reaction O +
. O +

The O +
reverse O +
reaction O +
and O +
proton O +
pumping O +
showed O +
a O +
less O +
pronounced O +
change O +
in O +
pH O +
dependence O +
, O +
demonstrating O +
the O +
regulatory O +
role O +
of O +
domain O +
II O +
in O +
these O +
reactions O +
. O +

Polymorphisms O +
in O +
the O +
CBS B-Gene +
gene O +
associated O +
with O +
decreased O +
risk O +
of O +
coronary O +
artery O +
disease O +
and O +
increased O +
responsiveness O +
to O +
total O +
homocysteine O +
lowering O +
by O +
folic O +
acid O +
. O +

Elevated O +
total O +
plasma O +
homocysteine O +
( O +
tHcy O +
) O +
is O +
an O +
established O +
risk O +
factor O +
for O +
the O +
development O +
of O +
vascular O +
disease O +
and O +
neural O +
tube O +
defects O +
. O +

Total O +
homocysteine O +
levels O +
can O +
be O +
lowered O +
by O +
folic O +
acid O +
supplements O +
but O +
individual O +
response O +
is O +
highly O +
variable O +
. O +

In O +
this O +
case O +
- O +
control O +
study O +
, O +
involving O +
142 O +
coronary O +
artery O +
disease O +
( O +
CAD O +
) O +
patients O +
and O +
102 O +
controls O +
, O +
we O +
have O +
typed O +
six O +
genetic O +
polymorphisms O +
in O +
three O +
homocysteine O +
metabolizing O +
genes O +
and O +
examined O +
their O +
relationship O +
to O +
the O +
incidence O +
of O +
CAD O +
, O +
tHcy O +
levels O +
, O +
and O +
lowering O +
of O +
tHcy O +
levels O +
in O +
response O +
to O +
folic O +
acid O +
supplementation O +
. O +

We O +
found O +
that O +
two O +
single O +
nucleotide O +
polymorphisms O +
in O +
the O +
cystathionine B-Gene +
beta I-Gene +
synthase I-Gene +
( O +
CBS B-Gene +
) O +
gene O +
, O +
699C O +
-- O -
> O +
T O +
and O +
1080 O -
T O +
-- O -
> O +
C O +
, O +
are O +
associated O +
with O +
decreased O +
risk O +
of O +
CAD O +
and O +
increased O +
responsiveness O +
to O +
the O +
tHcy O +
lowering O +
effects O +
of O +
folic O +
acid O +
. O +

Individuals O +
homozygous O +
for O +
699 O -
T O +
were O +
significantly O +
underrepresented O +
in O +
CAD O +
patients O +
as O +
compared O +
to O +
controls O +
( O +
4.9 O +
% O +
vs O +
17.3 O +
% O +
, O +
P O +
= O +
0.0015 O +
) O +
, O +
as O +
were O +
individuals O +
homozygous O +
for O +
the O +
1080C O +
( O +
29.6 O +
% O +
vs O +
44.2 O +
% O +
, O +
P O +
= O +
0.018 O +
) O +
. O +

Additionally O +
, O +
699 O -
T O +
and O +
1080C O +
homozygous O +
individuals O +
were O +
the O +
most O +
responsive O +
to O +
folate O +
supplementation O +
. O +

699 O -
T O +
homozygotes O +
lowered O +
tHcy O +
levels O +
13.6 O +
% O +
on O +
average O +
, O +
compared O +
to O +
4.8 O +
% O +
lowering O +
in O +
699C O +
homozygotes O +
( O +
P O +
= O +
0.009 O +
) O +
, O +
while O +
1080C O +
homozygotes O +
lowered O +
12.9 O +
% O +
compared O +
to O +
just O +
2.7 O +
% O +
for O +
1080 O -
T O +
homozygotes O +
( O +
P O +
= O +
0.005 O +
) O +
. O +

The O +
two O +
polymorphisms O +
in O +
CBS B-Gene +
are O +
third O +
codon O +
changes O +
and O +
would O +
not O +
be O +
predicted O +
to O +
affect O +
the O +
underlying O +
protein O +
. O +

However O +
, O +
there O +
is O +
strong O +
linkage O +
disequilibrium O +
between O +
these O +
two O +
positions O +
, O +
suggesting O +
that O +
they O +
may O +
also O +
be O +
linked O +
to O +
other O +
as O +
yet O +
unidentified O +
polymorphisms O +
within O +
the O +
CBS B-Gene +
gene O +
. O +

These O +
observations O +
suggest O +
that O +
specific O +
CBS B-Gene +
alleles O +
are O +
a O +
risk O +
factor O +
for O +
the O +
development O +
of O +
vascular O +
disease O +
and O +
that O +
genetic O +
information O +
could O +
be O +
predictive O +
of O +
individual O +
response O +
to O +
folic O +
acid O +
supplementation O +
. O +

Basal O +
metabolic O +
rate O +
in O +
anorexia O +
nervosa O +
: O +
relation O +
to O +
body O +
composition O +
and O +
leptin B-Gene +
concentrations O +
. O +

BACKGROUND O +
: O +

Leptin B-Gene +
is O +
thought O +
to O +
represent O +
a O +
peripheral O +
signal O +
involved O +
in O +
the O +
regulation O +
of O +
energy O +
balance O +
. O +

Its O +
action O +
has O +
been O +
studied O +
in O +
animals O +
and O +
obese O +
subjects O +
. O +

Little O +
is O +
known O +
about O +
leptin B-Gene +
's O +
role O +
during O +
negative O +
energy O +
balance O +
. O +

OBJECTIVE O +
: O +

The O +
objective O +
was O +
to O +
evaluate O +
the O +
relation O +
between O +
energy O +
turnover O +
, O +
body O +
composition O +
, O +
and O +
plasma O +
leptin B-Gene +
concentrations O +
in O +
anorexia O +
nervosa O +
( O +
AN O +
) O +
. O +

DESIGN O +
: O +

Sixteen O +
weight O +
- O +
stable O +
women O +
with O +
AN O +
were O +
compared O +
with O +
22 O +
control O +
subjects O +
and O +
14 O +
rehabilitated O +
AN O +
patients O +
( O +
R O -
- O -
AN O +
) O +
. O +

Basal O +
metabolic O +
rate O +
( O +
BMR O +
) O +
was O +
measured O +
by O +
indirect O +
calorimetry O +
; O +
fat O +
- O +
free O +
mass O +
( O +
FFM O +
) O +
and O +
fat O +
mass O +
( O +
FM O +
) O +
were O +
calculated O +
according O +
to O +
a O +
4 O +
- O +
compartment O +
model O +
. O +

Plasma O +
leptin B-Gene +
was O +
determined O +
by O +
radioimmunoassay O +
. O +

RESULTS O +
: O +

The O +
BMR O +
of O +
AN O +
patients O +
( O +
2.73 O +
+ O -
/- O +
0.37 O +
kJ O +
/ O +
min O +
) O +
was O +
significantly O +
lower O +
than O +
that O +
of O +
control O +
subjects O +
( O +
3.45 O +
+ O -
/- O +
0.34 O +
kJ O +
/ O +
min O +
) O +
( O +
P O +
< O +
0.001 O +
) O +
, O +
even O +
after O +
adjustment O +
for O +
FFM O +
( O +
2.92 O +
+ O -
/- O +
0.33 O +
kJ O +
/ O +
min O +
in O +
AN O +
patients O +
and O +
3.30 O +
+ O -
/- O +
0.26 O +
kJ O +
/ O +
min O +
in O +
control O +
subjects O +
; O +
P O +
< O +
0.004 O +
) O +
. O +

Plasma O +
leptin B-Gene +
concentrations O +
in O +
AN O +
patients O +
were O +
76 O +
% O +
lower O +
than O +
in O +
control O +
subjects O +
, O +
even O +
after O +
body O +
fat O +
was O +
controlled O +
for O +
. O +

In O +
R O -
- O -
AN O +
patients O +
, O +
BMR O +
was O +
not O +
significantly O +
different O +
from O +
that O +
of O +
control O +
subjects O +
and O +
leptin B-Gene +
concentrations O +
were O +
generally O +
close O +
to O +
normal O +
. O +

Plasma O +
leptin B-Gene +
concentrations O +
correlated O +
significantly O +
with O +
FM O +
( O +
r O -
( O -
2 O -
) O +
= O +
0.53 O +
, O +
P O +
< O +
0.0000 O +
) O +
and O +
BMR O +
, O +
even O +
after O +
adjustment O +
for O +
FFM O +
( O +
r O +
( O +
2 O +
) O +
= O +
0.21 O +
, O +
P O +
< O +
0.0003 O +
) O +
. O +

CONCLUSIONS O +
: O +

BMR O +
and O +
plasma O +
leptin B-Gene +
concentrations O +
are O +
depressed O +
in O +
patients O +
with O +
AN O +
; O +
this O +
is O +
not O +
explained O +
by O +
body O +
- O +
composition O +
changes O +
. O +

The O +
relation O +
between O +
leptin B-Gene +
and O +
BMR O +
suggests O +
that O +
leptin O +
plays O +
a O +
role O +
in O +
the O +
energy O +
sparing O +
response O +
to O +
exposure O +
to O +
chronic O +
energy O +
deficiency O +
. O +

The O +
return O +
of O +
BMR O +
to O +
normal O +
and O +
the O +
significant O +
increase O +
in O +
leptin B-Gene +
concentrations O +
in O +
R O -
- O -
AN O +
patients O +
suggests O +
a O +
full O +
reversibility O +
of O +
this O +
adaptation O +
mechanism O +
. O +

Lung O +
overexpression O +
of O +
the O +
vascular B-Gene +
endothelial I-Gene +
growth I-Gene +
factor I-Gene +
gene O +
induces O +
pulmonary O +
edema O +
. O +

We O +
hypothesized O +
that O +
the O +
angiogenic O +
mediator O +
, O +
vascular B-Gene +
endothelial I-Gene +
growth I-Gene +
factor I-Gene +
( O +
VEGF B-Gene +
) O +
, O +
known O +
to O +
be O +
expressed O +
in O +
the O +
lung O +
and O +
to O +
be O +
capable O +
of O +
inducing O +
local O +
edema O +
in O +
skin O +
, O +
might O +
evoke O +
the O +
development O +
of O +
lung O +
edema O +
if O +
expressed O +
in O +
excess O +
amounts O +
. O +

To O +
test O +
this O +
hypothesis O +
, O +
we O +
developed O +
an O +
in O +
vivo O +
model O +
of O +
VEGF B-Gene +
overexpression O +
in O +
the O +
lung O +
on O +
the O +
basis O +
of O +
delivery O +
to O +
the O +
respiratory O +
epithelium O +
of O +
the O +
VEGF165 B-Gene +
complementary O +
DNA O +
by O +
an O +
E1 O +
( O +
- O +
) O +
adenovirus O +
vector O +
( O +
AdVEGF165 B-Gene +
) O +
. O +

Administration O +
of O +
AdVEGF165 B-Gene +
by O +
the O +
intratracheal O +
route O +
( O +
10 O +
( O +
9 O +
) O +
plaque O +
- O +
forming O +
units O +
[ O +
pfu O +
] O +
) O +
to O +
C57Bl O +
/ O +
6 O +
mice O +
showed O +
increased O +
expression O +
of O +
VEGF B-Gene +
messenger O +
RNA O +
in O +
lung O +
tissue O +
by O +
Northern O +
analysis O +
. O +

Overexpression O +
of O +
VEGF B-Gene +
protein O +
in O +
the O +
lung O +
at O +
Days O +
1 O +
to O +
10 O +
was O +
confirmed O +
by O +
enzyme O +
- O +
linked O +
immunosorbent O +
assay O +
. O +

Intratracheal O +
administration O +
of O +
AdVEGF165 B-Gene +
resulted O +
in O +
a O +
dose O +
- O +
dependent O +
increase O +
in O +
lung O +
wet O +
/ O +
dry O +
weight O +
ratios O +
over O +
time O +
, O +
lung O +
histology O +
showed O +
widespread O +
intra O +
- O +
alveolar O +
edema O +
, O +
and O +
pulmonary O +
capillary O +
permeability O +
was O +
significantly O +
increased O +
as O +
quantified O +
by O +
the O +
Evans O +
blue O +
dye O +
assay O +
and O +
[ O -
( O -
131 O -
) O -
I O +
] O +
albumin B-Gene +
permeability O +
. O +

To O +
confirm O +
the O +
specificity O +
of O +
these O +
observations O +
, O +
mice O +
were O +
pretreated O +
with O +
intranasal O +
administration O +
of O +
an O +
adenovirus O +
vector O +
expressing O +
a O +
truncated O +
soluble O +
form O +
of O +
the O +
VEGF B-Gene +
receptor I-Gene +
flt-1 I-Gene +
( O +
Adsflt O +
) O +
. O +

Adsflt O +
( O +
10 O +
( O +
9 O +
) O +
pfu O +
) O +
pretreatment O +
completely O +
abrogated O +
the O +
increased O +
lung O +
wet O +
/ O +
dry O +
weight O +
ratio O +
caused O +
by O +
AdVEGF165 B-Gene +
administration O +
, O +
whereas O +
an O +
identical O +
adenovirus O +
vector O +
with O +
an O +
irrelevant O +
transgene O +
had O +
no O +
effect O +
upon O +
subsequent O +
AdVEGF165 B-Gene +
- O +
induced O +
pulmonary O +
edema O +
. O +

Together O +
, O +
these O +
data O +
suggest O +
that O +
overexpression O +
of O +
VEGF B-Gene +
in O +
the O +
lung O +
may O +
be O +
one O +
mechanism O +
of O +
increased O +
pulmonary O +
vascular O +
permeability O +
in O +
the O +
early O +
stages O +
of O +
acute O +
lung O +
injury O +
. O +

Development O +
of O +
a O +
polynucleotide O +
vaccine O +
from O +
melanoma B-Gene +
antigen I-Gene +
recognized I-Gene +
by I-Gene +
T I-Gene +
cells-1 I-Gene +
and O +
recombinant O +
protein O +
from O +
melanoma B-Gene +
antigen I-Gene +
recognized I-Gene +
by I-Gene +
T I-Gene +
cells-1 I-Gene +
for O +
melanoma O +
vaccine O +
clinical O +
trials O +
. O +

MART-1 B-Gene +
, O +
a O +
melanoma B-Gene +
antigen I-Gene +
recognized I-Gene +
by I-Gene +
T I-Gene +
cells I-Gene +
- I-Gene +
1 I-Gene +
, O +
is O +
a O +
melanocyte O +
lineage O +
- O +
differentiation O +
antigen O +
expressed O +
only O +
in O +
melanocytes O +
and O +
melanoma O +
cells O +
. O +

This O +
protein O +
is O +
recognized O +
by O +
many O +
T O -
- O -
lymphocyte O +
lines O +
that O +
are O +
human B-Gene +
leukocyte I-Gene +
antigen I-Gene +
( I-Gene +
HLA I-Gene +
) I-Gene +
- I-Gene +
A2 I-Gene +
restricted O +
and O +
melanoma O +
reactive O +
. O +

These O +
observations O +
have O +
culminated O +
in O +
an O +
array O +
of O +
clinical O +
trials O +
of O +
MART-1 B-Gene +
immunization O +
using O +
recombinant O +
viruses O +
or O +
MART-1 B-Gene +
immunodominant O +
peptides O +
. O +

Polynucleotide O +
immunization O +
is O +
a O +
promising O +
alternative O +
to O +
recombinant O +
viral O +
vaccines O +
that O +
allows O +
delivery O +
of O +
the O +
full O +
- O +
length O +
cDNA O +
encoding O +
all O +
potential O +
peptide O +
epitopes O +
in O +
a O +
vector O +
that O +
is O +
uncompromised O +
by O +
anti O +
- O +
viral O +
immunity O +
. O +

In O +
preparation O +
for O +
a O +
phase O +
I O +
clinical O +
trial O +
of O +
MART-1 B-Gene +
polynucleotide O +
immunization O +
in O +
patients O +
with O +
resected O +
melanoma O +
who O +
were O +
at O +
significant O +
risk O +
for O +
recurrence O +
, O +
the O +
authors O +
constructed O +
a O +
plasmid O +
DNA O +
encoding O +
the O +
MART-1 B-Gene +
cDNA O +
under O +
transcriptional O +
regulatory O +
control O +
of O +
the O +
cytomegalovirus O +
immediate O +
early O +
promoter O +
- O +
enhancer O +
and O +
partially O +
deleted O +
intron O +
A O +
. O +

This O +
plasmid O +
directs O +
high O +
- O +
level O +
MART-1 B-Gene +
expression O +
in O +
transduced O +
myoblasts O +
and O +
maturing O +
myocytes O +
diffusely O +
throughout O +
the O +
cytoplasm O +
. O +

Immunization O +
of O +
mice O +
with O +
this O +
construct O +
by O +
intramuscular O +
injection O +
elicited O +
MART-1 B-Gene +
- O +
specific O +
immune O +
responses O +
in O +
all O +
animals O +
. O +

Previous O +
trials O +
of O +
MART-1 B-Gene +
immunization O +
have O +
been O +
unable O +
to O +
examine O +
the O +
humoral O +
immune O +
response O +
to O +
MART-1 B-Gene +
because O +
of O +
a O +
lack O +
of O +
sufficient O +
, O +
highly O +
purified O +
protein O +
. O +

We O +
have O +
produced O +
and O +
purified O +
Escherichia O +
coli O +
recombinant O +
MART-1 B-Gene +
protein O +
using O +
a O +
glutathione B-Gene -
- I-Gene -
S I-Gene -
- I-Gene -
transferase I-Gene +
fusion O +
protein O +
expression O +
system O +
. O +

Protein O +
staining O +
of O +
a O +
sodium O +
dodecyl O +
sulfate O +
- O +
polyacrylamide O +
gel O +
electrophoresis O +
revealed O +
a O +
band O +
of O +
MART-1 B-Gene +
protein O +
at O +
approximately O +
20 O +
kD O +
; O +
and O +
Western O +
immunoblotting O +
with O +
an O +
anti O +
- O +
MART B-Gene +
- I-Gene +
1 I-Gene +
monoclonal O +
antibody O +
confirmed O +
a O +
doublet O +
at O +
approximately O +
20 O +
kD O +
. O +

These O +
findings O +
are O +
consistent O +
with O +
previous O +
reports O +
using O +
different O +
expression O +
systems O +
for O +
recombinant O +
MART-1 B-Gene +
. O +

This O +
protein O +
preparation O +
functioned O +
well O +
in O +
enzyme O +
- O +
linked O +
immunosorbent O +
assays O +
( O +
ELISAs O +
) O +
to O +
detect O +
anti O +
- O +
MART B-Gene +
- I-Gene +
1 I-Gene +
antibody O +
responses O +
in O +
a O +
mouse O +
model O +
; O +
and O +
a O +
panel O +
of O +
healthy O +
donor O +
human O +
sera O +
showed O +
minimal O +
binding O +
to O +
ELISA O +
plates O +
coated O +
with O +
the O +
protein O +
, O +
supporting O +
its O +
utility O +
in O +
monitoring O +
human O +
anti O +
- O +
MART B-Gene +
- I-Gene +
1 I-Gene +
antibody O +
responses O +
. O +

The O +
glutathione B-Gene -
- I-Gene -
S I-Gene -
- I-Gene -
transferase I-Gene +
fusion O +
method O +
yielded O +
approximately O +
200 O +
micrograms O +
MART-1 B-Gene +
per O +
2-L O +
bacterial O +
culture O +
, O +
enough O +
to O +
coat O +
100 O +
ELISA O +
plates O +
. O +

Molecular O +
mechanism O +
of O +
ultraviolet O +
- O +
induced O +
keratinocyte O +
apoptosis O +
. O +

This O +
article O +
reviews O +
advances O +
in O +
the O +
study O +
of O +
the O +
molecular O +
mechanisms O +
for O +
ultraviolet O +
( O +
UV O +
) O +
- O +
induced O +
keratinocyte O +
apoptosis O +
, O +
with O +
particular O +
reference O +
to O +
the O +
cytokines B-Gene +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
( O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
) O +
and O +
Fas B-Gene +
ligand I-Gene +
( O +
FasL B-Gene +
) O +
. O +

TNF B-Gene -
- I-Gene -
alpha I-Gene +
and O +
FasL B-Gene +
induce O +
their O +
respective O +
receptors O +
and O +
then O +
activate O +
caspase B-Gene +
enzymes O +
that O +
are O +
critically O +
involved O +
in O +
the O +
apoptotic O +
process O +
. O +

This O +
activation O +
is O +
further O +
amplified O +
by O +
intracellular O +
mitochondria O +
- O +
associated O +
mechanisms O +
. O +

Using O +
gene O +
- O +
targeted O +
knockout O +
mice O +
lacking O +
either O +
the O +
TNF B-Gene +
- I-Gene +
Rp55 I-Gene +
or O +
the O +
TNF B-Gene -
- I-Gene -
Rp75 I-Gene +
, O +
we O +
have O +
shown O +
that O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
plays O +
an O +
important O +
role O +
in O +
UV O +
- O +
induced O +
keratinocyte O +
apoptosis O +
via O +
TNF B-Gene -
- I-Gene -
Rp55 I-Gene +
. O +

TNF B-Gene +
- I-Gene +
Rp55 I-Gene +
shares O +
homology O +
with O +
Fas B-Gene +
and O +
contains O +
an O +
intracellular O +
death O +
domain O +
. O +

UV O +
seems O +
to O +
directly O +
stimulate O +
cross O +
- O +
linking O +
of O +
Fas B-Gene +
, O +
resulting O +
in O +
the O +
engagement O +
of O +
the O +
death O +
machinery O +
. O +

Fas B-Gene +
- I-Gene +
associated I-Gene +
death I-Gene +
domain I-Gene +
protein I-Gene +
( O +
FADD B-Gene +
) O +
acts O +
as O +
an O +
adapter B-Gene +
protein I-Gene +
in O +
both O +
the O +
TNF B-Gene +
- I-Gene +
Rp55 I-Gene +
and O +
Fas B-Gene +
death O +
- O +
inducing O +
cascades O +
and O +
is O +
responsible O +
for O +
downstream O +
signal O +
transduction O +
by O +
recruiting O +
caspases O +
. O +

Moreover O +
, O +
signaling O +
of O +
p53 B-Gene +
contributes O +
to O +
the O +
induction O +
of O +
apoptosis O +
by O +
regulating O +
Bcl-2 B-Gene +
family I-Gene +
expression O +
and O +
increasing O +
surface O +
Fas B-Gene +
expression O +
. O +

In O +
addition O +
to O +
induction O +
mechanisms O +
of O +
apoptosis O +
, O +
there O +
are O +
numerous O +
inhibitory O +
molecules O +
that O +
play O +
a O +
role O +
in O +
restricting O +
the O +
apoptotic O +
pathway O +
. O +

Thus O +
, O +
the O +
ultimate O +
determination O +
of O +
whether O +
or O +
not O +
a O +
cell O +
undergoes O +
apoptosis O +
after O +
UV O +
radiation O +
is O +
based O +
on O +
the O +
balance O +
between O +
agonist O +
and O +
antagonist O +
pathways O +
. O +

Inhibitory O +
effects O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
acyclovir O +
on O +
the O +
glioblastoma O +
cell O +
cycle O +
. O +

Glioblastoma O +
multiforme O +
is O +
one O +
of O +
the O +
most O +
aggressive O +
and O +
frequently O +
occurring O +
forms O +
of O +
brain O +
cancer O +
. O +

It O +
originates O +
from O +
astrocytes O +
and O +
is O +
characterized O +
by O +
a O +
loss O +
of O +
cell O +
cycle O +
control O +
frequently O +
involving O +
mutations O +
in O +
tumor O +
suppressor O +
genes O +
, O +
such O +
as O +
p53 B-Gene +
and O +
p16 B-Gene +
. O +

Nucleoside O +
analogs O +
, O +
such O +
as O +
acyclovir O +
( O +
ACV O +
) O +
, O +
are O +
currently O +
being O +
used O +
in O +
the O +
treatment O +
of O +
viral O +
diseases O +
, O +
such O +
as O +
those O +
caused O +
by O +
members O +
of O +
the O +
herpes O +
family O +
. O +

Further O +
, O +
ACV O +
in O +
combination O +
with O +
type B-Gene +
I I-Gene +
interferons I-Gene +
( O +
IFN B-Gene +
) O +
has O +
been O +
shown O +
to O +
be O +
more O +
effective O +
at O +
lower O +
doses O +
in O +
treatment O +
of O +
viral O +
diseases O +
. O +

We O +
show O +
here O +
that O +
ACV O +
at O +
high O +
concentrations O +
( O +
up O +
to O +
500 O +
microg O +
/ O +
ml O +
) O +
inhibited O +
growth O +
in O +
tissue O +
culture O +
of O +
the O +
human O +
glioblastoma O +
cell O +
lines O +
T98 O -
G O +
, O +
SNB-19 O +
, O +
and O +
U-373 O +
by O +
as O +
much O +
as O +
68.3 O +
% O +
while O +
inhibiting O +
normal O +
human O +
astrocytes O +
by O +
only O +
38.3 O +
% O +
. O +

Related O +
to O +
this O +
, O +
the O +
tumor O +
cells O +
were O +
more O +
than O +
sevenfold O +
more O +
efficient O +
in O +
phosphorylation O +
of O +
ACV O +
to O +
the O +
active O +
phosphate O +
form O +
than O +
normal O +
human O +
astrocytes O +
. O +

Analogous O +
to O +
treatment O +
of O +
virus O +
- O +
infected O +
cells O +
, O +
suboptimal O +
concentrations O +
of O +
ACV O +
were O +
as O +
effective O +
as O +
high O +
concentrations O +
when O +
used O +
in O +
conjunction O +
with O +
low O +
concentrations O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
in O +
inhibition O +
of O +
tumor O +
cell O +
growth O +
. O +

At O +
the O +
cellular O +
level O +
, O +
ACV O +
and O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
inhibited O +
the O +
cell O +
cycle O +
in O +
both O +
the O +
G1 O +
and O +
S O +
phases O +
. O +

The O +
cooperative O +
effect O +
of O +
ACV O +
and O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
against O +
the O +
glioblastomas O +
appears O +
to O +
be O +
due O +
to O +
direct O +
inhibition O +
of O +
DNA O +
synthesis O +
by O +
ACV O +
in O +
the O +
S O +
phase O +
of O +
the O +
cell O +
cycle O +
and O +
induction O +
by O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
of O +
the O +
tumor O +
suppressor O +
gene O +
p21wAF1 B-Gene +
/ O +
CIP1 B-Gene +
, O +
which O +
in O +
turn O +
acts O +
at O +
the O +
level O +
of O +
proliferating B-Gene +
cell I-Gene +
nuclear I-Gene +
antigen I-Gene +
( O +
PCNA B-Gene +
) O +
and O +
cyclin B-Gene +
E I-Gene +
/ O +
cyclin B-Gene +
- I-Gene +
dependent I-Gene +
kinase I-Gene +
2 I-Gene +
( O +
Cdk2 B-Gene +
) O +
binding O +
and O +
inhibition O +
of O +
function O +
. O +

These O +
studies O +
show O +
that O +
the O +
combination O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
ACV O +
at O +
suboptimal O +
concentrations O +
elicits O +
significant O +
antiproliferative O +
effects O +
on O +
the O +
glioblastoma O +
cell O +
lines O +
T98 O -
G O +
, O +
SNB-19 O +
, O +
and O +
U-373 O +
while O +
having O +
very O +
little O +
effect O +
on O +
normal O +
human O +
astrocyte O +
cell O +
proliferation O +
. O +

Stimulation O +
of O +
osteoclast O +
differentiation O +
in O +
vitro O +
by O +
mouse O +
oncostatin B-Gene +
M I-Gene +
, O +
leukaemia B-Gene +
inhibitory I-Gene +
factor I-Gene +
, O +
cardiotrophin-1 B-Gene +
and O +
interleukin B-Gene +
6 I-Gene +
: O +
synergy O +
with O +
dexamethasone O +
. O +

The O +
role O +
of O +
oncostatin B-Gene +
M I-Gene +
in O +
bone O +
metabolism O +
is O +
not O +
clearly O +
defined O +
, O +
and O +
the O +
actions O +
of O +
mouse O +
oncostatin B-Gene +
M I-Gene +
( O +
mOSM B-Gene +
) O +
on O +
osteoclast O +
development O +
has O +
not O +
been O +
previously O +
determined O +
. O +

We O +
therefore O +
examined O +
the O +
ability O +
of O +
recombinant O +
mOSM B-Gene +
to O +
stimulate O +
osteoclast O +
formation O +
and O +
activity O +
using O +
cocultures O +
of O +
murine O +
calvaria O +
and O +
bone O +
marrow O +
cells O +
, O +
and O +
compared O +
the O +
responses O +
to O +
other O +
members O +
of O +
the O +
interleukin B-Gene +
6 I-Gene +
family I-Gene +
of I-Gene +
cytokines I-Gene +
including O +
mouse O +
leukaemia B-Gene +
inhibitory I-Gene +
factor I-Gene +
( O +
LIF B-Gene +
) O +
, O +
cardiotrophin-1 B-Gene +
( O +
CT-1 B-Gene +
) O +
and O +
IL-6 B-Gene +
. O +

Mouse O +
OSM B-Gene +
, O +
LIF B-Gene +
and O +
CT-1 B-Gene +
strongly O +
induced O +
the O +
formation O +
of O +
tartrate B-Gene +
resistant I-Gene +
acid I-Gene +
phosphatase I-Gene +
positive O +
( O +
TRAP B-Gene +
( O +
+ O +
) O +
) O +
multinucleated O +
cells O +
( O +
MNC O +
) O +
in O +
a O +
dose O +
- O +
dependent O +
fashion O +
. O +

OSM B-Gene +
, O +
LIF B-Gene +
or O +
CT-1 B-Gene +
also O +
elevated O +
the O +
number O +
and O +
size O +
of O +
resorptive O +
pits O +
when O +
cocultures O +
were O +
added O +
to O +
smooth O +
cortical O +
bone O +
slices O +
, O +
indicating O +
enhancement O +
of O +
osteoclast O +
activity O +
. O +

The O +
activity O +
of O +
OSM B-Gene +
was O +
reduced O +
by O +
indomethacin O +
( O +
10 O -
( O -
-8 O -
) O +
- O +
10 O -
( O -
-6 O -
) O +
M O +
) O +
, O +
whereas O +
addition O +
of O +
dexamethasone O +
( O +
DEX O +
) O +
at O +
10 O -
( O -
-7 O -
) O -
-10 O -
( O -
-5 O -
) O +
M O +
synergistically O +
enhanced O +
OSM B-Gene +
- O +
induced O +
numbers O +
of O +
TRAP B-Gene +
( O +
+ O +
) O +
MNC O +
. O +

DEX O +
( O +
10 O -
( O -
-7 O -
) O +
M O +
) O +
costimulation O +
also O +
synergistically O +
enhanced O +
TRAP B-Gene +
( O +
+ O +
) O +
cell O +
numbers O +
of O +
LIF B-Gene +
, O +
and O +
CT-1 B-Gene +
treated O +
cocultures O +
. O +

IL-6 B-Gene +
had O +
no O +
activity O +
alone O +
, O +
but O +
further O +
enhanced O +
TRAP B-Gene +
( O +
+ O +
) O +
cell O +
formation O +
in O +
mOSM B-Gene +
or O +
DEX O +
( O +
10 O -
( O -
-7 O -
) O +
M O +
) O +
treated O +
cocultures O +
. O +

When O +
added O +
to O +
mouse O +
calvarial O +
osteoblast O +
cultures O +
, O +
mOSM B-Gene +
induced O +
secretion O +
of O +
IL-6 B-Gene +
protein O +
and O +
elevation O +
of O +
mRNA O +
whereas O +
LIF B-Gene +
or O +
CT-1 B-Gene +
did O +
not O +
. O +

IL-6 B-Gene +
mRNA O +
levels O +
and O +
protein O +
secretion O +
were O +
reduced O +
in O +
osteoblasts O +
by O +
costimulation O +
with O +
DEX O +
. O +

These O +
results O +
show O +
that O +
mouse O +
OSM B-Gene +
, O +
LIF B-Gene +
and O +
CT-1 B-Gene +
induce O +
osteoclast O +
differentiation O +
and O +
activation O +
, O +
that O +
DEX O +
synergizes O +
with O +
each O +
in O +
this O +
activity O +
, O +
and O +
that O +
mouse O +
OSM B-Gene +
induces O +
responses O +
in O +
osteoblasts O +
that O +
are O +
not O +
shown O +
by O +
LIF B-Gene +
or O +
CT-1 B-Gene +
. O +

Collectively O +
these O +
data O +
suggest O +
an O +
important O +
role O +
of O +
these O +
cytokines B-Gene +
in O +
osteoporosis O +
caused O +
by O +
high O +
levels O +
of O +
corticosteroid O +
. O +

The O +
effect O +
of O +
interleukin-6 B-Gene +
( O +
IL-6 B-Gene +
) O +
/ O +
gp130 B-Gene +
signalling O +
on O +
biliary O +
epithelial O +
cell O +
growth O +
, O +
in O +
vitro O +
. O +

The O +
effect O +
of O +
IL-6 B-Gene +
on O +
the O +
growth O +
of O +
mouse O +
biliary O +
epithelial O +
cells O +
( O +
BEC O +
) O +
, O +
in O +
vitro O +
, O +
was O +
tested O +
by O +
comparing O +
BEC O +
obtained O +
IL-6 B-Gene +
- O +
deficient O +
mice O +
( O +
IL-6 B-Gene +
( O +
- O -
/ O -
- O +
) O +
) O +
to O +
wild O +
- O +
type O +
littermate O +
controls O +
( O +
IL-6 B-Gene +
( O +
+ O -
/+ O +
) O +
) O +
, O +
in O +
two O +
different O +
media O +
: O +
simple O +
serum O +
- O +
free O +
media O +
( O +
S O -
- O -
SFM O +
) O +
, O +
and O +
complete O +
serum O +
- O +
free O +
media O +
( O +
C O -
- O -
SFM O +
) O +
containing O +
forskolin O +
, O +
which O +
stimulates O +
BEC O +
IL-6 B-Gene +
production O +
. O +

In O +
S O -
- O -
SFM O +
, O +
neither O +
IL-6 B-Gene +
( O +
+ O -
/+ O +
) O +
nor O +
IL-6 B-Gene +
( O -
- O -
/ O -
- O -
) O -
BEC O +
constitutively O +
produced O +
IL-6 B-Gene +
mRNA O +
or O +
protein O +
, O +
and O +
there O +
was O +
no O +
difference O +
between O +
IL-6 B-Gene +
( O +
+ O -
/+ O +
) O +
and O +
IL-6 B-Gene +
( O -
- O -
/ O -
- O +
) O +
BEC O +
growth O +
. O +

In O +
contrast O +
, O +
when O +
the O +
BEC O +
were O +
maintained O +
in O +
C O -
- O -
SFM O +
, O +
over O +
48 O +
h O +
, O +
the O +
growth O +
of O +
IL-6 B-Gene +
( O -
+ O -
/+ O +
) O +
BEC O +
was O +
40 O +
% O +
greater O +
than O +
IL-6 B-Gene +
( O -
- O -
/ O -
- O -
) O -
BEC O +
( O +
P O +
< O +
0.006 O +
) O +
. O +

Enhanced O +
IL-6 B-Gene +
( O -
+ O -
/+ O +
) O +
BEC O +
growth O +
in O +
C O -
- O -
SFM O +
was O +
associated O +
with O +
induced O +
expression O +
of O +
IL-6 B-Gene +
mRNA O +
and O +
IL-6 B-Gene +
protein O +
secretion O +
into O +
the O +
medium O +
, O +
upregulation O +
of O +
the O +
IL-6Ralpha B-Gene +
( O +
gp80 B-Gene +
) O +
and O +
phosphorylation O +
of O +
the O +
signal O +
transducing O +
molecule O +
gp130 B-Gene +
. O +

In O +
C O -
- O -
SFM O +
, O +
anti O +
- O +
IL-6 B-Gene +
neutralizing O +
antibodies O +
blocked O +
enhanced O +
IL-6 B-Gene +
( O -
+ O -
/+ O +
) O +
BEC O +
growth O +
, O +
whereas O +
exogenous O +
rhIL-6 B-Gene +
stimulated O +
retarded O +
growth O +
of O +
IL-6 B-Gene +
( O -
- O -
/ O -
- O -
) O -
BEC O +
. O +

Thus O +
, O +
under O +
conditions O +
that O +
mimic O +
an O +
inflammatory O +
or O +
stressful O +
microenvironment O +
in O +
vivo O +
, O +
BEC O +
produce O +
, O +
secrete O +
and O +
respond O +
to O +
IL-6 B-Gene +
, O +
via O +
upregulation O +
and O +
activation O +
of O +
the O +
IL-6Ralpha B-Gene +
( O +
gp80 B-Gene +
) O +
/ O +
gp130 B-Gene +
signaling O +
system O +
in O +
an O +
autocrine O +
/ O +
paracrine O +
manner O +
. O +

Characterization O +
of O +
the O +
zinc O +
binding O +
activity O +
of O +
the O +
rubella O +
virus O +
nonstructural B-Gene +
protease I-Gene +
. O +

The O +
rubella O +
virus O +
( O +
RUB O +
) O +
nonstructural B-Gene +
( I-Gene +
NS I-Gene +
) I-Gene +
protein I-Gene +
( O +
NSP B-Gene +
) O +
ORF O +
encodes O +
a O +
protease B-Gene +
that O +
cleaves O +
the O +
NSP B-Gene +
precursor O +
( O +
240 O +
kDa O +
) O +
at O +
a O +
single O +
site O +
to O +
produce O +
two O +
products O +
. O +

A O +
cleavage O +
site O +
mutation O +
was O +
introduced O +
into O +
a O +
RUB O +
infectious O +
cDNA O +
clone O +
and O +
found O +
to O +
be O +
lethal O +
, O +
demonstrating O +
that O +
cleavage O +
of O +
the O +
NSP B-Gene +
precursor O +
is O +
necessary O +
for O +
RUB O +
replication O +
. O +

Based O +
on O +
computer O +
alignments O +
, O +
the O +
RUB O +
NS B-Gene +
protease I-Gene +
was O +
predicted O +
to O +
be O +
a O +
papain B-Gene +
- O +
like O +
cysteine B-Gene +
protease I-Gene +
( O +
PCP O +
) O +
with O +
the O +
residues O +
Cys1152 O +
and O +
His1273 O +
as O +
the O +
catalytic O +
dyad O +
; O +
however O +
, O +
the O +
RUB O +
NS B-Gene +
protease I-Gene +
was O +
recently O +
found O +
to O +
require O +
divalent O +
cations O +
such O +
as O +
Zn O +
, O +
Co O +
, O +
and O +
Cd O +
for O +
activity O +
( O +
X. O +
Liu O +
, O +
S. O +
L. O +
Ropp O +
, O +
R. O +
J. O +
Jackson O +
, O +
and O +
T. O +
K. O +
Frey O +
, O +
J. O +
Virol O -
. O +
72 O +
: O +
4463 O +
- O +
4466 O +
, O +
1998 O +
) O +
. O +

To O +
analyze O +
the O +
function O +
of O +
metal O +
cation O +
binding O +
in O +
protease B-Gene +
activity O +
, O +
Zn O +
binding O +
studies O +
were O +
performed O +
using O +
the O +
minimal O +
NS B-Gene +
protease I-Gene +
domain O +
within O +
the O +
NSP B-Gene +
ORF O +
. O +

When O +
expressed O +
as O +
a O +
maltose B-Gene +
binding I-Gene +
protein I-Gene +
( O +
MBP B-Gene +
) O +
fusion O +
protein O +
by O +
bacteria O +
, O +
the O +
NS B-Gene +
protease I-Gene +
exhibited O +
activity O +
both O +
in O +
the O +
bacteria O +
and O +
in O +
vitro O +
following O +
purification O +
when O +
denatured O +
and O +
refolded O +
in O +
the O +
presence O +
of O +
Zn O +
. O +

Atomic O +
absorption O +
analysis O +
detected O +
1.6 O +
mol O +
of O +
Zn O +
bound O +
per O +
mol O +
of O +
protein O +
refolded O +
in O +
this O +
manner O +
. O +

Expression O +
of O +
individual O +
domains O +
within O +
the O +
protease B-Gene +
as O +
MBP B-Gene +
fusions O +
and O +
analysis O +
by O +
a O +
Zn O -
( O -
65 O -
) O +
binding O +
assay O +
revealed O +
two O +
Zn O +
binding O +
domains O +
: O +
one O +
located O +
at O +
a O +
predicted O +
metal O +
binding O +
motif O +
beginning O +
at O +
Cys1175 O +
and O +
the O +
other O +
one O +
close O +
to O +
the O +
cleavage O +
site O +
. O +

Mutagenesis O +
studies O +
showed O +
that O +
Cys1175 O +
and O +
Cys1178 O +
in O +
the O +
first O +
domain O +
and O +
Cys1227 O +
and O +
His1273 O +
, O +
the O +
His O +
in O +
the O +
predicted O +
catalytic O +
site O +
, O +
in O +
the O +
second O +
domain O +
are O +
essential O +
for O +
zinc O +
binding O +
. O +

All O +
of O +
these O +
residues O +
are O +
also O +
necessary O +
for O +
the O +
protease B-Gene +
activity O +
, O +
as O +
were O +
several O +
other O +
Cys O +
residues O +
not O +
involved O +
in O +
Zn O +
binding O +
. O +

Far O -
- O -
UV O +
circular O +
dichroism O +
( O +
CD O +
) O +
analysis O +
of O +
the O +
MBP B-Gene +
- O +
NS B-Gene +
protease I-Gene +
fusion O +
protein O +
showed O +
that O +
the O +
protease B-Gene +
domain O +
contained O +
a O +
large O +
amount O +
of O +
alpha O +
- O +
helical O +
structure O +
, O +
which O +
is O +
consistent O +
with O +
the O +
results O +
of O +
secondary O +
- O +
structural O +
prediction O +
. O +

Both O +
far O -
- O -
UV O -
- O -
CD O +
and O +
fluorescence O +
studies O +
suggested O +
that O +
Zn O +
did O +
not O +
exert O +
a O +
major O +
effect O +
on O +
the O +
overall O +
structure O +
of O +
the O +
fusion O +
protein O +
. O +

Finally O +
, O +
protease B-Gene +
inhibitor O +
assays O +
found O +
that O +
the O +
protease B-Gene +
activity O +
can O +
be O +
blocked O +
by O +
both O +
metal O +
ion O +
chelators O +
and O +
the O +
metalloprotease B-Gene +
inhibitor O +
captopril O +
. O +

In O +
conjunction O +
with O +
the O +
finding O +
that O +
the O +
previously O +
predicted O +
catalytic O +
site O +
, O +
His1273 O +
, O +
is O +
essential O +
for O +
zinc O +
binding O +
, O +
this O +
suggests O +
that O +
the O +
RUB O +
NS B-Gene +
protease I-Gene +
is O +
actually O +
a O +
novel O +
virus O +
metalloprotease B-Gene +
rather O +
than O +
a O +
PCP O +
. O +

Amino O +
- O +
and O +
carboxy O +
- O +
terminal O +
PEST O +
domains O +
mediate O +
gastrin B-Gene +
stabilization O +
of O +
rat O +
L B-Gene -
- I-Gene -
histidine I-Gene +
decarboxylase I-Gene +
isoforms O +
. O +

Control O +
of O +
enzymatic O +
function O +
by O +
peptide O +
hormones O +
can O +
occur O +
at O +
a O +
number O +
of O +
different O +
levels O +
and O +
can O +
involve O +
diverse O +
pathways O +
that O +
regulate O +
cleavage O +
, O +
intracellular O +
trafficking O +
, O +
and O +
protein O +
degradation O +
. O +

Gastrin B-Gene +
is O +
a O +
peptide B-Gene +
hormone I-Gene +
that O +
binds O +
to O +
the O +
cholecystokinin B-Gene +
B I-Gene -
- I-Gene -
gastrin I-Gene +
receptor I-Gene +
and O +
regulates O +
the O +
activity O +
of O +
L B-Gene -
- I-Gene -
histidine I-Gene +
decarboxylase I-Gene +
( O +
HDC B-Gene +
) O +
, O +
the O +
enzyme O +
that O +
produces O +
histamine O +
. O +

Here O +
we O +
show O +
that O +
gastrin B-Gene +
can O +
increase O +
the O +
steady O +
- O +
state O +
levels O +
of O +
at O +
least O +
six O +
HDC B-Gene +
isoforms O +
without O +
affecting O +
HDC B-Gene +
mRNA O +
levels O +
. O +

Pulse O +
- O +
chase O +
experiments O +
indicated O +
that O +
HDC B-Gene +
isoforms O +
are O +
rapidly O +
degraded O +
and O +
that O +
gastrin B-Gene +
- O +
dependent O +
increases O +
are O +
due O +
to O +
enhanced O +
isoform O +
stability O +
. O +

Deletion O +
analysis O +
identified O +
two O +
PEST O +
domains O +
( O +
PEST1 O +
and O +
PEST2 O +
) O +
and O +
an O +
intracellular O +
targeting O +
domain O +
( O +
ER2 O +
) O +
which O +
regulate O +
HDC B-Gene +
protein O +
expression O +
levels O +
. O +

Experiments O +
with O +
PEST O +
domain O +
fusion O +
proteins O +
demonstrated O +
that O +
PEST1 O +
and O +
PEST2 O +
are O +
strong O +
and O +
portable O +
degradation O +
- O +
promoting O +
elements O +
which O +
are O +
positively O +
regulated O +
by O +
both O +
gastrin B-Gene +
stimulation O +
and O +
proteasome O +
inhibition O +
. O +

A O +
chimeric O +
protein O +
containing O +
the O +
PEST O +
domain O +
of O +
ornithine B-Gene +
decarboxylase I-Gene +
was O +
similarly O +
affected O +
, O +
indicating O +
that O +
gastrin B-Gene +
can O +
regulate O +
the O +
stability O +
of O +
other O +
PEST O +
domain O +
- O +
containing O +
proteins O +
and O +
does O +
so O +
independently O +
of O +
antizyme B-Gene +
/ O +
antizyme B-Gene +
inhibitor I-Gene +
regulation O +
. O +

At O +
the O +
same O +
time O +
, O +
endoplasmic O +
reticulum O +
localization O +
of O +
a O +
fluorescent O +
chimera O +
containing O +
the O +
ER2 O +
domain O +
of O +
HDC B-Gene +
was O +
unaltered O +
by O +
gastrin B-Gene +
stimulation O +
. O +

We O +
conclude O +
that O +
gastrin B-Gene +
stabilization O +
of O +
HDC B-Gene +
isoforms O +
is O +
dependent O +
upon O +
two O +
transferable O +
and O +
sequentially O +
unrelated O +
PEST O +
domains O +
that O +
regulate O +
degradation O +
. O +

These O +
experiments O +
revealed O +
a O +
novel O +
regulatory O +
mechanism O +
by O +
which O +
a O +
peptide O +
hormone O +
such O +
as O +
gastrin B-Gene +
can O +
disrupt O +
the O +
degradation O +
function O +
of O +
multiple O +
PEST O +
- O +
domain O +
- O +
containing O +
proteins O +
. O +

Snail B-Gene +
is O +
an O +
immediate O +
early O +
target O +
gene O +
of O +
parathyroid B-Gene +
hormone I-Gene +
related I-Gene +
peptide I-Gene +
signaling O +
in O +
parietal O +
endoderm O +
formation O +
. O +

In O +
mouse O +
development O +
, O +
parietal O +
endoderm O +
( O +
PE O +
) O +
is O +
formed O +
from O +
both O +
primitive O +
endoderm O +
( O +
PrE O +
) O +
and O +
visceral O +
endoderm O +
( O +
VE O +
) O +
. O +

This O +
process O +
can O +
be O +
mimicked O +
in O +
vitro O +
by O +
using O +
F9 O +
embryonal O +
carcinoma O +
cells O +
( O +
EC O +
) O +
cells O +
, O +
differentiated O +
to O +
PrE O +
or O +
VE O +
cells O +
, O +
and O +
treating O +
these O +
with O +
Parathyroid B-Gene +
Hormone I-Gene +
related I-Gene +
Peptide I-Gene +
( O +
PTHrP B-Gene +
) O +
. O +

By O +
means O +
of O +
differential O +
display O +
RT O +
- O +
PCR O +
, O +
we O +
identified O +
Snail B-Gene +
( O +
Sna B-Gene +
) O +
as O +
a O +
gene O +
upregulated O +
during O +
the O +
differentiation O +
from O +
F9 O +
PrE O +
to O +
PE O +
. O +

We O +
show O +
that O +
Sna B-Gene +
is O +
an O +
immediate O +
early O +
target O +
gene O +
of O +
PTHrP B-Gene +
action O +
in O +
the O +
formation O +
of O +
F9 O +
PE O +
cells O +
. O +

Using O +
RT O +
- O +
PCR O +
, O +
we O +
detected O +
Sna B-Gene +
transcripts O +
in O +
pre O +
- O +
implantation O +
mouse O +
embryos O +
from O +
the O +
zygote O +
- O +
stage O +
onwards O +
. O +

Sna B-Gene +
was O +
strongly O +
upregulated O +
in O +
parallel O +
with O +
type B-Gene +
1 I-Gene +
PTH I-Gene +
/ I-Gene +
PTHrP I-Gene +
Receptor I-Gene +
( O +
PTH B-Gene -
( I-Gene -
rP I-Gene -
) I-Gene -
-R1 I-Gene +
) O +
mRNA O +
in O +
mouse O +
blastocysts O +
plated O +
in O +
culture O +
, O +
concomitant O +
with O +
detection O +
of O +
the O +
PE O +
- O +
marker O +
Follistatin B-Gene +
and O +
appearance O +
of O +
PE O +
cells O +
. O +

By O +
radioactive O +
in O +
situ O +
hybridization O +
on O +
sections O +
of O +
mouse O +
embryos O +
, O +
we O +
found O +
Sna B-Gene +
expression O +
in O +
the O +
earliest O +
PE O +
cells O +
at O +
E5.5 O +
. O +

Sna O +
remained O +
expressed O +
until O +
at O +
least O +
E7.5 O +
. O +

At O +
this O +
stage O +
, O +
we O +
also O +
observed O +
clear O +
expression O +
in O +
endoderm O +
cells O +
delaminating O +
from O +
the O +
epithelial O +
sheet O +
of O +
VE O +
cells O +
in O +
the O +
marginal O +
zone O +
. O +

We O +
conclude O +
that O +
PTH B-Gene -
( I-Gene -
rP I-Gene -
) I-Gene +
- I-Gene +
R1 I-Gene +
and O +
Sna B-Gene +
are O +
expressed O +
in O +
endodermal O +
cells O +
that O +
change O +
from O +
an O +
epithelial O +
to O +
a O +
mesenchymal O +
phenotype O +
. O +

Since O +
Sna B-Gene +
expression O +
has O +
been O +
described O +
at O +
other O +
sites O +
where O +
epithelio O +
- O +
mesenchymal O +
transitions O +
( O +
EMT O +
) O +
occur O +
, O +
such O +
as O +
the O +
primitive O +
streak O +
at O +
gastrulation O +
and O +
in O +
pre O +
- O +
migratory O +
neural O +
crest O +
cells O +
, O +
we O +
hypothesize O +
that O +
Sna O +
is O +
instrumental O +
in O +
the O +
action O +
of O +
PTHrP B-Gene +
inducing O +
PE O +
formation O +
, O +
which O +
we O +
propose O +
to O +
be O +
the O +
first O +
EMT O +
in O +
mouse O +
development O +
. O +

Identification O +
and O +
functional O +
characterization O +
of O +
human O +
soluble B-Gene +
epoxide I-Gene +
hydrolase I-Gene +
genetic O +
polymorphisms O +
. O +

Human O +
soluble B-Gene +
epoxide I-Gene +
hydrolase I-Gene +
( O +
sEH B-Gene +
) O +
, O +
an O +
enzyme O +
directing O +
the O +
functional O +
disposition O +
of O +
a O +
variety O +
of O +
endogenous O +
and O +
xenobiotic O +
- O +
derived O +
chemical O +
epoxides O +
, O +
was O +
characterized O +
at O +
the O +
genomic O +
level O +
for O +
interindividual O +
variation O +
capable O +
of O +
impacting O +
function O +
. O +

RNA O +
was O +
isolated O +
from O +
25 O +
human O +
liver O +
samples O +
and O +
used O +
to O +
generate O +
full O +
- O +
length O +
copies O +
of O +
soluble B-Gene +
epoxide I-Gene +
hydrolase I-Gene +
cDNA O +
. O +

The O +
resulting O +
cDNAs O +
were O +
polymerase O +
chain O +
reaction O +
amplified O +
, O +
sequenced O +
, O +
and O +
eight O +
variant O +
loci O +
were O +
identified O +
. O +

The O +
coding O +
region O +
contained O +
five O +
silent O +
single O +
nucleotide O +
polymorphisms O +
( O +
SNPs O +
) O +
and O +
two O +
variant O +
loci O +
resulting O +
in O +
altered O +
protein O +
sequence O +
. O +

An O +
amino O +
acid O +
substitution O +
was O +
identified O +
at O +
residue O +
287 O +
in O +
exon O +
8 O +
, O +
where O +
the O +
more O +
common O +
arginine O +
was O +
replaced O +
by O +
glutamine O +
. O +

A O +
second O +
variant O +
locus O +
was O +
identified O +
in O +
exon O +
13 O +
where O +
an O +
arginine O +
residue O +
was O +
inserted O +
following O +
serine O +
402 O +
resulting O +
in O +
the O +
sequence O +
, O +
arginine O +
403 O +
- O +
404 O +
, O +
instead O +
of O +
the O +
more O +
common O +
, O +
arginine O +
403 O +
. O +

This O +
amino O +
acid O +
insertion O +
was O +
confirmed O +
by O +
analyzing O +
genomic O +
DNA O +
from O +
individuals O +
harboring O +
the O +
polymorphic O +
allele O +
. O +

Slot O +
blot O +
hybridization O +
analyses O +
of O +
the O +
liver O +
samples O +
indicated O +
that O +
sEH B-Gene +
mRNA O +
steady O +
- O +
state O +
expression O +
varied O +
approximately O +
10 O +
- O +
fold O +
. O +

Transient O +
transfection O +
experiments O +
with O +
CHO O +
and O +
COS-7 O +
cells O +
were O +
used O +
to O +
demonstrate O +
that O +
the O +
two O +
new O +
alleles O +
possess O +
catalytic O +
activity O +
using O +
trans O +
- O +
stilbene O +
oxide O +
as O +
a O +
model O +
substrate O +
. O +

Although O +
the O +
activity O +
of O +
the O +
glutamine O +
287 O +
variant O +
was O +
similar O +
to O +
the O +
sEH B-Gene +
wild O +
type O +
allele O +
, O +
proteins O +
containing O +
the O +
arginine O +
insertion O +
exhibited O +
strikingly O +
lower O +
activity O +
. O +

Allelic O +
forms O +
of O +
human O +
sEH B-Gene +
, O +
with O +
markedly O +
different O +
enzymatic O +
profiles O +
, O +
may O +
have O +
important O +
physiological O +
implications O +
with O +
respect O +
to O +
the O +
disposition O +
of O +
epoxides O +
formed O +
from O +
the O +
oxidation O +
of O +
fatty O +
acids O +
, O +
such O +
as O +
arachidonic O +
acid O +
- O +
derived O +
intermediates O +
, O +
as O +
well O +
in O +
the O +
regulation O +
of O +
toxicity O +
due O +
to O +
xenobiotic O +
epoxide O +
exposures O +
. O +

Rrp8p B-Gene +
is O +
a O +
yeast O +
nucleolar O +
protein O +
functionally O +
linked O +
to O +
Gar1p B-Gene +
and O +
involved O +
in O +
pre O +
- O +
rRNA O +
cleavage O +
at O +
site O +
A2 O +
. O +

Chemical O +
modifications O +
and O +
processing O +
of O +
the O +
18S O +
, O +
5.8S O +
, O +
and O +
25S O +
ribosomal O +
RNAs O +
from O +
the O +
35S O +
pre O +
- O +
ribosomal O +
RNA O +
depend O +
on O +
an O +
important O +
set O +
of O +
small O +
nucleolar O +
ribonucleoprotein O +
particles O +
( O +
snoRNPs O +
) O +
. O +

Genetic O +
depletion O +
of O +
yeast O +
Gar1p B-Gene +
, O +
an O +
essential O +
common O +
component O +
of O +
H O +
/ O +
ACA O +
snoRNPs O +
, O +
leads O +
to O +
inhibition O +
of O +
uridine O +
isomerizations O +
to O +
pseudo O +
- O +
uridines O +
on O +
the O +
35S O +
pre O +
- O +
rRNA O +
and O +
of O +
the O +
early O +
pre O +
- O +
rRNA O +
cleavages O +
at O +
sites O +
A1 O +
and O +
A2 O +
, O +
resulting O +
in O +
a O +
loss O +
of O +
mature O +
18S O +
rRNA O +
synthesis O +
. O +

To O +
identify O +
Gar1p B-Gene +
functional O +
partners O +
, O +
we O +
screened O +
for O +
mutations O +
that O +
are O +
synthetically O +
lethal O +
with O +
a O +
gar1 B-Gene +
mutant O +
allele O +
encoding O +
a O +
Gar1p B-Gene +
mutant O +
protein O +
lacking O +
its O +
two O +
glycine O +
/ O +
arginine O +
- O +
rich O +
( O +
GAR O +
) O +
domains O +
. O +

We O +
identified O +
a O +
previously O +
uncharacterized O +
Saccharomyces O +
cerevisiae O +
open O +
reading O +
frame O +
, O +
YDR083W B-Gene +
( O +
now O +
designated O +
RRP8 B-Gene +
) O +
, O +
that O +
encodes O +
a O +
highly O +
conserved O +
protein O +
containing O +
motifs O +
found O +
in O +
methyltransferases B-Gene +
. O +

Rrp8p B-Gene +
localizes O +
to O +
the O +
nucleolus O +
. O +

A O +
yeast O +
strain O +
lacking O +
this O +
protein O +
is O +
viable O +
at O +
30 O +
degrees O +
C O +
but O +
displays O +
strong O +
growth O +
impairment O +
at O +
lower O +
temperatures O +
. O +

In O +
this O +
strain O +
, O +
cleavage O +
of O +
the O +
pre O +
- O +
rRNA O +
at O +
site O +
A2 O +
is O +
strongly O +
affected O +
whereas O +
cleavages O +
at O +
sites O +
A0 O +
and O +
A1 O +
are O +
only O +
slightly O +
inhibited O +
or O +
delayed O +
. O +

Src B-Gene +
homology I-Gene +
domain I-Gene +
2 I-Gene +
- I-Gene +
containing I-Gene +
tyrosine I-Gene +
phosphatase I-Gene +
2 I-Gene +
associates O +
with O +
intercellular B-Gene +
adhesion I-Gene +
molecule I-Gene +
1 I-Gene +
to O +
regulate O +
cell O +
survival O +
. O +

Intercellular B-Gene +
adhesion I-Gene +
molecule-1 I-Gene +
( O +
ICAM-1 B-Gene +
) O +
binds O +
to O +
the O +
plasma O +
protein O +
fibrinogen B-Gene +
( O +
Fg B-Gene +
) O +
to O +
mediate O +
leukocyte O +
/ O +
endothelial O +
cell O +
interactions O +
. O +

In O +
our O +
studies O +
, O +
the O +
ligation O +
of O +
Fg B-Gene +
to O +
ICAM-1 B-Gene +
on O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene -
- I-Gene -
alpha I-Gene +
- O +
stimulated O +
endothelial O +
cells O +
resulted O +
in O +
the O +
tyrosine O +
phosphorylation O +
of O +
Src B-Gene +
homology I-Gene +
domain I-Gene +
2 I-Gene +
( I-Gene +
SH2 I-Gene +
) I-Gene +
- I-Gene +
containing I-Gene +
phosphatase-2 I-Gene +
( O +
SHP-2 B-Gene +
) O +
. O +

The O +
ICAM-1 B-Gene +
cytoplasmic O +
sequence O +
IKKYRLQ O +
conforms O +
poorly O +
to O +
the O +
concensus O +
immunoreceptor O +
tyrosine O +
- O +
based O +
inhibition O +
motifs O +
found O +
in O +
receptors O +
that O +
bind O +
SHP-2 B-Gene +
. O +

Nevertheless O +
, O +
the O +
tyrosine O +
phosphorylated O +
sequence O +
( O +
IKKpYRLQ O +
) O +
bound O +
specifically O +
to O +
the O +
SH2 O +
domain O +
proximal O +
to O +
the O +
NH O -
( O -
2 O -
) O +
- O +
terminal O +
of O +
SHP-2 B-Gene +
( O +
SHP-2 B-Gene +
- O +
N O +
) O +
but O +
not O +
to O +
the O +
SH2 O +
domain O +
proximal O +
on O +
the O +
COOH O +
- O +
terminal O +
side O +
( O +
SHP-2 B-Gene +
- O +
C O +
) O +
. O +

Phosphorylated O +
ICAM-1 B-Gene +
bound O +
SHP-2 B-Gene +
- O +
N O +
. O +

In O +
immunoprecipitation O +
experiments O +
, O +
SHP-2 B-Gene +
associated O +
with O +
phosphorylated O +
ICAM-1 B-Gene +
. O +

Cells O +
expressing O +
truncated O +
ICAM-1 B-Gene +
that O +
lacked O +
the O +
cytoplasmic O +
sequence O +
( O +
ICAM-1 B-Gene +
( O +
TR O +
) O +
) O +
failed O +
to O +
associate O +
with O +
SHP-2 B-Gene +
. O +

ICAM-1 B-Gene +
containing O +
the O +
tyrosine O +
to O +
alanine O +
substitution O +
at O +
position O +
485 O +
( O +
ICAM-1 B-Gene +
( O +
Y485A O +
) O +
) O +
associated O +
weakly O +
with O +
SHP-2 B-Gene +
. O +

Cells O +
expressing O +
ICAM-1 B-Gene +
( O +
TR O +
) O +
and O +
ICAM-1 B-Gene +
( O +
Y485A O +
) O +
underwent O +
apoptosis O +
upon O +
adhesion O +
to O +
Fg B-Gene +
, O +
whereas O +
the O +
wild O +
type O +
ICAM-1 B-Gene +
maintained O +
cell O +
survival O +
. O +

These O +
results O +
indicate O +
that O +
ICAM-1 B-Gene +
interactions O +
with O +
SHP-2 B-Gene +
allow O +
better O +
cellular O +
survival O +
mediated O +
through O +
Fg B-Gene +
- O +
ICAM-1 B-Gene +
ligation O +
. O +

Interaction O +
of O +
the O +
iron B-Gene +
- I-Gene +
sulfur I-Gene +
cluster I-Gene +
assembly I-Gene +
protein I-Gene +
IscU B-Gene +
with O +
the O +
Hsc66 B-Gene +
/ O +
Hsc20 B-Gene +
molecular O +
chaperone B-Gene +
system O +
of O +
Escherichia O +
coli O +
. O +

The O +
iscU B-Gene +
gene O +
in O +
bacteria O +
is O +
located O +
in O +
a O +
gene O +
cluster O +
encoding O +
proteins O +
implicated O +
in O +
iron O +
- O +
sulfur O +
cluster O +
assembly O +
and O +
an O +
hsc70 B-Gene +
- O +
type O +
( O +
heat O +
shock O +
cognate O +
) O +
molecular O +
chaperone B-Gene +
system O +
, O +
iscSUA B-Gene -
- I-Gene -
hscBA I-Gene +
. O +

To O +
investigate O +
possible O +
interactions O +
between O +
these O +
systems O +
, O +
we O +
have O +
overproduced O +
and O +
purified O +
the O +
IscU B-Gene +
protein O +
from O +
Escherichia O +
coli O +
and O +
have O +
studied O +
its O +
interactions O +
with O +
the O +
hscA B-Gene +
and O +
hscB B-Gene +
gene O +
products O +
Hsc66 B-Gene +
and O +
Hsc20 B-Gene +
. O +

IscU B-Gene +
and O +
its O +
iron O +
- O +
sulfur O +
complex O +
( O +
IscU B-Gene +
- O +
Fe O +
/ O +
S O +
) O +
stimulated O +
the O +
basal O +
steady O +
- O +
state O +
ATPase B-Gene +
activity O +
of O +
Hsc66 B-Gene +
weakly O +
in O +
the O +
absence O +
of O +
Hsc20 B-Gene +
but O +
, O +
in O +
the O +
presence O +
of O +
Hsc20 B-Gene +
, O +
increased O +
the O +
ATPase B-Gene +
activity O +
up O +
to O +
480 O +
- O +
fold O +
. O +

Hsc20 B-Gene +
also O +
decreased O +
the O +
apparent O +
K O -
( O -
m O -
) O +
for O +
IscU B-Gene +
stimulation O +
of O +
Hsc66 B-Gene +
ATPase B-Gene +
activity O +
, O +
and O +
surface O +
plasmon O +
resonance O +
studies O +
revealed O +
that O +
Hsc20 B-Gene +
enhances O +
binding O +
of O +
IscU B-Gene +
to O +
Hsc66 B-Gene +
. O +

Surface O +
plasmon O +
resonance O +
and O +
isothermal O +
titration O +
calorimetry O +
further O +
showed O +
that O +
IscU B-Gene +
and O +
Hsc20 B-Gene +
form O +
a O +
complex O +
, O +
and O +
Hsc20 B-Gene +
may O +
thereby O +
aid O +
in O +
the O +
targeting O +
of O +
IscU B-Gene +
to O +
Hsc66 B-Gene +
. O +

These O +
results O +
establish O +
a O +
direct O +
and O +
specific O +
role O +
for O +
the O +
Hsc66 B-Gene +
/ O +
Hsc20 B-Gene +
chaperone B-Gene +
system O +
in O +
functioning O +
with O +
isc B-Gene +
gene O +
components O +
for O +
the O +
assembly O +
of O +
iron O +
- O +
sulfur O +
cluster O +
proteins O +
. O +

The O +
aquaporin B-Gene +
sidedness O +
revisited O +
. O +

Aquaporins B-Gene +
are O +
transmembrane O +
water B-Gene +
channel I-Gene +
proteins O +
, O +
which O +
play O +
important O +
functions O +
in O +
the O +
osmoregulation O +
and O +
water O +
balance O +
of O +
micro O +
- O +
organisms O +
, O +
plants O +
, O +
and O +
animal O +
tissues O +
. O +

All O +
aquaporins B-Gene +
studied O +
to O +
date O +
are O +
thought O +
to O +
be O +
tetrameric O +
assemblies O +
of O +
four O +
subunits O +
each O +
containing O +
its O +
own O +
aqueous O +
pore O +
. O +

Moreover O +
, O +
the O +
subunits O +
contain O +
an O +
internal O +
sequence O +
repeat O +
forming O +
two O +
obversely O +
symmetric O +
hemichannels O +
predicted O +
to O +
resemble O +
an O +
hour O +
- O +
glass O +
. O +

This O +
unique O +
arrangement O +
of O +
two O +
highly O +
related O +
protein O +
domains O +
oriented O +
at O +
180 O +
degrees O +
to O +
each O +
other O +
poses O +
a O +
significant O +
challenge O +
in O +
the O +
determination O +
of O +
sidedness O +
. O +

Aquaporin B-Gene +
Z I-Gene +
( O +
AqpZ B-Gene +
) O +
from O +
Escherichia O +
coli O +
was O +
reconstituted O +
into O +
highly O +
ordered O +
two O +
- O +
dimensional O +
crystals O +
. O +

They O +
were O +
freeze O +
- O +
dried O +
and O +
metal O +
- O +
shadowed O +
to O +
establish O +
the O +
relationship O +
between O +
surface O +
structure O +
and O +
underlying O +
protein O +
density O +
by O +
electron O +
microscopy O +
. O +

The O +
shadowing O +
of O +
some O +
surfaces O +
was O +
prevented O +
by O +
protruding O +
aggregates O +
. O +

Thus O +
, O +
images O +
collected O +
from O +
freeze O +
- O +
dried O +
crystals O +
that O +
exhibited O +
both O +
metal O +
- O +
coated O +
and O +
uncoated O +
regions O +
allowed O +
surface O +
relief O +
reconstructions O +
and O +
projection O +
maps O +
to O +
be O +
obtained O +
from O +
the O +
same O +
crystal O +
. O +

Cross O +
- O +
correlation O +
peak O +
searches O +
along O +
lattices O +
crossing O +
metal O +
- O +
coated O +
and O +
uncoated O +
regions O +
allowed O +
an O +
unambiguous O +
alignment O +
of O +
the O +
surface O +
reliefs O +
to O +
the O +
underlying O +
density O +
maps O +
. O +

AqpZ B-Gene +
topographs O +
previously O +
determined O +
by O +
AFM O +
could O +
then O +
be O +
aligned O +
with O +
projection O +
maps O +
of O +
AqpZ B-Gene +
, O +
and O +
finally O +
with O +
human O +
erythrocyte O +
aquaporin-1 B-Gene +
( O +
AQP1 B-Gene +
) O +
. O +

Thereby O +
features O +
of O +
the O +
AqpZ B-Gene +
topography O +
could O +
be O +
interpreted O +
by O +
direct O +
comparison O +
to O +
the O +
6 O +
A O +
three O +
- O +
dimensional O +
structure O +
of O +
AQP1 B-Gene +
. O +

We O +
conclude O +
that O +
the O +
sidedness O +
we O +
originally O +
proposed O +
for O +
aquaporin B-Gene +
density O +
maps O +
was O +
inverted O +
. O +

Isolation O +
of O +
two O +
novel O +
human O +
RhoGEFs B-Gene +
, O +
ARHGEF3 B-Gene +
and O +
ARHGEF4 B-Gene +
, O +
in O +
3p13 O +
- O +
21 O +
and O +
2q22 O +
. O +

RhoGEFs B-Gene +
play O +
an O +
important O +
role O +
in O +
various O +
signaling O +
cascades O +
and O +
are O +
implicated O +
in O +
human O +
conditions O +
like O +
cancer O +
and O +
mental O +
retardation O +
. O +

A O +
database O +
search O +
combined O +
with O +
screening O +
of O +
a O +
human O +
neuronal O +
teratocarcinoma O +
library O +
identified O +
two O +
novel O +
RhoGEFs B-Gene +
, O +
ARHGEF3 B-Gene +
and O +
ARHGEF4 B-Gene +
( O +
HGMW O -
- O -
approved O +
symbols O +
) O +
. O +

The O +
widely O +
expressed O +
ARHGEF3 B-Gene +
transcript O +
of O +
3561 O +
nucleotides O +
encodes O +
a O +
polypeptide O +
of O +
526 O +
amino O +
acids O +
with O +
homology O +
to O +
NET1 B-Gene +
. O +

The O +
ARHGEF4 B-Gene +
gene O +
generates O +
two O +
transcripts O +
of O +
3665 O +
and O +
4000 O +
nucleotides O +
that O +
translate O +
into O +
720 O +
amino O +
acid O +
residues O +
. O +

Expression O +
of O +
ARHGEF4 B-Gene +
is O +
restricted O +
to O +
brain O +
and O +
the O +
encoded O +
protein O +
shows O +
homology O +
to O +
collybistin B-Gene +
. O +

FISH O +
analysis O +
of O +
genomic O +
clones O +
mapped O +
ARHGEF3 B-Gene +
to O +
3p13 O -
- O -
21 O +
and O +
ARHGEF4 B-Gene +
to O +
2q22 O +
. O +

The O +
HIV-1 O +
Env B-Gene +
protein O +
signal O +
sequence O +
retards O +
its O +
cleavage O +
and O +
down O +
- O +
regulates O +
the O +
glycoprotein O +
folding O +
. O +

Secretory O +
proteins O +
and O +
most O +
membrane O +
proteins O +
are O +
synthesized O +
with O +
a O +
signal O +
sequence O +
that O +
is O +
usually O +
cleaved O +
from O +
the O +
nascent O +
polypeptide O +
chain O +
, O +
during O +
its O +
transport O +
, O +
into O +
the O +
lumen O +
of O +
the O +
endoplasmic O +
reticulum O +
( O +
ER O +
) O +
. O +

We O +
have O +
analyzed O +
the O +
kinetics O +
of O +
the O +
cleavage O +
of O +
the O +
HIV-1 O +
Env B-Gene +
protein O +
signal O +
sequence O +
from O +
gp160 B-Gene +
and O +
gp120 B-Gene +
in O +
HeLa O +
, O +
BHK O +
, O +
and O +
Jurkat O +
cells O +
. O +

Furthermore O +
, O +
we O +
have O +
determined O +
the O +
effects O +
of O +
this O +
cleavage O +
on O +
the O +
association O +
of O +
the O +
gp160 B-Gene +
and O +
gp120 B-Gene +
glycoproteins O +
with O +
the O +
ER O +
protein O +
calnexin B-Gene +
and O +
the O +
effects O +
of O +
the O +
signal O +
sequence O +
cleavage O +
on O +
protein O +
folding O +
. O +

The O +
cleavage O +
of O +
the O +
HIV-1 O +
Env B-Gene +
protein O +
signal O +
sequence O +
on O +
both O +
gp160 B-Gene +
and O +
gp120 B-Gene +
occurred O +
very O +
slowly O +
in O +
all O +
three O +
cell O +
lines O +
with O +
a O +
t O +
( O +
1 O +
/ O +
2 O +
) O +
of O +
45 O +
- O +
60 O +
min O +
. O +

The O +
core O +
glycosylated O +
and O +
signal O +
- O +
sequence O +
- O +
retained O +
forms O +
of O +
gp160 B-Gene +
and O +
gp120 B-Gene +
associated O +
with O +
calnexin B-Gene +
while O +
the O +
signal O +
- O +
sequence O +
- O +
cleaved O +
forms O +
of O +
gp160 B-Gene +
and O +
gp120 B-Gene +
had O +
disassociated O +
from O +
calnexin B-Gene +
and O +
correctly O +
folded O +
as O +
determined O +
by O +
their O +
ability O +
to O +
associate O +
with O +
the O +
CD4 B-Gene +
cellular O +
receptor O +
. O +

Further O +
analysis O +
of O +
the O +
folding O +
state O +
of O +
gp160 B-Gene +
and O +
gp120 B-Gene +
in O +
nonreducing O +
SDS O +
- O +
PAGE O +
revealed O +
that O +
the O +
signal O +
- O +
sequence O +
- O +
retained O +
and O +
calnexin B-Gene +
- O +
associated O +
forms O +
of O +
gp160 B-Gene +
and O +
gp120 B-Gene +
migrated O +
as O +
broad O +
, O +
diffuse O +
bands O +
, O +
whereas O +
the O +
signal O +
- O +
sequence O +
- O +
cleaved O +
or O +
CD4 B-Gene +
- O +
associated O +
forms O +
of O +
gp160 B-Gene +
and O +
gp120 B-Gene +
migrated O +
as O +
single O +
sharper O +
bands O +
. O +

The O +
cause O +
of O +
this O +
retardation O +
in O +
the O +
rate O +
of O +
folding O +
and O +
intracellular O +
transport O +
of O +
HIV-1 O +
glycoproteins O +
was O +
localized O +
to O +
their O +
signal O +
sequences O +
by O +
fusing O +
the O +
vesicular O +
stomatitis O +
virus O +
G O +
protein O +
with O +
the O +
HIV-1 O +
Env B-Gene +
protein O +
signal O +
sequence O +
and O +
expressing O +
this O +
chimeric O +
protein O +
in O +
mammalian O +
cells O +
. O +

The O +
HIV-1 O +
Env B-Gene +
protein O +
signal O +
sequence O +
on O +
the O +
VSV O +
- O +
G O +
protein O +
also O +
confers O +
a O +
reduced O +
rate O +
of O +
cleavage O +
and O +
slow O +
intracellular O +
transport O +
and O +
folding O +
of O +
the O +
chimeric O +
G O +
protein O +
. O +

These O +
results O +
provide O +
direct O +
evidence O +
that O +
in O +
vivo O +
the O +
HIV-1 O +
glycoprotein O +
signal O +
sequence O +
inhibits O +
the O +
folding O +
of O +
HIV-1 O +
Env B-Gene +
protein O +
. O +

Our O +
data O +
also O +
suggest O +
a O +
direct O +
correlation O +
between O +
the O +
rate O +
of O +
the O +
signal O +
sequence O +
cleavage O +
and O +
protein O +
folding O +
. O +

Transcription O +
of O +
the O +
insecticidal O +
crystal B-Gene +
protein I-Gene +
genes O +
of O +
Bacillus O +
thuringiensis O +
. O +

Production O +
of O +
a O +
large O +
amount O +
of O +
insecticidal O +
crystal B-Gene +
proteins I-Gene +
encoded O +
on O +
large O +
plasmids O +
is O +
largely O +
dependent O +
upon O +
the O +
mother O +
cell O +
, O +
Bacillus O +
thuringiensis O +
( O +
B. O +
thuringiensis O +
, O +
also O +
Bt O +
) O +
, O +
specific O +
transcription O +
systems O +
attributable O +
to O +
sporulation O +
. O +

In O +
the O +
middle O +
stages O +
of O +
sporulation O +
, O +
cry4A B-Gene +
is O +
most O +
actively O +
transcribed O +
from O +
the O +
promoter O +
cry4A B-Gene +
- O +
P1 O +
. O +

The O +
proximal O +
transcriptional O +
start O +
point O +
of O +
cry4A B-Gene +
, O +
which O +
is O +
under O +
the O +
control O +
of O +
the O +
promoter O +
P1 O +
, O +
is O +
used O +
in O +
Bacillus O +
subtilis O +
( O +
B. O +
subtilis O +
) O +
in O +
the O +
middle O +
stage O +
of O +
sporulation O +
. O +

The O +
nucleotide O +
sequence O +
that O +
determines O +
the O +
cry4A B-Gene +
- O +
P1 O +
promoter O +
is O +
homologous O +
to O +
the O +
consensus O +
sequence O +
for O +
the O +
promoter O +
of O +
sigma B-Gene +
E I-Gene +
- O +
specific O +
genes O +
in O +
B. O +
subtilis O +
, O +
and O +
to O +
those O +
promoters O +
of O +
the O +
insecticidal O +
protein O +
genes O +
that O +
are O +
efficiently O +
transcribed O +
in O +
vitro O +
with O +
the O +
RNA B-Gene +
polymerase I-Gene +
E I-Gene +
sigma I-Gene +
35 I-Gene +
isolated O +
from O +
B. O +
thuringiensis O +
. O +

The O +
sigma B-Gene +
factor I-Gene +
sigma B-Gene +
35 I-Gene +
of O +
B. O +
thuringiensis O +
is O +
highly O +
homologous O +
and O +
functionally O +
equivalent O +
to O +
sigma B-Gene +
E I-Gene +
of O +
B. O +
subtilis O +
. O +

These O +
results O +
suggest O +
that O +
the O +
cry4A B-Gene +
transcription O +
from O +
P1 O +
is O +
under O +
the O +
control O +
of O +
sigma B-Gene +
E I-Gene +
in O +
B. O +
subtilis O +
, O +
and O +
under O +
the O +
control O +
of O +
sigma B-Gene +
35 I-Gene +
in O +
B. O +
thuringiensis O +
. O +

Loss O +
of O +
a O +
member O +
of O +
the O +
aquaporin B-Gene +
gene O +
family O +
, O +
aqpA B-Gene +
affects O +
spore O +
dormancy O +
in O +
Dictyostelium O +
. O +

We O +
isolated O +
and O +
characterized O +
a O +
gene O +
from O +
Dictyostelium O +
discoideum O +
, O +
which O +
encodes O +
a O +
protein O +
of O +
279 O +
amino O +
acids O +
( O +
30.6kDa O +
) O +
containing O +
six O +
transmembrane O +
domains O +
with O +
two O +
highly O +
conserved O +
motifs O +
of O +
asparagine O -
- O -
proline O -
- O -
alanine O +
( O +
NPA O +
) O +
found O +
in O +
the O +
aquaporin B-Gene +
family I-Gene +
of O +
water B-Gene +
- I-Gene +
channel I-Gene +
proteins O +
, O +
although O +
the O +
second O +
motif O +
of O +
the O +
protein O +
has O +
been O +
modified O +
into O +
NPV O +
( O +
asparagine O +
- O +
proline O +
- O +
valine O +
) O +
. O +

The O +
deduced O +
amino O +
acid O +
sequence O +
of O +
the O +
gene O +
, O +
which O +
we O +
have O +
named O +
aqpA B-Gene +
, O +
is O +
39 O +
% O +
identical O +
to O +
D. O +
discoideum O +
WacA B-Gene +
, O +
26 O +
% O +
identical O +
to O +
human O +
Aqp5 B-Gene +
, O +
26 O +
% O +
identical O +
to O +
Oryza O +
sativa O +
PIP2a B-Gene +
, O +
25 O +
% O +
identical O +
to O +
yeast O +
Aqy1 B-Gene +
and O +
24 O +
% O +
identical O +
to O +
E.coli O +
AqpZ B-Gene +
. O +

Southern O +
analyses O +
indicated O +
that O +
aqpA B-Gene +
is O +
present O +
as O +
a O +
single O +
copy O +
in O +
the O +
genome O +
. O +

Northern O +
blot O +
analysis O +
showed O +
that O +
the O +
developmentally O +
regulated O +
1 O -
kb O +
mRNA O +
transcript O +
first O +
appears O +
at O +
the O +
tight O +
mound O +
stage O +
( O +
12h O +
) O +
, O +
and O +
is O +
abundant O +
in O +
fingers O +
( O +
16h O +
) O +
and O +
late O +
culminants O +
( O +
20h O +
) O +
. O +

In O +
- O +
situ O +
hybridization O +
of O +
slugs O +
revealed O +
that O +
aqpA B-Gene +
mRNA O +
accumulated O +
in O +
cells O +
of O +
the O +
prespore O +
region O +
but O +
not O +
in O +
those O +
of O +
the O +
prestalk O +
region O +
. O +

Disruption O +
of O +
aqpA B-Gene +
by O +
homologous O +
recombination O +
did O +
not O +
significantly O +
affect O +
growth O +
or O +
developmental O +
morphogenesis O +
. O +

Although O +
mutant O +
spores O +
were O +
viable O +
, O +
when O +
assayed O +
soon O +
after O +
encapsulation O +
, O +
they O +
became O +
permeable O +
to O +
propidium O +
iodide O +
and O +
lost O +
viability O +
after O +
a O +
week O +
on O +
the O +
top O +
of O +
a O +
fruiting O +
body O +
. O +

Thus O +
, O +
AqpA B-Gene +
is O +
essential O +
to O +
maintain O +
spore O +
dormancy O +
perhaps O +
through O +
the O +
regulation O +
of O +
water O +
flow O +
. O +

Cloning O +
and O +
functional O +
characterization O +
of O +
a O +
novel O +
c B-Gene -
- I-Gene -
mpl I-Gene +
variant O +
expressed O +
in O +
human O +
CD34 B-Gene +
cells O +
and O +
platelets O +
. O +

The O +
thrombopoietin B-Gene +
receptor I-Gene +
, O +
c B-Gene -
- I-Gene -
mpl I-Gene +
, O +
is O +
a O +
crucial O +
element O +
not O +
only O +
in O +
thrombopoietin B-Gene +
( O +
TPO B-Gene +
) O +
- O +
initiated O +
signaling O +
pathways O +
but O +
also O +
in O +
the O +
regulation O +
of O +
the O +
circulating O +
amount O +
of O +
TPO B-Gene +
. O +

We O +
have O +
identified O +
a O +
new O +
c B-Gene -
- I-Gene -
mpl I-Gene +
isoform O +
, O +
called O +
c B-Gene -
- I-Gene -
mpl I-Gene +
- O +
del O +
, O +
that O +
lacks O +
72 O +
bp O +
( O +
24 O +
amino O +
acids O +
) O +
in O +
the O +
extracellular O +
region O +
of O +
c B-Gene -
- I-Gene -
mpl I-Gene +
and O +
arises O +
as O +
a O +
consequence O +
of O +
alternative O +
RNA O +
splicing O +
between O +
exons O +
8 O +
and O +
9 O +
. O +

c B-Gene -
- I-Gene -
mpl I-Gene +
- O +
del O +
is O +
expressed O +
along O +
with O +
c B-Gene -
- I-Gene -
mpl I-Gene +
- O +
wt O +
in O +
blood O +
mononuclear O +
cells O +
, O +
CD34 B-Gene +
( O +
+ O +
) O +
cells O +
, O +
megakaryocytes O +
, O +
and O +
platelets O +
prepared O +
from O +
either O +
normal O +
donors O +
or O +
ET O +
patients O +
, O +
although O +
its O +
relative O +
expression O +
appears O +
to O +
increase O +
with O +
megakaryocyte O +
differentiation O +
. O +

The O +
c B-Gene -
- I-Gene -
mpl I-Gene +
- O +
del O +
- O +
transfected O +
cells O +
expressed O +
greater O +
amounts O +
of O +
c B-Gene -
- I-Gene -
mpl I-Gene +
- O +
del O +
RNA O +
and O +
protein O +
than O +
the O +
comparable O +
c B-Gene -
- I-Gene -
mpl I-Gene +
- O +
wt O -
- O -
transfected O +
cells O +
, O +
however O +
flow O +
cytometry O +
analysis O +
could O +
not O +
detect O +
any O +
c B-Gene -
- I-Gene -
mpl I-Gene +
receptor O +
on O +
the O +
surface O +
of O +
the O +
c B-Gene -
- I-Gene -
mpl I-Gene +
- O +
del O +
- O +
transfected O +
cells O +
. O +

Further O +
evidence O +
for O +
the O +
absence O +
of O +
surface O +
c B-Gene -
- I-Gene -
mpl I-Gene +
- O +
del O +
was O +
that O +
in O +
contrast O +
to O +
cells O +
transfected O +
with O +
c B-Gene -
- I-Gene -
mpl I-Gene +
- O +
wt O +
, O +
those O +
transfected O +
with O +
c B-Gene -
- I-Gene -
mpl I-Gene +
- O +
del O +
did O +
not O +
grow O +
in O +
response O +
to O +
TPO B-Gene +
, O +
failed O +
to O +
undergo O +
tyrosine O +
phosphorylation O +
of O +
TPO B-Gene +
- O +
specific O +
signal O +
molecules O +
, O +
and O +
did O +
not O +
bind O -
( O -
125 O -
) O -
I O +
- O +
rHuTPO B-Gene +
. O +

Taken O +
together O +
, O +
these O +
results O +
demonstrate O +
that O +
c B-Gene -
- I-Gene -
mpl I-Gene +
- O +
del O +
, O +
a O +
naturally O +
occurring O +
variant O +
of O +
c B-Gene -
- I-Gene -
mpl I-Gene +
, O +
fails O +
to O +
be O +
incorporated O +
into O +
the O +
cell O +
membrane O +
but O +
might O +
serve O +
as O +
a O +
mechanism O +
to O +
decrease O +
the O +
overall O +
expression O +
of O +
functional O +
c B-Gene -
- I-Gene -
mpl I-Gene +
late O +
in O +
megakaryocyte O +
differentiation O +
. O +

Elevated O +
plasma O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
in O +
renal O +
diseases O +
: O +
cause O +
or O +
consequence O +
? O +

We O +
previously O +
reported O +
elevated O +
levels O +
of O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
in O +
patients O +
with O +
renal O +
carcinoma O +
. O +

Certain O +
aspects O +
led O +
us O +
to O +
ask O +
whether O +
they O +
might O +
be O +
caused O +
by O +
chronic O +
damage O +
to O +
the O +
kidney O -
( O -
s O -
) O +
. O +

Here O +
we O +
report O +
on O +
an O +
extended O +
set O +
of O +
patients O +
with O +
various O +
renal O +
diseases O +
, O +
lung O +
cancer O +
, O +
humoral O +
immunodeficiency O +
and O +
controls O +
. O +

For O +
latent O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
in O +
plasma O +
, O +
we O +
find O +
that O +
the O +
control O +
, O +
immunodeficiency O +
, O +
lung O +
cancer O +
and O +
kidney O +
transplant O +
groups O +
do O +
not O +
differ O +
significantly O +
( O +
means O +
, O +
7.0 O +
- O +
8.8 O +
ng O +
/ O +
ml O +
) O +
. O +

Also O +
, O +
acute O +
short O +
- O +
term O +
renal O +
stress O +
( O +
extracorporal O +
lithotrypsy O +
) O +
does O +
not O +
lead O +
to O +
an O +
increase O +
of O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
. O +

However O +
, O +
the O +
pyelonephritis O +
patients O +
present O +
with O +
levels O +
of O +
19.0 O +
ng O +
/ O +
ml O +
, O +
chronic O +
extracorporal O +
dialysis O +
patients O +
with O +
15.5 O +
ng O +
/ O +
ml O +
, O +
and O +
renal O +
cell O +
carcinoma O +
patients O +
with O +
22.8 O +
ng O +
/ O +
ml O +
. O +

For O +
active O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
these O +
findings O +
are O +
exactly O +
recovered O +
. O +

For O +
serum O +
levels O +
, O +
only O +
the O +
renal O +
carcinoma O +
group O +
presents O +
with O +
significantly O +
elevated O +
levels O +
of O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
. O +

Kidney O +
transplantation O +
seems O +
to O +
normalize O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
levels O +
, O +
while O +
in O +
the O +
kidney O +
cancer O +
patients O +
surgery O +
has O +
an O +
effect O +
only O +
in O +
part O +
of O +
the O +
group O +
. O +

We O +
conclude O +
that O +
elevated O +
plasma O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
levels O +
are O +
common O +
in O +
at O +
least O +
two O +
chronic O +
renal O +
disease O +
conditions O +
, O +
and O +
that O +
it O +
normalizes O +
with O +
restoration O +
of O +
renal O +
function O +
. O +

It O +
is O +
tempting O +
to O +
speculate O +
that O +
chronic O +
elevation O +
of O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
in O +
these O +
patients O +
may O +
be O +
critically O +
involved O +
in O +
these O +
conditions O +
predisposing O +
to O +
renal O +
cancer O +
. O +

Identification O +
and O +
functional O +
characterization O +
of O +
a O +
novel O +
subtype O +
of O +
neuromedin B-Gene +
U I-Gene +
receptor I-Gene +
. O +

Neuromedin B-Gene +
U I-Gene +
is O +
a O +
bioactive O +
peptide O +
isolated O +
originally O +
from O +
the O +
porcine O +
spinal O +
cord O +
. O +

We O +
recently O +
identified O +
neuromedin B-Gene +
U I-Gene +
as O +
the O +
cognate O +
ligand O +
for O +
the O +
orphan O +
G B-Gene +
protein I-Gene +
- I-Gene +
coupled I-Gene +
receptor I-Gene +
FM-3 B-Gene +
. O +

In O +
this O +
study O +
, O +
we O +
isolated O +
cDNA O +
coding O +
for O +
a O +
novel O +
G B-Gene +
protein I-Gene +
- I-Gene +
coupled I-Gene +
receptor I-Gene +
, O +
TGR-1 B-Gene +
, O +
which O +
was O +
highly O +
homologous O +
with O +
FM B-Gene +
- I-Gene +
3 I-Gene +
. O +

We O +
found O +
that O +
neuromedin B-Gene +
U I-Gene +
specifically O +
and O +
clearly O +
elevated O +
the O +
extracellular O +
acidification O +
rates O +
, O +
arachidonic O +
acid O +
metabolite O +
release O +
, O +
and O +
intracellular O +
Ca O -
( O -
2 O -
+ O -
) O +
mobilization O +
in O +
Chinese O +
hamster O +
ovary O +
cells O +
expressing O +
TGR-1 B-Gene +
. O +

Radiolabeled O +
neuromedin B-Gene +
U I-Gene +
specifically O +
bound O +
with O +
high O +
affinity O +
to O +
membrane O +
fractions O +
prepared O +
from O +
these O +
cells O +
. O +

These O +
results O +
show O +
that O +
TGR-1 B-Gene +
, O +
like O +
FM-3 B-Gene +
, O +
is O +
a O +
specific O +
and O +
functional O +
receptor B-Gene +
for I-Gene +
neuromedin I-Gene +
U I-Gene +
. O +

We O +
analyzed O +
TGR-1 B-Gene +
mRNA O +
tissue O +
distribution O +
in O +
rats O +
using O +
quantitative O +
reverse O +
transcription O +
- O +
polymerase O +
chain O +
reaction O +
and O +
found O +
it O +
to O +
considerably O +
differ O +
from O +
that O +
of O +
FM-3 B-Gene +
mRNA O +
. O +

TGR-1 B-Gene +
mRNA O +
was O +
primarily O +
expressed O +
in O +
the O +
uterus O +
, O +
suggesting O +
that O +
TGR-1 B-Gene +
mediates O +
the O +
contractile O +
activity O +
of O +
neuromedin B-Gene +
U I-Gene +
in O +
this O +
tissue O +
. O +

The O +
identification O +
of O +
specific O +
and O +
functional O +
receptor O +
subtypes O +
for O +
neuromedin B-Gene +
U I-Gene +
will O +
facilitate O +
the O +
study O +
of O +
their O +
physiological O +
roles O +
and O +
the O +
search O +
for O +
their O +
specific O +
agonists O +
and O +
antagonists O +
. O +

Rescue O +
of O +
human O +
T O +
cells O +
by O +
interleukin-9 B-Gene +
( O +
IL-9 B-Gene +
) O +
from O +
IL-2 B-Gene +
deprivation O +
- O +
induced O +
apoptosis O +
: O +
correlation O +
with O +
alpha O +
subunit O +
expression O +
of O +
the O +
IL-9 B-Gene +
receptor I-Gene +
. O +

Interleukin-9 B-Gene +
( O +
IL-9 B-Gene +
) O +
is O +
a O +
Th2 O +
- O +
derived O +
cytokine B-Gene +
that O +
uses O +
the O +
gamma B-Gene +
- I-Gene +
chain I-Gene +
of I-Gene +
the I-Gene +
IL-2 I-Gene +
receptor I-Gene +
for O +
signaling O +
. O +

Therefore O +
, O +
the O +
responsiveness O +
of O +
human O +
Th1 O +
and O +
Th2 O +
cell O +
clones O +
to O +
IL-9 B-Gene +
was O +
measured O +
by O +
examining O +
the O +
ability O +
of O +
this O +
cytokine B-Gene +
to O +
prevent O +
apoptosis O +
induced O +
by O +
IL-2 B-Gene +
deprivation O +
. O +

A O +
time O +
course O +
study O +
demonstrated O +
that O +
both O +
subsets O +
of O +
T O +
cell O +
clones O +
underwent O +
apoptosis O +
with O +
similar O +
kinetics O +
when O +
deprived O +
of O +
IL-2 B-Gene +
and O +
that O +
viability O +
could O +
be O +
maintained O +
by O +
the O +
addition O +
of O +
either O +
IL-4 B-Gene +
or O +
IL-7 B-Gene +
. O +

Interestingly O +
, O +
IL-9 B-Gene +
prevented O +
apoptosis O +
in O +
only O +
2 O +
( O +
Th2 O +
) O +
of O +
14 O +
clones O +
tested O +
. O +

Analysis O +
of O +
IL-9R B-Gene +
alpha I-Gene +
subunit O +
expression O +
on O +
18 O +
T O +
cell O +
clones O +
revealed O +
that O +
IL-9 B-Gene +
responsiveness O +
was O +
directly O +
proportional O +
to O +
the O +
expression O +
of O +
the O +
high O +
- O +
affinity O +
receptor O +
. O +

IL-9 B-Gene +
responsiveness O +
was O +
also O +
dependent O +
on O +
long O +
- O +
term O +
culturing O +
because O +
neither O +
freshly O +
isolated O +
nor O +
3 O +
- O +
day O +
phytohemagglutinin B-Gene +
( O +
PHA B-Gene +
) O +
- O +
stimulated O +
peripheral O +
blood O +
lymphocytes O +
( O +
PBL O +
) O +
expressed O +
IL-9R B-Gene +
alpha I-Gene +
. O +

In O +
summary O +
, O +
the O +
data O +
showed O +
that O +
IL-9 B-Gene +
can O +
rescue O +
only O +
a O +
small O +
subset O +
of O +
Th2 O +
cells O +
from O +
apoptosis O +
induced O +
by O +
growth B-Gene +
factor I-Gene +
withdrawal O +
and O +
that O +
expression O +
of O +
IL-9R B-Gene +
alpha I-Gene +
is O +
required O +
for O +
the O +
antiapoptotic O +
signals O +
mediated O +
by O +
this O +
cytokine B-Gene +
. O +

20 O +
kDa O +
human O +
growth B-Gene +
hormone I-Gene +
( O +
20 O -
K O +
hGH B-Gene +
) O +
stimulates O +
insulin B-Gene +
- I-Gene +
like I-Gene +
growth I-Gene +
factor I-Gene -
- I-Gene -
I I-Gene +
( O +
IGF B-Gene -
- I-Gene -
I I-Gene +
) O +
gene O +
expression O +
at O +
lower O +
concentrations O +
than O +
22 O -
K O +
hGH B-Gene +
in O +
hGH B-Gene +
receptor I-Gene +
- O +
expressing O +
Ba O +
/ O +
F3 O +
cells O +
. O +

Growth B-Gene +
hormone I-Gene +
( O +
GH B-Gene +
) O +
secreted O +
from O +
the O +
pituitary O +
is O +
essential O +
for O +
postnatal O +
growth O +
in O +
animals O +
. O +

GH B-Gene +
exerts O +
its O +
actions O +
by O +
a O +
direct O +
effect O +
on O +
target O +
organs O +
and O +
by O +
stimulating O +
insulin B-Gene +
- I-Gene +
like I-Gene +
growth I-Gene +
factor I-Gene +
I I-Gene +
( O +
IGF B-Gene -
- I-Gene -
I I-Gene +
) O +
production O +
. O +

In O +
the O +
human O +
pituitary O +
, O +
there O +
is O +
a O +
naturally O +
occurring O +
variant O +
protein O +
which O +
has O +
a O +
molecular O +
mass O +
of O +
20 O +
kDa O +
( O +
20 O -
K O +
hGH B-Gene +
) O +
besides O +
the O +
major O +
22 O +
kDa O +
hGH B-Gene +
( O +
22 O -
K O +
hGH B-Gene +
) O +
, O +
but O +
the O +
physiological O +
actions O +
of O +
20 O -
K O +
hGH B-Gene +
are O +
still O +
poorly O +
understood O +
. O +

In O +
this O +
study O +
we O +
have O +
examined O +
its O +
effects O +
on O +
the O +
IGF B-Gene -
- I-Gene -
I I-Gene +
mRNA O +
expression O +
in O +
the O +
pro O +
B O -
- O -
cell O +
line O +
Ba O +
/ O +
F3 O +
cells O +
stably O +
expressing O +
hGH B-Gene +
receptor I-Gene +
( O +
Ba O +
/ O +
F3 O +
- O +
hGHR B-Gene +
) O +
. O +

Ba O +
/ O +
F3 O +
- O +
hGHR B-Gene +
cells O +
were O +
incubated O +
for O +
2 O +
h O +
with O +
a O +
series O +
of O +
various O +
concentrations O +
( O +
10 O +
pM O +
to O +
approximately O +
10 O +
nM O +
) O +
of O +
20 O -
K O +
or O +
22 O -
K O +
hGH B-Gene +
. O +

The O +
IGF B-Gene -
- I-Gene -
I I-Gene +
mRNA O +
expression O +
in O +
the O +
Ba O +
/ O +
F3 O +
- O +
hGHR B-Gene +
cells O +
was O +
detected O +
by O +
the O +
RT O +
- O +
PCR O +
method O +
. O +

IGF B-Gene -
- I-Gene -
I I-Gene +
gene O +
expression O +
was O +
increased O +
by O +
20 O -
K O +
and O +
22 O -
K O +
hGH B-Gene +
stimulation O +
, O +
but O +
not O +
by O +
PRL B-Gene +
or O +
IL-3 B-Gene +
in O +
the O +
Ba O +
/ O +
F3 O +
- O +
hGHR B-Gene +
. O +

And O +
this O +
effect O +
was O +
not O +
observed O +
in O +
parental O +
Ba O +
/ O +
F3 O +
cells O +
. O +

Lower O +
concentrations O +
of O +
20 O -
K O +
hGH B-Gene +
more O +
strongly O +
induced O +
IGF B-Gene -
- I-Gene -
I I-Gene +
gene O +
expression O +
than O +
22 O -
K O +
- O +
hGH B-Gene +
. O +

These O +
results O +
suggest O +
that O +
20 O -
K O +
and O +
22 O -
K O +
hGH B-Gene +
stimulate O +
the O +
IGF B-Gene -
- I-Gene -
I I-Gene +
gene O +
expression O +
in O +
the O +
Ba O +
/ O +
F3 O +
- O +
hGHR B-Gene +
through O +
hGH B-Gene +
receptors I-Gene +
, O +
and O +
that O +
the O +
stronger O +
effect O +
of O +
20 O -
K O +
hGH B-Gene +
than O +
that O +
of O +
22 O -
K O +
hGH B-Gene +
in O +
enhancing O +
the O +
IGF B-Gene -
- I-Gene -
I I-Gene +
gene O +
expression O +
may O +
be O +
correlated O +
with O +
a O +
20 O -
K O +
hGH B-Gene +
specific O +
receptor O +
dimerization O +
mechanism O +
. O +

Pemphigus O +
vulgaris O +
antibody O +
identifies O +
pemphaxin B-Gene +
. O +

A O +
novel O +
keratinocyte O +
annexin B-Gene +
- O +
like O +
molecule O +
binding O +
acetylcholine O +
. O +

Because O +
pemphigus O +
vulgaris O +
( O +
PV O +
) O +
IgGs B-Gene +
adsorbed O +
on O +
the O +
rDsg3 B-Gene +
- O +
Ig B-Gene +
- O +
His O +
baculoprotein O +
induced O +
blisters O +
in O +
neonatal O +
mice O +
, O +
it O +
was O +
proposed O +
that O +
anti O +
- O +
desmoglein B-Gene +
3 I-Gene +
( O +
Dsg B-Gene +
3 I-Gene +
) O +
autoantibody O +
causes O +
PV O +
. O +

However O +
, O +
we O +
found O +
that O +
rDsg3 B-Gene +
- O +
Ig B-Gene +
- O +
His O +
absorbs O +
autoantibodies O +
to O +
different O +
antigens O +
, O +
including O +
a O +
non O +
- O +
Dsg B-Gene +
3 I-Gene +
keratinocyte O +
protein O +
of O +
130 O +
kDa O +
. O +

This O +
prompted O +
our O +
search O +
for O +
novel O +
targets O +
of O +
PV O +
autoimmunity O +
. O +

The O +
PV O +
IgG B-Gene +
eluted O +
from O +
a O +
75 O +
- O +
kDa O +
keratinocyte O +
protein O +
band O +
both O +
stained O +
epidermis O +
in O +
a O +
pemphigus O +
- O +
like O +
pattern O +
and O +
induced O +
acantholysis O +
in O +
keratinocyte O +
monolayers O +
. O +

Screening O +
of O +
a O +
keratinocyte O +
lambdagt11 O +
cDNA O +
library O +
with O +
this O +
antibody O +
identified O +
clones O +
carrying O +
cDNA O +
inserts O +
encoding O +
a O +
novel O +
molecule O +
exhibiting O +
approximately O +
40 O +
% O +
similarity O +
with O +
annexin-2 B-Gene +
, O +
named O +
pemphaxin B-Gene +
( O +
PX B-Gene +
) O +
. O +

Recombinant O +
PX B-Gene +
( O +
rPX B-Gene +
- O +
His O +
) O +
was O +
produced O +
in O +
Escherichia O +
coli O +
M15 O +
cells O +
, O +
and O +
, O +
because O +
annexins B-Gene +
can O +
act O +
as O +
cholinergic B-Gene +
receptors I-Gene +
, O +
its O +
conformation O +
was O +
tested O +
in O +
a O +
cholinergic O +
radioligand O +
binding O +
assay O +
. O +

rPX B-Gene +
- O +
His O +
specifically O +
bound O +
[ O -
( O -
3 O -
) O -
H O -
] O -
acetylcholine O +
, O +
suggesting O +
that O +
PX B-Gene +
is O +
one O +
of O +
the O +
keratinocyte O +
cholinergic B-Gene +
receptors I-Gene +
known O +
to O +
be O +
targeted O +
by O +
disease O +
- O +
causing O +
PV O +
antibodies O +
. O +

Preabsorption O +
of O +
PV O +
sera O +
with O +
rPX B-Gene +
- O +
His O +
eliminated O +
acantholytic O +
activity O +
, O +
and O +
eluted O +
antibody O +
immunoprecipitated O +
native O +
PX B-Gene +
. O +

This O +
antibody O +
alone O +
did O +
not O +
cause O +
skin O +
blisters O +
in O +
vivo O +
, O +
but O +
its O +
addition O +
to O +
the O +
preabsorbed O +
PV O +
IgG B-Gene +
fraction O +
restored O +
acantholytic O +
activity O +
, O +
indicating O +
that O +
acantholysis O +
in O +
PV O +
results O +
from O +
synergistic O +
action O +
of O +
antibodies O +
to O +
different O +
keratinocyte O +
self O +
- O +
antigens O +
, O +
including O +
both O +
acetylcholine B-Gene +
receptors I-Gene +
and O +
desmosomal O +
cadherins B-Gene +
. O +

Identification O +
and O +
characterization O +
of O +
two O +
neuromedin B-Gene +
U I-Gene +
receptors I-Gene +
differentially O +
expressed O +
in O +
peripheral O +
tissues O +
and O +
the O +
central O +
nervous O +
system O +
. O +

Two O +
structurally O +
related O +
, O +
G B-Gene -
- I-Gene -
protein I-Gene -
- I-Gene -
coupled I-Gene +
receptors I-Gene +
were O +
identified O +
as O +
receptors O +
for O +
the O +
neuropeptide B-Gene +
, O +
neuromedin B-Gene +
U I-Gene +
. O +

This O +
peptide O +
is O +
found O +
in O +
highest O +
levels O +
in O +
the O +
gut O +
and O +
genitourinary O +
system O +
where O +
it O +
potently O +
contracts O +
smooth O +
muscle O +
but O +
is O +
also O +
expressed O +
in O +
the O +
spinal O +
cord O +
and O +
discrete O +
regions O +
of O +
the O +
brain O +
. O +

Binding O +
sites O +
for O +
neuromedin B-Gene +
U I-Gene +
have O +
been O +
characterized O +
in O +
rat O +
uterus O +
, O +
however O +
, O +
little O +
is O +
known O +
about O +
the O +
activity O +
of O +
this O +
peptide O +
in O +
the O +
regions O +
of O +
the O +
central O +
nervous O +
system O +
where O +
it O +
is O +
expressed O +
. O +

The O +
receptors O +
characterized O +
in O +
this O +
report O +
are O +
activated O +
by O +
neuromedin B-Gene +
U I-Gene +
at O +
nanomolar O +
potency O +
in O +
heterologous O +
expression O +
systems O +
and O +
bind O +
radiolabeled O +
neuromedin B-Gene +
U I-Gene +
with O +
high O +
affinity O +
. O +

Localization O +
of O +
the O +
receptor O +
RNA O +
by O +
quantitative O +
reverse O +
transcription O +
- O +
polymerase O +
chain O +
reaction O +
in O +
a O +
variety O +
of O +
human O +
tissues O +
shows O +
distinct O +
expression O +
patterns O +
for O +
the O +
two O +
receptors O +
. O +

NMU1 B-Gene +
is O +
expressed O +
predominantly O +
in O +
peripheral O +
tissues O +
, O +
whereas O +
NMU2 B-Gene +
is O +
more O +
highly O +
expressed O +
in O +
the O +
central O +
nervous O +
system O +
. O +

Identification O +
of O +
neuromedin B-Gene +
U I-Gene +
receptor I-Gene +
subtypes O +
will O +
greatly O +
aid O +
in O +
the O +
determination O +
of O +
the O +
physiological O +
roles O +
of O +
this O +
peptide O +
. O +

Thioesterases O +
and O +
the O +
premature O +
termination O +
of O +
polyketide O +
chain O +
elongation O +
in O +
rifamycin O +
B O +
biosynthesis O +
by O +
Amycolatopsis O +
mediterranei O +
S699 O +
. O +

The O +
role O +
of O +
two O +
thioesterase B-Gene +
genes O +
in O +
the O +
premature O +
release O +
of O +
polyketide B-Gene +
synthase I-Gene +
intermediates O +
during O +
rifamycin O +
biosynthesis O +
in O +
the O +
Amycolatopsis O +
mediterranei O +
S699 O +
strain O +
was O +
investigated O +
. O +

Creation O +
of O +
an O +
in O -
- O -
frame O +
deletion O +
in O +
the O +
rifR B-Gene +
gene O +
led O +
to O +
a O +
30 O +
approximately O +
60 O +
% O +
decrease O +
in O +
the O +
production O +
of O +
both O +
rifamycin O +
B O +
by O +
the O +
S699 O +
strain O +
or O +
a O +
series O +
of O +
tetra O +
- O +
to O +
decaketide O +
shunt O +
products O +
of O +
polyketide O +
chain O +
assembly O +
by O +
the O +
rifF B-Gene +
strain O +
. O +

Since O +
a O +
similar O +
percentage O +
decrease O +
was O +
seen O +
in O +
both O +
genetic O +
backgrounds O +
, O +
we O +
conclude O +
that O +
the O +
RifR B-Gene +
thioesterase B-Gene +
2 O +
is O +
not O +
involved O +
in O +
premature O +
release O +
of O +
the O +
carbon O +
chain O +
assembly O +
intermediates O +
. O +

Similarly O +
, O +
fusion O +
of O +
the O +
Saccharopolyspora O +
erythraea O +
DEBS3 B-Gene +
thioesterase B-Gene +
I O +
domain O +
to O +
the O +
C O +
- O +
terminus O +
of O +
the O +
RifE B-Gene +
PKS O +
subunit O +
did O +
not O +
result O +
in O +
a O +
noticeable O +
increase O +
in O +
the O +
amount O +
of O +
the O +
undecaketide O +
intermediate O +
formed O +
nor O +
in O +
the O +
amounts O +
of O +
the O +
tetra O +
- O +
to O +
decaketide O +
shunt O +
products O +
. O +

Hence O +
, O +
premature O +
release O +
of O +
the O +
carbon O +
chain O +
assembly O +
intermediates O +
is O +
an O +
unusual O +
property O +
of O +
the O +
Rif B-Gene +
PKS O +
itself O +
. O +

Glucose B-Gene +
transporter I-Gene +
mutants O +
of O +
Escherichia O +
coli O +
K-12 O +
with O +
changes O +
in O +
substrate O +
recognition O +
of O +
IICB B-Gene -
( I-Gene -
Glc I-Gene -
) I-Gene +
and O +
induction O +
behavior O +
of O +
the O +
ptsG B-Gene +
gene O +
. O +

In O +
Escherichia O +
coli O +
K-12 O +
, O +
the O +
major O +
glucose B-Gene +
transporter I-Gene +
with O +
a O +
central O +
role O +
in O +
carbon O +
catabolite O +
repression O +
and O +
in O +
inducer O +
exclusion O +
is O +
the O +
phosphoenolpyruvate B-Gene +
- I-Gene +
dependent I-Gene +
glucose I-Gene +
: I-Gene +
phosphotransferase I-Gene +
system I-Gene +
( O +
PTS B-Gene +
) O +
. O +

Its O +
membrane O +
- O +
bound O +
subunit O +
, O +
IICB B-Gene +
( I-Gene +
Glc I-Gene +
) I-Gene +
, O +
is O +
encoded O +
by O +
the O +
gene O +
ptsG B-Gene +
; O +
its O +
soluble O +
domain O +
, O +
IIA B-Gene +
( I-Gene +
Glc I-Gene +
) I-Gene +
, O +
is O +
encoded O +
by O +
crr B-Gene +
, O +
which O +
is O +
a O +
member O +
of O +
the O +
pts B-Gene +
operon I-Gene +
. O +

The O +
system O +
is O +
inducible O +
by O +
D O -
- O -
glucose O +
and O +
, O +
to O +
a O +
lesser O +
degree O +
, O +
by O +
L O -
- O -
sorbose O +
. O +

The O +
regulation O +
of O +
ptsG B-Gene +
transcription O +
was O +
analyzed O +
by O +
testing O +
the O +
induction O +
of O +
IICB B-Gene -
( I-Gene -
Glc I-Gene -
) I-Gene +
transporter O +
activity O +
and O +
of O +
a O +
single O +
- O +
copy O +
Phi O +
( O +
ptsGop B-Gene +
- O +
lacZ B-Gene +
) O +
fusion O +
. O +

Among O +
mutations O +
found O +
to O +
affect O +
directly O +
ptsG B-Gene +
expression O +
were O +
those O +
altering O +
the O +
activity O +
of O +
adenylate B-Gene +
cyclase I-Gene +
( O +
cyaA B-Gene +
) O +
, O +
the O +
repressor O +
DgsA B-Gene +
( O +
dgsA B-Gene +
; O +
also O +
called O +
Mlc B-Gene +
) O +
, O +
the O +
general O +
PTS B-Gene +
proteins I-Gene +
enzyme I-Gene +
I I-Gene +
( O +
ptsI B-Gene +
) O +
and O +
histidine O +
carrier O +
protein O +
HPr B-Gene +
( O +
ptsH B-Gene +
) O +
, O +
and O +
the O +
IIA B-Gene +
( I-Gene +
Glc I-Gene +
) I-Gene +
and O +
IIB B-Gene +
( I-Gene +
Glc I-Gene +
) I-Gene +
domains O +
, O +
as O +
well O +
as O +
several O +
authentic O +
and O +
newly O +
isolated O +
UmgC B-Gene +
mutations O +
. O +

The O +
latter O +
, O +
originally O +
thought O +
to O +
map O +
in O +
the O +
repressor O +
gene O +
umgC B-Gene +
outside O +
the O +
ptsG B-Gene +
locus O +
, O +
were O +
found O +
to O +
represent O +
ptsG B-Gene +
alleles O +
. O +

These O +
affected O +
invariably O +
the O +
substrate O +
specificity O +
of O +
the O +
IICB B-Gene +
( I-Gene +
Glc I-Gene +
) I-Gene +
domain O +
, O +
thus O +
allowing O +
efficient O +
transport O +
and O +
phosphorylation O +
of O +
substrates O +
normally O +
transported O +
very O +
poorly O +
or O +
not O +
at O +
all O +
by O +
this O +
PTS B-Gene +
. O +

Simultaneously O +
, O +
all O +
of O +
these O +
substrates O +
became O +
inducers O +
for O +
ptsG B-Gene +
. O +

From O +
the O +
analysis O +
of O +
the O +
mutants O +
, O +
from O +
cis O +
- O +
trans O +
dominance O +
tests O +
, O +
and O +
from O +
the O +
identification O +
of O +
the O +
amino O +
acid O +
residues O +
mutated O +
in O +
the O +
UmgC B-Gene +
mutants O +
, O +
a O +
new O +
regulatory O +
mechanism O +
involved O +
in O +
ptsG B-Gene +
induction O +
is O +
postulated O +
. O +

According O +
to O +
this O +
model O +
, O +
the O +
phosphorylation O +
state O +
of O +
IIB B-Gene +
( I-Gene +
Glc I-Gene +
) I-Gene +
modulates O +
IIC B-Gene -
( I-Gene -
Glc I-Gene -
) I-Gene +
which O +
, O +
directly O +
or O +
indirectly O +
, O +
controls O +
the O +
repressor O +
DgsA B-Gene +
and O +
hence O +
ptsG B-Gene +
expression O +
. O +

By O +
the O +
same O +
mechanism O +
, O +
glucose O +
uptake O +
and O +
phosphorylation O +
also O +
control O +
the O +
expression O +
of O +
the O +
pts B-Gene +
operon I-Gene +
and O +
probably O +
of O +
all O +
operons O +
controlled O +
by O +
the O +
repressor O +
DgsA B-Gene +
. O +

H B-Gene +
- I-Gene +
NS I-Gene +
- O +
Dependent O +
regulation O +
of O +
flagellar O +
synthesis O +
is O +
mediated O +
by O +
a O +
LysR B-Gene +
family I-Gene +
protein O +
. O +

H B-Gene -
- I-Gene -
NS I-Gene +
regulates O +
the O +
flagellar O +
master O +
operon O +
( O +
flhDC B-Gene +
) O +
and O +
thus O +
is O +
necessary O +
for O +
flagellation O +
of O +
Escherichia O +
coli O +
. O +

However O +
, O +
the O +
molecular O +
mechanism O +
of O +
its O +
regulation O +
has O +
remained O +
unknown O +
. O +

Genetic O +
screening O +
of O +
a O +
transposon O +
insertion O +
abolishing O +
the O +
H B-Gene -
- I-Gene -
NS I-Gene +
effect O +
revealed O +
a O +
previously O +
unidentified O +
gene O +
, O +
named O +
hdfR B-Gene +
, O +
encoding O +
a O +
LysR B-Gene +
family I-Gene +
protein O +
. O +

Binding O +
of O +
purified O +
HdfR B-Gene +
to O +
the O +
flhDC B-Gene +
promoter O +
was O +
demonstrated O +
by O +
a O +
DNA O +
mobility O +
shift O +
assay O +
, O +
indicating O +
that O +
HdfR B-Gene +
is O +
a O +
transcriptional O +
regulator O +
for O +
the O +
flagellar O +
master O +
operon O +
. O +

Furthermore O +
, O +
the O +
expression O +
of O +
the O +
hdfR B-Gene +
gene O +
was O +
shown O +
to O +
be O +
negatively O +
regulated O +
by O +
H B-Gene -
- I-Gene -
NS I-Gene +
. O +

Role O +
of O +
A B-Gene +
and I-Gene +
B I-Gene +
blood I-Gene +
group I-Gene +
antigens I-Gene +
in O +
the O +
expression O +
of O +
adhesive O +
activity O +
of O +
von B-Gene +
Willebrand I-Gene +
factor I-Gene +
. O +

ABO B-Gene +
( O +
H O +
) O +
blood O +
group O +
antigens O +
are O +
covalently O +
linked O +
to O +
the O +
oligosaccharide O +
side O +
- O +
chains O +
of O +
von B-Gene +
Willebrand I-Gene +
factor I-Gene +
( O +
VWF B-Gene +
) O +
. O +

In O +
this O +
study O +
, O +
we O +
investigated O +
the O +
role O +
of O +
the O +
A O +
and O +
B O +
antigens O +
in O +
the O +
expression O +
of O +
VWF B-Gene +
adhesive O +
activity O +
. O +

VWF B-Gene +
of O +
type O +
A O +
, O +
B O +
or O +
O O +
was O +
purified O +
from O +
fresh O +
frozen O +
plasma O +
. O +

Presence O +
of O +
A O +
or O +
B O +
antigen O +
on O +
the O +
VWF B-Gene +
was O +
confirmed O +
by O +
enzyme O +
- O +
linked O +
immunosorbent O +
assay O +
( O +
ELISA O +
) O +
and O +
by O +
immunoblotting O +
with O +
monoclonal O +
anti O +
- O +
A O +
or O +
anti O +
- O +
B O +
. O +

The O +
A O +
or O +
B O +
antigen O +
was O +
also O +
detected O +
in O +
the O +
48 O +
/ O +
52 O +
- O +
kDa O +
fragment O +
of O +
the O +
respective O +
VWF B-Gene +
after O +
trypsin B-Gene +
digestion O +
. O +

Removal O +
of O +
A O +
antigen O +
with O +
alpha B-Gene -
- I-Gene -
N I-Gene -
- I-Gene -
acetylgalactosaminidase I-Gene +
or O +
B O +
antigen O +
with O +
alpha B-Gene -
- I-Gene -
galactosidase I-Gene +
did O +
not O +
affect O +
its O +
multimer O +
size O +
or O +
antigenic O +
level O +
, O +
but O +
decreased O +
the O +
ristocetin O +
cofactor O +
( O +
RCoF O +
) O +
activity O +
of O +
the O +
respective O +
VWF B-Gene +
by O +
33 O +
- O +
39 O +
% O +
( O +
P O +
< O +
0.01 O +
- O +
0.002 O +
) O +
. O +

Removal O +
of O +
A O +
or O +
B O +
antigen O +
from O +
VWF B-Gene +
did O +
not O +
affect O +
the O +
binding O +
of O +
the O +
VWF B-Gene +
to O +
immobilized O +
type B-Gene +
III I-Gene +
collagen I-Gene +
. O +

A O +
and O +
B O +
antigens O +
were O +
not O +
detected O +
in O +
platelet O +
VWF B-Gene +
. O +

These O +
results O +
indicate O +
that O +
AB O +
structures O +
play O +
a O +
role O +
in O +
platelet O +
aggregating O +
activity O +
of O +
VWF B-Gene +
. O +

Interleukin B-Gene +
secretion O +
, O +
proteoglycan O +
and O +
procollagen B-Gene +
alpha I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
( I-Gene -
I I-Gene -
) I-Gene +
gene O +
expression O +
in O +
Crouzon O +
fibroblasts O +
treated O +
with O +
basic B-Gene +
fibroblast I-Gene +
growth I-Gene +
factor I-Gene +
. O +

The O +
present O +
study O +
provides O +
the O +
first O +
evidence O +
that O +
fibroblasts O +
obtained O +
from O +
patients O +
affected O +
by O +
Crouzon O +
syndrome O +
, O +
a O +
rare O +
craniosynostosis O +
, O +
despite O +
mutations O +
in O +
the O +
high O +
- O +
affinity O +
bFGF B-Gene +
receptor I-Gene +
retain O +
their O +
capacity O +
to O +
respond O +
to O +
bFGF B-Gene +
. O +

The O +
growth B-Gene +
factor I-Gene +
reduces O +
IL-1 B-Gene +
secretion O +
, O +
downregulates O +
biglycan O +
and O +
procollagen B-Gene +
alpha I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
( I-Gene -
I I-Gene -
) I-Gene +
, O +
and O +
increases O +
betaglycan B-Gene +
expression O +
. O +

Since O +
betaglycan B-Gene +
is O +
a O +
co O +
- O +
receptor O +
for O +
bFGF B-Gene +
signalling O +
, O +
an O +
alternative O +
signal O +
transduction O +
pathway O +
is O +
suggested O +
in O +
Crouzon O +
fibroblasts O +
, O +
to O +
explain O +
the O +
documented O +
changes O +
in O +
ECM O +
macromolecule O +
production O +
. O +

Analysis O +
of O +
bruchid O +
resistance O +
in O +
the O +
wild O +
common O +
bean O +
accession O +
G02771 O +
: O +
no O +
evidence O +
for O +
insecticidal O +
activity O +
of O +
arcelin B-Gene +
5 I-Gene +
. O +

Arcelins B-Gene +
are O +
abundant O +
seed O +
storage O +
proteins O +
thought O +
to O +
be O +
implicated O +
in O +
the O +
resistance O +
of O +
wild O +
Phaseolus O +
vulgaris O +
( O +
L. O +
) O +
genotypes O +
against O +
Zabrotes O +
subfasciatus O +
( O +
Boheman O +
) O +
, O +
an O +
important O +
storage O +
insect O +
pest O +
of O +
common O +
bean O +
. O +

Here O +
, O +
the O +
insecticidal O +
activity O +
of O +
the O +
arcelin-5 B-Gene +
variant O +
that O +
is O +
present O +
in O +
the O +
highly O +
resistant O +
P. O +
vulgaris O +
accession O +
G02771 O +
was O +
investigated O +
. O +

No O +
correlation O +
could O +
be O +
established O +
between O +
the O +
presence O +
of O +
arcelin B-Gene +
5 I-Gene +
and O +
the O +
insecticidal O +
effects O +
observed O +
in O +
G02771 O +
seeds O +
. O +

Insect O +
feeding O +
assays O +
with O +
artificial O +
seeds O +
into O +
which O +
purified O +
arcelin-5 B-Gene +
protein O +
was O +
incorporated O +
and O +
with O +
transgenic O +
P. O +
acutifolius O +
( O +
A. O +
Gray O +
) O +
seeds O +
in O +
which O +
the O +
arcelin B-Gene +
- I-Gene +
5 I-Gene +
genes O +
were O +
expressed O +
, O +
showed O +
that O +
the O +
presence O +
of O +
arcelin B-Gene +
- I-Gene +
5 I-Gene +
proteins O +
, O +
even O +
at O +
elevated O +
levels O +
, O +
was O +
not O +
sufficient O +
to O +
achieve O +
adequate O +
resistance O +
against O +
Z. O +
subfasciatus O +
. O +

The O +
same O +
might O +
apply O +
to O +
other O +
arcelin B-Gene +
variants O +
. O +

Nevertheless O +
, O +
as O +
resistance O +
is O +
clearly O +
closely O +
linked O +
to O +
the O +
presence O +
of O +
the O +
arcelin-1 B-Gene +
or O +
arcelin-5 B-Gene +
locus O +
, O +
arcelins B-Gene +
remain O +
useful O +
markers O +
in O +
breeding O +
programmes O +
aimed O +
at O +
introgressing O +
high O +
levels O +
of O +
resistance O +
to O +
Z. O +
subfasciatus O +
in O +
P. O +
vulgaris O +
cultivars O +
. O +

ApoE B-Gene +
polymorphism O +
and O +
fish O +
oil O +
supplementation O +
in O +
subjects O +
with O +
an O +
atherogenic O +
lipoprotein O +
phenotype O +
. O +

The O +
study O +
assessed O +
the O +
efficacy O +
of O +
fish O +
oil O +
supplementation O +
in O +
counteracting O +
the O +
classic O +
dyslipidemia O +
of O +
the O +
atherogenic O +
lipoprotein O +
phenotype O +
( O +
ALP O +
) O +
. O +

In O +
addition O +
, O +
the O +
impact O +
of O +
the O +
common O +
apolipoprotein B-Gene +
E I-Gene +
( O +
apoE B-Gene +
) O +
polymorphism O +
on O +
the O +
fasting O +
and O +
postprandial O +
lipid O +
profile O +
and O +
on O +
responsiveness O +
to O +
the O +
dietary O +
intervention O +
was O +
established O +
. O +

Fifty O +
- O +
five O +
ALP O +
males O +
( O +
aged O +
34 O +
to O +
69 O +
years O +
, O +
body O +
mass O +
index O +
22 O +
to O +
35 O +
kg O +
/ O +
m O -
( O -
2 O -
) O +
, O +
triglyceride O +
[ O +
TG O +
] O +
levels O +
1.5 O +
to O +
4.0 O +
mmol O +
/ O +
L O +
, O +
high B-Gene +
density I-Gene +
lipoprotein I-Gene +
cholesterol O +
[ O +
HDL B-Gene +
- O +
C O +
] O +
< O +
1.1 O +
mmol O +
/ O +
l O +
, O +
and O +
percent O +
low B-Gene +
density I-Gene +
lipoprotein I-Gene +
[ I-Gene -
LDL I-Gene -
] I-Gene -
-3 I-Gene +
> O +
40 O +
% O +
total O +
LDL B-Gene +
) O +
completed O +
a O +
randomized O +
placebo O +
- O +
controlled O +
crossover O +
trial O +
of O +
fish O +
oil O +
( O +
3.0 O +
g O +
eicosapentaenoic O +
acid O +
/ O +
docosahexaenoic O +
acid O +
per O +
day O +
) O +
and O +
placebo O +
( O +
olive O +
oil O +
) O +
capsules O +
with O +
the O +
6 O +
- O +
week O +
treatment O +
arms O +
separated O +
by O +
a O +
12 O +
- O +
week O +
washout O +
period O +
. O +

In O +
addition O +
to O +
fasting O +
blood O +
samples O +
, O +
at O +
the O +
end O +
of O +
each O +
intervention O +
arm O +
, O +
a O +
postprandial O +
assessment O +
of O +
lipid O +
metabolism O +
was O +
carried O +
out O +
. O +

Fish O +
oil O +
supplementation O +
resulted O +
in O +
a O +
reduction O +
in O +
fasting O +
TG O +
level O +
of O +
35 O +
% O +
( O +
P O +
< O +
0.001 O +
) O +
, O +
in O +
postprandial O +
TG O +
response O +
of O +
26 O +
% O +
( O +
TG O +
area O +
under O +
the O +
curve O +
, O +
P O +
< O +
0.001 O +
) O +
, O +
and O +
in O +
percent O +
LDL-3 B-Gene +
of O +
26 O +
% O +
( O +
P O +
< O +
0.05 O +
) O +
. O +

However O +
, O +
no O +
change O +
in O +
HDL B-Gene +
- O +
C O +
levels O +
was O +
evident O +
( O +
P O +
= O +
0.752 O +
) O +
. O +

ANCOVA O +
showed O +
that O +
baseline O +
HDL B-Gene +
- O +
C O +
levels O +
were O +
significantly O +
lower O +
in O +
apoE4 B-Gene +
carriers O +
( O +
P O +
= O +
0.035 O +
) O +
. O +

The O +
apoE B-Gene +
genotype O +
also O +
had O +
a O +
striking O +
impact O +
on O +
lipid O +
responses O +
to O +
fish O +
oil O +
intervention O +
. O +

Individuals O +
with O +
an O +
apoE2 B-Gene +
allele O +
displayed O +
a O +
marked O +
reduction O +
in O +
postprandial O +
incremental O +
TG O +
response O +
( O +
TG O +
incremental O +
area O +
under O +
the O +
curve O +
, O +
P O +
= O +
0.023 O +
) O +
and O +
a O +
trend O +
toward O +
an O +
increase O +
in O +
lipoprotein B-Gene +
lipase I-Gene +
activity O +
relative O +
to O +
non O +
- O +
E2 O +
carriers O +
. O +

In O +
apoE4 B-Gene +
individuals O +
, O +
a O +
significant O +
increase O +
in O +
total O +
cholesterol O +
and O +
a O +
trend O +
toward O +
a O +
reduction O +
in O +
HDL B-Gene +
- O +
C O +
relative O +
to O +
the O +
common O +
homozygous O +
E3 O +
/ O +
E3 O +
profile O +
was O +
evident O +
. O +

Our O +
data O +
demonstrate O +
the O +
efficacy O +
of O +
fish O +
oil O +
fatty O +
acids O +
in O +
counteracting O +
the O +
proatherogenic O +
lipid O +
profile O +
of O +
the O +
ALP O +
but O +
also O +
that O +
the O +
apoE B-Gene +
genotype O +
influences O +
responsiveness O +
to O +
this O +
dietary O +
treatment O +
. O +

Decreased O +
NADH B-Gene +
glutamate I-Gene +
synthase I-Gene +
activity O +
in O +
nodules O +
and O +
flowers O +
of O +
alfalfa O +
( O +
Medicago O +
sativa O +
L. O +
) O +
transformed O +
with O +
an O +
antisense O +
glutamate B-Gene +
synthase I-Gene +
transgene O +
. O +

Legumes O +
obtain O +
a O +
substantial O +
portion O +
of O +
their O +
nitrogen O +
( O +
N O +
) O +
from O +
symbiotic O +
N2 O +
fixation O +
in O +
root O +
nodules O +
. O +

The O +
glutamine B-Gene +
synthetase I-Gene +
( O +
GS B-Gene +
, O +
EC B-Gene +
6.3.1.2 I-Gene +
) O +
/ O +
glutamate B-Gene +
synthase I-Gene +
( O +
GOGAT B-Gene +
) O +
cycle O +
is O +
responsible O +
for O +
the O +
initial O +
N O +
assimilation O +
. O +

This O +
report O +
describes O +
the O +
analysis O +
of O +
a O +
transgenic O +
alfalfa O +
( O +
Medicago O +
sativa O +
L. O +
) O +
line O +
containing O +
an O +
antisense O +
NADH B-Gene -
- I-Gene -
GOGAT I-Gene +
( O +
EC B-Gene +
1.4.1.14 I-Gene +
) O +
under O +
the O +
control O +
of O +
the O +
nodule O +
- O +
enhanced O +
aspartate B-Gene +
amino I-Gene +
- I-Gene +
transferase I-Gene +
( I-Gene +
AAT-2 I-Gene +
) I-Gene +
promoter O +
. O +

In O +
one O +
transgenic O +
line O +
, O +
NADH B-Gene -
- I-Gene -
GOGAT I-Gene +
enzyme O +
activity O +
was O +
reduced O +
to O +
approximately O +
50 O +
% O +
, O +
with O +
a O +
corresponding O +
reduction O +
in O +
protein O +
and O +
mRNA O +
. O +

The O +
transcript O +
abundance O +
for O +
cytosolic O +
GS B-Gene +
, O +
ferredoxin B-Gene +
- I-Gene +
dependent I-Gene +
GOGAT I-Gene +
( O +
EC B-Gene +
1.4.7.1 I-Gene +
) O +
, O +
AAT-2 B-Gene +
( O +
EC B-Gene +
2.6.1.1 I-Gene +
) O +
, O +
asparagine B-Gene +
synthase I-Gene +
( O +
EC B-Gene +
6.3.5.4 I-Gene +
) O +
, O +
and O +
phosphoenolpyruvate B-Gene +
carboxylase I-Gene +
( O +
PEPC B-Gene +
, O +
EC B-Gene +
4.1.1.31 I-Gene +
) O +
were O +
unaffected O +
, O +
as O +
were O +
enzyme O +
activities O +
for O +
AAT B-Gene +
, O +
PEPC B-Gene +
and O +
GS B-Gene +
. O +

Antisense O +
NADH B-Gene +
- I-Gene +
GOGAT I-Gene +
plants O +
grown O +
under O +
symbiotic O +
conditions O +
were O +
moderately O +
chlorotic O +
and O +
reduced O +
in O +
growth O +
and O +
N O +
content O +
, O +
even O +
though O +
symbiotic O +
N2 O +
fixation O +
was O +
not O +
significantly O +
reduced O +
. O +

The O +
addition O +
of O +
nitrate O +
relieved O +
the O +
chlorosis O +
and O +
restored O +
growth O +
and O +
N O +
content O +
. O +

Surprisingly O +
, O +
the O +
antisense O +
NADH B-Gene +
- I-Gene +
GOGAT I-Gene +
plants O +
were O +
male O +
sterile O +
resulting O +
from O +
inviable O +
pollen O +
. O +

A O +
reduction O +
in O +
NADH B-Gene +
- I-Gene +
GOGAT I-Gene +
enzyme O +
activity O +
and O +
transcript O +
abundance O +
in O +
the O +
antisense O +
plants O +
was O +
measured O +
during O +
the O +
early O +
stages O +
of O +
flower O +
development O +
. O +

Inheritance O +
of O +
the O +
transgene O +
was O +
stable O +
and O +
resulted O +
in O +
progeny O +
with O +
a O +
range O +
of O +
NADH B-Gene +
- I-Gene +
GOGAT I-Gene +
activity O +
. O +

These O +
data O +
indicate O +
that O +
NADH B-Gene -
- I-Gene -
GOGAT I-Gene +
plays O +
a O +
critical O +
role O +
in O +
the O +
assimilation O +
of O +
symbiotically O +
fixed O +
N O +
and O +
during O +
pollen O +
development O +
. O +

HIV-1 O +
TAR O +
RNA O +
enhances O +
the O +
interaction O +
between O +
Tat B-Gene +
and O +
cyclin B-Gene +
T1 I-Gene +
. O +

Human O +
immunodeficiency O +
virus O +
, O +
type O +
1 O +
( O +
HIV O +
- O +
1 O +
) O +
, O +
Tat B-Gene +
activates O +
elongation O +
of O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
transcription O +
at O +
the O +
HIV-1 O +
promoter O +
through O +
interaction O +
with O +
the O +
cyclin B-Gene +
T1 I-Gene +
( O +
CycT1 B-Gene +
) O +
subunit O +
of O +
the O +
positive B-Gene +
transcription I-Gene +
elongation I-Gene +
factor I-Gene +
complex I-Gene +
, O +
P B-Gene +
- I-Gene +
TEFb I-Gene +
. O +

Binding O +
of O +
Tat B-Gene +
to O +
CycT1 B-Gene +
induces O +
cooperative O +
binding O +
of O +
the O +
P B-Gene -
- I-Gene -
TEFb I-Gene +
complex O +
onto O +
nascent O +
HIV-1 O +
TAR O +
RNA O +
. O +

Here O +
the O +
specific O +
interaction O +
between O +
Tat B-Gene +
protein O +
, O +
human O +
cyclin B-Gene +
T1 I-Gene +
, O +
and O +
HIV-1 O +
TAR O +
RNA O +
was O +
analyzed O +
by O +
fluorescence O +
resonance O +
energy O +
transfer O +
, O +
using O +
fluorescein O +
- O +
labeled O +
TAR O +
RNA O +
and O +
a O +
rhodamine O +
- O +
labeled O +
Tat B-Gene +
protein O +
synthesized O +
through O +
solid O +
- O +
phase O +
chemistry O +
. O +

We O +
find O +
that O +
CycT1 B-Gene +
remodels O +
the O +
structure O +
of O +
Tat B-Gene +
to O +
enhance O +
its O +
affinity O +
for O +
TAR O +
RNA O +
and O +
that O +
TAR O +
RNA O +
further O +
enhances O +
the O +
interaction O +
between O +
Tat B-Gene +
and O +
CycT1 B-Gene +
. O +

We O +
conclude O +
that O +
TAR O +
RNA O +
nucleates O +
the O +
formation O +
of O +
the O +
Tat B-Gene +
. O +
P B-Gene +
- I-Gene +
TEFb I-Gene +
complex O +
through O +
an O +
induced O +
fit O +
mechanism O +
. O +

Fibroblast B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
10 I-Gene +
: O +
a O +
stromal O +
mediator O +
of O +
epithelial O +
function O +
in O +
the O +
ovine O +
uterus O +
. O +

Fibroblast B-Gene +
growth I-Gene +
factor-10 I-Gene +
( O +
FGF-10 B-Gene +
) O +
is O +
a O +
stromal O +
- O +
derived O +
paracrine O +
growth B-Gene +
factor I-Gene +
considered O +
to O +
be O +
important O +
during O +
embryogenesis O +
; O +
however O +
, O +
its O +
expression O +
by O +
cells O +
in O +
the O +
female O +
reproductive O +
tract O +
has O +
not O +
been O +
investigated O +
. O +

Therefore O +
, O +
an O +
ovine O +
FGF-10 B-Gene +
cDNA O +
was O +
cloned O +
from O +
an O +
ovine O +
endometrial O +
cDNA O +
library O +
to O +
investigate O +
expression O +
and O +
potential O +
paracrine O +
characteristics O +
of O +
FGF-10 B-Gene +
in O +
the O +
ovine O +
uterus O +
. O +

The O +
ovine O +
FGF-10 B-Gene +
cDNA O +
encodes O +
a O +
protein O +
of O +
213 O +
amino O +
acids O +
and O +
possesses O +
an O +
unusually O +
long O +
5 O -
' O +
untranslated O +
region O +
( O +
UTR O +
) O +
. O +

In O +
situ O +
hybridization O +
demonstrated O +
that O +
ovine O +
FGF-10 B-Gene +
mRNA O +
was O +
expressed O +
by O +
endometrial O +
stromal O +
cells O +
and O +
by O +
mesenchymal O +
cells O +
of O +
the O +
chorioallantoic O +
placenta O +
. O +

The O +
mRNA O +
for O +
FGF-7 B-Gene +
, O +
a O +
homologue O +
of O +
FGF-10 B-Gene +
, O +
was O +
localized O +
in O +
the O +
tunica O +
muscularis O +
of O +
blood O +
vessels O +
in O +
endometrium O +
and O +
myometrium O +
. O +

In O +
contrast O +
, O +
FGF B-Gene +
receptor I-Gene +
2IIIb I-Gene +
, O +
the O +
high O +
- O +
affinity O +
receptor O +
for O +
both O +
FGF-10 B-Gene +
and O +
FGF-7 B-Gene +
, O +
was O +
expressed O +
exclusively O +
in O +
luminal O +
epithelium O +
, O +
glandular O +
epithelium O +
, O +
and O +
placental O +
trophectoderm O +
. O +

The O +
in O +
vivo O +
spatial O +
expression O +
pattern O +
suggests O +
that O +
FGF-10 B-Gene +
is O +
a O +
novel O +
endometrial O +
stromal O +
cell O +
- O +
derived O +
mediator O +
of O +
uterine O +
epithelial O +
and O +
conceptus O +
trophectodermal O +
functions O +
. O +

The O +
nonoverlapping O +
spatial O +
patterns O +
of O +
expression O +
for O +
FGF-10 B-Gene +
and O +
FGF-7 B-Gene +
in O +
ovine O +
uterus O +
and O +
conceptus O +
suggest O +
independent O +
roles O +
in O +
uterine O +
function O +
and O +
conceptus O +
development O +
. O +

The O +
impact O +
of O +
the O +
ovulatory O +
cycle O +
on O +
cytokine B-Gene +
production O +
: O +
evaluation O +
of O +
systemic O +
, O +
cervicovaginal O +
, O +
and O +
salivary O +
compartments O +
. O +

To O +
understand O +
the O +
impact O +
of O +
the O +
menstrual O +
cycle O +
on O +
immunologic O +
parameters O +
, O +
we O +
measured O +
the O +
level O +
of O +
cytokines B-Gene +
and O +
chemokines B-Gene +
from O +
plasma O +
, O +
cervicovaginal O +
lavage O +
( O +
CVL O +
) O +
, O +
and O +
saliva O +
samples O +
of O +
6 O +
premenopausal O +
women O +
during O +
the O +
follicular O +
and O +
luteal O +
phases O +
of O +
the O +
ovulatory O +
cycle O +
. O +

We O +
demonstrate O +
that O +
the O +
level O +
of O +
plasma O +
interleukin-8 B-Gene +
( O +
IL-8 B-Gene +
) O +
was O +
4 O +
- O +
fold O +
higher O +
during O +
the O +
follicular O +
phase O +
than O +
the O +
luteal O +
phase O +
( O +
p O +
= O +
0.004 O +
) O +
, O +
whereas O +
plasma O +
IL-1beta B-Gene +
, O +
IL-4 B-Gene +
, O +
IL-6 B-Gene +
, O +
IL-10 B-Gene +
, O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
( O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
, O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
beta I-Gene +
( O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
) O +
, O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
( O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
) O +
, O +
macrophage B-Gene +
inflammatory I-Gene +
protein-1alpha I-Gene +
( O +
MIP-1alpha B-Gene +
) O +
, O +
and O +
TNF B-Gene +
receptor I-Gene +
II I-Gene +
( O +
TNFR B-Gene +
II I-Gene +
) O +
were O +
not O +
altered O +
during O +
the O +
ovulatory O +
cycle O +
. O +

In O +
the O +
vaginal O +
compartment O +
, O +
as O +
measured O +
from O +
CVL O +
samples O +
, O +
the O +
levels O +
of O +
IL-6 B-Gene +
and O +
IL-1beta B-Gene +
were O +
both O +
5 O +
- O +
fold O +
higher O +
in O +
the O +
follicular O +
than O +
the O +
luteal O +
phase O +
( O +
p O +
= O +
0.0002 O +
and O +
0.03 O +
, O +
respectively O +
) O +
. O +

Salivary O +
cytokine B-Gene +
and O +
chemokine B-Gene +
samples O +
were O +
similar O +
when O +
measured O +
during O +
the O +
luteal O +
and O +
the O +
follicular O +
phases O +
. O +

Additional O +
analysis O +
of O +
lymphocyte O +
subsets O +
for O +
phenotypic O +
and O +
functional O +
markers O +
indicated O +
that O +
they O +
were O +
not O +
influenced O +
by O +
the O +
ovulatory O +
cycle O +
. O +

Collectively O +
, O +
these O +
data O +
suggest O +
that O +
IL-6 B-Gene +
, O +
IL-8 B-Gene +
, O +
and O +
IL-1beta B-Gene +
are O +
differentially O +
regulated O +
during O +
the O +
ovulatory O +
cycle O +
. O +

Structure O +
- O +
function O +
relationships O +
in O +
an O +
anion O +
- O +
translocating O +
ATPase B-Gene +
. O +

The O +
ArsAB B-Gene +
ATPase I-Gene +
is O +
an O +
efflux O +
pump O +
located O +
in O +
the O +
inner O +
membrane O +
of O +
Escherichia O +
coli O +
. O +

This O +
transport B-Gene +
ATPase I-Gene +
confers O +
resistance O +
to O +
arsenite O +
and O +
antimonite O +
by O +
their O +
extrusion O +
from O +
the O +
cells O +
. O +

The O +
pump O +
is O +
composed O +
of O +
two O +
subunits O +
, O +
the O +
catalytic O +
ArsA B-Gene +
subunit O +
and O +
the O +
membrane O +
subunit O +
ArsB B-Gene +
. O +

The O +
complex O +
is O +
similar O +
in O +
many O +
ways O +
to O +
ATP B-Gene +
- I-Gene +
binding I-Gene +
cassette I-Gene +
( I-Gene -
' I-Gene -
ABC I-Gene -
' I-Gene +
) I-Gene +
transporters I-Gene +
, O +
which O +
typically O +
have O +
two O +
groups O +
of O +
six O +
transmembrane O +
- O +
spanning O +
helical O +
segments O +
and O +
two O +
nucleotide O +
- O +
binding O +
domains O +
( O +
NBDs O +
) O +
. O +

The O +
45 O +
kDa O +
ArsB B-Gene +
protein O +
has O +
12 O +
transmembrane O +
- O +
spanning O +
segments O +
. O +

ArsB B-Gene +
contains O +
the O +
substrate O +
translocation O +
pathway O +
and O +
is O +
capable O +
of O +
functioning O +
as O +
an O +
anion B-Gene +
uniporter I-Gene +
. O +

The O +
63 O +
kDa O +
ArsA B-Gene +
protein O +
is O +
a O +
substrate O +
- O +
activated O +
ATPase B-Gene +
. O +

It O +
has O +
two O +
homologous O +
halves O +
, O +
A1 O +
and O +
A2 O +
, O +
which O +
are O +
clearly O +
the O +
result O +
of O +
an O +
ancestral O +
gene O +
duplication O +
and O +
fusion O +
. O +

Each O +
half O +
has O +
a O +
consensus O +
NBD O +
. O +

The O +
mechanism O +
of O +
allosteric O +
activation O +
of O +
the O +
ArsA B-Gene +
ATPase I-Gene +
has O +
been O +
elucidated O +
by O +
a O +
combination O +
of O +
molecular O +
genetics O +
and O +
biochemical O +
, O +
structural O +
and O +
kinetic O +
analyses O +
. O +

Conformational O +
changes O +
produced O +
by O +
binding O +
of O +
substrates O +
, O +
activator O +
and/or O +
products O +
could O +
be O +
revealed O +
by O +
stopped O +
- O +
flow O +
fluorescence O +
measurements O +
with O +
single O +
- O +
tryptophan O +
derivatives O +
of O +
ArsA B-Gene +
. O +

The O +
results O +
demonstrate O +
that O +
the O +
rate O +
- O +
limiting O +
step O +
in O +
the O +
overall O +
reaction O +
is O +
a O +
slow O +
isomerization O +
between O +
two O +
conformations O +
of O +
the O +
enzyme O +
. O +

Allosteric O +
activation O +
increases O +
the O +
rate O +
of O +
this O +
isomerization O +
such O +
that O +
product O +
release O +
becomes O +
rate O +
- O +
limiting O +
, O +
thus O +
accelerating O +
catalysis O +
. O +

ABC B-Gene +
transporters I-Gene +
, O +
which O +
exhibit O +
similar O +
substrate O +
activation O +
of O +
ATPase B-Gene +
activity O +
, O +
can O +
undergo O +
similar O +
conformational O +
changes O +
to O +
overcome O +
a O +
rate O +
- O +
limiting O +
step O +
. O +

Thus O +
the O +
ArsAB B-Gene +
pump O +
is O +
a O +
useful O +
model O +
for O +
elucidating O +
mechanistic O +
aspects O +
of O +
the O +
ABC B-Gene +
superfamily I-Gene +
of I-Gene +
transport I-Gene +
ATPases I-Gene +
. O +

Mechanisms O +
of O +
HIV-1 O +
to O +
escape O +
from O +
the O +
host O +
immune O +
surveillance O +
. O +

Since O +
the O +
beginning O +
of O +
the O +
acquired O +
immune O +
deficiency O +
syndrome O +
( O +
AIDS O +
) O +
pandemic O +
in O +
1981 O +
, O +
research O +
on O +
human O +
immunodeficiency O +
virus O +
( O +
HIV O +
) O +
has O +
been O +
focused O +
on O +
mechanisms O +
by O +
which O +
the O +
virus O +
escapes O +
from O +
immune O +
surveillance O +
. O +

Several O +
human B-Gene +
leucocyte I-Gene +
antigen I-Gene +
haplotypes O +
have O +
been O +
shown O +
to O +
be O +
associated O +
with O +
rapid O +
disease O +
progression O +
or O +
resistance O +
to O +
disease O +
progression O +
. O +

In O +
addition O +
, O +
HIV O +
is O +
able O +
to O +
down O +
- O +
regulate O +
major B-Gene +
histocompatibility I-Gene +
complex I-Gene +
type I-Gene +
I I-Gene +
( O +
MHC B-Gene +
- I-Gene +
I I-Gene +
) O +
on O +
the O +
surface O +
of O +
the O +
host O +
cell O +
. O +

For O +
this O +
down O +
- O +
regulation O +
HIV O +
seems O +
to O +
use O +
three O +
different O +
mechanisms O +
mediated O +
by O +
three O +
different O +
viral O +
proteins O +
. O +

The O +
viral O +
Tat B-Gene +
protein O +
represses O +
transcription O +
of O +
the O +
MHC B-Gene -
- I-Gene -
I I-Gene +
, O +
Vpu B-Gene +
retains O +
nascent O +
MHC B-Gene -
- I-Gene -
I I-Gene +
chains O +
in O +
the O +
endoplasmic O +
reticulum O +
and O +
Nef B-Gene +
mediates O +
selective O +
internalization O +
of O +
MHC B-Gene -
- I-Gene -
I I-Gene +
molecules O +
from O +
the O +
plasma O +
membrane O +
. O +

The O +
last O +
mechanism O +
also O +
provides O +
protection O +
to O +
natural O +
killer O +
cells O +
that O +
attack O +
cells O +
with O +
little O +
or O +
no O +
MHC B-Gene -
- I-Gene -
I I-Gene +
on O +
the O +
cell O +
surface O +
. O +

Together O +
these O +
mechanisms O +
provide O +
a O +
very O +
efficient O +
escape O +
from O +
the O +
host O +
immune O +
system O +
. O +

Effects O +
of O +
age O +
on O +
gene O +
expression O +
during O +
estrogen O +
- O +
induced O +
synaptic O +
sprouting O +
in O +
the O +
female O +
rat O +
. O +

Age O +
and O +
estrogen O +
treatment O +
influenced O +
fiber O +
outgrowth O +
and O +
compensatory O +
neuronal O +
sprouting O +
after O +
unilateral O +
entorhinal O +
cortex O +
lesions O +
( O +
ECL O +
) O +
which O +
model O +
Alzheimer O +
disease O +
- O +
like O +
deafferentation O +
in O +
the O +
dentate O +
gyrus O +
of O +
the O +
hippocampus O +
. O +

In O +
young O +
F344 O +
rats O +
( O +
3 O +
months O +
old O +
) O +
, O +
ovariectomy O +
( O +
OVX O +
) O +
decreased O +
reactive O +
fiber O +
outgrowth O +
by O +
60 O +
% O +
. O +

Sprouting O +
in O +
middle O +
- O +
aged O +
rats O +
( O +
18 O +
months O +
old O +
) O +
was O +
reduced O +
in O +
intact O +
females O +
; O +
no O +
further O +
reduction O +
was O +
caused O +
by O +
OVX O +
. O +

Several O +
astrocyte O +
mRNAs O +
were O +
measured O +
in O +
the O +
dentate O +
gyrus O +
of O +
young O +
and O +
middle O +
- O +
aged O +
female O +
rats O +
in O +
three O +
different O +
estrogen O +
states O +
( O +
sham O +
OVX O +
, O +
OVX O +
, O +
or O +
OVX O +
+ O +
estradiol O +
) O +
1 O +
week O +
after O +
ECL O +
. O +

Glial B-Gene +
fibrillary I-Gene +
acidic I-Gene +
protein I-Gene +
( O +
GFAP B-Gene +
) O +
mRNA O +
was O +
twofold O +
greater O +
in O +
middle O +
- O +
aged O +
rats O +
than O +
young O +
, O +
although O +
both O +
ages O +
showed O +
threefold O +
increases O +
in O +
response O +
to O +
ECL O +
. O +

In O +
prior O +
studies O +
GFAP B-Gene +
was O +
found O +
to O +
be O +
decreased O +
by O +
estradiol O +
treatment O +
3 O +
- O +
4 O +
days O +
after O +
ECL O +
; O +
in O +
this O +
study O +
GFAP B-Gene +
mRNA O +
had O +
returned O +
to O +
sham O +
OVX O +
levels O +
in O +
young O +
rats O +
by O +
7 O +
days O +
post O +
- O +
ECL O +
. O +

Surprisingly O +
, O +
estradiol O +
treatment O +
increased O +
GFAP B-Gene +
mRNA O +
levels O +
by O +
25 O +
% O +
above O +
OVX O +
in O +
middle O +
- O +
aged O +
rats O +
. O +

Apolipoprotein B-Gene +
E I-Gene +
( O +
apoE B-Gene +
) O +
mRNA O +
was O +
decreased O +
20 O +
% O +
by O +
age O +
in O +
the O +
dentate O +
, O +
although O +
both O +
age O +
groups O +
showed O +
a O +
25 O +
% O +
increase O +
in O +
apoE B-Gene +
mRNA O +
in O +
response O +
to O +
ECL O +
. O +

Apolipoprotein B-Gene +
J I-Gene +
( O +
apoJ B-Gene +
) O +
mRNA O +
was O +
increased O +
20 O +
% O +
in O +
the O +
dentate O +
gyrus O +
of O +
middle O +
- O +
aged O +
rats O +
, O +
and O +
both O +
age O +
groups O +
responded O +
to O +
ECL O +
with O +
a O +
65 O +
% O +
increase O +
in O +
apoJ B-Gene +
mRNA O +
. O +

The O +
estrogen O +
state O +
did O +
not O +
alter O +
levels O +
of O +
either O +
apolipoprotein B-Gene +
mRNA O +
in O +
the O +
deafferented O +
dentate O +
. O +

The O +
data O +
suggest O +
that O +
the O +
estrogen O +
- O +
induced O +
decrease O +
of O +
GFAP B-Gene +
in O +
response O +
to O +
lesions O +
does O +
not O +
persist O +
at O +
7 O +
days O +
post O +
- O +
ECL O +
during O +
sprouting O +
. O +

Overall O +
effects O +
of O +
age O +
on O +
the O +
dentate O +
gyrus O +
include O +
elevated O +
GFAP B-Gene +
mRNA O +
and O +
decreased O +
apoE B-Gene +
mRNA O +
. O +

The O +
cortical O +
wound O +
site O +
showed O +
consistent O +
enhancement O +
of O +
GFAP B-Gene +
mRNA O +
in O +
both O +
age O +
groups O +
by O +
estradiol O +
above O +
sham O +
OVX O +
and O +
greater O +
responses O +
in O +
middle O +
- O +
aged O +
rats O +
. O +

Clinical O +
, O +
endocrine O +
, O +
and O +
molecular O +
genetic O +
findings O +
in O +
patients O +
with O +
17beta B-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
deficiency O +
. O +

Mutations O +
in O +
the O +
17beta B-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
( I-Gene +
17beta I-Gene -
- I-Gene -
HSD I-Gene +
) I-Gene +
type I-Gene +
3 I-Gene +
gene O +
are O +
associated O +
with O +
the O +
clinical O +
findings O +
of O +
17beta B-Gene -
- I-Gene -
HSD I-Gene +
deficiency O +
. O +

We O +
investigated O +
5 O +
patients O +
of O +
German O +
descent O +
with O +
46,XY O +
karyotype O +
and O +
predominantly O +
female O +
phenotype O +
. O +

Androstenedione O +
( O +
A O +
) O +
and O +
testosterone O +
( O +
T O +
) O +
levels O +
in O +
serum O +
were O +
determined O +
before O +
and O +
after O +
stimulation O +
with O +
human O +
chorionic O +
gonadotropin B-Gene +
. O +

DNA O +
analysis O +
of O +
the O +
whole O +
coding O +
region O +
of O +
the O +
17beta B-Gene -
- I-Gene -
HSD I-Gene +
type I-Gene +
3 I-Gene +
gene O +
was O +
performed O +
by O +
PCR O +
, O +
single O +
- O +
strand O +
conformation O +
analysis O +
, O +
and O +
direct O +
sequencing O +
. O +

In O +
all O +
patients O +
we O +
found O +
highly O +
variable O +
A O +
and O +
T O +
levels O +
before O +
and O +
after O +
stimulation O +
. O +

However O +
, O +
the O +
A O +
- O +
to O +
- O +
T O +
ratio O +
was O +
abnormal O +
in O +
all O +
cases O +
suggestive O +
of O +
17beta B-Gene -
- I-Gene -
HSD I-Gene +
deficiency O +
. O +

Molecular O +
genetic O +
analysis O +
revealed O +
mutations O +
in O +
all O +
patients O +
. O +

We O +
conclude O +
that O +
A O +
and O +
T O +
levels O +
may O +
be O +
highly O +
variable O +
in O +
patients O +
with O +
17beta B-Gene -
- I-Gene -
HSD I-Gene +
deficiency O +
. O +

Molecular O +
genetic O +
analysis O +
of O +
the O +
17beta B-Gene -
- I-Gene -
HSD I-Gene +
gene O +
may O +
support O +
the O +
diagnosis O +
of O +
this O +
disorder O +
. O +

Identification O +
of O +
transcription O +
activators O +
that O +
regulate O +
gonococcal O +
adaptation O +
from O +
aerobic O +
to O +
anaerobic O +
or O +
oxygen O +
- O +
limited O +
growth O +
. O +

Analysis O +
of O +
the O +
Neisseria O +
gonorrhoeae O +
DNA O +
sequence O +
database O +
revealed O +
the O +
presence O +
of O +
two O +
genes O +
, O +
one O +
encoding O +
a O +
protein O +
predicted O +
to O +
be O +
37 O +
. O +

5 O +
% O +
identical O +
( O +
50 O +
% O +
similar O +
) O +
in O +
amino O +
acid O +
sequence O +
to O +
the O +
Escherichia O +
coli O +
FNR B-Gene +
protein O +
and O +
the O +
other O +
encoding O +
a O +
protein O +
41 O +
% O +
and O +
42 O +
% O +
identical O +
( O +
54 O +
and O +
51 O +
% O +
sequence O +
similarity O +
) O +
to O +
the O +
E. O +
coli O +
NarL B-Gene +
and O +
NarP B-Gene +
proteins O +
respectively O +
. O +

Both O +
genes O +
have O +
been O +
cloned O +
into O +
E. O +
coli O +
and O +
insertionally O +
inactivated O +
in O +
vitro O +
. O +

The O +
mutated O +
genes O +
have O +
been O +
transformed O +
into O +
gonococci O +
and O +
recombined O +
into O +
the O +
chromosome O +
. O +

The O +
fnr B-Gene +
mutation O +
totally O +
abolished O +
and O +
the O +
narP B-Gene +
mutation O +
severely O +
diminished O +
the O +
ability O +
of O +
gonococci O +
to O +
: O +
( O -
i O -
) O +
grow O +
anaerobically O +
; O +
( O -
ii O -
) O +
adapt O +
to O +
oxygen O +
- O +
limited O +
growth O +
; O +
( O -
iii O -
) O +
initiate O +
transcription O +
from O +
the O +
aniA B-Gene +
promoter O +
( O +
which O +
directs O +
the O +
expression O +
of O +
a O +
copper B-Gene +
- I-Gene +
containing I-Gene +
nitrite I-Gene +
reductase I-Gene +
, O +
AniA B-Gene +
, O +
in O +
response O +
to O +
the O +
presence O +
of O +
nitrite O +
) O +
; O +
and O +
( O +
iv O +
) O +
reduce O +
nitrite O +
during O +
growth O +
in O +
oxygen O +
- O +
limited O +
media O +
. O +

The O +
product O +
of O +
nitrite O +
reduction O +
was O +
identified O +
to O +
be O +
nitrous O +
oxide O +
. O +

Immediately O +
upstream O +
of O +
the O +
narL B-Gene +
/ O +
narP B-Gene +
gene O +
is O +
an O +
open O +
reading O +
frame O +
that O +
, O +
if O +
translated O +
, O +
would O +
encode O +
a O +
homologue O +
of O +
the O +
E. O +
coli O +
nitrate O +
- O +
and O +
nitrite O +
- O +
sensing O +
proteins O +
NarX B-Gene +
and O +
NarQ B-Gene +
. O +

As O +
transcription O +
from O +
the O +
aniA B-Gene +
promoter O +
was O +
not O +
activated O +
during O +
oxygen O +
- O +
limited O +
growth O +
in O +
the O +
presence O +
of O +
nitrate O +
, O +
the O +
gonococcal O +
two O +
- O +
component O +
regulatory O +
system O +
is O +
designated O +
NarQ B-Gene +
- O +
NarP B-Gene +
rather O +
than O +
NarX B-Gene +
- O +
NarL B-Gene +
. O +

As O +
far O +
as O +
we O +
are O +
aware O +
, O +
this O +
is O +
the O +
first O +
well O +
- O +
documented O +
example O +
of O +
a O +
two O +
- O +
component O +
regulatory O +
system O +
working O +
in O +
partnership O +
with O +
a O +
transcription O +
activator O +
in O +
pathogenic O +
neisseria O +
. O +

A O +
45 O +
kDa O +
c B-Gene +
- I-Gene +
type I-Gene +
cytochrome I-Gene +
that O +
was O +
synthesized O +
during O +
oxygen O +
- O +
limited O +
, O +
but O +
not O +
during O +
oxygen O +
sufficient O +
, O +
growth O +
was O +
identified O +
as O +
a O +
homologue O +
of O +
cytochrome B-Gene +
c I-Gene +
peroxidases I-Gene +
( O +
CCP B-Gene +
) O +
of O +
other O +
bacteria O +
. O +

The O +
gene O +
for O +
this O +
cytochrome B-Gene +
, O +
designated O +
ccp B-Gene +
, O +
was O +
located O +
, O +
and O +
its O +
regulatory O +
region O +
was O +
cloned O +
into O +
the O +
promoter O +
probe O +
vector O +
pLES94 O +
. O +

Transcription O +
from O +
the O +
ccp B-Gene +
promoter O +
was O +
repressed O +
during O +
aerobic O +
growth O +
and O +
induced O +
during O +
oxygen O +
- O +
limited O +
growth O +
and O +
was O +
totally O +
FNR B-Gene +
dependent O +
, O +
suggesting O +
that O +
the O +
gonococcal O +
FNR B-Gene +
protein O +
is O +
a O +
transcription O +
activator O +
of O +
at O +
least O +
two O +
genes O +
. O +

However O +
, O +
unlike O +
AniA B-Gene +
, O +
synthesis O +
of O +
the O +
CCP B-Gene +
homologue O +
was O +
insensitive O +
to O +
the O +
presence O +
of O +
nitrite O +
during O +
oxygen O +
- O +
limited O +
growth O +
. O +

Suppression O +
of O +
FNR B-Gene +
- O +
dependent O +
transcription O +
activation O +
at O +
the O +
Escherichia O +
coli O +
nir B-Gene +
promoter O +
by O +
Fis B-Gene +
, O +
IHF B-Gene +
and O +
H B-Gene -
- I-Gene -
NS I-Gene +
: O +
modulation O +
of O +
transcription O +
initiation O +
by O +
a O +
complex O +
nucleo O +
- O +
protein O +
assembly O +
. O +

Expression O +
from O +
the O +
Escherichia O +
coli O +
nir B-Gene +
promoter O +
is O +
co O +
- O +
dependent O +
on O +
both O +
the O +
FNR B-Gene +
protein O +
( O +
an O +
anaerobically O +
triggered O +
transcription O +
activator O +
) O +
and O +
the O +
NarL B-Gene +
or O +
NarP B-Gene +
proteins O +
( O +
transcription O +
activators O +
triggered O +
by O +
nitrite O +
and O +
nitrate O +
) O +
. O +

Under O +
anaerobic O +
conditions O +
, O +
FNR B-Gene +
binds O +
to O +
a O +
site O +
centred O +
between O +
positions O +
- O +
41 O +
and O +
- O +
42 O +
, O +
activating O +
transcription O +
of O +
the O +
nir B-Gene +
operon I-Gene +
. O +

In O +
previous O +
work O +
, O +
we O +
showed O +
that O +
this O +
activation O +
is O +
suppressed O +
by O +
the O +
binding O +
of O +
Fis B-Gene +
protein O +
, O +
and O +
at O +
least O +
one O +
other O +
protein O +
, O +
to O +
sequence O +
elements O +
located O +
upstream O +
of O +
the O +
nir B-Gene +
promoter O +
. O +

We O +
proposed O +
that O +
the O +
binding O +
of O +
NarL B-Gene +
or O +
NarP B-Gene +
to O +
a O +
site O +
centred O +
between O +
positions O +
- O +
69 O +
and O +
- O +
70 O +
counteracts O +
this O +
suppression O +
, O +
resulting O +
in O +
increased O +
transcription O +
in O +
response O +
to O +
nitrite O +
or O +
nitrate O +
. O +

Here O +
we O +
have O +
further O +
investigated O +
the O +
different O +
proteins O +
that O +
downregulate O +
the O +
nir B-Gene +
promoter O +
. O +

We O +
show O +
that O +
the O +
nir B-Gene +
promoter O +
is O +
repressed O +
by O +
three O +
DNA O +
binding O +
proteins O +
, O +
Fis B-Gene +
, O +
IHF B-Gene +
and O +
H B-Gene -
- I-Gene -
NS I-Gene +
. O +

We O +
demonstrate O +
that O +
, O +
in O +
addition O +
to O +
binding O +
to O +
its O +
previously O +
characterized O +
upstream O +
site O +
located O +
at O +
position O +
- O +
142 O +
, O +
Fis B-Gene +
also O +
binds O +
to O +
a O +
second O +
downstream O +
site O +
located O +
at O +
position O +
+ O +
23 O +
. O +

A O +
second O +
suppressing O +
factor O +
is O +
IHF B-Gene +
, O +
that O +
binds O +
to O +
a O +
site O +
located O +
at O +
position O +
- O +
88 O +
. O +

Finally O +
, O +
the O +
nucleoid O +
associated O +
protein O +
, O +
H B-Gene -
- I-Gene -
NS I-Gene +
, O +
preferentially O +
binds O +
to O +
upstream O +
sequences O +
at O +
the O +
nir B-Gene +
promoter O +
and O +
represses O +
promoter O +
activity O +
. O +

The O +
association O +
of O +
Fis B-Gene +
, O +
IHF B-Gene +
and O +
H B-Gene -
- I-Gene -
NS I-Gene +
suggests O +
that O +
nir B-Gene +
promoter O +
DNA O +
is O +
sequestrated O +
into O +
a O +
highly O +
ordered O +
nucleo O +
- O +
protein O +
structure O +
that O +
represses O +
FNR B-Gene +
- O +
dependent O +
transcription O +
activation O +
. O +

NarL B-Gene +
and O +
NarP B-Gene +
can O +
relieve O +
both O +
IHF B-Gene +
- O +
and O +
Fis B-Gene +
- O +
mediated O +
repression O +
, O +
but O +
are O +
unable O +
to O +
counteract O +
H B-Gene -
- I-Gene -
NS I-Gene +
- O +
mediated O +
repression O +
. O +

IL-5 B-Gene +
- O +
Induced O +
JAB B-Gene +
- O +
JAK2 B-Gene +
interaction O +
. O +

Receptor O +
activation O +
by O +
the O +
haematopoietic O +
growth B-Gene +
factor I-Gene +
proteins O +
interleukin B-Gene +
5 I-Gene +
( O +
IL-5 B-Gene +
) O +
and O +
granulocyte B-Gene +
- I-Gene +
macrophage I-Gene +
colony I-Gene +
- I-Gene +
stimulating I-Gene +
factor I-Gene +
( O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
) O +
leads O +
to O +
phosphorylation O +
of O +
JAK2 B-Gene +
as O +
a O +
key O +
trigger O +
of O +
signal O +
transduction O +
. O +

JAB B-Gene +
has O +
recently O +
been O +
identified O +
as O +
a O +
regulator O +
of O +
JAK2 B-Gene +
phosphorylation O +
and O +
activity O +
by O +
binding O +
phosphorylated O +
JAK2 B-Gene +
and O +
inducing O +
its O +
degradation O +
. O +

As O +
part O +
of O +
our O +
effort O +
to O +
define O +
molecular O +
recognition O +
networks O +
that O +
lead O +
to O +
signalling O +
, O +
we O +
investigated O +
the O +
effect O +
of O +
JAB B-Gene +
on O +
both O +
JAK2 B-Gene +
phosphorylation O +
and O +
JAK2 B-Gene +
interaction O +
state O +
that O +
ensue O +
upon O +
IL-5 B-Gene +
stimulation O +
in O +
recombinant O +
293 O -
T O +
cells O +
cotransfected O +
293 O -
T O +
cells O +
with O +
IL-5R B-Gene +
alpha I-Gene +
, O +
beta B-Gene +
c I-Gene +
and O +
hJAK2 B-Gene +
either O +
with O +
or O +
without O +
JAB B-Gene +
. O +

Without O +
JAB B-Gene +
, O +
stimulation O +
with O +
wild O +
- O +
type O +
and O +
re O +
- O +
engineered O +
single O +
chain O +
( O +
sc O +
) O +
IL-5 B-Gene +
induced O +
a O +
time O +
- O +
dependent O +
phosphorylation O +
of O +
JAK2 B-Gene +
. O +

In O +
the O +
presence O +
of O +
JAB B-Gene +
cotransfection O +
, O +
no O +
phospho O +
- O +
JAK2 B-Gene +
was O +
observed O +
, O +
and O +
JAB B-Gene +
was O +
observed O +
co O +
- O +
immunoprecipitated O +
with O +
non O +
- O +
phosphorylated O +
JAK2 B-Gene +
. O +

The O +
time O +
dependence O +
of O +
JAB B-Gene +
co O +
- O +
immunoprecipitation O +
correlated O +
with O +
the O +
time O +
dependence O +
of O +
JAK2 B-Gene +
phosphorylation O +
when O +
JAB B-Gene +
was O +
absent O +
. O +

Since O +
JAB B-Gene +
has O +
already O +
been O +
shown O +
to O +
bind O +
JAK2 B-Gene +
via O +
a O +
phosphorylated O +
tyrosine O +
, O +
the O +
current O +
data O +
suggest O +
that O +
JAB B-Gene +
binds O +
to O +
phosphorylated O +
JAK2 B-Gene +
, O +
enhances O +
JAK2 B-Gene +
dephosphorylation O +
and O +
remains O +
associated O +
in O +
a O +
complex O +
, O +
with O +
dephosphorylated O +
JAK2 B-Gene +
, O +
that O +
may O +
be O +
a O +
precursor O +
leading O +
to O +
irreversible O +
JAK2 B-Gene +
degradation O +
. O +

SURVEY O +
AND O +
SUMMARY O +
: O +
holliday B-Gene +
junction I-Gene +
resolvases I-Gene +
and O +
related O +
nucleases B-Gene +
: O +
identification O +
of O +
new O +
families O +
, O +
phyletic O +
distribution O +
and O +
evolutionary O +
trajectories O +
. O +

Holliday B-Gene +
junction I-Gene +
resolvases I-Gene +
( O +
HJRs B-Gene +
) O +
are O +
key O +
enzymes O +
of O +
DNA O +
recombination O +
. O +

A O +
detailed O +
computer O +
analysis O +
of O +
the O +
structural O +
and O +
evolutionary O +
relationships O +
of O +
HJRs B-Gene +
and O +
related O +
nucleases B-Gene +
suggests O +
that O +
the O +
HJR B-Gene +
function O +
has O +
evolved O +
independently O +
from O +
at O +
least O +
four O +
distinct O +
structural O +
folds O +
, O +
namely O +
RNase B-Gene +
H I-Gene +
, O +
endonuclease B-Gene +
, O +
endonuclease B-Gene +
VII I-Gene +
- O +
colicin B-Gene +
E I-Gene +
and O +
RusA B-Gene +
. O +

The O +
endonuclease B-Gene +
fold O +
, O +
whose O +
structural O +
prototypes O +
are O +
the O +
phage O +
lambda O +
exonuclease B-Gene +
, O +
the O +
very B-Gene +
short I-Gene +
patch I-Gene +
repair I-Gene +
nuclease I-Gene +
( O +
Vsr B-Gene +
) O +
and O +
type B-Gene +
II I-Gene +
restriction I-Gene +
enzymes I-Gene +
, O +
is O +
shown O +
to O +
encompass O +
by O +
far O +
a O +
greater O +
diversity O +
of O +
nucleases B-Gene +
than O +
previously O +
suspected O +
. O +

This O +
fold O +
unifies O +
archaeal O +
HJRs B-Gene +
, O +
repair B-Gene +
nucleases I-Gene +
such O +
as O +
RecB B-Gene +
and O +
Vsr B-Gene +
, O +
restriction B-Gene +
enzymes I-Gene +
and O +
a O +
variety O +
of O +
predicted O +
nucleases B-Gene +
whose O +
specific O +
activities O +
remain O +
to O +
be O +
determined O +
. O +

Within O +
the O +
RNase B-Gene +
H I-Gene +
fold O +
a O +
new O +
family O +
of O +
predicted O +
HJRs B-Gene +
, O +
which O +
is O +
nearly O +
ubiquitous O +
in O +
bacteria O +
, O +
was O +
discovered O +
, O +
in O +
addition O +
to O +
the O +
previously O +
characterized O +
RuvC B-Gene +
family I-Gene +
. O +

The O +
proteins O +
of O +
this O +
family O +
, O +
typified O +
by O +
Escherichia O +
coli O +
YqgF B-Gene +
, O +
are O +
likely O +
to O +
function O +
as O +
an O +
alternative O +
to O +
RuvC B-Gene +
in O +
most O +
bacteria O +
, O +
but O +
could O +
be O +
the O +
principal O +
HJRs B-Gene +
in O +
low O +
- O +
GC O +
Gram O +
- O +
positive O +
bacteria O +
and O +
AQUIFEX O +
: O +

Endonuclease B-Gene +
VII I-Gene +
of O +
phage O +
T4 O +
is O +
shown O +
to O +
serve O +
as O +
a O +
structural O +
template O +
for O +
many O +
nucleases B-Gene +
, O +
including O +
MCR B-Gene +
: I-Gene +
A I-Gene +
and O +
other O +
type B-Gene +
II I-Gene +
restriction I-Gene +
enzymes I-Gene +
. O +

Together O +
with O +
colicin B-Gene +
E7 I-Gene +
, O +
endonuclease B-Gene +
VII I-Gene +
defines O +
a O +
distinct O +
metal O +
- O +
dependent O +
nuclease B-Gene +
fold O +
. O +

As O +
a O +
result O +
of O +
this O +
analysis O +
, O +
the O +
principal O +
HJRs B-Gene +
are O +
now O +
known O +
or O +
confidently O +
predicted O +
for O +
all O +
bacteria O +
and O +
archaea O +
whose O +
genomes O +
have O +
been O +
completely O +
sequenced O +
, O +
with O +
many O +
species O +
encoding O +
multiple O +
potential O +
HJRs B-Gene +
. O +

Horizontal O +
gene O +
transfer O +
, O +
lineage O +
- O +
specific O +
gene O +
loss O +
and O +
gene O +
family O +
expansion O +
, O +
and O +
non O +
- O +
orthologous O +
gene O +
displacement O +
seem O +
to O +
have O +
been O +
major O +
forces O +
in O +
the O +
evolution O +
of O +
HJRs B-Gene +
and O +
related O +
nucleases B-Gene +
. O +

A O +
remarkable O +
case O +
of O +
displacement O +
is O +
seen O +
in O +
the O +
Lyme O +
disease O +
spirochete O +
Borrelia O +
burgdorferi O +
, O +
which O +
does O +
not O +
possess O +
any O +
of O +
the O +
typical O +
HJRs B-Gene +
, O +
but O +
instead O +
encodes O +
, O +
in O +
its O +
chromosome O +
and O +
each O +
of O +
the O +
linear O +
plasmids O +
, O +
members O +
of O +
the O +
lambda B-Gene +
exonuclease I-Gene +
family I-Gene +
predicted O +
to O +
function O +
as O +
HJRs B-Gene +
. O +

The O +
diversity O +
of O +
HJRs B-Gene +
and O +
related O +
nucleases B-Gene +
in O +
bacteria O +
and O +
archaea O +
contrasts O +
with O +
their O +
near O +
absence O +
in O +
eukaryotes O +
. O +

The O +
few O +
detected O +
eukaryotic O +
representatives O +
of O +
the O +
endonuclease B-Gene +
fold O +
and O +
the O +
RNase B-Gene +
H I-Gene +
fold O +
have O +
probably O +
been O +
acquired O +
from O +
bacteria O +
via O +
horizontal O +
gene O +
transfer O +
. O +

The O +
identity O +
of O +
the O +
principal O +
HJR B-Gene -
( I-Gene -
s I-Gene -
) I-Gene +
involved O +
in O +
recombination O +
in O +
eukaryotes O +
remains O +
uncertain O +
; O +
this O +
function O +
could O +
be O +
performed O +
by O +
topoisomerase B-Gene +
IB I-Gene +
or O +
by O +
a O +
novel O +
, O +
so O +
far O +
undetected O +
, O +
class O +
of O +
enzymes O +
. O +

Likely O +
HJRs B-Gene +
and O +
related O +
nucleases B-Gene +
were O +
identified O +
in O +
the O +
genomes O +
of O +
numerous O +
bacterial O +
and O +
eukaryotic O +
DNA O +
viruses O +
. O +

Gene O +
flow O +
between O +
viral O +
and O +
cellular O +
genomes O +
has O +
probably O +
played O +
a O +
major O +
role O +
in O +
the O +
evolution O +
of O +
this O +
class O +
of O +
enzymes O +
. O +

This O +
analysis O +
resulted O +
in O +
the O +
prediction O +
of O +
numerous O +
previously O +
unnoticed O +
nucleases B-Gene +
, O +
some O +
of O +
which O +
are O +
likely O +
to O +
be O +
new O +
restriction B-Gene +
enzymes I-Gene +
. O +

New O +
structural O +
and O +
functional O +
aspects O +
of O +
the O +
type B-Gene +
I I-Gene +
interferon I-Gene +
- I-Gene +
receptor I-Gene +
interaction O +
revealed O +
by O +
comprehensive O +
mutational O +
analysis O +
of O +
the O +
binding O +
interface O +
. O +

Type B-Gene +
I I-Gene +
interferons I-Gene +
bind O +
to O +
two O +
cell O +
surface O +
receptors O +
, O +
ifnar1 B-Gene +
and O +
ifnar2 B-Gene +
, O +
as O +
the O +
first O +
step O +
in O +
the O +
activation O +
of O +
several O +
signal O +
transduction O +
pathways O +
that O +
elicit O +
an O +
anti O +
- O +
viral O +
state O +
and O +
an O +
anti O +
- O +
proliferative O +
response O +
. O +

Here O +
, O +
we O +
quantitatively O +
mapped O +
the O +
complete O +
binding O +
region O +
of O +
ifnar2 B-Gene +
on O +
interferon B-Gene +
( I-Gene +
IFN I-Gene +
) I-Gene +
alpha2 I-Gene +
by O +
35 O +
individual O +
mutations O +
to O +
alanine O +
and O +
isosteric O +
residues O +
. O +

Of O +
the O +
six O +
" O +
hot O +
- O +
spot O +
" O +
residues O +
identified O +
( O +
Leu O +
- O +
30 O +
, O +
Arg-33 O +
, O +
Arg-144 O +
, O +
Ala-145 O +
, O +
Met-148 O +
, O +
and O +
Arg O +
- O +
149 O +
) O +
, O +
four O +
are O +
located O +
on O +
the O +
E O -
- O -
helix O +
, O +
which O +
is O +
located O +
at O +
the O +
center O +
of O +
the O +
binding O +
site O +
flanked O +
by O +
residues O +
on O +
the O +
A O -
- O -
helix O +
and O +
the O +
AB O +
- O +
loop O +
. O +

The O +
contribution O +
of O +
residues O +
of O +
the O +
D O -
- O -
helix O +
, O +
which O +
have O +
been O +
previously O +
implicated O +
in O +
binding O +
, O +
proved O +
to O +
be O +
marginal O +
for O +
the O +
interaction O +
with O +
the O +
extracellular O +
domain O +
of O +
ifnar2 B-Gene +
. O +

Interestingly O +
, O +
the O +
ifnar2 B-Gene +
binding O +
site O +
overlaps O +
the O +
largest O +
continuous O +
hydrophobic O +
patch O +
on O +
IFNalpha2 B-Gene +
. O +

Thus O +
, O +
hydrophobic O +
interactions O +
seem O +
to O +
play O +
a O +
significant O +
role O +
stabilizing O +
this O +
interaction O +
, O +
with O +
the O +
charged O +
residues O +
contributing O +
toward O +
the O +
rapid O +
association O +
of O +
the O +
complex O +
. O +

Relating O +
the O +
anti O +
- O +
viral O +
and O +
anti O +
- O +
proliferative O +
activity O +
of O +
the O +
various O +
interferon O +
mutants O +
with O +
their O +
affinity O +
toward O +
ifnar2 B-Gene +
results O +
in O +
linear O +
function O +
over O +
the O +
whole O +
range O +
of O +
affinities O +
investigated O +
, O +
suggesting O +
that O +
ifnar2 B-Gene +
binding O +
is O +
the O +
rate O +
- O +
determining O +
step O +
in O +
cellular O +
activation O +
. O +

Dose O +
- O +
time O +
analysis O +
of O +
the O +
anti O +
- O +
viral O +
response O +
revealed O +
that O +
shortening O +
the O +
incubation O +
time O +
of O +
low O +
- O +
level O +
activation O +
can O -
not O +
be O +
compensated O +
by O +
higher O +
IFN B-Gene +
doses O +
. O +

Considering O +
the O +
strict O +
dependence O +
of O +
the O +
cellular O +
response O +
on O +
affinity O +
, O +
these O +
results O +
suggest O +
that O +
for O +
maintaining O +
transcription O +
of O +
IFN B-Gene +
- O +
responsive O +
genes O +
over O +
a O +
longer O +
time O +
period O +
, O +
low O +
but O +
continuous O +
signaling O +
through O +
the O +
IFN B-Gene +
receptor I-Gene +
is O +
essential O +
. O +

Purine O +
catabolism O +
in O +
Escherichia O +
coli O +
and O +
function O +
of O +
xanthine B-Gene +
dehydrogenase I-Gene +
in O +
purine O +
salvage O +
. O +

Escherichia O +
coli O +
is O +
not O +
known O +
to O +
utilize O +
purines O +
, O +
other O +
than O +
adenine O +
and O +
adenosine O +
, O +
as O +
nitrogen O +
sources O +
. O +

We O +
reinvestigated O +
purine O +
catabolism O +
because O +
a O +
computer O +
analysis O +
suggested O +
several O +
potential O +
sigma B-Gene -
( I-Gene -
54 I-Gene -
) I-Gene +
- O +
dependent O +
promoters O +
within O +
a O +
23 O +
- O +
gene O +
cluster O +
whose O +
products O +
have O +
homology O +
to O +
purine O +
catabolic O +
enzymes O +
. O +

Our O +
results O +
did O +
not O +
provide O +
conclusive O +
evidence O +
that O +
the O +
sigma B-Gene -
( I-Gene -
54 I-Gene -
) I-Gene +
- O +
dependent O +
promoters O +
are O +
active O +
. O +

Nonetheless O +
, O +
our O +
results O +
suggest O +
that O +
some O +
of O +
the O +
genes O +
are O +
metabolically O +
significant O +
. O +

We O +
found O +
that O +
even O +
though O +
several O +
purines O +
did O +
not O +
support O +
growth O +
as O +
the O +
sole O +
nitrogen O +
source O +
, O +
they O +
did O +
stimulate O +
growth O +
with O +
aspartate O +
as O +
the O +
nitrogen O +
source O +
. O +

Cells O +
produced O +
( O +
14 O +
) O +
CO O +
( O +
2 O +
) O +
from O +
minimal O +
medium O +
containing O +
[ O -
( O -
14 O -
) O -
C O -
] O -
adenine O +
, O +
which O +
implies O +
allantoin O +
production O +
. O +

However O +
, O +
neither O +
ammonia O +
nor O +
carbamoyl O +
phosphate O +
was O +
produced O +
, O +
which O +
implies O +
that O +
purine O +
catabolism O +
is O +
incomplete O +
and O +
does O +
not O +
provide O +
nitrogen O +
during O +
nitrogen O +
- O +
limited O +
growth O +
. O +

We O +
constructed O +
strains O +
with O +
deletions O +
of O +
two O +
genes O +
whose O +
products O +
might O +
catalyze O +
the O +
first O +
reaction O +
of O +
purine O +
catabolism O +
. O +

Deletion O +
of O +
one O +
eliminated O +
( O +
14 O +
) O +
CO O -
( O -
2 O -
) O +
production O +
from O +
[ O -
( O -
14 O -
) O -
C O -
] O -
adenine O +
, O +
which O +
implies O +
that O +
its O +
product O +
is O +
necessary O +
for O +
xanthine B-Gene +
dehydrogenase I-Gene +
activity O +
. O +

We O +
changed O +
the O +
name O +
of O +
this O +
gene O +
to O +
xdhA B-Gene +
. O +

The O +
xdhA B-Gene +
mutant O +
grew O +
faster O +
with O +
aspartate O +
as O +
a O +
nitrogen O +
source O +
. O +

The O +
mutant O +
also O +
exhibited O +
sensitivity O +
to O +
adenine O +
, O +
which O +
guanosine O +
partially O +
reversed O +
. O +

Adenine O +
sensitivity O +
has O +
been O +
previously O +
associated O +
with O +
defective O +
purine O +
salvage O +
resulting O +
from O +
impaired O +
synthesis O +
of O +
guanine O +
nucleotides O +
from O +
adenine O +
. O +

We O +
propose O +
that O +
xanthine B-Gene +
dehydrogenase I-Gene +
contributes O +
to O +
this O +
purine O +
interconversion O +
. O +

Amino O +
acid O +
sequence O +
of O +
the O +
protease B-Gene +
inhibitor I-Gene +
BWI-4a I-Gene +
from O +
buckwheat O +
seeds O +
. O +

The O +
complete O +
amino O +
acid O +
sequence O +
of O +
protease B-Gene +
inhibitor I-Gene +
BWI-4a I-Gene +
from O +
buckwheat O +
( O +
Fagopyrum O +
esculentum O +
Moench O +
) O +
seeds O +
, O +
consisting O +
of O +
67 O +
amino O +
acid O +
residues O +
with O +
a O +
single O +
disulfide O +
bond O +
, O +
has O +
been O +
established O +
by O +
Edman O +
degradation O +
in O +
combination O +
with O +
matrix O +
- O +
assisted O +
laser O +
desorption O +
ionization O +
time O +
- O +
of O +
- O +
flight O +
mass O +
spectrometry O +
. O +

Its O +
N O +
terminus O +
is O +
blocked O +
by O +
a O +
pyroglutamic O +
acid O +
residue O +
. O +

Mass O +
spectrometric O +
analysis O +
revealed O +
that O +
inhibitor B-Gene +
BWI-4a I-Gene +
is O +
present O +
in O +
buckwheat O +
seeds O +
in O +
two O +
isoforms O +
with O +
a O +
single O +
amino O +
acid O +
substitution O +
of O +
Ala40 O +
for O +
Gly40 O +
. O +

The O +
reactive O +
site O +
of O +
the O +
inhibitor O +
contains O +
an O +
Arg43 O +
- O +
Asp44 O +
bond O +
. O +

Analysis O +
of O +
the O +
amino O +
acid O +
sequence O +
suggests O +
that O +
the O +
buckwheat O +
seed O +
protease O +
inhibitor O +
is O +
a O +
member O +
of O +
the O +
potato B-Gene +
proteinase I-Gene +
inhibitor I-Gene +
I I-Gene +
family I-Gene +
. O +

DNA O +
sequence O +
variation O +
in O +
human O +
apolipoprotein B-Gene +
C4 I-Gene +
gene O +
and O +
its O +
effect O +
on O +
plasma O +
lipid O +
profile O +
. O +

Human O +
apolipoprotein B-Gene +
C I-Gene -
- I-Gene -
IV I-Gene +
( O +
apoC B-Gene +
- I-Gene +
IV I-Gene +
, O +
protein O +
; O +
APOC4 B-Gene +
, O +
gene O +
) O +
is O +
a O +
new O +
member O +
of O +
the O +
APO B-Gene +
E I-Gene -
/ I-Gene -
C1 I-Gene +
/ I-Gene +
C2 I-Gene +
gene O +
cluster O +
. O +

In O +
transgenic O +
mice O +
, O +
human O +
apoC B-Gene -
- I-Gene -
IV I-Gene +
is O +
predominantly O +
associated O +
with O +
very B-Gene +
low I-Gene +
- I-Gene +
density I-Gene +
lipoprotein I-Gene +
( O +
VLDL B-Gene +
) O +
and O +
thus O +
may O +
play O +
an O +
important O +
role O +
in O +
lipid O +
metabolism O +
. O +

To O +
our O +
knowledge O +
, O +
the O +
extent O +
and O +
nature O +
of O +
APOC4 B-Gene +
genetic O +
variation O +
and O +
its O +
role O +
in O +
lipid O +
metabolism O +
are O +
unknown O +
. O +

In O +
this O +
study O +
we O +
have O +
assessed O +
the O +
presence O +
of O +
genetic O +
variation O +
in O +
all O +
three O +
exons O +
of O +
APOC4 B-Gene +
and O +
their O +
flanking O +
intronic O +
sequence O +
by O +
SSCP O +
and O +
DNA O +
sequencing O +
. O +

A O +
total O +
of O +
five O +
point O +
mutations O +
were O +
observed O +
, O +
including O +
two O +
in O +
the O +
non O +
- O +
coding O +
part O +
of O +
exon O +
1 O +
( O +
A609 O -
G O +
and O +
G620A O +
) O +
, O +
two O +
in O +
exon O +
2 O +
( O +
codons O +
36 O +
and O +
52 O +
) O +
and O +
one O +
in O +
exon O +
3 O +
( O +
codon O +
96 O +
) O +
. O +

The O +
three O +
mutations O +
in O +
exons O +
2 O +
and O +
3 O +
predict O +
amino O +
acid O +
substitutions O +
, O +
Leu36Pro O +
, O +
Gly52Asp O +
, O +
and O +
Leu96Arg O +
. O +

The O +
frequencies O +
of O +
the O +
variant O +
alleles O +
were O +
: O +
0.010 O +
for O +
609 O -
G O +
, O +
0.039 O +
for O +
620A O +
, O +
0.502 O +
for O +
Pro36 O +
, O +
0.003 O +
for O +
Asp52 O +
and O +
0.357 O +
for O +
Arg96 O +
. O +

Significant O +
pairwise O +
linkage O +
disequilibrium O +
was O +
observed O +
between O +
five O +
of O +
the O +
ten O +
APOC4 B-Gene +
pairs O +
, O +
including O +
nt O -
. O +
620 O +
/ O +
codon O +
36 O +
, O +
nt O -
. O +
620 O +
/ O +
codon O +
96 O +
, O +
codon O +
36 O +
/ O +
codon O +
52 O +
, O +
codon O +
36 O +
/ O +
codon O +
96 O +
and O +
codon O +
52 O +
/ O +
codon O +
96 O +
. O +

A O +
general O +
linear O +
model O +
analysis O +
reveled O +
a O +
significant O +
association O +
of O +
the O +
Leu36Pro O +
and O +
the O +
Leu96Arg O +
polymorphisms O +
with O +
triglyceride O +
levels O +
in O +
women O +
. O +

This O +
is O +
consistent O +
with O +
the O +
proposed O +
role O +
of O +
apoC B-Gene -
- I-Gene -
IV I-Gene +
in O +
triglyceride O +
metabolism O +
. O +

The O +
characterization O +
of O +
APOC4 B-Gene +
genetic O +
variation O +
may O +
lead O +
to O +
the O +
identification O +
of O +
a O +
specific O +
role O +
of O +
apoC B-Gene -
- I-Gene -
IV I-Gene +
in O +
lipid O +
metabolism O +
or O +
in O +
other O +
physiologic O +
pathways O +
. O +

ASD4 B-Gene +
, O +
a O +
new O +
GATA B-Gene +
factor I-Gene +
of O +
Neurospora O +
crassa O +
, O +
displays O +
sequence O +
- O +
specific O +
DNA O +
binding O +
and O +
functions O +
in O +
ascus O +
and O +
ascospore O +
development O +
. O +

A O +
new O +
gene O +
encoding O +
a O +
novel O +
GATA B-Gene +
factor I-Gene +
, O +
ASD4 B-Gene +
, O +
of O +
Neurospora O +
crassa O +
was O +
isolated O +
and O +
demonstrated O +
to O +
possess O +
one O +
intron O +
and O +
to O +
specify O +
an O +
open O +
reading O +
frame O +
encoding O +
a O +
protein O +
with O +
427 O +
amino O +
acid O +
residues O +
. O +

The O +
ASD4 B-Gene +
protein O +
contains O +
a O +
single O +
GATA O +
- O +
type O +
zinc O +
finger O +
and O +
a O +
putative O +
coiled O +
- O +
coil O +
domain O +
. O +

Unlike O +
related O +
proteins O +
, O +
DAL80 B-Gene +
in O +
yeast O +
and O +
NREB B-Gene +
in O +
Penicillium O +
, O +
ASD4 B-Gene +
does O +
not O +
appear O +
to O +
be O +
involved O +
in O +
regulation O +
of O +
nitrogen O +
metabolism O +
. O +

An O +
Asd-4 B-Gene +
null O +
mutant O +
obtained O +
by O +
the O +
rip O +
procedure O +
did O +
not O +
show O +
any O +
effect O +
upon O +
nitrogen O +
control O +
, O +
but O +
instead O +
resulted O +
in O +
severe O +
defects O +
in O +
ascus O +
and O +
ascospore O +
genesis O +
. O +

The O +
Asd-4 B-Gene +
rip O +
mutant O +
is O +
dominant O +
to O +
Asd-4 B-Gene +
+ O +
. O +

A O +
cross O +
of O +
the O +
Asd-4 B-Gene +
mutant O +
with O +
wild O +
- O +
type O +
resulted O +
in O +
fruiting O +
bodies O +
that O +
appeared O +
to O +
be O +
normal O +
macroscopically O +
but O +
which O +
were O +
complete O +
devoid O +
of O +
asci O +
and O +
ascospores O +
. O +

Introduction O +
of O +
the O +
Asd-4 B-Gene +
+ O +
gene O +
into O +
the O +
Asd-4 B-Gene +
rip O +
mutant O +
corrected O +
the O +
defect O +
in O +
ascus O +
and O +
ascospore O +
development O +
in O +
crosses O +
with O +
wild O +
- O +
type O +
. O +

Mobility O +
shift O +
assays O +
demonstrated O +
that O +
ASD4 B-Gene +
acts O +
as O +
a O +
sequence O +
- O +
specific O +
DNA O +
binding O +
protein O +
and O +
recognizes O +
DNA O +
fragments O +
that O +
contain O +
GATA O +
core O +
elements O +
. O +

Gel O +
filtration O +
and O +
cross O +
- O +
linking O +
experiments O +
revealed O +
that O +
the O +
ASD4 B-Gene +
protein O +
exists O +
as O +
a O +
tetramer O +
in O +
solution O +
. O +

These O +
results O +
suggest O +
that O +
the O +
ASD4 B-Gene +
protein O +
functions O +
positively O +
as O +
a O +
transcriptional O +
regulator O +
of O +
sexual O +
development O +
in O +
Neurospora O +
. O +

Identification O +
of O +
a O +
novel O +
neuromedin B-Gene +
U I-Gene +
receptor I-Gene +
subtype O +
expressed O +
in O +
the O +
central O +
nervous O +
system O +
. O +

Neuromedin B-Gene +
U I-Gene +
is O +
a O +
neuropeptide B-Gene +
prominently O +
expressed O +
in O +
the O +
upper O +
gastrointestinal O +
tract O +
and O +
central O +
nervous O +
system O +
. O +

Recently O +
, O +
GPR66 B-Gene +
/ O +
FM B-Gene +
- I-Gene +
3 I-Gene +
( O +
NmU B-Gene -
- I-Gene -
R1 I-Gene +
) O +
was O +
identified O +
as O +
a O +
specific O +
receptor O +
for O +
neuromedin O +
U O +
. O +

A O +
BLAST O +
search O +
of O +
the O +
GenBank O +
( O +
TM O +
) O +
genomic O +
database O +
using O +
the O +
NmU B-Gene -
- I-Gene -
R1 I-Gene +
cDNA O +
sequence O +
revealed O +
a O +
human O +
genomic O +
fragment O +
encoding O +
a O +
G B-Gene +
protein I-Gene +
- I-Gene +
coupled I-Gene +
receptor I-Gene +
that O +
we O +
designated O +
NmU B-Gene -
- I-Gene -
R2 I-Gene +
based O +
on O +
its O +
homology O +
to O +
NmU B-Gene -
- I-Gene -
R1 I-Gene +
. O +

The O +
full O +
- O +
length O +
NmU B-Gene -
- I-Gene -
R2 I-Gene +
cDNA O +
was O +
subsequently O +
cloned O +
, O +
stably O +
expressed O +
in O +
293 O +
cells O +
, O +
and O +
shown O +
to O +
mobilize O +
intracellular O +
calcium O +
in O +
response O +
to O +
neuromedin B-Gene +
U I-Gene +
. O +

This O +
response O +
was O +
dose O +
- O +
dependent O +
( O +
EC O -
( O -
50 O -
) O +
= O +
5 O +
nm O +
) O +
and O +
specific O +
in O +
that O +
other O +
neuromedins B-Gene +
did O +
not O +
induce O +
a O +
calcium O +
flux O +
in O +
receptor O +
- O +
transfected O +
cells O +
. O +

Expression O +
analysis O +
of O +
human O +
NmU B-Gene -
- I-Gene -
R2 I-Gene +
demonstrated O +
its O +
mRNA O +
to O +
be O +
most O +
highly O +
expressed O +
in O +
central O +
nervous O +
system O +
tissues O +
. O +

Based O +
on O +
these O +
data O +
, O +
we O +
conclude O +
that O +
NmU B-Gene -
- I-Gene -
R2 I-Gene +
is O +
a O +
novel O +
neuromedin B-Gene +
U I-Gene +
receptor I-Gene +
subtype O +
that O +
is O +
likely O +
to O +
mediate O +
central O +
nervous O +
system O +
- O +
specific O +
neuromedin B-Gene +
U I-Gene +
effects O +
. O +

Modulation O +
of O +
amyloid O +
precursor O +
protein O +
metabolism O +
by O +
X11alpha B-Gene +
/ O +
Mint-1 B-Gene +
. O +

A O +
deletion O +
analysis O +
of O +
protein O +
- O +
protein O +
interaction O +
domains O +
. O +

Modulation O +
of O +
amyloid B-Gene +
precursor I-Gene +
protein I-Gene +
( O +
APP B-Gene +
) O +
metabolism O +
plays O +
a O +
pivotal O +
role O +
in O +
the O +
pathogenesis O +
of O +
Alzheimer O +
' O +
s O +
disease O +
. O +

The O +
phosphotyrosine O +
- O +
binding O +
/ O +
protein O +
interaction O +
( O +
PTB O +
/ O +
PI O +
) O +
domain O +
of O +
X11alpha B-Gene +
, O +
a O +
neuronal O +
cytosolic O +
adaptor B-Gene +
protein I-Gene +
, O +
binds O +
to O +
the O +
YENPTY O +
sequence O +
in O +
the O +
cytoplasmic O +
carboxyl O +
terminus O +
of O +
APP B-Gene +
. O +

This O +
interaction O +
prolongs O +
the O +
half O +
- O +
life O +
of O +
APP B-Gene +
and O +
inhibits O +
Abeta40 B-Gene +
and O +
Abeta42 B-Gene +
secretion O +
. O +

X11alpha B-Gene +
/ O +
Mint-1 B-Gene +
has O +
multiple O +
protein O +
- O +
protein O +
interaction O +
domains O +
, O +
a O +
Munc B-Gene +
- I-Gene +
18 I-Gene +
interaction O +
domain O +
( O +
MID O +
) O +
, O +
a O +
Cask B-Gene +
/ O +
Lin B-Gene +
- I-Gene +
2 I-Gene +
interaction O +
domain O +
( O +
CID O +
) O +
, O +
a O +
PTB O +
/ O +
PI O +
domain O +
, O +
and O +
two O +
PDZ O +
domains O +
. O +

These O +
X11alpha B-Gene +
protein O +
interaction O +
domains O +
may O +
modulate O +
its O +
effect O +
on O +
APP B-Gene +
processing O +
. O +

To O +
test O +
this O +
hypothesis O +
, O +
we O +
performed O +
a O +
deletion O +
analysis O +
of O +
X11alpha B-Gene +
effects O +
on O +
metabolism O +
of O +
APP B-Gene +
( O +
695 O +
) O +
Swedish O +
( O +
K595N O +
/ O +
M596L O +
) O +
( O +
APP B-Gene +
( O -
sw O -
) O +
) O +
by O +
transient O +
cotransfection O +
of O +
HEK O +
293 O +
cells O +
with O +
: O +
1 O +
) O +
X11alpha B-Gene +
( O +
X11alpha B-Gene +
- O +
wt O +
, O +
N O +
- O +
MID O +
- O +
CID O +
- O +
PTB O +
- O +
PDZ O +
- O +
PDZ O +
- O +
C O +
) O +
, O +
2 O +
) O +
amino O +
- O +
terminal O +
deletion O +
( O +
X11alpha B-Gene +
- O +
DeltaN O +
, O +
PTB O +
- O +
PDZ O +
- O +
PDZ O +
) O +
, O +
3 O +
) O +
carboxyl O +
- O +
terminal O +
deletion O +
( O +
X11alpha B-Gene +
- O +
DeltaPDZ O +
, O +
MID O +
- O +
CID O +
- O +
PTB O +
) O +
, O +
or O +
4 O +
) O +
deletion O +
of O +
both O +
termini O +
( O +
PTB O +
domain O +
only O +
, O +
PTB O +
) O +
. O +

The O +
carboxyl O +
terminus O +
of O +
X11alpha B-Gene +
was O +
required O +
for O +
stabilization O +
of O +
APP B-Gene +
( O -
sw O -
) O +
in O +
cells O +
. O +

In O +
contrast O +
, O +
the O +
amino O +
terminus O +
of O +
X11alpha B-Gene +
was O +
required O +
to O +
stimulate O +
APPs B-Gene +
secretion O +
. O +

X11alpha B-Gene +
, O +
X11alpha B-Gene +
- O +
DeltaN O +
, O +
and O +
X11alpha B-Gene +
- O +
PTB O +
, O +
but O +
not O +
X11alpha B-Gene +
- O +
DeltaPDZ O +
, O +
were O +
effective O +
inhibitors O +
of O +
Abeta40 B-Gene +
and O +
Abeta42 B-Gene +
secretion O +
. O +

These O +
results O +
suggest O +
that O +
additional O +
protein O +
interaction O +
domains O +
of O +
X11alpha B-Gene +
modulate O +
various O +
aspects O +
of O +
APP B-Gene +
metabolism O +
. O +

A O +
novel O +
bifunctional O +
phospholipase B-Gene +
c I-Gene +
that O +
is O +
regulated O +
by O +
Galpha B-Gene +
12 I-Gene +
and O +
stimulates O +
the O +
Ras B-Gene +
/ O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
pathway O +
. O +

Three O +
families O +
of O +
phospholipase B-Gene +
C I-Gene +
( O +
PI B-Gene -
- I-Gene -
PLCbeta I-Gene +
, I-Gene +
gamma I-Gene +
, I-Gene +
and I-Gene +
delta I-Gene +
) O +
are O +
known O +
to O +
catalyze O +
the O +
hydrolysis O +
of O +
polyphosphoinositides O +
such O +
as O +
phosphatidylinositol O +
4,5-bisphosphate O +
( O +
PIP O -
( O -
2 O -
) O +
) O +
to O +
generate O +
the O +
second O +
messengers O +
inositol O +
1,4,5 O +
trisphosphate O +
and O +
diacylglycerol O +
, O +
leading O +
to O +
a O +
cascade O +
of O +
intracellular O +
responses O +
that O +
result O +
in O +
cell O +
growth O +
, O +
cell O +
differentiation O +
, O +
and O +
gene O +
expression O +
. O +

Here O +
we O +
describe O +
the O +
founding O +
member O +
of O +
a O +
novel O +
, O +
structurally O +
distinct O +
fourth O +
family B-Gene +
of I-Gene +
PI I-Gene -
- I-Gene -
PLC I-Gene +
. O +

PLCepsilon B-Gene +
not O +
only O +
contains O +
conserved O +
catalytic O +
( O +
X O +
and O +
Y O +
) O +
and O +
regulatory O +
domains O +
( O +
C2 O +
) O +
common O +
to O +
other O +
eukaryotic O +
PLCs B-Gene +
, O +
but O +
also O +
contains O +
two O +
Ras B-Gene +
- O +
associating O +
( O +
RA O +
) O +
domains O +
and O +
a O +
Ras B-Gene +
guanine I-Gene +
nucleotide I-Gene +
exchange I-Gene +
factor I-Gene +
( O +
RasGEF B-Gene +
) O +
motif O +
. O +

PLCepsilon B-Gene +
hydrolyzes O +
PIP O -
( O -
2 O -
) O +
, O +
and O +
this O +
activity O +
is O +
stimulated O +
selectively O +
by O +
a O +
constitutively O +
active O +
form O +
of O +
the O +
heterotrimeric B-Gene +
G I-Gene +
protein I-Gene +
Galpha B-Gene +
( I-Gene +
12 I-Gene +
) I-Gene +
. O +

PLCepsilon B-Gene +
and O +
a O +
mutant O +
( O +
H1144L O +
) O +
incapable O +
of O +
hydrolyzing O +
phosphoinositides O +
promote O +
formation O +
of O +
GTP O +
- O +
Ras B-Gene +
. O +

Thus O +
PLCepsilon B-Gene +
is O +
a O +
RasGEF B-Gene +
. O +

PLCepsilon B-Gene +
, O +
the O +
mutant O +
H1144L O +
, O +
and O +
the O +
isolated O +
GEF B-Gene +
domain O +
activate O +
the O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
pathway O +
in O +
a O +
manner O +
dependent O +
on O +
Ras B-Gene +
but O +
independent O +
of O +
PIP O -
( O -
2 O -
) O +
hydrolysis O +
. O +

Our O +
findings O +
demonstrate O +
that O +
PLCepsilon B-Gene +
is O +
a O +
novel O +
bifunctional O +
enzyme O +
that O +
is O +
regulated O +
by O +
the O +
heterotrimeric B-Gene +
G I-Gene +
protein I-Gene +
Galpha B-Gene +
( I-Gene +
12 I-Gene +
) I-Gene +
and O +
activates O +
the O +
small B-Gene +
G I-Gene +
protein I-Gene +
Ras B-Gene +
/ O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
signaling O +
pathway O +
. O +

Regulation O +
of O +
a O +
novel O +
human O +
phospholipase B-Gene +
C I-Gene +
, O +
PLCepsilon B-Gene +
, O +
through O +
membrane O +
targeting O +
by O +
Ras B-Gene +
. O +

Phosphoinositide B-Gene +
- I-Gene +
specific I-Gene +
phospholipase I-Gene +
C I-Gene +
( O +
PI B-Gene -
- I-Gene -
PLC I-Gene +
) O +
plays O +
a O +
pivotal O +
role O +
in O +
regulation O +
of O +
intracellular O +
signal O +
transduction O +
from O +
various O +
receptor O +
molecules O +
. O +

More O +
than O +
10 O +
members O +
of O +
human O +
PI B-Gene -
- I-Gene -
PLC I-Gene +
isoforms O +
have O +
been O +
identified O +
and O +
classified O +
into O +
three O +
classes O +
beta O +
, O +
gamma O +
, O +
and O +
delta O +
, O +
which O +
are O +
regulated O +
by O +
distinct O +
mechanisms O +
. O +

Here O +
we O +
report O +
identification O +
of O +
a O +
novel O +
class O +
of O +
human O +
PI B-Gene -
- I-Gene -
PLC I-Gene +
, O +
named O +
PLCepsilon B-Gene +
, O +
which O +
is O +
characterized O +
by O +
the O +
presence O +
of O +
a O +
Ras B-Gene +
- O +
associating O +
domain O +
at O +
its O +
C O +
terminus O +
and O +
a O +
CDC25 B-Gene +
- O +
like O +
domain O +
at O +
its O +
N O +
terminus O +
. O +

The O +
Ras B-Gene +
- O +
associating O +
domain O +
of O +
PLCepsilon B-Gene +
specifically O +
binds O +
to O +
the O +
GTP O +
- O +
bound O +
forms O +
of O +
Ha B-Gene -
- I-Gene -
Ras I-Gene +
and O +
Rap1A B-Gene +
. O +

The O +
dissociation O +
constant O +
for O +
Ha B-Gene -
- I-Gene -
Ras I-Gene +
is O +
estimated O +
to O +
be O +
approximately O +
40 O +
nm O +
, O +
comparable O +
with O +
those O +
of O +
other O +
Ras B-Gene +
effectors O +
. O +

Co O +
- O +
expression O +
of O +
an O +
activated O +
Ha B-Gene -
- I-Gene -
Ras I-Gene +
mutant O +
with O +
PLCepsilon B-Gene +
induces O +
its O +
translocation O +
from O +
the O +
cytosol O +
to O +
the O +
plasma O +
membrane O +
. O +

Upon O +
stimulation O +
with O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
, O +
similar O +
translocation O +
of O +
ectopically O +
expressed O +
PLCepsilon B-Gene +
is O +
observed O +
, O +
which O +
is O +
inhibited O +
by O +
co O +
- O +
expression O +
of O +
dominant O +
- O +
negative O +
Ha B-Gene -
- I-Gene -
Ras I-Gene +
. O +

Furthermore O +
, O +
using O +
a O +
liposome O +
- O +
based O +
reconstitution O +
assay O +
, O +
it O +
is O +
shown O +
that O +
the O +
phosphatidylinositol O +
4,5-bisphosphate O -
- O -
hydrolyzing O +
activity O +
of O +
PLCepsilon B-Gene +
is O +
stimulated O +
in O +
vitro O +
by O +
Ha B-Gene -
- I-Gene -
Ras I-Gene +
in O +
a O +
GTP O +
- O +
dependent O +
manner O +
. O +

These O +
results O +
indicate O +
that O +
Ras B-Gene +
directly O +
regulates O +
phosphoinositide O +
breakdown O +
through O +
membrane O +
targeting O +
of O +
PLCepsilon B-Gene +
. O +

Differential O +
contributions O +
of O +
NADPH B-Gene +
- I-Gene +
cytochrome I-Gene +
P450 I-Gene +
oxidoreductase I-Gene +
FAD O +
binding O +
site O +
residues O +
to O +
flavin O +
binding O +
and O +
catalysis O +
. O +

Transfer O +
of O +
reducing O +
equivalents O +
from O +
NADPH O +
to O +
the O +
cytochromes B-Gene +
P450 I-Gene +
is O +
mediated O +
by O +
NADPH B-Gene +
- I-Gene +
cytochrome I-Gene +
P450 I-Gene +
oxidoreductase I-Gene +
, O +
which O +
contains O +
stoichiometric O +
amounts O +
of O +
tightly O +
bound O +
FMN O +
and O +
FAD O +
. O +

Hydrogen O +
bonding O +
and O +
van O +
der O +
Waals O +
interactions O +
between O +
FAD O +
and O +
amino O +
acid O +
residues O +
in O +
the O +
FAD O +
binding O +
site O +
of O +
the O +
reductase B-Gene +
serve O +
to O +
regulate O +
both O +
flavin O +
binding O +
and O +
reactivity O +
. O +

The O +
precise O +
orientation O +
of O +
key O +
residues O +
( O +
Arg O +
( O +
454 O +
) O +
, O +
Tyr O -
( O -
456 O -
) O +
, O +
Cys O -
( O -
472 O -
) O +
, O +
Gly O +
( O +
488 O +
) O +
, O +
Thr O -
( O -
491 O -
) O +
, O +
and O +
Trp O -
( O -
677 O -
) O +
) O +
has O +
been O +
defined O +
by O +
x O +
- O +
ray O +
crystallography O +
( O +
Wang O +
, O +
M. O +
, O +
Roberts O +
, O +
D. O +
L. O +
, O +
Paschke O +
, O +
R. O +
, O +
Shea O +
, O +
T. O +
M. O +
, O +
Masters O +
, O +
B. O +
S. O +
, O +
Kim O +
, O +
J. O +
- O +
J. O +
P. O +
( O +
1997 O +
) O +
Proc O -
. O +
Natl O -
. O +
Acad O -
. O +
Sci O -
. O +
U. O +
S. O +
A. O +
94 O +
, O +
8411 O +
- O +
8416 O +
) O +
. O +

The O +
current O +
study O +
examines O +
the O +
relative O +
contributions O +
of O +
these O +
residues O +
to O +
FAD O +
binding O +
and O +
catalysis O +
by O +
site O +
- O +
directed O +
mutagenesis O +
and O +
kinetic O +
analysis O +
. O +

Mutation O +
of O +
either O +
Tyr O -
( O -
456 O -
) O +
, O +
which O +
makes O +
van O +
der O +
Waals O +
contact O +
with O +
the O +
FAD O +
isoalloxazine O +
ring O +
and O +
also O +
hydrogen O +
- O +
bonds O +
to O +
the O +
ribityl O +
4 O +
' O +
- O +
hydroxyl O +
, O +
or O +
Arg O -
( O -
454 O -
) O +
, O +
which O +
bonds O +
to O +
the O +
FAD O +
pyrophosphate O +
, O +
decreases O +
the O +
affinity O +
for O +
FAD O +
8000 O +
- O +
and O +
25 O +
, O +
000 O +
- O +
fold O +
, O +
respectively O +
, O +
with O +
corresponding O +
decreases O +
in O +
cytochrome B-Gene +
c I-Gene +
reductase I-Gene +
activity O +
. O +

In O +
contrast O +
, O +
substitution O +
of O +
Thr O +
( O +
491 O +
) O +
, O +
which O +
also O +
interacts O +
with O +
the O +
pyrophosphate O +
grouping O +
, O +
had O +
a O +
relatively O +
modest O +
effect O +
on O +
both O +
FAD O +
binding O +
( O +
100 O +
- O +
fold O +
decrease O +
) O +
and O +
catalytic O +
activity O +
( O +
2 O +
- O +
fold O +
decrease O +
) O +
, O +
while O +
the O +
G488L O +
mutant O +
exhibited O +
, O +
respectively O +
, O +
800 O +
- O +
and O +
50 O +
- O +
fold O +
decreases O +
in O +
FAD O +
binding O +
and O +
catalytic O +
activity O +
. O +

Enzymic O +
activity O +
of O +
each O +
of O +
these O +
mutants O +
could O +
be O +
restored O +
by O +
addition O +
of O +
FAD O +
. O +

Kinetic O +
properties O +
and O +
the O +
FMN O +
content O +
of O +
these O +
mutants O +
were O +
not O +
affected O +
by O +
these O +
substitutions O +
, O +
with O +
the O +
exception O +
of O +
a O +
3 O +
- O +
fold O +
increase O +
in O +
Y456S O +
K O -
( O -
m O -
) O +
( O +
cyt O +
) O -
( O -
c O -
) O +
and O +
a O +
70 O +
% O +
decrease O +
in O +
R454E O +
FMN O +
content O +
, O +
suggesting O +
that O +
the O +
FMN O +
- O +
and O +
FAD O +
- O +
binding O +
domains O +
are O +
largely O +
, O +
but O +
not O +
completely O +
, O +
independent O +
. O +

Even O +
though O +
Trp O -
( O -
677 O -
) O +
is O +
stacked O +
against O +
the O +
re O +
- O +
face O +
of O +
FAD O +
, O +
suggesting O +
an O +
important O +
role O +
in O +
FAD O +
binding O +
, O +
deletion O +
of O +
both O +
Trp O +
( O +
677 O +
) O +
and O +
the O +
carboxyl O +
- O +
terminal O +
Ser O +
( O +
678 O +
) O +
decreased O +
catalytic O +
activity O +
50 O +
- O +
fold O +
without O +
affecting O +
FAD O +
content O +
. O +

Interleukin B-Gene +
8 I-Gene +
, O +
neutrophil B-Gene +
- I-Gene +
activating I-Gene +
peptide-2 I-Gene +
and O +
GRO B-Gene -
- I-Gene -
alpha I-Gene +
bind O +
to O +
and O +
elicit O +
cell O +
activation O +
via O +
specific O +
and O +
different O +
amino O +
acid O +
residues O +
of O +
CXCR2 B-Gene +
. O +

The O +
objective O +
of O +
this O +
investigation O +
was O +
to O +
determine O +
the O +
amino O +
acid O +
residues O +
of O +
the O +
human O +
neutrophil O +
CXC B-Gene +
chemokine I-Gene +
receptor-2 I-Gene +
( O +
CXCR2 B-Gene +
) O +
that O +
are O +
critical O +
for O +
binding O +
the O +
ligands O +
interleukin B-Gene +
8 I-Gene +
( O +
IL-8 B-Gene +
) O +
, O +
neutrophil B-Gene +
- I-Gene +
activating I-Gene +
peptide-2 I-Gene +
( O +
NAP-2 B-Gene +
) O +
, O +
and O +
growth B-Gene +
- I-Gene +
related I-Gene +
protein I-Gene +
alpha I-Gene +
( O +
GROalpha B-Gene +
) O +
and O +
critical O +
for O +
receptor O +
- O +
mediated O +
signal O +
transduction O +
. O +

Charged O +
residues O +
of O +
the O +
amino O +
terminus O +
and O +
the O +
first O +
extracellular O +
loop O +
of O +
CXCR2 B-Gene +
were O +
targeted O +
for O +
point O +
mutagenesis O +
studies O +
. O +

Seven O +
separate O +
CXCR2 B-Gene +
mutants O +
( O +
Glu7 O +
, O +
Asp9 O +
, O +
Glu12 O +
, O +
Asp13 O +
, O +
Lys108 O +
, O +
Asn110 O +
, O +
and O +
Lys120 O +
, O +
all O +
to O +
Ala O +
) O +
were O +
generated O +
. O +

Based O +
on O +
the O +
Scatchard O +
analysis O +
of O +
radioligand O +
binding O +
studies O +
, O +
the O +
following O +
amino O +
acids O +
were O +
deemed O +
critical O +
for O +
ligand O +
binding O +
: O +
( O -
i O -
) O +
Asp9 O +
, O +
Glu12 O +
, O +
Lys108 O +
, O +
and O +
Lys120 O +
for O +
IL-8 B-Gene +
and O +
( O -
ii O -
) O +
Glu7 O +
, O +
Asp9 O +
, O +
and O +
Glu12 O +
for O +
GROalpha B-Gene +
. O +

Point O +
mutations O +
in O +
the O +
amino O +
terminus O +
domain O +
( O +
Asp9 O +
and O +
Glu12 O +
) O +
and O +
the O +
first O +
extracellular O +
loop O +
( O +
Lys108 O +
, O +
Asn110 O +
, O +
and O +
Lys120 O +
) O +
of O +
CXCR2 B-Gene +
reduced O +
cell O +
activation O +
to O +
all O +
three O +
ligands O +
as O +
measured O +
by O +
changes O +
in O +
intracellular O +
calcium O +
concentration O +
. O +

In O +
conclusion O +
, O +
high O +
- O +
affinity O +
binding O +
of O +
IL-8 B-Gene +
, O +
NAP-2 B-Gene +
, O +
and O +
GROalpha B-Gene +
to O +
CXCR2 B-Gene +
involves O +
interaction O +
with O +
specific O +
and O +
different O +
amino O +
acid O +
residues O +
of O +
CXCR2 B-Gene +
. O +

Furthermore O +
, O +
we O +
propose O +
that O +
the O +
CXCR2 B-Gene +
amino O +
acid O +
residues O +
required O +
for O +
cell O +
activation O +
are O +
not O +
necessarily O +
the O +
same O +
residues O +
required O +
for O +
ligand O +
binding O +
. O +

Cytokines B-Gene +
and O +
osteolysis O +
around O +
total O +
hip O +
prostheses O +
. O +

The O +
aim O +
of O +
this O +
work O +
is O +
to O +
assess O +
the O +
correlation O +
between O +
the O +
osteolysis O +
around O +
the O +
prosthesis O +
and O +
the O +
presence O +
of O +
cytokines B-Gene +
favouring O +
inflammation O +
in O +
the O +
tissues O +
at O +
the O +
interface O +
between O +
loosened O +
prosthesis O +
and O +
bone O +
. O +

In O +
this O +
study O +
, O +
twenty O +
- O +
nine O +
patients O +
that O +
underwent O +
revision O +
surgery O +
were O +
examined O +
. O +

Bioptic O +
samples O +
were O +
collected O +
at O +
the O +
interface O +
between O +
bone O +
and O +
implant O +
both O +
at O +
the O +
stem O +
and O +
socket O +
level O +
. O +

Semiquantitative O +
immunohistochemistry O +
was O +
performed O +
to O +
detect O +
interleukin B-Gene +
1 I-Gene +
alpha I-Gene +
, O +
interleukin B-Gene +
1 I-Gene +
beta I-Gene +
, O +
interleukin B-Gene +
6 I-Gene +
and O +
tumour B-Gene +
necrosis I-Gene +
factor I-Gene +
, O +
cytokines B-Gene +
that O +
directly O +
cause O +
bone O +
resorption O +
and O +
indirectly O +
induce O +
synthesis O +
of O +
other O +
bone O +
resorbing O +
cytokines B-Gene +
. O +

Wear O +
particles O +
were O +
identified O +
and O +
quantified O +
by O +
light O +
microscopy O +
. O +

Radiographic O +
evidence O +
for O +
osteolysis O +
was O +
scored O +
by O +
the O +
Engh O +
and O +
Bobyn O +
score O +
. O +

In O +
tissues O +
collected O +
at O +
the O +
interface O +
, O +
the O +
percentage O +
of O +
cells O +
positive O +
to O +
IL1 B-Gene +
, O +
IL6 B-Gene +
and O +
particularly O +
to O +
TNF B-Gene +
increased O +
in O +
relation O +
to O +
the O +
tissues O +
collected O +
at O +
the O +
interface O +
with O +
stable O +
components O +
. O +

The O +
cells O +
occurring O +
in O +
the O +
new O +
capsule O +
do O +
not O +
secrete O +
cytokines B-Gene +
in O +
quantities O +
that O +
can O +
be O +
related O +
to O +
severity O +
of O +
wear O +
. O +

Cemented O +
prostheses O +
showed O +
higher O +
incidence O +
of O +
severe O +
osteolysis O +
, O +
and O +
higher O +
levels O +
of O +
cytokines B-Gene +
. O +

It O +
can O +
be O +
concluded O +
that O +
TNF B-Gene +
, O +
and O +
to O +
a O +
lesser O +
extent O +
IL1 B-Gene +
and O +
IL6 B-Gene +
, O +
are O +
positively O +
related O +
to O +
the O +
severity O +
of O +
osteolysis O +
around O +
the O +
prosthesis O +
and O +
therefore O +
a O +
pharmacological O +
treatment O +
can O +
be O +
hypothesized O +
with O +
anti O +
- O +
inflammatory O +
or O +
anti O +
- O +
cytokine B-Gene +
drugs O +
in O +
order O +
to O +
limit O +
or O +
to O +
avoid O +
prosthesis O +
loosening O +
. O +

Peroxisomal O +
degradation O +
of O +
trans O +
- O +
unsaturated O +
fatty O +
acids O +
in O +
the O +
yeast O +
Saccharomyces O +
cerevisiae O +
. O +

Degradation O +
of O +
trans O +
- O +
unsaturated O +
fatty O +
acids O +
was O +
studied O +
in O +
the O +
yeast O +
Saccharomyces O +
cerevisiae O +
. O +

Propagation O +
of O +
yeast O +
cells O +
on O +
trans-9 O +
elaidic O +
acid O +
medium O +
resulted O +
in O +
transcriptional O +
up O +
- O +
regulation O +
of O +
the O +
SPS19 B-Gene +
gene O +
, O +
whose O +
promoter O +
contains O +
an O +
oleate O +
response O +
element O +
. O +

This O +
up O +
- O +
regulation O +
depended O +
on O +
the O +
Pip2p B-Gene +
- O +
Oaf1p B-Gene +
transcription B-Gene +
factor I-Gene +
and O +
was O +
accompanied O +
by O +
induction O +
of O +
import O +
- O +
competent O +
peroxisomes O +
. O +

Utilization O +
of O +
trans O +
fatty O +
acids O +
as O +
a O +
single O +
carbon O +
and O +
energy O +
source O +
was O +
evaluated O +
by O +
monitoring O +
the O +
formation O +
of O +
clear O +
zones O +
around O +
cell O +
growth O +
on O +
turbid O +
media O +
containing O +
fatty O +
acids O +
dispersed O +
with O +
Tween O +
80 O +
. O +

For O +
metabolizing O +
odd O +
- O +
numbered O +
trans O +
double O +
bonds O +
, O +
cells O +
required O +
the O +
beta O +
- O +
oxidation O +
auxiliary O +
enzyme O +
Delta B-Gene +
( I-Gene +
3 I-Gene +
) I-Gene +
- I-Gene +
Delta I-Gene +
( I-Gene +
2 I-Gene +
) I-Gene +
- I-Gene +
enoyl I-Gene +
- I-Gene +
CoA I-Gene +
isomerase I-Gene +
Eci1p B-Gene +
. O +

Metabolism O +
of O +
the O +
corresponding O +
even O +
- O +
numbered O +
double O +
bonds O +
proceeded O +
in O +
the O +
absence O +
of O +
Sps19p B-Gene +
( O +
2,4-dienoyl B-Gene -
- I-Gene -
CoA I-Gene +
reductase I-Gene +
) O +
and O +
Dci1p B-Gene +
( O +
Delta B-Gene +
( I-Gene +
3,5 I-Gene -
) I-Gene -
-Delta I-Gene -
( I-Gene -
2,4 I-Gene -
) I-Gene -
-dienoyl I-Gene -
- I-Gene -
CoA I-Gene +
isomerase I-Gene +
) O +
. O +

trans-2,trans-4-Dienoyl O +
- O +
CoAs O +
could O +
enter O +
beta O -
- O -
oxidation O +
directly O +
via O +
Fox2p B-Gene +
( O +
2-enoyl B-Gene -
- I-Gene -
CoA I-Gene +
hydratase I-Gene +
2 I-Gene +
and O +
d O +
- O +
specific O +
3-hydroxyacyl B-Gene -
- I-Gene -
CoA I-Gene +
dehydrogenase I-Gene +
) O +
without O +
the O +
involvement O +
of O +
Sps19p B-Gene +
, O +
whereas O +
trans-2,cis-4-dienoyl O -
- O -
CoAs O +
could O +
not O +
. O +

This O +
reductase B-Gene +
- O +
independent O +
metabolism O +
of O +
trans-2,trans-4-dienoyl O -
- O -
CoAs O +
resembled O +
the O +
situation O +
postulated O +
for O +
mammalian O +
mitochondria O +
in O +
which O +
oleic O +
acid O +
is O +
degraded O +
through O +
a O +
di O +
- O +
isomerase B-Gene +
- O +
dependent O +
pathway O +
. O +

In O +
this O +
hypothetical O +
process O +
, O +
trans-2 O +
, O +
trans O +
- O +
4 O +
- O +
dienoyl O +
- O +
CoA O +
metabolites O +
are O +
generated O +
by O +
Delta B-Gene +
( I-Gene +
3 I-Gene +
) I-Gene +
- I-Gene +
Delta I-Gene +
( I-Gene +
2 I-Gene +
) I-Gene +
- I-Gene +
enoyl I-Gene +
- I-Gene +
CoA I-Gene +
isomerase I-Gene +
and O +
Delta B-Gene +
( I-Gene +
3 I-Gene +
, I-Gene +
5 I-Gene +
) I-Gene +
- I-Gene +
Delta I-Gene +
( I-Gene +
2 I-Gene +
, I-Gene +
4 I-Gene +
) I-Gene +
- I-Gene +
dienoyl I-Gene +
- I-Gene +
CoA I-Gene +
isomerase I-Gene +
and O +
are O +
degraded O +
by O +
2 B-Gene +
- I-Gene +
enoyl I-Gene +
- I-Gene +
CoA I-Gene +
hydratase I-Gene +
1 I-Gene +
in O +
the O +
absence O +
of O +
2 B-Gene +
, I-Gene +
4 I-Gene +
- I-Gene +
dienoyl I-Gene +
- I-Gene +
CoA I-Gene +
reductase I-Gene +
. O +

Growth O +
of O +
a O +
yeast O +
fox2sps19Delta B-Gene +
mutant O +
in O +
which O +
Fox2p B-Gene +
was O +
exchanged O +
with O +
rat O +
peroxisomal B-Gene +
multifunctional I-Gene +
enzyme I-Gene +
type I-Gene +
1 I-Gene +
on O +
trans-9,trans-12 O +
linolelaidic O +
acid O +
medium O +
gave O +
credence O +
to O +
this O +
theory O +
. O +

We O +
propose O +
an O +
amendment O +
to O +
the O +
current O +
scheme O +
of O +
the O +
carbon O +
flux O +
through O +
beta O -
- O -
oxidation O +
taking O +
into O +
account O +
the O +
dispensability O +
of O +
beta O -
- O -
oxidation O +
auxiliary O +
enzymes O +
for O +
metabolizing O +
trans O +
double O +
bonds O +
at O +
even O +
- O +
numbered O +
positions O +
. O +

Homogenous O +
expression O +
of O +
killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIR B-Gene +
) O +
on O +
polyclonal O +
natural O +
killer O +
cells O +
detected O +
by O +
a O +
monoclonal O +
antibody O +
to O +
KIR2D B-Gene +
. O +

The O +
activity O +
of O +
human O +
natural O +
killer O +
( O +
NK O +
) O +
cells O +
is O +
in O +
part O +
regulated O +
by O +
the O +
expression O +
of O +
killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
( I-Gene +
Ig I-Gene +
) I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIR B-Gene +
) O +
that O +
recognize O +
major B-Gene +
histocompatibility I-Gene +
complex I-Gene +
( I-Gene +
MHC I-Gene +
) I-Gene +
class I-Gene +
I I-Gene +
and O +
can O +
inhibit O +
NK O +
cell O +
cytotoxicity O +
. O +

A O +
monoclonal O +
anti O +
- O +
KIR B-Gene +
antibody O +
was O +
established O +
and O +
designated O +
Lig1 O +
. O +

Lig1 O +
was O +
shown O +
to O +
be O +
specific O +
for O +
KIR B-Gene +
in O +
cell O +
- O +
surface O +
staining O +
and O +
to O +
react O +
with O +
all O +
KIR2D B-Gene +
, O +
except O +
KIR2DL4 B-Gene +
which O +
lacks O +
a O +
D1 O +
domain O +
, O +
but O +
not O +
with O +
KIR3D B-Gene +
molecules O +
in O +
an O +
enzyme O +
- O +
linked O +
immunoadsorbent O +
assay O +
( O +
ELISA O +
) O +
and O +
Western O +
blotting O +
. O +

Unlike O +
other O +
anti O +
- O +
KIR B-Gene +
antibodies O +
, O +
Lig1 O +
did O +
not O +
inhibit O +
binding O +
of O +
KIR B-Gene +
- O +
Ig B-Gene +
- O +
fusion O +
proteins O +
to O +
MHC B-Gene -
- I-Gene -
class I-Gene +
I I-Gene +
expressing O +
cells O +
nor O +
did O +
it O +
interfere O +
with O +
KIR B-Gene +
- O +
mediated O +
inhibition O +
of O +
NK O +
cell O +
cytotoxicity O +
in O +
a O +
functional O +
assay O +
. O +

Lig1 O +
reacted O +
with O +
all O +
NK O +
cells O +
in O +
polyclonal O +
NK O +
populations O +
from O +
different O +
donors O +
, O +
demonstrating O +
that O +
all O +
NK O +
cells O +
express O +
at O +
least O +
one O +
KIR2D B-Gene +
receptor O +
. O +

The O +
specificity O +
of O +
antibody O +
responses O +
in O +
cattle O +
naturally O +
exposed O +
to O +
Fasciola O +
hepatica O +
. O +

Fasciola O +
hepatica O +
causes O +
significant O +
morbidity O +
and O +
mortality O +
in O +
dairy O +
cattle O +
in O +
the O +
Andean O +
region O +
of O +
Cajamarca O +
, O +
Peru O +
, O +
where O +
prevalence O +
of O +
infection O +
of O +
up O +
to O +
78 O +
% O +
has O +
been O +
reported O +
. O +

ELISA O +
and O +
Western O +
blot O +
analyses O +
were O +
used O +
to O +
characterise O +
antibody O +
responses O +
in O +
dairy O +
cattle O +
to O +
adult O +
F. O +
hepatica O +
to O +
excretory O +
- O +
secretory O +
( O +
E O -
/ O -
S O +
) O +
, O +
somatic O +
( O +
SO O +
) O +
and O +
surface O +
( O +
SU O +
) O +
antigens O +
. O +

Three O +
groups O +
of O +
dairy O +
cattle O +
- O +
calves O +
, O +
heifers O +
and O +
adult O +
cows O +
- O +
naturally O +
exposed O +
to O +
F. O +
hepatica O +
in O +
this O +
region O +
, O +
were O +
monitored O +
every O +
2 O +
months O +
over O +
a O +
2 O +
- O +
year O +
period O +
. O +

Calves O +
, O +
heifers O +
and O +
adult O +
cows O +
all O +
had O +
antibodies O +
which O +
recognised O +
a O +
28kDa O +
protein O +
in O +
the O +
SO O +
preparation O +
, O +
whereas O +
only O +
adult O +
cows O +
had O +
antibodies O +
that O +
recognised O +
a O +
28kDa O +
protein O +
in O +
E O -
/ O -
S O +
products O +
. O +

All O +
three O +
groups O +
of O +
cattle O +
responded O +
to O +
a O +
60 O +
- O +
66kDa O +
group O +
of O +
proteins O +
in O +
E O -
/ O -
S O +
and O +
SU O +
preparations O +
and O +
a O +
17kDa O +
antigen O +
in O +
SO O +
products O +
was O +
recognised O +
by O +
antibodies O +
from O +
cows O +
and O +
heifers O +
but O +
not O +
calves O +
. O +

The O +
total O +
antibody O +
response O +
to O +
E O -
/ O -
S O +
antigens O +
measured O +
by O +
ELISA O +
, O +
increased O +
over O +
time O +
in O +
calves O +
and O +
remained O +
constantly O +
high O +
over O +
the O +
2 O +
- O +
year O +
period O +
in O +
all O +
three O +
groups O +
of O +
cattle O +
. O +

Slight O +
fluctuations O +
in O +
the O +
antibody O +
response O +
occurred O +
in O +
the O +
group O +
of O +
heifers O +
and O +
cows O +
coinciding O +
with O +
seasonal O +
changes O +
in O +
the O +
level O +
of O +
challenge O +
. O +

Antimicrobial O +
activity O +
of O +
MHC B-Gene +
class I-Gene +
I I-Gene +
- O +
restricted O +
CD8 B-Gene +
+ O +
T O +
cells O +
in O +
human O +
tuberculosis O +
. O +

Studies O +
of O +
mouse O +
models O +
of O +
tuberculosis O +
( O +
TB O +
) O +
infection O +
have O +
indicated O +
a O +
central O +
role O +
for O +
MHC B-Gene +
class I-Gene +
I I-Gene +
- O +
restricted O +
CD8 B-Gene +
+ O +
T O +
cells O +
in O +
protective O +
immunity O +
. O +

To O +
define O +
antigens O +
and O +
epitopes O +
of O +
Mycobacterium O +
tuberculosis O +
( O +
MTB O +
) O +
proteins O +
that O +
are O +
presented O +
by O +
infected O +
cells O +
to O +
CD8 B-Gene +
+ O +
T O +
cells O +
, O +
we O +
screened O +
40 O +
MTB O +
proteins O +
for O +
HLA B-Gene +
class I-Gene +
I I-Gene +
A*0201 I-Gene +
- O +
binding O +
motifs O +
. O +

Peptides O +
that O +
bound O +
with O +
high O +
affinity O +
to O +
purified O +
HLA B-Gene +
molecules O +
were O +
subsequently O +
analyzed O +
for O +
recognition O +
by O +
CD8 B-Gene +
+ O +
cytotoxic O +
T O +
lymphocytes O +
. O +

We O +
identified O +
three O +
epitopes O +
recognized O +
by O +
CD8 B-Gene +
+ O +
T O +
cells O +
from O +
patients O +
recovering O +
from O +
TB O +
infection O +
. O +

Those O +
three O +
epitopes O +
were O +
derived O +
from O +
three O +
different O +
antigens O +
: O +
thymidylate B-Gene +
synthase I-Gene +
( O +
ThyA B-Gene +
( O +
30 O -
- O -
38 O +
) O +
) O +
, O +
RNA B-Gene +
polymerase I-Gene +
beta I-Gene +
- O +
subunit O +
( O +
RpoB B-Gene +
( O +
127 O -
- O -
135 O +
) O +
) O +
, O +
and O +
a O +
putative O +
phosphate B-Gene +
transport I-Gene +
system I-Gene +
permease I-Gene +
protein I-Gene +
A-1 I-Gene +
( O +
PstA1 B-Gene +
( O +
75 O -
- O -
83 O +
) O +
) O +
. O +

In O +
addition O +
, O +
CD8 B-Gene +
+ O +
T O +
cell O +
lines O +
specific O +
for O +
three O +
peptides O +
( O +
ThyA B-Gene +
( O +
30 O -
- O -
38 O +
) O +
, O +
PstA1 B-Gene +
( O +
75 O -
- O -
83 O +
) O +
, O +
and O +
85B B-Gene +
( O +
15 O -
- O -
23 O +
) O +
) O +
were O +
generated O +
from O +
peripheral O +
blood O +
mononuclear O +
cells O +
of O +
normal O +
HLA B-Gene -
- I-Gene -
A*0201 I-Gene +
donors O +
. O +

These O +
CD8 B-Gene +
+ O +
T O +
cell O +
lines O +
specifically O +
recognized O +
MTB O +
- O +
infected O +
macrophages O +
, O +
as O +
demonstrated O +
by O +
production O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
lysis O +
of O +
the O +
infected O +
target O +
cells O +
. O +

Finally O +
, O +
CD8 B-Gene +
+ O +
cytotoxic O +
T O +
lymphocytes O +
reduced O +
the O +
viability O +
of O +
the O +
intracellular O +
MTB O +
, O +
providing O +
evidence O +
that O +
CD8 B-Gene +
+ O +
T O +
cell O +
recognition O +
of O +
MHC B-Gene +
class I-Gene +
I I-Gene +
- O +
restricted O +
epitopes O +
of O +
these O +
MTB O +
antigens O +
can O +
contribute O +
to O +
effective O +
immunity O +
against O +
the O +
pathogen O +
. O +

The O +
MAPK B-Gene +
kinase I-Gene +
kinase I-Gene +
TAK1 B-Gene +
plays O +
a O +
central O +
role O +
in O +
coupling O +
the O +
interleukin-1 B-Gene +
receptor I-Gene +
to O +
both O +
transcriptional O +
and O +
RNA O +
- O +
targeted O +
mechanisms O +
of O +
gene O +
regulation O +
. O +

Mechanisms O +
of O +
fulminant O +
gene O +
induction O +
during O +
an O +
inflammatory O +
response O +
were O +
investigated O +
using O +
expression O +
of O +
the O +
chemoattractant O +
cytokine B-Gene +
interleukin-8 B-Gene +
( O +
IL-8 B-Gene +
) O +
as O +
a O +
model O +
. O +

Recently O +
we O +
found O +
that O +
coordinate O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
and O +
c B-Gene -
- I-Gene -
Jun I-Gene +
N I-Gene +
- I-Gene +
terminal I-Gene +
protein I-Gene +
kinase I-Gene +
( O +
JNK B-Gene +
) O +
is O +
required O +
for O +
strong O +
IL-8 B-Gene +
transcription O +
, O +
whereas O +
the O +
p38 B-Gene +
MAP I-Gene +
kinase I-Gene +
( O +
MAPK B-Gene +
) O +
pathway O +
stabilizes O +
the O +
IL-8 B-Gene +
mRNA O +
. O +

It O +
is O +
unclear O +
how O +
these O +
pathways O +
are O +
coupled O +
to O +
the O +
receptor B-Gene +
for I-Gene +
IL-1 I-Gene +
, O +
an O +
important O +
physiological O +
inducer O +
of O +
IL-8 B-Gene +
. O +

Expression O +
of O +
the O +
MAP B-Gene +
kinase I-Gene +
kinase I-Gene +
kinase I-Gene +
( O +
MAPKKK B-Gene +
) O +
TAK1 B-Gene +
together O +
with O +
its O +
coactivator O +
TAB1 B-Gene +
in O +
HeLa O +
cells O +
activated O +
all O +
three O +
pathways O +
and O +
was O +
sufficient O +
to O +
induce O +
IL-8 B-Gene +
formation O +
, O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
+ O +
JNK2 B-Gene +
- O +
mediated O +
transcription O +
from O +
a O +
minimal O +
IL-8 B-Gene +
promoter O +
, O +
and O +
p38 B-Gene +
MAPK I-Gene +
- O +
mediated O +
stabilization O +
of O +
a O +
reporter O +
mRNA O +
containing O +
IL-8 B-Gene +
- O +
derived O +
regulatory O +
mRNA O +
sequences O +
. O +

Expression O +
of O +
a O +
kinase B-Gene +
- O +
inactive O +
mutant O +
of O +
TAK1 B-Gene +
largely O +
blocked O +
IL-1 B-Gene +
- O +
induced O +
transcription O +
and O +
mRNA O +
stabilization O +
, O +
as O +
well O +
as O +
formation O +
of O +
endogenous O +
IL-8 B-Gene +
. O +

Truncated O +
TAB1 B-Gene +
, O +
lacking O +
the O +
TAK1 B-Gene +
binding O +
domain O +
, O +
or O +
a O +
TAK1 B-Gene +
- O +
derived O +
peptide O +
containing O +
a O +
TAK1 B-Gene +
autoinhibitory O +
domain O +
were O +
also O +
efficient O +
in O +
inhibition O +
. O +

These O +
data O +
indicate O +
that O +
the O +
previously O +
described O +
three O +
- O +
pathway O +
model O +
of O +
IL-8 B-Gene +
induction O +
is O +
operative O +
in O +
response O +
to O +
a O +
physiological O +
stimulus O +
, O +
IL-1 B-Gene +
, O +
and O +
that O +
the O +
MAPKKK B-Gene +
TAK1 B-Gene +
couples O +
the O +
IL-1 B-Gene +
receptor I-Gene +
to O +
both O +
transcriptional O +
and O +
RNA O +
- O +
targeted O +
mechanisms O +
mediated O +
by O +
the O +
three O +
pathways O +
. O +

Expression O +
analysis O +
and O +
characterization O +
of O +
alternatively O +
spliced O +
transcripts O +
of O +
human O +
IL-7Ralpha B-Gene +
chain O +
encoding O +
two O +
truncated O +
receptor O +
proteins O +
in O +
relapsed O +
childhood O +
all O +
. O +

In O +
the O +
family O +
of O +
cytokines B-Gene +
and O +
cytokine B-Gene +
receptors I-Gene +
, O +
alternative O +
splicing O +
of O +
pre O +
- O +
mRNA O +
is O +
a O +
frequently O +
observed O +
process O +
that O +
generates O +
different O +
protein O +
isoforms O +
from O +
a O +
single O +
genetic O +
locus O +
. O +

The O +
splicing O +
- O +
derived O +
cytokine B-Gene +
receptor I-Gene +
protein O +
isoforms O +
are O +
mostly O +
soluble O +
receptors O +
or O +
show O +
alterations O +
in O +
their O +
cytoplasmic O +
domain O +
. O +

It O +
is O +
possible O +
that O +
receptor O +
abnormalities O +
or O +
a O +
pathological O +
ratio O +
of O +
different O +
isoforms O +
may O +
contribute O +
to O +
leukaemia O +
by O +
circumventing O +
normal O +
growth B-Gene +
factor I-Gene +
control O +
or O +
altering O +
the O +
balance O +
of O +
proliferation O +
and O +
differentiation O +
. O +

IL-7 B-Gene +
plays O +
a O +
critical O +
role O +
in O +
early O +
stages O +
of O +
both O +
B O +
and O +
T O +
cell O +
maturation O +
. O +

Moreover O +
, O +
it O +
stimulates O +
the O +
expansion O +
of O +
mature O +
T O +
cells O +
including O +
anti O +
- O +
tumour O +
reactive O +
cells O +
as O +
well O +
as O +
a O +
number O +
of O +
T O +
and O +
B O +
cell O +
malignancies O +
underlining O +
its O +
potential O +
importance O +
for O +
deregulated O +
lymphoid O +
proliferation O +
and O +
leukaemogenesis O +
. O +

Here O +
, O +
we O +
present O +
detailed O +
data O +
on O +
the O +
expression O +
of O +
the O +
interleukin B-Gene +
7 I-Gene +
receptor I-Gene +
alpha I-Gene +
chain O +
( O +
IL-7Ralpha B-Gene +
) O +
in O +
leukaemic O +
cells O +
from O +
210 O +
children O +
with O +
acute O +
lymphoblastic O +
leukaemia O +
( O +
ALL O +
) O +
and O +
describe O +
two O +
novel O +
alternatively O +
spliced O +
transcripts O +
of O +
human O +
IL-7Ralpha B-Gene +
coding O +
for O +
truncated O +
receptor O +
proteins O +
which O +
are O +
still O +
capable O +
of O +
binding O +
IL-7 B-Gene +
. O +

IL-7Ralpha B-Gene +
mRNA O +
expression O +
was O +
more O +
frequent O +
in O +
more O +
mature O +
pre O +
- O +
B O +
ALL O +
[ O +
91 O +
% O +
( O +
30 O +
/ O +
33 O +
) O +
] O +
than O +
in O +
common O +
[ O +
81 O +
% O +
( O +
81 O +
/ O +
100 O +
) O +
] O +
or O +
pro O +
- O +
B O +
ALL O +
[ O +
64 O +
% O +
( O +
18 O +
/ O +
28 O +
) O +
] O +
, O +
or O +
even O +
in O +
T O +
ALL O +
[ O +
64 O +
% O +
( O +
29 O +
/ O +
45 O +
) O +
] O +
. O +

These O +
results O +
are O +
in O +
concordance O +
with O +
flow O +
cytometric O +
analyses O +
on O +
the O +
proportion O +
of O +
IL-7Ralpha B-Gene +
bearing O +
cells O +
among O +
total O +
blast O +
cell O +
population O +
. O +

Our O +
results O +
lead O +
us O +
to O +
assume O +
that O +
splicing O +
derived O +
IL-7Ralpha B-Gene +
isoforms O +
play O +
a O +
potential O +
role O +
in O +
modulating O +
IL-7 B-Gene +
signal O +
transduction O +
and O +
might O +
be O +
important O +
for O +
the O +
pathogenesis O +
of O +
leukaemia O +
. O +

Role O +
of O +
type B-Gene +
I I-Gene +
interferons I-Gene +
during O +
macrophage O +
activation O +
by O +
lipopolysaccharide O +
. O +

Activation O +
of O +
macrophages O +
by O +
bacterial O +
lipopolysaccharide O +
( O +
LPS O +
) O +
is O +
accompanied O +
by O +
the O +
secretion O +
of O +
type B-Gene +
I I-Gene +
interferons I-Gene +
( O +
IFNs B-Gene +
) O +
which O +
can O +
act O +
in O +
an O +
autocrine O +
manner O +
. O +

We O +
examined O +
the O +
role O +
of O +
type B-Gene +
I I-Gene +
IFNs I-Gene +
in O +
macrophage O +
responses O +
to O +
LPS O +
using O +
bone O +
marrow O +
- O +
derived O +
macrophages O +
( O +
BMM O +
) O +
from O +
IFNAR1 B-Gene +
- O -
/ O -
- O +
mice O +
, O +
which O +
lack O +
a O +
component O +
of O +
the O +
type B-Gene +
I I-Gene +
IFN I-Gene +
receptor I-Gene +
and O +
do O +
not O +
respond O +
to O +
type B-Gene +
I I-Gene +
IFNs I-Gene +
. O +

We O +
found O +
that O +
, O +
unlike O +
wild O +
- O +
type O +
( O +
WT O +
) O +
BMM O +
, O +
LPS O +
- O +
treated O +
IFNAR1 B-Gene +
- O -
/ O -
- O +
cells O +
failed O +
to O +
produce O +
nitric O +
oxide O +
( O +
NO O +
) O +
, O +
or O +
express O +
inducible B-Gene +
NO I-Gene +
synthase I-Gene +
( O +
iNOS B-Gene +
) O +
, O +
indicating O +
that O +
type B-Gene +
I I-Gene +
IFNs I-Gene +
are O +
essential O +
for O +
all O +
LPS O +
- O +
stimulated O +
NO O +
production O +
in O +
BMM O +
. O +

Exogenously O +
added O +
type B-Gene +
II I-Gene +
IFN I-Gene +
( O +
IFNgamma B-Gene +
) O +
rescued O +
these O +
responses O +
in O +
LPS O +
- O +
treated O +
IFNAR1 B-Gene +
- O -
/ O -
- O +
BMM O +
. O +

In O +
contrast O +
to O +
effects O +
on O +
NO O +
, O +
type B-Gene +
I I-Gene +
IFNs I-Gene +
negatively O +
regulated O +
respiratory O +
burst O +
activity O +
in O +
LPS O +
- O +
primed O +
BMM O +
. O +

We O +
also O +
found O +
that O +
while O +
type B-Gene +
I I-Gene +
IFNs I-Gene +
mediated O +
the O +
anti O +
- O +
proliferative O +
effects O +
of O +
lower O +
concentrations O +
of O +
LPS O +
, O +
at O +
higher O +
concentrations O +
LPS O +
acted O +
in O +
a O +
type B-Gene +
I I-Gene +
IFNs I-Gene +
- O +
independent O +
manner O +
. O +

Finally O +
, O +
we O +
report O +
that O +
type B-Gene +
I I-Gene +
IFNs I-Gene +
are O +
a O +
survival O +
factor O +
for O +
BMM O +
. O +

Despite O +
this O +
, O +
the O +
ability O +
of O +
LPS O +
to O +
also O +
prevent O +
apoptosis O +
in O +
BMM O +
was O +
independent O +
of O +
type B-Gene +
I I-Gene +
IFNs I-Gene +
. O +

These O +
findings O +
highlight O +
the O +
diverse O +
roles O +
of O +
type B-Gene +
I I-Gene +
IFNs I-Gene +
in O +
mediating O +
LPS O +
- O +
stimulated O +
macrophage O +
responses O +
. O +

Endotoxin O +
and O +
cytokine B-Gene +
regulation O +
of O +
toll B-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( I-Gene +
TLR I-Gene +
) I-Gene +
2 I-Gene +
and O +
TLR4 B-Gene +
gene O +
expression O +
in O +
murine O +
liver O +
and O +
hepatocytes O +
. O +

Toll B-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( I-Gene +
TLR I-Gene +
) I-Gene +
2 I-Gene +
and O +
TLR4 B-Gene +
are O +
members O +
of O +
the O +
interleukin-1 B-Gene +
receptor I-Gene +
( I-Gene +
IL-1R I-Gene +
) I-Gene +
family I-Gene +
and O +
transduce O +
similar O +
signals O +
as O +
IL-1R B-Gene +
in O +
response O +
to O +
bacteria O +
and O +
bacterial O +
components O +
. O +

In O +
this O +
study O +
, O +
we O +
investigated O +
the O +
regulation O +
of O +
their O +
gene O +
expression O +
in O +
murine O +
tissues O +
, O +
especially O +
in O +
the O +
liver O +
and O +
hepatocytes O +
. O +

When O +
mice O +
were O +
administered O +
lipopolysaccharide O +
( O +
LPS O +
) O +
, O +
TLR2 B-Gene +
mRNA O +
was O +
upregulated O +
in O +
the O +
brain O +
, O +
heart O +
, O +
lung O +
, O +
liver O +
, O +
and O +
kidney O +
. O +

In O +
contrast O +
, O +
it O +
was O +
downregulated O +
in O +
the O +
spleen O +
. O +

TLR4 B-Gene +
mRNA O +
was O +
decreased O +
in O +
the O +
brain O +
. O +

In O +
the O +
heart O +
and O +
lung O +
, O +
it O +
increased O +
, O +
and O +
it O +
was O +
not O +
affected O +
in O +
the O +
liver O +
, O +
kidney O +
, O +
and O +
spleen O +
. O +

TLR B-Gene +
mRNA O +
was O +
further O +
analyzed O +
in O +
the O +
liver O +
and O +
hepatocytes O +
. O +

Like O +
LPS O +
treatment O +
, O +
administration O +
of O +
IL-1 B-Gene +
, O +
IL-6 B-Gene +
, O +
or O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
( O +
TNF B-Gene +
) O +
upregulated O +
TLR2 B-Gene +
mRNA O +
. O +

However O +
, O +
none O +
of O +
them O +
affected O +
the O +
TLR4 B-Gene +
mRNA O +
level O +
. O +

In O +
primary O +
cultured O +
hepatocytes O +
, O +
TLR2 B-Gene +
mRNA O +
was O +
upregulated O +
by O +
LPS O +
, O +
IL-1 B-Gene +
, O +
or O +
TNF B-Gene +
but O +
not O +
by O +
IL-6 B-Gene +
or O +
dexamethasone O +
. O +

None O +
of O +
them O +
affected O +
TLR4 B-Gene +
mRNA O +
expression O +
. O +

Similar O +
responses O +
were O +
observed O +
in O +
the O +
murine O +
hepatoma O +
cell O +
line O +
Hepa O +
1 O +
- O +
6 O +
. O +

These O +
results O +
suggest O +
that O +
in O +
infection O +
with O +
gram O +
- O +
negative O +
bacteria O +
, O +
LPS O +
and O +
proinflammatory O +
cytokines B-Gene +
differentially O +
regulate O +
gene O +
expression O +
of O +
TLR2 B-Gene +
and O +
TLR4 B-Gene +
in O +
murine O +
hepatocytes O +
, O +
which O +
may O +
lead O +
to O +
pathologic O +
and O +
host O +
defense O +
reactions O +
in O +
the O +
liver O +
. O +

Molecular O +
cloning O +
and O +
characterization O +
of O +
a O +
cDNA O +
and O +
a O +
gene O +
for O +
subtilisin B-Gene +
- I-Gene +
like I-Gene +
serine I-Gene +
proteases I-Gene +
from O +
rice O +
( O +
Oryza O +
sativa O +
L. O +
) O +
and O +
Arabidopsis O +
thaliana O +
. O +

The O +
complete O +
nucleotide O +
sequences O +
of O +
a O +
cDNA O +
( O +
RSP1 B-Gene +
) O +
that O +
encodes O +
a O +
subtilisin B-Gene +
- I-Gene +
like I-Gene +
serine I-Gene +
protease I-Gene +
( O +
subtilase B-Gene +
) O +
of O +
rice O +
( O +
Oryza O +
sativa O +
L. O +
) O +
and O +
a O +
gene O +
( O +
ASP48 B-Gene +
) O +
for O +
Arabidopsis O +
subtilase B-Gene +
were O +
analyzed O +
. O +

The O +
RSPI B-Gene +
cDNA O +
and O +
ASP48 B-Gene +
DNA O +
encoded O +
736 O +
- O +
and O +
757 O +
- O +
residue O +
pre O +
- O +
pro O +
- O +
polypeptides O +
including O +
a O +
signal O +
peptide O +
with O +
molecular O +
masses O +
of O +
78,668 O +
Da O +
and O +
79 O +
, O +
414 O +
Da O +
, O +
respectively O +
. O +

RSP1 B-Gene +
is O +
the O +
first O +
known O +
serine B-Gene +
protease I-Gene +
in O +
rice O +
, O +
and O +
ASP48 B-Gene +
is O +
a O +
gene O +
for O +
ara12 B-Gene +
cDNA O +
. O +

Sequence O +
comparison O +
and O +
phylogenetic O +
analysis O +
showed O +
that O +
RSP1 B-Gene +
is O +
distantly O +
related O +
to O +
all O +
other O +
plant O +
subtilases B-Gene +
and O +
ASP48 B-Gene +
is O +
closely O +
related O +
to O +
a O +
tomato O +
subtilase B-Gene +
, O +
SBT1 B-Gene +
. O +

The O +
ASP48 B-Gene +
gene O +
was O +
found O +
to O +
lack O +
introns O +
. O +

The O +
Arabidopsis O +
subtilase B-Gene +
gene O +
appears O +
to O +
consist O +
of O +
a O +
small O +
gene O +
family O +
. O +

The O +
RSP1 B-Gene +
was O +
found O +
to O +
be O +
expressed O +
in O +
seed O +
and O +
shoots O +
of O +
seedlings O +
while O +
ASP48 B-Gene +
transcripts O +
was O +
found O +
to O +
be O +
accumulated O +
in O +
immature O +
silique O +
and O +
flowers O +
, O +
indicating O +
that O +
both O +
RSP1 B-Gene +
and O +
ASP48 B-Gene +
are O +
organ O +
- O +
specific O +
and O +
may O +
be O +
involved O +
in O +
the O +
specific O +
proteolytic O +
events O +
that O +
occur O +
during O +
organ O +
development O +
. O +

An O +
approach O +
to O +
the O +
removal O +
of O +
yeast O +
specific O +
O O +
- O +
linked O +
oligo O +
- O +
mannoses O +
from O +
human O +
midkine B-Gene +
expressed O +
in O +
Pichia O +
pastoris O +
using O +
site O +
- O +
specific O +
mutagenesis O +
. O +

Human O +
midkine B-Gene +
is O +
expressed O +
and O +
secreted O +
in O +
the O +
medium O +
under O +
the O +
control O +
of O +
an O +
AOX1 B-Gene +
gene O +
promoter O +
in O +
Pichia O +
pastoris O +
using O +
its O +
own O +
secretion O +
signal O +
. O +

The O +
midkine B-Gene +
precursor O +
is O +
properly O +
processed O +
to O +
yield O +
the O +
correct O +
amino O +
- O +
terminus O +
of O +
mature O +
midkine B-Gene +
. O +

However O +
, O +
more O +
than O +
half O +
of O +
the O +
product O +
receives O +
yeast O +
specific O +
mannosylations O +
. O +

The O +
sites O +
for O +
the O +
mannosylations O +
were O +
determined O +
to O +
be O +
the O +
three O +
threonine O +
residues O +
in O +
the O +
carboxy O +
- O +
terminal O +
region O +
of O +
human O +
midkine B-Gene +
. O +

In O +
order O +
to O +
obtain O +
non O +
- O +
mannosylated O +
midkine B-Gene +
, O +
alanine O +
residues O +
were O +
substituted O +
for O +
the O +
three O +
threonine O +
residues O +
by O +
site O +
specific O +
mutagenesis O +
. O +

HPLC O +
and O +
mass O +
spectrometry O +
confirmed O +
that O +
the O +
mutant O +
midkine B-Gene +
contained O +
almost O +
no O +
mannose O +
residues O +
. O +

Despite O +
the O +
amino O +
acid O +
substitutions O +
in O +
the O +
carboxy O +
- O +
terminal O +
region O +
, O +
mutant O +
human O +
midkine B-Gene +
, O +
promoted O +
CHO O +
cell O +
proliferation O +
as O +
well O +
as O +
normal O +
midkine B-Gene +
. O +

Interaction O +
of O +
CBF B-Gene +
alpha I-Gene +
/ O +
AML B-Gene +
/ O +
PEBP2 B-Gene +
alpha I-Gene +
transcription B-Gene +
factors I-Gene +
with O +
nucleosomes O +
containing O +
promoter O +
sequences O +
requires O +
flexibility O +
in O +
the O +
translational O +
positioning O +
of O +
the O +
histone B-Gene +
octamer O +
and O +
exposure O +
of O +
the O +
CBF B-Gene +
alpha I-Gene +
site O +
. O +

Chromatin O +
remodeling O +
at O +
eukaryotic O +
gene O +
promoter O +
sequences O +
accompanies O +
transcriptional O +
activation O +
. O +

Both O +
molecular O +
events O +
rely O +
on O +
specific O +
protein O +
- O +
DNA O +
interactions O +
that O +
occur O +
within O +
these O +
promoter O +
sequences O +
. O +

Binding O +
of O +
CBFalpha B-Gene +
/ O +
AML B-Gene +
/ O +
PEBP2alpha B-Gene +
( O +
core B-Gene +
binding I-Gene +
factor I-Gene +
alpha I-Gene +
/ O +
acute B-Gene +
myelogenous I-Gene +
leukemia I-Gene +
/ O +
polyoma B-Gene +
enhancer I-Gene +
binding I-Gene +
protein I-Gene +
2alpha I-Gene +
) O +
proteins O +
is O +
a O +
key O +
event O +
in O +
both O +
tissue O +
- O +
specific O +
and O +
developmentally O +
regulated O +
osteocalcin B-Gene +
( O +
OC B-Gene +
) O +
promoter O +
activity O +
. O +

To O +
address O +
linkage O +
between O +
chromatin O +
organization O +
and O +
transcription B-Gene +
factor I-Gene +
binding O +
, O +
we O +
reconstituted O +
segments O +
of O +
the O +
rat O +
OC B-Gene +
gene O +
proximal O +
promoter O +
into O +
mononucleosomes O +
and O +
studied O +
binding O +
of O +
CBFalpha B-Gene +
proteins O +
. O +

We O +
analyzed O +
binding O +
of O +
bacterially O +
produced O +
Cbfalpha2Alpha B-Gene +
and O +
Cbfalpha2B B-Gene +
, O +
two O +
splice O +
variants O +
of O +
the O +
human O +
CBFalpha2 B-Gene +
gene O +
, O +
and O +
determined O +
the O +
effect O +
of O +
heterodimerization O +
with O +
the O +
Cbfbeta B-Gene +
subunit O +
on O +
binding O +
activity O +
. O +

Our O +
results O +
indicate O +
that O +
binding O +
of O +
the O +
truncated O +
Cbfalpha2A B-Gene +
protein O +
to O +
naked O +
DNA O +
is O +
independent O +
of O +
Cbfbeta B-Gene +
whereas O +
Cbfalpha2A B-Gene +
binding O +
to O +
nucleosomal O +
DNA O +
was O +
enhanced O +
by O +
Cbfbeta B-Gene +
. O +

In O +
contrast O +
, O +
the O +
Cbfalpha2B B-Gene +
interaction O +
with O +
either O +
naked O +
or O +
nucleosomal O +
DNA O +
was O +
strongly O +
dependent O +
on O +
heterodimerization O +
with O +
the O +
Cbfbeta B-Gene +
subunit O +
. O +

Additionally O +
, O +
our O +
results O +
demonstrate O +
that O +
both O +
Cbfalpha2A B-Gene +
alone O +
and O +
Cbfalpha2B B-Gene +
complexed O +
with O +
Cbfbeta B-Gene +
can O +
interact O +
with O +
nucleosomal O +
DNA O +
only O +
if O +
there O +
is O +
a O +
degree O +
of O +
flexibility O +
in O +
the O +
positioning O +
of O +
the O +
histone B-Gene +
octamer O +
on O +
the O +
DNA O +
fragment O +
and O +
exposure O +
of O +
the O +
CBFalpha B-Gene +
site O +
. O +

This O +
situation O +
was O +
achieved O +
with O +
a O +
DNA O +
segment O +
of O +
182 O +
bp O +
from O +
the O +
rat O +
OC B-Gene +
promoter O +
that O +
preferentially O +
positions O +
mononucleosomes O +
upstream O +
of O +
the O +
CBFalpha B-Gene +
binding O +
site O +
and O +
leaves O +
this O +
element O +
partially O +
exposed O +
. O +

Taken O +
together O +
, O +
these O +
results O +
suggest O +
that O +
nucleosomal O +
translational O +
positioning O +
is O +
a O +
major O +
determinant O +
of O +
the O +
binding O +
of O +
CBFalpha B-Gene +
factors O +
to O +
nucleosomal O +
DNA O +
. O +

Multiple O +
histidine B-Gene +
kinases I-Gene +
regulate O +
entry O +
into O +
stationary O +
phase O +
and O +
sporulation O +
in O +
Bacillus O +
subtilis O +
. O +

Protein O +
homology O +
studies O +
identified O +
five O +
kinases B-Gene +
potentially O +
capable O +
of O +
phosphorylating O +
the O +
Spo0F B-Gene +
response O +
regulator O +
and O +
initiating O +
sporulation O +
in O +
Bacillus O +
subtilis O +
. O +

Two O +
of O +
these O +
kinases B-Gene +
, O +
KinA B-Gene +
and O +
KinB B-Gene +
, O +
were O +
known O +
from O +
previous O +
studies O +
to O +
be O +
responsible O +
for O +
sporulation O +
in O +
laboratory O +
media O +
. O +

In O +
vivo O +
studies O +
of O +
the O +
activity O +
of O +
four O +
of O +
the O +
kinases B-Gene +
, O +
KinA B-Gene +
, O +
KinC B-Gene +
, O +
KinD B-Gene +
( O +
ykvD B-Gene +
) O +
and O +
KinE B-Gene +
( O +
ykrQ B-Gene +
) O +
, O +
using O +
abrB B-Gene +
transcription O +
as O +
an O +
indicator O +
of O +
Spo0A B-Gene +
approximately O +
P O +
level O +
, O +
revealed O +
that O +
KinC B-Gene +
and O +
KinD B-Gene +
were O +
responsible O +
for O +
Spo0A B-Gene +
approximately O +
P O +
production O +
during O +
the O +
exponential O +
phase O +
of O +
growth O +
in O +
the O +
absence O +
of O +
KinA B-Gene +
and O +
KinB B-Gene +
. O +

In O +
vitro O +
, O +
all O +
four O +
kinases B-Gene +
dephosphorylated O +
Spo0F B-Gene +
approximately O +
P O +
with O +
the O +
production O +
of O +
ATP O +
at O +
approximately O +
the O +
same O +
rate O +
, O +
indicating O +
that O +
they O +
possess O +
approximately O +
equal O +
affinity O +
for O +
Spo0F B-Gene +
. O +

All O +
the O +
kinases B-Gene +
were O +
expressed O +
during O +
growth O +
and O +
early O +
stationary O +
phase O +
, O +
suggesting O +
that O +
the O +
differential O +
activity O +
observed O +
in O +
growth O +
and O +
sporulation O +
results O +
from O +
differential O +
activation O +
by O +
signal O +
ligands O +
unique O +
to O +
each O +
kinase B-Gene +
. O +

Novel O +
G B-Gene +
proteins I-Gene +
, O +
Rag B-Gene +
C I-Gene +
and O +
Rag B-Gene +
D I-Gene +
, O +
interact O +
with O +
GTP O +
- O +
binding O +
proteins O +
, O +
Rag B-Gene +
A I-Gene +
and O +
Rag B-Gene +
B I-Gene +
. O +

Rag B-Gene +
A I-Gene +
/ O +
Gtr1p B-Gene +
are O +
G B-Gene +
proteins I-Gene +
and O +
are O +
known O +
to O +
be O +
involved O +
in O +
the O +
RCC1 B-Gene +
- O +
Ran B-Gene +
pathway O +
. O +

We O +
employed O +
the O +
two O +
- O +
hybrid O +
method O +
using O +
Rag B-Gene +
A I-Gene +
as O +
the O +
bait O +
to O +
identify O +
proteins O +
binding O +
to O +
Rag B-Gene +
A I-Gene +
, O +
and O +
we O +
isolated O +
two O +
novel O +
human O +
G B-Gene +
proteins I-Gene +
, O +
Rag B-Gene +
C I-Gene +
and O +
Rag B-Gene +
D I-Gene +
. O +

Rag B-Gene +
C I-Gene +
demonstrates O +
homology O +
with O +
Rag B-Gene +
D I-Gene +
( O +
81.1 O +
% O +
identity O +
) O +
and O +
with O +
Gtr2p B-Gene +
of O +
Saccharomyces O +
cerevisiae O +
( O +
46.1 O +
% O +
identity O +
) O +
, O +
and O +
it O +
belongs O +
to O +
the O +
Rag B-Gene +
A I-Gene +
subfamily I-Gene +
of O +
the O +
Ras B-Gene +
family I-Gene +
. O +

Rag B-Gene +
C I-Gene +
and O +
Rag B-Gene +
D I-Gene +
contain O +
conserved O +
GTP O +
- O +
binding O +
motifs O +
( O +
PM-1 O +
, O +
- O +
2 O +
, O +
and O +
-3 O +
) O +
in O +
their O +
N O +
- O +
terminal O +
regions O +
. O +

Recombinant O +
glutathione B-Gene +
S I-Gene -
- I-Gene -
transferase I-Gene +
fusion O +
protein O +
of O +
Rag B-Gene +
C I-Gene +
efficiently O +
bound O +
to O +
both O +
[ O -
( O -
3 O -
) O -
H O -
] O -
GTP O +
and O +
[ O -
( O -
3 O -
) O -
H O -
] O -
GDP O +
. O +

Rag B-Gene +
A I-Gene +
was O +
associated O +
with O +
both O +
Rag B-Gene +
C I-Gene +
and O +
Rag B-Gene +
D I-Gene +
in O +
their O +
C O +
- O +
terminal O +
regions O +
where O +
a O +
potential O +
leucine O +
zipper O +
motif O +
and O +
a O +
coiled O +
- O +
coil O +
structure O +
were O +
found O +
. O +

Rag B-Gene +
C I-Gene +
and I-Gene +
D I-Gene +
were O +
associated O +
with O +
both O +
the O +
GDP O +
and O +
GTP O +
forms O +
of O +
Rag B-Gene +
A I-Gene +
. O +

Both O +
Rag B-Gene +
C I-Gene +
and O +
Rag B-Gene +
D I-Gene +
changed O +
their O +
subcellular O +
localization O +
, O +
depending O +
on O +
the O +
nucleotide O +
- O +
bound O +
state O +
of O +
Rag B-Gene +
A I-Gene +
. O +

In O +
a O +
similar O +
way O +
, O +
the O +
disruption O +
of O +
S. O +
cerevisiae O +
GTR1 B-Gene +
resulted O +
in O +
a O +
change O +
in O +
the O +
localization O +
of O +
Gtr2p B-Gene +
. O +

Mucin B-Gene +
gene O +
expression O +
in O +
Barrett O +
's O +
oesophagus O +
: O +
an O +
in O +
situ O +
hybridisation O +
and O +
immunohistochemical O +
study O +
. O +

BACKGROUND O +
AND O +
AIMS O +
: O +

Mucin B-Gene +
genes O +
are O +
expressed O +
in O +
a O +
site O +
specific O +
manner O +
throughout O +
the O +
gastrointestinal O +
tract O +
. O +

Little O +
is O +
known O +
about O +
the O +
expression O +
pattern O +
in O +
the O +
oesophagus O +
. O +

In O +
this O +
study O +
we O +
have O +
investigated O +
MUC B-Gene +
gene O +
expression O +
in O +
both O +
the O +
normal O +
oesophagus O +
and O +
specialised O +
intestinal O +
metaplasia O +
( O +
Barrett O +
's O +
oesophagus O +
) O +
. O +

PATIENTS O +
: O +

Archived O +
paraffin O +
embedded O +
material O +
from O +
eight O +
specimens O +
of O +
normal O +
oesophagus O +
, O +
18 O +
Barrett O +
' O +
s O +
oesophagus O +
, O +
eight O +
gastric O +
metaplasia O +
, O +
six O +
high O +
grade O +
dysplasia O +
, O +
and O +
six O +
cases O +
of O +
adenocarcinoma O +
were O +
examined O +
for O +
expression O +
of O +
the O +
mucin B-Gene +
genes O +
MUC1 B-Gene +
- I-Gene +
6 I-Gene +
. O +

METHODS O +
: O +

Mucin B-Gene +
mRNA O +
was O +
detected O +
by O +
in O +
situ O +
hybridisation O +
using O +
[ O -
( O -
35 O -
) O -
S O -
] O +
dATP O +
labelled O +
oligonucleotide O +
probes O +
. O +

Mucin B-Gene +
core O +
protein O +
was O +
detected O +
by O +
immunohistochemistry O +
. O +

RESULTS O +
: O +

Normal O +
oesophagus O +
expressed O +
MUC5B B-Gene +
in O +
the O +
submucosal O +
glands O +
and O +
MUC1 B-Gene +
and O +
MUC4 B-Gene +
in O +
the O +
stratified O +
squamous O +
epithelium O +
. O +

Barrett O +
's O +
oesophagus O +
strongly O +
expressed O +
MUC5AC B-Gene +
and O +
MUC3 B-Gene +
in O +
the O +
superficial O +
columnar O +
epithelium O +
, O +
MUC2 B-Gene +
in O +
the O +
goblet O +
cells O +
, O +
and O +
MUC6 B-Gene +
in O +
the O +
glands O +
. O +

In O +
high O +
grade O +
dysplasia O +
and O +
adenocarcinoma O +
there O +
was O +
downregulation O +
of O +
MUC2 B-Gene +
, O +
MUC3 B-Gene +
, O +
MUC5AC B-Gene +
, O +
and O +
MUC6 B-Gene +
, O +
but O +
upregulation O +
of O +
MUC1 B-Gene +
and O +
MUC4 B-Gene +
in O +
half O +
of O +
the O +
specimens O +
examined O +
. O +

CONCLUSIONS O +
: O +

Normal O +
oesophagus O +
and O +
Barrett O +
's O +
oesophagus O +
have O +
a O +
novel O +
pattern O +
of O +
mucin B-Gene +
gene O +
expression O +
. O +

Barrett O +
's O +
oesophagus O +
expressed O +
the O +
mucins B-Gene +
associated O +
with O +
normal O +
gastric O +
epithelium O +
and O +
normal O +
intestinal O +
epithelium O +
. O +

While O +
most O +
mucin B-Gene +
genes O +
were O +
downregulated O +
in O +
severely O +
dysplastic O +
and O +
neoplastic O +
tissues O +
, O +
there O +
was O +
upregulation O +
of O +
the O +
membrane O +
bound O +
mucins B-Gene +
MUC1 B-Gene +
and O +
MUC4 B-Gene +
. O +

This O +
may O +
prove O +
useful O +
in O +
detecting O +
early O +
signs O +
of O +
progression O +
to O +
adenocarcinoma O +
of O +
the O +
oesophagus O +
. O +

Crystal O +
structure O +
of O +
the O +
Escherichia O +
coli O +
peptide O +
methionine B-Gene +
sulphoxide I-Gene +
reductase I-Gene +
at O +
1.9 O +
A O +
resolution O +
. O +

BACKGROUND O +
: O +

Peptide O +
methionine B-Gene +
sulphoxide I-Gene +
reductases I-Gene +
catalyze O +
the O +
reduction O +
of O +
oxidized O +
methionine O +
residues O +
in O +
proteins O +
. O +

They O +
are O +
implicated O +
in O +
the O +
defense O +
of O +
organisms O +
against O +
oxidative O +
stress O +
and O +
in O +
the O +
regulation O +
of O +
processes O +
involving O +
peptide O +
methionine O +
oxidation O +
/ O +
reduction O +
. O +

These O +
enzymes O +
are O +
found O +
in O +
numerous O +
organisms O +
, O +
from O +
bacteria O +
to O +
mammals O +
and O +
plants O +
. O +

Their O +
primary O +
structure O +
shows O +
no O +
significant O +
similarity O +
to O +
any O +
other O +
known O +
protein O +
. O +

RESULTS O +
: O +

The O +
X O +
- O +
ray O +
structure O +
of O +
the O +
peptide O +
methionine B-Gene +
sulphoxide I-Gene +
reductase I-Gene +
from O +
Escherichia O +
coli O +
was O +
determined O +
at O +
3 O +
A O +
resolution O +
by O +
the O +
multiple O +
wavelength O +
anomalous O +
dispersion O +
method O +
for O +
the O +
selenomethionine O +
- O +
substituted O +
enzyme O +
, O +
and O +
it O +
was O +
refined O +
to O +
1.9 O +
A O +
resolution O +
for O +
the O +
native O +
enzyme O +
. O +

The O +
23 O +
kDa O +
protein O +
is O +
folded O +
into O +
an O +
alpha O +
/ O +
beta O +
roll O +
and O +
contains O +
a O +
large O +
proportion O +
of O +
coils O +
. O +

Among O +
the O +
three O +
cysteine O +
residues O +
involved O +
in O +
the O +
catalytic O +
mechanism O +
, O +
Cys-51 O +
is O +
positioned O +
at O +
the O +
N O +
terminus O +
of O +
an O +
alpha O +
helix O +
, O +
in O +
a O +
solvent O +
- O +
exposed O +
area O +
composed O +
of O +
highly O +
conserved O +
amino O +
acids O +
. O +

The O +
two O +
others O +
, O +
Cys-198 O +
and O +
Cys-206 O +
, O +
are O +
located O +
in O +
the O +
C O +
- O +
terminal O +
coil O +
. O +

CONCLUSIONS O +
: O +

Sequence O +
alignments O +
show O +
that O +
the O +
overall O +
fold O +
of O +
the O +
peptide O +
methionine B-Gene +
sulphoxide I-Gene +
reductase I-Gene +
from O +
E. O +
coli O +
is O +
likely O +
to O +
be O +
conserved O +
in O +
many O +
species O +
. O +

The O +
characteristics O +
observed O +
in O +
the O +
Cys-51 O +
environment O +
are O +
in O +
agreement O +
with O +
the O +
expected O +
accessibility O +
of O +
the O +
active O +
site O +
of O +
an O +
enzyme O +
that O +
reduces O +
methionine O +
sulphoxides O +
in O +
various O +
proteins O +
. O +

Cys-51 O +
could O +
be O +
activated O +
by O +
the O +
influence O +
of O +
an O +
alpha O +
helix O +
dipole O +
. O +

The O +
involvement O +
of O +
the O +
two O +
other O +
cysteine O +
residues O +
in O +
the O +
catalytic O +
mechanism O +
requires O +
a O +
movement O +
of O +
the O +
C O +
- O +
terminal O +
coil O +
. O +

Several O +
conserved O +
amino O +
acids O +
and O +
water O +
molecules O +
are O +
discussed O +
as O +
potential O +
participants O +
in O +
the O +
reaction O +
. O +

The O +
role O +
of O +
CD40 B-Gene +
ligand I-Gene +
and O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
alpha I-Gene +
signaling O +
in O +
the O +
transgenic O +
K O +
/ O +
BxN O +
mouse O +
model O +
of O +
rheumatoid O +
arthritis O +
. O +

OBJECTIVE O +
: O +

Spontaneous O +
arthritis O +
in O +
the O +
KRN O +
transgenic O +
mouse O +
( O +
K O -
/ O -
BxN O +
) O +
model O +
is O +
due O +
to O +
the O +
autoreactivity O +
of O +
the O +
transgenic O +
T B-Gene +
cell I-Gene +
receptor I-Gene +
and O +
subsequent O +
induction O +
of O +
autoantibodies O +
directed O +
against O +
glucose-6-phosphate B-Gene +
isomerase I-Gene +
( O +
G6PI B-Gene +
) O +
. O +

This O +
study O +
sought O +
to O +
analyze O +
the O +
potential O +
of O +
anti O +
- O +
CD40 B-Gene +
ligand I-Gene +
( O +
anti O +
- O +
CD40L B-Gene +
) O +
and O +
anti O +
- O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
alpha I-Gene +
( O +
anti O +
- O +
TNFalpha B-Gene +
) O +
antibodies O +
in O +
preventing O +
and O +
treating O +
arthritis O +
in O +
this O +
murine O +
model O +
. O +

METHODS O +
: O +

Groups O +
of O +
K O -
/ O -
BxN O +
mice O +
were O +
injected O +
with O +
anti O +
- O +
CD40L B-Gene +
and O +
anti O +
- O +
TNFalpha B-Gene +
antibodies O +
during O +
various O +
stages O +
of O +
arthritis O +
. O +

Disease O +
was O +
assessed O +
by O +
clinical O +
scoring O +
, O +
measurements O +
of O +
paw O +
swelling O +
, O +
and O +
histology O +
. O +

The O +
results O +
were O +
correlated O +
with O +
the O +
levels O +
of O +
autoantibodies O +
in O +
the O +
serum O +
, O +
as O +
assessed O +
by O +
enzyme O +
- O +
linked O +
immunosorbent O +
assay O +
. O +

RESULTS O +
: O +

Anti O +
- O +
CD40L B-Gene +
antibody O +
treatment O +
was O +
able O +
to O +
diminish O +
significantly O +
the O +
arthritis O +
development O +
in O +
K O -
/ O -
BxN O +
mice O +
when O +
given O +
a O +
week O +
before O +
the O +
onset O +
of O +
clinically O +
apparent O +
disease O +
. O +

However O +
, O +
no O +
effect O +
on O +
disease O +
was O +
seen O +
when O +
the O +
antibodies O +
were O +
administered O +
after O +
clinical O +
onset O +
. O +

Surprisingly O +
, O +
neutralizing O +
anti O +
- O +
TNFalpha B-Gene +
antibodies O +
were O +
unable O +
to O +
prevent O +
arthritis O +
in O +
K O -
/ O -
BxN O +
mice O +
. O +

The O +
success O +
of O +
antibody O +
treatment O +
in O +
preventing O +
disease O +
correlated O +
with O +
low O +
levels O +
of O +
anti O +
- O +
G6PI B-Gene +
antibodies O +
in O +
the O +
serum O +
. O +

CONCLUSION O +
: O +

These O +
results O +
suggest O +
that O +
anti O +
- O +
CD40L B-Gene +
treatment O +
can O +
prevent O +
arthritis O +
development O +
in O +
a O +
model O +
of O +
immunoglobulin B-Gene +
- O +
mediated O +
arthritis O +
, O +
but O +
anti O +
- O +
TNFalpha B-Gene +
treatment O +
can O -
not O +
. O +

The O +
unsuccessful O +
treatment O +
of O +
established O +
disease O +
was O +
possibly O +
due O +
to O +
the O +
continued O +
presence O +
of O +
autoreactive O +
antibodies O +
in O +
the O +
arthritic O +
mice O +
. O +

Functional O +
interaction O +
of O +
phytochrome B-Gene +
B I-Gene +
and O +
cryptochrome B-Gene +
2 I-Gene +
. O +

Light O +
is O +
a O +
crucial O +
environmental O +
signal O +
that O +
controls O +
many O +
photomorphogenic O +
and O +
circadian O +
responses O +
in O +
plants O +
. O +

Perception O +
and O +
transduction O +
of O +
light O +
is O +
achieved O +
by O +
at O +
least O +
two O +
principal O +
groups O +
of O +
photoreceptors B-Gene +
, O +
phytochromes B-Gene +
and O +
cryptochromes B-Gene +
. O +

Phytochromes B-Gene +
are O +
red O +
/ O +
far O +
- O +
red O +
light O +
- O +
absorbing O +
receptors O +
encoded O +
by O +
a O +
gene O +
family O +
of O +
five O +
members O +
( O +
phyA B-Gene +
to I-Gene +
phyE I-Gene +
) O +
in O +
Arabidopsis O +
. O +

Cryptochrome B-Gene +
1 I-Gene +
( O +
cry1 B-Gene +
) O +
, O +
cryptochrome B-Gene +
2 I-Gene +
( O +
cry2 B-Gene +
) O +
and O +
phototropin B-Gene +
are O +
the O +
blue B-Gene +
/ I-Gene +
ultraviolet I-Gene +
- I-Gene +
A I-Gene +
light I-Gene +
receptors I-Gene +
that O +
have O +
been O +
characterized O +
in O +
Arabidopsis O +
. O +

Previous O +
studies O +
showed O +
that O +
modulation O +
of O +
many O +
physiological O +
responses O +
in O +
plants O +
is O +
achieved O +
by O +
genetic O +
interactions O +
between O +
different O +
photoreceptors B-Gene +
; O +
however O +
, O +
little O +
is O +
known O +
about O +
the O +
nature O +
of O +
these O +
interactions O +
and O +
their O +
roles O +
in O +
the O +
signal O +
transduction O +
pathway O +
. O +

Here O +
we O +
show O +
the O +
genetic O +
interaction O +
that O +
occurs O +
between O +
the O +
Arabidopsis O +
photoreceptors B-Gene +
phyB B-Gene +
and O +
cry2 B-Gene +
in O +
the O +
control O +
of O +
flowering O +
time O +
, O +
hypocotyl O +
elongation O +
and O +
circadian O +
period O +
by O +
the O +
clock O +
. O +

PhyB B-Gene +
interacts O +
directly O +
with O +
cry2 B-Gene +
as O +
observed O +
in O +
co O +
- O +
immunoprecipitation O +
experiments O +
with O +
transgenic O +
Arabidopsis O +
plants O +
overexpressing O +
cry2 B-Gene +
. O +

Using O +
fluorescent O +
resonance O +
energy O +
transfer O +
microscopy O +
, O +
we O +
show O +
that O +
phyB B-Gene +
and O +
cry2 B-Gene +
interact O +
in O +
nuclear O +
speckles O +
that O +
are O +
formed O +
in O +
a O +
light O +
- O +
dependent O +
fashion O +
. O +

Development O +
of O +
a O +
PCR O +
- O +
SSOP O +
approach O +
capable O +
of O +
defining O +
the O +
natural O +
killer O +
cell O +
inhibitory O +
receptor O +
( O +
KIR B-Gene +
) O +
gene O +
sequence O +
repertoires O +
. O +

A O +
molecular O +
typing O +
method O +
based O +
on O +
polymerase O +
chain O +
reaction O +
( O +
PCR O +
) O +
amplification O +
of O +
three O +
different O +
target O +
domains O +
( O +
immunoglobulin B-Gene +
domains O +
1 O +
and O +
3 O +
, O +
and O +
the O +
transmembrane O +
- O +
cytoplasmic O +
domain O +
) O +
, O +
followed O +
by O +
hybridisation O +
with O +
26 O +
digoxigenin O +
- O +
labelled O +
sequence O +
- O +
specific O +
oligonucleotide O +
probes O +
( O +
SSOP O +
) O +
has O +
been O +
established O +
for O +
the O +
polymorphic O +
killer O +
inhibitory O +
receptor O +
( O +
KIR B-Gene +
) O +
genes O +
. O +

In O +
addition O +
to O +
identifying O +
the O +
12 O +
KIR B-Gene +
subfamilies I-Gene +
, O +
our O +
PCR O +
- O +
SSOP O +
typing O +
approach O +
could O +
also O +
distinguish O +
the O +
putative O +
alleles O +
, O +
NKB1 B-Gene +
and O +
NKAT3 B-Gene +
, O +
that O +
comprise O +
the O +
KIR3DL1 B-Gene +
subfamily I-Gene +
. O +

Ninety O +
unrelated O +
blood O +
donors O +
and O +
13 O +
families O +
( O +
52 O +
individuals O +
) O +
, O +
including O +
both O +
parents O +
, O +
were O +
subjected O +
to O +
our O +
KIR B-Gene +
PCR O +
- O +
SSOP O +
typing O +
approach O +
. O +

All O +
12 O +
KIR B-Gene +
subfamilies I-Gene +
, O +
including O +
a O +
2DS5 B-Gene +
variant O +
sequence O +
, O +
were O +
present O +
in O +
the O +
90 O +
individuals O +
and O +
displayed O +
varied O +
phenotype O +
frequencies O +
: O +
2DL1 B-Gene +
( O +
0.96 O +
) O +
, O +
2DL2 B-Gene +
( O +
0.31 O +
) O +
, O +
2DL3 B-Gene +
( O +
0.95 O +
) O +
, O +
2DS1 B-Gene +
( O +
0.56 O +
) O +
2DS2 B-Gene +
( O +
0.51 O +
) O +
, O +
2DS3 B-Gene +
( O +
0.27 O +
) O +
, O +
2DS4 B-Gene +
( O +
0.96 O +
) O +
, O +
2DS5v B-Gene +
( O +
0.35 O +
) O +
, O +
3DS1 B-Gene +
( O +
0.47 O +
) O +
, O +
3DL1 B-Gene +
( O +
0.96 O +
) O +
, O +
3DL2 B-Gene +
( O +
1.0 O +
) O +
and O +
2DL4 B-Gene +
( O +
1.0 O +
) O +
. O +

A O +
total O +
of O +
23 O +
different O +
KIR B-Gene +
phenotypes O +
were O +
defined O +
in O +
this O +
study O +
, O +
and O +
10 O +
of O +
these O +
were O +
only O +
found O +
on O +
one O +
occasion O +
in O +
one O +
individual O +
, O +
indicating O +
considerable O +
diversity O +
in O +
the O +
KIR B-Gene +
phenotype O +
profiles O +
within O +
the O +
Irish O +
population O +
. O +

Most O +
individuals O +
( O +
93 O +
% O +
) O +
possessed O +
the O +
complement O +
of O +
inhibitory O +
KIR B-Gene +
specificities O +
for O +
the O +
three O +
well O +
- O +
defined O +
HLA B-Gene -
- I-Gene -
B I-Gene +
and I-Gene +
- I-Gene +
C I-Gene +
ligands O +
. O +

An O +
unusual O +
probe O +
pattern O +
for O +
3DS1 B-Gene +
was O +
observed O +
in O +
3 O +
individuals O +
indicating O +
a O +
variant O +
3DS1 B-Gene +
gene O +
sequence O +
with O +
changes O +
at O +
nucleotide O +
positions O +
1185 O +
- O +
1186 O +
, O +
within O +
the O +
cytoplasmic O +
domain O +
. O +

Sequencing O +
analysis O +
revealed O +
a O +
new O +
single O +
nucleotide O +
polymorphism O +
in O +
exon O +
3 O +
of O +
3DL1 B-Gene +
NKB1 B-Gene +
( O +
195 O +
, O +
G O -
- O -
A O +
) O +
and O +
a O +
22 O +
- O +
bp O +
deletion O +
polymorphism O +
in O +
exon O +
5 O +
of O +
2DS4 B-Gene +
( O +
nucleotides O +
777 O +
- O +
798 O +
deleted O +
) O +
. O +

A O +
number O +
of O +
strong O +
KIR B-Gene +
associations O +
were O +
observed O +
, O +
namely O +
2DL1 B-Gene +
with O +
2DL3 B-Gene +
, O +
2DS4 B-Gene +
with O +
3DL1 B-Gene +
, O +
2DL2 B-Gene +
with O +
2DS1 B-Gene +
/ O +
2DS2 B-Gene +
/ O +
2DS3 B-Gene +
, O +
2DS1 B-Gene +
with O +
2DS3 B-Gene +
/ O +
2DS5v B-Gene +
/ O +
3DS1 B-Gene +
, O +
2DS2 B-Gene +
with O +
2DS3 B-Gene +
and O +
2DS5v B-Gene +
with O +
3DS1 B-Gene +
. O +

Analysis O +
of O +
the O +
KIR B-Gene +
segregation O +
observed O +
in O +
the O +
13 O +
families O +
confirmed O +
these O +
strong O +
associations O +
and O +
permitted O +
the O +
definition O +
of O +
a O +
number O +
of O +
partial O +
KIR B-Gene +
haplotypes O +
, O +
e.g. O +
2DL2 B-Gene +
- O +
2DS1 B-Gene +
- O +
2DS2 B-Gene +
- O +
2DS3 B-Gene +
- O +
3DL1 B-Gene +
. O +

The O +
segregation O +
analysis O +
concluded O +
that O +
at O +
least O +
3 O +
distinct O +
gene O +
loci O +
encode O +
2DL1 B-Gene +
- I-Gene +
4 I-Gene +
and O +
at O +
least O +
4 O +
gene O +
loci O +
encode O +
the O +
non O +
- O +
inhibitory O +
KIR2DS1 B-Gene +
- I-Gene +
2DS5 I-Gene +
. O +

In O +
the O +
case O +
of O +
3DL1 B-Gene +
- I-Gene +
2 I-Gene +
and O +
3DS1 B-Gene +
, O +
our O +
data O +
suggests O +
3 O +
gene O +
loci O +
, O +
one O +
for O +
each O +
subfamily O +
. O +

YeiL B-Gene +
, O +
the O +
third O +
member O +
of O +
the O +
CRP B-Gene -
- I-Gene -
FNR I-Gene +
family I-Gene +
in O +
Escherichia O +
coli O +
. O +

The O +
yeiL B-Gene +
open O +
reading O +
frame O +
located O +
at O +
48.5 O +
min O +
( O +
2254 O +
kb O +
) O +
in O +
the O +
nfo B-Gene +
- O +
fruA B-Gene +
region O +
of O +
the O +
Escherichia O +
coli O +
chromosome O +
was O +
predicted O +
to O +
encode O +
a O +
CRP B-Gene +
and O +
FNR B-Gene +
paralogue O +
capable O +
of O +
forming O +
inter O +
- O +
or O +
intra O +
- O +
molecular O +
disulphide O +
bonds O +
and O +
incorporating O +
one O +
iron O +
- O +
sulphur O +
centre O +
per O +
25 O +
kDa O +
subunit O +
. O +

Purified O +
MBP B-Gene +
- O +
YeiL B-Gene +
( O +
a O +
maltose B-Gene +
- I-Gene +
binding I-Gene +
- I-Gene +
protein I-Gene +
- O +
YeiL B-Gene +
fusion O +
protein O +
) O +
was O +
a O +
high O +
- O +
molecular O +
- O +
mass O +
oligomer O +
or O +
aggregate O +
which O +
released O +
unstable O +
monomers O +
( O +
68 O +
kDa O +
) O +
under O +
reducing O +
conditions O +
. O +

The O +
MBP B-Gene +
- O +
YeiL B-Gene +
protein O +
contained O +
substoichiometric O +
amounts O +
of O +
iron O +
and O +
acid O +
- O +
labile O +
sulphide O +
, O +
and O +
an O +
average O +
of O +
one O +
disulphide O +
bond O +
per O +
monomer O +
. O +

The O +
iron O +
and O +
sulphide O +
contents O +
increased O +
consistent O +
with O +
the O +
acquisition O +
of O +
one O +
[ O +
4Fe-4S O +
] O +
cluster O +
per O +
monomer O +
after O +
anaerobic O +
NifS B-Gene +
- O +
catalysed O +
reconstitution O +
. O +

By O +
analogy O +
with O +
FNR B-Gene +
and O +
FLP B-Gene +
( O +
the O +
FNR B-Gene +
- O +
like O +
protein O +
of O +
Lactobacillus O +
casei O +
) O +
it O +
was O +
suggested O +
that O +
the O +
transcription O +
- O +
regulatory O +
activity O +
of O +
YeiL B-Gene +
might O +
be O +
modulated O +
by O +
a O +
sensory O +
iron O +
- O +
sulphur O +
cluster O +
and/or O +
by O +
reversible O +
disulphide O +
bond O +
formation O +
. O +

A O +
yeiL B-Gene +
- O +
lacZ B-Gene +
transcriptional O +
fusion O +
showed O +
that O +
aerobic O +
yeiL B-Gene +
expression O +
increases O +
at O +
least O +
sixfold O +
during O +
stationary O +
phase O +
, O +
requires O +
RpoS B-Gene +
, O +
and O +
is O +
positively O +
autoregulated O +
by O +
YeiL B-Gene +
, O +
positively O +
activated O +
by O +
Lrp B-Gene +
( O +
and O +
IHF B-Gene +
in O +
the O +
absence O +
of O +
FNR B-Gene +
) O +
and O +
negatively O +
regulated O +
by O +
FNR B-Gene +
. O +

A O +
regulatory O +
link O +
between O +
the O +
synthesis O +
of O +
YeiK B-Gene +
( O +
a O +
potential O +
nucleoside B-Gene +
hydrolase I-Gene +
) O +
and O +
YeiL B-Gene +
was O +
inferred O +
by O +
showing O +
that O +
the O +
yeiK B-Gene +
and O +
yeiL B-Gene +
genes O +
are O +
divergently O +
transcribed O +
from O +
overlapping O +
promoters O +
. O +

A O +
10 O +
- O +
15 O +
% O +
deficiency O +
in O +
aerobic O +
growth O +
yield O +
and O +
an O +
enhanced O +
loss O +
of O +
viability O +
under O +
nitrogen O +
starvation O +
conditions O +
were O +
detected O +
with O +
a O +
yeiL B-Gene +
: O +
: O +
kan O -
( O -
R O -
) O +
mutant O +
, O +
suggesting O +
that O +
YeiL B-Gene +
might O +
function O +
as O +
a O +
post O +
- O +
exponential O +
- O +
phase O +
nitrogen O +
- O +
starvation O +
regulator O +
. O +

Identification O +
of O +
two O +
putative O +
novel O +
folate B-Gene +
receptor I-Gene +
genes O +
in O +
humans O +
and O +
mouse O +
. O +

Utilizing O +
a O +
' O +
database O +
mining O +
' O +
strategy O +
to O +
detect O +
novel O +
folate B-Gene +
receptors I-Gene +
( O +
FR B-Gene +
) O +
, O +
we O +
identified O +
two O +
potential O +
novel O +
members O +
in O +
the O +
mouse O +
and O +
human O +
. O +

The O +
mouse O +
gene O +
( O +
Folbp3 B-Gene +
) O +
was O +
sequenced O +
and O +
found O +
to O +
predict O +
a O +
28.2 O +
kDa O +
protein O +
that O +
consists O +
of O +
244 O +
amino O +
acids O +
that O +
is O +
highly O +
expressed O +
in O +
both O +
the O +
thymus O +
and O +
spleen O +
, O +
suggesting O +
a O +
potential O +
role O +
in O +
the O +
immune O +
system O +
. O +

The O +
human O +
gene O +
( O +
FR B-Gene +
- I-Gene +
delta I-Gene +
) O +
is O +
mapped O +
to O +
chromosome O +
11q14 O +
, O +
and O +
predicts O +
a O +
27.7 O +
kDa O +
protein O +
that O +
is O +
comprised O +
of O +
241 O +
amino O +
acids O +
. O +

However O +
, O +
expression O +
of O +
the O +
human O +
gene O +
was O +
not O +
detected O +
in O +
59 O +
samples O +
from O +
both O +
adult O +
and O +
embryonic O +
tissue O +
sources O +
, O +
suggesting O +
a O +
highly O +
restricted O +
spatial O +
/ O +
temporal O +
expression O +
pattern O +
, O +
an O +
alternatively O +
spliced O +
variant O +
or O +
an O +
additional O +
FR B-Gene +
pseudogene I-Gene +
. O +

Using O +
T31 O +
mouse O +
radiation O +
hybrid O +
mapping O +
, O +
Folbp3 B-Gene +
was O +
mapped O +
to O +
a O +
region O +
on O +
mouse O +
chromosome O +
9 O +
that O +
is O +
syntenic O +
to O +
human O +
chromosome O +
19p13 O +
. O +

As O +
the O +
chromosomal O +
locations O +
of O +
Folbp1 B-Gene +
murine O +
and O +
Folbp2 B-Gene +
genes O +
were O +
previously O +
unknown O +
, O +
we O +
utilized O +
the O +
same O +
approach O +
and O +
mapped O +
both O +
genes O +
to O +
a O +
region O +
of O +
mouse O +
chromosome O +
7 O +
that O +
is O +
syntenic O +
to O +
the O +
human O +
FR B-Gene +
loci O +
on O +
chromosome O +
11q13 O +
. O +

Transcriptional O +
regulation O +
of O +
transport O +
and O +
utilization O +
systems O +
for O +
hexuronides O +
, O +
hexuronates O +
and O +
hexonates O +
in O +
gamma O +
purple O +
bacteria O +
. O +

The O +
comparative O +
approach O +
is O +
a O +
powerful O +
tool O +
for O +
the O +
analysis O +
of O +
gene O +
regulation O +
in O +
bacterial O +
genomes O +
. O +

It O +
can O +
be O +
applied O +
to O +
the O +
analysis O +
of O +
regulons O +
that O +
have O +
been O +
studied O +
experimentally O +
as O +
well O +
as O +
that O +
of O +
regulons O +
for O +
which O +
no O +
known O +
regulatory O +
sites O +
are O +
available O +
. O +

It O +
is O +
assumed O +
that O +
the O +
set O +
of O +
co O +
- O +
regulated O +
genes O +
and O +
the O +
regulatory O +
signal O +
itself O +
are O +
conserved O +
in O +
related O +
genomes O +
. O +

Here O +
, O +
we O +
use O +
genomic O +
comparisons O +
to O +
study O +
the O +
regulation O +
of O +
transport O +
and O +
utilization O +
systems O +
for O +
sugar O +
acids O +
in O +
gamma O +
purple O +
bacteria O +
Escherichia O +
coli O +
, O +
Salmonella O +
typhi O +
, O +
Klebsiella O +
pneumoniae O +
, O +
Yersinia O +
pestis O +
, O +
Erwinia O +
chrysanthemi O +
, O +
Haemophilus O +
influenzae O +
and O +
Vibrio O +
cholerae O +
. O +

The O +
variability O +
of O +
the O +
operon O +
structure O +
and O +
the O +
location O +
of O +
the O +
operator O +
sites O +
for O +
the O +
main O +
transcription B-Gene +
factors I-Gene +
are O +
demonstrated O +
. O +

The O +
common O +
metabolic O +
map O +
is O +
combined O +
with O +
known O +
and O +
predicted O +
regulatory O +
interactions O +
. O +

It O +
includes O +
all O +
known O +
and O +
predicted O +
members O +
of O +
the O +
GntR B-Gene +
, O +
UxuR B-Gene +
/ O +
ExuR B-Gene +
, O +
KdgR B-Gene +
, O +
UidR B-Gene +
and O +
IdnR B-Gene +
regulons O +
. O +

Moreover O +
, O +
most O +
members O +
of O +
these O +
regulons O +
seem O +
to O +
be O +
under O +
catabolite O +
repression O +
mediated O +
by O +
CRP B-Gene +
. O +

The O +
candidate O +
UxuR B-Gene +
/ O +
ExuR B-Gene +
signal O +
is O +
proposed O +
, O +
the O +
KdgR B-Gene +
consensus O +
is O +
extended O +
, O +
and O +
new O +
operators O +
for O +
all O +
transcription B-Gene +
factors I-Gene +
are O +
identified O +
in O +
all O +
studied O +
genomes O +
. O +

Two O +
new O +
members O +
of O +
the O +
KdgR B-Gene +
regulon O +
, O +
a O +
hypothetical O +
ATP O +
- O +
dependent O +
transport O +
system O +
OgtABCD B-Gene +
and O +
YjgK B-Gene +
protein O +
with O +
unknown O +
function O +
, O +
are O +
detected O +
. O +

The O +
former O +
is O +
likely O +
to O +
be O +
the O +
transport O +
system O +
for O +
the O +
products O +
of O +
pectin O +
degradation O +
, O +
oligogalacturonides O +
. O +

Effects O +
of O +
a O +
thyromimetic O +
on O +
apolipoprotein B-Gene +
B-100 I-Gene +
in O +
rats O +
. O +

We O +
have O +
studied O +
the O +
effects O +
of O +
a O +
cardiac O +
sparing O +
thyromimetic O +
, O +
CGS O +
23425 O +
, O +
on O +
postprandial O +
levels O +
of O +
triglycerides O +
, O +
abundance O +
of O +
apolipoprotein B-Gene +
B I-Gene +
( O +
apo B-Gene +
B I-Gene +
) O +
protein O +
and O +
hepatic O +
apo B-Gene +
B I-Gene +
mRNA O +
expression O +
in O +
rats O +
. O +

When O +
compared O +
with O +
control O +
rats O +
, O +
triglyceride O +
clearance O +
was O +
significantly O +
accelerated O +
by O +
treatment O +
with O +
CGS O +
23425 O +
. O +

A O +
full O +
return O +
to O +
baseline O +
values O +
was O +
achieved O +
within O +
8 O +
h O +
after O +
ingesting O +
a O +
large O +
quantity O +
of O +
fat O +
, O +
as O +
compared O +
to O +
> O +
24 O +
h O +
in O +
control O +
animals O +
. O +

The O +
abundance O +
of O +
apo B-Gene +
B-100 I-Gene +
protein O +
in O +
CGS O +
23425 O +
- O +
treated O +
hyperlipidemic O +
rats O +
decreased O +
in O +
a O +
dose O +
- O +
dependent O +
manner O +
, O +
but O +
levels O +
of O +
apo B-Gene +
B-48 I-Gene +
were O +
not O +
significantly O +
affected O +
. O +

Like O +
L O -
- O -
tri O -
- O -
iodothyronine O +
( O +
L O -
- O -
T O -
( O -
3 O -
) O +
) O +
, O +
treatment O +
with O +
30 O +
microg O +
/ O +
kg O +
CGS O +
23425 O +
for O +
6 O +
or O +
9 O +
days O +
decreased O +
the O +
levels O +
of O +
apo B-Gene +
B-100 I-Gene +
protein O +
by O +
80 O +
% O +
and O +
40 O +
% O +
respectively O +
. O +

This O +
change O +
was O +
paralleled O +
by O +
a O +
27 O +
% O +
reduction O +
in O +
hepatic O +
apo B-Gene +
B-100 I-Gene +
mRNA O +
. O +

To O +
investigate O +
a O +
potential O +
mechanism O +
of O +
CGS O +
23425 O +
action O +
, O +
we O +
measured O +
in O +
vitro O +
apo B-Gene +
B I-Gene +
mRNA O +
editing O +
activity O +
in O +
hepatocellular O +
extract O +
from O +
control O +
or O +
CGS O +
23425 O +
- O +
treated O +
rats O +
. O +

Treatment O +
with O +
CGS O +
23425 O +
increased O +
activity O +
of O +
the O +
hepatic O +
apo B-Gene +
B-100 I-Gene +
editosome O +
, O +
apobec-1 B-Gene +
. O +

In O +
human O +
hepatoma O +
cells O +
which O +
lack O +
apobec-1 B-Gene +
activity O +
, O +
apo B-Gene +
B-100 I-Gene +
mRNA O +
levels O +
remained O +
the O +
same O +
in O +
cells O +
treated O +
with O +
or O +
without O +
the O +
agent O +
. O +

In O +
summary O +
, O +
these O +
observations O +
show O +
that O +
CGS O +
23425 O +
decreases O +
the O +
levels O +
of O +
apo B-Gene +
B-100 I-Gene +
in O +
rats O +
. O +

This O +
action O +
of O +
CGS O +
23425 O +
involves O +
apo B-Gene +
B-100 I-Gene +
mRNA O +
editing O +
activity O +
. O +

Antibodies O +
against O +
keratinocyte O +
antigens O +
other O +
than O +
desmogleins B-Gene +
1 I-Gene +
and I-Gene +
3 I-Gene +
can O +
induce O +
pemphigus O +
vulgaris O +
- O +
like O +
lesions O +
. O +

Pemphigus O +
is O +
an O +
autoimmune O +
disease O +
of O +
skin O +
adhesion O +
associated O +
with O +
autoantibodies O +
against O +
a O +
number O +
of O +
keratinocyte O +
antigens O +
, O +
such O +
as O +
the O +
adhesion B-Gene +
molecules I-Gene +
desmoglein I-Gene +
( I-Gene +
Dsg I-Gene +
) I-Gene +
1 I-Gene +
and I-Gene +
3 I-Gene +
and O +
acetylcholine B-Gene +
receptors I-Gene +
. O +

The O +
notion O +
that O +
anti O +
- O +
Dsg B-Gene +
antibodies O +
alone O +
are O +
responsible O +
for O +
blisters O +
in O +
patients O +
with O +
pemphigus O +
vulgaris O +
( O +
PV O +
) O +
stems O +
from O +
the O +
ability O +
of O +
rDsg1 B-Gene +
and O +
rDsg3 B-Gene +
to O +
absorb O +
antibodies O +
that O +
cause O +
PV O +
- O +
like O +
skin O +
blisters O +
in O +
neonatal O +
mice O +
. O +

Here O +
, O +
we O +
demonstrate O +
that O +
PV O +
IgGs B-Gene +
eluted O +
from O +
rDsg1 B-Gene +
- O +
Ig B-Gene +
- O +
His O +
and O +
rDsg3 B-Gene +
- O +
Ig B-Gene +
- O +
His O +
show O +
similar O +
antigenic O +
profiles O +
, O +
including O +
the O +
38 O +
- O +
, O +
43 O +
- O +
, O +
115 O +
- O +
, O +
and O +
190 O +
- O +
kDa O +
keratinocyte O +
proteins O +
and O +
a O +
non O +
- O +
Dsg B-Gene +
3 I-Gene +
130 O +
- O +
kDa O +
polypeptide O +
present O +
in O +
keratinocytes O +
from O +
Dsg B-Gene +
3 I-Gene +
knockout O +
mouse O +
. O +

We O +
injected O +
into O +
Dsg B-Gene +
3 I-Gene +
- O +
lacking O +
mice O +
the O +
PV O +
IgGs B-Gene +
that O +
did O +
not O +
cross O +
- O +
react O +
with O +
the O +
160 O +
- O +
kDa O +
Dsg B-Gene +
1 I-Gene +
or O +
its O +
45 O +
- O +
kDa O +
immunoreactive O +
fragment O +
and O +
that O +
showed O +
no O +
reactivity O +
with O +
recombinant O +
Dsg B-Gene +
1 I-Gene +
. O +

We O +
used O +
both O +
the O +
Dsg3 B-Gene +
( O +
null O +
) O +
mice O +
with O +
a O +
targeted O +
mutation O +
of O +
the O +
Dsg3 B-Gene +
gene O +
and O +
the O +
" O +
balding O +
" O +
Dsg3 B-Gene +
( O +
bal O +
) O +
/ O +
Dsg3 B-Gene +
( O +
bal O +
) O +
mice O +
that O +
carry O +
a O +
spontaneous O +
null O +
mutation O +
in O +
Dsg3 B-Gene +
. O +

These O +
PV O +
IgGs B-Gene +
caused O +
gross O +
skin O +
blisters O +
with O +
PV O +
- O +
like O +
suprabasal O +
acantholysis O +
and O +
stained O +
perilesional O +
epidermis O +
in O +
a O +
fishnet O +
- O +
like O +
pattern O +
, O +
indicating O +
that O +
the O +
PV O +
phenotype O +
can O +
be O +
induced O +
without O +
anti O +
- O +
Dsg B-Gene +
3 I-Gene +
antibody O +
. O +

The O +
anti O +
- O +
Dsg B-Gene +
1 I-Gene +
antibody O +
also O +
was O +
not O +
required O +
, O +
as O +
its O +
presence O +
in O +
PV O +
IgG B-Gene +
does O +
not O +
alter O +
the O +
PV O +
- O +
like O +
phenotype O +
in O +
skin O +
organ O +
cultures O +
and O +
because O +
pemphigus O +
foliaceus O +
IgGs B-Gene +
produce O +
a O +
distinct O +
phenotype O +
in O +
Dsg3 B-Gene +
( O +
null O +
) O +
mice O +
. O +

Therefore O +
, O +
mucocutaneous O +
lesions O +
in O +
PV O +
patients O +
could O +
be O +
caused O +
by O +
non O +
- O +
Dsg B-Gene +
antibodies O +
. O +

Loss O +
of O +
fibroblast B-Gene +
growth I-Gene +
factor I-Gene +
receptor I-Gene +
2 I-Gene +
ligand O +
- O +
binding O +
specificity O +
in O +
Apert O +
syndrome O +
. O +

Craniosynostosis O +
syndromes O +
are O +
autosomal O +
dominant O +
human O +
skeletal O +
diseases O +
that O +
result O +
from O +
various O +
mutations O +
in O +
fibroblast B-Gene +
growth I-Gene +
factor I-Gene +
receptor I-Gene +
genes O +
( O +
Fgfrs B-Gene +
) O +
. O +

Apert O +
syndrome O +
( O +
AS O +
) O +
is O +
one O +
of O +
the O +
most O +
severe O +
craniosynostosis O +
syndromes O +
and O +
is O +
associated O +
with O +
severe O +
syndactyly O +
of O +
the O +
hands O +
and O +
feet O +
and O +
with O +
central O +
nervous O +
system O +
malformations O +
. O +

AS O +
is O +
caused O +
by O +
specific O +
missense O +
mutations O +
in O +
one O +
of O +
two O +
adjacent O +
amino O +
acid O +
residues O +
( O +
S252W O +
or O +
P253R O +
) O +
in O +
the O +
highly O +
conserved O +
region O +
linking O +
Ig B-Gene +
- O +
like O +
domains O +
II O +
and O +
III O +
of O +
FGFR2 B-Gene +
. O +

Here O +
we O +
demonstrate O +
that O +
these O +
mutations O +
break O +
one O +
of O +
the O +
cardinal O +
rules O +
governing O +
ligand O +
specificity O +
of O +
FGFR2 B-Gene +
. O +

We O +
show O +
that O +
the O +
S252W O +
mutation O +
allows O +
the O +
mesenchymal O +
splice O +
form O +
of O +
FGFR2 B-Gene +
( O +
FGFR2c B-Gene +
) O +
to O +
bind O +
and O +
to O +
be O +
activated O +
by O +
the O +
mesenchymally O +
expressed O +
ligands O +
FGF7 B-Gene +
or O +
FGF10 B-Gene +
and O +
the O +
epithelial O +
splice O +
form O +
of O +
FGFR2 B-Gene +
( O +
FGFR2b B-Gene +
) O +
to O +
be O +
activated O +
by O +
FGF2 B-Gene +
, O +
FGF6 B-Gene +
, O +
and O +
FGF9 B-Gene +
. O +

These O +
data O +
demonstrate O +
loss O +
of O +
ligand O +
specificity O +
of O +
FGFR2 B-Gene +
with O +
retained O +
ligand O +
dependence O +
for O +
receptor O +
activation O +
. O +

These O +
data O +
suggest O +
that O +
the O +
severe O +
phenotypes O +
of O +
AS O +
likely O +
result O +
from O +
ectopic O +
ligand O +
- O +
dependent O +
activation O +
of O +
FGFR2 B-Gene +
. O +

Development O +
- O +
related O +
increase O +
in O +
cortisol O +
biosynthesis O +
by O +
human O +
granulosa O +
cells O +
. O +

Antiinflammatory O +
mechanisms O +
are O +
important O +
in O +
ovulation O +
and O +
may O +
be O +
regulated O +
by O +
cortisol O +
( O +
F O +
) O +
. O +

We O +
previously O +
showed O +
that O +
after O +
administration O +
of O +
human O +
( O +
h O +
) O +
CG B-Gene +
for O +
ovulation O +
induction O +
, O +
luteinized O +
granulosa O +
cells O +
( O +
LGC O +
) O +
abundantly O +
express O +
11beta B-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
type I-Gene +
1 I-Gene +
( O +
11betaHSD1 B-Gene +
) O +
messenger O +
RNA O +
but O +
not O +
11betaHSD B-Gene +
type I-Gene +
2 I-Gene +
( O +
11betaHSD2 B-Gene +
) O +
messenger O +
RNA O +
. O +

11ssHSD1 B-Gene +
is O +
responsible O +
for O +
the O +
reversible O +
formation O +
of O +
antiinflammatory O +
F O +
from O +
its O +
inactive O +
precursor O +
cortisone O +
( O +
E O +
) O +
, O +
whereas O +
11betaHSD2 B-Gene +
unidirectionally O +
converts O +
F O +
to O +
E O +
through O +
11-oxidation O +
. O +

This O +
pattern O +
of O +
gene O +
expression O +
predicts O +
that O +
LGC O +
from O +
periovulatory O +
follicles O +
would O +
show O +
increased O +
activation O +
of O +
E O +
to O +
F O +
, O +
compared O +
with O +
granulosa O +
cells O +
from O +
immature O +
follicles O +
( O +
IGC O +
) O +
, O +
and O +
that O +
follicular O +
fluid O +
concentrations O +
of O +
E O +
and O +
F O +
would O +
alter O +
accordingly O +
. O +

To O +
test O +
this O +
hypothesis O +
, O +
we O +
isolated O +
IGC O +
, O +
thecal O +
cells O +
( O +
TC O +
) O +
, O +
and O +
follicular O +
fluid O +
, O +
from O +
ovaries O +
of O +
cyclic O +
women O +
, O +
removed O +
during O +
surgery O +
for O +
benign O +
gynecological O +
disease O +
. O +

LGC O +
and O +
follicular O +
fluid O +
were O +
aspirated O +
from O +
periovulatory O +
follicles O +
, O +
35 O +
h O +
after O +
hCG B-Gene +
injection O +
, O +
in O +
patients O +
undergoing O +
in O +
vitro O +
fertilization O +
treatment O +
. O +

In O +
an O +
11betaHSD B-Gene +
assay O +
based O +
on O +
interconversion O +
of O +
tritiated O +
E O +
and O +
F O +
by O +
cell O +
suspensions O +
in O +
vitro O +
, O +
IGC O +
( O +
% O +
conversion O +
, O +
0.6 O +
+ O -
/- O +
0.4 O +
, O +
mean O +
+ O -
/- O +
SEM O +
) O +
and O +
collagenase B-Gene +
- O +
dispersed O +
TC O +
( O +
0.2 O +
+ O -
/- O +
0.1 O +
% O +
) O +
were O +
unable O +
to O +
convert O +
E O +
to O +
F O +
, O +
whereas O +
LGC O +
( O +
36.3 O +
+ O -
/- O +
3.7 O +
% O +
) O +
were O +
highly O +
efficient O +
at O +
this O +
reaction O +
. O +

Immature O +
granulosa O +
cells O +
, O +
LGC O +
, O +
and O +
( O +
to O +
a O +
lesser O +
extent O +
) O +
TC O +
were O +
all O +
able O +
to O +
convert O +
F O +
to O +
E O +
. O +

Correspondingly O +
, O +
follicular O +
fluid O +
concentrations O +
of O +
total O +
F O +
and O +
F O +
: O +
E O +
ratios O +
were O +
significantly O +
higher O +
in O +
periovulatory O +
follicles O +
, O +
compared O +
with O +
immature O +
follicles O +
. O +

Culturing O +
IGC O +
for O +
48 O +
h O +
in O +
the O +
presence O +
of O +
hFSH B-Gene +
resulted O +
in O +
increased O +
11betaHSD1 B-Gene +
reductase I-Gene +
activity O +
, O +
paralleling O +
stimulation O +
of O +
estrogen O +
( O +
aromatase B-Gene +
activity O +
) O +
and O +
progesterone O +
biosynthesis O +
. O +

Similar O +
treatment O +
with O +
hLH B-Gene +
did O +
not O +
influence O +
11betaHSD1 B-Gene +
reductase I-Gene +
activity O +
, O +
except O +
in O +
a O +
patient O +
with O +
more O +
mature O +
IGC O +
, O +
which O +
also O +
showed O +
a O +
significant O +
increase O +
in O +
E O -
- O -
to O -
- O -
F O +
conversion O +
, O +
as O +
well O +
as O +
progesterone O +
synthesis O +
in O +
response O +
to O +
hLH B-Gene +
. O +

These O +
data O +
confirm O +
that O +
11betaHSD B-Gene +
activity O +
in O +
the O +
human O +
ovary O +
is O +
developmentally O +
regulated O +
and O +
gonadotropin B-Gene +
responsive O +
, O +
favoring O +
metabolism O +
of O +
F O +
to O +
E O +
in O +
immature O +
follicles O +
and O +
E O +
to O +
F O +
in O +
periovulatory O +
follicles O +
. O +

Increased O +
formation O +
of O +
F O +
by O +
LGC O +
in O +
periovulatory O +
follicles O +
is O +
consistent O +
with O +
an O +
antiinflammatory O +
function O +
for O +
this O +
glucocorticoid O +
at O +
ovulation O +
. O +

Cross O +
- O +
reconstitution O +
of O +
various O +
extrinsic O +
proteins O +
and O +
photosystem B-Gene +
II I-Gene +
complexes I-Gene +
from O +
cyanobacteria O +
, O +
red O +
algae O +
and O +
higher O +
plants O +
. O +

Photosystem B-Gene +
II I-Gene +
( O +
PSII B-Gene +
) O +
contains O +
different O +
extrinsic O +
proteins O +
required O +
for O +
oxygen O +
evolution O +
among O +
different O +
organisms O +
. O +

Cyanobacterial O +
PSII B-Gene +
contains O +
the O +
33 O +
kDa O +
, O +
12 O +
kDa O +
proteins O +
and O +
cytochrome B-Gene +
( I-Gene +
cyt I-Gene +
) I-Gene +
c-550 I-Gene +
; O +
red O +
algal O +
PSII B-Gene +
contains O +
a O +
20 O +
kDa O +
protein O +
in O +
addition O +
to O +
the O +
three O +
homologous O +
cyanobacterial O +
proteins O +
; O +
whereas O +
higher O +
plant O +
PSII B-Gene +
contains O +
the O +
33 O +
kDa O +
, O +
23 O +
kDa O +
and O +
17 O +
kDa O +
proteins O +
. O +

In O +
order O +
to O +
understand O +
the O +
binding O +
and O +
functional O +
properties O +
of O +
these O +
proteins O +
, O +
we O +
performed O +
cross O +
- O +
reconstitution O +
experiments O +
with O +
combinations O +
of O +
PSII B-Gene +
and O +
extrinsic O +
proteins O +
from O +
three O +
different O +
sources O +
: O +
higher O +
plant O +
( O +
spinach O +
) O +
, O +
red O +
alga O +
( O +
Cyanidium O +
caldarium O +
) O +
and O +
cyanobacterium O +
( O +
Synechococcus O +
vulcanus O +
) O +
. O +

Among O +
all O +
of O +
the O +
extrinsic O +
proteins O +
, O +
the O +
33 O +
kDa O +
protein O +
is O +
common O +
to O +
all O +
of O +
the O +
organisms O +
and O +
is O +
totally O +
exchangeable O +
in O +
binding O +
to O +
PSII B-Gene +
from O +
any O +
of O +
the O +
three O +
organisms O +
. O +

Oxygen O +
evolution O +
of O +
higher O +
plant O +
and O +
red O +
algal O +
PSII B-Gene +
was O +
restored O +
to O +
a O +
more O +
or O +
less O +
similar O +
level O +
by O +
binding O +
of O +
any O +
one O +
of O +
the O +
three O +
33 O +
kDa O +
proteins O +
, O +
whereas O +
oxygen O +
evolution O +
of O +
cyanobacterial O +
PSII B-Gene +
was O +
restored O +
to O +
a O +
larger O +
extent O +
with O +
its O +
own O +
33 O +
kDa O +
protein O +
than O +
with O +
the O +
33 O +
kDa O +
protein O +
from O +
other O +
sources O +
. O +

In O +
addition O +
to O +
the O +
33 O +
kDa O +
protein O +
, O +
the O +
red O +
algal O +
20 O +
kDa O +
, O +
12 O +
kDa O +
proteins O +
and O +
cyt B-Gene +
c-550 I-Gene +
were O +
able O +
to O +
bind O +
to O +
cyanobacterial O +
and O +
higher O +
plant O +
PSII B-Gene +
, O +
leading O +
to O +
a O +
partial O +
restoration O +
of O +
oxygen O +
evolution O +
in O +
both O +
organisms O +
. O +

The O +
cyanobacterial O +
12 O +
kDa O +
protein O +
and O +
cyt B-Gene +
c-550 I-Gene +
partially O +
bound O +
to O +
the O +
red O +
algal O +
PSII B-Gene +
, O +
but O +
this O +
binding O +
did O +
not O +
restore O +
oxygen O +
evolution O +
. O +

The O +
higher O +
plant O +
23 O +
kDa O +
and O +
17 O +
kDa O +
proteins O +
bound O +
to O +
the O +
cyanobacterial O +
and O +
red O +
algal O +
PSII B-Gene +
only O +
through O +
non O +
- O +
specific O +
interactions O +
. O +

Thus O +
, O +
only O +
the O +
red O +
algal O +
extrinsic O +
proteins O +
are O +
partially O +
functional O +
in O +
both O +
the O +
cyanobacterial O +
and O +
higher O +
plant O +
PSII B-Gene +
, O +
which O +
implies O +
a O +
possible O +
intermediate O +
position O +
of O +
the O +
red O +
algal O +
PSII B-Gene +
during O +
its O +
evolution O +
from O +
cyanobacteria O +
to O +
higher O +
plants O +
. O +

Differential O +
regulation O +
of O +
3beta B-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
type I-Gene +
II I-Gene +
and O +
17alpha B-Gene -
- I-Gene -
hydroxylase I-Gene +
/ I-Gene +
lyase I-Gene +
P450 I-Gene +
in O +
human O +
adrenocortical O +
carcinoma O +
cells O +
by O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
and O +
basic B-Gene +
fibroblast I-Gene +
growth I-Gene +
factor I-Gene +
. O +

Epidermal B-Gene +
growth I-Gene +
factor I-Gene +
( O +
EGF B-Gene +
) O +
and O +
basic B-Gene +
fibroblast I-Gene +
growth I-Gene +
factor I-Gene +
( O +
bFGF B-Gene +
) O +
are O +
pluripotent O +
growth B-Gene +
factors I-Gene +
that O +
stimulate O +
both O +
the O +
proliferation O +
and O +
steroidogenesis O +
of O +
adrenocortical O +
cells O +
. O +

Here O +
we O +
demonstrate O +
that O +
EGF B-Gene +
and O +
bFGF B-Gene +
specifically O +
induce O +
mRNA O +
of O +
3beta B-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
type I-Gene +
II I-Gene +
( O +
3betaHSD B-Gene +
II I-Gene +
) O +
and O +
suppress O +
that O +
of O +
17alpha B-Gene -
- I-Gene -
hydroxylase I-Gene +
/ I-Gene +
lyase I-Gene +
P450 I-Gene +
( O +
CYP17 B-Gene +
) O +
in O +
human O +
adrenocortical O +
H295R O +
cells O +
. O +

The O +
induction O +
of O +
3betaHSD B-Gene +
II I-Gene +
mRNA O +
did O +
not O +
occur O +
until O +
6 O +
h O +
after O +
the O +
growth O +
factor O +
treatment O +
and O +
was O +
completely O +
abolished O +
in O +
the O +
presence O +
of O +
a O +
protein O +
synthesis O +
inhibitor O +
, O +
cycloheximide O +
( O +
CHX O +
) O +
, O +
suggesting O +
that O +
the O +
induction O +
required O +
de O +
novo O +
protein O +
synthesis O +
. O +

The O +
CYP17 B-Gene +
mRNA O +
suppression O +
began O +
at O +
almost O +
the O +
same O +
time O +
as O +
the O +
induction O +
of O +
the O +
3betaHSD B-Gene +
II I-Gene +
mRNA O +
. O +

Interestingly O +
, O +
the O +
CYP17 B-Gene +
mRNA O +
level O +
was O +
increased O +
by O +
the O +
CHX O +
treatment O +
. O +

Both O +
the O +
3betaHSD B-Gene +
II I-Gene +
and O +
CYP17 B-Gene +
mRNAs O +
were O +
repressed O +
by O +
treatment O +
with O +
a O +
calmodulin B-Gene +
kinase I-Gene +
II I-Gene +
( O +
CaMK B-Gene +
II I-Gene +
) O +
inhibitor O +
, O +
KN O +
- O +
93 O +
, O +
and O +
were O +
enhanced O +
by O +
a O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
( O +
MAPK B-Gene +
) O +
inhibitor O +
, O +
PD98059 O +
. O +

The O +
PD98059 O +
- O +
mediated O +
induction O +
of O +
the O +
3betaHSD B-Gene +
II I-Gene +
mRNA O +
was O +
completely O +
blocked O +
by O +
the O +
CHX O +
treatment O +
. O +

Interestingly O +
, O +
treatment O +
with O +
EGF B-Gene +
in O +
the O +
presence O +
of O +
both O +
PD98059 O +
and O +
CHX O +
produced O +
a O +
greater O +
increase O +
in O +
the O +
CYP17 B-Gene +
mRNA O +
than O +
did O +
treatment O +
in O +
the O +
presence O +
of O +
PD98059 O +
alone O +
. O +

These O +
results O +
suggest O +
that O +
CHX O +
- O +
sensitive O +
factor O -
( O -
s O -
) O +
and O +
CaMK B-Gene +
II I-Gene +
- O +
and O +
MAPK B-Gene +
- O +
signaling O +
pathways O +
may O +
have O +
important O +
roles O +
in O +
both O +
induction O +
of O +
3betaHSD B-Gene +
II I-Gene +
and O +
suppression O +
of O +
CYP17 B-Gene +
by O +
EGF B-Gene +
or O +
bFGF B-Gene +
in O +
H295R O +
cells O +
. O +

Discovery O +
of O +
two O +
novel O +
variants O +
of O +
KIR2DS5 B-Gene +
reveals O +
this O +
gene O +
to O +
be O +
a O +
common O +
component O +
of O +
human O +
KIR B-Gene +
' O +
B O -
' O +
haplotypes O +
. O +

The O +
gene O +
encoding O +
the O +
non O +
- O +
inhibitory O +
receptor O +
KIR2DS5 B-Gene +
has O +
so O +
far O +
been O +
represented O +
by O +
a O +
single O +
cDNA O +
sequence O +
, O +
NKAT9 B-Gene +
. O +

A O +
previous O +
study O +
by O +
polymerase O +
chain O +
reaction O +
using O +
sequence O +
- O +
specific O +
primers O +
( O +
PCR O +
- O +
SSP O +
) O +
failed O +
to O +
detect O +
NKAT9 B-Gene +
in O +
genomic O +
DNA O +
of O +
52 O +
donors O +
, O +
which O +
suggested O +
that O +
KIR2DS5 B-Gene +
could O +
be O +
a O +
rare O +
gene O +
. O +

Here O +
, O +
we O +
have O +
characterized O +
two O +
novel O +
variants O +
of O +
KIR2DS5 B-Gene +
that O +
differ O +
from O +
NKAT9 B-Gene +
by O +
8 O +
and O +
10 O +
nucleotide O +
substitutions O +
. O +

The O +
frequency O +
of O +
KIR2DS5 B-Gene +
was O +
then O +
re O +
- O +
assessed O +
by O +
PCR O -
- O -
SSP O +
using O +
primers O +
specific O +
for O +
conserved O +
sequences O +
of O +
all O +
three O +
known O +
KIR2DS5 B-Gene +
variants O +
. O +

We O +
found O +
KIR2DS5 B-Gene +
is O +
not O +
a O +
rare O +
gene O +
, O +
but O +
one O +
present O +
in O +
26 O +
% O +
of O +
34 O +
donors O +
representing O +
the O +
major O +
ethnic O +
groups O +
. O +

Like O +
other O +
non O +
- O +
inhibitory O +
KIR B-Gene +
, O +
the O +
distribution O +
of O +
KIR2DS5 B-Gene +
is O +
restricted O +
to O +
the O +
' O +
B O -
' O +
subset O +
of O +
KIR B-Gene +
- O +
gene O +
haplotypes O +
. O +

Transcription O +
of O +
the O +
KIR2DS5 B-Gene +
gene O +
was O +
studied O +
by O +
reverse O +
transcriptase O +
( O +
RT O +
) O +
- O +
PCR O +
in O +
natural O +
killer O +
( O +
NK O +
) O +
cells O +
from O +
one O +
donor O +
and O +
shown O +
to O +
follow O +
the O +
clonal O +
distribution O +
seen O +
for O +
most O +
other O +
KIR B-Gene +
genes O +
. O +

IL-1H B-Gene +
, O +
an O +
interleukin B-Gene +
1 I-Gene +
- O +
related O +
protein O +
that O +
binds O +
IL-18 B-Gene +
receptor I-Gene +
/ O +
IL-1Rrp B-Gene +
. O +

IL-18 B-Gene +
, O +
or O +
IGIF B-Gene +
( O +
interferon B-Gene +
- I-Gene +
gamma I-Gene +
inducing I-Gene +
factor I-Gene +
) O +
, O +
is O +
an O +
IL-1 B-Gene +
- O +
related O +
, O +
pro O +
- O +
inflammatory O +
cytokine B-Gene +
, O +
which O +
plays O +
a O +
pivotal O +
role O +
in O +
systemic O +
and O +
local O +
inflammation O +
. O +

We O +
have O +
identified O +
and O +
characterized O +
IL-1H B-Gene +
, O +
a O +
novel O +
IL-1 B-Gene +
- O +
related O +
molecule O +
. O +

IL-1H B-Gene +
appears O +
to O +
be O +
expressed O +
in O +
most O +
tissues O +
with O +
relatively O +
high O +
levels O +
in O +
testis O +
, O +
thymus O +
and O +
uterus O +
. O +

The O +
IL-1H B-Gene +
transcripts O +
were O +
stimulated O +
by O +
phorbol O +
ester O +
( O +
PMA O +
) O +
in O +
human O +
cell O +
lines O +
( O +
A431 O +
, O +
THP-1 O +
and O +
KG-1 O +
) O +
and O +
peripheral O +
blood O +
mononuclear O +
cells O +
( O +
HPBMC O +
) O +
and O +
dendritic O +
cells O +
( O +
NHDC O +
) O +
. O +

The O +
protein O +
sequence O +
of O +
IL-1H B-Gene +
is O +
mostly O +
related O +
to O +
IL-1ra B-Gene +
with O +
a O +
similarity O +
of O +
36 O +
% O +
. O +

A O +
short O +
form O +
of O +
IL-1H B-Gene +
was O +
identified O +
, O +
and O +
lacks O +
a O +
40 O +
- O +
amino O +
acid O +
segment O +
in O +
the O +
amino O +
- O +
terminal O +
region O +
of O +
the O +
protein O +
. O +

When O +
expressed O +
in O +
mammalian O +
cells O +
, O +
two O +
secreted O +
polypeptides O +
of O +
IL-1H B-Gene +
were O +
identified O +
: O +
an O +
uncleaved O +
and O +
a O +
cleaved O +
form O +
starting O +
with O +
amino O +
acid O +
Val-46 O +
. O +

Furthermore O +
, O +
IL-1H B-Gene +
binds O +
the O +
IL-18 B-Gene +
receptor I-Gene +
, O +
but O +
not O +
the O +
IL-1 B-Gene +
receptor I-Gene +
. O +

These O +
findings O +
suggest O +
that O +
IL-1H B-Gene +
may O +
be O +
another O +
ligand O +
for O +
the O +
IL-18 B-Gene +
receptor I-Gene +
and O +
a O +
new O +
player O +
in O +
the O +
inflammatory O +
and O +
immune O +
responses O +
mediated O +
by O +
the O +
IL-18 B-Gene +
/ O +
IL-18R B-Gene +
axis O +
. O +

Localization O +
of O +
human O +
interleukin B-Gene +
13 I-Gene +
receptor I-Gene +
in O +
non O +
- O +
haematopoietic O +
cells O +
. O +

Although O +
the O +
functional O +
roles O +
of O +
interleukin B-Gene +
( I-Gene +
IL- I-Gene -
) I-Gene +
13 I-Gene +
in O +
haematopoietic O +
cells O +
are O +
well O +
investigated O +
, O +
those O +
in O +
non O +
- O +
haematopoietic O +
cells O +
remain O +
to O +
be O +
addressed O +
. O +

IL-13 B-Gene +
exerts O +
its O +
actions O +
by O +
binding O +
to O +
the O +
IL-13 B-Gene +
receptor I-Gene +
( O +
IL-13R B-Gene +
) O +
on O +
target O +
cells O +
, O +
which O +
is O +
composed O +
of O +
IL-13Ralpha1 B-Gene +
and O +
the O +
IL-4 B-Gene +
receptor I-Gene +
alpha I-Gene +
chain O +
( O +
IL-4Ralpha B-Gene +
) O +
. O +

However O +
, O +
there O +
has O +
been O +
no O +
study O +
of O +
localization O +
of O +
IL-13R B-Gene +
in O +
each O +
tissue O +
. O +

To O +
address O +
this O +
question O +
, O +
we O +
generated O +
monoclonal O +
anti O +
- O +
IL-13Ralpha1 B-Gene +
antibody O +
, O +
and O +
performed O +
immunohistochemistry O +
using O +
this O +
antibody O +
and O +
anti O +
- O +
IL-4Ralpha B-Gene +
antibody O +
. O +

Distribution O +
of O +
these O +
two O +
components O +
was O +
the O +
same O +
in O +
all O +
examined O +
tissues O +
. O +

Staining O +
was O +
positive O +
in O +
keratinocytes O +
, O +
hair O +
follicles O +
, O +
and O +
sebaceous O +
and O +
sweat O +
glands O +
in O +
skin O +
; O +
in O +
ciliated O +
respiratory O +
epithelial O +
cells O +
in O +
nasal O +
tissue O +
; O +
in O +
heart O +
muscle O +
cells O +
; O +
in O +
foveola O +
cells O +
, O +
gastric O +
glands O +
, O +
and O +
the O +
smooth O +
muscle O +
layer O +
in O +
stomach O +
; O +
and O +
in O +
hepatocytes O +
in O +
liver O +
. O +

However O +
, O +
staining O +
was O +
undetectable O +
in O +
brain O +
and O +
bone O +
marrow O +
. O +

Fibroblasts O +
and O +
endothelial O +
cells O +
were O +
stained O +
in O +
some O +
tissues O +
. O +

These O +
results O +
provide O +
clues O +
to O +
elucidate O +
the O +
known O +
pathological O +
roles O +
of O +
IL-13 B-Gene +
in O +
atopic O +
dermatitis O +
and O +
allergic O +
rhinitis O +
, O +
as O +
well O +
as O +
its O +
unknown O +
physiological O +
roles O +
. O +

The O +
skeletal B-Gene +
muscle I-Gene +
ryanodine I-Gene +
receptor I-Gene +
identified O +
as O +
a O +
molecular O +
target O +
of O +
[ O -
3H O -
] O -
azidodantrolene O +
by O +
photoaffinity O +
labeling O +
. O +

Dantrolene O +
is O +
a O +
skeletal O +
muscle O +
relaxant O +
which O +
acts O +
by O +
inhibiting O +
intracellular O +
Ca O -
( O -
2 O -
+ O -
) O +
release O +
from O +
sarcoplasmic O +
reticulum O +
( O +
SR O +
) O +
. O +

It O +
is O +
used O +
primarily O +
in O +
the O +
treatment O +
of O +
malignant O +
hyperthermia O +
( O +
MH O +
) O +
, O +
a O +
pharmacogenetic O +
sensitivity O +
to O +
volatile O +
anesthetics O +
resulting O +
in O +
massive O +
intracellular O +
Ca O -
( O -
2 O -
+ O -
) O +
release O +
. O +

Determination O +
of O +
the O +
site O +
and O +
mechanism O +
of O +
action O +
of O +
dantrolene O +
should O +
contribute O +
to O +
the O +
understanding O +
of O +
the O +
regulation O +
of O +
intracellular O +
Ca O -
( O -
2 O -
+ O -
) O +
release O +
in O +
skeletal O +
muscle O +
. O +

Photoaffinity O +
labeling O +
of O +
porcine O +
SR O +
with O +
[ O -
( O -
3 O -
) O -
H O -
] O -
azidodantrolene O +
, O +
a O +
photoactivatable O +
analogue O +
of O +
dantrolene O +
, O +
has O +
identified O +
a O +
160 O +
kDa O +
SR O +
protein O +
with O +
immunologic O +
cross O +
- O +
reactivity O +
to O +
skeletal B-Gene +
muscle I-Gene +
ryanodine I-Gene +
receptor I-Gene +
( O +
RyR B-Gene +
) O +
as O +
a O +
possible O +
target O +
[ O +
Palnitkar O +
et O +
al. O +
( O +
1999 O +
) O +
J. O +
Med O -
. O +
Chem O -
. O +
42 O +
, O +
1872 O +
- O +
1880 O +
] O +
. O +

Here O +
we O +
demonstrate O +
specific O +
, O +
AMP O -
- O -
PCP O +
- O +
enhanced O +
, O +
[ O -
( O -
3 O -
) O -
H O -
] O -
azidodantrolene O +
photolabeling O +
of O +
both O +
the O +
RyR B-Gene +
monomer O +
and O +
a O +
160 O +
or O +
172 O +
kDa O +
protein O +
in O +
porcine O +
and O +
rabbit O +
SR O +
, O +
respectively O +
. O +

The O +
160 O +
/ O +
172 O +
kDa O +
protein O +
is O +
shown O +
to O +
be O +
the O +
NH O -
( O -
2 O -
) O +
- O +
terminus O +
of O +
the O +
RyR B-Gene +
cleaved O +
from O +
the O +
monomer O +
by O +
an O +
endogenous O +
protease B-Gene +
activity O +
consistent O +
with O +
that O +
of O +
n B-Gene -
- I-Gene -
calpain I-Gene +
. O +

MALDI O +
- O +
mass O +
spectrometric O +
analysis O +
of O +
the O +
porcine O +
160 O +
kDa O +
protein O +
identifies O +
it O +
as O +
the O +
1400 O +
amino O +
acid O +
NH O -
( O -
2 O -
) O +
- O +
terminal O +
fragment O +
of O +
the O +
skeletal B-Gene +
muscle I-Gene +
RyR I-Gene +
reportedly O +
generated O +
by O +
n B-Gene -
- I-Gene -
calpain I-Gene +
[ O +
Shevchenko O +
et O +
al. O +
( O +
1998 O +
) O +
J. O +
Membr O -
. O +
Biol O -
. O +
161 O +
, O +
33 O +
- O +
34 O +
] O +
. O +

Immunoprecipitation O +
of O +
solubilized O +
, O +
[ O -
( O -
3 O -
) O -
H O -
] O -
azidodantrolene O -
- O -
photolabeled O +
SR O +
protein O +
reveals O +
that O +
the O +
cleaved O +
160 O +
/ O +
172 O +
kDa O +
protein O +
remains O +
associated O +
with O +
the O +
C O +
- O +
terminal O +
, O +
410 O +
kDa O +
portion O +
of O +
the O +
RyR B-Gene +
. O +

[ O -
( O -
3 O -
) O -
H O -
] O -
Dantrolene O +
binding O +
to O +
both O +
the O +
intact O +
and O +
the O +
n B-Gene +
- I-Gene +
calpain I-Gene +
- O +
cleaved O +
channel O +
RyR B-Gene +
is O +
similarly O +
enhanced O +
by O +
AMP O -
- O -
PCP O +
. O +

n B-Gene -
- I-Gene -
Calpain I-Gene +
cleavage O +
of O +
the O +
RyR B-Gene +
does O +
not O +
affect O +
[ O -
( O -
3 O -
) O -
H O -
] O -
dantrolene O +
binding O +
in O +
the O +
presence O +
of O +
AMP O -
- O -
PCP O +
, O +
but O +
depresses O +
drug O +
binding O +
in O +
the O +
absence O +
of O +
nucleotide O +
. O +

These O +
results O +
demonstrate O +
that O +
the O +
NH O -
( O -
2 O -
) O +
- O +
terminus O +
of O +
the O +
RyR B-Gene +
is O +
a O +
molecular O +
target O +
for O +
dantrolene O +
, O +
and O +
suggest O +
a O +
regulatory O +
role O +
for O +
both O +
n B-Gene -
- I-Gene -
calpain I-Gene +
activity O +
and O +
ATP O +
in O +
the O +
interaction O +
of O +
dantrolene O +
with O +
the O +
RyR B-Gene +
in O +
vivo O +
. O +

Targeting O +
Pyk2 B-Gene +
to O +
beta B-Gene +
1 I-Gene +
- I-Gene +
integrin I-Gene +
- O +
containing O +
focal O +
contacts O +
rescues O +
fibronectin B-Gene +
- O +
stimulated O +
signaling O +
and O +
haptotactic O +
motility O +
defects O +
of O +
focal B-Gene +
adhesion I-Gene +
kinase I-Gene +
- O +
null O +
cells O +
. O +

Focal B-Gene +
adhesion I-Gene +
kinase I-Gene +
- O +
null O +
( O +
FAK B-Gene +
( O +
- O -
/ O -
- O +
) O +
fibroblasts O +
exhibit O +
morphological O +
and O +
motility O +
defects O +
that O +
are O +
reversed O +
by O +
focal B-Gene +
adhesion I-Gene +
kinase I-Gene +
( O +
FAK B-Gene +
) O +
reexpression O -
. O +
The O +
FAK B-Gene +
- O +
related O +
kinase O +
, O +
proline B-Gene +
- I-Gene +
rich I-Gene +
tyrosine I-Gene +
kinase I-Gene +
2 I-Gene +
( O +
Pyk2 B-Gene +
) O +
, O +
is O +
expressed O +
in O +
FAK B-Gene +
( O +
- O +
/ O +
- O +
) O +
cells O +
, O +
yet O +
it O +
exhibits O +
a O +
perinuclear O +
distribution O +
and O +
does O +
not O +
functionally O +
substitute O +
for O +
FAK B-Gene +
. O +
Chimeric O +
Pyk2 B-Gene +
/ O +
FAK B-Gene +
proteins O +
were O +
created O +
and O +
expressed O +
in O +
FAK B-Gene +
( O +
- O +
/ O +
- O +
) O +
cells O +
to O +
determine O +
the O +
impact O +
of O +
Pyk2 B-Gene +
localization O +
to O +
focal O +
contacts O +
. O +

Whereas O +
an O +
FAK B-Gene +
/ O +
Pyk2 B-Gene +
COOH O +
- O +
terminal O +
( O +
CT O +
) O +
domain O +
chimera O +
was O +
perinuclear O +
distributed O +
, O +
stable O +
expression O +
of O +
a O +
Pyk2 B-Gene +
chimera O +
with O +
the O +
FAK B-Gene +
- O +
CT O +
domain O +
( O +
Pyk2 B-Gene +
/ O +
FAK B-Gene +
- O +
CT O +
) O +
localized O +
to O +
focal O +
contact O +
sites O +
and O +
enhanced O +
fibronectin B-Gene +
( O +
FN B-Gene +
) O +
- O +
stimulated O +
haptotactic O +
cell O +
migration O +
equal O +
to O +
FAK B-Gene +
- O +
reconstituted O +
cells O +
. O +

Disruption O +
of O +
paxillin B-Gene +
binding O +
to O +
the O +
FAK B-Gene +
- O +
CT O +
domain O +
( O +
S-1034 O +
) O +
inhibited O +
Pyk2 B-Gene +
/ O +
FAK B-Gene +
- O +
CT O +
localization O +
to O +
focal O +
contacts O +
and O +
its O +
capacity O +
to O +
promote O +
cell O +
motility O +
. O +

Paxillin B-Gene +
binding O +
to O +
the O +
FAK B-Gene +
- O +
CT O +
was O +
necessary O +
but O +
not O +
sufficient O +
to O +
mediate O +
the O +
indirect O +
association O +
of O +
FAK B-Gene +
or O +
Pyk2 B-Gene +
/ O +
FAK B-Gene +
- O +
CT O +
with O +
a O +
beta B-Gene +
1 I-Gene +
- I-Gene +
integrin I-Gene +
- O +
containing O +
complex O +
. O +

Both O +
FAK B-Gene +
and O +
Pyk2 B-Gene +
/ O +
FAK B-Gene +
- O +
CT O +
but O +
not O +
Pyk2 B-Gene +
/ O +
FAK B-Gene +
- O +
CT O +
S-1034 O +
reconstituted O +
FAK B-Gene +
( O +
- O -
/ O -
- O +
) O +
cells O +
, O +
exhibit O +
elevated O +
FN B-Gene +
- O +
stimulated O +
extracellular B-Gene +
signal I-Gene +
- I-Gene +
regulated I-Gene +
kinase I-Gene +
2 I-Gene +
( O +
ERK2 B-Gene +
) O +
and O +
c B-Gene -
- I-Gene -
Jun I-Gene +
NH I-Gene +
( I-Gene +
2 I-Gene +
) I-Gene +
- I-Gene +
terminal I-Gene +
kinase I-Gene +
( O +
JNK B-Gene +
) O +
kinase B-Gene +
activation O +
. O +

FN B-Gene +
- O +
stimulated O +
FAK B-Gene +
or O +
Pyk2 B-Gene +
/ O +
FAK B-Gene +
- O +
CT O +
activation O +
enhanced O +
both O +
the O +
extent O +
and O +
duration O +
of O +
FN B-Gene +
- O +
stimulated O +
ERK2 B-Gene +
activity O +
which O +
was O +
necessary O +
for O +
cell O +
motility O +
. O +

Transient O +
overexpression O +
of O +
the O +
FAK B-Gene +
- O +
CT O +
but O +
not O +
FAK B-Gene +
- O +
CT O +
S-1034 O +
domain O +
inhibited O +
both O +
FN O +
- O +
stimulated O +
ERK2 B-Gene +
and O +
JNK B-Gene +
activation O +
as O +
well O +
as O +
FN B-Gene +
- O +
stimulated O +
motility O +
of O +
Pyk2 B-Gene +
/ O +
FAK B-Gene +
- O +
CT O +
reconstituted O +
cells O +
. O +

These O +
gain O +
- O +
of O +
- O +
function O +
studies O +
show O +
that O +
the O +
NH O -
( O -
2 O -
) O +
- O +
terminal O +
and O +
kinase B-Gene +
domains O +
of O +
Pyk2 B-Gene +
can O +
functionally O +
substitute O +
for O +
FAK B-Gene +
in O +
promoting O +
FN B-Gene +
- O +
stimulated O +
signaling O +
and O +
motility O +
events O +
when O +
localized O +
to O +
beta B-Gene -
- I-Gene -
integrin I-Gene +
- O +
containing O +
focal O +
contact O +
sites O +
via O +
interactions O +
mediated O +
by O +
the O +
FAK B-Gene +
- O +
CT O +
domain O +
. O +

Identification O +
of O +
a O +
novel O +
exon O +
in O +
apolipoprotein B-Gene +
E I-Gene +
receptor I-Gene +
2 I-Gene +
leading O +
to O +
alternatively O +
spliced O +
mRNAs O +
found O +
in O +
cells O +
of O +
the O +
vascular O +
wall O +
but O +
not O +
in O +
neuronal O +
tissue O +
. O +

Novel O +
members O +
of O +
the O +
low B-Gene +
density I-Gene +
lipoprotein I-Gene +
receptor I-Gene +
family I-Gene +
were O +
identified O +
in O +
human O +
endothelial O +
and O +
vascular O +
smooth O +
muscle O +
cells O +
utilizing O +
a O +
homology O +
- O +
cloning O +
strategy O +
. O +

Four O +
novel O +
mRNA O +
transcripts O +
could O +
be O +
identified O +
as O +
isoforms O +
of O +
the O +
apolipoprotein B-Gene +
E I-Gene +
receptor I-Gene +
2 I-Gene +
( O +
apoEr2 B-Gene +
) O +
: O +
one O +
form O +
lacking O +
three O +
ligand O +
binding O +
repeats O +
( O +
nucleotides O +
497 O +
- O +
883 O +
) O +
but O +
containing O +
a O +
novel O +
ligand O +
binding O +
repeat O +
adjacent O +
to O +
a O +
unique O +
cysteine O +
- O +
rich O +
domain O +
preceding O +
the O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
precursor O +
domain O +
of O +
apoEr2 B-Gene +
, O +
forms O +
lacking O +
the O +
O O +
- O +
linked O +
sugar O +
domain O +
, O +
and O +
forms O +
containing O +
a O +
59 O +
- O +
amino O +
acid O +
deletion O +
within O +
the O +
cytoplasmic O +
tail O +
. O +

By O +
fluorescence O +
in O +
situ O +
hybridization O +
for O +
chromosome O +
mapping O +
, O +
we O +
could O +
confirm O +
that O +
the O +
novel O +
alternative O +
forms O +
of O +
apoEr2 B-Gene +
are O +
splice O +
variants O +
of O +
transcripts O +
from O +
a O +
single O +
copy O +
gene O +
on O +
chromosome O +
1p34 O +
. O +

To O +
analyze O +
whether O +
the O +
different O +
splice O +
variants O +
of O +
apoEr2 B-Gene +
mRNA O +
are O +
expressed O +
in O +
a O +
splice O +
variant O +
- O +
specific O +
pattern O +
, O +
we O +
concentrated O +
on O +
the O +
central O +
nervous O +
system O +
, O +
where O +
high O +
expression O +
of O +
apoEr2 B-Gene +
has O +
been O +
described O +
originally O +
. O +

By O +
means O +
of O +
splice O +
variant O +
- O +
specific O +
in O +
situ O +
hybridization O +
, O +
we O +
could O +
confirm O +
that O +
apoEr2 B-Gene +
mRNA O +
is O +
abundantly O +
expressed O +
in O +
brain O +
tissue O +
and O +
, O +
with O +
exception O +
of O +
the O +
newly O +
identified O +
ligand O +
binding O +
domain O +
, O +
all O +
mRNA O +
splice O +
variants O +
exhibited O +
a O +
similar O +
expression O +
pattern O +
. O +

The O +
mRNA O +
of O +
the O +
newly O +
identified O +
ligand O +
binding O +
domain O +
, O +
however O +
, O +
was O +
expressed O +
in O +
brain O +
only O +
in O +
cells O +
of O +
the O +
vascular O +
wall O +
, O +
confirming O +
data O +
from O +
Northern O +
blotting O +
, O +
where O +
the O +
mRNA O +
of O +
the O +
newly O +
identified O +
ligand O +
binding O +
domain O +
was O +
found O +
in O +
several O +
tissues O +
but O +
was O +
absent O +
in O +
brain O +
tissue O +
. O +

Clonal O +
accumulation O +
of O +
T O +
cells O +
bearing O +
V O +
beta O +
6 O +
T B-Gene -
- I-Gene -
cell I-Gene +
receptor I-Gene +
in O +
chronic O +
inflammatory O +
periodontal O +
disease O +
. O +

Our O +
previous O +
study O +
demonstrated O +
that O +
among O +
the O +
various O +
T O -
- O -
cell O +
receptor O +
V O +
beta O +
gene O +
segments O +
, O +
T B-Gene -
- I-Gene -
cell I-Gene +
receptor I-Gene +
V O +
beta O +
6 O +
gene O +
- O +
bearing O +
T O +
cells O +
are O +
predominant O +
in O +
periodontitis O +
lesions O +
. O +

To O +
explore O +
the O +
clonality O +
of O +
T O +
cells O +
expressing O +
V O +
beta O +
6 O +
T B-Gene -
- I-Gene -
cell I-Gene +
receptor I-Gene +
, O +
which O +
is O +
determined O +
by O +
the O +
heterogeneity O +
of O +
the O +
complementarity O +
- O +
determining O +
region O +
3 O +
( O +
CDR3 O +
) O +
, O +
V O +
beta O +
6 O +
- O +
C O +
beta O +
polymerase O +
chain O +
reaction O +
products O +
derived O +
from O +
gingival O +
tissue O +
and O +
peripheral O +
blood O +
of O +
periodontitis O +
patients O +
were O +
analyzed O +
by O +
single O +
- O +
strand O +
conformation O +
polymorphism O +
and O +
nucleotide O +
sequence O +
. O +

Both O +
techniques O +
provided O +
quite O +
similar O +
results O +
in O +
terms O +
of O +
the O +
number O +
of O +
accumulated O +
clones O +
in O +
which O +
clonal O +
accumulation O +
of O +
T B-Gene -
- I-Gene -
cell I-Gene +
receptor I-Gene +
V O +
beta O +
6 O +
- O +
bearing O +
T O +
cells O +
was O +
found O +
in O +
most O +
periodontitis O +
lesions O +
but O +
not O +
in O +
peripheral O +
blood O +
. O +

From O +
the O +
analysis O +
of O +
deduced O +
amino O +
acid O +
sequences O +
, O +
a O +
possible O +
conserved O +
amino O +
acid O +
residue O +
in O +
the O +
CDR3 O +
region O +
of O +
the O +
periodontitis O +
lesion O +
- O +
derived O +
sequences O +
was O +
found O +
in O +
most O +
patients O +
. O +

This O +
conserved O +
amino O +
acid O +
motif O +
however O +
, O +
was O +
not O +
identified O +
. O +

Furthermore O +
, O +
skewed O +
J O +
beta O +
gene O +
segment O +
usage O +
was O +
observed O +
for O +
expanded O +
clones O +
from O +
periodontitis O +
lesions O +
. O +

Our O +
results O +
suggest O +
that O +
T O +
cells O +
infiltrating O +
periodontitis O +
lesions O +
are O +
responding O +
to O +
a O +
restricted O +
number O +
of O +
antigens O +
or O +
epitopes O +
. O +

Parameters O +
underlying O +
successful O +
protection O +
with O +
live O +
attenuated O +
mutants O +
in O +
experimental O +
shigellosis O +
. O +

Because O +
the O +
use O +
of O +
live O +
attenuated O +
mutants O +
of O +
Shigella O +
spp O -
. O +
represents O +
a O +
promising O +
approach O +
to O +
protection O +
against O +
bacillary O +
dysentery O +
( O +
M. O +
E. O +
Etherridge O +
, O +
A. O +
T. O +
M. O +
Shamsul O +
Hoque O +
, O +
and O +
D. O +
A. O +
Sack O +
, O +
Lab O -
. O +
Anim O -
. O +
Sci O -
. O +
46 O +
: O +
61 O +
- O +
66 O +
, O +
1996 O +
) O +
, O +
it O +
becomes O +
essential O +
to O +
rationalize O +
this O +
approach O +
in O +
animal O +
models O +
in O +
order O +
to O +
optimize O +
attenuation O +
of O +
virulence O +
in O +
the O +
vaccine O +
candidates O +
, O +
as O +
well O +
as O +
their O +
route O +
and O +
mode O +
of O +
administration O +
, O +
and O +
to O +
define O +
the O +
correlates O +
of O +
protection O +
. O +

In O +
this O +
study O +
, O +
we O +
have O +
compared O +
three O +
strains O +
of O +
Shigella O +
flexneri O +
5 O -
- O -
-the O +
wild O +
- O +
type O +
M90 O -
T O +
, O +
an O +
aroC B-Gene +
mutant O +
, O +
and O +
a O +
double O +
purE B-Gene +
aroC B-Gene +
mutant O -
-- O -
for O +
their O +
pathogenicity O +
, O +
immunogenicity O +
, O +
and O +
protective O +
capacity O +
. O +

Protection O +
against O +
keratoconjunctivitis O +
, O +
induced O +
by O +
wild O +
- O +
type O +
M90 O -
T O +
, O +
was O +
used O +
as O +
the O +
protection O +
read O +
out O +
in O +
guinea O +
pigs O +
that O +
were O +
inoculated O +
either O +
intranasally O +
or O +
intragastrically O +
. O +

Following O +
intranasal O +
immunization O +
, O +
the O +
aroC B-Gene +
mutant O +
elicited O +
weak O +
nasal O +
tissue O +
destruction O +
compared O +
to O +
M90 O -
T O +
and O +
achieved O +
protection O +
correlated O +
with O +
high O +
levels O +
of O +
local O +
anti O +
- O +
lipopolysaccharide O +
immunoglobulin B-Gene +
A I-Gene +
( O +
IgA B-Gene +
) O +
, O +
whereas O +
the O +
purE B-Gene +
aroC B-Gene +
double O +
mutant O +
, O +
which O +
also O +
elicited O +
weak O +
tissue O +
destruction O +
, O +
was O +
not O +
protective O +
and O +
elicited O +
a O +
low O +
IgA B-Gene +
response O +
. O +

Conversely O +
, O +
following O +
intragastric O +
immunization O +
, O +
only O +
the O +
M90 O -
T O +
purE B-Gene +
aroC B-Gene +
double O +
mutant O +
elicited O +
protection O +
compared O +
to O +
both O +
the O +
aroC B-Gene +
mutant O +
and O +
the O +
wild O +
- O +
type O +
strain O +
. O +

This O +
mutant O +
caused O +
mild O +
inflammatory O +
destruction O +
, O +
particularly O +
at O +
the O +
level O +
of O +
Peyer O +
's O +
patches O +
, O +
but O +
it O +
persisted O +
much O +
longer O +
within O +
the O +
tissues O +
. O +

This O +
could O +
represent O +
an O +
essential O +
parameter O +
of O +
the O +
protective O +
response O +
that O +
, O +
in O +
this O +
case O +
, O +
did O +
not O +
clearly O +
correlate O +
with O +
high O +
anti O +
- O +
lipopolysaccharide O +
IgA B-Gene +
titers O +
. O +

Antigen O +
- O +
specific O +
mediated O +
suppression O +
of O +
beta O +
cell O +
autoimmunity O +
by O +
plasmid O +
DNA O +
vaccination O +
. O +

In O +
this O +
study O +
, O +
we O +
have O +
investigated O +
the O +
use O +
of O +
plasmid O +
DNA O +
( O +
pDNA O +
) O +
vaccination O +
to O +
elicit O +
Th2 O +
effector O +
cell O +
function O +
in O +
an O +
Ag O +
- O +
specific O +
manner O +
and O +
in O +
turn O +
prevent O +
insulin B-Gene +
- O +
dependent O +
diabetes O +
mellitus O +
( O +
IDDM O +
) O +
in O +
nonobese O +
diabetic O +
( O +
NOD O +
) O +
mice O +
. O +

pDNA O +
recombinants O +
were O +
engineered O +
encoding O +
a O +
secreted O +
fusion O +
protein O +
consisting O +
of O +
a O +
fragment O +
of O +
glutamic B-Gene +
acid I-Gene +
decarboxylase I-Gene +
65 I-Gene +
( O +
GAD65 B-Gene +
) O +
linked O +
to O +
IgGFc B-Gene +
, O +
and O +
IL-4 B-Gene +
. O +

Intramuscular O +
injection O +
of O +
pDNA O +
encoding O +
GAD65 B-Gene +
- O +
IgGFc B-Gene +
and O +
IL-4 B-Gene +
effectively O +
prevented O +
diabetes O +
in O +
NOD O +
mice O +
treated O +
at O +
early O +
or O +
late O +
preclinical O +
stages O +
of O +
IDDM O +
. O +

This O +
protection O +
was O +
GAD65 B-Gene +
- O +
specific O +
since O +
NOD O +
mice O +
immunized O +
with O +
pDNA O +
encoding O +
hen O +
egg O +
lysozyme B-Gene +
- O +
IgGFc B-Gene +
and O +
IL-4 B-Gene +
continued O +
to O +
develop O +
diabetes O +
. O +

Furthermore O +
, O +
disease O +
prevention O +
correlated O +
with O +
suppression O +
of O +
insulitis O +
and O +
induction O +
of O +
GAD65 B-Gene +
- O +
specific O +
regulatory O +
Th2 O +
cells O +
. O +

Importantly O +
, O +
GAD65 B-Gene +
- O +
specific O +
immune O +
deviation O +
was O +
dependent O +
on O +
pDNA O +
- O +
encoded O +
IL-4 B-Gene +
. O +

In O +
fact O +
, O +
GAD65 B-Gene +
- O +
specific O +
Th1 O +
cell O +
reactivity O +
was O +
significantly O +
enhanced O +
in O +
animals O +
immunized O +
with O +
pDNA O +
encoding O +
only O +
GAD65 B-Gene +
- O +
IgGFc B-Gene +
. O +

Finally O +
, O +
NOD O +
. O +
IL4 B-Gene +
( O +
null O +
) O +
mice O +
treated O +
with O +
pDNA O +
encoding O +
GAD65 B-Gene +
- O +
IgGFc B-Gene +
and O +
IL-4 B-Gene +
continued O +
to O +
develop O +
diabetes O +
, O +
indicating O +
that O +
endogenous O +
IL-4 B-Gene +
was O +
also O +
required O +
for O +
disease O +
prevention O +
. O +

These O +
results O +
demonstrate O +
that O +
pDNA O +
vaccination O +
is O +
an O +
effective O +
strategy O +
to O +
elicit O +
beta O +
cell O +
- O +
specific O +
Th2 O +
regulatory O +
cell O +
function O +
for O +
the O +
purpose O +
of O +
preventing O +
IDDM O +
even O +
at O +
a O +
late O +
stage O +
of O +
disease O +
development O +
. O +

Interleukin B-Gene +
1 I-Gene +
beta I-Gene +
( O +
IL-1 B-Gene +
beta I-Gene +
) O +
action O +
in O +
porcine O +
thyroid O +
cells O +
involves O +
the O +
ceramide O +
signalling O +
pathway O +
. O +

Interleukin B-Gene +
1 I-Gene +
beta I-Gene +
( O +
IL-1beta B-Gene +
) O +
is O +
often O +
associated O +
with O +
thyroidal O +
autoimmune O +
diseases O +
. O +

This O +
cytokine B-Gene +
has O +
been O +
largely O +
described O +
to O +
trigger O +
an O +
important O +
biological O +
signalling O +
pathway O +
: O +
the O +
sphingomyelin O +
/ O +
ceramide O +
pathway O +
. O +

In O +
this O +
report O +
we O +
show O +
that O +
IL-1beta B-Gene +
induces O +
ceramide O +
formation O +
and O +
sphingomyelin O +
degradation O +
in O +
porcine O +
thyroid O +
cells O +
via O +
the O +
activation O +
of O +
a O +
neutral B-Gene +
sphingomyelinase I-Gene +
. O +

Among O +
the O +
potential O +
targets O +
of O +
IL-1beta B-Gene +
and O +
ceramides O +
action O +
, O +
we O +
have O +
investigated O +
the O +
role O +
of O +
an O +
atypical B-Gene +
protein I-Gene +
kinase I-Gene +
C I-Gene +
( O +
PKC B-Gene +
) O +
, O +
the O +
PKC B-Gene +
zeta I-Gene +
. O +

We O +
show O +
that O +
both O +
IL-1beta B-Gene +
and O +
ceramides O +
lead O +
to O +
an O +
increase O +
of O +
PKCzeta B-Gene +
activity O +
. O +

All O +
these O +
results O +
suggest O +
an O +
important O +
role O +
for O +
ceramides O +
and O +
IL-1beta B-Gene +
in O +
regulation O +
of O +
thyroid O +
function O +
, O +
leading O +
to O +
cell O +
survival O +
or O +
to O +
apoptosis O +
. O +

N O -
- O -
linked O +
carbohydrate O +
on O +
human B-Gene +
leukocyte I-Gene +
antigen I-Gene +
- I-Gene +
C I-Gene +
and O +
recognition O +
by O +
natural O +
killer O +
cell O +
inhibitory O +
receptors O +
. O +

The O +
possible O +
role O +
of O +
carbohydrate O +
in O +
the O +
interaction O +
of O +
HLA B-Gene -
- I-Gene -
C I-Gene +
with O +
a O +
human O +
inhibitory O +
natural O +
Killer B-Gene +
cell I-Gene +
Immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
Receptor I-Gene +
with O +
two O +
Ig B-Gene +
domains O +
, O +
KIR2DL1 B-Gene +
, O +
was O +
investigated O +
. O +

Transfectants O +
of O +
721.221 O +
( O +
a O +
class B-Gene +
I I-Gene +
MHC I-Gene +
- O +
negative O +
human O +
B O +
cell O +
line O +
) O +
expressing O +
only O +
HLA B-Gene -
- I-Gene -
Cw4 I-Gene +
or I-Gene +
- I-Gene +
Cw6 I-Gene +
or O +
their O +
respective O +
non O +
- O +
glycosylated O +
mutants O +
( O +
N86Q O +
, O +
S88A O +
) O +
were O +
made O +
. O +

The O +
binding O +
of O +
a O +
KIR2DL1 B-Gene +
- O +
Ig B-Gene +
fusion O +
protein O +
to O +
the O +
non O +
- O +
glycosylated O +
mutant O +
HLA B-Gene -
- I-Gene -
Cw4 I-Gene +
- I-Gene +
or I-Gene +
-Cw6 I-Gene +
- O +
expressing O +
cells O +
was O +
markedly O +
decreased O +
compared O +
to O +
the O +
wild O +
type O +
- O +
expressing O +
cells O +
. O +

The O +
ability O +
to O +
induce O +
an O +
inhibitory O +
signal O +
in O +
the O +
NK O +
tumor O +
line O +
YTS O +
transfected O +
with O +
KIR2DL1 B-Gene +
was O +
also O +
impaired O +
in O +
the O +
nonglycosylated O +
mutant O +
expressing O +
cells O +
. O +

Furthermore O +
, O +
in O +
a O +
second O +
functional O +
assay O +
, O +
mutant O +
HLA B-Gene -
- I-Gene -
Cw4 I-Gene +
and I-Gene +
- I-Gene +
Cw6 I-Gene +
molecules O +
had O +
impaired O +
ability O +
to O +
induce O +
signal O +
transduction O +
in O +
BW O +
cells O +
expressing O +
a O +
KIR2DL1 B-Gene +
- O +
CD3 B-Gene +
zeta I-Gene +
chain O +
chimeric O +
protein O +
. O +

Thus O +
, O +
the O +
deletion O +
of O +
the O +
N O +
- O +
linked O +
glycosylation O +
signal O +
in O +
HLA B-Gene -
- I-Gene -
Cw4 I-Gene +
and I-Gene +
- I-Gene +
Cw6 I-Gene +
greatly O +
reduced O +
recognition O +
by O +
KIR2DL1 B-Gene +
. O +

Alternative O +
interpretations O +
of O +
the O +
data O +
are O +
discussed O +
. O +

Identification O +
and O +
molecular O +
characterization O +
of O +
a O +
natural O +
mutant O +
of O +
the O +
p50.2 B-Gene +
/ O +
KIR2DS2 B-Gene +
activating O +
NK O +
receptor O +
that O +
fails O +
to O +
mediate O +
NK O +
cell O +
triggering O +
. O +

P50 B-Gene +
/ O +
KIR2DS B-Gene +
molecules O +
represent O +
the O +
activating O +
form O +
of O +
the O +
HLA B-Gene -
- I-Gene -
C I-Gene +
- O +
specific O +
inhibitory O +
NK O +
receptors O +
. O +

They O +
are O +
characterized O +
, O +
in O +
the O +
transmembrane O +
portion O +
, O +
by O +
a O +
charged O +
amino O +
acid O +
that O +
is O +
involved O +
in O +
coupling O +
with O +
signal O +
- O +
transducing O +
adaptor O +
polypeptides O +
. O +

In O +
this O +
study O +
we O +
identified O +
a O +
novel O +
p50.2 B-Gene +
/ O +
KIR2DS2 B-Gene +
surface O +
molecule O +
, O +
isolated O +
from O +
NK O +
cell O +
clones O +
derived O +
from O +
an O +
otherwise O +
normal O +
donor O +
, O +
that O +
was O +
unable O +
to O +
transduce O +
activating O +
signals O +
. O +

Sequence O +
analysis O +
of O +
the O +
cDNA O +
encoding O +
this O +
molecule O +
revealed O +
six O +
non O +
- O +
conservative O +
codon O +
mutations O +
in O +
the O +
exon O +
coding O +
for O +
the O +
putative O +
transmembrane O +
portion O +
. O +

Notably O +
, O +
one O +
of O +
such O +
mutations O +
involved O +
the O +
charged O +
residue O +
lysine O +
thought O +
to O +
be O +
important O +
for O +
the O +
association O +
with O +
signal O +
- O +
transducing O +
polypeptides O +
. O +

Indeed O +
, O +
co O +
- O +
transfection O +
experiments O +
revealed O +
that O +
this O +
naturally O +
occurring O +
p50.2 B-Gene +
/ O +
KIR2DS2 B-Gene +
mutant O +
, O +
termed O +
Mp50.2 O +
, O +
displayed O +
a O +
sharply O +
reduced O +
ability O +
to O +
associate O +
with O +
DAP12 B-Gene +
polypeptides O +
. O +

These O +
data O +
provide O +
the O +
first O +
in O +
vivo O +
demonstration O +
of O +
the O +
crucial O +
role O +
played O +
by O +
the O +
transmembrane O +
region O +
of O +
p50.2 B-Gene +
receptor O +
molecules O +
in O +
the O +
functional O +
association O +
with O +
DAP12 B-Gene +
adaptor O +
molecules O +
and O +
in O +
the O +
process O +
of O +
activation O +
of O +
NK O +
- O +
mediated O +
cytotoxicity O +
. O +

The O +
molecular O +
basis O +
of O +
3-methylcrotonylglycinuria O +
, O +
a O +
disorder O +
of O +
leucine O +
catabolism O +
. O +

3-Methylcrotonylglycinuria O +
is O +
an O +
inborn O +
error O +
of O +
leucine O +
catabolism O +
and O +
has O +
a O +
recessive O +
pattern O +
of O +
inheritance O +
that O +
results O +
from O +
the O +
deficiency O +
of O +
3-methylcrotonyl B-Gene -
- I-Gene -
CoA I-Gene +
carboxylase I-Gene +
( O +
MCC B-Gene +
) O +
. O +

The O +
introduction O +
of O +
tandem O +
mass O +
spectrometry O +
in O +
newborn O +
screening O +
has O +
revealed O +
an O +
unexpectedly O +
high O +
incidence O +
of O +
this O +
disorder O +
, O +
which O +
, O +
in O +
certain O +
areas O +
, O +
appears O +
to O +
be O +
the O +
most O +
frequent O +
organic O +
aciduria O +
. O +

MCC B-Gene +
, O +
an O +
heteromeric O +
enzyme O +
consisting O +
of O +
alpha O +
( O +
biotin O +
- O +
containing O +
) O +
and O +
beta O +
subunits O +
, O +
is O +
the O +
only O +
one O +
of O +
the O +
four O +
biotin O +
- O +
dependent O +
carboxylases B-Gene +
known O +
in O +
humans O +
that O +
has O +
genes O +
that O +
have O +
not O +
yet O +
been O +
characterized O +
, O +
precluding O +
molecular O +
studies O +
of O +
this O +
disease O +
. O +

Here O +
we O +
report O +
the O +
characterization O +
, O +
at O +
the O +
genomic O +
level O +
and O +
at O +
the O +
cDNA O +
level O +
, O +
of O +
both O +
the O +
MCCA B-Gene +
gene O +
and O +
the O +
MCCB B-Gene +
gene O +
, O +
encoding O +
the O +
MCC B-Gene +
alpha I-Gene +
and O +
MCC B-Gene +
beta I-Gene +
subunits O +
, O +
respectively O +
. O +

The O +
19 O +
- O +
exon O +
MCCA B-Gene +
gene O +
maps O +
to O +
3q25 O -
- O -
27 O +
and O +
encodes O +
a O +
725 O +
- O +
residue O +
protein O +
with O +
a O +
biotin O +
attachment O +
site O +
; O +
the O +
17-exon O +
MCCB B-Gene +
gene O +
maps O +
to O +
5q12 O +
- O +
q13 O +
and O +
encodes O +
a O +
563 O +
- O +
residue O +
polypeptide O +
. O +

We O +
show O +
that O +
disease O +
- O +
causing O +
mutations O +
can O +
be O +
classified O +
into O +
two O +
complementation O +
groups O +
, O +
denoted O +
" O +
CGA O +
" O +
and O +
" O +
CGB O -
. O +
" O +

We O +
detected O +
two O +
MCCA B-Gene +
missense O +
mutations O +
in O +
CGA O +
patients O +
, O +
one O +
of O +
which O +
leads O +
to O +
absence O +
of O +
biotinylated O +
MCC B-Gene +
alpha I-Gene +
. O +

Two O +
MCCB B-Gene +
missense O +
mutations O +
and O +
one O +
splicing O +
defect O +
mutation O +
leading O +
to O +
early O +
MCC B-Gene +
beta I-Gene +
truncation O +
were O +
found O +
in O +
CGB O +
patients O +
. O +

A O +
fourth O +
MCCB B-Gene +
mutation O +
also O +
leading O +
to O +
early O +
MCC B-Gene +
beta I-Gene +
truncation O +
was O +
found O +
in O +
two O +
nonclassified O +
patients O +
. O +

A O +
fungal O +
model O +
carrying O +
an O +
mccA B-Gene +
null O +
allele O +
has O +
been O +
constructed O +
and O +
was O +
used O +
to O +
demonstrate O +
, O +
in O +
vivo O +
, O +
the O +
involvement O +
of O +
MCC B-Gene +
in O +
leucine O +
catabolism O +
. O +

These O +
results O +
establish O +
that O +
3-methylcrotonylglycinuria O +
results O +
from O +
loss O +
- O +
of O +
- O +
function O +
mutations O +
in O +
the O +
genes O +
encoding O +
the O +
alpha B-Gene +
and I-Gene +
beta I-Gene +
subunits I-Gene +
of I-Gene +
MCC I-Gene +
and O +
complete O +
the O +
genetic O +
characterization O +
of O +
the O +
four O +
human O +
biotin O +
- O +
dependent O +
carboxylases B-Gene +
. O +

Interleukin-6 B-Gene +
and O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
beta I-Gene +
1 I-Gene +
control O +
expression O +
of O +
cathepsins B-Gene +
B I-Gene +
and I-Gene +
L I-Gene +
in O +
human O +
lung O +
epithelial O +
cells O +
. O +

Cathepsins B-Gene +
B I-Gene +
and I-Gene +
L I-Gene +
are O +
commonly O +
expressed O +
cysteine B-Gene +
proteinases I-Gene +
that O +
play O +
a O +
major O +
role O +
in O +
lysosomal O +
bulk O +
proteolysis O +
, O +
protein O +
processing O +
, O +
matrix O +
degradation O +
, O +
and O +
tissue O +
remodeling O +
. O +

Cathepsins B-Gene +
are O +
also O +
implicated O +
in O +
tumor O +
progression O +
and O +
metastasis O +
, O +
tissue O +
injury O +
, O +
and O +
inflammation O +
. O +

Cells O +
at O +
sites O +
of O +
inflammation O +
often O +
show O +
upregulation O +
and O +
secretion O +
of O +
cathepsins B-Gene +
. O +

The O +
regulation O +
of O +
cathepsin B-Gene +
expression O +
by O +
inflammatory O +
mediators O +
is O +
not O +
well O +
understood O +
. O +

The O +
aims O +
of O +
this O +
study O +
were O +
to O +
investigate O +
the O +
effect O +
of O +
the O +
cytokines B-Gene +
interleukin-1 B-Gene +
beta I-Gene +
( O +
IL-1 B-Gene +
beta I-Gene +
) O +
, O +
IL-6 B-Gene +
, O +
IL-10 B-Gene +
, O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
beta I-Gene +
1 I-Gene +
( O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
1 I-Gene +
) O +
, O +
and O +
hepatocyte B-Gene +
growth I-Gene +
factor I-Gene +
( O +
HGF B-Gene +
) O +
on O +
expression O +
of O +
cathepsin B-Gene +
B I-Gene +
and O +
cathepsin B-Gene +
L I-Gene +
mRNA O +
( O +
quantitative O +
RT O +
- O +
PCR O +
) O +
, O +
on O +
protein O +
expression O +
( O +
ELISA O +
, O +
Western O +
blot O +
) O +
, O +
and O +
also O +
on O +
enzymatic O +
activity O +
of O +
cathepsins B-Gene +
B I-Gene +
and I-Gene +
L I-Gene +
. O +

Investigations O +
were O +
performed O +
using O +
the O +
human O +
lung O +
epithelial O +
cell O +
line O +
A-549 O +
. O +

IL-6 B-Gene +
was O +
found O +
to O +
induce O +
a O +
concentration O +
- O +
dependent O +
increase O +
in O +
mRNA O +
expression O +
, O +
protein O +
concentration O +
, O +
and O +
enzymatic O +
activity O +
of O +
cathepsin B-Gene +
L I-Gene +
. O +

Cathepsin B-Gene +
B I-Gene +
mRNA O +
and O +
protein O +
expression O +
were O +
not O +
affected O +
by O +
IL-6 B-Gene +
. O +

In O +
contrast O +
, O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
1 I-Gene +
decreased O +
the O +
amount O +
of O +
cathepsin B-Gene +
L I-Gene +
mRNA O +
and O +
cathepsin B-Gene +
B I-Gene +
mRNA O +
. O +

At O +
protein O +
level O +
, O +
it O +
was O +
shown O +
that O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
1 I-Gene +
clearly O +
reduced O +
the O +
concentration O +
of O +
cathepsin B-Gene +
L I-Gene +
but O +
not O +
cathepsin B-Gene +
B I-Gene +
. O +

The O +
cytokines B-Gene +
IL-1 B-Gene +
beta I-Gene +
, O +
IL-10 B-Gene +
, O +
and O +
HGF B-Gene +
were O +
found O +
to O +
exert O +
no O +
effect O +
on O +
cathepsin B-Gene +
B I-Gene +
and I-Gene +
L I-Gene +
expression O +
. O +

In O +
conclusion O +
, O +
these O +
results O +
are O +
the O +
first O +
to O +
show O +
that O +
IL-6 B-Gene +
and O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
1 I-Gene +
have O +
opposite O +
effects O +
on O +
the O +
regulation O +
of O +
expression O +
of O +
cathepsins B-Gene +
B I-Gene +
and I-Gene +
L I-Gene +
in O +
A-549 O +
human O +
lung O +
epithelial O +
cells O +
. O +

The O +
proinflammatory O +
cytokine B-Gene +
IL-6 B-Gene +
induced O +
an O +
upregulation O +
of O +
cathepsin B-Gene +
L I-Gene +
, O +
whereas O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
1 I-Gene +
suppressed O +
cathepsin B-Gene +
B I-Gene +
and I-Gene +
L I-Gene +
expression O +
. O +

Further O +
studies O +
are O +
needed O +
to O +
clarify O +
the O +
mechanism O +
that O +
affects O +
cathepsin B-Gene +
B I-Gene +
and I-Gene +
L I-Gene +
expression O +
. O +

Identification O +
of O +
clathrin B-Gene +
- I-Gene +
adaptor I-Gene +
medium I-Gene +
chains O +
in O +
Dictyostelium O +
discoideum O +
: O +
differential O +
expression O +
during O +
development O +
. O +

Clathrin B-Gene +
- I-Gene +
adaptor I-Gene +
complexes I-Gene +
( O +
APs B-Gene +
) O +
are O +
vesicle O +
coat O +
components O +
that O +
participate O +
in O +
cargo O +
selectivity O +
and O +
transport O +
vesicle O +
formation O +
. O +

Here O +
we O +
cloned O +
and O +
characterized O +
apm1 B-Gene +
, O +
apm3 B-Gene +
and O +
apm4 B-Gene +
cDNAs O +
encoding O +
AP B-Gene +
medium I-Gene +
chains O +
( O +
mu B-Gene +
) O +
in O +
D. O +
discoideum O +
. O +

Amino O +
acid O +
comparison O +
suggested O +
that O +
predicted O +
proteins O +
were O +
homologous O +
to O +
known O +
mu1 B-Gene +
, O +
mu3 B-Gene +
and O +
mu4 B-Gene +
subunits O +
of O +
mammalian O +
APs B-Gene +
as O +
they O +
shared O +
69 O +
, O +
51 O +
, O +
and O +
26 O +
% O +
identity O +
with O +
mouse O +
mu1A B-Gene +
, O +
human O +
mu3A B-Gene +
and O +
human O +
mu4 B-Gene +
, O +
respectively O +
. O +

In O +
all O +
chains O +
, O +
amino O +
acid O +
residues O +
predicted O +
to O +
interact O +
with O +
tyrosine O +
based O +
sorting O +
signals O +
were O +
conserved O +
. O +

Southern O +
blot O +
analysis O +
indicated O +
only O +
one O +
copy O +
of O +
each O +
gene O +
in O +
D. O +
discoideum O +
genome O +
. O +

Expression O +
of O +
apm1 B-Gene +
and O +
apm3 B-Gene +
mRNAs O +
stayed O +
relatively O +
constant O +
during O +
vegetative O +
growth O +
and O +
throughout O +
development O +
. O +

In O +
contrast O +
, O +
apm4 B-Gene +
was O +
poorly O +
expressed O +
in O +
amoebae O +
but O +
became O +
well O +
detectable O +
by O +
RT O +
- O +
PCR O +
upon O +
cell O +
differentiation O +
. O +

This O +
regulated O +
expression O +
of O +
coat O +
proteins O +
enlightens O +
the O +
importance O +
of O +
intracellular O +
membrane O +
transport O +
vesicles O +
during O +
development O +
in O +
D. O +
discoideum O +
and O +
strengthens O +
this O +
attractive O +
model O +
organism O +
for O +
studying O +
the O +
function O +
of O +
coat O +
complexes O +
in O +
vivo O +
. O +

Characterization O +
of O +
promoter O +
region O +
and O +
genomic O +
structure O +
of O +
the O +
murine O +
and O +
human O +
genes O +
encoding O +
Src B-Gene +
like I-Gene +
adapter I-Gene +
protein I-Gene +
. O +

Src B-Gene +
- I-Gene +
like I-Gene +
adapter I-Gene +
protein I-Gene +
( O +
SLAP B-Gene +
) O +
was O +
identified O +
as O +
a O +
signaling O +
molecule O +
in O +
a O +
yeast O +
two O +
- O +
hybrid O +
system O +
using O +
the O +
cytoplasmic O +
domain O +
of O +
EphA2 B-Gene +
, O +
a O +
receptor B-Gene +
protein I-Gene +
tyrosine I-Gene +
kinase I-Gene +
( O +
Pandey O +
et O +
al. O +
, O +
1995 O -
. O +
Characterization O +
of O +
a O +
novel O +
Src B-Gene +
- I-Gene +
like I-Gene +
adapter I-Gene +
protein I-Gene +
that O +
associates O +
with O +
the O +
Eck B-Gene +
receptor B-Gene +
tyrosine I-Gene +
kinase I-Gene +
. O +
J. O +
Biol O -
. O +
Chem O -
. O +
270 O +
, O +
19201 O +
- O +
19204 O +
) O +
. O +

It O +
is O +
very O +
similar O +
to O +
members O +
of O +
the O +
Src B-Gene +
family I-Gene +
of O +
cytoplasmic O +
tyrosine B-Gene +
kinases I-Gene +
in O +
that O +
it O +
contains O +
very O +
homologous O +
SH3 O +
and O +
SH2 O +
domains O +
( O +
Abram O +
and O +
Courtneidge O +
, O +
2000 O -
. O +
Src B-Gene +
family I-Gene +
tyrosine I-Gene +
kinases I-Gene +
and O +
growth B-Gene +
factor I-Gene +
signaling O -
. O +
Exp O -
. O +
Cell O -
. O +
Res O -
. O +
254 O +
, O +
1 O +
- O +
13 O -
. O +
) O +
. O +

However O +
, O +
instead O +
of O +
a O +
kinase B-Gene +
domain O +
at O +
the O +
C O +
- O +
terminus O +
, O +
it O +
contains O +
a O +
unique O +
C O +
- O +
terminal O +
region O +
. O +

In O +
order O +
to O +
exclude O +
the O +
possibility O +
that O +
an O +
alternative O +
form O +
exists O +
, O +
we O +
have O +
isolated O +
genomic O +
clones O +
containing O +
the O +
murine O +
Slap B-Gene +
gene O +
as O +
well O +
as O +
the O +
human O +
SLA B-Gene +
gene O +
. O +

The O +
coding O +
regions O +
of O +
murine O +
Slap B-Gene +
and O +
human O +
SLA B-Gene +
genes O +
contain O +
seven O +
exons O +
and O +
six O +
introns O +
. O +

Absence O +
of O +
any O +
kinase B-Gene +
domain O +
in O +
the O +
genomic O +
region O +
confirm O +
its O +
designation O +
as O +
an O +
adapter B-Gene +
protein I-Gene +
. O +

Additionally O +
, O +
we O +
have O +
cloned O +
and O +
sequenced O +
approximately O +
2.6 O +
kb O +
of O +
the O +
region O +
5 O -
' O +
to O +
the O +
initiator O +
methionine O +
of O +
the O +
murine O +
Slap B-Gene +
gene O +
. O +

When O +
subcloned O +
upstream O +
of O +
a O +
luciferase B-Gene +
gene O +
, O +
this O +
fragment O +
increased O +
the O +
transcriptional O +
activity O +
about O +
6 O +
- O +
fold O +
in O +
a O +
human O +
Jurkat O +
T O +
cell O +
line O +
and O +
approximately O +
52 O +
- O +
fold O +
in O +
a O +
murine O +
T O +
cell O +
line O +
indicating O +
that O +
this O +
region O +
contains O +
promoter O +
elements O +
that O +
dictate O +
SLAP B-Gene +
expression O +
. O +

We O +
have O +
also O +
cloned O +
the O +
promoter O +
region O +
of O +
the O +
human O +
SLA B-Gene +
gene O +
. O +

Since O +
SLAP B-Gene +
is O +
transcriptionally O +
regulated O +
by O +
retinoic O +
acid O +
and O +
by O +
activation O +
of O +
B O +
cells O +
, O +
the O +
cloning O +
of O +
its O +
promoter O +
region O +
will O +
permit O +
a O +
detailed O +
analysis O +
of O +
the O +
elements O +
required O +
for O +
its O +
transcriptional O +
regulation O +
. O +

Nephrogenic O +
diabetes O +
insipidus O +
. O +

Nephrogenic O +
diabetes O +
insipidus O +
, O +
which O +
can O +
be O +
inherited O +
or O +
acquired O +
, O +
is O +
characterized O +
by O +
an O +
inability O +
to O +
concentrate O +
urine O +
despite O +
normal O +
or O +
elevated O +
plasma O +
concentrations O +
of O +
the O +
antidiuretic O +
hormone O +
arginine B-Gene +
vasopressin I-Gene +
. O +

Polyuria O +
, O +
with O +
hyposthenuria O +
, O +
and O +
polydipsia O +
are O +
the O +
cardinal O +
clinical O +
manifestations O +
of O +
the O +
disease O +
. O +

About O +
90 O +
% O +
of O +
patients O +
with O +
congenital O +
nephrogenic O +
diabetes O +
insipidus O +
are O +
males O +
with O +
the O +
X O +
- O +
linked O +
recessive O +
form O +
of O +
the O +
disease O +
( O +
OMIM O +
304800 O +
) O +
who O +
have O +
mutations O +
in O +
the O +
arginine B-Gene +
vasopressin I-Gene +
receptor I-Gene +
2 I-Gene +
gene O +
( O +
AVPR2 B-Gene +
) O +
, O +
which O +
codes O +
for O +
the O +
vasopressin B-Gene +
V2 I-Gene +
receptor I-Gene +
. O +

The O +
gene O +
is O +
located O +
in O +
chromosomal O +
region O +
Xq28 O +
. O +

In O +
< O +
10 O +
% O +
of O +
the O +
families O +
studied O +
, O +
congenital O +
nephrogenic O +
diabetes O +
insipidus O +
has O +
an O +
autosomal O +
- O +
recessive O +
or O +
autosomal O +
- O +
dominant O +
( O +
OMIM O +
222000 O +
and O +
125800 O +
, O +
respectively O +
) O +
mode O +
of O +
inheritance O +
. O +

Mutations O +
have O +
been O +
identified O +
in O +
the O +
aquaporin-2 B-Gene +
gene O +
( O +
AQP2 B-Gene +
) O +
, O +
which O +
is O +
located O +
in O +
chromosome O +
region O +
12q13 O +
and O +
codes O +
for O +
the O +
vasopressin B-Gene +
- O +
sensitive O +
water B-Gene +
channel I-Gene +
. O +

When O +
studied O +
in O +
vitro O +
, O +
most O +
AVPR2 B-Gene +
mutations O +
result O +
in O +
receptors O +
that O +
are O +
trapped O +
intracellularly O +
and O +
are O +
unable O +
to O +
reach O +
the O +
plasma O +
membrane O +
. O +

A O +
few O +
mutant O +
receptors O +
reach O +
the O +
cell O +
surface O +
but O +
are O +
unable O +
to O +
bind O +
arginine B-Gene +
vasopressin I-Gene +
or O +
to O +
properly O +
trigger O +
an O +
intracellular O +
cyclic O +
AMP O +
signal O +
. O +

Similarly O +
, O +
aquaporin-2 B-Gene +
mutant O +
proteins O +
are O +
misrouted O +
and O +
can O -
not O +
be O +
expressed O +
at O +
the O +
luminal O +
membrane O +
. O +

Chemical O +
or O +
pharmacological O +
chaperones O +
have O +
been O +
found O +
to O +
reverse O +
the O +
intracellular O +
retention O +
of O +
aquaporin-2 B-Gene +
and O +
arginine B-Gene +
vasopressin I-Gene +
receptor I-Gene +
2 I-Gene +
mutant O +
proteins O +
. O +

Because O +
many O +
hereditary O +
diseases O +
stem O +
from O +
the O +
intracellular O +
retention O +
of O +
otherwise O +
functional O +
proteins O +
, O +
this O +
mechanism O +
may O +
offer O +
a O +
new O +
therapeutic O +
approach O +
to O +
the O +
treatment O +
of O +
those O +
diseases O +
that O +
result O +
from O +
errors O +
in O +
protein O +
kinesis O +
. O +

Trifunctional B-Gene +
protein I-Gene +
deficiency O +
: O +
three O +
families O +
with O +
significant O +
maternal O +
hepatic O +
dysfunction O +
in O +
pregnancy O +
not O +
associated O +
with O +
E474Q O +
mutation O +
. O +

We O +
report O +
five O +
families O +
with O +
trifunctional B-Gene +
protein I-Gene +
deficiency O +
in O +
which O +
, O +
during O +
pregnancy O +
, O +
three O +
mothers O +
experienced O +
significant O +
hepatic O +
disease O +
when O +
carrying O +
an O +
affected O +
fetus O +
. O +

Diagnoses O +
were O +
based O +
on O +
increased O +
levels O +
of O +
long O +
- O +
chain O +
hydroxyacylcarnitines O +
and O +
deficiencies O +
of O +
3-hydroxyacyl B-Gene -
- I-Gene -
CoA I-Gene +
dehydrogenase I-Gene +
( O +
LCHAD B-Gene +
) O +
and O +
3-ketoacyl B-Gene -
- I-Gene -
CoA I-Gene +
thiolase I-Gene +
activity O +
in O +
fibroblasts O +
. O +

All O +
affected O +
infants O +
lacked O +
the O +
common O +
E474Q O +
mutation O +
associated O +
with O +
isolated O +
LCHAD B-Gene +
deficiency O +
. O +

This O +
mutation O +
is O +
thought O +
to O +
be O +
a O +
predisposing O +
factor O +
for O +
maternal O +
hepatic O +
disease O +
in O +
pregnancy O +
. O +

Our O +
findings O +
suggest O +
that O +
other O +
defects O +
in O +
this O +
enzyme O +
complex O +
might O +
be O +
responsible O +
for O +
maternal O +
hepatic O +
complications O +
in O +
pregnancy O +
. O +

Ku B-Gene +
autoantigen I-Gene +
( O +
DNA B-Gene +
helicase I-Gene +
) O +
is O +
required O +
for O +
interleukins B-Gene +
- I-Gene +
13 I-Gene +
/ I-Gene +
- I-Gene +
4 I-Gene +
- O +
induction O +
of O +
15-lipoxygenase-1 B-Gene +
gene O +
expression O +
in O +
human O +
epithelial O +
cells O +
. O +

As O +
reported O +
previously O +
in O +
human O +
monocytes O +
, O +
a O +
human O +
lung O +
epithelial O +
cell O +
line O +
, O +
A549 O +
, O +
showed O +
de O +
novo O +
induction O +
of O +
15-Lipoxygenase-1 B-Gene +
( O +
15-LO-1 B-Gene +
) O +
in O +
response O +
to O +
interleukins B-Gene +
- I-Gene +
13 I-Gene +
( I-Gene +
IL-13 I-Gene +
) I-Gene +
and I-Gene +
- I-Gene +
4 I-Gene +
( O +
IL-4 B-Gene +
) O +
. O +

In O +
this O +
cell O +
line O +
, O +
15-LO-1 B-Gene +
expression O +
, O +
by O +
RT O +
- O +
PCR O +
and O +
western O +
blotting O +
, O +
was O +
observed O +
following O +
6 O +
and O +
24 O +
h O +
of O +
exposure O +
to O +
human O +
IL-13 B-Gene +
( O +
ED50 O +
5 O +
ng O +
/ O +
ml O +
) O +
and O +
IL-4 B-Gene +
( O +
ED50 O +
0.2 O +
ng O +
/ O +
ml O +
) O +
. O +

We O +
have O +
previously O +
shown O +
that O +
no O +
cis O +
- O +
acting O +
regulatory O +
elements O +
exist O +
within O +
the O +
15-LO-1 B-Gene +
promoter O +
region O +
. O +

To O +
define O +
IL-13 B-Gene +
and O +
IL-4 B-Gene +
responsive O +
trans O +
- O +
acting O +
elements O +
, O +
we O +
identified O +
a O +
region O +
( O +
DP2 O +
: O +
- O +
353 O +
to O +
- O +
304 O +
bp O +
site O +
) O +
within O +
the O +
15-LO-1 B-Gene +
promoter O +
( O +
by O +
footprinting O +
experiments O +
) O +
to O +
which O +
IL-13 B-Gene +
- O +
responsive O +
elements O +
( O +
or O +
factors O +
) O +
bind O +
specifically O +
( O +
Kelavkar O +
et O +
al O +
, O +
1998 O +
, O +
Mol O +
Biol O +
Rep O +
25 O +
, O +
173 O +
- O +
182 O +
) O +
. O +

To O +
further O +
delineate O +
this O +
region O +
, O +
we O +
constructed O +
( O +
by O +
site O +
- O +
directed O +
mutagenesis O +
) O +
several O +
deletion O +
mutants O +
in O +
the O +
' O +
LOPB5 O +
' O +
region O +
containing O +
the O +
29 O +
bp O +
within O +
the O +
- O +
353 O +
to O +
- O +
304 O +
bp O +
of O +
the O +
DP2 O +
core O +
element O +
. O +

These O +
were O +
: O +
DP3 O +
( O +
site O +
totally O +
deleted O +
) O +
, O +
DP4 O +
( O +
5 O +
bp O +
deleted O +
at O +
the O +
center O +
of O +
the O +
site O +
) O +
, O +
DP5 O +
( O +
8 O +
bp O +
at O +
the O +
5'-end O +
of O +
the O +
site O +
) O +
and O +
DP6 O +
( O +
13 O +
bp O +
at O +
the O +
3 O -
' O +
- O +
end O +
of O +
the O +
site O +
) O +
. O +

Cotransfection O +
of O +
these O +
deletion O +
constructs O +
( O +
driving O +
luciferase B-Gene +
reporter O +
genes O +
) O +
was O +
associated O +
with O +
90 O +
% O +
( O +
DP4 O +
, O +
DP5 O +
and O +
DP6 O +
) O +
or O +
100 O +
% O +
( O +
DP3 O +
) O +
abrogation O +
of O +
promoter O +
activity O +
at O +
24 O +
h O +
. O +

Purification O +
of O +
nuclear O +
protein O +
extracts O +
from O +
IL-13 B-Gene +
and O +
IL-4 B-Gene +
- O +
stimulated O +
A549 O +
cells O +
, O +
using O +
a O +
DP2 O +
core O +
containing O +
affinity O +
column O +
, O +
identified O +
a O +
150 O +
kDa O +
protein O +
under O +
non O +
- O +
denaturing O +
conditions O +
, O +
and O +
two O +
, O +
70 O +
and O +
85 O +
kDa O +
proteins O +
under O +
denaturing O +
conditions O +
. O +

These O +
were O +
not O +
detectable O +
by O +
Coomassie O +
blue O +
staining O +
in O +
control O +
nuclear O +
protein O +
extracts O +
. O +

Matrix O +
assisted O +
laser O +
desorption O +
ionization O +
mass O +
spectrometry O +
( O +
MALDI O +
- O +
MS O +
) O +
of O +
the O +
tryptic O +
digests O +
of O +
these O +
proteins O +
, O +
identified O +
one O +
as O +
the O +
86 B-Gene +
kDA I-Gene +
Lupus I-Gene +
KU I-Gene +
autoantigen I-Gene +
protein I-Gene +
P86 I-Gene +
and O +
the O +
second O +
as O +
the O +
70 B-Gene +
kDa I-Gene +
Lupus I-Gene +
KU I-Gene +
autoantigen I-Gene +
protein I-Gene +
P70 I-Gene +
. O +

Gel O +
shift O +
and O +
supershift O +
experiments O +
using O +
monoclonal O +
antibodies O +
toward O +
Ku B-Gene +
antigen I-Gene +
and O +
its O +
individual O +
subunits O +
, O +
and O +
utilizing O +
DP2 O +
and O +
other O +
mutant O +
oligonucleotides O +
with O +
purified O +
nuclear O +
protein O +
extracts O +
from O +
control O +
and O +
cytokine B-Gene +
- O +
treated O +
A549 O +
cells O +
, O +
confirmed O +
our O +
findings O +
. O +

Furthermore O +
, O +
electroporation O +
of O +
neutralizing O +
anti O +
- O +
Ku70 B-Gene +
, O +
Ku B-Gene +
80 I-Gene +
and O +
Ku70 B-Gene +
/ I-Gene +
80 I-Gene +
antibodies O +
into O +
A549 O +
cells O +
totally O +
suppressed O +
IL-13 B-Gene +
and O +
IL-4 B-Gene +
- O +
stimulated O +
15-LO-1 B-Gene +
induction O +
in O +
these O +
cells O +
. O +

Further O +
, O +
immunoprecipitation O +
experiments O +
data O +
suggests O +
that O +
IL-4 B-Gene +
and O +
IL-13 B-Gene +
activate O +
Ku B-Gene +
antigens I-Gene +
and O +
15-LO-1 B-Gene +
expression O +
through O +
distinct O +
signaling O +
events O +
. O +

In O +
summary O +
, O +
in O +
A549 O +
cells O +
, O +
Ku B-Gene +
antigen I-Gene +
is O +
induced O +
in O +
response O +
to O +
the O +
cytokines O +
, O +
IL-13 B-Gene +
and I-Gene +
- I-Gene +
4 I-Gene +
, O +
and O +
a O +
29 O +
bp O +
region O +
within O +
the O +
- O +
353 O +
to O +
- O +
304 O +
bp O +
region O +
of O +
the O +
15-LO-1 B-Gene +
promoter O +
is O +
required O +
for O +
its O +
binding O +
and O +
subsequent O +
induction O +
of O +
15-LO-1 B-Gene +
gene O +
expression O +
. O +

The O +
findings O +
may O +
provide O +
an O +
important O +
link O +
between O +
the O +
established O +
dysregulated O +
function O +
of O +
Ku B-Gene +
antigen I-Gene +
in O +
auto O +
- O +
immune O +
diseases O +
, O +
such O +
as O +
systemic O +
lupus O +
erythematosus O +
and O +
thyroiditis O +
, O +
and O +
the O +
increasingly O +
recognized O +
' O +
anti O +
- O +
inflammatory O +
' O +
role O +
of O +
15-LO-1 B-Gene +
. O +

Different O +
NK O +
cell O +
surface O +
phenotypes O +
defined O +
by O +
the O +
DX9 O +
antibody O +
are O +
due O +
to O +
KIR3DL1 B-Gene +
gene O +
polymorphism O +
. O +

KIR3DL1 B-Gene +
and O +
KIR3DL2 B-Gene +
are O +
NK O +
cell O +
receptors O +
for O +
polymorphic O +
HLA B-Gene -
- I-Gene -
B I-Gene +
and I-Gene +
- I-Gene +
A I-Gene +
determinants O +
. O +

The O +
proportion O +
of O +
NK O +
cells O +
that O +
bind O +
anti O +
- O +
KIR3DL1 B-Gene +
- O +
specific O +
Ab O +
DX9 O +
and O +
their O +
level O +
of O +
binding O +
vary O +
between O +
individuals O +
. O +

To O +
determine O +
whether O +
these O +
differences O +
are O +
due O +
to O +
KIR B-Gene +
polymorphism O +
, O +
we O +
assessed O +
KIR3D B-Gene +
gene O +
diversity O +
in O +
unrelated O +
individuals O +
and O +
families O +
. O +

Both O +
KIR3DL1 B-Gene +
and O +
KIR3DL2 B-Gene +
are O +
highly O +
polymorphic O +
genes O +
, O +
with O +
KIR3DS1 B-Gene +
segregating O +
like O +
an O +
allele O +
of O +
KIR3DL1 B-Gene +
. O +

A O +
KIR B-Gene +
haplotype O +
lacking O +
KIR3DL1 B-Gene +
and O +
KIR3DS1 B-Gene +
was O +
defined O +
. O +

The O +
two O +
KIR3DL1 B-Gene +
alleles O +
of O +
a O +
heterozygous O +
donor O +
were O +
expressed O +
by O +
different O +
, O +
but O +
overlapping O +
, O +
subsets O +
of O +
NK O +
cell O +
clones O +
. O +

Sequence O +
variation O +
in O +
KIR3DL1 B-Gene +
and O +
KIR3DL2 B-Gene +
appear O +
distinct O +
; O +
recombination O +
is O +
more O +
evident O +
in O +
KIR3DL1 B-Gene +
, O +
and O +
point O +
mutation O +
is O +
more O +
evident O +
in O +
KIR3DL2 B-Gene +
. O +

The O +
KIR3DL1 B-Gene +
genotype O +
correlates O +
well O +
with O +
levels O +
of O +
DX9 O +
binding O +
by O +
NK O +
cells O +
, O +
but O +
not O +
with O +
the O +
frequency O +
of O +
DX9 O +
- O +
binding O +
cells O +
. O +

Different O +
KIR3DL1 B-Gene +
alleles O +
determine O +
high O +
, O +
low O +
, O +
and O +
no O +
binding O +
of O +
DX9 O +
Ab O +
. O +

Consequently O +
, O +
heterozygotes O +
for O +
high O +
and O +
low O +
binding O +
KIR3DL1 B-Gene +
alleles O +
have O +
distinct O +
subpopulations O +
of O +
NK O +
cells O +
that O +
bind O +
DX9 O +
at O +
high O +
and O +
low O +
levels O +
, O +
giving O +
characteristic O +
bimodal O +
distributions O +
in O +
flow O +
cytometry O +
. O +

The O +
Z27 O +
Ab O +
gave O +
binding O +
patterns O +
similar O +
to O +
those O +
of O +
DX9 O +
. O +

Four O +
KIR3DL1 B-Gene +
alleles O +
producing O +
high O +
DX9 O +
binding O +
phenotypes O +
were O +
distinguished O +
from O +
four O +
alleles O +
producing O +
low O +
or O +
no O +
binding O +
phenotypes O +
by O +
substitution O +
at O +
one O +
or O +
more O +
of O +
four O +
positions O +
in O +
the O +
encoded O +
protein O +
: O +
182 O +
and O +
283 O +
in O +
the O +
extracellular O +
Ig B-Gene +
- O +
like O +
domains O +
, O +
320 O +
in O +
the O +
transmembrane O +
region O +
, O +
and O +
373 O +
in O +
the O +
cytoplasmic O +
tail O +
. O +

Significance O +
of O +
endothelial O +
prostacyclin O +
and O +
nitric O +
oxide O +
in O +
peripheral O +
and O +
pulmonary O +
circulation O +
. O +

BACKGROUND O +
: O +

Vasoprotective O +
function O +
of O +
endothelial O +
cells O +
is O +
associated O +
, O +
among O +
others O +
, O +
with O +
biosynthesis O +
and O +
release O +
of O +
nitric O +
oxide O +
( O +
NO O +
) O +
, O +
prostacyclin O +
( O +
PGI2 O +
) O +
, O +
prostaglandin O +
E2 O +
( O +
PGE2 O +
) O +
, O +
carbon O +
monoxide O +
( O +
CO O +
) O +
and O +
plasminogen B-Gene +
activator I-Gene +
( O +
t B-Gene -
- I-Gene -
PA I-Gene +
) O +
. O +

These O +
endothelial O +
mediators O +
calm O +
down O +
activated O +
platelets O +
and O +
leukocytes O +
, O +
prevent O +
the O +
occurrence O +
of O +
parietal O +
thrombotic O +
events O +
, O +
promote O +
thrombolysis O +
, O +
maintain O +
tissue O +
perfusion O +
and O +
protect O +
vascular O +
wall O +
against O +
acute O +
damage O +
and O +
against O +
chronic O +
remodeling O +
. O +

Endothelial O +
dysfunction O +
in O +
patients O +
suffering O +
from O +
atherosclerosis O +
or O +
diabetes O +
type O +
2 O +
is O +
associated O +
not O +
only O +
with O +
suppression O +
in O +
release O +
of O +
the O +
above O +
mediators O +
but O +
also O +
with O +
deleterious O +
discharge O +
of O +
prostaglandin O +
endoperoxides O +
( O +
PGH2 O +
, O +
PGG2 O +
) O +
, O +
superoxide O +
anion O +
( O +
O2 O +
- O +
, O +
peroxynitrite O +
( O +
ONOO- O -
) O +
, O +
and O +
plasminogen B-Gene +
activator I-Gene +
inhibitor I-Gene +
( O +
PAI-1 B-Gene +
) O +
. O +
We O +
looked O +
for O +
mechanisms O +
of O +
protective O +
endothelial O +
function O +
, O +
with O +
a O +
special O +
respect O +
to O +
the O +
differences O +
between O +
peripheral O +
and O +
pulmonary O +
circulation O -
. O +
METHODS O +
: O +
Cultured O +
endothelial O +
cells O +
of O +
bovine O +
aorta O +
( O +
BAEC O +
) O +
were O +
used O +
to O +
study O +
physiological O +
and O +
pharmacological O +
mechanisms O +
of O +
increasing O +
free O +
cytoplasmic O +
calcium O +
[ O -
Ca2+ O -
] O -
i O +
. O +

A O +
porphyrinic O +
sensor O +
quantified O +
the O +
release O +
of O +
NO O +
from O +
BAEC O +
. O +

In O +
cultured O +
human O +
umbilical O +
vein O +
endothelial O +
cells O +
( O +
HUVEC O +
) O +
we O +
looked O +
for O +
induction O +
by O +
bradykinin B-Gene +
( O +
Bk B-Gene +
) O +
of O +
mRNAs O +
for O +
a O +
number O +
of O +
enzymes O +
. O +

In O +
blood O +
perfused O +
rat O +
lungs O +
we O +
studied O +
protective O +
role O +
of O +
NO O +
against O +
injury O +
inferred O +
by O +
lipopolysaccharide O +
on O +
pulmonary O +
microcirculation O +
that O +
was O +
accomplished O +
by O +
thromboxane O +
A2 O +
( O +
TXA2 O +
) O +
, O +
platelet O +
activating O +
factor O +
( O +
PAF O +
) O +
, O +
cysteinyl O +
- O +
leukotrienes O +
( O +
cyst O +
- O +
LTs O +
) O +
and O +
the O +
complement O +
system O +
. O +

In O +
vivo O +
we O +
analyzed O +
the O +
influence O +
of O +
Bk B-Gene +
, O +
perindopril O +
and O +
quinapril O +
( O +
' O +
tissue O +
type O +
' O +
angiotensin B-Gene +
converting I-Gene +
enzyme I-Gene +
inhibitors O +
, O +
ACE B-Gene -
- I-Gene -
Is I-Gene +
) O +
on O +
endothelial O +
function O +
in O +
entire O +
circulation O +
of O +
anaesthetized O +
rats O +
using O +
a O +
thrombolytic O +
bioassay O +
and O +
EIA O +
for O +
6-keto O -
- O -
PGF1 O +
alpha O +
and O +
t B-Gene -
- I-Gene -
PA I-Gene +
antigen O +
. O +

RESULTS O +
: O +

In O +
BAEC O +
Bk B-Gene +
via O +
kinin B-Gene +
B2 I-Gene +
receptors I-Gene +
raised O +
in O +
a O +
concentration O +
- O +
dependent O +
manner O +
( O +
1 O +
pM-10 O +
nM O +
) O +
free O +
cytoplasmic O +
calcium O +
ions O +
[ O +
Ca2 O -
+ O +
] O +
i O +
, O +
that O +
triggered O +
the O +
release O +
of O +
NO O +
from O +
BAEC O +
. O +

Calcium O +
ionophore O +
( O +
A23187 O +
, O +
1 O +
- O +
100 O +
nM O +
) O +
as O +
well O +
as O +
receptor O +
agonists O +
such O +
as O +
adenosine O +
diphosphate O +
( O +
ADP O +
, O +
10 O +
nM-1 O +
microM O +
) O +
, O +
adrenaline O +
( O +
Adr O +
, O +
1 O -
- O -
10 O +
microM O +
) O +
or O +
acetylcholine O +
( O +
Ach O +
, O +
10 O +
- O +
100 O +
microM O +
) O +
produced O +
a O +
similar O +
rise O +
in O +
endothelial O +
[ O +
Ca2 O -
+ O +
] O +
i O +
as O +
did O +
Bk B-Gene +
at O +
a O +
nanomolar O +
concentration O +
. O +

' O +
Tissue O +
type O +
' O +
ACE B-Gene +
- O +
Is O +
, O +
e.g. O +
quinapril O +
or O +
perindopril O +
acted O +
through O +
accumulation O +
of O +
endogenous O +
Bk B-Gene +
. O +

However O +
, O +
the O +
potency O +
of O +
ACE B-Gene +
- O +
I O +
to O +
change O +
endothelial O +
function O +
is O +
by O +
several O +
orders O +
of O +
magnitude O +
lower O +
than O +
that O +
for O +
exogenous O +
Bk B-Gene +
. O +

In O +
vivo O +
the O +
major O +
difference O +
between O +
thrombolytic O +
actions O +
by O +
quinapril O +
or O +
perindopril O +
on O +
one O +
hand O +
, O +
and O +
by O +
exogenous O +
Bk B-Gene +
on O +
the O +
other O +
was O +
longevity O +
of O +
thrombolysis O +
by O +
ACE B-Gene +
I O +
and O +
a O +
distinct O +
hypotensive O +
action O +
of O +
exogenous O +
Bk B-Gene +
. O +

Still O +
, O +
the O +
long O +
- O +
lasting O +
isolated O +
thrombolytic O +
effect O +
of O +
ACE B-Gene +
I O +
was O +
mediated O +
entirely O +
by O +
endogenous O +
BK B-Gene +
as O +
evidenced O +
by O +
the O +
preventive O +
action O +
of O +
icatibant O +
, O +
a O +
kinin B-Gene +
B2 I-Gene +
receptor I-Gene +
antagonist O +
. O +

Moreover O +
, O +
in O +
vivo O +
the O +
immediate O +
thrombolysis O +
by O +
ACE B-Gene +
- O +
I O +
was O +
mediated O +
by O +
PGI2 O +
rather O +
than O +
by O +
NO O +
or O +
t B-Gene -
- I-Gene -
PA I-Gene +
, O +
as O +
shown O +
by O +
pharmacological O +
analysis O +
, O +
and O +
by O +
direct O +
blood O +
assays O +
of O +
6-keto O -
- O -
PGF1 O +
alpha O +
and O +
t B-Gene -
- I-Gene -
PA I-Gene +
antigen O +
. O +

Bradykinin O +
as O +
a O +
mediator O +
of O +
pleiotropic O +
endothelial O +
action O +
of O +
several O +
cardiovascular O +
drugs O +
( O +
e.g. O +
ACE B-Gene +
- O +
I O +
) O +
may O +
complete O +
its O +
mission O +
not O +
only O +
through O +
B2 B-Gene +
receptor I-Gene +
and O +
[ O -
Ca2 O -
+ O +
] O +
i O +
- O +
- O +
mediated O +
release O +
of O +
PGI2 O +
or O +
NO O +
. O +

Here O +
, O +
we O +
describe O +
a O +
new O +
route O +
of O +
the O +
Bk B-Gene +
action O +
. O +

Bk B-Gene +
mediated O +
induction O +
of O +
the O +
[ O -
Ca2+ O -
] O -
i O -
- O -
independent O +
, O +
so O +
called O +
' O +
inducible O +
' O +
, O +
endothelial O +
isoenzymes O +
required O +
for O +
generation O +
of O +
CO O +
, O +
PGI2 O +
and O +
PGE2 O +
. O +

After O +
4 O +
hours O +
of O +
incubation O +
of O +
HUVEC O +
with O +
Bk B-Gene +
( O +
10 O +
nM O +
) O +
it O +
induced O +
mRNAs O +
for O +
haemooxygenase B-Gene +
1 I-Gene +
( O +
HO-1 B-Gene +
) O +
, O +
cyclooxygenase B-Gene +
2 I-Gene +
( O +
COX-2 B-Gene +
) O +
, O +
prostaglandin B-Gene +
E I-Gene +
synthase I-Gene +
( O +
PGE B-Gene -
- I-Gene -
S I-Gene +
) O +
whereas O +
mRNA O +
for O +
nitric B-Gene +
oxide I-Gene +
synthase I-Gene +
2 I-Gene +
( O +
NOS-2 B-Gene +
) O +
was O +
weakly O +
affected O +
. O +

We O +
proved O +
also O +
that O +
unlike O +
in O +
peripheral O +
circulation O +
, O +
in O +
pulmonary O +
circulation O +
only O +
NO O +
but O +
not O +
PGI2 O +
would O +
play O +
a O +
protective O +
role O +
. O +

In O +
the O +
blood O +
- O +
perfused O +
lung O +
, O +
endotoxaemia O +
liberates O +
lipids O +
, O +
such O +
as O +
TXA2 O +
, O +
PAF O +
and O +
cyst O +
- O +
LTs O +
. O +

These O +
toxic O +
lipids O +
along O +
with O +
the O +
activated O +
complement O +
mediate O +
pulmonary O +
damage O +
. O +

Pulmonary O +
endothelial O +
nitric O +
oxide O +
is O +
the O +
only O +
local O +
protector O +
against O +
lung O +
injury O +
evoked O +
by O +
the O +
phagocytised O +
bacterial O +
lipopolysaccharide O +
. O +

SUMMARY O +
: O +

Summing O +
up O +
, O +
in O +
peripheral O +
circulation O +
endogenous O +
Bk B-Gene +
is O +
the O +
most O +
efficient O +
activator O +
of O +
protective O +
endothelial O +
function O +
. O +

For O +
instance O +
, O +
thrombolytic O +
action O +
of O +
' O +
tissue O +
type O +
' O +
ACE B-Gene +
- O +
I O +
depends O +
on O +
the O +
Bk B-Gene +
- O +
released O +
PGI2 O +
. O +

Acting O +
as O +
an O +
agonist O +
of O +
endothelial O +
B2 B-Gene +
kinin I-Gene +
receptors I-Gene +
Bk B-Gene +
rises O +
[ O -
Ca2+ O -
] O -
i O +
with O +
a O +
subsequent O +
activation O +
of O +
constitutive O +
COX B-Gene +
1 I-Gene +
and O +
NOS-3 B-Gene +
. O +

This O +
is O +
followed O +
by O +
an O +
immediate O +
release O +
of O +
PGI2 O +
and O +
NO O +
. O +

Moreover O +
, O +
acting O +
as O +
' O -
microcytokine O -
' O +
Bk B-Gene +
induces O +
mRNAs O +
for O +
HO-1 B-Gene +
, O +
COX-2 B-Gene +
and O +
PGE B-Gene +
S I-Gene +
, O +
the O +
isoenzymes O +
responsible O +
for O +
a O +
delayed O +
endothelial O +
biosynthesis O +
of O +
CO O +
, O +
PGI2 O +
and O +
PGE2 O +
. O +

( O +
ABSTRACT O +
TRUNCATED O +
) O +

Phase O +
I O +
trial O +
of O +
intravenous O +
peptide O +
- O +
pulsed O +
dendritic O +
cells O +
in O +
patients O +
with O +
metastatic O +
melanoma O +
. O +

Sixteen O +
patients O +
with O +
metastatic O +
stage O +
IV O +
melanoma O +
were O +
treated O +
with O +
use O +
of O +
intravenous O +
infusions O +
of O +
dendritic O +
cells O +
( O +
DC O +
) O +
derived O +
by O +
incubation O +
of O +
plastic O +
- O +
adherent O +
peripheral O +
blood O +
mononuclear O +
cells O +
( O +
PBMC O +
) O +
with O +
IL-4 B-Gene +
and O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
for O +
8 O +
days O +
in O +
serumless O +
AIM O +
- O +
V O +
medium O +
, O +
followed O +
by O +
overnight O +
pulsing O +
with O +
peptides O +
. O +

The O +
tyrosinase368 B-Gene -
- I-Gene -
376 I-Gene +
( O +
370D O +
) O +
and O +
gp100 B-Gene +
( O +
209 O +
- O +
217 O +
( O +
210 O -
M O +
) O +
) O +
peptides O +
restricted O +
to O +
HLA B-Gene +
class I-Gene +
I I-Gene +
A*0201 I-Gene +
each O +
differed O +
from O +
wild O +
type O +
by O +
one O +
amino O +
acid O +
modified O +
to O +
increase O +
HLA B-Gene +
binding O +
. O +

Median O +
age O +
was O +
49 O +
, O +
with O +
nine O +
men O +
and O +
seven O +
women O +
. O +

All O +
patients O +
, O +
except O +
one O +
, O +
had O +
visceral O +
disease O +
. O +

Patients O +
received O +
escalating O +
doses O +
of O +
peptide O +
- O +
pulsed O +
DCs O +
at O +
10e7 O +
, O +
3 O +
x O +
10e7 O +
, O +
and O +
10e8 O +
cells O +
/ O +
dose O +
twice O +
at O +
2 O +
weeks O +
apart O +
, O +
with O +
toxicity O +
and O +
clinical O +
and O +
immune O +
responses O +
as O +
the O +
principal O +
endpoints O +
. O +

The O +
first O +
infusion O +
of O +
DCs O +
was O +
fresh O +
, O +
and O +
frozen O +
DCs O +
were O +
given O +
for O +
the O +
second O +
infusion O +
of O +
each O +
cycle O +
. O +

Mean O +
DC O +
purity O +
by O +
flow O +
cytometry O +
was O +
49 O +
% O +
, O +
with O +
a O +
mean O +
HLA B-Gene +
- I-Gene +
DR I-Gene +
level O +
of O +
57 O +
% O +
, O +
CD86 B-Gene +
of O +
41 O +
% O +
, O +
CD58 B-Gene +
of O +
46 O +
% O +
, O +
and O +
mean O +
CD14 B-Gene +
cells O +
of O +
0.9 O +
% O +
. O +

Toxicity O +
was O +
minimal O +
, O +
with O +
two O +
patients O +
having O +
transient O +
grade O +
III O +
DC O +
- O +
related O +
toxicity O +
. O +

Ten O +
patients O +
received O +
one O +
cycle O +
of O +
treatment O +
and O +
six O +
patients O +
received O +
two O +
cycles O +
of O +
treatment O +
. O +

One O +
patient O +
had O +
a O +
complete O +
remission O +
( O +
CR O +
) O +
of O +
lung O +
and O +
pleural O +
disease O +
after O +
two O +
cycles O +
of O +
DC O +
therapy O +
. O +

Two O +
additional O +
patients O +
had O +
stable O +
disease O +
and O +
two O +
patients O +
had O +
mixed O +
responses O +
. O +

Overall O +
immunity O +
was O +
assessed O +
by O +
recall O +
skin O +
testing O +
with O +
peptides O +
, O +
gamma B-Gene +
interferon I-Gene +
ELISA O +
assays O +
of O +
peptide O +
specific O +
cytolytic O +
T O +
cell O +
( O +
CTL O +
) O +
stimulated O +
twice O +
with O +
peptide O +
, O +
IL-2 B-Gene +
, O +
and O +
IL B-Gene +
- I-Gene +
7 I-Gene +
over O +
24 O +
days O +
, O +
and O +
peptide O +
- O +
specific O +
tetramer O +
assays O +
performed O +
before O +
and O +
after O +
vaccination O +
. O +

Five O +
of O +
16 O +
patients O +
had O +
an O +
immune O +
response O +
to O +
gp100 B-Gene +
or O +
tyrosinase O +
by O +
gamma O +
interferon O +
ELISA O +
assay O +
; O +
four O +
of O +
five O +
were O +
clinically O +
stable O +
or O +
had O +
tumor O +
regression O +
. O +

These O +
data O +
suggest O +
that O +
melanoma O +
antigen O +
peptide O +
- O +
pulsed O +
DC O +
given O +
intravenously O +
are O +
not O +
toxic O +
, O +
and O +
regression O +
or O +
stability O +
of O +
tumor O +
appeared O +
to O +
correlate O +
with O +
the O +
detection O +
of O +
a O +
peptide O +
- O +
specific O +
immune O +
response O +
in O +
the O +
peripheral O +
blood O +
. O +

Pretreatment O +
with O +
paclitaxel O +
enhances O +
apo-2 B-Gene +
ligand I-Gene +
/ O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
related I-Gene +
apoptosis I-Gene +
- I-Gene +
inducing I-Gene +
ligand I-Gene +
- O +
induced O +
apoptosis O +
of O +
prostate O +
cancer O +
cells O +
by O +
inducing O +
death B-Gene +
receptors I-Gene +
4 I-Gene +
and I-Gene +
5 I-Gene +
protein O +
levels O +
. O +

We O +
have O +
demonstrated O +
that O +
Apo-2 B-Gene +
ligand I-Gene +
( O +
Apo-2L B-Gene +
) O +
/ O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
related I-Gene +
apoptosis I-Gene +
- I-Gene +
inducing I-Gene +
ligand I-Gene +
( O +
TRAIL B-Gene +
) O +
induces O +
apoptosis O +
of O +
human O +
prostate O +
cancer O +
PC-3 O +
, O +
DU145 O +
, O +
and O +
LNCaP O +
cells O +
in O +
a O +
dose O +
- O +
dependent O +
manner O +
, O +
with O +
PC-3 O +
cells O +
displaying O +
the O +
greatest O +
sensitivity O +
to O +
Apo-2L B-Gene +
/ O +
TRAIL B-Gene +
. O +

Susceptibility O +
of O +
the O +
prostate O +
cancer O +
cell O +
types O +
to O +
Apo-2L B-Gene +
/ O +
TRAIL B-Gene +
- O +
induced O +
apoptosis O +
did O +
not O +
appear O +
to O +
correlate O +
with O +
the O +
levels O +
of O +
the O +
Apo-2L B-Gene +
/ I-Gene +
TRAIL I-Gene +
receptors I-Gene +
death B-Gene +
receptor I-Gene +
( I-Gene +
DR I-Gene +
) I-Gene +
4 I-Gene +
( O +
TRAIL B-Gene +
receptor I-Gene +
1 I-Gene +
) O +
or O +
DR5 B-Gene +
( O +
TRAIL B-Gene +
receptor I-Gene +
2 I-Gene +
) O +
, O +
decoy B-Gene +
receptor I-Gene +
( I-Gene +
DcR I-Gene +
) I-Gene +
1 I-Gene +
and O +
DcR2 B-Gene +
, O +
Flame-1 B-Gene +
, O +
or O +
the O +
inhibitors B-Gene +
of I-Gene +
apoptosis I-Gene +
proteins I-Gene +
family I-Gene +
of O +
proteins O +
. O +

Apo-2L B-Gene +
/ O +
TRAIL B-Gene +
- O +
induced O +
apoptosis O +
of O +
PC-3 O +
cells O +
was O +
associated O +
with O +
the O +
processing O +
of O +
caspase-8 B-Gene +
, O +
caspase-10 B-Gene +
, O +
and O +
the O +
proapoptotic O +
Bid B-Gene +
protein O +
, O +
resulting O +
in O +
the O +
cytosolic O +
accumulation O +
of O +
cytochrome B-Gene +
c I-Gene +
as O +
well O +
as O +
the O +
processing O +
of O +
procaspase B-Gene +
- I-Gene +
9 I-Gene +
and O +
procaspase B-Gene +
- I-Gene +
3 I-Gene +
. O +

Cotreatment O +
with O +
the O +
caspase-8 B-Gene +
inhibitor O +
z O -
- O -
IETD O -
- O -
fmk O +
or O +
DR4 B-Gene +
: O +
Fc O +
significantly O +
inhibited O +
Apo-2L B-Gene +
/ O +
TRAIL B-Gene +
- O +
induced O +
apoptosis O +
. O +

Treatment O +
with O +
paclitaxel O +
or O +
taxotere O +
increased O +
DR4 B-Gene +
and/or O +
DR5 B-Gene +
protein O +
levels O +
( O +
up O +
to O +
8 O +
- O +
fold O +
) O +
without O +
affecting O +
the O +
protein O +
levels O +
of O +
DcR1 B-Gene +
and O +
DcR2 B-Gene +
, O +
Apo-2L B-Gene +
/ O +
TRAIL B-Gene +
, O +
Fas B-Gene +
, O +
or O +
Fas B-Gene +
ligand I-Gene +
. O +

Up O +
- O +
regulation O +
of O +
DR4 B-Gene +
and O +
DR5 B-Gene +
was O +
not O +
preceded O +
by O +
the O +
induction O +
of O +
their O +
mRNA O +
levels O +
but O +
was O +
inhibited O +
by O +
cotreatment O +
with O +
cycloheximide O +
. O +

Importantly O +
, O +
sequential O +
treatment O +
of O +
PC-3 O +
, O +
DU145 O +
, O +
and O +
LNCaP O +
cells O +
with O +
paclitaxel O +
followed O +
by O +
Apo-2L B-Gene +
/ O +
TRAIL B-Gene +
induced O +
significantly O +
more O +
apoptosis O +
than O +
Apo-2L B-Gene +
/ O +
TRAIL B-Gene +
treatment O +
alone O +
( O +
P O +
< O +
0.01 O +
) O +
. O +

This O +
was O +
also O +
associated O +
with O +
greater O +
processing O +
of O +
procaspase-8 B-Gene +
and O +
Bid B-Gene +
, O +
as O +
well O +
as O +
greater O +
cytosolic O +
accumulation O +
of O +
cytochrome B-Gene +
c I-Gene +
and O +
the O +
processing O +
of O +
caspase-3 B-Gene +
. O +

These O +
findings O +
indicate O +
that O +
up O +
- O +
regulation O +
of O +
DR4 B-Gene +
and O +
DR5 B-Gene +
protein O +
levels O +
by O +
treatment O +
with O +
paclitaxel O +
enhances O +
subsequent O +
Apo-2L B-Gene +
/ O +
TRAIL B-Gene +
- O +
induced O +
apoptosis O +
of O +
human O +
prostate O +
cancer O +
cells O +
. O +

[ O +
Aggregation O +
of O +
human O +
blood O +
platelets O +
by O +
remnant B-Gene +
- I-Gene +
like I-Gene +
lipoprotein I-Gene +
particles O +
] O +

The O +
action O +
of O +
lipoprotein B-Gene +
lipase I-Gene +
on O +
chylomicrons B-Gene +
( O +
CM B-Gene +
) O +
and O +
very B-Gene +
low I-Gene +
density I-Gene +
lipoproteins I-Gene +
( O +
VLDL B-Gene +
) O +
produces O +
remnant B-Gene +
lipoproteins I-Gene +
( O +
RLP B-Gene +
) O +
that O +
are O +
rich O +
in O +
triglycerides O +
, O +
cholesterol O +
and O +
apolipoprotein B-Gene +
E I-Gene +
( O +
apo B-Gene +
E I-Gene +
) O +
. O +

Apo B-Gene +
E I-Gene +
serves O +
as O +
a O +
ligand O +
for O +
the O +
LDL B-Gene +
receptor I-Gene +
and O +
mediates O +
uptake O +
of O +
RLP B-Gene +
by O +
macrophages O +
, O +
vascular O +
wall O +
and O +
other O +
cells O +
that O +
express O +
the O +
LDL B-Gene +
receptor I-Gene +
. O +

Uptake O +
of O +
RLP B-Gene +
can O +
profoundly O +
alter O +
the O +
physiology O +
of O +
cells O +
and O +
promote O +
atherosclerosis O +
and O +
thrombosis O +
. O +

Like O +
RLP B-Gene +
, O +
blood O +
platelets O +
also O +
have O +
roles O +
in O +
atherosclerosis O +
and O +
thrombosis O +
; O +
hence O +
it O +
is O +
likely O +
that O +
RLP B-Gene +
can O +
influence O +
platelet O +
activity O +
as O +
well O +
. O +

Platelet O +
aggregation O +
was O +
assessed O +
by O +
measuring O +
the O +
loss O +
of O +
single O +
platelets O +
. O +

Apo B-Gene +
E3 I-Gene +
/ I-Gene +
3 I-Gene +
- O +
rich O +
RLP B-Gene +
derived O +
from O +
normal O +
human O +
plasma O +
VLDL B-Gene +
and O +
CM B-Gene +
were O +
prepared O +
by O +
an O +
immunoseparation O +
method O +
. O +

At O +
2.5 O +
to O +
10 O +
microliters O +
, O +
RLP B-Gene +
induced O +
platelet O +
aggregation O +
that O +
increased O +
with O +
the O +
dose O +
of O +
RLP B-Gene +
, O +
but O +
decreased O +
it O +
at O +
25 O +
to O +
200 O +
microliters O +
. O +

Unlike O +
apo B-Gene +
E3 I-Gene +
/ I-Gene +
3 I-Gene +
- O +
rich O +
RLP B-Gene +
, O +
apo B-Gene +
E4 I-Gene +
/ I-Gene +
3 I-Gene +
( O +
heterozygous O +
phenotype O +
) O +
rich O +
RLP B-Gene +
caused O +
platelet O +
aggregation O +
in O +
a O +
dose O +
- O +
dependent O +
manner O +
, O +
without O +
producing O +
a O +
bell O +
- O +
shape O +
dose O +
- O +
response O +
relationship O +
. O +

Scanning O +
electron O +
microscopy O +
revealed O +
that O +
activated O +
platelets O +
had O +
adhered O +
to O +
and O +
formed O +
aggregates O +
on O +
the O +
red O +
cell O +
membrane O +
. O +

The O +
platelet O +
response O +
was O +
unaffected O +
by O +
aspirin O +
, O +
but O +
was O +
inhibited O +
by O +
apyrase B-Gene +
( O +
an O +
ADP O +
scavenger O +
) O +
, O +
2-chloroadenosine O +
( O +
a O +
platelet B-Gene +
ADP I-Gene +
- I-Gene +
receptor I-Gene +
antagonist O +
) O +
and O +
cilostazol O +
, O +
a O +
phosphodiesterase B-Gene +
type I-Gene +
III I-Gene +
inhibitor O +
. O +

It O +
is O +
thought O +
that O +
RLP B-Gene +
cause O +
leakage O +
of O +
ADP O +
from O +
red O +
cells O +
, O +
which O +
then O +
mediates O +
platelet O +
aggregation O +
. O +

121R B-Gene +
protein O +
from O +
the O +
E3 O +
region O +
of O +
bovine O +
adenovirus-3 O +
inhibits O +
cytolysis O +
of O +
mouse O +
cells O +
by O +
human O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
. O +

Based O +
on O +
the O +
DNA O +
sequence O +
and O +
known O +
mRNA O +
structures O +
, O +
the O +
early O +
region O +
3 O +
( O +
E3 O +
) O +
of O +
bovine O +
adenovirus O +
( O +
BAV O +
) O +
- O +
3 O +
has O +
the O +
potential O +
to O +
encode O +
four O +
proteins O +
. O +

One O +
of O +
them O +
( O +
121R B-Gene +
) O +
is O +
produced O +
as O +
a O +
14.5 B-Gene +
- I-Gene +
kD I-Gene +
protein I-Gene +
throughout O +
infection O +
. O +

Analysis O +
of O +
the O +
121R B-Gene +
protein O +
showed O +
limited O +
homology O +
to O +
a O +
14.7 B-Gene -
K I-Gene +
protein O +
of O +
human O +
adenovirus O +
( O +
HAV O +
) O +
- O +
5 O +
. O +

Interestingly O +
, O +
both O +
anti O +
- O +
14.7 B-Gene -
K I-Gene +
and O +
anti O +
- O +
121R B-Gene +
sera O +
immunoprecipitated O +
a O +
14.5 B-Gene +
- I-Gene +
kD I-Gene +
protein I-Gene +
from O +
cells O +
infected O +
with O +
BAV-3 O +
. O +

To O +
determine O +
if O +
121R B-Gene +
is O +
functionally O +
related O +
to O +
14.7 B-Gene -
K I-Gene +
, O +
we O +
constructed O +
a O +
recombinant O +
E3-deleted O +
HAV-5 O +
( O +
AdKV121 O +
) O +
expressing O +
the O +
BAV-3 O +
E3 O +
121R B-Gene +
protein O +
. O +

Mouse O +
C3HA O +
cells O +
infected O +
with O +
HAV-5 O +
mutant O +
dl O +
758 O +
( O +
deletion O +
of O +
14.7 B-Gene -
K I-Gene +
) O +
were O +
sensitive O +
to O +
TNF B-Gene +
lysis O +
. O +

However O +
, O +
wild O +
- O +
type O +
HAV-5 O +
- O +
or O +
recombinant O +
AdKV121 O +
- O +
infected O +
cells O +
were O +
resistant O +
to O +
TNF B-Gene +
- O +
induced O +
cytolysis O +
. O +

Our O +
result O +
show O +
that O +
the O +
BAV-3 O +
E3 O +
121R B-Gene +
protein O +
is O +
serologically O +
and O +
functionally O +
related O +
to O +
the O +
14.7 B-Gene -
K I-Gene +
protein I-Gene +
encoded O +
by O +
the O +
E3 O +
region O +
of O +
HAV-5 O +
. O +

Antisense O +
targeting O +
of O +
c B-Gene -
- I-Gene -
fos I-Gene +
transcripts O +
inhibits O +
serum O +
- O +
and O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
1 I-Gene +
- O +
stimulated O +
PAI-1 B-Gene +
gene O +
expression O +
and O +
directed O +
motility O +
in O +
renal O +
epithelial O +
cells O +
. O +

Plasminogen B-Gene +
activator I-Gene +
inhibitor I-Gene +
type-1 I-Gene +
( O +
PAI-1 B-Gene +
) O +
, O +
the O +
major O +
regulator O +
of O +
pericellular O +
plasmin B-Gene +
generation O +
, O +
and O +
the O +
c B-Gene -
- I-Gene -
FOS I-Gene +
transcription B-Gene +
factor I-Gene +
are O +
expressed O +
by O +
migrating O +
cells O +
in O +
response O +
to O +
monolayer O +
wounding O +
. O +

Induced O +
c B-Gene -
- I-Gene -
fos I-Gene +
and O +
PAI-1 B-Gene +
transcripts O +
were O +
evident O +
within O +
30 O +
min O +
and O +
2 O +
h O +
, O +
respectively O +
, O +
of O +
scrape O +
injury O +
to O +
confluent O +
, O +
growth O +
- O +
arrested O +
, O +
cultures O +
of O +
NRK O +
epithelial O +
cells O +
. O +

Since O +
c B-Gene -
- I-Gene -
FOS I-Gene +
/ O +
AP-1 B-Gene +
DNA O +
- O +
binding O +
activity O +
modulates O +
both O +
basal O +
and O +
inducible O +
modes O +
of O +
PAI-1 B-Gene +
gene O +
control O +
, O +
and O +
AP-1 B-Gene +
motif O +
binding O +
factors O +
were O +
present O +
in O +
quiescent O +
as O +
well O +
as O +
stimulated O +
NRK O +
cells O +
, O +
a O +
model O +
of O +
directionally O +
regulated O +
cell O +
movement O +
( O +
migration O +
into O +
scrape O +
- O +
denuded O +
" O +
wounds O +
" O +
) O +
was O +
used O +
to O +
assess O +
the O +
consequences O +
of O +
c B-Gene -
- I-Gene -
fos I-Gene +
transcript O +
targeting O +
on O +
PAI-1 B-Gene +
expression O +
and O +
cell O +
motility O +
. O +

This O +
in O +
vitro O +
model O +
of O +
epithelial O +
injury O +
closely O +
approximated O +
in O +
vivo O +
wound O +
repair O +
with O +
regard O +
to O +
the O +
spatial O +
and O +
temporal O +
emergence O +
of O +
cohorts O +
of O +
cells O +
involved O +
in O +
migration O +
, O +
proliferation O +
, O +
and O +
PAI-1 B-Gene +
expression O +
. O +

Stable O +
cell O +
lines O +
( O +
NRKsof O +
) O +
were O +
generated O +
by O +
transfection O +
of O +
parental O +
NRK O +
cells O +
with O +
a O +
c B-Gene -
- I-Gene -
fos I-Gene +
antisense O +
expression O +
vector O +
. O +

Serum O +
- O +
inducible O +
c B-Gene -
- I-Gene -
fos I-Gene +
transcripts O +
and O +
PAI-1 B-Gene +
protein O +
levels O +
were O +
significantly O +
attenuated O +
in O +
NRKsof O +
transfectants O +
relative O +
to O +
parental O +
controls O +
or O +
cells O +
transfected O +
with O +
a O +
neo O -
( O -
R O -
) O +
vector O +
without O +
the O +
sof O +
insert O +
. O +

NRKsof O +
cells O +
had O +
a O +
markedly O +
impaired O +
ability O +
to O +
repair O +
scrape O +
- O +
generated O +
monolayer O +
wounds O +
under O +
basal O +
, O +
serum O +
- O +
stimulated O +
, O +
or O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
1 I-Gene +
- O +
supplemented O +
culture O +
conditions O +
. O +

Since O +
injury O +
closure O +
and O +
PAI-1 B-Gene +
induction O +
were O +
attenuated O +
in O +
c B-Gene -
- I-Gene -
fos I-Gene +
antisense O +
cells O +
, O +
it O +
was O +
important O +
to O +
clarify O +
the O +
role O +
of O +
specific O +
AP-1 B-Gene +
sites O +
in O +
serum O +
- O +
mediated O +
PAI-1 B-Gene +
transcription O +
. O +

PAI-1 B-Gene +
" O +
promoter O +
" O +
- O +
driven O +
CAT B-Gene +
reporter O +
expression O +
was O +
assessed O +
within O +
the O +
real O +
time O +
of O +
serum O +
- O +
stimulated O +
PAI-1 B-Gene +
induction O +
. O +

A O +
segment O +
of O +
the O +
PAI-1 B-Gene +
promoter O +
corresponding O +
to O +
nucleotides O +
- O +
533 O +
to O +
- O +
764 O +
upstream O +
of O +
the O +
transcription O +
start O +
site O +
functioned O +
as O +
a O +
prominent O +
serum O +
- O +
responsive O +
region O +
( O +
SSR O +
) O +
. O +

The O +
9 O +
- O +
fold O +
increase O +
in O +
CAT B-Gene +
mRNA O +
levels O +
attained O +
with O +
the O +
- O +
533 O +
to O +
- O +
764 O +
bp O +
PAI-1 B-Gene +
SRR O +
ligated O +
to O +
a O +
minimal O +
PAI-1 B-Gene +
promoter O +
( O +
i.e. O +
, O +
162 O +
bp O +
of O +
5 O -
' O +
flanking O +
sequence O +
containing O +
the O +
basal O +
transcription O +
complex O +
) O +
closely O +
approximated O +
the O +
serum O +
- O +
induced O +
transcriptional O +
activity O +
of O +
a O +
fully O +
responsive O +
( O +
1 O +
, O +
230 O +
bp O +
) O +
PAI-1 B-Gene +
promoter O +
construct O +
as O +
well O +
as O +
the O +
endogenous O +
PAI-1 B-Gene +
gene O +
. O +

AP-1 B-Gene +
- O +
like O +
, O +
CTF B-Gene +
/ O +
NF-1 B-Gene +
- O +
like O +
, O +
and O +
AP-2 B-Gene +
sites O +
were O +
identified O +
in O +
the O +
SRR O +
. O +

The O +
SRR O +
AP-1 B-Gene +
motif O +
was O +
homologous O +
to O +
the O +
sequence O +
TGACACA O +
that O +
mapped O +
between O +
nucleotides O +
- O +
740 O +
and O +
- O +
703 O +
in O +
the O +
human O +
PAI-1 B-Gene +
gene O +
, O +
a O +
region O +
essential O +
for O +
growth B-Gene +
factor I-Gene +
- O +
inducible O +
PAI-1 B-Gene +
transcription O +
. O +

While O +
the O +
functionality O +
of O +
this O +
AP-1 B-Gene +
site O +
in O +
wound O +
- O +
regulated O +
PAI-1 B-Gene +
synthesis O +
remains O +
to O +
be O +
determined O +
, O +
antisense O +
c B-Gene -
- I-Gene -
fos I-Gene +
transcripts O +
effectively O +
attenuated O +
PAI-1 B-Gene +
induction O +
and O +
basal O +
as O +
well O +
as O +
growth B-Gene +
factor I-Gene +
- O +
stimulated O +
cell O +
locomotion O +
, O +
indicating O +
that O +
expression O +
of O +
both O +
the O +
PAI-1 B-Gene +
and O +
c B-Gene -
- I-Gene -
fos I-Gene +
genes O +
is O +
necessary O +
for O +
wound O +
- O +
initiated O +
NRK O +
cell O +
migration O +
. O +

Petunia O +
Ap2 B-Gene +
- O +
like O +
genes O +
and O +
their O +
role O +
in O +
flower O +
and O +
seed O +
development O +
. O +

We O +
have O +
isolated O +
three O +
Apetala2 B-Gene +
( B-Gene -
Ap2 I-Gene -
) I-Gene +
- O +
like O +
genes O +
from O +
petunia O +
and O +
studied O +
their O +
expression O +
patterns O +
by O +
in O +
situ O +
hybridization O +
. O +

PhAp2A B-Gene +
has O +
a O +
high O +
sequence O +
similarity O +
to O +
the O +
A O +
function O +
gene O +
Ap2 B-Gene +
from O +
Arabidopsis O +
and O +
a O +
similar O +
expression O +
pattern O +
during O +
flower O +
development O +
, O +
suggesting O +
that O +
they O +
are O +
cognate O +
orthologs O +
. O +

PhAp2B B-Gene +
and O +
PhAp2C B-Gene +
encode O +
for O +
AP2 B-Gene +
- O +
like O +
proteins O +
that O +
belong O +
to O +
a O +
different O +
subgroup O +
of O +
the O +
AP2 B-Gene +
family I-Gene +
of I-Gene +
transcription I-Gene +
factors I-Gene +
and O +
exhibit O +
divergent O +
, O +
nearly O +
complementary O +
expression O +
patterns O +
during O +
flower O +
development O +
compared O +
with O +
PhAp2A B-Gene +
. O +

In O +
contrast O +
, O +
all O +
three O +
PhAp2 B-Gene +
genes O +
are O +
strongly O +
expressed O +
in O +
endosperm O +
. O +

The O +
phenotype O +
of O +
the O +
petunia O +
A O +
- O +
type O +
mutant O +
blind O +
can O -
not O +
be O +
attributed O +
to O +
mutations O +
in O +
the O +
petunia O +
Ap2 B-Gene +
homologs O +
identified O +
in O +
this O +
study O +
, O +
and O +
reverse O +
genetics O +
strategies O +
applied O +
to O +
identify O +
phap2a B-Gene +
mutants O +
indicate O +
that O +
PhAp2A B-Gene +
might O +
not O +
be O +
essential O +
for O +
normal O +
perianth O +
development O +
in O +
petunia O +
. O +

Nevertheless O +
, O +
we O +
show O +
that O +
PhAp2A B-Gene +
is O +
capable O +
of O +
restoring O +
the O +
homeotic O +
transformations O +
observed O +
in O +
flowers O +
and O +
seed O +
of O +
the O +
ap2 B-Gene -
- I-Gene -
1 I-Gene +
mutant O +
of O +
Arabidopsis O +
. O +

Although O +
the O +
interspecific O +
complementation O +
proves O +
that O +
PhAp2A B-Gene +
encodes O +
a O +
genuine O +
Ap2 B-Gene +
ortholog O +
from O +
petunia O +
, O +
additional O +
factors O +
may O +
be O +
involved O +
in O +
the O +
control O +
of O +
perianth O +
identity O +
in O +
this O +
species O +
. O +

C B-Gene +
- I-Gene +
reactive I-Gene +
protein I-Gene +
and O +
interleukin B-Gene +
6 I-Gene +
receptor I-Gene +
in O +
post O +
- O +
traumatic O +
stress O +
disorder O +
: O +
a O +
pilot O +
study O +
. O +

BACKGROUND O +
: O +

it O +
has O +
been O +
reported O +
that O +
psychological O +
stress O +
in O +
humans O +
is O +
associated O +
with O +
a O +
derangement O +
of O +
biological O +
homeostasis O +
. O +

This O +
pilot O +
study O +
aimed O +
to O +
examine O +
the O +
inflammatory O +
response O +
to O +
post O +
- O +
traumatic O +
stress O +
disorder O +
( O +
PTSD O +
) O +
through O +
measurements O +
of O +
the O +
serum O +
levels O +
of O +
the O +
receptor B-Gene +
to I-Gene +
interleukin I-Gene +
6 I-Gene +
( O +
sIL-6r B-Gene +
) O +
and O +
C B-Gene +
- I-Gene +
reactive I-Gene +
protein I-Gene +
( O +
CRP B-Gene +
) O +
, O +
in O +
relation O +
to O +
measures O +
of O +
psychological O +
disturbance O +
. O +

METHODS O +
: O +

15 O +
patients O +
with O +
established O +
PTSD O +
and O +
eight O +
control O +
patients O +
with O +
musculoskeletal O +
injuries O +
were O +
studied O +
at O +
least O +
three O +
months O +
after O +
their O +
index O +
trauma O +
. O +

All O +
completed O +
revised O +
impact O +
of O +
events O +
scale O +
( O +
RIES O +
) O +
, O +
Davidson O +
's O +
trauma O +
scale O +
( O +
DTS O +
) O +
and O +
the O +
general O +
health O +
questionnaire O +
( O +
GHQ O +
) O +
, O +
and O +
gave O +
blood O +
samples O +
that O +
were O +
assayed O +
for O +
CRP B-Gene +
and O +
sIL-6r B-Gene +
. O +

Statistical O +
analysis O +
was O +
by O +
the O +
Mann O +
- O +
Whitney O +
U O -
- O -
Wilcoxon O +
rank O +
sum O +
tests O +
. O +

RESULTS O +
: O +

positive O +
relationships O +
were O +
found O +
between O +
sIL-6r B-Gene +
and O +
the O +
RIES O +
intrusion O +
score O +
( O +
P O +
= O +
0.026 O +
) O +
, O +
and O +
between O +
CRP B-Gene +
and O +
DTS O +
intrusion O +
scores O +
( O +
P O +
= O +
0.016 O +
) O +
, O +
GHQ O +
depression O +
( O +
P O +
= O +
0.028 O +
) O +
, O +
and O +
RIES O +
intrusion O +
( O +
P O +
= O +
0.044 O +
) O +
in O +
the O +
case O +
group O +
. O +

DISCUSSION O +
: O +
we O +
have O +
demonstrated O +
a O +
relationship O +
between O +
post O +
- O +
traumatic O +
psychological O +
and O +
biological O +
disturbance O +
, O +
which O +
provides O +
the O +
basis O +
for O +
further O +
research O +
on O +
the O +
effects O +
of O +
psychological O +
disturbance O +
on O +
physical O +
recovery O +
after O +
injury O +
. O +

Binding O +
free O +
energies O +
and O +
free O +
energy O +
components O +
from O +
molecular O +
dynamics O +
and O +
Poisson O +
- O +
Boltzmann O +
calculations O +
. O +

Application O +
to O +
amino O +
acid O +
recognition O +
by O +
aspartyl B-Gene +
- I-Gene +
tRNA I-Gene +
synthetase I-Gene +
. O +

Specific O +
amino O +
acid O +
binding O +
by O +
aminoacyl B-Gene +
- I-Gene +
tRNA I-Gene +
synthetases I-Gene +
( O +
aaRS B-Gene +
) O +
is O +
necessary O +
for O +
correct O +
translation O +
of O +
the O +
genetic O +
code O +
. O +

Engineering O +
a O +
modified O +
specificity O +
into O +
aminoacyl B-Gene +
- I-Gene +
tRNA I-Gene +
synthetases I-Gene +
has O +
been O +
proposed O +
as O +
a O +
means O +
to O +
incorporate O +
artificial O +
amino O +
acid O +
residues O +
into O +
proteins O +
in O +
vivo O +
. O +

In O +
a O +
previous O +
paper O +
, O +
the O +
binding O +
to O +
aspartyl B-Gene +
- I-Gene +
tRNA I-Gene +
synthetase I-Gene +
of O +
the O +
substrate O +
Asp O +
and O +
the O +
analogue O +
Asn O +
were O +
compared O +
by O +
molecular O +
dynamics O +
free O +
energy O +
simulations O +
. O +

Molecular O +
dynamics O +
combined O +
with O +
Poisson O +
- O +
Boltzmann O +
free O +
energy O +
calculations O +
represent O +
a O +
less O +
expensive O +
approach O +
, O +
suitable O +
for O +
examining O +
multiple O +
active O +
site O +
mutations O +
in O +
an O +
engineering O +
effort O +
. O +

Here O +
, O +
Poisson O +
- O +
Boltzmann O +
free O +
energy O +
calculations O +
for O +
aspartyl B-Gene +
- I-Gene +
tRNA I-Gene +
synthetase I-Gene +
are O +
first O +
validated O +
by O +
their O +
ability O +
to O +
reproduce O +
selected O +
molecular O +
dynamics O +
binding O +
free O +
energy O +
differences O +
, O +
then O +
used O +
to O +
examine O +
the O +
possibility O +
of O +
Asn O +
binding O +
to O +
native O +
and O +
mutant O +
aspartyl B-Gene +
- I-Gene +
tRNA I-Gene +
synthetase I-Gene +
. O +

A O +
component O +
analysis O +
of O +
the O +
Poisson O +
- O +
Boltzmann O +
free O +
energies O +
is O +
employed O +
to O +
identify O +
specific O +
interactions O +
that O +
determine O +
the O +
binding O +
affinities O +
. O +

The O +
combined O +
use O +
of O +
molecular O +
dynamics O +
free O +
energy O +
simulations O +
to O +
study O +
one O +
binding O +
process O +
thoroughly O +
, O +
followed O +
by O +
molecular O +
dynamics O +
and O +
Poisson O +
- O +
Boltzmann O +
free O +
energy O +
calculations O +
to O +
study O +
a O +
series O +
of O +
related O +
ligands O +
or O +
mutations O +
is O +
proposed O +
as O +
a O +
paradigm O +
for O +
protein O +
or O +
ligand O +
design O -
. O -
The O +
binding O +
of O +
Asn O +
in O +
an O +
alternate O +
, O +
" O +
head O +
- O +
to O +
- O +
tail O +
" O +
orientation O +
observed O +
in O +
the O +
homologous O +
asparagine B-Gene +
synthetase I-Gene +
is O +
analyzed O +
, O +
and O +
found O +
to O +
be O +
more O +
stable O +
than O +
the O +
" O +
Asp O +
- O +
like O +
" O +
orientation O +
studied O +
earlier O +
. O +

The O +
new O +
orientation O +
is O +
probably O +
unsuitable O +
for O +
catalysis O +
. O +

A O +
conserved O +
active O +
site O +
lysine O +
( O +
Lys198 O +
in O +
Escherichia O +
coli O +
) O +
that O +
recognizes O +
the O +
Asp O +
side O +
- O +
chain O +
is O +
changed O +
to O +
a O +
leucine O +
residue O +
, O +
found O +
at O +
the O +
corresponding O +
position O +
in O +
asparaginyl B-Gene +
- I-Gene +
tRNA I-Gene +
synthetase I-Gene +
. O +

It O +
is O +
interesting O +
that O +
the O +
binding O +
of O +
Asp O +
is O +
calculated O +
to O +
increase O +
slightly O +
( O +
rather O +
than O +
to O +
decrease O +
) O +
, O +
while O +
that O +
of O +
Asn O +
is O +
calculated O +
, O +
as O +
expected O +
, O +
to O +
increase O +
strongly O +
, O +
to O +
the O +
same O +
level O +
as O +
Asp O +
binding O +
. O +

Insight O +
into O +
the O +
origin O +
of O +
these O +
changes O +
is O +
provided O +
by O +
the O +
component O +
analyses O +
. O +

The O +
double O +
mutation O +
( O +
K198L O +
, O +
D233E O +
) O +
has O +
a O +
similar O +
effect O +
, O +
while O +
the O +
triple O +
mutation O +
( O +
K198L O +
, O +
Q199E O +
, O +
D233E O +
) O +
reduces O +
Asp O +
binding O +
strongly O +
. O +

No O +
binding O +
measurements O +
are O +
available O +
, O +
but O +
the O +
three O +
mutants O +
are O +
known O +
to O +
have O +
no O +
ability O +
to O +
adenylate O +
Asn O +
, O +
despite O +
the O +
" O +
Asp O +
- O +
like O +
" O +
binding O +
affinities O +
calculated O +
here O +
. O +

In O +
molecular O +
dynamics O +
simulations O +
of O +
all O +
three O +
mutants O +
, O +
the O +
Asn O +
ligand O +
backbone O +
shifts O +
by O +
1 O -
- O -
2 O +
A O +
compared O +
to O +
the O +
experimental O +
Asp O +
: O +
AspRS B-Gene +
complex O +
, O +
and O +
significant O +
side O +
- O +
chain O +
rearrangements O +
occur O +
around O +
the O +
pocket O +
. O +

These O +
could O +
reduce O +
the O +
ATP O +
binding O +
constant O +
and/or O +
the O +
adenylation O +
reaction O +
rate O +
, O +
explaining O +
the O +
lack O +
of O +
catalytic O +
activity O +
in O +
these O +
complexes O +
. O +

Finally O +
, O +
Asn O +
binding O +
to O +
AspRS B-Gene +
with O +
neutral O +
K198 O +
or O +
charged O +
H449 O +
is O +
considered O +
, O +
and O +
shown O +
to O +
be O +
less O +
favorable O +
than O +
with O +
the O +
charged O +
K198 O +
and O +
neutral O +
H449 O +
used O +
in O +
the O +
analysis O +
. O +

Specific O +
IgA B-Gene +
antibody O +
response O +
to O +
coproantigens O +
of O +
Cryptosporidium O +
parvum O +
in O +
serum O +
and O +
saliva O +
of O +
calves O +
after O +
experimental O +
infection O +
. O +

The O +
antibody O +
response O +
to O +
coproantigens O +
of O +
Cryptosporidium O +
parvum O +
was O +
examined O +
in O +
saliva O +
and O +
sera O +
of O +
calves O +
experimentally O +
infected O +
with O +
C. O +
parvum O +
. O +

Coproantigens O +
of O +
C. O +
parvum O +
with O +
approximate O +
molecular O +
masses O +
of O +
17 O +
, O +
15 O +
and O +
less O +
than O +
14kDa O +
were O +
found O +
in O +
the O +
feces O +
of O +
infected O +
calves O +
on O +
day O +
3 O +
or O +
later O +
, O +
and O +
60 O +
and O +
23kDa O +
coproantigens O +
observed O +
between O +
days O +
4 O +
and O +
9 O +
post O +
- O +
infection O +
, O +
respectively O +
. O +

The O +
antibody O +
reactivity O +
to O +
the O +
coproantigens O +
was O +
mainly O +
attributable O +
to O +
IgA B-Gene +
class O +
antibodies O +
in O +
saliva O +
and O +
was O +
detectable O +
during O +
the O +
convalescent O +
phase O +
of O +
infection O +
. O +

A O +
15kDa O +
protein O +
isolated O +
from O +
the O +
feces O +
of O +
infected O +
calves O +
by O +
immunoaffinity O +
adsorption O +
using O +
a O +
monoclonal O +
anti O +
C. O +
parvum O +
antibody O +
was O +
recognized O +
by O +
IgA B-Gene +
antibodies O +
present O +
in O +
the O +
saliva O +
during O +
the O +
convalescent O +
phase O +
of O +
infection O +
. O +

These O +
results O +
suggest O +
that O +
this O +
coproantigen O +
may O +
be O +
released O +
from O +
C. O +
parvum O +
sporozoites O +
and O +
may O +
induce O +
IgA B-Gene +
antibody O +
production O +
in O +
the O +
mucosal O +
immune O +
system O +
of O +
infected O +
calves O +
. O +

Interferon B-Gene +
- I-Gene +
beta I-Gene +
induces O +
the O +
development O +
of O +
type O +
2 O +
dendritic O +
cells O +
. O +

Suppression O +
of O +
interleukin B-Gene +
12 I-Gene +
( O +
IL-12 B-Gene +
) O +
production O +
by O +
dendritic O +
cells O +
( O +
DCs O +
) O +
has O +
been O +
hypothesized O +
to O +
be O +
a O +
principal O +
mechanism O +
underlying O +
the O +
biological O +
action O +
of O +
interferon B-Gene +
( I-Gene +
IFN I-Gene +
) I-Gene +
- I-Gene +
beta I-Gene +
used O +
for O +
treatment O +
of O +
multiple O +
sclerosis O +
( O +
MS O +
) O +
, O +
a O +
chronic O +
inflammatory O +
disease O +
of O +
the O +
central O +
nervous O +
system O +
with O +
possible O +
autoimmune O +
origin O +
. O +

How O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
interacts O +
with O +
DCs O +
to O +
inhibit O +
IL-12 B-Gene +
production O +
remains O +
unclear O +
. O +

In O +
this O +
study O +
, O +
we O +
found O +
that O +
DCs O +
derived O +
from O +
human O +
blood O +
monocytes O +
, O +
upon O +
culture O +
in O +
the O +
presence O +
of O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
with O +
granulocyte B-Gene +
- I-Gene +
macrophage I-Gene +
colony I-Gene +
- I-Gene +
stimulating I-Gene +
factor I-Gene +
( O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
) O +
and O +
IL-4 B-Gene +
, O +
differentiated O +
into O +
a O +
population O +
expressing O +
CD14 B-Gene +
- O +
CD1a B-Gene +
- O +
HLA B-Gene -
- I-Gene -
DR I-Gene +
+ O +
. O +

This O +
population O +
expressed O +
CD123 B-Gene +
( O +
IL-3Ralpha B-Gene +
) O +
. O +

IFN B-Gene -
- I-Gene -
beta I-Gene +
dose O +
- O +
dependently O +
increased O +
IL-3Ralpha B-Gene +
+ O +
DCs O +
and O +
decreased O +
CD1a B-Gene +
+ O +
DCs O +
. O +

After O +
7 O +
days O +
' O +
culture O +
with O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
at O +
a O +
concentration O +
of O +
10 O +
000 O +
U O +
/ O +
ml O +
, O +
more O +
than O +
40 O +
% O +
of O +
DCs O +
expressed O +
IL-3Ralpha B-Gene +
. O +

IFN B-Gene -
- I-Gene -
beta I-Gene +
, O +
together O +
with O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
and O +
IL-4 B-Gene +
, O +
also O +
induced O +
maturation O +
of O +
IL-3Ralpha B-Gene +
- O +
expressing O +
cells O +
, O +
as O +
reflected O +
by O +
upregulation O +
of O +
HLA B-Gene -
- I-Gene -
DR I-Gene +
and O +
of O +
the O +
costimulatory O +
molecules O +
CD40 B-Gene +
, O +
CD80 B-Gene +
and O +
CD86 B-Gene +
. O +

In O +
contrast O +
to O +
control O +
DCs O +
, O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
- O +
treated O +
DCs O +
produced O +
predominantly O +
IL-10 B-Gene +
but O +
only O +
low O +
levels O +
of O +
IL-12p40 B-Gene +
. O +

Correspondingly O +
, O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
- O +
treated O +
DCs O +
strongly O +
suppressed O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
production O +
but O +
enhanced O +
IL-10 B-Gene +
production O +
by O +
allogeneic O +
blood O +
mononuclear O +
cells O +
. O +

Our O +
data O +
suggest O +
that O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
in O +
vitro O +
can O +
induce O +
the O +
development O +
of O +
DC2 O +
, O +
which O +
provide O +
a O +
permissive O +
environment O +
for O +
Th2 O +
differentiation O +
. O +

This O +
finding O +
represents O +
a O +
novel O +
mechanism O +
for O +
action O +
of O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
in O +
MS O +
. O +

Growth B-Gene +
hormone I-Gene +
receptor I-Gene +
interaction O +
with O +
Jak B-Gene +
proteins O +
differs O +
between O +
tissues O +
. O +

Janus B-Gene +
kinases I-Gene +
( O +
Jak B-Gene +
) O +
play O +
an O +
important O +
role O +
in O +
the O +
initial O +
steps O +
of O +
cytokine B-Gene +
receptor I-Gene +
signaling O +
. O +

The O +
specificity O +
of O +
the O +
four O +
members O +
of O +
the O +
Jak B-Gene +
family I-Gene +
( O +
Jak1 B-Gene +
, O +
Jak2 B-Gene +
, O +
Jak3 B-Gene +
, O +
and O +
Tyk2 B-Gene +
) O +
for O +
different O +
cytokine B-Gene +
receptors I-Gene +
is O +
not O +
fully O +
understood O +
. O +

Recent O +
studies O +
have O +
indicated O +
that O +
a O +
specific O +
cytokine B-Gene +
receptor I-Gene +
can O +
activate O +
several O +
Jak B-Gene +
and O +
that O +
this O +
may O +
differ O +
between O +
tissues O +
. O +

The O +
growth B-Gene +
hormone I-Gene +
receptor I-Gene +
( O +
GHR B-Gene +
) O +
is O +
believed O +
to O +
interact O +
predominantly O +
with O +
Jak2 B-Gene +
, O +
but O +
studies O +
on O +
cell O +
lines O +
have O +
shown O +
that O +
it O +
may O +
also O +
induce O +
phosphorylation O +
of O +
Jak1 B-Gene +
and O +
Jak3 B-Gene +
. O +

Little O +
is O +
known O +
about O +
the O +
interaction O +
between O +
the O +
GHR B-Gene +
and O +
Jak B-Gene +
in O +
tissues O +
. O +

Our O +
aim O +
, O +
therefore O +
, O +
was O +
to O +
elucidate O +
which O +
Jak B-Gene +
interact O +
with O +
the O +
GHR B-Gene +
in O +
two O +
target O +
tissues O +
for O +
GH B-Gene +
, O +
liver O +
and O +
adipose O +
tissue O +
. O +

Western O +
blot O +
analysis O +
showed O +
that O +
all O +
four O +
members O +
of O +
the O +
Jak B-Gene +
family I-Gene +
are O +
present O +
in O +
both O +
rat O +
liver O +
and O +
adipose O +
tissue O +
. O +

However O +
, O +
coprecipitation O +
using O +
an O +
anti O +
- O +
GHR B-Gene +
antibody O +
revealed O +
that O +
only O +
Jak1 B-Gene +
and O +
Jak2 B-Gene +
were O +
associated O +
with O +
the O +
GHR B-Gene +
in O +
these O +
tissues O +
. O +

The O +
relative O +
amount O +
of O +
Jak1 B-Gene +
and O +
Jak2 B-Gene +
that O +
coprecipitated O +
with O +
the O +
GHR B-Gene +
differed O +
markedly O +
between O +
tissues O +
. O +

In O +
the O +
liver O +
, O +
Jak2 B-Gene +
dominated O +
, O +
and O +
only O +
a O +
small O +
amount O +
of O +
Jak1 B-Gene +
was O +
detected O +
. O +

In O +
adipose O +
tissue O +
, O +
at O +
least O +
one O +
third O +
of O +
the O +
coprecipitated O +
Jak B-Gene +
was O +
Jak1 B-Gene +
. O +

This O +
is O +
the O +
first O +
study O +
to O +
show O +
that O +
both O +
Jak1 B-Gene +
and O +
Jak2 B-Gene +
are O +
associated O +
with O +
the O +
GHR B-Gene +
in O +
rat O +
tissues O +
. O +

The O +
difference O +
in O +
the O +
ratio O +
between O +
GHR B-Gene +
- O +
associated O +
Jak1 B-Gene +
and O +
Jak2 B-Gene +
in O +
liver O +
and O +
adipose O +
tissue O +
may O +
indicate O +
that O +
GHR B-Gene +
signaling O +
in O +
different O +
tissues O +
could O +
differ O +
in O +
terms O +
of O +
Jak B-Gene +
specificity O +
. O +

In70 O +
of O +
plasmid O +
pAX22 O +
, O +
a O +
bla B-Gene -
( I-Gene -
VIM-1 I-Gene +
) I-Gene +
- O +
containing O +
integron O +
carrying O +
a O +
new O +
aminoglycoside B-Gene +
phosphotransferase I-Gene +
gene O +
cassette O +
. O +

An O +
Achromobacter O +
xylosoxydans O +
strain O +
showing O +
broad O +
- O +
spectrum O +
resistance O +
to O +
beta O -
- O -
lactams O +
( O +
including O +
carbapenems O +
) O +
and O +
aminoglycosides O +
was O +
isolated O +
at O +
the O +
University O +
Hospital O +
of O +
Verona O +
( O +
Verona O +
, O +
Italy O +
) O +
. O +

This O +
strain O +
was O +
found O +
to O +
produce O +
metallo B-Gene -
- I-Gene -
beta I-Gene -
- I-Gene -
lactamase I-Gene +
activity O +
and O +
to O +
harbor O +
a O +
30 O +
- O +
kb O +
nonconjugative O +
plasmid O +
, O +
named O +
pAX22 O +
, O +
carrying O +
a O +
bla B-Gene -
( I-Gene -
VIM-1 I-Gene +
) I-Gene +
determinant O +
inserted O +
into O +
a O +
class O +
1 O +
integron O +
. O +

Characterization O +
of O +
this O +
integron O +
, O +
named O +
In70 O +
, O +
revealed O +
an O +
original O +
array O +
of O +
four O +
gene O +
cassettes O +
containing O +
, O +
respectively O +
, O +
the O +
bla B-Gene -
( I-Gene -
VIM-1 I-Gene +
) I-Gene +
gene O +
and O +
three O +
different O +
aminoglycoside O +
resistance O +
determinants O +
, O +
including O +
an O +
aacA4 B-Gene +
allele O +
, O +
a O +
new O +
aph B-Gene +
- O +
like O +
gene O +
named O +
aphA15 B-Gene +
, O +
and O +
an O +
aadA1 B-Gene +
allele O +
. O +

The O +
aphA15 B-Gene +
gene O +
is O +
the O +
first O +
example O +
of O +
an O +
aph B-Gene +
- O +
like O +
gene O +
carried O +
on O +
a O +
mobile O +
gene O +
cassette O +
, O +
and O +
its O +
product O +
exhibits O +
close O +
similarity O +
to O +
the O +
APH B-Gene -
( I-Gene -
3' I-Gene -
) I-Gene -
-IIa I-Gene +
aminoglycoside I-Gene +
phosphotransferase I-Gene +
encoded O +
by O +
Tn5 O +
( O +
36 O +
% O +
amino O +
acid O +
identity O +
) O +
and O +
to O +
an O +
APH B-Gene -
( I-Gene -
3 I-Gene -
' I-Gene +
) I-Gene +
- I-Gene +
IIb I-Gene +
enzyme O +
from O +
Pseudomonas O +
aeruginosa O +
( O +
38 O +
% O +
amino O +
acid O +
identity O +
) O +
. O +

Expression O +
of O +
the O +
cloned O +
aphA15 B-Gene +
gene O +
in O +
Escherichia O +
coli O +
reduced O +
the O +
susceptibility O +
to O +
kanamycin O +
and O +
neomycin O +
as O +
well O +
as O +
( O +
slightly O +
) O +
to O +
amikacin O +
, O +
netilmicin O +
, O +
and O +
streptomycin O +
. O +

Characterization O +
of O +
the O +
5 O -
' O +
and O +
3 O -
' O +
conserved O +
segments O +
of O +
In70 O +
and O +
of O +
their O +
flanking O +
regions O +
showed O +
that O +
In70 O +
belongs O +
to O +
the O +
group O +
of O +
class O +
1 O +
integrons O +
associated O +
with O +
defective O +
transposon O +
derivatives O +
originating O +
from O +
Tn402 O +
- O +
like O +
elements O +
. O +

The O +
structure O +
of O +
the O +
3 O -
' O +
conserved O +
segment O +
indicates O +
the O +
closest O +
ancestry O +
with O +
members O +
of O +
the O +
In0-In2 O +
lineage O +
. O +

In70 O +
, O +
with O +
its O +
array O +
of O +
cassette O +
- O +
borne O +
resistance O +
genes O +
, O +
can O +
mediate O +
broad O +
- O +
spectrum O +
resistance O +
to O +
most O +
beta O -
- O -
lactams O +
and O +
aminoglycosides O +
. O +

Transcription B-Gene +
factors I-Gene +
TFIIF B-Gene +
, O +
ELL B-Gene +
, O +
and O +
Elongin B-Gene +
negatively O +
regulate O +
SII B-Gene +
- O +
induced O +
nascent O +
transcript O +
cleavage O +
by O +
non O +
- O +
arrested O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
elongation O +
intermediates O +
. O +

TFIIF B-Gene +
, O +
ELL B-Gene +
, O +
and O +
Elongin B-Gene +
belong O +
to O +
a O +
class O +
of O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
transcription B-Gene +
factors I-Gene +
that O +
function O +
similarly O +
to O +
activate O +
the O +
rate O +
of O +
elongation O +
by O +
suppressing O +
transient O +
pausing O +
by O +
polymerase B-Gene +
at O +
many O +
sites O +
along O +
DNA O +
templates O +
. O +

SII B-Gene +
is O +
a O +
functionally O +
distinct O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
elongation B-Gene +
factor I-Gene +
that O +
promotes O +
elongation O +
by O +
reactivating O +
arrested O +
polymerase B-Gene +
. O +

Studies O +
of O +
the O +
mechanism O +
of O +
SII B-Gene +
action O +
have O +
shown O +
( O -
i O -
) O +
that O +
arrest O +
of O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
results O +
from O +
irreversible O +
displacement O +
of O +
the O +
3 O -
' O +
- O +
end O +
of O +
the O +
nascent O +
transcript O +
from O +
the O +
polymerase B-Gene +
catalytic O +
site O +
and O +
( O +
ii O +
) O +
that O +
SII B-Gene +
reactivates O +
arrested O +
polymerase B-Gene +
by O +
inducing O +
endonucleolytic O +
cleavage O +
of O +
the O +
nascent O +
transcript O +
by O +
the O +
polymerase B-Gene +
catalytic O +
site O +
thereby O +
creating O +
a O +
new O +
transcript O +
3 O +
' O +
- O +
end O +
that O +
is O +
properly O +
aligned O +
with O +
the O +
catalytic O +
site O +
and O +
can O +
be O +
extended O +
. O +

SII B-Gene +
also O +
induces O +
nascent O +
transcript O +
cleavage O +
by O +
paused O +
but O +
non O +
- O +
arrested O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
elongation O +
intermediates O +
, O +
leading O +
to O +
the O +
proposal O +
that O +
pausing O +
may O +
result O +
from O +
reversible O +
displacement O +
of O +
the O +
3 O -
' O +
- O +
end O +
of O +
nascent O +
transcripts O +
from O +
the O +
polymerase B-Gene +
catalytic O +
site O +
. O +

On O +
the O +
basis O +
of O +
evidence O +
consistent O +
with O +
the O +
model O +
that O +
TFIIF B-Gene +
, O +
ELL B-Gene +
, O +
and O +
Elongin B-Gene +
suppress O +
pausing O +
by O +
preventing O +
displacement O +
of O +
the O +
3 O -
' O +
- O +
end O +
of O +
the O +
nascent O +
transcript O +
from O +
the O +
polymerase B-Gene +
catalytic O +
site O +
, O +
we O +
investigated O +
the O +
possibility O +
of O +
cross O +
- O +
talk O +
between O +
SII B-Gene +
and O +
transcription B-Gene +
factors I-Gene +
TFIIF B-Gene +
, O +
ELL B-Gene +
, O +
and O +
Elongin B-Gene +
. O +

These O +
studies O +
led O +
to O +
the O +
discovery O +
that O +
TFIIF B-Gene +
, O +
ELL B-Gene +
, O +
and O +
Elongin B-Gene +
are O +
all O +
capable O +
of O +
inhibiting O +
SII B-Gene +
- O +
induced O +
nascent O +
transcript O +
cleavage O +
by O +
non O +
- O +
arrested O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
elongation O +
intermediates O +
. O +

Here O +
we O +
present O +
these O +
findings O +
, O +
which O +
bring O +
to O +
light O +
a O +
novel O +
activity O +
associated O +
with O +
TFIIF B-Gene +
, O +
ELL B-Gene +
, O +
and O +
Elongin B-Gene +
and O +
suggest O +
that O +
these O +
transcription B-Gene +
factors I-Gene +
may O +
expedite O +
elongation O +
not O +
only O +
by O +
increasing O +
the O +
forward O +
rate O +
of O +
nucleotide O +
addition O +
by O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
, O +
but O +
also O +
by O +
inhibiting O +
SII B-Gene +
- O +
induced O +
nascent O +
transcript O +
cleavage O +
by O +
non O +
- O +
arrested O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
elongation O +
intermediates O +
. O +

Brachytelephalangic O +
dwarfism O +
due O +
to O +
the O +
loss O +
of O +
ARSE B-Gene +
and O +
SHOX B-Gene +
genes O +
resulting O +
from O +
an O +
X O +
; O +
Y O +
translocation O +
. O +

Here O +
we O +
report O +
an O +
8 O +
- O +
year O +
- O +
old O +
male O +
patient O +
who O +
had O +
mesomelic O +
shortening O +
of O +
forearms O +
and O +
legs O +
, O +
brachytelephalangia O +
and O +
ichthyotic O +
skin O +
lesions O +
. O +

Chromosomal O +
analysis O +
showed O +
an O +
X O +
; O +
Y O +
translocation O +
involving O +
the O +
short O +
arm O +
of O +
the O +
X O +
chromosome O +
( O +
Xp O +
) O +
. O +

Fluorescence O +
in O +
situ O +
hybridization O +
( O +
FISH O +
) O +
and O +
molecular O +
studies O +
localized O +
the O +
breakpoints O +
on O +
Xp22.3 O +
in O +
the O +
immediate O +
vicinity O +
of O +
the O +
KAL B-Gene +
gene O +
demonstrating O +
deletions O +
of O +
steroid B-Gene +
sulfatase I-Gene +
( O +
STS B-Gene +
) O +
, O +
arylsulfatase B-Gene +
E I-Gene +
( O +
ARSE B-Gene +
) O +
, O +
and O +
short B-Gene +
stature I-Gene +
homeo I-Gene +
box I-Gene +
( O +
SHOX B-Gene +
) O +
genes O +
. O +

It O +
was O +
suspected O +
that O +
the O +
patient O +
was O +
suffering O +
from O +
chondrodysplasia O +
punctata O +
because O +
of O +
a O +
loss O +
of O +
the O +
arylsulfatase B-Gene +
E I-Gene +
( O +
ARSE B-Gene +
) O +
gene O +
. O +

However O +
, O +
no O +
stippled O +
epiphyses O +
were O +
to O +
be O +
seen O +
in O +
the O +
neonatal O +
radiograph O +
. O +

Interestingly O +
, O +
this O +
patient O +
is O +
the O +
first O +
case O +
with O +
a O +
proven O +
loss O +
of O +
the O +
ARSE B-Gene +
gene O +
without O +
chondrodysplasia O +
punctata O +
, O +
assuming O +
that O +
chondrodysplasia O +
punctata O +
is O +
not O +
an O +
obligatory O +
sign O +
of O +
ARSE B-Gene +
gene O +
loss O +
. O +

Brachytelephalangia O +
was O +
the O +
only O +
result O +
of O +
ARSE B-Gene +
gene O +
deletion O +
in O +
this O +
case O +
. O +

The O +
patient O +
's O +
mother O +
also O +
had O +
dwarfism O +
and O +
showed O +
Madelung O +
deformity O +
of O +
the O +
forearms O +
. O +

She O +
was O +
detected O +
as O +
a O +
carrier O +
of O +
the O +
same O +
aberrant O +
X O +
chromosome O +
. O +

The O +
male O +
patient O +
did O +
not O +
show O +
Madelung O +
deformity O +
, O +
demonstrating O +
that O +
Lerri O +
- O +
Weill O +
syndrome O +
phenotype O +
may O +
be O +
still O +
incomplete O +
in O +
children O +
with O +
SHOX B-Gene +
gene O +
deletion O +
. O +

The O +
wide O +
clinical O +
spectrum O +
in O +
the O +
male O +
and O +
the O +
Leri O +
- O +
Weill O +
phenotype O +
in O +
his O +
mother O +
are O +
the O +
results O +
of O +
both O +
a O +
deletion O +
involving O +
several O +
sulfatase B-Gene +
genes O +
in O +
Xp22.3 O +
and O +
the O +
SHOX B-Gene +
gene O +
located O +
in O +
the O +
pseudoautosomal O +
region O +
. O +

Nevertheless O +
, O +
there O +
is O +
no O +
explanation O +
for O +
the O +
absence O +
of O +
chondrodysplasia O +
punctata O +
despite O +
the O +
total O +
loss O +
of O +
the O +
ARSE B-Gene +
gene O +
. O +

Further O +
studies O +
are O +
necessary O +
to O +
investigate O +
genotype O +
/ O +
phenotype O +
correlation O +
in O +
cases O +
with O +
translocations O +
or O +
microdeletions O +
on O +
Xp22.3 O +
, O +
including O +
the O +
ARSE B-Gene +
and O +
the O +
SHOX B-Gene +
gene O +
loci O +
. O +

The O +
human O +
tumor O +
suppressor O +
arf B-Gene +
interacts O +
with O +
spinophilin B-Gene +
/ O +
neurabin B-Gene +
II I-Gene +
, O +
a O +
type O +
1 O +
protein B-Gene +
- I-Gene +
phosphatase I-Gene +
- O +
binding O +
protein O +
. O +

The O +
INK4a B-Gene +
gene O +
, O +
one O +
of O +
the O +
most O +
often O +
disrupted O +
loci O +
in O +
human O +
cancer O +
, O +
encodes O +
two O +
unrelated O +
proteins O +
, O +
p16 B-Gene +
( I-Gene +
INK4a I-Gene +
) I-Gene +
and O +
p14 B-Gene +
( I-Gene +
ARF I-Gene +
) I-Gene +
( O +
ARF B-Gene +
) O +
both O +
capable O +
of O +
inducing O +
cell O +
cycle O +
arrest O +
. O +

Although O +
it O +
has O +
been O +
clearly O +
demonstrated O +
that O +
ARF B-Gene +
inhibits O +
cell O +
cycle O +
via O +
p53 B-Gene +
stabilization O +
, O +
very O +
little O +
is O +
known O +
about O +
the O +
involvement O +
of O +
ARF B-Gene +
in O +
other O +
cell O +
cycle O +
regulatory O +
pathways O +
, O +
as O +
well O +
as O +
on O +
the O +
mechanisms O +
responsible O +
for O +
activating O +
ARF B-Gene +
following O +
oncoproliferative O +
stimuli O +
. O +

In O +
search O +
of O +
factors O +
that O +
might O +
associate O +
with O +
ARF B-Gene +
to O +
control O +
its O +
activity O +
or O +
its O +
specificity O +
, O +
we O +
performed O +
a O +
yeast O +
two O +
- O +
hybrid O +
screen O +
. O +

We O +
report O +
here O +
that O +
the O +
human O +
homologue O +
of O +
spinophilin B-Gene +
/ O +
neurabin B-Gene +
II I-Gene +
, O +
a O +
regulatory O +
subunit O +
of O +
protein B-Gene +
phosphatase I-Gene +
1 I-Gene +
catalytic I-Gene +
subunit I-Gene +
specifically O +
interacts O +
with O +
ARF B-Gene +
, O +
both O +
in O +
yeast O +
and O +
in O +
mammalian O +
cells O +
. O +

We O +
also O +
show O +
that O +
ectopic O +
expression O +
of O +
spinophilin B-Gene +
/ O +
neurabin B-Gene +
II I-Gene +
inhibits O +
the O +
formation O +
of O +
G418 O +
- O +
resistant O +
colonies O +
when O +
transfected O +
into O +
human O +
and O +
mouse O +
cell O +
lines O +
, O +
regardless O +
of O +
p53 B-Gene +
and O +
ARF B-Gene +
status O +
. O +

Moreover O +
, O +
spinophilin B-Gene +
/ O +
ARF B-Gene +
coexpression O +
in O +
Saos-2 O +
cells O +
, O +
where O +
ARF B-Gene +
ectopic O +
expression O +
is O +
ineffective O +
, O +
somehow O +
results O +
in O +
a O +
synergic O +
effect O +
. O +

These O +
data O +
demonstrate O +
a O +
role O +
for O +
spinophilin B-Gene +
in O +
cell O +
growth O +
and O +
suggest O +
that O +
ARF B-Gene +
and O +
spinophilin B-Gene +
could O +
act O +
in O +
partially O +
overlapping O +
pathways O +
. O +

Thrombin B-Gene +
regulates O +
vascular O +
smooth O +
muscle O +
cell O +
growth O +
and O +
heat B-Gene +
shock I-Gene +
proteins I-Gene +
via O +
the O +
JAK B-Gene +
- O +
STAT B-Gene +
pathway O +
. O +

The O +
growth O +
- O +
stimulating O +
effects O +
of O +
thrombin B-Gene +
are O +
mediated O +
primarily O +
via O +
activation O +
of O +
a O +
G B-Gene +
protein I-Gene +
- I-Gene +
coupled I-Gene +
receptor I-Gene +
, O +
PAR-1 B-Gene +
. O +

Because O +
PAR-1 B-Gene +
has O +
no O +
intrinsic O +
tyrosine B-Gene +
kinase I-Gene +
activity O +
, O +
yet O +
requires O +
tyrosine O +
phosphorylation O +
events O +
to O +
induce O +
mitogenesis O +
, O +
we O +
investigated O +
the O +
role O +
of O +
the O +
Janus B-Gene +
tyrosine I-Gene +
kinases I-Gene +
( O +
JAKs B-Gene +
) O +
in O +
thrombin B-Gene +
- O +
mediated O +
signaling O +
. O +

JAK2 B-Gene +
was O +
activated O +
rapidly O +
in O +
rat O +
vascular O +
smooth O +
muscle O +
cells O +
( O +
VSMC O +
) O +
treated O +
with O +
thrombin B-Gene +
, O +
and O +
signal B-Gene +
transducers I-Gene +
and I-Gene +
activators I-Gene +
of I-Gene +
transcription I-Gene +
( O +
STAT1 B-Gene +
and O +
STAT3 B-Gene +
) O +
were O +
phosphorylated O +
and O +
translocated O +
to O +
the O +
nucleus O +
in O +
a O +
JAK2 B-Gene +
- O +
dependent O +
manner O +
. O +

AG-490 O +
, O +
a O +
JAK2 B-Gene +
- O +
specific O +
inhibitor O +
, O +
and O +
a O +
dominant O +
negative O +
JAK2 B-Gene +
mutant O +
inhibited O +
thrombin B-Gene +
- O +
induced O +
ERK2 B-Gene +
activity O +
and O +
VSMC O +
proliferation O +
suggesting O +
that O +
JAK2 B-Gene +
is O +
upstream O +
of O +
the O +
Ras B-Gene +
/ O +
Raf B-Gene +
/ O +
MEK B-Gene +
/ O +
ERK B-Gene +
pathway O +
. O +

To O +
elucidate O +
the O +
functional O +
significance O +
of O +
JAK B-Gene +
- O +
STAT B-Gene +
activation O +
, O +
we O +
studied O +
the O +
effect O +
of O +
thrombin B-Gene +
on O +
heat B-Gene +
shock I-Gene +
protein I-Gene +
( O +
Hsp B-Gene +
) O +
expression O +
, O +
based O +
upon O +
the O +
following O +
: O +
1 O +
) O +
reports O +
that O +
thrombin B-Gene +
stimulates O +
reactive O +
oxygen O +
species O +
production O +
in O +
VSMC O +
; O +
2 O -
) O +
the O +
putative O +
role O +
of O +
Hsps B-Gene +
in O +
modulating O +
cellular O +
responses O +
to O +
reactive O +
oxygen O +
species O +
; O +
and O +
3 O -
) O +
the O +
presence O +
of O +
functional O +
STAT1 B-Gene +
/ I-Gene +
3 I-Gene +
- O +
binding O +
sites O +
in O +
Hsp70 B-Gene +
and O +
Hsp90beta B-Gene +
promoters O +
. O +

Indeed O +
, O +
thrombin O +
up O +
- O +
regulated O +
Hsp70 B-Gene +
and O +
Hsp90 B-Gene +
protein O +
expression O +
via O +
enhanced O +
binding O +
of O +
STATs B-Gene +
to O +
cognate O +
binding O +
sites O +
in O +
the O +
Hsp70 B-Gene +
and O +
Hsp90 B-Gene +
promoters O +
. O +

Together O +
, O +
these O +
results O +
suggest O +
that O +
JAK B-Gene +
- O +
STAT B-Gene +
pathway O +
activation O +
is O +
necessary O +
for O +
thrombin B-Gene +
- O +
induced O +
VSMC O +
growth O +
and O +
Hsp B-Gene +
gene O +
expression O +
. O +

Gaf-1 B-Gene +
, O +
a O +
gamma B-Gene +
- I-Gene +
SNAP I-Gene +
- O +
binding O +
protein O +
associated O +
with O +
the O +
mitochondria O +
. O +

The O +
role O +
of O +
alpha B-Gene -
/ I-Gene -
beta I-Gene -
- I-Gene -
SNAP I-Gene +
( O +
Soluble B-Gene +
NSF I-Gene +
Attachment I-Gene +
Protein I-Gene +
) O +
in O +
vesicular O +
trafficking O +
is O +
well O +
established O +
; O +
however O +
, O +
the O +
function O +
of O +
the O +
ubiquitously O +
expressed O +
gamma B-Gene -
- I-Gene -
SNAP I-Gene +
remains O +
unclear O +
. O +

To O +
further O +
characterize O +
the O +
cellular O +
role O +
of O +
this O +
enigmatic O +
protein O +
, O +
a O +
two O +
- O +
hybrid O +
screen O +
was O +
used O +
to O +
identify O +
new O +
, O +
gamma B-Gene -
- I-Gene -
SNAP I-Gene +
- O +
binding O +
proteins O +
and O +
to O +
uncover O +
potentially O +
novel O +
functions O +
for O +
gamma B-Gene -
- I-Gene -
SNAP I-Gene +
. O +

One O +
such O +
SNAP B-Gene +
- O +
binding O +
protein O +
, O +
termed O +
Gaf-1 B-Gene +
( O +
gamma B-Gene -
- I-Gene -
SNAP I-Gene +
associate I-Gene +
factor-1 I-Gene -
) I-Gene +
specifically O +
binds O +
gamma B-Gene +
- I-Gene +
but I-Gene +
not I-Gene +
alpha I-Gene -
- I-Gene -
SNAP I-Gene +
. O +

The O +
full O +
- O +
length O +
Gaf-1 B-Gene +
( O +
75 O +
kDa O +
) O +
is O +
ubiquitously O +
expressed O +
and O +
is O +
found O +
stoichiometrically O +
associated O +
with O +
gamma B-Gene -
- I-Gene -
SNAP I-Gene +
in O +
cellular O +
extracts O +
. O +

This O +
binding O +
is O +
distinct O +
from O +
other O +
SNAP B-Gene +
interactions O +
since O +
no O +
alpha B-Gene -
- I-Gene -
SNAP I-Gene +
or O +
NSF B-Gene +
coprecipitated O +
with O +
Gaf-1 B-Gene +
. O +

Subcellular O +
fractionation O +
and O +
immunofluorescence O +
analysis O +
show O +
that O +
Gaf-1 B-Gene +
is O +
peripherally O +
associated O +
with O +
the O +
outer O +
mitochondrial O +
membrane O +
. O +

Only O +
a O +
fraction O +
of O +
gamma B-Gene -
- I-Gene -
SNAP I-Gene +
was O +
mitochondrial O +
with O +
the O +
balance O +
being O +
either O +
cytosolic O +
or O +
associated O +
with O +
other O +
membrane O +
fractions O +
. O +

gamma B-Gene -
- I-Gene -
SNAP I-Gene +
and O +
the O +
C O +
- O +
terminal O +
domain O +
of O +
Gaf-1 B-Gene +
both O +
show O +
a O +
reticular O +
distribution O +
in O +
HEK-293 O +
cells O +
. O +

This O +
reticular O +
structure O +
colocalizes O +
with O +
Gaf-1 B-Gene +
and O +
mitochondria O +
as O +
well O +
as O +
with O +
microtubules O +
but O +
not O +
with O +
other O +
cytoskeletal O +
elements O +
. O +

These O +
data O +
identify O +
a O +
class O +
of O +
gamma B-Gene -
- I-Gene -
SNAP I-Gene +
interactions O +
that O +
is O +
distinct O +
from O +
other O +
members O +
of O +
the O +
SNAP B-Gene +
family I-Gene +
and O +
point O +
to O +
a O +
potential O +
role O +
for O +
gamma B-Gene -
- I-Gene -
SNAP I-Gene +
in O +
mitochondrial O +
dynamics O +
. O +

Identification O +
and O +
characterization O +
of O +
a O +
mammalian O +
enzyme O +
catalyzing O +
the O +
asymmetric O +
oxidative O +
cleavage O +
of O +
provitamin O +
A O +
. O +

In O +
vertebrates O +
, O +
symmetric O +
versus O +
asymmetric O +
cleavage O +
of O +
beta O -
- O -
carotene O +
in O +
the O +
biosynthesis O +
of O +
vitamin O +
A O +
and O +
its O +
derivatives O +
has O +
been O +
controversially O +
discussed O +
. O +

Recently O +
we O +
have O +
been O +
able O +
to O +
identify O +
a O +
cDNA O +
encoding O +
a O +
metazoan O +
beta B-Gene -
, I-Gene -
beta I-Gene -
- I-Gene -
carotene-15,15'-dioxygenase I-Gene +
from O +
the O +
fruit O +
fly O +
Drosophila O +
melanogaster O +
. O +

This O +
enzyme O +
catalyzes O +
the O +
key O +
step O +
in O +
vitamin O +
A O +
biosynthesis O +
, O +
symmetrically O +
cleaving O +
beta O -
- O -
carotene O +
to O +
give O +
two O +
molecules O +
of O +
retinal O +
. O +

Mutations O +
in O +
the O +
corresponding O +
gene O +
are O +
known O +
to O +
lead O +
to O +
a O +
blind O +
, O +
vitamin O +
A O +
- O +
deficient O +
phenotype O +
. O +

Orthologs O +
of O +
this O +
enzyme O +
have O +
very O +
recently O +
been O +
found O +
also O +
in O +
vertebrates O +
and O +
molecularly O +
characterized O +
. O +

Here O +
we O +
report O +
the O +
identification O +
of O +
a O +
cDNA O +
from O +
mouse O +
encoding O +
a O +
second O +
type O +
of O +
carotene B-Gene +
dioxygenase I-Gene +
catalyzing O +
exclusively O +
the O +
asymmetric O +
oxidative O +
cleavage O +
of O +
beta O -
- O -
carotene O +
at O +
the O +
9 O +
' O +
, O +
10 O +
' O +
double O +
bond O +
of O +
beta O -
- O -
carotene O +
and O +
resulting O +
in O +
the O +
formation O +
of O +
beta O -
- O -
apo-10'-carotenal O +
and O +
beta O -
- O -
ionone O +
, O +
a O +
substance O +
known O +
as O +
a O +
floral O +
scent O +
from O +
roses O +
, O +
for O +
example O +
. O +

Besides O +
beta O -
- O -
carotene O +
, O +
lycopene O +
is O +
also O +
oxidatively O +
cleaved O +
by O +
the O +
enzyme O +
. O +

The O +
deduced O +
amino O +
acid O +
sequence O +
shares O +
significant O +
sequence O +
identity O +
with O +
the O +
beta B-Gene -
, I-Gene -
beta I-Gene -
- I-Gene -
carotene-15,15'-dioxygenases I-Gene +
, O +
and O +
the O +
two O +
enzyme O +
types O +
have O +
several O +
conserved O +
motifs O +
. O +

To O +
establish O +
its O +
occurrence O +
in O +
different O +
vertebrates O +
, O +
we O +
then O +
attempted O +
and O +
succeeded O +
in O +
cloning O +
cDNAs O +
encoding O +
this O +
new O +
type O +
of O +
carotene B-Gene +
dioxygenase I-Gene +
from O +
human O +
and O +
zebrafish O +
as O +
well O +
. O +

As O +
regards O +
their O +
possible O +
role O +
, O +
the O +
apocarotenals O +
formed O +
by O +
this O +
enzyme O +
may O +
be O +
the O +
precursors O +
for O +
the O +
biosynthesis O +
of O +
retinoic O +
acid O +
or O +
exert O +
unknown O +
physiological O +
effects O +
. O +

Thus O +
, O +
in O +
contrast O +
to O +
Drosophila O +
, O +
in O +
vertebrates O +
both O +
symmetric O +
and O +
asymmetric O +
cleavage O +
pathways O +
exist O +
for O +
carotenes O +
, O +
revealing O +
a O +
greater O +
complexity O +
of O +
carotene O +
metabolism O +
. O +

Thiazolidinediones O +
but O +
not O +
metformin O +
directly O +
inhibit O +
the O +
steroidogenic O +
enzymes O +
P450c17 B-Gene +
and O +
3beta B-Gene +
- I-Gene +
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
. O +

Androgen O +
biosynthesis O +
requires O +
3beta B-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
type I-Gene +
II I-Gene +
( O +
3betaHSDII B-Gene +
) O +
and O +
the O +
17alpha B-Gene -
- I-Gene -
hydroxylase I-Gene +
and O +
17,20-lyase B-Gene +
activities O +
of O +
cytochrome B-Gene +
P450c17 I-Gene +
. O +

Thiazolidinedione O +
and O +
biguanide O +
drugs O +
, O +
which O +
are O +
used O +
to O +
increase O +
insulin B-Gene +
sensitivity O +
in O +
type O +
2 O +
diabetes O +
, O +
lower O +
serum O +
androgen O +
concentrations O +
in O +
women O +
with O +
polycystic O +
ovary O +
syndrome O +
. O +

However O +
, O +
it O +
is O +
unclear O +
whether O +
this O +
is O +
secondary O +
to O +
increased O +
insulin B-Gene +
sensitivity O +
or O +
to O +
direct O +
effects O +
on O +
steroidogenesis O +
. O +

To O +
investigate O +
potential O +
actions O +
of O +
these O +
drugs O +
on O +
P450c17 B-Gene +
and O +
3betaHSDII B-Gene +
, O +
we O +
used O +
" O +
humanized O +
yeast O +
" O +
that O +
express O +
these O +
steroidogenic O +
enzymes O +
in O +
microsomal O +
environments O +
. O +

The O +
biguanide O +
metformin O +
had O +
no O +
effect O +
on O +
either O +
enzyme O +
, O +
whereas O +
the O +
thiazolidinedione O +
troglitazone O +
inhibited O +
3betaHSDII B-Gene +
( O +
K O -
( O -
I O -
) O +
= O +
25.4 O +
+ O -
/- O +
5.1 O +
microm O +
) O +
and O +
both O +
activities O +
of O +
P450c17 B-Gene +
( O +
K O -
( O -
I O -
) O +
for O +
17alpha O -
- O -
hydroxylase O +
, O +
8.4 O +
+ O -
/- O +
0.6 O +
microm O +
; O +
K O -
( O -
I O -
) O +
for O +
17,20-lyase O +
, O +
5.3 O +
+ O -
/- O +
0.7 O +
microm O +
) O +
. O +

The O +
action O +
of O +
troglitazone O +
on O +
P450c17 B-Gene +
was O +
competitive O +
, O +
but O +
it O +
was O +
mainly O +
a O +
noncompetitive O +
inhibitor O +
of O +
3betaHSDII B-Gene +
. O +

The O +
thiazolidinediones O +
rosiglitazone O +
and O +
pioglitazone O +
exerted O +
direct O +
but O +
weaker O +
inhibitory O +
effects O +
on O +
both O +
P450c17 B-Gene +
and O +
3betaHSDII B-Gene +
. O +

These O +
differential O +
effects O +
of O +
the O +
thiazolidinediones O +
do O +
not O +
correlate O +
with O +
their O +
effects O +
on O +
insulin B-Gene +
sensitivity O +
, O +
suggesting O +
that O +
distinct O +
regions O +
of O +
the O +
thiazolidinedione O +
molecule O +
mediate O +
these O +
two O +
actions O +
. O +

Thus O +
, O +
thiazolidinediones O +
inhibit O +
two O +
key O +
enzymes O +
in O +
human O +
androgen O +
synthesis O +
contributing O +
to O +
their O +
androgen O +
- O +
lowering O +
effects O +
, O +
whereas O +
metformin O +
affects O +
androgen O +
synthesis O +
indirectly O +
, O +
probably O +
by O +
lowering O +
circulating O +
insulin B-Gene +
concentrations O +
. O +

The O +
AraC B-Gene +
transcriptional O +
activators O +
. O +

The O +
AraC B-Gene +
family I-Gene +
of O +
bacterial O +
transcriptional O +
activators O +
regulate O +
diverse O +
genetic O +
systems O +
. O +

Recent O +
X O -
- O -
ray O +
diffraction O +
studies O +
show O +
that O +
the O +
monomeric O +
MarA B-Gene +
and O +
Rob B-Gene +
activators O +
bind O +
to O +
their O +
asymmetric O +
degenerate O +
DNA O +
sites O +
via O +
two O +
different O +
helix O +
- O +
turn O +
- O +
helix O +
elements O +
. O +

Activation O +
by O +
MarA B-Gene +
, O +
SoxS B-Gene +
or O +
Rob B-Gene +
requires O +
a O +
particular O +
orientation O +
of O +
the O +
asymmetric O +
binding O +
sequence O +
( O +
and O +
hence O +
the O +
activator O +
) O +
, O +
depending O +
on O +
its O +
distance O +
from O +
the O +
- O +
10 O +
RNAP B-Gene +
signal O +
. O +

Genetic O +
studies O +
are O +
beginning O +
to O +
clarify O +
how O +
the O +
activators O +
interact O +
with O +
RNAP B-Gene +
. O +

Growing O +
evidence O +
suggests O +
that O +
for O +
the O +
sugar O +
metabolism O +
activators O +
, O +
multiple O +
binding O +
sites O +
upstream O +
of O +
the O +
promoter O +
anchor O +
the O +
activator O +
in O +
a O +
repressing O +
or O +
nonactivating O +
configuration O +
. O +

By O +
interaction O +
with O +
the O +
sugar O +
and/or O +
CRP B-Gene +
, O +
the O +
activator O +
is O +
allosterically O +
altered O +
so O +
it O +
can O +
bind O +
a O +
new O +
set O +
of O +
sites O +
that O +
enable O +
it O +
to O +
activate O +
the O +
promoter O +
. O +

Surprisingly O +
, O +
the O +
virulence O +
activator O +
, O +
Rns B-Gene +
, O +
must O +
bind O +
to O +
both O +
upstream O +
and O +
downstream O +
sites O +
in O +
order O +
to O +
activate O +
the O +
rns B-Gene +
promoter O +
. O +

Involvement O +
of O +
Rel B-Gene +
/ O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
in O +
regulation O +
of O +
ascidian O +
notochord O +
formation O +
. O +

The O +
Rel B-Gene +
/ I-Gene +
NF I-Gene -
- I-Gene -
kappaB I-Gene +
family I-Gene +
is O +
known O +
to O +
be O +
involved O +
in O +
a O +
wide O +
variety O +
of O +
biological O +
processes O +
, O +
including O +
morphogenesis O +
. O +

In O +
the O +
present O +
study O +
, O +
two O +
protochordate O +
cDNA O +
clones O +
encoding O +
Rel B-Gene +
/ O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
proteins O +
, O +
named O +
As O +
- O +
rel1 B-Gene +
and O +
As O +
- O +
rel2 B-Gene +
, O +
were O +
isolated O +
from O +
a O +
fertilized O +
egg O +
cDNA O +
library O +
of O +
the O +
ascidian O +
Halocynthia O +
roretzi O +
. O +

The O +
As O +
- O +
rel1 B-Gene +
protein O +
is O +
a O +
typical O +
Rel B-Gene +
/ I-Gene +
NF I-Gene -
- I-Gene -
kappaB I-Gene +
family I-Gene +
member O +
, O +
containing O +
a O +
Rel B-Gene +
homology O +
domain O +
, O +
a O +
nuclear O +
localization O +
sequence O +
and O +
a O +
C O +
- O +
terminal O +
putative O +
transcription O +
activation O +
domain O +
, O +
while O +
the O +
As O +
- O +
rel2 B-Gene +
protein O +
is O +
a O +
novel O +
Rel B-Gene +
/ I-Gene +
NF I-Gene -
- I-Gene -
kappaB I-Gene +
family I-Gene +
member O +
that O +
lacks O +
a O +
nuclear O +
localization O +
sequence O +
and O +
the O +
C O +
- O +
terminal O +
domain O +
. O +

Northern O +
blot O +
analyses O +
showed O +
that O +
both O +
transcripts O +
were O +
maternally O +
expressed O +
and O +
that O +
their O +
expression O +
changed O +
during O +
development O +
of O +
H. O +
roretzi O +
embryos O +
. O +

Although O +
injection O +
of O +
the O +
As O +
- O +
rel2 B-Gene +
mRNA O +
into O +
H. O +
roretzi O +
fertilized O +
eggs O +
had O +
little O +
effect O +
on O +
embryonic O +
development O +
, O +
injection O +
of O +
the O +
As O +
- O +
rel1 B-Gene +
mRNA O +
interfered O +
greatly O +
with O +
notochord O +
formation O +
, O +
resulting O +
in O +
a O +
shortened O +
tail O +
with O +
a O +
reduced O +
number O +
of O +
notochord O +
cells O +
. O +

In O +
contrast O +
, O +
embryos O +
co O +
- O +
injected O +
with O +
As O +
- O +
rel1 B-Gene +
and O +
As O +
- O +
rel2 B-Gene +
mRNA O +
developed O +
normally O +
, O +
indicating O +
that O +
the O +
As O +
- O +
rel2 B-Gene +
protein O +
rescued O +
the O +
defect O +
in O +
notochord O +
formation O +
induced O +
by O +
the O +
injection O +
of O +
As O +
- O +
rel1 B-Gene +
mRNA O +
alone O +
. O +

These O +
results O +
strongly O +
suggest O +
that O +
the O +
As O +
- O +
rel1 B-Gene +
protein O +
functions O +
as O +
a O +
suppressor O +
in O +
ascidian O +
notochord O +
formation O +
, O +
while O +
the O +
As O +
- O +
rel2 B-Gene +
protein O +
has O +
an O +
antagonistic O +
effect O +
on O +
the O +
action O +
of O +
the O +
As O +
- O +
rel1 B-Gene +
protein O +
. O +

Identification O +
of O +
EPI64 B-Gene +
, O +
a O +
TBC O +
/ O +
rabGAP B-Gene +
domain O +
- O +
containing O +
microvillar O +
protein O +
that O +
binds O +
to O +
the O +
first O +
PDZ O +
domain O +
of O +
EBP50 B-Gene +
and O +
E3KARP B-Gene +
. O +

The O +
cortical O +
scaffolding O +
proteins O +
EBP50 B-Gene +
( O +
ERM B-Gene +
- I-Gene +
binding I-Gene +
phosphoprotein-50 I-Gene +
) O +
and O +
E3KARP B-Gene +
( O +
NHE3 B-Gene +
kinase I-Gene +
A I-Gene +
regulatory I-Gene +
protein I-Gene +
) O +
contain O +
two O +
PDZ O +
( O +
PSD-95 B-Gene +
/ O +
DlgA B-Gene +
/ O +
ZO-1 B-Gene +
- O +
like O +
) O +
domains O +
followed O +
by O +
a O +
COOH O +
- O +
terminal O +
sequence O +
that O +
binds O +
to O +
active O +
ERM O +
family O +
members O +
. O +

Using O +
affinity O +
chromatography O +
, O +
we O +
identified O +
polypeptides O +
from O +
placental O +
microvilli O +
that O +
bind O +
the O +
PDZ O +
domains O +
of O +
EBP50 B-Gene +
. O +

Among O +
these O +
are O +
64 O +
- O +
and/or O +
65 O +
- O +
kD O +
differentially O +
phosphorylated O +
polypeptides O +
that O +
bind O +
preferentially O +
to O +
the O +
first O +
PDZ O +
domain O +
of O +
EBP50 B-Gene +
, O +
as O +
well O +
as O +
to O +
E3KARP B-Gene +
, O +
and O +
that O +
we O +
call O +
EPI64 B-Gene +
( O +
EBP50 B-Gene +
- I-Gene +
PDZ I-Gene +
interactor I-Gene +
of I-Gene +
64 I-Gene +
kD I-Gene +
) O +
. O +

The O +
gene O +
for O +
human O +
EPI64 B-Gene +
lies O +
on O +
chromosome O +
22 O +
where O +
nine O +
exons O +
specify O +
a O +
protein O +
of O +
508 O +
residues O +
that O +
contains O +
a O +
Tre B-Gene +
/ O +
Bub2 B-Gene +
/ O +
Cdc16 B-Gene +
( O +
TBC O +
) O +
/ O +
rab B-Gene +
GTPase I-Gene +
- I-Gene +
activating I-Gene +
protein I-Gene +
( O +
GAP B-Gene +
) O +
domain O +
. O +

EPI64 B-Gene +
terminates O +
in O +
DTYL O +
, O +
which O +
is O +
necessary O +
for O +
binding O +
to O +
the O +
PDZ O +
domains O +
of O +
EBP50 B-Gene +
, O +
as O +
a O +
mutant O +
ending O +
in O +
DTYLA O +
no O +
longer O +
interacts O +
. O +

EPI64 B-Gene +
colocalizes O +
with O +
EBP50 B-Gene +
and O +
ezrin B-Gene +
in O +
syncytiotrophoblast O +
and O +
cultured O +
cell O +
microvilli O +
, O +
and O +
this O +
localization O +
in O +
cultured O +
cells O +
is O +
abolished O +
by O +
introduction O +
of O +
the O +
DTYLA O +
mutation O +
. O +

In O +
addition O +
to O +
EPI64 B-Gene +
, O +
immobilized O +
EBP50 B-Gene +
PDZ O +
domains O +
retain O +
several O +
polypeptides O +
from O +
placental O +
microvilli O +
, O +
including O +
an O +
isoform O +
of O +
nadrin B-Gene +
, O +
a O +
rhoGAP B-Gene +
domain O +
- O +
containing O +
protein O +
implicated O +
in O +
regulating O +
vesicular O +
transport O +
. O +

Nadrin B-Gene +
binds O +
EBP50 B-Gene +
directly O +
, O +
probably O +
through O +
its O +
COOH O +
- O +
terminal O +
STAL O +
sequence O +
. O +

Thus O +
, O +
EBP50 B-Gene +
appears O +
to O +
bind O +
membrane O +
proteins O +
as O +
well O +
as O +
factors O +
potentially O +
involved O +
in O +
regulating O +
membrane O +
traffic O +
. O +

Apolipoprotein B-Gene +
L I-Gene +
gene I-Gene +
family I-Gene +
: O +
tissue O +
- O +
specific O +
expression O +
, O +
splicing O +
, O +
promoter O +
regions O +
; O +
discovery O +
of O +
a O +
new O +
gene O +
. O +

Previously O +
we O +
identified O +
and O +
cloned O +
the O +
cDNA O +
for O +
a O +
new O +
protein O +
, O +
apolipoprotein B-Gene +
L I-Gene +
( O +
apoL B-Gene +
) O +
, O +
present O +
in O +
plasma O +
and O +
mainly O +
associated O +
with O +
large B-Gene +
high I-Gene +
density I-Gene +
lipoprotein I-Gene +
particles O +
. O +

Using O +
5 O -
' O +
rapid O +
amplification O +
of O +
cDNA O +
ends O +
, O +
RT O +
- O +
PCR O +
and O +
comparison O +
with O +
three O +
Human O +
Genome O +
Project O +
and O +
three O +
expressed O +
sequence O +
tag O +
sequences O +
, O +
we O +
have O +
characterized O +
the O +
gene O +
for O +
apoL B-Gene +
and O +
for O +
three O +
additional O +
, O +
highly O +
homologous O +
proteins O +
that O +
constitute O +
a O +
new O +
family O +
of O +
proteins O +
that O +
display O +
no O +
homology O +
with O +
previously O +
described O +
apolipoproteins B-Gene +
. O +

The O +
genes O +
for O +
all O +
four O +
proteins O +
, O +
apoL B-Gene +
- I-Gene +
I I-Gene +
, O +
apoL B-Gene +
- I-Gene +
II I-Gene +
, O +
apoL B-Gene +
- I-Gene +
III I-Gene +
, O +
and O +
apoL B-Gene +
- I-Gene +
IV I-Gene +
, O +
are O +
located O +
at O +
chromosome O +
22q12.1 O +
- O +
13.1 O +
within O +
a O +
127,000 O +
- O +
bp O +
region O +
. O +

The O +
apoL B-Gene -
- I-Gene -
I I-Gene +
gene O +
is O +
in O +
the O +
opposite O +
orientation O +
to O +
the O +
other O +
three O +
. O +

All O +
four O +
genes O +
have O +
TATA O +
- O +
less O +
promoters O +
, O +
which O +
contain O +
putative O +
sterol O +
regulatory O +
elements O +
, O +
suggesting O +
that O +
transcription O +
of O +
these O +
genes O +
may O +
be O +
coordinated O +
with O +
that O +
of O +
the O +
low B-Gene +
density I-Gene +
lipoprotein I-Gene +
receptor I-Gene +
and O +
genes O +
in O +
pathways O +
involving O +
the O +
synthesis O +
of O +
triglycerides O +
and O +
cholesterol O +
. O +

The O +
gene O +
family O +
has O +
a O +
consensus O +
eight O +
- O +
exon O +
structure O +
with O +
alternative O +
splice O +
sites O +
that O +
could O +
produce O +
as O +
many O +
as O +
eight O +
distinct O +
gene O +
products O +
. O +

The O +
apoL B-Gene -
- I-Gene -
II I-Gene +
and O +
apoL B-Gene +
- I-Gene +
III I-Gene +
genes O +
have O +
alternative O +
transcriptional O +
start O +
sites O +
as O +
a O +
result O +
of O +
additional O +
5 O -
' O +
exons O +
. O +

apoL B-Gene -
- I-Gene -
I I-Gene +
, O +
apoL B-Gene -
- I-Gene -
II I-Gene +
, O +
and O +
apoL B-Gene -
- I-Gene -
III I-Gene +
are O +
expressed O +
to O +
the O +
highest O +
degree O +
in O +
the O +
lung O +
. O +

Other O +
tissues O +
with O +
high O +
expression O +
are O +
the O +
pancreas O +
, O +
prostate O +
, O +
spleen O +
, O +
liver O +
, O +
and O +
placenta O +
. O +

Four O +
clustered O +
common O +
polymorphisms O +
, O +
three O +
of O +
which O +
altered O +
the O +
protein O +
sequence O +
, O +
were O +
found O +
in O +
apoL B-Gene -
- I-Gene -
I I-Gene +
, O +
all O +
in O +
linkage O +
disequilibrium O +
, O +
and O +
describing O +
two O +
haplotypes O +
: O +
the O +
more O +
common O +
Lys166 O +
/ O +
Ile244 O +
/ O +
Lys271 O +
and O +
the O +
rarer O +
Glu166 O +
/ O +
Met244 O +
/ O +
Arg271 O +
. O +

Platelet B-Gene +
- I-Gene +
derived I-Gene +
growth I-Gene +
factor I-Gene +
C I-Gene +
( O +
PDGF B-Gene -
- I-Gene -
C I-Gene +
) O +
, O +
a O +
novel O +
growth B-Gene +
factor I-Gene +
that O +
binds O +
to O +
PDGF B-Gene +
alpha I-Gene +
and I-Gene +
beta I-Gene +
receptor I-Gene +
. O +

We O +
have O +
characterized O +
platelet B-Gene +
- I-Gene +
derived I-Gene +
growth I-Gene +
factor I-Gene +
( I-Gene +
PDGF I-Gene +
) I-Gene +
C I-Gene +
, O +
a O +
novel O +
growth B-Gene +
factor I-Gene +
belonging O +
to O +
the O +
PDGF B-Gene +
family I-Gene +
. O +

PDGF B-Gene -
- I-Gene -
C I-Gene +
is O +
a O +
multidomain O +
protein O +
with O +
the O +
N O +
- O +
terminal O +
region O +
homologous O +
to O +
the O +
extracellular O +
CUB O +
domain O +
of O +
neuropilin-1 B-Gene +
, O +
and O +
the O +
C O +
- O +
terminal O +
region O +
consists O +
of O +
a O +
growth B-Gene +
factor I-Gene +
domain O +
( O +
GFD O +
) O +
with O +
homology O +
to O +
vascular B-Gene +
endothelial I-Gene +
growth I-Gene +
factor I-Gene +
( O +
25 O +
% O +
) O +
and O +
PDGF B-Gene +
A I-Gene +
- O +
chain O +
( O +
23 O +
% O +
) O +
. O +

A O +
serum O +
- O +
sensitive O +
cleavage O +
site O +
between O +
the O +
two O +
domains O +
allows O +
release O +
of O +
the O +
GFD O +
from O +
the O +
CUB O +
domain O +
. O +

Competition O +
binding O +
and O +
immunoprecipitation O +
studies O +
on O +
cells O +
bearing O +
both O +
PDGF B-Gene +
alpha I-Gene +
and I-Gene +
beta I-Gene +
receptors I-Gene +
reveal O +
a O +
high O +
affinity O +
binding O +
of O +
recombinant O +
GFD O +
( O +
PDGF B-Gene -
- I-Gene -
CC I-Gene +
) O +
to O +
PDGF B-Gene +
receptor I-Gene +
- I-Gene +
alpha I-Gene +
homodimers O +
and O +
PDGF B-Gene +
receptor I-Gene +
- I-Gene +
alpha I-Gene +
/ I-Gene +
beta I-Gene +
heterodimers O +
. O +

PDGF B-Gene -
- I-Gene -
CC I-Gene +
exhibits O +
greater O +
mitogenic O +
potency O +
than O +
PDGF B-Gene -
- I-Gene -
AA I-Gene +
and O +
comparable O +
or O +
greater O +
mitogenic O +
activity O +
than O +
PDGF B-Gene -
- I-Gene -
AB I-Gene +
and O +
PDGF B-Gene -
- I-Gene -
BB I-Gene +
on O +
several O +
mesenchymal O +
cell O +
types O +
. O +

Analysis O +
of O +
PDGF B-Gene -
- I-Gene -
CC I-Gene +
in O +
vivo O +
in O +
a O +
diabetic O +
mouse O +
model O +
of O +
delayed O +
wound O +
healing O +
showed O +
that O +
PDGF B-Gene -
- I-Gene -
CC I-Gene +
significantly O +
enhanced O +
repair O +
of O +
a O +
full O +
- O +
thickness O +
skin O +
excision O +
. O +

Together O +
, O +
these O +
studies O +
describe O +
a O +
third O +
member O +
of O +
the O +
PDGF B-Gene +
family I-Gene +
( O +
PDGF B-Gene -
- I-Gene -
C I-Gene +
) O +
as O +
a O +
potent O +
mitogen O +
for O +
cells O +
of O +
mesenchymal O +
origin O +
in O +
in O +
vitro O +
and O +
in O +
vivo O +
systems O +
with O +
a O +
binding O +
pattern O +
similar O +
to O +
PDGF B-Gene -
- I-Gene -
AB I-Gene +
. O +

IL-10 B-Gene +
mediation O +
of O +
activation O +
- O +
induced O +
TH1 O +
cell O +
apoptosis O +
and O +
lymphoid O +
dysfunction O +
in O +
polymicrobial O +
sepsis O +
. O +

Recent O +
studies O +
suggest O +
that O +
increased O +
activation O +
- O +
induced O +
lymphocyte O +
apoptosis O +
( O +
AICD O +
) O +
is O +
detected O +
in O +
mouse O +
splenocytes O +
during O +
polymicrobial O +
sepsis O +
which O +
may O +
contribute O +
to O +
lymphocyte O +
immune O +
dysfunction O +
[ O +
i.e. O +
, O +
decreased O +
interleukin B-Gene +
( I-Gene +
IL- I-Gene -
) I-Gene +
2 I-Gene +
and O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
( O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
production O +
] O +
leading O +
to O +
the O +
associated O +
morbidity O +
seen O +
in O +
those O +
animals O +
. O +

Thus O +
, O +
we O +
wanted O +
to O +
examine O +
the O +
hypothesis O +
that O +
immune O +
suppressive O +
agents O +
, O +
such O +
as O +
IL-4 B-Gene +
, O +
IL-10 B-Gene +
or O +
prostaglandin O +
E2 O +
( O +
PGE2 O +
) O +
, O +
known O +
to O +
be O +
elevated O +
in O +
septic O +
animals O +
, O +
also O +
contribute O +
to O +
this O +
increase O +
in O +
AICD O +
. O +

Here O +
we O +
demonstrate O +
that O +
the O +
inclusion O +
of O +
monoclonal O +
antibody O +
( O +
mAb O +
) O +
to O +
IL-10 B-Gene +
, O +
but O +
not O +
anti O +
- O +
IL-4 B-Gene +
or O +
ibuprofen O +
( O +
IBU O +
) O +
, O +
blunted O +
this O +
sepsis O +
induced O +
increase O +
in O +
splenocyte O +
AICD O +
. O +

Additionally O +
, O +
septic O +
mice O +
deficient O +
in O +
the O +
IL-10 B-Gene +
gene O +
product O +
( O +
- O -
/ O -
- O +
) O +
showed O +
neither O +
an O +
increase O +
in O +
AICD O +
nor O +
a O +
loss O +
of O +
IL-2 B-Gene +
/ O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
release O +
capacity O +
. O +

Interestingly O +
, O +
mAb O +
to O +
IL-10 B-Gene +
did O +
not O +
altered O +
the O +
extent O +
of O +
AICD O +
in O +
a O +
Th2 O +
- O +
cell O +
line O +
, O +
but O +
exogenous O +
IL-10 B-Gene +
did O +
potentiate O +
Th1 O +
- O +
like O +
cell O +
line O +
AICD O +
. O +

This O +
was O +
consistent O +
with O +
the O +
finding O +
that O +
the O +
increased O +
AICD O +
seen O +
in O +
septic O +
mouse O +
splenocytes O +
was O +
restricted O +
largely O +
to O +
the O +
CD4 B-Gene +
+ O +
cells O +
producing O +
IL-2 B-Gene +
( O +
Th1 O +
- O +
cells O +
) O +
and O +
that O +
mAb O +
to O +
IL-10 B-Gene +
treatment O +
suppressed O +
this O +
change O +
. O +

Furthermore O +
, O +
IL-10 B-Gene +
appears O +
to O +
mediate O +
its O +
AICD O +
effect O +
by O +
upregulation O +
of O +
the O +
Fas B-Gene +
receptor O +
and O +
Fas B-Gene +
receptor O +
signaling O +
protein O +
components O +
, O +
but O +
not O +
by O +
altered O +
expression O +
of O +
Bcl B-Gene +
/ I-Gene +
Bax I-Gene +
/ I-Gene +
Bad I-Gene +
family I-Gene +
members O +
, O +
in O +
septic O +
mouse O +
splenocytes O +
. O +

To O +
the O +
extent O +
that O +
these O +
processes O +
contribute O +
in O +
a O +
pathological O +
fashion O +
to O +
the O +
animal O +
's O +
capacity O +
to O +
survive O +
sepsis O +
we O +
have O +
previously O +
observed O +
that O +
in O +
vivo O +
post O +
- O +
treatment O +
of O +
mice O +
with O +
mAb O +
IL-10 B-Gene +
markedly O +
attenuated O +
septic O +
mortality O +
. O +

Collectively O +
, O +
these O +
data O +
indicate O +
that O +
in O +
the O +
septic O +
mouse O +
the O +
Th2 O +
cytokine B-Gene +
IL-10 B-Gene +
not O +
only O +
serves O +
to O +
actively O +
induce O +
Th1 O +
lymphocyte O +
immune O +
dysfunction O +
but O +
also O +
plays O +
a O +
role O +
in O +
their O +
apoptotic O +
depletion O +
. O +

These O +
processes O +
in O +
turn O +
appear O +
to O +
contribute O +
to O +
the O +
animal O +
's O +
inability O +
to O +
ward O +
off O +
lethal O +
septic O +
challenge O +
. O +

Molecular O +
characterization O +
of O +
tomato O +
3-dehydroquinate B-Gene +
dehydratase I-Gene +
- I-Gene +
shikimate I-Gene +
: I-Gene +
NADP I-Gene +
oxidoreductase I-Gene +
. O +

Analysis O +
of O +
cDNAs O +
encoding O +
the O +
bifunctional O +
3-dehydroquinate B-Gene +
dehydratase I-Gene +
- I-Gene +
shikimate I-Gene +
: I-Gene +
NADP I-Gene +
oxidoreductase I-Gene +
( O +
DHQase B-Gene +
- I-Gene +
SORase I-Gene +
) O +
from O +
tomato O +
( O +
Lycopersicon O +
esculentum O +
) O +
revealed O +
two O +
classes O +
of O +
cDNAs O +
that O +
differed O +
by O +
57 O +
bp O +
within O +
the O +
coding O +
regions O +
, O +
but O +
were O +
otherwise O +
identical O +
. O +

Comparison O +
of O +
these O +
cDNA O +
sequences O +
with O +
the O +
sequence O +
of O +
the O +
corresponding O +
single O +
gene O +
unequivocally O +
proved O +
that O +
the O +
primary O +
transcript O +
is O +
differentially O +
spliced O +
, O +
potentially O +
giving O +
rise O +
to O +
two O +
polypeptides O +
that O +
differ O +
by O +
19 O +
amino O +
acids O +
. O +

Quantitative O +
real O +
- O +
time O +
polymerase O +
chain O +
reaction O +
revealed O +
that O +
the O +
longer O +
transcript O +
constitutes O +
at O +
most O +
1 O +
% O +
to O +
2 O +
% O +
of O +
DHQase B-Gene +
- I-Gene +
SORase I-Gene +
transcripts O +
. O +

Expression O +
of O +
the O +
respective O +
polypeptides O +
in O +
Escherichia O +
coli O +
mutants O +
lacking O +
the O +
DHQase B-Gene +
or O +
the O +
SORase B-Gene +
activity O +
gave O +
functional O +
complementation O +
only O +
in O +
case O +
of O +
the O +
shorter O +
polypeptide O +
, O +
indicating O +
that O +
skipping O +
of O +
a O +
potential O +
exon O +
is O +
a O +
prerequisite O +
for O +
the O +
production O +
of O +
an O +
enzymatically O +
active O +
protein O +
. O +

The O +
deduced O +
amino O +
acid O +
sequence O +
revealed O +
that O +
the O +
DHQase B-Gene +
- I-Gene +
SORase I-Gene +
is O +
most O +
likely O +
synthesized O +
as O +
a O +
precursor O +
with O +
a O +
very O +
short O +
( O +
13-amino O +
acid O +
) O +
plastid O +
- O +
specific O +
transit O +
peptide O +
. O +

Like O +
other O +
genes O +
encoding O +
enzymes O +
of O +
the O +
prechorismate O +
pathway O +
in O +
tomato O +
, O +
this O +
gene O +
is O +
elicitor O +
- O +
inducible O +
. O +

Tissue O +
- O +
specific O +
expression O +
resembles O +
the O +
patterns O +
obtained O +
for O +
3-deoxy B-Gene -
- I-Gene -
D I-Gene -
- I-Gene -
arabino I-Gene -
- I-Gene -
heptulosonate I-Gene +
7-phosphate I-Gene +
synthase I-Gene +
2 I-Gene +
and O +
dehydroquinate B-Gene +
synthase I-Gene +
genes O +
. O +

This O +
work O +
completes O +
our O +
studies O +
of O +
the O +
prechorismate O +
pathway O +
in O +
that O +
cDNAs O +
for O +
all O +
seven O +
enzymes O +
( O +
including O +
isozymes O +
) O +
of O +
the O +
prechorismate O +
pathway O +
from O +
tomato O +
have O +
now O +
been O +
characterized O +
. O +

A O +
novel O +
actin B-Gene +
- I-Gene +
related I-Gene +
protein I-Gene +
gene O +
of O +
Colletotrichum O +
gloeosporioides O +
f. O +
sp. O +
malvae O +
shows O +
altered O +
expression O +
corresponding O +
with O +
spore O +
production O +
. O +

A O +
novel O +
actin B-Gene +
- I-Gene +
related I-Gene +
protein I-Gene +
( O +
arp B-Gene +
) O +
was O +
found O +
in O +
the O +
plant O +
pathogenic O +
fungus O +
, O +
Colletotrichum O +
gloeosporioides O +
f. O +
sp. O +
malvae O +
( O +
Cgm O +
) O +
, O +
which O +
causes O +
anthracnose O +
disease O +
of O +
round O +
- O +
leaved O +
mallow O +
( O +
Malva O +
pusilla O +
) O +
. O +

Sequence O +
comparisons O +
showed O +
that O +
this O +
gene O +
, O +
arpA B-Gene +
, O +
belongs O +
to O +
the O +
highly O +
divergent O +
' O +
other O +
arps B-Gene +
' O +
category O +
in O +
the O +
current O +
arp B-Gene +
classification O +
system O +
. O +

ArpA B-Gene +
is O +
most O +
similar O +
to O +
the O +
arp11 B-Gene +
gene O +
of O +
Mus O +
musculus O +
but O +
has O +
a O +
unique O +
structure O +
with O +
deletions O +
at O +
the O +
C O +
- O +
terminus O +
similar O +
to O +
that O +
of O +
the O +
arp10 B-Gene +
gene O +
of O +
Saccharomyces O +
cerevisiae O +
. O +

A O +
portion O +
of O +
another O +
putative O +
arp B-Gene +
gene O +
, O +
arpB B-Gene +
, O +
was O +
found O +
immediately O +
downstream O +
of O +
arpA B-Gene +
. O +

Expression O +
of O +
arpA B-Gene +
was O +
compared O +
to O +
the O +
constitutively O +
expressed O +
Cgm O +
actin B-Gene +
gene O +
, O +
actA B-Gene +
. O +

In O +
culture O +
, O +
the O +
relative O +
expression O +
of O +
arpA B-Gene +
increased O +
when O +
growth O +
conditions O +
favored O +
sporulation O +
. O +

During O +
infection O +
, O +
arpA B-Gene +
expression O +
was O +
greatest O +
at O +
the O +
late O +
necrotrophic O +
phase O +
, O +
when O +
sporulation O +
occurred O +
. O +

Arps B-Gene +
have O +
been O +
shown O +
to O +
be O +
important O +
in O +
nuclear O +
migration O +
in O +
fungal O +
hyphae O +
, O +
and O +
the O +
expression O +
pattern O +
of O +
arpA B-Gene +
indicates O +
that O +
it O +
may O +
have O +
a O +
particular O +
role O +
during O +
sporulation O +
. O +

High O +
- O +
level O +
production O +
of O +
heme O +
- O +
containing O +
holoproteins O +
in O +
Escherichia O +
coli O +
. O +

The O +
expression O +
of O +
recombinant O +
protein O +
is O +
essential O +
for O +
the O +
investigation O +
of O +
the O +
functions O +
and O +
properties O +
of O +
heme O +
- O +
containing O +
protein O +
as O +
an O +
electron O +
carrier O +
. O +

For O +
the O +
expression O +
of O +
fully O +
active O +
recombinant O +
protein O +
, O +
conversion O +
of O +
the O +
expressed O +
apoprotein O +
into O +
holoprotein O +
is O +
the O +
most O +
important O +
and O +
difficult O +
problem O +
. O +

In O +
this O +
study O +
, O +
a O +
system O +
was O +
developed O +
for O +
the O +
production O +
of O +
heme O +
- O +
containing O +
protein O +
in O +
a O +
pure O +
, O +
recombinant O +
holoprotein O +
form O +
, O +
using O +
the O +
bovine O +
cytochrome B-Gene +
b5 I-Gene +
tryptic O +
fragment O +
and O +
Escherichia O +
coli O +
bacterioferritin B-Gene +
as O +
heterologous O +
and O +
homologous O +
heme O +
- O +
containing O +
model O +
proteins O +
, O +
respectively O +
. O +

This O +
system O +
is O +
based O +
on O +
the O +
slow O +
synthesis O +
of O +
recombinant O +
apoprotein O +
, O +
which O +
can O +
maintain O +
the O +
balanced O +
consumption O +
of O +
amino O +
acids O +
between O +
protein O +
synthesis O +
and O +
heme O +
synthesis O +
, O +
so O +
that O +
the O +
synthesized O +
apoprotein O +
continues O +
to O +
act O +
as O +
a O +
heme O +
sink O +
. O +

From O +
a O +
1 O -
- O -
1 O +
culture O +
, O +
15 O +
mg O +
of O +
cytochrome B-Gene +
b5 I-Gene +
and O +
40 O +
mg O +
of O +
bacterioferritin B-Gene +
were O +
purified O +
as O +
pure O +
holoprotein O +
forms O +
. O +

Our O +
expression O +
system O +
provides O +
a O +
rapid O +
and O +
simple O +
method O +
for O +
obtaining O +
large O +
quantities O +
of O +
the O +
active O +
holo O +
- O +
form O +
of O +
heme O +
- O +
containing O +
proteins O +
. O +

Cloning O +
of O +
a O +
novel O +
phosphatidylinositol B-Gene +
kinase I-Gene +
- O +
related O +
kinase B-Gene +
: O +
characterization O +
of O +
the O +
human O +
SMG-1 B-Gene +
RNA O +
surveillance O +
protein O +
. O +

We O +
have O +
cloned O +
and O +
characterized O +
a O +
new O +
member O +
of O +
the O +
phosphatidylinositol B-Gene +
kinase I-Gene +
( I-Gene +
PIK I-Gene +
) I-Gene +
- I-Gene +
related I-Gene +
kinase I-Gene +
family I-Gene +
. O +

This O +
gene O +
, O +
which O +
we O +
term O +
human O +
SMG-1 B-Gene +
( O +
hSMG-1 B-Gene +
) O +
, O +
is O +
orthologous O +
to O +
Caenorhabditis O +
elegans O +
SMG-1 B-Gene +
, O +
a O +
protein O +
that O +
functions O +
in O +
nonsense O +
- O +
mediated O +
mRNA O +
decay O +
( O +
NMD O +
) O +
. O +

cDNA O +
sequencing O +
revealed O +
that O +
hSMG-1 B-Gene +
encodes O +
a O +
protein O +
of O +
3031 O +
amino O +
acids O +
containing O +
a O +
conserved O +
kinase B-Gene +
domain O +
, O +
a O +
C O +
- O +
terminal O +
domain O +
unique O +
to O +
the O +
PIK B-Gene +
- O +
related O +
kinases B-Gene +
and O +
an O +
FKBP12 B-Gene +
- O +
rapamycin O +
binding O +
- O +
like O +
domain O +
similar O +
to O +
that O +
found O +
in O +
the O +
PIK B-Gene +
- O +
related O +
kinase O +
mTOR B-Gene +
. O +

Immunopurified O +
FLAG O +
- O +
tagged O +
hSMG-1 B-Gene +
exhibits O +
protein B-Gene +
kinase I-Gene +
activity O +
as O +
measured O +
by O +
autophosphorylation O +
and O +
phosphorylation O +
of O +
the O +
generic O +
PIK B-Gene +
- O +
related O +
kinase O +
substrate O +
PHAS-1 B-Gene +
. O +

hSMG-1 B-Gene +
kinase B-Gene +
activity O +
is O +
inhibited O +
by O +
high O +
nanomolar O +
concentrations O +
of O +
wortmannin O +
( O +
IC O -
( O -
50 O -
) O +
= O +
105 O +
nm O +
) O +
but O +
is O +
not O +
inhibited O +
by O +
a O +
FKBP12 B-Gene +
- O +
rapamycin O +
complex O +
. O +

Mutation O +
of O +
conserved O +
residues O +
within O +
the O +
kinase B-Gene +
domain O +
of O +
hSMG-1 B-Gene +
abolishes O +
both O +
autophosphorylation O +
and O +
substrate O +
phosphorylation O +
, O +
demonstrating O +
that O +
hSMG-1 B-Gene +
exhibits O +
intrinsic O +
protein O +
kinase B-Gene +
activity O +
. O +

hSMG-1 B-Gene +
phosphorylates O +
purified O +
hUpf1 B-Gene +
protein O +
, O +
a O +
phosphoprotein O +
that O +
plays O +
a O +
critical O +
role O +
in O +
NMD O +
, O +
at O +
sites O +
that O +
are O +
also O +
phosphorylated O +
in O +
whole O +
cells O +
. O +

Based O +
on O +
these O +
data O +
, O +
we O +
conclude O +
that O +
hSMG-1 B-Gene +
is O +
the O +
human O +
orthologue O +
to O +
C. O +
elegans O +
SMG-1 B-Gene +
. O +

Our O +
data O +
indicate O +
that O +
hSMG-1 B-Gene +
may O +
function O +
in O +
NMD O +
by O +
directly O +
phosphorylating O +
hUpf1 B-Gene +
protein O +
at O +
physiologically O +
relevant O +
sites O +
. O +

Ontogenetic O +
changes O +
in O +
protein O +
level O +
of O +
amyloid B-Gene +
precursor I-Gene +
protein I-Gene +
( O +
APP B-Gene +
) O +
in O +
growth O +
cones O +
and O +
synaptosomes O +
from O +
rat O +
brain O +
and O +
prenatal O +
expression O +
pattern O +
of O +
APP B-Gene +
mRNA O +
isoforms O +
in O +
developing O +
rat O +
embryo O +
. O +

To O +
elucidate O +
the O +
functional O +
role O +
of O +
the O +
amyloid B-Gene +
precursor I-Gene +
protein I-Gene +
( O +
APP B-Gene +
) O +
during O +
brain O +
ontogeny O +
, O +
developmental O +
changes O +
of O +
APP B-Gene +
levels O +
in O +
growth O +
cones O +
and O +
synaptosomes O +
were O +
studied O +
from O +
embryonic O +
day O +
14 O +
up O +
to O +
postnatal O +
day O +
( O +
PD O +
) O +
400 O +
using O +
Western O +
analysis O +
. O +

APP B-Gene +
level O +
in O +
growth O +
cones O +
was O +
low O +
during O +
prenatal O +
stages O +
of O +
development O +
, O +
but O +
demonstrating O +
a O +
continuous O +
increase O +
from O +
PD O +
3 O +
up O +
to O +
PD O +
10 O +
. O +

Highest O +
concentration O +
of O +
APP B-Gene +
in O +
synaptosomes O +
was O +
found O +
between O +
PD O +
7 O +
and O +
10 O +
, O +
followed O +
by O +
a O +
considerable O +
decrease O +
up O +
to O +
PD O +
30 O +
and O +
persisting O +
at O +
this O +
level O +
up O +
to O +
PD O +
400 O +
. O +

In O +
situ O +
hybridization O +
to O +
differentiate O +
between O +
APP695 B-Gene +
mRNA O +
, O +
APP751 B-Gene +
mRNA O +
and O +
APP770 B-Gene +
mRNA O +
revealed O +
distinct O +
age O +
- O +
related O +
expression O +
pattern O +
of O +
various O +
APP B-Gene +
isoforms O +
. O +

During O +
prenatal O +
brain O +
development O +
APP695 B-Gene +
mRNA O +
is O +
maximally O +
expressed O +
in O +
brain O +
structures O +
, O +
containing O +
differentiating O +
nerve O +
cells O +
. O +

APP751 B-Gene +
and O +
APP770 B-Gene +
mRNA O +
isoforms O +
are O +
diffusely O +
distributed O +
in O +
the O +
embryo O +
throughout O +
the O +
prenatal O +
period O +
examined O +
and O +
their O +
expression O +
is O +
higher O +
in O +
peripheral O +
organs O +
such O +
as O +
skin O +
, O +
lung O +
, O +
liver O +
and O +
bones O +
as O +
compared O +
to O +
the O +
brain O +
. O +

The O +
increase O +
of O +
APP B-Gene +
level O +
during O +
synaptogenesis O +
suggests O +
a O +
functional O +
role O +
of O +
APP B-Gene +
in O +
the O +
processes O +
of O +
neurite O +
outgrowth O +
and O +
cell O +
targeting O +
as O +
well O +
as O +
in O +
the O +
maintenance O +
of O +
the O +
functional O +
integrity O +
of O +
synapses O +
in O +
the O +
mature O +
brain O +
. O +

The O +
APP695 B-Gene +
isoform O +
seems O +
to O +
be O +
the O +
major O +
form O +
involved O +
in O +
embryonic O +
brain O +
maturation O +
. O +

A O +
novel O +
nucleolar O +
protein O +
, O +
NIFK B-Gene +
, O +
interacts O +
with O +
the O +
forkhead O +
associated O +
domain O +
of O +
Ki-67 B-Gene +
antigen I-Gene +
in O +
mitosis O +
. O +

In O +
a O +
previous O +
study O +
, O +
we O +
demonstrated O +
that O +
the O +
forkhead O +
associated O +
( O +
FHA O +
) O +
domain O +
of O +
pKi-67 B-Gene +
interacts O +
with O +
the O +
novel O +
kinesin B-Gene +
- O +
like O +
protein O +
, O +
Hklp2 B-Gene +
( O +
Sueishi O +
, O +
M. O +
, O +
Takagi O +
, O +
M. O +
, O +
and O +
Yoneda O +
, O +
Y. O +
( O +
2000 O +
) O +
J. O +
Biol O -
. O +
Chem O -
. O +
275 O +
, O +
28888 O +
- O +
28892 O +
) O +
. O +

In O +
this O +
study O +
, O +
we O +
report O +
on O +
the O +
identification O +
of O +
a O +
putative O +
RNA O +
- O +
binding O +
protein O +
of O +
293 O +
residues O +
as O +
another O +
binding O +
partner O +
of O +
the O +
FHA O +
domain O +
of O +
pKi-67 B-Gene +
( O +
referred O +
to O +
as O +
NIFK B-Gene +
for O +
nucleolar B-Gene +
protein I-Gene +
interacting I-Gene +
with I-Gene +
the I-Gene +
FHA I-Gene +
domain I-Gene +
of I-Gene +
pKi-67 I-Gene +
) O +
. O +

Human O +
NIFK B-Gene +
( O +
hNIFK B-Gene +
) O +
interacted O +
with O +
the O +
FHA O +
domain O +
of O +
pKi-67 B-Gene +
( O +
Ki O -
- O -
FHA O +
) O +
efficiently O +
in O +
vitro O +
when O +
hNIFK B-Gene +
was O +
derived O +
from O +
mitotically O +
arrested O +
cells O +
. O +

In O +
addition O +
, O +
a O +
moiety O +
of O +
hNIFK B-Gene +
was O +
co O +
- O +
localized O +
with O +
pKi-67 B-Gene +
at O +
the O +
peripheral O +
region O +
of O +
mitotic O +
chromosomes O +
. O +

The O +
hNIFK B-Gene +
domain O +
that O +
interacts O +
with O +
Ki O -
- O -
FHA O +
was O +
mapped O +
in O +
the O +
yeast O +
two O +
- O +
hybrid O +
system O +
to O +
a O +
portion O +
encompassed O +
by O +
residues O +
226 O +
- O +
269 O +
. O +

In O +
a O +
binding O +
assay O +
utilizing O +
Xenopus O +
egg O +
extracts O +
, O +
it O +
was O +
found O +
that O +
the O +
mitosis O +
- O +
specific O +
environment O +
and O +
two O +
threonine O +
residues O +
within O +
this O +
portion O +
of O +
hNIFK B-Gene +
( O +
Thr-234 O +
and O +
Thr-238 O +
) O +
were O +
crucial O +
for O +
the O +
efficient O +
interaction O +
of O +
hNIFK B-Gene +
and O +
Ki O -
- O -
FHA O +
, O +
suggesting O +
that O +
hNIFK B-Gene +
interacts O +
with O +
Ki O -
- O -
FHA O +
in O +
a O +
mitosis O +
- O +
specific O +
and O +
phosphorylation O +
- O +
dependent O +
manner O +
. O +

These O +
findings O +
provide O +
a O +
new O +
clue O +
to O +
our O +
understanding O +
of O +
the O +
cellular O +
function O +
of O +
pKi-67 B-Gene +
. O +

Tobacco O +
and O +
Arabidiopsis O +
SLT1 B-Gene +
mediate O +
salt O +
tolerance O +
of O +
yeast O +
. O +

A O +
tobacco O +
cDNA O +
( O +
NtSLT1 B-Gene +
, O +
for O +
Nicotiana O +
tabacum O +
sodium B-Gene +
- I-Gene +
and I-Gene +
lithium I-Gene +
- I-Gene +
tolerant I-Gene +
) O +
was O +
isolated O +
by O +
functional O +
complementation O +
of O +
the O +
salt O +
- O +
sensitive O +
phenotype O +
of O +
a O +
calcineurin B-Gene +
( O +
CaN B-Gene +
) O +
- O +
deficient O +
yeast O +
mutant O +
( O +
cnb B-Gene +
delta O +
, O +
regulatory O +
subunit O +
null O +
) O +
. O +

CaN B-Gene +
is O +
a O +
Ca2 B-Gene -
+ I-Gene +
/ I-Gene +
calmodulin I-Gene +
- I-Gene +
dependent I-Gene +
type I-Gene +
2B I-Gene +
protein I-Gene +
phosphatase I-Gene +
that O +
regulates O +
Na+ O +
homeostasis O +
in O +
yeast O +
. O +

This O +
phosphatase B-Gene +
modulates O +
plasma O +
membrane O +
K O +
+ O +
/ O +
Na O +
+ O +
selectivity O +
through O +
the O +
activation O +
of O +
high O +
- O +
affinity O +
K O +
+ O +
transport O +
, O +
and O +
increaseses O +
extracellular O +
Na O +
+ O +
efflux O +
by O +
activation O +
and O +
transcriptional O +
induction O +
of O +
the O +
Na O +
+ O +
/ O +
Li O +
+ O +
translocating O +
P B-Gene +
- I-Gene +
type I-Gene +
ATPase I-Gene +
encoded O +
by O +
ENA1 B-Gene +
. O +

Expression O +
of O +
N O +
- O +
terminally O +
truncated O +
NtSLT1 B-Gene +
( O +
Met-304 O +
) O +
, O +
but O +
not O +
full O +
- O +
length O +
protein O +
, O +
suppressed O +
salt O +
sensitivity O +
of O +
cnb1 B-Gene +
. O +

Truncated O +
NtSLT1 B-Gene +
also O +
increased O +
salt O +
tolerance O +
of O +
wild O +
- O +
type O +
yeast O +
, O +
indicating O +
functional O +
sufficiency O +
. O +

NtSLT1 B-Gene +
encodes O +
a O +
protein O +
of O +
yet O +
unknown O +
function O +
but O +
experimentation O +
in O +
yeast O +
confirms O +
it O +
as O +
a O +
salt O +
tolerance O +
determinant O +
. O +

The O +
Arabidopsis O +
thaliana O +
orthologue O +
, O +
AtSLT1 B-Gene +
, O +
also O +
suppressed O +
salt O +
sensitivity O +
of O +
cnb B-Gene +
delta O +
but O +
only O +
when O +
expressed O +
without O +
the O +
N O +
- O +
terminus O +
( O +
Met O +
- O +
301 O +
) O +
, O +
suggesting O +
that O +
this O +
region O +
of O +
the O +
proteins O +
from O +
these O +
evolutionarily O +
diverse O +
plant O +
species O +
contains O +
an O +
autoinhibitory O +
domain O +
. O +

NtSLT1 B-Gene +
enhanced O +
transcription O +
of O +
the O +
CaN B-Gene +
- O +
dependent O +
ENA1 B-Gene +
gene O +
promoter O +
and O +
compensated O +
the O +
salt O +
sensitivity O +
of O +
a O +
mutant O +
deficient O +
in O +
TCN1 B-Gene +
-- O +
a O +
transcription B-Gene +
factor I-Gene +
that O +
is O +
activated O +
by O +
CaN B-Gene +
and O +
then O +
induces O +
ENA1 B-Gene +
expression O +
. O +

NtSLT1 B-Gene +
partially O +
suppressed O +
the O +
salt O +
sensitivity O +
of O +
ena1 B-Gene -
- I-Gene -
4 I-Gene +
indicating O +
that O +
NtSLT1 B-Gene +
has O +
both O +
ENA B-Gene +
- O +
dependent O +
and O +
independent O +
functions O +
. O +

NtSLT1 B-Gene +
suppressed O +
spk1 B-Gene +
hal4 B-Gene +
( O +
SPK1 B-Gene +
/ O +
HAL4 B-Gene +
which O +
encodes O +
a O +
serine B-Gene +
- I-Gene +
threonine I-Gene +
kinase I-Gene +
that O +
regulates O +
TRK1 B-Gene -
- I-Gene -
2 I-Gene +
transporters O +
to O +
have O +
high O +
K O +
+ O +
/ O +
Na O +
+ O +
selectivity O +
) O +
but O +
not O +
ena1 B-Gene +
- I-Gene +
4 I-Gene +
trk1 B-Gene +
- I-Gene +
2 I-Gene +
implicating O +
the O +
ENA B-Gene +
- O +
independent O +
function O +
to O +
be O +
through O +
TRK1 B-Gene +
- I-Gene +
2 I-Gene +
. O +

Together O +
, O +
these O +
results O +
implicate O +
SLT1 B-Gene +
as O +
a O +
signal O +
regulatory O +
molecule O +
that O +
mediates O +
salt O +
tolerance O +
by O +
modulating O +
Na O +
+ O +
homeostasis O +
. O +

Hypokalaemic O +
periodic O +
paralysis O +
type O +
2 O +
caused O +
by O +
mutations O +
at O +
codon O +
672 O +
in O +
the O +
muscle O +
sodium B-Gene +
channel I-Gene +
gene O +
SCN4A B-Gene +
. O +

Hypokalaemic O +
periodic O +
paralysis O +
( O +
hypoPP O +
) O +
is O +
an O +
autosomal O +
dominant O +
muscle O +
disorder O +
characterized O +
by O +
episodic O +
attacks O +
of O +
muscle O +
weakness O +
associated O +
with O +
a O +
decrease O +
in O +
blood O +
potassium O +
levels O +
. O +

Mutations O +
in O +
the O +
gene O +
encoding O +
the O +
skeletal O +
muscle O +
voltage O +
- O +
gated O +
calcium B-Gene +
channel I-Gene +
alpha-1 I-Gene +
subunit O +
( O +
CACNL1A3 B-Gene +
) O +
account O +
for O +
the O +
majority O +
of O +
cases O +
. O +

Recently O +
, O +
mutations O +
in O +
the O +
gene O +
coding O +
for O +
the O +
skeletal O +
muscle O +
voltage O +
- O +
gated O +
sodium B-Gene +
channel I-Gene +
alpha I-Gene +
subunit O +
( O +
SCN4A B-Gene +
) O +
have O +
been O +
reported O +
in O +
a O +
small O +
number O +
of O +
hypoPP O +
families O +
. O +

In O +
order O +
to O +
determine O +
the O +
relative O +
frequency O +
of O +
the O +
CANCL1A3 B-Gene +
and O +
SCN4A B-Gene +
mutations O +
in O +
a O +
large O +
population O +
of O +
hypoPP O +
patients O +
, O +
and O +
to O +
specify O +
the O +
clinical O +
and O +
pathological O +
features O +
associated O +
with O +
each O +
of O +
them O +
, O +
we O +
searched O +
for O +
mutations O +
in O +
58 O +
independent O +
hypoPP O +
index O +
cases O +
. O +

We O +
detected O +
the O +
causative O +
mutation O +
in O +
45 O +
cases O +
: O +
40 O +
were O +
linked O +
to O +
the O +
CACNL1A3 B-Gene +
gene O +
and O +
five O +
to O +
the O +
SCN4A B-Gene +
gene O +
. O +

One O +
mutation O +
has O +
not O +
been O +
described O +
before O +
. O +

Some O +
remarkable O +
clinical O +
features O +
were O +
observed O +
in O +
a O +
large O +
hypoPP O +
family O +
carrying O +
an O +
SCN4A B-Gene +
mutation O +
: O +
a O +
complete O +
penetrance O +
in O +
men O +
and O +
women O +
, O +
an O +
early O +
age O +
at O +
onset O +
, O +
postcritic O +
myalgias O +
and O +
an O +
increased O +
number O +
and O +
severity O +
of O +
attacks O +
induced O +
by O +
acetazolamide O +
. O +

A O +
muscle O +
biopsy O +
, O +
performed O +
in O +
two O +
members O +
of O +
this O +
family O +
, O +
revealed O +
a O +
peculiar O +
myopathy O +
characterized O +
by O +
tubular O +
aggregates O +
. O +

In O +
contrast O +
, O +
vacuoles O +
were O +
predominant O +
in O +
muscles O +
from O +
hypoPP O +
patients O +
carrying O +
CACNL1A3 B-Gene +
mutations O +
. O +

Our O +
findings O +
point O +
to O +
the O +
usefulness O +
of O +
a O +
molecular O +
characterization O +
of O +
hypoPP O +
patients O +
in O +
clinical O +
practice O +
. O +

They O +
also O +
provide O +
new O +
clues O +
for O +
understanding O +
the O +
mechanisms O +
behind O +
functional O +
and O +
structural O +
alterations O +
of O +
the O +
skeletal O +
muscle O +
in O +
hypoPP O +
. O +

Control O +
of O +
electron O +
transfer O +
in O +
neuronal B-Gene +
NO I-Gene +
synthase I-Gene +
. O +

The O +
nitric B-Gene +
oxide I-Gene +
synthases I-Gene +
( O +
NOSs B-Gene +
) O +
are O +
dimeric O +
flavocytochromes O +
consisting O +
of O +
an O +
oxygenase B-Gene +
domain O +
with O +
cytochrome B-Gene +
P450 I-Gene +
- O +
like O +
Cys O +
- O +
ligated O +
haem O +
, O +
coupled O +
to O +
a O +
diflavin O +
reductase B-Gene +
domain O +
, O +
which O +
is O +
related O +
to O +
cytochrome B-Gene +
P450 I-Gene +
reductase I-Gene +
. O +

The O +
NOSs B-Gene +
catalyse O +
the O +
sequential O +
mono O +
- O +
oxygenation O +
of O +
arginine O +
to O +
N O -
- O -
hydroxyarginine O +
and O +
then O +
to O +
citrulline O +
and O +
NO O +
. O +

The O +
constitutive B-Gene +
NOS I-Gene +
isoforms O +
( O +
cNOSs B-Gene +
) O +
are O +
regulated O +
by O +
calmodulin B-Gene +
( O +
CaM B-Gene +
) O +
, O +
which O +
binds O +
at O +
elevated O +
concentrations O +
of O +
free O +
Ca O -
( O -
2 O -
+ O -
) O +
, O +
whereas O +
the O +
inducible O +
isoform O +
binds O +
CaM B-Gene +
irreversibly O +
. O +

One O +
of O +
the O +
main O +
structural O +
differences O +
between O +
the O +
constitutive O +
and O +
inducible O +
isoforms O +
is O +
an O +
insert O +
of O +
40 O +
- O +
50 O +
amino O +
acids O +
in O +
the O +
FMN O +
- O +
binding O +
domain O +
of O +
the O +
cNOSs B-Gene +
. O +

Deletion O +
of O +
the O +
insert O +
in O +
rat O +
neuronal B-Gene +
NOS I-Gene +
( O +
nNOS B-Gene +
) O +
led O +
to O +
a O +
mutant O +
enzyme O +
which O +
binds O +
CaM B-Gene +
at O +
lower O +
Ca O -
( O -
2 O -
+ O -
) O +
concentrations O +
and O +
which O +
retains O +
activity O +
in O +
the O +
absence O +
of O +
CaM B-Gene +
. O +

In O +
order O +
to O +
resolve O +
the O +
mechanism O +
of O +
action O +
of O +
CaM B-Gene +
activation O +
we O +
determined O +
reduction O +
potentials O +
for O +
the O +
FMN O +
and O +
FAD O +
cofactors O +
of O +
rat O +
nNOS B-Gene +
in O +
the O +
presence O +
and O +
absence O +
of O +
CaM B-Gene +
using O +
a O +
recombinant O +
form O +
of O +
the O +
reductase B-Gene +
domain O +
. O +

The O +
results O +
indicate O +
that O +
CaM B-Gene +
binding O +
does O +
not O +
modulate O +
the O +
reduction O +
potentials O +
of O +
the O +
flavins O +
, O +
but O +
appears O +
to O +
control O +
electron O +
transfer O +
primarily O +
via O +
a O +
large O +
structural O +
rearrangement O +
. O +

We O +
also O +
report O +
the O +
creation O +
of O +
chimaeric O +
enzymes O +
in O +
which O +
the O +
reductase B-Gene +
domains O +
of O +
nNOS B-Gene +
and O +
flavocytochrome B-Gene +
P450 I-Gene +
BM3 I-Gene +
( O +
Bacillus O +
megaterium O +
III O +
) O +
have O +
been O +
exchanged O +
. O +

Despite O +
its O +
very O +
different O +
flavin O +
redox O +
potentials O +
, O +
the O +
BM3 B-Gene +
reductase I-Gene +
domain O +
was O +
able O +
to O +
support O +
low O +
levels O +
of O +
CaM B-Gene +
- O +
dependent O +
NO O +
synthesis O +
, O +
whereas O +
the O +
NOS B-Gene +
reductase I-Gene +
domain O +
did O +
not O +
effectively O +
substitute O +
for O +
that O +
of O +
cytochrome B-Gene +
P450 I-Gene +
BM3 I-Gene +
. O +

HMGN3a B-Gene +
and O +
HMGN3b B-Gene +
, O +
two O +
protein O +
isoforms O +
with O +
a O +
tissue O +
- O +
specific O +
expression O +
pattern O +
, O +
expand O +
the O +
cellular O +
repertoire O +
of O +
nucleosome O +
- O +
binding O +
proteins O +
. O +

HMGN1 B-Gene +
( O +
HMG-14 B-Gene +
) O +
and O +
HMGN2 B-Gene +
( O +
HMG-17 B-Gene +
) O +
are O +
nuclear O +
proteins O +
that O +
bind O +
specifically O +
to O +
nucleosomes O +
, O +
reduce O +
the O +
compactness O +
of O +
the O +
chromatin O +
fiber O +
, O +
and O +
enhance O +
transcription O +
from O +
chromatin O +
templates O +
. O +

Here O +
we O +
report O +
that O +
many O +
vertebrates O +
contain O +
an O +
additional O +
type O +
of O +
HMGN B-Gene +
protein O +
named O +
HMGN3 B-Gene +
( O +
Trip B-Gene +
7 I-Gene +
) O +
. O +

The O +
human O +
HMGN3 B-Gene +
gene O +
is O +
located O +
on O +
chromosome O +
6 O +
and O +
spans O +
32 O +
kilobase O +
pairs O +
, O +
which O +
is O +
nearly O +
10 O +
- O +
fold O +
longer O +
than O +
the O +
closely O +
related O +
HMGN2 B-Gene +
gene O +
. O +

However O +
, O +
the O +
intron O +
/ O +
exon O +
boundaries O +
of O +
the O +
HMGN3 B-Gene +
gene O +
are O +
identical O +
to O +
those O +
of O +
HMGN1 B-Gene +
and O +
HMGN2 B-Gene +
. O +

Unique O +
within O +
the O +
HMGN B-Gene +
family I-Gene +
, O +
the O +
HMGN3 B-Gene +
transcript O +
undergoes O +
alternative O +
splicing O +
and O +
generates O +
two O +
different O +
variants O +
, O +
HMGN3a B-Gene +
and O +
HMGN3b B-Gene +
. O +

The O +
shorter O +
variant O +
, O +
HMGN3b B-Gene +
, O +
arises O +
from O +
an O +
additional O +
splice O +
site O +
that O +
truncates O +
exon O +
V O +
and O +
causes O +
a O +
frameshift O +
. O +

The O +
resulting O +
HMGN3b B-Gene +
protein O +
lacks O +
the O +
majority O +
of O +
the O +
C O +
- O +
terminal O +
chromatin O +
- O +
unfolding O +
domain O +
. O +

Both O +
splice O +
variants O +
are O +
found O +
in O +
many O +
vertebrates O +
from O +
frogs O +
to O +
man O +
and O +
are O +
expressed O +
in O +
many O +
tissues O +
. O +

The O +
pattern O +
of O +
tissue O +
- O +
specific O +
expression O +
differs O +
considerably O +
from O +
those O +
of O +
HMGN1 B-Gene +
and O +
HMGN2 B-Gene +
at O +
both O +
the O +
mRNA O +
and O +
the O +
protein O +
level O +
. O +

Our O +
results O +
expand O +
the O +
multiplicity O +
of O +
the O +
HMGN B-Gene +
protein I-Gene +
family I-Gene +
and O +
raise O +
the O +
possibility O +
that O +
these O +
nucleosome O +
- O +
binding O +
proteins O +
function O +
as O +
co O +
- O +
activators O +
in O +
tissue O +
- O +
specific O +
gene O +
expression O +
. O +

BALB O -
/ O -
c O +
mice O +
bearing O +
a O +
transgenic O +
IL-12 B-Gene +
receptor I-Gene +
beta I-Gene +
2 I-Gene +
gene O +
exhibit O +
a O +
nonhealing O +
phenotype O +
to O +
Leishmania O +
major O +
infection O +
despite O +
intact O +
IL-12 B-Gene +
signaling O +
. O +

In O +
BALB O -
/ O -
c O +
mice O +
infected O +
with O +
Leishmania O +
major O +
, O +
early O +
secretion O +
of O +
IL-4 B-Gene +
leads O +
to O +
a O +
Th2 O +
- O +
type O +
response O +
and O +
nonhealing O +
. O +

We O +
explored O +
the O +
role O +
of O +
IL-4 B-Gene +
- O +
induced O +
down O +
- O +
regulation O +
of O +
the O +
IL-12Rbeta2 B-Gene +
chain O +
in O +
the O +
establishment O +
of O +
this O +
Th2 O +
response O +
. O +

First O +
, O +
we O +
showed O +
that O +
the O +
draining O +
lymph O +
nodes O +
of O +
resistant O +
C57BL O +
/ O +
6 O +
mice O +
infected O +
with O +
L. O +
major O +
were O +
enriched O +
in O +
CD4 B-Gene +
+ O +
/ O +
IL B-Gene +
- I-Gene +
12Rbeta2 I-Gene +
chain O +
+ O +
cells O +
producing O +
IFN B-Gene +
- I-Gene +
gamma I-Gene +
. O +

Next O +
, O +
we O +
demonstrated O +
that O +
BALB O +
/ O +
c O +
background O +
mice O +
bearing O +
an O +
IL B-Gene +
- I-Gene +
12Rbeta2 I-Gene +
- O +
chain O +
transgene O +
manifested O +
a O +
nonhealing O +
phenotype O +
similar O +
to O +
wild O +
- O +
type O +
littermates O +
despite O +
the O +
persistence O +
of O +
their O +
ability O +
to O +
undergo O +
STAT4 B-Gene +
activation O +
. O +

Finally O +
, O +
we O +
found O +
that O +
such O +
transgenic O +
mice O +
display O +
more O +
severe O +
infection O +
than O +
wild O +
- O +
type O +
littermates O +
when O +
treated O +
with O +
IL-12 B-Gene +
7 O +
days O +
after O +
infection O +
, O +
and O +
under O +
this O +
condition O +
, O +
the O +
mice O +
display O +
increased O +
Leishmania O +
Ag O +
- O +
induced O +
IL B-Gene +
- I-Gene +
4 I-Gene +
secretion O +
. O +

These O +
studies O +
indicate O +
that O +
although O +
CD4 B-Gene +
+ O +
/ O +
IL-12Rbeta2 B-Gene +
chain O +
+ O +
T O +
cells O +
are O +
important O +
components O +
of O +
the O +
Th1 O +
response O +
, O +
maintenance O +
of O +
IL-12Rbeta2 B-Gene +
chain O +
expression O +
is O +
not O +
sufficient O +
to O +
change O +
a O +
Th2 O +
response O +
to O +
a O +
Th1 O +
response O +
in O +
vivo O +
and O +
thus O +
to O +
allow O +
BALB O +
/ O +
c O +
mice O +
to O +
heal O +
L. O +
major O +
infection O +
. O +

Functionality O +
of O +
aquaporin-2 B-Gene +
missense O +
mutants O +
in O +
recessive O +
nephrogenic O +
diabetes O +
insipidus O +
. O +

Aquaporin-2 B-Gene +
( O +
AQP2 B-Gene +
) O +
missense O +
mutants O +
in O +
recessive O +
nephrogenic O +
diabetes O +
insipidus O +
( O +
NDI O +
) O +
are O +
all O +
retained O +
in O +
the O +
endoplasmic O +
reticulum O +
( O +
ER O +
) O +
, O +
but O +
some O +
could O +
function O +
as O +
water B-Gene +
channels I-Gene +
. O +

No O +
conclusions O +
could O +
be O +
drawn O +
about O +
the O +
water O +
permeability O +
( O +
Pf O +
) O +
of O +
others O +
, O +
because O +
there O +
was O +
no O +
method O +
for O +
quantifying O +
AQP2 B-Gene +
expression O +
in O +
the O +
plasma O +
membrane O +
. O +

We O +
recently O +
developed O +
such O +
a O +
method O +
, O +
which O +
has O +
allowed O +
us O +
to O +
study O +
the O +
functionality O +
of O +
these O +
AQP2 B-Gene +
mutants O +
. O +

Immunoblot O +
analysis O +
of O +
membranes O +
of O +
injected O +
oocytes O +
revealed O +
that O +
all O +
mutants O +
( O +
AQP2 B-Gene +
- O +
G64R O +
, O +
AQP2 B-Gene +
- O +
N68S O +
, O +
AQP2 B-Gene +
T126 O -
M O +
, O +
AQP2 B-Gene +
- O +
A147 O -
T O +
, O +
AQP2 B-Gene +
- O +
R187C O +
, O +
AQP2 B-Gene +
- O +
S216P O +
) O +
are O +
expressed O +
as O +
unglycosylated O +
and O +
high O +
- O +
mannose O +
glycosylated O +
AQP2 B-Gene +
. O +

The O +
level O +
of O +
the O +
high O +
- O +
mannose O +
form O +
of O +
AQP2 B-Gene +
- O +
A147 O -
T O +
in O +
the O +
plasma O +
membranes O +
was O +
low O +
, O +
indicating O +
that O +
this O +
mutation O +
has O +
a O +
less O +
severe O +
effect O +
on O +
proper O +
folding O +
. O +

Analysis O +
of O +
Pf O +
values O +
and O +
plasma O +
membrane O +
expression O +
levels O +
reveals O +
that O +
AQP2 B-Gene +
- O +
N68S O +
, O +
AQP2 B-Gene +
- O +
R187C O +
and O +
AQP2 B-Gene +
- O +
S216P O +
are O +
non O +
- O +
functional O +
, O +
AQP2 B-Gene +
- O +
A147 O -
T O +
is O +
as O +
functional O +
as O +
wt O +
- O +
AQP2 B-Gene +
, O +
while O +
AQP2 B-Gene +
- O +
T126 O -
M O +
and O +
AQP2 B-Gene +
- O +
G64R O +
retain O +
20 O +
% O +
of O +
the O +
permeability O +
of O +
wt O +
- O +
AQP2 B-Gene +
. O +

Since O +
G64 O +
is O +
highly O +
conserved O +
between O +
AQPs B-Gene +
and O +
expected O +
to O +
form O +
essential O +
interactions O +
with O +
other O +
amino O +
acids O +
within O +
AQP1 B-Gene +
, O +
the O +
residual O +
functionality O +
of O +
AQP2 B-Gene +
- O +
G64R O +
is O +
surprising O +
. O +

Our O +
data O +
furthermore O +
indicate O +
that O +
an O +
eventual O +
therapy O +
with O +
chemical O +
chaperones O +
that O +
restores O +
the O +
routing O +
of O +
AQP2 B-Gene +
mutants O +
to O +
the O +
apical O +
membrane O +
of O +
collecting O +
ducts O +
cells O +
might O +
relieve O +
NDI O +
in O +
patients O +
encoding O +
AQP2 B-Gene +
- O +
A147 O -
T O +
, O +
and O +
to O +
a O +
lesser O +
extent O +
AQP2 B-Gene +
- O +
T126 O -
M O +
and O +
AQP2 B-Gene +
- O +
G64R O +
, O +
but O +
not O +
in O +
patients O +
encoding O +
AQP2 B-Gene +
- O +
N68S O +
, O +
AQP2 B-Gene +
- O +
R187C O +
or O +
AQP2 B-Gene +
- O +
S216P O +
. O +

Cloning O +
of O +
a O +
mouse O +
beta B-Gene +
1 I-Gene +
, I-Gene +
3 I-Gene +
N I-Gene -
- I-Gene -
acetylglucosaminyltransferase I-Gene +
GlcNAc I-Gene +
( I-Gene +
beta I-Gene +
1,3 I-Gene -
) I-Gene +
Gal I-Gene +
( I-Gene +
beta I-Gene +
1,4 I-Gene -
) I-Gene -
Glc I-Gene -
- I-Gene -
ceramide I-Gene +
synthase I-Gene +
gene O +
encoding O +
the O +
key O +
regulator O +
of O +
lacto O +
- O +
series O +
glycolipid O +
biosynthesis O +
. O +

The O +
distinction O +
between O +
the O +
different O +
classes O +
of O +
glycolipids O +
is O +
conditioned O +
by O +
the O +
action O +
of O +
specific O +
core O +
transferases B-Gene +
. O +

The O +
entry O +
point O +
for O +
lacto O +
- O +
series O +
glycolipids O +
is O +
catalyzed O +
by O +
the O +
beta1 B-Gene +
, I-Gene +
3 I-Gene +
N I-Gene -
- I-Gene -
acetylglucosaminyltransferase I-Gene +
GlcNAc I-Gene -
( I-Gene -
beta1,3 I-Gene -
) I-Gene -
Gal I-Gene -
( I-Gene -
beta1,4 I-Gene -
) I-Gene -
Glc I-Gene -
- I-Gene -
ceramide I-Gene +
( I-Gene +
Lc3 I-Gene +
) I-Gene +
synthase I-Gene +
enzyme O +
. O +

The O +
Lc3 B-Gene +
synthase I-Gene +
activity O +
has O +
been O +
shown O +
to O +
be O +
regulated O +
during O +
development O +
, O +
especially O +
during O +
brain O +
morphogenesis O +
. O +

Here O +
, O +
we O +
report O +
the O +
molecular O +
cloning O +
of O +
a O +
mouse O +
gene O +
encoding O +
an O +
Lc3 B-Gene +
synthase I-Gene +
enzyme O +
. O +

The O +
mouse O +
cDNA O +
included O +
an O +
open O +
reading O +
frame O +
of O +
1131 O +
base O +
pairs O +
encoding O +
a O +
protein O +
of O +
376 O +
amino O +
acids O +
. O +

The O +
Lc3 B-Gene +
synthase I-Gene +
protein O +
shared O +
several O +
structural O +
motifs O +
previously O +
identified O +
in O +
the O +
members O +
of O +
the O +
beta1 B-Gene +
, I-Gene +
3 I-Gene +
glycosyltransferase I-Gene +
superfamily I-Gene +
. O +

The O +
Lc3 B-Gene +
synthase I-Gene +
enzyme O +
efficiently O +
utilized O +
the O +
lactosyl O +
ceramide O +
glycolipid O +
acceptor O +
. O +

The O +
identity O +
of O +
the O +
reaction O +
products O +
of O +
Lc3 B-Gene +
synthase I-Gene +
- O +
transfected O +
CHOP2 O -
/ O -
1 O +
cells O +
was O +
confirmed O +
by O +
thin O +
- O +
layer O +
chromatography O +
immunostaining O +
using O +
antibodies O +
TE-8 O +
and O +
1B2 O +
that O +
recognize O +
Lc3 O +
and O +
Gal O -
( O -
beta1,4 O -
) O +
GlcNAc O -
( O -
beta1,3 O -
) O -
Gal O -
( O -
beta1,4 O -
) O -
Glc O -
- O -
ceramide O +
( O +
nLc4 O +
) O +
structures O +
, O +
respectively O +
. O +

In O +
addition O +
to O +
the O +
initiating O +
activity O +
for O +
lacto O +
- O +
chain O +
synthesis O +
, O +
the O +
Lc3 B-Gene +
synthase I-Gene +
could O +
extend O +
the O +
terminal O +
N O -
- O -
acetyllactosamine O +
unit O +
of O +
nLc4 O +
and O +
also O +
had O +
a O +
broad O +
specificity O +
for O +
gangliosides O +
GA1 O +
, O +
GM1 O +
, O +
and O +
GD1b O +
to O +
generate O +
neolacto O +
- O +
ganglio O +
hybrid O +
structures O +
. O +

The O +
mouse O +
Lc3 B-Gene +
synthase I-Gene +
gene O +
was O +
mainly O +
expressed O +
during O +
embryonic O +
development O +
. O +

In O +
situ O +
hybridization O +
analysis O +
revealed O +
that O +
that O +
the O +
Lc3 B-Gene +
synthase I-Gene +
was O +
expressed O +
in O +
most O +
tissues O +
at O +
embryonic O +
day O +
11 O +
with O +
elevated O +
expression O +
in O +
the O +
developing O +
central O +
nervous O +
system O +
. O +

Postnatally O +
, O +
the O +
expression O +
was O +
restricted O +
to O +
splenic O +
B O -
- O -
cells O +
, O +
the O +
placenta O +
, O +
and O +
cerebellar O +
Purkinje O +
cells O +
where O +
it O +
colocalized O +
with O +
HNK-1 B-Gene +
reactivity O +
. O +

These O +
data O +
support O +
a O +
key O +
role O +
for O +
the O +
Lc3 B-Gene +
synthase I-Gene +
in O +
regulating O +
neolacto O +
- O +
series O +
glycolipid O +
synthesis O +
during O +
embryonic O +
development O +
. O +

AXOR12 B-Gene +
, O +
a O +
novel O +
human O +
G B-Gene +
protein I-Gene +
- I-Gene +
coupled I-Gene +
receptor I-Gene +
, O +
activated O +
by O +
the O +
peptide O +
KiSS-1 B-Gene +
. O +

A O +
novel O +
human O +
G B-Gene +
protein I-Gene +
- I-Gene +
coupled I-Gene +
receptor I-Gene +
named O +
AXOR12 B-Gene +
, O +
exhibiting O +
81 O +
% O +
homology O +
to O +
the O +
rat O +
orphan O +
receptor O +
GPR54 B-Gene +
, O +
was O +
cloned O +
from O +
a O +
human O +
brain O +
cDNA O +
library O +
. O +

Heterologous O +
expression O +
of O +
AXOR12 B-Gene +
in O +
mammalian O +
cells O +
permitted O +
the O +
identification O +
of O +
three O +
surrogate O +
agonist O +
peptides O +
, O +
all O +
with O +
a O +
common O +
C O +
- O +
terminal O +
amidated O +
motif O +
. O +

High O +
potency O +
agonism O +
, O +
indicative O +
of O +
a O +
cognate O +
ligand O +
, O +
was O +
evident O +
from O +
peptides O +
derived O +
from O +
the O +
gene O +
KiSS-1 B-Gene +
, O +
the O +
expression O +
of O +
which O +
prevents O +
metastasis O +
in O +
melanoma O +
cells O +
. O +

Quantitative O +
reverse O +
transcriptase O +
- O +
polymerase O +
chain O +
reaction O +
was O +
used O +
to O +
study O +
the O +
expression O +
of O +
AXOR12 B-Gene +
and O +
KiSS-1 B-Gene +
in O +
a O +
variety O +
of O +
tissues O +
. O +

The O +
highest O +
levels O +
of O +
expression O +
of O +
AXOR12 B-Gene +
mRNA O +
were O +
observed O +
in O +
brain O +
, O +
pituitary O +
gland O +
, O +
and O +
placenta O +
. O +

The O +
highest O +
levels O +
of O +
KiSS-1 B-Gene +
gene O +
expression O +
were O +
observed O +
in O +
placenta O +
and O +
brain O +
. O +

A O +
polyclonal O +
antibody O +
raised O +
to O +
the O +
C O +
terminus O +
of O +
AXOR12 B-Gene +
was O +
generated O +
and O +
used O +
to O +
show O +
localization O +
of O +
the O +
receptor O +
to O +
neurons O +
in O +
the O +
cerebellum O +
, O +
cerebral O +
cortex O +
, O +
and O +
brainstem O +
. O +

The O +
biological O +
significance O +
of O +
these O +
expression O +
patterns O +
and O +
the O +
nature O +
of O +
the O +
putative O +
cognate O +
ligand O +
for O +
AXOR12 B-Gene +
are O +
discussed O +
. O +

The O +
role O +
of O +
antibodies O +
to O +
Bacillus O +
anthracis O +
and O +
anthrax O +
toxin O +
components O +
in O +
inhibiting O +
the O +
early O +
stages O +
of O +
infection O +
by O +
anthrax O +
spores O +
. O +

Vaccines O +
which O +
are O +
efficacious O +
against O +
anthrax O +
, O +
such O +
as O +
the O +
human O +
vaccine O +
, O +
Anthrax O +
Vaccine O +
Absorbed O +
( O +
AVA O +
) O +
, O +
contain O +
the O +
protective B-Gene +
antigen I-Gene +
( O +
PA B-Gene +
) O +
component O +
of O +
the O +
anthrax O +
toxins O +
as O +
the O +
major O +
protective O +
immunogen O +
. O +

Although O +
AVA O +
protects O +
against O +
inhalational O +
anthrax O +
, O +
the O +
immune O +
responses O +
to O +
and O +
role O +
in O +
protection O +
of O +
PA B-Gene +
and O +
possibly O +
other O +
antigens O +
have O +
yet O +
to O +
be O +
fully O +
elucidated O +
. O +

Sera O +
from O +
animals O +
immunized O +
with O +
a O +
toxin O +
- O +
producing O +
, O +
unencapsulated O +
live O +
vaccine O +
strain O +
of O +
Bacillus O +
anthracis O +
have O +
been O +
reported O +
to O +
have O +
anti O +
- O +
spore O +
activities O +
associated O +
with O +
the O +
antitoxin O +
humoral O +
response O +
. O +

The O +
authors O +
performed O +
studies O +
to O +
determine O +
whether O +
anti O +
- O +
PA B-Gene +
antibody O +
( O +
Ab O +
) O +
- O +
containing O +
preparations O +
stimulated O +
spore O +
uptake O +
by O +
phagocytes O +
and O +
suppressed O +
the O +
germination O +
of O +
spores O +
in O +
vitro O +
. O +

AVA O +
- O +
and O +
PA B-Gene +
- O +
immune O +
sera O +
from O +
several O +
species O +
enhanced O +
the O +
phagocytosis O +
by O +
murine O +
peritoneal O +
macrophages O +
of O +
spores O +
of O +
the O +
virulent O +
Ames O +
and O +
the O +
Sterne O +
vaccine O +
strains O +
. O +

Antitoxin O +
Abs O +
appeared O +
to O +
contribute O +
significantly O +
, O +
although O +
not O +
solely O +
, O +
to O +
the O +
enhanced O +
uptake O +
. O +

Rabbit O +
antisera O +
to O +
PA B-Gene +
purified O +
from O +
either O +
Sterne O +
or O +
a O +
PA B-Gene +
- O +
producing O +
pX01 O +
- O +
cured O +
recombinant O +
, O +
affinity O +
- O +
purified O +
anti O +
- O +
PA B-Gene +
IgG B-Gene +
, O +
and O +
monkey O +
antisera O +
to O +
AVA O +
were O +
used O +
to O +
assess O +
the O +
role O +
of O +
anti O +
- O +
PA B-Gene +
ABS O +
: O +

Rabbit O +
anti O +
- O +
PA B-Gene +
Abs O +
promoted O +
the O +
uptake O +
of O +
spores O +
of O +
the O +
PA B-Gene +
- O +
producing O +
strains O +
Sterne O +
, O +
Ames O +
and O +
RP42 O +
, O +
a O +
mutant O +
of O +
Sterne O +
producing O +
only O +
PA B-Gene +
, O +
but O +
not O +
of O +
the O +
pX01 O +
- O +
Sterne O +
- O +
1 O +
strain O +
, O +
Ames O +
strain O +
, O +
or O +
RP4 O +
, O +
a O +
mutant O +
of O +
Sterne O +
with O +
deletions O +
in O +
the O +
loci O +
encoding O +
PA B-Gene +
and O +
the O +
oedema B-Gene +
factor I-Gene +
( O +
EF B-Gene +
) O +
toxin O +
component O +
and O +
producing O +
only O +
the O +
lethal B-Gene +
factor I-Gene +
toxin O +
component O +
. O +

Rabbit O +
anti O +
- O +
PA B-Gene +
and O +
monkey O +
anti O +
- O +
AVA O +
Abs O +
also O +
significantly O +
inhibited O +
spore O +
germination O +
in O +
vitro O +
compared O +
to O +
preimmune O +
serum O +
or O +
medium O +
. O +

Spore O +
- O +
associated O +
proteins O +
recognized O +
by O +
anti O +
- O +
PA B-Gene +
Abs O +
were O +
detected O +
by O +
electron O +
microscopy O +
and O +
confirmed O +
by O +
immunoblotting O +
of O +
spore O +
coat O +
extracts O +
. O +

Thus O +
, O +
the O +
anti O +
- O +
PA B-Gene +
Ab O +
- O +
specific O +
immunity O +
induced O +
by O +
AVA O +
has O +
anti O +
- O +
spore O +
activity O +
and O +
might O +
have O +
a O +
role O +
in O +
impeding O +
the O +
early O +
stages O +
of O +
infection O +
with O +
B. O +
anthracis O +
spores O +
. O +

In O +
vitro O +
processing O +
of O +
the O +
16S O +
rRNA O +
of O +
the O +
thermophilic O +
archaeon O +
Sulfolobus O +
solfataricus O +
. O +

In O +
this O +
paper O +
we O +
have O +
analyzed O +
the O +
processing O +
in O +
vitro O +
of O +
the O +
16S O +
rRNA O +
of O +
the O +
thermophilic O +
archaeon O +
Sulfolobus O +
solfataricus O +
, O +
using O +
pre O +
- O +
rRNA O +
substrates O +
transcribed O +
in O +
vitro O +
and O +
different O +
protein O +
preparations O +
as O +
the O +
source O +
of O +
processing O +
enzymes O +
. O +

We O +
show O +
that O +
the O +
5 O -
' O +
external O +
transcribed O +
spacer O +
of O +
the O +
S. O +
solfataricus O +
pre O +
- O +
rRNA O +
transcript O +
contains O +
a O +
target O +
site O +
for O +
a O +
specific O +
endonuclease B-Gene +
, O +
which O +
recognizes O +
a O +
conserved O +
sequence O +
also O +
existing O +
in O +
the O +
early O +
A0 O +
and O +
0 O +
processing O +
sites O +
of O +
Saccharomyces O +
cerevisiae O +
and O +
vertebrates O +
. O +

This O +
site O +
is O +
present O +
in O +
other O +
members O +
of O +
the O +
kingdom O +
Crenarchaeota O +
but O +
apparently O +
not O +
in O +
the O +
Euryarchaeota O +
. O +

Furthermore O +
, O +
S. O +
solfataricus O +
pre O +
- O +
16S O +
RNA O +
is O +
processed O +
within O +
the O +
double O +
- O +
helical O +
stem O +
formed O +
by O +
the O +
inverted O +
repeats O +
flanking O +
the O +
16S O +
RNA O +
sequence O +
, O +
in O +
correspondence O +
with O +
a O +
bulge O +
- O +
helix O +
- O +
bulge O +
motif O +
. O +

The O +
endonuclease B-Gene +
responsible O +
for O +
this O +
cleavage O +
is O +
present O +
in O +
both O +
the O +
Crenarchaeota O +
and O +
the O +
Euryarchaeota O +
. O +

The O +
processing O +
pattern O +
remained O +
the O +
same O +
when O +
the O +
substrate O +
was O +
a O +
30S O +
ribonucleoprotein O +
particle O +
instead O +
of O +
the O +
naked O +
RNA O +
. O +

Maturation O +
of O +
either O +
the O +
5 O -
' O +
or O +
the O +
3 O -
' O +
end O +
of O +
the O +
16S O +
RNA O +
molecule O +
was O +
not O +
observed O +
, O +
suggesting O +
either O +
that O +
maturation O +
requires O +
conditions O +
not O +
easily O +
reproducible O +
in O +
vitro O +
or O +
that O +
the O +
responsible O +
endonucleases B-Gene +
are O +
scarcely O +
represented O +
in O +
cell O +
extracts O +
. O +

Upregulation O +
of O +
bone B-Gene +
morphogenetic I-Gene +
protein I-Gene +
GDF-3 B-Gene +
/ O +
Vgr-2 B-Gene +
expression O +
in O +
adipose O +
tissue O +
of O +
FABP4 B-Gene +
/ O +
aP2 B-Gene +
null O +
mice O +
. O +

High O +
- O +
fat O +
- O +
fed O +
C57Bl O +
/ O +
6J O +
FABP4 B-Gene +
/ O +
aP2 B-Gene +
null O +
mice O +
develop O +
obesity O +
but O +
not O +
the O +
related O +
hyperglycemia O +
or O +
hyperinsulinemia O +
characteristic O +
of O +
type O +
II O +
diabetes O +
. O +

FABP4 B-Gene +
/ O +
aP2 B-Gene +
protein O +
's O +
function O +
to O +
bind O +
fatty O +
acids O +
in O +
the O +
adipocytes O +
may O +
promote O +
total O +
body O +
energy O +
homeostasis O +
by O +
linking O +
energy O +
depots O +
to O +
the O +
ability O +
to O +
express O +
signaling O +
molecules O +
similar O +
to O +
leptin B-Gene +
. O +

To O +
test O +
this O +
hypothesis O +
, O +
proteomic O +
analysis O +
of O +
serum O +
proteins O +
from O +
high O +
- O +
fat O +
- O +
fed O +
wild O +
- O +
type O +
and O +
FABP4 B-Gene +
/ O +
aP2 B-Gene +
null O +
mice O +
revealed O +
that O +
the O +
GDF-3 B-Gene +
/ O +
Vgr-2 B-Gene +
protein O +
, O +
a O +
bone B-Gene +
morphogenetic I-Gene +
protein I-Gene +
, O +
was O +
upregulated O +
in O +
C57Bl O +
/ O +
6J O +
FABP4 B-Gene +
/ O +
aP2 B-Gene +
null O +
mice O +
. O +

The O +
increase O +
in O +
serum O +
GDF-3 B-Gene +
/ O +
Vgr-2 B-Gene +
protein O +
was O +
correlated O +
with O +
a O +
27 O +
- O +
fold O +
increase O +
in O +
adipose O +
GDF-3 B-Gene +
/ O +
Vgr-2 B-Gene +
mRNA O +
. O +

In O +
contrast O +
, O +
leptin B-Gene +
expression O +
was O +
unaltered O +
between O +
FABP4 B-Gene +
/ O +
aP2 B-Gene +
null O +
and O +
wild O +
- O +
type O +
animals O +
. O +

The O +
expression O +
of O +
GDF-3 B-Gene +
/ O +
Vgr-2 B-Gene +
mRNA O +
was O +
not O +
substantially O +
different O +
in O +
adipose O +
tissue O +
of O +
db O +
/ O +
db O +
and O +
tb O +
/ O +
tb O +
mice O +
compared O +
to O +
wild O +
- O +
type O +
controls O +
. O +

The O +
expression O +
of O +
GDF-3 B-Gene +
/ O +
Vgr-2 B-Gene +
mRNA O +
was O +
dependent O +
upon O +
the O +
age O +
and O +
diet O +
of O +
the O +
animals O +
, O +
declining O +
as O +
a O +
function O +
of O +
age O +
in O +
high O +
- O +
fat O +
- O +
fed O +
wild O +
- O +
type O +
animals O +
while O +
increasing O +
in O +
the O +
FABP4 B-Gene +
/ O +
aP2 B-Gene +
null O +
strain O +
. O +

These O +
results O +
identify O +
GDF-3 B-Gene +
/ O +
Vgr-2 B-Gene +
as O +
an O +
age O +
- O +
and O +
fat O +
- O +
regulated O +
, O +
adipose O +
- O +
derived O +
cytokine B-Gene +
suggesting O +
a O +
linkage O +
between O +
adipocyte O +
fatty O +
acid O +
metabolism O +
and O +
the O +
expression O +
of O +
the O +
bone B-Gene +
morphogenetic I-Gene +
family I-Gene +
of O +
differentiation O +
regulators O +
. O +

Identification O +
and O +
characterization O +
of O +
a O +
new O +
mammalian O +
glutaredoxin B-Gene +
( O +
thioltransferase B-Gene +
) O +
, O +
Grx2 B-Gene +
. O +

A O +
thiol B-Gene +
/ I-Gene +
disulfide I-Gene +
oxidoreductase I-Gene +
component O +
of O +
the O +
GSH O +
system O +
, O +
glutaredoxin B-Gene +
( O +
Grx B-Gene +
) O +
, O +
is O +
involved O +
in O +
the O +
reduction O +
of O +
GSH O +
- O +
based O +
mixed O +
disulfides O +
and O +
participates O +
in O +
a O +
variety O +
of O +
cellular O +
redox O +
pathways O +
. O +

A O +
single O +
cytosolic O +
Grx B-Gene +
( O +
Grx1 B-Gene +
) O +
was O +
previously O +
described O +
in O +
mammals O +
. O +

We O +
now O +
report O +
identification O +
and O +
characterization O +
of O +
a O +
second O +
mammalian O +
Grx B-Gene +
, O +
designated O +
Grx2 B-Gene +
. O +

Grx2 B-Gene +
exhibited O +
36 O +
% O +
identity O +
with O +
Grx1 B-Gene +
and O +
had O +
a O +
disulfide O +
active O +
center O +
containing O +
the O +
Cys O -
- O -
Ser O -
- O -
Tyr O -
- O -
Cys O +
motif O +
. O +

Grx2 B-Gene +
was O +
encoded O +
in O +
the O +
genomes O +
of O +
mammals O +
and O +
birds O +
and O +
expressed O +
in O +
a O +
variety O +
of O +
cell O +
types O +
. O +

The O +
gene O +
for O +
human O +
Grx2 B-Gene +
consisted O +
of O +
four O +
exons O +
and O +
three O +
introns O +
, O +
spanned O +
10 O +
kilobase O +
pairs O +
, O +
and O +
localized O +
to O +
chromosome O +
1q31.2 O +
- O +
31.3 O +
. O +

The O +
coding O +
sequence O +
was O +
present O +
in O +
all O +
exons O +
, O +
with O +
the O +
first O +
exon O +
encoding O +
a O +
mitochondrial O +
signal O +
peptide O +
. O +

The O +
mitochondrial O +
leader O +
sequence O +
was O +
also O +
present O +
in O +
mouse O +
and O +
rat O +
Grx2 B-Gene +
sequences O +
and O +
was O +
shown O +
to O +
direct O +
either O +
Grx2 B-Gene +
or O +
green B-Gene +
fluorescent I-Gene +
protein I-Gene +
to O +
mitochondria O +
. O +

Alternative O +
splicing O +
forms O +
of O +
mammalian O +
Grx2 B-Gene +
mRNAs O +
were O +
identified O +
that O +
differed O +
in O +
sequences O +
upstream O +
of O +
exon O +
2 O +
. O +

To O +
functionally O +
characterize O +
the O +
new O +
protein O +
, O +
human O +
and O +
mouse O +
Grx2 B-Gene +
proteins O +
were O +
expressed O +
in O +
Escherichia O +
coli O +
, O +
and O +
the O +
purified O +
proteins O +
were O +
shown O +
to O +
reduce O +
mixed O +
disulfides O +
formed O +
between O +
GSH O +
and O +
S O -
- O -
sulfocysteine O +
, O +
hydroxyethyldisulfide O +
, O +
or O +
cystine O +
. O +

Grx1 B-Gene +
and O +
Grx2 B-Gene +
were O +
sensitive O +
to O +
inactivation O +
by O +
iodoacetamide O +
and O +
H O -
( O -
2 O -
) O -
O O -
( O -
2 O -
) O +
and O +
exhibited O +
similar O +
pH O +
dependence O +
of O +
catalytic O +
activity O +
. O +

However O +
, O +
H O -
( O -
2 O -
) O -
O O -
( O -
2 O -
) O -
-inactivated O +
Grx2 B-Gene +
could O +
only O +
be O +
reactivated O +
with O +
5 O +
mm O +
GSH O +
, O +
whereas O +
Grx1 B-Gene +
could O +
also O +
be O +
reactivated O +
with O +
dithiothreitol O +
or O +
thioredoxin B-Gene +
/ I-Gene +
thioredoxin I-Gene +
reductase I-Gene +
. O +

The O +
Grx2 B-Gene +
structural O +
model O +
suggested O +
a O +
common O +
reaction O +
mechanism O +
for O +
this O +
class O +
of O +
proteins O +
. O +

The O +
data O +
provide O +
the O +
first O +
example O +
of O +
a O +
mitochondrial O +
Grx B-Gene +
and O +
also O +
indicate O +
the O +
occurrence O +
of O +
a O +
second O +
functional O +
Grx B-Gene +
in O +
mammals O +
. O +

Retinoid B-Gene +
receptors I-Gene +
in O +
the O +
human O +
endometrium O +
and O +
its O +
disorders O +
: O +
a O +
possible O +
modulator O +
of O +
17 B-Gene +
beta I-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
. O +

Retinoids O +
have O +
recently O +
been O +
proposed O +
to O +
modulate O +
estrogenic O +
actions O +
in O +
various O +
sex O +
steroid O +
- O +
dependent O +
neoplasms O +
, O +
but O +
little O +
has O +
been O +
studied O +
in O +
human O +
endometrial O +
disorders O +
. O +

Therefore O +
, O +
in O +
this O +
study O +
, O +
we O +
first O +
examined O +
the O +
immunolocalization O +
of O +
retinoic B-Gene +
acid I-Gene +
receptor I-Gene +
alpha I-Gene +
, I-Gene +
beta I-Gene +
, I-Gene +
and I-Gene +
gamma I-Gene +
, O +
and O +
retinoid B-Gene +
X I-Gene +
receptor I-Gene +
( I-Gene +
RXR I-Gene +
) I-Gene +
alpha I-Gene +
, I-Gene +
beta I-Gene +
, I-Gene +
and I-Gene +
gamma I-Gene +
in O +
20 O +
normal O +
cycling O +
human O +
endometria O +
, O +
34 O +
endometrial O +
hyperplasia O +
, O +
and O +
46 O +
endometrioid O +
endometrial O +
adenocarcinomas O +
. O +

We O +
then O +
correlated O +
these O +
findings O +
with O +
other O +
clinicopathological O +
parameters O +
, O +
especially O +
in O +
the O +
correlation O +
between O +
retinoid O +
receptor O +
subtypes O +
and O +
the O +
status O +
of O +
steroid B-Gene +
hormone I-Gene +
receptors I-Gene +
, O +
17 B-Gene +
beta I-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
( O +
17 B-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
) O +
and O +
aromatase B-Gene +
. O +

We O +
also O +
then O +
examined O +
the O +
effects O +
of O +
retinoic O +
acid O +
on O +
the O +
expression O +
of O +
17 B-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
type I-Gene +
2 I-Gene +
in O +
cell O +
lines O +
derived O +
from O +
endometrial O +
carcinoma O +
using O +
Northern O +
blotting O +
analysis O +
to O +
examine O +
the O +
possible O +
roles O +
of O +
retinoids O +
in O +
in O +
situ O +
endometrial O +
estrogen O +
metabolism O +
. O +

Among O +
these O +
six O +
retinoid B-Gene +
receptors I-Gene +
examined O +
, O +
RXR B-Gene +
gamma I-Gene +
immunoreactivity O +
was O +
exclusively O +
detected O +
in O +
the O +
epithelial O +
cells O +
of O +
the O +
secretory O +
phase O +
endometrium O +
but O +
not O +
of O +
the O +
proliferative O +
phase O +
, O +
which O +
was O +
well O +
correlated O +
with O +
17 B-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
type I-Gene +
2 I-Gene +
immunolocalization O +
. O +

However O +
, O +
in O +
endometrial O +
hyperplasia O +
, O +
RXR B-Gene +
gamma I-Gene +
was O +
not O +
correlated O +
with O +
17 B-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
type I-Gene +
2 I-Gene +
. O +

In O +
endometrioid O +
endometrial O +
adenocarcinoma O +
, O +
there O +
was O +
a O +
statistically O +
significant O +
correlation O +
between O +
17 B-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
type I-Gene +
2 I-Gene +
immunoreactivity O +
and O +
RXR B-Gene +
gamma I-Gene +
labeling O +
index O +
( O +
LI O +
) O +
( O +
P O +
< O +
0.001 O +
) O +
and O +
between O +
RXR B-Gene +
gamma I-Gene +
LI O +
and O +
progesterone B-Gene +
receptor I-Gene +
LI O +
( O +
r O +
= O +
0.501 O +
, O +
P O +
= O +
0.003 O +
) O +
. O +

A O +
significant O +
inverse O +
correlation O +
was O +
also O +
detected O +
between O +
RXR B-Gene +
gamma I-Gene +
LI O +
and O +
patient O +
age O +
( O +
r O +
= O +
0.449 O +
, O +
P O +
= O +
0.015 O +
) O +
. O +

No O +
statistically O +
significant O +
correlation O +
was O +
obtained O +
between O +
LIs O +
of O +
receptors O +
and O +
other O +
clinicopathological O +
parameters O +
including O +
the O +
status O +
of O +
intratumoral O +
aromatase B-Gene +
examined O +
by O +
immunohistochemistry O +
. O +

In O +
the O +
endometrial O +
carcinoma O +
cell O +
line O +
, O +
RL95 O -
- O -
2 O +
, O +
retinoic O +
acid O +
markedly O +
increased O +
the O +
level O +
of O +
17 B-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
type I-Gene +
2 I-Gene +
messenger O +
RNA O +
in O +
a O +
time O +
- O +
and O +
dose O +
- O +
dependent O +
manner O +
. O +

These O +
results O +
all O +
suggest O +
that O +
retinoic O +
acids O +
may O +
be O +
involved O +
in O +
modulation O +
of O +
in O +
situ O +
estrogen O +
metabolism O +
in O +
both O +
normal O +
and O +
neoplastic O +
human O +
endometrium O +
possibly O +
through O +
RXR B-Gene +
gamma I-Gene +
by O +
stimulating O +
the O +
expression O +
of O +
17 B-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
type I-Gene +
2 I-Gene +
. O +

Expression O +
of O +
11 B-Gene +
beta I-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
isoenzymes O +
in O +
the O +
human O +
pituitary O +
: O +
induction O +
of O +
the O +
type O +
2 O +
enzyme O +
in O +
corticotropinomas O +
and O +
other O +
pituitary O +
tumors O +
. O +

One O +
of O +
the O +
defining O +
biochemical O +
features O +
of O +
Cushing O +
's O +
disease O +
is O +
a O +
relative O +
insensitivity O +
to O +
glucocorticoid O +
( O +
GC O +
) O +
feedback O +
, O +
but O +
an O +
analysis O +
of O +
the O +
GC B-Gene +
receptor I-Gene +
has O +
failed O +
to O +
detect O +
any O +
major O +
abnormalities O +
. O +

However O +
, O +
two O +
isoenzymes O +
of O +
11 B-Gene +
beta I-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
( O +
11 B-Gene +
beta I-Gene +
HSD I-Gene +
) O +
, O +
either O +
by O +
converting O +
cortisone O +
( O +
E O +
) O +
to O +
cortisol O +
( O +
F O +
) O +
( O +
type O +
1 O +
) O +
or O +
conversely O +
by O +
converting O +
F O +
to O +
E O +
( O +
type O +
2 O +
) O +
, O +
play O +
an O +
important O +
prereceptor O +
role O +
in O +
regulating O +
corticosteroid O +
hormone O +
action O +
at O +
several O +
sites O +
. O +

11 B-Gene +
beta I-Gene +
HSD1 I-Gene +
and I-Gene +
- I-Gene +
2 I-Gene +
expression O +
within O +
the O +
anterior O +
pituitary O +
gland O +
itself O +
may O +
modulate O +
GC O +
feedback O +
at O +
an O +
autocrine O +
level O +
, O +
and O +
we O +
have O +
speculated O +
that O +
this O +
may O +
be O +
deranged O +
in O +
Cushing O +
's O +
disease O +
. O +

Detection O +
of O +
11 B-Gene +
beta I-Gene +
HSD I-Gene +
type I-Gene +
1 I-Gene +
and I-Gene +
2 I-Gene +
immunoreactive O +
protein O +
was O +
performed O +
using O +
fluorescence O +
immunohistochemistry O +
. O +

Double O +
immunofluorescent O +
studies O +
were O +
undertaken O +
on O +
normal O +
pituitary O +
to O +
define O +
the O +
cellular O +
localization O +
of O +
11 B-Gene +
beta I-Gene +
HSD I-Gene +
isoenzymes O +
using O +
antisera O +
against O +
GH B-Gene +
, O +
ACTH B-Gene +
, O +
LH B-Gene +
, O +
FSH B-Gene +
, O +
PRL B-Gene +
, O +
and O +
S100 B-Gene +
, O +
a O +
nonhormonal O +
marker O +
of O +
folliculo O +
- O +
stellate O +
cells O +
. O +

In O +
normal O +
pituitary O +
, O +
positive O +
staining O +
for O +
11 B-Gene +
beta I-Gene +
HSD1 I-Gene +
- O +
immunoreactive O +
protein O +
was O +
observed O +
in O +
GH B-Gene +
- O +
and O +
PRL B-Gene +
- O +
secreting O +
cells O +
and O +
in O +
folliculo O +
- O +
stellate O +
cells O +
; O +
gonadotrophs O +
, O +
thyrotrophs O +
, O +
and O +
ACTH B-Gene +
- O +
positive O +
cells O +
were O +
negative O +
. O +

11 B-Gene +
beta I-Gene +
HSD2 I-Gene +
immunoreactivity O +
was O +
absent O +
in O +
all O +
cell O +
types O +
. O +

RT O +
- O +
PCR O +
detected O +
11 B-Gene +
beta I-Gene +
HSD1 I-Gene +
messenger O +
ribonucleic O +
acid O +
( O +
mRNA O +
) O +
expression O +
in O +
the O +
normal O +
pituitary O +
; O +
11 B-Gene +
beta I-Gene +
HSD2 I-Gene +
mRNA O +
expression O +
was O +
also O +
seen O +
in O +
most O +
normal O +
tissue O +
. O +

By O +
contrast O +
, O +
in O +
ACTH B-Gene +
- O +
secreting O +
adenomas O +
11 B-Gene +
beta I-Gene +
HSD2 I-Gene +
immunostaining O +
was O +
strongly O +
positive O +
in O +
every O +
case O +
of O +
corticotroph O +
adenoma O +
. O +

11 B-Gene +
beta I-Gene +
HSD1 I-Gene +
immunoreactivity O +
was O +
also O +
observed O +
occasionally O +
, O +
but O +
to O +
a O +
much O +
lesser O +
extent O +
. O +

In O +
other O +
pituitary O +
tumors O +
, O +
both O +
functional O +
and O +
nonfunctional O +
, O +
11 B-Gene +
beta I-Gene +
HSD I-Gene +
expression O +
was O +
variable O +
in O +
terms O +
of O +
isoenzyme O +
mRNA O +
and O +
intensity O +
of O +
protein O +
staining O +
. O +

The O +
expression O +
of O +
11 B-Gene +
beta I-Gene +
HSD1 I-Gene +
( O +
which O +
generates O +
F O +
from O +
E O +
) O +
in O +
somatotrophs O +
and O +
lactotrophs O +
suggests O +
an O +
autocrine O +
role O +
for O +
this O +
isoenzyme O +
in O +
the O +
glucocorticoid O +
regulation O +
of O +
pituitary O +
GH B-Gene +
and O +
PRL B-Gene +
secretion O +
. O +

11 B-Gene +
beta I-Gene +
HSD2 I-Gene +
expression O +
is O +
markedly O +
induced O +
in O +
ACTH B-Gene +
- O +
secreting O +
pituitary O +
tumors O +
and O +
, O +
by O +
converting O +
F O +
to O +
E O +
, O +
may O +
explain O +
the O +
resetting O +
of O +
glucocorticoid O +
feedback O +
control O +
in O +
Cushing O +
's O +
disease O +
. O +

Pharmacokinetics O +
and O +
safety O +
of O +
amprenavir O +
and O +
ritonavir O +
following O +
multiple O +
- O +
dose O +
, O +
co O +
- O +
administration O +
to O +
healthy O +
volunteers O +
. O +

OBJECTIVE O +
: O +

To O +
evaluate O +
the O +
safety O +
and O +
pharmacokinetic O +
interaction O +
between O +
amprenavir O +
( O +
APV O +
) O +
and O +
ritonavir O +
( O +
RTV O +
) O +
. O +

METHODS O +
: O +

Three O +
open O +
- O +
label O +
, O +
randomized O +
, O +
two O +
- O +
sequence O +
, O +
multiple O +
- O +
dose O +
studies O +
having O +
the O +
same O +
design O +
( O +
7 O +
days O +
of O +
APV O +
or O +
RTV O +
alone O +
followed O +
by O +
7 O +
days O +
of O +
both O +
drugs O +
together O +
) O +
used O +
450 O +
or O +
900 O +
mg O +
APV O +
with O +
100 O +
or O +
300 O +
mg O +
RTV O +
every O +
12 O +
h O +
with O +
pharmacokinetic O +
assessments O +
on O +
days O +
7 O +
and O +
14 O +
. O +

Safety O +
was O +
monitored O +
as O +
clinical O +
adverse O +
events O +
( O +
AEs O +
) O +
and O +
laboratory O +
abnormalities O +
. O +

RESULTS O +
: O +

Relative O +
to O +
APV O +
alone O +
, O +
RTV O +
co O +
- O +
administration O +
resulted O +
in O +
a O +
3.3 O +
- O +
to O +
4 O +
- O +
fold O +
and O +
10.84 O +
to O +
14.25 O +
- O +
fold O +
increase O +
in O +
the O +
geometric O +
least O +
- O +
square O +
( O +
GLS O +
) O +
mean O +
area O +
under O +
the O +
plasma O +
concentration O +
- O +
- O +
time O +
curve O +
( O +
AUC O -
( O -
tau O -
, O -
ss O -
) O +
) O +
and O +
minimum O +
concentration O +
( O +
C O -
( O -
min O -
, O -
ss O +
) O +
) O +
, O +
respectively O +
. O +

APV O +
900 O +
mg O +
with O +
RTV O +
100 O +
mg O +
resulted O +
in O +
a O +
2.09 O +
- O +
fold O +
and O +
6.85 O +
- O +
fold O +
increase O +
in O +
the O +
GLS O +
mean O +
AUC O -
( O -
tau O -
, O -
ss O +
) O +
and O +
C O -
( O -
min O -
, O -
ss O +
) O +
, O +
respectively O +
. O +

On O +
day O +
14 O +
, O +
the O +
geometric O +
mean O +
( O +
95 O +
% O +
confidence O +
interval O +
) O +
for O +
450 O +
mg O +
APV O +
AUC O +
( O +
tau O +
, O +
ss O +
) O +
( O +
micro O +
x O +
h O +
/ O +
mL O +
) O +
was O +
23.49 O +
( O +
19.32 O +
- O +
- O +
28.57 O +
) O +
with O +
300 O +
mg O +
RTV O +
and O +
35.42 O +
( O +
30.46 O +
--44.42 O +
) O +
with O +
100 O +
microg O +
RTV O +
, O +
and O +
for O +
the O +
900 O +
mg O +
APV O +
with O +
100 O +
mg O +
RTV O +
47.11 O +
( O +
39.47 O +
- O +
- O +
61.24 O +
) O +
. O +

The O +
450 O +
mg O +
APV O +
C O -
( O -
min O -
, O -
ss O +
) O +
( O +
microg O +
/ O +
ml O +
) O +
were O +
1.32 O +
( O +
1.05 O +
-- O +
1.67 O +
) O +
and O +
2.01 O +
( O +
1.70 O +
-- O +
2.61 O +
) O +
, O +
and O +
2.47 O +
( O +
2.08 O +
- O +
- O +
3.32 O +
) O +
for O +
900 O +
mg O +
APV O +
. O +

The O +
most O +
common O +
AEs O +
were O +
mild O +
and O +
included O +
diarrhea O +
, O +
nausea O +
/ O +
vomiting O +
, O +
oral O +
parasthesias O +
, O +
and O +
rash O +
. O +

The O +
triglyceride O +
and O +
cholesterol O +
increased O +
significantly O +
from O +
RTV O +
exposure O +
. O +

CONCLUSION O +
: O +

Adding O +
RTV O +
to O +
APV O +
resulted O +
in O +
clinically O +
and O +
statistically O +
significant O +
increases O +
in O +
APV O +
AUC O +
and O +
C O -
( O -
min O -
) O +
with O +
variable O +
effects O +
on O +
maximum O +
concentration O +
. O +

The O +
two O +
RTV O +
doses O +
had O +
similar O +
effects O +
on O +
APV O +
but O +
AEs O +
were O +
more O +
frequent O +
with O +
300 O +
mg O +
RTV O +
. O +

Expression O +
of O +
AP-2 B-Gene +
alpha I-Gene +
in O +
SV40 O +
immortalized O +
human O +
lung O +
fibroblasts O +
is O +
associated O +
with O +
a O +
distinct O +
pattern O +
of O +
cytosine O +
methylation O +
in O +
the O +
AP-2 B-Gene +
alpha I-Gene +
promoter O +
. O +

Activator B-Gene +
protein-2 I-Gene +
alpha I-Gene +
( O +
AP-2 B-Gene +
alpha I-Gene +
) O +
is O +
a O +
cell O +
type O +
- O +
specific O +
, O +
developmentally O +
regulated O +
, O +
transcription B-Gene +
factor I-Gene +
that O +
has O +
been O +
implicated O +
as O +
a O +
critical O +
regulator O +
of O +
gene O +
expression O +
during O +
vertebrate O +
development O +
and O +
carcinogenesis O +
. O +

We O +
found O +
that O +
AP-2 B-Gene +
alpha I-Gene +
was O +
differentially O +
expressed O +
in O +
the O +
normal O +
human O +
lung O +
fibroblast O +
cell O +
strains O +
WI38 O +
, O +
MRC-5 O +
and O +
their O +
respective O +
SV40 O +
- O +
transformed O +
cell O +
counterparts O +
WI38 O +
- O +
VA O +
, O +
MRC-5VA O +
. O +

Since O +
CpG O +
methylation O +
within O +
genetic O +
regulatory O +
regions O +
has O +
been O +
implicated O +
as O +
a O +
mechanism O +
of O +
gene O +
regulation O +
, O +
we O +
investigated O +
the O +
CpG O +
methylation O +
status O +
of O +
the O +
AP-2 B-Gene +
alpha I-Gene +
gene O +
promoter O +
in O +
these O +
cells O +
. O +

High O +
resolution O +
mapping O +
of O +
methylated O +
cytosines O +
revealed O +
that O +
differential O +
expression O +
of O +
the O +
AP-2 B-Gene +
alpha I-Gene +
gene O +
in O +
normal O +
human O +
lung O +
fibroblasts O +
and O +
their O +
SV40 O +
- O +
transformed O +
counterparts O +
was O +
associated O +
with O +
distinct O +
patterns O +
of O +
cytosine O +
methylation O +
in O +
the O +
AP-2 B-Gene +
alpha I-Gene +
promoter O +
just O +
5 O -
' O +
to O +
the O +
transcription O +
initiation O +
site O +
. O +

Site O +
- O +
specific O +
methylation O +
was O +
positively O +
correlated O +
with O +
increased O +
AP-2 B-Gene +
alpha I-Gene +
gene O +
expression O +
in O +
both O +
transformed O +
cell O +
lines O +
investigated O +
. O +

Interestingly O +
, O +
one O +
of O +
the O +
two O +
major O +
centers O +
of O +
hypermethylation O +
in O +
the O +
transformed O +
cells O +
encompassed O +
the O +
cis O +
- O +
element O +
for O +
the O +
AP-2 B-Gene +
repressing I-Gene +
transcription I-Gene +
factor I-Gene +
AP-2rep B-Gene +
( O +
KLF12 B-Gene +
) O +
. O +

Finally O +
, O +
a O +
sequence O +
variation O +
in O +
human O +
lung O +
fibroblasts O +
relative O +
to O +
the O +
published O +
sequence O +
revealed O +
a O +
previously O +
unidentified O +
AP-2 B-Gene +
binding O +
site O +
at O +
position O +
- O +
528 O +
with O +
respect O +
to O +
the O +
transcription O +
initiation O +
site O +
that O +
overlapped O +
the O +
AP-2rep B-Gene +
site O +
. O +

Our O +
results O +
suggest O +
that O +
transcriptional O +
activation O +
of O +
AP-2 B-Gene +
alpha I-Gene +
in O +
the O +
SV40 O +
- O +
transformed O +
cells O +
is O +
mediated O +
, O +
at O +
least O +
in O +
part O +
, O +
by O +
site O +
- O +
specific O +
methylation O +
of O +
a O +
negative O +
regulatory O +
cis O -
- O -
element O +
in O +
the O +
AP-2 B-Gene +
alpha I-Gene +
promoter O +
. O +

Maternal O +
undernutrition O +
during O +
early O +
to O +
midgestation O +
programs O +
tissue O +
- O +
specific O +
alterations O +
in O +
the O +
expression O +
of O +
the O +
glucocorticoid B-Gene +
receptor I-Gene +
, O +
11beta B-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
isoforms O +
, O +
and O +
type B-Gene +
1 I-Gene +
angiotensin I-Gene +
ii I-Gene +
receptor I-Gene +
in O +
neonatal O +
sheep O +
. O +

We O +
have O +
investigated O +
the O +
effects O +
of O +
maternal O +
nutrient O +
restriction O +
in O +
the O +
sheep O +
during O +
the O +
period O +
of O +
rapid O +
placental O +
growth O +
( O +
i.e. O +
28 O +
- O +
77 O +
days O +
gestation O +
; O +
term O +
= O +
147 O +
days O +
) O +
on O +
feto O +
- O +
placental O +
growth O +
and O +
expression O +
of O +
the O +
glucocorticoid B-Gene +
receptor I-Gene +
( O +
GR B-Gene +
) O +
, O +
types B-Gene +
1 I-Gene +
and I-Gene +
2 I-Gene +
11beta I-Gene +
- I-Gene +
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
( O +
11betaHSD1 B-Gene +
, O +
11betaHSD2 B-Gene +
) O +
, O +
and O +
types B-Gene +
1 I-Gene +
and I-Gene +
2 I-Gene +
angiotensin I-Gene +
II I-Gene +
receptor I-Gene +
( O +
AT1 B-Gene +
, O +
AT2 B-Gene +
) O +
in O +
fetal O +
and O +
neonatal O +
offspring O +
. O +

Ewes O +
( O +
n O +
= O +
63 O +
) O +
of O +
similar O +
age O +
, O +
body O +
weight O +
, O +
and O +
body O +
composition O +
were O +
randomly O +
allocated O +
to O +
a O +
nutrient O +
- O +
restricted O +
( O +
NR O +
) O +
group O +
in O +
which O +
they O +
consumed O +
3.2 O +
MJ O +
/ O +
day O +
metabolizable O +
energy O +
( O +
ME O +
; O +
equivalent O +
to O +
50 O +
% O +
of O +
predicted O +
requirements O +
) O +
or O +
to O +
a O +
control O +
group O +
in O +
which O +
they O +
consumed O +
6.7 O +
MJ O +
/ O +
day O +
ME O +
( O +
equivalent O +
to O +
110 O +
% O +
of O +
predicted O +
requirements O +
) O +
. O +

After O +
77 O +
days O +
gestation O +
, O +
ewes O +
from O +
both O +
dietary O +
groups O +
consumed O +
close O +
to O +
100 O +
% O +
of O +
ME O +
requirements O +
up O +
to O +
term O +
. O +

Newborn O +
offspring O +
of O +
NR O +
ewes O +
were O +
of O +
similar O +
body O +
weight O +
, O +
but O +
had O +
increased O +
crown O +
- O +
rump O +
length O +
, O +
greater O +
placental O +
weight O +
, O +
and O +
increased O +
placental O +
/ O +
body O +
weight O +
ratio O +
( O +
P O +
< O +
0.01 O +
) O +
compared O +
with O +
controls O +
. O +

Their O +
kidneys O +
were O +
heavier O +
( O +
P O +
< O +
0.05 O +
) O +
, O +
but O +
shorter O +
in O +
length O +
, O +
with O +
increased O +
ratios O +
of O +
transverse O +
width O +
to O +
length O +
( O +
P O +
< O +
0.001 O +
) O +
. O +

GR B-Gene +
messenger O +
RNA O +
( O +
mRNA O +
) O +
expression O +
in O +
neonatal O +
offspring O +
from O +
NR O +
ewes O +
was O +
increased O +
in O +
adrenal O +
, O +
kidney O +
, O +
liver O +
, O +
lung O +
, O +
and O +
perirenal O +
adipose O +
tissue O +
( O +
P O +
< O +
0.01 O +
) O +
. O +

Conversely O +
, O +
11betaHSD1 B-Gene +
mRNA O +
expression O +
was O +
unaffected O +
, O +
except O +
in O +
perirenal O +
adipose O +
tissue O +
, O +
where O +
it O +
was O +
higher O +
in O +
lambs O +
born O +
to O +
NR O +
ewes O +
( O +
P O +
< O +
0.01 O +
) O +
. O +

11betaHSD2 B-Gene +
mRNA O +
expression O +
was O +
decreased O +
in O +
adrenals O +
and O +
kidney O +
( O +
P O +
< O +
0.001 O +
) O +
. O +

Maternal O +
NR O +
also O +
resulted O +
in O +
significantly O +
increased O +
AT1 B-Gene +
expression O +
in O +
those O +
tissues O +
in O +
which O +
expression O +
of O +
GR B-Gene +
was O +
increased O +
and/or O +
11betaHSD2 B-Gene +
was O +
decreased O +
, O +
i.e. O +
adrenals O +
, O +
kidney O +
, O +
liver O +
, O +
and O +
lung O +
. O +

AT2 B-Gene +
expression O +
was O +
unaffected O +
by O +
maternal O +
NR O +
. O +

Although O +
11betaHSD2 B-Gene +
mRNA O +
was O +
undetectable O +
in O +
term O +
placenta O +
, O +
it O +
was O +
abundant O +
in O +
midgestation O +
placenta O +
and O +
was O +
lower O +
after O +
maternal O +
NR O +
( O +
P O +
< O +
0.001 O +
) O +
. O +

There O +
was O +
close O +
agreement O +
between O +
levels O +
of O +
11betaHSD B-Gene +
enzyme O +
( O +
i.e. O +
11beta B-Gene -
- I-Gene -
dehydrogenase I-Gene +
and O +
11-oxoreductase B-Gene +
) O +
activities O +
and O +
abundance O +
of O +
11betaHSD1 B-Gene +
mRNA O +
and O +
11betaHSD2 B-Gene +
mRNA O +
expression O +
. O +

The O +
persistence O +
of O +
tissue O +
- O +
specific O +
increases O +
in O +
the O +
expression O +
of O +
GR B-Gene +
, O +
11betaHSD1 B-Gene +
and O +
AT1 B-Gene +
and O +
decreases O +
in O +
the O +
expression O +
of O +
11betaHSD2 B-Gene +
in O +
adrenals O +
and O +
kidney O +
in O +
newborn O +
offspring O +
in O +
response O +
to O +
a O +
defined O +
period O +
of O +
maternal O +
nutrient O +
restriction O +
during O +
early O +
to O +
midgestation O +
suggests O +
that O +
gene O +
expression O +
has O +
been O +
programmed O +
by O +
nutrient O +
availability O +
to O +
the O +
fetus O +
before O +
birth O +
. O +

These O +
data O +
suggest O +
key O +
potential O +
mechanisms O +
by O +
which O +
maternal O +
nutrition O +
prenatally O +
programs O +
physiological O +
pathways O +
, O +
such O +
as O +
the O +
renin B-Gene +
- O +
angiotensin B-Gene +
system O +
, O +
in O +
the O +
offspring O +
that O +
may O +
lead O +
to O +
raised O +
blood O +
pressure O +
and O +
other O +
cardiovascular O +
disease O +
risk O +
factors O +
in O +
later O +
life O +
. O +

Therapeutic O +
alteration O +
of O +
insulin B-Gene +
- O +
dependent O +
diabetes O +
mellitus O +
progression O +
by O +
T O +
cell O +
tolerance O +
to O +
glutamic B-Gene +
acid I-Gene +
decarboxylase I-Gene +
65 I-Gene +
peptides O +
in O +
vitro O +
and O +
in O +
vivo O +
. O +

We O +
have O +
reported O +
previously O +
that O +
nonobese O +
diabetic O +
( O +
NOD O +
) O +
fetal O +
pancreas O +
organ O +
cultures O +
lose O +
the O +
ability O +
to O +
produce O +
insulin B-Gene +
when O +
maintained O +
in O +
contact O +
with O +
NOD O +
fetal O +
thymus O +
organ O +
cultures O +
( O +
FTOC O +
) O +
. O +

Initial O +
studies O +
indicated O +
that O +
exposure O +
to O +
glutamic B-Gene +
acid I-Gene +
decarboxylase I-Gene +
( O +
GAD65 B-Gene +
) O +
peptides O +
in O +
utero O +
resulted O +
in O +
delay O +
or O +
transient O +
protection O +
from O +
insulin B-Gene +
- O +
dependent O +
diabetes O +
mellitus O +
( O +
IDDM O +
) O +
in O +
NOD O +
mice O +
. O +

We O +
also O +
found O +
that O +
exposure O +
of O +
young O +
adult O +
NOD O +
mice O +
to O +
the O +
same O +
peptides O +
could O +
result O +
in O +
acceleration O +
of O +
the O +
disease O +
. O +

To O +
more O +
closely O +
examine O +
the O +
effects O +
of O +
early O +
and O +
late O +
exposure O +
to O +
diabetogenic O +
Ags O +
on O +
T O +
cells O +
, O +
we O +
applied O +
peptides O +
derived O +
from O +
GAD65 B-Gene +
( O +
GAD B-Gene +
AA O +
246 O +
- O +
266 O +
, O +
509 O +
- O +
528 O +
, O +
and O +
524 O +
- O +
543 O +
) O +
, O +
to O +
our O +
" O +
in O +
vitro O +
IDDM O +
" O +
( O +
ivIDDM O +
) O +
model O +
. O +

T O +
cells O +
derived O +
from O +
NOD O +
FTOC O +
primed O +
during O +
the O +
latter O +
stages O +
of O +
organ O +
culture O +
, O +
when O +
mature O +
T O +
cell O +
phenotypes O +
are O +
present O +
, O +
had O +
the O +
ability O +
to O +
proliferate O +
to O +
GAD B-Gene +
peptides O +
. O +

ivIDDM O +
was O +
exacerbated O +
under O +
these O +
conditions O +
, O +
suggesting O +
that O +
GAD B-Gene +
responsiveness O +
correlates O +
with O +
the O +
ivIDDM O +
phenotype O +
, O +
and O +
parallels O +
the O +
acceleration O +
of O +
IDDM O +
we O +
had O +
seen O +
in O +
young O +
adult O +
NOD O +
mice O +
. O +

When O +
GAD B-Gene +
peptides O +
were O +
present O +
during O +
the O +
initiation O +
of O +
FTOC O +
, O +
GAD B-Gene +
proliferative O +
responses O +
were O +
inhibited O +
, O +
and O +
ivIDDM O +
was O +
reduced O +
. O +

This O +
result O +
suggests O +
that O +
tolerance O +
to O +
GAD B-Gene +
peptides O +
may O +
reduce O +
the O +
production O +
of O +
diabetogenic O +
T O +
cells O +
or O +
their O +
capacity O +
to O +
respond O +
, O +
as O +
suggested O +
by O +
the O +
in O +
utero O +
therapies O +
studied O +
in O +
NOD O +
mice O +
. O +

Structure O +
of O +
aspergillopepsin B-Gene +
I I-Gene +
from O +
Aspergillus O +
phoenicis O +
: O +
variations O +
of O +
the O +
S1'-S2 O +
subsite O +
in O +
aspartic B-Gene +
proteinases I-Gene +
. O +

The O +
crystal O +
structure O +
of O +
aspergillopepsin B-Gene +
I I-Gene +
( O +
AP B-Gene +
) O +
from O +
Aspergillus O +
phoenicis O +
has O +
been O +
determined O +
at O +
2.18 O +
A O +
resolution O +
and O +
refined O +
to O +
R O +
and O +
R O +
( O +
free O +
) O +
factors O +
of O +
21.5 O +
and O +
26.0 O +
% O +
, O +
respectively O +
. O +

AP B-Gene +
has O +
the O +
typical O +
two O +
beta O -
- O -
barrel O +
domain O +
structure O +
of O +
aspartic B-Gene +
proteinases I-Gene +
. O +

The O +
structures O +
of O +
the O +
two O +
independent O +
molecules O +
are O +
partly O +
different O +
, O +
exemplifying O +
the O +
flexible O +
nature O +
of O +
the O +
aspartic B-Gene +
proteinase I-Gene +
structure O +
. O +

Notably O +
, O +
the O +
' O +
flap O +
' O +
in O +
one O +
molecule O +
is O +
closer O +
, O +
with O +
a O +
largest O +
separation O +
of O +
4.0 O +
A O +
, O +
to O +
the O +
active O +
site O +
than O +
in O +
the O +
other O +
molecule O +
. O +

AP B-Gene +
is O +
most O +
structurally O +
homologous O +
to O +
penicillopepsin B-Gene +
( O +
PP B-Gene +
) O +
and O +
then O +
to O +
endothiapepsin B-Gene +
( O +
EP B-Gene +
) O +
, O +
which O +
share O +
sequence O +
identities O +
of O +
68 O +
and O +
56 O +
% O +
, O +
respectively O +
. O +

However O +
, O +
AP B-Gene +
is O +
similar O +
to O +
EP B-Gene +
but O +
differs O +
from O +
PP B-Gene +
in O +
the O +
combined O +
S1 O +
' O -
-S2 O +
subsite O +
that O +
is O +
delineated O +
by O +
a O +
flexible O +
psi O +
- O +
loop O +
in O +
the O +
C O +
- O +
terminal O +
domain O +
. O +

The O +
S1 O +
' O +
and O +
S2 O +
subsites O +
are O +
well O +
defined O +
and O +
small O +
in O +
AP B-Gene +
, O +
while O +
there O +
is O +
no O +
definite O +
border O +
between O +
S1 O +
' O +
and O +
S2 O +
and O +
the O +
open O +
space O +
for O +
the O +
S2 O +
subsite O +
is O +
larger O +
in O +
PP B-Gene +
. O +

Comparison O +
of O +
the O +
structures O +
indicates O +
that O +
the O +
two O +
amino O +
- O +
acid O +
residues O +
equivalent O +
to O +
Leu295 O +
and O +
Leu297 O +
of O +
AP B-Gene +
are O +
the O +
major O +
determining O +
factors O +
in O +
shaping O +
the O +
S1'-S2 O +
subsite O +
in O +
the O +
fungal O +
aspartic B-Gene +
proteinases I-Gene +
. O +

Recombinant O +
, O +
soluble O +
LIGHT B-Gene +
( O +
HVEM B-Gene +
ligand I-Gene +
) O +
induces O +
increased O +
IL-8 B-Gene +
secretion O +
and O +
growth O +
arrest O +
in O +
A375 O +
melanoma O +
cells O +
. O +

The O +
heterotrimeric O +
lymphotoxin B-Gene +
alpha I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
beta I-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
( O +
LTalpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
beta I-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
) O +
complex O +
and O +
LIGHT B-Gene +
, O +
a O +
new O +
member O +
of O +
the O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
( I-Gene +
TNF I-Gene +
) I-Gene +
superfamily I-Gene +
, O +
have O +
been O +
identified O +
as O +
membrane O +
- O +
anchored O +
ligands O +
for O +
the O +
LTbeta B-Gene +
receptor I-Gene +
( O +
LTbetaR B-Gene +
) O +
, O +
a O +
member O +
of O +
the O +
TNF B-Gene +
receptor I-Gene +
( I-Gene +
TNFR I-Gene +
) I-Gene +
superfamily I-Gene +
. O +

Although O +
some O +
of O +
the O +
biologic O +
activities O +
of O +
this O +
receptor O +
have O +
been O +
described O +
using O +
either O +
soluble O +
LTalpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
beta I-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
as O +
a O +
ligand O +
or O +
agonistic O +
monoclonal O +
antibodies O +
( O +
mAb O +
) O +
, O +
very O +
little O +
is O +
known O +
about O +
the O +
signaling O +
of O +
LIGHT B-Gene +
via O +
the O +
LTbetaR B-Gene +
. O +

To O +
gain O +
more O +
insight O +
into O +
the O +
biologic O +
functions O +
of O +
LIGHT B-Gene +
, O +
we O +
generated O +
a O +
recombinant O +
soluble O +
form O +
of O +
human O +
LIGHT B-Gene +
( O +
rsHuLIGHT B-Gene +
) O +
. O +

We O +
demonstrate O +
here O +
that O +
this O +
rsHuLIGHT B-Gene +
is O +
capable O +
of O +
binding O +
to O +
the O +
LTbetaR B-Gene +
. O +

Interestingly O +
, O +
receptor O +
- O +
mediated O +
ligand O +
precipitation O +
analysis O +
revealed O +
that O +
rsHuLIGHT B-Gene +
bound O +
only O +
to O +
human O +
LTbetaR B-Gene +
but O +
not O +
to O +
mouse O +
LTbetaR B-Gene +
, O +
indicating O +
a O +
species O +
- O +
specific O +
receptor O +
ligand O +
interaction O +
. O +

Activation O +
of O +
A375 O +
human O +
melanoma O +
cells O +
by O +
rsHuLIGHT B-Gene +
induced O +
an O +
increased O +
secretion O +
of O +
interleukin-8 B-Gene +
( O +
IL-8 B-Gene +
) O +
. O +

Furthermore O +
, O +
rsHuLIGHT B-Gene +
caused O +
growth O +
arrest O +
of O +
A375 O +
cells O +
even O +
in O +
the O +
absence O +
of O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
( O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
. O +

Breaking O +
through O +
the O +
acid O +
barrier O +
: O +
an O +
orchestrated O +
response O +
to O +
proton O +
stress O +
by O +
enteric O +
bacteria O +
. O +

The O +
ability O +
of O +
enteropathogens O +
such O +
as O +
Salmonella O +
and O +
Escherichia O +
coli O +
to O +
adapt O +
and O +
survive O +
acid O +
stress O +
is O +
fundamental O +
to O +
their O +
pathogenesis O +
. O +

Once O +
inside O +
the O +
host O +
, O +
these O +
organisms O +
encounter O +
life O +
- O +
threatening O +
levels O +
of O +
inorganic O +
acid O +
( O +
H+ O -
) O +
in O +
the O +
stomach O +
and O +
a O +
combination O +
of O +
inorganic O +
and O +
organic O +
acids O +
( O +
volatile O +
fatty O +
acids O +
) O +
in O +
the O +
small O +
intestine O +
. O +

To O +
combat O +
these O +
stresses O +
, O +
enteric O +
bacteria O +
have O +
evolved O +
elegant O +
, O +
overlapping O +
strategies O +
that O +
involve O +
both O +
constitutive O +
and O +
inducible O +
defense O +
systems O +
. O +

This O +
article O +
reviews O +
the O +
recent O +
progress O +
made O +
in O +
understanding O +
the O +
pH O +
3 O +
acid O +
tolerance O +
systems O +
of O +
Salmonella O +
and O +
the O +
even O +
more O +
effective O +
pH O +
2 O +
acid O +
resistance O +
systems O +
of O +
E. O +
coli O +
. O +

Focus O +
is O +
placed O +
on O +
how O +
Salmonella O +
orchestrates O +
acid O +
tolerance O +
by O +
modulating O +
the O +
activities O +
or O +
levels O +
of O +
diverse O +
regulatory O +
proteins O +
in O +
response O +
to O +
pH O +
stress O +
. O +

The O +
result O +
is O +
induction O +
of O +
overlapping O +
arrays O +
of O +
acid O +
shock O +
proteins O +
that O +
protect O +
the O +
cell O +
against O +
acid O +
and O +
other O +
environmental O +
stresses O +
. O +

Most O +
notable O +
among O +
these O +
pH O +
- O +
response O +
regulators O +
are O +
RpoS B-Gene +
, O +
Fur B-Gene +
, O +
PhoP B-Gene +
and O +
OmpR B-Gene +
. O +

In O +
addition O +
, O +
we O +
will O +
review O +
three O +
dedicated O +
acid O +
resistance O +
systems O +
of O +
E. O +
coli O +
, O +
not O +
present O +
in O +
Salmonella O +
, O +
that O +
allow O +
this O +
organism O +
to O +
survive O +
extreme O +
( O +
pH O +
2 O +
) O +
acid O +
challenge O +
. O +

Mutations O +
of O +
the O +
beta B-Gene +
- I-Gene +
and I-Gene +
gamma I-Gene +
- I-Gene +
catenin I-Gene +
genes O +
are O +
uncommon O +
in O +
human O +
lung O +
, O +
breast O +
, O +
kidney O +
, O +
cervical O +
and O +
ovarian O +
carcinomas O +
. O +

Beta B-Gene -
- I-Gene -
catenin I-Gene +
forms O +
complexes O +
with O +
Tcf B-Gene +
and O +
Lef-1 B-Gene +
and O +
functions O +
as O +
a O +
transcriptional O +
activator O +
in O +
the O +
Wnt B-Gene +
signalling O +
pathway O +
. O +

Although O +
recent O +
investigations O +
have O +
been O +
focused O +
on O +
the O +
role O +
of O +
the O +
adenomatous B-Gene +
polyposis I-Gene +
coli I-Gene +
( O +
APC B-Gene +
) O +
/ O +
beta B-Gene -
- I-Gene -
catenin I-Gene +
/ O +
Tcf B-Gene +
pathway O +
in O +
human O +
tumorigenesis O +
, O +
there O +
have O +
been O +
very O +
few O +
reports O +
on O +
mutations O +
of O +
the O +
beta B-Gene -
- I-Gene -
catenin I-Gene +
gene O +
in O +
a O +
variety O +
of O +
tumour O +
types O +
. O +

Using O +
PCR O +
and O +
single O +
- O +
strand O +
conformational O +
polymorphism O +
analysis O +
, O +
we O +
examined O +
93 O +
lung O +
, O +
9 O +
breast O +
, O +
6 O +
kidney O +
, O +
19 O +
cervical O +
and O +
7 O +
ovarian O +
carcinoma O +
cell O +
lines O +
for O +
mutations O +
in O +
exon O +
3 O +
of O +
the O +
beta B-Gene +
- I-Gene +
catenin I-Gene +
gene O +
. O +

In O +
addition O +
, O +
we O +
tested O +
these O +
same O +
samples O +
for O +
mutations O +
in O +
the O +
NH2 O +
- O +
terminal O +
regulatory O +
region O +
of O +
the O +
gamma B-Gene -
- I-Gene -
catenin I-Gene +
gene O +
. O +

Mutational O +
analysis O +
for O +
the O +
entire O +
coding O +
region O +
of O +
beta B-Gene -
- I-Gene -
catenin I-Gene +
cDNA O +
was O +
also O +
undertaken O +
in O +
20 O +
lung O +
, O +
9 O +
breast O +
, O +
5 O +
kidney O +
and O +
6 O +
cervical O +
carcinoma O +
cell O +
lines O +
. O +

Deletion O +
of O +
most O +
beta B-Gene -
- I-Gene -
catenin I-Gene +
coding O +
exons O +
was O +
confirmed O +
in O +
line O +
NCI O -
- O -
H28 O +
( O +
lung O +
mesothelioma O +
) O +
and O +
a O +
silent O +
mutation O +
at O +
codon O +
214 O +
in O +
exon O +
5 O +
was O +
found O +
in O +
HeLa O +
( O +
cervical O +
adenocarcinoma O +
) O +
. O +

A O +
missense O +
mutation O +
at O +
codon O +
19 O +
and O +
a O +
silent O +
mutation O +
at O +
codon O +
28 O +
in O +
the O +
NH2 O +
- O +
terminal O +
regulatory O +
region O +
of O +
the O +
gamma B-Gene -
- I-Gene -
catenin I-Gene +
gene O +
were O +
found O +
in O +
H1726 O +
( O +
squamous O +
cell O +
lung O +
carcinoma O +
) O +
and O +
H1048 O +
( O +
small O +
cell O +
lung O +
carcinoma O +
) O +
, O +
respectively O +
. O +

Neither O +
deletions O +
nor O +
mutations O +
of O +
these O +
genes O +
were O +
detected O +
in O +
the O +
other O +
cell O +
lines O +
examined O +
. O +

These O +
results O +
suggest O +
that O +
beta B-Gene +
- I-Gene +
and I-Gene +
gamma I-Gene +
- I-Gene +
catenins I-Gene +
are O +
infrequent O +
mutational O +
targets O +
during O +
development O +
of O +
human O +
lung O +
, O +
breast O +
, O +
kidney O +
, O +
cervical O +
and O +
ovarian O +
carcinomas O +
. O +

Identification O +
of O +
a O +
cis O +
- O +
regulatory O +
element O +
for O +
L1 O +
layer O +
- O +
specific O +
gene O +
expression O +
, O +
which O +
is O +
targeted O +
by O +
an O +
L1 O +
- O +
specific O +
homeodomain B-Gene +
protein I-Gene +
. O +

The O +
Arabidopsis O +
thaliana O +
PROTODERMAL B-Gene +
FACTOR1 I-Gene +
( O +
PDF1 B-Gene +
) O +
gene O +
encoding O +
a O +
putative O +
extracellular O +
proline O +
- O +
rich O +
protein O +
is O +
exclusively O +
expressed O +
in O +
the O +
L1 O +
layer O +
of O +
shoot O +
apices O +
and O +
the O +
protoderm O +
of O +
organ O +
primordia O +
. O +

In O +
order O +
to O +
identify O +
essential O +
cis O +
- O +
regulatory O +
sequences O +
required O +
for O +
the O +
L1 O +
layer O +
- O +
specific O +
expression O +
, O +
a O +
series O +
of O +
5 O +
' O +
deletions O +
of O +
the O +
PDF1 B-Gene +
promoter O +
were O +
fused O +
to O +
the O +
beta B-Gene +
- I-Gene +
glucronidase I-Gene +
( O +
GUS B-Gene +
) O +
gene O +
and O +
introduced O +
into O +
Arabidopsis O +
plants O +
. O +

Our O +
analysis O +
revealed O +
that O +
the O +
minimum O +
region O +
necessary O +
to O +
confer O +
L1 O +
- O +
specific O +
expression O +
of O +
PDF1 B-Gene +
is O +
confined O +
within O +
a O +
260 O +
- O +
bp O +
fragment O +
upstream O +
of O +
the O +
transcription O +
start O +
site O +
. O +

We O +
identified O +
an O +
8 O +
- O +
bp O +
motif O +
in O +
this O +
region O +
that O +
is O +
conserved O +
between O +
promoter O +
regions O +
of O +
all O +
the O +
L1 O +
- O +
specific O +
genes O +
so O +
far O +
cloned O +
, O +
and O +
we O +
designated O +
it O +
the O +
L1 O +
box O +
. O +

Electrophoretic O +
mobility O +
shift O +
assays O +
demonstrated O +
that O +
the O +
L1 O +
- O +
specific O +
homeodomain B-Gene +
protein I-Gene +
ATML1 B-Gene +
can O +
bind O +
to O +
the O +
L1 O +
box O +
sequence O +
in O +
vitro O +
. O +

The O +
GUS B-Gene +
expression O +
in O +
transgenic O +
plants O +
disappeared O +
when O +
a O +
mutation O +
that O +
abolishes O +
binding O +
of O +
ATML1 B-Gene +
was O +
introduced O +
into O +
the O +
PDF1 B-Gene +
l1 O +
box O +
sequence O +
of O +
the O +
construct O +
. O +

These O +
results O +
suggest O +
that O +
the O +
L1 O +
box O +
plays O +
a O +
crucial O +
role O +
in O +
the O +
regulation O +
of O +
PDF1 B-Gene +
expression O +
in O +
L1 O +
cells O +
and O +
that O +
ATML1 B-Gene +
could O +
cooperate O +
to O +
drive O +
L1 O +
- O +
specific O +
expression O +
. O +

An O +
anti O +
- O +
inflammatory O +
drug O +
, O +
propagermanium O +
, O +
may O +
target O +
GPI O +
- O +
anchored O +
proteins O +
associated O +
with O +
an O +
MCP-1 B-Gene +
receptor I-Gene +
, O +
CCR2 B-Gene +
. O +

Monocyte B-Gene +
chemoattractant I-Gene +
protein-1 I-Gene +
( O +
MCP-1 B-Gene +
) O +
promotes O +
the O +
migration O +
and O +
activation O +
of O +
monocytes O +
and O +
plays O +
a O +
pivotal O +
role O +
in O +
the O +
development O +
of O +
chronic O +
inflammation O +
. O +

Propagermanium O +
( O +
3-oxygermylpropionic O +
acid O +
polymer O +
) O +
has O +
been O +
used O +
as O +
a O +
therapeutic O +
agent O +
against O +
chronic O +
hepatitis O +
B O +
in O +
Japan O +
. O +

We O +
report O +
here O +
that O +
propagermanium O +
specifically O +
inhibits O +
in O +
vitro O +
chemotactic O +
migration O +
of O +
monocytes O +
by O +
MCP-1 B-Gene +
. O +

Propagermanium O +
did O +
not O +
inhibit O +
binding O +
of O +
MCP-1 B-Gene +
to O +
a O +
human O +
monocytic O +
cell O +
line O +
, O +
THP-1 O +
cells O +
, O +
or O +
affect O +
intracellular O +
Ca O -
( O -
2 O -
+ O -
) O +
mobilization O +
or O +
the O +
cAMP O +
concentration O +
in O +
MCP-1 B-Gene +
- O +
treated O +
THP-1 O +
cells O +
. O +

The O +
effect O +
of O +
propagermanium O +
seems O +
to O +
require O +
glycosylphosphatidylinositol O +
( O +
GPI O +
) O +
- O +
anchored O +
proteins O +
, O +
as O +
cleavage O +
of O +
GPI O +
anchors O +
by O +
phosphatidylinositol B-Gene +
- I-Gene +
phospholipase I-Gene +
C I-Gene +
( O +
PI B-Gene -
- I-Gene -
PLC I-Gene +
) O +
eliminated O +
the O +
inhibitory O +
activity O +
of O +
propagermanium O +
. O +

Anti O +
- O +
GPI O +
- O +
anchored O +
protein O +
antibodies O +
, O +
such O +
as O +
anti O +
- O +
CD55 B-Gene +
and O +
anti O +
- O +
CD59 B-Gene +
, O +
reduced O +
staining O +
of O +
C B-Gene -
- I-Gene -
C I-Gene +
chemokine I-Gene +
receptor I-Gene +
2 I-Gene +
( O +
CCR2 B-Gene +
) O +
with O +
an O +
anti O +
- O +
CCR2 B-Gene +
antibody O +
against O +
the O +
N O -
- O -
terminus O +
of O +
CCR2 B-Gene +
in O +
a O +
flow O +
cytometric O +
analysis O +
, O +
and O +
these O +
antibodies O +
also O +
selectively O +
inhibited O +
MCP-1 B-Gene +
- O +
induced O +
migration O +
of O +
THP-1 O +
cells O +
. O +

Furthermore O +
, O +
under O +
fluorescence O +
microscopy O +
, O +
GPI O +
- O +
anchored O +
proteins O +
colocalized O +
with O +
CCR2 B-Gene +
on O +
THP-1 O +
cells O +
. O +

These O +
results O +
suggest O +
that O +
propagermanium O +
may O +
target O +
GPI O +
- O +
anchored O +
proteins O +
that O +
are O +
closely O +
associated O +
with O +
CCR2 B-Gene +
to O +
selectively O +
inhibit O +
the O +
MCP-1 B-Gene +
- O +
induced O +
chemotaxis O +
, O +
thus O +
providing O +
a O +
mechanistic O +
basis O +
for O +
the O +
anti O +
- O +
inflammatory O +
effects O +
of O +
the O +
drug O +
. O +

Identification O +
and O +
characterization O +
of O +
RRM B-Gene +
- I-Gene +
containing I-Gene +
coactivator I-Gene +
activator I-Gene +
( O +
CoAA B-Gene +
) O +
as O +
TRBP B-Gene +
- O +
interacting O +
protein O +
, O +
and O +
its O +
splice O +
variant O +
as O +
a O +
coactivator O +
modulator O +
( O +
CoAM B-Gene +
) O +
. O +

We O +
previously O +
cloned O +
and O +
characterized O +
thyroid B-Gene +
hormone I-Gene +
receptor I-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
( O +
TRBP B-Gene +
) O +
as O +
an O +
LXXLL O +
- O +
containing O +
general O +
coactivator O +
that O +
associates O +
with O +
coactivator O +
complexes O +
through O +
its O +
C O +
terminus O +
. O +

To O +
identify O +
protein O +
cofactors O +
for O +
TRBP B-Gene +
action O +
, O +
a O +
Sos B-Gene +
- O +
Ras B-Gene +
yeast O +
two O +
- O +
hybrid O +
cDNA O +
library O +
was O +
screened O +
using O +
TRBP B-Gene +
C O +
terminus O +
as O +
bait O +
. O +

A O +
novel O +
coactivator O +
was O +
isolated O +
, O +
coactivator O +
activator O +
( O +
CoAA B-Gene +
) O +
, O +
that O +
specifically O +
associates O +
with O +
TRBP B-Gene +
. O +

Human O +
CoAA B-Gene +
is O +
composed O +
of O +
669 O +
amino O +
acids O +
with O +
a O +
TRBP B-Gene +
- O +
interacting O +
domain O +
and O +
two O +
highly O +
conserved O +
RNA O +
recognition O +
motifs O +
( O +
RRM O +
) O +
commonly O +
found O +
in O +
ribonucleoproteins B-Gene +
. O +

A O +
splice O +
variant O +
lacking O +
the O +
entire O +
TRBP B-Gene +
- O +
interacting O +
domain O +
was O +
also O +
isolated O +
as O +
a O +
coactivator O +
modulator O +
( O +
CoAM B-Gene +
) O +
, O +
a O +
156 O +
- O +
amino O +
acid O +
protein O +
containing O +
only O +
the O +
RRM O +
region O +
. O +

Human O +
CoAA B-Gene +
and O +
CoAM B-Gene +
mRNAs O +
are O +
encoded O +
by O +
a O +
single O +
gene O +
located O +
on O +
chromosome O +
11q13 O +
; O +
alternative O +
splicing O +
in O +
exon O +
2 O +
of O +
CoAA B-Gene +
yields O +
CoAM B-Gene +
. O +

CoAA B-Gene +
interacts O +
with O +
both O +
TRBP B-Gene +
and O +
p300 B-Gene +
in O +
vitro O +
. O +

In O +
addition O +
, O +
CoAA B-Gene +
potently O +
coactivates O +
transcription O +
mediated O +
by O +
multiple O +
hormone O +
- O +
response O +
elements O +
and O +
acts O +
synergistically O +
with O +
TRBP B-Gene +
and O +
CREB B-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
( O +
CBP B-Gene +
) O +
. O +

Furthermore O +
, O +
CoAA B-Gene +
is O +
associated O +
with O +
the O +
DNA B-Gene +
- I-Gene +
dependent I-Gene +
protein I-Gene +
kinase I-Gene +
- O +
poly B-Gene -
( I-Gene -
ADP I-Gene -
- I-Gene -
ribose I-Gene +
) I-Gene +
polymerase I-Gene +
complex O +
. O +

Strikingly O +
, O +
CoAM B-Gene +
, O +
which O +
lacks O +
a O +
TRBP B-Gene +
- O +
interacting O +
domain O +
, O +
strongly O +
represses O +
both O +
TRBP B-Gene +
and O +
CBP B-Gene +
action O +
suggesting O +
that O +
CoAM B-Gene +
may O +
modulate O +
endogenous O +
CoAA B-Gene +
function O +
. O +

These O +
data O +
suggest O +
that O +
CoAA B-Gene +
may O +
serve O +
as O +
a O +
mediator O +
of O +
coactivators O +
such O +
as O +
TRBP B-Gene +
in O +
gene O +
activation O +
. O +

YfiD B-Gene +
of O +
Escherichia O +
coli O +
and O +
Y06I B-Gene +
of O +
bacteriophage O +
T4 O +
as O +
autonomous O +
glycyl O +
radical O +
cofactors O +
reconstituting O +
the O +
catalytic O +
center O +
of O +
oxygen O +
- O +
fragmented O +
pyruvate B-Gene +
formate I-Gene +
- I-Gene +
lyase I-Gene +
. O +

Reaction O +
of O +
oxygen O +
with O +
the O +
glycyl O +
radical O +
in O +
pyruvate B-Gene +
formate I-Gene +
- I-Gene +
lyase I-Gene +
( O +
PFL B-Gene +
) O +
leads O +
to O +
cleavage O +
of O +
the O +
polypeptide O +
backbone O +
between O +
N O -
- O -
Calpha O +
of O +
Gly734 O +
. O +

A O +
recombinant O +
protein O +
comprising O +
the O +
core O +
of O +
PFL B-Gene +
( O +
Ser1 O +
- O +
Ser733 O +
) O +
is O +
shown O +
here O +
to O +
associate O +
with O +
the O +
YfiD B-Gene +
protein O +
( O +
14 O +
kDa O +
) O +
of O +
Escherichia O +
coli O +
and O +
likewise O +
with O +
the O +
homologous O +
T4 O +
encoded O +
Y06I B-Gene +
protein O +
, O +
yielding O +
upon O +
reaction O +
with O +
PFL B-Gene +
activase I-Gene +
a O +
heterooligomeric O +
PFL B-Gene +
enzyme O +
that O +
has O +
full O +
catalytic O +
activity O +
( O +
35 O +
U O +
/ O +
nmol O +
) O +
. O +

Treatment O +
of O +
the O +
activated O +
complexes O +
with O +
oxygen O +
led O +
to O +
cleavage O +
of O +
the O +
14 O +
kDa O +
proteins O +
into O +
11 O +
and O +
3 O +
kDa O +
polypeptides O +
as O +
expected O +
for O +
the O +
localization O +
of O +
the O +
putative O +
glycyl O +
radical O +
at O +
Gly102 O +
( O +
YfiD B-Gene +
) O +
or O +
Gly95 O +
( O +
Y06I B-Gene +
) O +
. O +

For O +
the O +
isolated O +
fragments O +
from O +
Y06I B-Gene +
, O +
mass O +
spectrometric O +
analysis O +
( O +
nanoESI O -
- O -
MS O +
) O +
determined O +
a O +
C O +
- O +
terminal O +
serine O +
carboxamide O +
in O +
the O +
11 O +
kDa O +
fragment O +
, O +
and O +
a O +
N O +
- O +
terminal O +
oxalyl O +
modification O +
in O +
the O +
3 O +
kDa O +
fragment O +
. O +

We O +
speculate O +
that O +
YfiD B-Gene +
in O +
E. O +
coli O +
and O +
other O +
facultative O +
anaerobic O +
bacteria O +
has O +
evolved O +
as O +
a O +
" O +
spare O +
part O +
" O +
for O +
PFL B-Gene +
's O +
glycyl O +
radical O +
domain O +
, O +
utilized O +
for O +
rapid O +
recovery O +
of O +
PFL B-Gene +
activity O +
( O +
and O +
thus O +
ATP O +
generation O +
) O +
in O +
cells O +
that O +
have O +
experienced O +
oxidative O +
stress O +
. O +

Developmental O +
expression O +
of O +
two O +
CXC B-Gene +
chemokines I-Gene +
, O +
MIP-2 B-Gene +
and O +
KC B-Gene +
, O +
and O +
their O +
receptors O +
. O +

CXC B-Gene +
chemokines I-Gene +
, O +
macrophage B-Gene +
inflammatory I-Gene +
protein-2 I-Gene +
( O +
MIP-2 B-Gene +
) O +
and O +
KC B-Gene +
, O +
( O +
a O +
cloning O +
designation O +
based O +
on O +
ordinate O +
and O +
abscissa O +
position O +
) O +
as O +
well O +
as O +
the O +
CXC B-Gene +
chemokine I-Gene +
receptor O +
, O +
CXCR2 B-Gene +
, O +
are O +
expressed O +
in O +
a O +
variety O +
of O +
cells O +
and O +
tissues O +
in O +
adult O +
mice O +
. O +

Targeted O +
deletion O +
of O +
the O +
gene O +
encoding O +
murine O +
CXCR2 B-Gene +
does O +
not O +
result O +
in O +
obvious O +
changes O +
in O +
the O +
development O +
of O +
the O +
organ O +
system O +
of O +
the O +
mouse O +
, O +
though O +
the O +
CXCR2 B-Gene +
- O -
/ O -
- O +
mouse O +
is O +
compromised O +
with O +
regard O +
to O +
its O +
ability O +
to O +
resist O +
infection O +
, O +
heal O +
wounds O +
, O +
and O +
maintain O +
homeostasis O +
when O +
challenged O +
with O +
microbes O +
and/or O +
chemicals O +
. O +

In O +
an O +
attempt O +
to O +
develop O +
insight O +
into O +
additional O +
possible O +
subtle O +
roles O +
of O +
CXCR2 B-Gene +
and O +
its O +
ligands O +
in O +
the O +
development O +
of O +
the O +
mouse O +
, O +
we O +
examined O +
the O +
expression O +
of O +
MIP-2 B-Gene +
, O +
KC B-Gene +
, O +
CXCR2 B-Gene +
, O +
as O +
well O +
as O +
the O +
Duffy B-Gene +
antigen I-Gene +
binding O +
protein O +
for O +
chemokines B-Gene +
during O +
embryonic O +
( O +
p.c O -
. O +
) O +
days O +
11.5 O +
through O +
14.5 O +
in O +
the O +
mouse O +
. O +

We O +
observed O +
strong O +
correlation O +
between O +
the O +
expression O +
of O +
MIP-2 B-Gene +
and O +
CXCR2 B-Gene +
in O +
the O +
developing O +
brain O +
, O +
cardiovascular O +
system O +
and O +
condensing O +
mesenchyme O +
between O +
11.5 O +
and O +
13.5 O +
days O +
. O +

Moreover O +
, O +
the O +
expression O +
of O +
KC B-Gene +
was O +
parallel O +
to O +
the O +
expression O +
of O +
the O +
Duffy B-Gene +
antigen I-Gene +
binding O +
protein O +
for O +
chemokines B-Gene +
with O +
regard O +
to O +
temporal O +
pattern O +
and O +
tissue O +
localization O +
. O +

MIP-2 B-Gene +
and O +
CXCR2 B-Gene +
are O +
highly O +
expressed O +
in O +
the O +
brain O +
, O +
first O +
in O +
the O +
cerebellum O +
and O +
in O +
the O +
head O +
mesenchyme O +
, O +
the O +
meninges O +
and O +
the O +
floor O +
plate O +
, O +
and O +
by O +
14.5 O +
days O +
are O +
also O +
present O +
in O +
the O +
telencephalon O +
, O +
thalamus O +
and O +
hypothalamus O +
. O +

In O +
the O +
developing O +
brain O +
KC B-Gene +
and O +
Duffy B-Gene +
were O +
prominently O +
expressed O +
in O +
the O +
neuronal O +
tracts O +
, O +
the O +
forebrain O +
, O +
sympathetic O +
ganglia O +
, O +
and O +
along O +
the O +
periphery O +
of O +
the O +
neural O +
tube O +
. O +

However O +
, O +
KC B-Gene +
and O +
Duffy B-Gene +
were O +
less O +
prevalent O +
in O +
the O +
developing O +
cardiovascular O +
system O +
, O +
lung O +
and O +
other O +
organs O +
, O +
muscle O +
and O +
bone O +
, O +
than O +
are O +
CXCR2 B-Gene +
and O +
MIP-2 B-Gene +
. O +

These O +
data O +
suggest O +
that O +
the O +
roles O +
for O +
these O +
chemokines B-Gene +
and O +
their O +
receptors O +
during O +
development O +
may O +
be O +
more O +
significant O +
than O +
was O +
initially O +
thought O +
based O +
upon O +
the O +
phenotype O +
of O +
the O +
mice O +
with O +
targeted O +
deletion O +
of O +
CXCR2 B-Gene +
and O +
Duffy B-Gene +
. O +

Astrocyte O +
differentiation O +
of O +
fetal O +
neuroepithelial O +
cells O +
involving O +
cardiotrophin-1 B-Gene +
- O +
induced O +
activation O +
of O +
STAT3 B-Gene +
. O +

Cardiotrophin-1 B-Gene +
( O +
CT-1 B-Gene +
) O +
belongs O +
to O +
the O +
interleukin B-Gene +
( I-Gene +
IL- I-Gene -
) I-Gene +
6 I-Gene +
family I-Gene +
of I-Gene +
cytokines I-Gene +
that O +
share O +
membrane O +
glycoprotein B-Gene +
130 I-Gene +
( O +
gp130 B-Gene +
) O +
as O +
a O +
receptor O +
component O +
critical O +
for O +
signal O +
transduction O +
. O +

We O +
here O +
observed O +
that O +
CT-1 B-Gene +
was O +
expressed O +
in O +
mouse O +
fetal O +
neuroepithelial O +
cells O +
, O +
and O +
was O +
capable O +
of O +
inducing O +
astrocyte O +
differentiation O +
from O +
these O +
cells O +
in O +
a O +
synergistic O +
manner O +
with O +
bone B-Gene +
morphogenetic I-Gene +
protein I-Gene +
( I-Gene +
BMP I-Gene +
) I-Gene +
- I-Gene +
2 I-Gene +
, O +
whose O +
expression O +
was O +
also O +
found O +
in O +
the O +
fetal O +
brain O +
. O +

CT-1 B-Gene +
- O +
induced O +
astrocyte O +
differentiation O +
was O +
solely O +
gp130 B-Gene +
- O +
dependent O +
. O +

CT-1 B-Gene +
- O +
stimulation O +
led O +
to O +
promoter O +
activation O +
of O +
the O +
gene O +
for O +
an O +
astrocyte O +
marker O +
, O +
glial B-Gene +
fibrillary I-Gene +
acidic I-Gene +
protein I-Gene +
( O +
GFAP B-Gene +
) O +
, O +
which O +
was O +
clearly O +
inhibited O +
by O +
expression O +
of O +
a O +
dominant O +
negative O +
form O +
of O +
a O +
gp130 B-Gene +
- O +
downstream O +
transcription B-Gene +
factor I-Gene +
, O +
signal B-Gene +
transducer I-Gene +
and I-Gene +
activator I-Gene +
of I-Gene +
transcription I-Gene +
3 I-Gene +
( O +
STAT3 B-Gene +
) O +
, O +
or O +
by O +
introduction O +
of O +
a O +
mutation O +
in O +
a O +
single O +
STAT3 B-Gene +
- O +
binding O +
site O +
in O +
the O +
promoter O +
, O +
suggesting O +
a O +
critical O +
role O +
of O +
STAT3 B-Gene +
in O +
the O +
CT-1 B-Gene +
- O +
induced O +
GFAP B-Gene +
transcription O +
. O +

These O +
results O +
suggest O +
that O +
astrocyte O +
differentiation O +
in O +
the O +
developing O +
brain O +
involves O +
CT-1 B-Gene +
- O +
signaling O +
which O +
cooperates O +
with O +
BMP2 B-Gene +
. O +

Regulation O +
of O +
microcin B-Gene +
C51 I-Gene +
operon I-Gene +
expression O +
: O +
the O +
role O +
of O +
global O +
regulators O +
of O +
transcription O +
. O +

Expression O +
of O +
the O +
microcin B-Gene +
C51 I-Gene +
operon I-Gene +
in O +
Escherichia O +
coli O +
cells O +
is O +
regulated O +
as O +
a O +
function O +
of O +
the O +
phase O +
of O +
growth O +
; O +
it O +
is O +
stimulated O +
during O +
the O +
decelerating O +
phase O +
of O +
growth O +
. O +

Using O +
single O +
- O +
copy O +
P O +
( O +
mcc B-Gene +
) O +
- O +
lac B-Gene +
transcriptional O +
fusion O +
( O +
the O +
promoter O +
region O +
of O +
the O +
microcin B-Gene +
C51 I-Gene +
operon I-Gene +
fused O +
to O +
a O +
promoterless O +
lac B-Gene +
operon I-Gene +
in O +
lambda O +
phage O +
) O +
, O +
we O +
showed O +
that O +
transcription O +
from O +
the O +
microcin B-Gene +
operon I-Gene +
promoter O +
is O +
dependent O +
on O +
sigma B-Gene -
( I-Gene -
s I-Gene -
) I-Gene +
( O +
RpoS B-Gene +
) O +
factor O +
. O +

However O +
, O +
some O +
level O +
of O +
P O +
( O +
mcc B-Gene +
) O +
- O +
lac B-Gene +
expression O +
is O +
possible O +
in O +
rpoS B-Gene +
null O +
mutants O +
, O +
indicating O +
that O +
another O +
sigma B-Gene +
factor I-Gene +
might O +
be O +
involved O +
in O +
transcription O +
of O +
the O +
microcin B-Gene +
C51 I-Gene +
operon I-Gene +
. O +

Overproduction O +
of O +
sigma70 B-Gene +
decreased O +
Pmcc O +
- O +
directed O +
transcription O +
, O +
presumably O +
as O +
a O +
result O +
of O +
competition O +
of O +
sigma B-Gene +
factors I-Gene +
for O +
the O +
limited O +
amount O +
of O +
core O +
RNA B-Gene +
polymerase I-Gene +
. O +

The O +
cyclic O +
AMP O +
- O +
CRP B-Gene +
complex O +
was O +
shown O +
to O +
stimulate O +
transcription O +
from O +
Pmcc O +
: O +
the O +
absence O +
of O +
CRP B-Gene +
or O +
cAMP O +
in O +
crp B-Gene +
or O +
cya B-Gene +
mutant O +
cells O +
strongly O +
decreased O +
the O +
level O +
of O +
P O +
( O +
mcc B-Gene +
) O +
- O +
lac B-Gene +
expression O +
. O +

The O +
production O +
of O +
C51 O +
microcin O +
decreased O +
or O +
was O +
absent O +
in O +
rpoS B-Gene +
, O +
crp B-Gene +
and O +
cya B-Gene +
mutant O +
cells O +
. O +

Leucine B-Gene +
- I-Gene +
responsive I-Gene +
protein I-Gene +
Lrp B-Gene +
and O +
histone B-Gene +
- O +
like O +
protein O +
H B-Gene -
- I-Gene -
NS I-Gene +
repressed O +
P O +
( O +
mcc B-Gene +
) O +
- O +
lac B-Gene +
expression O +
in O +
the O +
exponential O +
and O +
decelerating O +
phases O +
of O +
growth O +
. O +

In O +
studies O +
of O +
P O +
( O +
mcc B-Gene +
) O +
- O +
lac B-Gene +
expression O +
in O +
double O +
mutant O +
cells O +
, O +
we O +
showed O +
that O +
proteins O +
CRP B-Gene +
, O +
Lrp B-Gene +
and O +
H B-Gene -
- I-Gene -
NS I-Gene +
acted O +
in O +
rpoS B-Gene +
- O +
dependent O +
and O +
rpoS B-Gene +
- O +
independent O +
ways O +
in O +
transcription O +
of O +
the O +
microcin B-Gene +
C51 I-Gene +
operon I-Gene +
. O +

Mutation O +
hns B-Gene +
( O -
- O -
) O +
resulted O +
in O +
an O +
increase O +
in O +
P O +
( O +
mcc B-Gene +
) O +
- O +
lac B-Gene +
expression O +
in O +
crp B-Gene +
, O +
rpoS B-Gene +
and O +
lrp B-Gene +
mutant O +
cells O +
, O +
as O +
in O +
wild O +
- O +
type O +
cells O +
. O +

Specific O +
inhibition O +
of O +
the O +
rat O +
ligand O +
- O +
gated O +
ion B-Gene +
channel I-Gene +
P2X3 B-Gene +
function O +
via O +
methoxyethoxy O +
- O +
modified O +
phosphorothioated O +
antisense O +
oligonucleotides O +
. O +

P2X3 B-Gene +
is O +
one O +
receptor O +
of O +
a O +
family O +
of O +
seven O +
ligand O +
- O +
gated O +
ion B-Gene +
channels I-Gene +
responding O +
to O +
purines O +
. O +

Increasing O +
evidence O +
indicates O +
its O +
involvement O +
in O +
neuronal O +
signaling O +
and O +
in O +
pain O +
. O +

However O +
, O +
there O +
is O +
currently O +
no O +
selective O +
inhibitor O +
known O +
for O +
this O +
subtype O +
. O +

In O +
order O +
to O +
obtain O +
such O +
a O +
specific O +
inhibitor O +
, O +
a O +
variety O +
of O +
antisense O +
oligonucleotides O +
( O +
ASO O +
) O +
against O +
rat O +
P2X3 B-Gene +
was O +
tested O +
, O +
and O +
dose O +
- O +
dependent O +
, O +
sequence O +
- O +
specific O +
downregulation O +
of O +
the O +
rat O +
P2X3 B-Gene +
receptor O +
( O +
expressed O +
in O +
a O +
Chinese O +
hamster O +
ovary O +
cell O +
line O +
[ O +
CHO O +
- O +
K1 O +
] O +
) O +
on O +
the O +
mRNA O +
, O +
protein O +
, O +
and O +
functional O +
levels O +
was O +
observed O +
. O +

Using O +
real O +
- O +
time O +
quantitative O +
PCR O +
, O +
a O +
dose O +
- O +
dependent O +
downregulation O +
of O +
P2X3 B-Gene +
mRNA O +
by O +
ASO O +
, O +
as O +
compared O +
with O +
untreated O +
and O +
mismatch O +
controls O +
, O +
was O +
demonstrated O +
. O +

Subsequently O +
, O +
downregulation O +
by O +
the O +
two O +
most O +
potent O +
ASO O +
was O +
confirmed O +
at O +
the O +
protein O +
level O +
by O +
Western O +
blot O +
. O +

Sequence O +
specificity O +
was O +
shown O +
by O +
titration O +
of O +
mismatches O +
to O +
the O +
original O +
selected O +
oligonucleotide O +
, O +
and O +
this O +
correlated O +
with O +
progressive O +
loss O +
of O +
P2X3 B-Gene +
inhibition O +
. O +

The O +
functional O +
response O +
of O +
the O +
P2X3 B-Gene +
receptor O +
was O +
examined O +
using O +
whole O +
- O +
cell O +
voltage O +
clamping O +
. O +

Upon O +
application O +
of O +
10 O +
microM O +
of O +
a O +
nonspecific O +
agonist O +
, O +
alpha O -
, O -
beta O +
- O +
methylene O +
- O +
ATP O +
( O +
alphabeta O +
meATP O +
) O +
, O +
pretreatment O +
with O +
increasing O +
amounts O +
of O +
the O +
most O +
active O +
ASO O +
5037 O +
correlated O +
with O +
a O +
decrease O +
in O +
depolarization O +
. O +

The O +
ability O +
to O +
specifically O +
downregulate O +
the O +
P2X3 B-Gene +
receptor O +
by O +
ASO O +
treatment O +
will O +
allow O +
investigation O +
of O +
the O +
biologic O +
role O +
of O +
this O +
receptor O +
in O +
neuronal O +
tissues O +
and O +
eventually O +
in O +
in O +
vivo O +
models O +
of O +
chronic O +
pain O +
. O +

Involvement O +
of O +
TRAIL B-Gene +
/ O +
TRAIL B-Gene -
- I-Gene -
R I-Gene +
interaction O +
in O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
- O +
induced O +
apoptosis O +
of O +
Daudi O +
B O +
lymphoma O +
cells O +
. O +

Interferon B-Gene -
- I-Gene -
alpha I-Gene +
( O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
) O +
exerts O +
the O +
anti O +
- O +
tumour O +
effect O +
on O +
various O +
tumours O +
at O +
least O +
partly O +
through O +
induction O +
of O +
apoptosis O +
. O +

Apoptosis O +
is O +
induced O +
by O +
members O +
of O +
the O +
tumour B-Gene +
necrosis I-Gene +
factor I-Gene +
( I-Gene +
TNF I-Gene +
) I-Gene +
family I-Gene +
, O +
including O +
Fas B-Gene +
( O +
CD95 B-Gene +
) O +
and O +
TNF B-Gene +
- I-Gene +
related I-Gene +
apoptosis I-Gene +
- I-Gene +
inducing I-Gene +
ligand I-Gene +
( O +
TRAIL B-Gene +
) O +
. O +

In O +
the O +
present O +
study O +
, O +
we O +
examined O +
whether O +
the O +
TRAIL B-Gene +
/ O +
TRAIL B-Gene -
- I-Gene -
R I-Gene +
system O +
is O +
involved O +
in O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
- O +
induced O +
apoptosis O +
using O +
Daudi O +
B O +
lymphoma O +
cells O +
. O +

IFN B-Gene -
- I-Gene -
alpha I-Gene +
upregulated O +
the O +
expression O +
of O +
TRAIL B-Gene +
within O +
12 O +
h O +
, O +
as O +
assessed O +
by O +
flow O +
cytometry O +
and O +
RT O +
- O +
PCR O +
, O +
and O +
the O +
level O +
increased O +
with O +
time O +
until O +
72 O +
h O +
. O +

The O +
levels O +
of O +
both O +
TRAIL B-Gene -
- I-Gene -
R1 I-Gene +
and O +
TRAIL B-Gene -
- I-Gene -
R2 I-Gene +
, O +
low O +
in O +
Daudi O +
cells O +
, O +
were O +
enhanced O +
by O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
. O +

The O +
enhanced O +
TRAIL B-Gene +
- I-Gene +
R1 I-Gene +
/ I-Gene +
- I-Gene +
R2 I-Gene +
appeared O +
to O +
function O +
as O +
a O +
death O +
- O +
inducing O +
molecule O +
since O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
- O +
stimulated O +
cells O +
were O +
more O +
susceptible O +
to O +
TRAIL B-Gene +
- O +
induced O +
cell O +
death O +
. O +

The O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
- O +
stimulated O +
Daudi O +
cells O +
or O +
their O +
derived O +
culture O +
supernatants O +
displayed O +
cytotoxicity O +
against O +
TRAIL B-Gene +
- O +
sensitive O +
, O +
but O +
not O +
resistant O +
lines O +
. O +

Moreover O +
, O +
the O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
- O +
induced O +
reduction O +
in O +
mitochondrial O +
membrane O +
potential O +
preceding O +
the O +
induction O +
of O +
apoptosis O +
was O +
substantially O +
prevented O +
by O +
neutralizing O +
anti O +
- O +
TRAIL B-Gene +
monoclonal O +
antibody O +
. O +

Taken O +
together O +
, O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
- O +
induced O +
apoptosis O +
appears O +
to O +
be O +
mediated O +
by O +
the O +
autocrine O +
and/or O +
paracrine O +
loop O +
involving O +
TRAIL B-Gene +
/ O +
TRAIL B-Gene -
- I-Gene -
R I-Gene +
. O +

IL-8 B-Gene +
and O +
MCP-1 B-Gene +
secretion O +
is O +
enhanced O +
by O +
the O +
peptide O +
- O +
nucleic O +
acid O +
immunomodulator O +
, O +
Product O +
R O +
, O +
in O +
U937 O +
cells O +
and O +
primary O +
human O +
monocytes O +
. O +

Product O +
R O +
( O +
Reticulose O +
) O +
is O +
a O +
peptide O +
- O +
nucleic O +
acid O +
immunomodulator O +
recently O +
shown O +
to O +
enhance O +
the O +
expression O +
of O +
mRNAs O +
encoding O +
pro O +
- O +
inflammatory O +
cytokines B-Gene +
. O +

Interleukin B-Gene +
8 I-Gene +
( O +
IL-8 B-Gene +
) O +
and O +
macrophage B-Gene +
chemoattractant I-Gene +
protein-1 I-Gene +
( O +
MCP-1 B-Gene +
) O +
are O +
pro O +
- O +
inflammatory O +
chemokines B-Gene +
involved O +
in O +
immune O +
cell O +
mobilization O +
and O +
stimulation O +
. O +

To O +
determine O +
whether O +
Product O +
R O +
acts O +
by O +
upregulating O +
these O +
chemokines B-Gene +
, O +
we O +
assayed O +
its O +
effects O +
on O +
the O +
expression O +
of O +
IL-8 B-Gene +
and O +
MCP-1 B-Gene +
mRNAs O +
and O +
proteins O +
by O +
human O +
monocytic O +
U937 O +
cells O +
and O +
by O +
adherent O +
peripheral O +
blood O +
mononuclear O +
cells O +
( O +
PBMCs O +
) O +
. O +

U937 O +
cells O +
were O +
cultured O +
for O +
0 O +
- O +
21 O +
days O +
in O +
media O +
containing O +
0 O +
- O +
20 O +
% O +
Product O +
R O +
or O +
phosphate O +
- O +
buffered O +
saline O +
( O +
PBS O +
) O +
. O +

Compared O +
to O +
control O +
cultures O +
, O +
cells O +
cultured O +
in O +
Product O +
R O +
expressed O +
increased O +
amounts O +
of O +
IL-8 B-Gene +
and O +
MCP-1 B-Gene +
mRNAs O +
, O +
as O +
measured O +
by O +
reverse O +
transcriptase O +
- O +
polymerase O +
chain O +
reaction O +
( O +
RT O +
- O +
PCR O +
) O +
. O +

Product O +
R O +
also O +
increased O +
secretion O +
of O +
IL-8 B-Gene +
and O +
MCP-1 B-Gene +
, O +
as O +
measured O +
by O +
enzyme O +
- O +
linked O +
immunosorbent O +
assay O +
( O +
ELISA O +
) O +
, O +
and O +
boosted O +
secretion O +
induced O +
by O +
bacterial O +
lipopolysaccharide O +
( O +
LPS O +
) O +
, O +
in O +
a O +
time O +
- O +
and O +
dose O +
- O +
dependent O +
manner O +
. O +

In O +
adherent O +
PBMCs O +
, O +
Product O +
R O +
increased O +
IL-8 B-Gene +
and O +
MCP-1 B-Gene +
secretion O +
, O +
but O +
reduced O +
LPS O +
- O +
induced O +
MCP-1 B-Gene +
secretion O +
. O +

While O +
mRNAs O +
encoding O +
the O +
IL-8 B-Gene +
receptor I-Gene +
, O +
CXCR2 B-Gene +
, O +
and O +
the O +
MCP-1 B-Gene +
receptor I-Gene +
, O +
CCR2 B-Gene +
, O +
were O +
increased O +
in O +
U937 O +
cells O +
cultured O +
in O +
5 O +
- O +
10 O +
% O +
Product O +
R O +
, O +
we O +
observed O +
no O +
change O +
in O +
binding O +
of O +
receptor O +
- O +
specific O +
antibodies O +
. O +

These O +
findings O +
suggest O +
that O +
Product O +
R O +
upregulates O +
the O +
expression O +
of O +
IL-8 B-Gene +
and O +
MCP-1 B-Gene +
, O +
which O +
may O +
boost O +
immune O +
system O +
activity O +
in O +
virally O +
- O +
infected O +
patients O +
. O +

Peptidoglycan B-Gene +
recognition I-Gene +
proteins I-Gene +
: O +
a O +
novel O +
family O +
of O +
four O +
human O +
innate O +
immunity O +
pattern O +
recognition O +
molecules O +
. O +

The O +
innate O +
immune O +
system O +
recognizes O +
microorganisms O +
through O +
a O +
series O +
of O +
pattern O +
recognition O +
receptors O +
that O +
are O +
highly O +
conserved O +
in O +
evolution O +
. O +

Insects O +
have O +
a O +
family O +
of O +
12 O +
peptidoglycan B-Gene +
recognition I-Gene +
proteins I-Gene +
( O +
PGRPs B-Gene +
) O +
that O +
recognize O +
peptidoglycan O +
, O +
a O +
ubiquitous O +
component O +
of O +
bacterial O +
cell O +
walls O +
. O +

We O +
report O +
cloning O +
of O +
three O +
novel O +
human O +
PGRPs B-Gene +
( O +
PGRP B-Gene +
- I-Gene +
L I-Gene +
, O +
PGRP B-Gene +
- I-Gene +
Ialpha I-Gene +
, O +
and O +
PGRP B-Gene -
- I-Gene -
Ibeta I-Gene +
) O +
that O +
together O +
with O +
the O +
previously O +
cloned O +
PGRP B-Gene -
- I-Gene -
S I-Gene +
, O +
define O +
a O +
new O +
family O +
of O +
human O +
pattern O +
recognition O +
molecules O +
. O +

PGRP B-Gene -
- I-Gene -
L I-Gene +
, O +
PGRP B-Gene +
- I-Gene +
Ialpha I-Gene +
, O +
and O +
PGRP B-Gene +
- I-Gene +
Ibeta I-Gene +
have O +
576 O +
, O +
341 O +
, O +
and O +
373 O +
amino O +
acids O +
coded O +
by O +
five O +
, O +
seven O +
, O +
and O +
eight O +
exons O +
on O +
chromosomes O +
19 O +
and O +
1 O +
, O +
and O +
they O +
all O +
have O +
two O +
predicted O +
transmembrane O +
domains O +
. O +

All O +
mammalian O +
and O +
insect O +
PGRPs B-Gene +
have O +
at O +
least O +
three O +
highly O +
conserved O +
C O +
- O +
terminal O +
PGRP B-Gene +
domains O +
located O +
either O +
in O +
the O +
extracellular O +
or O +
in O +
the O +
cytoplasmic O +
( O +
or O +
in O +
both O +
) O +
portions O +
of O +
the O +
molecules O +
. O +

PGRP B-Gene -
- I-Gene -
L I-Gene +
is O +
expressed O +
in O +
liver O +
, O +
PGRP B-Gene -
- I-Gene -
Ialpha I-Gene +
and O +
PGRP B-Gene -
- I-Gene -
Ibeta I-Gene +
in O +
esophagus O +
( O +
and O +
to O +
a O +
lesser O +
extent O +
in O +
tonsils O +
and O +
thymus O +
) O +
, O +
and O +
PGRP B-Gene -
- I-Gene -
S I-Gene +
in O +
bone O +
marrow O +
( O +
and O +
to O +
a O +
lesser O +
extent O +
in O +
neutrophils O +
and O +
fetal O +
liver O +
) O +
. O +

All O +
four O +
human O +
PGRPs B-Gene +
bind O +
peptidoglycan O +
and O +
Gram O +
- O +
positive O +
bacteria O +
. O +

Thus O +
, O +
these O +
PGRPs B-Gene +
may O +
play O +
a O +
role O +
in O +
recognition O +
of O +
bacteria O +
in O +
these O +
organs O +
. O +

ASH2L B-Gene +
: O +
alternative O +
splicing O +
and O +
downregulation O +
during O +
induced O +
megakaryocytic O +
differentiation O +
of O +
multipotential O +
leukemia O +
cell O +
lines O +
. O +

Abstract O +
Drosophila O +
ash2 B-Gene +
is O +
a O +
member O +
of O +
the O +
trxG B-Gene +
gene I-Gene +
super I-Gene +
family I-Gene +
, O +
some O +
human O +
homologues O +
of O +
which O +
are O +
involved O +
in O +
hematopoiesis O +
and O +
leukemia O +
. O +

We O +
report O +
here O +
the O +
identification O +
of O +
the O +
human O +
homologue O +
of O +
Drosophila O +
ash2 B-Gene +
and O +
its O +
alternative O +
splicing O +
isoform O +
, O +
ASH2L1 B-Gene +
and O +
ASH2L2 B-Gene +
. O +

ASH2L B-Gene +
proteins O +
are O +
60 O +
% O +
homologous O +
to O +
Drosophila O +
ash2 B-Gene +
. O +

ASH2L B-Gene +
also O +
has O +
a O +
zinc O +
finger O +
motif O +
( O +
C2C2 O +
) O +
although O +
it O +
is O +
not O +
identical O +
to O +
that O +
in O +
ASH2 B-Gene +
. O +

Expression O +
profile O +
analysis O +
showed O +
that O +
the O +
amount O +
of O +
ASH2L B-Gene +
transcripts O +
is O +
extremely O +
high O +
in O +
fetal O +
liver O +
, O +
testis O +
, O +
and O +
leukemia O +
cell O +
lines O +
with O +
erythroid O +
and O +
megakaryocytic O +
potential O +
such O +
as O +
K562 O +
, O +
Hel O +
, O +
and O +
Dami O +
. O +

We O +
treated O +
these O +
cells O +
with O +
differentiation O +
inducers O +
phorbol O +
ester O +
and O +
hemin O +
. O +

We O +
found O +
that O +
ASH2L B-Gene +
is O +
downregulated O +
rapidly O +
and O +
dramatically O +
in O +
K562 O +
, O +
Hel O +
, O +
and O +
Dami O +
cells O +
during O +
phorbol O +
ester O +
induced O +
differentiation O +
with O +
megakaryocytic O +
features O +
. O +

However O +
, O +
its O +
expression O +
is O +
maintained O +
at O +
a O +
high O +
level O +
during O +
erythroid O +
differentiation O +
of O +
K562 O +
cells O +
induced O +
with O +
hemin O +
. O +

These O +
results O +
suggest O +
that O +
ASH2L B-Gene +
plays O +
a O +
role O +
in O +
hematopoiesis O +
and O +
is O +
associated O +
with O +
some O +
special O +
kinds O +
of O +
leukemia O +
. O +

Regulation O +
of O +
the O +
plant O +
- O +
type O +
5'-adenylyl B-Gene +
sulfate I-Gene +
reductase I-Gene +
by O +
oxidative O +
stress O +
. O +

5'-Adenylyl B-Gene +
sulfate I-Gene +
( I-Gene +
APS I-Gene +
) I-Gene +
reductase I-Gene +
( O +
EC B-Gene +
1.8.4.9 I-Gene +
) O +
catalyzes O +
a O +
key O +
reaction O +
in O +
the O +
plant O +
sulfate O +
assimilation O +
pathway O +
leading O +
to O +
the O +
synthesis O +
of O +
cysteine O +
and O +
the O +
antioxidant O +
glutathione O +
. O +

In O +
Arabidopsis O +
thaliana O +
APS B-Gene +
reductase I-Gene +
is O +
encoded O +
by O +
a O +
family O +
of O +
three O +
genes O +
. O +

In O +
vitro O +
biochemical O +
studies O +
revealed O +
that O +
the O +
enzyme O +
product O +
derived O +
from O +
one O +
of O +
them O +
( O +
APR1 B-Gene +
) O +
is O +
activated O +
by O +
oxidation O +
, O +
probably O +
through O +
the O +
formation O +
of O +
a O +
disulfide O +
bond O +
. O +

The O +
APR1 B-Gene +
enzyme O +
is O +
45 O +
- O +
fold O +
more O +
active O +
when O +
expressed O +
in O +
a O +
trxB B-Gene +
strain O +
of O +
Escherichia O +
coli O +
than O +
in O +
a O +
trxB B-Gene +
( O +
+ O +
) O +
wild O +
type O +
. O +

The O +
enzyme O +
is O +
inactivated O +
in O +
vitro O +
by O +
treatment O +
with O +
disulfide O +
reductants O +
and O +
is O +
reactivated O +
with O +
thiol O +
oxidants O +
. O +

Redox O +
titrations O +
show O +
that O +
the O +
regulation O +
site O +
has O +
a O +
midpoint O +
potential O +
of O +
- O +
330 O +
mV O +
at O +
pH O +
8.5 O +
and O +
involves O +
a O +
two O +
- O +
electron O +
redox O +
reaction O +
. O +

Exposure O +
of O +
a O +
variety O +
of O +
plants O +
to O +
ozone O +
induces O +
a O +
rapid O +
increase O +
in O +
APS B-Gene +
reductase I-Gene +
activity O +
that O +
correlates O +
with O +
the O +
oxidation O +
of O +
the O +
glutathione O +
pool O +
and O +
is O +
followed O +
by O +
an O +
increase O +
in O +
free O +
cysteine O +
and O +
total O +
glutathione O +
. O +

During O +
the O +
response O +
to O +
ozone O +
, O +
the O +
level O +
of O +
immunodetectable O +
APS B-Gene +
reductase I-Gene +
enzyme O +
does O +
not O +
increase O +
. O +

Treatment O +
of O +
A. O +
thaliana O +
seedlings O +
with O +
oxidized O +
glutathione O +
or O +
paraquat O +
induces O +
APS B-Gene +
reductase I-Gene +
activity O +
even O +
when O +
transcription O +
or O +
translation O +
is O +
blocked O +
with O +
inhibitors O +
. O +

The O +
results O +
suggest O +
that O +
a O +
posttranslational O +
mechanism O +
controls O +
APS B-Gene +
reductase I-Gene +
. O +

A O +
model O +
is O +
proposed O +
whereby O +
redox O +
regulation O +
of O +
APS B-Gene +
reductase I-Gene +
provides O +
a O +
rapidly O +
responding O +
, O +
self O +
- O +
regulating O +
mechanism O +
to O +
control O +
the O +
glutathione O +
synthesis O +
necessary O +
to O +
combat O +
oxidative O +
stress O +
. O +

Human O +
CC B-Gene +
chemokine I-Gene +
liver B-Gene +
- I-Gene +
expressed I-Gene +
chemokine I-Gene +
/ O +
CCL16 B-Gene +
is O +
a O +
functional O +
ligand O +
for O +
CCR1 B-Gene +
, O +
CCR2 B-Gene +
and O +
CCR5 B-Gene +
, O +
and O +
constitutively O +
expressed O +
by O +
hepatocytes O +
. O +

Liver B-Gene +
- I-Gene +
expressed I-Gene +
chemokine I-Gene +
( O +
LEC B-Gene +
) O +
/ O +
CCL16 B-Gene +
is O +
a O +
human O +
CC B-Gene +
chemokine I-Gene +
selectively O +
expressed O +
in O +
the O +
liver O +
. O +

Here O +
, O +
we O +
investigated O +
its O +
receptor O +
usage O +
by O +
calcium O +
mobilization O +
and O +
chemotactic O +
assays O +
using O +
mouse O +
L1.2 O +
pre O -
- O -
B O +
cell O +
lines O +
stably O +
expressing O +
a O +
panel O +
of O +
12 O +
human O +
chemokine O +
receptors O +
. O +

At O +
relatively O +
high O +
concentrations O +
, O +
LEC B-Gene +
induced O +
calcium O +
mobilization O +
and O +
chemotaxis O +
via O +
CCR1 B-Gene +
and O +
CCR2 B-Gene +
. O +

LEC B-Gene +
also O +
induced O +
calcium O +
mobilization O +
, O +
but O +
marginal O +
chemotaxis O +
via O +
CCR5 B-Gene +
. O +

Consistently O +
, O +
LEC B-Gene +
was O +
found O +
to O +
bind O +
to O +
CCR1 B-Gene +
, O +
CCR2 B-Gene +
and O +
CCR5 B-Gene +
with O +
relatively O +
low O +
affinities O +
. O +

The O +
binding O +
of O +
LEC B-Gene +
to O +
CCR8 B-Gene +
was O +
much O +
less O +
significant O +
. O +

In O +
spite O +
of O +
its O +
binding O +
to O +
CCR5 B-Gene +
, O +
LEC B-Gene +
was O +
unable O +
to O +
inhibit O +
infection O +
of O +
an O +
R5 O +
- O +
type O +
HIV-1 O +
to O +
activated O +
human O +
peripheral O +
blood O +
mononuclear O +
cells O +
even O +
at O +
high O +
concentrations O +
. O +

In O +
human O +
liver O +
sections O +
, O +
hepatocytes O +
were O +
strongly O +
stained O +
by O +
anti O +
- O +
LEC B-Gene +
antibody O +
. O +

HepG2 O +
, O +
a O +
human O +
hepatocarcinoma O +
cell O +
line O +
, O +
was O +
found O +
to O +
constitutively O +
express O +
LEC B-Gene +
. O +

LEC B-Gene +
was O +
also O +
present O +
in O +
the O +
plasma O +
samples O +
from O +
healthy O +
adult O +
donors O +
at O +
relatively O +
high O +
concentrations O +
( O +
0.3 O +
-- O +
4 O +
nM O +
) O +
. O +

Taken O +
together O +
, O +
LEC B-Gene +
is O +
a O +
new O +
low O +
- O +
affinity O +
functional O +
ligand O +
for O +
CCR1 B-Gene +
, O +
CCR2 B-Gene +
and O +
CCR5 B-Gene +
, O +
and O +
is O +
constitutively O +
expressed O +
by O +
liver O +
parenchymal O +
cells O +
. O +

The O +
presence O +
of O +
LEC B-Gene +
in O +
normal O +
plasma O +
at O +
relatively O +
high O +
concentrations O +
may O +
modulate O +
inflammatory O +
responses O +
. O +

An O +
isoform O +
- O +
specific O +
inhibitory O +
domain O +
regulates O +
the O +
LHX3 B-Gene +
LIM O +
homeodomain O +
factor O +
holoprotein O +
and O +
the O +
production O +
of O +
a O +
functional O +
alternate O +
translation O +
form O +
. O +

The O +
LHX3 B-Gene +
LIM O +
homeodomain O +
transcription B-Gene +
factor I-Gene +
is O +
required O +
for O +
pituitary O +
development O +
and O +
motor O +
neuron O +
specification O +
. O +

The O +
Lhx3 B-Gene +
gene O +
encodes O +
two O +
isoforms O +
, O +
LHX3a B-Gene +
and O +
LHX3b B-Gene +
, O +
that O +
differ O +
in O +
their O +
amino O +
- O +
terminal O +
sequences O +
. O +

Humans O +
and O +
mice O +
with O +
defective O +
Lhx3 B-Gene +
genes O +
are O +
deficient O +
in O +
gonadotrope O +
, O +
lactotrope O +
, O +
somatotrope O +
, O +
and O +
thyrotrope O +
pituitary O +
cells O +
. O +

We O +
show O +
that O +
, O +
whereas O +
Lhx3b B-Gene +
is O +
highly O +
expressed O +
in O +
these O +
Lhx3 B-Gene +
- O +
dependent O +
cell O +
types O +
, O +
high O +
levels O +
of O +
Lhx3a B-Gene +
expression O +
are O +
restricted O +
to O +
alpha O +
glycoprotein O +
subunit O +
- O +
expressing O +
thyrotropes O +
and O +
gonadotropes O +
. O +

Cross O +
- O +
species O +
comparison O +
reveals O +
the O +
LHX3b B-Gene +
- O +
specific O +
domain O +
is O +
more O +
conserved O +
than O +
the O +
LHX3a B-Gene +
- O +
specific O +
domain O +
. O +

We O +
demonstrate O +
that O +
the O +
LHX3b B-Gene +
- O +
specific O +
domain O +
is O +
a O +
transferable O +
inhibitor O +
that O +
reduces O +
gene O +
activation O +
and O +
DNA O +
binding O +
by O +
homeodomain O +
proteins O +
. O +

In O +
addition O +
, O +
we O +
identify O +
a O +
novel O +
LHX3 B-Gene +
protein O +
( O +
M2-LHX3 B-Gene +
) O +
and O +
determine O +
that O +
this O +
molecule O +
is O +
generated O +
by O +
an O +
internal O +
translation O +
initiation O +
codon O +
. O +

The O +
LHX3a B-Gene +
- O +
and O +
LHX3b B-Gene +
- O +
specific O +
coding O +
sequences O +
regulate O +
differential O +
usage O +
of O +
this O +
internal O +
start O +
codon O +
. O +

Further O +
, O +
we O +
identify O +
the O +
major O +
activation O +
domain O +
of O +
LHX3 B-Gene +
in O +
the O +
carboxyl O +
terminus O +
of O +
the O +
molecule O +
. O +

M2-LHX3 B-Gene +
is O +
active O +
because O +
it O +
retains O +
this O +
domain O +
and O +
binds O +
DNA O +
better O +
than O +
LHX3a B-Gene +
or O +
LHX3b B-Gene +
. O +

Other O +
LIM O +
homeodomain O +
genes O +
, O +
including O +
Lhx4 B-Gene +
, O +
generate O +
similar O +
truncated O +
proteins O +
. O +

These O +
studies O +
describe O +
how O +
transcriptional O +
regulatory O +
genes O +
can O +
generate O +
multiple O +
functional O +
proteins O +
. O +

Molecular O +
cloning O +
and O +
characterization O +
of O +
a O +
dermatan B-Gene +
- I-Gene +
specific I-Gene +
N I-Gene -
- I-Gene -
acetylgalactosamine I-Gene +
4-O I-Gene -
- I-Gene -
sulfotransferase I-Gene +
. O +

We O +
have O +
identified O +
and O +
characterized O +
an O +
N B-Gene -
- I-Gene -
acetylgalactosamine-4-O I-Gene -
- I-Gene -
sulfotransferase I-Gene +
designated O +
dermatan-4-sulfotransferase-1 B-Gene +
( O +
D4ST-1 B-Gene +
) O +
( O +
GenBank O +
( O +
TM O +
) O +
accession O +
number O +
AF401222 O +
) O +
based O +
on O +
its O +
homology O +
to O +
HNK-1 B-Gene +
sulfotransferase I-Gene +
. O +

The O +
cDNA O +
predicts O +
an O +
open O +
reading O +
frame O +
encoding O +
a O +
type O +
II O +
membrane O +
protein O +
of O +
376 O +
amino O +
acids O +
with O +
a O +
43 O +
- O +
amino O +
acid O +
cytoplasmic O +
domain O +
and O +
a O +
316 O +
- O +
amino O +
acid O +
luminal O +
domain O +
containing O +
two O +
potential O +
N O +
- O +
linked O +
glycosylation O +
sites O +
. O +

D4ST-1 B-Gene +
has O +
significant O +
amino O +
acid O +
identity O +
with O +
HNK-1 B-Gene +
sulfotransferase I-Gene +
( O +
21.4 O +
% O +
) O +
, O +
N B-Gene -
- I-Gene -
acetylgalactosamine-4-O I-Gene -
- I-Gene -
sulfotransferase I-Gene +
1 I-Gene +
( O +
GalNAc-4-ST1 B-Gene +
) O +
( O +
24.7 O +
% O +
) O +
, O +
N B-Gene -
- I-Gene -
acetylgalactosamine-4-O I-Gene -
- I-Gene -
sulfotransferase I-Gene +
2 I-Gene +
( O +
GalNAc-4-ST2 B-Gene +
) O +
( O +
21.0 O +
% O +
) O +
, O +
chondroitin-4-O B-Gene -
- I-Gene -
sulfotransferase I-Gene +
1 I-Gene +
( O +
27.3 O +
% O +
) O +
, O +
and O +
chondroitin-4-O B-Gene -
- I-Gene -
sulfotransferase I-Gene +
2 I-Gene +
( O +
22.8 O +
% O +
) O +
. O +

D4ST-1 B-Gene +
transfers O +
sulfate O +
to O +
the O +
C-4 O +
hydroxyl O +
of O +
beta1,4-linked O +
GalNAc O +
that O +
is O +
substituted O +
with O +
an O +
alpha O +
- O +
linked O +
iduronic O +
acid O +
( O +
IdoUA O +
) O +
at O +
the O +
C-3 O +
hydroxyl O +
. O +

D4ST-1 B-Gene +
shows O +
a O +
strong O +
preference O +
in O +
vitro O +
for O +
sulfate O +
transfer O +
to O +
IdoUAalpha1 O +
, O +
3GalNAcbeta1 O +
, O +
4 O +
that O +
is O +
flanked O +
by O +
GlcUAbeta1 O +
, O +
3GalNAcbeta1 O +
, O +
4 O +
as O +
compared O +
with O +
IdoUAalpha1 O +
, O +
3GalNAcbeta1 O +
, O +
4 O +
flanked O +
by O +
IdoUAalpha1 O +
, O +
3GalNAcbeta1 O +
, O +
4 O +
. O +

The O +
specificity O +
of O +
D4ST-1 B-Gene +
when O +
assayed O +
in O +
vitro O +
suggests O +
that O +
the O +
addition O +
of O +
sulfate O +
to O +
GalNAc O +
occurs O +
immediately O +
after O +
epimerization O +
of O +
GlcUA O +
to O +
IdoUA O +
. O +

The O +
open O +
reading O +
frame O +
of O +
D4ST-1 B-Gene +
is O +
encoded O +
by O +
a O +
single O +
exon O +
located O +
on O +
human O +
chromosome O +
15q14 O +
. O +

Northern O +
blot O +
analysis O +
reveals O +
a O +
single O +
2.4 O +
- O +
kilobase O +
transcript O +
. O +

D4ST-1 B-Gene +
message O +
is O +
expressed O +
in O +
virtually O +
all O +
tissues O +
at O +
some O +
level O +
but O +
is O +
most O +
highly O +
expressed O +
in O +
pituitary O +
, O +
placenta O +
, O +
uterus O +
, O +
and O +
thyroid O +
. O +

The O +
properties O +
of O +
D4ST-1 B-Gene +
indicate O +
that O +
sulfation O +
of O +
the O +
GalNAc O +
moieties O +
in O +
dermatan O +
is O +
mediated O +
by O +
a O +
distinct O +
GalNAc-4-O B-Gene -
- I-Gene -
sulfotransferase I-Gene +
and O +
occurs O +
following O +
epimerization O +
of O +
GlcUA O +
to O +
IdoUA O +
. O +

Identification O +
of O +
a O +
novel O +
kinesin B-Gene +
- I-Gene +
related I-Gene +
protein I-Gene +
, O +
KRMP1 B-Gene +
, O +
as O +
a O +
target O +
for O +
mitotic O +
peptidyl B-Gene +
- I-Gene +
prolyl I-Gene +
isomerase I-Gene +
Pin1 B-Gene +
. O +

Mitosis O +
utilizes O +
a O +
number O +
of O +
kinesin B-Gene +
- I-Gene +
related I-Gene +
proteins I-Gene +
( O +
KRPs B-Gene +
) O +
. O +

Here O +
we O +
report O +
the O +
identification O +
of O +
a O +
novel O +
KRP B-Gene +
termed O +
KRMP1 B-Gene +
, O +
which O +
has O +
a O +
deduced O +
1780 O +
- O +
amino O +
acid O +
sequence O +
composed O +
of O +
ternary O +
domains O +
. O +

The O +
amino O +
- O +
terminal O +
head O +
domain O +
is O +
most O +
similar O +
to O +
the O +
kinesin B-Gene +
motor O +
domain O +
of O +
the O +
MKLP-1 B-Gene +
subfamily I-Gene +
and O +
has O +
an O +
intrinsic O +
ATPase B-Gene +
activity O +
that O +
is O +
diminished O +
by O +
substituting O +
the O +
consensus O +
Lys-168 O +
with O +
Arg O +
. O +

The O +
central O +
stalk O +
domain O +
is O +
predicted O +
to O +
form O +
a O +
long O +
alpha O -
- O -
helical O +
coiled O +
- O +
coil O +
, O +
and O +
can O +
interact O +
with O +
each O +
other O +
in O +
vivo O +
. O +

An O +
in O +
vivo O +
labeling O +
experiment O +
revealed O +
that O +
KRMP1 B-Gene +
is O +
phosphorylated O +
, O +
and O +
we O +
also O +
found O +
that O +
the O +
region O +
within O +
the O +
tail O +
domain O +
containing O +
Thr-1604 O +
as O +
the O +
cdc2 B-Gene +
kinase B-Gene +
phosphorylation O +
site O +
differs O +
from O +
the O +
bimC B-Gene +
box O +
conserved O +
in O +
the O +
bimC B-Gene +
subfamily I-Gene +
of I-Gene +
KRPs I-Gene +
. O +

Immunofluorescence O +
analysis O +
showed O +
that O +
endogenous O +
KRMP1 B-Gene +
was O +
localized O +
predominantly O +
to O +
the O +
cytoplasm O +
during O +
interphase O +
and O +
dispersed O +
throughout O +
the O +
cell O +
during O +
mitosis O +
. O +

Consistent O +
with O +
this O +
finding O +
, O +
overexpressed O +
KRMP1 B-Gene +
was O +
detected O +
in O +
a O +
complicated O +
nuclear O +
or O +
cytoplasmic O +
pattern O +
reflecting O +
multiple O +
nuclear O +
localization O +
/ O +
export O +
signals O +
. O +

Furthermore O +
, O +
KRMP1 B-Gene +
interacted O +
with O +
the O +
mitotic O +
peptidyl B-Gene +
- I-Gene +
prolyl I-Gene +
isomerase I-Gene +
Pin1 B-Gene +
in O +
vivo O +
, O +
and O +
an O +
in O +
vitro O +
interaction O +
was O +
detected O +
between O +
the O +
tail O +
domain O +
of O +
KRMP1 B-Gene +
and O +
the O +
WW O +
domain O +
of O +
Pin1 B-Gene +
. O +

Overexpression O +
of O +
KRMP1 B-Gene +
caused O +
COS-7 O +
cells O +
to O +
arrest O +
at O +
G O -
( O -
2 O -
) O -
-M O +
, O +
and O +
co O +
- O +
expression O +
of O +
Pin1 B-Gene +
reversed O +
this O +
effect O +
, O +
indicating O +
their O +
physiological O +
interaction O +
. O +

Together O +
, O +
our O +
results O +
suggest O +
that O +
KRMP1 B-Gene +
is O +
a O +
mitotic O +
target O +
regulated O +
by O +
Pin1 B-Gene +
and O +
vice O +
versa O +
. O +

Energetically O +
most O +
likely O +
substrate O +
and O +
active O +
- O +
site O +
protonation O +
sites O +
and O +
pathways O +
in O +
the O +
catalytic O +
mechanism O +
of O +
dihydrofolate B-Gene +
reductase I-Gene +
. O +

Despite O +
much O +
experimental O +
and O +
computational O +
study O +
, O +
key O +
aspects O +
of O +
the O +
mechanism O +
of O +
reduction O +
of O +
dihydrofolate O +
( O +
DHF O +
) O +
by O +
dihydrofolate B-Gene +
reductase I-Gene +
( O +
DHFR B-Gene +
) O +
remain O +
unresolved O +
, O +
while O +
the O +
secondary O +
DHFR B-Gene +
- O +
catalyzed O +
reduction O +
of O +
folate O +
has O +
been O +
little O +
studied O +
. O +

Major O +
differences O +
between O +
proposed O +
DHF O +
mechanisms O +
are O +
whether O +
the O +
carboxylate O +
group O +
of O +
the O +
conserved O +
active O +
- O +
site O +
Asp O +
or O +
Glu O +
residue O +
is O +
protonated O +
or O +
ionized O +
during O +
the O +
reaction O +
, O +
and O +
whether O +
there O +
is O +
direct O +
protonation O +
of O +
N5 O +
or O +
a O +
proton O +
shuttle O +
from O +
an O +
initially O +
protonated O +
carboxylate O +
group O +
via O +
O4 O +
. O +

We O +
have O +
addressed O +
these O +
questions O +
for O +
both O +
reduction O +
steps O +
with O +
a O +
comprehensive O +
set O +
of O +
ab O +
initio O +
quantum O +
chemical O +
calculations O +
on O +
active O +
- O +
site O +
fragment O +
complexes O +
, O +
including O +
the O +
carboxyl O +
side O +
chain O +
and O +
, O +
progressively O +
, O +
all O +
other O +
polar O +
active O +
- O +
site O +
residue O +
groups O +
including O +
conserved O +
water O +
molecules O +
. O +

Addition O +
of O +
two O +
protons O +
in O +
two O +
steps O +
was O +
considered O +
. O +

The O +
polarization O +
effects O +
of O +
the O +
remainder O +
of O +
the O +
enzyme O +
system O +
were O +
approximated O +
by O +
a O +
dielectric O +
continuum O +
self O +
- O +
consistent O +
reaction O +
field O +
( O +
SCRF O +
) O +
model O +
using O +
an O +
effective O +
dielectric O +
constant O +
( O +
epsilon O +
) O +
of O +
2 O +
. O +

Optimized O +
geometries O +
were O +
calculated O +
using O +
the O +
density O +
functional O +
( O +
B3LYP O +
) O +
method O +
and O +
Onsager O +
SCRF O +
model O +
with O +
the O +
6 O -
- O -
31 O -
G O +
basis O +
. O +

Single O +
- O +
point O +
energy O +
calculations O +
were O +
then O +
carried O +
out O +
at O +
the O +
B3LYP O +
/ O +
6 O -
- O -
311+G O +
level O +
with O +
either O +
the O +
Onsager O +
or O +
dielectric O +
polarizable O +
continuum O +
model O +
. O +

Additional O +
checking O +
calculations O +
at O +
MP2 O +
and O +
HF O +
levels O +
, O +
or O +
with O +
other O +
basis O +
sets O +
or O +
values O +
of O +
epsilon O +
, O +
were O +
also O +
done O +
. O +

From O +
the O +
results O +
, O +
the O +
conserved O +
water O +
molecule O +
, O +
corresponding O +
to O +
W206 O +
in O +
the O +
E. O +
coli O +
DHFR B-Gene +
complexes O +
, O +
that O +
is O +
H O +
- O +
bonded O +
to O +
both O +
the O +
OD2 O +
oxygen O +
atom O +
of O +
the O +
carboxyl O +
( O +
Asp O +
) O +
side O +
chain O +
and O +
O4 O +
of O +
the O +
pterin O +
/ O +
dihydropterin O +
ring O +
, O +
appears O +
critically O +
important O +
and O +
may O +
determine O +
the O +
protonation O +
site O +
for O +
the O +
enzyme O +
- O +
bound O +
substrates O +
. O +

In O +
the O +
absence O +
of O +
W206 O +
, O +
the O +
most O +
stable O +
monoprotonated O +
species O +
are O +
the O +
neutral O +
- O +
pair O +
4 O +
- O +
enol O +
forms O +
of O +
substrates O +
with O +
the O +
carboxyl O +
group O +
OD2 O +
oxygen O +
protonated O +
and O +
H O -
- O -
bonded O +
to O +
N3 O +
. O +

If O +
W206 O +
is O +
included O +
, O +
then O +
the O +
most O +
stable O +
forms O +
are O +
still O +
the O +
neutral O +
- O +
pair O +
complexes O +
but O +
now O +
for O +
the O +
N3-H O +
keto O +
forms O +
with O +
the O +
protonated O +
OD2 O +
atom O +
H O -
- O -
bonding O +
with O +
W206 O +
. O +

A O +
second O +
proton O +
addition O +
to O +
these O +
complexes O +
gives O +
protonations O +
at O +
N8 O +
( O +
folate O +
) O +
or O +
N5 O +
( O +
DHF O +
) O +
. O +

Calculated O +
H O -
- O -
bond O +
distances O +
correlate O +
well O +
with O +
those O +
for O +
the O +
conserved O +
W206 O +
observed O +
in O +
many O +
X O +
- O +
ray O +
structures O +
. O +

For O +
all O +
structures O +
with O +
occluded O +
M20 O +
loop O +
conformations O +
( O +
closed O +
active O +
site O +
) O +
, O +
OD2-N3 O +
distances O +
are O +
less O +
than O +
OD2 O +
- O +
NA2 O +
distances O +
, O +
which O +
is O +
consistent O +
with O +
those O +
calculated O +
for O +
protonated O +
OD2 O +
complexes O +
. O +

Thus O +
, O +
the O +
results O +
( O +
B3LYP O +
; O +
epsilon O +
= O +
2 O +
calculations O +
) O +
support O +
a O +
mechanism O +
for O +
both O +
folate O +
and O +
DHF O +
reduction O +
in O +
which O +
the O +
OD2 O +
carboxyl O +
oxygen O +
is O +
first O +
protonated O +
, O +
followed O +
by O +
a O +
direct O +
protonation O +
at O +
N8 O +
( O +
folate O +
) O +
and O +
N5 O +
( O +
DHF O +
) O +
to O +
obtain O +
the O +
active O +
cation O +
complexes O +
, O +
i.e. O +
, O +
doubly O +
protonated O +
. O +

The O +
results O +
do O +
not O +
support O +
a O +
proposed O +
protonated O +
carboxyl O +
with O +
DHF O +
in O +
the O +
enol O +
form O +
for O +
the O +
Michaelis O +
complex O +
, O +
nor O +
an O +
ionized O +
carboxyl O +
with O +
protonated O +
enol O -
- O -
DHF O +
as O +
a O +
catalytic O +
intermediate O +
. O +

However O +
, O +
as O +
additional O +
calculations O +
for O +
the O +
monoprotonated O +
complete O +
complexes O +
show O +
a O +
reduction O +
in O +
the O +
energy O +
differences O +
between O +
the O +
neutral O +
- O +
pair O +
keto O +
and O +
ion O +
- O +
pair O +
keto O +
( O +
N8 O +
- O +
or O +
N5 O +
- O +
protonated O +
) O +
forms O +
, O +
we O +
are O +
extending O +
the O +
treatment O +
using O +
combined O +
quantum O +
mechanics O +
and O +
molecular O +
mechanics O +
( O +
QM O +
/ O +
MM O +
) O +
and O +
molecular O +
dynamics O +
simulation O +
methods O +
to O +
refine O +
the O +
description O +
of O +
the O +
protein O +
/ O +
solvent O +
environment O +
and O +
prediction O +
of O +
the O +
relative O +
stabilization O +
free O +
energies O +
of O +
the O +
various O +
( O +
OD2 O +
, O +
O4 O +
, O +
N5 O +
, O +
and O +
N8 O +
) O +
protonation O +
sites O +
. O +

Folding O +
of O +
malate B-Gene +
dehydrogenase I-Gene +
inside O +
the O +
GroEL B-Gene +
- O +
GroES B-Gene +
cavity O +
. O +

The O +
chaperonin B-Gene +
GroEL B-Gene +
binds O +
nonnative O +
substrate O +
protein O +
in O +
the O +
hydrophobic O +
central O +
cavity O +
of O +
an O +
open O +
ring O +
. O +

ATP O +
and O +
GroES B-Gene +
binding O +
to O +
the O +
same O +
ring O +
converts O +
this O +
cavity O +
into O +
an O +
encapsulated O +
, O +
hydrophilic O +
chamber O +
that O +
mediates O +
productive O +
folding O +
. O +

A O +
' O +
rack O +
' O +
mechanism O +
of O +
initial O +
protein O +
unfolding O +
proposes O +
that O +
, O +
upon O +
GroES B-Gene +
and O +
ATP O +
binding O +
, O +
the O +
polypeptide O +
is O +
stretched O +
between O +
the O +
binding O +
sites O +
on O +
the O +
twisting O +
apical O +
domains O +
of O +
GroEL B-Gene +
before O +
complete O +
release O +
into O +
the O +
chamber O +
. O +

Here O +
, O +
the O +
structure O +
of O +
malate B-Gene +
dehydrogenase I-Gene +
( O +
MDH B-Gene +
) O +
subunit O +
during O +
folding O +
is O +
monitored O +
by O +
deuterium O +
exchange O +
, O +
peptic O +
fragment O +
production O +
and O +
mass O +
spectrometry O +
. O +

When O +
bound O +
to O +
GroEL B-Gene +
, O +
MDH B-Gene +
exhibits O +
a O +
core O +
of O +
partially O +
protected O +
secondary O +
structure O +
that O +
is O +
only O +
modestly O +
deprotected O +
upon O +
ATP O +
and O +
GroES B-Gene +
binding O +
. O +

Moreover O +
, O +
deprotection O +
is O +
broadly O +
distributed O +
throughout O +
MDH B-Gene +
, O +
suggesting O +
that O +
it O +
results O +
from O +
breaking O +
hydrogen O +
bonds O +
between O +
MDH B-Gene +
and O +
the O +
cavity O +
wall O +
or O +
global O +
destabilization O +
, O +
as O +
opposed O +
to O +
forced O +
mechanical O +
unfolding O +
. O +

CD89 B-Gene +
: O +
the O +
human O +
myeloid O +
IgA B-Gene +
Fc I-Gene +
receptor I-Gene +
. O +

CD89 B-Gene +
( O +
Fc B-Gene +
alphaRI I-Gene +
) O +
is O +
the O +
human O +
myeloid O +
IgA B-Gene +
Fc I-Gene +
receptor I-Gene +
expressed O +
on O +
cells O +
, O +
such O +
as O +
neutrophils O +
, O +
eosinophils O +
and O +
monocytes O +
/ O +
macrophages O +
. O +

Cross O +
- O +
linking O +
of O +
CD89 B-Gene +
on O +
these O +
cells O +
, O +
by O +
IgA B-Gene +
- O +
opsonised O +
particles O +
( O +
e.g. O +
bacteria O +
, O +
viruses O +
) O +
or O +
anti O +
- O +
CD89 B-Gene +
monoclonal O +
antibodies O +
, O +
can O +
trigger O +
various O +
immunological O +
effector O +
functions O +
which O +
are O +
generally O +
protective O +
but O +
may O +
also O +
cause O +
harm O +
to O +
the O +
body O +
. O +

CD89 B-Gene +
is O +
a O +
transmembrane O +
glycoprotein O +
that O +
binds O +
both O +
subclasses O +
of O +
IgA B-Gene +
in O +
all O +
its O +
molecular O +
forms O +
( O +
i.e. O +
monomeric O +
, O +
dimeric O +
and O +
secretory O +
IgA B-Gene +
) O +
via O +
a O +
region O +
of O +
its O +
membrane O +
- O +
distal O +
EC1 O +
domain O +
. O +

DNA O +
studies O +
have O +
shown O +
that O +
the O +
CD89 B-Gene +
gene O +
is O +
located O +
within O +
the O +
newly O +
described O +
leukocyte O +
receptor O +
cluster O +
( O +
LRC O +
) O +
on O +
chromosome O +
19 O +
. O +

CD89 B-Gene +
is O +
more O +
closely O +
related O +
to O +
the O +
KIR B-Gene +
and O +
MIR B-Gene +
proteins O +
, O +
whose O +
genes O +
are O +
also O +
found O +
in O +
the O +
LRC O +
, O +
than O +
to O +
other O +
human O +
Fc B-Gene +
receptors I-Gene +
( O +
FcRs B-Gene +
) O +
. O +

On O +
myeloid O +
cells O +
, O +
CD89 B-Gene +
is O +
able O +
to O +
associate O +
with O +
the O +
immunoreceptor O +
tyrosine O +
- O +
based O +
activation O +
motif O +
( O +
ITAM O +
) O +
- O +
containing O +
the O +
FcR B-Gene +
gamma I-Gene +
chain O +
, O +
which O +
is O +
responsible O +
for O +
intracellular O +
signaling O +
via O +
CD89 B-Gene +
. O +

Recently O +
, O +
it O +
has O +
been O +
suggested O +
that O +
some O +
cells O +
express O +
CD89 B-Gene +
in O +
a O +
form O +
that O +
does O +
not O +
associate O +
with O +
the O +
FcR B-Gene +
gamma I-Gene +
chain O +
. O +

Although O +
the O +
biological O +
relevance O +
of O +
this O +
observation O +
is O +
not O +
yet O +
clear O +
, O +
it O +
may O +
explain O +
certain O +
anti O +
- O +
inflammatory O +
/ O +
inhibitory O +
effects O +
attributed O +
to O +
IgA B-Gene +
. O +

Here O +
we O +
review O +
current O +
knowledge O +
concerning O +
the O +
genetics O +
, O +
structure O +
and O +
biological O +
function O +
of O +
CD89 B-Gene +
. O +

Effects O +
of O +
tri O -
- O -
iodothyronine O +
on O +
alternative O +
splicing O +
events O +
in O +
the O +
coding O +
region O +
of O +
cytochrome B-Gene +
P450 I-Gene +
aromatase I-Gene +
in O +
immature O +
rat O +
Sertoli O +
cells O +
. O +

Transient O +
postnatal O +
hypothyroidism O +
in O +
male O +
rats O +
induces O +
a O +
prolonged O +
proliferation O +
of O +
immature O +
Sertoli O +
cells O +
. O +

This O +
change O +
in O +
Sertoli O +
cell O +
replication O +
at O +
young O +
ages O +
is O +
coincident O +
with O +
enhanced O +
and O +
prolonged O +
aromatase B-Gene +
activity O +
that O +
leads O +
to O +
a O +
marked O +
increase O +
in O +
the O +
conversion O +
of O +
androgens O +
into O +
estrogens O +
. O +

Both O +
events O +
are O +
drastically O +
inhibited O +
by O +
tri O +
- O +
iodothyronine O +
( O +
T O -
( O -
3 O -
) O +
) O +
replacement O +
either O +
in O +
vivo O +
or O +
in O +
vitro O +
. O +

This O +
study O +
, O +
after O +
the O +
immunolocalization O +
of O +
aromatase B-Gene +
in O +
cultured O +
rat O +
Sertoli O +
cells O +
, O +
examined O +
the O +
effects O +
elicited O +
by O +
T O -
( O -
3 O -
) O +
on O +
this O +
enzyme O +
, O +
by O +
simultaneously O +
investigating O +
three O +
functional O +
levels O +
of O +
aromatase B-Gene +
: O +
mRNA O +
expression O +
, O +
protein O +
content O +
, O +
and O +
enzymatic O +
activity O +
. O +

The O +
immunolocalization O +
of O +
cytochrome B-Gene +
P450 I-Gene +
aromatase I-Gene +
( O +
P450 B-Gene +
arom I-Gene +
) O +
was O +
shown O +
in O +
the O +
cytoplasm O +
of O +
cultured O +
Sertoli O +
cells O +
from O +
15 O +
- O +
and O +
21 O +
- O +
day O +
- O +
old O +
rats O +
. O +

Western O +
blot O +
analysis O +
revealed O +
an O +
enhancement O +
of O +
aromatase B-Gene +
protein O +
content O +
upon O +
stimulation O +
with O +
N O -
( O -
6 O -
) O -
,2'-O O -
- O -
dibutyryladenosine-3':5'-cyclic O +
monophosphate O +
( O -
( O -
Bu O -
) O -
( O -
2 O -
) O -
cAMP O +
) O +
that O +
was O +
clearly O +
down O +
- O +
regulated O +
by O +
T O -
( O -
3 O -
) O +
. O +

The O +
presence O +
of O +
a O +
functional O +
P450 B-Gene +
arom I-Gene +
protein O +
in O +
purified O +
Sertoli O +
cells O +
was O +
confirmed O +
by O +
the O +
measurement O +
of O +
[ O -
( O -
3 O -
) O -
H O -
] O -
H O -
( O -
2 O -
) O -
O O +
released O +
after O +
incubation O +
with O +
[ O -
1 O +
beta- O -
( O -
3 O -
) O -
H O -
] O -
androst-4-ene-3,17-dione O +
. O +

With O +
100 O +
nM O +
T3 O +
, O +
a O +
decrease O +
in O +
both O +
P450 B-Gene +
arom I-Gene +
mRNA O +
levels O +
and O +
aromatase O +
activity O +
was O +
observed O +
. O +

The O +
aromatase B-Gene +
enzymatic O +
activity O +
was O +
strongly O +
stimulated O +
by O +
( O -
Bu O -
) O -
( O -
2 O -
) O -
cAMP O +
and O +
markedly O +
down O +
- O +
regulated O +
by O +
T O -
( O -
3 O -
) O +
. O +

In O +
contrast O +
, O +
the O +
strong O +
increase O +
in O +
aromatase B-Gene +
mRNA O +
upon O +
( O -
Bu O -
) O -
( O -
2 O -
) O -
cAMP O +
stimulation O +
was O +
apparently O +
unaffected O +
by O +
T O -
( O -
3 O -
) O +
administration O +
. O +

This O +
paper O +
shows O +
how O +
the O +
identification O +
of O +
an O +
altered O +
transcript O +
induced O +
by O +
T O -
( O -
3 O -
) O +
coding O +
for O +
putative O +
truncated O +
and O +
inactive O +
aromatase B-Gene +
protein O +
might O +
explain O +
such O +
a O +
decrease O +
in O +
aromatase B-Gene +
activity O +
in O +
T O -
( O -
3 O -
) O +
- O +
treated O +
cells O +
. O +

On O +
the O +
basis O +
of O +
these O +
results O +
, O +
it O +
is O +
concluded O +
that O +
at O +
least O +
two O +
mechanisms O +
could O +
be O +
involved O +
in O +
the O +
down O +
- O +
regulatory O +
effect O +
of O +
T O -
( O -
3 O -
) O +
on O +
aromatase B-Gene +
activity O +
in O +
prepuberal O +
Sertoli O +
cells O +
. O +

The O +
first O +
mechanism O +
is O +
linked O +
to O +
a O +
possible O +
direct O +
modulatory O +
role O +
for O +
T O -
( O -
3 O -
) O +
in O +
the O +
regulation O +
of O +
the O +
aromatase B-Gene +
promoter O +
, O +
whilst O +
the O +
second O +
one O +
is O +
represented O +
by O +
the O +
induction O +
of O +
altered O +
transcripts O +
coding O +
for O +
truncated O +
and O +
inactive O +
aromatase B-Gene +
proteins O +
. O +

Sulfonate O +
- O +
sulfur O +
metabolism O +
and O +
its O +
regulation O +
in O +
Escherichia O +
coli O +
. O +

In O +
the O +
absence O +
of O +
sulfate O +
and O +
cysteine O +
, O +
Escherichia O +
coli O +
can O +
use O +
aliphatic O +
sulfonates O +
as O +
a O +
source O +
of O +
sulfur O +
for O +
growth O +
. O +

Starvation O +
for O +
sulfate O +
leads O +
to O +
the O +
expression O +
of O +
the O +
tauABCD B-Gene +
and O +
ssuEADCB B-Gene +
genes O +
. O +

Each O +
of O +
these O +
gene O +
clusters O +
encodes O +
an O +
ABC O +
- O +
type O +
transport O +
system O +
required O +
for O +
uptake O +
of O +
aliphatic O +
sulfonates O +
and O +
a O +
desulfonation O +
enzyme O +
. O +

The O +
TauD B-Gene +
protein O +
is O +
an O +
alpha B-Gene -
- I-Gene -
ketoglutarate I-Gene +
- I-Gene +
dependent I-Gene +
dioxygenase I-Gene +
that O +
preferentially O +
liberates O +
sulfite O +
from O +
taurine O +
( O +
2-aminoethanesulfonic O +
acid O +
) O +
. O +

SsuD B-Gene +
is O +
a O +
monooxygenase B-Gene +
that O +
catalyzes O +
the O +
oxygenolytic O +
desulfonation O +
of O +
a O +
range O +
of O +
aliphatic O +
sulfonates O +
other O +
than O +
taurine O +
. O +

Its O +
cosubstrate O +
is O +
FMNH2 O +
, O +
which O +
is O +
provided O +
by O +
SsuE B-Gene +
, O +
an O +
NAD O -
( O -
P O -
) O -
H O +
- O +
dependent O +
FMN B-Gene +
reductase I-Gene +
. O +

In O +
contrast O +
to O +
many O +
other O +
bacteria O +
, O +
E. O +
coli O +
is O +
unable O +
to O +
grow O +
with O +
arylsulfonates O +
or O +
with O +
sulfate O +
esters O +
as O +
sulfur O +
source O +
. O +

The O +
tau B-Gene +
and O +
ssu B-Gene +
systems O +
thus O +
provide O +
all O +
genes O +
for O +
the O +
utilization O +
of O +
known O +
organosulfur O +
sources O +
by O +
this O +
organism O +
, O +
except O +
the O +
as O +
yet O +
unidentified O +
gene O -
( O -
s O -
) O +
that O +
enable O +
some O +
E. O +
coli O +
strains O +
to O +
grow O +
with O +
methanesulfonate O +
or O +
cysteate O +
as O +
a O +
sulfur O +
source O +
. O +

Expression O +
of O +
the O +
tau B-Gene +
and O +
ssu B-Gene +
genes O +
requires O +
the O +
LysR B-Gene +
- O +
type O +
transcriptional O +
regulatory O +
proteins O +
CysB B-Gene +
and O +
Cbl B-Gene +
. O +

Synthesis O +
of O +
Cbl B-Gene +
itself O +
is O +
under O +
control O +
of O +
the O +
CysB B-Gene +
protein O +
, O +
and O +
the O +
CysB B-Gene +
protein O +
may O +
therefore O +
be O +
regarded O +
as O +
the O +
master O +
regulator O +
for O +
sulfur O +
assimilation O +
in O +
E. O +
coli O +
, O +
while O +
the O +
Cbl B-Gene +
protein O +
functions O +
as O +
an O +
accessory O +
element O +
specific O +
for O +
utilization O +
of O +
sulfur O +
from O +
organosulfur O +
sources O +
. O +

A O +
Ca O -
( O -
2 O -
+ O -
) O +
- O +
activated O +
NADPH B-Gene +
oxidase I-Gene +
in O +
testis O +
, O +
spleen O +
, O +
and O +
lymph O +
nodes O +
. O +

Superoxide O +
and O +
its O +
derivatives O +
are O +
increasingly O +
implicated O +
in O +
the O +
regulation O +
of O +
physiological O +
functions O +
from O +
oxygen O +
sensing O +
and O +
blood O +
pressure O +
regulation O +
to O +
lymphocyte O +
activation O +
and O +
sperm O +
- O +
oocyte O +
fusion O +
. O +

Here O +
we O +
describe O +
a O +
novel O +
superoxide O +
- O +
generating O +
NADPH B-Gene +
oxidase I-Gene +
referred O +
to O +
as O +
NADPH B-Gene +
oxidase I-Gene +
5 I-Gene +
( O +
NOX5 B-Gene +
) O +
. O +

NOX5 B-Gene +
is O +
distantly O +
related O +
to O +
the O +
gp91 B-Gene +
( I-Gene +
phox I-Gene +
) I-Gene +
subunit O +
of O +
the O +
phagocyte O +
NADPH B-Gene +
oxidase I-Gene +
with O +
conserved O +
regions O +
crucial O +
for O +
the O +
electron O +
transport O +
( O +
NADPH O +
, O +
FAD O +
and O +
heme O +
binding O +
sites O +
) O +
. O +

However O +
, O +
NOX5 B-Gene +
has O +
a O +
unique O +
N O +
- O +
terminal O +
extension O +
that O +
contains O +
three O +
EF O +
hand O +
motifs O +
. O +

The O +
mRNA O +
of O +
NOX5 B-Gene +
is O +
expressed O +
in O +
pachytene O +
spermatocytes O +
of O +
testis O +
and O +
in O +
B O +
- O +
and O +
T O +
- O +
lymphocyte O +
- O +
rich O +
areas O +
of O +
spleen O +
and O +
lymph O +
nodes O +
. O +

When O +
heterologously O +
expressed O +
, O +
NOX5 B-Gene +
was O +
quiescent O +
in O +
unstimulated O +
cells O +
. O +

However O +
, O +
in O +
response O +
to O +
elevations O +
of O +
the O +
cytosolic O +
Ca O -
( O -
2 O -
+ O -
) O +
concentration O +
it O +
generated O +
large O +
amounts O +
of O +
superoxide O +
. O +

Upon O +
Ca O -
( O -
2 O -
+ O -
) O +
activation O +
, O +
NOX5 B-Gene +
also O +
displayed O +
a O +
second O +
function O +
: O +
it O +
became O +
a O +
proton O +
channel O +
, O +
presumably O +
to O +
compensate O +
charge O +
and O +
pH O +
alterations O +
due O +
to O +
electron O +
export O +
. O +

In O +
summary O +
, O +
we O +
have O +
identified O +
a O +
novel O +
NADPH B-Gene +
oxidase I-Gene +
that O +
generates O +
superoxide O +
and O +
functions O +
as O +
a O +
H B-Gene -
( I-Gene -
+ I-Gene -
) I-Gene +
channel I-Gene +
in O +
a O +
Ca O -
( O -
2 O -
+ O -
) O +
- O +
dependent O +
manner O +
. O +

NOX5 B-Gene +
is O +
likely O +
to O +
be O +
involved O +
in O +
Ca O -
( O -
2+ O -
) O -
-activated O +
, O +
redox O +
- O +
dependent O +
processes O +
of O +
spermatozoa O +
and O +
lymphocytes O +
such O +
as O +
sperm O +
- O +
oocyte O +
fusion O +
, O +
cell O +
proliferation O +
, O +
and O +
cytokine B-Gene +
secretion O +
. O +

Transcriptional O +
regulation O +
of O +
the O +
two O +
sterol O +
esterification O +
genes O +
in O +
the O +
yeast O +
Saccharomyces O +
cerevisiae O +
. O +

Saccharomyces O +
cerevisiae O +
transcribes O +
two O +
genes O +
, O +
ARE1 B-Gene +
and O +
ARE2 B-Gene +
, O +
that O +
contribute O +
disproportionately O +
to O +
the O +
esterification O +
of O +
sterols O +
. O +

Are2p B-Gene +
is O +
the O +
major O +
enzyme O +
isoform O +
in O +
a O +
wild O +
- O +
type O +
cell O +
growing O +
aerobically O +
. O +

This O +
likely O +
results O +
from O +
a O +
combination O +
of O +
differential O +
transcription O +
initiation O +
and O +
transcript O +
stability O +
. O +

By O +
using O +
ARE1 B-Gene +
and O +
ARE2 B-Gene +
promoter O +
fusions O +
to O +
lacZ B-Gene +
reporters O +
, O +
we O +
demonstrated O +
that O +
transcriptional O +
initiation O +
from O +
the O +
ARE1 B-Gene +
promoter O +
is O +
significantly O +
reduced O +
compared O +
to O +
that O +
from O +
the O +
ARE2 B-Gene +
promoter O +
. O +

Furthermore O +
, O +
the O +
half O +
- O +
life O +
of O +
the O +
ARE2 B-Gene +
mRNA O +
is O +
approximately O +
12 O +
times O +
as O +
long O +
as O +
that O +
of O +
the O +
ARE1 B-Gene +
transcript O +
. O +

We O +
present O +
evidence O +
that O +
the O +
primary O +
role O +
of O +
the O +
minor O +
sterol O +
esterification O +
isoform O +
encoded O +
by O +
ARE1 B-Gene +
is O +
to O +
esterify O +
sterol O +
intermediates O +
, O +
whereas O +
the O +
role O +
of O +
the O +
ARE2 B-Gene +
enzyme O +
is O +
to O +
esterify O +
ergosterol O +
, O +
the O +
end O +
product O +
of O +
the O +
pathway O +
. O +

Accordingly O +
, O +
the O +
ARE1 B-Gene +
promoter O +
is O +
upregulated O +
in O +
strains O +
that O +
accumulate O +
ergosterol O +
precursors O +
. O +

Furthermore O +
, O +
ARE1 B-Gene +
and O +
ARE2 B-Gene +
are O +
oppositely O +
regulated O +
by O +
heme O +
. O +

Under O +
heme O +
- O +
deficient O +
growth O +
conditions O +
, O +
ARE1 B-Gene +
was O +
upregulated O +
fivefold O +
while O +
ARE2 B-Gene +
was O +
down O +
- O +
regulated O +
. O +

ARE2 B-Gene +
requires O +
the O +
HAP1 B-Gene +
transcription B-Gene +
factor I-Gene +
for O +
optimal O +
expression O +
, O +
and O +
both O +
ARE B-Gene +
genes O +
are O +
derepressed O +
in O +
a O +
rox1 B-Gene +
( O +
repressor B-Gene +
of I-Gene +
oxygen I-Gene +
) O +
mutant O +
genetic O +
background O +
. O +

We O +
further O +
report O +
that O +
the O +
ARE B-Gene +
genes O +
are O +
not O +
subject O +
to O +
end O +
product O +
inhibition O +
; O +
neither O +
ARE1 B-Gene +
nor O +
ARE2 B-Gene +
transcription O +
is O +
altered O +
in O +
an O +
are O +
mutant O +
background O +
, O +
nor O +
does O +
overexpression O +
of O +
either O +
ARE B-Gene +
gene O +
alter O +
the O +
response O +
of O +
the O +
ARE B-Gene +
- O +
lacZ B-Gene +
reporter O +
constructs O +
. O +

Our O +
observations O +
are O +
consistent O +
with O +
an O +
important O +
physiological O +
role O +
for O +
Are1p B-Gene +
during O +
anaerobic O +
growth O +
when O +
heme O +
is O +
limiting O +
and O +
sterol O +
precursors O +
may O +
accumulate O +
. O +

Conversely O +
, O +
Are2p B-Gene +
is O +
optimally O +
required O +
during O +
aerobiosis O +
when O +
ergosterol O +
is O +
plentiful O +
. O +

Peptide O +
insertions O +
in O +
domain O +
4 O +
of O +
hbeta B-Gene -
( I-Gene -
c I-Gene -
) I-Gene +
, O +
the O +
shared O +
signalling O +
receptor O +
subunit O +
for O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
, O +
IL3 B-Gene +
and O +
IL5 B-Gene +
, O +
induce O +
ligand O +
- O +
independent O +
activation O +
. O +

A O +
mutant O +
form O +
of O +
the O +
common B-Gene +
beta I-Gene +
- I-Gene +
subunit I-Gene +
of I-Gene +
the I-Gene +
GM I-Gene -
- I-Gene -
CSF I-Gene +
, I-Gene +
interleukin-3 I-Gene +
( I-Gene +
IL3 I-Gene +
) I-Gene +
and I-Gene +
IL5 I-Gene +
receptors I-Gene +
is O +
activated O +
by O +
a O +
37 O +
residue O +
duplicated O +
segment O +
which O +
includes O +
the O +
WSXWS O +
motif O +
and O +
an O +
adjacent O +
, O +
highly O +
conserved O +
, O +
aliphatic O +
/ O +
basic O +
element O +
. O +

Haemopoietic O +
expression O +
of O +
this O +
mutant O +
, O +
hbeta B-Gene -
( I-Gene -
c I-Gene -
) I-Gene +
FIDelta O +
, O +
in O +
mice O +
leads O +
to O +
myeloproliferative O +
disease O +
. O +

To O +
examine O +
the O +
mechanism O +
of O +
activation O +
of O +
this O +
mutant O +
we O +
targetted O +
the O +
two O +
conserved O +
motifs O +
in O +
each O +
repeat O +
for O +
mutagenesis O +
. O +

Here O +
we O +
show O +
that O +
this O +
mutant O +
exhibits O +
constitutive O +
activity O +
in O +
BaF O -
- O -
B03 O +
cells O +
in O +
the O +
presence O +
of O +
mouse O +
or O +
human O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
receptor I-Gene +
alpha I-Gene +
- O +
subunit O +
( O +
GMRalpha B-Gene +
) O +
and O +
this O +
activity O +
is O +
disrupted O +
by O +
mutations O +
of O +
the O +
conserved O +
motifs O +
in O +
the O +
first O +
repeat O +
. O +

In O +
the O +
presence O +
of O +
these O +
mutations O +
the O +
receptor O +
reverts O +
to O +
an O +
alternative O +
conformation O +
which O +
retains O +
responsiveness O +
to O +
human O +
IL3 B-Gene +
in O +
a O +
CTLL O +
cell O +
line O +
co O +
- O +
expressing O +
the O +
human O +
IL3 B-Gene +
receptor I-Gene +
alpha I-Gene +
- O +
subunit O +
( O +
hIL3Ralpha B-Gene +
) O +
. O +

Remarkably O +
, O +
the O +
activated O +
conformation O +
is O +
maintained O +
in O +
the O +
presence O +
of O +
substitutions O +
, O +
deletions O +
or O +
replacement O +
of O +
the O +
second O +
repeat O +
. O +

This O +
suggests O +
that O +
activation O +
occurs O +
due O +
to O +
insertion O +
of O +
extra O +
sequence O +
after O +
the O +
WSXWS O +
motif O +
and O +
is O +
not O +
dependent O +
on O +
the O +
length O +
or O +
specific O +
sequence O +
of O +
the O +
insertion O +
. O +

Thus O +
hbeta B-Gene -
( I-Gene -
c I-Gene -
) I-Gene +
displays O +
an O +
ability O +
to O +
fold O +
into O +
functional O +
receptor O +
conformations O +
given O +
insertion O +
of O +
up O +
to O +
37 O +
residues O +
in O +
the O +
membrane O +
- O +
proximal O +
region O +
. O +

Constitutive O +
activation O +
most O +
likely O +
results O +
from O +
a O +
specific O +
conformational O +
change O +
which O +
alters O +
a O +
dormant O +
, O +
inactive O +
receptor O +
complex O +
, O +
permitting O +
functional O +
association O +
with O +
GMRalpha B-Gene +
and O +
ligand O +
- O +
independent O +
mitogenic O +
signalling O +
. O +

Evidence O +
for O +
a O +
novel O +
thrombopoietin B-Gene +
signalling O +
event O +
: O +
activation O +
of O +
protein B-Gene +
kinase I-Gene +
A I-Gene +
in O +
human O +
megakaryoblastic O +
CMK O +
cells O +
. O +

Thrombopoietin B-Gene +
( O +
TPO B-Gene +
) O +
plays O +
a O +
crucial O +
role O +
in O +
megakaryocyte O +
development O +
. O +

TPO B-Gene +
signalling O +
, O +
which O +
is O +
mediated O +
by O +
its O +
receptor O +
Mpl B-Gene +
, O +
includes O +
Janus B-Gene +
kinase I-Gene +
, O +
( O +
JAK B-Gene +
) O +
signal B-Gene +
transducer I-Gene +
and I-Gene +
activator I-Gene +
of I-Gene +
transcription I-Gene +
( O +
STAT B-Gene +
) O +
and O +
Shc B-Gene +
/ O +
Ras B-Gene +
/ O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
( O +
MAPK B-Gene +
) O +
pathways O +
. O +

The O +
precise O +
nature O +
of O +
these O +
signalling O +
routes O +
has O +
not O +
been O +
clarified O +
in O +
detail O +
up O +
until O +
now O +
. O +

We O +
investigated O +
the O +
effect O +
of O +
TPO B-Gene +
on O +
activation O +
of O +
cAMP B-Gene +
- I-Gene +
dependent I-Gene +
protein I-Gene +
kinase I-Gene +
( O +
PKA B-Gene +
) O +
and O +
its O +
involvement O +
in O +
MAPK B-Gene +
signalling O +
in O +
human O +
megakaryoblastic O +
leukaemia O +
CMK O +
cells O +
. O +

For O +
estimation O +
of O +
PKA B-Gene +
activity O +
, O +
phosphorylation O +
of O +
a O +
PKA B-Gene +
- O +
specific O +
peptide O +
substrate O +
was O +
assayed O +
in O +
CMK O +
cell O +
lysates O +
. O +

Since O +
activation O +
of O +
PKA B-Gene +
is O +
associated O +
with O +
translocation O +
of O +
its O +
catalytic O +
subunit O +
alpha O +
( O +
C O +
- O +
PKA B-Gene +
) O +
into O +
the O +
cell O +
nucleus O +
, O +
Western O +
blot O +
analysis O +
of O +
nuclear O +
fractions O +
with O +
an O +
anti O +
- O +
C O +
- O +
PKA B-Gene +
antibody O +
was O +
additionally O +
performed O +
. O +

The O +
activation O +
of O +
TPO B-Gene +
- O +
induced O +
MAPK B-Gene +
activation O +
and O +
the O +
effect O +
of O +
the O +
PKA B-Gene +
inhibitor O +
H-89 O +
was O +
measured O +
using O +
immunoblotting O +
with O +
a O +
monoclonal O +
anti O +
- O +
pERK B-Gene +
antibody O +
. O +

TPO B-Gene +
enhanced O +
cAMP O +
and O +
induced O +
activation O +
of O +
PKA B-Gene +
in O +
CMK O +
cells O +
. O +

In O +
addition O +
, O +
H-89 O +
partly O +
blocked O +
TPO B-Gene +
- O +
induced O +
MAPK B-Gene +
activation O +
in O +
CMK O +
cells O +
. O +

Our O +
results O +
indicate O +
a O +
novel O +
TPO B-Gene +
- O +
triggered O +
signalling O +
event O +
, O +
activation O +
of O +
the O +
cAMP O +
/ O +
PKA B-Gene +
pathway O +
in O +
human O +
megakaryoblastic O +
CMK O +
cells O +
. O +

This O +
signal O +
transduction O +
route O +
seems O +
to O +
be O +
involved O +
in O +
TPO B-Gene +
- O +
induced O +
MAPK B-Gene +
signaling O +
. O +

Genomic O +
organization O +
and O +
promoter O +
analysis O +
of O +
human O +
KCNN3 B-Gene +
gene O +
. O +

KCNN3 B-Gene +
is O +
a O +
member O +
of O +
the O +
gene O +
family O +
, O +
KCNN1 B-Gene -
- I-Gene -
4 I-Gene +
, O +
encoding O +
the O +
small O +
and O +
intermediate O +
conductance O +
calcium O +
- O +
activated O +
potassium O +
channels O +
. O +

Long O +
CAG O -
- O -
repeat O +
alleles O +
of O +
this O +
gene O +
have O +
been O +
found O +
to O +
be O +
over O +
- O +
represented O +
in O +
patients O +
with O +
schizophrenia O +
in O +
a O +
number O +
of O +
population O +
- O +
based O +
association O +
studies O +
, O +
and O +
this O +
gene O +
maps O +
to O +
human O +
chromosome O +
1q21 O +
, O +
a O +
region O +
recently O +
implicated O +
in O +
schizophrenia O +
by O +
linkage O +
. O +

To O +
set O +
the O +
stage O +
for O +
a O +
further O +
functional O +
evaluation O +
of O +
KCNN3 B-Gene +
, O +
we O +
defined O +
the O +
nature O +
of O +
the O +
genomic O +
locus O +
in O +
the O +
size O +
, O +
structure O +
, O +
and O +
sequence O +
of O +
its O +
introns O +
and O +
exons O +
and O +
the O +
function O +
of O +
potential O +
upstream O +
regulatory O +
regions O +
. O +

We O +
isolated O +
P1 O +
- O +
derived O +
artificial O +
chromosome O +
( O +
PAC O +
) O +
clones O +
from O +
a O +
genomic O +
library O +
and O +
identified O +
an O +
overlapping O +
available O +
bacterial O +
artificial O +
chromosome O +
( O +
BAC O +
) O +
clone O +
. O +

Cosmids O +
subcloned O +
from O +
the O +
PAC O +
and O +
BAC O +
clones O +
were O +
then O +
sequenced O +
and O +
merged O +
with O +
the O +
sequence O +
in O +
the O +
public O +
database O +
. O +

The O +
KCNN3 B-Gene +
gene O +
spans O +
over O +
163.1 O +
kb O +
and O +
is O +
composed O +
of O +
eight O +
exons O +
and O +
seven O +
introns O +
. O +

All O +
of O +
the O +
exon O +
- O +
intron O +
junctions O +
conform O +
closely O +
to O +
consensus O +
splice O +
sites O +
. O +

The O +
proximal O +
2.5 O +
kb O +
of O +
the O +
5 O -
' O +
- O +
flanking O +
sequence O +
was O +
obtained O +
and O +
analyzed O +
for O +
potential O +
transcription B-Gene +
factor I-Gene +
binding O +
sites O +
. O +

In O +
the O +
proximal O +
2.5 O +
kb O +
upstream O +
region O +
, O +
potential O +
sites O +
for O +
the O +
Ikaros B-Gene +
factor I-Gene +
( O +
IK2 B-Gene +
) O +
, O +
homeodomain O +
factor O +
Nkx-2.5 B-Gene +
/ O +
Csx B-Gene +
( O +
NKX25 B-Gene +
) O +
, O +
nuclear B-Gene +
factor I-Gene +
of I-Gene +
activated I-Gene +
T I-Gene -
- I-Gene -
cells I-Gene +
( O +
NFAT B-Gene +
) O +
, O +
upstream B-Gene +
stimulating I-Gene +
factor I-Gene +
( O +
USF B-Gene +
) O +
, O +
c B-Gene -
- I-Gene -
AMP I-Gene +
responsive I-Gene +
element I-Gene +
binding I-Gene +
protein I-Gene +
( O +
CREB B-Gene +
) O +
, O +
POU O +
factor O +
Brn2 B-Gene +
( O +
BRN-2 B-Gene +
) O +
, O +
myeloid B-Gene +
zinc I-Gene +
finger I-Gene +
protein I-Gene +
( O +
MZF1 B-Gene +
) O +
, O +
vitellogenin B-Gene +
binding I-Gene +
protein I-Gene +
( O +
VBP B-Gene +
) O +
, O +
HNF3 B-Gene +
forkhead I-Gene +
homologue I-Gene +
2 I-Gene +
( O +
HFH2 B-Gene +
) O +
, O +
and O +
transcription O +
initiation O +
were O +
identified O +
, O +
as O +
well O +
as O +
several O +
potential O +
AP-1 B-Gene +
and O +
AP-4 B-Gene +
sites O +
. O +

Finally O +
, O +
a O +
2261 O +
- O +
bp O +
fragment O +
of O +
this O +
upstream O +
region O +
was O +
cloned O +
into O +
a O +
promoterless O +
pGL3 O +
- O +
luciferase B-Gene +
vector O +
, O +
where O +
it O +
produced O +
orientation O +
- O +
dependent O +
expression O +
of O +
the O +
reporter O +
gene O +
in O +
transiently O +
transfected O +
PC12 O +
cells O +
, O +
cells O +
which O +
natively O +
express O +
functional O +
KCNN3 B-Gene +
channels O +
, O +
suggesting O +
that O +
this O +
cloned O +
fragment O +
includes O +
competent O +
promoter O +
elements O +
of O +
this O +
gene O +
. O +

Inhibition O +
of O +
natural O +
killer O +
cell O +
activation O +
signals O +
by O +
killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
CD158 B-Gene +
) O +
. O +

The O +
killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( I-Gene +
KIR I-Gene +
) I-Gene +
family I-Gene +
includes O +
receptors O +
that O +
bind O +
to O +
HLA B-Gene +
class I-Gene +
I I-Gene +
molecules O +
on O +
target O +
cells O +
and O +
inhibit O +
natural O +
killer O +
( O +
NK O +
) O +
- O +
cell O +
cytotoxicity O +
, O +
and O +
receptors O +
such O +
as O +
KIR3DL7 B-Gene +
with O +
no O +
known O +
ligand O +
and O +
function O +
. O +

Inhibitory O +
KIR B-Gene +
recruit O +
the O +
tyrosine B-Gene +
phosphatase I-Gene +
SHP-1 B-Gene +
to O +
block O +
signals O +
transduced O +
by O +
any O +
one O +
of O +
a O +
number O +
of O +
activation O +
receptors O +
. O +

Inhibition O +
of O +
overall O +
protein O +
tyrosine O +
phosphorylation O +
by O +
SHP-1 B-Gene +
during O +
binding O +
of O +
KIR B-Gene +
to O +
MHC B-Gene +
class I-Gene +
I I-Gene +
on O +
target O +
cells O +
is O +
selective O +
, O +
suggesting O +
that O +
a O +
limited O +
number O +
of O +
substrates O +
are O +
dephosphorylated O +
by O +
SHP-1 B-Gene +
. O +

We O +
have O +
chosen O +
to O +
study O +
KIR B-Gene +
inhibition O +
as O +
it O +
occurs O +
during O +
binding O +
of O +
KIR B-Gene +
to O +
MHC B-Gene +
class I-Gene +
I I-Gene +
on O +
target O +
cells O +
, O +
despite O +
the O +
technical O +
limitations O +
inherent O +
to O +
studies O +
of O +
processes O +
regulated O +
by O +
cell O +
contact O +
. O +

KIR O +
binding O +
to O +
MHC B-Gene +
class I-Gene +
I I-Gene +
on O +
target O +
cells O +
inhibits O +
tyrosine O +
phosphorylation O +
of O +
the O +
activation O +
receptor O +
2B4 B-Gene +
( O +
CD244 B-Gene +
) O +
and O +
disrupts O +
adhesion O +
of O +
NK O +
cells O +
to O +
target O +
cells O +
. O +

Inhibition O +
of O +
proximal O +
events O +
in O +
NK O +
activation O +
may O +
increase O +
the O +
availability O +
of O +
NK O +
cells O +
by O +
liberating O +
them O +
from O +
non O +
- O +
productive O +
interactions O +
with O +
resistant O +
target O +
cells O +
. O +

As O +
the O +
receptors O +
and O +
the O +
signaling O +
pathways O +
that O +
induce O +
NK O +
cytotoxicity O +
are O +
not O +
fully O +
characterized O +
, O +
elucidation O +
of O +
the O +
inhibitory O +
mechanism O +
employed O +
by O +
KIR B-Gene +
may O +
provide O +
insight O +
into O +
NK O +
activation O +
. O +

Two O +
similar O +
gene O +
clusters O +
coding O +
for O +
enzymes O +
of O +
a O +
new O +
type O +
of O +
aerobic O +
2-aminobenzoate O +
( O +
anthranilate O +
) O +
metabolism O +
in O +
the O +
bacterium O +
Azoarcus O +
evansii O +
. O +

In O +
the O +
beta O -
- O -
proteobacterium O +
Azoarcus O +
evansii O +
, O +
the O +
aerobic O +
metabolism O +
of O +
2-aminobenzoate O +
( O +
anthranilate O +
) O +
, O +
phenylacetate O +
, O +
and O +
benzoate O +
proceeds O +
via O +
three O +
unprecedented O +
pathways O +
. O +

The O +
pathways O +
have O +
in O +
common O +
that O +
all O +
three O +
substrates O +
are O +
initially O +
activated O +
to O +
coenzyme O +
A O +
( O +
CoA O +
) O +
thioesters O +
and O +
further O +
processed O +
in O +
this O +
form O +
. O +

The O +
two O +
initial O +
steps O +
of O +
2-aminobenzoate O +
metabolism O +
are O +
catalyzed O +
by O +
a O +
2-aminobenzoate B-Gene -
- I-Gene -
CoA I-Gene +
ligase I-Gene +
forming O +
2-aminobenzoyl O -
- O -
CoA O +
and O +
by O +
a O +
2-aminobenzoyl B-Gene -
- I-Gene -
CoA I-Gene +
monooxygenase I-Gene +
/ I-Gene +
reductase I-Gene +
( O +
ACMR B-Gene +
) O +
forming O +
2-amino-5-oxo O -
- O -
cyclohex-1-ene-1-carbonyl O -
- O -
CoA O +
. O +

Eight O +
genes O +
possibly O +
involved O +
in O +
this O +
pathway O +
, O +
including O +
the O +
genes O +
encoding O +
2-aminobenzoate B-Gene -
- I-Gene -
CoA I-Gene +
ligase I-Gene +
and O +
ACMR B-Gene +
, O +
were O +
detected O +
, O +
cloned O +
, O +
and O +
sequenced O +
. O +

The O +
sequence O +
of O +
the O +
ACMR B-Gene +
gene O +
showed O +
that O +
this O +
enzyme O +
is O +
an O +
87 O +
- O +
kDa O +
fusion O +
protein O +
of O +
two O +
flavoproteins O +
, O +
a O +
monooxygenase B-Gene +
( O +
similar O +
to O +
salicylate B-Gene +
monooxygenase I-Gene +
) O +
and O +
a O +
reductase B-Gene +
( O +
similar O +
to O +
old B-Gene +
yellow I-Gene +
enzyme I-Gene +
) O +
. O +

Besides O +
the O +
genes O +
for O +
the O +
initial O +
two O +
enzymes O +
, O +
genes O +
for O +
three O +
enzymes O +
of O +
a O +
beta O -
- O -
oxidation O +
pathway O +
were O +
found O +
. O +

A O +
substrate O +
binding O +
protein O +
of O +
an O +
ABC O +
transport O +
system O +
, O +
a O +
MarR B-Gene +
- O +
like O +
regulator O +
, O +
and O +
a O +
putative O +
translation O +
inhibitor O +
protein O +
were O +
also O +
encoded O +
by O +
the O +
gene O +
cluster O +
. O +

The O +
data O +
suggest O +
that O +
, O +
after O +
monooxygenation O +
/ O +
reduction O +
of O +
2-aminobenzoyl O -
- O -
CoA O +
, O +
the O +
nonaromatic O +
CoA O +
thioester O +
intermediate O +
is O +
metabolized O +
further O +
by O +
beta O -
- O -
oxidation O +
. O +

This O +
implies O +
that O +
all O +
subsequent O +
intermediates O +
are O +
CoA O +
thioesters O +
and O +
that O +
the O +
alicyclic O +
carbon O +
ring O +
is O +
not O +
cleaved O +
oxygenolytically O +
. O +

Surprisingly O +
, O +
the O +
cluster O +
of O +
eight O +
genes O +
, O +
which O +
form O +
an O +
operon O +
, O +
is O +
duplicated O +
. O +

The O +
two O +
copies O +
differ O +
only O +
marginally O +
within O +
the O +
coding O +
regions O +
but O +
differ O +
substantially O +
in O +
the O +
respective O +
intergenic O +
regions O +
. O +

Both O +
copies O +
of O +
the O +
genes O +
are O +
coordinately O +
expressed O +
in O +
cells O +
grown O +
aerobically O +
on O +
2-aminobenzoate O +
. O +

Sac1 B-Gene +
lipid B-Gene +
phosphatase I-Gene +
and O +
Stt4 B-Gene +
phosphatidylinositol B-Gene +
4-kinase I-Gene +
regulate O +
a O +
pool O +
of O +
phosphatidylinositol O +
4-phosphate O +
that O +
functions O +
in O +
the O +
control O +
of O +
the O +
actin B-Gene +
cytoskeleton O +
and O +
vacuole O +
morphology O +
. O +

Synthesis O +
and O +
turnover O +
of O +
phosphoinositides O +
are O +
tightly O +
regulated O +
processes O +
mediated O +
by O +
a O +
set O +
of O +
recently O +
identified O +
kinases B-Gene +
and O +
phosphatases B-Gene +
. O +

We O +
analyzed O +
the O +
primary O +
role O +
of O +
the O +
phosphoinositide B-Gene +
phosphatase I-Gene +
Sac1p B-Gene +
in O +
Saccharomyces O +
cerevisiae O +
with O +
the O +
use O +
of O +
a O +
temperature O +
- O +
sensitive O +
allele O +
of O +
this O +
gene O +
. O +

Our O +
analysis O +
demonstrates O +
that O +
inactivation O +
of O +
Sac1p B-Gene +
leads O +
to O +
a O +
specific O +
increase O +
in O +
the O +
cellular O +
levels O +
of O +
phosphatidylinositol O +
4-phosphate O +
( O +
PtdIns O -
( O -
4 O -
) O -
P O +
) O +
, O +
accompanied O +
by O +
changes O +
in O +
vacuole O +
morphology O +
and O +
an O +
accumulation O +
of O +
lipid O +
droplets O +
. O +

We O +
have O +
found O +
that O +
the O +
majority O +
of O +
Sac1p B-Gene +
localizes O +
to O +
the O +
endoplasmic O +
reticulum O +
, O +
and O +
this O +
localization O +
is O +
crucial O +
for O +
the O +
efficient O +
turnover O +
of O +
PtdIns O -
( O -
4 O -
) O -
P O +
. O +

By O +
generating O +
double O +
mutant O +
strains O +
harboring O +
the O +
sac1 B-Gene +
( O +
ts O +
) O +
allele O +
and O +
one O +
of O +
two O +
temperature O +
- O +
sensitive O +
PtdIns B-Gene +
4-kinase I-Gene +
genes O +
, O +
stt4 B-Gene +
( O -
ts O -
) O +
or O +
pik1 B-Gene +
( O +
ts O +
) O +
, O +
we O +
have O +
demonstrated O +
that O +
the O +
bulk O +
of O +
PtdIns O -
( O -
4 O -
) O -
P O +
that O +
accumulates O +
in O +
sac1 B-Gene +
mutant O +
cells O +
is O +
generated O +
by O +
the O +
Stt4 B-Gene +
PtdIns B-Gene +
4-kinase I-Gene +
, O +
and O +
not O +
Pik1p B-Gene +
. O +

Consistent O +
with O +
these O +
findings O +
, O +
inactivation O +
of O +
Sac1p B-Gene +
partially O +
rescued O +
defects O +
associated O +
with O +
stt4 B-Gene +
( O +
ts O +
) O +
but O +
not O +
pik1 B-Gene +
( O +
ts O +
) O +
mutant O +
cells O +
. O +

To O +
analyze O +
potential O +
overlapping O +
functions O +
between O +
Sac1p B-Gene +
and O +
other O +
homologous O +
phosphoinositide B-Gene +
phosphatases I-Gene +
, O +
sac1 B-Gene +
( O +
ts O +
) O +
mutant O +
cells O +
lacking O +
various O +
other O +
synaptojanin B-Gene +
- O +
like O +
phosphatases B-Gene +
were O +
generated O +
. O +

These O +
double O +
and O +
triple O +
mutants O +
exacerbated O +
the O +
accumulation O +
of O +
intracellular O +
phosphoinositides O +
and O +
caused O +
defects O +
in O +
Golgi O +
function O +
. O +

Together O +
, O +
our O +
results O +
demonstrate O +
that O +
Sac1p B-Gene +
primarily O +
turns O +
over O +
Stt4p B-Gene +
- O +
generated O +
PtdIns O -
( O -
4 O -
) O -
P O +
and O +
that O +
the O +
membrane O +
localization O +
of O +
Sac1p B-Gene +
is O +
important O +
for O +
its O +
function O +
in O +
vivo O +
. O +

Regulation O +
of O +
this O +
PtdIns O -
( O -
4 O -
) O -
P O +
pool O +
appears O +
to O +
be O +
crucial O +
for O +
the O +
maintenance O +
of O +
vacuole O +
morphology O +
, O +
regulation O +
of O +
lipid O +
storage O +
, O +
Golgi O +
function O +
, O +
and O +
actin B-Gene +
cytoskeleton O +
organization O +
. O +

The O +
ASK1 B-Gene +
gene O +
regulates O +
B O +
function O +
gene O +
expression O +
in O +
cooperation O +
with O +
UFO B-Gene +
and O +
LEAFY B-Gene +
in O +
Arabidopsis O +
. O +

The O +
Arabidopsis O +
floral O +
regulatory O +
genes O +
APETALA3 B-Gene +
( O +
AP3 B-Gene +
) O +
and O +
PISTILLATA B-Gene +
( O +
PI B-Gene +
) O +
are O +
required O +
for O +
the O +
B O +
function O +
according O +
to O +
the O +
ABC O +
model O +
for O +
floral O +
organ O +
identity O +
. O +

AP3 B-Gene +
and O +
PI B-Gene +
expression O +
are O +
positively O +
regulated O +
by O +
the O +
LEAFY B-Gene +
( O +
LFY B-Gene +
) O +
and O +
UNUSUAL B-Gene +
FLORAL I-Gene +
ORGANS I-Gene +
( O +
UFO B-Gene +
) O +
genes O +
. O +

UFO B-Gene +
encodes O +
an O +
F O -
- O -
box O +
protein O +
, O +
and O +
we O +
have O +
shown O +
previously O +
that O +
UFO B-Gene +
genetically O +
interacts O +
with O +
the O +
ASK1 B-Gene +
gene O +
encoding O +
a O +
SKP1 B-Gene +
homologue O +
; O +
both O +
the O +
F O -
- O -
box O +
containing O +
protein O +
and O +
SKP1 B-Gene +
are O +
subunits O +
of O +
ubiquitin B-Gene +
ligases I-Gene +
. O +

We O +
show O +
here O +
that O +
the O +
ask1 B-Gene +
- O +
1 O +
mutation O +
can O +
enhance O +
the O +
floral O +
phenotypes O +
of O +
weak O +
lfy B-Gene +
and O +
ap3 B-Gene +
mutants O +
; O +
therefore O +
, O +
like O +
UFO B-Gene +
, O +
ASK1 B-Gene +
also O +
interacts O +
with O +
LFY B-Gene +
and O +
AP3 B-Gene +
genetically O +
. O +

Furthermore O +
, O +
our O +
results O +
from O +
RNA O +
in O +
situ O +
hybridizations O +
indicate O +
that O +
ASK1 B-Gene +
regulates O +
early O +
AP3 B-Gene +
and O +
PI B-Gene +
expression O +
. O +

These O +
results O +
support O +
the O +
idea O +
that O +
UFO B-Gene +
and O +
ASK1 B-Gene +
together O +
positively O +
regulate O +
AP3 B-Gene +
and O +
PI B-Gene +
expression O +
. O +

We O +
propose O +
that O +
the O +
UFO B-Gene +
and O +
ASK1 B-Gene +
proteins O +
are O +
components O +
of O +
a O +
ubiquitin B-Gene +
ligase I-Gene +
that O +
mediates O +
the O +
proteolysis O +
of O +
a O +
repressor O +
of O +
AP3 B-Gene +
and O +
PI B-Gene +
expression O +
. O +

Our O +
genetic O +
studies O +
also O +
indicate O +
that O +
ASK1 B-Gene +
and O +
UFO B-Gene +
play O +
a O +
role O +
in O +
regulating O +
the O +
number O +
of O +
floral O +
organ O +
primordia O +
, O +
and O +
we O +
discuss O +
possible O +
mechanisms O +
for O +
such O +
a O +
regulation O +
. O +

Structure O +
of O +
the O +
C O +
- O +
terminal O +
RNA O +
- O +
binding O +
domain O +
of O +
hnRNP B-Gene +
D0 I-Gene +
( O +
AUF1 B-Gene +
) O +
, O +
its O +
interactions O +
with O +
RNA O +
and O +
DNA O +
, O +
and O +
change O +
in O +
backbone O +
dynamics O +
upon O +
complex O +
formation O +
with O +
DNA O +
. O +

Heterogeneous B-Gene +
nuclear I-Gene +
ribonucleoprotein I-Gene +
( I-Gene +
hnRNP I-Gene +
) I-Gene +
D0 I-Gene +
has O +
two O +
ribonucleoprotein O +
( O +
RNP O +
) O +
- O +
type O +
RNA O +
- O +
binding O +
domains O +
( O +
RBDs O +
) O +
, O +
each O +
of O +
which O +
can O +
specifically O +
bind O +
to O +
the O +
UUAG O +
- O +
sequence O +
. O +

hnRNP B-Gene +
D0 I-Gene +
also O +
binds O +
specifically O +
to O +
single O +
- O +
stranded O +
d O -
( O -
TTAGGG O -
) O -
( O -
n O -
) O +
, O +
the O +
human O +
telomeric O +
DNA O +
repeat O +
. O +

We O +
have O +
already O +
reported O +
the O +
structure O +
and O +
interactions O +
with O +
RNA O +
of O +
the O +
N O +
- O +
terminal O +
RBD O +
( O +
RBD1 O +
) O +
. O +

Here O +
, O +
the O +
structure O +
of O +
the O +
C O +
- O +
terminal O +
RBD O +
( O +
RBD2 O +
) O +
determined O +
by O +
NMR O +
is O +
presented O +
. O +

It O +
folds O +
into O +
a O +
compact O +
alpha O +
beta O +
structure O +
comprising O +
an O +
antiparallel O +
beta O -
- O -
sheet O +
packed O +
against O +
two O +
alpha O -
- O -
helices O +
, O +
which O +
is O +
characteristic O +
of O +
RNP O +
- O +
type O +
RBDs O +
. O +

In O +
addition O +
to O +
the O +
four O +
beta O -
- O -
strands O +
commonly O +
found O +
in O +
RNP O +
- O +
type O +
RBDs O +
, O +
an O +
extra O +
beta O -
- O -
strand O +
, O +
termed O +
beta O +
4 O +
( O +
- O +
) O +
, O +
was O +
found O +
just O +
before O +
the O +
fourth O +
beta O -
- O -
strand O +
, O +
yielding O +
a O +
five O +
- O +
stranded O +
beta O -
- O -
sheet O +
. O +

Candidate O +
residues O +
of O +
RBD2 O +
involved O +
in O +
the O +
interactions O +
with O +
RNA O +
were O +
identified O +
by O +
chemical O +
shift O +
perturbation O +
analysis O +
. O +

Perturbation O +
was O +
detected O +
on O +
the O +
beta O +
- O +
sheet O +
side O +
, O +
not O +
on O +
the O +
opposite O +
alpha O +
- O +
helix O +
side O +
, O +
as O +
observed O +
for O +
RBD1 O +
. O +

It O +
is O +
notable O +
that O +
the O +
beta O +
4 O -
( O -
- O -
) O +
to O +
beta O +
4 O +
region O +
of O +
RBD2 O +
is O +
involved O +
in O +
the O +
interactions O +
in O +
contrast O +
to O +
the O +
case O +
of O +
RBD1 O +
. O +

The O +
chemical O +
shift O +
perturbation O +
analysis O +
also O +
showed O +
that O +
RBD2 O +
interacts O +
with O +
DNA O +
in O +
essentially O +
the O +
same O +
way O +
as O +
with O +
RNA O +
. O +

Changes O +
in O +
the O +
backbone O +
dynamics O +
upon O +
complex O +
formation O +
with O +
DNA O +
were O +
examined O +
by O +
means O +
of O +
model O +
free O +
analysis O +
of O +
relaxation O +
data O +
. O +

In O +
free O +
RBD2 O +
, O +
the O +
beta O +
4 O -
( O -
- O -
) O +
to O +
beta O +
4 O +
region O +
exhibits O +
slow O +
conformational O +
exchange O +
on O +
the O +
milli O +
- O +
to O +
microsecond O +
time O +
scale O +
. O +

The O +
exchange O +
is O +
quenched O +
upon O +
complex O +
formation O +
. O +

The O +
flexibility O +
of O +
free O +
RBD2 O +
may O +
be O +
utilized O +
in O +
the O +
recognition O +
process O +
by O +
allowing O +
different O +
conformational O +
states O +
to O +
be O +
accessed O +
and O +
facilitating O +
induced O +
fit O +
. O +

Additionally O +
, O +
faster O +
flexibility O +
on O +
the O +
nano O +
- O +
to O +
picosecond O +
time O +
scale O +
was O +
observed O +
for O +
loop O +
3 O +
located O +
between O +
beta O +
2 O +
and O +
beta O +
3 O +
in O +
free O +
RBD2 O +
, O +
which O +
is O +
retained O +
by O +
the O +
complex O +
as O +
well O +
. O +

Ara6 B-Gene +
, O +
a O +
plant O +
- O +
unique O +
novel O +
type O +
Rab B-Gene +
GTPase I-Gene +
, O +
functions O +
in O +
the O +
endocytic O +
pathway O +
of O +
Arabidopsis O +
thaliana O +
. O +

Ara6 B-Gene +
of O +
Arabidopsis O +
thaliana O +
is O +
a O +
novel O +
member O +
of O +
the O +
Rab B-Gene +
/ I-Gene +
Ypt I-Gene +
GTPase I-Gene +
family I-Gene +
with O +
unique O +
structural O +
features O +
. O +

It O +
resembles O +
Rab5 B-Gene +
GTPases B-Gene +
best O +
, O +
but O +
lacks O +
a O +
large O +
part O +
of O +
the O +
C O +
- O +
terminal O +
hypervariable O +
region O +
and O +
the O +
cysteine O +
motif O +
, O +
and O +
instead O +
harbors O +
an O +
extra O +
stretch O +
of O +
amino O +
acid O +
residues O +
containing O +
myristoylation O +
and O +
palmitoylation O +
sites O +
at O +
the O +
N O -
- O -
terminus O +
. O +

Ara6 B-Gene +
is O +
tightly O +
associated O +
with O +
membranes O +
and O +
is O +
expressed O +
constitutively O +
. O +

In O +
contrast O +
, O +
the O +
conventional O +
Rab5 B-Gene +
ortholog O +
, O +
Ara7 B-Gene +
, O +
is O +
highly O +
expressed O +
only O +
in O +
actively O +
dividing O +
cells O +
. O +

Examination O +
of O +
green B-Gene +
fluorescent I-Gene +
protein I-Gene +
( O +
GFP B-Gene +
) O +
- O +
tagged O +
proteins O +
indicates O +
that O +
both O +
Ara6 B-Gene +
and O +
Ara7 B-Gene +
are O +
distributed O +
on O +
a O +
subpopulation O +
of O +
endosomes O +
and O +
suggests O +
their O +
roles O +
in O +
endosomal O +
fusion O +
. O +

The O +
endosomal O +
localization O +
of O +
Ara6 B-Gene +
requires O +
N O +
- O +
terminal O +
fatty O +
acylation O +
, O +
nucleotide O +
binding O +
and O +
the O +
C O +
- O +
terminal O +
amino O +
acid O +
sequence O +
coordinately O +
. O +

Proteins O +
similar O +
to O +
Ara6 B-Gene +
are O +
found O +
only O +
in O +
higher O +
plants O +
and O +
thus O +
represent O +
a O +
novel O +
class O +
of O +
Rab B-Gene +
GTPases I-Gene +
regulating O +
endocytic O +
function O +
in O +
a O +
plant O +
- O +
specific O +
manner O +
. O +

Endofin B-Gene +
, O +
an O +
endosomal O +
FYVE O +
domain O +
protein O +
. O +

KIAA0305 B-Gene +
is O +
an O +
uncharacterized O +
member O +
of O +
the O +
FYVE B-Gene +
domain I-Gene +
protein I-Gene +
family I-Gene +
. O +

It O +
is O +
closely O +
related O +
to O +
SARA B-Gene +
, O +
with O +
about O +
50 O +
% O +
identity O +
in O +
the O +
carboxyl O +
- O +
terminal O +
800 O +
- O +
amino O +
acid O +
region O +
. O +

Indirect O +
immunofluorescence O +
microscopy O +
using O +
polyclonal O +
antibodies O +
raised O +
against O +
KIAA0305 B-Gene +
revealed O +
that O +
it O +
is O +
enriched O +
in O +
early O +
endosomes O +
. O +

The O +
Myc B-Gene +
- O +
tagged O +
version O +
is O +
also O +
faithfully O +
targeted O +
to O +
the O +
early O +
endosome O +
. O +

We O +
have O +
tentatively O +
called O +
KIAA0305 B-Gene +
endofin B-Gene +
( O +
for O +
endosome B-Gene +
- I-Gene +
associated I-Gene +
FYVE I-Gene +
- I-Gene +
domain I-Gene +
protein I-Gene +
) O +
. O +

The O +
association O +
of O +
endofin B-Gene +
with O +
endosomes O +
is O +
mediated O +
by O +
its O +
FYVE O +
domain O +
because O +
deletion O +
mutants O +
lacking O +
the O +
central O +
FYVE O +
finger O +
motif O +
are O +
distributed O +
in O +
the O +
cytoplasm O +
. O +

In O +
addition O +
, O +
a O +
single O +
point O +
mutation O +
in O +
the O +
FYVE O +
finger O +
motif O +
at O +
cysteine O +
residue O +
753 O +
( O +
C753S O +
) O +
is O +
sufficient O +
to O +
abolish O +
its O +
endosomal O +
association O +
. O +

Its O +
endosomal O +
localization O +
is O +
also O +
sensitive O +
to O +
the O +
phosphatidylinositol B-Gene +
3-kinase I-Gene +
inhibitor O +
, O +
wortmannin O +
. O +

Using O +
in O +
vitro O +
liposome O +
binding O +
assays O +
, O +
we O +
demonstrate O +
that O +
Myc B-Gene +
- O +
tagged O +
endofin B-Gene +
associates O +
preferentially O +
with O +
phosphatidylinositol O +
3-phosphate O +
, O +
whereas O +
the O +
C753S O +
point O +
mutant O +
was O +
unable O +
to O +
do O +
so O +
. O +

We O +
also O +
show O +
that O +
endofin B-Gene +
co O +
- O +
localizes O +
with O +
SARA B-Gene +
but O +
that O +
they O +
are O +
not O +
associated O +
in O +
a O +
common O +
complex O +
because O +
they O +
failed O +
to O +
co O +
- O +
immunoprecipitate O +
in O +
co O +
- O +
expressing O +
cells O +
. O +

Endofin B-Gene +
also O +
does O +
not O +
associate O +
with O +
Smad2 B-Gene +
nor O +
behave O +
like O +
SARA B-Gene +
in O +
affecting O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
beta I-Gene +
signaling O +
. O +

At O +
high O +
levels O +
of O +
expression O +
, O +
both O +
endofin B-Gene +
and O +
SARA B-Gene +
can O +
cause O +
an O +
endosome O +
aggregation O +
/ O +
fusion O +
effect O +
. O +

In O +
COS7 O +
cells O +
, O +
which O +
can O +
support O +
high O +
levels O +
of O +
exogenous O +
protein O +
expression O +
, O +
both O +
proteins O +
can O +
also O +
cause O +
other O +
structural O +
anomalies O +
in O +
the O +
endocytic O +
pathway O +
, O +
as O +
represented O +
by O +
enlarged O +
vesicular O +
structures O +
. O +

These O +
endosomal O +
aggregates O +
/ O +
fusions O +
accumulated O +
endocytosed O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
. O +

Taken O +
together O +
, O +
this O +
report O +
provides O +
evidence O +
to O +
suggest O +
that O +
endofin B-Gene +
and O +
the O +
highly O +
related O +
SARA B-Gene +
are O +
endosomal O +
proteins O +
with O +
potential O +
roles O +
in O +
regulating O +
membrane O +
traffic O +
. O +

Protease B-Gene +
inhibitors O +
as O +
potential O +
antiviral O +
agents O +
for O +
the O +
treatment O +
of O +
picornaviral O +
infections O +
. O +

The O +
picornavirus O +
family O +
contains O +
several O +
human O +
pathogens O +
including O +
human O +
rhinovirus O +
( O +
HRV O +
) O +
and O +
hepatitis O +
A O +
virus O +
( O +
HAV O +
) O +
. O +

In O +
the O +
case O +
of O +
HRVs O +
, O +
these O +
small O +
single O +
- O +
stranded O +
positive O +
- O +
sense O +
RNA O +
viruses O +
translate O +
their O +
genetic O +
information O +
into O +
a O +
polyprotein O +
precursor O +
which O +
is O +
further O +
processed O +
mainly O +
by O +
two O +
viral O +
proteases B-Gene +
designated O +
2A B-Gene +
and O +
3C B-Gene +
. O +

The O +
2A B-Gene +
protease I-Gene +
( O +
2Apro B-Gene +
) O +
makes O +
the O +
first O +
cleavage O +
between O +
the O +
structural B-Gene +
and I-Gene +
non I-Gene +
- I-Gene +
structural I-Gene +
proteins I-Gene +
, O +
while O +
3C B-Gene +
protease I-Gene +
( O +
3Cpro B-Gene +
) O +
catalyzes O +
most O +
of O +
the O +
remaining O +
internal O +
cleavages O +
. O +

It O +
has O +
been O +
shown O +
that O +
both O +
2Apro B-Gene +
and O +
3Cpro B-Gene +
are O +
cysteine B-Gene +
proteases I-Gene +
but O +
their O +
overall O +
protein O +
folding O +
is O +
more O +
like O +
trypsin B-Gene +
- I-Gene +
type I-Gene +
serine I-Gene +
proteases I-Gene +
. O +

Due O +
to O +
their O +
unique O +
protein O +
structure O +
and O +
essential O +
roles O +
in O +
viral O +
replication O +
, O +
2Apro B-Gene +
and O +
3Cpro B-Gene +
have O +
been O +
viewed O +
as O +
excellent O +
targets O +
for O +
antiviral O +
intervention O +
. O +

In O +
recent O +
years O +
, O +
considerable O +
efforts O +
have O +
been O +
made O +
in O +
the O +
development O +
of O +
antiviral O +
compounds O +
targeting O +
these O +
proteases B-Gene +
. O +

This O +
article O +
summarizes O +
the O +
recent O +
approaches O +
in O +
the O +
design O +
of O +
novel O +
2A B-Gene +
and I-Gene +
3C I-Gene +
protease I-Gene +
inhibitors O +
as O +
potential O +
antiviral O +
agents O +
for O +
the O +
treatment O +
of O +
picornaviral O +
infections O +
. O +

Developmental O +
regulation O +
and O +
overexpression O +
of O +
the O +
transcription B-Gene +
factor I-Gene +
AP-2 I-Gene +
, O +
a O +
potential O +
regulator O +
of O +
the O +
timing O +
of O +
Schwann O +
cell O +
generation O +
. O +

There O +
is O +
now O +
evidence O +
from O +
in O +
vivo O +
and O +
in O +
vitro O +
studies O +
that O +
the O +
rate O +
of O +
Schwann O +
cell O +
generation O +
is O +
regulated O +
by O +
the O +
balance O +
of O +
two O +
opposing O +
signals O +
, O +
beta B-Gene +
neuregulins I-Gene +
and O +
endothelins B-Gene +
. O +

The O +
beta B-Gene +
neuregulins I-Gene +
promote O +
the O +
development O +
of O +
precursors O +
to O +
Schwann O +
cells O +
whereas O +
endothelins B-Gene +
retard O +
it O +
through O +
an O +
action O +
on O +
endothelin B-Gene +
- I-Gene +
B I-Gene +
receptors I-Gene +
. O +

The O +
present O +
work O +
has O +
shown O +
additional O +
controls O +
of O +
this O +
transition O +
, O +
and O +
implicates O +
AP-2 B-Gene +
transcription I-Gene +
factors I-Gene +
, O +
in O +
particular O +
AP-2 B-Gene +
alpha I-Gene +
, O +
as O +
negative O +
regulators O +
of O +
Schwann O +
cell O +
generation O +
. O +

We O +
found O +
that O +
both O +
AP-2 B-Gene +
alpha I-Gene +
and O +
AP-2 B-Gene +
gamma I-Gene +
are O +
present O +
in O +
early O +
embryonic O +
nerves O +
, O +
whereas O +
AP-2 B-Gene +
beta I-Gene +
was O +
not O +
. O +

Isoform O +
- O +
specific O +
analysis O +
of O +
AP-2 B-Gene +
alpha I-Gene +
showed O +
that O +
isoform O +
3 O +
was O +
most O +
abundant O +
with O +
isoforms O +
1 O +
and O +
2 O +
present O +
in O +
lesser O +
amounts O +
; O +
isoform O +
4 O +
was O +
absent O +
. O +

Maximal O +
AP-2 B-Gene +
alpha I-Gene +
and O +
AP-2 B-Gene +
gamma I-Gene +
mRNA O +
expression O +
occurred O +
at O +
embryonic O +
day O +
( O +
E O +
) O +
12 O +
/ O +
13 O +
in O +
the O +
mouse O +
and O +
at O +
E14 O +
/ O +
15 O +
in O +
the O +
rat O +
, O +
which O +
correlates O +
with O +
the O +
presence O +
of O +
Schwann O +
cell O +
precursors O +
in O +
the O +
nerve O +
. O +

In O +
both O +
rats O +
and O +
in O +
mice O +
, O +
in O +
vivo O +
and O +
in O +
vitro O +
, O +
downregulation O +
of O +
AP-2 B-Gene +
alpha I-Gene +
mRNA O +
and O +
protein O +
coincided O +
with O +
one O +
of O +
the O +
main O +
steps O +
in O +
Schwann O +
cell O +
development O +
, O +
the O +
precursor O +
- O +
Schwann O +
cell O +
transition O +
. O +

Moreover O +
, O +
Schwann O +
cell O +
generation O +
was O +
delayed O +
if O +
this O +
downregulation O +
was O +
prevented O +
by O +
enforced O +
expression O +
of O +
AP-2 B-Gene +
alpha I-Gene +
in O +
precursors O +
. O +

These O +
studies O +
suggest O +
that O +
AP-2 B-Gene +
is O +
involved O +
in O +
the O +
control O +
of O +
the O +
timing O +
of O +
Schwann O +
cell O +
development O +
. O +

Characterization O +
of O +
the O +
human O +
beta B-Gene +
- I-Gene +
glucan I-Gene +
receptor I-Gene +
and O +
its O +
alternatively O +
spliced O +
isoforms O +
. O +

beta-1,3-d O -
- O -
Glucans O +
are O +
biological O +
response O +
modifiers O +
with O +
potent O +
effects O +
on O +
the O +
immune O +
system O +
. O +

A O +
number O +
of O +
receptors O +
are O +
thought O +
to O +
play O +
a O +
role O +
in O +
mediating O +
these O +
responses O +
, O +
including O +
murine O +
Dectin-1 B-Gene +
, O +
which O +
we O +
recently O +
identified O +
as O +
a O +
beta B-Gene -
- I-Gene -
glucan I-Gene +
receptor I-Gene +
. O +

In O +
this O +
study O +
we O +
describe O +
the O +
characterization O +
of O +
the O +
human O +
homologue O +
of O +
this O +
receptor O +
and O +
show O +
that O +
it O +
is O +
structurally O +
and O +
functionally O +
similar O +
to O +
the O +
mouse O +
receptor O +
. O +

The O +
human O +
beta B-Gene -
- I-Gene -
glucan I-Gene +
receptor I-Gene +
is O +
a O +
type O +
II O +
transmembrane O +
receptor O +
with O +
a O +
single O +
extracellular O +
carbohydrate O +
recognition O +
domain O +
and O +
an O +
immunoreceptor O +
tyrosine O +
activation O +
motif O +
in O +
its O +
cytoplasmic O +
tail O +
. O +

The O +
human O +
beta B-Gene -
- I-Gene -
glucan I-Gene +
receptor I-Gene +
is O +
widely O +
expressed O +
and O +
functions O +
as O +
a O +
pattern O +
recognition O +
receptor O +
, O +
recognizing O +
a O +
variety O +
of O +
beta-1,3- O +
and/or O +
beta-1 O +
, O +
6 O +
- O +
linked O +
glucans O +
as O +
well O +
as O +
intact O +
yeast O +
. O +

In O +
contrast O +
to O +
the O +
murine O +
receptor O +
, O +
the O +
human O +
receptor O +
mRNA O +
is O +
alternatively O +
spliced O +
, O +
resulting O +
in O +
two O +
major O +
( O +
A O +
and O +
B O +
) O +
and O +
six O +
minor O +
isoforms O +
. O +

The O +
two O +
major O +
isoforms O +
differ O +
by O +
the O +
presence O +
of O +
a O +
stalk O +
region O +
separating O +
the O +
carbohydrate O +
recognition O +
domain O +
from O +
the O +
transmembrane O +
region O +
and O +
are O +
the O +
only O +
isoforms O +
that O +
are O +
functional O +
for O +
beta O -
- O -
glucan O +
binding O +
. O +

The O +
human O +
receptor O +
also O +
binds O +
T O -
- O -
lymphocytes O +
at O +
a O +
site O +
distinct O +
from O +
the O +
beta O -
- O -
glucan O +
binding O +
site O +
, O +
indicating O +
that O +
this O +
receptor O +
can O +
recognize O +
both O +
endogenous O +
and O +
exogenous O +
ligands O +
. O +

Mutations O +
in O +
the O +
human O +
orthologue O +
of O +
the O +
mouse O +
underwhite B-Gene +
gene O +
( O +
uw B-Gene +
) O +
underlie O +
a O +
new O +
form O +
of O +
oculocutaneous O +
albinism O +
, O +
OCA4 O +
. O +

Oculocutaneous O +
albinism O +
( O +
OCA O +
) O +
affects O +
approximately O +
1 O +
/ O +
20,000 O +
people O +
worldwide O +
. O +

All O +
forms O +
of O +
OCA O +
exhibit O +
generalized O +
hypopigmentation O +
. O +

Reduced O +
pigmentation O +
during O +
eye O +
development O +
results O +
in O +
misrouting O +
of O +
the O +
optic O +
nerves O +
, O +
nystagmus O +
, O +
alternating O +
strabismus O +
, O +
and O +
reduced O +
visual O +
acuity O +
. O +

Loss O +
of O +
pigmentation O +
in O +
the O +
skin O +
leads O +
to O +
an O +
increased O +
risk O +
for O +
skin O +
cancer O +
. O +

Two O +
common O +
forms O +
and O +
one O +
infrequent O +
form O +
of O +
OCA O +
have O +
been O +
described O +
. O +

OCA1 O +
( O +
MIM O +
203100 O +
) O +
is O +
associated O +
with O +
mutations O +
of O +
the O +
TYR B-Gene +
gene O +
encoding O +
tyrosinase B-Gene +
( O +
the O +
rate O +
- O +
limiting O +
enzyme O +
in O +
the O +
production O +
of O +
melanin O +
pigment O +
) O +
and O +
accounts O +
for O +
approximately O +
40 O +
% O +
of O +
OCA O +
worldwide O +
. O +

OCA2 O +
( O +
MIM O +
203200 O +
) O +
, O +
the O +
most O +
common O +
form O +
of O +
OCA O +
, O +
is O +
associated O +
with O +
mutations O +
of O +
the O +
P B-Gene +
gene O +
and O +
accounts O +
for O +
approximately O +
50 O +
% O +
of O +
OCA O +
worldwide O +
. O +

OCA3 O +
( O +
MIM O +
203290 O +
) O +
, O +
a O +
rare O +
form O +
of O +
OCA O +
and O +
also O +
known O +
as O +
" O +
rufous O +
/ O +
red O +
albinism O +
, O +
" O +
is O +
associated O +
with O +
mutations O +
in O +
TYRP1 B-Gene +
( O +
encoding O +
tyrosinase B-Gene +
- I-Gene +
related I-Gene +
protein I-Gene +
1 I-Gene +
) O +
. O +

Analysis O +
of O +
the O +
TYR B-Gene +
and O +
P B-Gene +
genes O +
in O +
patients O +
with O +
OCA O +
suggests O +
that O +
other O +
genes O +
may O +
be O +
associated O +
with O +
OCA O +
. O +

We O +
have O +
identified O +
the O +
mouse O +
underwhite B-Gene +
gene O +
( O +
uw B-Gene +
) O +
and O +
its O +
human O +
orthologue O +
, O +
which O +
underlies O +
a O +
new O +
form O +
of O +
human O +
OCA O +
, O +
termed O +
" O +
OCA4 O -
. O +
" O +

The O +
encoded O +
protein O +
, O +
MATP B-Gene +
( O +
for O +
" O +
membrane B-Gene +
- I-Gene +
associated I-Gene +
transporter I-Gene +
protein I-Gene +
" O +
) O +
is O +
predicted O +
to O +
span O +
the O +
membrane O +
12 O +
times O +
and O +
likely O +
functions O +
as O +
a O +
transporter O +
. O +

Immune O +
responsiveness O +
following O +
academic O +
stress O +
in O +
first O +
- O +
year O +
medical O +
students O +
. O +

Many O +
studies O +
illustrate O +
that O +
physical O +
or O +
psychologic O +
stressors O +
can O +
alter O +
human O +
immune O +
function O +
, O +
which O +
might O +
predispose O +
one O +
to O +
an O +
increased O +
susceptibility O +
to O +
infections O +
. O +

In O +
the O +
present O +
study O +
, O +
we O +
monitored O +
immune O +
responsiveness O +
in O +
16 O +
first O +
- O +
year O +
medical O +
students O +
( O +
age O +
23.8 O +
+ O -
/- O +
2.2 O +
years O +
) O +
during O +
the O +
first O +
examination O +
session O +
. O +

Baseline O +
blood O +
samples O +
were O +
collected O +
30 O +
days O +
prior O +
to O +
the O +
first O +
examination O +
session O +
. O +

Subsequently O +
, O +
subjects O +
were O +
randomly O +
assigned O +
to O +
two O +
groups O +
, O +
and O +
blood O +
samples O +
were O +
collected O +
at O +
24 O +
h O +
( O +
POST24h O +
) O +
or O +
48 O +
h O +
( O +
POST48h O +
) O +
after O +
an O +
examination O +
. O +

The O +
percentage O +
of O +
CD3 B-Gene +
( O +
+ O +
) O +
, O +
CD3 B-Gene +
( O +
+ O +
) O +
CD4 B-Gene +
( O +
+ O +
) O +
, O +
CD3 B-Gene +
( O +
+ O +
) O +
CD8 B-Gene +
( O +
+ O +
) O +
, O +
CD3 B-Gene +
( O +
+ O +
) O +
CD45RO B-Gene +
( O +
+ O +
) O +
, O +
CD3 B-Gene +
( O +
+ O +
) O +
CD45RA B-Gene +
( O +
+ O +
) O +
, O +
CD3 B-Gene +
( O +
- O +
) O +
CD16 B-Gene +
( O +
+ O +
) O +
56 O +
( O +
+ O +
) O +
, O +
CD19 B-Gene +
( O +
+ O +
) O +
, O +
and O +
CD14 B-Gene +
( O +
+ O +
) O +
cells O +
in O +
whole O +
blood O +
was O +
examined O +
to O +
determine O +
changes O +
in O +
circulating O +
immune O +
cell O +
populations O +
. O +

Activation O +
of O +
peripheral O +
blood O +
mononuclear O +
cells O +
( O +
PBMC O +
) O +
with O +
a O +
mixture O +
of O +
phorbol O +
myristate O +
acetate O +
( O +
PMA O +
) O +
and O +
ionomycin O +
or O +
lipopolysaccharide O +
( O +
LPS O +
) O +
for O +
4 O +
h O +
was O +
used O +
to O +
assess O +
the O +
distribution O +
of O +
interleukin-2 B-Gene +
( O +
IL-2 B-Gene +
) O +
- O +
secreting O +
or O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
( O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
- O +
secreting O +
CD4 B-Gene +
( O +
+ O +
) O +
and O +
CD8 B-Gene +
( O +
+ O +
) O +
cells O +
, O +
as O +
well O +
as O +
IL-1alpha B-Gene +
- O +
secreting O +
CD14 B-Gene +
( O +
+ O +
) O +
cells O +
. O +

Activation O +
with O +
a O +
combination O +
of O +
phytohemagglutinin O +
( O +
PHA O +
) O +
and O +
LPS O +
was O +
used O +
to O +
assess O +
secretion O +
of O +
IL-2 B-Gene +
, O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
, O +
IL-4 B-Gene +
, O +
IL-10 B-Gene +
, O +
soluble O +
IL-2 B-Gene +
receptor I-Gene +
- I-Gene +
alpha I-Gene +
( O +
sIL-2Ralpha B-Gene +
) O +
, O +
IL-1beta B-Gene +
, O +
and O +
IL-1R B-Gene +
antagonist I-Gene +
( O +
IL-1Ra B-Gene +
) O +
by O +
PBMC O +
in O +
48 O +
- O +
h O +
cell O +
culture O +
. O +

A O +
significantly O +
higher O +
level O +
of O +
total O +
T O +
cells O +
was O +
found O +
at O +
POST24h O +
, O +
and O +
CD14 B-Gene +
( O +
+ O +
) O +
was O +
elevated O +
at O +
both O +
POST24h O +
and O +
POST48h O +
. O +

The O +
percentage O +
of O +
CD4 B-Gene +
( O +
+ O +
) O +
and O +
CD8 B-Gene +
( O +
+ O +
) O +
cells O +
significantly O +
declined O +
at O +
POST24 O +
and O +
POST48h O +
. O +

A O +
significant O +
elevation O +
in O +
the O +
percentage O +
of O +
memory O +
T O +
cells O +
was O +
observed O +
at O +
POST48h O +
, O +
whereas O +
the O +
percentage O +
of O +
naive O +
T O +
cells O +
was O +
elevated O +
at O +
POST24h O +
and O +
POST48h O +
. O +

These O +
changes O +
were O +
accompanied O +
by O +
a O +
significant O +
decline O +
in O +
percentage O +
of O +
natural O +
killer O +
( O +
NK O +
) O +
cells O +
24 O +
h O +
after O +
the O +
examination O +
. O +

The O +
percentage O +
of O +
IL-2 B-Gene +
- O +
producing O +
CD4 B-Gene +
( O +
+ O +
) O +
and O +
CD8 B-Gene +
( O +
+ O +
) O +
cells O +
was O +
significantly O +
lower O +
at O +
POST24h O +
, O +
and O +
the O +
percentage O +
of O +
CD8 B-Gene +
( O +
+ O +
) O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
( O -
+ O -
) O +
cells O +
significantly O +
declined O +
at O +
POST48h O +
. O +

The O +
percentage O +
of O +
CD14 B-Gene +
( O +
+ O +
) O +
IL-1alpha B-Gene +
( O +
+ O +
) O +
significantly O +
declined O +
at O +
both O +
POST24 O +
and O +
POST48h O +
. O +

A O +
significant O +
decrease O +
was O +
observed O +
in O +
IL-2 B-Gene +
secretion O +
24 O +
h O +
after O +
the O +
examinations O +
, O +
and O +
the O +
secretion O +
of O +
IL-4 B-Gene +
and O +
IL-1beta B-Gene +
significantly O +
declined O +
at O +
POST48h O +
. O +

No O +
changes O +
in O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
, O +
IL-10 B-Gene +
, O +
sIL-2Ralpha B-Gene +
, O +
and O +
IL-1Ra B-Gene +
secretion O +
were O +
observed O +
. O +

We O +
conclude O +
that O +
the O +
stress O +
outcomes O +
of O +
academic O +
examinations O +
in O +
first O +
- O +
year O +
medical O +
students O +
can O +
significantly O +
alter O +
immune O +
cell O +
distribution O +
and O +
in O +
vitro O +
production O +
and O +
secretion O +
of O +
specific O +
cytokines B-Gene +
. O +

Alpha B-Gene -
- I-Gene -
B I-Gene +
crystallin I-Gene +
gene O +
( O +
CRYAB B-Gene +
) O +
mutation O +
causes O +
dominant O +
congenital O +
posterior O +
polar O +
cataract O +
in O +
humans O +
. O +

Congenital O +
cataracts O +
are O +
an O +
important O +
cause O +
of O +
bilateral O +
visual O +
impairment O +
in O +
infants O +
. O +

In O +
a O +
four O +
- O +
generation O +
family O +
of O +
English O +
descent O +
, O +
we O +
mapped O +
dominant O +
congenital O +
posterior O +
polar O +
cataract O +
to O +
chromosome O +
11q22 O +
- O +
q22.3 O +
. O +

The O +
maximum O +
LOD O +
score O +
, O +
3.92 O +
at O +
recombination O +
fraction O +
0 O +
, O +
was O +
obtained O +
for O +
marker O +
D11S898 O +
, O +
near O +
the O +
gene O +
that O +
encodes O +
crystallin B-Gene +
alpha I-Gene -
- I-Gene -
B I-Gene +
protein O +
( O +
CRYAB B-Gene +
) O +
. O +

By O +
sequencing O +
the O +
coding O +
regions O +
of O +
CRYAB B-Gene +
, O +
we O +
found O +
in O +
exon O +
3 O +
a O +
deletion O +
mutation O +
, O +
450delA O +
, O +
that O +
is O +
associated O +
with O +
cataract O +
in O +
this O +
family O +
. O +

The O +
mutation O +
resulted O +
in O +
a O +
frameshift O +
in O +
codon O +
150 O +
and O +
produced O +
an O +
aberrant O +
protein O +
consisting O +
of O +
184 O +
residues O +
. O +

This O +
is O +
the O +
first O +
report O +
of O +
a O +
mutation O +
, O +
in O +
this O +
gene O +
, O +
resulting O +
in O +
isolated O +
congenital O +
cataract O +
. O +

Cortical O +
dysplasia O +
: O +
electroclinical O +
, O +
imaging O +
, O +
and O +
neuropathologic O +
study O +
of O +
13 O +
patients O +
. O +

PURPOSE O +
: O +

The O +
aim O +
of O +
this O +
study O +
was O +
to O +
correlate O +
the O +
electroclinical O +
and O +
radiologic O +
data O +
with O +
the O +
neuropathologic O +
findings O +
and O +
surgical O +
outcome O +
in O +
epileptic O +
patients O +
with O +
epilepsy O +
and O +
Taylor O +
's O +
focal O +
cortical O +
dysplasia O +
( O +
TFCD O +
) O +
and O +
to O +
characterize O +
further O +
the O +
abnormal O +
intermediate O +
filaments O +
expression O +
in O +
the O +
balloon O +
cell O +
present O +
in O +
the O +
peculiar O +
dysplasia O +
. O +

METHODS O +
: O +

We O +
retrospectively O +
selected O +
13 O +
TFCD O +
patients O +
who O +
underwent O +
surgery O +
for O +
intractable O +
epilepsy O +
with O +
the O +
aim O +
of O +
removing O +
the O +
magnetic O +
resonance O +
( O +
MR O +
) O +
- O +
detectable O +
lesion O +
and/or O +
the O +
epileptogenic O +
zone O +
defined O +
by O +
stereoelectroencephalographic O +
recordings O +
. O +

The O +
surgical O +
specimens O +
were O +
analyzed O +
by O +
means O +
of O +
routine O +
neuropathologic O +
and O +
immunocytochemical O +
studies O +
. O +

Antisera O +
against O +
different O +
intermediate O +
filaments O +
also O +
were O +
used O +
in O +
serial O +
adjacent O +
sections O +
to O +
evaluate O +
their O +
coexpression O +
in O +
balloon O +
cells O +
. O +

RESULTS O +
: O +

Histopathologic O +
abnormalities O +
typical O +
of O +
TFCD O +
were O +
found O +
not O +
only O +
within O +
the O +
MR O +
- O +
visible O +
lesions O +
but O +
also O +
in O +
most O +
of O +
the O +
epileptogenic O +
zones O +
with O +
no O +
MR O +
signal O +
alterations O +
. O +

Furthermore O +
, O +
the O +
MR O +
- O +
visible O +
lesions O +
contained O +
a O +
high O +
proportion O +
of O +
cells O +
with O +
an O +
abnormal O +
expression O +
of O +
intermediate O +
filament O +
proteins O +
. O +

After O +
a O +
long O +
follow O +
- O +
up O +
, O +
10 O +
of O +
the O +
patients O +
are O +
now O +
seizure O +
free O +
. O +

CONCLUSIONS O +
: O +

Our O +
findings O +
indicate O +
that O +
highly O +
epileptogenic O +
zones O +
may O +
correspond O +
to O +
tissue O +
alterations O +
not O +
revealed O +
by O +
neuroimaging O +
. O +

Furthermore O +
, O +
the O +
immunocytochemical O +
data O +
show O +
that O +
the O +
dysplastic O +
tissue O +
detected O +
by O +
MR O +
contained O +
high O +
concentrations O +
of O +
cells O +
filled O +
with O +
abnormal O +
intermediate O +
filaments O +
. O +

The O +
detected O +
colocalization O +
of O +
neuronal O +
and O +
glial O +
markers O +
in O +
balloon O +
cells O +
indicates O +
a O +
failure O +
of O +
cellular O +
commitment O +
during O +
development O +
. O +

Effect O +
of O +
bilateral O +
subthalamic O +
electrical O +
stimulation O +
in O +
Parkinson O +
's O +
disease O +
. O +

BACKGROUND O +
: O +

Bilateral O +
high O +
frequency O +
subthalamic O +
stimulation O +
has O +
been O +
reported O +
to O +
be O +
effective O +
in O +
the O +
treatment O +
of O +
Parkinson O +
's O +
disease O +
and O +
levodopa O +
- O +
induced O +
dyskinesias O +
. O +

To O +
analyze O +
the O +
results O +
of O +
this O +
surgical O +
procedure O +
we O +
critically O +
reviewed O +
17 O +
parkinsonian O +
patients O +
with O +
advanced O +
disease O +
complicated O +
by O +
motor O +
fluctuations O +
and O +
dyskinesias O +
. O +

METHODS O +
: O +

Between O +
January O +
1998 O +
and O +
June O +
1999 O +
these O +
17 O +
consecutive O +
patients O +
( O +
age O +
48 O +
- O +
68 O +
years O +
; O +
illness O +
duration O +
8 O +
- O +
27 O +
years O +
) O +
underwent O +
bilateral O +
stereotactically O +
guided O +
implantation O +
of O +
electrodes O +
into O +
the O +
subthalamic O +
nucleus O +
in O +
the O +
Department O +
of O +
Neurosurgery O +
of O +
the O +
Istituto O +
Nazionale O +
Neurologico O +
" O +
C. O +
Besta O -
. O +
" O +

Parameters O +
used O +
for O +
continuous O +
high O +
- O +
frequency O +
stimulation O +
were O +
: O +
frequency O +
160 O +
Hz O +
, O +
pulse O +
width O +
90 O +
microsec O +
, O +
mean O +
amplitude O +
2.05 O +
+ O -
/- O +
0.45 O +
V O +
. O +

Parts O +
II O +
and O +
III O +
of O +
the O +
UPDRS O +
were O +
used O +
to O +
assess O +
motor O +
performance O +
before O +
and O +
after O +
operation O +
by O +
the O +
neurologic O +
team O +
. O +

The O +
follow O +
- O +
up O +
ranged O +
between O +
6 O +
and O +
18 O +
months O +
. O +

RESULTS O +
: O +

At O +
latest O +
examination O +
, O +
mean O +
UPDRS O +
II O +
and O +
III O +
scores O +
had O +
improved O +
by O +
30 O +
% O +
( O +
on O +
stimulation O +
, O +
off O +
therapy O +
) O +
with O +
mean O +
50 O +
% O +
reduction O +
in O +
daily O +
off O +
time O +
. O +

Peak O +
dyskinesias O +
and O +
early O +
morning O +
dystonias O +
also O +
improved O +
in O +
relation O +
to O +
therapy O +
reduction O +
. O +

Side O +
effects O +
were O +
persistent O +
postoperative O +
supranuclear O +
oculomotor O +
palsy O +
and O +
postural O +
instability O +
in O +
one O +
case O +
, O +
worsened O +
off O +
- O +
medication O +
hypophonia O +
in O +
three O +
, O +
and O +
temporary O +
nocturnal O +
confusion O +
episodes O +
in O +
three O +
. O +

Postoperative O +
MRI O +
revealed O +
a O +
clinically O +
silent O +
intracerebral O +
haematoma O +
in O +
one O +
case O +
. O +

One O +
electrode O +
required O +
repositioning O +
. O +

CONCLUSIONS O +
: O +

Continuous O +
high O +
frequency O +
STN O +
stimulation O +
is O +
an O +
effective O +
treatment O +
for O +
advanced O +
PD O +
. O +

A O +
functionally O +
useful O +
and O +
safe O +
electrode O +
placement O +
can O +
be O +
performed O +
without O +
microrecording O +
. O +

Dietary O +
adipic O +
acid O +
reduces O +
ammonia O +
emission O +
from O +
swine O +
excreta O +
. O +

Adipic O +
acid O +
is O +
only O +
partially O +
catabolized O +
when O +
it O +
is O +
fed O +
to O +
animals O +
, O +
and O +
a O +
portion O +
of O +
it O +
is O +
excreted O +
in O +
urine O +
. O +

The O +
excreted O +
portion O +
may O +
lower O +
urinary O +
pH O +
and O +
, O +
as O +
a O +
result O +
, O +
ammonia O +
emission O +
. O +

The O +
present O +
study O +
tested O +
this O +
hypothesis O +
. O +

In O +
Exp O -
. O +
1 O +
, O +
nursery O +
pigs O +
( O +
n O +
= O +
14 O +
) O +
were O +
fed O +
( O +
for O +
a O +
period O +
of O +
7 O +
d O +
) O +
either O +
a O +
standard O +
nursery O +
diet O +
or O +
the O +
same O +
diet O +
supplemented O +
with O +
1 O +
% O +
adipic O +
acid O +
to O +
assess O +
effects O +
on O +
urinary O +
pH O +
( O +
collected O +
on O +
d O +
5 O +
or O +
6 O +
) O +
and O +
in O +
vitro O +
ammonia O +
emission O +
from O +
the O +
collected O +
urine O +
samples O +
that O +
were O +
mixed O +
with O +
control O +
feces O +
. O +

In O +
Exp O -
. O +
2 O +
, O +
grower O +
pigs O +
housed O +
10 O +
each O +
in O +
one O +
of O +
two O +
chambers O +
were O +
fed O +
a O +
control O +
diet O +
or O +
the O +
same O +
diet O +
supplemented O +
with O +
1 O +
% O +
adipic O +
acid O +
. O +

Ventilated O +
air O +
was O +
quantified O +
and O +
analyzed O +
for O +
ammonia O +
using O +
Fourier O +
transform O +
infrared O +
spectroscopy O +
to O +
determine O +
the O +
effects O +
of O +
feeding O +
1 O +
% O +
adipic O +
acid O +
on O +
ammonia O +
emission O +
. O +

The O +
results O +
from O +
Exp O +
. O +

1 O +
showed O +
that O +
adipic O +
acid O +
strongly O +
reduced O +
urinary O +
pH O +
( O +
from O +
7.7 O +
to O +
5.5 O +
, O +
P O +
< O +
0.05 O +
) O +
. O +

In O +
vitro O +
ammonia O +
emission O +
from O +
these O +
urine O +
samples O +
was O +
significantly O +
reduced O +
at O +
all O +
the O +
time O +
points O +
evaluated O +
( O +
1 O +
, O +
3 O +
, O +
18 O +
, O +
and O +
46 O +
h O +
with O +
reductions O +
of O +
94 O +
, O +
93 O +
, O +
70 O +
, O +
and O +
39 O +
% O +
, O +
respectively O +
, O +
P O +
< O +
0.05 O +
) O +
. O +

Experiment O +
2 O +
showed O +
that O +
adipic O +
acid O +
supplementation O +
reduced O +
ammonia O +
emission O +
by O +
25 O +
% O +
( O +
P O +
< O +
0.05 O +
) O +
, O +
which O +
corresponded O +
to O +
the O +
predicted O +
reduction O +
in O +
ammonia O +
emission O +
based O +
on O +
the O +
reduction O +
in O +
manure O +
pH O +
observed O +
. O +

In O +
conclusion O +
, O +
feeding O +
adipic O +
acid O +
lowers O +
urinary O +
pH O +
and O +
reduces O +
ammonia O +
emission O +
. O +

The O +
reduction O +
in O +
ammonia O +
emission O +
, O +
though O +
, O +
does O +
not O +
correspond O +
to O +
the O +
reduction O +
in O +
urinary O +
pH O +
but O +
corresponds O +
to O +
the O +
reduction O +
in O +
fecal O +
pH O +
as O +
a O +
result O +
of O +
mixing O +
the O +
urine O +
and O +
feces O +
, O +
in O +
which O +
feces O +
act O +
as O +
a O +
strong O +
buffer O +
. O +

Identification O +
of O +
hTAF B-Gene -
( I-Gene -
II I-Gene -
) I-Gene +
80 I-Gene +
delta O +
links O +
apoptotic O +
signaling O +
pathways O +
to O +
transcription B-Gene +
factor I-Gene +
TFIID B-Gene +
function O +
. O +

Apoptotic O +
cell O +
death O +
is O +
associated O +
with O +
altered O +
levels O +
of O +
mRNA O +
expression O +
, O +
yet O +
the O +
mechanisms O +
that O +
coordinate O +
changes O +
in O +
gene O +
expression O +
with O +
activation O +
of O +
the O +
cell O +
death O +
machinery O +
remain O +
obscure O +
. O +

Here O +
, O +
we O +
report O +
the O +
cloning O +
and O +
characterization O +
of O +
hTAF B-Gene +
( I-Gene +
II I-Gene +
) I-Gene +
80 I-Gene +
delta O +
, O +
a O +
specialized O +
isoform O +
of O +
the O +
general O +
transcription B-Gene +
factor I-Gene +
TFIID B-Gene +
subunit O +
hTAF B-Gene +
( I-Gene +
II I-Gene +
) I-Gene +
80 I-Gene +
. O +

Several O +
distinct O +
apoptotic O +
stimuli O +
induce O +
the O +
expression O +
and O +
caspase O +
- O +
dependent O +
cleavage O +
of O +
hTAF B-Gene -
( I-Gene -
II I-Gene -
) I-Gene +
80 I-Gene +
delta O +
. O +

hTAF B-Gene -
( I-Gene -
II I-Gene -
) I-Gene +
80 I-Gene +
delta O +
, O +
unlike O +
hTAF B-Gene +
( I-Gene +
II I-Gene +
) I-Gene +
80 I-Gene +
, O +
forms O +
a O +
TFIID B-Gene +
- O +
like O +
complex O +
lacking O +
hTAF B-Gene +
( I-Gene +
II I-Gene +
) I-Gene +
31 I-Gene +
. O +

Elevated O +
expression O +
of O +
hTAF B-Gene -
( I-Gene -
II I-Gene -
) I-Gene +
80 I-Gene +
delta O +
in O +
HeLa O +
cells O +
is O +
sufficient O +
to O +
trigger O +
apoptotic O +
cell O +
death O +
and O +
selectively O +
alters O +
cellular O +
transcription O +
, O +
including O +
the O +
induction O +
of O +
the O +
target O +
genes O +
gadd45 B-Gene +
and O +
p21 B-Gene +
. O +

These O +
data O +
define O +
a O +
signaling O +
pathway O +
that O +
couples O +
apoptotic O +
signals O +
to O +
a O +
reprogramming O +
of O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
transcription O +
. O +

Direct O +
ligand O +
- O +
receptor O +
complex O +
interaction O +
controls O +
Brassica O +
self O +
- O +
incompatibility O +
. O +

Many O +
higher O +
plants O +
have O +
evolved O +
self O +
- O +
incompatibility O +
mechanisms O +
to O +
prevent O +
self O +
- O +
fertilization O +
. O +

In O +
Brassica O +
self O +
- O +
incompatibility O +
, O +
recognition O +
between O +
pollen O +
and O +
the O +
stigma O +
is O +
controlled O +
by O +
the O +
S O +
locus O +
, O +
which O +
contains O +
three O +
highly O +
polymorphic O +
genes O +
: O +
S B-Gene -
- I-Gene -
receptor I-Gene +
kinase I-Gene +
( O +
SRK B-Gene +
) O +
, O +
S B-Gene -
- I-Gene -
locus I-Gene +
protein I-Gene +
11 I-Gene +
( O +
SP11 B-Gene +
) O +
( O +
also O +
called O +
S B-Gene -
- I-Gene -
locus I-Gene +
cysteine I-Gene +
- I-Gene +
rich I-Gene +
protein I-Gene +
; O +
SCR B-Gene +
) O +
and O +
S B-Gene -
- I-Gene -
locus I-Gene +
glycoprotein I-Gene +
( O +
SLG B-Gene +
) O +
. O +

SRK B-Gene +
encodes O +
a O +
membrane O +
- O +
spanning O +
serine B-Gene +
/ I-Gene +
threonine I-Gene +
kinase I-Gene +
that O +
determines O +
the O +
S O -
- O -
haplotype O +
specificity O +
of O +
the O +
stigma O +
, O +
and O +
SP11 B-Gene +
encodes O +
a O +
small O +
cysteine O +
- O +
rich O +
protein O +
that O +
determines O +
the O +
S O -
- O -
haplotype O +
specificity O +
of O +
pollen O +
. O +

SP11 B-Gene +
is O +
localized O +
in O +
the O +
pollen O +
coat O +
. O +

It O +
is O +
thought O +
that O +
, O +
during O +
self O +
- O +
pollination O +
, O +
SP11 B-Gene +
is O +
secreted O +
from O +
the O +
pollen O +
coat O +
and O +
interacts O +
with O +
its O +
cognate O +
SRK B-Gene +
in O +
the O +
papilla O +
cell O +
of O +
the O +
stigma O +
to O +
elicit O +
the O +
self O +
- O +
incompatibility O +
response O +
. O +

SLG B-Gene +
is O +
a O +
secreted O +
stigma O +
protein O +
that O +
is O +
highly O +
homologous O +
to O +
the O +
SRK B-Gene +
extracellular O +
domain O +
. O +

Although O +
it O +
is O +
not O +
required O +
for O +
S O -
- O -
haplotype O +
specificity O +
of O +
the O +
stigma O +
, O +
SLG B-Gene +
enhances O +
the O +
self O +
- O +
incompatibility O +
response O +
; O +
however O +
, O +
how O +
this O +
is O +
accomplished O +
remains O +
controversial O +
. O +

Here O +
we O +
show O +
that O +
a O +
single O +
form O +
of O +
SP11 B-Gene +
of O +
the O +
S8 O +
haplotype O +
( O +
S8 O +
- O +
SP11 B-Gene +
) O +
stabilized O +
with O +
four O +
intramolecular O +
disulphide O +
bonds O +
specifically O +
binds O +
the O +
stigma O +
membrane O +
of O +
the O +
S8 O +
haplotype O +
to O +
induce O +
autophosphorylation O +
of O +
SRK8 B-Gene +
, O +
and O +
that O +
SRK8 B-Gene +
and O +
SLG8 B-Gene +
together O +
form O +
a O +
high O +
- O +
affinity O +
receptor O +
complex O +
for O +
S8 O +
- O +
SP11 B-Gene +
on O +
the O +
stigma O +
membrane O +
. O +

Hermansky O +
- O +
Pudlak O +
syndrome O +
type O +
3 O +
in O +
Ashkenazi O +
Jews O +
and O +
other O +
non O +
- O +
Puerto O +
Rican O +
patients O +
with O +
hypopigmentation O +
and O +
platelet O +
storage O +
- O +
pool O +
deficiency O +
. O +

Hermansky O +
- O +
Pudlak O +
syndrome O +
( O +
HPS O +
) O +
, O +
consisting O +
of O +
oculocutaneous O +
albinism O +
and O +
a O +
bleeding O +
diathesis O +
due O +
to O +
the O +
absence O +
of O +
platelet O +
dense O +
granules O +
, O +
displays O +
extensive O +
locus O +
heterogeneity O +
. O +

HPS1 B-Gene +
mutations O +
cause O +
HPS-1 O +
disease O +
, O +
and O +
ADTB3A O +
mutations O +
cause O +
HPS-2 O +
disease O +
, O +
which O +
is O +
known O +
to O +
involve O +
abnormal O +
intracellular O +
vesicle O +
formation O +
. O +

A O +
third O +
HPS O +
- O +
causing O +
gene O +
, O +
HPS3 B-Gene +
, O +
was O +
recently O +
identified O +
on O +
the O +
basis O +
of O +
homozygosity O +
mapping O +
of O +
a O +
genetic O +
isolate O +
of O +
HPS O +
in O +
central O +
Puerto O +
Rico O +
. O +

We O +
now O +
describe O +
the O +
clinical O +
and O +
molecular O +
characteristics O +
of O +
eight O +
patients O +
with O +
HPS-3 O +
who O +
are O +
of O +
non O +
- O +
Puerto O +
Rican O +
heritage O +
. O +

Five O +
are O +
Ashkenazi O +
Jews O +
; O +
three O +
of O +
these O +
are O +
homozygous O +
for O +
a O +
1303 O +
+ O +
1 O -
G O +
-- O -
> O +
A O +
splice O +
- O +
site O +
mutation O +
that O +
causes O +
skipping O +
of O +
exon O +
5 O +
, O +
deleting O +
an O +
RsaI B-Gene +
restriction O +
site O +
and O +
decreasing O +
the O +
amounts O +
of O +
mRNA O +
found O +
on O +
northern O +
blotting O +
. O +

The O +
other O +
two O +
are O +
heterozygous O +
for O +
the O +
1303 O +
+ O -
1 O -
G O +
-- O -
> O +
A O +
mutation O +
and O +
for O +
either O +
an O +
1831 O +
+ O -
2 O -
T O +
-- O -
> O +
G O +
or O +
a O +
2621 O +
-2A O +
-- O -
> O +
G O +
splicing O +
mutation O +
. O +

Of O +
235 O +
anonymous O +
Ashkenazi O +
Jewish O +
DNA O +
samples O +
, O +
one O +
was O +
heterozygous O +
for O +
the O +
1303 O +
+ O +
1 O -
G O +
-- O -
> O +
A O +
mutation O +
. O +

One O +
seven O +
- O +
year O +
- O +
old O +
boy O +
of O +
German O +
/ O +
Swiss O +
extraction O +
was O +
compound O +
heterozygous O +
for O +
a O +
2729 O +
+ O +
1 O -
G O +
-- O -
> O +
C O +
mutation O +
, O +
causing O +
skipping O +
of O +
exon O +
14 O +
, O +
and O +
resulting O +
in O +
a O +
C1329 O -
T O +
missense O +
( O +
R396W O +
) O +
, O +
with O +
decreased O +
mRNA O +
production O +
. O +

A O +
15 O +
- O +
year O +
- O +
old O +
Irish O +
/ O +
English O +
boy O +
was O +
heterozygous O +
for O +
an O +
89 O +
- O +
bp O +
insertion O +
between O +
exons O +
16 O +
and O +
17 O +
resulting O +
from O +
abnormal O +
splicing O +
; O +
his O +
fibroblast O +
HPS3 B-Gene +
mRNA O +
is O +
normal O +
in O +
amount O +
but O +
is O +
increased O +
in O +
size O +
. O +

A O +
12 O +
- O +
year O +
- O +
old O +
girl O +
of O +
Puerto O +
Rican O +
and O +
Italian O +
background O +
has O +
the O +
3,904-bp O +
founder O +
deletion O +
from O +
central O +
Puerto O +
Rico O +
on O +
one O +
allele O +
. O +

All O +
eight O +
patients O +
have O +
mild O +
symptoms O +
of O +
HPS O +
; O +
two O +
Jewish O +
patients O +
had O +
received O +
the O +
diagnosis O +
of O +
ocular O +
, O +
rather O +
than O +
oculocutaneous O +
, O +
albinism O +
. O +

These O +
findings O +
expand O +
the O +
molecular O +
diagnosis O +
of O +
HPS O +
, O +
provide O +
a O +
screening O +
method O +
for O +
a O +
mutation O +
common O +
among O +
Jews O +
, O +
and O +
suggest O +
that O +
other O +
patients O +
with O +
mild O +
hypopigmentation O +
and O +
decreased O +
vision O +
should O +
be O +
examined O +
for O +
HPS O +
. O +

Effect O +
of O +
orally O +
administered O +
cimetidine O +
and O +
ranitidine O +
on O +
abomasal O +
luminal O +
pH O +
in O +
clinically O +
normal O +
milk O +
- O +
fed O +
calves O +
. O +

OBJECTIVE O +
: O +

To O +
characterize O +
the O +
change O +
of O +
pH O +
in O +
the O +
abomasal O +
lumen O +
throughout O +
a O +
24 O +
- O +
hour O +
period O +
, O +
to O +
determine O +
whether O +
pH O +
of O +
the O +
abomasal O +
body O +
differs O +
from O +
pH O +
of O +
the O +
pyloric O +
antrum O +
, O +
and O +
to O +
determine O +
whether O +
oral O +
administration O +
of O +
cimetidine O +
and O +
ranitidine O +
alters O +
pH O +
of O +
the O +
abomasal O +
lumen O +
in O +
milk O +
- O +
fed O +
calves O +
. O +

ANIMALS O +
: O +

5 O +
male O +
dairy O +
calves O +
( O +
4 O +
Holsteins O +
- O +
Friesian O +
, O +
1 O +
Ayrshire O +
) O +
, O +
5 O +
to O +
15 O +
days O +
old O +
. O +

PROCEDURE O +
: O +

Cannulas O +
were O +
surgically O +
positioned O +
in O +
the O +
abomasal O +
body O +
and O +
pyloric O +
antrum O +
of O +
each O +
calf O +
. O +

Calves O +
received O +
the O +
following O +
treatments O +
in O +
a O +
randomized O +
crossover O +
design O +
: O +
milk O +
replacer O +
( O +
60 O +
ml O +
/ O +
kg O +
of O +
body O +
weight O +
, O +
q O +
12 O +
h O +
[ O +
untreated O +
control O +
calves O +
] O +
) O +
, O +
milk O +
replacer O +
and O +
cimetidine O +
( O +
50 O +
or O +
100 O +
mg O +
/ O +
kg O +
, O +
q O +
8 O +
h O +
) O +
, O +
or O +
milk O +
replacer O +
and O +
ranitidine O +
( O +
10 O +
or O +
50 O +
mg O +
/ O +
kg O +
, O +
q O +
8 O +
h O +
) O +
. O +

The O +
pH O +
of O +
the O +
abomasal O +
body O +
and O +
pyloric O +
antrum O +
was O +
measured O +
for O +
24 O +
hours O +
, O +
using O +
miniature O +
glass O +
pH O +
electrodes O +
. O +

RESULTS O +
: O +

Suckling O +
of O +
milk O +
replacer O +
immediately O +
increased O +
abomasal O +
luminal O +
pH O +
from O +
1.4 O +
to O +
6.0 O +
, O +
followed O +
by O +
a O +
gradual O +
decrease O +
to O +
preprandial O +
values O +
by O +
6 O +
hours O +
. O +

Preprandial O +
and O +
postprandial O +
pH O +
values O +
were O +
not O +
significantly O +
different O +
between O +
the O +
abomasal O +
body O +
and O +
pyloric O +
antrum O +
, O +
indicating O +
lack O +
of O +
pH O +
compartmentalization O +
in O +
the O +
abomasum O +
of O +
milk O +
- O +
fed O +
calves O +
. O +

Administration O +
of O +
cimetidine O +
and O +
ranitidine O +
caused O +
a O +
significant O +
dose O +
- O +
dependent O +
increase O +
in O +
mean O +
24-hour O +
abomasal O +
luminal O +
pH O +
. O +

CONCLUSIONS O +
AND O +
CLINICAL O +
RELEVANCE O +
: O +

Abomasal O +
acid O +
secretion O +
in O +
milk O +
- O +
fed O +
calves O +
is O +
mediated O +
in O +
part O +
by O +
histamine B-Gene +
type-2 I-Gene +
receptors I-Gene +
. O +

Cimetidine O +
and O +
ranitidine O +
may O +
be O +
efficacious O +
in O +
the O +
treatment O +
of O +
abomasal O +
ulcers O +
in O +
milk O +
- O +
fed O +
calves O +
. O +

Evaluation O +
of O +
glaucomatous O +
visual O +
field O +
loss O +
with O +
locally O +
condensed O +
grids O +
using O +
fundus O +
- O +
oriented O +
perimetry O +
( O +
FOP O +
) O +
. O +

PURPOSE O +
: O +

We O +
compared O +
detection O +
rates O +
of O +
glaucomatous O +
visual O +
field O +
defects O +
( O +
VFDs O +
) O +
between O +
a O +
conventional O +
rectangular O +
stimulus O +
grid O +
and O +
locally O +
condensed O +
test O +
point O +
arrangements O +
in O +
morphologically O +
suspicious O +
regions O +
. O +

METHODS O +
: O +

Humphrey O +
Field O +
Analyzer O +
model O +
630 O +
( O +
HFA O +
I O +
, O +
program O +
30 O +
- O +
2 O +
with O +
a O +
rectangular O +
6 O +
degrees O +
x O +
6 O +
degrees O +
grid O +
) O +
was O +
used O +
as O +
the O +
conventional O +
perimetric O +
method O +
. O +

Individual O +
local O +
test O +
- O +
point O +
condensation O +
was O +
realized O +
by O +
fundus O +
- O +
oriented O +
perimetry O +
( O +
FOP O +
) O +
on O +
the O +
Tuebingen O +
Computer O +
Campimeter O +
( O +
TCC O +
) O +
. O +

RESULTS O +
: O +

Of O +
a O +
total O +
of O +
66 O +
glaucoma O +
patients O +
, O +
or O +
suspected O +
sufferers O +
, O +
23 O +
showed O +
normal O +
findings O +
and O +
27 O +
showed O +
pathological O +
findings O +
with O +
both O +
methods O +
. O +

In O +
15 O +
cases O +
we O +
found O +
normal O +
visual O +
fields O +
in O +
HFA O +
30 O +
- O +
2 O +
, O +
whereas O +
FOP O +
revealed O +
early O +
glaucomatous O +
functional O +
damage O +
. O +

Only O +
one O +
case O +
showed O +
pathological O +
HFA O +
results O +
, O +
while O +
FOP O +
was O +
normal O +
. O +

Detection O +
rates O +
of O +
VFDs O +
significantly O +
differed O +
between O +
the O +
two O +
methods O +
( O +
p O +
< O +
0.001 O +
; O +
sign O +
test O +
) O +
. O +

CONCLUSIONS O +
: O +

FOP O +
, O +
using O +
individually O +
condensed O +
test O +
grids O +
, O +
significantly O +
increases O +
detection O +
rates O +
of O +
glaucomatous O +
VFDs O +
in O +
morphologically O +
suspicuous O +
areas O +
compared O +
with O +
a O +
conventional O +
HFA O +
30 O +
- O +
2 O +
technique O +
using O +
equidistant O +
rectangular O +
( O +
6 O +
degrees O +
x O +
6 O +
degrees O +
) O +
test O +
point O +
arrangements O +
. O +

The O +
rat O +
interleukin B-Gene +
10 I-Gene +
receptor I-Gene +
: O +
cloning O +
and O +
sequencing O +
of O +
cDNA O +
coding O +
for O +
the O +
alpha O +
- O +
chain O +
protein O +
sequence O +
, O +
and O +
demonstration O +
by O +
western O +
blotting O +
of O +
expression O +
in O +
the O +
rat O +
brain O +
. O +

cDNA O +
coding O +
for O +
the O +
alpha B-Gene +
chain I-Gene +
of I-Gene +
the I-Gene +
rat I-Gene +
interleukin I-Gene +
10 I-Gene +
( I-Gene +
IL-10 I-Gene +
) I-Gene +
receptor I-Gene +
was O +
amplified O +
by O +
polymerase O +
chain O +
reaction O +
( O +
PCR O +
) O +
, O +
cloned O +
and O +
sequenced O +
. O +

The O +
nucleic O +
acid O +
coding O +
sequence O +
exhibited O +
88 O +
% O +
and O +
68 O +
% O +
homology O +
with O +
the O +
mouse O +
and O +
human O +
IL-10 B-Gene +
receptor I-Gene +
sequences O +
, O +
respectively O +
. O +

The O +
translated O +
protein O +
exhibited O +
83 O +
% O +
and O +
61 O +
% O +
homology O +
with O +
the O +
mouse O +
and O +
human O +
IL-10 B-Gene +
receptor I-Gene +
proteins O +
. O +

Specific O +
antibodies O +
were O +
raised O +
to O +
the O +
extracellular O +
domain O +
of O +
the O +
rat O +
IL-10 B-Gene +
receptor I-Gene +
expressed O +
as O +
a O +
secreted O +
protein O +
in O +
recombinant O +
Drosophila O +
S2 O +
cells O +
. O +

Western O +
blotting O +
using O +
these O +
antibodies O +
demonstrated O +
the O +
presence O +
of O +
the O +
IL-10 B-Gene +
receptor I-Gene +
in O +
five O +
major O +
regions O +
of O +
the O +
rat O +
brain O +
( O +
cortex O +
, O +
cerebellum O +
, O +
hippocampus O +
, O +
hypothalamus O +
and O +
pituitary O +
) O +
, O +
supporting O +
a O +
role O +
for O +
IL-10 B-Gene +
as O +
a O +
central O +
regulator O +
of O +
inflammation O +
. O +

A20 B-Gene +
inhibits O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activation O +
downstream O +
of O +
multiple O +
Map3 B-Gene +
kinases I-Gene +
and O +
interacts O +
with O +
the O +
I B-Gene +
kappa I-Gene +
B I-Gene +
signalosome O +
. O +

A20 B-Gene +
, O +
a O +
TNF O +
inducible O +
gene O +
, O +
inhibits O +
TNF B-Gene +
- O +
mediated O +
apoptosis O +
as O +
well O +
as O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
induced O +
by O +
this O +
cytokine B-Gene +
. O +

Reporter O +
assay O +
experiments O +
revealed O +
that O +
A20 B-Gene +
is O +
a O +
very O +
effective O +
inhibitor O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
signaling O +
induced O +
by O +
TRAFs B-Gene +
and O +
several O +
Map3 B-Gene +
kinases I-Gene +
, O +
including O +
NIK B-Gene +
, O +
MEKK1 B-Gene +
, O +
COT B-Gene +
, O +
and O +
TAK1 B-Gene +
. O +

Similarly O +
, O +
the O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
inducing O +
activity O +
of O +
TAX B-Gene +
, O +
an O +
activator O +
of O +
the O +
I B-Gene +
kappa I-Gene +
B I-Gene +
kinase I-Gene +
complex I-Gene +
, O +
is O +
also O +
abrogated O +
by O +
A20 B-Gene +
. O +

Inhibition O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
is O +
specific O +
as O +
A20 B-Gene +
has O +
no O +
effect O +
on O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
- O +
induced O +
JNK B-Gene +
activation O +
. O +

These O +
results O +
suggest O +
that O +
the O +
molecular O +
target O +
of O +
A20 B-Gene +
is O +
more O +
distal O +
to O +
the O +
receptor O +
than O +
TRAFs B-Gene +
as O +
previously O +
proposed O +
. O +

A20 B-Gene +
inhibits O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
- O +
dependent O +
transcription O +
without O +
a O +
concomitant O +
decrease O +
in O +
nuclear O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
DNA O +
binding O +
activity O +
or O +
nuclear O +
translocation O +
of O +
p65 B-Gene +
. O +

This O +
apparent O +
discrepancy O +
between O +
transcriptional O +
readout O +
and O +
gel O +
shift O +
experiments O +
is O +
observed O +
with O +
a O +
variety O +
of O +
stimuli O +
, O +
including O +
expression O +
of O +
IKK B-Gene +
beta I-Gene +
. O +

Therefore O +
, O +
in O +
addition O +
to O +
the O +
phosphorylation O +
of O +
I B-Gene +
kappa I-Gene +
B I-Gene +
, O +
another O +
signal O +
is O +
needed O +
for O +
transcriptional O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
. O +

A20 B-Gene +
inhibits O +
this O +
non O +
- O +
redundant O +
signal O +
. O +

The O +
observation O +
that O +
A20 B-Gene +
associates O +
with O +
IKK B-Gene +
alpha I-Gene +
and O +
is O +
phosphorylated O +
upon O +
IKK B-Gene +
beta I-Gene +
co O +
- O +
expression O +
may O +
suggest O +
that O +
A20 B-Gene +
interferes O +
with O +
some O +
aspects O +
of O +
signalosome O +
function O +
. O +

Genetic O +
factors O +
in O +
the O +
development O +
of O +
gastric O +
precancerous O +
lesions O +
-- O +
a O +
role O +
of O +
Helicobacter O +
pylori O +
? O +

Helicobacter O +
pylori O +
is O +
believed O +
to O +
predispose O +
to O +
gastric O +
cancer O +
by O +
inducing O +
gastric O +
precancerous O +
alterations O +
. O +

There O +
is O +
a O +
well O +
known O +
predisposition O +
to O +
gastric O +
cancer O +
and O +
the O +
risk O +
of O +
developing O +
it O +
is O +
greater O +
in O +
relatives O +
of O +
patients O +
with O +
familial O +
cases O +
of O +
this O +
malignancy O +
. O +

The O +
aim O +
of O +
this O +
study O +
was O +
to O +
determine O +
the O +
prevalence O +
of O +
gastric O +
precancerous O +
lesions O +
( O +
atrophy O +
and O +
intestinal O +
metaplasia O +
) O +
and O +
their O +
association O +
with O +
Hp O +
infection O +
in O +
first O +
- O +
degree O +
relatives O +
in O +
patients O +
with O +
noncardia O +
gastric O +
cancer O +
. O +

METHODS O +
: O +

Hp O +
status O +
and O +
gastric O +
histology O +
assessed O +
by O +
upper O +
gastrointestinal O +
endoscopy O +
, O +
biopsies O +
from O +
the O +
antral O +
and O +
body O +
region O +
, O +
the O +
rapid O +
urease O +
test O +
and O +
staining O +
for O +
Hp O +
, O +
inflammation O +
, O +
activity O +
, O +
atrophy O +
and O +
intestinal O +
metaplasia O +
( O +
prevalence O +
and O +
grading O +
) O +
were O +
studied O +
in O +
108 O +
first O +
- O +
degree O +
relatives O +
of O +
patients O +
with O +
noncardia O +
gastric O +
cancer O +
and O +
compared O +
with O +
73 O +
controls O +
with O +
mild O +
non O +
- O +
ulcer O +
dyspepsia O +
who O +
had O +
no O +
cancer O +
relatives O +
and O +
were O +
examined O +
in O +
the O +
same O +
way O +
. O +

RESULTS O +
: O +

subjects O +
with O +
and O +
without O +
cancer O +
relatives O +
had O +
a O +
similar O +
prevalence O +
of O +
Hp O +
infection O +
( O +
49 O +
vs. O +
47 O +
% O +
) O +
. O +

Endoscopy O +
revealed O +
a O +
few O +
asymptomatic O +
duodenal O +
ulcers O +
and O +
small O +
hiatus O +
hernias O +
in O +
Hp O +
positive O +
subjects O +
of O +
both O +
groups O +
. O +

Hp O +
positive O +
relatives O +
of O +
gastric O +
cancer O +
had O +
a O +
markedly O +
higher O +
prevalence O +
of O +
atrophy O +
than O +
those O +
with O +
Hp O +
negativity O +
without O +
cancer O +
relatives O +
( O +
29 O +
vs. O +
9 O +
% O +
) O +
and O +
those O +
with O +
Hp O +
negativity O +
and O +
cancer O +
relatives O +
( O +
29 O +
vs. O +
3 O +
% O +
. O +
Prevalence O +
of O +
intestinal O +
metaplasia O +
was O +
also O +
higher O +
in O +
those O +
with O +
Hp O +
positivity O +
and O +
cancer O +
relatives O +
than O +
in O +
those O +
without O +
cancer O +
relatives O +
( O +
15 O +
vs. O +
5 O +
% O +
and O +
was O +
not O +
present O +
in O +
Hp O +
negative O +
subjects O +
with O +
cancer O +
relatives O -
. O +
Inflammation O +
and O +
activity O +
showed O +
similar O +
scores O +
in O +
subjects O +
with O +
and O +
without O +
cancer O +
relatives O +
with O +
higher O +
scores O +
in O +
both O +
Hp O +
positive O +
groups O +
. O +

The O +
prevalence O +
of O +
precancerous O +
lesions O +
in O +
the O +
relatives O +
of O +
gastric O +
cancer O +
was O +
nearly O +
always O +
confined O +
to O +
those O +
with O +
Hp O +
positivity O +
. O +

One O +
year O +
after O +
eradication O +
the O +
prevalence O +
of O +
atrophy O +
in O +
cancer O +
relatives O +
decreased O +
from O +
29 O +
to O +
14 O +
% O +
; O +
prevalence O +
of O +
intestinal O +
metaplasia O +
remained O +
without O +
substantial O +
changes O +
. O +

Scores O +
for O +
inflammation O +
and O +
activity O +
were O +
also O +
lower O +
after O +
eradication O +
. O +

CONCLUSIONS O +
: O +

First O +
- O +
degree O +
relatives O +
of O +
patients O +
with O +
gastric O +
cancer O +
have O +
an O +
increased O +
prevalence O +
of O +
gastric O +
precancerous O +
abnormalities O +
which O +
are O +
strongly O +
confined O +
to O +
those O +
with O +
Hp O +
infection O +
. O +

Eradication O +
of O +
Hp O +
in O +
these O +
subjects O +
with O +
cancer O +
relatives O +
reduces O +
the O +
prevalence O +
of O +
precancerous O +
lesions O +
( O +
atrophy O +
) O +
and O +
grades O +
of O +
inflammation O +
and O +
activity O +
. O +

In O +
view O +
of O +
these O +
results O +
, O +
eradication O +
of O +
Hp O +
should O +
be O +
offered O +
to O +
such O +
subjects O +
. O +

Cloning O +
and O +
characterization O +
of O +
Plx2 B-Gene +
and O +
Plx3 B-Gene +
, O +
two O +
additional O +
Polo B-Gene +
- I-Gene +
like I-Gene +
kinases I-Gene +
from O +
Xenopus O +
laevis O +
. O +

Members O +
of O +
the O +
family B-Gene +
of I-Gene +
Polo I-Gene +
- I-Gene +
like I-Gene +
kinases I-Gene +
are O +
implicated O +
in O +
the O +
regulation O +
of O +
cell O +
cycle O +
progression O +
in O +
all O +
eukaryotes O +
. O +

In O +
Xenopus O +
laevis O +
, O +
only O +
one O +
member O +
of O +
this O +
family O +
, O +
Plx1 B-Gene +
, O +
has O +
previously O +
been O +
described O +
. O +

Here O +
we O +
report O +
the O +
cloning O +
and O +
characterization O +
of O +
X. O +
laevis O +
Plx2 B-Gene +
and O +
Plx3 B-Gene +
, O +
the O +
likely O +
homologs O +
of O +
mammalian O +
Plk2 B-Gene +
( O +
Snk B-Gene +
) O +
and O +
Plk3 B-Gene +
( O +
Fnk B-Gene +
/ O +
Prk B-Gene +
) O +
, O +
respectively O +
. O +

RNA O +
expression O +
studies O +
indicate O +
that O +
all O +
three O +
Xenopus O +
Plks B-Gene +
are O +
present O +
in O +
both O +
oocytes O +
and O +
unfertilized O +
eggs O +
. O +

Further O +
analysis O +
by O +
in O +
situ O +
hybridization O +
revealed O +
that O +
Plx1 B-Gene +
RNA O +
is O +
ubiquitously O +
expressed O +
in O +
early O +
embryos O +
, O +
but O +
shows O +
more O +
restricted O +
expression O +
at O +
later O +
stages O +
. O +

In O +
contrast O +
, O +
Plx2 B-Gene +
and O +
Plx3 B-Gene +
expression O +
is O +
highly O +
restricted O +
in O +
both O +
early O +
and O +
late O +
- O +
stage O +
embryos O +
. O +

Using O +
Plx B-Gene +
- O +
specific O +
antisera O +
, O +
Plx1 B-Gene +
and O +
Plx3 B-Gene +
polypeptides O +
could O +
readily O +
be O +
detected O +
on O +
immunoblots O +
of O +
oocyte O +
and O +
egg O +
extracts O +
. O +

Both O +
Plx1 B-Gene +
and O +
Plx3 B-Gene +
protein O +
levels O +
remained O +
virtually O +
constant O +
during O +
oocyte O +
maturation O +
. O +

However O +
, O +
whereas O +
Plx1 B-Gene +
is O +
more O +
active O +
in O +
M O +
phase O +
than O +
in O +
I O +
phase O +
( O +
P. O +
Descombes O +
and O +
E. O +
A. O +
Nigg O +
( O +
1998 O +
) O +
EMBO O +
J. O +
17 O +
, O +
1328 O +
- O +
1335 O +
) O +
, O +
Plx3 B-Gene +
protein O +
and O +
activity O +
levels O +
remained O +
constant O +
upon O +
release O +
of O +
meiotic O +
metaphase O +
II O +
- O +
arrested O +
egg O +
extracts O +
into O +
interphase O +
. O +

Finally O +
, O +
microinjection O +
of O +
in O +
vitro O +
- O +
transcribed O +
RNAs O +
for O +
Plx1 B-Gene +
, O +
Plx2 B-Gene +
, O +
and O +
Plx3 B-Gene +
increased O +
the O +
rate O +
of O +
progesterone O +
- O +
induced O +
oocyte O +
maturation O +
, O +
and O +
concomitantly O +
, O +
all O +
three O +
kinases B-Gene +
became O +
activated O +
. O +

Conversely O +
, O +
overexpression O +
of O +
the O +
corresponding O +
catalytically O +
inactive O +
kinases B-Gene +
delayed O +
maturation O +
. O +

This O +
suggests O +
that O +
, O +
at O +
least O +
in O +
oocytes O +
, O +
all O +
three O +
kinases B-Gene +
may O +
be O +
regulated O +
by O +
similar O +
mechanisms O +
, O +
and O +
they O +
may O +
also O +
share O +
common O +
substrates O +
. O +

However O +
, O +
the O +
strikingly O +
restricted O +
pattern O +
of O +
expression O +
of O +
Plx2 B-Gene +
and O +
Plx3 B-Gene +
observed O +
in O +
embryos O +
strongly O +
suggests O +
that O +
individual O +
Plk B-Gene +
family I-Gene +
members O +
perform O +
at O +
least O +
partly O +
distinct O +
functions O +
at O +
later O +
stages O +
of O +
development O +
. O +

Isolation O +
and O +
characterization O +
of O +
a O +
novel O +
cDNA O +
, O +
UBAP1 B-Gene +
, O +
derived O +
from O +
the O +
tumor O +
suppressor O +
locus O +
in O +
human O +
chromosome O +
9p21 O +
- O +
22 O +
. O +

PURPOSE O +
: O +

To O +
clone O +
the O +
putative O +
tumor O +
suppressor O +
gene O -
( O -
s O -
) O +
in O +
a O +
refined O +
region O +
at O +
9p21 O -
- O -
22 O +
undergoing O +
loss O +
of O +
heterozygosity O +
in O +
nasopharyngeal O +
carcinoma O +
( O +
NPC O +
) O +
. O +

METHODS O +
: O +

We O +
systematically O +
screened O +
the O +
expression O +
patterns O +
of O +
25 O +
novel O +
ESTs O +
( O +
expressed O +
sequence O +
tags O +
) O +
in O +
a O +
minimal O +
common O +
deleted O +
region O +
of O +
9p21 O -
- O -
22 O +
in O +
NPC O +
. O +

One O +
of O +
these O +
ESTs O +
was O +
found O +
down O +
- O +
regulated O +
in O +
NPC O +
. O +

Subsequently O +
, O +
the O +
corresponding O +
gene O +
sequence O +
of O +
this O +
EST O +
was O +
established O +
by O +
cDNA O +
cloning O +
and O +
RACE O +
( O +
rapid O +
amplification O +
of O +
cDNA O +
end O +
) O +
procedures O +
. O +

Furthermore O +
, O +
a O +
mouse O +
homologue O +
of O +
this O +
gene O +
was O +
identified O +
. O +

The O +
expression O +
of O +
this O +
gene O +
was O +
examined O +
using O +
Northern O +
blot O +
or O +
reverse O +
transcription O +
- O +
polymerase O +
chain O +
reaction O +
( O +
RT O +
- O +
PCR O +
) O +
in O +
various O +
human O +
and O +
mouse O +
tissues O +
. O +

A O +
limited O +
screen O +
for O +
mutation O +
of O +
coding O +
sequence O +
of O +
this O +
novel O +
human O +
gene O +
was O +
undertaken O +
using O +
RT O +
- O +
PCR O +
and O +
direct O +
sequencing O +
analysis O +
. O +

RESULTS O +
: O +

A O +
novel O +
gene O +
was O +
cloned O +
. O +

This O +
gene O +
is O +
a O +
new O +
member O +
of O +
the O +
UBA O +
domain O +
family O +
, O +
so O +
we O +
named O +
it O +
UBAPI B-Gene +
for O +
ubiquitin B-Gene +
- I-Gene +
associated I-Gene +
protein I-Gene +
1 I-Gene +
( O +
HUGO O +
Gene O +
Nomenclature O +
Committee O +
- O +
approved O +
symbol O +
) O +
. O +

Northern O +
blot O +
and O +
RT O +
- O +
PCR O +
analysis O +
demonstrate O +
a O +
ubiquitous O +
pattern O +
of O +
gene O +
expression O +
in O +
human O +
and O +
mouse O +
tissues O +
. O +

The O +
direct O +
sequencing O +
analysis O +
of O +
the O +
coding O +
region O +
of O +
hUBAP1 B-Gene +
following O +
RT O +
- O +
PCR O +
failed O +
to O +
reveal O +
any O +
mutations O +
in O +
a O +
preliminary O +
screen O +
of O +
NPC O +
cell O +
line O +
HNE1 O +
and O +
primary O +
nasopharyngeal O +
carcinoma O +
samples O +
. O +

CONCLUSIONS O +
: O +

We O +
cloned O +
a O +
novel O +
gene O +
UBAPI B-Gene +
, O +
which O +
is O +
highly O +
conserved O +
between O +
human O +
and O +
mouse O +
. O +

Clearly O +
, O +
as O +
a O +
novel O +
member O +
of O +
UBA O +
domain O +
protein O +
family O +
and O +
taking O +
its O +
map O +
location O +
into O +
account O +
, O +
a O +
more O +
extensive O +
analysis O +
is O +
essential O +
to O +
establish O +
whether O +
subtle O +
mutations O +
are O +
present O +
in O +
nasopharyngeal O +
carcinomas O +
. O +

Sequence O +
analysis O +
of O +
a O +
fish O +
vitellogenin B-Gene +
cDNA O +
with O +
a O +
large O +
phosvitin B-Gene +
domain O +
. O +

Vitellogenins B-Gene +
( O +
Vtg O +
) O +
are O +
egg O +
- O +
yolk O +
precursor O +
proteins O +
crucial O +
for O +
reproductive O +
success O +
in O +
oviparous O +
animals O +
. O +

We O +
have O +
cloned O +
the O +
first O +
complete O +
cichlid O +
Vtg B-Gene +
cDNA O +
from O +
the O +
tilapia O +
fish O +
, O +
Oreochromis O +
aureus O +
. O +

This O +
cDNA O +
has O +
the O +
largest O +
phosvitin B-Gene +
( O +
PV B-Gene +
) O +
domain O +
amongst O +
piscine O +
Vtgs B-Gene +
, O +
being O +
comparable O +
to O +
those O +
of O +
lamprey O +
, O +
Xenopus O +
, O +
and O +
chicken O +
. O +

Thus O +
, O +
the O +
size O +
of O +
PV B-Gene +
is O +
independent O +
of O +
the O +
evolutionary O +
advancement O +
of O +
a O +
species O +
. O +

The O +
closer O +
interspecific O +
relationship O +
between O +
O. O +
aureus O +
Vtg1 B-Gene +
and O +
Fundulus O +
VtgII B-Gene +
than O +
the O +
intraspecific O +
relationship O +
between O +
Fundulus O +
VtgI B-Gene +
and I-Gene +
II I-Gene +
isoforms O +
suggests O +
that O +
teleost O +
ancestors O +
had O +
at O +
least O +
two O +
Vtg B-Gene +
isoforms O +
. O +

Contrary O +
to O +
the O +
results O +
of O +
previous O +
phylogenetic O +
inference O +
using O +
Vtgs B-Gene +
which O +
indicate O +
that O +
insect O +
lineage O +
is O +
most O +
diverged O +
and O +
nematodes O +
are O +
closer O +
to O +
vertebrate O +
lineage O +
, O +
our O +
results O +
show O +
that O +
nematodes O +
and O +
hexapods O +
form O +
two O +
monophyletic O +
sister O +
groups O +
. O +

Another O +
arthropod O +
taxon O +
, O +
represented O +
by O +
a O +
malacostracan O +
crustacean O +
, O +
Penaeus O +
japonicus O +
, O +
appears O +
to O +
be O +
more O +
closely O +
related O +
to O +
the O +
vertebrates O +
than O +
the O +
hexapods O +
. O +

NHE6 B-Gene +
protein O +
possesses O +
a O +
signal O +
peptide O +
destined O +
for O +
endoplasmic O +
reticulum O +
membrane O +
and O +
localizes O +
in O +
secretory O +
organelles O +
of O +
the O +
cell O +
. O +

The O +
NHE6 B-Gene +
protein O +
is O +
a O +
unique O +
Na B-Gene +
( I-Gene +
+ I-Gene +
) I-Gene +
/ I-Gene +
H I-Gene -
( I-Gene -
+ I-Gene -
) I-Gene +
exchanger I-Gene +
isoform O +
believed O +
to O +
localize O +
in O +
mitochondria O +
. O +

It O +
possesses O +
a O +
hydrophilic O +
N O +
- O +
terminal O +
portion O +
that O +
is O +
rich O +
in O +
positively O +
charged O +
residues O +
and O +
many O +
hydrophobic O +
segments O +
. O +

In O +
the O +
present O +
study O +
, O +
signal O +
sequences O +
in O +
the O +
NHE6 B-Gene +
molecule O +
were O +
examined O +
for O +
organelle O +
localization O +
and O +
membrane O +
topogenesis O +
. O +

When O +
the O +
full O +
- O +
length O +
protein O +
was O +
expressed O +
in O +
COS7 O +
cells O +
, O +
it O +
localized O +
in O +
the O +
endoplasmic O +
reticulum O +
and O +
on O +
the O +
cell O +
surface O +
. O +

Furthermore O +
, O +
the O +
protein O +
was O +
fully O +
N O -
- O -
glycosylated O +
. O +

When O +
green B-Gene +
fluorescent I-Gene +
protein I-Gene +
was O +
fused O +
after O +
the O +
second O +
( O +
H2 O +
) O +
or O +
third O +
( O +
H3 O +
) O +
hydrophobic O +
segment O +
, O +
the O +
fusion O +
proteins O +
were O +
targeted O +
to O +
the O +
endoplasmic O +
reticulum O +
( O +
ER O +
) O +
membrane O +
. O +

The O +
localization O +
pattern O +
was O +
the O +
same O +
as O +
that O +
of O +
fusion O +
proteins O +
in O +
which O +
green B-Gene +
fluorescent I-Gene +
protein I-Gene +
was O +
fused O +
after O +
H2 O +
of O +
NHE1 B-Gene +
. O +

In O +
an O +
in O +
vitro O +
system O +
, O +
H1 O +
behaved O +
as O +
a O +
signal O +
peptide O +
that O +
directs O +
the O +
translocation O +
of O +
the O +
following O +
polypeptide O +
chain O +
and O +
is O +
then O +
processed O +
off O +
. O +

The O +
next O +
hydrophobic O +
segment O +
( O +
H2 O +
) O +
halted O +
translocation O +
and O +
eventually O +
became O +
a O +
transmembrane O +
segment O +
. O +

The O +
N O +
- O +
terminal O +
hydrophobic O +
segment O +
( O +
H1 O +
) O +
of O +
NHE1 B-Gene +
also O +
behaved O +
as O +
a O +
signal O +
peptide O +
. O +

Cell O +
fractionation O +
studies O +
using O +
antibodies O +
against O +
the O +
15 O +
C O +
- O +
terminal O +
residues O +
indicated O +
that O +
NHE6 B-Gene +
protein O +
localized O +
in O +
the O +
microsomal O +
membranes O +
of O +
rat O +
liver O +
cells O +
. O +

All O +
of O +
the O +
NHE6 B-Gene +
molecules O +
in O +
liver O +
tissue O +
possess O +
an O +
endoglycosidase B-Gene +
H I-Gene +
- O +
resistant O +
sugar O +
chain O +
. O +

These O +
findings O +
indicate O +
that O +
NHE6 B-Gene +
protein O +
is O +
targeted O +
to O +
the O +
ER O +
membrane O +
via O +
the O +
N O +
- O +
terminal O +
signal O +
peptide O +
and O +
is O +
sorted O +
to O +
organelle O +
membranes O +
derived O +
from O +
the O +
ER O +
membrane O +
. O +

17 B-Gene +
beta I-Gene -
- I-Gene -
Hydroxysteroid I-Gene +
dehydrogenase I-Gene +
type I-Gene +
2 I-Gene +
expression O +
and O +
enzyme O +
activity O +
in O +
the O +
human O +
gastrointestinal O +
tract O +
. O +

The O +
17 B-Gene +
beta I-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenases I-Gene +
( O +
17 B-Gene +
beta I-Gene +
HSDs I-Gene +
) O +
play O +
an O +
important O +
role O +
in O +
the O +
regulation O +
of O +
intracellular O +
levels O +
of O +
biologically O +
active O +
sex O +
steroid O +
hormones O +
in O +
various O +
human O +
tissues O +
. O +

To O +
date O +
, O +
eight O +
distinctive O +
17 B-Gene +
beta I-Gene +
HSD I-Gene +
enzymes O +
have O +
been O +
cloned O +
and O +
characterized O +
in O +
humans O +
. O +

Among O +
these O +
isoenzymes O +
, O +
17 B-Gene +
beta I-Gene +
HSD I-Gene +
type I-Gene +
2 I-Gene +
( O +
17 B-Gene +
beta I-Gene +
HSD2 I-Gene +
) O +
catalyses O +
the O +
conversion O +
of O +
testosterone O +
into O +
androstenedione O +
and/or O +
oestradiol O +
into O +
oestrone O +
in O +
various O +
tissues O +
, O +
and O +
it O +
has O +
thus O +
been O +
suggested O +
to O +
be O +
involved O +
in O +
the O +
biological O +
inactivation O +
of O +
these O +
sex O +
steroids O +
. O +

The O +
human O +
gastrointestinal O +
tract O +
and O +
liver O +
are O +
considered O +
as O +
the O +
principle O +
sites O +
of O +
inactivation O +
and O +
metabolism O +
of O +
various O +
forms O +
of O +
orally O +
administered O +
sex O +
steroids O +
. O +

We O +
therefore O +
examined O +
17 B-Gene +
beta I-Gene +
HSD2 I-Gene +
expression O +
and O +
activity O +
in O +
human O +
adult O +
non O +
- O +
pathological O +
gastrointestinal O +
tract O +
in O +
order O +
to O +
clarify O +
further O +
the O +
biological O +
significance O +
of O +
this O +
enzyme O +
. O +

A O +
total O +
of O +
80 O +
specimens O +
( O +
40 O +
from O +
males O +
and O +
40 O +
from O +
females O +
) O +
of O +
normal O +
oesophageal O +
, O +
stomach O +
, O +
duodenal O +
, O +
ileal O +
, O +
colonic O +
and O +
rectal O +
tissues O +
were O +
examined O +
for O +
immunohistochemistry O +
. O +

Altogether O +
, O +
17 O +
tissue O +
specimens O +
were O +
used O +
for O +
enzyme O +
assay O +
, O +
and O +
eight O +
for O +
RNA O +
analysis O +
. O +

17 B-Gene +
beta I-Gene +
HSD2 I-Gene +
activity O +
was O +
detected O +
in O +
the O +
stomach O +
, O +
duodenum O +
, O +
ileum O +
, O +
colon O +
and O +
rectum O +
. O +

17 B-Gene +
beta I-Gene +
HSD2 I-Gene +
mRNA O +
was O +
most O +
abundant O +
in O +
the O +
small O +
intestine O +
. O +

17 B-Gene +
beta I-Gene +
HSD2 I-Gene +
immunoreactivity O +
was O +
localized O +
almost O +
exclusively O +
to O +
the O +
absorptive O +
epithelium O +
, O +
which O +
may O +
be O +
involved O +
in O +
the O +
inactivation O +
of O +
excessive O +
endogenous O +
and O +
exogenous O +
active O +
sex O +
steroids O +
. O +

Results O +
from O +
the O +
present O +
study O +
thus O +
suggest O +
that O +
the O +
human O +
gastrointestinal O +
tract O +
is O +
an O +
important O +
sex O +
steroid O +
metabolizing O +
organ O +
in O +
humans O +
. O +

The O +
presence O +
of O +
chemokine B-Gene +
receptor I-Gene +
( O +
CCR5 B-Gene +
, O +
CXCR3 B-Gene +
, O +
CCR3 B-Gene +
) O +
- O +
positive O +
cells O +
and O +
chemokine B-Gene +
( O +
MCP1 B-Gene +
, O +
MIP-1alpha B-Gene +
, O +
MIP-1beta B-Gene +
, O +
IP-10 B-Gene +
) O +
- O +
positive O +
cells O +
in O +
human O +
periapical O +
granulomas O +
. O +

The O +
infiltration O +
of O +
leukocytes O +
into O +
inflammation O +
sites O +
such O +
as O +
observed O +
in O +
human O +
periapical O +
granulomas O +
is O +
considered O +
to O +
be O +
mediated O +
by O +
chemotactic O +
factors O +
. O +

In O +
this O +
study O +
, O +
we O +
examined O +
the O +
presence O +
of O +
chemokine B-Gene +
- O +
and O +
chemokine B-Gene +
receptor I-Gene +
- O +
positive O +
cells O +
in O +
samples O +
obtained O +
from O +
human O +
subjects O +
by O +
means O +
of O +
immunohistochemical O +
methods O +
. O +

Macrophage B-Gene +
chemotactic I-Gene +
protein-1 I-Gene +
( O +
MCP-1 B-Gene +
) O +
, O +
macrophage B-Gene +
inflammatory I-Gene +
protein I-Gene +
( I-Gene +
MIP I-Gene +
) I-Gene +
- I-Gene +
1alpha I-Gene +
, O +
MIP-1beta B-Gene +
and O +
IFN B-Gene +
- I-Gene +
inducible I-Gene +
protein I-Gene +
10 I-Gene +
( O +
IP-10 B-Gene +
) O +
- O +
producing O +
cells O +
were O +
present O +
in O +
periapical O +
granulomas O +
. O +

In O +
addition O +
, O +
chemokine B-Gene +
receptor I-Gene +
CCR3 B-Gene +
- O +
, O +
CCR5 B-Gene +
- O +
, O +
and O +
CXCR3 B-Gene +
- O +
positive O +
cells O +
were O +
also O +
present O +
. O +

In O +
contrast O +
, O +
no O +
factor O +
expression O +
was O +
observed O +
in O +
clinically O +
healthy O +
periodontal O +
ligament O +
, O +
serving O +
as O +
a O +
negative O +
control O +
. O +

Our O +
findings O +
suggest O +
that O +
these O +
chemokines B-Gene +
are O +
responsible O +
for O +
modulating O +
the O +
process O +
of O +
disease O +
, O +
such O +
as O +
human O +
apical O +
periodontitis O +
. O +

Serine O +
- O +
arginine O +
( O +
SR O +
) O +
protein O +
- O +
like O +
factors O +
that O +
antagonize O +
authentic O +
SR O +
proteins O +
and O +
regulate O +
alternative O +
splicing O +
. O +

We O +
have O +
characterized O +
two O +
RNA O +
- O +
binding O +
proteins O +
, O +
of O +
apparent O +
molecular O +
masses O +
of O +
approximately O +
40 O +
and O +
35 O +
kDa O +
, O +
which O +
possess O +
a O +
single O +
N O +
- O +
terminal O +
RNA O +
- O +
recognition O +
motif O +
( O +
RRM O +
) O +
followed O +
by O +
a O +
C O +
- O +
terminal O +
domain O +
rich O +
in O +
serine O +
- O +
arginine O +
dipeptides O +
. O +

Their O +
primary O +
structures O +
resemble O +
the O +
single O +
- O +
RRM O +
serine O +
- O +
arginine O +
( O +
SR O +
) O +
protein O +
, O +
SC35 B-Gene +
; O +
however O +
their O +
functional O +
effects O +
are O +
quite O +
distinctive O +
. O +

The O +
40 O +
- O +
kDa O +
protein O +
can O -
not O +
complement O +
SR O +
protein O +
- O +
deficient O +
HeLa O +
cell O +
S100 O +
extract O +
and O +
showed O +
a O +
dominant O +
negative O +
effect O +
in O +
vitro O +
against O +
the O +
authentic O +
SR O +
proteins O +
, O +
SF2 B-Gene +
/ O +
ASF B-Gene +
and O +
SC35 B-Gene +
. O +

Interestingly O +
, O +
the O +
40 O +
- O +
and O +
35 O +
- O +
kDa O +
proteins O +
antagonize O +
SR O +
proteins O +
and O +
activate O +
the O +
most O +
distal O +
alternative O +
5 O -
' O +
splice O +
site O +
of O +
adenovirus O +
E1A B-Gene +
pre O +
- O +
mRNA O +
in O +
vivo O +
, O +
an O +
activity O +
that O +
is O +
similar O +
to O +
that O +
characterized O +
previously O +
for O +
the O +
heterogeneous O +
nuclear O +
ribonucleoprotein O +
particles O +
A O +
/ O +
B O +
group O +
of O +
proteins O +
. O +

A O +
series O +
of O +
recombinant O +
chimeric O +
proteins O +
consisting O +
of O +
domains O +
from O +
these O +
proteins O +
and O +
SC35 B-Gene +
in O +
various O +
combinations O +
showed O +
that O +
the O +
RRM O +
, O +
but O +
not O +
the O +
C O +
- O +
terminal O +
domain O +
rich O +
in O +
serine O +
- O +
arginine O +
dipeptides O +
, O +
has O +
a O +
dominant O +
role O +
in O +
this O +
activity O +
. O +

Because O +
of O +
the O +
similarity O +
to O +
SR O +
proteins O +
we O +
have O +
named O +
these O +
proteins O +
SRrp40 B-Gene +
and O +
SRrp35 B-Gene +
, O +
respectively O +
, O +
for O +
SR O -
- O -
repressor O +
proteins O +
of O +
approximately O +
40 O +
and O +
approximately O +
35 O +
kDa O +
. O +

Both O +
factors O +
show O +
tissue O +
- O +
and O +
cell O +
type O +
- O +
specific O +
patterns O +
of O +
expression O +
. O +

We O +
propose O +
that O +
these O +
two O +
proteins O +
are O +
SR O +
protein O +
- O +
like O +
alternative O +
splicing O +
regulators O +
that O +
antagonize O +
authentic O +
SR O +
proteins O +
in O +
the O +
modulation O +
of O +
alternative O +
5 O -
' O +
splice O +
site O +
choice O +
. O +

Expression O +
pattern O +
of O +
human O +
P2Y B-Gene +
receptor I-Gene +
subtypes O +
: O +
a O +
quantitative O +
reverse O +
transcription O +
- O +
polymerase O +
chain O +
reaction O +
study O +
. O +

The O +
diverse O +
biological O +
actions O +
of O +
extracellular O +
nucleotides O +
in O +
tissues O +
and O +
cells O +
are O +
mediated O +
by O +
two O +
distinct O +
classes O +
of O +
P2 B-Gene +
receptor I-Gene +
, O +
P2X B-Gene +
and O +
P2Y B-Gene +
. O +

The O +
G B-Gene +
protein I-Gene +
- O +
coupled O +
P2Y B-Gene +
receptors I-Gene +
comprise O +
at O +
least O +
six O +
mammalian O +
subtypes O +
( O +
P2Y B-Gene -
( I-Gene -
1,2,4,6,11,12 I-Gene -
) I-Gene +
) O +
, O +
all O +
of O +
which O +
have O +
been O +
cloned O +
from O +
human O +
tissues O +
, O +
as O +
well O +
as O +
other O +
species O +
. O +

The O +
P2Y B-Gene +
receptor I-Gene +
subtypes O +
differ O +
in O +
their O +
pharmacological O +
selectivity O +
for O +
various O +
adenosine O +
and O +
uridine O +
nucleotides O +
, O +
which O +
overlap O +
in O +
some O +
cases O +
. O +

Data O +
concerning O +
the O +
mRNA O +
expression O +
patterns O +
of O +
five O +
P2Y B-Gene +
receptors I-Gene +
( O +
P2Y B-Gene -
( I-Gene -
1,2,4,6,11 I-Gene -
) I-Gene +
) O +
in O +
different O +
human O +
tissues O +
and O +
cells O +
are O +
currently O +
quite O +
limited O +
, O +
while O +
P2Y B-Gene +
mRNA O +
distribution O +
in O +
the O +
human O +
brain O +
has O +
not O +
previously O +
been O +
studied O +
. O +

In O +
this O +
study O +
, O +
we O +
have O +
addressed O +
this O +
deficiency O +
in O +
receptor O +
expression O +
data O +
by O +
using O +
a O +
quantitative O +
reverse O +
transcription O +
- O +
polymerase O +
chain O +
reaction O +
approach O +
to O +
measure O +
the O +
precise O +
mRNA O +
expression O +
pattern O +
of O +
each O +
P2Y B-Gene +
receptor I-Gene +
subtype O +
in O +
a O +
number O +
of O +
human O +
peripheral O +
tissues O +
and O +
brain O +
regions O +
, O +
from O +
multiple O +
individuals O +
, O +
as O +
well O +
as O +
numerous O +
human O +
cell O +
lines O +
and O +
primary O +
cells O +
. O +

All O +
five O +
P2Y B-Gene +
receptors I-Gene +
exhibited O +
widespread O +
yet O +
subtype O +
- O +
selective O +
mRNA O +
expression O +
profiles O +
throughout O +
the O +
human O +
tissues O +
, O +
brain O +
regions O +
and O +
cells O +
used O +
. O +

Our O +
extensive O +
expression O +
data O +
indicate O +
the O +
many O +
potentially O +
important O +
roles O +
of O +
P2Y B-Gene +
receptors I-Gene +
throughout O +
the O +
human O +
body O +
, O +
and O +
will O +
help O +
in O +
elucidating O +
the O +
physiological O +
function O +
of O +
each O +
receptor O +
subtype O +
in O +
a O +
wide O +
variety O +
of O +
human O +
systems O +
. O +

Expression O +
and O +
function O +
of O +
adrenomedullin B-Gene +
and O +
its O +
receptors O +
in O +
Conn O +
's O +
adenoma O +
cells O +
. O +

Adrenomedullin B-Gene +
( O +
ADM B-Gene +
) O +
is O +
a O +
hypotensive O +
peptide O +
, O +
that O +
derives O +
from O +
the O +
proteolytic O +
cleavage O +
of O +
pro O -
( O -
p O -
) O +
ADM B-Gene +
and O +
acts O +
through O +
two O +
subtypes O +
of O +
receptors O +
, O +
called O +
L1 B-Gene +
- I-Gene +
receptor I-Gene +
( O +
L1-R B-Gene +
) O +
and O +
calcitonin B-Gene +
receptor I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( O +
CRLR B-Gene +
) O +
. O +

CRLR B-Gene +
may O +
function O +
as O +
a O +
calcitonin B-Gene +
gene I-Gene +
- I-Gene +
related I-Gene +
peptide I-Gene +
or O +
a O +
selective O +
ADM B-Gene +
receptor O +
depending O +
on O +
the O +
expression O +
of O +
the O +
subtype O +
1 O +
or O +
the O +
subtypes O +
2 O +
and O +
3 O +
of O +
a O +
family O +
of O +
proteins O +
, O +
named O +
receptor B-Gene +
- I-Gene +
activity I-Gene +
modifying I-Gene +
proteins I-Gene +
( O +
RAMPs B-Gene +
) O +
. O +

Reverse O +
transcription O +
( O +
RT O +
) O +
- O +
polymerase O +
chain O +
reaction O +
( O +
PCR O +
) O +
allowed O +
the O +
detection O +
of O +
pADM B-Gene +
mRNA O +
in O +
dispersed O +
cells O +
of O +
eight O +
Conn O +
's O +
adenomas O +
( O +
aldosteronomas O +
) O +
. O +

These O +
cells O +
also O +
expressed O +
peptidyl B-Gene +
- I-Gene +
glycine I-Gene +
alpha I-Gene -
- I-Gene -
amidating I-Gene +
monooxigenase I-Gene +
, O +
the O +
enzyme O +
converting O +
immature O +
ADM B-Gene +
to O +
the O +
mature O +
form O +
, O +
and O +
contained O +
sizeable O +
amounts O +
of O +
ADM B-Gene +
- O +
immunoreactivity O +
as O +
measured O +
by O +
radioimmunoassay O +
. O +

RT O +
- O +
PCR O +
also O +
demonstrated O +
the O +
presence O +
in O +
aldosteronoma O +
cells O +
of O +
the O +
specific O +
mRNAs O +
of O +
L1-R B-Gene +
, O +
CRLR B-Gene +
and O +
RAMPs B-Gene +
1 I-Gene -
- I-Gene -
3 I-Gene +
. O +

ADM B-Gene +
( O +
10 O -
( O -
-8 O -
) O +
M O +
) O +
inhibited O +
angiotensin B-Gene +
- I-Gene +
II I-Gene +
( O +
10 O -
( O -
-9 O -
) O +
M O +
) O +
- O +
simulated O +
aldosterone O +
secretion O +
from O +
cultured O +
aldosteronoma O +
cells O +
, O +
without O +
affecting O +
basal O +
production O +
. O +

ADM B-Gene +
( O +
10 O -
( O -
-8 O -
) O +
M O +
) O +
also O +
enhanced O +
basal O +
proliferation O +
rate O +
of O +
cultured O +
cells O +
, O +
as O +
estimated O +
by O +
the O +
5-bromo-2 O -
' O +
- O +
deoxyuridine O +
immunocytochemical O +
technique O +
. O +

Both O +
effects O +
of O +
ADM B-Gene +
were O +
annulled O +
by O +
the O +
ADM B-Gene +
- O +
receptor O +
selective O +
antagonist O +
ADM22 B-Gene -
- I-Gene -
52 I-Gene +
( O +
10 O -
( O -
-7 O -
) O +
M O +
) O +
. O +

In O +
conclusion O +
, O +
our O +
study O +
provides O +
evidence O +
that O +
aldosteronoma O +
cells O +
express O +
both O +
ADM B-Gene +
and O +
ADM22 B-Gene +
- O +
52 O +
- O +
sensitive O +
receptors O +
. O +

These O +
findings O +
, O +
coupled O +
with O +
the O +
demonstration O +
that O +
ADM B-Gene +
exerts O +
an O +
aldosterone O +
antisecretagogue O +
action O +
and O +
a O +
proliferogenic O +
effect O +
on O +
cultured O +
aldosteronoma O +
cells O +
, O +
make O +
it O +
likely O +
that O +
endogenous O +
ADM B-Gene +
system O +
plays O +
a O +
potentially O +
important O +
role O +
in O +
the O +
paracrine O +
or O +
autocrine O +
functional O +
control O +
of O +
Conn O +
's O +
adenomas O +
. O +

Genetic O +
influences O +
on O +
lipid O +
metabolism O +
trait O +
variability O +
within O +
the O +
Stanislas O +
Cohort O +
. O +

The O +
contribution O +
of O +
17 O +
polymorphisms O +
within O +
13 O +
candidate O +
genes O +
on O +
lipid O +
trait O +
variability O +
was O +
investigated O +
by O +
a O +
multiplex O +
assay O +
in O +
772 O +
men O +
and O +
780 O +
women O +
coming O +
for O +
a O +
health O +
checkup O +
examination O +
. O +

The O +
studied O +
genes O +
were O +
APOE B-Gene +
, O +
APOB B-Gene +
, O +
APOC3 B-Gene +
, O +
CETP B-Gene +
, O +
LPL B-Gene +
, O +
PON B-Gene +
, O +
MTHFR B-Gene +
, O +
FGB B-Gene +
, O +
GpIIIa B-Gene +
, O +
SELE B-Gene +
, O +
ACE B-Gene +
, O +
and O +
AGT B-Gene +
. O +

We O +
found O +
that O +
APOB B-Gene +
- O +
Thr71Ile O +
, O +
APOE B-Gene +
- O +
( O +
112 O +
/ O +
158 O +
) O +
, O +
APOC3 B-Gene +
- O +
1100C O +
/ O +
T O +
, O +
and O +
SELE B-Gene +
- O +
98 O -
G O +
/ O +
T O +
polymorphisms O +
had O +
a O +
significant O +
effect O +
on O +
lipid O +
traits O +
( O +
P O +
< O +
or O +
= O +
0.001 O +
to O +
P O +
< O +
or O +
= O +
0.01 O +
) O +
. O +

Genetic O +
effects O +
accounted O +
for O +
3.5 O +
- O +
5.7 O +
% O +
of O +
variation O +
in O +
apolipoprotein B-Gene +
B I-Gene +
( O +
apoB B-Gene +
) O +
- O +
related O +
traits O +
among O +
men O +
, O +
and O +
for O +
5.7 O +
- O +
9.0 O +
% O +
among O +
women O +
. O +

The O +
contribution O +
of O +
APOE B-Gene +
polymorphism O +
on O +
apoB B-Gene +
- O +
related O +
traits O +
variability O +
was O +
two O +
to O +
three O +
times O +
more O +
important O +
in O +
women O +
than O +
in O +
men O +
. O +

We O +
found O +
suggestive O +
evidence O +
for O +
interactive O +
effects O +
between O +
genetics O +
and O +
age O +
, O +
smoking O +
status O +
, O +
and O +
oral O +
contraceptives O +
. O +

Increase O +
of O +
LDL B-Gene +
- O +
cholesterol O +
and O +
apoB B-Gene +
concentrations O +
with O +
age O +
was O +
stronger O +
among O +
the O +
epsilon4 O +
carriers O +
in O +
women O +
, O +
and O +
apolipoprotein B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
( O +
apoA B-Gene -
- I-Gene -
I I-Gene +
) O +
concentration O +
decreased O +
with O +
age O +
in O +
epsilon4 O +
male O +
carriers O +
. O +

The O +
effect O +
of O +
epsilon2 O +
allele O +
on O +
LDL B-Gene +
- O +
cholesterol O +
was O +
more O +
important O +
in O +
the O +
oral O +
contraceptive O +
users O +
. O +

In O +
nonsmokers O +
only O +
, O +
the O +
APOC3 B-Gene +
- O +
1100C O +
allele O +
in O +
women O +
was O +
related O +
to O +
lower O +
apoB B-Gene +
- O +
related O +
traits O +
concentrations O +
, O +
and O +
in O +
men O +
to O +
higher O +
apoA B-Gene -
- I-Gene -
I I-Gene +
and O +
HDL B-Gene +
- O +
cholesterol O +
concentrations O +
. O +

In O +
conclusion O +
, O +
this O +
work O +
, O +
in O +
addition O +
to O +
the O +
reinforcement O +
of O +
the O +
already O +
known O +
associations O +
between O +
APOB B-Gene +
, O +
APOE B-Gene +
, O +
and O +
APOC3 B-Gene +
genes O +
and O +
lipids O +
, O +
leads O +
to O +
new O +
perspectives O +
in O +
the O +
complex O +
relationships O +
among O +
genes O +
and O +
environmental O +
factors O +
. O +

The O +
newly O +
observed O +
relationships O +
between O +
E B-Gene -
- I-Gene -
selectine I-Gene +
gene O +
and O +
lipid O +
concentrations O +
support O +
the O +
hypotheses O +
of O +
multiple O +
metabolic O +
pathways O +
contributing O +
to O +
the O +
complexity O +
of O +
lipids O +
variability O +
. O +

Molecular O +
cloning O +
and O +
characterization O +
of O +
the O +
human O +
diacylglycerol B-Gene +
kinase I-Gene +
beta I-Gene +
( O +
DGKbeta B-Gene +
) O +
gene O +
: O +
alternative O +
splicing O +
generates O +
DGKbeta B-Gene +
isotypes O +
with O +
different O +
properties O +
. O +

Diacylglycerol B-Gene +
kinases I-Gene +
are O +
key O +
modulators O +
of O +
levels O +
of O +
diacylglycerol O +
, O +
a O +
second O +
messenger O +
involved O +
in O +
a O +
variety O +
of O +
cellular O +
responses O +
to O +
extracellular O +
stimuli O +
. O +

A O +
number O +
of O +
diacylglycerol B-Gene +
kinases I-Gene +
encoded O +
by O +
separate O +
genes O +
are O +
present O +
in O +
mammalian O +
genomes O +
. O +

We O +
have O +
cloned O +
cDNAs O +
encoding O +
several O +
isoforms O +
of O +
the O +
human O +
homologue O +
of O +
the O +
rat O +
diacylglycerol B-Gene +
kinase I-Gene +
beta I-Gene +
gene O +
and O +
characterized O +
two O +
such O +
isoforms O +
that O +
differ O +
at O +
their O +
carboxyl O +
terminus O +
through O +
alternative O +
splicing O +
and O +
the O +
usage O +
of O +
different O +
polyadenylation O +
signals O +
. O +

Quantitative O +
analysis O +
of O +
gene O +
expression O +
in O +
a O +
panel O +
of O +
human O +
tissue O +
cDNAs O +
revealed O +
that O +
transcripts O +
corresponding O +
to O +
both O +
isoforms O +
are O +
co O +
- O +
expressed O +
in O +
central O +
nervous O +
system O +
tissues O +
and O +
in O +
the O +
uterus O +
, O +
with O +
one O +
variant O +
being O +
expressed O +
at O +
relatively O +
higher O +
levels O +
. O +

As O +
green B-Gene +
fluorescent I-Gene +
protein I-Gene +
fusions O +
, O +
the O +
two O +
isoforms O +
displayed O +
localization O +
to O +
different O +
subcellular O +
compartments O +
, O +
with O +
one O +
variant O +
being O +
associated O +
with O +
the O +
plasma O +
membrane O +
, O +
while O +
the O +
other O +
isoform O +
was O +
predominantly O +
localized O +
within O +
the O +
cytoplasm O +
. O +

Differences O +
were O +
also O +
observed O +
in O +
their O +
subcellular O +
localization O +
in O +
response O +
to O +
phorbol O +
ester O +
stimulation O +
. O +

Enzymatic O +
assays O +
demonstrated O +
that O +
the O +
two O +
isoforms O +
display O +
comparable O +
diacylglycerol B-Gene +
kinase I-Gene +
activities O +
. O +

Therefore O +
, O +
the O +
human O +
diacylglycerol B-Gene +
kinase I-Gene +
beta I-Gene +
gene O +
can O +
generate O +
several O +
enzyme O +
isoforms O +
, O +
which O +
can O +
display O +
different O +
expression O +
levels O +
and O +
subcellular O +
localization O +
but O +
similar O +
enzymatic O +
activities O +
in O +
vitro O +
. O +

[ O +
Clinical O +
and O +
epidemiological O +
characteristics O +
of O +
squamous O +
cell O +
carcinoma O +
of O +
the O +
oral O +
cavity O +
in O +
women O +
] O +

BACKGROUND O +
: O +

Squamous O +
cell O +
carcinoma O +
( O +
SCC O +
) O +
of O +
the O +
oral O +
cavity O +
occurs O +
mainly O +
in O +
the O +
male O +
population O +
. O +

The O +
objective O +
of O +
the O +
study O +
is O +
to O +
identify O +
the O +
main O +
clinical O +
and O +
epidemiological O +
differences O +
of O +
the O +
oral O +
SCC O +
between O +
men O +
and O +
women O +
. O +

METHODS O +
: O +

Retrospective O +
analysis O +
of O +
the O +
charts O +
of O +
228 O +
cases O +
of O +
SCC O +
of O +
the O +
oral O +
cavity O +
in O +
women O +
treated O +
at O +
the O +
Head O +
& O +
Neck O +
Surgery O +
Service O +
, O +
Heliopolis O +
Hospital O +
, O +
SÃ?Â£o O +
Paulo O +
, O +
Brazil O +
from O +
1977 O +
to O +
1996 O +
. O +

The O +
clinical O +
and O +
epidemiological O +
characteristics O +
of O +
these O +
cases O +
were O +
compared O +
with O +
those O +
of O +
849 O +
male O +
patients O +
. O +

RESULTS O +
: O +

The O +
mean O +
age O +
of O +
women O +
was O +
60.7 O +
years O +
( O +
ranging O +
2 O +
to O +
100 O +
years O +
) O +
and O +
in O +
the O +
male O +
group O +
was O +
55.6 O +
years O +
( O +
p O +
< O +
0.00001 O +
) O +
. O +

In O +
cases O +
where O +
the O +
alcohol O +
intake O +
and O +
tobacco O +
use O +
were O +
absent O +
, O +
the O +
tumors O +
ocurred O +
in O +
older O +
patients O +
. O +

The O +
isolated O +
tobacco O +
use O +
didn O +
' O +
t O +
affect O +
the O +
distribuction O +
by O +
age O +
but O +
for O +
the O +
alcohol O +
intake O +
( O +
alone O +
or O +
combined O +
with O +
tobacco O +
) O +
the O +
patients O +
were O +
younger O +
. O +

On O +
the O +
alcohol O +
intake O +
, O +
71 O +
% O +
of O +
the O +
women O +
and O +
8 O +
% O +
of O +
the O +
man O +
used O +
no O +
alcohol O +
. O +

The O +
most O +
common O +
sites O +
of O +
tumors O +
were O +
tongue O +
and O +
floor O +
of O +
the O +
mouth O +
but O +
in O +
the O +
women O +
group O +
the O +
incidence O +
of O +
tumors O +
in O +
these O +
sites O +
were O +
43 O +
% O +
compared O +
with O +
61 O +
% O +
in O +
the O +
men O +
. O +

CONCLUSIONS O +
: O +

The O +
highest O +
incidence O +
of O +
SCC O +
the O +
of O +
oral O +
cavity O +
occurs O +
later O +
in O +
women O +
, O +
than O +
in O +
men O +
. O +

This O +
could O +
be O +
explained O +
by O +
a O +
lesser O +
exposure O +
to O +
alcohol O +
and O +
tobacco O +
in O +
women O +
. O +

Other O +
factors O +
seem O +
to O +
be O +
involved O +
in O +
this O +
issue O +
. O +

Skill O +
transfer O +
from O +
virtual O +
reality O +
to O +
a O +
real O +
laparoscopic O +
task O +
. O +

BACKGROUND O +
: O +

To O +
validate O +
the O +
usefulness O +
of O +
virtual O +
reality O +
surgical O +
simulators O +
, O +
we O +
investigated O +
the O +
transfer O +
of O +
skills O +
achieved O +
by O +
their O +
use O +
to O +
real O +
tasks O +
. O +

METHODS O +
: O +

Thirty O +
medical O +
students O +
underwent O +
a O +
pretest O +
using O +
a O +
real O +
laparoscopic O +
trainer O +
. O +

They O +
were O +
then O +
randomized O +
to O +
the O +
following O +
three O +
groups O +
: O +
group O +
I O +
received O +
no O +
training O +
; O +
group O +
II O +
received O +
training O +
using O +
the O +
Minimal O +
Invasive O +
Surgical O +
Trainer O +
in O +
Virtual O +
Reality O +
( O +
MIST O -
- O -
VR O +
) O +
; O +
and O +
group O +
III O +
received O +
training O +
using O +
conventional O +
training O +
exercises O +
. O +

Each O +
group O +
then O +
underwent O +
a O +
posttest O +
. O +

Using O +
the O +
Imperial O +
College O +
Surgical O +
Assessment O +
Device O +
( O +
ICSAD O +
) O +
, O +
scores O +
were O +
generated O +
for O +
time O +
taken O +
, O +
distance O +
traveled O +
, O +
number O +
of O +
movements O +
made O +
, O +
and O +
speed O +
of O +
instrument O +
movement O +
. O +

RESULTS O +
: O +

Significant O +
changes O +
between O +
the O +
MIST O +
- O +
VR O +
group O +
( O +
group O +
II O +
) O +
and O +
the O +
conventionally O +
trained O +
group O +
( O +
group O +
III O +
) O +
, O +
were O +
observed O +
in O +
the O +
speed O +
of O +
movement O +
of O +
the O +
left O +
hand O +
and O +
the O +
numbers O +
of O +
movements O +
taken O +
by O +
each O +
hand O +
, O +
when O +
compared O +
to O +
the O +
untrained O +
group O +
( O +
group O +
I O +
) O +
. O +

CONCLUSION O +
: O +

The O +
training O +
of O +
novices O +
using O +
MIST O -
- O -
VR O +
yields O +
quantifiable O +
changes O +
in O +
skill O +
that O +
are O +
transferable O +
to O +
a O +
simple O +
real O +
task O +
and O +
are O +
similar O +
to O +
the O +
results O +
achieved O +
with O +
conventional O +
training O +
. O +

MUC4 B-Gene +
expression O +
is O +
increased O +
in O +
dysplastic O +
cervical O +
disorders O +
. O +

The O +
female O +
uterine O +
cervix O +
has O +
2 O +
characteristic O +
populations O +
of O +
epithelial O +
cells O +
: O +
the O +
endocervix O +
is O +
composed O +
by O +
mucus O +
- O +
secreting O +
cells O +
that O +
express O +
several O +
mucin B-Gene +
genes O +
, O +
and O +
the O +
exocervix O +
has O +
a O +
typical O +
stratified O +
squamous O +
epithelium O +
and O +
does O +
not O +
express O +
secreted O +
mucins B-Gene +
. O +

Among O +
human O +
mucin B-Gene +
genes O +
, O +
the O +
MUC4 B-Gene +
sequence O +
has O +
a O +
transmembrane O +
domain O +
, O +
and O +
its O +
molecular O +
structure O +
suggests O +
that O +
it O +
has O +
a O +
protective O +
role O +
and O +
also O +
may O +
be O +
implicated O +
in O +
intracellular O +
signalling O +
. O +

The O +
aim O +
of O +
this O +
study O +
is O +
to O +
analyze O +
whether O +
changes O +
in O +
the O +
expression O +
of O +
MUC4 B-Gene +
can O +
be O +
detected O +
associated O +
with O +
the O +
squamous O +
dysplastic O +
transformation O +
of O +
exocervical O +
epithelium O +
. O +

MUC4 B-Gene +
expression O +
has O +
been O +
analyzed O +
by O +
immunohistochemistry O +
, O +
Western O +
blotting O +
, O +
and O +
in O +
situ O +
hybridization O +
. O +

Using O +
immunohistochemical O +
techniques O +
, O +
MUC4 B-Gene +
is O +
found O +
in O +
normal O +
endocervix O +
( O +
n O +
= O +
11 O +
) O +
and O +
is O +
absent O +
or O +
only O +
focally O +
detected O +
in O +
the O +
normal O +
stratified O +
cervical O +
epithelium O +
( O +
n O +
= O +
18 O +
) O +
. O +

In O +
samples O +
from O +
squamous O +
metaplasia O +
( O +
n O +
= O +
9 O +
) O +
, O +
MUC4 B-Gene +
is O +
variably O +
expressed O +
( O +
10 O +
% O +
to O +
50 O +
% O +
positive O +
cells O +
) O +
, O +
whereas O +
MUC4 B-Gene +
is O +
strongly O +
detected O +
in O +
dysplastic O +
cervical O +
epithelia O +
. O +

The O +
greatest O +
number O +
of O +
positive O +
cells O +
is O +
found O +
in O +
samples O +
with O +
moderate O +
and O +
severe O +
dysplasia O +
in O +
which O +
MUC4 B-Gene +
is O +
detected O +
in O +
100 O +
% O +
of O +
the O +
analyzed O +
samples O +
( O +
n O +
= O +
16 O +
) O +
. O +

These O +
results O +
have O +
been O +
confirmed O +
by O +
Western O +
blotting O +
and O +
by O +
detection O +
of O +
MUC4 B-Gene +
transcripts O +
using O +
in O +
situ O +
hybridization O +
. O +

The O +
present O +
data O +
suggest O +
that O +
MUC4 B-Gene +
is O +
activated O +
during O +
the O +
process O +
of O +
squamous O +
dysplastic O +
transformation O +
and O +
may O +
be O +
used O +
as O +
a O +
marker O +
for O +
this O +
pathologic O +
process O +
. O +

Expression O +
of O +
multidrug B-Gene +
resistance I-Gene +
1 I-Gene +
and O +
glutathione B-Gene -
- I-Gene -
S I-Gene -
- I-Gene -
transferase I-Gene -
- I-Gene -
Pi I-Gene +
protein O +
in O +
nasopharyngeal O +
carcinoma O +
. O +

Radiotherapy O +
is O +
the O +
modality O +
of O +
choice O +
for O +
the O +
treatment O +
of O +
nasopharyngeal O +
carcinoma O +
( O +
NPC O +
) O +
. O +

However O +
, O +
systemic O +
chemotherapy O +
has O +
recently O +
been O +
found O +
to O +
play O +
an O +
increasing O +
role O +
in O +
the O +
treatment O +
of O +
advanced O +
or O +
metastatic O +
disease O +
. O +

The O +
status O +
of O +
drug O +
resistance O +
gene O +
expression O +
that O +
has O +
crucial O +
impact O +
on O +
chemotherapy O +
has O +
not O +
been O +
fully O +
addressed O +
for O +
patients O +
with O +
NPC O +
. O +

In O +
this O +
study O +
, O +
we O +
examined O +
the O +
expression O +
of O +
multidrug B-Gene +
resistance I-Gene +
1 I-Gene +
( O +
MDR-1 B-Gene +
) O +
and O +
glutathione B-Gene +
- I-Gene +
S I-Gene -
- I-Gene -
transferase I-Gene -
- I-Gene -
Pi I-Gene +
( O +
GST B-Gene -
- I-Gene -
Pi I-Gene +
) O +
in O +
primary O +
, O +
recurrent O +
, O +
and O +
metastatic O +
NPC O +
using O +
results O +
of O +
immunohistochemical O +
examinations O +
. O +

The O +
results O +
were O +
correlated O +
with O +
the O +
expression O +
of O +
Epstein O +
- O +
Barr O +
virus O +
( O +
EBV O +
) O +
latent O +
protein O +
, O +
latent B-Gene +
membrane I-Gene +
protein I-Gene +
1 I-Gene +
( O +
LMP1 B-Gene +
) O +
, O +
and O +
clinicopathologic O +
features O +
, O +
including O +
stage O +
, O +
histopathologic O +
types O +
, O +
and O +
survival O +
rates O +
. O +

MDR-1 B-Gene +
protein O +
expression O +
was O +
detected O +
in O +
18 O +
( O +
12.6 O +
% O +
) O +
of O +
143 O +
patients O +
with O +
primary O +
NPC O +
, O +
14 O +
( O +
32.6 O +
% O +
) O +
of O +
43 O +
with O +
recurrent O +
NPC O +
, O +
and O +
O O +
( O +
0 O +
% O +
) O +
of O +
20 O +
with O +
metastatic O +
NPC O +
, O +
whereas O +
83 O +
( O +
58 O +
% O +
) O +
of O +
143 O +
patients O +
with O +
primary O +
NPC O +
, O +
30 O +
( O +
69.8 O +
% O +
) O +
of O +
43 O +
with O +
recurrent O +
NPC O +
, O +
and O +
13 O +
( O +
65 O +
% O +
) O +
of O +
20 O +
with O +
metastatic O +
NPC O +
expressed O +
GST B-Gene -
- I-Gene -
Pi I-Gene +
. O +

EBV O +
- O +
LMP1 B-Gene +
was O +
expressed O +
in O +
59 O +
( O +
41.3 O +
% O +
) O +
of O +
143 O +
patients O +
with O +
primary O +
NPC O +
, O +
23 O +
( O +
53.5 O +
% O +
) O +
of O +
43 O +
with O +
recurrent O +
NPC O +
, O +
and O +
9 O +
( O +
45 O +
% O +
) O +
of O +
20 O +
with O +
metastatic O +
NPC O +
. O +

Simultaneous O +
expression O +
of O +
MDR1 B-Gene +
and O +
GST B-Gene -
- I-Gene -
Pi I-Gene +
was O +
observed O +
in O +
13 O +
( O +
72.2 O +
% O +
) O +
of O +
18 O +
patients O +
with O +
primary O +
NPC O +
and O +
12 O +
( O +
85.7 O +
% O +
) O +
of O +
14 O +
with O +
recurrent O +
NPC O +
. O +

The O +
expression O +
of O +
LMP1 B-Gene +
was O +
detected O +
in O +
only O +
6 O +
of O +
the O +
13 O +
patients O +
with O +
primary O +
NPC O +
and O +
6 O +
of O +
the O +
12 O +
with O +
recurrent O +
NPC O +
. O +

We O +
concluded O +
that O +
the O +
expression O +
of O +
GST B-Gene -
- I-Gene -
Pi I-Gene +
was O +
more O +
frequent O +
in O +
NPC O +
tumor O +
tissues O +
than O +
the O +
expression O +
of O +
MDR-1 B-Gene +
. O +

The O +
expression O +
of O +
MDR-1 B-Gene +
correlated O +
with O +
clinicopathologic O +
features O +
of O +
primary O +
NPC O +
, O +
including O +
the O +
histopathologic O +
types O +
and O +
survival O +
rates O +
, O +
but O +
not O +
with O +
disease O +
stage O +
. O +

The O +
expression O +
of O +
GST B-Gene -
- I-Gene -
Pi I-Gene +
did O +
not O +
correlate O +
with O +
clinicopathologic O +
features O +
. O +

The O +
expression O +
of O +
MDR-1 B-Gene +
and O +
GST B-Gene -
- I-Gene -
Pi I-Gene +
did O +
not O +
correlate O +
with O +
expression O +
of O +
EBV O +
- O +
LMP1 B-Gene +
for O +
patients O +
with O +
NPC O +
. O +

Delineation O +
of O +
mRNA O +
export O +
pathways O +
by O +
the O +
use O +
of O +
cell O +
- O +
permeable O +
peptides O +
. O +

The O +
transport O +
of O +
messenger O +
RNAs O +
( O +
mRNAs O +
) O +
from O +
the O +
nucleus O +
to O +
the O +
cytoplasm O +
involves O +
adapter O +
proteins O +
that O +
bind O +
the O +
mRNA O +
as O +
well O +
as O +
receptor O +
proteins O +
that O +
interact O +
with O +
the O +
nuclear O +
pore O +
complex O +
. O +

We O +
demonstrate O +
the O +
utility O +
of O +
cell O +
- O +
permeable O +
peptides O +
designed O +
to O +
interfere O +
with O +
interactions O +
between O +
potential O +
adapter O +
and O +
receptor O +
proteins O +
to O +
define O +
the O +
pathways O +
accessed O +
by O +
particular O +
mRNAs O +
. O +

We O +
show O +
that O +
HuR B-Gene +
, O +
a O +
protein O +
implicated O +
in O +
the O +
stabilization O +
of O +
short O +
- O +
lived O +
mRNAs O +
containing O +
AU O +
- O +
rich O +
elements O +
( O +
AREs O +
) O +
, O +
serves O +
as O +
an O +
adapter O +
for O +
c B-Gene -
- I-Gene -
fos I-Gene +
mRNA O +
export O +
through O +
two O +
pathways O +
. O +

One O +
involves O +
the O +
HuR B-Gene +
shuttling O +
domain O +
, O +
HNS O +
, O +
which O +
exhibits O +
a O +
heat O +
shock O +
- O +
sensitive O +
interaction O +
with O +
transportin B-Gene +
2 I-Gene +
( O +
Trn2 B-Gene +
) O +
; O +
the O +
other O +
involves O +
two O +
protein O +
ligands O +
of O +
HuR B-Gene +
- O +
pp32 B-Gene +
and O +
APRIL B-Gene +
- O +
which O +
contain O +
leucine O +
- O +
rich O +
nuclear O +
export O +
signals O +
( O +
NES O +
) O +
recognized O +
by O +
the O +
export O +
receptor O +
CRM1 B-Gene +
. O +

Heterokaryon O +
and O +
in O +
situ O +
hybridization O +
experiments O +
reveal O +
that O +
the O +
peptides O +
selectively O +
block O +
the O +
nucleocytoplasmic O +
shuttling O +
of O +
their O +
respective O +
adapter B-Gene +
proteins I-Gene +
without O +
perturbing O +
the O +
overall O +
cellular O +
distribution O +
of O +
polyadenylated O +
mRNAs O +
. O +

Hepatocyte B-Gene +
nuclear I-Gene +
factor I-Gene +
1alpha I-Gene +
controls O +
the O +
expression O +
of O +
terminal O +
complement O +
genes O +
. O +

The O +
terminal O +
components O +
of O +
the O +
complement O +
system O +
contribute O +
to O +
host O +
defense O +
by O +
forming O +
the O +
multiprotein O +
membrane B-Gene +
attack I-Gene +
complex I-Gene +
( O +
MAC B-Gene +
) O +
which O +
is O +
responsible O +
for O +
cell O +
lysis O +
and O +
several O +
noncytotoxic O +
effects O +
. O +

Most O +
of O +
the O +
complement O +
proteins O +
are O +
synthesized O +
in O +
the O +
liver O +
, O +
but O +
the O +
mechanisms O +
controlling O +
their O +
tissue O +
- O +
specific O +
expression O +
have O +
not O +
been O +
elucidated O +
. O +

In O +
this O +
study O +
we O +
show O +
that O +
mice O +
lacking O +
the O +
hepatic O +
transcription B-Gene +
factor I-Gene +
hepatocyte B-Gene +
nuclear I-Gene +
factor I-Gene +
1alpha I-Gene +
( O +
HNF1alpha B-Gene +
) O +
fail O +
to O +
transcribe O +
C5 B-Gene +
and O +
C8A B-Gene +
complement O +
genes O +
. O +

In O +
addition O +
, O +
mRNAs O +
encoding O +
for O +
several O +
other O +
terminal O +
complement B-Gene +
components I-Gene +
or O +
subunits O +
are O +
expressed O +
at O +
lower O +
levels O +
, O +
including O +
C8beta B-Gene +
, O +
C8gamma B-Gene +
, O +
and O +
C9 B-Gene +
. O +

We O +
next O +
used O +
a O +
reconstitution O +
assay O +
involving O +
human O +
sera O +
with O +
selective O +
complement O +
deficiencies O +
to O +
assess O +
mouse O +
complement O +
activity O +
. O +

Sera O +
from O +
HNF1alpha B-Gene +
- O +
deficient O +
mice O +
showed O +
negligible O +
hemolytic O +
activity O +
of O +
both O +
C5 B-Gene +
and O +
C8alpha B-Gene +
- I-Gene +
gamma I-Gene +
subunits O +
. O +

The O +
activity O +
of O +
C8beta B-Gene +
was O +
severely O +
affected O +
despite O +
only O +
a O +
50 O +
% O +
reduction O +
in O +
C8beta B-Gene +
mRNA O +
levels O +
in O +
the O +
liver O +
. O +

This O +
is O +
reminiscent O +
of O +
C8alpha B-Gene +
- I-Gene +
gamma I-Gene +
- O +
deficient O +
patients O +
who O +
accumulate O +
extremely O +
low O +
levels O +
of O +
the O +
C8beta B-Gene +
subunit O +
. O +

Our O +
results O +
demonstrate O +
that O +
HNF1alpha B-Gene +
plays O +
a O +
key O +
role O +
in O +
the O +
expression O +
of O +
C5 B-Gene +
and O +
C8A B-Gene +
genes O +
, O +
two O +
terminal O +
complement O +
component O +
genes O +
that O +
are O +
essential O +
for O +
the O +
assembly O +
of O +
MAC B-Gene +
as O +
a O +
result O +
of O +
complement O +
activation O +
. O +

Nucleotide O +
sequence O +
, O +
genomic O +
organization O +
, O +
and O +
chromosomal O +
localization O +
of O +
genes O +
encoding O +
the O +
human O +
NMDA B-Gene +
receptor I-Gene +
subunits O +
NR3A B-Gene +
and O +
NR3B B-Gene +
. O +

The O +
N B-Gene -
- I-Gene -
methyl I-Gene -
- I-Gene -
D I-Gene -
- I-Gene -
aspartate I-Gene +
( I-Gene +
NMDA I-Gene +
) I-Gene +
receptors I-Gene +
are O +
glutamate O +
- O +
regulated O +
ion B-Gene +
channels I-Gene +
that O +
are O +
critically O +
involved O +
in O +
important O +
physiological O +
and O +
pathological O +
functions O +
of O +
the O +
mammalian O +
central O +
nervous O +
system O +
. O +

We O +
have O +
identified O +
and O +
characterized O +
the O +
gene O +
encoding O +
the O +
human O +
NMDA B-Gene +
receptor I-Gene +
subunit O +
NR3A B-Gene +
( O +
GRIN3A B-Gene +
) O +
, O +
as O +
well O +
as O +
the O +
gene O +
( O +
GRIN3B B-Gene +
) O +
encoding O +
an O +
entirely O +
novel O +
subunit O +
that O +
we O +
named O +
NR3B B-Gene +
, O +
as O +
it O +
is O +
most O +
closely O +
related O +
to O +
NR3A B-Gene +
( O +
57.4 O +
% O +
identity O +
) O +
. O +

GRIN3A B-Gene +
localizes O +
to O +
chromosome O +
9q34 O +
, O +
in O +
the O +
region O +
13 O +
- O +
34 O +
, O +
and O +
consists O +
of O +
nine O +
coding O +
exons O +
. O +

The O +
deduced O +
protein O +
contains O +
1115 O +
amino O +
acids O +
and O +
shows O +
92.7 O +
% O +
identity O +
to O +
rat O +
NR3A B-Gene +
. O +

GRIN3B B-Gene +
localizes O +
to O +
chromosome O +
19p13.3 O +
and O +
contains O +
, O +
as O +
does O +
the O +
mouse O +
NR3B B-Gene +
gene O +
( O +
Grin3b B-Gene +
) O +
, O +
eight O +
coding O +
exons O +
. O +

The O +
deduced O +
proteins O +
of O +
human O +
and O +
mouse O +
NR3B B-Gene +
contain O +
901 O +
and O +
900 O +
amino O +
acid O +
residues O +
, O +
respectively O +
( O +
81.6 O +
% O +
identity O +
) O +
. O +

In O +
situ O +
hybridization O +
shows O +
a O +
widespread O +
distribution O +
of O +
Grin3b B-Gene +
mRNA O +
in O +
the O +
brain O +
of O +
the O +
adult O +
rat O +
. O +

The O +
effects O +
of O +
iron O +
deficiency O +
on O +
lymphocyte O +
cytokine B-Gene +
production O +
and O +
activation O +
: O +
preservation O +
of O +
hepatic O +
iron O +
but O +
not O +
at O +
all O +
cost O +
. O +

Worldwide O +
, O +
over O +
40 O +
% O +
of O +
children O +
have O +
iron O +
deficiency O +
anaemia O +
, O +
frequently O +
associated O +
with O +
infections O +
. O +

Certain O +
cytokines B-Gene +
are O +
involved O +
in O +
both O +
immune O +
activation O +
/ O +
response O +
to O +
infection O +
and O +
iron O +
transport O +
/ O +
metabolism O +
. O +

We O +
therefore O +
assessed O +
the O +
relations O +
among O +
iron O +
deficiency O +
, O +
cytokine B-Gene +
production O +
and O +
lymphocyte O +
activation O +
markers O +
in O +
142 O +
hospitalized O +
Malawian O +
children O +
. O +

We O +
examined O +
peripheral O +
blood O +
lymphocyte O +
antigens O +
/ O +
cytokine B-Gene +
production O +
using O +
four O +
- O +
colour O +
flow O +
cytometry O +
and O +
serum O +
transferrin B-Gene +
receptor I-Gene +
( O +
TfR B-Gene +
) O +
levels O +
, O +
an O +
inverse O +
measure O +
of O +
iron O +
status O +
unaffected O +
by O +
acute O +
illness O +
or O +
infection O +
, O +
with O +
an O +
enzyme O +
- O +
linked O +
immunosorbent O +
assay O +
. O +

Wilcoxon O +
rank O +
sum O +
tests O +
and O +
logistic O +
regression O +
analyses O +
( O +
LRA O +
) O +
were O +
performed O +
. O +

Iron O +
deficiency O +
( O +
TfR B-Gene +
> O +
or O +
= O +
10 O +
microg O +
/ O +
ml O +
) O +
versus O +
TfR B-Gene +
< O +
10 O +
microg O +
/ O +
ml O +
, O +
was O +
associated O +
with O +
higher O +
percentages O +
of O +
lymphocytes O +
producing O +
: O +
( O +
a O +
) O +
induced O +
or O +
spontaneous O +
IL-6 B-Gene +
( O +
medians O +
: O +
induced O +
, O +
15.9 O +
% O +
for O +
iron O +
- O +
deficient O +
children O +
versus O +
8.8 O +
% O +
for O +
iron O +
- O +
replete O +
children O +
, O +
P O +
= O +
0.002 O +
; O +
spontaneous O +
, O +
24.4 O +
% O +
versus O +
13.0 O +
% O +
, O +
P O +
< O +
0.001 O +
) O +
and O +
( O +
b O +
) O +
induced O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
( O +
medians O +
: O +
18.4 O +
% O +
versus O +
12.4 O +
% O +
, O +
P O +
= O +
0.006 O +
) O +
. O +

The O +
percentages O +
of O +
CD8 B-Gene +
( O +
+ O +
) O +
T O +
cells O +
spontaneously O +
producing O +
IL-6 B-Gene +
and O +
of O +
all O +
lymphocytes O +
producing O +
induced O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
and O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
in O +
the O +
same O +
cell O +
had O +
the O +
strongest O +
relationships O +
to O +
iron O +
deficiency O +
( O +
b O +
= O +
+ O +
0.0211 O +
, O +
P O +
= O +
0.005 O +
and O +
b O +
= O +
+ O +
0.1158 O +
, O +
P O +
= O +
0.012 O +
, O +
respectively O +
, O +
LRA O +
) O +
and O +
were O +
also O +
positively O +
related O +
to O +
the O +
co O +
- O +
expression O +
of O +
the O +
T O +
cell O +
activation O +
markers O +
HLA B-Gene +
DR I-Gene +
and O +
CD38 B-Gene +
. O +

Severe O +
iron O +
deficiency O +
( O +
TfR B-Gene +
> O +
or O +
= O +
30 O +
microg O +
/ O +
ml O +
) O +
was O +
associated O +
with O +
the O +
percentage O +
of O +
lymphocytes O +
producing O +
induced O +
IL-4 B-Gene +
( O +
medians O +
: O +
0.5 O +
% O +
versus O +
1.6 O +
% O +
, O +
P O +
< O +
0.010 O +
) O +
. O +

The O +
cytokine B-Gene +
patterns O +
associated O +
with O +
iron O +
deficiency O +
in O +
our O +
study O +
would O +
preserve O +
iron O +
stores O +
but O +
also O +
preferentially O +
retain O +
the O +
activation O +
capabilities O +
of O +
T O +
cells O +
, O +
albeit O +
not O +
necessarily O +
other O +
immune O +
cells O +
, O +
until O +
a O +
critical O +
level O +
of O +
iron O +
depletion O +
is O +
reached O +
. O +

Cloning O +
, O +
characterisation O +
and O +
crystallisation O +
of O +
a O +
diadenosine B-Gene +
5',5"'-P I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
,P I-Gene -
( I-Gene -
4 I-Gene -
) I-Gene -
-tetraphosphate I-Gene +
pyrophosphohydrolase I-Gene +
from O +
Caenorhabditis O +
elegans O +
. O +

Asymmetrically O +
cleaving O +
diadenosine B-Gene +
5',5"'-P I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
,P I-Gene -
( I-Gene -
4 I-Gene -
) I-Gene -
-tetraphosphate I-Gene +
( I-Gene +
Ap4A I-Gene +
) I-Gene +
hydrolase I-Gene +
activity O +
has O +
been O +
detected O +
in O +
extracts O +
of O +
adult O +
Caenorhabditis O +
elegans O +
and O +
the O +
corresponding O +
cDNA O +
amplified O +
and O +
expressed O +
in O +
Escherichia O +
coli O +
. O +

As O +
expected O +
, O +
sequence O +
analysis O +
shows O +
the O +
enzyme O +
to O +
be O +
a O +
member O +
of O +
the O +
Nudix B-Gene +
hydrolase I-Gene +
family I-Gene +
. O +

The O +
purified O +
recombinant O +
enzyme O +
behaves O +
as O +
a O +
typical O +
animal O +
Ap4A B-Gene +
hydrolase I-Gene +
. O +

It O +
hydrolyses O +
Ap4A O +
with O +
a O +
K O -
( O -
m O -
) O +
of O +
7 O +
microM O +
and O +
k O -
( O -
cat O -
) O +
of O +
27 O +
s O -
( O -
-1 O -
) O +
producing O +
AMP O +
and O +
ATP O +
as O +
products O +
. O +

It O +
is O +
also O +
active O +
towards O +
other O +
adenosine O +
and O +
diadenosine O +
polyphosphates O +
with O +
four O +
or O +
more O +
phosphate O +
groups O +
, O +
but O +
not O +
diadenosine O +
triphosphate O +
, O +
always O +
generating O +
ATP O +
as O +
one O +
of O +
the O +
products O +
. O +

It O +
is O +
inhibited O +
non O +
- O +
competitively O +
by O +
fluoride O +
( O +
K O -
( O -
i O -
) O +
= O +
25 O +
microM O +
) O +
and O +
competitively O +
by O +
adenosine O +
5'-tetraphosphate O +
with O +
Ap4A O +
as O +
substrate O +
( O +
K O -
( O -
i O -
) O +
= O +
10 O +
nM O +
) O +
. O +

Crystals O +
of O +
diffraction O +
quality O +
with O +
the O +
morphology O +
of O +
rectangular O +
plates O +
were O +
readily O +
obtained O +
and O +
preliminary O +
data O +
collected O +
. O +

These O +
crystals O +
diffract O +
to O +
a O +
minimum O +
d O +
- O +
spacing O +
of O +
2 O +
A O +
and O +
belong O +
to O +
either O +
space O +
group O +
C222 O +
or O +
C222 O -
( O -
1 O -
) O +
. O +

Phylogenetic O +
analysis O +
of O +
known O +
and O +
putative O +
Ap4A B-Gene +
hydrolases I-Gene +
of O +
the O +
Nudix B-Gene +
family I-Gene +
suggests O +
that O +
they O +
fall O +
into O +
two O +
groups O +
comprising O +
plant O +
and O +
Proteobacterial O +
enzymes O +
on O +
the O +
one O +
hand O +
and O +
animal O +
and O +
archaeal O +
enzymes O +
on O +
the O +
other O +
. O +

Complete O +
structural O +
determination O +
of O +
the O +
C. O +
elegans O +
Ap4A B-Gene +
hydrolase I-Gene +
will O +
help O +
determine O +
the O +
basis O +
of O +
this O +
grouping O +
. O +

The O +
biochemical O +
basis O +
for O +
increased O +
testosterone O +
production O +
in O +
theca O +
cells O +
propagated O +
from O +
patients O +
with O +
polycystic O +
ovary O +
syndrome O +
. O +

Ovarian O +
theca O +
cells O +
propagated O +
from O +
patients O +
with O +
polycystic O +
ovary O +
syndrome O +
( O +
PCOS O +
) O +
convert O +
steroid O +
precursors O +
into O +
T O +
more O +
efficiently O +
than O +
normal O +
theca O +
cells O +
. O +

To O +
identify O +
the O +
basis O +
for O +
increased O +
T O +
production O +
by O +
PCOS O +
theca O +
cells O +
, O +
we O +
examined O +
type B-Gene +
I I-Gene -
- I-Gene -
V I-Gene +
17 I-Gene +
beta I-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
( O +
17 B-Gene +
beta I-Gene +
HSD I-Gene +
) O +
isoform O +
expression O +
in O +
long O +
- O +
term O +
cultures O +
of O +
theca O +
and O +
granulosa O +
cells O +
isolated O +
from O +
normal O +
and O +
PCOS O +
ovaries O +
. O +

RT O +
- O +
PCR O +
analysis O +
demonstrated O +
that O +
theca O +
cells O +
express O +
type B-Gene +
V I-Gene +
17 I-Gene +
beta I-Gene +
HSD I-Gene +
a O +
member O +
of O +
the O +
aldo B-Gene +
- I-Gene +
keto I-Gene +
reductase I-Gene +
( I-Gene +
AKR I-Gene +
) I-Gene +
superfamily I-Gene +
( O +
17 B-Gene +
beta I-Gene +
HSDV I-Gene +
, O +
AKR1C3 B-Gene +
) O +
, O +
whereas O +
expression O +
of O +
type B-Gene +
I I-Gene +
, I-Gene +
II I-Gene +
, I-Gene +
and I-Gene +
IV I-Gene +
17 I-Gene +
beta I-Gene +
HSD I-Gene +
, O +
which O +
are O +
members O +
of O +
the O +
short B-Gene +
- I-Gene +
chain I-Gene +
dehydrogenase I-Gene +
/ I-Gene +
reductase I-Gene +
superfamily I-Gene +
, O +
was O +
limited O +
to O +
granulosa O +
cells O +
. O +

Type B-Gene +
III I-Gene +
17 I-Gene +
beta I-Gene +
HSD I-Gene +
, O +
the O +
testicular O +
isoform O +
, O +
was O +
not O +
detected O +
in O +
either O +
granulosa O +
or O +
theca O +
cells O +
. O +

Northern O +
and O +
real O +
- O +
time O +
PCR O +
analyses O +
demonstrated O +
that O +
17 B-Gene +
beta I-Gene +
HSDV I-Gene +
transcripts O +
were O +
not O +
significantly O +
increased O +
in O +
PCOS O +
theca O +
cells O +
compared O +
with O +
normal O +
theca O +
cells O +
. O +

RT O +
- O +
PCR O +
analysis O +
revealed O +
that O +
theca O +
cells O +
also O +
express O +
another O +
AKR B-Gene +
, O +
20 B-Gene +
alpha I-Gene +
HSD I-Gene +
( O +
AKR1C1 B-Gene +
) O +
. O +

Both O +
basal O +
and O +
forskolin O +
- O +
stimulated O +
20 B-Gene +
alpha I-Gene +
HSD I-Gene +
mRNA O +
levels O +
were O +
increased O +
in O +
PCOS O +
theca O +
cells O +
compared O +
with O +
normal O +
theca O +
cells O +
. O +

However O +
, O +
17 B-Gene +
beta I-Gene +
HSD I-Gene +
enzyme O +
activity O +
per O +
theca O +
cell O +
was O +
not O +
significantly O +
increased O +
in O +
PCOS O +
, O +
suggesting O +
that O +
neither O +
AKR1C3 B-Gene +
nor O +
AKR1C1 B-Gene +
contributes O +
to O +
the O +
formation O +
of O +
T O +
in O +
this O +
condition O +
. O +

In O +
contrast O +
, O +
17 B-Gene +
alpha I-Gene -
- I-Gene -
hydroxylase I-Gene +
/ I-Gene +
C17,20 I-Gene +
lyase I-Gene +
and O +
3 B-Gene +
beta I-Gene +
HSD I-Gene +
enzyme O +
activities O +
were O +
elevated O +
in O +
PCOS O +
theca O +
cells O +
, O +
driving O +
increased O +
production O +
of O +
T O +
precursors O +
. O +

These O +
findings O +
indicate O +
that O +
1 O -
) O +
increased O +
T O +
production O +
in O +
PCOS O +
theca O +
cells O +
does O +
not O +
result O +
from O +
dysregulation O +
of O +
" O +
androgenic O +
" O +
17 B-Gene +
beta I-Gene +
HSD I-Gene +
activity O +
or O +
altered O +
expression O +
of O +
AKRs B-Gene +
that O +
may O +
express O +
17 B-Gene +
beta I-Gene +
HSD I-Gene +
activity O +
; O +
and O +
2 O +
) O +
increased O +
synthesis O +
of O +
T O +
precursors O +
is O +
the O +
primary O +
factor O +
driving O +
enhanced O +
T O +
secretion O +
in O +
PCOS O +
. O +

CT-1 B-Gene +
mediated O +
cardioprotection O +
against O +
ischaemic O +
re O +
- O +
oxygenation O +
injury O +
is O +
mediated O +
by O +
PI3 B-Gene +
kinase I-Gene +
, O +
Akt B-Gene +
and O +
MEK1 B-Gene +
/ I-Gene +
2 I-Gene +
pathways O +
. O +

Cardiotrophin-1 B-Gene +
protects O +
cardiac O +
myocytes O +
from O +
ischaemic O +
re O +
- O +
oxygenation O +
( O +
IR O +
) O +
injury O +
. O +

CT-1 B-Gene +
activates O +
MEK1 B-Gene +
/ I-Gene +
2 I-Gene +
, O +
p42 B-Gene +
/ I-Gene +
44MAPK I-Gene +
as O +
well O +
as O +
the O +
phosphatidylinositol B-Gene +
( I-Gene +
PI I-Gene +
) I-Gene +
3-OH I-Gene +
kinase I-Gene +
( O +
PI3 O +
) O +
protein B-Gene +
kinase I-Gene +
B I-Gene +
( O +
PKB B-Gene +
/ O +
Akt B-Gene +
) O +
pathway O +
. O +

In O +
this O +
study O +
we O +
investigate O +
the O +
signalling O +
pathways O +
that O +
mediate O +
the O +
anti O +
- O +
apoptotic O +
cell O +
survival O +
effect O +
of O +
CT-1 B-Gene +
in O +
IR O +
. O +

Dominant O +
negative O +
gene O +
based O +
inhibitors O +
of O +
MEK1 B-Gene +
/ I-Gene +
2 I-Gene +
, O +
PI3 B-Gene +
- I-Gene +
kinase I-Gene +
and O +
Akt B-Gene +
inhibited O +
CT-1 B-Gene +
mediated O +
cardioprotection O +
in O +
re O +
- O +
oxygenation O +
as O +
did O +
chemical O +
inhibitors O +
of O +
the O +
PI3 B-Gene +
- I-Gene +
kinase I-Gene +
pathway O +
. O +

Hence O +
the O +
PI3-kinase B-Gene +
/ O +
Akt B-Gene +
pathway O +
is O +
required O +
in O +
addition O +
to O +
MEK1 B-Gene +
/ I-Gene +
2 I-Gene +
to O +
mediate O +
CT-1 B-Gene +
cardioprotection O +
in O +
IR O +
. O +

A O +
lipid O +
- O +
regulated O +
docking O +
site O +
on O +
vinculin B-Gene +
for O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
. O +

During O +
cell O +
spreading O +
, O +
binding O +
of O +
actin B-Gene +
- O +
organizing O +
proteins O +
to O +
acidic O +
phospholipids O +
and O +
phosphorylation O +
are O +
important O +
for O +
localization O +
and O +
activity O +
of O +
these O +
proteins O +
at O +
nascent O +
cell O +
- O +
matrix O +
adhesion O +
sites O +
. O +

Here O +
, O +
we O +
report O +
on O +
a O +
transient O +
interaction O +
between O +
the O +
lipid O +
- O +
dependent O +
protein B-Gene +
kinase I-Gene +
Calpha I-Gene +
and O +
vinculin B-Gene +
, O +
an O +
early O +
component O +
of O +
these O +
sites O +
, O +
during O +
spreading O +
of O +
HeLa O +
cells O +
on O +
collagen B-Gene +
. O +

In O +
vitro O +
binding O +
of O +
protein B-Gene +
kinase I-Gene +
Calpha I-Gene +
to O +
vinculin B-Gene +
tail O +
was O +
found O +
dependent O +
on O +
free O +
calcium O +
and O +
acidic O +
phospholipids O +
but O +
independent O +
of O +
a O +
functional O +
kinase B-Gene +
domain O +
. O +

The O +
interaction O +
was O +
enhanced O +
by O +
conditions O +
that O +
favor O +
the O +
oligomerization O +
of O +
vinculin B-Gene +
. O +

Phosphorylation O +
by O +
protein B-Gene +
kinase I-Gene +
Calpha I-Gene +
reached O +
1.5 O +
mol O +
of O +
phosphate O +
/ O +
mol O +
of O +
vinculin B-Gene +
tail O +
and O +
required O +
the O +
C O +
- O +
terminal O +
hydrophobic O +
hairpin O +
, O +
a O +
putative O +
phosphatidylinositol O +
4,5-bisphosphate O -
- O -
binding O +
site O +
. O +

Mass O +
spectroscopy O +
of O +
peptides O +
derived O +
from O +
in O +
vitro O +
phosphorylated O +
vinculin B-Gene +
tail O +
identified O +
phosphorylation O +
of O +
serines O +
1033 O +
and O +
1045 O +
. O +

Inhibition O +
of O +
C O +
- O +
terminal O +
phospholipid O +
binding O +
at O +
the O +
vinculin B-Gene +
tail O +
by O +
mutagenesis O +
or O +
deletion O +
reduced O +
the O +
rate O +
of O +
phosphorylation O +
to O +
< O +
or O +
= O +
50 O +
% O +
. O +

We O +
suggest O +
a O +
possible O +
mechanism O +
whereby O +
phospholipid O +
- O +
regulated O +
conformational O +
changes O +
in O +
vinculin B-Gene +
may O +
lead O +
to O +
exposure O +
of O +
a O +
docking O +
site O +
for O +
protein B-Gene +
kinase I-Gene +
Calpha I-Gene +
and O +
subsequent O +
phosphorylation O +
of O +
vinculin B-Gene +
and/or O +
vinculin B-Gene +
interaction O +
partners O +
, O +
thereby O +
affecting O +
the O +
formation O +
of O +
cell O +
adhesion O +
complexes O +
. O +

IscR B-Gene +
, O +
an O +
Fe O -
- O -
S O +
cluster O +
- O +
containing O +
transcription B-Gene +
factor I-Gene +
, O +
represses O +
expression O +
of O +
Escherichia O +
coli O +
genes O +
encoding O +
Fe O -
- O -
S O +
cluster O +
assembly O +
proteins O +
. O +

IscR B-Gene +
( O +
iron B-Gene +
- I-Gene +
sulfur I-Gene +
cluster I-Gene +
regulator I-Gene +
) O +
is O +
encoded O +
by O +
an O +
ORF O +
located O +
immediately O +
upstream O +
of O +
genes O +
coding O +
for O +
the O +
Escherichia O +
coli O +
Fe O -
- O -
S O +
cluster O +
assembly O +
proteins O +
, O +
IscS B-Gene +
, O +
IscU B-Gene +
, O +
and O +
IscA B-Gene +
. O +

IscR B-Gene +
shares O +
amino O +
acid O +
similarity O +
with O +
MarA B-Gene +
, O +
a O +
member O +
of O +
the O +
MarA B-Gene +
/ I-Gene +
SoxS I-Gene +
/ I-Gene +
Rob I-Gene +
family I-Gene +
of O +
transcription B-Gene +
factors I-Gene +
. O +

In O +
this O +
study O +
, O +
we O +
found O +
that O +
IscR B-Gene +
functions O +
as O +
a O +
repressor O +
of O +
the O +
iscRSUA B-Gene +
operon I-Gene +
, O +
because O +
strains O +
deleted O +
for O +
iscR B-Gene +
have O +
increased O +
expression O +
of O +
this O +
operon O +
. O +

In O +
addition O +
, O +
in O +
vitro O +
transcription O +
reactions O +
established O +
a O +
direct O +
role O +
for O +
IscR B-Gene +
in O +
repression O +
of O +
the O +
iscR B-Gene +
promoter O +
. O +

Analysis O +
of O +
IscR B-Gene +
by O +
electron O +
paramagnetic O +
resonance O +
showed O +
that O +
the O +
anaerobically O +
isolated O +
protein O +
contains O +
a O +
[ O -
2Fe-2S O -
] O -
( O -
1 O -
+ O +
) O +
cluster O +
. O +

The O +
Fe O -
- O -
S O +
cluster O +
appears O +
to O +
be O +
important O +
for O +
IscR B-Gene +
function O +
, O +
because O +
repression O +
of O +
iscR B-Gene +
expression O +
is O +
significantly O +
reduced O +
in O +
strains O +
containing O +
null O +
mutations O +
of O +
the O +
Fe O -
- O -
S O +
cluster O +
assembly O +
genes O +
iscS B-Gene +
or O +
hscA B-Gene +
. O +

The O +
finding O +
that O +
IscR B-Gene +
activity O +
is O +
decreased O +
in O +
strain O +
backgrounds O +
in O +
which O +
Fe O -
- O -
S O +
cluster O +
assembly O +
is O +
impaired O +
suggests O +
that O +
this O +
protein O +
may O +
be O +
part O +
of O +
a O +
novel O +
autoregulatory O +
mechanism O +
that O +
senses O +
the O +
Fe O -
- O -
S O +
cluster O +
assembly O +
status O +
of O +
cells O +
. O +

Alternate O +
signalling O +
pathways O +
from O +
the O +
interleukin-2 B-Gene +
receptor I-Gene +
. O +

Interleukin-2 B-Gene +
( O +
IL-2 B-Gene +
) O +
plays O +
a O +
major O +
role O +
in O +
the O +
proliferation O +
of O +
cell O +
populations O +
during O +
an O +
immune O +
reaction O +
. O +

The O +
beta B-Gene -
( I-Gene -
c I-Gene -
) I-Gene +
and O +
gamma B-Gene -
( I-Gene -
c I-Gene -
) I-Gene +
subunits O +
of O +
the O +
IL-2 B-Gene +
receptor I-Gene +
( O +
IL-2R B-Gene +
) O +
are O +
sufficient O +
and O +
necessary O +
for O +
signal O +
transduction O +
. O +

Despite O +
lacking O +
known O +
catalytic O +
domains O +
, O +
receptor O +
engagement O +
leads O +
to O +
the O +
activation O +
of O +
a O +
diverse O +
array O +
protein B-Gene +
tyrosine I-Gene +
kinases I-Gene +
( O +
PTKs B-Gene +
) O +
. O +

In O +
resting O +
or O +
anergised O +
T O +
cells O +
, O +
Jak3 B-Gene +
is O +
not O +
activated O +
. O +

Signals O +
arising O +
from O +
the O +
PROX O +
domain O +
of O +
the O +
gamma B-Gene -
( I-Gene -
c I-Gene -
) I-Gene +
subunit O +
activate O +
p56 B-Gene -
( I-Gene -
lck I-Gene -
) I-Gene +
( O +
lck B-Gene +
) O +
leading O +
to O +
the O +
induction O +
of O +
anti O +
- O +
apoptotic O +
mechanisms O +
. O +

When O +
Jak3 B-Gene +
is O +
activated O +
, O +
in O +
primed O +
T O +
cells O +
, O +
other O +
PTKs B-Gene +
predominantly O +
mediate O +
the O +
induction O +
of O +
anti O +
- O +
apoptotic O +
mechanisms O +
and O +
drive O +
cellular O +
proliferation O +
. O +

This O +
review O +
intends O +
to O +
suggest O +
a O +
role O +
for O +
these O +
differences O +
within O +
the O +
context O +
of O +
the O +
immune O +
system O +
. O +

Direct O +
interaction O +
of O +
YidC B-Gene +
with O +
the O +
Sec B-Gene +
- O +
independent O +
Pf3 O +
coat B-Gene +
protein I-Gene +
during O +
its O +
membrane O +
protein O +
insertion O +
. O +

YidC B-Gene +
is O +
a O +
newly O +
defined O +
translocase B-Gene +
component O +
that O +
mediates O +
the O +
insertion O +
of O +
proteins O +
into O +
the O +
membrane O +
bilayer O +
. O +

How O +
YidC B-Gene +
functions O +
in O +
the O +
insertion O +
process O +
is O +
not O +
known O +
. O +

In O +
this O +
study O +
, O +
we O +
report O +
that O +
the O +
Sec B-Gene +
- O +
independent O +
Pf3 O +
coat B-Gene +
protein I-Gene +
requires O +
the O +
YidC B-Gene +
protein O +
specifically O +
for O +
the O +
membrane O +
translocation O +
step O +
. O +

Using O +
photocrosslinking O +
techniques O +
and O +
ribosome O +
- O +
bound O +
Pf3 O +
coat O +
derivatives O +
with O +
an O +
extended O +
carboxyl O +
- O +
terminal O +
region O +
, O +
we O +
found O +
that O +
the O +
transmembrane O +
region O +
of O +
the O +
Pf3 O +
coat B-Gene +
protein I-Gene +
physically O +
interacts O +
with O +
YidC B-Gene +
and O +
the O +
bacterial O +
signal O +
recognition O +
particle O +
Ffh B-Gene +
component O +
. O +

We O +
also O +
find O +
that O +
in O +
the O +
insertion O +
pathway O +
, O +
Pf3 O +
coat O +
interacts O +
strongly O +
with O +
YidC B-Gene +
only O +
after O +
its O +
transmembrane O +
segment O +
is O +
fully O +
exposed O +
outside O +
the O +
ribosome O +
tunnel O +
. O +

Interaction O +
between O +
Pf3 O +
coat O +
and O +
YidC B-Gene +
occurs O +
even O +
in O +
the O +
absence O +
of O +
the O +
proton O +
motive O +
force O +
and O +
with O +
a O +
Pf3 O +
coat O +
mutant O +
that O +
is O +
defective O +
in O +
transmembrane O +
insertion O +
. O +

Our O +
study O +
demonstrates O +
that O +
YidC B-Gene +
can O +
directly O +
interact O +
with O +
a O +
Sec B-Gene +
- O +
independent O +
membrane O +
protein O +
, O +
and O +
the O +
role O +
of O +
YidC B-Gene +
is O +
at O +
the O +
stage O +
of O +
folding O +
the O +
Pf3 O +
protein O +
into O +
a O +
transmembrane O +
configuration O +
. O +

BCR B-Gene +
- O +
ABL B-Gene +
suppresses O +
C B-Gene +
/ I-Gene +
EBPalpha I-Gene +
expression O +
through O +
inhibitory O +
action O +
of O +
hnRNP B-Gene +
E2 I-Gene +
. O +

The O +
arrest O +
of O +
differentiation O +
is O +
a O +
feature O +
of O +
both O +
chronic O +
myelogenous O +
leukemia O +
cells O +
in O +
myeloid O +
blast O +
crisis O +
and O +
myeloid O +
precursors O +
that O +
ectopically O +
express O +
the O +
p210BCR B-Gene +
- O +
ABL B-Gene +
oncoprotein O +
; O +
however O +
, O +
its O +
underlying O +
mechanisms O +
remain O +
poorly O +
understood O +
. O +

Here O +
we O +
show O +
that O +
expression O +
of O +
BCR B-Gene +
- O +
ABL B-Gene +
in O +
myeloid O +
precursor O +
cells O +
leads O +
to O +
transcriptional O +
suppression O +
of O +
the O +
granulocyte B-Gene +
colony I-Gene +
- I-Gene +
stimulating I-Gene +
factor I-Gene +
receptor I-Gene +
G B-Gene -
- I-Gene -
CSF I-Gene -
- I-Gene -
R I-Gene +
( O +
encoded O +
by O +
CSF3R B-Gene +
) O +
, O +
possibly O +
through O +
down O +
- O +
modulation O +
of O +
C B-Gene +
/ I-Gene +
EBPalpha I-Gene +
- O +
the O +
principal O +
regulator O +
of O +
granulocytic O +
differentiation O +
. O +

Expression O +
of O +
C B-Gene +
/ I-Gene +
EBPalpha I-Gene +
protein O +
is O +
barely O +
detectable O +
in O +
primary O +
marrow O +
cells O +
taken O +
from O +
individuals O +
affected O +
with O +
chronic O +
myeloid O +
leukemia O +
in O +
blast O +
crisis O +
. O +

In O +
contrast O +
, O +
CEBPA B-Gene +
RNA O +
is O +
clearly O +
present O +
. O +

Ectopic O +
expression O +
of O +
C B-Gene +
/ I-Gene +
EBPalpha I-Gene +
induces O +
granulocytic O +
differentiation O +
of O +
myeloid O +
precursor O +
cells O +
expressing O +
BCR B-Gene +
- O +
ABL B-Gene +
. O +

Expression O +
of O +
C B-Gene +
/ I-Gene +
EBPalpha I-Gene +
is O +
suppressed O +
at O +
the O +
translational O +
level O +
by O +
interaction O +
of O +
the O +
poly O +
( O +
rC O +
) O +
- O +
binding O +
protein O +
hnRNP B-Gene +
E2 I-Gene +
with O +
CEBPA B-Gene +
mRNA O +
, O +
and O +
ectopic O +
expression O +
of O +
hnRNP B-Gene +
E2 I-Gene +
in O +
myeloid O +
precursor O +
cells O +
down O +
- O +
regulates O +
both O +
C B-Gene +
/ I-Gene +
EBPalpha I-Gene +
and O +
G B-Gene +
- I-Gene +
CSF I-Gene +
- I-Gene +
R I-Gene +
and O +
leads O +
to O +
rapid O +
cell O +
death O +
on O +
treatment O +
with O +
G B-Gene -
- I-Gene -
CSF I-Gene +
( O +
encoded O +
by O +
CSF3 B-Gene +
) O +
. O +

Our O +
results O +
indicate O +
that O +
BCR B-Gene +
- O +
ABL B-Gene +
regulates O +
the O +
expression O +
of O +
C B-Gene +
/ I-Gene +
EBPalpha I-Gene +
by O +
inducing O +
hnRNP B-Gene +
E2 I-Gene +
- O +
which O +
inhibits O +
the O +
translation O +
of O +
CEBPA B-Gene +
mRNA O +
. O +

Cloning O +
, O +
mapping O +
and O +
expression O +
analysis O +
of O +
C15orf4 B-Gene +
, O +
a O +
novel O +
human O +
gene O +
with O +
homology O +
to O +
the O +
yeast O +
mitochondrial O +
ribosomal O +
protein O +
Ym130 B-Gene +
gene O +
. O +

We O +
have O +
identified O +
C15orf4 B-Gene +
, O +
a O +
novel O +
human O +
gene O +
showing O +
homology O +
to O +
the O +
yeast O +
mitochondrial O +
ribosomal O +
protein O +
YmL30 B-Gene +
. O +

C15orf4 B-Gene +
encodes O +
a O +
transcript O +
of O +
1 O +
, O +
006 O +
nt O +
with O +
an O +
ORF O +
of O +
279 O +
amino O +
acids O +
and O +
a O +
predicted O +
protein O +
size O +
of O +
31.7 O +
kDa O +
. O +

Expression O +
of O +
C15orf4 B-Gene +
is O +
enriched O +
in O +
testis O +
. O +

C15orf4 B-Gene +
was O +
positioned O +
to O +
chromosome O +
15q24 O +
by O +
radiation O +
hybrid O +
mapping O +
. O +

We O +
have O +
identified O +
the O +
C15orf4 B-Gene +
mouse O +
orthologue O +
as O +
well O +
as O +
homologues O +
in O +
other O +
species O +
. O +

Effect O +
of O +
300 O +
- O +
and O +
450 O +
- O +
mg O +
clopidogrel O +
loading O +
doses O +
on O +
membrane O +
and O +
soluble O +
P B-Gene -
- I-Gene -
selectin I-Gene +
in O +
patients O +
undergoing O +
coronary O +
stent O +
implantation O +
. O +

BACKGROUND O +
: O +

After O +
coronary O +
artery O +
stent O +
implantation O +
patients O +
are O +
treated O +
with O +
the O +
adenosine B-Gene +
diphosphatase I-Gene +
( I-Gene +
ADP I-Gene +
) I-Gene +
receptor I-Gene +
antagonist O +
clopidogrel O +
to O +
prevent O +
subacute O +
stent O +
thromboses O +
. O +

Today O +
these O +
patients O +
initially O +
receive O +
a O +
loading O +
dose O +
of O +
300 O +
mg O +
of O +
clopidogrel O +
to O +
accelerate O +
the O +
complete O +
drug O +
effect O +
. O +

In O +
the O +
current O +
study O +
we O +
investigated O +
whether O +
a O +
higher O +
loading O +
dose O +
can O +
shorten O +
the O +
time O +
until O +
the O +
maximum O +
platelet O +
inhibitory O +
effect O +
of O +
clopidogrel O +
is O +
achieved O +
. O +

METHODS O +
: O +

P B-Gene -
- I-Gene -
selectin I-Gene +
expression O +
of O +
nonstimulated O +
and O +
ADP O +
- O +
stimulated O +
platelets O +
was O +
flow O +
cytometrically O +
measured O +
before O +
the O +
clopidogrel O +
loading O +
dose O +
and O +
on O +
3 O +
consecutive O +
days O +
in O +
52 O +
patients O +
with O +
coronary O +
artery O +
disease O +
: O +
21 O +
patients O +
in O +
group O +
1 O +
received O +
300 O +
mg O +
of O +
clopidogrel O +
after O +
stent O +
implantation O +
and O +
11 O +
patients O +
in O +
group O +
2 O +
received O +
the O +
higher O +
450 O +
- O +
mg O +
clopidogrel O +
loading O +
dose O +
followed O +
by O +
a O +
daily O +
dose O +
of O +
75 O +
mg O +
of O +
clopidogrel O +
for O +
both O +
groups O +
. O +

The O +
control O +
group O +
consisted O +
of O +
20 O +
patients O +
who O +
were O +
monitored O +
over O +
2 O +
days O +
before O +
coronary O +
intervention O +
. O +

Soluble O +
P B-Gene -
- I-Gene -
selectin I-Gene +
levels O +
in O +
plasma O +
were O +
determined O +
by O +
an O +
enzyme O +
- O +
linked O +
immunosorbent O +
assay O +
. O +

RESULTS O +
: O +

Inducible O +
P B-Gene -
- I-Gene -
selectin I-Gene +
expression O +
on O +
ADP O +
- O +
stimulated O +
platelets O +
was O +
significantly O +
reduced O +
( O +
P O +
= O +
.05 O +
) O +
on O +
days O +
1 O +
and O +
2 O +
in O +
patient O +
group O +
2 O +
( O +
450 O +
- O +
mg O +
loading O +
dose O +
) O +
compared O +
with O +
group O +
1 O +
( O +
300 O +
- O +
mg O +
loading O +
dose O +
) O +
. O +

No O +
influence O +
of O +
clopidogrel O +
on O +
the O +
P B-Gene -
- I-Gene -
selectin I-Gene +
levels O +
in O +
plasma O +
was O +
observed O +
. O +

CONCLUSIONS O +
: O +

In O +
our O +
study O +
the O +
application O +
of O +
450 O +
mg O +
of O +
clopidogrel O +
as O +
the O +
loading O +
dose O +
in O +
patients O +
undergoing O +
coronary O +
stenting O +
shortens O +
the O +
period O +
until O +
the O +
maximum O +
effect O +
of O +
the O +
ADP B-Gene +
receptor I-Gene +
antagonist O +
is O +
achieved O +
and O +
thus O +
may O +
lead O +
to O +
a O +
more O +
successful O +
prevention O +
of O +
subacute O +
coronary O +
stent O +
thromboses O +
. O +

RseB B-Gene +
binding O +
to O +
the O +
periplasmic O +
domain O +
of O +
RseA B-Gene +
modulates O +
the O +
RseA B-Gene +
: O +
sigmaE B-Gene +
interaction O +
in O +
the O +
cytoplasm O +
and O +
the O +
availability O +
of O +
sigmaE B-Gene +
. B-Gene +
RNA I-Gene +
polymerase I-Gene +
. O +

The O +
Escherichia O +
coli O +
sigmaE B-Gene +
regulon O +
has O +
evolved O +
to O +
sense O +
the O +
presence O +
of O +
misfolded O +
proteins O +
in O +
the O +
bacterial O +
envelope O +
. O +

Expression O +
of O +
periplasmic O +
chaperones B-Gene +
and O +
folding O +
catalysts O +
is O +
under O +
the O +
control O +
of O +
sigmaE B-Gene +
RNA B-Gene +
polymerase I-Gene +
. O +

The O +
N O +
- O +
terminal O +
domain O +
of O +
RseA B-Gene +
sequesters O +
sigmaE B-Gene +
in O +
the O +
cytoplasmic O +
membrane O +
, O +
preventing O +
its O +
association O +
with O +
core O +
RNA B-Gene +
polymerase I-Gene +
. O +

The O +
C O +
- O +
terminal O +
domain O +
of O +
RseA B-Gene +
interacts O +
with O +
RseB B-Gene +
, O +
a O +
periplasmic O +
protein O +
. O +

The O +
relative O +
concentration O +
of O +
sigmaE B-Gene +
: O +
RseA B-Gene +
: O +
RseB B-Gene +
is O +
2:5:1 O +
and O +
this O +
ratio O +
remains O +
unaltered O +
upon O +
heat O +
shock O +
induction O +
of O +
the O +
sigmaE B-Gene +
regulon O +
. O +

Purification O +
from O +
crude O +
cellular O +
extracts O +
yields O +
cytoplasmic O +
, O +
soluble O +
sigmaE B-Gene +
RNA B-Gene +
polymerase I-Gene +
as O +
well O +
as O +
membrane O +
sequestered O +
sigmaE B-Gene +
. O +
RseA B-Gene +
and O +
sigmaE B-Gene +
. O +
RseA B-Gene +
. O +
RseB B-Gene +
. O +

RseB B-Gene +
binding O +
to O +
the O +
C O +
- O +
terminal O +
domain O +
of O +
RseA B-Gene +
increases O +
the O +
affinity O +
of O +
RseA B-Gene +
for O +
sigmaE B-Gene +
by O +
2 O +
- O +
to O +
3 O +
- O +
fold O +
( O +
Kd O +
50 O +
- O +
100 O +
nM O +
) O +
. O +

RseB B-Gene +
binds O +
also O +
to O +
the O +
misfolded O +
aggregates O +
of O +
MalE31 B-Gene +
, O +
a O +
variant O +
of O +
maltose O +
binding O +
protein O +
that O +
forms O +
inclusion O +
bodies O +
in O +
the O +
periplasm O +
. O +

We O +
discuss O +
a O +
model O +
whereby O +
the O +
RseB B-Gene +
- O +
RiseA B-Gene +
interaction O +
represents O +
a O +
measure O +
for O +
misfolded O +
polypeptides O +
in O +
the O +
bacterial O +
envelope O +
, O +
modulating O +
the O +
assembly O +
of O +
sigmaE B-Gene +
RNA B-Gene +
polymerase I-Gene +
and O +
the O +
cellular O +
heat O +
shock O +
response O +
. O +

Th1 O +
/ O +
Th2 O +
type O +
cytokines B-Gene +
in O +
hepatitis O +
B O +
patients O +
treated O +
with O +
interferon B-Gene -
- I-Gene -
alpha I-Gene +
. O +

OBJECTIVE O +
: O +

To O +
investigate O +
the O +
relationship O +
between O +
the O +
expression O +
of O +
Th1 O +
/ O +
Th2 O +
type O +
cytokines B-Gene +
and O +
the O +
effect O +
of O +
interferon B-Gene -
- I-Gene -
alpha I-Gene +
therapy O +
. O +

METHODS O +
: O +

Th1 O +
/ O +
Th2 O +
type O +
cytokines B-Gene +
were O +
assayed O +
by O +
enzyme O +
- O +
linked O +
immunosorbent O +
assay O +
( O +
ELISA O +
) O +
and O +
reverse O +
transcription O +
polymerase O +
chain O +
reaction O +
( O +
RT O +
- O +
PCR O +
) O +
on O +
23 O +
patients O +
with O +
chronic O +
hepatitis O +
B O +
who O +
were O +
treated O +
with O +
interferon B-Gene -
- I-Gene -
alpha I-Gene +
. O +

RESULTS O +
: O +

Levels O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
in O +
the O +
supernatant O +
of O +
peripheral O +
blood O +
mononuclear O +
cells O +
( O +
PBMC O +
) O +
cultures O +
from O +
the O +
patients O +
with O +
hepatitis O +
B O +
were O +
slightly O +
lower O +
than O +
those O +
of O +
controls O +
( O +
P O +
= O +
0.07 O +
) O +
. O +

However O +
, O +
the O +
levels O +
of O +
IL-4 B-Gene +
were O +
higher O +
than O +
those O +
of O +
controls O +
( O +
P O +
= O +
0.01 O +
) O +
. O +

Cytokines B-Gene +
measurements O +
during O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
treatment O +
showed O +
a O +
trend O +
to O +
decreasing O +
levels O +
of O +
IL-4 B-Gene +
at O +
4 O +
, O +
12 O +
, O +
and O +
24 O +
weeks O +
. O +

Levels O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
were O +
slightly O +
increased O +
following O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
treatment O +
( O +
P O +
= O +
0.09 O +
) O +
. O +

In O +
patients O +
with O +
a O +
complete O +
response O +
to O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
, O +
the O +
levels O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
were O +
higher O +
at O +
24 O +
weeks O +
following O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
treatment O +
than O +
that O +
of O +
pre O +
- O +
treatment O +
( O +
P O +
= O +
0.04 O +
) O +
, O +
and O +
the O +
levels O +
of O +
IL-4 B-Gene +
decreased O +
markedly O +
at O +
12 O +
and O +
24 O +
weeks O +
( O +
P O +
= O +
0.02 O +
, O +
0.03 O +
, O +
respectively O +
) O +
. O +

mRNA O +
expression O +
positively O +
correlated O +
with O +
the O +
level O +
of O +
Th1 O +
/ O +
Th2 O +
type O +
cytokines B-Gene +
in O +
the O +
supernatant O +
. O +

CONCLUSION O +
: O +

The O +
expression O +
of O +
Th2 O +
type O +
cytokines B-Gene +
is O +
predominant O +
in O +
patients O +
with O +
chronic O +
hepatitis O +
B O +
. O +

Interferon B-Gene -
- I-Gene -
alpha I-Gene +
therapy O +
can O +
modulate O +
the O +
balance O +
of O +
Th1 O +
/ O +
Th2 O +
type O +
cytokines B-Gene +
, O +
and O +
this O +
is O +
related O +
to O +
its O +
clinical O +
effect O +
. O +

Levels O +
of O +
Th1 O +
/ O +
Th2 O +
type O +
cytokines B-Gene +
could O +
be O +
a O +
predictor O +
of O +
clinical O +
response O +
during O +
Interferon B-Gene +
- I-Gene +
alpha I-Gene +
treatment O +
. O +

The O +
molar O +
ratio O +
of O +
serum O +
retinol B-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
( O +
RBP B-Gene +
) O +
to O +
transthyretin B-Gene +
( O +
TTR B-Gene +
) O +
is O +
not O +
useful O +
to O +
assess O +
vitamin O +
A O +
status O +
during O +
infection O +
in O +
hospitalised O +
children O +
. O +

OBJECTIVE O +
: O +

To O +
assess O +
the O +
usefulness O +
of O +
the O +
molar O +
ratio O +
of O +
serum O +
retinol B-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
( O +
RBP B-Gene +
) O +
to O +
transthyretin B-Gene +
( O +
TTR B-Gene +
) O +
to O +
determine O +
vitamin O +
A O +
( O +
VA O +
) O +
status O +
during O +
infection O +
. O +

DESIGN O +
: O +

We O +
took O +
advantage O +
of O +
previously O +
collected O +
data O +
during O +
a O +
randomised O +
double O +
- O +
blind O +
, O +
placebo O +
- O +
controlled O +
clinical O +
trial O +
to O +
conduct O +
a O +
secondary O +
analysis O +
of O +
the O +
RBP B-Gene +
/ O +
TTR B-Gene +
ratio O +
and O +
its O +
relationship O +
to O +
infection O +
and O +
VA O +
status O +
. O +

In O +
this O +
clinical O +
trial O +
, O +
children O +
were O +
randomly O +
assigned O +
to O +
one O +
of O +
three O +
groups O +
and O +
received O +
either O +
one O +
single O +
oral O +
high O +
dose O +
of O +
VA O +
( O +
200 O +
000 O +
IU O +
) O +
on O +
the O +
day O +
of O +
admission O +
and O +
subsequently O +
a O +
placebo O +
daily O +
until O +
discharge O +
or O +
daily O +
oral O +
low O +
doses O +
of O +
VA O +
( O +
5000 O +
IU O +
) O +
from O +
admission O +
until O +
discharge O +
or O +
a O +
placebo O +
daily O +
from O +
admission O +
until O +
discharge O +
. O +

SETTING O +
: O +

Lwiro O +
pediatric O +
hospital O +
, O +
Province O +
of O +
South O +
Kivu O +
, O +
Democratic O +
Republic O +
of O +
Congo O +
. O +

SUBJECTS O +
: O +

A O +
total O +
of O +
900 O +
children O +
aged O +
0 O +
- O +
72 O +
months O +
hospitalised O +
consecutively O +
between O +
March O +
1994 O +
and O +
March O +
1996 O +
. O +

MAIN O +
OUTCOME O +
MEASURES O +
: O +

RBP B-Gene +
/ O +
TTR B-Gene +
molar O +
ratio O +
after O +
7 O +
days O +
hospitalisation O +
. O +

RESULTS O +
: O +

After O +
7 O +
days O +
hospitalisation O +
, O +
molar O +
RBP B-Gene +
: O +
TTR B-Gene +
ratio O +
( O +
mean O +
+ O +
/ O +
- O +
s.d O -
. O +
) O +
of O +
infected O +
children O +
( O +
C O +
- O +
reactive O +
proteins O +
> O +
10 O +
mg O +
/ O +
l O +
) O +
was O +
0.67 O +
+ O -
/- O +
0.31 O +
in O +
the O +
high O +
- O +
dose O +
group O +
( O +
n O +
= O +
81 O +
) O +
, O +
0.74 O +
+ O -
/- O +
0.44 O +
in O +
the O +
low O +
dose O +
group O +
( O +
n O +
= O +
71 O +
) O +
and O +
0.73 O +
+ O -
/- O +
0.39 O +
in O +
the O +
placebo O +
group O +
( O +
n O +
= O +
81 O +
) O +
. O +

These O +
values O +
did O +
not O +
differ O +
significantly O +
( O +
one O +
- O +
way O +
ANOVA O +
P O +
= O +
0.472 O +
) O +
. O +

In O +
patients O +
with O +
baseline O +
serum O +
retinol O +
concentrations O +
< O +
0.70 O +
micromol O +
/ O +
l O +
, O +
changes O +
in O +
RBP B-Gene +
: O +
TTR B-Gene +
ratio O +
between O +
admission O +
and O +
day O +
7 O +
were O +
not O +
statistically O +
different O +
in O +
the O +
three O +
groups O +
( O +
one O +
- O +
way O +
ANOVA O +
P O +
= O +
0.548 O +
) O +
. O +

CONCLUSIONS O +
: O +

In O +
this O +
population O +
of O +
malnourished O +
hospitalised O +
children O +
, O +
molar O +
RBP B-Gene +
: O +
TTR B-Gene +
ratio O +
does O +
not O +
appear O +
to O +
be O +
useful O +
to O +
assess O +
VA O +
status O +
during O +
infection O +
. O +

SPONSORSHIP O +
: O +

Our O +
research O +
was O +
partially O +
supported O +
by O +
a O +
grant O +
from O +
the O +
Fonds O +
de O +
la O +
Recherche O +
Scientifique O +
et O +
MÃ?Â O -
© O -
dicale O +
( O +
contract O +
3.4505.94 O +
) O +
and O +
the O +
David O +
and O +
Alice O +
Van O +
Buuren O +
Foundation O +
. O +

Inhibition O +
of O +
nNOS B-Gene +
activity O +
in O +
rat O +
brain O +
by O +
synthetic O +
kynurenines O +
: O +
structure O +
- O +
activity O +
dependence O +
. O +

The O +
overstimulation O +
of O +
the O +
N B-Gene -
- I-Gene -
methyl I-Gene -
- I-Gene -
D I-Gene -
- I-Gene -
aspartate I-Gene +
( I-Gene +
NMDA I-Gene +
) I-Gene +
subtype I-Gene +
of I-Gene +
glutamate I-Gene +
receptors I-Gene +
is O +
involved O +
in O +
excitotoxicity O +
, O +
a O +
process O +
participating O +
in O +
neurodegeneration O +
that O +
characterizes O +
some O +
neurological O +
disorders O +
and O +
acute O +
cerebral O +
insults O +
. O +

In O +
looking O +
for O +
compounds O +
with O +
neuroprotective O +
properties O +
, O +
a O +
series O +
of O +
kynurenine O +
derivatives O +
were O +
synthesized O +
, O +
and O +
their O +
effects O +
on O +
both O +
the O +
NMDA O +
and O +
nNOS B-Gene +
activity O +
in O +
rat O +
striatum O +
were O +
evaluated O +
. O +

Two O +
compounds O +
, O +
15a O +
( O -
2-acetamido-4- O -
( O -
2-amino-5-methoxyphenyl O -
) O -
-4-oxobutyric O +
acid O +
) O +
and O +
15c O +
( O -
2-butyramido-4- O -
( O -
2-amino-5-methoxyphenyl O -
) O -
-4-oxobutyric O +
acid O +
) O +
, O +
displayed O +
more O +
potent O +
activities O +
than O +
the O +
other O +
synthetic O +
compounds O +
tested O +
for O +
the O +
inhibition O +
of O +
NMDA O +
excitability O +
and O +
nNOS B-Gene +
activity O +
. O +

Two O +
other O +
compounds O +
, O +
18a O +
( O -
2-acetamido-4- O -
( O -
3-methoxyphenyl O -
) O -
-4-oxobutyric O +
acid O +
) O +
and O +
18c O +
( O -
2-butyramido-4- O -
( O -
3-methoxyphenyl O -
) O -
-4-oxobutyric O +
acid O +
) O +
, O +
that O +
have O +
the O +
same O +
structure O +
as O +
15a O +
and O +
15c O +
, O +
except O +
the O +
amino O +
group O +
in O +
R O -
( O -
1 O -
) O +
, O +
showed O +
different O +
effects O +
. O +

Whereas O +
compound O +
18a O +
showed O +
lower O +
electrophysiological O +
potency O +
than O +
compounds O +
15a O +
and O +
15c O +
in O +
the O +
inhibition O +
of O +
the O +
NMDA O +
- O +
dependent O +
excitability O +
, O +
compound O +
18c O +
showed O +
the O +
opposite O +
effect O +
. O +

Moreover O +
, O +
compounds O +
18a O +
and O +
18c O +
were O +
unable O +
to O +
modify O +
nNOS B-Gene +
activity O +
. O +

The O +
remaining O +
kynurenines O +
tested O +
behave O +
like O +
compound O +
18a O +
. O +

These O +
results O +
suggest O +
that O +
a O +
structure O +
- O +
related O +
activity O +
of O +
these O +
synthetic O +
kynurenines O +
and O +
a O +
N O -
- O -
H O +
bond O +
in O +
a O +
specific O +
direction O +
is O +
necessary O +
for O +
some O +
kynurenine O +
analogues O +
to O +
inhibit O +
nNOS B-Gene +
activity O +
. O +

Calpain B-Gene +
- O +
mediated O +
cleavage O +
of O +
the O +
cyclin B-Gene +
- I-Gene +
dependent I-Gene +
kinase-5 I-Gene +
activator I-Gene +
p39 I-Gene +
to O +
p29 O +
. O +

The O +
activity O +
of O +
cyclin B-Gene +
- I-Gene +
dependent I-Gene +
kinase-5 I-Gene +
( O +
Cdk5 B-Gene +
) O +
is O +
tightly O +
regulated O +
by O +
binding O +
of O +
its O +
neuronal O +
activators O +
p35 B-Gene +
and O +
p39 B-Gene +
. O +

Upon O +
neurotoxic O +
insults O +
, O +
p35 B-Gene +
is O +
cleaved O +
to O +
p25 B-Gene +
by O +
the O +
Ca O -
( O -
2 O -
+ O -
) O +
- O +
dependent O +
protease B-Gene +
calpain B-Gene +
. O +

p25 B-Gene +
is O +
accumulated O +
in O +
ischemic O +
brains O +
and O +
in O +
brains O +
of O +
patients O +
with O +
Alzheimer O +
's O +
disease O +
. O +

p25 B-Gene +
deregulates O +
Cdk5 B-Gene +
activity O +
by O +
causing O +
prolonged O +
activation O +
and O +
mislocalization O +
of O +
Cdk5 B-Gene +
. O +

It O +
is O +
unknown O +
whether O +
p39 B-Gene +
, O +
which O +
is O +
expressed O +
throughout O +
the O +
adult O +
rat O +
brain O +
, O +
is O +
cleaved O +
by O +
calpain B-Gene +
, O +
and O +
whether O +
this O +
contributes O +
to O +
deregulation O +
of O +
Cdk5 B-Gene +
. O +

Here O +
, O +
we O +
show O +
that O +
calpain B-Gene +
cleaved O +
p39 B-Gene +
in O +
vitro O +
, O +
resulting O +
in O +
generation O +
of O +
a O +
C O +
- O +
terminal O +
p29 O +
fragment O +
. O +

In O +
vivo O +
, O +
p29 O +
was O +
generated O +
in O +
ischemic O +
brain O +
concomitant O +
with O +
increased O +
calpain B-Gene +
activity O +
. O +

In O +
fresh O +
brain O +
lysates O +
, O +
generation O +
of O +
p29 O +
was O +
Ca O -
( O -
2 O -
+ O -
) O +
- O +
dependent O +
, O +
and O +
calpain O +
inhibitors O +
abolished O +
p29 O +
production O +
. O +

The O +
Ca O -
( O -
2 O -
+ O -
) O +
ionophore O +
ionomycin O +
and O +
the O +
excitotoxin O +
glutamate O +
induced O +
production O +
of O +
p29 O +
in O +
cultures O +
of O +
cortical O +
neurons O +
in O +
a O +
calpain B-Gene +
- O +
dependent O +
manner O +
. O +

Like O +
p25 B-Gene +
, O +
p29 O +
was O +
more O +
stable O +
than O +
p39 B-Gene +
and O +
caused O +
redistribution O +
of O +
Cdk5 B-Gene +
in O +
cortical O +
neurons O +
. O +

Our O +
data O +
suggest O +
that O +
neurotoxic O +
insults O +
lead O +
to O +
calpain B-Gene +
- O +
mediated O +
conversion O +
of O +
p39 B-Gene +
to O +
p29 B-Gene +
, O +
which O +
might O +
contribute O +
to O +
deregulation O +
of O +
Cdk5 B-Gene +
. O +

[ O +
Comparative O +
analysis O +
of O +
various O +
techniques O +
of O +
prostatic O +
drainage O +
in O +
patients O +
with O +
chronic O +
obstructive O +
prostatitis O +
] O +

The O +
efficacy O +
of O +
prostatic O +
drainage O +
using O +
transurethral O +
vacuum O +
aspiration O +
( O +
Introl-4 O +
unit O +
) O +
and O +
transrectal O +
pneumovibromassage O +
( O +
PVM O -
- O -
R-01 O +
) O +
was O +
compared O +
in O +
1511 O +
patients O +
with O +
chronic O +
obstructive O +
prostatitis O +
. O +

The O +
drainage O +
was O +
accompanied O +
by O +
local O +
( O +
urethral O +
, O +
rectal O +
and O +
urethral O +
- O +
rectal O +
tripsin O +
or O +
chimotripsin O +
electrophoresis O +
) O +
or O +
systemic O +
enzymic O +
therapy O +
( O +
vobenzim O +
) O +
. O +

The O +
highest O +
effect O +
of O +
the O +
drainage O +
was O +
achieved O +
in O +
patients O +
pretreated O +
for O +
5 O +
- O +
7 O +
days O +
with O +
systemic O +
enzymes O +
. O +

Transrectal O +
pneumovibromassage O +
proved O +
more O +
effective O +
and O +
safe O +
but O +
the O +
transurethral O +
technique O +
if O +
indicated O +
can O +
be O +
also O +
used O +
in O +
the O +
combined O +
treatment O +
. O +

[ O +
Influence O +
of O +
different O +
methods O +
of O +
chemical O +
disinfection O +
on O +
the O +
physical O +
properties O +
of O +
type O +
IV O +
and O +
V O +
gypsum O +
dies O +
] O +

Several O +
instruments O +
and O +
materials O +
frequently O +
used O +
in O +
prosthodontics O +
-- O +
such O +
as O +
stone O +
casts O +
, O +
dental O +
impressions O +
, O +
interocclusal O +
records O +
- O +
- O +
are O +
classified O +
, O +
by O +
the O +
dental O +
literature O +
, O +
as O +
vehicles O +
of O +
transmission O +
of O +
infectious O +
diseases O +
to O +
those O +
who O +
handle O +
them O +
. O +

The O +
present O +
study O +
aims O +
at O +
comparing O +
dimensional O +
alteration O +
, O +
superficial O +
texture O +
and O +
compression O +
resistance O +
of O +
stone O +
dies O +
submitted O +
to O +
different O +
disinfection O +
methods O +
: O +
30-minute O +
immersion O +
in O +
1 O +
% O +
sodium O +
hypochlorite O +
or O +
in O +
2.2 O +
% O +
alkaline O +
glutaraldehyde O +
( O +
with O +
or O +
without O +
previous O +
ultrasonic O +
washing O +
) O +
and O +
addition O +
of O +
2.2 O +
% O +
alkaline O +
glutaraldehyde O +
or O +
5 O +
% O +
sodium O +
hypochlorite O +
to O +
the O +
gypsum O +
during O +
its O +
preparation O +
. O +

It O +
was O +
possible O +
to O +
conclude O +
that O +
: O +
( O -
1 O -
) O +
chemical O +
disinfection O +
did O +
not O +
cause O +
significant O +
dimensional O +
alteration O +
in O +
stone O +
dies O +
; O +
( O -
2 O -
) O +
superficial O +
texture O +
was O +
altered O +
according O +
to O +
the O +
disinfection O +
method O +
utilized O +
; O +
( O -
3 O -
) O +
immersion O +
in O +
disinfectant O +
solution O +
during O +
30 O +
min O +
, O +
as O +
well O +
as O +
the O +
addition O +
of O +
disinfectant O +
to O +
the O +
gypsum O +
during O +
its O +
preparation O +
, O +
reduced O +
the O +
compression O +
resistance O +
of O +
dies O +
. O +

Positive O +
inotropic O +
responses O +
mediated O +
by O +
endothelin B-Gene +
ET I-Gene +
( I-Gene +
A I-Gene +
) I-Gene +
and I-Gene +
ET I-Gene +
( I-Gene +
B I-Gene +
) I-Gene +
receptors I-Gene +
in O +
human O +
myocardial O +
trabeculae O +
. O +

The O +
aim O +
of O +
the O +
present O +
study O +
was O +
to O +
determine O +
possible O +
inotropic O +
effects O +
mediated O +
by O +
endothelin B-Gene +
ET I-Gene +
( I-Gene +
A I-Gene +
) I-Gene +
and I-Gene +
ET I-Gene +
( I-Gene +
B I-Gene +
) I-Gene +
receptors I-Gene +
in O +
human O +
myocardial O +
trabeculae O +
from O +
the O +
right O +
atrium O +
and O +
the O +
left O +
ventricle O +
. O +

Isolated O +
trabeculae O +
from O +
human O +
hearts O +
were O +
paced O +
at O +
1.0 O +
Hz O +
in O +
tissue O +
baths O +
, O +
and O +
changes O +
in O +
isometric O +
contractile O +
force O +
upon O +
exposure O +
to O +
agonist O +
were O +
studied O +
. O +

Endothelin-1 B-Gene +
( O +
ET-1 B-Gene +
) O +
and O +
ET-3 B-Gene +
had O +
a O +
strong O +
positive O +
inotropic O +
effect O +
in O +
all O +
trabeculae O +
. O +

ET-1 B-Gene +
was O +
significantly O +
more O +
potent O +
than O +
ET-3 B-Gene +
in O +
both O +
atrial O +
( O +
P O +
< O +
0.001 O +
) O +
and O +
ventricular O +
( O +
P O +
< O +
0.05 O +
) O +
trabeculae O +
. O +

Preincubation O +
with O +
the O +
ET B-Gene -
( I-Gene -
A I-Gene -
) I-Gene +
receptor I-Gene +
antagonist O +
FR139317 O +
( O +
1 O +
microM O +
) O +
decreased O +
significantly O +
( O +
P O +
< O +
0.005 O +
) O +
the O +
potency O +
of O +
ET B-Gene +
- I-Gene +
I I-Gene +
in O +
both O +
atrial O +
and O +
ventricular O +
trabeculae O +
, O +
without O +
any O +
significant O +
changes O +
in O +
Emax O +
( O +
maximum O +
effect O +
obtained O +
with O +
an O +
agonist O +
) O +
. O +

The O +
ET B-Gene +
( I-Gene +
B I-Gene +
) I-Gene +
receptor I-Gene +
agonist O +
IRL O +
1620 O +
had O +
a O +
positive O +
inotropic O +
effect O +
only O +
in O +
some O +
trabeculae O +
, O +
and O +
the O +
ET B-Gene +
( I-Gene +
B I-Gene +
) I-Gene +
receptor I-Gene +
antagonist O +
BQ O +
788 O +
( O +
1 O +
microM O +
) O +
almost O +
completely O +
blocked O +
this O +
effect O +
. O +

These O +
results O +
suggest O +
that O +
both O +
ET B-Gene +
( I-Gene +
A I-Gene +
) I-Gene +
and I-Gene +
ET I-Gene +
( I-Gene +
B I-Gene +
) I-Gene +
receptors I-Gene +
mediate O +
positive O +
inotropic O +
responses O +
at O +
both O +
the O +
atrial O +
and O +
ventricular O +
level O +
in O +
the O +
human O +
heart O +
. O +

Burn O +
injury O +
upregulates O +
the O +
activity O +
and O +
gene O +
expression O +
of O +
the O +
20 O +
S O +
proteasome O +
in O +
rat O +
skeletal O +
muscle O +
. O +

There O +
is O +
evidence O +
that O +
burn O +
injury O +
stimulates O +
ubiquitin B-Gene +
- O +
proteasome O +
- O +
dependent O +
protein O +
breakdown O +
in O +
skeletal O +
muscle O +
. O +

In O +
this O +
proteolytic O +
pathway O +
, O +
protein O +
substrates O +
are O +
conjugated O +
to O +
multiple O +
molecules O +
of O +
ubiquitin B-Gene +
, O +
whereafter O +
they O +
are O +
recognized O +
, O +
unfolded O +
and O +
degraded O +
by O +
the O +
multicatalytic O +
26 O +
S O +
protease O +
complex O +
. O +

The O +
20 O +
S O +
proteasome O +
is O +
the O +
catalytic O +
core O +
of O +
the O +
26 O +
S O +
protease O +
complex O +
. O +

The O +
influence O +
of O +
burn O +
injury O +
on O +
the O +
expression O +
and O +
activity O +
of O +
the O +
20 O +
S O +
proteasome O +
has O +
not O +
been O +
reported O +
. O +

We O +
tested O +
the O +
hypothesis O +
that O +
burn O +
injury O +
increases O +
20 O +
S O +
proteasome O +
activity O +
and O +
the O +
expression O +
of O +
mRNA O +
for O +
the O +
20 O +
S O +
proteasome O +
subunits O +
RC3 B-Gene +
and O +
RC7 B-Gene +
. O +

Proteolytic O +
activity O +
of O +
isolated O +
20 O +
S O +
proteasomes O +
, O +
assessed O +
as O +
activity O +
against O +
fluorogenic O +
peptide O +
substrates O +
, O +
was O +
increased O +
in O +
extensor O +
digitorum O +
longus O +
muscles O +
from O +
burned O +
rats O +
. O +

Northern O +
- O +
blot O +
analysis O +
revealed O +
that O +
the O +
expression O +
of O +
mRNA O +
for O +
RC3 B-Gene +
and O +
RC7 B-Gene +
was O +
increased O +
by O +
100 O +
% O +
and O +
80 O +
% O +
respectively O +
following O +
burn O +
injury O +
. O +

Increased O +
activity O +
and O +
expression O +
of O +
the O +
20 O +
S O +
proteasome O +
in O +
muscles O +
from O +
burned O +
rats O +
support O +
the O +
concept O +
that O +
burn O +
- O +
induced O +
muscle O +
cachexia O +
is O +
at O +
least O +
, O +
in O +
part O +
, O +
regulated O +
by O +
the O +
ubiquitin B-Gene +
- O +
proteasome O +
proteolytic O +
pathway O +
. O +

Apoptotic O +
proteins O +
. O +

p53 B-Gene +
and O +
c B-Gene -
- I-Gene -
myc I-Gene +
related O +
pathways O +
. O +

c B-Gene -
- I-Gene -
Myc I-Gene +
and O +
p53 B-Gene +
are O +
two O +
proteins O +
that O +
have O +
critical O +
roles O +
in O +
the O +
regulation O +
of O +
apoptosis O +
and O +
the O +
cell O +
cycle O +
. O +

The O +
authors O +
review O +
how O +
these O +
two O +
proteins O +
are O +
thought O +
to O +
control O +
the O +
opposing O +
events O +
of O +
proliferation O +
and O +
apoptosis O +
and O +
examine O +
whether O +
their O +
well O +
- O +
documented O +
biological O +
roles O +
in O +
tumorigenesis O +
can O +
be O +
applied O +
to O +
the O +
vascular O +
system O +
. O +

A O +
comparative O +
study O +
of O +
E B-Gene -
- I-Gene -
cadherin I-Gene +
and O +
stromelysin-3 B-Gene +
expression O +
in O +
de O +
novo O +
and O +
ex O +
adenoma O +
carcinoma O +
of O +
the O +
colorectum O +
. O +

An O +
apparent O +
exception O +
to O +
the O +
colorectal O +
adenoma O +
- O +
carcinoma O +
carcinogenetic O +
pathway O +
is O +
the O +
so O +
- O +
called O +
" O +
de O +
novo O +
" O +
carcinoma O +
which O +
has O +
no O +
evidence O +
of O +
adenoma O +
in O +
its O +
vicinity O +
. O +

Despite O +
the O +
fact O +
that O +
they O +
are O +
often O +
quite O +
small O +
, O +
these O +
lesions O +
appear O +
to O +
be O +
more O +
aggressive O +
( O +
i.e. O +
, O +
greater O +
likelihood O +
of O +
lymph O +
- O +
node O +
metastases O +
) O +
than O +
carcinomas O +
that O +
clearly O +
arise O +
from O +
surrounding O +
adenomas O +
exadenoma O +
carcinoma O +
. O +

The O +
purpose O +
of O +
the O +
present O +
comparative O +
immunohistochemical O +
study O +
was O +
to O +
compare O +
rates O +
of O +
cell B-Gene +
adhesion I-Gene +
molecule I-Gene +
( O +
E B-Gene -
- I-Gene -
cadherin I-Gene +
) O +
and O +
protease B-Gene +
[ O +
stromelysin-3 B-Gene +
( O +
ST-3 B-Gene +
) O +
] O +
expression O +
in O +
groups O +
of O +
de O +
novo O +
( O +
n O +
= O +
64 O +
) O +
and O +
ex O +
adenoma O +
( O +
n O +
= O +
42 O +
) O +
lesions O +
in O +
order O +
to O +
see O +
whether O +
their O +
more O +
aggressive O +
behavior O +
is O +
associated O +
with O +
decreased O +
cell O +
adhesion O +
and O +
increased O +
protease O +
expression O +
. O +

The O +
rates O +
of O +
extensive O +
ST-3 B-Gene +
expression O +
and O +
decreased O +
E B-Gene -
- I-Gene -
cadherin I-Gene +
expression O +
were O +
significantly O +
higher O +
in O +
the O +
de O +
novo O +
group O +
( O +
P O +
= O +
0.014 O +
and O +
0.005 O +
, O +
respectively O +
) O +
. O +

Histopathologically O +
, O +
the O +
de O +
novo O +
group O +
also O +
had O +
a O +
significantly O +
higher O +
percentage O +
of O +
cases O +
with O +
an O +
infiltrative O +
invasion O +
pattern O +
. O +

These O +
differences O +
highlight O +
the O +
more O +
aggressive O +
phenotype O +
of O +
the O +
de O +
novo O +
colorectal O +
carcinoma O +
and O +
fit O +
with O +
their O +
greater O +
invasive O +
potential O +
. O +

Human O +
gastrinoma O +
cells O +
express O +
calcium B-Gene +
- I-Gene +
sensing I-Gene +
receptor I-Gene +
. O +

The O +
intravenous O +
calcium O +
injection O +
test O +
has O +
been O +
reported O +
to O +
be O +
useful O +
for O +
the O +
diagnosis O +
of O +
gastrinoma O +
. O +

However O +
, O +
the O +
mechanism O +
underlying O +
calcium O +
- O +
evoked O +
gastrin B-Gene +
release O +
is O +
not O +
fully O +
understood O +
. O +

We O +
investigated O +
the O +
mechanism O +
of O +
calcium O +
- O +
stimulated O +
gastrin B-Gene +
release O +
from O +
gastrinoma O +
cells O +
in O +
vitro O +
with O +
a O +
particular O +
focus O +
on O +
the O +
calcium B-Gene +
- I-Gene +
sensing I-Gene +
receptor I-Gene +
( O +
CaR B-Gene +
) O +
. O +

Human O +
gastrinoma O +
cells O +
were O +
taken O +
from O +
mechanically O +
minced O +
gastrinoma O +
tissues O +
obtained O +
at O +
surgery O +
. O +

In O +
the O +
perifusion O +
system O +
, O +
high O +
[ O +
Ca2 O -
+ O +
] O +
o O +
induced O +
gastrin B-Gene +
release O +
from O +
gastrinoma O +
cells O +
. O +

As O +
[ O -
Ca2+ O -
] O -
o O +
increased O +
, O +
[ O -
Ca2 O -
+ O +
] O +
i O +
rapidly O +
increased O +
, O +
as O +
monitored O +
by O +
fluorometry O +
. O +

The O +
response O +
was O +
not O +
inhibited O +
by O +
nifedipine O +
, O +
a O +
blocker O +
of O +
the O +
voltage B-Gene +
- I-Gene +
dependent I-Gene +
calcium I-Gene +
channel I-Gene +
. O +

Reverse O +
transcriptase O +
- O +
polymerase O +
chain O +
reaction O +
and O +
subsequent O +
Southern O +
blot O +
hybridization O +
revealed O +
the O +
presence O +
of O +
the O +
CaR B-Gene +
gene O +
in O +
human O +
gastrinoma O +
tissues O +
. O +

Moreover O +
, O +
the O +
expression O +
of O +
CaR B-Gene +
in O +
gastrinoma O +
tissues O +
was O +
confirmed O +
by O +
immunohistochemistry O +
. O +

Our O +
results O +
demonstrated O +
that O +
CaR B-Gene +
was O +
expressed O +
in O +
human O +
gastrinoma O +
cells O +
and O +
could O +
be O +
involved O +
in O +
the O +
mechanism O +
of O +
calcium O +
- O +
evoked O +
gastrin B-Gene +
release O +
. O +

Consequences O +
of O +
mevalonate O +
depletion O +
. O +

Differential O +
transcriptional O +
, O +
translational O +
, O +
and O +
post O +
- O +
translational O +
up O +
- O +
regulation O +
of O +
Ras B-Gene +
, O +
Rap1a B-Gene +
, O +
RhoA B-Gene +
, O +
AND O +
RhoB B-Gene +
. O +

Ras B-Gene +
- O +
related O +
proteins O +
are O +
small B-Gene +
GTPases I-Gene +
that O +
are O +
post O +
- O +
translationally O +
modified O +
with O +
mevalonate O +
- O +
derived O +
isoprenoids O +
. O +

Although O +
the O +
effects O +
of O +
inhibition O +
of O +
isoprenylation O +
on O +
protein O +
function O +
have O +
been O +
examined O +
, O +
the O +
consequences O +
of O +
depletion O +
of O +
isoprenoid O +
pools O +
on O +
regulation O +
of O +
expression O +
of O +
isoprenylated O +
proteins O +
have O +
yet O +
to O +
be O +
investigated O +
. O +

In O +
these O +
studies O +
we O +
have O +
shown O +
that O +
depletion O +
of O +
mevalonate O +
results O +
in O +
increased O +
total O +
levels O +
of O +
Ras B-Gene +
, O +
Rap1a B-Gene +
, O +
RhoA B-Gene +
, O +
and O +
RhoB B-Gene +
in O +
K562 O +
cells O +
. O +

Cycloheximide O +
and O +
[ O -
( O -
35 O -
) O -
S O -
] O -
methionine O +
pulse O +
/ O +
pulse O +
- O +
chase O +
experiments O +
reveal O +
that O +
mevalonate O +
depletion O +
increases O +
the O +
de O +
novo O +
synthesis O +
of O +
Ras B-Gene +
and O +
RhoA B-Gene +
and O +
decreases O +
the O +
degradation O +
of O +
existing O +
Ras B-Gene +
and O +
RhoA B-Gene +
protein O +
. O +

Pretreatment O +
with O +
actinomycin O +
D O +
completely O +
prevents O +
the O +
induced O +
up O +
- O +
regulation O +
of O +
RhoB B-Gene +
and O +
only O +
partially O +
prevents O +
the O +
up O +
- O +
regulation O +
of O +
Ras B-Gene +
, O +
Rap1a B-Gene +
, O +
and O +
RhoA B-Gene +
. O +

Although O +
depletion O +
of O +
mevalonate O +
does O +
not O +
alter O +
steady O +
state O +
levels O +
of O +
Ras B-Gene +
mRNA O +
, O +
there O +
is O +
an O +
increase O +
in O +
RhoB B-Gene +
mRNA O +
. O +

Our O +
results O +
are O +
the O +
first O +
to O +
demonstrate O +
that O +
mevalonate O +
depletion O +
induces O +
up O +
- O +
regulation O +
of O +
Ras B-Gene +
and O +
Ras B-Gene +
- O +
related O +
proteins O +
by O +
discrete O +
mechanisms O +
that O +
include O +
modulation O +
of O +
transcriptional O +
, O +
translational O +
, O +
and O +
post O +
- O +
translational O +
processes O +
. O +

BMP-4 B-Gene +
and O +
BMP-6 B-Gene +
involvement O +
in O +
the O +
osteogenic O +
properties O +
of O +
the O +
HeLa O +
cell O +
line O +
. O +

The O +
heterotopically O +
induced O +
ossicles O +
are O +
used O +
in O +
our O +
research O +
on O +
bone O +
tissue O +
. O +

The O +
ossicles O +
are O +
formed O +
in O +
the O +
thigh O +
muscle O +
of O +
BALB O -
/ O -
c O +
mice O +
under O +
the O +
influence O +
of O +
injected O +
suspension O +
of O +
3 O +
x O +
10 O -
( O -
6 O -
) O +
HeLa O +
cells O +
. O +

We O +
postulate O +
that O +
the O +
mechanism O +
of O +
bone O +
induction O +
is O +
based O +
on O +
the O +
secretion O +
of O +
bone B-Gene +
morphogenetic I-Gene +
proteins I-Gene +
BMP-4 B-Gene +
and O +
BMP-6 B-Gene +
by O +
the O +
grafted O +
HeLa O +
cells O +
. O +

This O +
was O +
proved O +
by O +
the O +
use O +
of O +
specific O +
immunohistochemical O +
reaction O +
and O +
Western O +
blots O +
of O +
conditioned O +
culture O +
medium O +
. O +

It O +
seems O +
that O +
HeLa O +
cells O +
secrete O +
BMPs B-Gene +
continuously O +
into O +
the O +
culture O +
medium O +
, O +
even O +
without O +
contact O +
with O +
the O +
mice O +
muscle O +
tissue O +
, O +
were O +
induction O +
of O +
bone O +
tissue O +
is O +
observed O +
. O +

Genetic O +
studies O +
on O +
the O +
role O +
of O +
proteinases B-Gene +
and O +
growth B-Gene +
factors I-Gene +
in O +
atherosclerosis O +
and O +
aneurysm O +
formation O +
. O +

Expression O +
analysis O +
and O +
epidemiologic O +
studies O +
have O +
provided O +
indirect O +
evidence O +
that O +
proteinases B-Gene +
and O +
growth B-Gene +
factors I-Gene +
play O +
a O +
role O +
in O +
the O +
development O +
of O +
atherosclerosis O +
and O +
complications O +
such O +
as O +
aneurysm O +
formation O +
and O +
plaque O +
rupture O +
. O +

Studies O +
using O +
genetically O +
altered O +
mice O +
have O +
proven O +
to O +
be O +
an O +
elegant O +
tool O +
to O +
study O +
the O +
causal O +
involvement O +
of O +
these O +
factors O +
in O +
atherogenesis O +
and O +
to O +
gain O +
insight O +
into O +
the O +
underlying O +
mechanisms O +
. O +

Recently O +
, O +
proteinases B-Gene +
of O +
the O +
plasminogen B-Gene +
and O +
matrix B-Gene +
metalloproteinase I-Gene +
( O +
MMP B-Gene +
) O +
systems O +
as O +
well O +
as O +
their O +
inhibitors O +
have O +
received O +
much O +
attention O +
, O +
and O +
these O +
studies O +
together O +
have O +
emphasized O +
the O +
complexity O +
of O +
their O +
role O +
in O +
vascular O +
disease O +
. O +

This O +
overview O +
summarizes O +
the O +
current O +
knowledge O +
on O +
plasminogen B-Gene +
activator I-Gene +
inhibitor-1 I-Gene +
( O +
PAI-1 B-Gene +
) O +
in O +
the O +
progression O +
of O +
atherosclerosis O +
and O +
the O +
influence O +
of O +
MMPs B-Gene +
in O +
aneurysm O +
formation O +
. O +

In O +
addition O +
, O +
a O +
possible O +
role O +
for O +
Gas6 B-Gene +
, O +
the O +
product O +
of O +
growth B-Gene +
arrest I-Gene +
- I-Gene +
specific I-Gene +
gene I-Gene +
6 I-Gene +
, O +
in O +
atherosclerotic O +
lesion O +
development O +
is O +
put O +
into O +
perspective O +
. O +

Regulated O +
trafficking O +
of O +
neurotransmitter B-Gene +
transporters I-Gene +
: O +
common O +
notes O +
but O +
different O +
melodies O +
. O +

The O +
activity O +
of O +
biogenic O +
amine O +
and O +
amino O +
acid O +
neurotransmitters O +
is O +
limited O +
by O +
presynaptic O +
and O +
astrocytic O +
Na O +
( O +
+ O +
) O +
- O +
dependent O +
transport O +
systems O +
. O +

Their O +
functional O +
importance O +
is O +
underscored O +
by O +
the O +
observation O +
that O +
these O +
transporters O +
are O +
the O +
targets O +
of O +
broad O +
classes O +
of O +
psychotherapeutic O +
agents O +
, O +
including O +
antidepressants O +
and O +
stimulants O +
. O +

Early O +
studies O +
suggested O +
that O +
the O +
activity O +
of O +
these O +
transporters O +
can O +
be O +
fine O +
tuned O +
by O +
a O +
number O +
of O +
different O +
signaling O +
pathways O +
. O +

In O +
the O +
past O +
five O +
years O +
, O +
several O +
groups O +
have O +
provided O +
compelling O +
evidence O +
that O +
changing O +
the O +
cell O +
surface O +
availability O +
of O +
these O +
transporters O +
contributes O +
to O +
this O +
fine O +
tuning O +
. O +

This O +
regulated O +
trafficking O +
can O +
result O +
in O +
rapid O +
( O +
within O +
minutes O +
) O +
increases O +
or O +
decreases O +
in O +
the O +
plasma O +
membrane O +
expression O +
of O +
these O +
transporters O +
and O +
is O +
independent O +
of O +
transcriptional O +
or O +
translational O +
control O +
mechanisms O +
. O +

Many O +
of O +
the O +
same O +
signaling O +
molecules O +
, O +
including O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
( O +
PKC B-Gene +
) O +
, O +
tyrosine B-Gene +
kinase I-Gene +
, O +
phosphatidylinositol B-Gene +
3-kinase I-Gene +
( O +
P13 B-Gene +
- I-Gene +
K I-Gene +
) O +
, O +
and O +
protein B-Gene +
phosphatase I-Gene +
, O +
regulate O +
the O +
transporters O +
for O +
different O +
neurotransmitters O +
. O +

In O +
addition O +
to O +
these O +
classical O +
receptor O +
activated O +
pathways O +
, O +
transporter O +
substrates O +
also O +
regulate O +
activity O +
and O +
cell O +
surface O +
expression O +
of O +
these O +
transporters O +
. O +

In O +
fact O +
, O +
some O +
of O +
the O +
transporters O +
form O +
complexes O +
with O +
signaling O +
molecules O +
. O +

Given O +
the O +
functional O +
and O +
genetic O +
similarities O +
of O +
these O +
transporters O +
, O +
it O +
is O +
not O +
surprising O +
that O +
the O +
same O +
signaling O +
molecules O +
regulate O +
their O +
trafficking O +
, O +
but O +
except O +
for O +
the O +
molecules O +
, O +
the O +
actual O +
effects O +
on O +
individual O +
transporters O +
are O +
remarkably O +
different O +
. O +

It O +
is O +
as O +
if O +
the O +
same O +
musical O +
notes O +
have O +
been O +
rearranged O +
into O +
several O +
different O +
melodies O +
. O +

Existence O +
of O +
MHC B-Gene +
class I-Gene +
I I-Gene +
- O +
restricted O +
alloreactive O +
CD4 B-Gene +
+ O +
T O +
cells O +
reacting O +
with O +
peptide B-Gene +
transporter I-Gene +
- O +
deficient O +
cells O +
. O +

It O +
is O +
generally O +
accepted O +
that O +
as O +
the O +
result O +
of O +
positive O +
thymic O +
selection O +
, O +
CD8 B-Gene +
- O +
expressing O +
T O +
cells O +
recognize O +
peptide O +
antigens O +
presented O +
in O +
the O +
context O +
of O +
MHC B-Gene +
class I-Gene +
I I-Gene +
molecules O +
and O +
CD4 B-Gene +
- O +
expressing O +
T O +
cells O +
interact O +
with O +
peptide O +
antigens O +
presented O +
by O +
MHC B-Gene +
class I-Gene +
II I-Gene +
molecules O +
. O +

Here O +
we O +
report O +
the O +
generation O +
of O +
TCRalpha B-Gene +
/ I-Gene +
beta I-Gene +
( O -
+ O -
) O +
, O +
CD3 B-Gene +
( O +
+ O +
) O +
, O +
CD4 B-Gene +
( O +
+ O +
) O +
, O +
CD8 B-Gene +
( O +
- O +
) O +
, O +
MHC B-Gene +
class I-Gene +
I I-Gene +
- O +
restricted O +
alloreactive O +
T O -
- O -
cell O +
clones O +
which O +
were O +
induced O +
using O +
peripheral O +
blood O +
mononuclear O +
cells O +
from O +
healthy O +
individuals O +
following O +
in O +
vitro O +
stimulation O +
with O +
transporter B-Gene +
associated I-Gene +
with I-Gene +
antigen I-Gene +
processing I-Gene +
( O +
TAP B-Gene +
) O +
- O +
deficient O +
cell O +
lines O +
T2 O +
. O +

The O +
CD4 B-Gene +
( O +
+ O +
) O +
T O -
- O -
cell O +
clones O +
showed O +
an O +
HLA B-Gene -
- I-Gene -
A2.1 I-Gene +
- O +
specific O +
proliferative O +
response O +
against O +
T2 O +
cells O +
which O +
was O +
inhibited O +
by O +
anti O +
- O +
CD3 B-Gene +
and O +
anti O +
- O +
CD4 B-Gene +
monoclonal O +
antibodies O +
. O +

These O +
results O +
suggest O +
that O +
interaction O +
of O +
the O +
TCR B-Gene +
with O +
peptide O +
- O +
bound O +
HLA B-Gene +
class I-Gene +
I I-Gene +
molecules O +
contributes O +
to O +
antigen O +
- O +
specific O +
activation O +
of O +
these O +
co O +
- O +
receptor O +
- O +
mismatched O +
T O -
- O -
cell O +
clones O +
. O +

Antigen O +
recognition O +
by O +
alloreactive O +
MHC B-Gene +
class I-Gene +
I I-Gene +
- O +
restricted O +
CD4 B-Gene +
( O +
+ O +
) O +
T O +
cells O +
was O +
inhibited O +
by O +
removing O +
peptides O +
bound O +
to O +
HLA B-Gene +
molecules O +
on O +
T2 O +
cells O +
suggesting O +
that O +
the O +
alloreactive O +
CD4 B-Gene +
( O +
+ O +
) O +
T O +
cells O +
recognize O +
peptides O +
that O +
bind O +
in O +
a O +
TAP B-Gene +
- O +
independent O +
manner O +
to O +
HLA B-Gene -
- I-Gene -
A2 I-Gene +
molecules O +
. O +

The O +
existence O +
of O +
such O +
MHC B-Gene +
class I-Gene +
I I-Gene +
- O +
restricted O +
CD4 B-Gene +
( O +
+ O +
) O +
T O +
cells O +
which O +
can O +
recognize O +
HLA B-Gene -
- I-Gene -
A2 I-Gene +
molecules O +
in O +
the O +
absence O +
of O +
TAP B-Gene +
function O +
may O +
provide O +
a O +
basis O +
for O +
the O +
development O +
of O +
immunotherapy O +
against O +
TAP B-Gene +
- O +
deficient O +
tumor O +
variants O +
which O +
would O +
be O +
tolerant O +
to O +
immunosurveillance O +
by O +
conventional O +
MHC B-Gene +
class I-Gene +
I I-Gene +
- O +
restricted O +
cytotoxic O +
lymphocytes O +
. O +

Present O +
data O +
concerning O +
the O +
renin B-Gene +
- O +
angiotensin B-Gene +
system O +
of O +
extrarenal O +
origin O +
. O +

After O +
a O +
brief O +
historical O +
incursion O +
regarding O +
RAS O +
of O +
renal O +
origin O +
, O +
we O +
present O +
the O +
main O +
extrarenal O +
angiotensin B-Gene +
- O +
forming O +
enzymes O +
, O +
starting O +
with O +
isorenin B-Gene +
, O +
tonin B-Gene +
, O +
D B-Gene +
and I-Gene +
G I-Gene +
cathepsin I-Gene +
and O +
ending O +
with O +
the O +
conversion B-Gene +
enzyme I-Gene +
and O +
chymase B-Gene +
. O +

This O +
is O +
followed O +
by O +
a O +
short O +
presentation O +
of O +
data O +
concerning O +
tissue O +
RAS O +
in O +
the O +
heart O +
and O +
vessels O +
, O +
brain O +
and O +
neurocranial O +
accessory O +
glands O +
, O +
cortico O +
- O +
suprarenal O +
and O +
gonadal O +
glandular O +
territory O +
. O +

In O +
the O +
end O +
we O +
refer O +
to O +
the O +
relations O +
between O +
circulating O +
RAS O +
of O +
renal O +
origin O +
and O +
the O +
extrarenal O +
RAS O +
specific O +
to O +
tissue O +
underlying O +
the O +
fact O +
that O +
the O +
two O +
RAS O +
components O +
cooperate O +
and O +
constitute O +
a O +
unitary O +
hormonal O +
system O +
, O +
regulating O +
the O +
major O +
functions O +
of O +
the O +
organism O +
and O +
maintaining O +
the O +
main O +
homeostatic O +
equilibria O +
. O +

While O +
the O +
circulating O +
RAS O +
of O +
renal O +
origin O +
is O +
acutely O +
activated O +
to O +
contribute O +
to O +
the O +
accomplishment O +
of O +
short O +
term O +
homeostatic O +
reactions O +
, O +
tissue O +
RAS O +
, O +
in O +
paracrine O +
or O +
autocrine O +
ways O +
, O +
exerts O +
local O +
- O +
regional O +
adaptive O +
actions O +
of O +
long O +
duration O +
. O +

Molecular O +
mechanics O +
of O +
cardiac O +
titin B-Gene +
's O +
PEVK O +
and O +
N2B O +
spring O +
elements O +
. O +

Titin B-Gene +
is O +
a O +
giant O +
elastic O +
protein O +
that O +
is O +
responsible O +
for O +
the O +
majority O +
of O +
passive O +
force O +
generated O +
by O +
the O +
myocardium O +
. O +

Titin B-Gene +
's O +
force O +
is O +
derived O +
from O +
its O +
extensible O +
I O +
- O +
band O +
region O +
, O +
which O +
, O +
in O +
the O +
cardiac O +
isoform O +
, O +
comprises O +
three O +
main O +
extensible O +
elements O +
: O +
tandem O +
Ig B-Gene +
segments O +
, O +
the O +
PEVK O +
domain O +
, O +
and O +
the O +
N2B O +
unique O +
sequence O +
( O +
N2B O -
- O -
Us O +
) O +
. O +

Using O +
atomic O +
force O +
microscopy O +
, O +
we O +
characterized O +
the O +
single O +
molecule O +
force O +
- O +
extension O +
curves O +
of O +
the O +
PEVK O +
and O +
N2B O -
- O -
Us O +
spring O +
elements O +
, O +
which O +
together O +
are O +
responsible O +
for O +
physiological O +
levels O +
of O +
passive O +
force O +
in O +
moderately O +
to O +
highly O +
stretched O +
myocardium O +
. O +

Stretch O +
- O +
release O +
force O +
- O +
extension O +
curves O +
of O +
both O +
the O +
PEVK O +
domain O +
and O +
N2B O -
- O -
Us O +
displayed O +
little O +
hysteresis O +
: O +
the O +
stretch O +
and O +
release O +
data O +
nearly O +
overlapped O +
. O +

The O +
force O +
- O +
extension O +
curves O +
closely O +
followed O +
worm O +
- O +
like O +
chain O +
behavior O +
. O +

Histograms O +
of O +
persistence O +
length O +
( O +
measure O +
of O +
chain O +
bending O +
rigidity O +
) O +
indicated O +
that O +
the O +
single O +
molecule O +
persistence O +
lengths O +
are O +
approximately O +
1.4 O +
and O +
approximately O +
0.65 O +
nm O +
for O +
the O +
PEVK O +
domain O +
and O +
N2B O -
- O -
Us O +
, O +
respectively O +
. O +

Using O +
these O +
mechanical O +
characteristics O +
and O +
those O +
determined O +
earlier O +
for O +
the O +
tandem O +
Ig B-Gene +
segment O +
( O +
assuming O +
folded O +
Ig B-Gene +
domains O +
) O +
, O +
we O +
modeled O +
the O +
cardiac O +
titin B-Gene +
extensible O +
region O +
in O +
the O +
sarcomere O +
and O +
calculated O +
the O +
extension O +
of O +
the O +
various O +
spring O +
elements O +
and O +
the O +
forces O +
generated O +
by O +
titin B-Gene +
, O +
both O +
as O +
a O +
function O +
of O +
sarcomere O +
length O +
. O +

In O +
the O +
physiological O +
sarcomere O +
length O +
range O +
, O +
predicted O +
values O +
and O +
those O +
obtained O +
experimentally O +
were O +
indistinguishable O +
. O +

Expression O +
of O +
glucocorticoid B-Gene +
receptors I-Gene +
and O +
cyclooxygenase-2 B-Gene +
in O +
nasal O +
polyps O +
from O +
nonallergic O +
patients O +
. O +

Glucocorticoid O +
treatment O +
has O +
been O +
widely O +
used O +
to O +
suppress O +
inflammatory O +
and O +
immune O +
responses O +
. O +

However O +
, O +
from O +
a O +
clinical O +
point O +
of O +
view O +
, O +
its O +
efficacy O +
in O +
the O +
treatment O +
of O +
nasal O +
polyposis O +
seems O +
to O +
vary O +
individually O +
from O +
patient O +
to O +
patient O +
. O +

In O +
the O +
present O +
study O +
, O +
we O +
examined O +
the O +
presence O +
of O +
glucocorticoid B-Gene +
receptors I-Gene +
( O +
GRs B-Gene +
) O +
and O +
cyclooxygenase-2 B-Gene +
( O +
COX-2 B-Gene +
) O +
in O +
the O +
nasal O +
polyps O +
of O +
nonallergic O +
patients O +
as O +
compared O +
with O +
normal O +
controls O +
. O +

Reverse O +
transcription O +
- O +
polymerase O +
chain O +
reaction O +
analyses O +
revealed O +
the O +
presence O +
of O +
both O +
GR B-Gene +
messenger O +
RNA O +
and O +
COX-2 B-Gene +
messenger O +
RNA O +
expression O +
in O +
nasal O +
polyps O +
from O +
nonallergic O +
patients O +
, O +
as O +
well O +
as O +
in O +
normal O +
nasal O +
mucosa O +
from O +
controls O +
. O +

Consistent O +
with O +
this O +
finding O +
, O +
immunohistochemical O +
analysis O +
demonstrated O +
that O +
GRs B-Gene +
and O +
COX-2 B-Gene +
were O +
labeled O +
in O +
both O +
tissues O +
. O +

In O +
nasal O +
polyps O +
, O +
GR B-Gene +
labeling O +
was O +
associated O +
with O +
the O +
cytoplasm O +
and O +
nucleus O +
of O +
surface O +
mucosa O +
, O +
submucosal O +
glands O +
, O +
endothelial O +
cells O +
, O +
and O +
inflammatory O +
cells O +
. O +

Importantly O +
, O +
COX-2 B-Gene +
labeling O +
was O +
seen O +
in O +
the O +
cytoplasm O +
of O +
surface O +
mucosa O +
, O +
submucosal O +
glands O +
, O +
and O +
the O +
vascular O +
wall O +
in O +
nasal O +
polyps O +
. O +

In O +
contrast O +
, O +
in O +
normal O +
nasal O +
tissues O +
, O +
COX-2 B-Gene +
labeling O +
was O +
only O +
found O +
in O +
the O +
vascular O +
wall O +
, O +
and O +
the O +
expression O +
was O +
weaker O -
-- O -
a O +
finding O +
demonstrating O +
that O +
COX-2 B-Gene +
is O +
upregulated O +
in O +
nasal O +
polyps O +
. O +

Therefore O +
, O +
1 O +
) O +
the O +
presence O +
of O +
GRs B-Gene +
and O +
COX-2 B-Gene +
in O +
nasal O +
polyps O +
from O +
nonallergic O +
patients O +
, O +
as O +
well O +
as O +
upregulation O +
of O +
COX-2 B-Gene +
expression O +
, O +
suggests O +
that O +
inflammation O +
may O +
play O +
an O +
important O +
role O +
in O +
the O +
pathophysiology O +
of O +
nasal O +
polyps O +
; O +
and O +
2 O +
) O +
glucocorticoid O +
could O +
be O +
a O +
potential O +
treatment O +
method O +
for O +
suppressing O +
inflammatory O +
processes O +
. O +

Differential O +
expression O +
of O +
granulysin B-Gene +
and O +
perforin B-Gene +
by O +
NK O +
cells O +
in O +
cancer O +
patients O +
and O +
correlation O +
of O +
impaired O +
granulysin B-Gene +
expression O +
with O +
progression O +
of O +
cancer O +
. O +

Granulysin B-Gene +
has O +
been O +
identified O +
as O +
an O +
effector O +
molecule O +
co O +
- O +
localized O +
with O +
perforin B-Gene +
in O +
the O +
cytotoxic O +
granules O +
of O +
cytotoxic O +
T O +
lymphocytes O +
and O +
natural O +
killer O +
( O +
NK O +
) O +
cells O +
, O +
and O +
has O +
been O +
reported O +
to O +
kill O +
intracellular O +
pathogens O +
in O +
infected O +
cells O +
in O +
the O +
presence O +
of O +
perforin B-Gene +
and O +
to O +
induce O +
a O +
cytotoxic O +
effect O +
against O +
tumor O +
cells O +
. O +

The O +
aim O +
of O +
the O +
present O +
study O +
was O +
to O +
elucidate O +
whether O +
intracellular O +
expression O +
of O +
granulysin B-Gene +
and O +
perforin B-Gene +
by O +
NK O +
cells O +
might O +
be O +
associated O +
with O +
progression O +
of O +
cancer O +
. O +

Flow O +
cytometric O +
analysis O +
demonstrated O +
high O +
levels O +
of O +
perforin B-Gene +
and O +
granulysin B-Gene +
expression O +
by O +
CD3 B-Gene +
( O +
- O +
) O +
CD16 B-Gene +
( O +
+ O +
) O +
cells O +
in O +
healthy O +
controls O +
. O +

In O +
contrast O +
, O +
cancer O +
patients O +
exhibited O +
significantly O +
decreased O +
levels O +
of O +
granulysin B-Gene +
expression O +
( O +
P O +
< O +
0.005 O +
) O +
, O +
despite O +
having O +
equally O +
high O +
levels O +
of O +
perforin B-Gene +
expression O +
in O +
comparison O +
with O +
healthy O +
controls O +
. O +

The O +
tumor O +
- O +
free O +
patients O +
expressed O +
granulysin B-Gene +
at O +
levels O +
similar O +
to O +
healthy O +
controls O +
, O +
while O +
the O +
progressive O +
tumor O +
- O +
bearing O +
patients O +
expressed O +
remarkably O +
lower O +
levels O +
of O +
granulysin B-Gene +
compared O +
to O +
healthy O +
controls O +
( O +
P O +
< O +
0.0001 O +
) O +
. O +

Similarly O +
, O +
patients O +
with O +
an O +
advanced O +
performance O +
status O +
had O +
significantly O +
fewer O +
granulysin B-Gene +
- O +
positive O +
NK O +
cells O +
than O +
healthy O +
controls O +
. O +

Meanwhile O +
, O +
a O +
considerable O +
number O +
of O +
the O +
tumor O +
- O +
bearing O +
patients O +
showed O +
a O +
decrease O +
in O +
the O +
number O +
of O +
circulating O +
NK O +
cells O +
, O +
and O +
a O +
correlation O +
between O +
impaired O +
granulysin B-Gene +
expression O +
and O +
reduced O +
circulating O +
NK O +
cells O +
was O +
observed O +
. O +

These O +
findings O +
suggest O +
that O +
the O +
tumor O +
- O +
bearing O +
patients O +
with O +
impaired O +
granulysin B-Gene +
expression O +
were O +
in O +
an O +
immunosuppressive O +
state O +
. O +

In O +
conclusion O +
, O +
impaired O +
expression O +
of O +
granulysin B-Gene +
by O +
NK O +
cells O +
correlates O +
with O +
progression O +
of O +
cancer O +
, O +
and O +
determination O +
of O +
granulysin B-Gene +
expression O +
might O +
prove O +
informative O +
for O +
assessing O +
the O +
immunological O +
condition O +
of O +
cancer O +
patients O +
. O +

Insulin B-Gene +
- I-Gene +
degrading I-Gene +
enzyme I-Gene +
rapidly O +
removes O +
the O +
beta B-Gene -
- I-Gene -
amyloid I-Gene +
precursor I-Gene +
protein I-Gene +
intracellular I-Gene +
domain I-Gene +
( O +
AICD B-Gene +
) O +
. O +

The O +
intramembranous O +
gamma B-Gene +
- I-Gene +
secretase I-Gene +
cleavage O +
of O +
the O +
beta B-Gene -
- I-Gene -
amyloid I-Gene +
precursor I-Gene +
protein I-Gene +
( O +
APP B-Gene +
) O +
is O +
dependent O +
on O +
biologically O +
active O +
presenilins B-Gene +
( O +
PS B-Gene +
) O +
. O +

Notch B-Gene +
also O +
undergoes O +
a O +
similar O +
PS B-Gene +
- O +
dependent O +
gamma B-Gene +
- I-Gene +
secretase I-Gene +
- O +
like O +
cleavage O +
, O +
resulting O +
in O +
the O +
liberation O +
of O +
the O +
Notch B-Gene +
intracellular I-Gene +
domain I-Gene +
( O +
NICD B-Gene +
) O +
, O +
which O +
is O +
critically O +
required O +
for O +
developmental O +
signal O +
transduction O +
. O +

gamma B-Gene +
- I-Gene +
Secretase I-Gene +
processing O +
of O +
APP B-Gene +
results O +
in O +
the O +
production O +
of O +
a O +
similar O +
fragment O +
called O +
AICD B-Gene +
( O +
APP B-Gene +
intracellular I-Gene +
domain I-Gene +
) O +
, O +
which O +
may O +
function O +
in O +
nuclear O +
signaling O +
as O +
well O +
. O +

AICD B-Gene +
, O +
like O +
NICD B-Gene +
, O +
is O +
rapidly O +
removed O +
. O +

By O +
using O +
a O +
battery O +
of O +
protease B-Gene +
inhibitors O +
we O +
demonstrate O +
that O +
AICD B-Gene +
, O +
in O +
contrast O +
to O +
NICD B-Gene +
, O +
is O +
degraded O +
by O +
a O +
cytoplasmic O +
metalloprotease B-Gene +
. O +

In O +
vitro O +
degradation O +
of O +
AICD B-Gene +
can O +
be O +
reconstituted O +
with O +
cytoplasmic O +
fractions O +
obtained O +
from O +
neuronal O +
and O +
non O +
- O +
neuronal O +
cells O +
. O +

Taking O +
into O +
account O +
the O +
inhibition O +
profile O +
and O +
the O +
cytoplasmic O +
localization O +
, O +
we O +
identified O +
three O +
candidate O +
enzymes O +
( O +
neurolysin B-Gene +
, O +
thimet B-Gene +
oligopeptidase I-Gene +
, O +
and O +
insulin B-Gene +
- I-Gene +
degrading I-Gene +
enzyme I-Gene +
( O +
IDE B-Gene +
) O +
, O +
also O +
known O +
as O +
insulysin B-Gene +
) O +
, O +
which O +
all O +
are O +
involved O +
in O +
the O +
degradation O +
of O +
bioactive O +
peptides O +
in O +
the O +
brain O +
. O +

When O +
insulin B-Gene +
, O +
a O +
well O +
characterized O +
substrate O +
of O +
IDE B-Gene +
, O +
was O +
added O +
to O +
the O +
in O +
vitro O +
degradation O +
assay O +
, O +
removal O +
of O +
AICD B-Gene +
was O +
efficiently O +
blocked O +
. O +

Moreover O +
, O +
overexpression O +
of O +
IDE B-Gene +
resulted O +
in O +
enhanced O +
degradation O +
of O +
AICD B-Gene +
, O +
whereas O +
overexpression O +
of O +
the O +
inactive O +
IDE B-Gene +
E111Q O +
mutant O +
did O +
not O +
affect O +
AICD B-Gene +
degradation O +
. O +

Finally O +
, O +
immunodepletion O +
of O +
IDE B-Gene +
significantly O +
reduced O +
the O +
AICD B-Gene +
degrading O +
activity O +
. O +

Therefore O +
our O +
data O +
demonstrate O +
that O +
IDE B-Gene +
, O +
which O +
is O +
one O +
of O +
the O +
proteases B-Gene +
implicated O +
in O +
the O +
removal O +
of O +
extracellular O +
Abeta B-Gene +
, O +
also O +
removes O +
the O +
cytoplasmic O +
product O +
of O +
gamma B-Gene -
- I-Gene -
secretase I-Gene +
cleaved O +
APP B-Gene +
. O +

Determining O +
the O +
differences O +
in O +
actin B-Gene +
binding O +
by O +
human O +
ADF B-Gene +
and O +
cofilin B-Gene +
. O +

The O +
actin B-Gene +
- I-Gene +
depolymerizing I-Gene +
factor I-Gene +
( I-Gene +
ADF I-Gene +
) I-Gene +
/ I-Gene +
cofilin I-Gene +
family I-Gene +
of O +
proteins O +
play O +
an O +
essential O +
role O +
in O +
actin B-Gene +
dynamics O +
and O +
cytoskeletal O +
re O +
- O +
organization O +
. O +

Human O +
tissues O +
express O +
two O +
isoforms O +
in O +
the O +
same O +
cells O +
, O +
ADF B-Gene +
and O +
cofilin B-Gene +
, O +
and O +
these O +
two O +
proteins O +
are O +
more O +
than O +
70 O +
% O +
identical O +
in O +
amino O +
acid O +
sequence O +
. O +

We O +
show O +
that O +
ADF B-Gene +
is O +
a O +
much O +
more O +
potent O +
actin B-Gene +
- O +
depolymerizing O +
agent O +
than O +
cofilin B-Gene +
: O +
the O +
maximum O +
level O +
of O +
depolymerization O +
at O +
pH O +
8 O +
by O +
ADF B-Gene +
is O +
about O +
20 O +
microM O +
compared O +
to O +
5 O +
microM O +
for O +
cofilin B-Gene +
, O +
but O +
little O +
depolymerization O +
occurs O +
at O +
pH O +
6.5 O +
with O +
either O +
protein O +
. O +

However O +
, O +
we O +
find O +
little O +
difference O +
between O +
the O +
two O +
proteins O +
in O +
their O +
binding O +
to O +
filaments O +
, O +
their O +
severing O +
activities O +
or O +
their O +
activation O +
of O +
subunit O +
release O +
from O +
the O +
pointed O +
ends O +
of O +
filaments O +
. O +

Likewise O +
, O +
they O +
show O +
no O +
significant O +
differences O +
in O +
their O +
affinities O +
for O +
monomeric O +
actin B-Gene +
: O +
both O +
bind O +
15 O +
- O +
fold O +
more O +
tightly O +
to O +
actin B-Gene +
. O +
ADP O +
than O +
to O +
actin B-Gene +
. O +
ATP O +
. O +

Complexes O +
between O +
actin B-Gene +
. O +
ADP O +
and O +
ADF B-Gene +
or O +
cofilin B-Gene +
associate O +
with O +
both O +
barbed O +
and O +
pointed O +
ends O +
of O +
filaments O +
at O +
similar O +
rates O +
( O +
close O +
to O +
those O +
of O +
actin B-Gene +
. O +
ATP O +
and O +
much O +
higher O +
than O +
those O +
of O +
actin B-Gene +
. O +
ADP O +
) O +
. O +

This O +
explains O +
why O +
high O +
concentrations O +
of O +
both O +
proteins O +
reverse O +
the O +
activation O +
of O +
subunit O +
release O +
at O +
pointed O +
ends O +
. O +

The O +
major O +
difference O +
between O +
the O +
two O +
proteins O +
is O +
that O +
the O +
nucleating O +
activity O +
of O +
cofilin B-Gene +
- O +
actin B-Gene +
. O +
ADP O +
complexes O +
is O +
twice O +
that O +
of O +
ADF B-Gene +
- O +
actin B-Gene +
. O +
ADP O +
complexes O +
and O +
this O +
, O +
in O +
turn O +
, O +
is O +
twice O +
that O +
of O +
actin B-Gene +
. O +
ATP O +
alone O +
. O +

It O +
is O +
this O +
weaker O +
nucleating O +
potential O +
of O +
ADF B-Gene +
- O +
actin B-Gene +
. O +
ADP O +
that O +
accounts O +
for O +
the O +
much O +
higher O +
steady O +
- O +
state O +
depolymerizing O +
activity O +
. O +

The O +
pH O +
- O +
sensitivity O +
is O +
due O +
to O +
the O +
nucleating O +
activity O +
of O +
complexes O +
being O +
greater O +
at O +
pH O +
6.5 O +
than O +
at O +
pH O +
8 O +
. O +

Sequence O +
analysis O +
of O +
mammalian O +
and O +
avian O +
isoforms O +
shows O +
a O +
consistent O +
pattern O +
of O +
charge O +
differences O +
in O +
regions O +
of O +
the O +
protein O +
associated O +
with O +
F B-Gene -
- I-Gene -
actin I-Gene +
- O +
binding O +
that O +
may O +
account O +
for O +
the O +
differences O +
in O +
activity O +
between O +
ADF B-Gene +
and O +
cofilin B-Gene +
. O +

Evidence O +
for O +
the O +
expression O +
of O +
the O +
EGF B-Gene +
receptor I-Gene +
on O +
human O +
monocytic O +
cells O +
. O +

Several O +
malignancies O +
over O +
- O +
express O +
the O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
receptor I-Gene +
, O +
ligation O +
of O +
which O +
results O +
in O +
cellular O +
differentiation O +
and O +
multiplication O +
. O +

Mononuclear O +
phagocytes O +
secrete O +
this O +
cytokine B-Gene +
and O +
its O +
receptor O +
has O +
been O +
detected O +
on O +
microglial O +
cells O +
. O +

This O +
communication O +
describes O +
the O +
expression O +
( O +
and O +
its O +
regulation O +
) O +
of O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
receptor I-Gene +
( O +
EGFR B-Gene +
) O +
on O +
U937 O +
cells O +
. O +

We O +
have O +
shown O +
that O +
a O +
few O +
are O +
EGFR B-Gene +
- O +
positive O +
, O +
with O +
expression O +
being O +
up O +
regulated O +
by O +
interleukin B-Gene +
6 I-Gene +
( O +
IL-6 B-Gene +
) O +
. O +

Also O +
, O +
when O +
cultured O +
in O +
the O +
presence O +
of O +
serum O +
with O +
the O +
monoclonal O +
anti O +
- O +
EGFR B-Gene +
, O +
ICR62 O +
, O +
U937s O +
showed O +
a O +
reduced O +
growth O +
rate O +
. O +

By O +
contrast O +
, O +
ICR9 O +
caused O +
a O +
significant O +
increase O +
in O +
cellular O +
proliferation O +
. O +

Both O +
antibodies O +
induced O +
cycle O +
arrest O +
in O +
late O +
G O -
( O -
1 O -
) O +
/ O +
S O +
phase O +
. O +

When O +
the O +
cells O +
were O +
cultured O +
in O +
the O +
absence O +
of O +
serum O +
, O +
low O +
antibody O +
concentration O +
( O +
10 O +
microg O +
/ O +
ml O +
) O +
showed O +
an O +
early O +
inhibitory O +
effect O +
on O +
cell O +
proliferation O +
. O +

By O +
contrast O +
, O +
at O +
high O +
antibody O +
concentrations O +
( O +
50 O +
micro O +
/ O +
ml O +
) O +
, O +
ICR62 O +
significantly O +
increased O +
the O +
proliferation O +
of O +
U937 O +
cells O +
. O +

We O +
suggest O +
that O +
these O +
results O +
provide O +
indirect O +
evidence O +
for O +
an O +
autocrine O +
action O +
of O +
EGF B-Gene +
on O +
U937 O +
cells O +
. O +

Two O +
proteins O +
essential O +
for O +
apolipoprotein B-Gene +
B I-Gene +
mRNA O +
editing O +
are O +
expressed O +
from O +
a O +
single O +
gene O +
through O +
alternative O +
splicing O +
. O +

Apolipoprotein B-Gene +
B I-Gene +
( O +
apoB B-Gene +
) O +
mRNA O +
editing O +
involves O +
site O +
- O +
specific O +
deamination O +
of O +
cytidine O +
to O +
form O +
uridine O +
, O +
resulting O +
in O +
the O +
production O +
of O +
an O +
in O +
- O +
frame O +
stop O +
codon O +
. O +

Protein O +
translated O +
from O +
edited O +
mRNA O +
is O +
associated O +
with O +
a O +
reduced O +
risk O +
of O +
atherosclerosis O +
, O +
and O +
hence O +
the O +
protein O +
factors O +
that O +
regulate O +
hepatic O +
apoB B-Gene +
mRNA O +
editing O +
are O +
of O +
interest O +
. O +

A O +
human O +
protein O +
essential O +
for O +
apoB B-Gene +
mRNA O +
editing O +
and O +
an O +
eight O +
- O +
amino O +
acid O +
- O +
longer O +
variant O +
of O +
no O +
known O +
function O +
have O +
been O +
recently O +
cloned O +
. O +

We O +
report O +
that O +
both O +
proteins O +
, O +
henceforth O +
referred O +
to O +
as O +
ACF64 B-Gene +
and O +
ACF65 B-Gene +
, O +
supported O +
APOBEC-1 B-Gene +
( O +
the O +
catalytic O +
subunit O +
of O +
the O +
editosome O +
) O +
equivalently O +
in O +
editing O +
of O +
apoB B-Gene +
mRNA O +
. O +

They O +
are O +
encoded O +
by O +
a O +
single O +
82 O +
- O +
kb O +
gene O +
on O +
chromosome O +
10 O +
. O +

The O +
transcripts O +
are O +
encoded O +
by O +
15 O +
exons O +
that O +
are O +
expressed O +
from O +
a O +
tissue O +
- O +
specific O +
promoter O +
minimally O +
contained O +
within O +
the O +
- O +
0.33 O +
- O +
kb O +
DNA O +
sequence O +
. O +

ACF64 B-Gene +
and O +
ACF65 B-Gene +
mRNAs O +
are O +
expressed O +
in O +
both O +
liver O +
and O +
intestinal O +
cells O +
in O +
an O +
approximate O +
1 O +
: O +
4 O +
ratio O +
. O +

Exon O +
11 O +
is O +
alternatively O +
spliced O +
to O +
include O +
or O +
exclude O +
24 O +
nucleotides O +
of O +
exon O +
12 O +
, O +
thereby O +
encoding O +
ACF65 B-Gene +
and O +
ACF64 B-Gene +
, O +
respectively O +
. O +

Recognition O +
motifs O +
for O +
the O +
serine O +
/ O +
arginine O +
- O +
rich O +
( O +
SR O +
) O +
proteins O +
SC35 B-Gene +
, O +
SRp40 B-Gene +
, O +
SRp55 B-Gene +
, O +
and O +
SF2 B-Gene +
/ O +
ASF B-Gene +
involved O +
in O +
alternative O +
RNA O +
splicing O +
were O +
predicted O +
in O +
exon O +
12 O +
. O +

Overexpression O +
of O +
these O +
SR O +
proteins O +
in O +
liver O +
cells O +
demonstrated O +
that O +
alternative O +
splicing O +
of O +
a O +
minigene O +
- O +
derived O +
transcript O +
to O +
express O +
ACF65 B-Gene +
was O +
enhanced O +
6 O +
- O +
fold O +
by O +
SRp40 B-Gene +
. O +

The O +
data O +
account O +
for O +
the O +
expression O +
of O +
two O +
editing O +
factors O +
and O +
provide O +
a O +
possible O +
explanation O +
for O +
their O +
different O +
levels O +
of O +
expression O +
. O +

Cytokine B-Gene +
signaling O +
: O +
STATS B-Gene +
in O +
plasma O +
membrane O +
rafts O +
. O +

STAT B-Gene +
transcription B-Gene +
factors I-Gene +
signal O +
from O +
the O +
plasma O +
membrane O +
to O +
the O +
nucleus O +
in O +
response O +
to O +
growth B-Gene +
factors I-Gene +
and O +
cytokines B-Gene +
. O +

We O +
have O +
investigated O +
whether O +
plasma O +
membrane O +
" O +
rafts O +
" O +
are O +
involved O +
in O +
cytokine B-Gene +
- O +
activated O +
STAT B-Gene +
signaling O +
. O +

Cytokine B-Gene +
- O +
free O +
human O +
hepatoma O +
Hep3B O +
cells O +
or O +
cells O +
treated O +
with O +
interleukin-6 B-Gene +
( O +
IL-6 B-Gene +
) O +
or O +
orthovanadate O +
( O +
a O +
general O +
activator O +
of O +
STATs B-Gene +
) O +
were O +
fractionated O +
, O +
and O +
plasma O +
membrane O +
raft O +
fractions O +
were O +
obtained O +
by O +
equilibrium O +
sedimentation O +
or O +
flotation O +
through O +
discontinuous O +
sucrose O +
gradients O +
using O +
either O +
non O +
- O +
detergent O +
or O +
detergent O +
- O +
based O +
( O +
saponin O +
or O +
Triton O +
X O +
- O +
100 O +
) O +
methods O +
. O +

By O +
Western O +
blotting O +
the O +
plasma O +
membrane O +
raft O +
fractions O +
obtained O +
using O +
either O +
non O +
- O +
detergent O +
or O +
detergent O +
- O +
based O +
methods O +
contained O +
significant O +
amounts O +
of O +
STAT1 B-Gene +
and O +
STAT3 B-Gene +
( O +
up O +
to O +
approximately O +
10 O +
% O +
of O +
the O +
total O +
cytoplasmic O +
amount O +
) O +
as O +
well O +
as O +
the O +
integral O +
raft O +
proteins O +
caveolin-1 B-Gene +
and O +
flotillin-1 B-Gene +
, O +
the O +
IL-6 B-Gene +
- I-Gene +
receptor I-Gene +
signal I-Gene +
transducing I-Gene +
chain I-Gene +
gp130 B-Gene +
, O +
the O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
receptor I-Gene +
alpha I-Gene +
chain I-Gene +
( O +
IFN B-Gene -
- I-Gene -
gammaRalpha I-Gene +
) O +
, O +
and O +
the O +
chaperone B-Gene +
glucose B-Gene +
- I-Gene +
regulated I-Gene +
protein I-Gene +
58 I-Gene +
( O +
GRP58 B-Gene +
/ O +
ER B-Gene +
- I-Gene +
60 I-Gene +
/ O +
ERp57 B-Gene +
) O +
. O +

Upon O +
activation O +
of O +
signaling O +
by O +
IL-6 B-Gene +
or O +
orthovanadate O +
the O +
respective O +
Tyr O +
- O +
phosphorylated O +
STAT B-Gene +
species O +
were O +
now O +
also O +
observed O +
in O +
the O +
membrane O +
raft O +
fraction O +
but O +
in O +
a O +
form O +
deficient O +
in O +
DNA O +
binding O +
. O +

The O +
data O +
show O +
pre O +
- O +
association O +
of O +
STATs B-Gene +
with O +
plasma O +
membrane O +
rafts O +
in O +
flotation O +
fractions O +
, O +
which O +
also O +
contained O +
caveolin-1 B-Gene +
and O +
flotillin-1 B-Gene +
, O +
and O +
suggest O +
that O +
Tyr O +
phosphorylation O +
may O +
not O +
in O +
itself O +
be O +
sufficient O +
to O +
cause O +
the O +
departure O +
of O +
PY O +
- O +
STATs B-Gene +
from O +
plasma O +
membrane O +
rafts O +
. O +

Methyl O -
- O -
beta O -
- O -
cyclodextrin O +
, O +
which O +
sequesters O +
cholesterol O +
and O +
disrupts O +
plasma O +
membrane O +
rafts O +
, O +
markedly O +
inhibited O +
IL-6 B-Gene +
- O +
and O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
- O +
induced O +
STAT B-Gene +
signaling O +
. O +

Signaling O +
through O +
specialized O +
raft O +
microdomains O +
may O +
be O +
a O +
general O +
mechanism O +
operating O +
at O +
the O +
level O +
of O +
the O +
plasma O +
membrane O +
through O +
which O +
cytokines B-Gene +
and O +
growth B-Gene +
factors I-Gene +
activate O +
STAT B-Gene +
species O +
( O +
the O +
" O +
raft O +
- O +
STAT B-Gene +
signaling O +
hypothesis O +
" O +
) O +
. O +

Regulation O +
of O +
cell O +
proliferation O +
, O +
apoptosis O +
, O +
and O +
carcinogenesis O +
by O +
activin B-Gene +
. O +

The O +
aim O +
of O +
this O +
review O +
is O +
to O +
provide O +
insight O +
into O +
the O +
molecular O +
mechanisms O +
by O +
which O +
activin B-Gene +
A I-Gene +
modulates O +
cell O +
proliferation O +
, O +
apoptosis O +
, O +
and O +
carcinogenesis O +
in O +
vitro O +
and O +
in O +
vivo O +
. O +

Activin B-Gene +
A I-Gene +
, O +
a O +
member O +
of O +
the O +
TGFbeta B-Gene +
superfamily I-Gene +
, O +
has O +
various O +
effects O +
on O +
diverse O +
biological O +
systems O +
, O +
including O +
cell O +
growth O +
inhibition O +
in O +
many O +
cell O +
types O +
. O +

However O +
, O +
the O +
mechanism O -
( O -
s O -
) O +
by O +
which O +
activin B-Gene +
exerts O +
its O +
inhibitory O +
effects O +
are O +
not O +
yet O +
understood O +
. O +

This O +
review O +
highlights O +
activin B-Gene +
's O +
effects O +
on O +
activin B-Gene +
receptors I-Gene +
and O +
signaling O +
pathway O +
, O +
modulation O +
of O +
activin B-Gene +
signaling O +
, O +
and O +
regulation O +
of O +
cell O +
proliferation O +
and O +
apoptosis O +
by O +
activin B-Gene +
. O +

Based O +
on O +
the O +
experiences O +
of O +
all O +
the O +
authors O +
, O +
we O +
emphasized O +
cell O +
cycle O +
inhibitors O +
such O +
as O +
p16 B-Gene +
and O +
p21 B-Gene +
and O +
regulators O +
of O +
apoptosis O +
such O +
as O +
p53 B-Gene +
and O +
members O +
of O +
the O +
bcl-2 B-Gene +
family I-Gene +
. O +

Aside O +
from O +
activin B-Gene +
's O +
inhibition O +
of O +
cell O +
proliferation O +
and O +
enhancement O +
of O +
apoptosis O +
, O +
other O +
newly O +
developed O +
methods O +
for O +
molecular O +
studies O +
of O +
apoptosis O +
by O +
activin B-Gene +
were O +
briefly O +
presented O +
that O +
support O +
the O +
role O +
of O +
activin B-Gene +
as O +
an O +
inhibitor O +
of O +
carcinogenesis O +
and O +
cancer O +
progression O +
. O +

These O +
methods O +
include O +
subtractive O +
hybridization O +
based O +
on O +
covalent O +
bonding O +
, O +
a O +
simple O +
and O +
accurate O +
means O +
to O +
determine O +
molecular O +
profile O +
of O +
as O +
few O +
as O +
20 O +
cells O +
based O +
on O +
an O +
RNA O +
- O +
PCR O +
approach O +
, O +
and O +
a O +
messenger O +
RNA O +
- O +
antisense O +
DNA O +
interference O +
phenomenon O +
( O +
D O -
- O -
RNAi O +
) O +
, O +
resulting O +
in O +
a O +
long O +
- O +
term O +
gene O +
knockout O +
effects O +
. O +

Expression O +
and O +
modulation O +
of O +
Rho B-Gene +
kinase I-Gene +
in O +
human O +
pregnant O +
myometrium O +
. O +

There O +
is O +
little O +
information O +
outlining O +
the O +
role O +
of O +
Rho B-Gene +
kinase I-Gene +
, O +
RhoA B-Gene +
, O +
and O +
calcium O +
sensitization O +
in O +
regulation O +
of O +
human O +
uterine O +
contractility O +
during O +
pregnancy O +
. O +

The O +
aims O +
of O +
this O +
study O +
were O +
to O +
investigate O +
the O +
expression O +
of O +
RhoA B-Gene +
, O +
and O +
the O +
Rho B-Gene +
kinases I-Gene +
ROCK B-Gene +
I I-Gene +
and O +
ROCK B-Gene +
II I-Gene +
in O +
human O +
pregnant O +
myometrium O +
, O +
to O +
evaluate O +
the O +
effects O +
of O +
Rho B-Gene +
kinase I-Gene +
inhibition O +
on O +
pregnant O +
human O +
myometrial O +
contractility O +
in O +
vitro O +
, O +
and O +
to O +
compare O +
these O +
effects O +
with O +
those O +
of O +
the O +
calcium B-Gene +
channel I-Gene +
blocker O +
nifedipine O +
. O +

RT O +
- O +
PCR O +
using O +
primers O +
for O +
RhoA B-Gene +
, O +
ROCK B-Gene +
I I-Gene +
and O +
ROCK B-Gene +
II I-Gene +
was O +
performed O +
on O +
mRNA O +
isolated O +
from O +
human O +
pregnant O +
myometrium O +
. O +

Isometric O +
recording O +
was O +
performed O +
in O +
isolated O +
myometrial O +
strips O +
obtained O +
at O +
Caesarean O +
section O +
. O +

The O +
effects O +
of O +
the O +
Rho B-Gene +
kinase I-Gene +
inhibitor O +
Y-27632 O +
( O +
1 O +
nmol O +
/ O +
l O +
to O +
10 O +
mmol O +
/ O +
l O +
) O +
, O +
and O +
nifedipine O +
( O +
1 O +
nmol O +
/ O +
l O +
to O +
10 O +
mmol O +
/ O +
l O +
) O +
, O +
on O +
oxytocin O +
( O +
0.5 O +
nmol O +
/ O +
l O +
) O +
induced O +
contractions O +
were O +
measured O +
and O +
compared O +
. O +

Expression O +
of O +
RhoA B-Gene +
, O +
ROCK B-Gene +
I I-Gene +
and O +
ROCK B-Gene +
II I-Gene +
mRNA O +
was O +
identified O +
in O +
human O +
pregnant O +
myometrium O +
( O +
n O +
= O +
3 O +
) O +
. O +

Y-27632 O +
exerted O +
a O +
potent O +
relaxant O +
effect O +
on O +
myometrial O +
contractility O +
with O +
a O +
pD O -
( O -
2 O -
) O +
value O +
( O +
+ O -
/- O +
SEM O +
) O +
of O +
7.63 O +
+ O -
/- O +
0.38 O +
( O +
n O +
= O +
6 O +
) O +
. O +

The O +
maximum O +
net O +
relaxant O +
effect O +
( O +
+ O -
/- O +
SEM O +
) O +
was O +
72.3 O +
+ O -
/- O +
6.1 O +
% O +
( O +
n O +
= O +
6 O +
) O +
. O +

Corresponding O +
values O +
for O +
nifedipine O +
were O +
7.24 O +
+ O -
/- O +
0.48 O +
( O +
n O +
= O +
6 O +
; O +
P O +
= O +
0.469 O +
) O +
and O +
93.40 O +
+ O -
/- O +
3.1 O +
% O +
( O +
n O +
= O +
6 O +
; O +
P O +
= O +
0.028 O +
) O +
. O +

Rho B-Gene +
A I-Gene +
/ O +
Rho B-Gene +
kinase I-Gene +
- O +
mediated O +
calcium O +
sensitization O +
may O +
play O +
role O +
in O +
the O +
physiology O +
of O +
human O +
parturition O +
, O +
and O +
pharmacological O +
inhibition O +
of O +
this O +
pathway O +
may O +
therefore O +
provide O +
a O +
novel O +
approach O +
to O +
tocolysis O +
for O +
pre O +
- O +
term O +
labour O +
. O +

Nutritional O +
considerations O +
in O +
renal O +
transplant O +
patients O +
. O +

In O +
renal O +
transplant O +
patients O +
, O +
weight O +
gain O +
generally O +
increases O +
after O +
renal O +
transplantation O +
, O +
which O +
will O +
be O +
influenced O +
by O +
improved O +
appetite O +
and O +
a O +
reversal O +
of O +
the O +
uremic O +
state O +
. O +

However O +
, O +
at O +
least O +
in O +
the O +
early O +
posttransplant O +
period O +
, O +
the O +
increase O +
in O +
body O +
weight O +
is O +
mainly O +
due O +
to O +
an O +
increase O +
in O +
body O +
fat O +
mass O +
. O +

This O +
phenomenon O +
may O +
be O +
partly O +
due O +
to O +
relatively O +
high O +
doses O +
of O +
steroids O +
in O +
the O +
early O +
period O +
after O +
renal O +
transplantation O +
, O +
possibly O +
mediated O +
by O +
their O +
inhibiting O +
effect O +
on O +
lipid O +
peroxidation O +
, O +
but O +
also O +
appears O +
to O +
be O +
related O +
to O +
physical O +
inactivity O +
. O +

The O +
increase O +
in O +
body O +
fat O +
mass O +
may O +
contribute O +
to O +
posttransplant O +
hyperlipidemia O +
, O +
which O +
is O +
improved O +
but O +
not O +
completely O +
normalized O +
by O +
dietary O +
intervention O +
. O +

Current O +
dietary O +
recommendations O +
in O +
stable O +
renal O +
transplant O +
patients O +
do O +
not O +
generally O +
differ O +
from O +
those O +
of O +
the O +
general O +
population O +
, O +
although O +
intense O +
dietary O +
counselling O +
may O +
be O +
indicated O +
in O +
patients O +
with O +
excessive O +
posttransplant O +
weight O +
gain O +
. O +

The O +
effect O +
of O +
supervised O +
exercise O +
training O +
on O +
body O +
composition O +
is O +
currently O +
under O +
investigation O +
. O +

Recombinant O +
human O +
laminin-10 B-Gene +
( O +
alpha5beta1gamma1 O +
) O +
. O +

Production O +
, O +
purification O +
, O +
and O +
migration O +
- O +
promoting O +
activity O +
on O +
vascular O +
endothelial O +
cells O +
. O +

The O +
laminin B-Gene +
( I-Gene +
LN I-Gene +
) I-Gene +
family I-Gene +
of O +
large O +
heterotrimeric O +
extracellular O +
matrix O +
glycoproteins O +
has O +
multiple O +
functions O +
: O +
LNs B-Gene +
take O +
part O +
in O +
the O +
regulation O +
of O +
processes O +
such O +
as O +
cell O +
migration O +
, O +
differentiation O +
, O +
and O +
proliferation O +
, O +
in O +
addition O +
to O +
contributing O +
to O +
the O +
structure O +
of O +
basement O +
membranes O +
. O +

LN-10 B-Gene +
, O +
composed O +
of O +
alpha5 O +
, O +
beta1 O +
, O +
and O +
gamma1 O +
chains O +
, O +
is O +
widely O +
distributed O +
in O +
most O +
basement O +
membranes O +
of O +
both O +
epithelia O +
and O +
endothelia O +
. O +

We O +
determined O +
the O +
complete O +
human O +
cDNA O +
sequence O +
for O +
the O +
LN B-Gene +
alpha5 I-Gene +
chain O +
and O +
produced O +
recombinant O +
human O +
LN-10 B-Gene +
( O +
rLN-10 B-Gene +
) O +
in O +
HEK293 O +
cells O +
by O +
triple O +
transfection O +
of O +
full O +
- O +
length O +
cDNAs O +
encoding O +
the O +
human O +
LN B-Gene +
alpha5 I-Gene +
, O +
beta1 B-Gene +
, I-Gene +
and I-Gene +
gamma1 I-Gene +
chains O +
. O +

The O +
rLN-10 B-Gene +
was O +
purified O +
using O +
affinity O +
chromatography O +
and O +
had O +
an O +
apparent O +
molecular O +
mass O +
of O +
approximately O +
800 O +
kDa O +
in O +
SDS O +
- O +
PAGE O +
and O +
a O +
native O +
domain O +
structure O +
in O +
rotary O +
shadowing O +
electron O +
microscopy O +
. O +

By O +
using O +
function O +
- O +
blocking O +
monoclonal O +
antibodies O +
, O +
integrin B-Gene +
alpha I-Gene -
( I-Gene -
3 I-Gene -
) I-Gene -
beta I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
was O +
found O +
to O +
be O +
a O +
major O +
mediator O +
of O +
adhesion O +
of O +
HT-1080 O +
and O +
human O +
saphenous O +
vein O +
endothelial O +
cells O +
. O +

Human O +
saphenous O +
vein O +
endothelial O +
cells O +
adhered O +
more O +
strongly O +
to O +
rLN-10 B-Gene +
than O +
to O +
LN-1 B-Gene +
and O +
LN-8 B-Gene +
and O +
showed O +
better O +
migration O +
on O +
rLN-10 B-Gene +
, O +
compared O +
with O +
several O +
other O +
matrices O +
. O +

Considering O +
the O +
cell O +
adhesive O +
and O +
migration O +
- O +
promoting O +
properties O +
of O +
rLN-10 B-Gene +
on O +
endothelial O +
cells O +
, O +
this O +
molecule O +
could O +
be O +
useful O +
in O +
improving O +
the O +
biocompatibility O +
and O +
endothelialization O +
of O +
vascular O +
grafts O +
. O +

Biological O +
activities O +
of O +
ecalectin B-Gene +
: O +
a O +
novel O +
eosinophil O +
- O +
activating O +
factor O +
. O +

Ecalectin B-Gene +
, O +
produced O +
by O +
Ag O +
- O +
stimulated O +
T O +
lymphocytes O +
, O +
is O +
a O +
potent O +
eosinophil O +
- O +
specific O +
chemoattractant O +
in O +
vitro O +
as O +
well O +
as O +
in O +
vivo O +
and O +
thus O +
is O +
implicated O +
in O +
allergic O +
responses O +
. O +

Ecalectin B-Gene +
differs O +
structurally O +
from O +
other O +
known O +
eosinophil O +
chemoattractants O +
( O +
ECAs O +
) O +
; O +
ecalectin B-Gene +
belongs O +
to O +
the O +
galectin B-Gene +
family I-Gene +
defined O +
by O +
their O +
affinity O +
for O +
beta O -
- O -
galactosides O +
and O +
by O +
their O +
conserved O +
carbohydrate O +
recognition O +
domains O +
. O +

These O +
characteristic O +
features O +
suggest O +
that O +
ecalectin B-Gene +
has O +
unique O +
activities O +
associated O +
with O +
allergic O +
inflammation O +
besides O +
ECA O +
activity O +
. O +

Conversely O +
, O +
ecalectin B-Gene +
may O +
mediate O +
ECA O +
activity O +
by O +
binding O +
to O +
a O +
receptor O +
of O +
a O +
known O +
ECA O +
via O +
affinity O +
for O +
the O +
beta O -
- O -
galactosides O +
present O +
on O +
this O +
receptor O +
. O +

In O +
this O +
study O +
, O +
we O +
have O +
tested O +
whether O +
ecalectin B-Gene +
mediates O +
ECA O +
activity O +
by O +
binding O +
to O +
a O +
receptor O +
of O +
a O +
known O +
ECA O +
, O +
and O +
we O +
have O +
assessed O +
its O +
effects O +
on O +
eosinophils O +
. O +

Ecalectin B-Gene +
did O +
not O +
mediate O +
ECA O +
activity O +
by O +
binding O +
to O +
the O +
IL-5R B-Gene +
or O +
to O +
CCR3 B-Gene +
. O +

Also O +
, O +
the O +
ECA O +
activity O +
of O +
ecalectin B-Gene +
was O +
mainly O +
chemokinetic O +
. O +

In O +
addition O +
, O +
ecalectin B-Gene +
induced O +
concentration O +
- O +
dependent O +
eosinophil O +
aggregation O +
, O +
a O +
marker O +
for O +
eosinophil O +
activation O +
. O +

Ecalectin B-Gene +
induced O +
concentration O +
- O +
dependent O +
superoxide O +
production O +
from O +
eosinophils O +
but O +
did O +
not O +
induce O +
degranulation O +
; O +
usually O +
these O +
two O +
events O +
are O +
coupled O +
in O +
eosinophil O +
activation O +
. O +

Moreover O +
, O +
ecalectin B-Gene +
directly O +
prolonged O +
eosinophil O +
survival O +
in O +
vitro O +
and O +
did O +
not O +
trigger O +
eosinophils O +
to O +
secrete O +
cytokines B-Gene +
that O +
prolong O +
eosinophil O +
survival O +
. O +

These O +
results O +
demonstrate O +
that O +
ecalectin B-Gene +
has O +
several O +
unique O +
effects O +
on O +
eosinophils O +
. O +

Therefore O +
, O +
we O +
conclude O +
that O +
ecalectin B-Gene +
is O +
a O +
novel O +
eosinophil O +
- O +
activating O +
factor O +
. O +

Presumably O +
, O +
these O +
effects O +
allow O +
ecalectin B-Gene +
to O +
play O +
a O +
distinctive O +
role O +
in O +
allergic O +
inflammation O +
. O +

Developing O +
a O +
taste O +
for O +
sweets O +
. O +

Lymphocytes O +
are O +
covered O +
with O +
sugars O +
. O +

Some O +
of O +
the O +
oligosaccharides O +
on O +
lymphocytes O +
may O +
be O +
recognized O +
by O +
specific O +
lectins B-Gene +
such O +
as O +
the O +
selectins B-Gene +
, O +
but O +
what O +
other O +
functions O +
do O +
all O +
of O +
these O +
oligosaccharides O +
serve O +
? O +

Two O +
recent O +
papers O +
in O +
Cell O +
( O +
Moody O +
et O +
al. O +
, O +
2001 O +
) O +
and O +
Immunity O +
( O +
Daniels O +
et O +
al. O +
, O +
2001 O +
) O +
describe O +
a O +
novel O +
role O +
for O +
glycosylation O +
in O +
the O +
thymus O -
-- O -
regulating O +
the O +
interaction O +
of O +
MHC B-Gene +
class I-Gene +
I I-Gene +
molecules O +
with O +
CD8 B-Gene +
during O +
thymocyte O +
maturation O +
. O +

Consequences O +
of O +
CK2 B-Gene +
signaling O +
to O +
the O +
nuclear O +
matrix O +
. O +

Protein B-Gene +
kinase I-Gene +
CK2 B-Gene +
is O +
recognized O +
as O +
one O +
of O +
the O +
key O +
cellular O +
signals O +
for O +
cell O +
growth O +
and O +
proliferation O +
. O +

Its O +
nuclear O +
targeting O +
appears O +
to O +
be O +
critical O +
to O +
its O +
role O +
in O +
these O +
functions O +
. O +

In O +
the O +
nucleus O +
, O +
nuclear O +
matrix O +
( O +
NM O +
) O +
which O +
plays O +
a O +
major O +
role O +
in O +
growth O +
- O +
related O +
activities O +
is O +
a O +
primary O +
locus O +
for O +
CK2 B-Gene +
signaling O +
. O +

A O +
variety O +
of O +
growth O +
stimuli O +
evoke O +
a O +
rapid O +
translocation O +
of O +
the O +
CK2 B-Gene +
to O +
the O +
NM O +
whereas O +
removal O +
of O +
these O +
factors O +
has O +
the O +
opposite O +
effect O +
. O +

These O +
studies O +
, O +
employing O +
various O +
experimental O +
models O +
of O +
cell O +
growth O +
( O +
involving O +
different O +
growth O +
- O +
stimulatory O +
factors O +
) O +
, O +
have O +
suggested O +
that O +
rapid O +
shuttling O +
of O +
CK2 B-Gene +
to O +
the O +
NM O +
is O +
a O +
key O +
feature O +
of O +
early O +
growth O +
control O +
. O +

By O +
contrast O +
, O +
removal O +
of O +
growth O +
- O +
stimulatory O +
factors O +
leading O +
to O +
the O +
loss O +
of O +
cell O +
viability O +
is O +
associated O +
with O +
early O +
loss O +
of O +
CK2 B-Gene +
from O +
the O +
NM O +
( O +
and O +
chromatin O +
) O +
. O +

This O +
indicates O +
that O +
absence O +
of O +
CK2 B-Gene +
from O +
the O +
nuclear O +
compartment O +
is O +
contributory O +
to O +
induction O +
of O +
cell O +
death O +
via O +
apoptosis O +
, O +
implying O +
a O +
protective O +
role O +
for O +
CK2 B-Gene +
against O +
cell O +
death O +
. O +

Here O +
, O +
we O +
review O +
the O +
evidence O +
that O +
suggests O +
that O +
CK2 B-Gene +
signaling O +
in O +
the O +
NM O +
is O +
not O +
only O +
involved O +
in O +
cell O +
growth O +
but O +
also O +
in O +
cell O +
survival O +
. O +

Suppression O +
of O +
15-lipoxygenase B-Gene +
synthesis O +
by O +
hnRNP B-Gene +
E1 I-Gene +
is O +
dependent O +
on O +
repetitive O +
nature O +
of O +
LOX B-Gene +
mRNA O +
3'-UTR O +
control O +
element O +
DICE O +
. O +

Cytidine O +
- O +
rich O +
15 B-Gene +
- I-Gene +
lipoxygenase I-Gene +
differentiation O +
control O +
element O +
( O +
15-LOX B-Gene +
DICE O +
) O +
is O +
a O +
multifunctional O +
cis O +
- O +
element O +
found O +
in O +
the O +
3'-UTR O +
of O +
numerous O +
eukaryotic O +
mRNAs O +
. O +

It O +
binds O +
KH O +
domain O +
proteins O +
of O +
the O +
type O +
hnRNP B-Gene +
E I-Gene +
and I-Gene +
K I-Gene +
, O +
thus O +
mediating O +
mRNA O +
stabilization O +
and O +
translational O +
control O +
. O +

Translational O +
silencing O +
is O +
caused O +
by O +
formation O +
of O +
a O +
simple O +
binary O +
complex O +
between O +
DICE O +
and O +
recombinant O +
hnRNP B-Gene +
E1 I-Gene +
( O +
E1 O +
) O +
. O +

Electromobility O +
shift O +
assays O +
and O +
sucrose O +
gradient O +
centrifugation O +
demonstrate O +
that O +
rabbit O +
15-LOX B-Gene +
DICE O +
, O +
which O +
is O +
composed O +
of O +
ten O +
subunits O +
of O +
the O +
sequence O +
( O +
CCCCPuCCCUCUUCCCCAAG O +
) O +
10 O +
= O +
10R O +
, O +
is O +
able O +
to O +
bind O +
up O +
to O +
ten O +
molecules O +
of O +
E1 O +
. O +

Protein O +
/ O +
RNA O +
interaction O +
was O +
studied O +
with O +
different O +
subunits O +
and O +
submotifs O +
of O +
the O +
10R O +
structure O +
. O +

Binding O +
appears O +
to O +
be O +
dependent O +
on O +
the O +
degree O +
of O +
polymerization O +
of O +
the O +
C O -
- O -
clusters O +
( O -
1R<2R<4R<10R O -
) O +
, O +
but O +
not O +
on O +
their O +
order O +
. O +

The O +
minimal O +
motif O +
, O +
which O +
still O +
functioned O +
in O +
E1 O +
binding O +
, O +
contained O +
two O +
C O -
- O -
clusters O +
( O +
CCCCPuCCCUCUU O +
) O +
. O +

For O +
efficient O +
translational O +
control O +
, O +
E1 O +
binding O +
is O +
a O +
necessary O +
, O +
but O +
not O +
sufficient O +
, O +
condition O +
. O +

Translational O +
inhibition O +
by O +
E1 O +
is O +
only O +
observed O +
when O +
at O +
least O +
a O +
dimeric O +
2R O +
configuration O +
of O +
the O +
DICE O +
is O +
present O +
in O +
the O +
3'-UTR O +
of O +
a O +
reporter O +
mRNA O +
. O +

We O +
conclude O +
that O +
binding O +
of O +
at O +
least O +
two O +
E1 O +
molecules O +
activate O +
or O +
expose O +
a O +
binding O +
site O +
to O +
enable O +
the O +
complex O +
to O +
interact O +
with O +
the O +
5'-end O +
of O +
the O +
mRNA O +
and O +
the O +
translational O +
machinery O +
. O +

DICE O +
- O +
motifs O +
are O +
widely O +
distributed O +
in O +
nature O +
. O +

The O +
UTR O +
database O +
UTRnr O +
contains O +
78 O +
entries O +
of O +
mRNAs O +
with O +
15-LOX B-Gene +
DICEs O +
. O +

Most O +
DICEs O +
were O +
two O +
- O +
to O +
fourfold O +
repetitive O +
, O +
but O +
also O +
highly O +
repetitive O +
structures O +
were O +
found O +
, O +
as O +
in O +
quail O +
myelin B-Gene +
protein I-Gene +
mRNA O +
( O +
31 O +
repeats O +
) O +
and O +
hyperglycemic B-Gene +
hormone I-Gene +
mRNA O +
of O +
two O +
crayfish O +
species O +
( O +
nine O +
and O +
11 O +
repeats O +
) O +
. O +

Crystal O +
structure O +
of O +
extracellular O +
human O +
BAFF B-Gene +
, O +
a O +
TNF B-Gene +
family I-Gene +
member I-Gene +
that O +
stimulates O +
B O +
lymphocytes O +
. O +

B B-Gene +
cell I-Gene +
activating I-Gene +
factor I-Gene +
( O +
BAFF B-Gene +
) O +
, O +
a O +
ligand O +
belonging O +
to O +
the O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
( I-Gene +
TNF I-Gene +
) I-Gene +
family I-Gene +
, O +
plays O +
a O +
critical O +
role O +
in O +
regulating O +
survival O +
and O +
activation O +
of O +
peripheral O +
B O +
cell O +
populations O +
and O +
has O +
been O +
associated O +
with O +
autoimmune O +
disease O +
. O +

BAFF B-Gene +
is O +
known O +
to O +
interact O +
with O +
three O +
receptors O +
, O +
BCMA B-Gene +
, O +
TACI B-Gene +
and O +
BAFF B-Gene -
- I-Gene -
R I-Gene +
, O +
that O +
have O +
distant O +
similarities O +
with O +
other O +
receptors O +
of O +
the O +
TNF B-Gene +
family I-Gene +
. O +

We O +
have O +
determined O +
the O +
crystal O +
structure O +
of O +
the O +
TNF B-Gene +
- O +
homologous O +
domain O +
of O +
BAFF B-Gene +
at O +
2.8 O +
A O +
resolution O +
. O +

The O +
structure O +
reveals O +
significant O +
differences O +
when O +
compared O +
to O +
other O +
TNF B-Gene +
family I-Gene +
members O +
, O +
including O +
an O +
unusually O +
long O +
D O -
- O -
E O +
loop O +
that O +
participates O +
in O +
the O +
formation O +
of O +
a O +
deep O +
, O +
concave O +
and O +
negatively O +
charged O +
region O +
in O +
the O +
putative O +
receptor O +
binding O +
site O +
. O +

The O +
BAFF B-Gene +
structure O +
was O +
further O +
used O +
to O +
generate O +
a O +
homology O +
model O +
of O +
APRIL B-Gene +
, O +
a O +
closely O +
related O +
TNF B-Gene +
family I-Gene +
ligand O +
that O +
also O +
binds O +
to O +
BCMA B-Gene +
and O +
TACI B-Gene +
, O +
but O +
not O +
BAFF B-Gene -
- I-Gene -
R I-Gene +
. O +

Analysis O +
of O +
the O +
putative O +
receptor O +
binding O +
sites O +
of O +
BAFF B-Gene +
and O +
APRIL B-Gene +
suggests O +
that O +
differences O +
in O +
the O +
D O -
- O -
E O +
loop O +
structure O +
and O +
electrostatic O +
surface O +
potentials O +
may O +
be O +
important O +
for O +
determining O +
binding O +
specificities O +
for O +
BCMA B-Gene +
, O +
TACI B-Gene +
and O +
BAFF B-Gene -
- I-Gene -
R I-Gene +
. O +

Expression O +
of O +
the O +
genes O +
of O +
methyl O +
- O +
binding O +
domain O +
proteins O +
in O +
human O +
gliomas O +
. O +

DNA O +
methylation O +
is O +
the O +
most O +
common O +
epigenetic O +
alteration O +
in O +
tumor O +
genomes O +
and O +
might O +
result O +
in O +
transcriptional O +
repression O +
of O +
tumor O +
suppressor O +
genes O +
. O +

Moreover O +
, O +
recent O +
results O +
have O +
demonstrated O +
that O +
both O +
specific O +
methylation O +
patterns O +
and O +
functional O +
components O +
of O +
the O +
mismatch O +
repair O +
system O +
are O +
involved O +
in O +
the O +
development O +
of O +
therapy O +
resistance O +
of O +
tumor O +
cells O +
. O +

Here O +
we O +
investigated O +
the O +
expression O +
of O +
the O +
genes O +
of O +
methyl O +
binding O +
domain O +
containing O +
proteins O +
( O +
MBD B-Gene +
) O +
in O +
human O +
gliomas O +
both O +
in O +
vivo O +
and O +
in O +
vitro O +
. O +

We O +
found O +
expression O +
of O +
MBDs B-Gene +
including O +
MBD1 B-Gene +
, O +
MBD2 B-Gene +
, O +
MBD3 B-Gene +
and O +
MBD4 B-Gene +
/ O +
MED1 B-Gene +
in O +
all O +
glioma O +
cell O +
lines O +
and O +
glioma O +
biopsies O +
. O +

No O +
differences O +
existed O +
in O +
vitro O +
with O +
regard O +
to O +
individual O +
MBDs B-Gene +
and O +
individual O +
cell O +
lines O +
. O +

In O +
vivo O +
, O +
MBD1 B-Gene +
and O +
MBD2 B-Gene +
were O +
also O +
expressed O +
in O +
all O +
biopsies O +
with O +
only O +
minor O +
differences O +
between O +
individual O +
tumors O +
. O +

MBD3 B-Gene +
and O +
MBD4 B-Gene +
/ O +
MED1 B-Gene +
, O +
however O +
, O +
showed O +
a O +
correlation O +
of O +
expression O +
with O +
the O +
grade O +
of O +
malignancy O +
. O +

Astrocytomas O +
and O +
anaplastic O +
astrocytomas O +
showed O +
a O +
weak O +
expression O +
compared O +
with O +
a O +
high O +
expression O +
in O +
glioblastoma O +
multiforme O +
. O +

[ O +
Investigation O +
on O +
skin O +
retrograde O +
degeneration O +
after O +
tissue O +
expansion O +
] O +

OBJECTIVE O +
: O +

To O +
study O +
the O +
effects O +
of O +
tissue O +
expansion O +
on O +
tissue O +
damage O +
and O +
retrograde O +
degeneration O +
. O +

METHODS O +
: O +

9 O +
cases O +
of O +
conventional O +
intermittent O +
tissue O +
expansion O +
( O +
CITE O +
) O +
and O +
9 O +
cases O +
of O +
continuous O +
pressure O +
- O +
controlled O +
tissue O +
expansion O +
( O +
CPTE O +
) O +
were O +
chosen O +
for O +
the O +
study O +
. O +

In O +
creating O +
of O +
the O +
expanded O +
flaps O +
, O +
tissue O +
samples O +
were O +
taken O +
for O +
histopathology O +
, O +
molecular O +
biology O +
and O +
transmission O +
electron O +
microscope O +
( O +
TEM O +
) O +
examinations O +
. O +

RESULTS O +
: O +

Capillary O +
bleeding O +
, O +
elastic O +
and O +
reticular O +
fiber O +
proliferation O +
, O +
arteriole O +
thrombosis O +
, O +
fibroblast O +
apoptosis O +
and O +
collagenolysis O +
were O +
observed O +
after O +
expansion O +
. O +

Retrograde O +
degeneration O +
was O +
obvious O +
in O +
CITE O +
group O +
and O +
acute O +
lesion O +
was O +
obvious O +
in O +
CPTE O +
group O +
. O +

CONCLUSION O +
: O +

Expansion O +
stimulation O +
induces O +
tissue O +
damage O +
and O +
retrograde O +
degeneration O +
, O +
which O +
indicates O +
that O +
the O +
time O +
for O +
conventional O +
intermittent O +
expansion O +
should O +
be O +
shortened O +
and O +
too O +
fast O +
continuous O +
expansion O +
is O +
harmful O +
. O +

v B-Gene -
- I-Gene -
Src I-Gene +
SH3 O +
- O +
enhanced O +
interaction O +
with O +
focal B-Gene +
adhesion I-Gene +
kinase I-Gene +
at O +
beta B-Gene +
1 I-Gene +
integrin I-Gene +
- O +
containing O +
invadopodia O +
promotes O +
cell O +
invasion O +
. O +

In O +
viral B-Gene +
Src I-Gene +
( O +
v B-Gene -
- I-Gene -
Src I-Gene +
) O +
- O +
transformed O +
cells O +
, O +
focal B-Gene +
adhesion I-Gene +
kinase I-Gene +
( O +
FAK B-Gene +
) O +
associates O +
with O +
v B-Gene +
- I-Gene +
Src I-Gene +
by O +
combined O +
v B-Gene +
- I-Gene +
Src I-Gene +
SH2 O +
and O +
gain O +
- O +
of O +
- O +
function O +
v B-Gene +
- I-Gene +
Src I-Gene +
SH3 O +
domain O +
binding O +
to O +
FAK B-Gene +
. O +

Here O +
we O +
assess O +
the O +
significance O +
of O +
the O +
Arg-95 O +
to O +
Trp O +
gain O +
- O +
of O +
- O +
function O +
mutation O +
in O +
the O +
v B-Gene -
- I-Gene -
Src I-Gene +
SH3 O +
domain O +
through O +
comparisons O +
of O +
Src B-Gene +
- O -
/ O -
- O +
fibroblasts O +
transformed O +
with O +
either O +
Prague O +
C O +
v B-Gene +
- I-Gene +
Src I-Gene +
or O +
a O +
point O +
mutant O +
( O +
v B-Gene +
- I-Gene +
Src I-Gene +
- O +
RT O +
) O +
containing O +
a O +
normal O +
( O +
Arg O +
- O +
95 O +
) O +
SH3 O +
domain O +
. O +

Both O +
v B-Gene -
- I-Gene -
Src I-Gene +
isoforms O +
exhibited O +
equivalent O +
kinase B-Gene +
activity O +
, O +
enhanced O +
Src B-Gene +
- O +
/ O +
- O +
cell O +
motility O +
, O +
and O +
stimulated O +
cell O +
growth O +
in O +
both O +
low O +
serum O +
and O +
soft O +
agar O +
. O +

The O +
stability O +
of O +
a O +
v B-Gene -
- I-Gene -
Src I-Gene +
- O +
RT O +
. O +
FAK B-Gene +
signaling O +
complex O +
and O +
FAK B-Gene +
phosphorylation O +
at O +
Tyr-861 O +
and O +
Tyr-925 O +
were O +
reduced O +
in O +
v B-Gene -
- I-Gene -
Src I-Gene +
- O +
RT O +
- O +
compared O +
with O +
v B-Gene +
- I-Gene +
Src I-Gene +
- O +
transformed O +
cells O +
. O +

v B-Gene -
- I-Gene -
Src I-Gene +
but O +
not O +
v B-Gene -
- I-Gene -
Src I-Gene +
- O +
RT O +
promoted O +
Src B-Gene +
- O -
/ O -
- O +
cell O +
invasion O +
through O +
a O +
reconstituted O +
Matrigel O +
basement O +
membrane O +
barrier O +
and O +
v B-Gene +
- I-Gene +
Src I-Gene +
co O +
- O +
localized O +
with O +
FAK B-Gene +
and O +
beta B-Gene +
( I-Gene +
1 I-Gene +
) I-Gene +
integrin I-Gene +
at O +
invadopodia O +
. O +

In O +
contrast O +
, O +
v B-Gene +
- I-Gene +
Src I-Gene +
- O +
RT O +
exhibited O +
a O +
partial O +
perinuclear O +
and O +
focal O +
contact O +
distribution O +
in O +
Src B-Gene +
- O +
/ O +
- O +
cells O +
. O +

Adenovirus O +
- O +
mediated O +
FAK B-Gene +
overexpression O +
promoted O +
v B-Gene -
- I-Gene -
Src I-Gene +
- O +
RT O +
recruitment O +
to O +
invadopodia O +
, O +
the O +
formation O +
of O +
a O +
v B-Gene +
- I-Gene +
Src I-Gene +
- O +
RT O +
. O +
FAK B-Gene +
signaling O +
complex O +
, O +
and O +
reversed O +
the O +
v B-Gene +
- I-Gene +
Src I-Gene +
- O +
RT O +
invasion O +
deficit O +
. O +

Adenovirus O +
- O +
mediated O +
inhibition O +
of O +
FAK B-Gene +
blocked O +
v B-Gene -
- I-Gene -
Src I-Gene +
- O +
stimulated O +
cell O +
invasion O +
. O +

These O +
studies O +
establish O +
that O +
gain O +
- O +
of O +
- O +
function O +
v B-Gene +
- I-Gene +
Src I-Gene +
SH3 O +
targeting O +
interactions O +
with O +
FAK B-Gene +
at O +
beta B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
integrin I-Gene +
- O +
containing O +
invadopodia O +
act O +
to O +
stabilize O +
a O +
v B-Gene +
- I-Gene +
Src I-Gene +
. O +
FAK O +
signaling O +
complex O +
promoting O +
cell O +
invasion O +
. O +

Lack O +
of O +
association O +
between O +
HoxA1 B-Gene +
and O +
HoxB1 B-Gene +
gene O +
variants O +
and O +
autism O +
in O +
110 O +
multiplex O +
families O +
. O +

A O +
recent O +
report O +
suggested O +
that O +
the O +
HoxA1 B-Gene +
and/or O +
HoxB1 B-Gene +
genes O +
play O +
a O +
role O +
in O +
susceptibility O +
to O +
autism O +
. O +

To O +
determine O +
whether O +
these O +
findings O +
could O +
be O +
confirmed O +
, O +
we O +
screened O +
these O +
genes O +
for O +
DNA O +
polymorphisms O +
by O +
sequencing O +
all O +
exons O +
in O +
24 O +
individuals O +
with O +
autism O +
. O +

We O +
identified O +
the O +
same O +
sequence O +
variants O +
in O +
the O +
genes O +
that O +
appeared O +
in O +
this O +
report O +
, O +
which O +
include O +
one O +
single O +
- O +
base O +
substitution O +
variant O +
in O +
HoxA1 B-Gene +
and O +
a O +
common O +
haplotype O +
in O +
HoxB1 B-Gene +
. O +

We O +
performed O +
an O +
association O +
study O +
by O +
applying O +
the O +
transmission O +
disequilibrium O +
test O +
to O +
detect O +
possible O +
association O +
of O +
these O +
variants O +
to O +
autism O +
in O +
110 O +
multiplex O +
families O +
. O +

Our O +
results O +
demonstrated O +
no O +
deviation O +
from O +
the O +
null O +
hypothesis O +
of O +
no O +
association O +
. O +

We O +
have O +
also O +
separately O +
examined O +
transmissions O +
within O +
individual O +
mating O +
types O +
, O +
for O +
paternal O +
versus O +
maternal O +
alleles O +
, O +
to O +
affected O +
versus O +
unaffected O +
children O +
, O +
and O +
for O +
transmission O +
to O +
affected O +
boys O +
versus O +
girls O +
. O +

None O +
of O +
these O +
subsets O +
revealed O +
significant O +
deviation O +
from O +
the O +
null O +
expectation O +
. O +

Our O +
interpretation O +
of O +
these O +
findings O +
is O +
that O +
it O +
is O +
unlikely O +
that O +
HoxA1 B-Gene +
and O +
HoxB1 B-Gene +
play O +
a O +
significant O +
role O +
in O +
the O +
genetic O +
predisposition O +
to O +
autism O +
. O +

Cloning O +
of O +
rhesus O +
monkey O +
killer B-Gene +
- I-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIRs B-Gene +
) O +
from O +
early O +
pregnancy O +
decidua O +
. O +

To O +
define O +
the O +
killer B-Gene +
- I-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIR B-Gene +
) O +
molecules O +
expressed O +
within O +
the O +
decidua O +
in O +
the O +
rhesus O +
monkey O +
, O +
an O +
early O +
pregnancy O +
rhesus O +
decidual O +
library O +
was O +
screened O +
with O +
an O +
oligonucleotide O +
located O +
within O +
the O +
KIR B-Gene +
D2 O +
domain O +
. O +

We O +
obtained O +
26 O +
full O +
- O +
length O +
clones O +
which O +
represented O +
11 O +
mRNAs O +
. O +

The O +
cDNAs O +
encode O +
proteins O +
containing O +
2 O +
or O +
3 O +
Ig B-Gene +
domains O +
, O +
and O +
short O +
or O +
long O +
cytoplasmic O +
domains O +
. O +

The O +
long O +
domains O +
contained O +
immunotyrosine O +
inhibitory O +
motifs O +
( O +
ITIM O +
) O +
motifs O +
indicating O +
inhibitory O +
function O +
. O +

Three O +
clones O +
contained O +
single O +
or O +
dinucleotide O +
deletions O +
within O +
the O +
D1 O +
domain O +
, O +
which O +
would O +
result O +
in O +
proteins O +
truncated O +
within O +
this O +
domain O +
. O +

Phylogenetic O +
analysis O +
of O +
the O +
Ig B-Gene +
domains O +
supports O +
a O +
D0 O +
- O +
D2 O +
organization O +
of O +
rhesus O +
KIR2DL4.1 B-Gene +
, O +
similar O +
to O +
human O +
KIR2DL4 B-Gene +
and O +
KIR2DL5 B-Gene +
. O +

The O +
rhesus O +
KIR2DL4.1 B-Gene +
transcript O +
contains O +
a O +
long O +
cytoplasmic O +
tail O +
homologous O +
with O +
human O +
KIR2DL4 B-Gene +
. O +

Structure O +
and O +
function O +
of O +
IRF-7 B-Gene +
. O +

Interferon B-Gene +
( I-Gene +
IFN I-Gene +
) I-Gene +
regulatory I-Gene +
factors I-Gene +
( O +
IRF B-Gene +
) O +
are O +
a O +
family O +
of O +
transcription B-Gene +
factors I-Gene +
with O +
multiple O +
functions O +
. O +

IRF-7 B-Gene +
was O +
initially O +
cloned O +
within O +
the O +
biologic O +
context O +
of O +
Epstein O +
- O +
Barr O +
virus O +
( O +
EBV O +
) O +
latency O +
and O +
discovered O +
to O +
have O +
an O +
intimate O +
relation O +
with O +
the O +
EBV O +
primary O +
oncogenic O +
protein O +
, O +
latent B-Gene +
membrane I-Gene +
protein-1 I-Gene +
( O +
LMP-1 B-Gene +
) O +
. O +

EBV O +
regulates O +
and O +
uses O +
IRF-7 B-Gene +
as O +
a O +
secondary O +
mediator O +
for O +
several O +
target O +
genes O +
involved O +
in O +
latency O +
and O +
immune O +
regulation O +
. O +

Other O +
than O +
its O +
functions O +
in O +
EBV O +
latency O +
, O +
IRF-7 B-Gene +
has O +
been O +
identified O +
as O +
one O +
of O +
the O +
major O +
players O +
in O +
virally O +
induced O +
IFN B-Gene +
production O +
that O +
is O +
central O +
to O +
innate O +
immunity O +
. O +

Thus O +
, O +
IRF-7 B-Gene +
plays O +
important O +
roles O +
in O +
a O +
variety O +
of O +
biologic O +
systems O +
. O +

Alternative O +
type O +
I O +
and O +
I O -
' O +
turn O +
conformations O +
in O +
the O +
beta8 O +
/ O +
beta9 O +
beta O -
- O -
hairpin O +
of O +
human O +
acidic B-Gene +
fibroblast I-Gene +
growth I-Gene +
factor I-Gene +
. O +

Human O +
acidic B-Gene +
fibroblast I-Gene +
growth I-Gene +
factor I-Gene +
( O +
FGF-1 B-Gene +
) O +
has O +
a O +
beta O +
- O +
trefoil O +
structure O +
, O +
one O +
of O +
the O +
fundamental O +
protein O +
superfolds O +
. O +

The O +
X O +
- O +
ray O +
crystal O +
structures O +
of O +
wild O +
- O +
type O +
and O +
various O +
mutant O +
forms O +
of O +
FGF-1 B-Gene +
have O +
been O +
solved O +
in O +
five O +
different O +
space O +
groups O +
: O +
C2 O +
, O +
C222 O -
( O -
1 O -
) O +
, O +
P2 O -
( O -
1 O -
) O +
( O +
four O +
molecules O +
/ O +
asu O +
) O +
, O +
P2 O -
( O -
1 O -
) O +
( O +
three O +
molecules O +
/ O +
asu O +
) O +
, O +
and O +
P2 O -
( O -
1 O -
) O -
2 O -
( O -
1 O -
) O -
2 O -
( O -
1 O -
) O +
. O +

These O +
structures O +
reveal O +
two O +
characteristically O +
different O +
conformations O +
for O +
the O +
beta8 O +
/ O +
beta9 O +
beta O -
- O -
hairpin O +
comprising O +
residue O +
positions O +
90 O +
- O +
94 O +
. O +

This O +
region O +
in O +
the O +
wild O +
- O +
type O +
FGF-1 B-Gene +
structure O +
( O +
P2 O -
( O -
1 O -
) O +
, O +
four O +
molecules O +
/ O +
asu O +
) O +
, O +
a O +
his O +
- O +
tagged O +
His93 O +
-- O -
> O +
Gly O +
mutant O +
( O +
P2 O +
( O +
1 O +
) O +
, O +
three O +
molecules O +
/ O +
asu O +
) O +
and O +
a O +
his O +
- O +
tagged O +
Asn106 O +
-- O -
> O +
Gly O +
mutant O +
( O +
P2 O -
( O -
1 O -
) O -
2 O -
( O -
1 O -
) O -
2 O -
( O -
1 O -
) O +
) O +
adopts O +
a O +
3 O +
: O +
5 O +
beta O -
- O -
hairpin O +
known O +
as O +
a O +
type O +
I O +
( O +
1 O -
- O -
4 O -
) O +
G1 O +
beta O -
- O -
bulge O +
( O +
containing O +
a O +
type O +
I O +
turn O +
) O +
. O +

However O +
, O +
a O +
his O +
- O +
tagged O +
form O +
of O +
wild O +
- O +
type O +
FGF-1 B-Gene +
( O +
C222 O -
( O -
1 O -
) O +
) O +
and O +
a O +
his O +
- O +
tagged O +
Leu44 O +
-- O -
> O +
Phe O +
mutant O +
( O +
C2 O +
) O +
adopt O +
a O +
3 O +
: O +
3 O +
beta O -
- O -
hairpin O +
( O +
containing O +
a O +
type O +
I O -
' O +
turn O +
) O +
for O +
this O +
same O +
region O +
. O +

A O +
feature O +
that O +
distinguishes O +
these O +
two O +
types O +
of O +
beta O -
- O -
hairpin O +
structures O +
is O +
the O +
number O +
and O +
location O +
of O +
side O +
chain O +
positions O +
with O +
eclipsed O +
C O -
( O -
beta O -
) O +
and O +
main O +
- O +
chain O +
carbonyl O +
oxygen O +
groups O +
( O +
Psi O +
is O +
equivalent O +
to O +
+ O +
60 O +
degrees O +
) O +
. O +

The O +
effects O +
of O +
glycine O +
mutations O +
upon O +
stability O +
, O +
at O +
positions O +
within O +
the O +
hairpin O +
, O +
have O +
been O +
used O +
to O +
identify O +
the O +
most O +
likely O +
structure O +
in O +
solution O +
. O +

Type O +
I O -
' O +
turns O +
in O +
the O +
structural O +
data O +
bank O +
are O +
quite O +
rare O +
, O +
and O +
a O +
survey O +
of O +
these O +
turns O +
reveals O +
that O +
a O +
large O +
percentage O +
exhibit O +
crystal O +
contacts O +
within O +
3.0 O +
A O +
. O +

This O +
suggests O +
that O +
many O +
of O +
the O +
type O +
I O +
' O +
turns O +
in O +
X O +
- O +
ray O +
structures O +
may O +
be O +
adopted O +
due O +
to O +
crystal O +
packing O +
effects O +
. O +

KRIT1 B-Gene +
association O +
with O +
the O +
integrin B-Gene +
- O +
binding O +
protein O +
ICAP-1 B-Gene +
: O +
a O +
new O +
direction O +
in O +
the O +
elucidation O +
of O +
cerebral O +
cavernous O +
malformations O +
( O +
CCM1 O +
) O +
pathogenesis O +
. O +

Mutations O +
in O +
KRIT1 B-Gene +
, O +
a O +
protein O +
initially O +
identified O +
based O +
on O +
a O +
yeast O +
two O +
- O +
hybrid O +
interaction O +
with O +
the O +
RAS B-Gene +
- I-Gene +
family I-Gene +
GTPase I-Gene +
RAP1A B-Gene +
, O +
are O +
responsible O +
for O +
the O +
development O +
of O +
the O +
inherited O +
vascular O +
disorder O +
cerebral O +
cavernous O +
malformations O +
( O +
CCM1 O +
) O +
. O +

As O +
the O +
function O +
of O +
the O +
KRIT1 B-Gene +
protein O +
and O +
its O +
role O +
in O +
CCM O +
pathogenesis O +
remain O +
unknown O +
, O +
we O +
performed O +
yeast O +
two O +
- O +
hybrid O +
screens O +
to O +
identify O +
additional O +
protein O +
binding O +
partners O +
. O +

A O +
fragment O +
containing O +
the O +
N O +
- O +
terminal O +
272 O +
amino O +
acid O +
residues O +
of O +
KRIT1 B-Gene +
, O +
a O +
region O +
lacking O +
similarity O +
to O +
any O +
known O +
protein O +
upon O +
database O +
searches O +
, O +
was O +
used O +
as O +
bait O +
. O +

From O +
parallel O +
screens O +
of O +
human O +
fetal O +
brain O +
and O +
HeLa O +
cDNA O +
libraries O +
, O +
we O +
obtained O +
multiple O +
independent O +
isolates O +
of O +
human O +
integrin B-Gene +
cytoplasmic I-Gene +
domain I-Gene +
- I-Gene +
associated I-Gene +
protein-1 I-Gene +
( O +
ICAP-1 B-Gene +
) O +
as O +
interacting O +
clones O +
. O +

The O +
interaction O +
of O +
KRIT1 B-Gene +
and O +
ICAP-1 B-Gene +
was O +
confirmed O +
by O +
GST B-Gene +
- O +
KRIT1 B-Gene +
trapping O +
of O +
endogenous O +
ICAP-1 B-Gene +
from O +
293 O -
T O +
cells O +
. O +

The O +
alpha O +
isoform O +
of O +
ICAP-1 B-Gene +
is O +
a O +
200 O +
amino O +
acid O +
serine O +
/ O +
threonine O +
- O +
rich O +
phosphoprotein O +
which O +
binds O +
the O +
cytoplasmic O +
tail O +
of O +
beta1 B-Gene +
integrins I-Gene +
. O +

We O +
show O +
that O +
mutagenesis O +
of O +
the O +
N O +
- O +
terminal O +
KRIT1 B-Gene +
NPXY O +
amino O +
acid O +
sequence O +
, O +
a O +
motif O +
critical O +
for O +
ICAP-1 B-Gene +
binding O +
to O +
beta1 B-Gene +
integrin I-Gene +
molecules O +
, O +
completely O +
abrogates O +
the O +
KRIT1 B-Gene +
/ O +
ICAP-1 B-Gene +
interaction O +
. O +

The O +
interaction O +
between O +
ICAP-1 B-Gene +
and O +
KRIT1 B-Gene +
, O +
and O +
the O +
presence O +
of O +
a O +
FERM O +
domain O +
in O +
the O +
latter O +
, O +
suggest O +
that O +
KRIT1 B-Gene +
might O +
be O +
involved O +
in O +
the O +
bidirectional O +
signaling O +
between O +
integrin B-Gene +
molecules O +
and O +
the O +
cytoskeleton O +
. O +

Furthermore O +
, O +
these O +
data O +
suggest O +
that O +
KRIT1 B-Gene +
might O +
affect O +
cell O +
adhesion O +
processes O +
via O +
integrin O +
signaling O +
in O +
CCM1 O +
pathogenesis O +
. O +

The O +
PGC-1 B-Gene +
- O +
related O +
protein O +
PERC B-Gene +
is O +
a O +
selective O +
coactivator B-Gene +
of I-Gene +
estrogen I-Gene +
receptor I-Gene +
alpha I-Gene +
. O +

Peroxisome B-Gene +
proliferator I-Gene +
- I-Gene +
activated I-Gene +
receptor I-Gene +
gamma I-Gene +
coactivator-1 I-Gene +
( O +
PGC-1 B-Gene +
) O +
is O +
a O +
tissue O +
- O +
specific O +
coactivator O +
that O +
enhances O +
the O +
activity O +
of O +
many O +
nuclear O +
receptors O +
and O +
coordinates O +
transcriptional O +
programs O +
important O +
for O +
energy O +
metabolism O +
. O +

We O +
describe O +
here O +
a O +
novel O +
PGC-1 B-Gene +
- O +
related O +
coactivator O +
that O +
is O +
expressed O +
in O +
a O +
similar O +
tissue O +
- O +
specific O +
manner O +
as O +
PGC-1 B-Gene +
, O +
with O +
the O +
highest O +
levels O +
in O +
heart O +
and O +
skeletal O +
muscle O +
. O +

In O +
contrast O +
to O +
PGC-1 B-Gene +
, O +
the O +
new O +
coactivator O +
shows O +
high O +
receptor O +
specificity O +
. O +

It O +
enhances O +
potently O +
the O +
activity O +
of O +
estrogen B-Gene +
receptor I-Gene +
( I-Gene +
ER I-Gene +
) I-Gene +
alpha I-Gene +
, O +
while O +
having O +
only O +
small O +
effects O +
on O +
other O +
receptors O +
. O +

Because O +
of O +
its O +
nuclear O +
receptor O +
selectivity O +
, O +
we O +
have O +
termed O +
the O +
new O +
protein O +
PERC B-Gene +
( O +
PGC-1 B-Gene +
related I-Gene +
Estrogen I-Gene +
Receptor I-Gene +
Coactivator I-Gene +
) O +
. O +

We O +
show O +
here O +
that O +
the O +
coactivation O +
function O +
of O +
PERC B-Gene +
relies O +
on O +
a O +
bipartite O +
transcriptional O +
activation O +
domain O +
and O +
two O +
LXXLL O +
motifs O +
that O +
interact O +
with O +
the O +
AF2 O +
domain O +
of O +
ERalpha B-Gene +
in O +
an O +
estrogen O +
- O +
dependent O +
manner O +
. O +

PERC B-Gene +
and O +
PGC-1 B-Gene +
are O +
likely O +
to O +
have O +
different O +
functions O +
in O +
ER B-Gene +
signaling O +
. O +

Whereas O +
PERC B-Gene +
acts O +
selectively O +
on O +
ERalpha B-Gene +
and O +
not O +
on O +
the O +
second O +
estrogen B-Gene +
receptor I-Gene +
ERbeta I-Gene +
, O +
PGC-1 B-Gene +
coactivates O +
strongly O +
both O +
ERs B-Gene +
. O +

Moreover O +
, O +
PERC B-Gene +
and O +
PGC-1 B-Gene +
show O +
distinct O +
preferences O +
for O +
enhancing O +
ERalpha B-Gene +
in O +
different O +
promoter O +
contexts O +
. O +

Finally O +
, O +
PERC B-Gene +
enhances O +
the O +
ERalpha B-Gene +
- O +
mediated O +
response O +
to O +
the O +
partial O +
agonist O +
tamoxifen O +
, O +
while O +
PGC-1 B-Gene +
modestly O +
represses O +
it O +
. O +

The O +
two O +
coactivators O +
are O +
likely O +
to O +
mediate O +
distinct O +
, O +
tissue O +
- O +
specific O +
responses O +
to O +
estrogens O +
. O +

Role O +
of O +
integrin B-Gene +
- I-Gene +
linked I-Gene +
kinase I-Gene +
in O +
leukocyte O +
recruitment O +
. O +

Chemokines B-Gene +
modulate O +
leukocyte O +
integrin B-Gene +
avidity O +
to O +
coordinate O +
adhesion O +
and O +
subsequent O +
transendothelial O +
migration O +
, O +
although O +
the O +
sequential O +
signaling O +
pathways O +
involved O +
remain O +
poorly O +
characterized O +
. O +

Here O +
we O +
show O +
that O +
integrin B-Gene +
- I-Gene +
linked I-Gene +
kinase I-Gene +
( O +
ILK B-Gene +
) O +
, O +
a O +
59 O +
- O +
kDa O +
serine B-Gene +
- I-Gene +
threonine I-Gene +
protein I-Gene +
kinase I-Gene +
that O +
interacts O +
principally O +
with O +
beta B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
integrins I-Gene +
, O +
is O +
highly O +
expressed O +
in O +
human O +
mononuclear O +
cells O +
and O +
is O +
activated O +
by O +
exposure O +
of O +
leukocytes O +
to O +
the O +
chemokine B-Gene +
monocyte B-Gene +
chemoattractant I-Gene +
protein-1 I-Gene +
. O +

Biochemical O +
inhibitor O +
studies O +
show O +
that O +
chemokine B-Gene +
- O +
triggered O +
activation O +
of O +
ILK B-Gene +
is O +
downstream O +
of O +
phosphoinositide B-Gene +
3-kinase I-Gene +
. O +

In O +
functional O +
assays O +
under O +
physiologically O +
relevant O +
flow O +
conditions O +
, O +
overexpression O +
of O +
wild O +
- O +
type O +
ILK B-Gene +
in O +
human O +
monocytic O +
cells O +
diminishes O +
beta B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
integrin I-Gene +
/ O +
vascular B-Gene +
cell I-Gene +
adhesion I-Gene +
molecule-1 I-Gene +
- O +
dependent O +
firm O +
adhesion O +
to O +
human O +
endothelial O +
cells O +
. O +

These O +
data O +
implicate O +
ILK B-Gene +
in O +
the O +
dynamic O +
signaling O +
events O +
involved O +
in O +
the O +
regulation O +
of O +
leukocyte O +
integrin B-Gene +
avidity O +
for O +
endothelial O +
substrates O +
. O +

Expression O +
pattern O +
and O +
further O +
characterization O +
of O +
human O +
MAGED2 B-Gene +
and O +
identification O +
of O +
rodent O +
orthologues O +
. O +

In O +
a O +
search O +
for O +
genes O +
involved O +
in O +
X O +
- O +
linked O +
mental O +
retardation O +
we O +
have O +
analyzed O +
the O +
expression O +
pattern O +
and O +
genomic O +
structure O +
of O +
human O +
MAGED2 B-Gene +
. O +

This O +
gene O +
is O +
a O +
member O +
of O +
a O +
new O +
defined O +
MAGE B-Gene -
- I-Gene -
D I-Gene +
cluster O +
in O +
Xp11.2 O +
, O +
a O +
hot O +
spot O +
for O +
X O +
- O +
linked O +
mental O +
retardation O +
. O +

Rat O +
and O +
mouse O +
orthologues O +
have O +
been O +
isolated O +
. O +

In O +
contrast O +
to O +
the O +
genes O +
of O +
the O +
MAGE B-Gene +
- I-Gene +
A I-Gene +
, O +
MAGE B-Gene +
- I-Gene +
B I-Gene +
and O +
MAGE B-Gene -
- I-Gene -
C I-Gene +
clusters O +
, O +
MAGED2 B-Gene +
is O +
expressed O +
ubiquitously O +
. O +

High O +
expression O +
was O +
detected O +
in O +
specific O +
brain O +
regions O +
and O +
in O +
the O +
interstitium O +
of O +
testes O +
. O +

Five O +
SNPs O +
in O +
the O +
coding O +
region O +
of O +
human O +
MAGED2 B-Gene +
were O +
characterized O +
and O +
their O +
allele O +
frequencies O +
determined O +
in O +
a O +
German O +
and O +
Turkish O +
population O +
. O +

Loss O +
of O +
polysialic O +
residues O +
accelerates O +
CNS O +
neural O +
precursor O +
differentiation O +
in O +
pathological O +
conditions O +
. O +

Using O +
the O +
model O +
of O +
lysolecithin O +
- O +
induced O +
demyelination O +
of O +
the O +
corpus O +
callosum O +
in O +
wild O +
- O +
type O +
, O +
NCAM B-Gene +
- O +
deficient O +
, O +
and O +
endoneuraminidase B-Gene +
- O +
injected O +
mice O +
, O +
we O +
have O +
analyzed O +
the O +
consequences O +
of O +
the O +
loss O +
of O +
expression O +
of O +
NCAM B-Gene +
or O +
PSA B-Gene +
residues O +
on O +
the O +
migration O +
and O +
proliferation O +
capacities O +
of O +
neural O +
precursors O +
of O +
the O +
subventricular O +
zone O +
( O +
SVZ O +
) O +
. O +

We O +
showed O +
that O +
the O +
absence O +
of O +
PSA B-Gene +
or O +
NCAM B-Gene +
delayed O +
migration O +
of O +
neural O +
precursors O +
to O +
the O +
olfactory O +
bulb O +
and O +
consequently O +
enhanced O +
their O +
recruitment O +
at O +
the O +
lesion O +
site O +
. O +

Moreover O +
, O +
after O +
demyelination O +
, O +
the O +
lack O +
of O +
NCAM B-Gene +
but O +
not O +
PSA B-Gene +
promoted O +
proliferation O +
in O +
the O +
SVZ O +
and O +
the O +
lesion O +
while O +
the O +
lack O +
of O +
PSA B-Gene +
favored O +
the O +
differentiation O +
of O +
the O +
traced O +
cells O +
into O +
the O +
oligodendroglial O +
fate O +
both O +
in O +
the O +
SVZ O +
and O +
in O +
the O +
lesion O +
. O +

As O +
previously O +
demonstrated O +
in O +
vitro O +
( O +
L. O +
Decker O +
et O +
al. O +
, O +
2000 O +
, O +
Mol O -
. O +
Cell O -
. O +
Neurosci O -
. O +
16 O +
, O +
422 O +
- O +
439 O +
) O +
, O +
these O +
data O +
illustrate O +
the O +
involvement O +
of O +
PSA B-Gene +
and O +
NCAM B-Gene +
in O +
neural O +
precursor O +
motility O +
and O +
differentiation O +
in O +
the O +
normal O +
and O +
injured O +
central O +
nervous O +
system O +
, O +
suggesting O +
distinct O +
roles O +
for O +
these O +
two O +
molecules O +
under O +
pathophysiological O +
conditions O +
. O +

Four O +
strains O +
of O +
spontaneously O +
hyperlipidemic O +
( O +
SHL O +
) O +
mice O +
: O +
phenotypic O +
distinctions O +
determined O +
by O +
genetic O +
backgrounds O +
. O +

Spontaneously O +
hyperlipidemic O +
( O +
SHL O +
) O +
mice O +
are O +
Japanese O +
wild O +
mice O +
( O +
KOR O +
) O +
with O +
disruption O +
of O +
the O +
apolipoprotein B-Gene +
E I-Gene +
( O +
Apo B-Gene +
E I-Gene +
) O +
gene O +
. O +

These O +
mice O +
( O +
KOR O +
- O +
Apoe B-Gene +
( O -
shl O -
) O +
) O +
are O +
superhypercholesterolemic O +
and O +
develop O +
severe O +
xanthoma O +
, O +
but O +
their O +
atherosclerosis O +
is O +
relatively O +
mild O +
compared O +
with O +
Apo B-Gene +
E I-Gene +
knockout O +
mice O +
. O +

First O +
, O +
we O +
tested O +
whether O +
this O +
distinction O +
is O +
due O +
to O +
additional O +
mutation O +
of O +
the O +
Apoc1 B-Gene +
and/or O +
Apoc2 B-Gene +
genes O +
in O +
KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
. O +

Southern O +
blot O +
analysis O +
, O +
but O +
found O +
no O +
gross O +
disruption O +
of O +
these O +
genes O +
. O +

Next O +
, O +
we O +
tested O +
whether O +
the O +
phenotypic O +
distinction O +
is O +
due O +
to O +
differences O +
in O +
the O +
genetic O +
background O +
. O +

To O +
this O +
end O +
, O +
we O +
established O +
three O +
lines O +
of O +
congenic O +
SHL O +
mice O +
with O +
a O +
genetic O +
background O +
of O +
C57BL O -
/ O -
6 O +
, O +
BALB O -
/ O -
c O +
or O +
C3H O +
/ O +
He O +
, O +
and O +
named O +
them O +
, O +
respectively O +
, O +
C57BL O -
/ O -
6.KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
( O +
B6.KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
) O +
, O +
BALB O +
/ O +
c O -
. O -
KOR O +
- O +
Apoe B-Gene +
( O -
shl O -
) O +
( O +
C.KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
) O +
and O +
C3H O +
/ O +
He O -
. O -
KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
( O +
C3.KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
) O +
. O +

Hypercholesterolemia O +
was O +
most O +
severe O +
in O +
KOR O +
- O +
Apoe B-Gene +
( O -
shl O -
) O +
followed O +
the O +
by O +
others O +
as O +
follows O +
; O +
KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
> O +
> O +
C3.KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
> O +
C.KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
> O +
B6.KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
. O +

In O +
contrast O +
, O +
atherosclerosis O +
was O +
most O +
severe O +
in O +
B6.KOR O +
Apoe B-Gene +
( O +
shl O +
) O +
followed O +
by O +
the O +
others O +
: O +
B6.KOR O +
- O +
Apoe B-Gene +
( O -
shl O -
) O +
> O +
C.KOR O +
- O +
Apoe B-Gene +
( O -
shl O -
) O +
> O -
> O +
C3.KOR O +
- O +
Apoe B-Gene +
( O -
shl O -
) O +
> O +
or O +
= O +
KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
. O +

This O +
order O +
, O +
however O +
, O +
did O +
not O +
match O +
that O +
in O +
xanthoma O +
, O +
which O +
was O +
highly O +
prominent O +
in O +
KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
but O +
mild O +
in O +
B6.KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
, O +
C.KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
and O +
C3.KORApoe O +
( O +
shl O +
) O +
. O +

This O +
order O +
, O +
however O +
, O +
did O +
not O +
match O +
that O +
in O +
xanthoma O +
, O +
which O +
was O +
highly O +
prominant O +
in O +
KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
but O +
mild O +
in O +
B6.KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
, O +
C.KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
and O +
C3.KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
. O +

These O +
distinctions O +
suggest O +
that O +
the O +
severity O +
of O +
each O +
of O +
the O +
phenotypes O +
is O +
determined O +
by O +
distinct O +
genetic O +
backgrounds O +
which O +
probably O +
are O +
composed O +
of O +
polymorphism O +
of O +
lipid O +
metabolism O +
- O +
related O +
proteins O +
. O +

We O +
found O +
that O +
apolipoprotein B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
is O +
decreased O +
in O +
each O +
SHL O +
strain O +
and O +
polymorphic O +
between O +
B6.KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
and O +
the O +
other O +
strains O +
examined O +
. O +

This O +
polymorphism O +
may O +
be O +
related O +
to O +
the O +
most O +
severe O +
atherosclerosis O +
observed O +
in O +
B6.KOR O +
- O +
Apoe B-Gene +
( O +
shl O +
) O +
. O +

It O +
is O +
most O +
likely O +
that O +
combination O +
of O +
such O +
polymorphisms O +
is O +
due O +
to O +
the O +
genetic O +
background O +
accountable O +
for O +
phenotype O +
distinctions O +
. O +

Characterization O +
of O +
a O +
feline O +
homologue O +
of O +
the O +
alphaE B-Gene +
integrin I-Gene +
subunit O +
( O +
CD103 B-Gene +
) O +
reveals O +
high O +
specificity O +
for O +
intra O +
- O +
epithelial O +
lymphocytes O +
. O +

The O +
characteristics O +
of O +
a O +
feline O +
homologue O +
of O +
the O +
alphaE B-Gene +
integrin I-Gene +
( O +
CD103 B-Gene +
) O +
, O +
defined O +
by O +
two O +
murine O +
monoclonal O +
antibodies O +
, O +
Fe7.1B8 O +
( O +
IgG1 B-Gene +
) O +
and O +
Fe7.2D8 O +
( O +
IgG1 B-Gene +
) O +
, O +
are O +
described O +
. O +

These O +
antibodies O +
recognized O +
75 O +
% O +
of O +
intra O +
- O +
epithelial O +
( O +
range O +
59 O +
- O +
88 O +
% O +
) O +
and O +
40 O +
% O +
of O +
lamina O +
proprial O +
( O +
range O +
28 O +
- O +
46 O +
% O +
) O +
T O +
cells O +
of O +
the O +
intestinal O +
mucosal O +
tissue O +
of O +
the O +
small O +
intestine O +
in O +
contrast O +
with O +
approximately O +
2 O +
% O +
of O +
peripheral O +
blood O +
lymphocytes O +
. O +

Both O +
antibodies O +
immunoprecipitated O +
a O +
180 O +
kDa O +
protein O +
from O +
biotinylated O +
feline O +
intra O +
- O +
epithelial O +
mucosal O +
leukocytes O +
consistent O +
with O +
the O +
alphaE B-Gene +
integrin I-Gene +
subunit O +
in O +
conjunction O +
with O +
a O +
120 O +
kDa O +
protein O +
consistent O +
with O +
the O +
beta7 B-Gene +
subunit O +
. O +

The O +
nucleotide O +
sequence O +
of O +
feline O +
alphaE B-Gene +
integrin I-Gene +
, O +
generated O +
from O +
molecular O +
cloning O +
of O +
the O +
feline O +
alphaE B-Gene +
encoding O +
cDNA O +
, O +
is O +
also O +
reported O +
. O +

This O +
feline O +
molecule O +
shares O +
72 O +
% O +
sequence O +
homology O +
with O +
human O +
and O +
69 O +
% O +
homology O +
with O +
murine O +
and O +
rat O +
counterparts O +
. O +

Homology O +
includes O +
the O +
presence O +
of O +
an O +
X O +
( O +
extra O +
) O +
domain O +
, O +
that O +
appears O +
unique O +
to O +
alphaE B-Gene +
molecules O +
as O +
described O +
for O +
human O +
, O +
rat O +
and O +
mouse O +
, O +
as O +
well O +
as O +
areas O +
of O +
homology O +
common O +
to O +
other O +
alpha B-Gene +
integrins I-Gene +
. O +

Of O +
note O +
is O +
a O +
typical O +
I O +
( O +
inserted O +
) O +
domain O +
, O +
the O +
presence O +
of O +
seven O +
repeat O +
regions O +
, O +
and O +
highly O +
conserved O +
sequences O +
in O +
the O +
cytoplasmic O +
tail O +
. O +

Transfection O +
studies O +
demonstrated O +
that O +
both O +
antibodies O +
recognized O +
an O +
extracellular O +
component O +
which O +
encompassed O +
the O +
X O +
and O +
I O +
domains O +
of O +
the O +
cloned O +
alphaE B-Gene +
integrin I-Gene +
subunit O +
. O +

These O +
studies O +
demonstrate O +
that O +
the O +
pattern O +
of O +
tissue O +
distribution O +
, O +
biochemical O +
characteristics O +
, O +
and O +
cDNA O +
sequence O +
of O +
the O +
feline O +
alphaE B-Gene +
integrin I-Gene +
subunit O +
are O +
largely O +
similar O +
to O +
that O +
described O +
for O +
other O +
species O +
. O +

Macrovascular O +
disease O +
risk O +
factors O +
and O +
insulin B-Gene +
resistance O +
in O +
Aboriginal O +
and O +
Torres O +
Strait O +
Islander O +
people O +
. O +

It O +
has O +
been O +
proposed O +
that O +
insulin B-Gene +
resistance O +
( O +
IR O +
) O +
underlies O +
a O +
cluster O +
of O +
cardiovascular O +
disease O +
( O +
CVD O +
) O +
risk O +
factors O +
constituting O +
a O +
" O +
metabolic O +
syndrome O -
. O +
" O +

CVD O +
is O +
a O +
leading O +
cause O +
of O +
premature O +
mortality O +
among O +
indigenous O +
Australians O +
. O +

In O +
a O +
group O +
of O +
younger O +
( O +
15 O +
- O +
44 O +
years O +
, O +
fasting O +
glucose O +
< O +
7.8 O +
mmol O +
/ O +
l O +
) O +
Aboriginal O +
( O +
n O +
= O +
643 O +
) O +
and O +
Torres O +
Strait O +
Islander O +
( O +
n O +
= O +
220 O +
) O +
people O +
participating O +
in O +
community O +
- O +
based O +
risk O +
factor O +
surveys O +
, O +
we O +
identified O +
high O +
prevalences O +
of O +
metabolic O +
syndrome O +
components O +
: O +
glucose O +
intolerance O +
, O +
dyslipidaemia O +
, O +
hypertension O +
, O +
and O +
IR O +
. O +

There O +
were O +
inconsistent O +
associations O +
of O +
IR O +
with O +
other O +
risk O +
factors O +
, O +
and O +
the O +
data O +
do O +
not O +
support O +
a O +
direct O +
causal O +
relationship O +
between O +
insulin B-Gene +
and O +
other O +
metabolic O +
variables O +
. O +

Rather O +
, O +
metabolic O +
syndrome O +
components O +
may O +
arise O +
from O +
social O +
and O +
environmental O +
factors O +
interacting O +
with O +
behavioural O +
and O +
biochemical O +
factors O +
in O +
individuals O +
. O +

Specific O +
identification O +
of O +
three O +
low O +
molecular O +
weight O +
membrane O +
- O +
associated O +
antigens O +
of O +
Helicobacter O +
pylori O +
. O +

BACKGROUND O +
: O +

A O +
large O +
number O +
of O +
Helicobacter O +
pylori O +
proteins O +
are O +
antigenic O +
, O +
but O +
antibodies O +
to O +
these O +
proteins O +
persist O +
in O +
spite O +
of O +
the O +
eradication O +
of O +
the O +
infection O +
. O +

METHODS O +
AND O +
RESULTS O +
: O +

The O +
analysis O +
of O +
sera O +
from O +
H. O +
pylori O +
- O +
infected O +
and O +
non O +
- O +
infected O +
patients O +
, O +
before O +
and O +
3 O +
and O +
5 O +
months O +
after O +
eradication O +
, O +
showed O +
that O +
the O +
antibody O +
response O +
against O +
unknown O +
H. O +
pylori O +
antigens O +
at O +
32 O +
, O +
30 O +
, O +
22 O +
and O +
14 O +
kDa O +
in O +
sodium O +
dodecylsulphate O +
polyacrylamide O +
gel O +
electrophoresis O +
decreased O +
by O +
> O +
or O +
= O +
60 O +
% O +
at O +
3 O +
months O +
and O +
> O +
or O +
= O +
70 O +
% O +
at O +
5 O +
months O +
after O +
treatment O +
. O +

Two O +
- O +
dimensional O +
gel O +
electrophoresis O +
and O +
mass O +
spectrometry O +
allowed O +
the O +
identification O +
of O +
eight O +
proteins O +
at O +
these O +
positions O +
: O +
neuraminyl O +
- O +
lactose O +
- O +
binding O +
haemagglutinin B-Gene +
precursor O +
, O +
3-oxoadipate B-Gene +
CoA I-Gene -
- I-Gene -
transferase I-Gene +
subunit I-Gene +
A I-Gene +
, O +
elongation B-Gene +
factor I-Gene +
P I-Gene +
, O +
peptidoglycan B-Gene +
- I-Gene +
associated I-Gene +
lipoprotein I-Gene +
precursor O +
, O +
hypothetical O +
protein O +
HP0596 B-Gene +
, O +
adhesin B-Gene +
- I-Gene +
thiol I-Gene +
peroxidase I-Gene +
, O +
50S B-Gene +
ribosomal I-Gene +
protein I-Gene +
L7 I-Gene +
/ I-Gene +
L12 I-Gene +
and O +
subunit O +
b B-Gene -
' I-Gene +
of I-Gene +
the I-Gene +
F I-Gene -
( I-Gene -
0 I-Gene -
) I-Gene +
ATP I-Gene +
synthase I-Gene +
. O +

Three O +
of O +
these O +
eight O +
, O +
expressed O +
as O +
recombinant O +
proteins O +
( O +
32 O +
kDa O +
neuraminyl O +
- O +
lactose O +
- O +
binding O +
haemagglutinin B-Gene +
precursor O +
, O +
30 O +
kDa O +
peptidoglycan B-Gene +
- I-Gene +
associated I-Gene +
lipoprotein I-Gene +
precursor O +
and O +
22 O +
kDa O +
hypothetical O +
protein O +
HP0596 B-Gene +
) O +
, O +
reacted O +
specifically O +
with O +
sera O +
from O +
infected O +
patients O +
, O +
while O +
the O +
14 O +
kDa O +
50S B-Gene +
ribosomal I-Gene +
protein I-Gene +
L7 I-Gene +
/ I-Gene +
L12 I-Gene +
cross O +
- O +
reacted O +
with O +
one O +
out O +
of O +
five O +
sera O +
from O +
H. O +
pylori O +
- O +
negative O +
patients O +
. O +

The O +
other O +
recombinant O +
proteins O +
did O +
not O +
show O +
significant O +
immunoreactivity O +
. O +

CONCLUSIONS O +
: O +

Four O +
low O +
molecular O +
weight O +
antigens O +
were O +
identified O +
by O +
these O +
methods O +
, O +
three O +
of O +
which O +
were O +
specific O +
. O +

Immunoreaction O +
with O +
these O +
three O +
proteins O +
( O +
neuraminyl O +
- O +
lactose O +
- O +
binding O +
haemagglutinin B-Gene +
precursor O +
, O +
peptidoglycan B-Gene +
- I-Gene +
associated I-Gene +
lipoprotein I-Gene +
precursor O +
and O +
hypothetical O +
protein O +
HP0596 B-Gene +
) O +
could O +
provide O +
a O +
serological O +
assessment O +
not O +
only O +
of O +
H. O +
pylori O +
infection O +
, O +
but O +
also O +
of O +
eradication O +
. O +

Effect O +
of O +
nonoxynol-9 O +
gel O +
on O +
urogenital O +
gonorrhea O +
and O +
chlamydial O +
infection O +
: O +
a O +
randomized O +
controlled O +
trial O +
. O +

CONTEXT O +
: O +

Nonoxynol-9 O +
has O +
been O +
suggested O +
as O +
a O +
vaginal O +
microbicide O +
to O +
protect O +
against O +
common O +
sexually O +
transmitted O +
infections O +
. O +

OBJECTIVE O +
: O +

To O +
compare O +
nonoxynol-9 O +
gel O +
and O +
condom O +
use O +
( O +
gel O +
group O +
) O +
vs O +
condom O +
use O +
alone O +
( O +
condom O +
group O +
) O +
for O +
the O +
prevention O +
of O +
male O +
- O +
to O +
- O +
female O +
transmission O +
of O +
urogenital O +
gonococcal O +
and O +
chlamydial O +
infection O +
. O +

DESIGN O +
AND O +
SETTING O +
: O +

Randomized O +
controlled O +
trial O +
conducted O +
at O +
10 O +
community O +
clinics O +
and O +
10 O +
pharmacies O +
in O +
YaoundÃ?Â O -
© O +
, O +
Cameroon O +
, O +
between O +
October O +
1998 O +
and O +
September O +
2000 O +
, O +
with O +
6 O +
months O +
of O +
follow O -
- O -
up O +
. O +

PARTICIPANTS O +
: O +

High O +
- O +
risk O +
population O +
of O +
1251 O +
women O +
( O +
excluding O +
sex O +
workers O +
) O +
being O +
treated O +
for O +
or O +
who O +
had O +
symptoms O +
of O +
sexually O +
transmitted O +
infections O +
. O +

Three O +
were O +
excluded O +
from O +
the O +
gel O +
group O +
( O +
0.5 O +
% O +
) O +
and O +
7 O +
from O +
the O +
condom O +
group O +
( O +
1 O +
% O +
) O +
because O +
of O +
no O +
follow O +
- O +
up O +
data O +
. O +

INTERVENTIONS O +
: O +

Nonoxynol-9 O +
gel O +
( O +
100 O +
mg O +
) O +
and O +
condoms O +
or O +
condoms O +
only O +
. O +

MAIN O +
OUTCOME O +
MEASURE O +
: O +

A O +
positive O +
test O +
result O +
for O +
gonococcal O +
or O +
chlamydial O +
infection O +
by O +
the O +
ligase O +
chain O +
reaction O +
assay O +
; O +
secondary O +
outcome O +
measure O +
was O +
a O +
positive O +
test O +
result O +
for O +
human O +
immunodeficiency O +
virus O +
( O +
HIV O +
) O +
. O +

RESULTS O +
: O +

The O +
rate O +
ratio O +
( O +
RR O +
) O +
for O +
new O +
urogenital O +
infections O +
was O +
1.2 O +
for O +
the O +
gel O +
group O +
vs O +
condom O +
group O +
( O +
95 O +
% O +
confidence O +
interval O +
[ O +
CI O +
] O +
, O +
0.9 O +
- O +
1.6 O +
; O +
P O +
= O +
.21 O +
) O +
. O +

The O +
gel O +
group O +
had O +
116 O +
diagnosed O +
gonococcal O +
infections O +
, O +
chlamydial O +
infections O +
, O +
or O +
both O +
for O +
a O +
rate O +
of O +
43.6 O +
per O +
100 O +
person O +
- O +
years O +
, O +
and O +
the O +
condom O +
group O +
had O +
100 O +
infections O +
for O +
a O +
rate O +
of O +
36.6 O +
per O +
100 O +
person O +
- O +
years O +
. O +

The O +
RR O +
for O +
gonococcal O +
infection O +
in O +
the O +
gel O +
group O +
vs O +
the O +
condom O +
group O +
was O +
1.5 O +
( O +
95 O +
% O +
CI O +
, O +
1.0 O +
- O +
2.3 O +
) O +
and O +
for O +
chlamydial O +
infection O +
was O +
1.0 O +
( O +
95 O +
% O +
CI O +
, O +
0.7 O +
- O +
1.4 O +
) O +
. O +

There O +
were O +
5 O +
new O +
cases O +
of O +
HIV O +
infections O +
in O +
the O +
gel O +
group O +
and O +
4 O +
in O +
the O +
condom O +
group O +
. O +

Three O +
women O +
in O +
each O +
group O +
became O +
pregnant O +
during O +
the O +
study O +
. O +

CONCLUSION O +
: O +

Nonoxynol-9 O +
gel O +
did O +
not O +
protect O +
against O +
urogenital O +
gonococcal O +
or O +
chlamydial O +
infection O +
. O +

RasGRP4 B-Gene +
is O +
a O +
novel O +
Ras B-Gene +
activator O +
isolated O +
from O +
acute O +
myeloid O +
leukemia O +
. O +

Although O +
a O +
number O +
of O +
genetic O +
defects O +
are O +
commonly O +
associated O +
with O +
acute O +
myeloid O +
leukemia O +
( O +
AML O +
) O +
, O +
a O +
large O +
percentage O +
of O +
AML O +
cases O +
are O +
cytogenetically O +
normal O +
. O +

This O +
suggests O +
a O +
functional O +
screen O +
for O +
transforming O +
genes O +
is O +
required O +
to O +
identify O +
genetic O +
mutations O +
that O +
are O +
missed O +
by O +
cytogenetic O +
analyses O +
. O +

We O +
utilized O +
a O +
retrovirus O +
- O +
based O +
cDNA O +
expression O +
system O +
to O +
identify O +
transforming O +
genes O +
expressed O +
in O +
cytogenetically O +
normal O +
AML O +
patients O +
. O +

We O +
identified O +
a O +
new O +
member O +
of O +
the O +
Ras B-Gene +
guanyl I-Gene +
nucleotide I-Gene +
- I-Gene +
releasing I-Gene +
protein I-Gene +
( I-Gene +
RasGRP I-Gene +
) I-Gene +
family I-Gene +
of O +
Ras B-Gene +
guanine I-Gene +
nucleotide I-Gene +
exchange I-Gene +
factors I-Gene +
, O +
designating O +
it O +
RasGRP4 B-Gene +
. O +

Subsequently O +
, O +
cDNA O +
sequences O +
encoding O +
rodent O +
and O +
human O +
RasGRP4 B-Gene +
proteins O +
were O +
deposited O +
in O +
GenBank O +
. O +

RasGRP4 B-Gene +
contains O +
the O +
same O +
protein O +
domain O +
structure O +
as O +
other O +
members O +
of O +
the O +
RasGRP B-Gene +
family I-Gene +
, O +
including O +
a O +
Ras B-Gene +
exchange O +
motif O +
, O +
a O +
CDC25 B-Gene +
homology O +
domain O +
, O +
a O +
C1 O +
/ O +
diacyglycerol O +
- O +
binding O +
domain O +
, O +
and O +
putative O +
calcium O +
- O +
binding O +
EF O +
hands O +
. O +

We O +
show O +
that O +
expression O +
of O +
RasGRP4 B-Gene +
induces O +
anchorage O +
- O +
independent O +
growth O +
of O +
Rat1 O +
fibroblasts O +
. O +

RasGRP4 B-Gene +
is O +
a O +
Ras B-Gene +
- O +
specific O +
activator O +
and O +
, O +
interestingly O +
, O +
is O +
highly O +
expressed O +
in O +
peripheral O +
blood O +
leukocytes O +
and O +
myeloid O +
cell O +
lines O +
. O +

Unlike O +
other O +
RasGRP B-Gene +
proteins O +
, O +
RasGRP4 B-Gene +
is O +
not O +
expressed O +
in O +
the O +
brain O +
or O +
in O +
lymphoid O +
cells O +
. O +

We O +
demonstrated O +
that O +
32D O +
myeloid O +
cells O +
expressing O +
RasGRP4 B-Gene +
have O +
elevated O +
levels O +
of O +
activated O +
Ras B-Gene +
compared O +
with O +
control O +
cells O +
, O +
and O +
phorbol O +
12-myristate O +
13-acetate O +
( O +
PMA O +
) O +
treatment O +
greatly O +
enhanced O +
Ras B-Gene +
activation O +
. O +

PMA O +
induced O +
membrane O +
localization O +
of O +
RasGRP4 B-Gene +
and O +
32D O +
cells O +
expressing O +
RasGRP4 B-Gene +
were O +
capable O +
of O +
cytokine B-Gene +
- O +
independent O +
proliferation O +
in O +
the O +
presence O +
of O +
PMA O +
. O +

We O +
conclude O +
that O +
RasGRP4 B-Gene +
is O +
a O +
member O +
of O +
the O +
RasGRP B-Gene +
family I-Gene +
of O +
Ras B-Gene +
guanine I-Gene +
nucleotide I-Gene +
exchange I-Gene +
factors I-Gene +
that O +
may O +
play O +
a O +
role O +
in O +
myeloid O +
cell O +
signaling O +
growth O +
regulation O +
pathways O +
that O +
are O +
responsive O +
to O +
diacylglycerol O +
levels O +
. O +

Partial O +
characterization O +
of O +
a O +
cerebral O +
thyroid B-Gene +
hormone I-Gene +
- I-Gene +
responsive I-Gene +
protein I-Gene +
. O +

The O +
thyroid B-Gene +
hormone I-Gene +
- I-Gene +
responsive I-Gene +
protein I-Gene +
( O +
THRP B-Gene +
) O +
is O +
expressed O +
in O +
rat O +
cerebral O +
tissue O +
and O +
has O +
83 O +
% O +
overall O +
sequence O +
homology O +
with O +
c B-Gene +
- I-Gene +
Abl I-Gene +
interactor I-Gene +
protein I-Gene +
, O +
Abi-2 B-Gene +
, O +
which O +
is O +
a O +
substrate O +
for O +
the O +
tyrosine B-Gene +
kinase I-Gene +
activity O +
of O +
c B-Gene -
- I-Gene -
Abl I-Gene +
. O +

Within O +
the O +
core O +
region O +
of O +
the O +
two O +
proteins O +
, O +
the O +
sequence O +
similarity O +
approaches O +
99 O +
% O +
. O +

To O +
determine O +
whether O +
THRP B-Gene +
is O +
a O +
rat O +
homologue O +
of O +
Abi-2 B-Gene +
or O +
is O +
a O +
distinct O +
protein O +
with O +
unique O +
properties O +
, O +
the O +
tissue O +
distribution O +
of O +
THRP B-Gene +
and O +
Abi B-Gene +
- I-Gene +
2 I-Gene +
mRNA O -
's O +
was O +
examined O +
using O +
a O +
sensitive O +
ribonuclease B-Gene +
protection O +
assay O +
and O +
probes O +
specific O +
for O +
THRP B-Gene +
and O +
Abi B-Gene +
- I-Gene +
2 I-Gene +
, O +
respectively O +
. O +

The O +
THRP B-Gene +
mRNA O +
content O +
of O +
cerebral O +
tissue O +
( O +
1340.0 O +
+ O -
/- O +
126.5 O +
arbitrary O +
units O +
) O +
was O +
2.3 O +
- O +
fold O +
higher O +
than O +
Abi B-Gene +
- I-Gene +
2 I-Gene +
mRNA O +
( O +
581.3 O +
+ O +
/ O +
- O +
73.7 O +
) O +
, O +
while O +
the O +
ratio O +
of O +
hepatic O +
content O +
of O +
THRP B-Gene +
mRNA O +
( O +
209.0 O +
+ O +
/ O +
- O +
49.1 O +
) O +
to O +
hepatic O +
Abi-2 B-Gene +
mRNA O +
( O +
2923.0 O +
+ O +
/ O +
- O +
378.7 O +
) O +
was O +
only O +
0.07 O +
( O +
P O +
< O +
0.004 O +
) O +
. O +

Very O +
low O +
levels O +
of O +
Abi-2 B-Gene +
mRNA O +
, O +
but O +
not O +
THRP B-Gene +
mRNA O +
, O +
were O +
also O +
found O +
in O +
the O +
heart O +
and O +
small O +
intestine O +
. O +

Experiments O +
with O +
PC12 O +
cells O +
transfected O +
with O +
the O +
full O +
- O +
length O +
THRP B-Gene +
cDNA O +
and O +
grown O +
in O +
the O +
presence O +
or O +
absence O +
of O +
a O +
tyrosine B-Gene +
kinase I-Gene +
inhibitor O +
, O +
along O +
with O +
experiments O +
where O +
PC12 O +
cells O +
were O +
cotransfected O +
with O +
the O +
THRP B-Gene +
cDNA O +
with O +
or O +
without O +
the O +
wild O +
- O +
type O +
or O +
mutant O +
( O +
tyrosine B-Gene +
kinase I-Gene +
deficient O +
) O +
c B-Gene +
- I-Gene +
Abl I-Gene +
cDNA O +
, O +
showed O +
that O +
THRP B-Gene +
is O +
tyrosine O +
phosphorylated O +
; O +
however O +
, O +
it O +
is O +
not O +
a O +
substrate O +
for O +
c B-Gene -
- I-Gene -
Abl I-Gene +
. O +

These O +
studies O +
demonstrate O +
that O +
THRP B-Gene +
and O +
Abi-2 B-Gene +
have O +
distinct O +
tissue O +
distribution O +
and O +
distinct O +
biological O +
properties O +
. O +

A O +
novel O +
negative O +
regulatory O +
element O +
in O +
the O +
human O +
collagenase-3 B-Gene +
proximal O +
promoter O +
region O +
. O +

We O +
have O +
identified O +
in O +
the O +
human O +
collagenase-3 B-Gene +
promoter O +
a O +
novel O +
negative O +
regulatory O +
element O +
, O +
GAAAAGAAAAAG O +
, O +
designated O +
AGRE O +
( O +
AG O +
- O +
Rich O +
Element O +
) O +
. O +

The O +
AGRE O +
site O +
functionality O +
was O +
characterized O +
in O +
human O +
osteoarthritic O +
( O +
OA O +
) O +
chondrocytes O +
as O +
well O +
as O +
four O +
cell O +
lines O +
. O +

The O +
cells O +
were O +
transfected O +
with O +
a O +
plasmid O +
consisting O +
of O +
the O +
first O +
133 O +
bp O +
of O +
the O +
collagenase-3 B-Gene +
promoter O +
and O +
its O +
AGRE O +
mutated O +
or O +
deleted O +
derivatives O +
. O +

The O +
absence O +
of O +
a O +
functional O +
AGRE B-Gene +
site O +
resulted O +
in O +
a O +
statistically O +
significant O +
increase O +
of O +
the O +
collagenase-3 B-Gene +
basal O +
transcription O +
that O +
was O +
not O +
affected O +
by O +
the O +
collagenase-3 B-Gene +
inducers O +
IL-1beta B-Gene +
and O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
. O +

Two O +
specific O +
protein O +
- O +
AGRE O +
binding O +
complexes O +
were O +
detected O +
by O +
EMSA O +
, O +
and O +
their O +
presence O +
depended O +
on O +
the O +
physiological O +
state O +
of O +
the O +
cell O +
. O +

Indeed O +
, O +
normal O +
chondrocytes O +
and O +
synovial O +
fibroblasts O +
and O +
the O +
four O +
cell O +
lines O +
showed O +
only O +
a O +
slower O +
- O +
migrating O +
complex O +
( O +
complex O +
1 O +
) O +
. O +

In O +
OA O +
chondrocytes O +
, O +
the O +
type O +
of O +
complex O +
discriminated O +
two O +
groups O -
-- O -
the O +
low O +
- O +
OA O +
chondrocytes O +
, O +
showing O +
low O +
collagenase B-Gene +
- I-Gene +
3 I-Gene +
basal O +
levels O +
and O +
high O +
inducibility O +
of O +
IL-1beta B-Gene +
stimulation O +
( O +
complex O +
1 O +
) O +
, O +
and O +
the O +
high O +
- O +
OA O +
chondrocytes O +
with O +
high O +
collagenase B-Gene +
- I-Gene +
3 I-Gene +
basal O +
levels O +
and O +
low O +
IL-1beta B-Gene +
inducibility O +
( O +
a O +
faster O +
- O +
migrating O +
complex O +
, O +
designated O +
complex O +
2 O +
) O +
. O +

UV O +
cross O +
- O +
linking O +
revealed O +
the O +
presence O +
of O +
48 O +
and O +
97 O +
kDa O +
proteins O +
in O +
complex O +
1 O +
and O +
27 O +
, O +
35 O +
, O +
and O +
73 O +
kDa O +
proteins O +
in O +
complex O +
2 O +
. O +

These O +
findings O +
suggest O +
that O +
the O +
AGRE O +
site O +
plays O +
a O +
rate O +
- O +
limiting O +
role O +
in O +
human O +
collagenase-3 B-Gene +
production O +
. O +

Production O +
and O +
characterization O +
of O +
bifunctional O +
enzymes O +
. O +

Domain O +
swapping O +
to O +
produce O +
new O +
bifunctional O +
enzymes O +
in O +
the O +
aspartate O +
pathway O +
. O +

The O +
bifunctional O +
enzyme O +
aspartokinase B-Gene +
- I-Gene +
homoserine I-Gene +
dehydrogenase I-Gene +
I I-Gene +
from O +
Escherichia O +
coli O +
catalyzes O +
non O +
- O +
consecutive O +
reactions O +
in O +
the O +
aspartate O +
pathway O +
of O +
amino O +
acid O +
biosynthesis O +
. O +

Both O +
catalytic O +
activities O +
are O +
subject O +
to O +
allosteric O +
regulation O +
by O +
the O +
end O +
product O +
amino O +
acid O +
L O -
- O -
threonine O +
. O +

To O +
examine O +
the O +
kinetics O +
and O +
regulation O +
of O +
the O +
enzymes O +
in O +
this O +
pathway O +
, O +
each O +
of O +
these O +
catalytic O +
domains O +
were O +
separately O +
expressed O +
and O +
purified O +
. O +

The O +
separated O +
catalytic O +
domains O +
remain O +
active O +
, O +
with O +
each O +
of O +
their O +
catalytic O +
activities O +
enhanced O +
in O +
comparison O +
to O +
the O +
native O +
enzyme O +
. O +

The O +
allosteric O +
regulation O +
of O +
the O +
kinase B-Gene +
activity O +
is O +
lost O +
, O +
and O +
regulation O +
of O +
the O +
dehydrogenase B-Gene +
activity O +
is O +
dramatically O +
decreased O +
in O +
these O +
separate O +
domains O +
. O +

To O +
create O +
a O +
new O +
bifunctional O +
enzyme O +
that O +
can O +
catalyze O +
consecutive O +
metabolic O +
reactions O +
, O +
the O +
aspartokinase B-Gene +
I I-Gene +
domain O +
was O +
fused O +
to O +
the O +
enzyme O +
that O +
catalyzes O +
the O +
intervening O +
reaction O +
in O +
the O +
pathway O +
, O +
aspartate B-Gene +
semialdehyde I-Gene +
dehydrogenase I-Gene +
. O +

A O +
hybrid O +
bifunctional O +
enzyme O +
was O +
also O +
created O +
between O +
the O +
native O +
monofunctional O +
aspartokinase B-Gene +
III I-Gene +
, O +
an O +
allosteric O +
enzyme O +
regulated O +
by O +
lysine O +
, O +
and O +
the O +
catalytic O +
domain O +
of O +
homoserine B-Gene +
dehydrogenase I-Gene +
I I-Gene +
with O +
its O +
regulatory O +
interface O +
domain O +
still O +
attached O +
. O +

In O +
this O +
hybrid O +
the O +
kinase B-Gene +
activity O +
remains O +
sensitive O +
to O +
lysine O +
, O +
while O +
the O +
dehydrogenase B-Gene +
activity O +
is O +
now O +
regulated O +
by O +
both O +
threonine O +
and O +
lysine O +
. O +

The O +
dehydrogenase B-Gene +
domain O +
is O +
less O +
thermally O +
stable O +
than O +
the O +
kinase B-Gene +
domain O +
and O +
becomes O +
further O +
destabilized O +
upon O +
removal O +
of O +
the O +
regulatory O +
domain O +
. O +

The O +
more O +
stable O +
aspartokinase B-Gene +
III I-Gene +
is O +
further O +
stabilized O +
against O +
thermal O +
denaturation O +
in O +
the O +
hybrid O +
bifunctional O +
enzyme O +
and O +
was O +
found O +
to O +
retain O +
some O +
catalytic O +
activity O +
even O +
at O +
temperatures O +
approaching O +
100 O +
degrees O +
C O +
. O +

Production O +
and O +
characterization O +
of O +
bifunctional O +
enzymes O +
. O +

Substrate O +
channeling O +
in O +
the O +
aspartate O +
pathway O +
. O +

The O +
direct O +
channeling O +
of O +
an O +
intermediate O +
between O +
enzymes O +
that O +
catalyze O +
consecutive O +
reactions O +
in O +
a O +
pathway O +
offers O +
the O +
possibility O +
of O +
an O +
efficient O +
, O +
exclusive O +
, O +
and O +
protected O +
means O +
of O +
metabolite O +
delivery O +
. O +

Aspartokinase B-Gene +
- I-Gene +
homoserine I-Gene +
dehydrogenase I-Gene +
I I-Gene +
( O +
AK B-Gene -
- I-Gene -
HDH I-Gene +
I I-Gene +
) O +
from O +
Escherichia O +
coli O +
is O +
an O +
unusual O +
bifunctional O +
enzyme O +
in O +
that O +
it O +
does O +
not O +
catalyze O +
consecutive O +
reactions O +
. O +

The O +
potential O +
channeling O +
of O +
the O +
intermediate O +
beta B-Gene -
- I-Gene -
aspartyl I-Gene +
phosphate I-Gene +
between O +
the O +
aspartokinase B-Gene +
of O +
this O +
bifunctional O +
enzyme O +
and O +
aspartate B-Gene +
semialdehyde I-Gene +
dehydrogenase I-Gene +
( O +
ASADH B-Gene +
) O +
, O +
the O +
enzyme O +
that O +
catalyzes O +
the O +
intervening O +
reaction O +
, O +
has O +
been O +
examined O +
. O +

The O +
introduction O +
of O +
increasing O +
levels O +
of O +
inactivated O +
ASADH B-Gene +
has O +
been O +
shown O +
to O +
compete O +
against O +
enzyme O +
- O +
enzyme O +
interactions O +
and O +
direct O +
intermediate O +
channeling O +
, O +
leading O +
to O +
a O +
decrease O +
in O +
the O +
overall O +
reaction O +
flux O +
through O +
these O +
consecutive O +
enzymes O +
. O +

These O +
same O +
results O +
are O +
obtained O +
whether O +
these O +
experiments O +
are O +
conducted O +
with O +
aspartokinase B-Gene +
III I-Gene +
, O +
a O +
naturally O +
occurring O +
monofunctional O +
isozyme O +
, O +
with O +
an O +
artificially O +
produced O +
monofunctional O +
aspartokinase B-Gene +
I I-Gene +
, O +
or O +
with O +
a O +
fusion O +
construct O +
of O +
AK B-Gene +
I I-Gene +
- O +
ASADH B-Gene +
. O +

These O +
results O +
provide O +
definitive O +
evidence O +
for O +
the O +
channeling O +
of O +
beta O -
- O -
aspartyl O +
phosphate O +
between O +
aspartokinase B-Gene +
and O +
aspartate B-Gene +
semialdehyde I-Gene +
dehydrogenase I-Gene +
in O +
E. O +
coli O +
and O +
suggest O +
that O +
ASADH B-Gene +
may O +
provide O +
a O +
bridge O +
to O +
channel O +
the O +
intermediates O +
between O +
the O +
non O +
- O +
consecutive O +
reactions O +
of O +
AK B-Gene -
- I-Gene -
HDH I-Gene +
I I-Gene +
. O +

Serum O +
TA90 O +
immune O +
complex O +
assay O +
can O +
predict O +
outcome O +
after O +
resection O +
of O +
thick O +
( O +
> O +
or O +
= O +
4 O +
mm O +
) O +
primary O +
melanoma O +
and O +
sentinel O +
lymphadenectomy O +
. O +

BACKGROUND O +
: O +

We O +
hypothesized O +
that O +
the O +
postoperative O +
serum O +
level O +
of O +
TA90-IC O +
, O +
an O +
immune O +
complex O +
of O +
a O +
90 O +
- O +
kDa O +
tumor O +
- O +
associated O +
antigen O +
and O +
its O +
antibody O +
, O +
might O +
have O +
a O +
significant O +
correlation O +
with O +
recurrence O +
and O +
survival O +
in O +
patients O +
with O +
thick O +
primary O +
melanomas O +
. O +

METHODS O +
: O +

We O +
used O +
our O +
prospective O +
melanoma O +
database O +
to O +
identify O +
all O +
patients O +
who O +
underwent O +
wide O +
local O +
excision O +
and O +
sentinel O +
lymphadenectomy O +
for O +
primary O +
melanomas O +
> O +
or O +
= O +
4 O +
mm O +
and O +
from O +
whom O +
sera O +
had O +
been O +
collected O +
and O +
cryopreserved O +
within O +
6 O +
months O +
after O +
surgery O +
. O +

These O +
sera O +
were O +
analyzed O +
in O +
a O +
blinded O +
fashion O +
for O +
TA90-IC O +
status O +
by O +
using O +
our O +
double O +
- O +
determinant O +
enzyme O +
- O +
linked O +
immunosorbent O +
assay O +
. O +

Results O +
were O +
correlated O +
with O +
disease O +
- O +
free O +
survival O +
( O +
DFS O +
) O +
and O +
overall O +
survival O +
( O +
OS O +
) O +
. O +

Standard O +
prognostic O +
factors O +
for O +
melanoma O +
were O +
then O +
compared O +
with O +
TA90-IC O +
status O +
for O +
the O +
prediction O +
of O +
DFS O +
and O +
OS O +
. O +

RESULTS O +
: O +

The O +
sensitivity O +
and O +
specificity O +
of O +
the O +
TA90 O +
- O +
IC O +
assay O +
for O +
predicting O +
recurrence O +
were O +
70 O +
% O +
and O +
85 O +
% O +
, O +
respectively O +
. O +

Five O +
- O +
year O +
DFS O +
and O +
OS O +
rates O +
were O +
higher O +
for O +
the O +
TA90 O +
- O +
IC O +
- O +
negative O +
group O +
than O +
the O +
positive O +
group O +
. O +

The O +
differences O +
in O +
DFS O +
and O +
OS O +
between O +
the O +
TA90 O +
- O +
IC O +
- O +
negative O +
and O +
- O +
positive O +
groups O +
were O +
significant O +
. O +

At O +
a O +
median O +
follow O +
- O +
up O +
of O +
25 O +
months O +
, O +
multivariate O +
analysis O +
identified O +
postoperative O +
TA90-IC O +
status O +
and O +
sex O +
as O +
significant O +
predictors O +
of O +
DFS O +
. O +

TA90 O +
- O +
IC O +
status O +
was O +
the O +
only O +
independent O +
prognostic O +
factor O +
with O +
multivariate O +
analysis O +
. O +

CONCLUSIONS O +
: O +

TA90 O +
- O +
IC O +
status O +
after O +
resection O +
of O +
thick O +
primary O +
melanoma O +
accurately O +
predicts O +
outcome O +
. O +

A O +
positive O +
postoperative O +
TA90 O +
- O +
IC O +
level O +
might O +
affect O +
a O +
decision O +
regarding O +
adjuvant O +
therapy O +
, O +
regardless O +
of O +
regional O +
nodal O +
status O +
. O +

A O +
switch O +
in O +
dehydrogenase B-Gene +
to O +
reductase B-Gene +
activity O +
of O +
11 B-Gene +
beta I-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
type I-Gene +
1 I-Gene +
upon O +
differentiation O +
of O +
human O +
omental O +
adipose O +
stromal O +
cells O +
. O +

As O +
exemplified O +
in O +
patients O +
with O +
Cushing O +
's O +
syndrome O +
, O +
glucocorticoids O +
play O +
an O +
important O +
role O +
in O +
regulating O +
adipose O +
tissue O +
distribution O +
and O +
function O +
, O +
but O +
circulating O +
cortisol O +
concentrations O +
are O +
normal O +
in O +
most O +
patients O +
with O +
obesity O +
. O +

However O +
, O +
human O +
omental O +
adipose O +
stromal O +
cells O +
( O +
ASCs O +
) O +
can O +
generate O +
glucocorticoid O +
locally O +
through O +
the O +
expression O +
of O +
the O +
enzyme O +
11 B-Gene +
beta I-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
( I-Gene +
11 I-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
) I-Gene +
type I-Gene +
1 I-Gene +
( O +
11 B-Gene +
beta I-Gene -
- I-Gene -
HSD1 I-Gene +
) O +
, O +
which O +
, O +
in O +
intact O +
cells O +
, O +
has O +
been O +
considered O +
to O +
be O +
an O +
oxoreductase B-Gene +
, O +
converting O +
inactive O +
cortisone O +
( O +
E O +
) O +
to O +
cortisol O +
( O +
F O +
) O +
. O +

Locally O +
produced O +
F O +
can O +
induce O +
ASC O +
differentiation O +
, O +
but O +
the O +
relationship O +
between O +
11 B-Gene +
beta I-Gene -
- I-Gene -
HSD1 I-Gene +
expression O +
and O +
adipocyte O +
differentiation O +
is O +
unknown O +
. O +

Primary O +
cultures O +
of O +
paired O +
omental O +
( O +
om O +
) O +
and O +
sc O +
ASC O +
and O +
adipocytes O +
were O +
prepared O +
from O +
17 O +
patients O +
undergoing O +
elective O +
abdominal O +
surgery O +
and O +
cultured O +
for O +
up O +
to O +
14 O +
d O +
. O +

Expression O +
and O +
activity O +
of O +
11 B-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
isozymes O +
were O +
analyzed O +
together O +
with O +
early O +
( O +
lipoprotein B-Gene +
lipase I-Gene +
) O +
and O +
terminal O +
( O +
glycerol B-Gene +
3 I-Gene +
phosphate I-Gene +
dehydrogenase I-Gene +
) O +
markers O +
of O +
adipocyte O +
differentiation O +
. O +

On O +
d O +
1 O +
of O +
culture O +
, O +
11 B-Gene +
beta I-Gene -
- I-Gene -
HSD1 I-Gene +
activity O +
in O +
intact O +
om O +
ASCs O +
exceeded O +
oxoreductase B-Gene +
activity O +
in O +
every O +
patient O +
( O +
78.9 O +
+ O -
/- O +
24.9 O +
vs. O +
15.8 O +
+ O -
/- O +
3.7 O +
[ O +
mean O +
+ O -
/- O +
SE O +
] O +
pmol O +
/ O +
mg O +
per O +
hour O +
, O +
P O +
< O +
0.001 O +
) O +
, O +
and O +
in O +
sc O +
ASCs O +
, O +
relative O +
activities O +
were O +
similar O +
( O +
40.6 O +
+ O -
/- O +
12.2 O +
vs. O +
36.9 O +
+ O -
/- O +
8.8 O +
) O +
. O +

Conversely O +
, O +
in O +
freshly O +
isolated O +
om O +
adipocytes O +
, O +
reductase B-Gene +
activity O +
exceeded O +
dehydrogenase B-Gene +
activity O +
( O +
23.6 O +
+ O -
/- O +
1.5 O +
vs. O +
6.2 O +
+ O -
/- O +
0.8 O +
pmol O +
/ O +
mg O +
per O +
hour O +
, O +
P O +
< O +
0.01 O +
) O +
. O +

Following O +
14 O +
d O +
of O +
culture O +
in O +
serum O +
- O +
free O +
conditions O +
with O +
addition O +
of O +
10 O +
nM O +
insulin B-Gene +
( O +
Ctr O +
) O +
or O +
insulin B-Gene +
with O +
100 O +
nM O +
F O +
( O -
+ O -
F O -
) O +
, O +
lipoprotein B-Gene +
lipase I-Gene +
/ O +
18S O +
RNA O +
levels O +
increased O +
in O +
both O +
the O +
Ctr O +
- O +
and O +
+ O +
F O +
- O +
treated O +
ASCs O +
, O +
but O +
glycerol B-Gene +
3 I-Gene +
phosphate I-Gene +
dehydrogenase I-Gene +
increased O +
only O +
in O +
the O +
+ O +
F O +
cultures O +
. O +

In O +
both O +
cases O +
, O +
however O +
, O +
11 B-Gene +
beta I-Gene -
- I-Gene -
HSD1 I-Gene +
oxoreductase B-Gene +
activity O +
exceeded O +
dehydrogenase B-Gene +
activity O +
( O +
Ctr O +
: O +
53.3 O +
+ O -
/- O +
9.0 O +
vs. O +
32.4 O +
+ O -
/- O +
10.5 O +
, O +
P O +
< O +
0.05 O +
; O +
+ O +
F O +
: O +
65.6 O +
+ O -
/- O +
15.6 O +
vs. O +
37.1 O +
+ O -
/- O +
11.5 O +
pmol O +
/ O +
mg O +
per O +
hour O +
, O +
P O +
< O +
0.05 O +
) O +
, O +
despite O +
no O +
significant O +
changes O +
in O +
11 B-Gene +
beta I-Gene -
- I-Gene -
HSD1 I-Gene +
mRNA O +
levels O +
. O +

In O +
sc O +
ASCs O +
, O +
dehydrogenase B-Gene +
activity O +
was O +
similar O +
to O +
reductase B-Gene +
activity O +
in O +
both O +
Ctr O +
- O +
and O +
+ O +
F O +
- O +
treated O +
cells O +
. O +

Type B-Gene +
2 I-Gene +
11 I-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
expression O +
was O +
undetectable O +
in O +
each O +
case O +
. O +

These O +
data O +
show O +
that O +
in O +
intact O +
, O +
undifferentiated O +
om O +
ASCs O +
, O +
11 B-Gene +
beta I-Gene -
- I-Gene -
HSD1 I-Gene +
acts O +
primarily O +
as O +
a O +
dehydrogenase B-Gene +
, O +
but O +
in O +
mature O +
adipocytes O +
oxoreductase B-Gene +
activity O +
predominates O +
. O +

Because O +
glucocorticoids O +
inhibit O +
cell O +
proliferation O +
, O +
we O +
postulate O +
that O +
11 B-Gene +
beta I-Gene -
- I-Gene -
HSD1 I-Gene +
activity O +
in O +
uncommitted O +
ASCs O +
may O +
facilitate O +
proliferation O +
rather O +
than O +
differentiation O +
. O +

Once O +
early O +
differentiation O +
is O +
initiated O +
, O +
a O +
" O +
switch O +
" O +
to O +
11 B-Gene +
beta I-Gene -
- I-Gene -
HSD1 I-Gene +
oxoreductase B-Gene +
activity O +
generates O +
F O +
, O +
thus O +
promoting O +
adipogenesis O +
. O +

Site O +
- O +
specific O +
regulation O +
of O +
the O +
set O +
- O +
point O +
of O +
11 B-Gene +
beta I-Gene -
- I-Gene -
HSD1 I-Gene +
activity O +
may O +
be O +
an O +
important O +
mechanism O +
underpinning O +
visceral O +
obesity O +
. O +

Laminin-10 B-Gene +
/ I-Gene +
11 I-Gene +
and O +
fibronectin B-Gene +
differentially O +
prevent O +
apoptosis O +
induced O +
by O +
serum O +
removal O +
via O +
phosphatidylinositol B-Gene +
3-kinase I-Gene +
/ O +
Akt B-Gene +
- O +
and O +
MEK1 B-Gene +
/ O +
ERK B-Gene +
- O +
dependent O +
pathways O +
. O +

Cell O +
adhesion O +
to O +
the O +
extracellular O +
matrix O +
inhibits O +
apoptosis O +
, O +
but O +
the O +
molecular O +
mechanisms O +
underlying O +
the O +
signals O +
transduced O +
by O +
different O +
matrix O +
components O +
are O +
not O +
well O +
understood O +
. O +

Here O +
, O +
we O +
examined O +
integrin B-Gene +
- O +
mediated O +
antiapoptotic O +
signals O +
from O +
laminin B-Gene +
- I-Gene +
10 I-Gene +
/ I-Gene +
11 I-Gene +
in O +
comparison O +
with O +
those O +
from O +
fibronectin B-Gene +
, O +
the O +
best O +
characterized O +
extracellular O +
adhesive O +
ligand O +
. O +

We O +
found O +
that O +
the O +
activation O +
of O +
protein B-Gene +
kinase I-Gene +
B I-Gene +
/ O +
Akt B-Gene +
in O +
cells O +
adhering O +
to O +
laminin B-Gene +
- I-Gene +
10 I-Gene +
/ I-Gene +
11 I-Gene +
can O +
rescue O +
cell O +
apoptosis O +
induced O +
by O +
serum O +
removal O +
. O +

Consistent O +
with O +
this O +
, O +
wortmannin O +
, O +
a O +
specific O +
inhibitor O +
of O +
phosphatidylinositol B-Gene +
3-kinase I-Gene +
, O +
or O +
ectopic O +
expression O +
of O +
a O +
dominant O +
- O +
negative O +
mutant O +
of O +
Akt B-Gene +
selectively O +
accelerated O +
cell O +
death O +
upon O +
serum O +
removal O +
. O +

In O +
contrast O +
to O +
laminin B-Gene +
- I-Gene +
10 I-Gene +
/ I-Gene +
11 I-Gene +
, O +
fibronectin B-Gene +
rescued O +
cells O +
from O +
serum O +
depletion O +
- O +
induced O +
apoptosis O +
mainly O +
through O +
the O +
extracellular B-Gene +
signal I-Gene +
- I-Gene +
regulated I-Gene +
kinase I-Gene +
pathway O +
. O +

Cell O +
survival O +
on O +
fibronectin B-Gene +
but O +
not O +
laminin B-Gene +
was O +
significantly O +
reduced O +
by O +
treatment O +
with O +
PD98059 O +
, O +
a O +
specific O +
inhibitor O +
of O +
mitogen B-Gene +
- I-Gene +
or I-Gene +
extracellular I-Gene +
signal I-Gene +
- I-Gene +
regulated I-Gene +
kinase I-Gene +
kinase-1 I-Gene +
( O +
MEK1 B-Gene +
) O +
and O +
by O +
expression O +
of O +
a O +
dominant O +
- O +
negative O +
mutant O +
of O +
MEK1 B-Gene +
. O +

Laminin-10 B-Gene +
/ I-Gene +
11 I-Gene +
was O +
more O +
potent O +
than O +
fibronectin B-Gene +
in O +
preventing O +
apoptosis O +
induced O +
by O +
serum O +
depletion O +
. O +

These O +
results O +
, O +
taken O +
together O +
, O +
demonstrate O +
laminin B-Gene +
- I-Gene +
10 I-Gene +
/ I-Gene +
11 I-Gene +
potency O +
as O +
a O +
survival O +
factor O +
and O +
demonstrate O +
that O +
different O +
extracellular O +
matrix O +
components O +
can O +
transduce O +
distinct O +
survival O +
signals O +
through O +
preferential O +
activation O +
of O +
subsets O +
of O +
multiple O +
integrin B-Gene +
- O +
mediated O +
signaling O +
pathways O +
. O +

Characterization O +
of O +
a O +
brain O +
- O +
enriched O +
chaperone B-Gene +
, O +
MRJ B-Gene +
, O +
that O +
inhibits O +
Huntingtin O +
aggregation O +
and O +
toxicity O +
independently O +
. O +

Molecular O +
chaperones B-Gene +
are O +
involved O +
in O +
a O +
wide O +
range O +
of O +
cellular O +
events O +
, O +
such O +
as O +
protein O +
folding O +
and O +
oligomeric O +
protein O +
complex O +
assembly O +
. O +

DnaK B-Gene +
- O +
and O +
DnaJ B-Gene +
- O +
like O +
proteins O +
are O +
the O +
two O +
major O +
classes O +
of O +
molecular O +
chaperones B-Gene +
in O +
mammals O +
. O +

Recent O +
studies O +
have O +
shown O +
that O +
DnaJ B-Gene +
- I-Gene +
like I-Gene +
family I-Gene +
proteins O +
can O +
inhibit O +
polyglutamine O +
aggregation O +
, O +
a O +
hallmark O +
of O +
many O +
neurodegenerative O +
diseases O +
, O +
including O +
Huntington O +
's O +
disease O +
( O +
HD O +
) O +
. O +

Although O +
most O +
DnaJ B-Gene +
- O +
like O +
proteins O +
studied O +
are O +
ubiquitously O +
expressed O +
, O +
some O +
have O +
restricted O +
expression O +
, O +
so O +
it O +
is O +
possible O +
that O +
some O +
specific O +
chaperones B-Gene +
may O +
affect O +
polyglutamine O +
aggregation O +
in O +
specific O +
neurons O +
. O +

In O +
this O +
report O +
, O +
we O +
describe O +
the O +
isolation O +
of O +
a O +
DnaJ B-Gene +
- O +
like O +
protein O +
MRJ B-Gene +
and O +
the O +
characterization O +
of O +
its O +
chaperone B-Gene +
activity O +
. O +

Tissue O +
distribution O +
studies O +
showed O +
that O +
MRJ B-Gene +
is O +
highly O +
enriched O +
in O +
the O +
central O +
nervous O +
system O +
. O +

In O +
an O +
in O +
vitro O +
cell O +
model O +
of O +
HD O +
, O +
overexpressed O +
MRJ B-Gene +
effectively O +
suppressed O +
polyglutamine O +
- O +
dependent O +
protein O +
aggregation O +
, O +
caspase B-Gene +
activity O +
, O +
and O +
cellular O +
toxicity O +
. O +

Collectively O +
, O +
these O +
results O +
suggest O +
that O +
MRJ B-Gene +
has O +
a O +
relevant O +
functional O +
role O +
in O +
neurons O +
. O +

Infantile O +
dilated O +
X O +
- O +
linked O +
cardiomyopathy O +
, O +
G4.5 B-Gene +
mutations O +
, O +
altered O +
lipids O +
, O +
and O +
ultrastructural O +
malformations O +
of O +
mitochondria O +
in O +
heart O +
, O +
liver O +
, O +
and O +
skeletal O +
muscle O +
. O +

Mutations O +
in O +
the O +
Xq28 O +
gene O +
G4.5 B-Gene +
lead O +
to O +
dilated O +
cardiomyopathy O +
( O +
DCM O +
) O +
. O +

Differential O +
splicing O +
of O +
G4.5 B-Gene +
results O +
in O +
a O +
family O +
of O +
proteins O +
called O +
" O +
tafazzins B-Gene +
" O +
with O +
homology O +
to O +
acyltransferases B-Gene +
. O +

These O +
enzymes O +
assemble O +
fatty O +
acids O +
into O +
membrane O +
lipids O +
. O +

We O +
sequenced O +
G4.5 B-Gene +
in O +
two O +
kindreds O +
with O +
X O +
- O +
linked O +
DCM O +
and O +
in O +
two O +
unrelated O +
men O +
, O +
one O +
with O +
idiopathic O +
DCM O +
and O +
the O +
other O +
with O +
DCM O +
of O +
arrhythmogenic O +
right O +
ventricular O +
dysplasia O +
. O +

We O +
examined O +
the O +
ultrastructure O +
of O +
heart O +
, O +
liver O +
, O +
and O +
muscle O +
biopsy O +
specimens O +
in O +
these O +
three O +
DCM O +
types O +
; O +
we O +
used O +
gas O +
chromatography O +
to O +
compare O +
fatty O +
acid O +
composition O +
in O +
heart O +
, O +
liver O +
, O +
and O +
muscle O +
autopsy O +
specimens O +
of O +
two O +
patients O +
of O +
kindred O +
1 O +
with O +
that O +
of O +
controls O +
. O +

In O +
X O +
- O +
linked O +
DCM O +
, O +
G4.5 B-Gene +
had O +
a O +
stop O +
codon O +
( O +
E188X O +
) O +
, O +
a O +
nonsense O +
mutation O +
, O +
in O +
kindred O +
1 O +
and O +
an O +
amino O +
acid O +
substitution O +
( O +
G240R O +
) O +
, O +
a O +
missense O +
mutation O +
, O +
in O +
kindred O +
2 O +
. O +

In O +
the O +
two O +
men O +
with O +
isolated O +
DCM O +
, O +
G4.5 B-Gene +
was O +
not O +
mutated O +
. O +

Ultrastructural O +
mitochondrial O +
malformations O +
were O +
present O +
in O +
the O +
biopsy O +
tissues O +
of O +
the O +
patients O +
with O +
DCM O +
. O +

Cardiac O +
biopsy O +
specimens O +
of O +
both O +
kindreds O +
with O +
X O +
- O +
linked O +
DCM O +
exhibited O +
greatly O +
enlarged O +
mitochondria O +
with O +
large O +
bundles O +
of O +
stacked O +
, O +
compacted O +
, O +
disarrayed O +
cristae O +
that O +
differed O +
from O +
those O +
of O +
the O +
two O +
types O +
of O +
isolated O +
DCM O +
. O +

Autopsy O +
tissue O +
of O +
patients O +
with O +
X O +
- O +
linked O +
DCM O +
had O +
decreased O +
unsaturated O +
and O +
increased O +
saturated O +
fatty O +
acid O +
concentrations O +
. O +

Seven O +
of O +
13 O +
published O +
G4.5 B-Gene +
missense O +
mutations O +
, O +
including O +
the O +
one O +
presented O +
here O +
, O +
occur O +
in O +
acyltransferase B-Gene +
motifs O +
. O +

Impaired O +
acyltransferase B-Gene +
function O +
could O +
result O +
in O +
increased O +
fatty O +
acid O +
saturation O +
that O +
would O +
decrease O +
membrane O +
fluidity O +
. O +

Mitochondrial O +
membrane O +
proliferation O +
may O +
be O +
an O +
attempt O +
to O +
compensate O +
for O +
impaired O +
function O +
of O +
acyltransferase B-Gene +
. O +

Cardiac O +
ultrastructure O +
separates O +
X O +
- O +
linked O +
DCM O +
with O +
G4.5 B-Gene +
mutations O +
from O +
the O +
two O +
types O +
of O +
isolated O +
DCM O +
without O +
G4.5 B-Gene +
mutations O +
. O +

Electron O +
microscopy O +
of O +
promptly O +
fixed O +
myocardial O +
biopsy O +
specimens O +
has O +
a O +
role O +
in O +
defining O +
the O +
differential O +
diagnosis O +
of O +
DCM O +
. O +

Mutational O +
analysis O +
of O +
the O +
G4.5 B-Gene +
gene O +
also O +
serves O +
this O +
purpose O +
. O +

Three O +
- O +
dimensional O +
nonfluoroscopic O +
mapping O +
and O +
ablation O +
of O +
inappropriate O +
sinus O +
tachycardia O +
. O +

Procedural O +
strategies O +
and O +
long O +
- O +
term O +
outcome O +
. O +

OBJECTIVES O +
: O +

We O +
conducted O +
this O +
study O +
to O +
assess O +
long O +
- O +
term O +
results O +
of O +
three O +
- O +
dimensional O +
( O +
3-D O +
) O +
mapping O +
- O +
guided O +
radiofrequency O +
ablation O +
( O +
RFA O +
) O +
of O +
inappropriate O +
sinus O +
tachycardia O +
( O +
IST O +
) O +
. O +

Change O +
in O +
activation O +
after O +
the O +
administration O +
of O +
esmolol O +
was O +
also O +
assessed O +
and O +
compared O +
to O +
the O +
shift O +
documented O +
with O +
successful O +
sinus O +
node O +
( O +
SN O +
) O +
modification O +
. O +

BACKGROUND O +
: O +

The O +
long O +
- O +
term O +
results O +
after O +
RFA O +
of O +
IST O +
have O +
been O +
reported O +
to O +
vary O +
between O +
27 O +
% O +
and O +
66 O +
% O +
. O +

METHODS O +
: O +

Thirty O -
- O -
nine O +
patients O +
( O +
35 O +
women O +
, O +
mean O +
age O +
31 O +
+ O -
/- O +
9 O +
years O +
) O +
with O +
debilitating O +
IST O +
were O +
included O +
in O +
the O +
study O +
. O +

The O +
area O +
around O +
the O +
earliest O +
site O +
of O +
activation O +
recorded O +
using O +
the O +
3-D O +
mapping O +
system O +
was O +
targeted O +
for O +
ablation O +
. O +

The O +
shift O +
in O +
the O +
earliest O +
activation O +
site O +
after O +
administration O +
of O +
esmolol O +
was O +
compared O +
with O +
the O +
shift O +
after O +
RFA O +
. O +

RESULTS O +
: O +

The O +
heart O +
rate O +
at O +
rest O +
and O +
in O +
drug O +
- O +
free O +
state O +
ranged O +
between O +
95 O +
and O +
125 O +
beats O +
/ O +
min O +
( O +
mean O +
99 O +
+ O -
/- O +
14 O +
beats O +
/ O +
min O +
) O +
. O +

Sinus O +
node O +
was O +
successfully O +
modified O +
in O +
all O +
patients O +
. O +

Following O +
ablation O +
, O +
the O +
mean O +
heart O +
rate O +
dropped O +
to O +
72 O +
+ O -
/- O +
8 O +
beats O +
/ O +
min O +
, O +
p O +
< O +
0.01 O +
. O +

The O +
extent O +
of O +
the O +
3-D O +
shift O +
in O +
caudal O +
activation O +
along O +
the O +
crista O +
terminalis O +
was O +
more O +
pronounced O +
after O +
RFA O +
than O +
during O +
esmolol O +
administration O +
( O +
23 O +
+ O -
/- O +
11 O +
mm O +
vs. O +
7 O +
+ O -
/- O +
5 O +
mm O +
, O +
respectively O +
, O +
p O +
< O +
0.05 O +
) O +
. O +

No O +
patient O +
required O +
pacemaker O +
implantation O +
after O +
a O +
mean O +
follow O +
- O +
up O +
time O +
of O +
32 O +
+ O -
/- O +
9 O +
months O +
; O +
21 O +
% O +
of O +
patients O +
experienced O +
recurrence O +
of O +
IST O +
and O +
were O +
successfully O +
re O +
- O +
ablated O +
. O +

CONCLUSIONS O +
: O +

Three O +
- O +
dimensional O +
electroanatomical O +
mapping O +
seems O +
to O +
facilitate O +
and O +
improve O +
the O +
ablation O +
results O +
of O +
IST O +
. O +

The O +
difference O +
in O +
caudal O +
shift O +
seen O +
after O +
esmolol O +
administration O +
and O +
following O +
SN O +
modification O +
suggests O +
that O +
adrenergic O +
hypersensitivity O +
is O +
not O +
the O +
only O +
mechanism O +
responsible O +
for O +
the O +
inappropriate O +
behavior O +
of O +
the O +
SN O +
. O +

Deregulated O +
human O +
Cdc14A B-Gene +
phosphatase B-Gene +
disrupts O +
centrosome O +
separation O +
and O +
chromosome O +
segregation O +
. O +

We O +
show O +
that O +
human O +
Cdc14A B-Gene +
phosphatase B-Gene +
interacts O +
with O +
interphase O +
centrosomes O +
, O +
and O +
that O +
this O +
interaction O +
is O +
independent O +
of O +
microtubules O +
and O +
Cdc14A B-Gene +
phosphatase B-Gene +
activity O +
, O +
but O +
requires O +
active O +
nuclear O +
export O +
. O +

Disrupting O +
the O +
nuclear O +
export O +
signal O +
( O +
NES O +
) O +
led O +
to O +
Cdc14A B-Gene +
being O +
localized O +
in O +
nucleoli O +
, O +
which O +
in O +
unperturbed O +
cells O +
selectively O +
contain O +
Cdc14B B-Gene +
( O +
ref O -
. O +
1 O +
) O +
. O +

Conditional O +
overproduction O +
of O +
Cdc14A B-Gene +
, O +
but O +
not O +
its O +
phosphatase B-Gene +
- O +
dead O +
or O +
NES O -
- O -
deficient O +
mutants O +
, O +
or O +
Cdc14B B-Gene +
, O +
resulted O +
in O +
premature O +
centrosome O +
splitting O +
and O +
formation O +
of O +
supernumerary O +
mitotic O +
spindles O +
. O +

In O +
contrast O +
, O +
downregulation O +
of O +
endogenous O +
Cdc14A B-Gene +
by O +
short O +
inhibitory O +
RNA O +
duplexes O +
( O +
siRNA O +
) O +
induced O +
mitotic O +
defects O +
including O +
impaired O +
centrosome O +
separation O +
and O +
failure O +
to O +
undergo O +
productive O +
cytokinesis O +
. O +

Consequently O +
, O +
both O +
overexpression O +
and O +
downregulation O +
of O +
Cdc14A B-Gene +
caused O +
aberrant O +
chromosome O +
partitioning O +
into O +
daughter O +
cells O +
. O +

These O +
results O +
indicate O +
that O +
Cdc14A B-Gene +
is O +
a O +
physiological O +
regulator O +
of O +
the O +
centrosome O +
duplication O +
cycle O +
, O +
which O +
, O +
when O +
disrupted O +
, O +
can O +
lead O +
to O +
genomic O +
instability O +
in O +
mammalian O +
cells O +
. O +

Evaluation O +
of O +
risk O +
prediction O +
criteria O +
for O +
episodes O +
of O +
febrile O +
neutropenia O +
in O +
children O +
with O +
cancer O +
. O +

PURPOSE O +
: O +

To O +
evaluate O +
the O +
feasibility O +
of O +
risk O +
stratification O +
of O +
children O +
with O +
cancer O +
and O +
febrile O +
neutropenia O +
using O +
a O +
simple O +
set O +
of O +
criteria O +
from O +
data O +
available O +
to O +
the O +
clinician O +
at O +
the O +
time O +
of O +
the O +
patient O +
's O +
presentation O +
. O +

PATIENTS O +
AND O +
METHODS O +
: O +

This O +
study O +
is O +
a O +
retrospective O +
cohort O +
study O +
of O +
all O +
children O +
with O +
cancer O +
admitted O +
to O +
a O +
single O +
institution O +
with O +
fever O +
and O +
neutropenia O +
( O +
defined O +
as O +
an O +
absolute O +
neutrophil O +
count O +
< O +
500 O +
cells O +
/ O +
mm3 O +
) O +
in O +
a O +
1 O +
- O +
year O +
period O +
. O +

Patients O +
were O +
defined O +
a O +
priori O +
as O +
low O +
risk O +
if O +
they O +
were O +
outpatients O +
at O +
the O +
time O +
of O +
presentation O +
with O +
febrile O +
neutropenia O +
, O +
had O +
an O +
anticipated O +
duration O +
of O +
neutropenia O +
less O +
than O +
7 O +
days O +
, O +
and O +
had O +
no O +
significant O +
comorbidity O +
. O +

All O +
others O +
were O +
considered O +
high O +
risk O +
. O +

Data O +
was O +
analyzed O +
by O +
first O +
admission O +
for O +
each O +
patient O +
and O +
secondarily O +
for O +
all O +
admissions O +
for O +
febrile O +
neutropenia O +
. O +

RESULTS O +
: O +

There O +
were O +
188 O +
admissions O +
in O +
104 O +
patients O +
for O +
febrile O +
neutropenia O +
during O +
the O +
study O +
period O +
. O +

Of O +
these O +
47 O +
% O +
were O +
high O +
risk O +
and O +
53 O +
% O +
were O +
low O +
risk O +
. O +

The O +
duration O +
of O +
fever O +
was O +
not O +
significantly O +
different O +
in O +
the O +
two O +
groups O +
. O +

However O +
, O +
the O +
duration O +
of O +
neutropenia O +
and O +
the O +
length O +
of O +
hospital O +
stay O +
were O +
significantly O +
longer O +
in O +
the O +
high O +
- O +
risk O +
group O +
. O +

The O +
frequency O +
of O +
bacteremia O +
, O +
other O +
documented O +
infection O +
, O +
and O +
serious O +
medical O +
complications O +
was O +
significantly O +
different O +
in O +
the O +
two O +
groups O +
. O +

Overall O +
, O +
the O +
rate O +
of O +
any O +
adverse O +
event O +
was O +
4 O +
% O +
in O +
the O +
low O +
- O +
risk O +
group O +
versus O +
41 O +
% O +
in O +
the O +
high O +
- O +
risk O +
group O +
. O +

CONCLUSIONS O +
: O +

Simple O +
criteria O +
available O +
to O +
the O +
clinician O +
at O +
the O +
time O +
of O +
evaluation O +
of O +
the O +
child O +
with O +
cancer O +
who O +
has O +
fever O +
and O +
neutropenia O +
allow O +
the O +
selection O +
of O +
a O +
population O +
at O +
low O +
risk O +
for O +
bacteremia O +
or O +
serious O +
medical O +
complication O +
. O +

A O +
prospective O +
study O +
is O +
planned O +
using O +
these O +
risk O +
criteria O +
, O +
evaluating O +
outpatient O +
oral O +
antibiotic O +
therapy O +
in O +
low O +
- O +
risk O +
children O +
with O +
cancer O +
. O +

Conformational O +
change O +
and O +
destabilization O +
of O +
cataract O +
gammaC B-Gene +
- I-Gene +
crystallin I-Gene +
T5P O +
mutant O +
. O +

Human O +
lens O +
gammaC B-Gene -
- I-Gene -
crystallin I-Gene +
and O +
T5P O +
mutant O +
were O +
cloned O +
, O +
and O +
their O +
biophysical O +
properties O +
and O +
thermodynamic O +
stability O +
were O +
studied O +
. O +

CRYGC B-Gene +
( O +
T5P O +
) O +
is O +
one O +
of O +
the O +
many O +
gamma B-Gene -
- I-Gene -
crystallin I-Gene +
mutant O +
genes O +
for O +
autosomal O +
dominant O +
congenital O +
cataracts O +
. O +

This O +
mutation O +
is O +
associated O +
with O +
Coppock O +
- O +
like O +
cataract O +
, O +
and O +
has O +
the O +
phenotype O +
of O +
a O +
dust O +
- O +
like O +
opacity O +
of O +
the O +
fetal O +
lens O +
nucleus O +
. O +

During O +
cloning O +
and O +
overexpression O +
, O +
the O +
majority O +
of O +
T5P O +
mutant O +
was O +
found O +
in O +
the O +
inclusion O +
body O +
. O +

This O +
property O +
is O +
unique O +
among O +
the O +
many O +
cataract O +
gamma B-Gene -
- I-Gene -
crystallin I-Gene +
mutant O +
genes O +
. O +

It O +
is O +
thus O +
worthwhile O +
to O +
study O +
what O +
factors O +
contribute O +
to O +
this O +
unique O +
property O +
of O +
gammaC B-Gene -
- I-Gene -
crystallin I-Gene +
. O +

One O +
possibility O +
is O +
changes O +
in O +
conformation O +
and O +
stability O +
, O +
which O +
can O +
be O +
studied O +
using O +
spectroscopic O +
measurements O +
. O +

In O +
this O +
study O +
, O +
conformational O +
change O +
was O +
studied O +
by O +
circular O +
dichroism O +
and O +
fluorescence O +
measurements O +
, O +
and O +
conformational O +
stability O +
was O +
determined O +
by O +
thermal O +
unfolding O +
probed O +
by O +
Trp O +
fluorescence O +
and O +
time O +
- O +
dependent O +
light O +
scattering O +
. O +

The O +
T5P O +
mutation O +
obviously O +
changes O +
conformation O +
and O +
decreases O +
conformational O +
stability O +
. O +

Coamplification O +
of O +
DAD B-Gene -
- I-Gene -
R I-Gene +
, O +
SOX5 B-Gene +
, O +
and O +
EKI1 B-Gene +
in O +
human O +
testicular O +
seminomas O +
, O +
with O +
specific O +
overexpression O +
of O +
DAD B-Gene -
- I-Gene -
R I-Gene +
, O +
correlates O +
with O +
reduced O +
levels O +
of O +
apoptosis O +
and O +
earlier O +
clinical O +
manifestation O +
. O +

Seminomas O +
and O +
nonseminomas O +
represent O +
the O +
invasive O +
stages O +
of O +
testicular O +
( O +
TGCTs O +
) O +
of O +
adolescents O +
and O +
adults O +
. O +

Although O +
TGCTs O +
are O +
characterized O +
by O +
extra O +
copies O +
of O +
the O +
short O +
arm O +
of O +
chromosome O +
12 O +
, O +
the O +
genetic O +
basis O +
for O +
gain O +
of O +
12p O +
in O +
the O +
pathogenesis O +
of O +
this O +
cancer O +
is O +
not O +
yet O +
understood O +
. O +

We O +
have O +
demonstrated O +
that O +
gain O +
of O +
12p O +
is O +
related O +
to O +
invasive O +
growth O +
and O +
that O +
amplification O +
of O +
specific O +
12p O +
sequences O +
, O +
i.e. O +
, O +
12p11.2 O +
- O +
p12.1 O +
, O +
correlates O +
with O +
reduced O +
apoptosis O +
in O +
the O +
tumors O +
. O +

Here O +
we O +
show O +
that O +
three O +
known O +
genes O +
map O +
within O +
the O +
newly O +
determined O +
shortest O +
region O +
of O +
overlap O +
of O +
amplification O +
( O +
SROA O +
) O +
: O +
DAD B-Gene -
- I-Gene -
R I-Gene +
, O +
SOX5 B-Gene +
, O +
and O +
EKI1 B-Gene +
. O +

Whereas O +
EKI1 B-Gene +
maps O +
close O +
to O +
the O +
telomeric O +
region O +
of O +
the O +
SROA O +
, O +
DAD B-Gene -
- I-Gene -
R I-Gene +
is O +
the O +
first O +
gene O +
at O +
the O +
centromeric O +
region O +
within O +
the O +
12p O +
amplicon O +
. O +

Although O +
all O +
three O +
genes O +
are O +
amplified O +
to O +
the O +
same O +
level O +
within O +
the O +
SROA O +
, O +
expression O +
of O +
DAD B-Gene -
- I-Gene -
R I-Gene +
is O +
significantly O +
up O +
- O +
regulated O +
in O +
seminomas O +
with O +
the O +
restricted O +
12p O +
amplification O +
compared O +
with O +
seminomas O +
without O +
this O +
amplicon O +
. O +

DAD B-Gene -
- I-Gene -
R I-Gene +
is O +
also O +
highly O +
expressed O +
in O +
nonseminomas O +
of O +
various O +
histologies O +
and O +
derived O +
cell O +
lines O +
, O +
both O +
lacking O +
such O +
amplification O +
. O +

This O +
finding O +
is O +
of O +
particular O +
interest O +
because O +
seminomas O +
with O +
the O +
restricted O +
12p O +
amplification O +
and O +
nonseminomas O +
are O +
manifested O +
clinically O +
in O +
the O +
third O +
decade O +
of O +
life O +
and O +
show O +
a O +
low O +
degree O +
of O +
apoptosis O +
. O +

In O +
contrast O +
, O +
seminomas O +
lacking O +
a O +
restricted O +
12p O +
amplification O +
, O +
showing O +
significantly O +
lower O +
levels O +
of O +
DAD B-Gene -
- I-Gene -
R I-Gene +
with O +
pronounced O +
apoptosis O +
, O +
manifest O +
clinically O +
in O +
the O +
fourth O +
decade O +
of O +
life O +
. O +

A O +
low O +
level O +
of O +
DAD B-Gene -
- I-Gene -
R I-Gene +
expression O +
is O +
also O +
observed O +
in O +
normal O +
testicular O +
parenchyma O +
and O +
in O +
parenchyma O +
containing O +
the O +
precursor O +
cells O +
of O +
this O +
cancer O +
, O +
i.e. O +
, O +
carcinoma O +
in O +
situ O +
. O +

Therefore O +
, O +
elevated O +
DAD B-Gene -
- I-Gene -
R I-Gene +
expression O +
in O +
seminomas O +
and O +
nonseminomas O +
correlates O +
with O +
invasive O +
growth O +
and O +
a O +
reduced O +
level O +
of O +
apoptosis O +
associated O +
with O +
an O +
earlier O +
clinical O +
presentation O +
. O +

These O +
data O +
implicate O +
DAD B-Gene -
- I-Gene -
R I-Gene +
as O +
a O +
candidate O +
gene O +
responsible O +
in O +
part O +
for O +
the O +
pathological O +
effects O +
resulting O +
from O +
gain O +
of O +
12p O +
sequences O +
in O +
TGCTs O +
. O +

In O +
addition O +
, O +
our O +
results O +
also O +
imply O +
differences O +
in O +
expression O +
regulation O +
of O +
DAD B-Gene -
- I-Gene -
R I-Gene +
between O +
seminomas O +
and O +
nonseminomas O +
. O +

Interaction O +
of O +
Alzheimer O +
's O +
beta B-Gene +
- I-Gene +
amyloid I-Gene +
precursor I-Gene +
family I-Gene +
proteins O +
with O +
scaffold O +
proteins O +
of O +
the O +
JNK B-Gene +
signaling O +
cascade O +
. O +

We O +
have O +
isolated O +
a O +
novel O +
protein O +
based O +
on O +
its O +
association O +
with O +
Drosophila O +
APP B-Gene +
- I-Gene +
like I-Gene +
protein I-Gene +
( O +
APPL B-Gene +
) O +
, O +
a O +
homolog O +
of O +
the O +
beta B-Gene -
- I-Gene -
amyloid I-Gene +
precursor I-Gene +
protein I-Gene +
( O +
APP B-Gene +
) O +
that O +
is O +
implicated O +
in O +
Alzheimer O +
's O +
disease O +
. O +

This O +
novel O +
APPL B-Gene +
- I-Gene +
interacting I-Gene +
protein I-Gene +
1 I-Gene +
( O +
APLIP1 B-Gene +
) O +
contains O +
a O +
Src B-Gene +
homology O +
3 O +
domain O +
and O +
a O +
phosphotyrosine O +
interaction O +
domain O +
and O +
is O +
expressed O +
abundantly O +
in O +
neural O +
tissues O +
. O +

The O +
phosphotyrosine O +
interaction O +
domain O +
of O +
APLIP1 B-Gene +
interacts O +
with O +
a O +
sequence O +
containing O +
GYENPTY O +
in O +
the O +
cytoplasmic O +
domain O +
of O +
APPL B-Gene +
. O +

APLIP1 B-Gene +
is O +
highly O +
homologous O +
to O +
the O +
carboxyl O +
- O +
terminal O +
halves O +
of O +
mammalian O +
c B-Gene -
- I-Gene -
Jun I-Gene +
NH I-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
- I-Gene +
terminal I-Gene +
kinase I-Gene +
( I-Gene +
JNK I-Gene +
) I-Gene +
- I-Gene +
interacting I-Gene +
protein I-Gene +
1b I-Gene +
( I-Gene +
JIP1b I-Gene +
) I-Gene +
and I-Gene +
2 I-Gene +
( O +
JIP2 B-Gene +
) O +
, O +
which O +
also O +
contain O +
Src B-Gene +
homology O +
3 O +
and O +
phosphotyrosine O +
interaction O +
domains O +
. O +

The O +
similarity O +
of O +
APLIP1 B-Gene +
to O +
JIP1b B-Gene +
and O +
JIP2 B-Gene +
includes O +
interaction O +
with O +
component O -
( O -
s O -
) O +
of O +
the O +
JNK B-Gene +
signaling O +
pathway O +
and O +
with O +
the O +
motor B-Gene +
protein I-Gene +
kinesin B-Gene +
and O +
the O +
formation O +
of O +
homo O +
- O +
oligomers O +
. O +

JIP1b B-Gene +
interacts O +
strongly O +
with O +
the O +
cytoplasmic O +
domain O +
of O +
APP B-Gene +
( O +
APPcyt B-Gene +
) O +
, O +
as O +
APLIP1 B-Gene +
does O +
with O +
APPL B-Gene +
, O +
but O +
the O +
interaction O +
of O +
JIP2 B-Gene +
with O +
APPcyt B-Gene +
is O +
weak O +
. O +

Overexpression O +
of O +
JIP1b B-Gene +
slightly O +
enhances O +
the O +
JNK B-Gene +
- O +
dependent O +
threonine O +
phosphorylation O +
of O +
APP B-Gene +
in O +
cultured O +
cells O +
, O +
but O +
that O +
of O +
JIP2 B-Gene +
suppresses O +
it O +
. O +

These O +
observations O +
suggest O +
that O +
the O +
interactions O +
of O +
APP B-Gene +
family I-Gene +
proteins O +
with O +
APLIP1 B-Gene +
, O +
JIP1b B-Gene +
, O +
and O +
JIP2 B-Gene +
are O +
conserved O +
and O +
play O +
important O +
roles O +
in O +
the O +
metabolism O +
and/or O +
the O +
function O +
of O +
APPs B-Gene +
including O +
the O +
regulation O +
of O +
APP B-Gene +
phosphorylation O +
by O +
JNK B-Gene +
. O +

Analysis O +
of O +
APP B-Gene +
family I-Gene +
proteins O +
and O +
their O +
associated O +
proteins O +
is O +
expected O +
to O +
contribute O +
to O +
understanding O +
the O +
molecular O +
process O +
of O +
neural O +
degeneration O +
in O +
Alzheimer O +
's O +
disease O +
. O +

Concentrations O +
of O +
proinsulin B-Gene +
like O +
molecules O +
predict O +
coronary O +
heart O +
disease O +
risk O +
independently O +
of O +
insulin B-Gene +
: O +
prospective O +
data O +
from O +
the O +
Caerphilly O +
Study O +
. O +

AIMS O +
/ O +
HYPOTHESIS O +
: O +

Higher O +
concentrations O +
of O +
insulin B-Gene +
correlate O +
with O +
several O +
coronary O +
heart O +
disease O +
( O +
CHD O +
) O +
risk O +
factors O +
and O +
have O +
been O +
shown O +
to O +
predict O +
incident O +
CHD O +
in O +
several O +
studies O +
, O +
leading O +
to O +
hypotheses O +
concerning O +
the O +
proatherogenic O +
properties O +
of O +
insulin B-Gene +
. O +

However O +
, O +
in O +
cross O +
- O +
sectional O +
studies O +
, O +
relationships O +
of O +
concentrations O +
of O +
the O +
insulin B-Gene +
precursor O +
molecules O +
, O +
proinsulin B-Gene +
and O +
des O +
31 O +
, O +
32 O +
proinsulin B-Gene +
, O +
relate O +
as O +
strongly O +
, O +
or O +
more O +
strongly O +
, O +
to O +
levels O +
of O +
risk O +
factors O +
and O +
to O +
( O +
prevalent O +
) O +
CHD O +
. O +

METHODS O +
: O +

We O +
investigated O +
the O +
relationship O +
between O +
concentrations O +
of O +
insulin B-Gene +
, O +
measured O +
with O +
a O +
specific O +
assay O +
, O +
and O +
of O +
proinsulin B-Gene +
- O +
like O +
molecules O +
, O +
and O +
risk O +
factors O +
in O +
1181 O +
non O +
- O +
diabetic O +
men O +
50 O +
- O +
64 O +
years O +
old O +
during O +
Phase O +
II O +
of O +
the O +
Caerphilly O +
Study O +
. O +

We O +
also O +
related O +
concentrations O +
of O +
these O +
molecules O +
to O +
incident O +
CHD O +
during O +
the O +
10 O +
- O +
14 O +
years O +
follow O +
- O +
up O +
. O +

RESULTS O +
: O +

The O +
relationship O +
between O +
concentrations O +
of O +
insulin B-Gene +
, O +
of O +
proinsulin B-Gene +
and O +
of O +
des O +
31 O +
, O +
32 O +
proinsulin B-Gene +
and O +
BMI O +
( O +
r O +
= O +
0.36 O +
- O +
0.45 O +
) O +
, O +
triglyceride O +
( O +
r O +
= O +
0.25 O +
- O +
0.31 O +
) O +
, O +
high B-Gene +
density I-Gene +
lipoprotein I-Gene +
- O +
( O +
HDL B-Gene +
- O +
) O +
cholesterol O +
( O +
r O +
= O +
- O +
0.17 O +
to O +
- O +
0.21 O +
) O +
, O +
systolic O +
( O +
r O +
= O +
0.05 O +
- O +
0.11 O +
) O +
and O +
diastolic O +
blood O +
pressure O +
( O +
r O +
= O +
0.11 O +
- O +
0.15 O +
) O +
were O +
similarly O +
close O +
, O +
those O +
with O +
risk O +
factors O +
being O +
somewhat O +
and O +
similarly O +
reduced O +
after O +
adjustment O +
for O +
BMI O +
. O +

The O +
correlation O +
between O +
insulin B-Gene +
and O +
of O +
proinsulin B-Gene +
- O +
like O +
molecules O +
and O +
those O +
plasminogen B-Gene +
activator I-Gene +
inhibitor-1 I-Gene +
( O +
PAI-1 B-Gene +
) O +
antigen O +
was O +
also O +
similar O +
( O +
r O +
= O +
0.28 O +
- O +
0.29 O +
) O +
. O +

There O +
was O +
a O +
negative O +
correlation O +
between O +
concentrations O +
of O +
proinsulin B-Gene +
- O +
like O +
molecules O +
- O +
but O +
not O +
insulin B-Gene +
- O +
and O +
birth O +
weight O +
. O +

Insulin B-Gene +
concentrations O +
correlated O +
positively O +
with O +
height O +
( O +
r O +
= O +
0.12 O +
) O +
. O +

In O +
logistic O +
regression O +
models O +
, O +
concentrations O +
of O +
proinsulin B-Gene +
- O +
like O +
molecules O +
, O +
but O +
not O +
insulin B-Gene +
, O +
predicted O +
incident O +
of O +
CHD O +
over O +
a O +
follow O +
- O +
up O +
of O +
10 O +
- O +
14 O +
years O +
( O +
insulin B-Gene +
- O +
standardised O +
odds O +
ratio O +
( O +
SOR O +
) O +
1.30 O +
( O +
95 O +
% O +
- O +
CI O +
) O +
0.91 O +
, O +
1.85 O +
) O +
, O +
p O +
= O +
0.15 O +
; O +
des O +
31 O +
, O +
32 O +
proinsulin B-Gene +
- O +
SOR O +
1.38 O +
( O +
95 O +
% O +
- O +
CI O +
1.02 O +
, O +
1.85 O +
) O +
, O +
p O +
= O +
0.034 O +
; O +
sum O +
of O +
proinsulin B-Gene +
- O +
like O +
molecules O +
- O +
SOR O +
1.54 O +
( O +
95 O +
% O +
- O +
CI O +
1.07 O +
, O +
2.20 O +
) O +
, O +
p O +
= O +
0.019 O +
after O +
adjusting O +
for O +
age O +
and O +
BMI O +
. O +

The O +
predictive O +
ability O +
of O +
these O +
molecules O +
was O +
reduced O +
by O +
around O +
one O +
third O +
after O +
adjustment O +
for O +
standard O +
risk O +
factors O +
and O +
concentrations O +
of O +
tryglyceride O +
and O +
HDL B-Gene +
- O +
cholesterol O +
, O +
and O +
by O +
about O +
half O +
after O +
further O +
adjustment O +
for O +
PAI-1 B-Gene +
concentrations O +
. O +

CONCLUSION O +
/ O +
INTERPRETATION O +
: O +

We O +
conclude O +
that O +
concentrations O +
of O +
proinsulin B-Gene +
- O +
like O +
molecules O +
provide O +
a O +
better O +
way O +
to O +
predict O +
the O +
incidence O +
of O +
CHD O +
than O +
those O +
of O +
insulin B-Gene +
. O +

However O +
, O +
the O +
lack O +
of O +
biological O +
evidence O +
for O +
a O +
causative O +
relationship O +
suggests O +
an O +
association O +
through O +
a O +
common O +
antecedent O +
, O +
and O +
this O +
antecedent O +
is O +
not O +
likely O +
to O +
be O +
intrauterine O +
growth O +
retardation O +
. O +

Mutation O +
screening O +
and O +
imprinting O +
analysis O +
of O +
four O +
candidate O +
genes O +
for O +
autism O +
in O +
the O +
7q32 O +
region O +
. O +

Genetic O +
studies O +
indicate O +
that O +
chromosome O +
7q O +
is O +
likely O +
to O +
contain O +
an O +
autism O +
susceptibility O +
locus O +
( O +
AUTS1 O +
) O +
. O +

We O +
have O +
followed O +
a O +
positional O +
candidate O +
gene O +
approach O +
to O +
identify O +
the O +
relevant O +
gene O +
and O +
report O +
the O +
analysis O +
of O +
four O +
adjacent O +
genes O +
localised O +
to O +
a O +
800 O +
kb O +
region O +
in O +
7q32 O +
that O +
contains O +
an O +
imprinted O +
domain O +
: O +
PEG1 B-Gene +
/ O +
MEST B-Gene +
, O +
COPG2 B-Gene +
, O +
CPA1 B-Gene +
and O +
CPA5 B-Gene +
- O +
a O +
previously O +
uncharacterised O +
member O +
of O +
the O +
carboxypeptidase B-Gene +
gene I-Gene +
family I-Gene +
. O +

Screening O +
these O +
genes O +
for O +
DNA O +
changes O +
and O +
association O +
analysis O +
using O +
intragenic O +
single O +
nucleotide O +
polymorphisms O +
( O +
SNPs O +
) O +
provided O +
no O +
evidence O +
for O +
an O +
etiological O +
role O +
in O +
IMGSAC O +
families O +
. O +

We O +
also O +
searched O +
for O +
imprinting O +
mutations O +
potentially O +
implicated O +
in O +
autism O +
: O +
analysis O +
of O +
both O +
DNA O +
methylation O +
and O +
replication O +
timing O +
indicated O +
a O +
normal O +
imprinting O +
regulation O +
of O +
the O +
PEG1 B-Gene +
/ O +
COPG2 B-Gene +
domain O +
in O +
blood O +
lymphocytes O +
of O +
all O +
patients O +
tested O +
. O +

The O +
analysis O +
of O +
these O +
four O +
genes O +
strongly O +
suggests O +
that O +
they O +
do O +
not O +
play O +
a O +
major O +
role O +
in O +
autism O +
aetiology O +
, O +
and O +
delineates O +
our O +
strategy O +
to O +
screen O +
additional O +
candidate O +
genes O +
in O +
the O +
AUTS1 B-Gene +
locus O +
. O +

Results O +
of O +
the O +
Lynn O +
Sage O +
Second O +
- O +
Opinion O +
Program O +
for O +
local O +
therapy O +
in O +
patients O +
with O +
breast O +
carcinoma O +
. O +

Changes O +
in O +
management O +
and O +
determinants O +
of O +
where O +
care O +
is O +
delivered O +
. O +

BACKGROUND O +
: O +

The O +
treatment O +
options O +
of O +
breast O +
conservation O +
therapy O +
( O +
BCT O +
) O +
and O +
immediate O +
reconstruction O +
for O +
patients O +
with O +
carcinoma O +
of O +
the O +
breast O +
have O +
not O +
been O +
adopted O +
widely O +
. O +

The O +
objectives O +
of O +
this O +
study O +
were O +
to O +
determine O +
how O +
often O +
a O +
second O +
opinion O +
on O +
the O +
local O +
therapy O +
of O +
breast O +
carcinoma O +
changed O +
patient O +
management O +
and O +
to O +
identify O +
factors O +
predictive O +
of O +
remaining O +
at O +
the O +
second O +
- O +
opinion O +
site O +
for O +
therapy O +
. O +

METHODS O +
: O +

Two O +
hundred O +
thirty O -
- O -
one O +
patients O +
with O +
intraductal O +
carcinoma O +
or O +
Stage O +
I O +
and O +
II O +
breast O +
carcinoma O +
were O +
reviewed O +
retrospectively O +
. O +

At O +
the O +
time O +
of O +
the O +
second O +
opinion O +
, O +
patients O +
completed O +
a O +
questionnaire O +
regarding O +
their O +
initial O +
surgical O +
opinion O +
and O +
the O +
reason O +
for O +
seeking O +
consultation O +
. O +

RESULTS O +
: O +

Only O +
46 O +
% O +
of O +
patients O +
had O +
a O +
complete O +
discussion O +
of O +
treatment O +
options O +
prior O +
to O +
the O +
second O +
opinion O +
. O +

The O +
second O +
opinion O +
changed O +
management O +
in O +
54 O +
patients O +
( O +
20.3 O +
% O +
) O +
. O +

The O +
most O +
common O +
finding O +
was O +
eligibility O +
for O +
BCT O +
in O +
patients O +
who O +
were O +
offered O +
only O +
mastectomy O +
. O +

Definitive O +
local O +
therapy O +
occurred O +
at O +
the O +
second O +
- O +
opinion O +
site O +
in O +
65.8 O +
% O +
of O +
patients O +
. O +

The O +
only O +
predictors O +
of O +
remaining O +
at O +
the O +
second O +
- O +
opinion O +
site O +
were O +
insurance O +
type O +
( O +
P O +
= O +
0.008 O +
) O +
and O +
the O +
patient O +
's O +
perception O +
that O +
options O +
were O +
not O +
discussed O +
at O +
the O +
initial O +
opinion O +
( O +
P O +
< O +
0.001 O +
) O +
. O +

CONCLUSIONS O +
: O +

Second O +
opinions O +
provide O +
useful O +
information O +
to O +
patients O +
and O +
may O +
change O +
the O +
management O +
of O +
their O +
disease O +
. O +

They O +
result O +
in O +
significant O +
patient O +
capture O +
for O +
an O +
institution O +
. O +

Mutational O +
and O +
haplotype O +
analysis O +
of O +
AGL O +
in O +
patients O +
with O +
glycogen O +
storage O +
disease O +
type O +
III O +
. O +

Glycogen O +
storage O +
disease O +
type O +
III O +
( O +
GSD O +
III O +
) O +
is O +
a O +
rare O +
autosomal O +
recessive O +
inherited O +
disorder O +
caused O +
by O +
a O +
deficiency O +
of O +
the O +
glycogen B-Gene +
- I-Gene +
debranching I-Gene +
enzyme I-Gene +
( O +
AGL B-Gene +
) O +
. O +

We O +
investigated O +
two O +
GSD O +
III O +
patients O +
and O +
identified O +
four O +
different O +
mutations O +
. O +

Nucleotide O +
sequence O +
analysis O +
revealed O +
patient O +
1 O +
of O +
Chinese O +
descent O +
to O +
be O +
a O +
compound O +
heterozygote O +
for O +
a O +
novel O +
nonsense O +
mutation O +
, O +
R34X O +
, O +
and O +
the O +
splicing O +
mutation O +
( O +
IVS32 O +
-12A O +
> O +
G O +
) O +
reported O +
in O +
a O +
Japanese O +
patient O +
. O +

Patient O +
2 O +
of O +
Japanese O +
origin O +
was O +
found O +
to O +
be O +
compound O +
heterozygous O +
for O +
a O +
novel O +
nonsense O +
mutation O +
, O +
Y1148X O +
, O +
and O +
the O +
splicing O +
mutation O +
( O +
IVS14 O +
+ O -
1 O -
G O +
> O +
T O +
) O +
that O +
we O +
had O +
described O +
previously O +
. O +

To O +
determine O +
whether O +
splicing O +
mutations O +
occurred O +
independently O +
, O +
we O +
performed O +
intense O +
AGL B-Gene +
haplotype O +
analysis O +
using O +
21 O +
intragenic O +
polymorphic O +
markers O +
plus O +
a O +
novel O +
polymorphism O +
IVS32 O -
- O -
97 O +
A O +
/ O +
G O +
in O +
the O +
vicinity O +
of O +
the O +
IVS32 O +
splicing O +
mutation O +
. O +

Patient O +
1 O +
of O +
Chinese O +
origin O +
and O +
the O +
Japanese O +
patient O +
homozygous O +
for O +
the O +
IVS32 O -
- O -
12A O +
> O +
G O +
were O +
found O +
to O +
have O +
different O +
haplotypes O +
, O +
indicating O +
the O +
IVS32 O -
- O -
12A O +
> O +
G O +
mutation O +
to O +
be O +
a O +
recurrent O +
mutation O +
. O +

This O +
is O +
the O +
first O +
recurrent O +
mutation O +
established O +
by O +
intense O +
haplotyping O +
in O +
the O +
AGL B-Gene +
gene O +
. O +

Distinct O +
expression O +
pattern O +
of O +
two O +
related O +
human O +
proteins O +
containing O +
multiple O +
types O +
of O +
protease B-Gene +
- O +
inhibitory O +
modules O +
. O +

We O +
have O +
recently O +
identified O +
a O +
gene O +
( O +
the O +
WFIKKN B-Gene +
gene O +
) O +
on O +
human O +
chromosome O +
16 O +
( O +
16p13.3 O +
) O +
that O +
encodes O +
a O +
secreted O +
protein O +
containing O +
WAP B-Gene +
- I-Gene +
type I-Gene +
, I-Gene +
Follistatin I-Gene +
/ I-Gene +
Kazal I-Gene +
type I-Gene +
, I-Gene +
Kunitz I-Gene +
- I-Gene +
type I-Gene +
and I-Gene +
NTR I-Gene +
- I-Gene +
type I-Gene +
protease I-Gene +
- O +
inhibitory O +
modules O +
and O +
an O +
Immunoglobulin B-Gene +
domain O +
[ O +
Trexler O +
et O +
al. O +
, O +
Proc O -
. O +
Natl O -
. O +
Acad O -
. O +
Sci O -
. O +
USA O +
98 O +
( O +
2001 O +
) O +
, O +
3705 O +
- O +
3709 O +
] O +
. O +

In O +
the O +
present O +
work O +
we O +
show O +
that O +
a O +
gene O +
on O +
chromosome O +
17 O +
encodes O +
a O +
WFIKKN B-Gene +
- I-Gene +
related I-Gene +
protein I-Gene +
( O +
WFIKKNRP B-Gene +
) O +
that O +
has O +
the O +
same O +
domain O +
organization O +
as O +
the O +
WFIKKN B-Gene +
protein O +
. O +

The O +
exon O +
- O +
intron O +
structure O +
of O +
the O +
two O +
genes O +
is O +
also O +
similar O +
as O +
both O +
genes O +
have O +
a O +
single O +
phase O +
0 O +
intron O +
that O +
splits O +
their O +
WAP O +
domains O +
in O +
equivalent O +
positions O +
. O +

In O +
view O +
of O +
the O +
presence O +
of O +
several O +
protease B-Gene +
inhibitory O +
modules O +
in O +
these O +
proteins O +
it O +
seems O +
likely O +
that O +
they O +
serve O +
to O +
control O +
the O +
action O +
of O +
multiple O +
types O +
of O +
proteases B-Gene +
. O +

The O +
tissue O +
expression O +
pattern O +
of O +
the O +
two O +
proteins O +
, O +
however O +
, O +
is O +
markedly O +
different O +
suggesting O +
that O +
they O +
have O +
distinct O +
biological O +
roles O +
. O +

Whereas O +
the O +
WFIKKN B-Gene +
gene O +
is O +
expressed O +
primarily O +
in O +
adult O +
pancreas O +
, O +
liver O +
and O +
thymus O +
but O +
not O +
in O +
brain O +
and O +
ovary O +
, O +
significant O +
expression O +
of O +
the O +
WFIKKNRP B-Gene +
gene O +
is O +
observed O +
in O +
ovary O +
, O +
testis O +
and O +
brain O +
, O +
but O +
not O +
in O +
liver O +
. O +

Pronounced O +
differences O +
could O +
also O +
be O +
seen O +
in O +
the O +
case O +
of O +
fetal O +
tissues O +
: O +
expression O +
of O +
the O +
WFIKKN B-Gene +
gene O +
was O +
highest O +
in O +
the O +
lung O +
, O +
skeletal O +
muscle O +
and O +
liver O +
, O +
whereas O +
the O +
WFIKKNRP B-Gene +
gene O +
was O +
expressed O +
primarily O +
in O +
brain O +
, O +
skeletal O +
muscle O +
, O +
thymus O +
and O +
kidney O +
. O +

Independent O +
regulation O +
of O +
the O +
divergent O +
Escherichia O +
coli O +
nrfA B-Gene +
and O +
acsP1 B-Gene +
promoters O +
by O +
a O +
nucleoprotein O +
assembly O +
at O +
a O +
shared O +
regulatory O +
region O +
. O +

Expression O +
from O +
the O +
Escherichia O +
coli O +
nrfA B-Gene +
promoter O +
( O +
pnrfA O +
) O +
is O +
activated O +
by O +
both O +
the O +
FNR B-Gene +
protein O +
( O +
an O +
anaerobically O +
triggered O +
transcription O +
activator O +
) O +
and O +
the O +
NarL B-Gene +
or O +
NarP B-Gene +
proteins O +
( O +
transcription O +
activators O +
triggered O +
by O +
nitrite O +
and O +
nitrate O +
) O +
. O +

Under O +
anaerobic O +
conditions O +
, O +
FNR B-Gene +
binds O +
to O +
a O +
site O +
centred O +
at O +
position O +
- O +
41.5 O +
at O +
pnrfA O +
and O +
activates O +
transcription O +
. O +

Further O +
activation O +
, O +
induced O +
by O +
the O +
presence O +
of O +
nitrite O +
, O +
results O +
from O +
the O +
binding O +
of O +
NarL B-Gene +
and O +
NarP B-Gene +
to O +
a O +
site O +
centred O +
at O +
position O +
- O +
74.5 O +
. O +

A O +
second O +
promoter O +
( O +
pacsP1 O +
) O +
, O +
which O +
directs O +
transcription O +
into O +
the O +
adjacent O +
gene O +
encoding O +
acetyl B-Gene +
coenzyme I-Gene +
A I-Gene +
synthetase I-Gene +
( O +
acs B-Gene +
) O +
, O +
is O +
overlapping O +
and O +
divergent O +
to O +
pnrfA O +
. O +

Despite O +
extensive O +
overlap O +
of O +
regulatory O +
elements O +
, O +
pnrfA O +
and O +
pacsP1 O +
are O +
regulated O +
independently O +
. O +

We O +
demonstrate O +
that O +
at O +
least O +
two O +
nucleoid O +
- O +
associated O +
factors O +
bind O +
to O +
the O +
nrfA B-Gene +
- O +
acs B-Gene +
intergenic O +
region O +
. O +

The O +
Fis B-Gene +
protein O +
binds O +
to O +
a O +
site O +
centred O +
at O +
position O +
- O +
15 O +
( O +
in O +
relation O +
to O +
pnrfA O +
transcription O +
) O +
, O +
whereas O +
the O +
IHF B-Gene +
protein O +
binds O +
to O +
a O +
site O +
centred O +
at O +
position O +
- O +
54 O +
. O +

Both O +
Fis B-Gene +
and O +
IHF B-Gene +
repress O +
in O +
vivo O +
expression O +
from O +
pacsP1 O +
, O +
but O +
have O +
smaller O +
repressive O +
effects O +
on O +
expression O +
from O +
pnrfA O +
. O +

Gel O +
retardation O +
assays O +
were O +
used O +
to O +
investigate O +
the O +
pairwise O +
binding O +
of O +
FNR B-Gene +
, O +
NarL B-Gene +
, O +
Fis B-Gene +
and O +
IHF B-Gene +
proteins O +
to O +
the O +
nrfA B-Gene +
- O +
acs B-Gene +
intergenic O +
region O +
. O +

The O +
binding O +
of O +
NarL B-Gene +
and O +
IHF B-Gene +
is O +
mutually O +
exclusive O +
, O +
whereas O +
all O +
other O +
combinations O +
can O +
bind O +
simultaneously O +
. O +

Experiments O +
in O +
which O +
deletions O +
and O +
point O +
mutations O +
were O +
introduced O +
into O +
the O +
upstream O +
region O +
of O +
pnrfA O +
demonstrated O +
that O +
an O +
additional O +
factor O +
must O +
bind O +
upstream O +
to O +
inhibit O +
FNR B-Gene +
- O +
dependent O +
transcription O +
. O +

We O +
conclude O +
that O +
the O +
nrfA B-Gene +
- O +
acs B-Gene +
intergenic O +
region O +
is O +
folded O +
into O +
an O +
ordered O +
nucleoprotein O +
structure O +
that O +
permits O +
the O +
two O +
divergent O +
promoters O +
to O +
be O +
regulated O +
independently O +
in O +
response O +
to O +
different O +
physiological O +
signals O +
. O +

Ran B-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
3 I-Gene +
links O +
Crm1 B-Gene +
to O +
the O +
Ran B-Gene +
guanine I-Gene +
nucleotide I-Gene +
exchange I-Gene +
factor I-Gene +
. O +

Ran B-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
3 I-Gene +
( O +
RanBP3 B-Gene +
) O +
is O +
an O +
approximately O +
55 O +
- O +
kDa O +
protein O +
that O +
functions O +
as O +
a O +
cofactor O +
for O +
Crm1 B-Gene +
- O +
mediated O +
nuclear O +
export O +
. O +

RanBP3 B-Gene +
stimulates O +
export O +
by O +
enhancing O +
the O +
affinity O +
of O +
Crm1 B-Gene +
for O +
Ran B-Gene +
. O +
GTP O +
and O +
cargo O +
. O +

However O +
, O +
important O +
additional O +
functions O +
for O +
this O +
cofactor O +
may O +
exist O +
. O +

We O +
now O +
report O +
that O +
RanBP3 B-Gene +
associates O +
with O +
the O +
Ran B-Gene +
- O +
specific O +
guanine B-Gene +
nucleotide I-Gene +
exchange I-Gene +
factor I-Gene +
, O +
regulator B-Gene +
of I-Gene +
chromosome I-Gene +
condensation I-Gene +
1 I-Gene +
( O +
RCC1 B-Gene +
) O +
. O +

This O +
interaction O +
was O +
stimulated O +
by O +
the O +
addition O +
of O +
Ran B-Gene +
; O +
moreover O +
, O +
Ran B-Gene +
. O +
GDP O +
, O +
Ran B-Gene +
. O +
GTP O +
, O +
and O +
Ran B-Gene +
without O +
nucleotide O +
could O +
all O +
stimulate O +
complex O +
formation O +
between O +
RanBP3 B-Gene +
and O +
RCC1 B-Gene +
even O +
though O +
binding O +
of O +
Ran B-Gene +
. O +
GDP O +
to O +
RanBP3 B-Gene +
alone O +
was O +
undetectable O +
. O +

RanBP3 B-Gene +
could O +
also O +
promote O +
binding O +
of O +
Crm1 B-Gene +
to O +
RCC1 B-Gene +
in O +
the O +
presence O +
of O +
Ran B-Gene +
. O +

Binding O +
of O +
RanBP3 B-Gene +
to O +
RCC1 B-Gene +
increased O +
the O +
catalytic O +
activity O +
of O +
RCC1 B-Gene +
toward O +
Ran B-Gene +
, O +
and O +
importantly O +
, O +
the O +
ability O +
of O +
RanBP3 B-Gene +
to O +
stimulate O +
RCC1 B-Gene +
was O +
not O +
affected O +
by O +
the O +
presence O +
of O +
Crm1 B-Gene +
. O +

These O +
data O +
indicate O +
that O +
RanBP3 B-Gene +
acts O +
as O +
a O +
scaffold O +
protein O +
to O +
promote O +
the O +
efficient O +
assembly O +
of O +
export O +
complexes O +
. O +

By O +
tethering O +
Crm1 B-Gene +
to O +
catalytically O +
enhanced O +
RCC1 B-Gene +
, O +
RanBP3 B-Gene +
may O +
lower O +
the O +
entropic O +
barrier O +
for O +
the O +
loading O +
of O +
Ran B-Gene +
. O +
GTP O +
onto O +
Crm1 B-Gene +
. O +

We O +
propose O +
that O +
this O +
provides O +
an O +
additional O +
mechanism O +
by O +
which O +
RanBP3 B-Gene +
facilitates O +
export O +
. O +

The O +
TRIM37 B-Gene +
gene O +
encodes O +
a O +
peroxisomal O +
RING O -
- O -
B O -
- O -
box O -
- O -
coiled O +
- O +
coil O +
protein O +
: O +
classification O +
of O +
mulibrey O +
nanism O +
as O +
a O +
new O +
peroxisomal O +
disorder O +
. O +

Mulibrey O +
nanism O +
is O +
a O +
rare O +
growth O +
disorder O +
of O +
prenatal O +
onset O +
caused O +
by O +
mutations O +
in O +
the O +
TRIM37 B-Gene +
gene O +
, O +
which O +
encodes O +
a O +
RING O +
- O +
B O -
- O -
box O +
- O +
coiled O +
- O +
coil O +
protein O +
. O +

The O +
pathogenetic O +
mechanisms O +
of O +
mulibrey O +
nanism O +
are O +
unknown O +
. O +

We O +
have O +
used O +
transiently O +
transfected O +
cells O +
and O +
antibodies O +
raised O +
against O +
the O +
predicted O +
TRIM37 B-Gene +
protein O +
to O +
characterize O +
the O +
TRIM37 B-Gene +
gene O +
product O +
and O +
to O +
determine O +
its O +
intracellular O +
localization O +
. O +

We O +
show O +
that O +
the O +
human O +
TRIM37 B-Gene +
cDNA O +
encodes O +
a O +
peroxisomal O +
protein O +
with O +
an O +
apparent O +
molecular O +
weight O +
of O +
130 O +
kD O +
. O +

Peroxisomal O +
localization O +
is O +
compromised O +
in O +
mutant O +
protein O +
representing O +
the O +
major O +
Finnish O +
TRIM37 B-Gene +
mutation O +
but O +
is O +
retained O +
in O +
the O +
protein O +
representing O +
the O +
minor O +
Finnish O +
mutation O +
. O +

Colocalization O +
of O +
endogenous O +
TRIM37 B-Gene +
with O +
peroxisomal O +
markers O +
was O +
observed O +
by O +
double O +
immunofluorescence O +
staining O +
in O +
HepG2 O +
and O +
human O +
intestinal O +
smooth O +
muscle O +
cell O +
lines O +
. O +

In O +
human O +
tissue O +
sections O +
, O +
TRIM37 B-Gene +
shows O +
a O +
granular O +
cytoplasmic O +
pattern O +
. O +

Endogenous O +
TRIM37 B-Gene +
is O +
not O +
imported O +
into O +
peroxisomes O +
in O +
peroxin B-Gene +
1 I-Gene +
( O +
PEX1 B-Gene +
( O +
- O -
/ O -
- O +
) O +
) O +
and O +
peroxin B-Gene +
5 I-Gene +
( O +
PEX5 B-Gene +
( O +
- O +
/ O +
- O +
) O +
) O +
mutant O +
fibroblasts O +
but O +
is O +
imported O +
normally O +
in O +
peroxin B-Gene +
7 I-Gene +
( O +
PEX7 B-Gene +
( O +
- O -
/ O -
- O +
) O +
) O +
deficient O +
fibroblasts O +
, O +
giving O +
further O +
evidence O +
for O +
a O +
peroxisomal O +
localization O +
of O +
TRIM37 B-Gene +
. O +

Fibroblasts O +
derived O +
from O +
patients O +
with O +
mulibrey O +
nanism O +
lack O +
C O +
- O +
terminal O +
TRIM37 B-Gene +
immunoreactivity O +
but O +
stain O +
normally O +
for O +
both O +
peroxisomal O +
matrix O +
and O +
membrane O +
markers O +
, O +
suggesting O +
apparently O +
normal O +
peroxisome O +
biogenesis O +
in O +
patient O +
fibroblasts O +
. O +

Taken O +
together O +
, O +
this O +
molecular O +
evidence O +
unequivocally O +
indicates O +
that O +
TRIM37 B-Gene +
is O +
located O +
in O +
the O +
peroxisomes O +
, O +
and O +
Mulibrey O +
nanism O +
thus O +
can O +
be O +
classified O +
as O +
a O +
new O +
peroxisomal O +
disorder O +
. O +

The O +
apolipoprotein B-Gene +
L I-Gene +
gene O +
cluster O +
has O +
emerged O +
recently O +
in O +
evolution O +
and O +
is O +
expressed O +
in O +
human O +
vascular O +
tissue O +
. O +

We O +
previously O +
isolated O +
APOL3 B-Gene +
( O +
CG12 B-Gene -
- I-Gene -
1 I-Gene +
) O +
cDNA O +
and O +
now O +
describe O +
the O +
isolation O +
of O +
APOL1 B-Gene +
and O +
APOL2 B-Gene +
cDNA O +
from O +
an O +
activated O +
endothelial O +
cell O +
cDNA O +
library O +
and O +
show O +
their O +
endothelialspecific O +
expression O +
in O +
human O +
vascular O +
tissue O +
. O +

APOL1 B-Gene +
- I-Gene +
APOL4 I-Gene +
are O +
clustered O +
on O +
human O +
chromosome O +
22q13.1 O +
, O +
as O +
a O +
result O +
of O +
tandem O +
gene O +
duplication O +
, O +
and O +
were O +
detected O +
only O +
in O +
primates O +
( O +
humans O +
and O +
African O +
green O +
monkeys O +
) O +
and O +
not O +
in O +
dogs O +
, O +
pigs O +
, O +
or O +
rodents O +
, O +
showing O +
that O +
this O +
gene O +
cluster O +
has O +
arisen O +
recently O +
in O +
evolution O +
. O +

The O +
specific O +
tissue O +
distribution O +
and O +
gene O +
organization O +
suggest O +
that O +
these O +
genes O +
have O +
diverged O +
rapidly O +
after O +
duplication O +
. O +

This O +
has O +
resulted O +
in O +
the O +
emergence O +
of O +
an O +
additional O +
signal O +
peptide O +
encoding O +
exon O +
that O +
ensures O +
secretion O +
of O +
the O +
plasma O +
high B-Gene +
- I-Gene +
density I-Gene +
lipoprotein I-Gene +
- O +
associated O +
APOL1 B-Gene +
. O +

Our O +
results O +
show O +
that O +
the O +
APOL1 B-Gene +
- I-Gene +
APOL4 I-Gene +
cluster O +
might O +
contribute O +
to O +
the O +
substantial O +
differences O +
in O +
the O +
lipid O +
metabolism O +
of O +
humans O +
and O +
mice O +
, O +
as O +
dictated O +
by O +
the O +
variable O +
expression O +
of O +
genes O +
involved O +
in O +
this O +
process O +
. O +

Cooperative O +
E O -
- O -
box O +
regulation O +
of O +
human O +
GLI1 B-Gene +
by O +
TWIST B-Gene +
and O +
USF B-Gene +
. O +

Sonic B-Gene +
hedgehog I-Gene +
signaling O +
plays O +
a O +
critical O +
role O +
in O +
vertebrate O +
patterning O +
, O +
and O +
signaling O +
defects O +
are O +
associated O +
with O +
severe O +
birth O +
defects O +
and O +
cancer O +
in O +
man O +
. O +

GLI1 B-Gene +
encodes O +
a O +
critical O +
transcription O +
activator O +
in O +
this O +
pathway O +
. O +

GLI1 B-Gene +
is O +
expressed O +
in O +
human O +
basal O +
cell O +
carcinomas O +
and O +
sarcomas O +
. O +

Despite O +
the O +
significance O +
of O +
the O +
GLI1 B-Gene +
gene O +
in O +
human O +
disease O +
, O +
few O +
immediate O +
upstream O +
regulators O +
of O +
GLI1 B-Gene +
expression O +
are O +
known O +
. O +

We O +
previously O +
demonstrated O +
that O +
a O +
5 O -
' O +
region O +
, O +
including O +
5 O +
' O +
flanking O +
sequence O +
, O +
an O +
untranslated O +
exon O +
, O +
and O +
425 O +
bp O +
of O +
the O +
first O +
intron O +
, O +
regulates O +
the O +
human O +
GLI1 B-Gene +
gene O +
. O +

Here O +
we O +
show O +
that O +
inactivating O +
mutations O +
in O +
E O -
- O -
box O +
, O +
GC O +
box O +
, O +
AP-2 B-Gene +
, O +
GATA O +
, O +
GSG O +
, O +
PuF B-Gene +
, O +
and O +
Zeste B-Gene +
sites O +
identified O +
three O +
critical O +
regulatory O +
elements O +
, O +
including O +
a O +
GC O +
box O +
that O +
binds O +
Sp1 B-Gene +
and O +
two O +
intronic O +
E O -
- O -
boxes O +
that O +
bind O +
USF B-Gene +
proteins O +
or O +
Twist B-Gene +
. O +

Expression O +
of O +
Twist B-Gene +
but O +
not O +
a O +
frame O +
shift O +
mutation O +
of O +
Twist B-Gene +
activates O +
the O +
wild O +
- O +
type O +
human O +
GLI1 B-Gene +
regulatory O +
sequences O +
but O +
not O +
with O +
inactivating O +
mutations O +
of O +
the O +
E O -
- O -
boxes O +
. O +

Twist B-Gene +
activates O +
GLI1 B-Gene +
reporter O +
expression O +
through O +
E O -
- O -
box O +
+ O +
482 O +
but O +
requires O +
binding O +
of O +
USF B-Gene +
proteins O +
to O +
E O -
- O -
box O +
+ O +
157 O +
. O +

Twist B-Gene +
mutations O +
cause O +
human O +
birth O +
defects O +
and O +
Twist B-Gene +
is O +
overexpressed O +
in O +
many O +
rhabdomyosarcomas O +
, O +
suggesting O +
that O +
one O +
of O +
Twist B-Gene +
's O +
primary O +
roles O +
is O +
the O +
regulation O +
of O +
GLI1 B-Gene +
. O +

Structure O +
of O +
the O +
16S B-Gene +
rRNA I-Gene +
pseudouridine I-Gene +
synthase I-Gene +
RsuA B-Gene +
bound O +
to O +
uracil O +
and O +
UMP O +
. O +

In O +
Escherichia O +
coli O +
, O +
the O +
pseudouridine B-Gene +
synthase I-Gene +
RsuA B-Gene +
catalyzes O +
formation O +
of O +
pseudouridine O +
( O +
psi O +
) O +
at O +
position O +
516 O +
in O +
16S O +
rRNA O +
during O +
assembly O +
of O +
the O +
30S O +
ribosomal O +
subunit O +
. O +

We O +
have O +
determined O +
the O +
crystal O +
structure O +
of O +
RsuA B-Gene +
bound O +
to O +
uracil O +
at O +
2.0 O +
A O +
resolution O +
and O +
to O +
uridine O +
5'-monophosphate O +
( O +
UMP O +
) O +
at O +
2.65 O +
A O +
resolution O +
. O +

RsuA B-Gene +
consists O +
of O +
an O +
N O +
- O +
terminal O +
domain O +
connected O +
by O +
an O +
extended O +
linker O +
to O +
the O +
central O +
and O +
C O +
- O +
terminal O +
domains O +
. O +

Uracil O +
and O +
UMP O +
bind O +
in O +
a O +
cleft O +
between O +
the O +
central O +
and O +
C O +
- O +
terminal O +
domains O +
near O +
the O +
catalytic O +
residue O +
Asp O +
102 O +
. O +

The O +
N O +
- O +
terminal O +
domain O +
shows O +
structural O +
similarity O +
to O +
the O +
ribosomal B-Gene +
protein I-Gene +
S4 I-Gene +
. O +

Despite O +
only O +
15 O +
% O +
amino O +
acid O +
identity O +
, O +
the O +
other O +
two O +
domains O +
are O +
structurally O +
similar O +
to O +
those O +
of O +
the O +
tRNA O +
- O +
specific O +
psi B-Gene +
- I-Gene +
synthase I-Gene +
TruA B-Gene +
, O +
including O +
the O +
position O +
of O +
the O +
catalytic O +
Asp O +
. O +

Our O +
results O +
suggest O +
that O +
all O +
four O +
families B-Gene +
of I-Gene +
pseudouridine I-Gene +
synthases I-Gene +
share O +
the O +
same O +
fold O +
of O +
their O +
catalytic O +
domain O -
( O -
s O -
) O +
and O +
uracil O +
- O +
binding O +
site O +
. O +

Transcriptional O +
control O +
of O +
the O +
human O +
thromboxane B-Gene +
synthase I-Gene +
gene O +
in O +
vivo O +
and O +
in O +
vitro O +
. O +

Thromboxane O +
A O -
( O -
2 O -
) O +
, O +
a O +
potent O +
mediator O +
of O +
vasoconstriction O +
and O +
platelet O +
aggregation O +
, O +
is O +
synthesized O +
from O +
prostaglandin O +
H O -
( O -
2 O -
) O +
by O +
thromboxane B-Gene +
synthase I-Gene +
( O +
TXAS B-Gene +
) O +
. O +

We O +
report O +
here O +
on O +
promoter O +
analyses O +
of O +
human O +
TXAS B-Gene +
using O +
in O +
vitro O +
transcription O +
and O +
in O +
vivo O +
transfection O +
methods O +
. O +

The O +
39 O +
- O +
bp O +
core O +
promoter O +
, O +
containing O +
both O +
TATA O +
and O +
initiator O +
elements O +
, O +
accurately O +
initiates O +
transcription O +
in O +
an O +
orientation O +
- O +
dependent O +
manner O +
in O +
a O +
cell O +
- O +
free O +
transcription O +
system O +
. O +

Mutation O +
of O +
either O +
TATA O +
or O +
initiator O +
abolished O +
transcriptional O +
activity O +
, O +
but O +
the O +
upstream O +
sequence O +
had O +
no O +
effect O +
on O +
TXAS B-Gene +
promoter O +
activities O +
in O +
vitro O +
, O +
suggesting O +
that O +
the O +
core O +
promoter O +
is O +
sufficient O +
for O +
transcriptional O +
activity O +
from O +
a O +
naked O +
DNA O +
template O +
. O +

In O +
contrast O +
, O +
mutation O +
of O +
both O +
elements O +
drastically O +
decreased O +
the O +
promoter O +
activity O +
in O +
vivo O +
. O +

Furthermore O +
, O +
TXAS B-Gene +
proximal O +
promoter O +
containing O +
the O +
nucleotides O +
- O +
90 O +
to O +
- O +
56 O +
relative O +
to O +
the O +
transcriptional O +
start O +
site O +
was O +
necessary O +
for O +
promoter O +
transactivation O +
in O +
vivo O +
. O +

Transcriptional O +
activities O +
from O +
5'-deletion O +
mutants O +
indicated O +
that O +
the O +
effects O +
of O +
the O +
nucleotides O +
- O +
90 O +
/ O +
- O +
56 O +
were O +
more O +
pronounced O +
in O +
stably O +
transfected O +
cells O +
( O +
a O +
150 O +
- O +
fold O +
difference O +
) O +
than O +
in O +
the O +
transiently O +
transfected O +
cells O +
( O +
an O +
8 O +
- O +
fold O +
difference O +
) O +
, O +
reflecting O +
the O +
effects O +
of O +
TXAS B-Gene +
transcriptional O +
activation O +
from O +
replicating O +
and O +
nonreplicating O +
DNA O +
templates O +
. O +

Partial O +
micrococcal O +
nuclease B-Gene +
digestion O +
indicated O +
that O +
the O +
sequence O +
- O +
90 O +
/ O +
- O +
56 O +
, O +
where O +
the O +
NF B-Gene -
- I-Gene -
E2 I-Gene +
site O +
is O +
located O +
, O +
is O +
associated O +
with O +
alterations O +
of O +
nucleosomal O +
structure O +
at O +
the O +
regions O +
of O +
promoter O +
and O +
reporter O +
gene O +
but O +
not O +
the O +
region O +
further O +
downstream O +
. O +

Mutagenesis O +
and O +
forced O +
expression O +
studies O +
demonstrated O +
a O +
critical O +
role O +
of O +
p45 B-Gene +
NF I-Gene -
- I-Gene -
E2 I-Gene +
in O +
controlling O +
TXAS B-Gene +
expression O +
under O +
native O +
chromatin O +
conditions O +
. O +

Band O +
shifting O +
and O +
chromatin O +
immunoprecipitation O +
assays O +
indicated O +
that O +
p45 B-Gene +
NF I-Gene -
- I-Gene -
E2 I-Gene +
was O +
bound O +
to O +
the O +
TXAS B-Gene +
promoter O +
in O +
vitro O +
and O +
in O +
vivo O +
. O +

Indirect O +
end O +
labeling O +
and O +
ligation O +
- O +
mediated O +
PCR O +
analyses O +
further O +
demonstrated O +
that O +
the O +
occupation O +
of O +
TXAS B-Gene +
promoter O +
NF B-Gene -
- I-Gene -
E2 I-Gene +
site O +
was O +
associated O +
with O +
disruption O +
of O +
nucleosomal O +
structure O +
. O +

Collectively O +
, O +
these O +
results O +
indicate O +
that O +
binding O +
of O +
NF B-Gene -
- I-Gene -
E2 I-Gene +
is O +
critical O +
both O +
for O +
alteration O +
of O +
the O +
nucleosomal O +
structure O +
and O +
for O +
activation O +
of O +
the O +
TXAS B-Gene +
promoter O +
, O +
whereas O +
the O +
TATA O +
and O +
initiator O +
elements O +
are O +
essential O +
for O +
transcription O +
. O +

Rapid O +
evolution O +
of O +
the O +
male O +
- O +
specific O +
antibacterial O +
protein O +
andropin B-Gene +
gene O +
in O +
Drosophila O +
. O +

Andropin B-Gene +
, O +
which O +
encodes O +
an O +
antibacterial O +
protein O +
, O +
is O +
closely O +
linked O +
to O +
the O +
Cecropin B-Gene +
gene O +
cluster O +
of O +
D. O +
melanogaster O +
. O +

Andropin B-Gene +
and O +
Cecropins B-Gene +
are O +
considered O +
to O +
have O +
originated O +
from O +
one O +
common O +
ancestor O +
. O +

However O +
, O +
the O +
expression O +
pattern O +
of O +
Andropin B-Gene +
is O +
distinct O +
from O +
that O +
of O +
Cecropins B-Gene +
, O +
being O +
restricted O +
to O +
the O +
adult O +
male O +
ejaculatory O +
duct O +
. O +

To O +
elucidate O +
the O +
evolutionary O +
process O +
of O +
Andropin B-Gene +
, O +
we O +
have O +
sequenced O +
Andropin B-Gene +
genes O +
from O +
D. O +
melanogaster O +
and O +
its O +
closely O +
related O +
species O +
. O +

In O +
D. O +
melanogaster O +
, O +
the O +
nucleotide O +
diversity O +
of O +
Andropin B-Gene +
is O +
remarkably O +
low O +
compared O +
to O +
that O +
of O +
Cecropin B-Gene +
. O +

In O +
contrast O +
, O +
nonsynonymous O +
substitutions O +
of O +
Andropin B-Gene +
are O +
conspicuously O +
frequent O +
between O +
species O +
. O +

From O +
genomic O +
Southern O +
analysis O +
, O +
Andropin B-Gene +
- O +
like O +
genes O +
are O +
present O +
in O +
at O +
least O +
the O +
melanogaster O +
species O +
subgroup O +
. O +

The O +
series O +
of O +
present O +
results O +
suggests O +
that O +
Andropin B-Gene +
was O +
born O +
in O +
the O +
course O +
of O +
constructing O +
the O +
Drosophila O +
Cecropin B-Gene +
gene I-Gene +
family I-Gene +
and O +
then O +
started O +
to O +
evolve O +
rapidly O +
, O +
in O +
contrast O +
to O +
Cecropins B-Gene +
. O +

Structural O +
insights O +
into O +
the O +
pro O +
- O +
apoptotic O +
function O +
of O +
mitochondrial O +
serine B-Gene +
protease I-Gene +
HtrA2 B-Gene +
/ O +
Omi B-Gene +
. O +

HtrA2 B-Gene +
/ O +
Omi B-Gene +
, O +
a O +
mitochondrial O +
serine B-Gene +
protease I-Gene +
in O +
mammals O +
, O +
is O +
important O +
in O +
programmed O +
cell O +
death O +
. O +

However O +
, O +
the O +
underlining O +
mechanism O +
of O +
HtrA2 B-Gene +
/ O +
Omi B-Gene +
- O +
mediated O +
apoptosis O +
remains O +
unclear O +
. O +

Analogous O +
to O +
the O +
bacterial O +
homolog O +
HtrA B-Gene +
( O +
DegP B-Gene +
) O +
, O +
the O +
mature O +
HtrA2 B-Gene +
protein O +
contains O +
a O +
central O +
serine B-Gene +
protease I-Gene +
domain O +
and O +
a O +
C O +
- O +
terminal O +
PDZ O +
domain O +
. O +

The O +
2.0 O +
A O +
crystal O +
structure O +
of O +
HtrA2 B-Gene +
/ O +
Omi B-Gene +
reveals O +
the O +
formation O +
of O +
a O +
pyramid O +
- O +
shaped O +
homotrimer O +
mediated O +
exclusively O +
by O +
the O +
serine B-Gene +
protease I-Gene +
domains O +
. O +

The O +
peptide O +
- O +
binding O +
pocket O +
of O +
the O +
PDZ O +
domain O +
is O +
buried O +
in O +
the O +
intimate O +
interface O +
between O +
the O +
PDZ O +
and O +
the O +
protease B-Gene +
domains O +
. O +

Mutational O +
analysis O +
reveals O +
that O +
the O +
monomeric O +
HtrA2 B-Gene +
/ O +
Omi B-Gene +
mutants O +
are O +
unable O +
to O +
induce O +
cell O +
death O +
and O +
are O +
deficient O +
in O +
protease B-Gene +
activity O +
. O +

The O +
PDZ O +
domain O +
modulates O +
HtrA2 B-Gene +
/ O +
Omi B-Gene +
- O +
mediated O +
cell O +
death O +
activity O +
by O +
regulating O +
its O +
serine B-Gene +
protease I-Gene +
activity O +
. O +

These O +
structural O +
and O +
biochemical O +
observations O +
provide O +
an O +
important O +
framework O +
for O +
deciphering O +
the O +
mechanisms O +
of O +
HtrA2 B-Gene +
/ O +
Omi B-Gene +
- O +
mediated O +
apoptosis O +
. O +

The O +
distribution O +
of O +
activin B-Gene +
and O +
activin B-Gene +
receptors I-Gene +
in O +
gestational O +
tissues O +
across O +
human O +
pregnancy O +
and O +
during O +
labour O +
. O +

The O +
aim O +
of O +
this O +
study O +
was O +
to O +
investigate O +
localization O +
and O +
content O +
of O +
activin B-Gene +
beta I-Gene +
A I-Gene +
- O +
subunit O +
and O +
activin B-Gene +
receptors I-Gene +
in O +
gestational O +
tissues O +
throughout O +
pregnancy O +
and O +
in O +
association O +
with O +
term O +
labour O +
. O +

Placenta O +
and O +
fetal O +
membranes O +
were O +
collected O +
from O +
women O +
undergoing O +
first O +
and O +
second O +
trimester O +
terminations O +
and O +
from O +
women O +
before O +
and O +
after O +
term O +
labour O +
. O +

Activin B-Gene +
beta I-Gene +
A I-Gene +
- O +
subunit O +
and O +
activin B-Gene +
receptors I-Gene +
IA I-Gene +
, I-Gene +
IB I-Gene +
, I-Gene +
IIA I-Gene +
and I-Gene +
IIB I-Gene +
were O +
studied O +
by O +
immunohistochemistry O +
. O +

Term O +
tissues O +
were O +
analysed O +
for O +
activin B-Gene +
A I-Gene +
and O +
follistatin B-Gene +
content O +
by O +
ELISA O +
and O +
the O +
presence O +
of O +
receptor O +
proteins O +
was O +
assessed O +
by O +
Western O +
hybridization O +
. O +

Activin B-Gene +
beta I-Gene +
A I-Gene +
- O +
subunit O +
was O +
localized O +
to O +
the O +
syncytiotrophoblast O +
and O +
cytotrophoblast O +
in O +
placentae O +
from O +
all O +
gestational O +
ages O +
, O +
and O +
to O +
the O +
amniotic O +
epithelial O +
and O +
chorionic O +
trophoblast O +
layer O +
at O +
term O +
. O +

In O +
placentae O +
of O +
first O +
and O +
second O +
trimester O +
, O +
receptor O +
proteins O +
were O +
localized O +
to O +
the O +
syncytium O +
, O +
whereas O +
at O +
term O +
, O +
the O +
distribution O +
was O +
confined O +
predominantly O +
to O +
vascular O +
endothelial O +
cells O +
of O +
villous O +
blood O +
vessels O +
. O +

Receptor O +
proteins O +
in O +
amnion O +
were O +
localized O +
to O +
some O +
epithelial O +
cells O +
, O +
mesenchyme O +
and O +
chorionic O +
trophoblast O +
. O +

These O +
findings O +
suggest O +
that O +
activin B-Gene +
A I-Gene +
is O +
secreted O +
by O +
and O +
targets O +
the O +
placental O +
syncytium O +
and O +
amniotic O +
epithelium O +
in O +
early O +
pregnancy O +
, O +
but O +
at O +
term O +
targets O +
the O +
vascular O +
endothelium O +
of O +
placenta O +
and O +
the O +
fetal O +
membranes O +
. O +

There O +
were O +
no O +
differences O +
with O +
labour O +
onset O +
. O +

Functional O +
modulation O +
of O +
expanded O +
CD8 B-Gene +
+ O +
synovial O +
fluid O +
T O +
cells O +
by O +
NK O +
cell O +
receptor O +
expression O +
in O +
HLA B-Gene -
- I-Gene -
B27 I-Gene +
- O +
associated O +
reactive O +
arthritis O +
. O +

The O +
aim O +
of O +
this O +
study O +
was O +
to O +
determine O +
whether O +
NK O +
cell O +
receptor O +
( O +
NKR O +
) O +
expression O +
could O +
modulate O +
cytotoxicity O +
of O +
oligoclonal O +
CD8 B-Gene +
+ O +
T O +
cells O +
present O +
in O +
the O +
synovial O +
fluid O +
( O +
SF O +
) O +
of O +
HLA B-Gene -
- I-Gene -
B27 I-Gene +
- O +
reactive O +
arthritis O +
( O +
ReA O +
) O +
patients O +
, O +
especially O +
in O +
a O +
TCRBV1 O +
population O +
shared O +
among O +
different O +
patients O +
and O +
cytotoxic O +
toward O +
HLA B-Gene -
- I-Gene -
B27 I-Gene +
. O +

A O +
CD8 B-Gene +
+ O +
T O +
cell O +
line O +
, O +
two O +
TCRBV1 O +
lines O +
and O +
clones O +
were O +
isolated O +
from O +
the O +
SF O +
of O +
an O +
HLA B-Gene -
- I-Gene -
B27 I-Gene +
+ O +
ReA O +
patient O +
, O +
and O +
tested O +
with O +
mAb O +
specific O +
for O +
Ig B-Gene +
- O +
like O +
( O +
KIR2DL1 B-Gene +
, O +
KIR2DL2 B-Gene +
, O +
KIR3DL1 B-Gene +
and O +
ILT2 B-Gene +
) O +
and O +
CD94 B-Gene +
C B-Gene +
- I-Gene +
type I-Gene +
lectin I-Gene +
NKR O +
. O +

Transcripts O +
for O +
NKG2 B-Gene +
subunits O +
( O +
NKG2A-2E B-Gene +
) O +
associated O +
with O +
CD94 B-Gene +
were O +
also O +
evaluated O +
. O +

Function O +
was O +
tested O +
in O +
a O +
51Cr O +
- O +
release O +
cytotoxic O +
assay O +
. O +

We O +
found O +
stable O +
but O +
distinct O +
levels O +
of O +
CD94 B-Gene +
/ O +
NKG2 B-Gene +
complexes O +
at O +
the O +
surface O +
of O +
T O +
cell O +
lines O +
and O +
clones O +
. O +

Different O +
NKG2 B-Gene +
members O +
could O +
be O +
associated O +
with O +
CD94 B-Gene +
, O +
either O +
inhibitory O +
( O +
NKG2A B-Gene +
/ I-Gene +
B I-Gene +
) O +
or O +
activating O +
( O +
NKG2C B-Gene +
) O +
. O +

The O +
inhibitory O +
ILT2 B-Gene +
receptor O +
could O +
also O +
be O +
differently O +
expressed O +
, O +
but O +
other O +
Ig B-Gene +
- O +
like O +
NKR O +
were O +
negative O +
. O +

Functionally O +
, O +
one O +
TCRBV1 O +
line O +
and O +
clones O +
with O +
a O +
high O +
CD94 B-Gene +
/ O +
NKG2A B-Gene +
expression O +
did O +
not O +
lyse O +
B27 O +
+ O +
targets O +
. O +

Another O +
TCRBV1 O +
line O +
with O +
the O +
same O +
TCRBV1 O +
rearrangement O +
had O +
a O +
low O +
expression O +
of O +
CD94 B-Gene +
/ O +
NKG2A B-Gene +
, O +
but O +
expressed O +
NKG2C B-Gene +
transcripts O +
and O +
was O +
cytotoxic O +
toward O +
HLA B-Gene -
- I-Gene -
B27 I-Gene +
. O +

HLA B-Gene -
- I-Gene -
B27 I-Gene +
is O +
a O +
ligand O +
for O +
ILT2 B-Gene +
and O +
we O +
observed O +
an O +
inhibitory O +
effect O +
of O +
ILT2 B-Gene +
engagement O +
on O +
B*2705 O +
targets O +
in O +
blockade O +
experiments O +
. O +

Altogether O +
, O +
these O +
data O +
indicate O +
a O +
high O +
degree O +
of O +
heterogeneity O +
in O +
the O +
expression O +
of O +
NKR O +
by O +
intrasynovial O +
CD8 B-Gene +
+ O +
T O +
cells O +
which O +
could O +
modulate O +
their O +
cytotoxicity O +
and O +
play O +
a O +
role O +
in O +
the O +
control O +
of O +
this O +
HLA B-Gene +
class I-Gene +
I I-Gene +
- O +
associated O +
autoimmune O +
disease O +
. O +

A O +
novel O +
asparaginase B-Gene +
- I-Gene +
like I-Gene +
protein I-Gene +
is O +
a O +
sperm O +
autoantigen O +
in O +
rats O +
. O +

A O +
novel O +
asparaginase B-Gene +
- I-Gene +
like I-Gene +
protein I-Gene +
( O +
ALP B-Gene +
) O +
of O +
spermatozoa O +
was O +
cloned O +
from O +
rat O +
and O +
human O +
testis O +
cDNA O +
libraries O +
on O +
the O +
basis O +
of O +
reactivity O +
with O +
antibodies O +
produced O +
after O +
vasectomy O +
. O +

Although O +
obstruction O +
of O +
the O +
male O +
reproductive O +
tract O +
is O +
known O +
to O +
cause O +
an O +
immunologic O +
response O +
, O +
few O +
of O +
the O +
sperm O +
antigens O +
responsible O +
for O +
the O +
generation O +
of O +
autoantibodies O +
have O +
been O +
characterized O +
. O +

We O +
are O +
identifying O +
proteins O +
of O +
interest O +
by O +
coring O +
autoantigenic O +
protein O +
spots O +
from O +
two O +
- O +
dimensional O +
( O +
2-D O +
) O +
gels O +
of O +
rat O +
sperm O +
extracts O +
and O +
microsequencing O +
them O +
by O +
mass O +
spectrometry O +
. O +

The O +
peptide O +
sequences O +
from O +
ALP B-Gene +
, O +
a O +
28 O +
kDa O +
, O +
pI O +
5.7 O +
protein O +
, O +
matched O +
to O +
a O +
single O +
partial O +
length O +
rat O +
EST O +
. O +

These O +
peptide O +
sequences O +
were O +
used O +
to O +
clone O +
a O +
cDNA O +
encoding O +
a O +
novel O +
333 O +
amino O +
acid O +
open O +
reading O +
frame O +
. O +

The O +
new O +
protein O +
had O +
a O +
similarity O +
to O +
portions O +
of O +
L B-Gene -
- I-Gene -
asparaginases I-Gene +
of O +
plants O +
( O +
43 O +
% O +
) O +
and O +
to O +
glycosylasparaginases B-Gene +
in O +
animal O +
cells O +
( O +
32 O +
% O +
) O +
. O +

Human O +
ALP B-Gene +
cDNA O +
was O +
subsequently O +
cloned O +
. O +

It O +
showed O +
77 O +
% O +
identity O +
to O +
the O +
rat O +
ALP B-Gene +
sequence O +
and O +
the O +
gene O +
, O +
ASRGL1 B-Gene +
( O +
asparaginase B-Gene +
- I-Gene +
like I-Gene +
1 I-Gene +
) O +
, O +
mapped O +
to O +
chromosome O +
locus O +
11q12.3 O +
. O +

Purified O +
recombinant O +
rat O +
ALP B-Gene +
( O +
rALP B-Gene +
) O +
, O +
expressed O +
in O +
E. O +
coli O +
, O +
was O +
used O +
to O +
raise O +
polyclonal O +
antiserum O +
in O +
guinea O +
pigs O +
. O +

Two O +
observations O +
verified O +
that O +
the O +
correct O +
protein O +
had O +
been O +
cloned O +
: O +
1 O +
) O +
the O +
anti O +
- O +
rALP B-Gene +
antibody O +
reacted O +
with O +
both O +
rALP B-Gene +
and O +
rat O +
sperm O +
; O +
and O +
2 O +
) O +
post O +
- O +
vasectomy O +
sera O +
bound O +
rALP B-Gene +
. O +

Anti O +
- O +
rALP B-Gene +
antibody O +
stained O +
the O +
midpiece O +
of O +
rat O +
and O +
human O +
sperm O +
coincident O +
with O +
staining O +
by O +
MitoTracker O +
Green O +
FM O +
, O +
suggesting O +
that O +
ALP B-Gene +
is O +
associated O +
with O +
the O +
mitochondria O +
. O +

Northern O +
analysis O +
revealed O +
that O +
rat O +
ALP B-Gene +
message O +
was O +
abundantly O +
expressed O +
in O +
the O +
testis O +
but O +
was O +
also O +
present O +
in O +
heart O +
, O +
brain O +
, O +
liver O +
, O +
skeletal O +
muscle O +
, O +
and O +
kidney O +
. O +

Proteinase B-Gene +
3 I-Gene +
and O +
dihydrolipoamide B-Gene +
dehydrogenase I-Gene +
( O +
E3 O +
) O +
are O +
major O +
autoantigens O +
in O +
hepatitis O +
C O +
virus O +
( O +
HCV O +
) O +
infection O +
. O +

Hepatitis O +
C O +
virus O +
( O +
HCV O +
) O +
infection O +
has O +
been O +
found O +
to O +
be O +
strikingly O +
associated O +
with O +
autoimmune O +
phenomena O +
. O +

The O +
aim O +
of O +
the O +
present O +
study O +
was O +
to O +
investigate O +
the O +
presence O +
of O +
various O +
autoantibodies O +
in O +
patients O +
with O +
HCV O +
infection O +
. O +

Anti O +
- O +
neutrophil O +
cytoplamic O +
antibody O +
( O +
ANCA O +
) O +
, O +
anti O +
- O +
dihydrolipoamide B-Gene +
dehydrogenase I-Gene +
( O +
anti O +
- O +
E3 O +
) O +
, O +
rheumatoid B-Gene +
factor I-Gene +
( O +
RF B-Gene +
) O +
, O +
anti O +
- O +
dihydrolipoamide B-Gene +
acetyltransferase I-Gene +
( O +
anti O +
- O +
E2 O +
) O +
, O +
anti O +
- O +
SS B-Gene -
- I-Gene -
A I-Gene +
/ O +
Ro B-Gene +
( I-Gene +
60 I-Gene +
kD I-Gene +
) I-Gene +
, O +
anti O +
- O +
SS B-Gene -
- I-Gene -
A I-Gene +
/ O +
Ro B-Gene +
( I-Gene +
52 I-Gene +
kD I-Gene +
) I-Gene +
, O +
anti O +
- O +
SS B-Gene -
- I-Gene -
B I-Gene +
/ O +
La B-Gene +
, O +
anti O +
- O +
topoisomerase B-Gene +
II I-Gene +
( O +
anti O +
- O +
topo B-Gene +
II I-Gene +
) O +
, O +
anti O +
- O +
cardiolipin O +
( O +
aCL O +
) O +
, O +
anti O +
- O +
dsDNA O +
, O +
anti O +
- O +
ssDNA O +
, O +
anti O +
- O +
nuclear O +
antibodies O +
( O +
ANA O +
) O +
, O +
anti O +
- O +
proteinase B-Gene +
3 I-Gene +
( O +
anti O +
- O +
Pr3 B-Gene +
) O +
and O +
anti O +
- O +
myeloperoxidase B-Gene +
( O +
anti O +
- O +
MPO B-Gene +
) O +
were O +
determined O +
in O +
sera O +
from O +
516 O +
patients O +
with O +
HCV O +
infection O +
, O +
11 O +
with O +
primary O +
biliary O +
cirrhosis O +
( O +
PBC O +
) O +
and O +
44 O +
healthy O +
controls O +
. O +

Assays O +
employed O +
were O +
indirect O +
immunofluoresence O +
, O +
the O +
particle O +
latex O +
agglutination O +
test O +
, O +
enzyme O +
- O +
linked O +
immunosorbent O +
assay O +
( O +
ELISA O +
) O +
and O +
immunoblotting O +
. O +

ANCA O +
, O +
anti O +
- O +
E3 O +
antibody O +
and O +
RF B-Gene +
were O +
positive O +
in O +
278 O +
/ O +
516 O +
( O +
55.6 O +
% O +
) O +
, O +
276 O +
/ O +
516 O +
( O +
53.3 O +
% O +
) O +
and O +
288 O +
/ O +
516 O +
( O +
56 O +
% O +
) O +
patients O +
with O +
HCV O +
infection O +
, O +
respectively O +
. O +

Positivity O +
for O +
ANA O +
was O +
present O +
in O +
15.8 O +
% O +
, O +
anti O +
- O +
ssDNA O +
in O +
15.6 O +
% O +
, O +
anti O +
- O +
dsDNA O +
in O +
8.5 O +
% O +
, O +
aCL O +
in O +
5 O +
% O +
, O +
anti O +
- O +
SS B-Gene +
- I-Gene +
B I-Gene +
/ O +
La B-Gene +
in O +
4.1 O +
% O +
, O +
anti O +
- O +
SS B-Gene -
- I-Gene -
A I-Gene +
/ O +
Ro B-Gene +
( I-Gene +
60 I-Gene +
kD I-Gene +
) I-Gene +
in O +
3.9 O +
% O +
, O +
anti O +
- O +
E2 O +
in O +
3.3 O +
% O +
and O +
anti O +
- O +
SSA B-Gene +
/ O +
Ro B-Gene +
( I-Gene +
52 I-Gene +
kD I-Gene +
) I-Gene +
in O +
1.2 O +
% O +
, O +
anti O +
- O +
MPO B-Gene +
in O +
4.8 O +
% O +
, O +
anti O +
- O +
Topo B-Gene +
II I-Gene +
and O +
anti O +
- O +
actinin B-Gene +
in O +
0 O +
% O +
. O +

All O +
sera O +
with O +
ANCA O +
showed O +
c O -
- O -
ANCA O +
patterns O +
and O +
contained O +
anti O +
- O +
PR3 B-Gene +
specificity O +
. O +

HCV O +
patients O +
with O +
ANCA O +
showed O +
a O +
higher O +
prevalence O +
of O +
skin O +
involvement O +
, O +
anaemia O +
, O +
abnormal O +
liver O +
function O +
and O +
alpha B-Gene -
- I-Gene -
Fetoprotein I-Gene +
( O +
alpha B-Gene -
- I-Gene -
FP I-Gene +
) O +
. O +

HCV O +
patients O +
with O +
anti O +
- O +
E3 O +
antibodies O +
showed O +
a O +
higher O +
prevalence O +
of O +
liver O +
cirrhosis O +
, O +
arthritis O +
, O +
abnormal O +
liver O +
function O +
and O +
elevated O +
alpha B-Gene -
- I-Gene -
FP I-Gene +
levels O +
. O +

The O +
prevalence O +
of O +
autoantibodies O +
was O +
not O +
affected O +
by O +
treatment O +
with O +
interferon B-Gene -
- I-Gene -
alpha I-Gene +
( O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
) O +
. O +

In O +
conclusion O +
, O +
autoantibodies O +
are O +
commonly O +
found O +
in O +
patients O +
with O +
HCV O +
infection O +
. O +

There O +
is O +
a O +
high O +
prevalence O +
of O +
anti O +
- O +
E3 O +
, O +
ANCA O +
and O +
RF B-Gene +
in O +
these O +
patients O +
. O +

Proteinase B-Gene +
3 I-Gene +
and O +
E3 O +
are O +
the O +
major O +
target O +
antigens O +
in O +
HCV O +
infection O +
. O +

HCV O +
may O +
be O +
regarded O +
as O +
a O +
possible O +
causative O +
factor O +
in O +
ANCA O +
- O +
related O +
vasculitis O +
. O +

Re O +
- O +
oxygenation O +
of O +
hypoxic O +
simian O +
virus O +
40 O +
( O +
SV40 O +
) O +
- O +
infected O +
CV1 O +
cells O +
causes O +
distinct O +
changes O +
of O +
SV40 O +
minichromosome O +
- O +
associated O +
replication O +
proteins O +
. O +

Hypoxia O +
interrupts O +
the O +
initiation O +
of O +
simian O +
virus O +
40 O +
( O +
SV40 O +
) O +
replication O +
in O +
vivo O +
at O +
a O +
stage O +
situated O +
before O +
unwinding O +
of O +
the O +
origin O +
region O +
. O +

After O +
re O +
- O +
oxygenation O +
, O +
unwinding O +
followed O +
by O +
a O +
synchronous O +
round O +
of O +
viral O +
replication O +
takes O +
place O +
. O +

To O +
further O +
characterize O +
the O +
hypoxia O +
- O +
induced O +
inhibition O +
of O +
unwinding O +
, O +
we O +
analysed O +
the O +
binding O +
of O +
several O +
replication O +
proteins O +
to O +
the O +
viral O +
minichromosome O +
before O +
and O +
after O +
re O +
- O +
oxygenation O +
. O +

T B-Gene +
antigen I-Gene +
, O +
the O +
34 B-Gene +
- I-Gene +
kDa I-Gene +
subunit I-Gene +
of I-Gene +
replication I-Gene +
protein I-Gene +
A I-Gene +
( O +
RPA B-Gene +
) O +
, O +
topoisomerase B-Gene +
I I-Gene +
, O +
the O +
48 B-Gene +
- I-Gene +
kDa I-Gene +
subunit I-Gene +
of I-Gene +
primase I-Gene +
, O +
the O +
125 B-Gene +
- I-Gene +
kDa I-Gene +
subunit I-Gene +
of I-Gene +
polymerase I-Gene +
delta I-Gene +
, O +
and O +
the O +
37 B-Gene +
- I-Gene +
kDa I-Gene +
subunit I-Gene +
of I-Gene +
replication I-Gene +
factor I-Gene +
C I-Gene +
( O +
RFC B-Gene +
) O +
were O +
present O +
at O +
the O +
viral O +
chromatin O +
already O +
under O +
hypoxia O +
. O +

The O +
70 B-Gene +
- I-Gene +
kDa I-Gene +
subunit I-Gene +
of I-Gene +
RPA I-Gene +
, O +
the O +
180 B-Gene +
- I-Gene +
kDa I-Gene +
subunit I-Gene +
of I-Gene +
polymerase I-Gene +
alpha I-Gene +
, O +
and O +
proliferating B-Gene +
cell I-Gene +
nuclear I-Gene +
antigen I-Gene +
( O +
PCNA B-Gene +
) O +
were O +
barely O +
detectable O +
at O +
the O +
SV40 O +
chromatin O +
under O +
hypoxia O +
and O +
significantly O +
increased O +
after O +
re O +
- O +
oxygenation O +
. O +

Immunoprecipitation O +
of O +
minichromosomes O +
with O +
T B-Gene +
antigen I-Gene +
- O +
specific O +
antibody O +
and O +
subsequent O +
digestion O +
with O +
micrococcus O +
nuclease O +
revealed O +
that O +
most O +
of O +
the O +
minichromosome O +
- O +
bound O +
T B-Gene +
antigen I-Gene +
was O +
associated O +
with O +
the O +
viral O +
origin O +
in O +
hypoxic O +
and O +
in O +
re O +
- O +
oxygenated O +
cells O +
. O +

T B-Gene +
antigen I-Gene +
- O +
catalysed O +
unwinding O +
of O +
the O +
SV40 O +
origin O +
occurred O +
, O +
however O +
, O +
only O +
after O +
re O +
- O +
oxygenation O +
as O +
indicated O +
by O +
( O -
a O -
) O +
increased O +
sensitivity O +
of O +
re O +
- O +
oxygenated O +
minichromosomes O +
against O +
digestion O +
with O +
single O +
- O +
stranded O +
DNA O +
- O +
specific O +
nuclease B-Gene +
P1 I-Gene +
; O +
( O -
b O -
) O +
stabilization O +
of O +
RPA-34 B-Gene +
binding O +
at O +
the O +
SV40 O +
minichromosome O +
; O +
and O +
( O -
c O -
) O +
additional O +
phosphorylations O +
of O +
RPA-34 B-Gene +
after O +
re O +
- O +
oxygenation O +
, O +
probably O +
catalysed O +
by O +
DNA B-Gene +
- I-Gene +
dependent I-Gene +
protein I-Gene +
kinase I-Gene +
. O +

The O +
results O +
presented O +
suggest O +
that O +
the O +
subunits O +
of O +
the O +
proteins O +
necessary O +
for O +
unwinding O +
, O +
primer O +
synthesis O +
and O +
primer O +
elongation O +
first O +
assemble O +
at O +
the O +
SV40 O +
origin O +
in O +
form O +
of O +
stable O +
, O +
active O +
complexes O +
directly O +
before O +
they O +
start O +
to O +
work O +
. O +

Crystal O +
structure O +
of O +
human O +
dehydroepiandrosterone B-Gene +
sulphotransferase I-Gene +
in O +
complex O +
with O +
substrate O +
. O +

Dehydroepiandrosterone B-Gene +
sulphotransferase I-Gene +
( O +
DHEA B-Gene -
- I-Gene -
ST I-Gene +
) O +
is O +
an O +
enzyme O +
that O +
converts O +
dehydroepiandrosterone O +
( O +
DHEA O +
) O +
, O +
and O +
some O +
other O +
steroids O +
, O +
into O +
their O +
sulphonated O +
forms O +
. O +

The O +
enzyme O +
catalyses O +
the O +
sulphonation O +
of O +
DHEA O +
on O +
the O +
3alpha O -
- O -
oxygen O +
, O +
with O +
3'-phosphoadenosine-5'-phosphosulphate O +
contributing O +
the O +
sulphate O +
. O +

The O +
structure O +
of O +
human O +
DHEA B-Gene -
- I-Gene -
ST I-Gene +
in O +
complex O +
with O +
its O +
preferred O +
substrate O +
DHEA O +
has O +
been O +
solved O +
here O +
to O +
1.99 O +
A O +
using O +
molecular O +
replacement O +
with O +
oestradiol B-Gene +
sulphotransferase I-Gene +
( O +
37 O +
% O +
sequence O +
identity O +
) O +
as O +
a O +
model O +
. O +

Two O +
alternative O +
substrate O +
- O +
binding O +
orientations O +
have O +
been O +
identified O +
. O +

The O +
primary O +
, O +
catalytic O +
, O +
orientation O +
has O +
the O +
DHEA O +
3alpha O +
- O +
oxygen O +
and O +
the O +
highly O +
conserved O +
catalytic O +
histidine O +
in O +
nearly O +
identical O +
positions O +
as O +
are O +
seen O +
for O +
the O +
related O +
oestradiol B-Gene +
sulphotransferase I-Gene +
. O +

The O +
substrate O +
, O +
however O +
, O +
shows O +
rotations O +
of O +
up O +
to O +
30 O +
degrees O +
, O +
and O +
there O +
is O +
a O +
corresponding O +
rearrangement O +
of O +
the O +
protein O +
loops O +
contributing O +
to O +
the O +
active O +
site O +
. O +

This O +
may O +
also O +
reflect O +
the O +
low O +
identity O +
between O +
the O +
two O +
enzymes O +
. O +

The O +
second O +
orientation O +
penetrates O +
further O +
into O +
the O +
active O +
site O +
and O +
can O +
form O +
a O +
potential O +
hydrogen O +
bond O +
with O +
the O +
desulphonated O +
cofactor O +
3',5'-phosphoadenosine O +
( O +
PAP O +
) O +
. O +

This O +
second O +
site O +
contains O +
more O +
van O +
der O +
Waal O +
interactions O +
with O +
hydrophobic O +
residues O +
than O +
the O +
catalytic O +
site O +
and O +
may O +
also O +
reflect O +
the O +
substrate O +
- O +
inhibition O +
site O +
. O +

The O +
PAP O +
position O +
was O +
obtained O +
from O +
the O +
previously O +
solved O +
structure O +
of O +
DHEA B-Gene -
- I-Gene -
ST I-Gene +
co O +
- O +
crystallized O +
with O +
PAP O +
. O +

This O +
latter O +
structure O +
, O +
due O +
to O +
the O +
arrangement O +
of O +
loops O +
within O +
the O +
active O +
site O +
and O +
monomer O +
interactions O +
, O +
can O -
not O +
bind O +
substrate O +
. O +

The O +
results O +
presented O +
here O +
describe O +
details O +
of O +
substrate O +
binding O +
to O +
DHEA B-Gene -
- I-Gene -
ST I-Gene +
and O +
the O +
potential O +
relationship O +
to O +
substrate O +
inhibition O +
. O +

Cardiac O +
expression O +
and O +
subcellular O +
localization O +
of O +
the O +
p38 B-Gene +
mitogen I-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
member O +
, O +
stress B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase-3 I-Gene +
( O +
SAPK3 B-Gene +
) O +
. O +

Despite O +
the O +
interest O +
in O +
the O +
roles O +
that O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinases I-Gene +
( O +
MAPKs B-Gene +
) O +
play O +
in O +
the O +
heart O +
, O +
the O +
role O +
of O +
the O +
different O +
MAPK B-Gene +
isoforms O +
has O +
been O +
relatively O +
poorly O +
defined O +
. O +

A O +
third O +
isoform O +
of O +
p38 B-Gene +
MAPK I-Gene +
, O +
known O +
variously O +
as O +
stress B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase-3 I-Gene +
( O +
SAPK3 B-Gene +
) O +
, O +
p38- B-Gene +
gamma I-Gene +
or O +
ERK6 B-Gene +
, O +
has O +
been O +
previously O +
shown O +
to O +
differ O +
from O +
p38 B-Gene +
- I-Gene +
alpha I-Gene +
/ I-Gene +
beta I-Gene +
both O +
in O +
its O +
molecular O +
weight O +
and O +
its O +
lack O +
of O +
inhibition O +
by O +
the O +
compound O +
SB203580 O +
. O +

We O +
have O +
generated O +
monoclonal O +
antibodies O +
with O +
specificity O +
for O +
SAPK3 B-Gene +
demonstrated O +
by O +
immunoblot O +
analysis O +
, O +
immunofluorescence O +
studies O +
, O +
and O +
cloning O +
of O +
SAPK3 B-Gene +
from O +
a O +
rat O +
heart O +
cDNA O +
expression O +
library O +
. O +

By O +
immunoblotting O +
, O +
we O +
confirmed O +
high O +
expression O +
of O +
SAPK3 B-Gene +
in O +
fast O +
, O +
slow O +
and O +
mixed O +
fibre O +
types O +
of O +
murine O +
skeletal O +
muscle O +
and O +
observed O +
significant O +
expression O +
restricted O +
to O +
heart O +
, O +
lung O +
, O +
thymus O +
and O +
testes O +
. O +

In O +
addition O +
to O +
expression O +
in O +
normal O +
heart O +
( O +
human O +
, O +
mouse O +
, O +
rat O +
, O +
dog O +
and O +
pig O +
) O +
, O +
we O +
observed O +
constant O +
expression O +
in O +
diseased O +
human O +
heart O +
, O +
as O +
well O +
as O +
control O +
and O +
hypertrophic O +
cultured O +
neonatal O +
rat O +
cardiac O +
myocytes O +
. O +

Immunolocalization O +
in O +
cultured O +
cardiac O +
myocytes O +
followed O +
by O +
confocal O +
microscopy O +
showed O +
punctate O +
, O +
non O +
- O +
nuclear O +
SAPK3 B-Gene +
staining O +
. O +

In O +
contrast O +
, O +
p38 B-Gene +
- I-Gene +
alpha I-Gene +
/ I-Gene +
beta I-Gene +
staining O +
was O +
non O +
- O +
punctate O +
and O +
distributed O +
throughout O +
the O +
cytosol O +
and O +
nucleus O +
. O +

Whereas O +
treatment O +
with O +
Leptomycin O +
B O +
to O +
prevent O +
nuclear O +
export O +
processes O +
promoted O +
higher O +
levels O +
of O +
p38 B-Gene +
- I-Gene +
alpha I-Gene +
/ I-Gene +
beta I-Gene +
staining O +
in O +
cardiac O +
myocyte O +
nuclei O +
, O +
there O +
was O +
no O +
apparent O +
change O +
in O +
SAPK3 B-Gene +
localization O +
under O +
these O +
conditions O +
. O +

These O +
differences O +
between O +
p38 B-Gene +
- I-Gene +
alpha I-Gene +
/ I-Gene +
beta I-Gene +
and O +
SAPK3 B-Gene +
probably O +
reflect O +
the O +
specialized O +
functions O +
of O +
SAPK3 B-Gene +
and O +
emphasize O +
the O +
need O +
to O +
evaluate O +
SAPK3 B-Gene +
upstream O +
activators O +
and O +
downstream O +
targets O +
in O +
the O +
heart O +
. O +

ROCK B-Gene +
and O +
Dia B-Gene +
have O +
opposing O +
effects O +
on O +
adherens O +
junctions O +
downstream O +
of O +
Rho B-Gene +
. O +

Adherens O +
junctions O +
( O +
AJs O +
) O +
are O +
crucial O +
for O +
maintaining O +
the O +
integrity O +
of O +
epithelial O +
tissues O +
and O +
are O +
often O +
disrupted O +
during O +
tumour O +
progression O +
. O +

Rho B-Gene +
family I-Gene +
proteins O +
have O +
been O +
shown O +
to O +
regulate O +
adherens O +
junctions O +
. O +

We O +
find O +
that O +
activation O +
of O +
the O +
effector O +
kinase B-Gene +
ROCK B-Gene +
and O +
acto O +
- O +
myosin B-Gene +
contraction O +
disrupts O +
AJs O +
downstream O +
of O +
Rho B-Gene +
. O +

In O +
contrast O +
, O +
signalling O +
through O +
the O +
Rho B-Gene +
effector O +
Dia1 B-Gene +
is O +
required O +
to O +
ensure O +
a O +
dynamically O +
stable O +
interface O +
between O +
cells O +
and O +
the O +
maintenance O +
of O +
adherens O +
junction O +
complexes O +
. O +

The O +
ability O +
of O +
Dia1 B-Gene +
to O +
regulate O +
the O +
actin B-Gene +
network O +
is O +
crucial O +
for O +
the O +
localization O +
of O +
adherens O +
junction O +
components O +
to O +
the O +
cell O +
periphery O +
. O +

Mutations O +
in O +
COL6A3 B-Gene +
cause O +
severe O +
and O +
mild O +
phenotypes O +
of O +
Ullrich O +
congenital O +
muscular O +
dystrophy O +
. O +

Ullrich O +
congenital O +
muscular O +
dystrophy O +
( O +
UCMD O +
) O +
is O +
an O +
autosomal O +
recessive O +
disorder O +
characterized O +
by O +
generalized O +
muscular O +
weakness O +
, O +
contractures O +
of O +
multiple O +
joints O +
, O +
and O +
distal O +
hyperextensibility O +
. O +

Homozygous O +
and O +
compound O +
heterozygous O +
mutations O +
of O +
COL6A2 B-Gene +
on O +
chromosome O +
21q22 O +
have O +
recently O +
been O +
shown O +
to O +
cause O +
UCMD O +
. O +

We O +
performed O +
a O +
genomewide O +
screening O +
with O +
microsatellite O +
markers O +
in O +
a O +
consanguineous O +
family O +
with O +
three O +
sibs O +
affected O +
with O +
UCMD O +
. O +

Linkage O +
of O +
the O +
disease O +
to O +
chromosome O +
2q37 O +
was O +
found O +
in O +
this O +
family O +
and O +
in O +
two O +
others O +
. O +

We O +
analyzed O +
COL6A3 B-Gene +
, O +
which O +
encodes O +
the O +
alpha3 B-Gene +
chain I-Gene +
of I-Gene +
collagen I-Gene +
VI I-Gene +
, O +
and O +
identified O +
one O +
homozygous O +
mutation O +
per O +
family O +
. O +

In O +
family O +
I O +
, O +
the O +
three O +
sibs O +
carried O +
an O +
A O +
-- O -
> O +
G O +
transition O +
in O +
the O +
splice O +
- O +
donor O +
site O +
of O +
intron O +
29 O +
( O +
6930 O +
+ O +
5A O +
-- O -
> O +
G O +
) O +
, O +
leading O +
to O +
the O +
skipping O +
of O +
exon O +
29 O +
, O +
a O +
partial O +
reduction O +
of O +
collagen B-Gene +
VI I-Gene +
in O +
muscle O +
biopsy O +
, O +
and O +
an O +
intermediate O +
phenotype O +
. O +

In O +
family O +
II O +
, O +
the O +
patient O +
had O +
an O +
unusual O +
mild O +
phenotype O +
, O +
despite O +
a O +
nonsense O +
mutation O +
, O +
R465X O +
, O +
in O +
exon O +
5 O +
. O +

Analysis O +
of O +
the O +
patient O +
's O +
COL6A3 B-Gene +
transcripts O +
showed O +
the O +
presence O +
of O +
various O +
mRNA O +
species O +
- O +
one O +
of O +
which O +
lacked O +
several O +
exons O +
, O +
including O +
the O +
exon O +
containing O +
the O +
nonsense O +
mutation O +
. O +

The O +
deleted O +
splice O +
variant O +
encodes O +
collagen B-Gene +
molecules O +
that O +
have O +
a O +
shorter O +
N O +
- O +
terminal O +
domain O +
but O +
that O +
may O +
assemble O +
with O +
other O +
chains O +
and O +
retain O +
a O +
functional O +
role O +
. O +

This O +
could O +
explain O +
the O +
mild O +
phenotype O +
of O +
the O +
patient O +
who O +
was O +
still O +
ambulant O +
at O +
age O +
18 O +
years O +
and O +
who O +
showed O +
an O +
unusual O +
combination O +
of O +
hyperlaxity O +
and O +
finger O +
contractures O +
. O +

In O +
family O +
III O +
, O +
the O +
patient O +
had O +
a O +
nonsense O +
mutation O +
, O +
R2342X O +
, O +
causing O +
absence O +
of O +
collagen B-Gene +
VI I-Gene +
in O +
muscle O +
and O +
fibroblasts O +
, O +
and O +
a O +
severe O +
phenotype O +
, O +
as O +
has O +
been O +
described O +
in O +
patients O +
with O +
UCMD O +
. O +

Mutations O +
in O +
COL6A3 B-Gene +
are O +
described O +
in O +
UCMD O +
for O +
the O +
first O +
time O +
and O +
illustrate O +
the O +
wide O +
spectrum O +
of O +
phenotypes O +
which O +
can O +
be O +
caused O +
by O +
collagen B-Gene +
VI I-Gene +
deficiency O +
. O +

The O +
XAGE B-Gene +
family I-Gene +
of O +
cancer O +
/ O +
testis O +
- O +
associated O +
genes O +
: O +
alignment O +
and O +
expression O +
profile O +
in O +
normal O +
tissues O +
, O +
melanoma O +
lesions O +
and O +
Ewing O +
's O +
sarcoma O +
. O +

The O +
existence O +
of O +
XAGE B-Gene +
genes O +
was O +
first O +
reported O +
after O +
database O +
homology O +
searches O +
for O +
PAGE O +
- O +
like O +
sequences O +
identified O +
3 O +
XAGE B-Gene +
EST O +
clusters O +
. O +

One O +
of O +
these O +
clusters O +
, O +
XAGE-1 B-Gene +
, O +
has O +
in O +
later O +
studies O +
been O +
identified O +
as O +
a O +
cancer O +
/ O +
testis O +
- O +
associated O +
gene O +
. O +

Here O +
, O +
we O +
report O +
the O +
expression O +
profiles O +
of O +
all O +
3 O +
reported O +
XAGE B-Gene +
genes O +
, O +
as O +
well O +
as O +
several O +
splice O +
variants O +
of O +
XAGE-1 B-Gene +
, O +
in O +
normal O +
human O +
tissues O +
, O +
Ewing O +
's O +
sarcoma O +
and O +
melanocytic O +
tumors O +
. O +

We O +
also O +
provide O +
the O +
genetic O +
structure O +
of O +
the O +
corresponding O +
genes O +
. O +

Moreover O +
, O +
by O +
searching O +
the O +
databases O +
for O +
XAGE B-Gene +
homologues O +
, O +
we O +
identified O +
3 O +
additional O +
GAGE B-Gene +
- O +
like O +
genes O +
. O +

RT O +
- O +
PCR O +
studies O +
showed O +
frequent O +
expression O +
in O +
melanoma O +
metastases O +
and O +
Ewing O +
's O +
sarcoma O +
for O +
2 O +
XAGE-1 B-Gene +
- O +
derived O +
transcripts O +
. O +

XAGE-2 B-Gene +
was O +
expressed O +
at O +
lower O +
frequency O +
in O +
these O +
tissues O +
, O +
while O +
XAGE-3 B-Gene +
was O +
seen O +
only O +
in O +
normal O +
placenta O +
. O +

Due O +
to O +
a O +
frameshift O +
, O +
the O +
largest O +
XAGE-1 B-Gene +
putative O +
protein O +
is O +
far O +
less O +
homologous O +
to O +
GAGE B-Gene +
- O +
like O +
proteins O +
than O +
the O +
other O +
XAGEs B-Gene +
. O +

Interestingly O +
, O +
all O +
GAGE B-Gene +
- O +
like O +
genes O +
contain O +
a O +
large O +
secondary O +
open O +
reading O +
frame O +
, O +
coding O +
for O +
putative O +
proteins O +
homologues O +
to O +
the O +
XAGE-1 B-Gene +
primary O +
protein O +
. O +

The O +
XAGE B-Gene +
family I-Gene +
of O +
cancer O +
/ O +
testis O +
- O +
associated O +
genes O +
is O +
located O +
on O +
chromosome O +
Xp11.21 O +
- O +
Xp11.22 O +
. O +

The O +
data O +
outline O +
a O +
superfamily B-Gene +
of I-Gene +
GAGE I-Gene +
- I-Gene +
like I-Gene +
cancer I-Gene +
/ I-Gene +
testis I-Gene +
antigens I-Gene +
, O +
consisting O +
of O +
at O +
least O +
19 O +
genes O +
. O +

The O +
Tol B-Gene +
/ O +
Pal B-Gene +
system O +
function O +
requires O +
an O +
interaction O +
between O +
the O +
C O +
- O +
terminal O +
domain O +
of O +
TolA B-Gene +
and O +
the O +
N O +
- O +
terminal O +
domain O +
of O +
TolB B-Gene +
. O +

The O +
Tol B-Gene +
/ O +
Pal B-Gene +
system O +
of O +
Escherichia O +
coli O +
is O +
composed O +
of O +
the O +
YbgC B-Gene +
, O +
TolQ B-Gene +
, O +
TolA B-Gene +
, O +
TolR B-Gene +
, O +
TolB B-Gene +
, O +
Pal B-Gene +
and O +
YbgF B-Gene +
proteins O +
. O +

It O +
is O +
involved O +
in O +
maintaining O +
the O +
integrity O +
of O +
the O +
outer O +
membrane O +
, O +
and O +
is O +
required O +
for O +
the O +
uptake O +
of O +
group O +
A O +
colicins O +
and O +
DNA O +
of O +
filamentous O +
bacteriophages O +
. O +

To O +
identify O +
new O +
interactions O +
between O +
the O +
components O +
of O +
the O +
Tol B-Gene +
/ O +
Pal B-Gene +
system O +
and O +
gain O +
insight O +
into O +
the O +
mechanism O +
of O +
colicin O +
import O +
, O +
we O +
performed O +
a O +
yeast O +
two O +
- O +
hybrid O +
screen O +
using O +
the O +
different O +
components O +
of O +
the O +
Tol B-Gene +
/ O +
Pal B-Gene +
system O +
and O +
colicin O +
A O +
. O +

Using O +
this O +
system O +
, O +
we O +
confirmed O +
the O +
already O +
known O +
interactions O +
and O +
identified O +
several O +
new O +
interactions O +
. O +

TolB B-Gene +
dimerizes O +
and O +
the O +
periplasmic O +
domain O +
of O +
TolA B-Gene +
interacts O +
with O +
YbgF B-Gene +
and O +
TolB B-Gene +
. O +

Our O +
results O +
indicate O +
that O +
the O +
central O +
domain O +
of O +
TolA B-Gene +
( O +
TolAII O +
) O +
is O +
sufficient O +
to O +
interact O +
with O +
YbgF B-Gene +
, O +
that O +
the O +
C O +
- O +
terminal O +
domain O +
of O +
TolA B-Gene +
( O +
TolAIII O +
) O +
is O +
sufficient O +
to O +
interact O +
with O +
TolB B-Gene +
, O +
and O +
that O +
the O +
amino O +
terminal O +
domain O +
of O +
TolB B-Gene +
( O +
D1 O +
) O +
is O +
sufficient O +
to O +
bind O +
TolAIII O +
. O +

The O +
TolA B-Gene +
/ O +
TolB B-Gene +
interaction O +
was O +
confirmed O +
by O +
cross O +
- O +
linking O +
experiments O +
on O +
purified O +
proteins O +
. O +

Moreover O +
, O +
we O +
show O +
that O +
the O +
interaction O +
between O +
TolA B-Gene +
and O +
TolB B-Gene +
is O +
required O +
for O +
the O +
uptake O +
of O +
colicin O +
A O +
and O +
for O +
the O +
membrane O +
integrity O +
. O +

These O +
results O +
demonstrate O +
that O +
the O +
TolA B-Gene +
/ O +
TolB B-Gene +
interaction O +
allows O +
the O +
formation O +
of O +
a O +
trans O +
- O +
envelope O +
complex O +
that O +
brings O +
the O +
inner O +
and O +
outer O +
membranes O +
in O +
close O +
proximity O +
. O +

SHP-1 B-Gene +
- O +
and O +
phosphotyrosine O +
- O +
independent O +
inhibitory O +
signaling O +
by O +
a O +
killer B-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
cytoplasmic O +
domain O +
in O +
human O +
NK O +
cells O +
. O +

Killer B-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIR B-Gene +
) O +
are O +
MHC B-Gene +
class I-Gene +
I I-Gene +
- O +
binding O +
immunoreceptors O +
that O +
can O +
suppress O +
activation O +
of O +
human O +
NK O +
cells O +
through O +
recruitment O +
of O +
the O +
Src B-Gene +
homology I-Gene +
2 I-Gene +
- I-Gene +
containing I-Gene +
protein I-Gene +
tyrosine I-Gene +
phosphatase-1 I-Gene +
( O +
SHP-1 B-Gene +
) O +
to O +
two O +
immunoreceptor O +
tyrosine O +
- O +
based O +
inhibitory O +
motifs O +
( O +
ITIMs O +
) O +
in O +
their O +
cytoplasmic O +
domains O +
. O +

KIR2DL4 B-Gene +
( O +
2DL4 B-Gene +
; O +
CD158d B-Gene +
) O +
is O +
a O +
structurally O +
distinct O +
member O +
of O +
the O +
KIR B-Gene +
family I-Gene +
, O +
which O +
is O +
expressed O +
on O +
most O +
, O +
if O +
not O +
all O +
, O +
human O +
NK O +
cells O +
. O +

2DL4 B-Gene +
contains O +
only O +
one O +
ITIM O +
in O +
its O +
cytoplasmic O +
domain O +
and O +
an O +
arginine O +
in O +
its O +
transmembrane O +
region O +
, O +
suggesting O +
both O +
inhibitory O +
and O +
activating O +
functions O +
. O +

While O +
2DL4 B-Gene +
can O +
activate O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
production O +
, O +
dependent O +
upon O +
the O +
transmembrane O +
arginine O +
, O +
the O +
function O +
of O +
the O +
single O +
ITIM O +
of O +
2DL4 B-Gene +
remains O +
unknown O +
. O +

In O +
this O +
study O +
, O +
tandem O +
ITIMs O +
of O +
KIR3DL1 B-Gene +
( O +
3DL1 B-Gene +
) O +
and O +
the O +
single O +
ITIM O +
of O +
2DL4 B-Gene +
were O +
directly O +
compared O +
in O +
functional O +
and O +
biochemical O +
assays O +
. O +

Using O +
a O +
retroviral O +
transduction O +
method O +
, O +
we O +
show O +
in O +
human O +
NK O +
cell O +
lines O +
that O +
1 O +
) O +
the O +
single O +
ITIM O +
of O +
2DL4 B-Gene +
efficiently O +
inhibits O +
natural O +
cytotoxicity O +
responses O +
; O +
2 O -
) O +
the O +
phosphorylated O +
single O +
ITIM O +
recruits O +
SHP-2 B-Gene +
protein B-Gene +
tyrosine I-Gene +
phosphatase I-Gene +
, O +
but O +
not O +
SHP-1 B-Gene +
in O +
NK O +
cells O +
; O +
3 O +
) O +
expression O +
of O +
dominant O +
- O +
negative O +
SHP-1 B-Gene +
does O +
not O +
block O +
the O +
ability O +
of O +
2DL4 B-Gene +
to O +
inhibit O +
natural O +
cytotoxicity O +
; O +
4 O +
) O +
surprisingly O +
, O +
mutation O +
of O +
the O +
tyrosine O +
within O +
the O +
single O +
ITIM O +
does O +
not O +
completely O +
abolish O +
inhibitory O +
function O +
; O +
and O +
5 O +
) O +
this O +
correlates O +
with O +
weak O +
SHP-2 B-Gene +
binding O +
to O +
the O +
mutant O +
ITIM O +
of O +
2DL4 B-Gene +
in O +
NK O +
cells O +
and O +
a O +
corresponding O +
nonphosphorylated O +
ITIM O +
peptide O +
in O +
vitro O +
. O +

These O +
results O +
reveal O +
new O +
aspects O +
of O +
the O +
KIR B-Gene +
- O +
inhibitory O +
pathway O +
in O +
human O +
NK O +
cells O +
, O +
which O +
are O +
SHP-1 B-Gene +
and O +
phosphotyrosine O +
independent O +
. O +

Closing O +
in O +
on O +
the O +
biological O +
functions O +
of O +
Fps B-Gene +
/ O +
Fes B-Gene +
and O +
Fer B-Gene +
. O +

Fps B-Gene +
/ O +
Fes B-Gene +
and O +
Fer B-Gene +
are O +
the O +
only O +
known O +
members O +
of O +
a O +
distinct O +
subfamily O +
of O +
the O +
non O +
- O +
receptor O +
protein B-Gene +
- I-Gene +
tyrosine I-Gene +
kinase I-Gene +
family I-Gene +
. O +

Recent O +
studies O +
indicate O +
that O +
these O +
kinases B-Gene +
have O +
roles O +
in O +
regulating O +
cytoskeletal O +
rearrangements O +
and O +
inside O +
out O +
signalling O +
that O +
accompany O +
receptor O +
ligand O +
, O +
cell O +
matrix O +
and O +
cell O +
cell O +
interactions O +
. O +

Genetic O +
analysis O +
using O +
transgenic O +
mouse O +
models O +
also O +
implicates O +
these O +
kinases B-Gene +
in O +
the O +
regulation O +
of O +
inflammation O +
and O +
innate O +
immunity O +
. O +

Systematic O +
structure O +
- O +
function O +
analysis O +
of O +
the O +
small B-Gene +
GTPase I-Gene +
Arf1 B-Gene +
in O +
yeast O +
. O +

Members O +
of O +
the O +
ADP B-Gene -
- I-Gene -
ribosylation I-Gene +
factor I-Gene +
( I-Gene +
Arf I-Gene +
) I-Gene +
family I-Gene +
of O +
small B-Gene +
GTPases I-Gene +
are O +
implicated O +
in O +
vesicle O +
traffic O +
in O +
the O +
secretory O +
pathway O +
, O +
although O +
their O +
precise O +
function O +
remains O +
unclear O +
. O +

We O +
generated O +
a O +
series O +
of O +
23 O +
clustered O +
charge O +
- O +
to O +
- O +
alanine O +
mutations O +
in O +
the O +
Arf1 B-Gene +
protein O +
of O +
Saccharomyces O +
cerevisiae O +
to O +
determine O +
the O +
portions O +
of O +
this O +
protein O +
important O +
for O +
its O +
function O +
in O +
cells O +
. O +

These O +
mutants O +
display O +
a O +
number O +
of O +
phenotypes O +
, O +
including O +
conditional O +
lethality O +
at O +
high O +
or O +
low O +
temperature O +
, O +
defects O +
in O +
glycosylation O +
of O +
invertase B-Gene +
, O +
dominant O +
lethality O +
, O +
fluoride O +
sensitivity O +
, O +
and O +
synthetic O +
lethality O +
with O +
the O +
arf2 B-Gene +
null O +
mutation O +
. O +

All O +
mutations O +
were O +
mapped O +
onto O +
the O +
available O +
crystal O +
structures O +
for O +
Arf1p B-Gene +
: O +
Arf1p B-Gene +
bound O +
to O +
GDP O +
, O +
to O +
GTP O +
, O +
and O +
complexed O +
with O +
the O +
regulatory O +
proteins O +
ArfGEF B-Gene +
and O +
ArfGAP B-Gene +
. O +

From O +
this O +
systematic O +
structure O +
- O +
function O +
analysis O +
we O +
demonstrate O +
that O +
all O +
essential O +
mutations O +
studied O +
map O +
to O +
one O +
hemisphere O +
of O +
the O +
protein O +
and O +
provide O +
strong O +
evidence O +
in O +
support O +
of O +
the O +
proposed O +
ArfGEF B-Gene +
contact O +
site O +
on O +
Arf1p B-Gene +
but O +
minimal O +
evidence O +
in O +
support O +
of O +
the O +
proposed O +
ArfGAP B-Gene +
- O +
binding O +
site O +
. O +

In O +
addition O +
, O +
we O +
describe O +
the O +
isolation O +
of O +
a O +
spatially O +
distant O +
intragenic O +
suppressor O +
of O +
a O +
dominant O +
lethal O +
mutation O +
in O +
the O +
guanine O +
nucleotide O +
- O +
binding O +
region O +
of O +
Arf1p B-Gene +
. O +

Inactivating O +
mutations O +
of O +
CASP10 B-Gene +
gene O +
in O +
non O +
- O +
Hodgkin O +
lymphomas O +
. O +

Caspase B-Gene +
10 I-Gene +
( O +
Mch4 B-Gene +
/ O +
FLICE2 B-Gene +
) O +
is O +
a O +
caspase O +
homologous O +
to O +
caspase B-Gene +
8 I-Gene +
. O +

A O +
recent O +
report O +
described O +
that O +
inherited O +
CASP10 B-Gene +
gene O +
mutations O +
underlie O +
defective O +
lymphocyte O +
and O +
dendritic O +
cell O +
apoptosis O +
in O +
autoimmune O +
lymphoproliferative O +
syndrome O +
( O +
ALPS O +
) O +
. O +

In O +
this O +
study O +
, O +
to O +
explore O +
the O +
possibility O +
that O +
mutation O +
of O +
this O +
gene O +
might O +
be O +
involved O +
in O +
the O +
development O +
of O +
non O +
- O +
Hodgkin O +
lymphoma O +
( O +
NHL O +
) O +
, O +
we O +
have O +
analyzed O +
the O +
entire O +
coding O +
region O +
and O +
all O +
splice O +
sites O +
of O +
the O +
CASP10 B-Gene +
gene O +
for O +
the O +
detection O +
of O +
somatic O +
mutations O +
in O +
117 O +
human O +
NHLs O +
. O +

Overall O +
, O +
17 O +
NHLs O +
( O +
14.5 O +
% O +
) O +
were O +
found O +
to O +
have O +
CASP10 B-Gene +
mutations O +
, O +
which O +
were O +
identified O +
in O +
the O +
coding O +
regions O +
of O +
the O +
prodomain O +
( O +
n O +
= O +
3 O +
) O +
, O +
the O +
p17 O +
large O +
protease B-Gene +
subunit O +
( O +
n O +
= O +
11 O +
) O +
, O +
and O +
the O +
p12 O +
small O +
protease O +
subunit O +
( O +
n O +
= O +
3 O +
) O +
. O +

We O +
expressed O +
the O +
tumor O +
- O +
derived O +
caspase B-Gene +
10 I-Gene +
mutants O +
in O +
293 O +
cells O +
and O +
found O +
that O +
apoptosis O +
was O +
suppressed O +
. O +

These O +
data O +
suggest O +
that O +
the O +
inactivating O +
mutations O +
of O +
the O +
CASP10 B-Gene +
gene O +
might O +
lead O +
to O +
the O +
loss O +
of O +
its O +
apoptotic O +
function O +
and O +
contribute O +
to O +
the O +
pathogenesis O +
of O +
some O +
human O +
NHLs O +
. O +

Systemic O +
effects O +
in O +
COPD O +
. O +

The O +
pathogenesis O +
and O +
clinical O +
manifestations O +
of O +
COPD O +
are O +
not O +
restricted O +
to O +
pulmonary O +
inflammation O +
and O +
structural O +
remodeling O +
. O +

Rather O +
, O +
this O +
disorder O +
is O +
associated O +
with O +
clinically O +
significant O +
systemic O +
alterations O +
in O +
biochemistry O +
and O +
organ O +
function O +
. O +

The O +
systemic O +
aspects O +
of O +
COPD O +
include O +
oxidative O +
stress O +
and O +
altered O +
circulating O +
levels O +
of O +
inflammatory O +
mediators O +
and O +
acute O +
- O +
phase O +
proteins O +
. O +

Indeed O +
, O +
an O +
impaired O +
endogenous O +
oxidant O +
- O +
antioxidant O +
balance O +
has O +
been O +
reported O +
in O +
patients O +
experiencing O +
exacerbations O +
of O +
COPD O +
, O +
and O +
others O +
have O +
observed O +
altered O +
circulating O +
levels O +
of O +
several O +
cytokines B-Gene +
and O +
adhesion B-Gene +
molecules I-Gene +
in O +
patients O +
with O +
stable O +
disease O +
. O +

As O +
in O +
other O +
chronic O +
inflammatory O +
conditions O +
, O +
weight O +
loss O +
, O +
muscle O +
wasting O +
, O +
and O +
tissue O +
depletion O +
are O +
commonly O +
seen O +
in O +
COPD O +
patients O +
. O +

Selective O +
wasting O +
of O +
fat O +
- O +
free O +
mass O +
coupled O +
with O +
impaired O +
respiratory O +
and O +
peripheral O +
muscle O +
function O +
and O +
a O +
reduced O +
capacity O +
for O +
exercise O +
occur O +
in O +
COPD O +
patients O +
. O +

Indeed O +
, O +
weight O +
loss O +
may O +
directly O +
impact O +
poor O +
prognosis O +
in O +
COPD O +
patients O +
. O +

The O +
mechanisms O +
underlying O +
weight O +
loss O +
and O +
muscle O +
wasting O +
are O +
incompletely O +
understood O +
but O +
likely O +
involve O +
an O +
imbalance O +
in O +
ongoing O +
processes O +
of O +
protein O +
degradation O +
and O +
replacement O +
. O +

This O +
may O +
include O +
alterations O +
in O +
the O +
relative O +
levels O +
or O +
activities O +
of O +
endocrine O +
hormones O +
such O +
as O +
insulin B-Gene +
, O +
growth B-Gene +
hormone I-Gene +
, O +
testosterone O +
, O +
and O +
glucocorticoids O +
. O +

Furthermore O +
, O +
chronic O +
systemic O +
inflammation O +
involving O +
cytokines B-Gene +
such O +
as O +
interleukin-1 B-Gene +
and O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
may O +
be O +
associated O +
with O +
these O +
hormonal O +
changes O +
and O +
muscle O +
wasting O +
in O +
COPD O +
patients O +
. O +

This O +
review O +
includes O +
a O +
discussion O +
of O +
the O +
mechanisms O +
of O +
skeletal O +
muscle O +
fiber O +
protein O +
metabolism O +
/ O +
catabolism O +
, O +
the O +
potential O +
roles O +
of O +
endogenous O +
cytokines B-Gene +
in O +
protein O +
loss O +
, O +
and O +
the O +
possibility O +
that O +
novel O +
drugs O +
that O +
inhibit O +
cytokine B-Gene +
signaling O +
may O +
provide O +
benefits O +
by O +
reducing O +
muscle O +
wasting O +
and O +
cachexia O +
, O +
thereby O +
improving O +
the O +
prognosis O +
and O +
quality O +
of O +
life O +
among O +
COPD O +
patients O +
. O +

Differences O +
in O +
the O +
regulation O +
of O +
the O +
classical O +
and O +
the O +
alternative O +
pathway O +
for O +
bile O +
acid O +
synthesis O +
in O +
human O +
liver O +
. O +

No O +
coordinate O +
regulation O +
of O +
CYP7A1 B-Gene +
and O +
CYP27A1 B-Gene +
. O +

It O +
has O +
been O +
reported O +
that O +
there O +
is O +
a O +
coordinate O +
regulation O +
of O +
sterol B-Gene +
27-hydroxylase I-Gene +
( O +
CYP27A1 B-Gene +
) O +
and O +
cholesterol B-Gene +
7alpha I-Gene -
- I-Gene -
hydroxylase I-Gene +
( O +
CYP7A1 B-Gene +
) O +
in O +
rats O +
. O +

Thus O +
, O +
the O +
levels O +
of O +
the O +
mRNA O +
corresponding O +
to O +
these O +
two O +
enzymes O +
were O +
found O +
to O +
change O +
in O +
the O +
same O +
direction O +
in O +
rat O +
liver O +
and O +
in O +
isolated O +
rat O +
hepatocytes O +
. O +

In O +
contrast O +
, O +
other O +
groups O +
have O +
not O +
seen O +
such O +
regulation O +
of O +
CYP27A1 B-Gene +
in O +
rabbit O +
liver O +
or O +
in O +
rat O +
liver O +
when O +
using O +
an O +
activity O +
assay O +
. O +

In O +
the O +
present O +
work O +
, O +
the O +
effect O +
of O +
bile O +
acid O +
treatment O +
on O +
human O +
CYP27A1 B-Gene +
/ O +
luciferase B-Gene +
reporter O +
activity O +
was O +
studied O +
in O +
a O +
transient O +
transfection O +
assay O +
in O +
human O +
liver O +
- O +
derived O +
HepG2 O +
cells O +
. O +

Neither O +
the O +
endogenous O +
27-hydroxylase B-Gene +
activity O +
nor O +
the O +
CYP27A1 B-Gene +
/ O +
luciferase B-Gene +
reporter O +
activity O +
were O +
down O +
- O +
regulated O +
by O +
treatment O +
of O +
HepG2 O +
cells O +
with O +
chenodeoxycholic O +
acid O +
or O +
taurochenodeoxycholic O +
acid O +
. O +

We O +
also O +
measured O +
CYP27A1 B-Gene +
mRNA O +
and O +
CYP7A1 B-Gene +
mRNA O +
in O +
liver O +
of O +
humans O +
subjected O +
to O +
treatment O +
with O +
chenodeoxycholic O +
acid O +
, O +
ursodeoxycholic O +
acid O +
, O +
hydroxymethylglutaryl B-Gene +
( I-Gene +
HMG I-Gene +
) I-Gene +
- I-Gene +
CoA I-Gene +
reductase I-Gene +
inhibitor O +
and O +
a O +
combination O +
of O +
HMG B-Gene -
- I-Gene -
CoA I-Gene +
reductase I-Gene +
inhibitor O +
and O +
cholestyramine O +
. O +

There O +
was O +
a O +
60 O +
- O +
fold O +
variation O +
in O +
the O +
levels O +
of O +
CYP7A1 B-Gene +
mRNA O +
but O +
only O +
a O +
5 O +
- O +
fold O +
variation O +
in O +
the O +
levels O +
of O +
CYP27A1 B-Gene +
mRNA O +
. O +

There O +
was O +
no O +
correlation O +
between O +
the O +
two O +
mRNA O +
species O +
. O +

It O +
is O +
concluded O +
that O +
, O +
in O +
humans O +
, O +
there O +
is O +
little O +
or O +
no O +
coordinate O +
regulation O +
of O +
CYP7A1 B-Gene +
and O +
CYP27A1 B-Gene +
at O +
the O +
transcriptional O +
level O +
, O +
and O +
that O +
CYP27A1 B-Gene +
is O +
not O +
subject O +
to O +
a O +
negative O +
feedback O +
control O +
by O +
bile O +
acids O +
. O +

The O +
results O +
underline O +
that O +
marked O +
species O +
differences O +
may O +
exist O +
in O +
mechanisms O +
for O +
control O +
of O +
synthesis O +
of O +
bile O +
acids O +
and O +
cholesterol O +
homeostasis O +
. O +

Extracellular O +
and O +
cytoplasmic O +
domains O +
of O +
endoglin B-Gene +
interact O +
with O +
the O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
beta I-Gene +
receptors I-Gene +
I I-Gene +
and I-Gene +
II I-Gene +
. O +

Endoglin B-Gene +
is O +
an O +
auxiliary O +
component O +
of O +
the O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
beta I-Gene +
( I-Gene +
TGF I-Gene -
- I-Gene -
beta I-Gene +
) I-Gene +
receptor I-Gene +
system O +
, O +
able O +
to O +
associate O +
with O +
the O +
signaling O +
receptor O +
types O +
I O +
( O +
TbetaRI B-Gene +
) O +
and O +
II O +
( O +
TbetaRII B-Gene +
) O +
in O +
the O +
presence O +
of O +
ligand O +
and O +
to O +
modulate O +
the O +
cellular O +
responses O +
to O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
. O +

Endoglin B-Gene +
can O -
not O +
bind O +
ligand O +
on O +
its O +
own O +
but O +
requires O +
the O +
presence O +
of O +
the O +
signaling O +
receptors O +
, O +
supporting O +
a O +
critical O +
role O +
for O +
the O +
interaction O +
between O +
endoglin B-Gene +
and O +
TbetaRI B-Gene +
or O +
TbetaRII B-Gene +
. O +

This O +
study O +
shows O +
that O +
full O +
- O +
length O +
endoglin B-Gene +
interacts O +
with O +
both O +
TbetaRI B-Gene +
and O +
TbetaRII B-Gene +
, O +
independently O +
of O +
their O +
kinase B-Gene +
activation O +
state O +
or O +
the O +
presence O +
of O +
exogenous O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
. O +

Truncated O +
constructs O +
encoding O +
either O +
the O +
extracellular O +
or O +
the O +
cytoplasmic O +
domains O +
of O +
endoglin B-Gene +
demonstrated O +
that O +
the O +
association O +
with O +
the O +
signaling O +
receptors O +
occurs O +
through O +
both O +
extracellular O +
and O +
cytoplasmic O +
domains O +
. O +

However O +
, O +
a O +
more O +
specific O +
mapping O +
revealed O +
that O +
the O +
endoglin B-Gene +
/ O +
TbetaRI B-Gene +
interaction O +
was O +
different O +
from O +
that O +
of O +
endoglin B-Gene +
/ O +
TbetaRII B-Gene +
. O +

TbetaRII B-Gene +
interacts O +
with O +
the O +
amino O +
acid O +
region O +
437 O +
- O +
558 O +
of O +
the O +
extracellular O +
domain O +
of O +
endoglin B-Gene +
, O +
whereas O +
TbetaRI B-Gene +
interacts O +
not O +
only O +
with O +
the O +
region O +
437 O +
- O +
558 O +
but O +
also O +
with O +
the O +
protein O +
region O +
located O +
between O +
amino O +
acid O +
437 O +
and O +
the O +
N O +
terminus O +
. O +

Both O +
TbetaRI B-Gene +
and O +
TbetaRII B-Gene +
interact O +
with O +
the O +
cytoplasmic O +
domain O +
of O +
endoglin B-Gene +
, O +
but O +
TbetaRI B-Gene +
only O +
interacts O +
when O +
the O +
kinase B-Gene +
domain O +
is O +
inactive O +
, O +
whereas O +
TbetaRII B-Gene +
remains O +
associated O +
in O +
its O +
active O +
and O +
inactive O +
forms O +
. O +

Upon O +
association O +
, O +
TbetaRI B-Gene +
and O +
TbetaRII B-Gene +
phosphorylate O +
the O +
endoglin O +
cytoplasmic O +
domain O +
, O +
and O +
then O +
TbetaRI B-Gene +
, O +
but O +
not O +
TbetaRII B-Gene +
, O +
kinase B-Gene +
dissociates O +
from O +
the O +
complex O +
. O +

Conversely O +
, O +
endoglin B-Gene +
expression O +
results O +
in O +
an O +
altered O +
phosphorylation O +
state O +
of O +
TbetaRII B-Gene +
, O +
TbetaRI B-Gene +
, O +
and O +
downstream O +
Smad B-Gene +
proteins O +
as O +
well O +
as O +
a O +
modulation O +
of O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
signaling O +
, O +
as O +
measured O +
by O +
the O +
reporter O +
gene O +
expression O +
. O +

These O +
results O +
suggest O +
that O +
by O +
interacting O +
through O +
its O +
extracellular O +
and O +
cytoplasmic O +
domains O +
with O +
the O +
signaling O +
receptors O +
, O +
endoglin O +
might O +
affect O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
responses O +
. O +

Analysis O +
of O +
human O +
cellular B-Gene +
retinol I-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
II I-Gene +
promoter O +
during O +
enterocyte O +
differentiation O +
. O +

Cellular B-Gene +
retinol I-Gene +
binding I-Gene +
protein I-Gene +
II I-Gene +
( O +
CRBP B-Gene +
II I-Gene +
) O +
is O +
a O +
vitamin O +
A O +
- O +
binding O +
protein O +
that O +
is O +
expressed O +
specifically O +
in O +
small O +
intestinal O +
villus O +
absorptive O +
cells O +
. O +

Previous O +
studies O +
have O +
shown O +
that O +
retinoic O +
acid O +
upregulates O +
endogenous O +
human O +
CRBP B-Gene +
II I-Gene +
gene O +
expression O +
in O +
differentiated O +
Caco-2 O +
cells O +
. O +

To O +
better O +
characterize O +
the O +
regulation O +
of O +
human O +
CRBP B-Gene +
II I-Gene +
expression O +
, O +
we O +
analyzed O +
the O +
ability O +
of O +
receptor O +
- O +
selective O +
agonists O +
to O +
enhance O +
transcription O +
from O +
the O +
5 O -
' O +
- O +
upstream O +
flanking O +
region O +
of O +
the O +
human O +
CRBP B-Gene +
II I-Gene +
gene O +
. O +

Stable O +
transfection O +
experiments O +
showed O +
that O +
the O +
proximal O +
2.8 O +
- O +
kb O +
region O +
of O +
the O +
human O +
CRBP B-Gene +
II I-Gene +
gene O +
is O +
sufficient O +
for O +
retinoic O +
acid O +
inducibility O +
in O +
differentiated O +
Caco-2 O +
cells O +
. O +

However O +
, O +
direct O +
sequence O +
analysis O +
and O +
transient O +
transfection O +
experiments O +
indicate O +
that O +
, O +
unlike O +
the O +
rat O +
CRBP B-Gene +
II I-Gene +
promoter O +
, O +
the O +
human O +
CRBP B-Gene +
II I-Gene +
promoter O +
is O +
not O +
a O +
direct O +
retinoid B-Gene +
X I-Gene +
receptor I-Gene +
target O +
. O +

The O +
results O +
indicate O +
that O +
the O +
retinoic O +
acid O +
responsiveness O +
of O +
the O +
human O +
CRBP B-Gene +
II I-Gene +
promoter O +
is O +
mediated O +
by O +
an O +
indirect O +
mechanism O +
and O +
that O +
this O +
mechanism O +
is O +
associated O +
with O +
enterocyte O +
differentiation O +
. O +

PYPAF7 B-Gene +
, O +
a O +
novel O +
PYRIN B-Gene +
- I-Gene +
containing I-Gene +
Apaf1 I-Gene +
- I-Gene +
like I-Gene +
protein I-Gene +
that O +
regulates O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
and O +
caspase-1 B-Gene +
- O +
dependent O +
cytokine B-Gene +
processing O +
. O +

PYRIN B-Gene +
- I-Gene +
containing I-Gene +
Apaf1 I-Gene +
- I-Gene +
like I-Gene +
proteins I-Gene +
( O +
PYPAFs B-Gene +
) O +
are O +
members O +
of O +
the O +
nucleotide B-Gene +
- I-Gene +
binding I-Gene +
site I-Gene +
/ I-Gene +
leucine I-Gene +
- I-Gene +
rich I-Gene +
repeat I-Gene +
( I-Gene +
NBS I-Gene +
/ I-Gene +
LRR I-Gene +
) I-Gene +
family I-Gene +
of O +
signal O +
transduction O +
proteins O +
. O +

We O +
report O +
here O +
that O +
PYPAF7 B-Gene +
is O +
a O +
novel O +
PYPAF B-Gene +
protein O +
that O +
activates O +
inflammatory O +
signaling O +
pathways O +
. O +

The O +
expression O +
of O +
PYPAF7 B-Gene +
is O +
highly O +
restricted O +
to O +
immune O +
cells O +
, O +
and O +
its O +
gene O +
maps O +
to O +
chromosome O +
19q13.4 O +
, O +
a O +
locus O +
that O +
contains O +
a O +
cluster O +
of O +
genes O +
encoding O +
numerous O +
PYPAF B-Gene +
family I-Gene +
members O +
. O +

Co O +
- O +
expression O +
of O +
PYPAF7 B-Gene +
with O +
ASC B-Gene +
results O +
in O +
the O +
recruitment O +
of O +
PYPAF7 B-Gene +
to O +
distinct O +
cytoplasmic O +
loci O +
and O +
a O +
potent O +
synergistic O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
. O +

To O +
identify O +
other O +
proteins O +
involved O +
in O +
PYPAF7 B-Gene +
and O +
ASC B-Gene +
signaling O +
pathways O +
, O +
we O +
performed O +
a O +
mammalian O +
two O +
- O +
hybrid O +
screen O +
and O +
identified O +
pro O +
- O +
caspase-1 B-Gene +
as O +
a O +
binding O +
partner O +
of O +
ASC B-Gene +
. O +

Co O +
- O +
expression O +
of O +
PYPAF7 B-Gene +
and O +
ASC B-Gene +
results O +
in O +
the O +
synergistic O +
activation O +
of O +
caspase-1 B-Gene +
and O +
a O +
corresponding O +
increase O +
in O +
secretion O +
of O +
interleukin-1 B-Gene +
beta I-Gene +
. O +

In O +
addition O +
, O +
PYPAF1 B-Gene +
induces O +
caspase-1 B-Gene +
- O +
dependent O +
cytokine B-Gene +
processing O +
when O +
co O +
- O +
expressed O +
with O +
ASC B-Gene +
. O +

These O +
findings O +
indicate O +
that O +
PYPAF B-Gene +
family I-Gene +
members O +
participate O +
in O +
inflammatory O +
signaling O +
by O +
regulating O +
the O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
and O +
cytokine B-Gene +
processing O +
. O +

Expression O +
of O +
somatostatin B-Gene +
receptor I-Gene +
types I-Gene +
1 I-Gene -
- I-Gene -
5 I-Gene +
in O +
81 O +
cases O +
of O +
gastrointestinal O +
and O +
pancreatic O +
endocrine O +
tumors O +
. O +

A O +
correlative O +
immunohistochemical O +
and O +
reverse O +
- O +
transcriptase O +
polymerase O +
chain O +
reaction O +
analysis O +
. O +

Somatostatin B-Gene +
receptors I-Gene +
( O +
SSTRs B-Gene +
) O +
have O +
been O +
extensively O +
mapped O +
in O +
human O +
tumors O +
by O +
means O +
of O +
autoradiography O +
, O +
reverse O +
- O +
transcriptase O +
polymerase O +
chain O +
reaction O +
( O +
RT O +
- O +
PCR O +
) O +
, O +
in O +
situ O +
hybridization O +
( O +
ISH O +
) O +
and O +
immunohistochemistry O +
( O +
IHC O +
) O +
. O +

We O +
analyzed O +
the O +
SSTR B-Gene +
type I-Gene +
1 I-Gene -
- I-Gene -
5 I-Gene +
expression O +
by O +
means O +
of O +
RT O +
- O +
PCR O +
and/or O +
IHC O +
in O +
a O +
series O +
of O +
81 O +
functioning O +
and O +
non O +
- O +
functioning O +
gastroenteropancreatic O +
( O +
GEP O +
) O +
endocrine O +
tumors O +
and O +
related O +
normal O +
tissues O +
. O +

Moreover O +
, O +
we O +
compared O +
the O +
results O +
with O +
clinical O +
, O +
pathological O +
and O +
hormonal O +
features O +
. O +

Forty O -
- O -
six O +
cases O +
( O +
13 O +
intestinal O +
and O +
33 O +
pancreatic O +
) O +
were O +
studied O +
for O +
SSTR B-Gene +
1 I-Gene -
- I-Gene -
5 I-Gene +
expression O +
using O +
RT O +
- O +
PCR O +
, O +
IHC O +
with O +
antibodies O +
to O +
SSTR B-Gene +
types I-Gene +
2 I-Gene +
, I-Gene +
3 I-Gene +
, I-Gene +
5 I-Gene +
and O +
ISH O +
for O +
SSTR2 B-Gene +
mRNA O +
. O +

The O +
vast O +
majority O +
of O +
tumors O +
expressed O +
SSTR B-Gene +
types I-Gene +
1 I-Gene +
, I-Gene +
2 I-Gene +
, I-Gene +
3 I-Gene +
and I-Gene +
5 I-Gene +
, O +
while O +
SSTR4 B-Gene +
was O +
detected O +
in O +
a O +
small O +
minority O +
. O +

Due O +
to O +
the O +
good O +
correlation O +
between O +
RT O +
- O +
PCR O +
and O +
IHC O +
data O +
on O +
SSTR B-Gene +
types I-Gene +
2 I-Gene +
, I-Gene +
3 I-Gene +
, I-Gene +
and I-Gene +
5 I-Gene +
, O +
thirty O +
- O +
five O +
additional O +
GEP O +
endocrine O +
tumors O +
were O +
studied O +
with O +
IHC O +
alone O +
. O +

Pancreatic O +
insulinomas O +
had O +
an O +
heterogeneous O +
SSTR B-Gene +
expression O +
, O +
while O +
100 O +
% O +
of O +
somatostatinomas O +
expressed O +
SSTR5 B-Gene +
and O +
100 O +
% O +
gastrinomas O +
and O +
glucagonomas O +
expressed O +
SSTR2 B-Gene +
. O +

Pre O +
- O +
operative O +
biopsy O +
material O +
showed O +
an O +
overlapping O +
immunoreactivity O +
with O +
that O +
of O +
surgical O +
specimens O +
, O +
suggesting O +
that O +
the O +
SSTR B-Gene +
status O +
can O +
be O +
detected O +
in O +
the O +
diagnostic O +
work O +
- O +
up O +
. O +

It O +
is O +
concluded O +
that O +
SSTRs B-Gene +
1 I-Gene -
- I-Gene -
5 I-Gene +
are O +
heterogeneously O +
expressed O +
in O +
GEP O +
endocrine O +
tumors O +
and O +
that O +
IHC O +
is O +
a O +
reliable O +
tool O +
to O +
detect O +
SSTR B-Gene +
types I-Gene +
2 I-Gene +
, I-Gene +
3 I-Gene +
and I-Gene +
5 I-Gene +
in O +
surgical O +
and O +
biopsy O +
specimens O +
. O +

Cardiotrophin-1 B-Gene +
and O +
urocortin B-Gene +
cause O +
protection O +
by O +
the O +
same O +
pathway O +
and O +
hypertrophy O +
via O +
distinct O +
pathways O +
in O +
cardiac O +
myocytes O +
. O +

Cardiotrophin-1 B-Gene +
( O +
CT-1 B-Gene +
) O +
is O +
an O +
Interleukin-6 B-Gene +
family I-Gene +
cytokine I-Gene +
with O +
known O +
hypertrophic O +
and O +
protective O +
effects O +
in O +
cardiac O +
cells O +
. O +

CT-1 B-Gene +
and O +
the O +
corticotrophin B-Gene +
releasing I-Gene +
hormone I-Gene +
- O +
like O +
hormone O +
urocortin B-Gene +
protect O +
cardiac O +
myocytes O +
by O +
the O +
same O +
p42 B-Gene +
/ I-Gene +
44 I-Gene +
mitogen I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
( O +
p42 B-Gene +
/ I-Gene +
44 I-Gene +
MAPK I-Gene +
) O +
dependent O +
pathway O +
. O +

We O +
investigated O +
whether O +
urocortin O +
is O +
also O +
hypertrophic O +
in O +
cardiac O +
myocytes O +
and O +
whether O +
it O +
shares O +
a O +
common O +
pathway O +
with O +
CT-1 B-Gene +
for O +
this O +
effect O +
. O +

Moreover O +
, O +
we O +
also O +
investigated O +
, O +
for O +
the O +
first O +
time O +
whether O +
CT-1 B-Gene +
and O +
urocortin B-Gene +
can O +
induce O +
hypertrophy O +
in O +
cultured O +
adult O +
as O +
opposed O +
to O +
neonatal O +
cardiac O +
cells O +
. O +

Urocortin O +
and O +
CT-1 B-Gene +
caused O +
hypertrophy O +
( O +
as O +
measured O +
by O +
an O +
increase O +
in O +
cell O +
area O +
and O +
enhanced O +
protein O +
: O +
DNA O +
ratio O +
) O +
in O +
both O +
adult O +
and O +
neonatal O +
rat O +
cultured O +
cardiac O +
myocytes O +
. O +

The O +
hypertrophic O +
effect O +
of O +
CT-1 B-Gene +
was O +
dependent O +
on O +
the O +
signal B-Gene +
transducer I-Gene +
and I-Gene +
activator I-Gene +
of I-Gene +
transcription I-Gene +
3 I-Gene +
( O +
STAT3 B-Gene +
) O +
pathway O +
but O +
the O +
hypertrophic O +
effect O +
of O +
urocortin O +
was O +
independent O +
of O +
this O +
pathway O +
. O +

In O +
contrast O +
, O +
inhibition O +
of O +
the O +
protective O +
p42 B-Gene +
/ I-Gene +
p44 I-Gene +
MAPK I-Gene +
pathway O +
has O +
no O +
effect O +
on O +
the O +
hypertrophic O +
effect O +
of O +
CT-1 B-Gene +
or O +
urocortin O +
. O +

Additionally O +
, O +
inhibition O +
of O +
the O +
STAT3 B-Gene +
pathway O +
has O +
no O +
effect O +
on O +
the O +
protective O +
effect O +
of O +
CT-1 B-Gene +
or O +
urocortin O +
. O +

These O +
results O +
identify O +
urocortin B-Gene +
as O +
a O +
novel O +
hypertrophic O +
and O +
protective O +
agent O +
whose O +
hypertrophic O +
effect O +
is O +
mediated O +
by O +
a O +
distinct O +
pathway O +
to O +
that O +
activated O +
by O +
CT-1 B-Gene +
, O +
although O +
the O +
two O +
factors O +
mediate O +
protection O +
via O +
the O +
same O +
pathway O +
. O +

Mutation O +
analysis O +
of O +
the O +
PIG B-Gene -
- I-Gene -
A I-Gene +
gene O +
in O +
Korean O +
patients O +
with O +
paroxysmal O +
nocturnal O +
haemoglobinuria O +
. O +

AIM O +
: O +

Paroxysmal O +
nocturnal O +
haemoglobinuria O +
( O +
PNH O +
) O +
is O +
caused O +
by O +
deficient O +
biosynthesis O +
of O +
the O +
glycosylphosphatidylinositol O +
( O +
GPI O +
) O +
anchor O +
in O +
haemopoietic O +
stem O +
cells O +
. O +

Mutation O +
of O +
the O +
phosphatidylinositol B-Gene +
glycan I-Gene +
class I-Gene +
A I-Gene +
( O +
PIG B-Gene -
- I-Gene -
A I-Gene +
) O +
gene O +
, O +
an O +
X O +
linked O +
gene O +
that O +
participates O +
in O +
the O +
first O +
step O +
of O +
GPI O +
anchor O +
biosynthesis O +
, O +
is O +
responsible O +
for O +
PNH O +
. O +

The O +
characteristics O +
of O +
somatic O +
mutation O +
of O +
the O +
PIG B-Gene -
- I-Gene -
A I-Gene +
gene O +
in O +
Korean O +
patients O +
with O +
PNH O +
were O +
studied O +
. O +

METHODS O +
: O +

Twenty O +
four O +
patients O +
with O +
PNH O +
were O +
selected O +
. O +

Ham O +
tests O +
and O +
sucrose O +
haemolysis O +
tests O +
were O +
carried O +
out O +
on O +
all O +
patients O +
. O +

The O +
expression O +
of O +
CD59 B-Gene +
in O +
erythrocytes O +
and O +
granulocytes O +
was O +
investigated O +
in O +
14 O +
and O +
five O +
patients O +
, O +
respectively O +
, O +
to O +
confirm O +
the O +
diagnosis O +
. O +

Dideoxy O +
fingerprinting O +
( O +
ddF O +
) O +
was O +
used O +
to O +
screen O +
mutations O +
, O +
and O +
direct O +
sequencing O +
of O +
DNA O +
was O +
performed O +
to O +
characterise O +
the O +
mutations O +
. O +

RESULTS O +
: O +

Gene O +
mutation O +
was O +
detected O +
in O +
12 O +
of O +
the O +
24 O +
patients O +
. O +

The O +
other O +
12 O +
patients O +
were O +
negative O +
in O +
ddF O +
screening O +
. O +

Ten O +
new O +
mutations O +
and O +
two O +
known O +
mutations O +
were O +
detected O +
. O +

The O +
mutations O +
consisted O +
of O +
five O +
deletions O +
, O +
six O +
substitutions O +
, O +
and O +
one O +
insertion O +
. O +

These O +
mutations O +
resulted O +
in O +
six O +
premature O +
terminations O +
, O +
three O +
abnormal O +
splicings O +
, O +
one O +
missense O +
mutation O +
in O +
exon O +
2 O +
, O +
and O +
two O +
nonsense O +
mutations O +
. O +

Two O +
patients O +
with O +
venous O +
thrombosis O +
showed O +
mutations O +
in O +
exon O +
3 O +
only O +
. O +

Substitution O +
mutations O +
were O +
seen O +
in O +
six O +
patients O +
and O +
frameshift O +
mutations O +
in O +
the O +
other O +
six O +
. O +

CONCLUSIONS O +
: O +

There O +
were O +
10 O +
new O +
mutations O +
among O +
the O +
12 O +
mutations O +
in O +
the O +
Korean O +
patients O +
with O +
PNH O +
and O +
the O +
characteristics O +
of O +
the O +
mutations O +
varied O +
, O +
with O +
no O +
significant O +
hot O +
spots O +
in O +
sites O +
or O +
types O +
. O +

CK2 B-Gene +
- O +
dependent O +
phosphorylation O +
of O +
the O +
E2 B-Gene +
ubiquitin I-Gene +
conjugating I-Gene +
enzyme I-Gene +
UBC3B B-Gene +
induces O +
its O +
interaction O +
with O +
beta B-Gene -
- I-Gene -
TrCP I-Gene +
and O +
enhances O +
beta B-Gene -
- I-Gene -
catenin I-Gene +
degradation O +
. O +

Protein B-Gene +
kinase I-Gene +
CK2 B-Gene +
is O +
a O +
ubiquitous O +
and O +
pleiotropic O +
Ser B-Gene +
/ I-Gene +
Thr I-Gene +
protein I-Gene +
kinase I-Gene +
involved O +
in O +
cell O +
growth O +
and O +
transformation O +
. O +

Here O +
we O +
report O +
the O +
identification O +
by O +
yeast O +
interaction O +
trap O +
of O +
a O +
CK2 B-Gene +
interacting O +
protein O +
, O +
UBC3B B-Gene +
, O +
which O +
is O +
highly O +
homologous O +
to O +
the O +
E2 B-Gene +
ubiquitin I-Gene +
conjugating I-Gene +
enzyme I-Gene +
UBC3 B-Gene +
/ O +
CDC34 B-Gene +
. O +

UBC3B B-Gene +
complements O +
the O +
yeast O +
cdc34 B-Gene -
- I-Gene -
2 I-Gene +
cell O +
cycle O +
arrest O +
mutant O +
in O +
S. O +
cerevisiae O +
and O +
transfers O +
ubiquitin O +
to O +
a O +
target O +
substrate O +
in O +
vitro O +
. O +

UBC3B B-Gene +
is O +
specifically O +
phosphorylated O +
by O +
CK2 B-Gene +
in O +
vitro O +
and O +
in O +
vivo O +
. O +

We O +
mapped O +
by O +
deletions O +
and O +
site O +
directed O +
mutagenesis O +
the O +
phosphorylation O +
site O +
to O +
a O +
serine O +
residue O +
within O +
the O +
C O +
- O +
terminal O +
domain O +
in O +
position O +
233 O +
of O +
UBC3B B-Gene +
and O +
in O +
the O +
corresponding O +
serine O +
residue O +
of O +
UBC3 B-Gene +
. O +

Following O +
CK2 B-Gene +
- O +
dependent O +
phosphorylation O +
both O +
UBC3B B-Gene +
and O +
UBC3 B-Gene +
bind O +
to O +
the O +
F O -
- O -
box O +
protein O +
beta B-Gene -
- I-Gene -
TrCP I-Gene +
, O +
the O +
substrate O +
recognition O +
subunit O +
of O +
an O +
SCF O +
( O +
Skp1 B-Gene +
, O +
Cul1 B-Gene +
, O +
F B-Gene -
- I-Gene -
box I-Gene +
) O +
ubiquitin B-Gene +
ligase I-Gene +
. O +

Furthermore O +
, O +
we O +
observed O +
that O +
co O +
- O +
transfection O +
of O +
CK2alpha B-Gene +
' I-Gene +
together O +
with O +
UBC3B B-Gene +
, O +
but O +
not O +
with O +
UBC3DeltaC B-Gene +
, O +
enhances O +
the O +
degradation O +
of O +
beta B-Gene -
- I-Gene -
catenin I-Gene +
. O +

Taken O +
together O +
these O +
data O +
suggest O +
that O +
CK2 B-Gene +
- O +
dependent O +
phosphorylation O +
of O +
UBC3 B-Gene +
and O +
UBC3B B-Gene +
functions O +
by O +
regulating O +
beta B-Gene -
- I-Gene -
TrCP I-Gene +
substrate O +
recognition O +
. O +

Acute O +
effects O +
of O +
acephate O +
and O +
methamidophos O +
and O +
interleukin-1 B-Gene +
on O +
corticotropin B-Gene +
- I-Gene +
releasing I-Gene +
factor I-Gene +
( O +
CRF B-Gene +
) O +
synthesis O +
in O +
and O +
release O +
from O +
the O +
hypothalamus O +
in O +
vitro O +
. O +

Acute O +
effects O +
of O +
Ace O +
, O +
Meth O +
and O +
IL-1 B-Gene +
on O +
AChE B-Gene +
activity O +
, O +
ACh O +
and O +
CRF B-Gene +
mRNA O +
levels O +
in O +
, O +
and O +
CRF B-Gene +
- O +
release O +
from O +
the O +
hypothalamus O +
were O +
studied O +
in O +
vitro O +
. O +

The O +
hypothalamus O +
samples O +
were O +
dissected O +
from O +
the O +
rat O +
brain O +
and O +
were O +
incubated O +
in O +
vitro O +
with O +
IL-1 B-Gene +
, O +
Ace O +
or O +
Meth O +
in O +
the O +
presence O +
or O +
absence O +
of O +
Dex O +
, O +
Atrop O +
, O +
PTL O +
, O +
PROP O +
and O +
GABA O +
. O +

Ace O +
and O +
Meth O +
, O +
but O +
not O +
IL-1 B-Gene +
, O +
inhibited O +
AChE B-Gene +
activity O +
, O +
while O +
all O +
three O +
compounds O +
; O +
( O +
1 O +
) O +
increased O +
ACh O +
and O +
CRF B-Gene +
mRNA O +
levels O +
in O +
and O +
CRF B-Gene +
release O +
from O +
; O +
( O +
2 O +
) O +
activated O +
the O +
CRE O +
promoter O +
region O +
of O +
CRF B-Gene +
- O +
gene O +
in O +
: O +
and O +
( O +
3 O +
) O +
increased O +
cFos B-Gene +
binding O +
to O +
the O +
AP-1 B-Gene +
region O +
of O +
the O +
CRF B-Gene +
- O +
gene O +
in O +
the O +
hypothalamus O +
. O +

Dex O +
suppressed O +
the O +
effects O +
of O +
IL-1 B-Gene +
, O +
possibly O +
by O +
inducing O +
the O +
nGRE O +
regulatory O +
sites O +
of O +
the O +
CRF B-Gene +
- O +
gene O +
. O +

Dex O +
, O +
however O +
, O +
did O +
not O +
modulate O +
the O +
effects O +
of O +
Ace O +
and O +
Meth O +
on O +
the O +
hypothalamus O +
, O +
which O +
may O +
be O +
attributed O +
to O +
the O +
failure O +
of O +
Dex O +
to O +
modulate O +
the O +
CRF B-Gene +
- O +
gene O +
' O +
s O +
nGRE O +
regulatory O +
sites O +
. O +

Atrop O +
caused O +
80 O +
- O +
90 O +
% O +
inhibition O +
of O +
the O +
effects O +
of O +
IL-1 B-Gene +
, O +
but O +
caused O +
only O +
50 O +
- O +
65 O +
% O +
inhibition O +
of O +
the O +
effects O +
of O +
Ace O +
or O +
Meth O +
on O +
CRF B-Gene +
mRNA O +
levels O +
in O +
and O +
CRF B-Gene +
release O +
from O +
the O +
hypothalamus O +
. O +

PTL O +
did O +
not O +
affect O +
, O +
while O +
PROP O +
slightly O +
attenuated O +
the O +
effects O +
of O +
IL-1 B-Gene +
and O +
the O +
insecticides O +
on O +
the O +
hypothalamus O +
. O +

GABA O +
attenuated O +
the O +
effects O +
of O +
the O +
insecticides O +
but O +
not O +
the O +
effects O +
of O +
IL-1 B-Gene +
on O +
the O +
hypothalamus O +
. O +

This O +
suggests O +
that O +
the O +
IL-1 B-Gene +
- O +
induced O +
augmentation O +
of O +
CRF B-Gene +
synthesis O +
in O +
and O +
release O +
from O +
the O +
hypothalamus O +
is O +
mediated O +
through O +
a O +
cholinergic O +
pathway O +
, O +
while O +
the O +
insecticide O +
- O +
induced O +
augmentation O +
of O +
CRF B-Gene +
synthesis O +
in O +
and O +
release O +
from O +
the O +
hypothalamus O +
is O +
mediated O +
through O +
the O +
cholinergic O +
and O +
GABAergic O +
pathways O +
. O +

The O +
insecticides O +
, O +
but O +
not O +
IL-1 B-Gene +
, O +
disrupt O +
feedback O +
regulation O +
of O +
CRF B-Gene +
synthesis O +
in O +
and O +
release O +
from O +
the O +
hypothalamus O +
. O +

Significance O +
of O +
the O +
parkin B-Gene +
gene O +
and O +
protein O +
in O +
understanding O +
Parkinson O +
's O +
disease O +
. O +

Mutations O +
in O +
the O +
parkin B-Gene +
gene O +
cause O +
autosomal O +
recessive O +
inherited O +
juvenile O +
parkinsonism O +
( O +
ARJP O +
) O +
and O +
account O +
for O +
the O +
majority O +
of O +
cases O +
of O +
inherited O +
Parkinson O +
's O +
disease O +
( O +
PD O +
) O +
of O +
young O +
onset O +
( O +
< O +
45 O +
years O +
of O +
age O +
) O +
. O +

Patients O +
with O +
parkin B-Gene +
mutations O +
commonly O +
have O +
atypical O +
clinical O +
features O +
such O +
as O +
dystonia O +
at O +
onset O +
, O +
hyper O +
- O +
reflexia O +
, O +
diurnal O +
fluctuations O +
, O +
and O +
sleep O +
benefit O +
; O +
however O +
, O +
parkin B-Gene +
mutation O +
patients O +
with O +
both O +
typical O +
PD O +
symptoms O +
and O +
older O +
age O +
of O +
onset O +
have O +
been O +
identified O +
. O +

Parkin B-Gene +
is O +
a O +
ubiquitin B-Gene +
protein I-Gene +
ligase I-Gene +
( I-Gene +
E3 I-Gene +
) I-Gene +
, O +
a O +
component O +
in O +
the O +
pathway O +
that O +
attaches O +
ubiquitin B-Gene +
to O +
specific O +
proteins O +
, O +
designating O +
them O +
for O +
degradation O +
by O +
the O +
proteasome O +
. O +

Several O +
substrates O +
for O +
parkin B-Gene +
have O +
been O +
identified O +
( O +
CDCrel-1 B-Gene +
, O +
o O +
- O +
glycosylated O +
alpha B-Gene -
- I-Gene -
synuclein I-Gene +
, O +
parkin B-Gene +
associated I-Gene +
endothelin I-Gene +
- I-Gene +
like I-Gene +
cell I-Gene +
receptor I-Gene +
, O +
and O +
synphilin B-Gene +
) O +
. O +

The O +
role O +
of O +
these O +
substrates O +
in O +
the O +
pathogenesis O +
of O +
ARJP O +
is O +
under O +
active O +
study O +
. O +

Most O +
patients O +
with O +
parkin B-Gene +
mutations O +
lack O +
Lewy O +
bodies O +
, O +
suggesting O +
that O +
functional O +
parkin B-Gene +
is O +
involved O +
in O +
the O +
formation O +
of O +
these O +
highly O +
ubiquitinated O +
inclusions O +
. O +

Furthermore O +
, O +
the O +
recognition O +
that O +
parkin B-Gene +
mutations O +
can O +
lead O +
to O +
a O +
disorder O +
clinically O +
similar O +
to O +
sporadic O +
PD O +
, O +
but O +
presumably O +
lacking O +
Lewy O +
bodies O +
, O +
calls O +
into O +
question O +
the O +
necessity O +
of O +
Lewy O +
bodies O +
for O +
the O +
diagnosis O +
of O +
PD O +
and O +
nigral O +
cell O +
death O +
. O +

Studies O +
of O +
parkin B-Gene +
are O +
increasing O +
the O +
focus O +
on O +
the O +
role O +
of O +
the O +
ubiquitin B-Gene +
- O +
proteasome O +
system O +
in O +
the O +
pathogenesis O +
of O +
both O +
familial O +
and O +
sporadic O +
PD O +
. O +

Normalization O +
of O +
natural O +
killer O +
cell O +
function O +
and O +
phenotype O +
with O +
effective O +
anti O +
- O +
HIV O +
therapy O +
and O +
the O +
role O +
of O +
IL-10 B-Gene +
. O +

OBJECTIVES O +
: O +

Natural O +
killer O +
( O +
NK O +
) O +
cell O +
function O +
is O +
likely O +
to O +
be O +
important O +
in O +
controlling O +
HIV O +
infection O +
and O +
opportunistic O +
pathogens O +
. O +

We O +
therefore O +
evaluated O +
NK O +
function O +
and O +
phenotype O +
over O +
the O +
course O +
of O +
antiretroviral O +
therapy O +
( O +
ART O +
) O +
and O +
examined O +
the O +
potential O +
mechanisms O +
of O +
altered O +
NK O +
activity O +
in O +
HIV O +
infection O +
. O +

METHODS O +
: O +

We O +
measured O +
NK O +
cell O +
percentage O +
, O +
NK O +
cytolytic O +
activity O +
( O +
both O +
by O +
flow O +
cytometry O +
) O +
and O +
plasma O +
IL-10 B-Gene +
concentrations O +
( O +
by O +
enzyme O +
- O +
linked O +
immunosorbent O +
assay O +
) O +
in O +
10 O +
HIV O +
- O +
seropositive O +
patients O +
before O +
and O +
over O +
one O +
year O +
of O +
effective O +
ART O +
. O +

To O +
examine O +
potential O +
mechanisms O +
of O +
altered O +
NK O +
activity O +
, O +
we O +
measured O +
NK O +
receptor O +
expression O +
in O +
ART O +
treated O +
and O +
untreated O +
HIV O +
- O +
positive O +
individuals O +
by O +
flow O +
cytometry O +
. O +

As O +
IL-10 B-Gene +
enhances O +
NK O +
activity O +
, O +
we O +
studied O +
the O +
effect O +
of O +
IL-10 B-Gene +
on O +
NK O +
receptor O +
expression O +
and O +
activity O +
in O +
peripheral O +
blood O +
mononuclear O +
cells O +
( O +
PBMC O +
) O +
from O +
HIV O +
- O +
seronegative O +
individuals O +
. O +

RESULTS O +
: O +

NK O +
cytolytic O +
activity O +
was O +
elevated O +
in O +
HIV O +
infection O +
and O +
decreased O +
with O +
ART O +
to O +
levels O +
observed O +
in O +
HIV O +
- O +
negative O +
individuals O +
. O +

A O +
greater O +
proportion O +
of O +
NK O +
cells O +
from O +
untreated O +
HIV O +
- O +
positive O +
individuals O +
expressed O +
the O +
NK O +
receptors O +
CD158a B-Gene +
and O +
CD161 B-Gene +
than O +
either O +
HIV O +
- O +
negative O +
volunteers O +
or O +
effectively O +
treated O +
HIV O +
- O +
positive O +
patients O +
. O +

NK O +
cells O +
from O +
PBMC O +
incubated O +
with O +
IL-10 B-Gene +
demonstrated O +
increases O +
in O +
CD158a B-Gene +
, O +
CD161 B-Gene +
and O +
CD94 B-Gene +
expression O +
and O +
increases O +
in O +
cytolytic O +
activity O +
. O +

The O +
treatment O +
- O +
associated O +
decrease O +
in O +
NK O +
activity O +
paralleled O +
a O +
decrease O +
in O +
IL-10 B-Gene +
production O +
. O +

CONCLUSION O +
: O +

The O +
observation O +
that O +
IL-10 B-Gene +
alters O +
NK O +
receptor O +
expression O +
similar O +
to O +
that O +
observed O +
in O +
HIV O +
infection O +
, O +
and O +
the O +
fact O +
that O +
NK O +
receptor O +
expression O +
and O +
activity O +
normalize O +
in O +
parallel O +
with O +
ART O +
- O +
induced O +
reduction O +
of O +
circulating O +
IL-10 B-Gene +
levels O +
supports O +
a O +
role O +
for O +
IL-10 B-Gene +
in O +
NK O +
cell O +
activity O +
and O +
HIV O +
immunopathogenesis O +
. O +

BAG-1 B-Gene +
, O +
an O +
anti O +
- O +
apoptotic O +
tumour O +
marker O +
. O +

BAG-1 B-Gene +
is O +
a O +
multifunctional O +
and O +
anti O +
- O +
apoptotic O +
or O +
anti O +
- O +
cell O +
death O +
protein O +
that O +
interacts O +
with O +
a O +
variety O +
of O +
cellular O +
proteins O +
and O +
affects O +
their O +
functions O +
. O +

On O +
the O +
cell O +
surface O +
, O +
it O +
binds O +
to O +
the O +
cytosolic O +
domain O +
of O +
the O +
growth B-Gene +
factor I-Gene +
receptors I-Gene +
and O +
enhances O +
the O +
protection O +
from O +
cell O +
death O +
triggered O +
by O +
growth B-Gene +
factor I-Gene +
receptors I-Gene +
. O +

In O +
the O +
cytosol O +
, O +
it O +
binds O +
to O +
Bcl-2 B-Gene +
and O +
heat B-Gene +
shock I-Gene +
protein I-Gene +
, O +
and O +
modulates O +
their O +
functions O +
. O +

In O +
the O +
nucleus O +
, O +
it O +
binds O +
to O +
a O +
variety O +
of O +
nuclear B-Gene +
hormone I-Gene +
receptors I-Gene +
and O +
inhibits O +
hormone O +
- O +
induced O +
apoptosis O +
. O +

BAG-1 B-Gene +
is O +
widely O +
overexpressed O +
in O +
a O +
variety O +
of O +
tumour O +
cell O +
lines O +
and O +
cancer O +
tissues O +
. O +

In O +
addition O +
, O +
differential O +
expression O +
of O +
BAG-1 B-Gene +
isoforms O +
has O +
been O +
observed O +
. O +

Preclinical O +
studies O +
indicate O +
that O +
overexpression O +
of O +
BAG-1 B-Gene +
, O +
especially O +
its O +
nuclear O +
and O +
cytoplasmic O +
isoforms O +
, O +
may O +
be O +
useful O +
as O +
a O +
prognostic O +
and/or O +
predictive O +
biomarker O +
. O +

Pilot O +
clinical O +
studies O +
have O +
demonstrated O +
that O +
overexpression O +
of O +
nuclear O +
BAG-1 B-Gene +
may O +
be O +
associated O +
with O +
a O +
shorter O +
survival O +
in O +
breast O +
and O +
laryngeal O +
carcinomas O +
. O +

Conversely O +
, O +
overexpression O +
of O +
cytoplasmic O +
BAG-1 B-Gene +
may O +
be O +
associated O +
with O +
a O +
better O +
clinical O +
outcome O +
in O +
early O +
stage O +
breast O +
cancer O +
and O +
in O +
non O +
- O +
small O +
cell O +
lung O +
cancer O +
. O +

Further O +
large O +
- O +
scale O +
clinical O +
studies O +
are O +
warranted O +
to O +
establish O +
the O +
role O +
of O +
BAG-1 B-Gene +
as O +
a O +
novel O +
prognostic O +
and/or O +
predictive O +
biomarker O +
in O +
the O +
clinical O +
management O +
of O +
these O +
common O +
malignancies O +
. O +

Identification O +
of O +
the O +
bacteria O +
- O +
binding O +
peptide O +
domain O +
on O +
salivary O +
agglutinin B-Gene +
( O +
gp-340 B-Gene +
/ O +
DMBT1 B-Gene +
) O +
, O +
a O +
member O +
of O +
the O +
scavenger B-Gene +
receptor I-Gene +
cysteine I-Gene +
- I-Gene +
rich I-Gene +
superfamily I-Gene +
. O +

Salivary O +
agglutinin B-Gene +
is O +
encoded O +
by O +
DMBT1 B-Gene +
and O +
identical O +
to O +
gp-340 B-Gene +
, O +
a O +
member O +
of O +
the O +
scavenger B-Gene +
receptor I-Gene +
cysteine I-Gene +
- I-Gene +
rich I-Gene +
( I-Gene +
SRCR I-Gene +
) I-Gene +
superfamily I-Gene +
. O +

Salivary O +
agglutinin B-Gene +
/ O +
DMBT1 B-Gene +
is O +
known O +
for O +
its O +
Streptococcus O +
mutans O +
agglutinating O +
properties O +
. O +

This O +
300 O +
- O +
400 O +
kDa O +
glycoprotein O +
is O +
composed O +
of O +
conserved O +
peptide O +
motifs O +
: O +
14 O +
SRCR B-Gene +
domains O +
that O +
are O +
separated O +
by O +
SRCR B-Gene +
- O +
interspersed O +
domains O +
( O +
SIDs O +
) O +
, O +
2 O +
CUB O +
( O +
C1r B-Gene +
/ O +
C1s B-Gene +
Uegf B-Gene +
Bmp1 B-Gene +
) O +
domains O +
, O +
and O +
a O +
zona O +
pellucida O +
domain O +
. O +

We O +
have O +
searched O +
for O +
the O +
peptide O +
domains O +
of O +
agglutinin B-Gene +
/ O +
DMBT1 B-Gene +
responsible O +
for O +
bacteria O +
binding O +
. O +

Digestion O +
with O +
endoproteinase B-Gene +
Lys B-Gene -
- I-Gene -
C I-Gene +
resulted O +
in O +
a O +
protein O +
fragment O +
containing O +
exclusively O +
SRCR B-Gene +
and O +
SID O +
domains O +
that O +
binds O +
to O +
S. O +
mutans O +
. O +

To O +
define O +
more O +
closely O +
the O +
S. O +
mutans O +
- O +
binding O +
domain O +
, O +
consensus O +
- O +
based O +
peptides O +
of O +
the O +
SRCR B-Gene +
domains O +
and O +
SIDs O +
were O +
designed O +
and O +
synthesized O +
. O +

Only O +
one O +
of O +
the O +
SRCR B-Gene +
peptides O +
, O +
designated O +
SRCRP2 O +
, O +
and O +
none O +
of O +
the O +
SID O +
peptides O +
bound O +
to O +
S. O +
mutans O +
. O +

Strikingly O +
, O +
this O +
peptide O +
was O +
also O +
able O +
to O +
induce O +
agglutination O +
of O +
S. O +
mutans O +
and O +
a O +
number O +
of O +
other O +
bacteria O +
. O +

The O +
repeated O +
presence O +
of O +
this O +
peptide O +
in O +
the O +
native O +
molecule O +
endows O +
agglutinin B-Gene +
/ O +
DMBT1 B-Gene +
with O +
a O +
general O +
bacterial O +
binding O +
feature O +
with O +
a O +
multivalent O +
character O +
. O +

Moreover O +
, O +
our O +
studies O +
demonstrate O +
for O +
the O +
first O +
time O +
that O +
the O +
polymorphic O +
SRCR B-Gene +
domains O +
of O +
salivary O +
agglutinin B-Gene +
/ O +
DMBT1 B-Gene +
mediate O +
ligand O +
interactions O +
. O +

Yeast O +
Ysl2p B-Gene +
, O +
homologous O +
to O +
Sec7 B-Gene +
domain O +
guanine B-Gene +
nucleotide I-Gene +
exchange I-Gene +
factors I-Gene +
, O +
functions O +
in O +
endocytosis O +
and O +
maintenance O +
of O +
vacuole O +
integrity O +
and O +
interacts O +
with O +
the O +
Arf B-Gene +
- I-Gene +
Like I-Gene +
small I-Gene +
GTPase I-Gene +
Arl1p B-Gene +
. O +

We O +
previously O +
described O +
the O +
isolation O +
of O +
ysl2 B-Gene -
- I-Gene -
1 I-Gene +
due O +
to O +
its O +
genetic O +
interaction O +
with O +
Delta O +
ypt51 B-Gene +
/ O +
vps21 B-Gene +
, O +
a O +
mutant O +
with O +
a O +
deletion O +
of O +
the O +
coding O +
sequence O +
for O +
the O +
yeast O +
Rab5 B-Gene +
homolog O +
, O +
which O +
regulates O +
endocytic O +
traffic O +
between O +
early O +
and O +
late O +
endosomes O +
. O +

Here O +
we O +
report O +
that O +
Ysl2p B-Gene +
is O +
a O +
novel O +
186.8 O +
- O +
kDa O +
peripheral O +
membrane O +
protein O +
homologous O +
to O +
members O +
of O +
the O +
Sec7 B-Gene +
family I-Gene +
. O +

We O +
provide O +
multiple O +
genetic O +
and O +
biochemical O +
evidence O +
for O +
an O +
interaction O +
between O +
Ysl12p B-Gene +
and O +
the O +
Arf B-Gene +
- I-Gene +
like I-Gene +
protein I-Gene +
Arl1p B-Gene +
, O +
consistent O +
with O +
a O +
potential O +
function O +
as O +
an O +
Arf B-Gene +
guanine I-Gene +
nucleotide I-Gene +
exchange I-Gene +
factor I-Gene +
( I-Gene +
GEF I-Gene +
) I-Gene +
. O +

The O +
temperature O +
- O +
sensitive O +
alleles O +
ysl2 B-Gene +
- O +
307 O +
and O +
ysl2 B-Gene +
- O +
316 O +
are O +
specifically O +
defective O +
in O +
ligand O +
- O +
induced O +
degradation O +
of O +
Ste2p B-Gene +
and O +
alpha B-Gene -
- I-Gene -
factor I-Gene +
and O +
exhibit O +
vacuole O +
fragmentation O +
directly O +
upon O +
a O +
shift O +
to O +
37 O +
degrees O +
C O +
. O +

In O +
living O +
cells O +
, O +
green B-Gene +
fluorescent I-Gene +
protein I-Gene +
( O +
GFP B-Gene +
) O +
- O +
Ysl2p B-Gene +
colocalizes O +
with O +
endocytic O +
elements O +
that O +
accumulate O +
FM4 O -
- O -
64 O +
. O +

The O +
GFP B-Gene +
- O +
Ysl2p B-Gene +
staining O +
is O +
sensitive O +
to O +
a O +
mutation O +
in O +
VPS27 B-Gene +
resulting O +
in O +
the O +
formation O +
of O +
an O +
aberrant O +
class O +
E O +
compartment O +
, O +
but O +
it O +
is O +
not O +
affected O +
by O +
a O +
sec7 B-Gene +
mutation O +
. O +

Consistent O +
with O +
the O +
idea O +
that O +
Ysl2p B-Gene +
and O +
Arl1p B-Gene +
have O +
closely O +
related O +
functions O +
, O +
Delta O +
arl1 B-Gene +
cells O +
are O +
defective O +
in O +
endocytic O +
transport O +
and O +
in O +
vacuolar O +
protein O +
sorting O +
. O +

Expression O +
of O +
the O +
Musashi1 B-Gene +
gene O +
encoding O +
the O +
RNA O +
- O +
binding O +
protein O +
in O +
human O +
hepatoma O +
cell O +
lines O +
. O +

Musashi1 B-Gene +
, O +
a O +
neural O +
RNA O +
- O +
binding O +
protein O +
, O +
plays O +
an O +
important O +
role O +
in O +
regulating O +
cell O +
differentiation O +
in O +
precursor O +
cells O +
. O +

Recently O +
, O +
expression O +
of O +
Musashi1 B-Gene +
has O +
been O +
detected O +
in O +
human O +
tumor O +
tissues O +
such O +
as O +
gliomas O +
and O +
melanomas O +
, O +
suggesting O +
its O +
involvement O +
in O +
oncogenic O +
development O +
. O +

To O +
determine O +
any O +
association O +
between O +
Musashi1 B-Gene +
and O +
the O +
development O +
of O +
liver O +
cancer O +
, O +
we O +
investigated O +
its O +
gene O +
expression O +
in O +
seven O +
human O +
hepatoma O +
cell O +
lines O +
: O +
HuH6 O +
, O +
HuH7 O +
, O +
Hep3B O +
, O +
SK O -
- O -
Hep1 O +
, O +
HepG2 O +
, O +
HLE O +
, O +
and O +
HLF O +
. O +

Musashi1 B-Gene +
mRNA O +
expression O +
was O +
analyzed O +
using O +
the O +
reverse O +
- O +
transcription O +
polymerase O +
chain O +
reaction O +
( O +
PCR O +
) O +
, O +
and O +
the O +
PCR O +
products O +
were O +
sequenced O +
using O +
a O +
subcloning O +
procedure O +
. O +

Musashi1 B-Gene +
protein O +
expression O +
was O +
analyzed O +
in O +
HuH7 O +
and O +
HepG2 O +
cells O +
by O +
Western O +
blot O +
and O +
immunofluorescence O +
staining O +
. O +

Musashi1 B-Gene +
mRNA O +
was O +
detected O +
in O +
the O +
HuH6 O +
, O +
HuH7 O +
, O +
and O +
Hep3B O +
hepatoma O +
cell O +
lines O +
, O +
but O +
not O +
in O +
the O +
others O +
. O +

Sequencing O +
of O +
the O +
PCR O +
- O +
amplified O +
Musashi1 B-Gene +
cDNA O +
in O +
these O +
three O +
cell O +
lines O +
showed O +
the O +
expected O +
sequence O +
of O +
the O +
human O +
Musashi1 B-Gene +
gene O +
. O +

Musashi1 B-Gene +
protein O +
expression O +
was O +
confirmed O +
in O +
HuH7 O +
cells O +
, O +
which O +
were O +
positive O +
for O +
Musashi1 B-Gene +
mRNA O +
expression O +
, O +
but O +
not O +
in O +
HepG2 O +
cells O +
. O +

These O +
results O +
suggest O +
that O +
Musashi1 B-Gene +
expression O +
may O +
be O +
an O +
important O +
factor O +
in O +
the O +
development O +
of O +
several O +
types O +
of O +
carcinoma O +
such O +
as O +
human O +
hepatoma O +
, O +
and O +
may O +
be O +
a O +
useful O +
molecular O +
marker O +
for O +
tumor O +
detection O +
. O +

Chromosomal O +
organization O +
and O +
localization O +
of O +
the O +
human O +
histone B-Gene +
deacetylase I-Gene +
9 I-Gene +
gene O +
( O +
HDAC9 B-Gene +
) O +
. O +

Epigenetically O +
mediated O +
modulation O +
of O +
gene O +
promoter O +
function O +
through O +
histone O +
acetylation O +
modifying O +
enzymes O +
, O +
which O +
regulate O +
the O +
acetylation O +
state O +
of O +
histone B-Gene +
proteins O +
and O +
other O +
promoter O +
- O +
bound O +
transcription B-Gene +
factors I-Gene +
, O +
is O +
increasingly O +
appreciated O +
as O +
a O +
key O +
component O +
in O +
the O +
regulation O +
of O +
reversible O +
gene O +
expression O +
. O +

While O +
histone B-Gene +
acetyltransferases I-Gene +
( O +
HATs B-Gene +
) O +
, O +
which O +
are O +
frequently O +
part O +
of O +
multisubunit O +
coactivator O +
complexes O +
, O +
lead O +
to O +
the O +
relaxation O +
of O +
chromatin O +
structure O +
and O +
transcriptional O +
activation O +
, O +
histone B-Gene +
deacetylases I-Gene +
( O +
HDACs B-Gene +
) O +
tend O +
to O +
associate O +
with O +
multisubunit O +
corepressor O +
complexes O +
, O +
which O +
result O +
in O +
chromatin O +
condensation O +
and O +
transcriptional O +
repression O +
of O +
specific O +
target O +
genes O +
. O +

We O +
have O +
isolated O +
and O +
characterized O +
the O +
human O +
HDAC9 B-Gene +
genomic O +
sequence O +
, O +
which O +
spans O +
a O +
region O +
of O +
458 O +
kb O +
and O +
which O +
has O +
one O +
single O +
chromosomal O +
locus O +
. O +

Determination O +
of O +
the O +
exon O +
- O +
intron O +
splice O +
- O +
junctions O +
established O +
that O +
HDAC9 B-Gene +
is O +
encoded O +
by O +
23 O +
exons O +
ranging O +
in O +
size O +
from O +
22 O +
bp O +
( O +
exon O +
1 O +
) O +
to O +
264 O +
bp O +
( O +
exon O +
11 O +
) O +
. O +

Characterization O +
of O +
the O +
5 O -
' O +
flanking O +
genomic O +
region O +
revealed O +
that O +
the O +
human O +
HDAC9 B-Gene +
promoter O +
lacks O +
both O +
the O +
canonical O +
TATA O +
and O +
CCAAT O +
boxes O +
; O +
CpG O +
elements O +
are O +
missing O +
. O +

The O +
human O +
HDAC9 B-Gene +
open O +
reading O +
frame O +
is O +
3036 O +
bp O +
long O +
and O +
encodes O +
a O +
1011 O +
aa O +
protein O +
with O +
a O +
predictive O +
molecular O +
weight O +
of O +
111.3 O +
kDa O +
and O +
an O +
isoelectric O +
point O +
of O +
6.41 O +
. O +

Fluorescence O +
in O +
situ O +
hybridization O +
analysis O +
localized O +
the O +
human O +
HDAC9 B-Gene +
gene O +
to O +
chromosome O +
7p21 O +
, O +
a O +
region O +
which O +
has O +
been O +
associated O +
particularly O +
with O +
the O +
pathogenesis O +
of O +
gynecological O +
tumors O +
. O +

Phospholipase B-Gene +
C I-Gene -
- I-Gene -
beta I-Gene +
2 I-Gene +
interacts O +
with O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
kinase I-Gene +
3 I-Gene +
. O +

Phospholipase B-Gene +
C I-Gene +
( I-Gene +
PLC I-Gene +
) I-Gene +
- I-Gene +
beta I-Gene +
enzymes O +
( O +
isoenzymes O +
beta O +
1-beta O +
4 O +
) O +
are O +
activated O +
by O +
G B-Gene +
protein I-Gene +
subunits O +
, O +
leading O +
to O +
the O +
generation O +
of O +
intracellular O +
messengers O +
which O +
mobilize O +
calcium O +
and O +
activate O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
. O +

It O +
has O +
recently O +
been O +
recognized O +
that O +
these O +
enzymes O +
interact O +
with O +
and O +
are O +
regulated O +
by O +
proteins O +
other O +
than O +
G B-Gene +
proteins I-Gene +
. O +

Using O +
the O +
yeast O +
two O +
- O +
hybrid O +
technique O +
to O +
screen O +
a O +
leukocyte O +
library O +
we O +
identified O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
kinase I-Gene +
3 I-Gene +
( O +
MKK3 B-Gene +
) O +
as O +
a O +
partner O +
of O +
PLC B-Gene -
- I-Gene -
beta I-Gene +
2 I-Gene +
. O +

The O +
interaction O +
was O +
confirmed O +
by O +
co O +
- O +
immunoprecipitation O +
assays O +
which O +
indicated O +
that O +
MKK3 B-Gene +
interacts O +
with O +
PLC B-Gene -
- I-Gene -
beta I-Gene +
2 I-Gene +
, O +
but O +
not O +
with O +
other O +
PLC B-Gene -
- I-Gene -
betas I-Gene +
. O +

PLC B-Gene -
- I-Gene -
beta I-Gene +
2 I-Gene +
interacted O +
weakly O +
with O +
MKK6 B-Gene +
, O +
which O +
is O +
related O +
to O +
MKK3 B-Gene +
, O +
but O +
not O +
with O +
the O +
other O +
MKK3 B-Gene +
tested O +
. O +

The O +
region O +
of O +
PLC B-Gene -
- I-Gene -
beta I-Gene +
2 I-Gene +
involved O +
in O +
the O +
interaction O +
with O +
MKK3 B-Gene +
was O +
mapped O +
to O +
the O +
C O +
- O +
terminus O +
of O +
PLC B-Gene -
- I-Gene -
beta I-Gene +
2 I-Gene +
. O +

p38MAPK B-Gene +
also O +
co O +
- O +
immunoprecipitated O +
with O +
PLC B-Gene -
- I-Gene -
beta I-Gene +
2 I-Gene +
. O +

The O +
data O +
suggest O +
that O +
PLC B-Gene -
- I-Gene -
beta I-Gene +
2 I-Gene +
serves O +
an O +
unappreciated O +
role O +
assembling O +
components O +
of O +
the O +
p38MAPK B-Gene +
signaling O +
module O +
. O +

Differential O +
regulation O +
of O +
multiple O +
proteins O +
of O +
Escherichia O +
coli O +
and O +
Salmonella O +
enterica O +
serovar O +
Typhimurium O +
by O +
the O +
transcriptional O +
regulator O +
SlyA B-Gene +
. O +

SlyA B-Gene +
is O +
a O +
transcriptional O +
regulator O +
of O +
Escherichia O +
coli O +
, O +
Salmonella O +
enterica O +
, O +
and O +
other O +
bacteria O +
belonging O +
to O +
the O +
ENTEROBACTERIACEAE O +
: O +

The O +
SlyA B-Gene +
protein O +
has O +
been O +
shown O +
to O +
be O +
involved O +
in O +
the O +
virulence O +
of O +
S. O +
enterica O +
serovar O +
Typhimurium O +
, O +
but O +
its O +
role O +
in O +
E. O +
coli O +
is O +
unclear O +
. O +

In O +
this O +
study O +
, O +
we O +
employed O +
the O +
proteome O +
technology O +
to O +
analyze O +
the O +
SlyA B-Gene +
regulons O +
of O +
enteroinvasive O +
E. O +
coli O +
( O +
EIEC O +
) O +
and O +
Salmonella O +
serovar O +
Typhimurium O +
. O +

In O +
both O +
cases O +
, O +
comparative O +
analysis O +
of O +
the O +
two O +
- O +
dimensional O +
protein O +
maps O +
of O +
a O +
wild O +
- O +
type O +
strain O +
, O +
a O +
SlyA B-Gene +
- O +
overproducing O +
derivative O +
, O +
and O +
a O +
corresponding O +
slyA B-Gene +
mutant O +
revealed O +
numerous O +
proteins O +
whose O +
expression O +
appeared O +
to O +
be O +
either O +
positively O +
or O +
negatively O +
controlled O +
by O +
SlyA B-Gene +
. O +

Twenty O +
of O +
the O +
putative O +
SlyA B-Gene +
- O +
induced O +
proteins O +
and O +
13 O +
of O +
the O +
putative O +
SlyA B-Gene +
- O +
repressed O +
proteins O +
of O +
the O +
tested O +
EIEC O +
strain O +
were O +
identified O +
by O +
mass O +
spectrometry O +
. O +

The O +
former O +
proteins O +
included O +
several O +
molecular O +
chaperones O +
( O +
GroEL B-Gene +
, O +
GroES B-Gene +
, O +
DnaK B-Gene +
, O +
GrpE B-Gene +
, O +
and O +
CbpA B-Gene +
) O +
, O +
proteins O +
involved O +
in O +
acid O +
resistance O +
( O +
HdeA B-Gene +
, O +
HdeB B-Gene +
, O +
and O +
GadA B-Gene +
) O +
, O +
the O +
" O +
starvation O +
lipoprotein O +
" O +
( O +
Slp B-Gene +
) O +
, O +
cytolysin O +
ClyA B-Gene +
( O +
HlyE B-Gene +
or O +
SheA B-Gene +
) O +
, O +
and O +
several O +
enzymes O +
involved O +
in O +
metabolic O +
pathways O +
, O +
whereas O +
most O +
of O +
the O +
latter O +
proteins O +
proved O +
to O +
be O +
biosynthetic O +
enzymes O +
. O +

Consistently O +
, O +
the O +
resistance O +
of O +
the O +
EIEC O +
slyA B-Gene +
mutant O +
to O +
heat O +
and O +
acid O +
stress O +
was O +
impaired O +
compared O +
to O +
that O +
of O +
the O +
wild O +
- O +
type O +
strain O +
. O +

Furthermore O +
, O +
the O +
implication O +
of O +
SlyA B-Gene +
in O +
the O +
regulation O +
of O +
several O +
of O +
the O +
identified O +
E. O +
coli O +
proteins O +
was O +
confirmed O +
at O +
the O +
level O +
of O +
transcription O +
with O +
lacZ B-Gene +
fusions O +
. O +

Twenty O -
- O -
three O +
of O +
the O +
Salmonella O +
serovar O +
Typhimurium O +
proteins O +
found O +
to O +
be O +
affected O +
by O +
SlyA B-Gene +
were O +
also O +
identified O +
by O +
mass O +
spectrometry O +
. O +

With O +
the O +
exception O +
of O +
GroEL B-Gene +
these O +
differed O +
from O +
those O +
identified O +
in O +
the O +
EIEC O +
strain O +
and O +
included O +
proteins O +
involved O +
in O +
various O +
processes O +
. O +

The O +
data O +
suggest O +
that O +
gene O +
regulation O +
by O +
SlyA B-Gene +
might O +
be O +
crucial O +
for O +
intracellular O +
survival O +
and/or O +
replication O +
of O +
both O +
EIEC O +
and O +
Salmonella O +
serovar O +
Typhimurium O +
in O +
phagocytic O +
host O +
cells O +
. O +

Coexpression O +
of O +
oncostatin B-Gene +
M I-Gene +
and O +
its O +
receptors O +
and O +
evidence O +
for O +
STAT3 B-Gene +
activation O +
in O +
human O +
ovarian O +
carcinomas O +
. O +

The O +
expression O +
of O +
oncostatin B-Gene +
M I-Gene +
and O +
leukemia B-Gene +
inhibitory I-Gene +
factor I-Gene +
( O +
LIF B-Gene +
) O +
, O +
JAK B-Gene +
- O +
STAT B-Gene +
activators O +
and O +
members O +
of O +
the O +
interleukin-6 B-Gene +
family I-Gene +
of I-Gene +
cytokines I-Gene +
, O +
were O +
examined O +
in O +
a O +
series O +
of O +
primary O +
ovarian O +
carcinomas O +
using O +
immunohistochemistry O +
. O +

The O +
malignant O +
epithelial O +
cells O +
of O +
all O +
29 O +
ovarian O +
carcinomas O +
examined O +
expressed O +
oncostatin B-Gene +
M I-Gene +
; O +
none O +
expressed O +
LIF B-Gene +
. O +

Oncostatin B-Gene +
M I-Gene +
can O +
activate O +
two O +
related O +
receptors O +
, O +
one O +
consisting O +
of O +
a O +
low O +
- O +
affinity O +
LIF B-Gene +
receptor I-Gene +
subunit O +
, O +
LIFR B-Gene +
beta O +
, O +
which O +
forms O +
a O +
heterocomplex O +
with O +
the O +
gp130 B-Gene +
signal O +
transducing O +
protein O +
and O +
can O +
recognize O +
both O +
oncostatin B-Gene +
M I-Gene +
and O +
LIF B-Gene +
, O +
and O +
a O +
second O +
heterocomplex O +
consisting O +
of O +
a O +
subunit O +
that O +
specifically O +
recognizes O +
oncostatin B-Gene +
M I-Gene +
, O +
OSMR B-Gene +
beta I-Gene +
, O +
and O +
the O +
gp130 B-Gene +
protein O +
. O +

By O +
immunohistochemistry O +
, O +
25 O +
of O +
25 O +
ovarian O +
carcinomas O +
examined O +
expressed O +
the O +
LIFR B-Gene +
beta O +
subunit O +
in O +
the O +
malignant O +
epithelial O +
cells O +
( O +
all O +
samples O +
express O +
gp130 B-Gene +
) O +
, O +
and O +
two O +
- O +
thirds O +
the O +
ovarian O +
carcinomas O +
studied O +
expressed O +
OSMR B-Gene +
beta I-Gene +
mRNA O +
as O +
determined O +
by O +
RT O +
- O +
PCR O +
. O +

Thus O +
oncostatin B-Gene +
M I-Gene +
and O +
its O +
receptors O +
are O +
commonly O +
coexpressed O +
in O +
malignant O +
ovarian O +
epithelial O +
cells O +
, O +
and O +
represent O +
a O +
potential O +
autocrine O +
loop O +
in O +
this O +
tumor O +
type O +
. O +

STAT3 B-Gene +
, O +
of O +
one O +
the O +
signaling O +
proteins O +
downstream O +
of O +
the O +
oncostatin B-Gene +
M I-Gene +
/ I-Gene +
LIF I-Gene +
receptors I-Gene +
, O +
was O +
found O +
in O +
its O +
phosphorylated O +
, O +
activated O +
form O +
( O +
phosphotyrosine O +
705 O +
STAT3 B-Gene +
) O +
in O +
the O +
malignant O +
epithelial O +
cells O +
of O +
17 O +
of O +
23 O +
ovarian O +
carcinomas O +
examined O +
( O +
74 O +
% O +
) O +
as O +
determined O +
by O +
immunohistochemistry O +
; O +
this O +
suggests O +
that O +
this O +
protein O +
is O +
constitutively O +
activated O +
in O +
most O +
ovarian O +
carcinomas O +
, O +
as O +
it O +
is O +
in O +
many O +
other O +
human O +
malignancies O +
. O +

Recombinant O +
human O +
Oncostatin B-Gene +
M I-Gene +
( O +
rhOSM B-Gene +
) O +
can O +
induce O +
the O +
transient O +
tyrosine O +
705 O +
phosphorylation O +
of O +
STAT3 B-Gene +
in O +
serum O +
- O +
starved O +
LIFR B-Gene +
beta O +
/ O +
OSMR B-Gene +
beta I-Gene +
expressing O +
ovarian O +
carcinoma O +
cell O +
lines O +
, O +
but O +
does O +
not O +
alter O +
cell O +
growth O +
and O +
effects O +
only O +
a O +
modest O +
increase O +
in O +
the O +
apoptotic O +
rate O +
in O +
these O +
cultured O +
cells O +
. O +

Oncostatin B-Gene +
M I-Gene +
and I-Gene +
its O +
receptors O +
may O +
be O +
part O +
of O +
a O +
network O +
of O +
cytokine B-Gene +
systems O +
within O +
ovarian O +
carcinomas O +
that O +
may O +
act O +
to O +
maintain O +
STAT3 B-Gene +
in O +
its O +
activated O +
form O +
, O +
a O +
phenomenon O +
associated O +
with O +
the O +
malignant O +
phenotype O +
. O +

The O +
dystrophin B-Gene +
gene O +
is O +
alternatively O +
spliced O +
throughout O +
its O +
coding O +
sequence O +
. O +

We O +
have O +
analysed O +
splicing O +
patterns O +
in O +
the O +
human O +
dystrophin B-Gene +
gene O +
region O +
encoding O +
the O +
rod O +
and O +
cysteine O +
- O +
rich O +
domains O +
in O +
normal O +
skeletal O +
muscle O +
, O +
brain O +
and O +
heart O +
tissues O +
. O +

Sixteen O +
novel O +
alternative O +
transcripts O +
were O +
identified O +
, O +
the O +
majority O +
of O +
them O +
being O +
present O +
in O +
all O +
three O +
tissues O +
. O +

Tissue O +
- O +
specific O +
variants O +
were O +
also O +
identified O +
, O +
suggesting O +
a O +
functional O +
role O +
of O +
transcriptional O +
diversity O +
. O +

Transcript O +
analysis O +
in O +
dystrophinopathic O +
autoptic O +
and O +
bioptic O +
specimens O +
revealed O +
that O +
pre O +
- O +
mRNAs O +
secondary O +
structure O +
formation O +
and O +
relative O +
strength O +
of O +
exon O +
/ O +
exon O +
association O +
play O +
little O +
or O +
no O +
role O +
in O +
directing O +
alternative O +
splicing O +
events O +
. O +

This O +
analysis O +
also O +
showed O +
that O +
independent O +
deletion O +
events O +
leading O +
to O +
the O +
loss O +
of O +
the O +
same O +
exons O +
may O +
be O +
associated O +
with O +
transcriptional O +
variability O +
. O +

14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
proteins I-Gene +
in O +
Schistosoma O +
mansoni O +
; O +
identification O +
of O +
a O +
second O +
epsilon O +
isoform O +
. O +

A O +
new O +
member O +
of O +
the O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
protein I-Gene +
family I-Gene +
in O +
Schistosoma O +
mansoni O +
has O +
been O +
identified O +
. O +

Sequence O +
analysis O +
demonstrated O +
that O +
this O +
protein O +
is O +
a O +
member O +
of O +
the O +
epsilon O +
sub O +
- O +
group O +
and O +
is O +
the O +
orthologue O +
of O +
Schistosoma O +
japonicum O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3epsilon I-Gene +
. O +

Since O +
we O +
had O +
previously O +
identified O +
a O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3epsilon I-Gene +
protein O +
from O +
S. O +
mansoni O +
, O +
we O +
termed O +
the O +
original O +
protein O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3epsilon-1 I-Gene +
and O +
this O +
second O +
epsilon O +
protein O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3epsilon-2 I-Gene +
. O +

Schistosoma O +
mansoni O +
encodes O +
at O +
least O +
four O +
different O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
isoforms O +
: O +
the O +
two O +
epsilon O +
proteins O +
and O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
protein I-Gene +
1 I-Gene +
and I-Gene +
protein I-Gene +
2 I-Gene +
, O +
which O +
are O +
zeta O +
- O +
like O +
isoforms O +
. O +

Phylogenetic O +
analysis O +
demonstrated O +
the O +
early O +
divergence O +
of O +
the O +
epsilon O +
isoforms O +
, O +
and O +
that O +
schistosome O +
proteins O +
1 O +
and O +
2 O +
are O +
among O +
the O +
oldest O +
non O +
- O +
epsilon O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
proteins I-Gene +
yet O +
identified O +
. O +

Schistosoma O +
mansoni O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3epsilon-1 I-Gene +
, O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3epsilon-2 I-Gene +
, O +
and O +
protein O +
1 O +
are O +
stage O +
specifically O +
expressed O +
in O +
a O +
similar O +
manner O +
, O +
being O +
absent O +
in O +
cercariae O +
and O +
schistosomula O +
, O +
and O +
abundant O +
in O +
lung O +
stage O +
and O +
adult O +
male O +
and O +
female O +
worms O +
. O +

Protein O +
2 O +
transcript O +
was O +
not O +
detected O +
at O +
any O +
of O +
the O +
life O +
cycle O +
stages O +
examined O +
. O +

All O +
three O +
detected O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
isoforms O +
elicit O +
an O +
immune O +
response O +
during O +
infection O +
, O +
with O +
the O +
greatest O +
response O +
directed O +
against O +
protein O +
1 O +
. O +

Binding O +
studies O +
with O +
S. O +
mansoni O +
receptor B-Gene +
kinase-1 I-Gene +
( O +
SmRK1 B-Gene +
) O +
and O +
human O +
Raf B-Gene +
kinase I-Gene +
revealed O +
that O +
the O +
three O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3epsilon I-Gene +
isoforms O +
exhibit O +
a O +
preference O +
for O +
target O +
protein O +
binding O +
. O +

Although O +
all O +
three O +
isoforms O +
do O +
bind O +
to O +
both O +
targets O +
, O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
protein I-Gene +
1 I-Gene +
interacts O +
most O +
strongly O +
with O +
Raf B-Gene +
, O +
whereas O +
the O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
1 I-Gene +
isoform O +
binds O +
SmRK1 B-Gene +
preferentially O +
. O +

These O +
results O +
suggest O +
that O +
the O +
individual O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
proteins I-Gene +
may O +
have O +
evolved O +
to O +
play O +
isoform O +
- O +
specific O +
roles O +
in O +
the O +
development O +
and O +
survival O +
of O +
S. O +
mansoni O +
within O +
its O +
host O +
. O +

Cryo O +
- O +
electron O +
microscopy O +
of O +
trichocyte O +
( O +
hard O +
alpha B-Gene -
- I-Gene -
keratin I-Gene +
) O +
intermediate O +
filaments O +
reveals O +
a O +
low O +
- O +
density O +
core O +
. O +

Trichocyte O +
intermediate O +
filaments O +
( O +
IF O +
) O +
are O +
the O +
principal O +
components O +
of O +
epidermal O +
appendages O +
such O +
as O +
hair O +
and O +
nail O +
. O +

Based O +
on O +
studies O +
by O +
a O +
variety O +
of O +
techniques O +
, O +
it O +
has O +
been O +
inferred O +
that O +
trichocyte O +
IF O +
are O +
structurally O +
similar O +
to O +
other O +
kinds O +
of O +
IF O +
. O +

However O +
, O +
some O +
basic O +
structural O +
attributes O +
have O +
yet O +
to O +
be O +
established O +
: O +
in O +
particular O +
, O +
it O +
has O +
remained O +
unclear O +
whether O +
IF O +
are O +
hollow O +
. O +

We O +
have O +
examined O +
trichocyte O +
IF O +
isolated O +
from O +
rat O +
vibrissae O +
and O +
human O +
hair O +
follicles O +
by O +
electron O +
microscopy O +
. O +

Scanning O +
transmission O +
electron O +
microscopy O +
of O +
freeze O +
- O +
dried O +
specimens O +
yielded O +
mass O +
- O +
per O +
- O +
unit O +
- O +
length O +
values O +
of O +
approximately O +
32 O +
kDa O +
/ O +
nm O +
, O +
with O +
the O +
human O +
preparations O +
also O +
containing O +
filaments O +
at O +
half O +
this O +
density O +
, O +
corresponding O +
to O +
two O +
rather O +
than O +
four O +
protofibrils O +
. O +

Radial O +
density O +
profiles O +
calculated O +
from O +
cryo O +
- O +
electron O +
micrographs O +
of O +
vitrified O +
specimens O +
preserved O +
in O +
a O +
near O +
- O +
native O +
state O +
revealed O +
a O +
low O +
- O +
density O +
region O +
of O +
approximately O +
3 O +
nm O +
diameter O +
around O +
the O +
filament O +
axis O +
. O +

A O +
minor O +
species O +
of O +
filament O +
with O +
the O +
same O +
internal O +
structure O +
was O +
surface O +
- O +
decorated O +
with O +
material O +
arranged O +
with O +
a O +
helical O +
pitch O +
length O +
of O +
9.3 O +
nm O +
. O +

These O +
filaments O +
appear O +
to O +
represent O +
IF O +
coated O +
with O +
associated O +
proteins O +
- O +
perhaps O +
, O +
" O +
high O +
- O +
sulfur O +
" O +
proteins O +
- O +
readied O +
for O +
incorporation O +
into O +
the O +
filament O +
- O +
matrix O +
biocomposite O +
of O +
the O +
mature O +
hair O +
. O +

Aberrant O +
methylation O +
of O +
the O +
CDH13 B-Gene +
( O +
H B-Gene -
- I-Gene -
cadherin I-Gene +
) O +
promoter O +
region O +
in O +
colorectal O +
cancers O +
and O +
adenomas O +
. O +

Expression O +
of O +
the O +
cadherin B-Gene +
family I-Gene +
member O +
CDH13 B-Gene +
( O +
H B-Gene -
- I-Gene -
cadherin I-Gene +
) O +
is O +
reduced O +
in O +
several O +
human O +
tumors O +
, O +
and O +
it O +
has O +
been O +
hypothesized O +
that O +
this O +
gene O +
functions O +
as O +
a O +
tumor O +
suppressor O +
gene O +
. O +

Previously O +
, O +
we O +
reported O +
that O +
the O +
5 O -
' O +
region O +
of O +
CDH13 B-Gene +
is O +
frequently O +
methylated O +
in O +
breast O +
and O +
lung O +
cancers O +
. O +

Here O +
we O +
confirmed O +
the O +
promoter O +
activity O +
of O +
5 O -
' O +
region O +
of O +
CDH13 B-Gene +
by O +
luciferase B-Gene +
assay O +
and O +
examined O +
its O +
aberrant O +
methylation O +
in O +
colorectal O +
cancers O +
, O +
cell O +
lines O +
, O +
and O +
adenomas O +
. O +

Methylation O +
status O +
was O +
investigated O +
by O +
methylation O +
- O +
specific O +
PCR O +
( O +
MSP O +
) O +
and O +
by O +
bisulfite O +
DNA O +
sequencing O +
of O +
cloned O +
DNA O +
of O +
PCR O +
amplicons O +
. O +

In O +
cell O +
lines O +
, O +
we O +
examined O +
the O +
correlation O +
between O +
methylation O +
status O +
and O +
mRNA O +
expression O +
by O +
reverse O +
transcription O +
- O +
PCR O +
. O +

Aberrant O +
methylation O +
of O +
CDH13 B-Gene +
was O +
present O +
in O +
7 O +
of O +
13 O +
( O +
54 O +
% O +
) O +
cell O +
lines O +
, O +
and O +
expression O +
was O +
absent O +
in O +
6 O +
of O +
13 O +
( O +
46 O +
% O +
) O +
cell O +
lines O +
. O +

CDH13 B-Gene +
expression O +
was O +
present O +
in O +
six O +
cell O +
lines O +
that O +
showed O +
only O +
the O +
unmethylated O +
form O +
by O +
MSP O +
and O +
in O +
one O +
cell O +
line O +
that O +
showed O +
both O +
the O +
methylated O +
and O +
unmethylated O +
forms O +
. O +

Treatment O +
with O +
5-aza-2'-deoxycytidine O +
restored O +
CDH13 B-Gene +
expression O +
in O +
methylated O +
cell O +
lines O +
. O +

In O +
surgically O +
resected O +
samples O +
, O +
17 O +
of O +
35 O +
( O +
49 O +
% O +
) O +
cases O +
of O +
primary O +
colorectal O +
cancer O +
, O +
2 O +
of O +
33 O +
( O +
6 O +
% O +
) O +
cases O +
of O +
corresponding O +
nonmalignant O +
colorectal O +
mucosa O +
, O +
and O +
8 O +
of O +
19 O +
( O +
42 O +
% O +
) O +
adenomas O +
were O +
methylated O +
. O +

Sequence O +
data O +
after O +
bisulfite O +
treatment O +
indicated O +
that O +
primary O +
cancers O +
and O +
two O +
cell O +
lines O +
with O +
loss O +
of O +
expression O +
were O +
highly O +
methylated O +
compared O +
with O +
nonmalignant O +
colorectal O +
epithelial O +
cells O +
, O +
especially O +
at O +
the O +
attachment O +
sites O +
of O +
primers O +
for O +
MSP O +
, O +
although O +
there O +
was O +
heterogeneity O +
in O +
methylation O +
status O +
. O +

Our O +
results O +
suggest O +
that O +
CDH13 B-Gene +
expression O +
is O +
frequently O +
silenced O +
by O +
aberrant O +
methylation O +
in O +
colorectal O +
cancers O +
and O +
adenomas O +
and O +
that O +
methylation O +
of O +
CDH13 B-Gene +
commences O +
at O +
an O +
early O +
stage O +
of O +
multistep O +
colorectal O +
tumorigenesis O +
. O +

Further O +
characterization O +
of O +
the O +
molecular O +
interaction O +
between O +
PSD-95 B-Gene +
and O +
NMDA B-Gene +
receptors I-Gene +
: O +
the O +
effect O +
of O +
the O +
NR1 B-Gene +
splice O +
variant O +
and O +
evidence O +
for O +
modulation O +
of O +
channel O +
gating O +
. O +

Coexpression O +
of O +
PSD-95 B-Gene +
( O +
c B-Gene -
- I-Gene -
Myc I-Gene +
) O +
with O +
NR1 B-Gene -
- I-Gene -
1a I-Gene +
/ O +
NR2A B-Gene +
NMDA B-Gene +
receptors I-Gene +
in O +
human O +
embryonic O +
kidney O +
( O +
HEK O +
) O +
293 O +
cells O +
resulted O +
in O +
a O +
decrease O +
in O +
efficacy O +
for O +
the O +
glycine O +
stimulation O +
of O +
[ O +
3 O +
H O +
] O +
MK801 O +
binding O +
similar O +
to O +
that O +
previously O +
described O +
for O +
l O +
- O +
glutamate O +
. O +

The O +
inhibition O +
constants O +
( O +
K O -
( O -
I O -
) O +
s O +
) O +
for O +
the O +
binding O +
of O +
l O -
- O -
glutamate O +
and O +
glycine O +
to O +
NR1 B-Gene -
- I-Gene -
1a I-Gene +
/ O +
NR2A B-Gene +
determined O +
by O +
[ O +
3 O +
H O -
] O -
CGP O +
39653 O +
and O +
[ O -
3H O -
] O -
MDL O +
105 O +
519 O +
displacement O +
assays O +
, O +
respectively O +
, O +
were O +
not O +
significantly O +
different O +
between O +
NR1 B-Gene -
- I-Gene -
1a I-Gene +
/ O +
NR2A B-Gene +
receptors O +
coexpressed O +
+ O -
/- O +
PSD-95 B-Gene +
( O +
c B-Gene -
- I-Gene -
Myc I-Gene +
) O +
. O +

The O +
increased O +
EC O -
( O -
50 O -
) O +
for O +
l O +
- O +
glutamate O +
enhancement O +
of O +
[ O +
3 O +
H O +
] O +
MK801 O +
binding O +
was O +
also O +
found O +
for O +
NR1 B-Gene -
- I-Gene -
2a I-Gene +
/ O +
NR2A B-Gene +
and O +
NR1 B-Gene -
- I-Gene -
4b I-Gene +
/ O +
NRA O +
receptors O +
thus O +
the O +
altered O +
EC O -
( O -
50 O -
) O +
is O +
not O +
dependent O +
on O +
the O +
N1 O +
, O +
C1 O +
or O +
C2 O +
exon O +
of O +
the O +
NR1 B-Gene +
subunit O +
. O +

The O +
NR1 B-Gene -
- I-Gene -
4b I-Gene +
but O +
not O +
the O +
NR1 B-Gene -
- I-Gene -
1a I-Gene +
subunit O +
was O +
expressed O +
efficiently O +
at O +
the O +
cell O +
surface O +
in O +
the O +
absence O +
of O +
NR2 B-Gene +
subunits O +
. O +

Total O +
NR1 B-Gene -
- I-Gene -
4b I-Gene +
and O +
NR1 B-Gene -
- I-Gene -
4b I-Gene +
/ O +
NR2A B-Gene +
expression O +
was O +
enhanced O +
by O +
PSD-95 B-Gene +
( O +
c B-Gene -
- I-Gene -
Myc I-Gene +
) O +
but O +
whole O +
cell O +
enzyme O +
- O +
linked O +
immunoadsorbent O +
assays O +
( O +
ELISAs O +
) O +
showed O +
that O +
this O +
increase O +
was O +
not O +
due O +
to O +
increased O +
expression O +
at O +
the O +
cell O +
surface O +
. O +

It O +
is O +
suggested O +
that O +
PSD-95 B-Gene +
( O +
c B-Gene -
- I-Gene -
Myc I-Gene +
) O +
has O +
a O +
dual O +
effect O +
on O +
NMDA B-Gene +
receptors I-Gene +
expressed O +
in O +
mammalian O +
cells O +
, O +
a O +
reduction O +
in O +
channel O +
gating O +
and O +
an O +
enhanced O +
expression O +
of O +
NMDA B-Gene +
receptor I-Gene +
subunits O +
containing O +
C O -
- O -
terminal O +
E O -
( O -
T O -
/ O -
S O +
) O +
XV O +
PSD B-Gene +
- I-Gene +
95 I-Gene +
binding O +
motifs O +
. O +

NK O +
cell O +
receptors O +
of O +
the O +
orangutan O +
( O +
Pongo O +
pygmaeus O +
) O +
: O +
a O +
pivotal O +
species O +
for O +
tracking O +
the O +
coevolution O +
of O +
killer B-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
with O +
MHC B-Gene -
- I-Gene -
C I-Gene +
. O +

CD94 B-Gene +
, O +
NKG2 B-Gene +
, O +
Ly49 B-Gene +
, O +
and O +
killer B-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( O +
KIR B-Gene +
) O +
expressed O +
by O +
orangutan O +
peripheral O +
blood O +
cells O +
were O +
examined O +
by O +
cloning O +
and O +
sequencing O +
cDNA O +
from O +
a O +
panel O +
of O +
individuals O +
. O +

Orthologs O +
of O +
human O +
CD94 B-Gene +
, O +
NKG2A B-Gene +
, I-Gene +
D I-Gene +
, I-Gene +
and I-Gene +
F I-Gene +
were O +
defined O +
. O +

NKG2C B-Gene +
and I-Gene +
E I-Gene +
are O +
represented O +
by O +
one O +
gene O +
, O +
Popy O +
- O +
NKG2CE B-Gene +
, O +
that O +
is O +
equidistant O +
from O +
the O +
two O +
human O +
genes O +
. O +

Several O +
Popy O +
- O +
CD94 B-Gene +
, O +
NKG2A B-Gene +
, O +
and O +
NKG2CE B-Gene +
alleles O +
were O +
defined O +
. O +

Ly49L B-Gene +
is O +
expressed O +
in O +
cultured O +
NK O +
cells O +
and O +
has O +
a O +
sequence O +
consistent O +
with O +
it O +
encoding O +
a O +
functional O +
receptor O +
. O +

Orangutan O +
KIR B-Gene +
corresponding O +
to O +
the O +
three O +
KIR B-Gene +
lineages O +
expressed O +
in O +
humans O +
and O +
chimpanzees O +
were O +
defined O +
. O +

Popy O +
- O +
KIR2DL4 B-Gene +
of O +
lineage O +
I O +
is O +
the O +
only O +
ortholog O +
of O +
a O +
human O +
or O +
chimpanzee O +
KIR B-Gene +
, O +
but O +
in O +
all O +
individuals O +
examined O +
, O +
the O +
transcripts O +
of O +
this O +
gene O +
produced O +
premature O +
termination O +
, O +
either O +
in O +
the O +
D2 O +
domain O +
or O +
at O +
the O +
beginning O +
of O +
the O +
cytoplasmic O +
domain O +
. O +

Ten O +
Popy O +
- O +
KIR3DL B-Gene +
and O +
one O +
Popy O +
- O +
KIR3DS B-Gene +
of O +
lineage O +
II O +
are O +
all O +
closely O +
related O +
, O +
but O +
represent O +
the O +
products O +
of O +
at O +
least O +
two O +
genes O +
. O +

The O +
two O +
Popy O +
- O +
KIR2DL B-Gene +
and O +
four O +
Popy O +
- O +
KIR2DS B-Gene +
of O +
lineage O +
III O +
also O +
represent O +
two O +
genes O +
, O +
both O +
being O +
more O +
related O +
to O +
KIR2DS4 B-Gene +
than O +
to O +
other O +
human O +
and O +
chimpanzee O +
KIR B-Gene +
of O +
lineage O +
III O +
. O +

The O +
Popy O +
- O +
KIR2D B-Gene +
include O +
ones O +
predicted O +
to O +
be O +
specific O +
for O +
the O +
C1 O +
epitope O +
of O +
MHC B-Gene -
- I-Gene -
C I-Gene +
, O +
but O +
none O +
specific O +
for O +
C2 O +
. O +

This O +
correlates O +
with O +
the O +
observation O +
that O +
all O +
orangutan O +
MHC B-Gene -
- I-Gene -
C I-Gene +
allotypes O +
examined O +
have O +
the O +
C1 O +
motif O +
. O +

Crystallization O +
and O +
preliminary O +
X O +
- O +
ray O +
crystallographic O +
studies O +
on O +
recombinant O +
human O +
carnitine B-Gene +
acetyltransferase I-Gene +
. O +

In O +
this O +
paper O +
, O +
the O +
purification O +
, O +
crystallization O +
and O +
preliminary O +
X O -
- O -
ray O +
crystallographic O +
studies O +
of O +
human O +
carnitine B-Gene +
acetyltransferase I-Gene +
are O +
reported O +
. O +

Recombinant O +
human O +
carnitine B-Gene +
acetyltransferase I-Gene +
crystals O +
were O +
grown O +
by O +
the O +
hanging O +
- O +
drop O +
vapor O +
- O +
diffusion O +
method O +
and O +
belong O +
to O +
the O +
orthorhombic O +
space O +
group O +
P2 O -
( O -
1 O -
) O -
2 O -
( O -
1 O -
) O -
2 O -
( O -
1 O -
) O +
, O +
with O +
unit O +
- O +
cell O +
parameters O +
a O +
= O +
137.65 O +
, O +
b O +
= O +
84.76 O +
, O +
c O +
= O +
57.65 O +
A O +
and O +
one O +
molecule O +
per O +
asymmetric O +
unit O +
. O +

The O +
intensity O +
data O +
were O +
collected O +
from O +
a O +
cryocooled O +
crystal O +
to O +
1.6 O +
A O +
resolution O +
using O +
a O +
conventional O +
X O +
- O +
ray O +
source O +
. O +

Mutations O +
in O +
the O +
cone O +
photoreceptor O +
G B-Gene -
- I-Gene -
protein I-Gene +
alpha I-Gene +
- O +
subunit O +
gene O +
GNAT2 B-Gene +
in O +
patients O +
with O +
achromatopsia O +
. O +

Achromatopsia O +
is O +
an O +
autosomal O +
recessively O +
inherited O +
visual O +
disorder O +
that O +
is O +
present O +
from O +
birth O +
and O +
that O +
features O +
the O +
absence O +
of O +
color O +
discrimination O +
. O +

We O +
here O +
report O +
the O +
identification O +
of O +
five O +
independent O +
families O +
with O +
achromatopsia O +
that O +
segregate O +
protein O +
- O +
truncation O +
mutations O +
in O +
the O +
GNAT2 B-Gene +
gene O +
, O +
located O +
on O +
chromosome O +
1p13 O +
. O +

GNAT2 B-Gene +
encodes O +
the O +
cone O +
photoreceptor O +
- O +
specific O +
alpha B-Gene +
- I-Gene +
subunit I-Gene +
of I-Gene +
transducin I-Gene +
, O +
a O +
G B-Gene +
- I-Gene +
protein I-Gene +
of O +
the O +
phototransduction O +
cascade O +
, O +
which O +
couples O +
to O +
the O +
visual O +
pigment O +
( O -
s O -
) O +
. O +

Our O +
results O +
demonstrate O +
that O +
GNAT2 B-Gene +
is O +
the O +
third O +
gene O +
implicated O +
in O +
achromatopsia O +
. O +

Activation O +
mechanism O +
of O +
CDK2 B-Gene +
: O +
role O +
of O +
cyclin B-Gene +
binding O +
versus O +
phosphorylation O +
. O +

Activation O +
of O +
the O +
cyclin B-Gene +
- I-Gene +
dependent I-Gene +
kinases I-Gene +
is O +
a O +
two O +
- O +
step O +
process O +
involving O +
cyclin B-Gene +
binding O +
followed O +
by O +
phosphorylation O +
at O +
a O +
conserved O +
threonine O +
residue O +
within O +
the O +
kinase B-Gene +
activation O +
loop O +
. O +

In O +
this O +
study O +
, O +
we O +
describe O +
the O +
separate O +
roles O +
of O +
cyclin B-Gene +
A I-Gene +
binding O +
versus O +
phosphorylation O +
in O +
the O +
overall O +
activation O +
mechanism O +
of O +
CDK2 B-Gene +
. O +

Interaction O +
of O +
CDK2 B-Gene +
with O +
cyclin B-Gene +
A I-Gene +
results O +
in O +
a O +
partially O +
active O +
complex O +
that O +
is O +
moderately O +
defective O +
in O +
the O +
binding O +
of O +
the O +
protein O +
substrate O +
, O +
but O +
not O +
ATP O +
, O +
and O +
severely O +
defective O +
in O +
both O +
phosphoryl O +
group O +
transfer O +
and O +
turnover O +
. O +

Alternatively O +
, O +
phosphorylation O +
of O +
the O +
CDK2 B-Gene +
monomer O +
also O +
results O +
in O +
a O +
partially O +
activated O +
species O +
, O +
but O +
one O +
that O +
is O +
severely O +
( O +
> O +
or O +
= O +
480 O +
- O +
fold O +
) O +
defective O +
in O +
substrate O +
binding O +
exclusively O +
. O +

Catalytic O +
turnover O +
in O +
the O +
phosphorylated O +
CDK2 B-Gene +
monomer O +
is O +
largely O +
unimpaired O +
( O +
approximately O +
8 O +
- O +
fold O +
lower O +
) O +
. O +

Our O +
data O +
support O +
a O +
model O +
for O +
the O +
activation O +
of O +
CDK2 B-Gene +
in O +
vivo O +
, O +
in O +
which O +
interaction O +
of O +
unphosphorylated O +
CDK2 B-Gene +
with O +
cyclin B-Gene +
A I-Gene +
serves O +
to O +
configure O +
the O +
active O +
site O +
for O +
ground O +
- O +
state O +
binding O +
of O +
both O +
ATP O +
and O +
the O +
protein O +
substrate O +
, O +
and O +
further O +
aligns O +
ATP O +
in O +
the O +
transition O +
state O +
for O +
phosphoryl O +
transfer O +
. O +

Optimizing O +
the O +
alignment O +
of O +
protein O +
substrates O +
in O +
the O +
phosphoryl O +
transfer O +
reaction O +
is O +
the O +
principal O +
role O +
of O +
phosphorylation O +
at O +
Thr O -
( O -
160 O -
) O +
. O +

Interaction O +
of O +
p58 B-Gene +
( I-Gene +
PITSLRE I-Gene +
) I-Gene +
, O +
a O +
G2 O +
/ O +
M O +
- O +
specific O +
protein B-Gene +
kinase I-Gene +
, O +
with O +
cyclin B-Gene +
D3 I-Gene +
. O +

The O +
p58 B-Gene +
( I-Gene +
PITSLRE I-Gene +
) I-Gene +
is O +
a O +
p34 B-Gene +
( I-Gene +
cdc2 I-Gene +
) I-Gene +
- O +
related O +
protein B-Gene +
kinase I-Gene +
that O +
plays O +
an O +
important O +
role O +
in O +
normal O +
cell O +
cycle O +
progression O +
. O +

Elevated O +
expression O +
of O +
p58 B-Gene +
( I-Gene +
PITSLRE I-Gene +
) I-Gene +
in O +
eukaryotic O +
cells O +
prevents O +
them O +
from O +
undergoing O +
normal O +
cytokinesis O +
and O +
appears O +
to O +
delay O +
them O +
in O +
late O +
telophase O +
. O +

To O +
investigate O +
the O +
molecular O +
mechanism O +
of O +
p58 B-Gene +
( I-Gene +
PITSLRE I-Gene +
) I-Gene +
action O +
, O +
we O +
used O +
the O +
yeast O +
two O +
- O +
hybrid O +
system O +
, O +
screened O +
a O +
human O +
fetal O +
liver O +
cDNA O +
library O +
, O +
and O +
identified O +
cyclin B-Gene +
D3 I-Gene +
as O +
an O +
interacting O +
partner O +
of O +
p58 B-Gene +
( I-Gene +
PITSLRE I-Gene +
) I-Gene +
. O +

In O +
vitro O +
binding O +
assay O +
, O +
in O +
vivo O +
coimmunoprecipitation O +
, O +
and O +
immunofluorescence O +
cell O +
staining O +
further O +
confirmed O +
the O +
association O +
of O +
p58 B-Gene +
( I-Gene +
PITSLRE I-Gene +
) I-Gene +
with O +
cyclin B-Gene +
D3 I-Gene +
. O +

This O +
binding O +
was O +
observed O +
only O +
in O +
the O +
G O -
( O -
2 O -
) O +
/ O +
M O +
phase O +
but O +
not O +
in O +
the O +
G O -
( O -
1 O -
) O +
/ O +
S O +
phase O +
of O +
the O +
cell O +
cycle O +
; O +
meanwhile O +
, O +
no O +
interaction O +
between O +
p110 O +
( O +
PITSLRE B-Gene +
) O +
and O +
cyclin B-Gene +
D3 I-Gene +
was O +
observed O +
in O +
all O +
the O +
cell O +
cycle O +
. O +

The O +
overexpression O +
of O +
cyclin B-Gene +
D3 I-Gene +
in O +
7721 O +
cells O +
leads O +
to O +
an O +
exclusively O +
accumulation O +
of O +
p58 B-Gene +
( I-Gene +
PITSLRE I-Gene +
) I-Gene +
in O +
the O +
nuclear O +
region O +
, O +
affecting O +
its O +
cellular O +
distribution O +
. O +

Histone O +
H1 O +
kinase B-Gene +
activity O +
of O +
p58 B-Gene +
( I-Gene +
PITSLRE I-Gene +
) I-Gene +
was O +
greatly O +
enhanced O +
upon O +
interaction O +
with O +
cyclin B-Gene +
D3 I-Gene +
. O +

Furthermore O +
, O +
kinase B-Gene +
activity O +
of O +
p58 B-Gene +
( I-Gene +
PITSLRE I-Gene +
) I-Gene +
was O +
found O +
to O +
increase O +
greatly O +
in O +
the O +
presence O +
of O +
cyclin B-Gene +
D3 I-Gene +
using O +
a O +
specific O +
substrate O +
, O +
beta-1,4-galactosyltransferase B-Gene +
1 I-Gene +
. O +

These O +
data O +
provide O +
a O +
new O +
clue O +
to O +
our O +
understanding O +
of O +
the O +
cellular O +
function O +
of O +
p58 B-Gene +
( I-Gene +
PITSLRE I-Gene +
) I-Gene +
and O +
cyclin B-Gene +
D3 I-Gene +
. O +

Cloning O +
and O +
identification O +
of O +
a O +
new O +
member O +
of O +
water B-Gene +
channel I-Gene +
( O +
AQP10 B-Gene +
) O +
as O +
an O +
aquaglyceroporin B-Gene +
. O +

Recently O +
, O +
a O +
new O +
member O +
of O +
aquaporins B-Gene +
was O +
reported O +
as O +
AQP10 B-Gene +
[ O +
Biochem O -
. O +
Biophys O -
. O +
Res O -
. O +
Commun O -
. O +
287 O +
( O +
2001 O +
) O +
814 O +
] O +
, O +
which O +
is O +
incompletely O +
spliced O +
to O +
lose O +
the O +
sixth O +
transmembrane O +
domain O +
and O +
has O +
poor O +
water O +
and O +
no O +
glycerol O +
/ O +
urea O +
permeabilities O +
. O +

Independently O +
, O +
we O +
identified O +
a O +
similar O +
clone O +
in O +
human O +
. O +

Our O +
AQP10 B-Gene +
consists O +
of O +
301 O +
amino O +
acids O +
with O +
a O +
highly O +
conserved O +
sixth O +
transmembrane O +
domain O +
. O +

AQP10 B-Gene +
has O +
higher O +
identity O +
with O +
aquaglyceroporins B-Gene +
( O +
50 O +
% O +
with O +
AQP9 B-Gene +
, O +
48 O +
% O +
with O +
AQP3 B-Gene +
, O +
42 O +
% O +
with O +
AQP7 B-Gene +
) O +
and O +
lower O +
identity O +
with O +
other O +
aquaporins B-Gene +
( O +
32 O +
% O +
with O +
AQP1 B-Gene +
and O +
AQP8 B-Gene +
) O +
. O +

AQP10 B-Gene +
is O +
expressed O +
only O +
in O +
the O +
small O +
intestine O +
with O +
( O +
approximately O +
2 O +
kb O +
) O +
. O +

RNase B-Gene +
protection O +
assay O +
revealed O +
the O +
absence O +
of O +
the O +
unspliced O +
form O +
, O +
supporting O +
the O +
authenticity O +
of O +
our O +
clone O +
. O +

When O +
expressed O +
in O +
Xenopus O +
oocytes O +
, O +
AQP10 B-Gene +
stimulated O +
osmotic O +
water O +
permeability O +
sixfold O +
in O +
a O +
mercury O +
- O +
sensitive O +
manner O +
. O +

Glycerol O +
and O +
urea O +
uptakes O +
were O +
also O +
stimulated O +
, O +
while O +
adenine O +
uptake O +
was O +
not O +
. O +

The O +
genome O +
structure O +
of O +
AQP10 B-Gene +
is O +
similar O +
to O +
those O +
of O +
other O +
aquaglyceroporins B-Gene +
( O +
AQP3 B-Gene +
, O +
AQP7 B-Gene +
, O +
AQP9 B-Gene +
) O +
with O +
six O +
exons O +
. O +

We O +
conclude O +
that O +
AQP10 B-Gene +
represents O +
a O +
new O +
member O +
of O +
aquaglyceroporins B-Gene +
functionally O +
as O +
well O +
as O +
structurally O +
. O +

Identification O +
of O +
human O +
male B-Gene +
germ I-Gene +
cell I-Gene +
- I-Gene +
associated I-Gene +
kinase I-Gene +
, O +
a O +
kinase B-Gene +
transcriptionally O +
activated O +
by O +
androgen O +
in O +
prostate O +
cancer O +
cells O +
. O +

Androgen O +
is O +
involved O +
in O +
both O +
normal O +
development O +
and O +
malignant O +
transformation O +
of O +
prostate O +
cells O +
. O +

The O +
signal O +
transduction O +
pathways O +
associated O +
with O +
these O +
processes O +
are O +
not O +
well O +
understood O +
. O +

Using O +
a O +
novel O +
kinase B-Gene +
display O +
approach O +
, O +
we O +
have O +
identified O +
a O +
protein B-Gene +
kinase I-Gene +
, O +
human O +
male B-Gene +
germ I-Gene +
cell I-Gene +
- I-Gene +
associated I-Gene +
kinase I-Gene +
( O +
hMAK B-Gene +
) O +
, O +
which O +
is O +
transcriptionally O +
induced O +
by O +
the O +
androgenic O +
hormone O +
5alpha O -
- O -
dihydrotestosterone O +
( O +
DHT O +
) O +
. O +

The O +
kinetics O +
of O +
induction O +
is O +
rapid O +
and O +
dose O +
- O +
dependent O +
, O +
and O +
the O +
induction O +
is O +
not O +
blocked O +
by O +
cycloheximide O +
treatment O +
. O +

Real O +
time O +
reverse O +
transcription O +
- O +
PCR O +
studies O +
demonstrated O +
a O +
9 O +
- O +
fold O +
induction O +
of O +
hMAK B-Gene +
by O +
10 O +
nm O +
DHT O +
at O +
24 O +
h O +
post O +
- O +
stimulation O +
. O +

The O +
expression O +
levels O +
of O +
hMAK B-Gene +
in O +
prostate O +
cancer O +
cell O +
lines O +
are O +
in O +
general O +
higher O +
than O +
those O +
of O +
normal O +
prostate O +
epithelial O +
cells O +
. O +

A O +
reverse O +
transcription O +
- O +
PCR O +
product O +
encompassing O +
the O +
entire O +
hMAK B-Gene +
open O +
reading O +
frame O +
was O +
isolated O +
. O +

The O +
results O +
from O +
sequencing O +
analysis O +
showed O +
that O +
the O +
hMAK B-Gene +
protein O +
is O +
623 O +
amino O +
acids O +
in O +
length O +
and O +
contains O +
a O +
kinase B-Gene +
catalytic O +
domain O +
at O +
its O +
N O +
terminus O +
, O +
followed O +
by O +
a O +
proline O +
/ O +
glutamine O +
- O +
rich O +
domain O +
. O +

The O +
catalytic O +
domain O +
of O +
this O +
kinase B-Gene +
contains O +
sequence O +
motifs O +
related O +
to O +
both O +
the O +
cyclin B-Gene +
- I-Gene +
dependent I-Gene +
kinase I-Gene +
and I-Gene +
the I-Gene +
mitogen I-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
families I-Gene +
. O +

When O +
expressed O +
in O +
COS1 O +
cells O +
, O +
hMAK B-Gene +
is O +
kinase B-Gene +
- O +
active O +
as O +
demonstrated O +
by O +
autophosphorylation O +
and O +
phosphorylation O +
of O +
exogenous O +
substrate O +
and O +
is O +
localized O +
in O +
the O +
nucleus O +
. O +

A O +
3.7 O +
- O +
kilobase O +
pair O +
promoter O +
of O +
the O +
hMAK B-Gene +
locus O +
was O +
isolated O +
from O +
a O +
human O +
genomic O +
DNA O +
bacterial O +
artificial O +
chromosome O +
clone O +
and O +
was O +
shown O +
to O +
be O +
activated O +
by O +
DHT O +
. O +

This O +
activation O +
can O +
be O +
blocked O +
by O +
an O +
anti O +
- O +
androgen O +
drug O +
bicalutamide O +
( O +
Casodex O +
) O +
, O +
implicating O +
the O +
involvement O +
of O +
androgen B-Gene +
receptor I-Gene +
in O +
this O +
process O +
. O +

Taken O +
together O +
, O +
these O +
data O +
suggest O +
that O +
hMAK B-Gene +
is O +
a O +
protein B-Gene +
kinase I-Gene +
targeted O +
by O +
androgen O +
that O +
may O +
participate O +
in O +
androgen O +
- O +
mediated O +
signaling O +
in O +
prostate O +
cancer O +
cells O +
. O +

Contrasting O +
nifD B-Gene +
and O +
ribosomal O +
gene O +
relationships O +
among O +
Mesorhizobium O +
from O +
Lotus O +
oroboides O +
in O +
northern O +
Mexico O +
. O +

PCR O +
screens O +
for O +
length O +
variation O +
in O +
a O +
5 O -
' O +
portion O +
of O +
23S O +
ribosomal O +
RNA O +
and O +
in O +
the O +
3 O -
' O +
end O +
of O +
the O +
16S O +
rRNA-23S O +
rRNA O +
internal O +
transcribed O +
spacer O +
( O +
ITS O +
) O +
region O +
indicated O +
that O +
nodule O +
bacteria O +
from O +
a O +
Mexican O +
population O +
of O +
Lotus O +
oroboides O +
were O +
diverse O +
on O +
a O +
local O +
scale O +
. O +

Three O +
23S O +
rRNA O +
length O +
variants O +
and O +
five O +
ITS O +
length O +
variants O +
were O +
detected O +
among O +
the O +
22 O +
isolates O +
. O +

Sequencing O +
of O +
nearly O +
full O -
- O -
length O +
16S O +
rRNA O +
genes O +
in O +
three O +
isolates O +
indicated O +
that O +
they O +
fell O +
into O +
the O +
genus O +
Mesorhizobium O +
, O +
but O +
comprised O +
two O +
distinct O +
groups O +
. O +

Two O +
isolates O +
were O +
closely O +
related O +
to O +
M. O +
loti O +
LMG O +
6125 O -
T O +
, O +
while O +
the O +
other O +
isolate O +
clustered O +
with O +
an O +
assemblage O +
of O +
Mesorhizobium O +
taxa O +
that O +
included O +
M. O +
amorphae O +
, O +
M. O +
plurifarium O +
and O +
M. O +
huakuii O +
. O +

However O +
, O +
a O +
phylogenetic O +
tree O +
based O +
on O +
715 O +
bp O +
of O +
the O +
nitrogenase B-Gene +
alpha I-Gene -
- I-Gene -
subunit I-Gene +
( O +
nifD B-Gene +
) O +
gene O +
was O +
significantly O +
discordant O +
with O +
the O +
relationships O +
inferred O +
from O +
rRNA O +
sequences O +
. O +

Two O +
isolates O +
that O +
were O +
nearly O +
identical O +
for O +
16S O +
rRNA O +
had O +
nifD B-Gene +
genes O +
that O +
varied O +
at O +
2 O +
% O +
of O +
sites O +
, O +
and O +
one O +
of O +
these O +
nifD B-Gene +
sequences O +
was O +
identical O +
to O +
that O +
of O +
another O +
isolate O +
with O +
a O +
strongly O +
divergent O +
16S O +
rRNA O +
gene O +
. O +

A O +
plasmid O +
screen O +
followed O +
by O +
Southern O +
hybridization O +
indicated O +
that O +
only O +
one O +
of O +
these O +
strains O +
harbored O +
a O +
plasmid O +
- O +
borne O +
nifD B-Gene +
gene O +
. O +

These O +
results O +
imply O +
that O +
gene O +
transfer O +
events O +
have O +
altered O +
the O +
distribution O +
of O +
nifD B-Gene +
sequences O +
among O +
lineages O +
within O +
this O +
natural O +
population O +
of O +
Mesorhizobium O +
strains O +
. O +

Infertility O +
of O +
CD9 B-Gene +
- O +
deficient O +
mouse O +
eggs O +
is O +
reversed O +
by O +
mouse O +
CD9 B-Gene +
, O +
human O +
CD9 B-Gene +
, O +
or O +
mouse O +
CD81 B-Gene +
; O +
polyadenylated O +
mRNA O +
injection O +
developed O +
for O +
molecular O +
analysis O +
of O +
sperm O -
- O -
egg O +
fusion O +
. O +

CD9 B-Gene +
is O +
a O +
membrane O +
protein O +
belonging O +
to O +
the O +
tetraspanin B-Gene +
family I-Gene +
. O +

Despite O +
CD9 B-Gene +
's O +
broad O +
tissue O +
distribution O +
, O +
the O +
only O +
abnormality O +
observed O +
in O +
CD9 B-Gene +
- O +
deficient O +
mice O +
was O +
infertility O +
of O +
females O +
, O +
which O +
was O +
responsible O +
for O +
a O +
defect O +
in O +
the O +
sperm O +
- O +
egg O +
fusion O +
process O +
. O +

However O +
, O +
the O +
function O +
of O +
CD9 B-Gene +
in O +
sperm O +
- O +
egg O +
fusion O +
is O +
not O +
clear O +
at O +
all O +
because O +
the O +
technique O +
to O +
analyze O +
the O +
activity O +
of O +
molecules O +
in O +
sperm O +
- O +
egg O +
fusion O +
has O +
not O +
been O +
established O +
. O +

We O +
demonstrated O +
that O +
the O +
exogenous O +
mouse O +
CD9 B-Gene +
, O +
expressed O +
by O +
polyadenylated O +
mRNA O +
injection O +
at O +
the O +
germinal O +
- O +
vesicle O +
stage O +
oocytes O +
, O +
was O +
precisely O +
localized O +
to O +
the O +
egg O +
plasma O +
membrane O +
, O +
and O +
the O +
expression O +
reversed O +
the O +
infertility O +
of O +
CD9 B-Gene +
( O +
- O -
/ O -
- O +
) O +
eggs O +
. O +

Then O +
, O +
two O +
other O +
tetraspanins B-Gene +
, O +
human O +
CD9 B-Gene +
and O +
mouse O +
CD81 B-Gene +
, O +
overexpressed O +
with O +
this O +
technique O +
on O +
CD9 O +
( O +
- O -
/ O -
- O +
) O +
eggs O +
restored O +
the O +
fertilization O +
rate O +
up O +
to O +
approximately O +
90 O +
and O +
approximately O +
50 O +
% O +
against O +
that O +
of O +
wild O +
type O +
eggs O +
, O +
respectively O +
. O +

Moreover O +
, O +
in O +
the O +
presence O +
of O +
an O +
anti O +
- O +
mouse O +
CD9 B-Gene +
mAb O +
, O +
which O +
blocks O +
sperm O +
- O +
egg O +
fusion O +
, O +
expression O +
of O +
human O +
CD9 B-Gene +
or O +
mouse O +
CD81 B-Gene +
on O +
eggs O +
also O +
rescued O +
the O +
fusibility O +
. O +

These O +
results O +
suggested O +
that O +
human O +
CD9 B-Gene +
plays O +
a O +
crucial O +
role O +
in O +
human O +
fertilization O +
, O +
and O +
mouse O +
CD81 B-Gene +
has O +
the O +
potential O +
to O +
compensate O +
for O +
CD9 B-Gene +
function O +
in O +
sperm O +
- O +
egg O +
fusion O +
. O +

In O +
addition O +
, O +
the O +
polyadenylated O +
mRNA O +
injection O +
is O +
effective O +
for O +
molecular O +
analysis O +
of O +
sperm O +
- O +
egg O +
fusion O +
. O +

Prostaglandins O +
and O +
mechanisms O +
of O +
preterm O +
birth O +
. O +

Increased O +
uterine O +
contractility O +
at O +
term O +
and O +
preterm O +
results O +
first O +
from O +
activation O +
and O +
then O +
stimulation O +
of O +
the O +
myometrium O +
. O +

Activation O +
can O +
be O +
provoked O +
by O +
mechanical O +
stretch O +
of O +
the O +
uterus O +
, O +
and O +
by O +
an O +
endocrine O +
pathway O +
resulting O +
from O +
increased O +
activity O +
of O +
the O +
fetal O +
hypothalamic O +
- O +
pituitary O +
- O +
adrenal O +
axis O +
. O +

In O +
sheep O +
fetuses O +
, O +
increased O +
cortisol O +
output O +
during O +
pregnancy O +
regulates O +
expression O +
of O +
prostaglandin B-Gene +
synthase I-Gene +
type I-Gene +
2 I-Gene +
( O +
PGHS-2 B-Gene +
) O +
in O +
the O +
placenta O +
in O +
an O +
oestrogen O +
- O +
independent O +
manner O +
, O +
resulting O +
in O +
increased O +
concentrations O +
of O +
prostaglandin O +
E2 O +
( O +
PGE2 O +
) O +
in O +
the O +
fetal O +
circulation O +
. O +

Later O +
increases O +
in O +
maternal O +
uterine O +
expression O +
of O +
PGHS-2 B-Gene +
require O +
increases O +
in O +
oestrogen O +
and O +
lead O +
to O +
increased O +
concentrations O +
of O +
PGF O -
( O -
2alpha O -
) O +
in O +
the O +
maternal O +
circulation O +
. O +

Thus O +
, O +
regulation O +
of O +
PGHS-2 B-Gene +
at O +
term O +
is O +
differentially O +
controlled O +
in O +
fetal O +
( O +
trophoblast O +
) O +
and O +
maternal O +
( O +
uterine O +
epithelium O +
) O +
tissue O +
. O +

This O +
difference O +
may O +
reflect O +
expression O +
of O +
glucocorticoid B-Gene +
receptor I-Gene +
but O +
not O +
oestrogen B-Gene +
receptor I-Gene +
( O +
ER B-Gene +
) O +
in O +
placental O +
trophoblast O +
cells O +
. O +

In O +
women O +
, O +
cortisol O +
also O +
contributes O +
to O +
increased O +
prostaglandin O +
production O +
in O +
fetal O +
tissues O +
through O +
upregulation O +
of O +
PGHS-2 B-Gene +
( O +
amnion O +
and O +
chorion O +
) O +
and O +
downregulation O +
of O +
15-OH B-Gene +
prostaglandin I-Gene +
dehydrogenase I-Gene +
( O +
PGDH B-Gene +
; O +
chorion O +
trophoblasts O +
) O +
. O +

The O +
effect O +
of O +
cortisol O +
on O +
expression O +
of O +
PGDH B-Gene +
in O +
the O +
chorion O +
reverses O +
a O +
tonic O +
stimulatory O +
effect O +
of O +
progesterone O +
, O +
potentially O +
through O +
a O +
paracrine O +
or O +
autocrine O +
action O +
. O +

In O +
membranes O +
, O +
cortisol O +
may O +
be O +
derived O +
from O +
cortisone O +
through O +
activity O +
of O +
11beta B-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
( I-Gene +
11beta I-Gene -
- I-Gene -
HSD I-Gene +
) I-Gene +
type I-Gene +
1 I-Gene +
, O +
in O +
addition O +
to O +
secretion O +
from O +
the O +
maternal O +
or O +
fetal O +
adrenal O +
glands O +
. O +

In O +
placenta O +
, O +
11beta B-Gene -
- I-Gene -
HSD-2 I-Gene +
oxidase I-Gene +
activity O +
predominates O +
and O +
expression O +
of O +
this O +
enzyme O +
is O +
reduced O +
with O +
hypoxaemia O +
and O +
in O +
placentae O +
from O +
pre O +
- O +
eclamptic O +
pregnancies O +
. O +

In O +
these O +
circumstances O +
, O +
increased O +
concentrations O +
of O +
maternal O +
cortisol O +
may O +
cross O +
into O +
the O +
fetal O +
compartment O +
, O +
contributing O +
to O +
growth O +
restriction O +
and O +
programming O +
later O +
life O +
disease O +
. O +

Expression O +
of O +
the O +
leucocyte B-Gene +
common I-Gene +
antigen I-Gene +
- I-Gene +
related I-Gene +
( I-Gene +
LAR I-Gene +
) I-Gene +
tyrosine I-Gene +
phosphatase I-Gene +
is O +
regulated O +
by O +
cell O +
density O +
through O +
functional O +
E B-Gene -
- I-Gene -
cadherin I-Gene +
complexes O +
. O +

The O +
leucocyte B-Gene +
common I-Gene +
antigen I-Gene +
- I-Gene +
related I-Gene +
phosphatase I-Gene +
( O +
LAR B-Gene +
) O +
has O +
been O +
implicated O +
in O +
receptor B-Gene +
tyrosine I-Gene +
kinase I-Gene +
signalling O +
pathways O +
while O +
also O +
displaying O +
cell O +
- O +
density O +
- O +
dependency O +
and O +
localization O +
to O +
adherens O +
junctions O +
. O +

Whereas O +
physiological O +
substrates O +
for O +
LAR B-Gene +
have O +
not O +
been O +
identified O +
unequivocally O +
, O +
beta B-Gene -
- I-Gene -
catenin I-Gene +
associates O +
with O +
LAR B-Gene +
and O +
is O +
a O +
substrate O +
in O +
vitro O +
. O +

With O +
the O +
implication O +
that O +
LAR B-Gene +
may O +
play O +
a O +
role O +
in O +
regulating O +
E B-Gene -
- I-Gene -
cadherin I-Gene +
- O +
dependent O +
cell O +
- O +
cell O +
communication O +
and O +
contact O +
inhibition O +
, O +
the O +
relationship O +
of O +
LAR B-Gene +
with O +
E B-Gene -
- I-Gene -
cadherin I-Gene +
was O +
investigated O +
. O +

LAR B-Gene +
expression O +
increased O +
with O +
cell O +
density O +
in O +
the O +
human O +
breast O +
cancer O +
cell O +
line O +
MCF-7 O +
and O +
in O +
Ln O +
3 O +
cells O +
derived O +
from O +
the O +
13762NF O +
rat O +
mammary O +
adenocarcinoma O +
. O +

LAR B-Gene +
protein O +
levels O +
decreased O +
rapidly O +
when O +
cells O +
were O +
replated O +
at O +
a O +
low O +
density O +
after O +
attaining O +
high O +
expression O +
of O +
LAR B-Gene +
at O +
high O +
cell O +
density O +
. O +

COS-7 O +
cells O +
displayed O +
comparable O +
density O +
- O +
dependent O +
regulation O +
of O +
LAR B-Gene +
expression O +
when O +
transiently O +
expressing O +
exogenous O +
LAR B-Gene +
under O +
the O +
control O +
of O +
a O +
constitutively O +
active O +
promoter O +
, O +
indicating O +
that O +
the O +
regulation O +
of O +
expression O +
is O +
not O +
at O +
the O +
level O +
of O +
gene O +
regulation O +
. O +

Disrupting O +
homophilic O +
E B-Gene -
- I-Gene -
cadherin I-Gene +
complexes O +
by O +
chelating O +
extracellular O +
calcium O +
caused O +
a O +
marked O +
decrease O +
in O +
LAR B-Gene +
protein O +
levels O +
. O +

Similarly O +
, O +
blocking O +
E B-Gene -
- I-Gene -
cadherin I-Gene +
interactions O +
with O +
saturating O +
amounts O +
of O +
E B-Gene -
- I-Gene -
cadherin I-Gene +
antibody O +
( O +
HECD-1 O +
) O +
also O +
led O +
to O +
a O +
rapid O +
and O +
pronounced O +
loss O +
of O +
cellular O +
LAR B-Gene +
. O +

In O +
contrast O +
, O +
mimicking O +
cell O +
- O +
surface O +
E B-Gene -
- I-Gene -
cadherin I-Gene +
engagement O +
by O +
plating O +
cells O +
at O +
low O +
density O +
on O +
to O +
dishes O +
coated O +
with O +
HECD-1 O +
resulted O +
in O +
a O +
2 O +
- O +
fold O +
increase O +
in O +
LAR B-Gene +
expression O +
compared O +
with O +
controls O +
. O +

These O +
results O +
suggest O +
that O +
density O +
- O +
dependent O +
regulation O +
of O +
LAR B-Gene +
expression O +
is O +
mediated O +
by O +
functional O +
E B-Gene -
- I-Gene -
cadherin I-Gene +
and O +
may O +
play O +
a O +
role O +
in O +
density O +
- O +
dependent O +
contact O +
inhibition O +
by O +
regulating O +
tyrosine O +
phosphorylation O +
in O +
E B-Gene -
- I-Gene -
cadherin I-Gene +
complexes O +
. O +

Direct O +
addition O +
of O +
BimL B-Gene +
to O +
mitochondria O +
does O +
not O +
lead O +
to O +
cytochrome B-Gene +
c I-Gene +
release O +
. O +

Pro O +
- O +
apoptotic O +
members O +
of O +
the O +
Bcl-2 B-Gene +
family I-Gene +
can O +
be O +
subdivided O +
in O +
two O +
classes O +
according O +
to O +
their O +
structure O +
: O +
a O +
group O +
including O +
Bax B-Gene +
, O +
Bak B-Gene +
, O +
and O +
Bok B-Gene +
that O +
display O +
Bcl-2 B-Gene +
homology O +
( O +
BH O +
) O +
1 O +
, O +
BH2 O +
and O +
BH3 O +
domains O +
and O +
a O +
second O +
group O +
including O +
Bid B-Gene +
( O +
BH3 O +
interacting O +
domain O +
death O +
agonist O +
) O +
, O +
Bad B-Gene +
, O +
Bim B-Gene +
( O +
Bcl-2 B-Gene +
interacting I-Gene +
mediator I-Gene +
of I-Gene +
cell I-Gene +
death I-Gene +
) O +
and O +
several O +
others O +
that O +
contain O +
only O +
a O +
BH3 O +
domain O +
, O +
the O +
BH3 O +
- O +
only O +
proteins O +
. O +

The O +
BH3 O +
- O +
only O +
proteins O +
have O +
been O +
proposed O +
to O +
activate O +
pro O +
- O +
apoptotic O +
members O +
of O +
the O +
Bax B-Gene +
subfamily I-Gene +
to O +
trigger O +
a O +
mitochondrial O +
pathway O +
that O +
leads O +
to O +
the O +
release O +
of O +
cytochrome B-Gene +
c I-Gene +
and O +
other O +
apoptogenic O +
factors O +
. O +

Here O +
we O +
report O +
that O +
the O +
mechanism O +
of O +
action O +
of O +
Bim B-Gene +
is O +
different O +
from O +
that O +
of O +
Bid B-Gene +
. O +

Although O +
overexpression O +
of O +
Bid B-Gene +
or O +
Bim B-Gene +
in O +
cells O +
leads O +
to O +
cytochrome B-Gene +
c I-Gene +
release O +
, O +
only O +
Bid B-Gene +
is O +
able O +
to O +
trigger O +
the O +
release O +
of O +
cytochrome B-Gene +
c I-Gene +
through O +
Bax B-Gene +
activation O +
when O +
added O +
directly O +
to O +
isolated O +
mitochondria O +
. O +

Bim B-Gene -
( I-Gene -
L I-Gene -
) I-Gene +
, O +
although O +
unable O +
to O +
activate O +
Bax B-Gene +
, O +
can O +
directly O +
inhibit O +
Bcl-2 B-Gene +
or O +
Bcl B-Gene -
- I-Gene -
x I-Gene -
( I-Gene -
L I-Gene -
) I-Gene +
. O +

Our O +
data O +
suggest O +
two O +
functional O +
classes O +
of O +
BH3 O +
- O +
only O +
proteins O +
: O +
those O +
such O +
as O +
Bid B-Gene +
which O +
directly O +
activate O +
Bax B-Gene +
- O +
like O +
proteins O +
leading O +
to O +
mitochondrial O +
membrane O +
permeability O +
and O +
apoptosis O +
and O +
those O +
such O +
as O +
Bim B-Gene +
which O +
inhibit O +
anti O +
- O +
apoptotic O +
proteins O +
and O +
render O +
the O +
cells O +
more O +
susceptible O +
to O +
apoptogenic O +
stimuli O +
. O +

Relationship O +
of O +
the O +
interleukin-1 B-Gene +
system O +
with O +
neuroendocrine O +
and O +
exocrine O +
markers O +
in O +
human O +
colon O +
cancer O +
cell O +
lines O +
. O +

Interleukin B-Gene +
1 I-Gene +
( O +
IL-1 B-Gene +
) O +
is O +
known O +
to O +
regulate O +
the O +
proliferation O +
and O +
differentiation O +
of O +
normal O +
and O +
malignant O +
immune O +
cells O +
as O +
well O +
as O +
other O +
cell O +
types O +
. O +

Expression O +
of O +
IL-1 B-Gene +
( I-Gene +
alpha I-Gene +
and I-Gene +
beta I-Gene +
) I-Gene +
, O +
IL-1 B-Gene +
receptors I-Gene +
( I-Gene +
RI I-Gene +
and I-Gene +
RII I-Gene +
) I-Gene +
and O +
IL-1 B-Gene +
receptor I-Gene +
antagonist I-Gene +
( O +
IL-1RA B-Gene +
) O +
was O +
determined O +
by O +
RT O +
- O +
PCR O +
in O +
seven O +
human O +
colon O +
carcinoma O +
cell O +
lines O +
( O +
COLO O +
320DM O +
, O +
LoVo O +
, O +
SW403 O +
, O +
SW1116 O +
, O +
SW1417 O +
, O +
LS123 O +
and O +
LS174 O -
t O +
) O +
. O +

Influence O +
of O +
IL-1 B-Gene +
on O +
the O +
secretion O +
of O +
the O +
neuroendocrine O +
( O +
NE O +
) O +
differentiation O +
marker O +
chromogranin O +
A O +
( O +
CGA O +
) O +
and O +
the O +
exocrine O +
marker O +
carcinoembryonic B-Gene +
antigen I-Gene +
( O +
CEA B-Gene +
) O +
was O +
examined O +
by O +
Western O +
blotting O +
. O +

Our O +
data O +
indicate O +
that O +
CGA O +
and O +
IL-1RI B-Gene +
are O +
expressed O +
by O +
all O +
seven O +
, O +
IL-1 B-Gene +
beta I-Gene +
by O +
five O +
, O +
IL-1RII B-Gene +
and O +
IL-1RA B-Gene +
by O +
six O +
lines O +
. O +

IL-1 B-Gene +
alpha I-Gene +
transcripts O +
were O +
found O +
only O +
in O +
three O +
lines O +
( O +
LoVo O +
, O +
SW1116 O +
and O +
LS174 O -
t O +
) O +
and O +
correlated O +
with O +
high O +
CEA B-Gene +
levels O +
and O +
aggressive O +
growth O +
behavior O +
. O +

" O +
Pure O +
" O +
NE O +
cell O +
lines O +
( O +
COLO O +
320DM O +
and O +
LS123 O +
) O +
secreted O +
the O +
highest O +
levels O +
of O +
CGA B-Gene +
, O +
but O +
the O +
lowest O +
levels O +
of O +
CEA B-Gene +
and O +
were O +
IL-1 B-Gene +
( I-Gene +
alpha I-Gene +
and I-Gene +
beta I-Gene +
) I-Gene +
negative O +
. O +

Exogenously O +
added O +
IL-1 B-Gene +
caused O +
a O +
decrease O +
in O +
CGA O +
, O +
but O +
an O +
increase O +
in O +
CEA B-Gene +
secretion O +
. O +

Our O +
results O +
suggest O +
an O +
inverse O +
relationship O +
between O +
IL-1 B-Gene +
and O +
NE O +
differentiation O +
, O +
as O +
well O +
as O +
a O +
direct O +
relationship O +
between O +
IL-1 B-Gene +
and O +
CEA B-Gene +
expression O +
in O +
colon O +
carcinoma O +
. O +

Activation O +
of O +
the O +
Escherichia O +
coli O +
nfnB B-Gene +
gene O +
by O +
MarA B-Gene +
through O +
a O +
highly O +
divergent O +
marbox O +
in O +
a O +
class O +
II O +
promoter O +
. O +

MarA B-Gene +
is O +
a O +
global O +
regulator O +
that O +
mediates O +
resistance O +
to O +
multiple O +
environmental O +
hazards O +
such O +
as O +
antibiotics O +
, O +
disinfectants O +
and O +
oxidative O +
stress O +
agents O +
by O +
modulating O +
the O +
expression O +
of O +
a O +
large O +
number O +
of O +
genes O +
in O +
the O +
Escherichia O +
coli O +
chromosome O +
. O +

Two O +
E. O +
coli O +
MarA B-Gene +
homologues O +
, O +
SoxS B-Gene +
and O +
Rob B-Gene +
also O +
control O +
, O +
to O +
different O +
extents O +
, O +
genes O +
in O +
the O +
mar B-Gene +
/ O +
sox B-Gene +
/ O +
rob B-Gene +
regulon O +
. O +

The O +
controlling O +
element O +
for O +
these O +
proteins O +
is O +
a O +
20 O +
bp O +
' O +
marbox O +
' O +
sequence O +
in O +
the O +
promoter O +
region O +
of O +
regulated O +
genes O +
. O +

Using O +
in O +
vitro O +
assays O +
and O +
mutagenesis O +
of O +
promoter O +
fusions O +
in O +
whole O +
cells O +
, O +
we O +
identified O +
the O +
cis O +
regulatory O +
element O +
involved O +
in O +
MarA B-Gene +
upregulation O +
of O +
the O +
oxygen B-Gene +
- I-Gene +
insensitive I-Gene +
nitroreductase I-Gene +
nfnB B-Gene +
gene O +
. O +

MarA B-Gene +
binds O +
to O +
a O +
marbox O +
that O +
is O +
highly O +
divergent O +
from O +
the O +
previously O +
proposed O +
consensus O +
( O +
eight O +
differences O +
out O +
of O +
14 O +
specified O +
nucleotides O +
) O +
. O +

Although O +
purified O +
SoxS B-Gene +
and O +
Rob B-Gene +
proteins O +
, O +
like O +
MarA B-Gene +
, O +
activated O +
nfnB B-Gene +
transcription O +
in O +
vitro O +
, O +
only O +
constitutive O +
expression O +
of O +
chromosomal O +
marA B-Gene +
, O +
but O +
not O +
of O +
soxS B-Gene +
and O +
rob B-Gene +
genes O +
, O +
affected O +
nfnB B-Gene +
expression O +
in O +
whole O +
cells O +
. O +

Increased O +
expression O +
, O +
but O +
limited O +
as O +
compared O +
with O +
MarA B-Gene +
, O +
was O +
only O +
achieved O +
by O +
plasmid O +
- O +
mediated O +
overexpression O +
of O +
SoxS B-Gene +
and O +
Rob B-Gene +
. O +

This O +
study O +
shows O +
that O +
MarA B-Gene +
can O +
regulate O +
gene O +
expression O +
through O +
a O +
functional O +
marbox O +
that O +
is O +
considerably O +
divergent O +
from O +
the O +
current O +
consensus O +
sequence O +
. O +

The O +
data O +
suggest O +
that O +
MarA B-Gene +
is O +
preferred O +
over O +
SoxS B-Gene +
and O +
Rob B-Gene +
in O +
upregulating O +
nfnB B-Gene +
. O +

The O +
findings O +
imply O +
that O +
other O +
different O +
but O +
physiologically O +
important O +
marbox O +
DNA O +
- O +
MarA B-Gene +
interactions O +
take O +
place O +
in O +
the O +
regulation O +
of O +
still O +
uncharacterized O +
members O +
of O +
the O +
mar B-Gene +
regulon O +
. O +

Complex O +
expression O +
of O +
natural O +
killer O +
receptor O +
genes O +
in O +
single O +
natural O +
killer O +
cells O +
. O +

Human O +
natural O +
killer O +
( O +
NK O +
) O +
cells O +
express O +
several O +
inhibitory O +
and O +
non O +
- O +
inhibitory O +
NK O +
receptors O +
per O +
cell O +
. O +

Understanding O +
the O +
expression O +
patterns O +
of O +
these O +
receptor O +
genes O +
in O +
individual O +
cells O +
is O +
important O +
to O +
understanding O +
their O +
function O +
. O +

Using O +
a O +
single O +
- O +
cell O +
reverse O +
transcription O +
- O +
polymerase O +
chain O +
reaction O +
( O +
RT O +
- O +
PCR O +
) O +
method O +
, O +
we O +
analysed O +
the O +
expression O +
of O +
nine O +
NK O +
receptor O +
genes O +
in O +
38 O +
resting O +
CD56 B-Gene +
+ O +
NK O +
cells O +
from O +
peripheral O +
blood O +
of O +
normal O +
donors O +
. O +

We O +
observed O +
highly O +
diverse O +
patterns O +
of O +
receptor O +
expression O +
in O +
these O +
cells O +
. O +

No O +
NK O +
receptor O +
is O +
expressed O +
universally O +
in O +
every O +
CD56 B-Gene +
+ O +
NK O +
cell O +
. O +

The O +
expressed O +
receptor O +
types O +
per O +
cell O +
varied O +
from O +
two O +
to O +
eight O +
. O +

We O +
specifically O +
analysed O +
the O +
distribution O +
of O +
inhibitory O +
( O +
DL O +
) O +
and O +
non O +
- O +
inhibitory O +
( O +
DS O +
) O +
killer B-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIR B-Gene +
) O +
. O +

The O +
frequency O +
of O +
individual O +
receptor O +
expression O +
varied O +
from O +
26 O +
% O +
for O +
2DS2 B-Gene +
to O +
68 O +
% O +
for O +
both O +
2DL1 B-Gene +
and O +
2DL4 B-Gene +
. O +

A O +
comparison O +
of O +
the O +
coexpression O +
of O +
DL O +
and O +
DS O +
receptors O +
showed O +
a O +
significant O +
association O +
in O +
the O +
expression O +
of O +
2DL2 B-Gene +
and O +
2DS2 B-Gene +
( O +
chi2 O +
= O +
16.6 O +
; O +
P O +
< O +
0.001 O +
) O +
genes O +
but O +
no O +
association O +
between O +
2DL1 B-Gene +
and O +
2DS1 B-Gene +
or O +
between O +
3DL1 B-Gene +
and O +
3DS1 B-Gene +
genes O +
. O +

Coexpression O +
analysis O +
of O +
the O +
2DL1 B-Gene +
and O +
2DL2 B-Gene +
genes O +
in O +
2DL4 B-Gene +
+ O +
and O +
2DL4 B-Gene +
- O +
cells O +
showed O +
a O +
strong O +
association O +
in O +
2DL4 B-Gene +
+ O +
but O +
not O +
in O +
2DL4 B-Gene +
- O +
cells O +
, O +
suggesting O +
a O +
differential O +
effect O +
of O +
the O +
2DL4 B-Gene +
gene O +
on O +
the O +
expression O +
of O +
2DL1 B-Gene +
and O +
2DL2 B-Gene +
genes O +
. O +

Single O +
- O +
cell O +
RT O +
- O +
PCR O +
is O +
a O +
powerful O +
tool O +
to O +
study O +
multiple O +
receptor O +
gene O +
expression O +
ex O +
vivo O +
in O +
individual O +
NK O +
cells O +
and O +
provides O +
information O +
about O +
the O +
expression O +
pattern O +
of O +
KIR B-Gene +
receptors O +
that O +
may O +
suggest O +
mechanisms O +
of O +
gene O +
expression O +
responsible O +
for O +
generation O +
of O +
the O +
KIR B-Gene +
repertoire O +
. O +

Critical O +
evaluation O +
of O +
the O +
role O +
of O +
the O +
Toll B-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
18-Wheeler B-Gene +
in O +
the O +
host O +
defense O +
of O +
Drosophila O +
. O +

Essential O +
aspects O +
of O +
innate O +
immune O +
responses O +
to O +
microbial O +
infections O +
appear O +
to O +
be O +
conserved O +
between O +
insects O +
and O +
mammals O +
. O +

In O +
particular O +
, O +
in O +
both O +
groups O +
, O +
transmembrane O +
receptors O +
of O +
the O +
Toll B-Gene +
superfamily I-Gene +
play O +
a O +
crucial O +
role O +
in O +
activating O +
immune O +
defenses O +
. O +

The O +
Drosophila O +
Toll B-Gene +
family I-Gene +
member O +
18-Wheeler B-Gene +
had O +
been O +
proposed O +
to O +
sense O +
Gram O +
- O +
negative O +
infection O +
and O +
direct O +
selective O +
expression O +
of O +
peptides O +
active O +
against O +
Gram O +
- O +
negative O +
bacteria O +
. O +

Here O +
we O +
re O +
- O +
examine O +
the O +
role O +
of O +
18-Wheeler B-Gene +
and O +
show O +
that O +
in O +
adults O +
it O +
is O +
dispensable O +
for O +
immune O +
responses O +
. O +

In O +
larvae O +
, O +
18wheeler B-Gene +
is O +
required O +
for O +
normal O +
fat O +
body O +
development O +
, O +
and O +
in O +
mutant O +
larvae O +
induction O +
of O +
all O +
antimicrobial O +
peptide O +
genes O +
, O +
and O +
not O +
only O +
of O +
those O +
directed O +
against O +
Gram O +
- O +
negative O +
bacteria O +
, O +
is O +
compromised O +
. O +

18-Wheeler B-Gene +
does O +
not O +
qualify O +
as O +
a O +
pattern O +
recognition O +
receptor O +
of O +
Gram O +
- O +
negative O +
bacteria O +
. O +

Relationship O +
between O +
plasma O +
malondialdehyde O +
levels O +
and O +
adenosine B-Gene +
deaminase I-Gene +
activities O +
in O +
preeclampsia O +
. O +

BACKGROUND O +
: O +

Preeclampsia O +
is O +
characterized O +
by O +
endothelial O +
cell O +
dysfunction O +
, O +
and O +
lipid O +
peroxidation O +
and O +
alterations O +
of O +
immune O +
responses O +
may O +
be O +
involved O +
in O +
the O +
pathogenesis O +
of O +
this O +
disease O +
. O +

The O +
aim O +
of O +
the O +
present O +
study O +
was O +
to O +
examine O +
changes O +
in O +
plasma O +
malondialdehyde O +
( O +
MDA O +
) O +
level O +
, O +
an O +
indicator O +
of O +
lipid O +
peroxidation O +
, O +
and O +
adenosine B-Gene +
deaminase I-Gene +
( O +
ADA B-Gene +
) O +
activity O +
, O +
as O +
a O +
marker O +
of O +
T O -
- O -
cell O +
activation O +
in O +
preeclampsia O +
, O +
and O +
evaluated O +
the O +
possible O +
relationship O +
between O +
those O +
parameters O +
in O +
the O +
pathogenesis O +
of O +
preeclampsia O +
. O +

METHODS O +
: O +

Plasma O +
levels O +
of O +
MDA O +
, O +
an O +
end O +
product O +
of O +
lipid O +
peroxidation O +
induced O +
by O +
reactive O +
oxygen O +
species O +
, O +
and O +
ADA B-Gene +
activities O +
were O +
measured O +
in O +
26 O +
women O +
with O +
preeclampsia O +
and O +
26 O +
normal O +
pregnancies O +
. O +

RESULTS O +
: O +

In O +
preeclampsia O +
, O +
plasma O +
MDA O +
level O +
and O +
ADA B-Gene +
activity O +
averaged O +
0.43 O +
+ O -
/- O +
0.03 O +
micromol O +
/ O +
l O +
and O +
15.8 O +
+ O -
/- O +
0.8 O +
U O +
/ O +
l O +
, O +
respectively O +
, O +
which O +
were O +
significantly O +
higher O +
than O +
those O +
of O +
normal O +
pregnancy O +
( O +
0.31 O +
+ O -
/- O +
0.02 O +
micromol O +
/ O +
l O +
and O +
9.5 O +
+ O +
/ O +
- O +
0.6 O +
U O +
/ O +
l O +
, O +
respectively O +
) O +
( O +
P O +
< O +
0.05 O +
) O +
. O +

In O +
addition O +
, O +
plasma O +
MDA O +
level O +
was O +
positively O +
correlated O +
to O +
ADA B-Gene +
activity O +
in O +
preeclampsia O +
( O +
r O +
= O +
0.52 O +
, O +
P O +
< O +
0.05 O +
) O +
. O +

CONCLUSIONS O +
: O +

These O +
results O +
suggest O +
that O +
enhanced O +
lipid O +
peroxidation O +
and O +
T O -
- O -
cell O +
activation O +
, O +
and O +
the O +
presence O +
of O +
possible O +
interrelationship O +
and O +
cross O +
talk O +
between O +
those O +
parameters O +
may O +
be O +
related O +
at O +
least O +
partly O +
to O +
the O +
pathogenesis O +
of O +
preeclampsia O +
. O +

Nuclear O +
localization O +
of O +
CDC25B1 B-Gene +
and O +
serine O +
146 O +
integrity O +
are O +
required O +
for O +
induction O +
of O +
mitosis O +
. O +

CDC25B B-Gene +
phosphatases I-Gene +
are O +
essential O +
regulators O +
that O +
control O +
cyclin B-Gene +
- I-Gene +
dependent I-Gene +
kinases I-Gene +
activities O +
at O +
the O +
entry O +
into O +
mitosis O +
. O +

In O +
this O +
study O +
, O +
we O +
demonstrate O +
that O +
serine O +
146 O +
is O +
required O +
for O +
two O +
crucial O +
features O +
of O +
CDC25B1 B-Gene +
. O +

It O +
is O +
essential O +
for O +
CDC25B1 B-Gene +
to O +
function O +
as O +
a O +
mitotic O +
inducer O +
and O +
to O +
prevent O +
CDC25B1 B-Gene +
export O +
from O +
the O +
nucleus O +
. O +

We O +
also O +
show O +
that O +
serine O +
146 O +
is O +
phosphorylated O +
in O +
vitro O +
by O +
CDK1 B-Gene +
- O +
cyclin B-Gene +
B I-Gene +
. O +

However O +
, O +
phosphorylation O +
of O +
CDC25B B-Gene +
does O +
not O +
stimulate O +
its O +
phosphatase B-Gene +
activity O +
, O +
and O +
mutation O +
of O +
serine O +
146 O +
had O +
no O +
effect O +
on O +
its O +
catalytic O +
activity O +
. O +

Serine O +
146 O +
phosphorylation O +
is O +
proposed O +
to O +
be O +
a O +
key O +
event O +
in O +
the O +
regulation O +
of O +
the O +
CDC25B B-Gene +
function O +
in O +
the O +
initiation O +
of O +
mammalian O +
mitosis O +
. O +

Identification O +
, O +
characterization O +
, O +
and O +
functional O +
study O +
of O +
the O +
two O +
novel O +
human O +
members O +
of O +
the O +
semaphorin B-Gene +
gene I-Gene +
family I-Gene +
. O +

We O +
cloned O +
two O +
novel O +
human O +
transmembrane O +
semaphorins B-Gene +
, O +
( O +
HSA O +
) O +
SEMA6C B-Gene +
and O +
( O +
HSA O +
) O +
SEMA6D B-Gene +
, O +
that O +
belong O +
to O +
the O +
class O +
VI O +
subgroup O +
of O +
the O +
semaphorin B-Gene +
family I-Gene +
. O +

The O +
genes O +
for O +
SEMA6C B-Gene +
and O +
SEMA6D B-Gene +
are O +
mapped O +
on O +
chromosome O +
1q12 O +
- O +
21.1 O +
and O +
15q21.1 O +
, O +
respectively O +
. O +

Among O +
the O +
adult O +
tissues O +
, O +
SEMA6C B-Gene +
is O +
expressed O +
only O +
in O +
skeletal O +
muscle O +
, O +
whereas O +
SEMA6D B-Gene +
is O +
expressed O +
abundantly O +
in O +
kidney O +
, O +
brain O +
, O +
and O +
placenta O +
and O +
moderately O +
in O +
the O +
heart O +
and O +
skeletal O +
muscles O +
. O +

During O +
murine O +
development O +
, O +
neither O +
SEMA6C B-Gene +
nor O +
SEMA6D B-Gene +
was O +
expressed O +
in O +
embryonic O +
day O +
10.5 O +
( O +
E10.5 O +
) O +
embryos O +
, O +
but O +
both O +
were O +
highly O +
expressed O +
in O +
the O +
areas O +
of O +
the O +
lateral O +
ventricle O +
, O +
the O +
striatum O +
, O +
the O +
wall O +
of O +
the O +
midbrain O +
, O +
the O +
pons O +
/ O +
midbrain O +
junction O +
, O +
and O +
the O +
choroid O +
plexus O +
of O +
E13 O +
embryos O +
. O +

Were O +
neurons O +
, O +
neither O +
axons O +
nor O +
astrocytes O +
, O +
highly O +
expressed O +
both O +
semaphorins B-Gene +
. O +

Three O +
isoforms O +
of O +
SEMA6C B-Gene +
and O +
five O +
isoforms O +
of O +
SEMA6D B-Gene +
derived O +
from O +
alternative O +
splicing O +
were O +
identified O +
, O +
and O +
their O +
expression O +
was O +
regulated O +
in O +
a O +
tissue O +
- O +
and O +
development O +
- O +
dependent O +
manner O +
. O +

Deletion O +
analysis O +
indicated O +
that O +
a O +
sema O +
domain O +
and O +
a O +
PSI O +
domain O +
are O +
integrally O +
necessary O +
for O +
correct O +
post O +
- O +
translation O +
modification O +
and O +
subcellular O +
localization O +
. O +

The O +
extracellular O +
domain O +
of O +
SEMA6C B-Gene +
inhibited O +
axonal O +
extension O +
of O +
nerve B-Gene +
growth I-Gene +
factor I-Gene +
- O +
differentiated O +
PC12 O +
cells O +
and O +
induced O +
the O +
growth O +
cone O +
collapse O +
of O +
chicken O +
dorsal O +
root O +
ganglion O +
, O +
rat O +
hippocampal O +
neurons O +
, O +
and O +
rat O +
cortical O +
neurons O +
in O +
a O +
dose O +
- O +
responsive O +
manner O +
. O +

SEMA6D B-Gene +
acted O +
like O +
SEMA6C B-Gene +
except O +
it O +
had O +
no O +
significant O +
effect O +
on O +
the O +
growth O +
cones O +
of O +
rat O +
cortical O +
neurons O +
. O +

Synaptotagmins B-Gene +
I I-Gene +
and I-Gene +
IV I-Gene +
promote O +
transmitter O +
release O +
independently O +
of O +
Ca O -
( O -
2 O -
+ O -
) O +
binding O +
in O +
the O +
C O -
( O -
2 O -
) O +
A O +
domain O +
. O +

At O +
nerve O +
terminals O +
, O +
a O +
focal O +
and O +
transient O +
increase O +
in O +
intracellular O +
Ca O -
( O -
2 O -
+ O -
) O +
triggers O +
the O +
fusion O +
of O +
neurotransmitter O +
- O +
filled O +
vesicles O +
with O +
the O +
plasma O +
membrane O +
. O +

The O +
most O +
extensively O +
studied O +
candidate O +
for O +
the O +
Ca O -
( O -
2 O -
+ O -
) O +
- O +
sensing O +
trigger O +
is O +
synaptotagmin B-Gene +
I I-Gene +
, O +
whose O +
Ca O -
( O -
2 O -
+ O -
) O +
- O +
dependent O +
interactions O +
with O +
acidic O +
phospholipids O +
and O +
syntaxin B-Gene +
have O +
largely O +
been O +
ascribed O +
to O +
its O +
C O -
( O -
2 O -
) O +
A O +
domain O +
, O +
although O +
the O +
C O -
( O -
2 O -
) O +
B O +
domain O +
also O +
binds O +
Ca O -
( O -
2 O -
+ O -
) O +
( O +
refs O +
7 O +
, O +
8 O +
) O +
. O +

Genetic O +
tests O +
of O +
synaptotagmin B-Gene +
I I-Gene +
have O +
been O +
equivocal O +
as O +
to O +
whether O +
it O +
is O +
the O +
Ca O -
( O -
2 O -
+ O -
) O +
- O +
sensing O +
trigger O +
of O +
fusion O +
. O +

Synaptotagmin B-Gene +
IV I-Gene +
, O +
a O +
related O +
isoform O +
that O +
does O +
not O +
bind O +
Ca O -
( O -
2 O -
+ O -
) O +
in O +
the O +
C O -
( O -
2 O -
) O +
A O +
domain O +
, O +
might O +
be O +
an O +
inhibitor O +
of O +
release O +
. O +

We O +
mutated O +
an O +
essential O +
aspartate O +
of O +
the O +
Ca O -
( O -
2 O -
+ O -
) O +
- O +
binding O +
site O +
of O +
the O +
synaptotagmin B-Gene +
I I-Gene +
C O -
( O -
2 O -
) O +
A O +
domain O +
and O +
expressed O +
it O +
in O +
Drosophila O +
lacking O +
synaptotagmin B-Gene +
I I-Gene +
. O +

Here O +
we O +
show O +
that O +
, O +
despite O +
the O +
disruption O +
of O +
the O +
binding O +
site O +
, O +
the O +
Ca O -
( O -
2 O -
+ O -
) O +
- O +
dependent O +
properties O +
of O +
transmission O +
were O +
not O +
altered O +
. O +

Similarly O +
, O +
we O +
found O +
that O +
synaptotagmin B-Gene +
IV I-Gene +
could O +
substitute O +
for O +
synaptotagmin B-Gene +
I I-Gene +
. O +

We O +
conclude O +
that O +
the O +
C O -
( O -
2 O -
) O +
A O +
domain O +
of O +
synaptotagmin B-Gene +
is O +
not O +
required O +
for O +
Ca O -
( O -
2 O -
+ O -
) O +
- O +
dependent O +
synaptic O +
transmission O +
, O +
and O +
that O +
synaptotagmin B-Gene +
IV I-Gene +
promotes O +
rather O +
than O +
inhibits O +
transmission O +
. O +

A O +
novel O +
polymorphism O +
in O +
exon O +
11 O +
of O +
the O +
WKL1 B-Gene +
gene O +
, O +
shows O +
no O +
association O +
with O +
schizophrenia O +
. O +

A O +
missense O +
mutation O +
in O +
exon O +
11 O +
of O +
the O +
WKL1 B-Gene +
gene O +
on O +
chromosome O +
22 O +
was O +
found O +
to O +
be O +
associated O +
with O +
cases O +
of O +
catatonic O +
schizophrenia O +
in O +
a O +
single O +
large O +
pedigree O +
. O +

We O +
have O +
screened O +
exon O +
11 O +
of O +
the O +
WKL1 B-Gene +
gene O +
in O +
174 O +
cases O +
of O +
schizophrenia O +
, O +
including O +
cases O +
of O +
22 O +
cases O +
of O +
catatonic O +
schizophrenia O +
, O +
but O +
could O +
not O +
detect O +
the O +
previously O +
reported O +
mis O +
- O +
sense O +
mutation O +
. O +

However O +
in O +
exon O +
11 O +
, O +
we O +
observed O +
an O +
insertion O +
/ O +
deletion O +
polymorphism O +
, O +
one O +
- O +
missense O +
substitution O +
and O +
two O +
synonymous O +
substitutions O +
. O +

In O +
addition O +
, O +
we O +
also O +
identified O +
a O +
nucleotide O +
substitution O +
in O +
intron O +
11 O +
. O +

All O +
these O +
polymorphisms O +
appeared O +
to O +
be O +
in O +
complete O +
linkage O +
disequilibrium O +
with O +
one O +
another O +
. O +

The O +
polymorphisms O +
were O +
also O +
identified O +
in O +
a O +
UK O +
pedigree O +
with O +
schizophrenia O +
, O +
however O +
the O +
polymorphisms O +
did O +
not O +
segregate O +
with O +
the O +
disease O +
. O +

To O +
test O +
for O +
potential O +
association O +
between O +
these O +
polymorphisms O +
and O +
schizophrenia O +
we O +
sequenced O +
an O +
equal O +
number O +
of O +
UK O +
control O +
individuals O +
who O +
were O +
free O +
of O +
all O +
psychiatric O +
symptoms O +
and O +
had O +
negative O +
family O +
histories O +
for O +
mental O +
illness O +
; O +
the O +
frequency O +
of O +
the O +
insertion O +
/ O +
deletion O +
polymorphism O +
was O +
not O +
significantly O +
different O +
in O +
schizophrenia O +
cases O +
( O +
42 O +
out O +
of O +
348 O +
chromosomes O +
, O +
allele O +
frequency O +
12 O +
% O +
) O +
compared O +
to O +
normal O +
controls O +
( O +
40 O +
out O +
of O +
356 O +
chromosomes O +
, O +
allele O +
frequency O +
11 O +
% O +
) O +
. O +

The O +
insertion O +
/ O +
deletion O +
was O +
found O +
to O +
be O +
in O +
Hardy O +
Weinberg O +
equilibrium O +
in O +
both O +
the O +
schizophrenic O +
and O +
control O +
groups O +
. O +

The O +
insertion O +
/ O +
deletion O +
is O +
composed O +
of O +
repeated O +
sequence O +
from O +
exon O +
11 O +
and O +
intron O +
11 O +
and O +
is O +
predicted O +
to O +
affect O +
WKL1 B-Gene +
protein O +
structure O +
. O +

HIV-1 O +
Tat B-Gene +
interaction O +
with O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
C O +
- O +
terminal O +
domain O +
( O +
CTD O +
) O +
and O +
a O +
dynamic O +
association O +
with O +
CDK2 B-Gene +
induce O +
CTD O +
phosphorylation O +
and O +
transcription O +
from O +
HIV-1 O +
promoter O +
. O +

Human O +
immunodeficiency O +
virus O +
, O +
type O +
1 O +
( O +
HIV-1 O +
) O +
, O +
Tat B-Gene +
protein O +
activates O +
viral O +
gene O +
expression O +
through O +
promoting O +
transcriptional O +
elongation O +
by O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
( O +
RNAPII B-Gene +
) O +
. O +

In O +
this O +
process O +
Tat B-Gene +
enhances O +
phosphorylation O +
of O +
the O +
C O +
- O +
terminal O +
domain O +
( O +
CTD O +
) O +
of O +
RNAPII B-Gene +
by O +
activating O +
cell B-Gene +
cycle I-Gene +
- I-Gene +
dependent I-Gene +
kinases I-Gene +
( O +
CDKs B-Gene +
) O +
associated O +
with O +
general O +
transcription B-Gene +
factors I-Gene +
of O +
the O +
promoter O +
complex O +
, O +
specifically O +
CDK7 B-Gene +
and O +
CDK9 B-Gene +
. O +

We O +
reported O +
a O +
Tat B-Gene +
- O +
associated O +
T O -
- O -
cell O +
- O +
derived O +
kinase B-Gene +
, O +
which O +
contained O +
CDK2 B-Gene +
. O +

Here O +
, O +
we O +
provide O +
further O +
evidence O +
that O +
CDK2 B-Gene +
is O +
involved O +
in O +
Tat B-Gene +
- O +
mediated O +
CTD O +
phosphorylation O +
and O +
in O +
HIV-1 O +
transcription O +
in O +
vitro O +
. O +

Tat B-Gene +
- O +
mediated O +
CTD O +
phosphorylation O +
by O +
CDK2 B-Gene +
required O +
cysteine O +
22 O +
in O +
the O +
activation O +
domain O +
of O +
Tat B-Gene +
and O +
amino O +
acids O +
42 O +
- O +
72 O +
of O +
Tat B-Gene +
. O +

CDK2 B-Gene +
phosphorylated O +
Tat B-Gene +
itself O +
, O +
apparently O +
by O +
forming O +
dynamic O +
contacts O +
with O +
amino O +
acids O +
15 O +
- O +
24 O +
and O +
36 O +
- O +
49 O +
of O +
Tat B-Gene +
. O +

Also O +
, O +
amino O +
acids O +
24 O +
- O +
36 O +
and O +
45 O +
- O +
72 O +
of O +
Tat B-Gene +
interacted O +
with O +
CTD O +
. O +

CDK2 B-Gene +
associated O +
with O +
RNAPII B-Gene +
and O +
was O +
found O +
in O +
elongation O +
complexes O +
assembled O +
on O +
HIV-1 O +
long O +
- O +
terminal O +
repeat O +
template O +
. O +

Recombinant O +
CDK2 B-Gene +
/ O +
cyclin B-Gene +
E I-Gene +
stimulated O +
Tat B-Gene +
- O +
dependent O +
HIV-1 O +
transcription O +
in O +
reconstituted O +
transcription O +
assay O +
. O +

Immunodepletion O +
of O +
CDK2 B-Gene +
/ O +
cyclin B-Gene +
E I-Gene +
in O +
HeLa O +
nuclear O +
extract O +
blocked O +
Tat B-Gene +
- O +
dependent O +
transcription O +
. O +

We O +
suggest O +
that O +
CDK2 B-Gene +
is O +
part O +
of O +
a O +
transcription O +
complex O +
that O +
is O +
required O +
for O +
Tat B-Gene +
- O +
dependent O +
transcription O +
and O +
that O +
interaction O +
of O +
Tat B-Gene +
with O +
CTD O +
and O +
a O +
dynamic O +
association O +
of O +
Tat B-Gene +
with O +
CDK2 B-Gene +
/ O +
cyclin B-Gene +
E I-Gene +
stimulated O +
CTD O +
phosphorylation O +
by O +
CDK2 B-Gene +
. O +

Inflammatory O +
mediator O +
mRNA O +
expression O +
by O +
adenovirus O +
E1A B-Gene +
- O +
transfected O +
bronchial O +
epithelial O +
cells O +
. O +

Lung O +
tissue O +
from O +
patients O +
with O +
emphysema O +
and O +
airway O +
obstruction O +
carries O +
excess O +
adenoviral O +
E1A B-Gene +
DNA O +
that O +
is O +
expressed O +
as O +
protein O +
in O +
airway O +
surface O +
epithelium O +
and O +
is O +
associated O +
with O +
an O +
increased O +
inflammatory O +
response O +
. O +

To O +
examine O +
mechanisms O +
by O +
which O +
latent O +
adenoviral O +
infection O +
might O +
amplify O +
the O +
inflammatory O +
process O +
, O +
we O +
transfected O +
primary O +
human O +
bronchial O +
epithelial O +
( O +
HBE O +
) O +
cells O +
from O +
three O +
separate O +
patients O +
undergoing O +
lung O +
resection O +
so O +
that O +
they O +
stably O +
expressed O +
adenovirus O +
E1A B-Gene +
. O +

Lipopolysaccharide O +
stimulation O +
of O +
the O +
E1A B-Gene +
- O +
transfected O +
HBE O +
cells O +
increased O +
intercellular B-Gene +
adhesion I-Gene +
molecule-1 I-Gene +
and O +
interleukin-8 B-Gene +
mRNA O +
and O +
protein O +
expression O +
compared O +
with O +
control O +
cells O +
from O +
the O +
same O +
patient O +
. O +

It O +
also O +
induced O +
greater O +
intercellular B-Gene +
adhesion I-Gene +
molecule-1 I-Gene +
promoter O +
activity O +
and O +
greater O +
nuclear B-Gene +
factor I-Gene +
- I-Gene +
kappa I-Gene +
B I-Gene +
binding O +
activity O +
of O +
nuclear O +
extracts O +
in O +
E1A B-Gene +
transfectants O +
than O +
controls O +
. O +

E1A B-Gene +
- O +
positive O +
transfectants O +
constitutively O +
expressed O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
beta I-Gene +
1 I-Gene +
mRNA O +
and O +
protein O +
, O +
whereas O +
this O +
expression O +
was O +
either O +
very O +
low O +
or O +
not O +
detected O +
in O +
control O +
cells O +
. O +

We O +
conclude O +
that O +
adenoviral O +
E1A B-Gene +
transfection O +
transforms O +
primary O +
HBE O +
cells O +
and O +
upregulates O +
their O +
production O +
of O +
mediators O +
that O +
are O +
clinically O +
relevant O +
to O +
the O +
pathogenesis O +
of O +
chronic O +
obstructive O +
pulmonary O +
disease O +
. O +

Novel O +
mode O +
of O +
transcription O +
regulation O +
of O +
divergently O +
overlapping O +
promoters O +
by O +
PhoP B-Gene +
, O +
the O +
regulator O +
of O +
two O +
- O +
component O +
system O +
sensing O +
external O +
magnesium O +
availability O +
. O +

PhoP B-Gene +
is O +
a O +
response O +
regulator O +
of O +
the O +
PhoQ B-Gene +
- O +
PhoP B-Gene +
two O +
- O +
component O +
system O +
controlling O +
a O +
set O +
of O +
the O +
Mg O +
( O +
II O +
) O +
- O +
response O +
genes O +
in O +
Escherichia O +
coli O +
. O +

Here O +
we O +
demonstrate O +
the O +
mode O +
of O +
transcription O +
regulation O +
by O +
phosphorylated O +
PhoP B-Gene +
of O +
divergently O +
transcribed O +
mgtA B-Gene +
and O +
treR B-Gene +
genes O +
, O +
each O +
encoding O +
a O +
putative O +
Mg O +
( O +
II O +
) O +
transporter O +
and O +
a O +
repressor O +
for O +
the O +
trehalose O +
utilization O +
operon O +
respectively O +
. O +

Under O +
Mg O +
( O +
II O +
) O +
- O +
limiting O +
conditions O +
in O +
vivo O +
, O +
two O +
promoters O +
, O +
the O +
upstream O +
constitutive O +
P2 O +
and O +
the O +
downstream O +
inducible O +
P1 O +
, O +
were O +
detected O +
for O +
the O +
mgtA B-Gene +
gene O +
. O +

Gel O +
- O +
shift O +
analysis O +
in O +
vitro O +
using O +
purified O +
PhoP B-Gene +
indicates O +
its O +
binding O +
to O +
a O +
single O +
DNA O +
target O +
, O +
centred O +
between O +
- O +
43 O +
and O +
- O +
24 O +
of O +
the O +
mgtAP1 O +
promoter O +
. O +

This O +
region O +
includes O +
the O +
PhoP B-Gene +
box O +
, O +
which O +
consists O +
of O +
a O +
direct O +
repeat O +
of O +
the O +
heptanucleotide O +
sequence O +
( O +
T O +
) O +
G O +
( O +
T O +
) O +
TT O +
( O +
AA O +
) O +
. O +

Site O +
- O +
directed O +
mutagenesis O +
studies O +
indicate O +
the O +
critical O +
roles O +
for O +
T O +
( O +
position O +
3 O +
) O +
, O +
T O +
( O +
position O +
4 O +
) O +
and O +
A O +
( O +
position O +
6 O +
) O +
for O +
PhoP B-Gene +
- O +
dependent O +
transcription O +
from O +
mgtAP1 O +
. O +

DNase B-Gene +
I I-Gene +
footprinting O +
assays O +
reveal O +
weak O +
binding O +
of O +
PhoP B-Gene +
to O +
this O +
PhoP B-Gene +
box O +
, O +
but O +
the O +
binding O +
becomes O +
stronger O +
in O +
the O +
simultaneous O +
presence O +
of O +
RNA B-Gene +
polymerase I-Gene +
. O +

Likewise O +
the O +
RNA B-Gene +
polymerase I-Gene +
binding O +
to O +
the O +
P1 O +
promoter O +
becomes O +
stronger O +
in O +
the O +
presence O +
of O +
PhoP B-Gene +
. O +

For O +
the O +
PhoP B-Gene +
- O +
assisted O +
formation O +
of O +
open O +
complex O +
at O +
the O +
mgtAP1 O +
promoter O +
, O +
however O +
, O +
the O +
carboxy O +
- O +
terminal O +
domain O +
of O +
alpha O +
subunit O +
( O +
alpha O +
CTD O +
) O +
is O +
not O +
needed O +
. O +

For O +
transcription O +
in O +
vivo O +
of O +
the O +
treR B-Gene +
gene O +
, O +
four O +
promoters O +
were O +
identified O +
. O +

The O +
most O +
upstream O +
promoter O +
treRP4 O +
divergently O +
overlaps O +
with O +
the O +
mgtAP1 O +
promoter O +
, O +
sharing O +
the O +
same O +
sequence O +
as O +
the O +
respective O +
- O +
10 O +
signal O +
in O +
the O +
opposite O +
direction O +
. O +

In O +
vitro O +
transcription O +
using O +
mutant O +
promoters O +
support O +
this O +
prediction O +
. O +

In O +
the O +
presence O +
of O +
PhoP B-Gene +
, O +
transcription O +
from O +
the O +
promoter O +
treRP3 O +
was O +
repressed O +
with O +
concomitant O +
activation O +
of O +
mgtAP1 O +
transcription O +
. O +

The O +
PhoP B-Gene +
box O +
is O +
located O +
between O +
- O +
46 O +
and O +
- O +
30 O +
with O +
respect O +
to O +
treRP3 O +
, O +
and O +
the O +
alpha O +
CTD O +
is O +
needed O +
for O +
this O +
repression O +
. O +

CNS O +
myelinogenesis O +
in O +
vitro O +
: O +
myelin B-Gene +
basic I-Gene +
protein I-Gene +
deficient O +
shiverer O +
oligodendrocytes O +
. O +

The O +
shiverer O +
mutant O +
mouse O +
is O +
an O +
autosomal O +
recessive O +
mutant O +
characterized O +
by O +
incomplete O +
myelin O +
sheath O +
formation O +
in O +
the O +
central O +
nervous O +
system O +
( O +
CNS O +
) O +
. O +

Such O +
mice O +
contain O +
a O +
deletion O +
in O +
the O +
MBP B-Gene +
gene O +
, O +
do O +
not O +
produce O +
MBP B-Gene +
proteins O +
, O +
and O +
have O +
little O +
or O +
no O +
compact O +
myelin O +
in O +
the O +
CNS O +
. O +

To O +
investigate O +
the O +
myelin O +
sheath O +
formation O +
in O +
shiverer O +
mutant O +
mice O +
resulting O +
from O +
the O +
absence O +
of O +
compact O +
myelin O +
, O +
firstly O +
we O +
developed O +
new O +
methods O +
for O +
generating O +
oligodendrocyte O +
precursor O +
cells O +
( O +
OPCs O +
) O +
from O +
an O +
E17 O +
mouse O +
brain O +
, O +
and O +
examined O +
homozygous O +
shiverer O +
( O +
shi O +
/ O +
shi O +
) O +
OPCs O +
with O +
respect O +
to O +
myelinogenesis O +
in O +
vitro O +
. O +

After O +
treatment O +
of O +
shi O +
/ O +
shi O +
OPCs O +
in O +
vitro O +
with O +
PDGF B-Gene +
or O +
bFGF B-Gene +
, O +
proliferation O +
of O +
shi O +
/ O +
shi O +
OPCs O +
was O +
enhanced O +
similar O +
to O +
that O +
observed O +
in O +
wild O +
- O +
type O +
OPCs O +
. O +

The O +
majority O +
of O +
cells O +
from O +
the O +
shiverer O +
mutant O +
mouse O +
, O +
however O +
, O +
remained O +
as O +
A2B5 O +
- O +
immunoreactive O +
early O +
OPCs O +
. O +

To O +
determine O +
which O +
molecular O +
events O +
affect O +
the O +
differentiation O +
of O +
shi O +
/ O +
shi O +
OPCs O +
, O +
we O +
determined O +
the O +
signaling O +
pathway O +
that O +
could O +
be O +
responsible O +
for O +
activating O +
myelin O +
sheath O +
- O +
specific O +
proteins O +
. O +

We O +
found O +
that O +
the O +
developmental O +
schedule O +
of O +
shi O +
/ O +
shi O +
OPCs O +
in O +
vitro O +
was O +
accelerated O +
by O +
the O +
addition O +
of O +
cyclic O +
AMP O +
analogs O +
, O +
dibutyryl O +
cAMP O +
( O +
dbcAMP O +
) O +
. O +

Treatment O +
of O +
shi O +
/ O +
shi O +
OPCs O +
with O +
dbcAMP O +
had O +
significant O +
effect O +
on O +
the O +
differentiation O +
of O +
OPCs O +
that O +
became O +
MAG B-Gene +
- O +
expressing O +
oligodendrocytes O +
. O +

To O +
further O +
determine O +
the O +
possible O +
mechanism O +
involved O +
in O +
the O +
activation O +
of O +
MAG B-Gene +
by O +
dbcAMP O +
, O +
we O +
examined O +
the O +
cAMP O +
- O +
dependent O +
signaling O +
cascades O +
. O +

The O +
activation O +
of O +
JNK B-Gene +
was O +
markedly O +
stimulated O +
by O +
treatment O +
with O +
dbcAMP O +
, O +
and O +
the O +
phosphorylation O +
of O +
transcription B-Gene +
factor I-Gene +
ATF B-Gene +
- I-Gene +
2 I-Gene +
was O +
also O +
stimulated O +
by O +
dbcAMP O +
. O +

We O +
demonstrated O +
that O +
the O +
MAG B-Gene +
- O +
positive O +
shi O +
/ O +
shi O +
oligodendrocytes O +
extend O +
processes O +
around O +
axons O +
and O +
finally O +
covered O +
the O +
axon O +
, O +
this O +
was O +
clearly O +
observed O +
by O +
immunocytochemistry O +
of O +
shi O +
/ O +
shi O +
oligodendrocyte O +
- O +
DRG O +
cocultures O +
. O +

These O +
results O +
suggest O +
that O +
ATF-2 B-Gene +
coupled O +
to O +
specific O +
signal O +
transduction O +
cascades O +
plays O +
an O +
important O +
regulatory O +
role O +
in O +
MAG B-Gene +
expression O +
at O +
a O +
specific O +
stage O +
of O +
shi O +
/ O +
shi O +
oligodendrocyte O +
differentiation O +
, O +
and O +
OPCs O +
grow O +
to O +
become O +
myelin O +
- O +
forming O +
cells O +
with O +
numerous O +
cell O +
processes O +
that O +
wraps O +
around O +
an O +
axon O +
to O +
form O +
a O +
thin O +
myelin O +
sheath O +
. O +

Human O +
lactiferous O +
mammary O +
gland O +
cells O +
produce O +
vascular B-Gene +
endothelial I-Gene +
growth I-Gene +
factor I-Gene +
( O +
VEGF B-Gene +
) O +
and O +
express O +
the O +
VEGF B-Gene +
receptors I-Gene +
, O +
Flt-1 B-Gene +
AND O +
KDR B-Gene +
/ O +
Flk-1 B-Gene +
. O +

Human O +
milk O +
contains O +
a O +
variety O +
of O +
growth B-Gene +
factors I-Gene +
. O +

Recently O +
, O +
it O +
was O +
reported O +
that O +
vascular B-Gene +
endothelial I-Gene +
growth I-Gene +
factor I-Gene +
( O +
VEGF B-Gene +
) O +
was O +
one O +
of O +
them O +
. O +

We O +
investigated O +
milk O +
VEGF B-Gene +
isoforms O +
, O +
their O +
functions O +
, O +
and O +
VEGF B-Gene +
receptors I-Gene +
on O +
mammary O +
gland O +
epithelial O +
cells O +
( O +
MEC O +
) O +
. O +

The O +
VEGF B-Gene +
concentration O +
in O +
human O +
milk O +
was O +
74.3 O +
+ O -
/-34.9ng O -
/ O -
ml O +
on O +
the O +
first O +
day O +
after O +
delivery O +
, O +
and O +
rapidly O +
decreased O +
in O +
a O +
couple O +
of O +
days O +
to O +
6.2 O +
+ O -
/-2.3ng O -
/ O -
ml O +
on O +
the O +
fifth O +
day O +
, O +
and O +
matured O +
milk O +
maintained O +
about O +
4ng O +
/ O +
ml O +
. O +

In O +
an O +
MTT O +
assay O +
, O +
human O +
milk O +
accelerated O +
HUVEC O +
proliferation O +
and O +
MV303 O +
, O +
a O +
neutralizing O +
antibody O +
of O +
VEGF B-Gene +
, O +
blocked O +
17.3 O +
% O +
of O +
the O +
effect O +
. O +

Immunoprecipitation O +
and O +
Western O +
blotting O +
showed O +
that O +
VEGF121 B-Gene +
and O +
VEGF165 B-Gene +
were O +
contained O +
in O +
human O +
colostrums O +
, O +
and O +
RT O +
- O +
PCR O +
of O +
human O +
MEC O +
confirmed O +
that O +
VEGF121 B-Gene +
, O +
VEGF165 B-Gene +
and O +
VEGF189 B-Gene +
were O +
present O +
. O +

By O +
immunostaining O +
of O +
human O +
breast O +
tissues O +
, O +
RT O +
- O +
PCR O +
of O +
MEC O +
from O +
human O +
colostrum O +
and O +
measurement O +
of O +
the O +
VEGF B-Gene +
concentrations O +
of O +
conditioned O +
media O +
of O +
cultured O +
human O +
MEC O +
, O +
it O +
was O +
confirmed O +
that O +
VEGF B-Gene +
was O +
produced O +
by O +
MEC O +
. O +

MEC O +
was O +
also O +
expressed O +
VEGF B-Gene +
receptors I-Gene +
, O +
flt-1 B-Gene +
and O +
Flk-1 B-Gene +
/ O +
KDR B-Gene +
. O +

These O +
results O +
speculate O +
us O +
that O +
the O +
existence O +
of O +
autocrine O +
or O +
paracrine O +
system O +
within O +
breast O +
tissue O +
via O +
VEGF B-Gene +
receptors I-Gene +
on O +
MEC O +
and O +
have O +
a O +
role O +
in O +
lactation O +
. O +

Functional O +
replacement O +
of O +
the O +
tobacco O +
rattle O +
virus O +
cysteine O +
- O +
rich O +
protein O +
by O +
pathogenicity O +
proteins O +
from O +
unrelated O +
plant O +
viruses O +
. O +

Mutation O +
of O +
the O +
16 B-Gene -
K I-Gene +
gene O +
encoded O +
by O +
RNA1 O +
of O +
Tobacco O +
rattle O +
virus O +
( O +
TRV O +
) O +
greatly O +
reduced O +
the O +
levels O +
of O +
viral O +
RNA O +
that O +
accumulated O +
in O +
both O +
infected O +
protoplasts O +
and O +
plants O +
, O +
showing O +
that O +
the O +
16 B-Gene -
K I-Gene +
cysteine O +
- O +
rich O +
protein O +
( O +
CRP O +
) O +
is O +
required O +
for O +
efficient O +
multiplication O +
of O +
TRV O +
. O +

Overexpression O +
of O +
the O +
16 B-Gene -
K I-Gene +
protein I-Gene +
, O +
either O +
from O +
an O +
additional O +
copy O +
of O +
the O +
gene O +
carried O +
on O +
TRV O +
RNA2 O +
or O +
from O +
a O +
PVX O +
vector O +
, O +
led O +
to O +
an O +
increase O +
in O +
the O +
severity O +
of O +
disease O +
symptoms O +
, O +
suggesting O +
that O +
the O +
protein O +
has O +
a O +
role O +
in O +
the O +
pathogenicity O +
of O +
the O +
virus O +
. O +

Mutation O +
of O +
the O +
16 B-Gene -
K I-Gene +
gene O +
could O +
be O +
overcome O +
by O +
expression O +
from O +
RNA2 O +
of O +
the O +
Cucumber O +
mosaic O +
virus O +
2b B-Gene +
gene O +
, O +
the O +
Soil O +
- O +
borne O +
wheat O +
mosaic O +
virus O +
19 B-Gene -
K I-Gene +
gene O +
, O +
or O +
the O +
Barley O +
stripe O +
mosaic O +
virus O +
gammab B-Gene +
gene O +
, O +
indicating O +
that O +
the O +
proteins O +
encoded O +
by O +
these O +
diverse O +
genes O +
may O +
have O +
similar O +
functions O +
. O +

One O +
known O +
function O +
of O +
the O +
CMV O +
2b B-Gene +
gene O +
is O +
as O +
a O +
suppressor O +
of O +
posttranscriptional O +
gene O +
silencing O +
, O +
suggesting O +
that O +
the O +
TRV O +
16 B-Gene -
K I-Gene +
protein O +
may O +
also O +
possess O +
this O +
activity O +
. O +

Association O +
of O +
the O +
adaptor O +
TANK B-Gene +
with O +
the O +
I B-Gene +
kappa I-Gene +
B I-Gene +
kinase I-Gene +
( O +
IKK B-Gene +
) O +
regulator O +
NEMO B-Gene +
connects O +
IKK B-Gene +
complexes I-Gene +
with O +
IKK B-Gene +
epsilon I-Gene +
and O +
TBK1 B-Gene +
kinases B-Gene +
. O +

Canonical O +
activation O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
is O +
mediated O +
via O +
phosphorylation O +
of O +
the O +
inhibitory O +
I B-Gene +
kappa I-Gene +
B I-Gene +
proteins O +
by O +
the O +
I B-Gene +
kappa I-Gene +
B I-Gene +
kinase I-Gene +
complex I-Gene +
( O +
IKK B-Gene +
) O +
. O +

IKK B-Gene +
is O +
composed O +
of O +
a O +
heterodimer O +
of O +
the O +
catalytic O +
IKK B-Gene +
alpha I-Gene +
and O +
IKK B-Gene +
beta I-Gene +
subunits O +
and O +
a O +
presumed O +
regulatory O +
protein O +
termed O +
NEMO B-Gene +
( O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
essential I-Gene +
modulator I-Gene +
) O +
or O +
IKK B-Gene +
gamma I-Gene +
. O +

NEMO B-Gene +
/ O +
IKK B-Gene +
gamma I-Gene +
is O +
indispensable O +
for O +
activation O +
of O +
the O +
IKKs B-Gene +
in O +
response O +
to O +
many O +
signals O +
, O +
but O +
its O +
mechanism O +
of O +
action O +
remains O +
unclear O +
. O +

Here O +
we O +
identify O +
TANK B-Gene +
( O +
TRAF B-Gene +
family I-Gene +
member I-Gene +
- I-Gene +
associated I-Gene +
NF I-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activator I-Gene +
) O +
as O +
a O +
NEMO B-Gene +
/ O +
IKK B-Gene +
gamma I-Gene +
- O +
interacting O +
protein O +
via O +
yeast O +
two O +
- O +
hybrid O +
analyses O +
. O +

This O +
interaction O +
is O +
confirmed O +
in O +
mammalian O +
cells O +
, O +
and O +
the O +
domains O +
required O +
are O +
mapped O +
. O +

TANK B-Gene +
was O +
previously O +
shown O +
to O +
assist O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activation O +
in O +
a O +
complex O +
with O +
TANK B-Gene +
- I-Gene +
binding I-Gene +
kinase I-Gene +
1 I-Gene +
( O +
TBK1 B-Gene +
) O +
or O +
IKK B-Gene +
epsilon I-Gene +
, O +
two O +
kinases B-Gene +
distantly O +
related O +
to O +
IKK B-Gene +
alpha I-Gene +
/ I-Gene +
beta I-Gene +
, O +
but O +
the O +
underlying O +
mechanisms O +
remained O +
unknown O +
. O +

Here O +
we O +
show O +
that O +
TBK1 B-Gene +
and O +
IKK B-Gene +
epsilon I-Gene +
synergize O +
with O +
TANK B-Gene +
to O +
promote O +
interaction O +
with O +
the O +
IKKs B-Gene +
. O +

The O +
TANK B-Gene +
binding O +
domain O +
within O +
NEMO B-Gene +
/ O +
IKK B-Gene +
gamma I-Gene +
is O +
required O +
for O +
proper O +
functioning O +
of O +
this O +
IKK B-Gene +
subunit O +
. O +

These O +
results O +
indicate O +
that O +
TANK B-Gene +
can O +
synergize O +
with O +
IKK B-Gene +
epsilon I-Gene +
or O +
TBK1 B-Gene +
to O +
link O +
them O +
to O +
IKK B-Gene +
complexes I-Gene +
, O +
where O +
the O +
two O +
kinases B-Gene +
may O +
modulate O +
aspects O +
of O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
activation O +
. O +

Characterization O +
of O +
mammalian O +
eIF2A B-Gene +
and O +
identification O +
of O +
the O +
yeast O +
homolog O +
. O +

To O +
begin O +
the O +
physical O +
characterization O +
of O +
eukaryotic B-Gene +
initiation I-Gene +
factor I-Gene +
( I-Gene +
eIF I-Gene +
) I-Gene +
2A I-Gene +
, O +
a O +
translation B-Gene +
initiation I-Gene +
factor I-Gene +
that O +
binds O +
Met O +
- O +
tRNA O +
( O +
i O +
) O +
, O +
tryptic O +
peptides O +
from O +
rabbit O +
reticulocyte O +
eIF2A B-Gene +
were O +
analyzed O +
to O +
obtain O +
amino O +
acid O +
sequence O +
information O +
. O +

Sequences O +
for O +
8 O +
peptides O +
were O +
matched O +
to O +
three O +
different O +
expressed O +
sequence O +
tag O +
clones O +
. O +

The O +
sequence O +
predicted O +
for O +
eIF2A B-Gene +
is O +
585 O +
amino O +
acids O +
. O +

Matching O +
of O +
the O +
cDNA O +
sequence O +
to O +
the O +
human O +
genome O +
revealed O +
that O +
the O +
eIF2A B-Gene +
mRNA O +
is O +
made O +
up O +
of O +
15 O +
or O +
16 O +
exons O +
, O +
and O +
the O +
gene O +
is O +
contained O +
on O +
chromosome O +
3 O +
. O +

A O +
homolog O +
in O +
Saccharomyces O +
cerevisiae O +
was O +
identified O +
, O +
YGR054W B-Gene +
, O +
which O +
is O +
a O +
non O +
- O +
essential O +
gene O +
. O +

Hemagglutinin B-Gene +
- O +
tagged O +
yeast O +
eIF2A B-Gene +
localizes O +
on O +
both O +
40 O +
S O +
and O +
80 O +
S O +
ribosomes O +
. O +

A O +
knockout O +
of O +
both O +
eIF2A B-Gene +
and O +
eIF5B B-Gene +
yielded O +
a O +
" O +
synthetically O +
sick O +
" O +
yeast O +
strain O +
with O +
a O +
severe O +
slow O +
growth O +
phenotype O +
. O +

The O +
phenotype O +
of O +
this O +
double O +
mutant O +
and O +
the O +
biochemical O +
localization O +
suggest O +
that O +
eIF2A B-Gene +
participates O +
in O +
translation O +
initiation O +
. O +

eIF2A B-Gene +
does O +
not O +
appear O +
to O +
participate O +
in O +
re O +
- O +
initiation O +
as O +
the O +
DeltaeIF2A O +
strain O +
shows O +
the O +
same O +
level O +
of O +
GCN4 B-Gene +
induction O +
with O +
amino O +
acid O +
starvation O +
as O +
seen O +
in O +
wild O +
type O +
yeast O +
. O +

The O +
lack O +
of O +
any O +
apparent O +
phenotype O +
in O +
the O +
DeltaeIF2A O +
strain O +
suggests O +
that O +
eIF2A B-Gene +
functions O +
in O +
a O +
minor O +
pathway O +
, O +
perhaps O +
internal O +
initiation O +
or O +
in O +
the O +
translation O +
of O +
a O +
small O +
number O +
of O +
specific O +
mRNAs O +
. O +

Unconventional O +
Rac B-Gene -
- I-Gene -
GEF I-Gene +
activity O +
is O +
mediated O +
through O +
the O +
Dock180 B-Gene +
- O +
ELMO B-Gene +
complex O +
. O +

Mammalian O +
Dock180 B-Gene +
and O +
ELMO B-Gene +
proteins O +
, O +
and O +
their O +
homologues O +
in O +
Caenorhabditis O +
elegans O +
and O +
Drosophila O +
melanogaster O +
, O +
function O +
as O +
critical O +
upstream O +
regulators O +
of O +
Rac B-Gene +
during O +
development O +
and O +
cell O +
migration O +
. O +

The O +
mechanism O +
by O +
which O +
Dock180 B-Gene +
or O +
ELMO B-Gene +
mediates O +
Rac B-Gene +
activation O +
is O +
not O +
understood O +
. O +

Here O +
, O +
we O +
identify O +
a O +
domain O +
within O +
Dock180 B-Gene +
( O +
denoted O +
Docker O +
) O +
that O +
specifically O +
recognizes O +
nucleotide O +
- O +
free O +
Rac B-Gene +
and O +
can O +
mediate O +
GTP O +
loading O +
of O +
Rac B-Gene +
in O +
vitro O +
. O +

The O +
Docker O +
domain O +
is O +
conserved O +
among O +
known O +
Dock180 B-Gene +
family I-Gene +
members O +
in O +
metazoans O +
and O +
in O +
a O +
yeast O +
protein O +
. O +

In O +
cells O +
, O +
binding O +
of O +
Dock180 B-Gene +
to O +
Rac B-Gene +
alone O +
is O +
insufficient O +
for O +
GTP O +
loading O +
, O +
and O +
a O +
Dock180 B-Gene +
ELMO1 B-Gene +
interaction O +
is O +
required O +
. O +

We O +
can O +
also O +
detect O +
a O +
trimeric O +
ELMO1 B-Gene +
Dock180 B-Gene +
Rac1 B-Gene +
complex O +
and O +
ELMO B-Gene +
augments O +
the O +
interaction O +
between O +
Dock180 B-Gene +
and O +
Rac B-Gene +
. O +

We O +
propose O +
that O +
the O +
Dock180 B-Gene +
ELMO B-Gene +
complex O +
functions O +
as O +
an O +
unconventional O +
two O +
- O +
part O +
exchange B-Gene +
factor I-Gene +
for I-Gene +
Rac I-Gene +
. O +

Epidermal B-Gene +
growth I-Gene +
factor I-Gene +
and O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
alpha I-Gene +
mimic O +
the O +
effects O +
of O +
insulin B-Gene +
in O +
human O +
fat O +
cells O +
and O +
augment O +
downstream O +
signaling O +
in O +
insulin B-Gene +
resistance O +
. O +

The O +
ability O +
of O +
the O +
growth B-Gene +
factors I-Gene +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
( O +
EGF B-Gene +
) O +
, O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
alpha I-Gene +
, O +
and O +
platelet B-Gene +
- I-Gene +
derived I-Gene +
growth I-Gene +
factor I-Gene +
to O +
exert O +
insulin B-Gene +
- O +
like O +
effects O +
on O +
glucose O +
transport O +
and O +
lipolysis O +
were O +
examined O +
in O +
human O +
and O +
rat O +
fat O +
cells O +
. O +

No O +
effects O +
were O +
found O +
in O +
rat O +
fat O +
cells O +
, O +
whereas O +
EGF B-Gene +
( O +
EC O -
( O -
50 O -
) O +
for O +
glucose O +
transport O +
approximately O +
0.02 O +
nm O +
) O +
and O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
alpha I-Gene +
( O +
EC O -
( O -
50 O -
) O +
approximately O +
0.2 O +
nm O +
) O +
, O +
but O +
not O +
platelet B-Gene +
- I-Gene +
derived I-Gene +
growth I-Gene +
factor I-Gene +
, O +
mimicked O +
the O +
effects O +
of O +
insulin B-Gene +
( O +
EC O -
( O -
50 O -
) O +
approximately O +
0.2 O +
nm O +
) O +
on O +
both O +
pathways O +
. O +

EGF B-Gene +
receptors I-Gene +
, O +
but O +
not O +
EGF B-Gene +
, O +
were O +
abundantly O +
expressed O +
in O +
human O +
fat O +
cells O +
as O +
well O +
as O +
in O +
human O +
skeletal O +
muscle O +
. O +

EGF B-Gene +
increased O +
the O +
tyrosine O +
phosphorylation O +
of O +
several O +
proteins O +
( O +
the O +
EGF B-Gene +
receptor I-Gene +
, O +
insulin B-Gene +
receptor I-Gene +
substrate I-Gene +
( I-Gene +
IRS I-Gene +
) I-Gene +
- I-Gene +
1 I-Gene +
, O +
IRS-2 B-Gene +
, O +
and O +
Grb2 B-Gene +
- I-Gene +
associated I-Gene +
binder I-Gene +
1 I-Gene +
) O +
, O +
whereas O +
Shc B-Gene +
and O +
Gab2 B-Gene +
were O +
only O +
weakly O +
and O +
inconsistently O +
phosphorylated O +
. O +

p85 B-Gene +
, O +
the O +
regulatory B-Gene +
subunit I-Gene +
of I-Gene +
phosphatidylinositol I-Gene +
3-kinase I-Gene +
( O +
PI B-Gene +
3-kinase I-Gene +
) O +
, O +
was O +
also O +
found O +
to O +
associate O +
with O +
all O +
of O +
these O +
docking O +
molecules O +
, O +
showing O +
that O +
EGF B-Gene +
activated O +
PI B-Gene +
3-kinase I-Gene +
pools O +
that O +
were O +
additional O +
to O +
those O +
of O +
insulin B-Gene +
. O +

EGF B-Gene +
and/or O +
insulin B-Gene +
increased O +
protein B-Gene +
kinase I-Gene +
B I-Gene +
/ O +
Akt B-Gene +
serine O +
phosphorylation O +
to O +
a O +
similar O +
extent O +
, O +
whereas O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
phosphorylation O +
was O +
more O +
pronounced O +
for O +
EGF B-Gene +
than O +
for O +
insulin B-Gene +
. O +

The O +
impaired O +
insulin B-Gene +
- O +
stimulated O +
downstream O +
signaling O +
, O +
measured O +
as O +
protein B-Gene +
kinase I-Gene +
B I-Gene +
/ O +
Akt B-Gene +
serine O +
phosphorylation O +
, O +
in O +
insulin B-Gene +
- O +
resistant O +
cells O +
( O +
Type O +
2 O +
diabetes O +
) O +
was O +
improved O +
by O +
the O +
addition O +
of O +
EGF B-Gene +
. O +

Thus O +
, O +
EGF B-Gene +
receptors I-Gene +
, O +
but O +
not O +
EGF B-Gene +
, O +
are O +
abundantly O +
expressed O +
in O +
human O +
fat O +
cells O +
and O +
skeletal O +
muscle O +
. O +

EGF B-Gene +
mimics O +
the O +
effects O +
of O +
insulin B-Gene +
on O +
both O +
the O +
metabolic O +
and O +
mitogenic O +
pathways O +
but O +
utilize O +
in O +
part O +
different O +
signaling O +
pathways O +
. O +

Both O +
insulin B-Gene +
and O +
EGF B-Gene +
increase O +
the O +
tyrosine O +
phosphorylation O +
and O +
activation O +
of O +
IRS-1 B-Gene +
and O +
IRS-2 B-Gene +
, O +
whereas O +
EGF B-Gene +
is O +
also O +
capable O +
of O +
activating O +
additional O +
PI B-Gene +
3-kinase I-Gene +
pools O +
and O +
, O +
thus O +
, O +
can O +
augment O +
the O +
downstream O +
signaling O +
of O +
insulin B-Gene +
in O +
insulin B-Gene +
- O +
resistant O +
states O +
like O +
Type O +
2 O +
diabetes O +
. O +

Heparan B-Gene +
sulfate I-Gene +
3-O I-Gene -
- I-Gene -
sulfotransferase I-Gene +
isoform I-Gene +
5 I-Gene +
generates O +
both O +
an O +
antithrombin B-Gene +
- O +
binding O +
site O +
and O +
an O +
entry O +
receptor O +
for O +
herpes O +
simplex O +
virus O +
, O +
type O +
1 O +
. O +

Heparan B-Gene +
sulfate I-Gene +
3-O I-Gene -
- I-Gene -
sulfotransferase I-Gene +
transfers O +
sulfate O +
to O +
the O +
3-OH O +
position O +
of O +
a O +
glucosamine O +
residue O +
of O +
heparan O +
sulfate O +
( O +
HS O +
) O +
to O +
form O +
3-O O -
- O -
sulfated O +
HS O +
. O +

The O +
3-O O -
- O -
sulfated O +
glucosamine O +
residue O +
contributes O +
to O +
two O +
important O +
biological O +
functions O +
of O +
HS O +
: O +
binding O +
to O +
antithrombin B-Gene +
and O +
thereby O +
carrying O +
anticoagulant O +
activity O +
, O +
and O +
binding O +
to O +
herpes O +
simplex O +
viral O +
envelope O +
glycoprotein B-Gene +
D I-Gene +
to O +
serve O +
as O +
an O +
entry O +
receptor O +
for O +
herpes O +
simplex O +
virus O +
1 O +
. O +

A O +
total O +
of O +
five O +
HS B-Gene +
3-O I-Gene -
- I-Gene -
sulfotransferase I-Gene +
isoforms O +
were O +
reported O +
previously O +
. O +

Here O +
we O +
report O +
the O +
isolation O +
and O +
characterization O +
of O +
a O +
novel O +
HS B-Gene +
3-O I-Gene -
- I-Gene -
sulfotransferase I-Gene +
isoform O +
, O +
designated O +
as O +
HS B-Gene +
3-O I-Gene -
- I-Gene -
sulfotransferase I-Gene +
isoform I-Gene +
5 I-Gene +
( O +
3-OST-5 B-Gene +
) O +
. O +

3-OST-5 B-Gene +
cDNA O +
was O +
isolated O +
from O +
a O +
human O +
placenta O +
cDNA O +
library O +
and O +
expressed O +
in O +
COS-7 O +
cells O +
. O +

The O +
disaccharide O +
analysis O +
of O +
3-OST-5 B-Gene +
- O +
modified O +
HS O +
revealed O +
that O +
3-OST-5 B-Gene +
generated O +
at O +
least O +
three O +
3-O O -
- O -
sulfated O +
disaccharides O +
as O +
follows O +
: O +
IdoUA2S O +
- O +
AnMan3S O +
, O +
GlcUA O +
- O +
AnMan3S6S O +
, O +
and O +
IdoUA2S O +
- O +
AnMan3S6S O +
. O +

Transfection O +
of O +
the O +
plasmid O +
expressing O +
3-OST-5 B-Gene +
rendered O +
wild O +
type O +
Chinese O +
hamster O +
ovary O +
cells O +
susceptible O +
to O +
the O +
infection O +
by O +
herpes O +
simplex O +
virus O +
1 O +
, O +
suggesting O +
that O +
3-OST-5 B-Gene +
- O +
modified O +
HS O +
serves O +
as O +
an O +
entry O +
receptor O +
for O +
herpes O +
simplex O +
virus O +
1 O +
. O +

In O +
addition O +
, O +
3-OST-5 B-Gene +
- O +
modified O +
HS O +
bound O +
to O +
herpes O +
simplex O +
viral O +
envelope O +
protein O +
glycoprotein B-Gene +
D I-Gene +
. O +

Furthermore O +
, O +
we O +
found O +
that O +
3-OST-5 B-Gene +
- O +
modified O +
HS O +
also O +
bound O +
to O +
antithrombin O +
, O +
suggesting O +
that O +
3-OST-5 B-Gene +
also O +
produces O +
anticoagulant O +
HS O +
. O +

In O +
summary O +
, O +
our O +
results O +
indicate O +
that O +
a O +
new O +
member O +
of O +
3-OST B-Gene +
family I-Gene +
generates O +
both O +
anticoagulant O +
HS O +
and O +
an O +
entry O +
receptor O +
for O +
herpes O +
simplex O +
virus O +
1 O +
. O +

These O +
results O +
provide O +
a O +
new O +
insight O +
regarding O +
the O +
mechanism O +
for O +
the O +
biosynthesis O +
of O +
biologically O +
active O +
HS O +
. O +

Transcription O +
of O +
cholesterol O +
side O +
- O +
chain O +
cleavage O +
cytochrome B-Gene +
P450 I-Gene +
in O +
the O +
placenta O +
: O +
activating B-Gene +
protein-2 I-Gene +
assumes O +
the O +
role O +
of O +
steroidogenic B-Gene +
factor-1 I-Gene +
by O +
binding O +
to O +
an O +
overlapping O +
promoter O +
element O +
. O +

Progesterone O +
is O +
essential O +
to O +
the O +
sustenance O +
of O +
pregnancy O +
in O +
humans O +
and O +
other O +
mammals O +
. O +

From O +
the O +
second O +
trimester O +
on O +
, O +
the O +
human O +
placenta O +
is O +
the O +
sole O +
origin O +
of O +
de O +
novo O +
synthesized O +
steroid O +
hormones O +
. O +

In O +
mice O +
, O +
placentation O +
at O +
midgestation O +
is O +
accompanied O +
by O +
a O +
temporal O +
rise O +
of O +
steroid O +
hormone O +
synthesis O +
commencing O +
in O +
the O +
giant O +
cells O +
of O +
the O +
mouse O +
trophoblast O +
. O +

In O +
doing O +
so O +
, O +
the O +
giant O +
trophoblasts O +
, O +
as O +
any O +
other O +
steroidogenic O +
cell O +
, O +
express O +
high O +
levels O +
of O +
the O +
key O +
steroidogenic O +
enzyme O +
, O +
cholesterol B-Gene +
side I-Gene +
- I-Gene +
chain I-Gene +
cleavage I-Gene +
cytochrome I-Gene +
P450 I-Gene +
( O +
P450scc B-Gene +
) O +
. O +

Because O +
steroidogenic B-Gene +
factor I-Gene +
1 I-Gene +
( O +
SF-1 B-Gene +
) O +
, O +
the O +
transcription B-Gene +
factor I-Gene +
required O +
for O +
expression O +
of O +
P450scc B-Gene +
in O +
the O +
adrenals O +
and O +
the O +
gonads O +
, O +
is O +
not O +
expressed O +
in O +
the O +
placenta O +
, O +
we O +
hypothesized O +
that O +
placenta O +
- O +
specific O +
nuclear O +
factor O -
( O -
s O -
) O +
( O +
PNF O +
) O +
assumes O +
the O +
role O +
of O +
SF-1 B-Gene +
by O +
binding O +
to O +
the O +
same O +
promoter O +
region O +
that O +
harbors O +
the O +
SF-1 B-Gene +
recognition O +
site O +
in O +
the O +
P450scc B-Gene +
gene O +
. O +

To O +
address O +
this O +
possibility O +
, O +
we O +
used O +
SCC1 B-Gene +
, O +
a O +
well O +
conserved O +
proximal O +
region O +
in O +
the O +
P450scc B-Gene +
genes O +
( O -
-60 O +
/ O +
- O +
32 O +
in O +
the O +
rat O +
gene O +
) O +
to O +
purify O +
PNF O +
from O +
human O +
term O +
placenta O +
. O +

Sequencing O +
of O +
the O +
purified O +
PNF O +
revealed O +
that O +
it O +
is O +
the O +
alpha B-Gene +
isoform I-Gene +
of I-Gene +
the I-Gene +
human I-Gene +
activating I-Gene +
protein-2 I-Gene +
( O +
AP-2alpha B-Gene +
) O +
. O +

Specific O +
antibodies O +
tested O +
in O +
EMSA O +
confirmed O +
that O +
AP-2alpha B-Gene +
is O +
the O +
predominant O +
isoform O +
that O +
binds O +
SCC1 B-Gene +
in O +
the O +
human O +
placenta O +
, O +
whereas O +
AP-2gamma B-Gene +
is O +
the O +
only O +
mouse O +
placental O +
protein O +
that O +
binds O +
this O +
oligonucleotide O +
. O +

Functional O +
studies O +
showed O +
that O +
coexpression O +
of O +
the O +
rat O +
P450scc B-Gene +
promoter O +
( O +
- O +
378 O +
/ O +
+ O +
8 O +
CAT O +
) O +
and O +
AP-2 B-Gene +
isoforms O +
( O +
alpha O +
or O +
gamma O +
) O +
in O +
human O +
embryonic O +
kidney O +
293 O +
cells O +
results O +
in O +
a O +
marked O +
activation O +
of O +
chloramphenicol B-Gene +
acetyltransferase I-Gene +
( O +
CAT B-Gene +
) O +
transcription O +
that O +
is O +
dependent O +
on O +
an O +
intact O +
AP-2 B-Gene +
motif O +
, O +
GCCTTGAGC O +
. O +

This O +
motif O +
conforms O +
with O +
consensus O +
sequences O +
previously O +
determined O +
for O +
binding O +
of O +
the O +
AP-2 B-Gene +
alpha I-Gene +
and I-Gene +
gamma I-Gene +
isoforms O +
. O +

Mutations O +
of O +
the O +
AP-2 B-Gene +
element O +
ablated O +
binding O +
of O +
AP-2 B-Gene +
to O +
SCC1 B-Gene +
, O +
as O +
well O +
as O +
severely O +
diminished O +
the O +
promoter O +
activity O +
in O +
primary O +
mouse O +
giant O +
trophoblasts O +
and O +
human O +
choriocarcinoma O +
JAR O +
cells O +
. O +

Collectively O +
, O +
these O +
studies O +
suggest O +
that O +
expression O +
of O +
placental O +
P450scc B-Gene +
is O +
governed O +
by O +
AP-2 B-Gene +
factors O +
that O +
bind O +
to O +
a O +
cis O +
- O +
element O +
that O +
largely O +
overlaps O +
the O +
sequence O +
required O +
for O +
recognition O +
of O +
SF-1 B-Gene +
in O +
other O +
steroidogenic O +
tissues O +
. O +

Evolutionary O +
divergence O +
of O +
the O +
archaeal O +
aspartyl B-Gene +
- I-Gene +
tRNA I-Gene +
synthetases I-Gene +
into O +
discriminating O +
and O +
nondiscriminating O +
forms O +
. O +

Asparaginyl O -
- O -
tRNA O +
( O +
Asn O -
- O -
tRNA O +
) O +
is O +
generated O +
in O +
nature O +
via O +
two O +
alternate O +
routes O +
, O +
either O +
direct O +
acylation O +
of O +
tRNA O +
with O +
asparagine O +
by O +
asparaginyl B-Gene +
- I-Gene +
tRNA I-Gene +
synthetase I-Gene +
( O +
AsnRS B-Gene +
) O +
or O +
in O +
a O +
two O +
- O +
step O +
pathway O +
that O +
requires O +
misacylated O +
Asp O +
- O +
tRNA O +
( O +
Asn O +
) O +
as O +
an O +
intermediate O +
. O +

This O +
misacylated O +
aminoacyl O +
- O +
tRNA O +
is O +
formed O +
by O +
a O +
nondiscriminating O +
aspartyl B-Gene +
- I-Gene +
tRNA I-Gene +
synthetase I-Gene +
( O +
AspRS B-Gene +
) O +
, O +
an O +
enzyme O +
that O +
in O +
addition O +
to O +
forming O +
Asp O +
- O +
tRNA O +
( O +
Asp O +
) O +
also O +
misacylates O +
tRNA O +
( O +
Asn O +
) O +
. O +

In O +
contrast O +
, O +
a O +
discriminating O +
AspRS B-Gene +
can O -
not O +
acylate O +
tRNA O +
( O +
Asn O +
) O +
. O +

It O +
has O +
been O +
suggested O +
that O +
the O +
archaeal O +
AspRS B-Gene +
enzymes O +
are O +
nondiscriminating O +
, O +
whereas O +
the O +
bacterial O +
ones O +
discriminate O +
. O +

The O +
archaeal O +
and O +
bacterial O +
AspRS B-Gene +
proteins O +
are O +
indeed O +
distinct O +
in O +
sequence O +
and O +
structure O +
. O +

However O +
, O +
we O +
show O +
that O +
both O +
discriminating O +
and O +
nondiscriminating O +
forms O +
of O +
AspRS B-Gene +
exist O +
among O +
the O +
archaea O +
. O +

Using O +
unfractionated O +
methanobacterial O +
and O +
pyrococcal O +
tRNA O +
, O +
the O +
Methanothermobacter O +
thermautotrophicus O +
AspRS B-Gene +
acylated O +
approximately O +
twice O +
as O +
much O +
tRNA O +
as O +
did O +
AspRS B-Gene +
from O +
Pyrococcus O +
kodakaraensis O +
or O +
Ferroplasma O +
acidarmanus O +
. O +

Proof O +
that O +
Asp O +
- O +
tRNA O +
( O +
Asn O +
) O +
was O +
generated O +
by O +
the O +
methanogen B-Gene +
synthetase I-Gene +
was O +
the O +
conversion O +
of O +
Asp O -
- O -
tRNA O +
formed O +
by O +
M. O +
thermautotrophicus O +
AspRS B-Gene +
to O +
Asn O -
- O -
tRNA O +
by O +
M. O +
thermautotrophicus O +
Asp B-Gene +
- I-Gene +
tRNA I-Gene +
( I-Gene +
Asn I-Gene +
) I-Gene +
amidotransferase I-Gene +
. O +

In O +
contrast O +
, O +
Asp O -
- O -
tRNA O +
formed O +
by O +
the O +
Pyrococcus O +
or O +
Ferroplasma O +
enzymes O +
was O +
not O +
a O +
substrate O +
for O +
the O +
amidotransferase B-Gene +
. O +

Also O +
, O +
although O +
all O +
three O +
AspRS B-Gene +
enzymes O +
charged O +
tRNA O +
( O +
Asp O +
) O +
transcripts O +
, O +
only O +
M. O +
thermautotrophicus O +
AspRS B-Gene +
aspartylated O +
the O +
tRNA O +
( O +
Asn O +
) O +
transcript O +
. O +

Genomic O +
analysis O +
provides O +
a O +
rationale O +
for O +
the O +
nature O +
of O +
these O +
enzymes O +
. O +

The O +
mischarging O +
AspRS B-Gene +
correlates O +
with O +
the O +
absence O +
in O +
the O +
genome O +
of O +
AsnRS B-Gene +
and O +
the O +
presence O +
of O +
Asp B-Gene -
- I-Gene -
tRNA I-Gene +
( I-Gene +
Asn I-Gene +
) I-Gene +
amidotransferase I-Gene +
, O +
employed O +
by O +
the O +
transamidation O +
pathway O +
. O +

In O +
contrast O +
, O +
the O +
discriminating O +
AspRS B-Gene +
correlates O +
with O +
the O +
absence O +
of O +
the O +
amidotransferase B-Gene +
and O +
the O +
presence O +
of O +
AsnRS B-Gene +
, O +
forming O +
Asn O +
- O +
tRNA O +
by O +
direct O +
aminoacylation O +
. O +

The O +
high O +
sequence O +
identity O +
, O +
up O +
to O +
60 O +
% O +
between O +
discriminating O +
and O +
nondiscriminating O +
archaeal O +
AspRSs B-Gene +
, O +
suggests O +
that O +
few O +
mutational O +
steps O +
may O +
be O +
necessary O +
to O +
convert O +
the O +
tRNA O +
- O +
discriminating O +
ability O +
of O +
a O +
tRNA B-Gene +
synthetase I-Gene +
. O +

Tissue O +
- O +
specific O +
expression O +
of O +
AHR2 B-Gene +
, O +
ARNT2 B-Gene +
, O +
and O +
CYP1A B-Gene +
in O +
zebrafish O +
embryos O +
and O +
larvae O +
: O +
effects O +
of O +
developmental O +
stage O +
and O +
2,3,7,8-tetrachlorodibenzo O -
- O -
p O -
- O -
dioxin O +
exposure O +
. O +

To O +
better O +
understand O +
the O +
role O +
of O +
the O +
aryl B-Gene +
hydrocarbon I-Gene +
receptor I-Gene +
( O +
AHR B-Gene +
) O +
signaling O +
pathway O +
in O +
causing O +
tissue O +
- O +
specific O +
signs O +
of O +
2,3,7,8-tetrachlorodibenzo O -
- O -
p O -
- O -
dioxin O +
( O +
TCDD O +
) O +
toxicity O +
in O +
zebrafish O +
, O +
the O +
temporal O +
and O +
spatial O +
expression O +
of O +
the O +
zebrafish O +
aryl B-Gene +
hydrocarbon I-Gene +
receptor I-Gene +
2 I-Gene +
( O +
zfAHR2 B-Gene +
) O +
, O +
aryl B-Gene +
hydrocarbon I-Gene +
receptor I-Gene +
nuclear I-Gene +
translocator I-Gene +
2 I-Gene +
( O +
zfARNT2 B-Gene +
) O +
, O +
and O +
an O +
AHR B-Gene +
regulated O +
gene O +
, O +
cytochrome B-Gene +
P4501A I-Gene +
( O +
zfCYP1A B-Gene +
) O +
, O +
were O +
assessed O +
in O +
larvae O +
exposed O +
to O +
vehicle O +
or O +
TCDD O +
( O +
1.55 O +
nM O +
) O +
from O +
3 O -
- O -
4 O +
h O +
postfertilization O +
( O +
hpf O +
) O +
. O +

Coexpression O +
of O +
a O +
transcriptionally O +
active O +
AHR B-Gene +
pathway O +
was O +
apparent O +
by O +
the O +
expression O +
of O +
zfCYP1A B-Gene +
mRNA O +
and O +
protein O +
in O +
certain O +
larval O +
tissues O +
. O +

zfCYP1A B-Gene +
protein O +
was O +
first O +
detected O +
in O +
the O +
skin O +
and O +
vasculature O +
of O +
TCDD O +
- O +
exposed O +
larvae O +
at O +
36 O +
hpf O +
. O +

Vascular O +
- O +
specific O +
zfCYP1A B-Gene +
protein O +
expression O +
continued O +
from O +
36 O +
to120 O +
hpf O +
at O +
which O +
time O +
it O +
was O +
also O +
detected O +
in O +
the O +
heart O +
, O +
kidney O +
, O +
and O +
liver O +
. O +

zfCYP1A B-Gene +
mRNA O +
was O +
observed O +
in O +
TCDD O +
treated O +
larvae O +
as O +
early O +
as O +
24 O +
hpf O +
in O +
the O +
developing O +
vascular O +
system O +
. O +

Vascular O +
specific O +
zfCYP1A B-Gene +
mRNA O +
expression O +
in O +
the O +
head O +
, O +
trunk O +
, O +
and O +
tail O +
by O +
36 O +
hpf O +
in O +
TCDD O +
- O +
exposed O +
larvae O +
, O +
confirmed O +
immunohistochemical O +
localization O +
. O +

The O +
expression O +
of O +
zfAHR2 B-Gene +
and O +
zfARNT2 B-Gene +
mRNAs O +
was O +
generally O +
similar O +
in O +
control O +
and O +
TCDD O +
- O +
exposed O +
larvae O +
. O +

Coexpression O +
of O +
zfAHR2 B-Gene +
, O +
zfARNT2 B-Gene +
, O +
and O +
zfCYP1A B-Gene +
mRNAs O +
was O +
evident O +
in O +
TCDD O +
- O +
exposed O +
larvae O +
by O +
36 O +
hpf O +
and O +
in O +
the O +
vasculature O +
, O +
heart O +
, O +
and O +
trunk O +
kidney O +
by O +
48 O +
hpf O +
, O +
well O +
before O +
the O +
first O +
signs O +
of O +
overt O +
developmental O +
toxicity O +
are O +
observed O +
. O +

In O +
addition O +
to O +
their O +
function O +
in O +
response O +
to O +
AHR B-Gene +
agonists O +
, O +
zfAHR2 B-Gene +
and O +
zfARNT2 B-Gene +
may O +
be O +
involved O +
in O +
development O +
and O +
function O +
of O +
the O +
nervous O +
system O +
. O +

zfAHR2 B-Gene +
and O +
zfARNT2 B-Gene +
were O +
detected O +
in O +
the O +
brain O +
, O +
spinal O +
cord O +
, O +
and O +
sensory O +
organs O +
. O +

However O +
, O +
TCDD O +
- O +
induced O +
zfCYP1A B-Gene +
expression O +
was O +
not O +
detected O +
in O +
these O +
tissues O +
. O +

Taken O +
together O +
, O +
these O +
results O +
are O +
consistent O +
with O +
the O +
notion O +
that O +
the O +
cardiovascular O +
system O +
is O +
a O +
primary O +
target O +
of O +
TCDD O +
developmental O +
toxicity O +
in O +
zebrafish O +
. O +

Regulation O +
of O +
the O +
CDK B-Gene +
- O +
related O +
protein B-Gene +
kinase I-Gene +
PCTAIRE-1 B-Gene +
and O +
its O +
possible O +
role O +
in O +
neurite O +
outgrowth O +
in O +
Neuro-2A O +
cells O +
. O +

PCTAIRE-1 B-Gene +
is O +
a O +
CDK B-Gene +
- O +
related O +
protein B-Gene +
kinase I-Gene +
found O +
in O +
terminally O +
differentiated O +
cells O +
in O +
brain O +
and O +
testis O +
, O +
and O +
in O +
many O +
immortalised O +
and O +
transformed O +
cell O +
lines O +
. O +

Bacterially O +
expressed O +
PCTAIRE B-Gene +
is O +
completely O +
inactive O +
as O +
a O +
protein B-Gene +
kinase I-Gene +
, O +
but O +
is O +
a O +
very O +
good O +
substrate O +
for O +
protein B-Gene +
kinase I-Gene +
A I-Gene +
( O +
PKA B-Gene +
) O +
, O +
which O +
phosphorylates O +
a O +
total O +
of O +
four O +
sites O +
in O +
the O +
N O -
- O -
terminus O +
of O +
PCTAIRE-1 B-Gene +
. O +

Phosphorylation O +
of O +
one O +
of O +
these O +
sites O +
, O +
Ser119 O +
, O +
generates O +
a O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
binding O +
site O +
, O +
which O +
is O +
functional O +
in O +
vitro O +
as O +
well O +
as O +
in O +
vivo O +
. O +

Mutation O +
of O +
another O +
PKA B-Gene +
site O +
, O +
Ser153 O +
, O +
to O +
an O +
alanine O +
residue O +
generated O +
an O +
activated O +
kinase B-Gene +
in O +
transfected O +
mammalian O +
cells O +
. O +

This O +
activity O +
was O +
comparable O +
to O +
that O +
of O +
CDK5 B-Gene +
activated O +
by O +
a O +
bacterially O +
expressed O +
, O +
truncated O +
version O +
of O +
p35 B-Gene +
( O +
nck B-Gene +
) O +
, O +
p21 O +
. O +

Gel O +
filtration O +
analysis O +
of O +
a O +
brain O +
extract O +
suggested O +
that O +
monomeric O +
PCTAIRE-1 B-Gene +
was O +
the O +
active O +
species O +
, O +
implying O +
that O +
PCTAIRE-1 B-Gene +
may O +
not O +
be O +
a O +
true O +
CDK B-Gene +
, O +
in O +
that O +
it O +
does O +
not O +
require O +
a O +
partner O +
( O +
cyclin B-Gene +
- O +
like O +
) O +
subunit O +
for O +
kinase B-Gene +
activity O +
. O +

Finally O +
, O +
we O +
found O +
that O +
various O +
forms O +
of O +
PCTAIRE-1 B-Gene +
transfected O +
into O +
neuroblastoma O +
cell O +
lines O +
could O +
either O +
promote O +
or O +
inhibit O +
neurite O +
outgrowth O +
, O +
suggesting O +
a O +
potential O +
role O +
for O +
the O +
PCTAIRE-1 B-Gene +
gene O +
product O +
in O +
the O +
control O +
of O +
neurite O +
outgrowth O +
. O +

RNAi O +
is O +
activated O +
during O +
Drosophila O +
oocyte O +
maturation O +
in O +
a O +
manner O +
dependent O +
on O +
aubergine B-Gene +
and O +
spindle B-Gene +
- I-Gene +
E I-Gene +
. O +

Gene O +
silencing O +
by O +
double O +
- O +
stranded O +
RNA O +
is O +
a O +
widespread O +
phenomenon O +
called O +
RNAi O +
, O +
involving O +
homology O +
- O +
dependent O +
degradation O +
of O +
mRNAs O +
. O +

Here O +
we O +
show O +
that O +
RNAi O +
is O +
established O +
in O +
the O +
Drosophila O +
female O +
germ O +
line O +
. O +

mRNA O +
transcripts O +
are O +
translationally O +
quiescent O +
at O +
the O +
arrested O +
oocyte O +
stage O +
and O +
are O +
insensitive O +
to O +
RNAi O +
. O +

Upon O +
oocyte O +
maturation O +
, O +
transcripts O +
that O +
are O +
translated O +
become O +
sensitive O +
to O +
degradation O +
while O +
untranslated O +
transcripts O +
remain O +
resistant O +
. O +

Mutations O +
in O +
aubergine B-Gene +
and O +
spindle B-Gene -
- I-Gene -
E I-Gene +
, O +
members O +
of O +
the O +
PIWI B-Gene +
/ I-Gene +
PAZ I-Gene +
and I-Gene +
DE I-Gene -
- I-Gene -
H I-Gene +
helicase I-Gene +
gene I-Gene +
families I-Gene +
, O +
respectively O +
, O +
block O +
RNAi O +
activation O +
during O +
egg O +
maturation O +
and O +
perturb O +
translation O +
control O +
during O +
oogenesis O +
, O +
supporting O +
a O +
connection O +
between O +
gene O +
silencing O +
and O +
translation O +
in O +
the O +
oocyte O +
. O +

Regulation O +
of O +
the O +
interleukin-1 B-Gene +
receptor I-Gene +
antagonist I-Gene +
in O +
THP-1 O +
cells O +
by O +
ligands O +
of O +
the O +
peroxisome B-Gene +
proliferator I-Gene +
- I-Gene +
activated I-Gene +
receptor I-Gene +
gamma I-Gene +
. O +

Monocytes O +
/ O +
macrophages O +
( O +
Mphi O +
) O +
play O +
a O +
pivotal O +
role O +
in O +
the O +
persistence O +
of O +
chronic O +
inflammation O +
and O +
local O +
tissue O +
destruction O +
in O +
diseases O +
such O +
as O +
rheumatoid O +
arthritis O +
and O +
atherosclerosis O +
. O +

The O +
production O +
by O +
Mphi O +
of O +
cytokines B-Gene +
, O +
chemokines B-Gene +
, O +
metalloproteinases B-Gene +
and O +
their O +
inhibitors O +
is O +
an O +
essential O +
component O +
in O +
this O +
process O +
, O +
which O +
is O +
tightly O +
regulated O +
by O +
multiple O +
factors O +
. O +

The O +
peroxisome B-Gene +
proliferator I-Gene +
- I-Gene +
activated I-Gene +
receptors I-Gene +
( O +
PPARs B-Gene +
) O +
were O +
shown O +
to O +
be O +
involved O +
in O +
modulating O +
inflammation O +
. O +

PPARgamma B-Gene +
is O +
activated O +
by O +
a O +
wide O +
variety O +
of O +
ligands O +
such O +
as O +
fatty O +
acids O +
, O +
the O +
anti O +
- O +
diabetic O +
thiazolidinediones O +
( O +
TZDs O +
) O +
, O +
and O +
also O +
by O +
certain O +
prostaglandins O +
of O +
which O +
15-deoxy O -
- O -
Delta O -
( O -
12,14 O -
) O -
-PGJ2 O +
( O +
PGJ2 O +
) O +
. O +

High O +
concentrations O +
of O +
PPARgamma B-Gene +
ligands O +
were O +
shown O +
to O +
have O +
anti O +
- O +
inflammatory O +
activities O +
by O +
inhibiting O +
the O +
secretion O +
of O +
interleukin-1 B-Gene +
( O +
IL-1 B-Gene +
) O +
, O +
interleukin-6 B-Gene +
( O +
IL-6 B-Gene +
) O +
and O +
tumour B-Gene +
necrosis I-Gene +
factor I-Gene +
alpha I-Gene +
( O +
TNFalpha B-Gene +
) O +
by O +
stimulated O +
monocytes O -
. O -
The O +
aim O +
of O +
this O +
study O +
was O +
to O +
determine O +
whether O +
PGJ2 O +
and O +
TZDs O +
would O +
also O +
exert O +
an O +
immunomodulatory O +
action O +
through O +
the O +
up O +
- O +
regulation O +
of O +
anti O +
- O +
inflammatory O +
cytokines B-Gene +
such O +
as O +
the O +
IL-1 B-Gene +
receptor I-Gene +
antagonist I-Gene +
( O +
IL-1Ra B-Gene +
) O +
. O +

THP-1 O +
monocytic O +
cells O +
were O +
stimulated O +
with O +
PMA O +
, O +
thereby O +
enhancing O +
the O +
secretion O +
of O +
IL-1 B-Gene +
, O +
IL-6 B-Gene +
, O +
TNFalpha B-Gene +
, O +
IL-1Ra B-Gene +
and O +
metalloproteinases B-Gene +
. O +

Addition O +
of O +
PGJ2 O +
had O +
an O +
inhibitory O +
effect O +
on O +
IL-1 B-Gene +
, O +
IL-6 B-Gene +
and O +
TNFalpha B-Gene +
secretion O +
, O +
while O +
increasing O +
IL-1Ra B-Gene +
production O +
. O +

In O +
contrast O +
, O +
the O +
bona O +
fide O +
PPARgamma B-Gene +
ligands O +
( O +
TZDs O +
; O +
rosiglitazone O +
, O +
pioglitazone O +
and O +
troglitazone O +
) O +
barely O +
inhibited O +
proinflammatory O +
cytokines B-Gene +
, O +
but O +
strongly O +
enhanced O +
the O +
production O +
of O +
IL-1Ra B-Gene +
from O +
PMA O +
- O +
stimulated O +
THP-1 O +
cells O +
. O +

Unstimulated O +
cells O +
did O +
not O +
respond O +
to O +
TZDs O +
in O +
terms O +
of O +
IL-1Ra B-Gene +
production O +
, O +
suggesting O +
that O +
in O +
order O +
to O +
be O +
effective O +
, O +
PPAR B-Gene +
ligands O +
depend O +
on O +
PMA O +
signalling O +
. O +

Basal O +
levels O +
of O +
PPARgamma B-Gene +
are O +
barely O +
detectable O +
in O +
unstimulated O +
THP-1 O +
cells O +
, O +
while O +
stimulation O +
with O +
PMA O +
up O +
- O +
regulates O +
its O +
expression O +
, O +
suggesting O +
that O +
higher O +
levels O +
of O +
PPARgamma B-Gene +
expression O +
are O +
necessary O +
for O +
receptor O +
ligand O +
effects O +
to O +
occur O +
. O +

In O +
conclusion O +
, O +
we O +
demonstrate O +
for O +
the O +
first O +
time O +
that O +
TZDs O +
may O +
exert O +
an O +
anti O +
- O +
inflammatory O +
activity O +
by O +
inducing O +
the O +
production O +
of O +
the O +
IL-1Ra B-Gene +
. O +

Retinoscleral O +
control O +
of O +
scleral O +
remodelling O +
in O +
refractive O +
development O +
: O +
a O +
role O +
for O +
endogenous O +
FGF-2 B-Gene +
? O +

AIMS O +
: O +

Studies O +
in O +
avian O +
models O +
of O +
myopia O +
have O +
shown O +
that O +
refractive O +
error O +
development O +
can O +
be O +
influenced O +
by O +
exogenously O +
delivered O +
fibroblast B-Gene +
growth I-Gene +
factor I-Gene +
( I-Gene +
FGF I-Gene +
) I-Gene +
- I-Gene +
2 I-Gene +
. O +

The O +
present O +
study O +
sought O +
to O +
determine O +
whether O +
endogenous O +
FGF-2 B-Gene +
was O +
associated O +
with O +
retinoscleral O +
signalling O +
or O +
scleral O +
remodelling O +
during O +
changes O +
in O +
refractive O +
error O +
in O +
a O +
mammalian O +
model O +
of O +
myopia O +
. O +

METHODS O +
: O +

Myopia O +
was O +
induced O +
in O +
tree O +
shrews O +
over O +
a O +
5 O +
- O +
day O +
period O +
. O +

One O +
group O +
of O +
animals O +
was O +
then O +
allowed O +
3 O +
days O +
of O +
recovery O +
from O +
the O +
induced O +
myopia O +
. O +

Endogenous O +
levels O +
of O +
FGF-2 B-Gene +
were O +
measured O +
in O +
scleral O +
and O +
retinal O +
homogenates O +
using O +
ELISA O +
. O +

Real O +
- O +
time O +
PCR O +
was O +
used O +
to O +
investigate O +
scleral O +
FGF-2 B-Gene +
and O +
FGF B-Gene +
receptor I-Gene +
( I-Gene +
FGFR I-Gene +
) I-Gene +
- I-Gene +
1 I-Gene +
mRNA O +
expression O +
. O +

RESULTS O +
: O +

No O +
difference O +
in O +
FGF-2 B-Gene +
content O +
was O +
found O +
in O +
posterior O +
scleral O +
or O +
retinal O +
extracts O +
of O +
myopic O +
eyes O +
( O +
scleral O +
-4+ O -
/ O -
- O +
9 O +
% O +
, O +
retinal O +
+ O +
23 O +
+ O -
/-17 O -
% O -
) O +
or O +
recovering O +
eyes O +
( O +
scleral O +
- O +
10+ O -
/ O -
- O +
18 O +
% O +
, O +
retinal O +
+ O -
1 O -
+ O +
/ O +
- O +
13 O +
% O +
) O +
, O +
when O +
compared O +
with O +
contralateral O +
control O +
eyes O +
. O +

In O +
addition O +
, O +
no O +
significant O +
changes O +
were O +
found O +
in O +
scleral O +
FGF-2 B-Gene +
mRNA O +
expression O +
in O +
myopic O +
or O +
recovering O +
eyes O +
( O -
+ O -
106+ O -
/ O -
- O +
56 O +
% O +
and O +
+ O +
14 O +
+ O -
/- O +
12 O +
% O +
respectively O +
, O +
P O +
= O +
0.21 O +
) O +
. O +

However O +
, O +
FGF-2 B-Gene +
concentration O +
was O +
significantly O +
higher O +
in O +
anterior O +
, O +
relative O +
to O +
posterior O +
, O +
scleral O +
regions O +
in O +
all O +
animals O +
( O +
1602 O +
+ O -
/- O +
105 O +
vs O +
1030 O +
+ O -
/-50pg O -
/ O -
mg O +
respectively O +
P O +
< O +
0.001 O +
) O +
. O +

Expression O +
of O +
scleral O +
FGFR-1 B-Gene +
mRNA O +
was O +
upregulated O +
in O +
myopic O +
eyes O +
( O -
+ O -
186+ O -
/ O -
- O +
32 O +
% O +
, O +
P O +
= O +
0.01 O +
) O +
but O +
returned O +
to O +
control O +
eye O +
levels O +
during O +
recovery O +
( O -
+ O -
63+ O -
/ O -
-20 O -
% O -
) O +
. O +

CONCLUSIONS O +
: O +

The O +
findings O +
indicate O +
that O +
alterations O +
in O +
endogenous O +
retinal O +
or O +
scleral O +
FGF-2 B-Gene +
levels O +
are O +
not O +
associated O +
with O +
changes O +
in O +
scleral O +
remodelling O +
in O +
this O +
mammalian O +
model O +
of O +
myopia O +
. O +

However O +
, O +
the O +
reversible O +
changes O +
found O +
in O +
FGFR-1 B-Gene +
expression O +
in O +
the O +
sclera O +
of O +
myopic O +
eyes O +
mean O +
that O +
an O +
indirect O +
role O +
for O +
FGF-2 B-Gene +
in O +
the O +
control O +
of O +
scleral O +
remodelling O +
is O +
implicated O +
. O +

The O +
anteroposterior O +
difference O +
found O +
in O +
scleral O +
FGF-2 B-Gene +
concentration O +
indicates O +
a O +
role O +
for O +
this O +
cytokine B-Gene +
in O +
the O +
control O +
of O +
normal O +
scleral O +
growth O +
and O +
development O +
and O +
, O +
presumably O +
, O +
eye O +
size O +
. O +

Paylean O +
alters O +
myosin B-Gene +
heavy I-Gene +
chain I-Gene +
isoform O +
content O +
in O +
pig O +
muscle O +
. O +

Feeding O +
beta O -
- O -
adrenergic O +
agonists O +
promotes O +
muscle O +
growth O +
. O +

Early O +
histological O +
techniques O +
failed O +
to O +
show O +
precisely O +
how O +
feeding O +
ractopamine O +
- O +
HCl O +
( O +
Paylean O +
) O +
alters O +
muscle O +
growth O +
in O +
pigs O +
. O +

To O +
understand O +
these O +
effects O +
, O +
an O +
indirect O +
enzyme O +
- O +
linked O +
immunosorbent O +
assay O +
( O +
ELISA O +
) O +
was O +
used O +
to O +
determine O +
the O +
abundance O +
of O +
each O +
adult O +
skeletal O +
muscle O +
myosin B-Gene +
heavy I-Gene +
chain I-Gene +
isoform O +
, O +
one O +
means O +
of O +
assigning O +
muscle O +
fiber O +
type O +
, O +
in O +
fast O +
and O +
slow O +
muscles O +
of O +
pigs O +
fed O +
Paylean O +
. O +

Sixty O +
growing O +
pigs O +
( O +
- O +
85 O +
kg O +
) O +
were O +
randomly O +
assigned O +
to O +
three O +
Paylean O +
doses O +
( O +
0 O +
, O +
20 O +
, O +
or O +
60 O +
ppm O +
) O +
. O +

At O +
3 O +
, O +
7 O +
, O +
14 O +
, O +
28 O +
, O +
and O +
42 O +
d O +
of O +
treatment O +
, O +
four O +
pigs O +
per O +
dose O +
were O +
harvested O +
and O +
white O +
( O +
WST O +
) O +
and O +
red O +
( O +
RST O +
) O +
semitendinosus O +
and O +
longissimus O +
( O +
LM O +
) O +
muscles O +
were O +
removed O +
and O +
processed O +
, O +
and O +
myosin B-Gene +
heavy I-Gene +
chain I-Gene +
was O +
quantified O +
by O +
ELISA O +
. O +

Feeding O +
Paylean O +
enhanced O +
( O +
P O +
< O +
0.05 O +
) O +
pigs O +
' O +
average O +
daily O +
gain O +
. O +

Muscle O +
myosin B-Gene +
heavy I-Gene +
chain I-Gene +
( O +
slow O +
, O +
2A O +
, O +
2AX O +
, O +
and O +
2B O +
) O +
composition O +
differed O +
( O +
P O +
< O +
0.05 O +
) O +
across O +
muscles O +
. O +

Compared O +
with O +
LM O +
, O +
RST O +
contained O +
approximately O +
five O +
times O +
more O +
( O +
P O +
< O +
0.0001 O +
) O +
slow O +
and O +
type O +
2A B-Gene +
myosin I-Gene +
heavy I-Gene +
chain I-Gene +
and O +
three O +
times O +
more O +
2AX B-Gene +
myosin I-Gene +
heavy I-Gene +
chain I-Gene +
but O +
nearly O +
undetectable O +
amounts O +
of O +
2B B-Gene +
myosin I-Gene +
heavy I-Gene +
chain I-Gene +
. O +

Myosin B-Gene +
heavy I-Gene +
chain I-Gene +
composition O +
of O +
the O +
WST O +
closely O +
resembled O +
that O +
of O +
the O +
LM O +
( O +
i.e. O +
, O +
greater O +
2AX O +
and O +
2B O +
and O +
less O +
slow O +
and O +
2A O +
) O +
. O +

After O +
42d O +
of O +
60 O +
ppm O +
Paylean O +
, O +
the O +
amount O +
of O +
slow O +
, O +
2A B-Gene +
, I-Gene +
and I-Gene +
2AX I-Gene +
myosin I-Gene +
heavy I-Gene +
chain I-Gene +
decreased O +
( O +
P O +
< O +
0.05 O +
) O +
across O +
the O +
three O +
muscles O +
whereas O +
the O +
amount O +
of O +
2B B-Gene +
myosin I-Gene +
heavy I-Gene +
chain I-Gene +
increased O +
( O +
P O +
< O +
0.05 O +
) O +
. O +

In O +
contrast O +
, O +
relative O +
amounts O +
of O +
2A B-Gene +
and I-Gene +
2AX I-Gene +
myosin I-Gene +
heavy I-Gene +
chain I-Gene +
increased O +
( O +
P O +
< O +
0.05 O +
) O +
in O +
muscle O +
of O +
control O +
pigs O +
at O +
42d O +
. O +

Changes O +
associated O +
with O +
the O +
20-ppm O +
dose O +
were O +
intermediate O +
to O +
and O +
different O +
from O +
( O +
P O +
< O +
0.05 O +
) O +
control O +
and O +
60 O +
ppm O +
treatments O +
. O +

Correlations O +
( O +
P O +
< O +
0.05 O +
) O +
among O +
various O +
myosin B-Gene +
heavy I-Gene +
chain I-Gene +
within O +
muscles O +
suggest O +
that O +
slow O +
, O +
type O +
2A O +
, O +
and O +
2X O +
decrease O +
with O +
increases O +
in O +
2B B-Gene +
myosin I-Gene +
heavy I-Gene +
chain I-Gene +
. O +

These O +
data O +
show O +
that O +
administration O +
of O +
Paylean O +
affects O +
myosin B-Gene +
heavy I-Gene +
chain I-Gene +
isoform O +
composition O +
in O +
a O +
time O +
- O +
and O +
dose O +
- O +
dependent O +
manner O +
and O +
provides O +
a O +
mechanism O +
of O +
action O +
for O +
Paylean O +
altering O +
animal O +
growth O +
. O +

Identification O +
and O +
expression O +
analysis O +
of O +
the O +
human O +
mu B-Gene +
- I-Gene +
protocadherin I-Gene +
gene O +
in O +
fetal O +
and O +
adult O +
kidneys O +
. O +

We O +
recently O +
cloned O +
mu B-Gene -
- I-Gene -
protocadherin I-Gene +
, O +
a O +
developmentally O +
regulated O +
cell O +
adhesion O +
molecule O +
that O +
contains O +
an O +
extracellular O +
region O +
with O +
four O +
cadherin B-Gene +
- O +
like O +
ectodomains O +
and O +
a O +
triply O +
repeating O +
mucin B-Gene +
domain O +
in O +
its O +
longer O +
isoform O +
. O +

Expression O +
of O +
mu B-Gene +
- I-Gene +
protocadherin I-Gene +
in O +
L929 O +
cells O +
resulted O +
in O +
cellular O +
aggregation O +
, O +
confirming O +
its O +
role O +
in O +
intercellular O +
adhesion O +
. O +

We O +
now O +
identify O +
the O +
human O +
mu B-Gene +
- I-Gene +
protocadherin I-Gene +
ortholog O +
and O +
study O +
its O +
distribution O +
in O +
vivo O +
and O +
its O +
targeting O +
in O +
polarized O +
epithelia O +
. O +

Basic O +
Local O +
Alignment O +
Search O +
Tool O +
searches O +
and O +
fluorescent O +
in O +
situ O +
hybridization O +
analysis O +
on O +
the O +
basis O +
of O +
human O +
- O +
mouse O +
synteny O +
reveal O +
that O +
mu B-Gene +
- I-Gene +
protocadherin I-Gene +
maps O +
to O +
11p15.5 O +
, O +
matching O +
a O +
previously O +
identified O +
gene O +
called O +
MUCDHL B-Gene +
. O +

At O +
least O +
three O +
different O +
splicing O +
isoforms O +
exist O +
for O +
MUCDHL B-Gene +
that O +
vary O +
in O +
expression O +
in O +
the O +
fetal O +
kidney O +
. O +

Mu B-Gene +
- I-Gene +
protocadherin I-Gene +
is O +
apically O +
expressed O +
along O +
the O +
brush O +
border O +
of O +
the O +
proximal O +
convoluted O +
tubule O +
of O +
the O +
adult O +
kidney O +
. O +

Transfection O +
of O +
truncated O +
forms O +
of O +
mu B-Gene +
- I-Gene +
protocadherin I-Gene +
into O +
polarized O +
Madin O +
- O +
Darby O +
canine O +
kidney O +
cells O +
reveals O +
that O +
the O +
NH O -
( O -
2 O -
) O +
terminus O +
is O +
essential O +
for O +
targeting O +
to O +
the O +
apical O +
surface O +
. O +

These O +
results O +
suggest O +
that O +
although O +
human O +
mu B-Gene +
- I-Gene +
protocadherin I-Gene +
may O +
mediate O +
a O +
homotypic O +
adhesive O +
interaction O +
, O +
it O +
may O +
have O +
additional O +
functions O +
in O +
terminally O +
differentiated O +
epithelia O +
. O +

Reelin B-Gene +
and O +
ApoE B-Gene +
receptors I-Gene +
cooperate O +
to O +
enhance O +
hippocampal O +
synaptic O +
plasticity O +
and O +
learning O +
. O +

Two O +
apolipoprotein B-Gene +
E I-Gene +
( I-Gene +
apoE I-Gene +
) I-Gene +
receptors I-Gene +
, O +
the O +
very B-Gene +
low I-Gene +
density I-Gene +
lipoprotein I-Gene +
( I-Gene +
VLDL I-Gene +
) I-Gene +
receptor I-Gene +
and O +
apoE B-Gene +
receptor I-Gene +
2 I-Gene +
( O +
apoER2 B-Gene +
) O +
, O +
are O +
also O +
receptors O +
for O +
Reelin B-Gene +
, O +
a O +
signaling O +
protein O +
that O +
regulates O +
neuronal O +
migration O +
during O +
brain O +
development O +
. O +

In O +
the O +
adult O +
brain O +
, O +
Reelin B-Gene +
is O +
expressed O +
by O +
GABA O +
- O +
ergic O +
interneurons O +
, O +
suggesting O +
a O +
potential O +
function O +
as O +
a O +
modulator O +
of O +
neurotransmission O +
. O +

ApoE B-Gene +
receptors I-Gene +
have O +
been O +
indirectly O +
implicated O +
in O +
memory O +
and O +
neurodegenerative O +
disorders O +
because O +
their O +
ligand O +
, O +
apoE B-Gene +
, O +
is O +
genetically O +
associated O +
with O +
Alzheimer O +
disease O +
. O +

We O +
have O +
used O +
knockout O +
mice O +
to O +
investigate O +
the O +
role O +
of O +
Reelin B-Gene +
and O +
its O +
receptors O +
in O +
cognition O +
and O +
synaptic O +
plasticity O +
. O +

Mice O +
lacking O +
either O +
the O +
VLDL B-Gene +
receptor I-Gene +
or O +
the O +
apoER2 B-Gene +
show O +
contextual O +
fear O +
conditioning O +
deficits O +
. O +

VLDL B-Gene +
receptor I-Gene +
- O +
deficient O +
mice O +
also O +
have O +
a O +
moderate O +
defect O +
in O +
long O +
term O +
potentiation O +
( O +
LTP O +
) O +
, O +
and O +
apoER2 B-Gene +
knockouts O +
have O +
a O +
pronounced O +
one O +
. O +

The O +
perfusion O +
of O +
mouse O +
hippocampal O +
slices O +
with O +
Reelin B-Gene +
has O +
no O +
effect O +
on O +
baseline O +
synaptic O +
transmission O +
but O +
significantly O +
enhances O +
LTP O +
in O +
area O +
CA1 O +
. O +

This O +
Reelin B-Gene +
- O +
dependent O +
augmentation O +
of O +
LTP O +
is O +
abolished O +
in O +
VLDL B-Gene +
receptor I-Gene +
and O +
apoER2 B-Gene +
knockout O +
mice O +
. O +

Our O +
results O +
reveal O +
a O +
role O +
for O +
Reelin B-Gene +
in O +
controlling O +
synaptic O +
plasticity O +
in O +
the O +
adult O +
brain O +
and O +
suggest O +
that O +
both O +
of O +
its O +
receptors O +
are O +
necessary O +
for O +
Reelin B-Gene +
- O +
dependent O +
enhancement O +
of O +
synaptic O +
transmission O +
in O +
the O +
hippocampus O +
. O +

Thus O +
, O +
the O +
impairment O +
of O +
apoE B-Gene +
receptor I-Gene +
- O +
dependent O +
neuromodulation O +
may O +
contribute O +
to O +
cognitive O +
impairment O +
and O +
synaptic O +
loss O +
in O +
Alzheimer O +
disease O +
. O +

Transcription B-Gene +
factor I-Gene +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
( O +
C B-Gene +
/ I-Gene +
EBPbeta I-Gene +
) O +
activates O +
the O +
expression O +
of O +
the O +
mouse O +
MHC B-Gene +
class I-Gene +
I I-Gene +
H2-Kb B-Gene +
gene O +
in O +
response O +
to O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
via O +
the O +
intragenic O +
downstream O +
regulatory O +
element O +
. O +

The O +
5'-enhancer O +
- O +
deleted O +
genomic O +
construct O +
of O +
the O +
H2-K B-Gene -
( I-Gene -
b I-Gene -
) I-Gene +
gene O +
, O +
stably O +
integrated O +
into O +
the O +
genome O +
of O +
L O -
( O -
tk- O -
) O +
fibroblasts O +
, O +
retains O +
full O +
competence O +
to O +
be O +
induced O +
by O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
( O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
) O +
treatment O +
. O +

The O +
only O +
defined O +
regulatory O +
region O +
in O +
this O +
construct O +
is O +
the O +
intragenic O +
downstream O +
regulatory O +
element O +
( O +
H2DRE O +
) O +
. O +

Computational O +
inspection O +
uncovered O +
two O +
potential O +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
( O +
C B-Gene +
/ I-Gene +
EBPbeta I-Gene +
) O +
binding O +
motifs O +
within O +
the O +
H2DRE O +
. O +

Chloramphenicol B-Gene +
acetyltransferase I-Gene +
( O +
CAT B-Gene +
) O +
reporter O +
gene O +
assay O +
revealed O +
that O +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
is O +
able O +
to O +
elevate O +
transcription O +
from O +
H2DRE O +
. O +

Moreover O +
, O +
transient O +
transfection O +
of O +
an O +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
expression O +
vector O +
increased O +
both O +
constitutive O +
and O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
- O +
induced O +
mRNA O +
levels O +
of O +
endogenous O +
H2 B-Gene +
class I-Gene +
I I-Gene +
genes O +
, O +
and O +
transfection O +
of O +
an O +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
dominant O +
negative O +
construct O +
decreased O +
the O +
expression O +
of O +
endogenous O +
H2 B-Gene +
class I-Gene +
I I-Gene +
genes O +
in O +
a O +
dose O +
- O +
dependent O +
manner O +
. O +

Using O +
the O +
electrophoretic O +
mobility O +
shift O +
assay O +
( O +
EMSA O +
) O +
and O +
antibody O +
supershift O +
assay O +
, O +
we O +
were O +
able O +
to O +
qualify O +
the O +
two O +
computationally O +
identified O +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
binding O +
motifs O +
as O +
one O +
high O +
- O +
affinity O +
and O +
one O +
low O +
- O +
affinity O +
binding O +
site O +
. O +

We O +
conclude O +
that O +
the O +
H2-K B-Gene -
( I-Gene -
b I-Gene -
) I-Gene +
gene O +
belongs O +
to O +
target O +
genes O +
of O +
the O +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
( O +
C B-Gene +
/ I-Gene +
EBPbeta I-Gene +
) O +
in O +
the O +
course O +
of O +
the O +
cellular O +
response O +
to O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
, O +
and O +
we O +
discuss O +
some O +
consequences O +
of O +
this O +
conclusion O +
in O +
a O +
general O +
framework O +
of O +
inducible O +
expression O +
of O +
the O +
H2-K B-Gene -
( I-Gene -
b I-Gene -
) I-Gene +
gene O +
. O +

The O +
beta O -
- O -
barrel O +
finder O +
( O +
BBF O +
) O +
program O +
, O +
allowing O +
identification O +
of O +
outer O +
membrane O +
beta O -
- O -
barrel O +
proteins O +
encoded O +
within O +
prokaryotic O +
genomes O +
. O +

Many O +
outer O +
membrane O +
proteins O +
( O +
OMPs O +
) O +
in O +
Gram O +
- O +
negative O +
bacteria O +
possess O +
known O +
beta O -
- O -
barrel O +
three O +
- O +
dimensional O +
( O +
3D O +
) O +
structures O +
. O +

These O +
proteins O +
, O +
including O +
channel O +
- O +
forming O +
transmembrane O +
porins B-Gene +
, O +
are O +
diverse O +
in O +
sequence O +
but O +
exhibit O +
common O +
structural O +
features O +
. O +

We O +
here O +
report O +
computational O +
analyses O +
of O +
six O +
outer O +
membrane O +
proteins O +
of O +
known O +
3D O +
structures O +
with O +
respect O +
to O +
( O -
1 O -
) O +
secondary O +
structure O +
, O +
( O +
2 O +
) O +
hydropathy O +
, O +
and O +
( O +
3 O +
) O +
amphipathicity O +
. O +

Using O +
these O +
characteristics O +
, O +
as O +
well O +
as O +
the O +
presence O +
of O +
an O +
N O +
- O +
terminal O +
targeting O +
sequence O +
, O +
a O +
program O +
was O +
developed O +
allowing O +
prediction O +
of O +
integral O +
membrane O +
beta O -
- O -
barrel O +
proteins O +
encoded O +
within O +
any O +
completely O +
sequenced O +
prokaryotic O +
genome O +
. O +

This O +
program O +
, O +
termed O +
the O +
beta O -
- O -
barrel O +
finder O +
( O +
BBF O +
) O +
program O +
, O +
was O +
used O +
to O +
analyze O +
the O +
proteins O +
encoded O +
within O +
the O +
Escherichia O +
coli O +
genome O +
. O +

Out O +
of O +
4290 O +
sequences O +
examined O +
, O +
118 O +
( O +
2.8 O +
% O +
) O +
were O +
retrieved O +
. O +

Of O +
these O +
, O +
almost O +
all O +
known O +
outer O +
membrane O +
proteins O +
with O +
established O +
beta O -
- O -
barrel O +
structures O +
as O +
well O +
as O +
many O +
probable O +
outer O +
membrane O +
proteins O +
were O +
identified O +
. O +

This O +
program O +
should O +
be O +
useful O +
for O +
predicting O +
the O +
occurrence O +
of O +
outer O +
membrane O +
proteins O +
in O +
bacteria O +
with O +
completely O +
sequenced O +
genomes O +
. O +

Identification O +
of O +
neurite O +
outgrowth O +
promoting O +
sites O +
on O +
the O +
laminin B-Gene +
alpha I-Gene +
3 I-Gene +
chain O +
G O +
domain O +
. O +

Laminins B-Gene +
are O +
expressed O +
in O +
specific O +
tissues O +
and O +
are O +
involved O +
in O +
various O +
biological O +
activities O +
including O +
promoting O +
cell O +
adhesion O +
, O +
growth O +
, O +
migration O +
, O +
neurite O +
outgrowth O +
, O +
and O +
differentiation O +
. O +

The O +
laminin B-Gene +
alpha3 I-Gene +
chain O +
is O +
mainly O +
located O +
in O +
the O +
skin O +
and O +
is O +
also O +
expressed O +
in O +
the O +
floor O +
plate O +
of O +
the O +
developing O +
neural O +
tube O +
. O +

Previously O +
, O +
we O +
showed O +
that O +
the O +
human O +
laminin B-Gene +
alpha3 I-Gene +
chain O +
LG4 O +
module O +
binds O +
to O +
syndecan-2 B-Gene +
/ I-Gene +
4 I-Gene +
, O +
a O +
membrane O +
- O +
associated O +
proteoglycan O +
, O +
and O +
promotes O +
human O +
fibroblast O +
adhesion O +
. O +

Here O +
, O +
we O +
have O +
evaluated O +
the O +
neurite O +
outgrowth O +
activity O +
of O +
the O +
laminin B-Gene +
alpha3 I-Gene +
chain O +
LG4 O +
and O +
LG5 O +
modules O +
. O +

Three O +
overlapping O +
recombinant O +
proteins O +
, O +
which O +
contained O +
LG4 O +
and/or O +
LG5 O +
modules O +
of O +
the O +
human O +
laminin B-Gene +
alpha3 I-Gene +
chain O +
, O +
were O +
prepared O +
using O +
a O +
mammalian O +
cell O +
expression O +
system O +
. O +

Two O +
proteins O +
, O +
rec O +
- O +
alpha3LG4 O +
- O +
5 O +
and O +
rec O -
- O -
alpha3LG4 O +
, O +
promoted O +
cell O +
attachment O +
and O +
neurite O +
outgrowth O +
of O +
rat O +
pheochromocytoma O +
PC12 O +
cells O +
, O +
but O +
rec O -
- O -
alpha3LG5 O +
was O +
inactive O +
. O +

Twenty O -
- O -
two O +
peptides O +
covering O +
the O +
entire O +
LG4 O +
module O +
were O +
synthesized O +
and O +
tested O +
for O +
cell O +
attachment O +
and O +
neurite O +
outgrowth O +
activity O +
to O +
identify O +
active O +
sites O +
of O +
the O +
LG4 O +
module O +
. O +

A3G75 O +
( O +
KNSFMALYLSKG O +
, O +
alpha3 O +
chain O +
1411 O +
- O +
1422 O +
) O +
and O +
A3G83 O +
( O +
GNSTISIRAPVY O +
, O +
alpha3 O +
chain O +
1476 O +
- O +
1487 O +
) O +
promoted O +
PC12 O +
cell O +
attachment O +
and O +
neurite O +
outgrowth O +
. O +

Additionally O +
, O +
A3G75 O +
and O +
A3G83 O +
inhibited O +
PC12 O +
cell O +
attachment O +
to O +
rec O -
- O -
alpha3LG4 O +
. O +

These O +
results O +
suggest O +
that O +
the O +
A3G75 O +
and O +
A3G83 O +
sites O +
are O +
important O +
for O +
PC12 O +
cell O +
attachment O +
and O +
neurite O +
outgrowth O +
in O +
the O +
laminin B-Gene +
alpha3 I-Gene +
chain O +
LG4 O +
module O +
. O +

We O +
also O +
conjugated O +
the O +
A3G75 O +
and O +
A3G83 O +
peptides O +
on O +
chitosan O +
membranes O +
to O +
test O +
their O +
potential O +
as O +
bio O +
- O +
materials O +
. O +

These O +
peptide O +
- O +
conjugated O +
chitosan O +
membranes O +
were O +
more O +
active O +
for O +
neurite O +
outgrowth O +
than O +
the O +
peptide O +
- O +
coated O +
plates O +
. O +

These O +
results O +
suggest O +
that O +
the O +
A3G75 O +
- O +
and O +
A3G83 O +
- O +
conjugated O +
chitosan O +
membranes O +
are O +
applicable O +
as O +
bio O +
- O +
medical O +
materials O +
for O +
neural O +
tissue O +
repair O +
and O +
engineering O +
. O +

Role O +
of O +
the O +
C O +
- O +
terminal O +
propeptide O +
in O +
the O +
activity O +
and O +
maturation O +
of O +
gamma B-Gene +
- I-Gene +
interferon I-Gene +
- I-Gene +
inducible I-Gene +
lysosomal I-Gene +
thiol I-Gene +
reductase I-Gene +
( O +
GILT B-Gene +
) O +
. O +

gamma B-Gene -
- I-Gene -
Interferon I-Gene +
- I-Gene +
inducible I-Gene +
lysosomal I-Gene +
thiol I-Gene +
reductase I-Gene +
( O +
GILT B-Gene +
) O +
is O +
constitutively O +
expressed O +
in O +
antigen O +
- O +
presenting O +
cells O +
. O +

GILT B-Gene +
facilitates O +
unfolding O +
of O +
endocytosed O +
antigens O +
in O +
MHC B-Gene +
class I-Gene +
II I-Gene +
- O +
containing O +
compartments O +
by O +
enzymatically O +
reducing O +
disulfide O +
bonds O +
. O +

The O +
enzyme O +
is O +
synthesized O +
as O +
a O +
35 O +
- O +
kDa O +
precursor O +
. O +

Although O +
a O +
fraction O +
of O +
the O +
precursor O +
is O +
secreted O +
as O +
a O +
disulfide O +
- O +
linked O +
dimer O +
, O +
the O +
majority O +
is O +
directed O +
via O +
the O +
mannose-6-phosphate B-Gene +
receptor I-Gene +
pathway O +
to O +
endocytic O +
compartments O +
where O +
its O +
N O +
- O +
and O +
C O +
- O +
terminal O +
propeptides O +
are O +
cleaved O +
to O +
generate O +
the O +
30 O +
- O +
kDa O +
mature O +
form O +
. O +

Both O +
precursor O +
and O +
mature O +
GILT B-Gene +
reduce O +
disulfide O +
bonds O +
with O +
an O +
acidic O +
pH O +
optimum O +
. O +

In O +
this O +
report O +
, O +
we O +
show O +
that O +
the O +
cysteine O +
residues O +
in O +
the O +
C O +
- O +
terminal O +
propeptide O +
, O +
Cys-211 O +
and O +
Cys-222 O +
, O +
serve O +
key O +
structural O +
roles O +
. O +

Mutation O +
of O +
Cys-222 O +
abolishes O +
disulfide O +
- O +
linked O +
dimerization O +
of O +
precursor O +
GILT B-Gene +
and O +
decreases O +
the O +
efficiency O +
of O +
GILT B-Gene +
maturation O +
. O +

Mutation O +
of O +
Cys-211 O +
results O +
in O +
both O +
impaired O +
intracellular O +
maturation O +
and O +
loss O +
of O +
enzymatic O +
activity O +
of O +
the O +
precursor O +
form O +
at O +
an O +
acidic O +
pH O +
. O +

A O +
similar O +
phenotype O +
was O +
obtained O +
upon O +
mutation O +
of O +
Cys-200 O +
, O +
which O +
is O +
retained O +
in O +
the O +
mature O +
form O +
. O +

Cys-200 O +
and O +
Cys-211 O +
seem O +
to O +
form O +
a O +
disulfide O +
bond O +
that O +
links O +
the O +
propeptide O +
and O +
the O +
mature O +
enzyme O +
until O +
reduction O +
in O +
the O +
lysosome O +
. O +

This O +
disulfide O +
bridge O +
is O +
essential O +
for O +
stability O +
of O +
the O +
enzyme O +
at O +
low O +
pH O +
and O +
for O +
its O +
proper O +
maturation O +
in O +
vivo O +
. O +

Linked O +
unresponsiveness O +
: O +
early O +
cytokine B-Gene +
gene O +
expression O +
profiles O +
in O +
cardiac O +
allografts O +
following O +
pretreatment O +
of O +
recipients O +
with O +
bone O +
marrow O +
cells O +
expressing O +
donor O +
MHC B-Gene +
alloantigen O +
. O +

Linked O +
unresponsiveness O +
operates O +
to O +
induce O +
specific O +
unresponsiveness O +
to O +
fully O +
mismatched O +
vascularized O +
allografts O +
in O +
recipients O +
pretreated O +
with O +
anti O +
- O +
CD4 B-Gene +
antibody O +
and O +
syngeneic O +
bone O +
marrow O +
cells O +
expressing O +
a O +
single O +
donor O +
MHC B-Gene +
class I-Gene +
I I-Gene +
alloantigen O +
. O +

The O +
aim O +
of O +
the O +
study O +
was O +
to O +
evaluate O +
early O +
post O +
transplant O +
cytokine B-Gene +
expression O +
in O +
allografts O +
where O +
linked O +
unresponsiveness O +
was O +
required O +
for O +
long O +
term O +
graft O +
survival O +
. O +

CBA O +
( O +
H2 B-Gene +
( O -
k O -
) O +
) O +
mice O +
were O +
pretreated O +
with O +
CBK O +
( O +
H2 B-Gene +
( O -
k O -
) O -
+K O -
( O -
b O -
) O +
) O +
bone O +
marrow O +
cells O +
under O +
the O +
cover O +
of O +
anti O +
- O +
CD4 B-Gene +
antibody O +
28 O +
days O +
before O +
transplantation O +
of O +
a O +
CBK O +
or O +
a O +
C57BL O -
/ O -
10 O +
( O +
H2 B-Gene +
( O -
b O -
) O +
) O +
cardiac O +
allograft O +
. O +

In O +
both O +
cases O +
graft O +
survival O +
was O +
prolonged O +
( O +
MST O +
= O +
100 O +
days O +
) O +
. O +

Intragraft O +
expression O +
for O +
interferon B-Gene +
( I-Gene +
IFN I-Gene +
) I-Gene +
- I-Gene +
gamma I-Gene +
, O +
interleukin B-Gene +
( I-Gene +
IL I-Gene +
) I-Gene +
- I-Gene +
2 I-Gene +
, O +
IL-4 B-Gene +
, O +
IL-10 B-Gene +
, O +
IL-12 B-Gene +
( I-Gene +
p40 I-Gene +
) I-Gene +
, O +
IL-18 B-Gene +
, O +
iNOS B-Gene +
, O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
( I-Gene +
TGF I-Gene +
) I-Gene +
- I-Gene +
beta I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
and O +
C O -
- O -
beta O +
was O +
determined O +
on O +
day O +
1.5 O +
, O +
3 O +
, O +
7 O +
and O +
14 O +
after O +
transplantation O +
. O +

Whereas O +
rejecting O +
allografts O +
displayed O +
a O +
sharp O +
peak O +
in O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
, O +
IL-2 B-Gene +
, O +
IL-4 B-Gene +
and O +
IL-10 B-Gene +
expression O +
, O +
non O +
- O +
rejecting O +
allografts O +
were O +
characterized O +
by O +
an O +
initial O +
TGF B-Gene -
- I-Gene -
beta I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
and O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
production O +
. O +

An O +
increasing O +
IL-4 B-Gene +
expression O +
towards O +
day O +
14 O +
was O +
a O +
unique O +
feature O +
of O +
linked O +
unresponsiveness O +
. O +

All O +
non O +
- O +
rejecting O +
allografts O +
were O +
characterized O +
by O +
an O +
increasing O +
IL-12 B-Gene -
( I-Gene -
p40 I-Gene -
) I-Gene +
production O +
towards O +
day O +
14 O +
. O +

In O +
summary O +
, O +
the O +
early O +
cytokine B-Gene +
expression O +
pattern O +
in O +
allografts O +
after O +
bone O +
marrow O +
induced O +
operational O +
tolerance O +
is O +
influenced O +
by O +
the O +
quantity O +
of O +
donor O +
alloantigens O +
expressed O +
on O +
the O +
graft O +
as O +
well O +
as O +
on O +
the O +
bone O +
marrow O +
inoculum O +
. O +

Identification O +
of O +
the O +
functional O +
elements O +
in O +
the O +
bidirectional O +
promoter O +
of O +
the O +
mouse O +
O B-Gene -
- I-Gene -
sialoglycoprotein I-Gene +
endopeptidase I-Gene +
and O +
APEX B-Gene +
nuclease I-Gene +
genes O +
. O +

The O +
gene O +
for O +
mammalian O +
O B-Gene -
- I-Gene -
sialoglycoprotein I-Gene +
endopeptidase I-Gene +
( O +
Osgep B-Gene +
) O +
lies O +
immediately O +
adjacent O +
to O +
the O +
gene O +
for O +
the O +
APEX B-Gene +
nuclease I-Gene +
( O +
Apex B-Gene +
) O +
, O +
a O +
multifunctional O +
DNA B-Gene +
repair I-Gene +
enzyme I-Gene +
, O +
in O +
a O +
head O +
- O +
to O +
- O +
head O +
orientation O +
. O +

To O +
clarify O +
the O +
regulation O +
of O +
these O +
divergent O +
genes O +
, O +
we O +
studied O +
their O +
promoter O +
regions O +
with O +
luciferase B-Gene +
reporters O +
. O +

Deletion O +
analysis O +
of O +
a O +
fragment O +
containing O +
the O +
entire O +
mouse O +
Apex B-Gene +
gene O +
suggested O +
that O +
cis O +
- O +
acting O +
elements O +
driving O +
in O +
the O +
direction O +
of O +
Osgep B-Gene +
are O +
widely O +
distributed O +
in O +
the O +
mApex B-Gene +
gene O +
, O +
in O +
the O +
antisense O +
orientation O +
. O +

We O +
investigated O +
in O +
detail O +
cis O +
- O +
acting O +
elements O +
near O +
the O +
transcription O +
initiation O +
site O +
of O +
mOsgep B-Gene +
. O +

The O +
spacer O +
sequence O +
between O +
mOsgep B-Gene +
and O +
mApex B-Gene +
was O +
shown O +
to O +
have O +
bidirectional O +
promoter O +
activity O +
and O +
it O +
has O +
been O +
reported O +
that O +
two O +
CCAAT O +
boxes O +
promote O +
basal O +
transcription O +
in O +
the O +
direction O +
of O +
mApex B-Gene +
. O +

However O +
, O +
only O +
one O +
of O +
the O +
CCAAT O +
boxes O +
proximal O +
to O +
the O +
transcription O +
initiation O +
site O +
of O +
mOsgep B-Gene +
was O +
important O +
for O +
transcription O +
towards O +
mOsgep B-Gene +
. O +

An O +
Sp1 B-Gene +
- O +
binding O +
sequence O +
was O +
found O +
to O +
be O +
involved O +
in O +
bidirectional O +
transcription O +
and O +
a O +
CRE O +
/ O +
ATF B-Gene +
- O +
like O +
sequence O +
was O +
shown O +
to O +
function O +
as O +
a O +
repressor O +
of O +
mOsgep B-Gene +
transcription O +
. O +

Quantitative O +
RT O +
- O +
PCR O +
showed O +
that O +
the O +
mApex B-Gene +
and O +
mOsgep B-Gene +
genes O +
were O +
expressed O +
in O +
all O +
tissues O +
examined O +
and O +
that O +
expression O +
of O +
mOsgep B-Gene +
was O +
low O +
compared O +
with O +
mApex B-Gene +
. O +

Hypoxia O +
activates O +
beta B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
-integrin I-Gene +
via O +
ERK B-Gene +
1 I-Gene +
/ I-Gene +
2 I-Gene +
and O +
p38 B-Gene +
MAP I-Gene +
kinase I-Gene +
in O +
human O +
vascular O +
smooth O +
muscle O +
cells O +
. O +

Hypoxia O +
plays O +
an O +
important O +
role O +
in O +
vascular O +
remodeling O +
and O +
directly O +
affects O +
vascular O +
smooth O +
muscle O +
cell O +
( O +
VSMC O +
) O +
functions O +
. O +

VSMC O +
adhesion O +
participates O +
in O +
changes O +
of O +
vascular O +
structure O +
; O +
however O +
, O +
little O +
is O +
known O +
about O +
VSMC O +
adhesion O +
under O +
hypoxic O +
conditions O +
. O +

It O +
was O +
the O +
aim O +
of O +
the O +
present O +
study O +
to O +
investigate O +
the O +
effects O +
of O +
hypoxia O +
on O +
adhesion O +
mechanisms O +
in O +
human O +
VSMCs O +
. O +

Compared O +
to O +
normoxic O +
cells O +
, O +
hypoxia O +
( O +
1 O +
% O +
O O -
( O -
2 O -
) O +
, O +
24h O +
) O +
significantly O +
increased O +
adhesion O +
of O +
VSMCs O +
to O +
collagen B-Gene +
I I-Gene +
by O +
30.2 O +
% O +
and O +
fibronectin B-Gene +
by O +
58.0 O +
% O +
. O +

This O +
effect O +
was O +
completely O +
inhibited O +
in O +
the O +
presence O +
of O +
the O +
pharmacological O +
ERK B-Gene +
1 I-Gene +
/ I-Gene +
2 I-Gene +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
( O +
MAPK B-Gene +
) O +
pathway O +
inhibitor O +
PD98059 O +
( O +
30 O +
microM O +
) O +
or O +
the O +
p38 B-Gene +
MAPK I-Gene +
inhibitor O +
SB203580 O +
( O +
1 O +
microM O +
) O +
. O +

Basal O +
adhesion O +
of O +
normoxic O +
cells O +
was O +
not O +
affected O +
by O +
pretreatment O +
with O +
PD98059 O +
and O +
SB203580 O +
. O +

Hypoxia O +
induced O +
a O +
time O +
- O +
dependent O +
activation O +
of O +
ERK B-Gene +
1 I-Gene +
/ I-Gene +
2 I-Gene +
and O +
p38 B-Gene +
MAPK I-Gene +
activation O +
in O +
human O +
VSMCs O +
, O +
which O +
were O +
completely O +
abolished O +
by O +
PD98059 O +
or O +
SB203580 O +
, O +
respectively O +
. O +

Since O +
adhesion O +
of O +
VSMCs O +
to O +
fibronectin B-Gene +
and O +
collagen B-Gene +
I I-Gene +
involves O +
beta B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
-integrin I-Gene +
receptors O +
, O +
we O +
used O +
a O +
blocking O +
antibody O +
against O +
beta B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
-integrin I-Gene +
( O +
P5D2 O +
) O +
to O +
examine O +
potential O +
effects O +
of O +
hypoxia O +
on O +
beta B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
- I-Gene +
integrins I-Gene +
. O +

P5D2 O +
significantly O +
reduced O +
VSMC O +
adhesion O +
to O +
fibronectin B-Gene +
and O +
collagen B-Gene +
I I-Gene +
in O +
normoxia O +
and O +
hypoxia O +
in O +
a O +
comparable O +
manner O +
; O +
however O +
, O +
beta B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
-integrin I-Gene +
protein O +
or O +
mRNA O +
levels O +
were O +
not O +
affected O +
by O +
hypoxia O +
. O +

As O +
evidenced O +
by O +
flow O +
cytometry O +
, O +
hypoxia O +
induced O +
a O +
activation O +
of O +
beta B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
-integrins I-Gene +
by O +
exposing O +
an O +
conformationally O +
sensitive O +
epitope O +
on O +
the O +
beta B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
- O +
subunit O +
. O +

These O +
results O +
demonstrate O +
that O +
hypoxia O +
enhances O +
adhesion O +
of O +
VSMC O +
on O +
extracellular O +
matrix O +
proteins O +
by O +
activating O +
beta B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
-integrin I-Gene +
. O +

RNA B-Gene +
polymerase I-Gene +
II I-Gene +
large I-Gene +
subunit I-Gene +
is O +
cleaved O +
by O +
caspases B-Gene +
during O +
DNA O +
damage O +
- O +
induced O +
apoptosis O +
. O +

UV O +
radiation O +
induces O +
DNA O +
lesions O +
that O +
are O +
repaired O +
by O +
the O +
nucleotide O +
excision O +
repair O +
( O +
NER O +
) O +
pathway O +
. O +

Cells O +
that O +
are O +
NER O +
deficient O +
such O +
as O +
those O +
derived O +
from O +
xeroderma O +
pigmentosum O +
( O +
XP O +
) O +
patients O +
are O +
susceptible O +
to O +
apoptosis O +
after O +
10J O -
/ O -
m O -
( O -
2 O -
) O +
UV O +
radiation O +
, O +
a O +
dose O +
largely O +
survivable O +
by O +
repair O +
proficient O +
cells O +
. O +

Herein O +
, O +
we O +
report O +
that O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
large I-Gene +
subunit I-Gene +
( O +
RNAP B-Gene +
II I-Gene -
- I-Gene -
LS I-Gene +
) O +
undergoes O +
caspase B-Gene +
- O +
mediated O +
cleavage O +
, O +
yielding O +
a O +
140kDa O +
C O +
- O +
terminal O +
fragment O +
in O +
XP O +
lymphoblasts O +
but O +
not O +
NER O +
proficient O +
lymphoblasts O +
after O +
10J O +
/ O +
m O -
( O -
2 O -
) O +
UV O +
irradiation O +
. O +

Cleavage O +
could O +
also O +
be O +
induced O +
by O +
cisplatin O +
or O +
oxaliplatin O +
, O +
but O +
not O +
transplatin O +
, O +
an O +
isomer O +
of O +
cisplatin O +
that O +
does O +
not O +
induce O +
DNA O +
adducts O +
. O +

The O +
cleavage O +
of O +
RNAP B-Gene +
II I-Gene -
- I-Gene -
LS I-Gene +
was O +
blocked O +
by O +
a O +
panel O +
of O +
caspase B-Gene +
inhibitors O +
but O +
not O +
by O +
proteasomal O +
inhibitors O +
or O +
inhibitors O +
of O +
other O +
proteases B-Gene +
. O +

In O +
vitro O +
cleavage O +
with O +
caspase B-Gene +
8 I-Gene +
yielded O +
the O +
same O +
140kDa O +
RNAP B-Gene +
II I-Gene +
- I-Gene +
LS I-Gene +
fragment O +
observed O +
in O +
vivo O +
. O +

Using O +
site O +
- O +
directed O +
mutagenesis O +
, O +
the O +
RNAP B-Gene +
II I-Gene +
- I-Gene +
LS I-Gene +
cleavage O +
site O +
was O +
localized O +
to O +
an O +
LETD O +
sequence O +
ending O +
at O +
residue O +
1339 O +
, O +
which O +
is O +
near O +
its O +
C O +
- O +
terminal O +
domain O +
. O +

Interaction O +
of O +
oncogenic O +
papillomavirus O +
E6 B-Gene +
proteins O +
with O +
fibulin-1 B-Gene +
. O +

Human O +
papillomavirus O +
( O +
HPV O +
) O +
infection O +
is O +
the O +
primary O +
risk O +
factor O +
for O +
the O +
development O +
of O +
cervical O +
cancer O +
. O +

The O +
papillomavirus O +
E6 B-Gene +
gene O +
is O +
essential O +
for O +
virus O +
- O +
induced O +
cellular O +
transformation O +
and O +
the O +
viral O +
life O +
cycle O +
. O +

Important O +
insight O +
into O +
the O +
mechanism O +
of O +
E6 B-Gene +
function O +
came O +
from O +
the O +
discovery O +
that O +
cancer O +
- O +
related O +
HPV O +
E6 B-Gene +
proteins O +
promote O +
the O +
degradation O +
of O +
the O +
tumor B-Gene +
suppressor I-Gene +
p53 I-Gene +
. O +

However O +
, O +
mounting O +
evidence O +
indicates O +
that O +
interaction O +
with O +
p53 B-Gene +
does O +
not O +
mediate O +
all O +
E6 B-Gene +
activities O +
. O +

To O +
explore O +
the O +
p53 B-Gene +
- O +
independent O +
functions O +
of O +
E6 B-Gene +
, O +
we O +
performed O +
a O +
yeast O +
two O +
- O +
hybrid O +
screen O +
and O +
identified O +
fibulin-1 B-Gene +
as O +
an O +
E6 B-Gene +
binding O +
protein O +
. O +

Fibulin-1 B-Gene +
is O +
a O +
calcium O +
- O +
binding O +
plasma O +
and O +
extracellular O +
matrix O +
protein O +
that O +
has O +
been O +
implicated O +
in O +
cellular O +
transformation O +
and O +
tumor O +
invasion O +
. O +

The O +
interaction O +
between O +
E6 B-Gene +
and O +
fibulin-1 B-Gene +
was O +
demonstrated O +
by O +
both O +
in O +
vitro O +
and O +
in O +
vivo O +
assays O +
. O +

Fibulin-1 B-Gene +
is O +
associated O +
specifically O +
with O +
cancer O +
- O +
related O +
HPV O +
E6s B-Gene +
and O +
the O +
transforming O +
bovine O +
papillomavirus O +
type O +
1 O +
E6 B-Gene +
. O +

Significantly O +
, O +
overexpression O +
of O +
fibulin-1 B-Gene +
specifically O +
inhibited O +
E6 B-Gene +
- O +
mediated O +
transformation O +
. O +

These O +
results O +
suggest O +
that O +
fibulin-1 B-Gene +
plays O +
an O +
important O +
role O +
in O +
the O +
biological O +
activities O +
of O +
E6 B-Gene +
. O +

Towards O +
a O +
new O +
T O +
- O +
fold O +
protein O +
? O +
: O +
the O +
coproporphyrinogen B-Gene +
III I-Gene +
oxidase I-Gene +
sequence O +
matches O +
many O +
structural O +
features O +
from O +
urate B-Gene +
oxidase I-Gene +
. O +

Urate B-Gene +
oxidase I-Gene +
( O +
UOX B-Gene +
) O +
and O +
coproporphyrinogen B-Gene +
III I-Gene +
oxidase I-Gene +
( O +
CPO B-Gene +
) O +
are O +
two O +
unusual O +
oxidases B-Gene +
as O +
they O +
accomplish O +
their O +
catalytic O +
act O +
with O +
no O +
co O +
- O +
factor O +
nor O +
metal O +
ion O +
. O +

They O +
both O +
require O +
molecular O +
oxygen O +
, O +
and O +
lead O +
to O +
hydrogen O +
peroxide O +
in O +
addition O +
to O +
the O +
product O +
. O +

UOX B-Gene +
is O +
composed O +
of O +
two O +
contiguous O +
Tunneling O +
- O +
fold O +
domains O +
and O +
CPO B-Gene +
appears O +
to O +
be O +
also O +
divided O +
into O +
two O +
structurally O +
equivalent O +
domains O +
. O +

Moreover O +
, O +
each O +
of O +
these O +
putative O +
domains O +
can O +
be O +
coherently O +
aligned O +
on O +
UOX B-Gene +
domains O +
. O +

Although O +
their O +
sequences O +
are O +
very O +
distant O +
, O +
we O +
therefore O +
suggest O +
that O +
functional O +
CPO B-Gene +
dimer O +
is O +
built O +
around O +
a O +
tunnel O +
, O +
with O +
the O +
substrate O +
sitting O +
above O +
it O +
, O +
on O +
the O +
N O +
- O +
and O +
C O +
- O +
terminal O +
side O +
. O +

This O +
overall O +
model O +
is O +
supported O +
by O +
mutation O +
data O +
and O +
is O +
coherent O +
with O +
the O +
chemical O +
events O +
expected O +
for O +
substrate O +
processing O +
by O +
CPO B-Gene +
. O +

Overexpression O +
of O +
ABCG5 B-Gene +
and O +
ABCG8 B-Gene +
promotes O +
biliary O +
cholesterol O +
secretion O +
and O +
reduces O +
fractional O +
absorption O +
of O +
dietary O +
cholesterol O +
. O +

Two O +
ATP O +
- O +
binding O +
cassette O +
( O +
ABC O +
) O +
transporters O +
, O +
ABCG5 B-Gene +
and O +
ABCG8 B-Gene +
, O +
have O +
been O +
proposed O +
to O +
limit O +
sterol O +
absorption O +
and O +
to O +
promote O +
biliary O +
sterol O +
excretion O +
in O +
humans O +
. O +

To O +
test O +
this O +
hypothesis O +
, O +
a O +
P1 O +
clone O +
containing O +
the O +
human O +
ABCG5 B-Gene +
and O +
ABCG8 B-Gene +
genes O +
was O +
used O +
to O +
generate O +
transgenic O +
mice O +
. O +

The O +
transgenes O +
were O +
expressed O +
primarily O +
in O +
the O +
liver O +
and O +
small O +
intestine O +
, O +
mirroring O +
the O +
expression O +
pattern O +
of O +
the O +
endogenous O +
genes O +
. O +

Transgene O +
expression O +
only O +
modestly O +
affected O +
plasma O +
and O +
liver O +
cholesterol O +
levels O +
but O +
profoundly O +
altered O +
cholesterol O +
transport O +
. O +

The O +
fractional O +
absorption O +
of O +
dietary O +
cholesterol O +
was O +
reduced O +
by O +
about O +
50 O +
% O +
, O +
and O +
biliary O +
cholesterol O +
levels O +
were O +
increased O +
more O +
than O +
fivefold O +
. O +

Fecal O +
neutral O +
sterol O +
excretion O +
was O +
increased O +
three O +
- O +
to O +
sixfold O +
and O +
hepatic O +
cholesterol O +
synthesis O +
increased O +
two O +
- O +
to O +
fourfold O +
in O +
the O +
transgenic O +
mice O +
. O +

No O +
significant O +
changes O +
in O +
the O +
pool O +
size O +
, O +
composition O +
, O +
and O +
fecal O +
excretion O +
of O +
bile O +
acids O +
were O +
observed O +
in O +
the O +
transgenic O +
mice O +
. O +

Transgene O +
expression O +
attenuated O +
the O +
increase O +
in O +
hepatic O +
cholesterol O +
content O +
induced O +
by O +
consumption O +
of O +
a O +
high O +
cholesterol O +
diet O +
. O +

These O +
results O +
demonstrate O +
that O +
increased O +
expression O +
of O +
ABCG5 B-Gene +
and O +
ABCG8 B-Gene +
selectively O +
drives O +
biliary O +
neutral O +
sterol O +
secretion O +
and O +
reduces O +
intestinal O +
cholesterol O +
absorption O +
, O +
leading O +
to O +
a O +
selective O +
increase O +
in O +
neutral O +
sterol O +
excretion O +
and O +
a O +
compensatory O +
increase O +
in O +
cholesterol O +
synthesis O +
. O +

C2PA B-Gene +
is O +
a O +
nuclear O +
protein O +
implicated O +
in O +
the O +
heat O +
shock O +
response O +
. O +

C2PA B-Gene +
is O +
a O +
protein O +
of O +
unknown O +
function O +
that O +
is O +
expressed O +
in O +
spermatocytes O +
. O +

PDZ B-Gene -
- I-Gene -
RGS3 I-Gene +
is O +
a O +
signaling O +
molecule O +
whose O +
PDZ O +
domain O +
binds O +
Ephrin B-Gene +
- I-Gene +
B2 I-Gene +
and O +
mediates O +
reverse O +
signaling O +
of O +
this O +
protein O +
. O +

C2PA B-Gene +
and O +
PDZ B-Gene -
- I-Gene -
RGS3 I-Gene +
have O +
identical O +
PDZ O +
domains O +
. O +

To O +
explore O +
the O +
function O +
of O +
C2PA B-Gene +
, O +
we O +
compared O +
it O +
with O +
PDZ B-Gene -
- I-Gene -
RGS3 I-Gene +
with O +
respect O +
to O +
tissue O +
distribution O +
, O +
subcellular O +
localization O +
, O +
and O +
biochemistry O +
. O +

C2PA B-Gene +
is O +
expressed O +
only O +
in O +
testis O +
, O +
whereas O +
PDZ B-Gene -
- I-Gene -
RGS3 I-Gene +
is O +
expressed O +
in O +
various O +
tissues O +
including O +
brain O +
, O +
heart O +
, O +
lung O +
, O +
liver O +
, O +
spleen O +
, O +
kidney O +
, O +
small O +
intestine O +
, O +
skeletal O +
muscles O +
, O +
and O +
testis O +
. O +

These O +
proteins O +
also O +
differ O +
in O +
their O +
subcellular O +
distribution O +
, O +
in O +
that O +
PDZ B-Gene -
- I-Gene -
RGS3 I-Gene +
is O +
cytosolic O +
while O +
C2PA B-Gene +
is O +
exclusively O +
nuclear O +
. O +

C2PA B-Gene +
is O +
distributed O +
diffusely O +
in O +
the O +
nucleus O +
and O +
forms O +
a O +
few O +
foci O +
at O +
37 O +
degrees O +
C O +
. O +

However O +
, O +
when O +
cells O +
are O +
exposed O +
to O +
42 O +
degrees O +
C O +
, O +
the O +
number O +
of O +
C2PA B-Gene +
foci O +
is O +
increased O +
. O +

These O +
heat O +
shock O +
- O +
induced O +
foci O +
colocalize O +
with O +
CREB B-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
and O +
heat B-Gene +
shock I-Gene +
factor-1 I-Gene +
. O +

In O +
contrast O +
, O +
the O +
distribution O +
of O +
PDZ B-Gene -
- I-Gene -
RGS3 I-Gene +
does O +
not O +
change O +
during O +
heat O +
stress O +
. O +

When O +
overexpressed O +
, O +
C2PA B-Gene +
induces O +
heat O +
shock O +
response O +
element O +
( O +
HSE O +
) O +
- O +
dependent O +
gene O +
transcription O +
, O +
whereas O +
PDZ B-Gene -
- I-Gene -
RGS3 I-Gene +
does O +
not O +
. O +

These O +
data O +
suggest O +
that O +
the O +
function O +
of O +
C2PA B-Gene +
is O +
distinct O +
from O +
that O +
of O +
PDZ B-Gene -
- I-Gene -
RGS3 I-Gene +
, O +
and O +
that O +
C2PA B-Gene +
may O +
be O +
involved O +
in O +
the O +
heat O +
shock O +
response O +
in O +
testis O +
. O +

X O +
- O +
linked O +
creatine O +
deficiency O +
syndrome O +
: O +
a O +
novel O +
mutation O +
in O +
creatine B-Gene +
transporter I-Gene +
gene O +
SLC6A8 B-Gene +
. O +

Among O +
creatine O +
deficiency O +
syndromes O +
, O +
an O +
X O +
- O +
linked O +
condition O +
related O +
to O +
a O +
defective O +
creatine O +
transport O +
into O +
the O +
central O +
nervous O +
system O +
has O +
been O +
described O +
recently O +
. O +

Hallmarks O +
of O +
the O +
disease O +
are O +
the O +
absence O +
of O +
a O +
creatine O +
signal O +
at O +
brain O +
spectroscopy O +
, O +
increased O +
creatine O +
levels O +
in O +
blood O +
and O +
urine O +
, O +
ineffectiveness O +
of O +
oral O +
supplementation O +
, O +
and O +
a O +
mutation O +
in O +
the O +
SLC6A8 B-Gene +
( O +
Online O +
Mendelian O +
Inheritance O +
in O +
Man O +
[ O +
OMIM O +
] O +
300036 O +
) O +
creatine B-Gene +
transporter I-Gene +
gene O +
. O +

We O +
report O +
on O +
a O +
patient O +
in O +
whom O +
a O +
novel O +
mutation O +
( O +
1221 O -
- O -
1223delTTC O +
) O +
was O +
identified O +
. O +

Genetic O +
and O +
environmental O +
risk O +
factors O +
for O +
Alzheimer O +
's O +
disease O +
in O +
Israeli O +
Arabs O +
. O +

OBJECTIVE O +
: O +

We O +
studied O +
the O +
genetic O +
and O +
environmental O +
risk O +
factors O +
and O +
prevalence O +
, O +
and O +
incidence O +
of O +
dementia O +
of O +
the O +
Alzheimer O +
type O +
( O +
DAT O +
) O +
among O +
the O +
elderly O +
in O +
an O +
Arab O +
community O +
in O +
Israel O +
. O +

BACKGROUND O +
: O +

Epidemiological O +
and O +
genetic O +
studies O +
of O +
dementia O +
have O +
rarely O +
been O +
reported O +
in O +
an O +
Arab O +
population O +
. O +

METHODS O +
: O +

All O +
persons O +
aged O +
60 O +
years O +
or O +
older O +
who O +
were O +
residents O +
of O +
the O +
rural O +
area O +
of O +
Wadi O +
Ara O +
were O +
examined O +
for O +
identification O +
of O +
DAT O +
, O +
vascular O +
dementia O +
( O +
VaD O +
) O +
and O +
conversion O +
from O +
age O +
related O +
cognitive O +
decline O +
( O +
ARCD O +
) O +
to O +
DAT O +
using O +
DSM O -
- O -
IV O +
criteria O +
and O +
a O +
semi O +
- O +
structured O +
questionnaire O +
for O +
collection O +
of O +
demographic O +
and O +
medical O +
data O +
. O +

ApoE B-Gene +
genotype O +
was O +
also O +
determined O +
. O +

Total O +
plasma O +
homocysteine O +
( O +
tHcy O +
) O +
was O +
determined O +
using O +
HPLC O +
with O +
fluorescence O +
detection O +
. O +

Vitamins O +
B12 O +
and O +
plasma O +
folate O +
were O +
determined O +
using O +
a O +
commercial O +
radioisotope O +
dilution O +
kit O +
assay O +
( O +
ICN O +
) O +
. O +

RESULTS O +
: O +

DAT O +
was O +
diagnosed O +
in O +
20.5 O +
% O +
of O +
this O +
population O +
. O +

Its O +
prevalence O +
increased O +
steeply O +
with O +
age O +
. O +

Illiteracy O +
was O +
very O +
common O +
, O +
and O +
strongly O +
associated O +
with O +
higher O +
prevalence O +
of O +
DAT O +
. O +

The O +
annual O +
incidence O +
of O +
DAT O +
among O +
ARCD O +
cases O +
was O +
4.4 O +
% O +
. O +

Subjects O +
with O +
ARCD O +
who O +
developed O +
DAT O +
were O +
older O +
than O +
ARCD O +
subjects O +
who O +
did O +
not O +
develop O +
dementia O +
. O +

Hypertension O +
was O +
significantly O +
more O +
common O +
among O +
converted O +
patients O +
than O +
among O +
non O +
- O +
converted O +
. O +

Illiteracy O +
was O +
insignificantly O +
more O +
common O +
among O +
those O +
who O +
developed O +
DAT O +
than O +
among O +
those O +
who O +
remained O +
ARCD O +
. O +

Vascular O +
dementia O +
( O +
VaD O +
) O +
constitutes O +
about O +
22 O +
% O +
of O +
the O +
total O +
dementia O +
population O +
. O +

We O +
also O +
confirm O +
the O +
association O +
between O +
VaD O +
, O +
illiteracy O +
and O +
hypertension O +
. O +

Smoking O +
did O +
not O +
represent O +
a O +
risk O +
factor O +
for O +
VaD O +
. O +

The O +
survival O +
rates O +
among O +
the O +
three O +
groups O +
( O +
healthy O +
subjects O +
, O +
ARCD O +
and O +
DAT O +
) O +
was O +
80.5 O +
% O +
, O +
58.8 O +
% O +
and O +
55.5 O +
% O +
respectively O +
. O +

Homocysteine O +
levels O +
were O +
significantly O +
higher O +
than O +
found O +
in O +
studies O +
in O +
Cleveland O +
. O +

Plasma O +
B12 O +
and O +
plasma O +
folate O +
levels O +
did O +
not O +
differ O +
significantly O +
between O +
DAT O +
patients O +
and O +
controls O +
after O +
adjusting O +
for O +
year O +
of O +
birth O +
. O +

CONCLUSIONS O +
: O +

Our O +
findings O +
suggest O +
that O +
the O +
Wadi O +
Ara O +
population O +
is O +
unique O +
because O +
of O +
high O +
prevalence O +
rates O +
of O +
dementia O +
. O +

We O +
found O +
old O +
age O +
, O +
female O +
gender O +
and O +
lack O +
of O +
education O +
to O +
be O +
risk O +
factors O +
for O +
the O +
development O +
of O +
DAT O +
. O +

The O +
ApoE B-Gene +
epsilon4 O +
allele O +
is O +
relatively O +
uncommon O +
in O +
this O +
population O +
and O +
it O +
can O -
not O +
explain O +
the O +
high O +
DAT O +
prevalence O +
. O +

We O +
also O +
confirm O +
the O +
association O +
between O +
VaD O +
, O +
illiteracy O +
and O +
hypertension O +
and O +
older O +
age O +
and O +
hypertension O +
are O +
risk O +
factors O +
for O +
the O +
transformation O +
of O +
ARCD O +
to O +
DAT O +
. O +

Human O +
fallopian O +
tubes O +
express O +
prostacyclin B-Gene +
( I-Gene +
PGI I-Gene +
) I-Gene +
synthase I-Gene +
and O +
cyclooxygenases B-Gene +
and O +
synthesize O +
abundant O +
PGI O +
. O +

Animal O +
studies O +
unequivocally O +
support O +
the O +
indispensable O +
role O +
of O +
prostaglandin O +
( O +
PG O +
) O +
and O +
cyclooxygenase B-Gene +
( O +
COX B-Gene +
) O +
in O +
ovulation O +
and O +
implantation O +
. O +

Available O +
data O +
also O +
suggest O +
that O +
PG O +
and O +
COX B-Gene +
may O +
be O +
important O +
in O +
the O +
transport O +
of O +
embryos O +
. O +

The O +
effects O +
of O +
PGE O -
( O -
2 O -
) O +
and O +
PGF O +
( O +
2alpha O +
) O +
on O +
the O +
contractility O +
of O +
human O +
tubal O +
muscle O +
have O +
been O +
studied O +
extensively O +
; O +
the O +
expression O +
of O +
COX B-Gene +
in O +
human O +
fallopian O +
tubes O +
was O +
also O +
reported O +
. O +

Despite O +
all O +
these O +
, O +
two O +
fundamentally O +
important O +
questions O +
remained O +
to O +
be O +
answered O +
: O +
1 O +
) O +
which O +
PGs O +
are O +
produced O +
by O +
human O +
fallopian O +
tubes O +
; O +
and O +
2 O +
) O +
which O +
COX B-Gene +
isoform O -
( O -
s O -
) O +
is O +
expressed O +
by O +
the O +
fallopian O +
tubes O +
. O +

We O +
used O +
reverse O +
- O +
phase O +
HPLC O +
to O +
study O +
the O +
metabolism O +
of O +
[ O -
1- O -
( O -
14 O -
) O -
C O +
] O +
arachidonic O +
acid O +
by O +
the O +
fallopian O +
tubes O +
. O +

We O +
found O +
that O +
6 O +
keto O +
- O +
PGF O -
( O -
1alpha O -
) O +
, O +
a O +
stable O +
metabolite O +
of O +
prostacyclin O +
( O +
PGI O +
) O +
, O +
and O +
PGE O -
( O -
2 O -
) O +
constituted O +
56 O +
% O +
+ O -
/- O +
10 O +
% O +
and O +
35 O +
% O +
+ O -
/- O +
10 O +
% O +
( O +
mean O +
+ O -
/- O +
SEM O +
, O +
four O +
samples O +
) O +
, O +
respectively O +
, O +
of O +
total O +
eicosanoids O +
synthesized O +
. O +

Western O +
blot O +
analysis O +
revealed O +
the O +
expression O +
of O +
both O +
COX B-Gene +
isoforms O +
. O +

Immunohistochemistry O +
study O +
showed O +
that O +
both O +
COX-1 B-Gene +
and I-Gene +
- I-Gene +
2 I-Gene +
were O +
localized O +
to O +
nonciliated O +
epithelia O +
and O +
tubal O +
smooth O +
muscle O +
. O +

In O +
addition O +
, O +
COX-2 B-Gene +
was O +
also O +
expressed O +
in O +
ciliated O +
epithelial O +
cells O +
. O +

Western O +
blot O +
analysis O +
revealed O +
the O +
expression O +
of O +
PGI B-Gene +
synthase I-Gene +
( O +
PGIS B-Gene +
) O +
and O +
PGI B-Gene +
receptor I-Gene +
by O +
fallopian O +
tubes O +
. O +

Immunohistochemistry O +
confirmed O +
the O +
expression O +
of O +
PGIS B-Gene +
by O +
luminal O +
epithelia O +
, O +
tubal O +
smooth O +
muscle O +
, O +
vascular O +
endothelial O +
cells O +
, O +
and O +
vascular O +
smooth O +
muscle O +
cells O +
. O +

Iloprost O +
, O +
a O +
PGI O +
analog O +
, O +
inhibited O +
the O +
activities O +
of O +
circular O +
and O +
longitudinal O +
muscles O +
of O +
the O +
fallopian O +
tube O +
. O +

Thus O +
, O +
the O +
fallopian O +
tube O +
expresses O +
both O +
COX B-Gene +
isoforms O +
and O +
PGIS B-Gene +
. O +

Furthermore O +
, O +
it O +
is O +
a O +
source O +
and O +
a O +
target O +
of O +
PGI O +
. O +

PGI O +
and O +
COX B-Gene +
may O +
be O +
important O +
to O +
gamete O +
function O +
, O +
embryo O +
transport O +
, O +
and O +
embryo O +
development O +
. O +

A O +
comprehensive O +
alanine O +
scanning O +
mutagenesis O +
of O +
the O +
Escherichia O +
coli O +
transcriptional O +
activator O +
SoxS B-Gene +
: O +
identifying O +
amino O +
acids O +
important O +
for O +
DNA O +
binding O +
and O +
transcription O +
activation O +
. O +

SoxS B-Gene +
is O +
the O +
direct O +
transcriptional O +
activator O +
of O +
the O +
superoxide O +
regulon O +
. O +

SoxS B-Gene +
recognizes O +
a O +
highly O +
degenerate O +
" O +
soxbox O +
" O +
DNA O +
sequence O +
, O +
and O +
activates O +
transcription O +
from O +
class O +
I O +
and O +
class O +
II O +
promoters O +
. O +

SoxS B-Gene +
is O +
the O +
smallest O +
member O +
of O +
the O +
AraC B-Gene +
/ I-Gene +
XylS I-Gene +
family I-Gene +
of O +
transcription O +
regulators O +
whose O +
hallmark O +
is O +
dual O +
helix O +
- O +
turn O +
- O +
helix O +
( O +
HTH O +
) O +
DNA O +
- O +
binding O +
motifs O +
. O +

Evidence O +
suggests O +
that O +
the O +
N O +
- O +
terminal O +
HTH O +
motif O +
of O +
SoxS B-Gene +
interacts O +
with O +
a O +
highly O +
conserved O +
region O +
of O +
the O +
soxbox O +
termed O +
recognition O +
element O +
1 O +
( O +
RE1 O +
) O +
, O +
while O +
the O +
C O +
- O +
terminal O +
HTH O +
motif O +
interacts O +
with O +
the O +
less O +
conserved O +
recognition O +
element O +
2 O +
( O +
RE2 O +
) O +
.In O +
the O +
work O +
described O +
here O +
, O +
we O +
prepared O +
a O +
complete O +
library O +
of O +
101 O +
SoxS B-Gene +
mutants O +
containing O +
single O +
alanine O +
substitutions O +
of O +
SoxS B-Gene +
, O +
and O +
we O +
characterized O +
the O +
mutant O +
proteins O +
in O +
vivo O +
and O +
in O +
vitro O +
. O +

With O +
SoxS B-Gene +
being O +
closely O +
related O +
to O +
MarA B-Gene +
, O +
we O +
analyzed O +
the O +
effects O +
of O +
the O +
SoxS B-Gene +
mutations O +
in O +
the O +
context O +
of O +
the O +
MarA B-Gene +
- O +
mar B-Gene +
crystal O +
structure O +
and O +
with O +
respect O +
to O +
the O +
NMR O +
study O +
of O +
MarA B-Gene +
- O +
DNA O +
complexes O +
in O +
solution O +
. O +

From O +
the O +
properties O +
of O +
the O +
alanine O +
substitutions O +
, O +
we O +
conclude O +
the O +
following O +
. O +

( O -
1 O +
) O +

Surface O +
- O +
exposed O +
residues O +
of O +
helix O +
3 O +
and O +
helix O +
6 O +
, O +
the O +
recognition O +
helices O +
of O +
the O +
dual O +
HTH O +
motifs O +
, O +
are O +
important O +
to O +
DNA O +
binding O +
and O +
transcription O +
activation O +
; O +
however O +
, O +
substitutions O +
of O +
residues O +
predicted O +
from O +
the O +
MarA B-Gene +
- O +
mar B-Gene +
crystal O +
structure O +
to O +
make O +
contact O +
with O +
the O +
sugar O +
- O +
phosphate O +
backbone O +
are O +
more O +
detrimental O +
to O +
DNA O +
binding O +
than O +
mutations O +
predicted O +
to O +
make O +
base O +
- O +
specific O +
contacts O +
. O +

( O -
2 O +
) O +

Substitution O +
of O +
several O +
residues O +
within O +
the O +
recognition O +
helix O +
predicted O +
to O +
make O +
base O +
- O +
specific O +
contacts O +
with O +
RE2 O +
have O +
relatively O +
little O +
effect O +
on O +
DNA O +
- O +
binding O +
, O +
suggesting O +
the O +
possibility O +
of O +
alternative O +
protein O +
- O +
DNA O +
interactions O +
than O +
those O +
inferred O +
from O +
the O +
MarA B-Gene +
- O +
mar B-Gene +
crystal O +
structure O +
. O +

( O -
3 O +
) O +

DNA O +
binding O +
and O +
transcription O +
activation O +
were O +
reduced O +
by O +
substitution O +
of O +
conserved O +
amino O +
acid O +
residues O +
comprising O +
the O +
hydrophobic O +
core O +
, O +
presumably O +
because O +
they O +
disrupt O +
the O +
structural O +
integrity O +
of O +
SoxS B-Gene +
. O +

( O -
4 O +
) O +

Mutant O +
K30A O +
appears O +
to O +
be O +
a O +
positive O +
control O +
mutant O +
defective O +
in O +
a O +
protein O +
- O +
protein O +
interaction O +
with O +
RNA B-Gene +
polymerase I-Gene +
that O +
is O +
required O +
for O +
transcription O +
activation O +
at O +
all O +
SoxS B-Gene +
- O +
dependent O +
promoters O +
because O +
it O +
binds O +
and O +
bends O +
DNA O +
normally O +
but O +
fails O +
to O +
activate O +
transcription O +
from O +
both O +
classes O +
of O +
promoters O +
. O +

Alanine O +
substitutions O +
of O +
surface O +
- O +
exposed O +
residues O +
H3 O +
, O +
K5 O +
, O +
D9 O +
, O +
S31 O +
, O +
and O +
V45 O +
confer O +
a O +
similar O +
phenotype O +
. O +

Since O +
these O +
residues O +
are O +
near O +
K30 O +
on O +
the O +
surface O +
of O +
the O +
protein O +
, O +
the O +
surface O +
formed O +
by O +
the O +
six O +
residues O +
may O +
be O +
used O +
to O +
make O +
protein O +
- O +
protein O +
interactions O +
with O +
RNA B-Gene +
polymerase I-Gene +
that O +
are O +
required O +
for O +
transcription O +
activation O +
at O +
both O +
class O +
I O +
and O +
class O +
II O +
SoxS B-Gene +
- O +
dependent O +
promoters O +
. O +

( O -
5 O +
) O +

Mutants O +
F74A O +
, O +
D75A O +
, O +
M78A O +
, O +
D79A O +
and O +
Q85A O +
appear O +
to O +
define O +
a O +
surface O +
required O +
for O +
protein O +
- O +
protein O +
interaction O +
with O +
RNA B-Gene +
polymerase I-Gene +
specifically O +
at O +
class O +
II O +
promoters O +
because O +
these O +
positive O +
control O +
mutants O +
bind O +
and O +
bend O +
DNA O +
normally O +
but O +
are O +
defective O +
in O +
activation O +
of O +
class O +
II O +
promoters O +
but O +
not O +
class O +
I O +
promoters O +
. O +

These O +
SoxS B-Gene +
mutants O +
that O +
bind O +
and O +
bend O +
DNA O +
normally O +
but O +
are O +
defective O +
in O +
transcription O +
activation O +
represent O +
the O +
first O +
positive O +
control O +
mutants O +
with O +
putative O +
defects O +
in O +
protein O +
- O +
protein O +
interactions O +
with O +
RNA B-Gene +
polymerase I-Gene +
among O +
the O +
SoxS B-Gene +
/ O +
MarA B-Gene +
/ O +
Rob B-Gene +
subset O +
of O +
the O +
AraC B-Gene +
/ I-Gene +
XylS I-Gene +
family I-Gene +
of O +
transcription O +
regulators O +
. O +

The O +
Escherichia O +
coli O +
metD B-Gene +
locus O +
encodes O +
an O +
ABC B-Gene +
transporter I-Gene +
which O +
includes O +
Abc B-Gene +
( O +
MetN B-Gene +
) O +
, O +
YaeE B-Gene +
( O +
MetI B-Gene +
) O +
, O +
and O +
YaeC B-Gene +
( O +
MetQ B-Gene +
) O +
. O +

We O +
report O +
that O +
the O +
genes O +
abc B-Gene +
, O +
yaeC B-Gene +
, O +
and O +
yaeE B-Gene +
comprise O +
metD B-Gene +
, O +
an O +
Escherichia O +
coli O +
locus O +
encoding O +
a O +
DL O -
- O -
methionine O +
uptake O +
system O +
. O +

MetD B-Gene +
is O +
an O +
ABC B-Gene +
transporter I-Gene +
with O +
Abc B-Gene +
the O +
ATPase B-Gene +
, O +
YaeE B-Gene +
the O +
permease B-Gene +
, O +
and O +
YaeC B-Gene +
the O +
likely O +
substrate O +
binding O +
protein O +
. O +

Expression O +
of O +
these O +
genes O +
is O +
regulated O +
by O +
L O -
- O -
methionine O +
and O +
MetJ B-Gene +
, O +
a O +
common O +
repressor O +
of O +
the O +
methionine O +
regulon O +
. O +

We O +
propose O +
to O +
rename O +
abc B-Gene +
, O +
yaeE B-Gene +
, O +
and O +
yaeC B-Gene +
as O +
metN B-Gene +
, O +
metI B-Gene +
, O +
and O +
metQ B-Gene +
, O +
respectively O +
. O +

IKKalpha B-Gene +
, O +
IKKbeta B-Gene +
, O +
and O +
NEMO B-Gene +
/ O +
IKKgamma B-Gene +
are O +
each O +
required O +
for O +
the O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
- O +
mediated O +
inflammatory O +
response O +
program O +
. O +

The O +
IKKbeta B-Gene +
and O +
NEMO B-Gene +
/ O +
IKKgamma B-Gene +
subunits O +
of O +
the O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
- O +
activating O +
signalsome O +
complex O +
are O +
known O +
to O +
be O +
essential O +
for O +
activating O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
by O +
inflammatory O +
and O +
other O +
stress O +
- O +
like O +
stimuli O +
. O +

However O +
, O +
the O +
IKKalpha B-Gene +
subunit O +
is O +
believed O +
to O +
be O +
dispensable O +
for O +
the O +
latter O +
responses O +
and O +
instead O +
functions O +
as O +
an O +
in O +
vivo O +
mediator O +
of O +
other O +
novel O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
- O +
dependent O +
and O +
- O +
independent O +
functions O +
. O +

In O +
contrast O +
to O +
this O +
generally O +
accepted O +
view O +
of O +
IKKalpha B-Gene +
's O +
physiological O +
functions O +
, O +
we O +
demonstrate O +
in O +
mouse O +
embryonic O +
fibroblasts O +
( O +
MEFs O +
) O +
that O +
, O +
akin O +
to O +
IKKbeta B-Gene +
and O +
NEMO B-Gene +
/ O +
IKKgamma B-Gene +
, O +
IKKalpha B-Gene +
is O +
also O +
a O +
global O +
regulator O +
of O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
alpha I-Gene +
- O +
and O +
IL-1 B-Gene +
- O +
responsive O +
IKK B-Gene +
signalsome O +
- O +
dependent O +
target O +
genes O +
including O +
many O +
known O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
targets O +
such O +
as O +
serum B-Gene +
amyloid I-Gene +
A3 I-Gene +
, O +
C3 B-Gene +
, O +
interleukin B-Gene +
( I-Gene +
IL I-Gene -
) I-Gene -
-6 I-Gene +
, O +
IL-11 B-Gene +
, O +
IL-1 B-Gene +
receptor I-Gene +
antagonist I-Gene +
, O +
vascular B-Gene +
endothelial I-Gene +
growth I-Gene +
factor I-Gene +
, O +
Ptx3 B-Gene +
, O +
beta B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene -
-microglobulin I-Gene +
, O +
IL-1alpha B-Gene +
, O +
Mcp-1 B-Gene +
and I-Gene +
- I-Gene +
3 I-Gene +
, O +
RANTES B-Gene +
( O +
regulated B-Gene +
on I-Gene +
activation I-Gene +
normal I-Gene +
T I-Gene +
cell I-Gene +
expressed I-Gene +
and I-Gene +
secreted I-Gene +
) O +
, O +
Fas B-Gene +
antigen I-Gene +
, O +
Jun B-Gene -
- I-Gene -
B I-Gene +
, O +
c B-Gene -
- I-Gene -
Fos I-Gene +
, O +
macrophage B-Gene +
colony I-Gene +
- I-Gene +
stimulating I-Gene +
factor I-Gene +
, O +
and O +
granulocyte B-Gene +
- I-Gene +
macrophage I-Gene +
colony I-Gene +
- I-Gene +
stimulating I-Gene +
factor I-Gene +
. O +

Only O +
a O +
small O +
number O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
- O +
dependent O +
target O +
genes O +
were O +
preferentially O +
dependent O +
on O +
IKKalpha B-Gene +
or O +
IKKbeta B-Gene +
. O +

Constitutive O +
expression O +
of O +
a O +
trans O +
- O +
dominant O +
IkappaBalpha B-Gene +
superrepressor I-Gene +
( O +
IkappaBalphaSR B-Gene +
) O +
in O +
wild O +
type O +
MEFs O +
confirmed O +
that O +
these O +
signalsome O +
- O +
dependent O +
target O +
genes O +
were O +
also O +
dependent O +
on O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
. O +

A O +
subset O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
target O +
genes O +
were O +
IKK B-Gene +
- O +
dependent O +
in O +
the O +
absence O +
of O +
exogenous O +
stimuli O +
, O +
suggesting O +
that O +
the O +
signalsome O +
was O +
also O +
required O +
to O +
regulate O +
basal O +
levels O +
of O +
activated O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
in O +
established O +
MEFs O +
. O +

Overall O +
, O +
a O +
sizable O +
number O +
of O +
novel O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
/ O +
IKK B-Gene +
- O +
dependent O +
genes O +
were O +
identified O +
including O +
Secreted B-Gene +
Frizzled I-Gene +
, O +
cadherin B-Gene +
13 I-Gene +
, O +
protocadherin B-Gene +
7 I-Gene +
, O +
CCAAT B-Gene +
/ I-Gene +
enhancer I-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
- I-Gene +
beta I-Gene +
and I-Gene +
- I-Gene +
delta I-Gene +
, O +
osteoprotegerin B-Gene +
, O +
FOXC2 B-Gene +
and O +
FOXF2 B-Gene +
, O +
BMP-2 B-Gene +
, O +
p75 B-Gene +
neurotrophin I-Gene +
receptor I-Gene +
, O +
caspase-11 B-Gene +
, O +
guanylate B-Gene +
- I-Gene +
binding I-Gene +
proteins I-Gene +
1 I-Gene +
and I-Gene +
2 I-Gene +
, O +
ApoJ B-Gene +
/ O +
clusterin B-Gene +
, O +
interferon B-Gene +
( I-Gene +
alpha I-Gene +
and I-Gene +
beta I-Gene +
) I-Gene +
receptor I-Gene +
2 I-Gene +
, O +
decorin B-Gene +
, O +
osteoglycin B-Gene +
, O +
epiregulin B-Gene +
, O +
proliferins B-Gene +
2 I-Gene +
and I-Gene +
3 I-Gene +
, O +
stromal B-Gene +
cell I-Gene +
- I-Gene +
derived I-Gene +
factor I-Gene +
, O +
and O +
cathepsins B-Gene +
B I-Gene +
, I-Gene +
F I-Gene +
, I-Gene +
and I-Gene +
Z. I-Gene +
SOCS B-Gene +
- I-Gene +
3 I-Gene +
, O +
a O +
negative O +
effector O +
of O +
STAT3 B-Gene +
signaling O +
, O +
was O +
found O +
to O +
be O +
an O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
/ O +
IKK B-Gene +
- O +
induced O +
gene O +
, O +
suggesting O +
that O +
IKK B-Gene +
- O +
mediated O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activation O +
can O +
coordinately O +
illicit O +
negative O +
effects O +
on O +
STAT B-Gene +
signaling O +
. O +

COP9 B-Gene +
signalosome I-Gene +
subunits I-Gene +
4 I-Gene +
and I-Gene +
5 I-Gene +
regulate O +
multiple O +
pleiotropic O +
pathways O +
in O +
Drosophila O +
melanogaster O +
. O +

The O +
COP9 B-Gene +
signalosome I-Gene +
( O +
CSN B-Gene +
) O +
is O +
an O +
essential O +
eight O +
- O +
subunit O +
repressor O +
of O +
light O +
- O +
regulated O +
development O +
in O +
ARABIDOPSIS O +
: O +

This O +
complex O +
has O +
also O +
been O +
identified O +
in O +
animals O +
, O +
though O +
its O +
developmental O +
role O +
remains O +
obscure O +
. O +

CSN B-Gene +
subunits O +
have O +
been O +
implicated O +
in O +
various O +
cellular O +
processes O +
, O +
suggesting O +
a O +
possible O +
role O +
for O +
the O +
CSN B-Gene +
as O +
an O +
integrator O +
of O +
multiple O +
signaling O +
pathways O +
. O +

In O +
order O +
to O +
elucidate O +
the O +
function O +
of O +
the O +
CSN B-Gene +
in O +
animals O +
, O +
a O +
Drosophila O +
model O +
system O +
has O +
previously O +
been O +
established O +
. O +

Gel O +
- O +
filtration O +
analysis O +
with O +
antibodies O +
against O +
CSN B-Gene +
subunits I-Gene +
4 I-Gene +
, I-Gene +
5 I-Gene +
and I-Gene +
7 I-Gene +
revealed O +
that O +
these O +
proteins O +
act O +
as O +
a O +
complex O +
in O +
Drosophila O +
that O +
is O +
similar O +
in O +
size O +
to O +
the O +
plant O +
and O +
mammalian O +
complexes O +
. O +

Null O +
mutations O +
in O +
either O +
one O +
of O +
two O +
subunits O +
, O +
CSN4 B-Gene +
or O +
CSN5 B-Gene +
, O +
are O +
larval O +
lethal O +
. O +

Successful O +
embryogenesis O +
appears O +
to O +
be O +
a O +
consequence O +
of O +
maternal O +
contribution O +
of O +
the O +
complex O +
. O +

Biochemical O +
analysis O +
indicates O +
that O +
the O +
different O +
subunits O +
are O +
found O +
in O +
both O +
CSN B-Gene +
- O +
dependent O +
and O +
CSN B-Gene +
- O +
independent O +
forms O +
, O +
and O +
that O +
these O +
forms O +
are O +
differentially O +
affected O +
by O +
the O +
mutations O +
. O +

Phenotypic O +
characterization O +
of O +
these O +
two O +
mutants O +
indicates O +
that O +
they O +
show O +
both O +
shared O +
and O +
unique O +
phenotypes O +
, O +
which O +
suggest O +
specific O +
roles O +
for O +
each O +
subunit O +
. O +

Both O +
mutants O +
have O +
defective O +
oocyte O +
and O +
embryo O +
patterning O +
, O +
and O +
defects O +
in O +
response O +
to O +
DNA O +
damage O +
, O +
while O +
csn5 B-Gene +
mutants O +
develop O +
melanotic O +
tumors O +
and O +
csn4 B-Gene +
mutants O +
have O +
phenotypes O +
reminiscent O +
of O +
defects O +
in O +
ecdysone O +
signaling O +
. O +

Tumor O +
suppressor O +
activity O +
of O +
AP2alpha B-Gene +
mediated O +
through O +
a O +
direct O +
interaction O +
with O +
p53 B-Gene +
. O +

The O +
AP2 B-Gene +
transcription I-Gene +
factor I-Gene +
family I-Gene +
is O +
a O +
set O +
of O +
developmentally O +
regulated O +
, O +
retinoic O +
acid O +
inducible O +
genes O +
composed O +
of O +
four O +
related O +
factors O +
, O +
AP2alpha B-Gene +
, O +
AP2beta B-Gene +
, O +
AP2gamma B-Gene +
, O +
and O +
AP2delta B-Gene +
. O +

AP2 B-Gene +
factors I-Gene +
orchestrate O +
a O +
variety O +
of O +
cell O +
processes O +
including O +
apoptosis O +
, O +
cell O +
growth O +
, O +
and O +
tissue O +
differentiation O +
during O +
embryogenesis O +
. O +

In O +
studies O +
of O +
primary O +
malignancies O +
, O +
AP2alpha B-Gene +
has O +
been O +
shown O +
to O +
function O +
as O +
a O +
tumor O +
suppressor O +
in O +
breast O +
cancer O +
, O +
colon O +
cancer O +
, O +
and O +
malignant O +
melanoma O +
. O +

In O +
cell O +
culture O +
models O +
, O +
overexpression O +
of O +
AP2alpha B-Gene +
inhibits O +
cell O +
division O +
and O +
stable O +
colony O +
formation O +
, O +
whereas O +
, O +
a O +
dominant O +
- O +
negative O +
AP2alpha B-Gene +
mutant O +
increases O +
invasiveness O +
and O +
tumorigenicity O +
. O +

Here O +
we O +
show O +
that O +
AP2alpha B-Gene +
targets O +
the O +
p53 B-Gene +
tumor I-Gene +
suppressor I-Gene +
protein O +
. O +

Studies O +
with O +
chromatin O +
immunoprecipitation O +
demonstrate O +
that O +
AP2alpha B-Gene +
is O +
brought O +
to O +
p53 B-Gene +
binding O +
sites O +
in O +
p53 B-Gene +
- O +
regulated O +
promoters O +
. O +

The O +
interaction O +
between O +
AP2alpha B-Gene +
and O +
p53 B-Gene +
augments O +
p53 B-Gene +
- O +
mediated O +
transcriptional O +
activation O +
, O +
which O +
results O +
in O +
up O +
- O +
regulation O +
of O +
the O +
cyclin B-Gene +
- I-Gene +
dependent I-Gene +
kinase I-Gene +
inhibitor I-Gene +
p21 I-Gene +
( O +
WAF1 B-Gene +
/ O +
CIP1 B-Gene +
) O +
. O +

AP2alpha B-Gene +
is O +
able O +
to O +
induce O +
G O -
( O -
1 O -
) O +
and O +
G O -
( O -
2 O -
) O +
cell O +
cycle O +
arrest O +
only O +
in O +
the O +
presence O +
of O +
wild O +
- O +
type O +
p53 B-Gene +
. O +

Thus O +
, O +
we O +
conclude O +
that O +
the O +
tumor O +
suppressor O +
activity O +
of O +
AP2alpha B-Gene +
is O +
mediated O +
through O +
a O +
direct O +
interaction O +
with O +
p53 B-Gene +
. O +

These O +
results O +
also O +
provide O +
a O +
mechanism O +
to O +
explain O +
patterns O +
of O +
gene O +
expression O +
in O +
cancers O +
where O +
AP2alpha B-Gene +
is O +
known O +
to O +
function O +
as O +
a O +
tumor O +
suppressor O +
. O +

Transgenic O +
overexpression O +
of O +
human O +
IL-17E B-Gene +
results O +
in O +
eosinophilia O +
, O +
B O -
- O -
lymphocyte O +
hyperplasia O +
, O +
and O +
altered O +
antibody O +
production O +
. O +

We O +
have O +
identified O +
and O +
cloned O +
a O +
novel O +
human O +
cytokine B-Gene +
with O +
homology O +
to O +
cytokines B-Gene +
of O +
the O +
interleukin-17 B-Gene +
( I-Gene +
IL-17 I-Gene +
) I-Gene +
family I-Gene +
, O +
which O +
we O +
have O +
termed O +
human O +
IL-17E B-Gene +
( O +
hIL-17E B-Gene +
) O +
. O +

With O +
the O +
identification O +
of O +
several O +
IL-17 B-Gene +
family I-Gene +
members O +
, O +
it O +
is O +
critical O +
to O +
understand O +
the O +
in O +
vivo O +
function O +
of O +
these O +
molecules O +
. O +

We O +
have O +
generated O +
transgenic O +
mice O +
overexpressing O +
hIL-17E B-Gene +
using O +
an O +
apolipoprotein B-Gene +
E I-Gene +
( O +
ApoE B-Gene +
) O +
hepatic O +
promoter O +
. O +

These O +
mice O +
displayed O +
changes O +
in O +
the O +
peripheral O +
blood O +
, O +
particularly O +
, O +
a O +
3 O +
- O +
fold O +
increase O +
in O +
total O +
leukocytes O +
consisting O +
of O +
increases O +
in O +
eosinophils O +
, O +
lymphocytes O +
, O +
and O +
neutrophils O +
. O +

Splenomegaly O +
and O +
lymphoadenopathy O +
were O +
predominant O +
and O +
included O +
marked O +
eosinophil O +
infiltrates O +
and O +
lymphoid O +
hyperplasia O +
. O +

CCR3 B-Gene +
( O +
+ O +
) O +
eosinophils O +
increased O +
in O +
the O +
blood O +
and O +
lymph O +
nodes O +
of O +
the O +
transgenic O +
mice O +
by O +
50 O +
- O +
and O +
300 O +
- O +
fold O +
, O +
respectively O +
. O +

Eosinophils O +
also O +
increased O +
8 O +
- O +
to O +
18 O +
- O +
fold O +
in O +
the O +
bone O +
marrow O +
and O +
spleen O +
, O +
respectively O +
. O +

In O +
the O +
bone O +
marrow O +
, O +
most O +
of O +
the O +
eosinophils O +
had O +
an O +
immature O +
appearance O +
. O +

CD19 B-Gene +
( O +
+ O +
) O +
B O +
cells O +
increased O +
2 O +
- O +
to O +
5 O +
- O +
fold O +
in O +
the O +
peripheral O +
blood O +
, O +
2 O +
- O +
fold O +
in O +
the O +
spleen O +
, O +
and O +
10 O +
- O +
fold O +
in O +
the O +
lymph O +
nodes O +
of O +
transgenic O +
mice O +
, O +
whereas O +
CD4 B-Gene +
( O +
+ O +
) O +
T O +
lymphocytes O +
increased O +
2 O +
- O +
fold O +
in O +
both O +
blood O +
and O +
spleen O +
. O +

High O +
serum O +
levels O +
of O +
the O +
cytokines B-Gene +
IL-2 B-Gene +
, O +
IL-4 B-Gene +
, O +
IL-5 B-Gene +
, O +
granulocyte B-Gene +
colony I-Gene +
- I-Gene +
stimulating I-Gene +
factor I-Gene +
, O +
eotaxin B-Gene +
, O +
and O +
interferon B-Gene +
gamma I-Gene +
were O +
observed O +
. O +

Consistent O +
with O +
B O -
- O -
lymphocyte O +
increases O +
, O +
serum O +
immunoglobulin B-Gene +
( I-Gene +
Ig I-Gene +
) I-Gene +
M I-Gene +
, O +
IgG B-Gene +
, O +
and O +
IgE B-Gene +
were O +
significantly O +
elevated O +
. O +

Antigenic O +
challenge O +
of O +
the O +
transgenic O +
mice O +
with O +
keyhole B-Gene +
limpet I-Gene +
hemocyanin I-Gene +
( O +
KLH B-Gene +
) O +
resulted O +
in O +
a O +
decrease O +
in O +
anti O +
- O +
KLH B-Gene +
IgG B-Gene +
accompanied O +
by O +
increases O +
of O +
anti O +
- O +
KLH B-Gene +
IgA B-Gene +
and O +
IgE B-Gene +
. O +

In O +
situ O +
hybridization O +
of O +
transgenic O +
tissues O +
revealed O +
that O +
IL-17Rh1 B-Gene +
( O +
IL-17BR B-Gene +
/ O +
Evi27 B-Gene +
) O +
, O +
a O +
receptor O +
that O +
binds O +
IL-17E B-Gene +
, O +
is O +
up O +
- O +
regulated O +
. O +

Taken O +
together O +
, O +
these O +
data O +
indicate O +
that O +
IL-17E B-Gene +
regulates O +
hematopoietic O +
and O +
immune O +
functions O +
, O +
stimulating O +
the O +
development O +
of O +
eosinophils O +
and O +
B O +
lymphocytes O +
. O +

The O +
fact O +
that O +
hIL-17E B-Gene +
overexpression O +
results O +
in O +
high O +
levels O +
of O +
circulating O +
eosinophils O +
, O +
IL-4 B-Gene +
, O +
IL-5 B-Gene +
, O +
eotaxin B-Gene +
, O +
and O +
IgE B-Gene +
suggests O +
that O +
IL-17E B-Gene +
may O +
be O +
a O +
proinflammatory O +
cytokine B-Gene +
favoring O +
Th2 O +
- O +
type O +
immune O +
responses O +
. O +

Distinctive O +
response O +
of O +
thyroid O +
- O +
infiltrating O +
mononuclear O +
cells O +
to O +
B O +
cell O +
activation O +
through O +
CD40 B-Gene +
and O +
interleukin-4 B-Gene +
in O +
Graves O +
' O +
patients O +
. O +

The O +
possible O +
role O +
of O +
abnormal O +
T O +
cell O +
- O +
dependent O +
B O -
- O -
cell O +
activation O +
in O +
Graves O +
' O +
disease O +
was O +
investigated O +
by O +
comparing O +
lymphocyte O +
subset O +
distribution O +
and O +
the O +
production O +
of O +
soluble O +
CD8 B-Gene +
( O +
sCD8 B-Gene +
) O +
, O +
sCD23 B-Gene +
, O +
IL-10 B-Gene +
and O +
IL-12 B-Gene +
by O +
peripheral O +
blood O +
cells O +
( O +
PBMC O +
) O +
and O +
thyroid O +
- O +
infiltrating O +
lymphocytes O +
( O +
TL O +
) O +
in O +
vitro O +
. O +

In O +
TL O +
, O +
the O +
percentage O +
of O +
CD8 B-Gene +
( O +
+ O +
) O +
cells O +
was O +
slightly O +
higher O +
and O +
the O +
sCD8 B-Gene +
concentration O +
was O +
significantly O +
higher O +
than O +
in O +
PBMC O +
. O +

The O +
ratio O +
CD23 B-Gene +
( O +
+ O +
) O +
cells O +
to O +
CD20 B-Gene +
( O +
+ O +
) O +
cells O +
( O +
activated O +
B O +
/ O +
pan O +
B O +
cells O +
) O +
was O +
increased O +
in O +
TL O +
compared O +
to O +
PBMC O +
from O +
Graves O +
' O +
or O +
normal O +
controls O +
, O +
although O +
the O +
percentage O +
of O +
CD20 B-Gene +
( O +
+ O +
) O +
cells O +
was O +
decreased O +
. O +

Compared O +
to O +
PBMC O +
in O +
Graves O +
' O +
disease O +
, O +
the O +
relative O +
ratio O +
of O +
IL-10 B-Gene +
to O +
IL-12 B-Gene +
release O +
( O +
IL-10 B-Gene +
/ O +
IL-12 B-Gene +
) O +
by O +
unstimulated O +
TL O +
was O +
increased O +
, O +
despite O +
a O +
lack O +
of O +
significant O +
difference O +
between O +
PBMC O +
and O +
TL O +
in O +
mean O +
values O +
for O +
either O +
IL-10 B-Gene +
or O +
IL-12 B-Gene +
secretion O +
. O +

Incubating O +
PBMC O +
with O +
a O +
combination O +
of O +
anti O +
- O +
CD40 B-Gene +
monoclonal O +
antibodies O +
and O +
interleukin-4 B-Gene +
( O +
IL-4 B-Gene +
) O +
resulted O +
in O +
B O +
cell O +
activation O +
, O +
reflected O +
in O +
an O +
increase O +
in O +
the O +
sCD23 B-Gene +
level O +
in O +
both O +
controls O +
and O +
Graves O +
' O +
patients O +
, O +
but O +
especially O +
prominent O +
in O +
the O +
latter O +
. O +

Stimulation O +
with O +
anti O +
- O +
CD40 B-Gene +
antibody O +
and O +
IL-4 B-Gene +
also O +
decreased O +
the O +
percentage O +
of O +
CD8 B-Gene +
( O +
+ O +
) O +
cells O +
in O +
PBMC O +
but O +
not O +
TL O +
from O +
both O +
Graves O +
' O +
disease O +
and O +
normal O +
controls O +
, O +
and O +
the O +
percentage O +
of O +
CD8 B-Gene +
( O +
+ O +
) O +
cells O +
in O +
TL O +
was O +
higher O +
than O +
PBMC O +
after O +
the O +
stimulation O +
. O +

The O +
sCD23 B-Gene +
concentration O +
in O +
TL O +
was O +
decreased O +
compared O +
to O +
PBMC O +
both O +
in O +
patients O +
with O +
Graves O +
' O +
disease O +
and O +
normal O +
controls O +
. O +

However O +
, O +
in O +
contrast O +
to O +
the O +
increased O +
responses O +
observed O +
in O +
Graves O +
' O +
PBMC O +
or O +
normal O +
controls O +
after O +
stimulation O +
, O +
sCD23 B-Gene +
levels O +
remained O +
the O +
same O +
in O +
stimulated O +
TL O +
from O +
Graves O +
' O +
patients O +
. O +

This O +
combination O +
of O +
B O +
cell O +
stimulants O +
increased O +
production O +
of O +
IL-10 B-Gene +
in O +
PBMC O +
but O +
not O +
in O +
TL O +
obtained O +
from O +
patients O +
with O +
Graves O +
' O +
disease O +
, O +
and O +
the O +
increased O +
IL-10 B-Gene +
/ O +
IL-12 B-Gene +
ratio O +
declined O +
to O +
a O +
value O +
no O +
different O +
from O +
that O +
in O +
PBMC O +
group O +
after O +
stimulation O +
. O +

Thus O +
, O +
T O +
cell O +
- O +
dependent O +
B O -
- O -
cell O +
activation O +
via O +
a O +
CD40 B-Gene +
pathway O +
may O +
cause O +
a O +
shift O +
in O +
the O +
Th O -
( O -
1 O -
) O +
/ O +
Th O -
( O -
2 O -
) O +
balance O +
to O +
Th O -
( O -
2 O -
) O +
dominance O +
in O +
Graves O +
' O +
disease O +
, O +
while O +
increased O +
CD8 B-Gene +
( O +
+ O +
) O +
cells O +
in O +
TL O +
may O +
suppress O +
sCD23 B-Gene +
production O +
and O +
IL-10 B-Gene +
- O +
producing O +
Th O -
( O -
2 O -
) O +
cells O +
. O +

Evidence O +
for O +
involvement O +
of O +
a O +
hydrophobic O +
patch O +
in O +
framework O +
region O +
1 O +
of O +
human O +
V4 O -
- O -
34-encoded O +
Igs B-Gene +
in O +
recognition O +
of O +
the O +
red O +
blood O +
cell O +
I O +
antigen O +
. O +

The O +
monoclonal O +
IgM B-Gene +
cold B-Gene +
agglutinins I-Gene +
that O +
bind O +
to O +
the O +
I O +
/ O +
i O +
carbohydrate O +
Ags O +
on O +
the O +
surface O +
of O +
RBCs O +
all O +
have O +
Ig B-Gene +
H I-Gene +
chains O +
encoded O +
by O +
the O +
V4 O -
- O -
34 O +
gene O +
segment O +
. O +

This O +
mandatory O +
use O +
indicates O +
that O +
distinctive O +
amino O +
acid O +
sequences O +
may O +
be O +
involved O +
in O +
recognition O +
. O +

Critical O +
amino O +
acids O +
exist O +
in O +
framework O +
region O +
1 O +
( O +
FR1 O +
) O +
of O +
V4 O -
- O -
34-encoded O +
Ig B-Gene +
, O +
and O +
these O +
generate O +
a O +
specific O +
I O -
d O +
determinant O +
which O +
apparently O +
lies O +
close O +
to O +
the O +
I O +
binding O +
site O +
. O +

However O +
, O +
I O +
binding O +
by O +
Id O -
- O -
expressing O +
Ig B-Gene +
can O +
be O +
modulated O +
by O +
sequences O +
in O +
complementarity O +
- O +
determining O +
region O +
( O +
CDR O +
) O +
( O +
H O +
) O +
3 O +
. O +

Examination O +
of O +
the O +
crystal O +
structure O +
of O +
an O +
anti O +
- O +
I O +
cold B-Gene +
agglutinin I-Gene +
has O +
revealed O +
a O +
hydrophobic O +
patch O +
in O +
FR1 O +
involving O +
residue O +
W7 O +
on O +
beta O -
- O -
strand O +
A O +
and O +
the O +
AVY O +
motif O +
( O +
residues O +
23 O +
- O +
25 O +
) O +
on O +
beta O +
- O +
strand O +
B O +
. O +

In O +
this O +
study O +
we O +
used O +
mutagenesis O +
to O +
show O +
that O +
each O +
of O +
the O +
strand O +
components O +
of O +
the O +
hydrophobic O +
patch O +
is O +
required O +
for O +
binding O +
the O +
I O +
carbohydrate O +
Ag O +
. O +

In O +
addition O +
, O +
the O +
crystal O +
structure O +
reveals O +
that O +
amino O +
acids O +
in O +
the O +
carboxyl O +
- O +
terminal O +
region O +
of O +
CDR O -
( O -
H O -
) O -
3 O +
form O +
a O +
surface O +
region O +
adjacent O +
to O +
the O +
hydrophobic O +
patch O +
. O +

We O +
propose O +
that O +
the O +
I O +
carbohydrate O +
Ag O +
interacts O +
simultaneously O +
with O +
the O +
entire O +
hydrophobic O +
patch O +
in O +
FR1 O +
and O +
with O +
the O +
outside O +
surface O +
of O +
CDR O -
( O -
H O -
) O -
3 O +
. O +

This O +
interaction O +
could O +
leave O +
most O +
of O +
the O +
conventional O +
binding O +
site O +
available O +
for O +
binding O +
other O +
Ags O +
. O +

Identification O +
of O +
a O +
novel O +
family O +
of O +
cell O +
- O +
surface O +
proteins O +
expressed O +
in O +
human O +
vascular O +
endothelium O +
. O +

Vascular O +
endothelial O +
cells O +
( O +
EC O +
) O +
play O +
a O +
key O +
role O +
in O +
a O +
variety O +
of O +
pathophysiologic O +
processes O +
, O +
such O +
as O +
angiogenesis O +
, O +
inflammation O +
, O +
cancer O +
metastasis O +
, O +
and O +
vascular O +
diseases O +
. O +

As O +
part O +
of O +
a O +
strategy O +
to O +
identify O +
all O +
genes O +
expressed O +
in O +
human O +
EC O +
, O +
a O +
full O +
- O +
length O +
cDNA O +
encoding O +
a O +
potential O +
secreted O +
protein O +
harboring O +
10 O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
( O +
EGF B-Gene +
) O +
- O +
like O +
domains O +
and O +
one O +
CUB O +
domain O +
at O +
the O +
carboxyl O +
terminus O +
( O +
termed O +
, O +
SCUBE1 B-Gene +
for O +
Signal B-Gene +
peptide I-Gene +
- I-Gene +
CUB I-Gene -
- I-Gene -
EGF I-Gene +
- I-Gene +
like I-Gene +
domain I-Gene +
containing I-Gene +
protein I-Gene +
1 I-Gene +
) O +
was O +
identified O +
. O +

SCUBE1 B-Gene +
shares O +
homology O +
with O +
several O +
protein O +
families O +
, O +
including O +
members O +
of O +
the O +
fibrillin B-Gene +
and I-Gene +
Notch I-Gene +
families I-Gene +
, O +
and O +
the O +
anticoagulant O +
proteins O +
, O +
thrombomodulin B-Gene +
and O +
protein B-Gene +
C I-Gene +
. O +

SCUBE1 B-Gene +
mRNA O +
is O +
found O +
in O +
several O +
highly O +
vascularized O +
tissues O +
such O +
as O +
liver O +
, O +
kidney O +
, O +
lung O +
, O +
spleen O +
, O +
and O +
brain O +
and O +
is O +
selectively O +
expressed O +
in O +
EC O +
by O +
in O +
situ O +
hybridization O +
. O +

SCUBE1 B-Gene +
is O +
a O +
secreted O +
glycoprotein O +
that O +
can O +
form O +
oligomers O +
and O +
manifests O +
a O +
stable O +
association O +
with O +
the O +
cell O +
surface O +
. O +

A O +
second O +
gene O +
encoding O +
a O +
homologue O +
( O +
designated O +
SCUBE2 B-Gene +
) O +
was O +
also O +
identified O +
and O +
is O +
expressed O +
in O +
EC O +
as O +
well O +
as O +
other O +
cell O +
types O +
. O +

SCUBE2 B-Gene +
is O +
also O +
a O +
cell O +
- O +
surface O +
protein O +
and O +
can O +
form O +
a O +
heteromeric O +
complex O +
with O +
SCUBE1 B-Gene +
. O +

Both O +
SCUBE1 B-Gene +
and O +
SCUBE2 B-Gene +
are O +
rapidly O +
down O +
- O +
regulated O +
in O +
EC O +
after O +
interleukin-1beta B-Gene +
and O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
treatment O +
in O +
vitro O +
and O +
after O +
lipopolysaccharide O +
injection O +
in O +
vivo O +
. O +

Thus O +
, O +
SCUBE1 B-Gene +
and O +
SCUBE2 B-Gene +
define O +
an O +
emerging O +
family O +
of O +
human O +
secreted O +
proteins O +
that O +
are O +
expressed O +
in O +
vascular O +
endothelium O +
and O +
may O +
play O +
important O +
roles O +
in O +
development O +
, O +
inflammation O +
, O +
and O +
thrombosis O +
. O +

Recombinant O +
glucocorticoid B-Gene +
induced I-Gene +
tumour I-Gene +
necrosis I-Gene +
factor I-Gene +
receptor I-Gene +
( O +
rGITR B-Gene +
) O +
induced O +
COX-2 B-Gene +
activity O +
in O +
murine O +
macrophage O +
Raw O +
264.7 O +
cells O +
. O +

Stimulation O +
of O +
murine O +
macrophages O +
with O +
recombinant O +
soluble O +
glucocorticoid B-Gene +
induced I-Gene +
tumour I-Gene +
necrosis I-Gene +
factor I-Gene +
receptor I-Gene +
( O +
GITR B-Gene +
) O +
induced O +
cyclooxygenase B-Gene +
( I-Gene +
COX I-Gene +
) I-Gene +
- I-Gene +
2 I-Gene +
protein O +
and O +
generated O +
significant O +
amounts O +
of O +
PGE O -
( O -
2 O -
) O +
. O +

Previous O +
result O +
demonstrated O +
that O +
macrophages O +
express O +
GITR B-Gene +
and O +
GITR B-Gene +
ligand I-Gene +
constitutively O +
. O +

Induction O +
of O +
COX-2 B-Gene +
was O +
synergistic O +
with O +
interferon B-Gene +
( I-Gene +
INF I-Gene +
) I-Gene +
- I-Gene +
gamma I-Gene +
. O +

GITR B-Gene +
/ O +
ligand O +
system O +
could O +
deliver O +
an O +
activation O +
signal O +
to O +
macrophages O +
in O +
inflammatory O +
processes O +
. O +

Expression O +
of O +
trophinin B-Gene +
in O +
the O +
cycling O +
endometrium O +
and O +
its O +
association O +
with O +
infertility O +
. O +

OBJECTIVE O +
: O +

To O +
observe O +
the O +
expression O +
of O +
trophinin B-Gene +
in O +
the O +
cycling O +
endometrium O +
and O +
investigate O +
its O +
relationship O +
with O +
infertility O +
. O +

METHODS O +
: O +

Trophinin B-Gene +
expression O +
in O +
the O +
endometrium O +
was O +
observed O +
in O +
39 O +
normal O +
cycling O +
women O +
during O +
different O +
menstrual O +
phases O +
and O +
24 O +
women O +
with O +
infertility O +
during O +
mid O +
- O +
luteal O +
phase O +
by O +
immunohistochemical O +
technique O +
. O +

RESULTS O +
: O +

Trophinin B-Gene +
expression O +
was O +
detected O +
in O +
the O +
luteal O +
- O +
phase O +
endometrium O +
of O +
both O +
normal O +
and O +
infertile O +
women O +
, O +
which O +
peaked O +
in O +
the O +
mid O +
- O +
luteal O +
phase O +
. O +

In O +
comparison O +
with O +
normal O +
women O +
, O +
infertile O +
women O +
with O +
endometriosis O +
or O +
unexplained O +
infertility O +
had O +
significantly O +
weakened O +
trophinin B-Gene +
expression O +
in O +
the O +
endometrium O +
in O +
the O +
mid O +
- O +
luteal O +
( O +
P O +
< O +
0.001 O +
) O +
. O +

CONCLUSIONS O +
: O +

Trophinin B-Gene +
may O +
play O +
an O +
important O +
role O +
in O +
the O +
process O +
of O +
implantation O +
, O +
and O +
abnormal O +
endometrial O +
trophinin B-Gene +
expression O +
might O +
be O +
one O +
of O +
the O +
major O +
causes O +
of O +
infertility O +
. O +

Mutations O +
in O +
ANKH B-Gene +
cause O +
chondrocalcinosis O +
. O +

Chondrocalcinosis O +
( O +
CC O +
) O +
is O +
a O +
common O +
cause O +
of O +
joint O +
pain O +
and O +
arthritis O +
that O +
is O +
caused O +
by O +
the O +
deposition O +
of O +
calcium O +
- O +
containing O +
crystals O +
within O +
articular O +
cartilage O +
. O +

Although O +
most O +
cases O +
are O +
sporadic O +
, O +
rare O +
familial O +
forms O +
have O +
been O +
linked O +
to O +
human O +
chromosomes O +
8 O +
( O +
CCAL1 B-Gene +
) O +
or O +
5p O +
( O +
CCAL2 B-Gene +
) O +
( O +
Baldwin O +
et O +
al. O +
1995 O +
; O +
Hughes O +
et O +
al. O +
1995 O +
; O +
Andrew O +
et O +
al. O +
1999 O +
) O +
. O +

Here O +
, O +
we O +
show O +
that O +
two O +
previously O +
described O +
families O +
with O +
CCAL2 B-Gene +
have O +
mutations O +
in O +
the O +
human O +
homolog O +
of O +
the O +
mouse O +
progressive B-Gene +
ankylosis I-Gene +
gene I-Gene +
( O +
ANKH B-Gene +
) O +
. O +

One O +
of O +
the O +
human O +
mutations O +
results O +
in O +
the O +
substitution O +
of O +
a O +
highly O +
conserved O +
amino O +
acid O +
residue O +
within O +
a O +
predicted O +
transmembrane O +
segment O +
. O +

The O +
other O +
creates O +
a O +
new O +
ATG O +
start O +
site O +
that O +
adds O +
four O +
additional O +
residues O +
to O +
the O +
ANKH B-Gene +
protein O +
. O +

Both O +
mutations O +
segregate O +
completely O +
with O +
disease O +
status O +
and O +
are O +
not O +
found O +
in O +
control O +
subjects O +
. O +

In O +
addition O +
, O +
1 O +
of O +
95 O +
U.K. O +
patients O +
with O +
sporadic O +
CC O +
showed O +
a O +
deletion O +
of O +
a O +
single O +
codon O +
in O +
the O +
ANKH B-Gene +
gene O +
. O +

The O +
same O +
change O +
was O +
found O +
in O +
a O +
sister O +
who O +
had O +
bilateral O +
knee O +
replacement O +
for O +
osteoarthritis O +
. O +

Each O +
of O +
the O +
three O +
human O +
mutations O +
was O +
reconstructed O +
in O +
a O +
full O +
- O +
length O +
ANK B-Gene +
expression O +
construct O +
previously O +
shown O +
to O +
regulate O +
pyrophosphate O +
levels O +
in O +
cultured O +
cells O +
in O +
vitro O +
. O +

All O +
three O +
of O +
the O +
human O +
mutations O +
showed O +
significantly O +
more O +
activity O +
than O +
a O +
previously O +
described O +
nonsense O +
mutation O +
that O +
causes O +
severe O +
hydroxyapatite O +
mineral O +
deposition O +
and O +
widespread O +
joint O +
ankylosis O +
in O +
mice O +
. O +

These O +
results O +
suggest O +
that O +
small O +
sequence O +
changes O +
in O +
ANKH B-Gene +
are O +
one O +
cause O +
of O +
CC O +
and O +
joint O +
disease O +
in O +
humans O +
. O +

Increased O +
ANK B-Gene +
activity O +
may O +
explain O +
the O +
different O +
types O +
of O +
crystals O +
commonly O +
deposited O +
in O +
human O +
CCAL2 B-Gene +
families O +
and O +
mutant O +
mice O +
and O +
may O +
provide O +
a O +
useful O +
pharmacological O +
target O +
for O +
treating O +
some O +
forms O +
of O +
human O +
CC O +
. O +

A O +
27 O +
bp O +
cis O +
- O +
acting O +
sequence O +
is O +
essential O +
for O +
L B-Gene -
- I-Gene -
type I-Gene +
calcium I-Gene +
channel I-Gene +
alpha I-Gene -
( I-Gene -
1C I-Gene -
) I-Gene +
subunit O +
expression O +
in O +
vascular O +
smooth O +
muscle O +
cells O +
. O +

Expression O +
of O +
L B-Gene -
- I-Gene -
type I-Gene +
calcium I-Gene +
channels I-Gene +
in O +
cardiac O +
myocytes O +
and O +
vascular O +
smooth O +
muscle O +
cells O +
( O +
VSMC O +
) O +
critically O +
regulates O +
the O +
contractile O +
state O +
of O +
these O +
cells O +
. O +

In O +
order O +
to O +
discover O +
the O +
elements O +
in O +
the O +
promoter O +
region O +
of O +
the O +
Ca B-Gene -
( I-Gene -
v I-Gene -
) I-Gene -
1.2 I-Gene +
gene O +
encoding O +
the O +
vascular O +
/ O +
cardiac O +
calcium B-Gene +
channel I-Gene +
alpha I-Gene -
( I-Gene -
1C I-Gene -
) I-Gene +
subunit O +
that O +
are O +
important O +
for O +
the O +
basal O +
gene O +
expression O +
, O +
approximately O +
2 O +
kb O +
of O +
the O +
5 O -
' O +
- O +
flanking O +
sequence O +
of O +
the O +
Ca B-Gene -
( I-Gene -
v I-Gene -
) I-Gene -
1.2 I-Gene +
gene O +
has O +
been O +
cloned O +
in O +
our O +
lab O +
. O +

In O +
this O +
study O +
, O +
using O +
various O +
lengths O +
of O +
the O +
5 O -
' O +
- O +
flanking O +
DNA O +
fused O +
with O +
a O +
luciferase B-Gene +
gene O +
as O +
a O +
reporter O +
, O +
we O +
have O +
defined O +
a O +
493 O +
- O +
bp O +
fragment O +
of O +
the O +
cis O +
- O +
regulatory O +
DNA O +
which O +
carries O +
the O +
majority O +
of O +
promoter O +
activity O +
in O +
pulmonary O +
artery O +
smooth O +
muscle O +
( O +
PAC1 O +
) O +
cells O +
. O +

DNase B-Gene +
I I-Gene +
footprinting O +
analysis O +
of O +
this O +
493 O +
- O +
bp O +
DNA O +
using O +
nuclear O +
extracts O +
from O +
PAC1 O +
cells O +
revealed O +
a O +
27 O +
- O +
bp O +
DNA O +
sequence O +
that O +
contains O +
a O +
c B-Gene -
- I-Gene -
Ets I-Gene +
like O +
motif O +
( O +
CAGGATGC O +
) O +
. O +

Mutation O +
of O +
the O +
Ets B-Gene +
- O +
like O +
site O +
and O +
the O +
respective O +
flanking O +
sequence O +
within O +
the O +
DNase B-Gene +
I I-Gene +
footprinting O +
protection O +
region O +
induced O +
a O +
marked O +
change O +
in O +
the O +
promoter O +
activity O +
in O +
PAC1 O +
cells O +
. O +

Electrophoretic O +
mobility O +
shift O +
assays O +
( O +
EMSA O +
) O +
confirmed O +
the O +
presence O +
of O +
specific O +
binding O +
factor O -
( O -
s O -
) O +
in O +
PAC1 O +
cells O +
' O +
nuclear O +
extracts O +
for O +
this O +
27 O +
- O +
bp O +
DNA O +
. O +

Competition O +
studies O +
with O +
the O +
wild O +
- O +
type O +
and O +
mutated O +
DNA O +
fragments O +
established O +
the O +
importance O +
of O +
the O +
27 O +
bp O +
DNA O +
sequence O +
for O +
high O +
- O +
affinity O +
binding O +
of O +
the O +
nuclear O +
proteins O +
to O +
the O +
promoter O +
. O +

We O +
conclude O +
that O +
there O +
is O +
a O +
27 O +
bp O +
region O +
in O +
the O +
promoter O +
of O +
the O +
Ca B-Gene -
( I-Gene -
v I-Gene -
) I-Gene -
1.2 I-Gene +
gene O +
to O +
which O +
nuclear O +
proteins O +
from O +
VSMC O +
bind O +
and O +
strongly O +
regulate O +
the O +
basal O +
promoter O +
activity O +
. O +

Microsomal B-Gene +
epoxide I-Gene +
hydrolase I-Gene +
and O +
glutathione B-Gene +
S I-Gene -
- I-Gene -
transferase I-Gene +
polymorphisms O +
in O +
relation O +
to O +
laryngeal O +
carcinoma O +
risk O +
. O +

Two O +
polymorphic O +
sites O +
of O +
the O +
microsomal B-Gene +
epoxide I-Gene +
hydrolase I-Gene +
gene O +
( O +
EPHX1 B-Gene +
, O +
113Tyr O +
-- O -
> O +
113His O +
, O +
139His O +
-- O -
> O +
139Arg O +
) O +
and O +
four O +
glutathione B-Gene +
S I-Gene -
- I-Gene -
transferase I-Gene +
genes O +
( O +
GSTM1 B-Gene +
, O +
GSTM3 B-Gene +
, O +
GSTP1 B-Gene +
, O +
GSTT1 B-Gene +
) O +
were O +
genotyped O +
in O +
a O +
group O +
of O +
patients O +
with O +
larynx O +
cancer O +
( O +
N O +
= O +
204 O +
) O +
and O +
in O +
a O +
group O +
of O +
healthy O +
controls O +
( O +
N O +
= O +
203 O +
) O +
, O +
all O +
Spanish O +
caucasians O +
. O +

After O +
adjusting O +
for O +
gender O +
, O +
age O +
, O +
and O +
tobacco O +
smoking O +
, O +
none O +
of O +
the O +
polymorphisms O +
alone O +
were O +
found O +
to O +
be O +
associated O +
with O +
larynx O +
cancer O +
risk O +
. O +

The O +
analysis O +
of O +
EPHX1 B-Gene +
/ O +
GST B-Gene +
combinations O +
, O +
however O +
, O +
showed O +
a O +
significant O +
over O +
- O +
representation O +
of O +
patients O +
with O +
a O +
combination O +
of O +
113Tyr O +
/ O +
113Tyr O +
EPHX1 B-Gene +
and O +
105Ile O +
/ O +
105Ile O +
GSTP1 B-Gene +
( O +
adjusted O +
odds O +
ratio O +
( O +
OR O +
) O +
: O +
1.95 O +
; O +
95 O +
% O +
confidence O +
interval O +
( O +
CI O +
) O +
: O +
1.02 O +
- O +
3.78 O +
) O +
. O +

The O +
calculation O +
of O +
the O +
predicted O +
epoxide B-Gene +
hydrolase I-Gene +
( O +
EH B-Gene +
) O +
activity O +
also O +
showed O +
an O +
increased O +
risk O +
for O +
the O +
individuals O +
with O +
both O +
predicted O +
high O +
activity O +
EH B-Gene +
and O +
105Ile O +
/ O +
105Ile O +
GSTP1 B-Gene +
( O +
OR O +
: O +
2.90 O +
; O +
95 O +
% O +
CI O +
: O +
1.10 O +
- O +
7.67 O +
) O +
. O +

These O +
results O +
on O +
larynx O +
cancer O +
tend O +
to O +
confirm O +
a O +
former O +
study O +
on O +
lung O +
cancer O +
( O +
Cancer O +
Lett O -
. O +
173 O +
( O +
2001 O +
) O +
155 O +
) O +
suggesting O +
the O +
existence O +
of O +
an O +
interaction O +
between O +
variants O +
of O +
EH B-Gene +
and O +
GSTpi B-Gene +
, O +
both O +
enzymes O +
being O +
involved O +
in O +
the O +
metabolism O +
of O +
aromatic O +
hydrocarbons O +
, O +
that O +
may O +
increase O +
susceptibility O +
to O +
tobacco O +
- O +
related O +
cancers O +
. O +

Caspase B-Gene +
- O +
mediated O +
cleavage O +
of O +
adenovirus O +
early B-Gene +
region I-Gene +
1A I-Gene +
proteins O +
. O +

Adenovirus O +
2 O +
and O +
12 O +
early B-Gene +
region I-Gene +
1A I-Gene +
( O +
Ad2 O +
and O +
Ad12 O +
E1A B-Gene +
) O +
proteins O +
were O +
cleaved O +
during O +
cisplatin O +
- O +
induced O +
apoptosis O +
of O +
Ad O +
- O +
transformed O +
rat O +
and O +
human O +
cells O +
. O +

Cleavage O +
was O +
inhibited O +
in O +
the O +
presence O +
of O +
caspase B-Gene +
inhibitors O +
such O +
as O +
Z O -
- O -
VAD O -
- O -
FMK O +
. O +

In O +
Ad12 O +
transformants O +
both O +
13S B-Gene +
and I-Gene +
12S I-Gene +
E1A I-Gene +
proteins I-Gene +
were O +
cleaved O +
at O +
a O +
similar O +
rate O +
. O +

In O +
Ad2 O +
transformants O +
the O +
E1A B-Gene +
13S I-Gene +
component O +
was O +
appreciably O +
less O +
stable O +
than O +
the O +
12S B-Gene +
component O +
. O +

In O +
in O +
vitro O +
studies O +
Ad2 O +
and O +
Ad12 O +
E1A B-Gene +
13S I-Gene +
and O +
Ad2 O +
12S B-Gene +
proteins I-Gene +
were O +
rapidly O +
cleaved O +
by O +
caspase B-Gene +
3 I-Gene +
whereas O +
Ad12 O +
12S B-Gene +
E1A I-Gene +
and O +
Ad12 O +
13S B-Gene +
E1A I-Gene +
were O +
rapidly O +
degraded O +
by O +
caspase B-Gene +
7 I-Gene +
. O +

Cleavage O +
sites O +
in O +
Ad12 O +
13S B-Gene +
proteins I-Gene +
for O +
caspase B-Gene +
3 I-Gene +
have O +
been O +
determined O +
. O +

Initial O +
cleavage O +
occurred O +
at O +
D24 O +
and O +
D150 O +
; O +
this O +
was O +
followed O +
by O +
cleavage O +
at O +
D204 O +
and O +
D242 O +
. O +

Caspase-3 B-Gene +
- O +
mediated O +
cleavage O +
of O +
Ad12 O +
13S B-Gene +
E1A I-Gene +
destroyed O +
its O +
ability O +
to O +
bind O +
to O +
CBP B-Gene +
and O +
TBP B-Gene +
but O +
interaction O +
between O +
C O +
terminal O +
E1A B-Gene +
polypeptides O +
and O +
CtBP B-Gene +
was O +
observed O +
. O +

During O +
viral O +
infection O +
Ad5 O +
and O +
Ad12 O +
E1A B-Gene +
12S I-Gene +
proteins I-Gene +
were O +
markedly O +
more O +
stable O +
than O +
13S B-Gene +
proteins I-Gene +
but O +
no O +
difference O +
was O +
observed O +
in O +
Ad O +
E1A B-Gene +
levels O +
in O +
the O +
absence O +
or O +
presence O +
of O +
the O +
caspase B-Gene +
inhibitors O +
Z O -
- O -
VAD O -
- O -
FMK O +
or O +
Z O -
- O -
D O -
( O -
OMe O -
) O -
-E O -
( O -
OMe O -
) O -
-V O -
- O -
D O -
( O -
OMe O -
) O -
-CH O -
( O -
2 O -
) O -
F O +
. O +

Limited O +
caspase B-Gene +
3 I-Gene +
and I-Gene +
10 I-Gene +
activation O +
occurred O +
during O +
infection O +
with O +
the O +
E1B B-Gene +
19 I-Gene -
K I-Gene +
( O -
- O -
) O +
virus O +
Ad2 O +
pm1722 O +
but O +
little O +
or O +
no O +
activation O +
of O +
caspase B-Gene +
3 I-Gene +
was O +
observed O +
during O +
wt O +
virus O +
infection O +
. O +

Examination O +
of O +
protein O +
cleavage O +
during O +
viral O +
infection O +
of O +
A549 O +
cells O +
showed O +
proteolysis O +
of O +
lamin B-Gene +
B I-Gene +
and O +
PARP B-Gene +
in O +
response O +
to O +
Ad5 O +
wt O +
and O +
Ad2 O +
pm1722 O +
. O +

Protein O +
degradation O +
in O +
response O +
to O +
both O +
viruses O +
was O +
partially O +
inhibited O +
by O +
Z O -
- O -
VAD O -
- O -
FMK O +
. O +

Following O +
infection O +
of O +
human O +
skin O +
fibroblasts O +
lamin B-Gene +
B I-Gene +
was O +
degraded O +
, O +
although O +
only O +
limited O +
changes O +
in O +
PARP B-Gene +
levels O +
were O +
observed O +
. O +

We O +
have O +
concluded O +
that O +
Ad O +
E1A B-Gene +
is O +
cleaved O +
by O +
caspases B-Gene +
during O +
apoptosis O +
but O +
not O +
during O +
viral O +
infection O +
. O +

However O +
, O +
some O +
of O +
the O +
processes O +
commonly O +
associated O +
with O +
apoptosis O +
occur O +
during O +
viral O +
infection O +
, O +
particularly O +
with O +
E1B B-Gene +
19 I-Gene -
K I-Gene +
( O -
- O -
) O +
mutants O +
, O +
although O +
apoptosis O +
per O +
se O +
is O +
not O +
evident O +
. O +

Regulation O +
of O +
HIV-1 O +
transcription O +
by O +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
in O +
activated O +
Jurkat O +
T O +
cells O +
. O +

To O +
examine O +
the O +
mechanism O +
of O +
HIV-1 O +
regulation O +
by O +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
in O +
activated O +
human O +
cells O +
, O +
we O +
selected O +
a O +
Jurkat O +
cell O +
line O +
that O +
did O +
not O +
contain O +
endogenous O +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
. O +

In O +
this O +
cellular O +
environment O +
, O +
we O +
evaluated O +
the O +
effect O +
of O +
exogenous O +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
on O +
transcription O +
mediated O +
by O +
native O +
and O +
deleted O +
LTR O +
sequences O +
. O +

In O +
Jurkat O +
cells O +
stimulated O +
with O +
LPS O +
and O +
PMA O +
, O +
LTR O +
- O +
mediated O +
transcription O +
was O +
enhanced O +
by O +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
. O +

The O +
results O +
of O +
deletion O +
studies O +
revealed O +
a O +
central O +
role O +
for O +
the O +
basal O +
LTR O +
region O +
and O +
the O +
TATA O +
element O +
in O +
the O +
LTR O +
, O +
in O +
upregulation O +
of O +
reporter O +
gene O +
expression O +
by O +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
in O +
activated O +
cells O +
. O +

In O +
the O +
selected O +
cellular O +
environment O +
, O +
regulation O +
of O +
transcription O +
by O +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
was O +
not O +
evident O +
in O +
studies O +
of O +
promoter O +
regions O +
of O +
other O +
genes O +
. O +

The O +
results O +
implied O +
that O +
the O +
basal O +
region O +
of O +
HIV-1 O +
LTR O +
includes O +
molecular O +
properties O +
that O +
support O +
activation O +
of O +
HIV-1 O +
by O +
NF B-Gene -
- I-Gene -
IL6 I-Gene +
in O +
stimulated O +
cells O +
. O +

MafA B-Gene +
is O +
a O +
glucose O +
- O +
regulated O +
and O +
pancreatic O +
beta O -
- O -
cell O +
- O +
specific O +
transcriptional O +
activator O +
for O +
the O +
insulin B-Gene +
gene O +
. O +

The O +
insulin B-Gene +
gene O +
is O +
specifically O +
expressed O +
in O +
beta O -
- O -
cells O +
of O +
the O +
Langerhans O +
islets O +
of O +
the O +
pancreas O +
, O +
and O +
its O +
transcription O +
is O +
regulated O +
by O +
the O +
circulating O +
glucose O +
level O +
. O +

Previous O +
reports O +
have O +
shown O +
that O +
an O +
unidentified O +
beta O -
- O -
cell O +
- O +
specific O +
nuclear O +
factor O +
binds O +
to O +
a O +
conserved O +
cis O +
- O +
regulatory O +
element O +
called O +
RIPE3b B-Gene +
and O +
is O +
critical O +
for O +
its O +
glucose O +
- O +
regulated O +
expression O +
. O +

Based O +
on O +
the O +
sequence O +
similarity O +
of O +
the O +
RIPE3b B-Gene +
element O +
and O +
the O +
consensus O +
binding O +
sequence O +
of O +
the O +
Maf B-Gene +
family I-Gene +
of O +
basic O +
leucine O +
zipper O +
transcription B-Gene +
factors I-Gene +
, O +
we O +
here O +
identified O +
mammalian O +
homologue O +
of O +
avian O +
MafA B-Gene +
/ O +
L B-Gene -
- I-Gene -
Maf I-Gene +
, O +
an O +
eye O +
- O +
specific O +
member O +
of O +
the O +
Maf B-Gene +
family I-Gene +
, O +
as O +
the O +
RIPE3b B-Gene +
- O +
binding O +
transcriptional O +
activator O +
. O +

Reverse O +
transcription O +
- O +
PCR O +
analysis O +
showed O +
that O +
mafA B-Gene +
mRNA O +
is O +
detected O +
only O +
in O +
the O +
eyes O +
and O +
in O +
pancreatic O +
beta O -
- O -
cells O +
and O +
not O +
in O +
alpha O -
- O -
cells O +
. O +

MafA B-Gene +
protein O +
as O +
well O +
as O +
its O +
mRNA O +
is O +
up O +
- O +
regulated O +
by O +
glucose O +
, O +
consistent O +
with O +
the O +
glucose O +
- O +
regulated O +
binding O +
of O +
MafA B-Gene +
to O +
the O +
RIPE3b B-Gene +
element O +
in O +
beta O -
- O -
cell O +
nuclear O +
extracts O +
. O +

In O +
transient O +
luciferase B-Gene +
assays O +
, O +
we O +
also O +
showed O +
that O +
expression O +
of O +
MafA B-Gene +
greatly O +
enhanced O +
insulin O +
promoter O +
activity O +
and O +
that O +
a O +
dominant O +
- O +
negative O +
form O +
of O +
MafA B-Gene +
inhibited O +
it O +
. O +

Therefore O +
, O +
MafA B-Gene +
is O +
a O +
beta O -
- O -
cell O +
- O +
specific O +
and O +
glucose O +
- O +
regulated O +
transcriptional O +
activator O +
for O +
insulin B-Gene +
gene O +
expression O +
and O +
thus O +
may O +
be O +
involved O +
in O +
the O +
function O +
and O +
development O +
of O +
beta O -
- O -
cells O +
as O +
well O +
as O +
in O +
the O +
pathogenesis O +
of O +
diabetes O +
. O +

The O +
common O +
aromatic O +
amino O +
acid O +
biosynthesis O +
pathway O +
is O +
essential O +
in O +
Mycobacterium O +
tuberculosis O +
. O +

Attempts O +
to O +
construct O +
Mycobacterium O +
tuberculosis O +
strains O +
with O +
a O +
defect O +
in O +
the O +
common O +
aromatic O +
amino O +
acid O +
biosynthesis O +
pathway O +
were O +
made O +
. O +

In O +
other O +
bacteria O +
the O +
genes O +
of O +
this O +
pathway O +
( O +
aro B-Gene +
) O +
can O +
be O +
disrupted O +
in O +
the O +
presence O +
of O +
suitable O +
media O +
supplements O +
. O +

The O +
genomic O +
organization O +
of O +
the O +
aro B-Gene +
genes O +
in O +
M. O +
tuberculosis O +
reveals O +
that O +
there O +
is O +
one O +
operon O +
( O +
aroCKBQ B-Gene +
) O +
and O +
three O +
isolated O +
aro B-Gene +
genes O +
( O +
aroE B-Gene +
, O +
aroG B-Gene +
and O +
aroA B-Gene +
) O +
. O +

The O +
aroK B-Gene +
gene O +
was O +
chosen O +
as O +
a O +
target O +
for O +
disruption O +
; O +
this O +
encodes O +
shikimate B-Gene +
kinase I-Gene +
, O +
which O +
catalyses O +
the O +
fifth O +
step O +
in O +
chorismate O +
biosynthesis O +
. O +

Attempts O +
to O +
replace O +
the O +
wild O +
- O +
type O +
aroK B-Gene +
gene O +
with O +
a O +
disrupted O +
allele O +
( O +
aroKDelta B-Gene +
: O +
: O +
hyg B-Gene +
) O +
by O +
a O +
two O +
- O +
step O +
homologous O +
recombination O +
procedure O +
were O +
unsuccessful O +
in O +
a O +
wild O +
- O +
type O +
strain O +
. O +

When O +
a O +
second O +
functional O +
copy O +
of O +
aroK B-Gene +
was O +
integrated O +
into O +
the O +
chromosome O +
, O +
it O +
was O +
possible O +
to O +
isolate O +
a O +
strain O +
carrying O +
the O +
disrupted O +
gene O +
. O +

Excision O +
of O +
the O +
L5 O +
- O +
integrated O +
copy O +
of O +
aroK B-Gene +
by O +
the O +
L5 O +
excisionase B-Gene +
could O +
be O +
not O +
be O +
achieved O +
in O +
the O +
strain O +
carrying O +
the O +
disrupted O +
copy O +
, O +
but O +
was O +
possible O +
in O +
a O +
strain O +
carrying O +
a O +
wild O +
- O +
type O +
copy O +
. O +

These O +
results O +
demonstrate O +
that O +
the O +
chorismate O +
pathway O +
is O +
essential O +
for O +
the O +
viability O +
of O +
M. O +
tuberculosis O +
. O +

Mycobacterium O +
tuberculosis O +
- O +
infected O +
human O +
macrophages O +
exhibit O +
enhanced O +
cellular O +
adhesion O +
with O +
increased O +
expression O +
of O +
LFA-1 B-Gene +
and O +
ICAM-1 B-Gene +
and O +
reduced O +
expression O +
and/or O +
function O +
of O +
complement B-Gene +
receptors I-Gene +
, O +
FcgammaRII B-Gene +
and O +
the O +
mannose B-Gene +
receptor I-Gene +
. O +

The O +
entry O +
of O +
Mycobacterium O +
tuberculosis O +
( O +
Mtb O +
) O +
into O +
the O +
host O +
macrophage O +
and O +
its O +
survival O +
in O +
this O +
environment O +
are O +
key O +
components O +
of O +
tuberculosis O +
pathogenesis O +
. O +

Following O +
intracellular O +
replication O +
of O +
the O +
bacterium O +
within O +
alveolar O +
macrophages O +
, O +
there O +
is O +
spread O +
of O +
bacilli O +
to O +
regional O +
lymph O +
nodes O +
in O +
the O +
lungs O +
and O +
subsequent O +
presentation O +
of O +
antigens O +
to O +
the O +
host O +
immune O +
system O +
. O +

How O +
this O +
process O +
occurs O +
remains O +
poorly O +
understood O +
, O +
but O +
one O +
mechanism O +
may O +
involve O +
the O +
migration O +
of O +
macrophages O +
containing O +
Mtb O +
across O +
the O +
alveoli O +
to O +
lymph O +
nodes O +
, O +
where O +
there O +
is O +
development O +
of O +
a O +
protective O +
host O +
response O +
with O +
formation O +
of O +
granulomas O +
composed O +
in O +
part O +
of O +
aggregated O +
and O +
fused O +
, O +
apoptotic O +
, O +
infected O +
macrophages O +
. O +

Leukocyte O +
integrins B-Gene +
, O +
including O +
lymphocyte B-Gene +
function I-Gene +
- I-Gene +
associated I-Gene +
antigen-1 I-Gene +
( O +
LFA-1 B-Gene +
) O +
and O +
complement B-Gene +
receptors I-Gene +
CR3 B-Gene +
and O +
CR4 B-Gene +
, O +
and O +
their O +
counter O +
receptors O +
play O +
a O +
major O +
role O +
in O +
macrophage O +
adhesion O +
processes O +
and O +
phagocytosis O +
. O +

In O +
this O +
study O +
, O +
the O +
appearance O +
of O +
Mtb O +
- O +
infected O +
macrophages O +
over O +
time O +
was O +
examined O +
, O +
using O +
inverted O +
- O +
phase O +
microscopy O +
and O +
an O +
in O +
vitro O +
culture O +
model O +
of O +
human O +
monocyte O +
- O +
derived O +
macrophages O +
( O +
MDMs O +
) O +
. O +

Prior O +
to O +
and O +
immediately O +
following O +
infection O +
of O +
the O +
MDMs O +
with O +
Mtb O +
, O +
the O +
macrophages O +
appeared O +
as O +
individual O +
cells O +
in O +
monolayer O +
culture O +
; O +
however O +
, O +
within O +
24 O +
h O +
of O +
infection O +
with O +
Mtb O +
, O +
the O +
MDMs O +
began O +
to O +
migrate O +
and O +
adhere O +
to O +
each O +
other O +
. O +

The O +
kinetics O +
of O +
this O +
response O +
were O +
dependent O +
on O +
both O +
the O +
m.o.i O -
. O +
and O +
the O +
length O +
of O +
infection O +
. O +

Quantitative O +
transmission O +
electron O +
microscopy O +
studies O +
revealed O +
that O +
macrophage O +
adhesion O +
was O +
accompanied O +
by O +
increases O +
in O +
levels O +
of O +
LFA-1 B-Gene +
and O +
its O +
counter O +
receptor O +
( O +
ICAM-1 B-Gene +
) O +
, O +
decreases O +
in O +
surface O +
levels O +
of O +
the O +
phagocytic O +
receptors O +
CR3 B-Gene +
, O +
CR4 B-Gene +
and O +
FcgammaRII B-Gene +
, O +
and O +
an O +
increase O +
in O +
major B-Gene +
histocompatibility I-Gene +
complex I-Gene +
Class I-Gene +
II I-Gene +
( O +
MHC B-Gene -
- I-Gene -
II I-Gene +
) O +
molecules O +
at O +
72 O +
h O +
post O +
- O +
infection O +
. O +

Decreases O +
in O +
surface O +
levels O +
of O +
CR3 B-Gene +
and O +
CR4 B-Gene +
had O +
a O +
functional O +
correlate O +
, O +
with O +
macrophages O +
containing O +
live O +
bacilli O +
showing O +
a O +
diminished O +
phagocytic O +
capacity O +
for O +
complement O +
- O +
opsonized O +
sheep O +
erythrocytes O +
; O +
macrophages O +
containing O +
heat O +
- O +
killed O +
bacilli O +
did O +
not O +
show O +
this O +
diminished O +
capacity O +
. O +

The O +
modulation O +
of O +
macrophage O +
adhesion O +
and O +
phagocytic O +
proteins O +
may O +
influence O +
the O +
trafficking O +
of O +
Mtb O +
- O +
infected O +
macrophages O +
within O +
the O +
host O +
, O +
with O +
increases O +
in O +
levels O +
of O +
LFA-1 B-Gene +
and O +
ICAM-1 B-Gene +
enhancing O +
the O +
adhesive O +
properties O +
of O +
the O +
macrophage O +
and O +
decreases O +
in O +
phagocytic O +
receptors O +
diminishing O +
the O +
phagocytic O +
capacity O +
of O +
an O +
already O +
- O +
infected O +
cell O +
, O +
potentially O +
allowing O +
for O +
maintenance O +
of O +
the O +
intracellular O +
niche O +
of O +
Mtb O +
. O +

Engineering O +
tolerance O +
and O +
hyperaccumulation O +
of O +
arsenic O +
in O +
plants O +
by O +
combining O +
arsenate B-Gene +
reductase I-Gene +
and O +
gamma B-Gene -
- I-Gene -
glutamylcysteine I-Gene +
synthetase I-Gene +
expression O +
. O +

We O +
have O +
developed O +
a O +
genetics O +
- O +
based O +
phytoremediation O +
strategy O +
for O +
arsenic O +
in O +
which O +
the O +
oxyanion O +
arsenate O +
is O +
transported O +
aboveground O +
, O +
reduced O +
to O +
arsenite O +
, O +
and O +
sequestered O +
in O +
thiol O +
- O +
peptide O +
complexes O +
. O +

The O +
Escherichia O +
coli O +
arsC B-Gene +
gene O +
encodes O +
arsenate B-Gene +
reductase I-Gene +
( O +
ArsC B-Gene +
) O +
, O +
which O +
catalyzes O +
the O +
glutathione O +
( O +
GSH O +
) O +
- O +
coupled O +
electrochemical O +
reduction O +
of O +
arsenate O +
to O +
the O +
more O +
toxic O +
arsenite O +
. O +

Arabidopsis O +
thaliana O +
plants O +
transformed O +
with O +
the O +
arsC B-Gene +
gene O +
expressed O +
from O +
a O +
light O +
- O +
induced O +
soybean O +
rubisco B-Gene +
promoter O +
( O +
SRS1p B-Gene +
) O +
strongly O +
express O +
ArsC B-Gene +
protein O +
in O +
leaves O +
, O +
but O +
not O +
roots O +
, O +
and O +
were O +
consequently O +
hypersensitive O +
to O +
arsenate O +
. O +

Arabidopsis O +
plants O +
expressing O +
the O +
E. O +
coli O +
gene O +
encoding O +
gamma B-Gene -
- I-Gene -
glutamylcysteine I-Gene +
synthetase I-Gene +
( O +
gamma B-Gene -
- I-Gene -
ECS I-Gene +
) O +
from O +
a O +
strong O +
constitutive O +
actin B-Gene +
promoter O +
( O +
ACT2p B-Gene +
) O +
were O +
moderately O +
tolerant O +
to O +
arsenic O +
compared O +
with O +
wild O +
type O +
. O +

However O +
, O +
plants O +
expressing O +
SRS1p B-Gene +
/ O +
ArsC B-Gene +
and O +
ACT2p B-Gene +
/ O +
gamma B-Gene -
- I-Gene -
ECS I-Gene +
together O +
showed O +
substantially O +
greater O +
arsenic O +
tolerance O +
than O +
gamma B-Gene -
- I-Gene -
ECS I-Gene +
or O +
wild O +
- O +
type O +
plants O +
. O +

When O +
grown O +
on O +
arsenic O +
, O +
these O +
plants O +
accumulated O +
4 O +
- O +
to O +
17 O +
- O +
fold O +
greater O +
fresh O +
shoot O +
weight O +
and O +
accumulated O +
2 O +
- O +
to O +
3 O +
- O +
fold O +
more O +
arsenic O +
per O +
gram O +
of O +
tissue O +
than O +
wild O +
type O +
or O +
plants O +
expressing O +
gamma B-Gene -
- I-Gene -
ECS I-Gene +
or O +
ArsC B-Gene +
alone O +
. O +

This O +
arsenic O +
remediation O +
strategy O +
should O +
be O +
applicable O +
to O +
a O +
wide O +
variety O +
of O +
plant O +
species O +
. O +

Truncation O +
analysis O +
of O +
TatA B-Gene +
and O +
TatB B-Gene +
defines O +
the O +
minimal O +
functional O +
units O +
required O +
for O +
protein O +
translocation O +
. O +

The O +
TatA B-Gene +
and O +
TatB B-Gene +
proteins O +
are O +
essential O +
components O +
of O +
the O +
twin O +
arginine O +
protein O +
translocation O +
pathway O +
in O +
Escherichia O +
coli O +
. O +

C O +
- O +
terminal O +
truncation O +
analysis O +
of O +
the O +
TatA B-Gene +
protein O +
revealed O +
that O +
a O +
plasmid O +
- O +
expressed O +
TatA B-Gene +
protein O +
shortened O +
by O +
40 O +
amino O +
acids O +
is O +
still O +
fully O +
competent O +
to O +
support O +
protein O +
translocation O +
. O +

Similar O +
truncation O +
analysis O +
of O +
TatB B-Gene +
indicated O +
that O +
the O +
final O +
30 O +
residues O +
of O +
TatB B-Gene +
are O +
dispensable O +
for O +
function O +
. O +

Further O +
deletion O +
experiments O +
with O +
TatB B-Gene +
indicated O +
that O +
removal O +
of O +
even O +
70 O +
residues O +
from O +
its O +
C O +
terminus O +
still O +
allowed O +
significant O +
transport O +
. O +

These O +
results O +
imply O +
that O +
the O +
transmembrane O +
and O +
amphipathic O +
helical O +
regions O +
of O +
TatA B-Gene +
and O +
TatB B-Gene +
are O +
critical O +
for O +
their O +
function O +
but O +
that O +
the O +
C O +
- O +
terminal O +
domains O +
are O +
not O +
essential O +
for O +
Tat B-Gene +
transport O +
activity O +
. O +

A O +
chimeric O +
protein O +
comprising O +
the O +
N O +
- O +
terminal O +
region O +
of O +
TatA B-Gene +
fused O +
to O +
the O +
amphipathic O +
and O +
C O +
- O +
terminal O +
domains O +
of O +
TatB B-Gene +
supports O +
a O +
low O +
level O +
of O +
Tat B-Gene +
activity O +
in O +
a O +
strain O +
in O +
which O +
the O +
wild O +
- O +
type O +
copy O +
of O +
either O +
tatA B-Gene +
or O +
tatB B-Gene +
( O +
but O +
not O +
both O +
) O +
is O +
deleted O +
. O +

Regulatory O +
effect O +
of O +
IFN B-Gene -
- I-Gene -
kappa I-Gene +
, O +
a O +
novel O +
type B-Gene +
I I-Gene +
IFN I-Gene +
, O +
on O +
cytokine B-Gene +
production O +
by O +
cells O +
of O +
the O +
innate O +
immune O +
system O +
. O +

IFN B-Gene -
- I-Gene -
kappa I-Gene +
is O +
a O +
recently O +
identified O +
type B-Gene +
I I-Gene +
IFN I-Gene +
that O +
exhibits O +
both O +
structural O +
and O +
functional O +
homology O +
with O +
the O +
other O +
type B-Gene +
I I-Gene +
IFN I-Gene +
subclasses O +
. O +

In O +
this O +
study O +
, O +
we O +
have O +
investigated O +
the O +
effect O +
of O +
IFN B-Gene -
- I-Gene -
kappa I-Gene +
on O +
cells O +
of O +
the O +
innate O +
immune O +
system O +
by O +
comparing O +
cytokine B-Gene +
release O +
following O +
treatment O +
of O +
human O +
cells O +
with O +
either O +
IFN B-Gene -
- I-Gene -
kappa I-Gene +
or O +
two O +
recombinant O +
IFN B-Gene +
subtypes O +
, O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
and O +
IFN B-Gene -
- I-Gene -
alpha2a I-Gene +
. O +

Although O +
IFN B-Gene -
- I-Gene -
alpha2a I-Gene +
failed O +
to O +
stimulate O +
monocyte O +
cytokine B-Gene +
secretion O +
, O +
IFN B-Gene -
- I-Gene -
kappa I-Gene +
, O +
like O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
, O +
induced O +
the O +
release O +
of O +
several O +
cytokines B-Gene +
from O +
both O +
monocytes O +
and O +
dendritic O +
cells O +
, O +
without O +
the O +
requirement O +
of O +
a O +
costimulatory O +
signal O +
. O +

IFN B-Gene -
- I-Gene -
kappa I-Gene +
was O +
particularly O +
effective O +
in O +
inhibiting O +
inducible O +
IL-12 B-Gene +
release O +
from O +
monocytes O +
. O +

Unlike O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
, O +
IFN B-Gene -
- I-Gene -
kappa I-Gene +
did O +
not O +
induce O +
release O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
by O +
PBL O +
. O +

Expression O +
of O +
the O +
IFN B-Gene -
- I-Gene -
kappa I-Gene +
mRNA O +
was O +
observed O +
in O +
resting O +
dendritic O +
cells O +
and O +
monocytes O +
, O +
and O +
it O +
was O +
up O +
- O +
regulated O +
by O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
stimulation O +
in O +
monocytes O +
, O +
while O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
mRNA O +
was O +
minimally O +
detectable O +
under O +
the O +
same O +
conditions O +
. O +

Monocyte O +
and O +
dendritic O +
cell O +
expression O +
of O +
IFN B-Gene -
- I-Gene -
kappa I-Gene +
was O +
also O +
confirmed O +
in O +
vivo O +
in O +
chronic O +
lesions O +
of O +
psoriasis O +
vulgaris O +
and O +
atopic O +
dermatitis O +
. O +

Finally O +
, O +
biosensor O +
- O +
based O +
binding O +
kinetic O +
analysis O +
revealed O +
that O +
IFN B-Gene -
- I-Gene -
kappa I-Gene +
, O +
like O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
, O +
binds O +
strongly O +
to O +
heparin O +
( O +
K O -
( O -
d O -
) O +
: O +
2.1 O +
nM O +
) O +
, O +
suggesting O +
that O +
the O +
cytokine B-Gene +
can O +
be O +
retained O +
close O +
to O +
the O +
local O +
site O +
of O +
production O +
. O +

The O +
pattern O +
of O +
cytokines B-Gene +
induced O +
by O +
IFN B-Gene -
- I-Gene -
kappa I-Gene +
in O +
monocytes O +
, O +
coupled O +
with O +
the O +
unique O +
induction O +
of O +
IFN B-Gene -
- I-Gene -
kappa I-Gene +
mRNA O +
by O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
, O +
indicates O +
a O +
potential O +
role O +
for O +
IFN B-Gene -
- I-Gene -
kappa I-Gene +
in O +
the O +
regulation O +
of O +
immune O +
cell O +
functions O +
. O +

Killer B-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
haplotype O +
analysis O +
by O +
gene O +
content O +
: O +
evidence O +
for O +
genomic O +
diversity O +
with O +
a O +
minimum O +
of O +
six O +
basic O +
framework O +
haplotypes O +
, O +
each O +
with O +
multiple O +
subsets O +
. O +

Killer B-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( O +
KIR B-Gene +
) O +
genes O +
constitute O +
a O +
multigene O +
family O +
whose O +
genomic O +
diversity O +
is O +
achieved O +
through O +
differences O +
in O +
gene O +
content O +
and O +
allelic O +
polymorphism O +
. O +

KIR B-Gene +
haplotypes O +
containing O +
a O +
single O +
activating O +
KIR B-Gene +
gene O +
( O +
A O -
- O -
haplotypes O +
) O +
, O +
and O +
KIR B-Gene +
haplotypes O +
with O +
multiple O +
activating O +
receptor O +
genes O +
( O +
B O -
- O -
haplotypes O +
) O +
have O +
been O +
described O +
. O +

We O +
report O +
the O +
evaluation O +
of O +
KIR B-Gene +
gene O +
content O +
in O +
extended O +
families O +
, O +
sibling O +
pairs O +
, O +
and O +
an O +
unrelated O +
Caucasian O +
panel O +
through O +
identification O +
of O +
the O +
presence O +
or O +
absence O +
of O +
14 O +
KIR B-Gene +
genes O +
and O +
2 O +
pseudogenes O +
. O +

Haplotype O +
definition O +
included O +
subtyping O +
for O +
the O +
expressed O +
and O +
nonexpressed O +
KIR2DL5 B-Gene +
variants O +
, O +
for O +
two O +
alleles O +
of O +
pseudogene O +
3DP1 B-Gene +
, O +
and O +
for O +
two O +
alleles O +
of O +
2DS4 B-Gene +
, O +
including O +
a O +
novel O +
2DS4 B-Gene +
allele O +
, O +
KIR1D B-Gene +
. O +

KIR1D B-Gene +
appears O +
functionally O +
homologous O +
to O +
the O +
rhesus O +
monkey O +
KIR1D B-Gene +
and O +
likely O +
arose O +
as O +
a O +
consequence O +
of O +
a O +
22 O +
nucleotide O +
deletion O +
in O +
the O +
coding O +
sequence O +
of O +
2DS4 B-Gene +
, O +
leading O +
to O +
disruption O +
of O +
Ig B-Gene +
- O +
domain O +
2D O +
and O +
a O +
premature O +
termination O +
codon O +
following O +
the O +
first O +
amino O +
acid O +
in O +
the O +
putative O +
transmembrane O +
domain O +
. O +

Our O +
investigations O +
identified O +
11 O +
haplotypes O +
within O +
12 O +
families O +
. O +

From O +
49 O +
sibling O +
pairs O +
and O +
17 O +
consanguineous O +
DNA O +
samples O +
, O +
an O +
additional O +
12 O +
haplotypes O +
were O +
predicted O +
. O +

Our O +
studies O +
support O +
a O +
model O +
for O +
KIR B-Gene +
haplotype O +
diversity O +
based O +
on O +
six O +
basic O +
gene O +
compositions O +
. O +

We O +
suggest O +
that O +
the O +
centromeric O +
half O +
of O +
the O +
KIR B-Gene +
genomic O +
region O +
is O +
comprised O +
of O +
three O +
major O +
combinations O +
, O +
while O +
the O +
telomeric O +
half O +
can O +
assume O +
a O +
short O +
form O +
with O +
either O +
2DS4 B-Gene +
or O +
KIR1D B-Gene +
or O +
a O +
long O +
form O +
with O +
multiple O +
combinations O +
of O +
several O +
stimulatory O +
KIR B-Gene +
genes O +
. O +

Additional O +
rare O +
haplotypes O +
can O +
be O +
identified O +
, O +
and O +
may O +
have O +
arisen O +
by O +
gene O +
duplication O +
, O +
intergenic O +
recombination O +
, O +
or O +
deletions O +
. O +

[ O +
Sequencing O +
and O +
comparative O +
analysis O +
of O +
the O +
lux B-Gene +
operon I-Gene +
of O +
Photorhabdus O +
luminescens O +
strain O +
ZM1 O +
: O +
ERIC O +
elements O +
as O +
putative O +
recombination O +
spots O +
] O +

The O +
EcoRI B-Gene +
chromosomal O +
fragment O +
( O +
6782 O +
bp O +
) O +
containing O +
the O +
lux B-Gene +
operon I-Gene +
of O +
Photorhabdus O +
luminescens O +
was O +
cloned O +
in O +
pUC18 O +
and O +
completely O +
sequenced O +
. O +

Enteric O +
repetitive O +
intergenic O +
consensus O +
( O +
ERIC O +
) O +
, O +
an O +
imperfect O +
palindrome O +
( O +
125 O +
- O +
127 O +
bp O +
) O +
characteristics O +
for O +
Enterobacteriaceae O +
genomes O +
, O +
was O +
found O +
in O +
three O +
sites O +
. O +

Strain O +
Zm1 O +
proved O +
to O +
differ O +
in O +
ERIC O +
number O +
and O +
location O +
from O +
strains O +
Hb O +
, O +
Hm O +
, O +
and O +
Hw O +
. O +

Nucleotide O +
substitution O +
analysis O +
showed O +
that O +
luxC B-Gene +
and O +
luxB B-Gene +
, O +
which O +
are O +
more O +
than O +
1 O +
kb O +
away O +
from O +
ERIC O +
, O +
are O +
similar O +
to O +
the O +
corresponding O +
Hb O +
genes O +
, O +
whereas O +
luxD B-Gene +
, O +
luxA B-Gene +
, O +
and O +
luxE B-Gene +
, O +
which O +
are O +
close O +
to O +
ERIC O +
, O +
are O +
intermediate O +
between O +
their O +
Hb O +
and O +
Hw O +
counterparts O +
. O +

The O +
Hb O +
/ O +
Hw O +
nucleotide O +
substitution O +
ratio O +
was O +
1 O +
: O +
1 O +
in O +
regions O +
adjacent O +
to O +
ERIC O +
. O +

Hence O +
ERIC O +
were O +
assumed O +
to O +
play O +
a O +
role O +
of O +
recombination O +
hot O +
spots O +
in O +
the O +
bacterial O +
genome O +
. O +

Pharmacological O +
analysis O +
of O +
signal O +
transduction O +
pathways O +
required O +
for O +
mycobacterium O +
tuberculosis O +
- O +
induced O +
IL-8 B-Gene +
and O +
MCP-1 B-Gene +
production O +
in O +
human O +
peripheral O +
monocytes O +
. O +

Signalling O +
cascades O +
involved O +
in O +
chemokine B-Gene +
production O +
by O +
human O +
phagocytes O +
following O +
infection O +
with O +
Mycobacterium O +
tuberculosis O +
are O +
still O +
not O +
defined O +
. O +

We O +
used O +
specific O +
pharmacologic O +
inhibitors O +
to O +
identify O +
the O +
signalling O +
molecules O +
which O +
lead O +
to O +
interleukin B-Gene +
( I-Gene +
IL I-Gene +
) I-Gene +
- I-Gene +
8 I-Gene +
and O +
MCP-1 B-Gene +
production O +
in O +
human O +
monocytes O +
in O +
response O +
to O +
M. O +
tuberculosis O +
infection O +
. O +

Inhibition O +
of O +
extracellular B-Gene +
signal I-Gene +
- I-Gene +
regulated I-Gene +
( O +
ERK B-Gene +
) O +
or O +
p38 B-Gene +
mitogen I-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
by O +
PD98059 O +
and O +
SB203580 O +
respectively O +
, O +
significantly O +
affected O +
chemokine B-Gene +
production O +
. O +

However O +
, O +
only O +
the O +
presence O +
of O +
both O +
inhibitors O +
completely O +
blocked O +
the O +
release O +
. O +

A O +
down O +
- O +
regulation O +
of O +
chemokine O +
secretion O +
was O +
found O +
in O +
presence O +
of O +
inhibitors O +
of O +
protein B-Gene +
kinase I-Gene +
( I-Gene +
PK I-Gene +
) I-Gene +
C I-Gene +
and O +
phospholipase B-Gene +
C I-Gene +
. O +

Moreover O +
, O +
production O +
depended O +
on O +
transcription O +
activation O +
via O +
the O +
nuclear B-Gene +
factor I-Gene +
- I-Gene +
kappa I-Gene +
B I-Gene +
( O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
) O +
, O +
as O +
demonstrated O +
by O +
treatment O +
with O +
actinomycin O +
D O +
and O +
caffeic O +
acid O +
phenethyl O +
ester O +
. O +

In O +
addition O +
, O +
activation O +
of O +
PKA B-Gene +
and O +
the O +
phosphoinoside B-Gene +
3-kinase I-Gene +
( O +
PI-3k B-Gene +
) O +
/ O +
p70 B-Gene +
ribosomal I-Gene +
S6 I-Gene +
kinase I-Gene +
cascade O +
was O +
required O +
to O +
have O +
maximal O +
MCP-1 B-Gene +
but O +
not O +
IL-8 B-Gene +
production O +
. O +

In O +
conclusion O +
, O +
this O +
study O +
provides O +
evidence O +
that O +
multiple O +
signal O +
transduction O +
pathways O +
are O +
involved O +
in O +
M. O +
tuberculosis O +
- O +
induced O +
chemokine B-Gene +
secretion O +
by O +
human O +
monocytes O +
. O +

Moreover O +
, O +
for O +
the O +
first O +
time O +
this O +
report O +
indicates O +
that O +
inhibitors O +
of O +
some O +
signalling O +
molecules O +
are O +
able O +
to O +
dissociate O +
IL-8 B-Gene +
from O +
MCP-1 B-Gene +
secretion O +
. O +

Differences O +
in O +
the O +
regulatory O +
pathways O +
of O +
chemokine B-Gene +
production O +
can O +
potentially O +
be O +
exploited O +
therapeutically O +
. O +

Differential O +
roles O +
of O +
SOCS B-Gene +
family I-Gene +
members O +
in O +
EpoR B-Gene +
signal O +
transduction O +
. O +

To O +
elucidate O +
the O +
roles O +
of O +
suppressor B-Gene +
of I-Gene +
cytokine I-Gene +
signaling I-Gene +
( I-Gene +
SOCS I-Gene +
) I-Gene +
family I-Gene +
members O +
in O +
erythropoietin B-Gene +
( O +
EPO B-Gene +
) O +
signaling O +
, O +
we O +
explored O +
SOCS B-Gene +
gene O +
regulation O +
, O +
mRNA O +
stability O +
, O +
and O +
protein O +
function O +
in O +
two O +
EPO B-Gene +
- O +
responsive O +
hematopoietic O +
cell O +
lines O +
. O +

Using O +
two O +
independent O +
approaches O +
, O +
one O +
involving O +
inhibition O +
of O +
specific O +
signaling O +
molecules O +
and O +
the O +
other O +
employing O +
cell O +
lines O +
that O +
express O +
particular O +
EpoR B-Gene +
mutants O +
and O +
thereby O +
activate O +
only O +
subsets O +
of O +
signaling O +
cascades O +
, O +
we O +
demonstrate O +
that O +
induction O +
of O +
SOCS1 B-Gene +
, O +
SOCS2 B-Gene +
, O +
SOCS3 B-Gene +
, O +
and O +
cytokine B-Gene +
- I-Gene +
inducible I-Gene +
SH2 I-Gene +
- I-Gene +
containing I-Gene +
protein I-Gene +
( O +
CIS B-Gene +
) O +
in O +
response O +
to O +
EPO B-Gene +
stimulation O +
appears O +
to O +
depend O +
on O +
Stat5 B-Gene +
but O +
not O +
on O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
( O +
MAPK B-Gene +
) O +
or O +
phosphatidylinositol B-Gene +
3-kinase I-Gene +
( O +
PI3 B-Gene -
K I-Gene +
) O +
. O +

SOCS4 B-Gene +
expression O +
, O +
in O +
contrast O +
, O +
does O +
not O +
appear O +
to O +
be O +
EPO B-Gene +
inducible O +
. O +

Furthermore O +
, O +
we O +
show O +
differential O +
stabilities O +
of O +
SOCS B-Gene +
transcripts O +
, O +
with O +
SOCS2 B-Gene +
the O +
longest O +
- O +
lived O +
and O +
SOCS1 B-Gene +
and O +
CIS B-Gene +
the O +
least O +
stable O +
, O +
and O +
provide O +
evidence O +
in O +
support O +
of O +
EPO B-Gene +
- O +
independent O +
expression O +
of O +
SOCS3 B-Gene +
and O +
SOCS4 B-Gene +
. O +

In O +
order O +
to O +
understand O +
the O +
effects O +
of O +
SOCS B-Gene +
on O +
EPO B-Gene +
- O +
mediated O +
effects O +
, O +
we O +
generated O +
multiple O +
stable O +
cell O +
lines O +
that O +
inducibly O +
express O +
particular O +
SOCS B-Gene +
proteins O +
. O +

Overexpression O +
of O +
SOCS1 B-Gene +
, O +
SOCS3 B-Gene +
, O +
or O +
CIS B-Gene +
negatively O +
regulates O +
EPO B-Gene +
- O +
mediated O +
cell O +
proliferation O +
Stat5 B-Gene +
phosphorylation O +
, O +
and O +
activation O +
of O +
a O +
Stat B-Gene +
- O +
dependent O +
luciferase B-Gene +
reporter O +
. O +

In O +
contrast O +
, O +
SOCS2 B-Gene +
is O +
less O +
effective O +
, O +
and O +
SOCS4 B-Gene +
is O +
ineffective O +
at O +
counteracting O +
EPO B-Gene +
- O +
mediated O +
events O +
. O +

Thus O +
, O +
we O +
have O +
demonstrated O +
differential O +
regulation O +
and O +
function O +
of O +
various O +
SOCS B-Gene +
family I-Gene +
members O +
in O +
EPO B-Gene +
- O +
dependent O +
hematopoietic O +
cells O +
. O +

Association O +
of O +
IL4R B-Gene +
haplotypes O +
with O +
type O +
1 O +
diabetes O +
. O +

We O +
have O +
investigated O +
, O +
in O +
282 O +
multiplex O +
Caucasian O +
families O +
( O +
the O +
Human O +
Biological O +
Data O +
Interchange O +
Repository O +
) O +
, O +
the O +
association O +
of O +
type O +
1 O +
diabetes O +
with O +
polymorphisms O +
in O +
the O +
IL4R B-Gene +
gene O +
. O +

IL4R B-Gene +
encodes O +
a O +
subunit O +
of O +
the O +
interleukin-4 B-Gene +
receptor I-Gene +
, O +
a O +
molecule O +
critical O +
to O +
T O -
- O -
helper O +
cell O +
development O +
. O +

By O +
genotyping O +
eight O +
different O +
IL4R B-Gene +
single O +
- O +
nucleotide O +
polymorphisms O +
( O +
SNPs O +
) O +
and O +
identifying O +
haplotypes O +
( O +
complex O +
alleles O +
) O +
in O +
the O +
multiplex O +
type O +
1 O +
diabetic O +
families O +
who O +
were O +
stratified O +
for O +
HLA B-Gene +
genotype O +
, O +
we O +
have O +
observed O +
significant O +
evidence O +
of O +
linkage O +
and O +
association O +
of O +
the O +
IL4R B-Gene +
gene O +
to O +
type O +
1 O +
diabetes O +
. O +

In O +
particular O +
, O +
we O +
have O +
identified O +
a O +
specific O +
haplotype O +
that O +
appears O +
to O +
be O +
protective O +
and O +
observed O +
that O +
this O +
protective O +
effect O +
is O +
strongest O +
among O +
individuals O +
not O +
carrying O +
the O +
HLA B-Gene +
DR3 I-Gene +
/ I-Gene +
DR4 I-Gene +
genotype O +
( O +
which O +
confers O +
the O +
strongest O +
genetic O +
risk O +
for O +
type O +
1 O +
diabetes O +
) O +
. O +

These O +
findings O +
suggest O +
an O +
important O +
role O +
for O +
the O +
IL4R B-Gene +
gene O +
in O +
immune O +
- O +
related O +
disease O +
susceptibility O +
and O +
illustrate O +
the O +
value O +
of O +
using O +
multi O +
- O +
SNP O +
haplotype O +
information O +
in O +
association O +
studies O +
. O +

Alternative O +
core O +
promoters O +
regulate O +
tissue O +
- O +
specific O +
transcription O +
from O +
the O +
autoimmune O +
diabetes O +
- O +
related O +
ICA1 B-Gene +
( O +
ICA69 B-Gene +
) O +
gene O +
locus O +
. O +

Islet B-Gene +
cell I-Gene +
autoantigen I-Gene +
69 I-Gene +
- I-Gene +
kDa I-Gene +
( O +
ICA69 B-Gene +
) O +
, O +
protein O +
product O +
of O +
the O +
human O +
ICA1 B-Gene +
gene O +
, O +
is O +
one O +
target O +
of O +
the O +
immune O +
processes O +
defining O +
the O +
pathogenesis O +
of O +
Type O +
1 O +
diabetes O +
. O +

We O +
have O +
characterized O +
the O +
genomic O +
structure O +
and O +
functional O +
promoters O +
within O +
the O +
5 O -
' O +
- O +
regulatory O +
region O +
of O +
ICA1 B-Gene +
. O +

5 B-Gene -
' I-Gene +
- I-Gene +
RNA I-Gene +
ligase I-Gene +
- O +
mediated O +
rapid O +
amplification O +
of O +
cDNA O +
ends O +
evaluation O +
of O +
ICA1 B-Gene +
transcripts O +
expressed O +
in O +
human O +
islets O +
, O +
testis O +
, O +
heart O +
, O +
and O +
cultured O +
neuroblastoma O +
cells O +
reveals O +
that O +
three O +
5 O -
' O +
- O +
untranslated O +
region O +
exons O +
are O +
variably O +
expressed O +
from O +
the O +
ICA1 B-Gene +
gene O +
in O +
a O +
tissue O +
- O +
specific O +
manner O +
. O +

Surrounding O +
the O +
transcription O +
initiation O +
sites O +
are O +
motifs O +
characteristic O +
of O +
non O +
- O +
TATA O +
, O +
non O +
- O +
CAAT O +
, O +
GC O +
- O +
rich O +
promoters O +
, O +
including O +
consensus O +
Sp1 O +
/ O +
GC O +
boxes O +
, O +
an O +
initiator O +
element O +
, O +
cAMP B-Gene +
- I-Gene +
responsive I-Gene +
element I-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
( O +
CREB B-Gene +
) O +
sites O +
, O +
and O +
clusters O +
of O +
other O +
putative O +
transcription B-Gene +
factor I-Gene +
sites O +
within O +
a O +
genomic O +
CpG O +
island O +
. O +

Luciferase B-Gene +
reporter O +
constructs O +
demonstrate O +
that O +
the O +
first O +
two O +
ICA1 B-Gene +
exon O +
promoters O +
reciprocally O +
stimulate O +
luciferase B-Gene +
expression O +
within O +
islet O +
- O +
( O +
RIN O +
1046 O +
- O +
38 O +
cells O +
) O +
and O +
brain O +
- O +
derived O +
( O +
NMB7 O +
) O +
cells O +
in O +
culture O +
; O +
the O +
exon O +
A O +
promoter O +
exhibits O +
greater O +
activity O +
in O +
islet O +
cells O +
, O +
whereas O +
the O +
exon O +
B O +
promoter O +
more O +
efficiently O +
activates O +
transcription O +
in O +
neuronal O +
cells O +
. O +

Mutation O +
of O +
a O +
CREB B-Gene +
site O +
within O +
the O +
ICA1 B-Gene +
exon O +
B O +
promoter O +
significantly O +
enhances O +
transcriptional O +
activity O +
in O +
both O +
cell O +
lines O +
. O +

Our O +
basic O +
understanding O +
of O +
expression O +
from O +
the O +
functional O +
core O +
promoter O +
elements O +
of O +
ICA1 B-Gene +
is O +
an O +
important O +
advance O +
that O +
will O +
not O +
only O +
add O +
to O +
our O +
knowledge O +
of O +
the O +
ICA69 B-Gene +
autoantigen O +
but O +
will O +
also O +
facilitate O +
a O +
rational O +
approach O +
to O +
discover O +
the O +
function O +
of O +
ICA69 B-Gene +
and O +
to O +
identify O +
relevant O +
ICA1 B-Gene +
promoter O +
polymorphisms O +
and O +
their O +
potential O +
associations O +
with O +
disease O +
. O +

alpha B-Gene +
1-Adrenergic I-Gene +
receptor I-Gene +
subtypes O +
differentially O +
control O +
the O +
cell O +
cycle O +
of O +
transfected O +
CHO O +
cells O +
through O +
a O +
cAMP O +
- O +
dependent O +
mechanism O +
involving O +
p27Kip1 B-Gene +
. O +

Three O +
distinct O +
subtypes O +
of O +
alpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
-adrenergic I-Gene +
receptors I-Gene +
( O +
alpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
A- I-Gene +
, I-Gene +
alpha I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
B I-Gene +
- I-Gene +
, I-Gene +
and I-Gene +
alpha I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
D I-Gene -
- I-Gene -
AR I-Gene +
) O +
play O +
a O +
prominent O +
role O +
in O +
cell O +
growth O +
. O +

However O +
, O +
little O +
is O +
known O +
about O +
subtype O +
- O +
specific O +
effects O +
on O +
cell O +
proliferation O +
. O +

The O +
activation O +
of O +
alpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
A- I-Gene +
or I-Gene +
alpha I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
B I-Gene -
- I-Gene -
AR I-Gene +
inhibits O +
serum O +
- O +
promoted O +
cell O +
proliferation O +
, O +
whereas O +
alpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
D I-Gene -
- I-Gene -
AR I-Gene +
activation O +
does O +
not O +
show O +
such O +
an O +
inhibitory O +
effect O +
. O +

Notably O +
, O +
cell O +
- O +
cycle O +
progression O +
was O +
blocked O +
at O +
G O -
( O -
1 O -
) O +
/ O +
S O +
transition O +
after O +
activation O +
of O +
alpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
A I-Gene -
/ I-Gene -
alpha I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
B I-Gene -
- I-Gene -
AR I-Gene +
but O +
not O +
of O +
alpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
D I-Gene -
- I-Gene -
AR I-Gene +
. O +

In O +
agreement O +
with O +
the O +
differential O +
cell O +
proliferation O +
effect O +
, O +
cAMP O +
production O +
was O +
increased O +
after O +
activation O +
of O +
alpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
A I-Gene -
/ I-Gene -
alpha I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
B I-Gene -
- I-Gene -
AR I-Gene +
but O +
not O +
alpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
D I-Gene -
- I-Gene -
AR I-Gene +
, O +
whereas O +
all O +
alpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
-AR I-Gene +
subtypes O +
are O +
associated O +
with O +
inositol O +
1,4,5-trisphosphate O +
production O +
and O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
activation O +
in O +
a O +
similar O +
fashion O +
. O +

Furthermore O +
, O +
the O +
serum O +
- O +
induced O +
reduction O +
in O +
the O +
levels O +
of O +
the O +
cyclin B-Gene +
- I-Gene +
dependent I-Gene +
kinase I-Gene +
inhibitor I-Gene +
, O +
p27 B-Gene +
( I-Gene +
Kip1 I-Gene +
) I-Gene +
, O +
was O +
blocked O +
after O +
activation O +
of O +
alpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
A I-Gene -
/ I-Gene -
alpha I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
B I-Gene -
- I-Gene -
AR I-Gene +
but O +
not O +
alpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
D I-Gene -
- I-Gene -
AR I-Gene +
. O +

These O +
results O +
show O +
that O +
alpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
-AR I-Gene +
subtypes O +
differentially O +
activate O +
the O +
cAMP O +
/ O +
p27 B-Gene +
( I-Gene +
Kip1 I-Gene +
) I-Gene +
pathway O +
and O +
thereby O +
have O +
differential O +
inhibitory O +
effects O +
on O +
cell O +
proliferation O +
. O +

Subtype O +
- O +
dependent O +
effects O +
should O +
be O +
taken O +
into O +
consideration O +
when O +
assessing O +
the O +
physiological O +
response O +
of O +
native O +
cells O +
where O +
alpha B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
-AR I-Gene +
subtypes O +
are O +
generally O +
co O +
- O +
expressed O +
. O +

A O +
naturally O +
occurring O +
point O +
substitution O +
in O +
Cdc25A B-Gene +
, O +
and O +
not O +
Fv2 B-Gene +
/ O +
Stk B-Gene +
, O +
is O +
associated O +
with O +
altered O +
cell O +
- O +
cycle O +
status O +
of O +
early O +
erythroid O +
progenitor O +
cells O +
. O +

The O +
Friend B-Gene +
virus I-Gene +
susceptibility I-Gene +
gene I-Gene +
2 I-Gene +
( O +
Fv2 B-Gene +
) O +
controls O +
the O +
polyclonal O +
expansion O +
of O +
infected O +
cells O +
that O +
occurs O +
early O +
during O +
Friend O +
erythroleukemia O +
virus O +
infection O +
. O +

Fv2 B-Gene +
has O +
recently O +
been O +
shown O +
to O +
encode O +
a O +
truncated O +
form O +
of O +
the O +
Stk B-Gene +
receptor B-Gene +
tyrosine I-Gene +
kinase I-Gene +
( O +
Sf B-Gene -
- I-Gene -
Stk I-Gene +
) O +
. O +

This O +
observation O +
, O +
coupled O +
with O +
earlier O +
work O +
, O +
suggested O +
that O +
Sf B-Gene -
- I-Gene -
Stk I-Gene +
drives O +
the O +
expansion O +
of O +
infected O +
cells O +
by O +
forming O +
a O +
complex O +
with O +
the O +
Friend O +
virus O +
envelope O +
glycoprotein O +
, O +
gp55 B-Gene +
, O +
and O +
the O +
erythropoietin B-Gene +
receptor I-Gene +
. O +

Fv2 B-Gene +
has O +
also O +
been O +
implicated O +
in O +
the O +
control O +
of O +
cell O +
cycling O +
in O +
early O +
erythroid O +
progenitors O +
( O +
erythroid O +
blast O +
- O +
forming O +
units O +
[ O +
BFU O -
- O -
Es O -
] O -
) O +
. O +

Mouse O +
strains O +
that O +
are O +
homozygous O +
for O +
the O +
resistant O +
allele O +
of O +
Fv2 B-Gene +
( O +
Fv2 B-Gene +
( O +
rr O +
) O +
) O +
have O +
few O +
actively O +
cycling O +
BFU O -
- O -
Es O +
. O +

In O +
this O +
report O +
, O +
we O +
demonstrate O +
that O +
the O +
control O +
of O +
BFU O -
- O -
E O +
cycling O +
is O +
encoded O +
by O +
a O +
gene O +
linked O +
to O +
, O +
but O +
distinct O +
from O +
, O +
Fv2 B-Gene +
, O +
and O +
suggest O +
that O +
this O +
gene O +
is O +
the O +
dual B-Gene +
- I-Gene +
specific I-Gene +
protein I-Gene +
phosphatase I-Gene +
Cdc25A B-Gene +
, O +
which O +
regulates O +
the O +
G1 O +
- O +
to O +
S O -
- O -
phase O +
transition O +
of O +
the O +
cell O +
cycle O +
. O +

We O +
show O +
that O +
a O +
naturally O +
occurring O +
allele O +
of O +
Cdc25A B-Gene +
, O +
which O +
increases O +
Cdc25A B-Gene +
phosphatase I-Gene +
activity O +
and O +
promotes O +
cell O +
- O +
cycle O +
progression O +
, O +
segregates O +
in O +
mouse O +
strains O +
that O +
exhibit O +
high O +
levels O +
of O +
BFU O -
- O -
E O +
cell O +
cycling O +
. O +

In O +
wild O +
- O +
type O +
mice O +
, O +
this O +
allele O +
of O +
Cdc25A B-Gene +
does O +
not O +
overtly O +
affect O +
erythropoiesis O +
; O +
however O +
, O +
when O +
this O +
allele O +
is O +
combined O +
with O +
a O +
mutation O +
of O +
the O +
Kit B-Gene +
receptor O +
( O +
Kit B-Gene +
( O +
WV O +
) O +
) O +
, O +
the O +
anemia O +
of O +
the O +
mice O +
is O +
enhanced O +
. O +

Furthermore O +
, O +
overexpression O +
of O +
Cdc25A B-Gene +
in O +
bone O +
marrow O +
cells O +
causes O +
a O +
defect O +
in O +
the O +
BFU O -
- O -
E O +
colony O +
formation O +
. O +

These O +
results O +
suggest O +
that O +
proper O +
regulation O +
of O +
the O +
cell O +
cycle O +
through O +
Cdc25A B-Gene +
is O +
required O +
for O +
normal O +
erythropoiesis O +
. O +

Characterization O +
of O +
t O +
( O +
3 O +
; O +
6 O +
) O +
( O +
q27 O +
; O +
p21 O +
) O +
breakpoints O +
in O +
B O -
- O -
cell O +
non O +
- O +
Hodgkin O +
's O +
lymphoma O +
and O +
construction O +
of O +
the O +
histone B-Gene +
H4 I-Gene +
/ O +
BCL6 B-Gene +
fusion O +
gene O +
, O +
leading O +
to O +
altered O +
expression O +
of O +
Bcl-6 B-Gene +
. O +

A O +
recurrent O +
translocation O +
, O +
t O +
( O +
3 O +
; O +
6 O +
) O +
( O +
q27 O +
; O +
p21 O +
) O +
, O +
in O +
non O +
- O +
Hodgkin O +
's O +
lymphoma O +
results O +
in O +
fusion O +
of O +
BCL6 B-Gene +
with O +
a O +
particular O +
histone B-Gene +
H4 I-Gene +
gene O +
on O +
6p21 O +
. O +

We O +
cloned O +
five O +
H4 B-Gene +
/ O +
BCL6 B-Gene +
junctions O +
from O +
both O +
der O -
( O -
3 O -
) O +
and O +
der O +
( O +
6 O +
) O +
chromosomes O +
. O +

The O +
breakpoints O +
on O +
H4 B-Gene +
were O +
distributed O +
within O +
the O +
single O +
exon O +
or O +
close O +
to O +
the O +
terminal O +
palindrome O +
, O +
and O +
those O +
on O +
BCL6 B-Gene +
were O +
localized O +
within O +
or O +
close O +
to O +
the O +
translocation O +
hypercluster O +
. O +

Deletions O +
or O +
duplications O +
of O +
variable O +
numbers O +
of O +
nucleotides O +
were O +
identified O +
at O +
the O +
junctions O +
. O +

A O +
total O +
of O +
eight O +
single O +
nucleotide O +
alterations O +
were O +
introduced O +
into O +
the O +
translocation O +
/ O +
mutation O +
cluster O +
of O +
BCL6 B-Gene +
, O +
whereas O +
four O +
single O +
nucleotide O +
substitutions O +
were O +
identified O +
within O +
a O +
360 O +
- O +
bp O +
region O +
of O +
H4 B-Gene +
. O +

Thus O +
, O +
the O +
somatic O +
hypermutation O +
mechanism O +
is O +
likely O +
to O +
target O +
H4 B-Gene +
, O +
resulting O +
in O +
a O +
predisposition O +
to O +
the O +
development O +
of O +
translocation O +
with O +
BCL6 B-Gene +
. O +

Lymphoma O +
cells O +
carrying O +
H4 B-Gene +
/ O +
BCL6 B-Gene +
produced O +
fusion O +
transcripts O +
containing O +
both O +
H4 B-Gene +
and O +
BCL6 B-Gene +
messages O +
; O +
however O +
, O +
the O +
cells O +
expressed O +
only O +
moderate O +
levels O +
of O +
BCL6 B-Gene +
mRNA O +
. O +

We O +
constructed O +
expression O +
plasmids O +
that O +
mimicked O +
the O +
H4 B-Gene +
/ O +
BCL6 B-Gene +
fusion O +
gene O +
and O +
transiently O +
introduced O +
them O +
into O +
COS-7 O +
cells O +
. O +

H4 B-Gene +
/ O +
BCL6 B-Gene +
- O +
transfected O +
cells O +
expressed O +
markedly O +
higher O +
levels O +
of O +
Bcl-6 B-Gene +
protein O +
than O +
cells O +
transfected O +
with O +
a O +
plasmid O +
carrying O +
BCL6 B-Gene +
driven O +
by O +
its O +
normal O +
promoter O +
and O +
displayed O +
bright O +
nuclear O +
staining O +
with O +
a O +
characteristic O +
punctate O +
pattern O +
with O +
an O +
anti O +
- O +
Bcl-6 B-Gene +
antibody O +
. O +

Deletion O +
analyses O +
revealed O +
that O +
the O +
high O +
- O +
level O +
Bcl-6 B-Gene +
expression O +
was O +
promoted O +
by O +
the O +
H4 B-Gene +
regulatory O +
sequences O +
. O +

The O +
levels O +
of O +
expression O +
of O +
activating B-Gene +
transcription I-Gene +
factor I-Gene +
3 I-Gene +
, O +
prefoldin B-Gene +
4 I-Gene +
, O +
and O +
retinoblastoma B-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
7 I-Gene +
significantly O +
increased O +
in O +
accordance O +
with O +
that O +
of O +
BCL6 B-Gene +
, O +
suggesting O +
that O +
Bcl-6 B-Gene +
may O +
act O +
as O +
a O +
transcriptional O +
activator O +
. O +

Our O +
study O +
suggested O +
that O +
t O +
( O +
3 O +
; O +
6 O +
) O +
( O +
q27 O +
; O +
p21 O +
) O +
leads O +
to O +
BCL6 B-Gene +
overexpression O +
; O +
however O +
, O +
the O +
high O +
- O +
level O +
BCL6 B-Gene +
expression O +
may O +
not O +
be O +
required O +
to O +
maintain O +
the O +
malignant O +
phenotype O +
of O +
lymphoma O +
cells O +
. O +

The O +
expression O +
of O +
alpha B-Gene -
- I-Gene -
dystrobrevin I-Gene +
and O +
dystrophin B-Gene +
during O +
skeletal O +
muscle O +
regeneration O +
. O +

The O +
expression O +
of O +
alpha B-Gene -
- I-Gene -
dystrobrevin I-Gene +
and O +
dystrophin B-Gene +
in O +
rat O +
tibialis O +
anterior O +
muscles O +
was O +
chronologically O +
evaluated O +
during O +
a O +
cycle O +
of O +
regeneration O +
after O +
myonecrosis O +
induced O +
by O +
the O +
injection O +
of O +
cardiotoxin B-Gene +
. O +

In O +
immunohistochemical O +
studies O +
, O +
alpha B-Gene -
- I-Gene -
dystrobrevin I-Gene +
and O +
dystrophin B-Gene +
were O +
first O +
stained O +
weakly O +
at O +
the O +
sarcolemma O +
of O +
some O +
regenerating O +
muscle O +
fibers O +
on O +
day O +
5 O +
. O +

On O +
day O +
7 O +
, O +
alpha B-Gene -
- I-Gene -
dystrobrevin I-Gene +
was O +
still O +
stained O +
weakly O +
, O +
whereas O +
dystrophin B-Gene +
was O +
stained O +
conspicuously O +
. O +

After O +
day O +
10 O +
, O +
alpha B-Gene +
- I-Gene +
dystrobrevin I-Gene +
and O +
dystrophin B-Gene +
were O +
both O +
stained O +
conspicuously O +
on O +
almost O +
all O +
regenerating O +
muscle O +
fibers O +
. O +

In O +
the O +
Western O +
blot O +
analysis O +
, O +
alpha B-Gene -
- I-Gene -
dystrobrevin I-Gene +
and O +
dystrophin B-Gene +
were O +
first O +
detected O +
as O +
visible O +
bands O +
on O +
days O +
5 O +
and O +
7 O +
, O +
respectively O +
. O +

The O +
bands O +
of O +
alpha B-Gene -
- I-Gene -
dystrobrevin I-Gene +
and O +
dystrophin B-Gene +
both O +
darkened O +
sequentially O +
up O +
to O +
day O +
10 O +
. O +

The O +
protein O +
levels O +
based O +
on O +
the O +
densitometrical O +
analysis O +
of O +
the O +
bands O +
on O +
each O +
day O +
were O +
converted O +
to O +
the O +
percentage O +
of O +
the O +
protein O +
level O +
on O +
day O +
28 O +
, O +
which O +
was O +
taken O +
as O +
100 O +
% O +
. O +

The O +
sequential O +
line O +
based O +
on O +
these O +
data O +
showed O +
that O +
alpha B-Gene -
- I-Gene -
dystrobrevin I-Gene +
and O +
dystrophin B-Gene +
reached O +
50 O +
% O +
of O +
the O +
protein O +
level O +
on O +
day O +
28 O +
by O +
6.6 O +
and O +
5.3 O +
days O +
, O +
respectively O +
. O +

These O +
data O +
provide O +
evidence O +
that O +
alpha B-Gene -
- I-Gene -
dystrobrevin I-Gene +
regenerates O +
more O +
slowly O +
than O +
dystrophin B-Gene +
in O +
skeletal O +
muscle O +
. O +

In O +
vivo O +
interference O +
with O +
Skp1 B-Gene +
function O +
leads O +
to O +
genetic O +
instability O +
and O +
neoplastic O +
transformation O +
. O +

Skp1 B-Gene +
is O +
involved O +
in O +
a O +
variety O +
of O +
crucial O +
cellular O +
functions O +
, O +
among O +
which O +
the O +
best O +
understood O +
is O +
the O +
formation O +
together O +
with O +
Cul1 B-Gene +
of O +
Skp1 B-Gene +
- O +
cullin B-Gene +
- O +
F O -
- O -
box O +
protein O +
ubiquitin B-Gene +
ligases I-Gene +
. O +

To O +
investigate O +
the O +
role O +
of O +
Skp1 B-Gene +
, O +
we O +
generated O +
transgenic O +
( O +
Tg O +
) O +
mice O +
expressing O +
a O +
Cul1 B-Gene +
deletion O +
mutant O +
( O +
Cul1 B-Gene +
- O +
N252 O +
) O +
able O +
to O +
sequestrate O +
and O +
inactivate O +
Skp1 B-Gene +
. O +

In O +
vivo O +
interference O +
with O +
Skp1 B-Gene +
function O +
through O +
expression O +
of O +
the O +
Cul1 B-Gene +
- O +
N252 O +
mutant O +
into O +
the O +
T O -
- O -
cell O +
lineage O +
results O +
in O +
lymphoid O +
organ O +
hypoplasia O +
and O +
reduced O +
proliferation O +
. O +

Nonetheless O +
, O +
after O +
a O +
period O +
of O +
latency O +
, O +
Cul1 B-Gene +
- O +
N252 O +
Tg O +
mice O +
succumb O +
to O +
T O -
- O -
cell O +
lymphomas O +
with O +
high O +
penetrance O +
( O +
> O +
80 O +
% O +
) O +
. O +

Both O +
T O -
- O -
cell O +
depletion O +
and O +
the O +
neoplastic O +
phenotype O +
of O +
Cul1 B-Gene +
- O +
N252 O +
Tg O +
mice O +
are O +
largely O +
rescued O +
in O +
Cul1 B-Gene +
- O +
N252 O +
, O +
Skp1 B-Gene +
double O +
- O +
Tg O +
mice O +
, O +
indicating O +
that O +
the O +
effects O +
of O +
Cul1 B-Gene +
- O +
N252 O +
are O +
due O +
to O +
a O +
sequestration O +
of O +
the O +
endogenous O +
Skp1 B-Gene +
. O +

Analysis O +
of O +
Cul1 B-Gene +
- O +
N252 O +
lymphomas O +
demonstrates O +
striking O +
karyotype O +
heterogeneity O +
associated O +
with O +
c B-Gene -
- I-Gene -
myc I-Gene +
amplification O +
and O +
c B-Gene -
- I-Gene -
Myc I-Gene +
overexpression O +
. O +

We O +
show O +
that O +
the O +
in O +
vitro O +
expression O +
of O +
the O +
Cul1 B-Gene +
- O +
N252 O +
mutant O +
causes O +
a O +
pleiotrophic O +
phenotype O +
, O +
which O +
includes O +
the O +
formation O +
of O +
multinucleated O +
cells O +
, O +
centrosome O +
and O +
mitotic O +
spindle O +
abnormalities O +
, O +
and O +
impaired O +
chromosome O +
segregation O +
. O +

Our O +
findings O +
support O +
a O +
crucial O +
role O +
for O +
Skp1 B-Gene +
in O +
proper O +
chromosomal O +
segregation O +
, O +
which O +
is O +
required O +
for O +
the O +
maintenance O +
of O +
euploidy O +
and O +
suppression O +
of O +
transformation O +
. O +

Localization O +
of O +
IL-1alpha B-Gene +
, O +
IL-1 B-Gene +
RI I-Gene +
, O +
TNF B-Gene +
, O +
TNF B-Gene -
- I-Gene -
RI I-Gene +
and O +
TNF B-Gene -
- I-Gene -
RII I-Gene +
during O +
physiological O +
drift O +
of O +
rat O +
molar O +
teeth O +
-- O +
an O +
immunohistochemical O +
and O +
in O +
situ O +
hybridization O +
study O +
. O +

Proinflammatory O +
cytokines B-Gene +
such O +
as O +
IL-1 B-Gene +
and O +
TNF B-Gene +
play O +
a O +
crucial O +
role O +
in O +
the O +
initiation O +
of O +
an O +
inflammatory O +
response O +
to O +
bacterial O +
irritants O +
and O +
subsequent O +
periodontal O +
tissue O +
destruction O +
. O +

The O +
object O +
of O +
the O +
present O +
investigation O +
was O +
to O +
examine O +
the O +
possible O +
role O +
of O +
these O +
cytokines B-Gene +
in O +
the O +
periodontal O +
tissues O +
under O +
physiological O +
conditions O +
. O +

To O +
this O +
end O +
we O +
studied O +
the O +
expression O +
of O +
IL-1alpha B-Gene +
and O +
TNF B-Gene +
both O +
at O +
the O +
transcription O +
and O +
protein O +
level O +
by O +
means O +
of O +
in O +
situ O +
hybridization O +
and O +
immunohistochemistry O +
and O +
investigated O +
the O +
distribution O +
of O +
IL-1RI B-Gene +
, O +
TNF B-Gene -
- I-Gene -
RI I-Gene +
and O +
TNF B-Gene -
- I-Gene -
RII I-Gene +
immunohistochemically O +
in O +
10 O +
jaw O +
specimens O +
taken O +
from O +
male O +
Wistar O +
rats O +
. O +

We O +
found O +
IL-1alpha B-Gene +
and O +
TNF B-Gene +
mRNA O +
to O +
be O +
focally O +
transcribed O +
in O +
bone O +
marrow O +
cells O +
of O +
the O +
monocyte O +
/ O +
macrophage O +
lineage O +
, O +
in O +
gingival O +
epithelium O +
as O +
well O +
as O +
in O +
single O +
osteoblasts O +
and O +
osteoclasts O +
. O +

Additionally O +
, O +
IL-1alpha B-Gene +
mRNA O +
was O +
detected O +
in O +
PDL O +
- O +
fibroblasts O +
and O +
epithelial O +
remnants O +
of O +
Malassez O +
. O +

The O +
IL-1alpha B-Gene +
immunohistochemistry O +
observations O +
were O +
corroborated O +
by O +
the O +
in O +
situ O +
hybridization O +
results O +
. O +

TNF O +
and O +
its O +
receptors O +
were O +
not O +
detected O +
at O +
the O +
protein O +
level O +
. O +

These O +
data O +
suggest O +
that O +
IL-1alpha B-Gene +
and O +
its O +
receptor O +
are O +
of O +
some O +
importance O +
in O +
the O +
maintenance O +
of O +
tissue O +
homeostasis O +
and O +
remodeling O +
events O +
accompanied O +
by O +
physiological O +
tooth O +
movement O +
. O +

Altered O +
biological O +
activity O +
associated O +
with O +
C O +
- O +
terminal O +
modifications O +
of O +
IL-7 B-Gene +
. O +

Interleukin B-Gene +
7 I-Gene +
( O +
IL-7 B-Gene +
) O +
is O +
a O +
pleiotropic O +
cytokine B-Gene +
which O +
plays O +
a O +
role O +
in O +
both O +
T O +
and O +
B O +
cell O +
function O +
as O +
well O +
as O +
in O +
establishment O +
and O +
maintenance O +
of O +
immunological O +
barriers O +
in O +
epithelial O +
tissues O +
. O +

The O +
heterodimeric O +
IL-7 B-Gene +
receptor I-Gene +
( O +
IL-7R B-Gene +
) O +
consists O +
of O +
the O +
p76 O +
IL-7Ralpha B-Gene +
subunit O +
and O +
the O +
p64 B-Gene +
common I-Gene +
gamma I-Gene +
( O +
gammac B-Gene +
) O +
subunit O +
. O +

Ligand O +
- O +
binding O +
induces O +
signal O +
transduction O +
through O +
tyrosine O +
phosphorylation O +
of O +
the O +
janus B-Gene +
( I-Gene +
Jak I-Gene +
) I-Gene +
and I-Gene +
src I-Gene +
- I-Gene +
related I-Gene +
kinases I-Gene +
as O +
well O +
as O +
by O +
activation O +
of O +
phosphatidinositol-3 B-Gene +
kinase I-Gene +
( O +
P13-kinase B-Gene +
) O +
. O +

In O +
an O +
effort O +
to O +
further O +
define O +
the O +
requirements O +
for O +
ligand O +
- O +
receptor O +
interactions O +
and O +
to O +
subsequently O +
develop O +
candidate O +
receptor O +
binding O +
antagonists O +
with O +
selective O +
biological O +
activities O +
, O +
we O +
examined O +
a O +
series O +
of O +
IL-7 B-Gene +
mutants O +
in O +
which O +
the O +
carboxy O +
terminal O +
hydrophobic O +
residues O +
were O +
substituted O +
with O +
aliphatic O +
amino O +
acids O +
. O +

In O +
this O +
study O +
we O +
describe O +
abrogation O +
of O +
IL-7 B-Gene +
driven O +
proliferation O +
and O +
attenuated O +
phosphotyrosine O +
signaling O +
by O +
IL-7 B-Gene +
( O -
143 O -
) O +
( O +
Trp O -
- O -
Ala O +
) O +
and O +
IL-7 B-Gene +
( O -
143 O -
) O +
( O +
Trp O -
- O -
His O +
) O +
in O +
IL-7R B-Gene +
expressing O +
T O +
and O +
B O +
leukemia O +
cells O +
. O +

Decreased O +
phosphorylation O +
of O +
Jak3 B-Gene +
kinase B-Gene +
by O +
IL-7W143A B-Gene +
, O +
IL-7W143P B-Gene +
and O +
IL-7W143H B-Gene +
suggest O +
that O +
alterations O +
in O +
this O +
region O +
of O +
the O +
carboxyterminal O +
region O +
of O +
IL-7 B-Gene +
affects O +
its O +
interaction O +
with O +
the O +
gammac B-Gene +
subunit O +
of O +
the O +
IL-7R B-Gene +
. O +

The O +
C O +
- O +
terminal O +
region O +
of O +
ammodytoxins B-Gene +
is O +
important O +
but O +
not O +
sufficient O +
for O +
neurotoxicity O +
. O +

Ammodytoxins B-Gene +
( O +
Atxs B-Gene +
) O +
are O +
presynaptically O +
acting O +
snake O +
venom O +
phospholipase B-Gene +
A2 I-Gene +
( O +
PLA2 B-Gene +
) O +
toxins O +
the O +
molecular O +
mechanism O +
of O +
whose O +
neurotoxicity O +
is O +
not O +
completely O +
understood O +
. O +

Two O +
chimeric O +
PLA2s B-Gene +
were O +
prepared O +
by O +
replacing O +
the O +
C O +
- O +
terminal O +
part O +
of O +
a O +
nontoxic O +
venom O +
PLA2 B-Gene +
, O +
ammodytin B-Gene +
I2 I-Gene +
, O +
with O +
that O +
of O +
AtxA B-Gene +
( O +
K108N O +
) O +
. O +

The O +
chimeras O +
were O +
not O +
toxic O +
, O +
but O +
were O +
able O +
to O +
bind O +
strongly O +
to O +
an O +
Atxs B-Gene +
- O +
specific O +
neuronal O +
receptor O +
, O +
R25 O +
. O +

They O +
also O +
showed O +
an O +
increased O +
affinity O +
for O +
calmodulin B-Gene +
, O +
a O +
recently O +
identified O +
high O +
- O +
affinity O +
binding O +
protein O +
for O +
Atxs B-Gene +
, O +
whereas O +
affinity O +
for O +
a O +
neuronal O +
M B-Gene +
- I-Gene +
type I-Gene +
PLA2 I-Gene +
receptor I-Gene +
remained O +
largely O +
unchanged O +
. O +

The O +
results O +
show O +
that O +
the O +
C O +
- O +
terminal O +
region O +
of O +
Atxs B-Gene +
, O +
which O +
is O +
known O +
to O +
be O +
involved O +
in O +
neurotoxicity O +
, O +
is O +
critical O +
for O +
their O +
interaction O +
with O +
specific O +
binding O +
proteins O +
, O +
but O +
that O +
some O +
other O +
part O +
of O +
the O +
molecule O +
also O +
contributes O +
to O +
toxicity O +
. O +

Collaborative O +
regulation O +
of O +
Escherichia O +
coli O +
glutamate O +
- O +
dependent O +
acid O +
resistance O +
by O +
two O +
AraC B-Gene +
- O +
like O +
regulators O +
, O +
GadX B-Gene +
and O +
GadW B-Gene +
( O +
YhiW B-Gene +
) O +
. O +

An O +
important O +
feature O +
of O +
Escherichia O +
coli O +
pathogenesis O +
is O +
an O +
ability O +
to O +
withstand O +
extremely O +
acidic O +
environments O +
of O +
pH O +
2 O +
or O +
lower O +
. O +

This O +
acid O +
resistance O +
property O +
contributes O +
to O +
the O +
low O +
infectious O +
dose O +
of O +
pathogenic O +
E. O +
coli O +
species O +
. O +

One O +
very O +
efficient O +
E. O +
coli O +
acid O +
resistance O +
system O +
encompasses O +
two O +
isoforms O +
of O +
glutamate B-Gene +
decarboxylase I-Gene +
( O +
gadA B-Gene +
and O +
gadB B-Gene +
) O +
and O +
a O +
putative O +
glutamate O +
: O +
gamma B-Gene +
- I-Gene +
amino I-Gene +
butyric I-Gene +
acid I-Gene +
( I-Gene +
GABA I-Gene +
) I-Gene +
antiporter I-Gene +
( O +
gadC B-Gene +
) O +
. O +

The O +
system O +
is O +
subject O +
to O +
complex O +
controls O +
that O +
vary O +
with O +
growth O +
media O +
, O +
growth O +
phase O +
, O +
and O +
growth O +
pH O +
. O +

Previous O +
work O +
has O +
revealed O +
that O +
the O +
system O +
is O +
controlled O +
by O +
two O +
sigma B-Gene +
factors I-Gene +
, O +
two O +
negative O +
regulators O +
( O +
cyclic B-Gene +
AMP I-Gene +
receptor I-Gene +
protein I-Gene +
[ O +
CRP B-Gene +
] O +
and O +
H B-Gene -
- I-Gene -
NS I-Gene +
) O +
, O +
and O +
an O +
AraC B-Gene +
- O +
like O +
regulator O +
called O +
GadX B-Gene +
. O +

Earlier O +
evidence O +
suggested O +
that O +
the O +
GadX B-Gene +
protein O +
acts O +
both O +
as O +
a O +
positive O +
and O +
negative O +
regulator O +
of O +
the O +
gadA B-Gene +
and O +
gadBC B-Gene +
genes O +
depending O +
on O +
environmental O +
conditions O +
. O +

New O +
data O +
clarify O +
this O +
finding O +
, O +
revealing O +
a O +
collaborative O +
regulation O +
between O +
GadX B-Gene +
and O +
another O +
AraC B-Gene +
- O +
like O +
regulator O +
called O +
GadW B-Gene +
( O +
previously O +
YhiW B-Gene +
) O +
. O +

GadX B-Gene +
and O +
GadW B-Gene +
are O +
DNA O +
binding O +
proteins O +
that O +
form O +
homodimers O +
in O +
vivo O +
and O +
are O +
42 O +
% O +
homologous O +
to O +
each O +
other O +
. O +

GadX B-Gene +
activates O +
expression O +
of O +
gadA B-Gene +
and O +
gadBC B-Gene +
at O +
any O +
pH O +
, O +
while O +
GadW B-Gene +
inhibits O +
GadX B-Gene +
- O +
dependent O +
activation O +
. O +

Regulation O +
of O +
gadA B-Gene +
and O +
gadBC B-Gene +
by O +
either O +
regulator O +
requires O +
an O +
upstream O +
, O +
20-bp O +
GAD B-Gene +
box O +
sequence O +
. O +

Northern O +
blot O +
analysis O +
further O +
indicates O +
that O +
GadW B-Gene +
represses O +
expression O +
of O +
gadX B-Gene +
. O +

The O +
results O +
suggest O +
a O +
control O +
circuit O +
whereby O +
GadW B-Gene +
interacts O +
with O +
both O +
the O +
gadA B-Gene +
and O +
gadX B-Gene +
promoters O +
. O +

GadW B-Gene +
clearly O +
represses O +
gadX B-Gene +
and O +
, O +
in O +
situations O +
where O +
GadX B-Gene +
is O +
missing O +
, O +
activates O +
gadA B-Gene +
and O +
gadBC B-Gene +
. O +

GadX B-Gene +
, O +
however O +
, O +
activates O +
only O +
gadA B-Gene +
and O +
gadBC B-Gene +
expression O +
. O +

CRP B-Gene +
also O +
represses O +
gadX B-Gene +
expression O +
. O +

It O +
does O +
this O +
primarily O +
by O +
repressing O +
production O +
of O +
sigma B-Gene +
S I-Gene +
, O +
the O +
sigma B-Gene +
factor I-Gene +
responsible O +
for O +
gadX B-Gene +
expression O +
. O +

In O +
fact O +
, O +
the O +
acid O +
induction O +
of O +
gadA B-Gene +
and O +
gadBC B-Gene +
observed O +
when O +
rich O +
- O +
medium O +
cultures O +
enter O +
stationary O +
phase O +
corresponds O +
to O +
the O +
acid O +
induction O +
of O +
sigma B-Gene +
S I-Gene +
production O +
. O +

These O +
complex O +
control O +
circuits O +
impose O +
tight O +
rein O +
over O +
expression O +
of O +
the O +
gadA B-Gene +
and O +
gadBC B-Gene +
system O +
yet O +
provide O +
flexibility O +
for O +
inducing O +
acid O +
resistance O +
under O +
many O +
conditions O +
that O +
presage O +
acid O +
stress O +
. O +

The O +
DNA B-Gene +
methyltransferase I-Gene +
- O +
like O +
protein O +
DNMT3L B-Gene +
stimulates O +
de O +
novo O +
methylation O +
by O +
Dnmt3a B-Gene +
. O +

Dnmt3L B-Gene +
is O +
required O +
for O +
the O +
establishment O +
of O +
maternal O +
methylation O +
imprints O +
at O +
imprinting O +
centers O +
( O +
ICs O +
) O +
. O +

Dnmt3L B-Gene +
, O +
however O +
, O +
lacks O +
the O +
conserved O +
catalytic O +
domain O +
common O +
to O +
DNA B-Gene +
methyltransferases I-Gene +
. O +

In O +
an O +
attempt O +
to O +
define O +
its O +
function O +
, O +
we O +
coexpressed O +
DNMT3L B-Gene +
with O +
each O +
of O +
the O +
two O +
known O +
de O +
novo O +
methyltransferases B-Gene +
, O +
Dnmt3a B-Gene +
and O +
DNMT3B B-Gene +
, O +
in O +
human O +
cells O +
and O +
monitored O +
de O +
novo O +
methylation O +
by O +
using O +
replicating O +
minichromosomes O +
carrying O +
various O +
ICs O +
as O +
targets O +
. O +

Coexpression O +
of O +
DNMT3L B-Gene +
with O +
DNMT3B B-Gene +
led O +
to O +
little O +
or O +
no O +
change O +
in O +
target O +
methylation O +
. O +

However O +
, O +
coexpression O +
of O +
DNMT3L B-Gene +
with O +
Dnmt3a B-Gene +
resulted O +
in O +
a O +
striking O +
stimulation O +
of O +
de O +
novo O +
methylation O +
by O +
Dnmt3a B-Gene +
. O +

Stimulation O +
was O +
observed O +
at O +
maternally O +
methylated O +
ICs O +
such O +
as O +
small B-Gene +
nuclear I-Gene +
ribonucleoprotein I-Gene +
polypeptide I-Gene +
N I-Gene +
( O +
SNRPN B-Gene +
) O +
, O +
Snrpn B-Gene +
, O +
and O +
Igf2rAir B-Gene +
, O +
as O +
well O +
as O +
at O +
various O +
nonimprinted O +
sequences O +
present O +
on O +
the O +
episomes O +
. O +

Stimulation O +
of O +
Dnmt3a B-Gene +
by O +
DNMT3L B-Gene +
was O +
also O +
observed O +
at O +
endogenous O +
sequences O +
in O +
the O +
genome O +
. O +

Therefore O +
, O +
DNMT3L B-Gene +
acts O +
as O +
a O +
general O +
stimulatory O +
factor O +
for O +
de O +
novo O +
methylation O +
by O +
Dnmt3a B-Gene +
. O +

The O +
implications O +
of O +
these O +
findings O +
for O +
the O +
function O +
of O +
DNMT3L B-Gene +
and O +
Dnmt3a B-Gene +
in O +
DNA O +
methylation O +
and O +
genomic O +
imprinting O +
are O +
discussed O +
. O +

Ethylene O +
synthesis O +
regulated O +
by O +
biphasic O +
induction O +
of O +
1-aminocyclopropane-1-carboxylic B-Gene +
acid I-Gene +
synthase I-Gene +
and O +
1-aminocyclopropane-1-carboxylic B-Gene +
acid I-Gene +
oxidase I-Gene +
genes O +
is O +
required O +
for O +
hydrogen O +
peroxide O +
accumulation O +
and O +
cell O +
death O +
in O +
ozone O +
- O +
exposed O +
tomato O +
. O +

We O +
show O +
that O +
above O +
a O +
certain O +
threshold O +
concentration O +
, O +
ozone O +
leads O +
to O +
leaf O +
injury O +
in O +
tomato O +
( O +
Lycopersicon O +
esculentum O +
) O +
. O +

Ozone O +
- O +
induced O +
leaf O +
damage O +
was O +
preceded O +
by O +
a O +
rapid O +
increase O +
in O +
1-aminocyclopropane-1-carboxylic B-Gene +
acid I-Gene +
( I-Gene +
ACC I-Gene +
) I-Gene +
synthase I-Gene +
activity O +
, O +
ACC O +
content O +
, O +
and O +
ethylene O +
emission O +
. O +

Changes O +
in O +
mRNA O +
levels O +
of O +
specific O +
ACC B-Gene +
synthase I-Gene +
, O +
ACC B-Gene +
oxidase I-Gene +
, O +
and O +
ethylene B-Gene +
receptor I-Gene +
genes O +
occurred O +
within O +
1 O +
to O +
5 O +
h O +
. O +

Expression O +
of O +
the O +
genes O +
encoding O +
components O +
of O +
ethylene O +
biosynthesis O +
and O +
perception O +
, O +
and O +
biochemistry O +
of O +
ethylene O +
synthesis O +
suggested O +
that O +
ozone O +
- O +
induced O +
ethylene O +
synthesis O +
in O +
tomato O +
is O +
under O +
biphasic O +
control O +
. O +

In O +
transgenic O +
plants O +
containing O +
an O +
LE O +
- O +
ACO1 B-Gene +
promoter O +
- O +
beta B-Gene +
- I-Gene +
glucuronidase I-Gene +
fusion O +
construct O +
, O +
beta B-Gene -
- I-Gene -
glucuronidase I-Gene +
activity O +
increased O +
rapidly O +
at O +
the O +
beginning O +
of O +
the O +
O O -
( O -
3 O -
) O +
exposure O +
and O +
had O +
a O +
spatial O +
distribution O +
resembling O +
the O +
pattern O +
of O +
extracellular O +
H O -
( O -
2 O -
) O -
O O -
( O -
2 O -
) O +
production O +
at O +
7 O +
h O +
, O +
which O +
coincided O +
with O +
the O +
cell O +
death O +
pattern O +
after O +
24 O +
h O +
. O +

Ethylene O +
synthesis O +
and O +
perception O +
were O +
required O +
for O +
active O +
H O -
( O -
2 O -
) O -
O O -
( O -
2 O -
) O +
production O +
and O +
cell O +
death O +
resulting O +
in O +
visible O +
tissue O +
damage O +
. O +

The O +
results O +
demonstrate O +
a O +
selective O +
ozone O +
response O +
of O +
ethylene O +
biosynthetic O +
genes O +
and O +
suggest O +
a O +
role O +
for O +
ethylene O +
, O +
in O +
combination O +
with O +
the O +
burst O +
of O +
H O -
( O -
2 O -
) O -
O O -
( O -
2 O -
) O +
production O +
, O +
in O +
regulating O +
the O +
spread O +
of O +
cell O +
death O +
. O +

Identification O +
of O +
oligomerization O +
and O +
drug O +
- O +
binding O +
domains O +
of O +
the O +
membrane O +
fusion O +
protein O +
EmrA B-Gene +
. O +

Many O +
pathogenic O +
Gram O +
- O +
negative O +
bacteria O +
possess O +
tripartite O +
transporters O +
that O +
catalyze O +
drug O +
extrusion O +
across O +
the O +
inner O +
and O +
outer O +
membranes O +
, O +
thereby O +
conferring O +
resistance O +
. O +

These O +
transporters O +
consist O +
of O +
inner O +
( O +
IMP O +
) O +
and O +
outer O +
( O +
OMP O +
) O +
membrane O +
proteins O +
, O +
which O +
are O +
coupled O +
by O +
a O +
periplasmic O +
membrane B-Gene +
fusion I-Gene +
( I-Gene +
MFP I-Gene +
) I-Gene +
protein I-Gene +
. O +

However O +
, O +
it O +
is O +
not O +
know O +
whether O +
the O +
MFP B-Gene +
translocates O +
the O +
drug O +
between O +
the O +
membranes O +
, O +
by O +
acting O +
as O +
a O +
channel O +
, O +
or O +
whether O +
it O +
brings O +
the O +
IMP O +
and O +
OMP O +
together O +
, O +
facilitating O +
drug O +
transfer O +
. O +

The O +
MFP B-Gene +
EmrA B-Gene +
has O +
an O +
elongated O +
periplasmic O +
domain O +
, O +
which O +
binds O +
transported O +
drugs O +
, O +
and O +
is O +
anchored O +
to O +
the O +
inner O +
membrane O +
by O +
a O +
single O +
alpha O -
- O -
helix O +
, O +
which O +
contains O +
a O +
leucine O +
zipper O +
dimerization O +
domain O +
. O +

Consistent O +
with O +
CD O +
and O +
hydrodynamic O +
analyses O +
, O +
the O +
periplasmic O +
domain O +
is O +
predicted O +
to O +
be O +
composed O +
of O +
a O +
beta O -
- O -
sheet O +
subdomain O +
and O +
an O +
alpha O +
- O +
helical O +
coiled O +
- O +
coil O +
. O +

We O +
propose O +
that O +
EmrA B-Gene +
forms O +
a O +
trimer O +
in O +
which O +
the O +
coiled O +
- O +
coils O +
radiate O +
across O +
the O +
periplasm O +
, O +
where O +
they O +
could O +
sequester O +
the O +
OMP O +
TolC B-Gene +
. O +

The O +
" O +
free O +
" O +
leucine O +
zipper O +
in O +
the O +
EmrA B-Gene +
trimer O +
might O +
stabilize O +
the O +
interaction O +
with O +
the O +
IMP O +
EmrB B-Gene +
, O +
which O +
also O +
possesses O +
leucine O +
zipper O +
motifs O +
in O +
the O +
putative O +
N O +
- O +
and O +
C O +
- O +
terminal O +
helices O +
. O +

The O +
beta O -
- O -
sheet O +
subdomain O +
of O +
EmrA B-Gene +
would O +
sit O +
at O +
the O +
membrane O +
surface O +
adjacent O +
to O +
the O +
EmrB B-Gene +
, O +
from O +
which O +
it O +
receives O +
the O +
transported O +
drug O +
, O +
inducing O +
a O +
conformational O +
change O +
that O +
triggers O +
the O +
interaction O +
with O +
the O +
OMP O +
. O +

Evidence O +
for O +
a O +
role O +
of O +
p38 B-Gene +
kinase I-Gene +
in O +
hypoxia B-Gene +
- I-Gene +
inducible I-Gene +
factor I-Gene +
1 I-Gene +
- O +
independent O +
induction O +
of O +
vascular B-Gene +
endothelial I-Gene +
growth I-Gene +
factor I-Gene +
expression O +
by O +
sodium O +
arsenite O +
. O +

Recently O +
we O +
have O +
demonstrated O +
that O +
sodium O +
arsenite O +
induces O +
the O +
expression O +
of O +
hypoxia B-Gene +
- I-Gene +
inducible I-Gene +
factor I-Gene +
1alpha I-Gene +
( O +
HIF-1alpha B-Gene +
) O +
protein O +
and O +
vascular B-Gene +
endothelial I-Gene +
growth I-Gene +
factor I-Gene +
( O +
VEGF B-Gene +
) O +
in O +
OVCAR-3 O +
human O +
ovarian O +
cancer O +
cells O +
. O +

We O +
now O +
show O +
that O +
arsenic O +
trioxide O +
, O +
an O +
experimental O +
anticancer O +
drug O +
, O +
exerts O +
the O +
same O +
effects O +
. O +

The O +
involvement O +
of O +
phosphatidylinositol B-Gene +
3-kinase I-Gene +
and O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
( O +
MAPK B-Gene +
) O +
pathways O +
in O +
the O +
effects O +
of O +
sodium O +
arsenite O +
was O +
investigated O +
. O +

By O +
using O +
kinase O +
inhibitors O +
in O +
OVCAR-3 O +
cells O +
, O +
both O +
effects O +
of O +
sodium O +
arsenite O +
were O +
found O +
to O +
be O +
independent O +
of O +
phosphatidylinositol B-Gene +
3-kinase I-Gene +
and O +
p44 B-Gene +
/ I-Gene +
p42 I-Gene +
MAPKS I-Gene +
but O +
were O +
attenuated O +
by O +
inhibition O +
of O +
p38 B-Gene +
MAPK I-Gene +
. O +

A O +
role O +
for O +
p38 B-Gene +
in O +
the O +
regulation O +
of O +
HIF-1alpha B-Gene +
and O +
VEGF B-Gene +
expression O +
was O +
supported O +
further O +
by O +
analysis O +
of O +
activation O +
kinetics O +
. O +

Experiments O +
in O +
mouse O +
fibroblast O +
cell O +
lines O +
, O +
lacking O +
expression O +
of O +
c B-Gene -
- I-Gene -
Jun I-Gene +
N I-Gene +
- I-Gene +
terminal I-Gene +
kinases I-Gene +
1 I-Gene +
and I-Gene +
2 I-Gene +
, O +
suggested O +
that O +
these O +
kinases B-Gene +
are O +
not O +
required O +
for O +
induction O +
of O +
HIF-1alpha B-Gene +
protein O +
and O +
VEGF B-Gene +
mRNA O +
. O +

Unexpectedly O +
, O +
sodium O +
arsenite O +
did O +
not O +
activate O +
a O +
HIF-1 B-Gene +
- O +
dependent O +
reporter O +
gene O +
in O +
OVCAR-3 O +
cells O +
, O +
indicating O +
that O +
functional O +
HIF-1 B-Gene +
was O +
not O +
induced O +
. O +

In O +
agreement O +
with O +
this O +
hypothesis O +
, O +
up O +
- O +
regulation O +
of O +
VEGF B-Gene +
mRNA O +
was O +
not O +
reduced O +
in O +
HIF-1alpha B-Gene +
( O +
- O -
/ O -
- O +
) O +
mouse O +
fibroblast O +
cell O +
lines O +
. O +

Altogether O +
, O +
these O +
data O +
suggest O +
that O +
not O +
HIF-1 B-Gene +
, O +
but O +
rather O +
p38 B-Gene +
, O +
mediates O +
induction O +
of O +
VEGF B-Gene +
mRNA O +
expression O +
by O +
sodium O +
arsenite O +
. O +

The O +
promoter O +
of O +
IL-18 B-Gene +
binding I-Gene +
protein I-Gene +
: O +
activation O +
by O +
an O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
- O +
induced O +
complex O +
of O +
IFN B-Gene +
regulatory I-Gene +
factor I-Gene +
1 I-Gene +
and O +
CCAAT B-Gene +
/ I-Gene +
enhancer I-Gene +
binding I-Gene +
protein I-Gene +
beta I-Gene +
. O +

The O +
IL-18 B-Gene +
binding I-Gene +
protein I-Gene +
( O +
IL-18BP B-Gene +
) O +
is O +
a O +
circulating O +
inhibitor O +
of O +
the O +
proinflammatory O +
cytokine B-Gene +
IL-18 B-Gene +
. O +

It O +
is O +
constitutively O +
expressed O +
in O +
mononuclear O +
cells O +
, O +
and O +
elevated O +
expression O +
is O +
induced O +
by O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
. O +

In O +
this O +
study O +
, O +
we O +
characterized O +
the O +
IL-18BP B-Gene +
promoter O +
. O +

We O +
first O +
showed O +
that O +
induction O +
is O +
at O +
the O +
transcriptional O +
level O +
and O +
requires O +
de O +
novo O +
protein O +
synthesis O +
. O +

The O +
IL-18BP B-Gene +
promoter O +
resides O +
within O +
1.6 O +
kb O +
DNA O +
upstream O +
of O +
the O +
first O +
exon O +
and O +
includes O +
at O +
least O +
six O +
regulatory O +
elements O +
. O +

We O +
identified O +
in O +
the O +
basal O +
promoter O +
a O +
gamma O +
- O +
activated O +
sequence O +
( O +
GAS O +
) O +
proximal O +
to O +
the O +
transcription O +
start O +
site O +
( O +
base O +
1 O +
) O +
, O +
followed O +
by O +
an O +
IFN B-Gene +
regulatory I-Gene +
factor I-Gene +
1 I-Gene +
response O +
element O +
( O +
IRF O -
- O -
E O +
) O +
and O +
two O +
CCAATenhancer B-Gene +
binding I-Gene +
protein I-Gene +
beta I-Gene +
( O +
CEBPbeta B-Gene +
) O +
sites O +
, O +
all O +
of O +
which O +
are O +
essential O +
for O +
basal O +
promoter O +
activity O +
. O +

Furthermore O +
, O +
GAS O +
and O +
IRF O -
- O -
E O +
were O +
essential O +
for O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
- O +
induced O +
transcription O +
. O +

Indeed O +
, O +
sera O +
of O +
IRF-1 B-Gene +
- O +
deficient O +
mice O +
lacked O +
basal O +
and O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
- O +
induced O +
IL-18BP B-Gene +
. O +

We O +
found O +
that O +
after O +
induction O +
of O +
IRF-1 B-Gene +
by O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
, O +
it O +
formed O +
a O +
complex O +
with O +
CEBPbeta B-Gene +
, O +
which O +
bound O +
to O +
the O +
IRF O -
- O -
E O +
and O +
GAS O +
- O +
containing O +
proximal O +
DNA O +
. O +

In O +
contrast O +
, O +
the O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
- O +
induced O +
signal B-Gene +
transducer I-Gene +
and I-Gene +
activator I-Gene +
of I-Gene +
transcription I-Gene +
1 I-Gene +
dimer O +
did O +
not O +
associate O +
with O +
this O +
GAS O +
. O +

In O +
addition O +
, O +
we O +
identified O +
a O +
silencer O +
element O +
and O +
a O +
distal O +
enhancer O +
at O +
bases O +
- O +
1081 O +
to O +
- O +
1272 O +
, O +
which O +
was O +
also O +
physically O +
associated O +
with O +
IRF-1 B-Gene +
. O +

The O +
IRF-1 B-Gene +
- O +
CEBPbeta B-Gene +
complex O +
described O +
here O +
probably O +
plays O +
a O +
fundamental O +
role O +
in O +
regulating O +
additional O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
- O +
responsive O +
genes O +
. O +

IFN B-Gene -
- I-Gene -
lambdas I-Gene +
mediate O +
antiviral O +
protection O +
through O +
a O +
distinct O +
class O +
II O +
cytokine B-Gene +
receptor I-Gene +
complex O +
. O +

We O +
report O +
here O +
the O +
identification O +
of O +
a O +
ligand O +
- O +
receptor O +
system O +
that O +
, O +
upon O +
engagement O +
, O +
leads O +
to O +
the O +
establishment O +
of O +
an O +
antiviral O +
state O +
. O +

Three O +
closely O +
positioned O +
genes O +
on O +
human O +
chromosome O +
19 O +
encode O +
distinct O +
but O +
paralogous O +
proteins O +
, O +
which O +
we O +
designate O +
interferon B-Gene -
- I-Gene -
lambda1 I-Gene +
( O +
IFN B-Gene -
- I-Gene -
lambda1 I-Gene +
) O +
, O +
IFN B-Gene -
- I-Gene -
lambda2 I-Gene +
and O +
IFN B-Gene -
- I-Gene -
lambda3 I-Gene +
( O +
tentatively O +
designated O +
as O +
IL-29 B-Gene +
, O +
IL-28A B-Gene +
and O +
IL-28B B-Gene +
, O +
respectively O +
, O +
by O +
HUGO O +
) O +
. O +

The O +
expression O +
of O +
IFN B-Gene -
- I-Gene -
lambda I-Gene +
mRNAs O +
was O +
inducible O +
by O +
viral O +
infection O +
in O +
several O +
cell O +
lines O +
. O +

We O +
identified O +
a O +
distinct O +
receptor O +
complex O +
that O +
is O +
utilized O +
by O +
all O +
three O +
IFN B-Gene -
- I-Gene -
lambda I-Gene +
proteins O +
for O +
signaling O +
and O +
is O +
composed O +
of O +
two O +
subunits O +
, O +
a O +
receptor O +
designated O +
CRF2 B-Gene -
- I-Gene -
12 I-Gene +
( O +
also O +
designated O +
as O +
IFN B-Gene -
- I-Gene -
lambdaR1 I-Gene +
) O +
and O +
a O +
second O +
subunit O +
, O +
CRF2 B-Gene -
- I-Gene -
4 I-Gene +
( O +
also O +
known O +
as O +
IL-10R2 B-Gene +
) O +
. O +

Both O +
receptor O +
chains O +
are O +
constitutively O +
expressed O +
on O +
a O +
wide O +
variety O +
of O +
human O +
cell O +
lines O +
and O +
tissues O +
and O +
signal O +
through O +
the O +
Jak B-Gene +
- O +
STAT B-Gene +
( O +
Janus B-Gene +
kinases I-Gene +
- O +
signal B-Gene +
transducers I-Gene +
and I-Gene +
activators I-Gene +
of I-Gene +
transcription I-Gene +
) O +
pathway O +
. O +

This O +
receptor O +
- O +
ligand O +
system O +
may O +
contribute O +
to O +
antiviral O +
or O +
other O +
defenses O +
by O +
a O +
mechanism O +
similar O +
to O +
, O +
but O +
independent O +
of O +
, O +
type B-Gene +
I I-Gene +
IFNs I-Gene +
. O +

Modulation O +
of O +
cystatin B-Gene +
C I-Gene +
expression O +
impairs O +
the O +
invasive O +
and O +
tumorigenic O +
potential O +
of O +
human O +
glioblastoma O +
cells O +
. O +

Increases O +
in O +
the O +
abundance O +
of O +
cathepsin B-Gene +
B I-Gene +
transcript O +
and O +
protein O +
with O +
increased O +
tumor O +
grade O +
and O +
changes O +
in O +
subcellular O +
localization O +
and O +
activity O +
of O +
this O +
enzyme O +
. O +

We O +
observed O +
progressive O +
reductions O +
in O +
levels O +
of O +
the O +
protease O +
inhibitor O +
cystatin B-Gene +
C I-Gene +
, O +
an O +
inhibitor O +
of O +
cathepsin B-Gene +
B I-Gene +
with O +
corresponding O +
increases O +
in O +
the O +
malignancy O +
of O +
glioma O +
cell O +
lines O +
, O +
implying O +
an O +
inverse O +
correlation O +
between O +
cystatin B-Gene +
C I-Gene +
and O +
tumor O +
grade O +
. O +

To O +
investigate O +
the O +
role O +
of O +
cystatin B-Gene +
C I-Gene +
in O +
the O +
invasion O +
of O +
brain O +
tumor O +
cells O +
, O +
we O +
stably O +
transfected O +
SNB19 O +
glioblastoma O +
cells O +
with O +
either O +
a O +
0.4 O +
- O +
kb O +
cDNA O +
construct O +
of O +
human O +
cystatin B-Gene +
C I-Gene +
in O +
the O +
sense O +
orientation O +
or O +
an O +
empty O +
vector O +
. O +

Clones O +
expressing O +
sense O +
- O +
cystatin B-Gene +
C I-Gene +
cDNA O +
had O +
higher O +
cystatin B-Gene +
C I-Gene +
mRNA O +
and O +
protein O +
levels O +
than O +
did O +
control O +
cells O +
. O +

Sense O +
- O +
transfected O +
cells O +
were O +
also O +
markedly O +
less O +
invasive O +
than O +
control O +
cells O +
in O +
a O +
Matrigel O +
invasion O +
assay O +
and O +
in O +
a O +
coculture O +
assay O +
of O +
SNB19 O +
spheroids O +
and O +
fetal O +
rat O +
brain O +
aggregates O +
. O +

Finally O +
, O +
the O +
sense O +
- O +
transfected O +
cells O +
did O +
not O +
form O +
tumors O +
in O +
nude O +
mice O +
upon O +
intracerebral O +
injection O +
. O +

These O +
results O +
strongly O +
implicate O +
cystatin B-Gene +
C I-Gene +
in O +
the O +
invasiveness O +
of O +
human O +
glioblastoma O +
cells O +
and O +
suggest O +
that O +
sense O +
transcripts O +
of O +
cystatin B-Gene +
C I-Gene +
may O +
prove O +
useful O +
in O +
cancer O +
therapy O +
. O +

The O +
killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( O +
KIR B-Gene +
) O +
genomic O +
region O +
: O +
gene O +
- O +
order O +
, O +
haplotypes O +
and O +
allelic O +
polymorphism O +
. O +

Recent O +
genetic O +
studies O +
have O +
established O +
that O +
the O +
killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( O +
KIR B-Gene +
) O +
genomic O +
region O +
displays O +
extensive O +
diversity O +
through O +
variation O +
in O +
gene O +
content O +
and O +
allelic O +
polymorphism O +
within O +
individual O +
KIR B-Gene +
genes O +
. O +

It O +
is O +
demonstrated O +
by O +
family O +
segregation O +
analysis O +
, O +
genomic O +
sequencing O +
, O +
and O +
gene O +
order O +
determination O +
that O +
genomic O +
diversity O +
by O +
gene O +
content O +
alone O +
gives O +
rise O +
to O +
more O +
than O +
20 O +
different O +
KIR B-Gene +
haplotypes O +
and O +
at O +
least O +
40 O -
- O -
50 O +
KIR B-Gene +
genotypes O +
. O +

In O +
the O +
most O +
reductionist O +
format O +
, O +
KIR B-Gene +
haplotypes O +
can O +
be O +
accommodated O +
within O +
one O +
of O +
10 O +
different O +
prototypes O +
, O +
each O +
with O +
multiple O +
permutations O +
. O +

Our O +
haplotype O +
model O +
considers O +
the O +
KIR B-Gene +
haplotype O +
as O +
two O +
separate O +
halves O +
: O +
the O +
centromeric O +
half O +
bordered O +
upstream O +
by O +
KIR3DL3 B-Gene +
and O +
downstream O +
by O +
2DL4 B-Gene +
, O +
and O +
the O +
telomeric O +
half O +
bordered O +
upstream O +
by O +
2DL4 B-Gene +
and O +
downstream O +
by O +
3DL2 B-Gene +
. O +

There O +
are O +
rare O +
KIR B-Gene +
haplotypes O +
that O +
do O +
not O +
fit O +
into O +
this O +
model O +
. O +

Recombination O +
, O +
gene O +
duplication O +
, O +
and O +
inversion O +
can O +
however O +
, O +
readily O +
explain O +
these O +
haplotypes O +
. O +

Additional O +
allelic O +
polymorphism O +
imposes O +
extensive O +
individual O +
variability O +
. O +

Accordingly O +
, O +
this O +
segment O +
of O +
the O +
human O +
genome O +
displays O +
a O +
level O +
of O +
diversity O +
similar O +
to O +
the O +
one O +
observed O +
for O +
the O +
human O +
major B-Gene +
histocompatibility I-Gene +
complex I-Gene +
. O +

Recent O +
application O +
of O +
immunogenetic O +
analysis O +
of O +
KIR B-Gene +
genes O +
in O +
patient O +
populations O +
implicates O +
these O +
genes O +
as O +
important O +
genetic O +
disease O +
susceptibility O +
factors O +
. O +

Up O +
- O +
regulation O +
of O +
neuronal B-Gene +
calcium I-Gene +
sensor-1 I-Gene +
( O +
NCS-1 B-Gene +
) O +
in O +
the O +
prefrontal O +
cortex O +
of O +
schizophrenic O +
and O +
bipolar O +
patients O +
. O +

The O +
delineation O +
of O +
dopamine O +
dysfunction O +
in O +
the O +
mentally O +
ill O +
has O +
been O +
a O +
long O +
- O +
standing O +
quest O +
of O +
biological O +
psychiatry O +
. O +

The O +
present O +
study O +
focuses O +
on O +
a O +
recently O +
recognized O +
group O +
of O +
dopamine B-Gene +
receptor I-Gene +
- O +
interacting O +
proteins O +
as O +
possible O +
novel O +
sites O +
of O +
dysfunction O +
in O +
schizophrenic O +
and O +
bipolar O +
patients O +
. O +

We O +
demonstrate O +
that O +
the O +
dorsolateral O +
prefrontal O +
cortex O +
in O +
schizophrenia O +
and O +
bipolar O +
cases O +
from O +
the O +
Stanley O +
Foundation O +
Neuropathology O +
Consortium O +
display O +
significantly O +
elevated O +
levels O +
of O +
the O +
D2 B-Gene +
dopamine I-Gene +
receptor I-Gene +
desensitization O +
regulatory O +
protein O +
, O +
neuronal B-Gene +
calcium I-Gene +
sensor-1 I-Gene +
. O +

These O +
levels O +
of O +
neuronal B-Gene +
calcium I-Gene +
sensor-1 I-Gene +
were O +
not O +
influenced O +
by O +
age O +
, O +
gender O +
, O +
hemisphere O +
, O +
cause O +
of O +
death O +
, O +
postmortem O +
period O +
, O +
alcohol O +
consumption O +
, O +
or O +
antipsychotic O +
and O +
mood O +
stabilizing O +
medications O +
. O +

The O +
present O +
study O +
supports O +
the O +
hypothesis O +
that O +
schizophrenia O +
and O +
bipolar O +
disorder O +
may O +
be O +
associated O +
with O +
abnormalities O +
in O +
dopamine B-Gene +
receptor I-Gene +
- O +
interacting O +
proteins O +
. O +

Histidine O +
407 O +
, O +
a O +
phantom O +
residue O +
in O +
the O +
E1 B-Gene +
subunit O +
of O +
the O +
Escherichia O +
coli O +
pyruvate B-Gene +
dehydrogenase I-Gene +
complex I-Gene +
, O +
activates O +
reductive O +
acetylation O +
of O +
lipoamide O +
on O +
the O +
E2 B-Gene +
subunit O +
. O +

An O +
explanation O +
for O +
conservation O +
of O +
active O +
sites O +
between O +
the O +
E1 B-Gene +
subunit O +
and O +
transketolase B-Gene +
. O +

Least O +
squares O +
alignment O +
of O +
the O +
E. O +
coli O +
pyruvate B-Gene +
dehydrogenase I-Gene +
multienzyme I-Gene +
complex I-Gene +
E1 I-Gene +
subunit O +
and O +
yeast O +
transketolase B-Gene +
crystal O +
structures O +
indicates O +
a O +
general O +
structural O +
similarity O +
between O +
the O +
two O +
enzymes O +
and O +
provides O +
a O +
plausible O +
location O +
for O +
a O +
short O +
- O +
loop O +
region O +
in O +
the O +
E1 B-Gene +
structure O +
that O +
was O +
unobserved O +
due O +
to O +
disorder O +
. O +

The O +
residue O +
H407 O +
, O +
located O +
in O +
this O +
region O +
, O +
is O +
shown O +
to O +
be O +
able O +
to O +
penetrate O +
the O +
active O +
site O +
. O +

Suggested O +
by O +
this O +
comparison O +
, O +
the O +
H407A O +
E1 B-Gene +
variant O +
was O +
created O +
, O +
and O +
H407 O +
was O +
shown O +
to O +
participate O +
in O +
the O +
reductive O +
acetylation O +
of O +
both O +
an O +
independently O +
expressed O +
lipoyl O +
domain O +
and O +
the O +
intact O +
1 O +
- O +
lipoyl O +
E2 B-Gene +
subunit O +
. O +

While O +
the O +
H407A O +
substitution O +
only O +
modestly O +
affected O +
the O +
reaction O +
through O +
pyruvate O +
decarboxylation O +
( O +
ca O -
. O +
14 O +
% O +
activity O +
compared O +
to O +
parental O +
E1 B-Gene +
) O +
, O +
the O +
overall O +
complex O +
has O +
a O +
much O +
impaired O +
activity O +
, O +
at O +
most O +
0.15 O +
% O +
compared O +
to O +
parental O +
E1 B-Gene +
. O +

Isothermal O +
titration O +
calorimetry O +
measurements O +
show O +
that O +
the O +
binding O +
of O +
the O +
lipoyl O +
domain O +
to O +
the O +
H407A O +
E1 B-Gene +
variant O +
is O +
much O +
weaker O +
than O +
that O +
to O +
parental O +
E1 B-Gene +
. O +

At O +
the O +
same O +
time O +
, O +
mass O +
spectrometric O +
measurements O +
clearly O +
demonstrate O +
much O +
impaired O +
reductive O +
acetylation O +
of O +
the O +
independently O +
expressed O +
lipoyl O +
domain O +
and O +
of O +
the O +
intact O +
1 O +
- O +
lipoyl O +
E2 B-Gene +
by O +
the O +
H407A O +
variant O +
compared O +
to O +
the O +
parental O +
E1 B-Gene +
. O +

A O +
proposal O +
is O +
presented O +
to O +
explain O +
the O +
remarkable O +
conservation O +
of O +
the O +
three O +
- O +
dimensional O +
structure O +
at O +
the O +
active O +
centers O +
of O +
the O +
E. O +
coli O +
E1 B-Gene +
subunit O +
and O +
transketolase B-Gene +
on O +
the O +
basis O +
of O +
the O +
parallels O +
in O +
the O +
ligation O +
- O +
type O +
reactions O +
carried O +
out O +
and O +
the O +
need O +
to O +
protonate O +
a O +
very O +
weak O +
acid O +
, O +
a O +
dithiolane O +
sulfur O +
atom O +
in O +
the O +
former O +
, O +
and O +
a O +
carbonyl O +
oxygen O +
atom O +
in O +
the O +
latter O +
. O +

Genomic O +
structure O +
, O +
expression O +
, O +
and O +
transcriptional O +
regulation O +
of O +
human O +
Gal B-Gene +
beta I-Gene +
1,3 I-Gene +
GalNAc I-Gene +
alpha I-Gene +
2,3-sialyltransferase I-Gene +
gene O +
. O +

In O +
this O +
report O +
, O +
we O +
describe O +
transcriptional O +
regulation O +
of O +
the O +
human O +
Gal B-Gene +
beta I-Gene +
1 I-Gene +
, I-Gene +
3 I-Gene +
GalNAc I-Gene +
alpha I-Gene +
2,3-sialyltransferase I-Gene +
II I-Gene +
( O +
hST3Gal B-Gene +
II I-Gene +
) O +
gene O +
. O +

The O +
results O +
of O +
5'-RACE O +
showed O +
that O +
the O +
forms O +
of O +
two O +
mRNAs O +
differed O +
only O +
in O +
the O +
5 O -
' O +
- O +
untranslated O +
region O +
( O +
Types O +
1 O +
and O +
2 O +
) O +
. O +

According O +
to O +
analysis O +
of O +
the O +
genomic O +
structure O +
, O +
the O +
transcriptional O +
regulation O +
of O +
Type O +
1 O +
and O +
Type O +
2 O +
mRNA O +
isoforms O +
depended O +
on O +
the O +
p1 O +
and O +
p2 O +
promoters O +
, O +
respectively O +
. O +

Both O +
the O +
mRNA O +
isoforms O +
were O +
detected O +
in O +
various O +
human O +
tissues O +
except O +
colon O +
, O +
skeletal O +
muscle O +
, O +
and O +
peripheral O +
blood O +
leukocytes O +
by O +
RT O +
- O +
PCR O +
analysis O +
. O +

In O +
colon O +
tissue O +
, O +
the O +
Type O +
2 O +
mRNA O +
was O +
detected O +
, O +
however O +
, O +
Type O +
1 O +
mRNA O +
was O +
not O +
detected O +
. O +

To O +
elucidate O +
the O +
molecular O +
basis O +
of O +
hST3Gal B-Gene +
II I-Gene +
gene O +
expression O +
, O +
we O +
isolated O +
and O +
characterized O +
the O +
function O +
of O +
the O +
genomic O +
region O +
of O +
hST3Gal B-Gene +
II I-Gene +
containing O +
the O +
p1 O +
and O +
p2 O +
promoters O +
. O +

The O +
activity O +
of O +
p2 O +
promoter O +
is O +
much O +
higher O +
than O +
that O +
of O +
the O +
p1 O +
promoter O +
in O +
the O +
colon O +
adenocarcinoma O +
cell O +
line O +
, O +
COLO205 O +
. O +

These O +
results O +
suggest O +
that O +
the O +
hST3Gal B-Gene +
II I-Gene +
gene O +
is O +
expressed O +
specifically O +
by O +
alternative O +
promoter O +
utilization O +
and O +
is O +
regulated O +
in O +
a O +
tissue O +
- O +
restricted O +
fashion O +
at O +
the O +
level O +
of O +
transcription O +
. O +

Role O +
of O +
metazoan O +
mediator O +
proteins O +
in O +
interferon B-Gene +
- O +
responsive O +
transcription O +
. O +

The O +
interferon B-Gene +
( O +
IFN B-Gene +
) O +
- O +
induced O +
signal O +
transduction O +
and O +
transcription O +
activation O +
complex O +
, O +
ISGF3 B-Gene +
, O +
is O +
assembled O +
from O +
three O +
proteins O +
, O +
STAT1 B-Gene +
, O +
STAT2 B-Gene +
, O +
and O +
IRF9 B-Gene +
. O +

Of O +
these O +
components O +
, O +
STAT2 B-Gene +
provides O +
a O +
fundamental O +
and O +
essential O +
transcriptional O +
activation O +
function O +
for O +
ISGF3 B-Gene +
. O +

In O +
the O +
present O +
study O +
, O +
we O +
show O +
that O +
ISGF3 B-Gene +
- O +
mediated O +
transcription O +
is O +
dependent O +
on O +
STAT2 B-Gene +
interactions O +
with O +
DRIP150 B-Gene +
, O +
a O +
subunit O +
of O +
the O +
multimeric O +
Mediator B-Gene +
coactivator I-Gene +
complex I-Gene +
. O +

Other O +
Mediator O +
subunits O +
, O +
DRIP77 B-Gene +
and O +
DRIP130 B-Gene +
, O +
were O +
found O +
either O +
to O +
bind O +
STAT2 B-Gene +
without O +
augmenting O +
ISGF3 B-Gene +
transcriptional O +
activity O +
or O +
to O +
enhance O +
ISGF3 B-Gene +
transcription O +
without O +
binding O +
STAT2 B-Gene +
, O +
but O +
only O +
DRIP150 B-Gene +
both O +
enhanced O +
IFN B-Gene +
- O +
dependent O +
transcription O +
and O +
coimmunoprecipitated O +
with O +
STAT2 B-Gene +
. O +

Endogenous O +
DRIP150 B-Gene +
and O +
STAT2 B-Gene +
were O +
able O +
to O +
interact O +
in O +
solution O +
, O +
and O +
DNA O +
affinity O +
chromatography O +
and O +
chromatin O +
immunoprecipitation O +
assays O +
demonstrated O +
that O +
DRIP150 B-Gene +
binds O +
to O +
the O +
mature O +
, O +
activated O +
ISGF3 B-Gene +
- O +
DNA O +
complex O +
and O +
is O +
recruited O +
to O +
target O +
gene O +
promoters O +
in O +
an O +
IFN B-Gene +
- O +
dependent O +
fashion O +
. O +

IFN B-Gene +
- O +
dependent O +
recruitment O +
of O +
DRIP130 B-Gene +
to O +
an O +
ISGF3 B-Gene +
target O +
promoter O +
and O +
SRB10 B-Gene +
- O +
STAT2 B-Gene +
coprecipitation O +
suggest O +
indirect O +
association O +
with O +
a O +
multisubunit O +
Mediator B-Gene +
complex I-Gene +
. O +

The O +
site O +
of O +
STAT2 B-Gene +
interaction O +
was O +
mapped O +
to O +
DRIP150 B-Gene +
residues O +
188 O +
to O +
566 O +
, O +
which O +
are O +
necessary O +
and O +
sufficient O +
for O +
interaction O +
with O +
STAT2 B-Gene +
. O +

Expression O +
of O +
this O +
DRIP150 B-Gene +
fragment O +
, O +
but O +
not O +
DRIP150 B-Gene +
fragments O +
outside O +
the O +
STAT2 B-Gene +
interaction O +
region O +
, O +
suppressed O +
ISGF3 B-Gene +
- O +
mediated O +
transcriptional O +
activity O +
in O +
a O +
dominant O +
- O +
negative O +
fashion O +
, O +
suggesting O +
a O +
direct O +
functional O +
role O +
of O +
this O +
domain O +
in O +
mediating O +
STAT2 B-Gene +
- O +
DRIP150 B-Gene +
interactions O +
. O +

These O +
findings O +
indicate O +
that O +
the O +
IFN B-Gene +
- O +
activated O +
ISGF3 B-Gene +
transcription O +
factor O +
regulates O +
transcription O +
through O +
contact O +
with O +
DRIP150 B-Gene +
and O +
implicate O +
the O +
Mediator B-Gene +
coactivator I-Gene +
complex I-Gene +
in O +
IFN B-Gene +
- O +
activated O +
gene O +
regulation O +
. O +

[ O +
A O +
new O +
missense O +
mutation O +
of O +
574C O +
> O +
T O +
in O +
the O +
SURF1 B-Gene +
gene O +
-- O +
biochemical O +
and O +
molecular O +
genetic O +
study O +
in O +
seven O +
children O +
with O +
Leigh O +
syndrome O +
] O +

BACKGROUND O +
: O +

Leigh O +
disease O +
, O +
subacute O +
necrotizing O +
encephalopathy O +
, O +
is O +
a O +
serious O +
mitochondrial O +
disorder O +
of O +
energy O +
- O +
providing O +
metabolism O +
. O +

Clinical O +
presentation O +
usually O +
starts O +
in O +
infancy O +
as O +
a O +
progressive O +
neurodegenerative O +
disorder O +
with O +
retardation O +
and O +
regression O +
of O +
psychomotor O +
development O +
. O +

The O +
most O +
common O +
form O +
of O +
the O +
disease O +
is O +
associated O +
with O +
deficiency O +
of O +
the O +
cytochrome B-Gene +
c I-Gene +
oxidase I-Gene +
( O +
COX B-Gene +
) O +
due O +
to O +
SURF1 B-Gene +
gene O +
mutations O +
. O +

SURF1 B-Gene +
encodes O +
an O +
inner O +
mitochondrial O +
membrane O +
protein O +
involved O +
in O +
the O +
biogenesis O +
and O +
assembly O +
of O +
COX B-Gene +
complex I-Gene +
. O +

METHODS O +
AND O +
RESULTS O +
: O +

The O +
activities O +
of O +
mitochondrial O +
respiratory O +
chain O +
complexes O +
were O +
determined O +
spectrophotometrically O +
in O +
isolated O +
lymphocytes O +
, O +
platelets O +
, O +
muscle O +
mitochondria O +
and O +
cultured O +
fibroblasts O +
. O +

Generalised O +
decrease O +
of O +
COX B-Gene +
activity O +
was O +
found O +
in O +
7 O +
children O +
with O +
typical O +
symptoms O +
of O +
Leigh O +
disease O +
. O +

Two O +
- O +
dimensional O +
electrophoresis O +
of O +
mitochondrial O +
proteins O +
showed O +
altered O +
assembly O +
pattern O +
of O +
COX B-Gene +
. O +

As O +
demonstrated O +
by O +
Western O +
blot O +
analysis O +
of O +
mitochondria O +
or O +
mitoplasts O +
with O +
anti O +
- O +
hSurf1 B-Gene +
antibodies O +
( O +
gift O +
from O +
Dr. O +
E. O +
A. O +
Shoubridge O +
) O +
, O +
the O +
Surf1 B-Gene +
protein O +
was O +
absent O +
in O +
all O +
5 O +
investigated O +
patients O +
. O +

Molecular O +
analyses O +
in O +
the O +
7 O +
patients O +
revealed O +
the O +
presence O +
of O +
mutations O +
in O +
the O +
SURF1 B-Gene +
gene O +
--six O +
patients O +
harboured O +
previously O +
described O +
SURF1 B-Gene +
mutations O +
, O +
a O +
new O +
mutation O +
574C O +
> O +
T O +
was O +
found O +
in O +
one O +
patient O +
. O +

CONCLUSIONS O +
: O +

The O +
co O +
- O +
operation O +
among O +
the O +
patient O +
's O +
families O +
, O +
clinicians O +
and O +
specialised O +
laboratories O +
is O +
essential O +
for O +
the O +
diagnostic O +
of O +
mitochondrial O +
disorders O +
. O +

The O +
treatment O +
of O +
Leigh O +
syndrome O +
is O +
only O +
symptomatic O +
and O +
the O +
prognosis O +
of O +
the O +
disease O +
is O +
unfavourable O +
. O +

The O +
diagnostics O +
on O +
biochemical O +
and O +
molecular O +
level O +
is O +
necessary O +
for O +
genetic O +
counselling O +
and O +
prenatal O +
diagnosis O +
in O +
affected O +
families O +
. O +

Ephrin B-Gene +
stimulation O +
modulates O +
T O +
cell O +
chemotaxis O +
. O +

Eph B-Gene +
receptor I-Gene +
tyrosine I-Gene +
kinases I-Gene +
and O +
their O +
ligands O +
, O +
the O +
ephrins B-Gene +
, O +
are O +
known O +
to O +
play O +
an O +
important O +
role O +
in O +
regulating O +
cell O +
migration O +
and O +
targeting O +
in O +
neuronal O +
and O +
endothelial O +
cells O +
. O +

Recently O +
, O +
it O +
has O +
been O +
shown O +
that O +
lymphoid O +
cells O +
also O +
express O +
Eph B-Gene +
receptors I-Gene +
, O +
raising O +
the O +
possibility O +
that O +
Eph B-Gene +
receptors I-Gene +
may O +
similarly O +
regulate O +
lymphocyte O +
migration O +
. O +

Chemotaxis O +
in O +
response O +
to O +
soluble O +
chemokine B-Gene +
factors O +
is O +
an O +
essential O +
facet O +
of O +
T O +
cell O +
biology O +
. O +

We O +
demonstrate O +
here O +
that O +
T O +
cell O +
chemotaxis O +
in O +
response O +
to O +
both O +
the O +
stromal B-Gene +
cell I-Gene +
- I-Gene +
derived I-Gene +
factor I-Gene +
( I-Gene +
SDF I-Gene +
) I-Gene +
- I-Gene +
1alpha I-Gene +
and O +
macrophage B-Gene +
inflammatory I-Gene +
protein I-Gene +
3beta I-Gene +
chemokines B-Gene +
is O +
modulated O +
by O +
costimulation O +
with O +
ephrins B-Gene +
. O +

Both O +
ephrin B-Gene +
- I-Gene +
A I-Gene +
and O +
ephrin B-Gene +
- I-Gene +
B I-Gene +
ligands O +
were O +
found O +
to O +
modify O +
the O +
chemotactic O +
responses O +
of O +
a O +
T O +
cell O +
line O +
and O +
primary O +
T O +
cells O +
. O +

Ephrin B-Gene -
- I-Gene -
A1 I-Gene +
, O +
in O +
particular O +
, O +
strongly O +
inhibited O +
chemotaxis O +
. O +

In O +
accordance O +
with O +
the O +
tyrosine B-Gene +
kinase I-Gene +
activity O +
of O +
EphA B-Gene +
receptors I-Gene +
, O +
ephrin B-Gene -
- I-Gene -
A1 I-Gene +
stimulation O +
induced O +
rapid O +
intracellular O +
tyrosine O +
phosphorylation O +
in O +
T O +
cells O +
. O +

Although O +
strongly O +
inhibiting O +
chemotaxis O +
, O +
ephrin B-Gene -
- I-Gene -
A1 I-Gene +
costimulus O +
did O +
not O +
affect O +
many O +
of O +
the O +
signaling O +
events O +
downstream O +
of O +
the O +
SDF-1alpha B-Gene +
receptor I-Gene +
CXCR4 B-Gene +
, O +
including O +
calcium O +
flux O +
and O +
activation O +
of O +
MAPK B-Gene +
. O +

Rather O +
, O +
ephrin B-Gene +
- I-Gene +
A1 I-Gene +
altered O +
the O +
balance O +
of O +
small B-Gene +
G I-Gene +
protein I-Gene +
activity O +
in O +
T O +
cells O +
. O +

Ephrin B-Gene -
- I-Gene -
A1 I-Gene +
stimulation O +
prevented O +
SDF-1alpha B-Gene +
- O +
induced O +
activation O +
of O +
cdc42 B-Gene +
, O +
while O +
simultaneously O +
inducing O +
rho B-Gene +
activation O +
. O +

Ultimately O +
, O +
ephrin B-Gene +
- I-Gene +
A1 I-Gene +
was O +
found O +
to O +
inhibit O +
chemokine B-Gene +
- O +
induced O +
actin B-Gene +
polymerization O +
, O +
thereby O +
blocking O +
migration O +
. O +

Ubiquitous O +
ephrin B-Gene +
expression O +
in O +
vivo O +
creates O +
enormous O +
potential O +
for O +
T O +
cells O +
to O +
encounter O +
these O +
ligands O +
, O +
suggesting O +
that O +
Eph B-Gene +
receptors I-Gene +
and O +
ephrins B-Gene +
may O +
be O +
important O +
regulators O +
of O +
T O +
cell O +
migration O +
. O +

iASPP B-Gene +
oncoprotein O +
is O +
a O +
key O +
inhibitor O +
of O +
p53 B-Gene +
conserved O +
from O +
worm O +
to O +
human O +
. O +

We O +
have O +
previously O +
shown O +
that O +
ASPP1 B-Gene +
and O +
ASPP2 B-Gene +
are O +
specific O +
activators O +
of O +
p53 B-Gene +
; O +
one O +
mechanism O +
by O +
which O +
wild O +
- O +
type O +
p53 B-Gene +
is O +
tolerated O +
in O +
human O +
breast O +
carcinomas O +
is O +
through O +
loss O +
of O +
ASPP B-Gene +
activity O +
. O +

We O +
have O +
further O +
shown O +
that O +
53BP2 B-Gene +
, O +
which O +
corresponds O +
to O +
a O +
C O +
- O +
terminal O +
fragment O +
of O +
ASPP2 B-Gene +
, O +
acts O +
as O +
a O +
dominant O +
negative O +
inhibitor O +
of O +
p53 B-Gene +
( O +
ref O -
. O +
1 O +
) O +
. O +

Hence O +
, O +
an O +
inhibitory O +
form O +
of O +
ASPP B-Gene +
resembling O +
53BP2 B-Gene +
could O +
allow O +
cells O +
to O +
bypass O +
the O +
tumor O +
- O +
suppressor O +
functions O +
of O +
p53 B-Gene +
and O +
the O +
ASPP B-Gene +
proteins O +
. O +

Here O +
, O +
we O +
characterize O +
such O +
a O +
protein O +
, O +
iASPP B-Gene +
( O +
inhibitory B-Gene +
member I-Gene +
of I-Gene +
the I-Gene +
ASPP I-Gene +
family I-Gene +
) O +
, O +
encoded O +
by O +
PPP1R13L B-Gene +
in O +
humans O +
and O +
ape-1 B-Gene +
in O +
Caenorhabditis O +
elegans O +
. O +

iASPP B-Gene +
is O +
an O +
evolutionarily O +
conserved O +
inhibitor O +
of O +
p53 B-Gene +
; O +
inhibition O +
of O +
iASPP B-Gene +
by O +
RNA O +
- O +
mediated O +
interference O +
or O +
antisense O +
RNA O +
in O +
C. O +
elegans O +
or O +
human O +
cells O +
, O +
respectively O +
, O +
induces O +
p53 B-Gene +
- O +
dependent O +
apoptosis O +
. O +

Moreover O +
, O +
iASPP B-Gene +
is O +
an O +
oncoprotein O +
that O +
cooperates O +
with O +
Ras B-Gene +
, O +
E1A B-Gene +
and O +
E7 O +
, O +
but O +
not O +
mutant O +
p53 B-Gene +
, O +
to O +
transform O +
cells O +
in O +
vitro O +
. O +

Increased O +
expression O +
of O +
iASPP B-Gene +
also O +
confers O +
resistance O +
to O +
ultraviolet O +
radiation O +
and O +
to O +
cisplatin O +
- O +
induced O +
apoptosis O +
. O +

iASPP B-Gene +
expression O +
is O +
upregulated O +
in O +
human O +
breast O +
carcinomas O +
expressing O +
wild O +
- O +
type O +
p53 B-Gene +
and O +
normal O +
levels O +
of O +
ASPP B-Gene +
. O +

Inhibition O +
of O +
iASPP B-Gene +
could O +
provide O +
an O +
important O +
new O +
strategy O +
for O +
treating O +
tumors O +
expressing O +
wild O +
- O +
type O +
p53 B-Gene +
. O +

Traffic O +
at O +
the O +
tmRNA O +
gene O +
. O +

A O +
partial O +
screen O +
for O +
genetic O +
elements O +
integrated O +
into O +
completely O +
sequenced O +
bacterial O +
genomes O +
shows O +
more O +
significant O +
bias O +
in O +
specificity O +
for O +
the O +
tmRNA O +
gene O +
( O +
ssrA O +
) O +
than O +
for O +
any O +
type O +
of O +
tRNA O +
gene O +
. O +

Horizontal O +
gene O +
transfer O +
, O +
a O +
major O +
avenue O +
of O +
bacterial O +
evolution O +
, O +
was O +
assessed O +
by O +
focusing O +
on O +
elements O +
using O +
this O +
single O +
attachment O +
locus O +
. O +

Diverse O +
elements O +
use O +
ssrA O +
; O +
among O +
enterobacteria O +
alone O +
, O +
at O +
least O +
four O +
different O +
integrase B-Gene +
subfamilies O +
have O +
independently O +
evolved O +
specificity O +
for O +
ssrA O +
, O +
and O +
almost O +
every O +
strain O +
analyzed O +
presents O +
a O +
unique O +
set O +
of O +
integrated O +
elements O +
. O +

Even O +
elements O +
using O +
essentially O +
the O +
same O +
integrase B-Gene +
can O +
be O +
very O +
diverse O +
, O +
as O +
is O +
a O +
group O +
with O +
an O +
ssrA O +
- O +
specific O +
integrase B-Gene +
of O +
the O +
P4 O +
subfamily O +
. O +

This O +
same O +
integrase B-Gene +
appears O +
to O +
promote O +
damage O +
routinely O +
at O +
attachment O +
sites O +
, O +
which O +
may O +
be O +
adaptive O +
. O +

Elements O +
in O +
arrays O +
can O +
recombine O +
; O +
one O +
such O +
event O +
mediated O +
by O +
invertible O +
DNA O +
segments O +
within O +
neighboring O +
elements O +
likely O +
explains O +
the O +
monophasic O +
nature O +
of O +
Salmonella O +
enterica O +
serovar O +
Typhi O +
. O +

One O +
of O +
a O +
limited O +
set O +
of O +
conserved O +
sequences O +
occurs O +
at O +
the O +
attachment O +
site O +
of O +
each O +
enterobacterial O +
element O +
, O +
apparently O +
serving O +
as O +
a O +
transcriptional O +
terminator O +
for O +
ssrA O +
. O +

Elements O +
were O +
usually O +
found O +
integrated O +
into O +
tRNA O +
- O +
like O +
sequence O +
at O +
the O +
3 O -
' O +
end O +
of O +
ssrA O +
, O +
at O +
subsites O +
corresponding O +
to O +
those O +
used O +
in O +
tRNA O +
genes O +
; O +
an O +
exception O +
was O +
found O +
at O +
the O +
non O +
- O +
tRNA O +
- O +
like O +
3 O -
' O +
end O +
produced O +
by O +
ssrA O +
gene O +
permutation O +
in O +
cyanobacteria O +
, O +
suggesting O +
that O +
, O +
during O +
the O +
evolution O +
of O +
new O +
site O +
specificity O +
by O +
integrases B-Gene +
, O +
tropism O +
toward O +
a O +
conserved O +
3 O -
' O +
end O +
of O +
an O +
RNA O +
gene O +
may O +
be O +
as O +
strong O +
as O +
toward O +
a O +
tRNA O +
- O +
like O +
sequence O +
. O +

The O +
proximity O +
of O +
ssrA O +
and O +
smpB B-Gene +
, O +
which O +
act O +
in O +
concert O +
, O +
was O +
also O +
surveyed O +
. O +

[ O +
Serum O +
apolipoprotein B-Gene +
A I-Gene +
I I-Gene +
, I-Gene +
B100 I-Gene +
and I-Gene +
E I-Gene +
levels O +
and O +
apolipoprotein B-Gene +
E I-Gene +
polymorphism O +
in O +
patients O +
with O +
Alzheimer O +
's O +
disease O +
and O +
multiple O +
infarction O +
dementia O +
in O +
Chinese O +
population O +
] O +

OBJECTIVE O +
: O +

To O +
investigate O +
the O +
relationship O +
of O +
serum O +
apolipoprotein B-Gene +
( I-Gene +
apo I-Gene +
) I-Gene +
A I-Gene +
I I-Gene +
, I-Gene +
B100 I-Gene +
and I-Gene +
E I-Gene +
levels O +
and O +
apo B-Gene +
E I-Gene +
polymorphism O +
to O +
Alzheimer O +
's O +
disease O +
( O +
AD O +
) O +
and O +
multiple O +
infarction O +
dementia O +
( O +
MID O +
) O +
in O +
Chinese O +
population O +
. O +

METHODS O +
: O +

The O +
apoE B-Gene +
phenotypes O +
were O +
assayed O +
by O +
isoelectric O +
focusing O +
and O +
immunoblotting O +
, O +
and O +
apolipoproteins B-Gene +
were O +
determined O +
by O +
radial O +
immunodiffusion O +
assay O +
in O +
75 O +
patients O +
with O +
AD O +
, O +
36 O +
patients O +
with O +
MID O +
and O +
60 O +
control O +
subjects O +
. O +

RESULTS O +
: O +

The O +
frequency O +
of O +
apo B-Gene +
E4 I-Gene +
allele O +
( O +
epsilon O +
4 O +
) O +
was O +
significantly O +
higher O +
and O +
the O +
frequency O +
of O +
epsilon O +
2 O +
allele O +
was O +
lower O +
in O +
AD O +
group O +
, O +
compared O +
with O +
those O +
in O +
the O +
control O +
group O +
( O +
0.2333 O +
vs O +
0.0666 O +
, O +
0.0467 O +
vs O +
0.0833 O +
, O +
P O +
< O +
0.05 O +
) O +
. O +

The O +
frequency O +
of O +
epsilon O +
4 O +
allele O +
in O +
MID O +
group O +
was O +
also O +
higher O +
than O +
that O +
in O +
the O +
control O +
group O +
( O +
0.2083 O +
vs O +
0.0666 O +
, O +
P O +
< O +
0.05 O +
) O +
. O +

The O +
fasting O +
serum O +
apoA B-Gene +
1 I-Gene +
and I-Gene +
E I-Gene +
levels O +
in O +
AD O +
and O +
MID O +
groups O +
were O +
remarkably O +
lower O +
than O +
those O +
in O +
the O +
control O +
group O +
( O +
P O +
< O +
0.001 O +
and O +
P O +
< O +
0.05 O +
) O +
. O +

CONCLUSION O +
: O +

Apo B-Gene +
E4 I-Gene +
allele O +
epsilon O +
4 O +
was O +
associated O +
with O +
AD O +
and O +
MID O +
. O +

ApoE4 B-Gene +
might O +
be O +
a O +
risk O +
factor O +
for O +
AD O +
and O +
MID O +
, O +
and O +
apo B-Gene +
E2 I-Gene +
might O +
be O +
a O +
protective O +
factor O +
for O +
AD O +
. O +

The O +
serum O +
apo B-Gene +
A I-Gene +
I I-Gene +
and O +
apoE B-Gene +
levels O +
were O +
significantly O +
decreased O +
in O +
patients O +
with O +
Alzheimer O +
's O +
disease O +
and O +
multiple O +
infarction O +
dementia O +
. O +

DNA O +
methylation O +
maintains O +
allele O +
- O +
specific O +
KIR B-Gene +
gene O +
expression O +
in O +
human O +
natural O +
killer O +
cells O +
. O +

Killer B-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIR B-Gene +
) O +
bind O +
self O +
- O +
major B-Gene +
histocompatibility I-Gene +
complex I-Gene +
class I-Gene +
I I-Gene +
molecules O +
, O +
allowing O +
natural O +
killer O +
( O +
NK O +
) O +
cells O +
to O +
recognize O +
aberrant O +
cells O +
that O +
have O +
down O +
- O +
regulated O +
class O +
I O +
. O +

NK O +
cells O +
express O +
variable O +
numbers O +
and O +
combinations O +
of O +
highly O +
homologous O +
clonally O +
restricted O +
KIR B-Gene +
genes O +
, O +
but O +
uniformly O +
express O +
KIR2DL4 B-Gene +
. O +

We O +
show O +
that O +
NK O +
clones O +
express O +
both O +
2DL4 B-Gene +
alleles O +
and O +
either O +
one O +
or O +
both O +
alleles O +
of O +
the O +
clonally O +
restricted O +
KIR B-Gene +
3DL1 I-Gene +
and O +
3DL2 B-Gene +
genes O +
. O +

Despite O +
allele O +
- O +
independent O +
expression O +
, O +
3DL1 B-Gene +
alleles O +
differed O +
in O +
the O +
core O +
promoter O +
by O +
only O +
one O +
or O +
two O +
nucleotides O +
. O +

Allele O +
- O +
specific O +
3DL1 B-Gene +
gene O +
expression O +
correlated O +
with O +
promoter O +
and O +
5 O -
' O +
gene O +
DNA O +
hypomethylation O +
in O +
NK O +
cells O +
in O +
vitro O +
and O +
in O +
vivo O +
. O +

The O +
DNA B-Gene +
methylase I-Gene +
inhibitor O +
, O +
5-aza-2'-deoxycytidine O +
, O +
induced O +
KIR B-Gene +
DNA O +
hypomethylation O +
and O +
heterogeneous O +
expression O +
of O +
multiple O +
KIR B-Gene +
genes O +
. O +

Thus O +
, O +
NK O +
cells O +
use O +
DNA O +
methylation O +
to O +
maintain O +
clonally O +
restricted O +
expression O +
of O +
highly O +
homologous O +
KIR B-Gene +
genes O +
and O +
alleles O +
. O +

Apolipoprotein B-Gene +
B I-Gene +
in O +
cholesterol O +
- O +
containing O +
drusen O +
and O +
basal O +
deposits O +
of O +
human O +
eyes O +
with O +
age O +
- O +
related O +
maculopathy O +
. O +

Lipids O +
accumulate O +
in O +
Bruch O +
's O +
membrane O +
( O +
BrM O +
) O +
, O +
a O +
specialized O +
vascular O +
intima O +
of O +
the O +
eye O +
, O +
and O +
in O +
extracellular O +
lesions O +
associated O +
with O +
aging O +
and O +
age O +
- O +
related O +
maculopathy O +
( O +
ARM O +
) O +
. O +

We O +
tested O +
the O +
hypothesis O +
that O +
ARM O +
and O +
atherosclerotic O +
cardiovascular O +
disease O +
share O +
molecules O +
and O +
mechanisms O +
pertaining O +
to O +
extracellular O +
lipid O +
accumulation O +
by O +
localizing O +
cholesterol O +
and O +
apolipoprotein B-Gene +
B I-Gene +
( O +
apo B-Gene +
B I-Gene +
) O +
in O +
BrM O +
, O +
basal O +
deposits O +
, O +
and O +
drusen O +
. O +

Human O +
donor O +
eyes O +
were O +
preserved O +
< O +
4 O +
hours O +
postmortem O +
and O +
cryosectioned O +
. O +

Sections O +
were O +
stained O +
with O +
traditional O +
lipid O +
stains O +
and O +
filipin O +
for O +
esterified O +
and O +
unesterified O +
cholesterol O +
or O +
probed O +
with O +
antibodies O +
to O +
apo B-Gene +
B I-Gene +
, O +
apo B-Gene +
E I-Gene +
, O +
and O +
apo B-Gene +
C I-Gene -
- I-Gene -
III I-Gene +
. O +

Normal O +
adult O +
retinal O +
pigment O +
epithelium O +
( O +
RPE O +
) O +
was O +
subjected O +
to O +
RT O +
- O +
PCR O +
and O +
Western O +
blot O +
analysis O +
for O +
apolipoprotein B-Gene +
mRNA O +
and O +
protein O +
. O +

Esterified O +
and O +
unesterified O +
cholesterol O +
was O +
present O +
in O +
all O +
drusen O +
and O +
basal O +
deposits O +
of O +
ARM O +
and O +
normal O +
eyes O +
. O +

Both O +
apo B-Gene +
B I-Gene +
and O +
apo B-Gene +
E I-Gene +
but O +
not O +
apo B-Gene +
C I-Gene -
- I-Gene -
III I-Gene +
were O +
found O +
in O +
BrM O +
, O +
drusen O +
, O +
and O +
basal O +
deposits O +
. O +

Fewer O +
macular O +
drusen O +
were O +
stained O +
by O +
traditional O +
lipid O +
stains O +
and O +
apolipoprotein B-Gene +
antibodies O +
than O +
peripheral O +
drusen O +
. O +

RPE O +
contained O +
apo B-Gene +
B I-Gene +
and O +
apo B-Gene +
E I-Gene +
mRNA O +
and O +
protein O +
. O +

Finding O +
cholesterol O +
and O +
apo B-Gene +
B I-Gene +
in O +
sub O +
- O +
RPE O +
deposits O +
links O +
ARM O +
with O +
important O +
molecules O +
and O +
mechanisms O +
in O +
atherosclerosis O +
initiation O +
and O +
progression O +
. O +

The O +
combination O +
of O +
apo B-Gene +
B I-Gene +
mRNA O +
and O +
protein O +
in O +
RPE O +
raises O +
the O +
possibility O +
that O +
intraocular O +
assembly O +
of O +
apo B-Gene +
B I-Gene +
- O +
containing O +
lipoproteins O +
is O +
a O +
pathway O +
involved O +
in O +
forming O +
cholesterol O +
- O +
enriched O +
lesions O +
in O +
ARM O +
. O +

Enhanced O +
11beta B-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
type I-Gene +
1 I-Gene +
activity O +
in O +
stress O +
adaptation O +
in O +
the O +
guinea O +
pig O +
. O +

The O +
11beta B-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenases I-Gene +
( O +
11beta B-Gene -
- I-Gene -
HSDs I-Gene +
) O +
convert O +
cortisol O +
to O +
its O +
inactive O +
metabolite O +
cortisone O +
and O +
vice O +
versa O +
. O +

11beta B-Gene -
- I-Gene -
HSD I-Gene +
type I-Gene +
1 I-Gene +
( O +
11beta B-Gene -
- I-Gene -
HSD-1 I-Gene +
) O +
functions O +
as O +
a O +
reductase B-Gene +
in O +
vivo O +
, O +
regulating O +
intracellular O +
cortisol O +
levels O +
and O +
its O +
access O +
to O +
the O +
glucocorticoid B-Gene +
receptor I-Gene +
. O +

In O +
contrast O +
, O +
11beta B-Gene -
- I-Gene -
HSD-2 I-Gene +
only O +
mediates O +
oxidation O +
of O +
natural O +
glucocorticoids O +
, O +
and O +
protects O +
the O +
mineralocorticoid B-Gene +
receptor I-Gene +
from O +
high O +
cortisol O +
concentrations O +
. O +

We O +
investigated O +
the O +
in O +
vivo O +
and O +
in O +
vitro O +
effects O +
of O +
ACTH B-Gene +
on O +
the O +
recently O +
characterized O +
11beta B-Gene -
- I-Gene -
HSDs I-Gene +
in O +
guinea O +
pig O +
liver O +
and O +
kidney O +
. O +

Tissue O +
slices O +
of O +
untreated O +
guinea O +
pigs O +
were O +
incubated O +
with O +
( O -
3 O -
) O -
H O -
- O -
labelled O +
cortisol O +
or O +
cortisone O +
and O +
ACTH B-Gene -
( I-Gene -
1 I-Gene -
- I-Gene -
24 I-Gene -
) I-Gene +
( O +
10 O -
( O -
-10 O -
) O +
and O +
10 O -
( O -
-9 O -
) O +
mol O +
/ O +
l O +
) O +
. O +

The O +
11beta B-Gene -
- I-Gene -
HSD I-Gene +
activities O +
in O +
liver O +
and O +
kidney O +
slices O +
were O +
not O +
influenced O +
by O +
in O +
vitro O +
incubation O +
with O +
ACTH B-Gene -
( I-Gene -
1 I-Gene -
- I-Gene -
24 I-Gene -
) I-Gene +
. O +

In O +
addition O +
, O +
guinea O +
pigs O +
were O +
treated O +
with O +
ACTH B-Gene -
( I-Gene -
1 I-Gene -
- I-Gene -
24 I-Gene +
) O +
or O +
saline O +
injections O +
s.c O -
. O +
for O +
3 O +
days O +
. O +

Liver O +
and O +
kidney O +
tissue O +
slices O +
of O +
these O +
animals O +
were O +
incubated O +
with O +
( O -
3 O -
) O -
H O -
- O -
labelled O +
cortisol O +
or O +
cortisone O +
. O +

In O +
vivo O +
ACTH B-Gene +
treatment O +
significantly O +
increased O +
reductase B-Gene +
and O +
decreased O +
oxidase B-Gene +
activity O +
in O +
liver O +
and O +
kidney O +
. O +

Furthermore O +
, O +
11beta B-Gene -
- I-Gene -
HSD-1 I-Gene +
activity O +
assessed O +
by O +
measurement O +
of O +
the O +
urinary O +
ratio O +
of O +
( O +
tetrahydrocortisol O +
( O +
THF O +
) O +
+ O +
5alphaTHF O +
) O +
/ O +
( O +
tetrahydrocortisone O +
) O +
was O +
significantly O +
increased O +
after O +
ACTH B-Gene +
treatment O +
compared O +
with O +
the O +
control O +
group O +
. O +

Plasma O +
levels O +
of O +
cortisol O +
, O +
cortisone O +
, O +
progesterone O +
, O +
17-hydroxyprogesterone O +
and O +
androstenedione O +
increased O +
significantly O +
following O +
in O +
vivo O +
ACTH B-Gene +
treatment O +
. O +

The O +
enhanced O +
reductase B-Gene +
activity O +
of O +
the O +
hepatic O +
and O +
renal O +
11beta B-Gene -
- I-Gene -
HSD-1 I-Gene +
is O +
apparently O +
caused O +
by O +
cortisol O +
or O +
other O +
ACTH B-Gene +
- O +
dependent O +
steroids O +
rather O +
than O +
by O +
ACTH B-Gene +
itself O +
. O +

This O +
may O +
be O +
an O +
important O +
fine O +
regulation O +
of O +
the O +
glucocorticoid O +
tonus O +
for O +
stress O +
adaptation O +
in O +
every O +
organ O +
, O +
e.g. O +
enhanced O +
gluconeogenesis O +
in O +
liver O +
. O +

Assessment O +
of O +
killer B-Gene +
cell I-Gene +
immunoglobulinlike I-Gene +
receptor I-Gene +
expression O +
and O +
corresponding O +
HLA B-Gene +
class I-Gene +
I I-Gene +
phenotypes O +
demonstrates O +
heterogenous O +
KIR B-Gene +
expression O +
independent O +
of O +
anticipated O +
HLA B-Gene +
class I-Gene +
I I-Gene +
ligands O +
. O +

Natural O +
killer O +
( O +
NK O +
) O +
cell O +
- O +
mediated O +
cytolysis O +
is O +
stimulated O +
and O +
downregulated O +
through O +
the O +
interaction O +
of O +
distinct O +
human B-Gene +
leukocyte I-Gene +
antigen I-Gene +
( I-Gene +
HLA I-Gene +
) I-Gene +
class I-Gene +
I I-Gene +
molecules O +
on O +
target O +
cells O +
with O +
specific O +
killer B-Gene +
cell I-Gene +
immunoglobulinlike I-Gene +
receptors I-Gene +
( O +
KIRs B-Gene +
) O +
on O +
NK O +
cells O +
. O +

Killer B-Gene +
cell I-Gene +
immunoglobulinlike I-Gene +
receptors I-Gene +
are O +
highly O +
polymorphic O +
and O +
are O +
clonally O +
distributed O +
on O +
NK O +
cell O +
populations O +
within O +
individuals O +
. O +

However O +
, O +
the O +
regulation O +
of O +
KIR B-Gene +
expression O +
by O +
individual O +
HLA B-Gene +
class I-Gene +
I I-Gene +
phenotypes O +
is O +
not O +
well O +
understood O +
. O +

To O +
examine O +
a O +
potential O +
influence O +
of O +
the O +
HLA B-Gene +
class I-Gene +
I I-Gene +
phenotype O +
on O +
KIR B-Gene +
expression O +
patterns O +
we O +
studied O +
the O +
KIR B-Gene +
expression O +
in O +
individuals O +
that O +
were O +
subgrouped O +
according O +
to O +
the O +
major O +
HLA B-Gene -
- I-Gene -
C I-Gene +
encoded O +
KIR B-Gene +
- O +
epitopes O +
( O +
group O +
C1 O +
versus O +
C2 O +
) O +
. O +

In O +
these O +
individuals O +
, O +
NK O +
cells O +
were O +
analyzed O +
for O +
KIR B-Gene +
expression O +
using O +
flow O +
cytometry O +
and O +
RNA O +
- O +
based O +
expression O +
analysis O +
. O +

Our O +
results O +
demonstrate O +
that O +
KIR B-Gene +
genes O +
are O +
transmitted O +
very O +
heterogeneously O +
with O +
two O +
main O +
patterns O +
of O +
KIR B-Gene +
genotypes O +
as O +
previously O +
described O +
; O +
group O +
A O +
and O +
group O +
B O +
( O +
with O +
21 O +
different O +
genotypes O +
) O +
. O +

There O +
are O +
distinct O +
populations O +
exhibiting O +
different O +
densities O +
of O +
CD158a B-Gene +
and/or O +
CD158b B-Gene +
positive O +
NK O +
cells O +
that O +
coexist O +
in O +
all O +
individuals O +
. O +

A O +
clear O +
correlation O +
between O +
KIR B-Gene +
expression O +
and O +
the O +
currently O +
known O +
HLA B-Gene +
class I-Gene +
I I-Gene +
ligands O +
was O +
not O +
observed O +
. O +

In O +
conclusion O +
, O +
the O +
surface O +
expression O +
of O +
KIRs B-Gene +
in O +
individuals O +
with O +
different O +
HLA B-Gene +
class I-Gene +
I I-Gene +
genotypes O +
indicates O +
that O +
other O +
non O +
- O +
HLA B-Gene +
class I-Gene +
I I-Gene +
encoded O +
factors O +
contribute O +
to O +
the O +
shaping O +
of O +
the O +
KIR B-Gene +
repertoire O +
. O +

Furin B-Gene +
processing O +
and O +
proteolytic O +
activation O +
of O +
Semliki O +
Forest O +
virus O +
. O +

The O +
alphavirus O +
Semliki O +
Forest O +
virus O +
( O +
SFV O +
) O +
infects O +
cells O +
via O +
a O +
low O +
- O +
pH O +
- O +
dependent O +
membrane O +
fusion O +
reaction O +
mediated O +
by O +
the O +
E1 B-Gene +
envelope I-Gene +
protein I-Gene +
. O +

Fusion O +
is O +
regulated O +
by O +
the O +
interaction O +
of O +
E1 B-Gene +
with O +
the O +
receptor O +
- O +
binding O +
protein O +
E2 B-Gene +
. O +

E2 B-Gene +
is O +
synthesized O +
as O +
a O +
precursor O +
termed O +
" O +
p62 B-Gene +
, O +
" O +
which O +
forms O +
a O +
stable O +
heterodimer O +
with O +
E1 B-Gene +
and O +
is O +
processed O +
late O +
in O +
the O +
secretory O +
pathway O +
by O +
a O +
cellular O +
furin B-Gene +
- O +
like O +
protease B-Gene +
. O +

Once O +
processing O +
to O +
E2 B-Gene +
occurs O +
, O +
the O +
E1 B-Gene +
/ O +
E2 B-Gene +
heterodimer O +
is O +
destabilized O +
so O +
that O +
it O +
is O +
more O +
readily O +
dissociated O +
by O +
exposure O +
to O +
low O +
pH O +
, O +
allowing O +
fusion O +
and O +
infection O +
. O +

We O +
have O +
used O +
FD11 O +
cells O +
, O +
a O +
furin B-Gene +
- O +
deficient O +
CHO O +
cell O +
line O +
, O +
to O +
characterize O +
the O +
processing O +
of O +
p62 B-Gene +
and O +
its O +
role O +
in O +
the O +
control O +
of O +
virus O +
fusion O +
and O +
infection O +
. O +

p62 B-Gene +
was O +
not O +
cleaved O +
in O +
FD11 O +
cells O +
and O +
cleavage O +
was O +
restored O +
in O +
FD11 O +
cell O +
transfectants O +
expressing O +
human O +
furin B-Gene +
. O +

Studies O +
of O +
unprocessed O +
virus O +
produced O +
in O +
FD11 O +
cells O +
( O +
wt O +
/ O +
p62 B-Gene +
) O +
demonstrated O +
that O +
the O +
p62 B-Gene +
protein O +
was O +
efficiently O +
cleaved O +
by O +
purified O +
furin B-Gene +
in O +
vitro O +
, O +
without O +
requiring O +
prior O +
exposure O +
to O +
low O +
pH O +
. O +

wt O +
/ O +
p62 B-Gene +
virus O +
particles O +
were O +
also O +
processed O +
during O +
their O +
endocytic O +
uptake O +
in O +
furin B-Gene +
- O +
containing O +
cells O +
, O +
resulting O +
in O +
more O +
efficient O +
virus O +
infection O +
. O +

wt O +
/ O +
p62 B-Gene +
virus O +
was O +
compared O +
with O +
mutant O +
L O +
, O +
in O +
which O +
p62 B-Gene +
cleavage O +
was O +
blocked O +
by O +
mutation O +
of O +
the O +
furin B-Gene +
- O +
recognition O +
motif O +
. O +

wt O +
/ O +
p62 B-Gene +
and O +
mutant O +
L O +
had O +
similar O +
fusion O +
properties O +
, O +
requiring O +
a O +
much O +
lower O +
pH O +
than O +
control O +
virus O +
to O +
trigger O +
fusion O +
and O +
fusogenic O +
E1 B-Gene +
conformational O +
changes O +
. O +

However O +
, O +
the O +
in O +
vivo O +
infectivity O +
of O +
mutant O +
L O +
was O +
more O +
strongly O +
inhibited O +
than O +
that O +
of O +
wt O +
/ O +
p62 B-Gene +
, O +
due O +
to O +
additional O +
effects O +
of O +
the O +
mutation O +
on O +
virus O +
- O +
cell O +
binding O +
. O +

Synergism O +
between O +
nuclear B-Gene +
receptors I-Gene +
bound O +
to O +
specific O +
hormone O +
response O +
elements O +
of O +
the O +
hepatic O +
control O +
region-1 O +
and O +
the O +
proximal O +
apolipoprotein B-Gene +
C I-Gene -
- I-Gene -
II I-Gene +
promoter O +
mediate O +
apolipoprotein B-Gene +
C I-Gene -
- I-Gene -
II I-Gene +
gene O +
regulation O +
by O +
bile O +
acids O +
and O +
retinoids O +
. O +

We O +
have O +
shown O +
previously O +
that O +
the O +
hepatic O +
control O +
region O +
1 O +
( O +
HCR-1 O +
) O +
enhances O +
the O +
activity O +
of O +
the O +
human O +
apolipoprotein B-Gene +
C I-Gene -
- I-Gene -
II I-Gene +
( O +
apoC B-Gene -
- I-Gene -
II I-Gene +
) O +
promoter O +
in O +
HepG2 O +
cells O +
via O +
two O +
hormone O +
response O +
elements O +
( O +
HREs O +
) O +
present O +
in O +
the O +
apoC B-Gene -
- I-Gene -
II I-Gene +
promoter O +
. O +

In O +
the O +
present O +
paper O +
, O +
we O +
report O +
that O +
the O +
HCR-1 O +
selectively O +
mediates O +
the O +
transactivation O +
of O +
the O +
apoC B-Gene -
- I-Gene -
II I-Gene +
promoter O +
by O +
chenodeoxycholic O +
acid O +
( O +
CDCA O +
) O +
and O +
9 O +
- O +
cis O +
- O +
retinoic O +
acid O +
. O +

CDCA O +
, O +
which O +
is O +
a O +
natural O +
ligand O +
of O +
farnesoid B-Gene +
X I-Gene +
receptor I-Gene +
alpha I-Gene +
( O +
FXRalpha B-Gene +
) O +
, O +
increases O +
the O +
steady O +
- O +
state O +
apoC B-Gene -
- I-Gene -
II I-Gene +
mRNA O +
levels O +
in O +
HepG2 O +
cells O +
. O +

This O +
increase O +
in O +
transcription O +
requires O +
the O +
binding O +
of O +
retinoid B-Gene +
X I-Gene +
receptor I-Gene +
alpha I-Gene +
( O +
RXRalpha B-Gene +
) O +
- O +
FXRalpha B-Gene +
heterodimers O +
to O +
a O +
novel O +
inverted O +
repeat O +
with O +
one O +
nucleotide O +
spacing O +
( O +
IR-1 O +
) O +
present O +
in O +
the O +
HCR-1 O +
. O +

This O +
element O +
also O +
binds O +
hepatocyte B-Gene +
nuclear I-Gene +
factor I-Gene +
4 I-Gene +
and O +
apoA B-Gene -
- I-Gene -
I I-Gene +
regulatory I-Gene +
protein-1 I-Gene +
. O +

Transactivation O +
of O +
the O +
HCR-1 O +
/ O +
apoC B-Gene -
- I-Gene -
II I-Gene +
promoter O +
cluster O +
by O +
RXRalpha B-Gene +
- O +
FXRalpha B-Gene +
heterodimers O +
in O +
the O +
presence O +
of O +
CDCA O +
was O +
abolished O +
by O +
mutations O +
either O +
in O +
the O +
IR-1 O +
HRE O +
of O +
the O +
HCR-1 O +
or O +
in O +
the O +
thyroid O +
HRE O +
of O +
the O +
proximal O +
apoC B-Gene -
- I-Gene -
II I-Gene +
promoter O +
, O +
which O +
binds O +
RXRalpha B-Gene +
- O +
thyroid B-Gene +
hormone I-Gene +
receptor I-Gene +
beta I-Gene +
( O +
T3Rbeta B-Gene +
) O +
heterodimers O +
. O +

The O +
same O +
mutations O +
also O +
abolished O +
transactivation O +
of O +
the O +
HCR-1 O +
/ O +
apoC B-Gene -
- I-Gene -
II I-Gene +
promoter O +
cluster O +
by O +
RXRalpha B-Gene +
- O +
T3Rbeta B-Gene +
heterodimers O +
in O +
the O +
presence O +
of O +
tri O +
- O +
iodothyronine O +
. O +

The O +
findings O +
establish O +
synergism O +
between O +
nuclear B-Gene +
receptors I-Gene +
bound O +
to O +
specific O +
HREs O +
of O +
the O +
proximal O +
apoC B-Gene -
- I-Gene -
II I-Gene +
promoter O +
and O +
the O +
HCR-1 O +
, O +
and O +
suggest O +
that O +
this O +
synergism O +
mediates O +
the O +
induction O +
of O +
the O +
HCR-1 O +
/ O +
apoC B-Gene -
- I-Gene -
II I-Gene +
promoter O +
cluster O +
by O +
bile O +
acids O +
and O +
retinoids O +
. O +

Oestradiol O +
- O +
dependent O +
and O +
- O +
independent O +
modulation O +
of O +
tyrosine B-Gene +
hydroxylase I-Gene +
mRNA O +
levels O +
in O +
subpopulations O +
of O +
A1 O +
and O +
A2 O +
neurones O +
with O +
oestrogen B-Gene +
receptor I-Gene +
( I-Gene +
ER I-Gene +
) I-Gene +
alpha I-Gene +
and O +
ER B-Gene +
beta I-Gene +
gene O +
expression O +
. O +

Oestradiol O +
( O +
E2 O +
) O +
induces O +
luteinizing B-Gene +
hormone I-Gene +
- I-Gene +
releasing I-Gene +
hormone I-Gene +
( O +
LHRH B-Gene +
) O +
hypersecretion O +
, O +
thereby O +
triggering O +
LH B-Gene +
surge O +
release O +
in O +
ovariectomized O +
( O +
OVX O +
) O +
rats O +
. O +

Neural O +
signals O +
responsible O +
for O +
the O +
surge O +
are O +
marked O +
by O +
a O +
morning O +
increase O +
in O +
LHRH B-Gene +
gene O +
expression O +
and O +
an O +
afternoon O +
increase O +
in O +
LHRH B-Gene +
release O +
. O +

Evidence O +
suggests O +
that O +
subpopulations O +
of O +
noradrenergic O +
neurones O +
may O +
be O +
responsible O +
for O +
one O +
or O +
both O +
of O +
these O +
signals O +
. O +

To O +
further O +
investigate O +
this O +
issue O +
, O +
we O +
examined O +
effects O +
of O +
E2 O +
on O +
the O +
activity O +
of O +
A1 O +
and O +
A2 O +
noradrenergic O +
neurones O +
, O +
as O +
reflected O +
in O +
changes O +
in O +
tyrosine B-Gene +
hydroxylase I-Gene +
( O +
TH B-Gene +
) O +
mRNA O +
expression O +
, O +
on O +
the O +
day O +
of O +
LH B-Gene +
surge O +
release O +
. O +

We O +
then O +
used O +
dual O +
- O +
label O +
in O +
situ O +
hybridization O +
to O +
determine O +
whether O +
E2 O +
- O +
induced O +
changes O +
occurred O +
primarily O +
in O +
A1 O +
and O +
A2 O +
subdivisions O +
wherein O +
most O +
noradrenergic O +
neurones O +
expressed O +
oestrogen B-Gene +
receptor I-Gene +
( I-Gene +
ER I-Gene +
) I-Gene +
alpha I-Gene +
and/or O +
ER B-Gene +
beta I-Gene +
mRNA O +
. O +

We O +
found O +
that O +
in O +
all O +
subdivisions O +
, O +
levels O +
of O +
TH B-Gene +
mRNA O +
were O +
higher O +
in O +
E2 O +
- O +
than O +
oil O +
- O +
treated O +
rats O +
at O +
12.00 O +
h O +
. O +

These O +
differences O +
resulted O +
from O +
a O +
decline O +
in O +
TH B-Gene +
mRNA O +
expression O +
in O +
oil O +
- O +
treated O +
rats O +
, O +
as O +
well O +
as O +
a O +
rise O +
in O +
levels O +
in O +
E2 O +
- O +
treated O +
rats O +
between O +
10.00 O +
h O +
and O +
12.00 O +
h O +
. O +

During O +
the O +
afternoon O +
, O +
TH B-Gene +
mRNA O +
expression O +
in O +
most O +
A1 O +
and O +
A2 O +
subdivisions O +
peaked O +
at O +
14.00 O +
h O +
when O +
LH B-Gene +
surge O +
release O +
began O +
. O +

However O +
, O +
in O +
all O +
but O +
the O +
middle O +
and O +
caudal O +
A2 O +
subdivisons O +
, O +
levels O +
were O +
similar O +
in O +
E2 O +
- O +
treated O +
and O +
control O +
rats O +
at O +
this O +
time O +
. O +

This O +
was O +
attributable O +
to O +
a O +
widespread O +
increase O +
in O +
TH B-Gene +
mRNA O +
expression O +
between O +
12.00 O +
h O +
and O +
14.00 O +
h O +
in O +
OVX O +
rats O +
. O +

There O +
was O +
no O +
evidence O +
that O +
E2 O +
induced O +
changes O +
in O +
TH B-Gene +
mRNA O +
expression O +
preferentially O +
in O +
regions O +
wherein O +
most O +
neurones O +
contained O +
ER B-Gene +
alpha I-Gene +
or O +
ER B-Gene +
beta I-Gene +
mRNA O +
. O +

Our O +
findings O +
suggest O +
that O +
E2 O +
activation O +
of O +
middle O +
and O +
caudal O +
A2 O +
neurones O +
, O +
in O +
conjunction O +
with O +
the O +
widespread O +
E2 O +
- O +
independent O +
activation O +
of O +
noradrenergic O +
neurones O +
in O +
other O +
subdivisions O +
, O +
may O +
play O +
a O +
role O +
in O +
the O +
induction O +
of O +
LH B-Gene +
surge O +
release O +
. O +

Cutting O +
edge O +
: O +
molecular O +
cloning O +
of O +
a O +
killer B-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
in O +
the O +
mouse O +
and O +
rat O +
. O +

We O +
report O +
the O +
molecular O +
cloning O +
of O +
a O +
KIR3DL1 B-Gene +
receptor O +
in O +
the O +
mouse O +
and O +
the O +
rat O +
, O +
between O +
37.4 O +
and O +
45.4 O +
% O +
identical O +
with O +
primate O +
killer B-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIRs B-Gene +
/ O +
CD158 B-Gene +
) O +
. O +

Both O +
mouse O +
and O +
rat O +
molecules O +
contain O +
a O +
pair O +
of O +
immunoreceptor O +
tyrosine O +
- O +
based O +
inhibition O +
motifs O +
in O +
their O +
cytoplasmic O +
regions O +
, O +
suggesting O +
an O +
inhibitory O +
function O +
. O +

Southern O +
blot O +
analysis O +
indicated O +
a O +
single O +
KIR B-Gene +
gene O +
in O +
the O +
rat O +
, O +
whereas O +
the O +
mouse O +
genome O +
contains O +
more O +
than O +
one O +
KIR B-Gene +
- O +
related O +
element O +
. O +

The O +
rat O +
Kir3dl1 B-Gene +
locus O +
was O +
mapped O +
to O +
the O +
leukocyte O +
receptor O +
gene O +
complex O +
on O +
chromosome O +
1 O +
, O +
whereas O +
mouse O +
Kir3dl1 B-Gene +
was O +
localized O +
to O +
the O +
X O +
chromosome O +
. O +

RT O +
- O +
PCR O +
demonstrated O +
that O +
KIR3DL1 B-Gene +
was O +
selectively O +
expressed O +
by O +
NK O +
cells O +
in O +
both O +
rat O +
and O +
mouse O +
. O +

An O +
epitope O +
- O +
tagged O +
expression O +
construct O +
of O +
mouse O +
KIR3DL1 B-Gene +
transfected O +
into O +
293 O -
T O +
cells O +
induced O +
expression O +
of O +
a O +
approximately O +
55 O +
- O +
kDa O +
protein O +
. O +

Our O +
data O +
indicate O +
that O +
KIR B-Gene +
receptors O +
may O +
contribute O +
to O +
the O +
NK O +
cell O +
receptor O +
repertoire O +
in O +
rodents O +
, O +
alongside O +
the O +
Ly-49 B-Gene +
family I-Gene +
. O +

Influence O +
of O +
interleukin-12 B-Gene +
receptor I-Gene +
beta1 I-Gene +
polymorphisms O +
on O +
tuberculosis O +
. O +

Host O +
genetic O +
factors O +
may O +
be O +
important O +
determinants O +
of O +
susceptibility O +
to O +
tuberculosis O +
, O +
and O +
several O +
candidate O +
gene O +
polymorphisms O +
have O +
been O +
shown O +
to O +
date O +
. O +

A O +
series O +
of O +
recent O +
reports O +
concerning O +
rare O +
human O +
deficiencies O +
in O +
the O +
type-1 O +
cytokine B-Gene +
pathway O +
suggest O +
that O +
more O +
subtle O +
variants O +
of O +
relevant O +
genes O +
may O +
also O +
contribute O +
to O +
susceptibility O +
to O +
tuberculosis O +
at O +
the O +
general O +
population O +
level O +
. O +

To O +
investigate O +
whether O +
polymorphisms O +
in O +
the O +
interleukin-12 B-Gene +
receptor I-Gene +
( O +
IL-12R B-Gene +
) O +
gene O +
predispose O +
individuals O +
to O +
tuberculosis O +
, O +
we O +
studied O +
these O +
genes O +
by O +
single O +
- O +
strand O +
conformational O +
polymorphism O +
analysis O +
and O +
direct O +
sequencing O +
. O +

Although O +
no O +
common O +
polymorphisms O +
could O +
be O +
identified O +
in O +
the O +
IL-12R B-Gene +
beta I-Gene +
2 I-Gene +
gene O +
( O +
IL-12RB2 B-Gene +
) O +
, O +
we O +
confirmed O +
four O +
single O +
nucleotide O +
polymorphisms O +
( O +
SNPs O +
; O +
641A O +
-- O -
> O +
G O +
, O +
684C O +
-- O -
> O +
T O +
, O +
1094 O -
T O +
-- O -
> O +
C O +
, O +
and O +
1132 O -
G O +
-- O -
> O +
C O +
) O +
causing O +
three O +
missense O +
variants O +
( O +
Q214R O +
, O +
M365 O -
T O +
, O +
G378R O +
) O +
and O +
one O +
synonymous O +
substitution O +
in O +
the O +
extracellular O +
domain O +
of O +
the O +
IL-12R B-Gene +
beta I-Gene +
1 I-Gene +
gene O +
( O +
IL12RB1 B-Gene +
) O +
. O +

All O +
SNPs O +
were O +
in O +
almost O +
perfect O +
linkage O +
disequilibrium O +
( O +
D'= O +
0.98 O +
) O +
, O +
and O +
two O +
common O +
haplotypes O +
of O +
IL12RB1 B-Gene +
( O +
allele O +
1 O +
: O +
Q214-M365 O +
- O +
G378 O +
; O +
allele O +
2 O +
: O +
R214 O +
- O +
T365 O +
- O +
R378 O +
) O +
were O +
revealed O +
. O +

Polymerase O +
chain O +
reaction O +
/ O +
restriction O +
fragment O +
length O +
polymorphism O +
and O +
sequence O +
analyses O +
were O +
used O +
to O +
type O +
IL12RB1polymorphisms B-Gene +
in O +
98 O +
patients O +
with O +
tuberculosis O +
and O +
197 O +
healthy O +
controls O +
in O +
Japanese O +
populations O +
. O +

In O +
our O +
case O +
- O +
control O +
association O +
study O +
of O +
tuberculosis O +
, O +
the O +
R214 O +
- O +
T365 O +
- O +
R378 O +
allele O +
( O +
allele O +
2 O +
) O +
was O +
over O +
- O +
represented O +
in O +
patients O +
with O +
tuberculosis O +
, O +
and O +
homozygosity O +
for O +
R214 O +
- O +
T365 O +
- O +
R378 O +
( O +
the O +
2 O -
/ O -
2 O +
genotype O +
) O +
was O +
significantly O +
associated O +
with O +
tuberculosis O +
( O +
odds O +
ratio O +
: O +
2.45 O +
; O +
95 O +
% O +
CI O +
: O +
1.20 O +
- O +
4.99 O +
; O +
P O +
= O +
0.013 O +
) O +
. O +

In O +
healthy O +
subjects O +
, O +
homozygotes O +
for O +
R214 O +
- O +
T365 O +
- O +
R378 O +
had O +
lower O +
levels O +
of O +
IL-12 B-Gene +
- O +
induced O +
signaling O +
, O +
according O +
to O +
differences O +
in O +
cellular O +
responses O +
to O +
IL-12 B-Gene +
between O +
two O +
haplotypes O +
. O +

These O +
data O +
suggest O +
that O +
the O +
R214 O +
- O +
T365 O +
- O +
R378 O +
allele O +
, O +
i.e. O +
, O +
variation O +
in O +
IL12RB1 B-Gene +
, O +
contribute O +
to O +
tuberculosis O +
susceptibility O +
in O +
the O +
Japanese O +
population O +
. O +

This O +
genetic O +
variation O +
may O +
predispose O +
individuals O +
to O +
tuberculosis O +
infection O +
by O +
diminishing O +
receptor O +
responsiveness O +
to O +
IL-12 B-Gene +
and O +
to O +
IL-23 B-Gene +
, O +
leading O +
to O +
partial O +
dysfunction O +
of O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
- O +
mediated O +
immunity O +
. O +

[ O +
Variation O +
of O +
gene O +
at O +
the O +
apolipoprotein B-Gene +
C I-Gene +
III I-Gene +
locus O +
with O +
the O +
changes O +
of O +
serum O +
lipid O +
profile O +
in O +
school O +
- O +
aged O +
children O +
] O +

The O +
variation O +
of O +
gene O +
at O +
the O +
apolipoprotein B-Gene +
C I-Gene +
III I-Gene +
locus O +
with O +
the O +
changes O +
of O +
serum O +
lipids O +
in O +
children O +
was O +
studied O +
. O +

Blood O +
samples O +
were O +
collected O +
from O +
308 O +
normal O +
children O +
aged O +
7 O +
- O +
11 O +
year O +
- O +
old O +
, O +
including O +
of O +
151 O +
boys O +
and O +
157 O +
girls O +
. O +

The O +
levels O +
of O +
serum O +
lipids O +
profile O +
, O +
including O +
TC O +
, O +
TG O +
, O +
LDL B-Gene +
- O +
C O +
, O +
HDL B-Gene +
- O +
C O +
, O +
apoB B-Gene +
, O +
apoA B-Gene +
I I-Gene +
and O +
Lp B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
were O +
detected O +
. O +

The O +
genome O +
DNA O +
was O +
extracted O +
from O +
blood O +
clot O +
, O +
then O +
ApoB B-Gene +
- O +
Xba B-Gene +
I I-Gene +
gene O +
polymorphism O +
were O +
tested O +
by O +
the O +
PCR O +
- O +
RFLP O +
method O +
. O +

The O +
frequency O +
of O +
ApoC B-Gene +
III I-Gene +
- O +
Sac B-Gene +
I I-Gene +
heterozygote O +
( O +
+ O -
/- O +
) O +
was O +
48.7 O +
% O +
, O +
homozygote O +
( O +
+ O -
/+ O +
) O +
was O +
7.5 O +
% O +
, O +
and O +
allele O +
( O -
+ O -
) O +
was O +
31.8 O +
% O +
of O +
the O +
308 O +
children O +
. O +

The O +
frequency O +
of O +
allele O -
( O -
+ O -
) O +
was O +
more O +
than O +
the O +
reports O +
in O +
Shanghai O +
( O +
12 O +
% O +
) O +
and O +
Guassian O +
( O +
6 O +
% O +
) O +
, O +
and O +
closed O +
to O +
the O +
Japanese O +
( O +
34 O +
% O +
) O +
. O +

The O +
results O +
showed O +
a O +
population O +
and O +
ethnic O +
difference O +
in O +
the O +
inheritance O +
variation O +
. O +

Comparing O +
the O +
serum O +
lipids O +
levels O +
among O +
different O +
genotypes O +
, O +
the O +
average O +
TG O +
levels O +
of O +
homozygotes O +
( O +
+ O -
/+ O +
) O +
were O +
more O +
than O +
wildtype O +
( O +
- O -
/ O -
+ O +
) O +
( O +
1.06 O +
mmol O +
/ O +
L O +
vs O +
0.85 O +
mmol O +
/ O +
L O +
, O +
P O +
< O +
0.05 O +
) O +
. O +

The O +
frequency O +
of O -
( O -
+ O -
/ O -
+ O +
) O +
genotype O +
in O +
hypertriglyceridemia O +
group O +
was O +
more O +
than O +
control O +
group O +
( O +
30.0 O +
% O +
vs O +
6.7 O +
% O +
, O +
P O +
< O +
0.05 O +
) O +
; O +
The O +
allele O +
( O +
+ O +
) O +
could O +
increase O +
the O +
TG O +
level O +
of O +
0.031 O +
mmol O +
/ O +
L O +
. O +

It O +
suggested O +
that O +
the O +
variation O +
of O +
Apolipoprotein B-Gene +
C I-Gene +
III I-Gene +
- O +
Sac B-Gene +
I I-Gene +
locus O +
was O +
correlated O +
with O +
the O +
TG O +
level O +
in O +
children O +
. O +

TGFbeta B-Gene +
- I-Gene +
induced I-Gene +
factor I-Gene +
: O +
a O +
candidate O +
gene O +
for O +
high O +
myopia O +
. O +

PURPOSE O +
: O +

To O +
investigate O +
the O +
coding O +
exons O +
of O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
( I-Gene +
TGF I-Gene +
) I-Gene +
- I-Gene +
beta I-Gene +
- I-Gene +
induced I-Gene +
factor I-Gene +
( O +
TGIF B-Gene +
) O +
for O +
mutations O +
in O +
Chinese O +
patients O +
with O +
high O +
myopia O +
. O +

METHODS O +
: O +

Seventy O +
- O +
one O +
individuals O +
with O +
high O +
myopia O +
of O +
- O +
6.00 O +
D O +
or O +
less O +
and O +
105 O +
control O +
subjects O +
were O +
screened O +
by O +
DNA O +
sequencing O +
for O +
sequence O +
alterations O +
. O +

Univariate O +
analysis O +
and O +
logistic O +
regression O +
were O +
performed O +
to O +
identify O +
single O +
- O +
nucleotide O +
polymorphisms O +
( O +
SNPs O +
) O +
and O +
their O +
interactions O +
in O +
TGIF B-Gene +
that O +
may O +
be O +
associated O +
with O +
myopia O +
. O +

RESULTS O +
: O +

Six O +
SNPs O +
showed O +
a O +
significant O +
difference O +
( O +
P O +
< O +
0.05 O +
) O +
between O +
patient O +
and O +
control O +
subject O +
in O +
univariate O +
analysis O +
. O +

Four O +
of O +
them O +
cause O +
codon O +
changes O +
: O +
G223R O +
, O +
G231S O +
, O +
P241 O -
T O +
, O +
and O +
A262 O -
G O +
. O +

Among O +
all O +
the O +
SNPs O +
that O +
entered O +
multivariate O +
analysis O +
, O +
only O +
657 O +
( O +
T-- O -
> O +
G O +
) O +
showed O +
statistical O +
significance O +
in O +
the O +
logistic O +
regression O +
model O +
( O +
odds O +
ratio O +
0.133 O +
; O +
95 O +
% O +
confidence O +
interval O +
0.037 O +
- O +
0.488 O +
; O +
P O +
= O +
0.002 O +
) O +
. O +

CONCLUSIONS O +
: O +

TGIF B-Gene +
is O +
a O +
probable O +
candidate O +
gene O +
for O +
high O +
myopia O +
. O +

Further O +
studies O +
are O +
needed O +
to O +
identify O +
the O +
underlying O +
mechanism O +
. O +

Transcriptional O +
activation O +
of O +
BMP-4 B-Gene +
and O +
regulation O +
of O +
mammalian O +
organogenesis O +
by O +
GATA-4 B-Gene +
and I-Gene +
- I-Gene +
6 I-Gene +
. O +

Transcription B-Gene +
factors I-Gene +
GATA-4 B-Gene +
, I-Gene +
- I-Gene +
5 I-Gene +
, I-Gene +
and I-Gene +
- I-Gene +
6 I-Gene +
constitute O +
an O +
evolutionary O +
conserved O +
subfamily O +
of O +
vertebrate O +
zinc O +
finger O +
regulators O +
highly O +
expressed O +
in O +
the O +
developing O +
heart O +
and O +
gut O +
. O +

Genetic O +
evidence O +
suggests O +
that O +
each O +
protein O +
is O +
essential O +
for O +
embryonic O +
development O +
, O +
but O +
their O +
exact O +
functions O +
are O +
not O +
fully O +
elucidated O +
. O +

Moreover O +
, O +
because O +
all O +
three O +
proteins O +
share O +
similar O +
transcriptional O +
properties O +
in O +
vitro O +
, O +
and O +
because O +
transcripts O +
for O +
two O +
or O +
more O +
GATA B-Gene +
genes O +
are O +
present O +
in O +
similar O +
tissues O +
, O +
the O +
molecular O +
basis O +
underlying O +
in O +
vivo O +
specificity O +
of O +
GATA B-Gene +
factors O +
remains O +
undefined O +
. O +

Knowledge O +
of O +
the O +
exact O +
cell O +
types O +
expressing O +
each O +
protein O +
and O +
identification O +
of O +
downstream O +
targets O +
would O +
greatly O +
help O +
define O +
their O +
function O +
. O +

We O +
have O +
used O +
high O +
- O +
resolution O +
immunohistochemistry O +
to O +
precisely O +
determine O +
the O +
cellular O +
distribution O +
of O +
the O +
GATA-4 B-Gene +
, I-Gene +
- I-Gene +
5 I-Gene +
, I-Gene +
and I-Gene +
- I-Gene +
6 I-Gene +
proteins O +
in O +
murine O +
embryogenesis O +
. O +

The O +
results O +
reveal O +
novel O +
sites O +
of O +
expression O +
in O +
mesodermal O +
and O +
ectodermal O +
cells O +
. O +

In O +
particular O +
, O +
GATA-4 B-Gene +
and I-Gene +
- I-Gene +
6 I-Gene +
expression O +
was O +
closely O +
associated O +
with O +
yolk O +
sac O +
vasculogenesis O +
and O +
early O +
endoderm O +
- O +
mesoderm O +
signaling O +
. O +

Additionally O +
, O +
GATA-6 B-Gene +
was O +
strongly O +
expressed O +
in O +
the O +
embryonic O +
ectoderm O +
, O +
neural O +
tube O +
, O +
and O +
neural O +
crest O +
- O +
derived O +
cells O +
. O +

This O +
pattern O +
of O +
expression O +
closely O +
paralled O +
that O +
of O +
BMP-4 B-Gene +
, O +
and O +
the O +
BMP-4 B-Gene +
gene O +
was O +
identified O +
as O +
a O +
direct O +
downstream O +
target O +
for O +
GATA-4 B-Gene +
and I-Gene +
- I-Gene +
6 I-Gene +
. O +

These O +
findings O +
offer O +
new O +
insight O +
into O +
the O +
function O +
of O +
GATA-4 B-Gene +
and I-Gene +
- I-Gene +
6 I-Gene +
during O +
early O +
stages O +
of O +
embryogenesis O +
and O +
reveal O +
the O +
existence O +
of O +
a O +
positive O +
cross O +
- O +
regulatory O +
loop O +
between O +
BMP-4 B-Gene +
and O +
GATA-4 B-Gene +
. O +

They O +
also O +
raise O +
the O +
possibility O +
that O +
part O +
of O +
the O +
early O +
defects O +
in O +
GATA-4 B-Gene +
and/or O +
GATA-6 B-Gene +
null O +
embryos O +
may O +
be O +
due O +
to O +
impaired O +
BMP-4 B-Gene +
signaling O +
. O +

Differential O +
regulation O +
of O +
lipoprotein O +
kinetics O +
by O +
atorvastatin O +
and O +
fenofibrate O +
in O +
subjects O +
with O +
the O +
metabolic O +
syndrome O +
. O +

The O +
metabolic O +
syndrome O +
is O +
characterized O +
by O +
insulin B-Gene +
resistance O +
and O +
abnormal O +
apolipoprotein B-Gene +
AI I-Gene +
( O +
apoAI B-Gene +
) O +
and O +
apolipoprotein B-Gene +
B-100 I-Gene +
( O +
apoB B-Gene +
) O +
metabolism O +
that O +
may O +
collectively O +
accelerate O +
atherosclerosis O +
. O +

The O +
effects O +
of O +
atorvastatin O +
( O +
40 O +
mg O +
/ O +
day O +
) O +
and O +
micronised O +
fenofibrate O +
( O +
200 O +
mg O +
/ O +
day O +
) O +
on O +
the O +
kinetics O +
of O +
apoAI B-Gene +
and O +
apoB B-Gene +
were O +
investigated O +
in O +
a O +
controlled O +
cross O +
- O +
over O +
trial O +
of O +
11 O +
dyslipidemic O +
men O +
with O +
the O +
metabolic O +
syndrome O +
. O +

ApoAI B-Gene +
and O +
apoB B-Gene +
kinetics O +
were O +
studied O +
following O +
intravenous O +
d O -
( O -
3 O -
) O -
-leucine O +
administration O +
using O +
gas O +
- O +
chromatography O +
mass O +
spectrometry O +
with O +
data O +
analyzed O +
by O +
compartmental O +
modeling O +
. O +

Compared O +
with O +
placebo O +
, O +
atorvastatin O +
significantly O +
decreased O +
( O +
P O +
< O +
0.001 O +
) O +
plasma O +
concentrations O +
of O +
cholesterol O +
, O +
triglyceride O +
, O +
LDL B-Gene +
cholesterol O +
, O +
VLDL B-Gene +
apoB B-Gene +
, O +
intermediate B-Gene +
- I-Gene +
density I-Gene +
lipoprotein I-Gene +
( O +
IDL B-Gene +
) O +
apoB B-Gene +
, O +
and O +
LDL B-Gene +
apoB B-Gene +
. O +

Fenofibrate O +
significantly O +
decreased O +
( O +
P O +
< O +
0.001 O +
) O +
plasma O +
triglyceride O +
and O +
VLDL B-Gene +
apoB B-Gene +
and O +
elevated O +
HDL B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
cholesterol O +
( O +
P O +
< O +
0.001 O +
) O +
, O +
HDL B-Gene -
( I-Gene -
3 I-Gene -
) I-Gene +
cholesterol O +
( O +
P O +
< O +
0.01 O +
) O +
, O +
apoAI B-Gene +
( O +
P O +
= O +
0.01 O +
) O +
, O +
and O +
apoAII B-Gene +
( O +
P O +
< O +
0.001 O +
) O +
concentrations O +
, O +
but O +
it O +
did O +
not O +
significantly O +
alter O +
LDL B-Gene +
cholesterol O +
. O +

Atorvastatin O +
significantly O +
increased O +
( O +
P O +
< O +
0.002 O +
) O +
the O +
fractional O +
catabolic O +
rate O +
( O +
FCR O +
) O +
of O +
VLDL B-Gene +
apoB B-Gene +
, O +
IDL B-Gene +
apoB B-Gene +
, O +
and O +
LDL B-Gene +
apoB B-Gene +
but O +
did O +
not O +
affect O +
the O +
production O +
of O +
apoB B-Gene +
in O +
any O +
lipoprotein O +
fraction O +
or O +
in O +
the O +
turnover O +
of O +
apoAI B-Gene +
. O +

Fenofibrate O +
significantly O +
increased O +
( O +
P O +
< O +
0.01 O +
) O +
the O +
FCR O +
of O +
VLDL B-Gene +
, O +
IDL B-Gene +
, O +
and O +
LDL B-Gene +
apoB B-Gene +
but O +
did O +
not O +
affect O +
the O +
production O +
of O +
VLDL B-Gene +
apoB B-Gene +
. O +

Relative O +
to O +
placebo O +
and O +
atorvastatin O +
, O +
fenofibrate O +
significantly O +
increased O +
the O +
production O +
( O +
P O +
< O +
0.001 O +
) O +
and O +
FCR O +
( O +
P O +
= O +
0.016 O +
) O +
of O +
apoAI B-Gene +
. O +

Both O +
agents O +
significantly O +
lowered O +
plasma O +
triglycerides O +
and O +
apoCIII B-Gene +
concentrations O +
, O +
but O +
only O +
atorvastatin O +
significantly O +
lowered O +
( O +
P O +
< O +
0.001 O +
) O +
plasma O +
cholesteryl O +
ester O +
transfer O +
protein O +
activity O +
. O +

Neither O +
treatment O +
altered O +
insulin B-Gene +
resistance O +
. O +

In O +
conclusion O +
, O +
these O +
differential O +
effects O +
of O +
atorvastatin O +
and O +
fenofibrate O +
on O +
apoAI B-Gene +
and O +
apoB B-Gene +
kinetics O +
support O +
the O +
use O +
of O +
combination O +
therapy O +
for O +
optimally O +
regulating O +
dyslipoproteinemia O +
in O +
the O +
metabolic O +
syndrome O +
. O +

Autosomal O +
dominant O +
macular O +
dystrophy O +
in O +
a O +
large O +
Canadian O +
family O +
. O +

BACKGROUND O +
: O +

We O +
studied O +
a O +
large O +
Canadian O +
family O +
( O +
178 O +
total O +
family O +
members O +
) O +
spanning O +
seven O +
generations O +
with O +
autosomal O +
dominant O +
macular O +
dystrophy O +
. O +

We O +
performed O +
a O +
study O +
to O +
identify O +
the O +
gene O +
mutation O +
responsible O +
for O +
the O +
disease O +
in O +
the O +
family O +
. O +

METHODS O +
: O +

Participating O +
family O +
members O +
were O +
evaluated O +
clinically O +
. O +

Genetic O +
linkage O +
, O +
genotyping O +
, O +
mutation O +
screening O +
and O +
an O +
extensive O +
genealogic O +
investigation O +
were O +
performed O +
. O +

RESULTS O +
: O +

The O +
common O +
clinical O +
findings O +
in O +
affected O +
family O +
members O +
included O +
progressive O +
early O +
- O +
to O +
mid O +
- O +
onset O +
visual O +
loss O +
and O +
extensive O +
areas O +
of O +
central O +
chorioretinal O +
atrophy O +
. O +

Two O +
- O +
point O +
linkage O +
analysis O +
indicated O +
linkage O +
to O +
chromosome O +
6p O +
. O +

Direct O +
DNA O +
sequencing O +
showed O +
a O +
C O +
/ O +
T O +
transition O +
in O +
codon O +
172 O +
of O +
the O +
retinal B-Gene +
degeneration I-Gene +
slow I-Gene +
( O +
RDS B-Gene +
) O +
gene O +
creating O +
an O +
amino O +
acid O +
change O +
to O +
Arg172Trp O +
. O +

Haplotype O +
analysis O +
of O +
affected O +
family O +
members O +
using O +
microsatellite O +
markers O +
distributed O +
around O +
the O +
RDS B-Gene +
gene O +
locus O +
revealed O +
that O +
the O +
markers O +
were O +
not O +
conserved O +
when O +
compared O +
to O +
members O +
of O +
British O +
families O +
with O +
the O +
Arg172Trp O +
mutation O +
. O +

Genealogic O +
studies O +
indicated O +
the O +
family O +
immigrated O +
to O +
Canada O +
from O +
Ireland O +
in O +
1843 O +
. O +

INTERPRETATION O +
: O +

A O +
newly O +
identified O +
large O +
family O +
with O +
autosomal O +
dominant O +
macular O +
dystrophy O +
is O +
described O +
. O +

The O +
phenotypic O +
appearance O +
of O +
the O +
fundus O +
is O +
similar O +
to O +
that O +
of O +
previously O +
described O +
patients O +
with O +
an O +
Arg172Trp O +
mutation O +
in O +
the O +
RDS B-Gene +
gene O +
. O +

Haplotype O +
analysis O +
of O +
markers O +
spanning O +
the O +
disease O +
locus O +
identified O +
a O +
new O +
founder O +
for O +
this O +
mutation O +
. O +

The O +
identification O +
of O +
the O +
disease O +
- O +
causing O +
gene O +
in O +
this O +
family O +
allows O +
for O +
better O +
genetic O +
counselling O +
for O +
patients O +
with O +
this O +
condition O +
and O +
provides O +
a O +
basis O +
to O +
distinguish O +
clinically O +
similar O +
types O +
of O +
macular O +
dystrophy O +
based O +
on O +
the O +
clinical O +
phenotype O +
. O +

Targeting O +
of O +
p0071 B-Gene +
to O +
desmosomes O +
and O +
adherens O +
junctions O +
is O +
mediated O +
by O +
different O +
protein O +
domains O +
. O +

p0071 B-Gene +
, O +
a O +
member O +
of O +
the O +
armadillo B-Gene +
protein I-Gene +
family I-Gene +
, O +
is O +
most O +
closely O +
related O +
to O +
p120 B-Gene +
( I-Gene +
ctn I-Gene +
) I-Gene +
and O +
the O +
plakophilins B-Gene +
1 I-Gene -
- I-Gene -
3 I-Gene +
. O +

Whereas O +
plakophilins B-Gene +
are O +
desmosomal O +
plaque O +
proteins O +
, O +
p120 B-Gene +
( I-Gene +
ctn I-Gene +
) I-Gene +
localizes O +
to O +
adherens O +
junctions O +
and O +
interacts O +
with O +
classical O +
cadherins B-Gene +
. O +

In O +
contrast O +
, O +
p0071 B-Gene +
has O +
been O +
described O +
as O +
a O +
protein O +
with O +
dual O +
localization O +
in O +
adherens O +
junctions O +
and O +
desmosomes O +
depending O +
on O +
the O +
cell O +
type O +
examined O +
. O +

Here O +
we O +
have O +
analyzed O +
the O +
localization O +
of O +
p0071 B-Gene +
and O +
its O +
domains O +
in O +
detail O +
. O +

Although O +
by O +
sequence O +
analysis O +
, O +
p0071 B-Gene +
is O +
more O +
closely O +
related O +
to O +
the O +
adherens O +
junction O +
proteins O +
p120 B-Gene -
( I-Gene -
ctn I-Gene -
) I-Gene +
, O +
ARVCF B-Gene +
and O +
delta B-Gene -
- I-Gene -
catenin I-Gene +
, O +
endogenous O +
p0071 B-Gene +
associated O +
preferentially O +
with O +
desmosomes O +
in O +
MCF-7 O +
epithelial O +
cells O +
. O +

Overexpressed O +
p0071 B-Gene +
localized O +
along O +
cell O +
borders O +
and O +
overlapped O +
only O +
partially O +
with O +
desmosomal O +
markers O +
but O +
colocalized O +
with O +
non O +
- O +
desmosomal O +
cadherins B-Gene +
and O +
recruited O +
cadherins B-Gene +
to O +
the O +
membrane O +
. O +

The O +
head O +
domain O +
of O +
p0071 B-Gene +
was O +
sufficient O +
for O +
desmosomal O +
targeting O +
, O +
whereas O +
the O +
arm O +
repeat O +
domain O +
associated O +
with O +
adherens O +
junctions O +
and O +
enhanced O +
membrane O +
association O +
of O +
classical O +
cadherins B-Gene +
. O +

The O +
tail O +
domain O +
localized O +
preferentially O +
to O +
the O +
nucleus O +
and O +
associated O +
with O +
desmosomes O +
. O +

To O +
examine O +
the O +
mechanism O +
underlying O +
this O +
dual O +
localization O +
more O +
closely O +
we O +
determined O +
binding O +
partners O +
of O +
p0071 B-Gene +
by O +
using O +
yeast O +
- O +
two O +
- O +
hybrid O +
and O +
mom O +
- O +
targeting O +
assays O +
. O +

These O +
approaches O +
show O +
that O +
the O +
head O +
domain O +
interacted O +
with O +
desmosomal O +
proteins O +
desmocollin B-Gene +
3a I-Gene +
and O +
desmoplakin B-Gene +
, O +
whereas O +
the O +
armadillo B-Gene +
repeat O +
domain O +
binds O +
to O +
non O +
- O +
desmosomal O +
cadherins B-Gene +
. O +

Head O +
and O +
armadillo B-Gene +
repeat O +
domains O +
both O +
interacted O +
with O +
plakoglobin B-Gene +
by O +
binding O +
to O +
different O +
sites O +
. O +

Our O +
data O +
suggest O +
that O +
, O +
in O +
addition O +
to O +
plakoglobin B-Gene +
, O +
p0071 B-Gene +
is O +
the O +
second O +
armadillo B-Gene +
protein I-Gene +
present O +
in O +
both O +
types O +
of O +
adhesive O +
junctions O +
and O +
may O +
play O +
a O +
role O +
in O +
regulating O +
crosstalk O +
between O +
adherens O +
junctions O +
and O +
desmosomes O +
. O +

Comprehensive O +
studies O +
of O +
drug O +
resistance O +
mediated O +
by O +
overexpression O +
of O +
response B-Gene +
regulators I-Gene +
of O +
two O +
- O +
component O +
signal O +
transduction O +
systems O +
in O +
Escherichia O +
coli O +
. O +

In O +
Escherichia O +
coli O +
, O +
there O +
are O +
32 O +
open O +
reading O +
frames O +
( O +
ORFs O +
) O +
that O +
are O +
assumed O +
to O +
be O +
response B-Gene +
regulator I-Gene +
genes O +
of O +
two O +
- O +
component O +
signal O +
transduction O +
systems O +
on O +
the O +
basis O +
of O +
sequence O +
similarities O +
. O +

We O +
cloned O +
all O +
of O +
these O +
32 O +
ORFs O +
into O +
a O +
multicopy O +
expression O +
vector O +
and O +
investigated O +
whether O +
or O +
not O +
they O +
confer O +
drug O +
resistance O +
via O +
control O +
of O +
drug O +
resistance O +
determinants O +
. O +

Fifteen O +
of O +
these O +
ORFs O +
, O +
i.e. O +
, O +
baeR B-Gene +
, O +
citB B-Gene +
, O +
cpxR B-Gene +
, O +
evgA B-Gene +
, O +
fimZ B-Gene +
, O +
kdpE B-Gene +
, O +
narL B-Gene +
, O +
narP B-Gene +
, O +
ompR B-Gene +
, O +
rcsB B-Gene +
, O +
rstA B-Gene +
, O +
torR B-Gene +
, O +
yedW B-Gene +
, O +
yehT B-Gene +
, O +
and O +
dcuR B-Gene +
, O +
conferred O +
increased O +
single O +
- O +
or O +
multidrug O +
resistance O +
. O +

Two O +
- O +
thirds O +
of O +
them O +
conferred O +
deoxycholate O +
resistance O +
. O +

Five O +
of O +
them O +
, O +
i.e. O +
, O +
evgA B-Gene +
, O +
baeR B-Gene +
, O +
ompR B-Gene +
, O +
cpxR B-Gene +
, O +
and O +
rcsB B-Gene +
, O +
modulated O +
the O +
expression O +
of O +
several O +
drug O +
exporter O +
genes O +
. O +

The O +
drug O +
resistance O +
mediated O +
by O +
evgA B-Gene +
, O +
baeR B-Gene +
, O +
and O +
cpxR B-Gene +
could O +
be O +
assigned O +
to O +
drug O +
exporters O +
by O +
using O +
drug O +
exporter O +
gene O +
knockout O +
strains O +
. O +

The O +
L1 B-Gene +
major I-Gene +
capsid I-Gene +
protein I-Gene +
of O +
human O +
papillomavirus O +
type O +
11 O +
interacts O +
with O +
Kap B-Gene +
beta2 I-Gene +
and O +
Kap B-Gene +
beta3 I-Gene +
nuclear O +
import O +
receptors O +
. O +

We O +
have O +
previously O +
shown O +
that O +
the O +
L1 B-Gene +
major I-Gene +
capsid I-Gene +
protein I-Gene +
of O +
low O +
- O +
risk O +
HPV11 O +
binds O +
to O +
the O +
Kap B-Gene +
alpha2 I-Gene +
adapter O +
and O +
enters O +
the O +
nucleus O +
via O +
a O +
Kap B-Gene +
alpha2beta1 I-Gene +
- O +
mediated O +
pathway O +
. O +

In O +
this O +
study O +
, O +
we O +
discovered O +
that O +
HPV11 O +
L1 B-Gene +
capsomeres O +
bind O +
to O +
Kap B-Gene +
beta2 I-Gene +
import O +
receptor O +
, O +
known O +
to O +
mediate O +
nuclear O +
import O +
of O +
hnRNP B-Gene +
A1 I-Gene +
via O +
interaction O +
with O +
its O +
nuclear O +
localization O +
signal O +
termed O +
M9 O +
. O +

Significantly O +
, O +
binding O +
of O +
HPV11 O +
L1 B-Gene +
capsomeres O +
to O +
Kap B-Gene +
beta2 I-Gene +
inhibited O +
the O +
nuclear O +
import O +
of O +
Kap B-Gene +
beta2 I-Gene +
, O +
and O +
its O +
specific O +
M9 O +
- O +
containing O +
cargo O +
. O +

Interestingly O +
, O +
HPV11 O +
L1 B-Gene +
capsomeres O +
also O +
interacted O +
with O +
Kap B-Gene +
beta3 I-Gene +
import O +
receptor O +
and O +
inhibited O +
Kap B-Gene +
beta3 I-Gene +
nuclear O +
import O +
. O +

Moreover O +
, O +
the O +
L1 B-Gene +
capsomeres O +
of O +
high O +
- O +
risk O +
HPV-16 O +
shared O +
these O +
activities O +
. O +

These O +
data O +
suggest O +
that O +
HPV O +
L1 B-Gene +
major I-Gene +
capsid I-Gene +
proteins I-Gene +
interact O +
with O +
Kap B-Gene +
beta2 I-Gene +
and O +
Kap B-Gene +
beta3 I-Gene +
, O +
and O +
they O +
may O +
inhibit O +
the O +
Kap B-Gene +
beta2 I-Gene +
- O +
and O +
Kap B-Gene +
beta3 I-Gene +
- O +
mediated O +
nuclear O +
import O +
pathways O +
during O +
the O +
productive O +
phase O +
of O +
the O +
viral O +
life O +
cycle O +
when O +
the O +
virions O +
are O +
assembled O +
and O +
released O +
. O +

Minimal O +
change O +
disease O +
in O +
a O +
patient O +
receiving O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
therapy O +
for O +
chronic O +
hepatitis O +
C O +
virus O +
infection O +
. O +

Chronic O +
hepatitis O +
C O +
virus O +
( O +
HCV O +
) O +
infection O +
is O +
associated O +
with O +
several O +
extrahepatic O +
syndromes O +
. O +

The O +
principal O +
types O +
of O +
renal O +
disorders O +
associated O +
with O +
chronic O +
HCV O +
infection O +
are O +
cryoglobulinemia O +
or O +
noncryoglobulinemic O +
membranoproliferative O +
glomerulonephritis O +
( O +
MPGN O +
) O +
. O +

Interferon B-Gene -
- I-Gene -
alpha I-Gene +
( O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
) O +
may O +
precipitate O +
or O +
exacerbate O +
the O +
occurrence O +
of O +
MPGN O +
. O +

Our O +
patient O +
was O +
a O +
32 O +
- O +
year O +
- O +
old O +
man O +
who O +
tested O +
positive O +
for O +
HCV O +
in O +
July O +
1997 O +
. O +

The O +
patient O +
was O +
treated O +
with O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
in O +
another O +
medical O +
center O +
for O +
6 O +
months O +
because O +
his O +
liver O +
biopsy O +
showed O +
chronic O +
active O +
hepatitis O +
. O +

In O +
December O +
1998 O +
, O +
he O +
applied O +
to O +
our O +
clinic O +
for O +
a O +
follow O +
- O +
up O +
examination O +
. O +

The O +
level O +
of O +
aspartate B-Gene +
aminotransferase I-Gene +
( O +
AST B-Gene +
) O +
was O +
44 O +
U O +
/ O +
L O +
, O +
and O +
that O +
of O +
alanine B-Gene +
aminotransferase I-Gene +
( O +
ALT B-Gene +
) O +
was O +
69 O +
U O +
/ O +
L O +
. O +

HCV O +
RNA O +
was O +
positive O +
in O +
serum O +
, O +
and O +
chronic O +
HCV O +
infection O +
was O +
detected O +
by O +
liver O +
biopsy O +
. O +

IFN B-Gene -
- I-Gene -
alpha I-Gene +
therapy O +
( O +
5 O +
million O +
U O +
/ O +
day O +
) O +
was O +
administered O +
for O +
6 O +
months O +
longer O +
. O +

In O +
May O +
1999 O +
, O +
the O +
patient O +
came O +
to O +
our O +
polyclinic O +
with O +
edema O +
of O +
the O +
feet O +
and O +
legs O +
. O +

We O +
detected O +
proteinuria O +
, O +
serum O +
cholesterol O +
of O +
269 O +
mg O +
/ O +
dl O +
, O +
AST B-Gene +
of O +
50 O +
U O +
/ O +
L O +
, O +
ALT B-Gene +
of O +
41 O +
U O +
/ O +
L O +
, O +
serum O +
total O +
protein O +
of O +
3.4 O +
g O +
/ O +
dl O +
, O +
serum B-Gene +
albumin I-Gene +
of O +
1.2 O +
g O +
/ O +
dl O +
, O +
positive O +
cryoglobulin O +
, O +
and O +
urine O +
protein O +
of O +
9.84 O +
g O +
/ O +
day O +
. O +

Cryoglobulinemic O +
MPGN O +
was O +
suspected O +
and O +
kidney O +
biopsy O +
was O +
performed O +
, O +
resulting O +
in O +
a O +
diagnosis O +
of O +
minimal O +
change O +
disease O +
( O +
MCD O +
) O +
. O +

A O +
novel O +
gene O +
, O +
MSI2 B-Gene +
, O +
encoding O +
a O +
putative O +
RNA O +
- O +
binding O +
protein O +
is O +
recurrently O +
rearranged O +
at O +
disease O +
progression O +
of O +
chronic O +
myeloid O +
leukemia O +
and O +
forms O +
a O +
fusion O +
gene O +
with O +
HOXA9 B-Gene +
as O +
a O +
result O +
of O +
the O +
cryptic O +
t O +
( O +
7 O +
; O +
17 O +
) O +
( O +
p15 O +
; O +
q23 O +
) O +
. O +

The O +
pathogenetic O +
role O +
of O +
the O +
P210 O +
BCR B-Gene +
/ O +
ABL1 B-Gene +
fusion O +
gene O +
in O +
the O +
chronic O +
phase O +
of O +
chronic O +
myeloid O +
leukemia O +
( O +
CML O +
) O +
has O +
been O +
well O +
established O -
. O -
In O +
contrast O +
, O +
the O +
genetic O +
mechanisms O +
underlying O +
the O +
disease O +
progression O +
into O +
the O +
accelerated O +
phase O +
( O +
AP O +
) O +
and O +
the O +
final O +
blast O +
crisis O +
( O +
BC O +
) O +
remain O +
poorly O +
understood O +
. O +

We O +
have O +
previously O +
identified O +
( O +
A. O +
Barbouti O +
et O +
al. O +
, O +
Genes O +
Chromosomes O +
Cancer O +
, O +
35 O +
: O +
127 O -
- O -
137 O +
, O +
2002 O +
) O +
two O +
cryptic O +
balanced O +
translocations O +
, O +
t O +
( O +
7 O +
; O +
17 O +
) O +
( O +
p15 O +
; O +
q23 O +
) O +
and O +
t O +
( O +
7 O +
; O +
17 O +
) O +
( O +
q32 O +
- O +
34 O +
; O +
q23 O +
) O +
, O +
in O +
CML O +
AP O +
/ O +
BC O +
using O +
multicolor O +
fluorescence O +
in O +
situ O +
hybridization O +
. O +

In O +
this O +
study O +
, O +
we O +
show O +
that O +
a O +
novel O +
gene O +
in O +
17q23 O +
, O +
Musashi-2 B-Gene +
( O +
MSI2 B-Gene +
) O +
, O +
encoding O +
a O +
putative O +
RNA O +
- O +
binding O +
protein O +
, O +
is O +
rearranged O +
in O +
both O +
cases O +
and O +
that O +
a O +
MSI2 B-Gene +
/ O +
HOXA9 B-Gene +
fusion O +
gene O +
is O +
formed O +
in O +
the O +
case O +
with O +
the O +
7p15 O +
breakpoint O +
. O +

The O +
identified O +
in O +
- O +
frame O +
MSI2 B-Gene +
/ O +
HOXA9 B-Gene +
fusion O +
transcript O +
retains O +
both O +
of O +
the O +
RNA O +
recognition O +
motif O +
domains O +
of O +
MSI2 B-Gene +
, O +
which O +
is O +
fused O +
to O +
the O +
homeobox O +
domain O +
of O +
HOXA9 B-Gene +
, O +
and O +
is O +
likely O +
to O +
play O +
an O +
important O +
role O +
in O +
the O +
disease O +
progression O +
of O +
CML O +
. O +

Arsenic O +
resistance O +
in O +
the O +
archaeon O +
" O +
Ferroplasma O +
acidarmanus O +
" O +
: O +
new O +
insights O +
into O +
the O +
structure O +
and O +
evolution O +
of O +
the O +
ars B-Gene +
genes O +
. O +

Arsenic O +
resistance O +
in O +
the O +
acidophilic O +
iron O +
- O +
oxidizing O +
archaeon O +
" O +
Ferroplasma O +
acidarmanus O +
" O +
was O +
investigated O +
. O +

F. O +
acidarmanus O +
is O +
native O +
to O +
arsenic O +
- O +
rich O +
environments O +
, O +
and O +
culturing O +
experiments O +
confirm O +
a O +
high O +
level O +
of O +
resistance O +
to O +
both O +
arsenite O +
and O +
arsenate O +
. O +

Analyses O +
of O +
the O +
complete O +
genome O +
revealed O +
protein O +
- O +
encoding O +
regions O +
related O +
to O +
known O +
arsenic B-Gene +
- I-Gene +
resistance I-Gene +
genes I-Gene +
. O +

Genes O +
encoding O +
for O +
ArsR B-Gene +
( O +
arsenite B-Gene +
- I-Gene +
sensitive I-Gene +
regulator I-Gene +
) O +
and O +
ArsB B-Gene +
( O +
arsenite B-Gene +
- I-Gene +
efflux I-Gene +
pump I-Gene +
) O +
homologues O +
were O +
found O +
located O +
on O +
a O +
single O +
operon O +
. O +

A O +
gene O +
encoding O +
for O +
an O +
ArsA B-Gene +
relative O +
( O +
anion B-Gene +
- I-Gene +
translocating I-Gene +
ATPase I-Gene +
) O +
located O +
apart O +
from O +
the O +
arsRB B-Gene +
operon I-Gene +
was O +
also O +
identified O +
. O +

Arsenate B-Gene +
- I-Gene +
resistance I-Gene +
genes I-Gene +
encoding O +
for O +
proteins O +
homologous O +
to O +
the O +
arsenate B-Gene +
reductase I-Gene +
ArsC B-Gene +
and O +
the O +
phosphate B-Gene +
- I-Gene +
specific I-Gene +
transporter I-Gene +
Pst B-Gene +
were O +
not O +
found O +
, O +
indicating O +
that O +
additional O +
unknown O +
arsenic O +
- O +
resistance O +
genes O +
exist O +
for O +
arsenate O +
tolerance O +
. O +

Phylogenetic O +
analyses O +
of O +
ArsA B-Gene +
- O +
related O +
proteins O +
suggest O +
separate O +
evolutionary O +
lines O +
for O +
these O +
proteins O +
and O +
offer O +
new O +
insights O +
into O +
the O +
formation O +
of O +
the O +
arsA B-Gene +
gene O +
. O +

The O +
ArsB B-Gene +
- O +
homologous O +
protein O +
of O +
F. O +
acidarmanus O +
had O +
a O +
high O +
degree O +
of O +
similarity O +
to O +
known O +
ArsB B-Gene +
proteins O +
. O +

An O +
evolutionary O +
analysis O +
of O +
ArsB B-Gene +
homologues O +
across O +
a O +
number O +
of O +
species O +
indicated O +
a O +
clear O +
relationship O +
in O +
close O +
agreement O +
with O +
16S O +
rRNA O +
evolutionary O +
lines O +
. O +

These O +
results O +
support O +
a O +
hypothesis O +
of O +
arsenic O +
resistance O +
developing O +
early O +
in O +
the O +
evolution O +
of O +
life O +
. O +

Crystal O +
structure O +
of O +
the O +
human O +
natural O +
killer O +
cell O +
activating O +
receptor O +
KIR2DS2 B-Gene +
( O +
CD158j B-Gene +
) O +
. O +

Killer B-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIRs B-Gene +
) O +
regulate O +
the O +
function O +
of O +
human O +
natural O +
killer O +
and O +
T O +
cell O +
subsets O +
. O +

A O +
feature O +
of O +
the O +
KIR B-Gene +
locus O +
is O +
the O +
clustering O +
of O +
homologous O +
genes O +
encoding O +
for O +
inhibitory O +
and O +
activating O +
KIR B-Gene +
. O +

Inhibitory O +
and O +
activating O +
KIR B-Gene +
differ O +
for O +
ligand O +
specificities O +
and/or O +
affinities O +
. O +

In O +
particular O +
, O +
we O +
show O +
here O +
with O +
KIR B-Gene +
tetramers O +
that O +
activating O +
KIR2DS2 B-Gene +
does O +
not O +
bind O +
HLA B-Gene -
- I-Gene -
Cw3 I-Gene +
molecules O +
recognized O +
by O +
inhibitory O +
KIR2DL2 B-Gene +
, O +
despite O +
99 O +
% O +
extracellular O +
amino O +
acid O +
identity O +
. O +

We O +
also O +
report O +
the O +
2.3 O +
- O +
A O +
structure O +
of O +
KIR2DS2 B-Gene +
, O +
which O +
reveals O +
subtle O +
displacements O +
of O +
two O +
residues O +
( O +
Tyr45 O +
and O +
Gln71 O +
) O +
involved O +
in O +
the O +
interaction O +
of O +
KIR2DL2 B-Gene +
with O +
HLA B-Gene -
- I-Gene -
Cw3 I-Gene +
. O +

These O +
results O +
show O +
that O +
KIR B-Gene +
molecules O +
can O -
not O +
tolerate O +
any O +
variability O +
in O +
their O +
three O +
- O +
dimensional O +
structure O +
without O +
altering O +
their O +
MHC B-Gene +
class I-Gene +
I I-Gene +
recognition O +
capacities O +
. O +

Therefore O +
, O +
the O +
mode O +
of O +
recognition O +
used O +
by O +
KIR B-Gene +
largely O +
differs O +
from O +
the O +
conformational O +
changes O +
that O +
characterize O +
T O +
cell O +
receptor O +
or O +
NKG2D B-Gene +
interaction O +
with O +
their O +
respective O +
ligands O +
. O +

Natural O +
killer O +
cell O +
receptors O +
in O +
cattle O +
: O +
a O +
bovine O +
killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
multigene I-Gene +
family I-Gene +
contains O +
members O +
with O +
divergent O +
signaling O +
motifs O +
. O +

Natural O +
killer O +
( O +
NK O +
) O +
cells O +
recognize O +
and O +
kill O +
certain O +
tumor O +
cells O +
, O +
virally O +
infected O +
cells O +
and O +
MHC B-Gene +
class I-Gene +
I I-Gene +
- O +
disparate O +
normal O +
hematopoietic O +
cells O +
. O +

NK O +
cell O +
cytotoxicity O +
is O +
regulated O +
by O +
a O +
multitude O +
of O +
receptors O +
with O +
either O +
activating O +
or O +
inhibitory O +
signaling O +
function O +
. O +

We O +
here O +
report O +
the O +
molecular O +
cloning O +
of O +
bovine O +
CD94 B-Gene +
[ O +
killer B-Gene +
cell I-Gene +
lectin I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( I-Gene +
KLR I-Gene -
) I-Gene -
-D1 I-Gene +
] O +
and O +
NKp46 B-Gene +
orthologues O +
, O +
four O +
members O +
of O +
a O +
bovine O +
CD158 B-Gene +
[ I-Gene +
killer I-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( I-Gene +
KIR I-Gene +
) I-Gene +
] I-Gene +
family I-Gene +
, O +
and O +
a O +
novel O +
KLR B-Gene +
. O +

This O +
novel O +
receptor O +
was O +
termed O +
KLRJ1 B-Gene +
and O +
is O +
most O +
similar O +
to O +
Ly-49 B-Gene +
( O +
KLRA B-Gene +
) O +
. O +

The O +
KLRD1 B-Gene +
and O +
KLRJ1 B-Gene +
loci O +
were O +
mapped O +
to O +
a O +
bovine O +
NK O +
gene O +
complex O +
on O +
chromosome O +
5 O +
by O +
radiation O +
hybrid O +
mapping O +
, O +
whereas O +
KIR2DL1 B-Gene +
and O +
NKP46 B-Gene +
were O +
localized O +
to O +
chromosome O +
18 O +
. O +

Two O +
of O +
the O +
bovine O +
KIR B-Gene +
( O +
KIR2DL1 B-Gene +
and O +
KIR3DL1 B-Gene +
) O +
contain O +
immunoreceptor O +
tyrosine O +
- O +
based O +
inhibition O +
motifs O +
( O +
ITIM O +
) O +
, O +
suggesting O +
an O +
inhibitory O +
function O +
. O +

Bovine O +
KIR2DS1 B-Gene +
and O +
KIR3DS1 B-Gene +
lack O +
ITIM O +
but O +
have O +
an O +
arginine O +
- O +
containing O +
motif O +
in O +
their O +
transmembrane O +
domain O +
, O +
similar O +
to O +
primate O +
KIR2DL4 B-Gene +
. O +

Thus O +
, O +
KIR B-Gene +
multigene I-Gene +
families I-Gene +
with O +
divergent O +
signaling O +
motifs O +
do O +
not O +
only O +
exist O +
in O +
primates O +
. O +

Based O +
on O +
sequence O +
comparison O +
, O +
it O +
appears O +
that O +
the O +
primate O +
and O +
bovine O +
KIR B-Gene +
multigene O +
families O +
may O +
have O +
evolved O +
independently O +
. O +

Superoxide O +
production O +
by O +
peripheral O +
polymorphonuclear O +
leukocytes O +
in O +
patients O +
with O +
COPD O +
. O +

Polymorphonuclear O +
leukocytes O +
( O +
PMNs O +
) O +
have O +
been O +
implicated O +
in O +
the O +
pathogenesis O +
of O +
COPD O +
, O +
partly O +
because O +
of O +
the O +
release O +
of O +
oxidants O +
, O +
like O +
superoxide O +
anion O +
( O +
SA O +
) O +
. O +

The O +
goal O +
of O +
this O +
study O +
was O +
to O +
measure O +
the O +
spontaneous O +
and O +
stimulated O +
release O +
of O +
SA O +
by O +
peripheral O +
PMN O +
in O +
stable O +
COPD O +
compared O +
with O +
healthy O +
controls O +
. O +

Seventeen O +
patients O +
with O +
stable O +
moderate O +
COPD O +
and O +
17 O +
healthy O +
age O +
- O +
matched O +
controls O +
were O +
included O +
. O +

SA O +
release O +
from O +
peripheral O +
PMN O +
was O +
measured O +
spectrophotometrically O +
as O +
the O +
superoxide B-Gene +
dismutase I-Gene +
( O +
SOD B-Gene +
) O +
inhibitable O +
reduction O +
of O +
cytochrome B-Gene +
c I-Gene +
. O +

PMNs O +
were O +
stimulated O +
with O +
phorbol O +
myristate O +
acetate O +
( O +
PMA O +
, O +
1 O +
and O +
10 O +
ng O +
/ O +
ml O +
) O +
, O +
diesel O +
exhaust O +
particles O +
( O +
DEPs O +
) O +
, O +
carbon O +
black O +
( O +
CB O +
) O +
and O +
ultrafine O +
CB O +
( O +
ufCB O +
, O +
125 O +
, O +
250 O +
and O +
500 O +
microg O +
/ O +
ml O +
) O +
. O +

The O +
spontaneous O +
SA O +
release O +
( O +
PMA-0 O +
) O +
between O +
patients O +
and O +
control O +
subjects O +
was O +
not O +
significantly O +
different O +
. O +

After O +
stimulation O +
with O +
PMA O +
, O +
SA O +
release O +
increased O +
in O +
both O +
patients O +
and O +
controls O +
. O +

The O +
SA O +
release O +
did O +
not O +
increase O +
after O +
stimulation O +
with O +
DEP O +
and O +
CB O +
in O +
patients O +
nor O +
in O +
controls O +
. O +

There O +
was O +
only O +
an O +
increase O +
after O +
stimulation O +
with O +
ufCB O +
in O +
the O +
patient O +
group O +
. O +

The O +
increased O +
SA O +
release O +
in O +
COPD O +
patients O +
after O +
stimulation O +
with O +
ufCB O +
may O +
suggest O +
that O +
PMN O +
of O +
COPD O +
patients O +
are O +
more O +
prone O +
to O +
stimulation O +
and O +
that O +
the O +
smaller O +
particle O +
size O +
of O +
ufCB O +
might O +
be O +
a O +
crucial O +
factor O +
. O +

Induction O +
of O +
Duffy B-Gene +
gene O +
( O +
FY B-Gene +
) O +
in O +
human O +
endothelial O +
cells O +
and O +
in O +
mouse O +
. O +

Duffy B-Gene +
Blood O +
Group O +
protein O +
is O +
a O +
glycoprotein O +
with O +
seven O +
transmembrane O +
domains O +
that O +
binds O +
to O +
C B-Gene -
- I-Gene -
X I-Gene -
- I-Gene -
C I-Gene +
and I-Gene +
C I-Gene -
- I-Gene -
C I-Gene +
chemokines I-Gene +
. O +

The O +
antigen O +
is O +
constitutively O +
expressed O +
in O +
endothelial O +
and O +
epithelial O +
cells O +
of O +
several O +
nonerythroid O +
tissues O +
and O +
in O +
Purkinje O +
cells O +
of O +
the O +
cerebellum O +
. O +

We O +
studied O +
the O +
effect O +
of O +
proinflammatory O +
cytokines B-Gene +
on O +
Duffy B-Gene +
gene O +
expression O +
in O +
endothelial O +
cells O +
from O +
human O +
umbilical O +
vein O +
( O +
HUVEC O +
) O +
and O +
human O +
pulmonary O +
arteries O +
( O +
HPAEC O +
) O +
. O +

Also O +
, O +
we O +
studied O +
the O +
effect O +
of O +
inflammatory O +
agents O +
like O +
bacterial O +
lipopolysaccharide O +
( O +
LPS O +
) O +
on O +
Duffy B-Gene +
gene O +
induction O +
in O +
mouse O +
. O +

Reverse O +
transcription O +
- O +
PCR O +
and O +
mRNA O +
blot O +
analyses O +
showed O +
that O +
Duffy B-Gene +
mRNA O +
was O +
present O +
in O +
these O +
cells O +
in O +
negligible O +
amounts O +
. O +

However O +
, O +
treatment O +
with O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
for O +
6 O -
- O -
24h O +
resulted O +
in O +
a O +
5 O +
to O +
8 O +
- O +
fold O +
increase O +
in O +
Duffy B-Gene +
mRNA O +
. O +

On O +
the O +
other O +
hand O +
, O +
treatment O +
with O +
interleukin-1 B-Gene +
( O +
IL-1 B-Gene +
) O +
, O +
IL-6 B-Gene +
or O +
LPS O +
did O +
not O +
have O +
any O +
effect O +
. O +

Fluorescence O +
microscopy O +
and O +
fluorescence O +
activated O +
cell O +
sorting O +
showed O +
greater O +
expression O +
of O +
Duffy B-Gene +
protein O +
in O +
treated O +
cells O +
correlating O +
the O +
increase O +
in O +
mRNA O +
synthesis O +
with O +
an O +
increase O +
in O +
antigen O +
production O +
. O +

In O +
mice O +
, O +
Duffy B-Gene +
gene O +
was O +
induced O +
in O +
lungs O +
and O +
brain O +
with O +
LPS O +
treatment O +
indicating O +
that O +
the O +
induction O +
is O +
a O +
physiological O +
event O +
. O +

Vascular O +
endothelial O +
cells O +
may O +
induce O +
Duffy B-Gene +
protein O +
to O +
regulate O +
leukocytes O +
and/or O +
chemokine B-Gene +
trafficking O +
. O +

14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
dimers O +
probe O +
the O +
assembly O +
status O +
of O +
multimeric O +
membrane O +
proteins O +
. O +

BACKGROUND O +
: O +

Arginine O +
- O +
based O +
endoplasmic O +
reticulum O +
( O +
ER O +
) O +
localization O +
signals O +
are O +
involved O +
in O +
the O +
heteromultimeric O +
assembly O +
of O +
membrane O +
protein O +
complexes O +
like O +
ATP B-Gene +
- I-Gene +
sensitive I-Gene +
potassium I-Gene +
channels I-Gene +
( O +
K O +
( O +
ATP O +
) O +
) O +
or O +
GABA B-Gene +
( I-Gene +
B I-Gene +
) I-Gene +
G I-Gene +
protein I-Gene +
- I-Gene +
coupled I-Gene +
receptors I-Gene +
. O +

They O +
constitute O +
a O +
trafficking O +
checkpoint O +
that O +
prevents O +
ER O +
exit O +
of O +
unassembled O +
subunits O +
or O +
partially O +
assembled O +
complexes O +
. O +

For O +
K O +
( O +
ATP O +
) O +
channels O +
, O +
the O +
mechanism O +
that O +
leads O +
to O +
masking O +
of O +
the O +
ER O +
localization O +
signals O +
in O +
the O +
fully O +
assembled O +
octameric O +
complex O +
is O +
unknown O +
. O +

RESULTS O +
: O +

By O +
employing O +
a O +
tetrameric O +
affinity O +
construct O +
of O +
the O +
C O +
terminus O +
of O +
the O +
K O +
( O +
ATP O +
) O +
channel O +
alpha O +
subunit O +
, O +
Kir6.2 B-Gene +
, O +
we O +
found O +
that O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
isoforms I-Gene +
epsilon I-Gene +
and I-Gene +
zeta I-Gene +
specifically O +
recognize O +
the O +
arginine O +
- O +
based O +
ER O +
localization O +
signal O +
present O +
in O +
this O +
cytosolic O +
tail O +
. O +

The O +
interaction O +
was O +
reconstituted O +
by O +
using O +
purified O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
proteins O +
. O +

Competition O +
with O +
a O +
nonphosphorylated O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
high O +
- O +
affinity O +
binding O +
peptide O +
implies O +
that O +
the O +
canonical O +
substrate O +
binding O +
groove O +
of O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
is O +
involved O +
. O +

Comparison O +
of O +
monomeric O +
CD4 B-Gene +
, O +
dimeric O +
CD8 B-Gene +
, O +
and O +
artificially O +
tetramerized O +
CD4 B-Gene +
fusions O +
correlates O +
the O +
copy O +
number O +
of O +
the O +
tail O +
containing O +
the O +
arginine O +
- O +
based O +
signal O +
with O +
14 B-Gene +
- I-Gene +
3 I-Gene +
- I-Gene +
3 I-Gene +
binding O +
, O +
resulting O +
in O +
the O +
surface O +
expression O +
of O +
the O +
membrane O +
protein O +
. O +

Binding O +
experiments O +
revealed O +
that O +
the O +
COPI B-Gene +
vesicle O +
coat O +
can O +
specifically O +
recognize O +
the O +
arginine O +
- O +
based O +
ER O +
localization O +
signal O +
and O +
competes O +
with O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
for O +
the O +
binding O +
site O +
. O +

CONCLUSIONS O +
: O +

The O +
COPI B-Gene +
vesicle O +
coat O +
and O +
proteins O +
of O +
the O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
family I-Gene +
recognize O +
arginine O +
- O +
based O +
ER O +
localization O +
signals O +
on O +
multimeric O +
membrane O +
proteins O +
. O +

The O +
equilibrium O +
between O +
these O +
two O +
competing O +
reactions O +
depends O +
on O +
the O +
valency O +
and O +
spatial O +
arrangement O +
of O +
the O +
signal O +
- O +
containing O +
tails O +
. O +

We O +
propose O +
a O +
mechanism O +
in O +
which O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
bound O +
to O +
the O +
correctly O +
assembled O +
multimer O +
mediates O +
release O +
of O +
the O +
complex O +
from O +
the O +
ER O +
. O +

Expression O +
and O +
purification O +
of O +
the O +
angiogenesis O +
inhibitor O +
16 O +
- O +
kDa O +
prolactin B-Gene +
fragment O +
from O +
insect O +
cells O +
. O +

The O +
16 O +
- O +
kDa O +
fragment O +
of O +
prolactin B-Gene +
( O +
16 O +
- O +
kDa O +
PRL B-Gene +
) O +
, O +
derived O +
from O +
proteolytic O +
cleavage O +
of O +
23-kDa O +
PRL B-Gene +
, O +
was O +
shown O +
to O +
have O +
antiangiogenic O +
activity O +
. O +

Previous O +
studies O +
have O +
shown O +
that O +
recombinant O +
16 O +
- O +
kDa O +
PRL B-Gene +
produced O +
from O +
bacteria O +
often O +
contained O +
endotoxins O +
, O +
which O +
are O +
cytotoxic O +
to O +
endothelial O +
cells O +
, O +
and O +
varied O +
in O +
its O +
biological O +
activity O +
due O +
to O +
changes O +
in O +
its O +
refolding O +
from O +
inclusion O +
bodies O +
. O +

These O +
problems O +
limited O +
the O +
use O +
of O +
recombinant O +
16 O +
- O +
kDa O +
PRL B-Gene +
. O +

To O +
improve O +
the O +
generation O +
of O +
recombinant O +
16 O +
- O +
kDa O +
PRL B-Gene +
, O +
we O +
expressed O +
16 O +
- O +
kDa O +
PRL B-Gene +
in O +
Sf9 O +
insect O +
cells O +
using O +
a O +
baculoviral O +
expression O +
system O +
. O +

The O +
signal O +
sequence O +
of O +
the O +
human O +
PRL B-Gene +
gene O +
and O +
codons O +
for O +
seven O +
histidines O +
were O +
added O +
to O +
the O +
N O +
- O +
and O +
C O +
- O +
termini O +
, O +
respectively O +
, O +
of O +
the O +
16-kDa O +
PRL B-Gene +
cDNA O +
construct O +
. O +

Recombinant O +
16 O +
- O +
kDa O +
PRL B-Gene +
was O +
detected O +
in O +
both O +
the O +
cell O +
pellet O +
and O +
the O +
medium O +
. O +

About O +
0.28 O +
mg O +
purified O +
protein O +
was O +
isolated O +
from O +
the O +
cell O +
pellet O +
of O +
4 O +
x O +
10 O -
( O -
7 O -
) O +
infected O +
cells O +
using O +
nickel O +
affinity O +
chromatography O +
. O +

Sixteen O +
kilodalton O +
PRL B-Gene +
was O +
posttranslationally O +
modified O +
with O +
apparent O +
molecular O +
weights O +
of O +
16 O +
and O +
18 O +
kDa O +
on O +
SDS O +
- O +
PAGE O +
. O +

The O +
level O +
of O +
18 O +
- O +
kDa O +
protein O +
was O +
significantly O +
reduced O +
after O +
digestion O +
with O +
peptidyl B-Gene -
- I-Gene -
N I-Gene -
- I-Gene -
glycosidase I-Gene +
, O +
suggesting O +
that O +
the O +
heterogeneity O +
was O +
due O +
to O +
glycosylation O +
of O +
16-kDa O +
PRL B-Gene +
. O +

N O +
- O +
terminal O +
sequence O +
analysis O +
confirmed O +
the O +
fact O +
that O +
both O +
proteins O +
were O +
human O +
16 O +
- O +
kDa O +
PRL B-Gene +
and O +
the O +
signal O +
sequences O +
were O +
cleaved O +
at O +
the O +
same O +
position O +
as O +
that O +
of O +
human O +
PRL B-Gene +
. O +

Consistent O +
with O +
its O +
role O +
as O +
an O +
angiogenesis O +
inhibitor O +
, O +
purified O +
recombinant O +
16-kDa O +
PRL B-Gene +
inhibits O +
the O +
proliferation O +
of O +
endothelial O +
cells O +
with O +
a O +
potency O +
similar O +
to O +
that O +
previously O +
reported O +
for O +
the O +
protein O +
generated O +
in O +
Escherichia O +
coli O +
. O +

This O +
16 O +
- O +
kDa O +
PRL B-Gene +
expressed O +
in O +
Sf9 O +
cells O +
is O +
a O +
useful O +
reagent O +
for O +
functional O +
studies O +
and O +
for O +
the O +
purification O +
and O +
identification O +
of O +
its O +
receptor O +
. O +

Smad3 B-Gene +
mediates O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
beta I-Gene +
- O +
induced O +
alpha O +
- O +
smooth O +
muscle O +
actin B-Gene +
expression O +
. O +

Transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
beta I-Gene +
( O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
) O +
- O +
induced O +
alpha B-Gene +
- I-Gene +
smooth I-Gene +
muscle I-Gene +
actin I-Gene +
( O +
ASMA B-Gene +
) O +
expression O +
is O +
a O +
key O +
indicator O +
of O +
myofibroblast O +
differentiation O +
from O +
fibroblasts O +
. O +

Recent O +
studies O +
suggest O +
that O +
a O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
control O +
element O +
is O +
important O +
in O +
the O +
regulation O +
of O +
the O +
ASMA B-Gene +
gene O +
promoter O +
by O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
. O +

In O +
this O +
study O +
, O +
the O +
role O +
of O +
Smad3 B-Gene +
, O +
a O +
key O +
component O +
of O +
the O +
Smad B-Gene +
pathway O +
that O +
mediates O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
signaling O +
in O +
regulation O +
of O +
ASMA B-Gene +
gene O +
expression O +
, O +
is O +
investigated O +
. O +

All O +
members O +
of O +
the O +
Smad B-Gene +
family I-Gene +
were O +
expressed O +
in O +
rat O +
lung O +
fibroblasts O +
, O +
and O +
Smad3 B-Gene +
expression O +
was O +
elevated O +
upon O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
1 I-Gene +
treatment O +
. O +

Transfection O +
with O +
a O +
Smad3 B-Gene +
- O +
expressing O +
plasmid O +
markedly O +
increased O +
Smad3 B-Gene +
and O +
ASMA B-Gene +
protein O +
expression O +
, O +
whereas O +
transfection O +
with O +
an O +
antisense O +
Smad3 B-Gene +
plasmid O +
suppressed O +
Smad3 B-Gene +
and O +
ASMA B-Gene +
expression O +
. O +

Similar O +
effects O +
were O +
noted O +
when O +
the O +
cloned O +
rat O +
ASMA B-Gene +
promoter O +
- O +
luciferase B-Gene +
reporter O +
gene O +
construct O +
was O +
used O +
to O +
monitor O +
transcriptional O +
activation O +
of O +
the O +
ASMA B-Gene +
gene O +
. O +

Electrophoretic O +
mobility O +
shift O +
assays O +
and O +
DNA O +
affinity O +
precipitation O +
indicated O +
Smad3 B-Gene +
binding O +
to O +
at O +
least O +
two O +
regions O +
of O +
the O +
promoter O +
containing O +
CAGA O +
motifs O +
, O +
termed O +
Smad3 B-Gene +
- O +
binding O +
elements O +
( O +
SBEs O +
) O +
. O +

Mutation O +
of O +
one O +
of O +
the O +
SBEs O +
decreased O +
promoter O +
activity O +
significantly O +
, O +
indicative O +
of O +
a O +
functional O +
role O +
for O +
this O +
SBE O +
. O +

Taken O +
together O +
, O +
these O +
findings O +
suggest O +
a O +
role O +
for O +
Smad3 B-Gene +
in O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
regulation O +
of O +
ASMA B-Gene +
gene O +
expression O +
in O +
myofibroblast O +
differentiation O +
. O +

2-Amino-3-benzoylthiophene O +
allosteric O +
enhancers O +
of O +
A1 O +
adenosine O +
agonist O +
binding O +
: O +
new O +
3 O +
, O +
4 O +
- O +
, O +
and O +
5 O +
- O +
modifications O +
. O +

2-Amino-3-aroylthiophenes O +
are O +
agonist O +
allosteric O +
enhancers O +
( O +
AE O +
) O +
at O +
the O +
A B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
adenosine I-Gene +
receptor I-Gene +
( O +
A B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
AR I-Gene +
) O +
. O +

Here O +
we O +
report O +
the O +
syntheses O +
of O +
three O +
kinds O +
of O +
novel O +
2-aminothiophenes O +
and O +
assays O +
of O +
their O +
AE O +
activity O +
at O +
the O +
human O +
A B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
AR I-Gene +
( O +
hA B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
AR I-Gene +
) O +
, O +
namely O +
, O +
( O -
1 O -
) O +
2-amino-4,5-diphenylthiophene-3-carboxylates O +
, O +
3a O -
- O -
h O +
, O +
( O -
2 O -
) O +
2-amino-3-benzoyl-4,5-diphenylthiophenes O +
, O +
7a O -
- O -
p O +
, O +
and O +
( O +
3 O +
) O +
2-amino-5-bromo-3-benzoyl-4-phenylthiophenes O +
, O +
10a O -
- O -
h O +
. O +

An O +
in O +
vitro O +
assay O +
employing O +
the O +
A B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
AR I-Gene +
agonist O +
[ O -
( O -
125 O -
) O -
I O -
] O -
ABA O +
and O +
membranes O +
from O +
CHO O -
- O -
K1 O +
cells O +
stably O +
expressing O +
the O +
hA B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
AR I-Gene +
measured O +
an O +
index O +
of O +
AE O +
activity O +
, O +
the O +
ability O +
of O +
a O +
candidate O +
AE O +
to O +
stabilize O +
the O +
agonist O +
- O +
A B-Gene -
( I-Gene -
1 I-Gene -
) I-Gene -
AR I-Gene +
- O +
G B-Gene +
protein I-Gene +
ternary O +
complex O +
, O +
scored O +
as O +
the O +
percentage O +
of O +
ternary O +
complex O +
remaining O +
after O +
10 O +
min O +
of O +
dissociation O +
initiated O +
by O +
CPX O +
and O +
GTPgammaS O +
. O +

The O +
AE O +
activity O +
score O +
of O +
2-amino-4,5-dimethyl-3- O -
( O -
3-trifluoromethylbenzoyl O +
) O +
thiophene O +
( O +
PD O +
81 O +
, O +
723 O +
) O +
, O +
which O +
was O +
19 O +
% O +
, O +
served O +
as O +
a O +
standard O +
for O +
comparison O +
. O +

Two O +
3-carboxythiophene O +
3-trifluoromethylbenzyl O +
esters O +
, O +
3d O +
( O +
49 O +
% O +
) O +
and O +
3f O +
( O +
63 O +
% O +
) O +
, O +
had O +
substantial O +
AE O +
activity O +
. O +

The O +
3- O -
( O -
1-naphthoyl O +
) O +
substituent O +
of O +
7e O +
( O +
52 O +
% O +
) O +
also O +
supported O +
AE O +
activity O +
. O +

Compounds O +
in O +
series O +
3 O +
tended O +
to O +
be O +
more O +
potent O +
, O +
10a O +
and O +
10c O +
having O +
scores O +
of O +
91 O +
and O +
80 O +
% O +
, O +
respectively O +
. O +

The O +
activity O +
of O +
2-amino-5-bromo-3-ethoxycarbonyl-4- O -
( O -
3-nitrophenyl O +
) O +
thiophene O +
, O +
10h O +
( O +
26 O +
% O +
) O +
, O +
is O +
an O +
exception O +
to O +
the O +
rule O +
that O +
a O +
3-ethoxycarbonyl O +
substituent O +
can O -
not O +
support O +
AE O +
activity O +
. O +

Cloning O +
and O +
overexpression O +
of O +
the O +
3-hydroxyisobutyrate B-Gene +
dehydrogenase I-Gene +
gene O +
from O +
pseudomonas O +
putida O +
E23 O +
. O +

The O +
structural O +
gene O +
for O +
NAD+-dependent O +
3-hydroxyisobutyrate B-Gene +
dehydrogenase I-Gene +
( O +
EC B-Gene +
1.1.1.31 I-Gene +
) O +
from O +
Pseudomonas O +
putida O +
E23 O +
was O +
cloned O +
in O +
Escherichia O +
coli O +
cells O +
to O +
obtain O +
a O +
large O +
amount O +
of O +
the O +
enzyme O +
and O +
its O +
nucleotides O +
were O +
sequenced O +
to O +
study O +
its O +
structural O +
relationship O +
with O +
other O +
proteins O +
. O +

The O +
gene O +
encoded O +
a O +
polypeptide O +
containing O +
295 O +
amino O +
acid O +
residues O +
and O +
was O +
in O +
a O +
cluster O +
with O +
the O +
gene O +
for O +
methylmalonate B-Gene +
semialdehyde I-Gene +
dehydrogenase I-Gene +
. O +

Transformed O +
E. O +
coli O +
cells O +
overproduced O +
3-hydroxyisobutyrate B-Gene +
dehydrogenase I-Gene +
, O +
and O +
the O +
recombinant O +
enzyme O +
was O +
purified O +
to O +
homogeneity O +
with O +
a O +
high O +
yield O +
. O +

Lysine O +
and O +
asparagine O +
residues O +
, O +
which O +
are O +
important O +
in O +
catalysis O +
of O +
the O +
3-hydroxyacid B-Gene +
dehydrogenase I-Gene +
family I-Gene +
, O +
are O +
conserved O +
in O +
this O +
enzyme O +
. O +

Cell O +
- O +
specific O +
and O +
hormone O +
- O +
regulated O +
expression O +
of O +
gonadotropin B-Gene +
- I-Gene +
regulated I-Gene +
testicular I-Gene +
RNA I-Gene +
helicase I-Gene +
gene O +
( O +
GRTH B-Gene +
/ O +
Ddx25 B-Gene +
) O +
resulting O +
from O +
alternative O +
utilization O +
of O +
translation O +
initiation O +
codons O +
in O +
the O +
rat O +
testis O +
. O +

Gonadotropin B-Gene +
- I-Gene +
regulated I-Gene +
testicular I-Gene +
RNA I-Gene +
helicase I-Gene +
( O +
GRTH B-Gene +
) O +
is O +
a O +
novel O +
DEAD O +
- O +
box O +
protein O +
with O +
ATPase B-Gene +
and O +
RNA B-Gene +
helicase I-Gene +
activities O +
. O +

GRTH B-Gene +
gene O +
transcription O +
is O +
stimulated O +
by O +
human B-Gene +
chorionic I-Gene +
gonadotropin I-Gene +
( O +
hCG B-Gene +
) O +
via O +
cyclic O +
AMP O +
- O +
induced O +
androgen O +
formation O +
in O +
testicular O +
Leydig O +
cells O +
. O +

In O +
this O +
study O +
, O +
immunocytochemical O +
and O +
Western O +
analyses O +
identified O +
GRTH B-Gene +
as O +
a O +
developmentally O +
regulated O +
protein O +
in O +
Leydig O +
cells O +
and O +
in O +
germ O +
cells O +
( O +
pachytene O +
spermatocytes O +
and O +
round O +
spermatids O +
) O +
of O +
the O +
rat O +
testis O +
. O +

Three O +
ATGs O +
with O +
the O +
potential O +
for O +
generation O +
of O +
multiple O +
protein O +
species O +
were O +
identified O +
. O +

Germ O +
cells O +
primarily O +
utilized O +
the O +
1st O +
ATG O +
codon O +
( O +
+ O +
1 O +
) O +
and O +
contained O +
major O +
proteins O +
of O +
61 O +
/ O +
56 O +
kDa O +
, O +
whereas O +
Leydig O +
cells O +
utilized O +
preferentially O +
the O +
2nd O +
ATG O +
codon O +
( O +
+ O +
343 O +
) O +
with O +
expression O +
of O +
48 O +
/ O +
43 O +
kDa O +
species O +
. O +

A O +
3rd O +
ATG O +
was O +
weakly O +
utilized O +
and O +
yielded O +
a O +
33 O +
- O +
kDa O +
protein O +
only O +
in O +
germ O +
cells O +
. O +

The O +
increase O +
in O +
GRTH B-Gene +
43 O +
- O +
kDa O +
protein O +
in O +
Leydig O +
cells O +
caused O +
by O +
hCG B-Gene +
treatment O +
was O +
prevented O +
by O +
the O +
androgen B-Gene +
receptor I-Gene +
antagonist O +
, O +
flutamide O +
. O +

In O +
round O +
spermatids O +
, O +
hCG B-Gene +
caused O +
a O +
significant O +
decrease O +
of O +
61 O +
kDa O +
species O +
and O +
an O +
induction O +
48 O +
/ O +
43 O +
kDa O +
species O +
, O +
whereas O +
no O +
changes O +
were O +
observed O +
in O +
pachytene O +
spermatocytes O +
. O +

Reversal O +
of O +
this O +
hormone O +
- O +
induced O +
switch O +
of O +
expression O +
by O +
flutamide O +
indicated O +
a O +
role O +
of O +
androgen O +
in O +
utilization O +
of O +
the O +
2nd O +
ATG O +
. O +

These O +
studies O +
have O +
demonstrated O +
a O +
cell O +
- O +
specific O +
and O +
hormone O +
- O +
dependent O +
alternative O +
usage O +
of O +
ATG O +
codons O +
in O +
the O +
testis O +
. O +

They O +
have O +
also O +
revealed O +
that O +
the O +
androgen O +
- O +
dependent O +
transcription O +
of O +
GRTH B-Gene +
expression O +
in O +
Leydig O +
cells O +
is O +
accompanied O +
by O +
a O +
marked O +
increase O +
of O +
43 O +
- O +
kDa O +
species O +
. O +

The O +
findings O +
indicate O +
that O +
expression O +
of O +
GRTH B-Gene +
proteins O +
is O +
regulated O +
by O +
gonadotropin B-Gene +
/ O +
androgen O +
at O +
the O +
translational O +
level O +
. O +

Cloning O +
and O +
characterization O +
of O +
porcine O +
common O +
gamma O +
chain O +
gene O +
. O +

The O +
common O +
gamma O +
chain O +
, O +
which O +
was O +
originally O +
identified O +
as O +
a O +
component O +
of O +
interleukin-2 O +
receptors O +
( O +
IL-2R O +
) O +
, O +
plays O +
a O +
key O +
role O +
in O +
differentiation O +
of O +
T O +
lymphocytes O +
and O +
natural O +
killer O +
( O +
NK O +
) O +
cells O +
. O +

In O +
the O +
present O +
study O +
, O +
cDNA O +
of O +
the O +
porcine O +
common O +
gamma O +
chain O +
gene O +
and O +
its O +
genomic O +
DNA O +
were O +
molecularly O +
cloned O +
and O +
characterized O +
. O +

The O +
porcine O +
common O +
gamma O +
chain O +
gene O +
was O +
found O +
to O +
consist O +
of O +
8 O +
exons O +
, O +
spanning O +
approximately O +
3.7 O +
kb O +
, O +
and O +
to O +
encode O +
a O +
368 O +
- O +
amino O +
acid O +
polypeptide O +
. O +

The O +
amino O +
acid O +
sequence O +
showed O +
82.4 O +
% O +
, O +
71.1 O +
% O +
, O +
86.1 O +
% O +
, O +
and O +
84.8 O +
% O +
similarities O +
with O +
that O +
of O +
human O +
, O +
murine O +
, O +
bovine O +
, O +
and O +
canine O +
chains O +
, O +
respectively O +
. O +

The O +
common O +
gamma O +
chain O +
gene O +
was O +
assigned O +
to O +
swine O +
chromosome O +
Xq13 O +
by O +
FISH O +
analysis O +
and O +
was O +
consistent O +
with O +
the O +
result O +
of O +
radiation O +
hybrid O +
( O +
RH O +
) O +
mapping O +
. O +

When O +
various O +
porcine O +
tissues O +
were O +
examined O +
for O +
the O +
expression O +
of O +
this O +
gene O +
, O +
the O +
expression O +
was O +
observed O +
in O +
lymphocytes O +
and O +
lymphocyte O +
- O +
related O +
tissues O +
. O +

Since O +
GATA O +
, O +
T O +
cell O +
factor-1 O +
( O +
TCF-1 O +
) O +
, O +
Ets-1 O +
, O +
activated O +
protein2 O +
( O +
AP-2 O +
) O +
, O +
and O +
Ikaros2 O +
binding O +
motifs O +
were O +
demonstrated O +
in O +
the O +
5 O -
' O +
upstream O +
region O +
of O +
this O +
gene O +
, O +
promoter O +
activity O +
was O +
investigated O +
using O +
luciferase O +
gene O +
as O +
a O +
reporter O +
. O +

The O +
results O +
indicate O +
that O +
the O +
Ets-1 O +
binding O +
motif O +
in O +
the O +
segment O +
from O +
- O +
95 O +
to O +
- O +
59 O +
( O +
major O +
transcription O +
initiation O +
site O +
: O +
+ O -
1 O +
) O +
was O +
an O +
essential O +
cis O +
- O +
acting O +
regulatory O +
element O +
for O +
the O +
common O +
gamma O +
chain O +
gene O +
in O +
lymphoid O +
cells O +
. O +

Methylation O +
of O +
histone B-Gene +
H3 I-Gene +
by O +
Set2 B-Gene +
in O +
Saccharomyces O +
cerevisiae O +
is O +
linked O +
to O +
transcriptional O +
elongation O +
by O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
. O +

Set2 B-Gene +
methylates O +
Lys36 O +
of O +
histone B-Gene +
H3 I-Gene +
. O +

We O +
show O +
here O +
that O +
yeast O +
Set2 B-Gene +
copurifies O +
with O +
RNA B-Gene +
polymerase I-Gene +
II I-Gene +
( O +
RNAPII B-Gene +
) O +
. O +

Chromatin O +
immunoprecipitation O +
analyses O +
demonstrated O +
that O +
Set2 B-Gene +
and O +
histone B-Gene +
H3 I-Gene +
Lys36 O +
methylation O +
are O +
associated O +
with O +
the O +
coding O +
regions O +
of O +
several O +
genes O +
that O +
were O +
tested O +
and O +
correlate O +
with O +
active O +
transcription O +
. O +

Both O +
depend O +
, O +
as O +
well O +
, O +
on O +
the O +
Paf1 B-Gene +
elongation I-Gene +
factor I-Gene +
complex I-Gene +
. O +

The O +
C O +
terminus O +
of O +
Set2 B-Gene +
, O +
which O +
contains O +
a O +
WW O +
domain O +
, O +
is O +
also O +
required O +
for O +
effective O +
Lys36 O +
methylation O +
. O +

Deletion O +
of O +
CTK1 B-Gene +
, O +
encoding O +
an O +
RNAPII B-Gene +
CTD B-Gene +
kinase I-Gene +
, O +
prevents O +
Lys36 O +
methylation O +
and O +
Set2 B-Gene +
recruitment O +
, O +
suggesting O +
that O +
methylation O +
may O +
be O +
triggered O +
by O +
contact O +
of O +
the O +
WW O +
domain O +
or O +
C O +
terminus O +
of O +
Set2 B-Gene +
with O +
Ser2 O +
- O +
phosphorylated O +
CTD O +
. O +

A O +
set2 B-Gene +
deletion O +
results O +
in O +
slight O +
sensitivity O +
to O +
6-azauracil O +
and O +
much O +
less O +
beta B-Gene -
- I-Gene -
galactosidase I-Gene +
produced O +
by O +
a O +
reporter O +
plasmid O +
, O +
resulting O +
from O +
a O +
defect O +
in O +
transcription O +
. O +

In O +
synthetic O +
genetic O +
array O +
( O +
SGA O +
) O +
analysis O +
, O +
synthetic O +
growth O +
defects O +
were O +
obtained O +
when O +
a O +
set2 B-Gene +
deletion O +
was O +
combined O +
with O +
deletions O +
of O +
all O +
five O +
components O +
of O +
the O +
Paf1 B-Gene +
complex I-Gene +
, O +
the O +
chromodomain O +
elongation B-Gene +
factor I-Gene +
Chd1 B-Gene +
, O +
the O +
putative O +
elongation B-Gene +
factor I-Gene +
Soh1 B-Gene +
, O +
the O +
Bre1 B-Gene +
or O +
Lge1 B-Gene +
components O +
of O +
the O +
histone B-Gene +
H2B I-Gene +
ubiquitination O +
complex O +
, O +
or O +
the O +
histone B-Gene +
H2A I-Gene +
variant O +
Htz1 B-Gene +
. O +

SET2 B-Gene +
also O +
interacts O +
genetically O +
with O +
components O +
of O +
the O +
Set1 B-Gene +
and O +
Set3 B-Gene +
complexes O +
, O +
suggesting O +
that O +
Set1 B-Gene +
, O +
Set2 B-Gene +
, O +
and O +
Set3 B-Gene +
similarly O +
affect O +
transcription O +
by O +
RNAPII B-Gene +
. O +

Cytokine B-Gene +
response O +
to O +
endotoxin O +
in O +
individuals O +
heterozygous O +
for O +
the O +
Delta32 O +
mutation O +
of O +
chemokine B-Gene +
receptor I-Gene +
CCR5 B-Gene +
. O +

Studies O +
of O +
mice O +
with O +
a O +
targeted O +
disruption O +
of O +
the O +
CCR5 B-Gene +
gene O +
suggest O +
that O +
the O +
CC B-Gene +
chemokine I-Gene +
receptor I-Gene +
5 I-Gene +
( O +
CCR5 B-Gene +
) O +
is O +
a O +
determinant O +
of O +
the O +
cytokine B-Gene +
response O +
to O +
endotoxin O +
. O +

In O +
humans O +
, O +
a O +
naturally O +
occurring O +
mutation O +
of O +
the O +
CCR5 B-Gene +
gene O +
is O +
a O +
32 O +
- O +
basepair O +
( O +
bp O +
) O +
deletion O +
which O +
precludes O +
the O +
translation O +
of O +
the O +
gene O +
into O +
a O +
functional O +
transmembrane O +
protein O +
. O +

To O +
evaluate O +
the O +
cytokine B-Gene +
phenotype O +
of O +
heterozygosity O +
for O +
the O +
32 O +
deletion O +
, O +
we O +
studied O +
the O +
endotoxin O +
- O +
stimulated O +
release O +
of O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
, O +
Interleukin B-Gene +
( I-Gene +
IL I-Gene +
) I-Gene +
- I-Gene +
6 I-Gene +
, O +
IL-8 B-Gene +
, O +
IL-10 B-Gene +
, O +
and O +
IL-12 B-Gene +
in O +
whole O +
blood O +
ex O +
- O +
vivo O +
of O +
healthy O +
volunteers O +
and O +
patients O +
undergoing O +
elective O +
cardiac O +
bypass O +
surgery O +
. O +

This O +
operation O +
represents O +
a O +
major O +
surgical O +
trauma O +
associated O +
with O +
ischemia O +
- O +
reperfusion O +
- O +
injury O +
and O +
triggers O +
a O +
profound O +
inflammatory O +
response O +
. O +

In O +
these O +
patients O +
, O +
cytokine B-Gene +
plasma O +
concentrations O +
were O +
measured O +
during O +
and O +
after O +
cardiac O +
surgery O +
. O +

No O +
difference O +
was O +
found O +
between O +
the O +
frequencies O +
of O +
the O +
observed O +
and O +
expected O +
CCR5 B-Gene +
genotypes O +
in O +
the O +
groups O +
of O +
individuals O +
studied O +
. O +

Furthermore O +
, O +
no O +
significant O +
difference O +
in O +
ex O +
- O +
vivo O +
or O +
peri O +
- O +
and O +
postoperative O +
cytokine B-Gene +
plasma O +
concentrations O +
was O +
detected O +
between O +
CCR5 B-Gene +
wild O +
- O +
type O +
homozygotes O +
and O +
individuals O +
carrying O +
one O +
defective O +
CCR5 B-Gene +
allele O +
. O +

Our O +
results O +
indicate O +
that O +
heterozygosity O +
for O +
the O +
32bp O +
deletion O +
of O +
CCR5 O +
is O +
not O +
associated O +
with O +
an O +
altered O +
cytokine B-Gene +
response O +
to O +
endotoxin O +
or O +
to O +
a O +
major O +
surgical O +
trauma O +
when O +
compared O +
with O +
individuals O +
homozygous O +
for O +
the O +
wild O +
- O +
type O +
allele O +
. O +

DNA B-Gene +
polymerase I-Gene +
zeta I-Gene +
: O +
new O +
insight O +
into O +
eukaryotic O +
mutagenesis O +
and O +
mammalian O +
embryonic O +
development O +
. O +

Information O +
about O +
the O +
mechanisms O +
that O +
generate O +
mutations O +
in O +
eukaryotes O +
is O +
likely O +
to O +
be O +
useful O +
for O +
understanding O +
human O +
health O +
concerns O +
, O +
such O +
as O +
genotoxicity O +
and O +
cancer O +
. O +

Eukaryotic O +
mutagenesis O +
is O +
largely O +
the O +
outcome O +
of O +
attacks O +
by O +
endogenous O +
and O +
environmental O +
agents O +
. O +

Except O +
for O +
DNA O +
repair O +
, O +
cell O +
cycle O +
checkpoints O +
and O +
DNA O +
damage O +
avoidance O +
, O +
cells O +
have O +
also O +
evolved O +
DNA O +
damage O +
tolerance O +
mechanism O +
, O +
by O +
which O +
lesion O +
- O +
targeted O +
mutation O +
might O +
occur O +
in O +
the O +
genome O +
during O +
replication O +
by O +
specific O +
DNA B-Gene +
polymerases I-Gene +
to O +
bypass O +
the O +
lesions O +
( O +
translesion O +
DNA O +
synthesis O +
, O +
TLS O +
) O +
, O +
or O +
mutation O +
on O +
undamaged O +
DNA O +
templates O +
( O +
untargeted O +
mutation O +
) O +
might O +
be O +
induced O +
. O +

DNA B-Gene +
polymerase I-Gene +
zeta I-Gene +
( O +
pol B-Gene +
zeta I-Gene +
) O +
, O +
which O +
was O +
found O +
firstly O +
in O +
budding O +
yeast O +
Saccharomyces O +
cerevisiae O +
and O +
consists O +
of O +
catalytic O +
subunit O +
scRev3 B-Gene +
and O +
stimulating O +
subunit O +
scRev7 B-Gene +
, O +
has O +
received O +
more O +
attention O +
in O +
recent O +
years O +
. O +

Pol B-Gene +
zeta I-Gene +
is O +
a O +
member O +
of O +
DNA B-Gene +
polymerase I-Gene +
eta I-Gene +
subfamily I-Gene +
, O +
which O +
belongs O +
to O +
DNA B-Gene +
polymerase I-Gene +
B I-Gene +
family I-Gene +
, O +
and O +
exists O +
in O +
almost O +
all O +
eukaryotes O +
. O +

Human O +
homolog O +
of O +
the O +
scRev3 B-Gene +
gene O +
is O +
located O +
in O +
chromosome O +
region O +
6q21 O +
, O +
and O +
the O +
mouse O +
equivalent O +
maps O +
to O +
chromosome O +
10 O +
, O +
distal O +
to O +
the O +
c B-Gene -
- I-Gene -
myb I-Gene +
gene O +
and O +
close O +
to O +
the O +
Macs B-Gene +
gene O +
. O +

Alternative O +
splicing O +
, O +
upstream O +
out O +
- O +
of O +
frame O +
ATG O +
can O +
be O +
found O +
in O +
yeast O +
scRev3 B-Gene +
, O +
mouse O +
and O +
human O +
homologs O +
. O +

Furthermore O +
, O +
the O +
sequence O +
from O +
253 O +
- O +
323 O +
immediate O +
upstream O +
of O +
the O +
AUG O +
initiator O +
codon O +
has O +
the O +
potential O +
to O +
form O +
a O +
stem O +
- O +
loop O +
hairpin O +
secondary O +
structure O +
in O +
REV3 B-Gene +
mRNA O +
, O +
suggesting O +
that O +
human O +
REV3 B-Gene +
protein O +
may O +
be O +
expressed O +
at O +
low O +
levels O +
in O +
human O +
cells O +
under O +
normal O +
growth O +
conditions O +
. O +

The O +
functional O +
domain O +
analysis O +
showed O +
that O +
yeast O +
Rev3 B-Gene +
- O +
980 O +
tyrosine O +
in O +
conserved O +
region O +
II O +
is O +
at O +
the O +
polymerase B-Gene +
active O +
site O +
. O +

Human O +
REV3 B-Gene +
amino O +
acid O +
residues O +
1 O +
776 O +
- O +
2 O +
195 O +
provide O +
a O +
REV7 B-Gene +
binding O +
domain O +
, O +
and O +
REV7 B-Gene +
amino O +
acid O +
residues O +
1 O +
- O +
211 O +
provide O +
a O +
bind O +
domain O +
for O +
REV1 B-Gene +
, O +
REV3 B-Gene +
and O +
REV7 B-Gene +
itself O +
. O +

More O +
interestingly O +
, O +
REV7 B-Gene +
interacts O +
with O +
hMAD2 B-Gene +
and O +
therefore O +
might O +
function O +
in O +
the O +
cell O +
cycle O +
control O +
by O +
affecting O +
the O +
activation O +
of O +
APC B-Gene +
( O +
anaphase B-Gene +
promoting I-Gene +
complex I-Gene +
) O +
. O +

Currently O +
it O +
has O +
been O +
known O +
that O +
pol B-Gene +
zeta I-Gene +
is O +
involved O +
in O +
most O +
spontaneous O +
mutation O +
, O +
lesion O +
- O +
targeted O +
mutation O +
via O +
TLS O +
, O +
chemical O +
carcinogen O +
induced O +
untargeted O +
mutation O +
and O +
somatic O +
hypermutation O +
of O +
antibody O +
genes O +
in O +
mammalian O +
. O +

In O +
TLS O +
pathway O +
, O +
pol B-Gene +
zeta I-Gene +
acts O +
as O +
a O +
" O +
mismatch O +
extender O +
" O +
with O +
combination O +
of O +
other O +
DNA B-Gene +
polymerases I-Gene +
, O +
such O +
as O +
pol B-Gene +
iota I-Gene +
. O +

Unlike O +
in O +
yeast O +
, O +
it O +
was O +
found O +
that O +
pol B-Gene +
zeta I-Gene +
also O +
functioned O +
in O +
mouse O +
embryonic O +
development O +
more O +
recently O +
. O +

It O +
was O +
hypothesized O +
that O +
the O +
roles O +
of O +
pol B-Gene +
zeta I-Gene +
in O +
TLS O +
and O +
cell O +
cycle O +
control O +
might O +
contribute O +
to O +
mouse O +
embryonic O +
lethality O +
. O +

Gene O +
expression O +
profiling O +
of O +
the O +
effects O +
of O +
castration O +
and O +
estrogen O +
treatment O +
in O +
the O +
rat O +
uterus O +
. O +

The O +
development O +
and O +
functions O +
of O +
female O +
reproductive O +
tissues O +
are O +
regulated O +
by O +
the O +
actions O +
of O +
two O +
major O +
sex O +
steroid O +
hormones O +
, O +
estrogen O +
and O +
progesterone O +
. O +

To O +
investigate O +
estrogen O +
- O +
dependent O +
gene O +
expression O +
in O +
the O +
rat O +
uterus O +
, O +
we O +
studied O +
the O +
effect O +
of O +
ovariectomy O +
with O +
or O +
without O +
estrogen O +
treatment O +
on O +
the O +
uterine O +
expression O +
of O +
3000 O +
genes O +
using O +
cDNA O +
microarrays O +
. O +

Many O +
genes O +
were O +
regulated O +
by O +
either O +
treatment O +
, O +
but O +
only O +
few O +
were O +
reciprocally O +
regulated O +
by O +
these O +
contrasting O +
treatments O +
. O +

The O +
present O +
study O +
confirms O +
previous O +
findings O +
and O +
identifies O +
several O +
genes O +
with O +
expressions O +
not O +
previously O +
known O +
to O +
be O +
influenced O +
by O +
estrogen O +
. O +

These O +
genes O +
include O +
follistatin B-Gene +
- I-Gene +
related I-Gene +
protein I-Gene +
, O +
Thy-1 B-Gene +
glycoprotein I-Gene +
, O +
alpha B-Gene -
- I-Gene -
fodrin I-Gene +
, O +
CD24 B-Gene +
, O +
immediate B-Gene +
early I-Gene +
response I-Gene +
5 I-Gene +
, O +
insulin B-Gene +
- I-Gene +
like I-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
2 I-Gene +
, O +
growth B-Gene +
response I-Gene +
protein I-Gene +
CL-6 I-Gene +
( O +
INSIG-1 B-Gene +
) O +
, O +
ladinin1 B-Gene +
, O +
class B-Gene +
I I-Gene +
major I-Gene +
histocompatibility I-Gene +
complex I-Gene +
heavy I-Gene +
chain I-Gene +
, O +
lactadherin B-Gene +
, O +
ezrin B-Gene +
, O +
and O +
Fas B-Gene +
- I-Gene +
activated I-Gene +
serine I-Gene +
/ I-Gene +
threonine I-Gene +
kinase I-Gene +
. O +

Because O +
of O +
their O +
function O +
as O +
regulators O +
of O +
proliferation O +
and O +
apoptosis O +
, O +
CD24 B-Gene +
, O +
insulin B-Gene +
- I-Gene +
like I-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
2 I-Gene +
, O +
and O +
Fas B-Gene +
/ O +
Fas B-Gene +
ligand I-Gene +
were O +
examined O +
further O +
by O +
immunohistochemical O +
expression O +
and O +
tissue O +
localization O +
analysis O +
. O +

Our O +
analysis O +
confirms O +
a O +
contrasting O +
regulation O +
of O +
these O +
gene O +
products O +
by O +
ovariectomy O +
and O +
estrogen O +
treatment O +
. O +

The O +
present O +
study O +
identifies O +
novel O +
mediators O +
of O +
estrogen O +
actions O +
in O +
the O +
uterus O +
and O +
provides O +
genome O +
- O +
wide O +
expression O +
data O +
from O +
which O +
novel O +
hypotheses O +
regarding O +
uterine O +
function O +
can O +
be O +
generated O +
. O +

Intramembrane O +
proteolysis O +
by O +
presenilin B-Gene +
and O +
presenilin B-Gene +
- O +
like O +
proteases B-Gene +
. O +

Regulated O +
intramembrane O +
proteolysis O +
is O +
a O +
novel O +
mechanism O +
involving O +
proteases B-Gene +
that O +
hydrolyze O +
their O +
substrates O +
in O +
a O +
hydrophobic O +
environment O +
. O +

Presenilin B-Gene +
( I-Gene +
PS I-Gene +
) I-Gene +
1 I-Gene +
and O +
PS B-Gene +
2 I-Gene +
are O +
required O +
for O +
intramembrane O +
cleavage O +
of O +
an O +
increasing O +
number O +
of O +
type O +
I O +
membrane O +
proteins O +
, O +
including O +
the O +
amyloid B-Gene +
precursor I-Gene +
protein I-Gene +
of O +
Alzheimer O +
' O +
s O +
disease O +
and O +
the O +
Notch B-Gene +
receptor O +
, O +
which O +
signals O +
during O +
differentiation O +
and O +
development O +
. O +

Mutagenesis O +
, O +
affinity O +
labeling O +
, O +
biochemical O +
isolation O +
, O +
and O +
reconstitution O +
in O +
cells O +
reveal O +
that O +
PS B-Gene +
, O +
in O +
complex O +
with O +
co O +
- O +
factors O +
nicastrin B-Gene +
, O +
APH B-Gene +
- I-Gene +
1 I-Gene +
and O +
PEN B-Gene +
- I-Gene +
2 I-Gene +
, O +
apparently O +
contains O +
the O +
active O +
site O +
of O +
gamma B-Gene +
- I-Gene +
secretase I-Gene +
, O +
a O +
novel O +
membrane O +
aspartyl B-Gene +
protease I-Gene +
. O +

In O +
addition O +
, O +
other O +
related O +
aspartyl B-Gene +
proteases I-Gene +
have O +
been O +
identified O +
. O +

These O +
include O +
members O +
of O +
the O +
type-4 B-Gene +
prepilin I-Gene +
peptidase I-Gene +
family I-Gene +
in O +
bacteria O +
, O +
which O +
are O +
known O +
proteases B-Gene +
and O +
carry O +
a O +
GD O +
motif O +
conserved O +
in O +
PS B-Gene +
. O +

A O +
group O +
of O +
multi O +
- O +
pass O +
membrane O +
proteins O +
found O +
in O +
eukaryotes O +
also O +
contain O +
YD O +
and O +
LGXGD O +
motifs O +
in O +
two O +
transmembrane O +
domains O +
that O +
are O +
conserved O +
in O +
PS B-Gene +
and O +
postulated O +
to O +
constitute O +
an O +
aspartyl B-Gene +
protease I-Gene +
active O +
site O +
. O +

Among O +
these O +
is O +
signal B-Gene +
peptide I-Gene +
peptidase I-Gene +
( O +
SPP B-Gene +
) O +
, O +
which O +
cleaves O +
remnant O +
signal O +
peptides O +
derived O +
from O +
signal B-Gene +
- I-Gene +
peptidase I-Gene +
- O +
mediated O +
ectodomain O +
shedding O +
. O +

SPP B-Gene +
cuts O +
type O +
II O +
membrane O +
proteins O +
, O +
illustrating O +
that O +
PS B-Gene +
- O +
like O +
proteases B-Gene +
play O +
a O +
key O +
role O +
in O +
intramembrane O +
proteolysis O +
of O +
single O +
- O +
pass O +
membrane O +
proteins O +
oriented O +
in O +
either O +
direction O +
. O +

Molecular O +
analysis O +
of O +
the O +
copper O +
- O +
transporting O +
efflux O +
system O +
CusCFBA B-Gene +
of O +
Escherichia O +
coli O +
. O +

The O +
cus B-Gene +
determinant O +
of O +
Escherichia O +
coli O +
encodes O +
the O +
CusCFBA B-Gene +
proteins O +
that O +
mediate O +
resistance O +
to O +
copper O +
and O +
silver O +
by O +
cation O +
efflux O +
. O +

CusA B-Gene +
and O +
CusB B-Gene +
were O +
essential O +
for O +
copper O +
resistance O +
, O +
and O +
CusC B-Gene +
and O +
CusF B-Gene +
were O +
required O +
for O +
full O +
resistance O +
. O +

Replacements O +
of O +
methionine O +
residues O +
573 O +
, O +
623 O +
, O +
and O +
672 O +
with O +
isoleucine O +
in O +
CusA B-Gene +
resulted O +
in O +
loss O +
of O +
copper O +
resistance O +
, O +
demonstrating O +
their O +
functional O +
importance O +
. O +

Substitutions O +
for O +
several O +
other O +
methionine O +
residues O +
of O +
this O +
protein O +
did O +
not O +
have O +
any O +
effect O +
. O +

The O +
small O +
10 O +
- O +
kDa O +
protein O +
CusF B-Gene +
( O +
previously O +
YlcC B-Gene +
) O +
was O +
shown O +
to O +
be O +
a O +
periplasmic O +
protein O +
. O +

CusF B-Gene +
bound O +
one O +
copper O +
per O +
polypeptide O +
. O +

The O +
pink O +
CusF B-Gene +
copper O +
protein O +
complex O +
exhibited O +
an O +
absorption O +
maximum O +
at O +
around O +
510 O +
nm O +
. O +

Methionine O +
residues O +
of O +
CusF B-Gene +
were O +
involved O +
in O +
copper O +
binding O +
as O +
shown O +
by O +
site O +
- O +
directed O +
mutagenesis O +
. O +

CusF B-Gene +
interacted O +
with O +
CusB B-Gene +
and O +
CusC B-Gene +
polypeptides O +
in O +
a O +
yeast O +
two O +
- O +
hybrid O +
assay O +
. O +

In O +
contrast O +
to O +
other O +
well O +
- O +
studied O +
CBA O +
- O +
type O +
heavy O +
metal O +
efflux O +
systems O +
, O +
Cus B-Gene +
was O +
shown O +
to O +
be O +
a O +
tetrapartite O +
resistance O +
system O +
that O +
involves O +
the O +
novel O +
periplasmic O +
copper O +
- O +
binding O +
protein O +
CusF B-Gene +
. O +

These O +
data O +
provide O +
additional O +
evidence O +
for O +
the O +
hypothesis O +
that O +
Cu O -
( O -
I O -
) O +
is O +
directly O +
transported O +
from O +
the O +
periplasm O +
across O +
the O +
outer O +
membrane O +
by O +
the O +
Cus B-Gene +
complex I-Gene +
. O +

Chemokine B-Gene +
receptor I-Gene +
inhibitor O +
, O +
Antileukinate O +
, O +
suppressed O +
ovalbumin B-Gene +
- O +
induced O +
eosinophilic O +
inflammation O +
in O +
the O +
airway O +
. O +

Accumulating O +
evidence O +
suggests O +
that O +
eosinophils O +
play O +
an O +
important O +
role O +
in O +
the O +
pathogenesis O +
of O +
allergic O +
diseases O +
. O +

An O +
eosinophil O +
- O +
active O +
chemokine B-Gene +
, O +
eotaxin B-Gene +
, O +
and O +
its O +
receptor O +
, O +
C B-Gene -
- I-Gene -
C I-Gene +
chemokine I-Gene +
receptor I-Gene +
3 I-Gene +
, O +
are O +
particularly O +
attractive O +
as O +
novel O +
targets O +
of O +
immunological O +
intervention O +
for O +
the O +
disease O +
. O +

In O +
this O +
study O +
, O +
we O +
examine O +
the O +
effects O +
of O +
a O +
hexa O +
- O +
peptide O +
( O +
Ac O -
- O -
RRWWCR O -
- O -
NH O -
( O -
2 O -
) O +
) O +
, O +
Antileukinate O +
, O +
which O +
we O +
have O +
previously O +
defined O +
as O +
a O +
potent O +
inhibitor O +
of O +
CXC B-Gene +
chemokine I-Gene +
receptor I-Gene +
1 I-Gene +
and I-Gene +
2 I-Gene +
, O +
on O +
eotaxin B-Gene +
in O +
vitro O +
and O +
in O +
vivo O +
. O +

Antileukinate O +
inhibited O +
the O +
binding O +
of O +
125I O +
- O +
labeled O +
human O +
eotaxin B-Gene +
to O +
human O +
eosinophils O +
with O +
an O +
IC O -
( O -
50 O -
) O +
of O +
approximately O +
10 O +
microM O +
and O +
eosinophil O +
chemotaxis O +
to O +
human O +
eotaxin B-Gene +
was O +
significantly O +
inhibited O +
by O +
10 O +
microM O +
of O +
Antileukinate O +
. O +

We O +
examined O +
the O +
effects O +
of O +
Antileukinate O +
on O +
eosinophil O +
accumulation O +
induced O +
by O +
intraperitoneal O +
administration O +
of O +
murine O +
eotaxin B-Gene +
, O +
and O +
confirmed O +
that O +
Antileukinate O +
is O +
also O +
active O +
in O +
the O +
murine O +
system O +
. O +

When O +
Antileukinate O +
was O +
tested O +
in O +
ovalbumin B-Gene +
- O +
induced O +
airway O +
inflammation O +
model O +
in O +
vivo O +
, O +
Antileukinate O +
significantly O +
inhibited O +
eosinophil O +
accumulation O +
and O +
allergen O +
- O +
induced O +
increase O +
in O +
total O +
protein O +
in O +
bronchoalveolar O +
lavage O +
fluids O +
. O +

Furthermore O +
, O +
Antileukinate O +
suppressed O +
fibrous O +
thickening O +
of O +
submucosal O +
tissue O +
induced O +
by O +
chronic O +
antigen O +
challenge O +
. O +

These O +
results O +
suggest O +
that O +
eotaxin B-Gene +
is O +
involved O +
in O +
the O +
pathogenesis O +
of O +
eosinophilic O +
airway O +
inflammation O +
, O +
and O +
that O +
Antileukinate O +
may O +
be O +
a O +
promising O +
tool O +
to O +
control O +
allergic O +
diseases O +
. O +

Glutamine O +
decreases O +
lipopolysaccharide O +
- O +
induced O +
IL-8 B-Gene +
production O +
in O +
Caco-2 O +
cells O +
through O +
a O +
non O +
- O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
p50 I-Gene +
mechanism O +
. O +

Glutamine O +
( O +
Gln O +
) O +
supplementation O +
has O +
been O +
shown O +
to O +
decrease O +
production O +
of O +
pro O +
- O +
inflammatory O +
cytokines B-Gene +
by O +
the O +
human O +
intestinal O +
mucosa O +
. O +

The O +
mechanism O +
of O +
this O +
is O +
poorly O +
understood O +
. O +

We O +
hypothesize O +
that O +
Gln O +
down O +
- O +
regulates O +
lipopolysaccharide O +
( O +
LPS O +
) O +
- O +
stimulated O +
pro O +
- O +
inflammatory O +
cytokine B-Gene +
production O +
in O +
Caco-2 O +
cells O +
by O +
nuclear B-Gene +
factor I-Gene +
- I-Gene +
kappa I-Gene +
B I-Gene +
( O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
) O +
. O +

Caco-2 O +
cells O +
were O +
incubated O +
with O +
different O +
concentrations O +
of O +
Gln O +
with O +
or O +
without O +
methionine O +
sulfoximine O +
( O +
MS O +
, O +
an O +
inhibitor O +
of O +
glutamine B-Gene +
synthetase I-Gene +
) O +
before O +
stimulation O +
with O +
LPS O +
. O +

IL-6 B-Gene +
, O +
IL-8 B-Gene +
, O +
IL-10 B-Gene +
and O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
protein O +
and O +
mRNA O +
level O +
were O +
determined O +
. O +

NF B-Gene -
- I-Gene -
kappaB I-Gene +
translocation O +
was O +
determined O +
using O +
an O +
ELISA O +
- O +
based O +
kit O +
. O +

IL-8 B-Gene +
was O +
the O +
only O +
detectable O +
cytokine B-Gene +
/ O +
chemokine B-Gene +
. O +

The O +
largest O +
amount O +
of O +
IL-8 B-Gene +
was O +
secreted O +
by O +
cells O +
in O +
the O +
presence O +
of O +
MS O +
with O +
no O +
Gln O +
in O +
the O +
medium O +
after O +
exposure O +
to O +
LPS O +
. O +

LPS O +
increased O +
IL-8 B-Gene +
production O +
, O +
peaking O +
10h O +
after O +
LPS O +
administration O +
. O +

The O +
addition O +
of O +
Gln O +
( O +
0.5 O +
or O +
5.0mM O +
) O +
decreased O +
IL-8 B-Gene +
peptide O +
and O +
mRNA O +
expression O +
. O +

LPS O +
increased O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
nuclear O +
translocation O +
in O +
the O +
presence O +
or O +
absence O +
of O +
MS O +
. O +

Neither O +
Gln O +
nor O +
MS O +
altered O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
nuclear O +
translocation O +
. O +

These O +
results O +
indicate O +
that O +
the O +
lack O +
of O +
glutamine O +
increases O +
IL-8 B-Gene +
production O +
by O +
Caco-2 O +
cells O +
after O +
LPS O +
stimulation O +
. O +

However O +
, O +
the O +
glutamine O +
- O +
mediated O +
decrease O +
in O +
LPS O +
- O +
stimulated O +
IL-8 B-Gene +
production O +
is O +
not O +
associated O +
with O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
p50 I-Gene +
nuclear O +
binding O +
. O +

IRAK B-Gene +
- O +
dependent O +
phosphorylation O +
of O +
Stat1 B-Gene +
on O +
serine O +
727 O +
in O +
response O +
to O +
interleukin-1 B-Gene +
and O +
effects O +
on O +
gene O +
expression O +
. O +

Interleukin-1 B-Gene +
( O +
IL-1 B-Gene +
) O +
induces O +
the O +
phosphorylation O +
of O +
Stat1 B-Gene +
on O +
serine O +
727 O +
but O +
not O +
on O +
tyrosine O +
701 O +
. O +

Analyses O +
of O +
mutant O +
I1A O +
cells O +
, O +
which O +
lack O +
the O +
IL-1 B-Gene +
receptor I-Gene +
- I-Gene +
associated I-Gene +
kinase I-Gene +
( O +
IRAK B-Gene +
) O +
, O +
and O +
of O +
I1A O +
cells O +
reconstituted O +
with O +
deletion O +
mutants O +
of O +
IRAK B-Gene +
show O +
that O +
the O +
IL-1 B-Gene +
- O +
mediated O +
phosphorylation O +
of O +
Stat1 B-Gene +
on O +
serine O +
requires O +
the O +
IRAK B-Gene +
protein O +
but O +
not O +
its O +
kinase B-Gene +
activity O +
and O +
does O +
not O +
involve O +
phosphatidylinositol-3'-kinase B-Gene +
( O +
PI3 B-Gene -
K I-Gene +
) O +
or O +
the O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
( I-Gene +
MAP I-Gene +
) I-Gene +
kinases I-Gene +
p38 B-Gene +
or O +
ERK B-Gene +
. O +

IRAK B-Gene +
and O +
Stat1 B-Gene +
interact O +
in O +
vivo O +
, O +
and O +
this O +
interaction O +
is O +
increased O +
in O +
response O +
to O +
IL-1 B-Gene +
, O +
suggesting O +
that O +
IRAK B-Gene +
may O +
serve O +
to O +
recruit O +
the O +
as O +
yet O +
unknown O +
IL-1 B-Gene +
- O +
induced O +
Stat1 B-Gene +
serine B-Gene +
kinase I-Gene +
. O +

Chemical O +
inhibitors O +
or O +
dominant O +
- O +
negative O +
forms O +
of O +
signaling O +
components O +
required O +
to O +
activate O +
NF B-Gene -
- I-Gene -
kappa I-Gene +
B I-Gene +
, O +
ATF B-Gene +
, O +
or O +
AP-1 B-Gene +
in O +
response O +
to O +
IL-1 B-Gene +
do O +
not O +
affect O +
the O +
phosphorylation O +
of O +
Stat1 B-Gene +
on O +
serine O +
. O +

IL-1 B-Gene +
and O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
( O +
TNF B-Gene +
) O +
enhance O +
the O +
serine O +
phosphorylation O +
of O +
Stat1 B-Gene +
that O +
occurs O +
in O +
response O +
to O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
( O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
and O +
potentiate O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
- O +
mediated O +
, O +
Stat1 B-Gene +
- O +
driven O +
gene O +
expression O +
, O +
thus O +
contributing O +
to O +
the O +
synergistic O +
activities O +
of O +
these O +
proinflammatory O +
cytokines B-Gene +
. O +

Structural O +
and O +
biochemical O +
dissection O +
of O +
photorespiration O +
in O +
hybrids O +
differing O +
in O +
genome O +
constitution O +
between O +
Diplotaxis O +
tenuifolia O +
( O +
C3-C4 O +
) O +
and O +
radish O +
( O +
C3 O +
) O +
. O +

We O +
compared O +
the O +
structural O +
, O +
biochemical O +
, O +
and O +
physiological O +
characteristics O +
involved O +
in O +
photorespiration O +
of O +
intergeneric O +
hybrids O +
differing O +
in O +
genome O +
constitution O +
( O +
DtDtR O +
, O +
DtDtRR O +
, O +
and O +
DtRR O +
) O +
between O +
the O +
C O -
( O -
3 O -
) O -
-C O -
( O -
4 O -
) O +
intermediate O +
species O +
Diplotaxis O +
tenuifolia O +
( O +
DtDt O +
) O +
and O +
the O +
C O -
( O -
3 O -
) O +
species O +
radish O +
( O +
Raphanus O +
sativus O +
; O +
RR O +
) O +
. O +

The O +
bundle O +
sheath O +
( O +
BS O +
) O +
cells O +
in O +
D. O +
tenuifolia O +
included O +
many O +
centripetally O +
located O +
chloroplasts O +
and O +
mitochondria O +
, O +
but O +
those O +
of O +
radish O +
had O +
only O +
a O +
few O +
chloroplasts O +
and O +
mitochondria O +
. O +

In O +
the O +
hybrids O +
, O +
the O +
numbers O +
of O +
chloroplasts O +
and O +
mitochondria O +
, O +
the O +
ratio O +
of O +
centripetally O +
located O +
organelles O +
to O +
total O +
organelles O +
, O +
and O +
the O +
mitochondrial O +
size O +
in O +
the O +
BS O +
cells O +
increased O +
with O +
an O +
increase O +
in O +
the O +
constitution O +
ratio O +
of O +
the O +
Dt O +
: O +
R O +
genome O +
. O +

The O +
P B-Gene -
- I-Gene -
protein I-Gene +
of I-Gene +
glycine I-Gene +
decarboxylase I-Gene +
( O +
GDC B-Gene +
) O +
was O +
confined O +
to O +
the O +
BS O +
mitochondria O +
in O +
D. O +
tenuifolia O +
, O +
whereas O +
in O +
radish O +
, O +
it O +
accumulated O +
more O +
densely O +
in O +
the O +
mesophyll O +
than O +
in O +
the O +
BS O +
mitochondria O +
. O +

In O +
the O +
hybrids O +
, O +
more O +
intense O +
accumulation O +
of O +
GDC B-Gene +
in O +
the O +
BS O +
relative O +
to O +
the O +
mesophyll O +
mitochondria O +
occurred O +
with O +
an O +
increase O +
in O +
the O +
Dt O +
: O +
R O +
ratio O +
. O +

These O +
structural O +
and O +
biochemical O +
features O +
in O +
the O +
hybrids O +
were O +
reflected O +
in O +
the O +
gas O +
exchange O +
characteristics O +
of O +
leaves O +
, O +
such O +
as O +
the O +
CO O +
( O +
2 O +
) O +
compensation O +
point O +
. O +

Our O +
data O +
indicate O +
that O +
the O +
leaf O +
structure O +
, O +
the O +
intercellular O +
pattern O +
of O +
GDC B-Gene +
expression O +
, O +
and O +
the O +
gas O +
exchange O +
characteristics O +
of O +
C O +
( O +
3 O +
) O +
- O +
C O +
( O +
4 O +
) O +
intermediate O +
photosynthesis O +
are O +
inherited O +
in O +
the O +
hybrids O +
depending O +
on O +
the O +
constitution O +
ratio O +
of O +
the O +
parent O +
genomes O +
. O +

Our O +
findings O +
also O +
demonstrate O +
that O +
the O +
apparent O +
reduced O +
photorespiration O +
in O +
C O -
( O -
3 O -
) O -
-C O -
( O -
4 O -
) O +
intermediate O +
plants O +
is O +
mainly O +
due O +
to O +
the O +
structural O +
differentiation O +
of O +
mitochondria O +
and O +
chloroplasts O +
in O +
the O +
BS O +
cells O +
combined O +
with O +
the O +
BS O +
- O +
dominant O +
expression O +
of O +
GDC B-Gene +
. O +

Expression O +
of O +
3beta B-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
and O +
P450 B-Gene +
side I-Gene +
chain I-Gene +
cleavage I-Gene +
enzyme O +
in O +
the O +
human O +
uterine O +
endometrium O +
. O +

The O +
enzyme O +
complex O +
3beta B-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
/ I-Gene +
Delta5 I-Gene +
- I-Gene +
Delta4 I-Gene +
- I-Gene +
isomerase I-Gene +
( O +
3beta B-Gene -
- I-Gene -
HSD I-Gene +
) O +
is O +
involved O +
in O +
the O +
biosynthesis O +
of O +
all O +
classes O +
of O +
active O +
steroids O +
. O +

The O +
expression O +
of O +
3b B-Gene -
- I-Gene -
HSD I-Gene +
in O +
human O +
uterine O +
endometrium O +
during O +
the O +
menstrual O +
cycle O +
and O +
decidua O +
was O +
examined O +
in O +
an O +
effort O +
to O +
understand O +
its O +
role O +
during O +
ova O +
implantation O +
. O +

3beta B-Gene -
- I-Gene -
HSD I-Gene +
was O +
weakly O +
expressed O +
in O +
the O +
glandular O +
epithelium O +
of O +
the O +
proliferative O +
phase O +
and O +
moderately O +
expressed O +
in O +
the O +
glandular O +
epithelium O +
of O +
secretory O +
phase O +
of O +
the O +
endometrium O +
. O +

In O +
the O +
decidua O +
of O +
the O +
ectopic O +
pregnancy O +
, O +
3beta B-Gene -
- I-Gene -
HSD I-Gene +
was O +
strongly O +
expressed O +
. O +

The O +
human O +
uterine O +
endometrial O +
3beta B-Gene -
- I-Gene -
HSD I-Gene +
was O +
identified O +
as O +
being O +
the O +
same O +
type O +
as O +
the O +
placental O +
3beta B-Gene -
- I-Gene -
HSD I-Gene +
by O +
RT O +
- O +
PCR O +
and O +
sequence O +
analysis O +
. O +

In O +
addition O +
to O +
the O +
expression O +
of O +
3beta B-Gene -
- I-Gene -
HSD I-Gene +
, O +
P450scc B-Gene +
was O +
expressed O +
in O +
the O +
decidua O +
of O +
the O +
ectopic O +
pregnancy O +
. O +

These O +
results O +
suggest O +
that O +
pregnenolone O +
might O +
be O +
synthesized O +
from O +
cholesterol O +
by O +
P450scc B-Gene +
de O +
novo O +
and O +
then O +
, O +
it O +
is O +
converted O +
to O +
progesterone O +
by O +
3beta B-Gene -
- I-Gene -
HSD I-Gene +
in O +
the O +
uterine O +
endometrium O +
. O +

The O +
data O +
implies O +
that O +
the O +
endometrial O +
3beta B-Gene -
- I-Gene -
HSD I-Gene +
can O +
use O +
not O +
only O +
the O +
out O +
- O +
coming O +
pregnenolone O +
from O +
the O +
adrenal O +
gland O +
but O +
also O +
the O +
self O +
- O +
made O +
pregnenolone O +
to O +
produce O +
progesterone O +
. O +

The O +
de O +
novo O +
synthesis O +
of O +
progesterone O +
in O +
the O +
endometrium O +
might O +
be O +
a O +
crucial O +
factor O +
for O +
implantation O +
and O +
maintenance O +
of O +
pregnancy O +
. O +

RcsCDB B-Gene +
His O +
- O +
Asp O +
phosphorelay O +
system O +
negatively O +
regulates O +
the O +
flhDC B-Gene +
operon I-Gene +
in O +
Escherichia O +
coli O +
. O +

The O +
genes O +
involved O +
in O +
flagellum O +
synthesis O +
, O +
motility O +
and O +
chemotaxis O +
in O +
Escherichia O +
coli O +
are O +
expressed O +
in O +
a O +
hierarchical O +
fashion O +
. O +

At O +
the O +
top O +
of O +
the O +
hierarchy O +
lies O +
the O +
master O +
regulator O +
FlhDC B-Gene +
, O +
required O +
for O +
the O +
expression O +
of O +
the O +
whole O +
set O +
of O +
genes O +
. O +

The O +
operon B-Gene +
flhDC I-Gene +
is O +
controlled O +
by O +
numerous O +
regulators O +
including O +
H B-Gene -
- I-Gene -
NS I-Gene +
, O +
CRP B-Gene +
, O +
EnvZ B-Gene +
/ O +
OmpR B-Gene +
, O +
QseBC B-Gene +
and O +
LrhA B-Gene +
. O +

In O +
the O +
present O +
work O +
, O +
we O +
report O +
that O +
the O +
flhDC B-Gene +
operon I-Gene +
is O +
also O +
negatively O +
regulated O +
by O +
the O +
His O +
- O +
Asp O +
phosphorelay O +
system O +
RcsCDB B-Gene +
. O +

The O +
regulation O +
is O +
potentiated O +
by O +
the O +
RcsB B-Gene +
cofactor O +
RcsA B-Gene +
. O +

Genetic O +
analysis O +
indicates O +
that O +
an O +
RcsAB B-Gene +
box O +
, O +
located O +
downstream O +
of O +
the O +
promoter O +
, O +
is O +
required O +
for O +
the O +
regulation O +
. O +

The O +
binding O +
of O +
RcsB B-Gene +
and O +
RcsA B-Gene +
to O +
this O +
site O +
was O +
demonstrated O +
by O +
gel O +
retardation O +
and O +
DNase B-Gene +
I I-Gene +
protection O +
assays O +
. O +

In O +
addition O +
, O +
mutation O +
analysis O +
suggests O +
that O +
RcsA B-Gene +
- O +
specific O +
determinants O +
lie O +
in O +
the O +
right O +
part O +
of O +
the O +
' O +
RcsAB B-Gene +
box O +
' O +
. O +

Transcriptional O +
expression O +
of O +
Escherichia O +
coli O +
glutamate O +
- O +
dependent O +
acid O +
resistance O +
genes O +
gadA B-Gene +
and O +
gadBC B-Gene +
in O +
an O +
hns B-Gene +
rpoS B-Gene +
mutant O +
. O +

Resistance O +
to O +
being O +
killed O +
by O +
acidic O +
environments O +
with O +
pH O +
values O +
lower O +
than O +
3 O +
is O +
an O +
important O +
feature O +
of O +
both O +
pathogenic O +
and O +
nonpathogenic O +
Escherichia O +
coli O +
. O +

The O +
most O +
potent O +
E. O +
coli O +
acid O +
resistance O +
system O +
utilizes O +
two O +
isoforms O +
of O +
glutamate B-Gene +
decarboxylase I-Gene +
encoded O +
by O +
gadA B-Gene +
and O +
gadB B-Gene +
and O +
a O +
putative O +
glutamate B-Gene +
: I-Gene +
gamma I-Gene -
- I-Gene -
aminobutyric I-Gene +
acid I-Gene +
antiporter I-Gene +
encoded O +
by O +
gadC B-Gene +
. O +

The O +
gad B-Gene +
system O +
is O +
controlled O +
by O +
two O +
repressors O +
( O +
H B-Gene -
- I-Gene -
NS I-Gene +
and O +
CRP B-Gene +
) O +
, O +
one O +
activator O +
( O +
GadX B-Gene +
) O +
, O +
one O +
repressor O +
- O +
activator O +
( O +
GadW B-Gene +
) O +
, O +
and O +
two O +
sigma B-Gene +
factors I-Gene +
( O +
sigma B-Gene -
( I-Gene -
S I-Gene -
) I-Gene +
and O +
sigma B-Gene +
( I-Gene +
70 I-Gene +
) I-Gene +
) O +
. O +

In O +
contrast O +
to O +
results O +
of O +
previous O +
reports O +
, O +
we O +
demonstrate O +
that O +
gad B-Gene +
transcription O +
can O +
be O +
detected O +
in O +
an O +
hns B-Gene +
rpoS B-Gene +
mutant O +
strain O +
of O +
E. O +
coli O +
K-12 O +
, O +
indicating O +
that O +
gad B-Gene +
promoters O +
can O +
be O +
initiated O +
by O +
sigma B-Gene -
( I-Gene -
70 I-Gene -
) I-Gene +
in O +
the O +
absence O +
of O +
H B-Gene -
- I-Gene -
NS I-Gene +
. O +

[ O +
Construction O +
and O +
stable O +
expression O +
of O +
intracellular O +
antibodies O +
to O +
glycoprotein O +
of O +
hantavirus O +
] O +

OBJECTIVE O +
: O +

To O +
understand O +
the O +
molecular O +
mechanisms O +
of O +
hantavirus O +
assembly O +
and O +
maturation O +
by O +
stably O +
expressing O +
the O +
intracellular O +
antibodies O +
to O +
hantavirus O +
glycoprotein B-Gene +
G1 I-Gene +
and I-Gene +
G2 I-Gene +
in O +
endoplasmic O +
reticulum O +
( O +
ER O +
) O +
and O +
cytoplasm O +
( O +
Cyto O +
) O +
of O +
Vero O +
E6 O +
cell O +
. O +

METHODS O +
: O +

The O +
genes O +
of O +
VH O +
and O +
VL O +
of O +
antibodies O +
against O +
glycoprotein O +
of O +
hantavirus O +
were O +
amplified O +
by O +
PCR O +
and O +
cloned O +
into O +
pOPE O +
101 O +
- O +
215 O +
( O +
Yol O +
) O +
vector O +
. O +

The O +
G1 B-Gene +
and O +
G2 B-Gene +
proteins O +
specific O +
ScFv O +
genes O +
were O +
first O +
expressed O +
in O +
E.coli O +
and O +
the O +
function O +
and O +
binding O +
properties O +
were O +
identified O +
. O +

The O +
gene O +
of O +
ScFv O +
were O +
further O +
inserted O +
into O +
intracellular O +
expression O +
vectyrs O +
pEF O +
/ O +
myc B-Gene +
/ O +
ER O +
and O +
pEF O +
/ O +
myc B-Gene +
/ O +
CYTO O +
vector O +
and O +
transfected O +
Vero O +
E6 O +
cell O +
. O +

The O +
clonal O +
cell O +
line O +
which O +
stabl O +
expresses O +
ScFv O +
were O +
isolated O +
under O +
the O +
pressure O +
of O +
G418 O +
. O +

RESULTS O +
: O +

The O +
ScFv O +
genes O +
of O +
hantavirus O +
G1 B-Gene +
and O +
G2 B-Gene +
specific O +
antibodies O +
were O +
successfully O +
expressed O +
in O +
subcellular O +
compartment O +
ER O +
and O +
Cyto O +
of O +
Vero O +
E6 O +
cells O +
and O +
specifically O +
targeted O +
G1 B-Gene +
and O +
G2 B-Gene +
protein O +
after O +
virus O +
infection O +
of O +
the O +
cells O +
. O +

CONCLUSIONS O +
: O +

The O +
recombination O +
of O +
intrabody O +
to O +
Hantann O +
virus O +
glycoprotein O +
was O +
constructed O +
successfully O +
, O +
and O +
it O +
may O +
provide O +
basic O +
material O +
for O +
the O +
studying O +
antiviral O +
gene O +
therapy O +
and O +
the O +
molecular O +
mechanism O +
of O +
viral O +
replication O +
and O +
infection O +
. O +

Cellular O +
mechanisms O +
of O +
the O +
hemostatic O +
effects O +
of O +
desmopressin O +
( O +
DDAVP O +
) O +
. O +

The O +
synthetic O +
analog O +
of O +
vasopressin B-Gene +
desmopressin O +
( O +
DDAVP O +
) O +
is O +
widely O +
used O +
for O +
the O +
treatment O +
of O +
patients O +
with O +
von O +
Willebrand O +
disease O +
( O +
VWD O +
) O +
, O +
hemophilia O +
A O +
, O +
several O +
platelet O +
disorders O +
, O +
and O +
uremic O +
bleeding O +
. O +

DDAVP O +
induces O +
an O +
increase O +
in O +
plasma O +
levels O +
of O +
von B-Gene +
Willebrand I-Gene +
factor I-Gene +
( O +
VWF B-Gene +
) O +
, O +
coagulation B-Gene +
factor I-Gene +
VIII I-Gene +
( O +
FVIII B-Gene +
) O +
, O +
and O +
tissue B-Gene +
plasminogen I-Gene +
activator I-Gene +
( O +
t B-Gene -
- I-Gene -
PA I-Gene +
) O +
. O +

It O +
also O +
has O +
a O +
vasodilatory O +
action O +
. O +

In O +
spite O +
of O +
its O +
extensive O +
clinical O +
use O +
, O +
its O +
cellular O +
mechanism O +
of O +
action O +
remains O +
incompletely O +
understood O +
. O +

Its O +
effect O +
on O +
VWF B-Gene +
and O +
t B-Gene -
- I-Gene -
PA I-Gene +
as O +
well O +
as O +
its O +
vasodilatory O +
effect O +
are O +
likely O +
explained O +
by O +
a O +
direct O +
action O +
on O +
the O +
endothelium O +
, O +
via O +
activation O +
of O +
endothelial O +
vasopressin B-Gene +
V2R I-Gene +
receptor I-Gene +
and O +
cAMP O +
- O +
mediated O +
signaling O +
. O +

This O +
leads O +
to O +
exocytosis O +
from O +
Weibel O +
Palade O +
bodies O +
where O +
both O +
VWF B-Gene +
and O +
t B-Gene -
- I-Gene -
PA I-Gene +
are O +
stored O +
, O +
as O +
well O +
as O +
to O +
nitric O +
oxide O +
( O +
NO O +
) O +
production O +
via O +
activation O +
of O +
endothelial B-Gene +
NO I-Gene +
synthase I-Gene +
. O +

The O +
mechanism O +
of O +
action O +
of O +
DDAVP O +
on O +
FVIII B-Gene +
plasma O +
levels O +
remains O +
to O +
be O +
elucidated O +
. O +

The O +
hemostatic O +
effect O +
of O +
DDAVP O +
likely O +
involves O +
additional O +
cellular O +
effects O +
that O +
remain O +
to O +
be O +
discovered O +
. O +

Abnormal O +
killer O +
inhibitory O +
receptor O +
expression O +
on O +
natural O +
killer O +
cells O +
in O +
patients O +
with O +
BehÃ?Â§et O +
's O +
disease O +
. O +

Viral O +
infection O +
has O +
been O +
assigned O +
some O +
role O +
in O +
the O +
pathogenesis O +
of O +
BehÃ?Â§et O +
's O +
disease O +
( O +
BD O +
) O +
. O +

Defects O +
in O +
natural O +
killer O +
( O +
NK O +
) O +
cell O +
repertoire O +
may O +
be O +
involved O +
in O +
impaired O +
antiviral O +
immunity O +
, O +
leading O +
to O +
the O +
development O +
of O +
BD O +
. O +

We O +
studied O +
killer O +
inhibitory O +
receptor O +
( O +
KIR B-Gene +
) O +
expression O +
in O +
40 O +
patients O +
with O +
BD O +
. O +

CD94 B-Gene +
and O +
CD158b B-Gene +
expression O +
of O +
NK O +
cells O +
was O +
normal O +
in O +
a O +
great O +
majority O +
of O +
BD O +
patients O +
. O +

NKB1 B-Gene +
expression O +
was O +
reduced O +
in O +
eight O +
and O +
increased O +
in O +
six O +
. O +

Twelve O +
of O +
these O +
14 O +
patients O +
( O +
86 O +
% O +
) O +
had O +
severe O +
eye O +
disease O +
. O +

Some O +
had O +
reduced O +
NKB1 B-Gene +
and O +
enhanced O +
CD158a B-Gene +
expression O +
simultaneously O +
, O +
or O +
enhanced O +
NKB1 B-Gene +
and O +
reduced O +
CD158a B-Gene +
simultaneously O +
, O +
suggesting O +
a O +
skewed O +
NK O +
cell O +
repertoire O +
in O +
BD O +
. O +

Collectively O +
, O +
KIR B-Gene +
expression O +
was O +
abnormal O +
in O +
the O +
BD O +
patients O +
with O +
severe O +
eye O +
disease O +
. O +

This O +
may O +
result O +
from O +
genetic O +
predisposition O +
, O +
or O +
certain O +
viruses O +
may O +
affect O +
the O +
KIR B-Gene +
repertoire O +
formation O +
in O +
BD O +
patients O +
. O +

Abnormal O +
KIR B-Gene +
expression O +
of O +
NK O +
cells O +
may O +
be O +
associated O +
with O +
the O +
development O +
of O +
BD O +
. O +

Impact O +
of O +
PGE1 O +
on O +
cyclosporine O +
A O +
induced O +
up O +
- O +
regulation O +
of O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
, O +
its O +
receptors O +
, O +
and O +
related O +
matrix O +
production O +
in O +
cultured O +
mesangial O +
cells O +
. O +

Transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
beta1 I-Gene +
( O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
) O +
plays O +
a O +
major O +
role O +
in O +
cyclosporine O +
A O +
( O +
CsA O +
) O +
induced O +
glomerulosclerosis O +
. O +

We O +
have O +
recently O +
shown O +
that O +
CsA O +
up O +
- O +
regulates O +
the O +
expression O +
of O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
and O +
its O +
receptors O +
type O +
I O +
( O +
TbetaR B-Gene -
- I-Gene -
I I-Gene +
) O +
and O +
type O +
II O +
( O +
TbetaR B-Gene -
- I-Gene -
II I-Gene +
) O +
in O +
rat O +
mesangial O +
cells O +
( O +
MCs O +
) O +
. O +

Prostaglandins O +
of O +
the O +
E O +
series O +
( O +
PGEs O +
) O +
are O +
known O +
to O +
exert O +
substantial O +
anti O +
- O +
fibrotic O +
effects O +
. O +

Here O +
, O +
we O +
assessed O +
the O +
effect O +
of O +
PGE1 O +
on O +
CsA O +
induced O +
up O +
- O +
regulation O +
of O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
, O +
TbetaR B-Gene -
- I-Gene -
I I-Gene +
, O +
TbetaR B-Gene -
- I-Gene -
II I-Gene +
and O +
related O +
matrix O +
production O +
in O +
MCs O +
. O +

Co O +
- O +
incubation O +
with O +
PGE1 O +
reduced O +
CsA O +
induced O +
up O +
- O +
regulation O +
of O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
and O +
TbetaR B-Gene -
- I-Gene -
II I-Gene +
at O +
the O +
mRNA O +
and O +
protein O +
level O +
. O +

Alike O +
, O +
PGE1 O +
reduced O +
TbetaR B-Gene -
- I-Gene -
I I-Gene +
protein O +
expression O +
, O +
which O +
is O +
posttranscriptionally O +
up O +
- O +
regulated O +
by O +
CsA O +
. O +

Whereas O +
a O +
low O +
PGE O -
( O -
1 O -
) O +
concentration O +
decreased O +
CsA O +
induced O +
production O +
of O +
fibronectin B-Gene +
( O +
FN B-Gene +
) O +
and O +
plasminogen B-Gene +
activator I-Gene +
inhibitor I-Gene +
type-1 I-Gene +
( O +
PAI-1 B-Gene +
) O +
, O +
a O +
higher O +
PGE1 O +
concentration O +
did O +
not O +
change O +
FN B-Gene +
production O +
, O +
but O +
further O +
increased O +
PAI-1 B-Gene +
production O +
. O +

In O +
vivo O +
studies O +
will O +
show O +
, O +
whether O +
treatment O +
with O +
PGE1 O +
analogues O +
will O +
be O +
useful O +
in O +
preventing O +
CsA O +
induced O +
glomerulosclerosis O +
. O +

YodA B-Gene +
from O +
Escherichia O +
coli O +
is O +
a O +
metal O +
- O +
binding O +
, O +
lipocalin B-Gene +
- O +
like O +
protein O +
. O +

We O +
have O +
determined O +
the O +
crystal O +
structure O +
of O +
YodA B-Gene +
, O +
an O +
Escherichia O +
coli O +
protein O +
of O +
unknown O +
function O +
. O +

YodA B-Gene +
had O +
been O +
identified O +
under O +
conditions O +
of O +
cadmium O +
stress O +
, O +
and O +
we O +
confirm O +
that O +
it O +
binds O +
metals O +
such O +
as O +
cadmium O +
and O +
zinc O +
. O +

We O +
have O +
also O +
found O +
nickel O +
bound O +
in O +
one O +
of O +
the O +
crystal O +
forms O +
. O +

YodA B-Gene +
is O +
composed O +
of O +
two O +
domains O +
: O +
a O +
main O +
lipocalin B-Gene +
/ O +
calycin B-Gene +
- O +
like O +
domain O +
and O +
a O +
helical O +
domain O +
. O +

The O +
principal O +
metal O +
- O +
binding O +
site O +
lies O +
on O +
one O +
side O +
of O +
the O +
calycin B-Gene +
domain O +
, O +
thus O +
making O +
YodA B-Gene +
the O +
first O +
metal O +
- O +
binding O +
lipocalin B-Gene +
known O +
. O +

Our O +
experiments O +
suggest O +
that O +
YodA B-Gene +
expression O +
may O +
be O +
part O +
of O +
a O +
more O +
general O +
stress O +
response O +
. O +

From O +
sequence O +
analogy O +
with O +
the O +
C O +
- O +
terminal O +
domain O +
of O +
a O +
metal O +
- O +
binding O +
receptor O +
of O +
a O +
member O +
of O +
bacterial O +
ATP B-Gene +
- I-Gene +
binding I-Gene +
cassette I-Gene +
transporters I-Gene +
, O +
we O +
propose O +
a O +
three O +
- O +
dimensional O +
model O +
for O +
this O +
receptor O +
and O +
suggest O +
that O +
YodA B-Gene +
may O +
have O +
a O +
receptor O +
- O +
type O +
partner O +
in O +
E. O +
coli O +
. O +

Identification O +
of O +
mutans O +
streptococci O +
by O +
restriction O +
fragment O +
length O +
polymorphism O +
analysis O +
of O +
polymerase O +
chain O +
reaction O +
- O +
amplified O +
16S O +
ribosomal O +
RNA O +
genes O +
. O +

Mutans O +
streptococci O +
are O +
frequently O +
isolated O +
from O +
dental O +
plaque O +
and O +
carious O +
lesions O +
. O +

These O +
bacteria O +
have O +
been O +
identified O +
by O +
conventional O +
methods O +
such O +
as O +
biochemical O +
and O +
serologic O +
tests O +
followed O +
by O +
the O +
isolation O +
of O +
colonies O +
on O +
the O +
mitis O +
- O +
salivarius O +
agar O +
, O +
which O +
are O +
sometimes O +
inconsistent O +
. O +

Recently O +
, O +
species O +
- O +
specific O +
polymerase O +
chain O +
reaction O +
( O +
PCR O +
) O +
has O +
been O +
reported O +
to O +
rapidly O +
identify O +
Streptococcus O +
mutans O +
and O +
Streptococcus O +
sobrinus O +
. O +

However O +
, O +
in O +
the O +
case O +
of O +
identification O +
and O +
classification O +
into O +
several O +
species O +
, O +
e.g. O +
within O +
the O +
group O +
of O +
mutans O +
streptococci O +
consisting O +
of O +
seven O +
species O +
, O +
the O +
identification O +
using O +
species O +
- O +
specific O +
PCR O +
seems O +
somewhat O +
inefficient O +
because O +
of O +
need O +
for O +
the O +
development O +
and O +
preparation O +
of O +
specific O +
primers O +
for O +
each O +
species O +
. O +

Therefore O +
, O +
in O +
this O +
study O +
we O +
developed O +
a O +
simple O +
method O +
using O +
restriction O +
fragment O +
length O +
polymorphism O +
analysis O +
of O +
PCR O +
- O +
amplified O +
16S O +
ribosomal O +
RNA O +
genes O +
( O +
16S O +
rRNA O +
genes O +
PCR O +
- O +
RFLP O +
) O +
for O +
the O +
identification O +
of O +
seven O +
different O +
species O +
included O +
in O +
the O +
group O +
of O +
mutans O +
streptococci O +
. O +

We O +
amplified O +
16S O +
rRNA O +
gene O +
sequences O +
from O +
genomic O +
DNA O +
samples O +
by O +
PCR O +
using O +
universal O +
primers O +
and O +
digested O +
the O +
PCR O +
products O +
with O +
the O +
restriction B-Gene +
endonucleases I-Gene +
, O +
HpaII B-Gene +
and O +
HaeIII B-Gene +
. O +

HpaII B-Gene +
produced O +
six O +
RFLP O +
patterns O +
for O +
eight O +
reference O +
strains O +
, O +
since O +
the O +
patterns O +
for O +
S. O +
sobrinus O +
, O +
Streptococcus O +
downei O +
and O +
Streptococcus O +
ferus O +
were O +
similar O +
. O +

RFLP O +
patterns O +
produced O +
with O +
HaeIII B-Gene +
could O +
separate O +
these O +
three O +
species O +
. O +

Furthermore O +
, O +
the O +
RFLP O +
patterns O +
predicted O +
from O +
the O +
16S O +
rRNA O +
gene O +
sequences O +
in O +
the O +
GenBank O +
database O +
agreed O +
with O +
the O +
actual O +
RFLP O +
patterns O +
produced O +
in O +
the O +
present O +
study O +
. O +

The O +
16S O +
rRNA O +
sequence O +
comparisons O +
can O +
be O +
used O +
to O +
identify O +
oral O +
mutans O +
streptococci O +
; O +
however O +
, O +
the O +
identification O +
by O +
sequencing O +
is O +
sometimes O +
difficult O +
in O +
large O +
- O +
scale O +
studies O +
and O +
for O +
small O +
laboratories O +
. O +

Therefore O +
, O +
16S O +
rRNA O +
genes O +
PCR O +
- O +
RFLP O +
, O +
using O +
HpaII B-Gene +
and O +
HaeIII B-Gene +
, O +
could O +
be O +
an O +
alternative O +
method O +
for O +
the O +
identification O +
of O +
mutans O +
streptococci O +
, O +
and O +
may O +
be O +
applicable O +
for O +
large O +
- O +
scale O +
studies O +
on O +
the O +
cariogenicity O +
of O +
mutans O +
streptococci O +
. O +

MyoR B-Gene +
is O +
expressed O +
in O +
nonmyogenic O +
cells O +
and O +
can O +
inhibit O +
their O +
differentiation O +
. O +

The O +
development O +
of O +
skeletal O +
muscle O +
in O +
mammals O +
is O +
promoted O +
by O +
the O +
muscle O +
- O +
specific O +
basic O +
helix O +
- O +
loop O +
- O +
helix O +
transcription O +
factors O +
of O +
the O +
MyoD B-Gene +
family I-Gene +
. O +

Evidence O +
also O +
suggests O +
that O +
there O +
are O +
basic O +
helix O +
- O +
loop O +
- O +
helix O +
proteins O +
that O +
specifically O +
inhibit O +
skeletal O +
myogenesis O +
, O +
including O +
Mtwist B-Gene +
, O +
Mist1 B-Gene +
, O +
and O +
the O +
most O +
recently O +
described O +
, O +
MyoR B-Gene +
. O +

It O +
has O +
been O +
suggested O +
that O +
MyoR B-Gene +
expression O +
is O +
limited O +
to O +
the O +
precursors O +
of O +
the O +
skeletal O +
muscle O +
lineage O +
and O +
acts O +
as O +
a O +
transcriptional O +
repressor O +
of O +
the O +
muscle O +
differentiation O +
program O +
. O +

However O +
, O +
our O +
results O +
demonstrate O +
that O +
MyoR B-Gene +
is O +
expressed O +
in O +
several O +
different O +
, O +
nonmuscle O +
adult O +
tissues O +
. O +

Furthermore O +
, O +
MyoR B-Gene +
is O +
expressed O +
in O +
the O +
embryonic O +
ectoderm O +
of O +
blastocyst O +
stage O +
mouse O +
embryos O +
, O +
well O +
before O +
skeletal O +
muscle O +
specification O +
and O +
even O +
before O +
delineation O +
of O +
the O +
mesodermal O +
germ O +
layer O +
. O +

Using O +
embryonic O +
ectoderm O +
analogous O +
stem O +
cells O +
, O +
we O +
demonstrate O +
that O +
in O +
these O +
nonmuscle O +
cells O +
, O +
as O +
in O +
skeletal O +
muscle O +
precursor O +
cells O +
, O +
expression O +
of O +
MyoR B-Gene +
is O +
inversely O +
correlated O +
with O +
the O +
extent O +
of O +
cellular O +
differentiation O +
as O +
induced O +
by O +
retinoic O +
acid O +
. O +

Our O +
preliminary O +
results O +
indicate O +
that O +
overexpression O +
of O +
exogenous O +
MyoR B-Gene +
inhibits O +
retinoic O +
- O +
acid O +
- O +
induced O +
differentiation O +
in O +
EC O +
cells O +
and O +
is O +
lethal O +
to O +
early O +
mouse O +
embryos O +
. O +

Our O +
results O +
suggest O +
a O +
much O +
broader O +
role O +
for O +
MyoR B-Gene +
in O +
the O +
repression O +
and/or O +
determination O +
of O +
embryonic O +
cell O +
differentiation O +
. O +

[ O +
Construction O +
of O +
the O +
synthetic O +
genes O +
for O +
protein O +
analogs O +
of O +
spider O +
silk O +
carcass O +
spidroin B-Gene +
1 I-Gene +
and O +
their O +
expression O +
in O +
tobacco O +
plants O +
] O +

To O +
obtain O +
transgenic O +
tobacco O +
plants O +
expressing O +
recombinant O +
analogs O +
of O +
spider O +
dragline O +
silk O +
spidroin B-Gene +
1 I-Gene +
, O +
artificial O +
1f5 O +
and O +
1f9 O +
coding O +
for O +
spidroin B-Gene +
1 I-Gene +
analogs O +
were O +
3'-fused O +
in O +
- O +
frame O +
with O +
the O +
reporter O +
lichenase B-Gene +
gene O +
. O +

The O +
Tr2 O -
' O +
weak O +
constitutive O +
promoter O +
of O +
Agrobacterium O +
tumefaciens O +
T O -
- O -
DNA O +
and O +
the O +
strong O +
constitutive O +
promoter O +
of O +
the O +
cauliflower O +
mosaic O +
virus O +
35S O +
RNA O +
gene O +
were O +
used O +
as O +
regulatory O +
elements O +
. O +

The O +
expression O +
cassettes O +
were O +
used O +
to O +
transform O +
agrobacteria O +
and O +
then O +
introduced O +
in O +
tobacco O +
leaf O +
disks O +
. O +

On O +
evidence O +
of O +
Southern O +
hybridization O +
, O +
transgenic O +
plants O +
each O +
carried O +
a O +
single O +
copy O +
of O +
a O +
hybrid O +
gene O +
, O +
which O +
corresponded O +
in O +
size O +
to O +
the O +
constructed O +
one O +
. O +

Zymography O +
and O +
Western O +
blotting O +
revealed O +
full O +
- O +
length O +
hybrid O +
proteins O +
in O +
leaf O +
extracts O +
of O +
transgenic O +
plants O +
. O +

The O +
results O +
testified O +
that O +
plants O +
can O +
maintain O +
and O +
express O +
synthetic O +
genes O +
for O +
spider O +
silks O +
and O +
, O +
consequently O +
, O +
may O +
be O +
used O +
as O +
a O +
convenient O +
producer O +
of O +
recombinant O +
silk O +
analogs O +
. O +

Distinct O +
molecular O +
mechanisms O +
involved O +
in O +
carbon O +
catabolite O +
repression O +
of O +
the O +
arabinose O +
regulon O +
in O +
Bacillus O +
subtilis O +
. O +

The O +
Bacillus O +
subtilis O +
proteins O +
involved O +
in O +
the O +
utilization O +
of O +
L O -
- O -
arabinose O +
are O +
encoded O +
by O +
the O +
araABDLMNPQ B-Gene +
- O +
abfA B-Gene +
metabolic O +
operon O +
and O +
by O +
the O +
araE B-Gene +
/ O +
araR B-Gene +
divergent O +
unit O +
. O +

Transcription O +
from O +
the O +
ara B-Gene +
operon I-Gene +
, O +
araE B-Gene +
transport O +
gene O +
and O +
araR B-Gene +
regulatory O +
gene O +
is O +
induced O +
by O +
L O -
- O -
arabinose O +
and O +
negatively O +
controlled O +
by O +
AraR B-Gene +
. O +

Additionally O +
, O +
expression O +
of O +
both O +
the O +
ara B-Gene +
operon I-Gene +
and O +
the O +
araE B-Gene +
gene O +
is O +
regulated O +
at O +
the O +
transcriptional O +
level O +
by O +
glucose O +
repression O +
. O +

Here O +
, O +
by O +
transcriptional O +
fusion O +
analysis O +
in O +
different O +
mutant O +
backgrounds O +
, O +
it O +
is O +
shown O +
that O +
CcpA B-Gene +
most O +
probably O +
complexed O +
with O +
HPr B-Gene +
- O +
Ser46-P O +
plays O +
the O +
major O +
role O +
in O +
carbon O +
catabolite O +
repression O +
of O +
the O +
ara B-Gene +
regulon O +
by O +
glucose O +
and O +
glycerol O +
. O +

Site O +
- O +
directed O +
mutagenesis O +
and O +
deletion O +
analysis O +
indicate O +
that O +
two O +
catabolite O +
responsive O +
elements O +
( O +
cres O +
) O +
present O +
in O +
the O +
ara B-Gene +
operon I-Gene +
( O +
cre O +
araA B-Gene +
and O +
cre O +
araB B-Gene +
) O +
and O +
one O +
cre O +
in O +
the O +
araE B-Gene +
gene O +
( O +
cre O +
araE B-Gene +
) O +
are O +
implicated O +
in O +
this O +
mechanism O +
. O +

Furthermore O +
, O +
cre O +
araA B-Gene +
located O +
between O +
the O +
promoter O +
region O +
of O +
the O +
ara B-Gene +
operon I-Gene +
and O +
the O +
araA B-Gene +
gene O +
, O +
and O +
cre O +
araB B-Gene +
placed O +
2 O +
kb O +
downstream O +
within O +
the O +
araB B-Gene +
gene O +
are O +
independently O +
functional O +
and O +
both O +
contribute O +
to O +
glucose O +
repression O +
. O +

In O +
Northern O +
blot O +
analysis O +
, O +
in O +
the O +
presence O +
of O +
glucose O +
, O +
a O +
CcpA B-Gene +
- O +
dependent O +
transcript O +
consistent O +
with O +
a O +
message O +
stopping O +
at O +
cre O +
araB B-Gene +
was O +
detected O +
, O +
suggesting O +
that O +
transcription O +
' O -
roadblocking O -
' O +
of O +
RNA B-Gene +
polymerase I-Gene +
elongation O +
is O +
the O +
most O +
likely O +
mechanism O +
operating O +
in O +
this O +
system O +
. O +

Glucose O +
exerts O +
an O +
additional O +
repression O +
of O +
the O +
ara B-Gene +
regulon O +
, O +
which O +
requires O +
a O +
functional O +
araR B-Gene +
. O +

Gene O +
expression O +
of O +
type B-Gene +
2 I-Gene +
17 I-Gene +
beta I-Gene +
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
in O +
scalp O +
hairs O +
of O +
hirsute O +
women O +
. O +

Androgens O +
are O +
the O +
main O +
hormonal O +
regulators O +
of O +
human O +
hair O +
growth O +
and O +
they O +
are O +
related O +
to O +
clinical O +
conditions O +
such O +
as O +
hirsutism O +
. O +

The O +
aim O +
of O +
this O +
study O +
was O +
to O +
analyze O +
the O +
gene O +
expression O +
of O +
androgen B-Gene +
receptor I-Gene +
( O +
AR B-Gene +
) O +
and O +
type B-Gene +
2 I-Gene +
17 I-Gene +
beta I-Gene +
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
( O +
17 B-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
) O +
in O +
keratinocytes O +
of O +
plucked O +
scalp O +
hairs O +
from O +
hirsute O +
patients O +
and O +
normal O +
subjects O +
. O +

We O +
studied O +
58 O +
women O +
with O +
hirsutism O +
( O +
31 O +
with O +
polycystic O +
ovary O +
syndrome O +
( O +
PCOS O +
) O +
, O +
27 O +
with O +
idiopathic O +
hirsutism O +
( O +
IH O +
) O +
) O +
; O +
15 O +
control O +
women O +
; O +
and O +
10 O +
control O +
men O +
. O +

Hirsutism O +
was O +
assessed O +
by O +
a O +
modified O +
Ferriman O +
- O +
Gallwey O +
method O +
. O +

Hormonal O +
status O +
was O +
assessed O +
between O +
days O +
2 O +
and O +
10 O +
of O +
the O +
menstrual O +
cycle O +
or O +
on O +
any O +
day O +
when O +
the O +
patients O +
were O +
amenorrheic O +
. O +

AR B-Gene +
and O +
type B-Gene +
2 I-Gene +
17 I-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
mRNA O +
levels O +
were O +
estimated O +
by O +
reverse O +
transcription O +
- O +
polymerase B-Gene +
chain O +
reaction O +
( O +
RT O +
- O +
PCR O +
) O +
. O +

AR B-Gene +
expression O +
was O +
similar O +
in O +
all O +
groups O +
. O +

Type B-Gene +
2 I-Gene +
17 I-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
gene O +
expression O +
in O +
untreated O +
hirsute O +
patients O +
was O +
lower O +
( O +
2.1 O +
+ O -
/- O +
0.10 O +
) O +
than O +
in O +
normal O +
women O +
( O +
3.1 O +
+ O -
/- O +
0.17 O +
) O +
, O +
and O +
similar O +
to O +
men O +
( O +
1.8 O +
+ O -
/- O +
0.22 O +
) O +
. O +

Comparing O +
hirsute O +
patients O +
, O +
type B-Gene +
2 I-Gene +
17 I-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
expression O +
was O +
higher O +
in O +
treated O +
PCOS O +
( O +
3.0 O +
+ O -
/- O +
0.34 O +
versus O +
2.2 O +
+ O -
/- O +
0.13 O +
) O +
and O +
IH O +
patients O +
( O +
2.5 O +
+ O -
/- O +
0.19 O +
versus O +
2.0 O +
+ O -
/- O +
0.15 O +
) O +
; O +
hirsutism O +
score O +
was O +
lower O +
( O +
P O +
= O +
0.003 O +
, O +
PCOS O +
; O +
P O +
= O +
0.003 O +
, O +
IH O +
) O +
; O +
and O +
SHBG O +
levels O +
were O +
higher O +
( O +
P O +
= O +
0.001 O +
, O +
PCOS O +
; O +
P O +
= O +
0.024 O +
, O +
IH O +
) O +
in O +
treated O +
patients O +
. O +

The O +
free O +
androgen O +
index O +
was O +
lower O +
in O +
treated O +
women O +
( O +
P O +
= O +
0.024 O +
for O +
the O +
IH O +
group O +
) O +
. O +

In O +
conclusion O +
, O +
the O +
lower O +
expression O +
of O +
type B-Gene +
2 I-Gene +
17 I-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
mRNA O +
in O +
scalp O +
hairs O +
of O +
untreated O +
hirsute O +
patients O +
suggests O +
androgen O +
metabolism O +
disturbances O +
with O +
predominance O +
of O +
more O +
potent O +
androgens O +
, O +
as O +
occurs O +
in O +
men O +
. O +

The O +
enzyme O +
's O +
higher O +
gene O +
expression O +
in O +
treated O +
hirsute O +
patients O +
could O +
be O +
an O +
indirect O +
evidence O +
of O +
restored O +
enzyme O +
activity O +
and O +
intracellular O +
androgen O +
metabolism O +
. O +

Killer B-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
and O +
leukocyte B-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
transgenic O +
mice O +
exhibit O +
tissue O +
- O +
and O +
cell O +
- O +
specific O +
transgene O +
expression O +
. O +

To O +
generate O +
an O +
experimental O +
model O +
for O +
exploring O +
the O +
function O +
, O +
expression O +
pattern O +
, O +
and O +
developmental O +
regulation O +
of O +
human O +
Ig B-Gene +
- O +
like O +
activating O +
and O +
inhibitory O +
receptors O +
, O +
we O +
have O +
generated O +
transgenic O +
mice O +
using O +
two O +
human O +
genomic O +
clones O +
: O +
52N12 O +
( O +
a O +
150 O +
- O +
Kb O +
clone O +
encompassing O +
the O +
leukocyte B-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( I-Gene +
LILR I-Gene +
) I-Gene +
B1 I-Gene +
( O +
ILT2 B-Gene +
) O +
, O +
LILRB4 B-Gene +
( O +
ILT3 B-Gene +
) O +
, O +
and O +
LILRA1 B-Gene +
( O +
LIR6 B-Gene +
) O +
genes O +
) O +
and O +
1060P11 O +
( O +
a O +
160 O +
- O +
Kb O +
clone O +
that O +
contains O +
ten O +
killer B-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( O +
KIR B-Gene +
) O +
genes O +
) O +
. O +

Both O +
the O +
KIR B-Gene +
and I-Gene +
LILR I-Gene +
families I-Gene +
are O +
encoded O +
within O +
the O +
leukocyte O +
receptor O +
complex O +
, O +
and O +
are O +
involved O +
in O +
immune O +
modulation O +
. O +

We O +
have O +
also O +
produced O +
a O +
novel O +
mAb O +
to O +
LILRA1 B-Gene +
to O +
facilitate O +
expression O +
studies O +
. O +

The O +
LILR B-Gene +
transgenes O +
were O +
expressed O +
in O +
a O +
similar O +
, O +
but O +
not O +
identical O +
, O +
pattern O +
to O +
that O +
observed O +
in O +
humans O +
: O +
LILRB1 B-Gene +
was O +
expressed O +
in O +
B O +
cells O +
, O +
most O +
NK O +
cells O +
, O +
and O +
a O +
small O +
number O +
of O +
T O +
cells O +
; O +
LILRB4 B-Gene +
was O +
expressed O +
in O +
a O +
B O +
cell O +
subset O +
; O +
and O +
LILRA1 B-Gene +
was O +
found O +
on O +
a O +
ring O +
of O +
cells O +
surrounding O +
B O +
cell O +
areas O +
on O +
spleen O +
sections O +
, O +
consistent O +
with O +
other O +
data O +
showing O +
monocyte O +
/ O +
macrophage O +
expression O +
. O +

KIR B-Gene +
transgenic O +
mice O +
showed O +
KIR2DL2 B-Gene +
expression O +
on O +
a O +
subset O +
of O +
NK O +
cells O +
and O +
T O +
cells O +
, O +
similar O +
to O +
the O +
pattern O +
seen O +
in O +
humans O +
, O +
and O +
expression O +
of O +
KIR2DL4 B-Gene +
, O +
KIR3DS1 B-Gene +
, O +
and O +
KIR2DL5 B-Gene +
by O +
splenic O +
NK O +
cells O +
. O +

These O +
observations O +
indicate O +
that O +
linked O +
regulatory O +
elements O +
within O +
the O +
genomic O +
clones O +
are O +
sufficient O +
to O +
allow O +
appropriate O +
expression O +
of O +
KIRs B-Gene +
in O +
mice O +
, O +
and O +
illustrate O +
that O +
the O +
presence O +
of O +
the O +
natural O +
ligands O +
for O +
these O +
receptors O +
, O +
in O +
the O +
form O +
of O +
human O +
MHC B-Gene +
class I-Gene +
I I-Gene +
proteins O +
, O +
is O +
not O +
necessary O +
for O +
the O +
expression O +
of O +
the O +
KIRs B-Gene +
observed O +
in O +
these O +
mice O +
. O +

Reduced O +
sulfhydryls O +
maintain O +
specific O +
incision O +
of O +
BPDE O +
- O +
DNA O +
adducts O +
by O +
recombinant O +
thermoresistant O +
Bacillus O +
caldotenax O +
UvrABC B-Gene +
endonuclease I-Gene +
. O +

Prokaryotic O +
DNA B-Gene +
repair I-Gene +
nucleases I-Gene +
are O +
useful O +
reagents O +
for O +
detecting O +
DNA O +
lesions O +
. O +

Escherichia O +
coli O +
UvrABC B-Gene +
endonuclease I-Gene +
can O +
incise O +
DNA O +
containing O +
UV O +
photoproducts O +
and O +
bulky O +
chemical O +
adducts O +
. O +

The O +
limited O +
stability O +
of O +
the O +
E. O +
coli O +
UvrABC B-Gene +
subunits O +
leads O +
to O +
difficulty O +
in O +
estimating O +
incision O +
efficiency O +
and O +
quantitative O +
adduct O +
detection O +
. O +

To O +
develop O +
a O +
more O +
stable O +
enzyme O +
with O +
greater O +
utility O +
for O +
the O +
detection O +
of O +
DNA O +
adducts O +
, O +
thermoresistant O +
UvrABC B-Gene +
endonuclease I-Gene +
was O +
cloned O +
from O +
the O +
eubacterium O +
Bacillus O +
caldotenax O +
( O +
Bca O +
) O +
and O +
individual O +
recombinant O +
protein O +
subunits O +
were O +
overexpressed O +
in O +
and O +
purified O +
from O +
E. O +
coli O +
. O +

Here O +
, O +
we O +
show O +
that O +
Bca O +
UvrC B-Gene +
that O +
had O +
lost O +
activity O +
or O +
specificity O +
could O +
be O +
restored O +
by O +
dialysis O +
against O +
buffer O +
containing O +
500 O +
mM O +
KCl O +
and O +
20mM O +
dithiothreitol O +
. O +

Our O +
data O +
indicate O +
that O +
UvrC B-Gene +
solubility O +
depended O +
on O +
high O +
salt O +
concentrations O +
and O +
UvrC B-Gene +
nuclease I-Gene +
activity O +
and O +
the O +
specificity O +
of O +
incisions O +
depended O +
on O +
the O +
presence O +
of O +
reduced O +
sulfhydryls O +
. O +

Optimal O +
conditions O +
for O +
BCA O +
UvrABC B-Gene +
- O +
specific O +
cleavage O +
of O +
plasmid O +
DNAs O +
treated O +
with O +
[ O -
3H O -
] O -
( O -
+ O -
) O -
-7R,8S O -
- O -
dihydroxy-9S,10R O -
- O -
epoxy-7,8,9,10-tetrahydrobenzo O -
[ O -
a O -
] O -
pyrene O +
( O +
BPDE O +
) O +
( O +
1 O +
- O +
5 O +
lesions O +
/ O +
plasmid O +
) O +
were O +
developed O +
. O +

Preincubation O +
of O +
substrates O +
with O +
UvrA B-Gene +
and O +
UvrB B-Gene +
enhanced O +
incision O +
efficiency O +
on O +
damaged O +
substrates O +
and O +
decreased O +
non O +
- O +
specific O +
nuclease B-Gene +
activity O +
on O +
undamaged O +
substrates O +
. O +

Under O +
optimal O +
conditions O +
for O +
damaged O +
plasmid O +
incision O +
, O +
approximately O +
70 O +
% O +
of O +
adducts O +
were O +
incised O +
in O +
1 O +
nM O +
plasmid O +
DNA O +
( O +
2 O +
BPDE O +
adducts O +
/ O +
5.4 O +
kbp O +
plasmid O +
) O +
with O +
UvrA B-Gene +
at O +
2.5 O +
nM O +
, O +
UvrB B-Gene +
at O +
62.5 O +
nM O +
, O +
and O +
UvrC B-Gene +
at O +
25 O +
nM O +
. O +

These O +
results O +
demonstrate O +
the O +
potential O +
usefulness O +
of O +
the O +
Bca O +
UvrABC B-Gene +
for O +
monitoring O +
the O +
distribution O +
of O +
chemical O +
carcinogen O +
- O +
induced O +
lesions O +
in O +
DNA O +
. O +

Differential O +
regulation O +
of O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
, O +
IL-6 B-Gene +
and O +
IL-10 B-Gene +
in O +
UVB O +
- O +
irradiated O +
human O +
keratinocytes O +
via O +
cyclic B-Gene +
AMP I-Gene +
/ I-Gene +
protein I-Gene +
kinase I-Gene +
A I-Gene +
pathway O +
. O +

Pro O +
- O +
inflammatory O +
cytokines B-Gene +
are O +
important O +
mediators O +
of O +
cutaneous O +
cellular O +
activities O +
during O +
many O +
skin O +
diseases O +
. O +

In O +
the O +
present O +
study O +
, O +
we O +
investigated O +
the O +
production O +
of O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
( O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
) O +
, O +
IL-6 B-Gene +
and O +
IL-10 B-Gene +
by O +
UVB O +
- O +
irradiated O +
human O +
keratinocytes O +
NCTC O +
2544 O +
cell O +
line O +
in O +
the O +
presence O +
of O +
cAMP O +
- O +
elevating O +
agents O +
and O +
we O +
attempted O +
to O +
determine O +
the O +
implication O +
of O +
cyclic O +
AMP O +
/ O +
PKA B-Gene +
pathway O +
in O +
the O +
regulation O +
of O +
cytokine B-Gene +
gene O +
expression O +
. O +

Cytokine B-Gene +
mRNA O +
expression O +
levels O +
and O +
cytokine B-Gene +
concentrations O +
were O +
investigated O +
by O +
reverse O +
transcription O +
polymerase O +
chain O +
reaction O +
and O +
by O +
ELISA O +
method O +
, O +
respectively O +
. O +

Treatment O +
of O +
UVB O +
- O +
irradiated O +
NCTC O +
2544 O +
cells O +
with O +
drugs O +
known O +
to O +
enhance O +
cAMP O +
concentration O +
[ O +
dibutyryl O +
cAMP O +
, O +
PGE O -
( O -
2 O -
) O +
and O +
cholera B-Gene +
toxin I-Gene +
] O +
results O +
in O +
a O +
significant O +
decrease O +
of O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
mRNA O +
expression O +
whereas O +
IL-6 B-Gene +
and O +
IL-10 B-Gene +
mRNAs O +
were O +
enhanced O +
. O +

In O +
the O +
same O +
experimental O +
conditions O +
, O +
treatment O +
of O +
irradiated O +
keratinocytes O +
with O +
PKA B-Gene +
inhibitors O +
[ O +
H89 O +
and O +
PKA B-Gene +
inhibitor O +
( O +
PKAi O +
) O +
] O +
induced O +
a O +
significant O +
inhibition O +
of O +
mRNA O +
expression O +
for O +
all O +
tested O +
cytokines B-Gene +
. O +

Except O +
for O +
IL-10 B-Gene +
, O +
the O +
pharmacological O +
effect O +
of O +
cAMP O +
- O +
elevating O +
agents O +
or O +
PKA B-Gene +
inhibitors O +
on O +
radiation O +
- O +
induced O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
and O +
IL-6 B-Gene +
mRNA O +
expression O +
was O +
associated O +
with O +
a O +
concomitant O +
regulation O +
of O +
cytokine B-Gene +
release O +
. O +

Taken O +
together O +
our O +
results O +
showed O +
: O +
( O -
i O -
) O +
a O +
differential O +
regulation O +
of O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
, O +
IL-6 B-Gene +
and O +
IL-10 B-Gene +
in O +
UVB O +
- O +
irradiated O +
human O +
keratinocytes O +
via O +
cyclic O +
AMP O +
/ O +
protein B-Gene +
kinase I-Gene +
A I-Gene +
pathway O +
, O +
and O +
( O -
ii O -
) O +
a O +
possible O +
reduction O +
of O +
deleterious O +
inflammatory O +
effects O +
of O +
cytokine B-Gene +
following O +
UVB O +
- O +
irradiation O +
by O +
using O +
pharmacological O +
agents O +
that O +
regulate O +
both O +
the O +
intracellular O +
cAMP O +
levels O +
and O +
the O +
cellular O +
PKA B-Gene +
activity O +
. O +

Analysis O +
of O +
plausible O +
downstream O +
target O +
genes O +
of O +
Hoxc8 B-Gene +
in O +
F9 O +
teratocarcinoma O +
cells O +
. O +

Putative O +
downstream O +
target O +
genes O +
of O +
Hoxc8 B-Gene +
. O +

Although O +
Hox B-Gene +
genes O +
are O +
known O +
to O +
mediate O +
developmental O +
decisions O +
involved O +
in O +
pattern O +
formation O +
during O +
embryogenesis O +
, O +
it O +
is O +
still O +
not O +
well O +
understood O +
what O +
Hox B-Gene +
regulates O +
. O +

In O +
order O +
to O +
analyze O +
Hoxc8 B-Gene +
downstream O +
target O +
genes O +
, O +
a O +
stable O +
cell O +
line O +
overexpressing O +
Hoxc8 B-Gene +
was O +
established O +
using O +
F9 O +
murine O +
teratocarcinoma O +
cells O +
, O +
proteom O +
samples O +
were O +
analyzed O +
by O +
2-DE O +
, O +
and O +
compared O +
with O +
controls O +
. O +

The O +
protein O +
spots O +
having O +
differences O +
more O +
than O +
4 O +
fold O +
in O +
intensity O +
were O +
selected O +
, O +
analyzed O +
by O +
MALDI O -
- O -
TOF O +
, O +
and O +
grouped O +
in O +
terms O +
of O +
putative O +
function O +
; O +
cytoskeleton O +
and O +
motility O +
( O +
vimentin B-Gene +
, O +
gamma B-Gene -
- I-Gene -
actin I-Gene +
, O +
tropomyosin B-Gene +
, O +
and O +
tubulin B-Gene +
beta-5 I-Gene +
chain O +
) O +
; O +
folding O +
, O +
modification O +
and O +
degradation O +
of O +
protein O +
( O +
GRP78 B-Gene +
, O +
proteasome B-Gene +
subunit I-Gene +
alpha I-Gene +
type I-Gene +
5 I-Gene +
, O +
26S B-Gene +
proteasome I-Gene +
regulatory I-Gene +
subunit I-Gene +
p27 I-Gene +
protein O +
, O +
and O +
PDIR B-Gene +
) O +
; O +
metabolism O +
( O +
ATP B-Gene +
synthase I-Gene +
beta I-Gene +
subunit I-Gene +
, O +
Pgam1 B-Gene +
, O +
and O +
CAII B-Gene +
) O +
; O +
transcription B-Gene +
/ I-Gene +
translation I-Gene +
factors I-Gene +
and O +
general O +
nucleic O +
acid O +
binding O +
proteins O +
( O +
RbAp46 B-Gene +
, O +
PCNA B-Gene +
, O +
eEF-1-beta B-Gene +
, O +
and O +
nucleophosmin B-Gene +
) O +
. O +

Although O +
it O +
may O +
not O +
be O +
significant O +
, O +
50 O +
% O +
of O +
the O +
genes O +
were O +
located O +
on O +
chromosomes O +
2 O +
and O +
3 O +
, O +
suggesting O +
the O +
possibility O +
of O +
a O +
non O +
- O +
random O +
distribution O +
of O +
Hox B-Gene +
downstream O +
genes O +
. O +

Almost O +
50 O +
% O +
of O +
the O +
genes O +
analyzed O +
showed O +
some O +
relation O +
with O +
Hox B-Gene +
protein O +
directly O +
or O +
indirectly O +
; O +
i.e. O +
, O +
tubulin B-Gene +
beta I-Gene +
5 I-Gene +
, O +
EF-1 B-Gene +
beta I-Gene +
and O +
PCNA B-Gene +
have O +
been O +
reported O +
to O +
contain O +
putative O +
Hox B-Gene +
binding O +
regulatory O +
sites O +
and O +
genes O +
like O +
vimentin B-Gene +
, O +
pgam1 B-Gene +
and O +
nucleophosmin B-Gene +
to O +
be O +
regulated O +
by O +
RA O +
, O +
a O +
potent O +
modulator O +
of O +
Hox B-Gene +
expression O +
. O +

These O +
results O +
altogether O +
imply O +
that O +
proteom O +
analysis O +
could O +
be O +
a O +
possible O +
tool O +
for O +
the O +
analysis O +
of O +
the O +
potent O +
Hox B-Gene +
realizator O +
genes O +
, O +
which O +
provides O +
a O +
new O +
insight O +
into O +
the O +
function O +
of O +
Hox B-Gene +
on O +
pattern O +
formation O +
during O +
embryogenesis O +
. O +

Reconstitution O +
of O +
the O +
multiprotein O +
complex O +
of O +
pp60src B-Gene +
, O +
hsp90 B-Gene +
, O +
and O +
p50 O +
in O +
a O +
cell O +
- O +
free O +
system O +
. O +

A O +
rabbit O +
reticulocyte O +
lysate O +
system O +
that O +
has O +
been O +
used O +
to O +
reconstitute O +
functional O +
complexes O +
between O +
steroid B-Gene +
receptors I-Gene +
and O +
the O +
90 B-Gene +
- I-Gene +
kDa I-Gene +
heat I-Gene +
shock I-Gene +
protein I-Gene +
( O +
hsp90 B-Gene +
) O +
has O +
been O +
used O +
here O +
to O +
form O +
complexes O +
between O +
the O +
pp60src B-Gene +
tyrosine B-Gene +
kinase I-Gene +
and O +
hsp90 B-Gene +
. O +

Reticulocyte O +
lysate O +
forms O +
complexes O +
between O +
hsp90 B-Gene +
and O +
a O +
temperature O +
- O +
sensitive O +
mutant O +
of O +
Rous O +
sarcoma O +
virus O +
pp60v B-Gene -
- I-Gene -
src I-Gene +
, O +
which O +
is O +
normally O +
present O +
in O +
cytosol O +
virtually O +
entirely O +
in O +
the O +
multiprotein O +
complex O +
form O +
. O +

In O +
addition O +
, O +
hsp90 B-Gene +
in O +
the O +
lysate O +
complexes O +
with O +
wild O +
- O +
type O +
pp60v B-Gene -
- I-Gene -
src I-Gene +
, O +
of O +
which O +
only O +
a O +
small O +
portion O +
is O +
normally O +
recovered O +
in O +
cytosol O +
in O +
the O +
native O +
multiprotein O +
complex O +
, O +
and O +
with O +
the O +
cellular O +
homolog O +
, O +
pp60c B-Gene -
- I-Gene -
src I-Gene +
, O +
which O +
has O +
never O +
been O +
recovered O +
in O +
cytosol O +
in O +
the O +
form O +
of O +
a O +
native O +
multiprotein O +
complex O +
with O +
hsp90 B-Gene +
. O +

Moreover O +
, O +
the O +
reticulocyte O +
lysate O +
- O +
reconstituted O +
complex O +
also O +
contains O +
the O +
50 O +
- O +
kDa O +
phosphoprotein O +
component O +
of O +
the O +
native O +
pp60v B-Gene -
- I-Gene -
src I-Gene +
multiprotein O +
complex O +
. O +

The O +
native O +
and O +
reconstituted O +
pp60src B-Gene +
- O +
hsp90 B-Gene +
complexes O +
have O +
similar O +
thermal O +
stability O +
and O +
, O +
like O +
steroid B-Gene +
receptor I-Gene +
heterocomplexes O +
, O +
they O +
are O +
stabilized O +
by O +
molybdate O +
. O +

As O +
previously O +
shown O +
with O +
reticulocyte O +
lysate O +
- O +
reconstituted O +
steroid B-Gene +
receptor I-Gene +
heteroprotein O +
complexes O +
, O +
the O +
reconstituted O +
pp60src B-Gene +
multiprotein O +
complex O +
contains O +
hsp70 B-Gene +
, O +
which O +
is O +
a O +
major O +
candidate O +
for O +
providing O +
the O +
protein O +
unfoldase O +
activity O +
required O +
for O +
hsp90 B-Gene +
association O +
. O +

Control O +
of O +
enzyme B-Gene +
IIscr I-Gene +
and O +
sucrose-6-phosphate B-Gene +
hydrolase I-Gene +
activities O +
in O +
Streptococcus O +
mutans O +
by O +
transcriptional O +
repressor O +
ScrR B-Gene +
binding O +
to O +
the O +
cis O +
- O +
active O +
determinants O +
of O +
the O +
scr B-Gene +
regulon O +
. O +

In O +
Streptococcus O +
mutans O +
, O +
enzyme B-Gene +
II I-Gene +
( I-Gene +
scr I-Gene +
) I-Gene +
and O +
sucrose-6-phosphate B-Gene +
hydrolase I-Gene +
are O +
two O +
important O +
enzymes O +
in O +
the O +
transport O +
and O +
metabolism O +
of O +
dietary O +
sucrose O +
. O +

The O +
scr B-Gene +
regulon O +
of O +
S. O +
mutans O +
is O +
composed O +
of O +
three O +
genes O +
, O +
scrA B-Gene +
and O +
scrB B-Gene +
, O +
which O +
code O +
for O +
enzyme B-Gene +
II I-Gene +
( I-Gene +
scr I-Gene +
) I-Gene +
and O +
sucrose B-Gene +
- I-Gene +
6 I-Gene +
- I-Gene +
phosphate I-Gene +
hydrolase I-Gene +
, O +
respectively O +
, O +
and O +
scrR B-Gene +
, O +
which O +
codes O +
for O +
a O +
GalR B-Gene +
- O +
LacI B-Gene +
- O +
type O +
transcription O +
regulator O +
. O +

It O +
was O +
previously O +
shown O +
that O +
expression O +
of O +
both O +
scrA B-Gene +
and O +
scrB B-Gene +
is O +
similarly O +
induced O +
by O +
sucrose O +
. O +

Mutation O +
in O +
the O +
scrR B-Gene +
gene O +
resulted O +
in O +
increased O +
expression O +
of O +
scrB B-Gene +
relative O +
to O +
that O +
in O +
the O +
wild O +
- O +
type O +
strain O +
. O +

In O +
this O +
study O +
, O +
we O +
employed O +
DNA O +
mobility O +
shift O +
and O +
DNase B-Gene +
I I-Gene +
protection O +
assays O +
with O +
a O +
purified O +
ScrR B-Gene +
- O +
histidine O +
tag O +
fusion O +
protein O +
to O +
examine O +
the O +
DNA O +
binding O +
properties O +
of O +
ScrR B-Gene +
to O +
the O +
promoter O +
regions O +
of O +
the O +
scrA B-Gene +
and O +
scrB B-Gene +
genes O +
. O +

The O +
results O +
showed O +
that O +
ScrR B-Gene +
bound O +
specifically O +
to O +
the O +
promoter O +
regions O +
of O +
both O +
scrA B-Gene +
and O +
scrB B-Gene +
. O +

Two O +
regions O +
with O +
high O +
affinity O +
for O +
ScrR B-Gene +
in O +
the O +
promoter O +
sequences O +
of O +
the O +
scrA B-Gene +
and O +
scrB B-Gene +
genes O +
were O +
identified O +
by O +
DNase B-Gene +
I I-Gene +
protection O +
assays O +
. O +

One O +
, O +
O O -
( O -
C O -
) O +
, O +
which O +
includes O +
a O +
20 O +
- O +
bp O +
imperfect O +
inverted O +
- O +
repeat O +
sequence O +
, O +
is O +
located O +
between O +
the O +
two O +
promoters O +
, O +
and O +
the O +
other O +
, O +
O O +
( O +
B O +
) O +
, O +
is O +
located O +
within O +
the O +
scrB B-Gene +
promoter O +
region O +
containing O +
a O +
37 O +
- O +
bp O +
imperfect O +
direct O +
- O +
repeat O +
sequence O +
. O +

Mutations O +
of O +
O O -
( O -
B O -
) O +
and O +
O O +
( O +
C O +
) O +
resulted O +
in O +
constitutive O +
transcription O +
and O +
expression O +
of O +
both O +
the O +
scrA B-Gene +
and O +
scrB B-Gene +
genes O +
. O +

Our O +
results O +
indicated O +
that O +
S. O +
mutans O +
coordinates O +
the O +
activities O +
of O +
enzyme B-Gene +
II I-Gene -
( I-Gene -
scr I-Gene -
) I-Gene +
and O +
sucrose B-Gene +
- I-Gene +
6 I-Gene +
- I-Gene +
phosphate I-Gene +
hydrolase I-Gene +
by O +
transcriptional O +
repressor O +
ScrR B-Gene +
binding O +
to O +
the O +
promoter O +
regions O +
of O +
the O +
scr B-Gene +
regulon O +
. O +

The O +
cadC B-Gene +
gene O +
product O +
of O +
alkaliphilic O +
Bacillus O +
firmus O +
OF4 O +
partially O +
restores O +
Na+ O +
resistance O +
to O +
an O +
Escherichia O +
coli O +
strain O +
lacking O +
an O +
Na B-Gene +
+ I-Gene -
/H I-Gene +
+ I-Gene +
antiporter I-Gene +
( O +
NhaA B-Gene +
) O +
. O +

A O +
5.6 O +
- O +
kb O +
fragment O +
of O +
alkaliphilic O +
Bacillus O +
firmus O +
OF4 O +
DNA O +
was O +
isolated O +
by O +
screening O +
a O +
library O +
of O +
total O +
genomic O +
DNA O +
constructed O +
in O +
pGEM3Zf O +
( O +
+ O +
) O +
for O +
clones O +
that O +
reversed O +
the O +
Na+ O +
sensitivity O +
of O +
Escherichia O +
coli O +
NM81 O +
, O +
in O +
which O +
the O +
gene O +
encoding O +
an O +
Na B-Gene +
+ I-Gene +
/ I-Gene +
H I-Gene +
+ I-Gene +
antiporter I-Gene +
( O +
NhaA B-Gene +
) O +
is O +
deleted O +
( O +
E. O +
Padan O +
, O +
N. O +
Maisler O +
, O +
D. O +
Taglicht O +
, O +
R. O +
Karpel O +
, O +
and O +
S. O +
Schuldiner O +
, O +
J. O +
Biol O -
. O +
Chem O -
. O +
264 O +
: O +
20297 O +
- O +
20302 O +
, O +
1989 O +
) O +
. O +

The O +
plasmid O +
, O +
designated O +
pJB22 O +
, O +
contained O +
two O +
genes O +
that O +
apparently O +
encode O +
transposition O +
functions O +
and O +
two O +
genes O +
that O +
are O +
apparent O +
homologs O +
of O +
the O +
cadA B-Gene +
and O +
cadC B-Gene +
genes O +
of O +
cadmium O +
resistance O +
- O +
conferring O +
plasmid O +
pI258 O +
of O +
Staphylococcus O +
aureus O +
. O +

E. O +
coli O +
NM81 O +
transformed O +
with O +
pJB22 O +
had O +
enhanced O +
membrane O +
Na+ B-Gene -
/ I-Gene -
H I-Gene +
+ I-Gene +
antiporter I-Gene +
activity O +
that O +
was O +
cold O +
labile O +
and O +
that O +
decreased O +
very O +
rapidly O +
following O +
isolation O +
of O +
everted O +
vesicles O +
. O +

Subclones O +
of O +
pJB22 O +
containing O +
cadC B-Gene +
as O +
the O +
only O +
intact O +
gene O +
showed O +
identical O +
complementation O +
patterns O +
in O +
vivo O +
and O +
in O +
vitro O +
. O +

The O +
cadC B-Gene +
gene O +
product O +
of O +
S. O +
aureus O +
has O +
been O +
proposed O +
to O +
act O +
as O +
an O +
accessory O +
protein O +
for O +
the O +
Cd2 B-Gene -
+ I-Gene +
efflux I-Gene +
ATPase I-Gene +
( O +
CadA B-Gene +
) O +
( O +
K. O +
P. O +
Yoon O +
and O +
S. O +
Silver O +
, O +
J. O +
Bacteriol O -
. O +
173 O +
: O +
7636 O +
- O +
7642 O +
, O +
1991 O +
) O +
; O +
perhaps O +
the O +
alkaliphile O +
CadC B-Gene +
also O +
binds O +
Na O +
+ O +
and O +
enhances O +
antiporter O +
activity O +
by O +
delivering O +
a O +
substrate O +
to O +
an O +
integral O +
membrane O +
antiporter B-Gene +
. O +

A O +
6.0 O +
- O +
kb O +
fragment O +
overlapping O +
the O +
pJB22 O +
insert O +
was O +
isolated O +
to O +
complete O +
the O +
sequence O +
of O +
the O +
cadA B-Gene +
homolog O +
. O +

A O +
partial O +
sequence O +
of O +
a O +
region O +
approximately O +
2 O +
kb O +
downstream O +
of O +
the O +
cadA B-Gene +
locus O +
shares O +
sequence O +
similarity O +
with O +
plasmids O +
from O +
several O +
gram O +
- O +
positive O +
bacteria O +
. O +

These O +
results O +
suggest O +
that O +
the O +
region O +
of O +
alkaliphile O +
DNA O +
containing O +
the O +
cadCA B-Gene +
locus O +
is O +
present O +
on O +
a O +
transposon O +
that O +
could O +
reside O +
on O +
a O +
heretofore O +
- O +
undetected O +
endogenous O +
plasmid O +
. O +

Activation O +
of O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
kinase I-Gene +
by O +
v B-Gene -
- I-Gene -
Raf I-Gene +
in O +
NIH O +
3T3 O +
cells O +
and O +
in O +
vitro O +
. O +

Mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
( I-Gene +
MAP I-Gene +
) I-Gene +
kinases I-Gene +
are O +
42 O +
- O +
and O +
44 O +
- O +
kD O +
serine B-Gene +
- I-Gene +
threonine I-Gene +
protein I-Gene +
kinases I-Gene +
that O +
are O +
activated O +
by O +
tyrosine O +
and O +
threonine O +
phosphorylation O +
in O +
cells O +
stimulated O +
with O +
mitogens O +
and O +
growth B-Gene +
factors I-Gene +
. O +

MAP B-Gene +
kinase I-Gene +
and O +
the O +
protein B-Gene +
kinase I-Gene +
that O +
activates O +
it O +
( O +
MAP B-Gene +
kinase I-Gene +
kinase I-Gene +
) O +
were O +
constitutively O +
activated O +
in O +
NIH O +
3T3 O +
cells O +
infected O +
with O +
viruses O +
containing O +
either O +
of O +
two O +
oncogenic O +
forms O +
( O +
p35EC12 O +
, O +
p3722W O +
) O +
of O +
the O +
c B-Gene -
- I-Gene -
Raf-1 I-Gene +
protein B-Gene +
kinase I-Gene +
. O +

The O +
v B-Gene +
- I-Gene +
Raf I-Gene +
proteins O +
purified O +
from O +
cells O +
infected O +
with O +
EC12 O +
or O +
22W O +
viruses O +
activated O +
MAP B-Gene +
kinase I-Gene +
kinase I-Gene +
from O +
skeletal O +
muscle O +
in O +
vitro O +
. O +

Furthermore O +
, O +
a O +
bacterially O +
expressed O +
v B-Gene +
- I-Gene +
Raf I-Gene +
fusion O +
protein O +
( O +
glutathione B-Gene +
S I-Gene -
- I-Gene -
transferase I-Gene +
- O +
p3722W O +
) O +
also O +
activated O +
MAP B-Gene +
kinase I-Gene +
kinase I-Gene +
in O +
vitro O +
. O +

These O +
findings O +
suggest O +
that O +
one O +
function O +
of O +
c B-Gene -
- I-Gene -
Raf-1 I-Gene +
in O +
mitogenic O +
signaling O +
is O +
to O +
phosphorylate O +
and O +
activate O +
MAP B-Gene +
kinase I-Gene +
kinase I-Gene +
. O +

Biochemical O +
properties O +
of O +
the O +
75 B-Gene +
- I-Gene +
kDa I-Gene +
tumor I-Gene +
necrosis I-Gene +
factor I-Gene +
receptor I-Gene +
. O +

Characterization O +
of O +
ligand O +
binding O +
, O +
internalization O +
, O +
and O +
receptor O +
phosphorylation O +
. O +

An O +
expression O +
plasmid O +
encoding O +
the O +
human O +
75 B-Gene +
- I-Gene +
kDa I-Gene +
tumor I-Gene +
necrosis I-Gene +
factor I-Gene +
( I-Gene +
TNF I-Gene +
) I-Gene +
type I-Gene +
2 I-Gene +
receptor I-Gene +
( O +
TNF B-Gene -
- I-Gene -
R2 I-Gene +
) O +
was O +
constructed O +
and O +
used O +
to O +
generate O +
a O +
stable O +
human O +
cell O +
line O +
( O +
293 O +
/ O +
TNF B-Gene -
- I-Gene -
R2 I-Gene +
) O +
overexpressing O +
TNF B-Gene -
- I-Gene -
R2 I-Gene +
. O +

Ligand O +
binding O +
analysis O +
revealed O +
high O +
affinity O +
binding O +
( O +
Kd O +
= O +
0.2 O +
nM O +
) O +
with O +
approximately O +
94,000 O +
+ O -
/- O +
7 O +
, O +
500 O +
sites O +
/ O +
cell O +
for O +
125I O +
- O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
and O +
approximately O +
5 O +
- O +
fold O +
lower O +
affinity O +
for O +
TNF B-Gene -
- I-Gene -
beta I-Gene +
( O +
Kd O +
= O +
1.1 O +
nM O +
) O +
with O +
264,000 O +
+ O -
/- O +
2,000 O +
sites O +
/ O +
cell O +
. O +

Cross O +
- O +
linking O +
of O +
125I O +
- O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
and O +
125I O +
- O +
TNF B-Gene -
- I-Gene -
beta I-Gene +
to O +
293 O +
/ O +
TNF B-Gene -
- I-Gene -
R2 I-Gene +
cells O +
yielded O +
predominant O +
complexes O +
with O +
apparent O +
molecular O +
weights O +
of O +
211,000 O +
for O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
and O +
205,000 O +
and O +
244,000 O +
for O +
TNF B-Gene -
- I-Gene -
beta I-Gene +
, O +
suggesting O +
these O +
complexes O +
contain O +
two O +
or O +
three O +
TNF B-Gene -
- I-Gene -
R2 I-Gene +
molecules O +
. O +

Immunoprecipitation O +
of O +
TNF B-Gene -
- I-Gene -
R2 I-Gene +
from O +
32P O +
- O +
labeled O +
293 O +
/ O +
TNF B-Gene -
- I-Gene -
R2 I-Gene +
cells O +
demonstrated O +
that O +
the O +
receptor O +
is O +
phosphorylated O +
. O +

The O +
majority O +
( O +
97 O +
% O +
) O +
of O +
32Pi O +
incorporation O +
was O +
found O +
in O +
serine O +
residues O +
with O +
a O +
very O +
low O +
level O +
of O +
incorporation O +
( O +
3 O +
% O +
) O +
in O +
threonine O +
residues O +
. O +

TNF B-Gene -
- I-Gene -
alpha I-Gene +
treatment O +
of O +
293 O +
/ O +
TNF B-Gene -
- I-Gene -
R2 I-Gene +
cells O +
did O +
not O +
significantly O +
affect O +
the O +
degree O +
or O +
pattern O +
of O +
phosphorylation O +
. O +

Cell O +
surface O +
- O +
bound O +
125I O +
- O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
was O +
slowly O +
internalized O +
by O +
the O +
293 O +
/ O +
TNF B-Gene -
- I-Gene -
R2 I-Gene +
cell O +
line O +
with O +
a O +
t1 O +
/ O +
2 O +
= O +
25 O +
min O +
. O +

Shedding O +
of O +
the O +
extracellular O +
domain O +
of O +
TNF B-Gene -
- I-Gene -
R2 I-Gene +
was O +
induced O +
by O +
4 O +
beta O -
- O -
phorbol O +
12-myristate O +
13-acetate O +
but O +
not O +
by O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
or O +
TNF B-Gene -
- I-Gene -
beta I-Gene +
. O +

DNA B-Gene +
deoxyribophosphodiesterase I-Gene +
of O +
Escherichia O +
coli O +
is O +
associated O +
with O +
exonuclease B-Gene +
I I-Gene +
. O +

DNA B-Gene +
deoxyribophosphodiesterase I-Gene +
( O +
dRpase B-Gene +
) O +
of O +
E. O +
coli O +
catalyzes O +
the O +
release O +
of O +
deoxyribose O +
- O +
phosphate O +
moieties O +
following O +
the O +
cleavage O +
of O +
DNA O +
at O +
an O +
apurinic O +
/ O +
apyrimidinic O +
( O +
AP O +
) O +
site O +
by O +
either O +
an O +
AP B-Gene +
endonuclease I-Gene +
or O +
AP B-Gene +
lyase I-Gene +
. O +

Exonuclease B-Gene +
I I-Gene +
is O +
a O +
single O +
- O +
strand O +
specific O +
DNA B-Gene +
nuclease I-Gene +
which O +
affects O +
the O +
expression O +
of O +
recombination O +
and O +
repair O +
pathways O +
in O +
E. O +
coli O +
. O +

We O +
show O +
here O +
that O +
a O +
major O +
dRpase B-Gene +
activity O +
in O +
E. O +
coli O +
is O +
associated O +
with O +
the O +
exonuclease B-Gene +
I I-Gene +
protein O +
. O +

Highly O +
purified O +
exonuclease B-Gene +
I I-Gene +
isolated O +
from O +
an O +
over O +
- O +
producing O +
stain O +
contains O +
high O +
levels O +
of O +
dRpase B-Gene +
activity O +
; O +
it O +
catalyzes O +
the O +
release O +
of O +
deoxyribose-5-phosphate O +
from O +
an O +
AP O +
site O +
incised O +
with O +
endonuclease B-Gene +
IV I-Gene +
of O +
E. O +
coli O +
and O +
the O +
release O +
of O +
4-hydroxy-2-pentenal-5-phosphate O +
from O +
an O +
AP O +
site O +
incised O +
by O +
the O +
AP B-Gene +
lyase I-Gene +
activity O +
of O +
endonuclease B-Gene +
III I-Gene +
of O +
E. O +
coli O +
. O +

A O +
strain O +
containing O +
a O +
deletion O +
of O +
the O +
sbcB B-Gene +
gene O +
showed O +
little O +
dRpase B-Gene +
activity O +
; O +
the O +
activity O +
could O +
be O +
restored O +
by O +
transformation O +
of O +
the O +
strain O +
with O +
a O +
plasmid O +
containing O +
the O +
sbcB B-Gene +
gene O +
. O +

The O +
dRpase B-Gene +
activity O +
isolated O +
from O +
an O +
overproducing O +
stain O +
was O +
increased O +
70 O +
- O +
fold O +
as O +
compared O +
to O +
a O +
normal O +
sbcB B-Gene +
+ O +
strain O +
( O +
AB3027 O +
) O +
. O +

These O +
results O +
suggest O +
that O +
the O +
dRpase B-Gene +
activity O +
may O +
be O +
important O +
in O +
pathways O +
for O +
both O +
DNA O +
repair O +
and O +
recombination O +
. O +

A O +
constitutive O +
expression O +
vector O +
system O +
driven O +
by O +
the O +
deo B-Gene +
P1P2 O +
promoters O +
of O +
Escherichia O +
coli O +
. O +

The O +
P1P2 O +
promoters O +
of O +
Escherichia O +
coli O +
K12 O +
deo B-Gene +
operon I-Gene +
, O +
residing O +
on O +
an O +
AvaII B-Gene +
restriction O +
fragment O +
, O +
were O +
used O +
to O +
construct O +
a O +
new O +
expression O +
vector O +
. O +

To O +
evaluate O +
the O +
potential O +
of O +
the O +
P1P2 O +
- O +
driven O +
expression O +
system O +
we O +
have O +
inserted O +
the O +
sequence O +
of O +
human O +
superoxide B-Gene +
dismutase I-Gene +
( O +
hSOD B-Gene +
) O +
downstream O +
of O +
the O +
deo B-Gene +
ribosome O +
binding O +
site O +
. O +

Expression O +
of O +
hSOD B-Gene +
was O +
evaluated O +
by O +
means O +
of O +
sodium O +
dodecyl O +
sulphate O +
- O +
polyacrylamide O +
gel O +
electrophoresis O +
and O +
enzyme O +
activity O +
. O +

In O +
crude O +
cell O +
extracts O +
hSOD B-Gene +
expression O +
levels O +
were O +
found O +
to O +
be O +
high O +
in O +
hosts O +
possessing O +
no O +
deoR B-Gene +
or O +
cytR B-Gene +
repressors O +
. O +

Highest O +
levels O +
of O +
hSOD B-Gene +
expression O +
were O +
obtained O +
with O +
a O +
high O +
- O +
copy O +
- O +
number O +
plasmid O +
regardless O +
of O +
the O +
host O +
used O +
. O +

Expressed O +
hSOD B-Gene +
can O +
account O +
for O +
35 O +
% O +
- O +
40 O +
% O +
of O +
total O +
protein O +
in O +
E. O +
coli O +
. O +

The O +
heat B-Gene +
- I-Gene +
shock I-Gene +
protein I-Gene +
ClpB B-Gene +
in O +
Escherichia O +
coli O +
is O +
a O +
protein O +
- O +
activated O +
ATPase B-Gene +
. O +

The O +
clpB B-Gene +
gene O +
in O +
Escherichia O +
coli O +
encodes O +
a O +
heat B-Gene +
- I-Gene +
shock I-Gene +
protein I-Gene +
that O +
is O +
a O +
close O +
homolog O +
of O +
the O +
clpA B-Gene +
gene O +
product O +
. O +

The O +
latter O +
is O +
the O +
ATPase B-Gene +
subunit O +
of O +
the O +
multimeric O +
ATP B-Gene +
- I-Gene +
dependent I-Gene +
protease I-Gene +
Ti I-Gene +
( I-Gene +
Clp I-Gene +
) I-Gene +
in O +
E. O +
coli O +
, O +
which O +
also O +
contains O +
the O +
21 O +
- O +
kDa O +
proteolytic O +
subunit O +
( O +
ClpP B-Gene +
) O +
. O +

The O +
clpB B-Gene +
gene O +
product O +
has O +
been O +
purified O +
to O +
near O +
homogeneity O +
by O +
DEAE O -
- O -
Sepharose O +
and O +
heparin O +
- O +
agarose O +
column O +
chromatographies O +
. O +

The O +
purified O +
ClpB B-Gene +
consists O +
of O +
a O +
major O +
93 O +
- O +
kDa O +
protein O +
and O +
a O +
minor O +
79 O +
- O +
kDa O +
polypeptide O +
as O +
analyzed O +
by O +
polyacrylamide O +
gel O +
electrophoresis O +
in O +
the O +
presence O +
of O +
sodium O +
dodecyl O +
sulfate O +
. O +

Upon O +
gel O +
filtration O +
on O +
a O +
Superose O +
- O +
6 O +
column O +
, O +
it O +
behaves O +
as O +
a O +
350 O +
- O +
kDa O +
protein O +
. O +

Thus O +
, O +
ClpB B-Gene +
appears O +
to O +
be O +
a O +
tetrameric O +
complex O +
of O +
the O +
93 O +
- O +
kDa O +
subunit O +
. O +

The O +
purified O +
ClpB B-Gene +
has O +
ATPase B-Gene +
activity O +
which O +
is O +
stimulated O +
5 O -
- O -
10 O +
- O +
fold O +
by O +
casein B-Gene +
. O +

It O +
is O +
also O +
activated O +
by O +
insulin B-Gene +
, O +
but O +
not O +
by O +
other O +
proteins O +
, O +
including O +
globin B-Gene +
and O +
denatured O +
bovine B-Gene +
serum I-Gene +
albumin I-Gene +
. O +

ClpB B-Gene +
cleaves O +
adenosine O +
5'- O -
( O -
alpha O -
, O -
beta O -
- O -
methylene O -
) O -
-triphosphate O +
as O +
rapidly O +
as O +
ATP O +
, O +
but O +
not O +
adenosine O +
5'- O -
( O -
beta O -
, O -
gamma O -
- O -
methylene O -
) O -
-triphosphate O +
. O +

GTP O +
, O +
CTP O +
, O +
and O +
UTP O +
are O +
hydrolyzed O +
15 O +
- O +
25 O +
% O +
as O +
well O +
as O +
ATP O +
. O +

ADP O +
strongly O +
inhibits O +
ATP O +
hydrolysis O +
with O +
a O +
Ki O +
of O +
34 O +
microM O +
. O +

ClpB B-Gene +
has O +
a O +
Km O +
for O +
ATP O +
of O +
1.1 O +
mM O +
, O +
and O +
casein B-Gene +
increases O +
its O +
Vmax O +
for O +
ATP O +
without O +
affecting O +
its O +
Km O +
. O +

A O +
Mg2 O -
+ O +
concentration O +
of O +
3 O +
mM O +
is O +
necessary O +
for O +
half O +
- O +
maximal O +
ATP O +
hydrolysis O +
. O +

Mn2 O -
+ O +
supports O +
ATPase B-Gene +
activity O +
as O +
well O +
as O +
Mg2 O -
+ O +
, O +
and O +
Ca2 O -
+ O +
has O +
about O +
20 O +
% O +
their O +
activity O +
. O +

Anti O +
- O +
ClpB B-Gene +
antiserum O +
does O +
not O +
cross O +
- O +
react O +
with O +
ClpA B-Gene +
nor O +
does O +
anti O +
- O +
ClpA B-Gene +
antiserum O +
react O +
with O +
ClpB B-Gene +
. O +

In O +
addition O +
, O +
ClpB B-Gene +
can O -
not O +
replace O +
ClpA B-Gene +
in O +
supporting O +
the O +
casein B-Gene +
- O +
degrading O +
activity O +
of O +
ClpP B-Gene +
. O +

Thus O +
, O +
ClpB B-Gene +
is O +
distinct O +
from O +
ClpA B-Gene +
in O +
its O +
structural O +
and O +
biochemical O +
properties O +
despite O +
the O +
similarities O +
in O +
their O +
sequences O +
. O +

Overexpression O +
, O +
purification O +
and O +
characterization O +
of O +
the O +
Escherichia O +
coli O +
MelR B-Gene +
transcription O +
activator O +
protein O +
. O +

The O +
gene O +
encoding O +
Escherichia O +
coli O +
MelR B-Gene +
protein O +
has O +
been O +
cloned O +
in O +
the O +
expression O +
vector O +
pJLA502 O +
. O +

MelR B-Gene +
has O +
been O +
overexpressed O +
, O +
substantially O +
purified O +
and O +
shown O +
to O +
bind O +
to O +
DNA O +
fragments O +
carrying O +
the O +
melAB B-Gene +
promoter O +
. O +

A O +
truncated O +
version O +
of O +
the O +
melR B-Gene +
gene O +
, O +
encoding O +
the O +
C O +
- O +
terminal O +
half O +
of O +
MelR B-Gene +
, O +
was O +
also O +
cloned O +
into O +
pJLA502 O +
; O +
the O +
protein O +
product O +
of O +
this O +
truncated O +
gene O +
binds O +
to O +
the O +
melAB B-Gene +
promoter O +
but O +
was O +
not O +
overproduced O +
. O +

A O +
number O +
of O +
amino O +
acid O +
substitutions O +
were O +
made O +
in O +
the O +
recognition O +
helices O +
of O +
two O +
putative O +
helix O +
- O +
turn O +
- O +
helix O +
motifs O +
in O +
the O +
C O +
- O +
terminal O +
part O +
of O +
MelR B-Gene +
, O +
and O +
the O +
effects O +
of O +
these O +
mutations O +
on O +
MelR B-Gene +
- O +
dependent O +
transcription O +
initiation O +
at O +
the O +
melAB B-Gene +
promoter O +
have O +
been O +
measured O +
. O +

IFN B-Gene -
- B-Gene -
alpha I-Gene +
skews O +
monocyte O +
differentiation O +
into O +
Toll B-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
7 I-Gene +
- O +
expressing O +
dendritic O +
cells O +
with O +
potent O +
functional O +
activities O +
. O +

IFN B-Gene -
- I-Gene -
alpha I-Gene +
is O +
an O +
important O +
cytokine B-Gene +
for O +
the O +
generation O +
of O +
a O +
protective O +
T O +
cell O +
- O +
mediated O +
immune O +
response O +
to O +
viruses O +
. O +

In O +
this O +
study O +
, O +
we O +
asked O +
whether O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
can O +
regulate O +
the O +
functional O +
properties O +
of O +
dendritic O +
cells O +
( O +
DCs O +
) O +
. O +

We O +
show O +
that O +
monocytes O +
cultured O +
in O +
the O +
presence O +
of O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
and O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
can O +
differentiate O +
into O +
DCs O +
( O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
- O +
derived O +
DCs O +
( O +
IFN B-Gene +
- O +
DCs O +
) O +
) O +
. O +

When O +
compared O +
with O +
DCs O +
generated O +
in O +
the O +
presence O +
of O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
and O +
IL-4 B-Gene +
( O +
IL-4 B-Gene +
- O +
derived O +
DCs O +
) O +
, O +
IFN B-Gene +
- O +
DCs O +
exhibited O +
a O +
typical O +
DC O +
morphology O +
and O +
expressed O +
, O +
in O +
addition O +
to O +
DC O +
markers O +
CD1a B-Gene +
and O +
blood O +
DC O +
Ag O +
4 O +
, O +
a O +
similar O +
level O +
of O +
costimulatory O +
and O +
class B-Gene +
II I-Gene +
MHC I-Gene +
molecules O +
, O +
but O +
a O +
significantly O +
higher O +
level O +
of O +
MHC B-Gene +
class I-Gene +
I I-Gene +
molecules O +
. O +

After O +
maturation O +
with O +
CD40 B-Gene +
ligand I-Gene +
, O +
IFN B-Gene +
- O +
DCs O +
up O +
- O +
regulated O +
costimulatory O +
, O +
class B-Gene +
I I-Gene +
and I-Gene +
II I-Gene +
MHC I-Gene +
molecules O +
and O +
expressed O +
mature O +
DC O +
markers O +
such O +
as O +
CD83 B-Gene +
and O +
DC O +
- O +
lysosome B-Gene +
- I-Gene +
associated I-Gene +
membrane I-Gene +
protein I-Gene +
. O +

DCs O +
were O +
endowed O +
with O +
potent O +
functional O +
activities O +
. O +

DCs O +
secreted O +
large O +
amounts O +
of O +
the O +
inflammatory O +
cytokines B-Gene +
IL-6 B-Gene +
, O +
IL-10 B-Gene +
, O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
, O +
IL-1beta B-Gene +
, O +
and O +
IL-18 B-Gene +
, O +
and O +
promoted O +
a O +
Th1 O +
response O +
that O +
was O +
independent O +
of O +
IL B-Gene +
- I-Gene +
12p70 I-Gene +
and O +
IL B-Gene +
- I-Gene +
18 I-Gene +
, O +
but O +
substantially O +
inhibited O +
by O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
neutralization O +
. O +

Furthermore O +
, O +
immature O +
IFN B-Gene +
- O +
DCs O +
induced O +
a O +
potent O +
autologous O +
Ag O +
- O +
specific O +
immune O +
response O +
, O +
as O +
evaluated O +
by O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
secretion O +
and O +
expansion O +
of O +
CD8 B-Gene +
( O +
+ O +
) O +
T O +
cells O +
specific O +
for O +
CMV O +
. O +

Also O +
, O +
IFN B-Gene +
- O +
DCs O +
expressed O +
a O +
large O +
number O +
of O +
Toll B-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
TLRs B-Gene +
) O +
, O +
including O +
acquisition O +
of O +
TLR7 B-Gene +
, O +
which O +
is O +
classically O +
found O +
on O +
the O +
natural O +
type B-Gene +
I I-Gene +
IFN I-Gene +
- O +
producing O +
plasmacytoid O +
DCs O +
. O +

Like O +
plasmacytoid O +
DCs O +
, O +
IFN B-Gene +
- O +
DCs O +
could O +
secrete O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
following O +
viral O +
stimulation O +
or O +
TLR7 B-Gene +
- O +
specific O +
stimulation O +
. O +

Taken O +
together O +
, O +
these O +
results O +
illustrate O +
the O +
critical O +
role O +
of O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
at O +
the O +
early O +
steps O +
of O +
immune O +
response O +
to O +
pathogens O +
or O +
in O +
autoimmune O +
diseases O +
. O +

Complexes O +
of O +
RecA B-Gene +
with O +
LexA B-Gene +
and O +
RecX B-Gene +
differentiate O +
between O +
active O +
and O +
inactive O +
RecA B-Gene +
nucleoprotein O +
filaments O +
. O +

The O +
bacterial O +
RecA B-Gene +
protein O +
has O +
been O +
the O +
dominant O +
model O +
system O +
for O +
understanding O +
homologous O +
genetic O +
recombination O +
. O +

Although O +
a O +
crystal O +
structure O +
of O +
RecA B-Gene +
was O +
solved O +
ten O +
years O +
ago O +
, O +
we O +
still O +
do O +
not O +
have O +
a O +
detailed O +
understanding O +
of O +
how O +
the O +
helical O +
filament O +
formed O +
by O +
RecA B-Gene +
on O +
DNA O +
catalyzes O +
the O +
recognition O +
of O +
homology O +
and O +
the O +
exchange O +
of O +
strands O +
between O +
two O +
DNA O +
molecules O +
. O +

Recent O +
structural O +
and O +
spectroscopic O +
studies O +
have O +
suggested O +
that O +
subunits O +
in O +
the O +
helical O +
filament O +
formed O +
in O +
the O +
RecA B-Gene +
crystal O +
are O +
rotated O +
when O +
compared O +
to O +
the O +
active O +
RecA B-Gene +
- O +
ATP O +
- O +
DNA O +
filament O +
. O +

We O +
examine O +
RecA B-Gene +
- O +
DNA O +
- O +
ATP O +
filaments O +
complexed O +
with O +
LexA B-Gene +
and O +
RecX B-Gene +
to O +
shed O +
more O +
light O +
on O +
the O +
active O +
RecA B-Gene +
filament O +
. O +

The O +
LexA B-Gene +
repressor I-Gene +
and O +
RecX B-Gene +
, O +
an O +
inhibitor O +
of O +
RecA B-Gene +
, O +
both O +
bind O +
within O +
the O +
deep O +
helical O +
groove O +
of O +
the O +
RecA B-Gene +
filament O +
. O +

Residues O +
on O +
RecA B-Gene +
that O +
interact O +
with O +
LexA B-Gene +
can O -
not O +
be O +
explained O +
by O +
the O +
crystal O +
filament O +
, O +
but O +
can O +
be O +
properly O +
positioned O +
in O +
an O +
existing O +
model O +
for O +
the O +
active O +
filament O +
. O +

We O +
show O +
that O +
the O +
strand O +
exchange O +
activity O +
of O +
RecA B-Gene +
, O +
which O +
can O +
be O +
inhibited O +
when O +
RecX B-Gene +
is O +
present O +
at O +
very O +
low O +
stoichiometry O +
, O +
is O +
due O +
to O +
RecX B-Gene +
forming O +
a O +
block O +
across O +
the O +
deep O +
helical O +
groove O +
of O +
the O +
RecA B-Gene +
filament O +
, O +
where O +
strand O +
exchange O +
occurs O +
. O +

It O +
has O +
previously O +
been O +
shown O +
that O +
changes O +
in O +
the O +
nucleotide O +
bound O +
to O +
RecA B-Gene +
are O +
associated O +
with O +
large O +
motions O +
of O +
RecA B-Gene +
's O +
C O +
- O +
terminal O +
domain O +
. O +

Since O +
RecX B-Gene +
binds O +
from O +
the O +
C O +
- O +
terminal O +
domain O +
of O +
one O +
subunit O +
to O +
the O +
nucleotide O +
- O +
binding O +
core O +
of O +
another O +
subunit O +
, O +
a O +
stabilization O +
of O +
RecA B-Gene +
's O +
C O +
- O +
terminal O +
domain O +
by O +
RecX B-Gene +
can O +
likely O +
explain O +
the O +
inhibition O +
of O +
RecA B-Gene +
's O +
ATPase B-Gene +
activity O +
by O +
RecX B-Gene +
. O +

Prospecting O +
for O +
novel O +
biocatalysts O +
in O +
a O +
soil O +
metagenome O +
. O +

The O +
metagenomes O +
of O +
complex O +
microbial O +
communities O +
are O +
rich O +
sources O +
of O +
novel O +
biocatalysts O +
. O +

We O +
exploited O +
the O +
metagenome O +
of O +
a O +
mixed O +
microbial O +
population O +
for O +
isolation O +
of O +
more O +
than O +
15 O +
different O +
genes O +
encoding O +
novel O +
biocatalysts O +
by O +
using O +
a O +
combined O +
cultivation O +
and O +
direct O +
cloning O +
strategy O +
. O +

A O +
16S O +
rRNA O +
sequence O +
analysis O +
revealed O +
the O +
presence O +
of O +
hitherto O +
uncultured O +
microbes O +
closely O +
related O +
to O +
the O +
genera O +
Pseudomonas O +
, O +
Agrobacterium O +
, O +
Xanthomonas O +
, O +
Microbulbifer O +
, O +
and O +
Janthinobacterium O +
. O +

Total O +
genomic O +
DNA O +
from O +
this O +
bacterial O +
community O +
was O +
used O +
to O +
construct O +
cosmid O +
DNA O +
libraries O +
, O +
which O +
were O +
functionally O +
searched O +
for O +
novel O +
enzymes O +
of O +
biotechnological O +
value O +
. O +

Our O +
searches O +
in O +
combination O +
with O +
cosmid O +
sequencing O +
resulted O +
in O +
identification O +
of O +
four O +
clones O +
encoding O +
12 O +
putative O +
agarase B-Gene +
genes O +
, O +
most O +
of O +
which O +
were O +
organized O +
in O +
clusters O +
consisting O +
of O +
two O +
or O +
three O +
genes O +
. O +

Interestingly O +
, O +
nine O +
of O +
these O +
agarase B-Gene +
genes O +
probably O +
originated O +
from O +
gene O +
duplications O +
. O +

Furthermore O +
, O +
we O +
identified O +
by O +
DNA O +
sequencing O +
several O +
other O +
biocatalyst O +
- O +
encoding O +
genes O +
, O +
including O +
genes O +
encoding O +
a O +
putative O +
stereoselective O +
amidase B-Gene +
( O +
amiA B-Gene +
) O +
, O +
two O +
cellulases B-Gene +
( O +
gnuB B-Gene +
and O +
uvs080 B-Gene +
) O +
, O +
an O +
alpha B-Gene -
- I-Gene -
amylase I-Gene +
( O +
amyA B-Gene +
) O +
, O +
a O +
1,4-alpha B-Gene -
- I-Gene -
glucan I-Gene +
branching I-Gene +
enzyme I-Gene +
( O +
amyB B-Gene +
) O +
, O +
and O +
two O +
pectate B-Gene +
lyases I-Gene +
( O +
pelA B-Gene +
and O +
uvs119 B-Gene +
) O +
. O +

Also O +
, O +
a O +
conserved O +
cluster O +
of O +
two O +
lipase B-Gene +
genes O +
was O +
identified O +
, O +
which O +
was O +
linked O +
to O +
genes O +
encoding O +
a O +
type O +
I O +
secretion O +
system O +
. O +

The O +
novel O +
gene O +
aguB B-Gene +
was O +
overexpressed O +
in O +
Escherichia O +
coli O +
, O +
and O +
the O +
enzyme O +
activities O +
were O +
determined O +
. O +

Finally O +
, O +
we O +
describe O +
more O +
than O +
162 O +
kb O +
of O +
DNA O +
sequence O +
that O +
provides O +
a O +
strong O +
platform O +
for O +
further O +
characterization O +
of O +
this O +
microbial O +
consortium O +
. O +

Analysis O +
of O +
the O +
alternative B-Gene +
oxidase I-Gene +
promoters O +
from O +
soybean O +
. O +

Alternative B-Gene +
oxidase I-Gene +
( O +
Aox B-Gene +
) O +
is O +
a O +
nuclear O +
- O +
encoded O +
mitochondrial O +
protein O +
. O +

In O +
soybean O +
( O +
Glycine O +
max O +
) O +
, O +
the O +
three O +
members O +
of O +
the O +
gene O +
family O +
have O +
been O +
shown O +
to O +
be O +
differentially O +
expressed O +
during O +
normal O +
plant O +
development O +
and O +
in O +
response O +
to O +
stresses O +
. O +

To O +
examine O +
the O +
function O +
of O +
the O +
Aox B-Gene +
promoters O +
, O +
genomic O +
fragments O +
were O +
obtained O +
for O +
all O +
three O +
soybean O +
genes O +
: O +
Aox1 B-Gene +
, O +
Aox2a B-Gene +
, O +
and O +
Aox2b B-Gene +
. O +

The O +
regions O +
of O +
these O +
fragments O +
immediately O +
upstream O +
of O +
the O +
coding O +
regions O +
were O +
used O +
to O +
drive O +
beta B-Gene -
- I-Gene -
glucuronidase I-Gene +
( O +
GUS B-Gene +
) O +
expression O +
during O +
transient O +
transformation O +
of O +
soybean O +
suspension O +
culture O +
cells O +
and O +
stable O +
transformation O +
of O +
Arabidopsis O +
. O +

The O +
expression O +
patterns O +
of O +
the O +
GUS B-Gene +
reporter O +
genes O +
in O +
soybean O +
cells O +
were O +
in O +
agreement O +
with O +
the O +
presence O +
or O +
absence O +
of O +
the O +
various O +
endogenous O +
Aox B-Gene +
proteins O +
, O +
determined O +
by O +
immunoblotting O +
. O +

Deletion O +
of O +
different O +
portions O +
of O +
the O +
upstream O +
regions O +
identified O +
sequences O +
responsible O +
for O +
both O +
positive O +
and O +
negative O +
regulation O +
of O +
Aox B-Gene +
gene O +
expression O +
in O +
soybean O +
cells O +
. O +

Reporter O +
gene O +
analysis O +
in O +
Arabidopsis O +
plants O +
showed O +
differential O +
tissue O +
expression O +
patterns O +
driven O +
by O +
the O +
three O +
upstream O +
regions O +
, O +
similar O +
to O +
those O +
reported O +
for O +
the O +
endogenous O +
proteins O +
in O +
soybean O +
. O +

The O +
expression O +
profiles O +
of O +
all O +
five O +
members O +
of O +
the O +
Arabidopsis O +
Aox B-Gene +
gene I-Gene +
family I-Gene +
were O +
examined O +
also O +
, O +
to O +
compare O +
with O +
GUS B-Gene +
expression O +
driven O +
by O +
the O +
soybean O +
upstream O +
fragments O +
. O +

Even O +
though O +
the O +
promoter O +
activity O +
of O +
the O +
upstream O +
fragments O +
from O +
soybean O +
Aox2a B-Gene +
and O +
Aox2b B-Gene +
displayed O +
the O +
same O +
tissue O +
specificity O +
in O +
Arabidopsis O +
as O +
they O +
do O +
in O +
soybean O +
, O +
the O +
most O +
prominently O +
expressed O +
endogenous O +
genes O +
in O +
all O +
tissues O +
of O +
Arabidopsis O +
were O +
of O +
the O +
Aox1 B-Gene +
type O +
. O +

Thus O +
although O +
regulation O +
of O +
Aox B-Gene +
expression O +
generally O +
appears O +
to O +
involve O +
the O +
same O +
signals O +
in O +
different O +
species O +
, O +
different O +
orthologs O +
of O +
Aox B-Gene +
may O +
respond O +
variously O +
to O +
these O +
signals O +
. O +

A O +
comparison O +
of O +
upstream O +
sequences O +
between O +
soybean O +
Aox B-Gene +
genes O +
and O +
similarly O +
expressed O +
Arabidopsis O +
Aox B-Gene +
genes O +
identified O +
common O +
motifs O +
. O +

[ O +
The O +
role O +
of O +
Smads B-Gene +
and O +
related O +
transcription B-Gene +
factors I-Gene +
in O +
the O +
signal O +
transduction O +
of O +
bone B-Gene +
morphogenetic I-Gene +
protein I-Gene +
inducing O +
bone O +
formation O +
] O +

OBJECTIVE O +
: O +

To O +
clarify O +
the O +
mechanisms O +
of O +
the O +
signal O +
transduction O +
of O +
bone B-Gene +
morphogenetic I-Gene +
proteins I-Gene +
( O +
BMPs B-Gene +
) O +
inducing O +
bone O +
formation O +
and O +
to O +
provide O +
theoretical O +
basis O +
for O +
basic O +
and O +
applying O +
research O +
of O +
BMPs B-Gene +
. O +

METHOD O +
: O +

We O +
looked O +
up O +
the O +
literature O +
of O +
the O +
role O +
of O +
Smads B-Gene +
and O +
related O +
transcription B-Gene +
factors I-Gene +
in O +
the O +
signal O +
transduction O +
of O +
BMPs B-Gene +
inducing O +
bone O +
formation O +
. O +

RESULTS O +
: O +

The O +
signal O +
transduction O +
processes O +
of O +
BMPs B-Gene +
included O +
: O +
1 O +
. O +

BMPs B-Gene +
combined O +
with O +
type O +
II O +
and O +
type O +
I O +
receptors O +
; O +
2 O -
. O +
the O +
type O +
I O +
receptor O +
phosphorylated O +
Smads B-Gene +
; O +
and O +
3 O +
. O +

Smads B-Gene +
entered O +
the O +
cell O +
nucleus O +
, O +
interacted O +
with O +
transcription B-Gene +
factors I-Gene +
and O +
influenced O +
the O +
transcription O +
of O +
related O +
proteins O +
. O +

Smads B-Gene +
could O +
be O +
divided O +
into O +
receptor O +
- O +
regulated O +
Smads B-Gene +
( O +
R B-Gene -
- I-Gene -
Smads I-Gene +
: O +
Smad1 B-Gene +
, O +
Smad2 B-Gene +
, O +
Smad3 B-Gene +
, O +
Smad5 B-Gene +
, O +
Smad8 B-Gene +
and O +
Smad9 B-Gene +
) O +
, O +
common O -
- O -
mediator O +
Smad B-Gene +
( O +
co O +
- O +
Smad B-Gene +
: O +
Smad4 B-Gene +
) O +
, O +
and O +
inhibitory O +
Smads B-Gene +
( O +
I- O +
Smads B-Gene +
: O +
Smad6 B-Gene +
and O +
Smad7 B-Gene +
) O +
. O +

Smad1 B-Gene +
, O +
Smad5 B-Gene +
, O +
Smad8 B-Gene +
, O +
and O +
probable O +
Smad9 B-Gene +
were O +
involved O +
in O +
the O +
signal O +
transduction O +
of O +
BMPs B-Gene +
. O +

Multiple O +
kinases B-Gene +
, O +
such O +
as O +
focal B-Gene +
adhesion I-Gene +
kinase I-Gene +
( O +
FAK B-Gene +
) O +
, O +
Ras B-Gene +
- O +
extracellular B-Gene +
signal I-Gene +
- I-Gene +
regulated I-Gene +
kinase I-Gene +
( O +
ERK B-Gene +
) O +
, O +
phosphatidylinositol B-Gene +
3 I-Gene +
- I-Gene +
kinase I-Gene +
( O +
PI3 B-Gene -
K I-Gene +
) O +
, O +
and O +
Akt B-Gene +
serine I-Gene +
/ I-Gene +
threonine I-Gene +
kinase I-Gene +
were O +
related O +
to O +
Smads B-Gene +
signal O +
transduction O +
. O +

Smad1 B-Gene +
and O +
Smad5 B-Gene +
related O +
with O +
transcription B-Gene +
factors I-Gene +
included O +
core B-Gene +
binding I-Gene +
factor I-Gene +
A1 I-Gene +
( O +
CBFA1 B-Gene +
) O +
, O +
smad B-Gene +
- I-Gene +
interacting I-Gene +
protein I-Gene +
1 I-Gene +
( O +
SIP1 B-Gene +
) O +
, O +
ornithine B-Gene +
decarboxylase I-Gene +
antizyme I-Gene +
( O +
OAZ B-Gene +
) O +
, O +
activating B-Gene +
protein I-Gene +
- I-Gene +
1 I-Gene +
( O +
AP-1 B-Gene +
) O +
, O +
xenopus O +
ventralizing B-Gene +
homeobox I-Gene +
protein-2 I-Gene +
( O +
Xvent B-Gene +
- I-Gene +
2 I-Gene +
) O +
, O +
sandostatin O +
( O +
Ski O +
) O +
, O +
antiproliferative O +
proteins O +
( O +
Tob O +
) O +
, O +
and O +
homeodomain B-Gene +
- I-Gene +
containing I-Gene +
transcriptian I-Gene +
factor I-Gene +
- I-Gene +
8 I-Gene +
( O +
Hoxc B-Gene +
- I-Gene +
8 I-Gene +
) O +
, O +
et O +
al. O +
CBFA1 B-Gene +
could O +
interact O +
with O +
Smad1 B-Gene +
, O +
Smad2 B-Gene +
, O +
Smad3 B-Gene +
, O +
and O +
Smad5 B-Gene +
, O +
so O +
it O +
was O +
involved O +
in O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
and O +
BMP-2 B-Gene +
signal O +
transduction O +
, O +
and O +
played O +
an O +
important O +
role O +
in O +
the O +
bone O +
formation O +
. O +

Cleidocranial O +
dysplasia O +
( O +
CCD O +
) O +
was O +
thought O +
to O +
be O +
caused O +
by O +
heterozygous O +
mutations O +
in O +
CBFA1 B-Gene +
. O +

The O +
CBFA1 B-Gene +
knockout O +
mice O +
showed O +
no O +
osteogenesis O +
and O +
had O +
maturational O +
disturbance O +
of O +
chondrocytes O +
. O +

CONCLUSION O +
: O +

Smads B-Gene +
and O +
related O +
transcription B-Gene +
factors I-Gene +
, O +
especially O +
Smad1 B-Gene +
, O +
Smad5 B-Gene +
, O +
Smad8 B-Gene +
and O +
CBFA1 B-Gene +
, O +
play O +
an O +
important O +
role O +
in O +
the O +
signal O +
transduction O +
of O +
BMPs B-Gene +
inducing O +
bone O +
formation O +
. O +

IL-27 B-Gene +
and O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
signal O +
via O +
Stat1 B-Gene +
and O +
Stat3 B-Gene +
and O +
induce O +
T O -
- O -
Bet O +
and O +
IL-12Rbeta2 B-Gene +
in O +
naive O +
T O +
cells O +
. O +

Interleukin-27 B-Gene +
( O +
IL-27 B-Gene +
) O +
supports O +
proliferation O +
of O +
naive O +
CD4 B-Gene +
( O +
+ O +
) O +
T O +
cells O +
and O +
enhances O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
( O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
production O +
by O +
activated O +
T O +
cells O +
and O +
natural O +
killer O +
( O +
NK O +
) O +
cells O +
. O +

We O +
report O +
here O +
that O +
IL-27 B-Gene +
induces O +
Stat1 B-Gene +
and O +
Stat3 B-Gene +
phosphorylation O +
and O +
activation O +
in O +
human O +
and O +
murine O +
cell O +
lines O +
and O +
primary O +
human O +
T O +
cells O +
. O +

IL-27 B-Gene +
also O +
induces O +
T B-Gene -
- I-Gene -
Bet I-Gene +
, O +
a O +
Stat1 B-Gene +
- O +
dependent O +
gene O +
crucial O +
to O +
Th1 O +
cell O +
commitment O +
. O +

Similarly O +
, O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
activates O +
Stat1 B-Gene +
and O +
Stat3 B-Gene +
and O +
T B-Gene -
- I-Gene -
Bet I-Gene +
expression O +
in O +
naive O +
T O +
cells O +
. O +

Induction O +
of O +
T B-Gene -
- I-Gene -
Bet I-Gene +
results O +
in O +
upregulation O +
of O +
IL-12Rbeta2 B-Gene +
on O +
naive O +
T O +
cells O +
, O +
which O +
is O +
essential O +
for O +
responsiveness O +
to O +
IL-12 B-Gene +
and O +
differentiation O +
to O +
a O +
Th1 O +
phenotype O +
. O +

Both O +
IL-27 B-Gene +
and O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
induce O +
expression O +
of O +
IL-12Rbeta2 B-Gene +
in O +
T O +
cells O +
. O +

In O +
contrast O +
, O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
, O +
which O +
activates O +
Stat1 B-Gene +
but O +
not O +
Stat3 B-Gene +
, O +
induces O +
expression O +
of O +
T B-Gene -
- I-Gene -
Bet I-Gene +
but O +
not O +
IL-12Rbeta2 B-Gene +
in O +
naive O +
T O +
cells O +
. O +

We O +
propose O +
that O +
IL-27 B-Gene +
and O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
are O +
important O +
for O +
early O +
Th1 O +
commitment O +
and O +
act O +
upstream O +
of O +
IL-12 B-Gene +
and O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
in O +
this O +
pathway O +
. O +

CD8 B-Gene +
( O +
+ O +
) O +
CD28 B-Gene +
( O +
- O +
) O +
T O +
lymphocytes O +
from O +
HIV-1 O +
- O +
infected O +
patients O +
secrete O +
factors O +
that O +
induce O +
endothelial O +
cell O +
proliferation O +
and O +
acquisition O +
of O +
Kaposi O +
's O +
sarcoma O +
cell O +
features O +
. O +

Kaposi O +
's O +
sarcoma O +
( O +
KS O +
) O +
develops O +
more O +
frequently O +
in O +
human O +
immunodeficiency O +
virus O +
type O +
1 O +
( O +
HIV-1 O +
) O +
- O +
infected O +
patients O +
. O +

In O +
this O +
study O +
, O +
we O +
report O +
that O +
molecules O +
released O +
by O +
CD8 B-Gene +
( O +
+ O +
) O +
CD28 B-Gene +
( O +
- O +
) O +
T O +
lymphocytes O +
from O +
HIV-1 O +
- O +
infected O +
patients O +
promote O +
endothelial O +
- O +
cell O +
( O +
EC O +
) O +
growth O +
and O +
induce O +
ECs O +
to O +
acquire O +
spindle O +
cell O +
morphology O +
and O +
upregulation O +
of O +
intercellular B-Gene +
adhesion I-Gene +
molecule-1 I-Gene +
( O +
ICAM-1 B-Gene +
) O +
, O +
E B-Gene -
- I-Gene -
selectin I-Gene +
, O +
and O +
vascular B-Gene +
endothelial I-Gene +
cell I-Gene +
growth I-Gene +
factor I-Gene +
receptor-3 I-Gene +
( O +
VEGFR-3 B-Gene +
) O +
( O +
a O +
typical O +
feature O +
of O +
the O +
KS O +
cell O +
phenotype O +
) O +
. O +

The O +
effects O +
observed O +
on O +
ECs O +
cocultured O +
with O +
in O +
vivo O +
activated O +
CD28 B-Gene +
( O +
- O +
) O +
cells O +
were O +
partly O +
reproduced O +
when O +
ECs O +
were O +
grown O +
in O +
medium O +
containing O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
( O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
and O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
( O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
) O +
. O +

At O +
concentrations O +
similar O +
to O +
those O +
found O +
in O +
the O +
supernatant O +
of O +
in O +
vivo O +
activated O +
CD28 B-Gene +
( O +
- O +
) O +
cells O +
, O +
the O +
two O +
proinflammatory O +
cytokines B-Gene +
sustained O +
EC O +
growth O +
and O +
survival O +
only O +
when O +
combined O +
. O +

We O +
, O +
therefore O +
, O +
conclude O +
that O +
CD28 B-Gene +
( O +
- O +
) O +
T O +
lymphocytes O +
from O +
HIV-1 O +
- O +
infected O +
patients O +
exert O +
their O +
effect O +
on O +
ECs O +
through O +
a O +
mechanism O +
involving O +
both O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
. O +

This O +
finding O +
may O +
have O +
wide O +
implications O +
for O +
our O +
basic O +
understanding O +
of O +
the O +
immunopathology O +
of O +
KS O +
. O +

Canavan O +
disease O +
: O +
a O +
monogenic O +
trait O +
with O +
complex O +
genomic O +
interaction O +
. O +

Canavan O +
disease O +
( O +
CD O +
) O +
is O +
an O +
inherited O +
leukodystrophy O +
, O +
caused O +
by O +
aspartoacylase B-Gene +
( O +
ASPA B-Gene +
) O +
deficiency O +
, O +
and O +
accumulation O +
of O +
N O -
- O -
acetylaspartic O +
acid O +
( O +
NAA O +
) O +
in O +
the O +
brain O +
. O +

The O +
gene O +
for O +
ASPA B-Gene +
has O +
been O +
cloned O +
and O +
more O +
than O +
40 O +
mutations O +
have O +
been O +
described O +
, O +
with O +
two O +
founder O +
mutations O +
among O +
Ashkenazi O +
Jewish O +
patients O +
. O +

Screening O +
of O +
Ashkenazi O +
Jews O +
for O +
these O +
two O +
common O +
mutations O +
revealed O +
a O +
high O +
carrier O +
frequency O +
, O +
approximately O +
1 O +
/ O +
40 O +
, O +
so O +
that O +
programs O +
for O +
carrier O +
testing O +
are O +
currently O +
in O +
practice O +
. O +

The O +
enzyme O +
deficiency O +
in O +
CD O +
interferes O +
with O +
the O +
normal O +
hydrolysis O +
of O +
NAA O +
, O +
which O +
results O +
in O +
disruption O +
of O +
myelin O +
and O +
spongy O +
degeneration O +
of O +
the O +
white O +
matter O +
of O +
the O +
brain O +
. O +

The O +
clinical O +
features O +
of O +
the O +
disease O +
are O +
macrocephaly O +
, O +
head O +
lag O +
, O +
progressive O +
severe O +
mental O +
retardation O +
, O +
and O +
hypotonia O +
in O +
early O +
life O +
, O +
which O +
later O +
changes O +
to O +
spasticity O +
. O +

A O +
knockout O +
mouse O +
for O +
CD O +
has O +
been O +
generated O +
, O +
and O +
used O +
to O +
study O +
the O +
pathophysiological O +
basis O +
for O +
CD O +
. O +

Findings O +
from O +
the O +
knockout O +
mouse O +
indicate O +
that O +
this O +
monogenic O +
trait O +
leads O +
to O +
a O +
series O +
of O +
genomic O +
interaction O +
in O +
the O +
brain O +
. O +

Changes O +
include O +
low O +
levels O +
of O +
glutamate O +
and O +
GABA O +
. O +

Microarray O +
expression O +
analysis O +
showed O +
low O +
level O +
of O +
expression O +
of O +
GABA B-Gene -
- I-Gene -
A I-Gene +
receptor I-Gene +
( O +
GABRA6 B-Gene +
) O +
and O +
glutamate B-Gene +
transporter I-Gene +
( O +
EAAT4 B-Gene +
) O +
. O +

The O +
gene O +
Spi2 B-Gene +
, O +
a O +
gene O +
involved O +
in O +
apoptosis O +
and O +
cell O +
death O +
, O +
showed O +
high O +
level O +
of O +
expression O +
. O +

Such O +
complexity O +
of O +
gene O +
interaction O +
results O +
in O +
the O +
phenotype O +
, O +
the O +
proteome O +
, O +
with O +
spongy O +
degeneration O +
of O +
the O +
brain O +
and O +
neurological O +
impairment O +
of O +
the O +
mouse O +
, O +
similar O +
to O +
the O +
human O +
counterpart O +
. O +

Aspartoacylase B-Gene +
gene O +
transfer O +
trial O +
in O +
the O +
mouse O +
brain O +
using O +
adenoassociated O +
virus O +
( O +
AAV O +
) O +
as O +
a O +
vector O +
are O +
encouraging O +
showing O +
improved O +
myelination O +
and O +
decrease O +
in O +
spongy O +
degeneration O +
in O +
the O +
area O +
of O +
the O +
injection O +
and O +
also O +
beyond O +
that O +
site O +
. O +

Cloning O +
and O +
characterization O +
of O +
the O +
mouse O +
AP-2 B-Gene +
epsilon I-Gene +
gene O +
: O +
a O +
novel O +
family O +
member O +
expressed O +
in O +
the O +
developing O +
olfactory O +
bulb O +
. O +

Members O +
of O +
the O +
mammalian O +
AP-2 B-Gene +
transcription I-Gene +
factor I-Gene +
family I-Gene +
have O +
critical O +
regulatory O +
roles O +
in O +
many O +
aspects O +
of O +
development O +
and O +
are O +
also O +
implicated O +
in O +
cancer O +
progression O +
. O +

Four O +
AP-2 B-Gene +
genes O +
have O +
been O +
previously O +
characterized O +
in O +
mouse O +
and O +
human O +
, O +
encoding O +
the O +
AP-2alpha B-Gene +
, O +
AP-2beta B-Gene +
, O +
AP-2gamma B-Gene +
, O +
and O +
AP-2delta B-Gene +
proteins O +
. O +

Here O +
we O +
report O +
the O +
cloning O +
and O +
characterization O +
of O +
the O +
fifth O +
member O +
of O +
the O +
vertebrate O +
AP-2 B-Gene +
family I-Gene +
, O +
AP-2epsilon B-Gene +
. O +

The O +
AP-2epsilon B-Gene +
protein O +
is O +
very O +
similar O +
to O +
the O +
other O +
family O +
members O +
in O +
its O +
DNA O +
binding O +
and O +
dimerization O +
domain O +
and O +
also O +
contains O +
conserved O +
proline O +
and O +
aromatic O +
amino O +
acid O +
residues O +
in O +
the O +
activation O +
domain O +
. O +

Consistent O +
with O +
these O +
observations O +
, O +
AP-2epsilon B-Gene +
can O +
bind O +
to O +
the O +
GC O +
- O +
rich O +
AP-2 B-Gene +
consensus O +
sequence O +
and O +
can O +
dimerize O +
either O +
with O +
itself O +
or O +
with O +
any O +
of O +
the O +
other O +
AP-2 B-Gene +
proteins O +
. O +

The O +
AP-2epsilon B-Gene +
protein O +
is O +
also O +
able O +
to O +
activate O +
transcription O +
in O +
a O +
binding O +
site O +
- O +
dependent O +
manner O +
. O +

However O +
, O +
the O +
mouse O +
AP-2epsilon B-Gene +
gene O +
is O +
distinctive O +
from O +
the O +
other O +
AP-2 B-Gene +
genes O +
in O +
its O +
pattern O +
of O +
expression O +
during O +
embryogenesis O +
. O +

Unlike O +
AP-2alpha B-Gene +
, O +
AP-2beta B-Gene +
, O +
and O +
AP-2gamma B-Gene +
, O +
transcripts O +
corresponding O +
to O +
AP-2epsilon B-Gene +
are O +
not O +
found O +
in O +
the O +
neural O +
crest O +
and O +
its O +
derivatives O +
. O +

Instead O +
, O +
AP-2epsilon B-Gene +
is O +
expressed O +
most O +
prominently O +
in O +
the O +
mitral O +
cell O +
layer O +
of O +
the O +
developing O +
olfactory O +
bulb O +
. O +

A O +
comparison O +
of O +
AP-2 B-Gene +
gene O +
family O +
expression O +
in O +
the O +
olfactory O +
system O +
suggests O +
both O +
distinct O +
and O +
overlapping O +
functions O +
for O +
these O +
transcription B-Gene +
factors I-Gene +
in O +
forebrain O +
development O +
. O +

Expression O +
profiles O +
of O +
peroxiredoxin B-Gene +
proteins O +
of O +
the O +
rodent O +
malaria O +
parasite O +
Plasmodium O +
yoelii O +
. O +

Patterns O +
of O +
expression O +
of O +
the O +
2-Cys B-Gene +
and I-Gene +
1-Cys I-Gene +
peroxiredoxin I-Gene +
( O +
Prx B-Gene +
) O +
proteins O +
of O +
the O +
rodent O +
malaria O +
parasite O +
Plasmodium O +
yoelii O +
during O +
its O +
life O +
cycle O +
were O +
observed O +
by O +
immunofluorescent O +
antibody O +
staining O +
and O +
confocal O +
laser O +
scanning O +
microscopy O +
. O +

2-Cys B-Gene +
Prx I-Gene +
was O +
expressed O +
in O +
the O +
parasite O +
cytoplasm O +
throughout O +
the O +
life O +
cycle O +
, O +
and O +
the O +
thioredoxin B-Gene +
( I-Gene +
Trx I-Gene +
) I-Gene +
- I-Gene +
peroxidase I-Gene +
activity O +
of O +
2-Cys B-Gene +
Prx I-Gene +
revealed O +
with O +
the O +
recombinant O +
protein O +
suggested O +
that O +
the O +
Prx B-Gene +
is O +
constitutively O +
expressed O +
and O +
, O +
thus O +
, O +
likely O +
plays O +
a O +
housekeeping O +
role O +
in O +
the O +
parasite O +
's O +
intracellular O +
redox O +
control O +
. O +

In O +
contrast O +
, O +
1-Cys B-Gene +
Prx I-Gene +
showed O +
stage O +
- O +
specific O +
expression O +
in O +
blood O +
- O +
stage O +
parasites O +
. O +

The O +
limited O +
expression O +
of O +
1-Cys B-Gene +
Prx I-Gene +
in O +
the O +
trophozoite O +
cytoplasm O +
suggests O +
that O +
1-Cys B-Gene +
Prx I-Gene +
may O +
be O +
involved O +
in O +
haemoglobin O +
metabolism O +
by O +
the O +
parasite O +
, O +
which O +
generates O +
a O +
prooxidative O +
haem O +
iron O +
and O +
increases O +
intracellular O +
oxidative O +
stress O +
. O +

The O +
antioxidant O +
activity O +
of O +
1-Cys B-Gene +
Prx I-Gene +
was O +
tested O +
for O +
its O +
ability O +
to O +
protect O +
yeast O +
enolase O +
against O +
inactivation O +
of O +
the O +
mixed O +
- O +
function O +
oxidation O +
system O +
. O +

Differential O +
expression O +
of O +
the O +
two O +
Prx B-Gene +
proteins O +
during O +
the O +
erythrocytic O +
and O +
insect O +
stages O +
suggests O +
the O +
importance O +
of O +
these O +
proteins O +
in O +
protecting O +
parasites O +
against O +
oxidative O +
stress O +
, O +
which O +
is O +
generated O +
by O +
the O +
parasite O +
's O +
metabolism O +
and O +
also O +
from O +
the O +
environment O +
. O +

Evidence O +
that O +
the O +
37 B-Gene +
kDa I-Gene +
protein I-Gene +
of O +
Soil O +
- O +
borne O +
wheat O +
mosaic O +
virus O +
is O +
a O +
virus O +
movement O +
protein O +
. O +

Experiments O +
were O +
conducted O +
to O +
determine O +
if O +
the O +
37 B-Gene +
kDa I-Gene +
protein I-Gene +
( O +
37 O -
K O +
) O +
of O +
Soil O +
- O +
borne O +
wheat O +
mosaic O +
virus O +
( O +
SBWMV O +
) O +
is O +
a O +
virus O +
movement O +
protein O +
. O +

First O +
, O +
evidence O +
was O +
obtained O +
that O +
indicated O +
that O +
37 B-Gene -
K I-Gene +
has O +
the O +
ability O +
to O +
move O +
from O +
cell O +
to O +
cell O +
, O +
similar O +
to O +
other O +
virus O +
movement O +
proteins O +
( O +
MPs O +
) O +
. O +

Plasmids O +
containing O +
the O +
GFP B-Gene +
gene O +
fused O +
to O +
the O +
SBWMV O +
37 B-Gene -
K I-Gene +
, O +
the O +
coat B-Gene +
protein I-Gene +
( O +
CP B-Gene +
) O +
or O +
the O +
CP B-Gene +
readthrough O +
domain O +
( O +
RT O +
) O +
ORFs O +
were O +
delivered O +
by O +
biolistic O +
bombardment O +
to O +
wheat O +
and O +
tobacco O +
leaves O +
. O +

In O +
wheat O +
leaves O +
, O +
cell O +
- O +
to O +
- O +
cell O +
movement O +
of O +
GFP B-Gene +
- O +
37 B-Gene -
K I-Gene +
was O +
observed O +
, O +
while O +
GFP B-Gene +
, O +
GFP B-Gene +
- O +
CP B-Gene +
and O +
GFP B-Gene +
- O +
RT O +
accumulated O +
primarily O +
in O +
single O +
cells O +
. O +

All O +
fusion O +
proteins O +
accumulated O +
in O +
single O +
cells O +
in O +
tobacco O +
leaves O +
. O +

Thus O +
, O +
cell O +
- O +
to O +
- O +
cell O +
movement O +
is O +
a O +
specific O +
property O +
of O +
37 B-Gene -
K I-Gene +
that O +
occurs O +
in O +
SBWMV O +
host O +
plants O +
. O +

Subcellular O +
accumulation O +
of O +
37 B-Gene -
K I-Gene +
was O +
studied O +
using O +
SBWMV O +
- O +
infected O +
and O +
37 O -
K O +
- O +
expressing O +
transgenic O +
wheat O +
. O +

In O +
infected O +
and O +
transgenic O +
wheat O +
leaves O +
, O +
37 B-Gene -
K I-Gene +
accumulated O +
in O +
the O +
cell O +
wall O +
, O +
similar O +
to O +
other O +
virus O +
MPs O +
, O +
and O +
in O +
aggregates O +
in O +
the O +
cytoplasm O +
. O +

Phylogenetic O +
studies O +
were O +
conducted O +
to O +
compare O +
the O +
furovirus O +
37 B-Gene -
K I-Gene +
proteins I-Gene +
with O +
members O +
of O +
the O +
30 B-Gene -
K I-Gene +
superfamily I-Gene +
of O +
virus O +
MPs O +
. O +

Amino O +
acid O +
sequences O +
of O +
the O +
furovirus O +
37 B-Gene -
K I-Gene +
proteins I-Gene +
were O +
aligned O +
with O +
the O +
MPs O +
from O +
43 O +
representative O +
viruses O +
. O +

The O +
furovirus O +
37 B-Gene -
K I-Gene +
proteins I-Gene +
were O +
found O +
to O +
reside O +
in O +
a O +
clade O +
that O +
also O +
contained O +
the O +
dianthovirus O +
MPs O +
. O +

Combined O +
, O +
these O +
data O +
suggest O +
that O +
SBWMV O +
37 B-Gene -
K I-Gene +
is O +
probably O +
a O +
virus O +
MP O +
. O +

Expression O +
of O +
nucleolar O +
- O +
related O +
proteins O +
in O +
porcine O +
preimplantation O +
embryos O +
produced O +
in O +
vivo O +
and O +
in O +
vitro O +
. O +

The O +
expression O +
of O +
nucleolar O +
- O +
related O +
proteins O +
was O +
studied O +
as O +
an O +
indirect O +
marker O +
of O +
the O +
ribosomal O +
RNA O +
( O +
rRNA O +
) O +
gene O +
activation O +
in O +
porcine O +
embryos O +
up O +
to O +
the O +
blastocyst O +
stage O +
produced O +
in O +
vivo O +
and O +
in O +
vitro O +
. O +

A O +
group O +
of O +
the O +
in O +
vivo O +
- O +
developed O +
embryos O +
were O +
cultured O +
with O +
alpha O -
- O -
amanitin O +
to O +
block O +
the O +
de O +
novo O +
embryonic O +
mRNA O +
transcription O +
. O +

Localization O +
of O +
proteins O +
involved O +
in O +
the O +
rRNA O +
transcription O +
( O +
upstream B-Gene +
binding I-Gene +
factor I-Gene +
[ O +
UBF B-Gene +
] O +
, O +
topoisomerase B-Gene +
I I-Gene +
, O +
RNA B-Gene +
polymerase I-Gene +
I I-Gene +
[ O +
RNA B-Gene +
Pol I-Gene +
I I-Gene +
] O +
, O +
and O +
the O +
RNA B-Gene +
Pol I-Gene +
I I-Gene +
- I-Gene +
associated I-Gene +
factor I-Gene +
PAF53 I-Gene +
) O +
and O +
processing O +
( O +
fibrillarin B-Gene +
, O +
nucleophosmin B-Gene +
, O +
and O +
nucleolin B-Gene +
) O +
was O +
assessed O +
by O +
immunocytochemistry O +
and O +
confocal O +
laser O +
- O +
scanning O +
microscopy O +
, O +
and O +
mRNA O +
expression O +
was O +
determined O +
by O +
semiquantitative O +
reverse O +
transcription O +
- O +
polymerase O +
chain O +
reaction O +
( O +
RT O +
- O +
PCR O +
) O +
. O +

These O +
findings O +
were O +
correlated O +
with O +
ultrastructural O +
data O +
and O +
autoradiography O +
following O +
20 O +
- O +
min O +
[ O -
3H O -
] O -
uridine O +
incubation O +
. O +

Additionally O +
, O +
expression O +
of O +
the O +
pocket B-Gene +
proteins I-Gene +
pRb B-Gene +
and O +
p130 B-Gene +
, O +
which O +
are O +
involved O +
in O +
cell O +
- O +
cycle O +
regulation O +
, O +
was O +
assessed O +
by O +
semiquantitative O +
RT O +
- O +
PCR O +
up O +
to O +
the O +
blastocyst O +
stage O +
. O +

Toward O +
the O +
end O +
of O +
third O +
cell O +
cycle O +
, O +
the O +
nuclei O +
in O +
non O +
- O +
alpha O +
- O +
amanitin O +
- O +
treated O +
, O +
in O +
vivo O +
- O +
produced O +
embryos O +
displayed O +
different O +
stages O +
of O +
transformation O +
of O +
the O +
nuclear O +
precursor O +
bodies O +
( O +
NPBs O +
) O +
into O +
fibrillogranular O +
nucleoli O +
associated O +
with O +
autoradiographic O +
labeling O +
. O +

However O +
, O +
on O +
culture O +
with O +
alpha O +
- O +
amanitin O +
, O +
NPBs O +
were O +
not O +
transformed O +
into O +
a O +
fibrillogranular O +
nucleolus O +
during O +
this O +
cell O +
cycle O +
, O +
demonstrating O +
that O +
embryonic O +
nucleogenesis O +
requires O +
de O +
novo O +
mRNA O +
transcription O +
. O +

Moreover O +
, O +
immunolocalization O +
of O +
RNA B-Gene +
Pol I-Gene +
I I-Gene +
, O +
but O +
not O +
of O +
UBF B-Gene +
, O +
and O +
the O +
mRNA O +
expression O +
of O +
PAF53 B-Gene +
and O +
UBF B-Gene +
were O +
significantly O +
reduced O +
or O +
absent O +
after O +
culture O +
with O +
alpha O +
- O +
amanitin O +
, O +
indicating O +
that O +
RNA B-Gene +
Pol I-Gene +
I I-Gene +
, O +
PAF53 B-Gene +
, O +
and O +
presumably O +
, O +
UBF B-Gene +
are O +
derived O +
from O +
de O +
novo O +
embryonic O +
transcription O +
. O +

Embryonic O +
genomic O +
activation O +
was O +
delayed O +
in O +
porcine O +
embryos O +
produced O +
in O +
vitro O +
compared O +
to O +
the O +
in O +
vivo O +
- O +
derived O +
counterparts O +
with O +
respect O +
to O +
mRNAs O +
encoding O +
PAF53 B-Gene +
and O +
UBF B-Gene +
. O +

Moreover O +
, O +
differences O +
existed O +
in O +
the O +
mRNA O +
expression O +
patterns O +
of O +
pRb B-Gene +
between O +
in O +
vivo O +
- O +
and O +
in O +
vitro O +
- O +
developed O +
embryos O +
. O +

These O +
findings O +
show O +
, O +
to O +
our O +
knowledge O +
for O +
the O +
first O +
time O +
, O +
a O +
nucleolus O +
- O +
related O +
gene O +
expression O +
in O +
the O +
preimplantation O +
porcine O +
embryo O +
, O +
and O +
they O +
highlight O +
the O +
differences O +
in O +
quality O +
between O +
in O +
vivo O +
and O +
in O +
vitro O +
- O +
produced O +
embryos O +
. O +

Identification O +
of O +
two O +
cyclooxygenase B-Gene +
active O +
site O +
residues O +
, O +
Leucine O +
384 O +
and O +
Glycine O +
526 O +
, O +
that O +
control O +
carbon O +
ring O +
cyclization O +
in O +
prostaglandin O +
biosynthesis O +
. O +

The O +
cyclooxygenase B-Gene +
( O +
COX B-Gene +
) O +
reaction O +
of O +
prostaglandin O +
( O +
PG O +
) O +
biosynthesis O +
begins O +
with O +
the O +
highly O +
specific O +
oxygenation O +
of O +
arachidonic O +
acid O +
in O +
the O +
11R O +
configuration O +
and O +
ends O +
with O +
a O +
15S O +
oxygenation O +
to O +
form O +
PGG2 O +
. O +

To O +
obtain O +
new O +
insights O +
into O +
the O +
mechanisms O +
of O +
stereocontrol O +
of O +
oxygenation O +
, O +
we O +
mutated O +
active O +
site O +
residues O +
of O +
human O +
COX-2 B-Gene +
that O +
have O +
potential O +
contacts O +
with O +
C-11 O +
of O +
the O +
reacting O +
substrate O +
. O +

Although O +
the O +
11R O +
oxygenation O +
was O +
not O +
perturbed O +
, O +
changing O +
Leu-384 O +
( O +
into O +
Phe O +
, O +
Trp O +
) O +
, O +
Trp-387 O +
( O +
Phe O +
, O +
Tyr O +
) O +
, O +
Phe-518 O +
( O +
Ile O +
, O +
Trp O +
, O +
Tyr O +
) O +
, O +
and O +
Gly-526 O +
( O +
Ala O +
, O +
Ser O +
, O +
Thr O +
, O +
Val O +
) O +
impaired O +
or O +
abrogated O +
PGG2 O +
synthesis O +
, O +
and O +
typically O +
11R O -
- O -
HETE O +
was O +
the O +
main O +
product O +
formed O +
. O +

The O +
Gly-526 O +
and O +
Leu-384 O +
mutants O +
formed O +
, O +
in O +
addition O +
, O +
three O +
novel O +
products O +
identified O +
by O +
LC O -
- O -
MS O +
, O +
NMR O +
, O +
and O +
circular O +
dichroism O +
as O +
8,9 O -
- O -
11,12-diepoxy-13R- O -
( O -
or O +
15R O +
) O +
- O +
hydro O +
( O +
pero O +
) O +
xy O +
derivatives O +
of O +
arachidonic O +
acid O +
. O +

Mechanistically O +
, O +
we O +
propose O +
these O +
arise O +
from O +
a O +
free O +
radical O +
intermediate O +
in O +
which O +
a O +
C-8 O +
carbon O +
radical O +
displaces O +
the O +
9,11-endoperoxide O +
O O -
- O -
O O +
bond O +
to O +
yield O +
an O +
8,9 O -
- O -
11,12-diepoxide O +
that O +
is O +
finally O +
oxygenated O +
stereospecifically O +
in O +
the O +
13R O +
or O +
15R O +
configuration O +
. O +

Formation O +
of O +
these O +
novel O +
products O +
signals O +
an O +
arrest O +
in O +
the O +
normal O +
course O +
of O +
prostaglandin O +
synthesis O +
just O +
prior O +
to O +
closing O +
of O +
the O +
5-membered O +
carbon O +
ring O +
, O +
and O +
points O +
to O +
a O +
crucial O +
role O +
for O +
Leu-384 O +
and O +
Gly-526 O +
in O +
the O +
correct O +
positioning O +
of O +
the O +
reacting O +
fatty O +
acid O +
intermediate O +
. O +

Some O +
of O +
the O +
Gly-526 O +
and O +
Leu-384 O +
mutants O +
catalyzed O +
both O +
formation O +
of O +
PGG2 O +
( O +
with O +
the O +
normal O +
15S O +
configuration O +
) O +
and O +
the O +
13R O +
- O +
or O +
15R O +
- O +
oxygenated O +
diepoxides O +
. O +

This O +
result O +
suggests O +
that O +
oxygenation O +
specificity O +
can O +
be O +
determined O +
by O +
the O +
orientation O +
of O +
the O +
reacting O +
fatty O +
acid O +
radical O +
and O +
is O +
not O +
a O +
predetermined O +
outcome O +
based O +
solely O +
on O +
the O +
structure O +
of O +
the O +
cyclooxygenase B-Gene +
active O +
site O +
. O +

Accumulation O +
of O +
the O +
amyloid B-Gene +
precursor I-Gene +
- I-Gene +
like I-Gene +
protein I-Gene +
APLP2 B-Gene +
and O +
reduction O +
of O +
APLP1 B-Gene +
in O +
retinoic O +
acid O +
- O +
differentiated O +
human O +
neuroblastoma O +
cells O +
upon O +
curcumin O +
- O +
induced O +
neurite O +
retraction O +
. O +

Amyloid B-Gene +
precursor I-Gene +
protein I-Gene +
( O +
APP B-Gene +
) O +
belongs O +
to O +
a O +
conserved O +
gene O +
family O +
, O +
also O +
including O +
the O +
amyloid B-Gene +
precursor I-Gene +
- I-Gene +
like I-Gene +
proteins I-Gene +
, O +
APLP1 B-Gene +
and O +
APLP2 B-Gene +
. O +

The O +
function O +
of O +
these O +
three O +
proteins O +
is O +
not O +
yet O +
fully O +
understood O +
. O +

One O +
of O +
the O +
proposed O +
roles O +
of O +
APP B-Gene +
is O +
to O +
promote O +
neurite O +
outgrowth O +
. O +

The O +
aim O +
of O +
this O +
study O +
was O +
to O +
investigate O +
the O +
regulation O +
of O +
the O +
expression O +
levels O +
of O +
APP B-Gene +
family I-Gene +
members O +
during O +
neurite O +
outgrowth O +
. O +

We O +
observed O +
that O +
retinoic O +
acid O +
( O +
RA O +
) O +
- O +
induced O +
neuronal O +
differentiation O +
of O +
human O +
SH O -
- O -
SY5Y O +
cells O +
resulted O +
in O +
increased O +
expression O +
of O +
APP B-Gene +
, O +
APLP1 B-Gene +
and O +
APLP2 B-Gene +
. O +

We O +
also O +
examined O +
the O +
effect O +
of O +
the O +
NFkappaB B-Gene +
, O +
AP-1 B-Gene +
and O +
c B-Gene -
- I-Gene -
Jun I-Gene +
N I-Gene +
- I-Gene +
terminal I-Gene +
kinase I-Gene +
inhibitor O +
curcumin O +
( O +
diferuloylmethane O +
) O +
on O +
the O +
RA O +
- O +
induced O +
expression O +
levels O +
of O +
these O +
proteins O +
. O +

We O +
found O +
that O +
treatment O +
with O +
curcumin O +
counteracted O +
the O +
RA O +
- O +
induced O +
mRNA O +
expression O +
of O +
all O +
APP B-Gene +
family I-Gene +
members O +
. O +

In O +
addition O +
, O +
we O +
observed O +
that O +
curcumin O +
treatment O +
resulted O +
in O +
neurite O +
retraction O +
without O +
any O +
effect O +
on O +
cell O +
viability O +
. O +

Surprisingly O +
, O +
curcumin O +
had O +
differential O +
effects O +
on O +
the O +
APLP B-Gene +
protein O +
levels O +
in O +
RA O +
- O +
differentiated O +
cells O +
. O +

RA O +
- O +
induced O +
APLP1 B-Gene +
protein O +
expression O +
was O +
blocked O +
by O +
curcumin O +
, O +
while O +
the O +
APLP2 B-Gene +
protein O +
levels O +
were O +
further O +
increased O +
. O +

APP B-Gene +
protein O +
levels O +
were O +
not O +
affected O +
by O +
curcumin O +
treatment O +
. O +

We O +
propose O +
that O +
the O +
sustained O +
levels O +
of O +
APP B-Gene +
and O +
the O +
elevated O +
levels O +
of O +
APLP2 B-Gene +
, O +
in O +
spite O +
of O +
the O +
reduced O +
mRNA O +
expression O +
, O +
are O +
due O +
to O +
altered O +
proteolytic O +
processing O +
of O +
these O +
proteins O +
. O +

Furthermore O +
, O +
our O +
results O +
suggest O +
that O +
APLP1 B-Gene +
does O +
not O +
undergo O +
the O +
same O +
type O +
of O +
regulated O +
processing O +
as O +
APP B-Gene +
and O +
APLP2 B-Gene +
. O +

Cloning O +
, O +
sequencing O +
, O +
and O +
expression O +
of O +
the O +
fadD B-Gene +
gene O +
of O +
Escherichia O +
coli O +
encoding O +
acyl B-Gene +
coenzyme I-Gene +
A I-Gene +
synthetase I-Gene +
. O +

In O +
the O +
enteric O +
bacterium O +
, O +
Escherichia O +
coli O +
, O +
acyl B-Gene +
coenzyme I-Gene +
A I-Gene +
synthetase I-Gene +
( O +
fatty B-Gene +
acid I-Gene +
: I-Gene +
CoA I-Gene +
ligase I-Gene +
( O +
AMP O -
- O -
forming O +
) O +
EC B-Gene +
6.2.1.3 I-Gene +
) O +
activates O +
exogenous O +
long O +
- O +
chain O +
fatty O +
acids O +
concomitant O +
with O +
their O +
transport O +
across O +
the O +
inner O +
membrane O +
into O +
metabolically O +
active O +
CoA O +
thioesters O +
. O +

These O +
compounds O +
serve O +
as O +
substrates O +
for O +
acyl B-Gene -
- I-Gene -
CoA I-Gene +
dehydrogenase I-Gene +
in O +
the O +
first O +
step O +
in O +
the O +
process O +
of O +
beta O -
- O -
oxidation O +
. O +

The O +
acyl B-Gene -
- I-Gene -
CoA I-Gene +
synthetase I-Gene +
structural O +
gene O +
, O +
fadD B-Gene +
, O +
has O +
been O +
identified O +
on O +
clone O +
6D1 O +
of O +
the O +
Kohara O +
E. O +
coli O +
gene O +
library O +
and O +
by O +
a O +
process O +
of O +
subcloning O +
and O +
complementation O +
analyses O +
shown O +
to O +
be O +
contained O +
on O +
a O +
2.2 O +
- O +
kilobase O +
NcoI B-Gene +
- O +
ClaI B-Gene +
fragment O +
of O +
genomic O +
DNA O +
. O +

The O +
polypeptide O +
encoded O +
within O +
this O +
DNA O +
fragment O +
was O +
identified O +
following O +
T7 B-Gene +
RNA I-Gene +
polymerase I-Gene +
- O +
dependent O +
induction O +
and O +
estimated O +
to O +
be O +
M O -
( O -
r O -
) O +
= O +
62,000 O +
using O +
SDS O -
- O -
polyacrylamide O +
gel O +
electrophoresis O +
. O +

The O +
N O +
- O +
terminal O +
amino O +
acid O +
sequence O +
of O +
acyl B-Gene -
- I-Gene -
CoA I-Gene +
synthetase I-Gene +
was O +
determined O +
by O +
automated O +
sequencing O +
to O +
be O +
Met O -
- O -
Lys O -
- O -
Lys O -
- O -
Val O -
- O -
Trp O -
- O -
Leu O -
- O -
Asn O -
- O -
Arg O -
- O -
Tyr O -
- O -
Pro O +
. O +

Sequence O +
analysis O +
of O +
the O +
2.2 O +
- O +
kilobase O +
NcoI B-Gene +
- O +
ClaI B-Gene +
fragment O +
revealed O +
a O +
single O +
open O +
reading O +
frame O +
encoding O +
these O +
amino O +
acids O +
as O +
the O +
first O +
10 O +
residues O +
of O +
a O +
protein O +
with O +
a O +
molecular O +
weight O +
of O +
62,028 O +
. O +

The O +
initiation O +
codon O +
for O +
methionine O +
was O +
TTG O +
. O +

Primer O +
extension O +
of O +
total O +
in O +
vivo O +
mRNA O +
from O +
two O +
fadD B-Gene +
- O +
specific O +
oligonucleotides O +
defined O +
the O +
transcriptional O +
start O +
at O +
an O +
adenine O +
residue O +
60 O +
base O +
pairs O +
upstream O +
from O +
the O +
predicted O +
translational O +
start O +
site O +
. O +

Two O +
FadR B-Gene +
operator O +
sites O +
of O +
the O +
fadD B-Gene +
gene O +
were O +
identified O +
at O +
positions O +
- O +
13 O +
to O +
- O +
29 O +
( O +
OD1 O +
) O +
and O +
positions O +
- O +
99 O +
to O +
- O +
115 O +
( O +
OD2 O +
) O +
by O +
DNase B-Gene +
I I-Gene +
footprinting O +
. O +

Comparisons O +
of O +
the O +
predicted O +
amino O +
acid O +
sequence O +
of O +
the O +
E. O +
coli O +
acyl B-Gene -
- I-Gene -
CoA I-Gene +
synthetase I-Gene +
to O +
the O +
deduced O +
amino O +
acid O +
sequences O +
of O +
the O +
rat O +
and O +
yeast O +
acyl B-Gene -
- I-Gene -
CoA I-Gene +
synthetases I-Gene +
and O +
the O +
firefly O +
luciferase B-Gene +
demonstrated O +
that O +
these O +
enzymes O +
shared O +
a O +
significant O +
degree O +
of O +
similarity O +
. O +

Based O +
on O +
the O +
similar O +
reaction O +
mechanisms O +
of O +
these O +
four O +
enzymes O +
, O +
this O +
similarity O +
may O +
define O +
a O +
region O +
required O +
for O +
the O +
same O +
function O +
. O +

pH O +
- O +
Dependent O +
modulation O +
of O +
cyclic O +
AMP O +
levels O +
and O +
GadW B-Gene +
- O +
dependent O +
repression O +
of O +
RpoS B-Gene +
affect O +
synthesis O +
of O +
the O +
GadX B-Gene +
regulator O +
and O +
Escherichia O +
coli O +
acid O +
resistance O +
. O +

Extreme O +
acid O +
resistance O +
is O +
a O +
remarkable O +
property O +
of O +
virulent O +
and O +
avirulent O +
Escherichia O +
coli O +
. O +

The O +
ability O +
to O +
resist O +
environments O +
in O +
which O +
the O +
pH O +
is O +
2.5 O +
and O +
below O +
is O +
predicted O +
to O +
contribute O +
significantly O +
to O +
the O +
survival O +
of O +
E. O +
coli O +
during O +
passage O +
through O +
the O +
gastric O +
acid O +
barrier O +
. O +

One O +
acid O +
resistance O +
system O +
imports O +
glutamate O +
from O +
acidic O +
environments O +
and O +
uses O +
it O +
as O +
a O +
proton O +
sink O +
during O +
an O +
intracellular O +
decarboxylation O +
reaction O +
. O +

Transcription O +
of O +
the O +
genes O +
encoding O +
the O +
glutamate B-Gene +
decarboxylases I-Gene +
and O +
the O +
substrate O +
- O +
product O +
antiporter B-Gene +
required O +
for O +
this O +
system O +
is O +
induced O +
under O +
a O +
variety O +
of O +
conditions O +
, O +
including O +
the O +
stationary O +
phase O +
and O +
a O +
low O +
pH O +
. O +

Acid O +
induction O +
during O +
log O +
- O +
phase O +
growth O +
in O +
minimal O +
medium O +
appears O +
to O +
occur O +
through O +
multiple O +
pathways O +
. O +

We O +
recently O +
demonstrated O +
that O +
GadE B-Gene +
, O +
the O +
essential O +
activator O +
of O +
the O +
genes O +
, O +
was O +
itself O +
acid O +
induced O +
. O +

In O +
this O +
report O +
we O +
present O +
evidence O +
that O +
there O +
is O +
a O +
regulatory O +
loop O +
involving O +
cross O +
- O +
repression O +
of O +
two O +
AraC B-Gene +
- O +
like O +
regulators O +
, O +
GadX B-Gene +
and O +
GadW B-Gene +
, O +
that O +
can O +
either O +
assist O +
or O +
interfere O +
with O +
GadE B-Gene +
activation O +
of O +
the O +
gad B-Gene +
decarboxylase I-Gene +
and I-Gene +
antiporter I-Gene +
genes O +
, O +
depending O +
on O +
the O +
culture O +
conditions O +
. O +

Balancing O +
cross O +
- O +
repression O +
appears O +
to O +
be O +
dependent O +
on O +
cAMP O +
and O +
the O +
cAMP B-Gene +
regulator I-Gene +
protein I-Gene +
( O +
CRP B-Gene +
) O +
. O +

The O +
control O +
loop O +
involves O +
the O +
GadX B-Gene +
protein O +
repressing O +
the O +
expression O +
of O +
gadW B-Gene +
and O +
the O +
GadW B-Gene +
protein O +
repressing O +
or O +
inhibiting O +
RpoS B-Gene +
, O +
which O +
is O +
the O +
alternative O +
sigma B-Gene +
factor I-Gene +
that O +
drives O +
transcription O +
of O +
gadX B-Gene +
. O +

CRP B-Gene +
and O +
cAMP O +
appear O +
to O +
influence O +
GadX B-Gene +
- O +
GadW B-Gene +
cross O +
- O +
repression O +
from O +
outside O +
the O +
loop O +
by O +
inhibiting O +
production O +
of O +
RpoS B-Gene +
. O +

We O +
found O +
that O +
GadW B-Gene +
represses O +
the O +
decarboxylase B-Gene +
genes O +
in O +
minimal O +
medium O +
and O +
that O +
growth O +
under O +
acidic O +
conditions O +
lowers O +
the O +
intracellular O +
cAMP O +
levels O +
. O +

These O +
results O +
indicate O +
that O +
CRP B-Gene +
and O +
cAMP O +
can O +
mediate O +
pH O +
control O +
over O +
gadX B-Gene +
expression O +
and O +
, O +
indirectly O +
, O +
expression O +
of O +
the O +
decarboxylase B-Gene +
genes O +
. O +

Mutational O +
or O +
physiological O +
lowering O +
of O +
cAMP O +
levels O +
increases O +
the O +
level O +
of O +
RpoS B-Gene +
and O +
thereby O +
increases O +
the O +
production O +
of O +
GadX B-Gene +
. O +

Higher O +
GadX B-Gene +
levels O +
, O +
in O +
turn O +
, O +
repress O +
gadW B-Gene +
and O +
contribute O +
to O +
induction O +
of O +
the O +
gad B-Gene +
decarboxylase I-Gene +
genes O +
. O +

The O +
presence O +
of O +
multiple O +
pH O +
control O +
pathways O +
governing O +
expression O +
of O +
this O +
acid O +
resistance O +
system O +
is O +
thought O +
to O +
reflect O +
different O +
environmental O +
routes O +
to O +
a O +
low O +
pH O +
. O +

Phosphotransferase B-Gene +
- O +
mediated O +
transport O +
of O +
the O +
osmolyte O +
2-O O -
- O -
alpha O -
- O -
mannosyl O -
- O -
D O -
- O -
glycerate O +
in O +
Escherichia O +
coli O +
occurs O +
by O +
the O +
product O +
of O +
the O +
mngA B-Gene +
( O +
hrsA B-Gene +
) O +
gene O +
and O +
is O +
regulated O +
by O +
the O +
mngR B-Gene +
( O +
farR B-Gene +
) O +
gene O +
product O +
acting O +
as O +
repressor O +
. O +

2-O O -
- O -
alpha O -
- O -
mannosyl O -
- O -
D O -
- O -
glycerate O +
( O +
MGs O +
) O +
has O +
been O +
recognized O +
as O +
an O +
osmolyte O +
in O +
hyperthermophilic O +
but O +
not O +
mesophilic O +
prokaryotes O +
. O +

We O +
report O +
that O +
MG O +
is O +
taken O +
up O +
and O +
utilized O +
as O +
sole O +
carbon O +
source O +
by O +
Escherichia O +
coli O +
K12 O +
, O +
strainMC4100 O +
. O +

Uptake O +
is O +
mediated O +
by O +
the O +
P B-Gene -
- I-Gene -
enolpyruvate I-Gene +
- I-Gene +
dependent I-Gene +
phosphotransferase I-Gene +
system O +
with O +
the O +
MG O +
- O +
inducible O +
HrsA B-Gene +
( O +
now O +
called O +
MngA B-Gene +
) O +
protein O +
as O +
its O +
specific O +
EIIABC B-Gene +
complex I-Gene +
. O +

The O +
apparent O +
Km O +
of O +
MG O +
uptake O +
in O +
induced O +
cells O +
was O +
10 O +
microm O +
, O +
and O +
the O +
Vmax O +
was O +
0.65 O +
nmol O +
/ O +
min O +
/ O +
10 O +
( O +
9 O +
) O +
cells O +
. O +

Inverted O +
membrane O +
vesicles O +
harboring O +
plasmid O +
- O +
encoded O +
MngA B-Gene +
phosphorylated O +
MG O +
in O +
a O +
P O -
- O -
enolpyruvate O +
- O +
dependent O +
manner O +
. O +

A O +
deletion O +
mutant O +
in O +
mngA B-Gene +
was O +
devoid O +
of O +
MG O +
transport O +
but O +
is O +
complemented O +
by O +
a O +
plasmid O +
harboring O +
mngA B-Gene +
. O +

Uptake O +
of O +
MG O +
in O +
MC4100 O +
also O +
caused O +
induction O +
of O +
a O +
regulon O +
specifying O +
the O +
uptake O +
and O +
the O +
metabolism O +
of O +
galactarate O +
and O +
glucarate O +
controlled O +
by O +
the O +
CdaR B-Gene +
activator O +
. O +

The O +
ybgG B-Gene +
gene O +
( O +
now O +
called O +
mngB B-Gene +
) O +
the O +
gene O +
immediately O +
downstream O +
of O +
mngA B-Gene +
encodes O +
a O +
protein O +
with O +
alpha B-Gene -
- I-Gene -
mannosidase I-Gene +
activity O +
. O +

farR B-Gene +
, O +
the O +
gene O +
upstream O +
of O +
mngA B-Gene +
( O +
now O +
called O +
mngR B-Gene +
) O +
had O +
previously O +
been O +
characterized O +
as O +
a O +
fatty O +
acyl O +
- O +
responsive O +
regulator O +
; O +
however O +
, O +
deletion O +
of O +
mngR B-Gene +
resulted O +
in O +
the O +
up O +
- O +
regulation O +
of O +
only O +
two O +
genes O +
, O +
mngA B-Gene +
and O +
mngB B-Gene +
. O +

The O +
mngR B-Gene +
deletion O +
caused O +
constitutive O +
MG O +
transport O +
that O +
became O +
MG O +
- O +
inducible O +
after O +
transformation O +
with O +
plasmid O +
expressed O +
mngR B-Gene +
. O +

Thus O +
, O +
MngR B-Gene +
is O +
the O +
regulator O +
( O +
repressor O +
) O +
of O +
the O +
MG O +
transport O +
/ O +
metabolism O +
system O +
. O +

Thus O +
, O +
the O +
mngR B-Gene +
mngA B-Gene +
mngB B-Gene +
gene O +
cluster O +
encodes O +
an O +
MG O +
utilizing O +
system O +
. O +

Deregulated O +
expression O +
of O +
interferon B-Gene +
regulatory I-Gene +
factor-1 I-Gene +
in O +
oncogene O +
- O +
transformed O +
mouse O +
fibroblasts O +
. O +

Interferon B-Gene +
( I-Gene +
IFN I-Gene +
) I-Gene +
regulatory I-Gene +
factor-1 I-Gene +
( O +
IRF-1 B-Gene +
) O +
is O +
a O +
transcription B-Gene +
factor I-Gene +
that O +
has O +
been O +
historically O +
associated O +
with O +
type B-Gene +
I I-Gene +
IFN I-Gene +
activation O +
and O +
antioncogenic O +
properties O +
. O +

We O +
studied O +
IRF-1 B-Gene +
expression O +
and O +
DNA O +
- O +
binding O +
capacity O +
in O +
nontransformed O +
and O +
transformed O +
mouse O +
fibroblasts O +
. O +

A O +
43 O +
- O +
kDa O +
nuclear O +
IRF-1 B-Gene +
protein O +
was O +
expressed O +
biphasically O +
during O +
the O +
cell O +
cycle O +
in O +
primary O +
mouse O +
embryo O +
fibroblasts O +
, O +
nontransformed O +
NIH O +
3T3 O +
cells O +
, O +
and O +
ras B-Gene +
revertants O +
. O +

IRF-1 B-Gene +
expression O +
became O +
constitutive O +
in O +
ras B-Gene +
- O +
transformed O +
NIH O +
3T3 O +
cells O +
and O +
in O +
cells O +
transformed O +
by O +
oncogenes O +
ets B-Gene +
, O +
fes B-Gene +
, O +
fos B-Gene +
, O +
her-2 B-Gene +
/ O +
neu B-Gene +
, O +
met B-Gene +
, O +
mos B-Gene +
, O +
raf B-Gene +
, O +
or O +
trk B-Gene +
, O +
suggesting O +
that O +
deregulated O +
IRF-1 B-Gene +
expression O +
may O +
be O +
associated O +
with O +
loss O +
of O +
growth O +
control O +
. O +

Lysyl B-Gene +
oxidase I-Gene +
( O +
LO B-Gene +
) O +
, O +
a O +
ras O +
suppressor O +
that O +
is O +
downregulated O +
in O +
ras B-Gene +
transformants O +
, O +
is O +
an O +
IRF-1 B-Gene +
target O +
gene O +
, O +
but O +
it O +
is O +
not O +
stimulated O +
by O +
abundant O +
IRF-1 B-Gene +
present O +
in O +
transformants O +
, O +
while O +
another O +
IRF-1 B-Gene +
target O +
gene O +
( O +
iNOS B-Gene +
) O +
is O +
transcribed O +
. O +

IRF-1 B-Gene +
from O +
either O +
normal O +
or O +
ras B-Gene +
- O +
transformed O +
cells O +
bound O +
to O +
IRF B-Gene +
elements O +
in O +
the O +
IFN B-Gene -
- I-Gene -
beta I-Gene +
and O +
LO B-Gene +
promoters O +
. O +

IRF-1 B-Gene +
in O +
transformants O +
can O +
, O +
therefore O +
, O +
bind O +
to O +
but O +
not O +
transactivate O +
the O +
LO B-Gene +
promoter O +
, O +
and O +
the O +
presence O +
of O +
IRF-1 B-Gene +
is O +
not O +
sufficient O +
to O +
suppress O +
ras B-Gene +
transformation O +
. O +

LO B-Gene +
expression O +
may O +
effect O +
the O +
regulated O +
expression O +
of O +
IRF-1 B-Gene +
: O +
a O +
ras O +
revertant O +
, O +
which O +
was O +
generated O +
by O +
stable O +
transfection O +
of O +
LO B-Gene +
cDNA O +
, O +
regained O +
the O +
normal O +
biphasic O +
IRF-1 B-Gene +
pattern O +
. O +

A O +
mainly O +
cytoplasmic O +
, O +
constitutively O +
expressed O +
46 O +
- O +
kDa O +
protein O +
with O +
immunologic O +
identity O +
to O +
the O +
43 O +
- O +
kDa O +
nuclear O +
IRF-1 B-Gene +
was O +
also O +
present O +
in O +
normal O +
and O +
transformed O +
cells O +
, O +
but O +
as O +
it O +
did O +
not O +
bind O +
to O +
the O +
IRF B-Gene +
elements O +
, O +
its O +
function O +
is O +
unclear O +
. O +

Calcium O +
regulates O +
the O +
expression O +
of O +
a O +
Dictyostelium O +
discoideum O +
asparaginyl B-Gene +
tRNA I-Gene +
synthetase I-Gene +
gene O +
. O +

In O +
a O +
screen O +
for O +
calcium O +
- O +
regulated O +
gene O +
expression O +
during O +
growth O +
and O +
development O +
of O +
Dictyostelium O +
discoideum O +
we O +
have O +
identified O +
an O +
asparaginyl B-Gene +
tRNA I-Gene +
synthetase I-Gene +
( O +
ddAsnRS B-Gene +
) O +
gene O +
, O +
the O +
second O +
tRNA B-Gene +
synthetase I-Gene +
gene O +
identified O +
in O +
this O +
organism O +
. O +

The O +
ddAsnRS B-Gene +
gene O +
shows O +
many O +
unique O +
features O +
. O +

One O +
, O +
it O +
is O +
repressed O +
by O +
lowering O +
cellular O +
calcium O +
, O +
making O +
it O +
the O +
first O +
known O +
calcium O +
- O +
regulated O +
tRNA B-Gene +
synthetase I-Gene +
. O +

Two O +
, O +
despite O +
the O +
calcium O +
- O +
dependence O +
, O +
its O +
expression O +
is O +
unaltered O +
during O +
the O +
cell O +
cycle O +
, O +
making O +
this O +
the O +
first O +
D. O +
discoideum O +
gene O +
to O +
show O +
a O +
calcium O +
- O +
dependent O +
but O +
cell O +
cycle O +
phase O +
- O +
independent O +
expression O +
. O +

Finally O +
, O +
the O +
N O +
- O +
terminal O +
domain O +
of O +
the O +
predicted O +
ddAsnRS B-Gene +
protein O +
shows O +
higher O +
sequence O +
similarity O +
to O +
Glutaminyl B-Gene +
tRNA I-Gene +
synthetases I-Gene +
than O +
to O +
other O +
Asn B-Gene +
tRNA I-Gene +
synthetases I-Gene +
. O +

These O +
unique O +
features O +
of O +
the O +
AsnRS B-Gene +
from O +
this O +
primitive O +
eukaryote O +
not O +
only O +
point O +
to O +
a O +
novel O +
mechanism O +
regulating O +
the O +
components O +
of O +
translation O +
machinery O +
and O +
gene O +
expression O +
by O +
calcium O +
, O +
but O +
also O +
hint O +
at O +
a O +
link O +
between O +
the O +
evolution O +
of O +
GlnRS B-Gene +
and O +
AsnRS B-Gene +
in O +
eukaryotes O +
. O +

Involvement O +
of O +
p38 B-Gene +
and O +
p42 B-Gene +
/ I-Gene +
44 I-Gene +
MAP I-Gene +
kinases I-Gene +
and O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
in O +
the O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
and O +
interleukin-1alpha B-Gene +
- O +
induced O +
phosphorylation O +
of O +
85 O +
- O +
kDa O +
cytosolic B-Gene +
phospholipase I-Gene +
A I-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
in O +
primary O +
human O +
bronchial O +
epithelial O +
cells O +
. O +

Interferon B-Gene -
- I-Gene -
gamma I-Gene +
( O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
and O +
interleukin-1 B-Gene +
( O +
IL-1 B-Gene +
) O +
play O +
an O +
important O +
role O +
in O +
the O +
modulation O +
of O +
acute O +
and O +
chronic O +
airway O +
inflammation O +
. O +

Both O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
IL-1 B-Gene +
are O +
known O +
to O +
increase O +
the O +
release O +
of O +
arachidonic O +
acid O +
( O +
AA O +
) O +
from O +
airway O +
epithelial O +
cells O +
, O +
suggesting O +
that O +
AA O +
metabolites O +
may O +
mediate O +
the O +
cytokine B-Gene +
- O +
induced O +
inflammation O +
. O +

This O +
study O +
was O +
designed O +
to O +
examine O +
the O +
direct O +
effect O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
IL B-Gene -
- I-Gene -
alpha I-Gene +
on O +
the O +
phosphorylation O +
of O +
85 O +
- O +
kDa O +
cytosolic B-Gene +
phospholipase I-Gene +
A I-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
( O +
cPLA B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
) O +
and O +
AA O +
release O +
in O +
primary O +
normal O +
human O +
bronchial O +
epithelial O +
( O +
NHBE O +
) O +
cells O +
. O +

Treatment O +
with O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
IL-1alpha B-Gene +
for O +
15 O +
min O +
induced O +
a O +
rapid O +
increase O +
of O +
AA O +
release O +
from O +
NHBE O +
cells O +
, O +
which O +
was O +
blocked O +
by O +
the O +
cPLA B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
inhibitor O +
MAFP O +
( O +
p O +
< O +
0.05 O +
) O +
but O +
not O +
by O +
the O +
sPLA B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
inhibitor O +
LY311727 O +
or O +
iPLA B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
inhibitor O +
HELSS O +
. O +

Immunoprecipitation O +
and O +
Western O +
blot O +
analysis O +
showed O +
that O +
both O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
IL-1alpha B-Gene +
induced O +
a O +
rapid O +
phosphorylation O +
of O +
cPLA B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
. O +

The O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
IL-1alpha B-Gene +
- O +
induced O +
cPLA B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
phosphorylation O +
and O +
AA O +
release O +
in O +
the O +
NHBE O +
cells O +
were O +
inhibited O +
by O +
the O +
p38 B-Gene +
MAP I-Gene +
kinase I-Gene +
( O +
MAPK B-Gene +
) O +
inhibitor O +
SB203580 O +
, O +
p42 B-Gene +
/ I-Gene +
44 I-Gene +
MAPK I-Gene +
inhibitor O +
PD98059 O +
and O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
( O +
PKC B-Gene +
) O +
inhibitor O +
bisindolylmaleimide O +
I O +
. O +

These O +
results O +
demonstrate O +
the O +
involvement O +
of O +
p38 B-Gene +
and O +
p42 B-Gene +
/ I-Gene +
44 I-Gene +
MAPKs I-Gene +
as O +
well O +
as O +
PKC B-Gene +
in O +
the O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
IL-1alpha B-Gene +
- O +
induced O +
cPLA B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
phosphorylation O +
and O +
AA O +
release O +
in O +
human O +
airway O +
epithelial O +
cells O +
. O +

Molecular O +
characterization O +
of O +
a O +
human O +
rotavirus O +
reveals O +
porcine O +
characteristics O +
in O +
most O +
of O +
the O +
genes O +
including O +
VP6 B-Gene +
and O +
NSP4 B-Gene +
. O +

Long O +
electropherotype O +
with O +
Subgroup O +
I O +
specificity O +
is O +
a O +
common O +
feature O +
of O +
animal O +
rotaviruses O +
. O +

In O +
an O +
epidemic O +
of O +
infantile O +
gastroenteritis O +
in O +
Manipur O +
, O +
India O +
, O +
long O +
but O +
SG O +
I O +
strains O +
predominated O +
in O +
the O +
outbreak O +
in O +
the O +
year O +
1987 O +
- O +
88 O +
. O +

One O +
such O +
strain O +
isolated O +
from O +
that O +
region O +
, O +
following O +
the O +
outbreak O +
had O +
G9P O +
[ O -
19 O -
] O +
specificity O +
. O +

As O +
this O +
is O +
a O +
rare O +
combination O +
, O +
the O +
gene O +
sequences O +
encoding O +
VP4 B-Gene +
, O +
VP6 B-Gene +
, O +
VP7 B-Gene +
, O +
NSP1 B-Gene +
, O +
NSP2 B-Gene +
, O +
NSP3 B-Gene +
, O +
NSP4 B-Gene +
and O +
NSP5 B-Gene +
of O +
this O +
strain O +
were O +
analyzed O +
. O +

All O +
these O +
genes O +
except O +
VP7 B-Gene +
were O +
closely O +
related O +
to O +
porcine O +
rotaviruses O +
( O +
95 O +
- O +
99 O +
% O +
identity O +
at O +
amino O +
acid O +
level O +
) O +
and O +
clustered O +
with O +
the O +
porcine O +
strains O +
in O +
phylogenetic O +
analysis O +
. O +

In O +
addition O +
, O +
it O +
had O +
subgroup O +
I O +
nature O +
and O +
belonged O +
to O +
NSP4 B-Gene +
genotype O +
B O +
which O +
is O +
characteristic O +
of O +
animal O +
rotaviruses O +
. O +

This O +
is O +
the O +
first O +
report O +
of O +
a O +
rotavirus O +
with O +
VP6 B-Gene +
and O +
NSP4 B-Gene +
, O +
two O +
crucial O +
proteins O +
thought O +
to O +
be O +
involved O +
in O +
host O +
range O +
restriction O +
and O +
pathogenicity O +
, O +
were O +
of O +
porcine O +
origin O +
and O +
caused O +
diarrhoea O +
in O +
a O +
human O +
host O +
. O +

Among O +
the O +
genes O +
of O +
this O +
strain O +
sequenced O +
so O +
far O +
, O +
only O +
VP7 B-Gene +
had O +
highest O +
identity O +
to O +
human O +
strains O +
at O +
amino O +
acid O +
level O +
. O +

This O +
study O +
suggests O +
reassortment O +
may O +
be O +
occurring O +
between O +
human O +
and O +
other O +
animal O +
strains O +
and O +
some O +
of O +
the O +
reassortant O +
viruses O +
may O +
be O +
virulent O +
to O +
humans O +
. O +

Purification O +
and O +
characterization O +
of O +
phytocystatins B-Gene +
from O +
kiwifruit O +
cortex O +
and O +
seeds O +
. O +

Kiwifruit O +
cysteine B-Gene +
proteinase I-Gene +
inhibitors I-Gene +
( O +
KCPIs B-Gene +
) O +
were O +
purified O +
from O +
the O +
cortex O +
and O +
seeds O +
of O +
kiwifruit O +
after O +
inactivation O +
of O +
the O +
abundant O +
cortex O +
cysteine B-Gene +
proteinase I-Gene +
actinidain B-Gene +
. O +

One O +
major O +
( O +
KCPI1 B-Gene +
) O +
and O +
four O +
minor O +
cystatins B-Gene +
were O +
identified O +
from O +
Actinidia O +
deliciosa O +
ripe O +
mature O +
kiwifruit O +
cortex O +
as O +
well O +
as O +
a O +
seed O +
KCPI B-Gene +
from O +
A. O +
chinensis O +
. O +

The O +
predominant O +
cortex O +
cystatin B-Gene +
, O +
KCPI1 B-Gene +
, O +
inhibited O +
clan B-Gene +
CA I-Gene +
, I-Gene +
family I-Gene +
C1 I-Gene +
( I-Gene +
papain I-Gene +
family I-Gene +
) I-Gene +
cysteine I-Gene +
proteinases I-Gene +
( O +
papain B-Gene +
, O +
chymopapain B-Gene +
, O +
bromelain B-Gene +
, O +
ficin B-Gene +
, O +
human O +
cathepsins B-Gene +
B I-Gene +
, I-Gene +
H I-Gene +
and I-Gene +
L I-Gene +
, O +
actinidain B-Gene +
and O +
the O +
house O +
dust O +
mite O +
endopeptidase B-Gene +
1 I-Gene +
) O +
, O +
while O +
cysteine B-Gene +
proteinases I-Gene +
belonging O +
to O +
other O +
families O +
, O +
[ O +
clostripain B-Gene +
( O +
C11 O +
) O +
, O +
streptopain B-Gene +
( O +
C10 O +
) O +
and O +
calpain B-Gene +
( O +
C2 O +
) O +
] O +
were O +
not O +
inhibited O +
. O +

Inhibition O +
constants O +
( O +
K O -
( O -
I O -
) O +
) O +
ranged O +
between O +
0.001 O +
nM O +
for O +
cathepsin B-Gene +
L I-Gene +
and O +
0.98 O +
nM O +
for O +
endopeptidase B-Gene +
1 I-Gene +
. O +

The O +
K O -
( O -
I O -
) O +
( O +
14 O +
nM O +
) O +
for O +
KCPI1 B-Gene +
inhibiting O +
actinidain B-Gene +
is O +
at O +
least O +
2 O +
orders O +
of O +
magnitude O +
higher O +
than O +
for O +
other O +
plant O +
proteinases B-Gene +
measured O +
. O +

The O +
cortex O +
KCPI1 B-Gene +
and O +
a O +
seed O +
KCPI B-Gene +
purified O +
from O +
seeds O +
had O +
the O +
same O +
N O +
- O +
terminal O +
sequence O +
( O +
VAAGGWRPIESLNSAEVQDV O +
) O +
. O +

BLAST O +
- O +
matching O +
the O +
peptide O +
sequence O +
against O +
an O +
in O +
- O +
house O +
generated O +
Actinidia O +
EST O +
database O +
, O +
identified O +
81 O +
cDNAs O +
that O +
exactly O +
matched O +
the O +
measured O +
KCPI1 B-Gene +
peptide O +
sequence O +
. O +

Peptide O +
sequences O +
of O +
two O +
other O +
cortex O +
KCPIs B-Gene +
each O +
exactly O +
matched O +
a O +
predicted O +
peptide O +
sequence O +
of O +
a O +
cDNA O +
from O +
kiwifruit O +
. O +

The O +
predicted O +
peptide O +
sequence O +
of O +
KCPI1 B-Gene +
of O +
116 O +
amino O +
acids O +
encodes O +
a O +
signal O +
peptide O +
and O +
does O +
not O +
contain O +
cysteine O +
. O +

Without O +
the O +
signal O +
peptide O +
( O +
mature O +
protein O +
) O +
, O +
KCPI1 B-Gene +
has O +
a O +
molecular O +
mass O +
of O +
approximately O +
11 O +
kDa O +
, O +
possesses O +
the O +
consensus O +
sequence O +
characteristic O +
for O +
the O +
phytocystatins B-Gene +
and O +
shows O +
the O +
highest O +
homology O +
to O +
a O +
cystatin B-Gene +
from O +
Citrusxparadisi O +
( O +
52 O +
% O +
identity O +
) O +
. O +

This O +
is O +
the O +
first O +
report O +
of O +
phytocystatins B-Gene +
from O +
the O +
Ericales O +
. O +

Glial O +
activation O +
and O +
TNFR B-Gene -
- I-Gene -
I I-Gene +
upregulation O +
precedes O +
motor O +
dysfunction O +
in O +
the O +
spinal O +
cord O +
of O +
mnd O +
mice O +
. O +

Mice O +
homozygous O +
for O +
the O +
spontaneous O +
motor O +
neuron O +
degeneration O +
mutation O +
( O +
mnd O +
) O +
show O +
at O +
the O +
age O +
of O +
8 O +
months O +
a O +
marked O +
impairment O +
of O +
the O +
motor O +
function O +
and O +
accumulation O +
of O +
lipofuscin O +
granules O +
in O +
the O +
cytoplasm O +
of O +
almost O +
all O +
neurons O +
of O +
the O +
central O +
nervous O +
system O -
. O -
We O +
previously O +
reported O +
a O +
significant O +
increase O +
in O +
GFAP B-Gene +
protein O +
levels O +
in O +
the O +
lumbar O +
spinal O +
cord O +
homogenates O +
by O +
western O +
blot O +
analysis O +
and O +
upregulation O +
of O +
TNF B-Gene +
, O +
a O +
proinflammatory O +
cytokine B-Gene +
, O +
in O +
the O +
motor O +
neurons O +
of O +
lumbar O +
spinal O +
cord O +
of O +
mnd O +
mice O +
, O +
already O +
in O +
a O +
presymptomatic O +
stage O +
( O +
4 O +
months O +
of O +
age O +
) O +
. O +

In O +
the O +
present O +
study O +
, O +
using O +
immunohistochemical O +
analysis O +
, O +
we O +
performed O +
a O +
time O +
course O +
in O +
mnd O +
mice O +
( O +
1 O +
, O +
4 O +
and O +
9 O +
months O +
of O +
age O +
) O +
evaluating O +
the O +
expression O +
and O +
the O +
distribution O +
of O +
astroglial O +
and O +
microglial O +
cells O +
and O +
the O +
expression O +
of O +
both O +
TNF B-Gene +
receptors I-Gene +
, O +
TNFR B-Gene -
- I-Gene -
I I-Gene +
and O +
TNFR B-Gene -
- I-Gene -
II I-Gene +
. O +

We O +
observed O +
a O +
marked O +
increase O +
in O +
astroglial O +
and O +
microglial O +
cells O +
and O +
in O +
TNFR B-Gene -
- I-Gene -
I I-Gene +
immunoreactivity O +
already O +
at O +
the O +
4th O +
month O +
. O +

Since O +
motor O +
neuron O +
dysfunction O +
occurs O +
in O +
mnd O +
mice O +
in O +
the O +
absence O +
of O +
evident O +
loss O +
of O +
spinal O +
motor O +
neurons O +
, O +
the O +
present O +
results O +
indicate O +
that O +
the O +
activation O +
of O +
microglial O +
cells O +
and O +
astrocytes O +
is O +
independent O +
from O +
neuronal O +
degeneration O +
. O +

The O +
role O +
of O +
TNF B-Gene +
and O +
TNFR B-Gene -
- I-Gene -
I I-Gene +
on O +
motor O +
neurons O +
is O +
still O +
to O +
be O +
demonstrated O +
. O +

Stat3 B-Gene +
- O +
dependent O +
induction O +
of O +
interleukin-3 B-Gene +
receptor I-Gene +
expression O +
in O +
leukemia B-Gene +
inhibitory I-Gene +
factor I-Gene +
- O +
stimulated O +
M1 O +
mouse O +
leukemia O +
cells O +
. O +

M1 O +
mouse O +
leukemia O +
cells O +
differentiate O +
to O +
macrophages O +
/ O +
monocytes O +
by O +
the O +
stimulation O +
of O +
interleukin-6 B-Gene +
( O +
IL-6 B-Gene +
) O +
/ O +
leukemia B-Gene +
inhibitory I-Gene +
factor I-Gene +
( O +
LIF B-Gene +
) O +
. O +

To O +
identify O +
new O +
LIF B-Gene +
- O +
induced O +
genes O +
, O +
we O +
have O +
performed O +
representational O +
difference O +
analysis O +
using O +
M1 O +
cells O +
and O +
cloned O +
mouse O +
interleukin-3 B-Gene +
( I-Gene +
IL-3 I-Gene +
) I-Gene +
receptor I-Gene +
beta I-Gene +
subunit O +
gene O +
. O +

The O +
mRNA O +
expression O +
of O +
both O +
IL-3 B-Gene +
receptor I-Gene +
( I-Gene +
IL-3R I-Gene +
) I-Gene +
alpha I-Gene +
and I-Gene +
beta I-Gene +
subunits O +
is O +
upregulated O +
after O +
1 O +
h O +
stimulation O +
of O +
LIF B-Gene +
and O +
remains O +
to O +
be O +
elevated O +
along O +
the O +
differentiation O +
of O +
M1 O +
cells O +
. O +

This O +
induction O +
is O +
almost O +
completely O +
suppressed O +
in O +
M1 O +
cells O +
expressing O +
a O +
dominant O +
negative O +
form O +
of O +
Stat3 B-Gene +
. O +

Furthermore O +
, O +
we O +
show O +
that O +
IL-3 B-Gene +
- O +
induced O +
Stat5 B-Gene +
phosphorylation O +
increases O +
in O +
LIF B-Gene +
- O +
stimulated O +
M1 O +
cells O +
. O +

These O +
results O +
suggest O +
that O +
Stat3 B-Gene +
may O +
play O +
a O +
role O +
in O +
the O +
differentiation O +
of O +
myeloid O +
cells O +
by O +
regulating O +
IL-3R B-Gene +
expression O +
. O +

Clinical O +
and O +
biochemical O +
characterisation O +
of O +
patients O +
with O +
autosomal O +
recessive O +
hypercholesterolemia O +
( O +
ARH O +
) O +
. O +

BACKGROUND O +
AND O +
AIM O +
: O +

Inherited O +
hypercholesterolemias O +
are O +
common O +
disorders O +
characterised O +
by O +
elevated O +
LDL B-Gene +
- O +
C O +
levels O +
and O +
premature O +
coronary O +
heart O +
disease O +
. O +

We O +
have O +
recently O +
described O +
a O +
recessive O +
form O +
of O +
hypercholesterolemia O +
( O +
autosomal O +
recessive O +
hypercholesterolemia O +
, O +
ARH O +
) O +
in O +
which O +
LDL B-Gene +
catabolism O +
is O +
reduced O +
because O +
of O +
a O +
mutation O +
in O +
the O +
gene O +
coding O +
for O +
an O +
adaptor B-Gene +
protein I-Gene +
that O +
impairs O +
LDL B-Gene -
- I-Gene -
receptor I-Gene +
( O +
LDL B-Gene -
- I-Gene -
R I-Gene +
) O +
activity O +
in O +
the O +
liver O +
. O +

The O +
aim O +
of O +
this O +
study O +
was O +
to O +
characterise O +
in O +
detail O +
the O +
phenotypes O +
of O +
subjects O +
with O +
homozygous O +
and O +
heterozygous O +
ARH O +
. O +

METHODS O +
AND O +
RESULTS O +
: O +

We O +
have O +
so O +
far O +
identified O +
six O +
Italian O +
families O +
with O +
ARH O +
and O +
studied O +
the O +
clinical O +
and O +
biochemical O +
characteristics O +
of O +
11 O +
homozygotes O +
( O +
age O +
13 O +
- O +
47 O +
years O +
) O +
and O +
12 O +
obligate O +
heterozygotes O +
( O +
age O +
42 O +
- O +
83 O +
years O +
) O +
. O +

The O +
study O +
protocol O +
included O +
an O +
evaluation O +
of O +
the O +
lipoprotein O +
profile O +
, O +
LDL B-Gene -
- I-Gene -
R I-Gene +
activity O +
in O +
fibroblasts O +
, O +
LDL B-Gene +
binding O +
activity O +
, O +
and O +
apo B-Gene +
E I-Gene +
genotype O +
; O +
a O +
structured O +
questionnaire O +
( O +
CHD O +
risk O +
factors O +
, O +
medical O +
history O +
, O +
current O +
medications O +
) O +
; O +
a O +
physical O +
examination O +
, O +
resting O +
and O +
stress O +
ECG O +
, O +
ultrasound O +
examinations O +
( O +
heart O +
, O +
carotid O +
arteries O +
, O +
Achilles O +
tendons O +
) O +
and O +
coronary O +
angiography O +
. O +

The O +
pedigrees O +
were O +
characterised O +
by O +
the O +
absence O +
of O +
vertical O +
transmission O +
; O +
consanguinity O +
was O +
documented O +
in O +
two O +
families O +
. O +

Only O +
the O +
two O +
previously O +
described O +
Sardinian O +
mutations O +
, O +
ARH1 O +
( O +
c.432insA O +
) O +
and O +
ARH2 O +
( O +
c.65 O -
G O +
> O +
A O +
) O +
, O +
were O +
identified O +
in O +
the O +
probands O +
. O +

All O +
of O +
the O +
ARH O +
homozygotes O +
had O +
large O +
tendinous O +
xanthomas O +
, O +
two O +
had O +
exertional O +
angina O +
, O +
and O +
four O +
a O +
positive O +
stress O +
ECG O +
. O +

None O +
had O +
experienced O +
myocardial O +
infarction O +
or O +
stroke O +
. O +

More O +
than O +
half O +
had O +
instrumental O +
signs O +
of O +
atherosclerosis O +
such O +
as O +
a O +
positive O +
stress O +
ECG O +
or O +
positive O +
carotid O +
echo O +
- O +
doppler O +
examination O +
. O +

The O +
ARH O +
heterozygotes O +
were O +
consistently O +
normal O +
and O +
had O +
a O +
normal O +
lipid O +
profile O +
. O +

CONCLUSIONS O +
: O +

The O +
ARH O +
phenotype O +
resembles O +
that O +
of O +
familial O +
hypercholesterolemia O +
( O +
FH O +
) O +
homozygotes O +
, O +
but O +
ARH O +
may O +
be O +
a O +
less O +
serious O +
illness O +
. O +

The O +
absence O +
of O +
vertical O +
transmission O +
, O +
and O +
the O +
presence O +
of O +
mild O +
coronary O +
heart O +
disease O +
and O +
consanguinity O +
, O +
can O +
suggest O +
a O +
possible O +
diagnosis O +
of O +
ARH O +
. O +

ARH O +
might O +
be O +
considered O +
a O +
phenocopy O +
of O +
FH O +
but O +
heterozygous O +
subjects O +
seem O +
to O +
have O +
a O +
consistently O +
normal O +
phenotype O +
. O +

Domain O +
- O +
dependent O +
action O +
of O +
urokinase B-Gene +
on O +
smooth O +
muscle O +
cell O +
responses O +
. O +

BACKGROUND O +
: O +

Single O +
- O +
chain O +
urokinase B-Gene +
- I-Gene +
type I-Gene +
plasminogen I-Gene +
activator I-Gene +
( O +
sc O +
- O +
uPA B-Gene +
) O +
is O +
one O +
of O +
the O +
key O +
serine B-Gene +
proteases I-Gene +
involved O +
in O +
modulating O +
cellular O +
and O +
extracellular O +
matrix O +
responses O +
during O +
tissue O +
remodeling O +
. O +

Sc O +
- O +
uPA B-Gene +
is O +
composed O +
of O +
three O +
domains O +
: O +
aminoterminal O +
fragment O +
( O +
ATF O +
) O +
, O +
kringle O +
domain O +
, O +
and O +
carboxyterminal O +
fragment O +
( O +
CTF O +
) O +
. O +

uPA B-Gene +
is O +
readily O +
cleaved O +
into O +
these O +
three O +
domain O +
fragments O +
in O +
vitro O +
, O +
each O +
of O +
which O +
is O +
biologically O +
active O +
; O +
however O +
, O +
their O +
roles O +
in O +
the O +
microenvironment O +
of O +
the O +
vessel O +
wall O +
are O +
poorly O +
understood O +
. O +

PURPOSE O +
: O +

The O +
purpose O +
of O +
this O +
study O +
was O +
to O +
determine O +
the O +
role O +
of O +
each O +
domain O +
of O +
sc O +
- O +
uPA B-Gene +
on O +
vascular O +
smooth O +
muscle O +
cell O +
( O +
SMC O +
) O +
proliferation O +
and O +
migration O +
. O +

METHODS O +
: O +

SMCs O +
were O +
cultured O +
in O +
vitro O +
. O +

Assays O +
of O +
DNA O +
synthesis O +
, O +
cell O +
proliferation O +
, O +
and O +
migration O +
were O +
performed O +
in O +
response O +
to O +
sc O +
- O +
uPA B-Gene +
, O +
ATF O +
, O +
kringle O +
, O +
and O +
CTF O +
in O +
the O +
presence O +
and O +
absence O +
of O +
the O +
plasmin B-Gene +
inhibitors O +
epsilon O +
- O +
aminocaproic O +
acid O +
( O +
EACA O +
) O +
and O +
aprotinin O +
, O +
the O +
Galphai B-Gene +
inhibitor O +
pertussis O +
toxin O +
, O +
and O +
the O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
1 I-Gene +
( O +
the O +
upstream O +
regulator O +
of O +
the O +
extracellular B-Gene +
- I-Gene +
signal I-Gene +
regulated I-Gene +
kinase I-Gene +
[ O +
ERK B-Gene +
] O +
) O +
inhibitor O +
PD98059 O +
. O +

RESULTS O +
: O +

sc O +
- O +
uPA B-Gene +
produced O +
dose O +
- O +
dependent O +
increases O +
in O +
DNA O +
synthesis O +
and O +
cell O +
proliferation O +
. O +

These O +
responses O +
were O +
dependent O +
on O +
the O +
CTF O +
domain O +
and O +
were O +
sensitive O +
to O +
plasmin B-Gene +
inhibitors O +
, O +
pertussis B-Gene +
toxin I-Gene +
, O +
and O +
PD98059 O +
. O +

Sc O +
- O +
uPA B-Gene +
also O +
induced O +
SMC O +
migration O +
, O +
which O +
could O +
be O +
elicited O +
by O +
both O +
ATF O +
and O +
kringle O +
. O +

Migration O +
to O +
sc O +
- O +
uPA B-Gene +
, O +
ATF O +
, O +
and O +
kringle O +
was O +
both O +
pertussis O +
toxin O +
and O +
PD98059 O +
sensitive O +
, O +
but O +
importantly O +
was O +
plasmin B-Gene +
- O +
independent O +
. O +

CONCLUSION O +
: O +

sc O +
- O +
uPA B-Gene +
induces O +
SMC O +
proliferation O +
and O +
migration O +
, O +
which O +
are O +
domain O +
- O +
dependent O +
and O +
mediated O +
in O +
part O +
by O +
Galphai B-Gene +
- O +
linked O +
, O +
ERK B-Gene +
- O +
dependent O +
processes O +
, O +
while O +
only O +
the O +
mitogenic O +
response O +
is O +
protease O +
dependent O +
. O +

These O +
findings O +
suggest O +
that O +
migration O +
is O +
linked O +
to O +
a O +
G B-Gene +
- I-Gene +
protein I-Gene +
coupled O +
nonprotease O +
receptor O +
, O +
while O +
proliferation O +
is O +
associated O +
with O +
a O +
G B-Gene +
- I-Gene +
protein I-Gene +
coupled O +
protease O +
receptor O +
. O +

Oxidative O +
stress O +
- O +
a O +
link O +
between O +
endothelial O +
injury O +
, O +
coagulation O +
activation O +
, O +
and O +
atherosclerosis O +
in O +
haemodialysis O +
patients O +
. O +

BACKGROUND O +
/ O +
AIM O +
: O +

Recently O +
emerging O +
evidence O +
suggests O +
that O +
oxidative O +
stress O +
( O +
SOX O +
) O +
may O +
participate O +
in O +
atherogenesis O +
. O +

The O +
aim O +
of O +
the O +
present O +
study O +
was O +
to O +
establish O +
whether O +
enhanced O +
SOX O +
, O +
involving O +
endothelial O +
injury O +
, O +
activation O +
of O +
coagulation O +
, O +
and O +
inflammatory O +
reaction O +
, O +
could O +
be O +
implicated O +
in O +
atherosclerotic O +
diseases O +
in O +
haemodialysis O +
( O +
HD O +
) O +
patients O +
. O +

METHODS O +
: O +

Markers O +
of O +
SOX O +
, O +
endothelial O +
injury O +
, O +
coagulation O +
, O +
and O +
cytokines B-Gene +
, O +
were O +
measured O +
in O +
the O +
plasma O +
of O +
HD O +
patients O +
with O +
and O +
without O +
cardiovascular O +
disease O +
( O +
CVD O +
) O +
, O +
and O +
of O +
healthy O +
controls O +
by O +
ELISA O +
methods O +
. O +

Remodeling O +
of O +
the O +
carotid O +
arteries O +
was O +
assessed O +
by O +
measuring O +
the O +
intima O +
- O +
media O +
thickness O +
( O +
IMT O +
) O +
as O +
a O +
surrogate O +
of O +
atherosclerotic O +
disease O +
in O +
all O +
groups O +
. O +

RESULTS O +
: O +

Markers O +
of O +
SOX O +
, O +
endothelial O +
injury O +
, O +
and O +
extrinsic O +
coagulation O +
pathway O +
activation O +
and O +
IMT O +
values O +
were O +
significantly O +
elevated O +
in O +
HD O +
patients O +
, O +
especially O +
in O +
those O +
with O +
CVD O +
when O +
compared O +
with O +
the O +
control O +
group O +
. O +

The O +
von B-Gene +
Willebrand I-Gene +
factor I-Gene +
antigen O +
( O +
vWF B-Gene +
: O +
Ag O +
) O +
levels O +
were O +
more O +
increased O +
in O +
the O +
patients O +
with O +
CVD O +
than O +
in O +
those O +
without O +
. O +

Furthermore O +
, O +
the O +
plasma O +
levels O +
of O +
tumour B-Gene +
necrosis I-Gene +
factor I-Gene +
alpha I-Gene +
, O +
monocyte B-Gene +
chemo I-Gene +
- I-Gene +
attractant I-Gene +
protein I-Gene +
1 I-Gene +
, O +
and O +
macrophage B-Gene +
inflammatory I-Gene +
protein I-Gene +
1 I-Gene +
beta I-Gene +
were O +
significantly O +
higher O +
only O +
in O +
the O +
HD O +
group O +
with O +
CVD O +
when O +
compared O +
with O +
the O +
controls O +
. O +

The O +
IMT O +
was O +
strongly O +
and O +
directly O +
correlated O +
with O +
Cu B-Gene +
/ I-Gene +
Zn I-Gene +
superoxide I-Gene +
dismutase I-Gene +
. O +

Both O +
IMT O +
and O +
Cu B-Gene +
/ I-Gene +
Zn I-Gene +
superoxide I-Gene +
dismutase I-Gene +
were O +
positively O +
correlated O +
with O +
age O +
, O +
thrombomodulin B-Gene +
, O +
vWF B-Gene +
: O +
Ag O +
, O +
tissue B-Gene +
factor I-Gene +
, O +
tissue B-Gene +
factor I-Gene +
pathway I-Gene +
inhibitor I-Gene +
, O +
prothrombin B-Gene +
fragment O +
F1 O +
+ O +
2 O +
, O +
monocte B-Gene +
chemo I-Gene +
- I-Gene +
attractant I-Gene +
protein I-Gene +
1 I-Gene +
, O +
macrophage B-Gene +
inflammatory I-Gene +
protein I-Gene +
1 I-Gene +
beta I-Gene +
, O +
and O +
tumour B-Gene +
necrosis I-Gene +
factor I-Gene +
alpha I-Gene +
levels O +
. O +

Multivariate O +
analysis O +
identified O +
vWF B-Gene +
: O +
Ag O +
as O +
the O +
only O +
independent O +
variable O +
significantly O +
associated O +
with O +
an O +
increased O +
IMT O +
. O +

CONCLUSIONS O +
: O +

The O +
present O +
study O +
suggests O +
that O +
enhanced O +
SOX O +
, O +
involved O +
pro O +
- O +
atherogenic O +
cytokine B-Gene +
and O +
chemokines B-Gene +
levels O +
, O +
endothelial O +
injury O +
, O +
and O +
coagulation O +
activation O +
may O +
constitute O +
a O +
pathway O +
for O +
accelerated O +
atherosclerosis O +
in O +
HD O +
patients O +
. O +

The O +
significant O +
, O +
independent O +
association O +
between O +
IMT O +
and O +
vWF B-Gene +
: O +
Ag O +
should O +
be O +
assessed O +
in O +
future O +
studies O +
to O +
determine O +
whether O +
vWF B-Gene +
: O +
Ag O +
elevation O +
is O +
causative O +
or O +
a O +
by O +
- O +
product O +
of O +
the O +
increased O +
IMT O +
. O +

Infection O +
- O +
induced O +
up O +
- O +
regulation O +
of O +
the O +
costimulatory O +
molecule O +
4 B-Gene -
- I-Gene -
1BB I-Gene +
in O +
osteoblastic O +
cells O +
and O +
its O +
inhibitory O +
effect O +
on O +
M B-Gene -
- I-Gene -
CSF I-Gene +
/ O +
RANKL B-Gene +
- O +
induced O +
in O +
vitro O +
osteoclastogenesis O +
. O +

Bacterial O +
infection O +
sometimes O +
impairs O +
bone O +
metabolism O +
. O +

In O +
this O +
study O +
, O +
we O +
infected O +
the O +
osteoblastic O +
cell O +
line O +
MC3T3-E1 O +
with O +
Mycobacterium O +
bovis O +
bacillus O +
Calmette O -
- O -
GuÃ?Â O -
© O -
rin O +
( O +
BCG O +
) O +
and O +
identified O +
genes O +
that O +
were O +
up O +
- O +
regulated O +
in O +
the O +
BCG O +
- O +
infected O +
cells O +
by O +
the O +
suppression O +
subtractive O +
hybridization O +
method O +
. O +

A O +
gene O +
encoding O +
4 B-Gene -
- I-Gene -
1BB I-Gene +
( O +
CD137 B-Gene +
) O +
, O +
a O +
member O +
of O +
the O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
receptor I-Gene +
family I-Gene +
, O +
was O +
found O +
to O +
be O +
one O +
of O +
the O +
up O +
- O +
regulated O +
genes O +
. O +

Up O +
- O +
regulation O +
of O +
4 B-Gene -
- I-Gene -
1BB I-Gene +
was O +
also O +
observed O +
by O +
infection O +
with O +
Escherichia O +
coli O +
, O +
Salmonella O +
typhimurium O +
, O +
and O +
Staphylococcus O +
aureus O +
, O +
and O +
by O +
treatment O +
with O +
lipopolysaccharides O +
and O +
heat O +
- O +
killed O +
BCG O +
. O +

Bone O +
marrow O +
cells O +
and O +
the O +
macrophage O +
- O +
like O +
cell O +
lines O +
J774 O +
and O +
RAW264.7 O +
were O +
found O +
to O +
express O +
4 B-Gene -
- I-Gene -
1BB I-Gene +
ligand I-Gene +
( O +
4 B-Gene -
- I-Gene -
1BBL I-Gene +
) O +
. O +

Recombinant O +
4 B-Gene -
- I-Gene -
1BB I-Gene +
( O +
r4 B-Gene -
- I-Gene -
1BB I-Gene +
) O +
that O +
was O +
immobilized O +
on O +
culture O +
plates O +
strongly O +
inhibited O +
macrophage B-Gene +
colony I-Gene +
stimulating I-Gene +
factor I-Gene +
( O +
M B-Gene -
- I-Gene -
CSF I-Gene +
) O +
/ O +
receptor B-Gene +
activator I-Gene +
of I-Gene +
nuclear I-Gene +
factor I-Gene +
- I-Gene +
kappaB I-Gene +
ligand I-Gene +
( O +
RANKL B-Gene +
) O +
- O +
induced O +
in O +
vitro O +
osteoclast O +
formation O +
from O +
bone O +
marrow O +
cells O +
. O +

4 B-Gene -
- I-Gene -
1BBL I-Gene +
antibody O +
also O +
inhibited O +
osteoclast O +
formation O +
to O +
a O +
lesser O +
extent O +
, O +
indicating O +
involvement O +
of O +
reverse O +
signaling O +
through O +
4 B-Gene -
- I-Gene -
1BBL I-Gene +
during O +
inhibition O +
of O +
osteoclast O +
formation O +
. O +

A O +
casein B-Gene +
kinase I-Gene +
I I-Gene +
( O +
CKI B-Gene +
) O +
inhibitor O +
markedly O +
suppressed O +
the O +
inhibitory O +
effect O +
of O +
r4 B-Gene -
- I-Gene -
1BB I-Gene +
on O +
M B-Gene -
- I-Gene -
CSF I-Gene +
/ O +
RANKL B-Gene +
- O +
induced O +
osteoclast O +
formation O +
, O +
suggesting O +
that O +
CKI B-Gene +
might O +
be O +
involved O +
in O +
4 B-Gene -
- I-Gene -
1BB I-Gene +
/ O +
4 B-Gene -
- I-Gene -
1BBL I-Gene +
reverse O +
signaling O +
. O +

r4 B-Gene -
- I-Gene -
1BB I-Gene +
showed O +
no O +
effects O +
on O +
M B-Gene -
- I-Gene -
CSF I-Gene +
- O +
or O +
RANKL B-Gene +
- O +
induced O +
phosphorylation O +
of O +
I B-Gene -
- I-Gene -
kappaB I-Gene +
, O +
ERK1 B-Gene +
/ I-Gene +
2 I-Gene +
, O +
p38 B-Gene +
, O +
or O +
JNK B-Gene +
, O +
whereas O +
RANKL B-Gene +
- O +
induced O +
phosphorylation O +
of O +
Akt B-Gene +
, O +
a O +
downstream O +
target O +
of O +
phosphatidylinositol B-Gene +
3-kinase I-Gene +
( O +
PI3 B-Gene -
K I-Gene +
) O +
, O +
was O +
completely O +
abolished O +
by O +
r4 B-Gene -
- I-Gene -
1BB I-Gene +
, O +
suggesting O +
that O +
4 B-Gene -
- I-Gene -
1BB I-Gene +
/ O +
4 B-Gene -
- I-Gene -
1BBL I-Gene +
reverse O +
signaling O +
may O +
interfere O +
with O +
PI3 B-Gene -
K I-Gene +
/ O +
Akt B-Gene +
pathway O +
. O +

r4 B-Gene -
- I-Gene -
1BB I-Gene +
also O +
abolished O +
RANKL B-Gene +
- O +
mediated O +
induction O +
of O +
nuclear O +
factor O +
of O +
activated O +
T O +
cells-2 O +
. O +

This O +
study O +
may O +
elucidate O +
a O +
novel O +
role O +
of O +
4 B-Gene -
- I-Gene -
1BB I-Gene +
in O +
cell O +
metabolism O +
, O +
especially O +
osteoclastogenesis O +
. O +

A O +
novel O +
role O +
for O +
an O +
insect O +
apolipoprotein B-Gene +
( O +
apolipophorin B-Gene +
III I-Gene +
) O +
in O +
beta-1,3-glucan O +
pattern O +
recognition O +
and O +
cellular O +
encapsulation O +
reactions O +
. O +

Lipoproteins O +
and O +
molecules O +
for O +
pattern O +
recognition O +
are O +
centrally O +
important O +
in O +
the O +
innate O +
immune O +
response O +
of O +
both O +
vertebrates O +
and O +
invertebrates O +
. O +

Mammalian O +
apolipoproteins B-Gene +
such O +
as O +
apolipoprotein B-Gene +
E I-Gene +
( O +
apoE B-Gene +
) O +
are O +
involved O +
in O +
LPS O +
detoxification O +
, O +
phagocytosis O +
, O +
and O +
possibly O +
pattern O +
recognition O +
. O +

The O +
multifunctional O +
insect O +
protein O +
, O +
apolipophorin B-Gene +
III I-Gene +
( O +
apoLp B-Gene -
- I-Gene -
III I-Gene +
) O +
, O +
is O +
homologous O +
to O +
apoE B-Gene +
. O +

In O +
this O +
study O +
we O +
describe O +
novel O +
roles O +
for O +
apoLp B-Gene -
- I-Gene -
III I-Gene +
in O +
pattern O +
recognition O +
and O +
multicellular O +
encapsulation O +
reactions O +
in O +
the O +
innate O +
immune O +
response O +
, O +
which O +
may O +
be O +
of O +
direct O +
relevance O +
to O +
mammalian O +
systems O +
. O +

It O +
is O +
known O +
that O +
apoLp B-Gene -
- I-Gene -
III I-Gene +
stimulates O +
antimicrobial O +
peptide O +
production O +
in O +
insect O +
blood O +
, O +
enhances O +
phagocytosis O +
by O +
insect O +
blood O +
cells O +
( O +
hemocytes O +
) O +
, O +
and O +
binds O +
and O +
detoxifies O +
LPS O +
and O +
lipoteichoic O +
acid O +
. O +

In O +
the O +
present O +
study O +
we O +
show O +
that O +
apoLp B-Gene -
- I-Gene -
III I-Gene +
from O +
the O +
greater O +
wax O +
moth O +
, O +
Galleria O +
mellonella O +
, O +
also O +
binds O +
to O +
fungal O +
conidia O +
and O +
beta-1,3-glucan O +
and O +
therefore O +
may O +
act O +
as O +
a O +
pattern O +
recognition O +
molecule O +
for O +
multiple O +
microbial O +
and O +
parasitic O +
invaders O +
. O +

This O +
protein O +
also O +
stimulates O +
increases O +
in O +
cellular O +
encapsulation O +
of O +
nonself O +
particles O +
by O +
the O +
blood O +
cells O +
and O +
exerts O +
shorter O +
term O +
, O +
time O +
- O +
dependent O +
, O +
modulatory O +
effects O +
on O +
cell O +
attachment O +
and O +
spreading O +
. O +

All O +
these O +
responses O +
are O +
dose O +
dependent O +
, O +
occur O +
within O +
physiological O +
levels O +
, O +
and O +
, O +
with O +
the O +
notable O +
exception O +
of O +
beta O -
- O -
glucan O +
binding O +
, O +
are O +
only O +
observed O +
with O +
the O +
lipid O +
- O +
associated O +
form O +
of O +
apoLp B-Gene -
- I-Gene -
III I-Gene +
. O +

Preliminary O +
studies O +
also O +
established O +
a O +
beneficial O +
role O +
for O +
apoLp B-Gene -
- I-Gene -
III I-Gene +
in O +
the O +
in O +
vivo O +
response O +
to O +
an O +
entomopathogenic O +
fungus O +
. O +

These O +
data O +
suggest O +
a O +
wide O +
range O +
of O +
immune O +
functions O +
for O +
a O +
multiple O +
specificity O +
pattern O +
recognition O +
molecule O +
and O +
may O +
provide O +
a O +
useful O +
model O +
for O +
identifying O +
further O +
potential O +
roles O +
for O +
homologous O +
proteins O +
in O +
mammalian O +
immunology O +
, O +
particularly O +
in O +
terms O +
of O +
fungal O +
infections O +
, O +
pneumoconiosis O +
, O +
and O +
granulomatous O +
reactions O +
. O +

Coexpression O +
of O +
genetically O +
engineered O +
3-ketoacyl B-Gene -
- I-Gene -
ACP I-Gene +
synthase I-Gene +
III I-Gene +
( O +
fabH B-Gene +
) O +
and O +
polyhydroxyalkanoate B-Gene +
synthase I-Gene +
( O +
phaC B-Gene +
) O +
genes O +
leads O +
to O +
short O +
- O +
chain O +
- O +
length O +
- O +
medium O +
- O +
chain O +
- O +
length O +
polyhydroxyalkanoate O +
copolymer O +
production O +
from O +
glucose O +
in O +
Escherichia O +
coli O +
JM109 O +
. O +

Polyhydroxyalkanoates O +
( O +
PHAs O +
) O +
can O +
be O +
divided O +
into O +
three O +
main O +
types O +
based O +
on O +
the O +
sizes O +
of O +
the O +
monomers O +
incorporated O +
into O +
the O +
polymer O +
. O +

Short O +
- O +
chain O +
- O +
length O +
( O +
SCL O +
) O +
PHAs O +
consist O +
of O +
monomer O +
units O +
of O +
C3 O +
to O +
C5 O +
, O +
medium O +
- O +
chain O +
- O +
length O +
( O +
MCL O +
) O +
PHAs O +
consist O +
of O +
monomer O +
units O +
of O +
C6 O +
to O +
C14 O +
, O +
and O +
SCL O -
- O -
MCL O +
PHAs O +
consist O +
of O +
monomers O +
ranging O +
in O +
size O +
from O +
C4 O +
to O +
C14 O +
. O +

Although O +
previous O +
studies O +
using O +
recombinant O +
Escherichia O +
coli O +
have O +
shown O +
that O +
either O +
SCL O +
or O +
MCL O +
PHA O +
polymers O +
could O +
be O +
produced O +
from O +
glucose O +
, O +
this O +
study O +
presents O +
the O +
first O +
evidence O +
that O +
an O +
SCL O -
- O -
MCL O +
PHA O +
copolymer O +
can O +
be O +
made O +
from O +
glucose O +
in O +
recombinant O +
E. O +
coli O +
. O +

The O +
3-ketoacyl B-Gene -
- I-Gene -
acyl I-Gene +
carrier I-Gene +
protein I-Gene +
synthase I-Gene +
III I-Gene +
gene O +
( O +
fabH B-Gene +
) O +
from O +
E. O +
coli O +
was O +
modified O +
by O +
saturation O +
point O +
mutagenesis O +
at O +
the O +
codon O +
encoding O +
amino O +
acid O +
87 O +
of O +
the O +
FabH B-Gene +
protein O +
sequence O +
, O +
and O +
the O +
resulting O +
plasmids O +
were O +
cotransformed O +
with O +
either O +
the O +
pAPAC O +
plasmid O +
, O +
which O +
harbors O +
the O +
Aeromonas O +
caviae O +
PHA B-Gene +
synthase I-Gene +
gene O +
( O +
phaC B-Gene +
) O +
, O +
or O +
the O +
pPPAC O +
plasmid O +
, O +
which O +
harbors O +
the O +
Pseudomonas O +
sp. O +
strain O +
61 O -
- O -
3 O +
PHA B-Gene +
synthase I-Gene +
gene O +
( O +
phaC1 B-Gene +
) O +
, O +
and O +
the O +
abilities O +
of O +
these O +
strains O +
to O +
accumulate O +
PHA O +
from O +
glucose O +
were O +
assessed O +
. O +

It O +
was O +
found O +
that O +
overexpression O +
of O +
several O +
of O +
the O +
mutant O +
fabH B-Gene +
genes O +
enabled O +
recombinant O +
E. O +
coli O +
to O +
induce O +
the O +
production O +
of O +
monomers O +
of O +
C4 O +
to O +
C10 O +
and O +
subsequently O +
to O +
produce O +
unusual O +
PHA O +
copolymers O +
containing O +
SCL O +
and O +
MCL O +
units O +
. O +

The O +
results O +
indicate O +
that O +
the O +
composition O +
of O +
PHA O +
copolymers O +
may O +
be O +
controlled O +
by O +
the O +
monomer O +
- O +
supplying O +
enzyme O +
and O +
further O +
reinforce O +
the O +
idea O +
that O +
fatty O +
acid O +
biosynthesis O +
may O +
be O +
used O +
to O +
supply O +
monomers O +
for O +
PHA O +
production O +
. O +

Poly B-Gene -
( I-Gene -
ADP I-Gene -
- I-Gene -
ribose I-Gene +
) I-Gene +
polymerase I-Gene +
inhibition O +
protect O +
neurons O +
and O +
the O +
white O +
matter O +
and O +
regulates O +
the O +
translocation O +
of O +
apoptosis B-Gene +
- I-Gene +
inducing I-Gene +
factor I-Gene +
in O +
stroke O +
. O +

Focal O +
cerebral O +
ischemia O +
activates O +
the O +
nuclear O +
protein O +
poly B-Gene -
( I-Gene -
ADP I-Gene -
- I-Gene -
ribose I-Gene +
) I-Gene +
polymerase I-Gene +
( O +
PARP B-Gene +
) O +
. O +

Apoptosis B-Gene +
- I-Gene +
inducing I-Gene +
factor I-Gene +
( O +
AIF B-Gene +
) O +
is O +
a O +
flavoprotein O +
that O +
is O +
normally O +
confined O +
to O +
the O +
mitochondria O +
, O +
but O +
translocates O +
to O +
the O +
nucleus O +
, O +
as O +
shown O +
by O +
in O +
vitro O +
models O +
of O +
neuronal O +
injury O +
. O +

Using O +
INO-1001 O +
, O +
a O +
novel O +
potent O +
inhibitor O +
of O +
PARP B-Gene +
, O +
we O +
determined O +
the O +
role O +
of O +
PARP B-Gene +
activation O +
in O +
the O +
process O +
of O +
AIF B-Gene +
translocation O +
in O +
a O +
rat O +
model O +
of O +
focal O +
cerebral O +
ischemia O +
. O +

The O +
potency O +
of O +
INO-1001 O +
as O +
a O +
PARP B-Gene +
inhibitor O +
and O +
its O +
cytoprotective O +
potential O +
in O +
oxidant O +
- O +
challenged O +
human O +
neuronal O +
SK O -
- O -
N O -
- O -
MC O +
cells O +
was O +
first O +
confirmed O +
in O +
vitro O +
. O +

PARP B-Gene +
inhibition O +
markedly O +
reduced O +
infarct O +
size O +
and O +
improved O +
neurological O +
status O +
in O +
both O +
transient O +
and O +
permanent O +
models O +
of O +
MCA O +
occlusion O +
in O +
Sprague O +
- O +
Dawley O +
rats O +
, O +
with O +
a O +
therapeutic O +
window O +
of O +
6 O +
h O +
and O +
2 O +
h O +
in O +
the O +
transient O +
and O +
permanent O +
ischemia O +
models O +
, O +
respectively O +
. O +

The O +
PARP B-Gene +
inhibitor O +
reduced O +
the O +
accumulation O +
of O +
poly O -
( O -
ADP O -
- O -
ribose O +
) O +
in O +
the O +
ischemic O +
/ O +
reperfused O +
hemisphere O +
and O +
reduced O +
the O +
accumulation O +
of O +
APP B-Gene +
in O +
the O +
white O +
matter O +
of O +
the O +
affected O +
hemisphere O +
, O +
consistently O +
with O +
protection O +
against O +
neuronal O +
necrosis O +
and O +
axonal O +
damage O +
, O +
respectively O +
. O +

Immunohistochemical O +
analysis O +
showed O +
the O +
appearance O +
of O +
AIF B-Gene +
labeling O +
in O +
neuronal O +
nuclei O +
of O +
the O +
border O +
zone O +
ischemic O +
area O +
in O +
the O +
striatum O +
after O +
stroke O +
. O +

Cytoplasmatic O +
( O +
axonal O +
) O +
AIF B-Gene +
staining O +
was O +
significantly O +
diminished O +
in O +
the O +
necrotic O +
core O +
of O +
the O +
striatum O +
, O +
while O +
it O +
was O +
somewhat O +
enhanced O +
at O +
the O +
borderline O +
ischemic O +
territories O +
of O +
the O +
white O +
matter O +
. O +

Inhibition O +
of O +
PARP B-Gene +
with O +
INO-1001 O +
reshifted O +
the O +
location O +
of O +
the O +
apoptotic O +
marker O +
to O +
the O +
axons O +
in O +
the O +
ipsilateral O +
striatum O +
. O +

Thus O +
, O +
PARP B-Gene +
inhibition O +
is O +
neuroprotective O +
and O +
regulates O +
the O +
ischemic O +
nuclear O +
translocation O +
of O +
AIF B-Gene +
in O +
stroke O +
. O +

PACT B-Gene +
- O +
mediated O +
enhancement O +
of O +
reporter O +
gene O +
expression O +
at O +
the O +
translational O +
level O +
. O +

The O +
cellular O +
protein O +
, O +
PACT B-Gene +
, O +
can O +
directly O +
activate O +
protein B-Gene +
kinase I-Gene +
( O +
PKR B-Gene +
) O +
in O +
vitro O +
by O +
the O +
interaction O +
of O +
PACT B-Gene +
domain O +
3 O +
with O +
PKR B-Gene +
. O +

In O +
contrast O +
, O +
in O +
vivo O +
, O +
PACT B-Gene +
- O +
mediated O +
PKR B-Gene +
activation O +
and O +
concomitant O +
inhibition O +
of O +
protein O +
synthesis O +
require O +
additional O +
cellular O +
stresses O +
. O +

We O +
observed O +
that O +
without O +
such O +
stresses O +
, O +
cotransfection O +
of O +
a O +
PACT B-Gene +
expression O +
vector O +
with O +
various O +
reporter O +
genes O +
enhances O +
their O +
levels O +
of O +
expression O +
. O +

This O +
effect O +
was O +
promoter O +
and O +
inducer O +
- O +
independent O +
and O +
PACT B-Gene +
specific O +
and O +
mediated O +
by O +
PACT B-Gene +
domains O +
1 O +
and O +
2 O +
. O +

PACT B-Gene +
did O +
not O +
increase O +
the O +
level O +
of O +
the O +
reporter O +
mRNA O +
but O +
enhanced O +
its O +
translation O +
by O +
suppressing O +
phosphorylation O +
of O +
eukaryotic B-Gene +
initiation I-Gene +
factor I-Gene +
2alpha I-Gene +
( O +
eIF2alpha B-Gene +
) O +
caused O +
by O +
the O +
transfection O +
process O +
. O +

To O +
further O +
examine O +
the O +
phenomenon O +
, O +
we O +
generated O +
cell O +
lines O +
expressing O +
a O +
PACT B-Gene +
mutant O +
containing O +
only O +
domains O +
1 O +
and O +
2 O +
. O +

Reporter O +
gene O +
expression O +
was O +
higher O +
and O +
eIF2alpha B-Gene +
phosphorylation O +
was O +
lower O +
in O +
such O +
cell O +
lines O +
compared O +
with O +
the O +
corresponding O +
control O +
cells O +
. O +

Thus O +
, O +
different O +
domains O +
of O +
PACT B-Gene +
can O +
either O +
promote O +
or O +
inhibit O +
translation O +
by O +
appropriately O +
modulating O +
the O +
status O +
of O +
eIF2alpha B-Gene +
phosphorylation O +
. O +

Avian O +
interleukin-12beta B-Gene +
( O +
p40 B-Gene +
) O +
: O +
cloning O +
and O +
characterization O +
of O +
the O +
cDNA O +
and O +
gene O +
. O +

We O +
isolated O +
the O +
chicken O +
interleukin-12 B-Gene +
( I-Gene +
ChIL-12 I-Gene +
) I-Gene +
p40 I-Gene +
cDNA O +
from O +
a O +
concanavalin O +
A O +
( O +
ConA O +
) O +
- O +
stimulated O +
spleen O +
cDNA O +
library O +
using O +
the O +
PCR O +
with O +
primers O +
based O +
on O +
a O +
partial O +
3 O -
' O +
EST O +
sequence O +
in O +
a O +
chicken O +
EST O +
library O +
. O +

The O +
cDNA O +
encodes O +
a O +
polypeptide O +
of O +
315 O +
amino O +
acids O +
( O +
aa O +
) O +
, O +
with O +
a O +
predicted O +
mature O +
peptide O +
of O +
300 O +
aa O +
. O +

ChIL-12 B-Gene +
p40 I-Gene +
has O +
46 O +
% O +
and O +
41 O +
% O +
amino O +
acid O +
identity O +
with O +
human O +
( O +
HuIL-12 B-Gene +
) O +
and O +
murine O +
IL-12 B-Gene +
( I-Gene +
MuIL I-Gene +
- I-Gene +
12 I-Gene +
) I-Gene +
p40 I-Gene +
, O +
respectively O +
. O +

We O +
also O +
isolated O +
a O +
partial O +
turkey O +
IL-12 B-Gene +
( I-Gene +
TuIL-12 I-Gene +
) I-Gene +
p40 I-Gene +
cDNA O +
sequence O +
with O +
95 O +
% O +
predicted O +
aa O +
identity O +
with O +
ChIL-12 B-Gene +
p40 I-Gene +
. O +

The O +
structures O +
of O +
the O +
ChIL-12 B-Gene +
p40 I-Gene +
gene O +
and O +
its O +
promoter O +
were O +
determined O +
by O +
direct O +
sequencing O +
of O +
a O +
chicken O +
BAC O +
identified O +
by O +
hybridization O +
with O +
the O +
cDNA O +
. O +

The O +
gene O +
structures O +
of O +
HuIL-12 B-Gene +
, I-Gene +
MuIL I-Gene +
- I-Gene +
12 I-Gene +
, I-Gene +
and I-Gene +
ChIL-12 I-Gene +
p40 I-Gene +
all O +
differ O +
. O +

The O +
promoter O +
of O +
the O +
ChIL-12 B-Gene +
p40 I-Gene +
gene O +
shares O +
some O +
( O +
an O +
ETS O +
consensus O +
sequence O +
, O +
a O +
C B-Gene +
/ I-Gene +
EBP I-Gene +
binding O +
site O +
, O +
and O +
a O +
TATA O +
box O +
) O +
but O +
not O +
all O +
( O +
an O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
binding O +
site O +
and O +
a O +
GA12 O +
site O +
are O +
absent O +
) O +
of O +
the O +
transcription B-Gene +
factor I-Gene +
binding O +
sites O +
identified O +
in O +
the O +
human O +
and O +
murine O +
promoters O +
. O +

IL-12 B-Gene +
p40 I-Gene +
mRNA O +
expression O +
was O +
identified O +
in O +
a O +
wide O +
variety O +
of O +
tissues O +
and O +
in O +
B O +
, O +
T O +
, O +
and O +
macrophage O +
cell O +
lines O +
by O +
RT O +
- O +
PCR O +
. O +

Simple O +
electrostatic O +
interaction O +
mechanisms O +
in O +
the O +
service O +
of O +
HIV-1 O +
pathogenesis O +
. O +

The O +
main O +
cell O +
population O +
affected O +
by O +
the O +
human O +
immunodeficiency O +
virus-1 O +
( O +
HIV-1 O +
) O +
infection O +
belongs O +
to O +
the O +
CD4 B-Gene +
+ O +
T O +
- O +
lymphocyte O +
family O +
. O +

Recent O +
convincing O +
evidence O +
indicates O +
that O +
the O +
majority O +
of O +
the O +
cells O +
that O +
die O +
due O +
to O +
HIV-1 O +
are O +
not O +
actually O +
infected O +
by O +
the O +
virus O +
. O +

Instead O +
, O +
these O +
cells O +
are O +
being O +
led O +
to O +
programmed O +
cell O +
death O +
after O +
the O +
activation O +
of O +
apoptotic O +
mechanisms O +
by O +
the O +
virus O +
or O +
its O +
components O +
. O +

We O +
propose O +
here O +
from O +
accumulated O +
evidence O +
that O +
the O +
virus O +
appears O +
to O +
deregulate O +
the O +
physiological O +
function O +
of O +
these O +
cells O +
during O +
the O +
process O +
of O +
antigen O +
presentation O +
. O +

Ionic O +
interactions O +
between O +
the O +
variable O +
V3 O +
domain O +
of O +
the O +
HIV-1 O +
coat O +
glycoprotein O +
gp120 B-Gene +
and O +
the O +
amino O +
terminal O +
of O +
the O +
chemokine B-Gene +
receptor I-Gene +
CCR5 B-Gene +
play O +
a O +
prominent O +
role O +
in O +
this O +
process O +
, O +
and O +
we O +
speculate O +
that O +
nature O +
has O +
evolved O +
simple O +
electrostatic O +
interaction O +
mechanisms O +
which O +
, O +
coupled O +
to O +
specific O +
recognition O +
systems O +
on O +
the O +
cell O +
surface O +
, O +
can O +
initiate O +
and O +
modulate O +
certain O +
cellular O +
events O +
without O +
the O +
need O +
for O +
specific O +
molecular O +
structures O +
. O +

HIV-1 O +
utilizes O +
such O +
a O +
mechanism O +
to O +
ensure O +
activation O +
of O +
the O +
target O +
host O +
cell O +
. O +

Anp32e B-Gene +
( O +
Cpd1 B-Gene +
) O +
and O +
related O +
protein B-Gene +
phosphatase I-Gene +
2 I-Gene +
inhibitors O +
. O +

Mouse O +
Anp32e B-Gene +
( O +
Acidic B-Gene +
leucine I-Gene +
- I-Gene +
rich I-Gene +
nuclear I-Gene +
phosphoprotein I-Gene +
32 I-Gene +
family I-Gene +
, I-Gene +
member I-Gene +
e I-Gene +
: O +
NM_023210 O +
, O +
P97822 O +
, O +
formerly O +
Cpd1 B-Gene +
) O +
, O +
a O +
protein O +
identified O +
in O +
postnatal O +
cerebellum O +
by O +
differential O +
display O +
, O +
belongs O +
to O +
the O +
superfamily B-Gene +
of I-Gene +
leucine I-Gene +
rich I-Gene +
repeat I-Gene +
( I-Gene +
LRR I-Gene +
) I-Gene +
proteins I-Gene +
and O +
to O +
the O +
Acidic B-Gene +
Nuclear I-Gene +
Phosphoprotein I-Gene +
32 I-Gene +
( I-Gene +
ANP32 I-Gene +
) I-Gene +
family I-Gene +
of O +
protein B-Gene +
phosphatase I-Gene +
2 I-Gene +
( O +
PPP2 B-Gene +
, O +
formerly O +
PP2A B-Gene +
) O +
inhibitors O +
. O +

Two O +
families O +
of O +
PPP2 B-Gene +
inhibitor O +
proteins O +
have O +
been O +
described O +
, O +
ANP32 B-Gene +
and O +
SET B-Gene +
, O +
represented O +
by O +
the O +
human O +
proteins O +
ANP32A B-Gene +
( O +
NM_006305 O +
, O +
formerly O +
LANP B-Gene +
, O +
PP32 B-Gene +
, O +
I1PPP2 B-Gene +
, O +
PHAPI B-Gene +
, O +
MAPM B-Gene +
, O +
mapmodulin B-Gene +
) O +
and O +
SET B-Gene +
( O +
NM_003011 O +
, O +
formerly O +
PHAPII B-Gene +
, O +
2PPP2 B-Gene +
, O +
I2PPP2 B-Gene +
, O +
TAF-1BETA B-Gene +
) O +
. O +

Besides O +
their O +
common O +
PPP2 B-Gene +
inhibitor O +
activity O +
, O +
described O +
several O +
years O +
ago O +
, O +
these O +
nucleo O +
- O +
cytoplasmic O +
shuttling O +
phosphoproteins O +
have O +
additional O +
and O +
very O +
important O +
functions O +
recently O +
reported O +
. O +

In O +
HeLa O +
cells O +
, O +
ANP32A B-Gene +
, O +
SET B-Gene +
( O +
isoforms O +
A O +
and O +
B O +
) O +
and O +
ANP32B B-Gene +
( O +
APRIL B-Gene +
) O +
, O +
form O +
a O +
multi O +
- O +
subunit O +
heterocomplex O +
with O +
ELAVL1 B-Gene +
( O +
NM_001419 O +
, O +
formerly O +
HuR B-Gene +
) O +
, O +
a O +
protein O +
that O +
stabilizes O +
short O +
- O +
lived O +
mRNAs O +
containing O +
AU O +
- O +
rich O +
elements O +
( O +
AREs O +
) O +
. O +

A O +
similar O +
heterocomplex O +
, O +
formed O +
by O +
SET B-Gene +
( O +
A O +
and O +
B O +
) O +
and O +
ANP32A B-Gene +
as O +
major O +
subunits O +
, O +
possess O +
histone B-Gene +
acetyltransferase I-Gene +
inhibitory O +
activity O +
( O +
INHAT B-Gene +
) O +
, O +
and O +
have O +
a O +
role O +
in O +
chromatin O +
remodeling O +
and O +
transcriptional O +
regulation O +
( O +
histone B-Gene +
code O +
) O +
. O +

The O +
possible O +
roles O +
of O +
these O +
multifunctional O +
proteins O +
are O +
discussed O +
here O +
, O +
with O +
emphasis O +
on O +
mouse O +
Anp32e B-Gene +
and O +
the O +
cerebellar O +
tissue O +
. O +

Transcription O +
activation O +
at O +
the O +
Escherichia O +
coli O +
melAB B-Gene +
promoter O +
: O +
interactions O +
of O +
MelR B-Gene +
with O +
its O +
DNA O +
target O +
site O +
and O +
with O +
domain O +
4 O +
of O +
the O +
RNA B-Gene +
polymerase I-Gene +
sigma I-Gene +
subunit O +
. O +

Activation O +
of O +
transcription O +
initiation O +
at O +
the O +
Escherichia O +
coli O +
melAB B-Gene +
promoter O +
is O +
dependent O +
on O +
MelR B-Gene +
, O +
a O +
transcription B-Gene +
factor I-Gene +
belonging O +
to O +
the O +
AraC B-Gene +
family I-Gene +
. O +

MelR B-Gene +
binds O +
to O +
18 O +
bp O +
target O +
sites O +
using O +
two O +
helix O +
- O +
turn O +
- O +
helix O +
( O +
HTH O +
) O +
motifs O +
that O +
are O +
both O +
located O +
in O +
its O +
C O +
- O +
terminal O +
domain O +
. O +

The O +
melAB B-Gene +
promoter O +
contains O +
four O +
target O +
sites O +
for O +
MelR B-Gene +
. O +

Previously O +
, O +
we O +
showed O +
that O +
occupation O +
of O +
two O +
of O +
these O +
sites O +
, O +
centred O +
at O +
positions O +
- O +
42.5 O +
and O +
- O +
62.5 O +
upstream O +
of O +
the O +
melAB B-Gene +
transcription O +
start O +
point O +
, O +
is O +
sufficient O +
for O +
activation O +
. O +

We O +
showed O +
that O +
MelR B-Gene +
binds O +
as O +
a O +
direct O +
repeat O +
to O +
these O +
sites O +
, O +
and O +
we O +
proposed O +
a O +
model O +
to O +
describe O +
how O +
the O +
two O +
HTH O +
motifs O +
are O +
positioned O +
. O +

Here O +
, O +
we O +
have O +
used O +
suppression O +
genetics O +
to O +
confirm O +
this O +
model O +
and O +
to O +
show O +
that O +
MelR B-Gene +
residue O +
273 O +
, O +
which O +
is O +
in O +
HTH O +
2 O +
, O +
interacts O +
with O +
basepair O +
13 O +
of O +
each O +
target O +
site O +
. O +

As O +
our O +
model O +
for O +
DNA O +
- O +
bound O +
MelR B-Gene +
suggests O +
that O +
HTH O +
2 O +
must O +
be O +
adjacent O +
to O +
the O +
melAB B-Gene +
promoter O +
- O +
35 O +
element O +
, O +
we O +
searched O +
this O +
part O +
of O +
MelR B-Gene +
for O +
amino O +
acid O +
side O +
- O +
chains O +
that O +
might O +
be O +
able O +
to O +
interact O +
with O +
sigma B-Gene +
. O +

We O +
describe O +
genetic O +
evidence O +
to O +
show O +
that O +
MelR B-Gene +
residue O +
261 O +
is O +
close O +
to O +
residues O +
596 O +
and O +
599 O +
of O +
the O +
RNA B-Gene +
polymerase I-Gene +
sigma I-Gene +
( I-Gene +
70 I-Gene +
) I-Gene +
subunit O +
, O +
and O +
that O +
they O +
can O +
interact O +
. O +

Similarly O +
, O +
MelR B-Gene +
residue O +
265 O +
is O +
shown O +
to O +
be O +
able O +
to O +
interact O +
with O +
residue O +
596 O +
of O +
sigma B-Gene +
( I-Gene +
70 I-Gene +
) I-Gene +
. O +

In O +
the O +
final O +
part O +
of O +
the O +
work O +
, O +
we O +
describe O +
experiments O +
in O +
which O +
the O +
MelR B-Gene +
binding O +
site O +
at O +
position O +
- O +
42.5 O +
was O +
improved O +
. O +

We O +
show O +
that O +
this O +
is O +
detrimental O +
to O +
MelR B-Gene +
- O +
dependent O +
transcription O +
activation O +
because O +
bound O +
MelR B-Gene +
is O +
mispositioned O +
so O +
that O +
it O +
is O +
unable O +
to O +
make O +
' O +
correct O +
' O +
interactions O +
with O +
sigma B-Gene +
. O +

Transcription O +
activation O +
at O +
the O +
Escherichia O +
coli O +
melAB B-Gene +
promoter O +
: O +
interactions O +
of O +
MelR B-Gene +
with O +
the O +
C O +
- O +
terminal O +
domain O +
of O +
the O +
RNA B-Gene +
polymerase I-Gene +
alpha I-Gene +
subunit O +
. O +

We O +
have O +
investigated O +
the O +
role O +
of O +
the O +
RNA B-Gene +
polymerase I-Gene +
alpha I-Gene +
subunit O +
during O +
MelR B-Gene +
- O +
dependent O +
activation O +
of O +
transcription O +
at O +
the O +
Escherichia O +
coli O +
melAB B-Gene +
promoter O +
. O +

To O +
do O +
this O +
, O +
we O +
used O +
a O +
simplified O +
melAB B-Gene +
promoter O +
derivative O +
that O +
is O +
dependent O +
on O +
MelR B-Gene +
binding O +
at O +
two O +
18 O +
bp O +
sites O +
, O +
located O +
from O +
position O +
- O +
34 O +
to O +
- O +
51 O +
and O +
from O +
position O +
- O +
54 O +
to O +
- O +
71 O +
, O +
upstream O +
of O +
the O +
transcription O +
start O +
site O +
. O +

Results O +
from O +
experiments O +
with O +
hydroxyl O +
radical O +
footprinting O +
, O +
and O +
with O +
RNA B-Gene +
polymerase I-Gene +
, O +
carrying O +
alpha O +
subunits O +
that O +
were O +
tagged O +
with O +
a O +
chemical O +
nuclease B-Gene +
, O +
show O +
that O +
the O +
C O +
- O +
terminal O +
domains O +
of O +
the O +
RNA B-Gene +
polymerase I-Gene +
alpha I-Gene +
subunits O +
are O +
located O +
near O +
position O +
- O +
52 O +
and O +
near O +
position O +
- O +
72 O +
during O +
transcription O +
activation O +
. O +

We O +
demonstrate O +
that O +
the O +
C O +
- O +
terminal O +
domain O +
of O +
the O +
RNA B-Gene +
polymerase I-Gene +
alpha I-Gene +
subunit O +
is O +
needed O +
for O +
open O +
complex O +
formation O +
, O +
and O +
we O +
describe O +
two O +
experiments O +
showing O +
that O +
the O +
RNA B-Gene +
polymerase I-Gene +
alpha I-Gene +
subunit O +
can O +
interact O +
with O +
MelR B-Gene +
. O +

Finally O +
, O +
we O +
used O +
alanine O +
scanning O +
to O +
identify O +
determinants O +
in O +
the O +
C O +
- O +
terminal O +
domain O +
of O +
the O +
RNA B-Gene +
polymerase I-Gene +
alpha I-Gene +
subunit O +
that O +
are O +
important O +
for O +
MelR B-Gene +
- O +
dependent O +
activation O +
of O +
the O +
melAB B-Gene +
promoter O +
. O +

Cloning O +
and O +
characterization O +
of O +
Kin5 B-Gene +
, O +
a O +
novel O +
Tetrahymena O +
ciliary O +
kinesin B-Gene +
II I-Gene +
. O +

Two O +
Tetrahymena O +
kinesin B-Gene +
- O +
like O +
proteins O +
( O +
klps O +
) O +
of O +
the O +
kinesin B-Gene +
II I-Gene +
subfamily I-Gene +
, O +
Kin1 B-Gene +
and O +
Kin2 B-Gene +
, O +
were O +
first O +
identified O +
by O +
Brown O +
et O +
al. O +
[ O +
1999 O +
: O +
Mol O +
Biol O +
Cell O +
10 O +
: O +
3081 O -
- O -
3096 O +
] O +
and O +
shown O +
to O +
be O +
involved O +
in O +
ciliary O +
morphogenesis O +
probably O +
as O +
molecular O +
motors O +
in O +
intraciliary O +
transport O +
( O +
ICT O +
) O +
. O +

Using O +
Tetrahymena O +
genomic O +
DNA O +
as O +
a O +
template O +
, O +
we O +
cloned O +
Kin5 B-Gene +
, O +
another O +
kinesin B-Gene +
II I-Gene +
subfamily I-Gene +
member O +
. O +

Kin5 B-Gene +
is O +
upregulated O +
upon O +
deciliation O +
, O +
suggesting O +
that O +
Kin5 B-Gene +
is O +
a O +
ciliary O +
protein O +
. O +

Kin5 B-Gene +
is O +
most O +
closely O +
related O +
to O +
Osm3 B-Gene +
, O +
a O +
Caenorhabditis O +
elegans O +
kinesin B-Gene +
II I-Gene +
; O +
Osm3 B-Gene +
and O +
Kin5 B-Gene +
have O +
a O +
56 O +
% O +
identity O +
, O +
which O +
rises O +
to O +
60.4 O +
% O +
in O +
the O +
motor O +
domain O +
and O +
a O +
45 O +
% O +
identity O +
in O +
a O +
60 O +
amino O +
acid O +
region O +
of O +
the O +
C O +
- O +
terminal O +
FERM O +
( O +
4.1 B-Gene +
, O +
Ezrin B-Gene +
, O +
Radixin B-Gene +
, O +
Moesin B-Gene +
) O +
domain O +
, O +
not O +
present O +
in O +
Kin1 B-Gene +
or O +
Kin2 B-Gene +
, O +
which O +
we O +
hypothesize O +
to O +
be O +
a O +
critical O +
domain O +
either O +
for O +
dimerization O +
or O +
for O +
cargo O +
recognition O +
in O +
ICT O +
. O +

An O +
antibody O +
to O +
a O +
peptide O +
sequence O +
from O +
the O +
tail O +
region O +
of O +
Kin5 B-Gene +
localizes O +
in O +
a O +
punctate O +
pattern O +
along O +
the O +
ciliary O +
axoneme O +
, O +
colocalizing O +
with O +
an O +
antibody O +
to O +
the O +
raft O +
protein O +
IFT139 B-Gene +
. O +

These O +
findings O +
suggest O +
that O +
Kin5 B-Gene +
is O +
an O +
ICT O +
motor O +
like O +
Osm3 B-Gene +
. O +

Osm3 B-Gene +
orthologs O +
apparently O +
transport O +
membrane O +
proteins O +
and O +
Kin5 B-Gene +
may O +
be O +
the O +
homodimeric O +
kinesin B-Gene +
II I-Gene +
that O +
performs O +
this O +
function O +
in O +
Tetrahymena O +
cilia O +
. O +

ARNT B-Gene +
gene O +
multiplicity O +
in O +
amphibians O +
: O +
characterization O +
of O +
ARNT2 B-Gene +
from O +
the O +
frog O +
Xenopus O +
laevis O +
. O +

The O +
aryl B-Gene +
hydrocarbon I-Gene +
receptor I-Gene +
nuclear I-Gene +
translocator I-Gene +
( O +
ARNT B-Gene +
) O +
is O +
a O +
member O +
of O +
the O +
Per B-Gene -
- I-Gene -
ARNT I-Gene -
- I-Gene -
Sim I-Gene +
( I-Gene +
PAS I-Gene +
) I-Gene +
protein I-Gene +
superfamily I-Gene +
, O +
transcription B-Gene +
factors I-Gene +
that O +
mediate O +
the O +
cellular O +
responses O +
to O +
various O +
developmental O +
signals O +
and O +
environmental O +
conditions O +
. O +

A O +
beta O -
- O -
class O +
( O +
" O +
partner O +
" O +
) O +
PAS O +
protein O +
, O +
ARNT B-Gene +
exhibits O +
the O +
capacity O +
to O +
form O +
transcriptionally O +
active O +
heterodimers O +
with O +
several O +
alpha O -
- O -
class O +
( O +
" O +
sensor O +
" O +
) O +
proteins O +
, O +
including O +
the O +
aryl B-Gene +
hydrocarbon I-Gene +
receptors I-Gene +
( O +
AHRs B-Gene +
) O +
, O +
the O +
hypoxia B-Gene +
- I-Gene +
inducible I-Gene +
factors I-Gene +
( O +
HIFs B-Gene +
) O +
, O +
and O +
the O +
Single B-Gene +
minded I-Gene +
( O +
Sim B-Gene +
) O +
proteins O +
. O +

Two O +
genes O +
encode O +
different O +
forms O +
of O +
ARNT B-Gene +
in O +
mammals O +
: O +
ARNT1 B-Gene +
, O +
which O +
is O +
widely O +
expressed O +
, O +
and O +
ARNT2 B-Gene +
, O +
which O +
is O +
limited O +
to O +
the O +
brain O +
and O +
kidneys O +
of O +
adults O +
and O +
specific O +
neural O +
and O +
branchial O +
tissues O +
of O +
embryos O +
. O +

In O +
contrast O +
, O +
fish O +
apparently O +
express O +
only O +
a O +
single O +
ARNT B-Gene +
gene O +
, O +
although O +
in O +
different O +
species O +
, O +
this O +
may O +
be O +
either O +
ARNT1 B-Gene +
or O +
ARNT2 B-Gene +
. O +

In O +
efforts O +
to O +
understand O +
the O +
evolution O +
of O +
ARNT B-Gene +
proteins O +
throughout O +
the O +
vertebrate O +
lineage O +
, O +
we O +
isolated O +
an O +
ARNT B-Gene +
cDNA O +
from O +
early O +
life O +
stages O +
of O +
the O +
amphibian O +
Xenopus O +
laevis O +
. O +

The O +
encoded O +
protein O +
binds O +
cognate O +
DNA O +
sequences O +
in O +
concert O +
with O +
mouse O +
AHR B-Gene +
. O +

Phylogenetic O +
analysis O +
reveals O +
that O +
this O +
sequence O +
is O +
orthologous O +
to O +
mammalian O +
ARNT2 B-Gene +
and O +
paralogous O +
to O +
the O +
recently O +
reported O +
X. O +
laevis O +
ARNT1 B-Gene +
. O +

ARNT2 B-Gene +
mRNA O +
expression O +
begins O +
later O +
than O +
ARNT1 B-Gene +
( O +
stage O +
22 O +
vs. O +
stage O +
8 O +
) O +
, O +
suggesting O +
the O +
two O +
proteins O +
play O +
distinct O +
roles O +
during O +
development O +
. O +

Hence O +
, O +
in O +
the O +
expression O +
of O +
two O +
well O +
- O +
conserved O +
ARNT B-Gene +
paralogs O +
with O +
distinct O +
expression O +
patterns O +
, O +
X. O +
laevis O +
resembles O +
mammals O +
rather O +
than O +
fish O +
. O +

Diversity O +
in O +
the O +
number O +
and O +
function O +
of O +
PAS O +
proteins O +
, O +
including O +
ARNT B-Gene +
, O +
may O +
underlie O +
significant O +
species O +
differences O +
in O +
developmental O +
programming O +
and O +
biochemical O +
response O +
to O +
environmental O +
conditions O +
. O +

The O +
identification O +
of O +
multiple O +
amphibian O +
ARNT B-Gene +
paralogs O +
represents O +
an O +
important O +
step O +
in O +
the O +
understanding O +
of O +
evolution O +
and O +
functional O +
variation O +
of O +
ARNT B-Gene +
in O +
vertebrates O +
. O +

Polymorphisms O +
of O +
mouse O +
apolipoprotein B-Gene +
A I-Gene -
- I-Gene -
II I-Gene +
: O +
seven O +
alleles O +
found O +
among O +
41 O +
inbred O +
strains O +
of O +
mice O +
. O +

In O +
mice O +
, O +
apolipoprotein B-Gene +
A I-Gene -
- I-Gene -
II I-Gene +
( O +
apoA B-Gene -
- I-Gene -
II I-Gene +
) O +
associates O +
to O +
form O +
amyloid O +
fibrils O +
in O +
an O +
age O +
- O +
associated O +
manner O +
. O +

We O +
determined O +
the O +
complete O +
nucleotide O +
sequences O +
of O +
the O +
apoA B-Gene -
- I-Gene -
II I-Gene +
gene O +
( O +
Apoa2 B-Gene +
) O +
cDNA O +
in O +
41 O +
inbred O +
strains O +
of O +
mice O +
including O +
Mus O +
musculus O +
domesticus O +
( O +
laboratory O +
mouse O +
) O +
, O +
Mus O +
musculus O +
castaneus O +
, O +
Mus O +
musculus O +
molossinus O +
, O +
Mus O +
musculus O +
musculus O +
and O +
Mus O +
spretus O +
. O +

Among O +
these O +
strains O +
we O +
identified O +
7 O +
alleles O +
( O +
Apoa2a1 B-Gene +
, O +
Apoa2a2 B-Gene +
, O +
Apoa2b B-Gene +
, O +
Apoa2c B-Gene +
, O +
Apoa2d B-Gene +
, O +
Apoa2e B-Gene +
and O +
Apoa2f B-Gene +
) O +
. O +

Polymorphisms O +
of O +
nucleotides O +
at O +
15 O +
positions O +
were O +
detected O +
and O +
amino O +
acid O +
substitutions O +
were O +
found O +
at O +
8 O +
positions O +
. O +

Apoa2a1 B-Gene +
was O +
found O +
in O +
all O +
mouse O +
subspecies O +
, O +
but O +
Apoa2b B-Gene +
and O +
Apoa2c B-Gene +
were O +
found O +
only O +
in O +
Mus O +
musculus O +
domesticus O +
. O +

Two O +
strains O +
of O +
Mus O +
spretus O +
have O +
the O +
unique O +
alleles O +
Apoa2e B-Gene +
and O +
Apoa2f B-Gene +
which O +
resemble O +
Apoa2c B-Gene +
. O +

We O +
confirmed O +
that O +
VICS O +
in O +
which O +
we O +
found O +
severe O +
amyloidosis O +
here O +
and O +
other O +
amyloidoneic O +
strains O +
in O +
published O +
reports O +
have O +
Apoa2c B-Gene +
allele O +
. O +

We O +
determined O +
the O +
plasma O +
concentrations O +
of O +
total O +
and O +
HDL B-Gene +
cholesterol O +
in O +
the O +
strains O +
of O +
Mus O +
musculus O +
domesticus O +
with O +
the O +
Apoa2a1 B-Gene +
, O +
Apoa2b B-Gene +
and O +
Apoa2c B-Gene +
alleles O +
. O +

Significantly O +
higher O +
concentrations O +
of O +
plasma O +
cholesterol O +
were O +
observed O +
in O +
mouse O +
strains O +
with O +
the O +
Apoa2b B-Gene +
allele O +
. O +

These O +
findings O +
provide O +
fundamental O +
data O +
on O +
mouse O +
Apoa2 B-Gene +
alleles O +
. O +

Furthermore O +
, O +
differences O +
in O +
these O +
alleles O +
likely O +
have O +
considerable O +
influence O +
on O +
traits O +
related O +
to O +
amyloidosis O +
and O +
lipid O +
metabolism O +
. O +

Regulation O +
of O +
expression O +
of O +
the O +
divergent O +
ulaG B-Gene +
and O +
ulaABCDEF B-Gene +
operons I-Gene +
involved O +
in O +
LaAscorbate O +
dissimilation O +
in O +
Escherichia O +
coli O +
. O +

The O +
ula B-Gene +
regulon O +
, O +
responsible O +
for O +
the O +
utilization O +
of O +
L O -
- O -
ascorbate O +
in O +
Escherichia O +
coli O +
, O +
is O +
formed O +
by O +
two O +
divergently O +
transcribed O +
operons O +
, O +
ulaG B-Gene +
and O +
ulaABCDEF B-Gene +
. O +

The O +
regulon O +
is O +
negatively O +
regulated O +
by O +
a O +
repressor O +
of O +
the O +
DeoR B-Gene +
family I-Gene +
which O +
is O +
encoded O +
by O +
the O +
constitutive O +
gene O +
ulaR B-Gene +
located O +
downstream O +
of O +
ulaG B-Gene +
. O +

Full O +
repression O +
of O +
the O +
ula B-Gene +
regulon O +
requires O +
simultaneous O +
interaction O +
of O +
the O +
repressor O +
with O +
both O +
divergent O +
promoters O +
and O +
seems O +
to O +
be O +
dependent O +
on O +
repressor O +
- O +
mediated O +
DNA O +
loop O +
formation O +
, O +
which O +
is O +
helped O +
by O +
the O +
action O +
of O +
integration B-Gene +
host I-Gene +
factor I-Gene +
. O +

Two O +
operator O +
sites O +
have O +
been O +
identified O +
in O +
each O +
promoter O +
. O +

Lack O +
of O +
either O +
of O +
the O +
two O +
sets O +
of O +
operators O +
partially O +
relieved O +
the O +
repression O +
of O +
the O +
other O +
operon O +
; O +
thus O +
, O +
each O +
promoter O +
is O +
dependent O +
on O +
the O +
UlaR B-Gene +
operator O +
sites O +
of O +
the O +
other O +
promoter O +
to O +
enhance O +
repression O +
. O +

Electrophoretic O +
mobility O +
shift O +
assays O +
with O +
purified O +
UlaR B-Gene +
protein O +
and O +
promoter O +
deletion O +
analyses O +
revealed O +
a O +
conserved O +
sequence O +
, O +
present O +
in O +
each O +
of O +
the O +
four O +
operators O +
, O +
acting O +
as O +
a O +
UlaR B-Gene +
binding O +
site O +
. O +

Glucose O +
represses O +
the O +
ula B-Gene +
regulon O +
via O +
at O +
least O +
two O +
mechanisms O +
, O +
one O +
dependent O +
on O +
cyclic O +
AMP O +
( O +
cAMP O +
) O +
- O +
cAMP B-Gene +
receptor I-Gene +
protein I-Gene +
( O +
CRP B-Gene +
) O +
and O +
the O +
other O +
( O +
possibly O +
inducer O +
exclusion O +
) O +
independent O +
of O +
it O +
. O +

Glucose O +
effects O +
mediated O +
by O +
other O +
global O +
regulators O +
can O -
not O +
be O +
ruled O +
out O +
with O +
the O +
present O +
information O +
. O +

Changes O +
in O +
cAMP O +
- O +
CRP B-Gene +
levels O +
affected O +
only O +
the O +
expression O +
of O +
the O +
ulaABCDEF B-Gene +
operon I-Gene +
. O +

Reconstitution O +
of O +
ATP O +
- O +
dependent O +
cGMP O +
transport O +
into O +
proteoliposomes O +
by O +
membrane O +
proteins O +
from O +
human O +
erythrocytes O +
. O +

The O +
cellular O +
efflux O +
of O +
cGMP O +
from O +
human O +
erythrocytes O +
has O +
previously O +
been O +
characterized O +
in O +
functional O +
studies O +
. O +

The O +
purpose O +
of O +
the O +
present O +
study O +
was O +
to O +
find O +
membrane O +
proteins O +
with O +
the O +
ability O +
to O +
restore O +
ATP O +
- O +
dependent O +
uptake O +
of O +
cGMP O +
into O +
proteoliposomes O +
. O +

Human O +
erythrocyte O +
membranes O +
were O +
solubilized O +
with O +
CHAPS O +
( O +
3- O -
( O -
[ O -
3-cholamidopropyl O -
] O -
dimethylammonio O -
) O -
-1-propanesulfonate O +
) O +
and O +
gel O +
filtration O +
gave O +
three O +
protein O +
fractions O +
with O +
the O +
ability O +
to O +
restore O +
active O +
transport O +
. O +

Only O +
two O +
of O +
these O +
fractions O +
were O +
retained O +
on O +
a O +
lentil O +
lectin B-Gene +
column O +
. O +

By O +
using O +
these O +
two O +
purification O +
steps O +
, O +
active O +
transport O +
was O +
11 O +
times O +
higher O +
in O +
the O +
first O +
fraction O +
compared O +
to O +
the O +
original O +
material O +
and O +
SDS O -
- O -
PAGE O +
showed O +
the O +
presence O +
of O +
proteins O +
with O +
sizes O +
of O +
145 O +
kDa O +
and O +
165 O +
kDa O +
. O +

The O +
second O +
fraction O +
gave O +
20 O +
times O +
higher O +
active O +
transport O +
after O +
purification O +
and O +
comprised O +
proteins O +
with O +
sizes O +
of O +
145 O +
kDa O +
and O +
180 O +
kDa O +
. O +

At O +
present O +
three O +
members O +
of O +
the O +
MRP B-Gene +
( I-Gene +
multi I-Gene +
- I-Gene +
resistance I-Gene +
associated I-Gene +
protein I-Gene +
) I-Gene +
family I-Gene +
have O +
been O +
detected O +
in O +
human O +
erythrocytes O +
: O +
MRPI B-Gene +
, O +
MRP4 B-Gene +
and O +
MRP5 B-Gene +
. O +

The O +
last O +
two O +
proteins O +
have O +
been O +
shown O +
to O +
transport O +
cyclic O +
nucleotides O +
. O +

The O +
present O +
findings O +
are O +
compatible O +
with O +
MRP4 B-Gene +
as O +
the O +
145 O +
kDa O +
protein O +
, O +
MRP5 B-Gene +
as O +
the O +
165 O +
kDa O +
protein O +
and O +
MRP1 B-Gene +
as O +
the O +
180 O +
kDa O +
protein O +
. O +

However O +
, O +
the O +
145 O +
kDa O +
protein O +
could O +
also O +
be O +
SMRP B-Gene +
( O +
short B-Gene +
multi I-Gene +
- I-Gene +
resistance I-Gene +
protein I-Gene +
) O +
, O +
the O +
gene O +
splice O +
variant O +
of O +
MRP5 B-Gene +
. O +

Immunoprecipitation O +
of O +
MRP5 B-Gene +
from O +
CHAPS O +
- O +
solubilized O +
extract O +
reduced O +
active O +
transport O +
and O +
specific O +
binding O +
by O +
about O +
45 O +
% O +
and O +
40 O +
% O +
, O +
respectively O +
. O +

This O +
shows O +
that O +
MRP5 B-Gene +
is O +
an O +
important O +
cGMP O +
- O +
transporting O +
protein O +
in O +
human O +
erythrocytes O +
. O +

Structure O +
- O +
function O +
of O +
human O +
3 B-Gene +
alpha I-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenases I-Gene +
: O +
genes O +
and O +
proteins O +
. O +

Four O +
soluble O +
human O +
3 B-Gene +
alpha I-Gene -
- I-Gene -
hydroxysteroid I-Gene +
dehydrogenase I-Gene +
( O +
HSD B-Gene +
) O +
isoforms O +
exist O +
which O +
are O +
aldo B-Gene +
- I-Gene +
keto I-Gene +
reductase I-Gene +
( I-Gene +
AKR I-Gene +
) I-Gene +
superfamily I-Gene +
members O +
. O +

They O +
share O +
86 O +
% O +
sequence O +
identity O +
and O +
correspond O +
to O +
: O +
AKR1C1 B-Gene +
( O +
20 B-Gene +
alpha I-Gene +
( I-Gene +
3 I-Gene +
alpha I-Gene +
) I-Gene +
- I-Gene +
HSD I-Gene +
) O +
; O +
AKR1C2 B-Gene +
( O +
type B-Gene +
3 I-Gene +
3 I-Gene +
alpha I-Gene -
- I-Gene -
HSD I-Gene +
and O +
bile B-Gene +
- I-Gene +
acid I-Gene +
binding I-Gene +
protein I-Gene +
) O +
; O +
AKR1C3 B-Gene +
( O +
type B-Gene +
2 I-Gene +
3 I-Gene +
alpha I-Gene -
- I-Gene -
HSD I-Gene +
and O +
type B-Gene +
5 I-Gene +
17 I-Gene +
beta I-Gene -
- I-Gene -
HSD I-Gene +
) O +
; O +
and O +
AKR1C4 B-Gene +
( O +
type B-Gene +
1 I-Gene +
3 I-Gene +
alpha I-Gene -
- I-Gene -
HSD I-Gene +
) O +
. O +

Each O +
of O +
the O +
homogeneous O +
recombinant O +
enzymes O +
are O +
plastic O +
and O +
display O +
3 B-Gene +
- I-Gene +
, I-Gene +
17 I-Gene +
- I-Gene +
and I-Gene +
20 I-Gene +
- I-Gene +
ketosteroid I-Gene +
reductase I-Gene +
and O +
3 B-Gene +
alpha- I-Gene +
17 I-Gene +
beta I-Gene +
- I-Gene +
and I-Gene +
20 I-Gene +
alpha I-Gene -
- I-Gene -
hydroxysteroid I-Gene +
oxidase I-Gene +
activities O +
with O +
different O +
k O -
( O -
cat O -
) O +
/ O +
K O -
( O -
m O -
) O +
ratios O +
in O +
vitro O +
. O +

The O +
crystal O +
structure O +
of O +
the O +
AKR1C2 B-Gene +
. O +
NADP O +
( O +
+ O +
) O +
.ursodeoxycholate O +
complex O +
provides O +
an O +
explanation O +
for O +
this O +
functional O +
plasticity O +
. O +

Ursodeoxycholate O +
is O +
bound O +
backwards O +
( O +
D O -
- O -
ring O +
in O +
the O +
A O +
- O +
ring O +
position O +
) O +
and O +
upside O +
down O +
( O +
beta O -
- O -
face O +
of O +
steroid O +
inverted O +
) O +
relative O +
to O +
the O +
position O +
of O +
3-ketosteroids O +
in O +
the O +
related O +
rat O +
liver O +
3 B-Gene +
alpha I-Gene -
- I-Gene -
HSD I-Gene +
( O +
AKR1C9 B-Gene +
) O +
structure O +
. O +

Transient O +
transfection O +
indicates O +
that O +
in O +
COS-1 O +
cells O +
, O +
AKR1C B-Gene +
enzymes O +
function O +
as O +
ketosteroid B-Gene +
reductases I-Gene +
due O +
to O +
potent O +
inhibition O +
of O +
their O +
oxidase B-Gene +
activity O +
by O +
NADPH O +
. O +

By O +
acting O +
as O +
ketosteroid B-Gene +
reductases I-Gene +
they O +
may O +
regulate O +
the O +
occupancy O +
of O +
the O +
androgen B-Gene +
, I-Gene +
estrogen I-Gene +
and I-Gene +
progesterone I-Gene +
receptors I-Gene +
. O +

RT O +
- O +
PCR O +
showed O +
that O +
AKRs B-Gene +
are O +
discretely O +
localized O +
. O +

AKR1C4 B-Gene +
is O +
virtually O +
liver O +
specific O +
, O +
while O +
AKR1C2 B-Gene +
and O +
AKR1C3 B-Gene +
are O +
dominantly O +
expressed O +
in O +
prostate O +
and O +
mammary O +
gland O +
. O +

AKR1C B-Gene +
genes O +
are O +
highly O +
conserved O +
in O +
structure O +
and O +
may O +
be O +
transcriptionally O +
regulated O +
by O +
steroid O +
hormones O +
and O +
stress O +
. O +

Construction O +
of O +
a O +
soluble O +
human O +
GH B-Gene -
- I-Gene -
receptor I-Gene +
/ O +
EGF B-Gene -
- I-Gene -
receptor I-Gene +
hybrid O +
and O +
its O +
activation O +
by O +
GH B-Gene +
. O +

To O +
develop O +
a O +
cell O +
- O +
free O +
system O +
that O +
can O +
be O +
used O +
to O +
measure O +
cytokine B-Gene +
bioactivity O +
we O +
have O +
designed O +
a O +
soluble O +
hybrid O +
molecule O +
consisting O +
of O +
the O +
extracellular O +
domain O +
of O +
the O +
GH B-Gene +
- I-Gene +
receptor I-Gene +
( O +
GHR B-Gene +
) O +
and O +
the O +
intracellular O +
domain O +
of O +
the O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
receptor I-Gene +
( O +
EGFR B-Gene +
) O +
. O +

A O +
DNA O +
construct O +
encoding O +
this O +
hybrid O +
- O +
receptor O +
was O +
inserted O +
into O +
a O +
baculoviral O +
expression O +
vector O +
and O +
expressed O +
in O +
Sf9 O +
- O +
cells O +
. O +

Activation O +
of O +
the O +
hybrid O +
- O +
receptor O +
by O +
ligand O +
- O +
induced O +
dimerization O +
can O +
be O +
measured O +
as O +
the O +
incorporation O +
of O +
radiolabeled O +
phosphate O +
into O +
a O +
biotinylated O +
tyrosine B-Gene +
kinase I-Gene +
peptide O +
substrate O +
. O +

The O +
kinase B-Gene +
activity O +
in O +
samples O +
stimulated O +
with O +
GH B-Gene +
( O +
10 O +
ng O +
/ O +
ml O +
) O +
increased O +
5 O +
- O +
fold O +
compared O +
to O +
samples O +
without O +
addition O +
of O +
GH B-Gene +
. O +

This O +
is O +
the O +
first O +
example O +
of O +
a O +
functional O +
hybrid O +
- O +
receptor O +
where O +
the O +
transmembrane O +
domain O +
has O +
been O +
deleted O +
. O +

Our O +
results O +
suggest O +
that O +
such O +
hybrid O +
- O +
receptors O +
may O +
be O +
used O +
for O +
detection O +
of O +
GH B-Gene +
and O +
other O +
cytokine B-Gene +
- I-Gene +
receptor I-Gene +
activating O +
substances O +
in O +
biological O +
fluids O +
. O +

The O +
inner O +
membrane O +
subassembly O +
of O +
the O +
enteropathogenic O +
Escherichia O +
coli O +
bundle O +
- O +
forming O +
pilus O +
machine O +
. O +

Type O +
IV O +
pili O +
( O +
Tfps O +
) O +
are O +
filamentous O +
surface O +
appendages O +
expressed O +
by O +
Gram O +
- O +
negative O +
microorganisms O +
and O +
play O +
numerous O +
roles O +
in O +
bacterial O +
cell O +
biology O +
. O +

Tfp O +
biogenesis O +
machineries O +
are O +
highly O +
conserved O +
and O +
resemble O +
protein O +
secretion O +
and O +
DNA O +
uptake O +
systems O +
. O +

Although O +
components O +
of O +
Tfp O +
biogenesis O +
systems O +
have O +
been O +
identified O +
, O +
it O +
is O +
not O +
known O +
how O +
they O +
interact O +
to O +
form O +
these O +
machineries O +
. O +

Using O +
the O +
bundle O +
- O +
forming O +
pilus O +
( O +
BFP O +
) O +
of O +
enteropathogenic O +
Escherichia O +
coli O +
as O +
a O +
model O +
Tfp O +
system O +
, O +
we O +
provide O +
evidence O +
of O +
a O +
cytoplasmic O +
membrane O +
subassembly O +
of O +
the O +
Tfp O +
assembly O +
machine O +
composed O +
of O +
putative O +
cytoplasmic O +
nucleotide O +
- O +
binding O +
and O +
cytoplasmic O +
membrane O +
proteins O +
. O +

A O +
combination O +
of O +
genetic O +
, O +
biochemical O +
and O +
biophysical O +
approaches O +
revealed O +
interactions O +
among O +
putative O +
cytoplasmic O +
nucleotide O +
- O +
binding O +
proteins O +
BfpD B-Gene +
and O +
BfpF B-Gene +
and O +
cytoplasmic O +
membrane O +
proteins O +
BfpC B-Gene +
and O +
BfpE B-Gene +
of O +
the O +
BFP B-Gene +
biogenesis O +
machine O +
. O +

The O +
polytopic O +
membrane O +
protein O +
BfpE B-Gene +
appears O +
to O +
be O +
a O +
central O +
component O +
of O +
this O +
subassembly O +
as O +
it O +
interacts O +
with O +
BfpC B-Gene +
, O +
BfpD B-Gene +
and O +
BfpF B-Gene +
. O +

We O +
report O +
that O +
BFP O +
biogenesis O +
probably O +
requires O +
interactions O +
among O +
BfpC B-Gene +
, O +
BfpD B-Gene +
and O +
BfpE B-Gene +
, O +
whereas O +
BFP O +
retraction O +
requires O +
interaction O +
of O +
the O +
PilT B-Gene +
- O +
like O +
putative O +
ATPase B-Gene +
BfpF B-Gene +
with O +
a O +
conserved O +
domain O +
of O +
BfpE B-Gene +
. O +

BfpE B-Gene +
is O +
the O +
first O +
protein O +
that O +
is O +
not O +
a O +
member O +
of O +
the O +
PilT B-Gene +
family I-Gene +
to O +
be O +
implicated O +
in O +
Tfp O +
retraction O +
. O +

Furthermore O +
, O +
we O +
found O +
that O +
the O +
putative O +
ATPases B-Gene +
BfpD B-Gene +
and O +
BfpF B-Gene +
play O +
antagonistic O +
roles O +
in O +
BFP O +
biogenesis O +
and O +
retraction O +
, O +
respectively O +
, O +
by O +
interacting O +
with O +
distinct O +
domains O +
of O +
the O +
BFP O +
biogenesis O +
machine O +
. O +

Co O +
- O +
expression O +
of O +
three O +
MEP O +
pathway O +
genes O +
and O +
geraniol B-Gene +
10-hydroxylase I-Gene +
in O +
internal O +
phloem O +
parenchyma O +
of O +
Catharanthus O +
roseus O +
implicates O +
multicellular O +
translocation O +
of O +
intermediates O +
during O +
the O +
biosynthesis O +
of O +
monoterpene O +
indole O +
alkaloids O +
and O +
isoprenoid O +
- O +
derived O +
primary O +
metabolites O +
. O +

In O +
higher O +
plants O +
, O +
isopentenyl O +
diphosphate O +
( O +
IPP O +
) O +
is O +
synthesised O +
both O +
from O +
the O +
plastidic O +
2-C O -
- O -
methyl O -
- O -
d O -
- O -
erythritol O +
4-phosphate O +
( O +
MEP O +
) O +
and O +
from O +
the O +
cytosolic O +
mevalonate O +
( O +
MVA O +
) O +
pathways O +
. O +

Primary O +
metabolites O +
, O +
such O +
as O +
phytol O +
group O +
of O +
chlorophylls O +
, O +
carotenoids O +
and O +
the O +
plant O +
hormones O +
abscisic O +
acid O +
( O +
ABA O +
) O +
and O +
gibberellins O +
( O +
GAs O +
) O +
are O +
derived O +
directly O +
from O +
the O +
MEP O +
pathway O +
. O +

Many O +
secondary O +
metabolites O +
, O +
such O +
as O +
monoterpene O +
indole O +
alkaloids O +
( O +
MIAs O +
) O +
in O +
Catharanthus O +
roseus O +
, O +
are O +
also O +
synthesised O +
from O +
this O +
source O +
of O +
IPP O +
. O +

Using O +
Northern O +
blot O +
and O +
in O +
situ O +
hybridisation O +
experiments O +
, O +
we O +
show O +
that O +
three O +
MEP O +
pathway O +
genes O +
( O +
1-deoxy B-Gene -
- I-Gene -
d I-Gene -
- I-Gene -
xylulose I-Gene +
5-phosphate I-Gene +
synthase I-Gene +
( O +
DXS B-Gene +
) O +
, O +
1-deoxy B-Gene -
- I-Gene -
d I-Gene -
- I-Gene -
xylulose I-Gene +
5-phosphate I-Gene +
reductoisomerase I-Gene +
( O +
DXR B-Gene +
) O +
and O +
2C B-Gene -
- I-Gene -
methyl I-Gene -
- I-Gene -
d I-Gene -
- I-Gene -
erythritol I-Gene +
2,4-cyclodiphosphate I-Gene +
synthase I-Gene +
( O +
MECS B-Gene +
) O +
) O +
and O +
the O +
gene O +
encoding O +
geraniol B-Gene +
10-hydroxylase I-Gene +
( O +
G10H B-Gene +
) O +
, O +
a O +
cytochrome B-Gene +
P450 I-Gene +
monooxygenase I-Gene +
involved O +
in O +
the O +
first O +
committed O +
step O +
in O +
the O +
formation O +
of O +
iridoid O +
monoterpenoids O +
display O +
identical O +
cell O +
- O +
specific O +
expression O +
patterns O +
. O +

The O +
co O +
- O +
localisation O +
of O +
these O +
four O +
transcripts O +
to O +
internal O +
phloem O +
parenchyma O +
of O +
young O +
aerial O +
organs O +
of O +
C. O +
roseus O +
adds O +
a O +
new O +
level O +
of O +
complexity O +
to O +
the O +
multicellular O +
nature O +
of O +
MIA O +
biosynthesis O +
. O +

We O +
predict O +
the O +
translocation O +
of O +
pathway O +
intermediates O +
from O +
the O +
internal O +
phloem O +
parenchyma O +
to O +
the O +
epidermis O +
and O +
, O +
ultimately O +
, O +
to O +
laticifers O +
and O +
idioblasts O +
during O +
MIA O +
biosynthesis O +
. O +

Similarly O +
, O +
the O +
translocation O +
of O +
intermediates O +
from O +
the O +
phloem O +
parenchyma O +
is O +
probably O +
also O +
required O +
during O +
the O +
biosynthesis O +
of O +
hormones O +
and O +
photosynthetic O +
primary O +
metabolites O +
derived O +
from O +
the O +
MEP O +
pathway O +
. O +

Calcium O +
- O +
regulated O +
changes O +
in O +
mitochondrial O +
phenotype O +
in O +
skeletal O +
muscle O +
cells O +
. O +

Cytochrome B-Gene +
c I-Gene +
expression O +
and O +
mitochondrial O +
biogenesis O +
can O +
be O +
invoked O +
by O +
elevated O +
intracellular O +
Ca O -
( O -
2 O -
+ O -
) O +
in O +
muscle O +
cells O +
. O +

To O +
characterize O +
the O +
potential O +
role O +
of O +
Ca O -
( O -
2 O -
+ O -
) O +
as O +
a O +
messenger O +
involved O +
in O +
mitochondrial O +
biogenesis O +
in O +
muscle O +
, O +
we O +
determined O +
the O +
effects O +
of O +
the O +
Ca O +
( O +
2 O +
+ O +
) O +
ionophore O +
A O +
- O +
23187 O +
on O +
the O +
expression O +
of O +
nuclear O +
- O +
and O +
mitochondrially O +
encoded O +
genes O +
. O +

Treatment O +
of O +
myotubes O +
with O +
1 O +
microM O +
A-23187 O +
for O +
48 O +
- O +
96 O +
h O +
increased O +
nuclear O +
- O +
encoded O +
beta B-Gene +
- I-Gene +
subunit I-Gene +
F I-Gene -
( I-Gene -
1 I-Gene -
) I-Gene +
ATPase I-Gene +
and O +
malate B-Gene +
dehydrogenase I-Gene +
( O +
MDH B-Gene +
) O +
mRNA O +
levels O +
by O +
50 O +
- O +
100 O +
% O +
( O +
P O +
< O +
0.05 O +
) O +
but O +
decreased O +
mRNA O +
levels O +
of O +
glutamate B-Gene +
dehydrogenase I-Gene +
( O +
GDH B-Gene +
) O +
by O +
19 O +
% O +
( O +
P O +
< O +
0.05 O +
) O +
. O +

mRNA O +
levels O +
of O +
the O +
cytochrome B-Gene +
c I-Gene +
oxidase I-Gene +
( O +
COX B-Gene +
) O +
nuclear O +
- O +
encoded O +
subunits O +
IV O +
, O +
Vb O +
, O +
and O +
VIc O +
were O +
unchanged O +
, O +
whereas O +
the O +
mitochondrially O +
encoded O +
subunits O +
COX B-Gene +
II I-Gene +
and O +
COX B-Gene +
III I-Gene +
were O +
decreased O +
by O +
30 O +
and O +
70 O +
% O +
, O +
respectively O +
( O +
P O +
< O +
0.05 O +
) O +
. O +

This O +
was O +
paralleled O +
by O +
a O +
20 O +
% O +
decrease O +
( O +
P O +
< O +
0.05 O +
) O +
in O +
COX B-Gene +
activity O +
. O +

These O +
data O +
suggest O +
that O +
cytoplasmic O +
Ca O -
( O -
2 O -
+ O -
) O +
differentially O +
regulates O +
the O +
mRNA O +
level O +
of O +
nuclear O +
and O +
mitochondrial O +
genes O +
. O +

The O +
decline O +
in O +
COX B-Gene +
II I-Gene +
and I-Gene +
III I-Gene +
mRNA O +
may O +
be O +
mediated O +
by O +
Tfam B-Gene +
, O +
because O +
A O +
- O +
23187 O +
modestly O +
reduced O +
Tfam B-Gene +
levels O +
by O +
48 O +
h O +
. O +

A-23187 O +
induced O +
time O +
- O +
dependent O +
increases O +
in O +
Egr-1 B-Gene +
mRNA O +
, O +
along O +
with O +
the O +
activation O +
of O +
ERK1 B-Gene +
/ I-Gene +
2 I-Gene +
and O +
AMP B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
. O +

MEK B-Gene +
inhibition O +
with O +
PD-98059 O +
attenuated O +
the O +
increase O +
in O +
Egr-1 B-Gene +
mRNA O +
. O +

A-23187 O +
also O +
increased O +
Egr-1 B-Gene +
, O +
serum B-Gene +
response I-Gene +
factor I-Gene +
, O +
and O +
Sp1 B-Gene +
protein O +
expression O +
, O +
transcription B-Gene +
factors I-Gene +
implicated O +
in O +
mitochondrial O +
biogenesis O +
. O +

Egr-1 B-Gene +
overexpression O +
increased O +
nuclear O +
- O +
encoded O +
cytochrome B-Gene +
c I-Gene +
transcriptional O +
activation O +
by O +
1.5 O +
- O +
fold O +
( O +
P O +
< O +
0.05 O +
) O +
and O +
reduced O +
GDH B-Gene +
mRNA O +
by O +
37 O +
% O +
( O +
P O +
< O +
0.05 O +
) O +
but O +
had O +
no O +
effect O +
on O +
MDH B-Gene +
or O +
beta B-Gene +
- I-Gene +
subunit I-Gene +
F I-Gene +
( I-Gene +
1 I-Gene +
) I-Gene +
ATPase I-Gene +
mRNA O +
. O +

These O +
results O +
indicate O +
that O +
changes O +
in O +
intracellular O +
Ca O -
( O -
2 O -
+ O -
) O +
can O +
modify O +
mitochondrial O +
phenotype O +
, O +
in O +
part O +
via O +
the O +
involvement O +
of O +
Egr-1 B-Gene +
. O +

Cyclooxygenase B-Gene +
2 I-Gene +
- O +
derived O +
prostaglandin O +
E2 O +
production O +
by O +
corticotropin B-Gene +
- I-Gene +
releasing I-Gene +
hormone I-Gene +
contributes O +
to O +
the O +
activated O +
cAMP B-Gene +
response I-Gene +
element I-Gene +
binding I-Gene +
protein I-Gene +
content O +
in O +
rheumatoid O +
arthritis O +
synovial O +
tissue O +
. O +

OBJECTIVE O +
: O +

To O +
determine O +
a O +
mechanism O +
by O +
which O +
corticotropin B-Gene +
- I-Gene +
releasing I-Gene +
hormone I-Gene +
( O +
CRH B-Gene +
) O +
promotes O +
human O +
inflammatory O +
joint O +
disease O +
progression O +
. O +

METHODS O +
: O +

An O +
ex O +
vivo O +
synovial O +
tissue O +
culture O +
system O +
was O +
established O +
to O +
investigate O +
the O +
functional O +
properties O +
of O +
CRH B-Gene +
at O +
peripheral O +
sites O +
of O +
inflammation O +
. O +

CRH B-Gene +
- O +
and O +
interleukin-1 B-Gene +
beta I-Gene +
( O +
IL-1 B-Gene +
beta I-Gene +
) O +
- O +
induced O +
prostaglandin O +
E O -
( O -
2 O -
) O +
( O +
PGE O -
( O -
2 O -
) O +
) O +
production O +
from O +
10 O +
fresh O +
rheumatoid O +
arthritis O +
( O +
RA O +
) O +
synovial O +
tissue O +
( O +
ST O +
) O +
explants O +
was O +
quantified O +
using O +
a O +
competitive O +
enzyme O +
- O +
linked O +
immunosorbent O +
assay O +
. O +

Modulation O +
of O +
PGE O -
( O -
2 O -
) O +
levels O +
was O +
further O +
examined O +
following O +
selective O +
and O +
nonselective O +
cyclooxygenase B-Gene +
2 I-Gene +
( O +
COX-2 B-Gene +
) O +
inhibition O +
. O +

Nuclear O +
extracts O +
were O +
analyzed O +
by O +
electrophoretic O +
mobility O +
shift O +
assays O +
to O +
determine O +
functional O +
cAMP B-Gene +
response I-Gene +
element I-Gene +
binding I-Gene +
protein I-Gene +
( O +
CREB B-Gene +
) O +
activity O +
in O +
response O +
to O +
CRH B-Gene +
and O +
PGE O -
( O -
2 O -
) O +
in O +
isolated O +
primary O +
synovial O +
cell O +
populations O +
. O +

Western O +
blot O +
analysis O +
measured O +
levels O +
of O +
total O +
and O +
activated O +
( O +
phosphospecific O +
) O +
CREB B-Gene +
/ I-Gene +
activating I-Gene +
transcription I-Gene +
factor I-Gene +
( I-Gene +
ATF I-Gene +
) I-Gene +
family I-Gene +
members O +
prior O +
to O +
and O +
following O +
stimulation O +
. O +

RESULTS O +
: O +

CRH B-Gene +
, O +
in O +
a O +
time O +
- O +
and O +
dose O +
- O +
dependent O +
manner O +
, O +
significantly O +
( O +
P O +
= O +
0.022 O +
) O +
up O +
- O +
regulated O +
PGE O -
( O -
2 O -
) O +
production O +
from O +
10 O +
fresh O +
RA O +
ST O +
explants O +
. O +

Costimulation O +
of O +
RA O +
ST O +
with O +
CRH B-Gene +
and O +
IL-1 B-Gene +
beta I-Gene +
significantly O +
augmented O +
( O +
P O +
= O +
0.036 O +
) O +
the O +
effects O +
on O +
PGE O -
( O -
2 O -
) O +
production O +
additively O +
over O +
24 O +
hours O +
. O +

We O +
demonstrated O +
that O +
selective O +
COX-2 B-Gene +
inhibitors O +
prevent O +
the O +
induction O +
of O +
PGE O -
( O -
2 O -
) O +
by O +
both O +
CRH B-Gene +
and O +
IL-1 B-Gene +
beta I-Gene +
. O +

Further O +
, O +
we O +
provided O +
evidence O +
that O +
CRH B-Gene +
and O +
PGE O -
( O -
2 O -
) O +
signal O +
through O +
the O +
induction O +
of O +
CREB B-Gene +
and O +
phosphorylated O +
CREB B-Gene +
/ I-Gene +
ATF I-Gene +
family I-Gene +
members O +
in O +
RA O +
ST O +
and O +
in O +
isolated O +
primary O +
RA O +
cell O +
populations O +
. O +

CONCLUSION O +
: O +

Our O +
findings O +
underscore O +
the O +
pathogenic O +
role O +
that O +
CRH B-Gene +
may O +
play O +
in O +
modulating O +
inflammatory O +
joint O +
disease O +
and O +
establish O +
the O +
CREB B-Gene +
/ I-Gene +
ATF I-Gene +
family I-Gene +
of O +
transcription B-Gene +
factors I-Gene +
as O +
principal O +
effector O +
molecules O +
of O +
proinflammatory O +
mediator O +
action O +
in O +
RA O +
. O +

Type O -
- O -
A O +
CpG O +
oligonucleotides O +
activate O +
exclusively O +
porcine O +
natural O +
interferon B-Gene +
- O +
producing O +
cells O +
to O +
secrete O +
interferon B-Gene -
- I-Gene -
alpha I-Gene +
, O +
tumour B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
and O +
interleukin-12 B-Gene +
. O +

Natural O +
interferon B-Gene +
- O +
producing O +
cells O +
( O +
NIPC O +
) O +
, O +
also O +
referred O +
to O +
as O +
immature O +
plasmacytoid O +
dendritic O +
cells O +
( O +
PDC O +
) O +
, O +
constitute O +
a O +
small O +
population O +
of O +
leucocytes O +
secreting O +
high O +
levels O +
of O +
type B-Gene +
I I-Gene +
interferons I-Gene +
in O +
response O +
to O +
certain O +
danger O +
signals O +
. O +

Amongst O +
these O +
signals O +
are O +
those O +
from O +
DNA O +
containing O +
unmethylated O +
CpG O +
motifs O +
. O +

The O +
present O +
work O +
demonstrated O +
that O +
the O +
CpG O +
oligonucleotides O +
( O +
CpG O -
- O -
ODN O +
) O +
2216 O +
, O +
D32 O +
and O +
D19 O +
induce O +
high O +
amounts O +
of O +
interferon B-Gene -
- I-Gene -
alpha I-Gene +
( O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
) O +
, O +
tumour B-Gene +
- I-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
( O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
) O +
and O +
interleukin B-Gene +
( I-Gene +
IL I-Gene +
) I-Gene +
- I-Gene +
12 I-Gene +
in O +
porcine O +
peripheral O +
blood O +
mononuclear O +
cells O +
( O +
PBMCs O +
) O +
. O +

Swine B-Gene +
workshop I-Gene +
cluster I-Gene +
3 I-Gene +
( O +
SWC3 B-Gene +
) O +
1ow O +
CD4high B-Gene +
cells O +
, O +
with O +
high O +
IL-3 B-Gene +
- O +
binding O +
activity O +
, O +
representing O +
NIPC O +
, O +
were O +
the O +
exclusive O +
cytokine B-Gene +
- O +
producing O +
cells O +
responding O +
to O +
the O +
CpG O -
- O -
ODN O +
. O +

These O +
cells O +
did O +
not O +
express O +
CD6 B-Gene +
, O +
CD8 B-Gene +
or O +
CD45RA B-Gene +
. O +

Importantly O +
, O +
monocyte O +
- O +
derived O +
DC O +
did O +
not O +
respond O +
to O +
CpG O -
- O -
ODN O +
by O +
secretion O +
of O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
or O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
or O +
by O +
the O +
up O +
- O +
regulation O +
of O +
costimulatory O +
molecule O +
expression O +
. O +

CpG O -
- O -
ODN O +
up O +
- O +
regulated O +
MHC B-Gene +
class I-Gene +
II I-Gene +
and O +
CD80 B-Gene +
\ I-Gene +
86 I-Gene +
expression O +
on O +
the O +
NIPC O +
, O +
but O +
were O +
unable O +
to O +
promote O +
NIPC O +
survival O +
. O +

Interestingly O +
, O +
certain O +
CpG O -
- O -
ODN O +
, O +
incapable O +
of O +
inducing O +
NIPC O +
to O +
secrete O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
or O +
up O +
- O +
regulate O +
MHC B-Gene +
class I-Gene +
II I-Gene +
and O +
CD80 B-Gene +
\ I-Gene +
86 I-Gene +
, O +
did O +
promote O +
NIPC O +
viability O +
. O +

Taken O +
together O +
, O +
the O +
influence O +
of O +
CpG O -
- O -
ODN O +
on O +
porcine O +
NIPC O +
, O +
monocytes O +
and O +
myeloid O +
DCs O +
relates O +
to O +
that O +
observed O +
with O +
their O +
human O +
equivalents O +
. O +

These O +
results O +
represent O +
an O +
important O +
basis O +
for O +
the O +
application O +
of O +
CpG O -
- O -
ODN O +
as O +
adjuvants O +
for O +
the O +
formulation O +
of O +
novel O +
vaccines O +
and O +
demonstrate O +
the O +
importance O +
of O +
the O +
pig O +
as O +
an O +
alternative O +
animal O +
model O +
for O +
this O +
approach O +
. O +

A O +
suf B-Gene +
operon I-Gene +
requirement O +
for O +
Fe O -
- O -
S O +
cluster O +
assembly O +
during O +
iron O +
starvation O +
in O +
Escherichia O +
coli O +
. O +

The O +
suf B-Gene +
and I-Gene +
isc I-Gene +
operons I-Gene +
of O +
Escherichia O +
coli O +
have O +
been O +
implicated O +
in O +
Fe O -
- O -
S O +
cluster O +
assembly O +
. O +

However O +
, O +
it O +
has O +
been O +
unclear O +
why O +
E. O +
coli O +
has O +
two O +
systems O +
for O +
Fe O -
- O -
S O +
cluster O +
biosynthesis O +
. O +

We O +
have O +
examined O +
the O +
regulatory O +
characteristics O +
and O +
mutant O +
phenotypes O +
of O +
both O +
operons O +
to O +
discern O +
if O +
the O +
two O +
operons O +
have O +
redundant O +
functions O +
or O +
if O +
their O +
cellular O +
roles O +
are O +
divergent O +
. O +

Both O +
operons O +
are O +
similarly O +
induced O +
by O +
hydrogen O +
peroxide O +
and O +
the O +
iron O +
chelator O +
2,2'-dipyridyl O +
, O +
although O +
by O +
different O +
mechanisms O +
. O +

Regulation O +
of O +
the O +
isc B-Gene +
operon I-Gene +
is O +
mediated O +
by O +
IscR B-Gene +
, O +
whereas O +
the O +
suf B-Gene +
operon I-Gene +
requires O +
OxyR B-Gene +
and O +
IHF B-Gene +
for O +
the O +
response O +
to O +
oxidative O +
stress O +
and O +
Fur B-Gene +
for O +
induction O +
by O +
iron O +
starvation O +
. O +

Simultaneous O +
deletion O +
of O +
iscS B-Gene +
and O +
most O +
suf O +
genes O +
is O +
synthetically O +
lethal O +
. O +

However O +
, O +
although O +
the O +
suf B-Gene +
and I-Gene +
isc I-Gene +
operons I-Gene +
have O +
overlapping O +
functions O +
, O +
they O +
act O +
as O +
distinct O +
complexes O +
because O +
the O +
SufS B-Gene +
desulphurase I-Gene +
alone O +
can O -
not O +
substitute O +
for O +
the O +
IscS B-Gene +
enzyme O +
. O +

In O +
addition O +
, O +
suf B-Gene +
deletion O +
mutants O +
are O +
more O +
sensitive O +
to O +
iron O +
starvation O +
than O +
isc B-Gene +
mutants O +
, O +
and O +
the O +
activity O +
of O +
the O +
Fe O -
- O -
S O +
enzyme O +
gluconate B-Gene +
dehydratase I-Gene +
is O +
diminished O +
in O +
the O +
suf B-Gene +
mutant O +
during O +
iron O +
starvation O +
. O +

These O +
findings O +
are O +
consistent O +
with O +
the O +
model O +
that O +
the O +
isc B-Gene +
operon I-Gene +
encodes O +
the O +
housekeeping O +
Fe O -
- O -
S O +
cluster O +
assembly O +
system O +
in O +
E. O +
coli O +
, O +
whereas O +
the O +
suf B-Gene +
operon I-Gene +
is O +
specifically O +
adapted O +
to O +
synthesize O +
Fe O -
- O -
S O +
clusters O +
when O +
iron O +
or O +
sulphur O +
metabolism O +
is O +
disrupted O +
by O +
iron O +
starvation O +
or O +
oxidative O +
stress O +
. O +

Abnormal O +
in O +
vivo O +
metabolism O +
of O +
apoB B-Gene +
- O +
containing O +
lipoproteins O +
in O +
human O +
apoE B-Gene +
deficiency O +
. O +

The O +
present O +
study O +
was O +
undertaken O +
to O +
elucidate O +
the O +
metabolic O +
basis O +
for O +
the O +
increased O +
remnants O +
and O +
lipoprotein B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
[ O +
Lp B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
] O +
and O +
decreased O +
LDL B-Gene +
apolipoprotein B-Gene +
B I-Gene +
( O +
apoB B-Gene +
) O +
levels O +
in O +
human O +
apoE B-Gene +
deficiency O +
. O +

A O +
primed O +
constant O +
infusion O +
of O +
( O -
13 O -
) O -
C O -
( O -
6 O -
) O -
-phenylalanine O +
was O +
administered O +
to O +
a O +
homozygous O +
apoE B-Gene +
- O +
deficient O +
subject O +
. O +

apoB-100 B-Gene +
and O +
apoB-48 B-Gene +
were O +
isolated O +
, O +
and O +
tracer O +
enrichments O +
were O +
determined O +
by O +
gas O +
chromatography O +
- O +
mass O +
spectrometry O +
, O +
then O +
kinetic O +
parameters O +
were O +
calculated O +
by O +
multicompartmental O +
modeling O +
. O +

In O +
the O +
apoE B-Gene +
- O +
deficient O +
subject O +
, O +
fractional O +
catabolic O +
rates O +
( O +
FCRs O +
) O +
of O +
apoB B-Gene +
- I-Gene +
100 I-Gene +
in O +
VLDL B-Gene +
and O +
intermediate B-Gene +
density I-Gene +
lipoprotein I-Gene +
and O +
apoB-48 B-Gene +
in O +
VLDL B-Gene +
were O +
3x O +
, O +
12x O +
, O +
and O +
12x O +
slower O +
than O +
those O +
of O +
controls O +
. O +

On O +
the O +
other O +
hand O +
, O +
the O +
LDL B-Gene +
apoB-100 B-Gene +
FCR O +
was O +
increased O +
by O +
2.6x O +
. O +

The O +
production O +
rate O +
of O +
VLDL B-Gene +
apoB-100 B-Gene +
was O +
decreased O +
by O +
45 O +
% O +
. O +

In O +
the O +
Lp B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
kinetic O +
study O +
, O +
two O +
types O +
of O +
Lp B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
were O +
isolated O +
from O +
plasma O +
with O +
apoE B-Gene +
deficiency O +
: O +
buoyant O +
and O +
normal O +
Lp B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
. O +

( O -
125 O -
) O -
I O -
- O -
buoyant O +
Lp B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
was O +
catabolized O +
at O +
a O +
slower O +
rate O +
in O +
the O +
patient O +
. O +

However O +
, O +
( O -
125 O -
) O -
I O -
- O -
buoyant O +
Lp B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
was O +
catabolized O +
at O +
twice O +
as O +
fast O +
as O +
( O +
131 O +
) O +
I O +
- O +
normal O +
Lp B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
in O +
the O +
control O +
subjects O +
. O +

In O +
summary O +
, O +
apoE B-Gene +
deficiency O +
results O +
in O +
: O +
1 O +
) O +
a O +
markedly O +
impaired O +
catabolism O +
of O +
VLDL B-Gene +
/ O +
chylomicron B-Gene +
and O +
their O +
remnants O +
due O +
to O +
lack O +
of O +
direct O +
removal O +
and O +
impaired O +
lipolysis O +
; O +
2 O +
) O +
an O +
increased O +
rate O +
of O +
catabolism O +
of O +
LDL B-Gene +
apoB B-Gene +
- I-Gene +
100 I-Gene +
, O +
likely O +
due O +
to O +
upregulation O +
of O +
LDL B-Gene +
receptor I-Gene +
activity O +
; O +
3 O +
) O +
reduced O +
VLDL B-Gene +
apoB B-Gene +
production O +
; O +
and O +
4 O -
) O +
a O +
delayed O +
catabolism O +
of O +
a O +
portion O +
of O +
Lp B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
. O +

Fructan O +
metabolising O +
enzymes O +
in O +
rhizophores O +
of O +
Vernonia O +
herbacea O +
upon O +
excision O +
of O +
aerial O +
organs O +
. O +

The O +
activities O +
of O +
fructan O +
metabolising O +
enzymes O +
and O +
fructan O +
contents O +
are O +
reported O +
for O +
rhizophores O +
of O +
Vernonia O +
herbacea O +
( O +
Vell O -
. O +
) O +
Rusby O +
induced O +
to O +
sprouting O +
by O +
shoot O +
excision O +
. O +

The O +
activities O +
of O +
fructan B-Gene +
exohydrolase I-Gene +
( O +
1-FEH B-Gene +
) O +
, O +
sucrose B-Gene +
: I-Gene +
sucrose I-Gene +
fructosyltransferase I-Gene +
( O +
1-SST B-Gene +
) O +
, O +
fructan B-Gene +
: I-Gene +
fructan I-Gene +
fructosyltransferase I-Gene +
( O +
1-FFT B-Gene +
) O +
and O +
invertase B-Gene +
( O +
INV B-Gene +
) O +
and O +
the O +
fructan O +
contents O +
were O +
analysed O +
every O +
3 O -
- O -
4 O +
days O +
for O +
1 O +
month O +
by O +
colorimetric O +
and O +
chromatographic O +
methods O +
. O +

Sprouting O +
of O +
new O +
shoots O +
started O +
on O +
day O +
9 O +
. O +

1-FEH B-Gene +
activity O +
increased O +
after O +
day O +
13 O +
and O +
reached O +
its O +
maximum O +
value O +
20 O +
days O +
after O +
shoot O +
excision O +
. O +

A O +
gradual O +
decrease O +
in O +
1-SST B-Gene +
activity O +
was O +
detected O +
between O +
days O +
3 O +
and O +
9 O +
. O +

1-FFT B-Gene +
activity O +
exhibited O +
fluctuations O +
throughout O +
the O +
experimental O +
period O +
and O +
a O +
peak O +
of O +
activity O +
for O +
invertase O +
was O +
detected O +
9 O +
days O +
after O +
shoot O +
excision O +
. O +

Variation O +
in O +
fructan O +
contents O +
in O +
vivo O +
included O +
a O +
decrease O +
until O +
day O +
13 O +
after O +
which O +
, O +
levels O +
remained O +
practically O +
unchanged O +
. O +

Fructan O +
depolymerization O +
and O +
sprouting O +
are O +
concomitant O +
processes O +
in O +
V. O +
herbacea O +
and O +
can O +
be O +
induced O +
by O +
shoot O +
excision O +
at O +
any O +
phenological O +
phase O +
. O +

1-FEH B-Gene +
and O +
1-FFT B-Gene +
seemed O +
to O +
act O +
in O +
a O +
concerted O +
way O +
to O +
catalyse O +
fructan O +
depolymerization O +
, O +
while O +
1-SST B-Gene +
was O +
inhibited O +
, O +
possibly O +
due O +
to O +
interruption O +
of O +
sucrose O +
supply O +
to O +
rhizophores O +
from O +
the O +
aerial O +
organs O +
. O +

Effect O +
of O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
and O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
on O +
intestinal O +
P B-Gene -
- I-Gene -
glycoprotein I-Gene +
expression O +
, O +
activity O +
, O +
and O +
localization O +
in O +
Caco-2 O +
cells O +
. O +

The O +
P B-Gene -
- I-Gene -
glycoprotein I-Gene +
( O +
Pgp B-Gene +
) O +
, O +
a O +
drug O +
efflux O +
pump O +
, O +
is O +
expressed O +
in O +
intestinal O +
epithelial O +
cells O +
, O +
where O +
it O +
constitutes O +
a O +
barrier O +
against O +
xenobiotics O +
. O +

In O +
inflammatory O +
bowel O +
disease O +
, O +
a O +
dysregulation O +
in O +
the O +
production O +
of O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
( I-Gene +
TNF I-Gene +
) I-Gene +
alpha I-Gene +
and O +
interferon B-Gene +
( I-Gene +
IFN I-Gene +
) I-Gene +
gamma I-Gene +
, O +
and O +
an O +
alteration O +
of O +
Pgp B-Gene +
expression O +
and O +
activity O +
have O +
been O +
reported O +
. O +

The O +
aim O +
of O +
this O +
study O +
was O +
to O +
investigate O +
the O +
effects O +
of O +
TNF B-Gene +
alpha I-Gene +
and O +
IFN B-Gene +
gamma I-Gene +
on O +
intestinal O +
Pgp B-Gene +
expression O +
, O +
activity O +
, O +
and O +
localization O +
in O +
Caco-2 O +
cells O +
grown O +
on O +
filters O +
. O +

TNF B-Gene +
alpha I-Gene +
induced O +
both O +
a O +
strong O +
time O +
- O +
dependent O +
diminution O +
( O +
- O +
56 O +
% O +
) O +
of O +
MDR1 B-Gene +
mRNA O +
( O +
semiquantitative O +
reverse O +
transcription O +
polymerase O +
chain O +
reaction O +
) O +
and O +
a O +
significant O +
decrease O +
of O +
unidirectional O +
transport O +
of O +
rhodamine O +
123 O +
after O +
48 O +
h O +
of O +
exposure O +
at O +
10 O +
ng O +
/ O +
mL O +
. O +

By O +
confocal O +
laser O +
scanning O +
microscopy O +
, O +
the O +
Pgp B-Gene +
was O +
mainly O +
localized O +
to O +
the O +
apical O +
plasma O +
membrane O +
of O +
both O +
control O +
and O +
TNF B-Gene +
alpha I-Gene +
- O +
treated O +
cells O +
. O +

By O +
contrast O +
, O +
IFN B-Gene +
gamma I-Gene +
induced O +
up O +
- O +
regulation O +
of O +
both O +
mRNA O +
MDR1 B-Gene +
and O +
Pgp B-Gene +
protein O +
expression O +
without O +
incidence O +
on O +
Pgp B-Gene +
activity O +
. O +

Interestingly O +
, O +
a O +
colocalization O +
of O +
Pgp B-Gene +
with O +
lateral O +
F B-Gene -
- I-Gene -
actin I-Gene +
was O +
observed O +
. O +

Associated O +
with O +
TNF B-Gene +
alpha I-Gene +
, O +
IFN B-Gene +
gamma I-Gene +
produced O +
neither O +
an O +
antagonist O +
nor O +
synergistic O +
effect O +
on O +
Pgp B-Gene +
activity O +
. O +

In O +
conclusion O +
, O +
our O +
results O +
demonstrate O +
an O +
inhibitory O +
effect O +
of O +
TNF B-Gene +
alpha I-Gene +
and O +
no O +
effect O +
of O +
IFN B-Gene +
gamma I-Gene +
on O +
Pgp B-Gene +
transport O +
activity O +
using O +
rhodamine O +
123 O +
as O +
a O +
substrate O +
. O +

Mechanisms O +
of O +
action O +
of O +
these O +
cytokines B-Gene +
remain O +
to O +
be O +
studied O +
. O +

Genetic O +
polymorphisms O +
of O +
killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
are O +
associated O +
with O +
susceptibility O +
to O +
psoriasis O +
vulgaris O +
. O +

To O +
elucidate O +
the O +
association O +
between O +
killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIRs B-Gene +
) O +
and O +
psoriasis O +
vulgaris O +
( O +
PV O +
) O +
, O +
we O +
typed O +
14 O +
KIR B-Gene +
genes O +
in O +
96 O +
Japanese O +
cases O +
and O +
50 O +
healthy O +
controls O +
using O +
PCR O +
with O +
sequence O +
- O +
specific O +
primers O +
( O +
PCR O +
- O +
SSP O +
) O +
. O +

Here O +
we O +
report O +
an O +
interesting O +
association O +
between O +
certain O +
KIRs B-Gene +
and O +
Japanese O +
cases O +
with O +
PV O +
. O +

The O +
frequencies O +
of O +
KIR2DS1 B-Gene +
and O +
KIR2DL5 B-Gene +
were O +
significantly O +
increased O +
in O +
PV O +
cases O +
compared O +
with O +
controls O +
( O +
KIR2DS1 B-Gene +
, O +
43 O +
of O +
96 O +
( O +
45 O +
% O +
) O +
in O +
cases O +
vs O +
14 O +
of O +
50 O +
( O +
28 O +
% O +
) O +
in O +
controls O +
; O +
KIR2DL5 B-Gene +
, O +
46 O +
of O +
96 O +
( O +
48 O +
% O +
) O +
in O +
cases O +
vs O +
15 O +
of O +
50 O +
( O +
30 O +
% O +
) O +
in O +
controls O +
, O +
p O +
< O +
0.05 O +
for O +
both O +
) O +
, O +
and O +
the O +
frequency O +
of O +
carriage O +
of O +
at O +
least O +
one O +
presumed O +
" O +
B O +
" O +
haplotype O +
, O +
inferred O +
from O +
patterns O +
including O +
KIR2DL2 B-Gene +
, O +
KIR2DL5 B-Gene +
, O +
and/or O +
various O +
combinations O +
of O +
activating O +
KIRs B-Gene +
, O +
was O +
also O +
statistically O +
increased O +
in O +
the O +
PV O +
cases O +
( O +
53 O +
of O +
96 O +
( O +
55 O +
% O +
) O +
in O +
cases O +
vs O +
18 O +
of O +
50 O +
( O +
36 O +
% O +
) O +
in O +
controls O +
, O +
p O +
< O +
0.04 O +
) O +
. O +

The O +
increase O +
in O +
KIR2DS1 B-Gene +
has O +
also O +
been O +
observed O +
in O +
psoriatic O +
arthritis O +
, O +
another O +
HLA B-Gene -
- I-Gene -
Cw6 I-Gene +
- O +
associated O +
disease O +
( O +
Martin O +
et O +
al O +
, O +
2002 O +
) O +
. O +

Accordingly O +
, O +
KIR2DS1 B-Gene +
may O +
be O +
a O +
common O +
denominator O +
of O +
both O +
diseases O +
. O +

Differential O +
contribution O +
of O +
IL-1Ra B-Gene +
isoforms O +
to O +
allele O +
- O +
specific O +
IL-1Ra B-Gene +
mRNA O +
accumulation O +
. O +

The O +
interleukin-1 B-Gene +
( I-Gene +
IL-1 I-Gene +
) I-Gene +
receptor I-Gene +
antagonist I-Gene +
( O +
IL-1Ra B-Gene +
) O +
gene O +
produces O +
two O +
isoforms O +
of O +
IL-1Ra B-Gene +
, O +
intracellular O +
( O +
icIL-1Ra B-Gene +
) O +
and O +
secreted O +
( O +
sIL-1Ra B-Gene +
) O +
. O +

Distinct O +
promoter O +
regions O +
control O +
synthesis O +
of O +
each O +
isoform O +
. O +

Five O +
alleles O +
of O +
this O +
gene O +
, O +
defined O +
by O +
sIL-1Ra B-Gene +
intron O +
2 O +
polymorphism O +
, O +
have O +
been O +
described O +
. O +

Although O +
differences O +
in O +
IL-1Ra B-Gene +
protein O +
production O +
have O +
been O +
demonstrated O +
in O +
various O +
tissues O +
and O +
cells O +
obtained O +
from O +
individuals O +
carrying O +
allele O +
1 O +
vs. O +
allele O +
2 O +
, O +
the O +
underlying O +
mechanisms O +
of O +
this O +
discrepancy O +
remain O +
poorly O +
understood O +
. O +

We O +
hypothesize O +
that O +
one O +
mechanism O +
contributing O +
to O +
differences O +
in O +
protein O +
levels O +
may O +
be O +
allele O +
- O +
specific O +
accumulation O +
of O +
icIL-1Ra B-Gene +
or O +
sIL-1Ra B-Gene +
mRNA O +
. O +

Quantification O +
of O +
allele O +
- O +
specific O +
differences O +
in O +
mRNA O +
accumulation O +
in O +
colonic O +
biopsies O +
and O +
peripheral O +
blood O +
mononuclear O +
cells O +
( O +
PBMC O +
) O +
of O +
heterozygous O +
individuals O +
shows O +
that O +
the O +
amount O +
of O +
allele O +
1 O +
- O +
specific O +
icIL-1Ra B-Gene +
mRNA O +
averaged O +
four O +
times O +
higher O +
relative O +
to O +
allele O +
2 O +
. O +

In O +
transfection O +
assays O +
, O +
gene O +
expression O +
directed O +
by O +
the O +
allele O +
1 O +
- O +
specific O +
icIL-1Ra B-Gene +
promoter O +
fragment O +
was O +
found O +
to O +
be O +
greater O +
than O +
that O +
directed O +
by O +
the O +
allele O +
2 O +
promoter O +
, O +
suggesting O +
that O +
icIL-1Ra B-Gene +
promoter O +
activity O +
contributes O +
to O +
the O +
disparity O +
in O +
the O +
allele O +
- O +
specific O +
icIL-1Ra B-Gene +
mRNA O +
accumulation O +
. O +

Our O +
data O +
show O +
that O +
differences O +
in O +
the O +
transcriptional O +
regulation O +
of O +
icIL-1Ra B-Gene +
alleles O +
1 O +
and O +
2 O +
may O +
be O +
involved O +
in O +
the O +
production O +
of O +
icIL-1Ra B-Gene +
protein O +
. O +

Disregulated O +
icIL-1Ra B-Gene +
production O +
may O +
play O +
a O +
role O +
in O +
chronic O +
inflammatory O +
diseases O +
where O +
the O +
balance O +
between O +
IL-1 B-Gene +
and O +
IL-1Ra B-Gene +
has O +
been O +
implicated O +
as O +
a O +
key O +
pathogenic O +
mechanism O +
. O +

Pathogens O +
and O +
symbionts O +
in O +
ticks O +
: O +
prevalence O +
of O +
Anaplasma O +
phagocytophilum O +
( O +
Ehrlichia O +
sp. O +
) O +
, O +
Wolbachia O +
sp. O +
, O +
Rickettsia O +
sp. O +
, O +
and O +
Babesia O +
sp. O +
in O +
Southern O +
Germany O +
. O +

Tick O +
- O +
transmitted O +
diseases O +
like O +
tick O +
- O +
borne O +
encephalitis O +
and O +
Lyme O +
borreliosis O +
have O +
been O +
well O +
known O +
in O +
Germany O +
for O +
decades O +
. O +

Ongoing O +
research O +
now O +
gives O +
an O +
additional O +
focus O +
to O +
a O +
broad O +
range O +
of O +
other O +
bacteria O +
and O +
parasites O +
in O +
ticks O +
like O +
Anaplasma O +
phagocytophilum O +
, O +
former O +
Ehrlichia O +
sp. O +
, O +
Rickettsia O +
sp. O +
and O +
Babesia O +
sp. O +
Knowledge O +
about O +
the O +
prevalence O +
of O +
these O +
infectious O +
agents O +
in O +
ticks O +
is O +
an O +
important O +
prerequisite O +
for O +
risk O +
assessment O +
of O +
human O +
diseases O +
. O +

Therefore O +
nymphs O +
and O +
adult O +
Ixodes O +
ricinus O +
ticks O +
were O +
collected O +
and O +
examined O +
for O +
Anaplasma O +
phagocytophilum O +
( O +
n O +
= O +
5424 O +
ticks O +
) O +
, O +
Rickettsia O +
sp. O +
( O +
n O +
= O +
1187 O +
) O +
, O +
and O +
Babesia O +
sp. O +
( O +
n O +
= O +
3113 O +
) O +
. O +

For O +
the O +
detection O +
of O +
Anaplasma O +
phagocytophilum O +
, O +
DNA O +
from O +
the O +
16S O +
rDNA O +
gene O +
was O +
amplified O +
by O +
nested O +
PCR O +
and O +
hybridized O +
with O +
a O +
DIG O +
- O +
labeled O +
oligonucleotide O +
probe O +
. O +

The O +
examination O +
of O +
Rickettsia O +
sp. O +
was O +
performed O +
by O +
single O +
PCR O +
. O +

A O +
partial O +
sequence O +
of O +
the O +
citrate B-Gene +
synthase I-Gene +
gene O +
was O +
amplified O +
. O +

As O +
a O +
target O +
for O +
the O +
detection O +
of O +
Babesia O +
sp. O +
, O +
DNA O +
from O +
the O +
18S O +
rDNA O +
gene O +
was O +
amplified O +
, O +
also O +
by O +
single O +
PCR O +
. O +

All O +
positive O +
PCR O +
products O +
were O +
sequenced O +
to O +
control O +
specificity O +
. O +

Anaplasma O +
phagocytophilum O +
was O +
detected O +
by O +
PCR O +
in O +
n O +
= O +
103 O +
( O +
1.9 O +
% O +
) O +
out O +
of O +
5,424 O +
examined O +
ticks O +
from O +
11 O +
investigation O +
areas O +
. O +

However O +
, O +
not O +
all O +
positive O +
PCR O +
products O +
hybridized O +
using O +
DIG O +
- O +
labeled O +
oligonucleotide O +
probe O +
. O +

Thus O +
, O +
the O +
result O +
of O +
sequencing O +
indicated O +
that O +
only O +
1.0 O +
% O +
( O +
n O +
= O +
54 O +
) O +
belonged O +
to O +
Anaplasma O +
phagocytophilum O +
and O +
nearly O +
half O +
of O +
these O +
PCR O +
products O +
( O +
0.9 O +
% O +
) O +
were O +
identified O +
as O +
Wolbachia O +
sp. O +
Rickettsia O +
sp. O +
in O +
Ixodes O +
ricinus O +
ticks O +
from O +
3 O +
areas O +
were O +
found O +
in O +
n O +
= O +
105 O +
( O +
8.9 O +
% O +
) O +
out O +
of O +
1,187 O +
ticks O +
examined O +
( O +
range O +
from O +
13.3 O +
% O +
to O +
5.6 O +
% O +
) O +
. O +

Sequencing O +
showed O +
Rickettsia O +
helvetica O +
exclusively O +
. O +

In O +
about O +
2.6 O +
% O +
of O +
Rickettsia O +
- O +
positive O +
ticks O +
, O +
double O +
infection O +
with O +
Anaplasma O +
phagocytophilum O +
was O +
found O +
. O +

Babesia O +
sp. O +
was O +
detected O +
in O +
n O +
= O +
31 O +
( O +
1.0 O +
% O +
) O +
out O +
of O +
3,113 O +
ticks O +
examined O +
, O +
which O +
originated O +
from O +
4 O +
different O +
areas O +
. O +

By O +
sequencing O +
, O +
n O +
= O +
28 O +
( O +
90.0 O +
% O +
) O +
were O +
identified O +
as O +
Babesia O +
divergens O +
. O +

Three O +
of O +
all O +
Babesia O +
- O +
positive O +
ticks O +
were O +
identified O +
as O +
harboring O +
Babesia O +
microti O +
. O +

The O +
detection O +
of O +
Anaplasma O +
phagocytophilum O +
, O +
Rickettsia O +
sp. O +
and O +
Babesia O +
sp. O +
demonstrates O +
their O +
possible O +
role O +
as O +
a O +
source O +
of O +
human O +
infection O +
in O +
Germany O +
. O +

The O +
role O +
of O +
human O +
mast O +
cell O +
- O +
derived O +
cytokines B-Gene +
in O +
eosinophil O +
biology O +
. O +

Eosinophil O +
- O +
mediated O +
diseases O +
, O +
such O +
as O +
allergic O +
asthma O +
, O +
eosinophilic O +
fasciitis O +
, O +
and O +
certain O +
hypersensitivity O +
pulmonary O +
disorders O +
, O +
are O +
characterized O +
by O +
eosinophil O +
infiltration O +
and O +
tissue O +
injury O +
. O +

Mast O +
cells O +
and O +
T O +
cells O +
often O +
colocalize O +
to O +
these O +
areas O +
. O +

Recent O +
data O +
suggest O +
that O +
mast O +
cells O +
can O +
contribute O +
to O +
eosinophil O +
- O +
mediated O +
inflammatory O +
responses O +
. O +

Activation O +
of O +
mast O +
cells O +
can O +
occur O +
by O +
antigen O +
and O +
immunoglobulin B-Gene +
E I-Gene +
( O +
IgE B-Gene +
) O +
via O +
the O +
high B-Gene +
- I-Gene +
affinity I-Gene +
receptor I-Gene +
( I-Gene +
FcepsilonRI I-Gene +
) I-Gene +
for I-Gene +
IgE I-Gene +
. O +

The O +
liberation O +
of O +
proteases O +
, O +
leukotrienes O +
, O +
lipid O +
mediators O +
, O +
and O +
histamine O +
can O +
contribute O +
to O +
tissue O +
inflammation O +
and O +
allow O +
recruitment O +
of O +
eosinophils O +
to O +
tissue O +
. O +

In O +
addition O +
, O +
the O +
synthesis O +
and O +
expression O +
of O +
a O +
plethora O +
of O +
cytokines B-Gene +
and O +
chemokines B-Gene +
( O +
such O +
as O +
granulocyte B-Gene +
- I-Gene +
macrophage I-Gene +
colony I-Gene +
- I-Gene +
stimulating I-Gene +
factor I-Gene +
[ O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
] O +
, O +
interleukin-1 B-Gene +
[ O +
IL-1 B-Gene +
] O +
, O +
IL-3 B-Gene +
, O +
IL-5 B-Gene +
, O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
[ O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
] O +
, O +
and O +
the O +
chemokines B-Gene +
IL-8 B-Gene +
, O +
regulated B-Gene +
upon I-Gene +
activation I-Gene +
normal I-Gene +
T I-Gene +
cell I-Gene +
expressed I-Gene +
and I-Gene +
secreted I-Gene +
[ O +
RANTES B-Gene +
] O +
, O +
monocyte B-Gene +
chemotactic I-Gene +
protein-1 I-Gene +
[ O +
MCP-1 B-Gene +
] O +
, O +
and O +
eotaxin B-Gene +
) O +
by O +
mast O +
cells O +
can O +
influence O +
eosinophil O +
biology O +
. O +

Stem B-Gene +
cell I-Gene +
factor I-Gene +
( O +
SCF B-Gene +
) O +
- O +
c B-Gene -
- I-Gene -
kit I-Gene +
, O +
cytokine B-Gene +
- O +
cytokine B-Gene +
receptor I-Gene +
, O +
and O +
chemokine B-Gene +
- O +
chemokine B-Gene +
receptor I-Gene +
( O +
CCR3 B-Gene +
) O +
interactions O +
leading O +
to O +
nuclear B-Gene +
factor I-Gene +
kappaB I-Gene +
( O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
) O +
, O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
( O +
MAPK B-Gene +
) O +
expression O +
, O +
and O +
other O +
signaling O +
pathways O +
can O +
modulate O +
eosinophil O +
function O +
. O +

Eosinophil O +
hematopoiesis O +
, O +
activation O +
, O +
survival O +
, O +
and O +
elaboration O +
of O +
mediators O +
can O +
all O +
be O +
regulated O +
thus O +
by O +
mast O +
cells O +
in O +
tissue O +
. O +

Moreover O +
, O +
because O +
eosinophils O +
can O +
secrete O +
SCF B-Gene +
, O +
eosinophils O +
can O +
regulate O +
mast O +
cell O +
function O +
in O +
a O +
paracrine O +
manner O +
. O +

This O +
two O +
- O +
way O +
interaction O +
between O +
eosinophils O +
and O +
mast O +
cells O +
can O +
pave O +
the O +
way O +
for O +
chronic O +
inflammatory O +
responses O +
in O +
a O +
variety O +
of O +
human O +
diseases O +
. O +

This O +
review O +
summarizes O +
this O +
pivotal O +
interaction O +
between O +
human O +
mast O +
cells O +
and O +
eosinophils O +
. O +

Comparative O +
genomic O +
analysis O +
, O +
diversity O +
and O +
evolution O +
of O +
two O +
KIR B-Gene +
haplotypes O +
A O +
and O +
B O +
. O +

Members O +
of O +
the O +
killer B-Gene +
immunoglobulin I-Gene +
( I-Gene +
Ig I-Gene +
) I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( I-Gene +
KIR I-Gene +
) I-Gene +
gene I-Gene +
family I-Gene +
are O +
tightly O +
clustered O +
on O +
human O +
chromosome O +
19q13.4 O +
. O +

Despite O +
considerable O +
variation O +
in O +
KIR B-Gene +
gene O +
content O +
and O +
allelic O +
polymorphism O +
, O +
most O +
KIR B-Gene +
haplotypes O +
belong O +
to O +
one O +
of O +
two O +
broad O +
groups O +
termed O +
A O +
and O +
B O +
. O +

The O +
availability O +
of O +
contiguous O +
genomic O +
sequences O +
for O +
these O +
haplotypes O +
has O +
allowed O +
us O +
to O +
compare O +
their O +
genomic O +
organization O +
, O +
nucleotide O +
( O +
nt O +
) O +
diversity O +
and O +
reconstruct O +
their O +
evolutionary O +
history O +
. O +

The O +
haplotypes O +
have O +
a O +
framework O +
of O +
three O +
conserved O +
blocks O +
containing O +
( O -
i O -
) O +
KIR3DL3 B-Gene +
, O +
( O -
ii O -
) O +
KIR3DP1 B-Gene +
, O +
2DL4 B-Gene +
, O +
and O +
( O -
iii O -
) O +
KIR3DL2 B-Gene +
that O +
are O +
interrupted O +
by O +
two O +
variable O +
segments O +
that O +
differ O +
in O +
the O +
number O +
and O +
type O +
of O +
KIR B-Gene +
genes O +
. O +

Low O +
( O +
0.05 O +
% O +
) O +
nucleotide O +
diversity O +
was O +
detected O +
across O +
the O +
centromeric O +
and O +
telomeric O +
boundaries O +
of O +
the O +
KIR B-Gene +
gene O +
cluster O +
while O +
higher O +
SNP O +
density O +
( O +
0.2 O +
% O +
) O +
occurred O +
within O +
the O +
central O +
region O +
containing O +
the O +
KIR2DL4 B-Gene +
gene O +
. O +

Phylogenetic O +
and O +
genomic O +
analyses O +
have O +
permitted O +
the O +
reconstruction O +
of O +
a O +
hypothetical O +
ancestral O +
haplotype O +
that O +
has O +
revealed O +
common O +
groupings O +
and O +
differences O +
between O +
the O +
KIR B-Gene +
genes O +
of O +
the O +
two O +
haplotypes O +
. O +

The O +
present O +
phylogenetic O +
and O +
genomic O +
comparison O +
of O +
the O +
two O +
sequenced O +
KIR B-Gene +
haplotypes O +
provides O +
a O +
framework O +
for O +
a O +
more O +
thorough O +
examination O +
of O +
KIR B-Gene +
haplotype O +
variations O +
, O +
diversity O +
and O +
evolution O +
in O +
human O +
populations O +
and O +
between O +
humans O +
and O +
non O +
- O +
human O +
primates O +
. O +

The O +
interaction O +
of O +
Bex B-Gene +
and O +
OMP B-Gene +
reveals O +
a O +
dimer O +
of O +
OMP B-Gene +
with O +
a O +
short O +
half O +
- O +
life O +
. O +

Olfactory B-Gene +
marker I-Gene +
protein I-Gene +
( O +
OMP B-Gene +
) O +
participates O +
in O +
the O +
olfactory O +
signal O +
transduction O +
pathway O +
. O +

This O +
is O +
evident O +
from O +
the O +
behavioral O +
and O +
electrophysiological O +
deficits O +
of O +
OMP B-Gene +
- O +
null O +
mice O +
, O +
which O +
can O +
be O +
reversed O +
by O +
intranasal O +
infection O +
of O +
olfactory O +
sensory O +
neurons O +
with O +
an O +
OMP B-Gene +
- O +
expressing O +
adenovirus O +
. O +

Bex B-Gene +
, O +
brain B-Gene +
expressed I-Gene +
X I-Gene +
- I-Gene +
linked I-Gene +
protein I-Gene +
, O +
has O +
been O +
identified O +
as O +
a O +
protein O +
that O +
interacts O +
with O +
OMP B-Gene +
. O +

We O +
have O +
now O +
further O +
characterized O +
the O +
interaction O +
of O +
OMP B-Gene +
and O +
Bex1 B-Gene +
/ I-Gene +
2 I-Gene +
by O +
in O +
vitro O +
binding O +
assays O +
and O +
by O +
immuno O +
- O +
coprecipitation O +
experiments O +
. O +

OMP B-Gene +
is O +
a O +
19 O +
kDa O +
protein O +
but O +
these O +
immunoprecipitation O +
studies O +
have O +
revealed O +
the O +
unexpected O +
presence O +
of O +
a O +
38 O +
kDa O +
band O +
in O +
addition O +
to O +
the O +
expected O +
19 O +
kDa O +
band O +
. O +

Furthermore O +
, O +
the O +
38 O +
kDa O +
form O +
was O +
preferentially O +
co O +
- O +
immunoprecipitated O +
with O +
Bex B-Gene +
from O +
cell O +
extracts O +
. O +

In O +
- O +
gel O +
tryptic O +
digestion O +
, O +
mass O +
spectrometry O +
, O +
and O +
two O +
- O +
dimensional O +
gel O +
electrophoresis O +
indicate O +
that O +
the O +
38 O +
kDa O +
protein O +
behaves O +
as O +
a O +
covalently O +
cross O +
- O +
linked O +
OMP B-Gene +
- O +
homodimer O +
. O +

The O +
38 O +
kDa O +
band O +
was O +
also O +
identified O +
in O +
western O +
blots O +
of O +
olfactory O +
epithelium O +
demonstrating O +
its O +
presence O +
in O +
vivo O +
. O +

The O +
stabilities O +
and O +
subcellular O +
localizations O +
of O +
the O +
OMP B-Gene +
- O +
monomer O +
and O +
- O +
dimer O +
were O +
studied O +
in O +
transfected O +
cells O +
. O +

These O +
results O +
demonstrated O +
that O +
the O +
OMP B-Gene +
- O +
dimer O +
is O +
much O +
less O +
stable O +
than O +
the O +
monomer O +
, O +
and O +
that O +
while O +
the O +
monomer O +
is O +
present O +
both O +
in O +
the O +
nuclear O +
and O +
cytosolic O +
compartments O +
, O +
the O +
dimer O +
is O +
preferentially O +
located O +
in O +
a O +
Triton O +
X-100 O +
insoluble O +
cytoskeletal O +
fraction O +
. O +

These O +
novel O +
observations O +
led O +
us O +
to O +
hypothesize O +
that O +
regulation O +
of O +
the O +
level O +
of O +
the O +
rapidly O +
turning O +
- O +
over O +
OMP B-Gene +
- O +
dimer O +
and O +
its O +
interaction O +
with O +
Bex1 B-Gene +
/ I-Gene +
2 I-Gene +
is O +
critical O +
for O +
OMP B-Gene +
function O +
in O +
sensory O +
transduction O +
. O +

Role O +
of O +
cytokine B-Gene +
gene O +
polymorphism O +
and O +
hepatic O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
beta1 I-Gene +
expression O +
in O +
recurrent O +
hepatitis O +
C O +
after O +
liver O +
transplantation O +
. O +

Recurrent O +
hepatitis O +
C O +
virus O +
( O +
HCV O +
) O +
infection O +
after O +
orthotopic O +
liver O +
transplantation O +
( O +
OLT O +
) O +
is O +
nearly O +
universal O +
. O +

Cytokines B-Gene +
play O +
an O +
important O +
role O +
in O +
the O +
immune O +
response O +
to O +
viral O +
infection O +
, O +
and O +
cytokine B-Gene +
gene O +
polymorphism O +
affects O +
the O +
overall O +
expression O +
and O +
secretion O +
of O +
cytokines B-Gene +
. O +

The O +
objective O +
of O +
this O +
study O +
was O +
to O +
define O +
the O +
relationship O +
between O +
cytokine B-Gene +
polymorphism O +
and O +
recurrent O +
hepatitis O +
C O +
after O +
OLT O +
. O +

Blood O +
samples O +
were O +
collected O +
from O +
36 O +
patients O +
at O +
a O +
mean O +
of O +
44.6 O +
+ O -
/- O +
30.4 O +
months O +
after O +
OLT O +
for O +
chronic O +
HCV O +
infection O +
. O +

DNA O +
was O +
extracted O +
from O +
peripheral O +
blood O +
mononuclear O +
cells O +
, O +
and O +
polymerase O +
chain O +
reaction O +
- O +
sequence O +
specific O +
primers O +
( O +
PCR O +
- O +
SSP O +
) O +
analysis O +
was O +
performed O +
on O +
promoter O +
sequences O +
of O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
beta1 I-Gene +
( O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
) O +
, O +
interleukin B-Gene +
6 I-Gene +
( O +
IL-6 B-Gene +
) O +
interleukin B-Gene +
10 I-Gene +
( O +
IL-10 B-Gene +
) O +
, O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
alpha I-Gene +
( O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
) O +
and O +
interferon B-Gene +
gamma I-Gene +
( O +
INF B-Gene -
- I-Gene -
gamma I-Gene +
) O +
. O +

Liver O +
biopsies O +
performed O +
at O +
diagnosis O +
of O +
recurrent O +
disease O +
were O +
graded O +
with O +
the O +
Knodell O +
score O +
, O +
and O +
hepatic O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
expression O +
was O +
determined O +
semiquantitatively O +
by O +
immunohistochemistry O +
. O +

The O +
gene O +
polymorphism O +
of O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
was O +
correlated O +
with O +
its O +
expression O +
on O +
hepatocytes O +
and O +
sinusoids O +
. O +

Polymorphism O +
in O +
all O +
studied O +
cytokine B-Gene +
genes O +
was O +
correlated O +
with O +
recurrence O +
, O +
and O +
interval O +
to O +
recurrence O +
( O +
> O +
12 O +
or O +
< O +
or O +
= O +
12 O +
months O +
post O +
- O +
OLT O +
) O +
, O +
and O +
clinical O +
( O +
ascites O +
, O +
Child O +
- O +
Pugh O +
score O +
and O +
death O +
) O +
, O +
biochemical O +
parameters O +
of O +
recurrent O +
HCV O +
( O +
serum B-Gene +
alanine I-Gene +
aminotransferase I-Gene +
( O +
ALT B-Gene +
) O +
) O +
, O +
INR O +
, O +
albumin B-Gene +
, O +
bilirubin O +
) O +
, O +
and O +
virological O +
parameters O +
( O +
HCV O +
genotype O +
and O +
load O +
) O +
. O +

Biopsies O +
revealed O +
recurrent O +
HCV O +
in O +
31 O +
patients O +
( O +
86.1 O +
% O +
) O +
; O +
in O +
21 O +
( O +
67.7 O +
% O +
) O +
, O +
the O +
interval O +
to O +
recurrence O +
was O +
12 O +
months O +
. O +

There O +
was O +
a O +
statistically O +
significant O +
correlation O +
between O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
gene O +
polymorphism O +
, O +
i.e. O +
, O +
the O +
genetic O +
ability O +
to O +
produce O +
high O +
levels O +
of O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
, O +
and O +
the O +
intensity O +
of O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
staining O +
on O +
hepatocytes O +
( O +
p O +
= O +
0.003 O +
) O +
and O +
sinusoids O +
( O +
p O +
= O +
0.003 O +
) O +
, O +
and O +
the O +
degree O +
of O +
fibrosis O +
( O +
p O +
= O +
0.02 O +
) O +
. O +

A O +
borderline O +
correlation O +
was O +
found O +
with O +
the O +
presence O +
of O +
ascites O +
( O +
p O +
= O +
0.007 O +
) O +
, O +
but O +
not O +
with O +
Child O +
- O +
Pugh O +
score O +
, O +
synthetic O +
liver O +
function O +
tests O +
or O +
HCV O +
genotype O +
and O +
load O +
. O +

The O +
genetic O +
ability O +
to O +
produce O +
low O +
levels O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
was O +
correlated O +
with O +
recurrent O +
disease O +
( O +
p O +
= O +
0.015 O +
) O +
. O +

No O +
such O +
correlation O +
was O +
found O +
for O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
gene O +
polymorphism O +
. O +

In O +
conclusion O +
, O +
polymorphism O +
in O +
the O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
gene O +
correlates O +
with O +
its O +
in O +
situ O +
hepatic O +
expression O +
in O +
patients O +
with O +
recurrent O +
HCV O +
after O +
liver O +
transplantation O +
. O +

INF B-Gene -
- I-Gene -
gamma I-Gene +
, O +
but O +
not O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
gene O +
polymorphism O +
, O +
correlates O +
with O +
early O +
recurrent O +
hepatitis O +
C O +
after O +
transplantation O +
. O +

These O +
findings O +
might O +
help O +
to O +
design O +
preemptive O +
prevention O +
therapy O +
in O +
selected O +
patients O +
at O +
risk O +
. O +

Interleukin-8 B-Gene +
production O +
by O +
THP-1 O +
cells O +
stimulated O +
by O +
Salmonella O +
enterica O +
serovar O +
Typhimurium O +
porins O +
is O +
mediated O +
by O +
AP-1 B-Gene +
, O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
and O +
MAPK B-Gene +
pathways O +
. O +

Interleukin-8 B-Gene +
( O +
IL-8 B-Gene +
) O +
is O +
released O +
in O +
response O +
to O +
inflammatory O +
stimuli O +
, O +
such O +
as O +
bacterial O +
products O +
. O +

Either O +
porins O +
or O +
lipopolysaccharide O +
( O +
LPS O +
) O +
stimulated O +
THP-1 O +
cells O +
to O +
release O +
IL-8 B-Gene +
after O +
24 O +
h O +
. O +

We O +
have O +
previously O +
reported O +
that O +
stimulation O +
of O +
monocytic O +
cells O +
with O +
Salmonella O +
enterica O +
serovar O +
Typhimurium O +
porins O +
led O +
to O +
the O +
activation O +
of O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
cascades O +
and O +
of O +
protein B-Gene +
tyrosine I-Gene +
kinases I-Gene +
( O +
PTKs B-Gene +
) O +
. O +

In O +
this O +
report O +
, O +
we O +
demonstrate O +
, O +
using O +
two O +
potent O +
and O +
selective O +
inhibitors O +
of O +
MEK B-Gene +
activation O +
by O +
Raf-1 B-Gene +
( O +
PD-098059 O +
) O +
and O +
p38 B-Gene +
( O +
SB-203580 O +
) O +
, O +
that O +
both O +
ERK1 B-Gene +
/ I-Gene +
2 I-Gene +
and O +
p38 B-Gene +
pathways O +
play O +
a O +
key O +
role O +
in O +
the O +
production O +
of O +
IL-8 B-Gene +
by O +
porins O +
and O +
LPS O +
. O +

Porin O +
- O +
stimulated O +
expression O +
of O +
activating B-Gene +
protein I-Gene +
1 I-Gene +
( O +
AP-1 B-Gene +
) O +
and O +
correlated O +
IL-8 B-Gene +
release O +
is O +
also O +
inhibited O +
by O +
PD-098059 O +
or O +
SB-203580 O +
indicating O +
that O +
the O +
Raf-1 B-Gene +
/ O +
MEK1 B-Gene +
- O +
MEK2 B-Gene +
/ O +
MAPK B-Gene +
cascade O +
is O +
required O +
for O +
their O +
activation O +
. O +

Also O +
PTKs B-Gene +
modulate O +
the O +
pathway O +
that O +
control O +
IL-8 B-Gene +
gene O +
expression O +
, O +
in O +
fact O +
its O +
expression O +
is O +
abolished O +
by O +
tyrphostin O +
. O +

By O +
using O +
N O -
- O -
acetyl O -
- O -
leucinyl O -
- O -
leucinyl O -
- O -
norleucinal O -
- O -
H O +
( O +
ALLN O +
) O +
an O +
inhibitor O +
of O +
nuclear B-Gene +
factor I-Gene +
- I-Gene +
kappaB I-Gene +
( O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
) O +
activity O +
, O +
we O +
also O +
observed O +
IL-8 B-Gene +
release O +
modulation O +
. O +

Our O +
results O +
elucidate O +
some O +
of O +
the O +
molecular O +
mechanisms O +
by O +
which O +
AP-1 B-Gene +
and O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
regulate O +
IL-8 B-Gene +
release O +
and O +
open O +
new O +
strategies O +
for O +
the O +
design O +
of O +
specific O +
molecules O +
that O +
will O +
modulate O +
IL-8 B-Gene +
effects O +
in O +
various O +
infectious O +
diseases O +
. O +

Amyloid B-Gene +
beta I-Gene +
prevents O +
activation O +
of O +
calcium B-Gene +
/ I-Gene +
calmodulin I-Gene +
- I-Gene +
dependent I-Gene +
protein I-Gene +
kinase I-Gene +
II I-Gene +
and O +
AMPA B-Gene +
receptor I-Gene +
phosphorylation O +
during O +
hippocampal O +
long O +
- O +
term O +
potentiation O +
. O +

Accumulation O +
of O +
amyloid B-Gene +
beta I-Gene -
- I-Gene -
peptides I-Gene +
( O +
Abeta B-Gene +
) O +
in O +
the O +
brain O +
has O +
been O +
linked O +
with O +
memory O +
loss O +
in O +
Alzheimer O +
' O +
s O +
disease O +
and O +
its O +
animal O +
models O +
. O +

However O +
, O +
the O +
synaptic O +
mechanism O +
by O +
which O +
Abeta B-Gene +
causes O +
memory O +
deficits O +
remains O +
unclear O +
. O +

We O +
previously O +
showed O +
that O +
acute O +
application O +
of O +
Abeta B-Gene +
inhibited O +
long O +
- O +
term O +
potentiation O +
( O +
LTP O +
) O +
in O +
the O +
hippocampal O +
perforant O +
path O +
via O +
activation O +
of O +
calcineurin B-Gene +
, O +
a O +
Ca2 O -
+ O +
- O +
dependent O +
protein B-Gene +
phosphatase I-Gene +
. O +

This O +
study O +
examined O +
whether O +
Abeta B-Gene +
could O +
also O +
inhibit O +
Ca2 B-Gene +
+ I-Gene +
/ I-Gene +
calmodulin I-Gene +
dependent I-Gene +
protein I-Gene +
kinase I-Gene +
II I-Gene +
( O +
CaMKII B-Gene +
) O +
, O +
further O +
disrupting O +
the O +
dynamic O +
balance O +
between O +
protein B-Gene +
kinase I-Gene +
and I-Gene +
phosphatase I-Gene +
during O +
synaptic O +
plasticity O +
. O +

Immunoblot O +
analysis O +
was O +
conducted O +
to O +
measure O +
autophosphorylation O +
of O +
CaMKII B-Gene +
at O +
Thr286 O +
and O +
phosphorylation O +
of O +
the O +
GluR1 B-Gene +
subunit O +
of O +
AMPA B-Gene +
receptors I-Gene +
in O +
single O +
rat O +
hippocampal O +
slices O +
. O +

A O +
high O +
- O +
frequency O +
tetanus O +
applied O +
to O +
the O +
perforant O +
path O +
significantly O +
increased O +
CaMKII B-Gene +
autophosphorylation O +
and O +
subsequent O +
phosphorylation O +
of O +
GluR1 B-Gene +
at O +
Ser831 O +
, O +
a O +
CaMKII B-Gene +
- O +
dependent O +
site O +
, O +
in O +
the O +
dentate O +
area O +
. O +

Acute O +
application O +
of O +
Abeta1 B-Gene +
- I-Gene +
42 I-Gene +
inhibited O +
dentate O +
LTP O +
and O +
associated O +
phosphorylation O +
processes O +
, O +
but O +
was O +
without O +
effect O +
on O +
phosphorylation O +
of O +
GluR1 B-Gene +
at O +
Ser845 O +
, O +
a O +
protein B-Gene +
kinase I-Gene +
A I-Gene +
- O +
dependent O +
site O +
. O +

These O +
results O +
suggest O +
that O +
activity O +
- O +
dependent O +
CaMKII B-Gene +
autophosphorylation O +
and O +
AMPA B-Gene +
receptor I-Gene +
phosphorylation O +
are O +
essential O +
for O +
dentate O +
LTP O +
. O +

Disruption O +
of O +
such O +
mechanisms O +
could O +
directly O +
contribute O +
to O +
Abeta B-Gene +
- O +
induced O +
deficits O +
in O +
hippocampal O +
synaptic O +
plasticity O +
and O +
memory O +
. O +

The O +
role O +
of O +
angiotensin B-Gene +
- I-Gene +
converting I-Gene +
enzyme I-Gene +
and O +
apolipoprotein B-Gene -
- I-Gene -
E I-Gene +
gene O +
polymorphisms O +
on O +
lipid O +
compositions O +
in O +
newborn O +
infants O +
with O +
intrauterine O +
growth O +
restriction O +
. O +

Recent O +
findings O +
suggest O +
that O +
hypertension O +
, O +
dyslipidemia O +
, O +
diabetes O +
mellitus O +
, O +
coronary O +
heart O +
disease O +
are O +
more O +
common O +
in O +
adults O +
who O +
born O +
with O +
intrauterine O +
growth O +
restriction O +
( O +
IUGR O +
) O +
. O +

Several O +
studies O +
have O +
shown O +
that O +
polymorphisms O +
in O +
angiotensin B-Gene +
- I-Gene +
converting I-Gene +
enzyme I-Gene +
( O +
ACE B-Gene +
) O +
and O +
apolipoprotein B-Gene -
- I-Gene -
E I-Gene +
( O +
Apo B-Gene -
- I-Gene -
E I-Gene +
) O +
are O +
effective O +
in O +
developing O +
the O +
insulin B-Gene +
resistance O +
and O +
also O +
in O +
increasing O +
the O +
risk O +
of O +
coronary O +
heart O +
disease O +
. O +

In O +
present O +
study O +
, O +
the O +
frequencies O +
of O +
ACE B-Gene +
, O +
Apo B-Gene -
- I-Gene -
E I-Gene +
gene O +
polymorphisms O +
, O +
apolipoprotein B-Gene +
- I-Gene +
B I-Gene +
( O +
Apo B-Gene -
- I-Gene -
B I-Gene +
) O +
mutation O +
and O +
lipid O +
compositions O +
were O +
determined O +
in O +
full O +
- O +
term O +
newborn O +
infants O +
with O +
IUGR O +
. O +

Forty O -
- O -
four O +
newborn O +
infants O +
who O +
had O +
completed O +
36 O +
weeks O +
of O +
gestational O +
age O +
, O +
24 O +
healthy O +
infants O +
and O +
20 O +
with O +
IUGR O +
, O +
were O +
taken O +
into O +
the O +
scope O +
of O +
the O +
study O +
. O +

While O +
total O +
cholesterol O +
( O +
TC O +
) O +
and O +
Apo B-Gene -
- I-Gene -
B I-Gene +
concentrations O +
in O +
infants O +
with O +
IUGR O +
was O +
found O +
to O +
be O +
significantly O +
higher O +
than O +
that O +
of O +
the O +
control O +
group O +
( O +
p O +
< O +
0.05 O +
) O +
, O +
triglyceride O +
( O +
TG O +
) O +
, O +
low B-Gene +
- I-Gene +
density I-Gene +
lipoproteins I-Gene +
( O +
LDL B-Gene +
) O +
, O +
high B-Gene +
- I-Gene +
density I-Gene +
lipoproteins I-Gene +
( O +
HDL B-Gene +
) O +
and O +
Apo B-Gene -
- I-Gene -
A1 I-Gene +
levels O +
were O +
similar O +
( O -
p O -
> O +
0.05 O +
) O +
. O +

An O +
insertion O +
/ O +
deletion O +
( O +
I O +
/ O +
D O +
) O +
polymorphism O +
with O +
a O +
significantly O +
increased O +
frequency O +
was O +
observed O +
in O +
the O +
IUGR O +
group O +
( O +
65 O +
% O +
) O +
as O +
compared O +
with O +
the O +
control O +
group O +
( O +
33 O +
% O +
) O +
( O +
p O +
< O +
0.05 O +
) O +
. O +

When O +
the O +
distribution O +
of O +
the O +
Apo B-Gene -
- I-Gene -
E I-Gene +
gene O +
polymorphism O +
( O +
E2 O +
, O +
E3 O +
and O +
E4 O +
) O +
was O +
studied O +
, O +
no O +
difference O +
was O +
found O +
between O +
the O +
IUGR O +
and O +
control O +
groups O +
with O +
respect O +
to O +
frequency O +
. O +

No O +
Apo B-Gene -
- I-Gene -
B I-Gene +
gene O +
mutation O +
was O +
identified O +
in O +
the O +
study O +
groups O +
. O +

In O +
conclusion O +
, O +
we O +
may O +
suggest O +
that O +
I O -
/ O -
D O +
polymorphism O +
is O +
responsible O +
, O +
though O +
in O +
part O +
, O +
for O +
the O +
etiology O +
of O +
intrauterine O +
growth O +
restriction O +
. O +

Levels O +
of O +
total O +
cholesterol O +
and O +
Apo B-Gene -
- I-Gene -
B I-Gene +
are O +
elevated O +
in O +
IUGR O +
infants O +
, O +
suggesting O +
a O +
linkage O +
between O +
low O +
birth O +
weight O +
and O +
atherosclerosis O +
. O +

Aquaporins B-Gene +
: O +
water B-Gene +
channel I-Gene +
proteins O +
of O +
the O +
cell O +
membrane O +
. O +

Aquaporins B-Gene +
( O +
AQP B-Gene +
) O +
are O +
integral O +
membrane O +
proteins O +
that O +
serve O +
as O +
channels O +
in O +
the O +
transfer O +
of O +
water O +
, O +
and O +
in O +
some O +
cases O +
, O +
small O +
solutes O +
across O +
the O +
membrane O +
. O +

They O +
are O +
conserved O +
in O +
bacteria O +
, O +
plants O +
, O +
and O +
animals O +
. O +

Structural O +
analyses O +
of O +
the O +
molecules O +
have O +
revealed O +
the O +
presence O +
of O +
a O +
pore O +
in O +
the O +
center O +
of O +
each O +
aquaporin B-Gene +
molecule O +
. O +

In O +
mammalian O +
cells O +
, O +
more O +
than O +
10 O +
isoforms O +
( O +
AQP0-AQP10 B-Gene +
) O +
have O +
been O +
identified O +
so O +
far O +
. O +

They O +
are O +
differentially O +
expressed O +
in O +
many O +
types O +
of O +
cells O +
and O +
tissues O +
in O +
the O +
body O +
. O +

AQP0 B-Gene +
is O +
abundant O +
in O +
the O +
lens O +
. O +

AQP1 B-Gene +
is O +
found O +
in O +
the O +
blood O +
vessels O +
, O +
kidney O +
proximal O +
tubules O +
, O +
eye O +
, O +
and O +
ear O +
. O +

AQP2 B-Gene +
is O +
expressed O +
in O +
the O +
kidney O +
collecting O +
ducts O +
, O +
where O +
it O +
shuttles O +
between O +
the O +
intracellular O +
storage O +
sites O +
and O +
the O +
plasma O +
membrane O +
under O +
the O +
control O +
of O +
antidiuretic B-Gene +
hormone I-Gene +
( O +
ADH B-Gene +
) O +
. O +

Mutations O +
of O +
AQP2 B-Gene +
result O +
in O +
diabetes O +
insipidus O +
. O +

AQP3 B-Gene +
is O +
present O +
in O +
the O +
kidney O +
collecting O +
ducts O +
, O +
epidermis O +
, O +
urinary O +
, O +
respiratory O +
, O +
and O +
digestive O +
tracts O +
. O +

AQP3 B-Gene +
in O +
organs O +
other O +
than O +
the O +
kidney O +
may O +
be O +
involved O +
in O +
the O +
supply O +
of O +
water O +
to O +
them O +
. O +

AQP4 B-Gene +
is O +
present O +
in O +
the O +
brain O +
astrocytes O +
, O +
eye O +
, O +
ear O +
, O +
skeletal O +
muscle O +
, O +
stomach O +
parietal O +
cells O +
, O +
and O +
kidney O +
collecting O +
ducts O +
. O +

AQP5 B-Gene +
is O +
in O +
the O +
secretory O +
cells O +
such O +
as O +
salivary O +
, O +
lacrimal O +
, O +
and O +
sweat O +
glands O +
. O +

AQP5 B-Gene +
is O +
also O +
expressed O +
in O +
the O +
ear O +
and O +
eye O +
. O +

AQP6 B-Gene +
is O +
localized O +
intracellular O +
vesicles O +
in O +
the O +
kidney O +
collecting O +
duct O +
cells O +
. O +

AQP7 B-Gene +
is O +
expressed O +
in O +
the O +
adipocytes O +
, O +
testis O +
, O +
and O +
kidney O +
. O +

AQP8 B-Gene +
is O +
expressed O +
in O +
the O +
kidney O +
, O +
testis O +
, O +
and O +
liver O +
. O +

AQP9 B-Gene +
is O +
present O +
in O +
the O +
liver O +
and O +
leukocytes O +
. O +

AQP10 B-Gene +
is O +
expressed O +
in O +
the O +
intestine O +
. O +

The O +
diverse O +
and O +
characteristic O +
distribution O +
of O +
aquaporins B-Gene +
in O +
the O +
body O +
suggests O +
their O +
important O +
and O +
specific O +
roles O +
in O +
each O +
organ O +
. O +

Methylprednisolone O +
favourably O +
alters O +
plasma O +
and O +
urinary O +
cytokine B-Gene +
homeostasis O +
and O +
subclinical O +
renal O +
injury O +
at O +
cardiac O +
surgery O +
. O +

Whilst O +
elevated O +
urinary O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
beta-1 I-Gene +
( O +
TGFbeta B-Gene +
) O +
is O +
associated O +
with O +
chronic O +
renal O +
dysfunction O +
its O +
role O +
in O +
acute O +
peri O +
- O +
operative O +
renal O +
dysfunction O +
is O +
unknown O +
. O +

In O +
contrast O +
, O +
peri O +
- O +
operative O +
increases O +
in O +
urinary O +
IL-1 B-Gene +
receptor I-Gene +
antagonist I-Gene +
( O +
IL-1ra B-Gene +
) O +
and O +
TNF B-Gene +
soluble I-Gene +
receptor-2 I-Gene +
( O +
TNFsr-2 B-Gene +
) O +
mirror O +
pro O +
- O +
inflammatory O +
activity O +
in O +
the O +
nephron O +
and O +
correlate O +
with O +
renal O +
complications O +
. O +

Steroids O +
modulate O +
some O +
plasma O +
cytokines B-Gene +
( O +
decreasing O +
TNFalpha B-Gene +
, O +
IL-8 B-Gene +
, O +
IL-6 B-Gene +
and O +
increasing O +
IL-10 B-Gene +
) O +
, O +
whereas O +
ability O +
to O +
reduce O +
plasma O +
and O +
urinary O +
TNFsr-2 B-Gene +
and O +
IL-1ra B-Gene +
and O +
peri O +
- O +
operative O +
renal O +
injury O +
is O +
unknown O +
. O +

Patients O +
undergoing O +
coronary O +
artery O +
bypass O +
grafting O +
with O +
cardiopulmonary O +
bypass O +
( O +
CPB O +
) O +
were O +
randomised O +
to O +
receive O +
methylprednisolone O +
( O +
n O +
= O +
18 O +
) O +
or O +
placebo O +
( O +
n O +
= O +
17 O +
) O +
before O +
induction O +
of O +
anaesthesia O +
. O +

Plasma O +
and O +
urinary O +
pro O +
- O +
and O +
anti O +
- O +
inflammatory O +
cytokine B-Gene +
balance O +
was O +
determined O +
along O +
with O +
subclinical O +
proximal O +
tubular O +
injury O +
and O +
dysfunction O +
, O +
measured O +
by O +
urinary O +
N O -
- O -
acetyl O -
- O -
beta O -
- O -
d O -
- O -
glucosaminidase O +
( O +
NAG O +
) O +
/ O +
creatinine O +
and O +
alpha-1-microglobulin O +
/ O +
creatinine O +
ratios O +
, O +
respectively O +
. O +

In O +
the O +
control O +
group O +
compared O +
with O +
baseline O +
, O +
plasma O +
IL-8 B-Gene +
, O +
TNFalpha B-Gene +
, O +
IL-10 B-Gene +
, O +
IL-1ra B-Gene +
and O +
TNFsr-2 B-Gene +
were O +
significantly O +
elevated O +
along O +
with O +
urinary O +
IL-1ra B-Gene +
, O +
TNFsr-2 B-Gene +
and O +
TGFbeta1 B-Gene +
. O +

Urinary O +
NAG O +
/ O +
creatinine O +
and O +
alpha-1-microglobulin B-Gene +
/ O +
creatinine O +
ratios O +
rose O +
from O +
completion O +
of O +
revascularisation O +
until O +
6 O +
h O +
with O +
recovery O +
at O +
24 O +
h O +
with O +
a O +
further O +
rise O +
in O +
NAG O +
/ O +
creatinine O +
ratio O +
at O +
48 O +
h O +
. O +

Compared O +
to O +
placebo O +
, O +
the O +
methylprednisolone O +
group O +
showed O +
significantly O +
reduced O +
plasma O +
IL-8 B-Gene +
, O +
TNFalpha B-Gene +
, O +
IL-1ra B-Gene +
and O +
TNFsr-2 B-Gene +
whereas O +
plasma O +
IL-10 B-Gene +
increased O +
. O +

Compared O +
to O +
placebo O +
, O +
the O +
methylprednisolone O +
group O +
demonstrated O +
significantly O +
reduced O +
urinary O +
NAG O +
/ O +
creatinine O +
ratio O +
, O +
TNFsr-2 B-Gene +
and O +
TGFbeta1 B-Gene +
at O +
24 O +
h O +
whereas O +
urinary O +
alpha-1-microglobulin B-Gene +
/ O +
creatinine O +
ratios O +
increased O +
. O +

CONCLUSIONS O +
: O +

Methylprednisolone O +
administration O +
during O +
cardiac O +
surgery O +
significantly O +
reduces O +
plasma O +
and O +
urinary O +
TNFsr-2 B-Gene +
and O +
IL-1ra B-Gene +
, O +
urinary O +
TGFbeta1 B-Gene +
and O +
subclinical O +
renal O +
injury O +
but O +
not O +
dysfunction O +
. O +

Genetic O +
polymorphism O +
of O +
NK O +
receptors O +
and O +
their O +
ligands O +
in O +
melanoma O +
patients O +
: O +
prevalence O +
of O +
inhibitory O +
over O +
activating O +
signals O +
. O +

Antitumor O +
cytotoxicity O +
of O +
NK O +
cells O +
and O +
T O +
cells O +
expressing O +
NK O +
- O +
associated O +
receptors O +
is O +
regulated O +
by O +
interaction O +
between O +
their O +
cell O +
surface O +
killer B-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIRs B-Gene +
) O +
and O +
CD94 B-Gene +
/ O +
NKG2 B-Gene +
heterodimers O +
with O +
MHC B-Gene +
class I-Gene +
I I-Gene +
ligands O +
on O +
target O +
cells O +
. O +

To O +
test O +
the O +
hypothesis O +
that O +
KIR B-Gene +
and/or O +
HLA B-Gene +
polymorphisms O +
, O +
and O +
KIR B-Gene +
/ O +
HLA B-Gene +
combinations O +
could O +
contribute O +
to O +
the O +
tumorigenesis O +
, O +
association O +
studies O +
were O +
performed O +
in O +
50 O +
patients O +
with O +
malignant O +
melanoma O +
( O +
MM O +
) O +
in O +
different O +
stages O +
of O +
disease O +
and O +
54 O +
controls O +
. O +

Our O +
data O +
showed O +
that O +
the O +
frequency O +
of O +
inhibitory O +
and O +
activating O +
KIR B-Gene +
genes O +
and O +
KIR B-Gene +
genotypes O +
did O +
not O +
differ O +
significantly O +
between O +
healthy O +
individuals O +
and O +
melanoma O +
patients O +
. O +

HLA B-Gene +
haplotype O +
distribution O +
showed O +
statistically O +
significant O +
increased O +
frequencies O +
of O +
A*01-B*35 O +
- O +
Cw*04 O +
( O +
0.069 O +
vs O +
0.000 O +
; O +
pc O +
< O +
0.05 O +
; O +
OR O +
= O +
19.9 O +
) O +
, O +
A*01-B*08 O +
- O +
DRB1 B-Gene -
* I-Gene -
03 I-Gene +
( O +
0.079 O +
vs O +
0.019 O +
; O +
pc O +
< O +
0.05 O +
; O +
OR O +
= O +
4.5 O +
) O +
, O +
and O +
A*24 O +
- O +
B*40 O +
- O +
DRB1 B-Gene -
* I-Gene -
11 I-Gene +
( O +
0.026 O +
vs O +
0.000 O +
; O +
pc O +
< O +
0.05 O +
; O +
OR O +
= O +
7.1 O +
) O +
in O +
melanoma O +
patients O +
compared O +
with O +
healthy O +
controls O +
. O +

Individuals O +
homozygous O +
for O +
group O +
2 O +
HLA B-Gene -
- I-Gene -
C I-Gene +
ligands O +
were O +
less O +
frequent O +
in O +
the O +
patient O +
group O +
compared O +
with O +
the O +
control O +
cohort O +
( O +
12 O +
% O +
vs O +
31.5 O +
% O +
; O +
p O +
< O +
0.017 O +
) O +
. O +

In O +
addition O +
, O +
we O +
observed O +
an O +
increased O +
frequency O +
( O +
88.0 O +
% O +
vs O +
68.5 O +
% O +
; O +
p O +
= O +
0.017 O +
; O +
OR O +
= O +
2.80 O +
) O +
of O +
KIR2DL2 B-Gene +
/ O +
2DL3 B-Gene +
in O +
combination O +
with O +
their O +
group O +
1 O +
HLA B-Gene -
- I-Gene -
C I-Gene +
ligands O +
, O +
while O +
the O +
presence O +
of O +
these O +
KIRs B-Gene +
in O +
the O +
absence O +
of O +
the O +
putative O +
ligands O +
was O +
decreased O +
( O +
12.0 O +
% O +
vs O +
31.5 O +
% O +
; O +
p O +
= O +
0.017 O +
) O +
in O +
the O +
patient O +
group O +
. O +

Furthermore O +
, O +
an O +
increased O +
frequency O +
of O +
activating O +
KIR2DS1 B-Gene +
in O +
the O +
absence O +
of O +
the O +
putative O +
HLA B-Gene +
- I-Gene +
C I-Gene +
( O +
Lys80 O +
) O +
ligands O +
was O +
found O +
in O +
melanoma O +
patients O +
( O +
16.0 O +
% O +
vs O +
9.2 O +
% O +
) O +
. O +

In O +
contrast O +
, O +
KIR2DS2 B-Gene +
was O +
absent O +
in O +
patients O +
more O +
often O +
( O +
38.0 O +
% O +
vs O +
25.9 O +
% O +
) O +
when O +
the O +
presumptive O +
HLA B-Gene -
- I-Gene -
C I-Gene +
( O -
Asn80 O -
) O +
ligands O +
were O +
present O +
. O +

A O +
slightly O +
higher O +
incidence O +
of O +
KIR3DL1 B-Gene +
in O +
combination O +
with O +
the O +
less O +
effective O +
Bw4 B-Gene +
( O +
Thr80 O +
) O +
ligands O +
was O +
seen O +
in O +
patients O +
with O +
primary O +
( O +
20.8 O +
% O +
) O +
compared O +
with O +
metastatic O +
( O +
4.2 O +
% O +
) O +
disease O +
. O +

The O +
data O +
obtained O +
in O +
this O +
study O +
imply O +
that O +
there O +
may O +
not O +
be O +
a O +
direct O +
association O +
between O +
KIR B-Gene +
gene O +
content O +
in O +
the O +
genome O +
and O +
the O +
presence O +
of O +
malignant O +
melanoma O +
, O +
or O +
melanoma O +
progression O +
. O +

However O +
, O +
some O +
HLA B-Gene +
haplotypes O +
could O +
be O +
predisposing O +
to O +
MM O +
in O +
the O +
Bulgarian O +
population O +
. O +

Furthermore O +
, O +
distinct O +
KIR B-Gene +
/ O +
HLA B-Gene +
ligand O +
combinations O +
may O +
be O +
relevant O +
to O +
the O +
development O +
of O +
malignancy O +
whereby O +
inhibition O +
overrides O +
activation O +
of O +
NK O +
cells O +
and O +
T O +
cells O +
expressing O +
NK O +
- O +
associated O +
receptors O +
, O +
which O +
in O +
turn O +
might O +
facilitate O +
tumor O +
escape O +
and O +
progression O +
. O +

Apoptotic B-Gene +
speck I-Gene +
protein I-Gene +
- I-Gene +
like I-Gene +
, O +
a O +
highly O +
homologous O +
protein O +
to O +
apoptotic B-Gene +
speck I-Gene +
protein I-Gene +
in O +
the O +
pyrin B-Gene +
domain O +
, O +
is O +
silenced O +
by O +
DNA O +
methylation O +
and O +
induces O +
apoptosis O +
in O +
human O +
hepatocellular O +
carcinoma O +
. O +

We O +
have O +
identified O +
a O +
novel O +
gene O +
encoding O +
a O +
pyrin B-Gene +
domain O +
protein O +
of O +
89 O +
amino O +
acids O +
that O +
is O +
expressed O +
in O +
various O +
tissues O +
including O +
liver O +
, O +
brain O +
, O +
and O +
spleen O +
. O +

The O +
protein O +
is O +
highly O +
homologous O +
to O +
the O +
pyrin B-Gene +
domain O +
of O +
apoptosis B-Gene +
- I-Gene +
associated I-Gene +
speck I-Gene +
- I-Gene +
like I-Gene +
protein I-Gene +
( O +
ASC B-Gene +
) O +
. O +

Therefore O +
, O +
we O +
termed O +
it O +
ASC B-Gene +
- I-Gene +
like I-Gene +
( O +
ASCL B-Gene +
) O +
. O +

We O +
found O +
that O +
ASCL B-Gene +
gene O +
was O +
densely O +
and O +
frequently O +
( O +
80 O +
% O +
) O +
methylated O +
in O +
hepatocellular O +
carcinoma O +
( O +
HCC O +
) O +
cell O +
lines O +
. O +

In O +
contrast O +
, O +
normal O +
liver O +
samples O +
did O +
not O +
show O +
any O +
significant O +
methylation O +
. O +

This O +
aberrant O +
methylation O +
correlated O +
well O +
with O +
the O +
suppression O +
of O +
RNA O +
expression O +
. O +

Furthermore O +
, O +
a O +
demethylating O +
agent O +
, O +
5-aza-2'-deoxycytidine O +
, O +
reactivated O +
the O +
ASCL B-Gene +
expression O +
in O +
the O +
methylation O +
- O +
silenced O +
cells O +
, O +
indicating O +
that O +
ASCL B-Gene +
is O +
silenced O +
by O +
the O +
associated O +
DNA O +
methylation O +
. O +

ASCL B-Gene +
methylation O +
was O +
also O +
found O +
in O +
primary O +
HCC O +
( O +
4 O +
of O +
17 O +
samples O +
) O +
, O +
although O +
the O +
frequency O +
was O +
less O +
than O +
that O +
in O +
cell O +
lines O +
. O +

In O +
addition O +
, O +
we O +
found O +
that O +
ASC B-Gene +
was O +
also O +
methylated O +
in O +
primary O +
samples O +
( O +
6 O +
of O +
the O +
17 O +
) O +
. O +

Interestingly O +
, O +
either O +
ASCL B-Gene +
or O +
ASC B-Gene +
methylation O +
was O +
observed O +
in O +
53 O +
% O +
( O +
9 O +
of O +
the O +
17 O +
) O +
of O +
primary O +
HCC O +
samples O +
. O +

Significantly O +
, O +
the O +
restoration O +
of O +
ASCL B-Gene +
in O +
the O +
methylation O +
- O +
silenced O +
cells O +
demonstrated O +
growth O +
suppression O +
in O +
colony O +
formation O +
assay O +
. O +

This O +
growth O +
suppression O +
effect O +
of O +
ASCL B-Gene +
was O +
supported O +
by O +
apoptotic O +
changes O +
observed O +
in O +
ASCL B-Gene +
- O +
transfected O +
cells O +
in O +
which O +
annexin B-Gene +
- I-Gene +
V I-Gene +
binding O +
was O +
positive O +
and O +
caspase-3 B-Gene +
was O +
activated O +
. O +

Based O +
on O +
the O +
methylation O +
- O +
silencing O +
and O +
the O +
growth O +
suppression O +
activity O +
, O +
we O +
propose O +
that O +
ASCL B-Gene +
plays O +
a O +
significant O +
role O +
in O +
the O +
development O +
of O +
HCC O +
. O +

The O +
omptin B-Gene +
family I-Gene +
of I-Gene +
enterobacterial I-Gene +
surface I-Gene +
proteases I-Gene +
/ I-Gene +
adhesins I-Gene +
: O +
from O +
housekeeping O +
in O +
Escherichia O +
coli O +
to O +
systemic O +
spread O +
of O +
Yersinia O +
pestis O +
. O +

The O +
omptins B-Gene +
are O +
a O +
family B-Gene +
of I-Gene +
enterobacterial I-Gene +
surface I-Gene +
proteases I-Gene +
/ I-Gene +
adhesins I-Gene +
that O +
share O +
high O +
sequence O +
identity O +
and O +
a O +
conserved O +
beta O +
- O +
barrel O +
fold O +
in O +
the O +
outer O +
membrane O +
. O +

The O +
omptins B-Gene +
are O +
multifunctional O +
, O +
and O +
the O +
individual O +
omptins B-Gene +
exhibit O +
differing O +
virulence O +
- O +
associated O +
functions O +
. O +

The O +
Pla B-Gene +
plasminogen I-Gene +
activator I-Gene +
of O +
Yersinia O +
pestis O +
contributes O +
by O +
several O +
mechanisms O +
to O +
bacterial O +
invasiveness O +
and O +
the O +
systemic O +
, O +
uncontrolled O +
proteolysis O +
in O +
plague O +
. O +

Pla B-Gene +
proteolytically O +
activates O +
the O +
human O +
proenzyme O +
plasminogen B-Gene +
and O +
inactivates O +
the O +
antiprotease O +
alpha2 B-Gene +
- I-Gene +
antiplasmin I-Gene +
, O +
and O +
its O +
binding O +
to O +
laminin B-Gene +
localizes O +
the O +
uncontrolled O +
plasmin B-Gene +
activity O +
onto O +
basement O +
membranes O +
. O +

These O +
properties O +
enhance O +
bacterial O +
migration O +
through O +
tissue O +
barriers O +
. O +

Pla B-Gene +
also O +
degrades O +
circulating O +
complement B-Gene +
proteins I-Gene +
and O +
functions O +
in O +
bacterial O +
invasion O +
into O +
human O +
epithelial O +
cells O +
. O +

PgtE B-Gene +
of O +
Salmonella O +
enterica O +
and O +
OmpT B-Gene +
of O +
Escherichia O +
coli O +
have O +
been O +
shown O +
to O +
degrade O +
cationic O +
antimicrobial O +
peptides O +
from O +
epithelial O +
cells O +
or O +
macrophages O +
. O +

PgtE B-Gene +
and O +
SopA B-Gene +
of O +
Shigella O +
flexneri O +
appear O +
important O +
in O +
the O +
intracellular O +
phases O +
of O +
salmonellosis O +
and O +
shigellosis O +
, O +
whereas O +
functions O +
of O +
OmpT B-Gene +
have O +
mainly O +
been O +
associated O +
with O +
protein O +
degradation O +
in O +
E. O +
coli O +
cells O +
. O +

The O +
differing O +
virulence O +
roles O +
and O +
functions O +
have O +
been O +
attributed O +
to O +
minor O +
sequence O +
variations O +
at O +
the O +
surface O +
- O +
exposed O +
regions O +
important O +
for O +
substrate O +
recognition O +
, O +
to O +
the O +
dependence O +
of O +
omptin B-Gene +
functions O +
on O +
lipopolysaccharide O +
, O +
and O +
to O +
the O +
different O +
regulation O +
of O +
omptin B-Gene +
expression O +
. O +

CD40 B-Gene +
engagement O +
enhances O +
antigen O +
- O +
presenting O +
langerhans O +
cell O +
priming O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
- O +
producing O +
CD4 B-Gene +
+ O +
and O +
CD8 B-Gene +
+ O +
T O +
cells O +
independently O +
of O +
IL-12 B-Gene +
. O +

The O +
delivery O +
of O +
CD40 B-Gene +
signaling O +
to O +
APCs O +
during O +
T O +
cell O +
priming O +
enhances O +
many O +
T O +
cell O +
- O +
mediated O +
immune O +
responses O +
. O +

Although O +
CD40 B-Gene +
signaling O +
up O +
- O +
regulates O +
APC O +
production O +
of O +
IL-12 B-Gene +
, O +
the O +
impact O +
of O +
this O +
increased O +
production O +
on O +
T O +
cell O +
priming O +
is O +
unclear O +
. O +

In O +
this O +
study O +
an O +
IL-12 B-Gene +
- O +
independent O +
T O +
cell O +
- O +
mediated O +
immune O +
response O +
, O +
contact O +
hypersensitivity O +
( O +
CHS O +
) O +
, O +
was O +
used O +
to O +
further O +
investigate O +
the O +
effect O +
of O +
CD40 B-Gene +
ligation O +
on O +
the O +
phenotypic O +
development O +
of O +
Ag O +
- O +
specific O +
CD4 B-Gene +
( O +
+ O +
) O +
and O +
CD8 B-Gene +
( O +
+ O +
) O +
T O +
cells O +
. O +

Normally O +
, O +
sensitization O +
for O +
CHS O +
responses O +
induces O +
hapten O +
- O +
specific O +
CD4 B-Gene +
( O +
+ O +
) O +
T O +
cells O +
producing O +
type O +
2 O +
cytokines B-Gene +
and O +
CD8 B-Gene +
( O +
+ O +
) O +
T O +
cells O +
producing O +
IFN B-Gene +
- I-Gene +
gamma I-Gene +
. O +

Treatment O +
of O +
mice O +
with O +
agonist O +
anti O +
- O +
CD40 B-Gene +
mAb O +
during O +
sensitization O +
with O +
the O +
hapten O +
2,4-dinitrofluorobenzene O +
resulted O +
in O +
CHS O +
responses O +
of O +
increased O +
magnitude O +
and O +
duration O +
. O +

These O +
augmented O +
responses O +
in O +
anti O +
- O +
CD40 B-Gene +
Ab O +
- O +
treated O +
mice O +
correlated O +
with O +
increased O +
numbers O +
of O +
hapten O +
- O +
specific O +
CD4 B-Gene +
( O +
+ O +
) O +
and O +
CD8 B-Gene +
( O +
+ O +
) O +
T O +
cells O +
producing O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
in O +
the O +
skin O +
draining O +
lymph O +
nodes O +
. O +

Identical O +
results O +
were O +
observed O +
using O +
IL-12 B-Gene +
( O +
- O -
/ O -
- O +
) O +
mice O +
, O +
indicating O +
that O +
CD40 B-Gene +
ligation O +
promotes O +
CHS O +
responses O +
and O +
development O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
- O +
producing O +
CD4 B-Gene +
( O +
+ O +
) O +
and O +
CD8 B-Gene +
( O +
+ O +
) O +
T O +
cells O +
in O +
the O +
absence O +
of O +
IL-12 B-Gene +
. O +

Engagement O +
of O +
CD40 B-Gene +
on O +
hapten O +
- O +
presenting O +
Langerhans O +
cells O +
( O +
hpLC O +
) O +
up O +
- O +
regulated O +
the O +
expression O +
of O +
both O +
class B-Gene +
I I-Gene +
and I-Gene +
class I-Gene +
II I-Gene +
MHC I-Gene +
and O +
promoted O +
hpLC O +
migration O +
into O +
the O +
T O +
cell O +
priming O +
site O +
. O +

These O +
results O +
indicate O +
that O +
hpLC O +
stimulated O +
by O +
CD40 B-Gene +
ligation O +
use O +
a O +
mechanism O +
distinct O +
from O +
increased O +
IL-12 B-Gene +
production O +
to O +
promote O +
Ag O +
- O +
specific O +
T O +
cell O +
development O +
to O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
- O +
producing O +
cells O +
. O +

alpha B-Gene +
- I-Gene +
thrombin I-Gene +
rapidly O +
induces O +
tyrosine O +
phosphorylation O +
of O +
a O +
novel O +
, O +
74 O +
- O +
78 O +
- O +
kDa O +
stress O +
response O +
protein O +
( O +
s O +
) O +
in O +
lung O +
fibroblast O +
cells O +
. O +

We O +
demonstrated O +
previously O +
that O +
exposure O +
of O +
CCL39 O +
lung O +
fibroblasts O +
to O +
alpha B-Gene -
- I-Gene -
thrombin I-Gene +
rapidly O +
inhibits O +
interleukin B-Gene +
6 I-Gene +
- O +
induced O +
tyrosine O +
phosphorylation O +
of O +
signal B-Gene +
transducers I-Gene +
and I-Gene +
activators I-Gene +
of I-Gene +
transcription I-Gene +
3 I-Gene +
( O +
Stat3 B-Gene +
) O +
. O +

While O +
studying O +
the O +
cross O +
- O +
talk O +
between O +
alpha B-Gene -
- I-Gene -
thrombin I-Gene +
and O +
interleukin B-Gene +
6 I-Gene +
, O +
we O +
observed O +
that O +
the O +
phospho O +
- O +
specific O +
( O +
tyrosine O +
) O +
anti O +
- O +
Stat3 B-Gene +
antibody O +
specifically O +
cross O +
- O +
reacted O +
with O +
a O +
74 O +
- O +
78 O +
- O +
kDa O +
protein O +
( O +
s O +
) O +
in O +
alpha B-Gene -
- I-Gene -
thrombin I-Gene +
- O +
treated O +
cells O +
. O +

In O +
this O +
study O +
, O +
we O +
demonstrate O +
that O +
in O +
alpha B-Gene +
- I-Gene +
thrombin I-Gene +
- O +
treated O +
CCL39 O +
cells O +
, O +
the O +
74 O +
- O +
78 O +
- O +
kDa O +
protein O +
( O +
s O +
) O +
rapidly O +
undergoes O +
tyrosine O +
phosphorylation O +
. O +

The O +
phosphorylation O +
by O +
alpha B-Gene -
- I-Gene -
thrombin I-Gene +
was O +
detected O +
as O +
early O +
as O +
5 O +
min O +
and O +
reached O +
a O +
maximum O +
at O +
15 O +
min O +
; O +
however O +
, O +
low O +
levels O +
were O +
present O +
at O +
2 O +
h O +
. O +

alpha B-Gene -
- I-Gene -
Thrombin I-Gene +
receptor I-Gene +
agonist O +
peptide O +
( O +
SFLLRN O +
) O +
induced O +
its O +
tyrosine O +
phosphorylation O +
, O +
suggesting O +
that O +
alpha B-Gene +
- I-Gene +
thrombin I-Gene +
mediates O +
the O +
effects O +
via O +
protease B-Gene +
- I-Gene +
activated I-Gene +
receptor I-Gene +
type I-Gene +
1 I-Gene +
. O +

Anti O +
- O +
Stat3 B-Gene +
antibodies O +
specific O +
to O +
different O +
regions O +
of O +
Stat3 B-Gene +
failed O +
to O +
recognize O +
the O +
74 O -
- O -
78-kDa O +
protein O -
( O -
s O -
) O +
, O +
suggesting O +
that O +
it O +
is O +
unrelated O +
to O +
Stat3 B-Gene +
. O +

Cell O +
fractionation O +
experiments O +
showed O +
that O +
it O +
is O +
localized O +
to O +
the O +
cytoplasm O +
. O +

Mass O +
spectrometric O +
analysis O +
of O +
the O +
immunoprecipitated O +
protein O +
showed O +
that O +
the O +
74 O -
- O -
78-kDa O +
protein O -
( O -
s O -
) O +
is O +
related O +
to O +
glucose B-Gene +
- I-Gene +
regulated I-Gene +
protein I-Gene +
75 I-Gene +
( O +
GRP B-Gene +
- I-Gene +
75 I-Gene +
) O +
, O +
a O +
member O +
of O +
the O +
heat B-Gene +
shock I-Gene +
/ I-Gene +
stress I-Gene +
- I-Gene +
response I-Gene +
protein I-Gene +
family I-Gene +
. O +

Consistent O +
with O +
these O +
data O +
, O +
we O +
observed O +
tyrosine O +
phosphorylation O +
of O +
GRP B-Gene +
- I-Gene +
75 I-Gene +
in O +
alpha B-Gene +
- I-Gene +
thrombin I-Gene +
- O +
treated O +
cells O +
. O +

Exposure O +
of O +
cells O +
to O +
pervanadate O +
, O +
a O +
stress O +
- O +
inducing O +
agent O +
, O +
stimulated O +
its O +
tyrosine O +
phosphorylation O +
; O +
however O +
, O +
cytokines B-Gene +
and O +
growth B-Gene +
factors I-Gene +
were O +
ineffective O +
. O +

This O +
is O +
the O +
first O +
report O +
of O +
tyrosine O +
phosphorylation O +
of O +
GRP-75 B-Gene +
- O +
related O +
stress O +
protein O -
( O -
s O -
) O +
by O +
alpha B-Gene +
- I-Gene +
thrombin I-Gene +
and O +
suggests O +
that O +
this O +
pathway O +
may O +
contribute O +
to O +
the O +
ability O +
of O +
alpha B-Gene +
- I-Gene +
thrombin I-Gene +
to O +
prevent O +
apoptosis O +
in O +
cells O +
exposed O +
to O +
stress O +
or O +
in O +
the O +
injured O +
tissue O +
. O +

Zinc O +
stabilizes O +
adenomatous B-Gene +
polyposis I-Gene +
coli I-Gene +
( O +
APC B-Gene +
) O +
protein O +
levels O +
and O +
induces O +
cell O +
cycle O +
arrest O +
in O +
colon O +
cancer O +
cells O +
. O +

In O +
the O +
present O +
study O +
, O +
we O +
investigated O +
the O +
mechanisms O +
by O +
which O +
zinc O +
causes O +
growth O +
arrest O +
in O +
colon O +
cancer O +
cells O +
. O +

The O +
results O +
suggest O +
that O +
zinc O +
treatment O +
stabilizes O +
the O +
levels O +
of O +
the O +
wild O +
- O +
type O +
adenomatous B-Gene +
polyposis I-Gene +
coli I-Gene +
( O +
APC B-Gene +
) O +
protein O +
at O +
the O +
post O +
- O +
translational O +
level O +
since O +
the O +
APC B-Gene +
mRNA O +
levels O +
and O +
the O +
promoter O +
activity O +
of O +
the O +
APC B-Gene +
gene O +
were O +
decreased O +
in O +
HCT-116 O +
cells O +
( O +
which O +
express O +
the O +
wild O +
- O +
type O +
APC B-Gene +
gene O +
) O +
after O +
treatment O +
with O +
ZnCl2 O +
. O +

Increased O +
levels O +
of O +
wild O +
- O +
type O +
but O +
not O +
truncated O +
APC B-Gene +
proteins O +
were O +
required O +
for O +
the O +
ZnCl2 O +
- O +
mediated O +
G2 O +
/ O +
M O +
phase O +
arrest O +
in O +
different O +
colon O +
cancer O +
cell O +
lines O +
. O +

We O +
further O +
tested O +
whether O +
serum O +
- O +
stimulation O +
, O +
which O +
induces O +
cell O +
cycle O +
arrest O +
in O +
the O +
S O +
phase O +
, O +
can O +
relieve O +
ZnCl2 O +
- O +
induced O +
G2 O -
/ O -
M O +
phase O +
arrest O +
of O +
HCT-116 O +
cells O +
. O +

Results O +
showed O +
that O +
in O +
the O +
HCT-116 O +
cells O +
pretreated O +
with O +
ZnCl2 O +
, O +
the O +
serum O +
- O +
stimulation O +
neither O +
changed O +
the O +
distribution O +
of O +
G2 O +
/ O +
M O +
phase O +
arrested O +
cells O +
nor O +
the O +
increased O +
levels O +
of O +
APC B-Gene +
protein O +
. O +

The O +
G2 O +
/ O +
M O +
phase O +
arrest O +
correlated O +
with O +
retarded O +
growth O +
of O +
HCT-116 O +
cells O +
. O +

To O +
further O +
establish O +
that O +
wild O +
- O +
type O +
APC B-Gene +
protein O +
plays O +
a O +
role O +
in O +
ZnCl2 O +
- O +
induced O +
G2 O +
/ O +
M O +
arrest O +
, O +
we O +
treated O +
SW480 O +
colon O +
cancer O +
cells O +
that O +
express O +
truncated O +
APC B-Gene +
protein O +
. O +

We O +
found O +
that O +
ZnCl2 O +
treatment O +
did O +
not O +
induce O +
G2 O -
/ O -
M O +
phase O +
arrest O +
in O +
SW480 O +
cells O +
; O +
however O +
, O +
the O +
cell O +
growth O +
was O +
retarded O +
due O +
to O +
the O +
loss O +
of O +
E B-Gene -
- I-Gene -
cadherin I-Gene +
and O +
alpha B-Gene -
- I-Gene -
tubulin I-Gene +
levels O +
. O +

These O +
results O +
suggest O +
that O +
ZnCl2 O +
inhibits O +
the O +
proliferation O +
of O +
colon O +
cancer O +
cells O +
( O +
which O +
carry O +
the O +
wild O +
- O +
type O +
APC B-Gene +
gene O +
) O +
through O +
stabilization O +
of O +
the O +
APC B-Gene +
protein O +
and O +
cell O +
cycle O +
arrest O +
in O +
the O +
G2 O +
/ O +
M O +
phase O +
. O +

On O +
the O +
other O +
hand O +
, O +
ZnCl2 O +
inhibits O +
the O +
proliferation O +
of O +
colon O +
cancer O +
cells O +
( O +
which O +
carry O +
the O +
mutant O +
APC B-Gene +
gene O +
) O +
by O +
disrupting O +
cellular O +
attachment O +
and O +
microtubule O +
stability O +
. O +

Mechanisms O +
of O +
bacillus O +
Calmette O +
- O +
Guerin O +
mediated O +
natural O +
killer O +
cell O +
activation O +
. O +

PURPOSE O +
: O +

Natural O +
killer O +
( O +
NK O +
) O +
cells O +
are O +
of O +
crucial O +
importance O +
for O +
bacillus O +
Calmette O +
- O +
Guerin O +
( O +
BCG O +
) O +
mediated O +
antitumor O +
effects O +
. O +

We O +
defined O +
the O +
mechanisms O +
of O +
BCG O +
mediated O +
NK O +
cell O +
activation O +
in O +
vitro O +
. O +

MATERIALS O +
AND O +
METHODS O +
: O +

A O +
standard O +
Cr O +
release O +
assay O +
was O +
used O +
to O +
measure O +
the O +
cytotoxicity O +
of O +
BCG O +
activated O +
NK O +
cells O +
. O +

Using O +
the O +
MACS O +
system O +
( O +
Miltenyi O +
Biotec O +
, O +
Bergisch O +
- O +
Gladbach O +
, O +
Germany O +
) O +
we O +
depleted O +
various O +
immune O +
cell O +
subpopulations O +
from O +
BCG O +
stimulated O +
peripheral O +
blood O +
mononuclear O +
cells O +
to O +
phenotype O +
activated O +
NK O +
cells O +
. O +

During O +
the O +
stimulation O +
process O +
anticytokine O +
antibodies O +
and O +
recombinant O +
cytokines B-Gene +
were O +
added O +
to O +
define O +
their O +
role O +
in O +
NK O +
cell O +
activation O +
. O +

For O +
costimulation O +
studies O +
peripheral O +
blood O +
mononuclear O +
cells O +
were O +
separated O +
into O +
lymphocytes O +
and O +
monocytes O +
by O +
counterflow O +
- O +
centrifugation O +
( O +
elutriation O +
) O +
. O +

Inhibitory O +
NK O +
cell O +
receptor O +
expression O +
on O +
activated O +
NK O +
cells O +
was O +
measured O +
by O +
flow O +
cytometry O +
by O +
antiCD3 B-Gene +
, O +
antiCD56 B-Gene +
and O +
anti O +
- O +
inhibitory O +
NK O +
cell O +
receptor O +
triple O +
staining O +
. O +

RESULTS O +
: O +

The O +
accessory O +
function O +
of O +
monocytes O +
was O +
indispensable O +
for O +
BCG O +
mediated O +
NK O +
cell O +
activation O +
. O +

However O +
, O +
the O +
stimulatory O +
potential O +
of O +
monocytes O +
did O +
not O +
require O +
direct O +
cell O +
- O +
cell O +
contact O +
to O +
NK O +
cells O +
or O +
major B-Gene +
histocompatibility I-Gene +
complex I-Gene +
dependent O +
antigen O +
presentation O +
to O +
T O +
cells O +
. O +

Monocyte O +
derived O +
interleukin B-Gene +
( I-Gene +
IL I-Gene +
) I-Gene +
- I-Gene +
12 I-Gene +
and O +
to O +
a O +
lesser O +
extent O +
interferon B-Gene +
( I-Gene +
IFN I-Gene +
) I-Gene +
- I-Gene +
alpha I-Gene +
were O +
key O +
mediators O +
for O +
stimulating O +
BCG O +
induced O +
NK O +
cell O +
cytotoxicity O +
and O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
production O +
. O +

In O +
contrast O +
, O +
IL-10 B-Gene +
inhibited O +
NK O +
cell O +
cytotoxicity O +
and O +
IL-18 B-Gene +
did O +
not O +
show O +
any O +
effect O +
. O +

Exogenous O +
recombinant O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
and O +
IL-12 B-Gene +
enhanced O +
BCG O +
mediated O +
secretion O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
and O +
yet O +
BCG O +
induced O +
NK O +
cell O +
cytotoxicity O +
remained O +
unchanged O +
. O +

While O +
the O +
CD158a B-Gene +
and O +
CD158b B-Gene +
subsets O +
did O +
not O +
have O +
a O +
significant O +
role O +
, O +
NKG2A B-Gene +
cells O +
represented O +
the O +
predominant O +
cytolytic O +
subset O +
in O +
BCG O +
activated O +
NK O +
cells O +
. O +

CONCLUSIONS O +
: O +

Following O +
BCG O +
stimulation O +
the O +
monocyte O +
derived O +
TH1 O +
cytokines B-Gene +
IL-12 B-Gene +
and O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
activate O +
tumor O +
cytotoxic O +
CD3 B-Gene +
/ O +
CD56 B-Gene +
/ O +
NKG2A B-Gene +
NK O +
cells O +
. O +

Our O +
results O +
elucidate O +
NK O +
activating O +
mechanisms O +
that O +
are O +
operative O +
during O +
BCG O +
immunotherapy O +
for O +
bladder O +
cancer O +
and O +
are O +
relevant O +
for O +
an O +
early O +
, O +
innate O +
antimycobacterial O +
immune O +
response O +
. O +

Binding O +
of O +
Spo0A B-Gene +
stimulates O +
spoIIG B-Gene +
promoter O +
activity O +
in O +
Bacillus O +
subtilis O +
. O +

The O +
spoIIG B-Gene +
promoter O +
is O +
used O +
by O +
RNA B-Gene +
polymerase I-Gene +
containing O +
sigma B-Gene +
A I-Gene +
( O +
E B-Gene +
sigma I-Gene +
A I-Gene +
) O +
, O +
the O +
primary O +
form O +
of O +
RNA B-Gene +
polymerase I-Gene +
found O +
in O +
vegetative O +
cells O +
in O +
Bacillus O +
subtilis O +
. O +

However O +
, O +
the O +
spoIIG B-Gene +
promoter O +
is O +
active O +
only O +
after O +
the O +
onset O +
of O +
sporulation O +
. O +

Activation O +
of O +
the O +
spoIIG B-Gene +
promoter O +
requires O +
the O +
product O +
of O +
the O +
spo0A B-Gene +
gene O +
( O +
Spo0A B-Gene +
) O +
. O +

Spo0A B-Gene +
is O +
a O +
sequence O +
- O +
specific O +
DNA O +
- O +
binding O +
protein O +
which O +
binds O +
to O +
two O +
sites O +
in O +
the O +
spoIIG B-Gene +
promoter O +
that O +
are O +
essential O +
for O +
promoter O +
activity O +
. O +

We O +
found O +
that O +
single O +
- O +
base O +
- O +
pair O +
substitutions O +
in O +
these O +
two O +
regions O +
that O +
reduced O +
promoter O +
activity O +
in O +
vivo O +
caused O +
reduced O +
binding O +
of O +
Spo0A B-Gene +
in O +
vitro O +
, O +
and O +
one O +
substitution O +
that O +
increased O +
promoter O +
activity O +
in O +
vivo O +
increased O +
the O +
affinity O +
of O +
Spo0A B-Gene +
for O +
this O +
DNA O +
in O +
vitro O +
. O +

Furthermore O +
, O +
Spo0A B-Gene +
stimulated O +
transcription O +
from O +
the O +
spoIIG B-Gene +
promoter O +
by O +
E B-Gene +
sigma I-Gene +
A I-Gene +
in O +
vitro O +
. O +

These O +
results O +
support O +
the O +
model O +
that O +
binding O +
of O +
Spo0A B-Gene +
activates O +
E B-Gene +
sigma I-Gene +
A I-Gene +
- O +
dependent O +
transcription O +
from O +
the O +
spoIIG B-Gene +
promoter O +
after O +
the O +
onset O +
of O +
sporulation O +
. O +

The O +
synergetic O +
effects O +
of O +
two O +
CCAAT O +
boxes O +
in O +
Aspergillus O +
niger O +
glaA B-Gene +
gene O +
promoter O +
on O +
activation O +
of O +
PglaA B-Gene +
transcription O +
. O +

EMSA O +
and O +
footprinting O +
analyses O +
have O +
revealed O +
that O +
the O +
- O +
489 O +
-- O +
- O +
414 O +
bp O +
and O +
the O +
- O +
390 O +
- O +
- O +
- O +
345 O +
bp O +
( O +
designated O +
DC O +
and O +
PC O +
respectively O +
) O +
upstream O +
of O +
the O +
Aspergillus O +
nigerT21 O +
glaA B-Gene +
gene O +
were O +
bound O +
by O +
one O +
protein O +
factor O +
in O +
the O +
A. O +
nigerT21 O +
whole O +
cell O +
extract O +
. O +

Both O +
DC O +
and O +
PC O +
contained O +
CCAAT O +
pentanucleotides O +
. O +

The O +
functions O +
of O +
DC O +
and O +
PC O +
in O +
regulation O +
of O +
expression O +
of O +
glucoamylase B-Gene +
( O +
GLA B-Gene +
) O +
were O +
studied O +
. O +

CCAAT O +
pentanucleotides O +
were O +
replaced O +
with O +
CGTAA O +
and O +
the O +
mutated O +
DNA O +
fragments O +
DCm O +
and O +
PCm O +
lost O +
the O +
binding O +
activities O +
of O +
protein O +
factors O +
in O +
vitro O +
. O +

In O +
vivo O +
when O +
either O +
DC O +
or O +
PC O +
was O +
mutated O +
or O +
the O +
relative O +
orientations O +
between O +
them O +
were O +
changed O +
on O +
the O +
PglaA B-Gene +
, O +
the O +
transcriptional O +
activity O +
of O +
PglaA B-Gene +
decreased O +
to O +
a O +
basal O +
level O +
. O +

Introduction O +
of O +
multi O +
- O +
copies O +
of O +
DC O +
into O +
the O +
original O +
site O +
at O +
the O +
PglaA B-Gene +
in O +
A. O +
nigerT21 O +
decreased O +
the O +
expression O +
of O +
endogenous O +
GLA B-Gene +
expression O +
and O +
the O +
exogenous O +
reporter O +
E. O +
coli O +
uidA B-Gene +
gene O +
introduced O +
under O +
the O +
PglaA B-Gene +
promoter O +
, O +
while O +
having O +
no O +
effect O +
on O +
the O +
uidA B-Gene +
gene O +
under O +
the O +
control O +
of O +
PgpdA B-Gene +
. O +

EMSA O +
revealed O +
that O +
the O +
levels O +
of O +
the O +
specific O +
DNA O +
- O +
binding O +
protein O +
factors O +
in O +
the O +
transformants O +
maintained O +
the O +
same O +
meaning O +
that O +
introduction O +
of O +
multi O +
- O +
copies O +
of O +
DC O +
caused O +
the O +
titration O +
effect O +
. O +

AnghapC B-Gene +
gene O +
was O +
cloned O +
from O +
A. O +
nigerT21 O +
cDNA O +
and O +
introduced O +
into O +
the O +
DC O +
multi O +
- O +
copied O +
strains O +
. O +

The O +
expression O +
of O +
AnghapC B-Gene +
improved O +
the O +
expression O +
of O +
the O +
endogenous O +
GLA B-Gene +
and O +
the O +
exogenous O +
gene O +
controlled O +
by O +
PglaA B-Gene +
. O +

These O +
results O +
showed O +
that O +
both O +
the O +
CCAAT O +
pentanucleotides O +
were O +
necessary O +
for O +
DC O +
and O +
PC O +
binding O +
to O +
the O +
protein O +
factors O +
, O +
and O +
the O +
simultaneous O +
binding O +
of O +
DC O +
and O +
PC O +
to O +
the O +
protein O +
was O +
necessary O +
for O +
promoting O +
the O +
transcriptional O +
activity O +
of O +
PglaA B-Gene +
. O +

AngHapC B-Gene +
was O +
the O +
specific O +
positive O +
trans O +
- O +
acting O +
protein O +
factor O +
binding O +
to O +
DC O +
. O +

Effect O +
of O +
different O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
( O +
TNF B-Gene +
) O +
reactive O +
agents O +
on O +
reverse O +
signaling O +
of O +
membrane O +
integrated O +
TNF B-Gene +
in O +
monocytes O +
. O +

Reverse O +
signaling O +
of O +
transmembrane O +
TNF B-Gene +
( O +
mTNF B-Gene +
) O +
contributes O +
to O +
the O +
versatility O +
of O +
this O +
cytokine B-Gene +
superfamily I-Gene +
. O +

Previously O +
, O +
we O +
could O +
demonstrate O +
that O +
mTNF B-Gene +
acting O +
as O +
receptor O +
confers O +
resistance O +
to O +
bacterial O +
lipopolysaccharide O +
in O +
monocytes O +
and O +
macrophages O +
( O +
MO O +
/ O +
MPhi O +
) O +
. O +

Reverse O +
signaling O +
can O +
be O +
induced O +
by O +
incubation O +
with O +
the O +
monoclonal O +
anti O +
- O +
TNF B-Gene +
antibody O +
195F O +
and O +
other O +
TNF B-Gene +
antagonists O +
, O +
such O +
as O +
the O +
humanized O +
monoclonal O +
antibody O +
infliximab O +
and O +
the O +
humanized O +
soluble O +
TNF B-Gene +
receptor I-Gene +
construct O +
etanercept O +
, O +
respectively O +
, O +
all O +
in O +
former O +
or O +
present O +
clinical O +
use O +
. O +

Here O +
, O +
we O +
addressed O +
the O +
question O +
whether O +
there O +
are O +
differences O +
in O +
modulating O +
the O +
LPS O +
response O +
in O +
MO O +
/ O +
MPhi O +
among O +
these O +
three O +
antagonists O +
. O +

Whereas O +
195F O +
and O +
infliximab O +
suppress O +
both O +
, O +
the O +
release O +
of O +
an O +
LPS O +
- O +
induced O +
endothelial O +
cell O +
apoptotic O +
factor O +
and O +
proinflammatory O +
cytokines B-Gene +
, O +
etanercept O +
only O +
protected O +
against O +
the O +
LPS O +
- O +
triggered O +
apoptosis O +
activity O +
, O +
but O +
left O +
the O +
LPS O +
- O +
induced O +
cytokine B-Gene +
release O +
unchanged O +
. O +

These O +
data O +
could O +
have O +
clinical O +
impact O +
with O +
regard O +
to O +
TNF B-Gene +
neutralization O +
strategies O +
. O +

Antigenic O +
properties O +
of O +
phage O +
displayed O +
peptides O +
comprising O +
disulfide O +
- O +
bonded O +
loop O +
of O +
the O +
immunodominant O +
region O +
of O +
HIV-1 O +
gp41 B-Gene +
. O +

The O +
HIV-1 O +
envelope O +
glycoprotein O +
gp41 B-Gene +
contains O +
Cys O -
( O -
X O -
) O +
5Cys O +
motif O +
, O +
which O +
has O +
been O +
shown O +
to O +
elicit O +
a O +
strong O +
antibody O +
response O +
in O +
almost O +
all O +
HIV O +
- O +
1 O +
infected O +
individuals O +
. O +

This O +
disulfide O +
- O +
bonded O +
loop O +
region O +
is O +
conserved O +
in O +
most O +
retroviruses O +
suggesting O +
the O +
existence O +
of O +
an O +
essential O +
function O +
in O +
virus O +
life O +
cycle O +
. O +

In O +
this O +
study O +
, O +
we O +
displayed O +
the O +
peptides O +
comprising O +
12 O +
amino O +
acids O +
of O +
the O +
immunodominant O +
loop O +
of O +
gp41 B-Gene +
on O +
the O +
surface O +
of O +
M13 O +
phage O +
as O +
N O +
- O +
terminal O +
fusions O +
to O +
the O +
minor B-Gene +
coat I-Gene +
protein I-Gene +
pIII I-Gene +
and O +
major B-Gene +
coat I-Gene +
protein I-Gene +
pVIII I-Gene +
of O +
the O +
phage O +
and O +
demonstrated O +
that O +
cysteine O +
loop O +
containing O +
peptide O +
expressed O +
on O +
phage O +
recognized O +
62 O +
out O +
of O +
63 O +
( O +
98.4 O +
% O +
) O +
HIV-1 O +
positive O +
samples O +
but O +
not O +
control O +
negative O +
sera O +
while O +
phage O +
bearing O +
linear O +
peptides O +
detected O +
4 O +
- O +
30 O +
% O +
of O +
HIV O +
- O +
1 O +
- O +
positive O +
sera O +
. O +

The O +
main O +
advantage O +
of O +
phage O +
- O +
based O +
ELISA O +
or O +
other O +
antibody O +
detection O +
- O +
based O +
diagnostic O +
tests O +
of O +
HIV O +
- O +
infection O +
to O +
be O +
used O +
for O +
massive O +
screening O +
in O +
developing O +
countries O +
is O +
the O +
reproducible O +
, O +
simple O +
, O +
rapid O +
and O +
low O +
- O +
cost O +
production O +
of O +
recombinant O +
antigens O +
. O +

Molecular O +
characterization O +
of O +
the O +
MalT B-Gene +
- O +
dependent O +
periplasmic O +
alpha B-Gene -
- I-Gene -
amylase I-Gene +
of O +
Escherichia O +
coli O +
encoded O +
by O +
malS B-Gene +
. O +

malS B-Gene +
, O +
the O +
gene O +
encoding O +
the O +
periplasmic O +
alpha B-Gene -
- I-Gene -
amylase I-Gene +
, O +
is O +
under O +
the O +
regulatory O +
control O +
of O +
the O +
MalT B-Gene +
protein O +
, O +
the O +
gene O +
activator O +
of O +
the O +
Escherichia O +
coli O +
maltose O +
system O +
. O +

We O +
sequenced O +
the O +
DNA O +
region O +
encoding O +
malS B-Gene +
and O +
its O +
control O +
elements O +
. O +

malS B-Gene +
consists O +
of O +
an O +
open O +
reading O +
frame O +
of O +
2 O +
, O +
028 O +
base O +
pairs O +
encoding O +
a O +
protein O +
of O +
676 O +
amino O +
acids O +
with O +
a O +
deduced O +
molecular O +
weight O +
of O +
75 O +
, O +
664 O +
including O +
a O +
typical O +
amino O +
- O +
terminal O +
signal O +
sequence O +
of O +
17 O +
amino O +
acids O +
. O +

The O +
deduced O +
amino O +
acid O +
sequence O +
of O +
malS B-Gene +
was O +
compared O +
with O +
that O +
of O +
other O +
proteins O +
. O +

We O +
found O +
homologies O +
to O +
alpha B-Gene -
- I-Gene -
amylases I-Gene +
and O +
a O +
cyclodextrin B-Gene +
glucanotransferase I-Gene +
but O +
not O +
to O +
beta B-Gene -
- I-Gene -
amylases I-Gene +
. O +

In O +
addition O +
, O +
MalS B-Gene +
showed O +
significant O +
homology O +
to O +
another O +
maltodextrin O +
- O +
utilizing O +
and O +
MalT B-Gene +
- O +
dependent O +
enzyme O +
of O +
E. O +
coli O +
, O +
maltodextrin B-Gene +
glucosidase I-Gene +
( O +
MalZ B-Gene +
) O +
but O +
not O +
to O +
amylomaltase B-Gene +
( O +
MalQ B-Gene +
) O +
, O +
the O +
major O +
maltodextrin O +
- O +
degrading O +
enzyme O +
. O +

Conserved O +
regions O +
that O +
have O +
been O +
proposed O +
to O +
constitute O +
enzymatically O +
active O +
sites O +
in O +
alpha B-Gene -
- I-Gene -
amylases I-Gene +
are O +
present O +
in O +
MalS B-Gene +
. O +

Two O +
of O +
these O +
sequences O +
can O +
also O +
be O +
found O +
in O +
the O +
amino O +
terminus O +
of O +
the O +
lambda B-Gene +
- I-Gene +
receptor I-Gene +
, O +
a O +
maltodextrin O +
- O +
specific O +
channel O +
in O +
the O +
outer O +
membrane O +
. O +

The O +
nucleotide O +
sequence O +
of O +
the O +
control O +
region O +
of O +
malS B-Gene +
revealed O +
MalT B-Gene +
binding O +
sites O +
correctly O +
spaced O +
for O +
the O +
start O +
of O +
the O +
malS B-Gene +
transcript O +
. O +

At O +
the O +
position O +
219 O +
base O +
pairs O +
upstream O +
of O +
malS B-Gene +
, O +
we O +
found O +
a O +
divergently O +
transcribed O +
gene O +
, O +
bax B-Gene +
, O +
which O +
has O +
been O +
recognized O +
previously O +
. O +

Downstream O +
of O +
malS B-Gene +
, O +
after O +
a O +
513 O +
- O +
base O +
pair O +
intergenic O +
region O +
, O +
lies O +
the O +
convergently O +
transcribed O +
gene O +
avtA B-Gene +
, O +
which O +
codes O +
for O +
the O +
alanine B-Gene +
/ I-Gene +
valine I-Gene +
transaminase I-Gene +
. O +

Cloning O +
and O +
sequencing O +
analysis O +
of O +
the O +
repressor O +
gene O +
of O +
temperate O +
mycobacteriophage O +
L1 O +
. O +

The O +
wild O +
- O +
type O +
and O +
temperature O +
- O +
sensitive O +
( O +
ts O +
) O +
repressor O +
genes O +
were O +
cloned O +
from O +
the O +
temperate O +
mycobacteriophage O +
L1 O +
and O +
its O +
mutant O +
L1cIts391 O +
, O +
respectively O +
. O +

A O +
sequencing O +
analysis O +
revealed O +
that O +
the O +
131st O +
proline O +
residue O +
of O +
the O +
wild O +
- O +
type O +
repressor O +
was O +
changed O +
to O +
leucine O +
in O +
the O +
ts O +
mutant O +
repressor O +
. O +

The O +
100 O +
% O +
identity O +
that O +
was O +
discovered O +
between O +
the O +
two O +
DNA O +
regions O +
of O +
phages O +
L1 O +
and O +
L5 O +
, O +
carrying O +
the O +
same O +
sets O +
of O +
genes O +
including O +
their O +
repressor O +
genes O +
, O +
strengthened O +
the O +
speculation O +
that O +
L1 O +
is O +
a O +
minor O +
variant O +
of O +
phage O +
L5 O +
or O +
vice O +
versa O +
. O +

A O +
comparative O +
analysis O +
of O +
the O +
repressor O +
proteins O +
of O +
different O +
mycobacteriophages O +
suggests O +
that O +
the O +
mycobacteriophage O +
- O +
specific O +
repressor O +
proteins O +
constitute O +
a O +
new O +
family O +
of O +
repressors O +
, O +
which O +
were O +
possibly O +
evolved O +
from O +
a O +
common O +
ancestor O +
. O +

Alignment O +
of O +
the O +
mycobacteriophage O +
- O +
specific O +
repressor O +
proteins O +
showed O +
at O +
least O +
7 O +
blocks O +
( O +
designated O +
I O -
- O -
VII O +
) O +
that O +
carried O +
3 O +
- O +
8 O +
identical O +
amino O +
acid O +
residues O +
. O +

The O +
amino O +
acid O +
residues O +
of O +
blocks O +
V O +
, O +
VI O +
, O +
and O +
some O +
residues O +
downstream O +
to O +
block O +
VI O +
are O +
crucial O +
for O +
the O +
function O +
of O +
the O +
L1 O +
( O +
or O +
L5 O +
) O +
repressor O +
. O +

Blocks O +
I O +
and O +
II O +
possibly O +
form O +
the O +
turn O +
and O +
helix O +
2 O +
regions O +
of O +
the O +
HTH O +
motif O +
of O +
the O +
repressor O +
. O +

Block O +
IV O +
in O +
the O +
L1 O +
repressor O +
is O +
part O +
of O +
the O +
most O +
charged O +
region O +
encompassing O +
amino O +
acid O +
residues O +
72 O +
- O +
92 O +
, O +
which O +
flanks O +
the O +
putative O +
N O +
- O +
terminal O +
basic O +
( O +
residues O +
1 O +
- O +
71 O +
) O +
and O +
C O +
- O +
terminal O +
acidic O +
( O +
residues O +
93 O +
- O +
183 O +
) O +
domains O +
of O +
L1 O +
repressor O +
. O +

The O +
effect O +
of O +
IL-5 B-Gene +
treatment O +
on O +
the O +
stimulation O +
- O +
induced O +
phosphorylation O +
of O +
proteins O +
in O +
blood O +
eosinophils O +
. O +

Eosinophils O +
are O +
selectively O +
primed O +
and O +
activated O +
by O +
the O +
cytokine B-Gene +
IL-5 B-Gene +
. O +

The O +
aim O +
of O +
this O +
investigation O +
was O +
to O +
study O +
the O +
effects O +
of O +
IL-5 B-Gene +
treatment O +
on O +
stimulation O +
- O +
dependent O +
protein O +
phosphorylations O +
, O +
in O +
human O +
peripheral O +
blood O +
eosinophils O +
. O +

After O +
IL-5 B-Gene +
treatment O +
, O +
basal O +
phosphorylation O +
patterns O +
showed O +
increases O +
in O +
the O +
phosphorylation O +
of O +
67 O +
, O +
80 O +
and O +
93 O +
kDa O +
proteins O +
. O +

Cell O +
stimulations O +
resulted O +
in O +
the O +
following O +
protein O +
phosphorylation O +
increases O +
: O +
50 O +
, O +
60 O +
, O +
67 O +
, O +
80 O +
and O +
93 O +
kDa O +
( O +
PMA O +
) O +
; O +
50 O +
, O +
67 O +
, O +
80 O +
and O +
93 O +
kDa O +
( O +
STZ O +
) O +
; O +
and O +
67 O +
, O +
80 O +
and O +
93 O +
kDa O +
( O +
IL-5 B-Gene +
) O +
. O +

The O +
phosphorylation O +
of O +
the O +
50 O +
and O +
60 O +
kDa O +
proteins O +
was O +
shown O +
to O +
be O +
MEK B-Gene +
- O +
independent O +
and O +
dependent O +
on O +
some O +
PKC B-Gene +
isoform O +
/ O +
s O +
, O +
whereas O +
that O +
of O +
the O +
67 O +
, O +
80 O +
and O +
93 O +
kDa O +
proteins O +
was O +
both O +
MEK B-Gene +
- O +
and O +
PKC B-Gene +
- I-Gene +
alpha I-Gene +
, I-Gene +
beta I-Gene +
, I-Gene +
delta I-Gene +
, I-Gene +
gamma I-Gene +
, I-Gene +
tau I-Gene +
and I-Gene +
zeta I-Gene +
- O +
independent O +
. O +

A O +
phosphoprotein O +
of O +
50 O +
kDa O +
was O +
identified O +
as O +
p47 B-Gene +
( I-Gene +
phox I-Gene +
) I-Gene +
and O +
another O +
of O +
67 O +
kDa O +
protein O +
as O +
the O +
tyrosine B-Gene +
phosphatase I-Gene +
SHPTP-1 B-Gene +
. O +

Incubation O +
with O +
IL-5 B-Gene +
followed O +
by O +
cell O +
stimulation O +
increased O +
the O +
total O +
phosphorylation O +
of O +
p47 B-Gene +
( I-Gene +
phox I-Gene +
) I-Gene +
. O +

Bidimensional O +
( O +
IEF O -
- O -
SDS O +
/ O +
PAGE O +
) O +
analysis O +
showed O +
that O +
the O +
combination O +
of O +
IL-5 B-Gene +
treatment O +
followed O +
by O +
stimulation O +
with O +
either O +
PMA O +
or O +
STZ O +
induced O +
the O +
formation O +
of O +
an O +
additional O +
, O +
hyperphosphorylated O +
form O +
of O +
p47 B-Gene +
( I-Gene +
phox I-Gene +
) I-Gene +
. O +

The O +
presence O +
of O +
this O +
form O +
would O +
explain O +
the O +
higher O +
NADPH B-Gene +
oxidase I-Gene +
activity O +
normally O +
observed O +
after O +
IL-5 B-Gene +
priming O +
. O +

Identification O +
of O +
a O +
new O +
member O +
of O +
the O +
phage B-Gene +
shock I-Gene +
protein I-Gene +
response O +
in O +
Escherichia O +
coli O +
, O +
the O +
phage B-Gene +
shock I-Gene +
protein I-Gene +
G I-Gene +
( O +
PspG B-Gene +
) O +
. O +

The O +
phage B-Gene +
shock I-Gene +
protein I-Gene +
operon I-Gene +
( O +
pspABCDE B-Gene +
) O +
of O +
Escherichia O +
coli O +
is O +
strongly O +
up O +
- O +
regulated O +
in O +
response O +
to O +
overexpression O +
of O +
the O +
filamentous O +
phage O +
secretin O +
protein B-Gene +
IV I-Gene +
( O +
pIV B-Gene +
) O +
and O +
by O +
many O +
other O +
stress O +
conditions O +
including O +
defects O +
in O +
protein O +
export O +
. O +

PspA B-Gene +
has O +
an O +
established O +
role O +
in O +
maintenance O +
of O +
the O +
proton O +
- O +
motive O +
force O +
of O +
the O +
cell O +
under O +
stress O +
conditions O +
. O +

Here O +
we O +
present O +
evidence O +
for O +
a O +
new O +
member O +
of O +
the O +
phage O +
shock O +
response O +
in O +
E. O +
coli O +
. O +

Using O +
transcriptional O +
profiling O +
, O +
we O +
show O +
that O +
the O +
synthesis O +
of O +
pIV B-Gene +
in O +
E. O +
coli O +
leads O +
to O +
a O +
highly O +
restricted O +
response O +
limited O +
to O +
the O +
up O +
- O +
regulation O +
of O +
the O +
psp B-Gene +
operon I-Gene +
genes O +
and O +
yjbO B-Gene +
. O +

The O +
psp B-Gene +
operon I-Gene +
and O +
yjbO B-Gene +
are O +
also O +
up O +
- O +
regulated O +
in O +
response O +
to O +
pIV B-Gene +
in O +
Salmonella O +
enterica O +
serovar O +
Typhimurium O +
. O +

yjbO B-Gene +
is O +
a O +
highly O +
conserved O +
gene O +
found O +
exclusively O +
in O +
bacteria O +
that O +
contain O +
a O +
psp B-Gene +
operon I-Gene +
but O +
is O +
physically O +
unlinked O +
to O +
the O +
psp B-Gene +
operon I-Gene +
. O +

yjbO B-Gene +
encodes O +
a O +
putative O +
inner O +
membrane O +
protein O +
that O +
is O +
co O +
- O +
controlled O +
with O +
the O +
psp B-Gene +
operon I-Gene +
genes O +
and O +
is O +
predicted O +
to O +
be O +
an O +
effector O +
of O +
the O +
psp B-Gene +
response O +
in O +
E. O +
coli O +
. O +

We O +
present O +
evidence O +
that O +
yjbO B-Gene +
expression O +
is O +
driven O +
by O +
sigma B-Gene -
( I-Gene -
54 I-Gene -
) I-Gene +
- O +
RNA B-Gene +
polymerase I-Gene +
, O +
activated O +
by O +
PspF B-Gene +
and O +
integration B-Gene +
host I-Gene +
factor I-Gene +
, O +
and O +
negatively O +
regulated O +
by O +
PspA B-Gene +
. O +

PspF B-Gene +
specifically O +
regulates O +
only O +
members O +
of O +
the O +
PspF B-Gene +
regulon O +
: O +
pspABCDE B-Gene +
and O +
yjbO B-Gene +
. O +

We O +
found O +
that O +
increased O +
expression O +
of O +
YjbO B-Gene +
results O +
in O +
decreased O +
motility O +
of O +
bacteria O +
. O +

Because O +
yjbO B-Gene +
is O +
co O +
- O +
conserved O +
and O +
co O +
- O +
regulated O +
with O +
the O +
psp B-Gene +
operon I-Gene +
and O +
is O +
a O +
member O +
of O +
the O +
phage B-Gene +
shock I-Gene +
protein I-Gene +
F I-Gene +
regulon O +
, O +
we O +
propose O +
that O +
yjbO B-Gene +
be O +
renamed O +
pspG B-Gene +
. O +

Molecular O +
cloning O +
, O +
expression O +
, O +
and O +
characterization O +
of O +
myo B-Gene +
- I-Gene +
inositol I-Gene +
oxygenase I-Gene +
from O +
mouse O +
, O +
rat O +
, O +
and O +
human O +
kidney O +
. O +

myo B-Gene -
- I-Gene -
Inositol I-Gene +
oxygenase I-Gene +
( O +
MIOX B-Gene +
) O +
is O +
a O +
non O +
- O +
heme O +
iron O +
enzyme O +
, O +
which O +
catalyzes O +
the O +
conversion O +
of O +
myo O -
- O -
inositol O +
to O +
d O -
- O -
glucuronic O +
acid O +
, O +
the O +
first O +
committed O +
step O +
in O +
myo O +
- O +
inositol O +
catabolism O +
. O +

Full O +
- O +
length O +
cDNAs O +
of O +
858bp O +
each O +
coding O +
for O +
33kDa O +
protein O +
were O +
cloned O +
from O +
kidney O +
cDNA O +
libraries O +
of O +
mouse O +
, O +
rat O +
, O +
and O +
human O +
. O +

The O +
individual O +
clones O +
were O +
expressed O +
in O +
Escherichia O +
coli O +
and O +
recombinant O +
MIOX B-Gene +
proteins O +
were O +
purified O +
to O +
electrophoretic O +
homogeneity O +
. O +

A O +
hydrophobic O +
interaction O +
chromatography O +
step O +
yielded O +
multiple O +
conformers O +
, O +
with O +
mouse O +
and O +
human O +
MIOX B-Gene +
showing O +
three O +
peaks O +
and O +
rat O +
enzyme O +
revealing O +
two O +
peaks O +
. O +

Individual O +
MIOX B-Gene +
peaks O +
exhibited O +
distinct O +
V O -
( O -
max O -
) O +
and O +
K O -
( O -
m O -
) O +
values O +
. O +

Interestingly O +
, O +
upon O +
storage O +
, O +
the O +
33kDa O +
protein O +
was O +
degraded O +
to O +
a O +
approximately O +
30kDa O +
truncated O +
protein O +
in O +
each O +
species O +
, O +
and O +
formed O +
small O +
amounts O +
of O +
dimers O +
of O +
identical O +
subunits O +
. O +

While O +
MIOX B-Gene +
is O +
a O +
highly O +
conserved O +
enzyme O +
in O +
all O +
mammalian O +
species O +
, O +
the O +
labile O +
nature O +
and O +
tendency O +
to O +
degrade O +
in O +
solution O +
may O +
be O +
the O +
source O +
of O +
significant O +
differences O +
in O +
size O +
previously O +
reported O +
in O +
the O +
literature O +
. O +

Regardless O +
of O +
the O +
source O +
, O +
our O +
results O +
strongly O +
dispel O +
previous O +
conflicting O +
literature O +
reports O +
on O +
the O +
size O +
of O +
the O +
protein O +
and O +
confirm O +
that O +
MIOX B-Gene +
is O +
a O +
33kDa O +
protein O +
. O +

Isolation O +
and O +
characterization O +
of O +
photosystem B-Gene +
II I-Gene +
of O +
Porphyra O +
yezoensis O +
Ueda O +
. O +

The O +
thylakoid O +
membranes O +
were O +
isolated O +
and O +
purified O +
from O +
gametophyte O +
of O +
Porphyra O +
yezoensis O +
Ueda O +
( O +
P. O +
yezoensis O +
) O +
by O +
sucrose O +
density O +
gradient O +
ultracentrifugation O +
. O +

After O +
P. O +
yezoensis O +
gametophyte O +
thylakoid O +
membranes O +
were O +
solubilized O +
with O +
SDS O +
, O +
the O +
photosystem B-Gene +
II I-Gene +
( O +
PSII B-Gene +
) O +
particles O +
were O +
isolated O +
and O +
purified O +
. O +

The O +
activity O +
of O +
PSII B-Gene +
particles O +
was O +
determined O +
with O +
DCIP O +
( O +
2,6-dichloroindophenol O +
) O +
photoreduction O +
reaction O +
. O +

The O +
composition O +
of O +
purified O +
PSII B-Gene +
particles O +
was O +
detected O +
by O +
SDS O +
- O +
PAGE O +
. O +

As O +
a O +
result O +
, O +
seven O +
proteins O +
including O +
55 O +
kD O +
protein O +
, O +
47 O +
kD O +
protein O +
, O +
43 O +
kD O +
protein O +
, O +
33 O +
kD O +
protein O +
, O +
31 O +
kD O +
protein O +
, O +
29 O +
kD O +
protein O +
, O +
and O +
18 O +
kD O +
protein O +
were O +
found O +
. O +

Compared O +
with O +
PSII B-Gene +
particles O +
of O +
higher O +
plants O +
and O +
other O +
algae O +
, O +
they O +
were O +
identified O +
as O +
D1 B-Gene +
/ I-Gene +
D2 I-Gene +
complex I-Gene +
, O +
CP47 B-Gene +
, O +
CP43 B-Gene +
, O +
33 O +
kD O +
protein O +
, O +
D1 O +
, O +
D2 O +
and O +
cyt B-Gene +
c-550 I-Gene +
respectively O +
. O +

Besides O +
, O +
other O +
three O +
new O +
proteins O +
of O +
20 O +
kD O +
, O +
16 O +
kD O +
and O +
14 O +
kD O +
respectively O +
were O +
found O +
. O +

Among O +
these O +
extrinsic O +
proteins O +
, O +
the O +
16 O +
kD O +
and O +
14 O +
kD O +
proteins O +
had O +
not O +
been O +
reported O +
previously O +
, O +
and O +
the O +
20 O +
kD O +
protein O +
was O +
found O +
for O +
the O +
first O +
time O +
in O +
multicellular O +
red O +
algae O +
. O +

Binding O +
of O +
the O +
C O +
- O +
terminal O +
domain O +
of O +
the O +
alpha B-Gene +
subunit I-Gene +
of I-Gene +
RNA I-Gene +
polymerase I-Gene +
to O +
the O +
phage O +
mu O +
middle O +
promoter O +
. O +

The O +
C O +
- O +
terminal O +
domain O +
of O +
the O +
alpha O +
subunit O +
( O +
alpha O +
CTD O +
) O +
of O +
Escherichia O +
coli O +
RNA B-Gene +
polymerase I-Gene +
is O +
often O +
involved O +
in O +
transcriptional O +
regulation O +
. O +

The O +
alpha O +
CTD O +
typically O +
stimulates O +
transcription O +
via O +
interactions O +
with O +
promoter O +
UP O +
element O +
DNA O +
and O +
transcriptional O +
activators O +
. O +

DNase B-Gene +
I I-Gene +
footprinting O +
and O +
gel O +
mobility O +
shift O +
assays O +
were O +
used O +
to O +
look O +
for O +
potential O +
interaction O +
of O +
the O +
alpha O +
CTD O +
with O +
the O +
phage O +
Mu O +
middle O +
promoter O +
P O -
( O -
m O -
) O +
and O +
its O +
activator O +
protein O +
Mor B-Gene +
. O +

Binding O +
of O +
RNA B-Gene +
polymerase I-Gene +
to O +
P O -
( O -
m O -
) O +
in O +
the O +
presence O +
of O +
Mor B-Gene +
resulted O +
in O +
production O +
of O +
a O +
DNase B-Gene +
I I-Gene +
footprint O +
downstream O +
of O +
Mor B-Gene +
due O +
to O +
open O +
complex O +
formation O +
and O +
generation O +
of O +
a O +
second O +
footprint O +
just O +
upstream O +
of O +
the O +
Mor B-Gene +
binding O +
site O +
. O +

Generation O +
of O +
the O +
upstream O +
footprint O +
did O +
not O +
require O +
open O +
complex O +
formation O +
and O +
also O +
occurred O +
in O +
reactions O +
in O +
which O +
the O +
alpha O +
CTD O +
or O +
His O -
- O -
alpha O +
proteins O +
were O +
substituted O +
for O +
RNA B-Gene +
polymerase I-Gene +
. O +

In O +
gel O +
mobility O +
shift O +
assays O +
, O +
the O +
formation O +
of O +
a O +
supershifted O +
ternary O +
complex O +
demonstrated O +
that O +
Mor B-Gene +
and O +
His O +
- O +
alpha O +
bind O +
synergistically O +
to O +
P O +
( O +
m O +
) O +
DNA O +
. O +

Gel O +
shift O +
assays O +
with O +
short O +
DNA O +
fragments O +
demonstrated O +
that O +
only O +
the O +
Mor B-Gene +
binding O +
site O +
and O +
a O +
single O +
upstream O +
alpha O +
CTD O +
binding O +
site O +
were O +
required O +
for O +
ternary O +
complex O +
formation O +
. O +

These O +
results O +
suggest O +
that O +
the O +
alpha O +
CTD O +
plays O +
a O +
role O +
in O +
P O -
( O -
m O -
) O +
transcription O +
by O +
binding O +
to O +
P O +
( O +
m O +
) O +
DNA O +
just O +
upstream O +
from O +
Mor B-Gene +
and O +
making O +
protein O +
- O +
protein O +
interactions O +
with O +
Mor B-Gene +
that O +
stabilize O +
the O +
binding O +
of O +
both O +
proteins O +
. O +

Expression O +
of O +
inhibitory O +
KIR B-Gene +
is O +
confined O +
to O +
CD8 B-Gene +
+ O +
effector O +
T O +
cells O +
and O +
limits O +
their O +
proliferative O +
capacity O +
. O +

A O +
subset O +
of O +
effector O +
/ O +
memory O +
CD8 B-Gene +
( O +
+ O +
) O +
T O +
cells O +
expresses O +
natural O +
killer O +
cell O +
receptors O +
( O +
NKR O +
) O +
. O +

Expression O +
of O +
inhibitory O +
NKR O +
at O +
that O +
stage O +
of O +
T O +
cell O +
differentiation O +
is O +
poorly O +
understood O +
. O +

Interestingly O +
, O +
recent O +
studies O +
in O +
mice O +
indicated O +
that O +
transgenic O +
expression O +
of O +
an O +
inhibitory O +
NKR O +
induced O +
the O +
accumulation O +
of O +
memory O +
T O +
cells O +
by O +
inhibiting O +
activation O +
- O +
induced O +
cell O +
death O +
( O +
AICD O +
) O +
. O +

To O +
further O +
understand O +
the O +
role O +
of O +
inhibitory O +
NKR O +
on O +
T O +
cells O +
, O +
we O +
characterized O +
the O +
subset O +
of O +
human O +
peripheral O +
T O +
cells O +
expressing O +
the O +
inhibitory O +
NKR O +
, O +
CD158b B-Gene +
, O +
and O +
studied O +
the O +
modulation O +
of O +
antigen O +
- O +
driven O +
T O +
cell O +
expansion O +
by O +
an O +
endogenous O +
inhibitory O +
NKR O +
. O +

We O +
found O +
that O +
CD158b B-Gene +
expression O +
was O +
confined O +
to O +
a O +
population O +
of O +
CD8 B-Gene +
( O -
+ O -
) O +
TCRalphabeta B-Gene +
( O -
+ O -
) O +
effector O +
T O +
cells O +
as O +
defined O +
by O +
a O +
CD45RA B-Gene +
( O +
+ O +
) O +
CCR7 B-Gene +
( O +
- O +
) O +
phenotype O +
and O +
high O +
constitutive O +
expression O +
of O +
granzyme B-Gene +
B1 I-Gene +
. O +

Few O +
cells O +
expressed O +
the O +
activating O +
form O +
CD158j B-Gene +
in O +
the O +
absence O +
of O +
CD158b B-Gene +
. O +

Functionally O +
, O +
engagement O +
of O +
CD158b B-Gene +
by O +
MHC B-Gene +
ligands O +
diminished O +
early O +
TCR B-Gene +
signaling O +
, O +
as O +
well O +
as O +
AICD O +
. O +

However O +
, O +
the O +
reduced O +
AICD O +
did O +
not O +
rescue O +
cells O +
for O +
proliferation O +
, O +
since O +
T O +
cell O +
expansion O +
in O +
the O +
presence O +
of O +
CD158b B-Gene +
triggering O +
was O +
impaired O +
. O +

Expression O +
of O +
inhibitory O +
NKR O +
on O +
effector O +
CD8 B-Gene +
( O +
+ O +
) O +
T O +
cells O +
may O +
explain O +
in O +
part O +
the O +
poor O +
replicative O +
capacity O +
of O +
T O +
cells O +
at O +
that O +
stage O +
of O +
differentiation O +
. O +

Cytokine B-Gene +
gene O +
polymorphisms O +
in O +
endemic O +
pemphigus O +
foliaceus O +
: O +
a O +
possible O +
role O +
for O +
IL6 B-Gene +
variants O +
. O +

Endemic O +
pemphigus O +
foliaceus O +
( O +
EPF O +
) O +
is O +
a O +
complex O +
autoimmune O +
disease O +
characterized O +
by O +
the O +
presence O +
of O +
antibodies O +
against O +
desmoglein B-Gene +
1 I-Gene +
, O +
which O +
lead O +
to O +
the O +
loss O +
of O +
adhesion O +
among O +
keratinocytes O +
( O +
acantholysis O +
) O +
. O +

Variants O +
of O +
HLA B-Gene +
class I-Gene +
II I-Gene +
genes O +
have O +
been O +
the O +
only O +
genetic O +
factors O +
found O +
to O +
modulate O +
susceptibility O +
to O +
EPF O +
. O +

This O +
study O +
aims O +
at O +
investigating O +
the O +
influence O +
of O +
cytokine B-Gene +
genetic O +
variants O +
in O +
the O +
pathogenesis O +
of O +
EPF O +
, O +
since O +
they O +
may O +
affect O +
the O +
expression O +
levels O +
of O +
these O +
immunomodulatory O +
molecules O +
. O +

The O +
sample O +
included O +
168 O +
patients O +
and O +
189 O +
controls O +
and O +
was O +
comprised O +
of O +
mostly O +
Caucasoids O +
and O +
Mulattos O +
. O +

The O +
approach O +
consisted O +
of O +
a O +
case O +
- O +
control O +
association O +
study O +
and O +
the O +
alleles O +
were O +
identified O +
by O +
mismatched O +
PCR O +
- O +
RFLP O +
. O +

No O +
associations O +
were O +
found O +
with O +
variants O +
of O +
IL1A B-Gene +
, O +
IL1B B-Gene +
, O +
IL1RN B-Gene +
, O +
IL4R B-Gene +
and O +
IL10 B-Gene +
. O +

There O +
was O +
a O +
weak O +
negative O +
association O +
with O +
the O +
haplotype O +
- O +
1082 O -
G O +
- O +
592C O +
( O +
OR O +
= O +
0.49 O +
) O +
of O +
the O +
IL10 B-Gene +
gene O +
in O +
Mulattos O +
. O +

In O +
regard O +
to O +
polymorphism O +
- O +
590 O +
of O +
the O +
IL4 B-Gene +
gene O +
, O +
a O +
positive O +
association O +
with O +
the O +
T O +
/ O +
T O +
genotype O +
( O +
OR O +
= O +
2.71 O +
) O +
and O +
a O +
negative O +
association O +
with O +
the O +
C O +
variant O +
( O +
OR O +
= O +
0.37 O +
) O +
were O +
found O +
. O +

Associations O +
with O +
IL6 B-Gene +
- O +
174 O +
variants O +
suggest O +
that O +
the O +
C O +
/ O +
C O +
genotype O +
has O +
a O +
protective O +
effect O +
( O +
OR O +
= O +
0.13 O +
) O +
while O +
carriers O +
of O +
the O +
G O +
allele O +
are O +
more O +
susceptible O +
( O +
OR O +
= O +
7.66 O +
) O +
to O +
EPF O +
. O +

Agrobacterium O +
VirB10 B-Gene +
, O +
an O +
ATP O +
energy O +
sensor O +
required O +
for O +
type O +
IV O +
secretion O +
. O +

Bacteria O +
use O +
type O +
IV O +
secretion O +
systems O +
( O +
T4SS O +
) O +
to O +
translocate O +
DNA O +
and O +
protein O +
substrates O +
to O +
target O +
cells O +
of O +
phylogenetically O +
diverse O +
taxa O +
. O +

Recently O +
, O +
by O +
use O +
of O +
an O +
assay O +
termed O +
transfer O +
DNA O +
immunoprecipitation O +
( O +
TrIP O +
) O +
, O +
we O +
described O +
the O +
translocation O +
route O +
for O +
a O +
DNA O +
substrate O +
[ O +
T O +
- O +
DNA O +
, O +
portion O +
of O +
the O +
Ti O +
( O +
tumor O +
- O +
inducing O +
) O +
plasmid O +
that O +
is O +
transferred O +
to O +
plant O +
cells O +
] O +
of O +
the O +
Agrobacterium O +
tumefaciens O +
VirB B-Gene +
/ I-Gene +
D4 I-Gene +
T4SS O +
in O +
terms O +
of O +
a O +
series O +
of O +
temporally O +
and O +
spatially O +
ordered O +
substrate O +
contacts O +
with O +
subunits O +
of O +
the O +
secretion O +
channel O +
. O +

Here O +
, O +
we O +
report O +
that O +
the O +
bitopic O +
inner O +
membrane O +
protein O +
VirB10 B-Gene +
undergoes O +
a O +
structural O +
transition O +
in O +
response O +
to O +
ATP O +
utilization O +
by O +
the O +
VirD4 B-Gene +
and O +
VirB11 B-Gene +
ATP O +
- O +
binding O +
subunits O +
, O +
as O +
monitored O +
by O +
protease B-Gene +
susceptibility O +
. O +

VirB10 B-Gene +
interacts O +
with O +
inner O +
membrane O +
VirD4 B-Gene +
independently O +
of O +
cellular O +
energetic O +
status O +
, O +
whereas O +
the O +
energy O +
- O +
induced O +
conformational O +
change O +
is O +
required O +
for O +
VirB10 B-Gene +
complex O +
formation O +
with O +
an O +
outer O +
membrane O +
- O +
associated O +
heterodimer O +
of O +
VirB7 B-Gene +
lipoprotein O +
and O +
VirB9 B-Gene +
, O +
as O +
shown O +
by O +
coimmunoprecipitation O +
. O +

Under O +
these O +
conditions O +
, O +
the O +
T O +
- O +
DNA O +
substrate O +
is O +
delivered O +
from O +
the O +
inner O +
membrane O +
channel O +
components O +
VirB6 B-Gene +
and O +
VirB8 B-Gene +
to O +
periplasmic O +
and O +
outer O +
membrane O +
- O +
associated O +
VirB2 B-Gene +
pilin O +
and O +
VirB9 B-Gene +
. O +

We O +
propose O +
that O +
VirD4 B-Gene +
and O +
VirB11 B-Gene +
coordinate O +
the O +
ATP O +
- O +
dependent O +
formation O +
of O +
a O +
VirB10 B-Gene +
" O +
bridge O +
" O +
between O +
inner O +
and O +
outer O +
membrane O +
subassemblies O +
of O +
the O +
VirB B-Gene +
/ I-Gene +
D4 I-Gene +
T4SS O +
, O +
and O +
that O +
this O +
morphogenetic O +
event O +
is O +
required O +
for O +
T O +
- O +
DNA O +
translocation O +
across O +
the O +
A. O +
tumefaciens O +
cell O +
envelope O +
. O +

Stimulation O +
, O +
monitoring O +
, O +
and O +
analysis O +
of O +
pathway O +
dynamics O +
by O +
metabolic O +
profiling O +
in O +
the O +
aromatic O +
amino O +
acid O +
pathway O +
. O +

Using O +
a O +
concerted O +
approach O +
of O +
biochemical O +
standard O +
preparation O +
, O +
analytical O +
access O +
via O +
LC O -
- O -
MS O +
/ O +
MS O +
, O +
glucose O +
pulse O +
, O +
metabolic O +
profiling O +
, O +
and O +
statistical O +
data O +
analysis O +
, O +
the O +
metabolism O +
dynamics O +
in O +
the O +
aromatic O +
amino O +
acid O +
pathway O +
has O +
been O +
stimulated O +
, O +
monitored O +
, O +
and O +
analyzed O +
in O +
different O +
tyrosine O +
- O +
auxotrophic O +
L O -
- O -
phenylalanine O -
- O -
producing O +
Escherichia O +
coli O +
strains O +
. O +

During O +
the O +
observation O +
window O +
from O +
- O +
4 O +
s O +
( O +
before O +
) O +
up O +
to O +
27 O +
s O +
after O +
the O +
glucose O +
pulse O +
, O +
the O +
dynamics O +
of O +
the O +
first O +
five O +
enzymatic O +
reactions O +
in O +
the O +
aromatic O +
amino O +
acid O +
pathway O +
was O +
observed O +
by O +
measuring O +
intracellular O +
concentrations O +
of O +
3-deoxy O -
- O -
d O -
- O -
arabino O -
- O -
heptulosonate O +
7-phosphate O +
DAH O -
( O -
P O -
) O +
, O +
3-dehydroquinate O +
( O +
3-DHQ O +
) O +
, O +
3-dehydroshikimate O +
( O +
3-DHS O +
) O +
, O +
shikimate O +
3-phosphate O +
( O +
S3P O +
) O +
, O +
and O +
shikimate O +
( O +
SHI O +
) O +
, O +
together O +
with O +
the O +
pathway O +
precursors O +
phosphoenolpyruvate O +
( O +
PEP O +
) O +
and O +
P5P O +
, O +
the O +
lumped O +
pentose O +
phosphate O +
pool O +
as O +
an O +
alternative O +
to O +
the O +
nondetectable O +
erythrose O +
4-phosphate O +
( O +
E4P O +
) O +
. O +

Provided O +
that O +
a O +
sufficient O +
fortification O +
of O +
the O +
carbon O +
flux O +
into O +
the O +
pathway O +
of O +
interest O +
is O +
ensured O +
, O +
respective O +
metabolism O +
dynamics O +
can O +
be O +
observed O +
. O +

On O +
the O +
basis O +
of O +
the O +
intracellular O +
pool O +
measurements O +
, O +
the O +
standardized O +
pool O +
velocities O +
were O +
calculated O +
, O +
and O +
a O +
simple O +
, O +
data O +
- O +
driven O +
criterion O +
--called O +
" O +
pool O +
efflux O +
capacity O +
" O +
( O +
PEC O +
) O +
-- O +
is O +
derived O +
. O +

Despite O +
its O +
simplifying O +
system O +
description O +
, O +
the O +
criterion O +
managed O +
to O +
identify O +
the O +
well O +
- O +
known O +
AroB B-Gene +
limitation O +
in O +
the O +
E. O +
coli O +
strain O +
A O +
( O +
genotype O +
delta O +
( O +
pheA B-Gene +
tyrA B-Gene +
aroF B-Gene +
) O +
/ O +
pJF119EH O +
aroF B-Gene +
( O +
fbr O +
) O +
pheA B-Gene +
( O +
fbr O +
) O +
amp O +
) O +
and O +
it O +
also O +
succeeded O +
to O +
identify O +
AroL B-Gene +
and O +
AroA B-Gene +
( O +
in O +
strain O +
B O +
, O +
genotype O +
delta O +
( O +
pheA B-Gene +
tyrA B-Gene +
aroF B-Gene +
) O +
/ O +
pJF119EH O +
aroF B-Gene +
( O +
fbr O +
) O +
pheA B-Gene +
( O +
fbr O +
) O +
aroB B-Gene +
amp O +
) O +
as O +
promising O +
metabolic O +
engineering O +
targets O +
to O +
alleviate O +
respective O +
flux O +
control O +
in O +
subsequent O +
L O -
- O -
Phe O +
producing O +
strains O +
. O +

Furthermore O +
, O +
using O +
of O +
a O +
simple O +
correlation O +
analysis O +
, O +
the O +
reconstruction O +
of O +
the O +
metabolite O +
sequence O +
of O +
the O +
observed O +
pathway O +
was O +
enabled O +
. O +

The O +
results O +
underline O +
the O +
necessity O +
to O +
extend O +
the O +
focus O +
of O +
glucose O +
pulse O +
experiments O +
by O +
studying O +
not O +
only O +
the O +
central O +
metabolism O +
but O +
also O +
anabolic O +
pathways O +
. O +

The O +
silent O +
KIR3DP1 B-Gene +
gene O +
( O +
CD158c B-Gene +
) O +
is O +
transcribed O +
and O +
might O +
encode O +
a O +
secreted O +
receptor O +
in O +
a O +
minority O +
of O +
humans O +
, O +
in O +
whom O +
the O +
KIR3DP1 B-Gene +
, O +
KIR2DL4 B-Gene +
and O +
KIR3DL1 B-Gene +
/ O +
KIR3DS1 B-Gene +
genes O +
are O +
duplicated O +
. O +

Killer B-Gene +
- I-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIR B-Gene +
) O +
are O +
structurally O +
and O +
functionally O +
diverse O +
, O +
and O +
enable O +
human O +
NK O +
cells O +
to O +
survey O +
the O +
expression O +
of O +
individual O +
HLA B-Gene +
class I-Gene +
I I-Gene +
molecules O +
, O +
often O +
altered O +
in O +
infections O +
and O +
tumors O +
. O +

Multiple O +
events O +
of O +
non O +
- O +
reciprocal O +
recombination O +
have O +
contributed O +
to O +
the O +
rapid O +
diversification O +
of O +
KIR B-Gene +
. O +

We O +
show O +
that O +
approximately O +
4.5 O +
% O +
of O +
the O +
individuals O +
of O +
a O +
Caucasoid O +
population O +
bear O +
a O +
recombinant O +
allele O +
of O +
KIR3DP1 B-Gene +
, O +
officially O +
designed O +
KIR3DP1 B-Gene -
* I-Gene -
004 I-Gene +
, O +
that O +
associates O +
tightly O +
with O +
gene O +
duplications O +
of O +
KIR3DP1 B-Gene +
, O +
KIR2DL4 B-Gene +
and O +
KIR3DL1 B-Gene +
/ O +
KIR3DS1 B-Gene +
. O +

The O +
KIR3DP1 B-Gene +
gene O +
is O +
normally O +
silent O +
, O +
but O +
the O +
recombinant O +
allele O +
carries O +
a O +
novel O +
promoter O +
sequence O +
and O +
, O +
as O +
a O +
consequence O +
, O +
is O +
transcribed O +
in O +
all O +
tested O +
individuals O +
. O +

Messenger O +
RNA O +
of O +
KIR3DP1 B-Gene -
* I-Gene -
004 I-Gene +
is O +
made O +
up O +
of O +
six O +
exons O +
; O +
of O +
these O +
, O +
exons O +
1 O +
- O +
5 O +
are O +
similar O +
to O +
, O +
and O +
spliced O +
like O +
, O +
those O +
encoding O +
the O +
leader O +
peptide O +
and O +
Ig B-Gene +
- O +
domains O +
of O +
KIR3D B-Gene +
. O +

By O +
contrast O +
, O +
exon O +
6 O +
is O +
homologous O +
to O +
no O +
other O +
human O +
KIR B-Gene +
sequence O +
, O +
but O +
only O +
to O +
possible O +
homologs O +
in O +
chimpanzees O +
and O +
rhesus O +
macaques O +
, O +
and O +
encodes O +
a O +
short O +
hydrophilic O +
tail O +
. O +

The O +
putative O +
KIR3DP1 B-Gene -
* I-Gene -
004 I-Gene +
product O +
, O +
like O +
those O +
of O +
the O +
related O +
genes O +
LAIR-2 B-Gene +
and O +
LILRA3 B-Gene +
/ O +
ILT6 B-Gene +
/ O +
LIR4 B-Gene +
, O +
is O +
predicted O +
to O +
be O +
secreted O +
to O +
the O +
extracellular O +
medium O +
rather O +
than O +
anchored O +
to O +
the O +
cell O +
membrane O +
. O +

Proteomic O +
analysis O +
of O +
antiproliferative O +
effects O +
by O +
treatment O +
of O +
5-fluorouracil O +
in O +
cervical O +
cancer O +
cells O +
. O +

The O +
global O +
effects O +
of O +
5-fluorouracil O +
( O +
FU O +
) O +
on O +
cervical O +
carcinoma O +
cells O +
were O +
analyzed O +
using O +
an O +
efficient O +
proteomic O +
method O +
. O +

More O +
than O +
50 O +
proteins O +
showed O +
a O +
significant O +
change O +
in O +
5-FU O +
- O +
treated O +
cervical O +
carcinoma O +
cells O +
compared O +
to O +
control O +
cells O +
. O +

Among O +
them O +
, O +
34 O +
proteins O +
have O +
been O +
identified O +
by O +
employing O +
two O +
- O +
dimensional O +
gel O +
electrophoresis O +
and O +
MALDI O +
- O +
TOF O +
- O +
MS O +
using O +
peptide O +
mass O +
fingerprinting O +
. O +

In O +
results O +
, O +
22 O +
proteins O +
were O +
upregulated O +
( O +
CIDE B-Gene +
- I-Gene +
B I-Gene +
[ O +
cell B-Gene +
death I-Gene +
- I-Gene +
inducing I-Gene +
DFFA I-Gene +
- I-Gene +
like I-Gene +
effector I-Gene +
B I-Gene +
] O +
, O +
caspase B-Gene +
- I-Gene +
3 I-Gene +
, O +
caspase B-Gene +
- I-Gene +
8 I-Gene +
, O +
Apo B-Gene +
- I-Gene +
1 I-Gene +
/ O +
CD95 B-Gene +
( O +
Fas B-Gene +
) O +
, O +
etc O -
. O +
) O +
and O +
12 O +
proteins O +
were O +
downregulated O +
( O +
mitotic B-Gene +
checkpoint I-Gene +
protein I-Gene +
BUB3 I-Gene +
, O +
myc B-Gene +
proto O +
- O +
oncogene O +
protein O +
[ O +
c B-Gene -
- I-Gene -
myc I-Gene +
] O +
, O +
src B-Gene +
substrate I-Gene +
cortactin I-Gene +
, O +
transforming O +
protein O +
p21A O +
, O +
etc O -
. O +
) O +
by O +
5 O +
- O +
FU O +
treatment O +
in O +
HeLa O +
cervical O +
carcinoma O +
cells O +
as O +
determined O +
by O +
spot O +
volume O +
( O +
P O +
< O +
0.05 O +
) O +
. O +

Our O +
experiments O +
showed O +
that O +
5-FU O +
engaged O +
the O +
mitochondrial O +
apoptotic O +
pathway O +
involving O +
cytosolic O +
cytochrome B-Gene +
c I-Gene +
release O +
and O +
subsequent O +
activation O +
of O +
caspase-9 B-Gene +
and O +
caspase-3 B-Gene +
as O +
well O +
as O +
the O +
membrane O +
death B-Gene +
receptor I-Gene +
( O +
DR B-Gene +
) O +
- O +
mediated O +
apoptotic O +
pathway O +
involving O +
activation O +
of O +
caspase-8 B-Gene +
with O +
an O +
Apo-1 B-Gene +
/ O +
CD95 B-Gene +
( O +
Fas B-Gene +
) O +
- O +
dependent O +
fashion O +
. O +

In O +
addition O +
, O +
we O +
could O +
observe O +
reduction O +
of O +
HPV O +
- O +
18 O +
E6 B-Gene +
/ O +
E7 B-Gene +
gene O +
expression O +
and O +
activation O +
of O +
p53 B-Gene +
, O +
pRb B-Gene +
, O +
and O +
p21waf1 B-Gene +
proteins O +
by O +
5-FU O +
treatment O +
in O +
HeLa O +
cervical O +
carcinoma O +
cells O +
. O +

In O +
conclusion O +
, O +
we O +
suggest O +
that O +
5 O +
- O +
FU O +
suppresses O +
the O +
growth O +
of O +
cervical O +
cancer O +
cells O +
not O +
only O +
by O +
antiproliferative O +
effect O +
but O +
also O +
antiviral O +
regulation O +
. O +

Our O +
findings O +
may O +
offer O +
new O +
insights O +
into O +
the O +
mechanism O +
of O +
anticancer O +
effect O +
affected O +
by O +
5-FU O +
treatment O +
in O +
cervical O +
cancer O +
cells O +
and O +
its O +
mode O +
of O +
action O +
. O +

Endogenous O +
IL-11 B-Gene +
is O +
pro O +
- O +
inflammatory O +
in O +
acute O +
methylated O +
bovine O +
serum B-Gene +
albumin I-Gene +
/ O +
interleukin-1 B-Gene +
- O +
induced O +
( O +
mBSA B-Gene +
/ O +
IL-1 B-Gene +
) O +
arthritis O +
. O +

OBJECTIVE O +
: O +

To O +
evaluate O +
the O +
role O +
of O +
interleukin-11 B-Gene +
( O +
IL-11 B-Gene +
) O +
in O +
acute O +
mBSA B-Gene +
/ O +
IL-1 B-Gene +
- O +
induced O +
inflammatory O +
arthritis O +
. O +

METHODS O +
: O +

IL-11 B-Gene +
was O +
administered O +
via O +
intra O +
- O +
articular O +
( O +
IA O +
) O +
injection O +
into O +
knee O +
joints O +
of O +
C57BL O -
/ O -
6 O +
mice O +
and O +
joint O +
histology O +
was O +
assessed O +
. O +

The O +
mitogenic O +
response O +
to O +
IL-11 B-Gene +
was O +
measured O +
in O +
wild O +
- O +
type O +
( O +
WT O +
) O +
synovial O +
fibroblasts O +
. O +

IL-1 B-Gene +
was O +
used O +
as O +
a O +
comparator O +
in O +
both O +
the O +
studies O +
. O +

The O +
severity O +
of O +
acute O +
methylated O +
bovine O +
serum O +
albumin O +
( O +
mBSA O +
) O +
/ O +
IL-1 B-Gene +
arthritis O +
was O +
determined O +
in O +
WT O +
and O +
IL-11 B-Gene +
receptor I-Gene +
null O +
( O +
IL-11Ra1 B-Gene +
- O -
/ O -
- O +
) O +
mice O +
. O +

In O +
parallel O +
experiments O +
, O +
a O +
neutralising O +
antibody O +
to O +
IL-11 B-Gene +
was O +
administered O +
to O +
WT O +
mice O +
throughout O +
this O +
model O +
. O +

RESULTS O +
: O +

IA O +
injections O +
of O +
IL-11 B-Gene +
resulted O +
in O +
mild O +
- O +
to O +
- O +
moderate O +
joint O +
inflammation O +
which O +
was O +
less O +
than O +
that O +
due O +
to O +
IA O +
IL-1 B-Gene +
. O +

IL-11 B-Gene +
had O +
a O +
dose O +
- O +
dependent O +
mitogenic O +
effect O +
on O +
WT O +
synovial O +
fibroblasts O +
( O +
P O +
< O +
0.01 O +
) O +
. O +

mBSA O +
/ O +
IL-1 B-Gene +
acute O +
arthritis O +
was O +
reduced O +
in O +
IL-11Ra1 B-Gene +
- O -
/ O -
- O +
versus O +
WT O +
mice O +
( O +
histological O +
arthritis O +
score O +
: O +
10.1 O +
+ O -
/- O +
0.5 O +
versus O +
12.8 O +
+ O -
/- O +
0.7 O +
, O +
respectively O +
; O +
P O +
= O +
0.01 O +
) O +
. O +

Administration O +
of O +
an O +
IL-11 B-Gene +
neutralising O +
antibody O +
to O +
WT O +
mice O +
reduced O +
mBSA B-Gene +
/ O +
IL-1 B-Gene +
acute O +
arthritis O +
scores O +
compared O +
to O +
control O +
antibody O +
( O +
10.6 O +
+ O -
/- O +
0.7 O +
versus O +
13.3 O +
+ O -
/- O +
0.6 O +
, O +
respectively O +
; O +
P O +
= O +
0.02 O +
) O +
. O +

CONCLUSIONS O +
: O +

These O +
data O +
demonstrate O +
that O +
endogenous O +
IL-11 B-Gene +
exerts O +
relatively O +
mild O +
but O +
consistent O +
pro O +
- O +
inflammatory O +
effects O +
in O +
acute O +
inflammatory O +
arthritis O +
. O +

Transforming B-Gene +
growth I-Gene +
factor I-Gene +
( I-Gene +
TGF I-Gene +
) I-Gene +
- I-Gene +
beta I-Gene +
in O +
conjunction O +
with O +
H B-Gene -
- I-Gene -
ras I-Gene +
activation O +
promotes O +
malignant O +
progression O +
of O +
MCF10A O +
breast O +
epithelial O +
cells O +
. O +

To O +
address O +
how O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
( I-Gene +
TGF I-Gene +
) I-Gene +
- I-Gene +
beta I-Gene +
and O +
oncogenic O +
H B-Gene -
- I-Gene -
ras I-Gene +
signal O +
transduction O +
pathways O +
interact O +
with O +
each O +
other O +
in O +
the O +
malignant O +
progression O +
of O +
breast O +
epithelial O +
cells O +
, O +
we O +
investigated O +
the O +
role O +
of O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
signaling O +
pathway O +
in O +
invasive O +
and O +
migrative O +
properties O +
of O +
H B-Gene -
- I-Gene -
ras I-Gene +
- O +
transformed O +
MCF10A O +
human O +
breast O +
epithelial O +
cells O +
in O +
this O +
study O +
. O +

Here O +
we O +
show O +
that O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
treatment O +
significantly O +
enhanced O +
invasion O +
and O +
migration O +
of O +
H B-Gene -
- I-Gene -
ras I-Gene +
MCF10A O +
cells O +
. O +

H B-Gene -
- I-Gene -
ras I-Gene +
- O +
mediated O +
activation O +
of O +
p38 B-Gene +
MAPK I-Gene +
and O +
ERK-1 B-Gene +
/ I-Gene +
2 I-Gene +
was O +
stimulated O +
by O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
. O +

TGF B-Gene -
- I-Gene -
beta I-Gene +
increased O +
expression O +
of O +
matrix B-Gene +
metalloproteinase I-Gene +
( I-Gene +
MMP I-Gene +
) I-Gene +
- I-Gene +
2 I-Gene +
through O +
transcriptional O +
activation O +
while O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
- O +
stimulated O +
MMP-9 B-Gene +
up O +
- O +
regulation O +
did O +
not O +
occur O +
at O +
transcription O +
level O +
. O +

Activation O +
of O +
p38 B-Gene +
MAPK I-Gene +
pathway O +
was O +
required O +
for O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
- O +
induced O +
cell O +
migration O +
, O +
invasion O +
and O +
MMP-2 B-Gene +
/ I-Gene +
- I-Gene +
9 I-Gene +
up O +
- O +
regulation O +
, O +
indicating O +
a O +
critical O +
role O +
of O +
p38 B-Gene +
MAPK I-Gene +
signaling O +
in O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
- O +
promoted O +
tumor O +
progression O +
of O +
H B-Gene -
- I-Gene -
ras I-Gene +
- O +
activated O +
cells O +
. O +

ERKs B-Gene +
signaling O +
was O +
also O +
crucial O +
for O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
- O +
enhanced O +
invasive O +
and O +
migrative O +
phenotypes O +
but O +
the O +
up O +
- O +
regulation O +
of O +
MMP-2 B-Gene +
/ I-Gene +
- I-Gene +
9 I-Gene +
was O +
not O +
dependent O +
on O +
ERKs B-Gene +
activity O +
. O +

Taken O +
together O +
, O +
we O +
show O +
that O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
promotes O +
H B-Gene -
- I-Gene -
ras I-Gene +
- O +
mediated O +
cell O +
migration O +
and O +
invasive O +
phenotypes O +
in O +
which O +
p38 B-Gene +
MAPK I-Gene +
and O +
ERKs B-Gene +
signaling O +
pathways O +
are O +
involved O +
. O +

Our O +
findings O +
revealing O +
how O +
H B-Gene -
- I-Gene -
ras I-Gene +
and O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
signal O +
pathways O +
interact O +
with O +
each O +
other O +
in O +
MCF10A O +
human O +
breast O +
cells O +
may O +
provide O +
an O +
insight O +
into O +
molecular O +
mechanisms O +
for O +
contribution O +
of O +
TGF B-Gene -
- I-Gene -
beta I-Gene +
to O +
a O +
malignant O +
progression O +
of O +
breast O +
cancer O +
in O +
collaboration O +
with O +
activated O +
H B-Gene -
- I-Gene -
ras I-Gene +
. O +

Genetic O +
diversity O +
among O +
A O +
- O +
proteins O +
of O +
atypical O +
strains O +
of O +
Aeromonas O +
salmonicida O +
. O +

The O +
virulence B-Gene +
array I-Gene +
protein I-Gene +
gene I-Gene +
A I-Gene +
( O +
vapA B-Gene +
) O +
encoding O +
the O +
A O +
- O +
protein O +
subunit O +
of O +
the O +
surface O +
layer O +
of O +
23 O +
typical O +
and O +
atypical O +
strains O +
of O +
Aeromonas O +
salmonicida O +
from O +
salmonids O +
and O +
marine O +
fish O +
species O +
were O +
sequenced O +
, O +
and O +
the O +
deduced O +
A O +
- O +
protein O +
sequences O +
compared O +
. O +

The O +
A O +
- O +
proteins O +
of O +
the O +
typical O +
A. O +
salmonicida O +
ssp O -
. O +
salmonicida O +
strains O +
were O +
shown O +
to O +
be O +
identical O +
, O +
while O +
amino O +
acid O +
variability O +
was O +
revealed O +
among O +
A O +
- O +
proteins O +
of O +
atypical O +
strains O +
. O +

The O +
highest O +
amino O +
acid O +
variability O +
appears O +
to O +
be O +
in O +
a O +
predicted O +
surface O +
exposed O +
region O +
and O +
is O +
believed O +
to O +
result O +
in O +
antigenic O +
differences O +
among O +
the O +
atypical O +
strains O +
of O +
A. O +
salmonicida O +
. O +

Escherichia O +
coli O +
dihydroxyacetone B-Gene +
kinase I-Gene +
controls O +
gene O +
expression O +
by O +
binding O +
to O +
transcription B-Gene +
factor I-Gene +
DhaR B-Gene +
. O +

Dihydroxyacetone B-Gene +
( I-Gene +
Dha I-Gene +
) I-Gene +
kinases I-Gene +
are O +
a O +
sequence O +
- O +
conserved O +
family O +
of O +
enzymes O +
, O +
which O +
utilize O +
either O +
ATP O +
( O +
in O +
animals O +
, O +
plants O +
, O +
bacteria O +
) O +
or O +
the O +
bacterial O +
phosphoenolpyruvate B-Gene +
carbohydrate I-Gene +
phosphotransferase I-Gene +
system O +
( O +
PTS B-Gene +
) O +
as O +
a O +
source O +
of O +
high O +
- O +
energy O +
phosphate O +
. O +

The O +
PTS B-Gene +
- I-Gene +
dependent I-Gene +
kinase I-Gene +
of O +
Escherichia O +
coli O +
consists O +
of O +
three O +
subunits O +
: O +
DhaK B-Gene +
contains O +
the O +
Dha O +
binding O +
site O +
, O +
DhaL B-Gene +
contains O +
ADP O +
as O +
cofactor O +
for O +
the O +
double O +
displacement O +
of O +
phosphate O +
from O +
DhaM B-Gene +
to O +
Dha O +
, O +
and O +
DhaM B-Gene +
provides O +
a O +
phospho O +
- O +
histidine O +
relay O +
between O +
the O +
PTS B-Gene +
and O +
DhaL B-Gene +
: O +
: O +
ADP O +
. O +

DhaR B-Gene +
is O +
a O +
transcription O +
activator O +
belonging O +
to O +
the O +
AAA B-Gene +
+ I-Gene +
family I-Gene +
of O +
enhancer O +
binding O +
proteins O +
. O +

It O +
stimulates O +
transcription O +
of O +
the O +
dhaKLM B-Gene +
operon I-Gene +
from O +
a O +
sigma70 B-Gene +
promoter O +
and O +
autorepresses O +
dhaR B-Gene +
transcription O +
. O +

Genetic O +
and O +
biochemical O +
studies O +
indicate O +
that O +
the O +
enzyme O +
subunits O +
DhaL B-Gene +
and O +
DhaK B-Gene +
act O +
antagonistically O +
as O +
coactivator O +
and O +
corepressor O +
of O +
the O +
transcription O +
activator O +
by O +
mutually O +
exclusive O +
binding O +
to O +
the O +
sensing O +
domain O +
of O +
DhaR B-Gene +
. O +

In O +
the O +
presence O +
of O +
Dha O +
, O +
DhaL B-Gene +
is O +
dephosphorylated O +
and O +
DhaL B-Gene +
: O +
: O +
ADP O +
displaces O +
DhaK B-Gene +
and O +
stimulates O +
DhaR B-Gene +
activity O +
. O +

In O +
the O +
absence O +
of O +
Dha O +
, O +
DhaL B-Gene +
: O +
: O +
ADP O +
is O +
converted O +
by O +
the O +
PTS B-Gene +
to O +
DhaL B-Gene +
: O +
: O +
ATP O +
, O +
which O +
does O +
not O +
bind O +
to O +
DhaR B-Gene +
. O +

Introns O +
in O +
the O +
cytolethal B-Gene +
distending I-Gene +
toxin I-Gene +
gene O +
of O +
Actinobacillus O +
actinomycetemcomitans O +
. O +

In O +
eukaryotic O +
cells O +
, O +
genes O +
are O +
interrupted O +
by O +
intervening O +
sequences O +
called O +
introns O +
. O +

Introns O +
are O +
transcribed O +
as O +
part O +
of O +
a O +
precursor O +
RNA O +
that O +
is O +
subsequently O +
removed O +
by O +
splicing O +
, O +
giving O +
rise O +
to O +
mature O +
mRNA O +
. O +

However O +
, O +
introns O +
are O +
rarely O +
found O +
in O +
bacteria O +
. O +

Actinobacillus O +
actinomycetemcomitans O +
is O +
a O +
periodontal O +
pathogen O +
implicated O +
in O +
aggressive O +
forms O +
of O +
periodontal O +
disease O +
. O +

This O +
organism O +
has O +
been O +
shown O +
to O +
produce O +
cytolethal B-Gene +
distending I-Gene +
toxin I-Gene +
( O +
CDT B-Gene +
) O +
, O +
which O +
causes O +
sensitive O +
eukaryotic O +
cells O +
to O +
become O +
irreversibly O +
blocked O +
at O +
the O +
G2 O +
/ O +
M O +
phase O +
of O +
the O +
cell O +
cycle O +
. O +

In O +
this O +
study O +
, O +
we O +
report O +
the O +
presence O +
of O +
introns O +
within O +
the O +
cdt B-Gene +
gene O +
of O +
A. O +
actinomycetemcomitans O +
. O +

By O +
use O +
of O +
reverse O +
transcription O +
- O +
PCR O +
, O +
cdt B-Gene +
transcripts O +
of O +
2.123 O +
, O +
1.572 O +
, O +
and O +
0.882 O +
kb O +
( O +
RTA1 B-Gene +
, O +
RTA2 B-Gene +
, O +
and O +
RTA3 B-Gene +
, O +
respectively O +
) O +
were O +
detected O +
. O +

In O +
contrast O +
, O +
a O +
single O +
2.123 O +
- O +
kb O +
amplicon O +
was O +
obtained O +
by O +
PCR O +
with O +
the O +
genomic O +
DNA O +
. O +

Similar O +
results O +
were O +
obtained O +
when O +
a O +
plasmid O +
carrying O +
cdt B-Gene +
was O +
cloned O +
into O +
Escherichia O +
coli O +
. O +

Sequence O +
analysis O +
of O +
RTA1 B-Gene +
, O +
RTA2 B-Gene +
, O +
and O +
RTA3 B-Gene +
revealed O +
that O +
RTA1 B-Gene +
had O +
undergone O +
splicing O +
, O +
giving O +
rise O +
to O +
RTA2 B-Gene +
and O +
RTA3 B-Gene +
. O +

Two O +
exon O +
- O +
intron O +
boundaries O +
, O +
or O +
splice O +
sites O +
, O +
were O +
identified O +
at O +
positions O +
863 O +
to O +
868 O +
and O +
1553 O +
to O +
1558 O +
of O +
RTA1 B-Gene +
. O +

Site O +
- O +
directed O +
and O +
deletion O +
mutation O +
studies O +
of O +
the O +
splice O +
site O +
sequence O +
indicated O +
that O +
sequence O +
conservation O +
was O +
important O +
in O +
order O +
for O +
accurate O +
splicing O +
to O +
occur O +
. O +

The O +
catalytic O +
region O +
of O +
the O +
cdt B-Gene +
RNA O +
was O +
located O +
within O +
the O +
cdtC B-Gene +
gene O +
. O +

This O +
0.56 O +
- O +
kb O +
RNA O +
behaved O +
independently O +
as O +
a O +
catalytically O +
active O +
RNA O +
molecule O +
( O +
a O +
ribozyme O +
) O +
in O +
vitro O +
, O +
capable O +
of O +
splicing O +
heterologous O +
RNA O +
in O +
both O +
cis O +
and O +
trans O +
configurations O +
. O +

Implication O +
of O +
membrane O +
localization O +
of O +
target O +
mRNA O +
in O +
the O +
action O +
of O +
a O +
small O +
RNA O +
: O +
mechanism O +
of O +
post O +
- O +
transcriptional O +
regulation O +
of O +
glucose B-Gene +
transporter I-Gene +
in O +
Escherichia O +
coli O +
. O +

Accumulation O +
of O +
phosphosugars O +
such O +
as O +
glucose-6-phosphate O +
causes O +
a O +
rapid O +
degradation O +
of O +
ptsG B-Gene +
mRNA O +
encoding O +
the O +
major O +
glucose B-Gene +
transporter I-Gene +
IICB I-Gene -
( I-Gene -
Glc I-Gene -
) I-Gene +
in O +
an O +
RNase B-Gene +
E I-Gene +
/ O +
degradosome O +
- O +
dependent O +
manner O +
. O +

The O +
destabilization O +
of O +
ptsG B-Gene +
mRNA O +
is O +
caused O +
by O +
a O +
small O +
antisense O +
RNA O +
( O +
SgrS O +
) O +
that O +
is O +
induced O +
by O +
phosphosugar O +
stress O +
. O +

In O +
this O +
study O +
, O +
we O +
analyzed O +
a O +
series O +
of O +
ptsG B-Gene +
- O +
crp B-Gene +
translational O +
fusions O +
to O +
identify O +
the O +
mRNA O +
region O +
required O +
for O +
the O +
rapid O +
degradation O +
of O +
ptsG B-Gene +
mRNA O +
. O +

We O +
found O +
that O +
the O +
ptsG B-Gene +
- O +
crp B-Gene +
mRNA O +
is O +
destabilized O +
in O +
response O +
to O +
phosphosugar O +
stress O +
when O +
it O +
contains O +
the O +
5 O -
' O +
portion O +
of O +
ptsG B-Gene +
mRNA O +
corresponding O +
up O +
to O +
the O +
first O +
two O +
transmembrane O +
domains O +
( O +
TM1 O +
and O +
TM2 O +
) O +
of O +
IICB B-Gene +
( I-Gene +
Glc I-Gene +
) I-Gene +
. O +

The O +
destabilization O +
of O +
ptsG B-Gene +
- O +
crp B-Gene +
mRNA O +
was O +
largely O +
eliminated O +
by O +
frameshift O +
mutations O +
in O +
the O +
transmembrane O +
region O +
. O +

The O +
IICB B-Gene +
( I-Gene +
Glc I-Gene +
) I-Gene +
- O +
CRP B-Gene +
fusion O +
proteins O +
containing O +
more O +
than O +
two O +
transmembrane O +
domains O +
were O +
localized O +
at O +
the O +
membrane O +
. O +

The O +
efficient O +
destabilization O +
of O +
ptsG B-Gene +
- O +
crp B-Gene +
mRNA O +
was O +
restored O +
when O +
TM1 O +
and O +
TM2 O +
of O +
IICB B-Gene -
( I-Gene -
Glc I-Gene -
) I-Gene +
were O +
replaced O +
by O +
part O +
of O +
the O +
LacY B-Gene +
transmembrane O +
region O +
. O +

We O +
conclude O +
that O +
the O +
membrane O +
- O +
targeting O +
property O +
of O +
IICB B-Gene +
( I-Gene +
Glc I-Gene +
) I-Gene +
protein O +
rather O +
than O +
the O +
particular O +
nucleotide O +
or O +
amino O +
acid O +
sequence O +
is O +
required O +
for O +
the O +
efficient O +
degradation O +
of O +
ptsG B-Gene +
mRNA O +
in O +
response O +
to O +
metabolic O +
stress O +
. O +

The O +
stimulation O +
of O +
ptsG B-Gene +
- O +
crp B-Gene +
mRNA O +
degradation O +
was O +
completely O +
eliminated O +
when O +
either O +
the O +
hfq B-Gene +
or O +
sgrS O +
gene O +
is O +
inactivated O +
. O +

The O +
efficient O +
mRNA O +
destabilization O +
was O +
observed O +
in O +
the O +
absence O +
of O +
membrane O +
localization O +
when O +
translation O +
was O +
reduced O +
by O +
introducing O +
a O +
mutation O +
in O +
the O +
ribosome O +
- O +
binding O +
site O +
in O +
the O +
cytoplasmic O +
ptsG B-Gene +
- O +
crp B-Gene +
mRNA O +
. O +

Taken O +
together O +
, O +
we O +
conclude O +
that O +
mRNA O +
localization O +
to O +
the O +
inner O +
membrane O +
coupled O +
with O +
the O +
membrane O +
insertion O +
of O +
nascent O +
peptide O +
mediates O +
the O +
Hfq B-Gene +
/ O +
SgrS O +
- O +
dependent O +
ptsG B-Gene +
mRNA O +
destabilization O +
presumably O +
by O +
reducing O +
second O +
rounds O +
of O +
translation O +
. O +

Heme O +
oxygenase-1 O +
alleviates O +
ischemia O +
/ O +
reperfusion O +
injury O +
in O +
aged O +
liver O +
. O +

AIM O +
: O +

To O +
investigate O +
if O +
ischemia O +
/ O +
reperfusion O +
( O +
I O +
/ O +
R O +
) O +
injury O +
in O +
aged O +
liver O +
could O +
be O +
alleviated O +
by O +
heme B-Gene +
oxygenase-1 I-Gene +
( O +
HO-1 B-Gene +
) O +
. O +

METHODS O +
: O +

Three O +
groups O +
of O +
SD O +
rats O +
( O +
16 O +
mo O +
old O +
) O +
were O +
studied O +
. O +

Group O +
1 O +
: O +
control O +
donors O +
received O +
physiological O +
saline O +
24 O +
h O +
before O +
their O +
livers O +
were O +
harvested O +
; O +
group O +
2 O +
: O +
donors O +
were O +
pretreated O +
with O +
hemin O +
24 O +
h O +
before O +
their O +
livers O +
were O +
harvested O +
; O +
and O +
group O +
3 O +
: O +
donors O +
received O +
hemin O +
24 O +
h O +
before O +
their O +
livers O +
were O +
harvested O +
and O +
zinc O +
protoporphyrin O +
( O +
ZnPP O +
, O +
HO B-Gene +
- I-Gene +
1 I-Gene +
inhibitor O +
) O +
was O +
given O +
to O +
recipients O +
at O +
reperfusion O +
. O +

The O +
harvested O +
livers O +
were O +
stored O +
in O +
University O +
of O +
Wisconsin O +
solution O +
( O +
4 O +
degrees O +
) O +
for O +
6 O +
h O +
, O +
and O +
then O +
transplanted O +
to O +
syngeneic O +
rats O +
. O +

Serum O +
glutamic B-Gene +
oxaloacetic I-Gene +
transaminase I-Gene +
( O +
SGOT O +
) O +
, O +
apoptotic O +
cells O +
, O +
and O +
apoptotic O +
gene O +
were O +
measured O +
3 O +
, O +
6 O +
, O +
12 O +
, O +
24 O +
, O +
48 O +
h O +
after O +
reperfusion O +
. O +

We O +
measured O +
the O +
apoptotic O +
index O +
by O +
TUNEL O +
, O +
determined O +
the O +
expression O +
of O +
antiapoptotic O +
Bcl-2 B-Gene +
and O +
proapoptotic O +
( O +
caspase B-Gene +
- I-Gene +
3 I-Gene +
) O +
gene O +
products O +
by O +
Western O +
blot O +
. O +

RESULTS O +
: O +

After O +
3 O +
, O +
6 O +
, O +
12 O +
, O +
24 O +
, O +
and O +
48 O +
h O +
of O +
reperfusion O +
, O +
the O +
SGOT O +
levels O +
( O +
584.4 O +
+ O +
/ O +
- O +
85.8 O +
u O +
/ O +
L O +
, O +
999.2 O +
+ O +
/ O +
- O +
125.2 O +
u O +
/ O +
L O +
, O +
423.4 O +
+ O +
/ O +
- O +
161.3 O +
u O +
/ O +
L O +
, O +
257.8 O +
+ O +
/ O +
- O +
95.8 O +
u O +
/ O +
L O +
, O +
and O +
122.4 O +
+ O -
/- O +
26.4 O +
u O -
/ O -
L O +
) O +
in O +
hemin O +
group O +
were O +
significantly O +
( O +
all O +
P O +
< O +
0.05 O +
) O +
lower O +
than O +
those O +
in O +
saline O +
group O +
( O +
1082.2 O +
+ O +
/ O +
- O +
101.2 O +
u O +
/ O +
L O +
, O +
1775.2 O +
+ O +
/ O +
- O +
328.3 O +
u O +
/ O +
L O +
, O +
840.4 O +
+ O +
/ O +
- O +
137.8 O +
u O +
/ O +
L O +
, O +
448.6 O +
+ O +
/ O +
- O +
74.3 O +
u O +
/ O +
L O +
, O +
and O +
306.2 O +
+ O +
/ O +
- O +
49.3 O +
u O +
/ O +
L O +
) O +
. O +

Liver O +
HO-1 B-Gene +
enzymatic O +
activity O +
correlated O +
with O +
beneficial O +
effects O +
of O +
hemin O +
and O +
deleterious O +
effects O +
of O +
adjunctive O +
ZnPP O +
treatment O +
. O +

Markedly O +
less O +
apoptotic O +
( O +
TUNEL O +
+ O +
) O +
liver O +
cells O +
3 O +
, O +
6 O +
, O +
12 O +
, O +
24 O +
, O +
and O +
48 O +
h O +
after O +
reperfusion O +
( O +
5.16 O +
+ O +
/ O +
- O +
0.73 O +
, O +
10.2 O +
+ O +
/ O +
- O +
0.67 O +
, O +
9.28 O +
+ O +
/ O +
- O +
0.78 O +
, O +
7.14 O +
+ O +
/ O +
- O +
1.12 O +
, O +
and O +
4.78 O +
+ O +
/ O +
- O +
0.65 O +
) O +
( O +
P O +
< O +
0.05 O +
) O +
could O +
be O +
detected O +
in O +
hemin O +
liver O +
grafts O -
, O -
as O +
compared O +
to O +
controls O +
( O +
7.82 O +
+ O +
/ O +
- O +
1.05 O +
, O +
15.94 O +
+ O +
/ O +
- O +
1.82 O +
, O +
11.67 O +
+ O +
/ O +
- O +
1.59 O +
, O +
8.28 O +
+ O +
/ O +
- O +
1.09 O +
, O +
and O +
6.36 O +
+ O +
/ O +
- O +
0.67 O +
) O +
. O +

We O +
detected O +
the O +
increased O +
levels O +
of O +
Bcl-2 B-Gene +
( O +
1.5 O +
- O +
fold O +
) O +
expression O +
and O +
compared O +
with O +
saline O +
controls O +
. O +

These O +
differences O +
were O +
most O +
pronounced O +
at O +
12 O +
h O +
after O +
transplantation O +
. O +

In O +
contrast O +
, O +
an O +
active O +
form O +
of O +
proapoptotic O +
caspase B-Gene +
- I-Gene +
3 I-Gene +
( O +
p20 B-Gene +
) O +
protein O +
was O +
found O +
to O +
be O +
2.9 O +
- O +
fold O +
lower O +
at O +
24 O +
h O +
in O +
hemin O +
- O +
pretreated O +
group O +
, O +
as O +
compared O +
to O +
saline O +
liver O +
transplant O +
controls O +
. O +

CONCLUSION O +
: O +

HO-1 B-Gene +
overexpression O +
can O +
provide O +
potent O +
protection O +
against O +
cold O +
I O +
/ O +
R O +
injury O +
. O +

This O +
effect O +
depends O +
, O +
at O +
least O +
in O +
part O +
, O +
on O +
HO-1 B-Gene +
- O +
mediated O +
inhibition O +
of O +
antiapoptotic O +
mechanism O +
. O +

The O +
effect O +
of O +
over O +
- O +
expression O +
of O +
the O +
alternative B-Gene +
oxidase I-Gene +
in O +
the O +
procyclic O +
forms O +
of O +
Trypanosoma O +
brucei O +
. O +

Trypanosome O +
alternative B-Gene +
oxidase I-Gene +
( O +
TAO B-Gene +
) O +
is O +
the O +
cyanide O +
- O +
resistant O +
but O +
SHAM B-Gene +
- I-Gene +
sensitive I-Gene +
terminal I-Gene +
oxidase I-Gene +
of O +
the O +
mitochondrial O +
electron O +
transport O +
chain O +
in O +
African O +
trypanosomes O +
. O +

The O +
bloodstream O +
forms O +
of O +
Trypanosoma O +
brucei O +
lack O +
cytochromes O +
and O +
respire O +
exclusively O +
via O +
TAO B-Gene +
. O +

On O +
the O +
other O +
hand O +
, O +
the O +
insect O +
, O +
or O +
procyclic O +
form O +
possesses O +
a O +
fully O +
developed O +
cytochrome B-Gene +
system O +
, O +
and O +
down O +
regulates O +
TAO B-Gene +
several O +
folds O +
by O +
reducing O +
the O +
stability O +
of O +
the O +
TAO B-Gene +
transcript O +
. O +

We O +
expressed O +
an O +
ectopic O +
copy O +
of O +
TAO B-Gene +
in O +
the O +
procyclic O +
form O +
from O +
a O +
tetracycline O +
regulated O +
stable O +
expression O +
vector O +
, O +
in O +
which O +
the O +
TAO B-Gene +
3 O +
' O +
- O +
UTR O +
was O +
replaced O +
by O +
T. O +
brucei O +
aldolase B-Gene +
3 O +
' O +
- O +
UTR O +
. O +

The O +
TAO B-Gene +
transcript O +
produced O +
from O +
the O +
ectopic O +
copy O +
was O +
stably O +
accumulated O +
in O +
the O +
procyclic O +
form O +
. O +

Upon O +
induction O +
with O +
doxycycline O +
, O +
TAO B-Gene +
protein O +
level O +
was O +
gradually O +
increased O +
about O +
five O +
- O +
fold O +
within O +
72 O +
h O +
. O +

TAO B-Gene +
over O +
- O +
expression O +
did O +
not O +
show O +
any O +
effect O +
on O +
the O +
growth O +
of O +
the O +
parasite O +
. O +

The O +
rate O +
of O +
respiration O +
and O +
the O +
SHAM O +
- O +
sensitive O +
respiratory O +
pathway O +
capacity O +
was O +
increased O +
about O +
two O +
- O +
and O +
five O +
- O +
fold O +
, O +
respectively O +
, O +
and O +
the O +
cytochrome B-Gene +
- O +
mediated O +
respiratory O +
pathway O +
capacity O +
was O +
reduced O +
two O +
- O +
to O +
three O +
- O +
folds O +
within O +
5 O +
days O +
after O +
induction O +
of O +
TAO B-Gene +
. O +

Doxycycline O +
induced O +
TAO B-Gene +
+ O +
cells O +
preferentially O +
utilized O +
CN O +
- O +
resistant O +
, O +
SHAM O +
- O +
sensitive O +
pathway O +
of O +
respiration O +
, O +
whereas O +
, O +
in O +
the O +
control O +
cells O +
70 O +
- O +
80 O +
% O +
of O +
total O +
respiration O +
was O +
via O +
the O +
CN O +
- O +
sensitive O +
pathway O +
. O +

Moreover O +
, O +
we O +
have O +
found O +
that O +
increased O +
expression O +
of O +
TAO B-Gene +
caused O +
about O +
two O +
- O +
fold O +
down O +
regulation O +
of O +
cytochrome B-Gene +
oxidase I-Gene +
subunit I-Gene +
IV I-Gene +
, O +
and O +
cytochrome B-Gene +
c1 I-Gene +
protein O +
level O +
and O +
also O +
caused O +
a O +
four O +
- O +
fold O +
up O +
- O +
regulation O +
of O +
the O +
expression O +
of O +
the O +
surface O +
coat O +
protein O +
, O +
GPEET B-Gene +
procyclin I-Gene +
in O +
the O +
procyclic O +
form O +
. O +

This O +
suggests O +
that O +
the O +
expression O +
of O +
two O +
terminal B-Gene +
oxidases I-Gene +
and O +
the O +
coat B-Gene +
protein I-Gene +
is O +
linked O +
in O +
T. O +
brucei O +
. O +

Differential O +
contribution O +
of O +
the O +
three O +
Aph1 B-Gene +
genes O +
to O +
gamma B-Gene -
- I-Gene -
secretase I-Gene +
activity O +
in O +
vivo O +
. O +

Gamma B-Gene +
- I-Gene +
secretase I-Gene +
is O +
the O +
protease B-Gene +
responsible O +
for O +
amyloid B-Gene +
beta I-Gene +
peptide I-Gene +
release O +
and O +
is O +
needed O +
for O +
Notch B-Gene +
, O +
N B-Gene -
- I-Gene -
Cadherin I-Gene +
, O +
and O +
possibly O +
other O +
signaling O +
pathways O +
. O +

The O +
protease B-Gene +
complex O +
consists O +
of O +
at O +
least O +
four O +
subunits O +
, O +
i.e. O +
, O +
Presenilin B-Gene +
, O +
Aph1 B-Gene +
, O +
Pen2 B-Gene +
, O +
and O +
Nicastrin B-Gene +
. O +

Two O +
different O +
genes O +
encode O +
Aph1A B-Gene +
and O +
Aph1B B-Gene +
in O +
man O +
. O +

A O +
duplication O +
of O +
Aph1B B-Gene +
in O +
rodents O +
has O +
given O +
rise O +
to O +
a O +
third O +
gene O +
, O +
Aph1C B-Gene +
. O +

Different O +
mixes O +
of O +
gamma B-Gene -
- I-Gene -
secretase I-Gene +
subunits O +
assemble O +
in O +
at O +
least O +
four O +
human O +
and O +
six O +
rodent O +
complexes O +
but O +
it O +
is O +
not O +
known O +
whether O +
they O +
have O +
different O +
activities O +
in O +
vivo O +
. O +

We O +
report O +
here O +
the O +
inactivation O +
of O +
the O +
three O +
Aph1 B-Gene +
genes O +
in O +
mice O +
. O +

Aph1A B-Gene +
- O +
/ O +
- O +
embryos O +
show O +
a O +
lethal O +
phenotype O +
characterized O +
by O +
angiogenesis O +
defects O +
in O +
the O +
yolk O +
sac O +
, O +
neuronal O +
tube O +
malformations O +
, O +
and O +
mild O +
somitogenesis O +
defects O +
. O +

Aph1B B-Gene +
- O +
/ O +
- O +
or O +
C O +
- O +
/ O +
- O +
or O +
the O +
combined O +
Aph1BC B-Gene +
- O +
/ O +
- O +
mice O +
( O +
which O +
can O +
be O +
considered O +
as O +
a O +
model O +
for O +
total O +
Aph1B B-Gene +
loss O +
in O +
human O +
) O +
survive O +
into O +
adulthood O +
. O +

However O +
, O +
Aph1BC B-Gene +
- O +
/ O +
- O +
deficiency O +
causes O +
a O +
mild O +
but O +
significant O +
reduction O +
in O +
amyloid B-Gene +
beta I-Gene +
percursor I-Gene +
protein O +
processing O +
in O +
selective O +
regions O +
of O +
the O +
adult O +
brain O +
. O +

We O +
conclude O +
that O +
the O +
biochemical O +
and O +
physiological O +
repercussions O +
of O +
genetically O +
reducing O +
gamma B-Gene -
- I-Gene -
secretase I-Gene +
activity O +
via O +
the O +
different O +
Aph1 B-Gene +
components O +
are O +
quite O +
divergent O +
and O +
tissue O +
specific O +
. O +

Our O +
work O +
provides O +
in O +
vivo O +
evidence O +
for O +
the O +
concept O +
that O +
different O +
gamma B-Gene +
- I-Gene +
secretase I-Gene +
complexes I-Gene +
may O +
exert O +
different O +
biological O +
functions O +
. O +

In O +
the O +
context O +
of O +
Alzheimer O +
's O +
disease O +
therapy O +
, O +
this O +
implies O +
the O +
theoretical O +
possibility O +
that O +
targeting O +
specific O +
gamma B-Gene +
- I-Gene +
secretase I-Gene +
subunit O +
combinations O +
could O +
yield O +
less O +
toxic O +
drugs O +
than O +
the O +
currently O +
available O +
general O +
inhibitors O +
of O +
gamma B-Gene -
- I-Gene -
secretase I-Gene +
activity O +
. O +

An O +
essential O +
role O +
for O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
in O +
the O +
overexpression O +
of O +
Fas B-Gene +
ligand I-Gene +
on O +
MRL O +
/ O +
lpr O +
lymphocytes O +
and O +
on O +
their O +
spontaneous O +
Fas B-Gene +
- O +
mediated O +
cytotoxic O +
potential O +
. O +

Lymphocytes O +
from O +
aged O +
autoimmune O +
MRL O +
/ O +
lpr O +
mice O +
overexpress O +
Fas B-Gene +
ligand I-Gene +
( O +
FasL B-Gene +
) O +
, O +
and O +
are O +
cytotoxic O +
against O +
Fas B-Gene +
+ O +
target O +
cells O +
. O +

This O +
cytotoxic O +
potential O +
is O +
only O +
partly O +
due O +
to O +
FasL B-Gene +
, O +
as O +
wild O +
- O +
type O +
MRL O +
+ O -
/+ O +
lymphocytes O +
are O +
not O +
able O +
to O +
kill O +
Fas B-Gene +
+ O +
targets O +
after O +
induction O +
of O +
FasL B-Gene +
. O +

In O +
addition O +
, O +
serum O +
levels O +
of O +
interferon B-Gene -
- I-Gene -
alpha I-Gene +
( O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
) O +
increase O +
in O +
parallel O +
with O +
the O +
Fas B-Gene +
- O +
dependent O +
cytotoxic O +
potential O +
of O +
lymphocytes O +
from O +
MRL O +
/ O +
lpr O +
mice O +
as O +
they O +
age O +
. O +

To O +
understand O +
the O +
mechanisms O +
underlying O +
these O +
observations O +
, O +
combined O +
suppression O +
subtractive O +
hybridization O +
( O +
SSH O +
) O +
and O +
RT O +
- O +
PCR O +
were O +
used O +
to O +
study O +
differential O +
gene O +
expression O +
in O +
splenocytes O +
from O +
MRL O +
/ O +
lpr O +
mice O +
compared O +
with O +
splenocytes O +
from O +
MRL O +
+ O -
/+ O +
mice O +
. O +

Twenty O -
- O -
two O +
genes O +
were O +
upregulated O +
transcriptionally O +
in O +
MRL O +
/ O +
lpr O +
splenocytes O +
compared O +
with O +
their O +
MRL O +
+ O -
/+ O +
counterparts O +
. O +

Furthermore O +
, O +
9 O +
of O +
these O +
genes O +
were O +
also O +
upregulated O +
after O +
treatment O +
of O +
MRL O +
/ O +
lpr O +
splenocytes O +
with O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
, O +
and O +
4 O +
were O +
strongly O +
downregulated O +
. O +

MRL O +
/ O +
lpr O +
lymphocytes O +
were O +
also O +
found O +
to O +
be O +
hyperresponsive O +
to O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
. O +

Thus O +
, O +
MRL O +
/ O +
lpr O +
lymphocytes O +
overexpressed O +
mRNA O +
for O +
the O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
receptor I-Gene +
( O +
IFNAR-1 B-Gene +
and O +
IFNAR-2 B-Gene +
) O +
chains O +
of O +
the O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
/ I-Gene +
beta I-Gene +
receptor I-Gene +
and O +
exhibited O +
high O +
endogenous O +
levels O +
of O +
both O +
Stat1 B-Gene +
and O +
phosphorylated O +
Stat1 B-Gene +
proteins O +
. O +

Lymphocytes O +
from O +
young O +
MRL O +
/ O +
lpr O +
mice O +
, O +
with O +
low O +
Fas B-Gene +
- O +
dependent O +
cytotoxic O +
activity O +
, O +
were O +
found O +
to O +
become O +
highly O +
cytotoxic O +
against O +
Fas B-Gene +
+ O +
targets O +
after O +
treatment O +
with O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
. O +

These O +
data O +
suggest O +
that O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
plays O +
an O +
important O +
role O +
in O +
the O +
physiopathology O +
of O +
the O +
systemic O +
lupus O +
erythematosus O +
( O +
SLE O +
) O +
- O +
like O +
syndrome O +
that O +
occurs O +
in O +
MRL O +
/ O +
lpr O +
mice O +
. O +

Bacillus O +
subtilis O +
early O +
sporulation O +
genes O +
kinA B-Gene +
, O +
spo0F B-Gene +
, O +
and O +
spo0A B-Gene +
are O +
transcribed O +
by O +
the O +
RNA B-Gene +
polymerase I-Gene +
containing O +
sigma B-Gene +
H I-Gene +
. O +

The O +
Bacillus O +
subtilis O +
genes O +
kinA B-Gene +
( O +
spoIIJ B-Gene +
) O +
, O +
spo0F B-Gene +
, O +
and O +
spo0A B-Gene +
encode O +
components O +
of O +
the O +
sporulation O +
signal O +
transduction O +
pathway O +
. O +

Recent O +
work O +
has O +
suggested O +
that O +
these O +
genes O +
are O +
transcribed O +
by O +
a O +
minor O +
form O +
of O +
RNA B-Gene +
polymerase I-Gene +
, O +
E B-Gene +
sigma I-Gene +
H I-Gene +
( O +
sigma B-Gene +
H I-Gene +
is O +
the O +
product O +
of O +
spo0H B-Gene +
, O +
another O +
early O +
sporulation O +
gene O +
) O +
. O +

We O +
directly O +
tested O +
this O +
hypothesis O +
by O +
performing O +
in O +
vitro O +
transcription O +
assays O +
with O +
reconstituted O +
E B-Gene +
sigma I-Gene +
H I-Gene +
and O +
a O +
set O +
of O +
plasmids O +
containing O +
the O +
kinA B-Gene +
, O +
spo0F B-Gene +
, O +
and O +
spo0A B-Gene +
promoter O +
regions O +
. O +

We O +
were O +
able O +
to O +
obtain O +
distinct O +
transcripts O +
of O +
the O +
expected O +
sizes O +
with O +
all O +
three O +
genes O +
by O +
using O +
linearized O +
or O +
supercoiled O +
templates O +
. O +

Furthermore O +
, O +
primer O +
extension O +
experiments O +
indicate O +
that O +
the O +
transcription O +
start O +
sites O +
for O +
the O +
three O +
genes O +
in O +
vitro O +
and O +
in O +
vivo O +
are O +
the O +
same O +
. O +

In O +
addition O +
, O +
we O +
measured O +
steady O +
- O +
state O +
levels O +
of O +
kinA B-Gene +
, O +
spo0F B-Gene +
, O +
and O +
spo0A B-Gene +
mRNAs O +
during O +
growth O +
in O +
sporulation O +
medium O +
; O +
all O +
of O +
them O +
were O +
increased O +
at O +
or O +
near O +
the O +
beginning O +
of O +
the O +
stationary O +
phase O +
. O +

Dna O +
probes O +
for O +
identification O +
of O +
leptospires O +
and O +
disease O +
diagnosis O +
. O +

A O +
newly O +
identified O +
1 O +
kb O +
DNA O +
fragment O +
amplified O +
by O +
PCR O +
using O +
( O +
AG O +
) O +
8 O -
T O +
inter O +
- O +
simple O +
sequence O +
repeats O +
( O +
ISSR O +
) O +
primer O +
and O +
a O +
631 O +
bp O +
segment O +
of O +
16S O +
rRNA O +
ribosomal O +
gene O +
amplified O +
by O +
PCR O +
using O +
reported O +
primers O +
were O +
labeled O +
with O +
a O +
alpha32P O +
dCTP O +
for O +
use O +
as O +
DNA O +
probes O +
. O +

These O +
probes O +
were O +
hybridized O +
with O +
DNA O +
extracted O +
from O +
19 O +
standard O +
pathogenic O +
serovars O +
, O +
3 O +
standard O +
saprophytic O +
serovars O +
, O +
33 O +
pathogenic O +
isolates O +
( O +
12 O +
from O +
patients O +
, O +
1 O +
from O +
a O +
tapwater O +
source O +
, O +
and O +
20 O +
from O +
rodents O +
) O +
, O +
and O +
22 O +
saprophytic O +
isolates O +
from O +
environmental O +
sources O +
. O +

The O +
pathogen O +
- O +
specific O +
16S O +
rRNA O +
DNA O +
probe O +
specifically O +
hybridized O +
all O +
33 O +
standard O +
pathogenic O +
serovars O +
, O +
to O +
13 O +
pathogenic O +
isolates O +
. O +

Similarly O +
, O +
the O +
saprophyte O +
specific O +
1 O +
kb O +
ISSR O +
DNA O +
probe O +
specifically O +
hybridized O +
the O +
3 O +
standard O +
saprophytic O +
serovars O +
and O +
the O +
22 O +
saprophytic O +
Leptospira O +
isolates O +
. O +

The O +
sensitivity O +
of O +
the O +
1 O +
kb O +
labeled O +
saprophytic O +
Leptospira O +
specific O +
DNA O +
probe O +
was O +
1.95 O +
ng O +
, O +
and O +
for O +
the O +
16S O +
rRNA O +
pathogen O +
specific O +
probe O +
3.90 O +
ng O +
. O +

The O +
16S O +
rRNA O +
gene O +
segment O +
DNA O +
probe O +
could O +
also O +
identify O +
the O +
leptospiremic O +
stage O +
in O +
mice O +
or O +
guinea O +
pigs O +
infected O +
experimentally O +
with O +
the O +
pathogenic O +
serovars O +
australis O +
, O +
autumnalis O +
or O +
icterohaemorrhagiae O +
. O +

DNA O +
probes O +
therefore O +
, O +
owing O +
to O +
their O +
high O +
specificity O +
and O +
sensitivity O +
, O +
appear O +
useful O +
for O +
easy O +
, O +
rapid O +
, O +
and O +
reliable O +
differentiation O +
of O +
pathogenic O +
Leptospira O +
strains O +
and O +
also O +
hold O +
promise O +
for O +
direct O +
identification O +
of O +
organisms O +
in O +
blood O +
samples O +
to O +
diagnose O +
leptopsirosis O +
. O +

RNA O +
interference O +
- O +
mediated O +
silencing O +
of O +
X11alpha B-Gene +
and O +
X11beta B-Gene +
attenuates O +
amyloid B-Gene +
beta I-Gene -
- I-Gene -
protein I-Gene +
levels O +
via O +
differential O +
effects O +
on O +
beta B-Gene -
- I-Gene -
amyloid I-Gene +
precursor I-Gene +
protein I-Gene +
processing O +
. O +

Processing O +
of O +
the O +
beta B-Gene -
- I-Gene -
amyloid I-Gene +
precursor I-Gene +
protein I-Gene +
( O +
APP B-Gene +
) O +
plays O +
a O +
key O +
role O +
in O +
Alzheimer O +
disease O +
neuropathogenesis O +
. O +

APP B-Gene +
is O +
cleaved O +
by O +
beta B-Gene +
- I-Gene +
and I-Gene +
alpha I-Gene +
- I-Gene +
secretase I-Gene +
to O +
produce O +
APP B-Gene -
- I-Gene -
C99 I-Gene +
and O +
APP B-Gene -
- I-Gene -
C83 I-Gene +
, O +
which O +
are O +
further O +
cleaved O +
by O +
gamma B-Gene -
- I-Gene -
secretase I-Gene +
to O +
produce O +
amyloid B-Gene +
beta I-Gene -
- I-Gene -
protein I-Gene +
( O +
Abeta B-Gene +
) O +
and O +
p3 O +
, O +
respectively O +
. O +

APP B-Gene +
adaptor O +
proteins O +
with O +
phosphotyrosine O +
- O +
binding O +
domains O +
, O +
including O +
X11alpha B-Gene +
( O +
MINT1 B-Gene +
, O +
encoded O +
by O +
gene O +
APBA1 B-Gene +
) O +
and O +
X11beta B-Gene +
( O +
MINT2 B-Gene +
, O +
encoded O +
by O +
gene O +
APBA2 B-Gene +
) O +
, O +
can O +
bind O +
to O +
the O +
conserved O +
YENPTY O +
motif O +
in O +
the O +
APP B-Gene +
C O +
terminus O +
. O +

Overexpression O +
of O +
X11alpha B-Gene +
and O +
X11beta B-Gene +
alters O +
APP B-Gene +
processing O +
and O +
Abeta B-Gene +
production O +
. O +

Here O +
, O +
for O +
the O +
first O +
time O +
, O +
we O +
have O +
described O +
the O +
effects O +
of O +
RNA O +
interference O +
( O +
RNAi O +
) O +
silencing O +
of O +
X11alpha B-Gene +
and O +
X11beta B-Gene +
expression O +
on O +
APP B-Gene +
processing O +
and O +
Abeta B-Gene +
production O +
. O +

RNAi O +
silencing O +
of O +
APBA1 B-Gene +
in O +
H4 O +
human O +
neuroglioma O +
cells O +
stably O +
transfected O +
to O +
express O +
either O +
full O +
- O +
length O +
APP B-Gene +
or O +
APP B-Gene -
- I-Gene -
C99 I-Gene +
increased O +
APP B-Gene +
C O +
- O +
terminal O +
fragment O +
levels O +
and O +
lowered O +
Abeta B-Gene +
levels O +
in O +
both O +
cell O +
lines O +
by O +
inhibiting O +
gamma B-Gene +
- I-Gene +
secretase I-Gene +
cleavage O +
of O +
APP B-Gene +
. O +

RNAi O +
silencing O +
of O +
APBA2 B-Gene +
also O +
lowered O +
Abeta B-Gene +
levels O +
, O +
but O +
apparently O +
not O +
via O +
attenuation O +
of O +
gamma B-Gene +
- I-Gene +
secretase I-Gene +
cleavage O +
of O +
APP B-Gene +
. O +

The O +
notion O +
of O +
attenuating O +
gamma B-Gene +
- I-Gene +
secretase I-Gene +
cleavage O +
of O +
APP B-Gene +
via O +
the O +
APP B-Gene +
adaptor B-Gene +
protein I-Gene +
X11alpha B-Gene +
is O +
particularly O +
attractive O +
with O +
regard O +
to O +
therapeutic O +
potential O +
given O +
that O +
side O +
effects O +
of O +
gamma B-Gene -
- I-Gene -
secretase I-Gene +
inhibition O +
due O +
to O +
impaired O +
proteolysis O +
of O +
other O +
gamma B-Gene +
- I-Gene +
secretase I-Gene +
substrates O +
, O +
e.g. O +
Notch B-Gene +
, O +
might O +
be O +
avoided O +
. O +

Differential O +
expression O +
of O +
aquaporins B-Gene +
in O +
the O +
kidneys O +
of O +
streptozotocin O +
- O +
induced O +
diabetic O +
mice O +
. O +

BACKGROUND O +
AND O +
AIM O +
: O +

Aquaporins B-Gene +
( O +
AQPs B-Gene +
) O +
are O +
members O +
of O +
the O +
water B-Gene +
channel I-Gene +
family I-Gene +
and O +
are O +
important O +
in O +
renal O +
physiology O +
as O +
it O +
affects O +
urinary O +
concentration O +
. O +

The O +
downregulation O +
of O +
aquaporins B-Gene +
is O +
often O +
observed O +
in O +
polyuria O +
associated O +
with O +
acquired O +
nephrogenic O +
diabetes O +
insipidus O +
. O +

In O +
this O +
study O +
, O +
we O +
examined O +
the O +
expression O +
of O +
AQP1 B-Gene +
, O +
AQP2 B-Gene +
, O +
AQP3 B-Gene +
and O +
AQP4 B-Gene +
in O +
streptozotocin O +
( O +
STZ O +
) O +
- O +
induced O +
diabetic O +
mice O +
. O +

RESULTS O +
: O +

By O +
semiquantitative O +
reverse O +
transcription O +
- O +
polymerase B-Gene +
chain O +
reaction O +
, O +
we O +
detected O +
no O +
change O +
in O +
the O +
gene O +
expression O +
of O +
AQP1 B-Gene +
or O +
AQP4 B-Gene +
in O +
whole O +
kidney O +
among O +
STZ O +
- O +
induced O +
diabetic O +
mice O +
( O +
STZ O +
mice O +
) O +
and O +
sham O +
( O +
control O +
group O +
that O +
received O +
citrate O +
buffer O +
injection O +
only O +
) O +
. O +

In O +
contrast O +
, O +
we O +
found O +
less O +
AQP2 B-Gene +
or O +
AQP3 B-Gene +
mRNA O +
expression O +
in O +
the O +
whole O +
kidney O +
from O +
STZ O +
mice O +
. O +

Immunoblotting O +
studies O +
confirmed O +
no O +
difference O +
in O +
AQP1 B-Gene +
or O +
AQP4 B-Gene +
protein O +
expression O +
of O +
whole O +
kidney O +
between O +
STZ O +
mice O +
and O +
sham O +
. O +

However O +
, O +
there O +
was O +
less O +
AQP2 B-Gene +
or O +
AQP3 B-Gene +
protein O +
expression O +
in O +
the O +
whole O +
kidney O +
from O +
STZ O +
mice O +
as O +
compared O +
to O +
sham O +
. O +

By O +
immunochemical O +
staining O +
, O +
the O +
reduction O +
of O +
AQP2 B-Gene +
protein O +
was O +
localized O +
to O +
the O +
principle O +
cells O +
of O +
the O +
collecting O +
ducts O +
. O +

The O +
expression O +
of O +
cortical O +
AQP3 B-Gene +
( O +
especially O +
the O +
outer O +
cortex O +
, O +
the O +
S1 O +
and O +
S2 O +
segments O +
of O +
the O +
proximal O +
tubules O +
) O +
was O +
downregulated O +
in O +
STZ O +
mice O +
whereas O +
the O +
expression O +
of O +
AQP3 B-Gene +
protein O +
in O +
medullary O +
collecting O +
ducts O +
was O +
similar O +
to O +
that O +
of O +
sham O +
. O +

CONCLUSION O +
: O +

Our O +
results O +
reveal O +
that O +
the O +
water O +
transport O +
in O +
urinary O +
concentration O +
involves O +
the O +
downregulation O +
of O +
AQP2 B-Gene +
and O +
AQP3 B-Gene +
expression O +
in O +
STZ O +
mice O +
. O +

Killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIR B-Gene +
) O +
of O +
the O +
African O +
- O +
origin O +
sabaeus O +
monkey O +
: O +
evidence O +
for O +
recombination O +
events O +
in O +
the O +
evolution O +
of O +
KIR B-Gene +
. O +

Killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
( I-Gene +
Ig I-Gene +
) I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIR B-Gene +
) O +
were O +
characterized O +
in O +
the O +
West O +
African O +
sabaeus O +
monkey O +
( O +
Chlorocebus O +
sabaeus O +
) O +
to O +
elucidate O +
the O +
mechanism O +
by O +
which O +
diversity O +
evolves O +
in O +
this O +
family O +
of O +
molecules O +
. O +

Complementary O +
DNA O +
encoding O +
four O +
forms O +
of O +
KIR B-Gene +
molecules O +
, O +
including O +
KIR3DL B-Gene +
, O +
KIR2DL4 B-Gene +
, O +
KIR2DL5 B-Gene +
, O +
and O +
KIR3DH B-Gene +
forms O +
, O +
were O +
identified O +
in O +
two O +
unrelated O +
sabaeus O +
monkeys O +
. O +

A O +
novel O +
hybrid O +
form O +
showing O +
features O +
found O +
in O +
both O +
KIR2DL5 B-Gene +
and O +
KIR3DH B-Gene +
was O +
also O +
identified O +
. O +

Both O +
the O +
KIR3DL B-Gene +
and O +
KIR3DH B-Gene +
forms O +
from O +
the O +
sabaeus O +
monkey O +
were O +
considerably O +
more O +
polymorphic O +
than O +
any O +
KIR B-Gene +
form O +
identified O +
in O +
great O +
apes O +
or O +
humans O +
. O +

The O +
polymorphic O +
residues O +
of O +
the O +
three O +
Ig B-Gene +
- O +
like O +
domains O +
were O +
frequently O +
located O +
in O +
structural O +
loops O +
, O +
indicating O +
that O +
point O +
mutations O +
have O +
occurred O +
in O +
these O +
regions O +
. O +

The O +
three O +
Ig B-Gene +
- O +
like O +
domains O +
of O +
the O +
KIR3D B-Gene +
forms O +
of O +
six O +
primate O +
species O +
were O +
found O +
to O +
have O +
different O +
patterns O +
of O +
clustering O +
in O +
phylogenetic O +
trees O +
, O +
suggesting O +
that O +
each O +
Ig B-Gene +
- O +
like O +
domain O +
has O +
a O +
distinct O +
phylogenetic O +
history O +
. O +

This O +
variation O +
in O +
relationships O +
suggests O +
that O +
repeated O +
recombination O +
events O +
have O +
occurred O +
between O +
the O +
Ig B-Gene +
- O +
like O +
domains O +
during O +
the O +
evolution O +
of O +
the O +
KIR B-Gene +
family I-Gene +
in O +
primates O +
. O +

Recombination O +
between O +
individual O +
Ig B-Gene +
- O +
like O +
domains O +
, O +
in O +
addition O +
to O +
point O +
mutations O +
, O +
provides O +
a O +
mechanism O +
for O +
generating O +
the O +
diversity O +
of O +
the O +
KIR B-Gene +
genes O +
. O +

Interaction O +
between O +
ArgR B-Gene +
and O +
AhrC B-Gene +
controls O +
regulation O +
of O +
arginine O +
metabolism O +
in O +
Lactococcus O +
lactis O +
. O +

The O +
expression O +
of O +
arginine O +
metabolism O +
in O +
Lactococcus O +
lactis O +
is O +
controlled O +
by O +
the O +
two O +
homologous O +
transcriptional O +
regulators O +
ArgR B-Gene +
and O +
AhrC B-Gene +
. O +

Genome O +
sequence O +
analyses O +
have O +
shown O +
that O +
the O +
occurrence O +
of O +
multiple O +
homologues O +
of O +
the O +
ArgR B-Gene +
family I-Gene +
of O +
transcriptional O +
regulators O +
is O +
a O +
common O +
feature O +
of O +
many O +
low O -
- O -
G O +
+ O +
C O +
Gram O +
- O +
positive O +
bacteria O +
. O +

Detailed O +
studies O +
of O +
ArgR B-Gene +
type O +
regulators O +
have O +
previously O +
only O +
been O +
carried O +
out O +
in O +
bacteria O +
containing O +
single O +
regulators O +
. O +

Here O +
, O +
we O +
present O +
a O +
first O +
characterization O +
of O +
the O +
two O +
L. O +
lactis O +
arginine O +
regulators O +
by O +
means O +
of O +
gel O +
retardation O +
and O +
DNase B-Gene +
I I-Gene +
footprinting O +
. O +

ArgR B-Gene +
of O +
L. O +
lactis O +
was O +
shown O +
to O +
bind O +
to O +
the O +
promoter O +
regions O +
of O +
both O +
the O +
arginine O +
biosynthetic O +
argCJDBF B-Gene +
operon I-Gene +
and O +
the O +
arginine O +
catabolic O +
arcABD1C1C2TD2yvaD B-Gene +
operon I-Gene +
, O +
but O +
in O +
an O +
arginine O +
- O +
independent O +
manner O +
. O +

Surprisingly O +
, O +
AhrC B-Gene +
alone O +
was O +
unable O +
to O +
bind O +
to O +
DNA O +
. O +

Arginine O +
- O +
dependent O +
DNA O +
binding O +
was O +
obtained O +
by O +
mixing O +
the O +
two O +
regulators O +
in O +
gel O +
retardation O +
assays O +
. O +

With O +
both O +
regulators O +
present O +
, O +
the O +
addition O +
of O +
arginine O +
led O +
to O +
increased O +
binding O +
of O +
ArgR B-Gene +
- O +
AhrC B-Gene +
to O +
the O +
biosynthetic O +
argC B-Gene +
promoter O +
but O +
also O +
to O +
diminished O +
binding O +
to O +
the O +
catabolic O +
arcA B-Gene +
promoter O +
. O +

Footprinting O +
showed O +
ArgR B-Gene +
- O +
AhrC B-Gene +
protection O +
of O +
regions O +
containing O +
ARG B-Gene +
box O +
operator O +
sequences O +
preceding O +
argC B-Gene +
. O +

In O +
the O +
absence O +
of O +
AhrC B-Gene +
, O +
ArgR B-Gene +
protected O +
sites O +
in O +
the O +
arcA B-Gene +
promoter O +
region O +
with O +
similarity O +
to O +
ARG B-Gene +
box O +
half O +
- O +
sites O +
, O +
here O +
called O +
ARC B-Gene +
boxes O +
. O +

We O +
propose O +
a O +
model O +
for O +
repression O +
of O +
arginine O +
biosynthesis O +
and O +
activation O +
of O +
catabolism O +
by O +
anti O +
- O +
repression O +
, O +
involving O +
arginine O +
- O +
dependent O +
interaction O +
between O +
the O +
two O +
L. O +
lactis O +
regulator O +
proteins O +
, O +
ArgR B-Gene +
and O +
AhrC B-Gene +
. O +

Compartmentalized O +
transcription O +
and O +
the O +
establishment O +
of O +
cell O +
type O +
during O +
sporulation O +
in O +
Bacillus O +
subtilis O +
. O +

An O +
early O +
step O +
in O +
sporulation O +
of O +
the O +
bacterium O +
Bacillus O +
subtilis O +
, O +
is O +
the O +
formation O +
of O +
two O +
compartments O +
in O +
the O +
developing O +
sporangium O +
: O +
the O +
mother O +
cell O +
and O +
the O +
forespore O +
. O +

These O +
compartments O +
differ O +
in O +
their O +
programs O +
of O +
gene O +
expression O +
and O +
developmental O +
fate O +
. O +

The O +
establishment O +
of O +
cell O +
type O +
within O +
this O +
simple O +
developmental O +
program O +
, O +
is O +
accomplished O +
by O +
the O +
compartmentalization O +
of O +
sigma O +
subunits O +
of O +
RNA B-Gene +
polymerase I-Gene +
. O +

The O +
localization O +
of O +
these O +
sigma B-Gene +
factors I-Gene +
results O +
in O +
compartment O +
- O +
specific O +
gene O +
expression O +
. O +

Recent O +
experiments O +
have O +
elucidated O +
some O +
of O +
the O +
early O +
steps O +
in O +
the O +
establishment O +
of O +
cell O +
type O +
. O +

After O +
septum O +
formation O +
, O +
the O +
activity O +
of O +
the O +
sigma B-Gene +
factor I-Gene +
, O +
sigma B-Gene +
F I-Gene +
, O +
is O +
confined O +
to O +
the O +
forespore O +
compartment O +
. O +

This O +
, O +
in O +
turn O +
, O +
results O +
in O +
the O +
localized O +
expression O +
of O +
another O +
developmental O +
sigma B-Gene +
factor I-Gene +
, O +
sigma B-Gene +
G I-Gene +
. O +

The O +
forespore O +
localization O +
of O +
these O +
two O +
sigma B-Gene +
factors I-Gene +
, O +
establishes O +
the O +
forespore O +
line O +
of O +
gene O +
expression O +
. O +

sigma B-Gene +
F I-Gene +
and O +
sigma B-Gene +
G I-Gene +
also O +
regulate O +
mother O +
cell O +
events O +
. O +

sigma B-Gene +
F I-Gene +
activity O +
in O +
the O +
forespore O +
regulates O +
the O +
proteolytic O +
processing O +
of O +
sigma B-Gene +
E I-Gene +
within O +
the O +
mother O +
cell O +
compartment O +
. O +

The O +
localization O +
sigma B-Gene +
E I-Gene +
activity O +
leads O +
to O +
mother O +
cell O +
expression O +
of O +
another O +
sigma B-Gene +
factor I-Gene +
, O +
pro O +
- O +
sigma B-Gene +
K I-Gene +
. O +

The O +
proteolytic O +
processing O +
of O +
pro O +
- O +
sigma B-Gene +
K I-Gene +
to O +
mature O +
sigma B-Gene +
K I-Gene +
is O +
controlled O +
by O +
the O +
forespore O +
sigma B-Gene +
factor I-Gene +
, O +
sigma B-Gene +
G I-Gene +
. O +

Mature O +
sigma B-Gene +
K I-Gene +
then O +
directs O +
the O +
transcription O +
of O +
mother O +
cell O +
specific O +
genes O +
. O +

Therefore O +
, O +
the O +
initial O +
localization O +
of O +
sigma B-Gene +
F I-Gene +
activity O +
to O +
the O +
forespore O +
compartment O +
, O +
orchestrates O +
the O +
establishment O +
of O +
cell O +
type O +
in O +
both O +
forespore O +
and O +
mother O +
cell O +
compartments O +
. O +

Cutting O +
edge O +
: O +
KIR2DL4 B-Gene +
transduces O +
signals O +
into O +
human O +
NK O +
cells O +
through O +
association O +
with O +
the O +
Fc B-Gene +
receptor I-Gene +
gamma I-Gene +
protein O +
. O +

KIR2DL4 B-Gene +
( O +
2DL4 B-Gene +
, O +
CD158d B-Gene +
) O +
, O +
a O +
member O +
of O +
the O +
human O +
killer B-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( I-Gene +
KIR I-Gene +
) I-Gene +
family I-Gene +
, O +
triggers O +
potent O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
responses O +
but O +
weak O +
cytotoxicity O +
in O +
resting O +
NK O +
cells O +
. O +

2DL4 B-Gene +
mRNA O +
has O +
been O +
detected O +
in O +
most O +
NK O +
cell O +
clones O +
from O +
most O +
humans O +
examined O +
, O +
but O +
surface O +
protein O +
expression O +
is O +
detectable O +
only O +
on O +
CD56 B-Gene +
( O +
high O +
) O +
NK O +
cells O +
from O +
certain O +
donors O +
. O +

The O +
receptor O +
possesses O +
a O +
transmembrane O +
arginine O +
residue O +
, O +
suggesting O +
association O +
with O +
a O +
signaling O +
accessory O +
protein O +
that O +
has O +
remained O +
elusive O +
. O +

We O +
provide O +
biochemical O +
and O +
functional O +
evidence O +
that O +
FcepsilonRI B-Gene -
- I-Gene -
gamma I-Gene +
( O +
gamma O +
) O +
associates O +
with O +
2DL4 B-Gene +
to O +
promote O +
surface O +
expression O +
and O +
provide O +
signal O +
transducing O +
function O +
. O +

Weak O +
cytolytic O +
responses O +
triggered O +
through O +
2DL4 B-Gene +
may O +
result O +
from O +
low O +
stoichiometric O +
association O +
with O +
gamma O +
. O +

Selective O +
association O +
with O +
gamma O +
distinguishes O +
2DL4 B-Gene +
from O +
all O +
other O +
activating O +
forms O +
of O +
the O +
KIR B-Gene +
family I-Gene +
, O +
which O +
alternatively O +
associate O +
with O +
DNAX B-Gene +
- I-Gene +
activating I-Gene +
protein I-Gene +
( I-Gene +
DAP I-Gene +
) I-Gene +
12 I-Gene +
. O +

Three O +
structurally O +
and O +
functionally O +
divergent O +
kinds O +
of O +
promoters O +
regulate O +
expression O +
of O +
clonally O +
distributed O +
killer B-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIR B-Gene +
) O +
, O +
of O +
KIR2DL4 B-Gene +
, O +
and O +
of O +
KIR3DL3 B-Gene +
. O +

The O +
generation O +
of O +
killer B-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( O +
KIR B-Gene +
) O +
expression O +
patterns O +
in O +
NK O +
cells O +
involves O +
variegated O +
silencing O +
of O +
KIR B-Gene +
genes O +
by O +
DNA O +
methylation O +
. O +

To O +
identify O +
regulatory O +
elements O +
involved O +
in O +
KIR B-Gene +
gene O +
activation O +
, O +
upstream O +
regions O +
of O +
KIR B-Gene +
genes O +
were O +
functionally O +
characterized O +
in O +
NK3.3 O +
cells O +
as O +
well O +
as O +
in O +
primary O +
NK O +
cells O +
. O +

Three O +
kinds O +
of O +
KIR B-Gene +
promoters O +
were O +
defined O +
, O +
controlling O +
clonally O +
expressed O +
KIR B-Gene +
genes O +
, O +
the O +
constitutively O +
active O +
KIR2DL4 B-Gene +
, O +
and O +
the O +
weakly O +
expressed O +
KIR3DL3 B-Gene +
. O +

Upstream O +
of O +
a O +
short O +
core O +
promoter O +
common O +
to O +
all O +
KIR B-Gene +
genes O +
, O +
a O +
region O +
containing O +
functionally O +
divergent O +
elements O +
was O +
characterized O +
. O +

Although O +
this O +
region O +
had O +
no O +
impact O +
on O +
the O +
activity O +
of O +
the O +
KIR2DL3 B-Gene +
promoter O +
, O +
an O +
inhibitory O +
element O +
was O +
identified O +
in O +
the O +
KIR2DL4 B-Gene +
promoter O +
and O +
an O +
activating O +
element O +
was O +
found O +
in O +
the O +
KIR3DL3 B-Gene +
promoter O +
. O +

Upon O +
treatment O +
with O +
a O +
methyltransferase B-Gene +
inhibitor O +
, O +
KIR3DL3 B-Gene +
expression O +
could O +
be O +
readily O +
induced O +
showing O +
that O +
the O +
low O +
levels O +
of O +
KIR3DL3 B-Gene +
expression O +
in O +
peripheral O +
blood O +
are O +
due O +
to O +
sustained O +
DNA O +
methylation O +
of O +
an O +
otherwise O +
fully O +
functional O +
promoter O +
. O +

Analysis O +
of O +
transcription B-Gene +
factor I-Gene +
binding O +
sites O +
identified O +
a O +
functional O +
acute O +
myeloid O +
leukemia O +
( O +
AML O +
) O +
site O +
common O +
to O +
all O +
three O +
KIR B-Gene +
promoters O +
. O +

Mutation O +
of O +
this O +
site O +
led O +
to O +
a O +
substantial O +
increase O +
in O +
activity O +
of O +
all O +
KIR B-Gene +
promoters O +
. O +

Among O +
the O +
different O +
members O +
of O +
the O +
AML B-Gene +
family I-Gene +
, O +
AML-2 B-Gene +
was O +
identified O +
as O +
the O +
predominant O +
KIR B-Gene +
binding O +
factor O +
. O +

The O +
present O +
study O +
suggests O +
that O +
AML-2 B-Gene +
acts O +
as O +
a O +
repressor O +
of O +
KIR B-Gene +
expression O +
in O +
mature O +
NK O +
cells O +
and O +
opens O +
the O +
possibility O +
that O +
AML B-Gene +
factors O +
and O +
associated O +
cofactors O +
are O +
involved O +
in O +
regulation O +
of O +
KIR B-Gene +
expression O +
during O +
NK O +
cell O +
development O +
. O +

Aspartyl B-Gene +
- I-Gene +
tRNA I-Gene +
synthetase I-Gene +
requires O +
a O +
conserved O +
proline O +
in O +
the O +
anticodon O +
- O +
binding O +
loop O +
for O +
tRNA O +
( O +
Asn O +
) O +
recognition O +
in O +
vivo O +
. O +

Most O +
prokaryotes O +
require O +
Asp O +
- O +
tRNA O +
( O +
Asn O +
) O +
for O +
the O +
synthesis O +
of O +
Asn O -
- O -
tRNA O +
( O +
Asn O +
) O +
. O +

This O +
misacylated O +
tRNA O +
species O +
is O +
synthesized O +
by O +
a O +
non O +
- O +
discriminating O +
aspartyl B-Gene +
- I-Gene +
tRNA I-Gene +
synthetase I-Gene +
( O +
AspRS B-Gene +
) O +
that O +
acylates O +
both O +
tRNA O +
( O +
Asp O +
) O +
and O +
tRNA O +
( O +
Asn O +
) O +
with O +
aspartate O +
. O +

In O +
contrast O +
, O +
a O +
discriminating O +
AspRS B-Gene +
forms O +
only O +
Asp O +
- O +
tRNA O +
( O +
Asp O +
) O +
. O +

Here O +
we O +
show O +
that O +
a O +
conserved O +
proline O +
( O +
position O +
77 O +
) O +
in O +
the O +
L1 O +
loop O +
of O +
the O +
non O +
- O +
discriminating O +
Deinococcus O +
radiodurans O +
AspRS2 B-Gene +
is O +
required O +
for O +
tRNA O +
( O +
Asn O +
) O +
recognition O +
in O +
vivo O +
. O +

Escherichia O +
coli O +
trpA34 O +
was O +
transformed O +
with O +
DNA O +
from O +
a O +
library O +
of O +
D. O +
radiodurans O +
aspS2 B-Gene +
genes O +
with O +
a O +
randomized O +
codon O +
77 O +
and O +
then O +
subjected O +
to O +
in O +
vivo O +
selection O +
for O +
Asp O +
- O +
tRNA O +
( O +
Asn O +
) O +
formation O +
by O +
growth O +
in O +
minimal O +
medium O +
. O +

Only O +
proline O +
codons O +
were O +
found O +
at O +
position O +
77 O +
in O +
the O +
aspS2 B-Gene +
genes O +
isolated O +
from O +
21 O +
of O +
the O +
resulting O +
viable O +
colonies O +
. O +

However O +
, O +
when O +
the O +
aspS B-Gene +
temperature O +
- O +
sensitive O +
E. O +
coli O +
strain O +
CS89 O +
was O +
transformed O +
with O +
the O +
same O +
DNA O +
library O +
and O +
then O +
screened O +
for O +
Asp O +
- O +
tRNA O +
( O +
Asp O +
) O +
formation O +
in O +
vivo O +
by O +
growth O +
at O +
the O +
non O +
- O +
permissive O +
temperature O +
, O +
codons O +
for O +
seven O +
other O +
amino O +
acids O +
besides O +
proline O +
were O +
identified O +
at O +
position O +
77 O +
in O +
the O +
isolates O +
examined O +
. O +

Thus O +
, O +
replacement O +
of O +
proline O +
77 O +
by O +
cysteine O +
, O +
isoleucine O +
, O +
leucine O +
, O +
lysine O +
, O +
phenylalanine O +
, O +
serine O +
, O +
or O +
valine O +
resulted O +
in O +
mutant O +
D. O +
radiodurans O +
AspRS2 B-Gene +
enzymes O +
still O +
capable O +
of O +
forming O +
Asp O +
- O +
tRNA O +
( O +
Asp O +
) O +
but O +
unable O +
to O +
recognize O +
tRNA O +
( O +
Asn O +
) O +
. O +

This O +
strongly O +
suggests O +
that O +
proline O +
77 O +
is O +
responsible O +
for O +
the O +
non O +
- O +
discriminatory O +
tRNA O +
recognition O +
properties O +
of O +
this O +
enzyme O +
. O +

Coenzyme O +
q10 O +
confers O +
cardiovascular O +
protection O +
against O +
acute O +
mevinphos O +
intoxication O +
by O +
ameliorating O +
bioenergetic O +
failure O +
and O +
hypoxia O +
in O +
the O +
rostral O +
ventrolateral O +
medulla O +
of O +
the O +
rat O +
. O +

Coenzyme O +
Q10 O +
( O +
CoQ10 O +
, O +
ubiquinone O +
) O +
is O +
a O +
highly O +
mobile O +
electron O +
carrier O +
in O +
the O +
mitochondrial O +
respiratory O +
chain O +
that O +
also O +
acts O +
as O +
an O +
antioxidant O +
. O +

We O +
evaluated O +
the O +
cardiovascular O +
protective O +
efficacy O +
of O +
CoQ10 O +
at O +
the O +
rostral O +
ventrolateral O +
medulla O +
( O +
RVLM O +
) O +
, O +
a O +
medullary O +
site O +
where O +
sympathetic O +
vasomotor O +
tone O +
originates O +
and O +
where O +
the O +
organophosphate O +
poison O +
mevinphos O +
( O +
Mev O +
) O +
acts O +
to O +
elicit O +
cardiovascular O +
intoxication O +
. O +

Experiments O +
were O +
carried O +
out O +
in O +
adult O +
male O +
Sprague O +
- O +
Dawley O +
rats O +
that O +
were O +
maintained O +
under O +
propofol O +
anesthesia O +
. O +

Microinjection O +
bilaterally O +
of O +
Mev O +
( O +
10 O +
nmol O +
) O +
into O +
the O +
RVLM O +
induced O +
progressive O +
hypotension O +
and O +
minor O +
bradycardia O +
, O +
alongside O +
significant O +
depression O +
of O +
the O +
activity O +
of O +
NADH B-Gene +
cytochrome I-Gene +
c I-Gene +
reductase I-Gene +
( O +
enzyme O +
marker O +
for O +
Complexes O +
I O +
and O +
III O +
) O +
or O +
cytochrome B-Gene +
c I-Gene +
oxidase I-Gene +
( O +
enzyme O +
marker O +
for O +
Complex O +
IV O +
) O +
in O +
the O +
mitochondrial O +
respiratory O +
chain O +
, O +
reduction O +
in O +
ATP O +
concentration O +
, O +
or O +
tissue O +
hypoxia O +
in O +
the O +
RVLM O +
. O +

On O +
the O +
other O +
hand O +
, O +
the O +
activity O +
of O +
succinate B-Gene +
cytochrome I-Gene +
c I-Gene +
reductase I-Gene +
( O +
enzyme O +
marker O +
for O +
Complexes O +
II O +
and O +
III O +
) O +
remained O +
unaltered O +
. O +

The O +
Mev O +
- O +
induced O +
hypotension O +
, O +
bioenergetic O +
failure O +
, O +
or O +
hypoxia O +
was O +
significantly O +
reversed O +
when O +
CoQ10 O +
( O +
4 O +
microg O +
) O +
was O +
coadministered O +
bilaterally O +
into O +
the O +
RVLM O +
with O +
the O +
organophosphate O +
poison O +
. O +

We O +
conclude O +
that O +
CoQ10 O +
confers O +
cardiovascular O +
protection O +
against O +
acute O +
Mev O +
intoxication O +
by O +
acting O +
on O +
the O +
RVLM O +
, O +
whose O +
neuronal O +
activity O +
is O +
intimately O +
related O +
to O +
the O +
" O +
life O +
- O +
and O +
- O +
death O +
" O +
process O +
. O +

We O +
also O +
showed O +
that O +
amelioration O +
of O +
the O +
selective O +
dysfunction O +
of O +
respiratory O +
enzyme O +
Complexes O +
I O +
and O +
IV O +
in O +
the O +
mitochondrial O +
respiratory O +
chain O +
, O +
the O +
reduced O +
ATP O +
level O +
, O +
and O +
the O +
induced O +
tissue O +
hypoxia O +
in O +
the O +
RVLM O +
are O +
among O +
some O +
of O +
the O +
underlying O +
mechanisms O +
for O +
the O +
elicited O +
protection O +
. O +

Molecular O +
analysis O +
of O +
the O +
role O +
of O +
two O +
aromatic B-Gene +
aminotransferases I-Gene +
and O +
a O +
broad O +
- O +
specificity O +
aspartate B-Gene +
aminotransferase I-Gene +
in O +
the O +
aromatic O +
amino O +
acid O +
metabolism O +
of O +
Pyrococcus O +
furiosus O +
. O +

The O +
genes O +
encoding O +
aromatic B-Gene +
aminotransferase I-Gene +
II I-Gene +
( O +
AroAT B-Gene +
II I-Gene +
) O +
and O +
aspartate B-Gene +
aminotransferase I-Gene +
( O +
AspAT B-Gene +
) O +
from O +
Pyrococcus O +
furiosus O +
have O +
been O +
identified O +
, O +
expressed O +
in O +
Escherichia O +
coli O +
and O +
the O +
recombinant O +
proteins O +
characterized O +
. O +

The O +
AroAT B-Gene +
II I-Gene +
enzyme O +
was O +
specific O +
for O +
the O +
transamination O +
reaction O +
of O +
the O +
aromatic O +
amino O +
acids O +
, O +
and O +
uses O +
a O +
- O +
ketoglutarate O +
as O +
the O +
amino O +
acceptor O +
. O +

Like O +
the O +
previously O +
characterized O +
AroAT B-Gene +
I I-Gene +
, O +
AroAT B-Gene +
II I-Gene +
has O +
highest O +
efficiency O +
for O +
phenylalanine O +
( O +
k O -
( O -
cat O -
) O +
/ O +
Km O +
= O +
923 O +
s O -
( O -
-1 O -
) O +
mM O -
( O -
-1 O -
) O +
) O +
. O +

Northern O +
blot O +
analyses O +
revealed O +
that O +
AroAT B-Gene +
I I-Gene +
was O +
mainly O +
expressed O +
when O +
tryptone O +
was O +
the O +
primary O +
carbon O +
and O +
energy O +
source O +
. O +

Although O +
the O +
expression O +
was O +
significantly O +
lower O +
, O +
a O +
similar O +
trend O +
was O +
observed O +
for O +
AroAT B-Gene +
II I-Gene +
. O +

These O +
observations O +
suggest O +
that O +
both O +
AroATs B-Gene +
are O +
involved O +
in O +
amino O +
acid O +
degradation O +
. O +

Although O +
AspAT B-Gene +
exhibited O +
highest O +
activity O +
with O +
aspartate O +
and O +
alpha O -
- O -
ketoglutarate O +
( O +
k O -
( O -
cat O -
) O +
approximately O +
105 O +
s O -
( O -
-1 O -
) O +
) O +
, O +
it O +
also O +
showed O +
significant O +
activity O +
with O +
alanine O +
, O +
glutamate O +
and O +
the O +
aromatic O +
amino O +
acids O +
. O +

With O +
aspartate O +
as O +
the O +
amino O +
donor O +
, O +
AspAT B-Gene +
catalyzed O +
the O +
amination O +
of O +
alpha O -
- O -
ketoglutarate O +
, O +
pyruvate O +
and O +
phenyl O +
- O +
pyruvate O +
. O +

No O +
activity O +
was O +
detected O +
with O +
either O +
branched O +
- O +
chain O +
amino O +
acids O +
or O +
alpha O +
- O +
keto O +
acids O +
. O +

The O +
AspAT B-Gene +
gene O +
( O +
aspC B-Gene +
) O +
was O +
expressed O +
as O +
a O +
polycistronic O +
message O +
as O +
part O +
of O +
the O +
aro B-Gene +
operon I-Gene +
, O +
with O +
expression O +
observed O +
only O +
when O +
the O +
aromatic O +
amino O +
acids O +
were O +
absent O +
from O +
the O +
growth O +
medium O +
, O +
indicating O +
a O +
role O +
in O +
the O +
biosynthesis O +
of O +
the O +
aromatic O +
amino O +
acids O +
. O +

The O +
effect O +
of O +
MCP-1 B-Gene +
depletion O +
on O +
chemokine B-Gene +
and O +
chemokine B-Gene +
- O +
related O +
gene O +
expression O +
: O +
evidence O +
for O +
a O +
complex O +
network O +
in O +
acute O +
inflammation O +
. O +

The O +
expression O +
of O +
chemokines B-Gene +
has O +
been O +
suggested O +
to O +
involve O +
an O +
interdependent O +
network O +
, O +
with O +
the O +
absence O +
of O +
a O +
single O +
chemokine B-Gene +
affecting O +
the O +
expression O +
of O +
multiple O +
other O +
chemokines B-Gene +
. O +

Monocyte B-Gene +
chemoattractant I-Gene +
protein I-Gene +
( O +
MCP-1 B-Gene +
) O +
, O +
a O +
member O +
of O +
C B-Gene -
- I-Gene -
C I-Gene +
chemokine I-Gene +
superfamily I-Gene +
, O +
plays O +
a O +
critical O +
role O +
in O +
the O +
recruitment O +
and O +
activation O +
of O +
leukocytes O +
during O +
acute O +
inflammation O +
. O +

To O +
examine O +
the O +
effect O +
of O +
the O +
loss O +
of O +
MCP-1 B-Gene +
on O +
expression O +
of O +
the O +
chemokine B-Gene +
network O +
, O +
we O +
compared O +
the O +
mRNA O +
expression O +
profiles O +
of O +
MCP-1 B-Gene +
( O +
- O -
/ O -
- O +
) O +
and O +
wild O +
type O +
mice O +
during O +
the O +
acute O +
inflammatory O +
phase O +
of O +
excisional O +
wounds O +
. O +

Utilizing O +
a O +
mouse O +
cDNA O +
array O +
containing O +
514 O +
chemokine B-Gene +
and O +
chemokine B-Gene +
related O +
genes O +
, O +
the O +
loss O +
of O +
MCP-1 B-Gene +
was O +
observed O +
to O +
cause O +
a O +
significant O +
upregulation O +
of O +
nine O +
genes O +
( O +
Decorin B-Gene +
, O +
Persephin B-Gene +
, O +
IL-1beta B-Gene +
, O +
MIP-2 B-Gene +
, O +
MSP B-Gene +
, O +
IL1ra B-Gene +
, O +
CCR5 B-Gene +
, O +
CCR3 B-Gene +
, O +
IL-11 B-Gene +
) O +
and O +
significant O +
downregulation O +
of O +
two O +
genes O +
( O +
CCR4 B-Gene +
and O +
CD3Z B-Gene +
) O +
in O +
acute O +
wounds O +
. O +

The O +
array O +
data O +
was O +
confirmed O +
by O +
semi O +
- O +
quantitative O +
RT O +
- O +
PCR O +
. O +

The O +
effect O +
of O +
MCP-1 B-Gene +
deletion O +
on O +
chemokine O +
expression O +
was O +
further O +
examined O +
in O +
isolated O +
macrophages O +
. O +

Compared O +
to O +
wild O +
type O +
, O +
LPS O +
- O +
stimulated O +
peritoneal O +
macrophages O +
from O +
MCP-1 B-Gene +
( O +
- O -
/ O -
- O +
) O +
mice O +
showed O +
a O +
significant O +
increase O +
in O +
the O +
expression O +
of O +
RANTES B-Gene +
, O +
MIP-1beta B-Gene +
, O +
MIP-1alpha B-Gene +
and O +
MIP-2 B-Gene +
mRNA O +
. O +

The O +
data O +
suggest O +
that O +
loss O +
of O +
a O +
single O +
chemokine B-Gene +
perturbs O +
the O +
chemokine O +
network O +
not O +
only O +
in O +
the O +
setting O +
of O +
acute O +
inflammation O +
but O +
even O +
in O +
an O +
isolated O +
inflammatory O +
cell O +
, O +
the O +
macrophage O +
. O +

Association O +
of O +
nucleotide O +
variations O +
in O +
the O +
apolipoprotein B-Gene +
B48 I-Gene +
receptor I-Gene +
gene O +
( O +
APOB48R B-Gene +
) O +
with O +
hypercholesterolemia O +
. O +

Factors O +
predisposing O +
to O +
the O +
phenotypic O +
features O +
of O +
high O +
total O +
cholesterol O +
( O +
T O -
- O -
Cho O +
) O +
in O +
human O +
plasma O +
have O +
not O +
been O +
clearly O +
defined O +
. O +

Here O +
we O +
report O +
an O +
association O +
between O +
two O +
variations O +
in O +
the O +
apolipoprotein B-Gene +
B48 I-Gene +
receptor I-Gene +
gene O +
( O +
APOB48R B-Gene +
) O +
and O +
plasma O +
T O -
- O -
Cho O +
levels O +
among O +
352 O +
adult O +
individuals O +
in O +
Japan O +
. O +

By O +
analyzing O +
phenotypic O +
associations O +
between O +
age O +
- O +
and O +
gender O +
- O +
adjusted O +
levels O +
of O +
plasma O +
T O -
- O -
Cho O +
, O +
low B-Gene +
- I-Gene +
density I-Gene +
lipoprotein I-Gene +
( O +
LDL B-Gene +
) O +
cholesterol O +
( O +
LDL B-Gene +
- O +
C O +
) O +
, O +
and O +
high B-Gene +
- I-Gene +
density I-Gene +
lipoprotein I-Gene +
( O +
HDL B-Gene +
) O +
cholesterol O +
( O +
HDL B-Gene +
- O +
C O +
) O +
, O +
we O +
detected O +
a O +
significant O +
correlation O +
between O +
genotypes O +
of O +
the O +
A419P O +
variation O +
and O +
adjusted O +
T O -
- O -
Cho O +
levels O +
. O +

Among O +
homozygous O +
G O +
- O +
allele O +
carriers O +
( O +
n O +
= O +
265 O +
) O +
, O +
heterozygous O +
carriers O +
( O +
n O +
= O +
78 O +
) O +
, O +
and O +
homozygous O +
minor O +
C O +
- O +
allele O +
carriers O +
( O +
n O +
= O +
9 O +
) O +
, O +
T O -
- O -
Cho O +
levels O +
were O +
2.43 O +
+ O -
/- O +
0.21 O +
mg O +
/ O +
cm O +
( O +
3 O +
) O +
, O +
2.48 O +
+ O +
/ O +
- O +
0.24 O +
mg O +
/ O +
cm O -
( O -
3 O -
) O +
, O +
and O +
2.63 O +
+ O -
/- O +
0.21 O +
mg O +
/ O +
cm O -
( O -
3 O -
) O +
, O +
respectively O +
, O +
indicating O +
a O +
codominant O +
T O -
- O -
Cho O -
- O -
elevating O +
effect O +
of O +
the O +
minor O +
C O -
- O -
allele O +
( O +
r O +
= O +
0.15 O +
, O +
P O +
= O +
0.007 O +
) O +
. O +

A O +
similar O +
effect O +
was O +
detected O +
for O +
c.934 O +
- O +
960 O +
/ O +
del O +
( O +
r O +
= O +
0.13 O +
, O +
P O +
= O +
0.015 O +
) O +
. O +

Linkage O +
disequilibrium O +
( O +
LD O +
) O +
analysis O +
detected O +
significant O +
LD O +
among O +
eight O +
variant O +
sites O +
that O +
included O +
neighboring O +
loci O +
. O +

Our O +
results O +
indicate O +
that O +
variations O +
in O +
APOB48R B-Gene +
and O +
nearby O +
genes O +
are O +
among O +
the O +
many O +
factors O +
involved O +
in O +
hypercholesterolemia O +
. O +

The O +
etiological O +
studies O +
should O +
now O +
include O +
consideration O +
of O +
this O +
novel O +
aspect O +
of O +
the O +
mechanism O -
( O -
s O -
) O +
leading O +
to O +
hypercholesterolemic O +
disease O +
. O +

B O +
cell O +
memory O +
to O +
3 O +
Plasmodium O +
falciparum O +
blood O +
- O +
stage O +
antigens O +
in O +
a O +
malaria O +
- O +
endemic O +
area O +
. O +

To O +
gain O +
insight O +
into O +
why O +
antibody O +
responses O +
to O +
malarial O +
antigens O +
tend O +
to O +
be O +
short O +
lived O +
, O +
we O +
studied O +
antigen O +
- O +
specific O +
memory O +
B O +
cells O +
from O +
donors O +
in O +
an O +
area O +
where O +
malaria O +
is O +
endemic O +
. O +

We O +
compared O +
antibody O +
and O +
memory O +
B O +
cell O +
responses O +
to O +
tetanus O +
toxoid O +
with O +
those O +
to O +
3 O +
Plasmodium O +
falciparum O +
candidate O +
vaccine O +
antigens O +
: O +
the O +
C O +
- O +
terminal O +
portion O +
of O +
merozoite B-Gene +
surface I-Gene +
protein I-Gene +
1 I-Gene +
( O +
MSP1 B-Gene +
( O +
19 O +
) O +
) O +
, O +
apical B-Gene +
membrane I-Gene +
antigen I-Gene +
1 I-Gene +
( O +
AMA1 B-Gene +
) O +
, O +
and O +
the O +
cysteine O +
- O +
rich O +
interdomain O +
region O +
1 O +
alpha O +
( O +
CIDR1 O +
alpha O +
) O +
of O +
a O +
protein O +
from O +
the O +
P. B-Gene +
falciparum I-Gene +
erythrocyte I-Gene +
membrane I-Gene +
protein I-Gene +
1 I-Gene +
( I-Gene +
PfEMP1 I-Gene +
) I-Gene +
family I-Gene +
. O +

These O +
data O +
are O +
the O +
first O +
to O +
be O +
generated O +
on O +
memory O +
B O +
cells O +
in O +
children O +
who O +
are O +
in O +
the O +
process O +
of O +
acquiring O +
antimalarial O +
immunity O +
, O +
and O +
they O +
reveal O +
defects O +
in O +
B O +
cell O +
memory O +
to O +
P. O +
falciparum O +
antigens O +
. O +

Compared O +
with O +
the O +
results O +
for O +
tetanus O +
toxoid O +
, O +
more O +
donors O +
who O +
were O +
positive O +
for O +
antibody O +
to O +
AMA1 B-Gene +
and O +
CIDR1 O +
alpha O +
were O +
negative O +
for O +
memory O +
B O +
cells O +
. O +

These O +
data O +
imply O +
that O +
some O +
exposures O +
to O +
malaria O +
do O +
not O +
result O +
in O +
the O +
establishment O +
of O +
stable O +
populations O +
of O +
circulating O +
antigen O +
- O +
specific O +
memory O +
B O +
cells O +
, O +
suggesting O +
possible O +
mechanisms O +
for O +
the O +
short O +
- O +
lived O +
nature O +
of O +
many O +
anti O +
- O +
malarial O +
antibody O +
responses O +
. O +

Restoration O +
of O +
aspartoacylase B-Gene +
activity O +
in O +
CNS O +
neurons O +
does O +
not O +
ameliorate O +
motor O +
deficits O +
and O +
demyelination O +
in O +
a O +
model O +
of O +
Canavan O +
disease O +
. O +

Canavan O +
disease O +
is O +
an O +
early O +
onset O +
leukodystrophy O +
associated O +
with O +
psychomotor O +
retardation O +
, O +
seizures O +
, O +
and O +
premature O +
death O +
. O +

This O +
disorder O +
is O +
caused O +
by O +
mutations O +
in O +
the O +
gene O +
encoding O +
the O +
enzyme O +
aspartoacylase B-Gene +
( O +
ASPA B-Gene +
) O +
. O +

Normally O +
, O +
ASPA B-Gene +
is O +
enriched O +
in O +
oligodendrocytes O +
and O +
ASPA B-Gene +
deficiency O +
results O +
in O +
elevated O +
levels O +
of O +
its O +
substrate O +
molecule O +
, O +
N O -
- O -
acetylaspartate O +
( O +
NAA O +
) O +
, O +
brain O +
edema O +
, O +
and O +
dysmyelination O +
. O +

Using O +
adeno O +
- O +
associated O +
virus O +
, O +
we O +
permanently O +
expressed O +
ASPA B-Gene +
in O +
CNS O +
neurons O +
of O +
the O +
tremor O +
rat O +
, O +
a O +
genetic O +
model O +
of O +
Canavan O +
disease O +
, O +
and O +
examined O +
the O +
efficacy O +
of O +
the O +
treatment O +
by O +
monitoring O +
NAA O +
metabolism O +
, O +
myelination O +
, O +
motor O +
behavior O +
, O +
and O +
seizures O +
. O +

Assessment O +
of O +
ASPA B-Gene +
protein O +
and O +
enzyme O +
activity O +
in O +
whole O +
brain O +
hemispheres O +
showed O +
restoration O +
to O +
normal O +
levels O +
as O +
long O +
as O +
6 O +
months O +
after O +
treatment O +
. O +

This O +
finding O +
correlated O +
with O +
a O +
reduction O +
of O +
NAA O +
levels O +
, O +
along O +
with O +
a O +
rescue O +
of O +
the O +
seizure O +
phenotype O +
. O +

However O +
, O +
gross O +
brain O +
pathology O +
, O +
such O +
as O +
dilated O +
ventricles O +
and O +
spongiform O +
vacuolization O +
, O +
was O +
unchanged O +
. O +

Moreover O +
, O +
hypomyelination O +
and O +
motor O +
deficits O +
were O +
not O +
resolved O +
by O +
ASPA B-Gene +
gene O +
transfer O +
. O +

Our O +
data O +
suggest O +
that O +
NAA O +
- O +
mediated O +
neuronal O +
hyperexcitation O +
but O +
not O +
oligodendrocyte O +
dysfunction O +
can O +
be O +
compensated O +
for O +
by O +
neuronal O +
ASPA B-Gene +
expression O +
. O +

[ O +
Study O +
on O +
p53 B-Gene +
tetramerization O +
domain O +
in O +
improving O +
functional O +
affinity O +
and O +
biological O +
activity O +
of O +
antibody O +
] O +

OBJECTIVE O +
: O +

To O +
fuse O +
the O +
genes O +
of O +
p53 B-Gene +
tetramerization O +
domain O +
and O +
anti O +
- O +
CD3 B-Gene +
/ O +
anti O +
- O +
prostate O +
- O +
cancer O +
bispecific O +
single O +
- O +
chain O +
antibody O +
( O +
BsAb O +
) O +
, O +
and O +
exploit O +
a O +
new O +
way O +
to O +
improve O +
the O +
functional O +
affinity O +
and O +
biological O +
activity O +
of O +
antibody O +
. O +

METHODS O +
: O +

Genes O +
of O +
p53 B-Gene +
tetramerization O +
domain O +
and O +
anti O +
- O +
CD3 B-Gene +
/ O +
anti O +
- O +
prostate O +
- O +
cancer O +
BsAb O +
was O +
fused O +
by O +
technique O +
of O +
DNA O +
sub O +
- O +
cloning O +
. O +

The O +
fusion O +
gene O +
confirmed O +
by O +
sequencing O +
was O +
subcloned O +
into O +
the O +
pSectag2 O +
- O +
B O +
plasmid O +
. O +

Then O +
the O +
recombinant O +
plasmid O +
was O +
transfected O +
into O +
HeLa O +
cells O +
. O +

The O +
expression O +
products O +
, O +
which O +
were O +
analyzed O +
by O +
both O +
SDS O -
- O -
PAGE O +
and O +
western O +
blotting O +
, O +
were O +
purified O +
with O +
Ni O -
( O -
2+ O -
) O -
-NTA O +
superflow O +
affinity O +
chromatography O +
. O +

mBsAb O -
- O -
pSectag2-B O +
plasmid O +
was O +
added O +
into O +
the O +
suspensions O +
of O +
human O +
peripheral O +
blood O +
mononuclear O +
cells O +
( O +
PBMCs O +
) O +
and O +
PC-3 O +
cells O +
respectively O +
. O +

Flow O +
cytometry O +
was O +
used O +
to O +
examine O +
the O +
binding O +
rate O +
of O +
multivalent O +
anti O +
- O +
prostate O +
- O +
cander O +
/ O +
anti O +
- O +
CD3 B-Gene +
bispecific O +
scFv O +
with O +
PBMCs O +
and O +
PC-3 O +
cells O +
. O +

T O +
cells O +
were O +
isolated O +
from O +
the O +
PBMCs O +
. O +

PC-3 O +
cells O +
were O +
labeled O +
with O +
Na O -
( O -
2 O -
) O -
[ O -
( O -
51 O -
) O -
Cr O -
] O -
O O -
( O -
4 O -
) O +
used O +
as O +
target O +
cells O +
. O +

Labeled O +
PC-3 O +
cells O +
, O +
T O +
cells O +
, O +
and O +
different O +
concentrations O +
of O +
mBsAb O +
were O +
mixed O +
. O +

Natural O +
release O +
control O +
well O +
with O +
labeled O +
target O +
cells O +
only O +
and O +
maximum O +
release O +
control O +
well O +
with O +
labeled O +
target O +
cells O +
and O +
10 O +
% O +
SDS O +
were O +
prepared O +
. O +

The O +
supernatants O +
were O +
extracted O +
. O +

gamma O +
calculator O +
was O +
used O +
to O +
calculate O +
the O +
counts O +
per O +
minute O +
( O +
cpm O +
) O +
values O +
to O +
calculate O +
the O +
specific O +
release O +
rate O +
of O +
( O +
51 O +
) O +
Cr O +
. O +

RESULTS O +
: O +

Sequencing O +
showed O +
a O +
fragment O +
from O +
mBsAb O -
- O -
pSectag2-B O +
with O +
the O +
size O +
of O +
1.7 O +
kb O +
corresponding O +
to O +
the O +
predicted O +
value O +
. O +

SDS O +
- O +
PAGE O +
and O +
Western O +
blotting O +
showed O +
expression O +
of O +
67 O +
000 O +
D O +
protein O +
in O +
the O +
supernatant O +
of O +
culture O +
fluid O +
of O +
HeLa O +
cells O +
transfected O +
with O +
MBsAb O -
- O -
pSectag2 O +
- O +
B O +
plasmid O +
. O +

The O +
binding O +
rates O +
of O +
multivalent O +
anti O +
- O +
prostate O +
- O +
cancer O +
/ O +
anti O +
- O +
CD3 B-Gene +
bispecific O +
scFv O +
with O +
PBMC O +
and O +
PC-3 O +
cells O +
were O +
70.4 O +
% O +
and O +
81 O +
% O +
respectively O +
, O +
significantly O +
higher O +
than O +
those O +
of O +
anti O +
- O +
prostate O +
- O +
cancer O +
/ O +
anti O +
- O +
CD3 B-Gene +
bispecific O +
scFv O +
. O +

In O +
the O +
presence O +
of O +
mBsAb O +
the O +
activated O +
T O +
cells O +
lysed O +
PC-3 O +
cells O +
in O +
positive O +
correlation O +
with O +
the O +
antibody O +
concentration O +
and O +
effective O +
cell O +
/ O +
target O +
cell O +
ratio O +
and O +
with O +
a O +
lysis O +
rate O +
significantly O +
higher O +
than O +
those O +
of O +
the O +
control O +
groups O +
. O +

CONCLUSION O +
: O +

Multivalent O +
anti O +
- O +
CD3 B-Gene +
x O +
anti O +
- O +
prostate O +
- O +
cancer O +
BsAb O +
exhibits O +
much O +
higher O +
functional O +
affinity O +
and O +
biological O +
activity O +
than O +
anti O +
- O +
CD3 B-Gene +
x O +
anti O +
- O +
prostate O +
- O +
cancer O +
BsAb O +
, O +
which O +
may O +
break O +
a O +
new O +
path O +
to O +
the O +
improvement O +
of O +
functional O +
affinity O +
and O +
biological O +
activity O +
of O +
antibody O +
. O +

Packages O +
of O +
vitreous O +
collagen B-Gene +
( I-Gene +
type I-Gene +
II I-Gene +
) I-Gene +
in O +
the O +
human O +
retina O +
: O +
an O +
indication O +
of O +
postnatal O +
collagen B-Gene +
turnover O +
? O +

The O +
purpose O +
of O +
this O +
study O +
was O +
to O +
evaluate O +
the O +
vitreoretinal O +
border O +
in O +
the O +
( O +
pre O +
- O +
) O +
equatorial O +
area O +
in O +
nonpathologic O +
human O +
donor O +
eyes O +
, O +
because O +
the O +
majority O +
of O +
retinal O +
defects O +
induced O +
by O +
posterior O +
vitreous O +
detachment O +
( O +
PVD O +
) O +
are O +
located O +
there O +
. O +

Nine O +
eyes O +
( O +
24 O +
- O +
80 O +
years O +
) O +
were O +
fixed O +
and O +
embedded O +
in O +
Technovit O +
8100 O +
. O +

After O +
evaluation O +
by O +
light O +
microscope O +
, O +
areas O +
of O +
interest O +
were O +
selected O +
for O +
immunotransmission O +
electron O +
microscope O +
. O +

Anti O +
- O +
type B-Gene +
II I-Gene +
collagen I-Gene +
antibody O +
was O +
used O +
to O +
stain O +
vitreous O +
fibrils O +
and O +
lamellae O +
; O +
anti O +
- O +
type B-Gene +
IV I-Gene +
collagen I-Gene +
antibody O +
was O +
used O +
to O +
identify O +
the O +
internal O +
limiting O +
lamina O +
( O +
ILL O +
) O +
; O +
anti O +
- O +
vimentin B-Gene +
and O +
anti O +
- O +
CD-68 B-Gene +
antibodies O +
stained O +
retinal O +
Muller O +
cells O +
and O +
macrophages O +
, O +
respectively O +
. O +

Observations O +
included O +
fusing O +
of O +
lamellae O +
with O +
the O +
ILL O +
, O +
an O +
intravitreal O +
course O +
of O +
the O +
ILL O +
, O +
and O +
clear O +
focal O +
interruptions O +
in O +
the O +
ILL O +
. O +

In O +
addition O +
, O +
an O +
obvious O +
finding O +
was O +
the O +
presence O +
of O +
intraretinal O +
packages O +
of O +
type B-Gene +
II I-Gene +
collagen I-Gene +
. O +

Interestingly O +
these O +
collagen O +
packages O +
were O +
closely O +
related O +
to O +
Muller O +
cells O +
and O +
, O +
in O +
several O +
eyes O +
, O +
also O +
to O +
macrophages O +
, O +
cell O +
debris O +
and O +
interruptions O +
in O +
the O +
ILL O +
. O +

In O +
our O +
opinion O +
, O +
the O +
collagen O +
packages O +
can O +
reflect O +
the O +
net O +
result O +
of O +
a O +
process O +
of O +
interactive O +
remodelling O +
, O +
in O +
which O +
both O +
breakdown O +
and O +
synthesis O +
of O +
vitreous O +
and O +
ILL O +
collagens O +
take O +
place O +
. O +

Connections O +
between O +
vitreous O +
and O +
intraretinal O +
collagen B-Gene +
networks O +
can O +
make O +
the O +
( O +
pre O +
- O +
) O +
equatorial O +
area O +
more O +
vulnerable O +
to O +
tearing O +
and O +
retinal O +
detachment O +
in O +
the O +
case O +
of O +
liquefaction O +
and O +
PVD O +
. O +

Interleukin-12 B-Gene +
p40 I-Gene +
promoter O +
activity O +
is O +
regulated O +
by O +
the O +
reversible O +
acetylation O +
mediated O +
by O +
HDAC1 B-Gene +
and I-Gene +
p300 I-Gene +
. O +

Interleukin-12 B-Gene +
( O +
IL-12 B-Gene +
) O +
is O +
a O +
heterodimeric O +
cytokine O +
produced O +
by O +
macrophages O +
in O +
response O +
to O +
intracellular O +
pathogens O +
. O +

The O +
importance O +
of O +
IL-12 B-Gene +
in O +
generation O +
of O +
Th1 O +
response O +
against O +
human O +
pathogens O +
has O +
been O +
characterized O +
. O +

The O +
coactivator O +
p300 B-Gene +
is O +
an O +
important O +
histone B-Gene +
acetyltransferase I-Gene +
( O +
HAT B-Gene +
) O +
and O +
has O +
been O +
implicated O +
in O +
the O +
regulation O +
of O +
many O +
genes O +
. O +

Histone B-Gene +
deacetylases I-Gene +
( O +
HDACs B-Gene +
) O +
regulate O +
gene O +
transcription O +
through O +
deacetylation O +
of O +
histones B-Gene +
. O +

Whether O +
the O +
reversible O +
histone B-Gene +
acetylation O +
/ O +
deacetylation O +
modification O +
participates O +
in O +
the O +
regulation O +
of O +
IL-12 B-Gene +
p40 I-Gene +
transcription O +
expression O +
has O +
not O +
been O +
investigated O +
before O +
. O +

In O +
this O +
study O +
, O +
we O +
analyzed O +
the O +
roles O +
of O +
HDAC1 B-Gene +
and O +
p300 B-Gene +
in O +
the O +
regulation O +
of O +
human O +
IL-12 B-Gene +
p40 I-Gene +
. O +

Co O +
- O +
transfection O +
studies O +
showed O +
that O +
HDAC1 B-Gene +
had O +
a O +
repressing O +
effect O +
on O +
the O +
activity O +
of O +
IL-12 B-Gene +
p40 I-Gene +
promoter O +
. O +

Contrarily O +
, O +
p300 B-Gene +
was O +
able O +
to O +
reinforce O +
the O +
C B-Gene +
/ I-Gene +
EBPbeta I-Gene +
- O +
mediated O +
activation O +
of O +
IL-12 B-Gene +
p40 I-Gene +
and O +
it O +
counteracted O +
the O +
HDAC1 B-Gene +
- O +
mediated O +
repression O +
of O +
the O +
IL-12 B-Gene +
promoter O +
. O +

Chromatin O +
immunoprecipitation O +
tests O +
( O +
ChIP O +
) O +
revealed O +
that O +
p300 B-Gene +
had O +
a O +
stimulating O +
effect O +
on O +
the O +
acetylation O +
of O +
the O +
histone B-Gene +
H3 I-Gene +
at O +
IL-12 B-Gene +
p40 I-Gene +
promoter O +
. O +

In O +
addition O +
, O +
we O +
showed O +
that O +
p300 B-Gene +
had O +
a O +
physical O +
interaction O +
with O +
C B-Gene +
/ I-Gene +
EBPbeta I-Gene +
and O +
can O +
enhance O +
acetylation O +
of O +
C B-Gene +
/ I-Gene +
EBPbeta I-Gene +
. O +

Data O +
presented O +
in O +
this O +
paper O +
indicate O +
that O +
the O +
reversible O +
histone B-Gene +
acetylation O +
/ O +
deacetylation O +
modification O +
plays O +
an O +
important O +
role O +
in O +
the O +
transcriptional O +
regulation O +
of O +
IL-12 B-Gene +
. O +

IL-6 B-Gene +
transsignaling O +
: O +
the O +
in O +
vivo O +
consequences O +
. O +

Cytokine B-Gene +
receptors I-Gene +
exist O +
in O +
membrane O +
- O +
bound O +
and O +
soluble O +
forms O +
. O +

They O +
bind O +
their O +
ligands O +
with O +
comparable O +
affinity O +
. O +

Although O +
most O +
soluble O +
receptors O +
are O +
antagonists O +
because O +
they O +
compete O +
with O +
their O +
membrane O +
counterparts O +
for O +
their O +
ligands O +
, O +
some O +
soluble O +
receptors O +
are O +
agonists O +
. O +

In O +
this O +
case O +
, O +
on O +
target O +
cells O +
, O +
the O +
complex O +
of O +
cytokine B-Gene +
and O +
soluble O +
cytokine B-Gene +
receptor I-Gene +
binds O +
to O +
a O +
second O +
receptor O +
subunit O +
and O +
initiates O +
intracellular O +
signal O +
transduction O +
. O +

The O +
soluble O +
receptors O +
of O +
the O +
interleukin-6 B-Gene +
( I-Gene +
IL-6 I-Gene +
) I-Gene +
family I-Gene +
of I-Gene +
cytokines I-Gene +
-- O +
soluble O +
IL-6 B-Gene +
receptor I-Gene +
( O +
sIL-6R B-Gene +
) O +
, O +
sIL-11R B-Gene +
, O +
and O +
soluble O +
ciliary B-Gene +
neurotrophic I-Gene +
factor I-Gene +
receptor I-Gene +
( O +
sCNTFR B-Gene +
) O +
-- O +
are O +
agonists O +
. O +

In O +
vivo O +
, O +
the O +
IL-6 B-Gene +
/ O +
sIL-6R B-Gene +
complex O +
stimulates O +
several O +
types O +
of O +
target O +
cells O +
not O +
stimulated O +
by O +
IL-6 B-Gene +
alone O +
, O +
as O +
they O +
do O +
not O +
express O +
the O +
membrane O +
- O +
bound O +
IL-6R B-Gene +
. O +

This O +
process O +
has O +
been O +
named O +
transsignaling O +
. O +

We O +
have O +
shown O +
recently O +
that O +
in O +
several O +
chronic O +
inflammatory O +
diseases O +
, O +
such O +
as O +
chronic O +
inflammatory O +
bowl O +
disease O +
, O +
peritonitis O +
, O +
and O +
rheumatoid O +
arthritis O +
, O +
as O +
well O +
as O +
in O +
colon O +
cancer O +
, O +
transsignaling O +
via O +
the O +
sIL-6R B-Gene +
complexed O +
to O +
IL-6 B-Gene +
is O +
a O +
crucial O +
point O +
in O +
the O +
maintenance O +
of O +
the O +
disease O +
. O +

The O +
mechanism O +
by O +
which O +
the O +
IL-6 B-Gene +
/ O +
sIL-6R B-Gene +
complex O +
regulates O +
the O +
inflammatory O +
or O +
neoplastic O +
state O +
is O +
discussed O +
. O +

Age O +
- O +
related O +
alteration O +
of O +
vitamin O +
D O +
metabolism O +
in O +
response O +
to O +
low O +
- O +
phosphate O +
diet O +
in O +
rats O +
. O +

The O +
responses O +
of O +
renal O +
vitamin O +
D O +
metabolism O +
to O +
its O +
major O +
stimuli O +
alter O +
with O +
age O +
. O +

Previous O +
studies O +
showed O +
that O +
the O +
increase O +
in O +
circulating O +
1,25-dihydroxyvitamin O +
D O +
( O +
1,25 O -
( O -
OH O -
) O -
2D3 O +
) O +
as O +
well O +
as O +
renal O +
25-hydroxyvitamin B-Gene +
D3 I-Gene +
1-alpha I-Gene +
hydroxylase I-Gene +
( O +
1-OHase B-Gene +
) O +
activity O +
in O +
response O +
to O +
dietary O +
Ca O +
or O +
P O +
restriction O +
reduced O +
with O +
age O +
in O +
rats O +
. O +

We O +
hypothesized O +
that O +
the O +
mechanism O +
involved O +
in O +
increasing O +
circulating O +
1,25 O -
( O -
OH O -
) O -
2D3 O +
in O +
response O +
to O +
mineral O +
deficiency O +
alters O +
with O +
age O +
. O +

In O +
the O +
present O +
study O +
, O +
we O +
tested O +
the O +
hypothesis O +
by O +
studying O +
the O +
expression O +
of O +
genes O +
involved O +
in O +
renal O +
vitamin O +
D O +
metabolism O +
( O +
renal O +
1 B-Gene +
- I-Gene +
OHase I-Gene +
, O +
25-hydroxyvitamin B-Gene +
D I-Gene +
24-hydroxylase I-Gene +
( O +
24 B-Gene +
- I-Gene +
OHase I-Gene +
) O +
and O +
vitamin B-Gene +
D I-Gene +
receptor I-Gene +
( O +
VDR B-Gene +
) O +
) O +
in O +
young O +
( O +
1-month O -
- O -
old O -
) O +
and O +
adult O +
( O +
6 O +
- O +
month O +
- O +
old O +
) O +
rats O +
in O +
response O +
to O +
low O +
- O +
phosphate O +
diet O +
( O +
LPD O +
) O +
. O +

As O +
expected O +
, O +
serum O +
1,25 O -
( O -
OH O -
) O -
2D3 O +
increased O +
in O +
both O +
young O +
and O +
adult O +
rats O +
upon O +
LPD O +
treatment O +
and O +
the O +
increase O +
was O +
much O +
higher O +
in O +
younger O +
rats O +
. O +

In O +
young O +
rats O +
, O +
LPD O +
treatment O +
decreased O +
renal O +
24 B-Gene +
- I-Gene +
OHase I-Gene +
( O +
days O +
1 O +
- O +
7 O +
, O +
P O +
< O +
0.01 O +
) O +
and O +
increased O +
renal O +
1 B-Gene +
- I-Gene +
OHase I-Gene +
mRNA O +
expression O +
( O +
days O +
1 O -
- O -
5 O +
, O +
P O +
< O +
0.01 O +
) O +
. O +

LPD O +
treatment O +
failed O +
to O +
increase O +
renal O +
1-OHase B-Gene +
but O +
did O +
suppress O +
24-OHase B-Gene +
mRNA O +
expression O +
( O +
P O +
< O +
0.01 O +
) O +
within O +
7 O +
d O +
of O +
LPD O +
treatment O +
in O +
adult O +
rats O +
. O +

Renal O +
expression O +
of O +
VDR B-Gene +
mRNA O +
decreased O +
with O +
age O +
( O +
P O +
< O +
0.001 O +
) O +
and O +
was O +
suppressed O +
by O +
LPD O +
treatment O +
in O +
both O +
age O +
groups O +
( O +
P O +
< O +
0.05 O +
) O +
. O +

Feeding O +
of O +
adult O +
rats O +
with O +
10 O +
d O +
of O +
LPD O +
increased O +
1-OHase O +
( O +
P O +
< O +
0.05 O +
) O +
and O +
suppressed O +
24-OHase B-Gene +
( O +
P O +
< O +
0.001 O +
) O +
as O +
well O +
as O +
VDR B-Gene +
( O +
P O +
< O +
0.05 O +
) O +
mRNA O +
expression O +
. O +

These O +
results O +
indicate O +
that O +
the O +
increase O +
in O +
serum O +
1,25 O -
( O -
OH O -
) O -
2D3 O +
level O +
in O +
adult O +
rats O +
during O +
short O +
- O +
term O +
LPD O +
treatment O +
is O +
likely O +
to O +
be O +
mediated O +
by O +
a O +
decrease O +
in O +
metabolic O +
clearance O +
via O +
the O +
down O +
- O +
regulation O +
of O +
both O +
renal O +
24-OHase B-Gene +
and O +
VDR B-Gene +
expression O +
. O +

The O +
induction O +
of O +
renal O +
1-OHase B-Gene +
mRNA O +
expression O +
in O +
adult O +
rats O +
requires O +
longer O +
duration O +
of O +
LPD O +
treatment O +
than O +
in O +
younger O +
rats O +
. O +

Two O +
naturally O +
occurring O +
deletion O +
mutants O +
of O +
12S B-Gene +
seed I-Gene +
storage I-Gene +
proteins I-Gene +
in O +
Arabidopsis O +
thaliana O +
. O +

Two O +
naturally O +
occurring O +
Arabidopsis O +
mutants O +
, O +
Cape O +
Verde O +
Islands O +
and O +
Monte O +
( O +
Mr-0 O +
) O +
, O +
with O +
aberrant O +
12S B-Gene +
seed I-Gene +
storage I-Gene +
protein I-Gene +
( I-Gene +
SSP I-Gene +
) I-Gene +
profiles O +
have O +
been O +
identified O +
by O +
SDS O +
- O +
PAGE O +
. O +

In O +
both O +
mutants O +
, O +
one O +
of O +
the O +
12S B-Gene +
globulin I-Gene +
bands O +
is O +
missing O +
while O +
a O +
new O +
band O +
of O +
lower O +
molecular O +
mass O +
is O +
present O +
. O +

Tandem O +
mass O +
spectrometry O +
- O +
mass O +
spectrometry O +
( O +
MS O +
/ O +
MS O +
) O +
analyses O +
of O +
the O +
mutant O +
peptides O +
have O +
revealed O +
that O +
both O +
are O +
shorter O +
variants O +
of O +
12S B-Gene +
globulin I-Gene +
with O +
deletion O +
sites O +
detected O +
within O +
the O +
alpha O +
- O +
subunits O +
of O +
12S B-Gene +
globulin I-Gene +
cruciferin I-Gene +
B I-Gene +
( I-Gene +
CRB I-Gene +
) I-Gene +
and I-Gene +
C I-Gene +
( O +
CRC B-Gene +
) O +
, O +
respectively O +
. O +

Sequence O +
analyses O +
of O +
the O +
genomic O +
DNA O +
flanking O +
the O +
deletion O +
sites O +
have O +
demonstrated O +
that O +
both O +
deletions O +
occurred O +
at O +
the O +
genomic O +
level O +
. O +

These O +
two O +
mutants O +
are O +
referred O +
to O +
as O +
CRBDelta12 O +
and O +
CRCDelta13 O +
with O +
the O +
delta O +
sign O +
indicating O +
a O +
deletion O +
and O +
the O +
number O +
indicating O +
amino O +
acids O +
deleted O +
. O +

Alignment O +
of O +
these O +
two O +
mutant O +
sequences O +
with O +
that O +
of O +
soybean O +
A3B4 B-Gene +
subunit O +
, O +
for O +
which O +
the O +
crystal O +
structure O +
was O +
determined O +
recently O +
, O +
have O +
revealed O +
that O +
the O +
CRCDelta13 O +
deletion O +
is O +
located O +
in O +
a O +
hypervariable O +
/ O +
disordered O +
region O +
, O +
and O +
will O +
probably O +
not O +
affect O +
the O +
structure O +
of O +
the O +
hexameric O +
globulin O +
. O +

The O +
CRBDelta12 O +
deletion O +
, O +
however O +
, O +
is O +
located O +
in O +
a O +
binding O +
region O +
that O +
is O +
thought O +
to O +
be O +
important O +
for O +
the O +
hexamer O +
formation O +
. O +

However O +
, O +
CRBDelta12 O +
appears O +
to O +
accumulate O +
normally O +
as O +
judged O +
by O +
its O +
band O +
intensity O +
relative O +
to O +
the O +
other O +
SSP B-Gene +
subunits O +
on O +
the O +
protein O +
gels O +
. O +

Thus O +
it O +
seems O +
that O +
the O +
seed O +
can O +
, O +
to O +
a O +
certain O +
extent O +
, O +
tolerate O +
some O +
mutations O +
in O +
its O +
storage O +
proteins O +
. O +

Decreased O +
IgG B-Gene +
production O +
but O +
increased O +
MIP-1beta B-Gene +
expression O +
in O +
collagen B-Gene +
- O +
induced O +
arthritis O +
in O +
C B-Gene -
- I-Gene -
C I-Gene +
chemokine I-Gene +
receptor I-Gene +
5 I-Gene +
- O +
deficient O +
mice O +
. O +

Collagen B-Gene +
- O +
induced O +
arthritis O +
( O +
CIA O +
) O +
is O +
a O +
widely O +
used O +
model O +
of O +
human O +
rheumatoid O +
arthritis O +
( O +
RA O +
) O +
characterized O +
by O +
chronic O +
inflammation O +
of O +
the O +
synovial O +
joints O +
. O +

The O +
pathogenesis O +
of O +
RA O +
and O +
CIA O +
has O +
not O +
been O +
completely O +
defined O +
, O +
but O +
both O +
involve O +
the O +
recruitment O +
of O +
leukocytes O +
and O +
lymphocytes O +
to O +
the O +
joints O +
and O +
Th1 O +
- O +
type O +
cell O +
mediated O +
autoimmune O +
responses O +
. O +

The O +
C B-Gene -
- I-Gene -
C I-Gene +
chemokine I-Gene +
receptor I-Gene +
5 I-Gene +
( O +
CCR5 B-Gene +
) O +
is O +
preferentially O +
expressed O +
on O +
Th1 O +
cells O +
and O +
has O +
been O +
strongly O +
implicated O +
in O +
inflammatory O +
process O +
through O +
trafficking O +
of O +
leukocytes O +
and O +
lymphocytes O +
into O +
the O +
sites O +
of O +
inflammation O +
. O +

We O +
investigated O +
the O +
role O +
of O +
the O +
CCR5 B-Gene +
in O +
CIA O +
using O +
CCR5 B-Gene +
knockout O +
mice O +
( O +
CCR5 B-Gene +
- O -
/ O -
- O +
) O +
in O +
which O +
we O +
analyzed O +
the O +
consequences O +
of O +
CCR5 B-Gene +
deficiency O +
for O +
the O +
immune O +
response O +
and O +
inflammation O +
. O +

We O +
found O +
that O +
CCR5 B-Gene +
- O -
/ O -
- O +
mice O +
showed O +
a O +
significant O +
reduction O +
in O +
the O +
incidence O +
of O +
CIA O +
after O +
collagen B-Gene +
II I-Gene +
( O +
CII B-Gene +
) O +
- O +
immunization O +
as O +
compared O +
to O +
wild O +
- O +
type O +
( O +
CCR5 B-Gene +
+ O -
/+ O +
) O +
mice O +
. O +

The O +
reduced O +
incidence O +
seen O +
in O +
CCR5 B-Gene +
- O -
/ O -
- O +
mice O +
was O +
associated O +
with O +
these O +
animals O +
having O +
significantly O +
lower O +
IgG B-Gene +
levels O +
, O +
especially O +
IgG2a B-Gene +
and O +
IgG2b B-Gene +
antibodies O +
against O +
CII B-Gene +
, O +
as O +
well O +
as O +
an O +
obviously O +
augmented O +
IL-10 B-Gene +
production O +
in O +
splenocytes O +
. O +

Overproduction O +
of O +
MIP-1beta B-Gene +
in O +
CCR5 B-Gene +
- O +
deficient O +
mice O +
after O +
CII B-Gene +
- O +
immunization O +
may O +
contribute O +
partially O +
to O +
the O +
occurrence O +
of O +
arthritis O +
. O +

IL-17 B-Gene +
reduces O +
TNF B-Gene +
- O +
induced O +
Rantes B-Gene +
and O +
VCAM-1 B-Gene +
expression O +
. O +

Functional O +
diversity O +
of O +
the O +
memory O +
T O -
- O -
cell O +
- O +
derived O +
cytokine B-Gene +
IL-17 B-Gene +
was O +
explored O +
at O +
the O +
receptor O +
level O +
. O +

IL-17 B-Gene +
inhibited O +
TNF B-Gene +
- O +
induced O +
chemokine B-Gene +
Rantes B-Gene +
expression O +
in O +
human O +
synovial O +
fibroblasts O +
and O +
mouse O +
lung O +
fibroblasts O +
. O +

This O +
inhibitory O +
activity O +
of O +
IL-17 B-Gene +
( O +
IC50 O +
= O +
0.2 O +
ng O +
/ O +
ml O +
) O +
was O +
6 O +
- O +
fold O +
more O +
potent O +
than O +
its O +
stimulatory O +
activity O +
on O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
- O +
induced O +
IL-6 B-Gene +
secretion O +
( O +
ED50 O +
= O +
1.2 O +
ng O +
/ O +
ml O +
) O +
, O +
measured O +
in O +
the O +
same O +
cells O +
. O +

IL-17 B-Gene +
also O +
inhibited O +
the O +
TNF B-Gene +
- O +
mediated O +
expression O +
of O +
adhesion B-Gene +
molecule I-Gene +
VCAM-1 B-Gene +
, O +
and O +
the O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
binding O +
to O +
the O +
VCAM-1 B-Gene +
promoter O +
- O +
specific O +
site O +
, O +
along O +
with O +
the O +
inhibitor O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
, O +
IkappaB B-Gene -
- I-Gene -
beta I-Gene +
. O +

Neutralization O +
of O +
the O +
human O +
IL-17 B-Gene +
receptor I-Gene +
( O +
IL-17R B-Gene +
) O +
by O +
M202 O +
antibody O +
competitively O +
reverses O +
the O +
IL-17 B-Gene +
- O +
induced O +
IL-6 B-Gene +
upregulation O +
. O +

However O +
, O +
M202 O +
only O +
partially O +
affected O +
the O +
inhibitions O +
by O +
IL-17 B-Gene +
. O +

Yet O +
, O +
IL-17R B-Gene +
was O +
essential O +
for O +
the O +
Rantes B-Gene +
inhibition O +
, O +
as O +
assessed O +
in O +
lung O +
- O +
derived O +
fibroblasts O +
from O +
IL-17R B-Gene +
gene O +
deficient O +
mice O +
. O +

Therefore O +
, O +
inhibitory O +
and O +
stimulatory O +
functions O +
of O +
IL-17 B-Gene +
involve O +
receptor O +
IL-17R B-Gene +
but O +
show O +
distinct O +
dose O +
- O +
responses O +
and O +
in O +
turn O +
different O +
sensitivities O +
to O +
an O +
IL-17R B-Gene +
antagonizing O +
antibody O +
. O +

Lymphocyte O +
subsets O +
and O +
cytokines B-Gene +
in O +
women O +
with O +
gestational O +
diabetes O +
mellitus O +
and O +
their O +
newborn O +
. O +

This O +
study O +
aimed O +
to O +
identify O +
potential O +
immunological O +
markers O +
for O +
predicting O +
type O +
1 O +
diabetes O +
in O +
patients O +
with O +
gestational O +
diabetes O +
mellitus O +
( O +
GDM O +
) O +
and O +
any O +
immunological O +
impairment O +
in O +
their O +
newborn O +
. O +

In O +
62 O +
GDM O +
patients O +
and O +
74 O +
women O +
with O +
normal O +
glucose O +
tolerance O +
( O +
NGT O +
) O +
, O +
and O +
their O +
babies O +
, O +
we O +
assessed O +
total O +
lymphocytes O +
, O +
T O +
lymphocyte O +
subsets O +
CD3 B-Gene +
and O +
CD8 B-Gene +
expressing O +
T B-Gene +
cell I-Gene +
receptor I-Gene +
( I-Gene +
TCR I-Gene +
) I-Gene +
alpha I-Gene +
/ I-Gene +
beta I-Gene +
or I-Gene +
gamma I-Gene +
/ I-Gene +
delta I-Gene +
, O +
CD16 B-Gene +
and O +
CD19 B-Gene +
, O +
pancreatic O +
autoantibodies O +
and O +
cytokines B-Gene +
( O +
IL-5 B-Gene +
, O +
IL-2 B-Gene +
, O +
soluble O +
receptor B-Gene +
IL-2 I-Gene +
) O +
. O +

At O +
delivery O +
, O +
umbilical O +
cord O +
blood O +
samples O +
were O +
taken O +
for O +
lymphocyte O +
subpopulations O +
and O +
cytokine B-Gene +
measurements O +
. O +

GDM O +
mothers O +
had O +
higher O +
levels O +
of O +
total O +
lymphocytes O +
, O +
CD8 B-Gene +
expressing O +
TCR B-Gene +
gamma I-Gene +
/ I-Gene +
delta I-Gene +
, O +
and O +
lower O +
levels O +
of O +
CD3 B-Gene +
expressing O +
TCR B-Gene +
alpha I-Gene +
/ I-Gene +
beta I-Gene +
than O +
NGT O +
controls O +
. O +

Insulin B-Gene +
- O +
treated O +
GDM O +
mothers O +
had O +
lower O +
CD4 B-Gene +
and O +
CD4 B-Gene +
/ O +
CD8 B-Gene +
ratios O +
, O +
and O +
higher O +
CD8 B-Gene +
and O +
IL-5 B-Gene +
than O +
diet O +
- O +
treated O +
GDM O +
or O +
controls O +
. O +

Five O +
women O +
were O +
positive O +
for O +
pancreatic O +
autoantibodies O +
, O +
with O +
lower O +
CD4 B-Gene +
( O +
p O +
< O +
0.01 O +
) O +
and O +
CD4 B-Gene +
/ O +
CD8 B-Gene +
ratios O +
( O +
p O +
< O +
0.05 O +
) O +
, O +
and O +
higher O +
CD8 B-Gene +
( O +
p O +
< O +
0.03 O +
) O +
and O +
CD19 B-Gene +
than O +
GDM O +
and O +
control O +
mothers O +
negative O +
for O +
autoantibodies O +
. O +

GDM O +
newborn O +
had O +
higher O +
CD8 B-Gene +
gamma O +
/ O +
delta O +
and O +
lower O +
CD16 B-Gene +
than O +
NGT O +
babies O +
. O +

There O +
were O +
no O +
significant O +
differences O +
in O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
concentrations O +
in O +
the O +
cord O +
blood O +
obtained O +
from O +
the O +
GDM O +
and O +
NGT O +
newborn O +
. O +

In O +
conclusion O +
, O +
GDM O +
women O +
and O +
their O +
newborn O +
have O +
lymphocyte O +
subset O +
impairments O +
, O +
which O +
are O +
more O +
important O +
in O +
patients O +
positive O +
for O +
autoantibodies O +
and/or O +
treated O +
with O +
insulin B-Gene +
. O +

New O +
lnu B-Gene -
( I-Gene -
C I-Gene -
) I-Gene +
gene O +
conferring O +
resistance O +
to O +
lincomycin O +
by O +
nucleotidylation O +
in O +
Streptococcus O +
agalactiae O +
UCN36 O +
. O +

Streptococcus O +
agalactiae O +
UCN36 O +
was O +
resistant O +
to O +
lincomycin O +
( O +
MIC O +
= O +
16 O +
microg O +
/ O +
ml O +
) O +
but O +
susceptible O +
to O +
clindamycin O +
( O +
MIC O +
= O +
0.12 O +
microg O +
/ O +
ml O +
) O +
and O +
erythromycin O +
( O +
MIC O +
= O +
0.06 O +
microg O +
/ O +
ml O +
) O +
. O +

A O +
4 O +
- O +
kb O +
HindIII B-Gene +
fragment O +
was O +
cloned O +
from O +
S. O +
agalactiae O +
UCN36 O +
total O +
DNA O +
on O +
plasmid O +
pUC18 O +
and O +
introduced O +
into O +
Escherichia O +
coli O +
AG100A O +
, O +
where O +
it O +
conferred O +
resistance O +
to O +
lincomycin O +
. O +

The O +
sequence O +
analysis O +
of O +
the O +
fragment O +
showed O +
the O +
presence O +
of O +
a O +
1,724-bp O +
element O +
delineated O +
by O +
imperfect O +
inverted O +
repeats O +
( O +
22 O +
of O +
25 O +
bp O +
) O +
and O +
inserted O +
in O +
the O +
operon O +
for O +
capsular O +
synthesis O +
of O +
S. O +
agalactiae O +
UCN36 O +
. O +

This O +
element O +
carried O +
two O +
open O +
reading O +
frames O +
( O +
ORF O +
) O +
. O +

The O +
deduced O +
amino O +
acid O +
sequence O +
of O +
the O +
upstream O +
ORF O +
displayed O +
similarity O +
with O +
transposases B-Gene +
from O +
anaerobes O +
and O +
IS1 O +
. O +

The O +
downstream O +
ORF O +
, O +
lnu B-Gene +
( I-Gene +
C I-Gene +
) I-Gene +
, O +
encoded O +
a O +
164 O +
- O +
amino O +
- O +
acid O +
protein O +
with O +
26 O +
% O +
to O +
27 O +
% O +
identity O +
with O +
the O +
LnuA B-Gene +
( O +
N2 O +
) O +
, O +
LnuA B-Gene +
, O +
and O +
LnuA B-Gene +
' O +
lincosamide O +
nucleotidyltransferases B-Gene +
reported O +
for O +
Bacteroides O +
and O +
Staphylococcus O +
, O +
respectively O +
. O +

Crude O +
lysates O +
of O +
E. O +
coli O +
AG100A O +
containing O +
the O +
cloned O +
lnu B-Gene +
( I-Gene +
C I-Gene +
) I-Gene +
gene O +
inactivated O +
lincomycin O +
and O +
clindamycin O +
in O +
the O +
presence O +
of O +
ATP O +
and O +
MgCl2 O +
. O +

Mass O +
spectrometry O +
experiments O +
demonstrated O +
that O +
the O +
LnuC B-Gene +
enzyme O +
catalyzed O +
adenylylation O +
of O +
lincomycin O +
. O +

Evolution O +
of O +
3-deoxy B-Gene -
- I-Gene -
D I-Gene -
- I-Gene -
arabino I-Gene -
- I-Gene -
heptulosonate-7-phosphate I-Gene +
synthase I-Gene +
- O +
encoding O +
genes O +
in O +
the O +
yeast O +
Saccharomyces O +
cerevisiae O +
. O +

The O +
shikimate O +
pathway O +
resulting O +
in O +
three O +
aromatic O +
amino O +
acids O +
is O +
initiated O +
in O +
different O +
organisms O +
by O +
two O +
and O +
three O +
3-deoxy B-Gene -
- I-Gene -
d I-Gene -
- I-Gene -
arabino I-Gene -
- I-Gene -
heptulosonate-7-phosphate I-Gene +
synthases I-Gene +
, O +
respectively O +
. O +

Aro3p B-Gene +
and O +
Aro4p B-Gene +
are O +
the O +
yeast O +
enzymes O +
feedback O +
- O +
inhibited O +
by O +
phenylalanine O +
and O +
tyrosine O +
, O +
respectively O +
. O +

A O +
yeast O +
strain O +
deficient O +
in O +
the O +
general O +
control O +
transcriptional O +
regulatory O +
system O +
of O +
amino O +
acid O +
biosynthesis O +
is O +
unable O +
to O +
live O +
in O +
the O +
presence O +
of O +
high O +
amounts O +
of O +
phenylalanine O +
and O +
tyrosine O +
. O +

Here O +
, O +
we O +
show O +
that O +
this O +
yeast O +
strain O +
can O +
be O +
rescued O +
by O +
the O +
expression O +
of O +
aroH B-Gene +
from O +
Escherichia O +
coli O +
encoding O +
the O +
tryptophan O +
- O +
regulated O +
AroH B-Gene +
as O +
third O +
isoenzyme O +
. O +

Yeast O +
carrying O +
Ec O +
AroH B-Gene +
as O +
the O +
only O +
enzyme O +
for O +
the O +
initial O +
step O +
of O +
the O +
shikimate O +
pathway O +
can O +
grow O +
in O +
the O +
absence O +
of O +
tryptophan O +
. O +

Without O +
aromatic O +
amino O +
acids O +
, O +
this O +
yeast O +
strain O +
survives O +
only O +
when O +
the O +
yeast O +
ARO3 B-Gene +
promoter O +
instead O +
of O +
the O +
ARO4 B-Gene +
promoter O +
drives O +
E. O +
coli O +
aroH B-Gene +
. O +

The O +
detailed O +
analysis O +
of O +
Aro3p B-Gene +
and O +
Aro4p B-Gene +
revealed O +
a O +
triple O +
feedback O +
control O +
by O +
tyrosine O +
/ O +
phenylalanine O +
and O +
tryptophan O +
. O +

Dissecting O +
this O +
control O +
allowed O +
engineering O +
of O +
Aro4p B-Gene +
S195A O +
as O +
an O +
enzyme O +
, O +
which O +
is O +
inhibited O +
like O +
AroH B-Gene +
only O +
by O +
tryptophan O +
. O +

In O +
addition O +
, O +
Aro4p B-Gene +
variants O +
were O +
constructed O +
that O +
show O +
an O +
equally O +
strong O +
inhibition O +
by O +
tyrosine O +
and O +
tryptophan O +
( O +
Aro4p B-Gene +
P165 O -
G O +
Q302R O +
) O +
and O +
in O +
which O +
the O +
regulation O +
by O +
tyrosine O +
and O +
tryptophan O +
was O +
reversed O +
( O +
Aro4p B-Gene +
P165 O -
G O +
) O +
. O +

Our O +
data O +
suggest O +
that O +
yeast O +
possesses O +
only O +
two O +
instead O +
of O +
three O +
isogenes O +
encoding O +
3-deoxy B-Gene -
- I-Gene -
D I-Gene -
- I-Gene -
arabino I-Gene -
- I-Gene -
heptulosonate-7-phosphate I-Gene +
synthases I-Gene +
because O +
both O +
isoenzymes O +
can O +
be O +
fine O +
tuned O +
by O +
tryptophan O +
as O +
additional O +
effector O +
and O +
because O +
transcriptional O +
regulation O +
by O +
the O +
general O +
control O +
system O +
can O +
be O +
induced O +
as O +
backup O +
when O +
aromatic O +
amino O +
acids O +
in O +
the O +
environment O +
are O +
imbalanced O +
. O +

Dysregulation O +
of O +
the O +
peroxisome B-Gene +
proliferator I-Gene +
- I-Gene +
activated I-Gene +
receptor I-Gene +
target O +
genes O +
by O +
XPD B-Gene +
mutations O +
. O +

Mutations O +
in O +
the O +
XPD B-Gene +
subunit O +
of O +
TFIIH B-Gene +
give O +
rise O +
to O +
human O +
genetic O +
disorders O +
initially O +
defined O +
as O +
DNA O +
repair O +
syndromes O +
. O +

Nevertheless O +
, O +
xeroderma O +
pigmentosum O +
( O +
XP O +
) O +
group O +
D O +
( O +
XP O +
- O +
D O +
) O +
patients O +
develop O +
clinical O +
features O +
such O +
as O +
hypoplasia O +
of O +
the O +
adipose O +
tissue O +
, O +
implying O +
a O +
putative O +
transcriptional O +
defect O +
. O +

Knowing O +
that O +
peroxisome B-Gene +
proliferator I-Gene +
- I-Gene +
activated I-Gene +
receptors I-Gene +
( O +
PPARs B-Gene +
) O +
are O +
implicated O +
in O +
lipid O +
metabolism O +
, O +
we O +
investigated O +
the O +
expression O +
of O +
PPAR B-Gene +
target O +
genes O +
in O +
the O +
adipose O +
tissues O +
and O +
the O +
livers O +
of O +
XPD B-Gene +
- O +
deficient O +
mice O +
and O +
found O +
that O +
( O +
i O +
) O +
some O +
genes O +
are O +
abnormally O +
overexpressed O +
in O +
a O +
ligand O +
- O +
independent O +
manner O +
which O +
parallels O +
an O +
increase O +
in O +
the O +
recruitment O +
of O +
RNA B-Gene +
polymerase I-Gene +
( I-Gene +
pol I-Gene +
) I-Gene +
II I-Gene +
but O +
not O +
PPARs B-Gene +
on O +
their O +
promoter O +
and O +
( O +
ii O +
) O +
upon O +
treatment O +
with O +
PPAR B-Gene +
ligands O +
, O +
other O +
genes O +
are O +
much O +
less O +
induced O +
compared O +
to O +
the O +
wild O +
type O +
, O +
which O +
is O +
due O +
to O +
a O +
lower O +
recruitment O +
of O +
both O +
PPARs B-Gene +
and O +
RNA B-Gene +
pol I-Gene +
II I-Gene +
. O +

The O +
defect O +
in O +
transactivation O +
by O +
PPARs B-Gene +
is O +
likely O +
attributable O +
to O +
their O +
weaker O +
phosphorylation O +
by O +
the O +
cdk7 B-Gene +
kinase B-Gene +
of O +
TFIIH B-Gene +
. O +

Having O +
identified O +
the O +
phosphorylated O +
residues O +
in O +
PPAR B-Gene +
isotypes O +
, O +
we O +
demonstrate O +
how O +
their O +
transactivation O +
defect O +
in O +
XPD B-Gene +
- O +
deficient O +
cells O +
can O +
be O +
circumvented O +
by O +
overexpression O +
of O +
either O +
a O +
wild O +
- O +
type O +
XPD B-Gene +
or O +
a O +
constitutively O +
phosphorylated O +
PPAR B-Gene +
S O +
/ O +
E O +
. O +

This O +
work O +
emphasizes O +
that O +
underphosphorylation O +
of O +
PPARs B-Gene +
affects O +
their O +
transactivation O +
and O +
consequently O +
the O +
expression O +
of O +
PPAR B-Gene +
target O +
genes O +
, O +
thus O +
contributing O +
in O +
part O +
to O +
the O +
XP O +
- O +
D O +
phenotype O +
. O +

Cloning O +
of O +
a O +
quail O +
homologue O +
of O +
hatching B-Gene +
enzyme I-Gene +
: O +
its O +
conserved O +
function O +
and O +
additional O +
function O +
in O +
egg O +
envelope O +
digestion O +
. O +

The O +
aim O +
of O +
the O +
present O +
study O +
was O +
to O +
reveal O +
molecular O +
entities O +
participating O +
in O +
the O +
digestion O +
of O +
the O +
egg O +
envelope O +
in O +
the O +
Japanese O +
quail O +
, O +
Coturnix O +
japonica O +
. O +

We O +
isolated O +
a O +
1,510-bp O +
cDNA O +
from O +
extraembryonic O +
tissues O +
of O +
developing O +
embryos O +
and O +
designated O +
it O +
quail B-Gene +
hatching I-Gene +
enzyme I-Gene +
( O +
QHE B-Gene +
) O +
cDNA O +
. O +

The O +
QHE B-Gene +
cDNA O +
was O +
found O +
to O +
code O +
a O +
protein O +
molecule O +
comprising O +
an O +
astacin B-Gene +
protease I-Gene +
domain O +
in O +
the O +
N O +
- O +
terminal O +
half O +
and O +
a O +
complement O +
subcomponents O +
C1r B-Gene +
/ O +
C1s B-Gene +
, O +
Uegf B-Gene +
, O +
Bmp1 B-Gene +
( O +
CUB O +
) O +
domain O +
in O +
the O +
C O +
- O +
terminal O +
half O +
. O +

A O +
phylogenetic O +
analysis O +
showed O +
that O +
QHE B-Gene +
belonged O +
to O +
the O +
hatching B-Gene +
enzyme I-Gene +
group I-Gene +
and O +
was O +
distinct O +
from O +
other O +
proteases B-Gene +
in O +
the O +
astacin B-Gene +
family I-Gene +
. O +

Northern O +
blotting O +
and O +
in O +
situ O +
hybridization O +
demonstrated O +
that O +
expression O +
of O +
the O +
QHE B-Gene +
mRNA O +
occurred O +
twice O +
during O +
the O +
development O +
: O +
first O +
in O +
ectodermal O +
cells O +
of O +
the O +
yolk O +
sac O +
on O +
days O +
0 O +
- O +
5 O +
, O +
then O +
in O +
those O +
of O +
the O +
albumen O +
sac O +
on O +
days O +
8 O +
- O +
13 O +
. O +

Zymography O +
revealed O +
that O +
proteolytic O +
activity O +
in O +
extracts O +
of O +
days O +
3 O -
- O -
4 O +
and O +
9 O +
- O +
12 O +
embryos O +
appeared O +
at O +
the O +
position O +
of O +
40 O +
kDa O +
. O +

Immunoblotting O +
tests O +
showed O +
that O +
anti O +
- O +
QHE B-Gene +
antiserum O +
stained O +
a O +
40 O +
- O +
kDa O +
molecule O +
in O +
extracts O +
of O +
day O +
3 O +
area O +
vitellina O +
. O +

Anti O +
- O +
QHE B-Gene +
antibody O +
stained O +
the O +
ectodermal O +
cells O +
of O +
the O +
area O +
opaca O +
on O +
days O +
0 O +
- O +
1 O +
, O +
those O +
of O +
the O +
area O +
vitellina O +
of O +
the O +
yolk O +
sac O +
on O +
days O +
2 O -
- O -
5 O +
, O +
and O +
those O +
of O +
the O +
albumen O +
sac O +
on O +
days O +
9 O +
- O +
12 O +
. O +

The O +
temporal O +
and O +
spatial O +
expression O +
pattern O +
of O +
QHE B-Gene +
mRNA O +
was O +
closely O +
associated O +
with O +
digestion O +
of O +
the O +
vitelline O +
membrane O +
occurring O +
on O +
days O +
1 O +
- O +
4 O +
, O +
and O +
with O +
that O +
of O +
the O +
egg O +
white O +
on O +
days O +
9 O +
- O +
12 O +
. O +

Control O +
of O +
root O +
cap O +
formation O +
by O +
MicroRNA O +
- O +
targeted O +
auxin B-Gene +
response I-Gene +
factors I-Gene +
in O +
Arabidopsis O +
. O +

The O +
plant O +
root O +
cap O +
mediates O +
the O +
direction O +
of O +
root O +
tip O +
growth O +
and O +
protects O +
internal O +
cells O +
. O +

Root O +
cap O +
cells O +
are O +
continuously O +
produced O +
from O +
distal O +
stem O +
cells O +
, O +
and O +
the O +
phytohormone O +
auxin O +
provides O +
position O +
information O +
for O +
root O +
distal O +
organization O +
. O +

Here O +
, O +
we O +
identify O +
the O +
Arabidopsis O +
thaliana O +
auxin B-Gene +
response I-Gene +
factors I-Gene +
ARF10 B-Gene +
and O +
ARF16 B-Gene +
, O +
targeted O +
by O +
microRNA160 O +
( O +
miR160 O +
) O +
, O +
as O +
the O +
controller O +
of O +
root O +
cap O +
cell O +
formation O +
. O +

The O +
Pro O -
( O -
35S O -
) O +
: O +
MIR160 O +
plants O +
, O +
in O +
which O +
the O +
expression O +
of O +
ARF10 B-Gene +
and O +
ARF16 B-Gene +
is O +
repressed O +
, O +
and O +
the O +
arf10 B-Gene +
- O +
2 O +
arf16 B-Gene +
- O +
2 O +
double O +
mutants O +
display O +
the O +
same O +
root O +
tip O +
defect O +
, O +
with O +
uncontrolled O +
cell O +
division O +
and O +
blocked O +
cell O +
differentiation O +
in O +
the O +
root O +
distal O +
region O +
and O +
show O +
a O +
tumor O +
- O +
like O +
root O +
apex O +
and O +
loss O +
of O +
gravity O +
- O +
sensing O +
. O +

ARF10 B-Gene +
and O +
ARF16 B-Gene +
play O +
a O +
role O +
in O +
restricting O +
stem O +
cell O +
niche O +
and O +
promoting O +
columella O +
cell O +
differentiation O +
; O +
although O +
functionally O +
redundant O +
, O +
the O +
two O +
ARFs B-Gene +
are O +
indispensable O +
for O +
root O +
cap O +
development O +
, O +
and O +
the O +
auxin O +
signal O +
can O -
not O +
bypass O +
them O +
to O +
initiate O +
columella O +
cell O +
production O +
. O +

In O +
root O +
, O +
auxin O +
and O +
miR160 O +
regulate O +
the O +
expression O +
of O +
ARF10 B-Gene +
and O +
ARF16 B-Gene +
genes O +
independently O +
, O +
generating O +
a O +
pattern O +
consistent O +
with O +
root O +
cap O +
development O +
. O +

We O +
further O +
demonstrate O +
that O +
miR160-uncoupled O +
production O +
of O +
ARF16 B-Gene +
exerts O +
pleiotropic O +
effects O +
on O +
plant O +
phenotypes O +
, O +
and O +
miR160 O +
plays O +
an O +
essential O +
role O +
in O +
regulating O +
Arabidopsis O +
development O +
and O +
growth O +
. O +

Deletion O +
of O +
Cg O +
- O +
emb B-Gene +
in O +
corynebacterianeae O +
leads O +
to O +
a O +
novel O +
truncated O +
cell O +
wall O +
arabinogalactan O +
, O +
whereas O +
inactivation O +
of O +
Cg O +
- O +
ubiA B-Gene +
results O +
in O +
an O +
arabinan O +
- O +
deficient O +
mutant O +
with O +
a O +
cell O +
wall O +
galactan O +
core O +
. O +

The O +
cell O +
wall O +
of O +
Mycobacterium O +
tuberculosis O +
has O +
a O +
complex O +
ultrastructure O +
that O +
consists O +
of O +
mycolic O +
acids O +
connected O +
to O +
peptidoglycan O +
via O +
arabinogalactan O +
( O +
AG O +
) O +
and O +
abbreviated O +
as O +
the O +
mAGP O +
complex O +
. O +

The O +
mAGP O +
complex O +
is O +
crucial O +
for O +
the O +
survival O +
and O +
pathogenicity O +
of O +
M. O +
tuberculosis O +
and O +
is O +
the O +
target O +
of O +
several O +
anti O +
- O +
tubercular O +
agents O +
. O +

Apart O +
from O +
sharing O +
a O +
similar O +
mAGP O +
and O +
the O +
availability O +
of O +
the O +
complete O +
genome O +
sequence O +
, O +
Corynebacterium O +
glutamicum O +
has O +
proven O +
useful O +
in O +
the O +
study O +
of O +
orthologous O +
M. O +
tuberculosis O +
genes O +
essential O +
for O +
viability O +
. O +

Here O +
we O +
examined O +
the O +
effects O +
of O +
particular O +
genes O +
involved O +
in O +
AG O +
polymerization O +
by O +
gene O +
deletion O +
in O +
C. O +
glutamicum O +
. O +

The O +
anti O +
- O +
tuberculosis O +
drug O +
ethambutol O +
is O +
thought O +
to O +
target O +
a O +
set O +
of O +
arabinofuranosyltransferases B-Gene +
( O +
Emb B-Gene +
) O +
that O +
are O +
involved O +
in O +
arabinan O +
polymerization O +
. O +

Deletion O +
of O +
emb B-Gene +
in O +
C. O +
glutamicum O +
results O +
in O +
a O +
slow O +
growing O +
mutant O +
with O +
profound O +
morphological O +
changes O +
. O +

Chemical O +
analysis O +
revealed O +
a O +
dramatic O +
reduction O +
of O +
arabinose O +
resulting O +
in O +
a O +
novel O +
truncated O +
AG O +
structure O +
possessing O +
only O +
terminal O +
arabinofuranoside O +
( O +
t O +
- O +
Araf O +
) O +
residues O +
with O +
a O +
corresponding O +
loss O +
of O +
cell O +
wall O +
bound O +
mycolic O +
acids O +
. O +

Treatment O +
of O +
wild O +
- O +
type O +
C. O +
glutamicum O +
with O +
ethambutol O +
and O +
subsequent O +
cell O +
wall O +
analyses O +
resulted O +
in O +
an O +
identical O +
phenotype O +
comparable O +
to O +
the O +
C. O +
glutamicum O +
emb B-Gene +
deletion O +
mutant O +
. O +

Additionally O +
, O +
disruption O +
of O +
ubiA B-Gene +
in O +
C. O +
glutamicum O +
, O +
the O +
first O +
enzyme O +
involved O +
in O +
the O +
biosynthesis O +
of O +
the O +
sugar O +
donor O +
decaprenol O +
phosphoarabinose O +
( O +
DPA O +
) O +
, O +
resulted O +
in O +
a O +
complete O +
loss O +
of O +
cell O +
wall O +
arabinan O +
. O +

Herein O +
, O +
we O +
establish O +
for O +
the O +
first O +
time O +
, O +
( O -
i O -
) O +
that O +
in O +
contrast O +
to O +
M. O +
tuberculosis O +
embA B-Gene +
and O +
embB B-Gene +
mutants O +
, O +
deletion O +
of O +
C. O +
glutamicum O +
emb B-Gene +
leads O +
to O +
a O +
highly O +
truncated O +
AG O +
possessing O +
t O +
- O +
Araf O +
residues O +
, O +
( O -
ii O -
) O +
the O +
exact O +
site O +
of O +
attachment O +
of O +
arabinan O +
chains O +
in O +
AG O +
, O +
and O +
( O -
iii O -
) O +
DPA O +
is O +
the O +
only O +
Araf O +
sugar O +
donor O +
in O +
AG O +
biosynthesis O +
suggesting O +
the O +
presence O +
of O +
a O +
novel O +
enzyme O +
responsible O +
for O +
" O +
priming O +
" O +
the O +
galactan O +
domain O +
for O +
further O +
elaboration O +
by O +
Emb B-Gene +
, O +
resulting O +
in O +
the O +
final O +
maturation O +
of O +
the O +
native O +
AG O +
polysaccharide O +
. O +

Human O +
high B-Gene +
density I-Gene +
lipoproteins I-Gene +
are O +
platforms O +
for O +
the O +
assembly O +
of O +
multi O +
- O +
component O +
innate O +
immune O +
complexes O +
. O +

Human O +
innate O +
immunity O +
to O +
non O +
- O +
pathogenic O +
species O +
of O +
African O +
trypanosomes O +
is O +
provided O +
by O +
human O +
high B-Gene +
density I-Gene +
lipoprotein I-Gene +
( O +
HDL B-Gene +
) O +
particles O +
. O +

Here O +
we O +
show O +
that O +
native O +
human O +
HDLs B-Gene +
containing O +
haptoglobin B-Gene +
- I-Gene +
related I-Gene +
protein I-Gene +
( O +
Hpr B-Gene +
) O +
, O +
apolipoprotein B-Gene +
L I-Gene -
- I-Gene -
I I-Gene +
( O +
apoL B-Gene -
- I-Gene -
I I-Gene +
) O +
and O +
apolipoprotein B-Gene +
A I-Gene -
- I-Gene -
I I-Gene +
( O +
apoA B-Gene -
- I-Gene -
I I-Gene +
) O +
are O +
the O +
principle O +
antimicrobial O +
molecules O +
providing O +
protection O +
from O +
trypanosome O +
infection O +
. O +

Other O +
HDL B-Gene +
subclasses O +
containing O +
either O +
apoA B-Gene -
- I-Gene -
I I-Gene +
and O +
apoL B-Gene -
- I-Gene -
I I-Gene +
or O +
apoA B-Gene -
- I-Gene -
I I-Gene +
and O +
Hpr B-Gene +
have O +
reduced O +
trypanolytic O +
activity O +
, O +
whereas O +
HDL B-Gene +
subclasses O +
lacking O +
apoL B-Gene -
- I-Gene -
I I-Gene +
and O +
Hpr B-Gene +
are O +
non O +
- O +
toxic O +
to O +
trypanosomes O +
. O +

Highly O +
purified O +
, O +
lipid O +
- O +
free O +
Hpr B-Gene +
and O +
apoL B-Gene -
- I-Gene -
I I-Gene +
were O +
both O +
toxic O +
to O +
Trypanosoma O +
brucei O +
brucei O +
but O +
with O +
specific O +
activities O +
at O +
least O +
500 O +
- O +
fold O +
less O +
than O +
those O +
of O +
native O +
HDLs B-Gene +
, O +
suggesting O +
that O +
association O +
of O +
these O +
apolipoproteins B-Gene +
within O +
the O +
HDL B-Gene +
particle O +
was O +
necessary O +
for O +
optimal O +
cytotoxicity O +
. O +

These O +
studies O +
show O +
that O +
HDLs B-Gene +
can O +
serve O +
as O +
platforms O +
for O +
the O +
assembly O +
of O +
multiple O +
synergistic O +
proteins O +
and O +
that O +
these O +
assemblies O +
may O +
play O +
a O +
critical O +
role O +
in O +
the O +
evolution O +
of O +
primate O +
- O +
specific O +
innate O +
immunity O +
to O +
trypanosome O +
infection O +
. O +

Novel O +
brain O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
interacting O +
proteins O +
involved O +
in O +
neurodegenerative O +
disease O +
. O +

We O +
isolated O +
two O +
novel O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
binding O +
proteins O +
using O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
zeta I-Gene +
as O +
bait O +
in O +
a O +
yeast O +
two O +
- O +
hybrid O +
screen O +
of O +
a O +
human O +
brain O +
cDNA O +
library O +
. O +

One O +
of O +
these O +
encoded O +
the O +
C O -
- O -
terminus O +
of O +
a O +
neural O +
specific O +
armadillo B-Gene +
- O +
repeat O +
protein O +
, O +
delta B-Gene -
- I-Gene -
catenin I-Gene +
( O +
neural B-Gene +
plakophilin I-Gene +
- I-Gene +
related I-Gene +
arm I-Gene +
- I-Gene +
repeat I-Gene +
protein I-Gene +
or O +
neurojungin B-Gene +
) O +
. O +

delta B-Gene -
- I-Gene -
Catenin I-Gene +
from O +
brain O +
lysates O +
was O +
retained O +
on O +
a O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
affinity O +
column O +
. O +

Mutation O +
of O +
serine O +
1072 O +
in O +
the O +
human O +
protein O +
and O +
serine O +
1094 O +
in O +
the O +
equivalent O +
site O +
in O +
the O +
mouse O +
homologue O +
( O +
in O +
a O +
consensus O +
binding O +
motif O +
for O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
) O +
abolished O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
binding O +
to O +
delta B-Gene -
- I-Gene -
catenin I-Gene +
in O +
vitro O +
and O +
in O +
transfected O +
cells O +
. O +

delta B-Gene -
- I-Gene -
catenin I-Gene +
binds O +
to O +
presenilin-1 B-Gene +
, O +
encoded O +
by O +
the O +
gene O +
most O +
commonly O +
mutated O +
in O +
familial O +
Alzheimer O +
' O +
s O +
disease O +
. O +

The O +
other O +
clone O +
was O +
identified O +
as O +
the O +
insulin B-Gene +
receptor I-Gene +
tyrosine I-Gene +
kinase I-Gene +
substrate I-Gene +
protein I-Gene +
of I-Gene +
53 I-Gene +
kDa I-Gene +
( O +
IRSp53 B-Gene +
) O +
. O +

Human O +
IRSp53 B-Gene +
interacts O +
with O +
the O +
gene O +
product O +
implicated O +
in O +
dentatorubral O +
- O +
pallidoluysian O +
atrophy O +
, O +
an O +
autosomal O +
recessive O +
disorder O +
associated O +
with O +
glutamine O +
repeat O +
expansion O +
of O +
atrophin B-Gene +
- I-Gene +
1 I-Gene +
. O +

Phosphatidylcholine B-Gene +
transfer I-Gene +
protein I-Gene +
regulates O +
size O +
and O +
hepatic O +
uptake O +
of O +
high O +
- O +
density O +
lipoproteins O +
. O +

Phosphatidylcholine B-Gene +
transfer I-Gene +
protein I-Gene +
( O +
PC B-Gene -
- I-Gene -
TP I-Gene +
) O +
is O +
a O +
steroidogenic O +
acute O +
regulatory O +
- O +
related O +
transfer O +
domain O +
protein O +
that O +
is O +
enriched O +
in O +
liver O +
cytosol O +
and O +
binds O +
phosphatidylcholines O +
with O +
high O +
specificity O +
. O +

In O +
tissue O +
culture O +
systems O +
, O +
PC B-Gene -
- I-Gene -
TP I-Gene +
promotes O +
ATP O +
- O +
binding O +
cassette O +
protein O +
A1 O +
- O +
mediated O +
efflux O +
of O +
cholesterol O +
and O +
phosphatidylcholine O +
molecules O +
as O +
nascent O +
pre O +
- O +
beta O +
- O +
high B-Gene +
- I-Gene +
density I-Gene +
lipoprotein I-Gene +
( O +
HDL B-Gene +
) O +
particles O +
. O +

Here O +
, O +
we O +
explored O +
a O +
role O +
for O +
PC B-Gene +
- I-Gene +
TP I-Gene +
in O +
HDL B-Gene +
metabolism O +
in O +
vivo O +
utilizing O +
8 O +
- O +
wk O +
- O +
old O +
male O +
Pctp B-Gene +
( O +
- O +
/ O +
- O +
) O +
and O +
wild O -
- O -
type O +
littermate O +
C57BL O +
/ O +
6J O +
mice O +
that O +
were O +
fed O +
for O +
7 O +
days O +
with O +
either O +
chow O +
or O +
a O +
high O +
- O +
fat O +
/ O +
high O +
- O +
cholesterol O +
diet O +
. O +

In O +
chow O +
- O +
fed O +
mice O +
, O +
neither O +
plasma O +
cholesterol O +
concentrations O +
nor O +
the O +
concentrations O +
and O +
compositions O +
of O +
plasma O +
phospholipids O +
were O +
influenced O +
by O +
PC B-Gene +
- I-Gene +
TP I-Gene +
expression O +
. O +

However O +
, O +
in O +
Pctp B-Gene +
( O +
- O +
/ O +
- O +
) O +
mice O +
, O +
there O +
was O +
an O +
accumulation O +
of O +
small O +
alpha O +
- O +
migrating O +
HDL B-Gene +
particles O +
. O +

This O +
occurred O +
without O +
changes O +
in O +
hepatic O +
expression O +
of O +
ATP B-Gene +
- I-Gene +
binding I-Gene +
cassette I-Gene +
protein I-Gene +
A1 I-Gene +
or O +
in O +
proteins O +
that O +
regulate O +
the O +
intravascular O +
metabolism O +
and O +
clearance O +
of O +
HDL B-Gene +
particles O +
. O +

In O +
Pctp B-Gene +
( O +
- O -
/ O -
- O +
) O +
mice O +
fed O +
the O +
high O +
- O +
fat O +
/ O +
high O +
- O +
cholesterol O +
diet O +
, O +
HDL B-Gene +
particle O +
sizes O +
were O +
normalized O +
, O +
whereas O +
plasma O +
cholesterol O +
and O +
phospholipid O +
concentrations O +
were O +
increased O +
compared O +
with O +
wild O +
- O +
type O +
mice O +
. O +

In O +
the O +
absence O +
of O +
upregulation O +
of O +
hepatic O +
ATP B-Gene +
- I-Gene +
binding I-Gene +
cassette I-Gene +
protein I-Gene +
A1 I-Gene +
, O +
reduced O +
HDL B-Gene +
uptake O +
from O +
plasma O +
into O +
livers O +
of O +
Pctp B-Gene +
( O +
- O +
/ O +
- O +
) O +
mice O +
contributed O +
to O +
higher O +
plasma O +
lipid O +
concentrations O +
. O +

These O +
data O +
indicate O +
that O +
PC B-Gene -
- I-Gene -
TP I-Gene +
is O +
not O +
essential O +
for O +
the O +
enrichment O +
of O +
HDL B-Gene +
with O +
phosphatidylcholines O +
but O +
that O +
it O +
does O +
modulate O +
particle O +
size O +
and O +
rates O +
of O +
hepatic O +
clearance O +
. O +

Dengue O +
virus O +
nonstructural B-Gene +
protein I-Gene +
NS5 B-Gene +
induces O +
interleukin-8 B-Gene +
transcription O +
and O +
secretion O +
. O +

Elevated O +
circulating O +
levels O +
of O +
chemokines B-Gene +
have O +
been O +
reported O +
in O +
patients O +
with O +
dengue O +
fever O +
and O +
are O +
proposed O +
to O +
contribute O +
to O +
the O +
pathogenesis O +
of O +
dengue O +
disease O +
. O +

To O +
establish O +
in O +
vitro O +
models O +
for O +
chemokine B-Gene +
induction O +
by O +
dengue O +
2 O +
virus O +
( O +
DEN2V O +
) O +
, O +
we O +
studied O +
a O +
variety O +
of O +
human O +
cell O +
lines O +
and O +
primary O +
cells O +
. O +

DEN2V O +
infection O +
of O +
HepG2 O +
and O +
primary O +
dendritic O +
cells O +
induced O +
the O +
production O +
of O +
interleukin-8 B-Gene +
( O +
IL-8 B-Gene +
) O +
, O +
RANTES B-Gene +
, O +
MIP-1alpha B-Gene +
, O +
and O +
MIP-1beta B-Gene +
, O +
whereas O +
only O +
IL-8 B-Gene +
and O +
RANTES B-Gene +
were O +
induced O +
following O +
dengue O +
virus O +
infection O +
of O +
HEK293 O +
cells O +
. O +

Chemokine B-Gene +
secretion O +
was O +
accompanied O +
by O +
an O +
increase O +
in O +
steady O +
- O +
state O +
mRNA O +
levels O +
. O +

No O +
chemokine B-Gene +
induction O +
was O +
observed O +
in O +
HEK293 O +
cells O +
treated O +
with O +
poly O -
( O -
I O -
: O -
C O -
) O +
or O +
alpha B-Gene +
interferon I-Gene +
, O +
suggesting O +
a O +
direct O +
effect O +
of O +
virus O +
infection O +
. O +

To O +
determine O +
the O +
mechanism O -
( O -
s O -
) O +
involved O +
in O +
the O +
induction O +
of O +
chemokine B-Gene +
production O +
by O +
DEN2V O +
, O +
individual O +
dengue O +
virus O +
genes O +
were O +
cloned O +
into O +
plasmids O +
and O +
expressed O +
in O +
HEK293 O +
cells O +
. O +

Transfection O +
of O +
a O +
plasmid O +
expressing O +
NS5 B-Gene +
or O +
a O +
dengue O +
virus O +
replicon O +
induced O +
IL-8 B-Gene +
gene O +
expression O +
and O +
secretion O +
. O +

RANTES B-Gene +
expression O +
was O +
not O +
induced O +
under O +
these O +
conditions O +
, O +
however O +
. O +

Reporter O +
assays O +
showed O +
that O +
IL-8 B-Gene +
induction O +
by O +
NS5 B-Gene +
was O +
principally O +
through O +
CAAT B-Gene +
/ I-Gene +
enhancer I-Gene +
binding I-Gene +
protein I-Gene +
, O +
whereas O +
DEN2V O +
infection O +
also O +
induced O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
. O +

These O +
results O +
indicate O +
a O +
role O +
for O +
the O +
dengue O +
virus O +
NS5 B-Gene +
protein O +
in O +
the O +
induction O +
of O +
IL-8 B-Gene +
by O +
DEN2V O +
infection O +
. O +

Recruitment O +
and O +
activation O +
of O +
potential O +
target O +
cells O +
to O +
sites O +
of O +
DEN2V O +
replication O +
by O +
virus O +
- O +
induced O +
chemokine B-Gene +
production O +
may O +
contribute O +
to O +
viral O +
replication O +
as O +
well O +
as O +
to O +
the O +
inflammatory O +
components O +
of O +
dengue O +
virus O +
disease O +
. O +

Hematopoietic O +
progenitor O +
cell O +
mobilization O +
in O +
mice O +
by O +
sustained O +
delivery O +
of O +
granulocyte B-Gene +
colony I-Gene +
- I-Gene +
stimulating I-Gene +
factor I-Gene +
. O +

The O +
objective O +
of O +
these O +
studies O +
was O +
to O +
determine O +
the O +
effect O +
of O +
sustained O +
delivery O +
of O +
growth B-Gene +
factors I-Gene +
( O +
GFs B-Gene +
) O +
on O +
hematopoietic O +
progenitor O +
cells O +
( O +
HPCs O +
) O +
in O +
mice O +
. O +

In O +
these O +
studies O +
, O +
granulocyte B-Gene +
colony I-Gene +
- I-Gene +
stimulating I-Gene +
factor I-Gene +
( O +
G B-Gene -
- I-Gene -
CSF I-Gene +
) O +
was O +
administered O +
using O +
the O +
poloxamer O +
- O +
based O +
matrix O +
, O +
ProGelz O +
( O +
PG O +
) O +
and O +
G B-Gene -
- I-Gene -
CSF I-Gene +
, O +
and O +
pharmacokinetics O +
( O +
PKs O +
) O +
and O +
HPC O +
mobilization O +
was O +
assessed O +
. O +

A O +
single O +
injection O +
of O +
G B-Gene -
- I-Gene -
CSF I-Gene +
formulated O +
in O +
PG O +
( O +
17 O +
% O +
poloxamer-407 O +
and O +
5 O +
% O +
hydroxypropyl O +
methylcellulose O +
[ O +
HPMC O +
] O +
) O +
administered O +
to O +
BALB O -
/ O -
c O +
mice O +
mobilized O +
HPC O +
significantly O +
more O +
rapidly O +
to O +
the O +
spleen O +
, O +
but O +
not O +
the O +
blood O +
, O +
than O +
multiple O +
injections O +
of O +
saline O +
- O +
formulated O +
G B-Gene -
- I-Gene -
CSF I-Gene +
. O +

Two O +
days O +
after O +
a O +
single O +
injection O +
of O +
PG O +
G B-Gene -
- I-Gene -
CSF I-Gene +
, O +
the O +
frequency O +
of O +
colony O +
- O +
forming O +
unit O +
- O +
culture O +
( O +
CFU O -
- O -
c O +
) O +
in O +
the O +
spleen O +
was O +
increased O +
289 O +
- O +
fold O +
compared O +
with O +
an O +
8 O +
- O +
fold O +
increase O +
after O +
2 O +
days O +
of O +
twice O +
- O +
daily O +
injections O +
of O +
saline O +
- O +
formulated O +
G B-Gene -
- I-Gene -
CSF I-Gene +
. O +

Indeed O +
, O +
4 O +
days O +
of O +
twice O +
- O +
daily O +
G B-Gene -
- I-Gene -
CSF I-Gene +
injections O +
were O +
required O +
to O +
achieve O +
the O +
same O +
level O +
of O +
HPC O +
mobilization O +
. O +

In O +
contrast O +
, O +
a O +
similar O +
mobilization O +
of O +
HPC O +
to O +
the O +
blood O +
was O +
observed O +
between O +
PG O +
and O +
saline O +
- O +
formulated O +
G B-Gene -
- I-Gene -
CSF I-Gene +
. O +

The O +
mechanism O +
for O +
the O +
accelerated O +
and O +
increased O +
mobilization O +
to O +
the O +
spleen O +
by O +
the O +
PG O +
- O +
formulation O +
of O +
G B-Gene -
- I-Gene -
CSF I-Gene +
is O +
due O +
, O +
in O +
part O +
, O +
to O +
its O +
increased O +
bioavailability O +
( O +
> O +
1.5 O +
- O +
fold O +
) O +
, O +
T O -
( O -
max O -
) O +
( O +
6 O +
- O +
fold O +
) O +
, O +
and O +
prolonged O +
elimination O +
( O +
Tbeta O +
) O +
half O +
- O +
life O +
( O +
> O +
3 O +
- O +
fold O +
) O +
as O +
compared O +
with O +
a O +
saline O +
formulation O +
. O +

In O +
addition O +
, O +
we O +
observed O +
a O +
more O +
rapid O +
trafficking O +
of O +
the O +
PG O +
G B-Gene -
- I-Gene -
CSF I-Gene +
to O +
the O +
marrow O +
, O +
which O +
could O +
also O +
facilitate O +
mobilization O +
. O +

Systemic O +
and O +
vascular O +
inflammation O +
is O +
elevated O +
in O +
early O +
IgA B-Gene +
and O +
type O +
1 O +
diabetic O +
nephropathies O +
and O +
relates O +
to O +
vascular O +
disease O +
risk O +
factors O +
and O +
renal O +
function O +
. O +

BACKGROUND O +
: O +

Inflammation O +
is O +
implicated O +
in O +
cardiovascular O +
disease O +
( O +
CVD O +
) O +
and O +
mortality O +
in O +
end O +
- O +
stage O +
renal O +
failure O +
( O +
ESRF O +
) O +
. O +

Its O +
importance O +
in O +
early O +
renal O +
disease O +
is O +
yet O +
to O +
be O +
defined O +
. O +

METHODS O +
: O +

Serum O +
levels O +
of O +
systemic O +
and O +
vascular O +
inflammatory O +
markers O +
in O +
early O +
IgA B-Gene +
nephropathy O +
( O +
IgAN O +
) O +
and O +
control O +
subjects O +
were O +
measured O +
and O +
related O +
to O +
renal O +
function O +
and O +
vascular O +
risk O +
factors O +
. O +

A O +
parallel O +
study O +
in O +
type O +
1 O +
diabetes O +
mellitus O +
subjects O +
with O +
( O +
T1DM O +
Nx O +
) O +
and O +
without O +
nephropathy O +
( O +
T1DM O +
No O +
Nx O +
) O +
was O +
performed O +
. O +

RESULTS O +
: O +

Fifty O +
- O +
one O +
IgAN O +
patients O +
aged O +
46 O +
+ O -
/-2 O +
years O +
( O +
mean O +
+ O -
/-SEM O +
) O +
, O +
calculated O +
creatinine O +
clearance O +
( O +
CrCl O +
) O +
88 O +
+ O +
/ O +
- O +
5 O +
ml O +
/ O +
min O +
, O +
were O +
compared O +
with O +
51 O +
matched O +
control O +
subjects O +
. O +

Forty O -
- O -
six O +
T1DM O +
Nx O +
patients O +
aged O +
40 O +
+ O +
/ O +
- O +
2 O +
years O +
, O +
CrCl O +
84 O +
+ O +
/ O +
- O +
5 O +
ml O +
/ O +
min O +
, O +
and O +
73 O +
T1DM O +
No O +
Nx O +
patients O +
aged O +
38 O +
+ O +
/ O +
- O +
2 O +
years O +
were O +
also O +
compared O +
. O +

High O +
sensitivity O +
C B-Gene +
- I-Gene +
reactive I-Gene +
protein I-Gene +
( O +
hsCRP B-Gene +
) O +
was O +
elevated O +
in O +
IgAN O +
, O +
T1DM O +
Nx O +
and O +
T1DM O +
No O +
Nx O +
patients O +
compared O +
with O +
controls O +
[ O +
4.2 O +
+ O -
/- O +
0.6 O +
( O +
P O +
< O +
0.001 O +
) O +
, O +
4.1 O +
+ O -
/- O +
0.6 O +
( O +
P O +
< O +
0.001 O +
) O +
, O +
2.6 O +
+ O -
/- O +
0.4 O +
( O +
P O +
< O +
0.05 O +
) O +
vs O +
1.6 O +
+ O +
/ O +
- O +
0.3 O +
mg O +
/ O +
l O +
] O +
. O +

Levels O +
in O +
T1DM O +
Nx O +
patients O +
were O +
higher O +
than O +
in O +
T1DM O +
No O +
Nx O +
patients O +
( O +
P O +
< O +
0.05 O +
) O +
. O +

Inflammation O +
and O +
vascular O +
dysfunction O +
as O +
measured O +
by O +
pulse O +
pressure O +
( O +
PP O +
) O +
were O +
related O +
. O +

HsCRP B-Gene +
correlated O +
with O +
PP O +
in O +
IgAN O +
and O +
T1DM O +
Nx O +
( O +
r O +
= O +
0.47 O +
, O +
P O +
= O +
0.001 O +
; O +
r O +
= O +
0.40 O +
, O +
P O +
< O +
0.05 O +
) O +
. O +

PP O +
was O +
the O +
strongest O +
independent O +
predictor O +
of O +
hsCRP B-Gene +
in O +
IgAN O +
( O +
T O +
= O +
2.45 O +
, O +
P O +
< O +
0.001 O +
) O +
, O +
while O +
body O +
mass O +
index O +
( O +
T O +
= O +
7.83 O +
, O +
P O +
< O +
0.001 O +
) O +
was O +
the O +
strongest O +
predictor O +
in O +
T1DM O +
Nx O +
. O +

Endothelial O +
cell O +
adhesion B-Gene +
molecules I-Gene +
were O +
increased O +
in O +
T1DM O +
Nx O +
> O +
IgAN O +
> O +
T1DM O +
No O +
Nx O +
vs O +
controls O +
: O +
soluble O +
vascular B-Gene +
adhesion I-Gene +
molecule-1 I-Gene +
( O +
sVCAM-1 B-Gene +
) O +
760 O +
+ O -
/- O +
30 O +
( O +
P O +
< O +
0.001 O +
) O +
> O +
663+ O -
/ O -
- O +
34 O +
( O +
P O +
= O +
0.001 O +
) O +
> O +
601 O -
+ O +
/ O +
- O +
21 O +
( O +
P O +
< O +
0.05 O +
) O +
vs O +
536 O +
+ O +
/ O +
- O +
15 O +
ng O +
/ O +
ml O +
; O +
soluble O +
intracellular B-Gene +
adhesion I-Gene +
molecule-1 I-Gene +
( O +
sICAM-1 B-Gene +
) O +
320 O +
+ O +
/ O +
- O +
8 O +
( O +
P O +
< O +
0.001 O +
) O +
> O +
313 O -
+ O +
/ O +
- O +
13 O +
( O +
P O +
< O +
0.001 O +
) O +
> O +
307+ O -
/ O -
- O +
8 O +
( O +
P O +
< O +
0.001 O +
) O +
vs O +
244 O +
+ O +
/ O +
- O +
6 O +
ng O +
/ O +
ml O +
. O +

sVCAM-1 B-Gene +
levels O +
were O +
higher O +
in O +
T1DM O +
Nx O +
than O +
in O +
T1DM O +
No O +
Nx O +
, O +
P O +
< O +
0.001 O +
. O +

In O +
IgAN O +
and O +
T1DM O +
Nx O +
, O +
hsCRP B-Gene +
correlated O +
with O +
sICAM-1 B-Gene +
( O +
r O +
= O +
0.33 O +
, O +
P O +
= O +
0.017 O +
; O +
r O +
= O +
0.37 O +
; O +
P O +
= O +
0.017 O +
) O +
. O +

sVCAM-1 B-Gene +
was O +
related O +
to O +
renal O +
function O +
in O +
IgAN O +
and O +
T1DM O +
Nx O +
: O +
serum O +
cystatin B-Gene +
C I-Gene +
( O +
r O +
= O +
0.63 O +
, O +
P O +
< O +
0.001 O +
: O +
r O +
= O +
0.425 O +
, O +
P O +
= O +
0.002 O +
) O +
, O +
and O +
urine O +
protein O +
: O +
creatinine O +
ratio O +
in O +
IgAN O +
( O +
r O +
= O +
0.48 O +
; O +
P O +
= O +
0.001 O +
) O +
. O +

CONCLUSIONS O +
: O +

Systemic O +
and O +
vascular O +
markers O +
of O +
inflammation O +
are O +
increased O +
in O +
early O +
renal O +
disease O +
and O +
relate O +
to O +
renal O +
dysfunction O +
and O +
cardiovascular O +
risk O +
factors O +
. O +

Inflammation O +
may O +
be O +
a O +
common O +
process O +
in O +
various O +
renal O +
diseases O +
and O +
may O +
link O +
and O +
accelerate O +
renal O +
dysfunction O +
and O +
CVD O +
. O +

Apolipoprotein B-Gene +
E I-Gene +
polymorphism O +
in O +
diabetic O +
and O +
non O +
- O +
diabetic O +
patients O +
: O +
does O +
it O +
really O +
contribute O +
to O +
atherosclerosis O +
? O +

OBJECTIVE O +
: O +

The O +
exact O +
mechanism O +
of O +
the O +
increased O +
cardiovascular O +
morbidity O +
and O +
mortality O +
in O +
type-2 O +
diabetes O +
is O +
still O +
undefined O +
. O +

The O +
aim O +
of O +
our O +
study O +
was O +
to O +
assess O +
the O +
impact O +
of O +
apolipoprotein B-Gene +
E I-Gene +
( O +
apo B-Gene +
E I-Gene +
) O +
polymorphism O +
and O +
other O +
factors O +
on O +
atherosclerotic O +
vascular O +
disease O +
in O +
type-2 O +
diabetic O +
patients O +
. O +

We O +
also O +
examined O +
the O +
association O +
between O +
apo B-Gene +
E I-Gene +
polymorphism O +
and O +
lipid O +
profile O +
in O +
diabetic O +
patients O +
. O +

METHODS O +
AND O +
RESULTS O +
: O +

We O +
assessed O +
the O +
apo B-Gene +
E I-Gene +
polymorphism O +
in O +
295 O +
atherosclerotic O +
patients O +
( O +
124 O +
of O +
them O +
had O +
diabetes O +
( O +
according O +
to O +
WHO O +
criteria O +
) O +
and O +
171 O +
of O +
them O +
had O +
coronary O +
artery O +
narrowing O +
> O +
50 O +
) O +
.The O +
detection O +
of O +
apo B-Gene +
E I-Gene +
polymorphism O +
was O +
made O +
by O +
Real O +
- O +
Time O +
PCR O +
using O +
a O +
Light O +
- O +
Cycler O +
( O +
Roche O +
diagnostics O +
, O +
GmbH O +
, O +
Mannheim O +
, O +
Germany O +
) O +
. O +

Serum O +
triglycerides O +
( O +
TG O +
) O +
, O +
total O +
cholesterol O +
( O +
TC O +
) O +
, O +
low B-Gene +
- I-Gene +
density I-Gene +
lipoprotein I-Gene +
( O +
LDL B-Gene +
) O +
, O +
high B-Gene +
- I-Gene +
density I-Gene +
lipoprotein I-Gene +
( O +
HDL B-Gene +
) O +
, O +
lipoprotein B-Gene +
( I-Gene +
a I-Gene +
) I-Gene +
[ O +
Lp B-Gene -
( I-Gene -
a I-Gene -
) I-Gene +
] O +
, O +
apolipoprotein B-Gene +
A I-Gene +
( O +
Apo B-Gene +
A I-Gene +
) O +
and O +
apolipoprotein B-Gene +
B I-Gene +
( O +
Apo B-Gene +
B I-Gene +
) O +
levels O +
were O +
determined O +
by O +
biochemical O +
analyser O +
. O +

Genotypic O +
distribution O +
of O +
apo B-Gene +
E I-Gene +
polymorphism O +
did O +
not O +
differ O +
between O +
diabetic O +
and O +
non O +
- O +
diabetic O +
atherosclerotic O +
patients O +
. O +

The O +
distributions O +
of O +
apo B-Gene +
E2 I-Gene +
/ I-Gene +
2 I-Gene +
, I-Gene +
E2 I-Gene +
/ I-Gene +
3 I-Gene +
, I-Gene +
E2 I-Gene +
/ I-Gene +
4 I-Gene +
, I-Gene +
E3 I-Gene +
/ I-Gene +
3 I-Gene +
, I-Gene +
E3 I-Gene +
/ I-Gene +
4 I-Gene +
and I-Gene +
E4 I-Gene +
/ I-Gene +
4 I-Gene +
genotypes O +
in O +
diabetic O +
and O +
non O +
- O +
diabetic O +
atherosclerotic O +
patients O +
were O +
7.3 O +
% O +
: O +
8.2 O +
% O +
, O +
15.3 O +
% O +
: O +
15.8 O +
% O +
, O +
4.0 O +
% O +
: O +
5.3 O +
% O +
, O +
50.8 O +
% O +
: O +
56.7 O +
% O +
, O +
16.9 O +
% O +
: O +
11.1 O +
% O +
and O +
5.6 O +
% O +
: O +
2.9 O +
% O +
, O +
respectively O +
. O +

Participants O +
were O +
grouped O +
as O +
apo B-Gene +
E2 I-Gene +
( I-Gene +
E2 I-Gene +
/ I-Gene +
2 I-Gene +
or I-Gene +
E2 I-Gene +
/ I-Gene +
3 I-Gene +
) I-Gene +
, O +
apo B-Gene +
E3 I-Gene +
( I-Gene +
E3 I-Gene +
/ I-Gene +
3 I-Gene +
) I-Gene +
, O +
or O +
apo B-Gene +
E4 I-Gene +
( I-Gene +
E4 I-Gene +
/ I-Gene +
4 I-Gene +
or I-Gene +
E4 I-Gene +
/ I-Gene +
3 I-Gene +
) I-Gene +
.The O +
distributions O +
of O +
apo B-Gene +
E2 I-Gene +
, I-Gene +
E3 I-Gene +
and I-Gene +
E4 I-Gene +
alleles O +
were O +
23.5 O +
% O +
, O +
52.9 O +
% O +
, O +
23.5 O +
% O +
, O +
for O +
diabetic O +
patients O +
, O +
and O +
25.3 O +
% O +
, O +
59.9 O +
% O +
, O +
14.8 O +
% O +
for O +
non O +
- O +
diabetic O +
patients O +
, O +
respectively O +
. O +

The O +
apolipoprotein B-Gene +
E I-Gene +
genotype O +
was O +
not O +
associated O +
with O +
the O +
lipid O +
levels O +
in O +
diabetic O +
patients O +
. O +

CONCLUSIONS O +
: O +

Our O +
findings O +
imply O +
that O +
apo B-Gene +
E I-Gene +
polymorphism O +
is O +
not O +
related O +
to O +
the O +
development O +
of O +
atherosclerosis O +
in O +
patients O +
with O +
type-2 O +
diabetes O +
. O +

Plasma O +
proteomic O +
analysis O +
of O +
the O +
acute O +
phase O +
response O +
of O +
rainbow O +
trout O +
( O +
Oncorhynchus O +
mykiss O +
) O +
to O +
intraperitoneal O +
inflammation O +
and O +
LPS O +
injection O +
. O +

Few O +
acute O +
phase O +
proteins O +
are O +
known O +
in O +
fish O +
and O +
better O +
knowledge O +
of O +
them O +
would O +
provide O +
a O +
basis O +
for O +
more O +
reliable O +
methods O +
to O +
objectively O +
assess O +
fish O +
health O +
and O +
welfare O +
. O +

An O +
acute O +
phase O +
response O +
was O +
induced O +
in O +
rainbow O +
trout O +
( O +
Oncorhynchus O +
mykiss O +
, O +
Walbaum O +
) O +
by O +
inflammation O +
triggered O +
by O +
intraperitoneal O +
administration O +
of O +
purified O +
Aeromonas O +
salmonicida O +
lipopolysaccharide O +
emulsified O +
in O +
Freund O -
's O +
incomplete O +
adjuvant O +
( O +
LPS O +
/ O +
FIA O +
) O +
or O +
a O +
commercial O +
oil O +
- O +
based O +
multivalent O +
vaccine O +
. O +

Acute O +
phase O +
proteins O +
were O +
characterized O +
by O +
comparative O +
densitometry O +
of O +
plasma O +
proteins O +
separated O +
by O +
two O +
- O +
dimensional O +
polyacrylamide O +
gel O +
electrophoresis O +
( O +
2D O -
- O -
PAGE O +
) O +
and O +
identified O +
by O +
MALDI O -
- O -
TOF O +
and O +
ESI O +
MS O +
/ O +
MS O +
mass O +
spectrometry O +
. O +

In O +
one O +
experiment O +
, O +
plasma O +
samples O +
were O +
compared O +
between O +
treatment O +
and O +
control O +
groups O +
in O +
which O +
fish O +
were O +
terminally O +
bled O +
. O +

In O +
another O +
experiment O +
, O +
individual O +
fish O +
were O +
sampled O +
repeatedly O +
. O +

Proteins O +
scored O +
as O +
increased O +
were O +
those O +
whose O +
normalized O +
value O +
increased O +
three O +
- O +
fold O +
or O +
greater O +
between O +
pre O +
- O +
and O +
post O +
- O +
stimulus O +
. O +

Proteins O +
scored O +
as O +
decreased O +
were O +
those O +
whose O +
normalized O +
values O +
decreased O +
two O +
- O +
fold O +
or O +
greater O +
. O +

Unaltered O +
proteins O +
were O +
those O +
that O +
were O +
not O +
altered O +
or O +
did O +
not O +
meet O +
either O +
of O +
these O +
criteria O +
. O +

Proteins O +
that O +
were O +
absent O +
in O +
pre O +
- O +
stimulus O +
gels O +
but O +
present O +
in O +
post O +
- O +
stimulus O +
profiles O +
were O +
considered O +
to O +
be O +
induced O +
. O +

Only O +
those O +
proteins O +
that O +
were O +
altered O +
in O +
all O +
fish O +
for O +
a O +
given O +
treatment O +
were O +
considered O +
. O +

In O +
both O +
experiments O +
, O +
protein O +
p36 O +
was O +
increased O +
up O +
to O +
13 O +
- O +
fold O +
and O +
several O +
proteins O +
were O +
detected O +
that O +
had O +
not O +
been O +
previously O +
. O +

In O +
all O +
fish O +
treated O +
with O +
LPS O +
/ O +
FIA O +
, O +
p9.5 O +
was O +
consistently O +
increased O +
an O +
average O +
of O +
75 O +
- O +
fold O +
in O +
plasma O +
. O +

We O +
have O +
constructed O +
a O +
plasma O +
protein O +
panel O +
of O +
eight O +
increased O +
or O +
induced O +
proteins O +
( O +
p9.5 O +
, O +
p10.5 O +
, O +
p24a O +
, O +
p24b O +
, O +
p24c O +
, O +
p25a O +
, O +
p36 O +
and O +
p37 O +
) O +
, O +
one O +
decreased O +
( O +
p16 O +
) O +
and O +
two O +
that O +
are O +
unaltered O +
( O +
p28a O +
, O +
p28b O +
) O +
in O +
rainbow O +
trout O +
following O +
inflammation O +
or O +
injection O +
with O +
LPS O +
/ O +
FIA O +
. O +

Proteins O +
from O +
this O +
panel O +
that O +
were O +
similar O +
to O +
previously O +
identified O +
proteins O +
were O +
pre O +
- O +
cerebellin B-Gene +
- O +
like O +
( O +
p24a O +
) O +
, O +
transferrin B-Gene +
( O +
p37 O +
) O +
and O +
apolipoprotein B-Gene +
( O +
p10.5 O +
, O +
p24c O +
and O +
p28 O +
) O +
. O +

Effect O +
of O +
nandrolone O +
decanonate O +
on O +
paraoxonase B-Gene +
activity O +
in O +
hemodialysis O +
patients O +
. O +

OBJECTIVES O +
: O +

This O +
study O +
was O +
designed O +
to O +
determine O +
the O +
effect O +
of O +
nandrolone O +
decanonate O +
( O +
ND O +
) O +
on O +
HDL B-Gene +
- O +
C O +
, O +
apolipoproteins B-Gene +
and O +
paraoxonase B-Gene +
( O +
PON B-Gene +
) O +
activity O +
in O +
stable O +
hemodialysis O +
patients O +
. O +

DESIGN O +
AND O +
METHODS O +
: O +

64 O +
hemodialysis O +
patients O +
were O +
treated O +
with O +
ND O +
at O +
a O +
dose O +
of O +
100 O +
mg O +
/ O +
I.M. O +
/ O +
week O +
for O +
4 O +
months O +
. O +

HDL B-Gene +
- O +
C O +
, O +
Apo B-Gene -
- I-Gene -
AI I-Gene +
, O +
Apo B-Gene +
B I-Gene +
, O +
concentrations O +
and O +
PON B-Gene +
activity O +
were O +
measured O +
before O +
and O +
after O +
2 O +
and O +
4 O +
months O +
of O +
treatment O +
as O +
well O +
as O +
2 O +
months O +
after O +
withdrawing O +
the O +
treatment O +
. O +

RESULTS O +
: O +

After O +
4 O +
months O +
of O +
treatment O +
, O +
an O +
elevation O +
in O +
the O +
serum O +
levels O +
of O +
Apo B-Gene +
B I-Gene +
( O +
P O +
< O +
0.0001 O +
) O +
and O +
a O +
marked O +
decrease O +
in O +
the O +
concentration O +
of O +
HDL B-Gene +
- O +
C O +
( O +
P O +
< O +
0.0001 O +
) O +
, O +
Apo B-Gene -
- I-Gene -
AI I-Gene +
( O +
P O +
< O +
0.0001 O +
) O +
and O +
PON B-Gene +
activity O +
( O +
P O +
< O +
0.0001 O +
) O +
were O +
found O +
. O +

A O +
significant O +
correlation O +
between O +
PON B-Gene +
and O +
both O +
Apo B-Gene -
- I-Gene -
AI I-Gene +
( O +
r O +
= O +
0.270 O +
, O +
P O +
< O +
0.04 O +
) O +
and O +
HDL B-Gene +
- O +
C O +
( O +
r O +
= O +
0.455 O +
, O +
P O +
< O +
0.0001 O +
) O +
and O +
also O +
between O +
HDL B-Gene +
- O +
C O +
and O +
Apo B-Gene -
- I-Gene -
AI I-Gene +
( O +
r O +
= O +
0.305 O +
, O +
P O +
< O +
0.02 O +
) O +
were O +
found O +
. O +

CONCLUSION O +
: O +

Results O +
revealed O +
the O +
adverse O +
effects O +
of O +
ND O +
on O +
apolipoprotein O +
levels O +
in O +
our O +
study O +
population O +
. O +

It O +
is O +
possible O +
that O +
ND O +
reduces O +
PON B-Gene +
activity O +
mostly O +
by O +
reducing O +
both O +
the O +
HDL B-Gene +
- O +
C O +
and O +
Apo B-Gene -
- I-Gene -
AI I-Gene +
levels O +
. O +

Three O +
- O +
dimensional O +
reconstruction O +
of O +
anomalous O +
chloroplasts O +
in O +
transgenic O +
ipt O +
tobacco O +
. O +

Anomalies O +
in O +
the O +
ultrastructure O +
of O +
chloroplasts O +
, O +
from O +
transgenic O +
ipt O +
tobacco O +
, O +
overproducing O +
endogenous O +
cytokinins B-Gene +
( O +
CKs O +
) O +
were O +
studied O +
. O +

Detailed O +
analyses O +
of O +
CKs O +
and O +
their O +
metabolites O +
showed O +
that O +
Pssu O +
- O +
ipt O +
tobacco O +
contained O +
enhanced O +
contents O +
of O +
CKs O +
both O +
in O +
leaves O +
and O +
in O +
isolated O +
chloroplasts O +
. O +

The O +
role O +
of O +
CKs O +
in O +
the O +
formation O +
of O +
anomalous O +
structures O +
is O +
suggested O +
. O +

Pssu O +
- O +
ipt O +
chloroplasts O +
frequently O +
formed O +
the O +
distinct O +
peripheral O +
reticulum O +
with O +
a O +
system O +
of O +
caverns O +
that O +
often O +
involved O +
mitochondria O +
and/or O +
peroxisomes O +
. O +

Large O +
crystalloids O +
, O +
which O +
were O +
found O +
in O +
chloroplasts O +
of O +
Pssu O +
- O +
ipt O +
, O +
occupied O +
up O +
to O +
16 O +
% O +
of O +
chloroplast O +
volume O +
. O +

We O +
suggested O +
that O +
the O +
crystalloids O +
were O +
formed O +
by O +
LHC B-Gene +
II I-Gene +
aggregates O +
. O +

This O +
was O +
supported O +
by O +
analysis O +
of O +
the O +
fluorescence O +
emission O +
spectra O +
at O +
77 O +
degrees O +
K O +
, O +
chlorophyll O +
a O +
/ O +
b O +
ratio O +
, O +
immunogold O +
staining O +
of O +
the O +
structures O +
, O +
and O +
crystallographic O +
unit O +
size O +
analysis O +
. O +

Cloning O +
and O +
sequencing O +
of O +
28 B-Gene +
kDa I-Gene +
outer I-Gene +
membrane I-Gene +
protein I-Gene +
gene O +
of O +
Brucella O +
melitensis O +
Rev. O +
1 O +
. O +

Brucella O +
melitensis O +
is O +
an O +
organism O +
of O +
paramount O +
zoonotic O +
importance O +
. O +

The O +
28 B-Gene +
kDa I-Gene +
outer I-Gene +
membrane I-Gene +
protein I-Gene +
( I-Gene +
OMP I-Gene +
) I-Gene +
is O +
one O +
of O +
the O +
immunodominant O +
antigens O +
of O +
B. O +
melitensis O +
. O +

The O +
gene O +
encoding O +
28 B-Gene +
kDa I-Gene +
OMP I-Gene +
( O +
omp28 B-Gene +
) O +
has O +
been O +
amplified O +
from O +
B. O +
melitensis O +
Rev. O +
1 O +
strain O +
. O +

A O +
PCR O +
product O +
of O +
753 O +
bp O +
, O +
encoding O +
complete O +
omp28 B-Gene +
gene O +
of O +
B. O +
melitensis O +
, O +
was O +
obtained O +
. O +

The O +
gene O +
was O +
further O +
cloned O +
and O +
sequenced O +
. O +

The O +
nucleotide O +
sequence O +
of O +
B. O +
melitensis O +
Rev. O +
1 O +
strain O +
showed O +
substitution O +
of O +
2 O +
nucleotides O +
from O +
that O +
of O +
16 O -
M O +
strain O +
. O +

Expression O +
of O +
hyaluronan B-Gene +
synthases I-Gene +
and O +
hyaluronidases B-Gene +
in O +
the O +
MG63 O +
osteoblast O +
cell O +
line O +
. O +

The O +
expression O +
of O +
hyaluronan B-Gene +
synthases I-Gene +
( I-Gene +
1 I-Gene +
, I-Gene +
2 I-Gene +
and I-Gene +
3 I-Gene +
) I-Gene +
and O +
hyaluronidases B-Gene +
( I-Gene +
1 I-Gene +
, I-Gene +
2 I-Gene +
, I-Gene +
3 I-Gene +
, I-Gene +
4 I-Gene +
and O +
PH20 B-Gene +
) O +
was O +
examined O +
in O +
the O +
MG63 O +
osteoblast O +
cell O +
line O +
induced O +
to O +
mineralize O +
in O +
vitro O +
and O +
compared O +
to O +
the O +
rate O +
of O +
glycosaminoglycan O +
production O +
. O +

Real O +
- O +
time O +
PCR O +
analysis O +
demonstrated O +
a O +
13 O +
- O +
fold O +
decrease O +
in O +
hyaluronan B-Gene +
synthase I-Gene +
3 I-Gene +
expression O +
in O +
mineralising O +
MG63 O +
cells O +
; O +
no O +
significant O +
change O +
in O +
hyaluronan B-Gene +
synthase I-Gene +
2 I-Gene +
expression O +
in O +
mineralising O +
cells O +
and O +
hyaluronan B-Gene +
synthase I-Gene +
1 I-Gene +
was O +
not O +
expressed O +
. O +

In O +
mineralising O +
MG63 O +
cells O +
a O +
62 O +
- O +
fold O +
increase O +
in O +
hyaluronidase B-Gene +
2 I-Gene +
, O +
a O +
13 O +
- O +
fold O +
increase O +
in O +
hyaluronidase B-Gene +
3 I-Gene +
, O +
and O +
a O +
3 O +
- O +
fold O +
increase O +
in O +
hyaluronidase B-Gene +
4 I-Gene +
expression O +
were O +
observed O +
when O +
compared O +
to O +
non O +
- O +
mineralising O +
cells O +
; O +
hyaluronidase B-Gene +
1 I-Gene +
and O +
PH20 B-Gene +
expression O +
was O +
not O +
detected O +
. O +

After O +
5 O +
weeks O +
in O +
mineralising O +
culture O +
conditions O +
a O +
2 O +
- O +
fold O +
increase O +
in O +
total O +
3H O -
- O -
glucosamine O +
incorporation O +
was O +
observed O +
in O +
cells O +
when O +
compared O +
to O +
24 O +
h O +
or O +
5 O +
week O +
control O +
cultures O +
. O +

This O +
was O +
made O +
up O +
of O +
a O +
5 O +
- O +
fold O +
decrease O +
in O +
hyaluronan O +
production O +
, O +
a O +
2 O +
- O +
fold O +
increase O +
in O +
chondroitin O +
sulphate O +
/ O +
dermatan O +
sulphate O +
and O +
a O +
10 O +
- O +
fold O +
increase O +
in O +
3H O +
- O +
glucosamine O +
incorporation O +
into O +
the O +
non O +
- O +
glycosaminoglycan O +
fraction O +
. O +

A O +
3 O +
- O +
fold O +
increase O +
in O +
35SO4 O +
incorporation O +
into O +
chondroitin O +
sulphate O +
/ O +
dermatan O +
sulphate O +
was O +
also O +
observed O +
. O +

Thus O +
there O +
is O +
co O +
- O +
ordinate O +
expression O +
of O +
genes O +
that O +
control O +
hyaluronan O +
metabolism O +
such O +
that O +
there O +
is O +
a O +
general O +
decrease O +
in O +
the O +
expression O +
of O +
hyaluronan B-Gene +
synthases I-Gene +
, O +
an O +
increase O +
in O +
the O +
expression O +
of O +
hyaluronidases B-Gene +
and O +
a O +
corresponding O +
decrease O +
in O +
hyaluronan O +
production O +
by O +
mineralising O +
MG63 O +
cells O +
. O +

Analysis O +
of O +
genes O +
involved O +
in O +
arsenic O +
resistance O +
in O +
Corynebacterium O +
glutamicum O +
ATCC O +
13032 O +
. O +

Corynebacterium O +
glutamicum O +
is O +
able O +
to O +
grow O +
in O +
media O +
containing O +
up O +
to O +
12 O +
mM O +
arsenite O +
and O +
500 O +
mM O +
arsenate O +
and O +
is O +
one O +
of O +
the O +
most O +
arsenic O +
- O +
resistant O +
microorganisms O +
described O +
to O +
date O +
. O +

Two O +
operons O +
( O +
ars1 B-Gene +
and O +
ars2 B-Gene +
) O +
involved O +
in O +
arsenate O +
and O +
arsenite O +
resistance O +
have O +
been O +
identified O +
in O +
the O +
complete O +
genome O +
sequence O +
of O +
Corynebacterium O +
glutamicum O +
. O +

The O +
operons B-Gene +
ars1 I-Gene +
and O +
ars2 B-Gene +
are O +
located O +
some O +
distance O +
from O +
each O +
other O +
in O +
the O +
bacterial O +
chromosome O +
, O +
but O +
they O +
are O +
both O +
composed O +
of O +
genes O +
encoding O +
a O +
regulatory O +
protein O +
( O +
arsR B-Gene +
) O +
, O +
an O +
arsenite B-Gene +
permease I-Gene +
( O +
arsB B-Gene +
) O +
, O +
and O +
an O +
arsenate B-Gene +
reductase I-Gene +
( O +
arsC B-Gene +
) O +
; O +
operon B-Gene +
ars1 I-Gene +
contains O +
an O +
additional O +
arsenate B-Gene +
reductase I-Gene +
gene O +
( O +
arsC1 B-Gene -
' I-Gene +
) O +
located O +
immediately O +
downstream O +
from O +
arsC1 B-Gene +
. O +

Additional O +
arsenite B-Gene +
permease I-Gene +
and O +
arsenate B-Gene +
reductase I-Gene +
genes O +
( O +
arsB3 B-Gene +
and O +
arsC4 B-Gene +
) O +
scattered O +
on O +
the O +
chromosome O +
were O +
also O +
identified O +
. O +

The O +
involvement O +
of O +
ars B-Gene +
operons I-Gene +
in O +
arsenic O +
resistance O +
in O +
C. O +
glutamicum O +
was O +
confirmed O +
by O +
gene O +
disruption O +
experiments O +
of O +
the O +
three O +
arsenite B-Gene +
permease I-Gene +
genes O +
present O +
in O +
its O +
genome O +
. O +

Wild O +
- O +
type O +
and O +
arsB3 B-Gene +
insertional O +
mutant O +
C. O +
glutamicum O +
strains O +
were O +
able O +
to O +
grow O +
with O +
up O +
to O +
12 O +
mM O +
arsenite O +
, O +
whereas O +
arsB1 B-Gene +
and O +
arsB2 B-Gene +
C. O +
glutamicum O +
insertional O +
mutants O +
were O +
resistant O +
to O +
4 O +
mM O +
and O +
9 O +
mM O +
arsenite O +
, O +
respectively O +
. O +

The O +
double O +
arsB1 B-Gene +
- O +
arsB2 B-Gene +
insertional O +
mutant O +
was O +
resistant O +
to O +
only O +
0.4 O +
mM O +
arsenite O +
and O +
10 O +
mM O +
arsenate O +
. O +

Gene O +
amplification O +
assays O +
of O +
operons B-Gene +
ars1 I-Gene +
and O +
ars2 B-Gene +
in O +
C. O +
glutamicum O +
revealed O +
that O +
the O +
recombinant O +
strains O +
containing O +
the O +
ars1 B-Gene +
operon I-Gene +
were O +
resistant O +
to O +
up O +
to O +
60 O +
mM O +
arsenite O +
, O +
this O +
being O +
one O +
of O +
the O +
highest O +
levels O +
of O +
bacterial O +
resistance O +
to O +
arsenite O +
so O +
far O +
described O +
, O +
whereas O +
recombinant O +
strains O +
containing O +
operon B-Gene +
ars2 I-Gene +
were O +
resistant O +
to O +
only O +
20 O +
mM O +
arsenite O +
. O +

Northern O +
blot O +
and O +
reverse O +
transcription O +
- O +
PCR O +
analysis O +
confirmed O +
the O +
presence O +
of O +
transcripts O +
for O +
all O +
the O +
ars B-Gene +
genes O +
, O +
the O +
expression O +
of O +
arsB3 B-Gene +
and O +
arsC4 B-Gene +
being O +
constitutive O +
, O +
and O +
the O +
expression O +
of O +
arsR1 B-Gene +
, O +
arsB1 B-Gene +
, O +
arsC1 B-Gene +
, O +
arsC1 B-Gene +
' I-Gene +
, O +
arsR2 B-Gene +
, O +
arsB2 B-Gene +
, O +
and O +
arsC2 B-Gene +
being O +
inducible O +
by O +
arsenite O +
. O +

Transient O +
effects O +
of O +
overexpressing O +
anthranilate B-Gene +
synthase I-Gene +
alpha I-Gene +
and I-Gene +
beta I-Gene +
subunits O +
in O +
Catharanthus O +
roseus O +
hairy O +
roots O +
. O +

Catharanthus O +
roseus O +
produces O +
two O +
economically O +
valuable O +
anticancer O +
drugs O +
, O +
vinblastine O +
and O +
vincristine O +
. O +

These O +
drugs O +
are O +
members O +
of O +
the O +
terpenoid O +
indole O +
alkaloids O +
and O +
accumulate O +
in O +
small O +
quantities O +
within O +
the O +
plant O +
; O +
thus O +
these O +
two O +
drugs O +
are O +
expensive O +
to O +
produce O +
. O +

Metabolic O +
engineering O +
efforts O +
have O +
focused O +
on O +
increasing O +
the O +
alkaloids O +
in O +
this O +
pathway O +
through O +
various O +
means O +
such O +
as O +
elicitation O +
, O +
precursor O +
feeding O +
, O +
and O +
gene O +
overexpression O +
. O +

Recently O +
we O +
successfully O +
expressed O +
Arabidopsis O +
genes O +
encoding O +
a O +
feedback O +
- O +
insensitive O +
anthranilate B-Gene +
synthase I-Gene +
alpha I-Gene +
subunit O +
under O +
the O +
control O +
of O +
the O +
glucocorticoid O +
- O +
inducible O +
promoter O +
system O +
and O +
the O +
anthranilate B-Gene +
synthase I-Gene +
beta I-Gene +
subunit O +
under O +
the O +
control O +
of O +
a O +
constitutive O +
promoter O +
in O +
C. O +
roseus O +
hairy O +
roots O +
. O +

In O +
this O +
work O +
we O +
look O +
at O +
the O +
transient O +
behaviors O +
of O +
terpenoid O +
indole O +
alkaloids O +
over O +
a O +
72 O +
h O +
induction O +
period O +
in O +
late O +
exponential O +
growth O +
phase O +
cultures O +
. O +

Upon O +
induction O +
, O +
the O +
tryptophan O +
, O +
tryptamine O +
, O +
and O +
ajmalicine O +
pools O +
accumulated O +
over O +
72 O +
h O +
. O +

In O +
contrast O +
, O +
the O +
lochnericine O +
, O +
hÃ?Â¶rhammericine O +
, O +
and O +
tabersonine O +
pools O +
decreased O +
and O +
leveled O +
out O +
over O +
the O +
72 O +
h O +
induction O +
period O +
. O +

Visible O +
changes O +
within O +
the O +
individual O +
compounds O +
usually O +
took O +
from O +
4 O +
to O +
12 O +
h O +
. O +

KIR3DL1 B-Gene +
polymorphisms O +
that O +
affect O +
NK O +
cell O +
inhibition O +
by O +
HLA B-Gene -
- I-Gene -
Bw4 I-Gene +
ligand O +
. O +

The O +
killer B-Gene +
cell I-Gene +
Ig I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( I-Gene +
KIR I-Gene +
) I-Gene +
gene I-Gene +
family I-Gene +
encodes O +
MHC B-Gene +
class I-Gene +
I I-Gene +
receptors O +
expressed O +
by O +
NK O +
cells O +
and O +
several O +
T O +
cell O +
subpopulations O +
. O +

Factors O +
contributing O +
to O +
human O +
KIR B-Gene +
haplotype O +
diversity O +
are O +
differences O +
in O +
gene O +
number O +
, O +
gene O +
content O +
, O +
and O +
allelic O +
polymorphism O +
. O +

Whereas O +
functional O +
and O +
clinical O +
consequences O +
of O +
the O +
first O +
two O +
factors O +
are O +
established O +
, O +
knowledge O +
of O +
the O +
effects O +
of O +
KIR B-Gene +
gene O +
polymorphism O +
is O +
limited O +
to O +
special O +
cases O +
in O +
which O +
signaling O +
function O +
is O +
reversed O +
or O +
cell O +
surface O +
expression O +
lost O +
. O +

In O +
this O +
study O +
we O +
use O +
retrovirally O +
transduced O +
human O +
cell O +
lines O +
to O +
show O +
that O +
3DL1 B-Gene -
* I-Gene -
002 I-Gene +
is O +
a O +
stronger O +
inhibitory O +
receptor O +
for O +
HLA B-Gene -
- I-Gene -
Bw4 I-Gene +
ligands O +
than O +
3DL1 B-Gene -
* I-Gene -
007 I-Gene +
. O +

Analysis O +
of O +
mutant O +
3DL1 B-Gene -
* I-Gene -
002 I-Gene +
and O +
3DL1 B-Gene -
* I-Gene -
007 I-Gene +
molecules O +
demonstrates O +
that O +
residue O +
238 O +
in O +
the O +
D2 O +
domain O +
and O +
320 O +
in O +
the O +
transmembrane O +
region O +
contribute O +
to O +
the O +
difference O +
in O +
receptor O +
strength O +
. O +

Neither O +
position O +
238 O +
nor O +
320 O +
is O +
predicted O +
to O +
interact O +
directly O +
with O +
HLA B-Gene -
- I-Gene -
Bw4 I-Gene +
ligand O +
. O +

This O +
study O +
also O +
revealed O +
that O +
KIR3DL1 B-Gene +
and O +
LILRB1 B-Gene +
both O +
contribute O +
to O +
developing O +
an O +
inhibitory O +
response O +
to O +
HLA B-Gene -
- I-Gene -
Bw4 I-Gene +
ligands O +
. O +

Role O +
of O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
receptors I-Gene +
in O +
an O +
animal O +
model O +
of O +
acute O +
colitis O +
. O +

TNF B-Gene -
- I-Gene -
alpha I-Gene +
is O +
known O +
to O +
play O +
an O +
important O +
role O +
in O +
inflammatory O +
bowel O +
disease O +
( O +
IBD O +
) O +
; O +
however O +
, O +
the O +
pathophysiological O +
role O +
of O +
its O +
receptors O +
is O +
still O +
under O +
study O +
. O +

Acute O +
colitis O +
was O +
induced O +
in O +
rats O +
by O +
intracolonic O +
administration O +
of O +
trinitrobenzene O +
sulfonic O +
acid O +
( O +
TNBS O +
) O +
. O +

Control O +
rats O +
received O +
the O +
ethanol O +
vehicle O +
. O +

Rats O +
were O +
sacrificed O +
72 O +
h O +
later O +
and O +
samples O +
of O +
tissue O +
and O +
fluids O +
were O +
collected O +
. O +

There O +
was O +
a O +
significant O +
increase O +
in O +
the O +
protein O +
levels O +
of O +
sTNF B-Gene -
- I-Gene -
alpha I-Gene +
, O +
sTNFRI B-Gene +
, O +
and O +
sTNFRII B-Gene +
in O +
the O +
peritoneal O +
fluid O +
( O +
PF O +
) O +
of O +
experimental O +
rats O +
. O +

TNF B-Gene -
- I-Gene -
alpha I-Gene +
, O +
TNFRI B-Gene +
, O +
and O +
TNFRII B-Gene +
mRNA O +
expression O +
was O +
increased O +
significantly O +
in O +
the O +
colon O +
of O +
experimental O +
animals O +
compared O +
to O +
controls O +
. O +

TRAF3 B-Gene +
and O +
TRAF5 B-Gene +
expression O +
was O +
also O +
significantly O +
higher O +
, O +
as O +
was O +
that O +
of O +
the O +
adhesion B-Gene +
molecules I-Gene +
ICAM-1 B-Gene +
and O +
E B-Gene -
- I-Gene -
selectin I-Gene +
. O +

The O +
increased O +
expression O +
of O +
TNF B-Gene +
- I-Gene +
alpha I-Gene +
, O +
TNFRs B-Gene +
, O +
and O +
the O +
associated O +
signaling O +
factors O +
in O +
the O +
colon O +
of O +
this O +
rat O +
model O +
of O +
IBD O +
provides O +
further O +
evidence O +
for O +
their O +
involvement O +
in O +
the O +
promotion O +
of O +
inflammation O +
and O +
tissue O +
damage O +
. O +

In O +
addition O +
, O +
increased O +
levels O +
of O +
sTNFRs B-Gene +
in O +
the O +
PF O +
of O +
experimental O +
rats O +
-- O +
particularly O +
sTNFRII B-Gene +
-- O +
may O +
be O +
involved O +
in O +
the O +
development O +
of O +
colitis O +
by O +
serving O +
as O +
a O +
reservoir O +
of O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
, O +
and O +
thus O +
provide O +
a O +
novel O +
therapeutic O +
target O +
for O +
IBD O +
. O +

Cytokine B-Gene +
- O +
mediated O +
modulation O +
of O +
leptin B-Gene +
and O +
adiponectin B-Gene +
secretion O +
during O +
in O +
vitro O +
adipogenesis O +
: O +
evidence O +
that O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
- O +
and O +
interleukin-1beta B-Gene +
- O +
treated O +
human O +
preadipocytes O +
are O +
potent O +
leptin B-Gene +
producers O +
. O +

Over O +
the O +
last O +
decade O +
, O +
compelling O +
evidence O +
has O +
been O +
presented O +
that O +
cytokines O +
affect O +
adipocyte O +
tissue O +
formation O +
and O +
function O +
. O +

In O +
this O +
study O +
we O +
explored O +
the O +
effect O +
of O +
pro O +
- O +
inflammatory O +
( O +
i.e. O +
interleukin B-Gene +
( I-Gene +
IL I-Gene +
) I-Gene +
- I-Gene +
1beta I-Gene +
, O +
IL-6 B-Gene +
, O +
interferon B-Gene +
( I-Gene +
IFN I-Gene +
) I-Gene +
- I-Gene +
gamma I-Gene +
, O +
and O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
( I-Gene +
TNF I-Gene +
) I-Gene +
- I-Gene +
alpha I-Gene +
) O +
versus O +
anti O +
- O +
inflammatory O +
cytokines B-Gene +
( O +
i.e. O +
IL-4 B-Gene +
, O +
IL-10 B-Gene +
, O +
and O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
( I-Gene +
TGF I-Gene +
) I-Gene +
- I-Gene +
beta1 I-Gene +
) O +
on O +
leptin B-Gene +
and O +
adiponectin B-Gene +
secretion O +
during O +
in O +
vitro O +
human O +
adipogenesis O +
. O +

Confirmative O +
to O +
previous O +
reports O +
, O +
conversion O +
of O +
precursor O +
preadipocytes O +
into O +
mature O +
adipocytes O +
was O +
completely O +
inhibited O +
upon O +
exposure O +
to O +
TNF B-Gene +
- I-Gene +
alpha I-Gene +
, O +
IL-1beta B-Gene +
, O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
, O +
or O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
. O +

Hence O +
, O +
all O +
these O +
anti O +
- O +
adipogenic O +
cytokines B-Gene +
prevented O +
release O +
of O +
adipocyte O +
- O +
specific O +
adiponectin B-Gene +
. O +

IFN B-Gene -
- I-Gene -
gamma I-Gene +
also O +
strongly O +
reduced O +
leptin B-Gene +
production O +
( O +
> O +
or O +
= O +
85 O +
% O +
) O +
. O +

However O +
, O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
, O +
IL-1beta B-Gene +
, O +
and O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
stimulated O +
leptin B-Gene +
production O +
from O +
preadipocytes O +
in O +
the O +
absence O +
of O +
mature O +
adipocytes O +
( O +
20.6 O +
+ O -
/- O +
5.4 O +
ng O +
/ O +
ml O +
, O +
100.8 O +
+ O -
/- O +
18.2 O +
ng O +
/ O +
ml O +
, O +
and O +
5.4 O +
+ O -
/- O +
0.4 O +
ng O +
/ O +
ml O +
, O +
respectively O +
, O +
compared O +
to O +
6.6 O +
+ O -
/- O +
0.8 O +
ng O +
/ O +
ml O +
in O +
control O +
adipocyte O +
cultures O +
on O +
day O +
21 O +
; O +
n O +
= O +
4 O +
) O +
. O +

IL-4 B-Gene +
, O +
IL-6 B-Gene +
and O +
IL-10 B-Gene +
did O +
not O +
, O +
or O +
only O +
slightly O +
, O +
affect O +
adipocyte O +
differentiation O +
and O +
their O +
hormonal O +
secretion O +
. O +

In O +
conclusion O +
, O +
adiponectin B-Gene +
and O +
leptin B-Gene +
are O +
both O +
synthesized O +
by O +
adipocytes O +
, O +
whereas O +
leptin B-Gene +
is O +
also O +
produced O +
by O +
preadipocytes O +
upon O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
or O +
IL-1beta B-Gene +
stimulation O +
. O +

These O +
data O +
suggest O +
that O +
preadipocytes O +
could O +
contribute O +
more O +
to O +
total O +
circulating O +
leptin B-Gene +
levels O +
than O +
has O +
been O +
previously O +
considered O +
, O +
especially O +
in O +
diseased O +
conditions O +
were O +
these O +
pro O +
- O +
inflammatory O +
factors O +
play O +
a O +
prominent O +
role O +
. O +

The O +
docosatriene O +
protectin O +
D1 O +
is O +
produced O +
by O +
TH2 O +
skewing O +
and O +
promotes O +
human O +
T O +
cell O +
apoptosis O +
via O +
lipid O +
raft O +
clustering O +
. O +

Docosahexaenoic O +
acid O +
, O +
a O +
major O +
omega-3 O +
fatty O +
acid O +
in O +
human O +
brain O +
, O +
synapses O +
, O +
retina O +
, O +
and O +
other O +
neural O +
tissues O +
, O +
displays O +
beneficial O +
actions O +
in O +
neuronal O +
development O +
, O +
cancer O +
, O +
and O +
inflammatory O +
diseases O +
by O +
mechanisms O +
that O +
remain O +
to O +
be O +
elucidated O +
. O +

In O +
this O +
study O +
we O +
found O +
, O +
using O +
lipid O +
mediator O +
informatics O +
employing O +
liquid O +
chromatography O +
- O +
tandem O +
mass O +
spectrometry O +
, O +
that O +
( O +
10,17S O -
) O -
-docosatriene O +
/ O +
neuroprotectin O +
D1 O +
, O +
now O +
termed O +
protectin O +
D1 O +
( O +
PD1 O +
) O +
, O +
is O +
generated O +
from O +
docosahexaenoic O +
acid O +
by O +
T O +
helper O +
type O +
2 O +
- O +
skewed O +
peripheral O +
blood O +
mononuclear O +
cells O +
in O +
a O +
lipoxygenase B-Gene +
- O +
dependent O +
manner O +
. O +

PD1 O +
blocked O +
T O +
cell O +
migration O +
in O +
vivo O +
, O +
inhibited O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
alpha I-Gene +
and O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
secretion O +
, O +
and O +
promoted O +
apoptosis O +
mediated O +
by O +
raft O +
clustering O +
. O +

These O +
results O +
demonstrated O +
novel O +
anti O +
- O +
inflammatory O +
roles O +
for O +
PD1 O +
in O +
regulating O +
events O +
associated O +
with O +
inflammation O +
and O +
resolution O +
. O +

Serum O +
evaluation O +
of O +
the O +
balance O +
between O +
soluble O +
interleukin-2 B-Gene +
and O +
interleukin-4 B-Gene +
receptors I-Gene +
. O +

To O +
elucidate O +
the O +
usefulness O +
of O +
the O +
simultaneous O +
analysis O +
of O +
the O +
multiple O +
kinds O +
of O +
soluble O +
cytokine B-Gene +
receptors I-Gene +
, O +
we O +
determined O +
both O +
the O +
soluble O +
interleukin B-Gene +
2 I-Gene +
receptor I-Gene +
( O +
sIL-2R B-Gene +
, O +
Th1 O +
- O +
type O +
cytokine B-Gene +
receptor I-Gene +
) O +
and O +
the O +
soluble O +
interleukin B-Gene +
4 I-Gene +
receptor I-Gene +
( O +
sIL-4R B-Gene +
, O +
Th2 O +
- O +
type O +
cytokine B-Gene +
receptor I-Gene +
) O +
levels O +
in O +
the O +
sera O +
of O +
healthy O +
subjects O +
as O +
reference O +
values O +
and O +
preliminarily O +
applied O +
to O +
evaluate O +
the O +
patients O +
with O +
diarrhea O +
positive O +
( O +
D+ O +
) O +
hemolytic O +
uremic O +
syndrome O +
( O +
HUS O +
) O +
as O +
the O +
diagnostic O +
parameter O +
of O +
the O +
severity O +
. O +

Both O +
sIL-2R B-Gene +
and O +
sIL-4R B-Gene +
levels O +
in O +
the O +
sera O +
of O +
healthy O +
children O +
were O +
significantly O +
higher O +
than O +
those O +
of O +
healthy O +
adults O +
( O +
p O +
< O +
0.01 O +
) O +
. O +

The O +
serum O +
sIL-2R B-Gene +
level O +
of O +
the O +
patients O +
with O +
severe O +
HUS O +
( O +
n O +
= O +
4 O +
) O +
was O +
higher O +
than O +
that O +
of O +
the O +
patients O +
with O +
mild O +
/ O +
moderate O +
HUS O +
( O +
n O +
= O +
6 O +
) O +
at O +
the O +
initial O +
stage O +
( O +
p O +
< O +
0.01 O +
) O +
or O +
healthy O +
children O +
( O +
n O +
= O +
51 O +
, O +
p O +
< O +
0.01 O +
) O +
. O +

Whereas O +
, O +
the O +
serum O +
sIL-4R B-Gene +
level O +
of O +
both O +
the O +
severe O +
and O +
mild O +
/ O +
moderate O +
groups O +
was O +
lower O +
than O +
that O +
of O +
the O +
healthy O +
control O +
children O +
, O +
although O +
there O +
was O +
no O +
significant O +
difference O +
among O +
the O +
three O +
groups O +
. O +

Namely O +
, O +
the O +
soluble O +
receptor O +
balance O +
( O +
sIL-2R B-Gene +
/ O +
sIL-4R B-Gene +
) O +
in O +
the O +
patients O +
with O +
severe O +
HUS O +
may O +
shift O +
. O +

We O +
considered O +
that O +
the O +
evaluation O +
of O +
the O +
balance O +
between O +
soluble O +
cytokine B-Gene +
receptors I-Gene +
might O +
be O +
informative O +
for O +
the O +
evaluation O +
of O +
the O +
immune O +
states O +
, O +
as O +
well O +
as O +
the O +
conventional O +
cytokine B-Gene +
balance O +
( O +
Th1 O +
/ O +
Th2 O +
) O +
. O +

F B-Gene -
- I-Gene -
spondin I-Gene +
interaction O +
with O +
the O +
apolipoprotein B-Gene +
E I-Gene +
receptor I-Gene +
ApoEr2 B-Gene +
affects O +
processing O +
of O +
amyloid B-Gene +
precursor I-Gene +
protein I-Gene +
. O +

A O +
recent O +
study O +
showed O +
that O +
F B-Gene -
- I-Gene -
spondin I-Gene +
, O +
a O +
protein O +
associated O +
with O +
the O +
extracellular O +
matrix O +
, O +
interacted O +
with O +
amyloid B-Gene +
precursor I-Gene +
protein I-Gene +
( O +
APP B-Gene +
) O +
and O +
inhibited O +
beta B-Gene +
- I-Gene +
secretase I-Gene +
cleavage O +
. O +

F B-Gene -
- I-Gene -
spondin I-Gene +
contains O +
a O +
thrombospondin B-Gene +
domain O +
that O +
we O +
hypothesized O +
could O +
interact O +
with O +
the O +
family B-Gene +
of I-Gene +
receptors I-Gene +
for I-Gene +
apolipoprotein I-Gene +
E I-Gene +
( O +
apoE B-Gene +
) O +
. O +

Through O +
coimmunoprecipitation O +
experiments O +
, O +
we O +
demonstrated O +
that O +
F B-Gene -
- I-Gene -
spondin I-Gene +
interacts O +
with O +
an O +
apoE B-Gene +
receptor I-Gene +
( O +
apoE B-Gene +
receptor I-Gene +
2 I-Gene +
[ O +
ApoEr2 B-Gene +
] O +
) O +
through O +
the O +
thrombospondin B-Gene +
domain O +
of O +
F B-Gene -
- I-Gene -
spondin I-Gene +
and O +
the O +
ligand O +
binding O +
domain O +
of O +
ApoEr2 B-Gene +
. O +

Full O +
- O +
length O +
F B-Gene -
- I-Gene -
spondin I-Gene +
increased O +
coimmunoprecipitation O +
of O +
ApoEr2 B-Gene +
and O +
APP B-Gene +
in O +
transfected O +
cells O +
and O +
primary O +
neurons O +
and O +
increased O +
surface O +
expression O +
of O +
APP B-Gene +
and O +
ApoEr2 B-Gene +
. O +

Full O +
- O +
length O +
F B-Gene -
- I-Gene -
spondin I-Gene +
, O +
but O +
none O +
of O +
the O +
individual O +
F B-Gene -
- I-Gene -
spondin I-Gene +
domains O +
, O +
increased O +
cleavage O +
of O +
APP B-Gene +
and O +
ApoEr2 B-Gene +
, O +
resulting O +
in O +
more O +
secreted O +
forms O +
of O +
APP B-Gene +
and O +
ApoEr2 B-Gene +
and O +
more O +
C O +
- O +
terminal O +
fragments O +
( O +
CTF O +
) O +
of O +
these O +
proteins O +
. O +

In O +
addition O +
, O +
full O +
- O +
length O +
F B-Gene -
- I-Gene -
spondin I-Gene +
, O +
but O +
not O +
the O +
individual O +
domains O +
, O +
decreased O +
production O +
of O +
the O +
beta O -
- O -
CTF O +
of O +
APP B-Gene +
and O +
Abeta B-Gene +
in O +
transfected O +
cells O +
and O +
primary O +
neurons O +
. O +

The O +
reduction O +
in O +
APP B-Gene +
beta I-Gene +
- O +
CTF O +
was O +
blocked O +
by O +
receptor B-Gene +
- I-Gene +
associated I-Gene +
protein I-Gene +
( O +
RAP B-Gene +
) O +
, O +
an O +
inhibitor O +
of O +
lipoprotein B-Gene +
receptors I-Gene +
, O +
implicating O +
ApoEr2 B-Gene +
in O +
the O +
altered O +
proteolysis O +
of O +
APP B-Gene +
. O +

ApoEr2 B-Gene +
coprecipitated O +
with O +
APP B-Gene +
alpha O +
- O +
and O +
beta O +
- O +
CTF O +
, O +
and O +
F B-Gene -
- I-Gene -
spondin I-Gene +
reduced O +
the O +
levels O +
of O +
APP B-Gene +
intracellular O +
domain O +
signaling O +
, O +
suggesting O +
that O +
there O +
are O +
also O +
intracellular O +
interactions O +
between O +
APP B-Gene +
and O +
ApoEr2 B-Gene +
, O +
perhaps O +
involving O +
adaptor B-Gene +
proteins I-Gene +
. O +

These O +
studies O +
suggest O +
that O +
the O +
extracellular O +
matrix O +
molecule O +
F B-Gene -
- I-Gene -
spondin I-Gene +
can O +
cluster O +
APP B-Gene +
and O +
ApoEr2 B-Gene +
together O +
on O +
the O +
cell O +
surface O +
and O +
affect O +
the O +
processing O +
of O +
each O +
, O +
resulting O +
in O +
decreased O +
production O +
of O +
Abeta B-Gene +
. O +

Sequence O +
analysis O +
of O +
Arabidopsis O +
thaliana O +
E O +
/ O +
ANTH O +
- O +
domain O +
- O +
containing O +
proteins O +
: O +
membrane O +
tethers O +
of O +
the O +
clathrin B-Gene +
- O +
dependent O +
vesicle O +
budding O +
machinery O +
. O +

The O +
epsin B-Gene +
N O +
- O +
terminal O +
homology O +
( O +
ENTH O +
) O +
domain O +
is O +
a O +
conserved O +
protein O +
module O +
present O +
in O +
cytosolic O +
proteins O +
which O +
are O +
required O +
in O +
clathrin B-Gene +
- O +
mediated O +
vesicle O +
budding O +
processes O +
. O +

A O +
highly O +
similar O +
, O +
yet O +
unique O +
module O +
is O +
the O +
AP180 B-Gene +
N O +
- O +
terminal O +
homology O +
( O +
ANTH O +
) O +
domain O +
, O +
which O +
is O +
present O +
in O +
a O +
set O +
of O +
proteins O +
that O +
also O +
support O +
clathrin B-Gene +
- O +
dependent O +
endocytosis O +
. O +

Both O +
ENTH O +
and O +
ANTH O +
( O +
E O +
/ O +
ANTH O +
) O +
domains O +
bind O +
to O +
phospholipids O +
and O +
proteins O +
, O +
in O +
order O +
to O +
support O +
the O +
nucleation O +
of O +
clathrin B-Gene +
coats O +
on O +
the O +
plasma O +
membrane O +
or O +
the O +
trans O +
- O +
Golgi O +
- O +
network O +
membrane O +
. O +

Therefore O +
, O +
E O +
/ O +
ANTH O +
proteins O +
might O +
be O +
considered O +
as O +
universal O +
tethering O +
components O +
of O +
the O +
clathrin B-Gene +
- O +
mediated O +
vesicle O +
budding O +
machinery O +
. O +

Since O +
the O +
E B-Gene +
/ I-Gene +
ANTH I-Gene +
protein I-Gene +
family I-Gene +
appears O +
to O +
be O +
crucial O +
in O +
the O +
first O +
steps O +
of O +
clathrin B-Gene +
- O +
coated O +
vesicle O +
budding O +
, O +
we O +
performed O +
data O +
base O +
searches O +
of O +
the O +
Arabidopsis O +
thaliana O +
genome O +
. O +

Sequence O +
analysis O +
revealed O +
three O +
proteins O +
containing O +
the O +
ENTH O +
signature O +
motif O +
and O +
eight O +
proteins O +
containing O +
the O +
ANTH O +
signature O +
motif O +
. O +

Another O +
six O +
proteins O +
were O +
found O +
that O +
do O +
not O +
contain O +
either O +
motif O +
but O +
seem O +
to O +
have O +
the O +
same O +
domain O +
structure O +
and O +
might O +
therefore O +
be O +
seen O +
as O +
VHS O -
- O -
domain O +
- O +
containing O +
plant O +
proteins O +
. O +

Functional O +
analysis O +
of O +
plant O +
E O +
/ O +
ANTH O +
proteins O +
are O +
rather O +
scarce O +
, O +
since O +
only O +
one O +
ANTH O +
homolog O +
from O +
A. O +
thaliana O +
, O +
At O +
- O +
AP180 B-Gene +
, O +
has O +
been O +
characterized O +
so O +
far O +
. O +

AP180 B-Gene +
displays O +
conserved O +
functions O +
as O +
a O +
clathrin B-Gene +
assembly I-Gene +
protein I-Gene +
and O +
as O +
an O +
alpha B-Gene -
- I-Gene -
adaptin I-Gene +
binding O +
partner O +
, O +
and O +
in O +
addition O +
shows O +
features O +
at O +
the O +
molecular O +
level O +
that O +
seem O +
to O +
be O +
plant O +
- O +
specific O +
. O +

Gene O +
cloning O +
and O +
molecular O +
characterization O +
of O +
an O +
extracellular O +
poly B-Gene -
( I-Gene -
L I-Gene -
- I-Gene -
lactic I-Gene +
acid I-Gene +
) I-Gene +
depolymerase I-Gene +
from O +
Amycolatopsis O +
sp. O +
strain O +
K104 O -
- O -
1 O +
. O +

We O +
have O +
isolated O +
a O +
polylactide O +
or O +
poly O -
( O -
L O -
- O -
lactic O +
acid O +
) O +
( O +
PLA O +
) O +
- O +
degrading O +
bacterium O +
, O +
Amycolatopsis O +
sp. O +
strain O +
K104 O -
- O -
1 O +
, O +
and O +
purified O +
PLA B-Gene +
depolymerase I-Gene +
( O +
PLD B-Gene +
) O +
from O +
the O +
culture O +
fluid O +
of O +
the O +
bacterium O +
. O +

Here O +
, O +
we O +
cloned O +
and O +
expressed O +
the O +
pld B-Gene +
gene O +
encoding O +
PLD B-Gene +
in O +
Streptomyces O +
lividans O +
1326 O +
and O +
characterized O +
a O +
recombinant O +
PLD B-Gene +
( O +
rPLD B-Gene +
) O +
preparation O +
. O +

We O +
also O +
describe O +
the O +
processing O +
mechanism O +
from O +
nascent O +
PLD B-Gene +
to O +
mature O +
PLD B-Gene +
. O +

The O +
pld B-Gene +
gene O +
encodes O +
PLD B-Gene +
as O +
a O +
24,225-Da O +
polypeptide O +
consisting O +
of O +
238 O +
amino O +
acids O +
. O +

Biochemical O +
and O +
Western O +
immunoblot O +
analyses O +
of O +
PLD B-Gene +
and O +
its O +
precursors O +
revealed O +
that O +
PLD B-Gene +
is O +
synthesized O +
as O +
a O +
precursor O +
( O +
prepro O +
- O +
type O +
) O +
, O +
requiring O +
proteolytic O +
cleavage O +
of O +
the O +
N O +
- O +
terminal O +
35 O +
- O +
amino O +
- O +
acid O +
extension O +
including O +
the O +
26 O +
- O +
amino O +
- O +
acid O +
signal O +
sequence O +
and O +
9-residue O +
prosequence O +
to O +
generate O +
the O +
mature O +
enzyme O +
of O +
20,904 O +
Da O +
. O +

The O +
cleavage O +
of O +
the O +
prosequence O +
was O +
found O +
to O +
be O +
autocatalytic O +
. O +

PLD B-Gene +
showed O +
about O +
45 O +
% O +
similarity O +
to O +
many O +
eukaryotic O +
serine B-Gene +
proteases I-Gene +
. O +

In O +
addition O +
, O +
three O +
amino O +
acid O +
residues O +
, O +
H57 O +
, O +
D102 O +
, O +
and O +
S195 O +
( O +
chymotrypsin B-Gene +
numbering O +
) O +
, O +
which O +
are O +
implicated O +
in O +
forming O +
the O +
catalytic O +
triad O +
necessary O +
for O +
cleavage O +
of O +
amide O +
bond O +
of O +
substrates O +
in O +
eukaryotic O +
serine B-Gene +
proteases I-Gene +
, O +
were O +
conserved O +
in O +
PLD B-Gene +
as O +
residues O +
H74 O +
, O +
D111 O +
, O +
and O +
S197 O +
. O +

The O +
G193 O +
residue O +
( O +
chymotrypsin B-Gene +
numbering O +
) O +
, O +
which O +
is O +
implicated O +
in O +
forming O +
an O +
oxyanion O +
hole O +
with O +
residue O +
S195 O +
and O +
forms O +
an O +
important O +
hydrogen O +
bond O +
for O +
interaction O +
with O +
the O +
carbonyl O +
group O +
of O +
the O +
scissile O +
peptide O +
bond O +
, O +
was O +
also O +
conserved O +
in O +
PLD B-Gene +
. O +

The O +
functional O +
analysis O +
of O +
the O +
PLD B-Gene +
mutants O +
H74A O +
, O +
D111A O +
, O +
and O +
S197A O +
revealed O +
that O +
residues O +
H74 O +
, O +
D111 O +
, O +
and O +
S197 O +
are O +
important O +
for O +
the O +
depolymerase B-Gene +
and O +
caseinolytic O +
activities O +
of O +
PLD B-Gene +
and O +
for O +
cleavage O +
of O +
the O +
prosequence O +
from O +
pro O +
- O +
type O +
PLD B-Gene +
to O +
form O +
the O +
mature O +
one O +
. O +

The O +
PLD B-Gene +
preparation O +
had O +
elastase B-Gene +
activity O +
which O +
was O +
not O +
inhibited O +
by O +
1 O +
mM O +
elastatinal O +
, O +
which O +
is O +
10 O +
times O +
higher O +
than O +
needed O +
for O +
complete O +
inhibition O +
of O +
porcine O +
pancreatic O +
elastase B-Gene +
. O +

The O +
rPLD B-Gene +
preparation O +
degraded O +
PLA O +
with O +
an O +
average O +
molecular O +
mass O +
of O +
220 O +
kDa O +
into O +
lactic O +
acid O +
dimers O +
through O +
lactic O +
acid O +
oligomers O +
and O +
finally O +
into O +
lactic O +
acid O +
. O +

The O +
PLD B-Gene +
preparation O +
bound O +
to O +
high O +
polymers O +
of O +
3-hydoxybutyrate O +
, O +
epsilon O -
- O -
caprolacton O +
, O +
and O +
butylene O +
succinate O +
as O +
well O +
as O +
PLA O +
, O +
but O +
it O +
degraded O +
only O +
PLA O +
. O +

Global O +
transcriptional O +
profiling O +
demonstrates O +
the O +
combination O +
of O +
type B-Gene +
I I-Gene +
and I-Gene +
type I-Gene +
II I-Gene +
interferon I-Gene +
enhances O +
antiviral O +
and O +
immune O +
responses O +
at O +
clinically O +
relevant O +
doses O +
. O +

A O +
role O +
for O +
type B-Gene +
II I-Gene +
interferon I-Gene +
( O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
in O +
resolving O +
viral O +
infection O +
is O +
suggested O +
by O +
the O +
correlation O +
of O +
hepatitis O +
C O +
virus O +
( O +
HCV O +
) O +
clearance O +
with O +
enhancement O +
of O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
- O +
producing O +
activated O +
T O +
cells O +
in O +
the O +
resolution O +
of O +
acute O +
HCV O +
infection O +
. O +

Using O +
vesicular O +
stomatitis O +
virus O +
( O +
VSV O +
) O +
, O +
a O +
synergistic O +
direct O +
antiviral O +
effect O +
was O +
documented O +
using O +
IFN B-Gene -
- I-Gene -
gamma1b I-Gene +
and O +
a O +
potent O +
, O +
consensus O +
type B-Gene +
I I-Gene +
IFN I-Gene +
( O +
IFN B-Gene +
alfacon-1 O +
) O +
. O +

Global O +
expression O +
profiling O +
following O +
EC50 O +
exposure O +
to O +
IFN B-Gene +
alfacon-1 O +
, O +
IFN B-Gene -
- I-Gene -
gamma1b I-Gene +
, O +
or O +
a O +
cocktail O +
of O +
the O +
two O +
allowed O +
the O +
antiviral O +
state O +
to O +
be O +
correlated O +
with O +
induction O +
of O +
a O +
subset O +
of O +
IFN B-Gene +
- O +
stimulated O +
genes O +
( O +
ISGs O +
) O +
. O +

Genes O +
identified O +
through O +
this O +
analysis O +
corresponded O +
to O +
classic O +
antiviral O +
components O +
, O +
ISGs O +
more O +
recently O +
associated O +
with O +
direct O +
antiviral O +
functions O +
, O +
as O +
well O +
as O +
expressed O +
sequence O +
tags O +
( O +
ESTs O +
) O +
and O +
hypothetical O +
proteins O +
. O +

The O +
magnitude O +
of O +
these O +
antiviral O +
EC50 O +
- O +
correlated O +
expression O +
events O +
in O +
human O +
hepatoma O +
( O +
Huh7 O +
) O +
cells O +
exposed O +
to O +
clinically O +
relevant O +
doses O +
of O +
IFN B-Gene +
alfacon-1 O +
, O +
IFN B-Gene -
- I-Gene -
gamma1b I-Gene +
, O +
or O +
a O +
cocktail O +
of O +
the O +
two O +
was O +
also O +
probed O +
because O +
the O +
standard O +
of O +
care O +
for O +
patients O +
with O +
chronic O +
hepatitis O +
C O +
is O +
type B-Gene +
I I-Gene +
IFN I-Gene +
- O +
containing O +
regimens O +
. O +

Relative O +
to O +
type B-Gene +
I I-Gene +
IFNs I-Gene +
used O +
alone O +
, O +
the O +
addition O +
of O +
type B-Gene +
II I-Gene +
IFN I-Gene +
caused O +
enhanced O +
expression O +
not O +
only O +
of O +
many O +
of O +
the O +
genes O +
correlated O +
with O +
the O +
direct O +
antiviral O +
state O +
but O +
also O +
of O +
genes O +
involved O +
in O +
( O -
1 O -
) O +
antigen O +
presentation O +
to O +
cytotoxic O +
T O +
lymphocytes O +
( O +
CTLs O +
) O +
, O +
( O -
2 O -
) O +
macrophage O +
, O +
natural O +
killer O +
( O +
NK O +
) O +
, O +
and O +
T O +
helper O +
1 O +
( O +
Th1 O +
) O +
cell O +
recruitment O +
and O +
activation O +
, O +
( O -
3 O -
) O +
complement O +
system O +
function O +
, O +
( O -
4 O -
) O +
apoptosis O +
, O +
and O +
( O +
5 O +
) O +
ISGs O +
with O +
unknown O +
functions O +
. O +

As O +
many O +
of O +
these O +
processes O +
are O +
correlated O +
clinically O +
with O +
resolution O +
of O +
chronic O +
HCV O +
infection O +
, O +
the O +
combined O +
use O +
of O +
these O +
IFNs B-Gene +
could O +
display O +
a O +
beneficial O +
effect O +
on O +
viral O +
clearance O +
in O +
patients O +
infected O +
with O +
HCV O +
and O +
other O +
viruses O +
through O +
enhancement O +
of O +
one O +
of O +
these O +
processes O +
or O +
of O +
the O +
direct O +
antiviral O +
state O +
. O +

In O +
vitro O +
gene O +
expression O +
changes O +
of O +
androgen B-Gene +
receptor I-Gene +
coactivators O +
after O +
hormone O +
deprivation O +
in O +
an O +
androgen O +
- O +
dependent O +
prostate O +
cancer O +
cell O +
line O +
. O +

BACKGROUND O +
AND O +
PURPOSE O +
: O +

Androgen B-Gene +
receptor I-Gene +
( O +
AR B-Gene +
) O +
coactivators O +
modulate O +
the O +
transcriptional O +
activity O +
of O +
AR B-Gene +
and O +
may O +
activate O +
AR B-Gene +
- O +
associated O +
genes O +
upon O +
androgen O +
deprivation O +
. O +

Changes O +
of O +
expression O +
patterns O +
may O +
help O +
reveal O +
the O +
role O +
of O +
AR B-Gene +
cofactors O +
in O +
androgen O +
- O +
independent O +
prostate O +
cancer O +
. O +

This O +
study O +
investigated O +
changes O +
of O +
expression O +
patterns O +
of O +
several O +
AR B-Gene +
coactivators O +
after O +
androgen O +
deprivation O +
in O +
an O +
androgen O +
- O +
dependent O +
prostate O +
cancer O +
cell O +
line O +
( O +
LNCaP O +
) O +
. O +

METHODS O +
: O +

LNCaP O +
cells O +
were O +
cultured O +
in O +
RPMI O +
medium O +
with O +
charcoal O +
/ O +
dextran O +
- O +
treated O +
fetal O +
bovine O +
serum O +
for O +
28 O +
days O +
. O +

Samples O +
of O +
total O +
RNA O +
collected O +
at O +
1 O +
- O +
week O +
intervals O +
were O +
analyzed O +
using O +
a O +
non O +
- O +
isotopic O +
multi O +
- O +
probe O +
ribonuclease B-Gene +
protection O +
assay O +
system O +
with O +
a O +
human O +
AR B-Gene +
multi O +
- O +
probe O +
template O +
set O +
. O +

Expression O +
changes O +
of O +
10 O +
mRNAs O +
of O +
interest O +
( O +
AR B-Gene +
, O +
Rb B-Gene +
, O +
ARA160 B-Gene +
, O +
ARA24 B-Gene +
, O +
ARA54 B-Gene +
, O +
ARA55 B-Gene +
, O +
ARA70 B-Gene +
, O +
BRCA1 B-Gene +
, O +
F B-Gene -
- I-Gene -
SRC-1 I-Gene +
, O +
and O +
RAC3 B-Gene +
) O +
were O +
analyzed O +
simultaneously O +
as O +
AR B-Gene +
and O +
AR B-Gene +
- O +
associated O +
cofactors O +
in O +
1 O +
hybridization O +
reaction O +
. O +

RESULTS O +
: O +

Seven O +
of O +
10 O +
cofactors O +
tested O +
were O +
expressed O +
in O +
LNCaP O +
cells O +
. O +

Only O +
Rb B-Gene +
, O +
ARA55 B-Gene +
and O +
BRCA1 B-Gene +
were O +
not O +
detected O +
. O +

LNCaP O +
cells O +
cultured O +
in O +
charcoal O +
- O +
treated O +
serum O +
for O +
28 O +
days O +
clearly O +
showed O +
more O +
than O +
1.5 O +
- O +
fold O +
increases O +
in O +
AR B-Gene +
, O +
ARA160 B-Gene +
, O +
and O +
ARA70 B-Gene +
expression O +
, O +
while O +
expression O +
of O +
ARA24 B-Gene +
and O +
ARA54 B-Gene +
increased O +
less O +
than O +
1.5 O +
- O +
fold O +
. O +

Only O +
RAC3 B-Gene +
and O +
F B-Gene -
- I-Gene -
SRC-1 I-Gene +
decreased O +
in O +
RNA O +
expression O +
. O +

Cell O +
morphology O +
features O +
changed O +
gradually O +
into O +
neuron O +
- O +
like O +
shapes O +
with O +
elongated O +
cytoplasm O +
during O +
the O +
culture O +
period O +
. O +

Cell O +
growth O +
almost O +
ceased O +
28 O +
days O +
after O +
the O +
start O +
of O +
culture O +
. O +

CONCLUSION O +
: O +

The O +
changes O +
in O +
expression O +
pattern O +
of O +
AR B-Gene +
and O +
AR B-Gene +
cofactors O +
and O +
in O +
particular O +
the O +
remarkable O +
increase O +
in O +
AR B-Gene +
, O +
ARA160 B-Gene +
and O +
ARA70 B-Gene +
support O +
the O +
role O +
of O +
AR B-Gene +
cofactors O +
in O +
modulating O +
prostate O +
cancer O +
cell O +
growth O +
from O +
androgen O +
dependence O +
to O +
androgen O +
independence O +
. O +

Upregulation O +
of O +
neuropilin-1 B-Gene +
by O +
basic B-Gene +
fibroblast I-Gene +
growth I-Gene +
factor I-Gene +
enhances O +
vascular O +
smooth O +
muscle O +
cell O +
migration O +
in O +
response O +
to O +
VEGF B-Gene +
. O +

Neuropilin-1 B-Gene +
( O +
NRP-1 B-Gene +
) O +
is O +
a O +
co O +
- O +
receptor O +
for O +
vascular B-Gene +
endothelial I-Gene +
growth I-Gene +
factor I-Gene +
( O +
VEGF B-Gene +
) O +
. O +

During O +
neovascularization O +
, O +
vascular O +
smooth O +
muscle O +
cells O +
( O +
VSMCs O +
) O +
and O +
pericytes O +
modulate O +
the O +
function O +
of O +
endothelial O +
cells O +
. O +

Factors O +
that O +
mediate O +
NRP-1 B-Gene +
in O +
human O +
VSMCs O +
( O +
hVSMCs O +
) O +
remain O +
to O +
be O +
elucidated O +
. O +

We O +
studied O +
various O +
angiogenic O +
cytokines B-Gene +
to O +
identify O +
factors O +
that O +
increase O +
NRP-1 B-Gene +
expression O +
in O +
hVSMCs O +
. O +

Treatment O +
of O +
hVSMCs O +
with O +
basic B-Gene +
fibroblast I-Gene +
growth I-Gene +
factor I-Gene +
( O +
b B-Gene -
- I-Gene -
FGF I-Gene +
) O +
induced O +
expressions O +
of O +
NRP-1 B-Gene +
mRNA O +
and O +
protein O +
whereas O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
, O +
insulin B-Gene +
- I-Gene +
like I-Gene +
growth I-Gene +
factor-1 I-Gene +
, O +
and O +
interleukin-1beta B-Gene +
did O +
not O +
. O +

b B-Gene -
- I-Gene -
FGF I-Gene +
induced O +
phosphorylation O +
of O +
Erk-1 B-Gene -
/ I-Gene -
2 I-Gene +
and O +
JNK B-Gene +
. O +

MEK1 B-Gene +
/ I-Gene +
2 I-Gene +
and O +
nuclear B-Gene +
factor I-Gene +
kappa I-Gene +
B I-Gene +
( O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
) O +
inhibitors O +
( O +
U0126 O +
and O +
TLCK O +
, O +
respectively O +
) O +
blocked O +
the O +
ability O +
of O +
b B-Gene -
- I-Gene -
FGF I-Gene +
to O +
induce O +
NRP-1 B-Gene +
mRNA O +
expression O +
, O +
but O +
inhibition O +
of O +
JNK B-Gene +
( O +
SP600125 O +
) O +
or O +
PI3 B-Gene +
- I-Gene +
kinase I-Gene +
activity O +
( O +
wortmannin O +
) O +
did O +
not O +
. O +

Further O +
, O +
the O +
increase O +
in O +
NRP-1 B-Gene +
expression O +
by O +
b B-Gene -
- I-Gene -
FGF I-Gene +
enhanced O +
hVSMCs O +
migration O +
in O +
response O +
to O +
VEGF B-Gene +
( O +
165 O +
) O +
. O +

This O +
effect O +
was O +
dependent O +
on O +
the O +
binding O +
of O +
VEGF B-Gene +
( O +
165 O +
) O +
to O +
VEGFR-2 B-Gene +
, O +
as O +
blocking O +
antibodies O +
to O +
VEGFR-2 B-Gene +
, O +
but O +
not O +
VEGFR-1 B-Gene +
, O +
inhibited O +
VEGF B-Gene -
( I-Gene -
165 I-Gene -
) I-Gene +
- O +
induced O +
migration O +
. O +

In O +
conclusion O +
, O +
b B-Gene -
- I-Gene -
FGF I-Gene +
increased O +
NRP-1 B-Gene +
expression O +
in O +
hVSMCs O +
that O +
in O +
turn O +
enhance O +
the O +
effect O +
of O +
VEGF B-Gene +
( O +
165 O +
) O +
on O +
cell O +
migration O +
. O +

The O +
enhanced O +
migration O +
of O +
hVSMCs O +
was O +
mediated O +
through O +
binding O +
of O +
VEGF B-Gene +
( O +
165 O +
) O +
to O +
both O +
NRP-1 B-Gene +
and O +
VEGFR-2 B-Gene +
, O +
as O +
inhibition O +
of O +
VEGFR-2 B-Gene +
on O +
these O +
cells O +
blocked O +
the O +
effect O +
of O +
VEGF B-Gene +
- O +
mediated O +
cell O +
migration O +
. O +

Pathogenesis O +
of O +
antiphospholipid O +
antibodies O +
: O +
impairment O +
of O +
fibrinolysis O +
and O +
monocyte O +
activation O +
via O +
the O +
p38 B-Gene +
mitogen I-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
pathway O +
. O +

Antiphospholipid O +
syndrome O +
( O +
APS O +
) O +
is O +
characterized O +
by O +
recurrent O +
thrombosis O +
or O +
pregnancy O +
morbidity O +
associated O +
with O +
antiphospholipid O +
antibodies O +
( O +
aPL O +
) O +
. O +

Impaired O +
fibrinolysis O +
is O +
a O +
contributing O +
factor O +
for O +
the O +
development O +
of O +
thrombosis O +
, O +
and O +
the O +
effect O +
of O +
aPL O +
in O +
the O +
fibrinolytic O +
system O +
has O +
been O +
investigated O +
. O +

Impaired O +
release O +
of O +
tPA B-Gene +
and O +
enhanced O +
release O +
of O +
PAI-1 B-Gene +
after O +
endothelial O +
activation O +
is O +
reported O +
in O +
patients O +
with O +
APS O +
. O +

Elevated O +
Lipoprotein B-Gene +
( I-Gene -
a I-Gene -
) I-Gene +
levels O +
have O +
been O +
found O +
in O +
APS O +
, O +
which O +
results O +
in O +
inhibition O +
of O +
fibrinolytic O +
activity O +
. O +

Phospholipid O +
- O +
bound O +
beta B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene -
-glycoprotein I-Gene +
I I-Gene +
( O +
beta B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene -
GPI I-Gene +
) O +
is O +
a O +
major O +
autoantigen O +
for O +
aPLs O +
. O +

beta B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene -
GPI I-Gene +
exerts O +
both O +
anti O +
- O +
coagulant O +
and O +
pro O +
- O +
coagulant O +
properties O +
mainly O +
by O +
interacting O +
with O +
other O +
phospholipid O +
- O +
binding O +
proteins O +
such O +
as O +
coagulation B-Gene +
factors I-Gene +
and O +
protein B-Gene +
C I-Gene +
. O +

Dramatic O +
increase O +
in O +
the O +
affinity O +
of O +
beta B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene -
GPI I-Gene +
to O +
the O +
cell O +
surface O +
is O +
induced O +
by O +
binding O +
of O +
pathogenic O +
anti O +
- O +
beta B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
GPI I-Gene +
antibodies O +
, O +
which O +
may O +
modify O +
the O +
physiological O +
function O +
of O +
beta B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene -
GPI I-Gene +
and O +
may O +
affect O +
the O +
coagulation O +
/ O +
fibrinolysis O +
balance O +
on O +
the O +
cell O +
surface O +
. O +

Using O +
chromogenic O +
assays O +
for O +
measuring O +
fibrinolytic O +
activity O +
, O +
we O +
demonstrated O +
that O +
addition O +
of O +
monoclonal O +
anticardiolipin O +
antibody O +
( O +
aCL O +
) O +
decreases O +
the O +
activity O +
of O +
extrinsic O +
/ O +
intrinsic O +
fibrinolysis O +
. O +

Significantly O +
lower O +
activity O +
of O +
intrinsic O +
fibrinolysis O +
was O +
also O +
demonstrated O +
in O +
the O +
euglobulin O +
fractions O +
from O +
APS O +
patients O +
. O +

Endothelial O +
cells O +
and O +
monocytes O +
are O +
activated O +
by O +
aPLs O +
in O +
vitro O +
, O +
resulting O +
in O +
production O +
of O +
tissue B-Gene +
factor I-Gene +
( O +
TF B-Gene +
) O +
, O +
a O +
major O +
initiator O +
of O +
the O +
coagulation O +
system O +
. O +

Recently O +
, O +
aPLs O +
are O +
reported O +
to O +
induce O +
thrombocytes O +
to O +
produce O +
thromboxane O +
. O +

The O +
importance O +
of O +
apoE B-Gene +
receptor I-Gene +
2 I-Gene +
on O +
platelets O +
for O +
the O +
binding O +
of O +
artificially O +
dimerized O +
beta B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene -
GPI I-Gene +
was O +
suggested O +
. O +

By O +
investigating O +
aPL O +
- O +
inducible O +
genes O +
in O +
peripheral O +
blood O +
mononuclear O +
cells O +
, O +
we O +
found O +
that O +
the O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
( O +
MAPK B-Gene +
) O +
pathway O +
was O +
up O +
- O +
regulated O +
. O +

Using O +
a O +
monocyte O +
cell O +
line O +
, O +
phosphorylation O +
of O +
p38 B-Gene +
MAPK I-Gene +
, O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
translocation O +
to O +
the O +
nuclear O +
fraction O +
, O +
and O +
up O +
- O +
regulated O +
TF B-Gene +
mRNA O +
expression O +
were O +
demonstrated O +
after O +
treatment O +
with O +
monoclonal O +
aCL O +
. O +

These O +
phenomena O +
were O +
observed O +
only O +
in O +
the O +
presence O +
of O +
beta B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene -
GPI I-Gene +
. O +

Moreover O +
, O +
a O +
specific O +
p38 B-Gene +
MAPK I-Gene +
inihibitor O +
SB203580 O +
decreased O +
aCL O +
/ O +
beta B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
GPI I-Gene +
- O +
induced O +
TF B-Gene +
mRNA O +
expression O +
. O +

Thus O +
, O +
aCL O +
/ O +
beta B-Gene -
( I-Gene -
2 I-Gene -
) I-Gene +
GPI I-Gene +
plays O +
dual O +
roles O +
in O +
the O +
pathogenesis O +
of O +
APS O +
, O +
firstly O +
by O +
deranging O +
the O +
fibrinolytic O +
system O +
and O +
secondly O +
by O +
activating O +
monocytes O +
, O +
endothelial O +
cells O +
and O +
thrombocytes O +
to O +
produce O +
TF B-Gene +
or O +
thromboxane O +
. O +

Molecular O +
evolution O +
of O +
the O +
AP2 B-Gene +
subfamily I-Gene +
. O +

The O +
AP2 B-Gene +
( I-Gene +
APETALA2 I-Gene +
) I-Gene +
/ I-Gene +
EREBP I-Gene +
( I-Gene +
Ethylene I-Gene +
Responsive I-Gene +
Element I-Gene +
Binding I-Gene +
Protein I-Gene +
) I-Gene +
multigene I-Gene +
family I-Gene +
includes O +
developmentally O +
and O +
physiologically O +
important O +
transcription B-Gene +
factors I-Gene +
. O +

AP2 B-Gene +
/ O +
EREBP B-Gene +
genes O +
are O +
divided O +
into O +
two O +
subfamilies O +
: O +
AP2 B-Gene +
genes O +
with O +
two O +
AP2 B-Gene +
domains O +
and O +
EREBP B-Gene +
genes O +
with O +
a O +
single O +
AP2 B-Gene +
/ O +
ERF B-Gene +
( O +
Ethylene B-Gene +
Responsive I-Gene +
Element I-Gene +
Binding I-Gene +
Factor I-Gene +
) O +
domain O +
. O +

Based O +
on O +
previous O +
phylogenetic O +
analyses O +
, O +
AP2 B-Gene +
genes O +
can O +
be O +
divided O +
into O +
two O +
clades O +
, O +
AP2 B-Gene +
and I-Gene +
ANT I-Gene +
groups I-Gene +
. O +

To O +
clarify O +
the O +
molecular O +
evolution O +
of O +
the O +
AP2 B-Gene +
subfamily I-Gene +
, O +
we O +
isolated O +
and O +
sequenced O +
genes O +
with O +
two O +
AP2 B-Gene +
domains O +
from O +
three O +
gymnosperms O +
, O +
Cycas O +
revoluta O +
, O +
Ginkgo O +
biloba O +
, O +
and O +
Gnetum O +
parvifolium O +
, O +
as O +
well O +
as O +
from O +
the O +
moss O +
Physcomitrella O +
patens O +
. O +

Expressions O +
of O +
AP2 B-Gene +
- O +
like O +
genes O +
, O +
including O +
AP2 B-Gene +
, O +
in O +
Arabidopsis O +
thaliana O +
are O +
regulated O +
by O +
the O +
microRNA O +
miR172 O +
. O +

We O +
found O +
that O +
the O +
target O +
site O +
of O +
miR172 O +
is O +
significantly O +
conserved O +
in O +
gymnosperm O +
AP2 B-Gene +
homologs O +
, O +
suggesting O +
that O +
regulatory O +
mechanisms O +
of O +
gene O +
expression O +
using O +
microRNA O +
have O +
been O +
conserved O +
over O +
the O +
three O +
hundred O +
million O +
years O +
since O +
the O +
divergence O +
of O +
gymnosperm O +
and O +
flowering O +
plant O +
lineages O +
. O +

We O +
inferred O +
a O +
phylogenetic O +
relationship O +
of O +
these O +
genes O +
with O +
the O +
green O +
alga O +
Chlamydomonas O +
reinhardtii O +
and O +
seed O +
- O +
plant O +
genes O +
available O +
in O +
public O +
DNA O +
databases O +
. O +

The O +
phylogenetic O +
tree O +
showed O +
that O +
the O +
AP2 B-Gene +
subfamily I-Gene +
diverged O +
into O +
the O +
AP2 B-Gene +
and I-Gene +
ANT I-Gene +
groups I-Gene +
before O +
the O +
last O +
common O +
ancestor O +
of O +
land O +
plants O +
and O +
after O +
C. O +
reinhardtii O +
diverged O +
from O +
the O +
land O +
- O +
plant O +
lineage O +
. O +

The O +
tree O +
also O +
indicated O +
that O +
each O +
AP2 B-Gene +
and I-Gene +
ANT I-Gene +
group I-Gene +
further O +
diverged O +
into O +
several O +
clades O +
through O +
gene O +
duplications O +
prior O +
to O +
the O +
divergence O +
of O +
gymnosperms O +
and O +
angiosperms O +
. O +

Endothelin-3-converting B-Gene +
enzyme I-Gene +
activity O +
of O +
the O +
KEL1 B-Gene +
and O +
KEL6 B-Gene +
phenotypes O +
of O +
the O +
Kell B-Gene +
blood I-Gene +
group I-Gene +
system O +
. O +

The O +
Kell B-Gene +
blood I-Gene +
group I-Gene +
protein I-Gene +
is O +
a O +
metalloendopeptidase B-Gene +
that O +
preferentially O +
cleaves O +
a O +
Trp O -
( O -
21 O -
) O -
-Ile O -
( O -
22 O -
) O +
bond O +
of O +
big O +
endothelin B-Gene +
- I-Gene +
3 I-Gene +
producing O +
bioactive O +
endothelin B-Gene +
- I-Gene +
3 I-Gene +
. O +

Kell B-Gene +
is O +
a O +
polymorphic O +
protein O +
, O +
and O +
25 O +
different O +
phenotypes O +
, O +
because O +
of O +
point O +
mutations O +
resulting O +
in O +
single O +
amino O +
acid O +
substitutions O +
, O +
have O +
been O +
described O +
. O +

It O +
was O +
recently O +
reported O +
that O +
a O +
recombinant O +
form O +
of O +
KEL1 B-Gene +
( O +
K O +
, O +
K1 O +
) O +
phenotype O +
, O +
expressed O +
in O +
K562 O +
and O +
HEK293 O +
cells O +
, O +
had O +
no O +
endothelin-3 B-Gene +
- O +
converting O +
activity O +
, O +
in O +
contrast O +
to O +
the O +
common O +
KEL2 B-Gene +
( O +
k O +
, O +
K2 O +
) O +
phenotype O +
. O +

We O +
demonstrate O +
that O +
KEL1 B-Gene +
red O +
blood O +
cells O +
and O +
also O +
a O +
soluble O +
recombinant O +
form O +
of O +
KEL1 B-Gene +
protein O +
( O +
s O +
- O +
Kell B-Gene +
KEL1 B-Gene +
) O +
have O +
similar O +
enzymatic O +
activity O +
as O +
the O +
common O +
Kell B-Gene +
phenotype O +
. O +

In O +
addition O +
we O +
show O +
that O +
KEL6 B-Gene +
red O +
blood O +
cells O +
, O +
which O +
are O +
more O +
prevalent O +
in O +
persons O +
of O +
African O +
heritage O +
than O +
in O +
Caucasians O +
also O +
have O +
endothelin B-Gene +
- I-Gene +
3 I-Gene +
- I-Gene +
converting I-Gene +
enzyme I-Gene +
activity O +
and O +
that O +
the O +
recombinant O +
soluble O +
form O +
of O +
KEL6 B-Gene +
protein O +
( O +
s O +
- O +
Kell O +
KEL6 B-Gene +
) O +
has O +
similar O +
K O -
( O -
m O -
) O +
values O +
as O +
the O +
wild O +
- O +
type O +
. O +

Posttranscriptional O +
regulation O +
of O +
TNFalpha B-Gene +
expression O +
via O +
eukaryotic B-Gene +
initiation I-Gene +
factor I-Gene +
4E I-Gene +
( O +
eIF4E B-Gene +
) O +
phosphorylation O +
in O +
mouse O +
macrophages O +
. O +

Resident O +
mouse O +
macrophages O +
secrete O +
Tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
alpha I-Gene +
( O +
TNFalpha B-Gene +
) O +
upon O +
challenge O +
with O +
LPS O +
. O +

The O +
production O +
of O +
TNFalpha B-Gene +
is O +
controlled O +
not O +
only O +
at O +
the O +
transcription O +
of O +
the O +
gene O +
, O +
but O +
also O +
by O +
strong O +
posttranscriptional O +
regulation O +
. O +

When O +
macrophages O +
are O +
stimulated O +
with O +
LPS O +
different O +
signal O +
transduction O +
pathways O +
become O +
activated O +
. O +

Here O +
we O +
show O +
that O +
the O +
combination O +
of O +
the O +
2 O +
kinases B-Gene +
p38 B-Gene +
and O +
MEK B-Gene +
and O +
presumably O +
ERK1 B-Gene +
/ I-Gene +
2 I-Gene +
regulate O +
translation O +
of O +
TNFalpha B-Gene +
, O +
through O +
the O +
downstream O +
kinase B-Gene +
Mnk1 B-Gene +
. O +

TNFalpha B-Gene +
production O +
is O +
inhibited O +
in O +
a O +
concentration O +
- O +
dependent O +
manner O +
by O +
CGP57380 O +
( O +
Mnk1 B-Gene +
inhibitor O +
) O +
. O +

The O +
corresponding O +
mRNA O +
results O +
show O +
that O +
the O +
inhibition O +
targets O +
posttranscriptional O +
regulation O +
and O +
is O +
paralleled O +
by O +
inhibition O +
of O +
the O +
phosphorylation O +
of O +
eukaryotic B-Gene +
initiation I-Gene +
factor I-Gene +
4E I-Gene +
( O +
eIF4E B-Gene +
) O +
. O +

Unexpectedly O +
, O +
the O +
activation O +
/ O +
inhibition O +
of O +
MAPKAP B-Gene +
kinase-2 I-Gene +
( O +
MK2 B-Gene +
) O +
does O +
not O +
parallel O +
TNFalpha B-Gene +
production O +
, O +
arguing O +
against O +
a O +
direct O +
/ O +
immediate O +
role O +
for O +
this O +
kinase B-Gene +
. O +

On O +
the O +
basis O +
of O +
the O +
present O +
and O +
previous O +
results O +
we O +
propose O +
that O +
ARE O +
- O +
containing O +
TNFalpha B-Gene +
mRNA O +
requires O +
phosphorylation O +
of O +
eIF4E B-Gene +
for O +
initiation O +
of O +
translation O +
. O +

[ O +
Amphiregulin B-Gene +
antisense O +
RNA O +
expression O +
inhibits O +
angiogenesis O +
of O +
human O +
breast O +
cancer O +
in O +
nude O +
mice O +
] O +

OBJECTIVE O +
: O +

To O +
investigate O +
the O +
anti O +
- O +
angiogenic O +
effect O +
of O +
amphiregulin B-Gene +
( O +
AR B-Gene +
) O +
antisense O +
RNA O +
expression O +
in O +
breast O +
cancer O +
. O +

METHODS O +
: O +

Human O +
AR B-Gene +
cDNA O +
antisense O +
plasmid O +
was O +
transfected O +
into O +
NS2T2A1 O +
cells O +
( O +
a O +
human O +
breast O +
cancer O +
cell O +
line O +
) O +
. O +

Two O +
selected O +
clones O +
expressed O +
AR B-Gene +
antisense O +
RNA O +
( O +
AR B-Gene +
AS1 O +
and O +
AR B-Gene +
AS3 O +
cell O +
lines O +
) O +
in O +
which O +
AR B-Gene +
protein O +
expression O +
was O +
reduced O +
. O +

Control O +
cell O +
line O +
NS2T2A1 O +
V O +
was O +
obtained O +
by O +
empty O +
vector O +
transfection O +
. O +

These O +
cells O +
were O +
injected O +
subcutaneously O +
into O +
nude O +
mice O +
. O +

The O +
effects O +
of O +
conditioned O +
media O +
on O +
proliferation O +
of O +
human O +
microvascular O +
endothelial O +
cells O +
( O +
HMEC O +
) O +
were O +
evaluated O +
and O +
VEGF B-Gene +
secreted O +
by O +
the O +
cells O +
was O +
measured O +
by O +
ELISA O +
method O +
. O +

In O +
tumor O +
tissues O +
, O +
VEGF B-Gene +
expression O +
levels O +
were O +
measured O +
by O +
quantitative O +
RT O +
- O +
PCR O +
, O +
and O +
CD31 B-Gene +
- O +
immunostaining O +
was O +
used O +
for O +
intra O +
- O +
tumoral O +
vascular O +
quantification O +
. O +

RESULTS O +
: O +

The O +
proliferation O +
index O +
of O +
HMEC O +
cells O +
grown O +
in O +
conditioned O +
media O +
with O +
AR B-Gene +
AS1 O +
and O +
AR B-Gene +
AS3 O +
was O +
significantly O +
reduced O +
in O +
comparison O +
with O +
that O +
of O +
control O +
cells O +
, O +
accompanied O +
by O +
a O +
decreased O +
VEGF B-Gene +
secretion O +
. O +

In O +
tumors O +
derived O +
from O +
AR B-Gene +
AS1 O +
and O +
AR B-Gene +
AS3 O +
cells O +
, O +
intra O +
- O +
tumoral O +
vascularization O +
was O +
reduced O +
to O +
about O +
50 O +
% O +
of O +
that O +
derived O +
from O +
control O +
cell O +
line O +
, O +
accompanied O +
with O +
a O +
decrease O +
of O +
VEGF B-Gene +
expression O +
. O +

CONCLUSION O +
: O +

Amphiregulin B-Gene +
antisense O +
RNA O +
expression O +
inhibits O +
efficiently O +
the O +
angiogenesis O +
in O +
breast O +
cancer O +
, O +
suggesting O +
this O +
growth B-Gene +
factor I-Gene +
could O +
represent O +
a O +
novel O +
therapeutic O +
target O +
in O +
breast O +
cancer O +
. O +

[ O +
Antiapoptotic O +
functions O +
of O +
the O +
retrovirally O +
transferred O +
API2 B-Gene +
- O +
MALT1 B-Gene +
gene O +
] O +
t O +
( O +
11 O +
; O +
18 O +
) O +
( O +
q21 O +
; O +
q21 O +
) O +
is O +
a O +
specific O +
chromosomal O +
aberration O +
in O +
mucosa O +
- O +
associated O +
lymphoid O +
tissue O +
( O +
MALT O +
) O +
lymphoma O +
, O +
and O +
produces O +
chimeric O +
transcript O +
Apoptosis B-Gene +
Inhibitor I-Gene +
2 I-Gene +
( O +
API2 B-Gene +
) O +
- O +
MALT1 B-Gene +
. O +

Although O +
it O +
is O +
known O +
that O +
API2 B-Gene +
has O +
an O +
antiapoptotic O +
effect O +
, O +
it O +
is O +
still O +
unclear O +
whether O +
this O +
also O +
applies O +
to O +
API2 B-Gene +
- O +
MALT1 B-Gene +
. O +

To O +
investigate O +
its O +
effects O +
against O +
various O +
apoptotic O +
stimuli O +
, O +
API2 B-Gene +
- O +
MALT1 B-Gene +
was O +
expressed O +
by O +
means O +
of O +
retroviral O +
infection O +
on O +
the O +
epithelial O +
cell O +
line O +
HeLa O +
and O +
the O +
murine O +
Pro O -
- O -
B O +
cell O +
line O +
Ba O +
/ O +
F3 O +
. O +

On O +
both O +
these O +
cell O +
lines O +
, O +
API2 B-Gene +
- O +
MALT1 B-Gene +
was O +
found O +
to O +
cause O +
a O +
significant O +
reduction O +
in O +
UV O +
- O +
induced O +
apoptosis O +
. O +

The O +
apoptosis O +
induced O +
by O +
doxorubicin O +
was O +
also O +
inhibited O +
by O +
API2 B-Gene +
- O +
MALT1 B-Gene +
, O +
but O +
not O +
that O +
induced O +
by O +
IL-3 B-Gene +
withdrawal O +
from O +
Ba O +
/ O +
F3 O +
. O +

These O +
findings O +
suggest O +
that O +
API2 B-Gene +
- O +
MALT1 B-Gene +
has O +
an O +
antiapoptotic O +
effect O +
on O +
both O +
epithelial O +
and O +
lymphoid O +
cells O +
and O +
that O +
this O +
effect O +
depends O +
on O +
the O +
apoptotic O +
stimulus O +
. O +

Protective O +
effect O +
of O +
the O +
G-765C O +
COX-2 B-Gene +
polymorphism O +
on O +
subclinical O +
atherosclerosis O +
and O +
inflammatory O +
markers O +
in O +
asymptomatic O +
subjects O +
with O +
cardiovascular O +
risk O +
factors O +
. O +

BACKGROUND O +
: O +

Cyclooxygenase B-Gene +
( I-Gene +
COX I-Gene +
) I-Gene +
- I-Gene +
2 I-Gene +
, O +
a O +
key O +
regulatory O +
enzyme O +
in O +
prostanoid O +
synthesis O +
, O +
plays O +
an O +
important O +
role O +
in O +
inflammatory O +
processes O +
. O +

The O +
-765G O -
> O -
C O +
COX-2 B-Gene +
polymorphism O +
has O +
been O +
associated O +
with O +
lower O +
promoter O +
activity O +
in O +
vitro O +
and O +
reduced O +
levels O +
of O +
C B-Gene +
- I-Gene +
reactive I-Gene +
protein I-Gene +
( O +
CRP B-Gene +
) O +
in O +
atherosclerotic O +
carriers O +
of O +
the O +
C O +
allele O +
. O +

However O +
, O +
its O +
pathophysiological O +
relevance O +
in O +
vivo O +
has O +
not O +
been O +
fully O +
elucidated O +
. O +

METHODS O +
AND O +
RESULTS O +
: O +

We O +
assessed O +
the O +
-765 O -
G O -
> O +
C O +
polymorphism O +
and O +
COX-2 B-Gene +
expression O +
in O +
220 O +
asymptomatic O +
subjects O +
free O +
of O +
cardiovascular O +
disease O +
, O +
in O +
relation O +
to O +
global O +
vascular O +
risk O +
, O +
carotid O +
intima O +
- O +
media O +
thickness O +
( O +
IMT O +
) O +
, O +
and O +
inflammatory O +
markers O +
( O +
fibrinogen B-Gene +
, O +
C B-Gene +
- I-Gene +
reactive I-Gene +
protein I-Gene +
[ O +
CRP B-Gene +
] O +
, O +
von B-Gene +
Willebrand I-Gene +
factor I-Gene +
[ O +
vWF B-Gene +
] O +
and O +
interleukin-6 B-Gene +
[ O +
IL-6 B-Gene +
] O +
) O +
. O +

Genotype O +
frequencies O +
were O +
: O +
CC O +
( O +
7.7 O +
% O +
) O +
, O +
CG O +
( O +
34.5 O +
% O +
) O +
, O +
GG O +
( O +
57.7 O +
% O +
) O +
. O +

Among O +
hypercholesterolemic O +
subjects O +
( O +
n O +
= O +
140 O +
) O +
, O +
C O +
allele O +
carriers O +
had O +
lower O +
COX-2 B-Gene +
expression O +
( O +
p O +
< O +
0.05 O +
) O +
, O +
reduced O +
carotid O +
IMT O +
( O +
p O +
< O +
0.01 O +
) O +
and O +
diminished O +
levels O +
of O +
inflammatory O +
markers O +
CRP B-Gene +
, O +
vWF B-Gene +
and O +
IL-6 B-Gene +
( O +
p O +
< O +
0.05 O +
) O +
, O +
as O +
compared O +
to O +
GG O +
homozygous O +
subjects O +
. O +

The O +
association O +
between O +
carotid O +
IMT O +
and O +
COX-2 B-Gene +
polymorphism O +
remained O +
significant O +
after O +
adjusting O +
for O +
cardiovascular O +
risk O +
factors O +
and O +
inflammatory O +
markers O +
( O +
p O +
= O +
0.008 O +
) O +
. O +

CONCLUSIONS O +
: O +

In O +
asymptomatic O +
hypercholesterolemic O +
subjects O +
the O +
C O +
allele O +
of O +
-765G O -
> O -
C O +
COX-2 B-Gene +
polymorphism O +
was O +
associated O +
with O +
lower O +
COX-2 B-Gene +
expression O +
, O +
and O +
reduced O +
subclinical O +
atherosclerosis O +
and O +
systemic O +
inflammation O +
compared O +
with O +
GG O +
homozygous O +
, O +
thus O +
conferring O +
atherosclerosis O +
protection O +
in O +
this O +
cardiovascular O +
risk O +
population O +
. O +

Identification O +
of O +
a O +
tandem O +
duplicated O +
array O +
in O +
the O +
Rhox B-Gene +
alpha O +
locus O +
on O +
mouse O +
chromosome O +
X O +
. O +

The O +
Rhox B-Gene +
family I-Gene +
of O +
homeobox O +
- O +
containing O +
genes O +
maps O +
to O +
three O +
gene O +
dense O +
clusters O +
, O +
alpha O +
, O +
beta O +
, O +
and O +
gamma O +
, O +
on O +
the O +
mouse O +
X O +
chromosome O +
. O +

Rhox B-Gene +
genes O +
are O +
expressed O +
primarily O +
in O +
reproductive O +
and O +
extra O +
- O +
embryonic O +
tissues O +
and O +
may O +
be O +
regulated O +
by O +
colinear O +
mechanisms O +
. O +

Uniquely O +
among O +
family O +
members O +
, O +
Rhox4 B-Gene +
is O +
also O +
expressed O +
in O +
the O +
developing O +
and O +
adult O +
thymus O +
, O +
where O +
its O +
striking O +
restriction O +
to O +
the O +
third O +
pharyngeal O +
pouch O +
has O +
suggested O +
a O +
role O +
in O +
lineage O +
specification O +
. O +

In O +
this O +
article O +
we O +
describe O +
a O +
previously O +
unreported O +
duplication O +
within O +
the O +
Rhox B-Gene +
alpha O +
locus O +
that O +
contains O +
seven O +
copies O +
of O +
Rhox4 B-Gene +
and O +
eight O +
copies O +
of O +
Rhox2 B-Gene +
and O +
Rhox3 B-Gene +
in O +
a O +
tandem O +
array O +
. O +

We O +
further O +
show O +
that O +
all O +
seven O +
Rhox4 B-Gene +
copies O +
are O +
expressed O +
, O +
although O +
preferential O +
expression O +
occurs O +
and O +
differs O +
between O +
tissues O +
. O +

In O +
contrast O +
to O +
reproductive O +
tissues O +
, O +
we O +
found O +
no O +
evidence O +
of O +
colinear O +
expression O +
of O +
the O +
Rhox B-Gene +
alpha O +
cluster O +
during O +
thymus O +
development O +
. O +

All O +
subspecies O +
of O +
mice O +
examined O +
contained O +
multiple O +
copies O +
of O +
Rhox4 B-Gene +
. O +

However O +
, O +
the O +
only O +
predicted O +
ortholog O +
of O +
Rhox4 B-Gene +
, O +
rat O +
Rhox4 B-Gene +
, O +
is O +
present O +
in O +
a O +
single O +
copy O +
, O +
suggesting O +
that O +
the O +
duplications O +
arose O +
at O +
the O +
time O +
of O +
rat O +
and O +
mouse O +
lineage O +
divergence O +
. O +

Finally O +
, O +
no O +
changes O +
in O +
Rhox4 B-Gene +
expression O +
were O +
detected O +
in O +
mice O +
with O +
defects O +
in O +
thymus O +
organogenesis O +
, O +
placing O +
it O +
upstream O +
or O +
outside O +
of O +
established O +
transcriptional O +
pathways O +
. O +

The O +
expansion O +
of O +
megakaryocyte O +
progenitors O +
from O +
CD34 B-Gene +
+ O +
- O +
enriched O +
mobilized O +
peripheral O +
blood O +
stem O +
cells O +
is O +
inhibited O +
by O +
Flt3 B-Gene +
- I-Gene +
L I-Gene +
. O +

This O +
study O +
aimed O +
to O +
determine O +
the O +
optimal O +
growth B-Gene +
factor I-Gene +
combination O +
for O +
expansion O +
of O +
megakaryocyte O +
( O +
Mk O +
) O +
progenitors O +
with O +
clonogenic O +
potential O +
from O +
CD34 B-Gene +
+ O +
- O +
enriched O +
mobilized O +
peripheral O +
blood O +
stem O +
cells O +
( O +
PBSC O +
) O +
. O +

Mobilized O +
PBSC O +
were O +
monocyte O +
depleted O +
and O +
CD34 B-Gene +
+ O +
enriched O +
, O +
then O +
cultured O +
with O +
various O +
combinations O +
of O +
interleukin-3 B-Gene +
( O +
IL-3 B-Gene +
) O +
, O +
IL-6 B-Gene +
, O +
IL-11 B-Gene +
, O +
Flt3 B-Gene +
ligand I-Gene +
( O +
Flt3-L B-Gene +
) O +
, O +
stem B-Gene +
cell I-Gene +
factor I-Gene +
( O +
SCF B-Gene +
) O +
, O +
granulocyte B-Gene +
- I-Gene +
macrophage I-Gene +
colonystimulating I-Gene +
factor I-Gene +
( O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
) O +
, O +
and O +
erythropoietin B-Gene +
( O +
EPO B-Gene +
) O +
, O +
using O +
a O +
2 O -
( O -
7 O -
- O -
3 O -
) O +
IV O +
fractional O +
factorial O +
design O +
. O +

Expansion O +
of O +
Mk O +
committed O +
progenitors O +
( O +
CD41 B-Gene +
+ O +
) O +
and O +
primitive O +
precursors O +
( O +
CD61 B-Gene +
+ O +
CD34 B-Gene +
+ O +
) O +
was O +
determined O +
using O +
FACS O +
and O +
colony O +
- O +
forming O +
assays O +
. O +

Amplification O +
of O +
Mk O +
progenitor O +
production O +
was O +
attributed O +
to O +
IL-3 B-Gene +
( O +
p O +
< O +
0.002 O +
) O +
, O +
SCF B-Gene +
( O +
p O +
< O +
0.001 O +
) O +
, O +
and O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
( O +
p O +
< O +
0.05 O +
) O +
. O +

Flt3 B-Gene +
- I-Gene +
L I-Gene +
inhibited O +
the O +
production O +
of O +
total O +
CD61 B-Gene +
+ O +
cells O +
( O +
p O +
< O +
0.05 O +
) O +
, O +
CD61 B-Gene +
+ O +
CD34 B-Gene +
+ O +
cells O +
( O +
p O +
< O +
0.03 O +
) O +
, O +
and O +
total O +
CD41a B-Gene +
+ O +
cells O +
( O +
p O +
< O +
0.01 O +
) O +
. O +

Addition O +
of O +
Flt3 B-Gene +
- I-Gene +
L I-Gene +
to O +
the O +
optimum O +
growth B-Gene +
factor I-Gene +
combination O +
of O +
megakaryocyte B-Gene +
growth I-Gene +
and I-Gene +
development I-Gene +
factor I-Gene +
( O +
MGDF B-Gene +
) O +
, O +
SCF B-Gene +
, O +
IL-3 B-Gene +
, O +
and O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
caused O +
the O +
greatest O +
increase O +
in O +
total O +
nucleated O +
cells O +
but O +
reduced O +
Mk O +
progenitor O +
expansion O +
. O +

There O +
was O +
also O +
a O +
20 O +
% O +
reduction O +
in O +
Mk O +
+ O +
colonies O +
from O +
cells O +
expanded O +
in O +
the O +
presence O +
of O +
Flt3 B-Gene +
- I-Gene +
L I-Gene +
. O +

Factorial O +
analysis O +
identified O +
the O +
optimal O +
combination O +
of O +
growth B-Gene +
factors I-Gene +
required O +
to O +
expand O +
Mk O +
precursors O +
with O +
clonogenic O +
potential O +
. O +

The O +
addition O +
of O +
Flt3 B-Gene +
- I-Gene +
L I-Gene +
to O +
the O +
optimal O +
combination O +
of O +
MGDF B-Gene +
, O +
SCF B-Gene +
, O +
IL-3 B-Gene +
, O +
and O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
reduced O +
both O +
the O +
fold O +
expansion O +
of O +
Mk O +
progenitors O +
and O +
Mk O +
colony O +
numbers O +
. O +

LPS O +
- O +
induced O +
release O +
of O +
IL-1beta B-Gene +
, O +
IL-1Ra B-Gene +
, O +
IL-6 B-Gene +
, O +
and O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
in O +
whole O +
blood O +
from O +
patients O +
with O +
familial O +
hypercholesterolemia O +
: O +
no O +
effect O +
of O +
cholesterol O +
- O +
lowering O +
treatment O +
. O +

Proinflammatory O +
cytokines B-Gene +
, O +
such O +
as O +
interleukin-1beta B-Gene +
( O +
IL-1beta B-Gene +
) O +
, O +
IL-6 B-Gene +
, O +
and O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
( O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
) O +
, O +
are O +
suggested O +
to O +
have O +
an O +
important O +
role O +
in O +
the O +
process O +
of O +
atherosclerosis O +
. O +

Patients O +
with O +
heterozygous O +
familial O +
hypercholesterolemia O +
( O +
FH O +
) O +
have O +
a O +
marked O +
elevation O +
in O +
the O +
plasma O +
level O +
of O +
low B-Gene +
- I-Gene +
density I-Gene +
lipoproteins I-Gene +
( O +
LDL B-Gene +
) O +
, O +
and O +
they O +
show O +
early O +
development O +
of O +
atherosclerosis O +
. O +

The O +
aim O +
of O +
the O +
present O +
study O +
was O +
to O +
test O +
with O +
a O +
whole O +
blood O +
culture O +
system O +
if O +
hyperlipoproteinemia O +
is O +
associated O +
with O +
increased O +
cytokine B-Gene +
production O +
capacity O +
in O +
these O +
patients O +
and O +
if O +
treatment O +
with O +
3-hydroxy-3-methylglutaryl B-Gene +
coenzyme I-Gene +
A I-Gene +
( I-Gene +
HMG I-Gene -
- I-Gene -
CoA I-Gene +
) I-Gene +
reductase I-Gene +
inhibitors O +
influences O +
this O +
production O +
capacity O +
of O +
blood O +
cells O +
, O +
at O +
both O +
the O +
protein O +
and O +
mRNA O +
levels O +
. O +

The O +
capacity O +
of O +
blood O +
cells O +
in O +
a O +
whole O +
blood O +
culture O +
to O +
produce O +
IL-1beta B-Gene +
, O +
IL-6 B-Gene +
, O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
, O +
IL-12 B-Gene +
, O +
IL-18 B-Gene +
, O +
and O +
IL-1 B-Gene +
receptor I-Gene +
antagonist I-Gene +
( O +
IL-1Ra B-Gene +
) O +
in O +
response O +
to O +
lipopolysaccharide O +
( O +
LPS O +
) O +
appeared O +
to O +
be O +
similar O +
for O +
heterozygous O +
FH O +
patients O +
and O +
healthy O +
volunteers O +
. O +

Furthermore O +
, O +
the O +
capacity O +
to O +
produce O +
IL-1beta B-Gene +
, O +
IL-6 B-Gene +
, O +
and O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
in O +
response O +
to O +
LPS O +
was O +
not O +
modified O +
by O +
cholesterol O +
synthesis O +
inhibitors O +
at O +
the O +
level O +
of O +
mRNA O +
expression O +
or O +
at O +
the O +
level O +
of O +
release O +
. O +

On O +
the O +
other O +
hand O +
, O +
the O +
release O +
of O +
IL-1Ra B-Gene +
was O +
significantly O +
increased O +
after O +
treatment O +
with O +
HMG B-Gene -
- I-Gene -
CoA I-Gene +
reductase I-Gene +
inhibitors O +
, O +
although O +
only O +
at O +
the O +
protein O +
level O +
. O +

This O +
suggests O +
a O +
possible O +
beneficial O +
anti O +
- O +
inflammatory O +
role O +
for O +
this O +
therapy O +
. O +

Association O +
of O +
killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
genotypes O +
with O +
microscopic O +
polyangiitis O +
. O +

OBJECTIVE O +
: O +

Genetic O +
background O +
and O +
infection O +
have O +
been O +
implicated O +
in O +
the O +
etiology O +
of O +
microscopic O +
polyangiitis O +
( O +
MPA O +
) O +
. O +

Killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIRs B-Gene +
) O +
are O +
a O +
diverse O +
family O +
of O +
activating O +
and O +
inhibitory O +
receptors O +
expressed O +
on O +
natural O +
killer O +
( O +
NK O +
) O +
cells O +
and O +
T O +
cells O +
, O +
the O +
genes O +
of O +
which O +
show O +
extreme O +
polymorphism O +
. O +

Some O +
KIRs B-Gene +
bind O +
to O +
HLA B-Gene +
class I-Gene +
I I-Gene +
subgroups O +
, O +
and O +
genetic O +
interactions O +
between O +
KIR B-Gene +
genes O +
and O +
their O +
ligand O +
HLA B-Gene +
have O +
been O +
shown O +
to O +
be O +
associated O +
with O +
several O +
autoimmune O +
and O +
viral O +
diseases O +
. O +

In O +
this O +
study O +
, O +
we O +
examined O +
possible O +
associations O +
of O +
the O +
presence O +
or O +
absence O +
of O +
KIR B-Gene +
loci O +
with O +
a O +
genetic O +
predisposition O +
to O +
MPA O +
. O +

METHODS O +
: O +

The O +
presence O +
or O +
absence O +
of O +
14 O +
KIR B-Gene +
loci O +
was O +
determined O +
in O +
57 O +
myeloperoxidase B-Gene +
antineutrophil O +
cytoplasmic O +
antibody O +
- O +
positive O +
Japanese O +
subjects O +
( O +
43 O +
patients O +
with O +
MPA O +
and O +
239 O +
healthy O +
controls O +
) O +
. O +

RESULTS O +
: O +

The O +
carrier O +
frequency O +
of O +
activating O +
KIR2DS3 B-Gene +
was O +
significantly O +
decreased O +
among O +
patients O +
with O +
MPA O +
compared O +
with O +
healthy O +
controls O +
( O +
4.7 O +
% O +
versus O +
16.7 O +
% O +
; O +
P O +
= O +
0.038 O +
, O +
odds O +
ratio O +
[ O +
OR O +
] O +
0.24 O +
, O +
95 O +
% O +
confidence O +
interval O +
[ O +
95 O +
% O +
CI O +
] O +
0.06 O +
- O +
0.94 O +
) O +
. O +

When O +
KIRs B-Gene +
were O +
analyzed O +
in O +
combination O +
with O +
their O +
HLA B-Gene +
ligands I-Gene +
, O +
the O +
proportion O +
of O +
individuals O +
carrying O +
inhibitory O +
KIR3DL1 B-Gene +
and O +
HLA B-Gene -
- I-Gene -
Bw4 I-Gene +
but O +
not O +
activating O +
receptor O +
KIR3DS1 B-Gene +
, O +
a O +
combination O +
presumed O +
to O +
be O +
the O +
most O +
inhibitory O +
of O +
all O +
KIR3DS1 B-Gene +
/ O +
3DL1 B-Gene +
/ O +
HLA B-Gene -
- I-Gene -
B I-Gene +
combinations O +
, O +
was O +
significantly O +
increased O +
in O +
the O +
MPA O +
group O +
compared O +
with O +
the O +
control O +
group O +
( O +
46.5 O +
% O +
versus O +
27.0 O +
% O +
; O +
P O +
= O +
0.014 O +
, O +
OR O +
2.35 O +
, O +
95 O +
% O +
CI O +
1.18 O +
- O +
4.70 O +
) O +
. O +

Furthermore O +
, O +
when O +
subjects O +
were O +
classified O +
according O +
to O +
KIR3DL1 B-Gene +
/ O +
3DS1 B-Gene +
/ O +
HLA B-Gene -
- I-Gene -
B I-Gene +
and O +
KIR2DL1 B-Gene +
/ O +
HLA B-Gene -
- I-Gene -
C I-Gene +
combinations O +
, O +
an O +
increasing O +
trend O +
toward O +
susceptibility O +
was O +
observed O +
as O +
combinations O +
became O +
more O +
inhibitory O +
. O +

CONCLUSION O +
: O +

The O +
decreased O +
activation O +
potential O +
of O +
NK O +
and/or O +
T O +
cells O +
associated O +
with O +
KIR B-Gene +
/ O +
HLA B-Gene +
genotypes O +
may O +
predispose O +
to O +
MPA O +
, O +
possibly O +
through O +
insufficient O +
resistance O +
against O +
infections O +
. O +

[ O +
SOS O +
- O +
induction O +
in O +
the O +
presence O +
of O +
the O +
plasmid O +
pKM101 O +
in O +
the O +
bacterial O +
cells O +
Escherichia O +
coli O +
K12 O +
] O +

Induction O +
of O +
transcription O +
by O +
the O +
plasmid O +
pKM101 O +
( O +
mutability O +
mediating O +
derivate O +
of O +
the O +
plasmid O +
R46 O +
) O +
of O +
the O +
sfiA B-Gene +
gene O +
controlling O +
cell O +
division O +
and O +
of O +
the O +
fruA B-Gene +
gene O +
encoding O +
the O +
fructose O +
specific O +
enzyme O +
II O +
of O +
the O +
phosphoenolpyruvate B-Gene +
- I-Gene +
phosphotransferase I-Gene +
system I-Gene +
in O +
intact O +
cultures O +
of O +
Escherichia O +
coli O +
was O +
studied O +
. O +

The O +
genes O +
under O +
study O +
were O +
fused O +
to O +
the O +
bacteriophage O +
Mu O +
dl O +
( O +
Ap O +
lac O +
) O +
. O +

Activation O +
of O +
the O +
sfiA B-Gene +
gene O +
, O +
a O +
typical O +
member O +
of O +
the O +
SOS O +
- O +
regulon O +
, O +
was O +
demonstrated O +
to O +
depend O +
on O +
the O +
key O +
genes O +
of O +
the O +
SOS O +
- O +
system O +
- O +
recA B-Gene +
and O +
lexA B-Gene +
. O +

In O +
contrast O +
, O +
the O +
fruA B-Gene +
gene O +
that O +
is O +
non O +
- O +
inducible O +
by O +
the O +
UV O +
- O +
light O +
, O +
a O +
classical O +
SOS O +
- O +
inducing O +
agent O +
, O +
is O +
not O +
activated O +
by O +
the O +
presence O +
of O +
the O +
plasmid O +
pKMIO1 O +
in O +
the O +
bacterial O +
cells O +
. O +

The O +
data O +
obtained O +
suggest O +
that O +
the O +
presence O +
of O +
pKMIO1 O +
plasmid O +
in O +
the O +
Escherichia O +
coli O +
cells O +
induces O +
a O +
SOS O +
- O +
signal O +
as O +
a O +
consequence O +
of O +
the O +
plasmid O +
DNA O +
replication O +
or O +
its O +
conjugative O +
transfer O +
. O +

Circulating O +
markers O +
of O +
endothelial O +
function O +
in O +
cardiovascular O +
disease O +
. O +

Endothelial O +
dysfunction O +
is O +
a O +
key O +
event O +
in O +
cardiovascular O +
disease O +
. O +

Measurement O +
of O +
endothelial O +
dysfunction O +
in O +
vivo O +
presents O +
a O +
major O +
challenge O +
, O +
but O +
has O +
important O +
implications O +
since O +
it O +
may O +
identify O +
the O +
clinical O +
need O +
for O +
therapeutic O +
intervention O +
, O +
specifically O +
in O +
primary O +
prevention O +
. O +

Several O +
biological O +
markers O +
have O +
been O +
used O +
as O +
indicators O +
of O +
endothelial O +
dysfunction O +
. O +

The O +
soluble O +
adhesion B-Gene +
molecules I-Gene +
sICAM-1 B-Gene +
and O +
sVCAM-1 B-Gene +
lack O +
specificity O +
and O +
are O +
increased O +
in O +
inflammatory O +
processes O +
. O +

Both O +
markers O +
are O +
increased O +
in O +
coronary O +
artery O +
disease O +
. O +

sICAM-1 B-Gene +
level O +
predicts O +
the O +
risk O +
for O +
cardiovascular O +
disease O +
or O +
diabetes O +
mellitus O +
in O +
healthy O +
individuals O +
. O +

sE B-Gene -
- I-Gene -
selectin I-Gene +
is O +
specific O +
for O +
the O +
endothelium O +
and O +
is O +
increased O +
in O +
coronary O +
artery O +
disease O +
and O +
diabetes O +
mellitus O +
. O +

sE B-Gene -
- I-Gene -
selectin I-Gene +
is O +
also O +
associated O +
with O +
diabetic O +
risk O +
. O +

The O +
endothelium O +
- O +
specific O +
marker O +
, O +
soluble O +
thrombomodulin B-Gene +
, O +
is O +
associated O +
with O +
severity O +
of O +
coronary O +
artery O +
disease O +
, O +
stroke O +
or O +
peripheral O +
occlusive O +
arterial O +
disease O +
and O +
is O +
not O +
increased O +
in O +
healthy O +
or O +
asymptomatic O +
subjects O +
. O +

Interestingly O +
, O +
thrombomodulin B-Gene +
decreases O +
during O +
treatment O +
of O +
hypercholesterolemia O +
or O +
hyperhomocysteinemia O +
. O +

In O +
contrast O +
, O +
von B-Gene +
Willebrand I-Gene +
factor I-Gene +
is O +
the O +
best O +
endothelial O +
biomarker O +
and O +
predicts O +
risk O +
for O +
ischemic O +
heart O +
disease O +
or O +
stroke O +
. O +

An O +
N O -
- O -
terminally O +
acetylated O +
Arf B-Gene +
- I-Gene +
like I-Gene +
GTPase I-Gene +
is O +
localised O +
to O +
lysosomes O +
and O +
affects O +
their O +
motility O +
. O +

Small B-Gene +
GTPases I-Gene +
of I-Gene +
the I-Gene +
Arf I-Gene +
and I-Gene +
Rab I-Gene +
families I-Gene +
play O +
key O +
roles O +
in O +
the O +
function O +
of O +
subcellular O +
organelles O +
. O +

Each O +
GTPase B-Gene +
is O +
usually O +
found O +
on O +
only O +
one O +
compartment O +
and O +
, O +
hence O +
, O +
they O +
confer O +
organelle O +
specificity O +
to O +
many O +
intracellular O +
processes O +
. O +

However O +
, O +
there O +
has O +
so O +
far O +
been O +
little O +
evidence O +
for O +
specific O +
GTPases B-Gene +
present O +
on O +
lysosomes O +
. O +

Here O +
, O +
we O +
report O +
that O +
two O +
closely O +
related O +
human O +
Arf B-Gene +
- I-Gene +
like I-Gene +
GTPases I-Gene +
, O +
Arl8a B-Gene +
and O +
Arl8b B-Gene +
( O +
also O +
known O +
as O +
Arl10b B-Gene +
/ I-Gene +
c I-Gene +
and O +
Gie1 B-Gene +
/ I-Gene +
2 I-Gene +
) O +
, O +
localise O +
to O +
lysosomes O +
in O +
mammalian O +
cells O +
, O +
with O +
the O +
single O +
homologue O +
in O +
Drosophila O +
cells O +
having O +
a O +
similar O +
location O +
. O +

Conventionally O +
, O +
membrane O +
binding O +
of O +
Arf B-Gene +
and O +
Arl B-Gene +
proteins O +
is O +
mediated O +
by O +
both O +
an O +
N O +
- O +
terminal O +
myristoyl O +
group O +
and O +
an O +
N O +
- O +
terminal O +
amphipathic O +
helix O +
that O +
is O +
inserted O +
into O +
the O +
lipid O +
bilayer O +
upon O +
activation O +
of O +
the O +
GTPase B-Gene +
. O +

Arl8a B-Gene +
and O +
Arl8b B-Gene +
do O +
not O +
have O +
N O +
- O +
terminal O +
myristoylation O +
sites O +
, O +
and O +
we O +
find O +
that O +
Arl8b B-Gene +
is O +
instead O +
N O -
- O -
terminally O +
acetylated O +
, O +
and O +
an O +
acetylated O +
methionine O +
is O +
necessary O +
for O +
its O +
lysosomal O +
localization O +
. O +

Overexpression O +
of O +
Arl8a B-Gene +
or O +
Arl8b B-Gene +
results O +
in O +
a O +
microtubule O +
- O +
dependent O +
redistribution O +
of O +
lysosomes O +
towards O +
the O +
cell O +
periphery O +
. O +

Live O +
cell O +
imaging O +
shows O +
that O +
lysosomes O +
move O +
more O +
frequently O +
both O +
toward O +
and O +
away O +
from O +
the O +
cell O +
periphery O +
, O +
suggesting O +
a O +
role O +
for O +
Arl8a B-Gene +
and O +
Arl8b B-Gene +
as O +
positive O +
regulators O +
of O +
lysosomal O +
transport O +
. O +

Bis O +
selenide O +
alkene O +
derivatives O +
: O +

A O +
class O +
of O +
potential O +
antioxidant O +
and O +
antinociceptive O +
agents O +
. O +

Bis O +
and O +
tris O +
- O +
selenide O +
alkene O +
derivatives O +
, O +
a O +
class O +
of O +
organoselenium O +
compounds O +
, O +
were O +
screened O +
for O +
antinociceptive O +
and O +
antioxidant O +
activities O +
. O +

In O +
vitro O +
, O +
bis O -
- O -
selenide O +
alkene O +
1c O +
( O -
R=2,4,6-Me O -
( O -
3 O -
) O -
C O -
( O -
6 O -
) O -
H O -
( O -
2 O -
) O +
) O +
, O +
1d O +
( O -
R=4-ClC O -
( O -
6 O -
) O -
H O -
( O -
4 O -
) O +
) O +
and O +
1e O +
( O -
R=4-MeOC O -
( O -
6 O -
) O -
H O -
( O -
4 O -
) O +
) O +
protected O +
against O +
lipid O +
peroxidation O +
about O +
50 O +
% O +
, O +
whereas O +
1b O +
( O -
R O -
= O -
C O -
( O -
6 O -
) O -
H O -
( O -
5 O -
) O +
) O +
and O +
1a O +
( O +
R O +
= O +
C O -
( O -
4 O -
) O -
H O -
( O -
9 O -
) O +
) O +
protected O +
only O +
23 O +
% O +
. O +

Compound O +
1d O +
presented O +
lesser O +
IC O -
( O -
50 O -
) O +
against O +
lipid O +
peroxidation O +
than O +
other O +
bis O -
- O -
selenide O +
alkene O +
compounds O +
( O -
1d>1e O -
> O +
or O +
= O +
1c O +
> O +
1a O +
= O +
1b O +
) O +
. O +

The O +
maximal O +
inhibitory O +
effect O +
of O +
tris O +
- O +
selenide O +
alkenes O +
on O +
lipid O +
peroxidation O +
was O +
in O +
the O +
following O +
order O +
2c O +
> O +
2a O +
= O +
2b O +
. O +

Compound O +
1e O +
increased O +
the O +
rate O +
of O +
GSH O +
, O +
but O +
not O +
DTT O +
, O +
oxidation O +
. O +

Tris O +
- O +
selenide O +
alkene O +
2c O +
( O -
R=4-MeOC O -
( O -
6 O -
) O -
H O -
( O -
4 O -
) O +
) O +
demonstrated O +
the O +
higher O +
rate O +
of O +
thiol O +
oxidation O +
, O +
while O +
2a O +
( O -
R O -
= O -
C O -
( O -
6 O -
) O -
H O -
( O -
5 O -
) O -
) O +
did O +
not O +
change O +
DTT O +
oxidation O +
but O +
oxidized O +
GSH O +
. O +

Conversely O +
, O +
compound O +
2b O +
( O -
R=4-ClC O -
( O -
6 O -
) O -
H O -
( O -
4 O -
) O +
) O +
did O +
not O +
change O +
the O +
rate O +
of O +
GSH O +
oxidation O +
, O +
but O +
oxidized O +
DDT O +
. O +

Bis O +
- O +
selenide O +
alkene O +
derivatives O +
1c O +
, O +
1d O +
and O +
1e O +
were O +
the O +
most O +
promising O +
compounds O +
tested O +
in O +
vitro O +
. O +

In O +
vivo O +
, O +
compounds O +
1c O +
and O +
1d O +
( O +
5 O -
- O -
50 O -
mg O +
/ O +
kg O +
, O +
subcutaneously O +
) O +
produced O +
significant O +
inhibition O +
of O +
acetic O +
acid O +
- O +
and O +
capsaicin O +
- O +
induced O +
pain O +
. O +

Compounds O +
1c O +
and O +
1d O +
increased O +
the O +
tail O +
- O +
flick O +
response O +
latency O +
time O +
. O +

The O +
antinociception O +
effect O +
of O +
1c O +
and O +
1d O +
was O +
not O +
abolished O +
by O +
naloxone O +
( O +
an O +
antagonist O +
of O +
opioid O +
receptor O +
, O +
1 O -
mg O +
/ O +
kg O +
, O +
subcutaneously O +
) O +
, O +
suggesting O +
that O +
the O +
antinociceptive O +
effect O +
is O +
not O +
influenced O +
by O +
the O +
opioidergic O +
mechanism O +
. O +

[ O +
Expression O +
, O +
purification O +
and O +
identification O +
of O +
Echinococcus O +
granulosus O +
recombinant O +
antigen B-Gene +
B I-Gene +
] O +

OBJECTIVE O +
: O +

To O +
purify O +
and O +
identify O +
recombinant O +
antigen B-Gene +
B I-Gene +
of O +
hydatid O +
disease O +
. O +

METHODS O +
: O +

The O +
recombinant O +
plasmid O +
pMalc2x O +
- O +
AgB B-Gene +
was O +
expressed O +
in O +
E. O +
coli O +
JM109 O +
. O +

The O +
fusion O +
protein O +
rAgB B-Gene +
- O +
MBP B-Gene +
was O +
made O +
up O +
of O +
antigen B-Gene +
B I-Gene +
and O +
MBP B-Gene +
( O +
maltose B-Gene +
binding I-Gene +
protein I-Gene +
) O +
which O +
was O +
designed O +
to O +
absorb O +
the O +
antigen B-Gene +
B I-Gene +
onto O +
the O +
amylose O +
column O +
. O +

In O +
order O +
to O +
get O +
the O +
pure O +
antigen O +
as O +
the O +
probe O +
for O +
selecting O +
phage O +
displayed O +
antibody O +
library O +
, O +
factor B-Gene +
Xa I-Gene +
protease B-Gene +
was O +
used O +
to O +
digest O +
the O +
fusion O +
protein O +
rAgB B-Gene +
- O +
MBP B-Gene +
so O +
that O +
MBP B-Gene +
was O +
cut O +
off O +
from O +
the O +
special O +
cleavage O +
site O +
. O +

Flowing O +
through O +
the O +
amylose O +
resin O +
column O +
and O +
hydroxyapatite O +
column O +
, O +
rAgB B-Gene +
was O +
purified O +
by O +
the O +
method O +
of O +
affinity O +
chromatography O +
. O +

Its O +
specificity O +
was O +
proved O +
by O +
patient O +
sera O +
with O +
Western O +
blotting O +
. O +

RESULTS O +
: O +

The O +
recombinant O +
antigen B-Gene +
B I-Gene +
was O +
Mr O +
12 O +
000 O +
, O +
and O +
it O +
showed O +
the O +
capability O +
to O +
combine O +
with O +
the O +
specific O +
antibody O +
. O +

CONCLUSION O +
: O +

Hydatid O +
disease O +
antigen B-Gene +
B I-Gene +
can O +
be O +
produced O +
by O +
molecular O +
method O +
and O +
applied O +
in O +
monoclonal O +
antibody O +
production O +
and O +
phage O +
antibody O +
library O +
scanning O +
. O +

Anti O +
- O +
HBc B-Gene +
& O +
HBV O -
- O -
DNA O +
detection O +
in O +
blood O +
donors O +
negative O +
for O +
hepatitis B-Gene +
B I-Gene +
virus I-Gene +
surface I-Gene +
antigen I-Gene +
in O +
reducing O +
risk O +
of O +
transfusion O +
associated O +
HBV O +
infection O +
. O +

BACKGROUND O +
& O +
OBJECTIVE O +
: O +

Though O +
sensitive O +
screening O +
assays O +
for O +
detection O +
of O +
hepatitis B-Gene +
B I-Gene +
virus I-Gene +
surface I-Gene +
antigen I-Gene +
( O +
HBsAg B-Gene +
) O +
are O +
available O +
, O +
occasional O +
cases O +
of O +
post O +
- O +
transfusion O +
hepatitis O +
B O +
virus O +
infection O +
( O +
PTH O +
) O +
still O +
occur O +
. O +

The O +
present O +
study O +
was O +
undertaken O +
to O +
assess O +
the O +
prevalence O +
of O +
anti O +
- O +
hepatitis B-Gene +
B I-Gene +
core I-Gene +
( O +
anti O +
- O +
HBc B-Gene +
) O +
positivity O +
and O +
presence O +
of O +
HBV O -
- O -
DNA O +
in O +
serum O +
sample O +
of O +
healthy O +
blood O +
donors O +
negative O +
for O +
both O +
HBsAg B-Gene +
and O +
anti O +
- O +
HCV O +
antibody O +
in O +
Shiraz O +
, O +
Iran O +
. O +

Since O +
anti O +
- O +
HBc B-Gene +
detection O +
is O +
not O +
mandatory O +
in O +
Iran O +
, O +
we O +
evaluated O +
whether O +
anti O +
- O +
HBc B-Gene +
detection O +
could O +
be O +
adopted O +
as O +
a O +
screening O +
assay O +
for O +
safety O +
of O +
donated O +
blood O +
. O +

METHODS O +
: O +

Two O +
thousands O +
serum O +
samples O +
negative O +
for O +
both O +
HBsAg B-Gene +
and O +
anti O +
- O +
HCV O +
collected O +
from O +
healthy O +
blood O +
donors O +
were O +
tested O +
for O +
the O +
presence O +
of O +
anti O +
HBc B-Gene +
antibody O +
. O +

All O +
samples O +
positive O +
for O +
anti O +
- O +
HBc B-Gene +
antibody O +
were O +
then O +
investigated O +
for O +
determination O +
of O +
anti O +
- O +
HBc B-Gene +
titre O +
, O +
anti O +
- O +
HBs B-Gene +
titre O +
, O +
HbeAg B-Gene +
and O +
anti O +
- O +
HBe B-Gene +
antibody O +
by O +
enzyme O +
immunoassay O +
( O +
EIA O +
) O +
. O +

Every O +
sample O +
that O +
tested O +
negative O +
for O +
HBsAg B-Gene +
but O +
positive O +
for O +
anti O +
- O +
HBc B-Gene +
alone O +
or O +
in O +
combination O +
with O +
other O +
serological O +
markers O +
was O +
also O +
examined O +
for O +
the O +
presence O +
of O +
HBV O -
- O -
DNA O +
by O +
polymerase B-Gene +
chain O +
reaction O +
( O +
PCR O +
) O +
. O +

RESULTS O +
: O +

Of O +
the O +
2000 O +
samples O +
tested O +
, O +
131 O +
( O +
6.55 O +
% O +
) O +
blood O +
samples O +
were O +
found O +
to O +
be O +
positive O +
for O +
anti O +
- O +
HBc B-Gene +
. O +

HBV O +
DNA O +
was O +
detected O +
among O +
16 O +
of O +
131 O +
( O +
12.2 O +
% O +
) O +
anti O +
- O +
HBc B-Gene +
positive O +
specimens O +
. O +

Further O +
, O +
there O +
was O +
an O +
association O +
between O +
the O +
titration O +
of O +
anti O +
- O +
HBc B-Gene +
antibody O +
and O +
the O +
intensity O +
of O +
expected O +
PCR O +
product O +
band O +
. O +

The O +
liver O +
function O +
test O +
results O +
were O +
all O +
in O +
normal O +
range O +
except O +
in O +
4 O +
of O +
16 O +
HBV O +
- O +
DNA O +
positive O +
subjects O +
. O +

The O +
mean O +
levels O +
of O +
alanine B-Gene +
aminotransferase I-Gene +
( O +
ALT B-Gene +
) O +
and O +
aspartate B-Gene +
aminotransferase I-Gene +
( O +
AST B-Gene +
) O +
in O +
HBV O +
- O +
PCR O +
positive O +
subjects O +
were O +
14 O +
IU O +
/ O +
l O +
and O +
23.7 O +
IU O +
/ O +
l O +
respectively O +
. O +

INTERPRETATION O +
& O +
CONCLUSION O +
: O +

Anti O +
- O +
HBc B-Gene +
antibody O +
should O +
be O +
tested O +
routinely O +
on O +
blood O +
donors O +
volunteers O +
and O +
if O +
the O +
sample O +
found O +
positive O +
regardless O +
of O +
anti O +
- O +
HBs B-Gene +
titre O +
, O +
the O +
blood O +
should O +
be O +
discarded O +
. O +

Further O +
testing O +
for O +
HBV O -
- O -
DNA O +
would O +
be O +
appropriate O +
to O +
follow O +
up O +
the O +
donor O +
for O +
HBV O +
infection O +
. O +

Increased O +
expression O +
of O +
renal O +
aquaporin B-Gene +
water I-Gene +
channels I-Gene +
in O +
spontaneously O +
hypertensive O +
rats O +
. O +

AIMS O +
: O +

The O +
present O +
study O +
was O +
aimed O +
to O +
determine O +
whether O +
there O +
exists O +
an O +
altered O +
regulation O +
of O +
aquaporin B-Gene +
( I-Gene +
AQP I-Gene +
) I-Gene +
water I-Gene +
channels I-Gene +
in O +
hypertension O +
. O +

METHODS O +
: O +

Male O +
spontaneously O +
hypertensive O +
rats O +
( O +
SHR O +
) O +
aged O +
10 O +
- O +
12 O +
weeks O +
were O +
used O +
. O +

Age O +
- O +
matched O +
Wistar O +
- O +
Kyoto O +
( O +
WKY O +
) O +
rats O +
served O +
as O +
control O +
. O +

The O +
abundance O +
of O +
AQP1 B-Gene -
- I-Gene -
4 I-Gene +
proteins O +
in O +
the O +
kidney O +
was O +
determined O +
by O +
Western O +
blot O +
analysis O +
. O +

The O +
protein O +
expression O +
and O +
activity O +
of O +
adenylyl B-Gene +
cyclase I-Gene +
were O +
also O +
determined O +
. O +

RESULTS O +
: O +

The O +
medullary O +
expression O +
of O +
AQP2 B-Gene +
and O +
AQP3 B-Gene +
proteins O +
was O +
increased O +
in O +
SHR O +
compared O +
with O +
that O +
in O +
WKY O +
rats O +
. O +

The O +
expression O +
of O +
AQP1 B-Gene +
protein O +
was O +
also O +
significantly O +
increased O +
in O +
the O +
inner O +
medulla O +
, O +
while O +
that O +
of O +
AQP4 B-Gene +
was O +
not O +
. O +

Immunohistochemistry O +
of O +
AQP2 B-Gene +
revealed O +
that O +
principal O +
cells O +
of O +
the O +
collecting O +
duct O +
have O +
strong O +
immunoreactivity O +
, O +
the O +
degree O +
of O +
which O +
was O +
augmented O +
with O +
prominent O +
apical O +
labeling O +
in O +
SHR O +
. O +

The O +
plasma O +
level O +
of O +
arginine B-Gene +
vasopressin I-Gene +
( O +
AVP B-Gene +
) O +
was O +
higher O +
in O +
SHR O +
; O +
the O +
adenylyl B-Gene +
cyclase I-Gene +
activity O +
stimulated O +
by O +
AVP B-Gene +
was O +
augmented O +
, O +
along O +
with O +
increased O +
expression O +
of O +
type B-Gene +
VI I-Gene +
adenylyl I-Gene +
cyclase I-Gene +
. O +

The O +
urine O +
was O +
more O +
concentrated O +
with O +
its O +
volume O +
decreased O +
in O +
SHR O +
. O +

CONCLUSION O +
: O +

The O +
expression O +
of O +
AQP1 B-Gene -
- I-Gene -
3 I-Gene +
channels O +
is O +
increased O +
in O +
the O +
kidney O +
, O +
in O +
association O +
with O +
enhanced O +
activity O +
of O +
the O +
AVP B-Gene +
/ O +
cAMP O +
pathway O +
, O +
in O +
SHR O +
. O +

Interactions O +
of O +
mRNAs O +
and O +
gRNAs O +
involved O +
in O +
trypanosome O +
mitochondrial O +
RNA O +
editing O +
: O +
structure O +
probing O +
of O +
a O +
gRNA O +
bound O +
to O +
its O +
cognate O +
mRNA O +
. O +

Expression O +
of O +
mitochondrial O +
genes O +
in O +
Trypanosoma O +
brucei O +
requires O +
RNA O +
editing O +
of O +
its O +
mRNA O +
transcripts O +
. O +

During O +
editing O +
, O +
uridylates O +
are O +
precisely O +
inserted O +
and O +
deleted O +
as O +
directed O +
by O +
the O +
gRNA O +
template O +
to O +
create O +
the O +
protein O +
open O +
reading O +
frame O +
. O +

This O +
process O +
involves O +
the O +
bimolecular O +
interaction O +
of O +
the O +
gRNA O +
with O +
its O +
cognate O +
pre O +
- O +
edited O +
mRNA O +
and O +
the O +
assembly O +
of O +
a O +
protein O +
complex O +
with O +
the O +
enzymatic O +
machinery O +
required O +
. O +

While O +
a O +
considerable O +
amount O +
of O +
work O +
has O +
been O +
done O +
identifying O +
the O +
protein O +
components O +
of O +
the O +
editing O +
complex O +
, O +
very O +
little O +
is O +
known O +
about O +
how O +
a O +
functional O +
editosome O +
is O +
assembled O +
. O +

In O +
addition O +
, O +
the O +
importance O +
of O +
RNA O +
structure O +
in O +
establishing O +
a O +
functional O +
editing O +
complex O +
is O +
poorly O +
understood O +
. O +

Work O +
in O +
our O +
lab O +
suggests O +
that O +
different O +
mRNA O +
/ O +
gRNA O +
pairs O +
can O +
form O +
similar O +
secondary O +
structures O +
suggesting O +
that O +
a O +
common O +
core O +
architecture O +
may O +
be O +
important O +
for O +
editosome O +
recognition O +
and O +
function O +
. O +

Using O +
solution O +
structure O +
probing O +
, O +
we O +
have O +
investigated O +
the O +
structure O +
of O +
the O +
initiating O +
gRNA O +
, O +
gCYb-558 O +
, O +
in O +
the O +
mRNA O +
/ O +
gRNA O +
complex O +
with O +
pre O +
- O +
edited O +
apocytochrome B-Gene +
b I-Gene +
mRNA O +
. O +

Our O +
data O +
indicate O +
that O +
the O +
stem O +
- O +
loop O +
formed O +
by O +
the O +
guiding O +
region O +
of O +
the O +
gRNA O +
alone O +
is O +
maintained O +
in O +
its O +
interaction O +
with O +
the O +
pre O +
- O +
edited O +
message O +
. O +

In O +
addition O +
, O +
our O +
data O +
suggest O +
that O +
a O +
gRNA O +
stem O +
- O +
loop O +
structure O +
is O +
maintained O +
through O +
the O +
first O +
few O +
editing O +
events O +
by O +
the O +
use O +
of O +
alternative O +
base O +
- O +
pairing O +
with O +
the O +
U O -
- O -
tail O +
. O +

Association O +
of O +
the O +
promoter O +
polymorphism O +
- O +
232C O +
/ O +
G O +
of O +
the O +
phosphoenolpyruvate B-Gene +
carboxykinase I-Gene +
gene O +
( O +
PCK1 B-Gene +
) O +
with O +
Type O +
2 O +
diabetes O +
mellitus O +
. O +

AIMS O +
: O +

The O +
phosphoenolpyruvate B-Gene +
carboxykinase I-Gene +
gene O +
( O +
PCK1 B-Gene +
) O +
is O +
a O +
potential O +
candidate O +
gene O +
in O +
the O +
pathogenesis O +
of O +
Type O +
2 O +
diabetes O +
mellitus O +
. O +

A O +
- O +
232C O +
/ O +
G O +
promoter O +
polymorphism O +
of O +
PCK1 B-Gene +
has O +
been O +
associated O +
with O +
an O +
increased O +
risk O +
of O +
Type O +
2 O +
diabetes O +
in O +
a O +
Canadian O +
population O +
. O +

The O +
purpose O +
of O +
the O +
present O +
study O +
was O +
to O +
examine O +
this O +
association O +
in O +
a O +
German O +
Caucasian O +
population O +
. O +

METHODS O +
: O +

We O +
investigated O +
397 O +
subjects O +
with O +
Type O +
2 O +
diabetes O +
[ O +
227 O +
men O +
, O +
170 O +
women O +
, O +
age O +
63 O +
+ O +
/ O +
- O +
11 O +
years O +
, O +
body O +
mass O +
index O +
( O +
BMI O +
) O +
28.7 O +
+ O -
/- O +
5.1 O +
kg O +
/ O +
m2 O +
] O +
and O +
431 O +
control O +
subjects O +
without O +
diabetes O +
( O +
247 O +
men O +
, O +
184 O +
women O +
, O +
age O +
64 O +
+ O -
/- O +
7 O +
years O +
, O +
BMI O +
26.5 O +
+ O -
/- O +
3.7 O +
kg O +
/ O +
m2 O +
) O +
matched O +
for O +
sex O +
and O +
age O +
. O +

RESULTS O +
: O +

In O +
the O +
diabetic O +
and O +
control O +
groups O +
, O +
the O +
CC O +
genotype O +
frequencies O +
were O +
18.1 O +
and O +
18.3 O +
% O +
, O +
the O +
CG O +
48.6 O +
and O +
48.7 O +
% O +
and O +
the O +
GG O +
33.2 O +
and O +
32.9 O +
% O +
, O +
respectively O +
( O +
P O +
= O +
0.995 O +
) O +
. O +

The O +
allelic O +
frequencies O +
were O +
0.51 O +
and O +
0.57 O +
for O +
the O +
G O +
allele O +
and O +
0.49 O +
and O +
0.43 O +
for O +
the O +
C O +
allele O +
, O +
respectively O +
. O +

In O +
a O +
logistic O +
regression O +
model O +
only O +
BMI O +
and O +
family O +
history O +
, O +
but O +
not O +
the O +
polymorphism O +
, O +
were O +
predictors O +
of O +
Type O +
2 O +
diabetes O +
. O +

In O +
both O +
the O +
control O +
and O +
diabetic O +
subjects O +
, O +
there O +
were O +
no O +
significant O +
differences O +
in O +
BMI O +
or O +
blood O +
pressure O +
between O +
the O +
groups O +
with O +
or O +
without O +
the O +
polymorphism O +
. O +

The O +
variant O +
also O +
had O +
no O +
significant O +
influence O +
on O +
the O +
presence O +
of O +
atherosclerotic O +
disease O +
, O +
while O +
the O +
influence O +
of O +
other O +
known O +
cardiovascular O +
risk O +
factors O +
was O +
confirmed O +
. O +

CONCLUSIONS O +
: O +

The O +
present O +
data O +
suggest O +
that O +
, O +
in O +
a O +
German O +
Caucasian O +
population O +
, O +
the O +
- O +
232C O +
/ O +
G O +
polymorphism O +
of O +
the O +
PEPCK B-Gene +
gene O +
is O +
not O +
associated O +
with O +
Type O +
2 O +
diabetes O +
. O +

Differential O +
distribution O +
of O +
non B-Gene +
- I-Gene +
structural I-Gene +
proteins I-Gene +
of O +
foot O +
- O +
and O +
- O +
mouth O +
disease O +
virus O +
in O +
BHK-21 O +
cells O +
. O +

Differences O +
in O +
the O +
kinetics O +
of O +
expression O +
and O +
cell O +
distribution O +
among O +
FMDV O +
non B-Gene +
- I-Gene +
structural I-Gene +
proteins I-Gene +
( O +
NSPs B-Gene +
) O +
have O +
been O +
observed O +
in O +
BHK-21 O +
- O +
infected O +
cells O +
. O +

3D B-Gene -
( I-Gene -
pol I-Gene -
) I-Gene +
was O +
the O +
first O +
protein O +
detected O +
by O +
immunofluorescence O +
( O +
1.5 O +
h O +
p.i O -
. O +
) O +
, O +
showing O +
a O +
perinuclear O +
distribution O +
. O +

At O +
2 O -
- O -
2.5 O +
h O +
p.i O -
. O +
, O +
2B B-Gene +
, O +
2C B-Gene +
, O +
3B B-Gene +
and O +
3C B-Gene +
were O +
detected O +
, O +
mostly O +
exhibiting O +
a O +
punctuated O +
, O +
scattered O +
pattern O +
, O +
while O +
3A O +
and O +
3D B-Gene +
( I-Gene +
pol I-Gene +
) I-Gene +
appeared O +
concentrated O +
at O +
one O +
side O +
of O +
the O +
nucleus O +
. O +

This O +
distribution O +
was O +
exhibited O +
by O +
all O +
the O +
NSPs B-Gene +
from O +
3 O +
h O +
p.i O -
. O +
, O +
being O +
2C B-Gene +
and O +
, O +
to O +
a O +
lesser O +
extent O +
, O +
precursors O +
2BC B-Gene +
and O +
3ABBB B-Gene +
, O +
the O +
only O +
proteins O +
detected O +
by O +
Western O +
blotting O +
at O +
that O +
infection O +
time O +
. O +

From O +
4 O +
h O +
p.i O -
. O +
, O +
all O +
mature O +
NSPs B-Gene +
as O +
well O +
as O +
precursors O +
2BC B-Gene +
, O +
3ABBB B-Gene +
, O +
3ABB B-Gene +
, O +
3AB B-Gene +
and O +
3CD B-Gene +
( I-Gene +
pol I-Gene +
) I-Gene +
were O +
detected O +
by O +
this O +
technique O +
. O +

In O +
spite O +
of O +
their O +
similar O +
immunofluorescence O +
patterns O +
, O +
2C B-Gene +
and O +
3A B-Gene +
co O +
- O +
localized O +
partially O +
by O +
confocal O +
microscopy O +
at O +
3.5 O +
h O +
p.i O -
. O +
, O +
and O +
3A B-Gene +
, O +
but O +
not O +
2C B-Gene +
, O +
co O +
- O +
localized O +
with O +
the O +
ER O +
marker O +
calreticulin O +
, O +
suggesting O +
differences O +
in O +
the O +
distribution O +
of O +
these O +
proteins O +
and/or O +
their O +
precursors O +
as O +
infection O +
proceeded O +
. O +

Transient O +
expression O +
of O +
2C B-Gene +
and O +
3AB B-Gene +
resulted O +
in O +
punctuated O +
fluorescence O +
patterns O +
similar O +
to O +
those O +
found O +
in O +
early O +
infected O +
cells O +
, O +
while O +
3A B-Gene +
showed O +
a O +
more O +
diffuse O +
distribution O +
. O +

A O +
shift O +
towards O +
a O +
fibrous O +
pattern O +
was O +
noticed O +
for O +
3ABB B-Gene +
, O +
while O +
a O +
major O +
change O +
was O +
observed O +
in O +
cells O +
expressing O +
3ABBB B-Gene +
, O +
which O +
displayed O +
a O +
perinuclear O +
fibrous O +
distribution O +
. O +

Interestingly O +
, O +
when O +
co O +
- O +
expressed O +
with O +
3D B-Gene -
( I-Gene -
pol I-Gene -
) I-Gene +
, O +
the O +
pattern O +
observed O +
for O +
3ABBB B-Gene +
fluorescence O +
was O +
altered O +
, O +
resembling O +
that O +
exhibited O +
by O +
cells O +
transfected O +
with O +
3AB B-Gene +
. O +

Transient O +
expression O +
of O +
3D B-Gene -
( I-Gene -
pol I-Gene -
) I-Gene +
showed O +
a O +
homogeneous O +
cell O +
distribution O +
that O +
included O +
, O +
as O +
determined O +
by O +
confocal O +
microscopy O +
, O +
the O +
nucleus O +
. O +

This O +
was O +
confirmed O +
by O +
the O +
detection O +
of O +
3D B-Gene -
( I-Gene -
pol I-Gene -
) I-Gene +
in O +
nuclear O +
fractions O +
of O +
transfected O +
cells O +
. O +

3D B-Gene -
( I-Gene -
pol I-Gene -
) I-Gene +
and O +
its O +
precursor O +
3CD B-Gene -
( I-Gene -
pol I-Gene -
) I-Gene +
were O +
also O +
detected O +
in O +
nuclear O +
fractions O +
of O +
infected O +
cells O +
, O +
suggesting O +
that O +
these O +
proteins O +
can O +
directly O +
interact O +
with O +
the O +
nucleus O +
during O +
FMDV O +
infection O +
. O +

T O +
cells O +
to O +
a O +
dominant O +
epitope O +
of O +
GAD65 B-Gene +
express O +
a O +
public O +
CDR3 O +
motif O +
. O +

Non O +
- O +
obese O +
diabetic O +
( O +
NOD O +
) O +
mice O +
spontaneously O +
develop O +
autoimmune O +
diabetes O +
, O +
and O +
serve O +
as O +
a O +
model O +
for O +
type O +
1 O +
diabetes O +
( O +
T1D O +
) O +
and O +
natural O +
autoimmunity O +
. O +

T O +
cell O +
responses O +
to O +
the O +
pancreatic O +
islet O +
antigen O +
glutamic B-Gene +
acid I-Gene +
decarboxylase I-Gene +
65 I-Gene +
( O +
GAD65 B-Gene +
) O +
can O +
be O +
detected O +
in O +
the O +
spleens O +
of O +
young O +
prediabetic O +
NOD O +
mice O +
, O +
which O +
display O +
a O +
unique O +
MHC B-Gene +
class I-Gene +
II I-Gene +
molecule O +
. O +

Here O +
, O +
we O +
report O +
that O +
a O +
distinct O +
TcR B-Gene +
beta I-Gene +
chain O +
and O +
CDR3 O +
motif O +
are O +
utilized O +
by O +
all O +
NOD O +
mice O +
in O +
response O +
to O +
a O +
dominant O +
determinant O +
on O +
GAD65 B-Gene +
, O +
establishing O +
a O +
public O +
repertoire O +
in O +
the O +
spontaneous O +
autoimmunity O +
to O +
an O +
important O +
islet O +
cell O +
antigen O +
. O +

GAD65 B-Gene +
530 O +
- O +
543 O +
( O +
p530 O +
) O +
- O +
reactive O +
T O +
cells O +
preferentially O +
utilize O +
the O +
Vbeta4 O +
, O +
Dbeta2.1 O +
and O +
Jbeta2.7 O +
gene O +
segments O +
, O +
with O +
a O +
CDR3 O +
that O +
is O +
characterized O +
by O +
a O +
triad O +
of O +
amino O +
acids O +
, O +
DWG O +
, O +
preceded O +
by O +
a O +
polar O +
residue O +
. O +

In O +
addition O +
, O +
we O +
used O +
CDR3 O +
length O +
spectratyping O +
, O +
CDR3 O +
- O +
specific O +
reverse O +
transcriptase O +
- O +
PCR O +
and O +
direct O +
TcR B-Gene +
sequencing O +
to O +
show O +
that O +
the O +
TcR B-Gene +
beta I-Gene +
chain O +
structural O +
patterns O +
associated O +
with O +
p530 O +
- O +
specific O +
T O +
cells O +
consistently O +
appeared O +
in O +
the O +
islets O +
of O +
young O +
NOD O +
mice O +
with O +
insulitis O +
, O +
but O +
not O +
in O +
the O +
inflamed O +
islets O +
of O +
streptozotocin O +
- O +
treated O +
C57BL O +
/ O +
6 O +
mice O +
, O +
or O +
in O +
inflamed O +
NOD O +
salivary O +
glands O +
. O +

To O +
our O +
knowledge O +
, O +
this O +
is O +
the O +
first O +
report O +
to O +
demonstrate O +
that O +
a O +
public O +
T O +
cell O +
repertoire O +
is O +
used O +
in O +
spontaneous O +
autoimmunity O +
to O +
a O +
dominant O +
self O +
- O +
determinant O +
. O +

These O +
findings O +
suggest O +
that O +
defined O +
clonotypes O +
and O +
repertoires O +
may O +
be O +
preferentially O +
selected O +
in O +
haplotypes O +
predisposed O +
to O +
spontaneous O +
autoimmunity O +
. O +

Degradation O +
of O +
the O +
Alzheimer O +
disease O +
amyloid B-Gene +
beta I-Gene -
- I-Gene -
peptide I-Gene +
by O +
metal O +
- O +
dependent O +
up O +
- O +
regulation O +
of O +
metalloprotease B-Gene +
activity O +
. O +

Biometals O +
play O +
an O +
important O +
role O +
in O +
Alzheimer O +
disease O +
, O +
and O +
recent O +
reports O +
have O +
described O +
the O +
development O +
of O +
potential O +
therapeutic O +
agents O +
based O +
on O +
modulation O +
of O +
metal O +
bioavailability O +
. O +

The O +
metal O +
ligand O +
clioquinol O +
( O +
CQ O +
) O +
has O +
shown O +
promising O +
results O +
in O +
animal O +
models O +
and O +
small O +
phase O +
clinical O +
trials O +
; O +
however O +
, O +
the O +
actual O +
mode O +
of O +
action O +
in O +
vivo O +
has O +
not O +
been O +
determined O +
. O +

We O +
now O +
report O +
a O +
novel O +
effect O +
of O +
CQ O +
on O +
amyloid B-Gene +
beta I-Gene -
- I-Gene -
peptide I-Gene +
( O +
Abeta B-Gene +
) O +
metabolism O +
in O +
cell O +
culture O +
. O +

Treatment O +
of O +
Chinese O +
hamster O +
ovary O +
cells O +
overexpressing O +
amyloid B-Gene +
precursor I-Gene +
protein I-Gene +
with O +
CQ O +
and O +
Cu O -
( O -
2 O -
+ O -
) O +
or O +
Zn O +
( O +
2 O +
+ O +
) O +
resulted O +
in O +
an O +
approximately O +
85 O +
- O +
90 O +
% O +
reduction O +
of O +
secreted O +
Abeta B-Gene +
- O +
( O +
1 O +
- O +
40 O +
) O +
and O +
Abeta B-Gene +
- O +
( O +
1 O +
- O +
42 O +
) O +
compared O +
with O +
untreated O +
controls O +
. O +

Analogous O +
effects O +
were O +
seen O +
in O +
amyloid B-Gene +
precursor I-Gene +
protein I-Gene +
- O +
overexpressing O +
neuroblastoma O +
cells O +
. O +

The O +
secreted O +
Abeta B-Gene +
was O +
rapidly O +
degraded O +
through O +
up O +
- O +
regulation O +
of O +
matrix B-Gene +
metalloprotease I-Gene +
( I-Gene +
MMP I-Gene +
) I-Gene +
- I-Gene +
2 I-Gene +
and O +
MMP-3 B-Gene +
after O +
addition O +
of O +
CQ O +
and O +
Cu O -
( O -
2 O -
+ O -
) O +
. O +

MMP B-Gene +
activity O +
was O +
increased O +
through O +
activation O +
of O +
phosphoinositol B-Gene +
3-kinase I-Gene +
and O +
JNK B-Gene +
. O +

CQ O +
and O +
Cu O -
( O -
2 O -
+ O -
) O +
also O +
promoted O +
phosphorylation O +
of O +
glycogen B-Gene +
synthase I-Gene +
kinase I-Gene +
- I-Gene +
3 I-Gene +
, O +
and O +
this O +
potentiated O +
activation O +
of O +
JNK B-Gene +
and O +
loss O +
of O +
Abeta B-Gene +
- O +
( O +
1 O +
- O +
40 O +
) O +
. O +

Our O +
findings O +
identify O +
an O +
alternative O +
mechanism O +
of O +
action O +
for O +
CQ O +
in O +
the O +
reduction O +
of O +
Abeta B-Gene +
deposition O +
in O +
the O +
brains O +
of O +
CQ O +
- O +
treated O +
animals O +
and O +
potentially O +
in O +
Alzheimer O +
disease O +
patients O +
. O +

Distribution O +
of O +
killer B-Gene +
- I-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( O +
KIR B-Gene +
) O +
in O +
Comoros O +
and O +
Southeast O +
France O +
. O +

Killer B-Gene +
- I-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIRs B-Gene +
) O +
expressed O +
by O +
natural O +
killer O +
cells O +
are O +
cell O +
surface O +
molecules O +
able O +
to O +
recognize O +
groups O +
of O +
HLA B-Gene +
class I-Gene +
I I-Gene +
alleles O +
. O +

The O +
number O +
and O +
distribution O +
of O +
KIR B-Gene +
genes O +
vary O +
among O +
individuals O +
and O +
populations O +
. O +

The O +
aim O +
of O +
this O +
study O +
is O +
to O +
analyse O +
the O +
KIR B-Gene +
gene O +
content O +
in O +
a O +
Comorian O +
population O +
in O +
order O +
to O +
investigate O +
genetic O +
relationships O +
with O +
other O +
populations O +
and O +
to O +
reconstruct O +
past O +
migration O +
events O +
. O +

The O +
Comorian O +
population O +
consisted O +
of O +
54 O +
unrelated O +
immigrants O +
living O +
in O +
France O +
and O +
a O +
control O +
population O +
consisted O +
of O +
38 O +
individuals O +
from O +
Southeast O +
France O +
. O +

We O +
investigated O +
the O +
presence O +
or O +
absence O +
of O +
15 O +
KIR B-Gene +
genes O +
, O +
two O +
pseudogenes O +
expressed O +
and O +
non O +
- O +
expressed O +
forms O +
of O +
KIR2DL5 B-Gene +
and O +
the O +
two O +
major O +
subtype O +
full O +
- O +
length O +
and O +
deleted O +
forms O +
of O +
KIR2DS4 B-Gene +
. O +

All O +
individuals O +
were O +
typed O +
positive O +
for O +
the O +
framework O +
genes O +
, O +
i.e. O +
KIR2DL4 B-Gene +
, O +
KIR3DL2 B-Gene +
and O +
KIR3DL3 B-Gene +
, O +
and O +
the O +
two O +
pseudogenes O +
KIR3DP1 B-Gene +
and O +
KIR2DP1 B-Gene +
. O +

The O +
frequencies O +
of O +
full O +
- O +
length O +
KIR2DS4 B-Gene +
( O +
* O -
00101 O +
/ O +
00102 O +
/ O +
002 O +
) O +
were O +
lower O +
in O +
the O +
French O +
population O +
( O +
F O +
= O +
29 O +
% O +
) O +
than O +
in O +
the O +
Comorian O +
population O +
( O +
F O +
= O +
72 O +
% O +
) O +
( O +
P O -
( O -
c O -
) O +
< O +
0.05 O +
) O +
. O +

No O +
significant O +
differences O +
were O +
found O +
for O +
other O +
KIR B-Gene +
genes O +
. O +

A O +
total O +
of O +
11 O +
genotypes O +
were O +
identified O +
in O +
the O +
Southeast O +
French O +
population O +
and O +
22 O +
genotypes O +
in O +
the O +
Comorian O +
population O +
. O +

The O +
most O +
common O +
genotype O +
( O +
2DL1 B-Gene +
, O +
2DL3 B-Gene +
, O +
2DL4 B-Gene +
, O +
3DL1 B-Gene +
, O +
3DL2 B-Gene +
, O +
3DL3 B-Gene +
and O +
2DS4 B-Gene +
) O +
accounted O +
for O +
41 O +
% O +
in O +
the O +
Comorian O +
population O +
and O +
34 O +
% O +
in O +
the O +
Southeast O +
French O +
population O +
. O +

Principal O +
component O +
analysis O +
using O +
KIR B-Gene +
gene O +
data O +
from O +
20 O +
populations O +
was O +
performed O +
to O +
determine O +
genetic O +
differences O +
and O +
relations O +
between O +
populations O +
. O +

The O +
Comorian O +
population O +
exhibited O +
closest O +
kinship O +
with O +
Africans O +
and O +
Asians O +
. O +

As O +
KIR B-Gene +
gene O +
content O +
is O +
heterogeneous O +
among O +
ethnic O +
groups O +
, O +
it O +
can O +
probably O +
be O +
used O +
to O +
assess O +
the O +
genetic O +
relationships O +
among O +
populations O +
from O +
different O +
geographic O +
areas O +
. O +

Avian O +
and O +
canine O +
aldehyde B-Gene +
oxidases I-Gene +
. O +

Novel O +
insights O +
into O +
the O +
biology O +
and O +
evolution O +
of O +
molybdo B-Gene +
- I-Gene +
flavoenzymes I-Gene +
. O +

Aldehyde B-Gene +
oxidases I-Gene +
are O +
molybdo B-Gene +
- I-Gene +
flavoenzymes I-Gene +
structurally O +
related O +
to O +
xanthine B-Gene +
oxidoreductase I-Gene +
. O +

They O +
catalyze O +
the O +
oxidation O +
of O +
aldehydes O +
or O +
N O -
- O -
heterocycles O +
of O +
physiological O +
, O +
pharmacological O +
, O +
and O +
toxicological O +
relevance O +
. O +

Rodents O +
are O +
characterized O +
by O +
four O +
aldehyde B-Gene +
oxidases I-Gene +
as O +
follows O +
: O +
AOX1 B-Gene +
and O +
aldehyde B-Gene +
oxidase I-Gene +
homologs I-Gene +
1 I-Gene -
- I-Gene -
3 I-Gene +
( O +
AOH1 B-Gene +
, O +
AOH2 B-Gene +
, O +
and O +
AOH3 B-Gene +
) O +
. O +

Humans O +
synthesize O +
a O +
single O +
functional O +
aldehyde B-Gene +
oxidase I-Gene +
, O +
AOX1 B-Gene +
. O +

Here O +
we O +
define O +
the O +
structure O +
and O +
the O +
characteristics O +
of O +
the O +
aldehyde B-Gene +
oxidase I-Gene +
genes O +
and O +
proteins O +
in O +
chicken O +
and O +
dog O +
. O +

The O +
avian O +
genome O +
contains O +
two O +
aldehyde B-Gene +
oxidase I-Gene +
genes O +
, O +
AOX1 B-Gene +
and O +
AOH B-Gene +
, O +
mapping O +
to O +
chromosome O +
7 O +
. O +

AOX1 B-Gene +
and O +
AOH B-Gene +
are O +
structurally O +
very O +
similar O +
and O +
code O +
for O +
proteins O +
whose O +
sequence O +
was O +
deduced O +
from O +
the O +
corresponding O +
cDNAs O +
. O +

AOX1 B-Gene +
is O +
the O +
ortholog O +
of O +
the O +
same O +
gene O +
in O +
mammals O +
, O +
whereas O +
AOH B-Gene +
represents O +
the O +
likely O +
ancestor O +
of O +
rodent O +
AOH1 B-Gene +
, O +
AOH2 B-Gene +
, O +
and O +
AOH3 B-Gene +
. O +

The O +
dog O +
genome O +
is O +
endowed O +
with O +
two O +
structurally O +
conserved O +
and O +
active O +
aldehyde B-Gene +
oxidases I-Gene +
clustering O +
on O +
chromosome O +
37 O +
. O +

Cloning O +
of O +
the O +
corresponding O +
cDNAs O +
and O +
tissue O +
distribution O +
studies O +
demonstrate O +
that O +
they O +
are O +
the O +
orthologs O +
of O +
rodent O +
AOH2 B-Gene +
and O +
AOH3 B-Gene +
. O +

The O +
vestiges O +
of O +
dog O +
AOX1 B-Gene +
and O +
AOH1 B-Gene +
are O +
recognizable O +
upstream O +
of O +
AOH2 B-Gene +
and O +
AOH3 B-Gene +
on O +
the O +
same O +
chromosome O +
. O +

Comparison O +
of O +
the O +
complement O +
and O +
the O +
structure O +
of O +
the O +
aldehyde B-Gene +
oxidase I-Gene +
and O +
xanthine B-Gene +
oxidoreductase I-Gene +
genes O +
in O +
vertebrates O +
and O +
other O +
animal O +
species O +
indicates O +
that O +
they O +
evolved O +
through O +
a O +
series O +
of O +
duplication O +
and O +
inactivation O +
events O +
. O +

Purification O +
of O +
the O +
chicken O +
AOX1 B-Gene +
protein O +
to O +
homogeneity O +
from O +
kidney O +
demonstrates O +
that O +
the O +
enzyme O +
possesses O +
retinaldehyde O +
oxidase B-Gene +
activity O +
. O +

Unlike O +
humans O +
and O +
most O +
other O +
mammals O +
, O +
dog O +
and O +
chicken O +
are O +
devoid O +
of O +
liver O +
aldehyde B-Gene +
oxidase I-Gene +
activity O +
. O +

Phosphorylation O +
of O +
the O +
spinach O +
chloroplast O +
24 B-Gene +
kDa I-Gene +
RNA I-Gene +
- I-Gene +
binding I-Gene +
protein I-Gene +
( O +
24RNP B-Gene +
) O +
increases O +
its O +
binding O +
to O +
petD B-Gene +
and O +
psbA B-Gene +
3 O -
' O +
untranslated O +
regions O +
. O +

The O +
chloroplast O +
24 B-Gene +
kDa I-Gene +
RNA I-Gene +
binding I-Gene +
protein I-Gene +
( O +
24RNP B-Gene +
) O +
from O +
Spinacea O +
oleracea O +
is O +
a O +
nuclear O +
encoded O +
protein O +
that O +
binds O +
the O +
3 O -
' O +
untranslated O +
region O +
( O +
3'UTR O +
) O +
of O +
some O +
chloroplast O +
mRNAs O +
and O +
seems O +
to O +
be O +
involved O +
in O +
some O +
processes O +
of O +
mRNA O +
metabolism O +
, O +
such O +
as O +
3'UTR O +
processing O +
, O +
maturation O +
and O +
stabilization O +
. O +

The O +
24RNP B-Gene +
is O +
similar O +
to O +
the O +
28RNP B-Gene +
which O +
is O +
involved O +
in O +
the O +
correct O +
maturation O +
of O +
petD B-Gene +
and O +
psbA B-Gene +
3 O -
' O +
UTRs O +
, O +
and O +
when O +
phosphorylated O +
, O +
decreases O +
its O +
binding O +
affinity O +
for O +
RNA O +
. O +

In O +
the O +
present O +
work O +
, O +
we O +
determined O +
that O +
the O +
recombinant O +
24RNP B-Gene +
was O +
phosphorylated O +
in O +
vitro O +
either O +
by O +
an O +
animal O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
, O +
a O +
plant O +
Ca O -
( O -
2 O -
+ O -
) O +
- O +
dependent O +
protein B-Gene +
kinase I-Gene +
, O +
or O +
a O +
chloroplastic O +
kinase B-Gene +
activity O +
present O +
in O +
a O +
protein O +
extract O +
with O +
3'-end O +
processing O +
activity O +
in O +
which O +
the O +
24RNP B-Gene +
is O +
also O +
present O +
. O +

Phosphorylation O +
of O +
24RNP B-Gene +
increased O +
the O +
binding O +
capacity O +
( O +
B O -
( O -
max O -
) O +
) O +
0.25 O +
time O +
for O +
petD B-Gene +
3'UTR O +
, O +
and O +
three O +
times O +
for O +
psbA B-Gene +
3 O -
' O +
UTR O +
; O +
the O +
affinity O +
for O +
P O +
- O +
24RNP B-Gene +
only O +
increased O +
when O +
the O +
interaction O +
with O +
petD B-Gene +
was O +
tested O +
. O +

Competition O +
experiments O +
suggested O +
that O +
B O -
( O -
max O -
) O +
, O +
not O +
K O -
( O -
d O -
) O +
, O +
might O +
be O +
a O +
more O +
important O +
factor O +
in O +
the O +
P O +
- O +
24RNP B-Gene +
- O +
3 O -
' O +
UTR O +
interaction O +
. O +

The O +
data O +
suggested O +
that O +
the O +
24RNP B-Gene +
role O +
in O +
chloroplast O +
mRNA O +
metabolism O +
may O +
be O +
regulated O +
in O +
vivo O +
by O +
changes O +
in O +
its O +
phosphorylation O +
status O +
carried O +
out O +
by O +
a O +
chloroplastic O +
kinase B-Gene +
. O +

Proteasome O +
- O +
mediated O +
proteolysis O +
of O +
the O +
interleukin-10 B-Gene +
receptor I-Gene +
is O +
important O +
for O +
signal O +
downregulation O +
. O +

The O +
cytokine B-Gene +
interleukin-10 B-Gene +
( O +
IL-10 B-Gene +
) O +
is O +
an O +
important O +
regulator O +
of O +
immune O +
cell O +
function O +
, O +
proliferation O +
, O +
and O +
survival O +
. O +

The O +
IL-10 B-Gene +
receptor I-Gene +
( O +
IL-10R B-Gene +
) O +
consists O +
of O +
two O +
subunits O +
, O +
IL-10R1 B-Gene +
and O +
IL-10R2 B-Gene +
, O +
both O +
belonging O +
to O +
the O +
class B-Gene +
II I-Gene +
cytokine I-Gene +
receptor I-Gene +
superfamily I-Gene +
. O +

Like O +
other O +
members O +
of O +
the O +
cytokine B-Gene +
receptor I-Gene +
superfamily I-Gene +
, O +
IL-10R B-Gene +
stimulation O +
leads O +
to O +
activation O +
of O +
Jak B-Gene +
family I-Gene +
kinases I-Gene +
and O +
Stat B-Gene +
transcription I-Gene +
factors I-Gene +
. O +

To O +
identify O +
additional O +
signal O +
transduction O +
pathways O +
used O +
by O +
the O +
IL-10R B-Gene +
, O +
we O +
purified O +
92 O +
- O +
kDa O +
and O +
100 O +
- O +
kDa O +
proteins O +
that O +
coprecipitated O +
with O +
IL-10R1 B-Gene +
from O +
IL-10 B-Gene +
- O +
stimulated O +
cells O +
. O +

Both O +
proteins O +
were O +
found O +
to O +
be O +
related O +
to O +
the O +
97 O +
- O +
kDa O +
subunit O +
of O +
the O +
regulatory O +
component O +
of O +
the O +
26S O +
proteasome O +
. O +

Subsequent O +
studies O +
confirmed O +
that O +
the O +
IL-10R1 B-Gene +
undergoes O +
ligand O +
- O +
dependent O +
internalization O +
and O +
proteasome O +
- O +
mediated O +
degradation O +
. O +

An O +
IL-10R1 B-Gene +
cytoplasmic O +
domain O +
mutant O +
deficient O +
for O +
internalization O +
exhibited O +
prolonged O +
signaling O +
through O +
Jak1 B-Gene +
and O +
Stat3 B-Gene +
, O +
reinforcing O +
the O +
importance O +
of O +
receptor O +
internalization O +
for O +
signal O +
termination O +
. O +

An O +
approach O +
to O +
analyze O +
mechanisms O +
of O +
intestinal O +
adaptation O +
following O +
total O +
proctocolectomy O +
. O +

We O +
hypothesized O +
that O +
epithelial O +
cells O +
of O +
the O +
remnant O +
small O +
intestine O +
display O +
" O +
colonic O +
" O +
phenotype O +
after O +
total O +
proctocolectomy O +
. O +

The O +
aims O +
of O +
the O +
present O +
study O +
were O +
to O +
identify O +
preferentially O +
expressed O +
molecules O +
in O +
the O +
colon O +
or O +
in O +
the O +
small O +
intestine O +
and O +
to O +
evaluate O +
mRNA O +
levels O +
of O +
those O +
in O +
the O +
ileal O +
pouch O +
. O +

Differential O +
gene O +
expression O +
was O +
investigated O +
between O +
the O +
small O +
intestine O +
and O +
the O +
colon O +
by O +
using O +
cDNA O +
microarray O +
and O +
was O +
confirmed O +
by O +
Northern O +
blotting O +
. O +

Expression O +
of O +
three O +
colonic O +
mRNAs O +
( O +
3-hydroxy-3-methylglutaryl B-Gene -
- I-Gene -
coenzyme I-Gene +
A I-Gene +
synthase I-Gene +
2 I-Gene +
, O +
deleted B-Gene +
malignant I-Gene +
brain I-Gene +
tumors I-Gene +
1 I-Gene +
, O +
carcinoembryonic B-Gene +
antigen I-Gene +
- I-Gene +
related I-Gene +
cell I-Gene +
adhesion I-Gene +
molecule I-Gene +
1 I-Gene +
) O +
and O +
one O +
" O +
small O +
intestinal O +
" O +
( O +
microsomal B-Gene +
triglyceride I-Gene +
transfer I-Gene +
protein I-Gene +
) O +
mRNA O +
were O +
compared O +
between O +
the O +
control O +
and O +
the O +
ileal O +
pouch O +
mucosae O +
by O +
quantitative O +
reverse O +
transcriptase O +
- O +
polymerase O +
chain O +
reaction O +
. O +

Seventy O +
- O +
four O +
clones O +
were O +
differentially O +
expressed O +
with O +
more O +
than O +
a O +
threefold O +
difference O +
. O +

Differential O +
expression O +
was O +
confirmed O +
in O +
all O +
mRNAs O +
examined O +
, O +
including O +
3-hydroxy-3-methylglutaryl B-Gene -
- I-Gene -
coenzyme I-Gene +
A I-Gene +
synthase I-Gene +
2 I-Gene +
and O +
microsomal B-Gene +
triglyceride I-Gene +
transfer I-Gene +
protein I-Gene +
. O +

The O +
mucosal O +
expression O +
of O +
carcinoembryonic B-Gene +
antigen I-Gene +
- I-Gene +
related I-Gene +
cell I-Gene +
adhesion I-Gene +
molecule I-Gene +
1 I-Gene +
mRNA O +
in O +
the O +
ileal O +
pouch O +
was O +
enhanced O +
in O +
humans O +
. O +

The O +
remnant O +
ileum O +
develops O +
some O +
, O +
but O +
not O +
all O +
, O +
colonic O +
phenotype O +
after O +
total O +
proctocolectomy O +
. O +

Comparative O +
study O +
of O +
epithelial O +
gene O +
expression O +
between O +
the O +
small O +
intestine O +
and O +
the O +
colon O +
enables O +
us O +
to O +
analyze O +
mechanisms O +
of O +
intestinal O +
adaptation O +
after O +
total O +
proctocolectomy O +
. O +

L O -
- O -
arginine O +
chlorination O +
results O +
in O +
the O +
formation O +
of O +
a O +
nonselective O +
nitric B-Gene -
- I-Gene -
oxide I-Gene +
synthase I-Gene +
inhibitor O +
. O +

Reduced O +
nitric O +
oxide O +
( O +
NO O +
) O +
bioavailability O +
and O +
impaired O +
vascular O +
function O +
are O +
the O +
key O +
pathological O +
characteristics O +
of O +
inflammatory O +
diseases O +
such O +
as O +
atherosclerosis O +
. O +

We O +
have O +
recently O +
found O +
that O +
leukocyte O +
- O +
derived O +
hypochlorous O +
acid O +
is O +
able O +
to O +
react O +
with O +
the O +
nitric B-Gene -
- I-Gene -
oxide I-Gene +
synthase I-Gene +
( O +
NOS B-Gene +
) O +
substrate O +
L O -
- O -
arginine O +
to O +
produce O +
chlorinated O +
L O -
- O -
arginine O +
( O +
cl O -
- O -
L O -
- O -
Arg O +
) O +
. O +

Interestingly O +
, O +
cl O -
- O -
L O -
- O -
Arg O +
potently O +
inhibits O +
the O +
formation O +
of O +
NO O +
metabolites O +
in O +
cultured O +
endothelial O +
cells O +
. O +

It O +
is O +
unknown O +
whether O +
cl O -
- O -
L O -
- O -
Arg O +
has O +
a O +
direct O +
inhibitory O +
effect O +
on O +
endothelial B-Gene +
NOS I-Gene +
( O +
eNOS B-Gene +
) O +
. O +

In O +
addition O +
, O +
the O +
effect O +
of O +
cl O -
- O -
L O -
- O -
Arg O +
on O +
the O +
other O +
NOS B-Gene +
isoforms O +
, O +
neuronal B-Gene +
NOS I-Gene +
( O +
nNOS B-Gene +
) O +
and O +
inducible B-Gene +
NOS I-Gene +
( O +
iNOS B-Gene +
) O +
, O +
is O +
also O +
unknown O +
. O +

Therefore O +
, O +
we O +
designed O +
the O +
current O +
study O +
to O +
test O +
the O +
effects O +
of O +
cl O -
- O -
L O -
- O -
Arg O +
on O +
eNOS B-Gene +
, O +
nNOS B-Gene +
, O +
and O +
iNOS B-Gene +
. O +

Using O +
recombinant O +
NOS B-Gene +
, O +
we O +
found O +
that O +
cl O -
- O -
L O -
- O -
Arg O +
had O +
a O +
direct O +
inhibitory O +
effect O +
on O +
the O +
activity O +
of O +
NOS B-Gene +
. O +

The O +
effect O +
of O +
cl O -
- O -
L O -
- O -
Arg O +
on O +
NOS B-Gene +
activity O +
is O +
nonselective O +
, O +
as O +
all O +
three O +
NOS B-Gene +
isoforms O +
were O +
inhibited O +
with O +
a O +
similar O +
IC O -
( O -
50 O -
) O +
. O +

We O +
further O +
determined O +
the O +
effect O +
of O +
cl O -
- O -
L O -
- O -
Arg O +
on O +
the O +
three O +
NOS B-Gene +
isoforms O +
at O +
the O +
tissue O +
level O +
. O +

The O +
results O +
demonstrated O +
that O +
cl O -
- O -
L O -
- O -
Arg O +
potently O +
inhibited O +
all O +
three O +
NOS B-Gene +
isoform O +
- O +
mediated O +
vessel O +
reactivities O +
, O +
as O +
well O +
as O +
the O +
NOS B-Gene +
signaling O +
molecule O +
cGMP O +
. O +

Cl O -
- O -
L O -
- O -
Arg O +
might O +
serve O +
as O +
a O +
novel O +
endogenous O +
NOS B-Gene +
inhibitor O +
and O +
an O +
important O +
mediator O +
for O +
vascular O +
dysfunction O +
under O +
inflammatory O +
conditions O +
such O +
as O +
atherosclerosis O +
. O +

Blocking O +
cl O -
- O -
L O -
- O -
Arg O +
formation O +
may O +
be O +
a O +
new O +
therapeutic O +
approach O +
to O +
cardiovascular O +
diseases O +
. O +

TNFalpha B-Gene +
induces O +
chromosomal O +
abnormalities O +
independent O +
of O +
ROS O +
through O +
IKK B-Gene +
, O +
JNK B-Gene +
, O +
p38 B-Gene +
and O +
caspase B-Gene +
pathways O +
. O +

A O +
role O +
for O +
pro O +
- O +
inflammatory O +
cytokines B-Gene +
in O +
inflammation O +
- O +
related O +
cancers O +
has O +
been O +
suggested O +
, O +
but O +
mechanisms O +
are O +
not O +
defined O +
. O +

Here O +
, O +
we O +
demonstrate O +
that O +
treatment O +
of O +
HeLa O +
cells O +
with O +
TNFalpha B-Gene +
increases O +
chromosomal O +
aberration O +
. O +

In O +
contrast O +
, O +
IL-1beta B-Gene +
did O +
not O +
increase O +
, O +
but O +
rather O +
decreased O +
chromosomal O +
aberration O +
. O +

TNFalpha B-Gene +
and O +
IL-1beta B-Gene +
increased O +
the O +
production O +
of O +
H2O2 O +
to O +
similar O +
levels O +
in O +
cells O +
, O +
suggesting O +
that O +
increased O +
production O +
of O +
reactive O +
oxygen O +
species O +
might O +
not O +
be O +
the O +
premier O +
factor O +
involved O +
. O +

Reducing O +
H2O2 O +
through O +
overexpression O +
of O +
catalase B-Gene +
or O +
treatment O +
of O +
cells O +
with O +
NAC O +
or O +
BHA O +
did O +
not O +
have O +
an O +
effect O +
on O +
TNF B-Gene +
- O +
induced O +
chromosomal O +
aberration O +
. O +

TNFalpha B-Gene +
- O +
induced O +
NO O +
production O +
has O +
been O +
implicated O +
in O +
DNA O +
damage O +
. O +

Inhibiting O +
NO O +
did O +
not O +
reduce O +
TNF B-Gene +
- O +
induced O +
chromosomal O +
aberration O +
. O +

Inhibiting O +
IKK B-Gene +
, O +
JNK B-Gene +
, O +
and O +
p38 B-Gene +
kinase I-Gene +
as O +
well O +
as O +
caspases O +
decreased O +
TNF B-Gene +
- O +
induced O +
chromosomal O +
aberration O +
, O +
and O +
a O +
correlation O +
between O +
TNF B-Gene +
- O +
induced O +
apoptosis O +
and O +
CA O +
generation O +
was O +
not O +
found O +
. O +

Single O +
- O +
strand O +
DNA O +
breaks O +
give O +
rise O +
to O +
double O +
- O +
strand O +
breaks O +
, O +
which O +
then O +
results O +
in O +
chromosomal O +
breaks O +
, O +
when O +
replication O +
forks O +
reach O +
the O +
single O +
- O +
strand O +
breaks O +
during O +
S O -
- O -
phase O +
. O +

In O +
cells O +
progressing O +
through O +
S O -
- O -
phase O +
, O +
TNFalpha B-Gene +
activation O +
of O +
IKK B-Gene +
, O +
JNK B-Gene +
, O +
and O +
p38 B-Gene +
is O +
significantly O +
reduced O +
. O +

However O +
, O +
these O +
kinases B-Gene +
were O +
activated O +
by O +
IL-1beta B-Gene +
in O +
S O -
- O -
phase O +
. O +

The O +
possibility O +
that O +
these O +
pathways O +
, O +
in O +
a O +
TNF B-Gene +
- O +
specific O +
manner O +
, O +
may O +
regulate O +
either O +
the O +
generation O +
of O +
single O +
- O +
and O +
double O +
- O +
strand O +
breaks O +
or O +
their O +
repair O +
, O +
thereby O +
resulting O +
in O +
increased O +
chromosomal O +
aberration O +
, O +
is O +
discussed O +
. O +

Engineering O +
human O +
IL-18 B-Gene +
with O +
increased O +
bioactivity O +
and O +
bioavailability O +
. O +

Cytokines B-Gene +
in O +
plasmid O +
form O +
can O +
act O +
as O +
potent O +
adjuvants O +
when O +
co O +
- O +
administered O +
with O +
DNA O +
vaccines O +
, O +
resulting O +
in O +
an O +
enhanced O +
immune O +
response O +
to O +
the O +
DNA O +
- O +
encoded O +
antigen O +
. O +

This O +
is O +
true O +
of O +
interleukin-18 B-Gene +
( O +
IL-18 B-Gene +
) O +
, O +
which O +
has O +
been O +
shown O +
to O +
serve O +
as O +
an O +
adjuvant O +
in O +
conjunction O +
with O +
certain O +
DNA O +
vaccines O +
. O +

To O +
determine O +
if O +
the O +
properties O +
of O +
IL-18 B-Gene +
could O +
be O +
optimized O +
for O +
use O +
as O +
a O +
DNA O +
vaccine O +
adjuvant O +
, O +
a O +
model O +
of O +
IL-18 B-Gene +
/ O +
IL-18R B-Gene +
binding O +
was O +
developed O +
to O +
identify O +
variants O +
of O +
human O +
IL-18 B-Gene +
that O +
were O +
predicted O +
to O +
improve O +
receptor O +
interactions O +
and O +
potentially O +
bioactivity O +
. O +

The O +
linkage O +
of O +
mature O +
IL-18 B-Gene +
to O +
a O +
secretion O +
signal O +
sequence O +
provided O +
improved O +
protein O +
expression O +
from O +
mammalian O +
cells O +
and O +
signal B-Gene +
peptidase I-Gene +
cleavage O +
of O +
this O +
protein O +
produced O +
the O +
authentic O +
N O -
- O -
terminus O +
. O +

The O +
IL-18 B-Gene +
variant O +
proteins O +
secreted O +
this O +
way O +
were O +
bioactive O +
, O +
as O +
demonstrated O +
by O +
their O +
ability O +
to O +
induce O +
interferon B-Gene +
gamma I-Gene +
( O +
IFNgamma B-Gene +
) O +
expression O +
by O +
human O +
peripheral O +
blood O +
mononuclear O +
cells O +
( O +
PBMCs O +
) O +
and O +
to O +
bind O +
to O +
IL-18R B-Gene +
, O +
as O +
demonstrated O +
by O +
BIAcore O +
analysis O +
. O +

The O +
IL-18 B-Gene +
variants O +
were O +
inhibited O +
by O +
IL-18 B-Gene +
binding I-Gene +
protein I-Gene +
( O +
IL-18BP B-Gene +
) O +
, O +
the O +
soluble O +
inhibitor O +
of O +
IL-18 B-Gene +
, O +
as O +
measured O +
by O +
neutralization O +
of O +
the O +
IFNgamma B-Gene +
response O +
in O +
PBMCs O +
. O +

One O +
variant O +
, O +
V11I O +
/ O +
T63A O +
, O +
demonstrated O +
increases O +
both O +
in O +
bioactivity O +
and O +
mammalian O +
cell O +
expression O +
as O +
compared O +
to O +
native O +
IL-18 B-Gene +
, O +
indicating O +
that O +
this O +
molecule O +
may O +
be O +
particularly O +
well O +
suited O +
for O +
use O +
as O +
a O +
DNA O +
- O +
encoded O +
vaccine O +
adjuvant O +
. O +

The O +
role O +
of O +
the O +
STAS O +
domain O +
in O +
the O +
function O +
and O +
biogenesis O +
of O +
a O +
sulfate B-Gene +
transporter I-Gene +
as O +
probed O +
by O +
random O +
mutagenesis O +
. O +

Sulfate B-Gene +
transporters I-Gene +
in O +
plants O +
represent O +
a O +
family O +
of O +
proteins O +
containing O +
transmembrane O +
domains O +
that O +
constitute O +
the O +
catalytic O +
part O +
of O +
the O +
protein O +
and O +
a O +
short O +
linking O +
region O +
that O +
joins O +
this O +
catalytic O +
moiety O +
with O +
a O +
C O +
- O +
terminal O +
STAS O +
domain O +
. O +

The O +
STAS O +
domain O +
resembles O +
an O +
anti B-Gene +
- I-Gene +
sigma I-Gene +
factor I-Gene +
antagonist I-Gene +
of O +
Bacillus O +
subtilis O +
, O +
which O +
is O +
one O +
distinguishing O +
feature O +
of O +
the O +
SLC26 B-Gene +
transporter I-Gene +
family I-Gene +
; O +
this O +
family O +
includes O +
transporters O +
for O +
sulfate O +
and O +
other O +
anions O +
such O +
as O +
iodide O +
and O +
carbonate O +
. O +

Recent O +
work O +
has O +
demonstrated O +
that O +
this O +
domain O +
is O +
critical O +
for O +
the O +
activity O +
of O +
Arabidopsis O +
thaliana O +
sulfate B-Gene +
transporters I-Gene +
, O +
and O +
specific O +
lesions O +
in O +
this O +
domain O +
, O +
or O +
the O +
exchange O +
of O +
STAS O +
domains O +
between O +
different O +
sulfate B-Gene +
transporters I-Gene +
, O +
can O +
severely O +
impair O +
transport O +
activity O +
. O +

In O +
this O +
work O +
we O +
generated O +
a O +
Saccharomyces O +
cerevisiae O +
expression O +
library O +
of O +
the O +
A. O +
thaliana O +
Sultr1 B-Gene +
; I-Gene +
2 I-Gene +
gene O +
with O +
random O +
mutations O +
in O +
the O +
linking O +
region O +
- O +
STAS O +
domain O +
and O +
identified O +
STAS O +
domain O +
lesions O +
that O +
altered O +
Sultr1 B-Gene +
; I-Gene +
2 I-Gene +
biogenesis O +
and/or O +
function O +
. O +

A O +
number O +
of O +
mutations O +
in O +
the O +
beta O -
- O -
sheet O +
that O +
forms O +
the O +
core O +
of O +
the O +
STAS O +
domain O +
prevented O +
intracellular O +
accumulation O +
of O +
Sultr1 B-Gene +
; I-Gene +
2 I-Gene +
. O +

In O +
contrast O +
, O +
the O +
linking O +
region O +
and O +
one O +
surface O +
of O +
the O +
STAS O +
domain O +
containing O +
N O +
termini O +
of O +
the O +
first O +
and O +
second O +
alpha O -
- O -
helices O +
have O +
a O +
number O +
of O +
amino O +
acids O +
critical O +
for O +
the O +
function O +
of O +
the O +
protein O +
; O +
mutations O +
in O +
these O +
regions O +
still O +
allow O +
protein O +
accumulation O +
in O +
the O +
plasma O +
membrane O +
, O +
but O +
the O +
protein O +
is O +
no O +
longer O +
capable O +
of O +
efficiently O +
transporting O +
sulfate O +
into O +
cells O +
. O +

These O +
results O +
suggest O +
that O +
the O +
STAS O +
domain O +
is O +
critical O +
for O +
both O +
the O +
activity O +
and O +
biosynthesis O +
/ O +
stability O +
of O +
the O +
transporter O +
, O +
and O +
that O +
STAS O +
sub O +
- O +
domains O +
correlate O +
with O +
these O +
specific O +
functions O +
. O +

The O +
G490E O +
mutation O +
in O +
reverse B-Gene +
transcriptase I-Gene +
does O +
not O +
impact O +
tRNA O +
primer O +
selection O +
by O +
HIV-1 O +
with O +
altered O +
PBS O +
and O +
A O +
- O +
loop O +
. O +

The O +
initiation O +
of O +
HIV-1 O +
reverse O +
transcription O +
utilizes O +
a O +
cellular O +
tRNA O -
( O -
Lys,3 O +
) O +
as O +
a O +
primer O +
. O +

The O +
3 O -
' O +
terminal O +
18 O +
- O +
nucleotides O +
of O +
the O +
cellular O +
tRNA O -
( O -
Lys,3 O -
) O +
are O +
complementary O +
to O +
a O +
region O +
on O +
the O +
viral O +
genome O +
, O +
designated O +
as O +
the O +
primer O +
binding O +
site O +
( O +
PBS O +
) O +
. O +

Previous O +
studies O +
have O +
shown O +
that O +
forcing O +
HIV-1 O +
to O +
utilize O +
alternative O +
tRNA O +
primers O +
through O +
alteration O +
of O +
the O +
PBS O +
results O +
in O +
viruses O +
that O +
revert O +
to O +
utilize O +
tRNA O +
( O +
Lys,3 O +
) O +
following O +
in O +
vitro O +
replication O +
. O +

In O +
some O +
instances O +
though O +
, O +
HIV-1 O +
has O +
been O +
shown O +
to O +
select O +
alternative O +
tRNAs O +
for O +
initiation O +
of O +
reverse O +
transcription O +
if O +
additional O +
mutations O +
upstream O +
in O +
the O +
U5 O +
region O +
( O +
A O -
- O -
loop O +
) O +
were O +
made O +
to O +
be O +
complementary O +
to O +
these O +
alternative O +
tRNAs O +
. O +

Recently O +
, O +
an O +
HIV-1 O +
has O +
been O +
described O +
in O +
which O +
the O +
U5 O +
region O +
distinct O +
from O +
the O +
A O +
- O +
loop O +
, O +
designated O +
as O +
the O +
primer O +
activation O +
site O +
( O +
PAS O +
) O +
, O +
was O +
mutated O +
in O +
conjunction O +
with O +
the O +
PBS O +
to O +
force O +
the O +
virus O +
to O +
use O +
tRNA O +
( O +
Lys1,2 O +
) O +
as O +
a O +
primer O +
. O +

An O +
additional O +
mutation O +
in O +
reverse B-Gene +
transcriptase I-Gene +
( O +
RT B-Gene +
) O +
, O +
G490E O +
, O +
was O +
found O +
to O +
facilitate O +
the O +
forced O +
use O +
of O +
tRNA O +
( O +
Lys1,2 O +
) O +
as O +
the O +
primer O +
. O +

In O +
the O +
current O +
study O +
, O +
we O +
have O +
investigated O +
the O +
impact O +
of O +
the O +
G490E O +
mutation O +
in O +
RT B-Gene +
on O +
the O +
selection O +
and O +
use O +
of O +
alternative O +
primers O +
by O +
HIV-1 O +
. O +

Viruses O +
were O +
first O +
constructed O +
in O +
which O +
the O +
PBS O +
and O +
A O +
- O +
loop O +
region O +
were O +
made O +
complementary O +
to O +
tRNA O +
( O +
Trp O +
) O +
. O +

Previous O +
studies O +
from O +
our O +
laboratory O +
have O +
shown O +
that O +
these O +
viruses O +
are O +
unstable O +
and O +
mutate O +
to O +
select O +
tRNA O +
( O +
Met O +
) O +
or O +
tRNA O +
( O +
Lys1,2 O +
) O +
. O +

Analysis O +
of O +
the O +
replication O +
of O +
viruses O +
with O +
the O +
U5 O +
and O +
PBS O +
complementary O +
to O +
tRNA O +
( O +
Trp O +
) O +
with O +
or O +
without O +
the O +
G490E O +
mutation O +
revealed O +
no O +
significant O +
differences O +
with O +
respect O +
to O +
infectivity O +
and O +
viral O +
growth O +
in O +
SupT1 O +
or O +
peripheral O +
blood O +
mononuclear O +
cells O +
( O +
PBMC O +
) O +
. O +

In O +
addition O +
, O +
the O +
presence O +
of O +
the O +
G490E O +
mutation O +
did O +
not O +
influence O +
the O +
capacity O +
of O +
this O +
virus O +
to O +
revert O +
to O +
utilize O +
tRNA O +
( O +
Met O +
) O +
as O +
the O +
primer O +
for O +
initiation O +
of O +
reverse O +
transcription O +
. O +

In O +
a O +
previous O +
study O +
, O +
we O +
have O +
described O +
an O +
HIV-1 O +
that O +
has O +
been O +
forced O +
to O +
utilize O +
tRNA O +
( O +
Lys1,2 O +
) O +
through O +
mutations O +
in O +
the O +
A O +
- O +
loop O +
and O +
PBS O +
. O +

The O +
G490E O +
RT B-Gene +
mutation O +
in O +
this O +
virus O +
did O +
not O +
impact O +
on O +
the O +
virus O +
infectivity O +
or O +
growth O +
in O +
SupT1 O +
or O +
PBMC O +
. O +

We O +
did O +
not O +
find O +
a O +
significant O +
fitness O +
advantage O +
to O +
viruses O +
in O +
which O +
the O +
A O +
- O +
loop O +
and O +
PBS O +
were O +
made O +
complementary O +
to O +
tRNA O -
( O -
Lys1,2 O +
) O +
that O +
also O +
contained O +
the O +
G490E O +
mutation O +
in O +
RT B-Gene +
. O +

The O +
results O +
of O +
these O +
studies O +
then O +
establish O +
that O +
HIV-1 O +
can O +
be O +
forced O +
to O +
use O +
alternative O +
primers O +
through O +
mutations O +
in O +
the O +
U5 O +
( O +
PAS O +
or O +
A O -
- O -
loop O +
) O +
for O +
certain O +
tRNAs O +
. O +

Furthermore O +
, O +
for O +
mutations O +
in O +
the O +
A O +
- O +
loop O +
and O +
PBS O +
, O +
the O +
RT B-Gene +
does O +
not O +
play O +
an O +
important O +
role O +
in O +
dictating O +
the O +
selection O +
of O +
the O +
alternative O +
primers O +
to O +
be O +
used O +
for O +
initiation O +
of O +
reverse O +
transcription O +
. O +

HIV-1 O +
infection O +
: O +
is O +
it O +
time O +
to O +
reconsider O +
our O +
concepts O +
? O +

The O +
long O +
asymptomatic O +
phase O +
of O +
HIV O +
infection O +
is O +
critical O +
in O +
the O +
progression O +
to O +
AIDS O +
. O +

It O +
probably O +
reflects O +
an O +
ancestral O +
relationship O +
with O +
lentiviruses O +
stemming O +
from O +
the O +
primate O +
- O +
simian O +
immunodeficiency O +
virus O +
evolutionary O +
pathway O +
leading O +
to O +
an O +
idiosyncratic O +
immune O +
tolerance O +
, O +
which O +
needs O +
to O +
be O +
understood O +
if O +
effective O +
vaccines O +
are O +
to O +
be O +
rationally O +
designed O +
. O +

The O +
majority O +
of O +
CD4 B-Gene +
+ O +
T O +
cells O +
that O +
die O +
due O +
to O +
HIV-1 O +
in O +
the O +
asymptomatic O +
phase O +
are O +
not O +
infected O +
with O +
the O +
virus O +
. O +

Transmission O +
of O +
the O +
predominant O +
HIV-1 O +
R5 O +
variants O +
to O +
T O +
cells O +
is O +
mediated O +
by O +
infected O +
monocyte O +
- O +
derived O +
macrophages O +
. O +

The O +
two O +
cell O +
populations O +
come O +
into O +
intimate O +
contact O +
mainly O +
in O +
the O +
lymph O +
nodes O +
during O +
antigen O +
presentation O +
where O +
there O +
is O +
also O +
active O +
viral O +
replication O +
. O +

We O +
propose O +
that O +
HIV O +
exploits O +
antigen O +
presentation O +
to O +
access O +
target O +
T O +
cells O +
and O +
evade O +
immune O +
surveillance O +
. O +

This O +
is O +
achieved O +
at O +
the O +
assembly O +
point O +
of O +
an O +
immunological O +
synapse O +
between O +
an O +
antigen O +
presenting O +
, O +
HIV-1 O +
- O +
infected O +
macrophage O +
and O +
a O +
responding O +
effector O +
/ O +
memory O +
CD4 B-Gene +
+ O +
T O +
cell O +
. O +

Viral O +
envelope O +
gp120 B-Gene +
glycoproteins O +
proximal O +
to O +
MHC B-Gene +
II I-Gene +
molecules O +
cross O +
- O +
link O +
with O +
T O +
cell O +
CD4 B-Gene +
molecules O +
, O +
thus O +
establishing O +
a O +
supra O +
molecular O +
immuno O +
- O +
viral O +
synapse O +
. O +

The O +
interaction O +
results O +
in O +
conformational O +
changes O +
of O +
gp120 B-Gene +
exposing O +
its O +
V3 O +
domain O +
. O +

Ionic O +
interaction O +
of O +
this O +
domain O +
with O +
the O +
synapse O +
- O +
recruited O +
chemokine B-Gene +
receptor I-Gene +
CCR5 B-Gene +
dimerizes O +
the O +
receptor O +
triggering O +
intracellular O +
signals O +
that O +
contribute O +
to O +
T B-Gene +
cell I-Gene +
receptor I-Gene +
transactivation O +
pathways O +
and O +
subsequent O +
enhancement O +
of O +
T O +
cell O +
activation O +
. O +

HIV O +
- O +
downregulated O +
MHC B-Gene +
II I-Gene +
gives O +
weak O +
immune O +
complexes O +
. O +

Disruption O +
of O +
the O +
immuno O +
- O +
viral O +
synapse O +
before O +
completion O +
of O +
cell O +
entry O +
is O +
a O +
frequent O +
outcome O +
condemning O +
the O +
responding O +
T O +
cell O +
to O +
a O +
premature O +
activation O +
- O +
induced O +
T O +
cell O +
death O +
. O +

Information O +
on O +
the O +
assembly O +
, O +
mechanistic O +
and O +
functional O +
interactions O +
at O +
the O +
immuno O +
- O +
viral O +
synapses O +
may O +
well O +
assist O +
in O +
elucidating O +
new O +
strategies O +
to O +
combat O +
HIV O +
infection O +
. O +

A O +
novel O +
gene O +
of O +
beta B-Gene +
chain I-Gene +
of I-Gene +
the I-Gene +
IFN I-Gene -
- I-Gene -
gamma I-Gene +
receptor I-Gene +
of O +
Huiyang O +
chicken O +
: O +
cloning O +
, O +
distribution O +
, O +
and O +
CD O +
assay O +
. O +

The O +
beta B-Gene +
chain I-Gene +
of I-Gene +
the I-Gene +
interferon I-Gene -
- I-Gene -
gamma I-Gene +
receptor I-Gene +
( O +
IFNGR-2 B-Gene +
) O +
plays O +
a O +
critical O +
role O +
in O +
signal O +
transmission O +
to O +
the O +
nucleus O +
by O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
. O +

Here O +
, O +
we O +
cloned O +
the O +
full O +
- O +
length O +
cDNA O +
of O +
IFNGR-2 B-Gene +
of O +
Huiyang O +
chicken O +
using O +
RACE O +
. O +

mRNA O +
transcripts O +
of O +
IFNGR-2 B-Gene +
were O +
detected O +
in O +
peripheral O +
blood O +
leukocytes O +
( O +
PBL O +
) O +
and O +
various O +
organs O +
using O +
Northern O +
blot O +
analysis O +
. O +

The O +
extracellular O +
region O +
of O +
IFNGR-2 B-Gene +
( O +
IFNGR-2EC B-Gene +
) O +
was O +
expressed O +
in O +
Pichia O +
pastoris O +
, O +
and O +
its O +
secondary O +
structure O +
was O +
investigated O +
by O +
circular O +
dichroism O +
( O +
CD O +
) O +
. O +

The O +
Huiyang O +
chicken O +
IFNGR-2 B-Gene +
gene O +
is O +
2221 O +
bp O +
with O +
a O +
polyA O +
+ O +
tail O +
, O +
and O +
it O +
encodes O +
334 O +
amino O +
acids O +
sharing O +
30 O +
% O +
- O +
33 O +
% O +
identity O +
with O +
that O +
of O +
rat O +
, O +
mouse O +
, O +
and O +
human O +
IFNGR-2 B-Gene +
. O +

IFNGR-2 B-Gene +
is O +
localized O +
on O +
chromosome O +
1 O +
of O +
chicken O +
in O +
tandem O +
with O +
IFNAR-1 B-Gene +
, O +
interleukin B-Gene +
- I-Gene +
10 I-Gene +
receptor I-Gene +
( O +
IL-10R-2 B-Gene +
) O +
, O +
and O +
IFNAR-2 B-Gene +
. O +

IFNGR-2 B-Gene +
was O +
highly O +
expressed O +
in O +
PBL O +
, O +
muscle O +
, O +
spleen O +
, O +
thymus O +
, O +
and O +
cecal O +
tonsil O +
, O +
whereas O +
its O +
expression O +
in O +
cardiac O +
muscle O +
, O +
cloacal O +
bursa O +
, O +
liver O +
, O +
and O +
kidney O +
was O +
comparatively O +
low O +
. O +

Recombinant O +
protein O +
of O +
IFNGR-2EC B-Gene +
expressed O +
in O +
P. O +
pastoris O +
formed O +
the O +
secondary O +
structure O +
including O +
19.8 O +
% O +
alpha O -
- O -
helix O +
, O +
29.6 O +
% O +
beta O -
- O -
sheet O +
, O +
19.7 O +
% O +
turn O +
, O +
and O +
30.9 O +
% O +
random O +
. O +

The O +
data O +
show O +
that O +
Huiyang O +
chicken O +
IFNGR-2 B-Gene +
shares O +
properties O +
of O +
the O +
IFN B-Gene +
receptor I-Gene +
family I-Gene +
in O +
gene O +
structure O +
and O +
distribution O +
in O +
multiple O +
tissues O +
and O +
PBL O +
. O +

CD O +
analysis O +
indicated O +
that O +
the O +
recombinant O +
protein O +
of O +
IFNGR-2EC B-Gene +
resembles O +
the O +
known O +
structure O +
of O +
human O +
IFN B-Gene +
receptors I-Gene +
. O +

Expression O +
of O +
multiple O +
isoforms O +
of O +
the O +
cAMP B-Gene +
- I-Gene +
dependent I-Gene +
protein I-Gene +
kinase I-Gene +
( I-Gene +
PK I-Gene -
- I-Gene -
A I-Gene +
) I-Gene +
catalytic I-Gene +
subunit I-Gene +
in O +
the O +
nematode O +
, O +
Caenorhabditis O +
elegans O +
. O +

The O +
cAMP B-Gene +
- I-Gene +
dependent I-Gene +
protein I-Gene +
kinase I-Gene +
( O +
protein B-Gene +
kinase I-Gene +
A I-Gene +
, O +
PK B-Gene -
- I-Gene -
A I-Gene +
) O +
plays O +
a O +
central O +
role O +
in O +
the O +
regulation O +
of O +
many O +
aspects O +
of O +
eukaryotic O +
cellular O +
activity O +
. O +

In O +
the O +
free O +
- O +
living O +
nematode O +
, O +
Caenorhabditis O +
elegans O +
, O +
two O +
genes O +
encode O +
PK B-Gene +
- I-Gene +
A I-Gene +
- O +
like O +
catalytic O +
subunits O +
. O +

The O +
kin-1 B-Gene +
gene O +
has O +
the O +
potential O +
to O +
generate O +
, O +
through O +
alternative O +
splicing O +
events O +
, O +
a O +
multiplicity O +
of O +
catalytic O +
subunit O +
isoforms O +
; O +
in O +
contrast O +
, O +
the O +
F47F2.1b B-Gene +
gene O +
appears O +
to O +
encode O +
just O +
a O +
single O +
authentic O +
catalytic O +
subunit O +
- O +
like O +
protein O +
. O +

Here O +
, O +
we O +
report O +
on O +
the O +
occurrence O +
of O +
, O +
and O +
developmental O +
changes O +
in O +
the O +
expression O +
of O +
, O +
polypeptide O +
products O +
of O +
these O +
genes O +
in O +
both O +
C. O +
elegans O +
and O +
the O +
closely O +
related O +
nematode O +
, O +
C. O +
briggsae O +
. O +

Polypeptides O +
derived O +
from O +
the O +
F47F2.1 B-Gene +
gene O +
and O +
its O +
orthologue O +
were O +
detected O +
in O +
mixed O +
stage O +
populations O +
of O +
C. O +
elegans O +
and O +
C. O +
briggsae O +
, O +
respectively O +
. O +

Likewise O +
, O +
a O +
number O +
of O +
polypeptides O +
arising O +
as O +
a O +
result O +
of O +
alternative O +
splicing O +
of O +
transcripts O +
from O +
kin B-Gene +
- I-Gene +
1 I-Gene +
, O +
or O +
its O +
orthologue O +
in O +
C. O +
briggsae O +
, O +
were O +
identified O +
in O +
mixed O +
stage O +
populations O +
of O +
nematodes O +
. O +

These O +
isoforms O +
included O +
polypeptides O +
with O +
N O -
- O -
termini O +
encoded O +
by O +
exons O +
N'1 O +
or O +
N'4 O +
and O +
C O -
- O -
termini O +
encoded O +
by O +
exons O +
7 O +
or O +
N O +
. O +

The O +
expression O +
of O +
isoforms O +
with O +
an O +
N O -
- O -
terminus O +
encoded O +
by O +
the O +
N'1 O +
exon O +
is O +
of O +
significance O +
because O +
the O +
amino O +
acid O +
sequence O +
encoded O +
by O +
this O +
exon O +
encompasses O +
an O +
N O -
- O -
myristoylation O +
motif O +
. O +

Isoform O +
abundance O +
appears O +
to O +
be O +
related O +
to O +
developmental O +
stage O +
. O +

Substantial O +
differences O +
in O +
polypeptide O +
expression O +
profiles O +
can O +
be O +
seen O +
in O +
embryonic O +
and O +
adult O +
nematodes O +
. O +

The O +
functional O +
significance O +
of O +
this O +
PK B-Gene -
- I-Gene -
A I-Gene +
catalytic I-Gene +
subunit I-Gene +
isoform O +
diversity O +
is O +
discussed O +
. O +

Differentiation O +
potential O +
of O +
bone O +
marrow O +
stromal O +
cells O +
to O +
enteric O +
neurons O +
in O +
vitro O +
. O +

OBJECTIVE O +
: O +

To O +
investigate O +
whether O +
bone O +
marrow O +
stromal O +
cells O +
( O +
BMSC O +
) O +
can O +
be O +
induced O +
to O +
differentiate O +
into O +
enteric O +
neurons O +
and O +
to O +
produce O +
more O +
nerve B-Gene +
growth I-Gene +
factor I-Gene +
( O +
NGF B-Gene +
) O +
and O +
glial B-Gene +
cell I-Gene +
line I-Gene +
- I-Gene +
derived I-Gene +
neurotrophic I-Gene +
factor I-Gene +
( O +
GDNF B-Gene +
) O +
. O +

METHODS O +
: O +

Bone O +
marrow O +
stromal O +
cells O +
were O +
harvested O +
from O +
male O +
Sprague O +
- O +
Dawley O +
rats O +
and O +
cultured O +
in O +
Dulbecco O +
's O +
modified O +
eagle O +
medium O +
supplemented O +
with O +
20 O +
% O +
fetal O +
bovine O +
serum O +
. O +

The O +
BMSC O +
were O +
passaged O +
six O +
times O +
and O +
characterized O +
by O +
flow O +
cytometry O +
. O +

The O +
BMSC O +
were O +
pre O +
- O +
induced O +
by O +
basic B-Gene +
fibroblast I-Gene +
growth I-Gene +
factor I-Gene +
( O +
10 O +
ng O +
/ O +
mL O +
) O +
for O +
24 O +
h O +
, O +
then O +
induced O +
with O +
GDNF B-Gene +
in O +
fetal O +
gut O +
condition O +
medium O +
( O +
FGCM O +
) O +
for O +
10 O +
days O +
. O +

The O +
expressions O +
of O +
neuronal O +
markers O +
neural B-Gene +
specific I-Gene +
enolase I-Gene +
( O +
NSE B-Gene +
) O +
, O +
neurofilament B-Gene +
( O +
NF B-Gene +
) O +
, O +
glial O +
cell O +
marker O +
, O +
glial B-Gene +
fibrillary I-Gene +
acedic I-Gene +
protein I-Gene +
( O +
GFAP B-Gene +
) O +
, O +
and O +
enteric O +
neuronal O +
marker O +
protein B-Gene +
gene I-Gene +
product I-Gene +
9.5 I-Gene +
( O +
PGP9.5 B-Gene +
) O +
, O +
neural B-Gene +
nitric I-Gene +
oxide I-Gene +
synthase I-Gene +
( O +
nNOS B-Gene +
) O +
, O +
and O +
enteric O +
neural O +
transmitter O +
vasoactive B-Gene +
intestinal I-Gene +
polypeptide I-Gene +
( O +
VIP B-Gene +
) O +
were O +
detected O +
by O +
fluorescent O +
immunohistochemistry O +
. O +

Expression O +
levels O +
of O +
GDNF B-Gene +
and O +
NGF B-Gene +
mRNA O +
were O +
determined O +
by O +
RT O +
- O +
PCR O +
. O +

RESULTS O +
: O +

The O +
cultured O +
BMSC O +
were O +
CD90 B-Gene +
( O +
99.7 O +
% O +
) O +
positive O +
and O +
CD45 B-Gene +
negative O +
on O +
flow O +
cytometry O +
. O +

At O +
day O +
10 O +
of O +
induction O +
, O +
58.5 O +
+ O -
/- O +
10.8 O +
% O +
cells O +
adopted O +
neuron O +
- O +
like O +
morphological O +
changes O +
and O +
showed O +
expression O +
of O +
NSE B-Gene +
( O +
47.6 O +
+ O -
/- O +
7.5 O +
% O +
) O +
, O +
NF B-Gene +
( O +
75.6 O +
+ O -
/- O +
8.4 O +
% O +
) O +
, O +
GFAP B-Gene +
( O +
negative O +
) O +
, O +
PGP9.5 B-Gene +
( O +
57.7 O +
+ O -
/- O +
6.5 O +
% O +
) O +
, O +
nNOS B-Gene +
( O +
46.6 O +
+ O -
/- O +
5.4 O +
% O +
) O +
and O +
VIP B-Gene +
( O +
72.3 O +
+ O -
/- O +
6.7 O +
% O +
) O +
by O +
immunofluorescence O +
. O +

The O +
BMSC O +
expressed O +
low O +
levels O +
of O +
NGF B-Gene +
and O +
GDNF B-Gene +
mRNA O +
; O +
however O +
, O +
after O +
induction O +
of O +
GDNF B-Gene +
in O +
FGCM O +
, O +
the O +
expression O +
levels O +
of O +
NGF B-Gene +
and O +
GDNF B-Gene +
mRNA O +
were O +
significantly O +
increased O +
. O +

CONCLUSION O +
: O +

Bone O +
marrow O +
stromal O +
cells O +
have O +
the O +
potential O +
to O +
be O +
induced O +
to O +
differentiate O +
into O +
enteric O +
neurons O +
, O +
express O +
enteric O +
neural O +
transmitters O +
, O +
and O +
produce O +
more O +
NGF B-Gene +
and O +
GDNF B-Gene +
. O +

Therefore O +
, O +
BMSC O +
could O +
be O +
used O +
as O +
new O +
method O +
to O +
treat O +
gastrointestinal O +
motility O +
disorders O +
associated O +
with O +
enteric O +
neural O +
lesions O +
. O +

Evolutionary O +
history O +
of O +
the O +
Asr B-Gene +
gene I-Gene +
family I-Gene +
. O +

The O +
Asr B-Gene +
gene I-Gene +
family I-Gene +
is O +
widespread O +
in O +
higher O +
plants O +
. O +

Most O +
Asr B-Gene +
genes O +
are O +
up O +
- O +
regulated O +
under O +
different O +
environmental O +
stress O +
conditions O +
and O +
during O +
fruit O +
ripening O +
. O +

ASR B-Gene +
proteins O +
are O +
localized O +
in O +
the O +
nucleus O +
and O +
their O +
likely O +
function O +
is O +
transcriptional O +
regulation O +
. O +

In O +
cultivated O +
tomato O +
, O +
we O +
identified O +
a O +
novel O +
fourth O +
family O +
member O +
, O +
named O +
Asr4 B-Gene +
, O +
which O +
maps O +
close O +
to O +
its O +
sibling O +
genes O +
Asr1 B-Gene +
- O +
Asr2 B-Gene +
- O +
Asr3 B-Gene +
and O +
displays O +
an O +
unshared O +
region O +
coding O +
for O +
a O +
domain O +
containing O +
a O +
13 O +
- O +
amino O +
acid O +
repeat O +
. O +

In O +
this O +
work O +
we O +
were O +
able O +
to O +
expand O +
our O +
previous O +
analysis O +
for O +
Asr2 B-Gene +
and O +
investigated O +
the O +
coding O +
regions O +
of O +
the O +
four O +
known O +
Asr B-Gene +
paralogous O +
genes O +
in O +
seven O +
tomato O +
species O +
from O +
different O +
geographic O +
locations O +
. O +

In O +
addition O +
, O +
we O +
performed O +
a O +
phylogenetic O +
analysis O +
on O +
ASR B-Gene +
proteins O +
. O +

The O +
first O +
conclusion O +
drawn O +
from O +
this O +
work O +
is O +
that O +
tomato O +
ASR B-Gene +
proteins O +
cluster O +
together O +
in O +
the O +
tree O +
. O +

This O +
observation O +
can O +
be O +
explained O +
by O +
a O +
scenario O +
of O +
concerted O +
evolution O +
or O +
birth O +
and O +
death O +
of O +
genes O +
. O +

Secondly O +
, O +
our O +
study O +
showed O +
that O +
Asr1 B-Gene +
is O +
highly O +
conserved O +
at O +
both O +
replacement O +
and O +
synonymous O +
sites O +
within O +
the O +
genus O +
Lycopersicon O +
. O +

ASR1 B-Gene +
protein O +
sequence O +
conservation O +
might O +
be O +
associated O +
with O +
its O +
multiple O +
functions O +
in O +
different O +
tissues O +
while O +
the O +
low O +
rate O +
of O +
synonymous O +
substitutions O +
suggests O +
that O +
silent O +
variation O +
in O +
Asr1 B-Gene +
is O +
selectively O +
constrained O +
, O +
which O +
is O +
probably O +
related O +
to O +
its O +
high O +
expression O +
levels O +
. O +

Finally O +
, O +
we O +
found O +
that O +
Asr1 B-Gene +
activation O +
under O +
water O +
stress O +
is O +
not O +
conserved O +
between O +
Lycopersicon O +
species O +
. O +

The O +
role O +
of O +
Schizosaccharomyces O +
pombe O +
DNA O +
repair O +
enzymes O +
Apn1p B-Gene +
and O +
Uve1p B-Gene +
in O +
the O +
base O +
excision O +
repair O +
of O +
apurinic O +
/ O +
apyrimidinic O +
sites O +
. O +

In O +
Schizosaccharomyces O +
pombe O +
the O +
repair O +
of O +
apurinic O +
/ O +
apyrimidinic O +
( O +
AP O +
) O +
sites O +
is O +
mainly O +
initiated O +
by O +
AP B-Gene +
lyase I-Gene +
activity O +
of O +
DNA B-Gene +
glycosylase I-Gene +
Nth1p B-Gene +
. O +

In O +
contrast O +
, O +
the O +
major O +
AP B-Gene +
endonuclease I-Gene +
Apn2p B-Gene +
functions O +
by O +
removing O +
3'-alpha O -
, O -
beta O -
- O -
unsaturated O +
aldehyde O +
ends O +
induced O +
by O +
Nth1p B-Gene +
, O +
rather O +
than O +
by O +
incising O +
the O +
AP O +
sites O +
. O +

S. O +
pombe O +
possesses O +
other O +
minor O +
AP B-Gene +
endonuclease I-Gene +
activities O +
derived O +
from O +
Apn1p B-Gene +
and O +
Uve1p B-Gene +
. O +

In O +
this O +
study O +
, O +
we O +
investigated O +
the O +
function O +
of O +
these O +
two O +
enzymes O +
in O +
base O +
excision O +
repair O +
( O +
BER O +
) O +
for O +
methyl O +
methanesulfonate O +
( O +
MMS O +
) O +
damage O +
using O +
the O +
nth1 B-Gene +
and O +
apn2 B-Gene +
mutants O +
. O +

Deletion O +
of O +
apn1 B-Gene +
or O +
uve1 B-Gene +
from O +
nth1Delta B-Gene +
cells O +
did O +
not O +
affect O +
sensitivity O +
to O +
MMS O +
. O +

Exogenous O +
expression O +
of O +
Apn1p B-Gene +
failed O +
to O +
suppress O +
the O +
MMS O +
sensitivity O +
of O +
nth1Delta B-Gene +
cells O +
. O +

Although O +
Apn1p B-Gene +
and O +
Uve1p B-Gene +
incised O +
the O +
oligonucleotide O +
containing O +
an O +
AP O +
site O +
analogue O +
, O +
these O +
enzymes O +
could O +
not O +
initiate O +
repair O +
of O +
the O +
AP O +
sites O +
in O +
vivo O +
. O +

Despite O +
this O +
, O +
expression O +
of O +
Apn1p B-Gene +
partially O +
restored O +
the O +
MMS O +
sensitivity O +
of O +
apn2Delta B-Gene +
cells O +
, O +
indicating O +
that O +
the O +
enzyme O +
functions O +
as O +
a O +
3'-phosphodiesterase B-Gene +
to O +
remove O +
3 O -
' O +
- O +
blocked O +
ends O +
. O +

Localization O +
of O +
Apn1p B-Gene +
in O +
the O +
nucleus O +
and O +
cytoplasm O +
hints O +
at O +
an O +
additional O +
function O +
of O +
the O +
enzyme O +
other O +
than O +
nuclear O +
DNA O +
repair O +
. O +

Heterologous O +
expression O +
of O +
Saccharomyces O +
cerevisiae O +
homologue O +
of O +
Apn1p B-Gene +
completely O +
restored O +
the O +
MMS O +
resistance O +
of O +
the O +
nth1Delta B-Gene +
and O +
apn2Delta B-Gene +
cells O +
. O +

This O +
result O +
confirms O +
a O +
difference O +
in O +
the O +
major O +
pathway O +
for O +
processing O +
the O +
AP B-Gene +
site O +
between O +
S. O +
pombe O +
and O +
S. O +
cerevisiae O +
cells O +
. O +

Increased O +
expression O +
of O +
the O +
natural O +
killer O +
cell O +
inhibitory O +
receptor O +
CD94 B-Gene +
/ O +
NKG2A B-Gene +
and O +
CD158b B-Gene +
on O +
circulating O +
and O +
lesional O +
T O +
cells O +
in O +
patients O +
with O +
chronic O +
plaque O +
psoriasis O +
. O +

BACKGROUND O +
: O +

Psoriasis O +
is O +
a O +
common O +
inflammatory O +
cutaneous O +
disorder O +
characterized O +
by O +
activated O +
T O -
- O -
cell O +
infiltration O +
. O +

T O +
lymphocytes O +
bearing O +
natural O +
killer O +
cell O +
receptors O +
( O +
NKRs O +
) O +
have O +
been O +
suggested O +
to O +
play O +
an O +
important O +
role O +
in O +
the O +
pathogenesis O +
of O +
psoriasis O +
. O +

However O +
, O +
the O +
expression O +
pattern O +
of O +
activating O +
and O +
inhibitory O +
NKRs O +
on O +
T O +
lymphocytes O +
from O +
psoriatic O +
patients O +
and O +
its O +
significance O +
in O +
psoriasis O +
needs O +
further O +
study O +
. O +

OBJECTIVES O +
: O +

To O +
investigate O +
the O +
pathogenesis O +
of O +
NKR O +
- O +
expressing O +
T O +
cells O +
in O +
psoriasis O +
. O +

MATERIALS O +
AND O +
METHODS O +
: O +

Thirty O +
patients O +
with O +
chronic O +
plaque O +
psoriasis O +
and O +
20 O +
healthy O +
controls O +
were O +
enrolled O +
in O +
this O +
study O +
. O +

The O +
immunophenotypic O +
profiles O +
of O +
NKRs O +
, O +
including O +
CD56 B-Gene +
, O +
CD16 B-Gene +
( O +
activating O +
NKRs O +
) O +
, O +
CD158a B-Gene +
, O +
CD158b B-Gene +
, O +
CD94 B-Gene +
and O +
NKG2A B-Gene +
( O +
inhibitory O +
NKRs O +
) O +
, O +
were O +
analysed O +
in O +
peripheral O +
blood O +
T O +
lymphocytes O +
, O +
as O +
well O +
as O +
psoriatic O +
lesional O +
infiltrating O +
T O +
cells O +
, O +
by O +
triple O +
- O +
fluorescence O +
flow O +
cytometry O +
. O +

RESULTS O +
: O +

A O +
significant O +
increase O +
of O +
inhibitory O +
CD8 B-Gene +
+ O +
CD158b B-Gene +
+ O +
, O +
CD4 B-Gene +
CD8 B-Gene +
CD158b B-Gene +
+ O +
and O +
CD8 B-Gene +
+ O +
CD94 B-Gene +
/ O +
NKG2A B-Gene +
+ O +
T O +
cells O +
was O +
found O +
in O +
the O +
peripheral O +
blood O +
of O +
patients O +
with O +
psoriasis O +
when O +
compared O +
with O +
controls O +
. O +

Tissue O +
- O +
infiltrating O +
T O +
lymphocytes O +
expressing O +
inhibitory O +
receptors O +
CD158b B-Gene +
, O +
CD94 B-Gene +
and O +
NKG2A B-Gene +
were O +
found O +
in O +
psoriatic O +
lesions O +
. O +

There O +
was O +
a O +
significant O +
positive O +
correlation O +
between O +
the O +
increased O +
percentage O +
of O +
circulating O +
CD8 B-Gene +
+ O +
CD94 B-Gene +
/ O +
NKG2A B-Gene +
+ O +
T O +
cells O +
and O +
the O +
Psoriasis O +
Area O +
and O +
Severity O +
Index O +
. O +

CONCLUSIONS O +
: O +

In O +
the O +
present O +
study O +
, O +
we O +
demonstrated O +
increased O +
proportions O +
of O +
particular O +
subsets O +
of O +
inhibitory O +
CD158b B-Gene +
+ O +
and/or O +
CD94 B-Gene +
/ O +
NKG2A B-Gene +
+ O +
T O +
cells O +
in O +
patients O +
with O +
psoriasis O +
. O +

The O +
elevation O +
of O +
these O +
inhibitory O +
NKR O +
- O +
expressing O +
T O +
cells O +
was O +
correlated O +
with O +
disease O +
severity O +
, O +
which O +
may O +
signify O +
the O +
possibility O +
of O +
chronic O +
antigen O +
- O +
driven O +
stimulation O +
and O +
dysregulated O +
cytokine B-Gene +
production O +
in O +
the O +
pathogenesis O +
of O +
psoriasis O +
. O +

The O +
influence O +
of O +
kainic O +
acid O +
on O +
core O +
temperature O +
and O +
cytokine B-Gene +
levels O +
in O +
the O +
brain O +
. O +

Excitotoxic O +
brain O +
injury O +
is O +
associated O +
with O +
hyperthermia O +
, O +
and O +
there O +
are O +
data O +
showing O +
beneficial O +
effects O +
of O +
hypothermia O +
on O +
neurodegeneration O +
and O +
that O +
hyperthermia O +
facilitates O +
the O +
neurodegeneration O +
. O +

Cytokines B-Gene +
are O +
inflammatory O +
proteins O +
that O +
seem O +
to O +
be O +
involved O +
in O +
the O +
neuroinflammation O +
associated O +
with O +
epilepsy O +
. O +

Core O +
temperature O +
changes O +
caused O +
by O +
the O +
epileptogenic O +
glutamate O +
analogue O +
kainic O +
acid O +
( O +
KA O +
) O +
were O +
investigated O +
in O +
relation O +
to O +
changes O +
in O +
levels O +
of O +
the O +
pro O +
- O +
inflammatory O +
cytokines B-Gene +
interleukin-1beta B-Gene +
( O +
IL-1beta B-Gene +
) O +
and O +
interleukin-6 B-Gene +
( O +
IL-6 B-Gene +
) O +
, O +
and O +
the O +
endogenous O +
interleukin-1 B-Gene +
receptor I-Gene +
antagonist I-Gene +
( O +
IL-1ra B-Gene +
) O +
. O +

The O +
temperature O +
was O +
measured O +
every O +
10 O +
min O +
during O +
the O +
first O +
hour O +
, O +
and O +
at O +
90 O +
and O +
120 O +
min O +
, O +
and O +
hourly O +
until O +
8 O +
h O +
after O +
KA O +
- O +
injection O +
( O +
10 O +
mg O +
/ O +
kg O +
) O +
. O +

The O +
cytokines B-Gene +
were O +
measured O +
in O +
the O +
hypothalamus O +
, O +
a O +
site O +
of O +
temperature O +
regulation O +
, O +
and O +
in O +
hippocampus O +
, O +
cerebellum O +
, O +
and O +
frontal O +
cortex O +
. O +

KA O +
induced O +
a O +
brief O +
hypothermia O +
followed O +
by O +
hyperthermia O +
. O +

IL-1beta B-Gene +
levels O +
were O +
increased O +
after O +
KA O +
- O +
administration O +
in O +
all O +
brain O +
regions O +
examined O +
and O +
, O +
excepting O +
hippocampus O +
, O +
returned O +
to O +
baseline O +
levels O +
at O +
24 O +
h O +
. O +

The O +
hippocampal O +
IL-1ra B-Gene +
levels O +
were O +
significantly O +
increased O +
at O +
24 O +
h O +
, O +
whereas O +
no O +
changes O +
in O +
IL-6 B-Gene +
levels O +
were O +
observed O +
. O +

The O +
changes O +
in O +
IL-1beta B-Gene +
levels O +
and O +
in O +
ratios O +
between O +
the O +
levels O +
of O +
the O +
three O +
cytokines B-Gene +
, O +
may O +
account O +
for O +
some O +
of O +
the O +
temperature O +
changes O +
and O +
the O +
behavioural O +
manifestations O +
induced O +
by O +
KA O +
. O +

Convergence O +
of O +
genes O +
implicated O +
in O +
Alzheimer O +
's O +
disease O +
on O +
the O +
cerebral O +
cholesterol O +
shuttle O +
: O +
APP B-Gene +
, O +
cholesterol O +
, O +
lipoproteins O +
, O +
and O +
atherosclerosis O +
. O +

Polymorphic O +
genes O +
associated O +
with O +
Alzheimer O +
's O +
disease O +
( O +
see O +
) O +
delineate O +
a O +
clearly O +
defined O +
pathway O +
related O +
to O +
cerebral O +
and O +
peripheral O +
cholesterol O +
and O +
lipoprotein O +
homoeostasis O +
. O +

They O +
include O +
all O +
of O +
the O +
key O +
components O +
of O +
a O +
glia O +
/ O +
neurone O +
cholesterol O +
shuttle O +
including O +
cholesterol O +
binding O +
lipoproteins O +
APOA1 B-Gene +
, O +
APOA4 B-Gene +
, O +
APOC1 B-Gene +
, O +
APOC2 B-Gene +
, O +
APOC3 B-Gene +
, O +
APOD B-Gene +
, O +
APOE B-Gene +
and O +
LPA B-Gene +
, O +
cholesterol O +
transporters O +
ABCA1 B-Gene +
, O +
ABCA2 B-Gene +
, O +
lipoprotein B-Gene +
receptors I-Gene +
LDLR B-Gene +
, O +
LRP1 B-Gene +
, O +
LRP8 B-Gene +
and O +
VLDLR B-Gene +
, O +
and O +
the O +
cholesterol O +
metabolising O +
enzymes O +
CYP46A1 B-Gene +
and O +
CH25H B-Gene +
, O +
whose O +
oxysterol O +
products O +
activate O +
the O +
liver B-Gene +
X I-Gene +
receptor I-Gene +
NR1H2 B-Gene +
and O +
are O +
metabolised O +
to O +
esters O +
by O +
SOAT1 B-Gene +
. O +

LIPA B-Gene +
metabolises O +
cholesterol O +
esters O +
, O +
which O +
are O +
transported O +
by O +
the O +
cholesteryl B-Gene +
ester I-Gene +
transport I-Gene +
protein I-Gene +
CETP B-Gene +
. O +

The O +
transcription B-Gene +
factor I-Gene +
SREBF1 B-Gene +
controls O +
the O +
expression O +
of O +
most O +
enzymes O +
of O +
cholesterol O +
synthesis O +
. O +

APP B-Gene +
is O +
involved O +
in O +
this O +
shuttle O +
as O +
it O +
metabolises O +
cholesterol O +
to O +
7-betahydroxycholesterol O +
, O +
a O +
substrate O +
of O +
SOAT1 B-Gene +
and O +
HSD11B1 B-Gene +
, O +
binds O +
to O +
APOE B-Gene +
and O +
is O +
tethered O +
to O +
LRP1 B-Gene +
via O +
APPB1 B-Gene +
, O +
APBB2 B-Gene +
and O +
APBB3 B-Gene +
at O +
the O +
cytoplasmic O +
domain O +
and O +
via O +
LRPAP1 B-Gene +
at O +
the O +
extracellular O +
domain O +
. O +

APP B-Gene +
cleavage O +
products O +
are O +
also O +
able O +
to O +
prevent O +
cholesterol O +
binding O +
to O +
APOE B-Gene +
. O +

BACE B-Gene +
cleaves O +
both O +
APP B-Gene +
and O +
LRP1 B-Gene +
. O +

Gamma B-Gene +
- I-Gene +
secretase I-Gene +
( O +
PSEN1 B-Gene +
, O +
PSEN2 B-Gene +
, O +
NCSTN B-Gene +
) O +
cleaves O +
LRP1 B-Gene +
and O +
LRP8 B-Gene +
as O +
well O +
as O +
APP B-Gene +
and O +
their O +
degradation O +
products O +
control O +
transcription B-Gene +
factor I-Gene +
TFCP2 B-Gene +
, O +
which O +
regulates O +
thymidylate B-Gene +
synthase I-Gene +
( O +
TS B-Gene +
) O +
and O +
GSK3B B-Gene +
expression O +
. O +

GSK3B B-Gene +
is O +
known O +
to O +
phosphorylate O +
the O +
microtubule B-Gene +
protein I-Gene +
tau I-Gene +
( O +
MAPT B-Gene +
) O +
. O +

Dysfunction O +
of O +
this O +
cascade O +
, O +
carved O +
out O +
by O +
genes O +
implicated O +
in O +
Alzheimer O +
's O +
disease O +
, O +
may O +
play O +
a O +
major O +
role O +
in O +
its O +
pathology O +
. O +

Many O +
other O +
genes O +
associated O +
with O +
Alzheimer O +
's O +
disease O +
affect O +
cholesterol O +
or O +
lipoprotein O +
function O +
and/or O +
have O +
also O +
been O +
implicated O +
in O +
atherosclerosis O +
, O +
a O +
feature O +
of O +
Alzheimer O +
's O +
disease O +
, O +
and O +
this O +
duality O +
may O +
well O +
explain O +
the O +
close O +
links O +
between O +
vascular O +
and O +
cerebral O +
pathology O +
in O +
Alzheimer O +
's O +
disease O +
. O +

The O +
definition O +
of O +
many O +
of O +
these O +
genes O +
as O +
risk O +
factors O +
is O +
highly O +
contested O +
. O +

However O +
, O +
when O +
polymorphic O +
susceptibility O +
genes O +
belong O +
to O +
the O +
same O +
signaling O +
pathway O +
, O +
the O +
risk O +
associated O +
with O +
multigenic O +
disease O +
is O +
better O +
related O +
to O +
the O +
integrated O +
effects O +
of O +
multiple O +
polymorphisms O +
of O +
genes O +
within O +
the O +
same O +
pathway O +
than O +
to O +
variants O +
in O +
any O +
single O +
gene O +
[ O +
Wu O +
, O +
X. O +
, O +
Gu O +
, O +
J. O +
, O +
Grossman O +
, O +
H.B. O +
, O +
Amos O +
, O +
C.I. O +
, O +
Etzel O +
, O +
C. O +
, O +
Huang O +
, O +
M. O +
, O +
Zhang O +
, O +
Q. O +
, O +
Millikan O +
, O +
R.E. O +
, O +
Lerner O +
, O +
S. O +
, O +
Dinney O +
, O +
C.P. O +
, O +
Spitz O +
, O +
M.R. O +
, O +
2006 O -
. O +
Bladder O +
cancer O +
predisposition O +
: O +
a O +
multigenic O +
approach O +
to O +
DNA O +
- O +
repair O +
and O +
cell O +
- O +
cycle O +
- O +
control O +
genes O -
. O +
Am O -
. O +
J. O +
Hum O -
. O +
Genet O -
. O +
78 O +
, O +
464 O +
- O +
479 O -
. O +
] O +
. O +

Thus O +
, O +
the O +
fact O +
that O +
Alzheimer O +
's O +
disease O +
susceptibility O +
genes O +
converge O +
on O +
a O +
clearly O +
defined O +
signaling O +
network O +
has O +
important O +
implications O +
for O +
genetic O +
association O +
studies O +
. O +

IL-18 B-Gene +
expression O +
in O +
pigs O +
following O +
infection O +
with O +
Mycoplasma O +
hyopneumoniae O +
. O +

Little O +
is O +
known O +
about O +
the O +
detail O +
of O +
the O +
immune O +
response O +
during O +
infection O +
of O +
pigs O +
with O +
Mycoplasma O +
hyopneumoniae O +
( O +
Mhp O +
) O +
. O +

To O +
further O +
understand O +
this O +
important O +
porcine O +
pathogen O +
, O +
we O +
examined O +
the O +
interleukin-18 B-Gene +
( O +
IL B-Gene +
- I-Gene +
18 I-Gene +
) O +
response O +
in O +
experimentally O +
infected O +
piglets O +
. O +

We O +
found O +
that O +
large O +
amounts O +
of O +
IL-18 B-Gene +
were O +
produced O +
in O +
the O +
bronchoalveolar O +
lavage O +
fluids O +
( O +
BALF O +
) O +
of O +
pigs O +
experimentally O +
infected O +
with O +
Mhp O +
. O +

However O +
, O +
the O +
concentration O +
of O +
interferon B-Gene -
- I-Gene -
gamma I-Gene +
( O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
) O +
in O +
the O +
same O +
BALF O +
was O +
negatively O +
correlated O +
with O +
that O +
of O +
IL-18 B-Gene +
. O +

The O +
antibody O +
response O +
against O +
Mhp O +
was O +
found O +
to O +
be O +
associated O +
with O +
the O +
IL-18 B-Gene +
concentration O +
in O +
the O +
BALF O +
. O +

Immunohistochemical O +
staining O +
revealed O +
that O +
both O +
IL-18 B-Gene +
and O +
IL-18 B-Gene +
receptor I-Gene +
alpha I-Gene +
chain I-Gene +
( O +
IL-18Ralpha B-Gene +
) O +
were O +
present O +
in O +
macrophages O +
and O +
plasma O +
cells O +
in O +
the O +
lungs O +
of O +
Mhp O +
- O +
infected O +
pigs O +
. O +

Lung O +
mononuclear O +
cells O +
isolated O +
from O +
pneumonic O +
lesions O +
secreted O +
IL-18 B-Gene +
and O +
prostaglandin O +
E O -
( O -
2 O -
) O +
( O +
PGE O -
( O -
2 O -
) O +
) O +
in O +
vitro O +
, O +
and O +
PGE O -
( O -
2 O -
) O +
production O +
was O +
enhanced O +
by O +
stimulation O +
with O +
IL-18 B-Gene +
. O +

These O +
results O +
indicate O +
that O +
IL-18 B-Gene +
produced O +
in O +
the O +
pig O +
lung O +
contributes O +
to O +
the O +
development O +
of O +
innate O +
and O +
acquired O +
immune O +
responses O +
against O +
Mhp O +
as O +
a O +
proinflammatory O +
cytokine B-Gene +
rather O +
than O +
as O +
an O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
- I-Gene +
inducing I-Gene +
factor I-Gene +
and O +
may O +
be O +
involved O +
in O +
immunomodulation O +
in O +
pigs O +
. O +

Identification O +
of O +
human O +
hepatic B-Gene +
stimulator I-Gene +
substance I-Gene +
gene O +
promoter O +
and O +
demonstration O +
of O +
dual O +
regulation O +
of O +
AP1 B-Gene +
/ O +
AP4 B-Gene +
cis O +
- O +
acting O +
element O +
in O +
different O +
cell O +
lines O +
. O +

Human O +
hepatic B-Gene +
stimulator I-Gene +
substance I-Gene +
( O +
hHSS B-Gene +
) O +
is O +
a O +
newly O +
identified O +
growth B-Gene +
- I-Gene +
promoting I-Gene +
factor I-Gene +
in O +
the O +
liver O +
. O +

HSS B-Gene +
is O +
capable O +
of O +
stimulating O +
hepatic O +
regeneration O +
in O +
partial O +
hepatectomized O +
rats O +
, O +
thus O +
, O +
promoting O +
growth O +
of O +
hepatic O +
tumor O +
cells O +
. O +

To O +
understand O +
and O +
elucidate O +
the O +
transcriptional O +
regulation O +
of O +
hHSS B-Gene +
gene O +
, O +
the O +
4890bp O +
of O +
5 O -
' O +
- O +
flanking O +
region O +
of O +
the O +
gene O +
have O +
been O +
isolated O +
and O +
sequenced O +
. O +

The O +
transcriptional O +
start O +
site O +
, O +
located O +
at O +
248nt O +
upstream O +
from O +
the O +
ATG O +
starting O +
codon O +
, O +
was O +
identified O +
by O +
5'-rapid O +
amplification O +
cDNA O +
end O +
( O +
5'-RACE O +
) O +
. O +

The O +
classical O +
promoter O +
sequences O +
, O +
such O +
as O +
TATA O +
box O +
or O +
GAATT O +
were O +
not O +
identified O +
in O +
the O +
promoter O +
region O +
, O +
instead O +
a O +
GC O +
- O +
rich O +
segment O +
was O +
formed O +
( O +
> O +
70 O +
% O +
) O +
by O +
expanding O +
to O +
a O +
longer O +
than O +
400bp O +
, O +
and O +
immediately O +
upstream O +
from O +
the O +
ATG O +
start O +
codon O +
. O +

The O +
transient O +
transfection O +
assays O +
, O +
using O +
promoter O +
deletion O +
constructs O +
, O +
showed O +
that O +
hHSS B-Gene +
promoter O +
was O +
efficiently O +
capable O +
in O +
driving O +
the O +
reporter O +
expression O +
not O +
only O +
in O +
HepG2 O +
cells O +
, O +
but O +
also O +
in O +
Cos7 O +
cells O +
. O +

A O +
region O +
spanning O +
nucleotides O +
in O +
the O +
range O +
of O +
- O +
447 O +
to O +
- O +
358bp O +
revealed O +
a O +
negative O +
regulation O +
on O +
promoter O +
activity O +
in O +
HepG2 O +
cells O +
, O +
but O +
with O +
positive O +
regulation O +
in O +
Cos7 O +
and O +
Hela O +
cells O +
. O +

The O +
promoter O +
activity O +
was O +
obviously O +
influenced O +
by O +
AP1 B-Gene +
/ O +
AP4 B-Gene +
( O +
- O +
375 O +
/ O +
- O +
369nt O +
) O +
mutation O +
in O +
these O +
three O +
cell O +
lines O +
. O +

EMSAs O +
showed O +
that O +
the O +
site O +
was O +
recognized O +
by O +
AP1 B-Gene +
in O +
HepG2 O +
cell O +
, O +
and O +
only O +
by O +
an O +
AP4 B-Gene +
protein O +
in O +
Cos7 O +
cells O +
. O +

The O +
c B-Gene -
- I-Gene -
Jun I-Gene +
bound O +
to O +
the O +
promoter O +
was O +
further O +
verified O +
by O +
supershift O +
in O +
HepG2 O +
cells O +
and O +
human O +
liver O +
tissue O +
. O +

Chromatin O +
immuno O +
- O +
precipitation O +
( O +
ChIP O +
) O +
demonstrated O +
that O +
there O +
was O +
a O +
direct O +
association O +
of O +
c B-Gene -
- I-Gene -
Jun I-Gene +
with O +
hHSS B-Gene +
promoter O +
in O +
HepG2 O +
cells O +
. O +

The O +
c B-Gene -
- I-Gene -
Jun I-Gene +
strongly O +
suppressed O +
hHSS B-Gene +
promoter O +
activity O +
in O +
transient O +
expression O +
analyses O +
in O +
HepG2 O +
cells O +
. O +

Mutations O +
in O +
the O +
AP1 B-Gene +
binding O +
sites O +
rescued O +
suppression O +
caused O +
by O +
c B-Gene -
- I-Gene -
Jun I-Gene +
, O +
suggesting O +
this O +
was O +
a O +
direct O +
regulation O +
of O +
the O +
hHSS B-Gene +
promoter O +
. O +

In O +
contrast O +
, O +
there O +
was O +
no O +
significant O +
effect O +
in O +
c B-Gene -
- I-Gene -
Jun I-Gene +
over O +
- O +
expressed O +
Cos7 O +
and O +
Hela O +
cells O +
. O +

The O +
tissue O +
- O +
specific O +
function O +
of O +
c B-Gene -
- I-Gene -
Jun I-Gene +
in O +
hHSS B-Gene +
promoter O +
activity O +
may O +
in O +
part O +
help O +
explain O +
the O +
differences O +
in O +
biology O +
function O +
of O +
hHSS B-Gene +
between O +
liver O +
and O +
non O +
- O +
liver O +
cells O +
. O +

Structure O +
of O +
a O +
human O +
ASF1a B-Gene +
- O +
HIRA B-Gene +
complex O +
and O +
insights O +
into O +
specificity O +
of O +
histone B-Gene +
chaperone I-Gene +
complex I-Gene +
assembly O +
. O +

Human O +
HIRA B-Gene +
, O +
ASF1a B-Gene +
, O +
ASF1b B-Gene +
and O +
CAF-1 B-Gene +
are O +
evolutionally O +
conserved O +
histone B-Gene +
chaperones I-Gene +
that O +
form O +
multiple O +
functionally O +
distinct O +
chromatin B-Gene +
- I-Gene +
assembly I-Gene +
complexes I-Gene +
, O +
with O +
roles O +
linked O +
to O +
diverse O +
nuclear O +
process O +
, O +
such O +
as O +
DNA O +
replication O +
and O +
formation O +
of O +
heterochromatin O +
in O +
senescent O +
cells O +
. O +

We O +
report O +
the O +
crystal O +
structure O +
of O +
an O +
ASF1a B-Gene +
- O +
HIRA B-Gene +
heterodimer O +
and O +
a O +
biochemical O +
dissection O +
of O +
ASF1a B-Gene +
's O +
mutually O +
exclusive O +
interactions O +
with O +
HIRA B-Gene +
and O +
the O +
p60 B-Gene +
subunit I-Gene +
of I-Gene +
CAF-1 I-Gene +
. O +

The O +
HIRA B-Gene +
B O +
domain O +
forms O +
an O +
antiparallel O +
beta O -
- O -
hairpin O +
that O +
binds O +
perpendicular O +
to O +
the O +
strands O +
of O +
the O +
beta O -
- O -
sandwich O +
of O +
ASF1a B-Gene +
, O +
via O +
beta O -
- O -
sheet O +
, O +
salt O +
bridge O +
and O +
van O +
der O +
Waals O +
contacts O +
. O +

The O +
N O +
- O +
and O +
C O +
- O +
terminal O +
regions O +
of O +
ASF1a B-Gene +
and O +
ASF1b B-Gene +
determine O +
the O +
different O +
affinities O +
of O +
these O +
two O +
proteins O +
for O +
HIRA B-Gene +
, O +
by O +
contacting O +
regions O +
outside O +
the O +
HIRA B-Gene +
B O +
domain O +
. O +

CAF-1 B-Gene +
p60 I-Gene +
also O +
uses O +
B O +
domain O +
- O +
like O +
motifs O +
for O +
binding O +
to O +
ASF1a B-Gene +
, O +
thereby O +
competing O +
with O +
HIRA B-Gene +
. O +

Together O +
, O +
these O +
studies O +
begin O +
to O +
define O +
the O +
molecular O +
determinants O +
of O +
assembly O +
of O +
functionally O +
diverse O +
macromolecular O +
histone B-Gene +
chaperone I-Gene +
complexes I-Gene +
. O +

Role O +
of O +
cytokines B-Gene +
in O +
inflammatory O +
process O +
in O +
Parkinson O +
's O +
disease O +
. O +

We O +
investigated O +
whether O +
the O +
cytokines B-Gene +
produced O +
in O +
activated O +
microglia O +
in O +
the O +
substantia O +
nigra O +
( O +
SN O +
) O +
and O +
putamen O +
in O +
sporadic O +
Parkinson O +
' O +
s O +
disease O +
( O +
PD O +
) O +
are O +
neuroprotective O +
or O +
neurotoxic O +
. O +

In O +
autopsy O +
brains O +
of O +
PD O +
, O +
the O +
number O +
of O +
MHC B-Gene +
class I-Gene +
II I-Gene +
( O +
CR3 O +
/ O +
43 O +
) O +
- O +
positive O +
activated O +
microglia O +
, O +
which O +
were O +
also O +
ICAM-1 B-Gene +
( O +
CD B-Gene +
54 I-Gene +
) O +
- O +
, O +
LFA-1 B-Gene +
( O +
CD B-Gene +
11a I-Gene +
) O +
- O +
, O +
TNF B-Gene +
- I-Gene +
alpha I-Gene +
- O +
, O +
and O +
IL-6 B-Gene +
- O +
positive O +
, O +
increased O +
in O +
the O +
SN O +
and O +
putamen O +
during O +
progress O +
of O +
PD O +
. O +

At O +
the O +
early O +
stage O +
activated O +
microglia O +
were O +
mainly O +
associated O +
with O +
tyrosine B-Gene +
hydroxylase I-Gene +
( O +
TH B-Gene +
) O +
- O +
positive O +
neurites O +
in O +
the O +
putamen O +
, O +
and O +
at O +
the O +
advanced O +
stage O +
with O +
damaged O +
TH B-Gene +
- O +
positive O +
neurons O +
in O +
the O +
SN O +
. O +

The O +
activated O +
microglia O +
in O +
PD O +
were O +
observed O +
not O +
only O +
in O +
the O +
nigro O +
- O +
striatal O +
region O +
, O +
but O +
also O +
in O +
various O +
brain O +
regions O +
such O +
as O +
the O +
hippocampus O +
and O +
cerebral O +
cortex O +
. O +

We O +
examined O +
the O +
distribution O +
of O +
activated O +
microglia O +
and O +
the O +
expression O +
of O +
cytokines B-Gene +
and O +
neurotrophins B-Gene +
in O +
the O +
hippocampus O +
of O +
PD O +
and O +
Lewy O +
body O +
disease O +
( O +
LBD O +
) O +
. O +

The O +
levels O +
of O +
IL-6 B-Gene +
and O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
mRNAs O +
increased O +
both O +
in O +
PD O +
and O +
LBD O +
, O +
but O +
those O +
of O +
BDNF B-Gene +
mRNA O +
and O +
protein O +
drastically O +
decreased O +
specifically O +
in O +
LBD O +
, O +
in O +
which O +
neuronal O +
loss O +
was O +
observed O +
not O +
only O +
in O +
the O +
nigro O +
- O +
striatum O +
but O +
also O +
in O +
the O +
hippocampus O +
. O +

The O +
results O +
suggest O +
activated O +
microglia O +
in O +
the O +
hippocampus O +
to O +
be O +
probably O +
neuroprotective O +
in O +
PD O +
, O +
but O +
those O +
to O +
be O +
neurotoxic O +
in O +
LBD O +
. O +

As O +
an O +
evidence O +
supporting O +
this O +
hypothesis O +
, O +
two O +
subsets O +
of O +
microglia O +
were O +
isolated O +
from O +
mouse O +
brain O +
by O +
cell O +
sorting O +
: O +
one O +
subset O +
with O +
high O +
production O +
of O +
reactive O +
oxygen O +
species O +
( O +
ROS O +
) O +
and O +
the O +
other O +
with O +
no O +
production O +
of O +
ROS O +
. O +

When O +
co O +
- O +
cultured O +
with O +
neuronal O +
cells O +
, O +
one O +
microglia O +
clone O +
with O +
high O +
ROS O +
production O +
was O +
neurotoxic O +
, O +
but O +
another O +
clone O +
with O +
no O +
ROS O +
production O +
neuroprotective O +
. O +

On O +
the O +
other O +
hand O +
, O +
Sawada O +
with O +
coworkers O +
found O +
that O +
a O +
neuroprotective O +
microglial O +
clone O +
in O +
a O +
culture O +
experiment O +
converted O +
to O +
a O +
toxic O +
microglial O +
clone O +
by O +
transduction O +
of O +
the O +
HIV-1 O +
Nef B-Gene +
protein O +
with O +
increasing O +
NADPH B-Gene +
oxidase I-Gene +
activity O +
. O +

Taken O +
together O +
, O +
all O +
these O +
results O +
suggest O +
that O +
activated O +
microglia O +
may O +
change O +
in O +
vivo O +
from O +
neuroprotective O +
to O +
neurotoxic O +
subtsets O +
as O +
degeneration O +
of O +
dopamine O +
neurons O +
in O +
the O +
SN O +
progresses O +
in O +
PD O +
. O +

We O +
conclude O +
that O +
the O +
cytokines B-Gene +
from O +
activated O +
microglia O +
in O +
the O +
SN O +
and O +
putamen O +
may O +
be O +
initially O +
neuroprotective O +
, O +
but O +
may O +
later O +
become O +
neurotoxic O +
during O +
the O +
progress O +
of O +
PD O +
. O +

Toxic O +
change O +
of O +
activated O +
microglia O +
may O +
also O +
occur O +
in O +
Alzheimer O +
's O +
disease O +
and O +
other O +
neurodegenerative O +
diseases O +
in O +
which O +
inflammatory O +
process O +
is O +
found O +
. O +

Metallothionein B-Gene -
- I-Gene -
I I-Gene +
and I-Gene +
- I-Gene +
III I-Gene +
expression O +
in O +
animal O +
models O +
of O +
Alzheimer O +
disease O +
. O +

Previous O +
studies O +
have O +
described O +
altered O +
expression O +
of O +
metallothioneins B-Gene +
( O +
MTs B-Gene +
) O +
in O +
neurodegenerative O +
diseases O +
like O +
multiple O +
sclerosis O +
( O +
MS O +
) O +
, O +
Down O +
syndrome O +
, O +
and O +
Alzheimer O +
' O +
s O +
disease O +
( O +
AD O +
) O +
. O +

In O +
order O +
to O +
gain O +
insight O +
into O +
the O +
possible O +
role O +
of O +
MTs B-Gene +
in O +
neurodegenerative O +
processes O +
and O +
especially O +
in O +
human O +
diseases O +
, O +
the O +
use O +
of O +
animal O +
models O +
is O +
a O +
valuable O +
tool O +
. O +

Several O +
transgenic O +
mouse O +
models O +
of O +
AD O +
amyloid O +
deposits O +
are O +
currently O +
available O +
. O +

These O +
models O +
express O +
human O +
beta B-Gene -
- I-Gene -
amyloid I-Gene +
precursor I-Gene +
protein I-Gene +
( O +
AbetaPP B-Gene +
) O +
carrying O +
different O +
mutations O +
that O +
subsequently O +
result O +
in O +
a O +
varied O +
pattern O +
of O +
beta O +
- O +
amyloid O +
( O +
Abeta O +
) O +
deposition O +
within O +
the O +
brain O +
. O +

We O +
have O +
evaluated O +
the O +
expression O +
of O +
MT B-Gene -
- I-Gene -
I I-Gene +
and O +
MT B-Gene -
- I-Gene -
III I-Gene +
mRNA O +
by O +
in O +
situ O +
hybridization O +
in O +
three O +
different O +
transgenic O +
mice O +
models O +
of O +
AD O +
: O +
Tg2576 O +
( O +
carrying O +
AbetaPP B-Gene +
harboring O +
the O +
Swedish O +
K670N O +
/ O +
M671L O +
mutations O +
) O +
, O +
TgCRND8 O +
( O +
Swedish O +
and O +
the O +
Indiana O +
V717F O +
mutations O +
) O +
, O +
and O +
Tg O -
- O -
SwDI O +
( O +
Swedish O +
and O +
Dutch O +
/ O +
Iowa O +
E693Q O +
/ O +
D694N O +
mutations O +
) O +
. O +

MT B-Gene -
- I-Gene -
I I-Gene +
mRNA O +
levels O +
were O +
induced O +
in O +
all O +
transgenic O +
lines O +
studied O +
, O +
although O +
the O +
pattern O +
of O +
induction O +
differed O +
between O +
the O +
models O +
. O +

In O +
the O +
Tg2576 O +
mice O +
MT B-Gene -
- I-Gene -
I I-Gene +
was O +
weakly O +
upregulated O +
in O +
cells O +
surrounding O +
Congo O +
Red O +
- O +
positive O +
plaques O +
in O +
the O +
cortex O +
and O +
hippocampus O +
. O +

A O +
more O +
potent O +
induction O +
of O +
MT B-Gene -
- I-Gene -
I I-Gene +
was O +
observed O +
in O +
the O +
cortex O +
and O +
hippocampus O +
of O +
the O +
TgCRND8 O +
mice O +
, O +
likely O +
reflecting O +
their O +
higher O +
amyloid O +
plaques O +
content O +
. O +

MT B-Gene -
- I-Gene -
I I-Gene +
upregulation O +
was O +
also O +
more O +
significant O +
in O +
Tg O +
- O +
SwDI O +
mice O +
, O +
especially O +
in O +
the O +
subiculum O +
and O +
hippocampus O +
CA1 O +
area O +
. O +

Immunofluorescence O +
stainings O +
demonstrate O +
that O +
astrocytes O +
and O +
microglia O +
/ O +
macrophages O +
surrounding O +
the O +
plaques O +
express O +
MT B-Gene -
- I-Gene -
I&II I-Gene +
. O +

In O +
general O +
, O +
MT B-Gene -
- I-Gene -
I I-Gene +
regulation O +
follows O +
a O +
similar O +
but O +
less O +
potent O +
response O +
than O +
glial B-Gene +
fibrillary I-Gene +
acidic I-Gene +
protein I-Gene +
( O +
GFAP B-Gene +
) O +
expression O +
. O +

In O +
contrast O +
to O +
MT B-Gene -
- I-Gene -
I I-Gene +
, O +
MT B-Gene -
- I-Gene -
III I-Gene +
mRNA O +
expression O +
was O +
not O +
significantly O +
altered O +
in O +
any O +
of O +
the O +
models O +
examined O +
suggesting O +
that O +
the O +
various O +
MT B-Gene +
isoforms O +
may O +
have O +
different O +
roles O +
in O +
these O +
experimental O +
systems O +
, O +
and O +
perhaps O +
also O +
in O +
human O +
AD O +
. O +

LexA B-Gene +
represses O +
CTXphi O +
transcription O +
by O +
blocking O +
access O +
of O +
the O +
alpha O +
C O +
- O +
terminal O +
domain O +
of O +
RNA B-Gene +
polymerase I-Gene +
to O +
promoter O +
DNA O +
. O +

CTXPhi O +
is O +
a O +
Vibrio O +
cholerae O +
- O +
specific O +
temperate O +
filamentous O +
phage O +
that O +
encodes O +
cholera B-Gene +
toxin I-Gene +
. O +

CTXPhi O +
lysogens O +
can O +
be O +
induced O +
with O +
DNA O +
damage O +
- O +
inducing O +
agents O +
such O +
as O +
UV O +
light O +
, O +
leading O +
to O +
the O +
release O +
of O +
CTXPhi O +
virions O +
and O +
the O +
rapid O +
dissemination O +
of O +
cholera B-Gene +
toxin I-Gene +
genes O +
to O +
new O +
V. O +
cholerae O +
hosts O +
. O +

This O +
environmental O +
regulation O +
is O +
directly O +
mediated O +
by O +
LexA B-Gene +
, O +
the O +
host O +
- O +
encoded O +
global O +
SOS O +
transcription B-Gene +
factor I-Gene +
. O +

LexA B-Gene +
and O +
a O +
phage O +
- O +
encoded O +
repressor O +
, O +
RstR B-Gene +
, O +
both O +
repress O +
transcription O +
from O +
P O +
( O +
rstA B-Gene +
) O +
, O +
the O +
primary O +
CTXPhi O +
promoter O +
. O +

Because O +
the O +
LexA B-Gene +
binding O +
site O +
is O +
located O +
upstream O +
of O +
the O +
core O +
P O +
( O +
rstA B-Gene +
) O +
promoter O +
and O +
overlaps O +
with O +
A O +
- O +
tract O +
sequences O +
, O +
we O +
speculated O +
that O +
LexA B-Gene +
represses O +
P O +
( O +
rstA B-Gene +
) O +
by O +
occluding O +
a O +
promoter O +
UP O +
element O +
, O +
a O +
binding O +
site O +
for O +
the O +
C O +
- O +
terminal O +
domain O +
of O +
the O +
alpha B-Gene +
subunit I-Gene +
of I-Gene +
RNA I-Gene +
polymerase I-Gene +
( O +
RNAP B-Gene +
) O +
( O +
alphaCTD O +
) O +
. O +

Using O +
in O +
vitro O +
transcription O +
assays O +
, O +
we O +
have O +
shown O +
that O +
the O +
LexA B-Gene +
binding O +
site O +
stimulates O +
maximal O +
rstA B-Gene +
transcription O +
in O +
the O +
absence O +
of O +
any O +
added O +
factors O +
. O +

The O +
alphaCTD O +
of O +
RNAP B-Gene +
is O +
required O +
for O +
this O +
stimulation O +
, O +
demonstrating O +
that O +
the O +
LexA B-Gene +
site O +
contains O +
, O +
or O +
overlaps O +
with O +
, O +
a O +
promoter O +
UP O +
element O +
. O +

LexA B-Gene +
represses O +
rstA B-Gene +
transcription O +
by O +
normal O +
RNAP B-Gene +
but O +
fails O +
to O +
repress O +
rstA B-Gene +
transcription O +
catalyzed O +
by O +
RNAP B-Gene +
lacking O +
the O +
alphaCTD O +
. O +

DNase B-Gene +
I I-Gene +
footprint O +
analysis O +
mapped O +
the O +
alphaCTD O +
binding O +
site O +
to O +
the O +
upstream O +
promoter O +
region O +
that O +
includes O +
the O +
LexA B-Gene +
binding O +
site O +
. O +

The O +
addition O +
of O +
free O +
alpha O +
subunits O +
blocked O +
the O +
binding O +
of O +
LexA B-Gene +
to O +
rstA B-Gene +
promoter O +
DNA O +
, O +
indicating O +
that O +
LexA B-Gene +
and O +
the O +
alphaCTD O +
directly O +
compete O +
for O +
binding O +
to O +
their O +
respective O +
sites O +
. O +

To O +
our O +
knowledge O +
, O +
this O +
is O +
the O +
first O +
report O +
of O +
a O +
repressor O +
blocking O +
transcription O +
initiation O +
by O +
occluding O +
a O +
promoter O +
UP O +
element O +
. O +

Effects O +
of O +
vasopressin B-Gene +
on O +
gene O +
expression O +
in O +
rat O +
inner O +
ear O +
. O +

Vasopressin B-Gene +
regulates O +
water O +
excretion O +
from O +
the O +
kidney O +
by O +
increasing O +
water O +
permeability O +
of O +
the O +
collecting O +
duct O +
as O +
a O +
hormone O +
secreted O +
from O +
the O +
posterior O +
pituitary O +
. O +

A O +
clinical O +
study O +
reported O +
that O +
plasma O +
levels O +
of O +
arginine B-Gene +
vasopressin I-Gene +
were O +
significantly O +
higher O +
in O +
patients O +
suffering O +
from O +
Meniere O +
's O +
disease O +
. O +

It O +
was O +
histologically O +
confirmed O +
that O +
chronic O +
administration O +
of O +
vasopressin B-Gene +
induced O +
endolymphatic O +
hydrops O +
in O +
guinea O +
pigs O +
. O +

However O +
, O +
the O +
mechanism O +
of O +
endolymphatic O +
hydrops O +
induced O +
by O +
vasopressin B-Gene +
is O +
still O +
unclear O +
. O +

We O +
use O +
cDNA O +
microarray O +
to O +
study O +
the O +
effects O +
of O +
vasopressin B-Gene +
on O +
gene O +
expression O +
profiles O +
in O +
rat O +
inner O +
ear O +
to O +
elucidate O +
the O +
possible O +
mechanism O +
of O +
the O +
induced O +
hydrolabyrinth O +
. O +

Wistar O +
rats O +
were O +
intraperitoneally O +
injected O +
with O +
50 O +
microg O +
/ O +
kg O +
arginine B-Gene +
vasopressin I-Gene +
once O +
a O +
day O +
for O +
one O +
week O +
. O +

Hydrolabyrinth O +
in O +
rat O +
inner O +
ear O +
induced O +
by O +
administration O +
of O +
vasopressin B-Gene +
was O +
detected O +
by O +
HE O +
stain O +
. O +

The O +
bullae O +
were O +
dissected O +
out O +
for O +
total O +
RNA O +
extraction O +
. O +

cDNAs O +
were O +
synthesized O +
by O +
reverse O +
transcription O +
and O +
labeled O +
with O +
Cyanine3 O +
( O +
Cy3 O +
) O +
or O +
Cyanine5 O +
( O +
Cy5 O +
) O +
. O +

The O +
BiostarR-40s O +
cDNA O +
microarray O +
was O +
hybridized O +
with O +
the O +
above O +
cDNAs O +
and O +
the O +
changes O +
of O +
mRNA O +
expression O +
intensity O +
were O +
showed O +
by O +
data O +
analysis O +
. O +

Furthermore O +
, O +
the O +
changes O +
of O +
aquaporins B-Gene +
expression O +
level O +
were O +
measured O +
by O +
reverse O +
transcription O +
polymerase B-Gene +
chain O +
( O +
RT O +
- O +
PCR O +
) O +
. O +

Endolymphatic O +
hydrops O +
were O +
present O +
in O +
rats O +
intraperitoneally O +
injected O +
with O +
vasopressin B-Gene +
. O +

226 O +
known O +
differentially O +
expressed O +
genes O +
were O +
screened O +
out O +
in O +
rat O +
inner O +
ear O +
induced O +
by O +
vasopressin B-Gene +
injection O +
. O +

Of O +
the O +
226 O +
genes O +
, O +
18 O +
transcripts O +
were O +
increased O +
by O +
5 O +
- O +
fold O +
or O +
more O +
, O +
and O +
7 O +
transcripts O +
were O +
decreased O +
to O +
0.2 O +
- O +
fold O +
or O +
less O +
. O +

Ten O +
differentially O +
expressed O +
genes O +
were O +
identified O +
that O +
associate O +
with O +
cell O +
signal O +
transduction O +
, O +
14 O +
differentially O +
expressed O +
genes O +
were O +
identified O +
that O +
relate O +
to O +
ion O +
transport O +
, O +
7 O +
differentially O +
expressed O +
genes O +
were O +
involved O +
in O +
vesicle O +
- O +
mediated O +
transport O +
, O +
and O +
2 O +
differentially O +
expressed O +
genes O +
were O +
aquaporin B-Gene +
2 I-Gene +
( O +
AQP2 B-Gene +
) O +
and O +
aquaporin B-Gene +
7 I-Gene +
( O +
AQP7 B-Gene +
) O +
. O +

The O +
expression O +
level O +
of O +
AQP2 B-Gene +
was O +
significantly O +
higher O +
and O +
AQP7 B-Gene +
was O +
significantly O +
lower O +
. O +

These O +
results O +
suggest O +
that O +
there O +
are O +
obvious O +
differences O +
in O +
gene O +
expression O +
profiles O +
in O +
inner O +
ear O +
between O +
vasopressin B-Gene +
injected O +
rats O +
and O +
normal O +
control O +
rats O +
. O +

Vasopressin B-Gene +
may O +
disturb O +
fluid O +
homeostasis O +
in O +
inner O +
ear O +
by O +
way O +
of O +
signal O +
transduction O +
, O +
ion O +
transport O +
, O +
vesicle O +
- O +
mediated O +
transport O +
and O +
aquaporins B-Gene +
. O +

It O +
is O +
likely O +
that O +
up O +
- O +
regulated O +
expression O +
of O +
AQP2 B-Gene +
mRNA O +
and O +
down O +
- O +
regulated O +
expression O +
of O +
AQP7 B-Gene +
mRNA O +
in O +
the O +
rat O +
inner O +
ear O +
caused O +
by O +
vasopressin B-Gene +
induce O +
an O +
increased O +
production O +
and O +
a O +
decreased O +
absorption O +
of O +
endolymph O +
, O +
resulting O +
in O +
endolymphatic O +
hydrops O +
. O +

APOE B-Gene +
distribution O +
in O +
world O +
populations O +
with O +
new O +
data O +
from O +
India O +
and O +
the O +
UK O +
. O +

BACKGROUND O +
: O +

The O +
APOE B-Gene +
gene O +
and O +
its O +
protein O +
product O +
is O +
associated O +
with O +
a O +
number O +
of O +
plasma O +
proteins O +
like O +
very B-Gene +
- I-Gene +
low I-Gene +
density I-Gene +
lipoprotein I-Gene +
( O +
VLDL B-Gene +
) O +
, O +
high B-Gene +
density I-Gene +
lipoprotein I-Gene +
( O +
HDL B-Gene +
) O +
chylomicrons B-Gene +
, O +
chylomicron B-Gene +
remnants I-Gene +
, O +
and O +
plays O +
a O +
crucial O +
role O +
in O +
lipid O +
metabolism O +
. O +

The O +
APOE B-Gene +
gene O +
is O +
polymorphic O +
and O +
common O +
alleles O +
( O +
* O -
E2 O +
, O +
* O -
E3 O +
and O +
* O -
E4 O +
) O +
have O +
been O +
associated O +
with O +
a O +
number O +
of O +
common O +
and O +
complex O +
diseases O +
in O +
different O +
populations O +
. O +

Due O +
to O +
their O +
crucial O +
role O +
in O +
metabolism O +
and O +
clinical O +
significance O +
, O +
it O +
is O +
imperative O +
that O +
allelic O +
variation O +
in O +
different O +
populations O +
is O +
analysed O +
to O +
evaluate O +
the O +
usage O +
of O +
APOE B-Gene +
in O +
an O +
evolutionary O +
and O +
clinical O +
context O +
. O +

AIM O +
: O +

We O +
report O +
allelic O +
variation O +
at O +
the O +
APOE B-Gene +
locus O +
in O +
three O +
European O +
and O +
four O +
Indian O +
populations O +
and O +
evaluate O +
global O +
patterns O +
of O +
genetic O +
variation O +
at O +
this O +
locus O +
. O +

The O +
large O +
, O +
intricate O +
and O +
unexpected O +
heterogeneity O +
of O +
this O +
locus O +
in O +
its O +
global O +
perspective O +
may O +
have O +
insightful O +
consequences O +
, O +
which O +
we O +
have O +
explored O +
in O +
this O +
paper O +
. O +

SUBJECT O +
AND O +
METHODS O +
: O +

Apolipoprotein B-Gene +
E I-Gene +
genotypes O +
were O +
determined O +
in O +
four O +
population O +
groups O +
( O +
Punjabi O +
Sikhs O +
, O +
Punjabi O +
Hindus O +
, O +
Maria O +
Gonds O +
and O +
Koch O +
, O +
total O +
individuals O +
= O +
497 O +
) O +
of O +
India O +
and O +
three O +
regionally O +
sub O +
- O +
divided O +
British O +
populations O +
( O +
Nottinghamshire O +
, O +
East O +
Midlands O +
and O +
West O +
Midlands O +
, O +
total O +
individuals O +
= O +
621 O +
) O +
. O +

The O +
extent O +
and O +
distribution O +
of O +
APOE B-Gene +
allele O +
frequencies O +
were O +
compared O +
with O +
292 O +
populations O +
of O +
the O +
world O +
using O +
a O +
variety O +
of O +
multivariate O +
methods O +
. O +

RESULTS O +
: O +

Three O +
alleles O +
, O +
APOE*E2 B-Gene +
, O +
APOE*E3 B-Gene +
and O +
APOE*E4 B-Gene +
, O +
were O +
observed O +
with O +
contrasting O +
variation O +
, O +
although O +
* O -
E4 O +
was O +
absent O +
in O +
the O +
tribal O +
population O +
of O +
Koch O +
. O +

Higher O +
heterozygosities O +
( O +
> O +
43 O +
% O +
) O +
in O +
British O +
populations O +
reflected O +
their O +
greater O +
genetic O +
diversity O +
at O +
this O +
locus O +
. O +

The O +
overall O +
pattern O +
of O +
allelic O +
diversity O +
among O +
these O +
populations O +
is O +
comparable O +
to O +
many O +
European O +
and O +
Indian O +
populations O -
. O -
At O +
a O +
global O +
level O +
, O +
higher O +
frequencies O +
of O +
the O +
* O -
E2 O +
allele O +
were O +
observed O +
in O +
Africa O +
and O +
Oceania O +
( O +
0.099 O +
+ O -
/- O +
0.083 O +
and O +
0.111 O +
+ O -
/- O +
0.052 O +
, O +
respectively O +
) O +
. O +

Similarly O +
, O +
* O -
E4 O +
allele O +
averages O +
were O +
higher O +
in O +
Oceania O +
( O +
0.221 O +
+ O -
/- O +
0.149 O +
) O +
and O +
Africa O +
( O +
0.209 O +
+ O -
/- O +
0.090 O +
) O +
, O +
while O +
Indian O +
and O +
Asian O +
populations O +
showed O +
the O +
highest O +
frequencies O +
of O +
* O -
E3 O +
allele O +
. O +

The O +
coefficient O +
of O +
gene O +
differentiation O +
was O +
found O +
to O +
be O +
highest O +
in O +
South O +
America O +
( O +
9.6 O +
% O +
) O +
, O +
although O +
the O +
highest O +
genetic O +
diversity O +
was O +
observed O +
in O +
Oceania O +
( O +
48.7 O +
% O +
) O +
and O +
Africa O +
( O +
46.3 O +
% O +
) O +
. O +

APOE*E2 B-Gene +
revealed O +
a O +
statistically O +
significant O +
decreasing O +
cline O +
towards O +
the O +
north O +
in O +
Asia O +
( O +
r O +
= O +
- O +
0.407 O +
, O +
d.f O -
. O +
= O +
70 O +
, O +
p O +
< O +
0.05 O +
) O +
, O +
which O +
is O +
not O +
compatible O +
with O +
the O +
coronary O +
heart O +
disease O +
statistics O +
in O +
this O +
continent O +
. O +

APOE*E4 B-Gene +
showed O +
a O +
significant O +
increasing O +
cline O +
in O +
North O +
European O +
populations O +
. O +

Spatial O +
autocorrelation O +
analysis O +
shows O +
that O +
the O +
variation O +
at O +
this O +
locus O +
is O +
influenced O +
by O +
' O +
isolation O +
by O +
distance O +
' O +
with O +
a O +
strong O +
positive O +
correlation O +
for O +
lower O +
distances O +
up O +
to O +
1313 O +
km O +
. O +

CONCLUSION O +
: O +

Overall O +
APOE B-Gene +
allelic O +
variation O +
in O +
UK O +
and O +
Indian O +
populations O +
is O +
comparable O +
to O +
previous O +
studies O +
but O +
in O +
tribal O +
populations O +
* O -
E4 O +
allele O +
frequency O +
was O +
very O +
low O +
or O +
absent O +
. O +

At O +
a O +
global O +
level O +
allelic O +
variation O +
shows O +
that O +
geography O +
, O +
isolation O +
by O +
distance O +
, O +
genetic O +
drift O +
and O +
possibly O +
pre O +
- O +
historical O +
selection O +
are O +
responsible O +
for O +
shaping O +
the O +
spectrum O +
of O +
genetic O +
variation O +
at O +
the O +
APOE B-Gene +
gene O +
. O +

Overall O +
, O +
APOE B-Gene +
is O +
a O +
good O +
anthropogenetic O +
and O +
clinical O +
diagnostic O +
marker O +
. O +

Extensive O +
proteolytic O +
processing O +
of O +
the O +
malaria O +
parasite O +
merozoite B-Gene +
surface I-Gene +
protein I-Gene +
7 I-Gene +
during O +
biosynthesis O +
and O +
parasite O +
release O +
from O +
erythrocytes O +
. O +

In O +
Plasmodium O +
falciparum O +
, O +
merozoite B-Gene +
surface I-Gene +
protein I-Gene +
7 I-Gene +
( O +
MSP7 B-Gene +
) O +
was O +
originally O +
identified O +
as O +
a O +
22kDa O +
protein O +
on O +
the O +
merozoite O +
surface O +
and O +
associated O +
with O +
the O +
MSP1 B-Gene +
complex I-Gene +
shed O +
during O +
erythrocyte O +
invasion O +
. O +

MSP7 B-Gene +
is O +
synthesised O +
in O +
schizonts O +
as O +
a O +
351 O +
- O +
amino O +
acid O +
precursor O +
that O +
undergoes O +
proteolytic O +
processing O +
. O +

During O +
biosynthesis O +
the O +
MSP1 B-Gene +
and O +
MSP7 B-Gene +
precursors O +
form O +
a O +
complex O +
that O +
is O +
targeted O +
to O +
the O +
surface O +
of O +
developing O +
merozoites O +
. O +

In O +
the O +
sequential O +
proteolytic O +
processing O +
of O +
MSP7 B-Gene +
, O +
N O +
- O +
and O +
C O +
- O +
terminal O +
20 O +
and O +
33kDa O +
products O +
of O +
primary O +
processing O +
, O +
MSP7 B-Gene +
( O +
20 O +
) O +
and O +
MSP7 B-Gene +
( O +
33 O +
) O +
are O +
formed O +
and O +
MSP7 B-Gene +
( O +
33 O +
) O +
remains O +
bound O +
to O +
full O +
length O +
MSP1 B-Gene +
. O +

Later O +
in O +
the O +
mature O +
schizont O +
, O +
MSP7 B-Gene +
( O +
20 O +
) O +
disappears O +
from O +
the O +
merozoite O +
surface O +
and O +
on O +
merozoite O +
release O +
MSP7 B-Gene +
( O +
33 O +
) O +
undergoes O +
a O +
secondary O +
cleavage O +
yielding O +
the O +
22kDa O +
MSP7 B-Gene +
( O +
22 O +
) O +
associated O +
with O +
MSP1 B-Gene +
. O +

In O +
free O +
merozoites O +
, O +
both O +
MSP7 B-Gene +
( O +
22 O +
) O +
and O +
a O +
further O +
cleaved O +
product O +
, O +
MSP7 B-Gene +
( O +
19 O +
) O +
present O +
only O +
in O +
some O +
parasite O +
lines O +
, O +
were O +
detected O +
; O +
these O +
two O +
derivatives O +
are O +
shed O +
as O +
part O +
of O +
the O +
protein O +
complex O +
with O +
MSP1 B-Gene +
fragments O +
during O +
erythrocyte O +
invasion O +
. O +

Primary O +
processing O +
of O +
MSP7 B-Gene +
is O +
brefeldin O +
A O +
- O +
sensitive O +
while O +
secondary O +
processing O +
is O +
resistant O +
to O +
both O +
calcium O +
chelators O +
and O +
serine B-Gene +
protease I-Gene +
inhibitors O +
. O +

Primary O +
processing O +
of O +
MSP7 B-Gene +
occurs O +
prior O +
to O +
that O +
of O +
MSP1 B-Gene +
in O +
a O +
post O +
- O +
Golgi O +
compartment O +
, O +
whereas O +
the O +
secondary O +
cleavage O +
occurs O +
on O +
the O +
surface O +
of O +
the O +
developing O +
merozoite O +
, O +
possibly O +
at O +
the O +
time O +
of O +
MSP1 B-Gene +
primary O +
processing O +
and O +
well O +
before O +
the O +
secondary O +
processing O +
of O +
MSP1 B-Gene +
. O +

Specific O +
interactions O +
by O +
the O +
N O +
- O +
terminal O +
arm O +
inhibit O +
self O +
- O +
association O +
of O +
the O +
AraC B-Gene +
dimerization O +
domain O +
. O +

Deletion O +
of O +
the O +
regulatory O +
N O +
- O +
terminal O +
arms O +
of O +
the O +
AraC B-Gene +
protein O +
from O +
its O +
dimerization O +
domain O +
fragments O +
increases O +
the O +
susceptibility O +
of O +
the O +
dimerization O +
domain O +
to O +
form O +
a O +
series O +
of O +
higher O +
order O +
polymers O +
by O +
indefinite O +
self O +
- O +
association O +
. O +

We O +
investigated O +
how O +
the O +
normal O +
presence O +
of O +
the O +
arm O +
inhibits O +
this O +
self O +
- O +
association O +
. O +

One O +
possibility O +
is O +
that O +
arms O +
can O +
act O +
as O +
an O +
entropic O +
bristles O +
to O +
interfere O +
with O +
the O +
approach O +
of O +
other O +
macromolecules O +
, O +
thereby O +
decreasing O +
collision O +
frequencies O +
. O +

We O +
examined O +
the O +
repulsive O +
effect O +
of O +
flexible O +
arms O +
by O +
measuring O +
the O +
rate O +
of O +
trypsin B-Gene +
cleavage O +
of O +
a O +
specially O +
constructed O +
ubiquitin B-Gene +
- O +
arm O +
protein O +
. O +

Adding O +
an O +
arm O +
to O +
ubiquitin B-Gene +
or O +
increasing O +
its O +
length O +
produced O +
only O +
a O +
modest O +
repulsive O +
effect O +
. O +

This O +
suggests O +
that O +
arms O +
such O +
as O +
the O +
N O +
- O +
terminal O +
arm O +
of O +
AraC B-Gene +
do O +
not O +
reduce O +
self O +
- O +
association O +
by O +
entropic O +
exclusion O +
. O +

We O +
consequently O +
tested O +
the O +
hypothesis O +
that O +
the O +
arm O +
on O +
AraC B-Gene +
reduces O +
self O +
- O +
association O +
by O +
binding O +
to O +
the O +
core O +
of O +
the O +
dimerization O +
domain O +
even O +
in O +
the O +
absence O +
of O +
arabinose O +
. O +

The O +
behaviors O +
of O +
dimerization O +
domain O +
mutants O +
containing O +
deletions O +
or O +
alterations O +
in O +
the O +
N O +
- O +
terminal O +
arms O +
substantiate O +
this O +
hypothesis O +
. O +

Apparently O +
, O +
interactions O +
between O +
the O +
N O -
- O -
terminal O +
arm O +
and O +
the O +
dimerization O +
domain O +
core O +
position O +
the O +
arm O +
to O +
interfere O +
with O +
the O +
protein O +
- O +
protein O +
contacts O +
necessary O +
for O +
self O +
- O +
association O +
. O +

Allosteric O +
monofunctional O +
aspartate B-Gene +
kinases I-Gene +
from O +
Arabidopsis O +
. O +

Plant O +
monofunctional O +
aspartate B-Gene +
kinase I-Gene +
is O +
unique O +
among O +
all O +
aspartate B-Gene +
kinases I-Gene +
, O +
showing O +
synergistic O +
inhibition O +
by O +
lysine O +
and O +
S O -
- O -
adenosyl O -
- O -
l O -
- O -
methionine O +
( O +
SAM O +
) O +
. O +

The O +
Arabidopsis O +
genome O +
contains O +
three O +
genes O +
for O +
monofunctional O +
aspartate B-Gene +
kinases I-Gene +
. O +

We O +
show O +
that O +
aspartate B-Gene +
kinase I-Gene +
2 I-Gene +
and O +
aspartate B-Gene +
kinase I-Gene +
3 I-Gene +
are O +
inhibited O +
only O +
by O +
lysine O +
, O +
and O +
that O +
aspartate B-Gene +
kinase I-Gene +
1 I-Gene +
is O +
inhibited O +
in O +
a O +
synergistic O +
manner O +
by O +
lysine O +
and O +
SAM O +
. O +

In O +
the O +
absence O +
of O +
SAM O +
, O +
aspartate B-Gene +
kinase I-Gene +
1 I-Gene +
displayed O +
low O +
apparent O +
affinity O +
for O +
lysine O +
compared O +
to O +
aspartate B-Gene +
kinase I-Gene +
2 I-Gene +
and O +
aspartate B-Gene +
kinase I-Gene +
3 I-Gene +
. O +

In O +
the O +
presence O +
of O +
SAM O +
, O +
the O +
apparent O +
affinity O +
of O +
aspartate B-Gene +
kinase I-Gene +
1 I-Gene +
for O +
lysine O +
increased O +
considerably O +
, O +
with O +
K O -
( O -
0.5 O -
) O +
values O +
for O +
lysine O +
inhibition O +
similar O +
to O +
those O +
of O +
aspartate B-Gene +
kinase I-Gene +
2 I-Gene +
and O +
aspartate B-Gene +
kinase I-Gene +
3 I-Gene +
. O +

For O +
all O +
three O +
enzymes O +
, O +
the O +
inhibition O +
resulted O +
from O +
an O +
increase O +
in O +
the O +
apparent O +
K O -
( O -
m O -
) O +
values O +
for O +
the O +
substrates O +
ATP O +
and O +
aspartate O +
. O +

The O +
mechanism O +
of O +
aspartate B-Gene +
kinase I-Gene +
1 I-Gene +
synergistic O +
inhibition O +
was O +
characterized O +
. O +

Inhibition O +
by O +
lysine O +
alone O +
was O +
fast O +
, O +
whereas O +
synergistic O +
inhibition O +
by O +
lysine O +
plus O +
SAM O +
was O +
very O +
slow O +
. O +

SAM O +
by O +
itself O +
had O +
no O +
effect O +
on O +
the O +
enzyme O +
activity O +
, O +
in O +
accordance O +
with O +
equilibrium O +
binding O +
analyses O +
indicating O +
that O +
SAM O +
binding O +
to O +
aspartate B-Gene +
kinase I-Gene +
1 I-Gene +
requires O +
prior O +
binding O +
of O +
lysine O +
. O +

The O +
three O +
- O +
dimensional O +
structure O +
of O +
the O +
aspartate B-Gene +
kinase I-Gene +
1 I-Gene +
- O +
Lys O -
- O -
SAM O +
complex O +
has O +
been O +
solved O +
[ O +
Mas O +
- O +
Droux O +
C O +
, O +
Curien O +
G O +
, O +
Robert O -
- O -
Genthon O +
M O +
, O +
Laurencin O +
M O +
, O +
Ferrer O +
JL O +
& O +
Dumas O +
R O +
( O +
2006 O +
) O +
Plant O +
Cell18 O +
, O +
1681 O -
- O -
1692 O +
] O +
. O +

Taken O +
together O +
, O +
the O +
data O +
suggest O +
that O +
, O +
upon O +
binding O +
to O +
the O +
inactive O +
aspartate B-Gene +
kinase I-Gene +
1 I-Gene +
- O +
Lys O +
complex O +
, O +
SAM O +
promotes O +
a O +
slow O +
conformational O +
transition O +
leading O +
to O +
formation O +
of O +
a O +
stable O +
aspartate B-Gene +
kinase I-Gene +
1 I-Gene +
- O +
Lys O -
- O -
SAM O +
complex O +
. O +

The O +
increase O +
in O +
aspartate B-Gene +
kinase I-Gene +
1 I-Gene +
apparent O +
affinity O +
for O +
lysine O +
in O +
the O +
presence O +
of O +
SAM O +
thus O +
results O +
from O +
the O +
displacement O +
of O +
the O +
unfavorable O +
equilibrium O +
between O +
aspartate B-Gene +
kinase I-Gene +
1 I-Gene +
and O +
aspartate B-Gene +
kinase I-Gene +
1 I-Gene +
- O +
Lys O +
towards O +
the O +
inactive O +
form O +
. O +

Immunogenetic O +
factors O +
determining O +
the O +
evolution O +
of O +
T O -
- O -
cell O +
large O +
granular O +
lymphocyte O +
leukaemia O +
and O +
associated O +
cytopenias O +
. O +

T O -
- O -
cell O +
large O +
granular O +
lymphocyte O +
leukaemia O +
( O +
T O -
- O -
LGL O +
) O +
is O +
a O +
chronic O +
clonal O +
proliferation O +
of O +
cytotoxic O +
T O +
lymphocytes O +
( O +
CTL O +
) O +
. O +

T O -
- O -
LGL O +
presents O +
with O +
cytopenias O +
, O +
often O +
accompanied O +
by O +
autoimmune O +
diseases O +
, O +
suggesting O +
clonal O +
transformation O +
arising O +
from O +
an O +
initially O +
polyclonal O +
immune O +
response O +
. O +

Various O +
immunogenetic O +
predisposition O +
factors O +
, O +
previously O +
described O +
for O +
both O +
immune O +
- O +
mediated O +
bone O +
marrow O +
failure O +
and O +
autoimmune O +
conditions O +
, O +
may O +
promote O +
T O -
- O -
LGL O +
evolution O +
and/or O +
development O +
of O +
cytopenias O +
. O +

The O +
association O +
of O +
T O -
- O -
LGL O +
was O +
analysed O +
with O +
a O +
number O +
of O +
immunogenetic O +
factors O +
in O +
66 O +
patients O +
, O +
including O +
human B-Gene +
leucocyte I-Gene +
antigen I-Gene +
( O +
HLA B-Gene +
) O +
and O +
killer B-Gene +
- I-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( O +
KIR B-Gene +
) O +
genotype O +
, O +
KIR B-Gene +
/ O +
KIR B-Gene +
- O +
L O +
mismatch O +
, O +
CTLA-4 B-Gene +
( O +
+ O +
49 O +
A O +
/ O +
G O +
) O +
, O +
CD16 B-Gene +
- O +
158V O +
/ O +
F O +
, O +
CD45 B-Gene +
polymorphisms O +
, O +
cytokine B-Gene +
single O +
nucleotide O +
polymorphisms O +
including O +
: O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
( O -
-308G O -
/ O -
A O +
) O +
, O +
TGF B-Gene -
- I-Gene -
beta1 I-Gene +
( O +
codons O +
10 O +
C O +
/ O +
T O +
, O +
25 O +
G O +
/ O +
C O +
) O +
, O +
IL-10 B-Gene +
( O +
- O +
1082 O +
G O +
/ O +
A O +
) O +
, O +
IL-6 B-Gene +
( O -
-174 O +
C O +
/ O +
G O +
) O +
, O +
and O +
IFN B-Gene -
- I-Gene -
gamma I-Gene +
( O +
+ O +
874 O +
T O +
/ O +
A O +
) O +
. O +

A O +
statistically O +
significant O +
increase O +
in O +
A O +
/ O +
A O +
genotype O +
for O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
- O +
308 O +
, O +
IL-10 B-Gene +
- O +
1082 O +
, O +
andCTLA-4 B-Gene +
+ O +
49 O +
was O +
observed O +
in O +
T O -
- O -
LGL O +
patients O +
compared O +
with O +
control O +
, O +
suggesting O +
that O +
the O +
G O +
allele O +
serves O +
a O +
protective O +
role O +
in O +
each O +
case O +
. O +

No O +
association O +
was O +
found O +
between O +
specific O +
KIR B-Gene +
/ O +
HLA B-Gene +
profile O +
and O +
disease O +
. O +

KIR B-Gene +
/ O +
KIR B-Gene +
- O +
L O +
analysis O +
revealed O +
significant O +
mismatches O +
between O +
KIR3DL2 B-Gene +
and O +
KIR2DS1 B-Gene +
and O +
their O +
ligands O +
HLA B-Gene -
- I-Gene -
A3 I-Gene +
/ O +
11 O +
and O +
HLA B-Gene -
- I-Gene -
C I-Gene +
group O +
2 O +
( O +
P O +
= O +
0.03 O +
and O +
0.01 O +
respectively O +
) O +
; O +
the O +
biological O +
relevance O +
of O +
this O +
finding O +
is O +
questionable O +
. O +

The O +
significance O +
of O +
additional O +
genetic O +
polymorphisms O +
and O +
their O +
clinical O +
correlation O +
to O +
evolution O +
of O +
T O -
- O -
LGL O +
requires O +
future O +
analysis O +
. O +

Antiviral O +
protein O +
APOBEC3 B-Gene -
G I-Gene +
localizes O +
to O +
ribonucleoprotein O +
complexes O +
found O +
in O +
P O +
bodies O +
and O +
stress O +
granules O +
. O +

Members O +
of O +
the O +
APOBEC B-Gene +
( I-Gene +
apolipoprotein I-Gene +
B I-Gene +
mRNA I-Gene +
- I-Gene +
editing I-Gene +
enzyme I-Gene +
catalytic I-Gene +
polypeptide I-Gene +
1 I-Gene +
- I-Gene +
like I-Gene +
) I-Gene +
family I-Gene +
of I-Gene +
cytidine I-Gene +
deaminases I-Gene +
inhibit O +
host O +
cell O +
genome O +
invasion O +
by O +
exogenous O +
retroviruses O +
and O +
endogenous O +
retrotransposons O +
. O +

Because O +
these O +
enzymes O +
can O +
edit O +
DNA O +
or O +
RNA O +
and O +
potentially O +
mutate O +
cellular O +
targets O +
, O +
their O +
activities O +
are O +
presumably O +
regulated O +
; O +
for O +
instance O +
, O +
APOBEC3 B-Gene -
G I-Gene +
( O +
A3 B-Gene -
G I-Gene +
) O +
recruitment O +
into O +
high O +
- O +
molecular O +
- O +
weight O +
ribonucleoprotein O +
( O +
RNP O +
) O +
complexes O +
has O +
been O +
shown O +
to O +
suppress O +
its O +
enzymatic O +
activity O +
. O +

We O +
used O +
tandem O +
affinity O +
purification O +
together O +
with O +
mass O +
spectrometry O +
( O +
MS O +
) O +
to O +
identify O +
protein O +
components O +
within O +
A3 B-Gene -
G I-Gene +
- O +
containing O +
RNPs O +
. O +

We O +
report O +
that O +
numerous O +
cellular O +
RNA O +
- O +
binding O +
proteins O +
with O +
diverse O +
roles O +
in O +
RNA O +
function O +
, O +
metabolism O +
, O +
and O +
fate O +
determination O +
are O +
present O +
in O +
A3 B-Gene -
G I-Gene +
RNPs O +
but O +
that O +
most O +
interactions O +
with O +
A3 B-Gene -
G I-Gene +
are O +
mediated O +
via O +
binding O +
to O +
shared O +
RNAs O +
. O +

Confocal O +
microscopy O +
demonstrated O +
that O +
substantial O +
quantities O +
of O +
A3 B-Gene -
G I-Gene +
localize O +
to O +
cytoplasmic O +
microdomains O +
that O +
are O +
known O +
as O +
P O +
bodies O +
and O +
stress O +
granules O +
( O +
SGs O +
) O +
and O +
are O +
established O +
sites O +
of O +
RNA O +
storage O +
and O +
metabolism O +
. O +

Indeed O +
, O +
subjecting O +
cells O +
to O +
stress O +
induces O +
the O +
rapid O +
redistribution O +
of O +
A3 B-Gene -
G I-Gene +
and O +
a O +
number O +
of O +
P O -
- O -
body O +
proteins O +
to O +
SGs O +
. O +

Among O +
these O +
proteins O +
are O +
Argonaute B-Gene +
1 I-Gene +
( O +
Ago1 B-Gene +
) O +
and O +
Argonaute B-Gene +
2 I-Gene +
( O +
Ago2 B-Gene +
) O +
, O +
factors O +
that O +
are O +
important O +
for O +
RNA O +
silencing O +
and O +
whose O +
interactions O +
with O +
A3 B-Gene -
G I-Gene +
are O +
resistant O +
to O +
RNase B-Gene +
treatment O +
. O +

Together O +
, O +
these O +
findings O +
reveal O +
that O +
A3 B-Gene -
G I-Gene +
associates O +
with O +
RNPs O +
that O +
are O +
found O +
throughout O +
the O +
cytosol O +
as O +
well O +
as O +
in O +
discrete O +
microdomains O +
. O +

We O +
also O +
speculate O +
that O +
the O +
interplay O +
between O +
A3 B-Gene -
G I-Gene +
, O +
RNA O +
- O +
silencing O +
pathways O +
, O +
and O +
cellular O +
sites O +
of O +
RNA O +
metabolism O +
may O +
contribute O +
to O +
A3 B-Gene -
G I-Gene -
's I-Gene +
role O +
as O +
an O +
inhibitor O +
of O +
retroelement O +
mobility O +
and O +
as O +
a O +
possible O +
regulator O +
of O +
cellular O +
RNA O +
function O +
. O +

Functional O +
polymorphism O +
of O +
the O +
KIR3DL1 B-Gene +
/ I-Gene +
S1 I-Gene +
receptor O +
on O +
human O +
NK O +
cells O +
. O +

NK O +
cells O +
express O +
both O +
inhibitory O +
and O +
activatory O +
receptors O +
that O +
allow O +
them O +
to O +
recognize O +
target O +
cells O +
through O +
HLA B-Gene +
class I-Gene +
I I-Gene +
Ag O +
expression O +
. O +

KIR3DL1 B-Gene +
is O +
a O +
receptor O +
that O +
recognizes O +
the O +
HLA B-Gene -
- I-Gene -
Bw4 I-Gene +
public O +
epitope O +
of O +
HLA B-Gene -
- I-Gene -
B I-Gene +
alleles O +
. O +

We O +
demonstrate O +
that O +
polymorphism O +
within O +
the O +
KIR3DL1 B-Gene +
receptor O +
has O +
functional O +
consequences O +
in O +
terms O +
of O +
NK O +
cell O +
recognition O +
of O +
target O +
. O +

Inhibitory O +
alleles O +
of O +
KIR3DL1 B-Gene +
differ O +
in O +
their O +
ability O +
to O +
recognize O +
HLA B-Gene -
- I-Gene -
Bw4 I-Gene +
ligand O +
, O +
and O +
a O +
consistent O +
hierarchy O +
of O +
ligand O +
reactivity O +
can O +
be O +
defined O +
. O +

KIR3DS1 B-Gene +
, O +
which O +
segregates O +
as O +
an O +
allele O +
of O +
KIR3DL1 B-Gene +
, O +
has O +
a O +
short O +
cytoplasmic O +
tail O +
characteristic O +
of O +
activatory O +
receptors O +
. O +

Because O +
it O +
is O +
very O +
similar O +
to O +
KIR3DL1 B-Gene +
in O +
the O +
extracellular O +
domains O +
, O +
it O +
has O +
been O +
assumed O +
that O +
KIR3DS1 B-Gene +
will O +
recognize O +
a O +
HLA B-Gene -
- I-Gene -
Bw4 I-Gene +
ligand O +
. O +

In O +
this O +
study O +
, O +
we O +
demonstrate O +
that O +
KIR3DS1 B-Gene +
is O +
expressed O +
as O +
a O +
protein O +
at O +
the O +
cell O +
surface O +
of O +
NK O +
cells O +
, O +
where O +
it O +
is O +
recognized O +
by O +
the O +
Z27 O +
Ab O +
. O +

Using O +
this O +
Ab O +
, O +
we O +
found O +
that O +
KIR3DS1 B-Gene +
is O +
expressed O +
on O +
a O +
higher O +
percentage O +
of O +
NK O +
cells O +
in O +
KIR3DS1 B-Gene +
homozygous O +
compared O +
with O +
heterozygous O +
donors O +
. O +

In O +
contrast O +
to O +
the O +
inhibitory O +
KIR3DL1 B-Gene +
allotypes O +
, O +
KIR3DS1 B-Gene +
did O +
not O +
recognize O +
HLA B-Gene -
- I-Gene -
Bw4 I-Gene +
on O +
EBV O +
- O +
transformed O +
cell O +
lines O +
. O +

Binding O +
Characteristics O +
of O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
Subvariants O +
to O +
IFNAR2 B-Gene +
- O +
EC O +
and O +
Influence O +
of O +
the O +
6-Histidine O +
Tag O +
. O +

The O +
expression O +
, O +
purification O +
, O +
detection O +
, O +
and O +
assay O +
of O +
recombinant O +
proteins O +
have O +
been O +
made O +
more O +
convenient O +
and O +
rapid O +
by O +
the O +
use O +
of O +
small O +
affinity O +
tags O +
. O +

To O +
facilitate O +
the O +
purification O +
of O +
interferon B-Gene -
- I-Gene -
alpha2c I-Gene +
( O +
IFN B-Gene -
- I-Gene -
alpha2c I-Gene +
) O +
by O +
metal O +
chelate O +
affinity O +
chromatography O +
, O +
N O +
- O +
terminal O +
6 O +
- O +
histidine O +
tag O +
was O +
introduced O +
via O +
genetic O +
manipulation O +
. O +

Two O +
preparations O +
of O +
IFN B-Gene +
material O +
were O +
purified O +
; O +
one O +
contained O +
IFN B-Gene -
- I-Gene -
alpha2c I-Gene +
with O +
the O +
6-histidine O +
tag O +
, O +
and O +
the O +
other O +
contained O +
IFN B-Gene -
- I-Gene -
alpha2c I-Gene +
without O +
the O +
6-histidine O +
tag O +
. O +

The O +
antigenic O +
properties O +
of O +
the O +
human O +
IFN B-Gene -
- I-Gene -
alpha2c I-Gene +
subvariant O +
with O +
and O +
without O +
the O +
6-histidine O +
tag O +
, O +
as O +
well O +
as O +
the O +
effects O +
of O +
the O +
N O +
- O +
terminal O +
6 O +
- O +
histidine O +
tag O +
on O +
IFN B-Gene -
- I-Gene -
alpha2c I-Gene +
interaction O +
with O +
the O +
extracellular O +
domain O +
of O +
human O +
IFN B-Gene -
- I-Gene -
alpha I-Gene +
receptor I-Gene +
chain I-Gene +
2 I-Gene +
( O +
IFNAR2 B-Gene +
- O +
EC O +
) O +
were O +
examined O +
. O +

For O +
the O +
purposes O +
of O +
this O +
study O +
, O +
IFNs B-Gene +
were O +
characterized O +
by O +
Western O +
blots O +
with O +
anti O +
- O +
IFN B-Gene +
monoclonal O +
antibodies O +
( O +
mAb O +
) O +
and O +
bioassays O +
. O +

Immunoblot O +
analyses O +
showed O +
differences O +
between O +
IFN B-Gene -
- I-Gene -
alpha2c I-Gene +
- O +
6-histidine O +
tag O +
and O +
IFN B-Gene -
- I-Gene -
alpha2a I-Gene +
, O +
b O +
, O +
c O +
in O +
their O +
interaction O +
with O +
IFNAR2 B-Gene +
- O +
EC O +
. O +

We O +
also O +
observed O +
differences O +
between O +
IFN B-Gene -
- I-Gene -
alpha2c I-Gene +
- O +
6-histidine O +
tag O +
and O +
IFN B-Gene -
- I-Gene -
alpha2a I-Gene +
, O +
b O +
, O +
c O +
in O +
bioactivities O +
. O +

This O +
study O +
is O +
the O +
first O +
report O +
that O +
shows O +
that O +
an O +
N O +
- O +
terminal O +
6 O +
- O +
histidine O +
tag O +
on O +
IFN B-Gene -
- I-Gene -
alpha2c I-Gene +
can O +
affect O +
its O +
interaction O +
with O +
receptor O +
and O +
cause O +
a O +
different O +
bioactivity O +
. O +

Helicobacter O +
equorum O +
sp. O +
nov. O +
, O +
a O +
urease B-Gene +
- O +
negative O +
Helicobacter O +
species O +
isolated O +
from O +
horse O +
faeces O +
. O +

Gram O +
- O +
negative O +
, O +
curved O +
, O +
motile O +
bacteria O +
( O +
strains O +
EqF1 O -
T O +
and O +
EqF2 O +
) O +
were O +
isolated O +
from O +
faecal O +
samples O +
from O +
two O +
clinically O +
healthy O +
horses O +
. O +

Both O +
strains O +
possessed O +
a O +
single O +
, O +
monopolar O +
, O +
sheathed O +
flagellum O +
and O +
were O +
urease B-Gene +
- O +
negative O +
. O +

The O +
novel O +
strains O +
grew O +
at O +
37 O +
degrees O +
C O +
under O +
microaerobic O +
conditions O +
and O +
were O +
positive O +
for O +
oxidase B-Gene +
, O +
catalase B-Gene +
and O +
alkaline B-Gene +
phosphatase I-Gene +
activities O +
. O +

The O +
isolates O +
reduced O +
nitrate O +
to O +
nitrite O +
, O +
but O +
gamma B-Gene +
- I-Gene +
glutamyl I-Gene +
transpeptidase I-Gene +
activity O +
was O +
not O +
detected O +
. O +

The O +
novel O +
isolates O +
did O +
not O +
grow O +
at O +
42 O +
degrees O +
C O +
or O +
on O +
media O +
containing O +
1 O +
% O +
glycine O +
. O +

They O +
were O +
resistant O +
to O +
cephalotin O +
and O +
nalidixic O +
acid O +
and O +
susceptible O +
to O +
metronidazole O +
. O +

Analysis O +
of O +
the O +
16S O +
and O +
23S O +
rRNA O +
gene O +
sequences O +
of O +
the O +
two O +
novel O +
strains O +
identified O +
them O +
as O +
representing O +
a O +
single O +
species O +
within O +
the O +
genus O +
Helicobacter O +
. O +

In O +
terms O +
of O +
16S O +
rRNA O +
gene O +
sequence O +
similarity O +
, O +
Helicobacter O +
pullorum O +
and O +
Helicobacter O +
canadensis O +
were O +
the O +
most O +
closely O +
related O +
species O +
( O +
98 O +
% O +
similarity O +
) O +
. O +

23S O +
rRNA O +
gene O +
sequence O +
analysis O +
also O +
classified O +
strains O +
EqF1 O -
T O +
and O +
EqF2 O +
within O +
the O +
enterohepatic O +
division O +
of O +
the O +
genus O +
Helicobacter O +
, O +
but O +
only O +
94 O +
% O +
similarity O +
was O +
detected O +
with O +
H. O +
pullorum O +
and O +
H. O +
canadensis O +
, O +
which O +
are O +
helicobacters O +
with O +
unsheathed O +
flagella O +
. O +

The O +
most O +
closely O +
related O +
species O +
in O +
terms O +
of O +
23S O +
rRNA O +
gene O +
sequence O +
similarity O +
was O +
Helicobacter O +
canis O +
( O +
95 O +
% O +
) O +
. O +

Numerical O +
analysis O +
of O +
whole O +
- O +
cell O +
protein O +
extracts O +
by O +
SDS O -
- O -
PAGE O +
was O +
performed O +
and O +
the O +
novel O +
isolates O +
were O +
clearly O +
differentiated O +
from O +
H. O +
pullorum O +
, O +
H. O +
canadensis O +
, O +
H. O +
canis O +
and O +
other O +
species O +
of O +
the O +
genus O +
Helicobacter O +
. O +

This O +
finding O +
was O +
also O +
confirmed O +
by O +
sequence O +
analysis O +
of O +
the O +
hsp60 B-Gene +
gene O +
. O +

On O +
the O +
basis O +
of O +
these O +
genetic O +
, O +
biochemical O +
and O +
protein O +
data O +
, O +
the O +
isolates O +
are O +
classified O +
as O +
representing O +
a O +
novel O +
species O +
, O +
for O +
which O +
the O +
name O +
Helicobacter O +
equorum O +
sp. O +
nov. O +
is O +
proposed O +
( O +
type O +
strain O +
EqF1 O -
T O +
= O +
LMG O +
23362 O -
T O +
= O +
CCUG O +
52199 O -
T O +
) O +
. O +

Allelic O +
expression O +
patterns O +
of O +
KIR3DS1 B-Gene +
and O +
3DL1 B-Gene +
using O +
the O +
Z27 O +
and O +
DX9 O +
antibodies O +
. O +

KIR3DL1 B-Gene +
is O +
one O +
of O +
the O +
best O +
- O +
characterised O +
inhibitory O +
NK O +
cell O +
receptors O +
. O +

Unusually O +
, O +
one O +
common O +
allele O +
at O +
the O +
3DL1 B-Gene +
locus O +
encodes O +
an O +
activating O +
receptor O +
known O +
as O +
3DS1 B-Gene +
. O +

There O +
is O +
genetic O +
evidence O +
for O +
a O +
protective O +
role O +
of O +
3DS1 B-Gene +
in O +
certain O +
viral O +
diseases O +
, O +
but O +
there O +
has O +
been O +
uncertainty O +
about O +
expression O +
of O +
the O +
3DS1 B-Gene +
protein O +
. O +

Using O +
transfection O +
, O +
we O +
show O +
that O +
surface O +
expression O +
of O +
3DS1 B-Gene +
is O +
reliant O +
on O +
the O +
adaptor B-Gene +
protein I-Gene +
DNAX B-Gene +
- I-Gene +
activating I-Gene +
protein I-Gene +
12 I-Gene +
( O +
DAP12 B-Gene +
) O +
. O +

KIR3DS1 B-Gene +
was O +
recognised O +
by O +
the O +
antibody O +
Z27 O +
, O +
a O +
reagent O +
that O +
also O +
detects O +
KIR3DL1 B-Gene +
but O +
no O +
other O +
killer B-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( O +
KIR B-Gene +
) O +
molecule O +
. O +

Z27 O +
stained O +
3DS1 B-Gene +
on O +
the O +
surface O +
of O +
fresh O +
circulating O +
NK O +
cells O +
from O +
3DS1 B-Gene +
/ O +
3DS1 B-Gene +
homozygotes O +
. O +

By O +
double O +
- O +
staining O +
with O +
Z27 O +
and O +
DX9 O +
, O +
an O +
antibody O +
specific O +
for O +
3DL1 B-Gene +
, O +
we O +
obtained O +
evidence O +
that O +
in O +
3DS1 B-Gene +
/ O +
3DL1 B-Gene +
heterozygous O +
donors O +
significant O +
numbers O +
of O +
NK O +
cells O +
express O +
3DS1 B-Gene +
without O +
co O +
- O +
expressing O +
3DL1 B-Gene +
and O +
that O +
NK O +
cells O +
expressing O +
both O +
alleles O +
are O +
difficult O +
to O +
detect O +
. O +

Chicken O +
Toll B-Gene +
- I-Gene +
like I-Gene +
Receptor I-Gene +
3 I-Gene +
Recognizes O +
Its O +
Cognate O +
Ligand O +
When O +
Ectopically O +
Expressed O +
in O +
Human O +
Cells O +
. O +

Recognition O +
of O +
pathogens O +
by O +
toll B-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
TLRs B-Gene +
) O +
causes O +
activation O +
of O +
signaling O +
cascades O +
that O +
trigger O +
cytokine B-Gene +
secretion O +
and O +
, O +
ultimately O +
, O +
innate O +
immunity O +
. O +

Genes O +
encoding O +
proteins O +
with O +
substantial O +
homology O +
to O +
mammalian O +
TLR1 B-Gene +
, O +
TLR2 B-Gene +
, O +
TLR3 B-Gene +
, O +
TLR4 B-Gene +
, O +
TLR5 B-Gene +
, O +
and O +
TLR7 B-Gene +
are O +
present O +
in O +
the O +
chicken O +
genome O +
, O +
whereas O +
orthologs O +
of O +
TLR8 B-Gene +
, O +
TLR9 B-Gene +
, O +
and O +
TLR10 B-Gene +
seem O +
to O +
be O +
defective O +
or O +
missing O +
. O +

Except O +
for O +
chicken O +
TLR2 B-Gene +
( O +
ChTLR2 B-Gene +
) O +
, O +
which O +
was O +
previously O +
shown O +
to O +
recognize O +
lipopeptides O +
and O +
lipopolysaccharides O +
( O +
LPS O +
) O +
, O +
the O +
ligand O +
specificity O +
of O +
ChTLRs B-Gene +
had O +
not O +
been O +
determined O +
. O +

We O +
found O +
that O +
polyI O +
: O +
C O +
, O +
LPS O +
, O +
R848 O +
, O +
S-28463 O +
, O +
and O +
ODN2006 O +
, O +
which O +
are O +
specifically O +
recognized O +
by O +
TLR3 B-Gene +
, O +
TLR4 B-Gene +
, O +
TLR7 B-Gene +
/ I-Gene +
8 I-Gene +
, O +
and O +
TLR9 B-Gene +
in O +
mammals O +
, O +
induced O +
substantial O +
amounts O +
of O +
type B-Gene +
I I-Gene +
interferon I-Gene +
( O +
IFN B-Gene +
) O +
and O +
interleukin-6 B-Gene +
( O +
IL-6 B-Gene +
) O +
in O +
freshly O +
prepared O +
chicken O +
splenocytes O +
. O +

To O +
determine O +
the O +
ligand O +
specificity O +
of O +
ChTLR3 B-Gene +
and O +
ChTLR7 B-Gene +
, O +
we O +
used O +
a O +
standard O +
reporter O +
assay O +
frequently O +
employed O +
for O +
analysis O +
of O +
mammalian O +
TLRs B-Gene +
. O +

Neither O +
S-28463 O +
nor O +
any O +
other O +
TLR B-Gene +
ligand O +
induced O +
reporter O +
activity O +
in O +
human O +
293 O +
cells O +
expressing O +
ChTLR7 B-Gene +
. O +

However O +
, O +
human O +
293 O +
cells O +
expressing O +
ChTLR3 B-Gene +
strongly O +
and O +
specifically O +
responded O +
to O +
polyI O +
: O +
C O +
, O +
demonstrating O +
that O +
this O +
chicken O +
receptor O +
represents O +
a O +
true O +
ortholog O +
of O +
mammalian O +
TLR3 B-Gene +
. O +

Macrophage B-Gene +
Migration I-Gene +
Inhibitory I-Gene +
Factor I-Gene +
Induces O +
MMP-9 B-Gene +
Expression O +
in O +
Macrophages O +
via O +
The O +
MEK B-Gene +
- O +
ERK B-Gene +
MAP B-Gene +
Kinase I-Gene +
Pathway O +
. O +

We O +
have O +
shown O +
previously O +
that O +
macrophage B-Gene +
migration I-Gene +
inhibitory I-Gene +
factor I-Gene +
( O +
MIF B-Gene +
) O +
may O +
play O +
a O +
role O +
in O +
the O +
destabilization O +
of O +
atherosclerotic O +
plaques O +
by O +
activating O +
matrix B-Gene +
metalloproteinase I-Gene +
protein-9 I-Gene +
( O +
MMP-9 B-Gene +
) O +
. O +

The O +
aim O +
of O +
this O +
study O +
is O +
to O +
investigate O +
the O +
signaling O +
mechanism O +
by O +
which O +
MIF B-Gene +
induces O +
MMP-9 B-Gene +
expression O +
and O +
activation O +
in O +
a O +
murine O +
macrophage O +
line O +
( O +
RAW264.7 O +
) O +
. O +

MIF B-Gene +
was O +
able O +
to O +
activate O +
extracellular B-Gene +
signal I-Gene +
- I-Gene +
regulated I-Gene +
kinase I-Gene +
1 I-Gene +
/ I-Gene +
2 I-Gene +
( O +
ERK1 B-Gene +
/ I-Gene +
2 I-Gene +
) O +
, O +
to O +
a O +
less O +
extent O +
JNK B-Gene +
, O +
but O +
not O +
p38 B-Gene +
mitogen O +
- O +
activated O +
protein O +
( O +
MAP O +
) O +
, O +
MAP B-Gene +
kinase I-Gene +
to O +
induce O +
MMP9 B-Gene +
mRNA O +
and O +
protein O +
expression O +
in O +
RAW264.7 O +
murine O +
macrophages O +
. O +

This O +
was O +
confirmed O +
by O +
the O +
findings O +
that O +
addition O +
of O +
an O +
ERK B-Gene +
MAP B-Gene +
kinase I-Gene +
inhibitor O +
( O +
PD98059 O +
) O +
but O +
not O +
a O +
p38 B-Gene +
inhibitor O +
( O +
SB203589 O +
) O +
abolished O +
MIF B-Gene +
- O +
induced O +
MMP-9 B-Gene +
expression O +
and O +
activation O +
, O +
whereas O +
addition O +
of O +
a O +
JNK B-Gene +
inhibitor O +
( O +
SP600125 O +
) O +
produced O +
a O +
partially O +
inhibitory O +
effect O +
. O +

The O +
functional O +
role O +
of O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
kinase I-Gene +
( O +
MEK B-Gene +
) O +
- O +
ERK B-Gene +
MAP B-Gene +
kinase I-Gene +
in O +
MIF B-Gene +
- O +
induced O +
MMP-9 B-Gene +
expression O +
was O +
further O +
confirmed O +
by O +
overexpressing O +
dominant O +
negative O +
MEK B-Gene +
( O +
DN O +
- O +
MEK B-Gene +
) O +
and O +
DN O +
- O +
ERK B-Gene +
MAP B-Gene +
kinases I-Gene +
. O +

Interestingly O +
, O +
constitutive O +
expression O +
of O +
a O +
wild O +
- O +
type O +
( O +
WT O +
) O +
- O +
MEK B-Gene +
alone O +
was O +
also O +
capable O +
of O +
inducing O +
a O +
low O +
, O +
but O +
significant O +
MMP-9 B-Gene +
mRNA O +
and O +
protein O +
expression O +
but O +
did O +
not O +
cause O +
a O +
further O +
increase O +
in O +
MMP-9 B-Gene +
in O +
response O +
to O +
MIF B-Gene +
. O +

MIF B-Gene +
activates O +
the O +
MEK B-Gene +
- O +
ERK B-Gene +
MAP B-Gene +
kinase I-Gene +
pathway O +
to O +
induce O +
MMP-9 B-Gene +
expression O +
by O +
murine O +
macrophages O +
. O +

Activation O +
of O +
this O +
pathway O +
is O +
necessary O +
for O +
MMP-9 B-Gene +
expression O +
and O +
activation O +
in O +
response O +
to O +
MIF B-Gene +
stimulation O +
. O +

Glutamatergic O +
or O +
GABAergic O +
neuron O +
- O +
specific O +
, O +
long O +
- O +
term O +
expression O +
in O +
neocortical O +
neurons O +
from O +
helper O +
virus O +
- O +
free O +
HSV-1 O +
vectors O +
containing O +
the O +
phosphate B-Gene +
- I-Gene +
activated I-Gene +
glutaminase I-Gene +
, O +
vesicular B-Gene +
glutamate I-Gene +
transporter-1 I-Gene +
, O +
or O +
glutamic B-Gene +
acid I-Gene +
decarboxylase I-Gene +
promoter O +
. O +

Many O +
potential O +
uses O +
of O +
direct O +
gene O +
transfer O +
into O +
neurons O +
require O +
restricting O +
expression O +
to O +
one O +
of O +
the O +
two O +
major O +
types O +
of O +
forebrain O +
neurons O +
, O +
glutamatergic O +
or O +
GABAergic O +
neurons O +
. O +

Thus O +
, O +
it O +
is O +
desirable O +
to O +
develop O +
virus O +
vectors O +
that O +
contain O +
either O +
a O +
glutamatergic O +
or O +
GABAergic O +
neuron O +
- O +
specific O +
promoter O +
. O +

The O +
brain O +
/ O +
kidney O +
phosphate B-Gene +
- I-Gene +
activated I-Gene +
glutaminase I-Gene +
( O +
PAG B-Gene +
) O +
, O +
the O +
product O +
of O +
the O +
GLS1 B-Gene +
gene O +
, O +
produces O +
the O +
majority O +
of O +
the O +
glutamate O +
for O +
release O +
as O +
neurotransmitter O +
, O +
and O +
is O +
a O +
marker O +
for O +
glutamatergic O +
neurons O +
. O +

A O +
PAG B-Gene +
promoter O +
was O +
partially O +
characterized O +
using O +
a O +
cultured O +
kidney O +
cell O +
line O +
. O +

The O +
three O +
vesicular B-Gene +
glutamate I-Gene +
transporters I-Gene +
( O +
VGLUTs B-Gene +
) O +
are O +
expressed O +
in O +
distinct O +
populations O +
of O +
neurons O +
, O +
and O +
VGLUT1 B-Gene +
is O +
the O +
predominant O +
VGLUT B-Gene +
in O +
the O +
neocortex O +
, O +
hippocampus O +
, O +
and O +
cerebellar O +
cortex O +
. O +

Glutamic B-Gene +
acid I-Gene +
decarboxylase I-Gene +
( O +
GAD B-Gene +
) O +
produces O +
GABA O +
; O +
the O +
two O +
molecular O +
forms O +
of O +
the O +
enzyme O +
, O +
GAD65 B-Gene +
and O +
GAD67 B-Gene +
, O +
are O +
expressed O +
in O +
distinct O +
, O +
but O +
largely O +
overlapping O +
, O +
groups O +
of O +
neurons O +
, O +
and O +
GAD67 B-Gene +
is O +
the O +
predominant O +
form O +
in O +
the O +
neocortex O +
. O +

In O +
transgenic O +
mice O +
, O +
an O +
approximately O +
9 O +
kb O +
fragment O +
of O +
the O +
GAD67 B-Gene +
promoter O +
supports O +
expression O +
in O +
most O +
classes O +
of O +
GABAergic O +
neurons O +
. O +

Here O +
, O +
we O +
constructed O +
plasmid O +
( O +
amplicon O +
) O +
Herpes O +
Simplex O +
Virus O +
( O +
HSV-1 O +
) O +
vectors O +
that O +
placed O +
the O +
Lac B-Gene +
Z I-Gene +
gene O +
under O +
the O +
regulation O +
of O +
putative O +
PAG B-Gene +
, O +
VGLUT1 B-Gene +
, O +
or O +
GAD67 B-Gene +
promoters O +
. O +

Helper O +
virus O +
- O +
free O +
vector O +
stocks O +
were O +
delivered O +
into O +
postrhinal O +
cortex O +
, O +
and O +
the O +
rats O +
were O +
sacrificed O +
4 O +
days O +
or O +
2 O +
months O +
later O +
. O +

The O +
PAG B-Gene +
or O +
VGLUT1 B-Gene +
promoters O +
supported O +
approximately O +
90 O +
% O +
glutamatergic O +
neuron O +
- O +
specific O +
expression O +
. O +

The O +
GAD67 B-Gene +
promoter O +
supported O +
approximately O +
90 O +
% O +
GABAergic O +
neuron O +
- O +
specific O +
expression O +
. O +

Long O +
- O +
term O +
expression O +
was O +
observed O +
using O +
each O +
promoter O +
. O +

Principles O +
for O +
obtaining O +
long O +
- O +
term O +
expression O +
from O +
HSV-1 O +
vectors O +
, O +
based O +
on O +
these O +
and O +
other O +
results O +
, O +
are O +
discussed O +
. O +

Long O +
- O +
term O +
glutamatergic O +
or O +
GABAergic O +
neuron O +
- O +
specific O +
expression O +
may O +
benefit O +
specific O +
experiments O +
on O +
learning O +
or O +
specific O +
gene O +
therapy O +
approaches O +
. O +

Of O +
note O +
, O +
promoter O +
analyses O +
might O +
identify O +
regulatory O +
elements O +
that O +
determine O +
a O +
glutamatergic O +
or O +
GABAergic O +
neuron O +
. O +

Pyrin B-Gene +
- I-Gene +
only I-Gene +
protein I-Gene +
2 I-Gene +
modulates O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
and O +
disrupts O +
ASC B-Gene +
: O +
CLR B-Gene +
interactions O +
. O +

NF B-Gene -
- I-Gene -
kappaB I-Gene +
is O +
pivotal O +
for O +
transactivation O +
of O +
cell O +
- O +
cycle O +
regulatory O +
, O +
cytokine B-Gene +
, O +
and O +
adhesion B-Gene +
molecule I-Gene +
genes O +
and O +
is O +
dysregulated O +
in O +
many O +
cancers O +
, O +
neurodegenerative O +
disorders O +
, O +
and O +
inflammatory O +
diseases O +
. O +

Proteins O +
with O +
pyrin O +
and/or O +
caspase B-Gene +
recruitment O +
domains O +
have O +
roles O +
in O +
apoptosis O +
, O +
innate O +
immunity O +
, O +
and O +
inflammation O +
. O +

Many O +
pyrin O +
domain O +
( O +
PYD O +
) O +
proteins O +
modulate O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activity O +
as O +
well O +
as O +
participate O +
in O +
assembling O +
both O +
the O +
perinuclear O +
" O +
apoptotic O +
speck O +
" O +
and O +
the O +
pro O +
- O +
IL1beta B-Gene +
/ O +
IL-18 B-Gene +
- O +
converting O +
inflammasome O +
complex O +
. O +

" O +
Pyrin B-Gene +
- I-Gene +
only I-Gene +
" I-Gene +
proteins I-Gene +
( O +
POP B-Gene +
) O +
are O +
attractive O +
as O +
negative O +
regulators O +
of O +
PYD O +
- O +
mediated O +
functions O +
and O +
one O +
such O +
protein O +
, O +
POP1 B-Gene +
, O +
has O +
been O +
reported O +
. O +

We O +
report O +
the O +
identification O +
and O +
initial O +
characterization O +
of O +
a O +
second O +
POP B-Gene +
. O +

POP2 B-Gene +
is O +
a O +
294 O +
nt O +
single O +
exon O +
gene O +
located O +
on O +
human O +
chromosome O +
3 O +
encoding O +
a O +
97 O +
- O +
aa O +
protein O +
with O +
sequence O +
and O +
predicted O +
structural O +
similarity O +
to O +
other O +
PYDs O +
. O +

Highly O +
similar O +
to O +
PYDs O +
in O +
CATERPILLER B-Gene +
( I-Gene +
CLR I-Gene +
, I-Gene +
NLR I-Gene +
, I-Gene +
NALP I-Gene +
) I-Gene +
family I-Gene +
proteins O +
, O +
POP2 B-Gene +
is O +
less O +
like O +
the O +
prototypic O +
pyrin O +
and O +
ASC B-Gene +
PYDs O +
. O +

POP2 B-Gene +
is O +
expressed O +
principally O +
in O +
peripheral O +
blood O +
leukocytes O +
and O +
displays O +
both O +
cytoplasmic O +
and O +
nuclear O +
expression O +
patterns O +
in O +
transfected O +
cells O +
. O +

TNF B-Gene -
- I-Gene -
alpha I-Gene +
- O +
stimulated O +
and O +
p65 B-Gene +
( O +
RelA B-Gene +
) O +
- O +
induced O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
- O +
dependent O +
gene O +
transcription O +
is O +
inhibited O +
by O +
POP2 B-Gene +
in O +
vitro O +
by O +
a O +
mechanism O +
involving O +
changes O +
in O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
nuclear O +
import O +
or O +
distribution O +
. O +

While O +
colocalizing O +
with O +
ASC B-Gene +
in O +
perinuclear O +
specks O +
, O +
POP2 B-Gene +
also O +
inhibits O +
the O +
formation O +
of O +
specks O +
by O +
the O +
CLR B-Gene +
protein O +
CIAS1 B-Gene +
/ O +
NALP3 B-Gene +
. O +

Together O +
, O +
these O +
observations O +
demonstrate O +
that O +
POP2 B-Gene +
is O +
a O +
negative O +
regulator O +
of O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
activity O +
that O +
may O +
influence O +
the O +
assembly O +
of O +
PYD O +
- O +
dependent O +
complexes O +
. O +

Expression O +
, O +
purification O +
and O +
characterization O +
of O +
human O +
IFN B-Gene -
- I-Gene -
lambda1 I-Gene +
in O +
Pichia O +
pastoris O +
. O +

Interferon B-Gene +
- I-Gene +
lambda I-Gene +
( O +
IFN B-Gene -
- I-Gene -
lambda I-Gene +
) O +
is O +
a O +
newly O +
identified O +
IFN B-Gene +
family I-Gene +
which O +
belongs O +
to O +
the O +
class O +
II O +
cytokines B-Gene +
. O +

The O +
three O +
members O +
of O +
this O +
family O +
represent O +
antiviral O +
activities O +
like O +
other O +
IFNs B-Gene +
. O +

In O +
the O +
present O +
study O +
, O +
recombinant O +
human O +
IFN B-Gene -
- I-Gene -
lambda1 I-Gene +
( O +
rhIFN B-Gene -
- I-Gene -
lambda1 I-Gene +
) O +
was O +
produced O +
by O +
using O +
the O +
methylotrophic O +
yeast O +
Pichia O +
pastoris O +
( O +
P. O +
pastoris O +
) O +
expression O +
system O +
. O +

cDNAs O +
encoding O +
amino O +
acids O +
23 O +
- O +
200 O +
or O +
20 O +
- O +
200 O +
of O +
human O +
IFN B-Gene -
- I-Gene -
lambda1 I-Gene +
were O +
cloned O +
and O +
joined O +
to O +
sequence O +
encoding O +
the O +
leader O +
region O +
( O +
prepro O +
segment O +
) O +
of O +
the O +
precursor O +
of O +
Saccharomyces O +
cerevisiae O +
alpha B-Gene +
- I-Gene +
factor I-Gene +
. O +

The O +
two O +
hybrid O +
genes O +
were O +
subcloned O +
into O +
yeast O +
integrative O +
vector O +
pAO815 O +
separately O +
to O +
construct O +
expression O +
plasmids O +
bearing O +
four O +
tandem O +
copies O +
of O +
IFN B-Gene -
- I-Gene -
lambda1 I-Gene +
expression O +
cassettes O +
. O +

The O +
expression O +
plasmids O +
were O +
then O +
used O +
to O +
transform O +
into O +
P. O +
pastoris O +
strain O +
GS115 O +
, O +
resulting O +
in O +
recombinant O +
strains O +
GS115 O +
/ O +
IFNlambda1P B-Gene +
and O +
GS115 O +
/ O +
IFNlambda1 B-Gene -
G I-Gene +
with O +
Mut O +
( O +
+ O +
) O +
or O +
Mut B-Gene +
( I-Gene +
s I-Gene +
) I-Gene +
phenotype O +
. O +

rhIFN B-Gene -
- I-Gene -
lambda1 I-Gene +
was O +
secreted O +
into O +
the O +
medium O +
upon O +
methanol O +
induction O +
. O +

In O +
GS115 O +
/ O +
IFNlambda1P B-Gene +
, O +
however O +
, O +
KEX2 B-Gene +
cleavage O +
for O +
mature O +
rhIFN B-Gene +
- I-Gene +
lambda1 I-Gene +
generation O +
was O +
inhibited O +
by O +
a O +
proline O +
at O +
[ O +
Formula O +
: O +
see O +
text O +
] O +
and O +
the O +
products O +
were O +
different O +
from O +
anticipation O +
. O +

GS115 O +
/ O +
IFNlambda1 B-Gene -
G I-Gene +
strain O +
secreted O +
two O +
forms O +
of O +
mature O +
rhIFN B-Gene +
- I-Gene +
lambda1 I-Gene +
with O +
the O +
same O +
N O +
- O +
terminal O +
sequence O +
and O +
different O +
molecular O +
weight O +
. O +

Periodic O +
acid O +
- O +
Schiff O +
( O +
PAS O +
) O +
staining O +
indicated O +
that O +
these O +
proteins O +
were O +
glycosylated O +
. O +

The O +
yield O +
of O +
low O +
- O +
glycosylated O +
rhIFN B-Gene +
- I-Gene +
lambda1 I-Gene +
in O +
GS115 O +
/ O +
IFNlambda1 B-Gene -
G I-Gene +
strain O +
was O +
approximately O +
65 O +
mg O +
l O -
( O -
-1 O -
) O +
in O +
shaking O +
flasks O +
, O +
representing O +
around O +
57 O +
% O +
of O +
the O +
total O +
secreted O +
proteins O +
. O +

rhIFN B-Gene -
- I-Gene -
lambda1 I-Gene +
was O +
purified O +
by O +
cation O +
exchange O +
chromatography O +
and O +
gel O +
filtration O +
. O +

The O +
purified O +
rhIFN B-Gene +
- I-Gene +
lambda1 I-Gene +
showed O +
specific O +
efficiency O +
to O +
activate O +
signal B-Gene +
transducer I-Gene +
and I-Gene +
activator I-Gene +
of I-Gene +
transcription I-Gene +
1 I-Gene +
( O +
STAT1 B-Gene +
) O +
and O +
STAT2 B-Gene +
that O +
was O +
comparable O +
to O +
that O +
of O +
commercial O +
IFNalpha2a B-Gene +
. O +

Crystal O +
structure O +
of O +
the O +
E1 O +
component O +
of O +
the O +
Escherichia O +
coli O +
2-oxoglutarate B-Gene +
dehydrogenase I-Gene +
multienzyme I-Gene +
complex I-Gene +
. O +

The O +
thiamine O +
- O +
dependent O +
E1o O +
component O +
( O +
EC B-Gene +
1.2.4.2 I-Gene +
) O +
of O +
the O +
2-oxoglutarate B-Gene +
dehydrogenase I-Gene +
complex I-Gene +
catalyses O +
a O +
rate O +
- O +
limiting O +
step O +
of O +
the O +
tricarboxylic O +
acid O +
cycle O +
( O +
TCA O +
) O +
of O +
aerobically O +
respiring O +
organisms O +
. O +

We O +
describe O +
the O +
crystal O +
structure O +
of O +
Escherichia O +
coli O +
E1o O +
in O +
its O +
apo O +
and O +
holo O +
forms O +
at O +
2.6 O +
A O +
and O +
3.5 O +
A O +
resolution O +
, O +
respectively O +
. O +

The O +
structures O +
reveal O +
the O +
characteristic O +
fold O +
that O +
binds O +
thiamine O +
diphosphate O +
and O +
resemble O +
closely O +
the O +
alpha O -
( O -
2 O -
) O -
beta O -
( O -
2 O -
) O +
hetero O +
- O +
tetrameric O +
E1 O +
components O +
of O +
other O +
2-oxo B-Gene +
acid I-Gene +
dehydrogenase I-Gene +
complexes I-Gene +
, O +
except O +
that O +
in O +
E1o O +
, O +
the O +
alpha O +
and O +
beta O +
subunits O +
are O +
fused O +
as O +
a O +
single O +
polypeptide O +
. O +

The O +
extended O +
segment O +
that O +
links O +
the O +
alpha O +
- O +
like O +
and O +
beta O +
- O +
like O +
domains O +
forms O +
a O +
pocket O +
occupied O +
by O +
AMP O +
, O +
which O +
is O +
recognised O +
specifically O +
. O +

Also O +
distinctive O +
to O +
E1o O +
are O +
N O +
- O +
terminal O +
extensions O +
to O +
the O +
core O +
fold O +
, O +
and O +
which O +
may O +
mediate O +
interactions O +
with O +
other O +
components O +
of O +
the O +
2-oxoglutarate B-Gene +
dehydrogenase I-Gene +
multienzyme I-Gene +
complex I-Gene +
. O +

The O +
active O +
site O +
pocket O +
contains O +
a O +
group O +
of O +
three O +
histidine O +
residues O +
and O +
one O +
serine O +
that O +
appear O +
to O +
confer O +
substrate O +
specificity O +
and O +
the O +
capacity O +
to O +
accommodate O +
the O +
TCA O +
metabolite O +
oxaloacetate O +
. O +

Oxaloacetate O +
inhibits O +
E1o O +
activity O +
at O +
physiological O +
concentrations O +
, O +
and O +
we O +
suggest O +
that O +
the O +
inhibition O +
may O +
allow O +
coordinated O +
activity O +
within O +
the O +
TCA O +
cycle O +
. O +

We O +
discuss O +
the O +
implications O +
for O +
metabolic O +
control O +
in O +
facultative O +
anaerobes O +
, O +
and O +
for O +
energy O +
homeostasis O +
of O +
the O +
mammalian O +
brain O +
. O +

Expression O +
of O +
the O +
halobacterial O +
transducer O +
protein O +
HtrII B-Gene +
from O +
Natronomonas O +
pharaonis O +
in O +
Escherichia O +
coli O +
. O +

Archaeal O +
phototaxis O +
is O +
mediated O +
by O +
sensory B-Gene +
rhodopsins I-Gene +
which O +
form O +
complexes O +
with O +
their O +
cognate O +
transducers O +
. O +

Whereas O +
the O +
receptors O +
sensory B-Gene +
rhodopsin I-Gene +
I I-Gene +
and O +
sensory B-Gene +
rhodopsin I-Gene +
II I-Gene +
( O +
SRII B-Gene +
) O +
have O +
been O +
expressed O +
in O +
Escherichia O +
coli O +
( O +
E. O +
coli O +
) O +
only O +
shortened O +
fragments O +
of O +
HtrII B-Gene +
from O +
Natronomonas O +
pharaonis O +
( O +
NpHtrII B-Gene +
) O +
are O +
available O +
. O +

Here O +
we O +
describe O +
the O +
heterologous O +
expression O +
of O +
full O +
length O +
NpHtrII B-Gene +
which O +
was O +
achieved O +
in O +
yields O +
of O +
up O +
to O +
0.9 O +
mg O +
per O +
litre O +
cell O +
culture O +
. O +

Gel O +
filtration O +
analysis O +
reveals O +
the O +
tendency O +
of O +
the O +
transducer O +
to O +
form O +
dimers O +
and O +
higher O +
- O +
order O +
oligomers O +
which O +
was O +
also O +
observed O +
when O +
complexed O +
to O +
NpSRII B-Gene +
. O +

A O +
circular O +
dichroism O +
( O +
CD O +
) O +
spectrum O +
of O +
NpHtrII B-Gene +
is O +
comparable O +
to O +
those O +
obtained O +
for O +
the O +
E. O +
coli O +
chemoreceptors B-Gene +
indicating O +
a O +
similar O +
folding O +
with O +
predominantly O +
alpha O -
- O -
helical O +
structure O +
. O +

NpHtrII B-Gene +
dissociates O +
from O +
the O +
NpSRII B-Gene +
/ O +
HtrII B-Gene +
complex O +
with O +
an O +
apparent O +
K O -
( O -
D O -
) O +
of O +
about O +
0.6 O +
microM O +
. O +

Photocycle O +
kinetics O +
of O +
the O +
complex O +
is O +
comparable O +
to O +
that O +
obtained O +
for O +
NpSRII B-Gene +
in O +
complex O +
with O +
a O +
truncated O +
transducer O +
with O +
slight O +
differences O +
in O +
the O +
M O -
- O -
decay O +
. O +

The O +
data O +
indicate O +
that O +
the O +
heterologously O +
expressed O +
NpHtrII B-Gene +
adopt O +
a O +
native O +
like O +
structure O +
, O +
providing O +
the O +
means O +
for O +
elucidating O +
transmembrane O +
signal O +
transduction O +
and O +
activation O +
of O +
microbial O +
signalling O +
cascades O +
. O +

Low O +
molecular O +
weight O +
proteins O +
of O +
outer O +
membrane O +
of O +
Salmonella O +
typhimurium O +
are O +
immunogenic O +
in O +
Salmonella O +
induced O +
reactive O +
arthritis O +
revealed O +
by O +
proteomics O +
. O +

In O +
patients O +
with O +
reactive O +
arthritis O +
( O +
ReA O +
) O +
/ O +
undifferentiated O +
spondyloarthropathy O +
( O +
uSpA O +
) O +
, O +
synovial O +
fluid O +
mononuclear O +
cells O +
( O +
SFMC O +
) O +
show O +
proliferation O +
to O +
bacterial O +
antigens O +
that O +
trigger O +
ReA O +
, O +
i.e. O +
Chlamydia O +
, O +
Yersinia O +
, O +
Campylobactor O +
, O +
Shigella O +
and O +
Salmonella O +
species O +
. O +

We O +
have O +
shown O +
previously O +
that O +
SFMC O +
proliferate O +
significantly O +
to O +
outer O +
membrane O +
proteins O +
of O +
S O +
typhimurium O +
in O +
Salmonella O +
induced O +
ReA O +
. O +

In O +
the O +
present O +
study O +
we O +
characterized O +
the O +
immunoreactive O +
fractions O +
of O +
outer O +
membrane O +
protein O +
( O +
Omp O +
) O +
of O +
S O +
typhimurium O +
in O +
Salmonella O +
induced O +
ReA O +
. O +

Omp O +
of O +
Salmonella O +
was O +
isolated O +
and O +
fractionated O +
by O +
continuous O +
elution O +
sodium O +
dodecyl O +
sulphate O +
- O +
polyacrylamide O +
gel O +
electrophoresis O +
( O +
SDS O +
- O +
PAGE O +
) O +
using O +
Prep O +
- O +
Cell O +
into O +
eight O +
Omp O +
fractions O +
based O +
on O +
molecular O +
weight O +
. O +

Twenty O -
- O -
three O +
patients O +
with O +
ReA O +
were O +
screened O +
for O +
the O +
bacterial O +
trigger O +
using O +
the O +
SFMC O +
proliferative O +
response O +
to O +
crude O +
lysates O +
of O +
Y O +
enterocolitica O +
, O +
S O +
flexneri O +
, O +
C O +
jejuni O +
and O +
S O +
typhimurium O +
using O +
thymidine O +
uptake O +
assay O +
. O +

SFMC O +
from O +
patients O +
with O +
salmonella O +
induced O +
ReA O +
were O +
tested O +
against O +
eight O +
fractions O +
. O +

Seven O +
of O +
23 O +
patients O +
with O +
ReA O +
had O +
S O +
typhimurium O +
- O +
induced O +
ReA O +
. O +

Of O +
these O +
seven O +
patients O +
, O +
five O +
patients O +
SFMC O +
had O +
a O +
significant O +
stimulation O +
index O +
( O +
SI O +
) O +
against O +
< O +
22 O +
, O +
22 O +
- O +
26 O +
, O +
25 O +
- O +
35 O +
and O +
28 O +
- O +
40 O +
kDa O +
fractions O +
of O +
Omp O +
. O +

These O +
fractions O +
were O +
analysed O +
by O +
SDS O +
- O +
PAGE O +
and O +
matrix O +
- O +
assisted O +
laser O +
desorption O +
ionization O +
time O +
- O +
of O +
- O +
flight O +
( O +
MALDI O +
- O +
TOF O +
) O +
mass O +
spectrometry O +
, O +
which O +
revealed O +
10 O +
proteins O +
. O +

These O +
proteins O +
were O +
37 O +
kDa O +
OmpA B-Gene +
, O +
33 O +
kDa O +
TsX B-Gene +
, O +
28 O +
kDa O +
putative O +
Omp O +
, O +
28 O +
kDa O +
Vac B-Gene +
J I-Gene +
, O +
39 O +
kDa O +
OmpD B-Gene +
, O +
18 O +
kDa O +
OmpX B-Gene +
, O +
23 O +
kDa O +
OmpW B-Gene +
, O +
43 O +
kDa O +
OmpS1 B-Gene +
and O +
19 O +
kDa O +
peptidoglycan O +
- O +
associated O +
lipoprotein O +
. O +

In O +
conclusion O +
, O +
for O +
the O +
first O +
time O +
we O +
have O +
identified O +
some O +
low O +
molecular O +
weight O +
proteins O +
in O +
the O +
Omps O +
of O +
Salmonella O +
which O +
are O +
T O +
cells O +
immunoreactive O +
in O +
patients O +
with O +
salmonella O +
induced O +
ReA O +
/ O +
uSpA O +
. O +

The O +
Arl4 B-Gene +
family I-Gene +
of I-Gene +
small I-Gene +
G I-Gene +
proteins I-Gene +
can O +
recruit O +
the O +
cytohesin B-Gene +
Arf6 I-Gene +
exchange I-Gene +
factors I-Gene +
to O +
the O +
plasma O +
membrane O +
. O +

The O +
small B-Gene +
GTPase I-Gene +
Arf6 B-Gene +
regulates O +
endocytosis O +
, O +
actin B-Gene +
dynamics O +
, O +
and O +
cell O +
adhesion O +
, O +
and O +
one O +
of O +
its O +
major O +
activators O +
is O +
the O +
exchange B-Gene +
factor I-Gene +
Arf I-Gene +
nucleotide I-Gene +
- I-Gene +
binding I-Gene +
site I-Gene +
opener I-Gene +
( O +
ARNO B-Gene +
) O +
, O +
also O +
called O +
cytohesin-2 B-Gene +
[ O +
1 O +
, O +
2 O +
] O +
. O +

ARNO B-Gene +
must O +
be O +
recruited O +
from O +
the O +
cytosol O +
to O +
the O +
plasma O +
membrane O +
in O +
order O +
to O +
activate O +
Arf6 B-Gene +
, O +
and O +
in O +
addition O +
to O +
a O +
Sec7 B-Gene +
nucleotide O +
- O +
exchange O +
domain O +
it O +
contains O +
a O +
C O +
- O +
terminal O +
pleckstrin B-Gene +
homology O +
( O +
PH O +
) O +
domain O +
that O +
binds O +
phosphoinositides O +
[ O +
3 O +
, O +
4 O +
] O +
. O +

ARNO B-Gene +
and O +
its O +
three O +
relatives O +
, O +
cytohesin-1 B-Gene +
, O +
Grp1 B-Gene +
/ O +
cytohesin B-Gene +
- I-Gene +
3 I-Gene +
, O +
and O +
cytohesin B-Gene +
- I-Gene +
4 I-Gene +
, O +
are O +
expressed O +
as O +
two O +
splice O +
variants O +
, O +
with O +
either O +
two O +
or O +
three O +
glycines O +
in O +
a O +
loop O +
in O +
the O +
phosphoinositide O +
- O +
binding O +
pocket O +
of O +
the O +
PH O +
domain O +
[ O +
5 O +
, O +
6 O +
] O +
. O +

The O +
diglycine O +
form O +
binds O +
PtdIns O -
( O -
3,4,5 O -
) O -
P O -
( O -
3 O -
) O +
with O +
high O +
affinity O +
and O +
mediates O +
recruitment O +
of O +
cytohesins B-Gene +
to O +
the O +
plasma O +
membrane O +
in O +
response O +
to O +
insulin B-Gene +
and O +
growth B-Gene +
factors I-Gene +
[ O +
7 O +
, O +
8 O +
] O +
. O +

However O +
, O +
the O +
triglycine O +
form O +
has O +
only O +
micromolar O +
affinity O +
for O +
both O +
PtdIns O -
( O -
3,4,5 O -
) O -
P O -
( O -
3 O -
) O +
and O +
PtdIns O -
( O -
4,5 O -
) O -
P O -
( O -
2 O -
) O +
, O +
affinities O +
that O +
are O +
insufficient O +
to O +
confer O +
membrane O +
recruitment O +
, O +
raising O +
the O +
question O +
of O +
how O +
the O +
triglycine O +
forms O +
of O +
cytohesins B-Gene +
are O +
regulated O +
[ O +
5 O +
, O +
9 O +
] O +
. O +

Here O +
we O +
show O +
that O +
three O +
related O +
Arf B-Gene +
- I-Gene +
like I-Gene +
GTPases I-Gene +
of O +
unknown O +
function O +
, O +
Arl4a B-Gene +
, O +
Arl4c B-Gene +
, O +
and O +
Arl4d B-Gene +
, O +
are O +
able O +
to O +
recruit O +
ARNO B-Gene +
and O +
other O +
cytohesins B-Gene +
to O +
the O +
plasma O +
membrane O +
by O +
binding O +
to O +
their O +
PH O +
domains O +
irrespective O +
of O +
whether O +
they O +
are O +
in O +
the O +
diglycine O +
or O +
triglycine O +
form O +
. O +

The O +
Arl4 B-Gene +
family I-Gene +
thus O +
defines O +
a O +
signal O +
- O +
transduction O +
pathway O +
that O +
can O +
mediate O +
the O +
plasma O +
- O +
membrane O +
recruitment O +
of O +
cytohesins B-Gene +
independently O +
of O +
a O +
requirement O +
for O +
the O +
generation O +
of O +
PtdIns O -
( O -
3,4,5 O -
) O -
P O -
( O -
3 O -
) O +
. O +

Stuck O +
in O +
reverse O +
: O +
loss O +
of O +
LC1 B-Gene +
in O +
Trypanosoma O +
brucei O +
disrupts O +
outer O +
dynein B-Gene +
arms O +
and O +
leads O +
to O +
reverse O +
flagellar O +
beat O +
and O +
backward O +
movement O +
. O +

Axonemal O +
dyneins B-Gene +
are O +
multisubunit O +
molecular O +
motors O +
that O +
provide O +
the O +
driving O +
force O +
for O +
flagellar O +
motility O +
. O +

Dynein B-Gene +
light I-Gene +
chain I-Gene +
1 I-Gene +
( O +
LC1 B-Gene +
) O +
has O +
been O +
well O +
studied O +
in O +
Chlamydomonas O +
reinhardtii O +
and O +
is O +
unique O +
among O +
all O +
dynein B-Gene +
components O +
as O +
the O +
only O +
protein O +
known O +
to O +
bind O +
directly O +
to O +
the O +
catalytic O +
motor O +
domain O +
of O +
the O +
dynein B-Gene +
heavy I-Gene +
chain I-Gene +
. O +

However O +
, O +
the O +
role O +
of O +
LC1 B-Gene +
in O +
dynein B-Gene +
assembly O +
and O +
/ O +
or O +
function O +
is O +
unknown O +
because O +
no O +
mutants O +
have O +
previously O +
been O +
available O +
. O +

We O +
identified O +
an O +
LC1 B-Gene +
homologue O +
( O +
TbLC1 B-Gene +
) O +
in O +
Trypanosoma O +
brucei O +
and O +
have O +
investigated O +
its O +
role O +
in O +
trypanosome O +
flagellar O +
motility O +
using O +
epitope O +
tagging O +
and O +
RNAi O +
studies O +
. O +

TbLC1 B-Gene +
is O +
localized O +
along O +
the O +
length O +
of O +
the O +
flagellum O +
and O +
partitions O +
between O +
the O +
axoneme O +
and O +
soluble O +
fractions O +
following O +
detergent O +
and O +
salt O +
extraction O +
. O +

RNAi O +
silencing O +
of O +
TbLC1 B-Gene +
gene O +
expression O +
results O +
in O +
the O +
complete O +
loss O +
of O +
the O +
dominant O +
tip O +
- O +
to O +
- O +
base O +
beat O +
that O +
is O +
a O +
hallmark O +
of O +
trypanosome O +
flagellar O +
motility O +
and O +
the O +
concomitant O +
emergence O +
of O +
a O +
sustained O +
reverse O +
beat O +
that O +
propagates O +
base O +
- O +
to O +
- O +
tip O +
and O +
drives O +
cell O +
movement O +
in O +
reverse O +
. O +

Ultrastructure O +
analysis O +
revealed O +
that O +
outer O +
arm O +
dyneins O +
are O +
disrupted O +
in O +
TbLC1 O +
mutants O +
. O +

Therefore O +
LC1 B-Gene +
is O +
required O +
for O +
stable O +
dynein B-Gene +
assembly O +
and O +
forward O +
motility O +
in O +
T. O +
brucei O +
. O +

Our O +
work O +
provides O +
the O +
first O +
functional O +
analysis O +
of O +
LC1 B-Gene +
in O +
any O +
organism O +
. O +

Together O +
with O +
the O +
recent O +
findings O +
in O +
T. O +
brucei O +
DNAI1 B-Gene +
mutants O +
[ O +
Branche O +
et O +
al. O +
( O +
2006 O +
) O +
. O +
Conserved O +
and O +
specific O +
functions O +
of O +
axoneme O +
components O +
in O +
trypanosome O +
motility O -
. O +
J. O +
Cell O +
Sci O -
. O +
119 O +
, O +
3443 O +
- O +
3455 O +
] O +
, O +
our O +
data O +
indicate O +
functionally O +
specialized O +
roles O +
for O +
outer O +
arm O +
dyneins O +
in O +
T. O +
brucei O +
and O +
C. O +
reinhardtii O +
. O +

Understanding O +
these O +
differences O +
will O +
provide O +
a O +
more O +
robust O +
description O +
of O +
the O +
fundamental O +
mechanisms O +
underlying O +
flagellar O +
motility O +
and O +
will O +
aid O +
efforts O +
to O +
exploit O +
the O +
trypanosome O +
flagellum O +
as O +
a O +
drug O +
target O +
. O +

Requirement O +
for O +
the O +
dynein B-Gene +
light I-Gene +
chain I-Gene +
km23 I-Gene -
- I-Gene -
1 I-Gene +
in O +
a O +
Smad2 B-Gene +
- O +
dependent O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
beta I-Gene +
signaling O +
pathway O +
. O +

We O +
have O +
identified O +
km23 B-Gene -
- I-Gene -
1 I-Gene +
as O +
a O +
novel O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
beta I-Gene +
( I-Gene +
TGFbeta I-Gene +
) I-Gene +
receptor I-Gene +
( I-Gene +
TbetaR I-Gene +
) I-Gene +
- O +
interacting O +
protein O +
that O +
is O +
also O +
a O +
light B-Gene +
chain I-Gene +
of I-Gene +
the I-Gene +
motor I-Gene +
protein I-Gene +
dynein I-Gene +
( O +
dynein B-Gene +
light I-Gene +
chain I-Gene +
) O +
. O +

Herein O +
, O +
we O +
demonstrate O +
by O +
sucrose O +
gradient O +
analyses O +
that O +
, O +
in O +
the O +
presence O +
of O +
TGFbeta B-Gene +
but O +
not O +
in O +
the O +
absence O +
, O +
km23 B-Gene -
- I-Gene -
1 I-Gene +
was O +
present O +
in O +
early O +
endosomes O +
with O +
the O +
TbetaRs B-Gene +
. O +

Further O +
, O +
confocal O +
microscopy O +
studies O +
indicate O +
that O +
endogenous O +
km23 B-Gene -
- I-Gene -
1 I-Gene +
was O +
co O +
- O +
localized O +
with O +
endogenous O +
Smad2 B-Gene +
at O +
early O +
times O +
after O +
TGFbeta B-Gene +
treatment O +
, O +
prior O +
to O +
Smad2 B-Gene +
translocation O +
to O +
the O +
nucleus O +
. O +

In O +
addition O +
, O +
immunoprecipitation O +
/ O +
blot O +
analyses O +
showed O +
that O +
TGFbeta B-Gene +
regulated O +
the O +
interaction O +
between O +
endogenous O +
km23 B-Gene -
- I-Gene -
1 I-Gene +
and O +
endogenous O +
Smad2 B-Gene +
in O +
vivo O +
. O +

Blockade O +
of O +
km23 B-Gene -
- I-Gene -
1 I-Gene +
using O +
a O +
small O +
interfering O +
RNA O +
approach O +
resulted O +
in O +
a O +
reduction O +
in O +
both O +
total O +
intracellular O +
Smad2 B-Gene +
levels O +
and O +
in O +
nuclear O +
levels O +
of O +
phosphorylated O +
Smad2 B-Gene +
after O +
TGFbeta B-Gene +
treatment O +
. O +

This O +
decrease O +
was O +
reversed O +
by O +
lactacystin O +
, O +
a O +
specific O +
inhibitor O +
of O +
the O +
26 O +
S O +
proteasome O +
, O +
suggesting O +
that O +
knockdown O +
of O +
km23 B-Gene -
- I-Gene -
1 I-Gene +
causes O +
proteasomal O +
degradation O +
of O +
phosphorylated O +
( O +
i.e. O +
activated O +
) O +
Smad2 B-Gene +
. O +

Blockade O +
of O +
km23 B-Gene -
- I-Gene -
1 I-Gene +
also O +
resulted O +
in O +
a O +
reduction O +
in O +
TGFbeta B-Gene +
/ O +
Smad2 B-Gene +
- O +
dependent O +
ARE O +
- O +
Lux B-Gene +
transcriptional O +
activity O +
, O +
which O +
was O +
rescued O +
by O +
a O +
km23 B-Gene -
- I-Gene -
1 I-Gene +
small O +
interfering O +
RNA O +
- O +
resistant O +
construct O +
. O +

In O +
contrast O +
, O +
a O +
reduction O +
in O +
TGFbeta B-Gene +
/ O +
Smad3 B-Gene +
- O +
dependent O +
SBE2 O +
- O +
Luc B-Gene +
transcriptional O +
activity O +
did O +
not O +
occur O +
under O +
similar O +
conditions O +
. O +

Furthermore O +
, O +
overexpression O +
of O +
the O +
dynactin B-Gene +
subunit O +
dynamitin B-Gene +
, O +
which O +
is O +
known O +
to O +
disrupt O +
dynein B-Gene +
- O +
mediated O +
intracellular O +
transport O +
, O +
blocked O +
TGFbeta B-Gene +
- O +
stimulated O +
nuclear O +
translocation O +
of O +
Smad2 B-Gene +
. O +

Collectively O +
, O +
our O +
findings O +
indicate O +
for O +
the O +
first O +
time O +
that O +
a O +
dynein B-Gene +
light I-Gene +
chain I-Gene +
is O +
required O +
for O +
a O +
Smad2 B-Gene +
- O +
dependent O +
TGFbeta B-Gene +
signaling O +
pathway O +
. O +

Improved O +
chemical O +
synthesis O +
and O +
demonstration O +
of O +
the O +
relaxin B-Gene +
receptor I-Gene +
binding O +
affinity O +
and O +
biological O +
activity O +
of O +
mouse O +
relaxin B-Gene +
. O +

The O +
primary O +
stored O +
and O +
circulating O +
form O +
of O +
relaxin B-Gene +
in O +
humans O +
, O +
human B-Gene +
gene I-Gene +
- I-Gene +
2 I-Gene +
( I-Gene +
H2 I-Gene +
) I-Gene +
relaxin I-Gene +
, O +
has O +
potent O +
antifibrotic O +
properties O +
with O +
rapidly O +
occurring O +
efficacy O +
. O +

However O +
, O +
when O +
administered O +
to O +
experimental O +
models O +
of O +
fibrosis O +
, O +
H2 B-Gene +
relaxin I-Gene +
can O +
only O +
be O +
applied O +
over O +
short O +
- O +
term O +
( O +
2 O +
- O +
4 O +
week O +
) O +
periods O +
, O +
due O +
to O +
rodents O +
mounting O +
an O +
antibody O +
response O +
to O +
the O +
exogenous O +
human O +
relaxin B-Gene +
, O +
resulting O +
in O +
delayed O +
clearance O +
and O +
, O +
hence O +
, O +
increased O +
and O +
variable O +
circulating O +
levels O +
. O +

To O +
overcome O +
this O +
problem O +
, O +
the O +
current O +
study O +
investigated O +
the O +
therapeutic O +
potential O +
of O +
mouse O +
relaxin B-Gene +
over O +
long O +
- O +
term O +
exposure O +
in O +
vivo O +
. O +

Mouse O +
relaxin B-Gene +
is O +
unique O +
among O +
the O +
known O +
relaxins B-Gene +
in O +
that O +
it O +
possesses O +
an O +
extra O +
residue O +
within O +
the O +
C O +
- O +
terminal O +
region O +
of O +
its O +
A O +
- O +
chain O +
. O +

To O +
enable O +
a O +
detailed O +
assessment O +
of O +
its O +
receptor O +
interaction O +
and O +
biological O +
properties O +
, O +
it O +
was O +
chemically O +
synthesized O +
in O +
good O +
overall O +
yield O +
by O +
the O +
separate O +
preparation O +
of O +
each O +
of O +
its O +
A O +
- O +
and O +
B O +
- O +
chains O +
followed O +
by O +
regioselective O +
formation O +
of O +
each O +
of O +
the O +
intramolecular O +
and O +
two O +
intermolecular O +
disulfide O +
bonds O +
. O +

Murine O +
relaxin B-Gene +
was O +
shown O +
to O +
bind O +
with O +
high O +
affinity O +
to O +
the O +
human O +
, O +
mouse O +
, O +
and O +
rat O +
RXFP1 B-Gene +
( O +
primary O +
relaxin B-Gene +
) O +
receptor O +
but O +
with O +
a O +
slightly O +
lower O +
affinity O +
to O +
that O +
of O +
H2 B-Gene +
relaxin I-Gene +
. O +

When O +
administered O +
to O +
relaxin B-Gene +
- O +
deficient O +
mice O +
( O +
which O +
undergo O +
an O +
age O +
- O +
dependent O +
progression O +
of O +
organ O +
fibrosis O +
) O +
over O +
a O +
4 O +
month O +
treatment O +
period O +
, O +
mouse O +
relaxin B-Gene +
was O +
able O +
to O +
significantly O +
inhibit O +
the O +
progression O +
of O +
collagen B-Gene +
accumulation O +
in O +
several O +
organs O +
including O +
the O +
lung O +
, O +
kidney O +
, O +
testis O +
, O +
and O +
skin O +
( O +
all O +
p O +
< O +
0.05 O +
vs O +
untreated O +
group O +
) O +
, O +
consistent O +
with O +
the O +
actions O +
of O +
H2 B-Gene +
relaxin I-Gene +
. O +

These O +
combined O +
data O +
demonstrate O +
that O +
mouse O +
relaxin B-Gene +
can O +
effectively O +
inhibit O +
collagen B-Gene +
deposition O +
and O +
accumulation O +
( O +
fibrosis O +
) O +
over O +
long O +
- O +
term O +
treatment O +
periods O +
. O +

KIRs B-Gene +
and O +
autoimmune O +
disease O +
: O +
studies O +
in O +
systemic O +
lupus O +
erythematosus O +
and O +
scleroderma O +
. O +

We O +
investigated O +
killer B-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIRs B-Gene +
) O +
and O +
the O +
human B-Gene +
leukocyte I-Gene +
antigen I-Gene +
( I-Gene +
HLA I-Gene +
) I-Gene +
- I-Gene +
C I-Gene +
ligands O +
for O +
the O +
corresponding O +
inhibitory O +
KIRs B-Gene +
in O +
Caucasian O +
patients O +
, O +
304 O +
with O +
systemic O +
lupus O +
erythematosus O +
( O +
SLE O +
) O +
and O +
90 O +
with O +
scleroderma O +
[ O +
or O +
progressive O +
systemic O +
sclerosis O +
( O +
PSS O +
) O +
] O +
compared O +
with O +
416 O +
Caucasian O +
controls O +
. O +

Compared O +
with O +
controls O +
, O +
KIR2DS1 B-Gene +
in O +
the O +
absence O +
of O +
KIR2DS2 B-Gene +
was O +
increased O +
in O +
both O +
SLE O +
( O +
P O +
= O +
0.04 O +
) O +
and O +
PSS O +
( O +
P O +
= O +
0.02 O +
) O +
. O +

Only O +
42 O +
% O +
of O +
KIR2DS1 B-Gene +
- O +
positive O +
PSS O +
patients O +
had O +
the O +
appropriate O +
HLA B-Gene -
- I-Gene -
C I-Gene +
ligand O +
for O +
the O +
corresponding O +
inhibitory O +
KIR B-Gene +
compared O +
with O +
61 O +
% O +
of O +
KIR2DS1 B-Gene +
positive O +
controls O +
( O +
P O +
= O +
0.02 O +
) O +
. O +

In O +
the O +
PSS O +
group O +
the O +
presence O +
of O +
at O +
least O +
either O +
activating O +
KIR2DS1 B-Gene +
and/or O +
2DS2 B-Gene +
was O +
significantly O +
increased O +
in O +
patients O +
when O +
compared O +
with O +
controls O +
( O +
P O +
= O +
0.001 O +
) O +
. O +

This O +
suggests O +
that O +
KIR B-Gene +
receptors O +
play O +
a O +
role O +
in O +
susceptibility O +
to O +
both O +
PSS O +
and O +
SLE O +
. O +

Increases O +
in O +
expression O +
of O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
eta I-Gene +
and O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
zeta I-Gene +
transcripts O +
during O +
neuroprotection O +
induced O +
by O +
delta9 O +
- O +
tetrahydrocannabinol O +
in O +
AF5 O +
cells O +
. O +

The O +
molecular O +
mechanisms O +
involved O +
in O +
N O -
- O -
methyl O -
- O -
D O -
- O -
aspartate O +
( O +
NMDA O +
) O +
- O +
induced O +
cell O +
death O +
and O +
Delta9 O +
- O +
tetrahydrocannabinol O +
( O +
THC O +
) O +
- O +
induced O +
neuroprotection O +
were O +
investigated O +
in O +
vitro O +
with O +
an O +
AF5 O +
neural O +
progenitor O +
cell O +
line O +
model O +
. O +

By O +
microarray O +
analysis O +
, O +
Ywhah B-Gene +
, O +
CK1 B-Gene +
, O +
Hsp60 B-Gene +
, O +
Pdcd B-Gene +
4 I-Gene +
, O +
and O +
Pdcd B-Gene +
7 I-Gene +
were O +
identified O +
as O +
being O +
strongly O +
regulated O +
by O +
both O +
NMDA O +
toxicity O +
and O +
THC O +
neuroprotection O +
. O +

The O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
eta I-Gene +
( O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3eta I-Gene +
; O +
gene O +
symbol O +
Ywhah B-Gene +
) O +
and O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
zeta I-Gene +
( O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3zeta I-Gene +
; O +
gene O +
symbol O +
Ywhaz B-Gene +
) O +
transcripts O +
were O +
deceased O +
by O +
NMDA O +
treatment O +
and O +
increased O +
by O +
THC O +
treatment O +
prior O +
to O +
NMDA O +
, O +
as O +
measured O +
by O +
cDNA O +
microarray O +
analysis O +
and O +
quantitative O +
real O +
- O +
time O +
RT O +
- O +
PCR O +
. O +

Other O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
isoforms O +
were O +
unchanged O +
. O +

Whereas O +
up O +
- O +
regulation O +
of O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3zeta I-Gene +
expression O +
was O +
observed O +
30 O +
min O +
after O +
treatment O +
with O +
THC O +
plus O +
NMDA O +
, O +
down O +
- O +
regulation O +
by O +
NMDA O +
alone O +
was O +
not O +
seen O +
until O +
16 O +
hr O +
after O +
treatment O +
. O +

By O +
Western O +
blotting O +
, O +
THC O +
increased O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
protein I-Gene +
only O +
in O +
cells O +
that O +
were O +
also O +
treated O +
with O +
NMDA O +
. O +

Overexpression O +
of O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3eta I-Gene +
or O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3zeta I-Gene +
by O +
transient O +
plasmid O +
transfection O +
increased O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
protein I-Gene +
levels O +
and O +
decreased O +
NMDA O +
- O +
induced O +
cell O +
death O +
. O +

These O +
data O +
suggest O +
that O +
increases O +
in O +
14 B-Gene -
- I-Gene -
3 I-Gene -
- I-Gene -
3 I-Gene +
proteins I-Gene +
mediate O +
THC O +
- O +
induced O +
neuroprotection O +
under O +
conditions O +
of O +
NMDA O +
- O +
induced O +
cellular O +
stress O +
. O +

Analysis O +
of O +
KIR B-Gene +
gene O +
frequencies O +
in O +
HLA B-Gene +
class I-Gene +
I I-Gene +
characterised O +
bladder O +
, O +
colorectal O +
and O +
laryngeal O +
tumours O +
. O +

Three O +
cohorts O +
of O +
patients O +
with O +
laryngeal O +
, O +
bladder O +
or O +
colorectal O +
tumours O +
were O +
investigated O +
for O +
frequency O +
of O +
killer B-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
( O +
KIR B-Gene +
) O +
genes O +
compared O +
with O +
a O +
normal O +
control O +
population O +
. O +

The O +
frequency O +
of O +
KIR3DL1 B-Gene +
and O +
KIR2DS4 B-Gene +
was O +
significantly O +
increased O +
( O +
but O +
not O +
after O +
correction O +
for O +
number O +
of O +
comparisons O +
made O +
) O +
in O +
patients O +
with O +
bladder O +
tumour O +
compared O +
with O +
controls O +
. O +

No O +
other O +
significant O +
differences O +
were O +
found O +
in O +
gene O +
frequencies O +
or O +
in O +
the O +
frequencies O +
of O +
those O +
KIR B-Gene +
genes O +
with O +
and O +
without O +
their O +
human B-Gene +
leucocyte I-Gene +
antigen I-Gene +
( O +
HLA B-Gene +
) O +
ligands O +
. O +

Furthermore O +
, O +
no O +
significant O +
differences O +
were O +
found O +
in O +
KIR B-Gene +
gene O +
frequencies O +
, O +
taking O +
into O +
consideration O +
the O +
type O +
of O +
loss O +
of O +
HLA B-Gene +
expression O +
in O +
the O +
individual O +
tumours O +
. O +

Finally O +
, O +
in O +
the O +
group O +
of O +
colorectal O +
carcinomas O +
, O +
there O +
was O +
an O +
overall O +
significant O +
difference O +
in O +
the O +
frequencies O +
of O +
C O +
group O +
heterozygosity O +
and O +
homozygosity O +
with O +
HLA B-Gene +
alterations O +
on O +
the O +
tumour O +
. O +

Laboratory O +
assessment O +
of O +
hypercoagulable O +
state O +
. O +

A O +
study O +
in O +
a O +
group O +
of O +
patients O +
with O +
venous O +
thromboembolism O +
born O +
in O +
Chioggia O +
. O +

AIM O +
: O +

Authors O +
performed O +
a O +
Laboratory O +
assessment O +
for O +
thrombophilia O +
risk O +
factors O +
in O +
a O +
group O +
of O +
patients O +
with O +
previous O +
deep O +
venous O +
thrombosis O +
. O +

METHODS O +
: O +

123 O +
consecutive O +
patients O +
were O +
considered O +
. O +

The O +
following O +
parameters O +
were O +
investigated O +
by O +
using O +
commercially O +
available O +
methods O +
: O +
PT O +
, O +
aPTT O +
, O +
TT O +
, O +
Fibrinogen B-Gene +
, O +
D O -
- O -
Dimer O +
, O +
Anti O +
thrombin B-Gene +
3 O +
( O +
AT O +
) O +
, O +
Protein B-Gene +
C I-Gene +
( O +
PC B-Gene +
) O +
, O +
Protein B-Gene +
S I-Gene +
( O +
PS B-Gene +
) O +
, O +
activated O +
C B-Gene +
protein I-Gene +
( O +
APC O +
) O +
resistance O +
, O +
Lupus O +
anticoagulant O +
( O +
LA O +
) O +
, O +
FV O +
Leiden O +
( O +
G1691a O +
mutation O +
) O +
, O +
Prothrombin B-Gene +
G20210A O +
mutation O +
, O +
MTHFR B-Gene +
mutation O +
( O +
G677 O -
T O +
mutation O +
) O +
, O +
anti O +
Prothrombin B-Gene +
auto O +
- O +
antibodies O +
( O +
PR O +
) O +
IgG B-Gene +
and O +
IgM B-Gene +
, O +
anti O +
Beta B-Gene +
2 I-Gene +
glycoprotein I-Gene +
1 I-Gene +
( O +
B2GP1 B-Gene +
) O +
auto O +
- O +
antibodies O +
IgG B-Gene +
and O +
IgM B-Gene +
, O +
anti O +
Cardiolipin O +
( O +
CL O +
) O +
auto O +
- O +
antibodies O +
IgG B-Gene +
and O +
IgM B-Gene +
, O +
homocysteine O +
. O +

RESULTS O +
: O +

In O +
the O +
123 O +
patients O +
considered O +
we O +
observed O +
: O +
two O +
AT O +
deficiency O +
, O +
one O +
PC B-Gene +
deficiencies O +
, O +
one O +
PS B-Gene +
deficiency O +
, O +
60 O +
FV O +
Leiden O +
mutation O +
( O +
six O +
homozygous O +
) O +
, O +
1 O +
Prothrombin B-Gene +
gene O +
mutations O +
( O +
heterozygous O +
) O +
, O +
71 O +
MTHFR B-Gene +
mutations O +
( O +
15 O +
homozygous O +
) O +
. O +

Study O +
of O +
anti O +
phospholipid O +
auto O +
antibodies O +
showed O +
10 O +
patients O +
positive O +
for O +
LA O +
, O +
9 O +
for O +
anti O +
CL O +
antibodies O +
( O +
6IgG O +
and O +
3IgM O +
) O +
, O +
10 O +
for O +
anti O +
B2GP1 B-Gene +
antibody O +
( O +
5 O +
IgG B-Gene +
and O +
5IgM B-Gene +
) O +
, O +
3 O +
for O +
anti O +
PR O +
antibody O +
( O +
IgG O +
) O +
. O +

Thirty O +
nine O +
patients O +
showed O +
hyper O +
homocysteinemia O +
. O +

CONCLUSION O +
: O +

In O +
our O +
study O +
only O +
19 O +
patients O +
were O +
free O +
of O +
demonstrable O +
thrombophilia O +
risk O +
factor O +
. O +

In O +
51 O +
subjects O +
a O +
single O +
risk O +
factor O +
was O +
identified O +
and O +
in O +
53 O +
multiple O +
( O +
from O +
2 O +
to O +
5 O +
) O +
risk O +
factors O +
were O +
identified O +
. O +

In O +
our O +
opinion O +
a O +
Laboratory O +
assessment O +
of O +
thrombophilia O +
risk O +
factors O +
after O +
a O +
previous O +
episode O +
of O +
deep O +
venous O +
thrombosis O +
is O +
a O +
diagnostic O +
tool O +
of O +
great O +
importance O +
. O +

As O +
a O +
matter O +
of O +
fact O +
, O +
in O +
our O +
experience O +
, O +
by O +
using O +
a O +
standard O +
analytical O +
panel O +
, O +
it O +
was O +
possible O +
to O +
highlight O +
one O +
or O +
more O +
risk O +
factors O +
in O +
about O +
85 O +
% O +
of O +
the O +
patients O +
considered O +
. O +

A O +
novel O +
mutation O +
of O +
gene O +
CBFA1 B-Gene +
/ O +
RUNX2 B-Gene +
in O +
cleidocranial O +
dysplasia O +
. O +

Cleidocranial O +
dysplasia O +
( O +
CCD O +
) O +
is O +
an O +
autosomal O +
dominant O +
skeletal O +
dysplasia O +
characterised O +
by O +
abnormal O +
clavicles O +
, O +
patent O +
sutures O +
and O +
fontanelles O +
, O +
supernumerary O +
teeth O +
, O +
short O +
stature O +
, O +
and O +
a O +
variety O +
of O +
other O +
skeletal O +
changes O +
. O +

The O +
disease O +
gene O +
is O +
CBFA1 B-Gene +
/ O +
RUNX2 B-Gene +
, O +
which O +
is O +
mapped O +
to O +
chromosome O +
6p21 O +
. O +

Inactivation O +
of O +
the O +
CBFA1 B-Gene +
/ O +
RUNX2 B-Gene +
gene O +
by O +
mutations O +
is O +
involved O +
in O +
the O +
skeletal O +
defects O +
that O +
occur O +
in O +
patients O +
with O +
CCD O +
. O +

CBFA1 B-Gene +
/ O +
RUNX2 B-Gene +
controls O +
the O +
differentiation O +
of O +
precursor O +
cells O +
into O +
osteoblasts O +
and O +
is O +
essential O +
for O +
membranous O +
as O +
well O +
as O +
endochondral O +
bone O +
formation O +
. O +

In O +
this O +
study O +
of O +
a O +
14 O +
- O +
yr O +
- O +
old O +
boy O +
with O +
typical O +
CCD O +
phenotype O +
, O +
the O +
authors O +
found O +
a O +
novel O +
CBFA1 B-Gene +
/ O +
RUNX2 B-Gene +
gene O +
mutation O +
. O +

All O +
of O +
the O +
amplified O +
segments O +
from O +
the O +
patient O +
's O +
CBFA1 B-Gene +
/ O +
RUNX2 B-Gene +
gene O +
were O +
identical O +
to O +
those O +
obtained O +
in O +
controls O +
, O +
except O +
for O +
the O +
one O +
spanning O +
the O +
exon O +
7 O +
and O +
intron O +
/ O +
exon O +
boundary O +
regions O +
. O +

Direct O +
sequencing O +
of O +
the O +
PCR O +
product O +
showed O +
a O +
heterozygous O +
T O +
- O +
to O +
- O +
A O +
transition O +
mutation O +
at O +
nucleotide O +
1182 O +
in O +
exon O +
7 O +
, O +
leading O +
to O +
Y394X O +
mutation O +
. O +

The O +
predicted O +
protein O +
product O +
lacks O +
128 O +
amino O +
acids O +
, O +
including O +
part O +
of O +
the O +
PST O +
domain O +
. O +

Identification O +
of O +
this O +
novel O +
mutation O +
constitutes O +
a O +
further O +
step O +
in O +
elucidating O +
the O +
pathogenesis O +
of O +
this O +
autosomal O +
disorder O +
. O +

Human O +
adipose O +
tissue O +
macrophages O +
are O +
of O +
an O +
anti O +
- O +
inflammatory O +
phenotype O +
but O +
capable O +
of O +
excessive O +
pro O +
- O +
inflammatory O +
mediator O +
production O +
. O +

OBJECTIVE O +
: O +

Obesity O +
is O +
associated O +
with O +
a O +
chronic O +
low O +
- O +
grade O +
inflammation O +
and O +
an O +
increased O +
abundance O +
of O +
macrophages O +
in O +
adipose O +
tissue O +
. O +

Adipose O +
tissue O +
macrophages O +
( O +
ATMs O +
) O +
are O +
assumed O +
to O +
interfere O +
with O +
adipocyte O +
function O +
leading O +
to O +
insulin B-Gene +
resistance O +
, O +
thereby O +
contributing O +
to O +
the O +
pathogenesis O +
of O +
type O +
2 O +
diabetes O +
mellitus O +
. O +

Macrophages O +
exist O +
in O +
separate O +
types O +
of O +
differentiation O +
, O +
but O +
the O +
nature O +
of O +
ATMs O +
is O +
largely O +
unknown O +
. O +

DESIGN O +
AND O +
MEASUREMENTS O +
: O +

Stromal O +
vascular O +
cells O +
( O +
SVCs O +
) O +
and O +
ATMs O +
were O +
isolated O +
from O +
human O +
adipose O +
tissues O +
from O +
different O +
locations O +
. O +

We O +
characterized O +
ATMs O +
phenotypically O +
and O +
functionally O +
by O +
flow O +
cytometry O +
, O +
endocytosis O +
assay O +
and O +
determination O +
of O +
secreted O +
cytokines B-Gene +
. O +

For O +
comparison O +
, O +
we O +
used O +
macrophages O +
of O +
the O +
' O -
classical O -
' O +
( O +
M1 O +
) O +
and O +
the O +
' O +
alternative O +
' O +
, O +
anti O +
- O +
inflammatory O +
( O +
M2 O +
) O +
type O +
differentiated O +
in O +
vitro O +
from O +
peripheral O +
blood O +
monocytes O +
. O +

RESULTS O +
: O +

Like O +
prototypic O +
M2 O +
macrophages O +
, O +
ATMs O +
expressed O +
considerable O +
amounts O +
of O +
mannose B-Gene +
receptor I-Gene +
, O +
haemoglobin B-Gene +
scavenger I-Gene +
receptor I-Gene +
CD163 B-Gene +
and O +
integrin B-Gene +
alphavbeta5 I-Gene +
. O +

The O +
number O +
of O +
cells O +
expressing O +
these O +
molecules O +
correlated O +
significantly O +
with O +
the O +
donors O +
' O +
body O +
mass O +
indices O +
( O +
BMIs O +
) O +
. O +

Notably O +
, O +
SVCs O +
positive O +
for O +
the O +
common O +
monocyte O +
/ O +
macrophage O +
marker O +
CD14 B-Gene +
contained O +
a O +
considerable O +
fraction O +
of O +
blood O +
monocytes O +
, O +
the O +
abundance O +
of O +
which O +
did O +
not O +
correlate O +
with O +
the O +
BMIs O +
, O +
pointing O +
to O +
the O +
requirement O +
of O +
the O +
surface O +
markers O +
identified O +
here O +
for O +
the O +
identification O +
of O +
ATMs O +
. O +

ATMs O +
showed O +
endocytic O +
activities O +
similar O +
to O +
M2 O +
macrophages O +
and O +
accordingly O +
secreted O +
high O +
amounts O +
of O +
IL-10 B-Gene +
and O +
IL-1 B-Gene +
receptor I-Gene +
antagonist I-Gene +
. O +

However O +
, O +
basal O +
and O +
induced O +
secretion O +
of O +
pro O +
- O +
inflammatory O +
mediators O +
TNF B-Gene -
- I-Gene -
alpha I-Gene +
, O +
IL-6 B-Gene +
, O +
IL-1 B-Gene +
, O +
MCP-1 B-Gene +
and O +
MIP-1alpha B-Gene +
was O +
even O +
higher O +
in O +
ATMs O +
than O +
in O +
pro O +
- O +
inflammatory O +
M1 O +
macrophages O +
. O +

CONCLUSION O +
: O +

ATMs O +
comprise O +
a O +
particular O +
macrophage O +
type O +
that O +
is O +
M2 O +
- O +
like O +
by O +
surface O +
marker O +
expression O +
, O +
but O +
they O +
are O +
competent O +
to O +
produce O +
extensive O +
amounts O +
of O +
inflammatory O +
cytokines B-Gene +
, O +
which O +
could O +
considerably O +
contribute O +
to O +
the O +
development O +
of O +
insulin B-Gene +
resistance O +
. O +

Effect O +
of O +
cigarette O +
smoke O +
extract O +
on O +
lipopolysaccha O +
- O +
ride O +
- O +
activated O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
signal O +
transduction O +
pathway O +
in O +
cultured O +
cells O +
. O +

BACKGROUND O +
: O +

Lipopolysaccharide O +
( O +
LPS O +
) O +
forms O +
outer O +
membrane O +
of O +
the O +
wall O +
of O +
Gram O +
- O +
negative O +
cells O +
. O +

LPS O +
can O +
directly O +
cause O +
damage O +
to O +
epithelia O +
of O +
respiratory O +
tract O +
and O +
is O +
the O +
major O +
factor O +
responsible O +
for O +
the O +
chronic O +
inflammation O +
of O +
respiratory O +
passage O +
. O +

The O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
( O +
MAPK B-Gene +
) O +
signal O +
transduction O +
pathway O +
of O +
the O +
airway O +
epithelia O +
is O +
intimately O +
associated O +
with O +
the O +
action O +
of O +
LPS O +
. O +

The O +
chronic O +
inflammation O +
of O +
respiratory O +
tract O +
and O +
smoking O +
are O +
interrelated O +
and O +
entwined O +
in O +
the O +
development O +
and O +
progression O +
of O +
chronic O +
lung O +
diseases O +
. O +

This O +
study O +
was O +
designed O +
to O +
examine O +
the O +
effects O +
of O +
cigarette O +
smoke O +
extract O +
( O +
CSE O +
) O +
and O +
LPS O +
on O +
MAPK B-Gene +
signal O +
transduction O +
pathway O +
in O +
order O +
to O +
further O +
understand O +
the O +
roles O +
CSE O +
and O +
LPS O +
play O +
in O +
chronic O +
lung O +
inflammation O +
. O +

METHODS O +
: O +

Cultured O +
primary O +
human O +
epithelial O +
cells O +
of O +
airway O +
were O +
divided O +
into O +
four O +
groups O +
according O +
to O +
the O +
stimulants O +
used O +
: O +
blank O +
control O +
group O +
, O +
LPS O +
- O +
stimulation O +
group O +
, O +
CSE O -
- O -
stimulation O +
group O +
and O +
CSE O +
plus O +
LPS O +
group O +
. O +

Western O +
blotting O +
was O +
employed O +
for O +
the O +
detection O +
of O +
phosphorylation O +
level O +
of O +
extracellular B-Gene +
- I-Gene +
signal I-Gene +
- I-Gene +
regulated I-Gene +
- I-Gene +
kinase I-Gene +
( O +
ERK B-Gene -
( I-Gene -
1 I-Gene -
/ I-Gene -
2 I-Gene +
) I-Gene +
) O +
, O +
p38 B-Gene +
MAPK I-Gene +
and O +
c B-Gene -
- I-Gene -
Jun I-Gene +
N I-Gene +
- I-Gene +
terminal I-Gene +
kinase I-Gene +
( O +
JNK B-Gene +
) O +
. O +

The O +
expression O +
of O +
cytokines B-Gene +
of O +
MAPK B-Gene +
transduction O +
pathway O +
( O +
granulocyte B-Gene +
- I-Gene +
macrophage I-Gene +
colony I-Gene +
stimulating I-Gene +
factor I-Gene +
( O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
) O +
and O +
mRNA O +
of O +
IL-8 B-Gene +
) O +
in O +
the O +
primary O +
epithelial O +
cells O +
of O +
respiratory O +
tract O +
was O +
also O +
determined O +
. O +

RESULTS O +
: O +

Western O +
blotting O +
revealed O +
that O +
the O +
phosphorylation O +
levels O +
of O +
ERK B-Gene -
( I-Gene -
1 I-Gene -
/ I-Gene -
2 I-Gene +
) I-Gene +
, O +
p38 B-Gene +
MAPK I-Gene +
and O +
JNK B-Gene +
were O +
low O +
and O +
2 O +
hours O +
after O +
the O +
LPS O +
stimulation O +
, O +
the O +
phosphorylation O +
of O +
ERK B-Gene +
( I-Gene +
1 I-Gene +
/ I-Gene +
2 I-Gene +
) I-Gene +
, O +
p38 B-Gene +
MAPK I-Gene +
and O +
JNK B-Gene +
were O +
all O +
increased O +
. O +

There O +
was O +
a O +
significant O +
difference O +
in O +
the O +
phosphorylation O +
between O +
the O +
LPS O +
- O +
stimulation O +
group O +
and O +
blank O +
control O +
group O +
( O +
P O +
< O +
0.05 O +
) O +
; O +
no O +
significant O +
difference O +
was O +
found O +
between O +
CSE O +
- O +
stimulation O +
group O +
and O +
blank O +
control O +
group O +
( O +
P O +
> O +
0.05 O +
) O +
; O +
there O +
was O +
a O +
significant O +
difference O +
between O +
CSE O +
+ O +
LPS O +
group O +
and O +
blank O +
control O +
group O +
and O +
between O +
CSE O +
+ O +
LPS O +
group O +
and O +
LPS O +
group O +
( O +
P O +
< O +
0.05 O +
) O +
. O +

The O +
phosphorylation O +
of O +
CSE O -
- O -
LPS O +
group O +
was O +
higher O +
than O +
that O +
of O +
blank O +
control O +
group O +
but O +
lower O +
than O +
that O +
of O +
LPS O +
group O +
. O +

In O +
blank O +
control O +
group O +
, O +
the O +
expression O +
of O +
IL B-Gene +
- I-Gene +
8 I-Gene +
and O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
mRNA O +
was O +
low O +
in O +
the O +
epithelial O +
cells O +
of O +
airway O +
and O +
the O +
release O +
of O +
IL-8 B-Gene +
and O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
was O +
also O +
at O +
a O +
low O +
level O +
. O +

One O +
hour O +
after O +
LPS O +
stimulation O +
, O +
the O +
level O +
of O +
IL-8 B-Gene +
mRNA O +
increased O +
( O +
P O +
< O +
0.05 O +
) O +
and O +
reached O +
a O +
peak O +
after O +
2 O +
hours O +
. O +

On O +
the O +
other O +
hand O +
, O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
mRNA O +
level O +
increased O +
2 O +
hours O +
after O +
the O +
stimulation O +
( O +
P O +
< O +
0.05 O +
) O +
and O +
reached O +
the O +
highest O +
level O +
4 O +
hours O +
after O +
the O +
stimulation O +
. O +

Two O +
hours O +
after O +
LPS O +
stimulation O +
, O +
IL-8 B-Gene +
and O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
protein O +
level O +
began O +
to O +
rise O +
( O +
P O +
< O +
0.05 O +
) O +
, O +
and O +
the O +
level O +
was O +
the O +
highest O +
8 O +
hours O +
after O +
the O +
stimulation O +
( O +
P O +
< O +
0.01 O +
) O +
. O +

Stimulation O +
with O +
CSE O +
alone O +
had O +
no O +
effect O +
on O +
the O +
release O +
of O +
IL-8 B-Gene +
and O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
and O +
expression O +
of O +
IL-8 B-Gene +
mRNA O +
( O +
P O +
> O +
0.05 O +
) O +
, O +
but O +
pre O +
- O +
treatment O +
with O +
CSE O +
could O +
delay O +
the O +
LPS O +
- O +
induced O +
release O +
of O +
IL-8 B-Gene +
and O +
GM B-Gene -
- I-Gene -
CSF I-Gene +
and O +
the O +
expression O +
of O +
IL-8 B-Gene +
mRNA O +
and O +
its O +
peak O +
was O +
lower O +
. O +

CONCLUSIONS O +
: O +

LPS O +
stimulation O +
can O +
significantly O +
increase O +
the O +
phosphorylation O +
of O +
ERK B-Gene -
( I-Gene -
1 I-Gene -
/ I-Gene -
2 I-Gene +
) I-Gene +
, O +
p38 B-Gene +
MAPK I-Gene +
and O +
JNK B-Gene +
in O +
the O +
epithelial O +
cells O +
of O +
airway O +
and O +
activate O +
the O +
MAPK B-Gene +
transduction O +
pathway O +
, O +
thereby O +
can O +
activate O +
the O +
downstream O +
signal O +
transduction O +
pathway O +
, O +
and O +
can O +
ultimately O +
result O +
in O +
the O +
release O +
of O +
cytokines B-Gene +
by O +
the O +
epithelial O +
cells O +
of O +
airway O +
. O +

CSE O +
can O +
partially O +
abolish O +
the O +
LPS O +
- O +
induced O +
activation O +
of O +
MAPK B-Gene +
signal O +
transduction O +
pathway O +
and O +
the O +
expression O +
of O +
cytokines B-Gene +
of O +
the O +
pathway O +
, O +
which O +
might O +
contribute O +
to O +
the O +
development O +
and O +
progression O +
of O +
the O +
inflammatory O +
reactions O +
in O +
COPD O +
patients O +
. O +

Evolutionarily O +
conserved O +
mammalian O +
adenine B-Gene +
nucleotide I-Gene +
translocase I-Gene +
4 I-Gene +
is O +
essential O +
for O +
spermatogenesis O +
. O +

The O +
adenine B-Gene +
nucleotide I-Gene +
translocases I-Gene +
( O +
Ant B-Gene +
) O +
facilitate O +
the O +
transport O +
of O +
ADP O +
and O +
ATP O +
by O +
an O +
antiport O +
mechanism O +
across O +
the O +
inner O +
mitochondrial O +
membrane O +
, O +
thus O +
playing O +
an O +
essential O +
role O +
in O +
cellular O +
energy O +
metabolism O +
. O +

We O +
recently O +
identified O +
a O +
novel O +
member O +
of O +
the O +
Ant B-Gene +
family I-Gene +
in O +
mouse O +
, O +
Ant4 B-Gene +
, O +
of O +
which O +
gene O +
configuration O +
as O +
well O +
as O +
amino O +
acid O +
homology O +
is O +
well O +
conserved O +
among O +
mammals O +
. O +

The O +
conservation O +
of O +
Ant4 B-Gene +
in O +
mammals O +
, O +
along O +
with O +
the O +
absence O +
of O +
Ant4 B-Gene +
in O +
nonmammalian O +
species O +
, O +
suggests O +
a O +
unique O +
and O +
indispensable O +
role O +
for O +
this O +
ADP O +
/ O +
ATP O +
carrier O +
in O +
mammalian O +
development O +
. O +

Of O +
interest O +
, O +
in O +
contrast O +
to O +
its O +
paralog O +
Ant2 B-Gene +
, O +
which O +
is O +
encoded O +
by O +
the O +
X O +
chromosome O +
and O +
ubiquitously O +
expressed O +
in O +
somatic O +
cells O +
, O +
Ant4 B-Gene +
is O +
encoded O +
by O +
an O +
autosome O +
and O +
selectively O +
expressed O +
in O +
testicular O +
germ O +
cells O +
. O +

Immunohistochemical O +
examination O +
as O +
well O +
as O +
RNA O +
expression O +
analysis O +
using O +
separated O +
spermatogenic O +
cell O +
types O +
revealed O +
that O +
Ant4 B-Gene +
expression O +
was O +
particularly O +
high O +
in O +
spermatocytes O +
. O +

When O +
we O +
generated O +
Ant4 B-Gene +
- O +
deficient O +
mice O +
by O +
targeted O +
disruption O +
, O +
a O +
significant O +
reduction O +
in O +
testicular O +
size O +
was O +
observed O +
without O +
any O +
other O +
distinguishable O +
abnormalities O +
in O +
the O +
mice O +
. O +

Histological O +
examination O +
as O +
well O +
as O +
stage O +
- O +
specific O +
gene O +
expression O +
analysis O +
in O +
adult O +
and O +
neonatal O +
testes O +
revealed O +
a O +
severe O +
reduction O +
of O +
spermatocytes O +
accompanied O +
by O +
increased O +
apoptosis O +
. O +

Subsequently O +
, O +
the O +
Ant4 B-Gene +
- O +
deficient O +
male O +
mice O +
were O +
infertile O +
. O +

Taken O +
together O +
, O +
these O +
data O +
elucidated O +
the O +
indispensable O +
role O +
of O +
Ant4 B-Gene +
in O +
murine O +
spermatogenesis O +
. O +

Considering O +
the O +
unique O +
conservation O +
and O +
chromosomal O +
location O +
of O +
the O +
Ant B-Gene +
family I-Gene +
genes O +
in O +
mammals O +
, O +
the O +
Ant4 B-Gene +
gene O +
may O +
have O +
arisen O +
in O +
mammalian O +
ancestors O +
and O +
been O +
conserved O +
in O +
mammals O +
to O +
serve O +
as O +
the O +
sole O +
and O +
essential O +
mitochondrial O +
ADP B-Gene +
/ I-Gene +
ATP I-Gene +
carrier I-Gene +
during O +
spermatogenesis O +
where O +
the O +
sex O +
chromosome O +
- O +
linked O +
Ant2 B-Gene +
gene O +
is O +
inactivated O +
. O +

Expression O +
and O +
selective O +
up O +
- O +
regulation O +
of O +
toxin O +
- O +
related O +
mono B-Gene +
ADP I-Gene -
- I-Gene -
ribosyltransferases I-Gene +
by O +
pathogen O +
- O +
associated O +
molecular O +
patterns O +
in O +
alveolar O +
epithelial O +
cells O +
. O +

Mono B-Gene +
ADP I-Gene -
- I-Gene -
ribosyltransferases I-Gene +
( O +
ARTs B-Gene +
) O +
are O +
a O +
family O +
of O +
enzymes O +
related O +
to O +
bacterial O +
toxins O +
that O +
possess O +
adenosine B-Gene +
diphosphate I-Gene +
ribosyltransferase I-Gene +
activity O +
. O +

We O +
have O +
assessed O +
that O +
A549 O +
constitutively O +
expressed O +
ART1 B-Gene +
on O +
the O +
cell O +
surface O +
and O +
shown O +
that O +
lipotheicoic O +
acid O +
( O +
LTA O +
) O +
and O +
flagellin B-Gene +
, O +
but O +
not O +
lipopolysaccharide O +
( O +
LPS O +
) O +
, O +
peptidoglycan O +
( O +
PG O +
) O +
and O +
poly O +
( O +
I O +
: O +
C O +
) O +
, O +
up O +
- O +
regulate O +
ART1 B-Gene +
in O +
a O +
time O +
and O +
dose O +
dependent O +
manner O +
. O +

These O +
agonists O +
did O +
not O +
alter O +
the O +
expression O +
of O +
ART3 B-Gene +
and O +
ART5 B-Gene +
genes O +
. O +

Indeed O +
, O +
LTA O +
and O +
flagellin B-Gene +
stimulation O +
increased O +
the O +
level O +
of O +
ART1 B-Gene +
protein O +
and O +
transcript O +
while O +
ART4 B-Gene +
gene O +
was O +
activated O +
after O +
stimulation O +
of O +
cells O +
with O +
LPS O +
, O +
LTA O +
, O +
PAM O +
and O +
PG O +
via O +
TLR2 B-Gene +
and O +
TLR4 B-Gene +
receptors O +
. O +

These O +
results O +
show O +
that O +
human O +
ARTs B-Gene +
possess O +
a O +
differential O +
capacity O +
to O +
respond O +
to O +
bacteria O +
cell O +
wall O +
components O +
and O +
might O +
play O +
a O +
crucial O +
role O +
in O +
innate O +
immune O +
response O +
in O +
airways O +
. O +

Tripodal O +
bis O +
( O +
imidazole O +
) O +
thioether O +
copper O +
( O +
I O +
) O +
complexes O +
: O +
mimics O +
of O +
the O +
Cu O +
( O +
M O +
) O +
site O +
of O +
copper B-Gene +
hydroxylase I-Gene +
enzymes O +
. O +

Tripodal O +
bis O +
( O +
imidazole O +
) O +
thioether O +
ligands O +
, O +
( O +
N O -
- O -
methyl-4,5-diphenyl-2-imidazolyl O -
) O -
2C O -
( O -
OR O -
) O -
C O -
( O -
CH3 O -
) O -
2SR O -
' O +
( O +
BIT O +
( O +
OR O -
, O -
SR O -
' O +
) O +
; O +
R O +
= O +
H O +
, O +
CH3 O +
; O +
R O -
' O +
= O +
CH3 O +
, O +
C O +
( O +
CH3 O +
) O +
3 O +
, O +
C O +
( O +
C6H5 O +
) O +
3 O +
) O +
, O +
have O +
been O +
prepared O +
, O +
offering O +
the O +
same O +
N2S O +
donor O +
atom O +
set O +
as O +
the O +
CuM O +
binding O +
site O +
of O +
the O +
hydroxylase B-Gene +
enzymes O +
, O +
dopamine B-Gene +
beta I-Gene +
hydroxylase I-Gene +
and O +
peptidylglycine B-Gene +
hydroxylating I-Gene +
monooxygenase I-Gene +
. O +

Isolable O +
copper O -
( O -
I O -
) O +
complexes O +
of O +
the O +
type O +
[ O -
( O -
BIT O -
( O -
OR O -
, O -
SMe O +
) O +
) O +
Cu O -
( O -
CO O -
) O -
] O -
PF6 O +
( O +
3a O +
and O +
3b O +
) O +
are O +
produced O +
in O +
reactions O +
of O +
the O +
respective O +
tripodal O +
ligands O +
1a O +
( O +
R O +
= O +
H O +
) O +
and O +
1b O +
( O +
R O +
= O +
Me O +
) O +
with O +
[ O +
Cu O -
( O -
CH3CN O -
) O -
4 O -
] O -
PF6 O +
in O +
CH2Cl2 O +
under O +
CO O +
( O +
1 O +
atm O +
) O +
; O +
the O +
pyramidal O +
structure O +
of O +
3a O +
has O +
been O +
determined O +
crystallographically O +
. O +

The O +
infrared O +
( O +
IR O +
) O +
nu O +
( O +
CO O +
) O +
's O +
of O +
3a O +
and O +
3b O +
( O +
L O +
= O +
CO O +
) O +
are O +
comparable O +
to O +
those O +
of O +
the O +
Cu O -
( O -
M O -
) O -
-carbonylated O +
enzymes O +
, O +
indicating O +
similar O +
electronic O +
character O +
at O +
the O +
copper O +
centers O +
. O +

The O +
reaction O +
of O +
[ O -
( O -
BIT O -
( O -
OH O -
, O -
SMe O +
) O +
) O +
Cu O -
( O -
CH3CN O -
) O -
] O -
PF6 O +
( O +
2a O +
) O +
with O +
dioxygen O +
produces O +
[ O -
( O -
BIT O -
( O -
O O -
, O -
SOMe O +
) O +
) O +
2Cu2 O -
( O -
DMF O -
) O -
2 O -
] O -
( O -
PF6 O -
) O -
2 O +
( O -
4 O -
) O +
, O +
whose O +
X O +
- O +
ray O +
structure O +
revealed O +
the O +
presence O +
of O +
bridging O +
BIT O +
- O +
alkoxo O +
ligands O +
and O +
terminal O +
- O +
SOMe O +
groups O +
. O +

In O +
contrast O +
, O +
oxygenation O +
of O +
2b O +
( O +
R O +
= O +
Me O +
) O +
affords O +
crystallographically O +
defined O +
[ O -
( O -
BIT O -
( O -
OMe O -
, O -
SMe O +
) O +
) O +
2Cu2 O -
( O -
mu O -
- O -
OH O -
) O -
2 O -
] O -
( O -
OTf O -
) O -
2 O +
( O +
5 O +
) O +
, O +
in O +
which O +
the O +
copper O +
centers O +
are O +
oxygenated O +
without O +
accompanying O +
sulfur O +
oxidation O +
. O +

Complex O +
5 O +
in O +
DMF O +
is O +
transformed O +
into O +
five O +
- O +
coordinate O +
, O +
mononuclear O +
[ O +
CuII O +
( O +
BIT O -
( O -
OMe O -
, O -
SMe O +
) O +
) O -
( O -
DMF O -
) O -
2 O -
] O -
( O -
PF6 O -
) O -
2 O +
( O +
6 O +
) O +
. O +

The O +
sterically O +
hindered O +
BIT O -
( O -
OR O -
, O -
SR O -
' O +
) O +
ligands O +
9 O +
and O +
10 O +
( O +
R O -
' O +
= O +
t O +
- O +
Bu O +
; O +
R O +
= O +
H O +
, O +
Me O +
) O +
and O +
11 O +
and O +
12 O +
( O +
R O -
' O +
= O +
CPh3 O +
; O +
R O +
= O +
H O +
, O +
Me O +
) O +
were O +
also O +
prepared O +
and O +
examined O +
for O +
copper O +
coordination O +
/ O +
oxygenation O +
. O +

Oxygenation O +
of O +
copper O -
( O -
I O -
) O +
complex O +
13b O +
derived O +
from O +
the O +
BIT O -
( O -
OMe O -
, O -
SBu O -
- O -
t O -
) O +
ligand O +
is O +
slow O +
, O +
relative O +
to O +
2b O +
, O +
producing O +
a O +
mixture O +
of O +
( O +
BIT O +
( O +
OMe O +
, O +
SBu O +
- O +
t O +
) O +
) O +
2Cu2 O +
( O +
mu O -
- O -
OH O -
) O -
2 O +
- O +
type O +
complexes O +
14b O +
and O +
15b O +
in O +
which O +
the O +
- O +
SBu O +
- O +
t O +
group O +
is O +
uncoordinated O +
; O +
one O +
of O +
these O +
complexes O +
( O +
15b O +
) O +
has O +
been O +
ortho O +
- O +
oxygenated O +
on O +
a O +
neighboring O +
aryl O +
group O +
according O +
to O +
the O +
X O +
- O +
ray O +
analysis O +
and O +
characterization O +
of O +
the O +
free O +
ligand O +
. O +

Oxygenation O +
of O +
the O +
copper O -
( O -
I O -
) O +
complex O +
derived O +
from O +
BIT O -
( O -
OMe O -
, O -
SCPh3 O +
) O +
ligand O +
12 O +
produces O +
a O +
novel O +
dinuclear O +
disulfide O +
complex O +
, O +
[ O -
( O -
BIT O -
( O -
OMe O -
, O -
S O -
) O -
2Cu2 O -
( O -
mu O -
- O -
OH O -
) O -
2 O -
] O -
( O -
PF6 O -
) O -
2 O +
( O +
17 O +
) O +
, O +
which O +
is O +
structurally O +
characterized O -
. O +
Reactivity O +
studies O +
under O +
anaerobic O +
conditions O +
in O +
the O +
presence O +
of O +
t O -
- O -
BuNC O +
indicate O +
that O +
17 O +
is O +
the O +
result O +
of O +
copper O -
( O -
I O -
) O +
- O +
induced O +
detritylation O +
followed O +
by O +
oxygenation O +
of O +
a O +
highly O +
reactive O +
copper O -
( O -
I O -
) O -
-thiolate O +
complex O +
. O +

MyRIP B-Gene +
anchors O +
protein B-Gene +
kinase I-Gene +
A I-Gene +
to O +
the O +
exocyst O +
complex O +
. O +

The O +
movement O +
of O +
signal O +
transduction O +
enzymes O +
in O +
and O +
out O +
of O +
multi O +
- O +
protein O +
complexes O +
coordinates O +
the O +
spatial O +
and O +
temporal O +
resolution O +
of O +
cellular O +
events O +
. O +

Anchoring O +
and O +
scaffolding O +
proteins O +
are O +
key O +
to O +
this O +
process O +
because O +
they O +
sequester O +
protein B-Gene +
kinases I-Gene +
and O +
phosphatases B-Gene +
with O +
a O +
subset O +
of O +
their O +
preferred O +
substrates O +
. O +

The O +
protein B-Gene +
kinase I-Gene +
A I-Gene +
- I-Gene +
anchoring I-Gene +
family I-Gene +
of I-Gene +
proteins I-Gene +
( O +
AKAPs B-Gene +
) O +
, O +
which O +
target O +
the O +
cAMP B-Gene +
- I-Gene +
dependent I-Gene +
protein I-Gene +
kinase I-Gene +
( O +
PKA B-Gene +
) O +
and O +
other O +
enzymes O +
to O +
defined O +
subcellular O +
microenvironments O +
, O +
represent O +
a O +
well O +
studied O +
group O +
of O +
these O +
signal O +
- O +
organizing O +
molecules O +
. O +

In O +
this O +
report O +
we O +
demonstrate O +
that O +
the O +
Rab27a B-Gene +
GTPase B-Gene +
effector O +
protein O +
MyRIP B-Gene +
is O +
a O +
member O +
of O +
the O +
AKAP B-Gene +
family I-Gene +
. O +

The O +
zebrafish O +
homolog O +
of O +
MyRIP B-Gene +
( O +
Ze O +
- O +
AKAP2 B-Gene +
) O +
was O +
initially O +
detected O +
in O +
a O +
two O +
- O +
hybrid O +
screen O +
for O +
AKAPs B-Gene +
. O +

A O +
combination O +
of O +
biochemical O +
, O +
cell O +
- O +
based O +
, O +
and O +
immunofluorescence O +
approaches O +
demonstrate O +
that O +
the O +
mouse O +
MyRIP B-Gene +
ortholog O +
targets O +
the O +
type B-Gene +
II I-Gene +
PKA I-Gene +
holoenzyme O +
via O +
an O +
atypical O +
mechanism O +
to O +
a O +
specific O +
perinuclear O +
region O +
of O +
insulin B-Gene +
- O +
secreting O +
cells O +
. O +

Similar O +
approaches O +
show O +
that O +
MyRIP B-Gene +
interacts O +
with O +
the O +
Sec6 B-Gene +
and O +
Sec8 B-Gene +
components O +
of O +
the O +
exocyst B-Gene +
complex I-Gene +
, O +
an O +
evolutionarily O +
conserved O +
protein O +
unit O +
that O +
controls O +
protein O +
trafficking O +
and O +
exocytosis O +
. O +

These O +
data O +
indicate O +
that O +
MyRIP B-Gene +
functions O +
as O +
a O +
scaffolding O +
protein O +
that O +
links O +
PKA B-Gene +
to O +
components O +
of O +
the O +
exocytosis O +
machinery O +
. O +

Structurally O +
related O +
TPR O +
subunits O +
contribute O +
differently O +
to O +
the O +
function O +
of O +
the O +
anaphase B-Gene +
- I-Gene +
promoting I-Gene +
complex I-Gene +
in O +
Drosophila O +
melanogaster O +
. O +

The O +
anaphase B-Gene +
- I-Gene +
promoting I-Gene +
complex I-Gene +
/ O +
cyclosome O +
or O +
APC B-Gene +
/ I-Gene +
C I-Gene +
is O +
a O +
key O +
regulator O +
of O +
chromosome O +
segregation O +
and O +
mitotic O +
exit O +
in O +
eukaryotes O +
. O +

It O +
contains O +
at O +
least O +
11 O +
subunits O +
, O +
most O +
of O +
which O +
are O +
evolutionarily O +
conserved O +
. O +

The O +
most O +
abundant O +
constituents O +
of O +
the O +
vertebrate O +
APC B-Gene +
/ I-Gene +
C I-Gene +
are O +
the O +
four O +
structurally O +
related O +
tetratrico O +
- O +
peptide O +
repeat O +
( O +
TPR O +
) O +
subunits O +
, O +
the O +
functions O +
of O +
which O +
are O +
not O +
yet O +
precisely O +
understood O +
. O +

Orthologues O +
of O +
three O +
of O +
the O +
TPR O +
subunits O +
have O +
been O +
identified O +
in O +
Drosophila O +
. O +

We O +
have O +
shown O +
previously O +
that O +
one O +
of O +
the O +
TPR O +
subunits O +
of O +
the O +
Drosophila O +
APC B-Gene +
/ I-Gene +
C I-Gene +
, O +
Apc3 B-Gene +
( O +
also O +
known O +
as O +
Cdc27 B-Gene +
or O +
MÃ?Â¡kos B-Gene +
) O +
, O +
is O +
essential O +
for O +
development O +
, O +
and O +
perturbation O +
of O +
its O +
function O +
results O +
in O +
mitotic O +
cyclin B-Gene +
accumulation O +
and O +
metaphase O +
- O +
like O +
arrest O +
. O +

In O +
this O +
study O +
we O +
demonstrate O +
that O +
the O +
Drosophila O +
APC B-Gene +
/ I-Gene +
C I-Gene +
associates O +
with O +
a O +
new O +
TPR O +
protein O +
, O +
a O +
genuine O +
orthologue O +
of O +
the O +
vertebrate O +
Apc7 B-Gene +
subunit O +
that O +
is O +
not O +
found O +
in O +
yeasts O +
. O +

In O +
addition O +
to O +
this O +
, O +
transgenic O +
flies O +
knocked O +
down O +
for O +
three O +
of O +
the O +
TPR O +
genes O +
Apc6 B-Gene +
( O +
Cdc16 B-Gene +
) O +
, O +
Apc7 B-Gene +
and O +
Apc8 B-Gene +
( O +
Cdc23 B-Gene +
) O +
, O +
by O +
RNA O +
interference O +
were O +
established O +
to O +
investigate O +
their O +
function O +
. O +

Whole O +
- O +
body O +
expression O +
of O +
subunit O +
- O +
specific O +
dsRNA O +
efficiently O +
silences O +
these O +
genes O +
resulting O +
in O +
only O +
residual O +
mRNA O +
concentrations O +
. O +

Apc6 B-Gene +
/ O +
Cdc16 B-Gene +
and O +
Apc8 B-Gene +
/ O +
Cdc23 B-Gene +
silencing O +
induces O +
developmental O +
delay O +
and O +
causes O +
different O +
pupal O +
lethality O +
. O +

Cytological O +
examination O +
showed O +
that O +
these O +
animals O +
had O +
an O +
elevated O +
level O +
of O +
apoptosis O +
, O +
high O +
mitotic O +
index O +
and O +
delayed O +
or O +
blocked O +
mitosis O +
in O +
a O +
prometaphase O +
- O +
metaphase O +
- O +
like O +
state O +
with O +
overcondensed O +
chromosomes O +
. O +

The O +
arrested O +
neuroblasts O +
contained O +
elevated O +
levels O +
of O +
cyclin B-Gene +
B I-Gene +
but O +
, O +
surprisingly O +
, O +
cyclin B-Gene +
A I-Gene +
appeared O +
to O +
be O +
degraded O +
normally O +
. O +

Contrary O +
to O +
the O +
situation O +
for O +
the O +
Apc6 B-Gene +
/ O +
Cdc16 B-Gene +
and O +
Apc8 B-Gene +
/ O +
Cdc23 B-Gene +
genes O +
, O +
the O +
apparent O +
loss O +
of O +
Apc7 B-Gene +
function O +
does O +
not O +
lead O +
to O +
the O +
above O +
abnormalities O +
. O +

Instead O +
, O +
the O +
Apc7 B-Gene +
knocked O +
down O +
animals O +
and O +
null O +
mutants O +
are O +
viable O +
and O +
fertile O +
, O +
although O +
they O +
display O +
mild O +
chromosome O +
segregation O +
defects O +
and O +
anaphase O +
delay O +
. O +

Nevertheless O +
, O +
the O +
Apc7 B-Gene +
subunit O +
shows O +
synergistic O +
genetic O +
interaction O +
with O +
Apc8 B-Gene +
/ O +
Cdc23 B-Gene +
that O +
, O +
together O +
with O +
the O +
phenotypic O +
data O +
, O +
assumes O +
a O +
limited O +
functional O +
role O +
for O +
Apc7 B-Gene +
. O +

Taken O +
together O +
, O +
these O +
data O +
suggest O +
that O +
the O +
structurally O +
related O +
TPR O +
subunits O +
contribute O +
differently O +
to O +
the O +
function O +
of O +
the O +
anaphase B-Gene +
- I-Gene +
promoting I-Gene +
complex I-Gene +
. O +

[ O +
Functional O +
dissociation O +
between O +
apelin B-Gene +
receptor I-Gene +
signaling O +
and O +
endocytosis O +
: O +
implications O +
for O +
the O +
effects O +
of O +
apelin B-Gene +
on O +
arterial O +
blood O +
pressure O +
] O +

Apelin B-Gene +
is O +
a O +
peptide O +
involved O +
in O +
the O +
regulation O +
of O +
body O +
fluid O +
homeostasis O +
and O +
cardiovascular O +
functions O +
, O +
that O +
was O +
recently O +
isolated O +
as O +
the O +
endogenous O +
ligand O +
for O +
the O +
human O +
orphan O +
APJ B-Gene +
receptor I-Gene +
, O +
a O +
G B-Gene +
protein I-Gene +
- I-Gene +
coupled I-Gene +
receptor I-Gene +
which O +
shares O +
31 O +
% O +
amino O +
- O +
acid O +
sequence O +
identity O +
with O +
the O +
angiotensin B-Gene +
II I-Gene +
type I-Gene +
1 I-Gene +
receptor I-Gene +
. O +

The O +
predominant O +
molecular O +
forms O +
of O +
apelin B-Gene +
naturally O +
occuring O +
in O +
vivo O +
are O +
apelin B-Gene +
36 I-Gene +
, O +
apelin B-Gene +
17 I-Gene +
( O +
K17F O +
) O +
and O +
the O +
pyroglutamyl O +
form O +
of O +
apelin B-Gene +
13 I-Gene +
( O +
pE13F O +
) O +
. O +

We O +
investigated O +
the O +
structure O +
- O +
activity O +
relationships O +
of O +
apelin B-Gene +
at O +
the O +
rat O +
apelin B-Gene +
receptor I-Gene +
, O +
tagged O +
at O +
its O +
C O +
- O +
terminal O +
end O +
with O +
enhanced O +
green B-Gene +
fluorescent I-Gene +
protein I-Gene +
and O +
stably O +
expressed O +
in O +
CHO O +
cells O +
. O +

We O +
compared O +
the O +
abilities O +
of O +
N O +
- O +
and O +
C O +
- O +
terminal O +
deleted O +
fragments O +
of O +
K17F O +
( O +
KFRRQRPRLSHKGPMPF O +
) O +
to O +
bind O +
with O +
high O +
affinity O +
to O +
the O +
apelin B-Gene +
receptor I-Gene +
, O +
to O +
inhibit O +
cAMP O +
production O +
and O +
to O +
induce O +
apelin B-Gene +
receptor I-Gene +
internalization O +
. O +

The O +
first O +
five O +
N O +
- O +
terminal O +
and O +
the O +
last O +
two O +
C O +
- O +
terminal O +
amino O +
acids O +
of O +
K17F O +
were O +
not O +
essential O +
for O +
apelin B-Gene +
binding O +
or O +
cAMP O +
response O +
. O +

In O +
contrast O +
, O +
deletion O +
of O +
the O +
arginine O +
in O +
position O +
6 O +
drastically O +
decreased O +
binding O +
and O +
cAMP O +
response O +
. O +

The O +
full O +
- O +
length O +
sequence O +
of O +
K17F O +
was O +
the O +
most O +
potent O +
inducer O +
of O +
apelin B-Gene +
receptor I-Gene +
internalization O +
because O +
successive O +
N O +
- O +
terminal O +
amino O +
- O +
acid O +
deletions O +
progressively O +
reduced O +
internalization O +
and O +
the O +
removal O +
of O +
a O +
single O +
amino O +
acid O +
, O +
the O +
phenylalanine O +
in O +
position O +
17 O +
at O +
the O +
C O +
- O +
terminus O +
of O +
K17F O +
abolished O +
this O +
process O +
. O +

Thus O +
, O +
K16P O +
binds O +
with O +
high O +
affinity O +
to O +
the O +
apelin B-Gene +
receptor I-Gene +
and O +
strongly O +
inhibits O +
cAMP O +
production O +
, O +
but O +
does O +
not O +
induce O +
apelin B-Gene +
receptor I-Gene +
endocytosis O +
. O +

These O +
data O +
indicate O +
that O +
apelin B-Gene +
receptor I-Gene +
signaling O +
( O +
coupling O +
to O +
Gi B-Gene +
) O +
and O +
endocytosis O +
are O +
functionally O +
dissociated O +
, O +
possibly O +
reflecting O +
the O +
existence O +
of O +
several O +
conformational O +
states O +
of O +
this O +
receptor O +
, O +
stabilized O +
by O +
the O +
binding O +
of O +
different O +
apelin B-Gene +
fragments O +
to O +
the O +
receptor O +
. O +

We O +
then O +
investigated O +
the O +
consequences O +
for O +
biological O +
activity O +
of O +
this O +
functional O +
dissociation O +
by O +
evaluating O +
the O +
effects O +
of O +
various O +
apelin B-Gene +
fragments O +
, O +
injected O +
iv O +
, O +
on O +
arterial O +
blood O +
pressure O +
in O +
normotensive O +
Wistar O +
Kyoto O +
rats O +
. O +

We O +
showed O +
that O +
apelin B-Gene +
fragments O +
, O +
that O +
did O +
not O +
induce O +
receptor O +
internalization O +
in O +
vitro O +
but O +
kept O +
their O +
ability O +
to O +
activate O +
receptor O +
coupling O +
to O +
Gi B-Gene +
, O +
did O +
not O +
decrease O +
arterial O +
blood O +
pressure O +
. O +

Our O +
data O +
showed O +
that O +
hypotensive O +
actions O +
of O +
apelin B-Gene +
peptides O +
correlate O +
with O +
the O +
ability O +
of O +
those O +
ligands O +
to O +
internalize O +
. O +

Thus O +
, O +
the O +
depressor O +
response O +
of O +
apelin B-Gene +
may O +
be O +
controlled O +
by O +
apelin B-Gene +
receptor I-Gene +
endocytosis O +
, O +
which O +
is O +
probably O +
required O +
for O +
initiation O +
of O +
a O +
second O +
wave O +
of O +
signal O +
transduction O +
. O +

The O +
development O +
of O +
biaised O +
agonists O +
of O +
the O +
apelin B-Gene +
receptor I-Gene +
capable O +
of O +
promoting O +
only O +
one O +
specific O +
signal O +
transduction O +
pathway O +
may O +
therefore O +
offer O +
new O +
therapeutic O +
avenues O +
for O +
the O +
treatment O +
of O +
cardiovascular O +
disorders O +
. O +

The O +
transcriptional O +
cycle O +
of O +
HIV-1 O +
in O +
real O +
- O +
time O +
and O +
live O +
cells O +
. O +

RNA B-Gene +
polymerase I-Gene +
II I-Gene +
( O +
RNAPII B-Gene +
) O +
is O +
a O +
fundamental O +
enzyme O +
, O +
but O +
few O +
studies O +
have O +
analyzed O +
its O +
activity O +
in O +
living O +
cells O +
. O +

Using O +
human O +
immunodeficiency O +
virus O +
( O +
HIV O +
) O +
type O +
1 O +
reporters O +
, O +
we O +
study O +
real O +
- O +
time O +
messenger O +
RNA O +
( O +
mRNA O +
) O +
biogenesis O +
by O +
photobleaching O +
nascent O +
RNAs O +
and O +
RNAPII B-Gene +
at O +
specific O +
transcription O +
sites O +
. O +

Through O +
modeling O +
, O +
the O +
use O +
of O +
mutant O +
polymerases B-Gene +
, O +
drugs O +
, O +
and O +
quantitative O +
in O +
situ O +
hybridization O +
, O +
we O +
investigate O +
the O +
kinetics O +
of O +
the O +
HIV O +
- O +
1 O +
transcription O +
cycle O +
. O +

Initiation O +
appears O +
efficient O +
because O +
most O +
polymerases B-Gene +
demonstrate O +
stable O +
gene O +
association O +
. O +

We O +
calculate O +
an O +
elongation O +
rate O +
of O +
approximately O +
1.9 O +
kb O +
/ O +
min O +
, O +
and O +
, O +
surprisingly O +
, O +
polymerases B-Gene +
remain O +
at O +
transcription O +
sites O +
2.5 O +
min O +
longer O +
than O +
nascent O +
RNAs O +
. O +

With O +
a O +
total O +
polymerase B-Gene +
residency O +
time O +
estimated O +
at O +
333 O +
s O +
, O +
114 O +
are O +
assigned O +
to O +
elongation O +
, O +
and O +
63 O +
are O +
assigned O +
to O +
3 O -
' O +
- O +
end O +
processing O +
and O +
/ O +
or O +
transcript O +
release O +
. O +

However O +
, O +
mRNAs O +
were O +
released O +
seconds O +
after O +
polyadenylation O +
onset O +
, O +
and O +
analysis O +
of O +
polymerase B-Gene +
density O +
by O +
chromatin O +
immunoprecipitation O +
suggests O +
that O +
they O +
pause O +
or O +
lose O +
processivity O +
after O +
passing O +
the O +
polyA O +
site O +
. O +

The O +
strengths O +
and O +
limitations O +
of O +
this O +
kinetic O +
approach O +
to O +
analyze O +
mRNA O +
biogenesis O +
in O +
living O +
cells O +
are O +
discussed O +
. O +

Mutations O +
in O +
the O +
UBIAD1 B-Gene +
gene O +
on O +
chromosome O +
short O +
arm O +
1 O +
, O +
region O +
36 O +
, O +
cause O +
Schnyder O +
crystalline O +
corneal O +
dystrophy O +
. O +

PURPOSE O +
: O +

Schnyder O +
crystalline O +
corneal O +
dystrophy O +
( O +
SCCD O +
; O +
MIM O +
121800 O +
) O +
is O +
a O +
rare O +
autosomal O +
dominant O +
disease O +
characterized O +
by O +
an O +
abnormal O +
increase O +
in O +
cholesterol O +
and O +
phospholipid O +
deposition O +
in O +
the O +
cornea O +
, O +
leading O +
to O +
progressive O +
corneal O +
opacification O +
. O +

Although O +
SCCD O +
has O +
been O +
mapped O +
to O +
a O +
genetic O +
interval O +
between O +
markers O +
D1S1160 O +
and O +
D1S1635 O +
, O +
reclassification O +
of O +
a O +
previously O +
unaffected O +
individual O +
expanded O +
the O +
interval O +
to O +
D1S2667 O +
and O +
included O +
nine O +
additional O +
genes O +
. O +

Three O +
candidate O +
genes O +
that O +
may O +
be O +
involved O +
in O +
lipid O +
metabolism O +
and/or O +
are O +
expressed O +
in O +
the O +
cornea O +
were O +
analyzed O +
. O +

METHODS O +
: O +

DNA O +
samples O +
were O +
obtained O +
from O +
six O +
families O +
with O +
clinically O +
confirmed O +
SCCD O +
. O +

Analysis O +
of O +
FRAP1 B-Gene +
, O +
ANGPTL7 B-Gene +
, O +
and O +
UBIAD1 B-Gene +
was O +
performed O +
by O +
PCR O +
- O +
based O +
DNA O +
sequencing O +
, O +
to O +
examine O +
protein O +
- O +
coding O +
regions O +
, O +
RNA O +
splice O +
junctions O +
, O +
and O +
5 O -
' O +
untranslated O +
region O +
( O +
UTR O +
) O +
exons O +
. O +

RESULTS O +
: O +

No O +
disease O +
- O +
causing O +
mutations O +
were O +
found O +
in O +
the O +
FRAP1 B-Gene +
or O +
ANGPTL7 B-Gene +
gene O +
. O +

A O +
mutation O +
in O +
UBIAD1 B-Gene +
was O +
identified O +
in O +
all O +
six O +
families O +
: O +
Five O +
families O +
had O +
the O +
same O +
N102S O +
mutation O +
, O +
and O +
one O +
family O +
had O +
a O +
G177R O +
mutation O +
. O +

Predictions O +
of O +
the O +
protein O +
structure O +
indicated O +
that O +
a O +
prenyl B-Gene +
- I-Gene +
transferase I-Gene +
domain O +
and O +
several O +
transmembrane O +
helices O +
are O +
affected O +
by O +
these O +
mutations O +
. O +

Each O +
mutation O +
cosegregated O +
with O +
the O +
disease O +
in O +
four O +
families O +
with O +
DNA O +
samples O +
from O +
both O +
affected O +
and O +
unaffected O +
individuals O +
. O +

Mutations O +
were O +
not O +
observed O +
in O +
100 O +
control O +
DNA O +
samples O +
( O +
200 O +
chromosomes O +
) O +
. O +

CONCLUSIONS O +
: O +

Nonsynonymous O +
mutations O +
in O +
the O +
UBIAD1 B-Gene +
gene O +
were O +
detected O +
in O +
six O +
SCCD O +
families O +
, O +
and O +
a O +
potential O +
mutation O +
hot O +
spot O +
was O +
observed O +
at O +
amino O +
acid O +
N102 O +
. O +

The O +
mutations O +
are O +
expected O +
to O +
interfere O +
with O +
the O +
function O +
of O +
the O +
UBIAD1 B-Gene +
protein O +
, O +
since O +
they O +
are O +
located O +
in O +
highly O +
conserved O +
and O +
structurally O +
important O +
domains O +
. O +

Activation O +
of O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
decreases O +
phosphorylation O +
of O +
c B-Gene -
- I-Gene -
Jun I-Gene +
at O +
sites O +
that O +
negatively O +
regulate O +
its O +
DNA O +
- O +
binding O +
activity O +
. O +

In O +
resting O +
human O +
epithelial O +
and O +
fibroblastic O +
cells O +
, O +
c B-Gene -
- I-Gene -
Jun I-Gene +
is O +
phosphorylated O +
on O +
serine O +
and O +
threonine O +
at O +
five O +
sites O +
, O +
three O +
of O +
which O +
are O +
phosphorylated O +
in O +
vitro O +
by O +
glycogen B-Gene +
synthase I-Gene +
kinase I-Gene +
3 I-Gene +
( O +
GSK-3 B-Gene +
) O +
. O +

These O +
three O +
sites O +
are O +
nested O +
within O +
a O +
single O +
tryptic O +
peptide O +
located O +
just O +
upstream O +
of O +
the O +
basic O +
region O +
of O +
the O +
c B-Gene -
- I-Gene -
Jun I-Gene +
DNA O +
- O +
binding O +
domain O +
( O +
residues O +
227 O +
- O +
252 O +
) O +
. O +

Activation O +
of O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
results O +
in O +
rapid O +
, O +
site O +
- O +
specific O +
dephosphorylation O +
of O +
c B-Gene -
- I-Gene -
Jun I-Gene +
at O +
one O +
or O +
more O +
of O +
these O +
three O +
sites O +
and O +
is O +
coincident O +
with O +
increased O +
AP-1 B-Gene +
- O +
binding O +
activity O +
. O +

Phosphorylation O +
of O +
recombinant O +
human O +
c B-Gene -
- I-Gene -
Jun I-Gene +
proteins O +
in O +
vitro O +
by O +
GSK-3 B-Gene +
decreases O +
their O +
DNA O +
- O +
binding O +
activity O +
. O +

Mutation O +
of O +
serine O +
243 O +
to O +
phenylalanine O +
blocks O +
phosphorylation O +
of O +
all O +
three O +
sites O +
in O +
vivo O +
and O +
increases O +
the O +
inherent O +
trans O +
- O +
activation O +
ability O +
of O +
c B-Gene -
- I-Gene -
Jun I-Gene +
at O +
least O +
10 O +
- O +
fold O +
. O +

We O +
propose O +
that O +
c B-Gene -
- I-Gene -
Jun I-Gene +
is O +
present O +
in O +
resting O +
cells O +
in O +
a O +
latent O +
, O +
phosphorylated O +
form O +
that O +
can O +
be O +
activated O +
by O +
site O +
- O +
specific O +
dephosphorylation O +
in O +
response O +
to O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
activation O +
. O +

Effect O +
of O +
promoter O +
mutations O +
and O +
upstream O +
deletions O +
on O +
the O +
expression O +
of O +
genes O +
coding O +
for O +
small O +
, O +
acid O +
- O +
soluble O +
spore O +
proteins O +
of O +
Bacillus O +
subtilis O +
. O +

The O +
sspB B-Gene +
and O +
sspE B-Gene +
genes O +
code O +
for O +
major O +
small O +
, O +
acid O +
- O +
soluble O +
proteins O +
of O +
Bacillus O +
subtilis O +
spores O +
and O +
are O +
transcribed O +
during O +
sporulation O +
by O +
RNA B-Gene +
polymerase I-Gene +
containing O +
sigma B-Gene +
G I-Gene +
. O +

Analysis O +
of O +
the O +
expression O +
in O +
vivo O +
and O +
the O +
sigma B-Gene +
G I-Gene +
- O +
dependent O +
transcription O +
in O +
vitro O +
of O +
sspB B-Gene +
and O +
sspE B-Gene +
genes O +
carrying O +
upstream O +
deletions O +
or O +
point O +
mutations O +
in O +
- O +
10 O +
and O +
- O +
35 O +
promoter O +
regions O +
is O +
consistent O +
with O +
sigma B-Gene +
G I-Gene +
being O +
the O +
only O +
major O +
transcriptional O +
regulator O +
of O +
these O +
genes O +
. O +

These O +
data O +
also O +
provide O +
information O +
on O +
the O +
residues O +
in O +
- O +
10 O +
and O +
- O +
35 O +
regions O +
which O +
are O +
most O +
important O +
for O +
sigma B-Gene +
G I-Gene +
recognition O +
. O +

Control O +
of O +
transcription O +
of O +
the O +
Bacillus O +
subtilis O +
spoIIIG B-Gene +
gene O +
, O +
which O +
codes O +
for O +
the O +
forespore O +
- O +
specific O +
transcription B-Gene +
factor I-Gene +
sigma B-Gene +
G I-Gene +
. O +

The O +
Bacillus O +
subtilis O +
spoIIIG B-Gene +
gene O +
codes O +
for O +
a O +
sigma B-Gene +
factor I-Gene +
termed O +
sigma B-Gene +
G I-Gene +
which O +
directs O +
transcription O +
of O +
genes O +
expressed O +
only O +
in O +
the O +
forespore O +
compartment O +
of O +
the O +
sporulating O +
cell O +
. O +

Use O +
of O +
spoIIIG B-Gene +
- O +
lacZ B-Gene +
transcriptional O +
fusions O +
showed O +
that O +
spoIIIG B-Gene +
is O +
cotranscribed O +
with O +
the O +
spoIIG B-Gene +
operon I-Gene +
beginning O +
at O +
t0.5 O -
- O -
1 O +
of O +
sporulation O +
. O +

However O +
, O +
this O +
large O +
mRNA O +
produced O +
little O +
if O +
any O +
sigma B-Gene +
G I-Gene +
, O +
and O +
transferring O +
the O +
spoIIIG B-Gene +
gene O +
without O +
the O +
spoIIG B-Gene +
promoter O +
into O +
the O +
amyE B-Gene +
locus O +
resulted O +
in O +
a O +
Spo B-Gene +
+ O +
phenotype O +
. O +

Significant O +
translation O +
of O +
spoIIIG B-Gene +
began O +
at O +
t2.5 O -
- O -
3 O +
with O +
use O +
of O +
an O +
mRNA O +
whose O +
5 O -
' O +
end O +
is O +
just O +
upstream O +
of O +
the O +
spoIIIG B-Gene +
coding O +
sequence O +
. O +

Synthesis O +
of O +
this O +
spoIIIG B-Gene +
- O +
specific O +
mRNA O +
was O +
not O +
abolished O +
by O +
a O +
deletion O +
in O +
spoIIIG B-Gene +
itself O +
. O +

Similar O +
results O +
were O +
obtained O +
when O +
a O +
spoIIIG B-Gene +
- O +
lacZ B-Gene +
translational O +
fusion O +
lacking O +
the O +
spoIIG B-Gene +
promoter O +
was O +
integrated O +
at O +
the O +
amyE B-Gene +
locus O +
. O +

These O +
data O +
suggest O +
that O +
synthesis O +
of O +
sigma B-Gene +
G I-Gene +
is O +
dependent O +
neither O +
on O +
transcription O +
from O +
the O +
spoIIG B-Gene +
promoter O +
nor O +
on O +
sigma B-Gene +
G I-Gene +
itself O +
but O +
can O +
be O +
due O +
to O +
another O +
transcription B-Gene +
factor I-Gene +
. O +

This O +
transcription B-Gene +
factor I-Gene +
may O +
be O +
sigma B-Gene +
F I-Gene +
, O +
the O +
product O +
of O +
the O +
spoIIAC B-Gene +
locus O +
, O +
since O +
a O +
spoIIAC B-Gene +
mutation O +
blocked O +
spoIIIG B-Gene +
expression O +
, O +
and O +
sequences O +
upstream O +
of O +
the O +
5 O -
' O +
end O +
of O +
the O +
spoIIIG B-Gene +
- O +
specific O +
mRNA O +
agree O +
well O +
with O +
the O +
recognition O +
sequence O +
for O +
sigma B-Gene +
F I-Gene +
. O +

RNA B-Gene +
polymerase I-Gene +
containing O +
sigma B-Gene +
F I-Gene +
( O +
E B-Gene +
sigma I-Gene +
F I-Gene +
) O +
initiated O +
transcription O +
in O +
vitro O +
on O +
a O +
spoIIIG B-Gene +
template O +
at O +
the O +
5 O -
' O +
end O +
found O +
in O +
vivo O +
, O +
as O +
did O +
E B-Gene +
sigma I-Gene +
G I-Gene +
. O +

However O +
, O +
E B-Gene +
sigma I-Gene +
F I-Gene +
showed O +
a O +
greater O +
than O +
20 O +
- O +
fold O +
preference O +
for O +
spoIIIG B-Gene +
over O +
a O +
known O +
sigma B-Gene +
G I-Gene +
- O +
dependent O +
gene O +
compared O +
with O +
the O +
activity O +
of O +
E B-Gene +
sigma I-Gene +
G I-Gene +
. O +

Phosphorylation O +
of O +
c B-Gene -
- I-Gene -
jun I-Gene +
mediated O +
by O +
MAP B-Gene +
kinases I-Gene +
. O +

The O +
proto O +
- O +
oncogene O +
c B-Gene -
- I-Gene -
jun I-Gene +
is O +
a O +
component O +
of O +
the O +
AP-1 B-Gene +
transcription I-Gene +
factor I-Gene +
family I-Gene +
involved O +
in O +
the O +
mediation O +
of O +
nuclear O +
events O +
elicited O +
by O +
extracellular O +
stimuli O +
. O +

The O +
c B-Gene -
- I-Gene -
jun I-Gene +
protein O +
is O +
negatively O +
regulated O +
by O +
phosphorylation O +
of O +
residues O +
near O +
the O +
carboxy O +
terminus O +
which O +
are O +
dephosphorylated O +
in O +
response O +
to O +
phorbol O +
esters O +
. O +

Here O +
we O +
identify O +
two O +
serine O +
residues O +
in O +
the O +
amino O +
terminal O +
A1 O +
transactivation O +
domain O +
which O +
are O +
phosphorylated O +
in O +
response O +
to O +
a O +
variety O +
of O +
mitogens O +
, O +
phorbol O +
esters O +
and O +
activated O +
ras B-Gene +
. O +

We O +
present O +
evidence O +
that O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
- I-Gene +
serine I-Gene +
( I-Gene +
MAP I-Gene +
) I-Gene +
kinases I-Gene +
( O +
pp54 O +
and O +
pp42 O +
/ O +
44 O +
) O +
specifically O +
phosphorylate O +
these O +
sites O +
and O +
that O +
their O +
phosphorylation O +
positively O +
regulates O +
the O +
transacting O +
activity O +
of O +
c B-Gene -
- I-Gene -
jun I-Gene +
. O +

The O +
MAP B-Gene +
kinase I-Gene +
enzymes O +
pp54 O +
and O +
pp42 O +
/ O +
44 O +
are O +
regulated O +
by O +
tyrosine O +
as O +
well O +
as O +
serine O +
/ O +
threonine O +
phosphorylation O +
. O +

MAP B-Gene +
kinase I-Gene +
activation O +
of O +
c B-Gene -
- I-Gene -
jun I-Gene +
may O +
underlie O +
the O +
common O +
stimulation O +
of O +
this O +
transcription B-Gene +
factor I-Gene +
by O +
mitogens O +
, O +
growth B-Gene +
factors I-Gene +
and O +
oncogenes O +
. O +

Promoter O +
specificity O +
of O +
sigma B-Gene +
G I-Gene +
- O +
containing O +
RNA B-Gene +
polymerase I-Gene +
from O +
sporulating O +
cells O +
of O +
Bacillus O +
subtilis O +
: O +
identification O +
of O +
a O +
group O +
of O +
forespore O +
- O +
specific O +
promoters O +
. O +

During O +
sporulation O +
in O +
Bacillus O +
subtilis O +
, O +
expression O +
of O +
the O +
genes O +
sspA B-Gene +
, O +
sspB B-Gene +
, O +
sspC B-Gene +
, O +
sspD B-Gene +
, O +
and O +
sspE B-Gene +
, O +
which O +
encode O +
a O +
family O +
of O +
small O +
, O +
acid O +
- O +
soluble O +
spore O +
proteins O +
, O +
as O +
well O +
as O +
of O +
the O +
spoVA B-Gene +
and O +
gdh B-Gene +
operons O +
is O +
transcriptionally O +
activated O +
at O +
stage O +
III O +
of O +
sporulation O +
only O +
in O +
the O +
forespore O +
compartment O +
. O +

Transcription O +
of O +
these O +
genes O +
is O +
mediated O +
by O +
RNA B-Gene +
polymerase I-Gene +
containing O +
sigma B-Gene +
G I-Gene +
( O +
E B-Gene +
sigma I-Gene +
G I-Gene +
) O +
, O +
the O +
product O +
of O +
the O +
sigG B-Gene +
gene O +
, O +
which O +
is O +
itself O +
expressed O +
at O +
stage O +
III O +
in O +
the O +
developing O +
forespore O +
. O +

We O +
have O +
determined O +
the O +
5 O -
' O +
ends O +
of O +
transcripts O +
generated O +
both O +
in O +
vivo O +
and O +
in O +
vitro O +
by O +
the O +
action O +
of O +
E B-Gene +
sigma I-Gene +
G I-Gene +
on O +
various O +
genes O +
of O +
B. O +
subtilis O +
and O +
other O +
bacilli O +
. O +

The O +
5 O -
' O +
ends O +
of O +
the O +
in O +
vivo O +
and O +
in O +
vitro O +
mRNAs O +
were O +
found O +
to O +
coincide O +
and O +
were O +
therefore O +
considered O +
to O +
define O +
the O +
transcription O +
initiation O +
sites O +
for O +
the O +
genes O +
examined O +
. O +

We O +
identified O +
highly O +
homologous O +
DNA O +
sequences O +
centered O +
at O +
35 O +
and O +
10 O +
base O +
pairs O +
preceding O +
the O +
transcriptional O +
start O +
sites O +
of O +
the O +
genes O +
examined O +
. O +

Consequently O +
, O +
we O +
propose O +
that O +
these O +
sequences O +
define O +
a O +
class O +
of O +
promoters O +
recognized O +
only O +
by O +
E B-Gene +
sigma I-Gene +
G I-Gene +
which O +
allow O +
transcription O +
of O +
genes O +
expressed O +
uniquely O +
at O +
stage O +
III O +
in O +
the O +
developing O +
forespore O +
. O +

Switch O +
protein O +
alters O +
specificity O +
of O +
RNA B-Gene +
polymerase I-Gene +
containing O +
a O +
compartment O +
- O +
specific O +
sigma B-Gene +
factor I-Gene +
. O +

During O +
sporulation O +
in O +
Bacillus O +
subtilis O +
, O +
expression O +
of O +
developmental O +
genes O +
spoIVCB B-Gene +
and O +
cotD B-Gene +
is O +
induced O +
in O +
the O +
mother O +
cell O +
compartment O +
of O +
the O +
sporangium O +
at O +
morphological O +
stages O +
IV O +
and O +
V O +
, O +
respectively O +
. O +

A O +
27 O +
- O +
kilodalton O +
RNA B-Gene +
polymerase I-Gene +
sigma I-Gene +
factor I-Gene +
called O +
sigma B-Gene +
K I-Gene +
( O +
or O +
sigma B-Gene +
27 I-Gene +
) O +
has O +
been O +
found O +
that O +
causes O +
weak O +
transcription O +
of O +
spoIVCB B-Gene +
and O +
strong O +
transcription O +
of O +
cotD B-Gene +
. O +

A O +
14 O +
- O +
kD O +
protein O +
was O +
also O +
discovered O +
that O +
changes O +
the O +
specificity O +
of O +
sigma B-Gene +
K I-Gene +
- O +
containing O +
RNA B-Gene +
polymerase I-Gene +
, O +
greatly O +
stimulating O +
spoIVCB B-Gene +
transcription O +
and O +
markedly O +
repressing O +
cotD B-Gene +
transcription O +
. O +

Both O +
sigma B-Gene +
K I-Gene +
and O +
the O +
14 O +
- O +
kD O +
protein O +
are O +
products O +
of O +
genes O +
known O +
to O +
be O +
required O +
for O +
expression O +
of O +
specific O +
genes O +
in O +
the O +
mother O +
cell O +
. O +

Thus O +
, O +
sigma B-Gene +
K I-Gene +
directs O +
gene O +
expression O +
in O +
the O +
mother O +
cell O +
and O +
it O +
is O +
proposed O +
that O +
inactivation O +
or O +
sequestering O +
of O +
the O +
14 O +
- O +
kD O +
protein O +
switches O +
the O +
temporal O +
pattern O +
of O +
gene O +
expression O +
during O +
the O +
transition O +
from O +
stages O +
IV O +
to O +
V O +
of O +
development O +
. O +

Mutation O +
changing O +
the O +
specificity O +
of O +
an O +
RNA B-Gene +
polymerase I-Gene +
sigma I-Gene +
factor I-Gene +
. O +

We O +
describe O +
a O +
mutation O +
that O +
changes O +
the O +
fine O +
specificity O +
of O +
promoter O +
selection O +
by O +
a O +
secondary O +
form O +
of O +
RNA B-Gene +
polymerase I-Gene +
holoenzyme O +
in O +
Bacillus O +
subtilis O +
. O +

The O +
product O +
of O +
regulatory O +
gene O +
spo0H B-Gene +
is O +
an O +
RNA B-Gene +
polymerase I-Gene +
sigma I-Gene +
factor I-Gene +
called O +
sigma B-Gene +
H I-Gene +
, O +
which O +
directs O +
transcription O +
of O +
a O +
sporulation O +
gene O +
known O +
as O +
spoVG B-Gene +
. O +

We O +
show O +
that O +
the O +
spo0H B-Gene +
mutation O +
spo0H81 B-Gene +
, O +
which O +
blocks O +
transcription O +
from O +
the O +
wild O +
- O +
type O +
spoVG B-Gene +
promoter O +
, O +
enhances O +
transcription O +
from O +
a O +
mutant O +
form O +
of O +
the O +
spoVG B-Gene +
promoter O +
( O +
spoVG249 B-Gene +
) O +
bearing O +
a O +
severe O +
down O +
- O +
mutation O +
( O +
a O +
G.C O +
to O +
A.T O +
transition O +
) O +
at O +
position O +
- O +
13 O +
in O +
the O +
" O +
- O +
10 O +
region O -
. O +
" O +

Suppression O +
of O +
the O +
spoVG249 B-Gene +
mutation O +
is O +
specific O +
in O +
the O +
sense O +
that O +
the O +
transcription O +
from O +
several O +
other O +
spoVG B-Gene +
mutant O +
promoters O +
was O +
not O +
restored O +
by O +
the O +
mutant O +
sigma O +
. O +

Evidently O +
, O +
spo0H81 B-Gene +
is O +
a O +
change O +
- O +
of O +
- O +
specificity O +
mutation O +
that O +
alters O +
sigma B-Gene +
H I-Gene +
- O +
RNA B-Gene +
polymerase I-Gene +
in O +
a O +
way O +
that O +
decreases O +
its O +
capacity O +
to O +
use O +
the O +
wild O +
- O +
type O +
spoVG B-Gene +
promoter O +
, O +
while O +
increasing O +
its O +
capacity O +
to O +
use O +
the O +
mutant O +
promoter O +
. O +

Transcription O +
experiments O +
in O +
vitro O +
using O +
RNA B-Gene +
polymerase I-Gene +
containing O +
the O +
wild O +
- O +
type O +
or O +
mutant O +
sigma O +
support O +
this O +
interpretation O +
. O +

The O +
spo0H81 B-Gene +
mutation O +
causes O +
a O +
threonine O +
( O +
Thr100 O +
) O +
to O +
isoleucine O +
substitution O +
in O +
a O +
region O +
of O +
sigma B-Gene +
H I-Gene +
that O +
is O +
highly O +
homologous O +
among O +
sigma B-Gene +
factors I-Gene +
of O +
diverse O +
origins O +
. O +

We O +
discuss O +
the O +
possibility O +
that O +
Thr100 O +
is O +
an O +
amino O +
acid O +
- O +
base O +
- O +
pair O +
contact O +
site O +
and O +
that O +
sigma B-Gene +
factors I-Gene +
contact O +
the O +
- O +
10 O +
region O +
of O +
their O +
cognate O +
promoters O +
by O +
means O +
of O +
amino O +
acid O +
residues O +
in O +
this O +
highly O +
conserved O +
region O +
. O +

Genetic O +
mapping O +
of O +
rpoD B-Gene +
implicates O +
the O +
major O +
sigma B-Gene +
factor I-Gene +
of O +
Bacillus O +
subtilis O +
RNA B-Gene +
polymerase I-Gene +
in O +
sporulation O +
initiation O +
. O +

We O +
have O +
mapped O +
the O +
chromosomal O +
locus O +
of O +
rpoD B-Gene +
, O +
which O +
encodes O +
the O +
major O +
sigma B-Gene +
factor I-Gene +
of O +
Bacillus O +
subtilis O +
RNA B-Gene +
polymerase I-Gene +
. O +

The O +
rpoD B-Gene +
locus O +
lay O +
between O +
aroD B-Gene +
and O +
lys B-Gene +
, O +
tightly O +
linked O +
to O +
dnaE B-Gene +
and O +
inseparable O +
from O +
crsA B-Gene +
. O +

Marker O +
order O +
in O +
this O +
region O +
was O +
acf O +
- O +
aroD B-Gene +
- O +
dnaE B-Gene +
- O +
rpoD B-Gene +
( O +
crsA B-Gene +
) O +
- O +
spoOG B-Gene +
- O +
lys B-Gene +
. O +

By O +
transformation O +
using O +
cloned O +
donor O +
DNA O +
from O +
the O +
rpoD B-Gene +
region O +
, O +
we O +
identified O +
the O +
gene O +
immediately O +
upstream O +
of O +
rpoD B-Gene +
as O +
dnaE B-Gene +
, O +
which O +
coded O +
for O +
a O +
62,000 O +
dalton O +
protein O +
essential O +
for O +
DNA O +
replication O +
. O +

Both O +
dnaE B-Gene +
and O +
rpoD B-Gene +
were O +
transcribed O +
in O +
the O +
same O +
direction O +
, O +
counterclockwise O +
on O +
the O +
chromosome O +
. O +

The O +
gene O +
functions O +
and O +
organization O +
in O +
the O +
rpoD B-Gene +
region O +
are O +
thus O +
similar O +
to O +
those O +
of O +
the O +
E. O +
coli O +
sigma O +
operon O +
. O +

We O +
also O +
used O +
transformation O +
to O +
identify O +
crsA47 O +
as O +
a O +
mutation O +
within O +
the O +
sigma O +
coding O +
region O +
itself O +
. O +

The O +
crsA B-Gene +
alteration O +
of O +
sigma O +
renders O +
the O +
sporulation O +
process O +
insensitive O +
to O +
glucose O +
catabolite O +
repression O +
, O +
and O +
also O +
restores O +
sporulation O +
ability O +
to O +
strains O +
carrying O +
early O +
- O +
blocked O +
spoOE B-Gene +
, O +
spoOF B-Gene +
, O +
and O +
spoOK B-Gene +
mutations O +
. O +

Thus O +
the O +
major O +
sigma B-Gene +
factor I-Gene +
and O +
these O +
spoO B-Gene +
gene O +
products O +
directly O +
or O +
indirectly O +
affect O +
the O +
same O +
cellular O +
function O +
. O +

Nucleotide O +
sequence O +
and O +
organization O +
of O +
Bacillus O +
subtilis O +
RNA B-Gene +
polymerase I-Gene +
major O +
sigma O +
( O +
sigma B-Gene +
43 I-Gene +
) O +
operon O +
. O +

The O +
gene O +
coding O +
for O +
Bacillus O +
subtilis O +
RNA B-Gene +
polymerase I-Gene +
major O +
sigma B-Gene +
43 I-Gene +
, O +
rpoD B-Gene +
, O +
was O +
cloned O +
together O +
with O +
its O +
neighboring O +
genes O +
in O +
a O +
7 O +
kb O +
EcoRI B-Gene +
fragment O +
. O +

The O +
complete O +
nucleotide O +
sequence O +
of O +
a O +
5 O +
kb O +
fragment O +
including O +
the O +
entire O +
rpoD B-Gene +
gene O +
revealed O +
the O +
presence O +
of O +
two O +
other O +
genes O +
preceding O +
rpoD B-Gene +
in O +
the O +
order O +
P23 B-Gene +
- O +
dnaE B-Gene +
- O +
rpoD B-Gene +
. O +

The O +
dnaE B-Gene +
codes O +
for O +
DNA B-Gene +
primase I-Gene +
while O +
the O +
function O +
of O +
P23 B-Gene +
remains O +
unknown O +
. O +

The O +
three O +
genes O +
reside O +
in O +
an O +
operon O +
that O +
is O +
similar O +
in O +
organization O +
to O +
the O +
E. O +
coli O +
RNA B-Gene +
polymerase I-Gene +
major O +
sigma B-Gene +
70 I-Gene +
operon O +
, O +
which O +
is O +
composed O +
of O +
genes O +
encoding O +
small B-Gene +
ribosome I-Gene +
protein I-Gene +
S21 I-Gene +
( O +
rpsU B-Gene +
) O +
, O +
DNA B-Gene +
primase I-Gene +
( O +
dnaG B-Gene +
) O +
, O +
and O +
RNA B-Gene +
polymerase I-Gene +
sigma I-Gene +
70 I-Gene +
( O +
rpoD B-Gene +
) O +
. O +

There O +
is O +
a O +
relatively O +
high O +
degree O +
of O +
base O +
and O +
amino O +
acid O +
homology O +
between O +
the O +
DNA B-Gene +
primase I-Gene +
and O +
sigma O +
genes O +
. O +

The O +
most O +
significant O +
differences O +
between O +
the O +
two O +
operons O +
are O +
observed O +
in O +
the O +
molecular O +
size O +
of O +
the O +
first O +
genes O +
( O +
P23 B-Gene +
and O +
rpsU B-Gene +
) O +
, O +
the O +
complete O +
lack O +
of O +
amino O +
acid O +
homology O +
between O +
P23 B-Gene +
and O +
S21 B-Gene +
, O +
the O +
molecular O +
weights O +
of O +
the O +
two O +
rpoD B-Gene +
genes O +
, O +
the O +
size O +
of O +
the O +
intercistronic O +
region O +
between O +
the O +
first O +
two O +
genes O +
, O +
and O +
the O +
regulatory O +
elements O +
of O +
the O +
operon O +
. O +

Use O +
of O +
a O +
lacZ B-Gene +
gene O +
fusion O +
to O +
determine O +
the O +
dependence O +
pattern O +
of O +
sporulation O +
operon O +
spoIIIC B-Gene +
in O +
spo O +
mutants O +
of O +
Bacillus O +
subtilis O +
: O +
a O +
branched O +
pathway O +
of O +
expression O +
of O +
sporulation O +
operons O +
. O +

The O +
sporulation O +
gene O +
spoIIIC B-Gene +
from O +
Bacillus O +
subtilis O +
was O +
fused O +
to O +
the O +
lacZ B-Gene +
gene O +
from O +
Escherichia O +
coli O +
, O +
so O +
that O +
the O +
transcription O +
of O +
the O +
lacZ B-Gene +
gene O +
was O +
under O +
the O +
control O +
of O +
the O +
spoIIIC B-Gene +
promoter O +
. O +

Production O +
of O +
beta B-Gene -
- I-Gene -
galactosidase I-Gene +
, O +
under O +
conditions O +
of O +
sporulation O +
, O +
was O +
then O +
used O +
as O +
an O +
indicator O +
to O +
study O +
the O +
expression O +
of O +
spoIIIC B-Gene +
in O +
relation O +
to O +
other O +
sporulation O +
loci O +
. O +

Expression O +
of O +
spoIIIC B-Gene +
, O +
which O +
occurred O +
only O +
in O +
the O +
mother O +
cell O +
compartment O +
, O +
was O +
prevented O +
by O +
mutations O +
in O +
all O +
of O +
the O +
stage O +
0 O +
and O +
stage O +
II O +
loci O +
, O +
and O +
also O +
by O +
spoIIID B-Gene +
, O +
spoIVA B-Gene +
and O +
spoIVB B-Gene +
mutations O +
. O +

By O +
contrast O +
, O +
the O +
last O +
three O +
operons O +
are O +
not O +
needed O +
for O +
expression O +
of O +
spoVA B-Gene +
, O +
which O +
has O +
previously O +
been O +
shown O +
to O +
be O +
spore O +
- O +
specific O +
. O +

In O +
consequence O +
, O +
a O +
branched O +
pathway O +
of O +
gene O +
expression O +
is O +
proposed O +
. O +

One O +
branch O +
leads O +
to O +
expression O +
of O +
spoVA B-Gene +
within O +
the O +
spore O +
compartment O +
, O +
the O +
other O +
to O +
expression O +
of O +
spoIIIC B-Gene +
in O +
the O +
mother O +
cell O +
. O +

Utilization O +
of O +
one O +
promoter O +
by O +
two O +
forms O +
of O +
RNA B-Gene +
polymerase I-Gene +
from O +
Bacillus O +
subtilis O +
. O +

Bacillus O +
subtilis O +
possesses O +
several O +
forms O +
of O +
RNA B-Gene +
polymerase I-Gene +
, O +
each O +
differing O +
in O +
its O +
sigma O +
subunit O +
and O +
its O +
specificity O +
of O +
promoter O +
recognition O +
. O +

The O +
sequential O +
appearance O +
of O +
sigma O +
subunits O +
, O +
which O +
change O +
the O +
promoter O +
recognition O +
specificity O +
of O +
RNA B-Gene +
polymerase I-Gene +
, O +
may O +
have O +
a O +
key O +
role O +
in O +
controlling O +
the O +
temporal O +
pattern O +
of O +
gene O +
expression O +
required O +
for O +
endospore O +
development O +
in O +
B. O +
subtilis O +
. O +

Several O +
genes O +
that O +
are O +
expressed O +
over O +
relatively O +
long O +
periods O +
of O +
time O +
during O +
the O +
developmental O +
cycle O +
are O +
transcribed O +
by O +
more O +
than O +
one O +
form O +
of O +
RNA B-Gene +
polymerase I-Gene +
, O +
which O +
initiate O +
transcription O +
from O +
either O +
tandem O +
or O +
overlapping O +
promoter O +
. O +

The O +
promoter O +
region O +
for O +
the O +
ctc B-Gene +
gene O +
is O +
interesting O +
because O +
transcription O +
is O +
initiated O +
at O +
or O +
near O +
the O +
same O +
position O +
by O +
both O +
sigma B-Gene +
37 I-Gene +
RNA B-Gene +
polymerase I-Gene +
( O +
E B-Gene +
sigma I-Gene +
37 I-Gene +
) O +
, O +
a O +
minor O +
form O +
in O +
growing O +
cells O +
, O +
and O +
sigma B-Gene +
29 I-Gene +
RNA B-Gene +
polymerase I-Gene +
( O +
E B-Gene +
sigma I-Gene +
29 I-Gene +
) O +
, O +
a O +
form O +
which O +
appears O +
approximately O +
2 O +
h O +
after O +
the O +
initiation O +
of O +
sproulation O +
. O +

Here O +
we O +
report O +
that O +
several O +
base O +
substitutions O +
in O +
the O +
ctc O +
promoter O +
differentially O +
affect O +
the O +
utilization O +
of O +
the O +
promoter O +
by O +
E B-Gene +
sigma I-Gene +
37 I-Gene +
or O +
E B-Gene +
sigma I-Gene +
29 I-Gene +
. O +

Evidence O +
that O +
the O +
transcriptional O +
activator O +
Spo0A B-Gene +
interacts O +
with O +
two O +
sigma B-Gene +
factors I-Gene +
in O +
Bacillus O +
subtilis O +
. O +

The O +
transcriptional O +
regulator O +
Spo0A B-Gene +
activates O +
transcription O +
from O +
two O +
types O +
of O +
promoters O +
. O +

One O +
type O +
of O +
promoter O +
is O +
used O +
by O +
RNA B-Gene +
polymerase I-Gene +
containing O +
sigma B-Gene +
A I-Gene +
, O +
whereas O +
the O +
other O +
type O +
is O +
used O +
by O +
RNA B-Gene +
polymerase I-Gene +
containing O +
sigma B-Gene +
H I-Gene +
. O +

There O +
are O +
Spo0A B-Gene +
- O +
binding O +
sites O +
near O +
the O +
- O +
35 O +
region O +
of O +
both O +
types O +
of O +
promoters O +
. O +

It O +
has O +
been O +
reported O +
that O +
some O +
transcriptional O +
regulators O +
that O +
bind O +
near O +
the O +
- O +
35 O +
regions O +
of O +
promoters O +
directly O +
interact O +
with O +
the O +
sigma O +
subunit O +
of O +
RNA B-Gene +
polymerase I-Gene +
. O +

Therefore O +
, O +
we O +
looked O +
for O +
evidence O +
that O +
Spo0A B-Gene +
interacts O +
with O +
both O +
sigma B-Gene +
factors I-Gene +
by O +
searching O +
for O +
single O +
amino O +
acid O +
substitutions O +
in O +
these O +
factors O +
that O +
specifically O +
prevent O +
expression O +
from O +
Spo0A B-Gene +
- O +
dependent O +
promoters O +
, O +
but O +
that O +
do O +
not O +
decrease O +
activity O +
of O +
Spo0A B-Gene +
- O +
independent O +
promoters O +
. O +

Two O +
such O +
amino O +
acid O +
substitutions O +
were O +
isolated O +
in O +
sigma B-Gene +
A I-Gene +
and O +
one O +
was O +
isolated O +
in O +
sigma B-Gene +
H I-Gene +
. O +

The O +
amino O +
acid O +
substitutions O +
in O +
sigma B-Gene +
A I-Gene +
prevented O +
expression O +
from O +
the O +
Spo0A B-Gene +
- O +
activated O +
promoters O +
, O +
spoIIG B-Gene +
and O +
spoIIE B-Gene +
, O +
but O +
expression O +
was O +
not O +
impaired O +
from O +
the O +
Spo0A B-Gene +
- O +
independent O +
, O +
sigma B-Gene +
A I-Gene +
- O +
dependent O +
promoter O +
tms B-Gene +
or O +
from O +
the O +
Spo0A B-Gene +
- O +
activated O +
, O +
sigma B-Gene +
H I-Gene +
- O +
dependent O +
promoter O +
, O +
spoIIA B-Gene +
. O +

The O +
amino O +
acid O +
substitution O +
in O +
sigma B-Gene +
H I-Gene +
prevented O +
expression O +
from O +
the O +
spoIIA B-Gene +
promoter O +
but O +
not O +
from O +
the O +
Spo0A B-Gene +
- O +
independent O +
promoter O +
, O +
citGp2 B-Gene +
, O +
which O +
is O +
used O +
by O +
sigma B-Gene +
H I-Gene +
- O +
RNA O +
polymerase O +
. O +

All O +
of O +
these O +
amino O +
acid O +
substitutions O +
occur O +
in O +
the O +
carboxyl O +
terminus O +
of O +
the O +
sigma B-Gene +
factors I-Gene +
. O +

These O +
amino O +
acid O +
substitutions O +
may O +
define O +
the O +
sites O +
of O +
contact O +
between O +
the O +
sigma B-Gene +
factors I-Gene +
and O +
Spo0A B-Gene +
. O +

The O +
ability O +
of O +
response O +
regulators O +
such O +
as O +
Spo0A B-Gene +
to O +
interact O +
with O +
multiple O +
sigma B-Gene +
factors I-Gene +
may O +
increase O +
the O +
variety O +
of O +
responses O +
made O +
by O +
bacteria O +
using O +
a O +
limited O +
number O +
of O +
transcription B-Gene +
factors I-Gene +
. O +

Expression O +
of O +
the O +
rocDEF B-Gene +
operon I-Gene +
involved O +
in O +
arginine O +
catabolism O +
in O +
Bacillus O +
subtilis O +
. O +

Three O +
genes O +
called O +
rocD B-Gene +
, O +
rocE B-Gene +
and O +
rocF B-Gene +
were O +
found O +
near O +
the O +
rocR B-Gene +
gene O +
in O +
B. O +
subtilis O +
. O +

The O +
product O +
of O +
rocD B-Gene +
is O +
similar O +
to O +
eukaryotic O +
ornithine B-Gene +
aminotransferases I-Gene +
. O +

The O +
product O +
of O +
rocE B-Gene +
shares O +
similarity O +
with O +
the O +
product O +
of O +
B. O +
subtilis O +
rocC B-Gene +
and O +
with O +
the O +
product O +
of O +
E. O +
coli O +
lysP B-Gene +
. O +

The O +
rocE B-Gene +
gene O +
may O +
encode O +
an O +
arginine O +
permease B-Gene +
. O +

The O +
rocF B-Gene +
gene O +
encodes O +
a O +
polypeptide O +
similar O +
to O +
several O +
arginases B-Gene +
. O +

Heterologous O +
expression O +
in O +
E. O +
coli O +
indicated O +
that O +
rocD B-Gene +
encodes O +
an O +
ornithine B-Gene +
aminotransferase I-Gene +
and O +
that O +
rocF B-Gene +
encodes O +
an O +
arginase B-Gene +
. O +

Arginine O +
utilization O +
was O +
abolished O +
in O +
both O +
rocD B-Gene +
and O +
rocF B-Gene +
mutants O +
of O +
B. O +
subtilis O +
confirming O +
the O +
role O +
of O +
these O +
genes O +
in O +
arginine O +
catabolism O +
. O +

The O +
rocDEF B-Gene +
genes O +
form O +
an O +
operon O +
transcribed O +
from O +
a O +
- O +
12 O +
, O +
- O +
24 O +
promoter O +
almost O +
identical O +
to O +
the O +
- O +
12 O +
, O +
- O +
24 O +
promoter O +
of O +
the O +
rocABC B-Gene +
operon I-Gene +
. O +

The O +
expression O +
of O +
the O +
rocDEF B-Gene +
operon I-Gene +
was O +
induced O +
by O +
the O +
presence O +
of O +
arginine O +
, O +
ornithine O +
or O +
proline O +
in O +
the O +
growth O +
medium O +
and O +
depended O +
on O +
the O +
presence O +
of O +
the O +
sigma B-Gene +
factor I-Gene +
SigL B-Gene +
. O +

Transcription O +
of O +
this O +
operon O +
was O +
also O +
abolished O +
in O +
a O +
B. O +
subtilis O +
strain O +
containing O +
a O +
null O +
mutation O +
in O +
the O +
regulatory O +
gene O +
rocR B-Gene +
. O +

Two O +
tandemly O +
repeated O +
upstream O +
activating O +
sequences O +
very O +
similar O +
to O +
those O +
previously O +
identified O +
in O +
the O +
rocABC B-Gene +
system O +
were O +
found O +
centered O +
at O +
positions O +
- O +
120 O +
and O +
- O +
70 O +
, O +
respectively O +
, O +
upstream O +
from O +
the O +
transcription O +
start O +
site O +
of O +
rocDEF B-Gene +
. O +

Deletion O +
analysis O +
showed O +
that O +
at O +
least O +
one O +
upstream O +
activating O +
sequence O +
is O +
involved O +
in O +
the O +
expression O +
of O +
the O +
rocDEF B-Gene +
operon I-Gene +
. O +

These O +
sequences O +
are O +
probably O +
the O +
target O +
of O +
RocR B-Gene +
. O +

Analysis O +
of O +
a O +
rocR B-Gene +
' O -
- O -
' O +
lacZ B-Gene +
fusion O +
strain O +
showed O +
that O +
the O +
expression O +
of O +
rocR B-Gene +
is O +
not O +
induced O +
by O +
arginine O +
and O +
is O +
negatively O +
autoregulated O +
. O +

The O +
HPr B-Gene +
protein O +
of O +
the O +
phosphotransferase B-Gene +
system I-Gene +
links O +
induction O +
and O +
catabolite O +
repression O +
of O +
the O +
Bacillus O +
subtilis O +
levanase B-Gene +
operon O +
. O +

The O +
LevR B-Gene +
protein O +
is O +
the O +
activator O +
of O +
expression O +
of O +
the O +
levanase B-Gene +
operon O +
of O +
Bacillus O +
subtilis O +
. O +

The O +
promoter O +
of O +
this O +
operon O +
is O +
recognized O +
by O +
RNA B-Gene +
polymerase I-Gene +
containing O +
the O +
sigma B-Gene +
54 I-Gene +
- O +
like O +
factor O +
sigma B-Gene +
L I-Gene +
. O +

One O +
domain O +
of O +
the O +
LevR B-Gene +
protein O +
is O +
homologous O +
to O +
activators O +
of O +
the O +
NtrC B-Gene +
family I-Gene +
, O +
and O +
another O +
resembles O +
antiterminator O +
proteins O +
of O +
the O +
BglG B-Gene +
family I-Gene +
. O +

It O +
has O +
been O +
proposed O +
that O +
the O +
domain O +
which O +
is O +
similar O +
to O +
antiterminators O +
is O +
a O +
target O +
of O +
phosphoenolpyruvate B-Gene +
: I-Gene +
sugar I-Gene +
phosphotransferase I-Gene +
system I-Gene +
( O +
PTS B-Gene +
) O +
- O +
dependent O +
regulation O +
of O +
LevR B-Gene +
activity O +
. O +

We O +
show O +
that O +
the O +
LevR B-Gene +
protein O +
is O +
not O +
only O +
negatively O +
regulated O +
by O +
the O +
fructose B-Gene +
- I-Gene +
specific I-Gene +
enzyme I-Gene +
IIA I-Gene +
/ I-Gene +
B I-Gene +
of O +
the O +
phosphotransferase B-Gene +
system I-Gene +
encoded O +
by O +
the O +
levanase B-Gene +
operon O +
( O +
lev O -
- O -
PTS O +
) O +
but O +
also O +
positively O +
controlled O +
by O +
the O +
histidine B-Gene +
- I-Gene +
containing I-Gene +
phosphocarrier I-Gene +
protein I-Gene +
( O +
HPr B-Gene +
) O +
of O +
the O +
PTS B-Gene +
. O +

This O +
second O +
type O +
of O +
control O +
of O +
LevR B-Gene +
activity O +
depends O +
on O +
phosphoenolpyruvate O +
- O +
dependent O +
phosphorylation O +
of O +
HPr B-Gene +
histidine O +
15 O +
, O +
as O +
demonstrated O +
with O +
point O +
mutations O +
in O +
the O +
ptsH B-Gene +
gene O +
encoding O +
HPr B-Gene +
. O +

In O +
vitro O +
phosphorylation O +
of O +
partially O +
purified O +
LevR B-Gene +
was O +
obtained O +
in O +
the O +
presence O +
of O +
phosphoenolpyruvate O +
, O +
enzyme O +
I O +
, O +
and O +
HPr B-Gene +
. O +

The O +
dependence O +
of O +
truncated O +
LevR B-Gene +
polypeptides O +
on O +
stimulation O +
by O +
HPr B-Gene +
indicated O +
that O +
the O +
domain O +
homologous O +
to O +
antiterminators O +
is O +
the O +
target O +
of O +
HPr B-Gene +
- O +
dependent O +
regulation O +
of O +
LevR B-Gene +
activity O +
. O +

This O +
domain O +
appears O +
to O +
be O +
duplicated O +
in O +
the O +
LevR B-Gene +
protein O +
. O +

The O +
first O +
antiterminator O +
- O +
like O +
domain O +
seems O +
to O +
be O +
the O +
target O +
of O +
enzyme O +
I O +
and O +
HPr B-Gene +
- O +
dependent O +
phosphorylation O +
and O +
the O +
site O +
of O +
LevR B-Gene +
activation O +
, O +
whereas O +
the O +
carboxy O +
- O +
terminal O +
antiterminator O +
- O +
like O +
domain O +
could O +
be O +
the O +
target O +
for O +
negative O +
regulation O +
by O +
the O +
lev O -
- O -
PTS O +
. O +

Complete O +
nucleotide O +
sequence O +
of O +
a O +
skin O +
element O +
excised O +
by O +
DNA O +
rearrangement O +
during O +
sporulation O +
in O +
Bacillus O +
subtilis O +
. O +

As O +
part O +
of O +
the O +
Bacillus O +
subtilis O +
genome O +
sequencing O +
project O +
, O +
we O +
have O +
determined O +
the O +
complete O +
nucleotide O +
sequence O +
of O +
a O +
skin O +
element O +
which O +
is O +
located O +
between O +
spoIVCB B-Gene +
and O +
spoIIIC B-Gene +
. O +

The O +
entire O +
sequence O +
of O +
this O +
element O +
is O +
48 O +
, O +
032 O +
bp O +
in O +
length O +
, O +
and O +
contains O +
57 O +
ORFs O +
with O +
putative O +
ribosome O +
- O +
binding O +
sites O +
. O +

Two O +
of O +
them O +
correspond O +
to O +
previously O +
sequenced O +
and O +
characterized O +
genes O +
, O +
cwIA B-Gene +
and O +
spoIVCA B-Gene +
. O +

Furthermore O +
, O +
seven O +
ORF O +
products O +
identified O +
in O +
this O +
element O +
show O +
interesting O +
similarities O +
with O +
known O +
proteins O +
present O +
in O +
data O +
banks O +
, O +
including O +
the O +
phi O +
105 O +
immunity B-Gene +
repressor I-Gene +
, O +
the O +
phi O +
105 O +
Cro B-Gene +
- O +
like O +
protein O +
and O +
the O +
SPP1 O +
terminase B-Gene +
. O +

These O +
results O +
indicate O +
the O +
possibility O +
that O +
the O +
skin O +
element O +
is O +
a O +
cryptic O +
remnant O +
of O +
an O +
ancestral O +
temperate O +
phage O +
. O +

A O +
gene O +
at O +
333 O +
degrees O +
on O +
the O +
Bacillus O +
subtilis O +
chromosome O +
encodes O +
the O +
newly O +
identified O +
sigma B-Gene +
B I-Gene +
- O +
dependent O +
general B-Gene +
stress I-Gene +
protein I-Gene +
GspA B-Gene +
. O +

In O +
Bacillus O +
subtilis O +
, O +
general B-Gene +
stress I-Gene +
proteins I-Gene +
( O +
Gsps B-Gene +
) O +
are O +
induced O +
in O +
response O +
to O +
different O +
stresses O +
( O +
heat O +
, O +
salt O +
, O +
or O +
ethanol O +
) O +
or O +
after O +
nutrient O +
starvation O +
. O +

The O +
majority O +
of O +
the O +
genes O +
for O +
the O +
Gsps B-Gene +
are O +
organized O +
in O +
a O +
very O +
large O +
stationary O +
- O +
phase O +
or O +
stress O +
regulon O +
which O +
is O +
controlled O +
by O +
alternative O +
sigma B-Gene +
factor I-Gene +
sigma B-Gene +
B I-Gene +
. O +

The O +
most O +
striking O +
spots O +
on O +
Coomassie O +
- O +
stained O +
two O +
- O +
dimensional O +
gels O +
belong O +
to O +
GsiB B-Gene +
and O +
GspA B-Gene +
, O +
which O +
are O +
synthesized O +
at O +
extremely O +
high O +
levels O +
in O +
response O +
to O +
different O +
stresses O +
. O +

Therefore O +
, O +
we O +
determined O +
the O +
N O +
- O +
terminal O +
protein O +
sequence O +
of O +
GspA B-Gene +
, O +
which O +
exhibited O +
total O +
identity O +
to O +
a O +
hypothetical O +
33.5 O +
- O +
kDa O +
protein O +
of O +
B. O +
subtilis O +
encoded O +
by O +
open O +
reading O +
frame O +
2 O +
( O +
ipa-12d O +
) O +
in O +
the O +
sacY B-Gene +
- O +
tyrS1 B-Gene +
intergenic O +
region O +
. O +

The O +
GspA B-Gene +
- O +
encoding O +
gene O +
gspA B-Gene +
and O +
the O +
upstream O +
and O +
downstream O +
regions O +
were O +
cloned O +
with O +
the O +
aid O +
of O +
the O +
PCR O +
technique O +
. O +

By O +
primer O +
extension O +
experiments O +
, O +
one O +
sigma B-Gene +
B I-Gene +
- O +
dependent O +
promoter O +
immediately O +
upstream O +
of O +
the O +
coding O +
region O +
was O +
identified O +
. O +

A O +
putative O +
factor O +
- O +
independent O +
terminator O +
closely O +
followed O +
the O +
coding O +
region O +
. O +

By O +
Northern O +
( O +
RNA O +
) O +
blot O +
analysis O +
, O +
a O +
0.95 O +
- O +
kb O +
transcript O +
was O +
detected O +
which O +
indicates O +
a O +
monocistronic O +
transcriptional O +
unit O +
. O +

The O +
gspA B-Gene +
mRNA O +
was O +
strongly O +
induced O +
by O +
different O +
stimuli O +
like O +
heat O +
or O +
salt O +
stress O +
and O +
starvation O +
for O +
glucose O +
. O +

Analysis O +
of O +
RNA O +
isolated O +
from O +
a O +
sigma B-Gene +
B I-Gene +
deletion O +
mutant O +
revealed O +
that O +
the O +
transcription O +
of O +
gspA B-Gene +
is O +
sigma B-Gene +
B I-Gene +
dependent O +
. O +

Insertional O +
inactivation O +
of O +
the O +
B. O +
subtilis O +
chromosomal O +
gspA B-Gene +
gene O +
confirmed O +
that O +
the O +
gspA B-Gene +
gene O +
is O +
not O +
essential O +
for O +
either O +
vegetative O +
growth O +
or O +
growth O +
under O +
the O +
influence O +
of O +
different O +
stresses O +
. O +

In O +
gspA B-Gene +
mutant O +
cells O +
, O +
the O +
level O +
of O +
flagellin B-Gene +
was O +
increased O +
severalfold O +
over O +
that O +
in O +
wild O +
- O +
type O +
cells O +
. O +

An O +
additional O +
GerE B-Gene +
- O +
controlled O +
gene O +
encoding O +
an O +
abundant O +
spore O +
coat O +
protein O +
from O +
Bacillus O +
subtilis O +
. O +

We O +
describe O +
the O +
identification O +
and O +
characterization O +
of O +
a O +
gene O +
, O +
herein O +
designated O +
cotG B-Gene +
, O +
encoding O +
an O +
abundant O +
coat B-Gene +
protein I-Gene +
from O +
the O +
spores O +
of O +
Bacillus O +
subtilis O +
. O +

The O +
cotG B-Gene +
open O +
reading O +
frame O +
is O +
195 O +
codons O +
in O +
length O +
and O +
is O +
capable O +
of O +
encoding O +
a O +
polypeptide O +
of O +
24 O +
kDa O +
that O +
contains O +
nine O +
tandem O +
copies O +
of O +
the O +
13 O +
- O +
amino O +
- O +
acid O +
long O +
, O +
approximately O +
repeated O +
sequence O +
H O +
/ O +
Y O -
- O -
K O -
- O -
K O -
- O -
S O -
- O -
Y O -
- O -
R O +
/ O +
C O -
- O -
S O +
/ O +
T O -
- O -
H O +
/ O +
Y O -
- O -
K O -
- O -
K O -
- O -
S O -
- O -
R O -
- O -
S O +
. O +

cotG B-Gene +
is O +
located O +
at O +
300 O +
degrees O +
on O +
the O +
genetic O +
map O +
close O +
to O +
another O +
coat B-Gene +
protein I-Gene +
gene O +
, O +
cotB B-Gene +
. O +

The O +
cotG B-Gene +
and O +
cotB B-Gene +
genes O +
are O +
in O +
divergent O +
orientation O +
and O +
are O +
separated O +
by O +
1.3 O +
kb O +
. O +

Like O +
the O +
promoter O +
for O +
cotB B-Gene +
, O +
the O +
cotG B-Gene +
promoter O +
is O +
induced O +
at O +
a O +
late O +
stage O +
of O +
sporulation O +
under O +
the O +
control O +
of O +
the O +
RNA B-Gene +
polymerase I-Gene +
sigma I-Gene +
factor I-Gene +
sigma B-Gene +
K I-Gene +
and O +
the O +
DNA O +
- O +
binding O +
protein O +
GerE B-Gene +
. O +

The O +
- O +
10 O +
and O +
- O +
35 O +
nucleotide O +
sequences O +
of O +
the O +
cotG B-Gene +
promoter O +
resemble O +
those O +
of O +
other O +
promoters O +
recognized O +
by O +
sigma B-Gene +
K I-Gene +
- O +
containing O +
RNA B-Gene +
polymerase I-Gene +
, O +
and O +
centered O +
70 O +
bp O +
upstream O +
of O +
the O +
apparent O +
start O +
site O +
is O +
a O +
sequence O +
that O +
matches O +
the O +
consensus O +
binding O +
site O +
for O +
GerE B-Gene +
. O +

Spore O +
coat B-Gene +
proteins I-Gene +
from O +
a O +
newly O +
constructed O +
cotG B-Gene +
null O +
mutant O +
lack O +
not O +
only O +
CotG B-Gene +
but O +
also O +
CotB B-Gene +
, O +
a O +
finding O +
that O +
suggests O +
that O +
CotG B-Gene +
may O +
be O +
a O +
morphogenetic O +
protein O +
that O +
is O +
required O +
for O +
the O +
incorporation O +
of O +
CotB B-Gene +
into O +
the O +
coat O +
. O +

Effects O +
of O +
Bacillus O +
subtilis O +
sporulation O +
regulatory O +
protein O +
SpoIIID B-Gene +
on O +
transcription O +
by O +
sigma B-Gene +
K I-Gene +
RNA B-Gene +
polymerase I-Gene +
in O +
vivo O +
and O +
in O +
vitro O +
. O +

SpoIIID B-Gene +
is O +
a O +
sequence O +
- O +
specific O +
, O +
DNA O +
- O +
binding O +
protein O +
that O +
activates O +
or O +
represses O +
transcription O +
of O +
different O +
genes O +
by O +
sigma B-Gene +
K I-Gene +
RNA B-Gene +
polymerase I-Gene +
in O +
vitro O +
. O +

A O +
Bacillus O +
subtilis O +
strain O +
engineered O +
to O +
produce O +
both O +
sigma B-Gene +
K I-Gene +
and O +
SpoIIID B-Gene +
during O +
growth O +
showed O +
effects O +
of O +
SpoIIID B-Gene +
on O +
expression O +
of O +
sigma B-Gene +
K I-Gene +
- O +
dependent O +
genes O +
that O +
were O +
consistent O +
with O +
the O +
effects O +
of O +
a O +
small O +
amount O +
of O +
SpoIIID B-Gene +
on O +
transcription O +
of O +
these O +
genes O +
in O +
vitro O +
, O +
indicating O +
that O +
the O +
strain O +
provides O +
a O +
simple O +
, O +
in O +
vivo O +
method O +
to O +
screen O +
for O +
effects O +
of O +
SpoIIID B-Gene +
on O +
transcription O +
of O +
sigma B-Gene +
K I-Gene +
- O +
dependent O +
genes O +
. O +

Four O +
additional O +
genes O +
in O +
the O +
sigB B-Gene +
operon O +
of O +
Bacillus O +
subtilis O +
that O +
control O +
activity O +
of O +
the O +
general O +
stress O +
factor O +
sigma B-Gene +
B I-Gene +
in O +
response O +
to O +
environmental O +
signals O +
. O +

sigma B-Gene +
B I-Gene +
of O +
the O +
gram O +
- O +
positive O +
bacterium O +
Bacillus O +
subtilis O +
is O +
an O +
alternative O +
transcription B-Gene +
factor I-Gene +
activated O +
by O +
a O +
variety O +
of O +
environmental O +
stresses O +
, O +
including O +
the O +
stress O +
imposed O +
upon O +
entry O +
into O +
the O +
stationary O +
growth O +
phase O +
. O +

Previous O +
reports O +
have O +
shown O +
that O +
this O +
stationary O +
- O +
phase O +
activation O +
is O +
enhanced O +
when O +
cells O +
are O +
grown O +
in O +
rich O +
medium O +
containing O +
glucose O +
and O +
glutamine O +
. O +

The O +
sigma B-Gene +
B I-Gene +
structural O +
gene O +
, O +
sigB B-Gene +
, O +
lies O +
in O +
an O +
operon O +
with O +
three O +
other O +
genes O +
whose O +
products O +
have O +
been O +
shown O +
to O +
control O +
sigma B-Gene +
B I-Gene +
activity O +
in O +
response O +
to O +
environmental O +
stress O +
. O +

However O +
, O +
none O +
of O +
these O +
is O +
sufficient O +
to O +
explain O +
the O +
enhanced O +
stationary O +
- O +
phase O +
activation O +
of O +
sigma B-Gene +
B I-Gene +
in O +
response O +
to O +
glucose O +
. O +

We O +
show O +
here O +
that O +
the O +
four O +
genes O +
previously O +
identified O +
in O +
the O +
sigB B-Gene +
operon O +
constitute O +
the O +
downstream O +
half O +
of O +
an O +
eight O +
- O +
gene O +
operon O +
. O +

The O +
complete O +
sigB B-Gene +
operon O +
is O +
preceded O +
by O +
a O +
sigma B-Gene +
A I-Gene +
- O +
like O +
promoter O +
( O +
PA O +
) O +
and O +
has O +
the O +
order O +
PA O -
- O -
orfR O +
- O +
orfS O +
- O +
orfT B-Gene +
- O +
orfU B-Gene +
- O +
PB O +
- O +
rsbV B-Gene +
- O +
rsbW B-Gene +
- O +
sig B-Gene +
B I-Gene +
- O +
rsbX B-Gene +
, O +
where O +
rsb O +
stands O +
for O +
regulator O +
of O +
sigma O -
- O -
B O +
and O +
the O +
previously O +
identified O +
sigma O +
B O +
- O +
dependent O +
promoter O +
( O +
PB O +
) O +
is O +
an O +
internal O +
promoter O +
preceding O +
the O +
downstream O +
four O +
- O +
gene O +
cluster O +
. O +

Although O +
the O +
genes O +
downstream O +
of O +
PB O +
were O +
also O +
transcribed O +
by O +
polymerase O +
activity O +
originating O +
at O +
PA O +
, O +
this O +
transcription O +
into O +
the O +
downstream O +
cluster O +
was O +
not O +
essential O +
for O +
normal O +
induction O +
of O +
a O +
sigma B-Gene +
B I-Gene +
- O +
dependent O +
ctc B-Gene +
- O +
lacZ B-Gene +
fusion O +
. O +

However O +
, O +
deletion O +
of O +
all O +
four O +
upstream O +
open O +
reading O +
frames O +
was O +
found O +
to O +
interfere O +
with O +
induction O +
of O +
the O +
ctc B-Gene +
- O +
lacZ B-Gene +
fusion O +
in O +
response O +
to O +
glucose O +
. O +

Additional O +
deletion O +
analysis O +
and O +
complementation O +
studies O +
showed O +
that O +
orfU B-Gene +
was O +
required O +
for O +
full O +
glucose O +
induction O +
of O +
sigma B-Gene +
B I-Gene +
- O +
dependent O +
genes O +
. O +

orfU B-Gene +
encodes O +
a O +
trans O +
- O +
acting O +
, O +
positive O +
factor O +
with O +
significant O +
sequence O +
identity O +
to O +
the O +
RsbX B-Gene +
negative O +
regulator O +
of O +
sigma B-Gene +
B I-Gene +
. O +

On O +
the O +
basis O +
of O +
these O +
results O +
, O +
we O +
rename O +
orfU B-Gene +
as O +
rsbU B-Gene +
to O +
symbolize O +
the O +
regulatory O +
role O +
of O +
its O +
product O +
. O +

High O +
- O +
level O +
transcription O +
of O +
the O +
major O +
Bacillus O +
subtilis O +
autolysin B-Gene +
operon O +
depends O +
on O +
expression O +
of O +
the O +
sigma B-Gene +
D I-Gene +
gene O +
and O +
is O +
affected O +
by O +
a O +
sin B-Gene +
( O +
flaD B-Gene +
) O +
mutation O +
. O +

Transcription O +
of O +
the O +
major O +
Bacillus O +
subtilis O +
autolysin B-Gene +
gene O +
( O +
cwlB B-Gene +
) O +
was O +
investigated O +
. O +

Deletion O +
of O +
the O +
region O +
upstream O +
of O +
the O +
gene O +
cluster O +
lppX B-Gene +
- O +
cwbA B-Gene +
- O +
cwlB B-Gene +
led O +
to O +
a O +
loss O +
of O +
promoter O +
activity O +
. O +

Primer O +
extension O +
analysis O +
suggested O +
that O +
the O +
cwlB B-Gene +
operon O +
is O +
transcribed O +
by O +
E B-Gene +
sigma I-Gene +
D I-Gene +
and O +
E B-Gene +
sigma I-Gene +
A I-Gene +
, O +
the O +
former O +
transcripts O +
being O +
predominants O +
at O +
the O +
exponential O +
growth O +
phase O +
. O +

Expression O +
of O +
the O +
lppX B-Gene +
- O +
lacZ B-Gene +
fusion O +
gene O +
was O +
reduced O +
by O +
about O +
90 O +
% O +
in O +
a O +
sigD B-Gene +
- O +
null O +
mutant O +
. O +

A O +
sin B-Gene +
( O +
flaD1 B-Gene +
) O +
mutation O +
caused O +
a O +
severe O +
defect O +
in O +
transcription O +
of O +
the O +
lppX B-Gene +
- O +
cwbA B-Gene +
- O +
cwlB B-Gene +
operon O +
. O +

The O +
sin B-Gene +
( O +
flaD1 B-Gene +
) O +
mutation O +
also O +
reduced O +
expression O +
of O +
a O +
sigD B-Gene +
- O +
lacZ B-Gene +
fusion O +
gene O +
constructed O +
in O +
the O +
B. O +
subtilis O +
chromosome O +
. O +

Since O +
the O +
sigD B-Gene +
- O +
null O +
mutant O +
exhibits O +
motility O +
and O +
autolysin B-Gene +
deficiencies O +
and O +
filamentation O +
, O +
similar O +
phenotypes O +
in O +
the O +
sin B-Gene +
( O +
flaD1 B-Gene +
) O +
mutant O +
may O +
be O +
caused O +
by O +
reduction O +
in O +
expression O +
of O +
the O +
sigma B-Gene +
D I-Gene +
protein O +
. O +

In O +
vitro O +
and O +
in O +
vivo O +
acceleration O +
of O +
the O +
neoplastic O +
phenotype O +
of O +
a O +
low O +
- O +
tumorigenicity O +
rat O +
bladder O +
carcinoma O +
cell O +
line O +
by O +
transfected O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
. O +

We O +
conducted O +
an O +
experiment O +
to O +
determine O +
whether O +
expression O +
of O +
transforming B-Gene +
growth I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
( O +
TGF B-Gene -
- I-Gene -
alpha I-Gene +
) O +
enhances O +
tumorigenicity O +
in O +
a O +
low O +
- O +
tumorigenicity O +
rat O +
bladder O +
carcinoma O +
cell O +
line O +
and O +
whether O +
it O +
is O +
sufficient O +
to O +
induce O +
a O +
tumorigenic O +
phenotype O +
in O +
a O +
nontumorigenic O +
rat O +
bladder O +
cell O +
line O +
. O +

D44c O +
cells O +
( O +
which O +
are O +
nontumorigenic O +
) O +
were O +
derived O +
from O +
a O +
minute O +
nodule O +
from O +
a O +
bladder O +
treated O +
with O +
N O -
- O -
methyl O -
- O -
N O -
- O -
nitrosourea O +
( O +
MNU O +
) O +
; O +
G1 O -
- O -
200 O +
cl-17 O +
cells O +
( O +
which O +
have O +
low O +
tumorigenicity O +
) O +
were O +
isolated O +
from O +
D44c O +
cells O +
exposed O +
to O +
MNU O +
in O +
vitro O +
. O +

Neither O +
cell O +
line O +
expressed O +
TGF B-Gene -
- I-Gene -
alpha I-Gene +
mRNA O +
. O +

The O +
cells O +
were O +
cotransfected O +
with O +
pSV2neo O +
and O +
pSR O +
alpha O +
- O +
rTGF B-Gene -
- I-Gene -
alpha I-Gene +
. O +

The O +
latter O +
plasmid O +
contains O +
the O +
rat O +
TGF B-Gene -
- I-Gene -
alpha I-Gene +
cDNA O +
under O +
the O +
transcriptional O +
control O +
of O +
the O +
SR O +
alpha O +
promoter O +
. O +

In O +
the O +
low O +
- O +
tumorigenicity O +
G1 O -
- O -
200 O +
cl-17 O +
cells O +
, O +
the O +
expression O +
of O +
TGF B-Gene -
- I-Gene -
alpha I-Gene +
mRNA O +
and O +
the O +
subsequent O +
synthesis O +
of O +
TGF B-Gene -
- I-Gene -
alpha I-Gene +
protein O +
activated O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
receptors I-Gene +
( O +
EGFRs B-Gene +
) O +
and O +
markedly O +
enhanced O +
tumorigenicity O +
in O +
nude O +
mice O +
( O +
i.e. O +
, O +
shortened O +
the O +
latency O +
period O +
before O +
tumor O +
appearance O +
, O +
accelerated O +
the O +
rate O +
of O +
growth O +
, O +
and O +
increased O +
the O +
size O +
of O +
the O +
tumors O +
) O +
as O +
well O +
as O +
anchorage O +
- O +
independent O +
growth O +
in O +
vitro O +
. O +

In O +
nontumorigenic O +
D44c O +
cells O +
, O +
however O +
, O +
transfected O +
TGF B-Gene -
- I-Gene -
alpha I-Gene +
did O +
not O +
induce O +
either O +
anchorage O +
- O +
independent O +
growth O +
or O +
tumorigenicity O +
in O +
nude O +
mice O +
, O +
in O +
spite O +
of O +
overexpression O +
of O +
EGFR B-Gene +
mRNA O +
and O +
the O +
constitutive O +
expression O +
of O +
c B-Gene -
- I-Gene -
jun I-Gene +
and O +
junB B-Gene +
mRNA O +
. O +

These O +
results O +
suggest O +
that O +
the O +
increased O +
signal O +
transduction O +
mediated O +
by O +
TGF B-Gene -
- I-Gene -
alpha I-Gene +
enhanced O +
tumorigenicity O +
in O +
a O +
cell O +
that O +
was O +
already O +
tumorigenic O +
but O +
was O +
not O +
sufficient O +
to O +
induce O +
tumorigenicity O +
in O +
a O +
nontumorigenic O +
cell O +
. O +

Phosphorylation O +
of O +
Spo0A B-Gene +
activates O +
its O +
stimulation O +
of O +
in O +
vitro O +
transcription O +
from O +
the O +
Bacillus O +
subtilis O +
spoIIG B-Gene +
operon I-Gene +
. O +

The O +
spoIIG B-Gene +
operon I-Gene +
of O +
Bacillus O +
subtilis O +
codes O +
for O +
a O +
sporulation O +
- O +
specific O +
sigma B-Gene +
factor I-Gene +
, O +
sigma B-Gene +
E I-Gene +
. O +

In O +
vivo O +
expression O +
of O +
the O +
spoIIG B-Gene +
promoter O +
is O +
activated O +
shortly O +
after O +
the O +
onset O +
of O +
sporulation O +
and O +
is O +
dependent O +
on O +
kinA B-Gene +
, O +
spo0F B-Gene +
, O +
spo0B B-Gene +
and O +
spo0A B-Gene +
genes O +
. O +

The O +
products O +
of O +
these O +
genes O +
have O +
been O +
shown O +
to O +
participate O +
in O +
a O +
phosphorelay O +
reaction O +
in O +
vitro O +
, O +
culminating O +
in O +
phosphorylation O +
of O +
the O +
transcription O +
factor O +
, O +
Spo0A B-Gene +
. O +

The O +
effect O +
of O +
Spo0A B-Gene +
phosphorylation O +
on O +
in O +
vitro O +
transcription O +
from O +
the O +
spoIIG B-Gene +
promoter O +
was O +
determined O +
. O +

Aliquots O +
from O +
phosphorelay O +
reactions O +
enhanced O +
spoIIG B-Gene +
promoter O +
activity O +
10 O +
- O +
fold O +
in O +
transcription O +
assays O +
and O +
stimulation O +
of O +
transcription O +
was O +
dependent O +
on O +
Spo0A B-Gene +
phosphorylation O +
. O +

Our O +
results O +
provide O +
biochemical O +
evidence O +
that O +
Spo0A B-Gene +
and O +
the O +
phosphorelay O +
form O +
a O +
signal O +
transduction O +
pathway O +
which O +
activates O +
spoII O +
gene O +
expression O +
in O +
development O +
. O +

The O +
Bacillus O +
subtilis O +
spoVD B-Gene +
gene O +
encodes O +
a O +
mother O +
- O +
cell O +
- O +
specific O +
penicillin O +
- O +
binding O +
protein O +
required O +
for O +
spore O +
morphogenesis O +
. O +

The O +
Bacillus O +
subtilis O +
spoVD B-Gene +
gene O +
has O +
been O +
cloned O +
and O +
sequenced O +
. O +

It O +
encodes O +
a O +
71 O +
, O +
262 O +
Da O +
protein O +
with O +
extensive O +
sequence O +
similarity O +
to O +
penicillin O +
- O +
binding O +
proteins O +
from O +
various O +
organisms O +
. O +

The O +
context O +
of O +
this O +
gene O +
in O +
the O +
B. O +
subtilis O +
chromosome O +
, O +
immediately O +
upstream O +
of O +
the O +
mur B-Gene +
operon I-Gene +
, O +
suggests O +
that O +
it O +
is O +
related O +
to O +
the O +
pbpB B-Gene +
gene O +
of O +
Escherichia O +
coli O +
, O +
which O +
is O +
involved O +
in O +
the O +
synthesis O +
of O +
septal O +
peptidoglycan O +
during O +
cell O +
division O +
. O +

Expression O +
of O +
spoVD B-Gene +
in O +
E. O +
coli O +
leads O +
to O +
the O +
synthesis O +
of O +
a O +
membrane O +
- O +
associated O +
protein O +
of O +
the O +
size O +
expected O +
for O +
SpoVD B-Gene +
, O +
which O +
can O +
bind O +
labelled O +
penicillin O +
. O +

However O +
, O +
insertional O +
disruption O +
of O +
the O +
spoVD B-Gene +
gene O +
has O +
no O +
effect O +
on O +
vegetative O +
growth O +
or O +
division O +
: O +
a O +
second O +
pbp B-Gene +
- O +
like O +
gene O +
immediately O +
upstream O +
of O +
spoVD B-Gene +
is O +
probably O +
the O +
functional O +
homologue O +
of O +
E. O +
coli O +
pbpB B-Gene +
. O +

spoVD B-Gene +
seems O +
instead O +
to O +
have O +
a O +
specialized O +
role O +
in O +
the O +
morphogenesis O +
of O +
the O +
spore O +
cortex O +
, O +
which O +
is O +
a O +
modified O +
form O +
of O +
peptidoglycan O +
. O +

spoVD B-Gene +
transcription O +
appears O +
to O +
occur O +
from O +
a O +
promoter O +
recognized O +
by O +
the O +
sigma B-Gene +
E I-Gene +
form O +
of O +
RNA B-Gene +
polymerase I-Gene +
. O +

Analysis O +
of O +
the O +
expression O +
of O +
a O +
spoVD B-Gene +
' O +
- O +
lacZ B-Gene +
reporter O +
gene O +
supports O +
this O +
notion O +
and O +
indicates O +
that O +
a O +
second O +
level O +
of O +
negative O +
regulation O +
is O +
dependent O +
on O +
the O +
SpoIIID B-Gene +
protein O +
. O +

SpoVD B-Gene +
synthesis O +
probably O +
occurs O +
only O +
in O +
the O +
mother O +
cell O +
since O +
both O +
sigma B-Gene +
E I-Gene +
and O +
SpoIIID B-Gene +
are O +
thought O +
to O +
be O +
specific O +
to O +
this O +
cell O +
type O +
. O +

Such O +
localization O +
of O +
SpoVD B-Gene +
synthesis O +
was O +
supported O +
by O +
the O +
results O +
of O +
a O +
genetic O +
test O +
showing O +
that O +
expression O +
of O +
spoVD B-Gene +
only O +
in O +
the O +
mother O +
cell O +
is O +
sufficient O +
for O +
spore O +
formation O +
. O +

The O +
results O +
support O +
the O +
proposition O +
that O +
spore O +
cortex O +
formation O +
is O +
determined O +
primarily O +
by O +
the O +
mother O +
cell O +
. O +

Bacillus O +
subtilis O +
sigma B-Gene +
B I-Gene +
is O +
regulated O +
by O +
a O +
binding O +
protein O +
( O +
RsbW B-Gene +
) O +
that O +
blocks O +
its O +
association O +
with O +
core O +
RNA B-Gene +
polymerase I-Gene +
. O +

sigma B-Gene +
B I-Gene +
is O +
a O +
secondary O +
sigma B-Gene +
factor I-Gene +
of O +
Bacillus O +
subtilis O +
. O +

RNA B-Gene +
polymerase I-Gene +
containing O +
sigma B-Gene +
B I-Gene +
transcribes O +
a O +
subset O +
of O +
genes O +
that O +
are O +
expressed O +
after O +
heat O +
shock O +
or O +
the O +
onset O +
of O +
the O +
stationary O +
phase O +
of O +
growth O +
. O +

Three O +
genes O +
( O +
rsbV B-Gene +
, O +
rsbW B-Gene +
, O +
and O +
rsbX B-Gene +
) O +
, O +
cotranscribed O +
with O +
the O +
sigma B-Gene +
B I-Gene +
structural O +
gene O +
( O +
sigB B-Gene +
) O +
, O +
regulate O +
sigma B-Gene +
B I-Gene +
- O +
dependent O +
gene O +
expression O +
. O +

RsbW B-Gene +
is O +
the O +
primary O +
inhibitor O +
of O +
this O +
system O +
with O +
the O +
other O +
gene O +
products O +
acting O +
upstream O +
of O +
RsbW B-Gene +
in O +
the O +
sigma B-Gene +
B I-Gene +
regulatory O +
pathway O +
. O +

Evidence O +
is O +
now O +
presented O +
that O +
RsbW B-Gene +
inhibits O +
sigma B-Gene +
B I-Gene +
- O +
dependent O +
transcription O +
by O +
binding O +
to O +
sigma B-Gene +
B I-Gene +
and O +
blocking O +
the O +
formation O +
of O +
a O +
sigma B-Gene +
B I-Gene +
- O +
containing O +
RNA B-Gene +
polymerase I-Gene +
holoenzyme O +
. O +

Antibodies O +
specific O +
for O +
either O +
RsbW B-Gene +
or O +
sigma B-Gene +
B I-Gene +
will O +
coprecipitate O +
both O +
proteins O +
from O +
crude O +
cell O +
extracts O +
. O +

This O +
is O +
not O +
due O +
to O +
the O +
presence O +
of O +
both O +
proteins O +
on O +
RNA B-Gene +
polymerase I-Gene +
. O +

Western O +
blot O +
analysis O +
of O +
B. O +
subtilis O +
extracts O +
that O +
had O +
been O +
fractionated O +
by O +
gel O +
- O +
filtration O +
chromatography O +
revealed O +
a O +
single O +
peak O +
of O +
RsbW B-Gene +
that O +
did O +
not O +
coelute O +
with O +
RNA B-Gene +
polymerase I-Gene +
and O +
two O +
peaks O +
of O +
sigma B-Gene +
B I-Gene +
protein O +
: O +
one O +
that O +
eluted O +
with O +
RNA B-Gene +
polymerase I-Gene +
and O +
a O +
second O +
that O +
overlapped O +
the O +
fractions O +
that O +
contained O +
RsbW B-Gene +
. O +

Reconstitution O +
experiments O +
were O +
performed O +
in O +
which O +
partially O +
purified O +
sigma B-Gene +
B I-Gene +
and O +
RsbW B-Gene +
were O +
added O +
to O +
core O +
RNA B-Gene +
polymerase I-Gene +
and O +
tested O +
for O +
their O +
ability O +
to O +
influence O +
the O +
transcription O +
of O +
a O +
sigma B-Gene +
B I-Gene +
- O +
dependent O +
promoter O +
( O +
ctc B-Gene +
) O +
in O +
vitro O +
. O +

RsbW B-Gene +
efficiently O +
blocked O +
sigma B-Gene +
B I-Gene +
- O +
dependent O +
transcription O +
but O +
only O +
if O +
it O +
was O +
incubated O +
with O +
sigma B-Gene +
B I-Gene +
prior O +
to O +
the O +
addition O +
of O +
the O +
core O +
enzyme O +
. O +

Negative O +
signalling O +
via O +
the O +
P58 B-Gene +
/ O +
NKR O +
for O +
HLA.C B-Gene +
alleles O +
. O +

Recent O +
studies O +
have O +
demonstrated O +
that O +
the O +
interaction O +
between O +
HLA B-Gene +
class I-Gene +
I I-Gene +
alleles O +
and O +
specific O +
NK O +
receptors O +
results O +
in O +
negative O +
signals O +
which O +
inhibit O +
NK O +
- O +
mediated O +
cytotoxicity O +
. O +

Such O +
NK O +
receptors O +
have O +
been O +
identified O +
by O +
GL183 B-Gene +
and O +
EB6 B-Gene +
mAbs O +
which O +
recognize O +
distinct O +
members O +
of O +
a O +
molecular O +
family O +
involved O +
in O +
the O +
recognition O +
of O +
two O +
groups O +
of O +
HLA.C B-Gene +
alleles O +
. O +

Now O +
we O +
describe O +
a O +
new O +
allospecific O +
NK O +
group O +
( O +
group O +
0 O +
) O +
which O +
recognize O +
all O +
HLA.C B-Gene +
alleles O +
and O +
we O +
demonstrate O +
that O +
, O +
on O +
these O +
clones O +
, O +
the O +
p58 B-Gene +
molecules O +
EB6 B-Gene +
and O +
GL183 B-Gene +
act O +
independently O +
to O +
recognize O +
Cw4 B-Gene +
( O +
and O +
related O +
alleles O +
) O +
and O +
Cw3 B-Gene +
( O +
and O +
related O +
alleles O +
) O +
respectively O +
. O +

Finally O +
we O +
investigate O +
whether O +
the O +
inhibitory O +
signal O +
mediated O +
by O +
the O +
NK O +
- O +
receptor O +
for O +
HLA.C B-Gene +
induce O +
a O +
temporary O +
turn O +
off O +
on O +
the O +
cytolytic O +
activity O +
. O +

Synthesis O +
of O +
the O +
osmoprotectant O +
glycine O +
betaine O +
in O +
Bacillus O +
subtilis O +
: O +
characterization O +
of O +
the O +
gbsAB B-Gene +
genes O +
. O +

Synthesis O +
of O +
the O +
osmoprotectant O +
glycine O +
betaine O +
from O +
the O +
exogenously O +
provided O +
precursor O +
choline O +
or O +
glycine O +
betaine O +
aldehyde O +
confers O +
considerable O +
osmotic O +
stress O +
tolerance O +
to O +
Bacillus O +
subtilis O +
in O +
high O +
- O +
osmolarity O +
media O +
. O +

Using O +
an O +
Escherichia O +
coli O +
mutant O +
( O +
betBA B-Gene +
) O +
defective O +
in O +
the O +
glycine O +
betaine O +
synthesis O +
enzymes O +
, O +
we O +
cloned O +
by O +
functional O +
complementation O +
the O +
genes O +
that O +
are O +
required O +
for O +
the O +
synthesis O +
of O +
the O +
osmoprotectant O +
glycine O +
betaine O +
in O +
B. O +
subtilis O +
. O +

The O +
DNA O +
sequence O +
of O +
a O +
4.1 O +
- O +
kb O +
segment O +
from O +
the O +
cloned O +
chromosomal O +
B. O +
subtilis O +
DNA O +
was O +
established O +
, O +
and O +
two O +
genes O +
( O +
gbsA B-Gene +
and O +
gbsB B-Gene +
) O +
whose O +
products O +
were O +
essential O +
for O +
glycine O +
betaine O +
biosynthesis O +
and O +
osmoprotection O +
were O +
identified O +
. O +

The O +
gbsA B-Gene +
and O +
gbsB B-Gene +
genes O +
are O +
transcribed O +
in O +
the O +
same O +
direction O +
, O +
are O +
separated O +
by O +
a O +
short O +
intergenic O +
region O +
, O +
and O +
are O +
likely O +
to O +
form O +
an O +
operon O +
. O +

The O +
deduced O +
gbsA B-Gene +
gene O +
product O +
exhibits O +
strong O +
sequence O +
identity O +
with O +
members O +
of O +
a O +
superfamily O +
of O +
specialized O +
and O +
nonspecialized O +
aldehyde B-Gene +
dehydrogenases I-Gene +
. O +

This O +
superfamily O +
comprises O +
glycine B-Gene +
betaine I-Gene +
aldehyde I-Gene +
dehydrogenases I-Gene +
from O +
bacteria O +
and O +
plants O +
with O +
known O +
involvement O +
in O +
the O +
cellular O +
adaptation O +
to O +
high O +
- O +
osmolarity O +
stress O +
and O +
drought O +
. O +

The O +
deduced O +
gbsB B-Gene +
gene O +
product O +
shows O +
significant O +
similarity O +
to O +
the O +
family O +
of O +
type O +
III O +
alcohol B-Gene +
dehydrogenases I-Gene +
. O +

B. O +
subtilis O +
mutants O +
with O +
defects O +
in O +
the O +
chromosomal O +
gbsAB B-Gene +
genes O +
were O +
constructed O +
by O +
marker O +
replacement O +
, O +
and O +
the O +
growth O +
properties O +
of O +
these O +
mutant O +
strains O +
in O +
high O +
- O +
osmolarity O +
medium O +
were O +
analyzed O +
. O +

Deletion O +
of O +
the O +
gbsAB B-Gene +
genes O +
destroyed O +
the O +
choline O +
- O +
glycine O +
betaine O +
synthesis O +
pathway O +
and O +
abolished O +
the O +
ability O +
of O +
B. O +
subtilis O +
to O +
deal O +
effectively O +
with O +
high O +
- O +
osmolarity O +
stress O +
in O +
choline O +
- O +
or O +
glycine O +
betaine O +
aldehyde O +
- O +
containing O +
medium O +
. O +

Uptake O +
of O +
radiolabelled O +
choline O +
was O +
unaltered O +
in O +
the O +
gbsAB B-Gene +
mutant O +
strain O +
. O +

The O +
continued O +
intracellular O +
accumulation O +
of O +
choline O +
or O +
glycine O +
betaine O +
aldehyde O +
in O +
a O +
strain O +
lacking O +
the O +
glycine O +
betaine O +
- O +
biosynthetic O +
enzymes O +
strongly O +
interfered O +
with O +
the O +
growth O +
of O +
B. O +
subtilis O +
, O +
even O +
in O +
medium O +
of O +
moderate O +
osmolarity O +
. O +

A O +
single O +
transcription O +
initiation O +
site O +
for O +
gbsAB B-Gene +
was O +
detected O +
by O +
high O +
- O +
resolution O +
primer O +
extension O +
analysis O +
. O +

gbsAB B-Gene +
transcription O +
was O +
initiated O +
from O +
a O +
promoter O +
with O +
close O +
homology O +
to O +
sigma B-Gene +
A I-Gene +
- O +
dependent O +
promoters O +
and O +
was O +
stimulated O +
by O +
the O +
presence O +
of O +
choline O +
in O +
the O +
growth O +
medium O +
. O +

Human B-Gene +
histocompatibility I-Gene +
leukocyte I-Gene +
antigen I-Gene +
( I-Gene +
HLA I-Gene +
) I-Gene +
- I-Gene +
G I-Gene +
molecules O +
inhibit O +
NKAT3 B-Gene +
expressing O +
natural O +
killer O +
cells O +
. O +

The O +
crucial O +
immunological O +
function O +
of O +
the O +
classical B-Gene +
human I-Gene +
major I-Gene +
histocompatibility I-Gene +
complex I-Gene +
( I-Gene +
MHC I-Gene +
) I-Gene +
class I-Gene +
I I-Gene +
molecules O +
, O +
human O +
histocompatibility B-Gene +
leukocyte I-Gene +
antigen I-Gene +
( I-Gene +
HLA I-Gene +
) I-Gene +
- I-Gene +
A I-Gene +
, I-Gene +
- I-Gene +
B I-Gene +
, I-Gene +
and I-Gene +
- I-Gene +
C I-Gene +
, O +
is O +
the O +
presentation O +
of O +
peptides O +
to O +
T O +
cells O +
. O +

A O +
secondary O +
function O +
is O +
the O +
inhibition O +
of O +
natural O +
killer O +
( O +
NK O +
) O +
cells O +
, O +
mediated O +
by O +
binding O +
of O +
class O +
I O +
molecules O +
to O +
NK O +
receptors O +
. O +

In O +
contrast O +
, O +
the O +
function O +
of O +
the O +
nonclassical B-Gene +
human I-Gene +
MHC I-Gene +
class I-Gene +
I I-Gene +
molecules O +
, O +
HLA B-Gene -
- I-Gene -
E I-Gene +
, I-Gene +
- I-Gene +
F I-Gene +
, I-Gene +
and I-Gene +
- I-Gene +
G I-Gene +
, O +
is O +
still O +
a O +
mystery O +
. O +

The O +
specific O +
expression O +
of O +
HLA B-Gene -
- I-Gene -
G I-Gene +
in O +
placental O +
trophoblast O +
suggests O +
an O +
important O +
role O +
for O +
this O +
molecule O +
in O +
the O +
immunological O +
interaction O +
between O +
mother O +
and O +
child O +
. O +

The O +
fetus O +
, O +
semiallograft O +
by O +
its O +
genotype O +
, O +
escapes O +
maternal O +
allorecognition O +
by O +
downregulation O +
of O +
HLA B-Gene -
- I-Gene -
A I-Gene +
and O +
HLA B-Gene -
- I-Gene -
B I-Gene +
molecules O +
at O +
this O +
interface O +
. O +

It O +
has O +
been O +
suggested O +
that O +
the O +
maternal O +
NK O +
recognition O +
of O +
this O +
downregulation O +
is O +
balanced O +
by O +
the O +
expression O +
of O +
HLA B-Gene -
- I-Gene -
G I-Gene +
, O +
thus O +
preventing O +
damage O +
to O +
the O +
placenta O +
. O +

Here O +
, O +
we O +
describe O +
the O +
partial O +
inhibition O +
of O +
NK O +
lysis O +
of O +
the O +
MHC B-Gene +
class I-Gene +
I I-Gene +
negative O +
cell O +
line O +
LCL721.221 O +
upon O +
HLA B-Gene -
- I-Gene -
G I-Gene +
transfection O +
. O +

We O +
present O +
three O +
NK O +
lines O +
that O +
are O +
inhibited O +
via O +
the O +
interaction O +
of O +
their O +
NKAT3 B-Gene +
receptor O +
with O +
HLA B-Gene -
- I-Gene -
G I-Gene +
and O +
with O +
HLA B-Gene -
- I-Gene -
Bw4 I-Gene +
molecules O +
. O +

Inhibition O +
can O +
be O +
blocked O +
by O +
the O +
anti O +
- O +
NKAT3 B-Gene +
antibody O +
5.133 O +
. O +

In O +
conclusion O +
, O +
NK O +
inhibition O +
by O +
HLA B-Gene -
- I-Gene -
G I-Gene +
via O +
NKAT3 B-Gene +
may O +
contribute O +
to O +
the O +
survival O +
of O +
the O +
fetal O +
semiallograft O +
in O +
the O +
mother O +
during O +
pregnancy O +
. O +

Bacillus O +
subtilis O +
ComK B-Gene +
negatively O +
regulates O +
degR B-Gene +
gene O +
expression O +
. O +

Exoprotease B-Gene +
production O +
in O +
Bacillus O +
subtilis O +
is O +
positively O +
regulated O +
by O +
a O +
two O +
- O +
component O +
regulatory O +
system O +
, O +
DegS B-Gene +
- O +
DegU B-Gene +
, O +
and O +
, O +
in O +
addition O +
, O +
by O +
several O +
minor O +
factors O +
. O +

The O +
product O +
of O +
the O +
degR B-Gene +
gene O +
belongs O +
to O +
the O +
latter O +
group O +
and O +
exerts O +
a O +
positive O +
effect O +
in O +
a O +
DegS B-Gene +
- O +
DegU B-Gene +
dependent O +
manner O +
. O +

We O +
found O +
that O +
transcription O +
of O +
degR B-Gene +
was O +
prevented O +
by O +
disruption O +
of O +
either O +
mecA B-Gene +
or O +
mecB B-Gene +
but O +
was O +
relieved O +
by O +
further O +
disruption O +
of O +
comK B-Gene +
. O +

Disruption O +
of O +
comK B-Gene +
alone O +
, O +
however O +
, O +
did O +
not O +
alter O +
degR B-Gene +
transcription O +
. O +

We O +
also O +
found O +
that O +
the O +
mecA B-Gene +
mutation O +
requires O +
a O +
region O +
around O +
position O +
- O +
52 O +
relative O +
to O +
the O +
transcription O +
start O +
point O +
of O +
degR B-Gene +
to O +
exert O +
its O +
effect O +
. O +

We O +
have O +
shown O +
previously O +
that O +
the O +
transcription O +
of O +
degR B-Gene +
is O +
driven O +
by O +
an O +
alternative O +
sigma B-Gene +
factor I-Gene +
, O +
sigmaD B-Gene +
. O +

When O +
degR B-Gene +
expression O +
was O +
directed O +
by O +
an O +
artificially O +
constructed O +
sigmaA B-Gene +
- O +
type O +
promoter O +
, O +
disruption O +
of O +
mecA B-Gene +
/ I-Gene +
B I-Gene +
did O +
not O +
result O +
in O +
any O +
significant O +
decrease O +
in O +
degR B-Gene +
expression O +
, O +
indicating O +
that O +
the O +
negative O +
effect O +
of O +
the O +
mec O +
mutations O +
acts O +
through O +
sigmaD B-Gene +
- O +
driven O +
transcription O +
. O +

It O +
has O +
been O +
demonstrated O +
that O +
MecA B-Gene +
and O +
MecB B-Gene +
negatively O +
regulate O +
ComK B-Gene +
, O +
and O +
mecA B-Gene +
/ I-Gene +
B I-Gene +
null O +
mutations O +
cause O +
enhanced O +
expression O +
of O +
comK B-Gene +
. O +

From O +
these O +
results O +
we O +
conclude O +
that O +
ComK B-Gene +
negatively O +
regulates O +
degR B-Gene +
expression O +
by O +
preventing O +
sigmaD B-Gene +
- O +
driven O +
transcription O +
of O +
degR B-Gene +
, O +
possibly O +
through O +
interaction O +
with O +
the O +
control O +
region O +
. O +

The O +
Bacillus O +
subtilis O +
sigma B-Gene -
( I-Gene -
X I-Gene -
) I-Gene +
protein O +
is O +
an O +
extracytoplasmic B-Gene +
function I-Gene +
sigma I-Gene +
factor I-Gene +
contributing O +
to O +
survival O +
at O +
high O +
temperature O +
. O +

The O +
sigX B-Gene +
gene O +
, O +
identified O +
as O +
part O +
of O +
the O +
international O +
effort O +
to O +
sequence O +
the O +
Bacillus O +
subtilis O +
genome O +
, O +
has O +
been O +
proposed O +
to O +
encode O +
an O +
alternative O +
sigma B-Gene +
factor I-Gene +
of I-Gene +
the I-Gene +
extracytoplasmic I-Gene +
function I-Gene +
( I-Gene +
ECF I-Gene +
) I-Gene +
subfamily I-Gene +
. O +

The O +
sigX B-Gene +
gene O +
is O +
cotranscribed O +
with O +
a O +
downstream O +
gene O +
, O +
ypuN B-Gene +
, O +
during O +
logarithmic O +
and O +
early O +
stationary O +
phases O +
of O +
growth O +
. O +

We O +
now O +
report O +
that O +
strains O +
lacking O +
sigma B-Gene -
( I-Gene -
X I-Gene -
) I-Gene +
are O +
impaired O +
in O +
the O +
ability O +
to O +
survive O +
at O +
high O +
temperature O +
whereas O +
a O +
ypuN B-Gene +
mutant O +
has O +
increased O +
thermotolerance O +
. O +

We O +
overproduced O +
and O +
purified O +
sigma B-Gene +
( I-Gene +
X I-Gene +
) I-Gene +
from O +
Escherichia O +
coli O +
and O +
demonstrate O +
that O +
in O +
vitro O +
, O +
both O +
sigma B-Gene -
( I-Gene -
A I-Gene -
) I-Gene +
and O +
sigma B-Gene +
( I-Gene +
X I-Gene +
) I-Gene +
holoenzymes O +
recognize O +
promoter O +
elements O +
within O +
the O +
sigX B-Gene +
- O +
ypuN B-Gene +
control O +
region O +
. O +

However O +
, O +
they O +
have O +
distinct O +
salt O +
optima O +
such O +
that O +
sigma B-Gene +
( I-Gene +
A I-Gene +
) I-Gene +
- O +
dependent O +
transcription O +
predominates O +
at O +
low O +
salt O +
while O +
sigma B-Gene -
( I-Gene -
X I-Gene -
) I-Gene +
- O +
dependent O +
transcription O +
predominates O +
at O +
high O +
salt O +
. O +

A O +
54 O +
- O +
bp O +
region O +
upstream O +
of O +
sigX B-Gene +
suffices O +
as O +
a O +
sigma B-Gene -
( I-Gene -
X I-Gene -
) I-Gene +
- O +
dependent O +
promoter O +
in O +
vivo O +
, O +
demonstrating O +
that O +
sigX B-Gene +
is O +
at O +
least O +
partially O +
under O +
positive O +
autoregulatory O +
control O +
. O +

Mutation O +
of O +
ypuN B-Gene +
increases O +
expression O +
from O +
the O +
sigma B-Gene -
( I-Gene -
X I-Gene -
) I-Gene +
- O +
dependent O +
promoter O +
in O +
vivo O +
, O +
suggesting O +
that O +
ypuN B-Gene +
may O +
encode O +
a O +
negative O +
regulator O +
of O +
sigma B-Gene -
( I-Gene -
X I-Gene -
) I-Gene +
activity O +
. O +

Genomic O +
organization O +
of O +
a O +
human O +
killer O +
cell O +
inhibitory O +
receptor O +
gene O +
. O +

We O +
have O +
cloned O +
a O +
region O +
of O +
human O +
chromosome O +
19q13.4 O +
which O +
contains O +
multiple O +
killer O +
cell O +
inhibitory O +
receptor O +
( O +
KIR B-Gene +
) O +
loci O +
. O +

By O +
random O +
and O +
directed O +
sequence O +
analysis O +
of O +
these O +
KIR B-Gene +
- O +
specific O +
clones O +
, O +
we O +
deduced O +
the O +
genomic O +
structure O +
of O +
KIR B-Gene +
genes O +
. O +

A O +
locus O +
encoding O +
a O +
member O +
of O +
the O +
NKAT-2 B-Gene +
family I-Gene +
of O +
KIRs B-Gene +
is O +
presented O +
here O +
. O +

The O +
structure O +
of O +
the O +
gene O +
is O +
reminiscent O +
of O +
loci O +
of O +
the O +
Fc B-Gene +
receptor I-Gene +
gene I-Gene +
family I-Gene +
, O +
and O +
the O +
two O +
sets O +
of O +
genes O +
may O +
derive O +
from O +
a O +
common O +
ancestor O +
. O +

The O +
KIR B-Gene +
gene O +
contains O +
potentially O +
nine O +
exons O +
. O +

The O +
first O +
two O +
exons O +
encode O +
the O +
leader O +
sequence O +
, O +
as O +
in O +
Fc B-Gene +
receptor I-Gene +
genes O +
. O +

The O +
third O +
exon O +
encodes O +
an O +
untranslated O +
pseudo O +
exon O +
specifying O +
an O +
immunoglobulin B-Gene +
domain O +
with O +
an O +
in O +
- O +
frame O +
stop O +
codon O +
. O +

Expressed O +
cDNAs O +
do O +
not O +
contain O +
this O +
exon O +
. O +

This O +
finding O +
is O +
consistent O +
with O +
the O +
hypothesis O +
that O +
certain O +
KIR B-Gene +
genes O +
may O +
have O +
been O +
derived O +
from O +
the O +
duplication O +
of O +
a O +
primordial O +
three O +
immunoglobulin B-Gene +
domain O +
structure O +
with O +
subsequent O +
skipping O +
of O +
one O +
exon O +
to O +
derive O +
genes O +
with O +
two O +
expressed O +
immunoglobulin B-Gene +
domains O +
. O +

Variation O +
in O +
numbers O +
of O +
immunoglobulin B-Gene +
domains O +
in O +
different O +
KIR B-Gene +
genes O +
is O +
facilitated O +
by O +
conservation O +
of O +
splicing O +
frame O +
in O +
respect O +
to O +
the O +
codon O +
triplet O +
for O +
each O +
immunoglobulin B-Gene +
domain O +
. O +

The O +
NAD B-Gene +
synthetase I-Gene +
NadE B-Gene +
( O +
OutB B-Gene +
) O +
of O +
Bacillus O +
subtilis O +
is O +
a O +
sigma B-Gene +
B I-Gene +
- O +
dependent O +
general O +
stress O +
protein O +
. O +

The O +
identification O +
of O +
sigma B-Gene +
B I-Gene +
- O +
dependent O +
general O +
stress O +
proteins O +
is O +
a O +
useful O +
strategy O +
to O +
understand O +
the O +
physiological O +
role O +
of O +
the O +
unspecific O +
stress O +
response O +
in O +
Bacillus O +
subtilis O +
. O +

By O +
N O +
- O +
terminal O +
sequencing O +
of O +
B. O +
subtilis O +
stress O +
proteins O +
Gsp38 B-Gene +
was O +
identified O +
as O +
the O +
NAD B-Gene -
- I-Gene -
synthetase I-Gene +
( O +
NadE B-Gene +
) O +
. O +

NadE B-Gene +
was O +
previously O +
characterized O +
as O +
spore B-Gene +
outgrowth I-Gene +
factor I-Gene +
B I-Gene +
( O +
OutB B-Gene +
) O +
conferring O +
a O +
temperature O +
- O +
sensitive O +
spore O +
outgrowth O +
defective O +
phenotype O +
. O +

Transcriptional O +
studies O +
showed O +
that O +
nadE B-Gene +
is O +
strongly O +
induced O +
in O +
response O +
to O +
heat O +
, O +
ethanol O +
and O +
salt O +
stress O +
or O +
after O +
starvation O +
for O +
glucose O +
in O +
a O +
sigma B-Gene +
B I-Gene +
- O +
dependent O +
manner O +
. O +

Two O +
promoters O +
are O +
involved O +
in O +
transcriptional O +
initiation O +
, O +
the O +
sigma B-Gene +
A I-Gene +
- O +
dependent O +
upstream O +
promoter O +
contributes O +
to O +
the O +
basal O +
level O +
during O +
growth O +
, O +
whereas O +
the O +
sigma B-Gene +
B I-Gene +
- O +
dependent O +
downstream O +
promoter O +
is O +
induced O +
after O +
different O +
stress O +
conditions O +
. O +

Activation O +
of O +
the O +
Bacillus O +
subtilis O +
spoIIG B-Gene +
promoter O +
requires O +
interaction O +
of O +
Spo0A B-Gene +
and O +
the O +
sigma B-Gene +
subunit I-Gene +
of I-Gene +
RNA I-Gene +
polymerase I-Gene +
. O +

Bacillus O +
subtilis O +
Spo0A B-Gene +
activates O +
transcription O +
from O +
both O +
sigmaA B-Gene +
- O +
and O +
sigmaH B-Gene +
- O +
dependent O +
promoters O +
. O +

Baldus O +
et O +
al. O +
( O +
2 O +
) O +
identified O +
two O +
amino O +
acid O +
substitutions O +
in O +
the O +
carboxyl O +
terminus O +
of O +
sigmaA B-Gene +
, O +
K356E O +
and O +
H359R O +
, O +
that O +
specifically O +
impaired O +
Spo0A B-Gene +
- O +
activated O +
transcription O +
in O +
vivo O +
. O +

To O +
test O +
the O +
model O +
in O +
which O +
the O +
K356E O +
and O +
H359R O +
substitutions O +
in O +
sigmaA B-Gene +
interfere O +
with O +
the O +
interaction O +
of O +
Spo0A B-Gene +
and O +
sigmaA B-Gene +
, O +
we O +
examined O +
the O +
effects O +
of O +
alanine O +
substitutions O +
at O +
these O +
positions O +
in O +
sigmaA B-Gene +
on O +
sigmaA B-Gene +
's O +
ability O +
to O +
direct O +
transcription O +
in O +
vivo O +
and O +
in O +
vitro O +
. O +

We O +
found O +
that O +
alanine O +
substitutions O +
at O +
these O +
positions O +
specifically O +
reduced O +
expression O +
from O +
the O +
sigmaA B-Gene +
- O +
dependent O +
, O +
Spo0A B-Gene +
- O +
dependent O +
promoters O +
, O +
spoIIG B-Gene +
and O +
spoIIE B-Gene +
, O +
in O +
vivo O +
. O +

Furthermore O +
, O +
we O +
found O +
that O +
stimulation O +
of O +
spoIIG B-Gene +
promoter O +
activity O +
by O +
Spo0A B-Gene +
in O +
vitro O +
was O +
reduced O +
by O +
the O +
single O +
substitutions O +
H359A O +
and O +
H359R O +
in O +
sigmaA B-Gene +
. O +

Cloning O +
, O +
functional O +
analysis O +
, O +
and O +
transcriptional O +
regulation O +
of O +
the O +
Bacillus O +
subtilis O +
araE B-Gene +
gene O +
involved O +
in O +
L O -
- O -
arabinose O +
utilization O +
. O +

The O +
Bacillus O +
subtilis O +
araR B-Gene +
locus O +
( O +
mapped O +
at O +
about O +
294 O +
degrees O +
on O +
the O +
genetic O +
map O +
) O +
comprises O +
two O +
open O +
reading O +
frames O +
with O +
divergently O +
arranged O +
promoters O +
, O +
the O +
regulatory O +
gene O +
, O +
araR B-Gene +
, O +
encoding O +
a O +
repressor O +
, O +
and O +
a O +
partially O +
cloned O +
gene O +
, O +
termed O +
araE B-Gene +
by O +
analogy O +
to O +
the O +
Escherichia O +
coli O +
L B-Gene -
- I-Gene -
arabinose I-Gene +
permease I-Gene +
gene O +
. O +

Here O +
, O +
we O +
report O +
the O +
cloning O +
and O +
sequencing O +
of O +
the O +
entire O +
araE B-Gene +
gene O +
encoding O +
a O +
50.4 O +
- O +
kDa O +
polypeptide O +
. O +

The O +
araE B-Gene +
gene O +
is O +
monocistronic O +
( O +
as O +
determined O +
by O +
Northern O +
blot O +
analysis O +
) O +
, O +
and O +
its O +
putative O +
product O +
is O +
very O +
similar O +
to O +
a O +
number O +
of O +
prokaryotic O +
proton O +
- O +
linked O +
monosaccharide O +
transporters O +
( O +
the O +
group O +
I O +
family O +
of O +
membrane O +
transport O +
proteins O +
) O +
. O +

Insertional O +
inactivation O +
of O +
the O +
araE B-Gene +
gene O +
leads O +
to O +
a O +
conditional O +
Ara B-Gene +
- O +
phenotype O +
dependent O +
on O +
the O +
concentration O +
of O +
L O -
- O -
arabinose O +
in O +
the O +
medium O +
. O +

Therefore O +
, O +
we O +
assume O +
that O +
araE B-Gene +
encodes O +
a O +
permease B-Gene +
involved O +
in O +
L O -
- O -
arabinose O +
transport O +
into O +
the O +
cell O +
. O +

The O +
araE B-Gene +
promoter O +
region O +
contains O +
- O +
10 O +
and O +
- O +
35 O +
regions O +
( O +
as O +
determined O +
by O +
primer O +
extension O +
analysis O +
) O +
very O +
similar O +
to O +
those O +
recognized O +
by O +
RNA B-Gene +
polymerase I-Gene +
containing O +
the O +
major O +
vegetative O +
- O +
cell O +
sigma B-Gene +
factor I-Gene +
sigmaA B-Gene +
, O +
and O +
the O +
- O +
35 O +
region O +
of O +
the O +
transcription O +
start O +
point O +
for O +
araE B-Gene +
is O +
located O +
2 O +
bp O +
from O +
the O +
- O +
35 O +
region O +
of O +
the O +
araR B-Gene +
gene O +
. O +

Transcriptional O +
studies O +
demonstrated O +
that O +
the O +
expression O +
from O +
the O +
araE B-Gene +
promoter O +
is O +
induced O +
by O +
L O -
- O -
arabinose O +
, O +
repressed O +
by O +
glucose O +
, O +
and O +
negatively O +
regulated O +
by O +
AraR B-Gene +
. O +

These O +
observations O +
are O +
consistent O +
with O +
a O +
model O +
according O +
to O +
which O +
in O +
the O +
absence O +
of O +
L O -
- O -
arabinose O +
, O +
AraR B-Gene +
binds O +
to O +
a O +
site O -
( O -
s O -
) O +
within O +
the O +
araE B-Gene +
/ O +
araR B-Gene +
promoter O +
, O +
preventing O +
transcription O +
from O +
the O +
araE B-Gene +
promoter O +
and O +
simultaneously O +
limiting O +
the O +
frequency O +
of O +
initiation O +
from O +
its O +
own O +
promoter O +
; O +
the O +
addition O +
of O +
L O -
- O -
arabinose O +
will O +
allow O +
transcription O +
from O +
the O +
araE B-Gene +
promoter O +
and O +
increase O +
the O +
frequency O +
of O +
initiation O +
from O +
the O +
araR B-Gene +
promoter O +
. O +

Role O +
of O +
amino O +
acid O +
position O +
70 O +
in O +
the O +
binding O +
affinity O +
of O +
p50.1 B-Gene +
and O +
p58.1 B-Gene +
receptors O +
for O +
HLA B-Gene -
- I-Gene -
Cw4 I-Gene +
molecules O +
. O +

In O +
an O +
attempt O +
to O +
identify O +
the O +
amino O +
acid O +
position O -
( O -
s O -
) O +
of O +
the O +
HLA B-Gene -
- I-Gene -
C I-Gene +
- O +
specific O +
p58.1 B-Gene +
/ O +
p50.1 B-Gene +
natural O +
killer O +
cell O +
receptors O +
that O +
determine O +
the O +
binding O +
affinity O +
for O +
their O +
ligand O +
, O +
we O +
used O +
soluble O +
fusion O +
proteins O +
formed O +
by O +
the O +
ectodomain O +
of O +
either O +
receptor O +
and O +
the O +
Fc O +
portion O +
of O +
human O +
IgG1 B-Gene +
. O +

We O +
show O +
that O +
the O +
soluble O +
p50.1 B-Gene +
( O +
activating O +
) O +
receptor O +
binds O +
weakly O +
to O +
221 O +
- O +
Cw4 B-Gene +
transfectants O +
. O +

In O +
contrast O +
, O +
the O +
soluble O +
p58.1 B-Gene +
( O +
inhibitory O +
) O +
receptor O +
binds O +
with O +
high O +
affinity O +
. O +

A O +
single O +
amino O +
acid O +
mutation O +
at O +
position O +
70 O +
, O +
obtained O +
by O +
site O +
- O +
directed O +
mutagenesis O +
, O +
was O +
found O +
to O +
affect O +
the O +
binding O +
affinity O +
of O +
both O +
the O +
p50.1 B-Gene +
and O +
the O +
p58.1 B-Gene +
receptors O +
. O +

Thus O +
, O +
substitution O +
in O +
p50.1 B-Gene +
of O +
lysine O +
70 O +
by O +
threonine O +
( O +
typical O +
of O +
the O +
inhibitory O +
p58.1 B-Gene +
molecule O +
) O +
resulted O +
in O +
a O +
dramatic O +
increase O +
in O +
binding O +
affinity O +
, O +
comparable O +
to O +
that O +
of O +
the O +
p58.1 B-Gene +
molecule O +
. O +

On O +
the O +
other O +
hand O +
, O +
substitution O +
of O +
threonine O +
70 O +
by O +
lysine O +
in O +
p58.1 B-Gene +
almost O +
abolished O +
binding O +
to O +
221 O +
- O +
Cw4 B-Gene +
cells O +
. O +

Our O +
present O +
data O +
indicate O +
that O +
a O +
single O +
amino O +
acid O +
difference O +
greatly O +
influences O +
the O +
p58.1 B-Gene +
/ O +
p50.1 B-Gene +
affinity O +
for O +
their O +
HLA B-Gene -
- I-Gene -
C I-Gene +
ligand O +
and O +
suggests O +
a O +
possible O +
role O +
of O +
position O +
70 O +
as O +
a O +
contact O +
site O +
in O +
the O +
natural O +
killer O +
cell O +
receptor O +
/ O +
major B-Gene +
histocompatibility I-Gene +
complex I-Gene +
class I-Gene +
I I-Gene +
interaction O +
. O +

The O +
repertoire O +
of O +
HLA B-Gene -
- I-Gene -
Cw I-Gene +
- O +
specific O +
NK O +
cell O +
receptors O +
CD158 B-Gene +
a I-Gene +
/ I-Gene +
b I-Gene +
( O +
EB6 B-Gene +
and O +
GL183 B-Gene +
) O +
in O +
individuals O +
with O +
different O +
HLA B-Gene +
phenotypes O +
. O +

Over O +
the O +
last O +
few O +
years O +
, O +
natural O +
killer O +
( O +
NK O +
) O +
cells O +
have O +
been O +
shown O +
to O +
express O +
major B-Gene +
histocompatibility I-Gene +
complex I-Gene +
( O +
MHC B-Gene +
) O +
molecules O +
recognizing O +
receptors O +
that O +
are O +
thought O +
to O +
function O +
primarily O +
as O +
negative O +
signalling O +
receptors O +
. O +

Much O +
attention O +
has O +
been O +
focused O +
on O +
the O +
NK O +
cell O +
receptors O +
CD158a B-Gene +
( O +
EB6 B-Gene +
) O +
and O +
CD158b B-Gene +
( O +
GI B-Gene +
183 I-Gene +
) O +
, O +
which O +
recognize O +
two O +
alternative O +
epitopes O +
on O +
the O +
HLA B-Gene -
- I-Gene -
Cw I-Gene +
locus O +
. O +

In O +
order O +
to O +
investigate O +
whether O +
HLA B-Gene +
type O +
affects O +
the O +
CD158a B-Gene +
/ I-Gene +
b I-Gene +
repertoire O +
, O +
expressed O +
as O +
percentage O +
positive O +
cells O +
for O +
a O +
particular O +
receptor O +
and O +
mean O +
expression O +
on O +
this O +
population O +
of O +
NK O +
cells O +
, O +
peripheral O +
blood O +
lymphocytes O +
of O +
47 O +
HLA B-Gene +
- O +
typed O +
donors O +
were O +
examined O +
. O +

Peripheral O +
blood O +
samples O +
were O +
examined O +
by O +
flow O +
cytometric O +
analysis O +
to O +
investigate O +
the O +
expression O +
of O +
CD158a B-Gene +
and O +
CD158b B-Gene +
receptors O +
on O +
the O +
surface O +
of O +
NK O +
cells O +
. O +

In O +
parallel O +
, O +
we O +
determined O +
each O +
individual O +
's O +
HLA B-Gene +
phenotype O +
. O +

There O +
was O +
a O +
great O +
heterogeneity O +
in O +
CD158 B-Gene +
expression O +
; O +
nevertheless O +
all O +
individuals O +
had O +
NK O +
cells O +
belonging O +
either O +
to O +
the O +
CD158 B-Gene +
a+b-,a I-Gene -
- I-Gene -
b+ I-Gene +
or I-Gene +
a I-Gene -
- I-Gene -
b I-Gene +
- I-Gene +
populations O +
. O +

No O +
positive O +
or O +
inverse O +
correlations O +
could O +
be O +
shown O +
between O +
either O +
receptor O +
expression O +
intensity O +
or O +
proportion O +
of O +
positive O +
cells O +
, O +
and O +
presence O +
of O +
the O +
appropriate O +
ligand O +
. O +

Thus O +
no O +
association O +
between O +
an O +
individual O +
's O +
NK O +
receptor O +
repertoire O +
and O +
HLA B-Gene +
serotype O +
could O +
be O +
demonstrated O +
. O +

It O +
is O +
concluded O +
that O +
CD158 B-Gene +
is O +
expressed O +
on O +
NK O +
cells O +
in O +
a O +
highly O +
redundant O +
fashion O +
. O +

Our O +
data O +
do O +
not O +
support O +
either O +
a O +
positive O +
selection O +
mechanism O +
or O +
the O +
receptor O +
calibration O +
model O +
. O +

The O +
sigmaD B-Gene +
- O +
dependent O +
transcription O +
of O +
the O +
ywcG B-Gene +
gene O +
from O +
Bacillus O +
subtilis O +
is O +
dependent O +
on O +
an O +
excess O +
of O +
glucose O +
and O +
glutamate O +
. O +

We O +
investigated O +
the O +
function O +
and O +
transcriptional O +
regulation O +
of O +
ywcG B-Gene +
. O +

The O +
protein O +
is O +
essential O +
for O +
Bacillus O +
subtilis O +
. O +

Biochemical O +
characterization O +
of O +
the O +
protein O +
revealed O +
that O +
it O +
is O +
an O +
FMN O +
- O +
containing O +
NADPH B-Gene +
oxidase I-Gene +
. O +

ywcG B-Gene +
is O +
transcribed O +
throughout O +
the O +
whole O +
life O +
cycle O +
of O +
B. O +
subtilis O +
. O +

The O +
start O +
point O +
of O +
transcription O +
is O +
preceded O +
by O +
potential O +
promoter O +
sequences O +
for O +
sigmaA B-Gene +
, O +
sigmaB B-Gene +
and O +
sigmaD B-Gene +
. O +

A O +
boost O +
in O +
transcription O +
occurs O +
at O +
the O +
beginning O +
of O +
stationary O +
phase O +
in O +
complex O +
media O +
containing O +
glutamate O +
and O +
glucose O +
. O +

The O +
induction O +
of O +
transcription O +
at O +
the O +
beginning O +
of O +
stationary O +
phase O +
needs O +
the O +
activity O +
of O +
a O +
different O +
alternative O +
sigma B-Gene +
- I-Gene +
factor I-Gene +
sigmaD B-Gene +
. O +

ywcG B-Gene +
is O +
, O +
therefore O +
, O +
the O +
first O +
gene O +
with O +
a O +
putative O +
role O +
in O +
energy O +
metabolism O +
from O +
B. O +
subtilis O +
that O +
is O +
transcribed O +
in O +
a O +
sigmaD B-Gene +
- O +
dependent O +
fashion O +
, O +
but O +
its O +
regulation O +
is O +
unique O +
and O +
the O +
reverse O +
of O +
that O +
described O +
for O +
all O +
other O +
sigmaD B-Gene +
- O +
dependent O +
genes O +
. O +

The O +
katX B-Gene +
gene O +
, O +
which O +
codes O +
for O +
the O +
catalase B-Gene +
in O +
spores O +
of O +
Bacillus O +
subtilis O +
, O +
is O +
a O +
forespore O +
- O +
specific O +
gene O +
controlled O +
by O +
sigmaF B-Gene +
, O +
and O +
KatX B-Gene +
is O +
essential O +
for O +
hydrogen O +
peroxide O +
resistance O +
of O +
the O +
germinating O +
spore O +
. O +

Previous O +
work O +
has O +
shown O +
that O +
the O +
katX B-Gene +
gene O +
encodes O +
the O +
major O +
catalase B-Gene +
in O +
dormant O +
spores O +
of O +
Bacillus O +
subtilis O +
but O +
that O +
this O +
enzyme O +
has O +
no O +
role O +
in O +
dormant O +
spore O +
resistance O +
to O +
hydrogen O +
peroxide O +
. O +

Expression O +
of O +
a O +
katX B-Gene +
- O +
lacZ B-Gene +
fusion O +
began O +
at O +
approximately O +
h O +
2 O +
of O +
sporulation O +
, O +
and O +
> O +
75 O +
% O +
of O +
the O +
katX B-Gene +
- O +
driven O +
beta B-Gene -
- I-Gene -
galactosidase I-Gene +
was O +
packaged O +
into O +
the O +
mature O +
spore O +
. O +

A O +
mutation O +
in O +
the O +
gene O +
coding O +
for O +
the O +
sporulation O +
- O +
specific O +
RNA B-Gene +
polymerase I-Gene +
sigma I-Gene +
factor I-Gene +
sigmaF B-Gene +
abolished O +
katX B-Gene +
- O +
lacZ B-Gene +
expression O +
, O +
while O +
mutations O +
in O +
genes O +
encoding O +
sigmaE B-Gene +
, O +
sigmaG B-Gene +
, O +
and O +
sigmaK B-Gene +
did O +
not O +
. O +

Induction O +
of O +
sigmaF B-Gene +
synthesis O +
in O +
vegetative O +
cells O +
also O +
resulted O +
in O +
katX B-Gene +
- O +
lacZ B-Gene +
expression O +
, O +
while O +
induction O +
of O +
sigmaG B-Gene +
expression O +
did O +
not O +
; O +
the O +
katX B-Gene +
- O +
lacZ B-Gene +
fusion O +
was O +
also O +
not O +
induced O +
by O +
hydrogen O +
peroxide O +
. O +

Upstream O +
of O +
the O +
in O +
vivo O +
katX B-Gene +
transcription O +
start O +
site O +
there O +
are O +
sequences O +
with O +
good O +
homology O +
to O +
those O +
upstream O +
of O +
known O +
sigmaF B-Gene +
- O +
dependent O +
start O +
sites O +
. O +

These O +
data O +
indicate O +
that O +
katX B-Gene +
is O +
an O +
additional O +
member O +
of O +
the O +
forespore O +
- O +
specific O +
sigmaF B-Gene +
regulon O +
. O +

A O +
mutant O +
in O +
the O +
katA B-Gene +
gene O +
, O +
encoding O +
the O +
major O +
catalase B-Gene +
in O +
growing O +
cells O +
, O +
was O +
sensitive O +
to O +
hydrogen O +
peroxide O +
during O +
sporulation O +
, O +
while O +
a O +
katX B-Gene +
mutant O +
was O +
not O +
. O +

However O +
, O +
outgrowth O +
of O +
katX B-Gene +
spores O +
, O +
but O +
not O +
katA B-Gene +
spores O +
, O +
was O +
sensitive O +
to O +
hydrogen O +
peroxide O +
. O +

Consequently O +
, O +
a O +
major O +
function O +
for O +
KatX B-Gene +
is O +
to O +
protect O +
germinating O +
spores O +
from O +
hydrogen O +
peroxide O +
. O +

Identification O +
of O +
target O +
promoters O +
for O +
the O +
Bacillus O +
subtilis O +
sigma B-Gene +
X I-Gene +
factor I-Gene +
using O +
a O +
consensus O +
- O +
directed O +
search O +
. O +

The O +
promoter O +
selectivity O +
of O +
RNA B-Gene +
polymerase I-Gene +
( O +
RNAP B-Gene +
) O +
can O +
be O +
altered O +
by O +
the O +
association O +
with O +
alternative O +
sigma O +
subunits O +
. O +

Bacillus O +
subtilis O +
hosts O +
a O +
multitude O +
of O +
sigma B-Gene +
factors I-Gene +
, O +
several O +
of O +
which O +
coordinate O +
the O +
complex O +
developmental O +
program O +
culminating O +
in O +
endospore O +
formation O +
. O +

Genome O +
sequencing O +
has O +
revealed O +
an O +
unanticipated O +
seven O +
new O +
sigma O +
factors O +
of O +
the O +
highly O +
divergent O +
extracytoplasmic B-Gene +
function I-Gene +
( I-Gene +
ECF I-Gene +
) I-Gene +
sub I-Gene +
- I-Gene +
family I-Gene +
. O +

Virtually O +
nothing O +
is O +
known O +
regarding O +
either O +
the O +
promoter O +
selectivity O +
or O +
the O +
target O +
genes O +
for O +
these O +
newly O +
identified O +
sigma B-Gene +
factors I-Gene +
. O +

We O +
have O +
used O +
saturation O +
mutagenesis O +
to O +
define O +
a O +
promoter O +
consensus O +
for O +
recognition O +
by O +
one O +
such O +
ECF B-Gene +
sigma I-Gene +
factor I-Gene +
, O +
sigma B-Gene +
X I-Gene +
. O +

The O +
resulting O +
consensus O +
sequence O +
was O +
used O +
to O +
identify O +
candidate O +
sigma B-Gene +
X I-Gene +
target O +
sites O +
. O +

Three O +
newly O +
identified O +
sigma B-Gene +
X I-Gene +
- O +
dependent O +
promoters O +
precede O +
genes O +
encoding O +
regulatory O +
proteins O +
: O +
an O +
AbrB B-Gene +
homolog I-Gene +
( O +
Abh B-Gene +
) O +
, O +
a O +
putative O +
response B-Gene +
regulator I-Gene +
aspartate I-Gene +
phosphatase I-Gene +
( O +
RapD B-Gene +
) O +
, O +
and O +
a O +
regulator O +
of O +
autolysin B-Gene +
expression O +
( O +
LytR B-Gene +
) O +
. O +
sigma B-Gene +
X I-Gene +
also O +
contributes O +
to O +
the O +
expression O +
of O +
CsbB B-Gene +
, O +
a O +
putative O +
membrane O +
- O +
bound O +
glucosyl B-Gene +
transferase I-Gene +
that O +
is O +
partially O +
controlled O +
by O +
the O +
sigma B-Gene +
B I-Gene +
stress O +
response O +
sigma B-Gene +
factor I-Gene +
. O +

Since O +
LytR B-Gene +
modulates O +
the O +
expression O +
of O +
the O +
major O +
autolytic O +
amidase B-Gene +
and O +
CsbB B-Gene +
may O +
function O +
in O +
peptidoglycan O +
synthesis O +
or O +
modification O +
, O +
we O +
suggest O +
that O +
sigma B-Gene +
X I-Gene +
participates O +
in O +
the O +
regulation O +
of O +
peptidoglycan O +
synthesis O +
and O +
turnover O +
. O +

One O +
of O +
two O +
osmC B-Gene +
homologs O +
in O +
Bacillus O +
subtilis O +
is O +
part O +
of O +
the O +
sigmaB B-Gene +
- O +
dependent O +
general O +
stress O +
regulon O +
. O +

In O +
this O +
report O +
we O +
present O +
the O +
identification O +
and O +
analysis O +
of O +
two O +
Bacillus O +
subtilis O +
genes O +
, O +
yklA B-Gene +
and O +
ykzA B-Gene +
, O +
which O +
are O +
homologous O +
to O +
the O +
partially O +
RpoS B-Gene +
- O +
controlled O +
osmC B-Gene +
gene O +
from O +
Escherichia O +
coli O +
. O +

The O +
yklA B-Gene +
gene O +
is O +
expressed O +
at O +
higher O +
levels O +
in O +
minimal O +
medium O +
than O +
in O +
rich O +
medium O +
and O +
is O +
driven O +
by O +
a O +
putative O +
vegetative O +
promoter O +
. O +

Expression O +
of O +
ykzA B-Gene +
is O +
not O +
medium O +
dependent O +
but O +
increases O +
dramatically O +
when O +
cells O +
are O +
exposed O +
to O +
stress O +
and O +
starvation O +
. O +

This O +
stress O +
- O +
induced O +
increase O +
in O +
ykzA B-Gene +
expression O +
is O +
absolutely O +
dependent O +
on O +
the O +
alternative O +
sigma B-Gene +
factor I-Gene +
sigmaB B-Gene +
, O +
which O +
controls O +
a O +
large O +
stationary O +
- O +
phase O +
and O +
stress O +
regulon O +
. O +

ykzA B-Gene +
is O +
therefore O +
another O +
example O +
of O +
a O +
gene O +
common O +
to O +
the O +
RpoS B-Gene +
and O +
sigmaB B-Gene +
stress O +
regulons O +
of O +
E. O +
coli O +
and O +
B. O +
subtilis O +
, O +
respectively O +
. O +

The O +
composite O +
complex O +
expression O +
pattern O +
of O +
the O +
two O +
B. O +
subtilis O +
genes O +
is O +
very O +
similar O +
to O +
the O +
expression O +
profile O +
of O +
osmC B-Gene +
in O +
E. O +
coli O +
. O +

A O +
molecular O +
switch O +
controlling O +
competence O +
and O +
motility O +
: O +
competence O +
regulatory O +
factors O +
ComS B-Gene +
, O +
MecA B-Gene +
, O +
and O +
ComK B-Gene +
control O +
sigmaD B-Gene +
- O +
dependent O +
gene O +
expression O +
in O +
Bacillus O +
subtilis O +
. O +

Bacillus O +
subtilis O +
, O +
like O +
many O +
bacteria O +
, O +
will O +
choose O +
among O +
several O +
response O +
pathways O +
when O +
encountering O +
a O +
stressful O +
environment O +
. O +

Among O +
the O +
processes O +
activated O +
under O +
growth O +
- O +
restricting O +
conditions O +
are O +
sporulation O +
, O +
establishment O +
of O +
motility O +
, O +
and O +
competence O +
development O +
. O +

Recent O +
reports O +
implicate O +
ComK B-Gene +
and O +
MecA B-Gene +
- O +
ClpC B-Gene +
as O +
part O +
of O +
a O +
system O +
that O +
regulates O +
both O +
motility O +
and O +
competence O +
development O +
. O +

MecA B-Gene +
, O +
while O +
negatively O +
controlling O +
competence O +
by O +
inhibiting O +
ComK B-Gene +
, O +
stimulates O +
sigmaD B-Gene +
- O +
dependent O +
transcription O +
of O +
genes O +
that O +
function O +
in O +
motility O +
and O +
autolysin B-Gene +
production O +
. O +

Both O +
ComK B-Gene +
- O +
dependent O +
and O +
- O +
independent O +
pathways O +
have O +
been O +
proposed O +
for O +
MecA B-Gene +
's O +
role O +
in O +
the O +
regulation O +
of O +
motility O +
. O +

Mutations O +
in O +
mecA B-Gene +
reduce O +
the O +
transcription O +
of O +
hag B-Gene +
. O +

encoding O +
flagellin B-Gene +
, O +
and O +
are O +
partially O +
suppressed O +
by O +
comK B-Gene +
in O +
both O +
medium O +
promoting O +
motility O +
and O +
medium O +
promoting O +
competence O +
. O +

Reduced O +
sigmaD B-Gene +
levels O +
are O +
observed O +
in O +
mecA B-Gene +
mutants O +
grown O +
in O +
competence O +
medium O +
, O +
but O +
no O +
change O +
in O +
sigmaD B-Gene +
concentration O +
is O +
detected O +
in O +
a O +
comK B-Gene +
mutant O +
. O +

The O +
comF B-Gene +
operon I-Gene +
, O +
transcription O +
of O +
which O +
requires O +
ComK B-Gene +
, O +
is O +
located O +
immediately O +
upstream O +
of O +
the O +
operon O +
that O +
contains O +
the O +
flgM B-Gene +
gene O +
, O +
encoding O +
the O +
sigmaD B-Gene +
- O +
specific O +
antisigma B-Gene +
factor I-Gene +
. O +

An O +
insertion O +
mutation O +
that O +
disrupts O +
the O +
putative O +
comF B-Gene +
- O +
flgM B-Gene +
transcription O +
unit O +
confers O +
a O +
phenotype O +
identical O +
to O +
that O +
of O +
the O +
comK B-Gene +
mutant O +
with O +
respect O +
to O +
hag B-Gene +
- O +
lacZ B-Gene +
expression O +
. O +

Expression O +
of O +
a O +
flgM B-Gene +
- O +
lacZ B-Gene +
operon O +
fusion O +
is O +
reduced O +
in O +
both O +
sigD B-Gene +
and O +
comK B-Gene +
mutant O +
cells O +
but O +
is O +
abolished O +
in O +
the O +
sigD B-Gene +
comK B-Gene +
double O +
mutant O +
. O +

Reverse O +
transcription O +
- O +
PCR O +
examination O +
of O +
the O +
comF B-Gene +
- O +
flgM B-Gene +
transcript O +
indicates O +
that O +
readthrough O +
from O +
comF B-Gene +
into O +
the O +
flgM B-Gene +
operon O +
is O +
dependent O +
on O +
ComK B-Gene +
. O +

ComK B-Gene +
negatively O +
controls O +
the O +
transcription O +
of O +
hag B-Gene +
by O +
stimulating O +
the O +
transcription O +
of O +
comF B-Gene +
- O +
flgM B-Gene +
, O +
thereby O +
increasing O +
the O +
production O +
of O +
the O +
FlgM B-Gene +
antisigma B-Gene +
factor I-Gene +
that O +
inhibits O +
sigmaD B-Gene +
activity O +
. O +

There O +
likely O +
exists O +
another O +
comK B-Gene +
- O +
independent O +
mechanism O +
of O +
hag B-Gene +
transcription O +
that O +
requires O +
mecA B-Gene +
and O +
possibly O +
affects O +
the O +
sigmaD B-Gene +
concentration O +
in O +
cells O +
undergoing O +
competence O +
development O +
. O +

Herpesvirus B-Gene +
entry I-Gene +
mediator I-Gene +
ligand I-Gene +
( O +
HVEM B-Gene -
- I-Gene -
L I-Gene +
) O +
, O +
a O +
novel O +
ligand O +
for O +
HVEM B-Gene +
/ O +
TR2 B-Gene +
, O +
stimulates O +
proliferation O +
of O +
T O +
cells O +
and O +
inhibits O +
HT29 O +
cell O +
growth O +
. O +

Herpesvirus B-Gene +
entry I-Gene +
mediator I-Gene +
( O +
HVEM B-Gene +
) O +
, O +
a O +
member O +
of O +
the O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
( I-Gene +
TNF I-Gene +
) I-Gene +
receptor I-Gene +
family I-Gene +
, O +
mediates O +
herpesvirus O +
entry O +
into O +
cells O +
during O +
infection O +
. O +

Upon O +
overexpression O +
, O +
HVEM B-Gene +
activates O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
and O +
AP-1 B-Gene +
through O +
a O +
TNF B-Gene +
receptor I-Gene +
- I-Gene +
associated I-Gene +
factor I-Gene +
( O +
TRAF B-Gene +
) O +
- O +
mediated O +
mechanism O +
. O +

Using O +
an O +
HVEM B-Gene +
- O +
Fc O +
fusion O +
protein O +
, O +
we O +
screened O +
soluble O +
forms O +
of O +
novel O +
TNF B-Gene +
- O +
related O +
proteins O +
derived O +
from O +
an O +
expressed O +
sequence O +
tag O +
data O +
base O +
. O +

One O +
of O +
these O +
, O +
which O +
we O +
designated O +
HVEM B-Gene +
- I-Gene +
L I-Gene +
, O +
specifically O +
bound O +
to O +
HVEM B-Gene +
- O +
Fc O +
with O +
an O +
affinity O +
of O +
44 O +
nM O +
. O +

This O +
association O +
was O +
confirmed O +
with O +
soluble O +
and O +
membrane O +
forms O +
of O +
both O +
receptor O +
and O +
ligand O +
. O +

HVEM B-Gene -
- I-Gene -
L I-Gene +
mRNA O +
is O +
expressed O +
in O +
spleen O +
, O +
lymph O +
nodes O +
, O +
macrophages O +
, O +
and O +
T O +
cells O +
and O +
encodes O +
a O +
240 O +
- O +
amino O +
acid O +
protein O +
. O +

A O +
soluble O +
, O +
secreted O +
form O +
of O +
the O +
protein O +
stimulates O +
proliferation O +
of O +
T O +
lymphocytes O +
during O +
allogeneic O +
responses O +
, O +
inhibits O +
HT-29 O +
cell O +
growth O +
, O +
and O +
weakly O +
stimulates O +
NF B-Gene -
- I-Gene -
kappaB I-Gene +
- O +
dependent O +
transcription O +
. O +

De O +
novo O +
fatty O +
acid O +
synthesis O +
is O +
required O +
for O +
establishment O +
of O +
cell O +
type O +
- O +
specific O +
gene O +
transcription O +
during O +
sporulation O +
in O +
Bacillus O +
subtilis O +
. O +

A O +
hallmark O +
of O +
sporulation O +
of O +
Bacillus O +
subtilis O +
is O +
the O +
formation O +
of O +
two O +
distinct O +
cells O +
by O +
an O +
asymmetric O +
septum O +
. O +

The O +
developmental O +
programme O +
of O +
these O +
two O +
cells O +
involves O +
the O +
compartmentalized O +
activities O +
of O +
sigmaE B-Gene +
in O +
the O +
larger O +
mother O +
cell O +
and O +
of O +
sigmaF B-Gene +
in O +
the O +
smaller O +
prespore O +
. O +

A O +
potential O +
role O +
of O +
de O +
novo O +
lipid O +
synthesis O +
on O +
development O +
was O +
investigated O +
by O +
treating O +
B. O +
subtilis O +
cells O +
with O +
cerulenin O +
, O +
a O +
specific O +
inhibitor O +
of O +
fatty O +
acid O +
biosynthesis O +
. O +

These O +
experiments O +
demonstrated O +
that O +
spore O +
formation O +
requires O +
de O +
novo O +
fatty O +
acid O +
synthesis O +
at O +
the O +
onset O +
of O +
sporulation O +
. O +

The O +
transcription O +
of O +
the O +
sporulation O +
genes O +
that O +
are O +
induced O +
before O +
the O +
formation O +
of O +
two O +
cell O +
types O +
or O +
that O +
are O +
under O +
the O +
exclusive O +
control O +
of O +
sigmaF B-Gene +
occurred O +
in O +
the O +
absence O +
of O +
fatty O +
acid O +
synthesis O +
, O +
as O +
monitored O +
by O +
spo B-Gene +
- O +
lacZ B-Gene +
fusions O +
. O +

However O +
, O +
expression O +
of O +
lacZ B-Gene +
fusions O +
to O +
genes O +
that O +
required O +
activation O +
of O +
sigmaE B-Gene +
for O +
transcription O +
was O +
inhibited O +
in O +
the O +
absence O +
of O +
fatty O +
acid O +
synthesis O +
. O +

The O +
block O +
in O +
sigmaE B-Gene +
- O +
directed O +
gene O +
expression O +
in O +
cerulenin O +
- O +
treated O +
cells O +
was O +
caused O +
by O +
an O +
inability O +
to O +
process O +
pro O +
- O +
sigmaE B-Gene +
to O +
its O +
active O +
form O +
. O +

Electron O +
microscopy O +
revealed O +
that O +
these O +
fatty O +
acid O +
- O +
starved O +
cells O +
initiate O +
abnormal O +
polar O +
septation O +
, O +
suggesting O +
that O +
de O +
novo O +
fatty O +
acid O +
synthesis O +
may O +
be O +
essential O +
to O +
couple O +
the O +
activation O +
of O +
the O +
mother O +
cell O +
transcription B-Gene +
factors I-Gene +
with O +
the O +
formation O +
of O +
the O +
differentiating O +
cells O +
. O +

Oncoprotein O +
TLS B-Gene +
interacts O +
with O +
serine O +
- O +
arginine O +
proteins O +
involved O +
in O +
RNA O +
splicing O +
. O +

The O +
gene O +
encoding O +
the O +
human O +
TLS B-Gene +
protein O +
, O +
also O +
termed O +
FUS B-Gene +
, O +
is O +
located O +
at O +
the O +
site O +
of O +
chromosomal O +
translocations O +
in O +
human O +
leukemias O +
and O +
sarcomas O +
where O +
it O +
forms O +
a O +
chimeric O +
fusion O +
gene O +
with O +
one O +
of O +
several O +
different O +
genes O +
. O +

To O +
identify O +
interacting O +
partners O +
of O +
TLS B-Gene +
, O +
we O +
screened O +
a O +
yeast O +
two O +
- O +
hybrid O +
cDNA O +
library O +
constructed O +
from O +
mouse O +
hematopoietic O +
cells O +
using O +
the O +
C O +
- O +
terminal O +
region O +
of O +
TLS B-Gene +
in O +
the O +
bait O +
plasmid O +
. O +

Two O +
cDNAs O +
encoding O +
members O +
of O +
the O +
serine O +
- O +
arginine O +
( O +
SR O +
) O +
family O +
of O +
proteins O +
were O +
isolated O +
. O +

The O +
first O +
SR O +
protein O +
is O +
the O +
mouse O +
homolog O +
of O +
human O +
splicing B-Gene +
factor I-Gene +
SC35 B-Gene +
, O +
and O +
the O +
second O +
SR O +
member O +
is O +
a O +
novel O +
183-amino O +
acid O +
protein O +
that O +
we O +
term O +
TASR B-Gene +
( O +
TLS B-Gene +
- I-Gene +
associated I-Gene +
serine I-Gene +
- I-Gene +
arginine I-Gene +
protein I-Gene +
) O +
. O +

cDNA O +
cloning O +
of O +
human O +
TASR B-Gene +
indicated O +
that O +
mouse O +
and O +
human O +
TASR B-Gene +
have O +
identical O +
amino O +
acid O +
sequences O +
. O +

The O +
interactions O +
between O +
TLS B-Gene +
and O +
these O +
two O +
SR O +
proteins O +
were O +
confirmed O +
by O +
co O +
- O +
transfection O +
and O +
immunoprecipitation O +
studies O +
. O +

In O +
vivo O +
splicing O +
assays O +
indicated O +
that O +
SC35 B-Gene +
and O +
TASR B-Gene +
influence O +
splice O +
site O +
selection O +
of O +
adenovirus O +
E1A B-Gene +
pre O +
- O +
mRNA O +
. O +

TLS B-Gene +
may O +
recruit O +
SR O +
splicing O +
factors O +
to O +
specific O +
target O +
genes O +
through O +
interaction O +
with O +
its O +
C O +
- O +
terminal O +
region O +
, O +
and O +
chromosomal O +
translocations O +
that O +
truncate O +
the O +
C O +
- O +
terminal O +
region O +
of O +
TLS B-Gene +
may O +
prevent O +
this O +
interaction O +
. O +

Thus O +
TLS B-Gene +
translocations O +
may O +
alter O +
RNA O +
processing O +
and O +
play O +
a O +
role O +
in O +
malignant O +
transformation O +
. O +

Molecular O +
cloning O +
of O +
the O +
oncofetal O +
isoform O +
of O +
the O +
human O +
pancreatic O +
bile B-Gene +
salt I-Gene +
- I-Gene +
dependent I-Gene +
lipase I-Gene +
. O +

Specific O +
transcripts O +
for O +
bile B-Gene +
salt I-Gene +
- I-Gene +
dependent I-Gene +
lipase I-Gene +
( O +
BSDL B-Gene +
) O +
, O +
a O +
100 O +
- O +
kDa O +
glycoprotein O +
secreted O +
by O +
the O +
human O +
pancreas O +
, O +
were O +
immunodetected O +
in O +
BxPC-3 O +
and O +
SOJ-6 O +
pancreatic O +
tumoral O +
cell O +
lines O +
. O +

Sequencing O +
of O +
fragments O +
, O +
obtained O +
by O +
mRNA O +
reverse O +
transcription O +
and O +
amplification O +
, O +
confirmed O +
the O +
presence O +
of O +
BSDL B-Gene +
transcripts O +
in O +
these O +
cancer O +
cells O +
. O +

The O +
protein O +
was O +
detected O +
in O +
lysates O +
of O +
pancreatic O +
tumoral O +
cells O +
, O +
where O +
it O +
was O +
mainly O +
associated O +
with O +
membranes O +
. O +

Only O +
a O +
minute O +
amount O +
of O +
the O +
enzyme O +
was O +
detected O +
in O +
the O +
culture O +
media O +
. O +

Immunofluorescence O +
studies O +
demonstrated O +
that O +
in O +
SOJ-6 O +
cells O +
, O +
BSDL B-Gene +
colocates O +
with O +
the O +
p58 O +
Golgi O +
protein O +
and O +
suggested O +
that O +
the O +
protein O +
may O +
be O +
sequestrated O +
within O +
the O +
Golgi O +
compartment O +
. O +

These O +
results O +
demonstrated O +
that O +
BSDL B-Gene +
is O +
expressed O +
in O +
human O +
pancreatic O +
tumoral O +
cells O +
and O +
can O -
not O +
be O +
secreted O +
( O +
or O +
for O +
the O +
least O +
very O +
poorly O +
) O +
. O +

Subsequently O +
, O +
a O +
cDNA O +
covering O +
the O +
entire O +
sequence O +
of O +
BSDL B-Gene +
was O +
obtained O +
by O +
reverse O +
transcription O +
- O +
polymerase O +
chain O +
reaction O +
. O +

The O +
sequence O +
of O +
this O +
cDNA O +
indicated O +
that O +
the O +
N O +
- O +
terminal O +
domain O +
encoded O +
by O +
exons O +
1 O +
- O +
10 O +
was O +
identical O +
to O +
that O +
of O +
BSDL B-Gene +
expressed O +
by O +
the O +
human O +
normal O +
pancreas O +
. O +

However O +
, O +
the O +
sequence O +
corresponding O +
to O +
exon O +
11 O +
, O +
which O +
should O +
code O +
for O +
the O +
16 O +
tandem O +
- O +
repeated O +
identical O +
mucin B-Gene +
- O +
like O +
sequences O +
of O +
BSDL B-Gene +
, O +
was O +
deleted O +
by O +
330 O +
base O +
pairs O +
( O +
bp O +
) O +
and O +
encoded O +
only O +
6 O +
of O +
these O +
repeated O +
sequences O +
. O +

We O +
conclude O +
that O +
this O +
truncated O +
variant O +
of O +
BSDL B-Gene +
would O +
be O +
its O +
oncofetal O +
form O +
, O +
referred O +
to O +
as O +
feto O +
- O +
acinar O +
pancreatic O +
protein O +
. O +

We O +
then O +
investigated O +
whether O +
the O +
deletion O +
of O +
330 O +
bp O +
affected O +
the O +
secretion O +
of O +
the O +
protein O +
. O +

For O +
this O +
purpose O +
, O +
the O +
cDNA O +
corresponding O +
to O +
the O +
mature O +
form O +
of O +
the O +
BSDL B-Gene +
variant O +
expressed O +
in O +
SOJ-6 O +
cells O +
was O +
cloned O +
into O +
an O +
expression O +
/ O +
secretion O +
vector O +
and O +
transfected O +
into O +
CHO O -
- O -
K1 O +
cells O +
. O +

Results O +
indicated O +
that O +
the O +
variant O +
of O +
BSDL B-Gene +
isolated O +
from O +
SOJ-6 O +
cells O +
was O +
expressed O +
and O +
secreted O +
by O +
transfected O +
cells O +
. O +

However O +
, O +
the O +
level O +
of O +
BSDL B-Gene +
secreted O +
by O +
these O +
transfected O +
CHO O -
- O -
K1 O +
cells O +
was O +
significantly O +
higher O +
than O +
that O +
observed O +
for O +
SOJ-6 O +
cells O +
. O +

Consequently O +
, O +
the O +
retention O +
of O +
the O +
oncofetal O +
variant O +
of O +
BSDL B-Gene +
observed O +
in O +
human O +
pancreatic O +
tumoral O +
cells O +
might O +
not O +
result O +
from O +
inherent O +
properties O +
of O +
the O +
protein O +
. O +

Differential O +
binding O +
to O +
HLA B-Gene -
- I-Gene -
C I-Gene +
of O +
p50 B-Gene +
- O +
activating O +
and O +
p58 B-Gene +
- O +
inhibitory O +
natural O +
killer O +
cell O +
receptors O +
. O +

Natural O +
killer O +
( O +
NK O +
) O +
cell O +
cytotoxicity O +
is O +
regulated O +
in O +
large O +
part O +
by O +
the O +
expression O +
of O +
NK O +
cell O +
receptors O +
able O +
to O +
bind O +
class B-Gene +
I I-Gene +
major I-Gene +
histocompatibility I-Gene +
complex I-Gene +
glycoproteins I-Gene +
. O +

The O +
receptors O +
associated O +
with O +
recognition O +
of O +
HLA B-Gene -
- I-Gene -
C I-Gene +
allospecificities O +
are O +
the O +
two O +
- O +
domain O +
Ig B-Gene +
- O +
like O +
molecules O +
, O +
p50 B-Gene +
and O +
p58 B-Gene +
proteins O +
, O +
with O +
highly O +
homologous O +
extracellular O +
domains O +
but O +
differing O +
in O +
that O +
they O +
have O +
either O +
an O +
activating O +
or O +
inhibitory O +
function O +
, O +
respectively O +
, O +
depending O +
on O +
the O +
transmembrane O +
domain O +
and O +
cytoplasmic O +
tails O +
that O +
they O +
possess O +
. O +

We O +
have O +
compared O +
the O +
binding O +
to O +
HLA B-Gene -
- I-Gene -
Cw7 I-Gene +
of O +
an O +
inhibitory O +
p58 B-Gene +
molecule O +
, O +
NKAT2 B-Gene +
, O +
the O +
highly O +
homologous O +
activating O +
p50 B-Gene +
molecule O +
, O +
clone B-Gene +
49 I-Gene +
, O +
and O +
a O +
second O +
activating O +
p50 B-Gene +
molecule O +
, O +
clone B-Gene +
39 I-Gene +
, O +
which O +
has O +
homologies O +
to O +
both O +
NKAT1 B-Gene +
and O +
NKAT2 B-Gene +
. O +

NKAT2 B-Gene +
binds O +
to O +
HLA B-Gene -
- I-Gene -
Cw7 I-Gene +
with O +
very O +
rapid O +
association O +
and O +
dissociation O +
rates O +
. O +

However O +
, O +
the O +
p50 B-Gene +
receptors O +
bind O +
only O +
very O +
weakly O +
, O +
if O +
at O +
all O +
, O +
to O +
HLA B-Gene -
- I-Gene -
C I-Gene +
. O +

The O +
molecular O +
basis O +
of O +
this O +
difference O +
is O +
analyzed O +
, O +
and O +
the O +
functional O +
significance O +
of O +
these O +
observations O +
is O +
discussed O +
. O +

The O +
first O +
gene O +
of O +
the O +
Bacillus O +
subtilis O +
clpC B-Gene +
operon O +
, O +
ctsR B-Gene +
, O +
encodes O +
a O +
negative O +
regulator O +
of O +
its O +
own O +
operon O +
and O +
other O +
class B-Gene +
III I-Gene +
heat I-Gene +
shock I-Gene +
genes I-Gene +
. O +

The O +
Bacillus O +
subtilis O +
clpC B-Gene +
operon O +
is O +
regulated O +
by O +
two O +
stress O +
induction O +
pathways O +
relying O +
on O +
either O +
sigmaB B-Gene +
or O +
a O +
class O +
III O +
stress O +
induction O +
mechanism O +
acting O +
at O +
a O +
sigmaA B-Gene +
- O +
like O +
promoter O +
. O +

When O +
the O +
clpC B-Gene +
operon O +
was O +
placed O +
under O +
the O +
control O +
of O +
the O +
isopropyl O -
- O -
beta O -
- O -
D O -
- O -
thiogalactopyranoside O +
( O +
IPTG O +
) O +
- O +
inducible O +
Pspac O +
promoter O +
, O +
dramatic O +
repression O +
of O +
the O +
natural O +
clpC B-Gene +
promoters O +
fused O +
to O +
a O +
lacZ B-Gene +
reporter O +
gene O +
was O +
noticed O +
after O +
IPTG O +
induction O +
. O +

This O +
result O +
strongly O +
indicated O +
negative O +
regulation O +
of O +
the O +
clpC B-Gene +
operon O +
by O +
one O +
of O +
its O +
gene O +
products O +
. O +

Indeed O +
, O +
the O +
negative O +
regulator O +
could O +
be O +
identified O +
which O +
is O +
encoded O +
by O +
the O +
first O +
gene O +
of O +
the O +
clpC B-Gene +
operon O +
, O +
ctsR B-Gene +
, O +
containing O +
a O +
predicted O +
helix O +
- O +
turn O +
- O +
helix O +
DNA O +
- O +
binding O +
motif O +
. O +

Deletion O +
of O +
ctsR B-Gene +
abolished O +
the O +
negative O +
regulation O +
and O +
resulted O +
in O +
high O +
expression O +
of O +
both O +
the O +
clpC B-Gene +
operon O +
and O +
the O +
clpP B-Gene +
gene O +
under O +
nonstressed O +
conditions O +
. O +

Nevertheless O +
, O +
a O +
further O +
increase O +
in O +
clpC B-Gene +
and O +
clpP B-Gene +
mRNA O +
levels O +
was O +
observed O +
after O +
heat O +
shock O +
, O +
even O +
in O +
the O +
absence O +
of O +
sigmaB B-Gene +
, O +
suggesting O +
a O +
second O +
induction O +
mechanism O +
at O +
the O +
vegetative O +
promoter O +
. O +

Two O +
- O +
dimensional O +
gel O +
analysis O +
and O +
mRNA O +
studies O +
showed O +
that O +
the O +
expression O +
of O +
other O +
class O +
III O +
stress O +
genes O +
was O +
at O +
least O +
partially O +
influenced O +
by O +
the O +
ctsR B-Gene +
deletion O +
. O +

Studies O +
with O +
different O +
clpC B-Gene +
promoter O +
fragments O +
either O +
fused O +
to O +
the O +
reporter O +
gene O +
bgaB B-Gene +
or O +
used O +
in O +
gel O +
mobility O +
shift O +
experiments O +
with O +
the O +
purified O +
CtsR B-Gene +
protein O +
revealed O +
a O +
possible O +
target O +
region O +
where O +
the O +
repressor O +
seemed O +
to O +
bind O +
in O +
vivo O +
and O +
in O +
vitro O +
. O +

Our O +
data O +
demonstrate O +
that O +
the O +
CtsR B-Gene +
protein O +
acts O +
as O +
a O +
global O +
repressor O +
of O +
the O +
clpC B-Gene +
operon O +
, O +
as O +
well O +
as O +
other O +
class O +
III O +
heat O +
shock O +
genes O +
, O +
by O +
preventing O +
unstressed O +
transcription O +
from O +
either O +
the O +
sigmaB B-Gene +
- O +
or O +
sigmaA B-Gene +
- O +
dependent O +
promoter O +
and O +
might O +
be O +
inactivated O +
or O +
dissociate O +
under O +
inducing O +
stress O +
conditions O +
. O +

Cloning O +
and O +
characterization O +
of O +
RLPK B-Gene +
, O +
a O +
novel O +
RSK B-Gene +
- O +
related O +
protein B-Gene +
kinase I-Gene +
. O +

A O +
novel O +
protein B-Gene +
kinase I-Gene +
whose O +
activity O +
can O +
be O +
stimulated O +
by O +
mitogen O +
in O +
vivo O +
was O +
cloned O +
and O +
characterized O +
. O +

The O +
cDNA O +
of O +
this O +
gene O +
encodes O +
an O +
802-amino O +
acid O +
protein O +
( O +
termed O +
RLPK B-Gene +
) O +
with O +
the O +
highest O +
homology O +
( O +
37 O +
% O +
identity O +
) O +
to O +
the O +
two O +
protein B-Gene +
kinase I-Gene +
families O +
, O +
p90 B-Gene +
( I-Gene +
RSK I-Gene +
) I-Gene +
and O +
p70 B-Gene +
( I-Gene +
RSK I-Gene +
) I-Gene +
. O +

Like O +
p90 B-Gene +
( I-Gene +
RSR I-Gene +
) I-Gene +
, O +
but O +
not O +
p70 B-Gene +
( I-Gene +
RSK I-Gene +
) I-Gene +
, O +
RLPK B-Gene +
also O +
contains O +
two O +
complete O +
nonidentical O +
protein B-Gene +
kinase I-Gene +
domains O +
. O +

RLPK B-Gene +
mRNA O +
is O +
widely O +
expressed O +
in O +
all O +
human O +
tissues O +
examined O +
and O +
is O +
enriched O +
in O +
the O +
brain O +
, O +
heart O +
, O +
and O +
placenta O +
. O +

In O +
HeLa O +
cells O +
, O +
transiently O +
expressed O +
epitope O +
- O +
tagged O +
RLPK B-Gene +
can O +
be O +
strongly O +
induced O +
by O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
, O +
serum O +
, O +
and O +
phorbol O +
12-myristate O +
13-acetate O +
, O +
but O +
only O +
moderately O +
up O +
- O +
regulated O +
by O +
tumor B-Gene +
necrosis I-Gene +
factor I-Gene +
- I-Gene +
alpha I-Gene +
and O +
other O +
stress O +
- O +
related O +
stimuli O +
. O +

The O +
activity O +
of O +
RLPK B-Gene +
stimulated O +
by O +
epidermal B-Gene +
growth I-Gene +
factor I-Gene +
was O +
not O +
inhibited O +
by O +
several O +
known O +
protein B-Gene +
kinase I-Gene +
C I-Gene +
inhibitors O +
nor O +
by O +
rapamycin O +
, O +
a O +
known O +
specific O +
inhibitor O +
for O +
p70 B-Gene +
( I-Gene +
RSK I-Gene +
) I-Gene +
, O +
but O +
could O +
be O +
inhibited O +
by O +
herbimycin O +
A O +
, O +
a O +
tyrosine B-Gene +
kinase I-Gene +
inhibitor O +
, O +
and O +
partially O +
inhibited O +
by O +
PD98059 O +
or O +
SB203580 O +
, O +
inhibitors O +
for O +
the O +
mitogen B-Gene +
- I-Gene +
activated I-Gene +
protein I-Gene +
kinase I-Gene +
pathways O +
. O +

Recombinant O +
RLPK B-Gene +
possesses O +
high O +
phosphorylation O +
activity O +
toward O +
histone B-Gene +
2B I-Gene +
and O +
the O +
S6 O +
peptide O +
, O +
RRRLSSLRA O +
. O +

Although O +
purified O +
recombinant O +
RLPK B-Gene +
can O +
be O +
phosphorylated O +
by O +
ERK2 B-Gene +
and O +
p38alpha B-Gene +
in O +
vitro O +
, O +
its O +
activity O +
is O +
not O +
affected O +
by O +
this O +
phosphorylation O +
. O +

Moreover O +
, O +
the O +
treatment O +
of O +
RLPK B-Gene +
with O +
acid B-Gene +
phosphatase I-Gene +
did O +
not O +
reduce O +
its O +
in O +
vitro O +
kinase B-Gene +
activity O +
. O +

These O +
data O +
suggest O +
that O +
RLPK B-Gene +
is O +
structurally O +
similar O +
to O +
previously O +
isolated O +
RSKs B-Gene +
, O +
but O +
its O +
regulatory O +
mechanism O +
may O +
be O +
distinct O +
from O +
either O +
p70 B-Gene +
( I-Gene +
RSK I-Gene +
) I-Gene +
or O +
p90 B-Gene -
( I-Gene -
RSK I-Gene -
) I-Gene -
s I-Gene +
. O +

Multiple O +
transcripts O +
of O +
the O +
killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptor I-Gene +
family I-Gene +
, O +
KIR3DL1 B-Gene +
( O +
NKB1 B-Gene +
) O +
, O +
are O +
expressed O +
by O +
natural O +
killer O +
cells O +
of O +
a O +
single O +
individual O +
. O +

Natural O +
killer O +
( O +
NK O +
) O +
cells O +
express O +
receptors O +
that O +
are O +
ligands O +
for O +
HLA B-Gene +
class I-Gene +
I I-Gene +
molecules O +
. O +

One O +
family O +
of O +
such O +
NK O +
receptors O +
are O +
called O +
killer B-Gene +
cell I-Gene +
immunoglobulin I-Gene +
- I-Gene +
like I-Gene +
receptors I-Gene +
( O +
KIR B-Gene +
) O +
. O +

The O +
KIR2DL B-Gene +
( O +
inhibiting O +
) O +
and O +
KIR2DS B-Gene +
( O +
activating O +
) O +
molecules O +
recognize O +
HLA B-Gene -
- I-Gene -
Cw I-Gene +
antigens O +
, O +
while O +
the O +
KIR3DL B-Gene +
( O +
inhibiting O +
) O +
and O +
KIR3DS B-Gene +
( O +
activating O +
) O +
molecules O +
interact O +
with O +
HLA B-Gene -
- I-Gene -
B I-Gene +
antigens O +
with O +
the O +
Bw4 B-Gene +
epitope O +
. O +

No O +
NK O +
receptors O +
have O +
yet O +
been O +
identified O +
for O +
HLA B-Gene -
- I-Gene -
B I-Gene +
antigens O +
with O +
the O +
Bw6 B-Gene +
epitope O +
. O +

We O +
here O +
report O +
four O +
novel O +
full O +
length O +
cDNA O +
transcripts O +
encoding O +
KIR3DL1 B-Gene +
- O +
like O +
proteins O +
isolated O +
from O +
mRNA O +
obtained O +
from O +
interleukin-2 B-Gene +
- O +
activated O +
peripheral O +
blood O +
mononuclear O +
cells O +
of O +
a O +
donor O +
with O +
two O +
HLA B-Gene -
- I-Gene -
B I-Gene +
antigens O +
expressing O +
the O +
Bw6 B-Gene +
epitope O +
. O +

These O +
four O +
transcripts O +
belong O +
to O +
a O +
group O +
of O +
closely O +
related O +
KIR3DL1 B-Gene +
- O +
like O +
molecules O +
initially O +
defined O +
by O +
the O +
cDNA O +
clone O +
NKB1 B-Gene +
. O +

They O +
differ O +
from O +
NKB1 B-Gene +
by O +
only O +
2 O +
to O +
7 O +
nucleotides O +
and O +
have O +
2 O +
to O +
4 O +
codon O +
changes O +
within O +
the O +
423 O +
residues O +
of O +
the O +
mature O +
protein O +
. O +

All O +
transcripts O +
were O +
detected O +
by O +
RT O +
- O +
PCR O +
, O +
together O +
with O +
the O +
previously O +
reported O +
KIR3DL1 B-Gene +
transcripts O +
, O +
NKB1 B-Gene +
and O +
KIR3DL1v B-Gene +
, O +
in O +
mRNA O +
from O +
NK O +
cells O +
of O +
10 O +
of O +
10 O +
donors O +
tested O +
, O +
and O +
in O +
seven O +
of O +
eight O +
NK O +
clones O +
derived O +
from O +
one O +
donor O +
. O +

Functionally O +
, O +
the O +
KIR3DL1 B-Gene +
receptors O +
expressed O +
by O +
five O +
DX9 O +
- O +
positive O +
NK O +
clones O +
were O +
not O +
inhibiting O +
NK O +
- O +
mediated O +
cytotoxicity O +
when O +
tested O +
against O +
the O +
721.221 O +
B O -
- O -
lymphoblastoid O +
cell O +
line O +
expressing O +
a O +
HLA B-Gene -
- I-Gene -
B I-Gene +
antigen O +
with O +
Bw4 B-Gene +
epitope O +
. O +

All O +
NK O +
clones O +
were O +
, O +
however O +
, O +
inhibited O +
by O +
721.221 O +
cells O +
transfected O +
with O +
a O +
HLA B-Gene -
- I-Gene -
B I-Gene +
antigen O +
carrying O +
the O +
Bw6 B-Gene +
epitope O +
. O +

A O +
four O +
- O +
dimensional O +
view O +
of O +
assembly O +
of O +
a O +
morphogenetic O +
protein O +
during O +
sporulation O +
in O +
Bacillus O +
subtilis O +
. O +

We O +
report O +
the O +
use O +
of O +
a O +
fusion O +
to O +
the O +
green B-Gene +
fluorescent I-Gene +
protein I-Gene +
to O +
visualize O +
the O +
assembly O +
of O +
the O +
morphogenetic O +
protein O +
SpoIVA B-Gene +
around O +
the O +
developing O +
forespore O +
during O +
the O +
process O +
of O +
sporulation O +
in O +
the O +
bacterium O +
Bacillus O +
subtilis O +
. O +

Using O +
a O +
deconvolution O +
algorithm O +
to O +
process O +
digitally O +
- O +
collected O +
optical O +
sections O +
, O +
we O +
show O +
that O +
SpoIVA B-Gene +
, O +
which O +
is O +
synthesized O +
in O +
the O +
mother O +
cell O +
chamber O +
of O +
the O +
sporangium O +
, O +
assembled O +
into O +
a O +
spherical O +
shell O +
around O +
the O +
outer O +
surface O +
of O +
the O +
forespore O +
. O +

Time O +
- O +
lapse O +
fluorescence O +
microscopy O +
showed O +
that O +
this O +
assembly O +
process O +
commenced O +
at O +
the O +
time O +
of O +
polar O +
division O +
and O +
seemed O +
to O +
continue O +
after O +
engulfment O +
of O +
the O +
forespore O +
was O +
complete O +
. O +

SpoIVA B-Gene +
remained O +
present O +
throughout O +
the O +
late O +
stages O +
of O +
morphogenesis O +
and O +
was O +
present O +
as O +
a O +
component O +
of O +
the O +
fully O +
mature O +
spore O +
. O +

Evidence O +
indicates O +
that O +
assembly O +
of O +
SpoIVA B-Gene +
depended O +
on O +
the O +
extreme O +
C O +
- O +
terminal O +
region O +
of O +
the O +
protein O +
and O +
an O +
additional O +
region O +
that O +
directly O +
or O +
indirectly O +
facilitated O +
interaction O +
among O +
SpoIVA B-Gene +
molecules O +
. O +

The O +
N O +
- O +
and O +
C O +
- O +
terminal O +
regions O +
of O +
SpoIVA B-Gene +
, O +
including O +
the O +
extreme O +
C O +
terminus O +
, O +
are O +
highly O +
similar O +
to O +
the O +
corresponding O +
regions O +
of O +
the O +
homologous O +
protein O +
from O +
the O +
distantly O +
related O +
endospore O +
- O +
forming O +
bacterium O +
Clostridium O +
acetobutylicum O +
, O +
attesting O +
to O +
their O +
importance O +
in O +
the O +
function O +
of O +
the O +
protein O +
. O +

Finally O +
, O +
we O +
show O +
that O +
proper O +
localization O +
of O +
SpoIVA B-Gene +
required O +
the O +
expression O +
of O +
one O +
or O +
more O +
genes O +
which O +
, O +
like O +
spoIVA B-Gene +
, O +
are O +
under O +
the O +
control O +
of O +
the O +
mother O +
cell O +
transcription B-Gene +
factor I-Gene +
sigmaE B-Gene +
. O +

One O +
such O +
gene O +
was O +
spoVM B-Gene +
, O +
whose O +
product O +
was O +
required O +
for O +
efficient O +
targeting O +
of O +
SpoIVA B-Gene +
to O +
the O +
outer O +
surface O +
of O +
the O +
forespore O +
. O +

